PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Melo-Gonzalez, F; Fenton, TM; Forss, C; Smedley, C; Goenka, A; MacDonald, AS; Thornton, DJ; Travis, MA				Melo-Gonzalez, Felipe; Fenton, Thomas M.; Forss, Cecilia; Smedley, Catherine; Goenka, Anu; MacDonald, Andrew S.; Thornton, David J.; Travis, Mark A.			Intestinal mucin activates human dendritic cells and IL-8 production in a glycan-specific manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dendritic cell; inflammation; intestine; mucin; mucosal immunology	MUCUS; EXPRESSION; INTERLEUKIN-8; TAK-242; CLONING; LAYER; COLON	Cross-talk between different components of the intestinal barrier and the immune system may be important in maintaining gut homeostasis. A crucial part of the gut barrier is the mucus layer, a cross-linked gel on top of the intestinal epithelium that consists predominantly of the mucin glycoprotein MUC2. However, whether the mucin layer actively regulates intestinal immune cell responses is not clear. Because recent evidence suggests that intestinal dendritic cells (DCs) may be regulated by the mucus layer, we purified intestinal mucin, incubated it with human DCs, and determined the functional effects. Here we show that expression of the chemokine IL-8 and co-stimulatory DC markers CD86 and CD83 are significantly up-regulated on human DCs in the presence of intestinal mucins. Additionally, mucin-exposed DCs promoted neutrophil migration in an IL-8-dependent manner. The stimulatory effects of mucins on DCs were not due to mucin sample contaminants such as lipopolysaccharide, DNA, or contaminant proteins. Instead, mucin glycans are important for the pro-inflammatory effects on DCs. Thus, intestinal mucins are capable of inducing important pro-inflammatory functions in DCs, which could be important in driving inflammatory responses upon intestinal barrier damage.	[Melo-Gonzalez, Felipe; Fenton, Thomas M.; Forss, Cecilia; Smedley, Catherine; Goenka, Anu; MacDonald, Andrew S.; Travis, Mark A.] Univ Manchester, Manchester Collaborat Ctr Inflammat Res, Manchester M13 9NT, Lancs, England; [Melo-Gonzalez, Felipe; Fenton, Thomas M.; Forss, Cecilia; Smedley, Catherine; Goenka, Anu; MacDonald, Andrew S.; Thornton, David J.; Travis, Mark A.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9NT, Lancs, England; [Melo-Gonzalez, Felipe; Fenton, Thomas M.; Smedley, Catherine; MacDonald, Andrew S.; Travis, Mark A.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Manchester Immunol Grp, Manchester M13 9NT, Lancs, England; [Fenton, Thomas M.] Tech Univ Denmark, Natl Vet Inst, Sect Immunol & Vaccinol, DK-1870 Frederiksberg C, Denmark	University of Manchester; University of Manchester; University of Manchester; Technical University of Denmark	Thornton, DJ (corresponding author), Univ Manchester, Fac Biol Med & Hlth, 4-016 AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.; Travis, MA (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Core Technol Facil 2 14b, Grafton St, Manchester M13 9NT, Lancs, England.	dave.thornton@manchester.ac.uk; mark.travis@manchester.ac.uk	Goenka, Anu/M-6700-2019; Travis, Mark/E-9643-2015	Goenka, Anu/0000-0002-8152-2155; Thornton, David/0000-0001-7148-1970; Melo-Gonzalez, Felipe/0000-0002-3711-2407; Fenton, Thomas/0000-0002-6200-6403; Travis, Mark/0000-0002-8485-2272	Wellcome Trust [203128/Z/16/Z]; Manchester Collaborative Centre for Inflammation Research; Medical Research Council; European Society of Paediatric Infectious Diseases; CONICYT Chile; Medical Research Council [MR/N001427/1]; MRC [MR/L011840/1, MR/N001427/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Manchester Collaborative Centre for Inflammation Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Society of Paediatric Infectious Diseases; CONICYT Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by core funding from the Wellcome Trust through Grant 203128/Z/16/Z (to the Wellcome Trust Centre for Cell-Matrix Research, University of Manchester), by core funding from the Manchester Collaborative Centre for Inflammation Research and the Medical Research Council (to M. A. T.), by a fellowship from the European Society of Paediatric Infectious Diseases and Medical Research Council Fellowship MR/N001427/1 (to A. G.), and by funds from CONICYT Chile (to F. M.-G.). The authors declare that they have no conflicts of interest with the contents of this article.	Alfaro C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017922; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Boltin D, 2013, J CLIN GASTROENTEROL, V47, P106, DOI 10.1097/MCG.0b013e3182688e73; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Bu XD, 2011, TISSUE CELL, V43, P201, DOI 10.1016/j.tice.2011.03.002; Cobo ER, 2015, MUCOSAL IMMUNOL, V8, P1360, DOI 10.1038/mi.2015.27; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Davies JR, 2012, METHODS MOL BIOL, V842, P27, DOI 10.1007/978-1-61779-513-8_2; Escande F, 2004, BBA-GENE STRUCT EXPR, V1676, P240, DOI 10.1016/j.bbaexp.2004.01.001; Fleck RA, 2005, CLIN DIAGN LAB IMMUN, V12, P19, DOI 10.1128/CDLI.12.1.19-27.2005; Hasnain SZ, 2010, GASTROENTEROLOGY, V138, P1763, DOI 10.1053/j.gastro.2010.01.045; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Hong JC, 2000, GLYCOCONJUGATE J, V17, P691, DOI 10.1023/A:1011014404707; Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; Ishida A, 2008, PROTEOMICS, V8, P3342, DOI 10.1002/pmic.200800039; Jacob C, 2002, INT IMMUNOPHARMACOL, V2, P1647, DOI 10.1016/S1567-5769(02)00141-8; Johansson MEV, 2016, NAT REV IMMUNOL, V16, P639, DOI 10.1038/nri.2016.88; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Kawamoto T, 2008, EUR J PHARMACOL, V584, P40, DOI 10.1016/j.ejphar.2008.01.026; Linden SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003952; MATSUSHIMA K, 1988, J EXP MED, V167, P1883, DOI 10.1084/jem.167.6.1883; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Millius A, 2009, METHODS MOL BIOL, V571, P167, DOI 10.1007/978-1-60761-198-1_11; Ohta M, 2010, BIOCHEM BIOPH RES CO, V402, P663, DOI 10.1016/j.bbrc.2010.10.079; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rousseau K, 2007, AM J PHYSIOL-LUNG C, V292, pL1396, DOI 10.1152/ajplung.00444.2006; Shan MM, 2013, SCIENCE, V342, P447, DOI 10.1126/science.1237910; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Thornton D J, 1994, Methods Mol Biol, V32, P119; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Van Klinken BJW, 1999, AM J PHYSIOL-GASTR L, V276, pG115, DOI 10.1152/ajpgi.1999.276.1.G115; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wenzel UA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130750; YOSHIMURA T, 1987, J IMMUNOL, V139, P788	35	17	19	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8543	8553		10.1074/jbc.M117.789305	http://dx.doi.org/10.1074/jbc.M117.789305			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29581231	Green Published, hybrid			2022-12-26	WOS:000434205700018
J	Guo, L; Yang, Z; Zhi, ST; Feng, Z; Lei, C; Zhou, Y				Guo, Lei; Yang, Zhen; Zhi, Shaotao; Feng, Zhu; Lei, Chong; Zhou, Yong			A sensitive and innovative detection method for rapid C-reactive proteins analysis based on a micro-fluxgate sensor system	PLOS ONE			English	Article							LABEL-FREE DETECTION; CRP DETECTION; IMMUNOASSAY; BIOSENSOR; CANCER; IMMUNOSENSOR; DIAGNOSIS; BIOMARKER; PLATFORM; DISEASE	A sensitive and innovative assay system based on a micro-MEMS-fluxgate sensor and immunomagnetic beads-labels was developed for the rapid analysis of C-reactive proteins (CRP). The fluxgate sensor presented in this study was fabricated through standard micro-electro-mechanical system technology. A multi-loop magnetic core made of Fe-based amorphous ribbon was employed as the sensing element, and 3-D solenoid copper coils were used to control the sensing core. Antibody-conjugated immunomagnetic microbeads were strategically utilized as signal tags to label the CRP via the specific conjugation of CRP to polyclonal CRP antibodies. Separate Au film substrates were applied as immunoplatforms to immobilize CRP-beads labels through classical sandwich assays. Detection and quantification of the CRP at different concentrations were implemented by detecting the stray field of CRP labeled magnetic beads using the newly-developed micro-fluxgate sensor. The resulting system exhibited the required sensitivity, stability, reproducibility, and selectivity. A detection limit as low as 0.002 mu g/mL CRP with a linearity range from 0.002 mu g/mL to 10 mu g/mL was achieved, and this suggested that the proposed biosystem possesses high sensitivity. In addition to the extremely low detection limit, the proposed method can be easily manipulated and possesses a quick response time. The response time of our sensor was less than 5 s, and the entire detection period for CRP analysis can be completed in less than 30 min using the current method. Given the detection performance and other advantages such as miniaturization, excellent stability and specificity, the proposed biosensor can be considered as a potential candidate for the rapid analysis of CRP, especially for point-of-care platforms.	[Guo, Lei; Zhi, Shaotao; Feng, Zhu; Lei, Chong; Zhou, Yong] Shanghai Jiao Tong Univ, Res Inst Micro Nano Sci & Technol, Minist Educ, Key Lab Thin Film & Microfahricat, Shanghai, Peoples R China; [Yang, Zhen] Xinyang Normal Univ, Sch Phys & Elect Engn, Xinyang, Peoples R China	Shanghai Jiao Tong University; Xinyang Normal University	Guo, L (corresponding author), Shanghai Jiao Tong Univ, Res Inst Micro Nano Sci & Technol, Minist Educ, Key Lab Thin Film & Microfahricat, Shanghai, Peoples R China.	g2252330@sjtu.edu.cn			National Natural Science Foundation of China [61273065]; National Science and Technology Support Program [2012BAK08B05]; Natural Science Foundation of Shanghai [13ZR1420800]; Shanghai Jiao Tong University [AgriX2015005]; Joint research center for advanced aerospace technology of Shanghai Academy of Spaceflight Technology-Shanghai Jiao Tong University [USCAST2015-2]; Natural Science Foundation of Henan Province [162300410233]; Support fund of aerospace technology [15GFZ-JJ02-05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Jiao Tong University; Joint research center for advanced aerospace technology of Shanghai Academy of Spaceflight Technology-Shanghai Jiao Tong University; Natural Science Foundation of Henan Province; Support fund of aerospace technology	This work is funded by The National Natural Science Foundation of China (No.61273065), National Science and Technology Support Program (2012BAK08B05), Natural Science Foundation of Shanghai (13ZR1420800), Support fund of Shanghai Jiao Tong University (AgriX2015005), Support fund of Joint research center for advanced aerospace technology of Shanghai Academy of Spaceflight Technology-Shanghai Jiao Tong University (USCAST2015-2), Natural Science Foundation of Henan Province (162300410233), Support fund of aerospace technology (15GFZ-JJ02-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MU, 2014, CRIT REV BIOTECHNOL, V34, P180, DOI 10.3109/07388551.2013.778228; Andersson PO, 2016, ANAL BIOANAL CHEM, V408, P3675, DOI 10.1007/s00216-016-9485-0; [Anonymous], 2014, IEEE T MAGN; Baschirotto A, 2006, SENSOR ACTUAT A-PHYS, V132, P90, DOI 10.1016/j.sna.2006.04.043; Bjerner J, 2005, CLIN CHEM, V51, P9, DOI 10.1373/clinchem.2004.042994; Bryan T, 2013, BIOSENS BIOELECTRON, V39, P94, DOI 10.1016/j.bios.2012.06.051; Fu S, 2017, IEEE INT C SOFTW ENG, P485; Funano S, 2015, ANALYST, V140, P1459, DOI 10.1039/c4an01781a; Guo L, 2017, SENSOR ACTUAT B-CHEM, V247, P1, DOI 10.1016/j.snb.2017.01.095; Gupta RK, 2014, BIOSENS BIOELECTRON, V59, P112, DOI 10.1016/j.bios.2014.03.027; Hu J, 2016, ANAL CHEM, V88, P6577, DOI 10.1021/acs.analchem.6b01427; Issadore D, 2014, LAB CHIP, V14, P2385, DOI 10.1039/c4lc00314d; Jebrail MJ, 2010, CURR OPIN CHEM BIOL, V14, P574, DOI 10.1016/j.cbpa.2010.06.187; Joung HA, 2014, BIOSENS BIOELECTRON, V53, P330, DOI 10.1016/j.bios.2013.10.004; Kokkinis G, 2017, SENSOR ACTUAT B-CHEM, V241, P438, DOI 10.1016/j.snb.2016.09.189; Lee J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172666; Lee SH, 2017, SENSOR ACTUAT B-CHEM, V246, P471, DOI 10.1016/j.snb.2017.01.188; Lei C, 2013, MICROSYST TECHNOL, V19, P591, DOI 10.1007/s00542-012-1669-8; Lei C, 2013, MICROSYST TECHNOL, V19, P167, DOI 10.1007/s00542-012-1523-z; Liu TZ, 2016, ANAL CHEM, V88, P12516, DOI 10.1021/acs.analchem.6b04191; Magnelind PE, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/4/044031; Makino A., 2008, MAT T, V50, P204; Meyer MHF, 2006, BIOSENS BIOELECTRON, V21, P1987, DOI 10.1016/j.bios.2005.09.010; Mirus JE, 2015, CLIN CANCER RES, V21, P1764, DOI 10.1158/1078-0432.CCR-13-3474; Nooney R, 2017, ANAL METHODS-UK, V9, P994, DOI 10.1039/c6ay03362h; Oh YK, 2013, LAB CHIP, V13, P768, DOI 10.1039/c2lc41016h; Okayasu I, 2014, J CLIN LAB ANAL, V28, P32, DOI 10.1002/jcla.21640; Pai JK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001395; Park J, 2017, SENSOR ACTUAT B-CHEM, V246, P1049, DOI 10.1016/j.snb.2017.02.150; Qian XB, 2005, IEEE T MAGN, V41, P3715, DOI 10.1109/TMAG.2005.854919; Reitz C, 2006, ALZHEIMERS DEMENT, V2, pS424; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Song KS, 2017, ANALYST, V142, P3816, DOI 10.1039/c7an01389b; Su HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102418; Sun XC, 2015, SENSOR ACTUAT B-CHEM, V221, P985, DOI 10.1016/j.snb.2015.07.040; Vermeeren V, 2011, SENSOR ACTUAT B-CHEM, V157, P130, DOI 10.1016/j.snb.2011.03.037; Violin JD, 2014, TRENDS PHARMACOL SCI, V35, P308, DOI 10.1016/j.tips.2014.04.007; Wei Gao, 2011, Proceedings of the 2011 IEEE International Conference on Mechatronics and Automation (ICMA 2011), P2386, DOI 10.1109/ICMA.2011.5986360; Wright EK, 2015, GASTROENTEROLOGY, V148, P938, DOI 10.1053/j.gastro.2015.01.026; Wu L, 2015, CHEM SOC REV, V44, P2963, DOI 10.1039/c4cs00370e; Yanbaeva DG, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-23; Yang Z, 2015, ANAL METHODS-UK, V7, P2391, DOI 10.1039/c4ay02727b; Zhang X, 2016, ANAL METHODS-UK, V8, P6202, DOI 10.1039/c6ay01464j	43	12	12	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0194631	10.1371/journal.pone.0194631	http://dx.doi.org/10.1371/journal.pone.0194631			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601593	Green Published, gold, Green Submitted			2022-12-26	WOS:000428845900007
J	Bordignon, DW; Caorsi, VZ; Colombo, P; Abadie, M; Brack, IV; Dasoler, BT; Borges-Martins, M				Bordignon, Debora Wolff; Caorsi, Valentina Zaffaroni; Colombo, Patrick; Abadie, Michelle; Brack, Ismael Verrastro; Dasoler, Bibiana Terra; Borges-Martins, Mario			Are the unken reflex and the aposematic colouration of Red-Bellied Toads efficient against bird predation?	PLOS ONE			English	Article							POISON FROG; MELANOPHRYNISCUS; BEHAVIOR; ANURA; CONSPICUOUSNESS; DIVERSITY; BUFONIDAE; ALKALOIDS; DEFENSES; SIGNALS	Aposematic signals as well as body behaviours may be important anti-predator defences. Species of the genus Melanophryniscus are characterised by having toxic lipophilic alkaloids in the skin and for presenting a red ventral colouration, which can be observed when they perform the behaviour called the unken reflex. Both the reflex behaviour and the colouration pattern are described as defence mechanisms. However, there are currently no studies testing their effectiveness against predators. This study aimed to test experimentally if both ventral conspicuous colouration and the unken reflex in Melanophryniscus cambaraensis function as aposematic signals against visually oriented predators (birds). We simulated the species studied using three different clay toad models as follows: (a) in a normal position with green coloured bodies, (b) in the unken reflex position with green coloured body and extremities and (c) in the unken reflex position with a green body and red extremities. Models were distributed on a known M. cambaraensis breeding site and in the adjacent forest. More than half of the attacks on the models were from birds; however, there was no preference for any model type. Thus, just the presence of the red colour associated with the motionless unken reflex position does not seem to prevent attacks from potential predators. It is possible that the effective aposematic signal in Melanophryniscus is achieved through the unken reflex movement together with the subsequent exhibition of the warning colouration and the secretion of toxins.	[Bordignon, Debora Wolff; Caorsi, Valentina Zaffaroni; Borges-Martins, Mario] Univ Fed Rio Grande do Sul, Programa Posgrad Biol Anim, Dept Zool, Inst Biociencias, Porto Alegre, RS, Brazil; [Colombo, Patrick] Fundacao Zoobot Rio Grande Sul, Museu Ciencias Nat, Porto Alegre, RS, Brazil; [Abadie, Michelle; Brack, Ismael Verrastro; Dasoler, Bibiana Terra] Univ Fed Rio Grande do Sul, Programa Posgrad Ecol, Inst Biociencias, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Bordignon, DW (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Biol Anim, Dept Zool, Inst Biociencias, Porto Alegre, RS, Brazil.	deborawbordignon@gmail.com	Caorsi, Valentina Zaffaroni/AAD-1093-2019; Bordignon, Debora Wolff/AAC-8975-2019; Colombo, Patrick/D-2989-2013; Borges-Martins, Marcio/I-3274-2012	Bordignon, Debora Wolff/0000-0002-7306-7025; Borges-Martins, Marcio/0000-0001-9328-5794; Dasoler de Oliveira, Bibiana Terra/0000-0001-7466-6719; Colombo, Patrick/0000-0003-3957-3255; Brack, Ismael/0000-0003-2988-9811; Zaffaroni-Caorsi, Valentina/0000-0003-4166-9600				Almeida-Santos Patricia, 2010, Herpetological Review, V41, P200; Andreone Franco, 2002, Herpetological Review, V33, P299; Angulo Ariadne, 2006, Herpetological Review, V37, P203; Backes A., 2005, Acta Bot. Bras., V19, P155, DOI 10.1590/S0102-33062005000100015; BAJGER J, 1980, HERPETOLOGICA, V36, P133; Bell WJ, 1984, CHEM ECOLOGY INSECTS; Blount JD, 2009, P ROY SOC B-BIOL SCI, V276, P871, DOI 10.1098/rspb.2008.1407; Bowmaker JK, 1997, VISION RES, V37, P2183, DOI 10.1016/S0042-6989(97)00026-6; Braun PC., 1979, SERIE ZOOLOGIA, V54, P7; BRODIE ED, 1977, COPEIA, P523, DOI 10.2307/1443271; BRODIE ED, 1993, EVOLUTION, V47, P227, DOI 10.1111/j.1558-5646.1993.tb01212.x; Brusquetti Francisco, 2007, Check List, V3, P141; Caorsi Valentina Zaffaroni, 2014, Herpetology Notes, V7, P585; Caorsi Valentina Zaffaroni, 2012, South American Journal of Herpetology, V7, P79; Caorsi VZ, 2014, ESTUDO TAXONOMICO FI; Caro T, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0344; Carretero Miguel A., 2011, Herpetology Notes, V4, P67; Comeault AA, 2011, J EVOLUTION BIOL, V24, P1374, DOI 10.1111/j.1420-9101.2011.02258.x; Cott H.B., 1940, ADAPTIVE COLORATION; Cuthill Innes C., 2006, P3; Daly JW, 2007, J CHEM ECOL, V33, P871, DOI 10.1007/s10886-007-9261-x; Daly JW, 2005, J NAT PROD, V68, P1556, DOI 10.1021/np0580560; DALY JW, 1992, TOXICON, V30, P887, DOI 10.1016/0041-0101(92)90387-K; Darst CR, 2006, P NATL ACAD SCI USA, V103, P5852, DOI 10.1073/pnas.0600625103; Das Indraneil, 2004, Herpetological Review, V35, P373; Di-Bernardo M, 2006, J HERPETOL, V40, P261, DOI 10.1670/05-008.1; Duong Le Thi Thuy, 2010, Herpetological Review, V41, P342; Edmunds M., 1974, DEFENCE ANIMALS; Endler JA, 2004, AM NAT, V163, P532, DOI 10.1086/382662; Fernandez K, 1927, BOLET N ACAD NACL CI, V29, P271; FIRSCHEIN IL, 1951, COPEIA, P74; Forsman A, 2004, BEHAV ECOL, V15, P141, DOI 10.1093/beheco/arg092; Frost D.R., 2017, AMPHIBIAN SPECIES WO; GARCIA PCA, 2003, LIVRO VERMELHO FAUNA, P147; Greenbaum Eli, 2012, Herpetological Review, V43, P320; Griffiths RA, 1996, NEWTS SALAMANDERS EU; Haberl Werner, 1997, British Herpetological Society Bulletin, V61, P16; Hegna RH, 2013, EVOL ECOL, V27, P831, DOI 10.1007/s10682-012-9605-z; Hegna RH, 2011, ANN ZOOL FENN, V48, P29, DOI 10.5735/086.048.0103; HINSCHE GEORG, 1926, BIOL ZENTRALBL, V46, P296; Jablonski D, 2009, ZIVA, V57, P228; Jablonski Daniel, 2014, Herpetology Notes, V7, P141; Jeckel AM, 2015, J CHEM ECOL, V41, P505, DOI 10.1007/s10886-015-0578-6; JOHNSON JA, 1975, AM MIDL NAT, V93, P139, DOI 10.2307/2424112; Kuchta SR, 2005, COPEIA, P265, DOI 10.1643/CH-04-173R; Kwet Axel, 2005, Salamandra, V41, P3; Lanza B., 1966, ETHOLOGY, V23, P855; Lindstedt C, 2008, ANIM BEHAV, V75, P1703, DOI 10.1016/j.anbehav.2007.10.024; Maan ME, 2012, AM NAT, V179, pE1, DOI 10.1086/663197; MADSEN T, 1987, OIKOS, V48, P265, DOI 10.2307/3565512; Maluf J.R.T., 2000, REV BRASILEIRA AGROM, V8, P141, DOI DOI 10.5902/198050981940; Mappes J, 2005, TRENDS ECOL EVOL, V20, P598, DOI 10.1016/j.tree.2005.07.011; Marco Adolfo, 2001, Revista Espanola de Herpetologia, V15, P5; Master TL, 1999, WILSON BULL, V111, P439; Mcelroy MT, 2016, BIOL J LINN SOC, V117, P285, DOI 10.1111/bij.12669; Means D. Bruce, 2004, Herpetological Review, V35, P163; Mebs D, 2005, TOXICON, V46, P641, DOI 10.1016/j.toxicon.2005.07.004; Ministerio do Meio Ambiente-MMA, 2014, DIARIO OFICIAL UNIAO, V126, P121; Noonan BP, 2009, BIOL LETTERS, V5, P51, DOI 10.1098/rsbl.2008.0586; Paluh DJ, 2015, COPEIA, V103, P58, DOI 10.1643/CE-13-126; Paluh DJ, 2014, J HERPETOL, V48, P249, DOI 10.1670/13-027; Poulton E., 1890, COLOUR ANIMALS, P360; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Santos RR, 2011, EVOL ECOL, V25, P249, DOI 10.1007/s10682-010-9407-0; Santos RR, 2010, J TROP ECOL, V26, P415, DOI 10.1017/S0266467410000180; Saporito RA, 2007, COPEIA, P1006, DOI 10.1643/0045-8511(2007)7[1006:EEFAIT]2.0.CO;2; Schluepmann Martin, 2000, Zeitschrift fuer Feldherpetologie, V7, P29; Skelhorn J, 2016, ANIM BEHAV, V113, pE1, DOI 10.1016/j.anbehav.2015.07.021; SMITH SM, 1976, BEHAVIOUR, V56, P309, DOI 10.1163/156853976X00082; SMITH SM, 1973, BEHAVIOUR, V44, P113, DOI 10.1163/156853973X00355; Sonego Rubia Cristina, 2007, Acta Bot. Bras., V21, P943, DOI 10.1590/S0102-33062007000400019; Streicher Jeffrey W., 2011, Herpetological Review, V42, P590; Toledo LF, 2011, ETHOL ECOL EVOL, V23, P1, DOI 10.1080/03949370.2010.534321; Umbers KDL, 2016, ANIM BEHAV, V113, pE5, DOI 10.1016/j.anbehav.2016.01.002; Utzeri Carlo, 2005, Herpetozoa, V18, P182; Vander Wall SB, 1998, ECOLOGY, V79, P233, DOI 10.2307/176878; Williams CR, 2000, J HERPETOL, V34, P431, DOI 10.2307/1565367; Zank C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094625	78	8	9	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0193551	10.1371/journal.pone.0193551	http://dx.doi.org/10.1371/journal.pone.0193551			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596437	Green Published, gold, Green Submitted			2022-12-26	WOS:000428630000010
J	Teixeira, MA; Sela, N; Atamian, HS; Bao, E; Chaudhary, R; MacWilliams, J; He, JM; Mantelin, S; Girke, T; Kaloshian, I				Teixeira, Marcella A.; Sela, Noa; Atamian, Hagop S.; Bao, Ergude; Chaudhary, Ritu; MacWilliams, Jacob; He, Jiangman; Mantelin, Sophie; Girke, Thomas; Kaloshian, Isgouhi			Sequence analysis of the potato aphid Macrosiphum euphorbiae transcriptome identified two new viruses	PLOS ONE			English	Article							NEMATODE-RESISTANCE GENE; TOMATO; MI; EXPRESSION; EFFECTORS	The potato aphid, Macrosiphum euphorbiae, is an important agricultural pest that causes economic losses to potato and tomato production. To establish the transcriptome for this aphid, RNA-Seq libraries constructed from aphids maintained on tomato plants were used in Illumina sequencing generating 52.6 million 75-105 bp paired-end reads. The reads were assembled using Velvet/Oases software with SEED preprocessing resulting in 22,137 contigs with an N50 value of 2,003bp. After removal of contigs from tomato host origin, 20,254 contigs were annotated using BLASTx searches against the non-redundant protein database from the National Center for Biotechnology Information (NCBI) as well as IntereProS-can. This identified matches for 74% of the potato aphid contigs. The highest ranking hits for over 12,700 contigs were against the related pea aphid, Acyrthosiphon pisum. Gene Ontology (GO) was used to classify the identified M. euphorbiae contigs into biological process, cellular component and molecular function. Among the contigs, sequences of microbial origin were identified. Sixty five contigs were from the aphid bacterial obligate endosymbiont Buchnera aphidicola origin and two contigs had amino acid similarities to viruses. The latter two were named Macrosiphum euphorbiae virus 2 (MeV-2) and Macrosiphum euphorbiae virus 3 (MeV-3). The highest sequence identity to MeV-2 had the Dysaphis plantaginea densovirus, while to MeV-3 is the Hubei sobemo-like virus 49. Characterization of MeV-2 and MeV-3 indicated that both are transmitted vertically from adult aphids to nymphs. MeV-2 peptides were detected in the aphid saliva and only MeV-2 and not MeV-3 nucleic acids were detected inside tomato leaves exposed to virus-infected aphids. However, MeV-2 nucleic acids did not persist in tomato leaf tissues, after clearing the plants from aphids, indicating that MeV-2 is likely an aphid virus.	[Teixeira, Marcella A.; Atamian, Hagop S.; Chaudhary, Ritu; MacWilliams, Jacob; He, Jiangman; Mantelin, Sophie; Kaloshian, Isgouhi] Univ Calif Riverside, Dept Nematol, Riverside, CA 92521 USA; [Sela, Noa] Volcani Ctr, Dept Plant Pathol & Weed Res, Bet Dagan, Israel; [Bao, Ergude] Univ Calif Riverside, Grad Program Comp Sci & Engn, Riverside, CA 92521 USA; [Girke, Thomas] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Girke, Thomas; Kaloshian, Isgouhi] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Kaloshian, Isgouhi] Univ Calif Riverside, Ctr Infect Dis Vector Res, Riverside, CA 92521 USA; [Teixeira, Marcella A.] Minist Agr Livestock & Food Supply, Brasilia, DF, Brazil; [Atamian, Hagop S.] Chapman Univ, Schmid Coll Sci & Technol, Orange, CA USA; [Bao, Ergude] Beijing Jiaotong Univ, Sch Software Engn, Beijing, Peoples R China; [Chaudhary, Ritu] NIH, Bldg 10, Bethesda, MD 20892 USA; [Mantelin, Sophie] James Hutton Inst, Cell & Mol Sci, Dundee, Scotland	University of California System; University of California Riverside; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; Chapman University System; Chapman University; Beijing Jiaotong University; National Institutes of Health (NIH) - USA; James Hutton Institute	Kaloshian, I (corresponding author), Univ Calif Riverside, Dept Nematol, Riverside, CA 92521 USA.; Kaloshian, I (corresponding author), Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.; Kaloshian, I (corresponding author), Univ Calif Riverside, Ctr Infect Dis Vector Res, Riverside, CA 92521 USA.	isgouhi.kaloshian@ucr.edu	Atamian, Hagop S/H-5595-2019; Sela, Noa/C-5133-2008	Sela, Noa/0000-0002-8282-215X; Girke, Thomas/0000-0003-0710-3777; Kaloshian, Isgouhi/0000-0002-9873-2810	NIH HHS [S10 OD016290] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016290] Funding Source: NIH RePORTER	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Agunbiade TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079929; Atamian HS, 2013, MOL PLANT MICROBE IN, V26, P67, DOI 10.1094/MPMI-06-12-0144-FI; Atamian Hagop S, 2012, Methods Mol Biol, V883, P47, DOI 10.1007/978-1-61779-839-9_3; Bao E, 2011, BIOINFORMATICS, V27, P2502, DOI 10.1093/bioinformatics/btr447; Bhattarai KK, 2007, MOL PLANT MICROBE IN, V20, P276, DOI 10.1094/MPMI-20-3-0276; Bhattarai KK, 2010, PLANT J, V63, P229, DOI 10.1111/j.1365-313X.2010.04232.x; Blackman R.L., 2000, J ECON ENTOMOL, V2; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Braendle C, 2006, HEREDITY, V97, P192, DOI 10.1038/sj.hdy.6800863; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Carolan JC, 2011, J PROTEOME RES, V10, P1505, DOI 10.1021/pr100881q; Chaudhary R, 2015, J PROTEOME RES, V14, P1762, DOI 10.1021/pr501128k; Chaudhary R, 2014, P NATL ACAD SCI USA, V111, P8919, DOI 10.1073/pnas.1407687111; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dedryver CA, 2010, CR BIOL, V333, P539, DOI 10.1016/j.crvi.2010.03.009; Elzinga DA, 2014, MOL PLANT MICROBE IN, V27, P747, DOI 10.1094/MPMI-01-14-0018-R; Hebert SL, 2007, ENVIRON ENTOMOL, V36, P458, DOI 10.1603/0046-225X(2007)36[458:QDIAVA]2.0.CO;2; Kaloshian I, 1997, ENTOMOL EXP APPL, V83, P181, DOI 10.1023/A:1002923104371; KALOSHIAN I, 1995, P NATL ACAD SCI USA, V92, P622, DOI 10.1073/pnas.92.2.622; Kaloshian I, 2016, J INTEGR PLANT BIOL, V58, P350, DOI 10.1111/jipb.12438; Katis NI, 2007, APHIDS AS CROP PESTS, P353, DOI 10.1079/9780851998190.0353; Kettles GJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01142; Leonardo TE, 2003, P ROY SOC B-BIOL SCI, V270, pS209, DOI 10.1098/rsbl.2003.0064; Li C, 2015, ELIFE, V4, DOI [10.7554/eLife.06587, 10.1155/2015/757269]; Liu S, 2016, VIRUSES, V8; Liu S., 2015, J SPECTROSC, V2015, P8; Liu SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045161; Liu SJ, 2011, VIRUSES-BASEL, V3, P1849, DOI 10.3390/v3101849; Mathers TC, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1145-3; Nault LR, 1997, ANN ENTOMOL SOC AM, V90, P521, DOI 10.1093/aesa/90.5.521; Nicholson SJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1525-1; Radcliffe EB, 2002, AM J POTATO RES, V79, P353, DOI 10.1007/BF02870173; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Roossinck MJ, 2012, ANNU REV GENET, V46, P359, DOI 10.1146/annurev-genet-110711-155600; Rossi M, 1998, P NATL ACAD SCI USA, V95, P9750, DOI 10.1073/pnas.95.17.9750; Ryabov EV, 2009, P NATL ACAD SCI USA, V106, P8465, DOI 10.1073/pnas.0901389106; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; TATTERSALL P, 2005, VIRUS TAXONOMY, P353; Teixeira M, 2016, J GEN VIROL, V97, P1261, DOI 10.1099/jgv.0.000414; Thorpe P, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2496-6; van Munster M, 2003, J INVERTEBR PATHOL, V84, P6, DOI 10.1016/S0022-2011(03)00013-2; Von Dohlen CD, 2003, ANN ENTOMOL SOC AM, V96, P107, DOI 10.1603/0013-8746(2003)096[0107:PAHBON]2.0.CO;2; Webster CL, 2016, EVOL BIOINFORM, V12, P13, DOI 10.4137/EBO.S39454; Wenger J.A., 2017, INSECT BIOCH MOL BIO; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16092-z; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2	49	6	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0193239	10.1371/journal.pone.0193239	http://dx.doi.org/10.1371/journal.pone.0193239			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596449	gold, Green Published			2022-12-26	WOS:000428630000007
J	Wolff, H; Bode, HB				Wolff, Hendrik; Bode, Helge B.			The benzodiazepine-like natural product tilivalline is produced by the entomopathogenic bacterium Xenorhabdus eapokensis	PLOS ONE			English	Article							KLEBSIELLA-OXYTOCA; PROLINE DEHYDROGENASE; PHOTORHABDUS; SIBIROMYCIN; TOMAYMYCIN; BIOSYNTHESIS; ANTHRAMYCIN; MICROBIOTA; MODELS	The pyrrolobenzodiazepine tilivalline (1) was originally identified in the human gut pathobiont Klebsiella oxytoca, the causative agent of antibiotic-associated hemorrhagic colitis. Here we show the identification of tilivalline and analogs thereof in the entomopathogenic bacterium Xenorhabdus eapokensis as well as the identification of its biosynthesis gene cluster encoding a bimodular non-ribosomal peptide synthetase. Heterologous expression of both genes in E. coli resulted in the production of 1 and from mutasynthesis and precursor directed biosynthesis 11 new tilivalline analogs were identified in X. eapokensis. These results allowed the prediction of the tilivalline biosynthesis being similar to that in K. oxytoca.	[Wolff, Hendrik; Bode, Helge B.] Goethe Univ Frankfurt, Mol Biotechnol, Fachbereich Biowissensch, Frankfurt, Germany; [Bode, Helge B.] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci BMLS, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Bode, HB (corresponding author), Goethe Univ Frankfurt, Mol Biotechnol, Fachbereich Biowissensch, Frankfurt, Germany.; Bode, HB (corresponding author), Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci BMLS, Frankfurt, Germany.	h.bode@bio.uni-frankfurt.de	Bode, Helge B/F-7022-2014	Bode, Helge B/0000-0001-6048-5909				ARIMA K, 1972, J ANTIBIOT, V25, P437, DOI 10.7164/antibiotics.25.437; Beaugerie L, 2003, CLIN GASTROENTEROL H, V1, P370, DOI 10.1053/S1542-3565(03)00183-6; Bode HB, 2009, CURR OPIN CHEM BIOL, V13, P224, DOI 10.1016/j.cbpa.2009.02.037; Bozhuyuk KAJ, 2017, CURR TOP MICROBIOL, V402, P55, DOI 10.1007/82_2016_24; BRAZHNIKOVA MG, 1972, J ANTIBIOT, V25, P668, DOI 10.7164/antibiotics.25.668; Challinor VL, 2015, ANN NY ACAD SCI, V1354, P82, DOI 10.1111/nyas.12954; Chaston JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027909; Chow J, 2011, CURR OPIN IMMUNOL, V23, P473, DOI 10.1016/j.coi.2011.07.010; Ciche TA, 2003, APPL ENVIRON MICROB, V69, P1890, DOI 10.1128/AEM.69.4.1890-1897.2003; Darby A, 2014, PLOONE PUBLIC LIB, V9; Dornisch E, 2017, ANGEW CHEM INT EDIT, P1; Duncan KR, 2015, CHEM BIOL, V22, P460, DOI 10.1016/j.chembiol.2015.03.010; Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47; FRANZA T, 1991, J BACTERIOL, V173, P6874, DOI 10.1128/jb.173.21.6874-6881.1991; Gerratana B, 2012, MED RES REV, V32, P254, DOI 10.1002/med.20212; Gietz RD, 2007, NAT PROTOC, V2, P1, DOI 10.1038/nprot.2007.17; Goodrich-Blair H, 2007, MOL MICROBIOL, V64, P260, DOI 10.1111/j.1365-2958.2007.05671.x; Haslinger K, 2015, NATURE, V521, P105, DOI 10.1038/nature14141; Herbert EE, 2007, NAT REV MICROBIOL, V5, P634, DOI 10.1038/nrmicro1706; Hogenauer C, 2006, NEW ENGL J MED, V355, P2418, DOI 10.1056/NEJMoa054765; Hu Y, 2007, CHEM BIOL, V14, P691, DOI 10.1016/j.chembiol.2007.05.009; HURLEY LH, 1977, J ANTIBIOT, V30, P349, DOI 10.7164/antibiotics.30.349; Jackson PJM, 2014, ACS CHEM BIOL, V9, P2432, DOI 10.1021/cb5002203; Kampfer P, 2017, INT J SYST EVOL MICR, V67, P1107, DOI 10.1099/ijsem.0.001770; KOPKA ML, 1994, BIOCHEMISTRY-US, V33, P13593, DOI 10.1021/bi00250a011; LEIMGRUBER W, 1965, J AM CHEM SOC, V87, P5791, DOI 10.1021/ja00952a050; Li W, 2009, APPL ENVIRON MICROB, V75, P2958, DOI 10.1128/AEM.02325-08; Li W, 2009, APPL ENVIRON MICROB, V75, P2869, DOI 10.1128/AEM.02326-08; LING MF, 1994, J MOL BIOL, V243, P950, DOI 10.1006/jmbi.1994.1696; Marahiel MA, 2009, J PEPT SCI, V15, P799, DOI 10.1002/psc.1183; MOHR N, 1982, TETRAHEDRON, V38, P147, DOI 10.1016/0040-4020(82)85058-8; Mohr N, 1981, LIEBIGS ANN CHEM, V1981, P1515; Nagasaka T, 1998, J ORG CHEM, V63, P6797, DOI 10.1021/jo972158g; Richards GR, 2010, APPL ENVIRON MICROB, V76, P221, DOI 10.1128/AEM.01715-09; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Satomura T, 2002, J BIOL CHEM, V277, P12861, DOI 10.1074/jbc.M112272200; Schimming O., 2015, ANGEW CHEM, V127, P12893; Schneditz G, 2014, P NATL ACAD SCI USA, V111, P13181, DOI 10.1073/pnas.1403274111; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi Y-M, 2018, NAT PROD REP ROYAL S, P1; Somvanshi VS, 2006, SYST APPL MICROBIOL, V29, P519, DOI 10.1016/j.syapm.2006.01.004; Sutherland MSK, 2013, BLOOD, V122, P1455, DOI 10.1182/blood-2013-03-491506; TENDLER MD, 1963, NATURE, V199, P501, DOI 10.1038/199501a0; Tercel M, 2003, J MED CHEM, V46, P2132, DOI 10.1021/jm020526p; Tobias NJ, 2017, NAT MICROBIOL, V2, P1676, DOI 10.1038/s41564-017-0039-9; TOZUKA Z, 1983, J ANTIBIOT, V36, P142, DOI 10.7164/antibiotics.36.142; Tse H, 2017, J BIOL CHEM AM SOC B, V292; Tsunematsu Y, 2013, NAT PROD REP, V30, P1139, DOI 10.1039/c3np70037b; vonTesmar A, 2017, CELL CHEM BIOL; vonTesmar A, 2018, ACS CHEM BIOL; Wang MX, 2016, NAT BIOTECHNOL, V34, P828, DOI 10.1038/nbt.3597; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Yonemoto IT, 2012, ACS CHEM BIOL, V7, P973, DOI 10.1021/cb200544u; Zhang XS, 2015, J AM CHEM SOC, V137, P1388, DOI 10.1021/ja5103986; Zollner-Schwetz I, 2015, DIGEST DIS SCI, V60, P3393, DOI 10.1007/s10620-015-3765-y	55	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194297	10.1371/journal.pone.0194297	http://dx.doi.org/10.1371/journal.pone.0194297			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596433	Green Published, Green Submitted, gold			2022-12-26	WOS:000428630000021
J	Kaur, A; Kapil, A; Elangovan, R; Jha, S; Kalyanasundaram, D				Kaur, Avinash; Kapil, Arti; Elangovan, Ravikrishnan; Jha, Sandeep; Kalyanasundaram, Dinesh			Highly-sensitive detection of Salmonella typhi in clinical blood samples by magnetic nanoparticle-based enrichment and in-situ measurement of isothermal amplification of nucleic acids	PLOS ONE			English	Article							IMMUNOMAGNETIC SEPARATION; RAPID DETECTION; DIAGNOSIS; CULTURE; FEVER; FOODS; ASSAY; DNA	Enteric fever continues to be a major cause of mortality and morbidity globally, particularly in poor resource settings. Lack of rapid diagnostic assays is a major driving factor for the empirical treatment of enteric fever. In this work, a rapid and sensitive method 'Miod 'has been developed. Miod includes a magnetic nanoparticle-based enrichment of target bacterial cells, followed by cell lysis and loop-mediated isothermal amplification (LAMP) of nucleic acids for signal augmentation along with concurrent measurement of signal via an in situ optical detection system. To identify positive/negative enteric fever infections in clinical blood samples, the samples were processed using Miod at time = 0 hours and time = 4 hours post-incubation in blood culture media. Primers specific for the STY2879 gene were used to amplify the nucleic acids isolated from S. typhicells. A limit of detection of 5 CFU/mL was achieved. No cross-reactivity of the primers were observed against 106 CFU/mL of common pathogenic bacterial species found in blood such as E. coli, P. aeruginosa, S. aureus, A. baumanni, E. faecalis, S. Paratyphi A and K. pneumonia. Miod was tested on 28 human clinical blood samples. The detection of both pre- and post-four-hours incubation confirmed the presence of viable S. typhicells and allowed clinical correlation of infection. The positive and negative samples were successfully detected in less than 6 hours with 100% sensitivity and specificity.	[Kaur, Avinash; Jha, Sandeep; Kalyanasundaram, Dinesh] Indian Inst Technol Delhi, Ctr Biomed Engn, New Delhi, India; [Kapil, Arti] All India Inst Med Sci, Dept Microbiol, New Delhi, India; [Elangovan, Ravikrishnan] Indian Inst Technol Delhi, Dept Biochem Engn & Biotechnol, New Delhi, India; [Jha, Sandeep; Kalyanasundaram, Dinesh] All India Inst Med Sci, Dept Biomed Engn, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Kalyanasundaram, D (corresponding author), Indian Inst Technol Delhi, Ctr Biomed Engn, New Delhi, India.; Kalyanasundaram, D (corresponding author), All India Inst Med Sci, Dept Biomed Engn, New Delhi, India.	dineshk@cbme.iitc.ac.in	Kalyanasundaram, Dinesh/AAE-8420-2019; Kalyanasundaram, Dinesh/AAY-7593-2021	Kalyanasundaram, Dinesh/0000-0001-5127-4122; Kaur, Avinash/0000-0003-2667-8146	Naval research board [NRB/4003/PG/359]; Department of Science and Technology [YSS/2014/000880]; Indo-German Science and Technology	Naval research board; Department of Science and Technology(Department of Science & Technology (India)); Indo-German Science and Technology	The funding agencies are: Naval research board (NRB/4003/PG/359); Department of Science and Technology (YSS/2014/000880); Indo-German Science and Technology (IGSTC/Call 2014/Sound4All/24/2015-16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah J, 2014, BRAZ J MICROBIOL, V45, P1385, DOI 10.1590/S1517-83822014000400032; Alba S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155286; Baron EJ, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1; Bhutta ZA, 2006, BMJ-BRIT MED J, V333, P78, DOI 10.1136/bmj.333.7558.78; Bozorgmehr A, 2016, J NANOPART RES, V18, DOI 10.1007/s11051-016-3657-x; Carter C, 2017, J VIROL METHODS, V244, P32, DOI 10.1016/j.jviromet.2017.02.013; Crichton PB, 1996, MACKIE MCCARTNEY PRA, V14, P361; CUDJOE KS, 1995, INT J FOOD MICROBIOL, V27, P11, DOI 10.1016/0168-1605(94)00134-R; da Silva FRC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162345; Dahiya S, 2017, INDIAN J MED MICROBI, V35, P61, DOI [10.4103/ijmm.IJMM_16_382, 10.4103/ijmm.ijmm_16_382]; Darton TC, 2017, J INFECTION, V74, P358, DOI 10.1016/j.jinf.2017.01.006; Dutta S., 2014, PLOS ONE, V9; Hejazian M, 2015, LAB CHIP, V15, P959, DOI 10.1039/c4lc01422g; Kang JH, 2015, SMALL, V11, P5657, DOI 10.1002/smll.201501820; Kim J, 2011, BIOANALYSIS, V3, P227, DOI 10.4155/BIO.10.172; Kivlehan F, 2011, ANALYST, V136, P3635, DOI 10.1039/c1an15289k; Kokkinos PA, 2014, FOOD ANAL METHOD, V7, P512, DOI 10.1007/s12161-013-9748-8; Kumar S, 2005, WORLD J MICROB BIOT, V21, P625, DOI 10.1007/s11274-004-3553-x; Lee D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122922; Liu YC, 2001, SENSOR ACTUAT B-CHEM, V72, P214, DOI 10.1016/S0925-4005(00)00663-8; Maan S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163014; Mancini N, 2010, CLIN MICROBIOL REV, V23, P235, DOI 10.1128/CMR.00043-09; Martiny D, 2013, CLIN MICROBIOL INFEC, V19, pE568, DOI 10.1111/1469-0691.12282; Mogasale V, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0147-z; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Notomi T, 2015, J MICROBIOL, V53, P1, DOI 10.1007/s12275-015-4656-9; Paolucci M, 2010, INT J ANTIMICROB AG, V36, pS6, DOI 10.1016/j.ijantimicag.2010.11.010; Parry CM, 2011, EXPERT REV ANTI-INFE, V9, P711, DOI [10.1586/eri.11.47, 10.1586/ERI.11.47]; Perera RS, 2017, PLOS ONE, P12; Phumkhachorn P, 2017, EMIR J FOOD AGR, V29, P1; Ranjbar R, 2017, IRAN J PUBLIC HEALTH, V46, P103; Ravan H, 2013, ANAL BIOCHEM, V439, P102, DOI 10.1016/j.ab.2013.04.014; Singh J, 2015, ANAL METHODS-UK, V7, P9281, DOI [10.1039/C5AY02271A, 10.1039/c5ay02271a]; Singh S, 2016, ANALYST, V141, P3358, DOI [10.1039/C6AN00291A, 10.1039/c6an00291a]; Toley BJ, 2015, ANALYST, V140, P7540, DOI 10.1039/c5an01632k; WHO, 2015, INT PHARM, P1; Yan L, 2014, MOL BIOSYST, V10, P970, DOI 10.1039/c3mb70304e; Yin Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115120	38	11	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194817	10.1371/journal.pone.0194817	http://dx.doi.org/10.1371/journal.pone.0194817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590194	Green Submitted, gold, Green Published			2022-12-26	WOS:000428603100076
J	Kumbhar, BV; Panda, D; Kunwar, A				Kumbhar, Bajarang Vasant; Panda, Dulal; Kunwar, Ambarish			Interaction of microtubule depolymerizing agent indanocine with different human alpha beta tubulin isotypes	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; CANCER-CELLS; EXPRESSION; BINDING; COLCHICINE; SIMULATIONS; RESISTANCE; CARCINOMA; APOPTOSIS; SITE	Tubulin isotypes are known to regulate the stability and dynamics of microtubules, and are also involved in the development of resistance against microtubule-targeted cancer drugs. Indanocine, a potent microtubule depolymerizing agent, is highly active against multidrug-resistant (MDR) cancer cells without affecting normal cells. It is known to disrupt microtubule dynamics in cells and induce apoptotic cell death. Indanocine is reported to bind to tubulin at the colchicine site i.e. at the interface of alpha beta tubulin heterodimer. However, it's precise binding mode, involved molecular interactions and the binding affinities with different alpha beta-tubulin isotypes present in MDR cells are not well understood. Here, the binding affinities of human alpha beta-tubulin isotypes with indanocine were examined, employing the molecular modeling approach i.e. docking, molecular dynamics simulation and binding energy calculations. Multiple sequence analysis suggests that the amino acid sequences are different in the indanocine binding pockets of beta I,beta IIa, beta III and beta VI isotypes. However, such differences are not observed in the amino acid sequences of beta IVa, beta IVb, and beta V tubulin isotypes at indanocine binding pockets. Docking and molecular dynamics simulation results show that indanocine prefers the interface binding pocket of alpha beta IIa, alpha beta III, alpha beta IVb, alpha beta V, and alpha beta VI tubulin isotypes; whereas it is expelled from the interface binding pocket of alpha beta IVa and alpha beta I-tubulin isotypes. Further, binding free energy calculations show that alpha beta VI has the highest binding affinity and alpha beta I has the lowest binding affinity for indanocine among all beta-tubulin isotypes. The binding free energy decreases in the order of alpha beta VI > alpha beta IVb > alpha beta IIa > alpha beta III > alpha beta V > alpha beta IVa > alpha beta I. Thus, our study provides a significant understanding of involved molecular interactions of indanocine with tubulin isotypes, which may help to design potent indanocine analogues for specific tubulin isotypes in MDR cells in future.	[Kumbhar, Bajarang Vasant; Panda, Dulal; Kunwar, Ambarish] Indian Inst Technol, Dept Biosci & Bioengn, Bombay, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Kunwar, A (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay, Maharashtra, India.	akunwar@iitb.ac.in	Kumbhar, Bajarang/AAR-3309-2020; Kunwar, Ambarish/AAD-3618-2022	Kumbhar, Bajarang/0000-0002-3839-9809; Kunwar, Ambarish/0000-0002-8671-7816	Indian Institute of Technology Bombay; Department of Biotechnology, Government of India; Pilot Project Grants, Program for young investigators in cancer biology from the Department of Biotechnology, Government of India [6242-P12/RGCB/PMD/DBT/AMBK/2015]	Indian Institute of Technology Bombay; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Pilot Project Grants, Program for young investigators in cancer biology from the Department of Biotechnology, Government of India	BVK is thankful to Indian Institute of Technology Bombay for Post Doctoral Fellowship. DP is thankful for the Tata Innovation Fellowship from the Department of Biotechnology, Government of India. AK is supported by Pilot Project Grants, Program for young investigators in cancer biology (Grant No. 6242-P12/RGCB/PMD/DBT/AMBK/2015) from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allner O, 2012, J CHEM THEORY COMPUT, V8, P1493, DOI 10.1021/ct3000734; BANERJEE A, 1992, J BIOL CHEM, V267, P13335; Case D. A., 2012, AMBERTOOLS12 REFEREN; Chakraborti S, 2012, BIOCHEMISTRY-US, V51, P7138, DOI 10.1021/bi300474q; Christoph DC, 2012, BRIT J CANCER, V107, P823, DOI 10.1038/bjc.2012.324; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Das L, 2009, BIOCHEMISTRY-US, V48, P1628, DOI 10.1021/bi801575e; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Derry WB, 1997, BIOCHEMISTRY-US, V36, P3554, DOI 10.1021/bi962724m; Dumontet C, 1999, J CLIN ONCOL, V17, P1061, DOI 10.1200/JCO.1999.17.3.1061; Goujon M., 2010, NUCL ACIDS RES, V38; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kapoor S, 2012, BIOCHEM PHARMACOL, V83, P1495, DOI 10.1016/j.bcp.2012.02.012; Kavallaris M, 1997, J CLIN INVEST, V100, P1282, DOI 10.1172/JCI119642; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kumbhar BV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156048; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leoni LM, 2000, JNCI-J NATL CANCER I, V92, P217, DOI 10.1093/jnci/92.3.217; Luchko T, 2008, BIOPHYS J, V94, P1971, DOI 10.1529/biophysj.107.115113; Luduena RF, 1998, INT REV CYTOL, V178, P207; LUDUENA RF, 1993, MOL BIOL CELL, V4, P445, DOI 10.1091/mbc.4.5.445; Luduena Richard E., 2008, P123, DOI 10.1007/978-1-59745-336-3_6; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Ohishi Y, 2007, GYNECOL ONCOL, V105, P586, DOI 10.1016/j.ygyno.2007.01.044; Pamula MC, 2016, J CELL BIOL, V213, P425, DOI 10.1083/jcb.201603050; PANDA D, 1994, P NATL ACAD SCI USA, V91, P11358, DOI 10.1073/pnas.91.24.11358; Pandey RK, 2017, J BIOMOL STRUCT DYN, V35, P141, DOI 10.1080/07391102.2015.1135298; Parker AL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071434; Rai A, 2013, BIOCHEM PHARMACOL, V86, P378, DOI 10.1016/j.bcp.2013.05.024; Ranganathan S, 1998, BRIT J CANCER, V77, P562, DOI 10.1038/bjc.1998.91; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tsui V, 2000, J AM CHEM SOC, V122, P2489, DOI 10.1021/ja9939385; Valiron O, 2001, CELL MOL LIFE SCI, V58, P2069, DOI 10.1007/PL00000837; Vemu A, 2017, MOL BIOL CELL; Venghateri JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075182; Xu K, 2002, DRUG DEVELOP RES, V55, P91, DOI 10.1002/ddr.10023	40	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194934	10.1371/journal.pone.0194934	http://dx.doi.org/10.1371/journal.pone.0194934			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584771	Green Published, gold			2022-12-26	WOS:000428373000050
J	Nguyen, CP; Adang, EMM				Chi Phuong Nguyen; Adang, Eddy M. M.			Cost-effectiveness of breast cancer screening using mammography in Vietnamese women	PLOS ONE			English	Article							PROGRAM; IMPACT	Background The incidence rate of breast cancer is increasing and has become the most common cancer in Vietnamese women while the survival rate is lower than that of developed countries. Early detection to improve breast cancer survival as well as reducing risk factors remains the cornerstone of breast cancer control according to the World Health Organization (WHO). This study aims to evaluate the costs and outcomes of introducing a mammography screening program for Vietnamese women aged 45-64 years, compared to the current situation of no screening. Methods Decision analytical modeling using Markov chain analysis was used to estimate costs and health outcomes over a lifetime horizon. Model inputs were derived from published literature and the results were reported as incremental cost-effectiveness ratios (ICERs) and/or incremental net monetary benefits (INMBs). One-way sensitivity analyses and probabilistic sensitivity analyses were performed to assess parameter uncertainty. Results The ICER per life year gained of the first round of mammography screening was US $3647.06 and US$4405.44 for women aged 50-54 years and 55-59 years, respectively. In probabilistic sensitivity analyses, mammography screening in the 50-54 age group and the 55-59 age group were cost-effective in 100% of cases at a threshold of three times the Vietnamese Gross Domestic Product (GDP) i.e., US$6332.70. However, less than 50% of the cases in the 60-64 age group and 0% of the cases in the 45-49 age group were cost effective at the WHO threshold. The ICERs were sensitive to the discount rate, mammography sensitivity, and transition probability from remission to distant recurrence in stage II for all age groups. Conclusion From the healthcare payer viewpoint, offering the first round of mammography screening to Vietnamese women aged 50-59 years should be considered, with the given threshold of three times the Vietnamese GDP per capita.	[Chi Phuong Nguyen] Hanoi Univ Pharm, Dept Pharmaceut Adm & Econ, Hanoi, Vietnam; [Chi Phuong Nguyen; Adang, Eddy M. M.] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, Nijmegen, Netherlands	Hanoi University of Pharmacy; Radboud University Nijmegen	Nguyen, CP (corresponding author), Hanoi Univ Pharm, Dept Pharmaceut Adm & Econ, Hanoi, Vietnam.	chinguyen@hup.edu.vn	Adang, E.M.M./L-4169-2015	Nguyen, Chi/0000-0002-8159-6680				Armstrong K, 2007, ANN INTERN MED, V146, P516, DOI 10.7326/0003-4819-146-7-200704030-00008; Azami-Aghdash Saber, 2015, Asian Pac J Cancer Prev, V16, P3463; Carles M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-192; CARTER R, 1993, AUST J PUBLIC HEALTH, V17, P42; de Gelder R, 2009, EUR J CANCER, V45, P127, DOI 10.1016/j.ejca.2008.09.015; DEKONING HJ, 1991, INT J CANCER, V49, P531, DOI 10.1002/ijc.2910490410; Duc NB, 2010, VIET J ONCOL, P21; Dung Phuong, 2015, CANCER BIOL MED, V12, P238; Edejer T, 2003, MAKING CHOICES HLTH; European Commission Intiative on Breast Cancer, 2018, SHOULD ORGANISED MAM; General statistics office of Vietnam, 2017, CONS PRIC IND 2017; General statistics office of Vietnam, 2011, CENSUS OF POPULATION; Gocgun Y, 2015, BREAST, V24, P440, DOI 10.1016/j.breast.2015.03.012; Hamashima C, 2016, JPN J CLIN ONCOL, V46, P482, DOI 10.1093/jjco/hyw008; Hubbard RA, 2011, ANN INTERN MED, V155, P481, DOI 10.7326/0003-4819-155-8-201110180-00004; Hung NT., 2012, J PRACT MED, V4, P61; International Agency for Research on Cancer, 2012, BREAST CANC EST INC; International Agency for Research on Cancer, 2017, GLOBOCAN 2012 EST CA; Kang MH, 2013, ASIAN PAC J CANCER P, V14, P2059, DOI 10.7314/APJCP.2013.14.3.2059; Kim Y, 2011, ASIAN PAC J CANCER P, V12, P725; Knaul Felicia M, 2010, J ONCOLOGY; Lan NH, 2013, GLOBAL HEALTH ACTION, V6, P23, DOI 10.3402/gha.v6i0.18860; Lauby-Secretan B, 2015, NEW ENGL J MED, V372, P2353, DOI 10.1056/NEJMsr1504363; Lee EH, 2016, KOREAN J RADIOL, V17, P489, DOI 10.3348/kjr.2016.17.4.489; Linsell L, 2010, J MED SCREEN, V17, P176, DOI 10.1258/jms.2010.010037; Michael FD., 2015, METHODS EC EVALUATIO, VFourth Edi; Ministry of Health Singapore, 2010, CANC SCREEN MOH CLIN; Morris E, 2015, POPUL HEALTH MANAG, V18, pS3, DOI 10.1089/pop.2015.29023.mor; Lan NH, 2013, GLOBAL HEALTH ACTION, V6, P32, DOI 10.3402/gha.v6i0.18872; Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783; Okonkwo QL, 2008, JNCI-J NATL CANCER I, V100, P1290, DOI 10.1093/jnci/djn292; Pace LE, 2014, JAMA-J AM MED ASSOC, V311, P1327, DOI 10.1001/jama.2014.1398; Parvin Yavari, 2016, IRAN J CANC PREV, V9; Rosenquist CJ, 1998, CANCER, V82, P2235, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2235::AID-CNCR19>3.0.CO;2-V; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; Stout NK, 2006, JNCI-J NATL CANCER I, V98, P774, DOI 10.1093/jnci/djj210; Suzuki A, 2008, CANCER SCI, V99, P2264, DOI 10.1111/j.1349-7006.2008.00926.x; [The International Agency for Research on Cancer (IARC) World Health Organisation], 2008, GLOBOCAN 2008 CANC I; Thomson MD, 2015, WOMEN HEALTH ISS, V25, P128, DOI 10.1016/j.whi.2014.11.003; Thuan TV, 2011, J PRACTICAL MED, V756, P29; van den Ende C, 2017, INT J CANCER, V141, P1295, DOI 10.1002/ijc.30794; Vietnamese Ministry of Health Vietnamese Ministry of Finance, 2015, 372015TTLTBYTBTC VIE; WHO, 2017, BREAST CANC PREV CON; Wong IOL, 2007, CANCER-AM CANCER SOC, V110, P885, DOI 10.1002/cncr.22848; Woo PPS, 2007, J CLIN ONCOL, V25, P617, DOI 10.1200/JCO.2006.06.0210; World Bank, 2017, GDP PER CAP CURR US	46	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194996	10.1371/journal.pone.0194996	http://dx.doi.org/10.1371/journal.pone.0194996			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579131	Green Published, gold, Green Submitted			2022-12-26	WOS:000428351800075
J	Leon, FJGD; Galvan-Tirado, C; Velasco, LS; Silva-Segundo, CA; Hernandez-Guzman, R; Barriga-Sosa, ID; Jaimes, PD; Canino, M; Cruz-Hernandez, P				Javier Garcia-De Leon, Francisco; Galvan-Tirado, Carolina; Sanchez Velasco, Laura; Silva-Segundo, Claudia A.; Hernandez-Guzman, Rafael; de los Angeles Barriga-Sosa, Irene; Diaz Jaimes, Pinder; Canino, Michael; Cruz-Hernandez, Pedro			Role of oceanography in shaping the genetic structure in the North Pacific hake Merluccius productus	PLOS ONE			English	Article							GULF-OF-CALIFORNIA; POPULATION-STRUCTURE; MITOCHONDRIAL-DNA; BAJA-CALIFORNIA; GAYI-GAYI; COMPUTER-PROGRAM; FISH; FLOW; SEA; DIFFERENTIATION	Determining the relative influence of biotic and abiotic factors on genetic connectivity among populations remains a major challenge in evolutionary biology and in the management and conservation of species. North Pacific hake (Merluccius productus) inhabits upwelling regions in the California Current ecosystem from the Gulf of California to the Gulf of Alaska. In this study, we examined mitochondrial DNA (mtDNA) and microsatellite variation to estimate levels of genetic differentiation of M. productus in relation to the role of oceanographic features as potential barriers to gene flow. Samples were obtained from nine sites spanning a large part of the geographic range of the species, from Puget Sound, Washington to Costa Rica. The microsatellite results revealed three genetically discrete populations: one spanning the eastern Pacific coast, and two apparently resident populations circumscribed to the Puget Sound and the northern Gulf of California (FST = 0.032, p = 0.036). Cytochrome b sequence data indicated that isolation between the Puget Sound and northern Gulf of California populations from the coastal Pacific were recent phenomena (18.5 kyr for Puget Sound and 40 kyr for the northern Gulf of California). Oceanographic data obtained from the Gulf of California support the hypothesis that permanent fronts within the region, and strong gradients at the entrance to the Gulf of California act as barriers to gene flow. A seascape genetics approach found significant genetic environment associations, where the daytime sea surface temperature and chlorophyll concentrations were the best predictive variables for the observed genetic differentiation. Considering the potential causes of genetic isolation among the three populations, e.g. spawning areas in different latitudes associated with upwelling processes, oceanographic barriers, asymmetric migration and specialized diet, that no competing interests exist. oceanographic barriers appear to be a likely mechanism restricting gene flow.	[Javier Garcia-De Leon, Francisco; Galvan-Tirado, Carolina; Silva-Segundo, Claudia A.] Ctr Invest Biol Noroeste, Lab Genet Conservac, La Paz, Baja California, Mexico; [Sanchez Velasco, Laura] Inst Politecn Nacl, Ctr Interdisciplinario Ciencias Marinas, Dept Plancton & Ecol Marina, La Paz, Baja California, Mexico; [Hernandez-Guzman, Rafael] Univ Michoacana, CONACYT Inst Invest Recursos Nat, Av San Juanito Itzicuaro S-N, Morelia, Michoacan, Mexico; [de los Angeles Barriga-Sosa, Irene] Univ Autonoma Metropolitana, Lab Genet & Biol Mol Planta Expt Prod Acuicola, Unidad Iztapalapa, Av San Rafael Atlixco 186 Col Vicentina, Mexico City, DF, Mexico; [Diaz Jaimes, Pinder] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Mexico City, DF, Mexico; [Canino, Michael] Alaska Fisheries Sci Ctr, Seattle, WA USA; [Cruz-Hernandez, Pedro] Ctr Invest Biol Noroeste, Lab Genet Acuicola, La Paz, Baja California, Mexico	CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Telefonica SA; Instituto Politecnico Nacional - Mexico; Universidad Michoacana de San Nicolas de Hidalgo; Universidad Autonoma Metropolitana - Mexico; Universidad Nacional Autonoma de Mexico; National Oceanic Atmospheric Admin (NOAA) - USA; CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Telefonica SA	Leon, FJGD (corresponding author), Ctr Invest Biol Noroeste, Lab Genet Conservac, La Paz, Baja California, Mexico.	fgarciadl@cibnor.mx	, Carolina/O-1912-2019; Hernández-Guzmán, Rafael/GLU-1422-2022; León, Francisco García-De/AAH-9391-2019; , Carolina/B-7079-2015	León, Francisco García-De/0000-0003-2323-2560; Hernandez Guzman, Rafael/0000-0002-2711-9015; , Carolina/0000-0003-3973-256X; Silva-Segundo, Claudia Alicia/0000-0002-5938-0576	Secretaria de Agricultura, Ganaderia, Desarrollo Rural, Pesca y Alimentacion de Mexico; Consejo Nacional de Ciencia y Tecnologia (SAGARPA-CONACYT) [2005-12058]; SAGARPA	Secretaria de Agricultura, Ganaderia, Desarrollo Rural, Pesca y Alimentacion de Mexico; Consejo Nacional de Ciencia y Tecnologia (SAGARPA-CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); SAGARPA	This project was funded by the Secretaria de Agricultura, Ganaderia, Desarrollo Rural, Pesca y Alimentacion de Mexico (www.gob.mx/sagarpa) and the Consejo Nacional de Ciencia y Tecnologia (http://www.conacyt.mx/) (SAGARPA-CONACYT. Grant 2005-12058 to FJGDL).; Thanks to Sarai Esquivel Bobadilla and Eric Iwamoto for laboratory work. Tissue samples were obtained with the help of Manuel Nevarez (Inapesca, Mexico), Maria de Lourdes Gonzalez, Hugo F. Cirilo, and Eva Isaak Vissuet. Collection permit numbers for U.S. samples were California # SC-009351 and Oregon #OR2007-3910. No permit was required for collections in Washington State. Samples from Mexico were collected under permits DGOPA/15073/311005.-07060 (November, 2005 April, 2006) and DGOPA/11371.101106.-5502 (November, 2006 November, 2007), issued by the Secretaria de Agricultura, Ganaderia, Desarrollo Rural, Pesca y Alimentacion) (SAGARPA). Samples from Costa Rica were purchased from commercial fishing operations. This project was funded by the SAGARPA and the Consejo Nacional de Ciencia y Tecnologia (SAGARPA-CONACYT grant 200512058 to FJGDL). Thanks to Pablo Presa and Romina Henriques for their valuable suggestions to improve this study.	Anderson MJ, 2008, PERMANOVA PRIMER GUI; [Anonymous], 2014, TRACER V1 6; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Bailey KM, 1982, CALCOFI REP, VXXIII; Balart-Paez EF, 1996, ESTUDIO POTENCIAL PE, P263; Banks SC, 2007, ECOLOGY, V88, P3055, DOI 10.1890/07-0091.1; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Benson AJ, 2002, CAN J FISH AQUAT SCI, V59, P1969, DOI 10.1139/F02-156; Bernardi G, 2003, EVOLUTION, V57, P1599; Bierne N, 2011, MOL ECOL, V20, P2044, DOI 10.1111/j.1365-294X.2011.05080.x; Blier PU, 2001, TRENDS GENET, V17, P400, DOI 10.1016/S0168-9525(01)02338-1; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brusca RC, 1973, HDB COMMON INTERTIDA; Calderon-Aguilera LE, 2003, J MARINE SYST, V39, P117, DOI 10.1016/S0924-7963(02)00265-8; Campo D, 2007, GENE, V406, P171, DOI 10.1016/j.gene.2007.09.008; Canino MF, 2010, MOL ECOL, V19, P4339, DOI 10.1111/j.1365-294X.2010.04815.x; Castillo AGF, 2005, ICES J MAR SCI, V62, P1699, DOI 10.1016/j.icesjms.2005.06.001; Castillo AGF, 2004, MAR BIOTECHNOL, V6, P299, DOI 10.1007/s10126-004-3027-z; Castro R, 2000, CIENC MAR, V26, P561; Chabot CL, 2015, ECOL EVOL, V5, P1585, DOI 10.1002/ece3.1458; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Clarke K. R., 2015, PRIMER V7 USER MANUA, P296; Coates AG, 2013, B MAR SCI, V89, P801, DOI 10.5343/bms.2012.1076; Consuegra S, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0138-0; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; Danell-Jimenez A, 2009, ESTUAR COAST SHELF S, V85, P487, DOI 10.1016/j.ecss.2009.09.010; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Pontual H, 2013, ICES J MAR SCI, V70, P1416, DOI 10.1093/icesjms/fst102; DORN MW, 1992, FISH B-NOAA, V90, P260; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ewing G., 2014, HAPLOVIEWER; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fu G., 1998, P 4 PAC OC REM SENS, P73; Fu YX, 1997, GENETICS, V147, P915; Funes-Rodriguez R, 2009, J FISH BIOL, V75, P630, DOI 10.1111/j.1095-8649.2009.02327.x; Funk WC, 2012, TRENDS ECOL EVOL, V27, P489, DOI 10.1016/j.tree.2012.05.012; Gaffney PM, 2007, J FISH BIOL, V70, P111, DOI 10.1111/j.1095-8649.2007.01393.x; Galleguillos R, 2000, HYDROBIOLOGIA, V420, P49, DOI 10.1023/A:1003925402062; Gebremedhin B, 2009, ANIM CONSERV, V12, P107, DOI 10.1111/j.1469-1795.2009.00255.x; Godinez VM, 2010, DATOS HODROGRAFICOS; Grant WS, 2001, J BIOGEOGR, V28, P699, DOI 10.1046/j.1365-2699.2001.00585.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HARPENDING HC, 1994, HUM BIOL, V66, P591; Haug GH, 2005, NATURE, V433, P821, DOI 10.1038/nature03332; Hemmer-Hansen J, 2007, MOL ECOL, V16, P3104, DOI 10.1111/j.1365-294X.2007.03367.x; Henriques R, 2016, MOL ECOL, V25, P5843, DOI 10.1111/mec.13890; Horne J, 1992, CANADIAN SPECIAL PUB, P373; Huang D, 2001, MAR BIOL, V138, P421, DOI 10.1007/s002270000454; Hurtado LA, 2007, MAR BIOL, V151, P1863, DOI 10.1007/s00227-007-0620-5; Hurtado LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011633; Inada T., 1981, Bulletin Far Seas Fisheries Research Laboratory (Shimizu), P1; Inda-Diaz EA, 2010, J PLANKTON RES, V32, P1241, DOI 10.1093/plankt/fbq051; Iwamoto E, 2004, ENVIRON BIOL FISH, V69, P187, DOI 10.1023/B:EBFI.0000022895.10683.c5; Iwamoto EM, 2015, ICES J MAR SCI, V72, P2720, DOI 10.1093/icesjms/fsv146; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; King JR, 2012, FISH RES, V114, P19, DOI 10.1016/j.fishres.2010.12.024; Knutsen H, 2012, MAR ECOL PROG SER, V460, P233, DOI 10.3354/meps09728; Lavin MF, 2003, NONLINEAR PROCESSES IN GEOPHYSICAL FLUID DYNAMICS, P173; Lavin MF, 1997, MONOGRAFIA UNION GEO, V3, P139; Lloris D, 2005, FAO SPECIES CATALOGU; Lopez M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025908; Lundy CJ, 2000, MOL ECOL, V9, P2067, DOI 10.1046/j.1365-294X.2000.01120.x; Lundy CJ, 1999, MOL ECOL, V8, P1889, DOI 10.1046/j.1365-294x.1999.00789.x; Machado-Schiaffino G, 2011, BIOL CONSERV, V144, P330, DOI 10.1016/j.biocon.2010.09.010; Machado-Schiaffino G, 2010, MOL PHYLOGENET EVOL, V55, P552, DOI 10.1016/j.ympev.2010.01.034; Machado-Schiaffino G, 2009, MOL PHYLOGENET EVOL, V53, P351, DOI 10.1016/j.ympev.2009.02.017; Maddison W. P, 2014, MESQUITE MODULAR SYS; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; MATHEWS CP, 1985, J NAT HIST, V19, P697, DOI 10.1080/00222938500770421; Milano I, 2014, MOL ECOL, V23, P118, DOI 10.1111/mec.12568; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Munguia-Vega A, 2014, PEERJ, V2, DOI 10.7717/peerj.511; Muniz-Salazar R, 2005, MOL ECOL, V14, P711, DOI 10.1111/j.1365-294X.2005.02454.x; Navarro-Olache LF, 2004, DEEP-SEA RES PT II, V51, P673, DOI 10.1016/j.dsr2.2004.05.014; Nosil P, 2008, MOL ECOL, V17, P2103, DOI 10.1111/j.1365-294X.2008.03715.x; Parker MS, 2003, J SHELLFISH RES, V22, P681; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Paya I, 2005, B MAR SCI, V76, P261; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pedersen M., 1985, MAR FISH REV, V47, P110; Pita A, 2016, FISH RES, V179, P291, DOI 10.1016/j.fishres.2016.03.017; Poortvliet M, 2013, ECOL EVOL, V3, P4558, DOI 10.1002/ece3.840; Present TMC, 1984, COPEIA, V7, P1010; Pritchard JK, 2000, GENETICS, V155, P945; Reiss H, 2009, FISH FISH, V10, P361, DOI 10.1111/j.1467-2979.2008.00324.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Riddle BR, 2000, P NATL ACAD SCI USA, V97, P14438, DOI 10.1073/pnas.250413397; Riginos C, 2001, MOL ECOL, V10, P1439, DOI 10.1046/j.1365-294X.2001.01294.x; Riginos C, 2016, CURR ZOOL, V62, P581, DOI 10.1093/cz/zow067; Riginos C, 2013, GEOGR COMPASS, V7, P197, DOI 10.1111/gec3.12032; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; ROLDAN MI, 1991, J FISH BIOL, V39, P53, DOI 10.1111/j.1095-8649.1991.tb05067.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; Saarman NP, 2010, CONSERV GENET, V11, P1989, DOI 10.1007/s10592-010-0092-x; Saavedra-Sotelo NC, 2013, ECOL EVOL, V3, P4070, DOI 10.1002/ece3.734; Sanchez-Velasco L, 2009, CONT SHELF RES, V29, P1697, DOI 10.1016/j.csr.2009.06.001; Saunders MW, 1997, 38 CALCOFI; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Schunter C, 2011, MOL ECOL, V20, P5167, DOI 10.1111/j.1365-294X.2011.05355.x; Selkoe KA, 2016, MAR ECOL PROG SER, V554, P1, DOI 10.3354/meps11792; Silva-Segundo CA, 2011, REV FISH BIOL FISHER, V21, P259, DOI 10.1007/s11160-010-9166-6; SIMARD Y, 1989, CAN J FISH AQUAT SCI, V46, P1238, DOI 10.1139/f89-160; STAUFFER GD, 1985, MAR FISH REV, V47, P2; TAJIMA F, 1989, GENETICS, V123, P585; Tamdrari H, 2012, J FISH BIOL, V81, P714, DOI 10.1111/j.1095-8649.2012.03367.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanner SE, 2014, ESTUAR COAST SHELF S, V142, P68, DOI 10.1016/j.ecss.2014.03.010; Taylor MH, 2008, PROG OCEANOGR, V79, P366, DOI 10.1016/j.pocean.2008.10.008; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Terry A, 2000, EVOLUTION, V54, P652; Vargas CA, 1997, ARCH FISH MAR RES, V45, P201; Vidal RR, 2012, J FISH BIOL, V81, P1763, DOI 10.1111/j.1095-8649.2012.03440.x; Vitalis R, 2001, GENETICS, V158, P1811; von der Heyden S, 2007, MOL PHYLOGENET EVOL, V42, P517, DOI 10.1016/j.ympev.2006.08.004; Vrooman AM, 1977, CAL COOP OCEAN FISH, V19, P67; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; White TA, 2010, MOL ECOL, V19, P216, DOI 10.1111/j.1365-294X.2009.04446.x; WILLIAM J, 1995, TRENDS ECOL EVOL, V10, P485, DOI 10.1016/S0169-5347(00)89195-8	127	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194646	10.1371/journal.pone.0194646	http://dx.doi.org/10.1371/journal.pone.0194646			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579060	Green Submitted, Green Published, gold			2022-12-26	WOS:000428351800041
J	Cong, Y; Hart, BJ; Gross, R; Zhou, HY; Frieman, M; Bollinger, L; Wade, J; Hensley, LE; Jahrling, PB; Dyall, J; Holbrook, MR				Cong, Yu; Hart, Brit J.; Gross, Robin; Zhou, Huanying; Frieman, Matthew; Bollinger, Laura; Wade, Jiro; Hensley, Lisa E.; Jahrling, Peter B.; Dyall, Julie; Holbrook, Michael R.			MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; MATURE DENDRITIC CELLS; VIRAL-INFECTIONS; REPLICATION; MACROPHAGES; CHLOROQUINE; MATURATION; INDUCTION; VS.	Middle East respiratory syndrome coronavirus (MERS-CoV) presents an emerging threat to public health worldwide by causing severe respiratory disease in humans with high virulence and case fatality rate (about 35%) since 2012. Little is known about the pathogenesis and innate antiviral response in primary human monocyte-derived macrophages (MDMs) and dendritic cells (MDDCs) upon MERS-CoV infection. In this study, we assessed MERS-CoV replication as well as induction of inflammatory cytokines and chemokines in MDMs and immature and mature MDDCs. Immature MDDCs and MDMs were permissive for MERS-CoV infection, while mature MDDCs were not, with stimulation of proinflammatory cytokine and chemokine upregulation in MDMs, but not in MDDCs. To further evaluate the antiviral activity of well-defined drugs in primary antigen presenting cells (APCs), three compounds (chloroquine, chlorpromazine and toremifine), each with broad-spectrum antiviral activity in immortalized cell lines, were evaluated in MDMs and MDDCs to determine their antiviral effect on MERS-CoV infection. While chloroquine was not active in these primary cells, chlorpromazine showed strong anti-MERS-CoV activity, but it was associated with high cytotoxicity narrowing the potential window for drug utilization. Unlike in established cells, toremifene had marginal activity when tested in antigen presenting cells, with high apparent cytotoxicity, also limiting its potential as a therapeutic option. These results demonstrate the value of testing drugs in primary cells, in addition to established cell lines, before initiating preclinical or clinical studies for MERS treatment and the importance of carefully assessing cytotoxicity in drug screen assays. Furthermore, these studies also highlight the role of APCs in stimulating a robust protective immune response to MERS-CoV infection.	[Cong, Yu; Hart, Brit J.; Gross, Robin; Zhou, Huanying; Bollinger, Laura; Wade, Jiro; Hensley, Lisa E.; Jahrling, Peter B.; Dyall, Julie; Holbrook, Michael R.] NIAID, Integrated Res Facil, NIH, Frederick, MD 21702 USA; [Frieman, Matthew] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD USA; [Jahrling, Peter B.] NIAID, Emerging Viral Pathogen Sect, NIH, Frederick, MD USA; [Hart, Brit J.] NMRC, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Naval Medical Research Center (NMRC)	Holbrook, MR (corresponding author), NIAID, Integrated Res Facil, NIH, Frederick, MD 21702 USA.	Michael.holbrook@nih.gov	Holbrook, Michael/AAT-6865-2020	Holbrook, Michael/0000-0002-0824-2667; Hensley, Lisa/0000-0003-1188-4342	Battelle Memorial Institute; US National Institute of Allergy and Infectious Diseases (NIAID) [HHSN272200700016I]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIDAI009006] Funding Source: NIH RePORTER	Battelle Memorial Institute; US National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part through Battelle Memorial Institute's prime contract with the US National Institute of Allergy and Infectious Diseases (NIAID) under Contract No. HHSN272200700016I. Y.C., R.G., H.Z., L.B., J.W., and M.R.H. performed this work as employees of Battelle Memorial Institute. Subcontractors to Battelle Memorial Institute who performed this work are: J.D. and B.H., employees of Tunnell Government Services, Inc. The content of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services (DHHS) or of the institutions and companies affiliated with the authors. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpovwa H, 2016, CELL BIOCHEM FUNCT, V34, P191, DOI 10.1002/cbf.3182; Alloatti A, 2016, IMMUNOL REV, V272, P97, DOI 10.1111/imr.12432; Almario CV, 2015, AM J GASTROENTEROL, V110, P170, DOI 10.1038/ajg.2014.356; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bergamaschi A, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-31; Chu H, 2014, VIROLOGY, V454, P197, DOI 10.1016/j.virol.2014.02.018; Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004; Collins RA, 1998, J LEUKOCYTE BIOL, V63, P707, DOI 10.1002/jlb.63.6.707; Cong Y, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004709; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; de Wilde AH, 2014, ANTIMICROB AGENTS CH, V58, P4875, DOI 10.1128/AAC.03011-14; Drosten C, 2013, LANCET INFECT DIS, V13, P745, DOI 10.1016/S1473-3099(13)70154-3; Dyall J, 2014, ANTIMICROB AGENTS CH, V58, P4885, DOI 10.1128/AAC.03036-14; FugierVivier I, 1997, J EXP MED, V186, P813, DOI 10.1084/jem.186.6.813; Funk CJ, 2012, J GEN VIROL, V93, P494, DOI 10.1099/vir.0.038414-0; Graham RL, 2013, NAT REV MICROBIOL, V11, P836, DOI 10.1038/nrmicro3143; Granelli-Piperno A, 1999, CURR BIOL, V9, P21, DOI 10.1016/S0960-9822(99)80043-8; Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X; Hart DNJ, 1997, BLOOD, V90, P3245, DOI 10.1182/blood.V90.9.3245; Huang KJ, 2005, J MED VIROL, V75, P185, DOI 10.1002/jmv.20255; Hui DS, 2014, CURR OPIN PULM MED, V20, P233, DOI 10.1097/MCP.0000000000000046; Jiang Y, 2005, AM J RESP CRIT CARE, V171, P850, DOI 10.1164/rccm.200407-857OC; Johansen LM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005471; Josset L, 2013, MBIO, V4, DOI 10.1128/mBio.00165-13; Kopf M, 2015, NAT IMMUNOL, V16, P36, DOI 10.1038/ni.3052; Kruse M, 2000, J VIROL, V74, P7127, DOI 10.1128/JVI.74.15.7127-7136.2000; Long Jason, 2015, F1000Res, V4, P30, DOI 10.12688/f1000research.6085.1; Madrid PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060579; Miyamoto S, 2012, MOL PSYCHIATR, V17, P1206, DOI 10.1038/mp.2012.47; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Poissy J, 2014, J CLIN VIROL, V61, P275, DOI 10.1016/j.jcv.2014.07.002; Porotto M, 2009, J VIROL, V83, P5148, DOI 10.1128/JVI.00164-09; Rescigno M, 1997, J LEUKOCYTE BIOL, V61, P415, DOI 10.1002/jlb.61.4.415; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; SANDOW D, 1990, Zeitschrift fuer die Gesamte Hygiene und ihre Grenzgebiete, V36, P471; Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5; Scheuplein VA, 2015, J VIROL, V89, P3859, DOI 10.1128/JVI.03607-14; Senga M, 2017, J INFECT PUBLIC HEAL, V10, P191, DOI 10.1016/j.jiph.2016.04.008; Spiegel M, 2006, J GEN VIROL, V87, P1953, DOI 10.1099/vir.0.81624-0; Thome R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065913; Tynell J, 2016, J GEN VIROL, V97, P344, DOI 10.1099/jgv.0.000351; WHO, 2017, MIDDL E RESP SYNDR C; World Health Organization, 2017, DIS OUTBREAK NE 0208; Wulff Niels H, 2012, J Clin Bioinforma, V2, P5, DOI 10.1186/2043-9113-2-5; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhou J, 2014, J INFECT DIS, V209, P1331, DOI 10.1093/infdis/jit504	46	67	73	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194868	10.1371/journal.pone.0194868	http://dx.doi.org/10.1371/journal.pone.0194868			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566060	Green Published, Green Submitted, gold			2022-12-26	WOS:000428093900113
J	Foschi, C; Laghi, L; D'Antuono, A; Gaspari, V; Zhu, CL; Dellarosa, N; Salvo, M; Marangoni, A				Foschi, Claudio; Laghi, Luca; D'Antuono, Antonietta; Gaspari, Valeria; Zhu, Chenglin; Dellarosa, Nicolo; Salvo, Melissa; Marangoni, Antonella			Urine metabolome in women with Chlamydia trachomatis infection	PLOS ONE			English	Article							2-FUROYLGLYCINE; H-1-NMR	The aim of this study was to characterize the urine metabolome of women with Chlamydia trachomatis (CT) uro-genital infection (n = 21), comparing it with a group of CT-negative subjects (n = 98). By means of a proton-based nuclear magnetic resonance (H-1-NMR) spectroscopy, we detected and quantified the urine metabolites of a cohort of 119 pre-menopausal Caucasian women, attending a STI Outpatients Clinic in Italy. In case of a CT positive result, CT molecular genotyping was performed by ompl gene semi-nested PCR followed by RFLP analysis. We were able to identify several metabolites whose concentrations were significantly higher in the urine samples of CT-positive subjects, including sucrose, mannitol, pyruvate and lactate. In contrast, higher urinary levels of acetone represented the main feature of CT-negative women. These results were not influenced by the age of patients nor by the CT serovars (D, E, F, G, K) responsible of the urethral infections. Since the presence of sugars can increase the stability of chlamydial proteins, higher levels of sucrose and mannitol in the urethral lumen, related to a higher sugar consumption, could have favoured CT infection acquisition or could have been of aid for the bacterial viability. Peculiar dietary habits of the subjects enrolled, in term of type and amount of food consumed, could probably explain these findings. Lactate and pyruvate could result from CT-induced immunopathology, as a product of the inflammatory microenvironment. Further studies are needed to understand the potential role of these metabolites in the pathogenesis of CT infection, as well as their diagnostic/prognostic use.	[Foschi, Claudio; Salvo, Melissa; Marangoni, Antonella] Univ Bologna, Microbiol, DIMES, Bologna, Italy; [Laghi, Luca; Zhu, Chenglin; Dellarosa, Nicolo] Univ Bologna, Dept Agrofood Sci & Technol, Ctr Food, Cesena, Italy; [D'Antuono, Antonietta; Gaspari, Valeria] Univ Bologna, Dermatol, DIMES, Bologna, Italy	University of Bologna; University of Bologna; University of Bologna	Foschi, C (corresponding author), Univ Bologna, Microbiol, DIMES, Bologna, Italy.	claudio.foschi2@uniba.it	Zhu, Chenglin/AAI-8190-2021; Zhu, Chenglin/AAR-9197-2021; Foschi, Claudio/A-7299-2016; Laghi, Luca/R-5278-2016	Zhu, Chenglin/0000-0003-3486-1936; Foschi, Claudio/0000-0001-7253-8799; Laghi, Luca/0000-0003-1593-7376; Marangoni, Antonella/0000-0002-7397-6560				BALES JR, 1986, MAGNET RESON MED, V3, P849, DOI 10.1002/mrm.1910030605; Barbara G, 2017, GUT, V66, P1252, DOI 10.1136/gutjnl-2016-312377; Battini S, 2018, J NEUROIMMUNOL, V314, P94, DOI 10.1016/j.jneuroim.2017.11.018; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; Cai SM, 2009, MOL PHARMACEUT, V6, P1553, DOI 10.1021/mp900110q; Campbell R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179508; De Filippis F, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0202-1; De Filippis F, 2016, GUT, V65, P1812, DOI 10.1136/gutjnl-2015-309957; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Elwell C, 2016, NAT REV MICROBIOL, V14, P385, DOI 10.1038/nrmicro.2016.30; Englert JA, 2016, CLIN CHEST MED, V37, P321, DOI 10.1016/j.ccm.2016.01.011; Foschi C, 2016, J MED MICROBIOL, V65, P510, DOI 10.1099/jmm.0.000261; Foschi Claudio, 2014, BMC Res Notes, V7, P225, DOI 10.1186/1756-0500-7-225; Haas R, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002202; Haas R, 2013, AM J CLIN EXP IMMUNO, V2, P146; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Heinzmann SS, 2015, J AGR FOOD CHEM, V63, P8615, DOI 10.1021/acs.jafc.5b03040; Hubert M, 2005, TECHNOMETRICS, V47, P64, DOI 10.1198/004017004000000563; Hussain H, 2016, CHEM-EUR J, V22, P7068, DOI 10.1002/chem.201600533; Kneen MA, 1996, NUCL INSTRUM METH B, V109, P209, DOI 10.1016/0168-583X(95)00908-6; Liland KH, 2010, APPL SPECTROSC, V64, P1007, DOI 10.1366/000370210792434350; Marangoni A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120979; Mauro C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00173; Mehlitz A, 2017, MOL MICROBIOL, V103, P1004, DOI 10.1111/mmi.13603; Omsland A, 2012, P NATL ACAD SCI USA, V109, P19781, DOI 10.1073/pnas.1212831109; PETTERSEN JE, 1972, CLIN CHIM ACTA, V41, P199, DOI 10.1016/0009-8981(72)90512-8; Rey-Ladino J, 2014, HUM VACC IMMUNOTHER, V10, P2664, DOI 10.4161/hv.29683; Saka HA, 2011, MOL MICROBIOL, V82, P1185, DOI 10.1111/j.1365-2958.2011.07877.x; Savini M, 2010, NUTRIENTS, V2, P330, DOI 10.3390/nu2030330; Senior K, 2012, LANCET INFECT DIS, V12, P517, DOI 10.1016/S1473-3099(12)70161-5; Sharma RK, 2017, INFLAMM RES, V66, P97, DOI 10.1007/s00011-016-0998-y; Tasevska N, 2005, CANCER EPIDEM BIOMAR, V14, P1287, DOI 10.1158/1055-9965.EPI-04-0827; Webster SJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006383; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; WOOD PK, 1990, MULTIVAR BEHAV RES, V25, P295, DOI 10.1207/s15327906mbr2503_3; Yeoman CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056111; Zhang B, 2012, FUTURE MED CHEM, V4, P1273, DOI [10.4155/FMC.12.59, 10.4155/fmc.12.59]; Zhang LM, 2018, J PROTEOME RES, V17, P680, DOI 10.1021/acs.jproteome.7b00730	38	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194827	10.1371/journal.pone.0194827	http://dx.doi.org/10.1371/journal.pone.0194827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566085	gold, Green Published			2022-12-26	WOS:000428093900110
J	Pothoulakis, G; Ellis, T				Pothoulakis, Georgios; Ellis, Tom			Construction of hybrid regulated mother specific yeast promoters for inducible differential gene expression	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; HO GENE; TRANSCRIPTION FACTOR; FACTOR-BINDING; MATING-TYPE; REPRESSION; POPULATIONS; PROTEINS; PLASMID; CASCADE	Engineered promoters with predefined regulation are a key tool for synthetic biology that enable expression on demand and provide the logic for genetic circuits. To expand the availability of synthetic biology tools for S. cerevisiae yeast, we here used hybrid promoter engineering to construct tightly-controlled, externally-inducible promoters that only express in haploid mother cells that have contributed a daughter cell to the population. This is achieved by combining elements from the native HO promoter and from a TetR-repressible synthetic promoter, with the performance of these promoters characterized by both flow cytometry and microfluidics-based fluorescence microscopy. These new engineered promoters are provided as an enabling tool for future synthetic biology applications that seek to exploit differentiation within a yeast population.	[Pothoulakis, Georgios; Ellis, Tom] Imperial Coll London, Ctr Synthet Biol & Innovat, London, England; [Pothoulakis, Georgios; Ellis, Tom] Imperial Coll London, Dept Bioengn, London, England	Imperial College London; Imperial College London	Ellis, T (corresponding author), Imperial Coll London, Ctr Synthet Biol & Innovat, London, England.; Ellis, T (corresponding author), Imperial Coll London, Dept Bioengn, London, England.	t.ellis@imperial.ac.uk		Pothoulakis, Georgios/0000-0003-2950-3990; Ellis, Thomas/0000-0001-5392-976X	Leverhulme Trust [RPG-2012-562]; Biotechnology and Biological Sciences Research Council [BB/K006290/1]; BBSRC [BB/K006290/1] Funding Source: UKRI	Leverhulme Trust(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work of GP and TE on this research was funded by The Leverhulme Trust under project grant RPG-2012-562 and Biotechnology and Biological Sciences Research Council BB/K006290/1 to TE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso B, 2010, NUCLEIC ACIDS RES, V38, P2727, DOI 10.1093/nar/gkq075; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Blazeck J, 2013, APPL MICROBIOL BIOT, V97, P3037, DOI 10.1007/s00253-012-4421-5; Blazeck J, 2012, BIOTECHNOL BIOENG, V109, P2884, DOI 10.1002/bit.24552; Blount BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033279; Chan KM, 2013, PLASMID, V70, P2, DOI 10.1016/j.plasmid.2013.03.001; Cosma MP, 2004, EMBO REP, V5, P953, DOI 10.1038/sj.embor.7400251; Curran KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5002; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; FLICK JS, 1990, MOL CELL BIOL, V10, P4757, DOI 10.1128/MCB.10.9.4757; GUARENTE L, 1982, P NATL ACAD SCI-BIOL, V79, P7410, DOI 10.1073/pnas.79.23.7410; Hackett EA, 2006, YEAST, V23, P333, DOI 10.1002/yea.1358; HERSKOWITZ I, 1988, MICROBIOL REV, V52, P536, DOI 10.1128/MMBR.52.4.536-553.1988; Houser JR, 2012, YEAST, V29, P519, DOI 10.1002/yea.2932; Karim AS, 2013, FEMS YEAST RES, V13, P107, DOI 10.1111/1567-1364.12016; Kaznessis YN, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-47; Leavitt JM, 2016, BIOTECHNOL J, V11, P866, DOI 10.1002/biot.201600029; Lee ME, 2015, ACS SYNTH BIOL, V4, P975, DOI 10.1021/sb500366v; Lindstrom DL, 2009, GENETICS, V183, P413, DOI 10.1534/genetics.109.106229; Mathias JR, 2004, NUCLEIC ACIDS RES, V32, P6469, DOI 10.1093/nar/gkh985; Matsuda F, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-119; Mattanovich D, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-34; Maxon ME, 2001, P NATL ACAD SCI USA, V98, P1495, DOI 10.1073/pnas.98.4.1495; Murphy KF, 2007, P NATL ACAD SCI USA, V104, P12726, DOI 10.1073/pnas.0608451104; NASMYTH K, 1987, EMBO J, V6, P243, DOI 10.1002/j.1460-2075.1987.tb04745.x; NASMYTH K, 1985, CELL, V42, P213, DOI 10.1016/S0092-8674(85)80117-3; NASMYTH KA, 1982, ANNU REV GENET, V16, P439, DOI 10.1146/annurev.ge.16.120182.002255; NEHLIN JO, 1991, EMBO J, V10, P3373, DOI 10.1002/j.1460-2075.1991.tb04901.x; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Porro D, 2009, CYTOM PART A, V75A, P114, DOI 10.1002/cyto.a.20689; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Redden H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8810; Sil A, 1996, CELL, V84, P711, DOI 10.1016/S0092-8674(00)81049-1; Steen EJ, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-36; Takahata S, 2011, J BIOL CHEM, V286, P34809, DOI 10.1074/jbc.M111.281626; Teo WS, 2014, BIOTECHNOL BIOENG, V111, P144, DOI 10.1002/bit.25001; Wu M, 2013, P NATL ACAD SCI USA, V110, P10610, DOI 10.1073/pnas.1305423110; Yarrington RM, 2016, GENETICS, V202, P551, DOI 10.1534/genetics.115.183715; Yarrington RM, 2015, MOL CELL BIOL, V35, P688, DOI 10.1128/MCB.01285-14; Zhang Q, 2013, P NATL ACAD SCI USA, V110, P14012, DOI 10.1073/pnas.1306113110	42	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194588	10.1371/journal.pone.0194588	http://dx.doi.org/10.1371/journal.pone.0194588			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566038	Green Published, gold, Green Submitted			2022-12-26	WOS:000428093900082
J	Skowasch, D; Ringquist, S; Nickenig, G; Andrie, R				Skowasch, Dirk; Ringquist, Steven; Nickenig, Georg; Andrie, Rene			Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator	PLOS ONE			English	Article							HIGH-RISK; CONSENSUS STATEMENT; ARRHYTHMIAS; EXPERIENCE; DIAGNOSIS	Background Patients with cardiac sarcoidosis are at increased risk of ventricular tachycardia/fibrillation. Objective We tested the hypothesis that the wearable cardioverter defibrillator can be used to mitigate the risk of sudden cardiac death among cardiac sarcoidosis patients. Methods A retrospective review of the commercial database identified cardiac sarcoidosis patients who wore the wearable cardioverter defibrillator. Evidence for cardiac sarcoidosis diagnosis as well as demographic, co-morbidity and left ventricular ejection fraction were provided by patient clinical records. Clinical data also included daily wearable cardioverter defibrillator wear, shock treatment and survival information. Results The wearable cardioverter defibrillator was worn by 46 cardiac sarcoidosis patients, 24 (52%) male. The median age was 48 years and median left ventricular ejection fraction was 30%. The wearable cardioverter defibrillator was worn a median of 23.6 hours each day. There were 11 ventricular tachycardia/fibrillation episodes occurring in 10 (22%) patients. Ventricular tachycardia/fibrillation occurred over a range of 1 to 79 days, median 24 days. First-shock success for conversion of ventricular tachycardia/fibrillation was 100%. Patient survival 24 hours after shock treatment was 100%. Follow up to determine the reason for discontinuing wearable cardioverter defibrillator use indicated that among shocked patients 7 received an implantable cardioverter defibrillator, 1 patient was admitted to the hospital ending in death 2 weeks after discontinuing wearable cardioverter defibrillator use, and 2 patients were lost to follow up. Among the not shocked patients, there were 16 who received an implantable cardioverter defibrillator while 7 achieved improved left ventricular ejection fraction. Conclusion Management of sudden cardiac death among cardiac sarcoidosis patients was aided by the wearable cardioverter defibrillator resulting in successful termination of ventricular tachycardia/fibrillation upon delivery of shock.	[Skowasch, Dirk; Nickenig, Georg; Andrie, Rene] Univ Bonn, Div Cardiol & Pneumol, Dept Internal Med 2, Bonn, Germany; [Ringquist, Steven] ZOLL, Pittsburgh, PA USA	University of Bonn	Skowasch, D (corresponding author), Univ Bonn, Div Cardiol & Pneumol, Dept Internal Med 2, Bonn, Germany.	Dirk.Skowasch@ukb.uni-bonn.de			ZOLL	ZOLL	The present registry is supported by an unrestricted grant from ZOLL. Steve Ringquist is an employee of ZOLL. The funder provided support in the form of salaries for author SR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Adler A, 2013, CIRCULATION, V127, P854, DOI 10.1161/CIRCULATIONAHA.112.146530; Andrie R, 2017, THORAX, V72, P286, DOI 10.1136/thoraxjnl-2016-208834; Betensky BP, 2012, HEART RHYTHM, V9, P884, DOI 10.1016/j.hrthm.2012.02.010; Birnie DH, 2016, J AM COLL CARDIOL, V68, P411, DOI 10.1016/j.jacc.2016.03.605; Birnie DH, 2016, HEART, V102, P411, DOI 10.1136/heartjnl-2015-308708; Birnie DH, 2014, HEART RHYTHM, V11, P1304, DOI 10.1016/j.hrthm.2014.03.043; Chung MK, 2010, J AM COLL CARDIOL, V56, P194, DOI 10.1016/j.jacc.2010.04.016; Costabel U, 2014, Pneumologie, V68, P124, DOI 10.1055/s-0033-1359197; Epstein AE, 2013, J AM COLL CARDIOL, V62, P2000, DOI 10.1016/j.jacc.2013.05.086; Greulich S, 2013, JACC-CARDIOVASC IMAG, V6, P501, DOI 10.1016/j.jcmg.2012.10.021; Iannuzzi MC, 2011, JAMA-J AM MED ASSOC, V305, P391, DOI 10.1001/jama.2011.10; Kandolin R, 2015, CIRCULATION, V131, P624, DOI 10.1161/CIRCULATIONAHA.114.011522; Kao AC, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-123; Klein HU, 2010, PACE, V33, P353, DOI 10.1111/j.1540-8159.2009.02590.x; Kron J, 2013, EUROPACE, V15, P347, DOI 10.1093/europace/eus316; Kusano KF, 2016, HEART, V102, P184, DOI 10.1136/heartjnl-2015-307877; Pabst S, 2012, Pneumologie, V66, P96, DOI 10.1055/s-0030-1257126; PERRY A, 1995, ARCH PATHOL LAB MED, V119, P167; Pizarro C, 2015, SARCOIDOSIS VASC DIF, V32, P325; Reek S, 2017, EUROPACE, V19, P335, DOI 10.1093/europace/euw180; SILVERMAN KJ, 1978, CIRCULATION, V58, P1204, DOI 10.1161/01.CIR.58.6.1204; Wassnig NK, 2016, CIRCULATION, V134, P635, DOI 10.1161/CIRCULATIONAHA.115.019124	22	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194496	10.1371/journal.pone.0194496	http://dx.doi.org/10.1371/journal.pone.0194496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566033	Green Published, gold, Green Submitted			2022-12-26	WOS:000428093900071
J	Allam, O; Samarani, S; Mehraj, V; Jenabian, MA; Tremblay, C; Routy, JP; Amre, D; Ahmad, A				Allam, Ossama; Samarani, Suzanne; Mehraj, Vikram; Jenabian, Mohammad-Ali; Tremblay, Cecile; Routy, Jean-Pierre; Amre, Devendra; Ahmad, Ali			HIV induces production of IL-18 from intestinal epithelial cells that increases intestinal permeability and microbial translocation	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NECROSIS-FACTOR-ALPHA; ENDOTHELIAL BARRIER DYSFUNCTION; IFN-GAMMA; INFECTED INDIVIDUALS; BINDING-PROTEIN; HIV-1-INFECTED PATIENTS; VIRAL REPLICATION; MONOCYTIC CELLS; ELEVATED LEVELS	Interleukin-18 (IL-18) is a pleiotropic cytokine of the IL-1 family with multiple context dependent functions. We and others have shown that HIV infection is accompanied by increased circulating levels of IL-18 along with decreased levels of its antagonist, Interleukin-18 Binding Protein (IL-18BP). The infection is also accompanied by intestinal inflammation and decreased intestinal integrity as measured by intestinal permeability, regeneration and repair. However, little is known concerning the relation between high level of IL-18 associated with the viral infection and intestinal permeability. Here we demonstrate that HIV treatment increases production of IL-18 and decreases that of IL-18BP production in human intestinal epithelial cell (IEC) lines. IL-18 causes apoptosis of the IEC by activating caspase-1 and caspase-3. It induces epithelial barrier hyperpermeability by decreasing and disrupting both tight and adherens junction proteins, occludin, claudin 2 and beta-catenin. Disorganization of F-actin was also observed in the IEC that were exposed to the cytokine. Moreover IL-18 decreases transepithelial electrical resistance (TEER) in Caco-2 and increases permeability in HT29 monolayers. The cells' treatment with IL-18 causes an increase in the expression of phosphorylated myosin II regulatory light-chain (p-MLC) and myosin light-chain kinase (MLCK), and a decrease in phosphorylated Signal Transducer and Activator of Transcription (p-STAT)-5. This increase in p-MLC is suppressed by a Rhokinase (ROCK)-specific inhibitor. Interestingly, the levels of the cytokine correlate with those of LPS in the circulation in three different categories of HIV infected patients (HAART-naive and HAART-treated HIV-infected individuals, and Elite controls) as well as in healthy controls. Collectively, these results suggest that the HIV-induced IL-18 plays a role in increased intestinal permeability and microbial translocation observed in HIV-infected individuals.	[Allam, Ossama; Samarani, Suzanne; Ahmad, Ali] Univ Montreal, Dept Microbiol Infect Dis & Immunol, CHU Ste Justine Res Ctr, Lab Innate Immun, Montreal, PQ, Canada; [Mehraj, Vikram; Routy, Jean-Pierre] McGill Univ, Div Hematol, Montreal, PQ, Canada; [Mehraj, Vikram; Routy, Jean-Pierre] McGill Univ, Chron Viral Illness Serv, Montreal, PQ, Canada; [Jenabian, Mohammad-Ali] Univ Quebec Montreal, Dept Biol Sci, Montreal, PQ, Canada; [Tremblay, Cecile] Univ Montreal, Dept Microbiol Infect Dis & Immunol, CHUM, Montreal, PQ, Canada; [Amre, Devendra] Univ Montreal, Dept Pediat, CHU Ste Justine Res Ctr, Montreal, PQ, Canada	Universite de Montreal; McGill University; McGill University; University of Quebec; University of Quebec Montreal; Universite de Montreal; Universite de Montreal	Ahmad, A (corresponding author), Univ Montreal, Dept Microbiol Infect Dis & Immunol, CHU Ste Justine Res Ctr, Lab Innate Immun, Montreal, PQ, Canada.	ali.ahmad@recherche-ste-justine.qc.ca			Ste-Justine Foundation; "Fondation des etoiles"	Ste-Justine Foundation; "Fondation des etoiles"	The work was not funded by any specific grant. However, the first author, Ossama Allam, had received a PhD scholarship from Ste-Justine Foundation and from "Fondation des etoiles" for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2002, J VIROL, V76, P12448, DOI 10.1128/JVI.76.24.12448-12456.2002; Ahmad R, 2006, AIDS, V20, P1907, DOI 10.1097/01.aids.0000244217.46445.45; Al-Sadi R, 2013, J IMMUNOL, V190, P6596, DOI 10.4049/jimmunol.1201876; Al-Sadi RM, 2007, J IMMUNOL, V178, P4641, DOI 10.4049/jimmunol.178.7.4641; Allam O, 2017, CYTOKINE, V90, P144, DOI 10.1016/j.cyto.2016.10.016; Amoozadeh Y, 2015, AM J PHYSIOL-CELL PH, V309, pC38, DOI 10.1152/ajpcell.00388.2014; Atluri VSR, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00212; Bahrami B, 2011, J APPL MICROBIOL, V110, P353, DOI 10.1111/j.1365-2672.2010.04889.x; Bai L, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-77; Batman PA, 2007, AIDS, V21, P433, DOI 10.1097/QAD.0b013e3280142ee8; Ben Haij N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129425; Blankenberg S, 2002, CIRCULATION, V106, P24, DOI 10.1161/01.CIR.0000020546.30940.92; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Buccigrossi V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029436; Cao M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061944; Chaipan C, 2006, J VIROL, V80, P8951, DOI 10.1128/JVI.00136-06; Chandrasekar B, 2006, BIOCHEM BIOPH RES CO, V339, P956, DOI 10.1016/j.bbrc.2005.11.100; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; Chiozzini C, 2016, CURR DRUG TARGETS, V17, P33, DOI 10.2174/1389450116666150825110658; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Clark E, 2017, ONCOTARGET, V8, P27569, DOI 10.18632/oncotarget.15174; DAYANITHI G, 1995, CELL CALCIUM, V18, P9, DOI 10.1016/0143-4160(95)90041-1; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Dinarello CA, 1998, J LEUKOCYTE BIOL, V63, P658, DOI 10.1002/jlb.63.6.658; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Du LJ, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/7374197; Epple HJ, 2010, GASTROENTEROLOGY, V139, P1289, DOI 10.1053/j.gastro.2010.06.065; Gauthier S, 2010, ANTIVIR RES, V88, P207, DOI 10.1016/j.antiviral.2010.08.015; Gilbert S, 2012, EMBO MOL MED, V4, P109, DOI 10.1002/emmm.201100192; Harrison OJ, 2015, MUCOSAL IMMUNOL, V8, P1226, DOI 10.1038/mi.2015.13; He F, 2012, CYTOKINE, V59, P264, DOI 10.1016/j.cyto.2012.04.008; Hilgendorf C, 2000, J PHARM SCI-US, V89, P63, DOI 10.1002/(SICI)1520-6017(200001)89:1<63::AID-JPS7>3.0.CO;2-6; Huigen MCDG, 2004, EUR J CLIN INVEST, V34, P57, DOI 10.1111/j.1365-2362.2004.01282.x; Hurgin V, 2002, P NATL ACAD SCI USA, V99, P16957, DOI 10.1073/pnas.262663399; Iannello A, 2011, VIRAL IMMUNOL, V24, P11, DOI 10.1089/vim.2010.0083; Iannello A, 2010, J INFECT DIS, V201, P608, DOI 10.1086/650314; Iannello A, 2009, AIDS REV, V11, P115; Iannello A, 2009, J VIROL, V83, P5999, DOI 10.1128/JVI.02350-08; Ivanov AI, 2008, FRONT BIOSCI-LANDMRK, V13, P6662, DOI 10.2741/3180; Ivanov AI, 2010, AM J PATHOL, V177, P512, DOI 10.2353/ajpath.2010.100168; Kalina U, 2002, EUR J IMMUNOL, V32, P2635, DOI 10.1002/1521-4141(200209)32:9<2635::AID-IMMU2635>3.0.CO;2-N; Kanai T, 2013, CURR DRUG TARGETS, V14, P1392, DOI 10.2174/13894501113149990006; Kimura K, 2009, INVEST OPHTH VIS SCI, V50, P597, DOI 10.1167/iovs.08-2606; Kitaura H, 2011, CALCIFIED TISSUE INT, V89, P65, DOI 10.1007/s00223-011-9494-0; Klein SA, 2000, EUR CYTOKINE NETW, V11, P47; Leonard F, 2010, MOL PHARMACEUT, V7, P2103, DOI 10.1021/mp1000795; Lindegaard B, 2004, JAIDS-J ACQ IMM DEF, V36, P588, DOI 10.1097/00126334-200405010-00006; Liu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068547; Marchetti G, 2013, CLIN MICROBIOL REV, V26, P2, DOI 10.1128/CMR.00050-12; Marks MA, 2013, AIDS, V27, P469, DOI 10.1097/QAD.0b013e32835c1333; Massanella M, 2013, EXPERT REV CLIN IMMU, V9, P1135, DOI 10.1586/1744666X.2013.842897; Mavigner M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007658; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Monforte AD, 2004, AIDS, V18, P1811, DOI 10.1097/00002030-200409030-00010; Moriwaki Y, 2003, METABOLISM, V52, P605, DOI 10.1053/meta.2003.50096; Munshi N, 2002, J IMMUNOL, V168, P5860, DOI 10.4049/jimmunol.168.11.5860; Murphy AJ, 2016, CELL METAB, V23, P155, DOI 10.1016/j.cmet.2015.09.024; NAKAMURA K, 1993, INFECT IMMUN, V61, P64, DOI 10.1128/IAI.61.1.64-70.1993; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Novick D, 2013, SEMIN IMMUNOL, V25, P439, DOI 10.1016/j.smim.2013.10.014; Nowarski R, 2015, CELL, V163, P1444, DOI 10.1016/j.cell.2015.10.072; Nowroozalizadeh S, 2010, J INFECT DIS, V201, P1150, DOI 10.1086/651430; Paulukat J, 2001, J IMMUNOL, V167, P7038, DOI 10.4049/jimmunol.167.12.7038; Pedersen KK, 2013, JAIDS-J ACQ IMM DEF, V64, P425, DOI 10.1097/QAI.0b013e31829f919d; Rigor RR, 2013, MED RES REV, V33, P911, DOI 10.1002/med.21270; Rosenthal R, 2010, J CELL SCI, V123, P1913, DOI 10.1242/jcs.060665; Samarani S, 2016, CYTOKINE, V82, P38, DOI 10.1016/j.cyto.2016.01.006; Shapiro L, 1998, P NATL ACAD SCI USA, V95, P12550, DOI 10.1073/pnas.95.21.12550; Siegmund B, 2001, AM J PHYSIOL-REG I, V281, pR1264, DOI 10.1152/ajpregu.2001.281.4.R1264; Siegmund B, 2010, IMMUNITY, V32, P300, DOI 10.1016/j.immuni.2010.03.010; Sivakumar PV, 2002, GUT, V50, P812, DOI 10.1136/gut.50.6.812; Song W, 2006, CLIN EXP IMMUNOL, V144, P117, DOI 10.1111/j.1365-2249.2006.03050.x; Strengell M, 2003, J IMMUNOL, V170, P5464, DOI 10.4049/jimmunol.170.11.5464; Stylianou E, 2003, CLIN EXP IMMUNOL, V132, P462, DOI 10.1046/j.1365-2249.2003.02179.x; Sugama S, 2008, BRAIN RES REV, V58, P85, DOI 10.1016/j.brainresrev.2007.11.003; Takagi H, 2003, SCAND J GASTROENTERO, V38, P837, DOI 10.1080/00365520310004047; Terme M, 2012, CANCER RES, V72, P2757, DOI 10.1158/0008-5472.CAN-11-3379; Torre D, 2000, AIDS, V14, P2211, DOI 10.1097/00002030-200009290-00023; Tugizov S, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1159276; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Villarroya F, 2007, INT J OBESITY, V31, P1763, DOI 10.1038/sj.ijo.0803698; Ward, 2000, Pharm Sci Technol Today, V3, P346, DOI 10.1016/S1461-5347(00)00302-3; Wirtz S, 2002, J IMMUNOL, V168, P411, DOI 10.4049/jimmunol.168.1.411; Xing JJ, 2011, J APPL PHYSIOL, V110, P213, DOI 10.1152/japplphysiol.00284.2010; Yamashita S, 2000, EUR J PHARM SCI, V10, P195, DOI 10.1016/S0928-0987(00)00076-2; Zhou GY, 2009, VASC PHARMACOL, V50, P171, DOI 10.1016/j.vph.2009.01.006	89	23	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0194185	10.1371/journal.pone.0194185	http://dx.doi.org/10.1371/journal.pone.0194185			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601578	Green Submitted, Green Published, gold			2022-12-26	WOS:000428845900005
J	Balyura, M; Gelfgat, E; Steenblock, C; Androutsellis-Theotokis, A; Ruiz-Babot, G; Guasti, L; Werdermann, M; Ludwig, B; Bornstein, T; Schally, AV; Brennand, A; Bornstein, SR				Balyura, Mariya; Gelfgat, Evgeny; Steenblock, Charlotte; Androutsellis-Theotokis, Andreas; Ruiz-Babot, Gerard; Guasti, Leonardo; Werdermann, Martin; Ludwig, Barbara; Bornstein, Tobias; Schally, Andrew V.; Brennand, Ana; Bornstein, Stefan R.			Expression of progenitor markers is associated with the functionality of a bioartificial adrenal cortex	PLOS ONE			English	Article							HORMONE-RELEASING-HORMONE; TUMOR-NECROSIS-FACTOR; ADRENOCORTICAL-CELLS; STEM-CELLS; NESTIN EXPRESSION; PANCREATIC-ISLETS; GENE-EXPRESSION; GROWTH; PROLIFERATION; STEROIDOGENESIS	Encapsulation of primary bovine adrenocortical cells in alginate is an efficacious model of a bioartificial adrenal cortex. Such a bioartificial adrenal cortex can be used for the restoration of lost adrenal function in vivo as well as for in vitro modeling of the adrenal microenvironment and for investigation of cell-cell interactions in the adrenals. The aim of this work was the optimization of a bioartificial adrenal cortex, that is the generation of a highly productive, self-regenerating, long-term functioning and immune tolerant bioartificial organ. To achieve this, it is necessary that adrenocortical stem and progenitor cells are present in the bioartificial gland, as these undifferentiated cells play important roles in the function of the mature gland. Here, we verified the presence of adrenocortical progenitors in cultures of bovine adrenocortical cells, studied the dynamics of their appearance and growth and determined the optimal time point for cell encapsulation. These procedures increased the functional life span and reduced the immunogenicity of the bioartificial adrenal cortex. This model allows the use of the luteinizing hormone-releasing hormone (LHRH) agonist triptorelin, the neuropeptide bombesin, and retinoic acid to alter cell number and the release of cortisol over long periods of time.	[Balyura, Mariya; Gelfgat, Evgeny; Steenblock, Charlotte; Androutsellis-Theotokis, Andreas; Werdermann, Martin; Ludwig, Barbara; Bornstein, Tobias; Brennand, Ana; Bornstein, Stefan R.] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Med 3, Dresden, Germany; [Ruiz-Babot, Gerard; Guasti, Leonardo] Queen Mary Univ London, William Harvey Res Inst, Ctr Endocrinol, London, England; [Ludwig, Barbara; Bornstein, Stefan R.] Tech Univ Dresden, Univ Clin Carl Gustav Carus, Paul Langerhans Inst Dresden, Helmholtz Ctr Munich,Fac Med, Dresden, Germany; [Ludwig, Barbara; Bornstein, Stefan R.] Tech Univ Dresden, Ctr Regenerat Therapies, Dresden, Germany; [Bornstein, Tobias; Brennand, Ana; Bornstein, Stefan R.] Kings Coll London, Diabet & Nutrit Sci Div, London, England; [Schally, Andrew V.] Univ Miami, Miller Sch Med, Div Endocrinol, Dept Med, Miami, FL 33136 USA; [Schally, Andrew V.] Univ Miami, Miller Sch Med, Div Hematol Oncol, Dept Med, Miami, FL 33136 USA; [Schally, Andrew V.] Univ Miami, Miller Sch Med, Div Endocrinol, Dept Pathol, Miami, FL 33136 USA; [Schally, Andrew V.] Univ Miami, Miller Sch Med, Div Hematol Oncol, Dept Pathol, Miami, FL 33136 USA; [Schally, Andrew V.] Vet Affairs Med Ctr, Miami, FL 33125 USA	Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of London; Queen Mary University London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; University of London; King's College London; University of Miami; University of Miami; University of Miami; University of Miami; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Balyura, M (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Med 3, Dresden, Germany.	mariya.balyura@uniklinikum-dresden.de	Steenblock, Charlotte/C-9038-2018	Steenblock, Charlotte/0000-0002-9635-4860; Androutsellis-Theotokis, Andreas/0000-0002-1985-4589				Babu PS, 2002, ENDOCRINOLOGY, V143, P665, DOI 10.1210/en.143.2.665; Balyura M, 2015, P NATL ACAD SCI USA, V112, P2527, DOI 10.1073/pnas.1500242112; Barney M, 2000, ENDOCRINE, V13, P369, DOI 10.1385/ENDO:13:3:369; Benjamins JA, 2014, J NEUROSCI RES, V92, P1243, DOI 10.1002/jnr.23416; Bertelli E, 2002, HISTOCHEM CELL BIOL, V117, P371, DOI 10.1007/s00418-002-0386-2; Call GB, 2000, GEN COMP ENDOCR, V118, P249, DOI 10.1006/gcen.2000.7458; Castellone MD, 2015, ONCOGENE, V34, P1679, DOI 10.1038/onc.2014.104; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Chang SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081865; Chung KF, 2011, MOL CELL ENDOCRINOL, V336, P141, DOI 10.1016/j.mce.2010.11.028; de Celis MFR, 2015, STEM CELLS, V33, P2037, DOI 10.1002/stem.2002; Doga M, 2001, ANN ONCOL, V12, pS89, DOI 10.1093/annonc/12.suppl_2.S89; Dubois-Pot-Schneider H, 2014, HEPATOLOGY, V60, P2077, DOI 10.1002/hep.27353; Dunn JCY, 2009, J SURG RES, V156, P317, DOI 10.1016/j.jss.2009.04.021; Finco I, 2015, ANNU REV PHYSIOL, V77, P105, DOI 10.1146/annurev-physiol-061214-111754; Florea V, 2014, P NATL ACAD SCI USA, V111, P17260, DOI 10.1073/pnas.1420375111; Freddi S, 2005, CLIN ENDOCRINOL, V62, P533, DOI 10.1111/j.1365-2265.2005.02253.x; Guasti L, 2011, MOL CELL ENDOCRINOL, V336, P117, DOI 10.1016/j.mce.2010.11.010; Guzman C., 2010, OPEN NEUROENDOCRINOL, V3, P161, DOI [10.2174/1876528901003010161, DOI 10.2174/1876528901003010161]; Haidan A, 1998, ENDOCRINOLOGY, V139, P772, DOI 10.1210/en.139.2.772; HANLEY N, 1992, J MOL ENDOCRINOL, V8, P131, DOI 10.1677/jme.0.0080131; HORNSBY PJ, 1980, J BIOL CHEM, V255, P4020; HORNSBY PJ, 1992, J STEROID BIOCHEM, V43, P951, DOI 10.1016/0960-0760(92)90323-B; Kim AC, 2009, ENDOCR REV, V30, P241, DOI 10.1210/er.2008-0039; King P, 2009, P NATL ACAD SCI USA, V106, P21185, DOI 10.1073/pnas.0909471106; Lee JH, 2005, ARTHRITIS RHEUM-US, V52, P2386, DOI 10.1002/art.21215; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Ludwig B, 2010, TRANSPL INT, V23, P61; Ludwig B, 2012, P NATL ACAD SCI USA, V109, P5022, DOI 10.1073/pnas.1201868109; MALENDOWICZ LK, 1991, RES EXP MED, V191, P121, DOI 10.1007/BF02576667; Merke DP, 1999, NEW ENGL J MED, V340, P1121, DOI 10.1056/NEJM199904083401416; Merke DP, 2005, LANCET, V365, P2125, DOI 10.1016/S0140-6736(05)66736-0; Mikhaylova IV, 2007, ENDOCRINOLOGY, V148, P386, DOI 10.1210/en.2006-0726; Mukai K, 1998, EUR J BIOCHEM, V256, P190, DOI 10.1046/j.1432-1327.1998.2560190.x; NEKOLA MV, 1981, BIOL REPROD, V24, P505, DOI 10.1095/biolreprod24.3.505; Romero E, 2012, J PHARMACOL EXP THER, V342, P788, DOI 10.1124/jpet.112.195560; Sewer MB, 2002, ENDOCRINOLOGY, V143, P1280, DOI 10.1210/en.143.4.1280; Steenblock C, 2016, MOL CELL ENDOCRINOL; Toti P, 2005, HISTOL HISTOPATHOL, V20, P1115, DOI 10.14670/HH-20.1115; Walczak E.M., 2014, NAT REV ENDOCRINOL; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Ziegler CG, 2009, P NATL ACAD SCI USA, V106, P15879, DOI 10.1073/pnas.0907843106; Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521	43	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194643	10.1371/journal.pone.0194643	http://dx.doi.org/10.1371/journal.pone.0194643			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596439	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000428630000036
J	Thierauf, J; Weissinger, SE; Veit, JA; Affolter, A; Laureano, NK; Beutner, D; Heiduschka, G; Kadletz, L; Meyer, M; Quaas, A; Plinkert, P; Hoffmann, TK; Hess, J				Thierauf, Julia; Weissinger, Stephanie E.; Veit, Johannes A.; Affolter, Annette; Laureano, Natalia K.; Beutner, Dirk; Heiduschka, Gregor; Kadletz, Lorenz; Meyer, Moritz; Quaas, Alexander; Plinkert, Peter; Hoffmann, Thomas K.; Hess, Jochen			Low SOX2 expression marks a distinct subset of adenoid cystic carcinoma of the head and neck and is associated with an advanced tumor stage	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; CANCER; SURVIVAL; LUNG	Introduction The transcription factor SOX2 has been identified as a lineage survival oncogene in squamous cell carcinoma and copy number gain is a common event in several human malignancies including head and neck cancer. However, the regulation and function of SOX2 during carcinogenesis as well as its prognostic value appears to be highly context dependent. As an example, high SOX2 expression in lung squamous cell carcinoma (SCC) is related to a favorable prognosis, while it is associated with poor outcome in lung adenocarcinoma. More recently, higher SOX2 levels and improved survival was also reported for head and neck SCC (HNSCC), and silencing of SOX2 expression in HNSCC cell lines revealed a mesenchymal- like phenotype with prominent vimentin expression. So far, SOX2 expression and its clinical relevance for other head and neck cancers, such as adenoid cystic carcinoma (HNACC) have not been sufficiently investigated. Material and methods SOX2, vimentin and E-cadherin expression was assessed by immunohistochemical staining on serial sections from formalin fixed and paraffin embedded tissue samples of a patient cohort (n = 45) with primary ACC and correlated with patient and tumor characteristics as well as survival. Results High SOX2 expression was found in 14 (31%) primary tumor specimens and was significantly correlated with a N0 lymph node status (p = 0.04), while low SOX2 expression was correlated with a solid growth pattern (p = 0.031). Of the 45 patients, 27 tumor samples resembled an EMT-like phenotype, as assessed by high vimentin and low E-cadherin levels. However, in HNACC SOX2 levels were neither correlated with vimentin nor with E-cadherin expression, further supporting a context dependent regulation and function of SOX2 in distinct tumor entities. Conclusion The absence of SOX2 was predominantly found in solid HNACC, which are characterized by a more aggressive phenotype in ACC. However, the underlying molecular mechanisms of SOX2 regulation and function in distinct HNACC subgroups remain to be fully elucidated.	[Thierauf, Julia; Affolter, Annette; Laureano, Natalia K.; Plinkert, Peter; Hess, Jochen] Heidelberg Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Heidelberg, Germany; [Thierauf, Julia; Veit, Johannes A.; Hoffmann, Thomas K.] Univ Med Ctr Ulm, Dept Otorhinolaryngol Head & Neck Surg, Ulm, Germany; [Weissinger, Stephanie E.] Univ Med Ctr Ulm, Inst Pathol, Ulm, Germany; [Affolter, Annette] Heidelberg Univ Hosp, Inst Pathol, Heidelberg, Germany; [Laureano, Natalia K.; Hess, Jochen] German Canc Res Ctr, Res Grp Mol Mech Head & Neck Tumors, Heidelberg, Germany; [Laureano, Natalia K.] Univ Fed Rio Grande do Sul, Dept Oral Pathol, Porto Alegre, RS, Brazil; [Beutner, Dirk; Meyer, Moritz] Univ Hosp Cologne, Dept Otorhinolaryngol Head & Neck Surg, Cologne, Germany; [Beutner, Dirk] Univ Med Ctr Gottingen, Dept Otorhinolaryngol Head & Neck Surg, Gottingen, Germany; [Heiduschka, Gregor; Kadletz, Lorenz] Vienna Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Vienna, Austria; [Quaas, Alexander] Univ Hosp Cologne, Inst Pathol, Cologne, Germany	Ruprecht Karls University Heidelberg; Ulm University; Ulm University; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Universidade Federal do Rio Grande do Sul; University of Cologne; University of Gottingen; University of Cologne	Thierauf, J (corresponding author), Heidelberg Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Heidelberg, Germany.; Thierauf, J (corresponding author), Univ Med Ctr Ulm, Dept Otorhinolaryngol Head & Neck Surg, Ulm, Germany.	JuliaCara.Thierauf@med.uni-heidelberg.de	Hess, Jochen/ABE-1144-2021	Hess, Jochen/0000-0003-3493-1711				Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bayo P, 2015, MOL ONCOL, V9, P1704, DOI 10.1016/j.molonc.2015.05.006; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Coca-Pelaz A, 2015, ORAL ONCOL, V51, P652, DOI 10.1016/j.oraloncology.2015.04.005; Dai W, 2014, INT J MOL SCI, V15, P8393, DOI 10.3390/ijms15058393; Ferone G, 2016, CANCER CELL, V30, P519, DOI 10.1016/j.ccell.2016.09.001; Honing J, 2014, ANN SURG ONCOL, V21, pS657, DOI 10.1245/s10434-014-3763-x; Huang YH, 2014, HISTOPATHOLOGY, V64, P494, DOI 10.1111/his.12257; Kim BW, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-2015-1; Moskaluk CA, 2013, HEAD NECK PATHOL, V7, P17, DOI 10.1007/s12105-013-0426-3; Otsubo T, 2008, BRIT J CANCER, V98, P824, DOI 10.1038/sj.bjc.6604193; Siegle JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5511; Siu A, 2012, ANTICANCER RES, V32, P3683; Tam WL, 2014, CANCER CELL, V26, P3, DOI 10.1016/j.ccr.2014.06.024; Thierauf J, 2015, MELANOMA RES; Toschi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095303; Wuebben E. L., 2017, ONCOTARGET; Zullig L, 2013, EUR J CANCER, V49, P1915, DOI 10.1016/j.ejca.2013.01.005	18	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194989	10.1371/journal.pone.0194989	http://dx.doi.org/10.1371/journal.pone.0194989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596469	Green Published, Green Submitted, gold			2022-12-26	WOS:000428630000062
J	Ziegler, SJ; Liu, C; Landau, M; Buzovetsky, O; Desimmie, BA; Zhao, Q; Sasaki, T; Burdick, RC; Pathak, VK; Anderson, KS; Xiong, Y				Ziegler, Samantha J.; Liu, Chang; Landau, Mark; Buzovetsky, Olga; Desimmie, Belete A.; Zhao, Qi; Sasaki, Tomoaki; Burdick, Ryan C.; Pathak, Vinay K.; Anderson, Karen S.; Xiong, Yong			Insights into DNA substrate selection by APOBEC3G from structural, biochemical, and functional studies	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SINGLE-STRANDED-DNA; INDUCED CYTIDINE DEAMINASE; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; HIV-1 INFECTION; RETROVIRAL RESTRICTION; REVERSE-TRANSCRIPTASE; AID/APOBEC FAMILY; TYPE-1 VIF	Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3 (A3) proteins are a family of cytidine deaminases that catalyze the conversion of deoxycytidine (dC) to deoxyuridine (dU) in single-stranded DNA (ssDNA). A3 proteins act in the innate immune response to viral infection by mutating the viral ssDNA. One of the most well-studied human A3 family members is A3G, which is a potent inhibitor of HIV-1. Each A3 protein prefers a specific substrate sequence for catalysis D for example, A3G deaminates the third dC in the CCCA sequence motif. However, the interaction between A3G and ssDNA is difficult to characterize due to poor solution behavior of the full-length protein and loss of DNA affinity of the truncated protein. Here, we present a novel DNA-anchoring fusion strategy using the protection of telomeres protein 1 (Pot1) which has nanomolar affinity for ssDNA, with which we captured an A3G-ssDNA interaction. We crystallized a non-preferred adenine in the -1 nucleotide-binding pocket of A3G. The structure reveals a unique conformation of the catalytic site loops that sheds light onto how the enzyme scans substrate in the -1 pocket. Furthermore, our biochemistry and virology studies provide evidence that the nucleotidebinding pockets on A3G influence each other in selecting the preferred DNA substrate. Together, the results provide insights into the mechanism by which A3G selects and deaminates its preferred substrates and help define how A3 proteins are tailored to recognize specific DNA sequences. This knowledge contributes to a better understanding of the mechanism of DNA substrate selection by A3G, as well as A3G antiviral activity against HIV-1.	[Ziegler, Samantha J.; Liu, Chang; Landau, Mark; Buzovetsky, Olga; Zhao, Qi; Anderson, Karen S.; Xiong, Yong] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Landau, Mark; Sasaki, Tomoaki; Anderson, Karen S.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Desimmie, Belete A.; Burdick, Ryan C.; Pathak, Vinay K.] NCI, Ctr Canc Res, HIV Dynam & Replicat Program, Viral Mutat Sect, Frederick, MD 21701 USA	Yale University; Yale University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Xiong, Y (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	yong.xiong@yale.edu		Pathak, Vinay/0000-0003-2441-8412; Desimmie, Belete/0000-0002-1157-4224; Ziegler, Samantha/0000-0003-2480-513X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049551, T32GM007223] Funding Source: NIH RePORTER; NCI NIH HHS [F31 CA203254] Funding Source: Medline; NIAID NIH HHS [T32 AI007019, R01 AI116313, R37 AI116313] Funding Source: Medline; NIGMS NIH HHS [T32 GM007223, R01 GM049551] Funding Source: Medline; NIH HHS [5T32AI007019-40, GM49551, 1F31CA203254-01, T32GM007223] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; [Anonymous], 2010, PYMOL MOL GRAPHICS S; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Carpenter MA, 2010, DNA REPAIR, V9, P579, DOI 10.1016/j.dnarep.2010.02.010; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chen KM, 2007, FEBS LETT, V581, P4761, DOI 10.1016/j.febslet.2007.08.076; Chen ZG, 2012, J IMMUNOL, V189, P3970, DOI 10.4049/jimmunol.1200416; Chiu YL, 2009, PHILOS T R SOC B, V364, P689, DOI 10.1098/rstb.2008.0193; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Delviks-Frankenberry KA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005646; Desimmie BA, 2016, NUCLEIC ACIDS RES, V44, P7848, DOI 10.1093/nar/gkw653; Desimmie BA, 2014, J MOL BIOL, V426, P1220, DOI 10.1016/j.jmb.2013.10.033; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Furukawa Ayako, 2009, Nucleic Acids Symp Ser (Oxf), P87, DOI 10.1093/nass/nrp044; Harjes E, 2009, J MOL BIOL, V389, P819, DOI 10.1016/j.jmb.2009.04.031; Harris RS, 2012, J BIOL CHEM, V287, P40875, DOI 10.1074/jbc.R112.416925; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Jern P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000367; Kohli RM, 2010, J BIOL CHEM, V285, P40956, DOI 10.1074/jbc.M110.177402; Kohli RM, 2009, J BIOL CHEM, V284, P22898, DOI 10.1074/jbc.M109.025536; Kouno T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15024; Lei M, 2003, NATURE, V426, P198, DOI 10.1038/nature02092; Lu XX, 2015, J BIOL CHEM, V290, P4010, DOI 10.1074/jbc.M114.624262; Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nguyen KL, 2004, VIROLOGY, V319, P163, DOI 10.1016/j.virol.2003.11.021; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rathore A, 2013, J MOL BIOL, V425, P4442, DOI 10.1016/j.jmb.2013.07.040; Ray AS, 2002, J BIOL CHEM, V277, P40479, DOI 10.1074/jbc.M205303200; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Russell RA, 2007, J VIROL, V81, P8201, DOI 10.1128/JVI.00395-07; Russell RA, 2009, J VIROL, V83, P1992, DOI 10.1128/JVI.01621-08; Sadler HA, 2010, J VIROL, V84, P7396, DOI 10.1128/JVI.00056-10; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shi K, 2017, NAT STRUCT MOL BIOL, V24, P131, DOI 10.1038/nsmb.3344; Shindo Keisuke, 2012, Biology (Basel), V1, P260, DOI 10.3390/biology1020260; Siriwardena SU, 2016, CHEM REV, V116, P12688, DOI 10.1021/acs.chemrev.6b00296; Smith JL, 2014, J VIROL, V88, P9893, DOI 10.1128/JVI.01318-14; Smith JL, 2010, J VIROL, V84, P12599, DOI 10.1128/JVI.01437-10; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Truckses DM, 1996, PROTEIN SCI, V5, P1907, DOI 10.1002/pro.5560050917; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Wang M, 2010, J EXP MED, V207, P141, DOI 10.1084/jem.20092238; Wedekind JE, 2006, J BIOL CHEM, V281, P38122, DOI 10.1074/jbc.C600253200; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Xiao X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12193; Xue XY, 2007, J MOL BIOL, V366, P965, DOI 10.1016/j.jmb.2006.11.073; YEE JK, 1994, METHOD CELL BIOL, V43, P99; Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758	59	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195048	10.1371/journal.pone.0195048	http://dx.doi.org/10.1371/journal.pone.0195048			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596531	Green Published, Green Submitted, gold			2022-12-26	WOS:000428630000072
J	Khalilova, IS; Dickerhof, N; Mocatta, TJ; Bhagra, CJ; McClean, DR; Obinger, C; Kettle, AJ				Khalilova, Irada S.; Dickerhof, Nina; Mocatta, Tessa J.; Bhagra, Catriona J.; McClean, Dougal R.; Obinger, Christian; Kettle, Anthony J.			A myeloperoxidase precursor, promyeloperoxidase, is present in human plasma and elevated in cardiovascular disease patients	PLOS ONE			English	Article							ACID RESPONSE ELEMENT; CHLORINATING ACTIVITY; LIPID-PEROXIDATION; OXIDATION; KINETICS; RECEPTOR; ATHEROSCLEROSIS; BIOSYNTHESIS; MACROPHAGES; LACTOFERRIN	Myeloperoxidase (MPO)-derived oxidants have emerged as a key contributor to tissue damage in inflammatory conditions such as cardiovascular disease. Pro-myeloperoxidase (pro-MPO), an enzymatically active precursor of myeloperoxidase (MPO), is known to be secreted from cultured bone marrow and promyelocytic leukemia cells, but evidence for the presence of pro-MPO in circulation is lacking. In the present study, we used a LC-MS/MS in addition to immunoblot analyses to show that pro-MPO is present in human blood plasma. Furthermore, we found that pro-MPO was more frequently detected in plasma from patients with myocardial infarction compared to plasma from control donors. Our study suggests that in addition to mature MPO, circulating pro-MPO may cause oxidative modifications of proteins thereby contributing to cardiovascular disease.	[Khalilova, Irada S.; Dickerhof, Nina; Mocatta, Tessa J.; Kettle, Anthony J.] Univ Otago Christchurch, Dept Pathol, Ctr Free Radical Res, Christchurch, New Zealand; [Bhagra, Catriona J.; McClean, Dougal R.] Christchurch Hosp, Cardiol Dept, Christchurch, New Zealand; [Obinger, Christian] BOKU Univ Nat Resources & Life Sci, Div Biochem, Dept Chem, Vienna, Austria; [Khalilova, Irada S.] Khazar Univ, Dept Biol Sci, Ctr Cell Pathol Res, Baku, Azerbaijan; [Bhagra, Catriona J.] Papworth Hosp NHS Fdn Trust, Cambridge, England	University of Otago; Christchurch Hospital New Zealand; University of Natural Resources & Life Sciences, Vienna; Ministry of Education of Azerbaijan Republic; Khazar University; Papworth Hospital	Dickerhof, N (corresponding author), Univ Otago Christchurch, Dept Pathol, Ctr Free Radical Res, Christchurch, New Zealand.	nina.dickerhof@otago.ac.nz	Khalilova, Irada/I-5103-2015; Obinger, Christian/AAV-3173-2021; Khalilova, Irada/AGF-0824-2022; Bhagra, Catriona/AAZ-2180-2020; Bhagra, Catriona/HGA-8106-2022	Khalilova, Irada/0000-0002-4238-3113; Bhagra, Catriona/0000-0002-3960-9273; Bhagra, Catriona/0000-0002-3960-9273; Obinger, Christian/0000-0002-7133-3430; Dickerhof, Nina/0000-0003-2269-4595; Kettle, Tony/0000-0002-8218-7766	Health Research Council of New Zealand	Health Research Council of New Zealand(Health Research Council of New Zealand)	This research was supported by the Health Research Council of New Zealand.	Arnhold J, 2006, EUR J INORG CHEM, P3801, DOI 10.1002/ejic.200600436; Auchere F, 1999, BIOCHEM J, V343, P603, DOI 10.1042/0264-6021:3430603; BAKKENIST ARJ, 1978, BIOCHIM BIOPHYS ACTA, V524, P45, DOI 10.1016/0005-2744(78)90101-8; Banerjee S, 2011, BBA-PROTEINS PROTEOM, V1814, P375, DOI 10.1016/j.bbapap.2010.09.015; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; Furtmuller PG, 2001, FEBS LETT, V503, P147, DOI 10.1016/S0014-5793(01)02725-9; Grishkovskaya I, 2017, J BIOL CHEM, V292, P8244, DOI 10.1074/jbc.M117.775031; Gullberg U, 1999, J IMMUNOL METHODS, V232, P201, DOI 10.1016/S0022-1759(99)00177-5; HANSEN NE, 1975, ACTA MED SCAND, V198, P437; Hansson M, 2006, ARCH BIOCHEM BIOPHYS, V445, P214, DOI 10.1016/j.abb.2005.08.009; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Heinecke JW, 2003, AM J CARDIOL, V91, p12A; Kettle AJ, 2014, BBA-GEN SUBJECTS, V1840, P781, DOI 10.1016/j.bbagen.2013.07.004; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; KLEBANOFF SJ, 1980, ANN INTERN MED, V93, P480, DOI 10.7326/0003-4819-93-3-480; Kumar AP, 2004, J BIOL CHEM, V279, P8300, DOI 10.1074/jbc.M311625200; Marshall CJ, 2010, AM J CARDIOL, V106, P316, DOI 10.1016/j.amjcard.2010.03.028; Marx N, 1998, AM J PATHOL, V153, P17, DOI 10.1016/S0002-9440(10)65540-X; MOGUILEVSKY N, 1991, EUR J BIOCHEM, V197, P605, DOI 10.1111/j.1432-1033.1991.tb15950.x; NAUSEEF WM, 1992, BLOOD, V80, P2622; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P1102, DOI 10.1161/01.ATV.0000163262.83456.6d; OLSEN RL, 1986, BIOCHEM J, V237, P559, DOI 10.1042/bj2370559; OLSSON I, 1984, BIOCHEM J, V223, P911, DOI 10.1042/bj2230911; Piedrafita FJ, 1996, J BIOL CHEM, V271, P14412, DOI 10.1074/jbc.271.24.14412; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; SEGAL AW, 1980, J CELL BIOL, V85, P42, DOI 10.1083/jcb.85.1.42; Senthilmohan R, 2006, ARCH BIOCHEM BIOPHYS, V445, P235, DOI 10.1016/j.abb.2005.07.005; Thomson E, 2010, FREE RADICAL BIO MED, V49, P1354, DOI 10.1016/j.freeradbiomed.2010.07.010; Van Antwerpen P, 2010, J BIOL CHEM, V285, P16351, DOI 10.1074/jbc.M109.089748; vanDalen CJ, 1997, BIOCHEM J, V327, P487; VANSANT G, 1995, P NATL ACAD SCI USA, V92, P8229, DOI 10.1073/pnas.92.18.8229; VENGE P, 1984, CLIN CHIM ACTA, V136, P121, DOI 10.1016/0009-8981(84)90283-3; YAMADA M, 1990, BIOCHEM BIOPH RES CO, V166, P852, DOI 10.1016/0006-291X(90)90888-T; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200; Zhang RL, 2002, BLOOD, V99, P1802, DOI 10.1182/blood.V99.5.1802.h8001802_1802_1810	37	12	13	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0192952	10.1371/journal.pone.0192952	http://dx.doi.org/10.1371/journal.pone.0192952			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590135	Green Submitted, Green Published, gold			2022-12-26	WOS:000428603100011
J	Szczesny, RJ; Kowalska, K; Klosowska-Kosicka, K; Chlebowski, A; Owczarek, EP; Warkocki, Z; Kulinski, TM; Adamska, D; Affek, K; Jedroszkowiak, A; Kotrys, AV; Tomecki, R; Krawczyk, PS; Borowski, LS; Dziembowski, A				Szczesny, Roman J.; Kowalska, Katarzyna; Klosowska-Kosicka, Kamila; Chlebowski, Aleksander; Owczarek, Ewelina P.; Warkocki, Zbigniew; Kulinski, Tomasz M.; Adamska, Dorota; Affek, Kamila; Jedroszkowiak, Agata; Kotrys, Anna V.; Tomecki, Rafal; Krawczyk, Pawel S.; Borowski, Lukasz S.; Dziembowski, Andrzej			Versatile approach for functional analysis of human proteins and efficient stable cell line generation using FLP-mediated recombination system	PLOS ONE			English	Article							INDUCIBLE GENE-EXPRESSION; MAMMALIAN-CELLS; FLUORESCENT PROTEIN; LIVING CELLS; HELA-CELLS; IN-VIVO; TRANSCRIPTION FACTORS; ENHANCED DETECTION; PROTEOMIC ANALYSIS; TRANSGENIC MICE	Deciphering a function of a given protein requires investigating various biological aspects. Usually, the protein of interest is expressed with a fusion tag that aids or allows subsequent analyses. Additionally, downregulation or inactivation of the studied gene enables functional studies. Development of the CRISPR/Cas9 methodology opened many possibilities but in many cases it is restricted to non-essential genes. Recombinase-dependent gene integration methods, like the Flp-In system, are very good alternatives. The system is widely used in different research areas, which calls for the existence of compatible vectors and efficient protocols that ensure straightforward DNA cloning and generation of stable cell lines. We have created and validated a robust series of 52 vectors for streamlined generation of stable mammalian cell lines using the FLP recombinase-based methodology. Using the sequence independent DNA cloning method all constructs for a given coding-sequence can be made with just three universal PCR primers. Our collection allows tetracycline-inducible expression of proteins with various tags suitable for protein localization, FRET, bimolecular fluorescence complementation (BiFC), protein dynamics studies (FRAP), co-immunoprecipitation, the RNA tethering assay and cell sorting. Some of the vectors contain a bidirectional promoter for concomitant expression of miRNA and mRNA, so that a gene can be silenced and its product replaced by a mutated miRNA-insensitive version. Our toolkit and protocols have allowed us to create more than 500 constructs with ease. We demonstrate the efficacy of our vectors by creating stable cell lines with various tagged proteins (numatrin, fibrillarin, coilin, centrin, THOC5, PCNA). We have analysed transgene expression over time to provide a guideline for future experiments and compared the effectiveness of commonly used inducers for tetracycline-responsive promoters. As proof of concept we examined the role of the exoribonuclease XRN2 in transcription termination by RNAseq.	[Szczesny, Roman J.; Kowalska, Katarzyna; Klosowska-Kosicka, Kamila; Chlebowski, Aleksander; Owczarek, Ewelina P.; Warkocki, Zbigniew; Kulinski, Tomasz M.; Adamska, Dorota; Affek, Kamila; Jedroszkowiak, Agata; Kotrys, Anna V.; Tomecki, Rafal; Krawczyk, Pawel S.; Borowski, Lukasz S.; Dziembowski, Andrzej] Polish Acad Sci, Inst Biochem & Biophys, Lab RNA Biol & Funct Genom, Warsaw, Poland; [Szczesny, Roman J.; Chlebowski, Aleksander; Tomecki, Rafal; Borowski, Lukasz S.; Dziembowski, Andrzej] Univ Warsaw, Inst Genet & Biotechnol, Fac Biol, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw	Szczesny, RJ; Dziembowski, A (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Lab RNA Biol & Funct Genom, Warsaw, Poland.; Szczesny, RJ; Dziembowski, A (corresponding author), Univ Warsaw, Inst Genet & Biotechnol, Fac Biol, Warsaw, Poland.	rszczesny@ibb.waw.pl; andrzejd@ibb.waw.pl	Kuliński, Tomasz/E-3292-2019; Borowski, Lukasz S./GRF-4642-2022; Tomecki, Rafal/Y-8438-2019; Krawczyk, Pawel/K-3463-2019	Kuliński, Tomasz/0000-0003-2830-9491; Borowski, Lukasz S./0000-0003-3766-0726; Krawczyk, Pawel/0000-0001-9531-1298; Chlebowski, Aleksander/0000-0001-5018-6294; Jabczynska, Agata/0000-0003-1528-8812; Szczesny, Roman/0000-0002-0686-1632; Adamska, Dorota/0000-0001-6223-1021; Affek, Kamila/0000-0003-4040-3288; Dziembowski, Andrzej/0000-0001-8492-7572; Owczarek, Ewelina Patrycja/0000-0002-1064-1245; Warkocki, Zbigniew/0000-0002-1684-1635; Kotrys, Anna/0000-0003-4983-1414; Tomecki, Rafal/0000-0003-2473-5004; Prokop, Katarzyna/0000-0002-8107-185X	Ministry of Science and Higher Education of Poland [IP2012 046372]; National Science Centre, Poland [UMO-2014/13/D/NZ2/01114, UMO-2012/04/S/NZ1/00036]; Foundation for Polish Science [TEAM/2016-1/3]; European Union - the European Regional Development Fund [POIG.02.02.00-14-024/08-00]	Ministry of Science and Higher Education of Poland(Ministry of Science and Higher Education, Poland); National Science Centre, Poland(National Science Centre, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Union - the European Regional Development Fund	This work was mainly supported by the Ministry of Science and Higher Education of Poland (IP2012 046372 to RJS, www.nauka.gov.pl) and cosupported by the National Science Centre, Poland (UMO-2014/13/D/NZ2/01114 to RJS, UMO-2012/04/S/NZ1/00036 to ZW, www.ncn.gov.pl) and the Foundation for Polish Science (TEAM/2016-1/3 to AD, www.fnp.org.pl). Experiments were carried out with the use of CePT infrastructure financed by the European Union - the European Regional Development Fund (Innovative economy 2007-13, Agreement POIG.02.02.00-14-024/08-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BY, 2013, CELL CYCLE, V12, P3640, DOI 10.4161/cc.26580; Adey A, 2013, NATURE, V500, P207, DOI 10.1038/nature12064; Agwuh KN, 2006, J ANTIMICROB CHEMOTH, V58, P256, DOI 10.1093/jac/dkl224; [Anonymous], 2003, NAT CELL BIOL, V5, P489, DOI 10.1038/ncb0603-490; Antonicka H, 2017, EMBO REP, V18, P28, DOI 10.15252/embr.201643391; Arfelt KN, 2017, CELL SIGNAL, V30, P9, DOI 10.1016/j.cellsig.2016.11.009; Bajar BT, 2016, SCI REP-UK, V6, DOI 10.1038/srep20889; Beckmann BM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10127; Berens C, 2003, EUR J BIOCHEM, V270, P3109, DOI 10.1046/j.1432-1033.2003.03694.x; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Boros J, 2009, NUCLEIC ACIDS RES, V37, P7368, DOI 10.1093/nar/gkp804; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Cesaratto F, 2016, J BIOTECHNOL, V231, P239, DOI 10.1016/j.jbiotec.2016.06.012; Chaudhry MA, 2002, ONCOGENE, V21, P1934, DOI 10.1038/sj.onc.1205264; Chu J, 2016, NAT BIOTECHNOL, V34, P760, DOI 10.1038/nbt.3550; Chu J, 2014, NAT METHODS, V11, P572, DOI [10.1038/NMETH.2888, 10.1038/nmeth.2888]; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Domanski Michal, 2012, Biotechniques, V0, P1, DOI 10.2144/000113864; Dundr M, 2004, J CELL BIOL, V164, P831, DOI 10.1083/jcb.200311121; Durisic N, 2014, NAT METHODS, V11, P156, DOI [10.1038/NMETH.2784, 10.1038/nmeth.2784]; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; Emmott E, 2008, VIROLOGY, V380, P191, DOI 10.1016/j.virol.2008.05.032; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Fong N, 2015, MOL CELL, V60, P256, DOI 10.1016/j.molcel.2015.09.026; Frattini A, 2015, SCI REP-UK, V5, DOI 10.1038/srep15377; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; Hakhverdyan Z, 2015, NAT METHODS, V12, P553, DOI 10.1038/nmeth.3395; Hebert MD, 2000, MOL BIOL CELL, V11, P4159, DOI 10.1091/mbc.11.12.4159; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hernan R, 2000, BIOTECHNIQUES, V28, P789, DOI 10.2144/00284pf01; Hernandez-Verdun D, 2010, WIRES RNA, V1, P415, DOI 10.1002/wrna.39; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Kazak L, 2013, NUCLEIC ACIDS RES, V41, P2354, DOI 10.1093/nar/gks1347; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519; Kohli P, 2014, AM J PHYSIOL-CELL PH, V306, pC805, DOI 10.1152/ajpcell.00339.2013; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Krueger C, 2004, BIOTECHNIQUES, V37, P546, DOI 10.2144/04374BM04; Kuzmenko A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00195; Labno A, 2016, NUCLEIC ACIDS RES, V44, P10437, DOI 10.1093/nar/gkw649; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Lee AV, 1997, BIOTECHNIQUES, V23, P1062, DOI 10.2144/97236st02; Lee SH, 2012, P NATL ACAD SCI USA, V109, P17436, DOI 10.1073/pnas.1215175109; Leonetti MD, 2016, P NATL ACAD SCI USA, V113, pE3501, DOI 10.1073/pnas.1606731113; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Lieu PT, 2009, J BIOMOL SCREEN, V14, P1207, DOI 10.1177/1087057109348941; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Liu HS, 1998, BIOTECHNIQUES, V24, P624, DOI 10.2144/98244st03; Lu HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017297; Lucey BP, 2009, ARCH PATHOL LAB MED, V133, P1463, DOI 10.1043/1543-2165-133.9.1463; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mapendano CK, 2010, MOL CELL, V40, P410, DOI 10.1016/j.molcel.2010.10.012; Martin RM, 2013, CELL REP, V4, P1144, DOI 10.1016/j.celrep.2013.08.013; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; Mechold U, 2005, J BIOTECHNOL, V116, P245, DOI 10.1016/j.jbiotec.2004.12.003; Meyer-Ficca ML, 2004, ANAL BIOCHEM, V334, P9, DOI 10.1016/j.ab.2004.07.011; Morris GE, 2008, BBA-MOL CELL RES, V1783, P2108, DOI 10.1016/j.bbamcr.2008.07.016; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Niewiadomski P, 2013, CELL SIGNAL, V25, P2222, DOI 10.1016/j.cellsig.2013.07.012; NILSSON B, 1987, PROTEIN ENG, V1, P107, DOI 10.1093/protein/1.2.107; No D, 1996, P NATL ACAD SCI USA, V93, P3346, DOI 10.1073/pnas.93.8.3346; Nov D, 2007, CURR OPIN BIOTECH, V18, P411, DOI 10.1016/j.copbio.2007.07.013; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; Pagliuca FW, 2011, MOL CELL, V43, P406, DOI 10.1016/j.molcel.2011.05.031; Paoletti A, 1996, J CELL SCI, V109, P3089; Park J, 2015, CURR PROTOC MOL BIOL, V110, P20; Pelkmans L, 2012, SCIENCE, V336, P425, DOI 10.1126/science.1222161; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Pina AS, 2014, BIOTECHNOL ADV, V32, P366, DOI 10.1016/j.biotechadv.2013.12.001; POSTLE K, 1984, NUCLEIC ACIDS RES, V12, P4849, DOI 10.1093/nar/12.12.4849; Pratt AJ, 2009, J BIOL CHEM, V284, P17897, DOI 10.1074/jbc.R900012200; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rorbach J, 2011, NUCLEIC ACIDS RES, V39, P7750, DOI 10.1093/nar/gkr470; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Saez E, 1997, CURR OPIN BIOTECH, V8, P608, DOI 10.1016/S0958-1669(97)80037-7; Sammarco MC, 2005, ANAL BIOCHEM, V346, P210, DOI 10.1016/j.ab.2005.08.033; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Shyu YJ, 2008, NAT PROTOC, V3, P1693, DOI 10.1038/nprot.2008.157; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Stepanenko AA, 2015, GENE, V569, P182, DOI 10.1016/j.gene.2015.05.065; Stevenson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083888; Stieger K, 2009, ADV DRUG DELIVER REV, V61, P527, DOI 10.1016/j.addr.2008.12.016; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; Sultan M, 2012, BIOCHEM BIOPH RES CO, V422, P643, DOI 10.1016/j.bbrc.2012.05.043; Sun YS, 2012, METHOD ENZYMOL, V504, P371, DOI 10.1016/B978-0-12-391857-4.00019-7; Szczepinska T, 2015, GENOME RES, V25, P1622, DOI 10.1101/gr.189597.115; Szczesny RJ, 2007, BIOL CELL, V99, P323, DOI 10.1042/BC20060108; TAN RY, 1995, P NATL ACAD SCI USA, V92, P5282, DOI 10.1073/pnas.92.12.5282; Thomas H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh144; Tomecki R, 2015, RNA BIOL, V12, P1010, DOI 10.1080/15476286.2015.1073437; Tomecki R, 2014, NUCLEIC ACIDS RES, V42, P1270, DOI 10.1093/nar/gkt930; Tran DDH, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-3; Vascotto C, 2009, MOL CELL BIOL, V29, P1834, DOI 10.1128/MCB.01337-08; Vickers ER, 2002, METHODS, V26, P270, DOI 10.1016/S1046-2023(02)00031-2; von Stetten D, 2012, ACTA CRYSTALLOGR F, V68, P878, DOI 10.1107/S1744309112028667; Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215; Ward RJ, 2011, METHODS MOL BIOL, V746, P21, DOI 10.1007/978-1-61779-126-0_2; Warkocki Z, 2009, NAT STRUCT MOL BIOL, V16, P1237, DOI 10.1038/nsmb.1729; Weidenfeld I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp108; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; White RA, 2000, MICROSC RES TECHNIQ, V49, P451, DOI 10.1002/(SICI)1097-0029(20000601)49:5<451::AID-JEMT7>3.0.CO;2-9; Williams CC, 2014, SCIENCE, V346, P748, DOI 10.1126/science.1257522; Wyborski DL, 1996, ENVIRON MOL MUTAGEN, V28, P447, DOI 10.1002/(SICI)1098-2280(1996)28:4<447::AID-EM22>3.0.CO;2-E; Wydro M, 2010, NUCLEIC ACIDS RES, V38, P3732, DOI 10.1093/nar/gkq068; Xiang S, 2009, NATURE, V458, P784, DOI 10.1038/nature07731; Yao F, 1998, HUM GENE THER, V9, P1939, DOI 10.1089/hum.1998.9.13-1939; Young CL, 2012, BIOTECHNOL J, V7, P620, DOI 10.1002/biot.201100155; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang GH, 1996, BIOCHEM BIOPH RES CO, V227, P707, DOI 10.1006/bbrc.1996.1573; Zhang L, 2001, MOL BIOTECHNOL, V19, P313, DOI 10.1385/MB:19:3:313; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	122	19	19	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194887	10.1371/journal.pone.0194887	http://dx.doi.org/10.1371/journal.pone.0194887			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590189	Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100085
J	Ballotari, P; Venturelli, F; Manicardi, V; Ferrarl, F; Vicentini, M; Greci, M; Pignatti, F; Storani, S; Rossi, PG				Ballotari, Paola; Venturelli, Francesco; Manicardi, Valeria; Ferrarl, Francesca; Vicentini, Massimo; Greci, Marina; Pignatti, Fabio; Storani, Simone; Rossi, Paolo Giorgi			Effectiveness of integrated care model for type 2 diabetes: A population-based study in Reggio Emilia (Italy)	PLOS ONE			English	Article							MELLITUS; ADULTS	Aims To compare the effectiveness of integrated care with that of the diabetes clinic care model in terms of mortality and hospitalisation of type 2 diabetes patients with low risk of complications. Methods Out of 27234 people with type 2 diabetes residing in the province of Reggio Emilia on 31/12/2011, 3071 were included in this cohort study as eligible for integrated care (i.e., low risk of complications) and cared for with the same care model for at least two years. These patients were followed up from 2012 to 2016, for all-cause and diabetes-related mortality and hospital admissions. We performed a Poisson regression model, using the proportion of eligible patients included in the integrated care model for each general practitioner as an instrumental variable. Results 1700 patients were cared for by integrated care and 1371 by diabetes clinics. Mortality rate ratios were 0.83 (95%CI 0.60-1.13) and 0.95 (95%CI 0.54-1.70) for all-cause and cardiovascular mortality, respectively, and incidence rate ratios were 0.90 (95%CI 0.76-1.06) and 0.91 (95%CI 0.69-1.20) for all-cause and cardiovascular disease hospitalisation, respectively. Conclusion For low risk patients with type 2 diabetes, the integrated care model involving both general practitioner and diabetes clinic professionals showed similar mortality and hospitalisation as a model with higher use of specialized care in an exclusively diabetes clinic setting.	[Ballotari, Paola; Venturelli, Francesco; Ferrarl, Francesca; Vicentini, Massimo; Rossi, Paolo Giorgi] Local Hlth Author Reggio Emilia IRCCS, Epidemiol Unit, Reggio Emilia, Italy; [Venturelli, Francesco] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Specializat Sch Hyg & Prevent Med, Modena, Italy; [Venturelli, Francesco] Univ Modena & Reggio Emilia, Clin & Expt Med PhD Program, Modena, Italy; [Manicardi, Valeria] Local Hlth Author Reggio Emilia IRCCS Reggio Emil, Dept Internal Med, Hosp Montecchio, Reggio Emilia, Italy; [Greci, Marina; Pignatti, Fabio; Storani, Simone] Local Hlth Author Reggio EmiliaIRCCS Reggio Emili, Primary Hlth Care, Reggio Emilia, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia	Venturelli, F (corresponding author), Local Hlth Author Reggio Emilia IRCCS, Epidemiol Unit, Reggio Emilia, Italy.; Venturelli, F (corresponding author), Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Specializat Sch Hyg & Prevent Med, Modena, Italy.; Venturelli, F (corresponding author), Univ Modena & Reggio Emilia, Clin & Expt Med PhD Program, Modena, Italy.	venturelli.dr.francesco@gmail.com	Rossi, Paolo Giorgi/K-6367-2016; Venturelli, Francesco/T-6468-2017	Rossi, Paolo Giorgi/0000-0001-9703-2460; Venturelli, Francesco/0000-0002-9190-8668	AMD - Associazione Medici Diabetologi (Italian Association of Clinical Diabetologists)	AMD - Associazione Medici Diabetologi (Italian Association of Clinical Diabetologists)	The study was partially funded through a scholarship by AMD - Associazione Medici Diabetologi (Italian Association of Clinical Diabetologists). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appalachian Trail Conservancy, 2017, 2000 MILERS RECENT Y; Baldo V, 2015, PRIM CARE DIABETES, V9, P54, DOI 10.1016/j.pcd.2014.03.005; Ballotari P, 2014, DIABETES RES CLIN PR, V103, P79, DOI 10.1016/j.diabres.2013.11.020; DICE Team, 1994, BMJ, V308; Duran A, 2008, BMC ENDOCR DISORD, V8; Emilia-Romagna Regional Committee, 2009, LIN GUID REG GEST IN, P2; Fox CS, 2015, DIABETES CARE, V38, P1777, DOI 10.2337/dci15-0012; Giorda C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033839; Goderis G, 2010, DIABETES RES CLIN PR, V88, P56, DOI 10.1016/j.diabres.2009.12.012; GUARIGUATA L, 2014, DIABETES RES CLIN PR, V103; Guo Z, 2014, STAT MED, V33, P3528, DOI 10.1002/sim.6227; Hoskins PL, DIABET MED, V10; HURWITZ B, 1993, BRIT MED J, V306, P624, DOI 10.1136/bmj.306.6878.624; Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042; Katon WJ, 2010, N ENGL J MED, V363; Lancet T., 2015, LANCET, V386, pe3, DOI 10.1016/S0140-6736(15)60692-4; Levey AS, 2006, ANN INTERN MED, V145; McAlister FA, 2007, QUAL SAF HEALTH CARE, V16, P6, DOI 10.1136/qshc.2006.018648; Munch L, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1409-y; Petitti DB, 2005, AM J EPIDEMIOL, V162, P415, DOI 10.1093/aje/kwi224; Prentice RL, 2005, AM J EPIDEMIOL, V162; Schneeweiss S, 2013, J CLIN EPIDEMIOL S, V66; Smith S, 2004, FAM PRACT, V21, P39, DOI 10.1093/fampra/cmh109; Smith SA, 2008, MAYO CLIN P, V83; Smith SM, 2017, COCHRANE DATABASE SY; Smith SM, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004910.pub3; Stukel TA, 2007, JAMA, V297; Vervoort GM, 2013, BR J GEN PRACT, V63; WHO, 2002, INNOVATIVE CARE CHRO	29	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194784	10.1371/journal.pone.0194784	http://dx.doi.org/10.1371/journal.pone.0194784			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584749	Green Published, Green Submitted, gold			2022-12-26	WOS:000428373000035
J	Chudecka-Glaz, A; Cymbaluk-Ploska, A; Wezowska, M; Menkiszak, J				Chudecka-Glaz, Anita; Cymbaluk-Ploska, Aneta; Wezowska, Matgorzata; Menkiszak, Janusz			Could HE4 level measurements during first line chemotherapy predict response to treatment among ovarian cancer patients?	PLOS ONE			English	Article							EPIDIDYMIS PROTEIN 4; SERUM HE-4; OPTIMAL DEBULKING; PROGNOSTIC-FACTOR; CARCINOMA; CA125; DIAGNOSIS; BIOMARKER; OVCAD; ROMA	Background This study assessed the prognostic value of HE4 marker measurements at various stages of first-line chemotherapy for ovarian cancer. Methods The study consisted of 90 ovarian cancer patients, including 48 women undergoing primary surgical treatment and 42 patients qualified for neoadjuvant chemotherapy. Each patient underwent HE4 and CA 125 level measurements at the time of diagnosis and subsequently as follows: after surgical treatment, after the third course of adjuvant chemotherapy, before interval cytoreductive surgery and after chemotherapy. The HE4 value was assessed based on the PSF, OS, DFS, surgical outcome, two-year survival and platinum sensitivity. Results Preoperative HE4 levels were a predictor of platinum sensitivity (AUC-0.644; p = 0.035) and DFS (AUC = 0.637; p = 0.0492). A univariate logistic regression analysis showed that serum HE4 significantly correlated with PFS (baseline results over median HR = 2.96, p = 0.0009; baseline over 75 percentile HR = 2.44, p = 0.0062; normalization after treatment HR = 0.46, p = 0.0125; 50% reduction before IDS HR = 0.64, p = 0.0017). In the multivariate analysis, normalization after treatment and 50% reduction before IDS significantly influenced the PFS (HR = 0.29, p = 0.00008; HR = 0.23, p = 0.0024). The HE4 levels also correlated with the OS as follows: values below the median (HR = 1.88, p = 0.0087), normalization after chemotherapy (HR = 0.08, p = 0.0003), and 50% reduction before IDS (HR = 0.39, p = 0.0496). Conclusions The significant effect of the normalization of the HE4 marker after therapy and 50% reduction of HE4 levels before interval cytoreductive surgery on PFS and OS confirmed that HE4 might be an independent prognostic factor of treatment response. HE4 measurements performed during first-line treatment of ovarian cancer may have prognostic significance.	[Chudecka-Glaz, Anita; Cymbaluk-Ploska, Aneta; Wezowska, Matgorzata; Menkiszak, Janusz] Pomeranian Med Univ, Dept Gynecol Surg & Gynecol Oncol Adults & Adoles, Szczecin, Poland	Pomeranian Medical University	Chudecka-Glaz, A (corresponding author), Pomeranian Med Univ, Dept Gynecol Surg & Gynecol Oncol Adults & Adoles, Szczecin, Poland.	anitagl@poczta.onet.pl	Menkiszak, Janusz JM/I-4036-2014; Chudecka-Glaz, Anita/A-5813-2015	Menkiszak, Janusz JM/0000-0001-8279-7196; Chudecka-Glaz, Anita/0000-0003-2784-7968	Pomeranian Medical University of Szczecin, Poland [WLA-119-01/S/12/2016]	Pomeranian Medical University of Szczecin, Poland	The study was supported by grants No WLA-119-01/S/12/2016 from Pomeranian Medical University of Szczecin, Poland.	Anastasi E, 2010, TUMOR BIOL, V31, P113, DOI 10.1007/s13277-009-0015-y; Angioli R, 2013, GYNECOL ONCOL, V128, P579, DOI 10.1016/j.ygyno.2012.11.040; Armstrong DK., 2001, ONCOLOGIST S7, P20; Braicu EI, 2013, GYNECOL ONCOL, V128, P245, DOI 10.1016/j.ygyno.2012.11.023; Braicu EI, 2014, ANN SURG ONCOL, V21, P955, DOI 10.1245/s10434-013-3347-1; Chen WT, 2014, ASIAN PAC J CANCER P, V15, P101, DOI 10.7314/APJCP.2014.15.1.101; Chhikara N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047672; Chudecka-Glaz A, 2012, EUR J GYNAECOL ONCOL, V33, P382; Chudecka-Glaz AM, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-62; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Hellstrom I, 2003, CANCER RES, V63, P3695; Hynninen J, 2011, INT J GYNECOL CANCER, V21, P1573, DOI 10.1097/IGC.0b013e3182225509; Kaijser J, 2014, INT J GYNECOL CANCER, V24, P1173, DOI 10.1097/IGC.0000000000000181; Kalapotharakos G, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-20; KIRCHHOFF C, 1991, BIOL REPROD, V45, P350, DOI 10.1095/biolreprod45.2.350; Kong SY, 2012, ANN SURG ONCOL, V19, P1707, DOI 10.1245/s10434-011-1943-5; Langmar Z, 2011, EUR J GYNAECOL ONCOL, V32, P605; Lu RQ, 2012, BIOCHEM BIOPH RES CO, V419, P274, DOI 10.1016/j.bbrc.2012.02.008; Manganaro L, 2013, ONCOL REP, V30, P2481, DOI 10.3892/or.2013.2682; Markowska J, 2013, CURR GYNECOL ONCOL, V11, P9; Nassir M, 2016, TUMOR BIOL, V37, P3009, DOI 10.1007/s13277-015-4031-9; Paek J, 2011, EUR J OBSTET GYN R B, V158, P338, DOI 10.1016/j.ejogrb.2011.05.021; Plotti F, 2012, TUMOR BIOL, V33, P2117, DOI 10.1007/s13277-012-0471-7; Ribeiro JR, 2016, J OVARIAN RES, V9, DOI 10.1186/s13048-016-0240-0; Rustin GJS, 2011, INT J GYNECOL CANCER, V21, P419, DOI 10.1097/IGC.0b013e3182070f17; Steffensen KD, 2012, INT J GYNECOL CANCER, V22, P1474, DOI 10.1097/IGC.0b013e3182681cfd; Steffensen KD, 2011, INT J GYNECOL CANCER, V21, P1040, DOI 10.1097/IGC.0b013e31821e052e; Trudel D, 2012, GYNECOL ONCOL, V127, P511, DOI 10.1016/j.ygyno.2012.09.003; Unterscheider J, 2012, AM J OBSTET GYNECOL, V206, pS309, DOI 10.1016/j.ajog.2011.12.028; Vallius T, 2014, TUMOR BIOL, V35, P12389, DOI 10.1007/s13277-014-2553-1; Wang JW, 2014, TUMOR BIOL, V35, P6127, DOI 10.1007/s13277-014-1811-6; Wu L, 2012, INT J GYNECOL CANCER, V22, P1106, DOI 10.1097/IGC.0b013e318263efa2; Yang ZJ, 2013, ONCOL LETT, V6, P28, DOI 10.3892/ol.2013.1339	33	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194270	10.1371/journal.pone.0194270	http://dx.doi.org/10.1371/journal.pone.0194270			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584739	Green Submitted, gold, Green Published			2022-12-26	WOS:000428373000020
J	Feral-Pierssens, AL; Carette, C; Rives-Lange, C; Matta, J; Goldberg, M; Juvinz, P; Zins, M; Czernichow, S				Feral-Pierssens, Anne-Laure; Carette, Claire; Rives-Lange, Claire; Matta, Joane; Goldberg, Marcel; Juvinz, Philippe; Zins, Marie; Czernichow, Sebastien			Obesity and emergency care in the French CONSTANCES cohort	PLOS ONE			English	Article							BODY-MASS INDEX; MILLION WOMEN; HEALTH; COSTS; COMPLICATIONS; MORTALITY; RISK	Context Obese patients are raising specific questions in emergency care such as equipment issues or urgent procedures. Even though obesity prevalence and subsequent health expenditure are increasing worldwide, there is scarce literature about their specific resource utilization of Emergency Departments (ED). These few studies do not take into account both socio-economic situation and comorbidities which are well-known factors influencing healthcare use. Our objective was to assess the emergency care resource utilization of obese individuals (Body Mass Index (BMI) >= 30kg.m(-2)) compared to normal-weight individuals taking into account comorbidities and social-economic situations. Methods The French CONSTANCES epidemiologic cohort is a randomly selected sample of French adults. Participants data are linked to the National Health Insurance Database collecting all medical acts. The rate of ED visits of obese (and each obesity class) and normal-weight participants were compared considering confounding factors (comorbidities, various socio-economic data). The primary endpoint was to have visited the ED between 2010 and 2013. Sex-separated analysis and multivariate logistic regression models were performed and adjusted odds-ratios [OR] (95% Confidence Intervals [CI]) were calculated. Results We included 21,035 normal-weight and 5,003 obese participants. Obese participants visited the ED more often than normal-weight participants (men: 30.5% vs. 26.7%; women: 30.3% vs. 24.4%, P<0.001). Obese participants presented more comorbidities and a lower socioeconomic situation than normal-weight participants. After adjustment, obese participants had a higher risk of visiting ED (men: OR = 1.18; 95% CI: 1.04-1.33; and women: OR = 1.36; 95% CI: 1.22-1.52), with a higher risk for class III participants (BMI > 40 kg.m(-2)) (men: OR = 2.18; CI 95%: 1.32-3.63; and women: OR = 1.85; 95% CI: 1.38-2.49). Conclusion Obese individuals have a higher level of emergency care resource utilization than normal weight individuals and it increases with severe obesity. Further studies are needed to better understand their healthcare pathways leading to EDs.	[Feral-Pierssens, Anne-Laure; Goldberg, Marcel; Zins, Marie] INSERM, UMS 11, Populat Based Epidemiol Cohorts Unit, Villejuif, France; [Feral-Pierssens, Anne-Laure; Juvinz, Philippe] Georges Pompidou European Hosp, AP HP, Emergency Dept, Paris, France; [Carette, Claire; Rives-Lange, Claire; Czernichow, Sebastien] Georges Pompidou European Hosp, AP HP, Ctr Specialise Obesite IdF, Nutr Dept, Paris, France; [Rives-Lange, Claire; Goldberg, Marcel; Juvinz, Philippe; Zins, Marie; Czernichow, Sebastien] Paris Descartes Univ, Paris, France; [Matta, Joane] Holy Spirit Univ, Fac Agr & Food Sci, Nutr Dept, Jounieh, Lebanon; [Czernichow, Sebastien] Epidemiol & Biostat Sorbonne Paris Cite Ctr CRESS, INSERM, UMR 1153, METHODS Team, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Feral-Pierssens, AL (corresponding author), INSERM, UMS 11, Populat Based Epidemiol Cohorts Unit, Villejuif, France.; Feral-Pierssens, AL (corresponding author), Georges Pompidou European Hosp, AP HP, Emergency Dept, Paris, France.	anne-laure.feral-pierssens@aphp.fr	Zins, Marie/AAX-6551-2021; Goldberg, Marcel/I-7834-2012	Goldberg, Marcel/0000-0002-6161-5880	Caisse nationale d'assurance maladie des travailleurs salaries (CNAMTS); french Ministry of Health; Council of the Ile de France Region; Cohorts TGIR IReSP-ISP INSERM (Ministere de la sante et des sports, Ministere delegue a la recherche, Institut national de la sante et de la recherche medicale, Institut national du cancer et Caisse nationale de solidarite pour l'autonomie); French Commissariat general a l'investissement [ANR-11-INBS-0002]; MSD; MSD, AstraZeneca; Lundbeck	Caisse nationale d'assurance maladie des travailleurs salaries (CNAMTS); french Ministry of Health; Council of the Ile de France Region(Region Ile-de-France); Cohorts TGIR IReSP-ISP INSERM (Ministere de la sante et des sports, Ministere delegue a la recherche, Institut national de la sante et de la recherche medicale, Institut national du cancer et Caisse nationale de solidarite pour l'autonomie); French Commissariat general a l'investissement; MSD; MSD, AstraZeneca; Lundbeck(Lundbeck Corporation)	The CONSTANCES Cohort Study was funded by the Caisse nationale dassurance maladie des travailleurs salaries (CNAMTS), the french Ministry of Health, the Council of the Ile de France Region, and by the Cohorts TGIR IReSP-ISP INSERM (Ministere de la sante et des sports, Ministere delegue a la recherche, Institut national de la sante et de la recherche medicale, Institut national du cancer et Caisse nationale de solidarite pour l'autonomie). CONSTANCES benefits from a grant from the French Commissariat general a linvestissement (contrat ANR-11-INBS-0002). CONSTANCES also receives funding from MSD, AstraZeneca and Lundbeck managed by INSERM-Transfert. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becerra MB, 2017, J ASTHMA, V54, P376, DOI 10.1080/02770903.2016.1218017; Bertakis KD, 2005, OBES RES, V13, P372, DOI 10.1038/oby.2005.49; Black MH, 2013, AM J EPIDEMIOL, V178, P1120, DOI 10.1093/aje/kwt093; Brunette DD, 2004, AM J EMERG MED, V22, P40, DOI 10.1016/S0735-6757(02)42250-4; Chang VW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188636; Chen Y, 2007, INT J OBESITY, V31, P962, DOI 10.1038/sj.ijo.0803530; Christiansen Bjorg, 2012, Int J Qual Stud Health Well-being, V7, P17255, DOI 10.3402/qhw.v7i0.17255; Collaborators TG, 2015, N ENGL J MED; Dargin J, 2010, ANN EMERG MED, V56, P95, DOI 10.1016/j.annemergmed.2010.03.011; De Jong A, 2015, BRIT J ANAESTH, V114, P297, DOI 10.1093/bja/aeu373; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Espallardo O, 2017, OBES SURG, V27, P2058, DOI 10.1007/s11695-017-2596-7; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Forhan M, 2013, BEST PRACT RES CL EN, V27, P129, DOI 10.1016/j.beem.2013.01.003; Frost G, 2005, OBES RES, V13, P1442; Fursevich DM, 2016, RADIOGRAPHICS, V36, P1076, DOI 10.1148/rg.2016150198; Fusco KL, 2017, SAGE OPEN MED, V5, DOI 10.1177/2050312117700065; Garver MJ, 2014, ARTHRITIS, DOI 10.1155/2014/375909; Goldberg M, 2016, REV EPIDEMIOL SANTE, V64, P313, DOI 10.1016/j.respe.2016.02.010; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Hales C, 2018, AUST CRIT CARE, V31, P37, DOI 10.1016/j.aucc.2017.02.070; Hart CL, 2007, J PUBLIC HEALTH, V29, P53, DOI 10.1093/pubmed/fdl088; Himes CL, 2012, J AM GERIATR SOC, V60, P124, DOI 10.1111/j.1532-5415.2011.03767.x; Kent S, 2017, LANCET PUBLIC HEALTH, V2, pE214, DOI 10.1016/S2468-2667(17)30062-2; Kent S, 2017, OBES REV, V18, P869, DOI 10.1111/obr.12560; Kitahara CM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001673; Lerdal A, 2011, QUAL LIFE RES, V20, P1187, DOI 10.1007/s11136-011-9865-z; Lette M, 2016, EUR J HEALTH ECON, V17, P61, DOI 10.1007/s10198-014-0655-8; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; Matta J., 2016, Bulletin Epidemiologique Hebdomadaire, P640; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Pepper DJ, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1360-z; Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Reeves GK, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-45; Ruiz F, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3439-5; Scantlebury R, 2015, BRIT J GEN PRACT, V65, pE649, DOI 10.3399/bjgp15X686893; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; von Lengerke T, 2011, MATURITAS, V69, P220, DOI 10.1016/j.maturitas.2011.04.005; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x; Wu YX, 2018, J CHEMOTHERAPY, V30, P49, DOI 10.1080/1120009X.2017.1338846; Zins M, 2015, EUR J EPIDEMIOL, V30, P1317, DOI 10.1007/s10654-015-0096-4; Zins M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-479; Zizza C, 2004, AM J PUBLIC HEALTH, V94, P1587, DOI 10.2105/AJPH.94.9.1587	44	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194831	10.1371/journal.pone.0194831	http://dx.doi.org/10.1371/journal.pone.0194831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5DH	29579083	gold, Green Published, Green Submitted			2022-12-26	WOS:000428351800058
J	Villanueva, B; Arteaga, A; Maiz, A; Cortes, VA				Villanueva, Beatriz; Arteaga, Antonio; Maiz, Alberto; Cortes, Victor A.			Abdominal obesity is a common finding in normal and overweight subjects of Chile and is associated with increased frequency of cardiometabolic risk factors	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; WAIST CIRCUMFERENCE; ADIPOSE-TISSUE; CONSENSUS STATEMENT; FAT; PATHOPHYSIOLOGY; PARTICIPANTS; MANAGEMENT	Background/Objectives Abdominal obesity (AO) is associated with elevated risk for cardiovascular diseases; however, this association is less clear for non-obese people. We estimated the association of AO and cardiovascular risk factors (CVRF) and disease in non-obese adult individuals from Chile. Subjects/Methods 5248 adults (15 years of age or older) of both sexes from the Chilean National Health Survey (October 2009 September 2010, response rate 85%.) were included. Information on myocardial infarction and stroke was self-reported. BMI, waist circumference (WC), arterial pressure, plasma glucose, and cholesterol levels were measured. Predictive accuracy of WC was evaluated by area under curve of receiver operating characteristic analysis and cut off points were established by Youden Index. Relationship between AO and CVRF was analyzed by Chi-squared tests. Results Normal weight/overweight/obesity were present in 34.4%/45.2%/18.1% of men and 33.4%/33.6%/27.5% of women. Predictive accuracy of WC to identify at least one CVRF was 0.70/0.67 and optimal cutoff points for WC in non-obese subjects were 91/83 cm in men/women, respectively. AO was present in 98.2%/99.1% of obese, 70.5%/77.4% of overweight and 12.4%/16.4% of normal weight men/women. AO was associated with increased frequency of CVRF in overweight men (6/8 and stroke) and women (4/8) and higher frequency in normal weight men (8/8 and myocardial infarction/stroke) and women (6/8 and myocardial infarction). Conclusions WC cutoff points calculated for non-obese chilean population discriminate more differences in CVRF in normal weight woman. AO significantly increases the frequency of CVRF and diseases in overweight and especially normal weight individuals. WC can be used as a low cost, feasible and reproducible predictor for CVRF in non-obese individuals in most clinical settings.	[Villanueva, Beatriz; Arteaga, Antonio; Maiz, Alberto; Cortes, Victor A.] Pontificia Univ Catolica Chile, Escuela Med, Dept Nutr Diabet & Metab, Santiago, Chile	Pontificia Universidad Catolica de Chile	Cortes, VA (corresponding author), Pontificia Univ Catolica Chile, Escuela Med, Dept Nutr Diabet & Metab, Santiago, Chile.	vcortesm@uc.cl		Cortes, Victor/0000-0002-1658-0965	Comision Nacional de Ciencia y tecnologia, Fondecyt [1141134]	Comision Nacional de Ciencia y tecnologia, Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Funded by Comision Nacional de Ciencia y tecnologia, Fondecyt grant 1141134 http:/www.conicyt.cl/fondecyt/.	Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; [Anonymous], 2014, OBESITY, V22, P20660; [Anonymous], 2000, PRACT GUID ID EV TRE; Ashwell M, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0207-1; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Czernichow S, 2007, INT J OBESITY, V31, P791, DOI 10.1038/sj.ijo.0803477; DESPRES JP, 1990, ARTERIOSCLEROSIS, V10, P497, DOI 10.1161/01.ATV.10.4.497; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Fasce H Eduardo, 2010, Rev Chil Cardiol, V29, P11; Gradmark AMI, 2010, BRIT J NUTR, V104, P582, DOI 10.1017/S0007114510000796; Grundy SM, 2015, EUR J CLIN INVEST, V45, P1209, DOI 10.1111/eci.12519; HAN TS, 1995, BRIT MED J, V311, P1401, DOI 10.1136/bmj.311.7017.1401; Hermsdorff HHM, 2014, EUR J PREV CARDIOL, V21, P884, DOI 10.1177/2047487312472420; Hermsdorff HHM, 2012, INFLAMM RES, V61, P427, DOI 10.1007/s00011-011-0429-z; Heymsfield SB, 2017, NEW ENGL J MED, V376, P254, DOI 10.1056/NEJMra1514009; Keys A, 1981, Prog Clin Biol Res, V67, P31; Klein S, 2007, OBESITY, V15, P1061, DOI 10.1038/oby.2007.632; Lanas F, 2017, J CLIN EPIDEMIOL, V86, P111, DOI 10.1016/j.jclinepi.2016.04.018; LAPIDUS L, 1984, BMJ-BRIT MED J, V289, P1257, DOI 10.1136/bmj.289.6454.1257; LARSSON B, 1984, BRIT MED J, V288, P1401, DOI 10.1136/bmj.288.6428.1401; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Li C, 2006, INT J OBESITY, V30, P1775, DOI 10.1038/sj.ijo.0803339; Lofgren I, 2004, J NUTR, V134, P1071, DOI 10.1093/jn/134.5.1071; MCNEIL BJ, 1984, MED DECIS MAKING, V4, P137, DOI 10.1177/0272989X8400400203; Millan J, 2007, CLIN INVEST ARTERIOS, V19, P61, DOI 10.1016/S0214-9168(07)74175-X; Muller MJ, 2016, P NUTR SOC, V75, P181, DOI 10.1017/S0029665115004206; Ray I, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00157; Salud Md, ENCUESTA NACL SALUD; Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035; Soutelo J, 2013, Rev. argent. endocrinol. metab., V50, P25; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Twig G, 2016, NEW ENGL J MED, V374, P2430, DOI 10.1056/NEJMoa1503840; World Health Organization (WHO), 2011, WAIST CIRCUMFERENCE; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Yang L, 2008, J INTERN MED, V264, P39, DOI 10.1111/j.1365-2796.2007.01907.x	37	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194644	10.1371/journal.pone.0194644	http://dx.doi.org/10.1371/journal.pone.0194644			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579094	Green Published, Green Submitted, gold			2022-12-26	WOS:000428351800040
J	Cortes, KC; Rosinska, M; Janiak, M; Stepien, M; Zagordi, O; Perlejewski, K; Osuch, S; Pawelczyk, A; Bukowska-Osko, I; Ploski, R; Grabarczyk, P; Laskus, T; Radkowski, M				Cortes, Kamila Caraballo; Rosinska, Magdalena; Janiak, Maciej; Stepien, Malgorzata; Zagordi, Osvaldo; Perlejewski, Karol; Osuch, Sylwia; Pawelczyk, Agnieszka; Bukowska-Osko, Iwona; Ploski, Rafal; Grabarczyk, Piotr; Laskus, Tomasz; Radkowski, Marek			Next-generation sequencing analysis of a cluster of hepatitis C virus infections in a haematology and oncology center	PLOS ONE			English	Article							TRANSMISSION; EVOLUTION; IDENTIFICATION; OUTBREAK; GLYCANS; REGION	Molecular characterization of early hepatitis C virus (HCV) infection remains rare. Ten out of 78 patients of a hematology/oncology center were found to be HCV RNA positive two to four months after hospitalization. Only two of the ten patients were anti-HCV positive. HCV hypervariable region 1 (HVR1) was amplified in seven patients (including one anti-HCV positive) and analyzed by next generation sequencing (NGS). Genetic variants were reconstructed by Shorah and an empirically established 0.5% variant frequency cut-off was implemented. These sequences were compared by phylogenetic and diversity analyses. Ten unrelated blood donors with newly acquired HCV infection detected at the time of donation (HCV RNA positive and anti-HCV negative) served as controls. One to seven HVR1 variants were found in each patient. Sequences intermixed phylogenetically with no evidence of clustering in individual patients. These sequences were more similar to each other (similarity 95.4% to 100.0%) than to those of controls (similarity 64.8% to 82.6%). An identical predominant variant was present in four patients, whereas other closely related variants dominated in the remaining three patients. In five patients the HCV population was limited to a single variant or one predominant variant and minor variants of less than 10% frequency. In conclusion, NGS analysis of a cluster of HCV infections acquired in the hospital setting revealed the presence of low diversity, very closely related variants in all patients, suggesting an early-stage infection with the same virus. NGS combined with phylogenetic analysis and classical epidemiological analysis could help in tracking of HCV outbreaks.	[Cortes, Kamila Caraballo; Janiak, Maciej; Perlejewski, Karol; Osuch, Sylwia; Pawelczyk, Agnieszka; Bukowska-Osko, Iwona; Laskus, Tomasz; Radkowski, Marek] Med Univ Warsaw, Dept Immunopathol Infect & Parasit Dis, Warsaw, Poland; [Rosinska, Magdalena; Stepien, Malgorzata] NIH, NIPH, Warsaw, Poland; [Zagordi, Osvaldo] Univ Zurich, Inst Med Virol, Zurich, Switzerland; [Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland; [Grabarczyk, Piotr] Inst Hematol & Transfusiol, Dept Virol, Warsaw, Poland	Medical University of Warsaw; National Institute of Hygiene (NIH); University of Zurich; Medical University of Warsaw	Cortes, KC (corresponding author), Med Univ Warsaw, Dept Immunopathol Infect & Parasit Dis, Warsaw, Poland.	kcaraballo@wum.edu.pl	Stępień, Małgorzata/AAV-4282-2020; Bukowska-Ośko, Iwona/V-3859-2018; Cortés, Kamila Caraballo/ABB-9291-2020; Rosińska, Magdalena/K-5857-2019; Rosińska, Magdalena/Q-2068-2018; Grabarczyk, Piotr/AAA-6224-2020; Caraballo Cortes, Kamila/W-2011-2018; Pawełczyk, Agnieszka/M-4934-2018; Perlejewski, Karol/V-3854-2018; Radkowski, Marek/V-3860-2018	Stępień, Małgorzata/0000-0002-4640-7290; Bukowska-Ośko, Iwona/0000-0002-0216-7184; Cortés, Kamila Caraballo/0000-0002-7924-7852; Rosińska, Magdalena/0000-0002-6256-7809; Rosińska, Magdalena/0000-0002-6256-7809; Grabarczyk, Piotr/0000-0001-5200-5629; Caraballo Cortes, Kamila/0000-0002-7924-7852; Pawełczyk, Agnieszka/0000-0001-9336-8258; Perlejewski, Karol/0000-0002-3782-6442; Ploski, Rafal/0000-0001-6286-5526; Osuch, Sylwia/0000-0003-2721-559X; Radkowski, Marek/0000-0003-1808-679X; Janiak, Maciej/0000-0002-8949-6094	National Science Center, Poland [UM0-2013/11/B/NZ6/01679, UM0-2015/19/D/NZ6/ 01303]; Medical University of Warsaw [1M24/PM11/14]; NIZP-PZH task [6/EM.1/2017]; National Health Program task [6/4/3.1k/1/NPZ/2017/1094/773]	National Science Center, Poland(National Science Centre, Poland); Medical University of Warsaw; NIZP-PZH task; National Health Program task	This study was funded by grants UM0-2013/11/B/NZ6/01679 and UM0-2015/19/D/NZ6/ 01303 from the National Science Center, Poland, 1M24/PM11/14 from the Medical University of Warsaw, NIZP-PZH task No. 6/EM.1/2017 and National Health Program task No. 6/4/3.1k/1/NPZ/2017/1094/773.	Arenas JI, 2004, J INFECT DIS, V189, P2037, DOI 10.1086/386338; Barzon L, 2013, J CLIN VIROL, V58, P346, DOI 10.1016/j.jcv.2013.03.003; Brown RJP, 2012, J VIROL, V86, P11956, DOI 10.1128/JVI.01079-12; Bull RA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002243; Burke KP, 2010, IMMUNOL RES, V47, P216, DOI 10.1007/s12026-009-8152-3; Campo DS, 2016, J INFECT DIS, V213, P957, DOI 10.1093/infdis/jiv542; Cantaloube JF, 2003, J GEN VIROL, V84, P441, DOI 10.1099/vir.0.18642-0; Cochrane A, 2002, J INFECT DIS, V186, P1212, DOI 10.1086/344314; Cortes KC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150311; Cortes KC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-389; Cortes KC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/626083; D'Arienzo V, 2013, J VIROL, V87, P13609, DOI 10.1128/JVI.02119-13; Di Lillo FA, 2015, ANN HEPATOL, V14, P442, DOI 10.1016/S1665-2681(19)31164-0; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Escobar-Gutierrez A, 2012, J CLIN MICROBIOL, V50, P1461, DOI 10.1128/JCM.00005-12; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Gotz HM, 2005, AIDS, V19, P969, DOI 10.1097/01.aids.0000171412.61360.f8; Helle F, 2007, J VIROL, V81, P8101, DOI 10.1128/JVI.00127-07; Helle F, 2010, J VIROL, V84, P11905, DOI 10.1128/JVI.01548-10; Herring BL, 2005, J VIROL, V79, P4340, DOI 10.1128/JVI.79.7.4340-4346.2005; Hussein N, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0231-y; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Laskus T, 2004, GASTROENTEROLOGY, V127, P764, DOI 10.1053/j.gastro.2004.06.005; Li H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002880; Liu Z, 2004, J CLIN MICROBIOL, V42, P4223, DOI 10.1128/JCM.42.9.4223-4229.2004; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Prosperi MCF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013619; Ray SC, 2005, J EXP MED, V201, P1753, DOI 10.1084/jem.20050122; Ray SC, 2000, J VIROL, V74, P3058, DOI 10.1128/JVI.74.7.3058-3066.2000; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Wang GP, 2010, J VIROL, V84, P6218, DOI 10.1128/JVI.02271-09; Zagordi O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-119	35	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194816	10.1371/journal.pone.0194816	http://dx.doi.org/10.1371/journal.pone.0194816			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566084	Green Published, gold, Green Submitted			2022-12-26	WOS:000428093900109
J	Narayanan, SA; Metzger, CE; Bloomfield, SA; Zawieja, DC				Narayanan, S. Anand; Metzger, Corinne E.; Bloomfield, Susan A.; Zawieja, David C.			Inflammation-induced lymphatic architecture and bone turnover changes are ameliorated by irisin treatment in chronic inflammatory bowel disease	FASEB JOURNAL			English	Article						Crohn's disease; immunolymph; osteoimmunology; therapeutic intervention	TNBS-INDUCED COLITIS; SKELETAL-MUSCLE; MYOKINE IRISIN; IN-VITRO; LYMPHANGIOGENESIS; EXERCISE; EXPRESSION; MICE; PODOPLANIN; CYTOKINES	Inflammatory bowel disease (IBD) is a chronic disease with gastrointestinal dysfunction as well as comorbidities such as inflammation-induced bone loss and impaired immune response. Current treatments for IBD all have negative, potentially severe side effects. We aimed to test whether exogenous treatment with irisin, a novel immunomodulatory adipomyokine, could ameliorate IBD-induced lymphatic and bone alterations. Irisin treatment improved both gut and bone outcomes by mitigating inflammation and restoring structure. In the gut, IBD caused colonic lymphatic hyperproliferation into the mucosal and submucosal compartments. This proliferation in the rodent model is akin to what is observed in IBD patient case studies. In bone, IBD increased osteoclast surface and decreased bone formation. Both gut and osteocytes in bone exhibited elevated levels of TNF- and receptor activator of NF-B ligand (RANKL) protein expression. Exogenous irisin treatment restored normal colonic lymphatic architecture and increased bone formation rate concurrent with decreased osteoclast surfaces. After irisin treatment, gut and osteocyte TNF- and RANKL protein expression levels were no different from vehicle controls. Our data indicate that the systemic immunologic changes that occur in IBD are initiated by damage in the gut and likely linked through the lymphatic system. Additionally, irisin is a potential novel intervention mitigating both local inflammatory changes in the gut and distant changes in bone.Narayanan, S. A., Metzger, C. E., Bloomfield, S. A., Zawieja, D. C. Inflammation-induced lymphatic architecture and bone turnover changes are ameliorated by irisin treatment in chronic inflammatory bowel disease.	[Narayanan, S. Anand; Zawieja, David C.] Texas A&M Univ, Dept Med Physiol, Hlth Sci Ctr, Temple, TX USA; [Metzger, Corinne E.; Bloomfield, Susan A.] Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station	Narayanan, SA (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Reynolds 339, College Stn, TX 77843 USA.; Metzger, CE (corresponding author), Bone Biol Lab 217,Heep Lab Bldg, College Stn, TX 77843 USA.	anarayan09@gmail.com; metzgercorinne@gmail.com			Department of Medical Physiology; Texas A&M University College of Education and Human Development Transforming Lives Seed Grant; U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [U01HL123420]; Sydney and J.L. Huffines Institute for Sports Medicine and Human Performance; National Space Biomedical Research Institute Space Life Sciences Fellowship [NCC 9-58]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL123420] Funding Source: NIH RePORTER	Department of Medical Physiology; Texas A&M University College of Education and Human Development Transforming Lives Seed Grant; U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Sydney and J.L. Huffines Institute for Sports Medicine and Human Performance; National Space Biomedical Research Institute Space Life Sciences Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank the Texas A&M University Health Science Center Integrated Microscope and Imaging Laboratory (supported by the Department of Medical Physiology) in providing the resources utilized in this work for immunofluorescence imaging. This work was supported by Texas A&M University College of Education and Human Development Transforming Lives Seed Grant (to S.A.B.), and U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant U01HL123420 (to D.C.Z.). Additional funds were provided by the Sydney and J.L. Huffines Institute for Sports Medicine and Human Performance (to C.E.M.). S.A.N. was supported, in part, by the National Space Biomedical Research Institute Space Life Sciences Fellowship (NCC 9-58). The authors declare no conflicts of interest.	Agollah GD, 2015, WORLD J GASTROENTERO, V21, P12767, DOI 10.3748/wjg.v21.i45.12767; Agrawal Manasi, 2011, Curr Osteoporos Rep, V9, P251, DOI 10.1007/s11914-011-0077-9; Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Antoniou E, 2016, ANN MED SURG, V11, P9, DOI 10.1016/j.amsu.2016.07.019; Askenase MH, 2015, IMMUNITY, V42, P1130, DOI 10.1016/j.immuni.2015.05.011; Atzeni F, 2013, AUTOIMMUN REV, V12, P703, DOI 10.1016/j.autrev.2012.10.021; Baek K, 2014, J CELL PHYSIOL, V229, P640, DOI 10.1002/jcp.24487; Benchimol EI, 2011, INFLAMM BOWEL DIS, V17, P423, DOI 10.1002/ibd.21349; Bjarnason I, 1997, GUT, V40, P228, DOI 10.1136/gut.40.2.228; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Chen WS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11302; Chen YX, 2017, MICROCIRCULATION, V24, DOI 10.1111/micc.12364; Colaianni G, 2015, P NATL ACAD SCI USA, V112, P12157, DOI 10.1073/pnas.1516622112; CONNELL WR, 1993, GUT, V34, P1081, DOI 10.1136/gut.34.8.1081; COOPER HS, 1993, LAB INVEST, V69, P238; Cordeiro OG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151848; Crohn BB, 1932, J AMER MED ASSOC, V99, P1323, DOI 10.1001/jama.1932.02740680019005; Cromer W, 2015, INFLAMM BOWEL DIS, V21, P1553, DOI 10.1097/MIB.0000000000000402; Cueni LN, 2009, EXP CELL RES, V315, P1715, DOI 10.1016/j.yexcr.2009.02.021; D'Alessio S, 2014, J CLIN INVEST, V124, P3863, DOI 10.1172/JCI72189; Danese S, 2004, AUTOIMMUN REV, V3, P394, DOI 10.1016/j.autrev.2004.03.002; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Ding T, 2007, FUT RHEUMATOL, V2, P587, DOI DOI 10.2217/17460816.2.6.587; Dong J, 2016, INT J OBESITY, V40, P434, DOI 10.1038/ijo.2015.200; Ebert T, 2014, EUR J ENDOCRINOL, V170, P501, DOI 10.1530/EJE-13-1053; Fakhoury M, 2014, J INFLAMM RES, V7, P113, DOI 10.2147/JIR.S65979; Gannon NP, 2015, INT J CANCER, V136, pE197, DOI 10.1002/ijc.29142; Ganta VC, 2010, INFLAMM BOWEL DIS, V16, P1029, DOI 10.1002/ibd.21150; Geleff S, 2003, VIRCHOWS ARCH, V442, P231, DOI 10.1007/s00428-002-0744-4; Ghishan FK, 2011, AM J PHYSIOL-GASTR L, V300, pG191, DOI 10.1152/ajpgi.00496.2010; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Hofbauer LC, 1998, BIOCHEM BIOPH RES CO, V250, P776, DOI 10.1006/bbrc.1998.9394; Hos D, 2016, AM J PATHOL, V186, P159, DOI 10.1016/j.ajpath.2015.09.012; Ji H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5944; Kaiserling E, 2001, LYMPHOLOGY, V34, P22; Kataru RP, 2011, IMMUNITY, V34, P96, DOI 10.1016/j.immuni.2010.12.016; Kerjaschki D, 2004, J AM SOC NEPHROL, V15, P603, DOI 10.1097/01.ASN.0000113316.52371.2E; Ko JK, 2014, CURR PHARM DESIGN, V20, P1082, DOI 10.2174/13816128113199990416; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kurdiova T, 2014, J PHYSIOL-LONDON, V592, P1091, DOI 10.1113/jphysiol.2013.264655; Li DJ, 2017, METABOLISM, V68, P31, DOI 10.1016/j.metabol.2016.12.003; Liao S, 2014, ANGIOGENESIS, V17, P325, DOI 10.1007/s10456-014-9416-7; Lu JY, 2015, ATHEROSCLEROSIS, V243, P438, DOI 10.1016/j.atherosclerosis.2015.10.020; Malmborg P, 2016, J INTERN MED, V279, P241, DOI 10.1111/joim.12413; Manolagas SC, 2013, BONE, V54, P272, DOI 10.1016/j.bone.2012.09.017; Matsuo Y, 2015, J CACHEXIA SARCOPENI, V6, P62, DOI 10.1002/jcsm.12006; Mazur-Bialy AI, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040701; Metzger CE, 2017, J BONE MINER RES, V32, P802, DOI 10.1002/jbmr.3027; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; MOONEY EE, 1995, J CLIN PATHOL, V48, P335, DOI 10.1136/jcp.48.4.335; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; Moschen AR, 2005, GUT, V54, P479, DOI 10.1136/gut.2004.044370; Qiao XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18732; Rahier JF, 2011, ALIMENT PHARM THER, V34, P533, DOI 10.1111/j.1365-2036.2011.04759.x; Seibel MJ, 2013, LANCET DIABETES ENDO, V1, P59, DOI 10.1016/S2213-8587(13)70045-7; Shao L, 2017, BIOCHEM BIOPH RES CO, V487, P194, DOI 10.1016/j.bbrc.2017.04.020; Shin K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7196; Tan SD, 2006, J DENT RES, V85, P905, DOI 10.1177/154405910608501006; Theoleyre S, 2004, CYTOKINE GROWTH F R, V15, P457, DOI 10.1016/j.cytogfr.2004.06.004; Zampell JC, 2012, AM J PHYSIOL-CELL PH, V302, pC392, DOI 10.1152/ajpcell.00306.2011; Zawieja David C., 2009, Lymphatic Research and Biology, V7, P87, DOI 10.1089/lrb.2009.0007; Zhang J, 2017, BONE RES, V5, DOI 10.1038/boneres.2016.56; Zhang YZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158038	64	35	36	2	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4848	4861		10.1096/fj.201800178R	http://dx.doi.org/10.1096/fj.201800178R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29596023	Bronze, Green Published			2022-12-26	WOS:000443817700020
J	Zhou, J; Zhao, LL; Yu, HY; Wang, YH; Zhang, W; Hu, SN; Zou, Z; Sun, JH				Zhou, Jiao; Zhao, Li-Lin; Yu, Hai-Ying; Wang, Yan-Hong; Zhang, Wei; Hu, Song-Nian; Zou, Zhen; Sun, Jiang-Hua			Immune tolerance of vector beetle to its partner plant parasitic nematode modulated by its insect parasitic nematode	FASEB JOURNAL			English	Article						tracheal immunity; antioxidative genes; Toll receptors; pinewood nematode	PINEWOOD NEMATODE; MONOCHAMUS-CAROLINENSIS; DUAL OXIDASE; DROSOPHILA; RESPONSES; ACTIVATION; INFECTION; PROTEIN; SYSTEM; LIFE	Immune response of insect vectors to transmitted pathogens or insect hosts against parasites are well studied, whereas the mechanism of tripartite interactions remains elusive. In this study, we investigated the immune interactions of the vector beetle Monochamus alternatus (Ma) to the devastating plant parasitic nematode Bursaphelenchus xylophilus (Bx) and the insect parasitic nematode Howardula phyllotretae (Hp). We report the unique immune mechanism by which the vector beetle tolerates many devastating Bx in its trachea, yet that immune tolerance is compromised by the parasitic nematode Hp. Contact with either nematode species triggers epithelial reactive oxygen species (ROS) production in Ma. Only the entry of Bx, not Hp, infection, induces increased expression of antioxidative genes, through which the ROS levels are balanced in the trachea of beetles. Furthermore, we found that up-regulation of antioxidative genes was induced by the interaction of Toll receptors. In contrast, beetles infected by Hp retain high levels of oxidative stress and melanization in trachea, and as a result, decrease Bx loading. This study highlights the role of Toll receptors in mediating the activation of antioxidative genes in immune tolerance to plant parasitic nematodes, and suggests the use of insect parasites as a biologic control.Zhou, J., Zhao, L.-L., Yu, H.-Y., Wang, Y.-H., Zhang, W., Hu, S.-N., Zou, Z., Sun, J.-H. Immune tolerance of vector beetle to its partner plant parasitic nematode modulated by its insect parasitic nematode.	[Zhou, Jiao; Zhao, Li-Lin; Wang, Yan-Hong; Zhang, Wei; Zou, Zhen; Sun, Jiang-Hua] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, 1 Beichen West Rd, Beijing 100101, Peoples R China; [Yu, Hai-Ying; Hu, Song-Nian] Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Zou, Zhen; Sun, Jiang-Hua] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zou, Z; Sun, JH (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, 1 Beichen West Rd, Beijing 100101, Peoples R China.	zouzhen@ioz.ac.cn; sunjh@ioz.ac.cn	Wang, Yuan/HHC-1520-2022; Wang, Yanbo/HFZ-8018-2022; wang, yi/GVT-8516-2022; Wang, Yin/HCI-9352-2022; zou, zhen/C-6134-2016; wang, yan/GSE-6489-2022; wangwangwang, yuanyaun/HHN-6432-2022	zou, zhen/0000-0003-3550-7656; Zhao, Lilin/0000-0002-3706-1267; Zhang, Wei/0000-0001-9580-6266; sun, jianghua/0000-0002-9465-3672	National Key Plan for Scientific Research and Development of China [2016YFC1200600, 2016YFD0500300, 2017YFD0200400]; National Natural Science Foundation of China [NSFC31572272, 31630013, 31672291, 31402013]; Chinese Academy of Sciences (CAS) Key Research Projects of the Frontier Science [QYZDB-SSW-SMC014, QYZDJ-SSW-SMC024]; China Postdoctoral Science Foundation [214M561058]	National Key Plan for Scientific Research and Development of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences (CAS) Key Research Projects of the Frontier Science; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work is funded by the National Key Plan for Scientific Research and Development of China (2016YFC1200600, 2016YFD0500300, 2017YFD0200400), National Natural Science Foundation of China (NSFC31572272, 31630013, 31672291, 31402013), the Chinese Academy of Sciences (CAS) Key Research Projects of the Frontier Science (QYZDB-SSW-SMC014, QYZDJ-SSW-SMC024), and a Financial Grant from the China Postdoctoral Science Foundation (214M561058). The authors declare no conflicts of interest.	Aliota MT, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000963; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Bae YS, 2010, TRENDS IMMUNOL, V31, P278, DOI 10.1016/j.it.2010.05.003; Banerjee U, 2008, PROTOC EXCH, V10, P1, DOI [DOI 10.1038/nprot.2008.23, DOI 10.1038/NPROT.2008.23]; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Bednarova A, 2013, PHYSIOL ENTOMOL, V38, P54, DOI 10.1111/phen.12008; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Castillo JC, 2011, TRENDS PARASITOL, V27, P537, DOI 10.1016/j.pt.2011.09.001; Dwinell LD, 1997, ANNU REV PHYTOPATHOL, V35, P153, DOI 10.1146/annurev.phyto.35.1.153; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Floyd RM, 2005, MOL ECOL NOTES, V5, P611, DOI 10.1111/j.1471-8286.2005.01009.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Hamilton PT, 2014, MOL ECOL, V23, P1558, DOI 10.1111/mec.12603; Harris HL, 2010, SYMBIOSIS, V51, P37, DOI 10.1007/s13199-010-0065-3; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Katiyar D, 2011, CURR MED CHEM, V18, P2174, DOI 10.2174/092986711795656234; Kim BY, 2008, COMP BIOCHEM PHYS B, V150, P161, DOI 10.1016/j.cbpb.2008.02.009; Kim SH, 2014, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00116; Koff JL, 2008, AM J PHYSIOL-LUNG C, V294, pL1068, DOI 10.1152/ajplung.00025.2008; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; MAMIYA Y, 1983, ANNU REV PHYTOPATHOL, V21, P201, DOI 10.1146/annurev.py.21.090183.001221; Martinez-Barricarte R, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau6759; Medeiros RB, 2004, J VIROL, V78, P4976, DOI 10.1128/JVI.78.10.4976-4982.2004; Meng Q, 2015, INSECT BIOCHEM MOLEC, V64, P1, DOI 10.1016/j.ibmb.2015.06.014; Mota M., 2008, PINE WILT DIS WORLDW; Necibi S, 1998, J NEMATOL, V30, P246; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; OLDHAM J. N., 1933, JOUR HELMINTHOL, V11, P119, DOI 10.1017/S0022149X00001796; Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Perez-Lopez A, 2016, NAT REV IMMUNOL, V16, P135, DOI 10.1038/nri.2015.17; Richman A, 1996, CURR OPIN IMMUNOL, V8, P14, DOI 10.1016/S0952-7915(96)80099-9; Shapiro-Ilan DI, 2006, BIOL CONTROL, V38, P124, DOI 10.1016/j.biocontrol.2005.09.005; Suzuki S, 2006, P NATL ACAD SCI USA, V103, P4252, DOI 10.1073/pnas.0508668103; Tang H, 2008, DEV CELL, V15, P617, DOI 10.1016/j.devcel.2008.08.017; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang YH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004931; WARREN JE, 1993, J NEMATOL, V25, P703; Wu SC, 2012, CELL HOST MICROBE, V11, P410, DOI 10.1016/j.chom.2012.03.004; Xiong GH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1509-1; Yaman Mustafa, 2002, Journal of Asia-Pacific Entomology, V5, P233, DOI 10.1016/S1226-8615(08)60159-4; Yuan CF, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006645; Zhao LL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12341; Zhao LL, 2014, TRENDS PARASITOL, V30, P299, DOI 10.1016/j.pt.2014.04.007; Zhao LL, 2013, CURR BIOL, V23, P2038, DOI 10.1016/j.cub.2013.08.041; Zhou J, 2017, INSECT SCI; Zou Z, 2008, P NATL ACAD SCI USA, V105, P18454, DOI 10.1073/pnas.0804658105; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177; Zou Z, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002394	59	8	11	1	44	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4862	4877		10.1096/fj.201800247R	http://dx.doi.org/10.1096/fj.201800247R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29608332	Bronze			2022-12-26	WOS:000443817700021
J	Wichmann, L; Vowinkel, KS; Perniss, A; Manzini, I; Althaus, M				Wichmann, Lukas; Vowinkel, Kirsty Sophia; Perniss, Alexander; Manzini, Ivan; Althaus, Mike			Incorporation of the -subunit into the epithelial sodium channel (ENaC) generates protease-resistant ENaCs in Xenopus laevis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epithelial sodium channel (ENaC); Xenopus laevis; protease; furin; electrophysiology; patch clamp; delta-subunit; chymotrypsin	NA+ CHANNEL; DELTA-SUBUNIT; GAMMA-SUBUNIT; CUTTING EDGE; FURIN; ACTIVATION; EMBRYOGENESIS; INHIBITION; CLEAVAGE; PEPTIDE	The epithelial sodium channel (ENaC) is a critical regulator of vertebrate electrolyte homeostasis. ENaC is the only constitutively open ion channel in the degenerin/ENaC protein family, and its expression, membrane abundance, and open probability therefore are tightly controlled. The canonical ENaC is composed of three subunits (, , and ), but a fourth -subunit may replace and form atypical -ENaCs. Using Xenopus laevis as a model, here we found that mRNAs of the - and -subunits are differentially expressed in different tissues and that -ENaC predominantly is present in the urogenital tract. Using whole-cell and single-channel electrophysiology of oocytes expressing Xenopus - or -ENaC, we demonstrate that the presence of the -subunit enhances the amount of current generated by ENaC due to an increased open probability, but also changes current into a transient form. Activity of canonical ENaCs is critically dependent on proteolytic processing of the - and -subunits, and immunoblotting with epitope-tagged ENaC subunits indicated that, unlike -ENaC, the -subunit does not undergo proteolytic maturation by the endogenous protease furin. Furthermore, currents generated by -ENaC were insensitive to activation by extracellular chymotrypsin, and presence of the -subunit prevented cleavage of -ENaC at the cell surface. Our findings suggest that subunit composition constitutes an additional level of ENaC regulation, and we propose that the Xenopus -ENaC subunit represents a functional example that demonstrates the importance of proteolytic maturation during ENaC evolution.	[Wichmann, Lukas; Althaus, Mike] Newcastle Univ, Sch Nat & Environm Sci, Ridley Bldg 2, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wichmann, Lukas; Vowinkel, Kirsty Sophia; Perniss, Alexander; Manzini, Ivan; Althaus, Mike] Justus Liebig Univ, Dept Anim Physiol & Mol Biomed, Inst Anim Physiol, D-35392 Giessen, Germany; [Vowinkel, Kirsty Sophia] Philipps Univ Marburg, Inst Physiol & Pathophysiol Vegetat Physiol, D-35037 Marburg, Germany; [Perniss, Alexander] Justus Liebig Univ, Inst Anat & Cell Biol, D-35392 Giessen, Germany	Newcastle University - UK; Justus Liebig University Giessen; Philipps University Marburg; Justus Liebig University Giessen	Althaus, M (corresponding author), Newcastle Univ, Sch Nat & Environm Sci, Ridley Bldg 2, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.; Althaus, M (corresponding author), Justus Liebig Univ, Dept Anim Physiol & Mol Biomed, Inst Anim Physiol, D-35392 Giessen, Germany.	Mike.Althaus@newcastle.ac.uk	Manzini, Ivan/V-4545-2019	Manzini, Ivan/0000-0002-3575-9637; Althaus, Mike/0000-0002-3554-7538; Wichmann, Lukas/0000-0001-9808-8407				Althaus M, 2007, FASEB J, V21, P2389, DOI 10.1096/fj.06-7694com; Babini E, 2003, J BIOL CHEM, V278, P28418, DOI 10.1074/jbc.M301315200; Baines Deborah, 2013, Curr Mol Pharmacol, V6, P50; Bengrine A, 2007, J BIOL CHEM, V282, P26884, DOI 10.1074/jbc.M611829200; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Collier DM, 2012, J BIOL CHEM, V287, P40907, DOI 10.1074/jbc.M112.417519; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Fronius Martin, 2013, Curr Mol Pharmacol, V6, P13; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; Giraldez T, 2012, AM J PHYSIOL-RENAL, V303, pF328, DOI 10.1152/ajprenal.00116.2012; Haerteis S, 2009, J BIOL CHEM, V284, P29024, DOI 10.1074/jbc.M109.018945; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Iijima R, 1999, J BIOCHEM-TOKYO, V126, P912, DOI 10.1093/oxfordjournals.jbchem.a022534; Ji HL, 2006, J BIOL CHEM, V281, P8233, DOI 10.1074/jbc.M512293200; Kleyman TR, 2018, ANNU REV PHYSIOL, V80, P263, DOI 10.1146/annurev-physiol-021317-121143; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; MARELLO K, 1992, NUCLEIC ACIDS RES, V20, P5593, DOI 10.1093/nar/20.21.5593; Rossier BC, 2015, PHYSIOL REV, V95, P297, DOI 10.1152/physrev.00011.2014; Schonberger M, 2014, NAT CHEM, V6, P712, DOI [10.1038/NCHEM.2004, 10.1038/nchem.2004]; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; Tavernarakis N, 1997, ANNU REV PHYSIOL, V59, P659, DOI 10.1146/annurev.physiol.59.1.659; Thibodeau PH, 2013, CELL TISSUE RES, V351, P309, DOI 10.1007/s00441-012-1439-z; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Uchiyama M, 2012, P ROY SOC B-BIOL SCI, V279, P4795, DOI 10.1098/rspb.2012.1945; WALDMANN R, 1995, J BIOL CHEM, V270, P27411, DOI 10.1074/jbc.270.46.27411	32	13	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6647	6658		10.1074/jbc.RA118.002543	http://dx.doi.org/10.1074/jbc.RA118.002543			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29576549	hybrid, Green Published			2022-12-26	WOS:000431487300002
J	Gomes, IR; Gomes, CR; Gomes, HS; Cavalcante, GPD				Gomes, Igor Ruiz; Gomes, Cristiane Ruiz; Gomes, Herminio Simoes; dos Santos Cavalcante, Gervasio Protasio			Empirical radio propagation model for DTV applied to non-homogeneous paths and different climates using machine learning techniques	PLOS ONE			English	Article							WAVE PROPAGATION; MIXED PATHS	The establishment and improvement of transmission systems rely on models that take into account, (among other factors), the geographical features of the region, as these can lead to signal degradation. This is particularly important in Brazil, where there is a great diversity of scenery and climates. This article proposes an outdoor empirical radio propagation model for Ultra High Frequency (UHF) band, that estimates received power values that can be applied to non-homogeneous paths and different climates, this last being of an innovative character for the UHF band. Different artificial intelligence techniques were chosen on a theoretical and computational basis and made it possible to introduce, organize and describe quantitative and qualitative data quickly and efficiently, and thus determine the received power in a wide range of settings and climates. The proposed model was applied to a city in the Amazon region with heterogeneous paths, wooded urban areas and fractions of freshwater among other factors. Measurement campaigns were conducted to obtain data signals from two digital TV stations in the metropolitan area of the city of Belem, in the State of Para A, to design, compare and validate the model. The results are consistent since the model shows a clear difference between the two seasons of the studied year and small RMS errors in all the cases studied.	[Gomes, Igor Ruiz] Fed Univ Para, Dept Computat, Belem, Para, Brazil; [Gomes, Cristiane Ruiz; Gomes, Herminio Simoes] Fed Univ Para, Dept Math, Belem, Para, Brazil; [dos Santos Cavalcante, Gervasio Protasio] Fed Univ Para, Dept Telecommun, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para	Gomes, IR (corresponding author), Fed Univ Para, Dept Computat, Belem, Para, Brazil.	ruiz.igor@gmail.com	Gomes, Cristiane Ruiz/AAJ-5752-2021	Gomes, Igor/0000-0001-7391-1903; Gomes, Cristiane/0000-0001-9368-6248				[Anonymous], 2012, ITURRP8337; [Anonymous], 2007, IRP6189 INT COMM UN; [Anonymous], 1995, IRP3707 INT TEL UN; [Anonymous], 2009, IRP15464 INT COMM UN; [Anonymous], 2012, IRP837 INT COMM UN; [Anonymous], 2013, IP53015; [Anonymous], 2001, IRP8393 INT COMM UN; [Anonymous], 2005, IRP15462 INT COMM UN; Castro Bruno S. L., 2011, J. Microw. Optoelectron. Electromagn. Appl., V10, P106, DOI 10.1590/S2179-10742011000100011; CASTRO Bruno Souza Lyra, 2010, MODELO PROPAGACAO RE; CAVALCANTE GPD, 1983, RADIO SCI, V18, P691, DOI 10.1029/RS018i005p00691; CAVALCANTE GPD, 1982, RADIO SCI, V17, P503, DOI 10.1029/RS017i003p00503; CAVALCANTE GPS, 1983, IEEE T ANTENN PROPAG, V31, P141, DOI 10.1109/TAP.1983.1142985; Cavalcante GPS, 1982, THESIS; Chee KL, 2011, IEEE T ANTENN PROPAG, V59, P2698, DOI 10.1109/TAP.2011.2152340; de Souza JF, 2009, MICROW OPT TECHN LET, V51, P1133, DOI 10.1002/mop.24212; Dias MHC, 2011, IEEE LAT AM T, V9, P288, DOI 10.1109/TLA.2011.5893774; Faruk N, 2013, 2013 IEEE EUROCON, P602, DOI 10.1109/EUROCON.2013.6625043; Gomes C, 2012, P MOMAG 2012; Gomes Cristiane R., 2015, J. Microw. Optoelectron. Electromagn. Appl., V14, P60, DOI 10.1590/2179-10742015v14i1427; HATA M, 1980, IEEE T VEH TECHNOL, V29, P317, DOI 10.1109/T-VT.1980.23859; Kawano T, 2008, IEEE ANTENNAS PROP, P400; Kirk Matthew, 2014, THOUGHTFUL MACHINE L; Li L, 1986, CHIN J RADIO SCI, V1, P10; Mandeep J. S., 2011, 2011 Proceedings of the International Conference on Space Science and Communication (IconSpace 2011), P89, DOI 10.1109/IConSpace.2011.6015858; Mayrink MAS, 2005, 2005 SBMO/IEEE MTT-S International Microwave and Optoelectronics Conference (IMOC), P394; Meng YS, 2009, PROG ELECTROMAGN RES, V99, P149, DOI 10.2528/PIER09102201; Meng YS, 2008, IEEE ANTENN WIREL PR, V7, P159, DOI 10.1109/LAWP.2008.922052; Meng YS, 2009, IEEE T VEH TECHNOL, V58, P4023, DOI 10.1109/TVT.2009.2021480; Meza Wilyam D. T., 2014, J. Microw. Optoelectron. Electromagn. Appl., V13, P97; Murphy KP, 2012, MACHINE LEARNING: A PROBABILISTIC PERSPECTIVE, P1; Negnevitsky M., 2005, ARTIF INTELL, V2nd ed.; Oliveira RAN, 2013, PROC EUR CONF ANTENN, P964; Russell S., 1995, ARTIFICIAL INTELLIGE; Silva D, 2014, P WIR TEL S; Soni S, 2011, MICROW OPT TECHN LET, V53, P1875, DOI 10.1002/mop.26152; TAMIR T, 1977, IEEE T ANTENN PROPAG, V25, P471, DOI 10.1109/TAP.1977.1141620; TAMIR T, 1967, IEEE T ANTENN PROPAG, VAP15, P806, DOI 10.1109/TAP.1967.1139054; Thorvaldsen P, 2014, RADIO SCI, V49, P531, DOI 10.1002/2013RS005338; Witvliet B. A., 2011, 2011 IEEE-APS Topical Conference on Antennas and Propagation in Wireless Communications, P303, DOI 10.1109/APWC.2011.6046762; Wu K, 2004, IEEE MILIT COMMUN C, P1515; Yeo JX, 2009 7 INT C INF COM; Zhang QL, 2013, IEEE T ELECTROMAGN C, V55, P733, DOI 10.1109/TEMC.2012.2235444	44	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194511	10.1371/journal.pone.0194511	http://dx.doi.org/10.1371/journal.pone.0194511			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596503	gold, Green Published, Green Submitted			2022-12-26	WOS:000428630000027
J	Park, B; Min, C; Choi, HG				Park, Bumjung; Min, Chanyang; Choi, Hyo Geun			Neck dissection does not increases the risk of stroke in thyroid cancer: A national cohort study	PLOS ONE			English	Article							PERIOPERATIVE STROKE; HEAD; POPULATION	Objectives The purpose of this study is to evaluate the risk of stroke (hemorrhagic or ischemic) after neck dissection in thyroid cancer patients in Korea using national cohort data. Methods Using the national cohort study from the Korean Health Insurance Review and Assessment Service, patients with neck dissection for thyroid cancer (1,041) and control participants (4,164) were selected and matched 1:4 (age, gender, income, and region of residence). The Chi-square test, Fischer's exact test, and the Cox-proportional hazard model were used. The Cox-proportional analysis used a crude model and an adjusted model for age, gender, income, region of residence, hypertension, diabetes, dyslipidemia. Results None of the participants had suffered hemorrhagic stroke in the neck dissection group, while 0.3% (13/4,164) of participants had suffered hemorrhagic stroke in the control group (P = 0.085). In total, 0.8% (8/1,041) of participants had suffered an ischemic stroke in the neck dissection group, and 0.7% (31/4,133) of participants had suffered an ischemic stroke in the control group (P = 0.936). The adjusted hazard ratio for ischemic stroke after neck dissection was 1.06 (95% confidence interval [CI] = 0.49-2.31, P = 0.884). Conclusion The risk of hemorrhagic or ischemic stroke was not higher in thyroid cancer patients who underwent neck dissection than that in the matched control group.	[Park, Bumjung; Choi, Hyo Geun] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea; [Min, Chanyang] Hallym Univ, Coll Med, Hallym Data Sci Lab, Anyang, South Korea	Hallym University; Hallym University	Choi, HG (corresponding author), Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019	Choi, Hyo Geun/0000-0003-1655-9549				Chang CF, 2017, HEAD NECK-J SCI SPEC, V39, P63, DOI 10.1002/hed.24535; Chu CN, 2011, BRIT J CANCER, V105, P1419, DOI 10.1038/bjc.2011.361; Hollander M, 2003, J NEUROL NEUROSUR PS, V74, P317, DOI 10.1136/jnnp.74.3.317; Hong KS, 2013, J STROKE, V15, P2, DOI 10.5853/jos.2013.15.1.2; Kim RB, 2013, J KOREAN MED SCI, V28, P16, DOI 10.3346/jkms.2013.28.1.16; MacNeil SD, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001106; Mead GE, 1999, J NEUROL NEUROSUR PS, V66, P16, DOI 10.1136/jnnp.66.1.16; NOSAN DK, 1993, ANN OTO RHINOL LARYN, V102, P717, DOI 10.1177/000348949310200913; Rechtweg J, 1998, LARYNGOSCOPE, V108, P1150, DOI 10.1097/00005537-199808000-00009; Sawicka-Gutaj N, 2014, ENDOKRYNOL POL, V65, P54, DOI 10.5603/EP.2014.0008; Thompson SK, 2004, ANN SURG, V239, P428, DOI 10.1097/01.sla.0000114130.01282.26; Thompson SK, 2003, CAN J SURG, V46, P332; Wang XF, 2016, ONCOTARGET, V7, P55912, DOI 10.18632/oncotarget.10352	13	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195074	10.1371/journal.pone.0195074	http://dx.doi.org/10.1371/journal.pone.0195074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596481	Green Published, Green Submitted, gold			2022-12-26	WOS:000428630000075
J	Lu, GM; Pine, P; Leeds, JM; DeGuzman, F; Pratikhya, P; Lin, J; Malinowski, J; Hollenbach, SJ; Curnutte, JT; Conley, PB				Lu, Genmin; Pine, Polly; Leeds, Janet M.; DeGuzman, Francis; Pratikhya, Pratikhya; Lin, Joyce; Malinowski, John; Hollenbach, Stanley J.; Curnutte, John T.; Conley, Pamela B.			Andexanet alfa effectively reverses edoxaban anticoagulation effects and associated bleeding in a rabbit acute hemorrhage model	PLOS ONE			English	Article							PROTHROMBIN COMPLEX CONCENTRATE; ANTAGONIST ORAL ANTICOAGULANTS; ACTIVATED FACTOR-VII; FACTOR-XA; ATRIAL-FIBRILLATION; RIVAROXABAN; MANAGEMENT; APIXABAN; WARFARIN; DABIGATRAN	Introduction Increasing use of factor Xa (FXa) inhibitors necessitates effective reversal agents to manage bleeding. Andexanet alfa, a novel modified recombinant human FXa, rapidly reverses the anticoagulation effects of direct and indirect FXa inhibitors. Objective To evaluate the ability of andexanet to reverse anticoagulation in vitro and reduce bleeding in rabbits administered edoxaban. Materials and methods In vitro studies characterized the interaction of andexanet with edoxaban and its ability to reverse edoxaban-mediated anti-FXa activity. In a rabbit model of surgically induced, acute hemorrhage, animals received edoxaban vehicle+andexanet vehicle (control), edoxaban (1 mg/kg)+andexanet vehicle, edoxaban+andexanet (75 mg, 5-minute infusion, 20 minutes after edoxaban), or edoxaban vehicle+andexanet prior to injury. Results Andexanet bound edoxaban with high affinity similar to FXa. Andexanet rapidly and dose dependently reversed the effects of edoxaban on FXa activity and coagulation pharmacodynamic parameters in vitro. In edoxaban-anticoagulated rabbits, andexanet reduced anti-FXa activity by 82% (from 548 +/- 87 to 100 +/- 41 ng/ml; P<0.0001), mean unbound edoxaban plasma concentration by similar to 80% (from 100 +/- 10 to 21 +/- 6 ng/ml; P<0.0001), and blood loss by 80% vs. vehicle (adjusted for control, 2.6 vs. 12.9 g; P= 0.003). The reduction in blood loss correlated with the decrease in anti-FXa activity (r = 0.6993, P<0.0001) and unbound edoxaban (r = 0.5951, P = 0.0035). Conclusion These data demonstrate that andexanet rapidly reversed the anticoagulant effects of edoxaban, suggesting it could be clinically valuable for the management of acute and surgery related bleeding. Correlation of blood loss with anti-FXa activity supports the use of anti-FXa activity as a biomarker for assessing anticoagulation reversal in clinical trials.	[Lu, Genmin; Pine, Polly; Leeds, Janet M.; DeGuzman, Francis; Pratikhya, Pratikhya; Lin, Joyce; Malinowski, John; Hollenbach, Stanley J.; Curnutte, John T.; Conley, Pamela B.] Portola Pharmaceut Inc, San Francisco, CA 94080 USA; [Lu, Genmin] Jazz Pharmaceut, Palo Alto, CA USA; [Hollenbach, Stanley J.] Novan Therapeut Inc, Durham, NC USA	Jazz Pharmaceuticals	Conley, PB (corresponding author), Portola Pharmaceut Inc, San Francisco, CA 94080 USA.	pconley@portola.com		DeGuzman, Francis/0000-0002-4479-1129	Portola Pharmaceuticals; Portola Pharmaceuticals, Inc.	Portola Pharmaceuticals; Portola Pharmaceuticals, Inc.	The study has been funded by Portola Pharmaceuticals. The study has been designed, performed, and analysed by all authors who were employees of Portola Pharmaceuticals and received salaries. Currently, all authors, besides PP and SJH, are employees of Portola. The authors have met the ICMJE criteria, participated in the development of the manuscript, agreed to the content, and approved its submission. No one other than the listed authors had control over the data, over how the data were analyzed or interpreted, or over the wording or conclusions used by the authors in the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; Financial support for medical editorial assistance was provided by Portola Pharmaceuticals, Inc. The authors thank Tamalette Loh, PhD; Supriya Bavadekar, PhD; and William Sinkins, PhD; all of Accuverus, and Iwona Bucior of Portola Pharmaceuticals, Inc. for medical editorial assistance with this manuscript.	Barco S, 2016, BRIT J HAEMATOL, V172, P255, DOI 10.1111/bjh.13821; Brown KS, 2015, THROMB RES, V136, P825, DOI 10.1016/j.thromres.2015.07.012; Cheung YW, 2015, J THROMB HAEMOST, V13, P1799, DOI 10.1111/jth.13115; Chowdary P, 2015, J THROMB HAEMOST, V13, P743, DOI 10.1111/jth.12864; Conley PB, 2016, AM SOC HEM 58 ANN M; Connolly SJ, 2016, NEW ENGL J MED, V375, P1131, DOI 10.1056/NEJMoa1607887; Crowther M, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.4269.4269; Desai NR, 2014, AM J MED, V127, P1075, DOI 10.1016/j.amjmed.2014.05.013; Dogliotti A, 2013, CLIN CARDIOL, V36, P61, DOI 10.1002/clc.22081; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; Frontera JA, 2016, NEUROCRIT CARE, V24, P6, DOI 10.1007/s12028-015-0222-x; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Godier A, 2012, ANESTHESIOLOGY, V116, P94, DOI 10.1097/ALN.0b013e318238c036; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; HARA T, 1995, THROMB RES, V80, P99, DOI 10.1016/0049-3848(95)00155-K; Heidbuchel H, 2015, EUROPACE, V17, P1467, DOI 10.1093/europace/euv309; Herzog E, 2015, THROMB RES, V135, P554, DOI 10.1016/j.thromres.2015.01.007; Herzog E, 2015, ANESTHESIOLOGY, V122, P387, DOI 10.1097/ALN.0000000000000520; Kaatz S, 2012, AM J HEMATOL, V87, pS141, DOI 10.1002/ajh.23202; Levi M, 2014, J THROMB HAEMOST, V12, P1428, DOI 10.1111/jth.12599; Levy JH, 2018, J THROMB HAEMOST, V16, P54, DOI 10.1111/jth.13894; Lip GYH, 2014, EUR HEART J, V35, P1844, DOI 10.1093/eurheartj/ehu181; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P558, DOI 10.1016/0167-4838(83)90273-X; Lu G, 2017, J THROMB HAEMOST, V15, P1747, DOI 10.1111/jth.13768; Lu G, 2015, INT SOC THROMB MAEM; Lu GM, 2013, NAT MED, V19, P446, DOI 10.1038/nm.3102; Majeed A, 2017, BLOOD, V130, P1706, DOI 10.1182/blood-2017-05-782060; Marlu R, 2012, THROMB HAEMOSTASIS, V108, P217, DOI 10.1160/TH12-03-0179; Martin AC, 2013, INT J CARDIOL, V168, P4228, DOI 10.1016/j.ijcard.2013.07.152; Nagalla S, 2016, CTS-CLIN TRANSL SCI, V9, P176, DOI 10.1111/cts.12398; Niessner A, 2017, EUR HEART J, V38, P1710, DOI 10.1093/eurheartj/ehv676; Oktay E., 2015, INT J CARDIOVAS ACAD, V1, P1; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Raval AN, 2017, CIRCULATION, V135, pE604, DOI 10.1161/CIR.0000000000000477; Ruff CT, 2016, CIRCULATION, V134, P248, DOI 10.1161/CIRCULATIONAHA.116.021831; Shatzel JJ, 2016, NEW ENGL J MED, V375, P2499, DOI 10.1056/NEJMc1613270; Siegal Deborah, 2017, Blood Adv, V1, P1827, DOI 10.1182/bloodadvances.2017007112; Siegal DM, 2015, NEW ENGL J MED, V373, P2413, DOI 10.1056/NEJMoa1510991; SKOGEN WF, 1984, J BIOL CHEM, V259, P2306; Slot KMHB, 2014, JAMA-J AM MED ASSOC, V311, P1150, DOI 10.1001/jama.2014.1403; Tomaselli GF, 2017, J AM COLL CARDIOL, V70, P3042, DOI 10.1016/j.jacc.2017.09.1085; US National Library of Medicine, STUD PAT AC MAJ BLEE; Zahir H, 2015, CIRCULATION, V131, P82, DOI 10.1161/CIRCULATIONAHA.114.013445	43	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0195122	10.1371/journal.pone.0195122	http://dx.doi.org/10.1371/journal.pone.0195122			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590221	Green Submitted, Green Published, gold			2022-12-26	WOS:000428603100105
J	Maia, LD; Peterle, GT; dos Santos, M; Trivilin, LO; Mendes, SO; de Oliveira, MM; dos Santos, JG; Stur, E; Agostini, LP; Couto, CVMD; Dalbo, J; de Assisi, ALEM; Archanjo, AB; Mercante, AMD; Lopez, RVM; Nunes, FD; de Carvalho, MB; Tajara, EH; Louro, LD; Alvares-da-Silva, AM				Maia, Lucas de Lima; Peterle, Gabriela Tonini; dos Santos, Marcelo; Trivilin, Leonardo Oliveira; Mendes, Suzanny Oliveira; de Oliveira, Mayara Mota; dos Santos, Joaquim Gasparini; Stur, Elaine; Agostini, Lidiane Pignaton; Monteiro da Silva Couto, Cinthia Vidal; Dalbo, Juliana; Evangelista Monteiro de Assisi, Aricia Leone; Archanjo, Anderson Barros; Da Cunha Mercante, Ana Maria; Mendoza Lopez, Rossana Veronica; Nunes, Fabio Daumas; de Carvalho, Marcos Brasilino; Tajara, Eloiza Helena; Louro, Luri Drumond; Alvares-da-Silva, Adriana Madeira			JMJD1A, H3K9me1, H3K9me2 and ADM expression as prognostic markers in oral and oropharyngeal squamous cell carcinoma	PLOS ONE			English	Article							HISTONE LYSINE DEMETHYLASES; HYPOXIA-INDUCED EXPRESSION; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; EPIGENETIC REGULATION; TISSUE MICROARRAYS; NECK-CANCER; ADRENOMEDULLIN; SURVIVAL; TUMOR	Aims Jumonji Domain-Containing 1 A (JMJD1A) protein promotes demethylation of histones, especially at lysin-9 of di-methylated histone H3 (H3K9me2) or mono-methylated (H3K9me1). Increased levels of H3 histone methylation at lysin-9 (H3K9) is related to tumor suppressor gene silencing. JMJD1A gene target Adrenomeduline (ADM) has shown to promote cell growth and tumorigenesis. JMJD1A and ADM expression, as well as H3K9 methylation level have been related with development risk and prognosis of several tumor types. Methods and results We aimed to evaluate JMJD1A, ADM, H3K9me1 and H3K9me2expression in paraffin embedded tissue microarrays from 84 oral and oropharyngeal squamous cell carcinoma samples through immunohistochemistry analysis. Our results showed that nuclear JMJD1A expression was related to lymph node metastasis risk. In addition, JMJD1A cytoplasmic expression was an independent risk marker for advanced tumor stages. H3K9me1 cytoplasmic expression was associated with reduced disease-specific death risk. Furthermore, high H3K9me2 nuclear expression was associated with worse specific-disease and disease-free survival. Finally, high ADM cytoplasmic expression was an independent marker of lymph node metastasis risk. Conclusion JMJD1A, H3K9me1/2 and ADM expression may be predictor markers of progression and prognosis in oral and oropharynx cancer patients, as well as putative therapeutic targets.	[Maia, Lucas de Lima; Peterle, Gabriela Tonini; Trivilin, Leonardo Oliveira; Mendes, Suzanny Oliveira; de Oliveira, Mayara Mota; dos Santos, Joaquim Gasparini; Stur, Elaine; Agostini, Lidiane Pignaton; Monteiro da Silva Couto, Cinthia Vidal; Dalbo, Juliana; Evangelista Monteiro de Assisi, Aricia Leone; Archanjo, Anderson Barros; Louro, Luri Drumond; Alvares-da-Silva, Adriana Madeira] Univ Fed Espirito Santo, Programa Posgrad Biotecnol, Vitoria, ES, Brazil; [dos Santos, Marcelo] Univ Fed Rio Grande do Norte, Escola Multicampi Ciencias Med Rio Grande Norte, Caico, RN, Brazil; [Da Cunha Mercante, Ana Maria] Hosp Heliopolis, Dept Anat Patol, Sao Paulo, Brazil; [Mendoza Lopez, Rossana Veronica] Inst Canc Estado Sao Paulo, Ctr Invest Translac Oncol, Sao Paulo, Brazil; [Nunes, Fabio Daumas] Univ Sao Paulo, Dept Patol Bucal, Fac Odontol, Sao Paulo, Brazil; [de Carvalho, Marcos Brasilino] Hosp Heliopolis, Lab Biol Mol, Sao Paulo, Brazil; [Tajara, Eloiza Helena] Fac Med, Dept Biol Mol, Sao Paulo, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Rio Grande do Norte; Universidade de Sao Paulo	Maia, LD (corresponding author), Univ Fed Espirito Santo, Programa Posgrad Biotecnol, Vitoria, ES, Brazil.	lucas_lmbio@hotmail.com	Tonini Peterle, Gabriela/GWU-6986-2022; Mendoza Lopez, Rossana Veronica/X-3968-2018; Álvares-da-Silva, Adriana M/J-2912-2018; Nunes, Fabio Daumas/B-4543-2011; Mendoza Lopez, Rossana Veronica/ABA-2587-2021; Archanjo, Anderson Barros/Q-5245-2017	Mendoza Lopez, Rossana Veronica/0000-0001-7993-767X; Álvares-da-Silva, Adriana M/0000-0002-8078-0304; Nunes, Fabio Daumas/0000-0002-7785-6785; Archanjo, Anderson Barros/0000-0002-9305-271X; STUR, ELAINE/0000-0001-5962-0050; Gasparini dos Santos, Joaquim/0000-0001-6096-116X; MOTA DE OLIVEIRA, MAYARA/0000-0003-2735-9788	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [04/12054-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Espirito Santo (FAPES); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Espirito Santo (FAPES); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (http://www.fapesp.br/) grants 04/12054-9; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (http://cnpq.br/); Fundacao de Amparo a Pesquisa do Estado do Espirito Santo (FAPES) (https://fapes.es.gov.br/); and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (http://capes.gov.br/).	Amar A, 2013, BRAZ J OTORHINOLAR, V79, P734, DOI 10.5935/1808-8694.20130134; [Anonymous], 1978, PLOS ONE; Baranello C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040678; Bauman JE, 2012, CURR OPIN ONCOL, V24, P235, DOI 10.1097/CCO.0b013e3283517920; Benard A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-531; Bono P, 2004, CLIN CANCER RES, V10, P7144, DOI 10.1158/1078-0432.CCR-03-0826; Bredell MG, 2016, ONCOTARGET, V7, P50781, DOI 10.18632/oncotarget.9549; Cajaiba MM, 2006, PEDIATR DEVEL PATHOL, V9, P196, DOI 10.2350/05-12-0002.1; Chakrabarti KR, 2015, ONCOTARGET, V6, P36292, DOI 10.18632/oncotarget.5345; Dambacher S, 2013, CELL CYCLE, V12, P2925, DOI 10.4161/cc.26179; dos Santos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045228; Du ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019137; Fan L, 2016, ONCOGENE, V35, P2441, DOI 10.1038/onc.2015.309; Galli P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-137; Gao YQ, 2016, ONCOTARGET, V7, P63374, DOI 10.18632/oncotarget.11463; Guo X, 2011, NEOPLASMA, V58, P153, DOI 10.4149/neo_2011_02_153; Harris AL, 2004, NAT REV CANCER, V2, P38; Hedvat CV, 2002, HUM PATHOL, V33, P968, DOI 10.1053/hupa.2002.127438; Hsu FD, 2002, MODERN PATHOL, V15, P1374, DOI 10.1097/01.MP.0000039571.02827.CE; Karpinich NO, 2013, FASEB J, V27, P590, DOI 10.1096/fj.12-214080; Kasioulis I, 2014, MOL BIOL CELL, V25, P1216, DOI 10.1091/mbc.E13-08-0471; Kaukonen R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12237; Keleg S, 2007, INT J CANCER, V121, P21, DOI 10.1002/ijc.22596; Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Li MQ, 2015, ONCOL LETT, V10, P1003, DOI 10.3892/ol.2015.3278; Lim S, 2010, INT J CANCER, V127, P1991, DOI 10.1002/ijc.25538; Liu J, 2016, ONCOTARGET, V7, P85151, DOI 10.18632/oncotarget.13208; Muller-Tidow C, 2010, BLOOD, V116, P3564, DOI 10.1182/blood-2009-09-240978; OCHOACALLEJERO L, 2017, SMALL MOL REL ADR, V7, DOI DOI 10.1038/S41598-017-17573-X; Oehler MK, 2003, BRIT J CANCER, V89, P1927, DOI 10.1038/sj.bjc.6601397; Park SJ, 2013, BIOCHEM BIOPH RES CO, V434, P722, DOI 10.1016/j.bbrc.2013.03.091; Park YS, 2008, ANN SURG ONCOL, V15, P1968, DOI 10.1245/s10434-008-9927-9; Ponnaluri VKC, 2011, BIOCHEM BIOPH RES CO, V415, P373, DOI 10.1016/j.bbrc.2011.10.075; Puram SV, 2015, HEMATOL ONCOL CLIN N, V29, P971, DOI 10.1016/j.hoc.2015.07.003; Rimm DL, 2001, EXP MOL PATHOL, V70, P255, DOI 10.1006/exmp.2001.2363; Rogenhofer S, 2012, ANTICANCER RES, V32, P879; Sobin L, 2009, TNM CLASSIFICATION M; Soini Y, 2000, BRIT J CANCER, V83, P880, DOI 10.1054/bjoc.2000.1384; Song JS, 2012, PATHOL INT, V62, P182, DOI 10.1111/j.1440-1827.2011.02776.x; Uemura M, 2010, CLIN CANCER RES, V16, P4636, DOI 10.1158/1078-0432.CCR-10-0407; Vavilala DT, 2012, BIOCHEM BIOPH RES CO, V422, P369, DOI 10.1016/j.bbrc.2012.04.143; Wellmann S, 2008, BIOCHEM BIOPH RES CO, V372, P892, DOI 10.1016/j.bbrc.2008.05.150; Xia RH, 2013, ARCH PATHOL LAB MED, V137, P1761, DOI 10.5858/arpa.2012-0704-OA; Yang HY, 2015, INT J CLIN EXP PATHO, V8, P11092; Yang J, 2009, ANN NY ACAD SCI, V1177, P185, DOI 10.1111/j.1749-6632.2009.05027.x; Zhang CJ, 2010, J HEPATOL, V53, P889, DOI 10.1016/j.jhep.2010.05.012	47	14	14	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194884	10.1371/journal.pone.0194884	http://dx.doi.org/10.1371/journal.pone.0194884			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590186	Green Published, gold, Green Submitted			2022-12-26	WOS:000428603100084
J	Moreno, X; Albala, C; Lera, L; Leyton, B; Angel, B; Sanchez, H				Moreno, Ximena; Albala, Cecilia; Lera, Lydia; Leyton, Barbara; Angel, Barbara; Sanchez, Hugo			Gender, nutritional status and disability-free life expectancy among older people in Santiago, Chile	PLOS ONE			English	Article							MOBILITY DISABILITY; BODY-COMPOSITION; SAO-PAULO; OBESITY; ADULTS; HEALTH; OVERWEIGHT; WEIGHT; IMPACT; LIMITATIONS	Background This study was aimed to estimate life expectancy (LE), disability-free life expectancy (DFLE) and disabled life expectancy (DLE) among older adults from Santiago, Chile, and to determine the existence of differences by gender and by body mass index (BMI) categories in these indicators. Methods A sample of 1216 people aged 60 or more, from the Chilean cohort of the Study of Health, Ageing and Well-Being was recruited in 2000; two follow-up assessments were carried out in a 10-year period. Functional limitation was assessed through self-report of difficulties in activities of daily living, instrumental activities of daily living and mobility. BMI was determined with measured weight and height. Multistate life tables were employed to estimate LE and healthy life expectancy (HLE). Results At 60 years, women could expect to live on average an additional 20.4 years (95% CI 19.0-21.6), and men an additional 16.4 years (95% CI 14.9-17.7). Total LE was longer among women at all ages, but they had a higher proportion of disabled years to be lived compared to men, with a difference of 14% at 60 years, and 10% at 90 years. There were no significant differences in LE, DFLE and DLE between BMI categories. Discussion Despite a longer LE, Chilean older women expect to live a higher proportion of years with disabilities, compared to men. Public health programs should address factors affecting LE of older men, and those associated with disability among older women.	[Moreno, Ximena; Albala, Cecilia; Lera, Lydia; Leyton, Barbara; Angel, Barbara; Sanchez, Hugo] Univ Chile, Inst Nutr & Food Technol, Santiago, Chile	Universidad de Chile	Albala, C (corresponding author), Univ Chile, Inst Nutr & Food Technol, Santiago, Chile.	calbala@uchile.cl	Lera, Lydia/A-8508-2015; Albala, Cecilia/A-7260-2015; Angel, Barbara B/A-8427-2015	Lera, Lydia/0000-0001-7470-2433; Angel, Barbara B/0000-0001-8773-5904; Moreno, Ximena/0000-0002-0586-4364	Chilean National Fund for Scientific and Technological Development [Fondecyt 1080589]	Chilean National Fund for Scientific and Technological Development	This study was supported by the Chilean National Fund for Scientific and Technological Development (project Fondecyt 1080589, main investigator: Cecilia Albala). This funding institution played no role in the design, execution, analysis and interpretation of the data, nor writing of the study.	Albala C, 2005, REV PANAM SALUD PUBL, V17, P307, DOI 10.1590/S1020-49892005000500003; Albala C, 2004, GERONTOLOGIST, V44, P550; ALBALA C, 2010, ESTUDIO NACL DEPENDE; Albala C, 2011, REV MED CHILE, V139, P1276, DOI [10.4067/S0034-98872011001000005, /S0034-98872011001000005]; Alley DE, 2007, JAMA-J AM MED ASSOC, V298, P2020, DOI 10.1001/jama.298.17.2020; Andrade FCD, 2010, J GERONTOL B-PSYCHOL, V65, P381, DOI 10.1093/geronb/gbp119; Apinonkul B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153763; Arroyo P, 2007, REV MED CHILE, V135, P846; Aune D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2156; Belon AP, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-88; Beltran-Sanchez H, 2013, J AGING HEALTH, V25, P815, DOI 10.1177/0898264313491425; Chen HL, 2008, J AM GERIATR SOC, V56, P689, DOI 10.1111/j.1532-5415.2007.01624.x; Dhana K, 2016, INT J OBESITY, V40, P1535, DOI 10.1038/ijo.2016.94; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Drumond Andrade Flavia Cristina, 2013, J Aging Res, V2013, P905094, DOI 10.1155/2013/905094; Andrade FCD, 2011, WOMEN HEALTH ISS, V21, P64, DOI 10.1016/j.whi.2010.08.007; Fabbri E, 2015, J AM GERIATR SOC, V63, P1791, DOI 10.1111/jgs.13608; Freedman VA, 2016, AM J PUBLIC HEALTH, V106, P1079, DOI 10.2105/AJPH.2016.303089; Froehlich-Grobe K, 2011, AM J PREV MED, V41, P541, DOI 10.1016/j.amepre.2011.07.015; Hoogendijk E, 2008, INT J PUBLIC HEALTH, V53, P281, DOI 10.1007/s00038-008-8079-9; Hosseinpoor AR, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-52; Houston DK, 2009, AM J EPIDEMIOL, V169, P927, DOI 10.1093/aje/kwp007; Jackson C., 2016, MULTISTATE MODELLING; Jackson CH, 2011, J STAT SOFTW, V38, P1; Jagger C, 2016, LANCET, V387, P779, DOI 10.1016/S0140-6736(15)00947-2; Kingston A, 2015, ARCH GERONTOL GERIAT, V60, P405, DOI 10.1016/j.archger.2015.02.006; Leigh L, 2016, BRIT J NUTR, V116, P692, DOI 10.1017/S0007114516002403; Lera L, 2017, J FRALITY AGING, V6, P12, DOI 10.14283/jfa.2016.117; Leveille SG, 2005, PAIN, V116, P332, DOI 10.1016/j.pain.2005.05.002; Majer IM, 2011, OBESITY, V19, P1451, DOI 10.1038/oby.2011.46; Ministry of Health, 2010, ENC NAC SAL ENS CHIL; Morrison A, 2013, CLINICOECONOMIC OUTC, V5, P9, DOI 10.2147/CEOR.S38721; Murphy RA, 2014, J AM GERIATR SOC, V62, P1476, DOI 10.1111/jgs.12954; Murtagh KN, 2004, AM J PUBLIC HEALTH, V94, P1406, DOI 10.2105/AJPH.94.8.1406; Nusselder WJ, 2010, EUR J AGEING, V7, P219, DOI 10.1007/s10433-010-0169-x; Oksuzyan A, 2010, EUR J AGEING, V7, P213, DOI 10.1007/s10433-010-0170-4; Payne CF, 2015, J GERONTOL B; Pongiglione B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130747; Reuser M, 2009, OBESITY, V17, P783, DOI 10.1038/oby.2008.640; Reynolds SL, 2009, OBESITY, V17, P363, DOI 10.1038/oby.2008.534; Reynolds SL, 2005, GERONTOLOGIST, V45, P438, DOI 10.1093/geront/45.4.438; Camargos MCS, 2007, J BIOSOC SCI, V39, P455, DOI 10.1017/S0021932006001428; Santosa A, 2016, J EPIDEMIOL COMMUN H, V70, P855, DOI 10.1136/jech-2015-206640; Stenholm S, 2017, INT J OBESITY, V41, P769, DOI 10.1038/ijo.2017.29; Stenholm S, 2008, CURR OPIN CLIN NUTR, V11, P693, DOI 10.1097/MCO.0b013e328312c37d; Stevens JA, 2005, INJURY PREV, V11, P115, DOI 10.1136/ip.2004.005835; UNFPA and HelpAge International, 2012, AG 21 CENT CEL CHALL; Van Oyen H, 2013, INT J PUBLIC HEALTH, V58, P143, DOI 10.1007/s00038-012-0361-1; Van Oyen H, 2010, EUR J AGEING, V7, P229, DOI 10.1007/s10433-010-0172-2; Campos ACV, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1666-9; Villareal DT, 2005, AM J CLIN NUTR, V82, P923, DOI 10.1093/ajcn/82.5.923; Vincent HK, 2010, OBES REV, V11, P568, DOI 10.1111/j.1467-789X.2009.00703.x; Walter S, 2009, INT J OBESITY, V33, P1410, DOI 10.1038/ijo.2009.176; World Health Organization, 1995, PHYS STAT US INT ANT; World Health Organization, 2017, PREVALENCE OBESITY A	55	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194074	10.1371/journal.pone.0194074	http://dx.doi.org/10.1371/journal.pone.0194074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590148	Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100048
J	Chauhan, R; Datzkiw, D; Shrivastav, SV; Shrivastav, A				Chauhan, Ranjit; Datzkiw, David; Shrivastav, Shailly Varma; Shrivastav, Anuraag			In silico identification of microRNAs predicted to regulate N-myristoyltransferase and Methionine Aminopeptidase 2 functions in cancer and infectious diseases	PLOS ONE			English	Article							BREAST-CANCER; CELL-PROLIFERATION; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION FACTORS; POTENTIAL BIOMARKERS; DOWN-REGULATION; T-CELLS; EXPRESSION; INVASION; MIRNA	Protein myristoylation is a key protein modification carried out by N-Myristoyltransferase (NMT) after Methionine aminopeptidase 2 (MetAP2) removes methionine from the amino-terminus of the target protein. Protein myristoylation by NMT augments several signaling pathways involved in a myriad of cellular processes, including developmental pathways and pathways that when dysregulated lead to cancer or immune dysfunction. The emerging evidence pointing to NMT-mediated myristoylation as a major cellular regulator underscores the importance of understanding the framework of this type of signaling event. Various studies have investigated the role that myristoylation plays in signaling dysfunction by examining differential gene or protein expression between normal and diseased states, such as cancers or following HIV-1 infection, however no study exists that addresses the role of microRNAs (miRNAs) in the regulation of myristoylation. By performing a large scale bioinformatics and functional analysis of the miRNAs that target key genes involved in myristoylation (NMT1, NMT2, MetAP2), we have narrowed down a list of promising candidates for further analysis. Our condensed panel of miRNAs identifies 35 miRNAs linked to cancer, 21 miRNAs linked to developmental and immune signaling pathways, and 14 miRNAs linked to infectious disease (primarily HIV). The miRNAs panel that was analyzed revealed several NMT-targeting mRNAs (messenger RNA) that are implicated in diseases associated with NMT signaling alteration, providing a link between the realms of miRNA and myristoylation signaling. These findings verify miRNA as an additional facet of myristoylation signaling that must be considered to gain a full perspective. This study provides the groundwork for future studies concerning NMT-transcript-binding miRNAs, and will potentially lead to the development of new diagnostic/prognostic biomarkers and therapeutic targets for several important diseases.	[Chauhan, Ranjit; Datzkiw, David; Shrivastav, Shailly Varma; Shrivastav, Anuraag] Univ Winnipeg, Dept Biol, Winnipeg, MB, Canada; [Shrivastav, Anuraag] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Shrivastav, Anuraag] CancerCare Manitoba, Res Inst Oncol & Hematol, Winnipeg, MB, Canada; [Chauhan, Ranjit] Mem Univ, Div Biomed Sci, Mol Virol & Hepatol Res Grp, Hlth Sci Ctr, St John, NF, Canada	University of Winnipeg; University of Manitoba; CancerCare Manitoba Foundation; Memorial University Newfoundland; University of Manitoba; Children's Hospital Research Institute of Manitoba	Shrivastav, A (corresponding author), Univ Winnipeg, Dept Biol, Winnipeg, MB, Canada.; Shrivastav, A (corresponding author), Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada.; Shrivastav, A (corresponding author), CancerCare Manitoba, Res Inst Oncol & Hematol, Winnipeg, MB, Canada.	a.shrivastav@uwinnipeg.ca			University of Winnipeg; Prostate Cancer Fight Foundation; CIHR; QE2; Manitoba Medical Service Foundation; CFI	University of Winnipeg; Prostate Cancer Fight Foundation; CIHR(Canadian Institutes of Health Research (CIHR)); QE2; Manitoba Medical Service Foundation; CFI(Canada Foundation for Innovation)	AS acknowledges the funding from The University of Winnipeg and the Prostate Cancer Fight Foundation. DD acknowledges financial support from CIHR and QE2. SV acknowledges funding support from Manitoba Medical Service Foundation. RC's position as an RA at the University of Winnipeg was supported by CFI.	Adoro S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8562; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Andrews K, 2017, FUNCTIONAL VALIDATIO; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Appert-Collin A, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00283; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Avraham R, 2012, BIOCHEM SOC T, V40, P26, DOI 10.1042/BST20110623; Bai RP, 2015, INT J CANCER, V137, P2310, DOI 10.1002/ijc.29607; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BAUMGART M, 2017, MIRNA CATALOGUE NCRN, V0018; Bibby BAS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134180; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Catalanotto C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101712; Chauhan Ranjit, 2016, Biomark Cancer, V8, P37, DOI 10.4137/BIC.S34413; Chen B, 2016, TUMOR BIOL, V37, P2765, DOI 10.1007/s13277-015-4046-2; CHEN DR, 2013, INT J DISTRIB SENS N, V2013, P7, DOI DOI 10.1371/J0URNAL.P0NE.0080625; Chen JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080266; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen QY, 2016, TUMOR BIOL, V37, P521, DOI 10.1007/s13277-015-3675-9; Chen ZJ, 2012, ORAL ONCOL, V48, P686, DOI 10.1016/j.oraloncology.2012.02.020; Chiang K, 2013, VIROLOGY, V438, P1, DOI 10.1016/j.virol.2012.12.016; Cui LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027071; Dey BK, 2012, GENE DEV, V26, P2180, DOI 10.1101/gad.198085.112; Dhayat SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140066; Diaz G, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1971-9; Dix A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00270; Dong YJ, 2013, MOL CANCER RES, V11, P1051, DOI 10.1158/1541-7786.MCR-13-0061; Donzelli S, 2016, METHODS MOL BIOL, V1379, P13, DOI 10.1007/978-1-4939-3191-0_2; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Ducker CE, 2005, MOL CANCER RES, V3, P463, DOI 10.1158/1541-7786.MCR-05-0037; Durojaiye V, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-187; EI-Guendy NM, 2016, HEPAT MON, V16; Emmrich S, 2016, ONCOGENE, V35, P1822, DOI 10.1038/onc.2015.247; Etheridge A, 2011, MUTAT RES-FUND MOL M, V717, P85, DOI 10.1016/j.mrfmmm.2011.03.004; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fang L, 2012, RADIOL ONCOL, V46, P233, DOI 10.2478/v10019-012-0025-z; Fang YT, 2015, CELL PHYSIOL BIOCHEM, V35, P227, DOI 10.1159/000369690; Fang ZX, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0198-6; Favreau AJ, 2012, LEUKEMIA RES, V36, P334, DOI 10.1016/j.leukres.2011.09.027; Fisher K, 2015, WORLD J GASTROENTERO, V21, P12274, DOI 10.3748/wjg.v21.i43.12274; Flores O, 2014, NUCLEIC ACIDS RES, V42, P4629, DOI 10.1093/nar/gkt1393; Floyd DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096239; Formosa A, 2014, ONCOGENE, V33, P5173, DOI 10.1038/onc.2013.451; Garzia L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004998; Giang DG, 1998, J BIOL CHEM, V273, P6595, DOI 10.1074/jbc.273.12.6595; Gigante M, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0841-9; Gonzalez-Martin A, 2016, NAT IMMUNOL, V17, P433, DOI 10.1038/ni.3385; Greco D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021646; Greenberg DS, 2014, CURR PHARM DESIGN, V20, P6022, DOI 10.2174/1381612820666140314151924; Guerra-Assuncao JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-218; Guglielmelli P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140445; Guo WJ, 2015, HEPATOLOGY, V62, P1132, DOI 10.1002/hep.27929; Han YM, 2013, EPIGENOMICS-UK, V5, P439, DOI [10.2217/epi.13.37, 10.2217/EPI.13.37]; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hariharan M, 2005, BIOCHEM BIOPH RES CO, V337, P1214, DOI 10.1016/j.bbrc.2005.09.183; Hoque MO, 2010, J THORAC ONCOL, V5, P1887, DOI 10.1097/JTO.0b013e3181f77a53; Hoy AM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002701; Hu J, 2016, CURR MOL MED, V16, P70, DOI 10.2174/1566524016666151222144656; Hu XM, 2016, HEPATOL RES, V46, P804, DOI 10.1111/hepr.12618; Hui ABY, 2013, CLIN CANCER RES, V19, P2154, DOI 10.1158/1078-0432.CCR-12-3572; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Iwafuchi-Doi M, 2014, GENE DEV, V28, P2679, DOI 10.1101/gad.253443.114; Jaeger A, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4070-2; Jebbawi F, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0218-x; Jeker LT, 2013, IMMUNOL REV, V253, P65, DOI 10.1111/imr.12061; Jha A, 2015, NUCLEIC ACIDS RES, V43, P8713, DOI 10.1093/nar/gkv871; Jha A, 2011, J BIOSCIENCES, V36, P621, DOI 10.1007/s12038-011-9109-y; Jones DZ, 2016, FASEB J S, V30, P9366; Jun H, 2015, SCI REP-UK, V5, DOI 10.1038/srep12226; Kasai M, 2011, BREEDING SCI, V61, P468, DOI 10.1270/jsbbs.61.468; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019518; Kong XJ, 2015, AM J CANCER RES, V5, P1795; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kurosaki T, 2010, ANNU REV IMMUNOL, V28, P21, DOI 10.1146/annurev.immunol.021908.132541; Kurzynska-Kokorniak A, 2015, NUCLEIC ACIDS RES, V43, P4365, DOI 10.1093/nar/gkv328; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li H, 2007, J VIROL, V81, P12899, DOI 10.1128/JVI.01280-07; Li WL, 2014, CELL PHYSIOL BIOCHEM, V34, P1466, DOI 10.1159/000366351; Li X., 2016, VIRUSES, V8; Liang H, 2007, RNA, V13, P1402, DOI 10.1261/rna.634607; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu CL, 2013, BLOOD, V122, P2083, DOI 10.1182/blood-2012-08-447375; Liu H, 2016, J CHEM-NY, V2016, DOI 10.1155/2016/2862567; Liu SG, 2013, ONCOL LETT, V5, P1639, DOI 10.3892/ol.2013.1251; Liu XG, 2010, J IMMUNOL, V185, P7244, DOI 10.4049/jimmunol.1001573; Lu YC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02058-8; Luo SY, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0063-7; Luo XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062880; Maccani A, 2014, APPL MICROBIOL BIOT, V98, P7535, DOI 10.1007/s00253-014-5911-4; Martin HC, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r51; Mathieu J, 2013, ADV EXP MED BIOL, V786, P329, DOI 10.1007/978-94-007-6621-1_18; Mei LL, 2017, CANCER BIOMARK, V19, P1, DOI 10.3233/CBM-160240; Meng DL, 2016, INT J BIOCHEM CELL B, V73, P30, DOI 10.1016/j.biocel.2016.01.018; Min S, 2012, GENES IMMUN, V13, P621, DOI 10.1038/gene.2012.45; Mulrane L, 2012, CLIN CANCER RES, V18, P6702, DOI 10.1158/1078-0432.CCR-12-1420; Nadal E, 2015, SCI REP-UK, V5, DOI 10.1038/srep12464; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Nygren MK, 2014, BRIT J CANCER, V110, P2072, DOI 10.1038/bjc.2014.113; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Orr-Burks NL, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.23; Otaegui D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006309; Pashkovskiy PP, 2013, BIOCHEMISTRY-MOSCOW+, V78, P627, DOI 10.1134/S0006297913060084; Pereira DM, 2013, DRUG DISCOV TODAY, V18, P282, DOI 10.1016/j.drudis.2012.10.002; Pers YM, 2013, NAT REV RHEUMATOL, V9, P76, DOI 10.1038/nrrheum.2012.236; Pertea M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-206; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Ramalinga M, 2015, ONCOTARGET, V6, P34446, DOI 10.18632/oncotarget.5920; Rampoldi F, 2015, J IMMUNOL, V195, P4228, DOI 10.4049/jimmunol.1500622; Rau CS, 2015, J BIOMEDICAL SCI, V22, P1; Riffo-Campos A.L., 2016, INT J MOL SCI, V17; Roderburg C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032999; Saini S, 2012, CANCER RES, V72, P3618, DOI 10.1158/0008-5472.CAN-12-0540; Sannigrahi MK, 2017, CLIN CANCER RES, V23, P3884, DOI 10.1158/1078-0432.CCR-16-2936; Santhakumar D, 2010, P NATL ACAD SCI USA, V107, P13830, DOI 10.1073/pnas.1008861107; Sass S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-136; Schmitt MJ, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-41; Schramedei K, 2011, ONCOGENE, V30, P2975, DOI 10.1038/onc.2011.15; Selvakumar P, 2007, INT J MOL MED, V19, P823; Shrestha S, 2014, CANCER MED-US, V3, P878, DOI 10.1002/cam4.246; Shrivastav A, 2008, J IMMUNOL, V180, P1019, DOI 10.4049/jimmunol.180.2.1019; Shrivastav A, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-58; Shrivastav A, 2009, J PATHOL, V218, P391, DOI 10.1002/path.2550; Smigielska-Czepiel K, 2014, GENES IMMUN, V15, P115, DOI 10.1038/gene.2013.69; Squillace N, 2014, J ANTIMICROB CHEMOTH, V69, P3067, DOI 10.1093/jac/dku264; Srivastava A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076994; Stern DF, 2000, BREAST CANCER RES, V2, P176, DOI 10.1186/bcr51; Thinon E, 2016, ACS CHEM BIOL, V11, P2165, DOI 10.1021/acschembio.6b00371; TOWLER DA, 1987, J BIOL CHEM, V262, P1030; Tu L, 2016, HSA MIR 376C 3P REGU, V2016; Turner M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-169; Utikal J, 2015, SEMIN CANCER BIOL, V35, P200, DOI 10.1016/j.semcancer.2015.07.001; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Varshney A, 2017, HEPATOLOGY; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Wan TMH, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/919283; Wang S, 2014, DIS MARKERS, V2014, DOI DOI 10.1155/2014/401986254777024244930; Wang XS, 2016, BIOCHEM BIOPH RES CO, V470, P620, DOI 10.1016/j.bbrc.2016.01.095; Wang YX, 2015, INT J CLIN EXP PATHO, V8, P786; Wang-Renault SF, 2018, ANN RHEUM DIS, V77, P133, DOI 10.1136/annrheumdis-2017-211417; Wei Jun-Qiang, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P291; Witten JT, 2011, TRENDS GENET, V27, P89, DOI 10.1016/j.tig.2010.12.001; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Wu CX, 2017, SHOCK, V47, P520, DOI 10.1097/SHK.0000000000000766; Wu DY, 2015, MOL MED REP, V11, P1469, DOI 10.3892/mmr.2014.2792; Wu DY, 2014, ONCOL LETT, V7, P1219, DOI 10.3892/ol.2014.1875; Wu J, 2015, BIOMED RES INT, V2015, P1, DOI DOI 10.1371/J0URNAL.P0NE.0128280; Xiao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032201; Xie H, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/6493241; Xie J, 2014, WORLD J GASTROENTERO, V20, P17439, DOI 10.3748/wjg.v20.i46.17439; Xing TJ, 2014, INT J CLIN EXP MED, V7, P4924; Xing TJ, 2014, INT J MOL SCI, V15, P14411, DOI 10.3390/ijms150814411; Yang SH, 2005, J BIOL CHEM, V280, P18990, DOI 10.1074/jbc.M412917200; Yen YC, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-6; Yu GD, 2017, LIFE SCI, V175, P47, DOI 10.1016/j.lfs.2017.03.010; Yu T, 2016, SCI REPORTS, V6, P30923; Yu X, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2015.43; Zekri ARN, 2016, TUMOR BIOL, V37, P12273, DOI 10.1007/s13277-016-5097-8; Zeng JS, 2017, INT J BIOCH CELL BIO; Zhang GL, 2010, ANTIVIR RES, V88, P169, DOI 10.1016/j.antiviral.2010.08.008; Zhang L, 2015, BREAST CANCER RES TR, V154, P423, DOI 10.1007/s10549-015-3591-0; Zhang WP, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0113-6; Zhang XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055733; Zhang YD, 2016, BIOCHEM BIOPH RES CO, V476, P607, DOI 10.1016/j.bbrc.2016.06.006; Zhang YP, 2015, INT J CLIN EXP PATHO, V8, P15677; Zhou JJ, 2015, CANCER LETT, V356, P669, DOI 10.1016/j.canlet.2014.10.014; Zhou L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-677; Zhou Xiaofeng, 2012, Microrna, V1, P1; Zhu MJ, 2014, FEBS J, V281, P3766, DOI 10.1111/febs.12902; Zhuang M, 2014, BIOCHEM BIOPH RES CO, V448, P315, DOI 10.1016/j.bbrc.2013.12.126	175	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194612	10.1371/journal.pone.0194612	http://dx.doi.org/10.1371/journal.pone.0194612			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579063	Green Submitted, Green Published, gold			2022-12-26	WOS:000428351800038
J	Di Fede, M; Biagini, M; Cartocci, E; Parillo, C; Greco, A; Martinelli, M; Marchi, S; Pezzicoli, A; Delany, I; Paccani, SR				Di Fede, Martina; Biagini, Massimiliano; Cartocci, Elena; Parillo, Carlo; Greco, Alessandra; Martinelli, Manuele; Marchi, Sara; Pezzicoli, Alfredo; Delany, Isabel; Paccani, Silvia Rossi			Neisseria Heparin Binding Antigen is targeted by the human alternative pathway C3-convertase	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; TISSUE KALLIKREIN; MENINGOCOCCAL CARRIAGE; MENINGITIDIS; COMPLEMENT; ACTIVATION; EXPRESSION; CONVERTASE; PROTEINS; TRACHEA	Neisserial Heparin Binding Antigen (NHBA) is a surface-exposed lipoprotein specific for Neisseria and constitutes one of the three main protein antigens of the Bexsero vaccine. Meningococcal and human proteases, cleave NHBA protein upstream or downstream of a conserved Arg-rich region, respectively. The cleavage results in the release of the C-terminal portion of the protein. The C-terminal fragment originating from the processing of meningococcal proteases, referred to as C2 fragment, exerts a toxic effect on endothelial cells altering the endothelial permeability. In this work, we reported that recombinant C2 fragment has no influence on the integrity of human airway epithelial cell monolayers, consistent with previous findings showing that Neisseria meningitidis traverses the epithelial barrier without disrupting the junctional structures. We showed that epithelial cells constantly secrete proteases responsible for a rapid processing of C2 fragment, generating a new fragment that does not contain the Arg-rich region, a putative docking domain reported to be essential for C2-mediated toxic effect. Moreover, we found that the C3-convertase of the alternative complement pathway is one of the proteases responsible for this processing. Overall, our data provide new insights on the cleavage of NHBA protein during meningococcal infection. NHBA cleavage may occur at different stages of the infection, and it likely has a different role depending on the environment the bacterium is interacting with.	[Di Fede, Martina; Biagini, Massimiliano; Cartocci, Elena; Parillo, Carlo; Greco, Alessandra; Martinelli, Manuele; Marchi, Sara; Pezzicoli, Alfredo; Delany, Isabel; Paccani, Silvia Rossi] GSK, Siena, Italy; [Di Fede, Martina] Inst Virol & Med Biochem, Munster, Germany	GlaxoSmithKline	Paccani, SR (corresponding author), GSK, Siena, Italy.	silvia.x.rossi-paccani@gsk.com	Greco, Alessandra/AAB-9743-2019	Greco, Alessandra/0000-0002-3130-0079	GlaxoSmithKline Biologicals SA	GlaxoSmithKline Biologicals SA(GlaxoSmithKline)	This work was sponsored and funded by GlaxoSmithKline Biologicals SA. GlaxoSmithKline Biologicals SA provided support in the form of salaries for MB, EC, CP, AG, SM, AP, ID, SRP. The specific roles of these authors are articulated in the author contributions section.	Alcorlo M, 2013, P NATL ACAD SCI USA, V110, P13504, DOI 10.1073/pnas.1309618110; Ali M, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-4; Arenas J, 2013, MOL MICROBIOL, V87, P254, DOI 10.1111/mmi.12097; Budroni S, 2011, P NATL ACAD SCI USA, V108, P4494, DOI 10.1073/pnas.1019751108; Casellato A, 2014, CELL MICROBIOL, V16, P925, DOI 10.1111/cmi.12250; Christensen H, 2010, LANCET INFECT DIS, V10, P853, DOI 10.1016/S1473-3099(10)70251-6; CHRISTIANSEN SC, 1987, J CLIN INVEST, V79, P188, DOI 10.1172/JCI112782; Crum-Cianflone N, 2016, INFECT DIS THER, V5, P89, DOI 10.1007/s40121-016-0107-0; Davis AS, 2015, J HISTOCHEM CYTOCHEM, V63, P312, DOI 10.1369/0022155415570968; DISCIPIO RG, 1982, IMMUNOLOGY, V45, P587; Forteza R, 1999, AM J RESP CELL MOL, V21, P666, DOI 10.1165/ajrcmb.21.6.3651; Giuliani MM, 2005, INFECT IMMUN, V73, P1151, DOI 10.1128/IAI.73.2.1151-1160.2005; Granoff DM, 2009, INFECT IMMUN, V77, P764, DOI 10.1128/IAI.01191-08; HIEMSTRA PS, 1985, THROMB RES, V38, P491, DOI 10.1016/0049-3848(85)90182-3; Keck T, 2000, LARYNGOSCOPE, V110, P651, DOI 10.1097/00005537-200004000-00021; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Lappann M, 2016, INFECT IMMUN, V84, P3484, DOI 10.1128/IAI.00584-16; Leu CH, 2015, ANTIMICROB AGENTS CH, V59, P5619, DOI 10.1128/AAC.00065-15; Lewis LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001027; Martinez-Anton A, 2013, AM J RESP CELL MOL, V49, P384, DOI 10.1165/rcmb.2012-0368OC; Moss ML, 2010, COMB CHEM HIGH T SCR, V13, P358; Pantano E, NEIS SERIA HEPARIN B; PROUD D, 1993, AM J RESP CELL MOL, V8, P16, DOI 10.1165/ajrcmb/8.1.16; Pujol C, 1997, INFECT IMMUN, V65, P4836, DOI 10.1128/IAI.65.11.4836-4842.1997; Read RC, 2014, LANCET, V384, P2123, DOI 10.1016/S0140-6736(14)60842-4; Ricklin D, 2016, NAT REV NEPHROL, V12, P383, DOI 10.1038/nrneph.2016.70; Serruto D, 2010, P NATL ACAD SCI USA, V107, P3770, DOI 10.1073/pnas.0915162107; Sim RJ, 2000, LANCET, V356, P1653, DOI 10.1016/S0140-6736(00)03162-7; STEPHENS DS, 1983, J INFECT DIS, V148, P369, DOI 10.1093/infdis/148.3.369; Sutherland TC, 2010, INFECT IMMUN, V78, P3832, DOI 10.1128/IAI.01377-09; Vacca I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162878; Varsano S, 2000, THORAX, V55, P364, DOI 10.1136/thorax.55.5.364	32	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194662	10.1371/journal.pone.0194662	http://dx.doi.org/10.1371/journal.pone.0194662			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579105	Green Published, gold, Green Submitted			2022-12-26	WOS:000428351800045
J	Geldenhuys, M; Mortlock, M; Weyer, J; Bezuidt, O; Seamark, ECJ; Kearney, T; Gleasner, C; Erkkila, TH; Cui, HL; Markotter, W				Geldenhuys, Marike; Mortlock, Marinda; Weyer, Jacqueline; Bezuidt, Oliver; Seamark, Ernest C. J.; Kearney, Teresa; Gleasner, Cheryl; Erkkila, Tracy H.; Cui, Helen; Markotter, Wanda			A metagenomic viral discovery approach identifies potential zoonotic and novel mammalian viruses in Neoromicia bats within South Africa	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; MERS CORONAVIRUS; DROMEDARY CAMELS; GENETIC DIVERSITY; GENOME ANALYSIS; PREVALENCE; CHINA; ADENOVIRUSES; PARAMYXOVIRUSES; CLASSIFICATION	Species within the Neoromicia bat genus are abundant and widely distributed in Africa. It is common for these insectivorous bats to roost in anthropogenic structures in urban regions. Additionally, Neoromicia capensis have previously been identified as potential hosts for Middle East respiratory syndrome (MERS)-related coronaviruses. This study aimed to ascertain the gastrointestinal virome of these bats, as viruses excreted in fecal material or which may be replicating in rectal or intestinal tissues have the greatest opportunities of coming into contact with other hosts. Samples were collected in five regions of South Africa over eight years. Initial virome composition was determined by viral metagenomic sequencing by pooling samples and enriching for viral particles. Libraries were sequenced on the Illumine MiSeq and NextSeq500 platforms, producing a combined 37 million reads. Bioinformatics analysis of the high throughput sequencing data detected the full genome of a novel species of the Circoviridae family, and also identified sequence data from the Adenoviridae, Coronaviridae, Herpesviridae, Parvoviridae, Papillomaviridae, Phenuiviridae, and Picornaviridae families. Metagenomic sequencing data was insufficient to determine the viral diversity of certain families due to the fragmented coverage of genomes and lack of suitable sequencing depth, as some viruses were detected from the analysis of reads-data only. Follow up conventional PCR assays targeting conserved gene regions for the Adenoviridae, Coronaviridae, and Herpesviridae families were used to confirm metagenomic data and generate additional sequences to determine genetic diversity. The complete coding genome of a MERS-related coronavirus was recovered with additional amplicon sequencing on the MiSeq platform. The new genome shared 97.2% overall nucleotide identity to a previous Neoromicia-associated MERS-related virus, also from South Africa. Conventional PCR analysis detected diverse adenovirus and herpesvirus sequences that were widespread throughout Neoromicia populations in South Africa. Furthermore, similar adenovirus sequences were detected within these populations throughout several years. With the exception of the coronaviruses, the study represents the first report of sequence data from several viral families within a Southern African insectivorous bat genus; highlighting the need for continued investigations in this regard.	[Geldenhuys, Marike; Mortlock, Marinda; Markotter, Wanda] Univ Pretoria, Dept Med Virol, Ctr Viral Zoonoses, Pretoria, South Africa; [Weyer, Jacqueline] Natl Inst Communicable Dis, Ctr Emerging Zoonot & Parasit Dis, Natl Hlth Lab Serv, Johannesburg, South Africa; [Bezuidt, Oliver] Univ Pretoria, Ctr Microbial Ecol & Genom, Pretoria, South Africa; [Seamark, Ernest C. J.] AfricanBats NPC, Pretoria, South Africa; [Seamark, Ernest C. J.] Univ Pretoria, Mammal Res Inst, Eugene Marais Chair Wildlife Management, Pretoria, South Africa; [Kearney, Teresa] Ditsong Natl Museum Nat Hist, Pretoria, South Africa; [Kearney, Teresa] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Johannesburg, South Africa; [Gleasner, Cheryl; Erkkila, Tracy H.; Cui, Helen] Los Alamos Natl Lab, Los Alamos, NM USA	University of Pretoria; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Pretoria; University of Pretoria; University of Witwatersrand; United States Department of Energy (DOE); Los Alamos National Laboratory	Markotter, W (corresponding author), Univ Pretoria, Dept Med Virol, Ctr Viral Zoonoses, Pretoria, South Africa.	wanda.markotter@up.ac.za	Geldenhuys, Marike/AAL-4868-2020	Geldenhuys, Marike/0000-0003-4005-118X; Kearney, Teresa/0000-0002-0050-4060; bezuidt, keoagile oliver/0000-0002-1690-9716; Markotter, Wanda/0000-0002-7550-0080; Mortlock, Marinda/0000-0001-9286-1040; Seamark, Ernest C. J./0000-0001-9741-9147	National Research Foundation (NRF) of South Africa: the South African Research Chair [98339, 92524, 85756, 91496]; Poliomyelitis Research Foundation [12/14]; Research Trust of the National Health Laboratory Service; Medical Research Council; Centers for Disease Control and Prevention [5 NU2GGH001874-02-00]; NRF's Innovation bursary award [UID: 79409]; University of Pretoria	National Research Foundation (NRF) of South Africa: the South African Research Chair; Poliomyelitis Research Foundation; Research Trust of the National Health Laboratory Service; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NRF's Innovation bursary award; University of Pretoria	This work was financially supported in part by the National Research Foundation (NRF) of South Africa: the South African Research Chair held by WM grant no. 98339, as well as grant numbers 92524, 85756, and 91496. The opinions, findings and conclusions expressed are those of the authors alone, and the NRF accepts no liability in this regard for research supported. Additional support was obtained by WM from the Poliomyelitis Research Foundation (grant number: 12/14). The Research Trust of the National Health Laboratory Service and the Medical Research Council was awarded to JW. This research was partially supported by the Grant or Cooperative Agreement Number [5 NU2GGH001874-02-00], funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services. MG was supported by funding from the NRF's Innovation bursary award (grant UID: 79409), the Poliomyelitis Research Foundation (grant no. 13/48), and the postgraduate study abroad bursary program of the University of Pretoria, which funded a research visit to the Los Alamos National Laboratory in New Mexico.	Amman BR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002877; Annan A, 2013, EMERG INFECT DIS, V19, P456, DOI 10.3201/eid1903.121503; Anthony SJ, 2017, MBIO, V8, DOI [10.1128/mBio.00373-17, 10.1128/mbio.00373-17]; Baker KS, 2013, VIROLOGY, V441, P95, DOI 10.1016/j.virol.2013.03.014; Benko M, 2014, FUTURE MICROBIOL, V9, P269, DOI 10.2217/fmb.13.170; Chu DKW, 2014, EMERG INFECT DIS, V20, P1049, DOI 10.3201/eid2006.140299; Corman VM, 2014, EMERG INFECT DIS, V20, P1319, DOI 10.3201/eid2008.140596; Corman VM, 2014, J VIROL, V88, P11297, DOI 10.1128/JVI.01498-14; Dacheux L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087194; Darriba D., 2015, NAT METHODS, V9, P6, DOI DOI 10.1038/NMETH.2109.JM0DELTEST; de Groot RJ, 2012, VIRUS TAXONOMY, P806, DOI DOI 10.1016/B978-0-12-384684-6.00068-9; Lima FED, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118070; Donaldson EF, 2010, J VIROL, V84, P13004, DOI 10.1128/JVI.01255-10; Drexler JF, 2014, ANTIVIR RES, V101, P45, DOI 10.1016/j.antiviral.2013.10.013; Drexler JF, 2013, P NATL ACAD SCI USA, V110, P16151, DOI 10.1073/pnas.1308049110; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Drexler JF, 2010, J VIROL, V84, P11336, DOI 10.1128/JVI.00650-10; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Escalera-Zamudio M, 2016, MBIO, V7, DOI [10.1128/mBio.01425-16, 10.1128/mbio.01425-16]; Faye B, 2015, EMIR J FOOD AGR, V27, P318, DOI 10.9755/ejfa.v27i4.19906; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Ge XY, 2012, J VIROL, V86, P4620, DOI 10.1128/JVI.06671-11; Geldenhuys M, 2013, VECTOR-BORNE ZOONOT, V13, P516, DOI 10.1089/vbz.2012.1101; Gloza-Rausch F, 2008, EMERG INFECT DIS, V14, P626, DOI 10.3201/eid1404.071439; Goodman SM, 2017, ZOOTAXA, V4236, P351, DOI 10.11646/zootaxa.4236.2.10; Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; He B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061950; Hemida MG, 2017, TRANSBOUND EMERG DIS, V64, P344, DOI 10.1111/tbed.12401; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huson DH, 2007, MEGAN ANAL METAGENOM, P377; Hutson AM, 2014, IUCN RED LIST THREAT; Ithete NL, 2013, EMERG INFECT DIS, V19, P1697, DOI 10.3201/eid1910.130946; Jacobs D, 2014, IUCN RED LIST THREAT; Janoska M, 2011, VET J, V189, P118, DOI 10.1016/j.tvjl.2010.06.020; Kemenesi G, 2015, J GEN VIROL, V96, P815, DOI 10.1099/jgv.0.000028; Kohl C, 2015, EMERG INFECT DIS, V21, P48, DOI 10.3201/eid2101.140766; Kohl C, 2012, J VIROL, V86, P1888, DOI 10.1128/JVI.05974-11; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Lau SKP, 2011, J VIROL, V85, P8819, DOI 10.1128/JVI.02364-10; Li L, 2015, J VIROL METHODS, V213, P139, DOI 10.1016/j.jviromet.2014.12.002; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Li LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09; Li Y, 2010, J VIROL, V84, P3889, DOI 10.1128/JVI.02497-09; Lukashev AN, 2017, J GEN VIROL, V98, P955, DOI 10.1099/jgv.0.000760; Miller M.A., 2010, P GAT COMP ENV WORKS; Mortlock M, 2015, EMERG INFECT DIS, V21, P1840, DOI 10.3201/eid2110.140368; Mourya DT, 2014, J VIROL, V88, P3605, DOI 10.1128/JVI.02617-13; Muller MA, 2014, EMERG INFECT DIS, V20, P2093, DOI 10.3201/eid2012.141026; Oude Munnink BBO, 2016, GENOME ANNOUNC, V4; Pankovics P, 2016, INFECT GENET EVOL, V37, P117, DOI 10.1016/j.meegid.2015.11.012; Pfefferle S, 2009, EMERG INFECT DIS, V15, P1377, DOI 10.3201/eid1509.090224; Phillips S. B., 2006, International Journal of Global Environmental Issues, V6, P231, DOI 10.1504/IJGENVI.2006.010156; Quan PL, 2013, P NATL ACAD SCI USA, V110, P8194, DOI 10.1073/pnas.1303037110; Rahman MA, 2012, VECTOR-BORNE ZOONOT, V12, P65, DOI 10.1089/vbz.2011.0656; Reusken CBEM, 2013, LANCET, V3099, P1; Reusken CBEM, 2014, EMERG INFECT DIS, V20, P1370, DOI 10.3201/eid2008.140590; Sabir JSM, 2016, SCIENCE, V351, P81, DOI 10.1126/science.aac8608; Sayre R, 2013, AFRICAN GEOGR REV, P1; Seamark ECJ, 2016, PRETORIA AFRICANBATS; Shabman RS, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00070-15; Sonntag M, 2009, EMERG INFECT DIS, V15, P2052, DOI 10.3201/eid1512.090646; Sumibcay L, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-34; Tang XC, 2006, J VIROL, V80, P7481, DOI 10.1128/JVI.00697-06; Tao Y, 2017, J VIROL, V91, DOI 10.1128/JVI.01953-16; TAYLOR P. J., 2010, BATS SO CENTRAL AFRI; Temmam S, 2014, INT J MOL SCI, V15, P10377, DOI 10.3390/ijms150610377; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163; Vidovszky MZ, 2015, ACTA VET HUNG, V63, P508, DOI 10.1556/004.2015.047; Wang J, 2015, J GEN VIROL, V96, P2442, DOI 10.1099/vir.0.000158; Wang SL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-451; Wilson R. T., 2013, African Journal of Agricultural Research, V8, P3716; Wu Z, 2015, ISME J, V2015, P1, DOI DOI 10.1038/ISMEJ.2015.138; Wu ZQ, 2012, J VIROL, V86, P10999, DOI 10.1128/JVI.01394-12; Yuan LH, 2014, VIRUSES-BASEL, V6, P2138, DOI 10.3390/v6052138; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhao GY, 2017, VIROLOGY, V503, P21, DOI 10.1016/j.virol.2017.01.005; Zheng XY, 2016, ARCH VIROL, V161, P135, DOI 10.1007/s00705-015-2614-9	82	48	48	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194527	10.1371/journal.pone.0194527	http://dx.doi.org/10.1371/journal.pone.0194527			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579103	Green Submitted, Green Published, gold			2022-12-26	WOS:000428351800035
J	Harris, RA; Haberer, JE; Musinguzi, N; Chang, KM; Schechter, CB; Doubeni, CA; Gross, R				Harris, Rebecca Arden; Haberer, Jessica E.; Musinguzi, Nicholas; Chang, Kyong-Mi; Schechter, Clyde B.; Doubeni, Chyke A.; Gross, Robert			Predicting short-term interruptions of antiretroviral therapy from summary adherence data: Development and test of a probability model	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; RURAL UGANDA; SUPPRESSION; RESISTANCE; FAILURE; KAMPALA; COHORT; BIAS; RNA; ERA	Antiretroviral therapy (ART) for HIV is vulnerable to unplanned treatment interruptions consecutively missed doses over a series of days which can result in virologic rebound. Yet clinicians lack a simple, valid method for estimating the risk of interruptions. If the likelihood of ART interruption could be derived from a convenient-to-gather summary measure of medication adherence, it might be a valuable tool for both clinical decision-making and research. We constructed an a priori probability model of ART interruption based on average adherence and tested its predictions using data collected on 185 HIV-infected, treatment-naive individuals over the first 90 days of ART in a prospective cohort study in Mbarara, Uganda. The outcome of interest was the presence or absence of a treatment gap, defined as >72 hours without a dose. Using the pre-determined value of 0.50 probability as the cut point for predicting an interruption, the classification accuracy of the model was 73% (95% CI = 66%-79%), the specificity was 87% (95% CI = 79%-93%), and the sensitivity was 59% (95% CI = 48%-69%). Overall model performance was satisfactory, with an area under the receiver operator characteristic curve (AUROC) of 0.85 (95% CI = 0.80-0.91) and Brier score of 0.20. The study serves as proof-of-concept that the probability model can accurately differentiate patients on the continuum of risk for short-term ART interruptions using a summary measure of adherence. The model may also aid in the design of targeted interventions.	[Harris, Rebecca Arden; Chang, Kyong-Mi; Doubeni, Chyke A.; Gross, Robert] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Haberer, Jessica E.] Harvard Med Sch, Boston, MA USA; [Haberer, Jessica E.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Musinguzi, Nicholas] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Chang, Kyong-Mi] Philadelphia VA Med Ctr, Philadelphia, PA USA; [Schechter, Clyde B.] Albert Einstein Coll Med, Bronx, NY 10467 USA	University of Pennsylvania; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Mbarara University of Science & Technology; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; Yeshiva University; Albert Einstein College of Medicine	Harris, RA (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.	Rebecca.Harris@uphs.upenn.edu	Haberer, Jessica/AAH-7976-2019	Haberer, Jessica/0000-0001-5845-3190; Harris, Rebecca Arden/0000-0001-6058-0463	University of Pennsylvania Center for AIDS Research; NIH [P30-AI045008]	University of Pennsylvania Center for AIDS Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	University of Pennsylvania Center for AIDS Research, an NIH-funded program (grant P30-AI045008 to R.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adakun SA, 2013, JAIDS-J ACQ IMM DEF, V62, P317, DOI 10.1097/QAI.0b013e3182800daf; Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Bangsberg DR, 2013, JAMA INTERN MED, V173, P306, DOI 10.1001/jamainternmed.2013.2858; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Chen LF, 2015, INFECT CONT HOSP EP, V36, P1444, DOI 10.1017/ice.2015.216; Derogatis L., 2010, CORSINI ENCY PSYCHOL, P1, DOI [DOI 10.1002/9780470479216.CORPSY0970, 10.1002/9780470479216.corpsy0970]; Ewald B, 2006, J CLIN EPIDEMIOL, V59, P798, DOI 10.1016/j.jclinepi.2005.11.025; Feller W., 1968, INTRO PROBABILITY TH, V1; Genberg BL, 2012, AIDS, V26, P1415, DOI 10.1097/QAD.0b013e328354bed6; Geng EH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014098; Gross R, 2006, J INFECT DIS, V194, P1108, DOI 10.1086/507680; Grossberg R, 2004, J CLIN EPIDEMIOL, V57, P1107, DOI 10.1016/j.jclinepi.2004.04.002; Haberer JE, 2017, AIDS, V31, P169, DOI 10.1097/QAD.0000000000001310; Haberer JE, 2015, JAIDS-J ACQ IMM DEF, V70, P386, DOI 10.1097/QAI.0000000000000737; Hastie T, 2013, ELEMENTS STAT LEARNI; Hoel PG., 1984, INTRO MATH STAT; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Imaz A, 2013, ANTIVIR THER, V18, P125, DOI 10.3851/IMP2249; Knafl GJ, 2010, AIDS BEHAV, V14, P755, DOI 10.1007/s10461-008-9512-z; Kranzer K, 2011, TROP MED INT HEALTH, V16, P1297, DOI 10.1111/j.1365-3156.2011.02828.x; Leeflang MMG, 2008, CLIN CHEM, V54, P729, DOI 10.1373/clinchem.2007.096032; Li XH, 2005, JAIDS-J ACQ IMM DEF, V38, P320; Lyimo RA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-92; Marzel A, 2016, CLIN INFECT DIS, V62, P115, DOI 10.1093/cid/civ732; MAYHEW BH, 1984, J MATH SOCIOL, V9, P259, DOI 10.1080/0022250X.1984.9989948; Medecins Sans Frontieres Access Campaign, 2016, UNT WEB ANT PRIC RED; Mood AM, 1940, ANN MATH STAT, V11, P367, DOI 10.1214/aoms/1177731825; Moriarty K, 2018, J ASSOC NURSE AIDS C, V29, P231, DOI 10.1016/j.jana.2017.09.014; Moye L. A., 2000, DIFFERENCE EQUATIONS; Munene E, 2016, AIDS CARE, V28, P1110, DOI 10.1080/09540121.2016.1140890; Musinguzi N, 2017, AIDS BEHAV, V21, P1735, DOI 10.1007/s10461-016-1447-1; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Rodger AJ, 2013, AIDS, V27, P973, DOI 10.1097/QAD.0b013e32835cae9c; Sauceda JA, 2016, AIDS BEHAV, V20, P2624, DOI 10.1007/s10461-015-1283-8; Sax PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031591; Seidu B, 2016, J AIDS HIV RES, V8, P44; Seneta E, 2013, BERNOULLI, V19, P1088, DOI 10.3150/12-BEJSP12; Smith GCS, 2014, AM J EPIDEMIOL, V180, P318, DOI 10.1093/aje/kwu140; Spacek LA, 2006, CLIN INFECT DIS, V42, P252, DOI 10.1086/499044; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; VanderWeele TJ, 2015, EXPLANATION CAUSAL I; Viswanathan S, 2015, JAIDS-J ACQ IMM DEF, V69, P493, DOI 10.1097/QAI.0000000000000643; Williams AB, 2013, AIDS BEHAV, V17, P284, DOI 10.1007/s10461-012-0172-7; World Health Organization, 2016, CONS GUID US ANT DRU	47	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194713	10.1371/journal.pone.0194713	http://dx.doi.org/10.1371/journal.pone.0194713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA1RF	29566096	Green Published, Green Submitted, gold			2022-12-26	WOS:000428093900096
J	Hyler, AR; Baudoin, NC; Brown, MS; Stremler, MA; Cimini, D; Davalos, RV; Schmelz, EM				Hyler, Alexandra R.; Baudoin, Nicolaas C.; Brown, Megan S.; Stremler, Mark A.; Cimini, Daniela; Davalos, Rafael V.; Schmelz, Eva M.			Fluid shear stress impacts ovarian cancer cell viability, subcellular organization, and promotes genomic instability	PLOS ONE			English	Article							MEROTELIC KINETOCHORE ORIENTATION; SURFACE EPITHELIAL-CELLS; FOCAL ADHESIONS; ACTIN-FILAMENTS; ANEUPLOIDY; PROGRESSION; METASTASIS; MIGRATION; MODEL; INVADOPODIA	Ovarian cancer cells are exposed to physical stress in the peritoneal cavity during both tumor growth and dissemination. Ascites build-up in metastatic ovarian cancer further increases the exposure to fluid shear stress. Here, we used a murine, in vitro ovarian cancer progression model in parallel with immortalized human cells to investigate how ovarian cancer cells of increasing aggressiveness respond to < 1 dyne/cm(2)of fluid-induced shear stress. This biophysical stimulus significantly reduced cell viability in all cells exposed, independent of disease stage. Fluid shear stress induced spheroid formation and altered cytoskeleton organization in more tumorigenic cell lines. While benign ovarian cells appeared to survive in higher numbers under the influence of fluid shear stress, they exhibited severe morphological changes and chromosomal instability. These results suggest that exposure of benign cells to low magnitude fluid shear stress can induce phenotypic changes that are associated with transformation and ovarian cancer progression. Moreover, exposure of tumorigenic cells to fluid shear stress enhanced anchorage-independent survival, suggesting a role in promoting invasion and metastasis.	[Hyler, Alexandra R.; Stremler, Mark A.; Davalos, Rafael V.; Schmelz, Eva M.] Wake Forest Univ, Virginia Tech, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA; [Baudoin, Nicolaas C.; Cimini, Daniela] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA; [Baudoin, Nicolaas C.; Cimini, Daniela] Virginia Tech, Biocomplex Inst, Blacksburg, VA 24061 USA; [Hyler, Alexandra R.; Brown, Megan S.; Schmelz, Eva M.] Virginia Tech, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA; [Stremler, Mark A.; Davalos, Rafael V.] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Wake Forest University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Davalos, RV; Schmelz, EM (corresponding author), Wake Forest Univ, Virginia Tech, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.; Cimini, D (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.; Cimini, D (corresponding author), Virginia Tech, Biocomplex Inst, Blacksburg, VA 24061 USA.; Schmelz, EM (corresponding author), Virginia Tech, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA.; Davalos, RV (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA.	cimini@vt.edu; davalos@vt.edu; eschmelz@vt.edu	Cimini, Daniela/A-3039-2016; Schmelz, Eva M/E-6579-2012; Stremler, Mark A./B-1309-2012	Cimini, Daniela/0000-0002-4082-4894; Stremler, Mark A./0000-0001-5785-7732; Hyler, Alexandra/0000-0002-8698-4455	National Science Foundation MultiSTEPS IGERT DGE Grant [0966125]; Center for Engineered Health (Virginia Tech Institute for Critical Technology and Applied Science) (ICTAS); USDA National Institute of Food and Agriculture Hatch project [1006578]; Fralin Life Science Institute; Virginia Polytechnic Institute; State University; Div Of Molecular and Cellular Bioscience [1517506] Funding Source: National Science Foundation	National Science Foundation MultiSTEPS IGERT DGE Grant; Center for Engineered Health (Virginia Tech Institute for Critical Technology and Applied Science) (ICTAS); USDA National Institute of Food and Agriculture Hatch project; Fralin Life Science Institute; Virginia Polytechnic Institute; State University; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded in part by the National Science Foundation MultiSTEPS IGERT DGE Grant 0966125 to ARH, by seed funds from Center for Engineered Health (Virginia Tech Institute for Critical Technology and Applied Science) (ICTAS) (to DC, RVD and EMS), the USDA National Institute of Food and Agriculture Hatch project Grant 1006578 to EMS, and the Fralin Life Science Institute, Virginia Polytechnic Institute and State University to EMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Anderson AS, 2014, EXP CELL RES, V328, P44, DOI 10.1016/j.yexcr.2014.08.028; Anderson AS, 2013, EXP CELL RES, V319, P1431, DOI 10.1016/j.yexcr.2013.02.017; Avraham-Chakim L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060965; Barnes JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050973; Carmignani C. Pablo, 2003, Cancer and Metastasis Reviews, V22, P465, DOI 10.1023/A:1023791229361; Cattaneo I, 2011, CELL PHYSIOL BIOCHEM, V28, P673, DOI 10.1159/000335813; Cimini D, 2002, J CELL SCI, V115, P507; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Cimini D, 2008, BBA-REV CANCER, V1786, P32, DOI 10.1016/j.bbcan.2008.05.003; Cohen CA, 2013, CANCER PREV RES, V6, P1182, DOI 10.1158/1940-6207.CAPR-13-0227; Colin A, 2016, SCI REP-UK, V6, DOI 10.1038/srep34657; Creekmore AL, 2013, BIOMOLECULES, V3, P386, DOI 10.3390/biom3030386; Creekmore AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017676; DEGRASSI F, 1988, MUTAT RES, V203, P339, DOI 10.1016/0165-1161(88)90030-1; Even-Tzur N, 2008, BIOPHYS J, V95, P2998, DOI 10.1529/biophysj.107.127142; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Galipeau PC, 1996, P NATL ACAD SCI USA, V93, P7081, DOI 10.1073/pnas.93.14.7081; Gardinier JD, 2009, CELL MOL BIOENG, V2, P133, DOI 10.1007/s12195-008-0038-2; Girard Peggy R., 1993, Frontiers of Medical and Biological Engineering, V5, P31; Gregoire L, 2001, CLIN CANCER RES, V7, P4280; Heng HHO, 2011, ADV CANCER RES, V112, P217, DOI 10.1016/B978-0-12-387688-1.00008-9; Howlader NNA, 2020, SEER CANC STAT REV; Ip CKM, 2016, SCI REP-UK, V6, DOI 10.1038/srep26788; Jacquemet G, 2015, CURR OPIN CELL BIOL, V37, P119, DOI 10.1016/j.ceb.2015.11.002; Jeffrey B, 2003, AM J PHYSIOL-GASTR L, V285, pG907, DOI 10.1152/ajpgi.00062.2003; Kawai Y, 2012, CANCER SCI, V103, P1245, DOI 10.1111/j.1349-7006.2012.02289.x; Ketene AN, 2012, INTEGR BIOL-UK, V4, P540, DOI 10.1039/c2ib00168c; Ketene AN, 2012, NANOMED-NANOTECHNOL, V8, P93, DOI 10.1016/j.nano.2011.05.012; Kim DH, 2014, J CELL SCI, V127, P2528, DOI 10.1242/jcs.144345; Kim DH, 2013, SOFT MATTER, V9, P5516, DOI 10.1039/c3sm50798j; KIM DW, 1989, CIRC RES, V64, P21, DOI 10.1161/01.RES.64.1.21; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Lien SC, 2013, BBA-MOL CELL RES, V1833, P3124, DOI 10.1016/j.bbamcr.2013.08.023; Luo CW, 2014, BBA-MOL CELL RES, V1843, P2129, DOI 10.1016/j.bbamcr.2014.06.007; Lv L, 2012, CELL CYCLE, V11, P2864, DOI 10.4161/cc.21196; Maggiorani D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131416; Merritt MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080314; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nicholson JM, 2012, CELL CYCLE, V11, P3354, DOI 10.4161/cc.21850; Olaharski AJ, 2006, CARCINOGENESIS, V27, P337, DOI 10.1093/carcin/bgi218; Paz H, 2014, ONCOGENE, V33, P4193, DOI 10.1038/onc.2013.393; Plotnikov SV, 2013, CURR OPIN CELL BIOL, V25, P619, DOI 10.1016/j.ceb.2013.06.003; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Polacheck WJ, 2014, P NATL ACAD SCI USA, V111, P2447, DOI 10.1073/pnas.1316848111; Raghavan S, 2015, GYNECOL ONCOL, V138, P181, DOI 10.1016/j.ygyno.2015.04.014; Reneman RS, 2008, MED BIOL ENG COMPUT, V46, P499, DOI 10.1007/s11517-008-0330-2; Rizvi I, 2013, P NATL ACAD SCI USA, V110, pE1974, DOI 10.1073/pnas.1216989110; Roberts PC, 2005, NEOPLASIA, V7, P944, DOI 10.1593/neo.05358; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Russo A, 2015, ENVIRON MOL MUTAGEN, V56, P563, DOI 10.1002/em.21945; Salmanzadeh A, 2013, INTEGR BIOL-UK, V5, P843, DOI [10.1039/c3ib00008g, 10.1039/c3b00008g]; Salmanzadeh A, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4788921; Salmanzadeh A, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3699973; Shemesh T, 2005, P NATL ACAD SCI USA, V102, P12383, DOI 10.1073/pnas.0500254102; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sodek KL, 2009, INT J CANCER, V124, P2060, DOI 10.1002/ijc.24188; Tan DSP, 2006, LANCET ONCOL, V7, P925, DOI 10.1016/S1470-2045(06)70939-1; Tucker RP, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0330; van der Meer AD, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3366720; Weaver BAA, 2007, CANCER RES, V67, P10103, DOI 10.1158/0008-5472.CAN-07-2266; Yoshida Y, 2008, INT J ONCOL, V32, P673; Yoshigi M, 2005, J CELL BIOL, V171, P209, DOI 10.1083/jcb.200505018; Zhou XZ, 2010, J BIOMECH, V43, P1598, DOI 10.1016/j.jbiomech.2009.12.028	66	42	42	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194170	10.1371/journal.pone.0194170	http://dx.doi.org/10.1371/journal.pone.0194170			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566010	Green Published, Green Submitted, gold			2022-12-26	WOS:000428093900038
J	Papakyriakou, A; Reeves, E; Beton, M; Mikolajek, H; Douglas, L; Cooper, G; Elliott, T; Werner, JM; James, E				Papakyriakou, Athanasios; Reeves, Emma; Beton, Mary; Mikolajek, Halina; Douglas, Leon; Cooper, Grace; Elliott, Tim; Werner, Jorn M.; James, Edward			The partial dissociation of MHC class I-bound peptides exposes their N terminus to trimming by endoplasmic reticulum aminopeptidase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-AMINOPEPTIDASE; ANTIGEN PRESENTATION; MOLECULAR-DYNAMICS; TRIMS PRECURSORS; COMPLEX; ERAP1; ERAAP; ASSOCIATION; PARAMETERS; AFFINITY	Endoplasmic reticulum aminopeptidase 1 (ERAP1) and ERAP2 process N-terminally extended antigenic precursors for optimal loading onto major histocompatibility complex class I (MHC I) molecules. We and others have demonstrated that ERAP1 processes peptides bound to MHC I, but the underlying mechanism is unknown. To this end, we utilized single-chain trimers (SCT) of the ovalbumin-derived epitope SIINFEKL (SL8) tethered to the H2-K-b MHC I determinant from mouse and introduced three substitutions, E63A, K66A, and W167A, at the A-pocket of the peptide-binding groove in the MHC I heavy chain, which interact with the N termini of peptides. These variants significantly decreased SL8-presenting SCT at the cell surface in the presence of ERAP1, but did not affect overall SCT expression, indicating that ERAP1 trims the SL8 N terminus. Comparison of the X-ray crystal structures of WT and three variant SCTs revealed only minor perturbations of the peptide-binding domain in the variants. However, molecular dynamics simulations suggested that SL8 can dissociate partially within a sub-microsecond timescale, exposing its N terminus to the solvent. We also found that the C terminus of MHC I-bound SL8 remains deeply buried in the F-pocket of MHC I. Furthermore, free-energy calculations revealed that the three SCT variants exhibit lower free-energy barriers of N terminus dissociation than the WT K-b. Taken together, our results are consistent with a previously observed model in which the partial dissociation of bound peptides from MHC I exposes their N terminus to trimming by ERAP1, whereas their C terminus is anchored at the F-pocket.	[Papakyriakou, Athanasios; Beton, Mary; Mikolajek, Halina; Werner, Jorn M.] Univ Southampton, Fac Nat & Environm Sci, Ctr Biol Sci, Southampton SO17 1BJ, Hants, England; [Papakyriakou, Athanasios; Reeves, Emma; Beton, Mary; Mikolajek, Halina; Douglas, Leon; Cooper, Grace; Elliott, Tim; Werner, Jorn M.; James, Edward] Univ Southampton, Inst Life Sci, Southampton SO17 1BJ, Hants, England; [Reeves, Emma; Cooper, Grace; Elliott, Tim; James, Edward] Univ Southampton, Fac Med, Univ Hosp Southampton, Ctr Canc Immunol, Southampton SO16 6YD, Hants, England	University of Southampton; University of Southampton; University of Southampton	James, E (corresponding author), Tremona Rd, Southampton SO16 6YD, Hants, England.	eddjames@soton.ac.uk	Papakyriakou, Athanasios/K-7033-2012	Papakyriakou, Athanasios/0000-0003-3931-6232; James, Edward/0000-0001-8638-7928; Cooper, Grace/0000-0002-4125-6278; Elliott, Tim/0000-0003-1097-0222; Werner, Jorn/0000-0002-4712-1833	EU Horizon2020 Marie Sklodowska-Curie fellowship "DynOMIS" [703530]; Cancer Research UK [A16997]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L010402/1]; BBSRC [BB/L010402/1] Funding Source: UKRI; EPSRC [EP/P030491/1] Funding Source: UKRI; MRC [MC_U117533887] Funding Source: UKRI	EU Horizon2020 Marie Sklodowska-Curie fellowship "DynOMIS"; Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the EU Horizon2020 Marie Sklodowska-Curie fellowship "DynOMIS" Grant 703530 (to A. P.). This work was also supported by Cancer Research UK Programme Grant A16997 (to E. J. and T. E.) and Biotechnology and Biological Sciences Research Council (BBSRC) Project Grant BB/L010402/1 (to J. M. W. and T. E.). The authors declare that they have no conflicts of interest with the contents of this article.	Abualrous ET, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135421; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; ATTAYA M, 1992, NATURE, V355, P647, DOI 10.1038/355647a0; Blanchard N, 2010, J IMMUNOL, V184, P3033, DOI 10.4049/jimmunol.0903712; Bulek AM, 2012, J IMMUNOL METHODS, V382, P203, DOI 10.1016/j.jim.2012.06.007; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; CERUNDOLO V, 1991, EUR J IMMUNOL, V21, P2069, DOI 10.1002/eji.1830210915; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; Chen LY, 2014, ARTHRITIS RHEUMATOL, V66, P284, DOI 10.1002/art.38249; Denton AE, 2011, J IMMUNOL, V187, P5733, DOI 10.4049/jimmunol.1003937; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisette O, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00408; FREMONT DH, 1995, P NATL ACAD SCI USA, V92, P2479, DOI 10.1073/pnas.92.7.2479; Glastras SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23525; Guerini FR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029931; Hammer GE, 2006, NAT IMMUNOL, V7, P103, DOI 10.1038/ni1286; Hammer GE, 2007, NAT IMMUNOL, V8, P101, DOI 10.1038/ni1409; Hearn A, 2009, J IMMUNOL, V183, P5526, DOI 10.4049/jimmunol.0803663; Hekkelman ML, 2010, NUCLEIC ACIDS RES, V38, pW719, DOI 10.1093/nar/gkq453; Howarth M, 2004, P NATL ACAD SCI USA, V101, P11737, DOI 10.1073/pnas.0306294101; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JAMESON SC, 1992, EUR J IMMUNOL, V22, P2663, DOI 10.1002/eji.1830221028; Kanaseki T, 2006, IMMUNITY, V25, P795, DOI 10.1016/j.immuni.2006.09.012; Keller M, 2015, EUR J IMMUNOL, V45, P3257, DOI 10.1002/eji.201445243; Knapp B, 2016, J CHEM INF MODEL, V56, P46, DOI 10.1021/acs.jcim.5b00511; Knapp B, 2016, BIOINFORMATICS, V32, P181, DOI 10.1093/bioinformatics/btv502; Kochan G, 2011, P NATL ACAD SCI USA, V108, P7745, DOI 10.1073/pnas.1101262108; Koopmann JO, 1996, EUR J IMMUNOL, V26, P1720, DOI 10.1002/eji.1830260809; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Kunisawa J, 2003, MOL CELL, V12, P565, DOI 10.1016/j.molcel.2003.08.009; Kunisawa J, 2006, IMMUNITY, V24, P523, DOI 10.1016/j.immuni.2006.03.015; Lehnert E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00010; Lybarger L, 2003, J BIOL CHEM, V278, P27105, DOI 10.1074/jbc.M303716200; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Mareeva T, 2008, J BIOL CHEM, V283, P29053, DOI 10.1074/jbc.M804996200; Mehta AM, 2007, GENE CHROMOSOME CANC, V46, P577, DOI 10.1002/gcc.20441; Mitaksov V, 2006, J BIOL CHEM, V281, P10618, DOI 10.1074/jbc.M510511200; Mitaksov V, 2007, CHEM BIOL, V14, P909, DOI 10.1016/j.chembiol.2007.07.010; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Nguyen TT, 2011, NAT STRUCT MOL BIOL, V18, P604, DOI 10.1038/nsmb.2021; Omasits U, 2008, MOL SIMULAT, V34, P781, DOI 10.1080/08927020802256298; Papakyriakou A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00946; Reeves E, 2014, P NATL ACAD SCI USA, V111, P17594, DOI 10.1073/pnas.1408882111; Reeves E, 2013, J IMMUNOL, V191, P35, DOI 10.4049/jimmunol.1300598; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; SHASTRI N, 1993, J IMMUNOL, V150, P2724; Stamogiannos A, 2017, BIOCHEMISTRY-US, V56, P1546, DOI 10.1021/acs.biochem.6b01170; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Truscott SM, 2007, J IMMUNOL, V178, P6280, DOI 10.4049/jimmunol.178.10.6280; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; York IA, 2006, P NATL ACAD SCI USA, V103, P9202, DOI 10.1073/pnas.0603095103; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860; Zervoudi E, 2013, P NATL ACAD SCI USA, V110, P19890, DOI 10.1073/pnas.1309781110	60	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7538	7548		10.1074/jbc.RA117.000313	http://dx.doi.org/10.1074/jbc.RA117.000313			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29599287	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000437256500008
J	Ameri, R; Laville, E; Potocki-Veronese, G; Trabelsi, S; Mezghani, M; Elgharbi, F; Bejar, S				Ameri, Rihab; Laville, Elisabeth; Potocki-Veronese, Gabrielle; Trabelsi, Sahar; Mezghani, Monia; Elgharbi, Fatma; Bejar, Samir			Two new gene clusters involved in the degradation of plant cell wall from the fecal microbiota of Tunisian dromedary	PLOS ONE			English	Article							CAMEL CAMELUS-DROMEDARIUS; POLYSACCHARIDE UTILIZATION; MOLECULAR DIVERSITY; BROILER-CHICKENS; HUMAN GUT; BACTERIA; RUMEN; IDENTIFICATION; MICROFLORA; EXPRESSION	Dromedaries are capable of digesting plant cell wall with high content of lignocellulose of poor digestibility. Consequently, their intestinal microbiota can be a source of novel carbohydrate-active enzymes (CAZymes). To the best of our knowledge, no data are available describing the biochemical analysis of enzymes in dromedary intestinal microbiota. To investigate new hydrolytic enzymes from the dromedary gut, a fosmid library was constructed using metagenomic DNA from feces of non-domestic adult dromedary camels living in the Tunisian desert. High-throughput functional screening of 13756 clones resulted in 47 hit clones active on a panel of various chromogenic and non-chromogenic glycan substrates. Two of them, harboring multiple activities, were retained for further analysis. Clone 26H3 displayed activity on AZO-CM-cellulose, AZCL Carob galactomannan and Tween 20, while clone 36A23 was active on AZCL carob galactomannan and AZCL barley beta-glucan. The functional annotation of their sequences highlighted original metagenomic loci originating from bacteria of the Bacteroidetes/Chlorobi group, involved in the metabolization of mannosides and beta-glucans thanks to a complete battery of endoand exo-acting glycoside hydrolases, esterases, phosphorylases and transporters.	[Ameri, Rihab; Trabelsi, Sahar; Mezghani, Monia; Elgharbi, Fatma; Bejar, Samir] Univ Sfax, LBMIE, CBS, Sfax, Tunisia; [Laville, Elisabeth; Potocki-Veronese, Gabrielle] Univ Toulouse, CNRS, LISBP, INRA,INSAT, Toulouse, France	Centre de Biotechnologie de Sfax; Universite de Sfax; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Bejar, S (corresponding author), Univ Sfax, LBMIE, CBS, Sfax, Tunisia.	samir.bejar@cbs.rnrt.tn	elgharbi, fatma/T-3409-2019; Veronese, Gabrielle/GTF-3473-2022		Tunisian Ministry of Higher Education and Scientific Research contract program CBS-LMBEE [LR15CBS06_2015-2018]; Region Midi-Pyrenees; European Regional Development Fund; Institut National de la Recherche Agronomique (INRA)	Tunisian Ministry of Higher Education and Scientific Research contract program CBS-LMBEE; Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); European Regional Development Fund(European Commission); Institut National de la Recherche Agronomique (INRA)	Grant from the Tunisian Ministry of Higher Education and Scientific Research contract program CBS-LMBEE/code: LR15CBS06_2015-2018. The high throughput screening work carried out at the Laboratory for BioSystems & Process Engineering (Toulouse, France) with the equipments of the ICEO facility, dedicated to the screening and the discovery of enzymes. ICEO is supported by grants from the Region Midi-Pyrenees, the European Regional Development Fund and the Institut National de la Recherche Agronomique (INRA).	Andre I, 2014, CURR OPIN CHEM BIOL, V19, P17, DOI 10.1016/j.cbpa.2013.11.014; Bastien G, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-78; Beckmann L, 2006, J BASIC MICROB, V46, P175, DOI 10.1002/jobm.200510107; Bhatt VD, 2013, MOL BIOL REP, V40, P3363, DOI 10.1007/s11033-012-2411-4; Cerdeno-Tarraga AM, 2005, SCIENCE, V307, P1463, DOI 10.1126/science.1107008; Dai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040430; Deusch S, 2015, COMPUT STRUCT BIOTEC, V13, P55, DOI 10.1016/j.csbj.2014.12.005; Donnell MMO, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S12; Duan CJ, 2009, J APPL MICROBIOL, V107, P245, DOI 10.1111/j.1365-2672.2009.04202.x; Ferrer M, 2005, ENVIRON MICROBIOL, V7, P1996, DOI 10.1111/j.1462-2920.2005.00920.x; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Ghanem ME, 2010, J PLANT PHYSIOL, V167, P382, DOI 10.1016/j.jplph.2009.10.012; Gharechahi J, 2015, SYST APPL MICROBIOL, V38, P67, DOI 10.1016/j.syapm.2014.09.004; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Jouany JP., 1989, OPT MEDITERR, V2, P89; KAYOULI C, 1993, ANIM FEED SCI TECH, V40, P343, DOI 10.1016/0377-8401(93)90063-P; Krah M, 1998, EUR J BIOCHEM, V257, P101, DOI 10.1046/j.1432-1327.1998.2570101.x; Lahteinen T, 2010, ANAEROBE, V16, P293, DOI 10.1016/j.anaerobe.2009.08.002; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Marcus SE, 2010, PLANT J, V64, P191, DOI 10.1111/j.1365-313X.2010.04319.x; Mathlouthi N, 2002, ANIM RES, V51, P395, DOI 10.1051/animres:2002034; McBride MJ, 2009, APPL ENVIRON MICROB, V75, P6864, DOI 10.1128/AEM.01495-09; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Ming L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173062; MITSUSHIMA K, 1995, APPL ENVIRON MICROB, V61, P2224, DOI 10.1128/AEM.61.6.2224-2229.1995; Patel DD, 2014, GENE, V545, P88, DOI 10.1016/j.gene.2014.05.003; Rai R, 2016, BIORESOURCE TECHNOL, V216, P958, DOI 10.1016/j.biortech.2016.06.040; Rakhimov D. A., 1993, Chemistry of Natural Compounds, V29, P674, DOI 10.1007/BF00630223; Sambrook J aRDW, 2001, FIREFIGHTERS HDB; Samsudin AA, 2012, APPL ENVIRON MICROB, V78, P8836, DOI 10.1128/AEM.02420-12; Samsudin AA, 2011, ENVIRON MICROBIOL, V13, P3024, DOI 10.1111/j.1462-2920.2011.02579.x; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Tasse L, 2010, GENOME RES, V20, P1605, DOI 10.1101/gr.108332.110; Terrapon N, 2015, BIOINFORMATICS, V31, P647, DOI 10.1093/bioinformatics/btu716; Turnbull KL, 2012, RES VET SCI, V93, P246, DOI 10.1016/j.rvsc.2011.08.013; Ufarte L, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00563; Wang SH, 2014, J AGR FOOD CHEM, V62, P8460, DOI 10.1021/jf501328n; Weiner RM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000087; Xu L, 2006, MOL BIOL EVOL, V23, P1107, DOI 10.1093/molbev/msk019; Zhang ML, 2014, MICROB ECOL, V68, P416, DOI 10.1007/s00248-014-0388-3	41	2	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0194621	10.1371/journal.pone.0194621	http://dx.doi.org/10.1371/journal.pone.0194621			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601586	Green Published, gold, Green Submitted			2022-12-26	WOS:000428845900006
J	Xu, MH; Sun, JY; Wang, Q; Zhang, QW; Wei, CS; Lai, DM				Xu, Minhua; Sun, Junyan; Wang, Qian; Zhang, Qiuwan; Wei, Chunsheng; Lai, Dongmei			Chronic restraint stress induces excessive activation of primordial follicles in mice ovaries	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; BINDING PROTEIN SYSTEM; ANTI-MULLERIAN HORMONE; FOLLICULAR DEVELOPMENT; CLINICAL-IMPLICATIONS; PSYCHOLOGICAL STRESS; MENSTRUAL-CYCLE; GRANULOSA-CELLS; KIT-LIGAND; GROWTH	Chronic stress is an important factor influencing people's health. It usually causes endocrinal disorders and a decline in reproduction in females. Although studies of both human and animals suggest a detrimental effect of stress on reproduction, the influence of chronic stress on the ovarian reservation and follicular development is still not clear. In this study, a chronic restraint stress (CRS) mouse model was used to investigate the effect of stress on ovarian reservation and follicular development and explore the underlying mechanism. In this study, after 8 weeks of CRS, primordial follicles were excessively activated in the ovaries of the CRS group compared with the control group. Further results showed that the activation of primordial follicles induced by CRS was involved in the increasing expression level of Kit ligand and its receptor Kit and the activation of phosphatidylinositol 3-kinase (PI3K)/phosphatase and tensin homolog deleted on chromosome 10 (PTEN)/protein kinase B (Akt) pathway. The corticotropin-releasing hormone (CRH) is a neuropeptide released due to stress, which plays an important role in regulating follicle development. A high level of serum CRH was detected in the CRS mouse model, and the real-time polymerase chain reaction assay showed that the mRNA level of its main receptor CRHR1 increased in the ovaries of the CRS mouse group. Moreover, 100nM CRH significantly improved the activation of primordial follicles in newborn mouse ovaries in vitro. These results demonstrated that CRS could induce immoderate activation of primordial follicles accompanied by the activation of Kit-PI3K signaling, in which CRH might be an important endocrine factor.	[Xu, Minhua; Sun, Junyan; Wang, Qian; Zhang, Qiuwan; Lai, Dongmei] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai, Peoples R China; [Wei, Chunsheng] Fudan Univ, Eye & ENT Hosp, Shanghai, Peoples R China	Shanghai Jiao Tong University; Fudan University	Lai, DM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai, Peoples R China.; Wei, CS (corresponding author), Fudan Univ, Eye & ENT Hosp, Shanghai, Peoples R China.	weics2003@hotmail.com; laidongmei@hotmail.com		Lai, Dongmei/0000-0003-3810-2136	National Natural Science Foundation of China [81370678]; Shanghai Municipal Education Commission Gaofeng Clinical Medicine Grant [20152236]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission Gaofeng Clinical Medicine Grant	This research was supported by fund from National Natural Science Foundation of China (No. 81370678) to Dongmei Lai and Shanghai Municipal Education Commission Gaofeng Clinical Medicine Grant (No. 20152236) to Dongmei Lai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari D, 2009, MOL HUM REPROD, V15, P765, DOI 10.1093/molehr/gap092; Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; Azuma K, 2015, INT J MED SCI, V12, P952, DOI 10.7150/ijms.13298; Broer SL, 2014, HUM REPROD UPDATE, V20, P688, DOI 10.1093/humupd/dmu020; Campos AC, 2013, REV BRAS PSIQUIATR, V35, pS101, DOI 10.1590/1516-4446-2013-1139; Daviu N, 2014, STRESS, V17, P176, DOI 10.3109/10253890.2014.880834; Dewailly D, 2014, HUM REPROD UPDATE, V20, P370, DOI 10.1093/humupd/dmt062; Dinopoulou V, 2013, ENDOCRINOLOGY, V154, P222, DOI 10.1210/en.2012-1838; Dorfman A, 2003, BIOL REPROD, V68, P2038, DOI 10.1095/biolreprod.102.008318; Fan HY, 2008, MOL ENDOCRINOL, V22, P2128, DOI 10.1210/me.2008-0095; Feng ZH, 2012, P NATL ACAD SCI USA, V109, P7013, DOI 10.1073/pnas.1203930109; Ghizzoni L, 1997, ENDOCRINOLOGY, V138, P4806, DOI 10.1210/en.138.11.4806; Hackett RA, 2017, NAT REV ENDOCRINOL, V13, P547, DOI 10.1038/nrendo.2017.64; Huang CTF, 2001, BIOL REPROD, V64, P451, DOI 10.1095/biolreprod64.2.451; Jagarlamudi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006186; Jezova D, 2008, ANN NY ACAD SCI, V1148, P495, DOI 10.1196/annals.1410.050; John GB, 2009, DEV BIOL, V331, P292, DOI 10.1016/j.ydbio.2009.05.546; Kalantaridou SN, 2010, J REPROD IMMUNOL, V85, P33, DOI 10.1016/j.jri.2010.02.005; Kalantaridou SN, 2004, J REPROD IMMUNOL, V62, P61, DOI 10.1016/j.jri.2003.09.004; Kalich-Philosoph L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005402; Kasahara E, 2015, REDOX REP, V20, DOI 10.1179/1351000214Y.0000000107; Kiapekou E, 2011, FERTIL STERIL, V95, P1497, DOI 10.1016/j.fertnstert.2010.12.023; Kim Jin Yeong, 2012, Clin Exp Reprod Med, V39, P10, DOI 10.5653/cerm.2012.39.1.10; Lague MN, 2008, CARCINOGENESIS, V29, P2062, DOI 10.1093/carcin/bgn186; Liang B, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110619; Liu K, 2006, DEV BIOL, V299, P1, DOI 10.1016/j.ydbio.2006.07.038; Liu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061574; Luisi S, 2015, J ENDOCRINOL INVEST, V38, P597, DOI 10.1007/s40618-014-0231-1; Marin MF, 2011, NEUROBIOL LEARN MEM, V96, P583, DOI 10.1016/j.nlm.2011.02.016; Merkwitz C, 2011, PROG HISTOCHEM CYTO, V46, P131, DOI 10.1016/j.proghi.2011.09.001; Moniruzzaman M, 2007, J REPROD DEVELOP, V53, P1273, DOI 10.1262/jrd.19107; Moniruzzaman M, 2010, REPRODUCTION, V139, P337, DOI 10.1530/REP-09-0207; Parrott JA, 1997, ENDOCRINOLOGY, V138, P3819, DOI 10.1210/en.138.9.3819; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Ren Y, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0151-3; Richards JS, 2010, J CLIN INVEST, V120, P963, DOI 10.1172/JCI41350; Roth Z, 2000, J REPROD FERTIL, V120, P83, DOI 10.1530/reprod/120.1.83; Shors TJ, 2001, J NEUROSCI, V21, P6292, DOI 10.1523/JNEUROSCI.21-16-06292.2001; Slomovitz BM, 2012, CLIN CANCER RES, V18, P5856, DOI 10.1158/1078-0432.CCR-12-0662; Sumner JA, 2015, CIRCULATION, V132, P251, DOI 10.1161/CIRCULATIONAHA.114.014492; Upton DH, 2016, HORM CANCER-US, V7, P316, DOI 10.1007/s12672-016-0272-3; VANDERHYDEN BC, 1992, BIOL REPROD, V46, P1196, DOI 10.1095/biolreprod46.6.1196; Visser JA, 2012, NAT REV ENDOCRINOL, V8, P331, DOI 10.1038/nrendo.2011.224; Vujovic Svetlana, 2009, Menopause Int, V15, P72, DOI 10.1258/mi.2009.009020; Wang S, 2013, CELL TISSUE RES, V354, P609, DOI 10.1007/s00441-013-1678-7; Westenbroek C, 2004, BRAIN RES BULL, V64, P303, DOI 10.1016/j.brainresbull.2004.08.006; Wood MA, 2013, SEMIN REPROD MED, V31, P399, DOI 10.1055/s-0033-1356476; Wu LM, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.093468; Wu L, 2016, CELL METAB, V23, P735, DOI 10.1016/j.cmet.2016.01.014; Xu J, 2006, J CLIN ENDOCR METAB, V91, P1544, DOI 10.1210/jc.2005-2776; Xu J, 2007, ENDOCRINOLOGY, V148, P5385, DOI 10.1210/en.2007-0541; Yang SX, 2016, CANCER TREAT REV, V45, P87, DOI 10.1016/j.ctrv.2016.03.004; Ye YH, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-26; Yoshida M, 2009, J TOXICOL SCI, V34; Zhang H, 2015, HUM REPROD UPDATE, V21, P779, DOI 10.1093/humupd/dmv037; Zhang H, 2014, CURR BIOL, V24, P2501, DOI 10.1016/j.cub.2014.09.023	57	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0194894	10.1371/journal.pone.0194894	http://dx.doi.org/10.1371/journal.pone.0194894			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601583	Green Published, gold, Green Submitted			2022-12-26	WOS:000428845900012
J	Lai, YH; Chen, HL; Yang, SN; Chang, SJ; Chuang, LY; Wu, WC				Lai, Yu-Hung; Chen, Hsiu-Lin; Yang, San-Nan; Chang, Shun-Jen; Chuang, Lea-Yea; Wu, Wen-Chuan			The characteristics of premature infants with transient corneal haze	PLOS ONE			English	Article							INTERNATIONAL CLASSIFICATION; SCREENING EXAMINATION; CATARACT-SURGERY; MATERNAL AGE; RISK-FACTORS; RETINOPATHY; CHILDREN; DISEASE; TRANSPARENCY; CRITERIA	Background The etiology of transient corneal haze in premature infants is not known and how it relates to clinical outcomes in premature infants is not clear. Objectives To study associated factors of transient corneal haze in premature infants. Methods We performed a retrospective study of 261 premature infants from retinopathy of prematurity (ROP) screening in the neonatal intensive care unit at a tertiary referral hospital. Characteristics of premature infants with and without corneal haze were analyzed by correlation tests, Chi-square tests, and logistic regressions were used for statistical analyses. Associations between corneal haze and birth weight (BW), gestational age at birth (GA), central corneal thickness, intraocular pressure, and other systemic and ophthalmic data were evaluated. Results The incidence of corneal haze was 13.4%. Lower BW, lower GA, packed red blood cells (RBC) transfusion, more days on oxygen, older maternal age, bronchopulmonary disease, and stage 3 ROP are associated with corneal haze. The severity of corneal haze decreased with infants' postmenstrual age. Multivariate logistic regression analyses revealed that BW and maternal age are the most important predictors of corneal haze. Conclusion Low BW and older maternal age are the most important predictors of corneal haze in premature infants. Premature infants with corneal haze could carry more systemic and ocular morbidities. Hence they may require more clinical attention. Corneal haze is unlikely to hinder the treatment of ROP. However, it is possible that corneal haze could hinder the examination of ROP in some infants. If corneal haze does interfere with ROP screening, a closer, more conservative follow-up schedule with a senior ophthalmologist experienced in managing ROP is recommended.	[Lai, Yu-Hung; Wu, Wen-Chuan] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Ophthalmol, Kaohsiung, Taiwan; [Lai, Yu-Hung; Wu, Wen-Chuan] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Ophthalmol, Kaohsiung, Taiwan; [Lai, Yu-Hung; Chuang, Lea-Yea; Wu, Wen-Chuan] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Chen, Hsiu-Lin] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan; [Chen, Hsiu-Lin] Kaohsiung Med Univ, Coll Med, Dept Resp Therapy, Kaohsiung, Taiwan; [Yang, San-Nan] I Shou Univ, E DA Hosp, Dept Pediat, Kaohsiung, Taiwan; [Yang, San-Nan] I Shou Univ, Coll Med, Sch Med, Kaohsiung, Taiwan; [Chang, Shun-Jen] Natl Univ Kaohsiung, Coll Humanities & Social Sci, Dept Kinesiol Hlth & Leisure Studies, Kaohsiung, Taiwan; [Chuang, Lea-Yea] Kaohsiung Med Univ, Coll Med, Dept Biochem, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; E-Da Hospital; I Shou University; I Shou University; National University Kaohsiung; Kaohsiung Medical University	Wu, WC (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Ophthalmol, Kaohsiung, Taiwan.; Wu, WC (corresponding author), Kaohsiung Med Univ, Coll Med, Sch Med, Dept Ophthalmol, Kaohsiung, Taiwan.; Wu, WC (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan.	wuoph@cc.kmu.edu.tw	Chen, Hsiu-Lin/S-8325-2019; Chen, Hsiu-Lin/B-9238-2012; Chen, Hsiu-Lin/GRY-7492-2022; Lai, Yu-Hung/HGA-2767-2022	Chen, Hsiu-Lin/0000-0002-0565-4631; Chen, Hsiu-Lin/0000-0002-0565-4631; Lai, Yu-Hung/0000-0003-1997-0587				[Anonymous], 1984, Br J Ophthalmol, V68, P690; Armitage P., 2001, STAT METHODS MED RES; Austeng D, 2011, ARCH OPHTHALMOL-CHIC, V129, P167, DOI 10.1001/archophthalmol.2010.346; Blackmon LR, 2004, PEDIATRICS, V114, P1362, DOI 10.1542/peds.2004-1915; Chakravarti S, 2000, INVEST OPHTH VIS SCI, V41, P3365; Chiambaretta F, 2004, MOL VIS, V10, P901; Cook A, 2008, INVEST OPHTH VIS SCI, V49, P5199, DOI 10.1167/iovs.06-0114; Ecsedy M, 2014, J PEDIAT OPHTH STRAB, V51, P235, DOI 10.3928/01913913-20140521-04; Edelhauser HF, 2006, INVEST OPHTH VIS SCI, V47, P1755, DOI 10.1167/iovs.05-1139; Fierson WM, 2013, PEDIATRICS, V131, P189, DOI 10.1542/peds.2012-2996; FRASER AM, 1995, NEW ENGL J MED, V332, P1113, DOI 10.1056/NEJM199504273321701; FRETTS RC, 1995, NEW ENGL J MED, V333, P953, DOI 10.1056/NEJM199510123331501; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Good WV, 2003, ARCH OPHTHALMOL-CHIC, V121, P1684; Hassell JR, 2010, EXP EYE RES, V91, P326, DOI 10.1016/j.exer.2010.06.021; Huynh SC, 2006, BRIT J OPHTHALMOL, V90, P597, DOI 10.1136/bjo.2005.083154; Ishikawa A, 2002, J CATARACT REFR SURG, V28, P1982, DOI 10.1016/S0886-3350(02)01502-X; Kirwan C, 2005, ACTA OPHTHALMOL SCAN, V83, P751, DOI 10.1111/j.1600-0420.2005.00559.x; Lai YH, 2013, OPHTHALMOLOGY, V120, P271, DOI 10.1016/j.ophtha.2012.08.009; Lai YH, 2012, KAOHSIUNG J MED SCI, V28, P601, DOI 10.1016/j.kjms.2012.04.026; Lai YH, 2012, BRIT J OPHTHALMOL, V96, P679, DOI 10.1136/bjophthalmol-2011-300632; Lichtenstein SJ, 2006, PEDIATRICS, V117, P572, DOI 10.1542/peds.2005-2749; McCormick AQ, 1994, THE EYE IN INFANCY, P67; MCWHAE JA, 1991, OPHTHALMOLOGY, V98, P666; PATZ A, 1987, ARCH OPHTHALMOL-CHIC, V105, P905, DOI 10.1001/archopht.1987.01060070041024; Qazi Y, 2010, BRAIN RES BULL, V81, P198, DOI 10.1016/j.brainresbull.2009.05.019; QUINN GE, 1992, OPHTHALMOLOGY, V99, P329; Reynolds JD, 2002, ARCH OPHTHALMOL-CHIC, V120, P1470, DOI 10.1001/archopht.120.11.1470; Rezende RA, 2005, CORNEA, P311; Sevel D, 1988, Trans Am Ophthalmol Soc, V86, P178; Soler N, 2015, J CATARACT REFR SURG, V41, P313, DOI 10.1016/j.jcrs.2014.04.043; Tornqvist K, 2002, ACTA OPHTHALMOL SCAN, V80, P300, DOI 10.1034/j.1600-0420.2002.800313.x	33	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195300	10.1371/journal.pone.0195300	http://dx.doi.org/10.1371/journal.pone.0195300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596534	gold, Green Submitted, Green Published			2022-12-26	WOS:000428630000104
J	Zhang, JF; Xu, YQ; Dong, JM; Peng, LN; Feng, X; Wang, X; Li, F; Miao, Y; Yao, SK; Zhao, QQ; Feng, SS; Hu, BZ; Li, FL				Zhang, Jun-Feng; Xu, Yong-Qing; Dong, Jia-Min; Peng, Li-Na; Feng, Xu; Wang, Xu; Li, Fei; Miao, Yu; Yao, Shu-Kuan; Zhao, Qiao-Qin; Feng, Shan-Shan; Hu, Bao-Zhong; Li, Feng-Lan			Genome-wide identification of wheat (Triticum aestivum) expansins and expansin expression analysis in cold-tolerant and cold-sensitive wheat cultivars	PLOS ONE			English	Article							BETA-EXPANSIN; MOLECULAR-CLONING; PLANT EXPANSINS; ALPHA-EXPANSIN; GENE; OVEREXPRESSION; GROWTH; SUPERFAMILY; ELONGATION; PROTEINS	Plant expansins are proteins involved in cell wall loosening, plant growth, and development, as well as in response to plant diseases and other stresses. In this study, we identified 128 expansin coding sequences from the wheat (Triticum aestivum) genome. These sequences belong to 45 homoeologous copies of TaEXPs, including 26 TaEXPAs, 15 TaEXPBs and four TaEXLAs. No TaEXLB was identified. Gene expression and sub-expression profiles revealed that most of the TaEXPs were expressed either only in root tissues or in multiple organs. Real-time qPCR analysis showed that many TaEXPs were differentially expressed in four different tissues of the two wheat cultivars-the cold-sensitive 'Chinese Spring (CS)' and the cold-tolerant 'Dongnongdongmai 1 (D1)' cultivars. Our results suggest that the differential expression of TaEXPs could be related to low-temperature tolerance or sensitivity of different wheat cultivars. Our study expands our knowledge on wheat expansins and sheds new light on the functions of expansins in plant development and stress response.	[Zhang, Jun-Feng; Xu, Yong-Qing; Dong, Jia-Min; Peng, Li-Na; Feng, Xu; Wang, Xu; Li, Fei; Miao, Yu; Yao, Shu-Kuan; Zhao, Qiao-Qin; Feng, Shan-Shan; Li, Feng-Lan] Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang, Peoples R China; [Hu, Bao-Zhong] Harbin Univ, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China; Harbin University	Li, FL (corresponding author), Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang, Peoples R China.; Hu, BZ (corresponding author), Harbin Univ, Harbin, Heilongjiang, Peoples R China.	bzhu@neau.edu.cn; lifenglan@neau.edu.cn	Feng, Xu/AAQ-6397-2021					Bae JM, 2014, TRANSGENIC RES, V23, P657, DOI 10.1007/s11248-014-9804-1; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bottley A, 2006, PLANT J, V47, P897, DOI 10.1111/j.1365-313X.2006.02841.x; Breen J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-99; Brummell DA, 1999, PLANT CELL, V11, P2203, DOI 10.1105/tpc.11.11.2203; Carey RE, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-4; Cheuk A, 2016, MOL GENET GENOMICS, V291, P873, DOI 10.1007/s00438-015-1152-1; Cosgrove DJ, 2015, CURR OPIN PLANT BIOL, V25, P162, DOI 10.1016/j.pbi.2015.05.014; Cosgrove DJ, 2000, CURR OPIN PLANT BIOL, V3, P73, DOI 10.1016/S1369-5266(99)00039-4; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Dal Santo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062206; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Ding AM, 2016, MOL GENET GENOMICS, V291, P1891, DOI 10.1007/s00438-016-1226-8; Ebringerova A, 2000, MACROMOL RAPID COMM, V21, P542; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; Fredslund J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-369; Gao Q, 2008, PROTOPLASMA, V233, P73, DOI 10.1007/s00709-008-0303-1; Guo WB, 2011, PLANT J, V66, P541, DOI 10.1111/j.1365-313X.2011.04511.x; Hoff KJ, 2013, NUCLEIC ACIDS RES, V41, pW123, DOI 10.1093/nar/gkt418; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Hu ZR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063667; Hu ZR, 2013, NEW PHYTOL, V197, P1344, DOI 10.1111/nph.12131; Igarashi M, 2014, BIOCHEM BIOPH RES CO, V443, P852, DOI 10.1016/j.bbrc.2013.12.059; Kende H, 2004, PLANT MOL BIOL, V55, P311, DOI 10.1007/s11103-004-0158-6; Kuluev B R, 2014, Genetika, V50, P560; Kuluev B R, 2012, Genetika, V48, P1162; Kwasniewski M, 2006, PLANT PHYSIOL, V141, P1149, DOI 10.1104/pp.106.078626; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee HW, 2013, PLANT CELL PHYSIOL, V54, P1600, DOI 10.1093/pcp/pct105; Lee HW, 2013, PLANT J, V73, P212, DOI 10.1111/tpj.12013; Lee Y, 2001, CURR OPIN PLANT BIOL, V4, P527, DOI 10.1016/S1369-5266(00)00211-9; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li F, 2011, J PLANT PHYSIOL, V168, P960, DOI 10.1016/j.jplph.2010.11.023; Li Y, 2003, CURR OPIN PLANT BIOL, V6, P603, DOI 10.1016/j.pbi.2003.09.003; Li Y, 2002, PLANT PHYSIOL, V128, P854, DOI 10.1104/pp.010658; Lin C, 2011, MOL CELLS, V31, P393, DOI 10.1007/s10059-011-0046-2; Lin Z, 2005, MOL GENET GENOMICS, V274, P548, DOI 10.1007/s00438-005-0029-0; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Liu Y, 2007, GENOMICS, V90, P516, DOI 10.1016/j.ygeno.2007.06.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu PT, 2013, PLANTA, V237, P1547, DOI 10.1007/s00425-013-1867-3; Lu YG, 2016, MOL GENET GENOMICS, V291, P597, DOI 10.1007/s00438-015-1133-4; Marowa P, 2016, PLANT CELL REP, V35, P949, DOI 10.1007/s00299-016-1948-4; O'Neill MA., 2003, ANN PLANT REV, P1; Pacheco-Villalobos D, 2016, PLANT CELL, V28, P1009, DOI 10.1105/tpc.15.01057; Pingault L, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0601-9; Rombauts S, 1999, NUCLEIC ACIDS RES, V27, P295, DOI 10.1093/nar/27.1.295; Rose JKC, 1997, P NATL ACAD SCI USA, V94, P5955, DOI 10.1073/pnas.94.11.5955; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Sampedro J, 2015, PLANT J, V81, P108, DOI 10.1111/tpj.12715; Schreiber AW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-492; Sharma R, 2012, ALCOHOL CLIN EXP RES, V36, p183A; Shitsukawa N, 2007, GENES GENET SYST, V82, P167, DOI 10.1266/ggs.82.167; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tello-Ruiz MK, 2016, METHODS MOL BIOL, V1374, P141, DOI 10.1007/978-1-4939-3167-5_7; Wang GF, 2011, PLANT BIOTECHNOL J, V9, P486, DOI 10.1111/j.1467-7652.2010.00569.x; Yan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085208; Yu Jing, 2009, Yingyong Shengtai Xuebao, V20, P1092; Yu ZM, 2011, PLANT J, V66, P725, DOI 10.1111/j.1365-313X.2011.04533.x; Zhang WL, 2014, MOL GENET GENOMICS, V289, P373, DOI 10.1007/s00438-014-0814-8; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhou J, 2014, PHYSIOL PLANTARUM, V150, P194, DOI 10.1111/ppl.12077; Zhu Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-93	63	17	19	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195138	10.1371/journal.pone.0195138	http://dx.doi.org/10.1371/journal.pone.0195138			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596529	Green Submitted, gold, Green Published			2022-12-26	WOS:000428630000084
J	Palaniappan, M; Edwards, D; Creighton, CJ; Medina, D; Conneely, OM				Palaniappan, Murugesan; Edwards, David; Creighton, Chad J.; Medina, Daniel; Conneely, Orla M.			Reprogramming of the estrogen responsive transcriptome contributes to tamoxifen-dependent protection against tumorigenesis in the p53 null mammary epithelial cells	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; SURGICAL ADJUVANT BREAST; RECEPTOR-B ISOFORM; BOWEL PROJECT P-1; MOLECULAR PORTRAITS; CANCER PREVENTION; GLAND DEVELOPMENT; GENE-EXPRESSION; MICE LACKING; ER-ALPHA	The tumor suppressor gene p53 is frequently mutated in human breast cancer and is a marker for poor prognosis and resistance to chemotherapy. Transplantation of p53 null mouse mammary epithelium into syngeneic wild-type mice leads to normal mammary gland development followed by spontaneous mammary tumors that recapitulate many of the phenotypic, molecular and genetic features of human breast cancer. Transient exposure of p53 null mice to the anti-estrogen, tamoxifen leads to sustained and robust protection against tumor development. However the mechanism underlying this anti-tumor activity remains poorly understood. Here we demonstrate that transient exposure to tamoxifen leads to a reduction in mammary ductal side-branching and epithelial cell proliferation after tamoxifen withdrawal. Global gene expression analysis showed that transient tamoxifen exposure leads to persistent changes in the expression of a subset of estrogen regulated gene signatures in mammary epithelial cells (MECs). Among these was the protein tyrosine phosphatase, non-receptor type 5 (Ptpn5). We show that Ptpn5 is a novel tamoxifen regulated target gene which is upregulated in MECs after transient tamoxifen exposure and displays tumor suppressor activity in human breast cancer cells. Further, PTPNS expression is strongly associated with good clinical outcome in tamoxifen treated human breast cancer patients suggesting that PTPNS may represent a novel biomarker of tamoxifen response in human breast cancer.	[Palaniappan, Murugesan; Edwards, David; Medina, Daniel; Conneely, Orla M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Creighton, Chad J.] Baylor Coll Med, Div Biostat, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Palaniappan, Murugesan] Baylor Coll Med, Dept Pathol & Immunol, One Baylor Plaza, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Conneely, OM (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	orlac@bcm.edu		PALANIAPPAN, MURUGESAN/0000-0003-4916-6565	CPRIT [RP110471-P3]	CPRIT	This work was supported by funding from CPRIT grant RP110471-P3 to OMC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldaz CM, 2002, ONCOGENE, V21, P6366, DOI 10.1038/sj.onc.1205816; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Ali S, 2011, ANNU REV MED, V62, P217, DOI 10.1146/annurev-med-052209-100305; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Bertheau P, 2013, BREAST, V22, pS27, DOI 10.1016/j.breast.2013.07.005; Brisken C, 2015, WIRES DEV BIOL, V4, P181, DOI 10.1002/wdev.172; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; Cuzick J, 2014, LANCET, V383, P1041, DOI 10.1016/S0140-6736(13)62292-8; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dupont S, 2000, DEVELOPMENT, V127, P4277; Finlay-Schultz J, 2015, J MAMMARY GLAND BIOL, V20, P39, DOI 10.1007/s10911-015-9340-5; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Fox JL, 2010, EMBO J, V29, P3853, DOI 10.1038/emboj.2010.244; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Goepfert TM, 2000, FASEB J, V14, P2221, DOI 10.1096/fj.00-0165com; Goss PE, 2011, NEW ENGL J MED, V364, P2381, DOI 10.1056/NEJMoa1103507; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jansen MPHM, 2013, CANCER RES, V73, P6632, DOI 10.1158/0008-5472.CAN-13-0704; Jerry DJ, 2000, ONCOGENE, V19, P1052, DOI 10.1038/sj.onc.1203270; Jerry DJ, 1998, ONCOGENE, V17, P2305, DOI 10.1038/sj.onc.1202157; Jordan VC, 2015, BRIT J CLIN PHARMACO, V79, P254, DOI 10.1111/bcp.12440; Jordan VC, 2014, ENDOCR-RELAT CANCER, V21, pR235, DOI 10.1530/ERC-14-0092; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lain AR, 2013, MOL ENDOCRINOL, V27, P1743, DOI 10.1210/me.2013-1144; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Magnani L, 2013, P NATL ACAD SCI USA, V110, pE1490, DOI 10.1073/pnas.1219992110; Medina D, 2005, CANCER RES, V65, P3493, DOI 10.1158/0008.5472.CAN-04-3869; Medina D, 2003, CANCER RES, V63, P1067; Medina D, 2002, FASEB J, V16, P881, DOI 10.1096/fj.01-0885fje; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mulac-Jericevic B, 2000, SCIENCE, V289, P1751, DOI 10.1126/science.289.5485.1751; Mulac-Jericevic B, 2003, P NATL ACAD SCI USA, V100, P9744, DOI 10.1073/pnas.1732707100; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Namba R, 2004, MOL CANCER RES, V2, P453; Nunes-Xavier CE, 2013, BBA-REV CANCER, V1836, P211, DOI 10.1016/j.bbcan.2013.06.001; Palaniappan M, 2012, MOL ENDOCRINOL, V26, P1732, DOI 10.1210/me.2012-1106; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pfefferle AD, 2016, DIS MODEL MECH, V9, P749, DOI 10.1242/dmm.025239; Powles TJ, 2007, JNCI-J NATL CANCER I, V99, P283, DOI 10.1093/jnci/djk050; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Thewes V, 2015, CANCER RES, V75, P720, DOI 10.1158/0008-5472.CAN-14-0652; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074	59	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194913	10.1371/journal.pone.0194913	http://dx.doi.org/10.1371/journal.pone.0194913			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590203	gold, Green Published, Green Submitted			2022-12-26	WOS:000428603100088
J	O'Geen, H; Ren, CH; Coggins, NB; Bates, SL; Segal, DJ				O'Geen, Henriette; Ren, Chonghua; Coggins, Nicole B.; Bates, Sofie L.; Segal, David J.			Unexpected binding behaviors of bacterial Argonautes in human cells cast doubts on their use as targetable gene regulators	PLOS ONE			English	Article							GUIDE RNA; CRISPR-CAS9; SYSTEM	Prokaryotic Argonaute proteins (pAgos) have been proposed as an alternative to the CRISPR/Cas9 platform for gene editing. Although Argonaute from Natronobacterium gregoryi (NgAgo) was recently shown unable to cleave genomic DNA in mammalian cells, the utility of NgAgo or other pAgos as a targetable DNA-binding platform for epigenetic editing has not been explored. In this report, we evaluated the utility of two prokaryotic Argonautes (NgAgo and TtAgo) as DNA-guided DNA-binding proteins. NgAgo showed no meaningful binding to chromosomal targets, while TtAgo displayed seemingly non-specific binding to chromosomal DNA even in the absence of guide DNA. The observed lack of DNA-guided targeting and unexpected guide-independent genome sampling under the conditions in this study provide evidence that these pAgos might be suitable for neither gene nor epigenome editing in mammalian cells.	[O'Geen, Henriette; Ren, Chonghua; Coggins, Nicole B.; Bates, Sofie L.; Segal, David J.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Segal, David J.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Ren, Chonghua] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China	University of California System; University of California Davis; University of California System; University of California Davis; Northwest A&F University - China	Segal, DJ (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.; Segal, DJ (corresponding author), Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA.	djsegal@ucdavis.edu	Ren, Chonghua/E-3870-2018	Ren, Chonghua/0000-0001-8221-0957; Halmai, Nicole/0000-0002-0790-6548	University of California, Davis, Academic Senate Faculty Research Grant; China State-Sponsored Postgraduates Study Abroad Program - Chinese Scholarship Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007377] Funding Source: NIH RePORTER	University of California, Davis, Academic Senate Faculty Research Grant; China State-Sponsored Postgraduates Study Abroad Program - Chinese Scholarship Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a University of California, Davis, Academic Senate Faculty Research Grant. C.R. was supported by the China State-Sponsored Postgraduates Study Abroad Program provided by the Chinese Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by a University of California, Davis, Academic Senate Faculty Research Grant. C.R. was supported by the China State-Sponsored Postgraduates Study Abroad Program provided by the Chinese Scholarship Council.	[Anonymous], 2017, NAT BIOTECHNOL, V35, P689, DOI 10.1038/nbt.3938; Braff JL, 2016, COLD SPRING HARBOR P; Brocken DJW, 2017, CRISPR/CAS SYSTEM: EMERGING TECHNOLOGY AND APPLICATION, P15, DOI 10.21775/9781910190630.02; Burgess S, 2016, PROTEIN CELL, V7, P913, DOI 10.1007/s13238-016-0343-9; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Gao F, 2016, NAT BIOTECHNOL, V34, P768, DOI 10.1038/nbt.3547; Gao L, 2017, NATURE BIOTECHNOLOGY; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hegge JW, 2017, NATURE REV MICROBIOL; Javidi-Parsijani P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177444; Kaya E, 2016, P NATL ACAD SCI USA, V113, P4057, DOI 10.1073/pnas.1524385113; Khin NC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178768; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; O'Geen H, 2017, NUCLEIC ACIDS RES, V45, P9901, DOI 10.1093/nar/gkx578; O'Geen H, 2015, NUCLEIC ACIDS RES, V43, P3389, DOI 10.1093/nar/gkv137; Olovnikov I, 2013, MOL CELL, V51, P594, DOI 10.1016/j.molcel.2013.08.014; Qi JL, 2016, CELL RES, V26, P1349, DOI 10.1038/cr.2016.134; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Swarts DC, 2017, MOL CELL, V65, P985, DOI 10.1016/j.molcel.2017.01.033; Swarts DC, 2015, NUCLEIC ACIDS RES, V43, P5120, DOI 10.1093/nar/gkv415; Swarts DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124880; Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971; Tak YE, 2017, NATURE METHODS; Vogel J, 2014, SCIENCE, V344, P972, DOI 10.1126/science.1252962; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Wu ZC, 2017, ANTIVIR RES, V145, P20, DOI 10.1016/j.antiviral.2017.07.005; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Ye S, 2017, BIORXIV	33	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0193818	10.1371/journal.pone.0193818	http://dx.doi.org/10.1371/journal.pone.0193818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584750	Green Submitted, Green Published, gold			2022-12-26	WOS:000428373000010
J	Chang, LC; Huang, CF; Lai, MS; Shen, LJ; Wu, FLL; Cheng, WF				Chang, Lin-Chau; Huang, Chih-Fen; Lai, Mei-Shu; Shen, Li-Jiuan; Wu, Fe-Lin Lin; Cheng, Wen-Fang			Prognostic factors in epithelial ovarian cancer: A population-based study	PLOS ONE			English	Article							CLEAR-CELL; SURVIVAL; CHEMOTHERAPY; PATHOGENESIS; CARCINOMAS; PREVENTION; HISTOLOGY; CENTERS; TRENDS; WOMEN	The overall survival (OS) of patients with ovarian cancer is poor while epithelial ovarian cancer (EOC) is the most lethal gynecologic cancer. The aim of the present study was to evaluate the clinico-pathologic characteristics, especially the prognostic factors, for patients with epithelial ovarian cancer (EOC) in Taiwan. Information about newly diagnosed patients with EOC from 2009 to 2012 was retrieved from the database of the Taiwan Cancer Registry. Data from 2009 to 2013 for the respective cases from the claims database of Taiwan's National Health Insurance and National Death Registry were then retrieved. Potential prognostic factors were analyzed. The mean age at diagnosis of the 2,498 patients was 52.8 years. Serous carcinoma and clear cell carcinoma were diagnosed in 43.3% and 22.8% of the total patients, respectively. For patients with early-stage disease, taxane-based adjuvant chemotherapy, stage I, and younger age at diagnosis led to better overall survival (p = 0.030, p = 0.002, p<0.001, respectively) in multivariable analysis. For advanced-stage patients, histology (endometrioid type), taxane-based adjuvant chemotherapy, stage, and age at diagnosis had a significant impact on OS (p<0.001, p = 0.020, p<0.001, p<0.001, respectively). In conclusion, taxane-based chemotherapy impacts the outcome of patients with EOC. Personalized medicine may be needed for different histological types of EOC because of their different outcomes.	[Chang, Lin-Chau; Huang, Chih-Fen; Shen, Li-Jiuan; Wu, Fe-Lin Lin] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei, Taiwan; [Huang, Chih-Fen; Shen, Li-Jiuan] Natl Taiwan Univ Hosp, Dept Pharm, Taipei, Taiwan; [Lai, Mei-Shu] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Shen, Li-Jiuan; Wu, Fe-Lin Lin] Natl Taiwan Univ, Coll Med, Grad Inst Clin Pharm, Taipei, Taiwan; [Cheng, Wen-Fang] Natl Taiwan Univ, Coll Med, Dept Obstet & Gynecol, Taipei, Taiwan; [Cheng, Wen-Fang] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei, Taiwan; [Cheng, Wen-Fang] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Cheng, WF (corresponding author), Natl Taiwan Univ, Coll Med, Dept Obstet & Gynecol, Taipei, Taiwan.; Cheng, WF (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei, Taiwan.; Cheng, WF (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.	wenfangcheng@yahoo.com		Chang, Lin-Chau/0000-0001-7441-9355	Ministry of Health and Welfare [A1021017]	Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	Prof. Mei-Shu Lai received grant number A1021017 from Ministry of Health and Welfare. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Joint Committee on Cancer (AJCC), 2010, AJCC 7 ED CANC STAG; Anuradha S, 2016, ACTA ONCOL, V55, P226, DOI 10.3109/0284186X.2015.1054950; Bristow RE, 2015, J AM COLL SURGEONS, V220, P940, DOI 10.1016/j.jamcollsurg.2015.01.056; Chan JK, 2008, GYNECOL ONCOL, V109, P370, DOI 10.1016/j.ygyno.2008.02.006; Chiang YC, 2013, J GYNECOL ONCOL, V24, P342, DOI 10.3802/jgo.2013.24.4.342; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gonzalez-Martin A, 2014, DRUGS, V74, P879, DOI 10.1007/s40265-014-0221-9; Health Promotion Administration, 2017, CANC REG ANN REP 201; Jordan S, 2013, GYNECOL ONCOL, V129, P310, DOI 10.1016/j.ygyno.2013.02.007; Kajiyama H, 2014, J GYNECOL ONCOL, V25, P43, DOI 10.3802/jgo.2014.25.1.43; Kobel M, 2010, INT J GYNECOL PATHOL, V29, P203, DOI 10.1097/PGP.0b013e3181c042b6; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Kurosaki A, 2016, INT J CANCER, V138, P1994, DOI 10.1002/ijc.29937; Lai MS, 2012, J FORMOS MED ASSOC, V111, P587, DOI 10.1016/j.jfma.2012.08.016; McCluggage WG, 2011, PATHOLOGY, V43, P420, DOI 10.1097/PAT.0b013e328348a6e7; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; National Health Insurance Administration Ministry of Health and Welfare Taiwan, 2016, PROGR OV; Nezhat FR, 2015, AM J OBSTET GYNECOL, V213, P262, DOI 10.1016/j.ajog.2015.03.044; O'Malley CD, 2012, J WOMENS HEALTH, V21, P887, DOI 10.1089/jwh.2012.3781; Polterauer S, 2012, INT J GYNECOL CANCER, V22, P380, DOI 10.1097/IGC.0b013e31823de6ae; Rooth Carolyn, 2013, Br J Nurs, V22, pS23; Schnack TH, 2016, INT J GYNECOL CANCER, V26, P82, DOI 10.1097/IGC.0000000000000585; Taiwan Cancer Registry, 2008, INTRODUCTION; Timmers PJ, 2009, INT J GYNECOL CANCER, V19, P88, DOI 10.1111/IGC.0b013e3181991546; Wei W, 2017, ONCOTARGET, V8, P23862, DOI 10.18632/oncotarget.13317; World Health Organization, 2000, CLASS INT CLASS DIS; Wright JD, 2015, OBSTET GYNECOL, V125, P1345, DOI 10.1097/AOG.0000000000000854; Ye S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133498	28	46	46	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194993	10.1371/journal.pone.0194993	http://dx.doi.org/10.1371/journal.pone.0194993			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579127	Green Published, gold, Green Submitted			2022-12-26	WOS:000428351800074
J	Wei, XH; Zhang, YJ; Yin, BL; Wen, J; Cheng, J; Fu, XD				Wei, Xiaohong; Zhang, Yujiao; Yin, Benlan; Wen, Jing; Cheng, Jun; Fu, Xiaodong			The expression and function of KCNQ potassium channels in human chorionic plate arteries from women with normal pregnancies and pre-eclampsia	PLOS ONE			English	Article							K(V)7 CHANNELS; DOWN-REGULATION; KV7 CHANNELS; MODULATION; FLOW	Pre-eclampsia is associated with altered maternal and placental vascular reactivity. Kv7 channels (encoded by KCNQ 1-5 genes) are a potential contributor to the regulation of vascular tone in CPAs (chorionic plate arteries) during normal pregnancy. The aim of this study is to establish the expression profile of KCNQ subunits in CPAs taken from women with preeclampsia or normotensive women and to examine the functional relevance of the Kv7 channels on an altered expression profile of KCNQ subunits. The effects of Kv7 channel modulators on CPAs were investigated by tension measurement. Quantitative PCR experiments were used to analyze the expression of KCNQ genes. Western blotting and immunofluorescence were both used to analyze the protein expression of Kv7 channels. Finally, in CPAs from normotensive women, the Kv7 channel blocker XE991 increased arterial basal tone and U46619 induced contraction, and pre-contracted CPAs (10(-7) M U46619) exhibited significant relaxation following treatment with Retigabine(Kv7.2-7.5 activator) and BMS-204352(Kv7.2-7.5 activator). However, ICA-27243(selective KCNQ2 and KCNQ3 activator) and ML277(selective KV7.1 activator) had no significant effect on tension in the pre-contracted CPAs. Conversely, compared with CPAs from normotensive women, the effects of XE991 on basal tone and agonist (U46619)-induced contractions in CPAs from women with preeclampsia were markedly attenuated. Moreover, the relaxation effects of Retigabine and BMS-204352 on pre contracted CPA vessels from women with pre-eclampsia were also markedly down-regulated. Interestingly, the relaxation ability of ICA-27243 in pre-contracted CPA vessels in women with pre-eclampsia was enhanced. The mRNA of KCNQ3 was specifically up-regulated, whereas those for KCNQ4 and KCNQ5 were down-regulated in CPAs from women with pre-eclampsia compared with those in normotensive women. Similar observations were found in a subsequent analysis of protein expression of KCNQ genes 3-5. Thus, down-regulated Kv7 channel function in tension regulation of CPAs in women with pre-eclampsia could be associated with considerably altered expression profiles of Kv7 subunits.	[Wei, Xiaohong; Zhang, Yujiao; Yin, Benlan; Fu, Xiaodong] Southwest Med Univ, Affiliated Hosp, Dept Gynecol & Obstet, Luzhou, Sichuan, Peoples R China; [Wen, Jing; Cheng, Jun] Southwest Med Univ, Collaborat Innovat Ctr Prevent & Treatment Cardio, Minist Educ, Key Lab Med Electrophysiol, Luzhou, Sichuan, Peoples R China	Southwest Medical University; Southwest Medical University	Fu, XD (corresponding author), Southwest Med Univ, Affiliated Hosp, Dept Gynecol & Obstet, Luzhou, Sichuan, Peoples R China.	dongerfu@163.com		FU, XIAODONG/0000-0003-0391-6551	Sichuan Provincial Science and Technology Department [10]	Sichuan Provincial Science and Technology Department	This study was supported by Sichuan Provincial Science and Technology Department, [2014]no.10, URL http://www.scst.gov/cn/. XDF is the author who received the funding. Contributions of the author XDF include conceptualization, formal analysis, resources, supervision, and writing review & editing.	Boeldt DS, 2017, J ENDOCRINOL, V232, pR27, DOI 10.1530/JOE-16-0340; Brainard AM, 2007, SEMIN CELL DEV BIOL, V18, P332, DOI 10.1016/j.semcdb.2007.05.008; Brereton MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057451; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Burton GJ, 2009, PLACENTA, V30, pS43, DOI 10.1016/j.placenta.2008.11.003; Burton GJ, 2009, J ANAT, V215, P27, DOI 10.1111/j.1469-7580.2008.00978.x; Caspi A, 2009, J NEUROSCI, V29, P11098, DOI 10.1523/JNEUROSCI.0942-09.2009; Chadha PS, 2012, HYPERTENSION, V59, P877, DOI 10.1161/HYPERTENSIONAHA.111.187427; Cunningham FC, 2014, WILLIAMS OBSTET, V24th, P728; Ghulmiyyah L, 2012, SEMIN PERINATOL, V36, P56, DOI 10.1053/j.semperi.2011.09.011; Jepps TA, 2016, BRIT J PHARMACOL, V173, P1478, DOI 10.1111/bph.13444; Jepps TA, 2011, CIRCULATION, V124, P602, DOI 10.1161/CIRCULATIONAHA.111.032136; Joshi S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-31; Khanamiri S, 2013, HYPERTENSION, V62, P1090, DOI 10.1161/HYPERTENSIONAHA.113.01244; Lee S, 2015, MICROCIRCULATION, V22, P109, DOI 10.1111/micc.12183; Li PY, 2013, N-S ARCH PHARMACOL, V386, P973, DOI 10.1007/s00210-013-0888-6; Luo XL, 2015, CHINESE MED J-PEKING, V128, P1137, DOI 10.4103/0366-6999.156076; Mackie AR, 2008, MOL PHARMACOL, V74, P1171, DOI 10.1124/mol.108.049825; Mattmann ME, 2012, BIOORG MED CHEM LETT, V22, P5936, DOI 10.1016/j.bmcl.2012.07.060; Mills TA, 2015, PLACENTA, V36, P638, DOI 10.1016/j.placenta.2015.03.007; Mistry HD, 2011, HYPERTENSION, V58, P497, DOI 10.1161/HYPERTENSIONAHA.111.173740; Mol BJ, 2016, LANCET, V387, P999, DOI 10.1016/S0140-6736(15)00070-7; Morales-Cano D, 2015, CARDIOVASC RES, V106, P98, DOI 10.1093/cvr/cvv020; Myers J, 2005, HYPERTENSION, V45, P258, DOI 10.1161/01.HYP.0000153461.58298.a4; Naljayan MV, 2013, ADV CHRONIC KIDNEY D, V20, P265, DOI 10.1053/j.ackd.2013.02.003; Ng FL, 2011, BRIT J PHARMACOL, V162, P42, DOI 10.1111/j.1476-5381.2010.01027.x; Ohya S, 2003, CIRC RES, V92, P1016, DOI 10.1161/01.RES.0000070880.20955.F4; Petkov GV, 2012, NAT REV UROL, V9, P30, DOI 10.1038/nrurol.2011.194; Pijnenborg R, 2006, PLACENTA, V27, P939, DOI 10.1016/j.placenta.2005.12.006; Saleem S, 2014, B WORLD HEALTH ORGAN, V92, P605, DOI 10.2471/BLT.13.127464; Sedivy V, 2015, AM J PHYSIOL-LUNG C, V308, pL48, DOI 10.1152/ajplung.00362.2013; Shamshirsaz AA, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/374047; Standen NB, 1998, ACTA PHYSIOL SCAND, V164, P549; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Wareing M, 2002, PLACENTA, V23, P400, DOI 10.1053/plac.2002.0825; Wareing M, 2012, J OBSTET GYNAECOL RE, V38, P185, DOI 10.1111/j.1447-0756.2011.01666.x; Wickenden AD, 2008, MOL PHARMACOL, V73, P977, DOI 10.1124/mol.107.043216; Yeung SYM, 2005, BRIT J PHARMACOL, V146, P585, DOI 10.1038/sj.bjp.0706342; Zhong XZ, 2010, J PHYSIOL-LONDON, V588, P3277, DOI 10.1113/jphysiol.2010.192823	39	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0192122	10.1371/journal.pone.0192122	http://dx.doi.org/10.1371/journal.pone.0192122			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579054	gold, Green Published, Green Submitted			2022-12-26	WOS:000428351800004
J	Polanco, C; de Miera, LES; Bett, K; de la Vega, MP				Polanco, Carlos; Saenz de Miera, Luis E.; Bett, Kirstin; Perez de la Vega, Marcelino			A genome-wide identification and comparative analysis of the lentil MLO genes	PLOS ONE			English	Article							POWDERY MILDEW RESISTANCE; PHYLOGENETIC ANALYSIS; LENS-CULINARIS; FAMILY; PROTEIN; LOCUS; REQUIREMENT; DISCOVERY; TOPOLOGY; GROWTH	Powdery mildew is a widespread fungal plant disease that can cause significant losses in many crops. Some MLO genes (Mildew resistance locus O) have proved to confer a durable resistance to powdery mildew in several species. Resistance granted by the MLO gene family members has prompted an increasing interest in characterizing these genes and implementing their use in plant breeding. Lentil (Lens culinaris Medik.) is a widely grown food legume almost exclusively consumed as dry seed with an average world production of 4.5 million tons. Powdery mildew causes severe losses on certain lentil cultivars under particular environmental conditions. Data mining of the lentil CDC Redberry draft genome allowed to identify up to 15 gene sequences with homology to known MLO genes, designated as LcMLOs. Further characterization of these gene sequences and their deduced protein sequences demonstrated conformity with key MLO protein characteristics such as the presence of transmembrane and calmodulin binding domains, as well as that of other conserved motifs. Phylogenetic and other comparative analyses revealed that LcMLO1 and LcMLO3 are the most likely gene orthologs related to powdery mildew response in other species, sharing a high similarity with other known resistance genes of dicot species, such as pea PsMLO1 and Medicago truncatula MtMLO1 and MtMLO3. Sets of primers were designed as tools to PCR amplify the genomic sequences of LcMLO1 and LcMLO3, also to screen lentil germplasm in search of resistance mutants. Primers were used to obtain the complete sequences of these two genes in all of the six wild lentil relatives. Respective to each gene, all Lens sequences shared a high similarity. Likewise, we used these primers to screen a working collection of 58 cultivated and 23 wild lentil accessions in search of length polymorphisms present in these two genes. All these data widen the insights on this gene family and can be useful for breeding programs in lentil and close related species.	[Polanco, Carlos; Saenz de Miera, Luis E.; Perez de la Vega, Marcelino] Univ Leon, Dept Biol Mol, Area Genet, Leon, Spain; [Bett, Kirstin] Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada	Universidad de Leon; University of Saskatchewan	Polanco, C (corresponding author), Univ Leon, Dept Biol Mol, Area Genet, Leon, Spain.	carlos.polanco@unileon.es	Polanco, Carlos/K-7793-2017; de Miera, Luis E Sáenz/D-6864-2018; De La Vega, Marcelino Perez/B-7988-2008; Sáenz de Miera, Luis/ABA-4573-2021	Polanco, Carlos/0000-0003-1175-306X; de Miera, Luis E Sáenz/0000-0003-1871-7379; De La Vega, Marcelino Perez/0000-0002-1744-7437; Sáenz de Miera, Luis/0000-0003-1871-7379	European Union [613551]; Spanish Ministerio de Economia y Competitividad [AGL2013-44714-R]; FEDER; Junta de Castilla y Leon [GR113]	European Union(European Commission); Spanish Ministerio de Economia y Competitividad(Spanish Government); FEDER(European Commission); Junta de Castilla y Leon(Junta de Castilla y Leon)	This project was mainly financed by the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no 613551 (LEGumes for the Agriculture of Tomorrow; LEGATO) to Marecelino Perez de la Vega and partially supported by the Spanish Ministerio de Economia y Competitividad (grant AGL2013-44714-R to Marcelino Perez de la Vega, co-financed with FEDER funds) and the Junta de Castilla y Leon to Research Groups (GR113) to Marcelino Perez de la Vega.	Acevedo-Garcia J, 2014, NEW PHYTOL, V204, P273, DOI 10.1111/nph.12889; Acevedo-Garcia J, 2013, THEOR APPL GENET, V126, P2969, DOI 10.1007/s00122-013-2186-6; Appiano M, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0639-6; Appiano M, 2015, TRANSGENIC RES, V24, P847, DOI 10.1007/s11248-015-9878-4; Attanayake RN, 2009, PLANT DIS, V93, P797, DOI 10.1094/PDIS-93-8-0797; Berg JA, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1029-z; Berg JA, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0635-x; Bertioli DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-45; Bett K., 2016, PLANT AN GEN 24 C JA; Bhadauria V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03463-9; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Chen Yongbing, 2014, Plant Omics, V7, P87; Cheng Hong, 2015, Horticultural Plant Journal, V1, P165, DOI 10.16420/j.issn.2095-9885.2015-0036; Choi HK, 2004, P NATL ACAD SCI USA, V101, P15289, DOI 10.1073/pnas.0402251101; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Consonni C, 2006, NAT GENET, V38, P716, DOI 10.1038/ng1806; Deshmukh R, 2017, J PLANT RES, V130, P239, DOI 10.1007/s10265-016-0868-2; Deshmukh R, 2016, GENETICA, V144, P229, DOI 10.1007/s10709-016-9893-2; Deshmukh R, 2014, MOL GENET GENOMICS, V289, P345, DOI 10.1007/s00438-014-0811-y; Dobson L, 2015, NUCLEIC ACIDS RES, V43, pW408, DOI 10.1093/nar/gkv451; Elliott C, 2005, BIOCHEM J, V385, P243, DOI 10.1042/BJ20040993; Fratini R, 2007, SPAN J AGRIC RES, V5, P348; Fratini R, 2011, GRAIN LEGUMES, V57, P18; Fujimura T, 2016, PLANT PATHOL, V65, P1358, DOI 10.1111/ppa.12498; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Glawe DA, 2008, ANNU REV PHYTOPATHOL, V46, P27, DOI 10.1146/annurev.phyto.46.081407.104740; Hong WJ, 2014, TRENDS CELL BIOL, V24, P35, DOI 10.1016/j.tcb.2013.09.006; Humphry M, 2011, MOL PLANT PATHOL, V12, P866, DOI [10.1111/J.1364-3703.2011.00718.X, 10.1111/j.1364-3703.2011.00718.x]; Ichikawa M, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.4161/15592324.2014.990847; Islam MZ, 2016, EUPHYTICA, V211, P379, DOI 10.1007/s10681-016-1752-9; Jayid M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00917; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; JORGENSEN JH, 1992, EUPHYTICA, V63, P141, DOI 10.1007/BF00023919; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Ksiazkiewicz M, 2015, PLANT MOL BIOL REP, V33, P84, DOI 10.1007/s11105-014-0730-4; Kumar J, 2014, PHYSIOL MOL BIOL PLA, V20, P125, DOI 10.1007/s12298-013-0214-2; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kusch S, 2017, MOL PLANT MICROBE IN, V30, P179, DOI 10.1094/MPMI-12-16-0255-CR; Kusch S, 2016, GENOME BIOL EVOL, V8, P878, DOI 10.1093/gbe/evw036; Mohapatra C, 2016, TURK J BIOL, V40, P184, DOI 10.3906/biy-1501-29; Mruk K, 2014, J GEN PHYSIOL, V144, P103, DOI 10.1085/jgp.201311140; Nguyen VNT, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01413; Panstruga R, 2005, PLANT MOL BIOL, V59, P485, DOI 10.1007/s11103-005-0353-0; Perez de la Vega M., 2011, Genetics, genomics and breeding of cool season grain legumes, P98; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rispail N, 2016, SCI REP-UK, V6, DOI 10.1038/srep32673; Rubiales D, 2009, CZECH J GENET PLANT, V45, P135, DOI 10.17221/75/2009-CJGPB; Singh A. K., 2013, Plant Pathology Journal (Faisalabad), V12, P71, DOI 10.3923/ppj.2013.71.77; Singh M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107781; Singh M, 2013, PLANT BREEDING, V132, P667, DOI 10.1111/pbr.12089; Sudheesh S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111887; Vail S, 2012, FIELD CROP RES, V126, P145, DOI 10.1016/j.fcr.2011.10.002; Wang XY, 2016, PLANT PHYSIOL BIOCH, V103, P106, DOI 10.1016/j.plaphy.2016.02.031; Yun HS, 2013, MOL CELLS, V35, P481, DOI 10.1007/s10059-013-2130-2; Zheng Z, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00380	55	13	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2018	13	3							e0194945	10.1371/journal.pone.0194945	http://dx.doi.org/10.1371/journal.pone.0194945			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA2QK	29570745	Green Submitted, Green Published, gold			2022-12-26	WOS:000428168400038
J	Bracci, L; Mandarini, E; Brunetti, J; Depau, L; Pini, A; Terzuoli, L; Scali, S; Falciani, C				Bracci, Luisa; Mandarini, Elisabetta; Brunetti, Jlenia; Depau, Lorenzo; Pini, Alessandro; Terzuoli, Lucia; Scali, Silvia; Falciani, Chiara			The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells	PLOS ONE			English	Article							BREAST-CANCER CELLS; FIBROBLAST GROWTH FACTOR-2; SULFATE PROTEOGLYCANS; NEUROTENSIN PEPTIDES; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; HEPARIN; RECEPTOR; THROMBIN; BINDING	Heparan sulfate proteoglycans, HSPGs, modulate major transformations of cancer cells, leading to tumor growth, invasion and metastasis. HSPGs also regulate neo-angiogenesis which prompts cancer progression and metastatic spread. A different aspect of heparin and analogs is their prominent role in the coagulation of blood. The interplay between coagulation and metastasis is being actively studied: anticoagulants such as heparin-derivatives have anticancer activity and procoagulants, such as thrombin, positively modulate proliferation, migration and invasion. The branched peptide NT4 binds to HSPGs and targets selectively cancer cells and tissues. For this, it had been extensively investigated in the last years and it proved to be efficient as chemotherapeutic and tumor tracer in in vivo models of cancer. We investigated the effects of the branched peptide in terms of modulation of angiogenesis and invasiveness of cancer cells. NT4 proved to have a major impact on endothelial cell proliferation, migration and tube formation, particularly when induced by FGF2 and thrombin. In addition, NT4 had important effects on aggressive tumor cells migration and invasion and it also had an anticoagulant profile.The peptide showed very interesting evidence of interference with tumor invasion pathways, offering a cue for its development as a tumor-targeting drug, and also for its use in the study of links between coagulation and tumor progression involving HSPGs.	[Bracci, Luisa; Mandarini, Elisabetta; Brunetti, Jlenia; Depau, Lorenzo; Pini, Alessandro; Terzuoli, Lucia; Scali, Silvia; Falciani, Chiara] Univ Siena, Dept Med Biotechnol, Siena, Italy	University of Siena	Falciani, C (corresponding author), Univ Siena, Dept Med Biotechnol, Siena, Italy.	chiara.falciani@unisi.it	Falciani, Chiara/R-1330-2018; Pini, Alessandro/R-1359-2018; Bracci, Luisa/V-9913-2018; Brunetti, Luisa/E-6464-2019	Falciani, Chiara/0000-0002-1027-8482; Pini, Alessandro/0000-0002-3832-8349; Bracci, Luisa/0000-0002-0738-5746; Brunetti, Luisa/0000-0001-8144-7186	Associazione Italiana perla Ricerca sul Cancro AIRC [15564]; Regione Toscana-ITT	Associazione Italiana perla Ricerca sul Cancro AIRC(Fondazione AIRC per la ricerca sul cancro); Regione Toscana-ITT	This work was funded by Associazione Italiana perla Ricerca sul Cancro AIRC (https:// www.airc.it/) IG 2014 Id 15564 (LB) and by Regione Toscana-ITT 2013 (LB) (www.ittumori.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADANY R, 1990, J BIOL CHEM, V265, P11389; Balduyck M, 2000, CLIN EXP METASTAS, V18, P171, DOI 10.1023/A:1006762425323; Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Barbouri D, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00004; Battinelli EM, 2014, BLOOD, V123, P101, DOI 10.1182/blood-2013-02-485011; Brunetti J, 2016, SCI REP-UK, V6, DOI 10.1038/srep27174; Brunetti J, 2015, SCI REP-UK, V5, DOI 10.1038/srep17736; Chiodelli P, 2015, MOLECULES, V20, P6342, DOI 10.3390/molecules20046342; Dos Santos C, 2014, BIOCHIMIE, V107, P350, DOI 10.1016/j.biochi.2014.10.002; Falanga A, 2013, J THROMB HAEMOST, V11, P223, DOI 10.1111/jth.12075; Falciani C, 2010, CURR CANCER DRUG TAR, V10, P695, DOI 10.2174/156800910793605875; Falciani C, 2007, MOL CANCER THER, V6, P2441, DOI 10.1158/1535-7163.MCT-07-0164; Falciani C, 2013, J PEPT SCI, V19, P198, DOI 10.1002/psc.2493; Falciani C, 2010, CHEMMEDCHEM, V5, P567, DOI 10.1002/cmdc.200900527; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Knelson EH, 2014, TRENDS BIOCHEM SCI, V39, P277, DOI 10.1016/j.tibs.2014.03.001; Lim HC, 2015, MOL CANCER, V14, DOI 10.1186/s12943-014-0279-8; Marcum JA, 1995, BIOCHEM BIOPH RES CO, V126, P365; Mellor P, 2007, BRIT J CANCER, V97, P761, DOI 10.1038/sj.bjc.6603928; Mundhenke C, 2002, AM J PATHOL, V160, P185, DOI 10.1016/S0002-9440(10)64362-3; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Noble S, 2014, THROMB RES, V133, pS133, DOI 10.1016/S0049-3848(14)50023-0; Nugent MA, 2000, P NATL ACAD SCI USA, V97, P10301, DOI 10.1073/pnas.97.19.10301; Nurcombe V, 2000, J BIOL CHEM, V275, P30009, DOI 10.1074/jbc.M003038200; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Piperigkou Z, 2016, CELL TISSUE RES, V365, P643, DOI 10.1007/s00441-016-2452-4; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Shen XK, 2011, J BIOL CHEM, V286, P26616, DOI 10.1074/jbc.M111.224212; Sodek KL, 2009, INT J CANCER, V124, P2060, DOI 10.1002/ijc.24188; Tang H, 2005, BLOOD, V105, P1977, DOI 10.1182/blood-2004-08-3308; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Vianello F, 2016, CANCER MED-US, V5, P2886, DOI 10.1002/cam4.857; Wade A, 2013, FEBS J, V280, P2399, DOI 10.1111/febs.12109; Wang HS, 1997, J SURG RES, V68, P139, DOI 10.1006/jsre.1997.5044; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; Wojtukiewicz MZ, 2015, CANCER METAST REV, V34, P775, DOI 10.1007/s10555-015-9599-4; Zhang WQ, 2006, J BIOL CHEM, V281, P37302, DOI 10.1074/jbc.M604905200	37	8	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194744	10.1371/journal.pone.0194744	http://dx.doi.org/10.1371/journal.pone.0194744			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566097	Green Published, gold			2022-12-26	WOS:000428093900100
J	Elattar, S; Dimri, M; Satyanarayana, A				Elattar, Sawsan; Dimri, Manali; Satyanarayana, Ande			The tumor secretory factor ZAG promotes white adipose tissue browning and energy wasting	FASEB JOURNAL			English	Article						cachexia; beige adipocyte; Ebf2; Prdm16; Ucp1	NECROSIS-FACTOR-ALPHA; SKELETAL-MUSCLE; PPAR-GAMMA; ZINC-ALPHA-2-GLYCOPROTEIN ZAG; FAT-CELL; ACTIVATION; CACHEXIA; SWITCH; INTERLEUKIN-6; ADIPOGENESIS	Cachexia is a complex tissue-wasting syndrome characterized by inflammation, hypermetabolism, increased energy expenditure, and anorexia. Browning of white adipose tissue (WAT) is one of the significant factors that contribute to energy wasting in cachexia. By utilizing a cell implantation model, we demonstrate here that the lipid mobilizing factor zinc-(2)-glycoprotein (ZAG) induces WAT browning in mice. Increased circulating levels of ZAG not only induced lipolysis in adipose tissues but also caused robust browning in WAT. Stimulating WAT progenitors with ZAG recombinant protein or expression of ZAG in mouse embryonic fibroblasts (MEFs) strongly enhanced brown-like differentiation. At the molecular level, ZAG stimulated peroxisome proliferator-activated receptor (PPAR) and early B cell factor 2 expression and promoted their recruitment to the PR/SET domain 16 (Prdm16) promoter, leading to enhanced expression of Prdm16, which determines brown cell fate. In brown adipose tissue, ZAG stimulated the expression of PPAR and PPAR coactivator 1 and promoted recruitment of PPAR to the uncoupling protein 1 (Ucp1) promoter, leading to increased expression of Ucp1. Overall, our results reveal a novel function of ZAG in WAT browning and highlight the targeting of ZAG as a potential therapeutic application in humans with cachexia.Elattar, S., Dimri, M., Satyanarayana, A. The tumor secretory factor ZAG promotes white adipose tissue browning and energy wasting.	[Elattar, Sawsan; Dimri, Manali; Satyanarayana, Ande] Augusta Univ, Dept Biochem & Mol Biol, Georgia Canc Ctr, Augusta, GA USA	University System of Georgia; Augusta University	Satyanarayana, A (corresponding author), Augusta Univ, 1410 Laney Walker Blvd,Room CN3150, Augusta, GA 30912 USA.	sande@augusta.edu			U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DP2DK105565]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK105565] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Patrick Seale (University of Pennsylvania, Philadelphia, PA, USA) for providing control and Prdm16 luciferase reporter vectors, and Dr. Mark Christian (University of Warwick, Coventry, United Kingdom) for providing Ucp1 luciferase vector. The authors thank Jinling Yuan (Georgia Cancer Center) for animal care and Georgia Cancer Center Small Animal Imaging Resource (Augusta, GA, USA) for technical help with multispectral optical imaging. The authors thank Dr. Rhea-Beth Markowitz (Augusta University) for reviewing and editing the manuscript. This research is supported by the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (Grant DP2DK105565 to A.S.). The authors declare no conflicts of interest.	Abdul-Rahman PS, 2007, ELECTROPHORESIS, V28, P1989, DOI 10.1002/elps.200600629; Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Aune UL, 2013, JOVE-J VIS EXP, DOI 10.3791/50191; Bayliss TJ, 2011, EXPERT OPIN BIOL TH, V11, P1663, DOI 10.1517/14712598.2011.627850; Bing C, 2004, P NATL ACAD SCI USA, V101, P2500, DOI 10.1073/pnas.0308647100; Bing C, 2002, BRIT J CANCER, V86, P612, DOI 10.1038/sj.bjc.6600101; Bondar OP, 2007, CLIN CHEM, V53, P673, DOI 10.1373/clinchem.2006.079681; BUERGI W, 1961, J BIOL CHEM, V236, P1066; Busquets S, 1998, FEBS LETT, V440, P348, DOI 10.1016/S0014-5793(98)01485-9; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao L, 2011, CELL METAB, V14, P324, DOI 10.1016/j.cmet.2011.06.020; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; DIEZITZA I, 1993, EUR J CANCER, V29A, P1256, DOI 10.1016/0959-8049(93)90068-Q; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Hale LP, 2001, CLIN CANCER RES, V7, P846; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Janssen SPM, 2005, CIRCULATION, V111, P996, DOI 10.1161/01.CIR.0000156469.96135.0D; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Kir S, 2014, NATURE, V513, P100, DOI 10.1038/nature13528; Li YP, 1998, FASEB J, V12, P871, DOI 10.1096/fasebj.12.10.871; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lowell BB, 1999, CELL, V99, P239, DOI 10.1016/S0092-8674(00)81654-2; Morley JE, 2006, AM J CLIN NUTR, V83, P735, DOI 10.1093/ajcn/83.4.735; Mracek T, 2010, J ENDOCRINOL, V204, P165, DOI 10.1677/JOE-09-0299; Mracek T, 2010, CLIN ENDOCRINOL, V72, P334, DOI 10.1111/j.1365-2265.2009.03658.x; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Patil M, 2017, DIABETES, V66, P1611, DOI 10.2337/db16-1079; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Petruzzelli M, 2014, CELL METAB, V20, P433, DOI 10.1016/j.cmet.2014.06.011; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Russell ST, 2002, BRIT J CANCER, V86, P424, DOI 10.1038/sj.bjc.6600086; Sanders PM, 2004, CANCER LETT, V212, P71, DOI 10.1016/j.canlet.2004.03.021; Satyanarayana A, 2012, FASEB J, V26, P309, DOI 10.1096/fj.11-190892; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Stine RR, 2016, MOL METAB, V5, P57, DOI 10.1016/j.molmet.2015.11.001; STRASSMANN G, 1992, J CLIN INVEST, V89, P1681, DOI 10.1172/JCI115767; TAYLOR DD, 1992, CANCER RES, V52, P829; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; van Hall G, 2008, J CLIN ENDOCR METAB, V93, P2851, DOI 10.1210/jc.2007-2223; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wargent ET, 2013, J ENDOCRINOL, V216, P157, DOI 10.1530/JOE-12-0402; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yeaman SJ, 2004, BIOCHEM J, V379, P11, DOI 10.1042/BJ20031811; Yusuf B, 2013, DEV GROWTH DIFFER, V55, P330, DOI 10.1111/dgd.12043	54	40	43	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4727	4743		10.1096/fj.201701465RR	http://dx.doi.org/10.1096/fj.201701465RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29570397	Green Published			2022-12-26	WOS:000443817700009
J	Morales-Soto, N; Dunham, SJB; Baig, NF; Ellis, JF; Madukoma, CS; Bohn, PW; Sweedler, JV; Shrout, JD				Morales-Soto, Nydia; Dunham, Sage J. B.; Baig, Nameera F.; Ellis, Joanna F.; Madukoma, Chinedu S.; Bohn, Paul W.; Sweedler, Jonathan V.; Shrout, Joshua D.			Spatially dependent alkyl quinolone signaling responses to antibiotics in Pseudomonas aeruginosa swarms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Pseudomonas aeruginosa (P; aeruginosa); antibiotics; quorum sensing; Raman spectroscopy; mass spectrometry (MS); biofilm; N-oxide; PQS; quinolone; secondary ion mass spectrometry; swarming	BIOFILM FORMATION; MEMBRANE-VESICLES; CELL-DENSITY; TOLERANCE; VIRULENCE; MOTILITY; SYSTEM; GROWTH; DNA; AMINOGLYCOSIDES	There is a general lack of understanding about how communities of bacteria respond to exogenous toxins such as antibiotics. Most of our understanding of community-level stress responses comes from the study of stationary biofilm communities. Although several community behaviors and production of specific biomolecules affecting biofilm development and associated behavior have been described for Pseudomonas aeruginosa and other bacteria, we have little appreciation for the production and dispersal of secreted metabolites within the 2D and 3D sUpaces they occupy as they colonize, spread, and grow on surfaces. Here we specifically studied the phenotypic responses and spatial variability of alkyl quinolones, including the Pseudomonas quinolone signal (PQS) and members of the alkyl hydroxyquinoline (AQNO) subclass, in P. aeruginosa plate-assay swarming communities. We found that PQS production was not a universal signaling response to antibiotics, as tobramycin elicited an alkyl quinolone response, whereas carbenicillin did not. We also found that PQS and AQNO profiles in response to tobramycin were markedly distinct and influenced these swarms on different spatial scales. At some tobramycin exposures, P. aeruginosa swarms produced alkyl quinolones in the range of 150 m PQS and 400 m AQNO that accumulated as aggregates. Our collective findings show that the distribution of alkyl quinolones can vary by several orders of magnitude within the same swarming community. More notably, our results suggest that multiple intercellular signals acting on different spatial scales can be triggered by one common cue.	[Morales-Soto, Nydia; Madukoma, Chinedu S.; Shrout, Joshua D.] Univ Notre Dame, Dept Civil & Environm Engn & Earth Sci, Notre Dame, IN 46556 USA; [Baig, Nameera F.; Bohn, Paul W.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Bohn, Paul W.] Univ Notre Dame, Dept Chem & Biomol Engn, Notre Dame, IN 46556 USA; [Shrout, Joshua D.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Dunham, Sage J. B.; Ellis, Joanna F.; Sweedler, Jonathan V.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Dunham, Sage J. B.; Ellis, Joanna F.; Sweedler, Jonathan V.; Shrout, Joshua D.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA	University of Notre Dame; University of Notre Dame; University of Notre Dame; University of Notre Dame; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Shrout, JD (corresponding author), Univ Notre Dame, Dept Civil & Environm Engn & Earth Sci, Notre Dame, IN 46556 USA.	joshua.shrout@nd.edu	Shrout, Joshua D/C-4743-2012; Baig, Nameera/S-8481-2019; Sweedler, Jonathan V/A-9405-2009; Ellis, Joanna F/O-6007-2016	Shrout, Joshua D/0000-0001-9509-2187; Baig, Nameera/0000-0002-7414-6833; Sweedler, Jonathan V/0000-0003-3107-9922; Ellis, Joanna F/0000-0003-4807-6840; Morales-Soto, Nydia/0000-0003-1155-6293; Madukoma, Chinedu S/0000-0003-3268-2600	NIAID, National Institutes of Health [R01AI113219]; Springborn Endowment; National Science Foundation Graduate Research Fellowship Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113219] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Springborn Endowment; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by NIAID, National Institutes of Health, Grant R01AI113219 (to J.D.S., P.W.B., and J.V.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by the Springborn Endowment and the National Science Foundation Graduate Research Fellowship Program.r Supported by the Springborn Endowment.	Aendekerk S, 2005, MICROBIOL-SGM, V151, P1113, DOI 10.1099/mic.0.27631-0; Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Anyan ME, 2014, P NATL ACAD SCI USA, V111, P18013, DOI 10.1073/pnas.1414661111; Baig NF, 2015, ANALYST, V140, P6544, DOI 10.1039/c5an01149c; BAO Y, 1991, GENE, V109, P167, DOI 10.1016/0378-1119(91)90604-A; Butler MT, 2010, P NATL ACAD SCI USA, V107, P3776, DOI 10.1073/pnas.0910934107; Calfee MW, 2005, INFECT IMMUN, V73, P878, DOI 10.1128/IAI.73.2.878-882.2005; Chiang WC, 2013, ANTIMICROB AGENTS CH, V57, P2352, DOI 10.1128/AAC.00001-13; Ciofu O, 2015, ADV DRUG DELIVER REV, V85, P7, DOI 10.1016/j.addr.2014.11.017; Cummins J, 2009, MICROBIOL-SGM, V155, P2826, DOI 10.1099/mic.0.025643-0; D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; Diggle SP, 2003, MOL MICROBIOL, V50, P29, DOI 10.1046/j.1365-2958.2003.03672.x; Diggle SP, 2007, CHEM BIOL, V14, P87, DOI 10.1016/j.chembiol.2006.11.014; Florez C, 2017, MBIO, V8, DOI 10.1128/mBio.01034-17; Formosa C, 2012, NANOMED-NANOTECHNOL, V8, P12, DOI 10.1016/j.nano.2011.09.009; Guo Q, 2014, J BASIC MICROB, V54, P633, DOI 10.1002/jobm.201300091; Haussler S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000166; Hazan R, 2016, CURR BIOL, V26, P195, DOI 10.1016/j.cub.2015.11.056; Hoffman LR, 2006, P NATL ACAD SCI USA, V103, P19890, DOI 10.1073/pnas.0606756104; Hoyle B D, 1991, Prog Drug Res, V37, P91; Jones EA, 2012, J PROTEOMICS, V75, P4962, DOI 10.1016/j.jprot.2012.06.014; KESSLER B, 1992, MOL GEN GENET, V233, P293, DOI 10.1007/BF00587591; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Koch B, 2001, J MICROBIOL METH, V45, P187, DOI 10.1016/S0167-7012(01)00246-9; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Kotra LP, 2000, ANTIMICROB AGENTS CH, V44, P3249, DOI 10.1128/AAC.44.12.3249-3256.2000; Lai S, 2009, ENVIRON MICROBIOL, V11, P126, DOI 10.1111/j.1462-2920.2008.01747.x; Lanni EJ, 2014, J AM SOC MASS SPECTR, V25, P1897, DOI 10.1007/s13361-014-0978-9; Lanni EJ, 2014, ANAL CHEM, V86, P9139, DOI 10.1021/ac5020222; Lepine F, 2004, J AM SOC MASS SPECTR, V15, P862; Lopez-Diez EC, 2005, ANAL CHEM, V77, P2901, DOI 10.1021/ac048147m; Mann EE, 2012, FEMS MICROBIOL REV, V36, P893, DOI 10.1111/j.1574-6976.2011.00322.x; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; Masyuko R, 2013, ANALYST, V138, P1924, DOI 10.1039/c3an36416j; MENDELMAN PM, 1985, AM REV RESPIR DIS, V132, P761; Merritt JH, 2007, J BACTERIOL, V189, P8154, DOI 10.1128/JB.00585-07; Morris JD, 2011, APPL ENVIRON MICROB, V77, P8310, DOI 10.1128/AEM.06644-11; NEU HC, 1983, AM J MED, V75, P9, DOI 10.1016/0002-9343(83)90089-X; Nonejuie P, 2013, P NATL ACAD SCI USA, V110, P16169, DOI 10.1073/pnas.1311066110; Olsen I, 2015, EUR J CLIN MICROBIOL, V34, P877, DOI 10.1007/s10096-015-2323-z; Partridge JD, 2013, J BACTERIOL, V195, P909, DOI 10.1128/JB.02063-12; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Phelan VV, 2015, J AM SOC MASS SPECTR, V26, P873, DOI 10.1007/s13361-015-1101-6; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Reis RS, 2011, BIORESOURCE TECHNOL, V102, P6377, DOI 10.1016/j.biortech.2011.03.074; Szamosvari D, 2017, ANGEW CHEM INT EDIT, V56, P7271, DOI 10.1002/anie.201702944; Tremblay J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-587; Turnbull L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11220; Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004; Viducic D, 2016, ANTIMICROB AGENTS CH, V60, P5752, DOI 10.1128/AAC.00260-16; Xiao GP, 2006, MOL MICROBIOL, V62, P1689, DOI 10.1111/j.1365-2958.2006.05462.x; Yeung ATY, 2009, J BACTERIOL, V191, P5592, DOI 10.1128/JB.00157-09	55	24	24	2	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9544	9552		10.1074/jbc.RA118.002605	http://dx.doi.org/10.1074/jbc.RA118.002605			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29588364	Green Published, hybrid			2022-12-26	WOS:000435441400037
J	Debnath, S; Kosek, D; Tagad, HD; Durell, SR; Appella, DH; Acevedo, R; Grishaev, A; Dyda, F; Appella, E; Mazur, SJ				Debnath, Subrata; Kosek, Dalibor; Tagad, Harichandra D.; Durell, Stewart R.; Appella, Daniel H.; Acevedo, Roderico; Grishaev, Alexander; Dyda, Fred; Appella, Ettore; Mazur, Sharlyn J.			A trapped human PPM1A-phosphopeptide complex reveals structural features critical for regulation of PPM protein phosphatase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic peptide; X-ray crystallography; enzyme structure; metalloenzyme; molecular dynamics; protein serine; threonine phosphatase (PSP); signal transduction; small-angle X-ray scattering (SAXS)	3RD METAL; SCATTERING DATA; MECHANISM; CONFORMATION; PP2C-ALPHA; ACTIVATION; TRANSITION; DYNAMICS; 2C-ALPHA; INSULIN	Metal-dependent protein phosphatases (PPM) are evolutionarily unrelated to other serine/threonine protein phosphatases and are characterized by their requirement for supplementation with millimolar concentrations of Mg2+ or Mn2+ ions for activity in vitro. The crystal structure of human PPM1A (also known as PP2C), the first PPM structure determined, displays two tightly bound Mn2+ ions in the active site and a small subdomain, termed the Flap, located adjacent to the active site. Some recent crystal structures of bacterial or plant PPM phosphatases have disclosed two tightly bound metal ions and an additional third metal ion in the active site. Here, the crystal structure of the catalytic domain of human PPM1A, PPM1A(cat), complexed with a cyclic phosphopeptide, c(MpSIpYVA), a cyclized variant of the activation loop of p38 MAPK (a physiological substrate of PPM1A), revealed three metal ions in the active site. The PPM1A(cat) D146E-c(MpSIpYVA) complex confirmed the presence of the anticipated third metal ion in the active site of metazoan PPM phosphatases. Biophysical and computational methods suggested that complex formation results in a slightly more compact solution conformation through reduced conformational flexibility of the Flap subdomain. We also observed that the position of the substrate in the active site allows solvent access to the labile third metal-binding site. Enzyme kinetics of PPM1A(cat) toward a phosphopeptide substrate supported a random-order, bi-substrate mechanism, with substantial interaction between the bound substrate and the labile metal ion. This work illuminates the structural and thermodynamic basis of an innate mechanism regulating the activity of PPM phosphatases.	[Debnath, Subrata; Tagad, Harichandra D.; Durell, Stewart R.; Appella, Ettore; Mazur, Sharlyn J.] NCI, Lab Cell Biol, Ctr Canc Res, Bethesda, MD 20892 USA; [Kosek, Dalibor; Dyda, Fred] NIDDK, Lab Mol Biol, NIH, Bethesda, MD 20892 USA; [Appella, Daniel H.] NIDDK, Lab Bioorgan Chem, NIH, Bethesda, MD 20892 USA; [Acevedo, Roderico; Grishaev, Alexander] Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Grishaev, Alexander] NIST, Gaithersburg, MD 20899 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institute of Standards & Technology (NIST) - USA	Mazur, SJ (corresponding author), Bldg 37,Rm 2140,37 Convent Dr, Bethesda, MD 20892 USA.	mazurs@mail.nih.gov	Košek, Dalibor/AAD-4715-2021; Tagad, HARICHANDRA D/S-2293-2018; Debnath, Subrata/X-8773-2019	Tagad, Harichandra/0000-0003-1595-6665; Mazur, Sharlyn/0000-0002-6378-0791	DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [ZIABC011197, ZIABC011379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075148, ZIADK075135, ZIADK031143] Funding Source: NIH RePORTER	DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work utilized the SAXS Core facility (CCR, NCI, National Institutes of Health) and the computational resources of the HPC Biowulf Cluster, National Institutes of Health. SAXS data were collected at beamline 12-ID-B at the Advanced Photon Source (Argonne, IL). The shared scattering beamline 12-ID-B resource is allocated under agreement PUP-24152 between the NCI and Argonne National Laboratory. Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility, was operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. We thank Dr. Lixin Fan (NCI, National Institutes of Health), and Dr. Xiaobing Zuo (Argonne National Laboratory) for expert support.	Barford D., 2011, HDB CELL SIGNALING, V1, P677; Bellinzoni M, 2007, STRUCTURE, V15, P863, DOI 10.1016/j.str.2007.06.002; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bork P, 1996, PROTEIN SCI, V5, P1421, DOI 10.1002/pro.5560050720; Bradshaw N, 2017, ELIFE, V6, DOI 10.7554/eLife.26111; Brautigan DL, 2013, FEBS J, V280, P324, DOI 10.1111/j.1742-4658.2012.08609.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen MJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag1796; Cheng AY, 2000, J BIOL CHEM, V275, P34744, DOI 10.1074/jbc.M006210200; ChinSang ID, 1996, GENE DEV, V10, P2314, DOI 10.1101/gad.10.18.2314; Cohen P. T., 2010, TRANSDUCTION MECH CE, P659; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; Delva P, 2006, J ENDOCRINOL, V190, P711, DOI 10.1677/joe.1.06389; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Fjeld CC, 1999, J BIOL CHEM, V274, P20336, DOI 10.1074/jbc.274.29.20336; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Frausto da Silva J.J.R., 2001, BIOL CHEM ELEMENTS I, P251; Geng J, 2014, ONCOTARGET, V5, P5700, DOI 10.18632/oncotarget.2144; Grishaev A, 2010, J AM CHEM SOC, V132, P15484, DOI 10.1021/ja106173n; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kerk D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132863; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krol E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174713; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Lassila JK, 2011, ANNU REV BIOCHEM, V80, P669, DOI 10.1146/annurev-biochem-060409-092741; Li R, 2013, FEBS J, V280, P2700, DOI 10.1111/febs.12275; Long YQ, 2003, BIOORGAN MED CHEM, V11, P3929, DOI 10.1016/S0968-0896(03)00411-5; Lu X, 2014, ONCOGENE, V33, P2918, DOI 10.1038/onc.2013.246; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; Mazur SJ, 2017, BIOCHEMISTRY-US, V56, P2676, DOI 10.1021/acs.biochem.6b01220; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Mitic N, 2006, CHEM REV, V106, P3338, DOI 10.1021/cr050318f; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Ofek P, 2003, J BIOL CHEM, V278, P14299, DOI 10.1074/jbc.M211699200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pan C, 2015, SCI REP-UK, V5, DOI 10.1038/srep08560; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pullen KE, 2004, STRUCTURE, V12, P1947, DOI 10.1016/j.str.2004.09.008; Rantanen MK, 2007, FEBS J, V274, P3128, DOI 10.1111/j.1742-4658.2007.05845.x; Schlicker C, 2008, J MOL BIOL, V376, P570, DOI 10.1016/j.jmb.2007.11.097; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Stern A, 2007, J MOL EVOL, V64, P61, DOI 10.1007/s00239-006-0033-y; Su JY, 2013, FEBS J, V280, P694, DOI 10.1111/j.1742-4658.2011.08466.x; Su JY, 2011, J BIOL CHEM, V286, P13481, DOI 10.1074/jbc.M109.036467; Sun WJ, 2009, CELL SIGNAL, V21, P95, DOI 10.1016/j.cellsig.2008.09.012; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Tamura S, 2006, CANCER SCI, V97, P563, DOI 10.1111/j.1349-7006.2006.00219.x; Tanoue K, 2013, BIOCHEMISTRY-US, V52, P5830, DOI 10.1021/bi4005649; Valdez CE, 2014, ACCOUNTS CHEM RES, V47, P3110, DOI 10.1021/ar500227u; Watson GM, 2015, J MED CHEM, V58, P7707, DOI 10.1021/acs.jmedchem.5b00609; Wei XP, 2015, PLANT CELL, V27, P1113, DOI 10.1105/tpc.15.00102; Westbrook JD, 2015, BIOINFORMATICS, V31, P1274, DOI 10.1093/bioinformatics/btu789; Xiang WW, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501889; Yamaguchi H, 2006, BIOCHEMISTRY-US, V45, P13193, DOI 10.1021/bi061356b; Yoshizaki T, 2004, J BIOL CHEM, V279, P22715, DOI 10.1074/jbc.M313745200	59	13	13	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					7993	8008		10.1074/jbc.RA117.001213	http://dx.doi.org/10.1074/jbc.RA117.001213			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29602904	Green Published, hybrid			2022-12-26	WOS:000433224600007
J	Kojima, S; Iwamoto, M; Oiki, S; Tochigi, S; Takahashi, H				Kojima, Seiji; Iwamoto, Masayuki; Oiki, Shigetoshi; Tochigi, Saeko; Takahashi, Hideyuki			Thylakoid membranes contain a non-selective channel permeable to small organic molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloroplast; cyanobacteria; membrane transport; permeability; liposome; photosynthesis; CpTPOR; diffusion channel; muroplast; porin; thylakoid membrane	SULFOCYSTEINE SYNTHASE ACTIVITY; CYANOPHORA-PARADOXA CYANELLES; ESCHERICHIA-COLI; PHOTOSYSTEM-II; OUTER-MEMBRANE; CRYOELECTRON TOMOGRAPHY; ARABIDOPSIS-THALIANA; CHLOROPLAST LUMEN; PORIN CHANNELS; HIGHER-PLANTS	The thylakoid lumen is a membrane-enclosed aqueous compartment. Growing evidence indicates that the thylakoid lumen is not only a sink for protons and inorganic ions translocated during photosynthetic reactions but also a place for metabolic activities, e.g. proteolysis of photodamaged proteins, to sustain efficient photosynthesis. However, the mechanism whereby organic molecules move across the thylakoid membranes to sustain these lumenal activities is not well understood. In a recent study of Cyanophora paradoxa chloroplasts (muroplasts), we fortuitously detected a conspicuous diffusion channel activity in the thylakoid membranes. Here, using proteoliposomes reconstituted with the thylakoid membranes from muroplasts and from two other phylogenetically distinct organisms, cyanobacterium Synechocystis sp. PCC 6803 and spinach, we demonstrated the existence of nonselective channels large enough for enabling permeation of small organic compounds (e.g. carbohydrates and amino acids with M-r < 1500) in the thylakoid membranes. Moreover, we purified, identified, and characterized a muroplast channel named here CpTPOR. Osmotic swelling experiments revealed that CpTPOR forms a nonselective pore with an estimated radius of approximate to 1.3 nm. A lipid bilayer experiment showed variable-conductance channel activity with a typical single-channel conductance of 1.8 nS in 1 m KCl with infrequent closing transitions. The CpTPOR amino acid sequence was moderately similar to that of a voltage-dependent anion-selective channel of the mitochondrial outer membrane, although CpTPOR exhibited no obvious selectivity for anions and no voltage-dependent gating. We propose that transmembrane diffusion pathways are ubiquitous in the thylakoid membranes, presumably enabling rapid transfer of various metabolites between the lumen and stroma.	[Kojima, Seiji; Tochigi, Saeko] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 9808577, Japan; [Kojima, Seiji; Tochigi, Saeko; Takahashi, Hideyuki] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9808577, Japan; [Iwamoto, Masayuki; Oiki, Shigetoshi] Univ Fukui, Fac Med Sci, Dept Mol Physiol & Biophys, Fukui 9101193, Japan	Tohoku University; Tohoku University; University of Fukui	Kojima, S (corresponding author), Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Aoba Ku, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan.	skojima0801@gmail.com	Kojima, Seiji/I-8643-2017	Kojima, Seiji/0000-0002-2184-1592; Oiki, Shigetoshi/0000-0002-8438-6750; Iwamoto, Masayuki/0000-0001-9505-2652	JSPS KAKENHI [15K20860, 17K07360, 16H00759, 17H04017]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Projects 15K20860 (to S. K.), 17K07360 (to M. I.), and 16H00759 and 17H04017 (to S. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Albiniak AM, 2012, J EXP BOT, V63, P1689, DOI 10.1093/jxb/err444; Bermudez MA, 2012, PLANT PHYSIOL, V160, P274, DOI 10.1104/pp.112.201491; Bermudez MA, 2010, PLANT CELL, V22, P403, DOI 10.1105/tpc.109.071985; BOHNERT HJ, 1982, EUR J BIOCHEM, V126, P381; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Carraretto L, 2016, MOL PLANT, V9, P371, DOI 10.1016/j.molp.2015.12.004; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Engel BD, 2015, ELIFE, V4, DOI 10.7554/eLife.04889; Facchinelli F, 2013, PLANTA, V237, P637, DOI 10.1007/s00425-012-1819-3; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; Hinnah SC, 1998, EUR J BIOCHEM, V253, P606, DOI 10.1046/j.1432-1327.1998.2530606.x; Homble F, 2012, BBA-BIOMEMBRANES, V1818, P1486, DOI 10.1016/j.bbamem.2011.11.028; Imai K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-79; Iwamoto M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07048-4; Iwamoto M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09110; Jarvi S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00434; Kapri-Pardes E, 2007, PLANT CELL, V19, P1039, DOI 10.1105/tpc.106.046573; Kato Y, 2012, PLANT PHYSIOL, V159, P1428, DOI 10.1104/pp.112.199042; Kieselbach T, 2003, PHOTOSYNTH RES, V78, P249, DOI 10.1023/B:PRES.0000006913.86689.f1; Kohler D, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00559; Koike H, 2000, PHOTOSYNTH RES, V65, P207, DOI 10.1023/A:1010734912776; Koike H, 2007, PHOTOSYNTH RES, V93, P45, DOI 10.1007/s11120-007-9156-2; Kojima S, 2016, J BIOL CHEM, V291, P20198, DOI 10.1074/jbc.M116.746131; Kojima S, 2016, BIOSCI BIOTECH BIOCH, V80, P1954, DOI 10.1080/09168451.2016.1194185; Kojima S, 2013, P NATL ACAD SCI USA, V110, pE2629, DOI 10.1073/pnas.1310333110; Komenda J, 2006, J BIOL CHEM, V281, P1145, DOI 10.1074/jbc.M503852200; Konorty M, 2008, J STRUCT BIOL, V161, P393, DOI 10.1016/j.jsb.2007.09.014; MANNELLA CA, 1975, BIOCHIM BIOPHYS ACTA, V413, P213, DOI 10.1016/0005-2736(75)90105-4; Mlayeh L, 2010, BIOPHYS J, V99, P2097, DOI 10.1016/j.bpj.2010.07.067; Mullineaux CW, 2005, TRENDS PLANT SCI, V10, P521, DOI 10.1016/j.tplants.2005.09.001; NAKATANI HY, 1977, BIOCHIM BIOPHYS ACTA, V461, P510, DOI 10.1016/0005-2728(77)90237-7; Nevo R, 2007, EMBO J, V26, P1467, DOI 10.1038/sj.emboj.7601594; Nickelsen J, 2013, ANNU REV PLANT BIOL, V64, P609, DOI 10.1146/annurev-arplant-050312-120124; NIKAIDO H, 1983, J BACTERIOL, V153, P232, DOI 10.1128/JB.153.1.232-240.1983; NIKAIDO H, 1981, J GEN PHYSIOL, V77, P121, DOI 10.1085/jgp.77.2.121; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; NIKAIDO H, 1991, J BIOL CHEM, V266, P770; OMATA T, 1985, BIOCHIM BIOPHYS ACTA, V810, P354, DOI 10.1016/0005-2728(85)90221-X; Peltier JB, 2002, PLANT CELL, V14, P211, DOI 10.1105/tpc.010304; Price DC, 2012, SCIENCE, V335, P843, DOI 10.1126/science.1213561; RENKIN EM, 1954, J GEN PHYSIOL, V38, P225; Rexroth S, 2011, PLANT CELL, V23, P2379, DOI 10.1105/tpc.111.085779; Schubert M, 2002, J BIOL CHEM, V277, P8354, DOI 10.1074/jbc.M108575200; SCHULTZ SG, 1961, J GEN PHYSIOL, V44, P1189, DOI 10.1085/jgp.44.6.1189; Spetea C, 2004, P NATL ACAD SCI USA, V101, P1409, DOI 10.1073/pnas.0308164100; Spetea C, 2012, FEBS LETT, V586, P2946, DOI 10.1016/j.febslet.2012.07.005; Spetea Cornelia, 2010, Commun Integr Biol, V3, P122; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Steiner JM, 2002, TRENDS PLANT SCI, V7, P72, DOI 10.1016/S1360-1385(01)02179-3; SUGAWARA E, 1992, J BIOL CHEM, V267, P2507; Szabo I, 2017, J EXP BOT, V68, P3115, DOI 10.1093/jxb/erx063; Thuswaldner S, 2007, J BIOL CHEM, V282, P8848, DOI 10.1074/jbc.M609130200; Ting CS, 2007, J BACTERIOL, V189, P4485, DOI 10.1128/JB.01948-06; Venturoli D, 2005, AM J PHYSIOL-RENAL, V288, pF605, DOI 10.1152/ajprenal.00171.2004; Young MJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-31; Yusa F, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-304	56	4	4	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7777	7785		10.1074/jbc.RA118.002367	http://dx.doi.org/10.1074/jbc.RA118.002367			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29602906	Green Published, hybrid			2022-12-26	WOS:000437256500026
J	Fu, JX; Huang, DY; Yuan, FW; Xie, N; Li, Q; Sun, XP; Zhou, XH; Li, GD; Tong, TJ; Zhang, Y				Fu, Jingxuan; Huang, Daoyuan; Yuan, Fuwen; Xie, Nan; Li, Qian; Sun, Xinpei; Zhou, Xuehong; Li, Guodong; Tong, Tanjun; Zhang, Yu			TRAF-interacting protein with forkhead-associated domain (TIFA) transduces DNA damage-induced activation of NF-B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; NF-B transcription factor; ubiquitylation (ubiquitination); carcinogenesis; TNF receptor associated factor (TRAF); NEMO; TIFA; TRAF-interacting protein with forkhead-associated domain	KAPPA-B; CELLULAR SENESCENCE; FHA DOMAIN; BINDING; CANCER; OLIGOMERIZATION; OVEREXPRESSION; STIMULATION; FIBROBLASTS; P16(INK4A)	DNA damage-induced NF-B activation and the secretion of inflammatory cytokines play crucial roles in carcinogenesis and cellular senescence. However, the underlying mechanisms, especially the initial sensors and transducers connecting the nuclear DNA damage signal with cytoplasmic NF-B activation remain incompletely understood. Here, we report that TRAF-interacting protein with forkhead-associated domain (TIFA), an established NF-B activator in the cytosol, unexpectedly exhibited nuclear translocation and accumulation on damaged chromatin following genotoxic stress. Accordingly, we also found that DNA damage-induced transcriptional activation and the resulting secretion of classic NF-B targets, including interleukin (IL)-6 and IL-8, was greatly enhanced in TIFA-overexpressing cells compared with control cells. Mechanistically, DNA damage-induced TIFA phosphorylation at threonine 9 (pThr-9), and this phosphorylation event, involving the pThr-binding forkhead-associated domain, was crucial for its enrichment on damaged chromatin and subsequent NF-B activation. Moreover, in conjunction with its partner protein, the E3 ligase TNF receptor-associated factor 2 (TRAF2), TIFA relayed the DNA damage signals by stimulating ubiquitination of NF-B essential modulator (NEMO), whose sumoylation, phosphorylation, and ubiquitination were critical for NF-B's response to DNA damage. Consistently, TRAF2 knockdown suppressed TIFA overexpression-enhanced NEMO ubiquitination under genotoxic stress, and a unphosphorylatable Thr-9-mutated TIFA variant had only minor effects on NEMO poly-ubiquitination. Finally, in agreement with the model of DNA damage-associated secretory senescence barrier against carcinogenesis, ectopic TIFA expression limited proliferation of multiple myeloma cancer cells. In conclusion our results indicate that TIFA functions as a key transducer in DNA damage-induced NF-B activation.	[Fu, Jingxuan; Huang, Daoyuan; Yuan, Fuwen; Xie, Nan; Sun, Xinpei; Li, Guodong; Tong, Tanjun; Zhang, Yu] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Res Ctr Aging, Beijing 100191, Peoples R China; [Fu, Jingxuan; Huang, Daoyuan; Yuan, Fuwen; Xie, Nan; Sun, Xinpei; Zhou, Xuehong; Li, Guodong; Tong, Tanjun; Zhang, Yu] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China; [Li, Qian] Peking Univ, Sch & Hosp Stomatol, Natl Engn Lab Digital & Mat Technol Stomatol, Dept Orthodont,Beijing Key Lab Digital Stomatol, Beijing 100081, Peoples R China	Peking University; Peking University; Peking University	Tong, TJ; Zhang, Y (corresponding author), 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	ttj@bjmu.edu.cn; zhang_yu@hsc.pku.edu.cn	ZHOU, XUE/F-6129-2013; Yuan, Fuwen/M-4704-2019	Yuan, Fuwen/0000-0001-5764-2504	National Natural Science Foundation of China [81771495, 81300254, 81372164]; National Basic Research Programs of China [2013CB530801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Programs of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 81771495, 81300254, and 81372164 and National Basic Research Programs of China Grant 2013CB530801. The authors declare that they have no conflicts of interest with the contents of this article.	Barash U, 2014, LEUKEMIA, V28, P2178, DOI 10.1038/leu.2014.121; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Brownell J, 2013, CLIN CANCER RES, V19, P1347, DOI 10.1158/1078-0432.CCR-12-0928; Brusky J, 2000, CURR GENET, V37, P168, DOI 10.1007/s002940050515; Cao XX, 2011, J BIOL CHEM, V286, P33447, DOI 10.1074/jbc.M111.225565; Chen TD, 2012, J BIOL CHEM, V287, P37540, DOI 10.1074/jbc.M111.260679; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Duckworth C, 2016, ONCOGENE, V35, P4036, DOI 10.1038/onc.2015.472; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Ea CK, 2004, P NATL ACAD SCI USA, V101, P15318, DOI 10.1073/pnas.0404132101; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Huang CCF, 2012, MOL CELL BIOL, V32, P2664, DOI 10.1128/MCB.00438-12; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Kanamori M, 2002, BIOCHEM BIOPH RES CO, V290, P1108, DOI 10.1006/bbrc.2001.6315; Li DQ, 2012, CELL REP, V2, P1657, DOI 10.1016/j.celrep.2012.11.018; Li Q, 2013, EMBO J, V32, P858, DOI 10.1038/emboj.2013.35; Lin TY, 2016, P NATL ACAD SCI USA, V113, P15078, DOI 10.1073/pnas.1618773114; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x; Messick TE, 2009, J CELL BIOL, V187, P319, DOI 10.1083/jcb.200908074; Miyamoto S, 2011, CELL RES, V21, P116, DOI 10.1038/cr.2010.179; Pennell S, 2010, STRUCTURE, V18, P1587, DOI 10.1016/j.str.2010.09.014; Pineda G, 2007, ADV EXP MED BIOL, V597, P80; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Takatsuna H, 2003, J BIOL CHEM, V278, P12144, DOI 10.1074/jbc.M300720200; Wang W, 2001, J BIOL CHEM, V276, P48655, DOI 10.1074/jbc.M108278200; Wei TYW, 2017, CANCER RES, V77, P494, DOI 10.1158/0008-5472.CAN-16-1004; Weng JH, 2015, BIOCHEMISTRY-US, V54, P6219, DOI 10.1021/acs.biochem.5b00500; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Zhang Y, 2016, NAT GENET, V48, P1003, DOI 10.1038/ng.3635; Zhang Y, 2014, BIOCHEM BIOPH RES CO, V453, P172, DOI 10.1016/j.bbrc.2014.09.092; Zhang Y, 2011, J BIOL CHEM, V286, P42414, DOI 10.1074/jbc.M111.271064; Zhao Q, 2009, J BIOL CHEM, V284, P30424, DOI 10.1074/jbc.M109.044982	36	11	12	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7268	7280		10.1074/jbc.RA117.001684	http://dx.doi.org/10.1074/jbc.RA117.001684			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29581234	Green Published, hybrid			2022-12-26	WOS:000432174500022
J	Owen, B; Brown, AD; Kuhlberg, J; Millar, L; Nichols, M; Economos, C; Allender, S				Owen, Brynle; Brown, Andrew D.; Kuhlberg, Jill; Millar, Lynne; Nichols, Melanie; Economos, Christina; Allender, Steven			Understanding a successful obesity prevention initiative in children under 5 from a systems perspective	PLOS ONE			English	Article							INCREASING COMMUNITY CAPACITY; CHILDHOOD OBESITY; PUBLIC-HEALTH; INTERVENTION; PREVALENCE; OVERWEIGHT; DYNAMICS; SCIENCE; ROMP; IMPACT	Introduction/Background Systems thinking represents an innovative and logical approach to understanding complexity in community-based obesity prevention interventions. We report on an approach to apply systems thinking to understand the complexity of a successful obesity prevention intervention in early childhood (children aged up to 5 years) conducted in a regional city in Victoria, Australia. Methods A causal loop diagram (CLD) was developed to represent system elements related to a successful childhood obesity prevention intervention in early childhood. Key stakeholder interviews (n = 16) were examined retrospectively to generate purposive text data, create microstructures, and form a CLD. Results A CLD representing key stakeholder perceptions of a successful intervention comprised six key feedback loops explaining changes in project implementation over time. The loops described the dynamics of collaboration, network formation, community awareness, human resources, project clarity, and innovation. Conclusion The CLD developed provides a replicable means to capture, evaluate and disseminate a description of the dynamic elements of a successful obesity prevention intervention in early childhood.	[Owen, Brynle; Brown, Andrew D.; Nichols, Melanie; Allender, Steven] Deakin Univ, Sch Hlth & Social Dev, Fac Hlth, Ctr Populat Hlth Res,Global Obes Ctr GLOBE, Geelong, Vic, Australia; [Kuhlberg, Jill] North Carolina State Univ, Dept Agr & Human Sci, NC Cooperat Extens, Raleigh, NC 27695 USA; [Millar, Lynne] Victoria Univ, Australian Hlth Policy Collaborat, Melbourne, Vic, Australia; [Economos, Christina] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA	Deakin University; University of North Carolina; North Carolina State University; Victoria University; Tufts University	Brown, AD (corresponding author), Deakin Univ, Sch Hlth & Social Dev, Fac Hlth, Ctr Populat Hlth Res,Global Obes Ctr GLOBE, Geelong, Vic, Australia.	andrew.brown@deakin.edu.au	Millar, Lynne/AAD-5983-2019; Millar, Lynne/AAS-4907-2020; Brown, Andrew/W-4026-2019; Allender, Steven/G-9881-2011	Brown, Andrew/0000-0002-6385-3225; Nichols, Melanie/0000-0002-7834-5899; Allender, Steven/0000-0002-4842-3294	NHLBI NIH HHS [R01 HL115485] Funding Source: Medline; NIH HHS [1R01HL115485-01A1] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115485] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allender S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129683; Borys JM, 2016, ANN NUTR METAB, V68, P35, DOI 10.1159/000446223; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; Daw C, 2016, HEALTH PROMOT INT, V31, P375, DOI 10.1093/heapro/dau118; de Groot FP, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-522; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; de Silva-Sanigorski A, 2011, CHILD CARE HLTH DEV, V37, P385, DOI 10.1111/j.1365-2214.2010.01205.x; de Silva-Sanigorski AM, 2012, CHILD OBES, V8, P205, DOI 10.1089/chi.2011.0118; de Silva-Sanigorski AM, 2010, AM J CLIN NUTR, V91, P831, DOI 10.3945/ajcn.2009.28826; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Economos CD, 2007, OBESITY, V15, P1325, DOI 10.1038/oby.2007.155; Finegood DT, 2010, OBESITY, V18, pS13, DOI 10.1038/oby.2009.426; Hammond RA, 2009, PREV CHRONIC DIS, V6; Homer JB, 2006, AM J PUBLIC HEALTH, V96, P452, DOI 10.2105/AJPH.2005.062059; Hovmand PS, 2014, COMMUNITY BASED SYST, DOI DOI 10.1007/978-1-4614-8763-0_2; Hunt H., 2011, LOND NATL I HLTH CAR; Kim H, 2012, SYST DYNAM REV, V28, P311, DOI 10.1002/sdr.1480; Lich KH, 2013, PREV SCI, V14, P279, DOI 10.1007/s11121-012-0285-2; Luke DA, 2012, ANNU REV PUBL HEALTH, V33, P357, DOI 10.1146/annurev-publhealth-031210-101222; Mabry PL, 2013, HEALTH EDUC BEHAV, V40, p9S, DOI 10.1177/1090198113503469; McGlashan J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165459; Meadows D., 1997, WHOLE EARTH REV, V91, P78; Millar L, 2011, OBES REV, V12; Millar L, 2013, PREV MED, V56, P379, DOI 10.1016/j.ypmed.2013.02.020; Power C, 1997, INT J OBESITY RELATE, V21; Sanigorski AM, 2008, INT J OBESITY, V32, P1060, DOI 10.1038/ijo.2008.79; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Sterman JD, 2006, AM J PUBLIC HEALTH, V96, P505, DOI 10.2105/AJPH.2005.066043; Strauss A. L, 1994, HDB QUALITATIVE RES, V1st, P273, DOI DOI 10.1007/BF00988593; Strugnell C, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0127-y; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Swinburn B, 2014, PEDIATR OBES, V9, P455, DOI 10.1111/j.2047-6310.2013.00201.x; Swinburn BA, 2011, OBES REV, V12, P3, DOI 10.1111/j.1467-789X.2011.00921.x; Swinburn B, 2015, LANCET, V386, P1716, DOI 10.1016/S0140-6736(15)00722-9; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Nguyen T, 2015, J EPIDEMIOL COMMUN H, V69, P693, DOI 10.1136/jech-2014-204523; Turner BL, 2013, SYST DYNAM REV, V29, P253, DOI 10.1002/sdr.1506; Van Koperen TM, 2013, OBES REV, V14, P162, DOI 10.1111/j.1467-789X.2012.01057.x; Vandenbroeck I.P., 2007, TACKLING OBESITIES F; Wake M, 2007, INT J OBESITY, V31, P1044, DOI 10.1038/sj.ijo.0803503; Wang Y, 2013, CHILDHOOD OBES PREVE; Wheaton N, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006963	42	37	37	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195141	10.1371/journal.pone.0195141	http://dx.doi.org/10.1371/journal.pone.0195141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596488	Green Published, Green Accepted, gold			2022-12-26	WOS:000428630000085
J	Eduardo, AA; Martinez, PA; Gouveia, SF; Santos, FD; de Aragao, WS; Morales-Barbero, J; Kerber, L; Liparini, A				Eduardo, Anderson Aires; Martinez, Pablo Ariel; Gouveia, Sidney Feitosa; Santos, Franciely da Silva; de Aragao, Wilcilene Santos; Morales-Barbero, Jennifer; Kerber, Leonardo; Liparini, Alexandre			Extending the paleontology-biogeography reciprocity with SDMs: Exploring models and data in reducing fossil taxonomic uncertainty	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; LATE PLEISTOCENE; PREDICTIONS; RODENTIA; PHYLOGEOGRAPHY; CHINCHILLIDAE; DISTRIBUTIONS; EQUILIBRIUM; EXTINCTION; RESPONSES	Historically, studies aimed at prospecting and analyzing paleontological and neontological data to investigate species distribution have developed separately. Research at the interface between paleontology and biogeography has shown a unidirectional bias, mostly focusing on how paleontological information can aid biogeography to understand species distribution through time. However, the modern suit of techniques of ecological biogeography, particularly species distribution models (SDM), can be instrumental for paleontologists as well, improving the biogeography-paleontology interchange. In this study, we explore how to use paleoclimatic data and SDMs to support paleontological investigation regarding reduction of taxonomic uncertainty. Employing current data from two neotropical species (Lagostomus maximus and Myocastor coipus), we implemented SDMs and performed model validation comparing hindcasts with dated fossil occurrences (similar to 14k and similar to 20k years back present, respectively). Finally, we employed the hindcasting process for two South American fossil records of a misidentified species of caiman (Caiman sp.) to show that C. latirostris is the most likely species identity of these fossils (among four candidate species: C. latirostris, C. yacare, C. crocodilus, and Melanosuchus niger). Possible limitations of the approach are discussed. With this strategy, we have shown that current developments in biogeography research can favour paleontology, extending the (biased) current interchange between these two scientific disciplines.	[Eduardo, Anderson Aires; Martinez, Pablo Ariel; Gouveia, Sidney Feitosa; Santos, Franciely da Silva; de Aragao, Wilcilene Santos; Liparini, Alexandre] Univ Fed Sergipe, PIBiLab Lab Pesquisa Integrat Biodiversid, Integrat Res Biodivers Lab, Aracaju, State Of Sergip, Brazil; [Eduardo, Anderson Aires; Martinez, Pablo Ariel; Liparini, Alexandre] Univ Fed Sergipe, Dept Biol, Aracaju, State Of Sergip, Brazil; [Gouveia, Sidney Feitosa] Univ Fed Sergipe, Dept Ecol, Aracaju, State Of Sergip, Brazil; [Morales-Barbero, Jennifer] Univ Salamanca, Fac Biol, Unit Ecol, Salamanca, CU Miguel De Un, Spain; [Kerber, Leonardo] Univ Fed Santa Maria, CAPPA Ctr Apoio Paleontol Quarta Colonia, Sao Joao Do Polesine, State Of Rio Gr, Brazil	Universidade Federal de Sergipe; Universidade Federal de Sergipe; Universidade Federal de Sergipe; University of Salamanca; Universidade Federal de Santa Maria (UFSM)	Eduardo, AA (corresponding author), Univ Fed Sergipe, PIBiLab Lab Pesquisa Integrat Biodiversid, Integrat Res Biodivers Lab, Aracaju, State Of Sergip, Brazil.; Eduardo, AA (corresponding author), Univ Fed Sergipe, Dept Biol, Aracaju, State Of Sergip, Brazil.	andersonaed@gmail.com	Kerber, Leonardo/M-3969-2019; Kerber, Leonardo/O-3980-2017; Morales-Barbero, Jennifer/AAF-1711-2021; Gouveia, Sidney F/G-6438-2013; Liparini, Alexandre/AAE-1477-2021; Martinez, Pablo Ariel/R-9374-2017; Eduardo, Anderson/J-2928-2015	Kerber, Leonardo/0000-0001-8139-1493; Kerber, Leonardo/0000-0001-8139-1493; Gouveia, Sidney F/0000-0003-4941-7440; Liparini, Alexandre/0000-0002-9967-2311; Martinez, Pablo Ariel/0000-0002-5583-3179; Eduardo, Anderson/0000-0001-8045-8043	Fundacao de Amparo a Pesquisa e a Inovacao Tecnologica do Estado do Sergipe [0.19.203.00428/2016-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [430807/2016-3, 402469/2016-0, 431463/2016-6]	Fundacao de Amparo a Pesquisa e a Inovacao Tecnologica do Estado do Sergipe; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa e a Inovacao Tecnologica do Estado do Sergipe - URL: http://fapitec.se.gov.br/, proc. 0.19.203.00428/2016-1 (authors who received the funding: AAE AL); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - URL: http://cnpq.br/, proc. 430807/2016-3 (author who received the funding: LK); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - URL: http://cnpq.br/, proc. 402469/2016-0, (author who received the funding: SFG); and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - URL: http://cnpq.br/, proc. 431463/2016-6 (author who received the funding: PAM).	Alba-Sanchez F, 2010, DIVERS DISTRIB, V16, P214, DOI 10.1111/j.1472-4642.2010.00636.x; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Behrensmeyer Anna K., 2012, P69; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Candela Adriana M., 2004, Instituto Superior de Correlacion Geologica (INSUGEO) Miscelanea, V12, P77; Carnaval AC, 2014, P R SOC B; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Castro MC, 2014, QUATERN INT, V352, P164, DOI 10.1016/j.quaint.2014.06.038; Chapman RE, 2007, PALAEOBIOLOGY, VII, P489; Collevatti RG, 2013, J BIOGEOGR, V40, P345, DOI 10.1111/jbi.12005; Crocodile Specialist Group, 1996, IUCN RED LIST THREAT; Diniz-Filho JAF, 2013, FRONT BIOGEOGR, V26, P217; Donoghue PCJ, 2007, TRENDS ECOL EVOL, V22, P424, DOI 10.1016/j.tree.2007.05.005; Elith J, 2002, ECOL MODEL, V157, P313, DOI 10.1016/S0304-3800(02)00202-8; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fortier DC, 2013, QUATERN INT, V305, P141, DOI 10.1016/j.quaint.2012.03.018; Franca LD, 2014, QUATERN INT, V352, P159, DOI 10.1016/j.quaint.2014.06.046; Fritz SA, 2013, TRENDS ECOL EVOL, V28, P509, DOI 10.1016/j.tree.2013.05.004; Hadler Patrica, 2008, REVISTA BRASILEIRA DE PALEONTOLOGIA, V11, P97; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2016, PACKAGE DISMO, P67; HOLZ M, 1994, PALAEOGEOGR PALAEOCL, V107, P179, DOI 10.1016/0031-0182(94)90170-8; Jackson John E., 1996, Mammalian Species, V543, P1; Kerber L, 2014, QUATERN INT, V352, P147, DOI 10.1016/j.quaint.2013.11.022; Kerber L, 2011, REV BRAS PALEONTOLOG, V14, P229, DOI 10.4072/rbp.2011.3.03; Langston W., 1965, FOSSIL CROCODILIANS; Liaw A., 2015, PACKAGE RANDOMFOREST; Lima-Ribeiro MS, 2012, NAT CONSERVACAO, V10, P145, DOI 10.4322/natcon.2012.022; Maguire KC, 2015, ANNU REV ECOL EVOL S, V46, P343, DOI 10.1146/annurev-ecolsys-112414-054441; Maiorano L, 2013, GLOBAL ECOL BIOGEOGR, V22, P302, DOI 10.1111/j.1466-8238.2012.00767.x; MCCULLAGH P, 1984, EUR J OPER RES, V16, P285, DOI 10.1016/0377-2217(84)90282-0; McCulloch RD, 2000, J QUATERNARY SCI, V15, P409, DOI 10.1002/1099-1417(200005)15:4<409::AID-JQS539>3.0.CO;2-#; McGuire JL, 2013, J BIOGEOGR, V40, P1490, DOI 10.1111/jbi.12106; Morales-Barbero J, 2017, ECOGRAPHY; Nogues-Bravo D, 2008, PLOS BIOL, V6, P685, DOI 10.1371/journal.pbio.0060079; Nogues-Bravo D, 2009, GLOBAL ECOL BIOGEOGR, V18, P521, DOI 10.1111/j.1466-8238.2009.00476.x; Ojeda R, 2013, IUCN RED LIST THREAT; Patton James L., 2015, P733; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peterson JE, 2014, PEERJ, V2, DOI 10.7717/peerj.347; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pimiento C, 2016, J BIOGEOGR, V43, P1645, DOI 10.1111/jbi.12754; Ramirez-Barahona S, 2013, ECOL EVOL, V3, P725, DOI 10.1002/ece3.483; Regan HM, 2002, ECOL APPL, V12, P618, DOI 10.2307/3060967; Roach N., 2016, IUCN RED LIST THREAT; Ross J.P., 2000, IUCN RED LIST THREAT; Singarayer JS, 2010, QUATERNARY SCI REV, V29, P43, DOI 10.1016/j.quascirev.2009.10.011; Stoklosa J, 2015, METHODS ECOL EVOL, V6, P412, DOI 10.1111/2041-210X.12217; Taberlet P, 2002, SCIENCE, V297, P2009, DOI 10.1126/science.297.5589.2009; Thorbjarnarson J., 1992, CROCODILES ACTION PL; Ubilla M, 2016, ALCHERINGA, V40, P354, DOI 10.1080/03115518.2016.1145466; Varela S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129037; Varela S, 2014, ECOGRAPHY, V37, P1084, DOI 10.1111/j.1600-0587.2013.00441.x; Varela S, 2011, PALAEOGEOGR PALAEOCL, V310, P451, DOI 10.1016/j.palaeo.2011.07.021; Varela S, 2010, QUATERNARY SCI REV, V29, P2027, DOI 10.1016/j.quascirev.2010.04.017; Varela S, 2009, J BIOGEOGR, V36, P1645, DOI 10.1111/j.1365-2699.2009.02125.x; Venegas-Anaya M, 2008, J EXP ZOOL PART A, V309A, P614, DOI 10.1002/jez.502; Wilkinson David M., 2012, P9; Williams JW, 2013, GLOBAL ECOL BIOGEOGR, V22, P289, DOI 10.1111/j.1466-8238.2012.00760.x; Willis KJ, 2000, SCIENCE, V287, P1406, DOI 10.1126/science.287.5457.1406; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004; Yannic G, 2012, BIOL J LINN SOC, V105, P864, DOI 10.1111/j.1095-8312.2011.01824.x	69	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194725	10.1371/journal.pone.0194725	http://dx.doi.org/10.1371/journal.pone.0194725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590174	Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100072
J	Heerfordt, IM; Torsnes, LR; Philipsen, PA; Wulf, HC				Heerfordt, Ida M.; Torsnes, Linnea R.; Philipsen, Peter A.; Wulf, Hans Christian			Sunscreen use optimized by two consecutive applications	PLOS ONE			English	Article							SUN-PROTECTION FACTOR; SKIN; PHOTOPROTECTION; PREVENTION; THICKNESS; HOLIDAY; BEACH	Sunscreen users are often inadequately protected and become sunburned. This study aimed to investigate how much two consecutive sunscreen applications increased the quantity of sunscreen applied and decreased the skin area left without sunscreen (missed area) compared to a single application. Thirty-one healthy volunteers wearing swimwear were included and applied sunscreen two consecutive times in a laboratory environment. Participants had pictures taken in black light before and after each application. As sunscreens absorb black light, the darkness of the skin increased with increasing amounts of sunscreen applied. We conducted a standard curve establishing a link between change in picture darkness and quantity of sunscreen. The quantity of sunscreen at selected skin sites as well as the percentage of missed area was determined after each application. Participants had missed a median of 20% of their available body surface after a single application. After double application they had missed 9%. The decrease in missed areas was significant for the whole body surface and for each of the body regions separately. The median participant had applied between 13% and 100% more sunscreen at the selected skin sites after double application than after single application. We recommend double application, especially before intense sun exposure.	[Heerfordt, Ida M.; Torsnes, Linnea R.; Philipsen, Peter A.; Wulf, Hans Christian] Univ Copenhagen, Bispebjerg Hosp, Dept Dermatol, Nv Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital	Heerfordt, IM (corresponding author), Univ Copenhagen, Bispebjerg Hosp, Dept Dermatol, Nv Copenhagen, Denmark.	ida.marie.heerfordt@regionh.dk	Heerfordt, Ida M./AAS-3890-2020	Heerfordt, Ida M./0000-0002-6130-875X; Philipsen, Peter Alshede/0000-0002-9656-733X	Bispebjerg Hospital	Bispebjerg Hospital	Galderma A/S provided sunscreen for the study but had no additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Except for this, the study was funded solely by Bispebjerg Hospital.	AUGUSTSSON A, 1992, ACTA DERM-VENEREOL, V72, P123; Azurdia RM, 1999, BRIT J DERMATOL, V140, P255; Bauer U, 2010, PHOTOCHEM PHOTOBIOL, V86, P1397, DOI 10.1111/j.1751-1097.2010.00816.x; BECHTHOMSEN N, 1993, PHOTODERMATOL PHOTO, V9, P242; Bodekaer M, 2008, PHOTODERMATOL PHOTO, V24, P296, DOI 10.1111/j.1600-0781.2008.00379.x; De Villa D, 2011, PHOTOCHEM PHOTOBIOL, V87, P457, DOI 10.1111/j.1751-1097.2010.00856.x; Faurschou A, 2007, BRIT J DERMATOL, V156, P716, DOI 10.1111/j.1365-2133.2006.07684.x; Gaughan MD, 1998, ARCH DERMATOL, V134, P515, DOI 10.1001/archderm.134.4.515; Green A, 1999, LANCET, V354, P723, DOI 10.1016/S0140-6736(98)12168-2; Heerfordt IM, 2018, PUBLIC HEALTH, V155, P88, DOI 10.1016/j.puhe.2017.11.018; Heerfordt IM, 2018, PHOTODERMATOL PHOTO, V34, P117, DOI 10.1111/phpp.12373; Heerfordt IM, 2017, ACTA DERM-VENEREOL, V97, P1202, DOI 10.2340/00015555-2772; Jeanmougin M, 2014, PHOTODERMATOL PHOTO, V30, P323, DOI 10.1111/phpp.12138; Kim SM, 2010, J AM ACAD DERMATOL, V62, P218, DOI 10.1016/j.jaad.2009.06.047; Lademann J, 2004, J Cosmet Dermatol, V3, P62, DOI 10.1111/j.1473-2130.2004.00107.x; Lautenschlager S, 2007, LANCET, V370, P528, DOI 10.1016/S0140-6736(07)60638-2; LYNFIELD YL, 1984, J AM ACAD DERMATOL, V10, P56, DOI 10.1016/S0190-9622(84)80043-2; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; ODIO MR, 1994, PHOTODERMATOL PHOTO, V10, P118; Ouyang H, 2018, J DRUGS DERMATOL, V17, P116; Petersen B, 2014, PHOTODERMATOL PHOTO, V30, P96, DOI 10.1111/phpp.12099; Petersen B, 2013, PHOTODERMATOL PHOTO, V29, P221, DOI 10.1111/phpp.12048; Petersen B, 2013, PHOTOCH PHOTOBIO SCI, V12, P190, DOI 10.1039/c2pp25127b; Pruim B, 1999, Australas J Dermatol, V40, P14, DOI 10.1046/j.1440-0960.1999.00309.x; Rhodes LE, 1997, BRIT J DERMATOL, V136, P12, DOI 10.1046/j.1365-2133.1997.d01-1135.x; Teramura T, 2012, CLIN EXP DERMATOL, V37, P904, DOI 10.1111/j.1365-2230.2012.04388.x; Ulrich C, 2009, BRIT J DERMATOL, V161, P78, DOI 10.1111/j.1365-2133.2009.09453.x; Verheugen G., 2006, OFFICIAL J EUR UNION, V265, P39; Wulf HC, 1997, PHOTODERMATOL PHOTO, V13, P129, DOI 10.1111/j.1600-0781.1997.tb00215.x	29	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193916	10.1371/journal.pone.0193916	http://dx.doi.org/10.1371/journal.pone.0193916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590142	gold, Green Published			2022-12-26	WOS:000428603100037
J	Lindquist, C; Bjorndall, B; Rossmann, CR; Svardal, A; Hallstrom, S; Berge, RK				Lindquist, Carine; Bjorndall, Bodil; Rossmann, Christine Renate; Svardal, Asbjorn; Hallstroem, Seth; Berge, Rolf Kristian			A fatty acid analogue targeting mitochondria exerts a plasma triacylglycerol lowering effect in rats with impaired carnitine biosynthesis	PLOS ONE			English	Article							BUTYROBETAINE HYDROXYLASE INHIBITOR; METABOLIC SYNDROME; LIVER-DISEASE; CARDIOVASCULAR-DISEASE; EICOSAPENTAENOIC ACID; ENDOPLASMIC-RETICULUM; UNCOUPLING PROTEINS; BETA-OXIDATION; MALONYL-COA; MILDRONATE	L-carnitine is important for the catabolism of long-chain fatty acids in the mitochondria. We investigated how the triacylglycerol (TAG)-lowering drug 2-(tridec-12-yn-1-ylthio)acetic acid (1-triple TTA) influenced lipid metabolism in carnitine-depleted, 3-(2,2,2-trimethylhydrazinium)propionate dehydrate (Mildronate; meldonium)-treated male Wistar rats. As indicated, carnitine biosynthesis was impaired by Mildronate. However, TAG levels of both plasma and liver were decreased by 1-triple TTA in Mildronate-treated animals. This was accompanied by increased gene expression of proteins involved in mitochondrial activity and proliferation and reduced mRNA levels of Dgat2, ApoB and ApoCIII in liver. The hepatic energy state was reduced in the group of Mildronate and 1-triple TTA as reflected by increased AMP/ATP ratio, reduced energy charge and induced gene expression of uncoupling proteins 2 and 3. The increase in mitochondrial fatty acid oxidation was observed despite low plasma carnitine levels, and was linked to strongly induced gene expression of carnitine acetyltransferase, translocase and carnitine transporter, suggesting an efficient carnitine turnover. The present data suggest that the plasma TAG-lowering effect of 1-triple TTA in Mildronate-treated rats is not only due to increased mitochondrial fatty acid oxidation reflected by increased mitochondrial biogenesis, but also to changes in plasma clearance and reduced TAG biosynthesis.	[Lindquist, Carine; Bjorndall, Bodil; Svardal, Asbjorn; Berge, Rolf Kristian] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Lindquist, Carine; Berge, Rolf Kristian] Haukeland Hosp, Dept Heart Dis, Bergen, Norway; [Rossmann, Christine Renate; Hallstroem, Seth] Med Univ Graz, Inst Physiol Chem, Graz, Austria	University of Bergen; University of Bergen; Haukeland University Hospital; Medical University of Graz	Lindquist, C; Berge, RK (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.; Lindquist, C; Berge, RK (corresponding author), Haukeland Hosp, Dept Heart Dis, Bergen, Norway.	carine.lindquist@uib.no; rolf.berge@uib.no		Rossmann, Christine/0000-0002-1791-1981	Bergen Research Foundation; Western Norway Regional Health Authority [911945]	Bergen Research Foundation; Western Norway Regional Health Authority	This work was financially supported by the Bergen Research Foundation and Western Norway Regional Health Authority (911945) to CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELINI C, 1992, CRIT REV CL LAB SCI, V29, P217, DOI 10.3109/10408369209114601; BATES EJ, 1977, FEBS LETT, V84, P229, DOI 10.1016/0014-5793(77)80694-7; BERGE RK, 1984, EUR J BIOCHEM, V141, P637, DOI 10.1111/j.1432-1033.1984.tb08239.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; BREMER J, 1981, BIOCHIM BIOPHYS ACTA, V665, P628, DOI 10.1016/0005-2760(81)90282-4; Bruce Alberts A. J., 2007, MOL BIOL CELL; Cannon B, 2006, BBA-BIOENERGETICS, V1757, P449, DOI 10.1016/j.bbabio.2006.05.016; Cao JS, 2007, J LIPID RES, V48, P583, DOI 10.1194/jlr.M600331-JLR200; DAAE LNW, 1970, BIOCHIM BIOPHYS ACTA, V210, P92; Dambrova M, 2002, TRENDS CARDIOVAS MED, V12, P275, DOI 10.1016/S1050-1738(02)00175-5; Dambrova M, 2016, PHARMACOL RES, V113, P771, DOI 10.1016/j.phrs.2016.01.019; Del Ben M, 2012, INTERN EMERG MED, V7, pS291, DOI 10.1007/s11739-012-0819-4; Du ZY, 2013, BBA-MOL CELL BIOL L, V1831, P291, DOI 10.1016/j.bbalip.2012.10.002; Du ZY, 2010, BBA-MOL CELL BIOL L, V1801, P526, DOI 10.1016/j.bbalip.2010.01.002; El-Hattab AW, 2015, MOL GENET METAB, V116, P107, DOI 10.1016/j.ymgme.2015.09.004; Fisher RA, 1935, DESIGN EXPT, Vxi; FURST W, 1992, J CHROMATOGR-BIOMED, V578, P39, DOI 10.1016/0378-4347(92)80222-C; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Grigat S, 2009, DRUG METAB DISPOS, V37, P330, DOI 10.1124/dmd.108.023929; Grube M, 2011, AM J PATHOL, V178, P2547, DOI 10.1016/j.ajpath.2011.02.020; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hallstrom S, 2002, CIRCULATION, V105, P3032, DOI 10.1161/01.CIR.0000018745.11739.9B; Harchaoui KEL, 2009, CURR CARDIOL REV, V5, P216, DOI 10.2174/157340309788970315; Hayashi Y, 2000, BIOL PHARM BULL, V23, P770; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; KIM YS, 1978, ARCH BIOCHEM BIOPHYS, V190, P585, DOI 10.1016/0003-9861(78)90314-4; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Kuka J, 2012, J CARDIOVASC PHARM T, V17, P215, DOI 10.1177/1074248411419502; LaBrecque DR, 2014, J CLIN GASTROENTEROL, V48, P467, DOI 10.1097/MCG.0000000000000116; Liemburg-Apers DC, 2015, ARCH TOXICOL, V89, P1209, DOI 10.1007/s00204-015-1520-y; Lindquist C, 2017, J LIPID RES, V58, P1362, DOI 10.1194/jlr.M074849; Madsen L, 1999, LIPIDS, V34, P951, DOI 10.1007/s11745-999-0445-x; Madsen L, 1998, J LIPID RES, V39, P583; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Nishimura Masuhiro, 2005, Drug Metab Pharmacokinet, V20, P452, DOI 10.2133/dmpk.20.452; Oppedisano F, 2008, J BIOCHEM MOL TOXIC, V22, P8, DOI 10.1002/jbt.20208; Paschos P, 2009, HIPPOKRATIA, V13, P9; Pelzmann B, 2003, BRIT J PHARMACOL, V139, P749, DOI 10.1038/sj.bjp.0705300; Pessayre D, 2005, J HEPATOL, V42, P928, DOI 10.1016/j.jhep.2005.03.004; PONS R, 1995, J CHILD NEUROL, V10, pS2, DOI 10.1177/0883073895010002S03; RAAKA BM, 1979, J BIOL CHEM, V254, P6755; REBOUCHE CJ, 1980, BIOCHIM BIOPHYS ACTA, V630, P22, DOI 10.1016/0304-4165(80)90133-6; Reuter SE, 2012, CLIN PHARMACOKINET, V51, P553, DOI 10.2165/11633940-000000000-00000; Roncari D A, 1981, Methods Enzymol, V71 Pt C, P73; ROSEKAHN G, 1985, J BIOL CHEM, V260, P8411; SIMKHOVICH BZ, 1988, BIOCHEM PHARMACOL, V37, P195, DOI 10.1016/0006-2952(88)90717-4; Sjakste N, 2005, CNS DRUG REV, V11, P151; SMALL GM, 1985, BIOCHEM J, V227, P205, DOI 10.1042/bj2270205; Souza-Mello V, 2015, WORLD J HEPATOL, V7, P1012, DOI 10.4254/wjh.v7.i8.1012; Spaniol M, 2001, EUR J BIOCHEM, V268, P1876, DOI 10.1046/j.1432-1327.2001.02065.x; SRERE PA, 1963, ACTA CHEM SCAND, V17, P129, DOI 10.3891/acta.chem.scand.17s-0129; Stadlmann S, 2006, CELL BIOCHEM BIOPHYS, V44, P179, DOI 10.1385/CBB:44:2:179; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Tanabe T, 1981, Methods Enzymol, V71 Pt C, P5; URBANIAK GC, 2013, RES RANDOMIZER; Vaz FM, 2002, BIOCHEM J, V361, P417, DOI 10.1042/0264-6021:3610417; Vernez L, 2004, RAPID COMMUN MASS SP, V18, P1233, DOI 10.1002/rcm.1470; Vigerust NF, 2012, FERTIL STERIL, V98, P1620, DOI 10.1016/j.fertnstert.2012.08.024; Wei YZ, 2008, WORLD J GASTROENTERO, V14, P193, DOI 10.3748/wjg.14.193; WILLUMSEN N, 1993, J LIPID RES, V34, P13	64	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194978	10.1371/journal.pone.0194978	http://dx.doi.org/10.1371/journal.pone.0194978			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590220	Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100093
J	Ortiz-Perea, N; Gander, R; Abbey, O; Callaghan, A				Ortiz-Perea, Natali; Gander, Rebecca; Abbey, Oliver; Callaghan, Amanda			The effect of pond dyes on oviposition and survival in wild UK Culex mosquitoes	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; WEST-NILE-VIRUS; CONTAINER SIZE; CULICIDAE; BEHAVIOR; COLOR; TRAP; CONSERVATION; TEMPERATURE; ALBOPICTUS	British Culex pipiens complex [Culex pipiens sensu lato) mosquito distribution, abundance, and potential for disease transmission are intimately linked to their environment. Pond and lake dyes that block light to restrict algal photosynthesis are a relatively new product assumed to be an environmentally friendly since they are based on food dyes. Their use in urban garden ponds raises questions linked to mosquito oviposition, since coloured water can be an attractant. Culex (mostly pipiens) is commonly found in UK gardens and is a potential vector of viruses including the West Nile Virus (WNV). Any factors that significantly change the distribution and population of Cx pipiens could impact future risks of disease transmission. A gravid trap was used to catch female Cx pipiens mosquitoes for use in oviposition choice tests in laboratory and semi-field conditions. Two types of pond dye, blue and shadow (which looks slightly red), were tested for their impact on oviposition and survival of wild caught Cx pipiens. There were no significant differences in the number of egg batches laid when gravid mosquitoes were given a choice between either blue dye and clear water or shadow dye and clear water indicating that these dyes are not attractants. Larvae hatched from egg batches laid by wild-caught gravid females were used to measure survival to adulthood with or without dye, in a habitat controlled to prevent further colonisation. The experiment was run twice, once in the summer and again in the autumn, whereas the dyes had no impact on emergence in the summer, there were highly significant reductions in emergence of adults in both dye treated habitats in the autumn. Containers with or without shadow dye were placed outside to colonise naturally and were sampled weekly for larvae and pupae over a 6 month period through summer and autumn. There was a significant negative effect of shadow dye on pupal abundance in a three week period over the summer, but otherwise there was no effect. It is likely that population abundance and food was a more powerful factor for mosquito survival than the dye.	[Ortiz-Perea, Natali; Gander, Rebecca; Abbey, Oliver; Callaghan, Amanda] Univ Reading, Sch Biol Sci, Ecol & Evolutionary Biol Sect, Reading, Berks, England	University of Reading	Callaghan, A (corresponding author), Univ Reading, Sch Biol Sci, Ecol & Evolutionary Biol Sect, Reading, Berks, England.	a.callaghan@reading.ac.uk			Colciencias: Department of Science, Technology and Innovation	Colciencias: Department of Science, Technology and Innovation	This research was funded by a scholarship to Natali Ortiz-Perea from Colciencias: Department of Science, Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dyofix provided the dyes but had no part in any aspect of the research design, aim, analysis or conclusion.	[Anonymous], 1992, BIOL MOSQUITOES DEV; Barbosa RMR, 2007, MEM I OSWALDO CRUZ, V102, P523, DOI 10.1590/S0074-02762007005000058; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Boyd C. E., 1982, N AM J FISH MANAGE, V2, P193; Brustolin M, 2016, MED VET ENTOMOL, V30, P166, DOI 10.1111/mve.12164; BUGLEWICZ E G, 1977, Transactions of the Nebraska Academy of Sciences, V4, P23; Collins LE, 2000, J VECTOR ECOL, V25, P127; Couret J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087468; Davies ZG, 2009, BIOL CONSERV, V142, P761, DOI 10.1016/j.biocon.2008.12.016; Day JF, 2016, INSECTS, V7, DOI 10.3390/insects7040065; Dhileepan K, 1997, ENVIRON ENTOMOL, V26, P318, DOI 10.1093/ee/26.2.318; DyoFix, DYOFIX LAK PONDS COL; DyoFix, 2016, DYOFIX PROD FAQS 201; DyoFix, DYOFIX LAK POND COL; Hamer GL, 2011, J AM MOSQUITO CONTR, V27, P142, DOI 10.2987/10-6090.1; Harrington LC, 2008, VECTOR-BORNE ZOONOT, V8, P415, DOI 10.1089/vbz.2007.0203; Hill MJ, 2014, FUND APPL LIMNOL, V185, P107, DOI 10.1127/fal/2014/0612; Hoel DF, 2011, J AM MOSQUITO CONTR, V27, P245, DOI 10.2987/11-6121.1; Huang J, 2007, PHYSIOL ENTOMOL, V32, P34, DOI 10.1111/j.1365-3032.2006.00538.x; Hunter MR, 2008, INSECT CONSERV DIVER, V1, P189, DOI 10.1111/j.1752-4598.2008.00024.x; KENNEDY JOHN S., 1942, BULL ENT RES, V32, P279, DOI 10.1017/S0007485300017235; Li J, 2009, J AGR URBAN ENTOMOL, V26, P23, DOI 10.3954/1523-5475-26.1.23; Marinho RA, 2016, J VECTOR ECOL, V41, P1, DOI 10.1111/jvec.12187; Medlock JM, 2005, MED VET ENTOMOL, V19, P2, DOI 10.1111/j.0269-283X.2005.00547.x; Oliva LO, 2014, J INSECT BEHAV, V27, P81, DOI 10.1007/s10905-013-9407-3; Panigrahi SK, 2014, J INSECTS; Costa EAPD, 2010, REV BRAS ENTOMOL, V54, P488, DOI 10.1590/S0085-56262010000300021; Perea NO, 2017, PEERJ, V5, DOI 10.7717/peerj.3361; R Development Core T, 2015, R 3 2 2 R PROJ STAT; Reiskind MH, 2012, J MED ENTOMOL, V49, P71, DOI 10.1603/ME10270; Reiter P, 2008, REV SCI TECH OIE, V27, P383, DOI 10.20506/rst.27.2.1804; REITER P, 1987, J AM MOSQUITO CONTR, V3, P325; Rizzoli A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0831-4; Snow Keith, 2006, European Mosquito Bulletin, V21, P1; SPENCER DF, 1984, J AQUAT PLANT MANAGE, V22, P80; Tew KS, 2003, IMPACTS ALGAL CONTRO; Torrisi GJ, 2013, NORTHEAST NAT, V20, P363, DOI 10.1656/045.020.0211; Townroe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095325; Vezzani D, 2005, ACTA TROP, V95, P123, DOI 10.1016/j.actatropica.2005.03.010; WILLIAMS RE, 1962, J PARASITOL, V48, P919, DOI 10.2307/3275123	40	6	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193847	10.1371/journal.pone.0193847	http://dx.doi.org/10.1371/journal.pone.0193847			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590133	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100035
J	Weech, S; Moon, J; Troje, NF				Weech, Seamas; Moon, Jae; Troje, Nikolaus F.			Influence of bone-conducted vibration on simulator sickness in virtual reality	PLOS ONE			English	Article							GALVANIC VESTIBULAR STIMULATION; EVOKED MYOGENIC POTENTIALS; MOTION SICKNESS; POSTURAL INSTABILITY; DRIVING SIMULATOR; CYBERSICKNESS; ENVIRONMENTS; SENSITIVITY; RESPONSES; EXPOSURE	Use of virtual reality (VR) technology is often accompanied by a series of unwanted symptoms, including nausea and headache, which are characterised as 'simulator sickness'. Sensory mismatch has been thought to lie at the heart of the problem and recent studies have shown that reducing cue mismatch in VR can have a therapeutic effect. Specifically, electrical stimulation of vestibular afferent nerves (galvanic vestibular stimulation; GVS) can reduce simulator sickness in VR. However, GVS poses a risk to certain populations and can also result in negative symptoms in normal, healthy individuals. Here, we tested whether noisy vestibular stimulation through bone-vibration can also reduce symptoms of simulator sickness. We carried out two experiments in which participants performed a spatial navigation task in VR and completed the Simulator Sickness Questionnaire over a series of trials. Experiment 1 was conducted using a high-end projection-based VR display, whereas Experiment 2 involved the use of a consumer head mounted display. During each trial, vestibular stimulation was either: 1) absent; 2) coupled with large angular accelerations of the projection camera; or 3) applied randomly throughout each trial. In half of the trials, participants actively navigated using a motion controller, and in the other half they were moved passively through the environment along pre-recorded motion trajectories. In both experiments we obtained lower simulator sickness scores when vestibular stimulation was coupled with angular accelerations of the camera. This effect was obtained for both active and passive movement control conditions, which did not differ. The results suggest that noisy vestibular stimulation can reduce simulator sickness, and that this effect appears to generalize across VR conditions. We propose further examination of this stimulation technique.	[Weech, Seamas; Troje, Nikolaus F.] Queens Univ, Dept Psychol, Kingston, ON, Canada; [Moon, Jae; Troje, Nikolaus F.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada; [Troje, Nikolaus F.] Queens Univ, Dept Biol, Kingston, ON, Canada; [Troje, Nikolaus F.] Queens Univ, Sch Comp, Kingston, ON, Canada; [Weech, Seamas] Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada; [Moon, Jae] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada; Queens University - Canada; University of Waterloo; University of Toronto	Weech, S (corresponding author), Queens Univ, Dept Psychol, Kingston, ON, Canada.; Weech, S (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada.	sweech@uwaterloo.ca	Troje, Niko/F-1107-2010	Weech, Seamas/0000-0003-2333-3505; Troje, Niko/0000-0002-1533-2847	Natural Sciences and Engineering Research Council of Canada (NSERC) [298198-11-388699]; NSERC Collaborative Research and Training Experience Grant [575375]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Collaborative Research and Training Experience Grant	This work was funded by Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC, grant number 298198-11-388699, URL: http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp) awarded to NFT, and an NSERC Collaborative Research and Training Experience Grant (grant number 575375, URL: www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/CREATE-FONCER_eng.asp) awarded to NFT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aykent B, 2014, P I MECH ENG D-J AUT, V228, P818, DOI 10.1177/0954407013516101; Bozgeyikli E, 2016, CHI PLAY 2016: PROCEEDINGS OF THE 2016 ANNUAL SYMPOSIUM ON COMPUTER-HUMAN INTERACTION IN PLAY, P205, DOI 10.1145/2967934.2968105; Cevette MJ, 2012, AVIAT SPACE ENVIR MD, V83, P549, DOI 10.3357/ASEM.3239.2012; Chara J., 2017, INTEGRATING LANDSCAP, V1st, P1; Curry R., 2002, P DRIV SIM C; Curthoys IS, 2012, ACTA OTORHINOLARYNGO, V32, P41; Curthoys IS, 2014, CLIN EXP PHARMACOL P, V41, P371, DOI 10.1111/1440-1681.12222; Curthoys Ian S, 2012, Front Neurol, V3, P117, DOI 10.3389/fneur.2012.00117; Dennison MS, 2017, APPL ERGON, V58, P215, DOI 10.1016/j.apergo.2016.06.014; Dong X, 2011, J EXP PSYCHOL-APPL, V17, P128, DOI 10.1037/a0024097; Dorado JL, 2014, 3D US INT 3DUI 2014; Duh HBL, 2004, HUM FACTORS, V46, P142, DOI 10.1518/hfes.46.1.142.30384; Dziuda L, 2014, APPL ERGON, V45, P406, DOI 10.1016/j.apergo.2013.05.003; Eisenman LM, 2009, MED HYPOTHESES, V73, P790, DOI 10.1016/j.mehy.2009.04.031; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Flanagan MB, 2004, J VESTIBUL RES-EQUIL, V14, P335; Galvez-Garcia G, 2015, HUM FACTORS, V57, P649, DOI 10.1177/0018720814554948; Gibson J.J., 1966, SENSES CONSIDERED PE; Gibson JJ, 1950, PERCEPTION VISUAL WO; Greenlee MW, 2016, MULTISENS RES, V29, P525, DOI 10.1163/22134808-00002527; Kennedy R. S., 1993, INT J AVIAT PSYCHOL, V3, P203; Kennedy RS, 2000, PRESENCE-TELEOP VIRT, V9, P463, DOI 10.1162/105474600566952; Keshavarz B, 2011, HUM FACTORS, V53, P415, DOI 10.1177/0018720811403736; Kluver M, 2016, TRANSPORT RES F-TRAF, V37, P78, DOI 10.1016/j.trf.2015.12.005; Kluver M, 2015, P DRIV SIM C; Kolasinski EM, 1995, 1027 ARI; La Viola J. J.  Jr., 2000, SIGCHI Bulletin, V32, P47, DOI 10.1145/333329.333344; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Lawson BD, 2001, P 72 ANN M AER MED A; Lenggenhager B, 2008, EXP BRAIN RES, V184, P211, DOI 10.1007/s00221-007-1095-9; Lin JJW, 2002, P IEEE VIRT REAL ANN, P164, DOI 10.1109/VR.2002.996519; McCauley M., 2006, DO ARMY HELICOPTER T; Min BC, 2004, APPL ERGON, V35, P549, DOI 10.1016/j.apergo.2004.06.002; Money K. E., 1990, MOTION SPACE SICKNES, P1; Munafo J, 2017, EXP BRAIN RES, V235, P889, DOI 10.1007/s00221-016-4846-7; Park JR, 2008, INT J NEUROSCI, V118, P857, DOI 10.1080/00207450701239459; Reason JT., 1975, MOTION SICKNESS; Rebenitsch L, 2016, VIRTUAL REAL-LONDON, V20, P101, DOI 10.1007/s10055-016-0285-9; Reed-Jones RJ, 2007, P 4 INT DRIV S HUM F, P534, DOI [10.17077/drivingassessment.1288, DOI 10.17077/DRIVINGASSESSMENT.1288]; RICCIO G E, 1991, Ecological Psychology, V3, P195, DOI 10.1207/s15326969eco0303_2; Riecke B. E., 2006, 7 INT MULT RES FOR I; ROLNICK A, 1991, ERGONOMICS, V34, P867, DOI 10.1080/00140139108964831; Rosengren SM, 2005, CLIN NEUROPHYSIOL, V116, P1938, DOI 10.1016/j.clinph.2005.03.019; Roston GP, 1997, IEEE INT CONF ROBOT, P3006, DOI 10.1109/ROBOT.1997.606744; Sadiq O, 2017, BALANCE CONTROL MOTI; Sheykholeslami K, 2000, ACTA OTO-LARYNGOL, V120, P731; Sheykholeslami K, 2001, HEARING RES, V160, P58, DOI 10.1016/S0378-5955(01)00333-1; Stanney KM, 2009, HUM FACTORS ERGON, P293; Stanney KM, 1998, PRESENCE-TELEOP VIRT, V7, P447, DOI 10.1162/105474698565848; Stanney KM, 1997, PROCEEDINGS OF THE HUMAN FACTORS AND ERGONOMICS SOCIETY 41ST ANNUAL MEETING, 1997, VOLS 1 AND 2, P1138, DOI 10.1177/107118139704100292; Stanney KM, 1999, APPL ERGON, V30, P27, DOI 10.1016/S0003-6870(98)00039-8; Todd NPM, 2000, HEARING RES, V141, P180, DOI 10.1016/S0378-5955(99)00222-1; TREISMAN M, 1977, SCIENCE, V197, P493, DOI 10.1126/science.301659; Utz KS, 2011, BRAIN INJURY, V25, P1058, DOI 10.3109/02699052.2011.607789; Weech S, 2017, MULTISENS RES, V30, P65, DOI 10.1163/22134808-00002545; Zao JK, 2016, LECT NOTES ARTIF INT, V9743, P121, DOI 10.1007/978-3-319-39955-3_12	56	46	46	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194137	10.1371/journal.pone.0194137	http://dx.doi.org/10.1371/journal.pone.0194137			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590147	Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100049
J	Ma, J; Saghatelian, A; Shokhirev, MN				Ma, Jiao; Saghatelian, Alan; Shokhirev, Maxim Nikolaievich			The influence of transcript assembly on the proteogenomics discovery of microproteins	PLOS ONE			English	Article							RNA-SEQ; PEPTIDES; GENOME; RECONSTRUCTION; REVEALS; MUSCLE; CELLS	Proteogenomics methods have identified many non-annotated protein-coding genes in the human genome. Many of the newly discovered protein-coding genes encode peptides and small proteins, referred to collectively as microproteins. Microproteins are produced through ribosome translation of small open reading frames (smORFs). The discovery of many smORFs reveals a blind spot in traditional gene-finding algorithms for these genes. Biological studies have found roles for microproteins in cell biology and physiology, and the potential that there exists additional bioactive microproteins drives the interest in detection and discovery of these molecules. A key step in any proteogenomics workflow is the assembly of RNA-Seq data into likely mRNA transcripts that are then used to create a searchable protein database. Here we demonstrate that specific features of the assembled transcriptome impact microprotein detection by shotgun proteomics. By tailoring transcript assembly for downstream mass spectrometry searching, we show that we can detect more than double the number of high-quality microprotein candidates and introduce a novel open-source mRNA assembler for proteogenomics (MAPS) that incorporates all of these features. By integrating our specialized assembler, MAPS, and a popular generalized assembler into our proteogenomics pipeline, we detect 45 novel human microproteins from a high quality proteogenomics dataset of a human cell line. We then characterize the features of the novel microproteins, identifying two classes of microproteins. Our work highlights the importance of specialized transcriptome assembly upstream of proteomics validation when searching for short and potentially rare and poorly conserved proteins.	[Ma, Jiao; Saghatelian, Alan; Shokhirev, Maxim Nikolaievich] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Shokhirev, Maxim Nikolaievich] Salk Inst Biol Studies, Razavi Newman Integrat Genom & Bioinformat Core, La Jolla, CA 92037 USA	Salk Institute; Salk Institute	Shokhirev, MN (corresponding author), Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Shokhirev, MN (corresponding author), Salk Inst Biol Studies, Razavi Newman Integrat Genom & Bioinformat Core, La Jolla, CA 92037 USA.	mshokhirev@salk.edu			Razavi Newman Integrative Genomics and Bioinformatics Core and Next Generation Sequencing Core Facilities of the Salk Institute [NIH-NCICCSG:P30 014195]; Chapman Foundation; Helmsley Charitable Trust; Larry Hillblom Foundation; NIH [R01 GM102491]; NCI Cancer Center Support Grant P30 [CA014195 MASS core]; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; Mary K. Chapman Foundation; Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102491] Funding Source: NIH RePORTER	Razavi Newman Integrative Genomics and Bioinformatics Core and Next Generation Sequencing Core Facilities of the Salk Institute; Chapman Foundation; Helmsley Charitable Trust; Larry Hillblom Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Support Grant P30; Leona M. and Harry B. Helmsley Charitable Trust; Mary K. Chapman Foundation; Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work and M. N. Shokhirev were supported by the Razavi Newman Integrative Genomics and Bioinformatics Core and Next Generation Sequencing Core Facilities of the Salk Institute with funding from NIH-NCICCSG:P30 014195, the Chapman Foundation and the Helmsley Charitable Trust. We thank M. Ku (Next Generation Sequencing Core) for performing RNA-Seq, J. K. Diedrich (Mass Spectrometry Core) for performing mass spectrometry, and Thomas Martinez, Arko Sen, and Hsiuyi Chen for helpful suggestions. J. Ma is supported by Larry Hillblom Foundation Fellowship Grant, A. Saghatelian is supported by NIH (R01 GM102491), the NCI Cancer Center Support Grant P30 (CA014195 MASS core), The Leona M. and Harry B. Helmsley Charitable Trust grant (#2012-PG-MED002), Mary K. Chapman Foundation, and Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaj1460; Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Aspden JL, 2014, ELIFE, V3, DOI 10.7554/eLife.03528; D'Lima NG, 2016, NATURE CHEM BIOL; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Frith MC, 2006, PLOS GENET, V2, P515, DOI 10.1371/journal.pgen.0020052; Galindo MI, 2007, PLOS BIOL, V5, P1052, DOI 10.1371/journal.pbio.0050106; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griebel T, 2012, NUCLEIC ACIDS RES, V40, P10073, DOI 10.1093/nar/gks666; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee C, 2015, CELL METAB, V21, P443, DOI 10.1016/j.cmet.2015.02.009; Lin D, 2003, BBA-PROTEINS PROTEOM, V1646, P1, DOI 10.1016/S1570-9639(02)00546-0; Ma J, 2016, ANAL CHEM, V88, P3967, DOI 10.1021/acs.analchem.6b00191; Ma J, 2014, J PROTEOME RES, V13, P1757, DOI 10.1021/pr401280w; Magny EG, 2013, SCIENCE, V341, P1116, DOI 10.1126/science.1238802; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nelson BR, 2016, SCIENCE, V351, P271, DOI 10.1126/science.aad4076; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Pueyo JI, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002395; Pueyo JI, 2008, DEV BIOL, V324, P192, DOI 10.1016/j.ydbio.2008.08.025; Slavoff SA, 2013, NAT CHEM BIOL, V9, P59, DOI [10.1038/NCHEMBIO.1120, 10.1038/nchembio.1120]; Steijger T, 2013, NAT METHODS, V10, P1177, DOI [10.1038/nmeth.2714, 10.1038/NMETH.2714]; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vanderperre B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070698; Vanderperre B, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas025; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Xu T, 2015, J PROTEOMICS, V129, P16, DOI 10.1016/j.jprot.2015.07.001; Yates JR, 1996, J AM SOC MASS SPECTR, V7, P1089, DOI 10.1016/S1044-0305(96)00079-7	33	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194518	10.1371/journal.pone.0194518	http://dx.doi.org/10.1371/journal.pone.0194518			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584760	Green Submitted, gold, Green Published			2022-12-26	WOS:000428373000026
J	Legione, AR; Amery-Gale, J; Lynch, M; Haynes, L; Gilkerson, JR; Sansom, FM; Devlin, JM				Legione, Alistair R.; Amery-Gale, Jemima; Lynch, Michael; Haynes, Leesa; Gilkerson, James R.; Sansom, Fiona M.; Devlin, Joanne M.			Variation in the microbiome of the urogenital tract of Chlamydia-free female koalas (Phascolarctos cinereus) with and without 'wet bottom'	PLOS ONE			English	Article							VICTORIAN KOALAS; DISEASE; PREVALENCE; INFECTION; SEQUENCES; DATABASE; ISLAND; TOOL	Koalas (Phascolarctos cinereus) are iconic Australian marsupials currently threatened by several processes, including infectious diseases and ecological disruption. Infection with Chlamydia pecorum, is considered a key driver of population decline. The clinical sign of 'wet bottom', a staining of the rump associated with urinary incontinence, is often caused by chlamydial urinary tract infections. However, wet bottom has been recorded in koalas free of C. pecorum, suggesting other causative agents in those individuals. We used 16S rRNA diversity profiling to investigate the microbiome of the urogenital tract of ten female koalas in order to identify potential causative agents of wet bottom, other than C. pecorum. Five urogenital samples were processed from koalas presenting with wet bottom and five were clinically normal. All koalas were negative for C. pecorum infection. We detected thirteen phyla across the ten samples, with Firmicutes occurring at the highest relative abundance (77.6%). The order Lactobacillales, within the Firmicutes, comprised 70.3% of the reads from all samples. After normalising reads using DESeq2 and testing for significant differences (P<0.05), there were 25 operational taxonomic units (OTUs) more commonly found in one group over the other. The families Aerococcaceae and Tissierellaceae both had four significantly differentially abundant OTUs. These four Tissierellaceae OTUs were all significantly more abundant in koalas with wet bottom. This study provides the foundation for future investigations of causes of koala wet bottom, other than C. pecorum infection. This is of clinical relevance as wet bottom is often assumed to be caused by C. pecorum and treated accordingly. Our research highlights that other organisms may be causing wet bottom, and these potential aetiological agents need to be further investigated to fully address the problems this species faces.	[Legione, Alistair R.; Amery-Gale, Jemima; Sansom, Fiona M.; Devlin, Joanne M.] Univ Melbourne, Asia Pacific Ctr Anim Hlth, Parkville, Vic, Australia; [Lynch, Michael] Melbourne Zoo, Vet Dept, Parkville, Vic, Australia; [Haynes, Leesa] Univ Melbourne, Fac Vet & Agr Sci, Werribee, Vic, Australia; [Gilkerson, James R.] Univ Melbourne, Ctr Equine Infect Dis, Parkville, Vic, Australia	University of Melbourne; University of Melbourne; University of Melbourne	Legione, AR (corresponding author), Univ Melbourne, Asia Pacific Ctr Anim Hlth, Parkville, Vic, Australia.	legionea@unimelb.edu.au	Sansom, Fiona M/W-8445-2019; Legione, Alistair/AAX-6064-2020	Legione, Alistair/0000-0003-2407-4496; Gilkerson, James/0000-0003-1801-4817; Devlin, Joanne/0000-0003-0400-9670; Sansom, Fiona/0000-0002-9433-2545	Holsworth Wildlife Research Endowment [HOLSW2015-1-F052]; Australian Postgraduate Award scholarship	Holsworth Wildlife Research Endowment; Australian Postgraduate Award scholarship	The research was supported by a grant from the Holsworth Wildlife Research Endowment (HOLSW2015-1-F052) (https://equitytrustees.smartygrants.com.au/holsworth). Alistair Legione was supported by an Australian Postgraduate Award scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano N, 2015, SCI REP-UK, V5, DOI 10.1038/srep10189; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Barker CJ, 2013, VET MICROBIOL, V167, P554, DOI 10.1016/j.vetmic.2013.08.025; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; BROWN AS, 1987, AUST VET J, V64, P346, DOI 10.1111/j.1751-0813.1987.tb06064.x; BROWN AS, 1984, AUST VET J, V61, P413, DOI 10.1111/j.1751-0813.1984.tb07182.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CHAO A, 1984, SCAND J STAT, V11, P265; Chhour KL, 2008, MICROBIOL-SGM, V154, P1535, DOI 10.1099/mic.0.2007/014803-0; Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276; CUNNINGHAM FG, 1978, OBSTET GYNECOL, V52, P161; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dickens RK, 1976, REFRESHER COURSE VET, V29; Edgar RC, 2015, BIOINFORMATICS, V31, P3476, DOI 10.1093/bioinformatics/btv401; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ezaki T, 2001, INT J SYST EVOL MICR, V51, P1521, DOI 10.1099/00207713-51-4-1521; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Griffith J., 2010, THESIS; Handasyde, 1999, KOALA NATURAL HIST C; Illumina, 2015, 16S MET SEQ LIB PREP; Legione AR, 2017, J MED MICROBIOL, V66, P236, DOI 10.1099/jmm.0.000416; Legione AR, 2016, J MED MICROBIOL, V65, P420, DOI 10.1099/jmm.0.000241; Legione AR, 2016, J WILDLIFE DIS, V52, P426, DOI 10.7589/2015-10-276; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MADSEN M, 1990, VET MICROBIOL, V22, P319, DOI 10.1016/0378-1135(90)90018-Q; Markey B, 2007, VET MICROBIOL, V120, P334, DOI 10.1016/j.vetmic.2006.11.022; Marschner C, 2014, AUST VET J, V92, P177, DOI 10.1111/avj.12167; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; NHMRC, 2013, AUSTR COD CAR US AN, V8th; Patterson JLS, 2015, J WILDLIFE DIS, V51, P309, DOI 10.7589/2014-07-176; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Robertson T, 2009, J APPL MICROBIOL, V107, P2017, DOI 10.1111/j.1365-2672.2009.04388.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Vidgen ME, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05454-2; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347; Zhou X, 2007, ISME J, V1, P121, DOI 10.1038/ismej.2007.12	44	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194881	10.1371/journal.pone.0194881	http://dx.doi.org/10.1371/journal.pone.0194881			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579080	Green Published, gold, Green Submitted			2022-12-26	WOS:000428351800064
J	Sauvagel, V; Boizeau, L; Candotti, D; Vandenbogaert, M; Servant-Delmas, A; Carol, V; Laperche, S				Sauvagel, Virginie; Boizeau, Laure; Candotti, Daniel; Vandenbogaert, Mathias; Servant-Delmas, Annabelle; Carol, Valerie; Laperche, Syria			Early MinION (TM) nanopore single-molecule sequencing technology enables the characterization of hepatitis B virus genetic complexity in clinical samples	PLOS ONE			English	Article							BLOOD-DONORS; REAL-TIME; BACTERIAL; GENOMES; IDENTIFICATION; GENOTYPES; VARIANTS	Until recently, the method of choice to characterize viral diversity consisted in cloning PCR amplicons of full-length viral genomes and Sanger-sequencing of multiple clones. However, this is extremely laborious, time-consuming, and low-throughput. Next generation short read sequencing appears also limited by its inability to directly sequence full-length viral genomes. The MinIONTM device recently developed by Oxford Nanopore Technologies can be a promising alternative by applying long-read single-molecule sequencing directly to the overall amplified products generated in a PCR reaction. This new technology was evaluated by using hepatitis B virus (HBV) as a model. Several previously characterized HBV-infected clinical samples were investigated including recombinant virus, variants that harbored deletions and mixed population. Original MinION device was able to generate individual complete 3,200-nt HBV genome sequences and to identify recombinant variants. MinION was particularly efficient in detecting HBV genomes with multiple large in-frame deletions and spliced variants concomitantly with non-deleted parental genomes. However, an average 12% sequencing error rate per individual reads associated to a low throughput challenged single-nucleotide resolution, polymorphism calling and phasing mutations directly from the sequencing reads. Despite this high error rate, the pairwise identity of MinION HBV consensus genome was consistent with Sanger sequencing method. MinION being under continuous development, further studies are needed to evaluate its potential use for viral infection characterization.	[Sauvagel, Virginie; Boizeau, Laure; Candotti, Daniel; Servant-Delmas, Annabelle; Laperche, Syria] INTS, Dept Etud Agents Transmissibles Sang, Ctr Natl Reference Risques Infectieux Transfus, Paris, France; [Vandenbogaert, Mathias; Carol, Valerie] Inst Pasteur, Genotyping Pathogens Pole, Lab Urgent Response Biol Threats Environm & Infec, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Sauvagel, V (corresponding author), INTS, Dept Etud Agents Transmissibles Sang, Ctr Natl Reference Risques Infectieux Transfus, Paris, France.	vsauvage@ints.fr		Sauvage, Virginie/0000-0003-0054-1109; Vandenbogaert, Mathias/0000-0002-3073-9688				Araujo NM, 2015, INFECT GENET EVOL, V36, P500, DOI 10.1016/j.meegid.2015.08.024; Ashton PM, 2015, NAT BIOTECHNOL, V33, P296, DOI 10.1038/nbt.3103; Benitez-Paez A, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0111-z; Betz-Stablein BD, 2016, J VIROL, V90, P7171, DOI 10.1128/JVI.00243-16; Candotti D, 2015, OCCULT HEPATITIS B I, P90; Candotti D, 2016, J MED VIROL, V88, P2145, DOI 10.1002/jmv.24589; Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238; Croagh CMN, 2015, WORLD J HEPATOL, V7, P289, DOI 10.4254/wjh.v7.i3.289; Echevarria JM, 2006, J MED VIROL, V78, pS36, DOI 10.1002/jmv.20605; Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9; GUNTHER S, 1995, J VIROL, V69, P5437; Gunther S, 1999, ADV VIRUS RES, V52, P25, DOI 10.1016/S0065-3527(08)60298-5; Harris RS, 2007, THESIS, DOI [10.5555/1414852, DOI 10.5555/1414852]; Hoenen T, 2016, EMERG INFECT DIS, V22, P331, DOI 10.3201/eid2202.151796; Houldcroft CJ, 2017, NAT REV MICROBIOL, V15, P183, DOI 10.1038/nrmicro.2016.182; Huang DW, 2016, J DATA MINING GENOMI, V7; Ip Camilla L C, 2015, F1000Res, V4, P1075, DOI 10.12688/f1000research.7201.1; Jain Miten, 2017, F1000Res, V6, P760, DOI 10.12688/f1000research.11354.1; Jansen HJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07650-6; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Kilianski A, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0051-z; Kramvis A, 2014, INTERVIROLOGY, V57, P141, DOI 10.1159/000360947; Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/NMETH.3444, 10.1038/nmeth.3444]; Magi A, 2017, BRIEF BIOINFORM; Nowak MA, 1996, P NATL ACAD SCI USA, V93, P4398, DOI 10.1073/pnas.93.9.4398; Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066; Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996; Quinones-Mateu ME, 2014, J CLIN VIROL, V61, P9, DOI 10.1016/j.jcv.2014.06.013; Rhoads A, 2015, GENOM PROTEOM BIOINF, V13, P278, DOI 10.1016/j.gpb.2015.08.002; Sauvage V, 2016, TRANSFUS CLIN BIOL, V23, P28, DOI 10.1016/j.tracli.2015.12.002; Schultz AK, 2012, NUCLEIC ACIDS RES, V40, pW193, DOI 10.1093/nar/gks414; Servant-Delmas A, 2010, TRANSFUSION, V50, P2607, DOI 10.1111/j.1537-2995.2010.02725.x; Sommer G, 2008, FRONT BIOSCI-LANDMRK, V13, P5533; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tong SP, 2016, J HEPATOL, V64, pS4, DOI 10.1016/j.jhep.2016.01.027; Wang J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00766; Zook JM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.25	37	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194366	10.1371/journal.pone.0194366	http://dx.doi.org/10.1371/journal.pone.0194366			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566006	gold, Green Published, Green Submitted			2022-12-26	WOS:000428093900057
J	Herrou, J; Czyz, DM; Fiebig, A; Willett, JW; Kim, Y; Wu, RY; Babnigg, G; Crosson, S				Herrou, Julien; Czyz, Daniel M.; Fiebig, Aretha; Willett, Jonathan W.; Kim, Youngchang; Wu, Ruiying; Babnigg, Gyorgy; Crosson, Sean			Molecular control of gene expression by Brucella BaaR, an IclR-type transcriptional repressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcription factor; gene regulation; fatty acid metabolism; metabolism; bacteria; adipic acid; aminocaproic acid; Brucella; caprolactone; IclR	INTRAMOLECULAR SIGNAL TRANSMISSION; EPSILON-AMINOCAPROIC ACID; ACYL-COA DEHYDROGENASES; STRESS-RESPONSE SYSTEM; SP STRAIN ADP1; STREPTOMYCES-COELICOLOR; ESCHERICHIA-COLI; CORYNEBACTERIUM-GLUTAMICUM; AGROBACTERIUM-TUMEFACIENS; TARGETED MUTAGENESIS	The general stress response sigma factor sigma(E1) directly and indirectly regulates the transcription of dozens of genes that influence stress survival and host infection in the zoonotic pathogen Brucella abortus. Characterizing the functions of sigma(E1)-regulated genes therefore would contribute to our understanding of B. abortus physiology and infection biology. sigma(E1) indirectly activates transcription of the IclR family regulator Bab2_0215, but the function of this regulator remains undefined. Here, we present a structural and functional characterization of Bab2_0215, which we have named Brucella adipic acid-activated regulator (BaaR). We found that BaaR adopts a classic IclR-family fold and directly represses the transcription of two operons with predicted roles in carboxylic acid oxidation. BaaR binds two sites on chromosome II between baaR and a divergently transcribed hydratase/dehydrogenase (acaD2), and it represses transcription of both genes. We identified three carboxylic acids (adipic acid, tetradecanedioic acid, and E-aminocaproic acid) and a lactone (E-caprolactone) that enhance transcription from the baaR and acaD2 promoters. However, neither the activating acids nor caprolactone enhanced transcription by binding directly to BaaR. Induction of baaR transcription by adipic acid required the gene bab2_0213, which encodes a major facilitator superfamily transporter, suggesting that Bab2_0213 transports adipic acid across the inner membrane. We conclude that a suite of structurally related organic molecules activate transcription of genes repressed by BaaR. Our study provides molecular-level understanding of a gene expression program in B. abortus that is downstream of sigma(E1).	[Herrou, Julien; Czyz, Daniel M.; Willett, Jonathan W.; Crosson, Sean] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA; [Crosson, Sean] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Herrou, Julien; Czyz, Daniel M.; Fiebig, Aretha; Willett, Jonathan W.; Crosson, Sean] Univ Chicago, Howard Taylor Ricketts Lab, Argonne, IL 60439 USA; [Kim, Youngchang; Wu, Ruiying; Babnigg, Gyorgy] Argonne Natl Lab, 9700 S Cass Ave, Argonne, IL 60439 USA	University of Chicago; University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory	Crosson, S (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.; Crosson, S (corresponding author), Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.; Crosson, S (corresponding author), Univ Chicago, Howard Taylor Ricketts Lab, Argonne, IL 60439 USA.	scrosson@uchicago.edu	Crosson, Sean/AAE-2453-2022; Czyz, Daniel/GSE-1859-2022	Crosson, Sean/0000-0002-1727-322X; Fiebig, Aretha/0000-0002-0612-5029; Kim, Youngchang/0000-0002-1610-4889; Czyz, Daniel/0000-0002-7491-5292; Herrou, Julien/0000-0002-8585-8043	National Institutes of Health from NIAID [U19AI107792, R01AI107159]; National Institutes of Health Ruth Kirschstein Postdoctoral Fellowship [F32GM109661]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI107792, R01AI107159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM109661] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health Ruth Kirschstein Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants U19AI107792 and R01AI107159 from NIAID (to S. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Ruth Kirschstein Postdoctoral Fellowship F32GM109661.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aguilar C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092920; ALKJAERSIG N, 1959, J BIOL CHEM, V234, P832; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Atluri VL, 2011, ANNU REV MICROBIOL, V65, P523, DOI 10.1146/annurev-micro-090110-102905; Aune K, 2012, J WILDLIFE MANAGE, V76, P253, DOI 10.1002/jwmg.274; Baric RS, 2016, MBIO, V7, DOI 10.1128/mBio.01245-16; Batut J, 2004, NAT REV MICROBIOL, V2, P933, DOI 10.1038/nrmicro1044; Berg J. M., 2012, BIOCHEMISTRY-US, P912; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brooks AN, 2011, WIRES SYST BIOL MED, V3, P544, DOI 10.1002/wsbm.136; Brune I, 2007, J BACTERIOL, V189, P2720, DOI 10.1128/JB.01876-06; Chao HJ, 2013, J BACTERIOL, V195, P1598, DOI 10.1128/JB.02216-12; Cooksley CM, 2012, METAB ENG, V14, P630, DOI 10.1016/j.ymben.2012.09.001; CORTAY JC, 1991, EMBO J, V10, P675, DOI 10.1002/j.1460-2075.1991.tb07996.x; Dotreppe D, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-257; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Esikova TZ, 2015, MICROBIOLOGY+, V84, P726, DOI 10.1134/S0026261715050070; Fillet S, 2011, P NATL ACAD SCI USA, V108, P15372, DOI 10.1073/pnas.1018894108; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fischer R, 2008, MICROBIOL-SGM, V154, P3095, DOI 10.1099/mic.0.2008/016907-0; Fujita Y, 2007, MOL MICROBIOL, V66, P829, DOI 10.1111/j.1365-2958.2007.05947.x; GERHARDT P, 1950, J BACTERIOL, V59, P777, DOI 10.1128/JB.59.6.777-782.1950; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; GRIFFIN JD, 1978, SEMIN THROMB HEMOST, V5, P27; Guazzaroni MAE, 2005, J BIOL CHEM, V280, P20887, DOI 10.1074/jbc.M500783200; Gui LZ, 1996, J BACTERIOL, V178, P321, DOI 10.1128/jb.178.1.321-324.1996; Haine V, 2005, INFECT IMMUN, V73, P5578, DOI 10.1128/IAI.73.9.5578-5586.2005; Hasegawa A, 2008, MICROBIOL-SGM, V154, P3366, DOI 10.1099/mic.0.2008/020016-0; Heider J, 2001, FEBS LETT, V509, P345, DOI 10.1016/S0014-5793(01)03178-7; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Herrou J, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00746-16; Herrou J, 2016, J BACTERIOL, V198, P1281, DOI 10.1128/JB.00982-15; Holden HM, 2001, ACCOUNTS CHEM RES, V34, P145, DOI 10.1021/ar000053l; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jiang H, 2000, J BACTERIOL, V182, P5521, DOI 10.1128/JB.182.19.5521-5529.2000; KATAGIRI M, 1957, J BIOL CHEM, V226, P439; Kim HS, 2014, MOL MICROBIOL, V94, P913, DOI 10.1111/mmi.12809; Kim HS, 2013, J BIOL CHEM, V288, P13906, DOI 10.1074/jbc.M113.459305; Kim JN, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1311-0; Kim J, 2007, MOL MICROBIOL, V64, P165, DOI 10.1111/j.1365-2958.2007.05646.x; Kim JJP, 2004, EUR J BIOCHEM, V271, P483, DOI 10.1046/j.1432-1033.2003.03948.x; Kim SH, 2012, J BACTERIOL, V194, P6837, DOI 10.1128/JB.00695-12; Krell T, 2006, PROTEIN SCI, V15, P1207, DOI 10.1110/ps.051857206; Lamontagne J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-300; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li QM, 2016, RSC ADV, V6, P54661, DOI 10.1039/c6ra07733a; Liu TG, 2010, ANNU REV GENET, V44, P53, DOI 10.1146/annurev-genet-102209-163440; Lorca GL, 2007, J BIOL CHEM, V282, P16476, DOI 10.1074/jbc.M610838200; Lu D, 2010, GENE DEV, V24, P2556, DOI 10.1101/gad.603510; Lu Y, 2011, J BACTERIOL, V193, P6674, DOI 10.1128/JB.05714-11; MARES F, 1978, IND ENG CHEM PROC DD, V17, P9, DOI 10.1021/i260065a003; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Molina-Henares AJ, 2006, FEMS MICROBIOL REV, V30, P157, DOI 10.1111/j.1574-6976.2005.00008.x; Molina-Santiago C, 2014, J BACTERIOL, V196, P588, DOI 10.1128/JB.00589-13; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson D. L., 2013, LEHNINGER PRINCIPLES, P650; Nomura K, 1998, P NATL ACAD SCI USA, V95, P14034, DOI 10.1073/pnas.95.24.14034; Pan Y, 2013, MICROBIOL-SGM, V159, P814, DOI 10.1099/mic.0.065680-0; PARALES RE, 1993, J BACTERIOL, V175, P5829, DOI 10.1128/JB.175.18.5829-5838.1993; Parke D, 2001, APPL ENVIRON MICROB, V67, P4817, DOI 10.1128/AEM.67.10.4817-4827.2001; Rojas A, 2003, J BACTERIOL, V185, P4755, DOI 10.1128/JB.185.16.4755-4763.2003; Rowe SE, 2016, METHODS MOL BIOL, V1373, P155, DOI 10.1007/7651_2015_277; Santamarta I, 2007, MOL MICROBIOL, V66, P511, DOI 10.1111/j.1365-2958.2007.05937.x; Shimizu T, 2014, MICROBIOL-SGM, V160, P623, DOI 10.1099/mic.0.074286-0; Sisson AL, 2013, POLYMER, V54, P4333, DOI 10.1016/j.polymer.2013.04.045; Slabinski L, 2007, BIOINFORMATICS, V23, P3403, DOI 10.1093/bioinformatics/btm477; Stuani L, 2014, METABOLOMICS, V10, P1223, DOI 10.1007/s11306-014-0662-x; Sycz G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124058; Teran W, 2007, MOL MICROBIOL, V66, P1416, DOI 10.1111/j.1365-2958.2007.06004.x; Traag BA, 2004, MOL MICROBIOL, V53, P985, DOI 10.1111/j.1365-2958.2004.04186.x; Trautwein G, 2001, J BACTERIOL, V183, P873, DOI 10.1128/JB.183.3.873-881.2001; Tropel D, 2004, MICROBIOL MOL BIOL R, V68, P474, DOI 10.1128/MMBR.68.3.474-500.2004; Vesely M, 2007, APPL MICROBIOL BIOT, V76, P159, DOI 10.1007/s00253-007-0997-6; WAKIL SJ, 1954, J BIOL CHEM, V207, P631; Walker JR, 2006, J MOL BIOL, V358, P810, DOI 10.1016/j.jmb.2006.02.034; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; Willett JW, 2016, VACCINE, V34, P5073, DOI 10.1016/j.vaccine.2016.08.076; Williams PA, 1997, J BACTERIOL, V179, P5935, DOI 10.1128/jb.179.18.5935-5942.1997; WILLIAMS SG, 1993, MOL MICROBIOL, V9, P751, DOI 10.1111/j.1365-2958.1993.tb01735.x; Yang YH, 2009, APPL MICROBIOL BIOT, V82, P501, DOI 10.1007/s00253-008-1802-x; Zhang HB, 2002, P NATL ACAD SCI USA, V99, P4638, DOI 10.1073/pnas.022056699; Zhang RG, 2002, J BIOL CHEM, V277, P19183, DOI 10.1074/jbc.M112171200; Zhou YX, 2012, CELL SIGNAL, V24, P1270, DOI 10.1016/j.cellsig.2012.02.008	85	3	3	5	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7437	7456		10.1074/jbc.RA118.002045	http://dx.doi.org/10.1074/jbc.RA118.002045			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29567835	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000432174500035
J	Parizi, KB; Akin, D; Wong, HSP				Parizi, Kokab B.; Akin, Demir; Wong, H. -S. Philip			Internalization of subcellular-scale microfabricated chips by healthy and cancer cells	PLOS ONE			English	Article							SILICON CHIPS; LIVING CELLS; SIZE; NANOFABRICATION; PHAGOCYTOSIS; POLYSILICON; PARTICLES; BARCODES; TRACKING; SYSTEM	Continuous monitoring of physiological parameters inside a living cell will lead to major advances in our understanding of biology and complex diseases, such as cancer. It also enables the development of new medical diagnostics and therapeutics. Progress in nano-fabrication and wireless communication has opened up the potential of making a wireless chip small enough that it can be wholly inserted into a living cell. To investigate how such chips could be internalized into various types of living single cells and how this process might affect cells' physiology, we designed and fabricated a series of multilayered micron-scale tag structures with different sizes as potential RFID (Radio Frequency IDentification) cell trackers. While the present structures are test structures that do not resonate, the tags that do resonate have similar structure from device fabrication, material properties, and device size point of view. The structures are in four different sizes, the largest with the lateral dimension of 9 mu m x 21 mu m. The thickness for these structures is kept constant at 1.5 mu m. We demonstrate successful delivery of our fabricated chips into various types of living cells, such as melanoma skin cancer, breast cancer, colon cancer and healthy/normal fibroblast skin cells. To our surprise, we observed a remarkable internalization rate difference between each cell type; the uptake rate was faster for more aggressive cancer cells than the normal/healthy cells. Cell viability before and after tag cellular internalization and persistence of the internalized tags have also been recorded over the course of five days of incubation. These results establish the foundations of the possibility of long term, wireless, intracellular physiological signal monitoring.	[Parizi, Kokab B.; Wong, H. -S. Philip] Stanford Univ, Sch Engn, Dept Elect Engn, Stanford, CA 94305 USA; [Akin, Demir] Stanford Univ, Sch Med, Dept Radiol, Ctr Canc Nanotechnol Excellence, Stanford, CA 94305 USA	Stanford University; Stanford University	Parizi, KB (corresponding author), Stanford Univ, Sch Engn, Dept Elect Engn, Stanford, CA 94305 USA.	kokab@alumni.stanford.edu	Akin, Demir/D-3581-2012	Akin, Demir/0000-0002-2296-4674	Stanford Bio-X Seed Grant; Center for Cancer Nanotechnology Excellence at Stanford through National Cancer Institute (NCI) of the National Institutes of Health (NIH) [U54 CM 99075]; ARRA from the National Center for Research Resources (NCRR) [1S10RR026780-01]; NATIONAL CANCER INSTITUTE [U54CA199075] Funding Source: NIH RePORTER	Stanford Bio-X Seed Grant; Center for Cancer Nanotechnology Excellence at Stanford through National Cancer Institute (NCI) of the National Institutes of Health (NIH); ARRA from the National Center for Research Resources (NCRR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by Stanford Bio-X Seed Grant (there is no grant number). The website is: https://biox.stanford.edu/. It was also supported partially by the Center for Cancer Nanotechnology Excellence at Stanford through an award (U54 CM 99075) from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) and finally it was supported in part by ARRA award number 1S10RR026780-01 from the National Center for Research Resources (NCRR). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NCRR or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betancourt T, 2006, INT J NANOMED, V1, P483, DOI 10.2147/nano.2006.1.4.483; Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103; Champion JA, 2008, PHARM RES-DORDR, V25, P1815, DOI 10.1007/s11095-008-9562-y; Chen LY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02295; Chen Y, 2001, ELECTROPHORESIS, V22, P187, DOI 10.1002/1522-2683(200101)22:2<187::AID-ELPS187>3.0.CO;2-0; Cunin F, 2002, NAT MATER, V1, P39, DOI 10.1038/nmat702; Fernandez-Rosas E, 2010, BIOMED MICRODEVICES, V12, P371, DOI 10.1007/s10544-009-9393-6; Fernandez-Rosas E, 2009, SMALL, V5, P2433, DOI 10.1002/smll.200900733; French PJ, 2002, SENSOR ACTUAT A-PHYS, V99, P3, DOI 10.1016/S0924-4247(01)00876-7; Gomez-Martinez R, 2013, NAT NANOTECHNOL, V8, P517, DOI [10.1038/NNANO.2013.118, 10.1038/nnano.2013.118]; Gomez-Martinez R, 2010, SMALL, V6, P499, DOI 10.1002/smll.200901041; Gonzalez O, 1996, J BIOMED MATER RES, V30, P463, DOI 10.1002/(SICI)1097-4636(199604)30:4<463::AID-JBM4>3.3.CO;2-I; Han MY, 2001, NAT BIOTECHNOL, V19, P631, DOI 10.1038/90228; Ho JS, 2014, P NATL ACAD SCI USA, V111, P7974, DOI 10.1073/pnas.1403002111; Hu X, 2015, MICROTAS, P25; Hu XL, 2017, PHYS REV APPL, V8, DOI 10.1103/PhysRevApplied.8.014031; McCarthy JR, 2006, SMALL, V2, P983, DOI 10.1002/smll.200600139; Molleman A., 2003, PATCH CLAMPING INTRO; Novo S, 2011, HUM REPROD, V26, P96, DOI 10.1093/humrep/deq309; Rogers WJ, 2006, NAT CLIN PRACT CARD, V3, P554, DOI 10.1038/ncpcardio0659; SAKMANN B, 1984, ANNU REV PHYSIOL, V46, P455, DOI 10.1146/annurev.ph.46.030184.002323; Tasciotti E, 2008, NAT NANOTECHNOL, V3, P151, DOI 10.1038/nnano.2008.34; Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616; Whitesides GM, 2003, NAT BIOTECHNOL, V21, P1161, DOI 10.1038/nbt872; Wightman RM, 2006, SCIENCE, V311, P1570, DOI 10.1126/science.1120027; Wilhelm C, 2008, BIOMATERIALS, V29, P3161, DOI 10.1016/j.biomaterials.2008.04.016	26	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0194712	10.1371/journal.pone.0194712	http://dx.doi.org/10.1371/journal.pone.0194712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601607	gold, Green Published, Green Submitted			2022-12-26	WOS:000428845900009
J	Bagloee, SA; Sarvi, M				Bagloee, Saeed Asadi; Sarvi, Majid			An outer approximation method for the road network design problem	PLOS ONE			English	Article							GLOBAL OPTIMIZATION METHOD; BENDERS DECOMPOSITION; ALGORITHM; EQUILIBRIUM; MODELS; INFRASTRUCTURE; PROJECTS	Best investment in the road infrastructure or the network design is perceived as a fundamental and benchmark problem in transportation. Given a set of candidate road projects with associated costs, finding the best subset with respect to a limited budget is known as a bilevel Discrete Network Design Problem (DNDP) of NP-hard computationally complexity. We engage with the complexity with a hybrid exact-heuristic methodology based on a two-stage relaxation as follows: (i) the bilevel feature is relaxed to a single-level problem by taking the network performance function of the upper level into the user equilibrium traffic assignment problem (UE-TAP) in the lower level as a constraint. It results in a mixed-integer nonlinear programming (MINLP) problem which is then solved using the Outer Approximation (OA) algorithm (ii) we further relax the multi-commodity UE-TAP to a single-commodity MILP problem, that is, the multiple OD pairs are aggregated to a single OD pair. This methodology has two main advantages: (i) the method is proven to be highly efficient to solve the DNDP for a large-sized network of Winnipeg, Canada. The results suggest that within a limited number of iterations (as termination criterion), global optimum solutions are quickly reached in most of the cases; otherwise, good solutions (close to global optimum solutions) are found in early iterations. Comparative analysis of the networks of Gao and Sioux-Falls shows that for such a non-exact method the global optimum solutions are found in fewer iterations than those found in some analytically exact algorithms in the literature. (ii) Integration of the objective function among the constraints provides a commensurate capability to tackle the multi-objective (or multi-criteria) DNDP as well.	[Bagloee, Saeed Asadi; Sarvi, Majid] Univ Melbourne, Melbourne Sch Engn, Dept Infrastruct Engn, Smart Cities Transport Grp, Melbourne, Vic, Australia	University of Melbourne	Bagloee, SA (corresponding author), Univ Melbourne, Melbourne Sch Engn, Dept Infrastruct Engn, Smart Cities Transport Grp, Melbourne, Vic, Australia.	saeed.bagloee@unimelb.edu.au	sarvi, majid/A-2397-2009	Asadi Bagloee, Saeed/0000-0001-6078-6314				[Anonymous], 2017, WINNIPEG DATASET EMM; Bagloee Saeed Asadi, 2013, International Journal of Logistics Systems and Management, V16, P41; Bagloee Saeed A., 2012, International Journal of Logistics Systems and Management, V11, P114, DOI 10.1504/IJLSM.2012.044052; Bagloee SA, 2017, PUBLIC TRANSPORT, V9, P571, DOI 10.1007/s12469-017-0159-x; Bagloee SA, 2017, COMPUT-AIDED CIV INF, V32, P562, DOI 10.1111/mice.12261; Bagloee SA, 2017, COMPUT-AIDED CIV INF, V32, P319, DOI 10.1111/mice.12224; Bagloee SA, 2017, TRANSPORT PLAN TECHN, V40, P143, DOI 10.1080/03081060.2016.1266164; Bagloee SA, 2016, J MOD TRANSP, V24, P284, DOI 10.1007/s40534-016-0117-3; Bagloee SA, 2016, TRANSPORT RES A-POL, V94, P558, DOI 10.1016/j.tra.2016.10.019; Bagloee SA, 2016, TRANSPORT RES A-POL, V87, P102, DOI 10.1016/j.tra.2016.03.004; Bagloee SA, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/847324; Bagloee SA, 2015, TRANSPORT RES REC, P1, DOI 10.3141/2498-01; Bagloee SA, 2015, TRANSPORT RES A-POL, V75, P196, DOI 10.1016/j.tra.2015.03.016; Bagloee SA, 2014, TRANSPORTMETRICA A, V10, P437, DOI 10.1080/23249935.2013.787557; Bagloee SA, 2012, TRANSPORT RES REC, P1, DOI 10.3141/2319-01; BALAS E, 1972, SIAM J APPL MATH, V23, P61, DOI 10.1137/0123007; Bar-Gera H., 2016, TRANSPORTATION NETWO; Beckmann M.J., 1956, STUDIES EC TRANSPORT; BENAYED O, 1990, OPER RES, V38, P556, DOI 10.1287/opre.38.3.556; Bertsekas D., 1999, NONLINEAR PROGRAMMIN; Bertsekas D.P, 2010, CONVEX OPTIMIZATION; Borwein J., 2010, CONVEX ANAL NONLINEA; Cabanes G, 2015, BEHAV ECOL, V26, P223, DOI 10.1093/beheco/aru175; Chen XQ, 2015, TRANSPORT RES REC, P124, DOI 10.3141/2497-13; Colson B., 2005, 4OR-Q J OPER RES, V3, P87, DOI DOI 10.1007/S10288-005-0071-0; Dempe S, 2003, OPTIMIZATION, V52, P333, DOI 10.1080/0233193031000149894; DURAN MA, 1986, MATH PROGRAM, V36, P307, DOI 10.1007/BF02592064; Faivaresh H, 2011, TRANSPORT RES E-LOG, V47, P623, DOI 10.1016/j.tre.2011.02.001; Farahani RZ, 2013, EUR J OPER RES, V229, P281, DOI 10.1016/j.ejor.2013.01.001; Farvaresh H, 2013, NETW SPAT ECON, V13, P67, DOI 10.1007/s11067-012-9173-3; Floudas C. A, 1995, NONLINEAR MIXED INTE; Fontaine P, 2017, ANN OPER RES, V253, P757, DOI 10.1007/s10479-016-2171-y; Fontaine P, 2014, TRANSPORT RES B-METH, V70, P163, DOI 10.1016/j.trb.2014.09.007; Gao ZY, 2005, TRANSPORT RES B-METH, V39, P479, DOI 10.1016/j.trb.2004.06.004; Gonzalez AD, 2016, COMPUT-AIDED CIV INF, V31, P334, DOI 10.1111/mice.12171; Hosseininasab SM, 2015, EUR J OPER RES, V246, P762, DOI 10.1016/j.ejor.2015.05.039; INRO, 2009, EMME3 V 3 2 EMME3 US; Khooban Z, 2015, EUR J OPER RES, V247, P699, DOI 10.1016/j.ejor.2015.06.025; Larsson T, 1999, TRANSPORT RES B-METH, V33, P233, DOI 10.1016/S0191-2615(98)00024-1; Leblanc L. J., 1975, Transportation Science, V9, P183, DOI 10.1287/trsc.9.3.183; Li D., 2006, NONLINEAR INTEGER PR; Liu HX, 2015, TRANSPORT RES B-METH, V72, P20, DOI 10.1016/j.trb.2014.10.009; Liu XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162618; Lu J, 2016, TRANSPORT RES REC, P31, DOI 10.3141/2550-05; Luathep P, 2011, TRANSPORT RES B-METH, V45, P808, DOI 10.1016/j.trb.2011.02.002; MAGNANTI TL, 1984, TRANSPORT SCI, V18, P1, DOI 10.1287/trsc.18.1.1; MathWorks, 2014, MATLAB STAT TOOLB RE; Miandoabchi E, 2015, J OPER RES SOC, V66, P894, DOI 10.1057/jors.2014.55; Miettinen K, 2012, NONLINEAR MULTIOBJEC, V12; Patriksson P., 1994, TRAFFIC ASSIGNMENT P; POORZAHEDY H, 1982, TRANSPORT RES B-METH, V16, P45, DOI 10.1016/0191-2615(82)90040-6; Poorzahedy H, 2007, EUR J OPER RES, V182, P578, DOI 10.1016/j.ejor.2006.07.038; Rockafellar R., 1970, CONVEX ANAL; Roughgarden T, 2002, J ACM, V49, P236, DOI 10.1145/506147.506153; Sarvi M, 2004, COMPUT-AIDED CIV INF, V19, P351, DOI 10.1111/j.1467-8667.2004.00362.x; Sarvi M, 2008, IEEE T INTELL TRANSP, V9, P580, DOI 10.1109/TITS.2008.2006812; Sheffi Y., 1985, URBAN TRANSPORTATION; Szeto WY, 2015, NETW SPAT ECON, V15, P791, DOI 10.1007/s11067-013-9191-9; Wang DZW, 2010, TRANSPORT RES B-METH, V44, P482, DOI 10.1016/j.trb.2009.10.003; Wang SA, 2013, TRANSPORT RES B-METH, V50, P42, DOI 10.1016/j.trb.2013.01.006; Wang X, 2017, J GLOBAL OPTIM, V67, P325, DOI 10.1007/s10898-015-0396-y; Wets RJB, 2010, VARIATIONAL ANAL; Yang H, 1998, TRANSPORT REV, V18, P257, DOI 10.1080/01441649808717016; Zhang HZ, 2009, J SYST SCI COMPLEX, V22, P446, DOI 10.1007/s11424-009-9177-3; Zhang X, 2015, J TRAFFIC LOGISTICS, V3; Zhang X, 2015, SCI REPORTS, V5	68	1	1	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0192454	10.1371/journal.pone.0192454	http://dx.doi.org/10.1371/journal.pone.0192454			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590111	Green Published, gold			2022-12-26	WOS:000428603100004
J	Chang, AY; Nabbaale, J; Nalubwama, H; Okello, E; Ssinabulya, I; Longenecker, CT; Webel, AR				Chang, Andrew Y.; Nabbaale, Juliet; Nalubwama, Haddy; Okello, Emmy; Ssinabulya, Isaac; Longenecker, Christopher T.; Webel, Allison R.			Motivations of women in Uganda living with rheumatic heart disease: A mixed methods study of experiences in stigma, childbearing, anticoagulation, and contraception	PLOS ONE			English	Article							PREGNANCY OUTCOMES; DECISION-MAKING; AFRICA; FOCUS	Background Rheumatic heart disease (RHD) is a leading cause of premature mortality in low- and middle-income countries (LMICs). Women of reproductive age are a unique and vulnerable group of RHD patients, due to increased risk of cardiovascular complications and death during pregnancy. Yet, less than 5% of women of childbearing age with RHD in LMICs use contraceptives, and one in five pregnant women with RHD take warfarin despite known teratogenicity. It is unclear whether this suboptimal contraception and anticoagulant use during pregnancy is due to lack of health system resources, limited health literacy, or social pressure to bear children. Methods We conducted a mixed methods study of 75 women living with RHD in Uganda. Questionnaires were administered to 50 patients. Transcripts from three focus groups with 25 participants were analyzed using qualitative description methodology. Results Several themes emerged from the focus groups, including pregnancy as a calculated risk; misconceptions about side-effects of contraceptives and anticoagulation; reproductive decision -making control by male partners, in-laws, or physicians; abandonment of patients by male partners; and considerable stigma against heart disease patients for both their reproductive and financial limitations (often worse than that directed against HIV patients). All questionnaire respondents were told by physicians that their hearts were not strong enough to support a pregnancy. Only 14% used contraception while taking warfarin. All participants felt that society would look poorly on a woman who cannot have children due to a heart condition. Conclusions To our knowledge, this is the first qualitative study of female RHD patients and their attitudes toward cardiovascular disorders and reproduction. Our results suggest that health programs targeting heart disease in LMICs must pay special attention to the needs of women of childbearing age. There are opportunities for improved family/societal education programs and community engagement, leading to better outcomes and patient empowerment.	[Chang, Andrew Y.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Nabbaale, Juliet; Okello, Emmy; Ssinabulya, Isaac] Mulago Hosp, Uganda Heart Inst, Kampala, Uganda; [Nabbaale, Juliet; Longenecker, Christopher T.] Case Western Reserve Univ, Univ Hosp Harrington Heart & Vasc Inst, Cleveland, OH 44106 USA; [Nalubwama, Haddy] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Webel, Allison R.] Case Western Reserve Univ, Frances Payne Bolton Sch Nursing, Cleveland, OH 44106 USA	Stanford University; Mulago National Referral Hospital; Case Western Reserve University; Makerere University; Case Western Reserve University	Webel, AR (corresponding author), Case Western Reserve Univ, Frances Payne Bolton Sch Nursing, Cleveland, OH 44106 USA.	Allison.webel@case.edu	Webel, Allison R./ABA-1972-2020; Webel, Allison R./AFW-1806-2022	Chang, Andrew/0000-0002-3009-6678; Webel, Allison/0000-0002-7538-5780; Ssinabulya, Isaac/0000-0001-6521-7778	Medtronic Foundation [FY13-000406]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001084] Funding Source: NIH RePORTER	Medtronic Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Author C.L. has financial support from the Medtronic Foundation (Grant FY13-000406) for the submitted work. The funder provided support in the form of salary/research materials for author C.L., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors report no financial relationships with any other organizations that might have an interest in the submitted work; no other relationships or activities that could appear to have influenced or benefited from the submitted work. The specific roles of these authors are articulated in the 'author contributions' section.	Adongo PB, 1997, SOC SCI MED, V45, P1789, DOI 10.1016/S0277-9536(97)00110-X; Alshawabkeh L, 2016, J AM COLL CARDIOL, V68, P1804, DOI 10.1016/j.jacc.2016.06.076; Behboodi-Moghadam Zahra, 2016, J Int Assoc Provid AIDS Care, V15, P148, DOI 10.1177/2325957415593636; Benin AL, 2006, PEDIATRICS, V117, P1532, DOI 10.1542/peds.2005-1728; Bronfenbrenner U., 1993, INT ENCY ED, V3, P37; Carlsson-Lalloo E, 2016, AIDS PATIENT CARE ST, V30, P56, DOI 10.1089/apc.2015.0260; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Corney R, 2014, EUR J ONCOL NURS, V18, P17, DOI 10.1016/j.ejon.2013.10.003; Curry LA, 2009, CIRCULATION, V119, P1442, DOI 10.1161/CIRCULATIONAHA.107.742775; Diao M, 2011, ARCH CARDIOVASC DIS, V104, P370, DOI 10.1016/j.acvd.2011.04.001; Farmer DB, 2015, GLOB HEALTH, V3, P242, DOI 10.9745/GHSP-D-14-00198; Ginsberg JS, 2001, CHEST, V119, p122S, DOI 10.1378/chest.119.1_suppl.122S; Greutmann M, 2015, EUR HEART J, V36, P2491, DOI 10.1093/eurheartj/ehv288; Haththotuwa HR, 2009, INT J GYNECOL OBSTET, V104, P194, DOI 10.1016/j.ijgo.2008.10.031; Jeng JS, 2004, J NEUROL SCI, V221, P25, DOI 10.1016/j.jns.2004.03.006; Kane S, 2016, BMC PUBLIC HEALTH, P16; Kibira SPS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141998; Liu H, 2013, INT J GYNECOL OBSTET, V120, P245, DOI 10.1016/j.ijgo.2012.09.025; Liu H, 2010, CHINESE MED J-PEKING, V123, P2324, DOI 10.3760/cma.j.issn.0366-6999.2010.17.008; Mocumbi AO, 2012, HEART, V98, P450, DOI 10.1136/heartjnl-2011-301025; Moodley J, 2000, S AFR MED J, V90, P367; Neergaard MA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-52; Ochako R, 2015, BMC PUBLIC HEALTH, P15; Paar JA, 2010, AM J CARDIOL, V105, P1809, DOI 10.1016/j.amjcard.2010.01.364; Pattenden J, 2002, BMJ-BRIT MED J, V324, P1006, DOI 10.1136/bmj.324.7344.1006; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sandelowski M., 2009, RES NURS HLTH; Siu SC, 2001, CIRCULATION, V104, P515, DOI 10.1161/hc3001.093437; Terreri MT, 2001, J RHEUMATOL, V28, P1394; Thorne S, 2006, HEART, V92, P1520, DOI 10.1136/hrt.2006.095240; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tong A, 2015, NEPHROL DIAL TRANSPL, V30, P652, DOI 10.1093/ndt/gfu378; Watkins DA, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-23; Zuhlke L, 2015, EUR HEART J, V36, P1115, DOI 10.1093/eurheartj/ehu449	34	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194030	10.1371/journal.pone.0194030	http://dx.doi.org/10.1371/journal.pone.0194030			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590159	Green Published, gold, Green Submitted			2022-12-26	WOS:000428603100045
J	Dalgaard, F; Ruwald, MH; Lindhardt, TB; Gislason, GH; Torp-Pedersen, C; Pallisgaard, JL				Dalgaard, Frederik; Ruwald, Martin H.; Lindhardt, Tommi Bo; Gislason, Gunnar H.; Torp-Pedersen, Christian; Pallisgaard, Jannik L.			Patients with atrial fibrillation and permanent pacemaker: Temporal changes in patient characteristics and pharmacotherapy	PLOS ONE			English	Article							HOSPITAL DISCHARGE; ELDERLY-PATIENTS; HEART-FAILURE; RISK; TRENDS; IMPLANTATION; PREVALENCE; MANAGEMENT; MORTALITY; DENMARK	Background The management of patients with non-valvular atrial fibrillation (NVAF) with rate-lowering or anti-arrhythmic drugs has markedly changed over the last decade, but it is unknown how these changes have affected patients with NVAF with a permanent pacemaker (PPM). Methods Through Danish nationwide registries, patients with NVAF and a PPM were identified from 2001 to 2012. Changes in concomitant pharmacotherapy and comorbidities were tested using the Cochran Armitage trend test and linear regression. Patients with NVAF were identified to calculate the proportional amount of PPM implants. Results A total of 12,231 NVAF patients with a PPM were included in the study, 55.6% of which were men. Median age was 78 years (interquartile range 70-84). From 2001 to 2012, the number of NVAF patients with a PPM increased from 850 to 1344, while the number of NVAF patients increased from 67,478 to 127,261. Thus, the proportional amount of NVAF patients with a PPM decreased from 1.3% to 1.1% (p = 0.015). Overall 45.9% had atrial fibrillation (AF) duration less than one year and the proportion declined from 55.5% to 42.4% (p <0.001). Diabetes mellitus increased from 7.2% to 16.8% (p <0.001). Heart failure (HF) decreased from 36.7% to 29.3% (p = 0.010) and ischemic heart disease (IHD) decreased from 32.4% to 26.1% (p <0.001). Beta-blocker use increased from 38.1% to 58.0% (p <0.001), while digoxin and anti-arrhythmic drug use decreased over time. Conclusion From 2001 to 2012, the absolute number of NVAF patients with a PPM increased while the proportional amount decreased. The number of NVAF patients receiving a PPM within one year of AF diagnosis decreased. The prevalence of DM increased, while the prevalence of HF and IHD was high but decreasing. The use of beta-blockers increased markedly, while use of digoxin and anti -arrhythmic drugs decreased over time.	[Dalgaard, Frederik; Ruwald, Martin H.; Lindhardt, Tommi Bo; Gislason, Gunnar H.; Torp-Pedersen, Christian; Pallisgaard, Jannik L.] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Cardiol, Hellerup, Denmark; [Gislason, Gunnar H.] Danish Heart Fdn, Copenhagen, Denmark; [Gislason, Gunnar H.] Univ Southern Denmark, Natl Inst Publ Hlth, Odense, Denmark; [Torp-Pedersen, Christian] Aalborg Univ Hosp, Dept Hlth Sci & Technol, Aalborg, Denmark	University of Copenhagen; University of Southern Denmark; Aalborg University; Aalborg University Hospital	Dalgaard, F (corresponding author), Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Cardiol, Hellerup, Denmark.	fdalgaard87@gmail.com	Dalgaard, Frederik/J-1878-2019; Gislason, Gunnar/B-7561-2009; Pallisgaard, Jannik Langtved/S-9546-2019	Dalgaard, Frederik/0000-0002-7287-4191; Gislason, Gunnar/0000-0002-0548-402X; Pallisgaard, Jannik Langtved/0000-0002-8072-3318	Danish Heart Foundation [16-R107-A6776-22972]; FUKAP; Department of Cardiology, Herlev & Gentofte Hospital	Danish Heart Foundation; FUKAP; Department of Cardiology, Herlev & Gentofte Hospital	This work has been supported by Danish Heart Foundation (www.hjerteforeningen.dk) [grant number: 16-R107-A6776-22972]; and FUKAP (www.fukap.dk), research fund of the Department of Cardiology, Herlev & Gentofte Hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, CIRCULATION, V104, P2118; Ball J, 2013, INT J CARDIOL, V167, P1807, DOI 10.1016/j.ijcard.2012.12.093; Barrett TW, 2012, AM J CARDIOL, V110, P1315, DOI 10.1016/j.amjcard.2012.06.037; Carlsson AC, 2013, EUR J CLIN PHARMACOL, V69, P245, DOI 10.1007/s00228-012-1322-6; Casale JC, 2013, ETHNIC DIS, V23, P275; Essebag V, 2003, J AM COLL CARDIOL, V41, P249, DOI 10.1016/S0735-1097(02)02709-2; Friberg L, 2013, J Intern Med, V274, P461, DOI 10.1111/joim.12114; Green A, 2015, CLIN EPIDEMIOL, V7, P421, DOI 10.2147/CLEP.S88577; Guha A, 2017, J CARDIOVASC ELECTR, V28, P933, DOI 10.1111/jce.13248; Hansen ML, 2008, EUROPACE, V10, P395, DOI 10.1093/europace/eun011; Karasoy D, 2013, EUROPACE, V15, P669, DOI 10.1093/europace/eus418; Kirchhof P, 2016, EUR J CARDIOTHORAC S; Kralev S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024964; Lear JT, 1996, ACTA DIABETOL, V33, P169; Lee Jang Hoon, 2009, Korean Circ J, V39, P367, DOI 10.4070/kcj.2009.39.9.367; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Michniewicz E, 2018, ADV MED SCI-POLAND, V63, P30, DOI 10.1016/j.advms.2017.06.005; Mond HG, 2011, PACE, V34, P1013, DOI 10.1111/j.1540-8159.2011.03150.x; Olesen Jonas Bjerring, 2011, BMJ, V342, pd124, DOI 10.1136/bmj.d124; Pallisgaard JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161768; Pallisgaard JL, 2015, EXPERT REV CARDIOVAS, V13, P643, DOI 10.1586/14779072.2015.1043892; Park S, 2013, J CARDIO VASC MED, V1; Ruwald MH, 2012, EUROPACE, V14, P1506, DOI 10.1093/europace/eus154; Schmidt M, 2016, HEAR RHYTHM, V12, P2018; Schmidt M, 2016, INT J CARDIOL, V225, P30, DOI 10.1016/j.ijcard.2016.09.071; Van Gelder IC, 2010, NEW ENGL J MED, V362, P1363, DOI 10.1056/NEJMoa1001337; Vaughan-Sarrazin MS, 2014, AM HEART J, V168, P53, DOI 10.1016/j.ahj.2014.03.024; Wandell P, 2017, J CARDIOL; Wandell P, 2017, EUR J EPIDEMIOL, V32, P785, DOI 10.1007/s10654-017-0283-6; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; Zoni-Berisso M, 2014, CLIN EPIDEMIOL, V6, P213, DOI 10.2147/CLEP.S47385	31	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0195175	10.1371/journal.pone.0195175	http://dx.doi.org/10.1371/journal.pone.0195175			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590209	gold, Green Published, Green Submitted			2022-12-26	WOS:000428603100106
J	Insley, P; Shaham, S				Insley, Peter; Shaham, Shai			Automated C-elegans embryo alignments reveal brain neuropil position invariance despite lax cell body placement	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; PLANE ILLUMINATION MICROSCOPY; IMAGE REGISTRATION; GENE-EXPRESSION; AXON GUIDANCE; NERVE RING; EMBRYOGENESIS; LINEAGE; SYSTEM; GROWTH	The Caenorhabditis elegans cell lineage is nearly invariant. Whether this stereotyped cell division pattern promotes reproducibility in cell shapes/positions is not generally known, as manual spatiotemporal cell-shape/position alignments are labor-intensive, and fully-automated methods are not described. Here, we report automated algorithms for spatiotemporal alignments of C. elegans embryos from pre-morphogenesis to motor-activity initiation. We use sparsely-labeled green-fluorescent nuclei and a pan-nuclear red-fluorescent reporter to register consecutive imaging time points and compare embryos. Using our method, we monitor early assembly of the nerve-ring (NR) brain neuropil. While NR pioneer neurons exhibit reproducible growth kinetics and axon positions, cell-body placements are variable. Thus, pioneer-neuron axon locations, but not cell-body positions, are under selection. We also show that anterior NR displacement in cam-1/ROR Wnt-receptor mutants is not an early NR assembly defect. Our results demonstrate the utility of automated spatiotemporal alignments of C. elegans embryos, and uncover key principles guiding nervous-system development in this animal.	[Insley, Peter; Shaham, Shai] Rockefeller Univ, Lab Dev Genet, 1230 York Ave, New York, NY 10021 USA	Rockefeller University	Shaham, S (corresponding author), Rockefeller Univ, Lab Dev Genet, 1230 York Ave, New York, NY 10021 USA.	shaham@rockefeller.edu			NIH [NS064273, NS095795, NS081490, HD078703]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants NS064273, NS095795, NS081490, HD078703 to SS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao ZR, 2008, DEV BIOL, V318, P65, DOI 10.1016/j.ydbio.2008.02.054; Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; BRENNER S, 1974, GENETICS, V77, P71; BROWN LG, 1992, COMPUT SURV, V24, P325, DOI 10.1145/146370.146374; Christensen RP, 2015, ELIFE, V4, DOI 10.7554/eLife.10070; Forrester WC, 1999, NATURE, V400, P881, DOI 10.1038/23722; Giurumescu CA, 2012, DEVELOPMENT, V139, P4271, DOI 10.1242/dev.086256; Ho T. K., 1995, INT C, V1, P278, DOI DOI 10.1109/ICDAR.1995.598994; HORN BKP, 1987, J OPT SOC AM A, V4, P629, DOI 10.1364/JOSAA.4.000629; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Kahaner D., 1989, NUMERICAL METHODS SO; Kennerdell JR, 2009, DEVELOPMENT, V136, P3801, DOI 10.1242/dev.038109; Kremser C, 1997, MAGN RESON IMAGING, V15, P579, DOI 10.1016/S0730-725X(97)00023-4; Murray JI, 2012, GENOME RES, V22, P1282, DOI 10.1101/gr.131920.111; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; Nath RD, 2016, CURRENT BIOL; Ooi SL, 2006, PLOS GENET, V2, P883, DOI 10.1371/journal.pgen.0020097; Peng HC, 2008, BIOINFORMATICS, V24, P234, DOI 10.1093/bioinformatics/btm569; Peng HC, 2011, NAT METHODS, V8, P493, DOI [10.1038/NMETH.1602, 10.1038/nmeth.1602]; Pujol N, 2000, DEVELOPMENT, V127, P3361; Rapti G, 2017, NAT NEUROSCI, V20, P1350, DOI 10.1038/nn.4630; Richards JL, 2013, DEV BIOL, V374, P12, DOI 10.1016/j.ydbio.2012.11.034; Sanders J, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-156; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Singhal A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14100; Sommer C, 2011, I S BIOMED IMAGING, P230, DOI 10.1109/ISBI.2011.5872394; Strnad P, 2016, NAT METHODS, V13, P139, DOI [10.1038/NMETH.3690, 10.1038/nmeth.3690]; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Van Aelst S, 2009, WIRES COMPUT STAT, V1, DOI 10.1002/wics.19; Van Buskirk C, 2007, NAT NEUROSCI, V10, P1300, DOI 10.1038/nn1981; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wu YC, 2011, P NATL ACAD SCI USA, V108, P17708, DOI 10.1073/pnas.1108494108; Zacharias AL, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005585; Zallen JA, 1999, DEVELOPMENT, V126, P3679; Zhang YL, 2015, MICRON, V68, P122, DOI 10.1016/j.micron.2014.10.002; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	37	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194861	10.1371/journal.pone.0194861	http://dx.doi.org/10.1371/journal.pone.0194861			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590193	Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100082
J	Lowe, NM; Kershaw, LE; Bernstein, JM; Withey, SB; Mais, K; Homer, JJ; Slevin, NJ; Bonington, SC; Carrington, BM; West, CM				Lowe, Natalie M.; Kershaw, Lucy E.; Bernstein, Jonathan M.; Withey, Stephanie B.; Mais, Kathleen; Homer, Jarrod J.; Slevin, Nicholas J.; Bonington, Suzanne C.; Carrington, Bernadette M.; West, Catharine M.			Pre-treatment tumour perfusion parameters and initial RECIST response do not predict long-term survival outcomes for patients with head and neck squamous cell carcinoma treated with induction chemotherapy	PLOS ONE			English	Article							LOCALLY ADVANCED HEAD; CONTRAST-ENHANCED MRI; INTRATUMOR HETEROGENEITY; COMPUTED-TOMOGRAPHY; CT PERFUSION; LOCOREGIONAL CONTROL; RADIATION-THERAPY; UNRESECTABLE HEAD; LUNG-CANCER; CHEMORADIOTHERAPY	Objectives Previously, we showed that pre-treatment tumour plasma perfusion (Fp) predicts RECIST response to induction chemotherapy (ICT) in locoregionally advanced head and neck squamous cell carcinoma (HNSCC). The aim here was to determine whether the pre-treatment tumour Fp estimate, changes in tumour Fp or RECIST response post 2 cycles of ICT were prognostic for long-term survival outcomes. Methods A prospective study enrolled patients with high stage HNSCC treated with docetaxel (T), cisplatin (P) and 5-fluorouracil (F) (ICT) followed by synchronous cisplatin and intensity modulated radiotherapy. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) before and after two cycles of ICT was used to measure Fp and RECIST response. Results Forty-two patients were recruited and 37 underwent two scans. The median follow-up was 36 (range 23-49) months. Pre-treatment tumour Fp (stratified by median) was not prognostic for overall survival (p = 0.42), disease specific survival (p = 0.20) and locoregional control (p = 0.64). Neither change in tumour Fp nor RECIST response post two cycles of ICT was prognostic for any outcome (p>0.21). Conclusion DCE-MRI parameters do not predict long-term survival outcomes following ICT and RECIST response to ICT may not be an appropriate endpoint to determine early efficacy of a treatment in HNSCC patients.	[Lowe, Natalie M.; Kershaw, Lucy E.; Bernstein, Jonathan M.; Homer, Jarrod J.; Slevin, Nicholas J.; West, Catharine M.] Univ Manchester, Christie NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Div Canc Sci, Manchester, Lancs, England; [Kershaw, Lucy E.] Christie NHS Fdn Trust, Christie Med Phys & Engn, Manchester, Lancs, England; [Bernstein, Jonathan M.] Royal Marsden NHS Fdn Trust, Dept Otorhinolaryngol Head & Neck Surg, London, England; [Withey, Stephanie B.] Univ Hosp Birmingham, Med Phys, Birmingham, W Midlands, England; [Mais, Kathleen; Slevin, Nicholas J.] Christie NHS Fdn Trust, Head & Neck Clin Oncol, Manchester, Lancs, England; [Homer, Jarrod J.] Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Univ Dept Otolaryngol Head & Neck Surg, Manchester, Lancs, England; [Bonington, Suzanne C.; Carrington, Bernadette M.] Christie NHS Fdn Trust, Dept Radiol, Manchester, Lancs, England; [West, Catharine M.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England	Christie NHS Foundation Trust; University of Manchester; Christie NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of Birmingham; Christie NHS Foundation Trust; University of Manchester; Christie NHS Foundation Trust; University of Manchester	West, CM (corresponding author), Univ Manchester, Christie NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Div Canc Sci, Manchester, Lancs, England.; West, CM (corresponding author), Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England.	Catharine.West@manchester.ac.uk	; West, Catharine/J-4152-2012	Withey, Stephanie/0000-0003-4804-9033; West, Catharine/0000-0002-0839-3449; Lowe, Natalie/0000-0002-0348-5184	Christie Hospital Charitable Trust; Head and Neck Oncology Research Fund; Christie NHS Foundation Trust; Experimental Cancer Medicine Centre Network, UK	Christie Hospital Charitable Trust; Head and Neck Oncology Research Fund; Christie NHS Foundation Trust; Experimental Cancer Medicine Centre Network, UK	The authors thank Helen Valentine for help with p16 staining; Farag Shuweidi and Clare Hodgson for help with statistical analysis and Jason Kennedy for database management. The work was funded by the Christie Hospital Charitable Trust.; This study was funded by the Head and Neck Oncology Research Fund (Prof Nick J Slevin), The Christie NHS Foundation Trust and The Experimental Cancer Medicine Centre Network, UK.	Balluff B, 2015, J PATHOL, V235, P3, DOI 10.1002/path.4436; Bernstein JM, 2015, ORAL ONCOL, V51, P508, DOI 10.1016/j.oraloncology.2015.01.013; Bisdas S, 2010, AM J NEURORADIOL, V31, P576, DOI 10.3174/ajnr.A1852; Bisdas S, 2009, AM J NEURORADIOL, V30, P793, DOI 10.3174/ajnr.A1449; Blanchard P, 2011, J CLIN EPIDEMIOL, V64, P985, DOI 10.1016/j.jclinepi.2010.10.016; Bourhis J, 2012, LANCET ONCOL, V13, P145, DOI 10.1016/S1470-2045(11)70346-1; Brix G, 2004, MAGNET RESON MED, V52, P420, DOI 10.1002/mrm.20161; Brizel DM, 1999, RADIOTHER ONCOL, V53, P113, DOI 10.1016/S0167-8140(99)00102-4; Brookes JA, 1999, JMRI-J MAGN RESON IM, V9, P163, DOI 10.1002/(SICI)1522-2586(199902)9:2<163::AID-JMRI3>3.0.CO;2-L; Buyse M, 2000, LANCET, V356, P373, DOI 10.1016/S0140-6736(00)02528-9; Cao Y, 2008, INT J RADIAT ONCOL, V72, P1287, DOI 10.1016/j.ijrobp.2008.08.024; Clinton B, 1996, REINVENTING REGULATI; Cohen EEW, 2014, J CLIN ONCOL, V32, P2735, DOI 10.1200/JCO.2013.54.6309; Cohen L, 2012, J CLIN ONCOL, V30; Donaldson SB, 2013, EUR J RADIOL, V82, P2161, DOI 10.1016/j.ejrad.2013.08.008; Edge SB, 2009, AJCC CANC STAGING MA, V7; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; El-Maraghi RH, 2008, J CLIN ONCOL, V26, P1346, DOI 10.1200/JCO.2007.13.5913; Ferlay J, 2014, INT J CANC; Gandhi D, 2006, AM J NEURORADIOL, V27, P101; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ghi M, 2017, ANN ONCOLOGY; Ghi MG, 2017, ANN ONCOL, V28, P2206, DOI 10.1093/annonc/mdx299; Goffin J, 2005, CLIN CANCER RES, V11, P5928, DOI 10.1158/1078-0432.CCR-05-0130; Hermans R, 2003, INT J RADIAT ONCOL, V57, P1351, DOI 10.1016/S0360-3016(03)00764-8; Hitt R, 2014, ANN ONCOL, V25, P216, DOI 10.1093/annonc/mdt461; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Lorch JH, 2011, LANCET ONCOL, V12, P153, DOI 10.1016/S1470-2045(10)70279-5; Ma J, 2012, ORAL ONCOL, V48, P1076, DOI 10.1016/j.oraloncology.2012.06.014; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Matoba M, 2015, J RADIAT RES, V56, P553, DOI 10.1093/jrr/rru123; Nguyen-Tan PF, 2014, J CLIN ONCOLOGY; Nordsmark M, 2005, RADIOTHER ONCOL, V77, P18, DOI 10.1016/j.radonc.2005.06.038; O'Connor JPB, 2015, CLIN CANCER RES, V21, P249, DOI 10.1158/1078-0432.CCR-14-0990; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Paesmans M, 1997, EUR J CANCER, V33, P2326, DOI 10.1016/S0959-8049(97)00325-0; Pascal J, 2013, P NATL ACAD SCI USA, V110, P14266, DOI 10.1073/pnas.1300619110; Passero VA, 2010, ANN ONCOL, V21, P2278, DOI 10.1093/annonc/mdq226; Patil V, 2013, ISRN Oncol, V2013, P259154, DOI 10.1155/2013/259154; Petralia G, 2009, J COMPUT ASSIST TOMO, V33, P552, DOI 10.1097/RCT.0b013e31818d446e; Pignon JP, 2009, RADIOTHER ONCOL, V92, P4, DOI 10.1016/j.radonc.2009.04.014; Popovic KS, 2014, J BUON, V19, P937; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Sinek J, 2004, BIOMED MICRODEVICES, V6, P297, DOI 10.1023/B:BMMD.0000048562.29657.64; Stadler P, 1999, INT J RADIAT ONCOL, V44, P749, DOI 10.1016/S0360-3016(99)00115-7; Stokes WA, 2017, HEAD NECK-J SCI SPEC, V39, P1113, DOI 10.1002/hed.24739; Truong MT, 2011, AM J NEURORADIOL, V32, P1195, DOI 10.3174/ajnr.A2501; Urba S, 2006, J CLIN ONCOL, V24, P593, DOI 10.1200/JCO.2005.01.2047; Ursino S, 2017, EUR REV MED PHARMACO, V21, P4882; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; Wang P, 2012, MED PHYS, V39, P5277, DOI 10.1118/1.4737022; Weber RS, 2003, ARCH OTOLARYNGOL, V129, P44, DOI 10.1001/archotol.129.1.44; William WN, 2013, J THORAC ONCOL, V8, P222, DOI 10.1097/JTO.0b013e3182774108; Zima A, 2007, AM J NEURORADIOL, V28, P328	54	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194841	10.1371/journal.pone.0194841	http://dx.doi.org/10.1371/journal.pone.0194841			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590180	Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100078
J	Pfeiffer, V; Gotz, R; Camarero, G; Heinsen, H; Blum, R; Rapp, UR				Pfeiffer, Verena; Goetz, Rudolf; Camarero, Guadelupe; Heinsen, Helmut; Blum, Robert; Rapp, Ulf Ruediger			Impaired neuronal maturation of hippocampal neural progenitor cells in mice lacking CRAF	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CENTRAL-NERVOUS-SYSTEM; ADULT NEUROGENESIS; DENTATE GYRUS; B-RAF; NOONAN-SYNDROME; STEM-CELLS; C-RAF; KNOCKOUT MICE; A-RAF	RAF kinases are major constituents of the mitogen activated signaling pathway, regulating cell proliferation, differentiation and cell survival of many cell types, including neurons. In mammals, the family of RAF proteins consists of three members, ARAF, BRAF, and CRAF. Ablation of CRAF kinase in inbred mouse strains causes major developmental defects during fetal growth and embryonic or perinatal lethality. Heterozygous germline mutations in CRAF result in Noonan syndrome, which is characterized by neurocognitive impairment that may involve hippocampal physiology. The role of CRAF signaling during hippocampal development and generation of new postnatal hippocampal granule neurons has not been examined and may provide novel insight into the cause of hippocampal dysfunction in Noonan syndrome. In this study, by crossing CRAF-deficiency to CD-1 outbred mice, a CRAF mouse model was established which enabled us to investigate the interplay of neural progenitor proliferation and postmitotic differentiation during adult neurogenesis in the hippo campus. Albeit the general morphology of the hippocampus was unchanged, CRAF-deficient mice displayed smaller granule cell layer (GCL) volume at postnatal day 30 (P30). In CRAF-deficient mice a substantial number of abnormal, chromophilic, fast dividing cells were found in the subgranular zone (SGZ) and hilus of the dentate gyrus (DG), indicating that CRAF signaling contributes to hippocampal neural progenitor proliferation. CRAF-deficient neural progenitor cells showed an increased cell death rate and reduced neuronal maturation. These results indicate that CRAF function affects postmitotic neural cell differentiation and points to a critical role of CRAF-dependent growth factor signaling pathway in the postmitotic development of adult-born neurons.	[Pfeiffer, Verena] Univ Wurzburg, Inst Anat & Cell Biol, Koellikerstr 6, Wurzburg, Germany; [Pfeiffer, Verena; Goetz, Rudolf; Camarero, Guadelupe; Rapp, Ulf Ruediger] Univ Wurzburg, Inst Med Radiat & Cell Res MSZ, Versbacher Str 5, Wurzburg, Germany; [Goetz, Rudolf; Blum, Robert] Univ Hosp Wurzburg, Inst Clin Neurobiol, Versbacher Str 5, Wurzburg, Germany; [Heinsen, Helmut] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Margarethe Hoppel Pl 1, Wurzburg, Germany; [Heinsen, Helmut] Univ Sao Paulo, Fac Med, Pathol LIM 44, Sao Paulo, SP, Brazil; [Rapp, Ulf Ruediger] Max Planck Inst Heart & Lung Res, Dept Lung Dev & Remodeling, Pk Str 1, Bad Nauheim, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; Universidade de Sao Paulo; Max Planck Society	Pfeiffer, V (corresponding author), Univ Wurzburg, Inst Anat & Cell Biol, Koellikerstr 6, Wurzburg, Germany.; Pfeiffer, V (corresponding author), Univ Wurzburg, Inst Med Radiat & Cell Res MSZ, Versbacher Str 5, Wurzburg, Germany.	verena.pfeiffer@mail.uni-wuerzburg.de	Blum, Robert/E-8899-2013	Blum, Robert/0000-0002-5270-3854; Pfeiffer, Verena/0000-0001-5397-9564	Deutsche Forschungsgemeinschaft [1048]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants of the Deutsche Forschungsgemeinschaft to the Graduate College 1048, University of Wurzburg. We are grateful to Doris Heim, Hilde Troll, Michaela Kessler and Daniel Pfeiffer for technical assistance. We also thank Prof. M. Sendtner and Prof E. Asan for their generous support.	Aimone JB, 2014, PHYSIOL REV, V94, P991, DOI 10.1152/physrev.00004.2014; Andersen J, 2014, NEURON, V83, P1085, DOI 10.1016/j.neuron.2014.08.004; BAYER SA, 1990, EXP NEUROL, V107, P48, DOI 10.1016/0014-4886(90)90062-W; Belanger LF, 2003, MOL CELL BIOL, V23, P4778, DOI 10.1128/MCB.23.14.4778-4787.2003; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; Fischer A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M607458200; Freeman Alyson K, 2013, Small GTPases, V4, P180, DOI 10.4161/sgtp.26117; Galabova-Kovacs G, 2008, J CELL BIOL, V180, P947, DOI 10.1083/jcb.200709069; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Garthe A, 2014, GENES BRAIN BEHAV, V13, P357, DOI 10.1111/gbb.12130; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; Hindley A, 2002, J CELL SCI, V115, P1575; HULEIHEL M, 1986, MOL CELL BIOL, V6, P2655, DOI 10.1128/MCB.6.7.2655; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; IKAWA S, 1988, MOL CELL BIOL, V8, P2651, DOI 10.1128/MCB.8.6.2651; Jinno S, 2011, HIPPOCAMPUS, V21, P467, DOI 10.1002/hipo.20762; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; KOZAK C, 1984, J VIROL, V49, P297, DOI 10.1128/JVI.49.1.297-299.1984; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Li XY, 2012, NEURON, V75, P1035, DOI 10.1016/j.neuron.2012.08.031; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Lutolf S, 2002, DEVELOPMENT, V129, P373; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Maurer G, 2011, ONCOGENE, V30, P3477, DOI 10.1038/onc.2011.160; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Pfeiffer V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058259; Pierpont EI, 2009, GENES BRAIN BEHAV, V8, P275, DOI 10.1111/j.1601-183X.2008.00469.x; Pierpont EI, 2013, AM J MED GENET A, V161, P2250, DOI 10.1002/ajmg.a.36075; Pritchard CA, 1996, CURR BIOL, V6, P614, DOI 10.1016/S0960-9822(02)00548-1; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Roskoski R, 2010, BIOCHEM BIOPH RES CO, V399, P313, DOI 10.1016/j.bbrc.2010.07.092; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Samuels IS, 2008, J NEUROSCI, V28, P6983, DOI 10.1523/JNEUROSCI.0679-08.2008; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Strelau J, 2009, J NEUROSCI, V29, P13640, DOI 10.1523/JNEUROSCI.1133-09.2009; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vithayathil J, 2015, J NEUROSCI, V35, P6836, DOI 10.1523/JNEUROSCI.4196-14.2015; Wang HG, 1996, P NATL ACAD SCI USA, V93, P7063, DOI 10.1073/pnas.93.14.7063; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Weber CK, 2001, CANCER RES, V61, P3595; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Wojnowski L, 2000, MECH DEVELOP, V91, P97, DOI 10.1016/S0925-4773(99)00276-2; Wojnowski L, 1998, MECH DEVELOP, V76, P141, DOI 10.1016/S0925-4773(98)00111-7; Wu X, 2012, MOL CELL BIOL, V32, P3872, DOI 10.1128/MCB.00751-12; Wu X, 2011, J CLIN INVEST, V121, P1009, DOI 10.1172/JCI44929; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	66	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0192067	10.1371/journal.pone.0192067	http://dx.doi.org/10.1371/journal.pone.0192067			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590115	Green Submitted, Green Published, gold			2022-12-26	WOS:000428603100002
J	Tanifuji, G; Takabayashi, S; Kume, K; Takagi, M; Nakayama, T; Kamikaw, R; Inagaki, Y; Hashimoto, T				Tanifuji, Goro; Takabayashi, Shun; Kume, Keitaro; Takagi, Mizue; Nakayama, Takuro; Kamikaw, Ryoma; Inagaki, Yuji; Hashimoto, Tetsuo			The draft genome of Kipferlia bialata reveals reductive genome evolution in fornicate parasites	PLOS ONE			English	Article							TRICHOMONAS-VAGINALIS; PROTEIN IMPORT; TARGETING SEQUENCES; GIARDIA-LAMBLIA; CLEAVAGE SITES; N. SP.; MITOCHONDRIAL; CARPEDIEMONAS; ULTRASTRUCTURE; CLASSIFICATION	The fornicata (fornicates) is a eukaryotic group known to consist of free-living and parasitic organisms. Genome datasets of two model fornicate parasites Giardia intestinalis and Spironucleus salmonicida are well annotated, so far. The nuclear genomes of G. intestinalis assemblages and S. salmonicida are small in terms of the genome size and simple in genome structure. However, an ancestral genomic structure and gene contents, from which genomes of the fornicate parasites have evolved, remains to be clarified. In order to understand genome evolution in fornicates, here, we present the draft genome sequence of a free-living fornicate, Kipferlia bialata, the divergence of which is earlier than those of the fornicate parasites, and compare it to the genomes of G. intestinalis and S. salmonicida. Our data show that the number of protein genes and introns in K. bialata genome are the most abundant in the genomes of three fornicates, reflecting an ancestral state of fornicate genome evolution. Evasion mechanisms of host immunity found in G. intestinalis and S. salmonicida are absent in the K. bialata genome, suggesting that the two parasites acquired the complex membrane surface proteins on the line leading to the common ancestor of G. intestinalis and S. salmonicida after the divergence from K. bialata. Furthermore, the mitochondrion related organelles (MROs) of K. bialata possess more complex suites of metabolic pathways than those in Giardia and in Spironucleus. In sum, our results unveil the process of reductive evolution which shaped the current genomes in two model fornicate parasites G. intestinalis and S. salmonicida.	[Tanifuji, Goro; Takabayashi, Shun; Kume, Keitaro; Takagi, Mizue; Inagaki, Yuji; Hashimoto, Tetsuo] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Tanifuji, Goro] Natl Museum Nat & Sci, Dept Zool, Tsukuba, Ibaraki, Japan; [Nakayama, Takuro; Inagaki, Yuji; Hashimoto, Tetsuo] Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki, Japan; [Nakayama, Takuro] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi, Japan; [Kamikaw, Ryoma] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Kyoto, Japan; [Kamikaw, Ryoma] Kyoto Univ, Grad Sch Global Environm Studies, Kyoto, Kyoto, Japan	University of Tsukuba; National Museum of Nature and Science; University of Tsukuba; Tohoku University; Kyoto University; Kyoto University	Tanifuji, G; Hashimoto, T (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.; Tanifuji, G (corresponding author), Natl Museum Nat & Sci, Dept Zool, Tsukuba, Ibaraki, Japan.; Hashimoto, T (corresponding author), Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki, Japan.	gorot@kahaku.go.jp; hashimoto.tetsuo.gm@u.tsukuba.ac.jp	NAKAYAMA, Takuro/AAT-9444-2020	NAKAYAMA, Takuro/0000-0001-5135-0156; Inagaki, Yuji/0000-0003-0101-8483	JSPS [23117005, 15H04406, 15H05231, 15K14591, 15H05606]; Grants-in-Aid for Scientific Research [16H04826] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	JSPS KAKENHI grant number 23117005, 15H04406, and 15H05231 to TH and 15K14591 and 15H05606 to RK.	Adam RD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-424; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Csuros M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002150; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Garg S, 2015, GENOME BIOL EVOL, V7, P2716, DOI 10.1093/gbe/evv175; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; Hamann E, 2017, ISME J, V11, P1205, DOI 10.1038/ismej.2016.197; Hampl V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001383; Hirt RP, 2007, TRENDS PARASITOL, V23, P540, DOI 10.1016/j.pt.2007.08.020; Hirt RP, 2013, SEX TRANSM INFECT, V89, P439, DOI 10.1136/sextrans-2013-051105; Ishida K, 1999, MOL BIOL EVOL, V16, P321, DOI 10.1093/oxfordjournals.molbev.a026113; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kamikawa Ryoma, 2014, BMC Research Notes, V7, P413, DOI 10.1186/1756-0500-7-413; Karnkowska A, 2016, CURR BIOL, V26, P1274, DOI 10.1016/j.cub.2016.03.053; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Koutsovoulos G, 2016, P NATL ACAD SCI USA, V113, P5053, DOI 10.1073/pnas.1600338113; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kusdian G, 2014, MOL BIOCHEM PARASIT, V198, P92, DOI 10.1016/j.molbiopara.2015.01.004; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Leger MM, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0092; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Makiuchi T, 2014, BIOCHIMIE, V100, P3, DOI 10.1016/j.biochi.2013.11.018; Maruyama Shinichiro, 2013, BMC Res Notes, V6, P145, DOI 10.1186/1756-0500-6-145; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; NASH TE, 1990, EXP PARASITOL, V71, P415, DOI 10.1016/0014-4894(90)90067-M; Park JS, 2010, J EUKARYOT MICROBIOL, V57, P520, DOI 10.1111/j.1550-7408.2010.00506.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Regoes A, 2005, J BIOL CHEM, V280, P30557, DOI 10.1074/jbc.M500787200; Richards TA, 2016, P NATL ACAD SCI USA, V113, P4892, DOI 10.1073/pnas.1603862113; Roy SW, 2006, GENOME RES, V16, P750, DOI 10.1101/gr.4845406; Savojardo C, 2014, BIOINFORMATICS, V30, P2973, DOI 10.1093/bioinformatics/btu411; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Simpson AGB, 1999, EUR J PROTISTOL, V35, P353, DOI 10.1016/S0932-4739(99)80044-3; Smith A, 2011, RES MICROBIOL, V162, P646, DOI 10.1016/j.resmic.2011.04.007; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stairs CW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0326; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Takishita K, 2012, PROTIST, V163, P344, DOI 10.1016/j.protis.2011.12.007; Waller RF, 2009, EUKARYOT CELL, V8, P19, DOI 10.1128/EC.00313-08; Wassmer SC, 2015, AM J TROP MED HYG, V93, P42, DOI 10.4269/ajtmh.14-0841; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Xu FF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004053; Yubuki N, 2007, J EUKARYOT MICROBIOL, V54, P191, DOI 10.1111/j.1550-7408.2007.00252.x; Yubuki N, 2013, PROTIST, V164, P423, DOI 10.1016/j.protis.2013.02.002	55	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194487	10.1371/journal.pone.0194487	http://dx.doi.org/10.1371/journal.pone.0194487			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590215	Green Submitted, Green Published, gold			2022-12-26	WOS:000428603100062
J	Linde, LE; Rasmussen, S; Kessler, J; Ebbing, C				Linde, Lorentz Erland; Rasmussen, Svein; Kessler, Jorg; Ebbing, Cathrine			Extreme umbilical cord lengths, cord knot and entanglement: Risk factors and risk of adverse outcomes, a population-based study	PLOS ONE			English	Article							PRENATAL ULTRASONOGRAPHIC DIAGNOSIS; BLOOD-FLOW DISTRIBUTION; MEDICAL BIRTH REGISTRY; HUMAN FETAL; TRUE KNOT; VALIDATION; COMPRESSION; MOVEMENTS; DELIVERY; NORWAY	Objectives To determine risk factors for short and long umbilical cord, entanglement and knot. Explore their associated risks of adverse maternal and perinatal outcome, including risk of recurrence in a subsequent pregnancy. To provide population based gestational age and sex and parity specific reference ranges for cord length. Design Population based registry study. Setting Medical Birth Registry of Norway 1999-2013. Population All singleton births (gestational age>22weeks<45 weeks) (n = 856 300). Methods Descriptive statistics and odds ratios of risk factors for extreme cord length and adverse outcomes based on logistic regression adjusted for confounders. Main outcome measures Short or long cord (<10th or >90th percentile), cord knot and entanglement, adverse pregnancy outcomes including perinatal and intrauterine death. Results Increasing parity, maternal height and body mass index, and diabetes were associated with increased risk of a long cord. Large placental and birth weight, and fetal male sex were factors for a long cord, which again was associated with a doubled risk of intrauterine and perinatal death, and increased risk of adverse neonatal outcome. Anomalous cord insertion, female sex, and a small placenta were associated with a short cord, which was associated with increased risk of fetal malformations, placental complications, caesarean delivery, non cephalic presentation, perinatal and intrauterine death. At term, cord knot was associated with a quadrupled risk of perinatal death. The combination of a cord knot and entanglement had a more than additive effect to the association to perinatal death. There was a more than doubled risk of recurrence of a long or short cord, knot and entanglement in a subsequent pregnancy of the same woman. Conclusion Cord length is influenced both by maternal and fetal factors, and there is increased risk of recurrence. Extreme cord length, entanglement and cord knot are associated with increased risk of adverse outcomes including perinatal death. We provide population based reference ranges for umbilical cord length.	[Linde, Lorentz Erland; Rasmussen, Svein; Kessler, Jorg; Ebbing, Cathrine] Haukeland Hosp, Dept Obstet & Gynecol, Bergen, Norway; [Rasmussen, Svein] Univ Bergen, Dept Clin Sci, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen	Ebbing, C (corresponding author), Haukeland Hosp, Dept Obstet & Gynecol, Bergen, Norway.	Cathrine.ebbing@helse-bergen.no	Ebbing, Cathrine/ABC-9123-2020	Ebbing, Cathrine/0000-0002-4331-1250; Linde, Lorentz Erland/0000-0001-5865-0581	Western Norway Regional Health Authority [911581]	Western Norway Regional Health Authority	Cathrine Ebbing was supported financially by the Western Norway Regional Health Authority (Post doctoral grant no 911581). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airas U, 2002, AM J PERINAT, V19, P127, DOI 10.1055/s-2002-25311; Almli CR, 2001, DEV PSYCHOBIOL, V38, P252, DOI 10.1002/dev.1019; Antoniou EE, 2011, BIOL REPROD, V85, P137, DOI 10.1095/biolreprod.110.088807; Baergen RN, 2001, PEDIATR DEVEL PATHOL, V4, P144, DOI 10.1007/s100240010135; Baghestan E, 2007, ACTA OBSTET GYN SCAN, V86, P205, DOI 10.1080/00016340601111364; Buss C, 2009, EARLY HUM DEV, V85, P633, DOI 10.1016/j.earlhumdev.2009.08.001; Charil A, 2010, BRAIN RES REV, V65, P56, DOI 10.1016/j.brainresrev.2010.06.002; Ebbing C., 2016, ACTA OBSTET GYNECOL; Ebbing C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070380; Engeland A, 2009, ACTA OBSTET GYN SCAN, V88, P1083, DOI 10.1080/00016340903128454; Gabory A, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-5; Gembruch U, 1996, ULTRASOUND OBST GYN, V8, P53, DOI 10.1046/j.1469-0705.1996.08010053.x; Georgiadis L, 2014, PLACENTA, V35, P275, DOI 10.1016/j.placenta.2014.02.001; Glynn LM, 2012, DEVELOPMENTAL SCI, V15, P601, DOI 10.1111/j.1467-7687.2012.01159.x; Guzikowski W, 2014, ARCH MED SCI, V10, P91, DOI 10.5114/aoms.2013.33068; Hepper PG, 2012, DEVELOPMENTAL SCI, V15, P373, DOI 10.1111/j.1467-7687.2011.01132.x; ITSKOVITZ J, 1987, AM J PHYSIOL, V252, pH100, DOI 10.1152/ajpheart.1987.252.1.H100; JENSEN A, 1991, J DEV PHYSIOL, V15, P309; Kiserud T, 2006, ULTRASOUND OBST GYN, V28, P126, DOI 10.1002/uog.2832; Koskinen A, 2015, PLACENTA, V36, P767, DOI 10.1016/j.placenta.2015.04.004; Krakowiak P, 2004, OBSTET GYNECOL, V103, P119, DOI 10.1097/01.AOG.0000102706.84063.C7; MILLER ME, 1982, J PEDIATR-US, V101, P844, DOI 10.1016/S0022-3476(82)80344-2; Olaya-C M, 2015, J Neonatal Perinatal Med, V8, P251, DOI 10.3233/NPM-15915056; Raisanen S, 2013, INT J GYNECOL OBSTET, V122, P18, DOI 10.1016/j.ijgo.2013.02.012; Rasmussen S, 2003, ACTA OBSTET GYN SCAN, V82, P109, DOI 10.1034/j.1600-0412.2003.00009.x; SALAFIA CM, 1990, AM J OBSTET GYNECOL, V163, P1282, DOI 10.1016/0002-9378(90)90708-F; SEPULVEDA W, 1995, ULTRASOUND OBST GYN, V5, P106; Sepulveda W, 2009, J ULTRAS MED, V28, P831, DOI 10.7863/jum.2009.28.6.831; Sherer DM, 1999, AM J PERINAT, V16, P445, DOI 10.1055/s-1999-6807; Skulstad SM, 2005, EARLY HUM DEV, V81, P325, DOI 10.1016/j.earlhumdev.2004.07.006; Sunde ID, ACTA OBSTET GYNECOLO; Taweevisit M, 2010, PEDIATR DEVEL PATHOL, V13, P112, DOI [10.2350/09-07-0680-CR.1, 10.2350/09-06-0669-CR.1]; Van der Meulen JA, 2008, DEV PSYCHOBIOL, V50, P530, DOI 10.1002/dev.20306; Verbruggen SW, 2016, BIOMECH MODEL MECHAN, V15, P995, DOI 10.1007/s10237-015-0738-1; Vintzileos AM, 1992, J MATERNAL FETAL MED, V1, P196; Vintzileos AM, 2015, AM J OBSTET GYNECOL, V213, pS70, DOI 10.1016/j.ajog.2015.05.059; Weiner E, 2015, J PERINATOL, V35, P919, DOI 10.1038/jp.2015.102	37	28	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194814	10.1371/journal.pone.0194814	http://dx.doi.org/10.1371/journal.pone.0194814			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584790	Green Submitted, Green Published, gold			2022-12-26	WOS:000428373000038
J	Makridakis, S; Spiliotis, E; Assimakopoulos, V				Makridakis, Spyros; Spiliotis, Evangelos; Assimakopoulos, Vassilios			Statistical and Machine Learning forecasting methods: Concerns and ways forward	PLOS ONE			English	Article							TIME-SERIES; NEURAL-NETWORKS; STATE; MODELS; ALGORITHMS; PREDICTION; ACCURACY; TREND	Machine Learning (ML) methods have been proposed in the academic literature as alternatives to statistical ones for time series forecasting. Yet, scant evidence is available about their relative performance in terms of accuracy and computational requirements. The purpose of this paper is to evaluate such performance across multiple forecasting horizons using a large subset of 1045 monthly time series used in the M3 Competition. After comparing the post-sample accuracy of popular ML methods with that of eight traditional statistical ones, we found that the former are dominated across both accuracy measures used and for all forecasting horizons examined. Moreover, we observed that their computational requirements are considerably greater than those of statistical methods. The paper discusses the results, explains why the accuracy of ML models is below that of statistical ones and proposes some possible ways forward. The empirical results found in our research stress the need for objective and unbiased ways to test the performance of forecasting methods that can be achieved through sizable and open competitions allowing meaningful comparisons and definite conclusions.	[Makridakis, Spyros] Univ Nicosia, IFF, Nicosia, Cyprus; [Spiliotis, Evangelos; Assimakopoulos, Vassilios] Natl Tech Univ Athens, Sch Elect & Comp Engn, Forecasting & Strategy Unit, Zografos, Greece	University of Nicosia; National Technical University of Athens	Spiliotis, E (corresponding author), Natl Tech Univ Athens, Sch Elect & Comp Engn, Forecasting & Strategy Unit, Zografos, Greece.	spiliotis@fsu.gr	Spiliotis, Evangelos/AAB-6214-2019	Spiliotis, Evangelos/0000-0002-1854-1206				Abadi M., 2016, TENSORFLOW LARGE SCA; Adya M, 1998, J FORECASTING, V17, P481, DOI 10.1002/(SICI)1099-131X(1998090)17:5/6<481::AID-FOR709>3.0.CO;2-Q; Ahmed NK, 2010, ECONOMET REV, V29, P594, DOI 10.1080/07474938.2010.481556; Alpaydin E., 2004, MACHINE LEARNING INT; Andrawis RR, 2011, INT J FORECASTING, V27, P672, DOI 10.1016/j.ijforecast.2010.09.005; [Anonymous], 2014, ACAD ACCOUNTING FINA; Assimakopoulos V, 2000, INT J FORECASTING, V16, P521, DOI 10.1016/S0169-2070(00)00066-2; Bauwens L, 2006, J APPL ECONOMET, V21, P79, DOI 10.1002/jae.842; Bergmeir C, 2012, J STAT SOFTW, V46, P1; Box G. E. P., 1970, Time series analysis, forecasting and control; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Breiman L, 1993, CLASSIFICATION REGRE; Chasset P -O., 2013, GRNN GEN REGRESSION; CHATFIELD C, 1993, INT J FORECASTING, V9, P1, DOI 10.1016/0169-2070(93)90043-M; Chollet F., 2015, KERAS; CONNOR JT, 1994, IEEE T NEURAL NETWOR, V5, P240, DOI 10.1109/72.279188; COTTRELL M, 1995, IEEE T NEURAL NETWOR, V6, P1355, DOI 10.1109/72.471372; COX DR, 1955, BIOMETRIKA, V42, P80, DOI 10.1093/biomet/42.1-2.80; Crone SF, 2011, INT J FORECASTING, V27, P635, DOI 10.1016/j.ijforecast.2011.04.001; Deng L, 2014, APSIPA TRANS SIGNAL, V3, DOI 10.1017/atsip.2013.9; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Gabor MR, 2017, TRANSFORM BUS ECON, V16, P187; GARDNER ES, 1985, J FORECASTING, V4, P1, DOI 10.1002/for.3980040103; Gardner ES, 2006, INT J FORECASTING, V22, P637, DOI 10.1016/j.ijforecast.2006.03.005; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Goodwin P, 1999, INT J FORECASTING, V15, P405, DOI 10.1016/S0169-2070(99)00007-2; GORR WL, 1994, INT J FORECASTING, V10, P1, DOI 10.1016/0169-2070(94)90044-2; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Green KC, 2015, J BUS RES, V68, P1678, DOI 10.1016/j.jbusres.2015.03.026; Hagan M., 1997, IEEE INT C NEUR NETW, V3, P1930, DOI DOI 10.1109/ICNN.1997.614194; Hamzacebi C, 2009, EXPERT SYST APPL, V36, P3839, DOI 10.1016/j.eswa.2008.02.042; HANSEN LK, 1990, IEEE T PATTERN ANAL, V12, P993, DOI 10.1109/34.58871; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hyndman RJ, 2002, INT J FORECASTING, V18, P439, DOI 10.1016/S0169-2070(01)00110-8; Hyndman RJ, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i03; Ilies I, 2007, TECHNICAL REPORT; Jain LC, 1999, INT SER COMPUTAT INT, P1; Kang YF, 2017, INT J FORECASTING, V33, P345, DOI 10.1016/j.ijforecast.2016.09.004; Karatzoglou A, 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i09, DOI 10.18637/JSS.V011.I09]; Keogh E, 2003, DATA MIN KNOWL DISC, V7, P349, DOI 10.1023/A:1024988512476; Kock AB, 2016, ECONOMET REV, V35, P1753, DOI 10.1080/07474938.2015.1035163; Laurent S, 2012, J APPL ECONOMET, V27, P934, DOI 10.1002/jae.1248; Lippmann R. P., 1987, IEEE ASSP Magazine, V4, P4, DOI 10.1145/44571.44572; Liu WB, 2017, NEUROCOMPUTING, V234, P11, DOI 10.1016/j.neucom.2016.12.038; MACKAY DJC, 1992, NEURAL COMPUT, V4, P415, DOI [10.1162/neco.1992.4.3.415, 10.1162/neco.1992.4.3.448]; Makridakis S, 2000, INT J FORECASTING, V16, P451, DOI 10.1016/S0169-2070(00)00057-1; MAKRIDAKIS S, 1979, J ROY STAT SOC A STA, V142, P97, DOI 10.2307/2345077; Makridakis S., 1998, FORECASTING METHODS; Makridakis S, 2017, FUTURES, V90, P46, DOI 10.1016/j.futures.2017.03.006; Marr B., 2016, FORBES; Meyer D, 2017, E1071 MISC FUNCTIONS; MOLLER MF, 1993, NEURAL NETWORKS, V6, P525, DOI 10.1016/S0893-6080(05)80056-5; NELSON CR, 1982, J MONETARY ECON, V10, P139, DOI 10.1016/0304-3932(82)90012-5; Nelson M., 1994, Proceedings of the Twenty-Seventh Hawaii International Conference on System Sciences. Vol.III: Information Systems: Decision Support and Knowledge-Based Systems (Cat. No.94TH0607-2), P649, DOI 10.1109/HICSS.1994.323316; Nguyen D., 1990, IN 1990 IJCNN INT JO, P21, DOI DOI 10.1109/IJCNN.1990.137819; Petropoulos F, 2014, EUR J OPER RES, V237, P152, DOI 10.1016/j.ejor.2014.02.036; Qiu MY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155133; Robinson C, 2017, APPL ENERG, V208, P889, DOI 10.1016/j.apenergy.2017.09.060; Rodriguez PP, 2016, BRNN BAYESIAN REGULA; Sakamoto Y, 1986, AKAIKE INFORM CRITER; Salaken SM, 2017, NEUROCOMPUTING, V267, P516, DOI 10.1016/j.neucom.2017.06.037; Scholkopf B, 2001, LEARNING KERNEL SUPP; Seeger Matthias, 2004, Int J Neural Syst, V14, P69, DOI 10.1142/S0129065704001899; SHARDA R, 1992, J INTELL MANUF, V3, P317, DOI 10.1007/BF01577272; SPECHT DF, 1991, IEEE T NEURAL NETWOR, V2, P568, DOI 10.1109/72.97934; Spiliotis E, 2018, WORKING PAPER; Therneau T., 2015, PACKAGE RPART, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/PACKAGE=RPART; Venables WN., 2002, MODERN APPL STAT S, V4; Voyant C, 2017, RENEW ENERG, V105, P569, DOI 10.1016/j.renene.2016.12.095; Wang J, 2017, NEURAL NETWORKS, V90, P8, DOI 10.1016/j.neunet.2017.03.004; Zaremba W, 2014, CORR; Zeng NY, 2018, NEUROCOMPUTING, V273, P643, DOI 10.1016/j.neucom.2017.08.043; Zhang GP, 2005, EUR J OPER RES, V160, P501, DOI 10.1016/j.ejor.2003.08.037; Zhang GP., 2007, IEEE T SYSTEMS MAN C, V37; Zhang GQ, 1998, INT J FORECASTING, V14, P35, DOI 10.1016/S0169-2070(97)00044-7; Zhang L, 2016, INFORM SCIENCES, V364, P146, DOI 10.1016/j.ins.2016.01.039; Zhao L., 2009, REV BUSINESS INFORM, V13, P57, DOI https://doi.org/10.19030/rbis.v13i3.4324	81	392	396	7	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194889	10.1371/journal.pone.0194889	http://dx.doi.org/10.1371/journal.pone.0194889			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5KQ	29584784	Green Published, gold, Green Submitted			2022-12-26	WOS:000428373000048
J	Toosizadeh, N; Mohler, J; Marlinski, V				Toosizadeh, Nima; Mohler, Jane; Marlinski, Vladimir			Low intensity vibration of ankle muscles improves balance in elderly persons at high risk of falling	PLOS ONE			English	Article							POSTURAL SWAY; OLDER-ADULTS; BODY SWAY; AGE; RESPONSES; MOTONEURONS; THRESHOLDS; PERCEPTION; ADAPTATION; STANCE	In our study we examined postural performance of young healthy persons (HY), elderly healthy persons (HE), and elderly persons at high risk of falling (FR). Anterio-posterior (AP) and medio-lateral (ML) ankle and hip angular deviations, as well as linear displacements of the center of mass (COM) were assessed in persons standing with eyes either open or closed, while none, and 40 and 30 Hz vibrations were applied bilaterally to the ankle muscle gastrocnemius. During quiet standing with eyes open, balance parameters in FR group differed from those in healthy groups. ML ankle and hip angular deviations, as well as COM linear displacements were noticeably larger in FR group. During quiet standing with eyes closed, all balance parameters in participants of all groups had a clear trend to increase. During standing with eyes open, 40 Hz vibration increased all but one balance parameter within HY group, ankle angular deviations in HE group, but none in FR group. In response to 30 Hz vibration, only ankle angular deviations and COM linear displacements increased in HY group. There were no changes in both elderly groups. During standing with eyes closed, 40 and 30 Hz vibrations did not produce consistent changes in balance parameters in HY and HE groups. In FR persons, 40 Hz vibration did not change balance parameters. However, in FR groups, 30 Hz vibration decreased ankle and hip angular deviations, and COM linear displacements. The major result of the study is a finding that low intensity vibration of ankle muscles makes balance better in elderly persons at high risk of falling. This result is clinically relevant because it suggests that applying mild vibration to ankle muscles while standing and walking might benefit elderly persons, improving their postural performance and reducing a risk of unexpected falls.	[Toosizadeh, Nima; Mohler, Jane] Univ Arizona, Dept Med, Arizona Ctr Aging, Tucson, AZ USA; [Toosizadeh, Nima; Mohler, Jane] Univ Arizona, Dept Med, Div Geriatr Gen Internal Med & Palliat Med, Tucson, AZ USA; [Toosizadeh, Nima; Mohler, Jane] Univ Arizona, Dept Biomed Engn, Tucson, AZ USA; [Marlinski, Vladimir] Barrow Neurol Inst, Div Neurobiol, Phoenix, AZ 85013 USA	University of Arizona; University of Arizona; University of Arizona; Barrow Neurological Institute	Marlinski, V (corresponding author), Barrow Neurol Inst, Div Neurobiol, Phoenix, AZ 85013 USA.	vladimir.marlinski@dignityhealth.org						Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Asslander L, 2015, HUM MOVEMENT SCI, V41, P147, DOI 10.1016/j.humov.2015.02.010; Bekkers EMJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00939; BERGIN PS, 1995, J NEUROL NEUROSUR PS, V58, P335, DOI 10.1136/jnnp.58.3.335; Brizzi L, 2002, J NEUROPHYSIOL, V88, P2207, DOI 10.1152/jn.01051.2001; BURKE D, 1976, J PHYSIOL-LONDON, V261, P673, DOI 10.1113/jphysiol.1976.sp011580; Cardinale M, 2003, J STRENGTH COND RES, V17, P621; Ceballos D, 1999, J ANAT, V195, P563, DOI 10.1046/j.1469-7580.1999.19540563.x; CHASE MH, 1985, EXP NEUROL, V90, P471, DOI 10.1016/0014-4886(85)90035-4; Cho CY, 1998, J AM GERIATR SOC, V46, P426, DOI 10.1111/j.1532-5415.1998.tb02461.x; COLLEDGE NR, 1994, GERONTOLOGY, V40, P273, DOI 10.1159/000213596; Daneault V, 2016, J PHYSIOL ANTHROPOL, V35, DOI 10.1186/s40101-016-0091-9; Deshpande N, 2008, NEUROBIOL AGING, V29, P765, DOI 10.1016/j.neurobiolaging.2006.12.002; Di Giminiani R, 2015, J ELECTROMYOGR KINES, V25, P853, DOI 10.1016/j.jelekin.2015.09.004; Dotson VM, 2016, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00250; Duchateau J, 2016, J EXP BIOL, V219, P197, DOI 10.1242/jeb.123158; Duclos NC, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-130; Eisen A, 1996, NEUROLOGY, V46, P1396, DOI 10.1212/WNL.46.5.1396; EKLUND G, 1972, UPSALA J MED SCI, V77, P112, DOI 10.1517/03009734000000016; ERA P, 1986, ACTA NEUROL SCAND, V74, P210, DOI 10.1111/j.1600-0404.1986.tb07857.x; Erim Z, 1999, J NEUROPHYSIOL, V82, P2081, DOI 10.1152/jn.1999.82.5.2081; Fallon JB, 2007, MUSCLE NERVE, V36, P21, DOI 10.1002/mus.20796; Farina D, 2010, CLIN NEUROPHYSIOL, V121, P1616, DOI 10.1016/j.clinph.2009.10.040; FERNIE GR, 1982, AGE AGEING, V11, P11, DOI 10.1093/ageing/11.1.11; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V478, P173, DOI 10.1113/jphysiol.1994.sp020240; Fransson PA, 2004, EUR J APPL PHYSIOL, V91, P595, DOI 10.1007/s00421-003-1013-1; Goel R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136335; Gomez S, 2009, GAIT POSTURE, V30, P93, DOI 10.1016/j.gaitpost.2009.03.009; Gravelle DC, 2002, NEUROREPORT, V13, P1853, DOI 10.1097/00001756-200210280-00004; Hay L, 1996, EXP BRAIN RES, V108, P129; HAYASHI R, 1981, EXP BRAIN RES, V43, P217; Hellebrandt FA, 1939, AM J PHYS ANTHROPOL, V24, P347, DOI 10.1002/ajpa.1330240318; Hilz MJ, 1998, J NEUROL SCI, V159, P219, DOI 10.1016/S0022-510X(98)00177-4; Howcroft J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172398; Kallio J, 2014, FRONT HUM NEUROSCI, V8, DOI [10.3389/Mhum.2014.00773, 10.3389/fnhum.2014.00773]; Kamen G, 1995, J APPL PHYSIOL, V79, P1908, DOI 10.1152/jappl.1995.79.6.1908; Kararizou E, 2005, ANAL QUANT CYTOL, V27, P1; Kavounoudias A, 2001, J PHYSIOL-LONDON, V532, P869, DOI 10.1111/j.1469-7793.2001.0869e.x; Kido A, 2004, CAN J PHYSIOL PHARM, V82, P238, DOI 10.1139/Y04-017; Kostyukov AI, 2005, EXP BRAIN RES, V163, P284, DOI 10.1007/s00221-004-2188-3; LACKNER JR, 1979, AVIAT SPACE ENVIR MD, V50, P346; Landers KA, 2001, J GERONTOL A-BIOL, V56, pB443, DOI 10.1093/gerona/56.10.B443; LeGates TA, 2014, NAT REV NEUROSCI, V15, P443, DOI 10.1038/nrn3743; Lin SI, 2002, J MOTOR BEHAV, V34, P37, DOI 10.1080/00222890209601929; Lipsitz LA, 2015, ARCH PHYS MED REHAB, V96, P432, DOI 10.1016/j.apmr.2014.10.004; Liu JX, 2005, J HISTOCHEM CYTOCHEM, V53, P445, DOI 10.1369/jhc.4A6257.2005; Liu RSN, 2003, NEUROIMAGE, V20, P22, DOI 10.1016/S1053-8119(03)00219-2; LORD SR, 1991, J GERONTOL, V46, pM69, DOI 10.1093/geronj/46.3.M69; Luft AR, 1999, CEREB CORTEX, V9, P712, DOI 10.1093/cercor/9.7.712; MAKI BE, 1990, J AM GERIATR SOC, V38, P1, DOI 10.1111/j.1532-5415.1990.tb01588.x; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; MANCHESTER D, 1989, J GERONTOL, V44, pM118; McNeil CJ, 2005, MUSCLE NERVE, V31, P461, DOI 10.1002/mus.20276; Melzer I, 2010, CLIN BIOMECH, V25, P984, DOI 10.1016/j.clinbiomech.2010.07.007; Mendez-Balbuena I, 2012, J NEUROSCI, V32, P12612, DOI 10.1523/JNEUROSCI.0680-12.2012; Metter EJ, 1997, J GERONTOL A-BIOL, V52, pB267, DOI 10.1093/gerona/52A.5.B267; Miwa T, 1995, NEUROSCI LETT, V201, P179, DOI 10.1016/0304-3940(95)12165-X; Najafi Bijan, 2010, J Diabetes Sci Technol, V4, P780; Naka M, 2015, PERCEPTION, V44, P39, DOI 10.1068/p7738; NARDONE A, 1995, ARCH PHYS MED REHAB, V76, P158, DOI 10.1016/S0003-9993(95)80025-5; PAULUS WM, 1984, BRAIN, V107, P1143, DOI 10.1093/brain/107.4.1143; Piotrkiewicz M, 2007, J PHYSIOL-LONDON, V585, P483, DOI 10.1113/jphysiol.2007.142356; Polonyova A, 2001, PHYSIOL RES, V50, P405; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Priplata AA, 2006, ANN NEUROL, V59, P4, DOI 10.1002/ana.20670; Priplata AA, 2003, LANCET, V362, P1123, DOI 10.1016/S0140-6736(03)14470-4; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Resnick SM, 2003, J NEUROSCI, V23, P3295; Rivner MH, 2001, MUSCLE NERVE, V24, P1134, DOI 10.1002/mus.1124; ROLL JP, 1989, EXP BRAIN RES, V76, P213; Rubenstein LZ, 2011, J SAFETY RES, V42, P493, DOI 10.1016/j.jsr.2011.08.006; SKINNER HB, 1984, CLIN ORTHOP RELAT R, P208; Sozzi S, 2011, HUM MOVEMENT SCI, V30, P172, DOI 10.1016/j.humov.2010.06.002; Thelen DG, 1998, J GERONTOL A-BIOL, V53, pM33, DOI 10.1093/gerona/53A.1.M33; Tokuno CD, 2010, CLIN NEUROPHYSIOL, V121, P109, DOI 10.1016/j.clinph.2009.09.025; TOMLINSON BE, 1977, J NEUROL SCI, V34, P213, DOI 10.1016/0022-510X(77)90069-7; Toosizadeh N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135255; Toosizadeh N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124763; Trevino M, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00572; Vandewalle G, 2009, TRENDS COGN SCI, V13, P429, DOI 10.1016/j.tics.2009.07.004; Verdu E, 2000, J PERIPHER NERV SYST, V5, P191, DOI 10.1046/j.1529-8027.2000.00026.x; Verschueren SMP, 2002, BEHAV BRAIN RES, V136, P593, DOI 10.1016/S0166-4328(02)00224-3; Walhovd KB, 2005, NEUROBIOL AGING, V26, P1261, DOI 10.1016/j.neurobiolaging.2005.05.020; Watanabe K, 2016, AGE, V38, DOI 10.1007/s11357-016-9915-0; Wierzbicka MM, 1998, J NEUROPHYSIOL, V79, P143, DOI 10.1152/jn.1998.79.1.143; Wiesmeier IK, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00097; Wingert JR, 2014, ARCH PHYS MED REHAB, V95, P253, DOI 10.1016/j.apmr.2013.08.012	87	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194720	10.1371/journal.pone.0194720	http://dx.doi.org/10.1371/journal.pone.0194720			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5DH	29579098	Green Published, gold, Green Submitted			2022-12-26	WOS:000428351800050
J	van Oevelen, D; Mueller, CE; Lundalv, T; van Duyl, FC; de Goeij, JM; Middelburg, JJ				van Oevelen, Dick; Mueller, Christina E.; Lundalv, Tomas; van Duyl, Fleur C.; de Goeij, Jasper M.; Middelburg, Jack J.			Niche overlap between a cold-water coral and an associated sponge for isotopically-enriched particulate food sources	PLOS ONE			English	Article							ORGANIC-CARBON; LOPHELIA-PERTUSA; ROCKALL-BANK; NE ATLANTIC; DEEP; FLOW; COMMUNITY; REEFS; SIZE; SEA	The cold-water coral Lophelia pertusa is an ecosystem engineer that builds reef structures on the seafloor. The interaction of the reef topography with hydrodynamics is known to enhance the supply of suspended food sources to the reef communities. However, the reef framework is also a substrate for other organisms that may compete for the very same suspended food sources. Here, we used the passive suspension feeder Lophelia pertusa and the active suspension feeding sponge Hymedesmia coriacea as model organisms to study niche overlap using isotopically-enriched algae and bacteria as suspended food sources. The coral and the sponge were fed with a combination of C-13-enriched bacteria/N-15-enriched algae or N-15-enriched bacteria/C-13-enriched algae, which was subsequently traced into bulk tissue, coral skeleton and dissolved inorganic carbon (i.e. respiration). Both the coral and the sponge assimilated and respired the suspended bacteria and algae, indicating niche overlap between these species. The assimilation rates of C and N into bulk tissue of specimens incubated separately were not significantly different from assimilation rates during incubations with co-occurring corals and sponges. Hence, no evidence for exploitative resource competition was found, but this is likely due to the saturating experimental food concentration that was used. We do not rule out that exploitative competition occurs in nature during periods of low food concentrations. Food assimilation and respiration rates of the sponge were almost an order of magnitude higher than those of the cold water coral. We hypothesize that the active suspension feeding mode of the sponge explains the observed differences in resource uptake as opposed to the passive suspension feeding mode of the cold-water coral. These feeding mode differences may set constraints on suitable habitats for cold-water corals and sponges in their natural habitats.	[van Oevelen, Dick; Mueller, Christina E.] Royal Netherlands Inst Sea Res NIOZ Yerseke, Dept Estuarine & Delta Syst, Yerseke, Netherlands; [van Oevelen, Dick; Mueller, Christina E.] Univ Utrecht, Yerseke, Netherlands; [Lundalv, Tomas] Univ Gothenburg, Sven Loven Ctr Marine Sci, Stromstad, Sweden; [van Duyl, Fleur C.] Royal Netherlands Inst Sea Res NIOZ Texel, Dept Marine Microbiol & Biogeochem, Texel, Netherlands; [van Duyl, Fleur C.] Univ Utrecht, Texel, Netherlands; [de Goeij, Jasper M.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Freshwater & Marine Ecol, Amsterdam, Netherlands; [Middelburg, Jack J.] Univ Utrecht, Dept Earth Sci, Utrecht, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University; University of Gothenburg; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University; University of Amsterdam; Utrecht University	van Oevelen, D (corresponding author), Royal Netherlands Inst Sea Res NIOZ Yerseke, Dept Estuarine & Delta Syst, Yerseke, Netherlands.; van Oevelen, D (corresponding author), Univ Utrecht, Yerseke, Netherlands.	Dick.van.Oevelen@nioz.nl	Middelburg, Jack/B-4951-2011; van Duyl, Fleur C./P-9711-2016; Lundälv, Tomas/O-7121-2019	Middelburg, Jack/0000-0003-3601-9072; van Duyl, Fleur C./0000-0002-8410-4151; 	CALMARO within the European Community's Seventh Framework Program; Netherlands Organisation for Scientific Research (VIDI grant) [864.13.007]; European Union's Horizon research and innovation programme [678760, 679849]	CALMARO within the European Community's Seventh Framework Program; Netherlands Organisation for Scientific Research (VIDI grant); European Union's Horizon research and innovation programme	This research was supported by the CALMARO project (FP7/2007-2013) within the European Communitys Seventh Framework Program (FP7/2007-2013), the Netherlands Organisation for Scientific Research (VIDI grant no. 864.13.007 to DvO) and has received funding from the European Unions Horizon 2020 research and innovation programme under grant agreements No. 678760 (ATLAS) and No. 679849 (SponGES). This output reflects only the authors view and the European Union cannot be held responsible for any use that may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins JF, 2003, GEOCHIM COSMOCHIM AC, V67, P1129, DOI 10.1016/S0016-7037(02)01203-6; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Cathalot C, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00037; Cyr F, 2016, GEOPHYS RES LETT, V43, P775, DOI 10.1002/2015GL067038; DAME R, 1991, ESTUARIES, V14, P130, DOI 10.2307/1351686; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; de Goeij JM, 2008, LIMNOL OCEANOGR, V53, P1376, DOI 10.4319/lo.2008.53.4.1376; Dodds LA, 2007, J EXP MAR BIOL ECOL, V349, P205, DOI 10.1016/j.jembe.2007.05.013; Duineveld GCA, 2007, B MAR SCI, V81, P449; Duineveld GCA, 2012, MAR ECOL PROG SER, V444, P97, DOI 10.3354/meps09430; Findlay HS, 2013, GLOBAL CHANGE BIOL, V19, P2708, DOI 10.1111/gcb.12256; Fossa JH, 2002, HYDROBIOLOGIA, V471, P1, DOI 10.1023/A:1016504430684; FREDERIKSEN R, 1992, SARSIA, V77, P157, DOI 10.1080/00364827.1992.10413502; Gili JM, 1998, TRENDS ECOL EVOL, V13, P316, DOI 10.1016/S0169-5347(98)01365-2; Gori A, 2014, DEEP-SEA RES PT II, V99, P42, DOI 10.1016/j.dsr2.2013.06.007; Guihen Damien, 2012, Marine Biodiversity Records, V5, P1; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Johnsen E, FOOD SUPPLY ME UNPUB; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kiriakoulakis K, 2007, INT J EARTH SCI, V96, P159, DOI 10.1007/s00531-006-0078-6; Kiriakoulakis K, 2005, ERLANGEN EARTH C SER, P715, DOI 10.1007/3-540-27673-4_37; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LARSEN PS, 1994, J THEOR BIOL, V168, P53, DOI 10.1006/jtbi.1994.1087; Lavaleye M, 2009, OCEANOGRAPHY, V22, P76, DOI 10.5670/oceanog.2009.08; LESSER MP, 1994, BIOL BULL-US, V187, P319, DOI 10.2307/1542289; Leys SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027787; Leys SP, LIMNOLOGY O IN PRESS; Long MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058581; Maier C, 2011, BIOGEOSCIENCES, V8, P2609, DOI 10.5194/bg-8-2609-2011; Middelburg JJ, 2015, SCI REPORTS, V5, P9; Mohn C, 2014, PROG OCEANOGR, V122, P92, DOI 10.1016/j.pocean.2013.12.003; Mortensen PB, 2001, OPHELIA, V54, P83, DOI 10.1080/00785236.2001.10409457; Mueller CE, 2014, BIOGEOSCIENCES, V11, P123, DOI 10.5194/bg-11-123-2014; Mueller CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058660; NIEUWENHUIZE J, 1994, MAR CHEM, V45, P217, DOI 10.1016/0304-4203(94)90005-1; Orejas C, 2016, J EXP MAR BIOL ECOL, V481, P34, DOI 10.1016/j.jembe.2016.04.002; Pile AJ, 1996, MAR ECOL PROG SER, V141, P95, DOI 10.3354/meps141095; Ribes M, 1998, MAR ECOL PROG SER, V175, P201, DOI 10.3354/meps175201; RIISGARD HU, 1995, BIOL REV, V70, P67, DOI 10.1111/j.1469-185X.1995.tb01440.x; Rix L, 2016, SCI REP-UK, V6, DOI 10.1038/srep18715; Roberts J. M., 2009, COLD WATER CORALS BI, DOI [10.1017/CBO9780511581588, DOI 10.1017/CBO9780511581588]; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; SEBENS KP, 1984, P NATL ACAD SCI-BIOL, V81, P5473, DOI 10.1073/pnas.81.17.5473; Soetaert K, 2016, SCI REP-UK, V6, DOI 10.1038/srep35057; SUESS E, 1980, NATURE, V288, P260, DOI 10.1038/288260a0; Tanaka Y, 2007, LIMNOL OCEANOGR, V52, P1139, DOI 10.4319/lo.2007.52.3.1139; Tsounis G, 2010, MAR ECOL PROG SER, V398, P149, DOI 10.3354/meps08312; Turon X, 1997, J EXP ZOOL, V278, P22, DOI 10.1002/(SICI)1097-010X(19970501)278:1<22::AID-JEZ3>3.0.CO;2-8; van Duyl FC, 2008, MAR ECOL PROG SER, V358, P137, DOI 10.3354/meps07370; van Oevelen D, 2016, BIOGEOSCIENCES, V13, P5789, DOI 10.5194/bg-13-5789-2016; van Oevelen D, 2009, LIMNOL OCEANOGR, V54, P1829, DOI 10.4319/lo.2009.54.6.1829; van Soest RWM, 2007, CONTRIB ZOOL, V76, P121, DOI 10.1163/18759866-07602005; Van Soest RWM, 2005, MAR BIOL RES, V1, P338, DOI 10.1080/17451000500380322; van Soest RWM, 2013, J MAR BIOL ASSOC UK, V95, P1461, DOI DOI 10.1017/S0025315413001410; van Weering TCE, 2003, MAR GEOL, V198, P67, DOI 10.1016/S0025-3227(03)00095-1; VOGEL S, 1977, P NATL ACAD SCI USA, V74, P2069, DOI 10.1073/pnas.74.5.2069; Wagner H, 2011, J MARINE SYST, V85, P19, DOI 10.1016/j.jmarsys.2010.11.003; Wild C, 2008, MAR ECOL PROG SER, V372, P67, DOI 10.3354/meps07724; Witte U, 1997, MAR ECOL PROG SER, V154, P241, DOI 10.3354/meps154241; Wulff JL, 2006, CAN J ZOOL, V84, P146, DOI 10.1139/Z06-019; Yahel G, 2007, LIMNOL OCEANOGR, V52, P428, DOI 10.4319/lo.2007.52.1.0428; Zetsche EM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146766	62	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194659	10.1371/journal.pone.0194659	http://dx.doi.org/10.1371/journal.pone.0194659			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579118	Green Published, gold			2022-12-26	WOS:000428351800043
J	Amery-Gale, J; Hartley, CA; Vaz, PK; Marenda, MS; Owens, J; Eden, PA; Devlin, JM				Amery-Gale, Jemima; Hartley, Carol A.; Vaz, Paola K.; Marenda, Marc S.; Owens, Jane; Eden, Paul A.; Devlin, Joanne M.			Avian viral surveillance in Victoria, Australia, and detection of two novel avian herpesviruses	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; NEWCASTLE-DISEASE VIRUS; INCLUSION-BODY DISEASE; WILD BIRD POPULATIONS; BUDGERIGAR MELOPSITTACUS-UNDULATUS; INFECTIOUS-BRONCHITIS VIRUSES; DOUBLE-CRESTED CORMORANTS; INFLUENZA-A VIRUSES; COLUMBID HERPESVIRUS-1; FEATHER DISEASE	Viruses in avian hosts can pose threats to avian health and some have zoonotic potential. Hospitals that provide veterinary care for avian patients may serve as a site of exposure of other birds and human staff in the facility to these viruses. They can also provide a useful location to collect samples from avian patients in order to examine the viruses present in wild birds. This study aimed to investigate viruses of biosecurity and/or zoonotic significance in Australian birds by screening samples collected from 409 birds presented to the Australian Wildlife Health Centre at Zoos Victoria's Healesville Sanctuary for veterinary care between December 2014 and December 2015. Samples were tested for avian influenza viruses, herpesviruses, paramyxoviruses and coronaviruses, using genus- or family-wide polymerase chain reaction methods coupled with sequencing and phylogenetic analyses for detection and identification of both known and novel viruses. A very low prevalence of viruses was detected. Columbid alphaherpesvirus 1 was detected from a powerful owl (Ninox strenua) with inclusion body hepatitis, and an avian paramyxovirus most similar to Avian avulavirus 5 was detected from a musk lorikeet (Glossopsitta concinna). Two distinct novel avian alphaherpesviruses were detected in samples from a sulphur-crested cockatoo (Cacatua galerita) and a tawny frogmouth (Podargus strigoides). Avian influenza viruses and avian coronaviruses were not detected. The clinical significance of the newly detected viruses remains undetermined. Further studies are needed to assess the host specificity, epidemiology, pathogenicity and host-pathogen relationships of these novel viruses. Further genome characterization is also indicated, and would be required before these viruses can be formally classified taxonomically. The detection of these viruses contributes to our knowledge on avian virodiversity. The low level of avian virus detection, and the absence of any viruses with zoonotic potential, suggests low risk to biosecurity and human health.	[Amery-Gale, Jemima; Hartley, Carol A.; Vaz, Paola K.; Owens, Jane; Devlin, Joanne M.] Univ Melbourne, Fac Vet & Agr Sci, Melbourne Vet Sch, Asia Pacific Ctr Anim Hlth, Parkville, Vic, Australia; [Amery-Gale, Jemima; Eden, Paul A.] Australian Wildlife Hlth Ctr, Healesville Sanctuary, Zoos Victoria, Badger Creek, Vic, Australia; [Marenda, Marc S.] Univ Melbourne, Fac Vet & Agr Sci, Melbourne Vet Sch, Asia Pacific Ctr Anim Hlth, Werribee, Vic, Australia	University of Melbourne; University of Melbourne	Amery-Gale, J (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Melbourne Vet Sch, Asia Pacific Ctr Anim Hlth, Parkville, Vic, Australia.; Amery-Gale, J (corresponding author), Australian Wildlife Hlth Ctr, Healesville Sanctuary, Zoos Victoria, Badger Creek, Vic, Australia.	j.amery-gale@student.unimelb.edu.au	Vaz, Paola K./D-8713-2015	Vaz, Paola K./0000-0001-6877-7383; Devlin, Joanne/0000-0003-0400-9670; MARENDA, MARC/0000-0001-6778-1110; Hartley, Carol/0000-0001-6174-7341	Cybec Foundation; Zoos Victoria; Australian Research Council [FT140101287]	Cybec Foundation; Zoos Victoria; Australian Research Council(Australian Research Council)	JAG was supported by the Cybec Foundation (www.cybec.com.au) and Zoos Victoria (www.zoo.org.au). JMD is supported by a grant (FT140101287) from the Australian Research Council (www.arc.gov.au). The Cybec Foundation and the Australian Research Council had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, while Zoos Victoria was involved in study design and facilitation of sample and data collection.	Aaziz R, 2015, APPL ENVIRON MICROB, V81, P4581, DOI 10.1128/AEM.00778-15; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; ALEXANDER DJ, 1982, WORLD POULTRY SCI J, V38, P97, DOI 10.1079/WPS19820008; ALEXANDER DJ, 1995, J COMP PATHOL, V112, P105, DOI 10.1016/S0021-9975(05)80054-4; ALEXANDER DJ, 1992, VET REC, V130, P65, DOI 10.1136/vr.130.4.65; Amery-Gale J, 2017, J MED MICROBIOL, V66, P1005, DOI 10.1099/jmm.0.000516; Arzey G, 2004, AUST VET J, V82, P377, DOI 10.1111/j.1751-0813.2004.tb11110.x; Arzey GG, 2012, EMERG INFECT DIS, V18, P814, DOI 10.3201/eid1805.111852; Australian Government Department of Agriculture and Water Resources, 2012, NOT LOW PATH AV INFL; Australian Government Department of Agriculture and Water Resources, 2013, NOT HIGHL PATH AV IN; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Callison SA, 2006, J VIROL METHODS, V138, P60, DOI 10.1016/j.jviromet.2006.07.018; Capua I, 2004, EUR J CLIN MICROBIOL, V23, P1, DOI 10.1007/s10096-003-1059-3; Chmielewicz B, 2003, XENOTRANSPLANTATION, V10, P349, DOI 10.1034/j.1399-3089.2003.02074.x; Cross TA, 2013, J WILDLIFE DIS, V49, P965, DOI 10.7589/2012-06-164; Domanska-Blicharz K, 2014, AVIAN PATHOL, V43, P406, DOI 10.1080/03079457.2014.949619; Duraes-Carvalho R, 2015, VIRUS RES, V201, P101, DOI 10.1016/j.virusres.2015.03.002; Ehlers B, 1999, VIRUS GENES, V18, P211, DOI 10.1023/A:1008064118057; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Gailbreath KL, 2008, J WILDLIFE DIS, V44, P427, DOI 10.7589/0090-3558-44.2.427; Gallagher A, 1997, AUST VET J, V75, P675, DOI 10.1111/j.1751-0813.1997.tb15372.x; GARNETT ST, 1989, AUST VET J, V66, P129, DOI 10.1111/j.1751-0813.1989.tb09777.x; Glaser LC, 1999, J WILDLIFE DIS, V35, P319, DOI 10.7589/0090-3558-35.2.319; Grillo VL, 2015, AUST VET J, V93, P387, DOI 10.1111/avj.12379; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo Y, 2017, ARCH VIROL, V162, P2131, DOI 10.1007/s00705-017-3329-x; Hansbro PM, 2010, EMERG INFECT DIS, V16, P1896, DOI 10.3201/eid1612.100776; Haynes L, 2009, AUST VET J, V87, P266, DOI 10.1111/j.1751-0813.2009.00446.x; Heine HG, 2007, AVIAN DIS, V51, P370, DOI 10.1637/7587-040206R.1; Hernandez-Jover M, 2015, PREV VET MED, V118, P128, DOI 10.1016/j.prevetmed.2014.11.018; Hill NJ, 2017, EMERG INFECT DIS, V23, P654, DOI 10.3201/eid2304.161668; Hiono T, 2016, GENOME ANNOUNC, V4; Hoque MA, 2012, PREV VET MED, V103, P49, DOI 10.1016/j.prevetmed.2011.08.013; Hughes LA, 2009, EMERG INFECT DIS, V15, P1091, DOI 10.3201/eid1507.090067; Hulbert CL, 2015, AUST VET J, V93, P287, DOI 10.1111/avj.12350; Jung A, 2009, J AVIAN MED SURG, V23, P205, DOI 10.1647/2008-022.1; Kalmar ID, 2014, VET J, V199, P300, DOI 10.1016/j.tvjl.2013.10.034; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kumar S, 2008, VIRUS RES, V137, P189, DOI 10.1016/j.virusres.2008.07.012; Kumar S, 2010, VIRUS RES, V149, P78, DOI 10.1016/j.virusres.2009.12.015; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Lycett SJ, 2016, SCIENCE, V354, P213, DOI 10.1126/science.aaf8852; Mardani K, 2008, J VIROL, V82, P2013, DOI 10.1128/JVI.01694-07; MARE CJ, 1973, INFECT IMMUN, V8, P118; Muradrasoli S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013640; MUSTAFFABABJEE A, 1974, AVIAN DIS, V18, P226, DOI 10.2307/1589130; Nemeth NM, 2013, J WILDLIFE DIS, V49, P437, DOI 10.7589/2012-09-224; NEROME K, 1978, J GEN VIROL, V38, P293, DOI 10.1099/0022-1317-38-2-293; NESTOROWICZ A, 1987, VIROLOGY, V160, P411, DOI 10.1016/0042-6822(87)90012-2; Olson SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090826; Patel JR, 2005, VET J, V170, P14, DOI 10.1016/j.tvjl.2004.04.018; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Perdue ML, 2005, AVIAN DIS, V49, P317, DOI 10.1637/7390-060305R.1; Peroulis I, 2004, AUST VET J, V82, P79, DOI 10.1111/j.1751-0813.2004.tb14650.x; Phalen DN, 2011, AUST VET J, V89, P193, DOI 10.1111/j.1751-0813.2011.00706.x; Phalen DN, 2017, J WILDLIFE DIS, V53, P543, DOI 10.7589/2016-07-158; Phalen DN, 2009, PSITTACID HERPESVIRU; Pinkerton ME, 2008, J WILDLIFE DIS, V44, P622, DOI 10.7589/0090-3558-44.3.622; Poovorawan Y, 2013, PATHOG GLOB HEALTH, V107, P217, DOI 10.1179/2047773213Y.0000000103; Prosser DJ, 2013, FRONTIERS PUBLIC HLT, V1, P1; Quinteros JA, 2016, VET MICROBIOL, V197, P27, DOI 10.1016/j.vetmic.2016.11.003; Quinteros JA, 2015, AVIAN PATHOL, V44, P182, DOI 10.1080/03079457.2015.1022857; Raidal SR, 2015, AUST VET J, V93, P466, DOI 10.1111/avj.12388; Raidal SR, 1998, AVIAN PATHOL, V27, P263, DOI 10.1080/03079459808419334; Reperant LA, 2012, HUM VACC IMMUNOTHER, V8, P7, DOI 10.4161/hv.8.1.18672; Richard M, 2014, FUTURE VIROL, V9, P513, DOI 10.2217/fvl.14.30; Rose N, 2012, CAN VET J, V53, P265; Samuel AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009269; Sharples E, 2009, VET REC, V164, P16, DOI 10.1136/vr.164.1.16; Shihmanter E, 1998, AVIAN DIS, V42, P829, DOI 10.2307/1592725; Shihmanter E, 1998, AVIAN DIS, V42, P418, DOI 10.2307/1592497; Shivaprasad HL, 2012, AVIAN PATHOL, V41, P531, DOI 10.1080/03079457.2012.732692; Smit T, 1976, Avian Pathol, V5, P21, DOI 10.1080/03079457608418166; STALLKNECHT DE, 1988, VET RES COMMUN, V12, P125, DOI 10.1007/BF00362792; Stojanovic D., 2017, EC RES, P1; Styles DK, 2005, AVIAN PATHOL, V34, P150, DOI 10.1080/03079450500059032; Subbiah M, 2010, VIRUS RES, V152, P85, DOI 10.1016/j.virusres.2010.06.009; Thureen DR, 2006, J VIROL, V80, P7863, DOI 10.1128/JVI.00134-06; Tomaszewski EK, 2003, J VIROL, V77, P11260, DOI 10.1128/JVI.77.20.11260-11267.2003; Tomaszewski EK, 2006, J VET DIAGN INVEST, V18, P536, DOI 10.1177/104063870601800603; Tong S, 2008, J CLIN MICROBIOL, V46, P2652, DOI 10.1128/JCM.00192-08; van Boheemen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034961; van Dijk JGB, 2018, CURR OPIN VIROL, V28, P26, DOI 10.1016/j.coviro.2017.10.006; Vaz PK, 2016, J GEN VIROL, V97, P747, DOI 10.1099/jgv.0.000378; Vijaykrishna D, 2013, J VIROL, V87, P10182, DOI 10.1128/JVI.03437-12; Xiao S, 2010, VIRUS RES, V150, P61, DOI 10.1016/j.virusres.2010.02.015; Xu Y, 2017, J VIROL, V91, DOI [10.1128/JVI.02208-16, 10.1128/jvi.02208-16]; Zhang LJ, 2015, ARCH VIROL, V160, P459, DOI 10.1007/s00705-014-2247-4	89	10	10	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2018	13	3							e0194457	10.1371/journal.pone.0194457	http://dx.doi.org/10.1371/journal.pone.0194457			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA2QK	29570719	Green Published, gold			2022-12-26	WOS:000428168400020
J	Barbosa, ALA; Vermeulen, SHHM; Aben, KK; Grotenhuis, AJ; Vrieling, A; Kiemeney, LA				Barbosa, Andre L. A.; Vermeulen, Sita H. H. M.; Aben, Katja K.; Grotenhuis, Anne J.; Vrieling, Alina; Kiemeney, Lambertus A.			Smoking intensity and bladder cancer aggressiveness at diagnosis	PLOS ONE			English	Article							RISK-FACTORS; UROTHELIAL CARCINOMA; CIGARETTE-SMOKING; GRADE; MUTATIONS; SUBTYPES; STAGE; OUTCOMES; UPDATE; IMPACT	Objective To explore the relation between cigarette smoking intensity and bladder cancer aggressiveness at first diagnosis. Methods Patients diagnosed with urinary bladder cancer (BC) between 1995 +/- 2011 under the age of 75 years were retrospectively identified from the Netherlands Cancer Registry and invited for a study on genetic and lifestyle risk factors for BC. Information on patients' self-reported smoking history was retrieved by means of a postal questionnaire. Tumors were stratified regarding the risk of progression defined by tumor stage and grade. Multinomial logistic regression was used to analyze the relation between smoking intensity and aggressiveness of the tumor. Results The UBC study population comprised 323 (17.4%) never smokers, 870 (46.8%) former cigarette smokers, and 630 (33.9%) current cigarette smokers. A higher smoking amount was a risk factor of getting high-risk non-muscle invasive bladder cancer (NMIBC) compared with low-risk NMIBC in ever and former cigarette smokers (OR: 1.02 per cigarette smoked, 95% CI: 1.00 +/- 1.03 and OR: 1.03, 95% CI: 1.01 +/- 1.05, respectively). A statistically significant dose-response increase in the risk of a more aggressive cancer type (high-risk NMIBC and MIBC) was observed with increasing smoking duration among former smokers (p for trend 0.035 and 0.008, respectively). No significant association of the evaluated smoking intensity variables was observed in current smokers. A longer time of smoking cessation correlated with a lower odds of a more aggressive cancer. Conclusion We observed a weak increase in the risk of a more aggressive tumor type with increasing smoking intensity in former smokers, but this association was absent in current smokers. This conflicting result may suggest that there is no strong relation between smoking intensity and bladder cancer aggressiveness. Analyses of prospective studies with longitudinal smoking assessment may provide a more definitive answer to the research question.	[Barbosa, Andre L. A.; Vermeulen, Sita H. H. M.; Aben, Katja K.; Grotenhuis, Anne J.; Vrieling, Alina; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Hlth Evidence, Nijmegen, Netherlands; [Barbosa, Andre L. A.] Univ Fed Bahia, Salvador, BA, Brazil; [Aben, Katja K.] Netherlands Comprehens Canc Org, Utrecht, Netherlands; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Urol, Nijmegen, Netherlands	Radboud University Nijmegen; Universidade Federal da Bahia; Radboud University Nijmegen	Kiemeney, LA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Hlth Evidence, Nijmegen, Netherlands.; Kiemeney, LA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Urol, Nijmegen, Netherlands.	Bart.kiemeney@radboudumc.nl	Kiemeney, Lambertus A./D-3357-2009; Aben, Katja KH/G-9686-2016; Vermeulen, Sita H./L-4716-2015; Vrieling, Alina/A-2725-2016	Kiemeney, Lambertus A./0000-0002-2368-1326; Aben, Katja KH/0000-0002-0214-2147; Vermeulen, Sita H./0000-0003-4913-8601; Vrieling, Alina/0000-0002-8178-2125				Ajili F, 2013, ULTRASTRUCT PATHOL, V37, P273, DOI 10.3109/01913123.2013.770111; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; BROOKS DR, 1992, AM J IND MED, V21, P699, DOI 10.1002/ajim.4700210510; Burger M, 2013, EUR UROL, V63, P234, DOI 10.1016/j.eururo.2012.07.033; Chamssuddin AK, 2013, ARAB J UROL, V11, P165, DOI 10.1016/j.aju.2012.12.009; Chang WC, 2012, AM J SURG PATHOL, V36, P454, DOI 10.1097/PAS.0b013e31823dafd3; Eble J.N, 2004, PATHOLOGY GENETICS T; El-Sebaie Medhat, 2005, Int J Clin Oncol, V10, P20, DOI 10.1007/s10147-004-0457-6; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Freedman ND, 2011, JAMA-J AM MED ASSOC, V306, P737, DOI 10.1001/jama.2011.1142; Grotenhuis AJ, 2015, UROL ONCOL-SEMIN ORI, V33, DOI 10.1016/j.urolonc.2014.06.002; HAYES RB, 1993, CANCER CAUSE CONTROL, V4, P157, DOI 10.1007/BF00053157; JENSEN OM, 1987, J EPIDEMIOL COMMUN H, V41, P30, DOI 10.1136/jech.41.1.30; Jiang XJ, 2012, INT J CANCER, V130, P896, DOI 10.1002/ijc.26068; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Knowles MA, 2015, NAT REV CANCER, V15, P25, DOI 10.1038/nrc3817; LaRue H, 2000, CARCINOGENESIS, V21, P101, DOI 10.1093/carcin/21.1.101; Leppert JT, 2006, EUR UROL, V49, P226, DOI 10.1016/j.eururo.2005.12.011; McConkey DJ, 2014, EUR UROL, V66, P609, DOI 10.1016/j.eururo.2014.05.006; McCormack VA, 2010, INT J CANCER, V127, P2402, DOI 10.1002/ijc.25252; Mitra AP, 2013, CANCER-AM CANCER SOC, V119, P756, DOI 10.1002/cncr.27763; Mohseni M G, 2004, Urol J, V1, P250; MORRISON AS, 1982, INT J CANCER, V30, P701, DOI 10.1002/ijc.2910300605; Mostofi FK, 1973, HISTOLOGICAL TYPING; Ouerhani S, 2009, CANCER INVEST, V27, P998, DOI 10.3109/07357900902849707; Persad R, UROL ONCOL, V3, P18; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Pietzak EJ, 2015, UROLOGY, V86, P968, DOI 10.1016/j.urology.2015.05.040; Rausch S, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2012.11.020; Rink M, 2013, EUR UROL, V64, P456, DOI 10.1016/j.eururo.2012.11.039; Robertson AG, 2017, CELL, V171, P540, DOI 10.1016/j.cell.2017.09.007; Ros MM, 2012, EUR J CANCER, V48, P3267, DOI 10.1016/j.ejca.2012.05.026; Serretta V, 2006, UROL INT, V77, P152, DOI 10.1159/000093911; Stenzl A, 2011, EUR UROL, V59, P1009, DOI 10.1016/j.eururo.2011.03.023; STURGEON SR, 1994, EPIDEMIOLOGY, V5, P218, DOI 10.1097/00001648-199403000-00012; Sun XZ, 2017, CANCER CAUSE CONTROL, V28, P539, DOI 10.1007/s10552-017-0885-z; van Roekel EH, 2013, INT J CANCER, V133, P446, DOI 10.1002/ijc.28017; Wallerand H, 2005, CARCINOGENESIS, V26, P177, DOI 10.1093/carcin/bgh275; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Yavorski JM, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.13045	40	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2018	13	3							e0194039	10.1371/journal.pone.0194039	http://dx.doi.org/10.1371/journal.pone.0194039			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA2QK	29570711	Green Published, gold			2022-12-26	WOS:000428168400011
J	Calizza, E; Careddu, G; Sporta Caputi, S; Rossi, L; Costantini, ML				Calizza, Edoardo; Careddu, Giulio; Sporta Caputi, Simona; Rossi, Loreto; Costantini, Maria Letizia			Time- and depth-wise trophic niche shifts in Antarctic benthos	PLOS ONE			English	Article							TERRA-NOVA BAY; FOOD-WEB STRUCTURE; ROSS SEA; ORGANIC-MATTER; CLIMATE-CHANGE; ADAMUSSIUM-COLBECKI; BODY-SIZE; COMMUNITIES; COMPETITION; DIVERSITY	Climate change is expected to affect resource-consumer interactions underlying stability in polar food webs. Polar benthic organisms have adapted to the marked seasonality characterising their habitats by concentrating foraging and reproductive activity in summer months, when inputs from sympagic and pelagic producers increase. While this enables the persistence of biodiverse food webs, the mechanisms underlying changes in resource use and nutrient transfer are poorly understood. Thus, our understanding of how temporal and spatial variations in the supply of resources may affect food web structure and functioning is limited. By means of C and N isotopic analyses of two key Antarctic benthic consumers (Adamussium colbecki, Bivalvia, and Sterechinus neumayeri, Echinoidea) and Bayesian mixing models, we describe changes in trophic niche and nutrient transfer across trophic levels associated with the long-and short-term diet and body size of specimens sampled in midsummer in both shallow and deep waters. Samplings occurred soon after the sea-ice broke up at Tethys Bay, an area characterised by extreme seasonality in sea-ice coverage and productivity in the Ross Sea. In the long term, the trophic niche was broader and variation between specimens was greater, with intermediate-size specimens generally consuming a higher number of resources than small and large specimens. The coupling of energy channels in the food web was consequently more direct than in the short term. Sediment and benthic algae were more frequently consumed in the long term, before the sea-ice broke up, while consumers specialised on sympagic algae and plankton in the short term. Regardless of the time scale, sympagic algae were more frequently consumed in shallow waters, while plankton was more frequently consumed in deep waters. Our results suggest a strong temporal relationship between resource availability and the trophic niche of benthic consumers in Antarctica. Potential climate-driven changes in the timing and quality of nutrient inputs may have profound implications for the structure of polar food webs and the persistence of their constituent species, which have adapted their trophic niches to a highly predictable schedule of resource inputs.	[Calizza, Edoardo; Careddu, Giulio; Sporta Caputi, Simona; Rossi, Loreto; Costantini, Maria Letizia] Sapienza Univ Rome, Dept Environm Biol, Rome, Italy; [Calizza, Edoardo; Rossi, Loreto; Costantini, Maria Letizia] Consorzio Nazl Interuniv Sci Mare, CoNISMa, Rome, Italy	Sapienza University Rome; CoNISMa	Rossi, L (corresponding author), Sapienza Univ Rome, Dept Environm Biol, Rome, Italy.; Rossi, L (corresponding author), Consorzio Nazl Interuniv Sci Mare, CoNISMa, Rome, Italy.	loreto.rossi@uniroma1.it	Sporta Caputi, Simona/AAL-1803-2021	Sporta Caputi, Simona/0000-0003-2878-6175; Careddu, Giulio/0000-0002-7553-9161	Programa Nazionale di Ricerche in Antartide [PNRA 2010/AZ1.07, PNRA 2013/AZ1.15]; Sapienza University of Rome - ATENEO	Programa Nazionale di Ricerche in Antartide; Sapienza University of Rome - ATENEO	This work was supported by the Programa Nazionale di Ricerche in Antartide: PNRA 2010/AZ1.07 and PNRA 2013/AZ1.15 to LR and Sapienza University of Rome - ATENEO to MLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade C, 2016, POLAR BIOL, V39, P2281, DOI 10.1007/s00300-016-1895-0; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Barnes DKA, 2011, NAT CLIM CHANGE, V1, P365, DOI 10.1038/NCLIMATE1232; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.1890/0012-9658(2002)083[2936:MILRS]2.0.CO;2; Bologna PAX, 1999, J EXP MAR BIOL ECOL, V242, P21, DOI 10.1016/S0022-0981(99)00092-1; BREY T, 1991, POLAR BIOL, V11, P227; Brockington S, 2001, MAR ECOL PROG SER, V219, P159, DOI 10.3354/meps219159; Brose U, 2006, ECOLOGY, V87, P2411, DOI 10.1890/0012-9658(2006)87[2411:CBRINF]2.0.CO;2; Calizza E, 2017, ECOL EVOL, V7, P5784, DOI 10.1002/ece3.2977; Calizza E, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00489.1; Calizza E, 2013, ESTUAR COAST SHELF S, V135, P137, DOI 10.1016/j.ecss.2013.07.019; Calizza E, 2012, FRESHWATER BIOL, V57, P2613, DOI 10.1111/fwb.12033; Careddu G, 2015, ESTUAR COAST SHELF S, V154, P158, DOI 10.1016/j.ecss.2015.01.013; Cattaneo-Vietti R, 2000, ROSS SEA ECOLOGY; Cattaneo-Vietti Riccardo, 1997, Scientia Marina, V61, P15; Cerrano C, 2009, POLAR BIOL, V32, P1067, DOI 10.1007/s00300-009-0606-5; Chiantore M, 1998, J MARINE SYST, V17, P411, DOI 10.1016/S0924-7963(98)00052-9; Chiantore M, 2002, POLAR BIOL, V25, P251, DOI 10.1007/s00300-001-0331-1; Chown SL, 2015, NATURE, V522, P427, DOI 10.1038/nature14505; Clark GF, 2013, GLOBAL CHANGE BIOL, V19, P3749, DOI 10.1111/gcb.12337; Clarke A, 2004, ANTARCT SCI, V16, P559, DOI 10.1017/S0954102004002329; Constable AJ, 2014, GLOBAL CHANGE BIOL, V20, P3004, DOI 10.1111/gcb.12623; Costantini ML, 2012, FOREST ECOL MANAG, V285, P133, DOI 10.1016/j.foreco.2012.08.029; Davis AM, 2012, FRESHWATER BIOL, V57, P2156, DOI 10.1111/j.1365-2427.2012.02858.x; Fabiano M, 1997, ANTARCT SCI, V9, P143, DOI 10.1017/S0954102097000187; Faranda F. M., 2000, ROSS SEA ECOLOGY; Fry B., 2006, STABLE ISOTOPE ECOLO; Gillies CL, 2012, ESTUAR COAST SHELF S, V97, P44, DOI 10.1016/j.ecss.2011.11.003; Grebmeier J.M., 1991, Journal of Marine Systems, V2, P495, DOI 10.1016/0924-7963(91)90049-Z; Griffiths HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011683; Gutt J, 2015, GLOBAL CHANGE BIOL, V21, P1434, DOI 10.1111/gcb.12794; HOBSON KA, 1992, MAR ECOL PROG SER, V84, P9, DOI 10.3354/meps084009; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; HUSTON MA, 1994, AM NAT, V144, P954, DOI 10.1086/285720; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jackson MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031757; Quartino ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058223; Lizotte MP, 2001, AM ZOOL, V41, P57, DOI 10.1668/0003-1569(2001)041[0057:TCOSIA]2.0.CO;2; Majewska R, 2013, POLAR BIOL, V36, P73, DOI 10.1007/s00300-012-1240-1; Mancinelli G, 2007, INT REV HYDROBIOL, V92, P117, DOI 10.1002/iroh.200510962; Maunsell SC, 2015, J ANIM ECOL, V84, P353, DOI 10.1111/1365-2656.12285; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; McMeans BC, 2015, TRENDS ECOL EVOL, V30, P662, DOI 10.1016/j.tree.2015.09.001; Melbourne-Thomas J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055093; Moncreiff CA, 2001, MAR ECOL PROG SER, V215, P93, DOI 10.3354/meps215093; MOORE JC, 1988, NATURE, V333, P261, DOI 10.1038/333261a0; Norkko A, 2007, ECOLOGY, V88, P2810, DOI 10.1890/06-1396.1; PEARSE JS, 1991, AM ZOOL, V31, P65; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Pusceddu A, 1999, POLAR BIOL, V22, P124, DOI 10.1007/s003000050399; Pusceddu A, 2000, POLAR BIOL, V23, P288, DOI 10.1007/s003000050446; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Rooney N, 2012, TRENDS ECOL EVOL, V27, P40, DOI 10.1016/j.tree.2011.09.001; Rossi L, 2015, ECOL COMPLEX, V23, P14, DOI 10.1016/j.ecocom.2015.04.005; Rossi L, 2010, AQUAT SCI, V72, P227, DOI 10.1007/s00027-009-0125-z; ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807; Saba GK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5318; Sanders D, 2015, J ANIM ECOL, V84, P134, DOI 10.1111/1365-2656.12271; Siegfried WR, 2013, ANTARCTIC NUTR CYCLE; Smith WO, 2007, PHILOS T R SOC B, V362, P95, DOI 10.1098/rstb.2006.1956; Svanback R, 2007, P ROY SOC B-BIOL SCI, V274, P839, DOI 10.1098/rspb.2006.0198; Whittaker RH., 1975, NICHE THEORY APPL; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005	64	23	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2018	13	3							e0194796	10.1371/journal.pone.0194796	http://dx.doi.org/10.1371/journal.pone.0194796			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA2QK	29570741	Green Submitted, Green Published, gold			2022-12-26	WOS:000428168400032
J	Klopf, E; Moes, M; Amman, F; Zimmermann, B; von Pelchrzim, F; Wagner, C; Schroeder, R				Klopf, Eva; Moes, Murielle; Amman, Fabian; Zimmermann, Bob; von Pelchrzim, Frederike; Wagner, Christina; Schroeder, Renee			Nascent RNA signaling to yeast RNA Pol II during transcription elongation	PLOS ONE			English	Article							POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; B2 RNA; BIDIRECTIONAL PROMOTERS; REGULATORY ELEMENTS; ANTITERMINATOR RNA; QUALITY-CONTROL; GENOMIC SELEX; HEAT-SHOCK; E. COLI	Transcription as the key step in gene expression is a highly regulated process. The speed of transcription elongation depends on the underlying gene sequence and varies on a gene by gene basis. The reason for this sequence dependence is not known in detail. Recently, our group studied the cross talk between the nascent RNA and the transcribing RNA polymerase by screening the Escherichia coli genome for RNA sequences with high affinity to RNA Pol by performing genomic SELEX. This approach led to the identification of RNA polymerase- binding APtamers termed "RAPs". RAPs can have positive and negative effects on gene expression. A subgroup is able to downregulate transcription via the activity of the termination factor Rho. In this study, we used a similar SELEX setup using yeast genomic DNA as source of RNA sequences and highly purified yeast RNA Pol II as bait and obtained almost 1300 yeast-derived RAPs. Yeast RAPs are found throughout the genome within genes and antisense to genes, they are overrepresented in the non-transcribed strand of yeast telomeres and underrepresented in intergenic regions. Genes harbouring a RAP are more likely to show lower mRNA levels. By determining the endogenous expression levels as well as using a reporter system, we show that RAPs located within coding regions can reduce the transcript level downstream of the RAP. Here we demonstrate that RAPs represent a novel type of regulatory RNA signal in Saccharomyces cerevisiae that act in cis and interfere with the elongating transcription machinery to reduce the transcriptional output.	[Klopf, Eva; Moes, Murielle; Amman, Fabian; von Pelchrzim, Frederike; Schroeder, Renee] Max F Perutz Labs, Vienna, Austria; [Klopf, Eva; Moes, Murielle; Amman, Fabian; Zimmermann, Bob; von Pelchrzim, Frederike; Wagner, Christina; Schroeder, Renee] Univ Vienna, Vienna, Austria; [Amman, Fabian; Wagner, Christina] Inst Theoret Chem, Vienna, Austria; [Zimmermann, Bob] Dept Mol Evolut & Dev, Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Vienna	Schroeder, R (corresponding author), Max F Perutz Labs, Vienna, Austria.; Schroeder, R (corresponding author), Univ Vienna, Vienna, Austria.	renee.schroeder@univie.ac.at		Moes, Murielle/0000-0002-5267-5582; Amman, Fabian/0000-0002-8646-859X; Wagner, Christina/0000-0003-4199-1616	Austrian Science Fund FWF [F4301, F4308]; Vienna RNA Doctoral School by the Austrian Science fund FWF [DK W1207-B09]	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Vienna RNA Doctoral School by the Austrian Science fund FWF	This work was supported by the Austrian Science Fund (http://www.fwf.ac.at/) FWF grants no F4301 and F4308 (to RS); and the Vienna RNA Doctoral School DK W1207-B09) supported by the Austrian Science fund FWF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Allen TA, 2004, NAT STRUCT MOL BIOL, V11, P816, DOI 10.1038/nsmb813; Azzalin CM, 2015, TRENDS CELL BIOL, V25, P29, DOI 10.1016/j.tcb.2014.08.007; Brannan K, 2012, GENET RES INT, V2012, DOI 10.1155/2012/170173; Cheung ACM, 2012, CELL, V149, P1431, DOI 10.1016/j.cell.2012.06.006; Chlebowski A, 2013, BBA-GENE REGUL MECH, V1829, P552, DOI 10.1016/j.bbagrm.2013.01.006; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Cusanelli E, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00143; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eidem TM, 2016, J MOL BIOL, V428, P2652, DOI 10.1016/j.jmb.2016.02.019; Espinoza CA, 2004, NAT STRUCT MOL BIOL, V11, P822, DOI 10.1038/nsmb812; Espinoza CA, 2007, RNA, V13, P583, DOI 10.1261/rna.310307; Feldmann EA, 2015, BIOPHYS CHEM, V198, P1, DOI 10.1016/j.bpc.2015.01.002; Grzechnik P, 2015, TERMINATION PATHWAYS, P1; Halley JE, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000401; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Hanes SD, 2014, BBA-GENE REGUL MECH, V1839, P316, DOI 10.1016/j.bbagrm.2014.02.001; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; Kettenberger H, 2006, NAT STRUCT MOL BIOL, V13, P44, DOI 10.1038/nsmb1032; Klopf E, 2009, MOL CELL BIOL, V29, P4994, DOI 10.1128/MCB.01858-08; Kuehner JN, 2011, NAT REV MOL CELL BIO, V12, P283, DOI 10.1038/nrm3098; Kulish D, 2001, MOL CELL BIOL, V21, P4162, DOI 10.1128/MCB.21.13.4162-4168.2001; Kwak H, 2013, ANNU REV GENET, V47, P483, DOI 10.1146/annurev-genet-110711-155440; LAMPHIER MS, 1992, P NATL ACAD SCI USA, V89, P5922, DOI 10.1073/pnas.89.13.5922; Lorenz C, 2006, NAT PROTOC, V1, P2204, DOI 10.1038/nprot.2006.372; Luke B, 2009, EMBO J, V28, P2503, DOI 10.1038/emboj.2009.166; Mariner PD, 2008, MOL CELL, V29, P499, DOI 10.1016/j.molcel.2007.12.013; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Milligan L, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20166869; Mischo HE, 2013, BBA-GENE REGUL MECH, V1829, P174, DOI 10.1016/j.bbagrm.2012.10.003; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Porrua O, 2013, BBA-GENE REGUL MECH, V1829, P604, DOI 10.1016/j.bbagrm.2013.02.012; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reiter W, 2013, MOL CELL BIOL, V33, P1057, DOI 10.1128/MCB.00834-12; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schaukowitch K, 2014, MOL CELL, V56, P29, DOI 10.1016/j.molcel.2014.08.023; Schulz D, 2013, CELL, V155, P1075, DOI 10.1016/j.cell.2013.10.024; Sedlyarova N, 2017, MOL CELL, V67, P30, DOI 10.1016/j.molcel.2017.05.025; Sen RJ, 2001, MOL CELL, V7, P993, DOI 10.1016/S1097-2765(01)00243-X; Sigova AA, 2015, SCIENCE, V350, P978, DOI 10.1126/science.aad3346; Sloan S, 2007, MOL MICROBIOL, V63, P1197, DOI 10.1111/j.1365-2958.2006.05579.x; Thomas M, 1997, J BIOL CHEM, V272, P27980, DOI 10.1074/jbc.272.44.27980; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Wassarman KM, 2011, REGULATORY RNAS IN PROKARYOTES, P109; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; Wellinger RJ, 2012, GENETICS, V191, P1073, DOI 10.1534/genetics.111.137851; WEST RW, 1984, MOL CELL BIOL, V4, P2467, DOI 10.1128/MCB.4.11.2467; Windbichler N, 2008, RNA BIOL, V5, P30, DOI 10.4161/rna.5.1.5694; Wolfinger MT, 2014, BIORXIV, P13011; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yakovchuk P, 2014, TRANSCRIPTION, V2, P45; Yakovchuk P, 2009, P NATL ACAD SCI USA, V106, P5569, DOI 10.1073/pnas.0810738106; Yamashita A, 2015, BIOCHIM BIOPHYS ACTA, V1859, P1; Yarragudi A, 2007, NUCLEIC ACIDS RES, V35, P193, DOI 10.1093/nar/gkl1059; Ye J, 2014, NAT REV GENET, V15, P491, DOI 10.1038/nrg3743; Zimmermann B, 2010, METHODS, V52, P125, DOI 10.1016/j.ymeth.2010.06.004	61	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2018	13	3							e0194438	10.1371/journal.pone.0194438	http://dx.doi.org/10.1371/journal.pone.0194438			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA2QK	29570714	Green Submitted, Green Published, gold			2022-12-26	WOS:000428168400019
J	Whiten, SR; Ray, WK; Helm, RF; Adelman, ZN				Whiten, Shavonn R.; Ray, W. Keith; Helm, Richard F.; Adelman, Zach N.			Characterization of the adult Aedes aegypti early midgut peritrophic matrix proteome using LC-MS	PLOS ONE			English	Article							DENGUE HEMORRHAGIC-FEVER; LATE TRYPSIN GENE; ANOPHELES-GAMBIAE; SALIVARY-GLANDS; BLOOD MEAL; MOSQUITO; PROTEINS; CLONING; HEME; IDENTIFICATION	The Aedes aegypti mosquito is the principal vector of arboviruses such as dengue, chikungunya, yellow fever, and Zika virus. These arboviruses are transmitted during adult female mosquito bloodfeeding. While these viruses must transverse the midgut to replicate, the blood meal must also reach the midgut to be digested, absorbed, or excreted, as aggregation of blood meal metabolites can be toxic to the female mosquito midgut. The midgut peritrophic matrix (PM), a semipermeable extracellular layer comprised of chitin fibrils, glycoproteins, and proteoglycans, is one such mechanism of protection for the mosquito midgut. However, this structure has not been characterized for adult female Ae. aegypti. We conducted a mass spectrometry based proteomic analysis to identify proteins that comprise or are associated with the adult female Ae. aegypti early midgut PM. Altogether, 474 unique proteins were identified, with 115 predicted as secreted. GO-term enrichment analysis revealed an abundance of serine-type proteases and several known and novel intestinal mucins. In addition, approximately 10% of the peptides identified corresponded to known salivary proteins, indicating Ae. aegypti mosquitoes extensively swallow their own salivary secretions. However, the physiological relevance of this remains unclear, and further studies are needed to determine PM proteins integral for midgut protection from blood meal derived toxicity and pathogen protection. Finally, we describe substantial discordance between previously described transcriptionally changes observed in the midgut in response to a bloodmeal and the presence of the corresponding protein in the PM. Data are available via ProteomeXchange with identifier PXD007627.	[Whiten, Shavonn R.; Adelman, Zach N.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Ray, W. Keith; Helm, Richard F.] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA	Texas A&M University System; Texas A&M University College Station; Virginia Polytechnic Institute & State University	Adelman, ZN (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	zachadel@tamu.edu	Helm, Richard/N-6249-2018	Helm, Richard/0000-0001-5317-0925; Adelman, Zach/0000-0001-5901-7171	Fralin Life Science Institute; Agricultural Experiment Station Hatch Program; McIntire-Stennis Program at Virginia Tech; Agrilife Research; National Institute of Allergies and Infectious Diseases of the National Institutes of Health [AI115138]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI115138] Funding Source: NIH RePORTER	Fralin Life Science Institute; Agricultural Experiment Station Hatch Program; McIntire-Stennis Program at Virginia Tech; Agrilife Research; National Institute of Allergies and Infectious Diseases of the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The mass spectrometry resources used in this work are maintained in part through funding by the Fralin Life Science Institute, the Agricultural Experiment Station Hatch Program, and the McIntire-Stennis Program at Virginia Tech. This study was supported in part by Agrilife Research, as well as by the National Institute of Allergies and Infectious Diseases of the National Institutes of Health under award number AI115138. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFT RL, 1984, J BIOL CHEM, V259, P301; Barillas-Mury C., 1993, Insect Molecular Biology, V2, P7, DOI 10.1111/j.1365-2583.1993.tb00119.x; BARILLASMURY CV, 1995, INSECT BIOCHEM MOLEC, V25, P241, DOI 10.1016/0965-1748(94)00061-L; BEIER MS, 1992, AM J TROP MED HYG, V47, P195; Bonizzoni M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-82; Brackney DE, 2010, J INSECT PHYSIOL, V56, P736, DOI 10.1016/j.jinsphys.2010.01.003; CHAMPAGNE DE, 1995, P NATL ACAD SCI USA, V92, P694, DOI 10.1073/pnas.92.3.694; Conus S, 2010, SWISS MED WKLY, V140, P4, DOI 10.4414/smw.2010.13042; Conway MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004941; Devenport M, 2006, BIOCHEMISTRY-US, V45, P9540, DOI 10.1021/bi0605991; Dinglasan RR, 2009, INSECT BIOCHEM MOLEC, V39, P125, DOI 10.1016/j.ibmb.2008.10.010; Distler U, 2014, NAT METHODS, V11, P167, DOI [10.1038/NMETH.2767, 10.1038/nmeth.2767]; Edwards MJ, 2000, INSECT MOL BIOL, V9, P33, DOI 10.1046/j.1365-2583.2000.00159.x; Freyvogel T. A., 1965, Acta Tropica Basle, V22, P148; GALUN R, 1963, SCIENCE, V142, P1674, DOI 10.1126/science.142.3600.1674; GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55; Hanington PC, 2011, J INNATE IMMUN, V3, P17, DOI 10.1159/000321882; HAWKINS RI, 1966, NATURE, V212, P738, DOI 10.1038/212738a0; HUDSON A, 1964, CAN J ZOOLOG, V42, P113, DOI 10.1139/z64-011; Jiang QJ, 1997, INSECT BIOCHEM MOLEC, V27, P283, DOI 10.1016/S0965-1748(97)00001-5; Juhn J., 2011, AEDES AEGYPTI PARASI, V4, P1, DOI DOI 10.1186/1756-3305-4-1; KOGAN PH, 1990, J MED ENTOMOL, V27, P709, DOI 10.1093/jmedent/27.4.709; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; Liao ZP, 2012, ANAL CHEM, V84, P4535, DOI 10.1021/ac300510t; Lowenberger C, 2001, INSECT BIOCHEM MOLEC, V31, P219, DOI 10.1016/S0965-1748(00)00141-7; Marquardt WC, 2005, BIOL DIS VECTORS, pxxiii; Matsumoto F, 2008, BIOCHEM BIOPH RES CO, V367, P693, DOI 10.1016/j.bbrc.2007.12.130; MELLINK JJ, 1981, MOSQ NEWS, V41, P115; Moskalyk LA, 1996, INSECT MOL BIOL, V5, P261, DOI 10.1111/j.1365-2583.1996.tb00100.x; Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440; Noriega FG, 1999, J INSECT PHYSIOL, V45, P613, DOI 10.1016/S0022-1910(99)00052-9; Noriega FG, 1996, INSECT MOL BIOL, V5, P25, DOI 10.1111/j.1365-2583.1996.tb00037.x; Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320; Pascoa V, 2002, INSECT BIOCHEM MOLEC, V32, P517, DOI 10.1016/S0965-1748(01)00130-8; Peters W, 1992, PERITROPHIC MEMBRANE; Rayms-Keller A, 2000, INSECT MOL BIOL, V9, P419, DOI 10.1046/j.1365-2583.2000.00202.x; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Ribeiro JMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-6; Ribeiro JMC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151400; RICHARDS AG, 1977, ANNU REV ENTOMOL, V22, P219, DOI 10.1146/annurev.en.22.010177.001251; Rodgers FH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006391; Rose C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002691; Rothman AL, 1999, VIROLOGY, V257, P1, DOI 10.1006/viro.1999.9656; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Schorderet S, 1998, INSECT BIOCHEM MOLEC, V28, P99, DOI 10.1016/S0965-1748(97)00103-3; Shao L, 2005, INSECT BIOCHEM MOLEC, V35, P947, DOI 10.1016/j.ibmb.2005.03.012; Shao L, 2001, ARCH INSECT BIOCHEM, V47, P119, DOI 10.1002/arch.1042; Shen ZC, 1998, J BIOL CHEM, V273, P17665, DOI 10.1074/jbc.273.28.17665; Stohler H. R., 1961, Acta Tropica Basle, V18, P263; TAPPEL AL, 1955, J BIOL CHEM, V217, P721; Tellam RL, 1999, INSECT BIOCHEM MOLEC, V29, P87, DOI 10.1016/S0965-1748(98)00123-4; Toprak U., 2010, Trends in Entomology, Volume 6, P23; Vincent S, 1989, SEMINARS HEMATOLOGY; VINCENT SH, 1988, ARCH BIOCHEM BIOPHYS, V265, P539, DOI 10.1016/0003-9861(88)90159-2; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Whiten SR, 2018, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01134; Wilder-Smith A, 2015, SCIENCE, V350, P626, DOI 10.1126/science.aab4047; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; YORKE Warrington, 1924, Annals of Tropical Medicine and Parasitology, V18, P103	61	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2018	13	3							e0194734	10.1371/journal.pone.0194734	http://dx.doi.org/10.1371/journal.pone.0194734			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA2QK	29570734	Green Submitted, Green Published, gold			2022-12-26	WOS:000428168400028
J	Buskermolen, ABC; Kurniawan, NA; Bouten, CVC				Buskermolen, Antonetta B. C.; Kurniawan, Nicholas A.; Bouten, Carlijn V. C.			An automated quantitative analysis of cell, nucleus and focal adhesion morphology	PLOS ONE			English	Article							IMAGE-ANALYSIS; STRESS FIBERS; ACTIN; DYNAMICS; FIBROBLASTS; MATURATION; MIGRATION; SOFTWARE; SURFACES; GUIDANCE	Adherent cells sense the physical properties of their environment via focal adhesions. Improved understanding of how cells sense and response to their physical surroundings is aided by quantitative evaluation of focal adhesion size, number, orientation, and distribution in conjunction with the morphology of single cells and the corresponding nuclei. We developed a fast, user-friendly and automated image analysis algorithm capable of capturing and characterizing these individual components with a high level of accuracy. We demonstrate the robustness and applicability of the algorithm by quantifying morphological changes in response to a variety of environmental changes as well as manipulations of cellular components of mechanotransductions. Finally, as a proof-of-concept we use our algorithm to quantify the effect of Rho-associated kinase inhibitor Y-27632 on focal adhesion maturation. We show that a decrease in cell contractility leads to a decrease in focal adhesion size and aspect ratio.	[Buskermolen, Antonetta B. C.; Kurniawan, Nicholas A.; Bouten, Carlijn V. C.] Eindhoven Univ Technol, Dept Biomed Engn, Eindhoven, Netherlands; [Buskermolen, Antonetta B. C.; Kurniawan, Nicholas A.; Bouten, Carlijn V. C.] Eindhoven Univ Technol, Inst Complex Mol Syst, Eindhoven, Netherlands	Eindhoven University of Technology; Eindhoven University of Technology	Kurniawan, NA (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Eindhoven, Netherlands.; Kurniawan, NA (corresponding author), Eindhoven Univ Technol, Inst Complex Mol Syst, Eindhoven, Netherlands.	n.a.kurniawan@tue.nl	Bouten, Carlijn/AAT-5187-2020	Bouten, Carlijn/0000-0003-1035-5094	Dutch Heart Foundation Antonetta B. C. Buskermolen [CVON 2012-01]; TU/e Impuls Antonetta B. C. Buskermolen	Dutch Heart Foundation Antonetta B. C. Buskermolen; TU/e Impuls Antonetta B. C. Buskermolen	This work was supported by CVON 2012-01 Dutch Heart Foundation Antonetta B. C. Buskermolen and TU/e Impuls Antonetta B. C. Buskermolen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Barry DJ, 2015, J CELL BIOL, V209, P163, DOI 10.1083/jcb.201501081; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; DUNN GA, 1986, J CELL SCI, V83, P313; Elosegui-Artola A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107393; Farrell DL, 2017, DEVELOPMENT, V144, P1725, DOI 10.1242/dev.146837; Gautrot JE, 2017, CELL SENSING PHYS PR; Geiger B., 2011, COLD SPRING HARBOR P, V3; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Goetsch KP, 2014, J CELL BIOCHEM, V115, P1299, DOI 10.1002/jcb.24784; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Horzum U, 2014, METHODSX, V1, P56, DOI 10.1016/j.mex.2014.06.004; Katoh K, 2001, AM J PHYSIOL-CELL PH, V280, pC1669, DOI 10.1152/ajpcell.2001.280.6.C1669; Kurniawan NA, 2016, J BIOMECH, V49, P1355, DOI 10.1016/j.jbiomech.2015.12.023; Mol A, 2006, CIRCULATION, V114, pI152, DOI 10.1161/CIRCULATIONAHA.105.001123; Munjal A, 2014, DEVELOPMENT, V141, P1789, DOI 10.1242/dev.091645; Myers G, 2012, NAT METHODS, V9, P659, DOI 10.1038/nmeth.2024; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Spanjaard E, 2015, EXP CELL RES, V330, P382, DOI 10.1016/j.yexcr.2014.10.012; Stricker J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070652; Tamiello C, 2015, CELLULAR MOL BIOENGI; Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383; Uttayarat P, 2005, J BIOMED MATER RES A, V75A, P668, DOI 10.1002/jbm.a.30478; Wiesmann V, 2015, J MICROSC-OXFORD, V257, P39, DOI 10.1111/jmi.12184; Wurflinger T, 2009, IEEE IMAGE PROC, P4209, DOI 10.1109/ICIP.2009.5413530; Yan PK, 2008, IEEE T INF TECHNOL B, V12, P109, DOI 10.1109/TITB.2007.898006; Yang MT, 2011, NAT PROTOC, V6, P187, DOI 10.1038/nprot.2010.189; Yang X, 2013, IEEE T CIRCUITS SYST, V53; Zamir E, 1999, J CELL SCI, V112, P1655	38	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195201	10.1371/journal.pone.0195201	http://dx.doi.org/10.1371/journal.pone.0195201			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601604	Green Published, Green Submitted, gold			2022-12-26	WOS:000428845900023
J	Brabcova, D; Kohout, J; Potuzak, D; Benova, B; Krsek, P				Brabcova, Dana; Kohout, Jiri; Potuzak, Daniel; Benova, Barbora; Krsek, Pavel			Psychometric properties of the Czech version of the Stigma Scale of Epilepsy	PLOS ONE			English	Article							VALIDATION; CHILDREN	Although significant attention has been devoted to analyzing stigma associated with epilepsy, there is still a significant lack of valid and reliable instruments. We aimed to validate the 23-item Czech version of the Stigma Scale of Epilepsy (SSE; originally developed in Brazil), which has been used to evaluate epilepsy-related stigma in the general population. Verification of the SSE questionnaire was carried out in a group of 207 students aged 15-18 years of whom none had epilepsy. These students completed the SSE twice in a period of 3-6 months as part of standard test-retest evaluation practice. The instrument exhibits good psychometric properties including internal consistency higher than in the original version (Cronbach's alpha of 0.856 here compared with 0.81 reported in Brazil) and acceptable test-retest reliability. Using exploratory factor analysis (not provided for the original version), four factors were identified and corresponding subscales were described and interpreted. Two items did not fit into the structure and were eliminated. Confirmatory factor analysis was used to propose and verify the hierarchical 4-factor structure of the Czech version of SSE confirming the existence of a common factor corresponding to stigma. The results showed that the Czech version of SSE has good psychometric properties and can be used in further research and clinical practice.	[Brabcova, Dana; Potuzak, Daniel] Univ West Bohemia, Dept Psychol, Fac Educ, Plzen, Czech Republic; [Kohout, Jiri] Univ West Bohemia, Dept Phys, Fac Educ, Plzen, Czech Republic; [Benova, Barbora; Krsek, Pavel] Univ Hosp Motol, Dept Child Neurol, Fac Med 2, Prague, Czech Republic	University of West Bohemia Pilsen; University of West Bohemia Pilsen; Charles University Prague; Motol University Hospital	Kohout, J (corresponding author), Univ West Bohemia, Dept Phys, Fac Educ, Plzen, Czech Republic.	kohout.j2@seznam.cz	Kohout, Jiri/AGY-2275-2022; Kohout, Jiří/N-8106-2016; Brabcová, Dana Buršíková/AAD-1423-2020; Benova, Barbora/AAB-3423-2019	Kohout, Jiri/0000-0002-5614-2126; Kohout, Jiří/0000-0002-5614-2126; Brabcová, Dana Buršíková/0000-0003-4189-7347; Benova, Barbora/0000-0001-8448-2833; Krsek, Pavel/0000-0002-5740-3690				Akaike H., 2011, INT ENCY STAT SCI, P25, DOI DOI 10.1007/978-3-642-04898-2_110; Beavers AS, PRAC ASSES RES EVAL, V18, P1; Brabcova D, 2017, EPILEPSY BEHAV, V69, P12, DOI 10.1016/j.yebeh.2017.01.019; Brabcova D, 2014, PHD EXISTENCE 2014, P10; Brabcova D, 2014, EPILEPSY BEHAV, V33, P31, DOI 10.1016/j.yebeh.2014.02.013; Bruno E, 2012, EPILEPSY BEHAV, V25, P131, DOI 10.1016/j.yebeh.2012.07.011; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; de Boer HM, 2008, EPILEPSY BEHAV, V12, P540, DOI 10.1016/j.yebeh.2007.12.019; Elafros MA, 2015, QUAL LIFE RES, V24, P1483, DOI 10.1007/s11136-014-0868-4; Fernandes PT, 2007, ARQ NEURO-PSIQUIAT, V65, P35, DOI 10.1590/S0004-282X2007001000006; Fernandes PT, 2011, EPILEPSY BEHAV, V22, P55, DOI 10.1016/j.yebeh.2011.02.014; Fernandes PT, 2004, J EPILEPSY CLIN NEUR, V10, P213; Fiest KM, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0444-x; FISCHER RA, 1954, STAT METHODS RES WOR; Goffman E., 1968, STIGMA NOTES MANAGEM; Hermann B, 2009, EPILEPSY BEHAV, V15, pS11, DOI 10.1016/j.yebeh.2009.03.029; Herrmann LK, 2016, EPILEPSY BEHAV, V60, P165, DOI 10.1016/j.yebeh.2016.04.003; Hooper D., 2008, EJBRM, V6, P53, DOI [DOI 10.1037/1082[HYPHEN]989X.12.1.58, 10.21427/D79B73]; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Pahl K, 2005, ATL EP CAR WORLD, P72; Reis R, 2002, EPILEPSY BEHAV, V3, pS33; Reno BA, 2007, ARQ NEURO-PSIQUIAT, V65, P49, DOI 10.1590/S0004-282X2007001000008; Salgado PC, 2005, ARQ NEURO-PSIQUIAT, V63, P395, DOI 10.1590/S0004-282X2005000300005	23	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195225	10.1371/journal.pone.0195225	http://dx.doi.org/10.1371/journal.pone.0195225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596486	Green Published, gold, Green Submitted			2022-12-26	WOS:000428630000094
J	Patt, JM; Robbins, PS; Niedz, R; McCollum, G; Alessandro, R				Patt, Joseph M.; Robbins, Paul S.; Niedz, Randy; McCollum, Greg; Alessandro, Rocco			Exogenous application of the plant signalers methyl jasmonate and salicylic acid induces changes in volatile emissions from citrus foliage and influences the aggregation behavior of Asian citrus psyllid (Diaphorina citri), vector of Huanglongbing	PLOS ONE			English	Article							CANDIDATUS LIBERIBACTER ASIATICUS; TERPENOID ACCUMULATION; HEMIPTERA LIVIIDAE; INDUCED RESISTANCE; INSECT VECTOR; RESPONSES; DISEASE; TOMATO; PATTERNS; FLORIDA	Huanglongbing, also known as citrus greening, is a destructive disease that threatens citrus production worldwide. It is putatively caused by the phloem-limited bacterium Candidatus Liberibacter asiaticus (Las). Currently, the disease is untreatable and efforts focus on intensive insecticide use to control the vector, Asian citrus psyllid (Diaphorina citri). Emerging psyllid resistance to multiple insecticides has generated investigations into the use of exogenously applied signaling compounds to enhance citrus resistance to D. citri and Las. In the present study, we examined whether foliar applications of methyl jasmonate (MJ), a volatile signaling compound associated with the induced systemic resistance pathway, and salicylic acid, a constituent of the systemic acquired resistance pathway, would elicit the emission of defense-related volatiles in citrus foliage, and what effect this might have on the host-plant searching behavior of D. citri. Comparisons were made of volatiles emitted from growing shoots of uninfected and Las-infected 'Valencia' sweet orange (Citrus sinensis) trees over two consecutive sampling days. A settling behavioral assay was used to compare psyllid attraction to MJ-treated vs. Tween-treated citrus sprigs. All three main effects, Las infection status, plant signaler application, and sampling day, influenced the proportions of individual volatile compounds emitted in different treatment groups. MJ- and SA-treated trees had higher emission rates than Tween-treated trees. Methyl salicylate (MeSA) and beta-caryophyllene were present in higher proportions in the volatiles collected from Las-infected + trees. On the other hand, Las-infected + MJ-treated trees emitted lower proportions of MeSA than did Las-infected + Tween-treated trees. Because MeSA is a key D. citri attractant, this result suggests that MJ application could suppress MeSA emission from Las-infected trees, an approach that could be used to discourage psyllid colonization during shoot growth. MJ application enhanced emission of E-beta-ocimene, indole, volatiles attractive to many of the psyllid's natural enemies, indicating that MJ application could be used in an 'attract and reward' conservation biological control strategy. Volatile emissions in SA-treated trees were dominated by MeSA. MJ application elicited aggregation behavior in D. citri. Similar numbers of psyllids settled on MJ-treated versus Tween-treated sprigs, but a significantly greater percentage of the MJ-treated sprigs had aggregations of nine or more psyllids on them. Taken together, the results of this study indicate that exogenous applications of MJ or SA could be used to influence Asian citrus psyllid settling behavior and attract its natural enemies.	[Patt, Joseph M.; Robbins, Paul S.; Niedz, Randy; McCollum, Greg; Alessandro, Rocco] ARS, USDA, US Hort Res Lab, Ft Pierce, FL 34945 USA	United States Department of Agriculture (USDA)	Patt, JM (corresponding author), ARS, USDA, US Hort Res Lab, Ft Pierce, FL 34945 USA.	joseph.patt@ars.usda.gov	Patt, Joseph/V-1113-2018; Robbins, Paul/AAC-3180-2020	Patt, Joseph/0000-0001-9105-8520; 				Aksenov AA, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00078; Aksenov AA, 2014, ANAL CHEM, V86, P2481, DOI 10.1021/ac403469y; Albrecht U, 2014, HORTSCIENCE, V49, P367, DOI 10.21273/HORTSCI.49.3.367; Ament K, 2004, PLANT PHYSIOL, V135, P2025, DOI 10.1104/pp.104.048694; Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072; Birkett MA, 2000, P NATL ACAD SCI USA, V97, P9329, DOI 10.1073/pnas.160241697; Boina DR, 2015, PEST MANAG SCI, V71, P808, DOI 10.1002/ps.3957; Bove JM, 2006, J PLANT PATHOL, V88, P7; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Cevallos-Cevallos JM, 2011, PHYTOCHEM ANALYSIS, V22, P236, DOI 10.1002/pca.1271; Chamberlain K, 2001, BIOCHEM SYST ECOL, V29, P1063, DOI 10.1016/S0305-1978(01)00050-3; Citrus Research and Education Center, 2015, GREEN HUANGL HLB WOR; Clarke KR, 2015, PRIMER V7 USER MANUA; Costa MG, 2010, SCI AGR, V67, P546, DOI 10.1590/S0103-90162010000500008; Davis TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049330; Dugo G., 2003, CITRUS GENUS CITRUS; Erb M, 2014, NATURE COMMUNICATION, P6; Folimonova SY, 2009, PHYTOPATHOLOGY, V99, P1346, DOI 10.1094/PHYTO-99-12-1346; Francis MI, 2009, EUR J PLANT PATHOL, V124, P283, DOI 10.1007/s10658-008-9415-x; Frey M, 2004, PHYTOCHEMISTRY, V65, P1047, DOI 10.1016/j.phytochem.2003.11.021; Frey M, 2000, P NATL ACAD SCI USA, V97, P14801, DOI 10.1073/pnas.260499897; GERSHENZON J, 1994, J CHEM ECOL, V20, P1281, DOI 10.1007/BF02059810; Godard KA, 2008, PHYTOCHEMISTRY, V69, P1838, DOI 10.1016/j.phytochem.2008.02.011; Gomi K, 2003, PLANT MOL BIOL, V53, P189, DOI 10.1023/B:PLAN.0000009287.95682.24; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hall DG, 2016, J ECON ENTOMOL, V109, P558, DOI 10.1093/jee/tow009; Hall DG, 2015, J INSECT BEHAV, V28, P555, DOI 10.1007/s10905-015-9525-1; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hijaz F, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1138193; Hijaz F, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25677; Huang Z, 2015, J ELECTR COMPUT ENG, V2015, DOI 10.1155/2015/258343; Kawazu K, 2012, ARTHROPOD-PLANT INTE, V6, P221, DOI 10.1007/s11829-011-9174-z; Kesonja D, 2017, ANAL COURT PRACTICE; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kishimoto K, 2006, PHYTOCHEMISTRY, V67, P1520, DOI 10.1016/j.phytochem.2006.05.027; Krol P, 2015, J PLANT PHYSIOL, V179, P122, DOI 10.1016/j.jplph.2015.01.018; Lewis-Rosenblum H, 2015, J ECON ENTOMOL, V108, P3, DOI 10.1093/jee/tou008; Li JY, 2017, MOL PLANT MICROBE IN, V30, P620, DOI [10.1094/mpmi-12-16-0257-r, 10.1094/MPMI-12-16-0257-R]; Li JY, 2016, PHYTOPATHOLOGY, V106, P37, DOI 10.1094/PHYTO-08-15-0196-R; LOUGHRIN JH, 1994, P NATL ACAD SCI USA, V91, P11836, DOI 10.1073/pnas.91.25.11836; Mann RS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002610; Martin D, 2002, PLANT PHYSIOL, V129, P1003, DOI 10.1104/pp.011001; Martinelli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038039; Martini X, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00008; Martini X, 2016, J CHEM ECOL, V42, P357, DOI 10.1007/s10886-016-0695-x; Martini X, 2014, ARTHROPOD-PLANT INTE, V8, P453, DOI 10.1007/s11829-014-9326-z; Maserti BE, 2011, J PLANT PHYSIOL, V168, P392, DOI 10.1016/j.jplph.2010.07.026; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; Mayer CJ, 2008, J CHEM ECOL, V34, P1045, DOI 10.1007/s10886-008-9516-1; Mayer CJ, 2011, AGR FOREST ENTOMOL, V13, P25, DOI 10.1111/j.1461-9563.2010.00495.x; McCormick AC, 2012, TRENDS PLANT SCI, V17, P303, DOI 10.1016/j.tplants.2012.03.012; Michaud JP, 2002, ENTOMOL NEWS, V113, P216; Michaud JP, 2001, FLA ENTOMOL, V84, P608, DOI 10.2307/3496392; Miresmailli S, 2010, PEST MANAG SCI, V66, P916, DOI 10.1002/ps.1967; Moss CB, EC COST HUANGLONGBIN; Niinemets U, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00262; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Patt Joseph M., 2014, Insects, V5, P921, DOI 10.3390/insects5040921; Pickett JA, 2003, BIOCHEM SOC T, V31, P123, DOI 10.1042/BST0310123; Pieterse CMJ, 2007, TRENDS PLANT SCI, V12, P564, DOI 10.1016/j.tplants.2007.09.004; Pluke RWH, 2005, FLA ENTOMOL, V88, P123, DOI 10.1653/0015-4040(2005)088[0123:PIOLBO]2.0.CO;2; Qureshi JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112331; Qureshi JA, 2009, BIOL CONTROL, V50, P129, DOI 10.1016/j.biocontrol.2009.04.001; Rid M, 2016, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00152; Setamou M, 2008, J ECON ENTOMOL, V101, P1478, DOI 10.1603/0022-0493(2008)101[1478:DPASPF]2.0.CO;2; Setamou M, 2016, J ECON ENTOMOL, V109, P1973, DOI 10.1093/jee/tow171; Stockton DG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149815; Stover E, 2011, HORTSCIENCE, V46, P1344, DOI 10.21273/HORTSCI.46.10.1344; Thaler JS, 2010, ECOLOGY, V91, P1075, DOI 10.1890/08-2347.1; THOMSON WW, 1976, BOT GAZ, V137, P330, DOI 10.1086/336880; Tiwari S, 2013, B ENTOMOL RES, V103, P592, DOI 10.1017/S0007485313000229; Tiwari S, 2011, PEST MANAG SCI, V67, P1258, DOI 10.1002/ps.2181; Turlings TCJ, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P21, DOI 10.1017/CBO9780511542664.003; Veyrat N, 2016, J ECOL, V104, P591, DOI 10.1111/1365-2745.12526; Walling LL, 2008, PLANT PHYSIOL, V146, P859, DOI 10.1104/pp.107.113142; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Yamasaki Yumiko, 2007, Journal of General Plant Pathology, V73, P168, DOI 10.1007/s10327-007-0013-0	79	20	28	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0193724	10.1371/journal.pone.0193724	http://dx.doi.org/10.1371/journal.pone.0193724			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596451	Green Submitted, Green Published, gold			2022-12-26	WOS:000428630000012
J	Raciti, GA; Fiory, F; Campitelli, M; Desiderio, A; Spinelli, R; Longo, M; Nigro, C; Pepe, G; Sommella, E; Campiglia, P; Formisano, P; Beguinot, F; Miele, C				Raciti, Gregory Alexander; Fiory, Francesca; Campitelli, Michele; Desiderio, Antonella; Spinelli, Rosa; Longo, Michele; Nigro, Cecilia; Pepe, Giacomo; Sommella, Eduardo; Campiglia, Pietro; Formisano, Pietro; Beguinot, Francesco; Miele, Claudia			Citrus aurantium L. dry extracts promote C/ebp beta expression and improve adipocyte differentiation in 3T3-L1 cells	PLOS ONE			English	Article							MITOTIC CLONAL EXPANSION; BINDING PROTEIN-BETA; WHITE ADIPOSE-TISSUE; GYMNEMA-SYLVESTRE; DIABETES-MELLITUS; TRANSCRIPTIONAL REGULATION; INSULIN-RESISTANCE; FENUGREEK SEEDS; IN-VIVO; OBESITY	Metabolic and/or endocrine dysfunction of the white adipose tissue (WAT) contribute to the development of metabolic disorders, such as Type 2 Diabetes (T2D). Therefore, the identification of products able to improve adipose tissue function represents a valuable strategy for the prevention and/or treatment of T2D. In the current study, we investigated the potential effects of dry extracts obtained from Citrus aurantium L. fruit juice (CAde) on the regulation of 3T3-L1 cells adipocyte differentiation and function in vitro. We found that CAde enhances terminal adipocyte differentiation of 3T3-L1 cells raising the expression of CCAAT/enhancer binding protein beta (C/Ebp beta), peroxisome proliferator activated receptor gamma (Ppar gamma), glucose transporter type 4 (Glut4) and fatty acid binding protein 4 (Fabp4). CAde improves insulin-induced glucose uptake of 3T3-L1 adipocytes, as well. A focused analysis of the phases occurring in the pre-adipocytes differentiation to mature adipocytes furthermore revealed that CAde promotes the early differentiation stage by up-regulating C/ebp beta expression at 2, 4 and 8 h post the adipogenic induction and anticipating the 3T3-L1 cell cycle entry and progression during mitotic clonal expansion (MCE). These findings provide evidence that the exposure to CAde enhances in vitro fat cell differentiation of pre-adipocytes and functional capacity of mature adipocytes, and pave the way to the development of products derived from Citrus aurantium L. fruit juice, which may improve WAT functional capacity and may be effective for the prevention and/or treatment of T2D.	[Raciti, Gregory Alexander; Fiory, Francesca; Campitelli, Michele; Desiderio, Antonella; Spinelli, Rosa; Longo, Michele; Nigro, Cecilia; Formisano, Pietro; Beguinot, Francesco; Miele, Claudia] CNR, URT Inst Expt Endocrinol & Oncol G Salvatore, Naples, Italy; [Raciti, Gregory Alexander; Fiory, Francesca; Campitelli, Michele; Desiderio, Antonella; Spinelli, Rosa; Longo, Michele; Nigro, Cecilia; Formisano, Pietro; Beguinot, Francesco; Miele, Claudia] Federico II Univ Naples, Dept Translat Med Sci, Naples, Italy; [Pepe, Giacomo; Sommella, Eduardo; Campiglia, Pietro] Univ Salerno, Dept Pharm, Sch Pharm, Fisciano, Italy; [Campiglia, Pietro] European Biomed Res Inst Salerno, Salerno, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; University of Salerno	Raciti, GA; Miele, C (corresponding author), CNR, URT Inst Expt Endocrinol & Oncol G Salvatore, Naples, Italy.; Raciti, GA; Miele, C (corresponding author), Federico II Univ Naples, Dept Translat Med Sci, Naples, Italy.	gregoryraciti@gmail.com; c.miele@ieos.cnr.it	Campiglia, Pietro/J-5625-2018; Formisano, Pietro/J-4237-2018; LONGO, Michele/AAB-9188-2019; Longo, Michele/AAB-5972-2020; Campitelli, Michele/AAB-9734-2019; NIGRO, Cecilia/AAB-9189-2019; Nigro, Cecilia/K-7338-2016	LONGO, Michele/0000-0003-4798-0504; Campitelli, Michele/0000-0001-7592-5022; NIGRO, Cecilia/0000-0001-8924-9731; Desiderio, Antonella/0000-0002-3510-7663; RACITI, GREGORYALEXANDER/0000-0003-2742-5634; Formisano, Pietro/0000-0001-7020-6870; Sommella, Eduardo/0000-0001-8654-6431				Al-Romaiyan A, 2010, PHYTOTHER RES, V24, P1370, DOI 10.1002/ptr.3125; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; ANDERSON JW, 2008, NUTRACEUTICALS GLYCE; Arbo MD, 2008, FOOD CHEM TOXICOL, V46, P2770, DOI 10.1016/j.fct.2008.04.037; Arias BA, 2005, J ETHNOPHARMACOL, V97, P89, DOI 10.1016/j.jep.2004.10.019; Armstrong WJ, 2001, J EXERC PHYSL, V4, P28; Basch Ethan, 2003, Altern Med Rev, V8, P20; Cassese A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060555; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; Coelho M, 2013, ARCH MED SCI, V9, P191, DOI 10.5114/aoms.2013.33181; Dey Lucy, 2002, Altern Med Rev, V7, P45; Fajas L, 1998, CURR OPIN CELL BIOL, V10, P165, DOI 10.1016/S0955-0674(98)80138-5; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fiory F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113655; Fox KAA, 2009, EUR HEART J, V30, P3055, DOI 10.1093/eurheartj/ehp371; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Grover JK, 2002, J ETHNOPHARMACOL, V81, P81, DOI 10.1016/S0378-8741(02)00059-4; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Guo L, 2015, J BIOL CHEM, V290, P755, DOI 10.1074/jbc.R114.619957; Gupta A, 2001, J Assoc Physicians India, V49, P1057; Gustafson B, 2013, DIABETES, V62, P2997, DOI 10.2337/db13-0473; Haaz S, 2006, OBES REV, V7, P79, DOI 10.1111/j.1467-789X.2006.00195.x; Jefcoate Colin R., 2008, V456, P173, DOI 10.1007/978-1-59745-245-8_13; Karimi E, 2012, MOLECULES, V17, P1203, DOI 10.3390/molecules17021203; Karoui IJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/345415; Kassaian N, 2009, INT J VITAM NUTR RES, V79, P34, DOI 10.1024/0300-9831.79.1.34; Kim GS, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-31; Kim HG, 2012, BIOMED CHROMATOGR, V26, P464, DOI 10.1002/bmc.1688; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; Leach MJ, 2007, J ALTERN COMPLEM MED, V13, P977, DOI 10.1089/acm.2006.6387; Lee DH, 2012, EVID-BASED COMPL ALT, V2012; Leung L, 2009, BRIT J NUTR, V102, P1703, DOI 10.1017/S0007114509992054; Liu XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038130; Longo M, 2016, BBA-MOL CELL RES, V1863, P1146, DOI 10.1016/j.bbamcr.2016.02.019; Lonn M, 2010, FASEB J, V24, P326, DOI 10.1096/fj.09-133058; Mattoli L, 2005, J AGR FOOD CHEM, V53, P9860, DOI 10.1021/jf051270+; Mecocci P, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00147; Nair HB, 2010, BIOCHEM PHARMACOL, V80, P1833, DOI 10.1016/j.bcp.2010.07.021; Nasri H, 2014, INT J PREVENTIVE MED, V5, P1487; Neelakantan N, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-7; Passaretti F, 2014, PLATELETS, V25, P252, DOI 10.3109/09537104.2013.809060; Pellati F, 2002, J PHARMACEUT BIOMED, V29, P1113, DOI 10.1016/S0731-7085(02)00153-X; Pellegrinelli V, 2016, DIABETOLOGIA, V59, P1075, DOI 10.1007/s00125-016-3933-4; Porchezhian E, 2003, PHARMAZIE, V58, P5; Raciti GA, 2010, DIABETOLOGIA, V53, P955, DOI 10.1007/s00125-010-1676-1; Raciti GA, 2017, SCI REP-UK, V7, DOI 10.1038/srep43526; Ramaa CS, 2006, CURR PHARM BIOTECHNO, V7, P15, DOI 10.2174/138920106775789647; Rayalam S, 2008, J NUTR BIOCHEM, V19, P717, DOI 10.1016/j.jnutbio.2007.12.007; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Shi Jun, 2008, V456, P307, DOI 10.1007/978-1-59745-245-8_23; Song Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069925; Stohs SJ, 2012, INT J MED SCI, V9, P527, DOI 10.7150/ijms.4446; Summers SA, 2000, INT J OBESITY, V24, pS67, DOI 10.1038/sj.ijo.0801509; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Trayhurn P, 2001, P NUTR SOC, V60, P329, DOI 10.1079/PNS200194; Weisiger RA, 2002, MOL CELL BIOCHEM, V239, P35, DOI 10.1023/A:1020550405578; Wronkowitz N, 2014, FRONT HORM RES, V43, P79, DOI 10.1159/000360560; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200	62	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0193704	10.1371/journal.pone.0193704	http://dx.doi.org/10.1371/journal.pone.0193704			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596447	gold, Green Published			2022-12-26	WOS:000428630000011
J	Slater, K; Barrett, A; Brown, LR				Slater, Kerry; Barrett, Alan; Brown, Leslie R.			Home range utilization by chacma baboon (Papio ursinus) troops on Suikerbosrand Nature Reserve, South Africa	PLOS ONE			English	Article							HABITAT USE; MOUNTAIN BABOONS; DAY LENGTH; POPULATION-STRUCTURE; BEHAVIORAL ECOLOGY; HAMADRYAS-URSINUS; FOOD AVAILABILITY; CAPE PENINSULA; PREDATION RISK; GROUP-SIZE	Rapid urbanization coupled with decreasing areas of natural habitat are causing baboon populations to become scattered and isolated, often resulting in increased levels of human-baboon conflict. To implement baboon-human conflict management strategies, it is essential to formulate realistic conservation policies that deal with all stakeholder concerns and ensure the conservation of viable baboon populations. A study was initiated in response to complaints of perceived excessive baboon numbers and associated lack of food resources on Suikerbosrand Nature Reserve in South Africa. Data obtained from GPS tracking collars fitted to one baboon from each of 10 identified troops were analyzed to determine home range size and utilization. The spatial representation of home ranges generated from this study will allow reserve management to identify areas of potential high and low human-baboon conflict and will contribute to the development of a formal baboon management plan to reduce human-baboon conflict on and around the reserve. Home ranges were unevenly distributed and had a mean size of 26.72 km(2) +/- 13.91 SD in the cold/dry season and 26.54 km(2) +/- 12.76 SD in the warm/wet season. Troop home ranges overlapped to some degree and five troops utilized areas outside the reserve. Although no significant relationship between troop size and home range was found, there was a positive relationship between troop size and daily distance travelled. All troops had significantly longer mean daily distances during the warm/wet season than during the cold/dry season (P <= 0.02).	[Slater, Kerry; Barrett, Alan; Brown, Leslie R.] Univ South Africa, Appl Behav Ecol & Ecosyst Res Unit, Dept Environm Sci, Florida, South Africa	University of South Africa	Slater, K (corresponding author), Univ South Africa, Appl Behav Ecol & Ecosyst Res Unit, Dept Environm Sci, Florida, South Africa.	slatek@unisa.ac.za	Slater, Kerry/C-7406-2015; Brown, Leslie R/N-9762-2015	Slater, Kerry/0000-0001-6362-1064; Brown, Leslie R/0000-0002-1026-5438				ABRAMS PA, 1991, ECOLOGY, V72, P1242, DOI 10.2307/1941098; Altmann SA, 1970, BABOON ECOLOGY AFRIC; Anderson C.M., 1981, International Journal of Primatology, V2, P285, DOI 10.1007/BF02693480; BARTON RA, 1992, ANIM BEHAV, V43, P831, DOI 10.1016/S0003-3472(05)80206-4; Beamish EK, 2010, THESIS; Birss C, 2007, SUIKERBOSRAND NATURE; Bronikowski AM, 1996, BEHAV ECOL SOCIOBIOL, V39, P11, DOI 10.1007/s002650050262; BYRNE RW, 1993, BEHAV ECOL SOCIOBIOL, V33, P233, DOI 10.1007/BF02027120; Chance MRA, 1970, SOCIAL GROUPS MONKEY; CLUTTONBROCK TH, 1977, J ZOOL, V183, P1, DOI 10.1111/j.1469-7998.1977.tb04171.x; COLLINS DA, 1984, ANIM BEHAV, V32, P536, DOI 10.1016/S0003-3472(84)80292-4; Cowlishaw G, 1997, ANIM BEHAV, V54, P241, DOI 10.1006/anbe.1996.0466; Cowlishaw G, 1997, ANIM BEHAV, V53, P667, DOI 10.1006/anbe.1996.0298; DAVIDGE C, 1978, ZOOL AFR, V13, P329, DOI 10.1080/00445096.1978.11447633; Davidge C, 1976, THESIS; Dias LG, 2003, INT J PRIMATOL, V24, P209, DOI 10.1023/A:1023054513354; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; DUNBAR RIM, 1992, BEHAV ECOL SOCIOBIOL, V31, P35, DOI 10.1007/BF00167814; Erasmus D, 1993, THESIS; Gaynor D., 1994, THESIS; Gillespie TR, 2001, BEHAV ECOL SOCIOBIOL, V50, P329, DOI 10.1007/s002650100371; HAMILTON WJ, 1976, ECOLOGY, V57, P1264, DOI 10.2307/1935050; Hemingway CA, 2005, CAM S BIO EVOL ANTHR, V44, P57, DOI 10.1017/CBO9780511542343.004; Hennop JA, 2007, PROJECT REPORT COLLE; Henzi SP, 2011, INT J PRIMATOL, V32, P1020, DOI 10.1007/s10764-011-9519-6; Henzi SP, 1997, ANIM BEHAV, V53, P525, DOI 10.1006/anbe.1996.0302; HENZI SP, 1995, AM J PRIMATOL, V35, P155, DOI 10.1002/ajp.1350350208; Henzi SP, 1998, ANIM BEHAV, V55, P1421, DOI 10.1006/anbe.1997.0716; HENZI SP, 1992, INT J PRIMATOL, V13, P601, DOI 10.1007/BF02551256; Hill CM, 2000, INT J PRIMATOL, V21, P299, DOI 10.1023/A:1005481605637; Hill RA, 2004, S AFR J WILDL RES, V34, P39; Hill RA, 2003, BEHAV ECOL SOCIOBIOL, V53, P278, DOI 10.1007/s00265-003-0590-7; Hill RA, 2002, EVOL ECOL, V16, P579, DOI 10.1023/A:1021625003597; Hoffman TS, 2012, AM J PRIMATOL, V74, P853, DOI 10.1002/ajp.22040; Hoffman TS, 2011, INT J PRIMATOL, V32, P308, DOI 10.1007/s10764-010-9467-6; Kansky R, 2000, BABOON MANAGEMENT ST; Kaplan BS, 2011, INT J PRIMATOL, V32, P1397, DOI 10.1007/s10764-011-9541-8; Klaassen RHG, 2006, THEOR POPUL BIOL, V70, P452, DOI 10.1016/j.tpb.2006.04.002; Marais A. J., 2006, Koedoe, V49, P67; Marais AJ, 2005, THESIS; MOHR CO, 1947, AM MIDL NAT, V37, P223, DOI 10.2307/2421652; Mucina L., 2006, VEGETATION S AFRICA; Naughton-Treves L, 1998, J APPL ECOL, V35, P596, DOI 10.1046/j.1365-2664.1998.3540596.x; Noser R, 2007, ANIM BEHAV, V73, P257, DOI 10.1016/j.anbehav.2006.04.012; Oates J.F., 1987, P197; Pahad G, 2010, THESIS; Panagos MD, 1999, SCALE PHYTOPHYSIOGNO; Sapolsky RM, 2004, PLOS BIOL, V2, P534, DOI 10.1371/journal.pbio.0020106; Segal C, 2008, THESIS; Skinner J. D., 2005, MAMMALS SO AFRICAN S; Stoltz L, 1977, THESIS; STOLTZ LP, 1973, J HUM EVOL, V2, P195, DOI 10.1016/0047-2484(73)90076-6; Stone OML, 2012, PRIMATES, V53, P337, DOI 10.1007/s10329-012-0303-9; STRUM SC, 1994, REV ECOL-TERRE VIE, V49, P295; Strum SC, 2010, INT J PRIMATOL, V31, P133, DOI 10.1007/s10764-009-9387-5; van Doorn AC, 2010, AM J PRIMATOL, V72, P104, DOI 10.1002/ajp.20759; WHITEN A, 1987, INT J PRIMATOL, V8, P367, DOI 10.1007/BF02737389	57	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194717	10.1371/journal.pone.0194717	http://dx.doi.org/10.1371/journal.pone.0194717			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596482	Green Submitted, gold, Green Published			2022-12-26	WOS:000428630000038
J	Wai, PP; Shewade, HD; Kyaw, NTT; Thein, S; Thu, AS; Kyaw, KWY; Aye, NN; Phyo, AM; Maung, HMW; Soe, KT; Aung, ST				Wai, Pyae Phyo; Shewade, Hemant Deepak; Kyaw, Nang Thu Thu; Thein, Saw; Thu, Aung Si; Kyaw, Khine Wut Yee; Aye, Nyein Nyein; Phyo, Aye Mon; Maung, Htet Myet Win; Soe, Kyaw Thu; Aung, Si Thu			Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; OUTCOMES; INDIA; TIME	Background The Union in collaboration with national TB programme (NTP) started the community-based MDR-TB care (CBMDR-TBC) project in 33 townships of upper Myanmar to improve treatment initiation and treatment adherence. Patients with MDR-TB diagnosed/registered under NTP received support through the project staff, in addition to the routine domiciliary care provided by NTP staff. Each township had a project nurse exclusively for MDR-TB and 30 USD per month (max. for 4 months) were provided to the patient as a pre-treatment support. Objectives To assess whether CBMDR-TBC project's support improved treatment initiation. Methods In this cohort study (involving record review) of all diagnosed MDR-TB between January 2015 and June 2016 in project townships, CBMDR-TBC status was categorized as "receiving support" if date of project initiation in patient's township was before the date of diagnosis and "not receiving support", if otherwise. Cox proportional hazards regression (censored on 31 Dec 2016) was done to identify predictors of treatment initiation. Results Of 456 patients, 57% initiated treatment: 64% and 56% among patients "receiving support (n = 208)" and "not receiving support (n = 228)" respectively (CBMDR-TBC status was not known in 20 (4%) patients due to missing diagnosis dates). Among those initiated on treatment (n = 261), median (IQR) time to initiate treatment was 38 (20, 76) days: 31 (18, 50) among patients "receiving support" and 50 (26,101) among patients "not receiving support". After adjusting other potential confounders (age, sex, region, HIV, past history of TB treatment), patients "receiving support" had 80% higher chance of initiating treatment [aHR (0.95 CI): 1.8 (1.3, 2.3)] when compared to patients "not receiving support". In addition, age 15-54 years, previous history of TB and being HIV negative were independent predictors of treatment initiation. Conclusion Receiving support under CBMDR-TBC project improved treatment initiation: it not only improved the proportion initiated but also reduced time to treatment initiation. We also recommend improved tracking of all diagnosed patients as early as possible.	[Wai, Pyae Phyo; Kyaw, Nang Thu Thu; Thu, Aung Si; Kyaw, Khine Wut Yee; Aye, Nyein Nyein; Phyo, Aye Mon] Int Union TB & Lung Dis Union, Mandalay, Myanmar; [Shewade, Hemant Deepak] Int Union TB & Lung Dis Union, South East Asia Off, New Delhi, India; [Thein, Saw] Minist Hlth & Sports, Natl TB Programme, Mandalay, Myanmar; [Maung, Htet Myet Win; Aung, Si Thu] Minist Hlth & Sports, Natl TB Programme, Nay Pyi Daw, Myanmar; [Soe, Kyaw Thu] Minist Hlth & Sports, Dept Med Res, Pyin Oo Lwin Branch, Pyin Oo Lwin, Myanmar		Wai, PP (corresponding author), Int Union TB & Lung Dis Union, Mandalay, Myanmar.	dr.p.p.wai2012@gmail.com	Kyaw, Khine Wut Yee/K-4130-2019	Kyaw, Khine Wut Yee/0000-0003-0709-484X; SOE, KYAW THU/0000-0003-0969-8815				Cleves M., 2008, INTRO SURVIVAL ANAL; Cox H, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002238; Ebonwu JI, 2013, INT J TUBERC LUNG D, V17, P1043, DOI 10.5588/ijtld.13.0071; Harris RC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1524-0; Hernan MA, 2010, EPIDEMIOLOGY, V21, P13, DOI 10.1097/EDE.0b013e3181c1ea43; Hossain ST, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129155; Loveday M, 2015, INT J TUBERC LUNG D, V19, P163, DOI 10.5588/ijtld.14.0369; Ministry of Immigration and Population M, 2014, POP HOUS CENS MYANM; Naidoo P, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1145-0; Nair D, 2016, T ROY SOC TROP MED H, V110, P534, DOI 10.1093/trstmh/trw060; National TB Programme Myanmar, 2016, NAT STRAT PLAN TB 20; National Tuberculosis Programme (NTP), 2016, GUID MAN DR IB MYANM; National Tuberculosis Programme (NTP), 2015, NAT TUB PROGR MYANM; National Tuberculosis Programme (NTP), 2016, MYANM NAT STRAT PLAN, P126; Shewade HD, 2016, PUBLIC HEALTH ACTION, V6, P242, DOI 10.5588/pha.16.0075; Singla N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102989; Wai PP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187223; WHO, 2014, END TB STRAT; World Bank, 2015, WORLD BANK REP 2015; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; Xu Z, 2017, PLOS ONE, V12	21	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194087	10.1371/journal.pone.0194087	http://dx.doi.org/10.1371/journal.pone.0194087			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596434	Green Published, Green Submitted, gold			2022-12-26	WOS:000428630000016
J	Kahuthia-Gathu, R; Thungu, DK; Wangu, L; Kimani, R				Kahuthia-Gathu, Ruth; Thungu, Duncan Kirubi; Wangu, Lucy; Kimani, Rachael			Wood-boring beetles associated with Acacia xanthophloea in Nairobi and Machakos Counties, Kenya	PLOS ONE			English	Article							F-MUELL FORESTS; COLEOPTERA BOSTRICHIDAE; NUTRIENT BALANCE; DREPANOLOBIUM; BIOMASS; STRESS	Naivasha thorn tree, Acacia xanthophloea, is grown for foliage, timber, shade and rehabilitation of soils in areas with high water tables in Kenya. Its production is threatened by insect pests, which cause major losses. Very little is documented on wood-boring beetles which cause considerable economic damage to lumber used in a variety of applications, and little is known about their natural enemies in Kenya. We conducted the study to evaluate the occurrence of wood-boring beetles on A. xanthophloea in two different regions of Kenya. Infested wood samples of A. xanthophloea with fresh exit holes were collected from three sites in Kenyatta University (KU), Nairobi and Mitaboni in Machakos, Kenya. The samples were placed in clear plastic buckets and kept at ambient temperatures 23 +/- 2 degrees C, 65 +/- 10% relative humidity and 12L: 12D in a laboratory where they were observed daily for adult emergence. Adult beetles were collected every three days for identification and data recording. The experiment was replicated four times and data collected twice a week for 6 months. Data on abundance was subjected to analysis of variance using SAS software. A total of 5,850 and 4,691 beetles were collected where 2,187 and 3,097 were Bostrichidae, accounting for 37% and 66% in KU and Mitaboni, respectively. A total of 12 bostrichid species was identified, including Sinoxylon ruficorne, S. doliolum, Xylion adustus, Xyloperthodes nitidipennis, Xyloperthella picea, Xylopsocus castanoptera, Lyctus brunneus, Heterbostrychus brunneus, Xylopsocus sp., and Dinoderus gabonicus. The most abundant species in KU was Xylion adustus with 1,915 beetles accounting for 88.4%, and Sinoxylon ruficorne in Mitaboni with 1,050 beetles accounting for 33.9% of the total. Sinoxylon ruficorne was only recorded in Mitaboni while only 2 specimens of D. gabonicus were found in KU. The mean number of exit holes on A. xanthophloea differed significantly between sites, which corresponded approximately to the amount of economic damage caused by the beetles to the structural integrity of the lumber. In addition, a number of predators in the family Cerambycidae, Cleridae, Histeridae and parasitoids from Braconidae, lchneumonidae, and Chalcididae were recovered, suggesting a need to conduct further studies to document these species' diversity, parasitism rates and efficacy for possible biological control.	[Kahuthia-Gathu, Ruth; Thungu, Duncan Kirubi; Wangu, Lucy; Kimani, Rachael] Kenyatta Univ, Dept Agr Sci & Technol, Nairobi, Kenya	Kenyatta University	Kahuthia-Gathu, R (corresponding author), Kenyatta Univ, Dept Agr Sci & Technol, Nairobi, Kenya.	rkahuthia@gmail.com	Kahuthia, Ruth/AAZ-6285-2021	Kahuthia, Ruth/0000-0001-9621-5310				ADAMS MA, 1984, AUST J BOT, V32, P205, DOI 10.1071/BT9840205; ADAMS MA, 1984, AUST J BOT, V32, P217, DOI 10.1071/BT9840217; Akhter K, 2005, 36 ANN M BANG IND AP, P24; Allen DC, 2005, NEW YORK FOREST OWNE, V38, P1; Balasubramanya R. H., 1990, Journal of the Indian Society for Cotton Improvement, V15, P34; Beaver Roger A., 2011, Tropical Natural History, V11, P135; Bellamy C.L., WORLD JEWEL BEETLES; Binda F., 1991, Boletin de Entomologia Venezolana, V6, P83; Borgemeister C, 1999, ANN ENTOMOL SOC AM, V92, P766, DOI 10.1093/aesa/92.5.766; Borowski J., 2007, WORLD CATALOGUE BOST; Bushara M. G., 1981, Sudan Silva, V4, P25; Chase KD, 2012, FLA ENTOMOL, V95, P767, DOI 10.1653/024.095.0329; Chippendale GM, 1963, TOP FEED FODDER TREE; Cookson LJ, 2004, TREATMENT METHODS PR; Creffield JW, 1991, WOOD DESTROYING INSE; Dharani N, 2006, AFR J ECOL, V44, P523, DOI 10.1111/j.1365-2028.2006.00668.x; European Environment Agency [EEA], 2012, 16 EEA; Everist S.L., 1969, USE FODDER TREES SHR; Findlay WPK., 1985, PRESERVATION TIMBER, P273; FISHER WS, 1950, USDA MISCELLANEOUS P, V698, P1, DOI DOI 10.5962/BHL.TITLE.65663; Gathuru G., 2011, THESIS; Gerberg E. J., 1957, Technical Bulletin United States Department of Agriculture Washington, Vno. 1157, P1; Hagstrum D.W., 2009, STORED PRODUCT INSEC; Hakeem KR, 2012, OMICS, V16, P621, DOI 10.1089/omi.2012.0041; Halperin J, 1999, PHYTOPARASITICA, V27, P257, DOI 10.1007/BF02981481; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; Herard F., 2009, Bulletin OEPP, V39, P146, DOI 10.1111/j.1365-2338.2009.02286.x; Ivie M. A., 2002, AM BEETLES, V2, P233; Kangkamanee T, 2011, J FOREST RES-JPN, V16, P302, DOI 10.1007/s10310-010-0224-7; Kuria SK, 2010, AFR ENTOMOL, V18, P87, DOI 10.4001/003.018.0109; Lawrence JF, 2010, HBK ZOOL, P209; Lek-Uthai P, 1982, WOOD PRODUCT SECTION, P1; Lesne P., 1924, ENCY ENTOMOLOGIQUE A, V3, P1; Liu Lan-Yu, 2008, Mitteilungen Muenchener Entomologischen Gesellschaft, V98, P91; Lopes-da-Silva M., 2014, Agricultural Sciences, V5, P634, DOI 10.4236/as.2014.57067; Lykidis Charalampos T., 2016, Fragmenta Entomologica, V48, P101, DOI 10.4081/fe.2016.171; Monks KA, 2000, EKOLOGI NUSA TENGGAR, P33; Nair KSS, 2007, NAIR KSS TROPICAL FO, P404; Okello BD, 2001, FOREST ECOL MANAG, V142, P143, DOI 10.1016/S0378-1127(00)00346-7; Orwa C., AGROFORESTREE DATABA; Filho OP, 2006, NEOTROP ENTOMOL, V35, P712, DOI 10.1590/S1519-566X2006000500023; Peters B. C., 2002, Australian Forestry, V65, P107; Price T, 2011, FLA ENTOMOL, V94, P354, DOI 10.1653/024.094.0235; Sakalian V, 2013, ACTA ZOOL BULGAR, V65, P457; SANDHU G S, 1975, Journal of Research Punjab Agricultural University, V12, P152; SAS Institute, 2001, STAT US GUID; Singh R. M. P., 1995, 70 INT CTR RES AGR N, P1; Sittichaya Wisut, 2009, Songklanakarin Journal of Science and Technology, V31, P381; Sittichaya W, 2009, ZOOKEYS, P33, DOI 10.3897/zookeys.26.88; Speight M.R., 2008, ECOLOGY INSECTS CONC, V2nd ed.; TEIXEIRA ÉDSON P., 2002, Neotrop. entomol., V31, P651, DOI 10.1590/S1519-566X2002000400021; Thomas FM, 2002, FOREST PATHOL, V32, P277, DOI 10.1046/j.1439-0329.2002.00291.x; Tomimura Y., 1993, B FOR FOR PROD RES I, V365, P33; Wargo PM, 1996, ANN SCI FOREST, V53, P359, DOI 10.1051/forest:19960218	54	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0188773	10.1371/journal.pone.0188773	http://dx.doi.org/10.1371/journal.pone.0188773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584732	Green Submitted, Green Published, gold			2022-12-26	WOS:000428373000001
J	Massad, E; dos Santos, PCC; da Rocha, AF; Stupple, EJN				Massad, Eduardo; Costa dos Santos, Paulo Cesar; da Rocha, Armando Freitas; Stupple, Edward J. N.			The Monty Hall problem revisited: Autonomic arousal in an inverted version of the game	PLOS ONE			English	Article							DECISION-MAKING; LOSS AVERSION; LOSSES; GAINS	The asymmetry of autonomic arousal for potential losses and gains was assessed by the galvanic skin response (GSR) of participants playing classic and inverted versions of the Monty Hall problem (MHP). In both versions, the prize remained the same (a pen valued at 10 pound for the right answer), but in the modified version, prizes were received prior to choosing the door. Both experimental groups showed increased levels of GSR while completing the task, demonstrating increased autonomic arousal during the game. However, a robust difference in GSR was detected between classic and inverted versions of the MHP, thus demonstrating the differing autonomic arousal involved in deciding between the alternatives presented by the game. Participants experienced a stronger autonomic response when they could lose the prize than when they could win the prize. This experiment presents the first demonstration of this effect on the MHP. The stronger autonomic arousal for the inverted task may indicate a stronger emotional reaction and/or greater attentional focus than for the standard version of the task. These data demonstrate that potential losses increase arousal in more complex tasks than is typically shown.	[Massad, Eduardo; Costa dos Santos, Paulo Cesar; da Rocha, Armando Freitas] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil; [Massad, Eduardo] London Sch Hyg & Trop Med, London, England; [Massad, Eduardo; Stupple, Edward J. N.] Univ Derby, Coll Life & Nat Sci, Derby, England; [Massad, Eduardo] Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil; [Costa dos Santos, Paulo Cesar] Univ Paulista, Sao Paulo, Brazil; [Costa dos Santos, Paulo Cesar] Univ Sao Paulo, Inst Adv Studies, Sao Paulo, Brazil	Universidade de Sao Paulo; University of London; London School of Hygiene & Tropical Medicine; University of Derby; Escola de Pos-Graduacao em Economia (EPGE); Getulio Vargas Foundation; Universidade Paulista; Universidade de Sao Paulo	Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.; Massad, E (corresponding author), London Sch Hyg & Trop Med, London, England.; Massad, E (corresponding author), Univ Derby, Coll Life & Nat Sci, Derby, England.; Massad, E (corresponding author), Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.	edmassad@usp.br	Stupple, Edward J N/H-2925-2016; Massad, Eduardo/B-1169-2012	Stupple, Edward J N/0000-0001-8545-9504; Massad, Eduardo/0000-0002-7200-2916				Atkinson KE, 1989, INTRO NUMERICAL ANAL; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Bland M., 2000, INTRO MED STAT, V3rd; Burns BD, 2004, J EXP PSYCHOL GEN, V133, P434, DOI 10.1037/0096-3445.133.3.434; Dawson ME, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P159, DOI 10.1017/cbo9780511546396.007; De Martino B, 2008, J NEUROSCI, V28, P10746, DOI 10.1523/JNEUROSCI.2895-08.2008; Gardner M., 1959, SCI AM, V201, P174; Gokay R, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON MULTISENSOR FUSION AND INTEGRATION FOR INTELLIGENT SYSTEMS (MFI), P178, DOI 10.1109/MFI.2015.7295805; GRANBERG D, 1995, PERS SOC PSYCHOL B, V21, P711; Hochman G, 2014, J ECON BEHAV ORGAN, V107, P582, DOI 10.1016/j.jebo.2014.01.014; Hochman G, 2011, J BEHAV DECIS MAKING, V24, P140, DOI 10.1002/bdm.692; Krauss S, 2003, J EXP PSYCHOL GEN, V132, P3, DOI 10.1037/0096-3445.132.1.3; LeDoux J.E., 2015, ANXIOUS MODERN MIND; Lejarraga T, 2017, PSYCHON B REV, V24, P708, DOI 10.3758/s13423-016-1158-7; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Oviatt S, 2006, P 14 ACM INT C MULTI, P871; Page SE, 1998, ECON LETT, V61, P175, DOI 10.1016/S0165-1765(98)00158-X; Piattelli-Palmarini M., 1991, PROBABILITY BLINDNES, P28; Rick S, 2011, J CONSUM PSYCHOL, V21, P453, DOI 10.1016/j.jcps.2010.04.004; Rosenhouse J., 2009, MONTY HALL PROBLEM; THALER R, 1980, J ECON BEHAV ORGAN, V1, P39, DOI 10.1016/0167-2681(80)90051-7; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Vaish A, 2008, PSYCHOL BULL, V134, P383, DOI 10.1037/0033-2909.134.3.383; Yechiam E, 2014, PSYCHOL SCI, V25, P494, DOI 10.1177/0956797613510725; Yechiam E, 2013, PSYCHOL BULL, V139, P497, DOI 10.1037/a0029383	26	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0192542	10.1371/journal.pone.0192542	http://dx.doi.org/10.1371/journal.pone.0192542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5DH	29579122	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000428351800005
J	Xavier, MJ; Nixon, B; Roman, SD; Aitken, RJ				Xavier, Miguel J.; Nixon, Brett; Roman, Shaun D.; Aitken, Robert John			Improved methods of DNA extraction from human spermatozoa that mitigate experimentally-induced oxidative DNA damage	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; CHROMATIN-STRUCTURE ASSAY; HUMAN SPERM; STRAND BREAKS; NUCLEOSOME OCCUPANCY; MAMMALIAN SPERM; TUNEL ASSAY; GERM-CELLS; INTEGRITY; MOUSE	Current approaches for DNA extraction and fragmentation from mammalian spermatozoa provide several challenges for the investigation of the oxidative stress burden carried in the genome of male gametes. Indeed, the potential introduction of oxidative DNA damage induced by reactive oxygen species, reducing agents (dithiothreitol or beta-mercaptoethanol), and DNA shearing techniques used in the preparation of samples for chromatin immunoprecipitation and next-generation sequencing serve to cofound the reliability and accuracy of the results obtained. Here we report optimised methodology that minimises, or completely eliminates, exposure to DNA damaging compounds during extraction and fragmentation procedures. Specifically, we show that Micrococcal nuclease (MNase) digestion prior to cellular lysis generates a greater DNA yield with minimal collateral oxidation while randomly fragmenting the entire paternal genome. This modified methodology represents a significant improvement over traditional fragmentation achieved via sonication in the preparation of genomic DNA from human spermatozoa for downstream applications, such as next-generation sequencing. We also present a redesigned bioinformatic pipeline framework adjusted to correctly analyse this form of data and detect statistically relevant targets of oxidation.	[Xavier, Miguel J.; Nixon, Brett; Roman, Shaun D.; Aitken, Robert John] Univ Newcastle, Reprod Sci Grp, Fac Sci, Callaghan, NSW, Australia; [Xavier, Miguel J.; Nixon, Brett; Roman, Shaun D.; Aitken, Robert John] Univ Newcastle, Prior Res Ctr Reprod Sci, Callaghan, NSW, Australia; [Roman, Shaun D.] Univ Newcastle, Prior Res Ctr Chem Biol & Clin Pharm, Callaghan, NSW, Australia; [Aitken, Robert John] Univ Newcastle, Fac Hlth & Med, Callaghan, NSW, Australia	University of Newcastle; University of Newcastle; University of Newcastle; University of Newcastle	Xavier, MJ (corresponding author), Univ Newcastle, Reprod Sci Grp, Fac Sci, Callaghan, NSW, Australia.; Xavier, MJ (corresponding author), Univ Newcastle, Prior Res Ctr Reprod Sci, Callaghan, NSW, Australia.	migueljoao.xavier@uon.edu.au	Aitken, Robert John/AAY-8238-2020; Xavier, Miguel/AAD-4576-2022; Roman, Shaun/AFR-5087-2022; ROMAN, SHAUN/G-7047-2013; Nixon, Brett/B-5121-2012	Aitken, Robert John/0000-0002-9152-156X; Xavier, Miguel/0000-0003-0709-7223; ROMAN, SHAUN/0000-0002-7758-7757; Nixon, Brett/0000-0003-2745-8188	University of Newcastle's Priority Research Centre for Reproductive Sciences	University of Newcastle's Priority Research Centre for Reproductive Sciences	This work was supported by the University of Newcastle's Priority Research Centre for Reproductive Sciences. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken J, 2007, REPROD BIOMED ONLINE, V14, P727, DOI 10.1016/S1472-6483(10)60676-1; Aitken RJ, 2013, MOL HUM REPROD, V19, P475, DOI 10.1093/molehr/gat025; Aitken RJ, 2013, ANDROLOGY-US, V1, P192, DOI 10.1111/j.2047-2927.2012.00056.x; Aitken RJ, 2009, J CLIN INVEST, V119, P1849, DOI 10.1172/JCI39688; Aitken RJ, 2009, INT J ANDROL, V32, P46, DOI 10.1111/j.1365-2605.2008.00943.x; Aitken RJ, 2004, J ANDROL, V25, P455; Aitken RJ, 1998, BIOL REPROD, V59, P1037, DOI 10.1095/biolreprod59.5.1037; Aravindan GR, 1997, EXP CELL RES, V236, P231, DOI 10.1006/excr.1997.3719; Arpanahi A, 2009, GENOME RES, V19, P1338, DOI 10.1101/gr.094953.109; BAHNAK BR, 1988, NUCLEIC ACIDS RES, V16, P1208, DOI 10.1093/nar/16.3.1208; Balhorn R, 2000, MOL REPROD DEV, V56, P230, DOI 10.1002/(SICI)1098-2795(200006)56:2+<230::AID-MRD3>3.3.CO;2-M; Barratt CLR, 2010, HUM REPROD, V25, P824, DOI 10.1093/humrep/dep465; BIGGERS J. D., 1971, Methods in mammalian embryology, P86; Braun RE, 2001, NAT GENET, V28, P10, DOI 10.1038/88194; Chabory E, 2009, J CLIN INVEST, V119, P2074, DOI 10.1172/JCI38940; Chankitisakul V, 2013, J REPROD DEVELOP, V59, P66; Charrier JG, 2012, ATMOS CHEM PHYS, V12, P9321, DOI 10.5194/acp-12-9321-2012; Chung HR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015754; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; Conwell CC, 2003, P NATL ACAD SCI USA, V100, P9296, DOI 10.1073/pnas.1533135100; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Cui KR, 2012, METHODS MOL BIOL, V833, P413, DOI 10.1007/978-1-61779-477-3_24; De Iuliis GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006446; De Iuliis GN, 2009, BIOL REPROD, V81, P517, DOI 10.1095/biolreprod.109.076836; Evenson DP, 2002, J ANDROL, V23, P25, DOI 10.1002/j.1939-4640.2002.tb02599.x; Fan XC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn535; FUCIARELLI AF, 1995, FREE RADICAL BIO MED, V18, P231, DOI 10.1016/0891-5849(94)00119-5; GATEWOOD JM, 1990, J BIOL CHEM, V265, P20662; Irvine DS, 2000, J ANDROL, V21, P33; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kimmins S, 2005, NATURE, V434, P583, DOI 10.1038/nature03368; Knierim E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028240; Kobayashi H, 2007, HUM MOL GENET, V16, P2542, DOI 10.1093/hmg/ddm187; Kocer A, 2015, FREE RADICAL BIO MED, V89, P993, DOI 10.1016/j.freeradbiomed.2015.10.419; Kumagai Y, 2002, CHEM RES TOXICOL, V15, P483, DOI 10.1021/tx0100993; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis SEM, 2008, MUTAGENESIS, V23, P163, DOI 10.1093/mutage/gem052; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; MICKEY B, 1995, J CELL BIOL, V130, P909, DOI 10.1083/jcb.130.4.909; Mieczkowski J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11485; Milowska K, 2007, BIOMOL ENG, V24, P263, DOI 10.1016/j.bioeng.2007.02.001; Mitchell LA, 2011, INT J ANDROL, V34, P2, DOI 10.1111/j.1365-2605.2009.01042.x; Noblanc A, 2013, FREE RADICAL BIO MED, V65, P719, DOI 10.1016/j.freeradbiomed.2013.07.044; Oger I, 2003, ZYGOTE, V11, P367, DOI 10.1017/S0967199403002442; Pan WW, 2013, GENE, V526, P287, DOI 10.1016/j.gene.2013.03.103; R Core Team, 2004, R LANG ENV STAT COMP; Ramos L, 2001, HUM REPROD, V16, P1703, DOI 10.1093/humrep/16.8.1703; Ravanat JL, 2002, CARCINOGENESIS, V23, P1911, DOI 10.1093/carcin/23.11.1911; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SAILER BL, 1995, J ANDROL, V16, P80; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Simon L, 2011, REPROD BIOMED ONLINE, V23, P724, DOI 10.1016/j.rbmo.2011.08.010; Simon L, 2011, FERTIL STERIL, V95, P652, DOI 10.1016/j.fertnstert.2010.08.019; Smit A.F.A., 2015, REPEATMASKER OPEN 4; Smith TB, 2013, J CELL SCI, V126, P1488, DOI 10.1242/jcs.121657; Spano M, 2005, CURR OPIN OBSTET GYN, V17, P255, DOI 10.1097/01.gco.0000169102.77504.66; Szczygiel MA, 2003, BIOL REPROD, V68, P1903, DOI 10.1095/biolreprod.102.012377; Szczygiel MA, 2002, BIOL REPROD, V67, P1532, DOI 10.1095/biolreprod.101.002667; Tolstorukov MY, 2010, EPIGENOMICS-UK, V2, P187, DOI 10.2217/EPI.09.48; van der Heijden GW, 2006, DEV BIOL, V298, P458, DOI 10.1016/j.ydbio.2006.06.051; van der Heijden GW, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-34; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Wykes SM, 2003, J BIOL CHEM, V278, P29471, DOI 10.1074/jbc.M304545200; Yamauchi Y, 2012, J ANDROL, V33, P229, DOI 10.2164/jandrol.111.013532; Zalenskaya IA, 2000, BIOCHEM BIOPH RES CO, V279, P213, DOI 10.1006/bbrc.2000.3917; Zhang ZH, 2011, CELL, V144, P175, DOI 10.1016/j.cell.2011.01.003; Zini A, 2008, HUM REPROD, V23, P2663, DOI 10.1093/humrep/den321	70	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0195003	10.1371/journal.pone.0195003	http://dx.doi.org/10.1371/journal.pone.0195003			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579126	Green Published, Green Submitted, gold			2022-12-26	WOS:000428351800077
J	Mulder, FAA				Mulder, Frans A. A.			Fuzzy and fast nuclear transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Exchange of macromolecules between the cytoplasm and the nucleus of all eukaryotic cells is controlled by nuclear pore complexes, which form a selective permeability barrier. The requirement for rapid but selective transport leads to a "transport paradox." A new experimental study now provides a thermodynamic explanation.	[Mulder, Frans A. A.] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark; [Mulder, Frans A. A.] Aarhus Univ, Dept Chem, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University	Mulder, FAA (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark.; Mulder, FAA (corresponding author), Aarhus Univ, Dept Chem, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark.	fmulder@chem.au.dk	Mulder, Frans AA/C-7158-2017	Mulder, Frans AA/0000-0001-9427-8406				Beck M, 2017, NAT REV MOL CELL BIO, V18, P73, DOI 10.1038/nrm.2016.147; Bhowmick A, 2016, J AM CHEM SOC, V138, P9730, DOI 10.1021/jacs.6b06543; Fischer E, 1984, BER DEUT CHEM GES, V27, P2985; Hayama R, 2018, J BIOL CHEM, V293, P4555, DOI 10.1074/jbc.AC117.001649; Kitov PI, 2003, J AM CHEM SOC, V125, P16271, DOI 10.1021/ja038223n; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271	7	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4564	+		10.1074/jbc.H118.002129	http://dx.doi.org/10.1074/jbc.H118.002129			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29572326	Green Published, hybrid			2022-12-26	WOS:000428204300027
J	Wojnacki, J; Galli, T				Wojnacki, Jose; Galli, Thierry			A new actin-binding domain glues autophagy together	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							EXCHANGE FACTOR DENND3; RAB12	Autophagy breaks down nonessential cellular components to replenish macromolecular building blocks during starvation. Nevertheless, the downstream events regulating vesicle trafficking during this essential cellular process are not yet fully defined. Xu et al. combined approaches of crystallography, biochemistry, and cell biology to show that the guanine nucleotide exchange factor DENND3 contains an actin-binding site they call "PHenn domain" in a region previously thought to be unstructured. PHenn domain binding to microfilaments is necessary for DENND3's participation in autophagy, providing a new link between autophagic stimulation and actin microfilaments. The findings by Xu et al. shed important new light on how membrane trafficking participates in critical steps of autophagy in relationship with actin microfilaments.	[Wojnacki, Jose; Galli, Thierry] Univ Paris 05, Sorbonne Paris Cite, INSERM, U894,Ctr Psychiat & Neurosci,Membrane Traff Hlth, F-75014 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Galli, T (corresponding author), INSERM, U894, 102-108 Rue Sante, F-75014 Paris, France.	thierry.galli@inserm.fr	Galli, Thierry/Q-2249-2019; Galli, Thierry/G-8842-2011	Galli, Thierry/0000-0001-8514-7455; Galli, Thierry/0000-0001-8514-7455	INSERM; Fondation pour la Recherche Medicale (FRM); French National Research Agency [ANR-13-BSV2-0018-02, ANR-16-CE16-0012]; Ecole des Neurosciences de Paris (ENP); Association Robert Debre pour la Recherche Medicale; Fondation Bettencourt Schueller; Who am I? Labex [Idex ANR-11-IDEX-0005-01]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); French National Research Agency(French National Research Agency (ANR)); Ecole des Neurosciences de Paris (ENP); Association Robert Debre pour la Recherche Medicale; Fondation Bettencourt Schueller; Who am I? Labex	This work was funded in part by INSERM, the Fondation pour la Recherche Medicale (FRM), the French National Research Agency (NeuroImmunoSynapse ANR-13-BSV2-0018-02 and MetDePaDi ANR-16-CE16-0012), the Ecole des Neurosciences de Paris (ENP), awards of the Association Robert Debre pour la Recherche Medicale and Fondation Bettencourt Schueller (to T. G.), and Who am I? Labex (Idex ANR-11-IDEX-0005-01). The authors declare that they have no conflicts of interest with the contents of this article.	Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Efergan A, 2016, J IMMUNOL, V196, P1091, DOI 10.4049/jimmunol.1500731; Galluzzi L, 2016, NAT REV NEUROSCI, V17, P467, DOI 10.1038/nrn.2016.51; Kast DJ, 2017, CURR BIOL, V27, pR318, DOI 10.1016/j.cub.2017.02.061; Maday S, 2016, J NEUROSCI, V36, P5933, DOI 10.1523/JNEUROSCI.4401-15.2016; Takats S, 2013, J CELL BIOL, V201, P531, DOI 10.1083/jcb.201211160; Xu J, 2018, J BIOL CHEM, V293, P4566, DOI 10.1074/jbc.RA117.001446; Xu J, 2017, J BIOL CHEM, V292, P7274, DOI 10.1074/jbc.M116.772434; Xu J, 2015, EMBO REP, V16, P709, DOI 10.15252/embr.201440006; Yamamoto A, 2014, ANNU REV NEUROSCI, V37, P55, DOI 10.1146/annurev-neuro-071013-014149	10	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4575	+		10.1074/jbc.H118.002041	http://dx.doi.org/10.1074/jbc.H118.002041			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29572327	hybrid, Green Published			2022-12-26	WOS:000428204300029
J	Zheng, PF; You, QS; Li, Q; Deng, HY; Wong, IYH; Peng, XY				Zheng, Peng Fei; You, Qi Sheng; Li, Qian; Deng, Hong Yan; Wong, Ian Y. H.; Peng, Xiao Yan			Injectable silicone rubber for ocular implantation after evisceration	PLOS ONE			English	Article							ORBITAL IMPLANT; ENUCLEATION	Objective To investigate the usefulness of addition type liquid silicone rubber (ATLSR) as injectable implant after evisceration to maintain the eyeball volume in an animal experiment. Methods Twelve adult New Zealand white rabbits were included. One eye of each rabbit was randomly selected for evisceration with the fellow eye as control. ATLSR was injected to fill the eyeball socket after evisceration. In vivo observation and photographs were performed up to 24 weeks post-op. Two rabbits were sacrificed respectively at post-operative week 1, 2, 4, 8, 12 and 24. After enucleation, the vertical, horizontal and sagittal diameters of the experimental eyeballs were measured and compared with the control eyes. Histopathological studies were performed to evaluate signs of inflammation. Results Cornea remained clear throughout the observation period despite mild epithelial edema and neovascularization. Compared to the control eyes, the experimental eyes were significantly smaller in vertical diameter (17.00 +/- 1.17 vs. 17.54 +/- 1.11 mm, P<0.001), but larger in sagittal diameter (16.85 +/- 1.48 vs. 16.40 +/- 1.38 mm, P = 0.008), and had no significant difference in horizontal diameter (17.49 +/- 1.53 vs. 17.64 +/- 1.21 mm, P = 0.34). Postoperative inflammation was observed at one week after surgery, which peaked at 2 +/- 3 weeks, then regressed gradually. At week 12 and week 24, most of the inflammatory cells disappeared with some residual plasma cells and eosinophils. Conclusion Injectable addition type silicon rubber may be a good choice for ocular implantation after evisceration, maintaining eyeball volume and cosmetically satisfactory when compared to the fellow eye. Spontaneous regression of inflammation implied good biocompatibility for at least 24 weeks.	[Zheng, Peng Fei; Li, Qian] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Dept Ophthalmol, Beijing, Peoples R China; [Zheng, Peng Fei; You, Qi Sheng; Peng, Xiao Yan] Capital Med Univ, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Hosp, Beijing Tongren Eye Ctr,Beijing Inst Ophthalmol, Beijing, Peoples R China; [Deng, Hong Yan] Capital Med Univ, Beijing Stomatol Hosp, Beijing, Peoples R China; [Wong, Ian Y. H.] Univ Hong Kong, Dept Ophthalmol, Hong Kong, Hong Kong, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; University of Hong Kong	Peng, XY (corresponding author), Capital Med Univ, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Hosp, Beijing Tongren Eye Ctr,Beijing Inst Ophthalmol, Beijing, Peoples R China.	drpengxy@163.com	You, Qisheng/AAG-7153-2020	You, Qisheng/0000-0003-0743-7320	Beijing Talents Fund [2015000021223ZK22]; National Natural Science Foundation of China [81400422]	Beijing Talents Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The project was partially supported by Beijing Talents Fund (2015000021223ZK22) and National Natural Science Foundation of China (No. 81400422).	Baino F, 2016, MAT SCI ENG C-MATER, V69, P1410, DOI 10.1016/j.msec.2016.08.003; Bi YP, 2013, J PROSTHET DENT, V110, P424; Federspil PA, 2009, VGMS CURR TOP OTORHI, V8; Huang DP, 2009, AM J OPHTHALMOL, V147, P924, DOI 10.1016/j.ajo.2008.11.022; Iordanidou V, 2004, AM J OPHTHALMOL, V138, P425, DOI 10.1016/j.ajo.2004.04.062; KARESH JW, 1994, OPHTHALMOLOGY, V101, P1688; Koreen IV, 2016, OPHTHAL PLAST RECONS; Mitra A, 2014, J CLIN DIAGN RES, V8, pZE8, DOI 10.7860/JCDR/2014/9229.5244; Moshfeghi DM, 2000, SURV OPHTHALMOL, V44, P277, DOI 10.1016/S0039-6257(99)00112-5; Nakra T, 2006, OPHTHALMOLOGY, V113, P2270, DOI 10.1016/j.ophtha.2006.06.021; Ozgur OR, 2005, AM J OPHTHALMOL, V139, P78, DOI 10.1016/j.ajo.2004.08.034; PERMAN KI, 1988, OTOLARYNG CLIN N AM, V21, P171; Perry AC, 1990, ADV PPHTHAL PLAST RE, P875; ROSE GE, 1990, BRIT J OPHTHALMOL, V74, P545, DOI 10.1136/bjo.74.9.545; RYCROFT PV, 1965, P ROY SOC MED, V58, P736, DOI 10.1177/003591576505800939; Sales-Sanz M, 2007, OPHTHAL PLAST RECONS, V23, P389, DOI 10.1097/IOP.0b013e318142cc4c; Shah RD, 2012, OPHTHAL SURG LAS IM, V43, P425, DOI 10.3928/15428877-20120725-01; Shah SU, 2015, OPHTHAL PLAST RECONS, V31, P108, DOI 10.1097/IOP.0000000000000207; Shields C L, 1993, Trans Am Ophthalmol Soc, V91, P177; SHIELDS CL, 1993, T AM OPHTHAL SOC, V91, P189; Smith RJ, 2011, OPHTHAL PLAST RECONS, V27, P227, DOI 10.1097/IOP.0b013e3181cff671; Stanley H R, 1994, Int Dent J, V44, P3; Vagefi MR, 2011, OPHTHAL PLAST RECONS, V27, P90, DOI 10.1097/IOP.0b013e3181cff9fd; Yeatts RP, 2002, OPHTHALMOLOGY, V109, P2123, DOI 10.1016/S0161-6420(02)01222-8; Zhang Y, 2015, INT J OPHTHALMOL-CHI, V8, P1024, DOI 10.3980/j.issn.2222-3959.2015.05.31	25	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2018	13	3							e0193448	10.1371/journal.pone.0193448	http://dx.doi.org/10.1371/journal.pone.0193448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA2QK	29570703	Green Submitted, Green Published, gold			2022-12-26	WOS:000428168400003
J	Aboubakr, HA; Mor, SK; Higgins, L; Armien, A; Youssef, MM; Bruggeman, PJ; Goyal, SM				Aboubakr, Hamada A.; Mor, Sunil K.; Higgins, LeeAnn; Armien, Anibal; Youssef, Mohammed M.; Bruggeman, Peter J.; Goyal, Sagar M.			Cold argon-oxygen plasma species oxidize and disintegrate capsid protein of feline calicivirus	PLOS ONE			English	Article							HUMAN NOROVIRUS; STRUCTURAL INSIGHTS; VIRUS INACTIVATION; AMINO-ACIDS; OXIDATION; OZONE; IDENTIFICATION; DISINFECTANTS; MICROSCOPY; RECEPTOR	Possible mechanisms that lead to inactivation of feline calicivirus (FCV) by cold atmospheric-pressure plasma (CAP) generated in 99% argon-1% O-2 admixture were studied. We evaluated the impact of CAP exposure on the FCV viral capsid protein and RNA employing several cultural, molecular, proteomic and morphologic characteristics techniques. In the case of long exposure (2 min) to CAP, the reactive species of CAP strongly oxidized the major domains of the viral capsid protein (VP1) leading to disintegration of a majority of viral capsids. In the case of short exposure (15 s), some of the virus particles retained their capsid structure undamaged but failed to infect the host cells in vitro. In the latter virus particles, CAP exposure led to the oxidation of specific amino acids located in functional peptide residues in the P2 subdomain of the protrusion (P) domain, the dimeric interface region of VP1 dimers, and the movable hinge region linking the S and P domains. These regions of the capsid are known to play an essential role in the attachment and entry of the virus to the host cell. These observations suggest that the oxidative effect of CAP species inactivates the virus by hindering virus attachment and entry into the host cell. Furthermore, we found that the oxidative impact of plasma species led to oxidation and damage of viral RNA once it becomes unpacked due to capsid destruction. The latter effect most likely plays a secondary role in virus inactivation since the intact FCV genome is infectious even after damage to the capsid.	[Aboubakr, Hamada A.; Mor, Sunil K.; Armien, Anibal; Goyal, Sagar M.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Aboubakr, Hamada A.; Mor, Sunil K.; Armien, Anibal; Goyal, Sagar M.] Univ Minnesota, Coll Vet Med, Vet Diagnost Lab, St Paul, MN 55108 USA; [Aboubakr, Hamada A.; Youssef, Mohammed M.] Alexandria Univ, Fac Agr, Food Sci & Technol Dept, Aflaton St, Alexandria, Egypt; [Higgins, LeeAnn] Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA; [Higgins, LeeAnn] Univ Minnesota, Prote Ctr Mass Spectrometry, St Paul, MN 55108 USA; [Bruggeman, Peter J.] Univ Minnesota, Dept Mech Engn, Coll Sci & Engn, 111 Church St SE, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Egyptian Knowledge Bank (EKB); Alexandria University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Goyal, SM (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA.; Goyal, SM (corresponding author), Univ Minnesota, Coll Vet Med, Vet Diagnost Lab, St Paul, MN 55108 USA.	goyal001@umn.edu	Bruggeman, Peter J/J-8273-2014; Aboubakr, Hamada/I-7604-2016; Mor, Sunil Kumar/M-6325-2018	Bruggeman, Peter J/0000-0003-3346-7275; Aboubakr, Hamada/0000-0002-8233-2353; Mor, Sunil Kumar/0000-0002-1112-088X	Agriculture and Food Research Initiative of the USDA's National Institute of Food and Agriculture [2017-67017-26172]; National Science Foundation for Major Research Instrumentation [9871237, NSF-DBI-0215759]; Cultural Affairs and Mission Sector, Ministry of Higher Education and Scientific Research, Egypt; University of Minnesota	Agriculture and Food Research Initiative of the USDA's National Institute of Food and Agriculture; National Science Foundation for Major Research Instrumentation; Cultural Affairs and Mission Sector, Ministry of Higher Education and Scientific Research, Egypt(Ministry of Higher Education & Scientific Research (MHESR)); University of Minnesota(University of Minnesota System)	Partial funding was provided by the Agriculture and Food Research Initiative of the USDA's National Institute of Food and Agriculture, grant number # 2017-67017-26172. Partial funding was provided National Science Foundation for Major Research Instrumentation grants 9871237 and NSF-DBI-0215759. Partial funding was provided by the Cultural Affairs and Mission Sector, Ministry of Higher Education and Scientific Research, Egypt, and partial funding was provided by University of Minnesota.	Aboubakr HA, 2016, J FOOD PROTECT, V79, P1001, DOI 10.4315/0362-028X.JFP-15-593; Aboubakr HA, 2016, J PHYS D APPL PHYS, V49, DOI 10.1088/0022-3727/49/20/204001; Aboubakr HA, 2015, APPL ENVIRON MICROB, V81, P3612, DOI 10.1128/AEM.00054-15; Aboubakr HA, 2014, FOOD ENVIRON VIROL, V6, P282, DOI 10.1007/s12560-014-9164-2; Ahlfeld B, 2015, MBIO, V6, DOI 10.1128/mBio.02300-14; Al-Molawi N, 2003, J GEN VIROL, V84, P1237, DOI 10.1099/vir.0.18840-0; Alkawareek MY, 2012, FEMS IMMUNOL MED MIC, V65, P381, DOI 10.1111/j.1574-695X.2012.00942.x; Bae SC, 2015, FOOD RES INT, V76, P342, DOI 10.1016/j.foodres.2015.06.039; Baier M, 2014, INNOV FOOD SCI EMERG, V22, P147, DOI 10.1016/j.ifset.2014.01.011; Bekele AZ, 2016, FOODBORNE PATHOG DIS, V13, P239, DOI 10.1089/fpd.2015.2054; Bhella D, 2008, J VIROL, V82, P8051, DOI 10.1128/JVI.00550-08; Bhella D, 2011, J VIROL, V85, P11381, DOI 10.1128/JVI.05621-11; Buesa J, 2016, FOOD MICROBIOL FOOD, P59, DOI 10.1007/978-3-319-30723-7_3; Chander Y., 2007, International Journal of Virology, V3, P100; Chen R, 2006, P NATL ACAD SCI USA, V103, P8048, DOI 10.1073/pnas.0600421103; Choi S, 2016, ANN MICROBIOL, V66, P685, DOI 10.1007/s13213-015-1147-5; GOYAL SM, 1987, DIAGN MICR INFEC DIS, V6, P249, DOI 10.1016/0732-8893(87)90019-8; Gracanin M, 2009, FREE RADICAL BIO MED, V47, P92, DOI 10.1016/j.freeradbiomed.2009.04.015; Graves DB, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/26/263001; Hertwig C, 2015, FOOD CONTROL, V55, P221, DOI 10.1016/j.foodcont.2015.03.003; Hofmann S, 2011, PLASMA SOURCES SCI T, V20, DOI 10.1088/0963-0252/20/6/065010; KIM CK, 1980, APPL ENVIRON MICROB, V39, P210, DOI 10.1128/AEM.39.1.210-218.1980; Kim J, 2008, FREE RADICAL BIO MED, V44, P1700, DOI 10.1016/j.freeradbiomed.2007.12.031; Kotiaho T, 2000, J AM SOC MASS SPECTR, V11, P526, DOI 10.1016/S1044-0305(00)00116-1; Lacombe A, 2017, FOOD MICROBIOL, V63, P1, DOI 10.1016/j.fm.2016.10.030; Lin-Moshier Y, 2013, J BIOL CHEM, V288, P355, DOI 10.1074/jbc.M112.405761; Liu HC, 2013, ANAL CHEM, V85, P11705, DOI 10.1021/ac403072w; Lou FF, 2012, APPL ENVIRON MICROB, V78, P5320, DOI 10.1128/AEM.00532-12; Makino A, 2006, J VIROL, V80, P4482, DOI 10.1128/JVI.80.9.4482-4490.2006; Manuel CS, 2015, APPL ENVIRON MICROB, V81, P4940, DOI 10.1128/AEM.00388-15; Misra N. N., 2011, Food Engineering Reviews, V3, P159; Montazeri N, 2017, FRONT MICROBIOL, V8, DOI [10.3389/fmicb.2017.01031, 10.3389/fmicb.2017.00025]; Moore MD, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00298-16; Nayak G, 2017, PLASMA PROCESSES POL; Nayak G, PLASMA SCIENCE ICOPS, P1; Oh YJ, 2017, INT J FOOD MICROBIOL, V249, P66, DOI 10.1016/j.ijfoodmicro.2017.03.005; Ossiboff RJ, 2010, J VIROL, V84, P5550, DOI 10.1128/JVI.02371-09; Plowman JE, 2013, PHOTOCH PHOTOBIO SCI, V12, P1960, DOI 10.1039/c3pp50182e; PODELL DN, 1978, BIOCHEM BIOPH RES CO, V81, P176, DOI 10.1016/0006-291X(78)91646-7; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; RAUTH AM, 1965, BIOPHYS J, V5, P257, DOI 10.1016/S0006-3495(65)86715-7; Sakudo A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157922; Sangsanont J, 2014, FOOD ENVIRON VIROL, V6, P269, DOI 10.1007/s12560-014-9162-4; SCHAFFER FL, 1980, J GEN VIROL, V47, P215, DOI 10.1099/0022-1317-47-1-215; Sharma VK, 2010, OZONE-SCI ENG, V32, P81, DOI 10.1080/01919510903510507; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terrier O, 2009, J CLIN VIROL, V45, P119, DOI 10.1016/j.jcv.2009.03.017; Tung G, 2013, J FOOD PROTECT, V76, P1210, DOI 10.4315/0362-028X.JFP-12-532; van Gils CAJ, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/17/175203; Van Riper SK, 2016, BIOINFORMATICS, V32, P2035, DOI 10.1093/bioinformatics/btw091; Wigginton KR, 2012, ENVIRON SCI TECHNOL, V46, P12069, DOI 10.1021/es3029473; Wu Y, 2015, APPL ENVIRON MICROB, V81, P996, DOI 10.1128/AEM.03322-14; Yasuda H, 2010, PLASMA PROCESS POLYM, V7, P301, DOI 10.1002/ppap.200900088; Zhang J., 2012, MOL CELL PROTEOMICS, V11; Zimmermann JL, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/50/505201	57	32	32	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194618	10.1371/journal.pone.0194618	http://dx.doi.org/10.1371/journal.pone.0194618			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566061	gold, Green Submitted, Green Published			2022-12-26	WOS:000428093900087
J	Boivin, S; Saucede, T; Laffont, R; Steimetz, E; Neige, P				Boivin, Simon; Saucede, Thomas; Laffont, Remi; Steimetz, Emilie; Neige, Pascal			Diversification rates indicate an early role of adaptive radiations at the origin of modern echinoid fauna	PLOS ONE			English	Article							POST-PALEOZOIC ECHINOIDS; FOSSIL RECORD; ORDOVICIAN BIODIVERSIFICATION; POSTPALEOZOIC ECHINOIDS; MORPHOLOGICAL DISPARITY; ECOLOGICAL OPPORTUNITY; EVOLUTIONARY BIOLOGY; IRREGULAR ECHINOIDS; MARINE REVOLUTION; MASS EXTINCTIONS	Evolutionary radiations are fascinating phenomena corresponding to a dramatic diversification of taxa and a burst of cladogenesis over short periods of time. Most evolutionary radiations have long been regarded as adaptive but this has seldom been demonstrated with large-scale comparative datasets including fossil data. Originating in the Early Jurassic, irregular echinoids are emblematic of the spectacular diversification of mobile marine faunas during the Mesozoic Marine Revolution. They diversified as they colonized various habitats, and now constitute the main component of echinoid fauna in modern seas. The evolutionary radiation of irregular echinoids has long been considered as adaptive but this hypothesis has never been tested. In the present work we analyze the evolution of echinoid species richness and morphological disparity over 37 million years based on an extensive fossil dataset. Our results demonstrate that morphological and functional diversifications in certain clades of irregular echinoids were exceptionally high compared to other clades and that they were associated with the evolution of new modes of life and so can be defined as adaptive radiations. The role played by ecological opportunities in the diversification of these clades was critical, with the evolution of the infaunal mode of life promoting the adaptive radiation of irregular echinoids.	[Boivin, Simon] Univ Geneva, Dept Earth Sci, Geneva, Switzerland; [Saucede, Thomas; Laffont, Remi; Steimetz, Emilie; Neige, Pascal] Univ Bourgogne Franche Comte, CNRS, UMR 6282, Biogeosci, Dijon, France	University of Geneva; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Saucede, T (corresponding author), Univ Bourgogne Franche Comte, CNRS, UMR 6282, Biogeosci, Dijon, France.	thomas.saucede@u-bourgogne.fr	Neige, Pascal/A-3346-2012; Neige, Pascal/ABC-8451-2021	Neige, Pascal/0000-0002-6543-3611; Boivin, Simon/0000-0002-3859-3337	SAMBA of the CNRS laboratory Biogeosciences [UMR 6282]	SAMBA of the CNRS laboratory Biogeosciences	This paper is a contribution of team SAMBA of the CNRS laboratory Biogeosciences (UMR 6282).	Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Adams DC, 2009, P ROY SOC B-BIOL SCI, V276, P2729, DOI 10.1098/rspb.2009.0543; Aguilee R, 2013, EVOLUTION, V67, P1291, DOI 10.1111/evo.12008; [Anonymous], 2021, LANG ENV STAT COMP; Barras CG, 2008, PALAEOGEOGR PALAEOCL, V263, P44, DOI 10.1016/j.palaeo.2008.01.026; Barras CG, 2007, J SYST PALAEONTOL, V5, P133, DOI 10.1017/S147720190600201X; Benson RBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001853; Benton Michael J., 1999, P249; Bookstein F L, 1997, Med Image Anal, V1, P225; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Brayard A, 2009, SCIENCE, V325, P1118, DOI 10.1126/science.1174638; Brosse M, 2013, J GEOL SOC LONDON, V170, P225, DOI 10.1144/jgs2012-084; de Ridder C., 1982, P57; Dromart G, 2002, J GEOL, V110, P195, DOI 10.1086/338412; Dryden I. L., 2016, WILEY SERIES PROBABI, V2nd; Eastman JT, 2000, J FISH BIOL, V57, P84, DOI 10.1111/j.1095-8649.2000.tb02246.x; Eble GJ, 2000, PALEOBIOLOGY, V26, P56, DOI 10.1666/0094-8373(2000)026<0056:CEFISG>2.0.CO;2; Eldredge N., 1980, PHYLOGENETIC PATTERN; Erwin D.H., 1992, Historical Biology, V6, P133; Erwin DH, 2001, P NATL ACAD SCI USA, V98, P5399, DOI 10.1073/pnas.091092698; FOOTE M, 1993, PALEOBIOLOGY, V19, P403, DOI 10.1017/S0094837300014056; Gaston Kevin J., 2004, BIODIVERSITY INTRO; Gavrilets S, 2014, J HERED, V105, P743, DOI 10.1093/jhered/esu045; Gavrilets S, 2009, SCIENCE, V323, P732, DOI 10.1126/science.1157966; GITTENBERGER E, 1991, BIOL J LINN SOC, V43, P263, DOI 10.1111/j.1095-8312.1991.tb00598.x; Gittenberger E, 2004, ORG DIVERS EVOL, V4, P135, DOI 10.1016/j.ode.2004.04.002; Goswami A, 2016, BIOL J LINN SOC, V118, P6, DOI 10.1111/bij.12763; Gould S. J., 1989, WONDERFUL LIFE; GOULD SJ, 1991, PALEOBIOLOGY, V17, P411, DOI 10.1017/S0094837300010745; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Grant P. R., 2008, WHY SPECIES MULTIPLY; Hallam A., 1997, MASS EXTINCTIONS THE; Harmon LJ, 2003, SCIENCE, V301, P961, DOI 10.1126/science.1084786; Harmon LJ, 2010, EVOLUTION, V64, P2385, DOI 10.1111/j.1558-5646.2010.01025.x; Harper DAT, 2006, PALAEOGEOGR PALAEOCL, V232, P148, DOI 10.1016/j.palaeo.2005.07.010; Hopkins MJ, 2015, P NATL ACAD SCI USA, V112, P3758, DOI 10.1073/pnas.1418153112; Hughes M, 2013, P NATL ACAD SCI USA, V110, P13875, DOI 10.1073/pnas.1302642110; Jablonski D, 2005, PALEOBIOLOGY, V31, P192, DOI 10.1666/0094-8373(2005)031[0192:MEAM]2.0.CO;2; Jablonski D, 2000, PALEOBIOLOGY, V26, P15, DOI 10.1666/0094-8373(2000)26[15:MAMSAH]2.0.CO;2; Jackson JBC, 2006, TRENDS ECOL EVOL, V21, P322, DOI 10.1016/j.tree.2006.03.017; Kaiser MJ, 2005, ARINE ECOLOGY PROCES; Kier P. M., 1966, P492; Kier P. M, 1977, Smithsonian Contributions to Paleobiology, VNo. 30, P1; Kier P.M., 1978, Smithsonian Contributions to Paleobiology, P1; KIER PM, 1974, J PALEONTOL, V48, P1; KIER PORTER M., 1962, SMITHSONIAN MISC COLL, V144, P1; Kozak KH, 2006, P ROY SOC LOND B BIO, V273, P513; Kroh Andreas, 2010, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V112A, P195; Kroh A, 2010, J SYST PALAEONTOL, V8, P147, DOI 10.1080/14772011003603556; Lambert J, 1925, 1925 ESSAI NOMENCLAT; Larson Allan, 1996, P187; Lecointre G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068787; Lieberman BS, 2012, EVOL BIOL, V39, P181, DOI 10.1007/s11692-012-9165-8; Losos JB, 2002, AM NAT, V160, P147, DOI 10.1086/341557; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; MEYER D L, 1977, Paleobiology, V3, P74; Moen D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001854; Morlon H, 2014, ECOL LETT, V17, P508, DOI 10.1111/ele.12251; Navarro N, 2003, COMPUT GEOSCI-UK, V29, P655, DOI 10.1016/S0098-3004(03)00043-8; Neige P, 2015, EVENTS INCREASED BIO; Neige P, 2013, PALAEONTOLOGY, V56, P1247, DOI 10.1111/pala.12062; Nichols D., 1959, Publications Systematics Association, VNo. 3, P61; Osborn HF, 1902, AM NAT, V36, P353, DOI 10.1086/278137; Rabosky DL, 2012, EVOLUTION, V66, P1807, DOI 10.1111/j.1558-5646.2011.01557.x; Ricklefs RE, 2006, SYST BIOL, V55, P151, DOI 10.1080/10635150500431205; Roy K, 1997, TRENDS ECOL EVOL, V12, P277, DOI 10.1016/S0169-5347(97)81026-9; ROY K, 1994, PALEOBIOLOGY, V20, P274, DOI 10.1017/S0094837300012781; Saucede T, 2007, GEOL MAG, V144, P333, DOI 10.1017/S0016756806003001; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Sepkoski J J Jr, 1994, Acta Palaeontol Pol, V38, P175; Sepkoski J.J. Jr, 1990, P37; SEPKOSKI JJ, 1981, PALEOBIOLOGY, V7, P36, DOI 10.1017/S0094837300003778; Servais T., 2009, GSA TODAY, V19, P4, DOI DOI 10.HTTP://DX.D0I.0RG/10.1130/GSATG37A.1; Simoes M, 2016, TRENDS ECOL EVOL, V31, P27, DOI 10.1016/j.tree.2015.10.007; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Simpson G.G., 1944, TEMPO MODE EVOLUTION, DOI DOI 10.1073/pnas.1821292116; Smith A.B., 1980, Palaeontology (Oxford), V23, P39; Smith A.B., 1984, ECHINOID PALAEOBIOLO; SMITH AB, 1981, PALAEONTOLOGY, V24, P779; Smith AB., 2011, ECHINOID DIRECTORY; Smith AB, 2006, MOL BIOL EVOL, V23, P1832, DOI 10.1093/molbev/msl039; Smith LH, 1999, PALEOBIOLOGY, V25, P396, DOI 10.1017/S0094837300021357; Sprinkle J., 1983, Echinoderm Studies, V1, P1; Stanley S. M., 1979, MACROEVEOLUTION PATT; THIERRY J, 1994, ECHINODERMS THROUGH TIME, P901; VERMEIJ G J, 1977, Paleobiology, V3, P245; Vermeij G.J, 1987, EVOLUTION ESCALATION; Vermeij GJ, 2008, PALAEOGEOGR PALAEOCL, V263, P3, DOI 10.1016/j.palaeo.2008.01.023; Vermeij GJ, 2011, PALEONTOL RES, V15, P54, DOI 10.2517/1342-8144-15.2.054; Webby BD, 2004, EPISODES, V27, P203, DOI 10.18814/epiiugs/2004/v27i3/009; Wills MA, 1998, PALEOBIOLOGY, V24, P177; WILLS MA, 1994, PALEOBIOLOGY, V20, P93, DOI 10.1017/S009483730001263X; Yoder JB, 2010, J EVOLUTION BIOL, V23, P1581, DOI 10.1111/j.1420-9101.2010.02029.x	94	12	12	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194575	10.1371/journal.pone.0194575	http://dx.doi.org/10.1371/journal.pone.0194575			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566024	Green Published, gold			2022-12-26	WOS:000428093900081
J	Jong, IS; Yu, BJ; Jang, JY; Jegal, J; Lee, JY				Jong, In-Seung; Yu, Byung Jo; Jang, Ji Yeon; Jegal, Jonggeon; Lee, Ju Young			Improving the efficiency of homologous recombination by chemical and biological approaches in Yarrowia lipolytica	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE DISRUPTION; YEAST; INTEGRATION; STRAINS; TRANSFORMATION; EXPRESSION; GLYCEROL; ACID; PROMOTERS	Gene targeting is a challenge in Yarrowia lipolytica (Y. lipolytica) where non-homologous end-joining (NHEJ) is predominant over homologous recombination (HR). To improve the frequency and efficiency of HR in Y. lipolytica, the ku70 gene responsible for a double stand break (DSB) repair in the NHEJ pathway was disrupted, and the cell cycle was synchronized to the S-phase with hydroxyurea, respectively. Consequently, the HR frequency was over 46% with very short homology regions (50 bp): the pex10 gene was accurately deleted at a frequency of 60% and the (beta-carotene biosynthetic genes were integrated at the correct locus at an average frequency of 53%. For repeated use, the URA3 marker gene was also excised and deleted at a frequency of 100% by HR between the 100 bp homology regions flanking the URA3 gene. It was shown that appropriate combination of these chemical and biological approaches was very effective to promote HR and construct genetically modified Y. lipolytica strains for biotechnological applications.	[Jong, In-Seung; Jegal, Jonggeon; Lee, Ju Young] KRICT, Ctr Biobased Chem, Ulsan, South Korea; [Jong, In-Seung; Yu, Byung Jo; Jang, Ji Yeon] KRICT, Res Inst Sustainable Mfg Syst, Intelligent Sustainable Mat R&D Grp, Cheonan Si, Chungcheongnam, South Korea	Korea Research Institute of Chemical Technology (KRICT); Korea Research Institute of Chemical Technology (KRICT)	Lee, JY (corresponding author), KRICT, Ctr Biobased Chem, Ulsan, South Korea.	juylee@krict.re.kr		Lee, Ju Young/0000-0001-7470-480X	National Research Foundation of Korea [NRF-2016M3A6A8928386]; Ministry of Strategy and Finance [PJG17220, JG170022]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Strategy and Finance	This work was supported by National Research Foundation of Korea, Grant recipient: Ju Young Lee, Grant number: NRF-2016M3A6A8928386 (the Intelligent Synthetic Biology Center of Global Frontier Project), and Ministry of Strategy and Finance, Grant recipient: In-Seung Jang, Byung Jo Yu, Ji Yeon Jang, Grant number: PJG17220 (Project JG170022: Development of Bio and Chemistry Convergence Technology for Producing Bio-retinol as a Cosmetic Material).	ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; Andre A, 2009, ENG LIFE SCI, V9, P468, DOI 10.1002/elsc.200900063; Barth G, 1997, FEMS MICROBIOL REV, V19, P219, DOI 10.1016/S0168-6445(97)00002-8; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Beckerich J M, 1998, Int Microbiol, V1, P123; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; DAVIDOW LS, 1985, CURR GENET, V10, P39, DOI 10.1007/BF00418492; Dominguez A, 1998, Int Microbiol, V1, P131; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Fickers P, 2005, FEMS YEAST RES, V5, P527, DOI 10.1016/j.femsyr.2004.09.004; Fickers P, 2003, J MICROBIOL METH, V55, P727, DOI 10.1016/j.mimet.2003.07.003; FOURNIER P, 1993, P NATL ACAD SCI USA, V90, P4912, DOI 10.1073/pnas.90.11.4912; Galli A, 1996, MUTAT RES-FUND MOL M, V354, P69, DOI 10.1016/0027-5107(96)00037-1; Gao SL, 2017, METAB ENG, V41, P192, DOI 10.1016/j.ymben.2017.04.004; Juretzek T, 2001, YEAST, V18, P97, DOI 10.1002/1097-0061(20010130)18:2<97::AID-YEA652>3.0.CO;2-U; Kretzschmar A, 2013, CURR GENET, V59, P63, DOI 10.1007/s00294-013-0389-7; Larroude M, 2018, BIOTECHNOL BIOENG, V115, P464, DOI 10.1002/bit.26473; LEDALL MT, 1994, CURR GENET, V26, P38, DOI 10.1007/BF00326302; Lee JY, 2015, BIOTECHNOL BIOENG, V112, P751, DOI 10.1002/bit.25488; Li Q, 2013, FEMS MICROBIOL LETT, V345, P94, DOI 10.1111/1574-6968.12187; Madzak C, 2004, J BIOTECHNOL, V109, P63, DOI 10.1016/j.jbiotec.2003.10.027; Madzak C, 2002, MOL MICROBIOL BIOTEC, P207; Mathiasen DP, 2014, FEMS MICROBIOL REV, V38, P172, DOI 10.1111/1574-6976.12066; MATSUOKA M, 1993, MOL GEN GENET, V237, P327, DOI 10.1007/BF00279435; Muller S, 1998, YEAST, V14, P1267, DOI 10.1002/(SICI)1097-0061(1998100)14:14<1267::AID-YEA327>3.0.CO;2-2; ORRWEAVER TL, 1981, P NATL ACAD SCI-BIOL, V78, P6354, DOI 10.1073/pnas.78.10.6354; Papanikolaou S, 2002, BIORESOURCE TECHNOL, V82, P43, DOI 10.1016/S0960-8524(01)00149-3; Papanikolaou S, 2003, CURR MICROBIOL, V46, P398, DOI 10.1007/s00284-002-3907-2; Papanikolaou S, 2002, J APPL MICROBIOL, V92, P737, DOI 10.1046/j.1365-2672.2002.01577.x; ROSENKRANZ HS, 1965, BIOCHIM BIOPHYS ACTA, V95, P181, DOI 10.1016/0005-2787(65)90225-X; Sambrook J., 2001, MOL CLONING LAB MANU; Schwartz C, 2017, BIOTECHNOL BIOENG, V114, P2896, DOI 10.1002/bit.26404; Schwartz C, 2017, ACS SYNTH BIOL, V6, P402, DOI 10.1021/acssynbio.6b00285; Schwartz CM, 2016, ACS SYNTH BIOL, V5, P356, DOI 10.1021/acssynbio.5b00162; Scioli C, 1997, WATER RES, V31, P2520, DOI 10.1016/S0043-1354(97)00083-3; Sherman D, 2006, NUCLEIC ACIDS RES, V34, pD432, DOI 10.1093/nar/gkj160; SINCLAIR WK, 1965, SCIENCE, V150, P1729, DOI 10.1126/science.150.3704.1729; Tsakraklides V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133434; van Attikum H, 2001, EMBO J, V20, P6550, DOI 10.1093/emboj/20.22.6550; van Attikum H, 2003, NUCLEIC ACIDS RES, V31, P826, DOI 10.1093/nar/gkg183; Van Dyck E, 1999, NATURE, V398, P728, DOI 10.1038/43942; VANHEERIKHUIZEN H, 1985, GENE, V39, P213, DOI 10.1016/0378-1119(85)90315-4; Verbeke J, 2013, BIOTECHNOL LETT, V35, P571, DOI 10.1007/s10529-012-1107-0; Vernis L, 2001, J MOL BIOL, V305, P203, DOI 10.1006/jmbi.2000.4300; Vernis L, 1997, MOL CELL BIOL, V17, P1995, DOI 10.1128/MCB.17.4.1995; Verwaal R, 2007, APPL ENVIRON MICROB, V73, P4342, DOI 10.1128/AEM.02759-06	46	19	20	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194954	10.1371/journal.pone.0194954	http://dx.doi.org/10.1371/journal.pone.0194954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566071	gold, Green Submitted, Green Published			2022-12-26	WOS:000428093900122
J	Moon, TM; Sheehe, JL; Nukareddy, P; Nausch, LW; Wohlfahrt, J; Matthews, DE; Blumenthal, DK; Dostmann, WR				Moon, Thomas M.; Sheehe, Jessica L.; Nukareddy, Praveena; Nausch, Lydia W.; Wohlfahrt, Jessica; Matthews, Dwight E.; Blumenthal, Donald K.; Dostmann, Wolfgang R.			An N-terminally truncated form of cyclic GMP-dependent protein kinase I (PKG I) is monomeric and autoinhibited and provides a model for activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic GMP (cGMP); protein kinase; allosteric regulation; signal transduction; small-angle X-ray scattering (SAXS); surface plasmon resonance (SPR); AGC kinases; cGMP-dependent protein kinase	SMALL-ANGLE SCATTERING; LEUCINE-ZIPPER MOTIF; SMOOTH-MUSCLE-CELLS; CRYSTAL-STRUCTURE; REGULATORY SUBUNIT; CGMP-BINDING; BIOLOGICAL MACROMOLECULES; CATALYTIC SUBUNIT; STRUCTURE REVEALS; STRUCTURAL BASIS	The type I cGMP-dependent protein kinases (PKG I) serve essential physiological functions, including smooth muscle relaxation, cardiac remodeling, and platelet aggregation. These enzymes form homodimers through their N-terminal dimerization domains, a feature implicated in regulating their cooperative activation. Previous investigations into the activation mechanisms of PKG I isoforms have been largely influenced by structures of the cAMP-dependent protein kinase (PKA). Here, we examined PKG I activation by cGMP and cAMP by engineering a monomeric form that lacks N-terminal residues 1-53 (53). We found that the construct exists as a monomer as assessed by whole-protein MS, size-exclusion chromatography, and small-angle X-ray scattering (SAXS). Reconstruction of the SAXS 3D envelope indicates that 53 has a similar shape to the heterodimeric RI-C complex of PKA. Moreover, we found that the 53 construct is autoinhibited in its cGMP-free state and can bind to and be activated by cGMP in a manner similar to full-length PKG I as assessed by surface plasmon resonance (SPR) spectroscopy. However, we found that the 53 variant does not exhibit cooperative activation, and its cyclic nucleotide selectivity is diminished. These findings support a model in which, despite structural similarities, PKG I activation is distinct from that of PKA, and its cooperativity is driven by in trans interactions between protomers.	[Moon, Thomas M.; Sheehe, Jessica L.; Nausch, Lydia W.; Wohlfahrt, Jessica; Dostmann, Wolfgang R.] Univ Vermont, Larner Coll Med, Dept Pharmacol, 89 Beaumont Ave, Burlington, VT 05405 USA; [Moon, Thomas M.; Sheehe, Jessica L.; Nausch, Lydia W.; Wohlfahrt, Jessica; Dostmann, Wolfgang R.] Univ Vermont, Dept Chem, Burlington, VT 05405 USA; [Blumenthal, Donald K.] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA; [Nausch, Lydia W.] Nuremberg Hosp, Med Sch PMU, Dept Physiol, Prof Ernst Nathan Str 1, D-90419 Nurnberg, Germany	University of Vermont; University of Vermont; Utah System of Higher Education; University of Utah; Klinikum Nurnberg Nord	Dostmann, WR (corresponding author), Univ Vermont, Larner Coll Med, Dept Pharmacol, 89 Beaumont Ave, Burlington, VT 05405 USA.; Moon, TM (corresponding author), Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA.	thomasmoon@email.arizona.edu; wolfgang.dostmann@uvm.edu	Moon, Thomas/S-4084-2018	Moon, Thomas/0000-0003-1568-8808	United States Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institute of General Medical Sciences at the National Institutes of Health (NIH) [P41GM103393]; Centers of Biomedical Research Excellence (COBRE) from the NIGMS, National Institutes of Health [P30-GM118228]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007594, T32HL007647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, P30GM118228] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018126] Funding Source: NIH RePORTER	United States Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institute of General Medical Sciences at the National Institutes of Health (NIH); Centers of Biomedical Research Excellence (COBRE) from the NIGMS, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the beamline scientists, Tsutomu Mitsui and Thomas Weiss, at Stanford Synchrotron Radiation Lightsource (SSRL) BL4-2 for assistance with SEC-SAXS data collection. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the United States Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institute of General Medical Sciences at the National Institutes of Health (NIH) (including Grant P41GM103393). Mass spectrometry measurements were supported by Centers of Biomedical Research Excellence (COBRE) Grant P30-GM118228 from the NIGMS, National Institutes of Health. Mass spectrometry measurements were assisted by Bruce O'Rourke. We thank Werner Tegge at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany for synthesizing the W15 peptide substrate used in the phosphotransferase assays. We also thank Wolfgang Peti at the University of Arizona for the generous use of a Superdex 200 10/300 analytical column and Akta PURE FPLC system and Ross Buchan for helpful discussions regarding this manuscript.	AITKEN A, 1984, BIOCHIM BIOPHYS ACTA, V790, P219, DOI 10.1016/0167-4838(84)90025-6; Alverdi V, 2008, J MOL BIOL, V375, P1380, DOI 10.1016/j.jmb.2007.11.053; Ammendola A, 2001, J BIOL CHEM, V276, P24153, DOI 10.1074/jbc.M101530200; Antl M, 2007, BLOOD, V109, P552, DOI 10.1182/blood-2005-10-026294; Bian K, 2007, J AM SOC HYPERTENS, V1, P17, DOI 10.1016/j.jash.2006.11.007; Blanton RM, 2013, J GERONTOL A-BIOL, V68, P1351, DOI 10.1093/gerona/glt042; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Byeon IJL, 2010, J BIOL CHEM, V285, P14062, DOI 10.1074/jbc.M110.106666; Casteel DE, 2010, J BIOL CHEM, V285, P32684, DOI 10.1074/jbc.C110.161430; Casteel DE, 2005, J BIOL CHEM, V280, P38211, DOI 10.1074/jbc.M507021200; Diller TC, 2001, STRUCTURE, V9, P73, DOI 10.1016/S0969-2126(00)00556-6; Dostmann WRG, 1996, FEBS LETT, V398, P206, DOI 10.1016/S0014-5793(96)01242-2; Dostmann WRG, 2000, P NATL ACAD SCI USA, V97, P14772, DOI 10.1073/pnas.97.26.14772; FEIL R, 1995, BIOCHEMISTRY-US, V34, P13152, DOI 10.1021/bi00040a029; FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237, DOI 10.1146/annurev.ph.56.030194.001321; Francis SH, 2005, FRONT BIOSCI-LANDMRK, V10, P2097, DOI 10.2741/1684; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hofmann Franz, 2009, V191, P137, DOI 10.1007/978-3-540-68964-5_8; Huang GY, 2014, STRUCTURE, V22, P116, DOI 10.1016/j.str.2013.09.021; Kato M, 2012, J BIOL CHEM, V287, P41342, DOI 10.1074/jbc.M112.421040; Kawabe J, 1996, J BIOL CHEM, V271, P20132, DOI 10.1074/jbc.271.33.20132; KEILBACH A, 1992, EUR J BIOCHEM, V208, P467, DOI 10.1111/j.1432-1033.1992.tb17209.x; Kemp-Harper Barbara, 2009, V191, P447, DOI 10.1007/978-3-540-68964-5_19; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kim JJ, 2016, STRUCTURE, V24, P710, DOI 10.1016/j.str.2016.03.009; Kim SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026131; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; LANDGRAF W, 1989, EUR J BIOCHEM, V181, P643, DOI 10.1111/j.1432-1033.1989.tb14771.x; LANDGRAF W, 1991, J BIOL CHEM, V266, P16305; Lee E, 2007, J MOL BIOL, V373, P1198, DOI 10.1016/j.jmb.2007.08.049; Lee YC, 2000, P NATL ACAD SCI USA, V97, P10763, DOI 10.1073/pnas.190333697; Moon TM, 2015, CHEM BIOL, V22, P1653, DOI 10.1016/j.chembiol.2015.11.005; Moon TM, 2013, BBA-PROTEINS PROTEOM, V1834, P1346, DOI 10.1016/j.bbapap.2013.02.009; Nausch LWM, 2008, P NATL ACAD SCI USA, V105, P365, DOI 10.1073/pnas.0710387105; OGREID D, 1988, J BIOL CHEM, V263, P17397; Orstavik S, 1997, GENOMICS, V42, P311, DOI 10.1006/geno.1997.4743; Osborne BW, 2011, STRUCTURE, V19, P1317, DOI 10.1016/j.str.2011.06.012; Pfeifer A, 1999, Rev Physiol Biochem Pharmacol, V135, P105, DOI 10.1007/BFb0033671; Potter Lincoln R., 2009, V191, P341, DOI 10.1007/978-3-540-68964-5_15; Qin LY, 2015, BIOCHEMISTRY-US, V54, P4419, DOI 10.1021/acs.biochem.5b00572; Richie-Jannetta R, 2006, J BIOL CHEM, V281, P6977, DOI 10.1074/jbc.M510886200; Richie-Jannetta R, 2003, J BIOL CHEM, V278, P50070, DOI 10.1074/jbc.M306796200; ROBERTSON BE, 1993, AM J PHYSIOL, V265, pC299; Ruth P, 1997, J BIOL CHEM, V272, P10522; Sausbier M, 2000, CIRC RES, V87, P825, DOI 10.1161/01.RES.87.9.825; Schmidtko A, 2008, J NEUROSCI, V28, P1320, DOI 10.1523/JNEUROSCI.5037-07.2008; Schneidman-Duhovny D, 2016, NUCLEIC ACIDS RES, V44, pW424, DOI 10.1093/nar/gkw389; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Steichen JM, 2012, J BIOL CHEM, V287, P14672, DOI 10.1074/jbc.M111.335091; STEINBERG RA, 1987, J BIOL CHEM, V262, P2664; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; TAKIO K, 1983, J BIOL CHEM, V258, P5531; Trivedi B, 1998, NEURON, V21, P895, DOI 10.1016/S0896-6273(00)80604-2; Valentini E, 2015, NUCLEIC ACIDS RES, V43, pD357, DOI 10.1093/nar/gku1047; van de Waterbeemd M, 2014, ANGEW CHEM INT EDIT, V53, P9660, DOI 10.1002/anie.201404637; Vigil D, 2005, J BIOL CHEM, V280, P35521, DOI 10.1074/jbc.M506769200; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wall ME, 2003, P NATL ACAD SCI USA, V100, P2380, DOI 10.1073/pnas.0534892100; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WERNET W, 1989, FEBS LETT, V251, P191, DOI 10.1016/0014-5793(89)81453-X; Wu J, 2004, STRUCTURE, V12, P1057, DOI 10.1016/j.str.2004.03.022; Zawadzki KM, 2004, J BIOL CHEM, V279, P7029, DOI 10.1074/jbc.M310804200; Zhao JK, 1998, J BIOL CHEM, V273, P30448, DOI 10.1074/jbc.273.46.30448; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423	71	7	7	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					7916	7929		10.1074/jbc.RA117.000647	http://dx.doi.org/10.1074/jbc.RA117.000647			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29602907	Green Published, hybrid			2022-12-26	WOS:000433224600002
J	Meadows, KRT; Steinberg, MW; Clemons, B; Stokes, ME; Opiteck, GJ; Peach, R; Scott, FL				Meadows, Kristen R. Taylor; Steinberg, Marcos W.; Clemons, Bryan; Stokes, Matthew E.; Opiteck, Gregory J.; Peach, Robert; Scott, Fiona L.			Ozanimod (RPC1063), a selective S1P(R1) and S1P(R5) modulator, reduces chronic inflammation and alleviates kidney pathology in murine systemic lupus erythematosus	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTOR; LYMPHOID ORGANS; FTY720; S1P(1); PATHOGENESIS; FINGOLIMOD; INFECTION; NEPHRITIS; EFFICACY; UPDATE	Ozanimod (RPC1063) is a specific and potent small molecule modulator of the sphingosine 1-phosphate receptor 1 (S1PRi) and receptor 5 (S1PR5), which has shown therapeutic benefit in clinical trials of relapsing multiple sclerosis and ulcerative colitis. Ozanimod and its active metabolite, RP-101075, exhibit a similar specificity profile at the S1P receptor family in vitro and pharmacodynamic profile in vivo. The NZBWF1 mouse model was used in therapeutic dosing mode to assess the potential benefit of ozanimod and RP-101075 in an established animal model of systemic lupus erythematosus. Compared with vehicle-treated animals, ozanimod and RP-101075 reduced proteinuria over the duration of the study and serum blood urea nitrogen at termination. Additionally, ozanimod and RP-101075 reduced kidney disease in a dose-dependent manner, as measured by histological assessment of mesangial expansion, endo- and exo-capillary proliferation, interstitial infiltrates and fibrosis, glomerular deposits, and tubular atrophy. Further exploration into gene expression changes in the kidney demonstrate that RP-101075 also significantly reduced expression of fibrotic and immune-related genes in the kidneys. Of note, RP-101075 lowered the number of plasmacytoid dendritic cells, a major source of interferon alpha in lupus patients, and reduced all B and T cell subsets in the spleen. Given the efficacy demonstrated by ozanimod and its metabolite RP-101075 in the NZBWF1 preclinical animal model, ozanimod may warrant clinical evaluation as a potential treatment for systemic lupus erythematosus.	[Meadows, Kristen R. Taylor; Steinberg, Marcos W.; Clemons, Bryan; Opiteck, Gregory J.; Peach, Robert; Scott, Fiona L.] Receptos, San Diego, CA 92121 USA; [Stokes, Matthew E.] Celgene Corp, Seattle, WA USA	Bristol-Myers Squibb; Celgene Corporation	Meadows, KRT (corresponding author), Receptos, San Diego, CA 92121 USA.	krtaylor@celgene.com		Stokes, Matthew/0000-0002-1953-1616	Celgene Corporation	Celgene Corporation(Bristol-Myers SquibbCelgene Corporation)	Celgene Corporation (http://www.celgene.com/) funded this study. The funder provided support in the form of salaries and research materials for authors KRTM, MWS, BC, MES, GJO, RP and FLS. KRTM, MWS, BC, MES, GJO, RP and FLS had additional roles in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Alperovich G, 2007, LUPUS, V16, P18, DOI 10.1177/0961203306073136; Ando S, 2010, BIOCHEM BIOPH RES CO, V394, P804, DOI 10.1016/j.bbrc.2010.03.078; Aoki M, 2016, MEDIAT INFLAMM, V2016, DOI [DOI 10.1155/2016/8606878, 10.1155/2016/8606878]; Brinkmann V, 2009, BRIT J PHARMACOL, V158, P1173, DOI 10.1111/j.1476-5381.2009.00451.x; Chang A, 2011, J IMMUNOL, V186, P1849, DOI 10.4049/jimmunol.1001983; Clark EA, 2005, ANN RHEUM DIS, V64, P77, DOI 10.1136/ard.2005.042507; Cohen JA, 2016, LANCET NEUROL, V15, P373, DOI 10.1016/S1474-4422(16)00018-1; Corsiero E, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00430; Gong Q, 2005, J IMMUNOL, V174, P817, DOI 10.4049/jimmunol.174.2.817; Gonzalez-Cabrera Pedro J, 2014, F1000Prime Rep, V6, P109, DOI 10.12703/P6-109; HURD ER, 1975, ARTHRITIS RHEUM-US, V18, P67, DOI 10.1002/art.1780180113; Kappos L, 2016, JAMA NEUROL, V73, P1089, DOI 10.1001/jamaneurol.2016.1451; Khatri BO, 2016, THER ADV NEUROL DISO, V9, P130, DOI 10.1177/1756285616628766; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim SS, 2012, THER ADV CHRONIC DIS, V3, P11, DOI 10.1177/2040622311424806; Lech M, 2013, J AM SOC NEPHROL, V24, P1357, DOI 10.1681/ASN.2013010026; Marro BS, 2017, P NATL ACAD SCI USA, V114, P3708, DOI 10.1073/pnas.1700878114; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mehling M, 2014, NEUROL-NEUROIMMUNOL, V1, DOI 10.1212/NXI.0000000000000028; Moulton VR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3251; Neyt K, 2012, TRENDS IMMUNOL, V33, P297, DOI 10.1016/j.it.2012.04.006; Noor S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-77; Okazaki H, 2002, J RHEUMATOL, V29, P707; Oldstone MBA, 2013, VIROLOGY, V435, P92, DOI 10.1016/j.virol.2012.09.039; Oon S, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.26; Perry D, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/271694; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Sandborn WJ, 2016, NEW ENGL J MED, V374, P1754, DOI 10.1056/NEJMoa1513248; SCHRIEBER L, 1986, RHEUMATOL INT, V6, P215, DOI 10.1007/BF00541370; Schurer SC, 2008, ACS CHEM BIOL, V3, P486, DOI 10.1021/cb800051m; Scott FL, 2016, BRIT J PHARMACOL, V173, P1778, DOI 10.1111/bph.13476; Sistigu A, 2011, SEMIN IMMUNOPATHOL, V33, P369, DOI 10.1007/s00281-011-0245-0; Smith MR, 2003, ONCOGENE, V22, P7359, DOI 10.1038/sj.onc.1206939; Teijaro JR, 2016, P NATL ACAD SCI USA, V113, P1351, DOI 10.1073/pnas.1525356113; Tobon GJ, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/827254	36	24	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0193236	10.1371/journal.pone.0193236	http://dx.doi.org/10.1371/journal.pone.0193236			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608575	Green Published, gold			2022-12-26	WOS:000428988800002
J	Coletta, NA; Mallette, MM; Gabriel, DA; Tyler, CJ; Cheung, SS				Coletta, Nico A.; Mallette, Matthew M.; Gabriel, David A.; Tyler, Christopher J.; Cheung, Stephen S.			Core and skin temperature influences on the surface electromyographic responses to an isometric force and position task	PLOS ONE			English	Article							PREDICTING BODY DENSITY; MOTOR UNIT RECRUITMENT; ELBOW FLEXOR MUSCLES; PASSIVE HYPERTHERMIA; FATIGUING CONTRACTIONS; NEUROMUSCULAR FUNCTION; GENERALIZED EQUATIONS; ACTIVATION; PERFORMANCE; EXERCISE	The large body of work demonstrating hyperthermic impairment of neuromuscular function has utilized maximal isometric contractions, but extrapolating these findings to whole-body exercise and submaximal, dynamic contractions may be problematic. We isolated and compared core and skin temperature influences on an isometric force task versus a position task requiring dynamic maintenance of joint angle. Surface electromyography (sEMG) was measured on the flexor carpi radialis at 60% of baseline maximal voluntary contraction while either pushing against a rigid restraint (force task) or while maintaining a constant wrist angle and supporting an equivalent inertial load (position task). Twenty participants performed each task at 0.5 degrees C rectal temperature (T-re) intervals while being passively heated from 37.1 +/- 0.3 degrees C to >= 1.5 degrees C T-re and then cooled to 37.8 +/- 0.3 degrees C, permitting separate analyses of core versus skin temperature influences. During a 3-s contraction, trend analysis revealed a quadratic trend that peaked during hyperthermia for root-mean-square (RMS) amplitude during the force task. In contrast, RMS amplitude during the position task remained stable with passive heating, then rapidly increased with the initial decrease in skin temperature at the onset of passive cooling (p = 0.010). Combined hot core and hot skin elicited shifts toward higher frequencies in the sEMG signal during the force task (p = 0.003), whereas inconsistent changes in the frequency spectra occurred for the position task. Based on the patterns of RMS amplitude in response to thermal stress, we conclude that core temperature was the primary thermal afferent influencing neuromuscular response during a submaximal force task, with minimal input from skin temperature. However, skin temperature was the primary thermal afferent during a position task with minimal core temperature influence. Therefore, temperature has a task-dependent impact on neuromuscular responses.	[Coletta, Nico A.; Mallette, Matthew M.; Gabriel, David A.; Cheung, Stephen S.] Brock Univ, Dept Kinesiol, St Catharines, ON, Canada; [Tyler, Christopher J.] Univ Roehampton, Dept Life Sci, London, England	Brock University; Roehampton University	Cheung, SS (corresponding author), Brock Univ, Dept Kinesiol, St Catharines, ON, Canada.	scheung@brocku.ca	Cheung, Stephen/HGU-6191-2022; Tyler, Chris/AAG-1087-2020; Cheung, Stephen/AAE-9136-2020	Cheung, Stephen/0000-0002-6149-4978; Mallette, Matthew/0000-0003-4582-2713; Tyler, Christopher/0000-0002-3233-0771				BELL DG, 1993, EUR J APPL PHYSIOL O, V67, P256, DOI 10.1007/BF00864225; Bigland-Ritchie B, 1981, Exerc Sport Sci Rev, V9, P75; BIGLANDRITCHIE B, 1984, MUSCLE NERVE, V7, P691, DOI 10.1002/mus.880070902; BUCHANAN TS, 1995, NEUROSCI LETT, V194, P61, DOI 10.1016/0304-3940(95)11727-E; Casa DJ, 2000, J ATHL TRAINING, V35, P212; Cheung SS, 2004, EXERC SPORT SCI REV, V32, P100, DOI 10.1097/00003677-200407000-00005; Cheung SS, 2004, EUR J APPL PHYSIOL, V91, P723, DOI 10.1007/s00421-004-1062-0; Cheung SS, 2007, APPL PHYSIOL NUTR ME, V32, P808, DOI 10.1139/H07-043; Dimitrov GV, 2008, J ELECTROMYOGR KINES, V18, P35, DOI 10.1016/j.jelekin.2006.07.002; Ely MR, 2007, MED SCI SPORT EXER, V39, P487, DOI 10.1249/mss.0b013e31802d3aba; Enoka RM, 2002, MUSCLE NERVE, V25, P763, DOI 10.1002/mus.10117; FALLENTIN N, 1993, EUR J APPL PHYSIOL O, V67, P335, DOI 10.1007/BF00357632; Galloway SDR, 1997, MED SCI SPORT EXER, V29, P1240, DOI 10.1097/00005768-199709000-00018; Green LA, 2015, MUSCLE NERVE, V52, P818, DOI 10.1002/mus.24631; Green LA, 2014, APPL PHYSIOL NUTR ME, V39, P275, DOI 10.1139/apnm-2013-0253; Hakkinen K, 1994, Electromyogr Clin Neurophysiol, V34, P205; Hunter SK, 2016, J APPL PHYSIOL, V121, P982, DOI 10.1152/japplphysiol.00475.2016; Hunter SK, 2003, J APPL PHYSIOL, V94, P2439, DOI 10.1152/japplphysiol.01038.2002; Hunter SK, 2002, J NEUROPHYSIOL, V88, P3087, DOI 10.1152/jn.00232.2002; Ivanova T, 1997, MUSCLE NERVE, V20, P867, DOI 10.1002/(SICI)1097-4598(199707)20:7<867::AID-MUS11>3.0.CO;2-P; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; JACKSON AS, 1980, MED SCI SPORT EXER, V12, P175; Kent-Braun JA, 2012, COMPR PHYSIOL, V2, P997, DOI 10.1002/cphy.c110029; Masuda K, 1999, J ELECTROMYOGR KINES, V9, P39, DOI 10.1016/S1050-6411(98)00021-2; Mero A., 1981, SCAND J SPORTS SCI, V3, P16; MORITANI T, 1987, EUR J APPL PHYSIOL, V56, P260, DOI 10.1007/BF00690890; Morrison S, 2004, EUR J APPL PHYSIOL, V91, P729, DOI 10.1007/s00421-004-1063-z; Morrison SA, 2006, MED SCI SPORT EXER, V38, P1754, DOI 10.1249/01.mss.0000230120.83641.98; Morrison SA, 2009, APPL PHYSIOL NUTR ME, V34, P66, DOI 10.1139/H08-139; MURPHY AJ, 1994, EUR J APPL PHYSIOL O, V69, P250, DOI 10.1007/BF01094797; Murphy AJ, 1996, EUR J APPL PHYSIOL O, V73, P353, DOI 10.1007/BF02425498; NAKAZAWA K, 1993, EUR J APPL PHYSIOL O, V66, P214, DOI 10.1007/BF00235096; NARDONE A, 1989, J PHYSIOL-LONDON, V409, P451, DOI 10.1113/jphysiol.1989.sp017507; Nybo L, 2001, J APPL PHYSIOL, V91, P1055, DOI 10.1152/jappl.2001.91.3.1055; Racinais S, 2010, SCAND J MED SCI SPOR, V20, P1, DOI 10.1111/j.1600-0838.2010.01204.x; RAMANATHAN NL, 1964, J APPL PHYSIOL, V19, P531, DOI 10.1152/jappl.1964.19.3.531; Roman-Liu D, 2016, INT J OCCUP SAF ERGO, V22, P77, DOI 10.1080/10803548.2015.1116817; Rutkove SB, 2001, MUSCLE NERVE, V24, P867, DOI 10.1002/mus.1084.abs; Rutkove SB, 1997, MUSCLE NERVE, V20, P431, DOI 10.1002/(SICI)1097-4598(199704)20:4<431::AID-MUS5>3.0.CO;2-B; Thomas MM, 2006, J APPL PHYSIOL, V100, P1361, DOI 10.1152/japplphysiol.00945.2005; Todd G, 2005, J PHYSIOL-LONDON, V563, P621, DOI 10.1113/jphysiol.2004.077115; Watanabe K, 2010, J ELECTROMYOGR KINES, V20, P661, DOI 10.1016/j.jelekin.2010.01.003; WINKEL J, 1991, EUR J APPL PHYSIOL O, V63, P345, DOI 10.1007/BF00364460	43	11	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195219	10.1371/journal.pone.0195219	http://dx.doi.org/10.1371/journal.pone.0195219			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596491	Green Published, gold, Green Submitted			2022-12-26	WOS:000428630000092
J	Liakoni, E; Gartwyl, F; Ricklin, M; Exadaktylos, AK; Krahenbuhl, S				Liakoni, Evangelia; Gartwyl, Fabienne; Ricklin, Meret; Exadaktylos, Aristomenis K.; Krahenbuhl, Stephan			Psychoactive substances and violent offences: A retrospective analysis of presentations to an urban emergency department in Switzerland	PLOS ONE			English	Article							ACUTE RECREATIONAL DRUG; CANNABIS USE; COCAINE; ALCOHOL; ABUSE; MARIJUANA; HOMICIDE; TOXICITY; INJURIES	Background Psychoactive substances are often regarded as causal factors contributing to violent injuries, sexual abuse and homicides. While these effects have been demonstrated for some substances (e.g. cocaine), current available data for others are more controversial (e.g. cannabis) or very limited (e.g. ecstasy). Aims of the study To collect data on the type and frequency of psychoactive substance use in cases of emergency department (ED) presentations related to interpersonal violence. Methods Retrospective study at the University Hospital of Bern, Switzerland, between May 2012 and June 2016. The study covered cases of violent crime associated with psychoactive substances. Cases of isolated ethanol intoxication, suicide attempts, and substance use for medical purposes were excluded. Results The study included 103 cases among the 164,846 ED attendances. In the majority of the cases, the type of violence was bodily force (52%) related to urban violence (83%). The mean patient age was 29 years and 79% were male. 63% of the patients reported use of more than one drug; alcohol co-use was reported in 60% of the cases. Besides alcohol, the substances most often reported were cannabis (50%) and cocaine (21%). Alcohol and cannabis was also the most commonly reported substance combination (36% of the total cases). Urine drug screening was performed in 34% of the cases and cannabis and cocaine were the most commonly detected substances (46% and 19%, respectively). There were no cases of novel substances. 23% of the patients were admitted to a hospital ward, 10% to a psychiatric clinic. Conclusion Cannabis and cocaine were, besides alcohol, the substances most often reported in ED presentations related to offences of violence. Because of the high prevalence of alcohol co-use, no final conclusions can be drawn on the contribution of single substances.	[Liakoni, Evangelia; Gartwyl, Fabienne; Krahenbuhl, Stephan] Univ Bern, Bern Univ Hosp, Inselspital, Clin Pharmacol & Toxicol,Dept Gen Internal Med, Bern, Switzerland; [Liakoni, Evangelia; Gartwyl, Fabienne] Univ Bern, Inst Pharmacol, Bern, Switzerland; [Ricklin, Meret; Exadaktylos, Aristomenis K.] Univ Bern, Bern Univ Hosp, Emergency Dept, Inselspital, Bern, Switzerland; [Krahenbuhl, Stephan] Basel Univ Hosp, Div Clin Pharmacol & Toxicol, Basel, Switzerland; [Krahenbuhl, Stephan] Univ Basel, Basel, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Basel; University of Basel	Liakoni, E (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Clin Pharmacol & Toxicol,Dept Gen Internal Med, Bern, Switzerland.; Liakoni, E (corresponding author), Univ Bern, Inst Pharmacol, Bern, Switzerland.	Evangelia.liakoni@insel.ch	Krähenbühl, Stephan/Z-4744-2019; Ricklin, Meret Elisabeth/AAY-7948-2021	Ricklin, Meret Elisabeth/0000-0003-3047-9350				Aderjan R, 2011, RICHTLINIEN BESTIMMU; [Anonymous], 2013, TOX DRUG SCREEN PROD; [Anonymous], 2016, TRENDS DEV; Blondell RD, 2005, J TRAUMA, V58, P561, DOI 10.1097/01.TA.0000152638.54978.53; Boles SM, 2003, AGGRESS VIOLENT BEH, V8, P155, DOI 10.1016/S1359-1789(01)00057-X; Buchan BJ, 2002, ADDICTION, V97, P98, DOI 10.1046/j.1360-0443.97.s01.1.x; Capriola M, 2013, CLIN PHARMACOL-ADV A, V5, P109, DOI 10.2147/CPAA.S42832; Chermack ST, 2002, DRUG ALCOHOL DEPEN, V66, P29, DOI 10.1016/S0376-8716(01)00180-6; Cherpitel CJ, 2013, AM J ADDICTION, V22, P87, DOI 10.1111/j.1521-0391.2013.00316.x; Dines AM, 2015, J MED TOXICOL, V11, P415, DOI 10.1007/s13181-014-0460-x; Dines AM, 2015, CLIN TOXICOL, V53, P893, DOI 10.3109/15563650.2015.1088157; EMCDDA (European Drug Report), 2014, TRENDS DEV; Falck R S, 2001, Violence Vict, V16, P79; Franklin FA, 2010, WEST J EMERG MED, V11, P283; Freeman D, 2015, SCHIZOPHRENIA BULL, V41, P391, DOI 10.1093/schbul/sbu098; Friedman AS, 2001, J ADDICT DIS, V20, P49, DOI 10.1300/J069v20n01_06; Gmel G, 2014, SUCHTMONITORING SCHW; Gmel G, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-40; Grisso JA, 1999, NEW ENGL J MED, V341, P1899, DOI 10.1056/NEJM199912163412506; Gunderson EW, 2014, SUBST ABUS, V35, P184, DOI 10.1080/08897077.2013.846288; HANZLICK R, 1991, JAMA-J AM MED ASSOC, V265, P760, DOI 10.1001/jama.265.6.760; HARRUFF RC, 1988, J FORENSIC SCI, V33, P1231; Hill SL, 2011, CLIN TOXICOL PHILA, V49; Hoaken PNS, 2003, ADDICT BEHAV, V28, P1533, DOI 10.1016/j.addbeh.2003.08.033; Kilpatrick DG, 1997, J CONSULT CLIN PSYCH, V65, P834, DOI 10.1037/0022-006X.65.5.834; Korcha RA, 2014, DRUG ALCOHOL REV, V33, P43, DOI 10.1111/dar.12087; Liakoni E, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0369-x; Liakoni E, 2016, BMC PHARMACOL TOXICO, V17, DOI 10.1186/s40360-016-0068-7; Liakoni E, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14166; LICATA A, 1993, PHARMACOL BIOCHEM BE, V45, P549, DOI 10.1016/0091-3057(93)90504-M; Lupi M, 2017, EAT WEIGHT DISORD-ST, V22, P619, DOI 10.1007/s40519-017-0429-2; Lynd LD, 2008, BMC EMERG MED, V8, DOI 10.1186/1471-227X-8-5; Macdonald S, 2008, ADDICT BEHAV, V33, P201, DOI 10.1016/j.addbeh.2007.07.002; Martinotti G, 2017, CNS NEUROL DISORD-DR, V16, P567, DOI 10.2174/1871527316666170413101839; Martinotti G, 2017, HUM PSYCHOPHARM CLIN, V32, DOI 10.1002/hup.2586; Moore TM, 2005, AGGRESS VIOLENT BEH, V10, P171, DOI 10.1016/j.avb.2003.10.002; Shafi A, 2017, HUM PSYCHOPHARM CLIN, V32, DOI 10.1002/hup.2606; Tardiff K, 1997, AM J PSYCHIAT, V154, P88; Vaughn MG, 2010, AM J DRUG ALCOHOL AB, V36, P181, DOI 10.3109/00952990.2010.491877; Wood DM, 2014, CLIN TOXICOL, V52, P239, DOI 10.3109/15563650.2014.898771	40	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195234	10.1371/journal.pone.0195234	http://dx.doi.org/10.1371/journal.pone.0195234			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596473	Green Published, Green Submitted, gold			2022-12-26	WOS:000428630000096
J	Sugiyama, M; Kikuchi, A; Misu, H; Igawa, H; Ashihara, M; Kushima, Y; Honda, K; Suzuki, Y; Kawabe, Y; Kaneko, S; Takamura, T				Sugiyama, Masakazu; Kikuchi, Akihiro; Misu, Hirofumi; Igawa, Hirobumi; Ashihara, Motooki; Kushima, Youichi; Honda, Kiyofumi; Suzuki, Yoshiyuki; Kawabe, Yoshiki; Kaneko, Shuichi; Takamura, Toshinari			Inhibin beta E (INHBE) is a possible insulin resistance-associated hepatokine identified by comprehensive gene expression analysis in human liver biopsy samples	PLOS ONE			English	Article							OXIDATIVE-PHOSPHORYLATION; GROWTH-HORMONE; MUSCLE MASS; ACTIVIN; DISEASE; OBESITY; GLUCOSE; CLONING; MICE; SUBUNITS	The liver plays a major role in whole-body energy homeostasis by releasing secretory factors, termed hepatokines. To identify novel target genes associated with insulin resistance, we performed a comprehensive analysis of gene expression profiles using a DNA chip method in liver biopsy samples from humans with varying degrees of insulin resistance. Inhibin beta E (INHBE) was identified as a novel putative hepatokine with hepatic gene expression that positively correlated with insulin resistance and body mass index in humans. Quantitative real time-PCR analysis also showed an increase in INHBE gene expression in independent liver samples from insulin-resistant human subjects. Additionally, Inhbe gene expression increased in the livers of db/db mice, a rodent model of type 2 diabetes. To preliminarily screen the role of Inhbe in vivo in whole-body energy metabolic status, hepatic mRNA was knocked down with siRNA for Inhbe (siINHBE) in db/db mice. Treatment with siINHBE suppressed body weight gain during the two-week experimental period, which was attributable to diminished fat rather than lean mass. Additionally, treatment with siINHBE decreased the respiratory quotient and increased plasma total ketone bodies compared with treatment with non-targeting siRNA, both of which suggest enhanced whole-body fat utilization. Our study suggests that INHBE functions as a possible hepatokine to alter the whole-body metabolic status under obese insulin-resistant conditions.	[Sugiyama, Masakazu; Ashihara, Motooki; Kushima, Youichi; Honda, Kiyofumi; Suzuki, Yoshiyuki; Kawabe, Yoshiki] Chugai Pharmaceut Co Ltd, Res Div, Gotemba, Shizuoka, Japan; [Kikuchi, Akihiro; Misu, Hirofumi; Igawa, Hirobumi; Takamura, Toshinari] Kanazawa Univ, Grad Sch Med Sci, Dept Endocrinol & Metab, Kanazawa, Ishikawa, Japan; [Kikuchi, Akihiro; Igawa, Hirobumi; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med Sci, Dept Syst Biol, Kanazawa, Ishikawa, Japan; [Misu, Hirofumi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	Chugai Pharmaceutical Co., Ltd.; Roche Holding; Kanazawa University; Kanazawa University; Japan Science & Technology Agency (JST)	Kikuchi, A; Takamura, T (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Endocrinol & Metab, Kanazawa, Ishikawa, Japan.; Kikuchi, A (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Syst Biol, Kanazawa, Ishikawa, Japan.	akikuchi@mail.kanazwa-u.ac.jp; ttakamura@med.kanazawa-u.ac.jp		Kawabe, Yoshiki/0000-0002-6465-7146; Suzuki, Yoshiyuki/0000-0002-0801-7793	Grants-in-Aid for Scientific Research [17K09822] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Bramnert M, 2003, J CLIN ENDOCR METAB, V88, P1455, DOI 10.1210/jc.2002-020542; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Chabicovsky M, 2003, ENDOCRINOLOGY, V144, P3497, DOI 10.1210/en.2003-0388; Chen JJ, 2014, SCI WORLD J, DOI 10.1155/2014/416530; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cusi K, 2016, DIABETOLOGIA, V59, P1112, DOI 10.1007/s00125-016-3952-1; Fang JM, 1996, BIOCHEM BIOPH RES CO, V228, P669, DOI 10.1006/bbrc.1996.1715; Fang JM, 1997, BIOCHEM BIOPH RES CO, V231, P655, DOI 10.1006/bbrc.1997.6162; Hashimoto O, 2002, MOL CELL ENDOCRINOL, V194, P117, DOI 10.1016/S0303-7207(02)00157-0; Hashimoto O, 2006, BIOCHEM BIOPH RES CO, V341, P416, DOI 10.1016/j.bbrc.2005.12.205; Hashimoto O, 2011, VITAM HORM, V85, P217, DOI 10.1016/B978-0-12-385961-7.00011-1; Hashimoto O, 2009, LIFE SCI, V85, P534, DOI 10.1016/j.lfs.2009.08.007; Kang HP, 2012, DIABETOLOGIA, V55, P2205, DOI 10.1007/s00125-012-2568-3; Kubota N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12977; Kubota T, 2017, CELL METAB, V25, P797, DOI 10.1016/j.cmet.2017.03.004; Lan F, 2014, DIABETES, V63, P1649, DOI 10.2337/db13-0728; Lau AL, 2000, MOL CELL BIOL, V20, P6127, DOI 10.1128/MCB.20.16.6127-6137.2000; Lee SJ, 2010, MOL ENDOCRINOL, V24, P1998, DOI 10.1210/me.2010-0127; Leslie RD, 2016, DIABETOLOGIA, V59, P13, DOI 10.1007/s00125-015-3789-z; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Magnusson B, 2010, BIOCHEM BIOPH RES CO, V395, P373, DOI 10.1016/j.bbrc.2010.04.022; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Misu H, 2007, DIABETOLOGIA, V50, P268, DOI 10.1007/s00125-006-0489-8; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; O'Bryan MK, 2000, J MOL ENDOCRINOL, V24, P409, DOI 10.1677/jme.0.0240409; Otero YF, 2014, J BIOL CHEM, V289, P20462, DOI 10.1074/jbc.R114.576355; Otoda T, 2013, DIABETES, V62, P811, DOI 10.2337/db11-1652; Pihlajamaki J, 2009, J CLIN ENDOCR METAB, V94, P3521, DOI 10.1210/jc.2009-0212; Rodt T, 2011, ACTA RADIOL, V52, P75, DOI 10.1258/ar.2010.100059; Sekiyama K, 2009, BIOCHEM BIOPH RES CO, V385, P319, DOI 10.1016/j.bbrc.2009.05.054; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Takamura T, 2008, OBESITY, V16, P2601, DOI 10.1038/oby.2008.419; Vejda S, 2002, J MOL ENDOCRINOL, V28, P137, DOI 10.1677/jme.0.0280137; Vejda S, 2003, CARCINOGENESIS, V24, P1801, DOI 10.1093/carcin/bgg154; Wada W, 2005, ENDOCR J, V52, P169, DOI 10.1507/endocrj.52.169	37	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194798	10.1371/journal.pone.0194798	http://dx.doi.org/10.1371/journal.pone.0194798			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596463	Green Published, gold, Green Submitted			2022-12-26	WOS:000428630000043
J	Shahid, MA; Marenda, MS; Markham, PF; Noormohammadi, AH				Shahid, Muhammad A.; Marenda, Marc S.; Markham, Philip F.; Noormohammadi, Amir H.			Complementation of the Mycoplasma synoviae MS-H vaccine strain with wild-type obg influencing its growth characteristics	PLOS ONE			English	Article							GTP-BINDING PROTEIN; 50S RIBOSOMAL-SUBUNIT; TEMPERATURE SHIFT EXPERIMENTS; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; PLASMID RK2; GENE; MUTANTS; GTPASES; DEGRADATION	The temperature-sensitive (ts(+)) Mycoplasma synoviae vaccine strain MS-H harbors a non-synonymous mutation which results in Glycine to Arginine substitution at position 123 in the highly conserved glycine-rich motif of Obg-fold in the GTP-binding protein Obg. In-silico analysis of the wild-type and mutant Obgs of M. synoviae has indicated that this amino acid substitution affects structure of the protein, potentially leading to abrogation of Obg function in vivo. Present study was conducted to develop the first expression vector for M. synoviae and to investigate the potential effect(s) of complementation of MS-H vaccine with the wild type obg from 86079/7NS, the parent strain of MS-H. An oriCvector, pKS-VOTL, harboring the 86079/7NS obg gene, downstream of the variable lipoprotein haemagglutinin (vIhA) gene promoter, also cloned from 86079/7NS, was used to transform MS-H. The plasmid was localised at the chromosomal oriC locus of MS-H without any detectable integration at the chromosomal obg locus. Analysis of the MS-H transformants revealed abundant obg transcripts as well as Obg protein, when compared to the MS-H transformed with a similar vector, pMAS-LoriC, lacking obg coding sequence. The MS-H transformants complemented with wild-type Obg maintained their original temperature-sensitivity phenotype (consistent with MS-H vaccine) but, when compared to the MS-H transformed with pMAS-LoriC, had significantly higher (p < 0.05) growth rate and viability at the permissive (33 degrees C) and non-permissive temperature (39.5 degrees C), respectively. Analysis of Obg expression in MS-H and its wild-type parent strain revealed comparatively lower levels of Obg in MS-H. These results indicate that not only the mutation in Obg, but also the level of Obg expression, can confer functional abnormalities in the bacterial host. Furthermore, with the construction of first expression vector for M. synoviae, this study has set foundation for the development of recombinant vaccine(s) based on MS-H.	[Shahid, Muhammad A.; Marenda, Marc S.; Noormohammadi, Amir H.] Univ Melbourne, Fac Vet & Agr Sci, Werribee, Vic, Australia; [Markham, Philip F.] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic, Australia; [Shahid, Muhammad A.] Bahauddin Zakariya Univ, Dept Pathobiol, Fac Vet Sci, Multan, Punjab, Pakistan	University of Melbourne; University of Melbourne; Bahauddin Zakariya University	Shahid, MA (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Werribee, Vic, Australia.; Shahid, MA (corresponding author), Bahauddin Zakariya Univ, Dept Pathobiol, Fac Vet Sci, Multan, Punjab, Pakistan.	drakbarshahid@gmail.com	Shahid, Muhammad Akbar/M-7608-2019	Shahid, Muhammad Akbar/0000-0003-2554-5990; NOORMOHAMMADI, AMIR/0000-0003-3459-2692; MARENDA, MARC/0000-0001-6778-1110	University of Melbourne; Higher Education Commission of Pakistan	University of Melbourne(University of Melbourne); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	Financial support to conduct this study was provided jointly by the University of Melbourne and the Higher Education Commission of Pakistan. The senior author was supported by the Higher Education Commission of Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addinall SG, 1997, J BACTERIOL, V179, P4277, DOI 10.1128/jb.179.13.4277-4284.1997; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Britton RA, 2009, ANNU REV MICROBIOL, V63, P155, DOI 10.1146/annurev.micro.091208.073225; Buglino J, 2002, STRUCTURE, V10, P1581, DOI 10.1016/S0969-2126(02)00882-1; Cardin SE, 2017, METHODS MOL BIOL, V1617, P39, DOI 10.1007/978-1-4939-7046-9_3; CHEN WP, 1993, NUCLEIC ACIDS RES, V21, P2260, DOI 10.1093/nar/21.9.2260; Czyz A, 2005, ACTA BIOCHIM POL, V52, P35; Datta K, 2004, MOL MICROBIOL, V54, P1379, DOI 10.1111/j.1365-2958.2004.04354.x; Dutkiewicz R, 2002, CURR MICROBIOL, V45, P440, DOI 10.1007/s00284-002-3713-x; Feng BY, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001866; Foti JJ, 2007, MOL MICROBIOL, V65, P569, DOI 10.1111/j.1365-2958.2007.05811.x; Foti JJ, 2005, MOL CELL, V17, P549, DOI 10.1016/j.molcel.2005.01.012; Fraser CM, 2000, EMERG INFECT DIS, V6, P505, DOI 10.3201/eid0605.000510; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; GOLDBERG AL, 1974, ANNU REV BIOCHEM, V43, P835, DOI 10.1146/annurev.bi.43.070174.004155; HAUGAN K, 1992, J BACTERIOL, V174, P7026, DOI 10.1128/JB.174.21.7026-7032.1992; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Jiang MX, 2006, J BACTERIOL, V188, P6757, DOI 10.1128/JB.00444-06; Karunakaran P, 1998, J BACTERIOL, V180, P3793, DOI 10.1128/JB.180.15.3793-3798.1998; Kint C, 2014, CRIT REV MICROBIOL, V40, P207, DOI 10.3109/1040841X.2013.776510; KIRSCHBAUM JB, 1975, P NATL ACAD SCI USA, V72, P2375, DOI 10.1073/pnas.72.6.2375; Kobayashi G, 2001, MOL MICROBIOL, V41, P1037, DOI 10.1046/j.1365-2958.2001.02574.x; KOK J, 1994, J BACTERIOL, V176, P7155, DOI 10.1128/JB.176.23.7155-7160.1994; Kuo S, 2008, J BACTERIOL, V190, P6625, DOI 10.1128/JB.00799-08; Lin B, 2004, J BACTERIOL, V186, P481, DOI 10.1128/JB.186.2.481-489.2004; Lin B, 2001, FEBS LETT, V489, P107, DOI 10.1016/S0014-5793(00)02214-6; Meynell G.G., 1970, THEORY PRACTICE EXPT, Vsecond; Morimoto T, 2002, MICROBIOL-SGM, V148, P3539, DOI 10.1099/00221287-148-11-3539; Morrow CJ, 1998, AVIAN DIS, V42, P667, DOI 10.2307/1592700; MORROW CJ, 1990, AUST VET J, V67, P121, DOI 10.1111/j.1751-0813.1990.tb07726.x; Okamoto S, 1997, J BACTERIOL, V179, P170, DOI 10.1128/jb.179.1.170-179.1997; Okamoto S, 1998, MOL MICROBIOL, V30, P107, DOI 10.1046/j.1365-2958.1998.01042.x; Persky NS, 2009, MOL MICROBIOL, V73, P253, DOI 10.1111/j.1365-2958.2009.06767.x; Polkinghorne A, 2011, MICROB PATHOGENESIS, V50, P200, DOI 10.1016/j.micpath.2010.12.005; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Roche, 2008, DIG APPL MANUAL FILT, P17; Sato A, 2005, GENES CELLS, V10, P393, DOI 10.1111/j.1365-2443.2005.00851.x; Scott JM, 1999, J BACTERIOL, V181, P4653, DOI 10.1128/JB.181.15.4653-4660.1999; Shahid MA, 2014, J MICROBIOL METH, V103, P70, DOI 10.1016/j.mimet.2014.05.014; Shahid MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073954; Shahid MA, 2013, AVIAN PATHOL, V42, P185, DOI 10.1080/03079457.2013.779363; Sikora AE, 2006, J BACTERIOL, V188, P1205, DOI 10.1128/JB.188.3.1205-1210.2006; Tan J, 2002, J BACTERIOL, V184, P2692, DOI 10.1128/JB.184.10.2692-2698.2002; TASCHNER PEM, 1988, J BACTERIOL, V170, P1533, DOI 10.1128/jb.170.4.1533-1540.1988; TRACH K, 1989, J BACTERIOL, V171, P1362, DOI 10.1128/jb.171.3.1362-1371.1989; VALLA S, 1991, PLASMID, V25, P131, DOI 10.1016/0147-619X(91)90025-R; Verstraeten N, 2011, MICROBIOL MOL BIOL R, V75, P507, DOI 10.1128/MMBR.00009-11; VIDWANS SJ, 1995, J BACTERIOL, V177, P3308, DOI 10.1128/jb.177.11.3308-3311.1995; Waters P J, 2001, Curr Issues Mol Biol, V3, P57; Whithear K., 1993, AUSTR STANDARD DIAGN, P1; Wout P, 2004, J BACTERIOL, V186, P5249, DOI 10.1128/JB.186.16.5249-5257.2004	54	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194528	10.1371/journal.pone.0194528	http://dx.doi.org/10.1371/journal.pone.0194528			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590172	Green Published, gold			2022-12-26	WOS:000428603100065
J	Wang, CS; Lie, L; Liu, SY; Liao, GN; Li, L; Chen, YN; Cheng, J; Lu, Y; Li, JP				Wang, Chengshi; Lie, Ling; Liu, Shuyun; Liao, Guangneng; Li, Lan; Chen, Younan; Cheng, Jingqiu; Lu, Yanrong; Li, Jingping			GLP-1 receptor agonist ameliorates obesity-induced chronic kidney injury via restoring renal metabolism homeostasis	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; BODY-MASS INDEX; DIABETIC-NEPHROPATHY; RENIN-ANGIOTENSIN; OXIDATIVE STRESS; PROTECTIVE ROLES; DISEASE; INFLAMMATION; INHIBITION; LIPOTOXICITY	Increasing evidence indicates that obesity is highly associated with chronic kidney disease (CKD). GLP-1 receptor (GLP-1R) agonist has shown benefits on kidney diseases, but its direct role on kidney metabolism in obesity is still not clear. This study aims to investigate the protection and metabolic modulation role of liraglutide (Lira) on kidney of obesity. Rats were induced obese by high-fat diet (HFD), and renal function and metabolism changes were evaluated by metabolomic, biological and histological methods. HFD rats exhibited systemic metabolic disorders such as obesity, hyperlipidemia and impaired glucose tolerance, as well as renal histological and function damages, while Lira significantly ameliorated these adverse effects in HFD rats. Metabolomic data showed that Lira directly reduced renal lipids including fatty acid residues, cholesterol, phospholipids and triglycerides, and improved mitochondria metabolites such as succinate, citrate, taurine, fumarate and nicotinamide adenine dinucleotide (NAD+) in the kidney of HFD rats. Furthermore, we revealed that Lira inhibited renal lipid accumulation by coordinating lipogenic and lipolytic signals, and partly rescued renal mitochondria function via Sirt1/AMPK/PGC1a pathways in HFD rats. This study suggested that Lira alleviated HFD-induced kidney injury at least partly via directly restoring renal metabolism, thus GLP-1R agonist is a promising therapy for obesity associated CKD.	[Wang, Chengshi; Liu, Shuyun; Liao, Guangneng; Li, Lan; Chen, Younan; Cheng, Jingqiu; Lu, Yanrong; Li, Jingping] Sichuan Univ, West China Hosp, Key Lab Transplant Engn & Immunol, Chengdu, Sichuan, Peoples R China; [Lie, Ling] Sichuan Univ, West China Hosp, Kidney Res Inst, Div Nephrol, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Lu, Y; Li, JP (corresponding author), Sichuan Univ, West China Hosp, Key Lab Transplant Engn & Immunol, Chengdu, Sichuan, Peoples R China.	luyanrong@scu.edu.cn; liujingping@scu.edu.cn	Liu, Jingping/P-8908-2019; wang, chengshi/AAX-4864-2021	wang, chengshi/0000-0002-0650-4109; Liao, Guangneng/0000-0002-5753-827X	National Natural Science Foundation of China [31200754, 81571808]; China Postdoctoral Science Foundation [2012M511931]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Natural Science Foundation of China, 31200754 (Dr. Jingping Liu); National Natural Science Foundation of China 81571808 (Dr. Jingping Liu); and China Postdoctoral Science Foundation, 2012M511931 (Dr. Jingping Liu).; This work was supported by grants from National Natural Science Foundation of China (31200754, 81571808) and China Postdoctoral Science Foundation (2012M511931).	Andersen K, 2017, J AM SOC NEPHROL, V28, P76, DOI 10.1681/ASN.2015111285; Bobulescu IA, 2010, CURR OPIN NEPHROL HY, V19, P393, DOI 10.1097/MNH.0b013e32833aa4ac; Bolignano D, 2013, NEPHROL DIAL TRANSPL, V28, P82, DOI 10.1093/ndt/gft302; Buteau J, 2008, DIABETES METAB, V34, pS73, DOI 10.1016/S1262-3636(08)73398-6; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Cheng ZY, 2014, CELL CYCLE, V13, P890, DOI 10.4161/cc.28189; Chung HW, 2012, NEPHROL DIAL TRANSPL, V27, P2213, DOI 10.1093/ndt/gfr613; CONSOLI A, 1990, J CLIN INVEST, V86, P2038, DOI 10.1172/JCI114940; Decleves AE, 2014, KIDNEY INT, V85, P611, DOI 10.1038/ki.2013.462; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Einbinder Y, 2016, DIABETES-METAB RES, V32, P805, DOI 10.1002/dmrr.2801; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Frederico MJS, 2011, SCAND J GASTROENTERO, V46, P1381, DOI 10.3109/00365521.2011.613945; Fujita H, 2014, KIDNEY INT, V85, P579, DOI 10.1038/ki.2013.427; Gelber RP, 2005, AM J KIDNEY DIS, V46, P871, DOI 10.1053/j.ajkd.2005.08.015; Goran MI, 2003, J CLIN ENDOCR METAB, V88, P1417, DOI 10.1210/jc.2002-021442; Guillet C, 2012, OBES REV, V13, P51, DOI 10.1111/j.1467-789X.2012.01037.x; Han XB, 2012, AMINO ACIDS, V43, P2249, DOI 10.1007/s00726-012-1314-y; Hocher B, 2017, NAT REV NEPHROL, V13, P728, DOI 10.1038/nrneph.2017.140; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Jelenik T, 2013, ANTIOXID REDOX SIGN, V19, P258, DOI 10.1089/ars.2012.4910; Katagiri D, 2013, J AM SOC NEPHROL, V24, P2034, DOI 10.1681/ASN.2013020134; Kodera R, 2011, DIABETOLOGIA, V54, P965, DOI 10.1007/s00125-010-2028-x; Liu JP, 2015, ANAL BIOANAL CHEM, V407, P2569, DOI 10.1007/s00216-015-8481-0; Liu SY, 2017, J CELL MOL MED, V21, P2553, DOI 10.1111/jcmm.13176; Mathew AV, 2011, CURR DIABETES REV, V7, P41, DOI 10.2174/157339911794273928; Mima A, 2012, DIABETES, V61, P2967, DOI 10.2337/db11-1824; Muenter K, 2001, HYPERTENSION, V37, pE13, DOI 10.1161/01.HYP.37.5.e13; Nosadini R, 2011, NUTR METAB CARDIOVAS, V21, P79, DOI 10.1016/j.numecd.2010.10.002; Raun K, 2007, DIABETES, V56, P8, DOI 10.2337/db06-0565; Sharma K, 2013, J AM SOC NEPHROL, V24, P1901, DOI 10.1681/ASN.2013020126; Stenvinkel P, 2013, J AM SOC NEPHROL, V24, P1727, DOI 10.1681/ASN.2013040330; Takashima S, 2016, KIDNEY INT, V90, P783, DOI 10.1016/j.kint.2016.06.012; Thethi T, 2012, CURR HYPERTENS REP, V14, P160, DOI 10.1007/s11906-012-0245-z; Toblli JE, 2017, DRUG DES DEV THER, V11, P3401, DOI 10.2147/DDDT.S151162; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Wang S.Q, 2013, 13 INT C FRACT, V9, P1, DOI DOI 10.1016/j.jnutbio.2013.09.001; Wang Y, 2008, KIDNEY INT, V73, P19, DOI 10.1038/sj.ki.5002586; Weinberg JM, 2006, KIDNEY INT, V70, P1560, DOI 10.1038/sj.ki.5001834; Wu LL, 1997, KIDNEY INT, V51, P1553, DOI 10.1038/ki.1997.214; Xu F, 2014, DIABETES, V63, P3637, DOI 10.2337/db14-0263; Xu S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.331; Yin QH, 2016, J BIOL CHEM, V291, P26487, DOI 10.1074/jbc.M116.730564; Zhong Z, 2003, CURR OPIN CLIN NUTR, V6, P229, DOI 10.1097/00075197-200303000-00013	45	53	55	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193473	10.1371/journal.pone.0193473	http://dx.doi.org/10.1371/journal.pone.0193473			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590132	Green Submitted, Green Published, gold			2022-12-26	WOS:000428603100021
J	Williams, GP; Wu, B; Liu, YC; Teo, E; Nyein, CL; Peh, G; Tan, DT; Mehta, JS				Williams, Geraint P.; Wu, Benjamin; Liu, Yu Chi; Teo, Ericia; Nyein, Chan L.; Peh, Gary; Tan, Donald T.; Mehta, Jodhbir S.			Hyperopic refractive correction by LASIK, SMILE or lenticule reimplantation in a non-human primate model	PLOS ONE			English	Article							FEMTOSECOND LASER; EXTRACTION SMILE; EYE-DISEASE; CROSS-LINKING; MYOPIA; OUTCOMES; SURGERY; PREDICTABILITY; IMPLANTATION; ASTIGMATISM	Hyperopia is a common refractive error, apparent in 25% of Europeans. Treatments include spectacles, contact lenses, laser interventions and surgery including implantable contact lenses and lens extraction. Laser treatment offers an expedient and reliable means of correcting ametropia. LASIK is well-established however SMILE (small-incision lenticule extraction) or lenticule implantation (derived from myopic laser-correction) are newer options. In this study we compared the outcomes of hyperopic LASIK, SMILE and lenticule re-implantation in a primate model at +2D/+4D treatment. While re-implantation showed the greatest regression, broadly comparable refractive results were seen at 3-months with SMILE and LASIK (<1.4D of intended), but a greater tendency to regression in +2D lenticule reimplantation. Central corneal thickness showed greater variation at +2D treatment, but central thickening during lenticule reimplantation at +4D treatment was seen (-17 +/- 27 mu m LASIK,-45 +/- 18 mu m SMILE and 28 +/- 17 mu m Re-implantation; p <0.01) with expected paracentral thinning following SMILE. Although in vivo confocal microscopy appeared to show higher reflectivity in all +4D treatment groups, there were minimal and inconsistent changes in inflammatory responses between modalities. SMILE and lenticule re-implantation may represent a safe and viable method for treating hyperopia, but further optimization for lower hyperopic treatments is warranted.	[Williams, Geraint P.; Liu, Yu Chi; Teo, Ericia; Nyein, Chan L.; Peh, Gary; Tan, Donald T.; Mehta, Jodhbir S.] Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore; [Williams, Geraint P.; Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore; [Wu, Benjamin; Tan, Donald T.; Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Ophthalmol Acad Clin Program, Singapore, Singapore; [Tan, Donald T.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore, Singapore; [Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; National University of Singapore; National University of Singapore; National University of Singapore	Mehta, JS (corresponding author), Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore.; Mehta, JS (corresponding author), Singapore Natl Eye Ctr, Singapore, Singapore.; Mehta, JS (corresponding author), Duke NUS Grad Med Sch, Ophthalmol Acad Clin Program, Singapore, Singapore.; Mehta, JS (corresponding author), Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore.	jodmehta@gmail.com	Liu, Yu Chi/AAM-7010-2020; Peh, Gary/A-8327-2010	Liu, Yu Chi/0000-0001-5408-0382; Peh, Gary/0000-0002-5387-4209	National Medical Research Council, Translational & Clinical Research (TCR) Flagship Programme, Singapore [NMRC/TCR/01020-SERI/2013]; Dowager Eleanor Peel Trust Travelling Grant; Royal College of Ophthalmologists/Pfizer Ophthalmic Fellowship	National Medical Research Council, Translational & Clinical Research (TCR) Flagship Programme, Singapore; Dowager Eleanor Peel Trust Travelling Grant; Royal College of Ophthalmologists/Pfizer Ophthalmic Fellowship	This study is supported by a National Medical Research Council, Translational & Clinical Research (TCR) Flagship Programme, Singapore Grant (NMRC/TCR/01020-SERI/2013). Geraint P Williams' SERI fellowship is supported by a Dowager Eleanor Peel Trust Travelling Grant and a Royal College of Ophthalmologists/Pfizer Ophthalmic Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alio JL, 2014, SURV OPHTHALMOL, V59, P579, DOI 10.1016/j.survophthal.2014.04.004; Ang M, 2012, INVEST OPHTH VIS SCI, V53, P1414, DOI 10.1167/iovs.11-8808; Angunawela RI, 2012, INVEST OPHTH VIS SCI, V53, P4975, DOI 10.1167/iovs.12-10170; Aslanides IM, 2013, CLIN OPHTHALMOL, V7, P637, DOI 10.2147/OPTH.S39796; BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999; Blum M, 2016, BRIT J OPHTHALMOL, V100, P1192, DOI 10.1136/bjophthalmol-2015-306822; Blum M, 2013, GRAEF ARCH CLIN EXP, V251, P349, DOI 10.1007/s00417-012-2064-y; Blum M, 2010, GRAEF ARCH CLIN EXP, V248, P1019, DOI 10.1007/s00417-009-1293-1; Borchert MS, 2011, OPHTHALMOLOGY, V118, P1966, DOI 10.1016/j.ophtha.2011.06.030; Chen SH, 2012, J REFRACT SURG, V28, P15, DOI 10.3928/1081597X-20111228-02; Denoyer A, 2015, OPHTHALMOLOGY, V122, P669, DOI 10.1016/j.ophtha.2014.10.004; Dong ZX, 2014, BRIT J OPHTHALMOL, V98, P263, DOI 10.1136/bjophthalmol-2013-303415; Ganesh S, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/263412; Ganesh S, 2014, J REFRACT SURG, V30, P590, DOI 10.3928/1081597X-20140814-02; Gil-Cazorla R, 2011, AM J OPHTHALMOL, V152, P16, DOI 10.1016/j.ajo.2011.01.009; Hansen RS, 2016, GRAEF ARCH CLIN EXP, V254, P399, DOI 10.1007/s00417-015-3226-5; Kamiya K, 2014, AM J OPHTHALMOL, V157, P128, DOI 10.1016/j.ajo.2013.08.011; Kanellopoulos AJ, 2012, J REFRACT SURG, V28, pS837, DOI 10.3928/1081597X-20121005-05; Lee BS, 2014, CURR OPIN OPHTHALMOL, V25, P281, DOI 10.1097/ICU.0000000000000066; Li MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081435; Lim CHL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083046; Liu R, 2015, INVEST OPHTH VIS SCI, V56, P3715, DOI 10.1167/iovs.14-15296; Liu YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep29802; Liu YC, 2016, J REFRACT SURG, V32, P346, DOI 10.3928/1081597X-20160217-05; Mimouni M, 2016, CORNEA, V35, P607, DOI 10.1097/ICO.0000000000000795; Mohamed-Noriega K, 2014, INVEST OPHTH VIS SCI, V55, P1823, DOI 10.1167/iovs.13-13324; Petrescu MS, 2007, INVEST OPHTH VIS SCI, V48, P5023, DOI 10.1167/iovs.07-0562; Pradhan KR, 2013, J REFRACT SURG, V29, P777, DOI 10.3928/1081597X-20131021-07; Reinstein DZ, 2017, J REFRACT SURG, V33, P370, DOI 10.3928/1081597X-20170331-01; Reinstein DZ, 2014, J REFRACT SURG, V30, P813, DOI 10.3928/1081597X-20141113-07; Riau AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067058; Santhiago MR, 2015, J REFRACT SURG, V31, P258, DOI 10.3928/1081597X-20150319-05; Santhiago MR, 2014, AM J OPHTHALMOL, V158, P87, DOI 10.1016/j.ajo.2014.04.002; Sekundo W, 2016, LASERS MED SCI; Sekundo W, 2011, BRIT J OPHTHALMOL, V95, P335, DOI 10.1136/bjo.2009.174284; Settas G, 2012, COCHRANE DB SYST REV, V6; Shah R, 2011, J CATARACT REFR SURG, V37, P127, DOI 10.1016/j.jcrs.2010.07.033; Shetty R, 2012, J REFRACT SURG, V28, pS815, DOI 10.3928/1081597X-20121005-01; Sun L, 2015, J REFRACT SURG, V31, P374, DOI 10.3928/1081597X-20150521-03; VANSETTEN GB, 1992, GRAEF ARCH CLIN EXP, V230, P178, DOI 10.1007/BF00164660; Vestergaard AH, 2014, ACTA OPHTHALMOL, V92, P492, DOI 10.1111/aos.12450; Wei SS, 2013, GRAEF ARCH CLIN EXP, V251, P1645, DOI 10.1007/s00417-013-2272-0; Wen G, 2013, OPHTHALMOLOGY, V120, P2109, DOI 10.1016/j.ophtha.2013.06.039; Williams KM, 2015, EUR J EPIDEMIOL, V30, P305, DOI 10.1007/s10654-015-0010-0	44	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194209	10.1371/journal.pone.0194209	http://dx.doi.org/10.1371/journal.pone.0194209			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590157	Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100052
J	Kou, N; Xue, M; Yang, L; Zang, MX; Qu, H; Wang, MM; Miao, Y; Yang, B; Shi, DZ				Kou, Na; Xue, Mei; Yang, Lin; Zang, Ming-Xuan; Qu, Hua; Wang, Ming-Ming; Miao, Yu; Yang, Bin; Shi, Da-Zhuo			Panax quinquefolius saponins combined with dual antiplatelet drug therapy alleviate gastric mucosal injury and thrombogenesis through the COX/PG pathway in a rat model of acute myocardial infarction	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INHIBITION; EXPRESSION; ASPIRIN; DAMAGE	Objectives Previous studies have found that Panax quinquefolius saponins (PQS) combined with dual antiplatelet therapy (DAPT) of aspirin and clopidogrel enhances antithrombotic effects while reducing gastric mucosal injury induced by DAPT. We investigated the effects of the combined drug therapy (PQS+DAPT) through the COX/PG pathways. Methods Acute myocardial infarction (AMI) was induced in Wistar rats by ligation of the left anterior descending (LAD) coronary artery, and the animals were randomly divided into Model, DAPT, and PQS+DAPT groups. Rats in the sham group did not undergo artery ligation. They were intragastrically treated for 14 days. Myocardial infarct size; myocardial pathology; platelet aggregation rate, CD62p activation, concentrations of thromboxane B-2 (TXB2), 6-keto-PGF1 alpha, tissue plasminogen activator (t-PA), and plasminogen activator inhibitor (PAI), the TXB2/6-keto-PGF1 alpha ratio were measured. The ultrastructure of the gastric mucosa was observed by scanning electron microscopy. The expression of PGE(2) and 6-keto-PGF1 alpha in gastric mucosa was measured by radio immunoassay, and levels of COX-1, COX-2, and VEGF in gastric mucosa were assessed using immunohistochemistry. Results The addition of Panax quinquefolius saponins (PQS+DAPT) to standard DAPT therapy significantly decreased the myocardial infarct area, degree of myocardial lesions, TXB2 and PAI levels, and the TXB2/6-keto-PGF1 alpha ratio, while increasing 6-keto-PGF1 alpha and t-PA levels and reducing the degree of gastric mucosal injury. Expression of PGE(2), 6-keto-PGF1 alpha, COX-2, and VEGF in the gastric mucosa was upregulated in the PQS+DAPT group compared with the standard DAPT group. Conclusion PQS increases the degree of DAPT inhibition of myocardial necrosis and antiplatelet effects in AMI rats, as well as reducing damage to the gastric mucosa caused by DAPT. The mechanism may be related to inhibition of TXB2 and PAI activity and elevation of 6-keto-PGF1 alpha and t-PA levels in blood, and may be associated with upregulated expression of COX-2, PGE(2), PGI(2), and VEGF in gastric tissue.	[Kou, Na; Xue, Mei; Yang, Lin; Zang, Ming-Xuan; Qu, Hua; Wang, Ming-Ming; Miao, Yu; Yang, Bin; Shi, Da-Zhuo] Xiyuan Hosp, China Acad Chinese Med Sci, Ctr Cardiol, Lab Cardiol, Beijing, Peoples R China; [Kou, Na; Qu, Hua; Shi, Da-Zhuo] Beijing Univ Chinese Med, Xiyuan Hosp, Clin Coll, Grad Sch, Beijing, Peoples R China	China Academy of Chinese Medical Sciences; Xiyuan Hospital, CACMS; Beijing University of Chinese Medicine; Xiyuan Hospital, CACMS	Shi, DZ (corresponding author), Xiyuan Hosp, China Acad Chinese Med Sci, Ctr Cardiol, Lab Cardiol, Beijing, Peoples R China.; Shi, DZ (corresponding author), Beijing Univ Chinese Med, Xiyuan Hosp, Clin Coll, Grad Sch, Beijing, Peoples R China.	shidazhuo_11@163.com	Qu, Hua/AAN-9145-2021		National Natural Science Foundation of China [81273933, 81102722]; International Science and Technology Cooperation Program of China [2014DFG32700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science and Technology Cooperation Program of China	This work was supported by the National Natural Science Foundation of China (81273933 and 81102722), and International Science and Technology Cooperation Program of China (2014DFG32700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bhatt DL, 2008, J AM COLL CARDIOL, V52, P1502, DOI 10.1016/j.jacc.2008.08.002; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Cattaneo M, 2011, HEMATOL-AM SOC HEMAT, P70, DOI 10.1182/asheducation-2011.1.70; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Gladding P, 2008, AM HEART J, V155, P591, DOI 10.1016/j.ahj.2007.12.034; Gundamaraju R, 2014, PHARMACOGN MAG, V10, P557, DOI 10.4103/0973-1296.139782; Guo M, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1531-x; JOHNS TNP, 1954, ANN SURG, V140, P675, DOI 10.1097/00000658-195411000-00006; Kakeji Y, 2002, J EXP CLIN CANC RES, V21, P125; Lan Y, 2012, WORLD CHINESE J DIGE; Liu M, 2013, SHOCK, V40, P339, DOI 10.1097/SHK.0b013e3182a3f9e5; [刘蜜 Liu Mi], 2013, [中国病理生理杂志, Chinese Journal of Pathophysiology], V29, P796; Luo JC, 2016, J FORMOS MED ASSOC, V115, P764, DOI 10.1016/j.jfma.2015.07.022; Michelson AD, 2011, HEMATOL-AM SOC HEMAT, P62, DOI 10.1182/asheducation-2011.1.62; Mitchell JA, 2006, NAT REV DRUG DISCOV, V5, P75, DOI 10.1038/nrd1929; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; Patrono C, 2015, J AM COLL CARDIOL, V66, P74, DOI 10.1016/j.jacc.2015.05.012; Ruschitzka FT, 1997, CARDIOLOGY, V88, P3, DOI 10.1159/000177500; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Takeuchi K, 2012, WORLD J GASTROENTERO, V18, P2147, DOI 10.3748/wjg.v18.i18.2147; Wallace JL, 2000, GASTROENTEROLOGY, V119, P706, DOI 10.1053/gast.2000.16510; Wang BJ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/932751; Wooten JG, 2008, AM J VET RES, V69, P457, DOI 10.2460/ajvr.69.4.457; Yang Lin, 2010, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V41, P1942; Yu CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099368; [张庆翔 Zhang Qingxiang], 2014, [科学通报, Chinese Science Bulletin], V59, P1133	26	7	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194082	10.1371/journal.pone.0194082	http://dx.doi.org/10.1371/journal.pone.0194082			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584740	gold, Green Submitted, Green Published			2022-12-26	WOS:000428373000013
J	Wang, LY; Xing, HX; Yuan, YC; Wang, XL; Saeed, M; Tao, JC; Feng, W; Zhang, GH; Song, XL; Sun, XZ				Wang, Liyuan; Xing, Huixian; Yuan, Yanchao; Wang, Xianlin; Saeed, Muhammad; Tao, Jincai; Feng, Wei; Zhang, Guihua; Song, Xianliang; Sun, Xuezhen			Genome-wide analysis of codon usage bias in four sequenced cotton species	PLOS ONE			English	Article							GOSSYPIUM-HIRSUTUM; CHLOROPLAST GENOME; PROVIDES INSIGHTS; BASE COMPOSITION; AMINO-ACID; GENE; EVOLUTION; PATTERN; SELECTION; RNA	Codon usage bias (CUB) is an important evolutionary feature in a genome which provides important information for studying organism evolution, gene function and exogenous gene expression. The CUB and its shaping factors in the nuclear genomes of four sequenced cotton species, G. arboreum (A(2)), G. raimondii (D-5), G. hirsutum (AD(1)) and G. barbadense (AD(2)) were analyzed in the present study. The effective number of codons (ENC) analysis showed the CUB was weak in these four species and the four subgenomes of the two tetraploids. Codon composition analysis revealed these four species preferred to use pyrimidinerich codons more frequently than purine-rich codons. Correlation analysis indicated that the base content at the third position of codons affect the degree of codon preference. PR2-bias plot and ENC-plot analyses revealed that the CUB patterns in these genomes and subgenomes were influenced by combined effects of translational selection, directional mutation and other factors. The translational selection (P2) analysis results, together with the non-significant correlation between GC12 and GC3, further revealed that translational selection played the dominant role over mutation pressure in the codon usage bias. Through relative synonymous codon usage (RSCU) analysis, we detected 25 high frequency codons preferred to end with T or A, and 31 low frequency codons inclined to end with C or G in these four species and four subgenomes. Finally, 19 to 26 optimal codons with 19 common ones were determined for each species and subgenomes, which preferred to end with A or T. We concluded that the codon usage bias was weak and the translation selection was the main shaping factor in nuclear genes of these four cotton genomes and four subgenomes.	[Wang, Liyuan; Xing, Huixian; Yuan, Yanchao; Wang, Xianlin; Tao, Jincai; Feng, Wei; Song, Xianliang; Sun, Xuezhen] Shandong Agr Univ, Agron Coll, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Saeed, Muhammad] Govt Coll Univ, Dept Bot, Faisalabad, Pakistan; [Zhang, Guihua] Heze Acad Agr Sci, Heze, Peoples R China	Shandong Agricultural University; Government College University Faisalabad	Song, XL; Sun, XZ (corresponding author), Shandong Agr Univ, Agron Coll, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	songx1999@163.com; sunxz@sdau.edu.cn	Saeed, Muhammad/O-3675-2019; Saeed, Muhammad/A-8562-2015; zhang, guihua/GVU-4494-2022	Saeed, Muhammad/0000-0002-7125-7394; Saeed, Muhammad/0000-0002-7125-7394; Wang, Liyuan/0000-0003-2975-4423	Major Projects for Transgenic Breeding of China [2017ZX08005-004-006]; System of Modern Agriculture Industrial Technology [SDAIT-03-03/05]; Natural Science foundation [ZR2017MC057]	Major Projects for Transgenic Breeding of China; System of Modern Agriculture Industrial Technology; Natural Science foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the Major Projects for Transgenic Breeding of China (2017ZX08005-004-006); The System of Modern Agriculture Industrial Technology (SDAIT-03-03/05) and the Natural Science foundation (ZR2017MC057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Baeza M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1493-5; Behura SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043111; Chakraborty S, 2017, GENE, V604, P48, DOI 10.1016/j.gene.2016.11.023; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Cong J, 2015, SCI REP-UK, V5, DOI [10.1038/srep10007, 10.1038/srep14139]; Das S, 2006, VIRUS RES, V117, P227, DOI 10.1016/j.virusres.2005.10.007; Deb S, 2015, COMPUTATIONAL MOL BI; Dohra H, 2015, FEBS LETT, V589, P3113, DOI 10.1016/j.febslet.2015.08.033; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; Endrizzi J. E., 1985, Advances in Genetics, V23, P271, DOI 10.1016/S0065-2660(08)60515-5; GALAU GA, 1989, THEOR APPL GENET, V78, P23, DOI 10.1007/BF00299748; Gallagher JP, 2017, SYST BOT, V42, P115, DOI 10.1600/036364417X694593; Gatherer D, 1997, BIOCHEM MOL BIOL INT, V43, P107; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; GROSJEAN H, 1978, J MOL EVOL, V12, P113, DOI 10.1007/BF01733262; Grover CE, 2012, PLANT SYST EVOL, V298, P1177, DOI 10.1007/s00606-012-0615-7; Gu WJ, 2004, VIRUS RES, V101, P155, DOI 10.1016/j.virusres.2004.01.006; Guo H, 2014, GENETICS, V197, P1153, DOI 10.1534/genetics.114.166124; Han ZG, 2006, THEOR APPL GENET, V112, P430, DOI 10.1007/s00122-005-0142-9; Hiraoka Y, 2009, GENES CELLS, V14, P499, DOI 10.1111/j.1365-2443.2009.01284.x; Huang Y, 2009, NUCLEIC ACIDS RES, V37, P6799, DOI 10.1093/nar/gkp712; Hussain S, 2017, ACTA TROP, V173, P136, DOI 10.1016/j.actatropica.2017.06.006; Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X; Jiang Y, 2008, ARCH VIROL, V153, P2273, DOI 10.1007/s00705-008-0260-1; Kattoor JJ, 2015, INFECT GENET EVOL, V34, P17, DOI 10.1016/j.meegid.2015.06.018; Krapovickas A., 2008, BONPLANDIA, V17, P55, DOI [10.30972/bon.1711361, DOI 10.30972/BON.1711361]; Lee SB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-61; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li N, 2016, J INTEGR AGR, V15, P983, DOI 10.1016/S2095-3119(16)61333-3; Liu GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072790; Liu H, 2012, GENET MOL RES, V11, P4695, DOI 10.4238/2012.October.17.3; Liu HM, 2010, MOL BIOL REP, V37, P677, DOI 10.1007/s11033-009-9521-7; Liu QP, 2005, J GENET, V84, P55, DOI 10.1007/BF02715890; Liu XS, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-68; Ma YP, 2014, ARCH VIROL, V159, P1841, DOI 10.1007/s00705-014-2000-z; Marais G, 2003, GENET RES, V81, P79, DOI 10.1017/S0016672302006079; McEwan NR, 1999, CAN J BOT, V77, P1287, DOI 10.1139/cjb-77-9-1287; 孙铮, 2009, [中国科学. C辑, 生命科学, Science in China. Series C, Life Sciences], V39, P948; Novembre JA, 2002, MOL BIOL EVOL, V19, P1390, DOI 10.1093/oxfordjournals.molbev.a004201; Olejniczak M, 2006, BIOCHIMIE, V88, P943, DOI 10.1016/j.biochi.2006.06.005; Pandit A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028889; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Prabha R, 2017, MAR GENOM, V32, P31, DOI 10.1016/j.margen.2016.10.001; Qiu S, 2011, GENOME BIOL EVOL, V3, P868, DOI 10.1093/gbe/evr085; Salim HMW, 2008, J BRAZIL CHEM SOC, V19, P257, DOI 10.1590/S0103-50532008000200008; Shang MingZhao, 2011, Scientia Agricultura Sinica, V44, P245; SHARP PM, 1987, MOL BIOL EVOL, V4, P222; Subramanian S, 2008, GENETICS, V178, P2429, DOI 10.1534/genetics.107.086405; Sueoka N, 2001, J MOL EVOL, V53, P469, DOI 10.1007/s002390010237; SUEOKA N, 1995, J MOL EVOL, V40, P318, DOI 10.1007/BF00163236; Suzuki H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154306; Tao T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075323; Valencia A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151001; Vicario S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-226; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang M, 2011, VIRUS GENES, V42, P245, DOI 10.1007/s11262-011-0574-z; Wang SF, 2016, J MICROBIOL IMMUNOL, V49, P477, DOI 10.1016/j.jmii.2014.08.011; Wei S, 2016, PLOS ONE, V11; WENDEL JF, 1992, SYST BOT, V17, P115, DOI 10.2307/2419069; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; Wendel JF, 2009, GENETICS GENOMICS CO, V3; Wendel JF, 2010, PHYSIOLOGY OF COTTON, P1, DOI 10.1007/978-90-481-3195-2_1; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Wu Xian-Ming, 2007, Yichuan, V29, P420, DOI 10.1360/yc-007-0420; Wu YX, 2013, CARYOLOGIA, V66, P368, DOI 10.1080/00087114.2013.857830; Yuan DJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17662; Zalucki YM, 2007, NUCLEIC ACIDS RES, V35, P5748, DOI 10.1093/nar/gkm577; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhao YC, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3021-7	72	64	80	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194372	10.1371/journal.pone.0194372	http://dx.doi.org/10.1371/journal.pone.0194372			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584741	Green Submitted, Green Published, gold			2022-12-26	WOS:000428373000021
J	Jubinville, E; Veillette, M; Milot, J; Maltais, F; Comeau, AM; Levesque, RC; Duchaine, C				Jubinville, Eric; Veillette, Marc; Milot, Julie; Maltais, Francois; Comeau, Andre M.; Levesque, Roger C.; Duchaine, Caroline			Exacerbation induces a microbiota shift in sputa of COPD patients	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; RESPIRATORY VIRUSES; INFECTION; BACTERIA; DIAGNOSIS	Little is known about the microbiota shift induced by exacerbation in chronic obstructive pulmonary disease (COPD) patients. The sputa microbiota of COPD patients was evaluated when clinically stable and during acute exacerbations of the disease. Sputa microbiota was analyzed using 16S ribosomal RNA gene pyrosequencing and quantitative polymerase chain reaction-based pathogen detection. Nine COPD patients were enrolled. Pyrosequencing of 16S rRNA genes identified 2,267 unique bacterial operational taxonomic units. Principal microbiota shifts during exacerbation were in either Proteobacteria, Firmicutes or Bacteroidetes. Streptococcus and Moraxella levels were detected during exacerbation in severe (Global Initiative for Chronic Obstructive Lung Disease 3) COPD patients. Most of the clinically-important genera found in the sputum with the pyrosequencing of 16S rRNA gene correlated with specific quantitative polymerase chain reactions for bacteria while respiratory viruses were nearly absent. Sputum microbiotas of exacerbated COPD patients are complex. This pilot study shows a clear shift in the microbiota of patients during exacerbation. The nature of this shift varies from patient to patient in such a way that the treatment should be patient-specific. Further studies are needed to establish the impact of microbial exacerbations on the pulmonary microbiota.	[Jubinville, Eric; Veillette, Marc; Milot, Julie; Maltais, Francois; Duchaine, Caroline] CRIUCPQ, Quebec City, PQ, Canada; [Jubinville, Eric; Duchaine, Caroline] Univ Laval, Fac Sci & Genie, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada; [Milot, Julie; Maltais, Francois] Univ Laval, Fac Med, Dept Med, Quebec City, PQ, Canada; [Comeau, Andre M.] Dalhousie Univ, CGEB IMR, Halifax, NS, Canada; [Levesque, Roger C.] Univ Laval, IBIS, Quebec City, PQ, Canada	Laval University; Laval University; Dalhousie University; Laval University	Duchaine, C (corresponding author), CRIUCPQ, Quebec City, PQ, Canada.; Duchaine, C (corresponding author), Univ Laval, Fac Sci & Genie, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada.	caroline.duchaine@bcm.ulaval.ca	Levesque, Roger C./ABD-8407-2021; Maltais, François/AAU-3415-2020	Duchaine, Caroline/0000-0002-9912-0349; Levesque, Roger/0000-0001-8315-5937	Natural Sciences and Engineering Research Council of Canada (CA) - Discovery Grant [5900]; Fondation de l'IUCPQ en parteneriat avec la chaire de pneumologie de la fondation J-D Begin de l'Universite Laval; Boehringer Ingelheim; GlaxoSmithKline; AstraZeneca; Grifols; Novartis	Natural Sciences and Engineering Research Council of Canada (CA) - Discovery Grant; Fondation de l'IUCPQ en parteneriat avec la chaire de pneumologie de la fondation J-D Begin de l'Universite Laval; Boehringer Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); AstraZeneca(AstraZeneca); Grifols; Novartis(Novartis)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (CA) - Discovery Grant (Grant no. 5900) to CD (http://www.nserc-crsng.gc.pa/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp) and the Fondation de l'IUCPQ en parteneriat avec la chaire de pneumologie de la fondation J-D Begin de l'Universite Laval. FM reports research support from Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Grifols and Novartis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Bach HJ, 2002, J MICROBIOL METH, V49, P235, DOI 10.1016/S0167-7012(01)00370-0; Bafadhel M, 2015, INT J CHRONIC OBSTR, V10, P1075, DOI 10.2147/COPD.S80091; Brook I, 2003, CHEST, V124, P832, DOI 10.1378/chest.124.3.832; Cabrera-Rubio R, 2012, J CLIN MICROBIOL, V50, P3562, DOI 10.1128/JCM.00767-12; Cameron RJ, 2006, INTENS CARE MED, V32, P1022, DOI 10.1007/s00134-006-0202-x; Comeau AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027492; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Engler K, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13509; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Garcha DS, 2012, THORAX; Global Initiative for Chronic Obstructive Lung Disease, 2006, GLOB STRAT DIAGN MAN; Global Initiative for Chronic Obstructive Lung Disease, 2011, GLOBAL STRATEGY DIAG; Groenewegen KH, 2003, RESP MED, V97, P770, DOI 10.1016/S0954-6111(03)00026-X; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2014, J CLIN MICROBIOLOGY; Huang YJ, 2010, OMICS, V14, P9, DOI 10.1089/omi.2009.0100; Hutchinson AF, 2007, RESP MED, V101, P2472, DOI 10.1016/j.rmed.2007.07.015; Kherad O, 2010, CHEST, V138, P896, DOI 10.1378/chest.09-2225; Ko FWS, 2005, INTERN MED J, V35, P661, DOI 10.1111/j.1445-5994.2005.00956.x; Lieberman D, 2002, EUR RESPIR J, V19, P392, DOI 10.1183/09031936.02.00256702; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Martinez Fernando J, 2013, Ann Am Thorac Soc, V10 Suppl, pS170, DOI 10.1513/AnnalsATS.201306-204AW; McManus TE, 2008, EUR RESPIR J, V31, P1221, DOI 10.1183/09031936.00107507; McManus TE, 2007, RESP MED, V101, P2084, DOI 10.1016/j.rmed.2007.05.015; Miravitlles M, 1999, CHEST, V116, P40, DOI 10.1378/chest.116.1.40; Monso E, 2003, EPIDEMIOL INFECT, V131, P799, DOI 10.1017/S0950268803008872; Nguyen NP, 2016, NPJ BIOFILMS MICROBI, V2, DOI 10.1038/npjbiofilms.2016.4; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Quint JK, 2010, CHEST, V137, P812, DOI 10.1378/chest.09-1541; Rodriguez-Roisin R, 2000, CHEST, V117, p398S, DOI 10.1378/chest.117.5_suppl_2.398S; Rohde G, 2003, THORAX, V58, P37, DOI 10.1136/thorax.58.1.37; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Sethi S, 2011, CLIN INFECT DIS, V52, pS290, DOI 10.1093/cid/cir044; Sykes Annemarie, 2007, Proc Am Thorac Soc, V4, P642, DOI 10.1513/pats.200707-101TH; Sze MA, 2014, INT J CHRONIC OBSTR, V9, P229, DOI 10.2147/COPD.S38932; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; Utokaparch S, 2011, PEDIATR INFECT DIS J, V30, pE18, DOI 10.1097/INF.0b013e3181ff2fac; Veeramachaneni Sateesh B, 2006, COPD, V3, P109; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330; Zhao JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033127	44	25	26	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194355	10.1371/journal.pone.0194355	http://dx.doi.org/10.1371/journal.pone.0194355			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579057	Green Submitted, gold, Green Published			2022-12-26	WOS:000428351800026
J	Shafie, M; Eyasu, M; Muzeyin, K; Worku, Y; Martin-Aragon, S				Shafie, Mensur; Eyasu, Mebrahtu; Muzeyin, Kedija; Worku, Yoseph; Martin-Aragon, Sagrario			Prevalence and determinants of self-medication practice among selected households in Addis Ababa community	PLOS ONE			English	Article							UNIVERSITY; STUDENTS	Background and aim Self-medication (SM) is one part of self-care which is known to contribute to primary health care. If practiced appropriately, it has major benefits for the consumers such as self-reliance and decreased expense. However, inappropriate practice can have potential dangers such as incorrect self-diagnosis, dangerous drug-drug interactions, incorrect manner of administration, incorrect dosage, incorrect choice of therapy, masking of a severe disease, and/or risk of dependence and abuse. The main objective of this study was to assess the prevalence and determinants of the self-medication practice (SMP) in Addis Ababa. Methodology A community based cross-sectional study was conducted among selected households in Addis Ababa from April 2016 to May 2016, with a recall period of two months before its conduction. Trained data collectors were employed to collect the data from the 604 sampled participants using pre-tested and validated questionnaires. Result Among the 604 participants involved in this study, 422 (69.9%) were female and 182 (30.1%) were male and there was a mean age of 41.04 ( 13.45) years. The prevalence of SM in this study was 75.5%. The three most frequently reported ailments were headache 117 (25.7%), abdominal pain 59 (12.9%) and cough 54 (11.8%). The two main reasons for SM were mildness of illness 216 (47.4%) and previous knowledge about the drug 106 (23.2%). The two most frequently consumed medications were paracetamol 92 (20.2%) and traditional remedies 73 (16.0%), while drug retail outlets 319 (83.3%) were the main source of drugs. The two most frequently reported source of drug information were health professionals 174 (45.4%) and experience from previous treatment 82 (21.4%). Moreover, there were statistically significant differences among respondents who reported practicing SM based on income and knowledge about appropriate SMP. Conclusion and recommendation Self-medication was practiced with a range of drugs from the conventional paracetamol and NSAIDs to antimicrobials. Being that the practice of SM is inevitable, health authorities and professionals are highly demanded to educate the public not only on the advantages and disadvantages of SM but on its proper use.	[Shafie, Mensur; Eyasu, Mebrahtu] St Pauls Hosp Millennium Med Coll, Dept Pharmacol, Addis Ababa, Ethiopia; [Muzeyin, Kedija] St Pauls Hosp Millennium Med Coll, Dept Nursing, Addis Ababa, Ethiopia; [Worku, Yoseph] St Pauls Hosp Millennium Med Coll, Dept Publ Hlth, Addis Ababa, Ethiopia; [Martin-Aragon, Sagrario] Univ Complutense Madrid, Sch Pharm, Dept Pharmacol, Madrid, Spain	Complutense University of Madrid	Shafie, M; Eyasu, M (corresponding author), St Pauls Hosp Millennium Med Coll, Dept Pharmacol, Addis Ababa, Ethiopia.	mensur2007@gmail.com; wedidellameb@gmail.com	Martín-Aragón, Sagrario/K-2052-2014; Worku, Yoseph/AAX-3398-2021	Martín-Aragón, Sagrario/0000-0003-1612-2726; Worku, Yoseph/0000-0002-6885-0437	Saint Paul's Hospital Millennium Medical College; Democratic Republic of Ethiopia	Saint Paul's Hospital Millennium Medical College; Democratic Republic of Ethiopia	This work was supported by Saint Paul's Hospital Millennium Medical College, Research Directorate Director, and Democratic Republic of Ethiopia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abay SM, 2010, J YOUNG PHARM, V2, P306, DOI 10.4103/0975-1483.66798; Abrha S, 2014, IJPSR, V5, P670; ADDIS ABABA CITY ADMINISTRATION, 2016, ADD AB HLTH BUR FACT; Ali A.N., 2012, INT CURR PHARM J, V1, P302, DOI DOI 10.3329/ICPJ.V1I10.11846; Andualem T., 2004, ETHIOP J HEALTH SCI, V14, P1; Awad A, 2005, J PHARM PHARM SCI, V8, P326; Belachew G., 2011, J APPL PHARM SCI, V1, P183; da Silva MGC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-339; Eticha T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097464; GORE PR, 1994, J CLIN PHARM THER, V19, P17, DOI 10.1111/j.1365-2710.1994.tb00803.x; Gupta P., 2011, ASIAN J PHARM CLIN R, V4, P54; Home W, 2000, WHO DRUG INF, P14; Hussain S, 2011, AFR J PHARM PHARMACO, V5, P972; Jaleta A, 2016, CUKUROVA MED J, V41, P447, DOI 10.17826/cukmedj.237467; Jalilian F, 2013, J RES HEALTH SCI, V13, P81; James H, 2006, MED PRIN PRACT, V15, P270, DOI 10.1159/000092989; Mishra Divya, 2016, International Journal of Medicine and Public Health, V6, P126, DOI 10.5530/ijmedph.2016.3.6; Mossa D. A., 2012, Turk Silahli Kuvvetleri,  Koruyucu Hekimlik Bulteni, V11, P529; Pagan J.A., 2006, HLTH POLICY, V75, P170, DOI [10. 1016/j. healthpol. 2005. 03. 007 16338480, DOI 10.1016/J.HEALTHP0L.2005.03.007]; Sado E., 2014, OPEN ACCESS LIB J, V1, P1, DOI [10.4236/oalib.1100651, DOI 10.4236/OALIB.1100651]; Shankar P R, 2002, BMC Fam Pract, V3, P17, DOI 10.1186/1471-2296-3-17; Skliros E, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-58; Solomon Worku, 2003, Ethiopian Journal of Health Development, V17, P111; Suleman S, 2009, RES SOC ADMIN PHARM, V5, P76, DOI 10.1016/j.sapharm.2008.04.002; United Nations, 2008, MILL DEV GOALS IND; Verma RK, 2010, ASIAN J PHARM CLIN R, V3, P60; Wijesinghe Pushpa R, 2012, WHO South East Asia J Public Health, V1, P28, DOI 10.4103/2224-3151.206911; World Health Organization (WHO), 2020, ROL PHARM SELFC SELF; World Self-medication Industry (WSMI), 2010, STOR SELF CAR SELF	29	34	35	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194122	10.1371/journal.pone.0194122	http://dx.doi.org/10.1371/journal.pone.0194122			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579074	Green Submitted, Green Published, gold			2022-12-26	WOS:000428351800020
J	Zhang, JY; Pan, DL; Jia, ZH; Wang, T; Wang, G; Guo, ZR				Zhang, Ji-Yu; Pan, De-Lin; Jia, Zhan-Hui; Wang, Tao; Wang, Gang; Guo, Zhong-Ren			Chlorophyll, carotenoid and vitamin C metabolism regulation in Actinidia chinensis 'Hongyang' outer pericarp during fruit development	PLOS ONE			English	Article							L-GALACTOSE GUANYLTRANSFERASE; HARVESTING-COMPLEX-II; GENE-EXPRESSION; FUNCTIONAL-CHARACTERIZATION; CLEAVAGE DIOXYGENASE; OVER-EXPRESSION; BIOSYNTHESIS; DEGRADATION; KIWIFRUIT; YELLOW	Ascorbic acid (AsA), chlorophyll and carotenoid contents and their associated gene expression patterns were analysed in Actinidia chinensis 'Hongyang' outer pericarp. The results showed chlorophyll degradation during fruit development and softening, exposed the yellow carotenoid pigments. LHCB1 and CLS1 gene expressions were decreased, while PPH2 and PPH3 gene expressions were increased, indicating that downregulation of chlorophyll biosynthesis and upregulation of its degradation, caused chlorophyll degradation. A decrease in the expression of the late carotenoid biosynthesis and maintenance genes (LCYB1, LCYE1, CYP1, CYP2, ZEP1, VDE1, VDE2, and NCED2) and degradation gene (CCD1), showed biosynthesis and degradation of carotenoid could be regulatory factors involved in fruit development. Most genes expression data of L-galactose and recycling pathway were agreement with the AsA concentrations in the fruit, suggesting these are the predominant pathways of AsA biosynthesis. GMP1, GME1 and GGP1 were identified as the key genes controlling AsA biosynthesis in 'Hongyang' outer pericarp.	[Zhang, Ji-Yu; Pan, De-Lin; Jia, Zhan-Hui; Wang, Tao; Wang, Gang; Guo, Zhong-Ren] Jiangsu Prov & Chinese Acad Sci, Inst Bot, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS	Zhang, JY; Guo, ZR (corresponding author), Jiangsu Prov & Chinese Acad Sci, Inst Bot, Beijing, Peoples R China.	maxzhangjy@163.com; zhongrenguo@cnbg.net		Zhang, Ji-Yu/0000-0002-4075-5008	National Natural Science Foundation of China (NSFC) [31401854]; Natural Science Foundation of Jiangsu Province [BK20140760]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This study was supported by grants from the National Natural Science Foundation of China (NSFC) (31401854) and the Natural Science Foundation of Jiangsu Province (grant no. BK20140760). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahveninen J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3585; Alquezar B, 2008, PHYTOCHEMISTRY, V69, P1997, DOI 10.1016/j.phytochem.2008.04.020; Ampomah-Dwamena C, 2009, J EXP BOT, V60, P3765, DOI 10.1093/jxb/erp218; Annpomah-Dwamena C, 2012, J EXP BOT, V63, P4497, DOI 10.1093/jxb/ers134; Barry CS, 2009, PLANT SCI, V176, P325, DOI 10.1016/j.plantsci.2008.12.013; Beekwilder J, 2008, BIOFACTORS, V34, P57; Brandi F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-24; Bulley S, 2012, PLANT BIOTECHNOL J, V10, P390, DOI 10.1111/j.1467-7652.2011.00668.x; Bulley SM, 2009, J EXP BOT, V60, P765, DOI 10.1093/jxb/ern327; Bulley SM, 2016, COMPEND PL GENOME, P163, DOI 10.1007/978-3-319-32274-2_13; Devitt LC, 2010, J EXP BOT, V61, P33, DOI 10.1093/jxb/erp284; Eckhardt U, 2004, PLANT MOL BIOL, V56, P1, DOI 10.1007/s11103-004-2331-3; Falchi R, 2013, PLANT J, V76, P175, DOI 10.1111/tpj.12283; Ferguson AR, 2003, ACTA HORTIC, P131, DOI 10.17660/ActaHortic.2003.610.16; Garcia-Limones C, 2008, J AGR FOOD CHEM, V56, P9277, DOI 10.1021/jf801096t; Henare SJ, 2016, NUTRITIONAL COMPOSITION OF FRUIT CULTIVARS, P337, DOI 10.1016/B978-0-12-408117-8.00015-5; Huang HW, 2016, KIWIFRUIT: THE GENUS ACTINIDIA, P239, DOI 10.1016/B978-0-12-803066-0.00006-X; Jiang ZY, 2018, PLANT PHYSIOL BIOCH, V124, P20, DOI 10.1016/j.plaphy.2018.01.005; Jing GX, 2015, POSTHARVEST BIOL TEC, V109, P114, DOI 10.1016/j.postharvbio.2015.06.006; Karppinen K, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0785-5; Kita M, 2007, J AGR FOOD CHEM, V55, P3414, DOI 10.1021/jf063552v; Krupa T, 2011, SCI HORTIC-AMSTERDAM, V130, P410, DOI 10.1016/j.scienta.2011.06.044; Kusaba M, 2007, PLANT CELL, V19, P1362, DOI 10.1105/tpc.106.042911; Laing WA, 2007, P NATL ACAD SCI USA, V104, P9534, DOI 10.1073/pnas.0701625104; Li HS, 2000, PLANT PHYSL BIOCH EX; Li J, 2014, SCI HORTIC-AMSTERDAM, V169, P206, DOI 10.1016/j.scienta.2014.02.024; Li J, 2013, PLANTA, V238, P535, DOI 10.1007/s00425-013-1915-z; Li J, 2013, MOL BIOL REP, V40, P1473, DOI 10.1007/s11033-012-2190-y; Li MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012183; Liu LH, 2015, MOL PLANT, V8, P28, DOI 10.1016/j.molp.2014.11.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv P, 2015, FOOD CHEM, V174, P52, DOI 10.1016/j.foodchem.2014.11.022; McGhie TK, 2002, J AGR FOOD CHEM, V50, P117, DOI 10.1021/jf010677l; Montefiori M, 2009, SCI HORTIC-AMSTERDAM, V119, P377, DOI 10.1016/j.scienta.2008.08.022; Montefiori M, 2016, COMPEND PL GENOME, P149, DOI 10.1007/978-3-319-32274-2_12; Ohmiya A, 2013, ACS SYM SER, V1134, P21; Pilkington SM, 2012, PLANTA, V236, P1615, DOI 10.1007/s00425-012-1723-x; Schelbert S, 2009, PLANT CELL, V21, P767, DOI 10.1105/tpc.108.064089; Sha SF, 2011, AFR J AGR RES, V6, P3560; Tong ZG, 2012, MOL BIOTECHNOL, V50, P229, DOI 10.1007/s12033-011-9433-3; Wolucka BA, 2007, PHYTOCHEMISTRY, V68, P2602, DOI 10.1016/j.phytochem.2007.08.034; Yin XR, 2012, POSTHARVEST BIOL TEC, V66, P1, DOI 10.1016/j.postharvbio.2011.11.009; Young PR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-243; Zelisko A, 2005, P NATL ACAD SCI USA, V102, P13699, DOI 10.1073/pnas.0503472102; Zhang B, 2015, NEW PHYTOL, V206, P1513, DOI 10.1111/nph.13335; Zhang JY, 2012, PLANT BIOLOGY, V14, P46, DOI 10.1111/j.1438-8677.2011.00483.x	46	13	13	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194835	10.1371/journal.pone.0194835	http://dx.doi.org/10.1371/journal.pone.0194835			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579114	Green Published, Green Submitted, gold			2022-12-26	WOS:000428351800060
J	Lee, CY; Lin, HJ; Viswanath, KK; Lin, CP; Chang, BCH; Chiu, PH; Chiu, CT; Wang, RH; Chin, SW; Chen, FC				Lee, Chen-Yu; Lin, Hui-Jun; Viswanath, Kotapati Kasi; Lin, Chih-Peng; Chang, Bill Chia-Han; Chiu, Pei-Hsun; Chiu, Chan-Tai; Wang, Ren-Huang; Chin, Shih-Wen; Chen, Fure-Chyi			The development of functional mapping by three sex-related loci on the third whorl of different sex types of Carica papaya L.	PLOS ONE			English	Article							RESOLUTION MELTING ANALYSIS; PRIMITIVE Y-CHROMOSOME; LEUCINE-RICH REPEAT; ARABIDOPSIS-THALIANA; DOSAGE COMPENSATION; KINASE 1; RECEPTOR; SEQUENCE; GENE; PROTEINS	Carica papaya L. is an important economic crop worldwide and is used as a model plant for sex-determination research. To study the different flower sex types, we screened sex related genes using alternative splicing sequences (AS-seqs) from a transcriptome database of the three flower sex types, i.e., males, females, and hermaphrodites, established at 28 days before flowering using 15 bacterial artificial chromosomes (BACs) of C. papaya L. After screening, the cDNA regions of the three sex-related loci, including short vegetative phase-like (CpSVPL), the chromatin assembly factor 1 subunit A-like (CpCAF1AL), and the somatic embryogenesis receptor kinase (CpSERK), which contained eight sex-related single-nucleotide polymorphisms (SNPs) from the different sex types of C. papaya L., were genotyped using high-resolution melting (HRM). The three loci were examined regarding the profiles of the third whorl, as described below. CpSVPL, which had one SNP associated with the three sex genotypes, was highly expressed in the male and female sterile flowers (abnormal hermaphrodite flowers) that lacked the fourth whorl structure. CpCAF1AL, which had three SNPs associated with the male genotype, was highly expressed in male and normal hermaphrodite flowers, and had no AS-seqs, whereas it exhibited low expression and an AS-seqs in intron 11 in abnormal hermaphrodite flowers. Conversely, carpellate flowers (abnormal hermaphrodite flowers) showed low expression of CpSVPL and AS-seqs in introns 5, 6, and 7 of CpSERK, which contained four SNPs associated with the female genotype. Specifically, the CpSERK and CpCAF1AL loci exhibited no AS-seq expression in the third whorl of the male and normal hermaphrodite flowers, respectively, and variance in the AS-seq expression of all other types of flowers. Functional mapping of the third whorl of normal hermaphrodites indicated no AS-seq expression in CpSERK, low CpSVPL expression, and, for CpCAF1AL, high expression and no AS-seq expression on XYh-type chromosomes.	[Lee, Chen-Yu; Lin, Hui-Jun; Viswanath, Kotapati Kasi; Chin, Shih-Wen; Chen, Fure-Chyi] Natl Pingtung Univ Sci & Technol, Dept Plant Ind, Pingtung, Taiwan; [Lin, Chih-Peng; Chang, Bill Chia-Han; Chiu, Pei-Hsun] Yourgene Biosci, New Taipei, Taiwan; [Chiu, Chan-Tai] Taiwan Seed Improvement & Propagat Stn, Pingtung Seed & Seedling Res Ctr, Pingtung, Taiwan; [Wang, Ren-Huang] Council Agr, Kaohsiung Dist Agr Res & Extens Stn, Pingtung, Taiwan	National Pingtung University Science & Technology	Lee, CY; Chen, FC (corresponding author), Natl Pingtung Univ Sci & Technol, Dept Plant Ind, Pingtung, Taiwan.	culee@mail.npust.edu.tw; fchen@mail.npust.edu.tw	Viswanath, Kotapati Kasi/AAV-5703-2021	Lee, Chen-Yu/0000-0003-2807-176X; Chang, Bill Chia-Han/0000-0001-5313-4852; K, Dr.K.Viswanath/0000-0002-2644-9389	Ministry of Science and Technology, Taiwan [105-2622-B-020-002-CC1]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grant number 105-2622-B-020-002-CC1 from Ministry of Science and Technology (https://www.most.gov.tw/), Taiwan (Chen-Yu Lee). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht C, 2005, PLANT CELL, V17, P3337, DOI 10.1105/tpc.105.036814; Albrecht C, 2008, PLANT PHYSIOL, V148, P611, DOI 10.1104/pp.108.123216; ARKLE TD, 1984, HORTSCIENCE, V19, P832; Aryal R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-20; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Baudino S, 2001, PLANTA, V213, P1, DOI 10.1007/s004250000471; Chen YH, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-96; Chen Z, 2008, DEVELOPMENT, V135, P65, DOI 10.1242/dev.010108; Colcombet J, 2005, PLANT CELL, V17, P3350, DOI 10.1105/tpc.105.036731; Croxford AE, 2008, NEW PHYTOL, V180, P594, DOI 10.1111/j.1469-8137.2008.02588.x; Dong H, 2001, GENE, V264, P187, DOI 10.1016/S0378-1119(01)00335-3; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Gady ALF, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-13; Gregis V, 2006, PLANT CELL, V18, P1373, DOI 10.1105/tpc.106.041798; Gschwend AR, 2012, P NATL ACAD SCI USA, V109, P13716, DOI 10.1073/pnas.1121096109; Han YH, 2012, MOL BREEDING, V29, P489, DOI 10.1007/s11032-011-9566-x; HANDEL MA, 1992, BIOESSAYS, V14, P817, DOI 10.1002/bies.950141205; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Hofmeyr J., 1938, GENETICAL STUDIES CA; Hull J, 2007, PLOS GENET, V3, P1009, DOI 10.1371/journal.pgen.0030099; Ichimura T, 2005, J BIOL CHEM, V280, P13928, DOI 10.1074/jbc.M413654200; Jaudal M, 2014, J EXP BOT, V65, P429, DOI 10.1093/jxb/ert384; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Kwon YJ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-136; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lemos B, 2010, P NATL ACAD SCI USA, V107, P15826, DOI 10.1073/pnas.1010383107; Liu ZY, 2004, NATURE, V427, P348, DOI 10.1038/nature02228; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Palusa SG, 2007, PLANT J, V49, P1091, DOI 10.1111/j.1365-313X.2006.03020.x; Penalva LOF, 2003, MICROBIOL MOL BIOL R, V67, P343, DOI 10.1128/MMBR.67.3.343-359.2003; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Schmidt EDL, 1997, DEVELOPMENT, V124, P2049; Shi YL, 2014, MOL BIOL REP, V41, P411, DOI 10.1007/s11033-013-2875-x; Simko I, 2016, TRENDS PLANT SCI, V21, P528, DOI 10.1016/j.tplants.2016.01.004; Song M, 2016, SCI REP-UK, V6, DOI 10.1038/srep34133; STOREY WB, 1953, J HERED, V44, P70, DOI 10.1093/oxfordjournals.jhered.a106358; Storey WB, 1938, P AM SOC HORT SCI; Ueno H, 2015, MOL GENET GENOMICS, V290, P661, DOI 10.1007/s00438-014-0955-9; Urasaki N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040904; VanBuren R, 2015, GENOME RES, V25, P524, DOI 10.1101/gr.183905.114; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019; Wang JP, 2012, P NATL ACAD SCI USA, V109, P13710, DOI 10.1073/pnas.1207833109; Wu RM, 2012, J EXP BOT, V63, P797, DOI 10.1093/jxb/err304; Yu QY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-371; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109; Zhang WL, 2008, GENOME RES, V18, P1938, DOI 10.1101/gr.078808.108; Zhou FL, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0744-1	48	9	10	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194605	10.1371/journal.pone.0194605	http://dx.doi.org/10.1371/journal.pone.0194605			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566053	Green Published, gold			2022-12-26	WOS:000428093900084
J	Marshall, J; Gollwitzer, A; Santos, LR				Marshall, Julia; Gollwitzer, Anton; Santos, Laurie R.			Does altercentric interference rely on mentalizing?: Results from two level-1 perspective-taking tasks	PLOS ONE			English	Article							VISUAL PERSPECTIVE; OTHERS BELIEFS; SOCIAL-PERCEPTION; AUTOMATIC THEORY; FALSE BELIEF; MIND; ADULTS; HUMANS; SEE; REPRESENTATION	Considerable debate has focused on whether adults possess an implicit system for representing others' mental states. Some argue that people automatically represent the perspective of others using evidence from altercentric interference-cases in which another agent's perspective affects the speed with which one can report one's own perspective. Others have argued that altercentric interference is not always specific to social stimuli and thus may represent a simpler process such as submentalizing. To distinguish between these positions, Study 1 developed a novel measure of altercentric interference-a "sandbox" measure that allowed us to more sensitively assess altercentric interference across social and non-social conditions. We replicated previous findings showing that participants experience both egocentric and altercentric interference, but we found that these effects emerge equally in social and non-social conditions. To further test whether altercentric interference emerges in social perspective-taking situations, Study 2 conducted a conceptual replication of a study which used a novel "goggle" paradigm to assess whether individuals implicitly represent others' perspectives. Although we failed to find evidence of altercentric interference in response times, participants' accuracy reflected the possibility of interference from others' perspectives. We argue that these findings provide support for the idea that altercentric interference in response to social stimuli (an avatar) is driven by perspective-taking mechanisms, while such interference in response to non-social stimuli (an arrow) is driven by attention-cuing mechanisms.	[Marshall, Julia; Gollwitzer, Anton; Santos, Laurie R.] Yale Univ, Psychol, New Haven, CT 06520 USA	Yale University	Marshall, J (corresponding author), Yale Univ, Psychol, New Haven, CT 06520 USA.	julia.marshall@yale.edu		Marshall, Julia/0000-0002-7981-0481	Templeton Foundation [GR006000]; Yale University	Templeton Foundation; Yale University	The research presented in the current manuscript was made possible by a grant provided to LSR from the Templeton Foundation (Grant #: GR006000; www.templeton.org) and from Yale University (a grant related to a course taught by LSR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apperly IA, 2009, PSYCHOL REV, V116, P953, DOI 10.1037/a0016923; Baker LJ, 2016, J EXP PSYCHOL HUMAN, V42, P508, DOI 10.1037/xhp0000164; Bernstein DM, 2011, EXP AGING RES, V37, P481, DOI 10.1080/0361073X.2011.619466; Birch SAJ, 2004, TRENDS COGN SCI, V8, P255, DOI 10.1016/j.tics.2004.04.011; Butterfill SA, 2013, MIND LANG, V28, P606, DOI 10.1111/mila.12036; Cantlon JF, 2006, PSYCHOL SCI, V17, P401, DOI 10.1111/j.1467-9280.2006.01719.x; Cole GG, 2016, ACTA PSYCHOL, V164, P165, DOI 10.1016/j.actpsy.2016.01.007; Conway JR, 2017, J EXP PSYCHOL HUMAN, V43, P454, DOI 10.1037/xhp0000319; Drayton LA, RACE AFFECTS V UNPUB; Freeman JB, 2016, TRENDS COGN SCI, V20, P362, DOI 10.1016/j.tics.2016.03.003; Heyes C, 2014, PERSPECT PSYCHOL SCI, V9, P131, DOI 10.1177/1745691613518076; Kovacs AM, 2010, SCIENCE, V330, P1830, DOI 10.1126/science.1190792; Lin SH, 2010, J EXP SOC PSYCHOL, V46, P551, DOI 10.1016/j.jesp.2009.12.019; Michael JM, 2017, J EXPT PSYCHOL HUMAN; Michael J, 2015, CONSCIOUS COGN, V36, P434, DOI 10.1016/j.concog.2014.12.009; Nielsen MK, 2015, Q J EXP PSYCHOL, V68, P1931, DOI 10.1080/17470218.2015.1023206; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Phillips J, 2015, PSYCHOL SCI, V26, P1353, DOI 10.1177/0956797614558717; Qureshi AW, 2010, COGNITION, V117, P230, DOI 10.1016/j.cognition.2010.08.003; Samson D, 2010, J EXP PSYCHOL HUMAN, V36, P1255, DOI 10.1037/a0018729; Santiesteban I, 2015, PSYCHON B REV, V22, P844, DOI 10.3758/s13423-014-0716-0; Santiesteban I, 2014, J EXP PSYCHOL HUMAN, V40, P929, DOI 10.1037/a0035175; Schneider D, 2017, COGNITION, V162, P27, DOI 10.1016/j.cognition.2017.01.018; Schneider D, 2013, COGNITION, V129, P410, DOI 10.1016/j.cognition.2013.08.004; Senju A, 2009, SCIENCE, V325, P883, DOI 10.1126/science.1176170; Sodian B, 2007, DEVELOPMENTAL SCI, V10, P199, DOI 10.1111/j.1467-7687.2007.00580.x; Sommerville JA, 2013, CHILD DEV, V84, P1846, DOI 10.1111/cdev.12110; van der Wel RPRD, 2014, COGNITION, V130, P128, DOI 10.1016/j.cognition.2013.10.004; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Wilson CJ, 2017, ACTA PSYCHOL, V178, P56, DOI 10.1016/j.actpsy.2017.05.010; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5	32	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194101	10.1371/journal.pone.0194101	http://dx.doi.org/10.1371/journal.pone.0194101			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA1RF	29566019	Green Published, gold, Green Submitted			2022-12-26	WOS:000428093900034
J	Monterisi, S; Lo Riso, P; Russo, K; Bertalot, G; Vecchi, M; Testa, G; Di Fiore, PP; Bianchi, F				Monterisi, Simona; Lo Riso, Pietro; Russo, Karin; Bertalot, Giovanni; Vecchi, Manuela; Testa, Giuseppe; Di Fiore, Pier Paolo; Bianchi, Fabrizio			HOXB7 overexpression in lung cancer is a hallmark of acquired stem-like phenotype	ONCOGENE			English	Article							CELL-PROLIFERATION; BREAST-CANCER; MALIGNANT PROGRESSION; SURVIVAL PREDICTION; GROWTH-FACTOR; EXPRESSION; GENE; LET-7; CARCINOMA; OCT4	HOXB7 is a homeodomain (HOX) transcription factor involved in regional body patterning of invertebrates and vertebrates. We previously identified HOXB7 within a ten-gene prognostic signature for lung adenocarcinoma, where increased expression of HOXB7 was associated with poor prognosis. This raises the question of how HOXB7 overexpression can influence the metastatic behavior of lung adenocarcinoma. Here, we analyzed publicly available microarray and RNA-seq lung cancer expression datasets and found that HOXB7-overexpressing tumors are enriched in gene signatures characterizing adult and embryonic stem cells (SC), and induced pluripotent stem cells (iPSC). Experimentally, we found that HOXB7 upregulates several canonical SC/iPSC markers and sustains the expansion of a subpopulation of cells with SC characteristics, through modulation of LIN28B, an emerging cancer gene and pluripotency factor, which we discovered to be a direct target of HOXB7. We validated this new circuit by showing that HOXB7 enhances reprogramming to iPSC with comparable efficiency to LIN28B or its target c-MYC, which is a canonical reprogramming factor.	[Monterisi, Simona; Bertalot, Giovanni; Di Fiore, Pier Paolo; Bianchi, Fabrizio] European Inst Oncol, Mol Med Program, I-20141 Milan, Italy; [Monterisi, Simona; Russo, Karin; Vecchi, Manuela; Di Fiore, Pier Paolo] Mol Oncol Fdn, FIRC Inst, IFOM, I-20139 Milan, Italy; [Lo Riso, Pietro; Testa, Giuseppe] European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; [Testa, Giuseppe; Di Fiore, Pier Paolo] Univ Milan, Dept Oncol & Hematooncol, DIPO, I-20122 Milan, Italy; [Bianchi, Fabrizio] Regenerat Med & Innovat Therapies IRCCS Casa Soll, Inst Stem Cell Biol, ISBREMIT, I-71013 San Giovanni Rotondo, FG, Italy; [Monterisi, Simona] Humanitas Clin & Res Ctr, I-20089 Rozzano, MI, Italy	IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Milan; IRCCS Humanitas Research Hospital	Bianchi, F (corresponding author), European Inst Oncol, Mol Med Program, I-20141 Milan, Italy.; Bianchi, F (corresponding author), Regenerat Med & Innovat Therapies IRCCS Casa Soll, Inst Stem Cell Biol, ISBREMIT, I-71013 San Giovanni Rotondo, FG, Italy.	f.bianchi@operapadrepio.it	Bertalot, Giovanni/O-8878-2017; Bianchi, Fabrizio/B-5995-2017; Di Fiore, Pier Paolo/K-2130-2012; Bertalot, Giovanni/AAV-8788-2021; Bianchi, Fabrizio/W-7037-2019	Bianchi, Fabrizio/0000-0001-7412-8638; Di Fiore, Pier Paolo/0000-0002-2252-0950; Bianchi, Fabrizio/0000-0001-7412-8638; Bertalot, Giovanni/0000-0002-4862-7705; LO RISO, PIETRO/0000-0003-2542-0637; Testa, Giuseppe/0000-0002-9104-0918	Associazione Italiana per la Ricerca sul Cancro (AIRC) [MFAG17568, IG 10349, 14040, MCO 10.000]; Monzino Foundation	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Monzino Foundation	We thank Bruno Amati for kindly providing the pBABE-MYC plasmid. We are indebted to Giuseppina Bonizzi, Giovanna Jodice, Elena Belloni, Elena Marino, Francesca De Santis, Stefania Pirroni, Pietro Vella, Valentina Melocchi, Davide Disalvatore and Stefano Freddi for technical support. We thank Ugo Cavallaro for inspiring discussions and comments on the paper. This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro (AIRC) (MFAG17568 to FB; IG 10349 and 14040 and MCO 10.000 to PPDF) and from the Monzino Foundation (to PPDF).	Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Kovochich AN, 2013, CANCER-AM CANCER SOC, V119, P529, DOI 10.1002/cncr.27725; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Bianchi F, 2007, J CLIN INVEST, V117, P3436, DOI 10.1172/JCI32007; Care A, 1998, ONCOGENE, V16, P3285, DOI 10.1038/sj.onc.1201875; Care A, 1996, MOL CELL BIOL, V16, P4842; Care A, 1999, ONCOGENE, V18, P1993, DOI 10.1038/sj.onc.1202498; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chien CS, 2015, CANCER RES, V75, P2553, DOI 10.1158/0008-5472.CAN-14-2215; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Copley MR, 2013, NAT CELL BIOL, V15, P916, DOI 10.1038/ncb2783; Dama E, 2017, CLIN CANCER RES, V23, P62, DOI 10.1158/1078-0432.CCR-15-3005; Destro MFDS, 2010, INT J ONCOL, V36, P141, DOI 10.3892/ijo_00000485; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Errico MC, 2016, CANCER RES, V76, P2857, DOI 10.1158/0008-5472.CAN-15-3444; Hammachi F, 2012, CELL REPORTS, V1, P99, DOI 10.1016/j.celrep.2011.12.002; He XJ, 2017, ONCOTARGET, V8, P1247, DOI 10.18632/oncotarget.13604; Huan HB, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0559-4; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jin K, 2012, P NATL ACAD SCI USA, V109, P2736, DOI 10.1073/pnas.1018859108; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KORNBERG TB, 1993, J BIOL CHEM, V268, P26813; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Liao WT, 2011, CLIN CANCER RES, V17, P3569, DOI 10.1158/1078-0432.CCR-10-2533; Liu S, 2015, CANCER RES, V75, P709, DOI 10.1158/0008-5472.CAN-14-3100; Liu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083083; Lu HH, 2014, NAT CELL BIOL, V16, P1105, DOI 10.1038/ncb3041; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Morgan R, 2006, TRENDS GENET, V22, P67, DOI 10.1016/j.tig.2005.11.004; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; RIDDIHOUGH G, 1992, NATURE, V357, P643, DOI 10.1038/357643a0; Shao YB, 2015, AM J CANCER RES, V5, P2643; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Storti P, 2011, LEUKEMIA, V25, P527, DOI 10.1038/leu.2010.270; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang PH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052088, 10.1371/journal.pone.0057020]; Wang XR, 2012, ONCOL LETT, V3, P955, DOI 10.3892/ol.2012.609; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wesselschmidt RL, 2011, METHODS MOL BIOL, V767, P231, DOI 10.1007/978-1-61779-201-4_17; Wetzel A, 2004, J IMMUNOL, V172, P3850, DOI 10.4049/jimmunol.172.6.3850; Whitfield TW, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r50; Wu XY, 2006, CANCER RES, V66, P9527, DOI 10.1158/0008-5472.CAN-05-4470; Yamanaka S, 2011, GOOGLE PATENTS; Yamauchi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043923; Yan XP, 2013, ONCOL REP, V30, P2733, DOI 10.3892/or.2013.2784; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yuan WW, 2014, MOL CARCINOGEN, V53, P49, DOI 10.1002/mc.21947	57	23	24	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2018	37	26					3575	3588		10.1038/s41388-018-0229-9	http://dx.doi.org/10.1038/s41388-018-0229-9			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GK7TM	29576613				2022-12-26	WOS:000436412500008
J	Mantani, PT; Duner, P; Bengtsson, E; Ljungcrantz, I; Sundius, L; To, F; Nilsson, J; Bjorkbacka, H; Fredrikson, GN				Mantani, Polyxeni T.; Duner, Pontus; Bengtsson, Eva; Ljungcrantz, Irena; Sundius, Lena; To, Fong; Nilsson, Jan; Bjorkbacka, Harry; Fredrikson, Gunilla Nordin			Interleukin-25 (IL-25) has a protective role in atherosclerosis development in the aortic arch in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein E (ApoE); atherosclerosis; antibody; animal model; cellular immune response; cytokine; immunodeficiency; inflammation; T cell; innate lymphoid cells type 2; interleukin-25	SMOOTH-MUSCLE-CELLS; E-DEFICIENT MICE; LOW-DENSITY-LIPOPROTEIN; INNATE LYMPHOID-CELLS; CARDIOVASCULAR EVENTS; TYPE-2 IMMUNITY; REDUCES ATHEROSCLEROSIS; HELMINTH EXPULSION; CYTOKINE RESPONSES; INTERFERON-GAMMA	Atherosclerosis is a chronic inflammatory disease characterized by the entrapment of apolipoprotein B-containing lipoproteins in the arterial intima, leading to local inflammation. T helper (Th) cell 1-mediated immune responses have been associated with atherosclerosis, and the cytokine interleukin-25 (IL-25 or IL-17E) has been reported to potentially regulate Th1 cell- and Th17 cell-related immune responses. In this study, we evaluated the effects of complete IL-25 deficiency or of a temporal IL-25 blockade on atherosclerosis development in apolipoprotein E-deficient (Apoe(-/-)) mice. Mice deficient in both apolipoprotein E and IL-25 (Apoe(-/-)/IL-25(-/-)) had more Th1 cells in the spleen, along with elevated plasma levels of IL-17 and an increased release of splenic interferon- (INF-). In support of this observation, a 4-week-long treatment of young Apoe(-/-) mice (at 10-14 weeks of age) with an IL-25-blocking antibody increased the release of Th1/Th17-associated cytokines in the spleen. In both mouse models, these findings were associated with increased atherosclerotic plaque formation in the aortic arch. We conclude that complete IL-25 deficiency and a temporal IL-25 blockade during early plaque development aggravate atherosclerosis development in the aortic arch of Apoe(-/-) mice, accompanied by an increase in Th1/Th17-mediated immune responses. Our finding that endogenous IL-25 has an atheroprotective role in the murine aortic arch has potential implications for atherosclerosis development and management in humans.	[Mantani, Polyxeni T.; Duner, Pontus; Bengtsson, Eva; Ljungcrantz, Irena; Sundius, Lena; To, Fong; Nilsson, Jan; Bjorkbacka, Harry; Fredrikson, Gunilla Nordin] Lund Univ, Skane Univ Hosp Malmo, Dept Clin Sci, S-20213 Malmo, Sweden	Lund University; Skane University Hospital	Mantani, PT; Fredrikson, GN (corresponding author), CRC, Dept Clin Sci, Bldg 91 12,Jan Waldenstroms Gata 35, S-20213 Malmo, Sweden.	Polyxeni.Mantani@med.lu.se; gunilla.nordin_fredrikson@med.lu.se	Bengtsson, Eva/AGH-2754-2022; Bengtsson, Eva/AAA-1968-2019; Björkbacka, Harry/I-7157-2019	Bengtsson, Eva/0000-0001-7075-1772; Björkbacka, Harry/0000-0003-3918-0857; Duner, Pontus/0000-0003-4171-5646	Swedish Medical Research Council [521-2010-2929, 2015-02811]; Swedish Heart-Lung Foundation [20150273]; Albert Pahlsson Foundation [27.21.0145]; Skane University Hospital Foundation [16000109]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Albert Pahlsson Foundation; Skane University Hospital Foundation	This work was supported by Swedish Medical Research Council Grants 521-2010-2929 (to G.N.F.) and 2015-02811 (to J.N.), Swedish Heart-Lung Foundation Grant 20150273 (to G.N.F.), Albert Pahlsson Foundation Grant 27.21.0145 (to G.N.F.), and Skane University Hospital Foundation Grant 16000109 (to J.N.). The authors declare that they have no conflicts of interest with the contents of this article.	Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; Buono C, 2005, P NATL ACAD SCI USA, V102, P1596, DOI 10.1073/pnas.0409015102; Buono C, 2003, ARTERIOSCL THROM VAS, V23, P454, DOI 10.1161/01.ATV.0000059419.11002.6E; Butcher MJ, 2012, CIRC RES, V110, P675, DOI 10.1161/CIRCRESAHA.111.261784; Caligiuri G, 2002, J CLIN INVEST, V109, P745, DOI 10.1172/JCI200207272; Cardilo-Reis L, 2012, EMBO MOL MED, V4, P1072, DOI 10.1002/emmm.201201374; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Danzaki K, 2012, ARTERIOSCL THROM VAS, V32, P273, DOI 10.1161/ATVBAHA.111.229997; Daugherty A, 2002, AM J MED SCI, V323, P3, DOI 10.1097/00000441-200201000-00002; Davenport P, 2003, AM J PATHOL, V163, P1117, DOI 10.1016/S0002-9440(10)63471-2; de Boer OJ, 2010, J PATHOL, V220, P499, DOI 10.1002/path.2667; Emami H, 2015, JACC-CARDIOVASC IMAG, V8, P121, DOI 10.1016/j.jcmg.2014.10.009; Engelbertsen D, 2015, ARTERIOSCL THROM VAS, V35, P2526, DOI 10.1161/ATVBAHA.115.306048; Erbel C, 2009, J IMMUNOL, V183, P8167, DOI 10.4049/jimmunol.0901126; FALLON PG, 2006, J EXP MED, V203, P1105, DOI DOI 10.1084/JEM.20051615; Feil S, 2014, CIRC RES, V115, P662, DOI 10.1161/CIRCRESAHA.115.304634; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Fredrikson GN, 2007, ATHEROSCLEROSIS, V194, pE188, DOI 10.1016/j.atherosclerosis.2006.12.014; Frostegard J, 1999, ATHEROSCLEROSIS, V145, P33, DOI 10.1016/S0021-9150(99)00011-8; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Huber SA, 2001, CIRCULATION, V103, P2610; King VL, 2007, AM J PATHOL, V171, P2040, DOI 10.2353/ajpath.2007.060857; King VL, 2002, ARTERIOSCL THROM VAS, V22, P456, DOI 10.1161/hq0302.104905; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Lee TS, 1999, ARTERIOSCL THROM VAS, V19, P734, DOI 10.1161/01.ATV.19.3.734; Mantani PT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117255; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Newland SA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15781; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Saenz SA, 2010, TRENDS IMMUNOL, V31, P407, DOI 10.1016/j.it.2010.09.001; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Shankman LS, 2015, NAT MED, V21, P628, DOI 10.1038/nm.3866; Sjogren P, 2008, EUR HEART J, V29, P2218, DOI 10.1093/eurheartj/ehn336; Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886; STEMME S, 1995, P NATL ACAD SCI USA, V92, P3893, DOI 10.1073/pnas.92.9.3893; Taleb S, 2009, J EXP MED, V206, P2067, DOI 10.1084/jem.20090545; Tsimikas S, 2007, J LIPID RES, V48, P425, DOI 10.1194/jlr.M600361-JLR200; Vengrenyuk Y, 2015, ARTERIOSCL THROM VAS, V35, P535, DOI 10.1161/ATVBAHA.114.304029; Whitman SC, 2000, AM J PATHOL, V157, P1819, DOI 10.1016/S0002-9440(10)64820-1; Wigren M, 2011, J INTERN MED, V269, P546, DOI 10.1111/j.1365-2796.2010.02311.x; Witztum JL, 2002, J CLIN INVEST, V109, P721, DOI 10.1172/JCI200215310	46	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6791	6801		10.1074/jbc.RA117.000292	http://dx.doi.org/10.1074/jbc.RA117.000292			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29572351	Green Published, hybrid			2022-12-26	WOS:000431487300014
J	Chen, SS; Mei, XH; Yin, A; Yin, H; Cui, XB; Chen, SY				Chen, Sisi; Mei, Xiaohan; Yin, Amelia; Yin, Hang; Cui, Xiao-Bing; Chen, Shi-You			Response Gene to Complement 32 Suppresses Adipose Tissue Thermogenic Genes through Inhibiting Beta3 Adrenergic Receptor mTORC1 Signaling	ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY			English	Meeting Abstract	Scientific Sessions of the American-Heart-Association on Vascular Discovery - From Genes to Medicine	MAY 10-12, 2018	San Francisco, CA	Amer Heart Assoc					[Chen, Sisi; Mei, Xiaohan; Yin, Amelia; Yin, Hang; Cui, Xiao-Bing; Chen, Shi-You] Univ Georgia, Athens, GA 30602 USA	University System of Georgia; University of Georgia					American Heart Association-American Stroke Association [17SDG32790003] Funding Source: Medline; NHLBI NIH HHS [R01 HL135854, R01 HL123302, R01 HL119053] Funding Source: Medline; NIAMS NIH HHS [R01 AR070178] Funding Source: Medline	American Heart Association-American Stroke Association(American Heart Association); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))			0	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1079-5642	1524-4636		ARTERIOSCL THROM VAS	Arterioscler. Thromb. Vasc. Biol.	MAY	2018	38			1		168				10.1161/atvb.38.suppl_1.168	http://dx.doi.org/10.1161/atvb.38.suppl_1.168			2	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Hematology; Cardiovascular System & Cardiology	JO3WN	29579398				2022-12-26	WOS:000497511500119
J	Lu, M; Cheng, XQ; Jiang, JZ; Lie, TT; Zhang, ZQ; Tsauo, CL; Liu, Y; Wang, ZG				Lu, Man; Cheng, Xueqing; Jiang, Jingzhen; Lie, TingTing; Zhang, Zhenqi; Tsauo, Chialing; Liu, Yin; Wang, Zhigang			Dual-modal photoacoustic and magnetic resonance tracking of tendon stem cells with PLGA/iron oxide microparticles in vitro	PLOS ONE			English	Article							SUPERPARAMAGNETIC IRON-OXIDE; VIVO; NANOPARTICLES; MODEL; MRI	Reliable cell tracking is essential to understand the fate of stem cells following implantation, and thus promote the clinical application of stem cell therapy. Dual or multiple modal imaging modalities mediated by different types of multifunctional contrast agent are generally needed for efficient cell tracking. Here, we created a new contrast agent PLGA/iron oxide microparticles (PLGA/IO MPs) and characterized the morphology, structure and function of enhancing both photoacoustic (PA) and magnetic resonance imaging (MRI). Both PA and MRI signal increased with increased Fe concentration of PLGA/IO MPs. Fluorescent staining, Prussian blue staining and transmission electron microscope (TEM) certified that PLGA/IO MPs were successfully encapsulated in the labeled TSCs. The established PLGA/IO MPs demonstrated superior ability of dual-modal PA/MRI tracking of TSCs without cytotoxicity at relatively lower Fe concentrations (50, 100 and 200 mu g/mL). The optimal Fe concentration of PLGA/IO MPs was determined to be 100 mu g/mL, thus laying a foundation for the further study of dual-modal PA/MRI tracking of TSCs in vivo and promoting the repair of injured tendon.	[Lu, Man; Wang, Zhigang] Chongqing Med Univ, Affiliated Hosp 2, Chongqing Key Lab Ultrasound Mol Imaging, Chongqing, Peoples R China; [Lu, Man; Cheng, Xueqing; Jiang, Jingzhen; Lie, TingTing; Zhang, Zhenqi] Univ Elect Sci & Technol China, Sch Med, Sichuan Canc Ctr, Sichuan Canc Hosp Inst,Ultrasound Med Ctr, Chengdu, Sichuan, Peoples R China; [Jiang, Jingzhen] North Sichuan Med Coll, Nanchong, Peoples R China; [Tsauo, Chialing; Liu, Yin] Sichuan Univ, West China Sch Preclin & Forens Med, Dept Pharmacol, Chengdu, Sichuan, Peoples R China; [Liu, Yin] Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Dept Anesthesiol, Chengdu, Sichuan, Peoples R China	Chongqing Medical University; University of Electronic Science & Technology of China; North Sichuan Medical University; Sichuan University; University of Electronic Science & Technology of China	Wang, ZG (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Chongqing Key Lab Ultrasound Mol Imaging, Chongqing, Peoples R China.	wzg62942443@163.com	zhang, zhenqi/GSN-1651-2022		National Natural Science Foundation of China [81571700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 81571700) to ML. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by the National Natural Science Foundation of China (Grant No.81571700).	Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Bossolasco P, 2012, INT J NANOMED, V7, P435, DOI 10.2147/IJN.S27537; Bulte JWM, 2009, AM J ROENTGENOL, V193, P314, DOI 10.2214/AJR.09.3107; Castaneda RT, 2011, JOVE-J VIS EXP, DOI 10.3791/3482; Chen PJ, 2015, ADV MATER, V27, P6488, DOI 10.1002/adma.201502784; Cheng L, PEGYLATED WS 2 NANOS; Gao DY, 2017, INT J BIOL SCI, V13, P401, DOI 10.7150/ijbs.18750; Geburek F, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0281-8; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Ha SH, 2012, CYTOM PART A, V81A, P910, DOI 10.1002/cyto.a.22160; Huang GJ, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3643033; Im GI, 2017, EUR CELLS MATER, V33, P183, DOI 10.22203/eCM.v033a14; Josephson L, NEAR INFRARED FLUORE; Lai CW, 2008, SMALL, V4, P218, DOI 10.1002/smll.200700283; Laurent S, IRON OXIDE BASED MR; Lewin M, TAT PEPTIDE DERIVATI; Li JC, 2017, ADV COLLOID INTERFAC, V249, P374, DOI 10.1016/j.cis.2017.02.009; Liu G, 2011, J MATER SCI-MATER M, V22, P601, DOI 10.1007/s10856-010-4227-x; Mailander V, INTERACTION NANOPART; Matuszewski L, CELL TAGGING WITH CL; Mou J, 2015, BIOMATERIALS, V57, P12, DOI 10.1016/j.biomaterials.2015.04.020; Nam SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037267; Rodriguez-Porcel M, 2012, JACC-CARDIOVASC IMAG, V5, P559, DOI 10.1016/j.jcmg.2011.12.018; Scharf A, 2015, CONTRAST MEDIA MOL I, V10, P388, DOI 10.1002/cmmi.1642; Sivakumar B, 2017, BIOMATER SCI-UK, V5, P432, DOI 10.1039/c6bm00621c; Taylor A, 2012, CHEM SOC REV, V41, P2707, DOI 10.1039/c2cs35031a; Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; Wu Y, IRON OXIDE NANOPARTI; Xu CJ, 2012, NANO LETT, V12, P4131, DOI 10.1021/nl301658q; Yang YF, 2013, ANN BIOMED ENG, V41, P2109, DOI 10.1007/s10439-013-0802-x; Zhang SJ, COMPARISON IMAGING T; Zhang YS, 2013, THERANOSTICS, V3, P532, DOI 10.7150/thno.5369	32	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0193362	10.1371/journal.pone.0193362	http://dx.doi.org/10.1371/journal.pone.0193362			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608568	gold, Green Published, Green Submitted			2022-12-26	WOS:000428988800003
J	Bai, XM; Zhang, FL; Hou, J; Lee, I; Kong, XJ; Tolba, A; Xia, F				Bai, Xiaomei; Zhang, Fuli; Hou, Jie; Lee, Ivan; Kong, Xiangjie; Tolba, Amr; Xia, Feng			Quantifying the impact of scholarly papers based on higher-order weighted citations	PLOS ONE			English	Article							WEB	Quantifying the impact of a scholarly paper is of great significance, yet the effect of geographical distance of cited papers has not been explored. In this paper, we examine 30,596 papers published in Physical Review C, and identify the relationship between citations and geographical distances between author affiliations. Subsequently, a relative citation weight is applied to assess the impact of a scholarly paper. A higher-order weighted quantum PageRank algorithm is also developed to address the behavior of multiple step citation flow. Capturing the citation dynamics with higher-order dependencies reveals the actual impact of papers, including necessary self-citations that are sometimes excluded in prior studies. Quantum PageRank is utilized in this paper to help differentiating nodes whose PageRank values are identical.	[Bai, Xiaomei] Anshan Normal Univ, Ctr Comp, Anshan 114007, Peoples R China; [Bai, Xiaomei; Hou, Jie; Lee, Ivan; Kong, Xiangjie; Xia, Feng] Dalian Univ Technol, Key Lab Ubiquitous Network & Serv Software Liaoni, Sch Software, Dalian 116620, Peoples R China; [Zhang, Fuli] Anshan Normal Univ, Lib, Anshan 114007, Peoples R China; [Lee, Ivan] Univ South Australia, Sch ITMS, Mawson Lakes, SA 5095, Australia; [Tolba, Amr] King Saud Univ, Dept Comp Sci, Community Coll, Riyadh 11437, Saudi Arabia; [Tolba, Amr] Menoufia Univ, Dept Math, Fac Sci, Shibin Al Kawm 32511, Egypt	Anshan Normal University; Dalian University of Technology; Anshan Normal University; University of South Australia; King Saud University; Egyptian Knowledge Bank (EKB); Menofia University	Lee, I (corresponding author), Dalian Univ Technol, Key Lab Ubiquitous Network & Serv Software Liaoni, Sch Software, Dalian 116620, Peoples R China.; Lee, I (corresponding author), Univ South Australia, Sch ITMS, Mawson Lakes, SA 5095, Australia.	ivan.lee@unisa.edu.au	Kong, Xiangjie/B-8809-2016; Tolba, Amr/O-8464-2016; Xia, Feng/Y-2859-2019; Lee, Ivan/F-4131-2013	Kong, Xiangjie/0000-0003-2698-3319; Tolba, Amr/0000-0003-3439-6413; Xia, Feng/0000-0002-8324-1859; Lee, Ivan/0000-0002-2826-6367	International Scientific Partnership Program ISPP at King Saud University [ISPP0078]	International Scientific Partnership Program ISPP at King Saud University	The authors extend their appreciation to the International Scientific Partnership Program ISPP at King Saud University for funding this research work through ISPP#0078. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinis H, 2012, ACAD MANAGE PERSPECT, V26, P105, DOI 10.5465/amp.2011.0088; Albarran P, 2015, J ASSOC INF SCI TECH, V66, P512, DOI 10.1002/asi.23219; Bai XM, 2017, WWW'17 COMPANION: PROCEEDINGS OF THE 26TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P1243, DOI 10.1145/3041021.3053061; Bai XM, 2017, INFORMATION, V8, DOI 10.3390/info8030073; Bai XM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162364; Bohlin L, 2015, J ASS INFORM SCI TE, V105, P443; Borner K, 2006, SCIENTOMETRICS, V68, P415, DOI 10.1007/s11192-006-0120-2; Box G.E.P., 2010, J TIME SER ANAL, V31, P303, DOI DOI 10.1111/J.1467-9892.2009.00643.X; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Cawkell T, 1998, ASLIB PROC, V50, P27, DOI 10.1108/eb051479; Chen P, 2007, J INFORMETR, V1, P8, DOI 10.1016/j.joi.2006.06.001; Chen YL, 2011, J INF SCI, V37, P254, DOI 10.1177/0165551511402421; Deshpande M., 2004, ACM T INTERNET TECHN, V4, P163, DOI DOI 10.1145/990301.990304; Diday E, 1980, CLUSTERING ANAL DIGI, P47; Dou R, 2016, PHYS REV PHYS EDUC R, V12, DOI 10.1103/PhysRevPhysEducRes.12.020124; Egghe L, 2006, SCIENTOMETRICS, V69, P131, DOI 10.1007/s11192-006-0144-7; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Evans JA, 2009, SCIENCE, V323, P1025, DOI 10.1126/science.1154562; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Gargouri Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013636; Gleich D. F., 2014, COMPUTER SCI, V57; Gleich DF, 2014, SIAM J MATRIX ANAL A, V36; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Jing Z, 2016, CHIN CONTR CONF, P211, DOI 10.1109/ChiCC.2016.7553085; Kalavri V, 2016, PROC VLDB ENDOW, V9, P672; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Liben-Nowell D, 2005, P NATL ACAD SCI USA, V102, P11623, DOI 10.1073/pnas.0503018102; Pan RK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00551; Paparo GD, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14150-y; Rosvall M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5630; Sayyadi H., 2009, SIAM INT C DAT MIN 2, P533; Schubert A, 2006, SCIENTOMETRICS, V69, P409, DOI 10.1007/s11192-006-0160-7; Shah N, 2015, S INDEX BETTER METRI; SILBERSWEIG DA, 1995, NATURE, V378, P176, DOI 10.1038/378176a0; Venkatramanan S, 2015, ENVIRON SCI POLLUT R, V22, P11209, DOI 10.1007/s11356-015-4290-4; Wang S., 2014, P 2014 SIAM INT C DA, P749, DOI DOI 10.1137/1.9781611973440.86; Wang Y., 2013, PROC AAAI C ARTIF IN, P933, DOI DOI 10.1609/AAAI.V27I1.8627; Wu J, 2013, GEOGRAPHICAL KNOWLED, P181; Xia F, 2017, IEEE T BIG DATA, V3, P18, DOI 10.1109/TBDATA.2016.2641460; Xia F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165997; Xie WL, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1325, DOI 10.1145/2783258.2783278; Xu J, 2015, SCI ADV, V2	42	15	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0193192	10.1371/journal.pone.0193192	http://dx.doi.org/10.1371/journal.pone.0193192			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596426	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000428630000005
J	Dvorak, KM; Pettee, KM; Rubinic-Minotti, K; Su, R; Nestor-Kalinoski, A; Eisenmann, KM				Dvorak, Kaitlyn M.; Pettee, Krista M.; Rubinic-Minotti, Kaitlin; Su, Robin; Nestor-Kalinoski, Andrea; Eisenmann, Kathryn M.			Carcinoma associated fibroblasts (CAFs) promote breast cancer motility by suppressing mammalian Diaphanous-related formin-2 (mDia2)	PLOS ONE			English	Article							TUMOR-CELL INVASION; PROSTATE-CANCER; INVADOPODIA FORMATION; TGF-ALPHA; ACTIN; MIGRATION; GROWTH; CHEMOKINE; EXPRESSION; MICROENVIRONMENT	The tumor microenvironment (TME) promotes tumor cell invasion and metastasis. An important step in the shift to a pro-cancerous microenvironment is the transformation of normal stromal fibroblasts to carcinoma-associated fibroblasts (CAFs). CAFs are present in a majority of solid tumors and can directly promote tumor cell motility via cytokine, chemokine and growth factor secretion into the TME. The exact effects that the TME has upon cytoskeletal regulation in motile tumor cells remain enigmatic. The conserved formin family of cytoskeleton regulating proteins plays an essential role in the assembly and/or bundling of unbranched actin filaments. Mammalian Diaphanous-related formin 2 (mDia2/DIAPH3/Drf3/Dia) assembles a dynamic F-actin cytoskeleton that underlies tumor cell migration and invasion. We therefore sought to understand whether CAF-derived chemokines impact breast tumor cell motility through modification of the formin-assembled F-actin cytoskeleton. In MDA-MB-231 cells, conditioned media (CM) from WS19T CAFs, a human breast tumor-adjacent CAF line, significantly and robustly increased wound closure and invasion relative to normal human mammary fibroblast (HMF)-CM. WS19T-CM also promoted proteasome-mediated mDia2 degradation in MDA-MB-231 cells relative to control HMF-CM and WS21T CAF-CM, a breast CAF cell line that failed to promote robust MDA-MB-231 migration. Cytokine array analysis of CM identified up-regulated secreted factors in WS19T relative to control WS21T CM. We identified CXCL12 as a CM factor influencing loss of mDia2 protein while increasing MDA-MB-231 cell migration. Our data suggest a mechanism whereby CAFs promote tumor cell migration and invasion through CXCL12 secretion to regulate the mDia2-directed cytoskeleton in breast tumor cells.	[Dvorak, Kaitlyn M.; Pettee, Krista M.; Rubinic-Minotti, Kaitlin; Su, Robin; Eisenmann, Kathryn M.] Univ Toledo, Dept Canc Biol, Hlth Sci Campus, Toledo, OH 43606 USA; [Nestor-Kalinoski, Andrea] Univ Toledo, Dept Surg, Hlth Sci Campus, Toledo, OH 43606 USA	University System of Ohio; University of Toledo; University of Toledo Health Science Campus; University System of Ohio; University of Toledo; University of Toledo Health Science Campus	Eisenmann, KM (corresponding author), Univ Toledo, Dept Canc Biol, Hlth Sci Campus, Toledo, OH 43606 USA.	Kathryn.Eisenmann@utoledo.edu		Eisenmann, Kathryn/0000-0002-5337-5928	NATIONAL CANCER INSTITUTE [R01CA151632] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA151632] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABERCROMBIE M, 1980, PROC R SOC SER B-BIO, V207, P129, DOI 10.1098/rspb.1980.0017; Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Alberts BJ, MOL BIOL CELL; Arden JD, 2015, MOL BIOL CELL, V26, P3704, DOI 10.1091/mbc.E14-11-1502; Baarlink C, 2010, CELL, V142, DOI 10.1016/j.cell.2010.06.030; Bartolini F, 2008, J CELL BIOL, V181, P523, DOI 10.1083/jcb.200709029; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Burger M, 2003, ONCOGENE, V22, P8093, DOI 10.1038/sj.onc.1207097; Calvo F, 2013, NAT CELL BIOL, V15, P637, DOI 10.1038/ncb2756; CHEN WT, 1989, J EXP ZOOL, V251, P167, DOI 10.1002/jez.1402510206; D'Errico A, 2000, BRIT J CANCER, V82, P865, DOI 10.1054/bjoc.1999.1013; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Deward AD, 2009, J BIOL CHEM, V284, P20061, DOI 10.1074/jbc.M109.000885; Dhimolea E, 2010, BIOMATERIALS, V31, P3622, DOI 10.1016/j.biomaterials.2010.01.077; Di Vizio D, 2009, CANCER RES, V69, P5601, DOI 10.1158/0008-5472.CAN-08-3860; Dona E, 2013, NATURE, V503, P285, DOI 10.1038/nature12635; Eisenmann KM, 2007, J BIOL CHEM, V282, P25152, DOI 10.1074/jbc.M703243200; Eisenmann KM, 2007, CURR BIOL, V17, P579, DOI 10.1016/j.cub.2007.03.024; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gialeli C, 2014, CURR PHARM DESIGN, V20, P2843, DOI 10.2174/13816128113199990592; Giricz O, 2013, INT J CANCER, V133, P2587, DOI 10.1002/ijc.28295; Goicoechea SM, 2014, ONCOGENE, V33, P1265, DOI 10.1038/onc.2013.68; Goulimari P, 2005, J BIOL CHEM, V280, P42242, DOI 10.1074/jbc.M508690200; Hager MH, 2012, EMBO MOL MED, V4, P743, DOI 10.1002/emmm.201200242; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Isogai T, 2016, J PROTEOME RES, V15, P4624, DOI 10.1021/acs.jproteome.6b00718; Isogai T, 2015, SCI REP-UK, V5, DOI 10.1038/srep09802; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Keenen B, 2010, ONCOGENE, V29, P81, DOI 10.1038/onc.2009.304; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Lee BC, 2004, MOL CANCER RES, V2, P327; Lee CC, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-85; Lim JB, 2015, CYTOKINE, V73, P16, DOI 10.1016/j.cyto.2015.01.010; Lizarraga F, 2009, CANCER RES, V69, P2792, DOI 10.1158/0008-5472.CAN-08-3709; Lukaszewicz-Zajac M, 2016, DIS MARKERS, V2016; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Matsuo Y, 2009, INT J CANCER, V124, P853, DOI 10.1002/ijc.24040; Nurnberg A, 2011, NAT REV CANCER, V11, P177, DOI 10.1038/nrc3003; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Peng J, 2007, CANCER RES, V67, P7565, DOI 10.1158/0008-5472.CAN-07-1467; Pettee KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090371; Phillips RJ, 2003, AM J RESP CRIT CARE, V167, P1676, DOI 10.1164/rccm.200301-071OC; Pignatelli J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005329; Popple A, 2012, BRIT J CANCER, V106, P1306, DOI 10.1038/bjc.2012.49; Righi E, 2011, CANCER RES, V71, P5522, DOI 10.1158/0008-5472.CAN-10-3143; Rivera GM, 2006, P NATL ACAD SCI USA, V103, P9536, DOI 10.1073/pnas.0603786103; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; Sarmiento C, 2008, J CELL BIOL, V180, P1245, DOI 10.1083/jcb.200708123; Shekhar MPV, 2007, AM J PATHOL, V170, P1546, DOI 10.2353/ajpath.2007.061004; Shekhar MPV, 2001, CANCER RES, V61, P1320; Shi YQ, 2009, BIOCHEM CELL BIOL, V87, P207, DOI 10.1139/O08-130; Shi YQ, 2009, J IMMUNOL, V182, P3837, DOI 10.4049/jimmunol.0803838; Sporn MB, 1996, LANCET, V347, P1377, DOI 10.1016/S0140-6736(96)91015-6; Stastna J, 2012, CELL RES, V22, P728, DOI 10.1038/cr.2011.202; Staus DP, 2014, AM J PHYSIOL-HEART C, V307, pH379, DOI 10.1152/ajpheart.01002.2013; Struckhoff AP, 2013, J CELL SCI, V126, P4514, DOI 10.1242/jcs.132381; Taichman RS, 2002, CANCER RES, V62, P1832; Toguchi M, 2010, BIOL CELL, V102, P215, DOI 10.1042/BC20090033; Vaday GG, 2004, CLIN CANCER RES, V10, P5630, DOI 10.1158/1078-0432.CCR-03-0633; Wallar BJ, 2006, J BIOL CHEM, V281, P4300, DOI 10.1074/jbc.M510277200; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Wallar BJ, 2007, EXP CELL RES, V313, P560, DOI 10.1016/j.yexcr.2006.10.033; Wang W, 2009, CLIN CANCER RES, V15, P6630, DOI 10.1158/1078-0432.CCR-09-1001; Wang X.J., 2010, J INEQUAL APPL, V2010, DOI DOI 10.1155/2010/465915; Watanabe N, 1999, COOPERATION MDIA1 RO; Watanabe S, 2008, MOL BIOL CELL, V19, P2328, DOI 10.1091/mbc.E07-10-1086; Witz IP, 2006, CANCER LETT, V242, P1, DOI 10.1016/j.canlet.2005.12.005; Wyse MM, 2017, BIOCHEM BIOPH RES CO, V484, P255, DOI 10.1016/j.bbrc.2017.01.087; Wyse MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045085; Yamaguchi H, 2012, EUR J CELL BIOL, V91, P902, DOI 10.1016/j.ejcb.2012.04.005; Yang W, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0044-z	80	21	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195278	10.1371/journal.pone.0195278	http://dx.doi.org/10.1371/journal.pone.0195278			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596520	Green Submitted, Green Published, gold			2022-12-26	WOS:000428630000102
J	Garelnabi, M; Taylor-Smith, LM; Bielska, E; Hall, RA; Stones, D; May, RC				Garelnabi, Mariam; Taylor-Smith, Leanne M.; Bielska, Ewa; Hall, Rebecca A.; Stones, Daniel; May, Robin C.			Quantifying donor-to-donor variation in macrophage responses to the human fungal pathogen Cryptococcus neoformans	PLOS ONE			English	Article							NERVOUS-SYSTEM CRYPTOCOCCOSIS; VAR. GRUBII; THERAPY; MENINGITIS	Cryptococcosis remains the leading cause of fungal meningitis worldwide, caused primarily by the pathogen Cryptococcus neoformans. Symptomatic cryptococcal infections typically affect immunocompromised patients. However, environmental exposure to cryptococcal spores is ubiquitous and most healthy individuals are thought to harbor infections from early childhood onwards that are either resolved, or become latent. Since macrophages are a key host cell for cryptococcal infection, we sought to quantify the extent of individual variation in this early phagocyte response within a small cohort of healthy volunteers with no reported immunocompromising conditions. We show that rates of both intracellular fungal proliferation and non-lytic expulsion (vomocytosis) are remarkably variable between individuals. However, we demonstrate that neither gender, in vitro host inflammatory cytokine profiles, nor polymorphisms in several key immune genes are responsible for this variation. Thus the data we present serve to quantify the natural variation in macrophage responses to this important human pathogen and will hopefully provide a useful "benchmark" for the research community.	[May, Robin C.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England; Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	May, RC (corresponding author), Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.	r.c.may@bham.ac.uk	Bielska, Ewa/B-4936-2019; May, Robin Charles/ABA-9266-2021	Bielska, Ewa/0000-0002-3138-4719; May, Robin Charles/0000-0001-5364-1838; Hall, Rebecca/0000-0002-4908-8168; Taylor-Smith, Leanne/0000-0001-6217-6499; Stones, Daniel H./0000-0002-8981-7943	European Research Council [614562] Funding Source: Medline; Medical Research Council [MR/J008176/1, MR/L00903X/1, G0601171] Funding Source: Medline; MRC [G0601171, MR/J008176/1, MR/L00903X/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alvarez M, 2006, CURR BIOL, V16, P2161, DOI 10.1016/j.cub.2006.09.061; Biondo C, 2005, EUR J IMMUNOL, V35, P870, DOI 10.1002/eji.200425799; Brizendine KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060431; Chen M, 2016, MYCOSES, V59, P494, DOI 10.1111/myc.12497; Chen YC, 2012, MYCOPATHOLOGIA, V173, P329, DOI 10.1007/s11046-011-9471-1; Ecevit IZ, 2006, CLIN INFECT DIS, V42, P1443, DOI 10.1086/503570; Fischer M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150632; George IA, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx004; Gilbert AS, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700898; Gilbert AS, 2014, COLD SPRING HARB PER; Giles SS, 2009, INFECT IMMUN, V77, P3491, DOI 10.1128/IAI.00334-09; Jarvis JN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004754; Kechichian TB, 2007, INFECT IMMUN, V75, P4792, DOI 10.1128/IAI.00587-07; Kronstad JW, 2011, NAT REV MICROBIOL, V9, P193, DOI 10.1038/nrmicro2522; Ma HS, 2006, CURR BIOL, V16, P2156, DOI 10.1016/j.cub.2006.09.032; Ma HS, 2009, P NATL ACAD SCI USA, V106, P12980, DOI 10.1073/pnas.0902963106; McClelland EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063632; Mihara T, 2013, MED MYCOL, V51, P252, DOI 10.3109/13693786.2012.708883; Nguyen MH, 2010, J INFECTION, V61, P419, DOI 10.1016/j.jinf.2010.08.004; Nielsen K, 2003, INFECT IMMUN, V71, P4831, DOI 10.1128/IAI.71.9.4831-4841.2003; Pappas PG, 2001, CLIN INFECT DIS, V33, P690, DOI 10.1086/322597; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Pyrgos V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056269; Qiu FM, 2013, MUTAGENESIS, V28, P561, DOI 10.1093/mutage/get033; Sabiiti W, 2012, FUTURE MICROBIOL, V7, P1297, DOI [10.2217/FMB.12.102, 10.2217/fmb.12.102]; Scriven JE, 2017, JAIDS-J ACQ IMM DEF, V75, P299, DOI [10.1097/QAI.0000000000001382, 10.1097/qai.0000000000001382]; Smith LM, 2014, CELLULAR MICROBIOLOG; Sorrell TC, 2016, MICROBES INFECT, V18, P57, DOI 10.1016/j.micinf.2015.08.017; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Tseng HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061921; Tucker SC, 2002, P NATL ACAD SCI USA, V99, P3165, DOI 10.1073/pnas.052702799; Voelz K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015968	32	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194615	10.1371/journal.pone.0194615	http://dx.doi.org/10.1371/journal.pone.0194615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596441	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000428630000034
J	Chow, NJ; Han, DJ; Lee, JH; Jang, SH; Kong, JS; Gill, HW; Park, S; Lee, EY				Chow, Nam-Jun; Han, Dong-Jae; Lee, Ji-Hye; Jang, Si-Hyong; Kong, Jeong Suk; Gill, Hyo-Wook; Park, Samel; Lee, Eun Young			Soluble klotho as a marker of renal fibrosis and podocyte injuries in human kidneys	PLOS ONE			English	Article							URINARY ANGIOTENSINOGEN; EXPRESSION; CONTRIBUTES; CLEAVAGE; RELEASE; STRESS; GENE	Klotho deficiency is relevant to renal fibrosis and podocyte injury in vivo and in vitro. We examined whether histological findings of renal biopsy specimens were associated with the levels of soluble klotho in humans. We investigated renal biopsy specimens of 67 patients and detailed microscopic findings were reviewed. Soluble serum/urinary klotho and urinary angiotensinogen were assessed by enzyme-linked immunosorbent assays, and tissue klotho expression was assessed by immunohistochemical staining. The median age of the study participants was 35.6 years. High serum klotho levels (>= 14 pg/mL) were associated with decreased odds ratios (ORs) of interstitial fibrosis (OR = 0.019, P= 0.003) and segmental sclerosis (OR = 0.190, P= 0.022) in multivariable logistic regression analysis. Patients with a lower urinary klotho-to-creatinine ratio (UKCR) were significantly more likely to have diffuse foot process effacement (OR = 0.450, P= 0.010). The area under the receiver-operating characteristic curve (AUC) of serum klotho for predicting interstitial fibrosis was 0.920 (95% CI, 0.844-0.996), and the best cut-off value of serum klotho was 138.1 pg/mL. The AUC of UKCR for predicting diffuse foot process effacement was 0.754 (95% CI, 0.636-0.872), and the best cut-off value of UKCR was 96.7 pg/mgCr. Urinary angiotensinogen-to-creatinine ratio was not associated with serum klotho, UKCR, or any pathological finding. Our data suggested that soluble serum and urinary klotho levels represent a potential biomarker to predict renal fibrosis and podocyte injury in humans.	[Chow, Nam-Jun; Han, Dong-Jae; Kong, Jeong Suk; Gill, Hyo-Wook; Park, Samel; Lee, Eun Young] Soonchunhyang Univ, Cheonan Hosp, Dept Internal Med, Cheonan, South Korea; [Lee, Ji-Hye; Jang, Si-Hyong] Soonchunhyang Univ, Cheonan Hosp, Dept Pathol, Cheonan, South Korea	Soonchunhyang University; Soonchunhyang University	Lee, EY (corresponding author), Soonchunhyang Univ, Cheonan Hosp, Dept Internal Med, Cheonan, South Korea.	eylee@sch.ac.kr	Lee, Eun Young/Q-6592-2019	Lee, Eun Young/0000-0002-4513-9888	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2017R1D1A3B03027898]; Soonchunhyang University Research Fund	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Soonchunhyang University Research Fund	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2017R1D1A3B03027898) and Soonchunhyang University Research Fund.	Akimoto T, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-155; An Y, 2015, NEPHROL DIAL TRANSPL, V30, P257, DOI 10.1093/ndt/gfu250; Carew RM, 2012, CELL TISSUE RES, V347, P103, DOI 10.1007/s00441-011-1227-1; Cha SK, 2009, MOL PHARMACOL, V76, P38, DOI 10.1124/mol.109.055780; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Chen JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062082, 10.1371/journal.pone.0069704, 10.1371/journal.pone.0066841]; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Haruna Y, 2007, P NATL ACAD SCI USA, V104, P2331, DOI 10.1073/pnas.0611079104; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Hu MC, 2012, NAT REV NEPHROL, V8, P423, DOI 10.1038/nrneph.2012.92; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Kim HR, 2013, AM J KIDNEY DIS, V61, P899, DOI 10.1053/j.ajkd.2013.01.024; Kim JH, 2017, J AM SOC NEPHROL, V28, P140, DOI 10.1681/ASN.2015080888; Kuro-O M, 2008, BIOL CHEM, V389, P233, DOI 10.1515/BC.2008.028; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Lee EY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102984; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lim SC, 2014, J RENIN-ANGIO-ALDO S, V15, P487, DOI 10.1177/1470320313475905; Liu QF, 2015, IRAN J KIDNEY DIS, V9, P291; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; MCCARTY KS, 1986, CANCER RES, V46, P4244; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Ohyama Y, 1998, BIOCHEM BIOPH RES CO, V251, P920, DOI 10.1006/bbrc.1998.9576; Rotondi S, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/872193; Sugiura H, 2012, AM J PHYSIOL-RENAL, V302, pF1252, DOI 10.1152/ajprenal.00294.2011; Sugiura H, 2010, NEPHROL DIAL TRANSPL, V25, P60, DOI 10.1093/ndt/gfp451; Urushihara M, 2010, AM J NEPHROL, V31, P318, DOI 10.1159/000286037; Wu C, 2014, DIABETES RES CLIN PR, V106, P343, DOI 10.1016/j.diabres.2014.08.026; Wu YL, 2017, KIDNEY INT, V91, P830, DOI 10.1016/j.kint.2016.09.039; Yamamoto T, 2007, J AM SOC NEPHROL, V18, P1558, DOI 10.1681/ASN.2006060554; Zhou LL, 2015, AM J PATHOL, V185, P3211, DOI 10.1016/j.ajpath.2015.08.004; Zhou LL, 2013, J AM SOC NEPHROL, V24, P771, DOI 10.1681/ASN.2012080865	34	13	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194617	10.1371/journal.pone.0194617	http://dx.doi.org/10.1371/journal.pone.0194617			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590173	Green Submitted, gold, Green Published			2022-12-26	WOS:000428603100069
J	Lee, SW; Kulkarni, K; Annoni, EM; Libbus, I; KenKnight, BH; Tolkacheva, EG				Lee, Steven W.; Kulkarni, Kanchan; Annoni, Elizabeth M.; Libbus, Imad; KenKnight, Bruce H.; Tolkacheva, Elena G.			Stochastic vagus nerve stimulation affects acute heart rate dynamics in rats	PLOS ONE			English	Article							RATE-VARIABILITY; VAGAL-STIMULATION; REFRACTORY EPILEPSY; CARDIAC-FUNCTION; POINCARE PLOT; FAILURE; ISOFLURANE; MODEL	Vagus nerve stimulation (VNS) is an approved therapy for treatment of epilepsy and depression. While also shown to be promising in several preclinical and clinical studies to treat cardiovascular diseases, optimal therapeutic stimulation paradigms are still under investigation. Traditionally, parameters such as frequency, current, and duty cycle are used to adjust the efficacy of VNS therapy. This study explored the effect of novel stochastic VNS (S-VNS) on acute heart rate (HR) dynamics. The effect of S-VNS was evaluated in Sprague Dawley rats by comparing the acute HR and HR variability (HRV) responses to standard, periodic VNS (P-VNS) across different frequencies (FREQs, 10-30 Hz). Our results demonstrate that both S-VNS and P-VNS produced negative chronotropic effects in a FREQ-dependent manner with S-VNS inducing a significantly smaller drop in HR at 10 Hz and 20 Hz compared to P-VNS (p<0.05). S-VNS demonstrated a FREQ-dependent drop in the SD1/SD2 ratio, a measure of HRV, which was absent in P-VNS, suggesting that S-VNS may acutely modulate the nonlinear relationship between short- and long-term HRV. In conclusion, S-VNS is a novel stimulation procedure that may provide different physiological outcomes from standard P-VNS, as indicated by our analysis of HR dynamics. Our study provides a rationale for further detailed investigations into the therapeutic potential of S-VNS as a novel neuromodulation technique.	[Lee, Steven W.; Kulkarni, Kanchan; Annoni, Elizabeth M.; Tolkacheva, Elena G.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Libbus, Imad; KenKnight, Bruce H.] Cyberonics Inc, Livallova PLC, Houston, TX USA	University of Minnesota System; University of Minnesota Twin Cities	Tolkacheva, EG (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.	talkacal@umn.edu	Kulkarni, Kanchan/AAZ-9557-2021	Kulkarni, Kanchan/0000-0002-3185-0484; Libbus, Imad/0000-0002-0675-8790	National Heart, Lung, and Blood Institute of the National Institutes of Health [F31HL129544, R21HL128790]; National Science Foundation CAREER [PHY-125541, DCSD 1662250]; LivaNova, PLC (Cyberonics, Inc); LivaNova, PLC	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation CAREER(National Science Foundation (NSF)); LivaNova, PLC (Cyberonics, Inc); LivaNova, PLC	This work was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health F31HL129544 (to SWL), R21HL128790 (to EGT), and by National Science Foundation CAREER PHY-125541 (to EGT), DCSD 1662250 (to EGT), as well as support from LivaNova, PLC (Cyberonics, Inc). The funder LivaNova, PLC provided support in the form of salaries for authors (to IL, BHK, and EGT) and research materials (vagus nerve electrodes), but did not have any additional role in the study design, data collection and analysis, and decision to publish. The specific roles of these authors are articulated in the 'Author Contributions' section.	Abramovich-Sivan S, 1998, J THEOR BIOL, V192, P567, DOI 10.1006/jtbi.1998.0684; Annoni EM, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12476; Ardell JL, 2015, AM J PHYSIOL-HEART C, V309, pH1740, DOI 10.1152/ajpheart.00557.2015; Azar T, 2011, J AM ASSOC LAB ANIM, V50, P175; Balasubramanian K, 2017, ANN INDIAN ACAD NEUR, V20, P403, DOI 10.4103/aian.AIAN_148_17; BERNTSON GG, 1992, J AUTONOM NERV SYST, V41, P221, DOI 10.1016/0165-1838(92)90062-L; Brennan M, 2001, IEEE T BIO-MED ENG, V48, P1342, DOI 10.1109/10.959330; Buschman HP, 2006, NEUROMODULATION, V9, P214, DOI 10.1111/j.1525-1403.2006.00062.x; De Ferrari GM, 2011, EUR HEART J, V32, P847, DOI 10.1093/eurheartj/ehq391; Dvir H, 2013, BIOPHYS J, V105, P533, DOI 10.1016/j.bpj.2013.06.012; Goel R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136335; Gold MR, 2016, J AM COLL CARDIOL, V68, P149, DOI 10.1016/j.jacc.2016.03.525; Guzik P, 2007, J PHYSIOL SCI, V57, P63, DOI 10.2170/physiolsci.RP005506; Harvey RD, 2003, BRIT J PHARMACOL, V139, P1074, DOI 10.1038/sj.bjp.0705338; Hori M, 2012, J CARDIOL, V60, P86, DOI 10.1016/j.jjcc.2012.06.013; Kapa S, 2016, TRENDS CARDIOVAS MED, V26, P245, DOI 10.1016/j.tcm.2015.07.001; Kong SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049475; Lee SW, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12786; Li M, 2004, CIRCULATION, V109, P120, DOI 10.1161/01.CIR.0000105721.71640.DA; Libbus I, 2017, J ELECTROCARDIOL; Libbus I, 2016, HEART RHYTHM, V13, P721, DOI 10.1016/j.hrthm.2015.11.030; Libbus Imad, 2002, Card Electrophysiol Rev, V6, P302, DOI 10.1023/A:1016349613464; Lund C, 2011, SEIZURE-EUR J EPILEP, V20, P34, DOI 10.1016/j.seizure.2010.10.002; Malik M., 1996, ANN NONINVAS ELECTRO, V1, P151, DOI DOI 10.1111/J.1542-474X.1996.TB00275.X; McIntyre SD, 2014, J THEOR BIOL, V350, P90, DOI 10.1016/j.jtbi.2014.02.015; Muppidi S, 2011, NEUROLOGY, V77, P1577, DOI 10.1212/WNL.0b013e318233b3a2; O'Reardon John P, 2006, Psychiatry (Edgmont), V3, P54; Olshansky B, 2016, J CARD FAIL, V22, P643, DOI 10.1016/j.cardfail.2016.05.005; PARKER P, 1984, J AUTONOM NERV SYST, V11, P226, DOI 10.1016/0165-1838(84)90080-8; Premchand RK, 2015, J CARD FAIL; Romero Ugalde HM, 2017, IEEE T BIOMED ENG, P1; Samniang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep19749; Shaffer F, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00258; Shen MJ, 2014, CIRC RES, V114, P1004, DOI 10.1161/CIRCRESAHA.113.302549; Stapelberg NJC, 2018, ANN NONINVAS ELECTRO, V23, DOI 10.1111/anec.12483; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Toader E, 2011, MINERVA ANESTESIOL, V77, P142; Tolkacheva EG, 2007, J BIOL PHYS, V33, P35, DOI 10.1007/s10867-007-9040-5; Ugalde HR, 2014, IEEE ENG MED BIO, P6262, DOI 10.1109/EMBC.2014.6945060; van der Groen O, 2017, BRAIN STIMUL, V10, pe4, DOI DOI 10.1016/J.BRS.2016.11.030; Xie XY, 2014, IEEE ENG MED BIO, P1575, DOI 10.1109/EMBC.2014.6943904; Yang CF, 2014, TZU CHI MED J, V26, P119, DOI 10.1016/j.tcmj.2014.07.005; YANG T, 1984, AM J PHYSIOL, V246, pH585, DOI 10.1152/ajpheart.1984.246.4.H585; Yoo PB, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12689; Yuan HK, 2016, HEADACHE, V56, P71, DOI 10.1111/head.12647; Zagon A, 2000, EPILEPSIA, V41, P1382, DOI 10.1111/j.1528-1157.2000.tb00113.x; Zannad F, 2015, EUR HEART J, V36, P425, DOI 10.1093/eurheartj/ehu345	47	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194910	10.1371/journal.pone.0194910	http://dx.doi.org/10.1371/journal.pone.0194910			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590213	Green Published, gold, Green Submitted			2022-12-26	WOS:000428603100087
J	Stockbridge, EL; Miller, TL; Carlson, EK; Ho, C				Stockbridge, Erica L.; Miller, Thaddeus L.; Carlson, Erin K.; Ho, Christine			Private sector tuberculosis prevention in the US: Characteristics associated with interferon gamma release assay or tuberculin skin testing	PLOS ONE			English	Article							UNITED-STATES; INFECTION; DIAGNOSIS; SERVICES; ADULTS; COST	Objective To determine whether latent tuberculosis infection risk factors are associated with an increased likelihood of latent tuberculosis infection testing in the US private healthcare sector. Data source A national sample of medical and pharmacy claims representing services rendered January 2011 through December 2013 for 3,997,986 commercially insured individuals in the US who were 0 to 64 years of age. Study design We used multivariable logistic regression models to determine whether TB/LTBI risk factors were associated with an increased likelihood of Interferon-Gamma Release Assay (IGRA) or Tuberculin Skin Test (TST) testing in the private sector. Principal findings 4.31% (4.27-4.34%) received at least one TST/IGRA test between 2011 and 2013 while 1.69% (1.67-1.72%) received a TST/IGRA test in 2013. Clinical risk factors associated with a significantly increased likelihood of testing included HIV, immunosuppressive therapy, exposure to tuberculosis, a history of tuberculosis, diabetes, tobacco use, end stage renal disease, and alcohol use disorder. Other significant variables included gender, age, asthma, the state tuberculosis rate, population density, and percent of foreign born persons in a county. Conclusions Private sector TST/IGRA testing is not uncommon and testing varies with clinical risk indicators. Thus, the private sector can be a powerful resource in the fight against tuberculosis. Analyses of administrative data can inform how best to leverage private sector healthcare toward tuberculosis prevention activities.	[Stockbridge, Erica L.; Miller, Thaddeus L.] Univ North Texas, Sch Publ Hlth, Hlth Sci Ctr, Dept Hlth Behav & Hlth Syst, Ft Worth, TX 76107 USA; [Stockbridge, Erica L.] Magellan Hlth Inc, Dept Adv Hlth Analyt & Solut, Scottsdale, AZ 85251 USA; [Carlson, Erin K.] Univ Texas Arlington, Coll Nursing & Hlth Innovat, Arlington, TX 76019 USA; [Ho, Christine] CDCP, Div TB Eliminat, Atlanta, GA USA	University of North Texas System; University of North Texas Denton; University of Texas System; University of Texas Arlington; Centers for Disease Control & Prevention - USA	Stockbridge, EL (corresponding author), Univ North Texas, Sch Publ Hlth, Hlth Sci Ctr, Dept Hlth Behav & Hlth Syst, Ft Worth, TX 76107 USA.; Stockbridge, EL (corresponding author), Magellan Hlth Inc, Dept Adv Hlth Analyt & Solut, Scottsdale, AZ 85251 USA.	Erica.Stockbridge@unthsc.edu			Magellan Health	Magellan Health	ELS is employed at a commercial company: Magellan Health, Inc. Magellan Health provided support in the form of salaries for author ELS and access to the data, but did not have any additional role in the study design, analysis, decision to publish, or preparation of the manuscript. No other authors have financial disclosures to report. The specific roles of all authors are articulated in the 'author contributions' section.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Alvarez F, 2012, UNIVERSAL TB TESTING; [Anonymous], 1990, MMWR Recomm Rep, V39, P1; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P962, DOI 10.1001/jama.2016.11046; Blumberg HM, 2016, JAMA-J AM MED ASSOC, V316, P931, DOI 10.1001/jama.2016.11021; Centers for Disease Control and Prevention, 2014, NCHS URB RUR CLASS S; Centers for Disease Control and Prevention, 2012, REP TUB US 2012; Centers for Disease Control and Prevention, 2015, DIV TUB EL STRAT PLA; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P269; Centers for Medicare & Medicaid Services, 2016, NAT MED PHYS FEE SCH; Dorman SE, 2014, AM J RESP CRIT CARE, V189, P77, DOI 10.1164/rccm.201302-0365OC; Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Flaherman VJ, 2007, PEDIATRICS, V120, P90, DOI 10.1542/peds.2006-2168; Fountain FF, 2005, CHEST, V128, P116, DOI 10.1378/chest.128.1.116; Health Resources and Services Administration, 2016, SHORT DES; Hennessey KA, 1998, JAMA-J AM MED ASSOC, V280, P2008, DOI 10.1001/jama.280.23.2008; *I MED COMM EL TUB, 2000, END NEGL EL TUB US; Kahwati LC, 2016, AHRQ PUBLICATION, V14-05212-EF-1; Laurence YV, 2015, PHARMACOECONOMICS, V33, P939, DOI 10.1007/s40273-015-0279-6; Lewinsohn DM, 2017, CLIN INFECT DIS, V64, P111, DOI 10.1093/cid/ciw778; LoBue PA, 2003, AM J RESP CRIT CARE, V168, P443, DOI 10.1164/rccm.200303-390OC; Mancuso JD, 2016, AM J RESP CRIT CARE, V194, P501, DOI 10.1164/rccm.201508-1683OC; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Miller TL, 2015, AM J PUBLIC HEALTH, V105, P930, DOI 10.2105/AJPH.2014.302431; Miller TL, 2010, ANN EPIDEMIOL, V20, P1, DOI 10.1016/j.annepidem.2009.09.004; Miller TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005080; Miramontes R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140881; Optum, 2015, RETR DAT; Owusu-Edusei K, 2017, INT J TUBERC LUNG D, V21, P684, DOI 10.5588/ijtld.16.0617; Reves RR, 2012, AM J RESP CRIT CARE, V186, pI, DOI 10.1164/rccm.201206-1039ED; Salinas JL, 2016, MMWR-MORBID MORTAL W, V65, P273, DOI 10.15585/mmwr.mm6511a2; Schmit KM, 2017, MMWR-MORBID MORTAL W, V66, P289, DOI 10.15585/mmwr.mm6611a2; Sterling TR, 2006, AM J RESP CRIT CARE, V173, P927, DOI 10.1164/rccm.200510-1563OC; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; U. S. Department of Commerce, 2012, US SUMM 2010 POP HOU; Vozoris NT, 2016, CAN RESPIR J, V2016, DOI 10.1155/2016/1850879; WHO, 2017, GLOB TUB REP 2017; World Health Organisation, 2015, GUID MAN LAT TUB INF	39	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193432	10.1371/journal.pone.0193432	http://dx.doi.org/10.1371/journal.pone.0193432			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590130	Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100019
J	Yoon, J; Zame, WR; Banerjee, A; Cadeiras, M; Alaa, AM; van der Schaar, M				Yoon, Jinsung; Zame, William R.; Banerjee, Amitava; Cadeiras, Martin; Alaa, Ahmed M.; van der Schaar, Mihaela			Personalized survival predictions via Trees of Predictors: An application to cardiac transplantation	PLOS ONE			English	Article							VENTRICULAR ASSIST DEVICE; SHORT-TERM MORTALITY; HEART-TRANSPLANTATION; RECIPIENT RISK; WAITING-LIST; FAILURE; INDEX; DONOR	Background Risk prediction is crucial in many areas of medical practice, such as cardiac transplantation, but existing clinical risk-scoring methods have suboptimal performance. We develop a novel risk prediction algorithm and test its performance on the database of all patients who were registered for cardiac transplantation in the United States during 1985-2015. Methods and findings We develop a new, interpretable, methodology (ToPs: Trees of Predictors) built on the principle that specific predictive (survival) models should be used for specific clusters within the patient population. ToPs discovers these specific clusters and the specific predictive model that performs best for each cluster. In comparison with existing clinical risk scoring methods and state-of-the-art machine learning methods, our method provides significant improvements in survival predictions, both post-and pre-cardiac transplantation. For instance: in terms of 3-month survival post-transplantation, our method achieves AUC of 0.660; the best clinical risk scoring method (RSS) achieves 0.587. In terms of 3-year survival/mortality predictions post-transplantation (in comparison to RSS), holding specificity at 80.0%, our algorithm correctly predicts survival for 2,442 (14.0%) more patients (of 17,441 who actually survived); holding sensitivity at 80.0%, our algorithm correctly predicts mortality for 694 (13.0%) more patients (of 5,339 who did not survive). ToPs achieves similar improvements for other time horizons and for predictions pre-transplantation. ToPs discovers the most relevant features (covariates), uses available features to best advantage, and can adapt to changes in clinical practice. Conclusions We show that, in comparison with existing clinical risk-scoring methods and other machine learning methods, ToPs significantly improves survival predictions both post-and pre-cardiac transplantation. ToPs provides a more accurate, personalized approach to survival prediction that can benefit patients, clinicians, and policymakers in making clinical decisions and setting clinical policy. Because survival prediction is widely used in clinical decision making across diseases and clinical specialties, the implications of our methods are far reaching.	[Yoon, Jinsung; Zame, William R.; Cadeiras, Martin; Alaa, Ahmed M.; van der Schaar, Mihaela] Univ Calif Los Angeles, Los Angeles, CA 90024 USA; [Banerjee, Amitava] UCL, Farr Inst Hlth Informat Res, London, England; [van der Schaar, Mihaela] Univ Oxford, Oxford, England; [van der Schaar, Mihaela] Alan Turing Inst, London, England	University of California System; University of California Los Angeles; University of London; University College London; University of Oxford	van der Schaar, M (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90024 USA.; van der Schaar, M (corresponding author), Univ Oxford, Oxford, England.; van der Schaar, M (corresponding author), Alan Turing Inst, London, England.	mihaela.vanderschaar@oxford-man.ox.ac.uk	; Banerjee, Amitava/D-4381-2014	van der schaar, Mihaela/0000-0003-3933-6049; Banerjee, Amitava/0000-0001-8741-3411	Office of Naval Research (ONR); National Science Foundation [ECCS1462245]; Alan Turing Institute [TU/B/000050] Funding Source: researchfish	Office of Naval Research (ONR)(Office of Naval Research); National Science Foundation(National Science Foundation (NSF)); Alan Turing Institute	This work was supported by the Office of Naval Research (ONR) to Mihaela van der Schaar (https://www.onr.navy.mil/) and the National Science Foundation (Grant Number: ECCS1462245) to Mihaela van der Schaar (https://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson KD, 1997, CIRCULATION, V95, P2660, DOI 10.1161/01.CIR.95.12.2660; Alan Agresti, 2003, CATEGORICAL DATA ANA, P482; Alan Agresti, 1996, INTRO CATEGORICAL DA, P135; Almond CSD, 2009, CIRCULATION, V119, P717, DOI 10.1161/CIRCULATIONAHA.108.815712; [Anonymous], 2016, AM HEART ASS NEWS; Arnaoutakis GJ, 2012, J THORAC CARDIOV SUR, V143, P157, DOI 10.1016/j.jtcvs.2011.09.040; BANKER RD, 1986, MANAGE SCI, V32, P1613, DOI 10.1287/mnsc.32.12.1613; Bellera CA, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-20; Buuren S., 2011, J STAT SOFTWARE, V45; Deng MC, 2000, BRIT MED J, V321, P540, DOI 10.1136/bmj.321.7260.540; Fang JC, 2013, MOVING BRIDGES; Gonen M, 2005, BIOMETRIKA, V92, P965, DOI 10.1093/biomet/92.4.965; Hardy Melissa A., 1993, REGRESSION DUMMY VAR, V93; Hong KN, 2011, ANN THORAC SURG, V92, P520, DOI 10.1016/j.athoracsur.2011.02.086; Klein JP, 2005, SURVIVAL ANAL TECHNI; Kleinbaum D.G., 2010, SURVIVAL ANAL, V3; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; Li HE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0111054; Mancini D, 2010, CIRCULATION, V122, P173, DOI 10.1161/CIRCULATIONAHA.109.858076; Maugh T.A., 2009, LOS ANGELES TIMES; Miller RG Jr, 2011, SURVIVAL ANAL, V66; Pagani FD, 2009, J AM COLL CARDIOL, V54, P312, DOI 10.1016/j.jacc.2009.03.055; Reynolds Henry T, 1984, ANAL NOMINAL DATA, V7; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Russo MJ, 2006, CIRCULATION, V114, P2280, DOI 10.1161/CIRCULATIONAHA.106.615708; Si XS, 2011, EUR J OPER RES, V213, P1, DOI 10.1016/j.ejor.2010.11.018; Singh T.P, 2012, CIRCULATION HEART FA; Weiss ES, 2012, J HEART LUNG TRANSPL, V31, P266, DOI 10.1016/j.healun.2011.10.004; Weiss ES, 2011, ANN THORAC SURG, V92, P914, DOI 10.1016/j.athoracsur.2011.04.030; Zannad F, 2012, EUR HEART J, V33, P1049, DOI 10.1093/eurheartj/ehr437	30	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194985	10.1371/journal.pone.0194985	http://dx.doi.org/10.1371/journal.pone.0194985			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590219	Green Submitted, Green Published, gold			2022-12-26	WOS:000428603100094
J	Trosan, P; Smeringaiova, I; Brejchova, K; Bednar, J; Benada, O; Kofronova, O; Jirsova, K				Trosan, Peter; Smeringaiova, Ingrida; Brejchova, Kristyna; Bednar, Jan; Benada, Oldrich; Kofronova, Olga; Jirsova, Katerina			The enzymatic de-epithelialization technique determines denuded amniotic membrane integrity and viability of harvested epithelial cells	PLOS ONE			English	Article							EX-VIVO EXPANSION; MESENCHYMAL STEM-CELLS; GROWTH-FACTOR-I; HUMAN PLURIPOTENT; LIMBAL; DIFFERENTIATION; TRANSPLANTATION; SURFACE; PROLIFERATION; CULTURE	The human amniotic membrane (HAM) is widely used for its wound healing effect in clinical practice, as a feeder for the cell cultivation, or a source of cells to be used in cell therapy. The aim of this study was to find effective and safe enzymatic HAM de-epithelialization method leading to harvesting of both denuded undamaged HAM and viable human amniotic epithelial cells (hAECs). The efficiency of de-epithelialization using TrypLE Express, trypsin/ethylenediaminetetraacetic (EDTA), and thermolysin was monitored by hematoxylin and eosin staining and by the measurement of DNA concentration. The cell viability was determined by trypan blue staining. Scanning electron microscopy and immunodetection of collagen type IV and laminin alpha 5 chain were used to check the basement membrane integrity. De-epithelialized hAECs were cultured and their stemness properties and proliferation potential was assessed after each passage. The HAM was successfully de-epithelialized using all three types of reagents, but morphological changes in basement membrane and stroma were observed after the thermolysin application. About 60% of cells remained viable using trypsin/EDTA, approximately 6% using TrypLE Express, and all cells were lethally damaged after thermolysin application. The hAECs isolated using trypsin/EDTA were successfully cultured up to the 5th passage with increasing proliferation potential and decreased stem cell markers expression (NANOG, SOX2 in prolonged cell culture. Trypsin/EDTA technique was the most efficient for obtaining both undamaged denuded HAM and viable hAECs for consequent culture.	[Trosan, Peter; Smeringaiova, Ingrida; Brejchova, Kristyna; Bednar, Jan; Jirsova, Katerina] Charles Univ Prague, Fac Med 1, Dept Paediat & Adolescent Med, Lab Biol & Pathol Eye, Prague, Czech Republic; [Trosan, Peter; Smeringaiova, Ingrida; Brejchova, Kristyna; Bednar, Jan; Jirsova, Katerina] Gen Univ Hosp, Prague, Czech Republic; [Trosan, Peter; Smeringaiova, Ingrida; Bednar, Jan; Jirsova, Katerina] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Lab Biol & Pathol Eye, Prague, Czech Republic; [Benada, Oldrich; Kofronova, Olga] Czech Acad Sci, Inst Microbiol, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; Charles University Prague; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Trosan, P (corresponding author), Charles Univ Prague, Fac Med 1, Dept Paediat & Adolescent Med, Lab Biol & Pathol Eye, Prague, Czech Republic.; Trosan, P (corresponding author), Gen Univ Hosp, Prague, Czech Republic.; Trosan, P (corresponding author), Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Lab Biol & Pathol Eye, Prague, Czech Republic.	peter.trosan@lf1.cuni.cz	Brejchova, Kristyna/H-5006-2017; Benada, Oldřich/H-2437-2014; Kofroňová, Olga/H-7239-2014; Smeringaiova, Ingrida/H-3625-2017	Brejchova, Kristyna/0000-0003-2839-6310; Benada, Oldřich/0000-0002-4592-6216; Kofroňová, Olga/0000-0002-5435-4088; Bednar, Jan/0000-0003-0879-6405; Smeringaiova, Ingrida/0000-0002-9254-5571	Norwegian Financial Mechanism; Ministry of Education, Youth and Sports [MSMT-28477/2014, 7F14156]; European Regional Development Fund [EF16_013/0001674]; SVV [260367/2017]; Ministry of Education, Youth and Sports of the Czech Republic [LO1509];  [Progres Q25/LF1];  [BBMRI_CZ LM2015089]	Norwegian Financial Mechanism; Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); European Regional Development Fund(European Commission); SVV; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); ; 	This work was supported by the Norwegian Financial Mechanism 2009-2014 and the Ministry of Education, Youth and Sports under Project Contract no. MSMT-28477/2014, project 7F14156 (http://www.msmt.cz/vyzkum-a-vyvoj-2/ financial-andreporting-issues-in-the-czech-norwegian). This study was further supported by the Progres Q25/LF1 (http://www.cuni.cz/UK-7368. html), European Regional Development Fund, project EF16_013/0001674 (http://ec.europa.eu/ regional_policy/en/funding/erdf/) and by BBMRI_CZ LM2015089 (http://biobanka.lf1.cuni. cz/cz/) projects. PT was supported by SVV, project 260367/2017 (http://www.cuni.cz/UK-3362.html). The electron microscopy facility of IMIC was supported by the project LO1509 of the Ministry of Education, Youth and Sports of the Czech Republic (http://www.msmt.cz/?lang=2).	Alcaraz A, 2013, CELL TRANSPLANT, V22, P1351, DOI 10.3727/096368912X657387; APLIN JD, 1985, J CELL SCI, V79, P119; Atlasi Y, 2008, STEM CELLS, V26, P3068, DOI 10.1634/stemcells.2008-0530; Avila-Gonzalez D, 2015, STEM CELL RES, V15, P322, DOI 10.1016/j.scr.2015.07.006; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; Cauffman G, 2006, STEM CELLS, V24, P2685, DOI 10.1634/stemcells.2005-0611; Chen YT, 2007, STEM CELLS, V25, P1995, DOI 10.1634/stemcells.2006-0677; Melo Gustavo Barreto de, 2007, Arq. Bras. Oftalmol., V70, P407, DOI 10.1590/S0004-27492007000300005; Diaz-Prado S, 2010, J CELL BIOCHEM, V111, P846, DOI 10.1002/jcb.22769; Dudakova L, 2012, EXP EYE RES, V104, P74, DOI 10.1016/j.exer.2012.09.005; Evron Ayelet, 2011, Int J Stem Cells, V4, P123; Fang CH, 2012, CELL TRANSPLANT, V21, P1687, DOI 10.3727/096368912X653039; Fatimah SS, 2012, J BIOSCI BIOENG, V114, P220, DOI 10.1016/j.jbiosc.2012.03.021; Fatimah SS, 2010, HUM CELL, V23, P141, DOI 10.1111/j.1749-0774.2010.00096.x; GERMAIN L, 1995, BURNS, V21, P175, DOI 10.1016/0305-4179(95)80004-8; Higa K, 2007, INVEST OPHTH VIS SCI, V48, P597, DOI 10.1167/iovs.06-0664; Hopkinson A, 2008, TISSUE ENG PART C-ME, V14, P371, DOI 10.1089/ten.tec.2008.0315; Ilancheran S, 2007, BIOL REPROD, V77, P577, DOI 10.1095/biolreprod.106.055244; Ito A, 2003, J BIOSCI BIOENG, V95, P589, DOI 10.1263/jbb.95.589; Izumi M, 2009, J REPROD IMMUNOL, V81, P39, DOI 10.1016/j.jri.2009.02.007; Jirsova K, 2017, CELL TISSUE BANK, V18, P193, DOI 10.1007/s10561-017-9618-5; Koizumi N, 2000, CORNEA, V19, P65, DOI 10.1097/00003226-200001000-00013; Koizumi N, 2007, GRAEF ARCH CLIN EXP, V245, P123, DOI 10.1007/s00417-005-0095-3; Kolli S, 2008, REGEN MED, V3, P329, DOI 10.2217/17460751.3.3.329; Lai DM, 2009, CLONING STEM CELLS, V11, P331, DOI 10.1089/clo.2008.0047; Lee J, 2006, J BIOL CHEM, V281, P33554, DOI 10.1074/jbc.M603937200; Li W, 2007, INVEST OPHTH VIS SCI, V48, P605, DOI 10.1167/iovs.06-0514; Garcia-Castro IL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146082; Madhira SL, 2008, MOL VIS, V14, P189; Mahmood R, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/841062; Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357; Miki Toshio, 2010, Curr Protoc Stem Cell Biol, VChapter 1, DOI [10.1002/9780470151808.sc01e03s3, 10.1002/9780470151808.sc01e03s12]; Miyoshi S, 1998, INFECT IMMUN, V66, P4851, DOI 10.1128/IAI.66.10.4851-4855.1998; Modesti A, 1989, Prog Clin Biol Res, V296, P459; Mohan R, 2017, J INT SOC PREV COMMU, V7, P15, DOI 10.4103/jispcd.JISPCD_359_16; Nishishita N, 2015, AM J STEM CELLS, V4, P38; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; NOGUCHI Y, 1995, BIOCHEM BIOPH RES CO, V210, P302, DOI 10.1006/bbrc.1995.1661; Perreault N, 1996, EXP CELL RES, V224, P354, DOI 10.1006/excr.1996.0145; Pratama G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026136; Reboun M, 2016, FOLIA BIOL-PRAGUE, V62, P82; Riau AK, 2010, BIOMATERIALS, V31, P216, DOI 10.1016/j.biomaterials.2009.09.034; Roy R, 2016, J SURG RES, V200, P409, DOI 10.1016/j.jss.2015.08.022; Rutigliano L, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt344; Saghizadeh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079632; Sangwan VS, 2003, BIOSCIENCE REP, V23, P169, DOI 10.1023/B:BIRE.0000007690.43273.73; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Shimazaki J, 1997, OPHTHALMOLOGY, V104, P2068, DOI 10.1016/S0161-6420(97)30057-8; Shortt AJ, 2008, OPHTHALMOLOGY, V115, P1989, DOI 10.1016/j.ophtha.2008.04.039; Shortt AJ, 2009, BIOMATERIALS, V30, P1056, DOI 10.1016/j.biomaterials.2008.10.048; Simat S F, 2008, Med J Malaysia, V63 Suppl A, P53; Sudha B, 2008, INDIAN J MED RES, V128, P149; Tabatabaei Meraj, 2014, Avicenna Journal of Medical Biotechnology, V6, P10; TAKEDA J, 1992, NUCLEIC ACIDS RES, V20, P4613, DOI 10.1093/nar/20.17.4613; Tenenhaus M, 2017, ANN PLAS SURG, V78, pS11, DOI 10.1097/SAP.0000000000000983; Trosan P, 2016, STEM CELLS DEV, V25, P874, DOI 10.1089/scd.2016.0030; Trosan P, 2012, STEM CELLS DEV, V21, P3341, DOI 10.1089/scd.2012.0180; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202; Tseng SCG, 1997, AM J OPHTHALMOL, V124, P765, DOI 10.1016/S0002-9394(14)71693-9; VANHERENDAEL BJ, 1978, AM J OBSTET GYNECOL, V131, P872, DOI 10.1016/S0002-9378(16)33135-0; Wilshaw SP, 2008, TISSUE ENG PT A, V14, P463, DOI 10.1089/tea.2007.0145; Wilshaw SP, 2006, TISSUE ENG, V12, P2117, DOI 10.1089/ten.2006.12.2117; Zajicova A, 2010, CELL TRANSPLANT, V19, P1281, DOI 10.3727/096368910X509040; Zhang T, 2013, INVEST OPHTH VIS SCI, V54, P3072, DOI 10.1167/iovs.12-10805	64	10	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194820	10.1371/journal.pone.0194820	http://dx.doi.org/10.1371/journal.pone.0194820			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584778	Green Published, Green Submitted, gold			2022-12-26	WOS:000428373000040
J	Wang, Y; Liu, HJ; Wu, FY; Yang, XD; Yue, MJ; Pang, YX; Lie, XX; Ma, J; Zhou, G; Gong, P; Liu, MT; Zhang, XM				Wang, Yun; Liu, Hongjian; Wu, Fangyuan; Yang, Xiaodi; Yue, Mengjia; Pang, Yingxin; Lie, Xuanxuan; Ma, Juan; Zhou, Ge; Gong, Ping; Liu, Meitian; Zhang, Xiumin			The association between BMI and body weight perception among children and adolescents in Jilin City, China	PLOS ONE			English	Article							HIGH-SCHOOL-STUDENTS; MASS INDEX; PSYCHOLOGICAL-FACTORS; MULTIETHNIC SAMPLE; CONTROL BEHAVIORS; PERCEIVED WEIGHT; HONG-KONG; OBESITY; OVERWEIGHT; HEALTH	Objectives We evaluated the association between BMI and body weight perception in a sample of children and adolescents. Methods A cross-sectional school-based study was conducted among 7-18 year-olds (N = 9727) from 4 districts in Jilin City, China. We calculated BMI from measured weight and height and assessed body weight perception using a single questionnaire item. We analyzed these data using SPSS version 20.0. Results Approximately 19.8% of these youth perceived themselves as underweight, 57.8% as normal weight, and 22.4% as overweight. In reality, 4.9% were underweight, 64.3% were normal weight, and 30.8% were overweight. Furthermore, approximately 66.4% of these Chinese youth correctly perceived their body image, 28.2% underestimated their true body image, and 5.4% overestimated their weight status. Girls were more likely than boys to overestimate their weight (chi(2) = 135.4, p < 0.05). Adolescents 13-18 years old were more likely than children 7-12 years old to overestimate their weight (chi(2) = 248.4, p < 0.05). Senior high school students were the most likely to overestimate their weight (chi(2) = 297.6, p < 0.05). Kappa tests revealed significant differences in consistency analysis of BMI and body weight perception (Kappa = 0.352, p < 0.05). Kappa < 0.4, the consistency of BMI and body weight perception was poor. Conclusions A mismatch existed between BMI and body weight perception among these children and adolescents. Thus, schools and parents should take steps to help them improve weight management and overall health awareness.	[Wang, Yun; Liu, Hongjian; Yang, Xiaodi; Yue, Mengjia; Pang, Yingxin; Zhou, Ge; Gong, Ping; Liu, Meitian] Jilin Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Changchun, Jilin, Peoples R China; [Wu, Fangyuan; Lie, Xuanxuan; Ma, Juan; Zhang, Xiumin] Jilin Univ, Sch Publ Hlth, Dept Social Med & Hlth Management, Changchun, Jilin, Peoples R China	Jilin University; Jilin University	Zhang, XM (corresponding author), Jilin Univ, Sch Publ Hlth, Dept Social Med & Hlth Management, Changchun, Jilin, Peoples R China.	xiu_min@jlu.edu.cn	Zhang, Xiumin/J-8135-2018; Gong, Ping/J-8072-2018	Zhang, Xiumin/0000-0003-3286-8667; Gong, Ping/0000-0002-3783-2957	Health and Family Planning Commission of Jilin Province, China [2015R022]	Health and Family Planning Commission of Jilin Province, China	This study was supported by grant from the Health and Family Planning Commission of Jilin Province, China (Grant Number: 2015R022, http://wsjsw.jl.gov.cn/) to Xiumin Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KL, 2006, INT J PEDIATR OBES, V1, P239, DOI 10.1080/17477160600913552; Brener ND, 2004, OBES RES, V12, P1866, DOI 10.1038/oby.2004.232; Cheung Patrick C. H., 2007, Hong Kong Medical Journal, V13, P16; Chung AE, 2013, ACAD PEDIATR, V13, P371, DOI 10.1016/j.acap.2013.04.011; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Derenne JL, 2006, ACAD PSYCHIATR, V30, P257, DOI 10.1176/appi.ap.30.3.257; Deschamps V, 2015, PEDIATR OBES, V10, P15, DOI 10.1111/j.2047-6310.2013.00211.x; Dietz WH, 1998, PEDIATRICS, V101, P518; Falkner NH, 2001, OBES RES, V9, P32, DOI 10.1038/oby.2001.5; Felts WM, 1996, J ADOLESCENT HEALTH, V18, P20, DOI 10.1016/1054-139X(95)00046-U; Gurnani M, 2015, PEDIATR CLIN N AM, V62, P821, DOI 10.1016/j.pcl.2015.04.001; Heshmat R, 2015, QUAL LIFE RES, V24, P263, DOI 10.1007/s11136-014-0757-x; Hussin DK, 2011, ALEX J MED, V47, P365, DOI 10.1016/j.ajme.2011.07.013; Jansen W, 2008, J ADOLESCENT HEALTH, V42, P128, DOI 10.1016/j.jadohealth.2007.07.015; Ji CY, 2009, INT J CARDIOL, V132, P1, DOI 10.1016/j.ijcard.2008.07.003; JI CY, 2006, WORLD J PEDIATR, V1, P29; Lee S, 2000, INT J EAT DISORDER, V27, P317, DOI 10.1002/(SICI)1098-108X(200004)27:3&lt;317::AID-EAT9&gt;3.0.CO;2-2; Monro F, 2005, INT J EAT DISORDER, V38, P85, DOI 10.1002/eat.20153; Neumark-Sztainer D, 2006, J ADOLESCENT HEALTH, V39, P244, DOI 10.1016/j.jadohealth.2005.12.001; Niu JJ, 2014, INT J BEHAV MED, V21, P691, DOI 10.1007/s12529-013-9332-z; Nye S., 2008, EAT DISORD, V17, P95, DOI [10.1080/10640260802570155, DOI 10.1080/10640260802570155]; O'Haver Judith, 2009, J Pediatr Nurs, V24, P474, DOI 10.1016/j.pedn.2008.06.011; Paeratakul S, 1998, INT J OBESITY, V22, P424, DOI 10.1038/sj.ijo.0800603; Pesa JA, 2000, J ADOLESCENT HEALTH, V26, P330, DOI 10.1016/S1054-139X(99)00118-4; Pritchard ME, 1997, ADOLESCENCE, V32, P863; Rierdan J, 1997, ADOLESCENCE, V32, P615; Shi ZM, 2007, PUBLIC HEALTH NUTR, V10, P298, DOI 10.1017/S1368980007352488; Standley R, 2009, BODY IMAGE, V6, P56, DOI 10.1016/j.bodyim.2008.08.004; Tatangelo GL, 2015, J HLTH PSYCHOL, DOI 10.1177/1359105315615409.; ter Bogt TFM, 2006, J ADOLESCENT HEALTH, V39, P27, DOI 10.1016/j.jadohealth.2005.09.007; Viner RM, 2006, INT J OBESITY, V30, P1514, DOI 10.1038/sj.ijo.0803352; Wang YF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-183; World Health Organization S-S, 2007, CHILD GROWTH STAND M; Xie B, 2006, PREV MED, V42, P229, DOI 10.1016/j.ypmed.2005.12.013; Xie B, 2006, AM J HEALTH BEHAV, V30, P115, DOI 10.5993/AJHB.30.2.1; Xie B, 2003, J ADOLESCENT HEALTH, V33, P202, DOI 10.1016/S1054-139X(03)00099-5; Yan AF, 2009, SOUTH MED J, V102, P354, DOI 10.1097/SMJ.0b013e318198720b	37	14	16	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194237	10.1371/journal.pone.0194237	http://dx.doi.org/10.1371/journal.pone.0194237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5DH	29579108	gold, Green Published, Green Submitted			2022-12-26	WOS:000428351800023
J	Baldwin, S; Hughes, RJ; Van, TTH; Moore, RJ; Stanley, D				Baldwin, Stephen; Hughes, Robert J.; Thi Thu Hao Van; Moore, Robert J.; Stanley, Dragana			At-hatch administration of probiotic to chickens can introduce beneficial changes in gut microbiota	PLOS ONE			English	Article							LACTOBACILLUS-ACIDOPHILUS; CLOSTRIDIUM-PERFRINGENS; INTESTINAL MICROBIOTA; BACTERIAL COMMUNITY; GROWTH-PERFORMANCE; SERUM-CHOLESTEROL; WEISSELLA-CONFUSA; BACILLUS-SUBTILIS; HEALTH; DISEASE	Recent advances in culture-free microbiological techniques bring new understanding of the role of intestinal microbiota in heath and performance. Intestinal microbial communities in chickens assume a near-stable state within the week which leaves a very small window for permanent microbiota remodelling. It is the first colonisers that determine the fate of microbial community in humans and birds alike, and after the microbiota has matured there are very small odds for permanent modification as stable community resists change. In this study we inoculated broiler chicks immediately post hatch, with 3 species of Lactobacillus, identified by sequencing of 16S rRNA and pheS genes as L. ingluviei, L. agilis and L. reuteri. The strains were isolated from the gut of healthy chickens as reproducibly persistent Lactobacillus strains among multiple flocks. Birds inoculated with the probiotic mix reached significantly higher weight by 28 days of age. Although each strain was able to colonise when administered alone, administering the probiotic mix at-hatch resulted in colonisation by only L. ingluviei. High initial abundance of L. ingluviei was slowly reducing, however, the effects of at-hatch administration of the Lactobacillus mix on modifying microbiota development and structure remained persistent. There was a tendency of promotion of beneficial and reduction in pathogenic taxa in the probiotic administered group.	[Baldwin, Stephen; Stanley, Dragana] Cent Queensland Univ, Inst Future Farming Syst, Rockhampton, Qld, Australia; [Hughes, Robert J.] South Australian Res & Dev Inst, Roseworthy, SA, Australia; [Hughes, Robert J.] Univ Adelaide, Sch Anim & Vet Sci Roseworthy, Adelaide, SA, Australia; [Thi Thu Hao Van; Moore, Robert J.] RMIT Univ, Sch Sci, Bundoora, Vic, Australia	Central Queensland University; South Australian Research & Development Institute (SARDI); University of Adelaide; Royal Melbourne Institute of Technology (RMIT)	Stanley, D (corresponding author), Cent Queensland Univ, Inst Future Farming Syst, Rockhampton, Qld, Australia.	D.Stanley@cqu.edu.au	Moore, Robert J/D-8352-2011; Stanley, Dragana/AAC-2596-2020	Moore, Robert J/0000-0002-0776-5861; Stanley, Dragana/0000-0001-7019-4726; Van, Thi Thu Hao/0000-0002-1559-568X	Australian Research Council (ARC); Australian Government's Cooperative Research Centres Program	Australian Research Council (ARC)(Australian Research Council); Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research is a part of a study funded by Australian Research Council (ARC). DS is an ARC DECRA fellow. The isolation of Lactobacillus strains was part of the project conducted within the Poultry CRC (CRC 2.1.5), established and supported under the Australian Government's Cooperative Research Centres Program.	Adlerberth I., 2000, MICROB ECOL HEALTH D, V12, P223; Alam A, 2016, INFLAMM BOWEL DIS, V22, pS4, DOI 10.1097/01.MIB.0000480098.23732.ba; Aliakbarpour HR, 2012, ASIAN AUSTRAL J ANIM, V25, P1285, DOI 10.5713/ajas.2012.12110; Alkhalf A., 2010, Saudi Journal of Biological Sciences, V17, P219, DOI 10.1016/j.sjbs.2010.04.005; [Anonymous], BIOINFORMATICS; Apajalahti J, 2004, WORLD POULTRY SCI J, V60, P223, DOI 10.1079/WPS200415; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Bailey R, 2013, GUT HLTH POULTRY D W; Bbosa GS, 2014, HEALTH, V06, P16; Bjorkroth KJ, 2002, INT J SYST EVOL MICR, V52, P141, DOI 10.1099/00207713-52-1-141; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chapman CMC, 2011, EUR J NUTR, V50, P1, DOI 10.1007/s00394-010-0166-z; CONWAY PL, 1994, EAAP PUBLIC, P231; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Donaldson EE, 2017, PEERJ, V5, DOI 10.7717/peerj.3587; Dunne C, 1999, ANTON LEEUW INT J G, V76, P279, DOI 10.1023/A:1002065931997; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Fooks LJ, 2002, BRIT J NUTR, V88, pS39, DOI [10.1079/BJN2002628, 10.1079/BJNBJN2002591]; Fujisaka S, 2016, J CLIN INVEST, V126, P4430, DOI 10.1172/JCI86674; FULLER R, 1989, J APPL BACTERIOL, V66, P365; Cano PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041079; Guinane CM, 2013, THER ADV GASTROENTER, V6, P295, DOI 10.1177/1756283X13482996; Gusils C, 2003, CAN J MICROBIOL, V49, P472, DOI [10.1139/w03-055, 10.1139/W03-055]; Haghighi HR, 2006, CLIN VACCINE IMMUNOL, V13, P975, DOI 10.1128/CVI.00161-06; Hiergeist A, 2015, ILAR J, V56, P228, DOI 10.1093/ilar/ilv017; Hinton A, 2004, INT J POULTRY SCI, V3, P603, DOI DOI 10.3923/IJPS.2004.603.607; Jin LZ, 1998, POULTRY SCI, V77, P1259, DOI 10.1093/ps/77.9.1259; Kailasapathy K, 2000, IMMUNOL CELL BIOL, V78, P80, DOI 10.1046/j.1440-1711.2000.00886.x; Kaushik JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008099; Kim M, 2005, INT J FOOD MICROBIOL, V103, P91, DOI 10.1016/j.ijfoodmicro.2004.11.030; Kosin B, 2006, FOOD TECHNOL BIOTECH, V44, P371; La Ragione RM, 2003, VET MICROBIOL, V94, P245, DOI 10.1016/S0378-1135(03)00077-4; Lan Y, 2005, WORLD POULTRY SCI J, V61, P95, DOI 10.1079/WPS200445; Lee YJ, 2003, INT J ANTIMICROB AG, V21, P340, DOI 10.1016/S0924-8579(02)00389-8; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; M'Sadeq SA, 2015, ANIM NUTR, V1, P1, DOI 10.1016/j.aninu.2015.02.004; Mohan B, 1996, BRIT POULTRY SCI, V37, P395, DOI 10.1080/00071669608417870; Mohan V, 2015, EUR J CLIN MICROBIOL, V34, P1503, DOI 10.1007/s10096-015-2392-z; Moreira JLS, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-15; Nam H, 2002, APPL ENVIRON MICROB, V68, P4642, DOI 10.1128/AEM.68.9.4642-4645.2002; Ohland C, 2014, CELLULAR MOL GASTROE, V1, P28; Pan D, 2014, GUT MICROBES, V5, P108, DOI 10.4161/gmic.26945; Renouf M, 2011, J NUTR, V141, P1120, DOI 10.3945/jn.111.140988; Ridaura VK, 2013, SCIENCE NEW YORK NY, V341; Rinttila T, 2013, J APPL POULTRY RES, V22, P647, DOI 10.3382/japr.2013-00742; Sanders ME, 2003, NUTR REV, V61, P91, DOI 10.1301/nr.2003.marr.91-99; Schiffrin EJ, 2002, EUR J CLIN NUTR, V56, pS60, DOI 10.1038/sj.ejcn.1601489; Stanley D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00187; Stanley D, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0388-6; Stanley D, 2014, APPL MICROBIOL BIOT, V98, P4301, DOI 10.1007/s00253-014-5646-2; Stanley D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084290; Stanley D, 2012, APPL MICROBIOL BIOT, V96, P1361, DOI 10.1007/s00253-011-3847-5; Stanley D, 2012, VET MICROBIOL, V159, P155, DOI 10.1016/j.vetmic.2012.03.032; Steer T, 2000, NUTR RES REV, V13, P229, DOI 10.1079/095442200108729089; TANNOCK GW, 1984, APPL ENVIRON MICROB, V47, P441, DOI 10.1128/AEM.47.2.441-442.1984; van der Wielen PWJJ, 2002, MICROBIAL ECOL, V44, P286, DOI 10.1007/s00248-002-2015-y; Walker WA, 2008, CLIN INFECT DIS, V46, pS87, DOI 10.1086/523335; WATKINS BA, 1982, POULTRY SCI, V61, P1298, DOI 10.3382/ps.0611298; ZAR FA, 1985, CHEMOTHERAPY, V31, P29, DOI 10.1159/000238310	60	45	49	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2018	13	3							e0194825	10.1371/journal.pone.0194825	http://dx.doi.org/10.1371/journal.pone.0194825			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA2QK	29570728	Green Published, gold			2022-12-26	WOS:000428168400034
J	Mavhu, W; Rowley, E; Thior, I; Kruse-Levy, N; Mugurungi, O; Ncube, G; Leclerc-Madlala, S				Mavhu, Webster; Rowley, Elizabeth; Thior, Ibou; Kruse-Levy, Natalie; Mugurungi, Owen; Ncube, Getrude; Leclerc-Madlala, Suzanne			Sexual behavior experiences and characteristics of male-female partnerships among HIV positive adolescent girls and young women: Qualitative findings from Zimbabwe	PLOS ONE			English	Article							SEROSTATUS DISCLOSURE; AGE-DIFFERENCES; RISK; INFECTION; PATTERNS; AIDS; MEN	Background New HIV infections among sub-Saharan Africa's adolescent girls and young women (AGYW, ages 15-24) greatly exceed those of their male peers. In addition, AGYW tend to acquire HIV at a much earlier age. Understanding the factors associated with HIV infection in AGYW could inform effective prevention and treatment interventions for these populations and their male sexual partners. Methods This qualitative study, conducted October-November 2016, was a follow on to a quantitative survey that sought to characterize male sexual partners and sexual behaviors of sexually active HIV positive AGYW in Zimbabwe. The qualitative study explored sexual behavior experiences and characteristics of male-female partnerships among the same participants. We conducted in-depth interviews with purposively sampled AGYW (16-24 years). Audio recorded qualitative data were transcribed, translated into English, and thematically coded using NVivo. Results 28 AGYW (n =14 urban, n = 14 rural) took part in the in-depth interviews. 50% were 16-19 years old. Discussions with 10/11 (91%) AGYW who were reportedly infected through sex suggested that they had acquired HIV from their husbands or romantic partners. Accounts also suggested that the age difference between respondents and their male sexual partners was >= 5 years. Overall, respondents described two types of male partners: those older ("sugar daddies", men >= 35 years old) and younger (<35 years). Respondents felt unable to suggest condom use to both older and younger partners. Evident in respondents' accounts was a general low HIV risk perception, particularly with younger men, which was largely due to poor HIV knowledge. Discussions suggested that an AGYW's relationship with either male partner was characterized by some form of violence. Conclusions Discussions highlighted the nature and characteristics of relationships between AGYW and their male sexual partners. Findings could inform interventions to engender risk perception among AGYW, promote female-controlled HIV prevention efforts and, foster risk -reduction among men.	[Mavhu, Webster] Ctr Sexual Hlth & HIV AIDS Res CeSHHAR, Harare, Zimbabwe; [Mavhu, Webster] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Rowley, Elizabeth; Thior, Ibou] PATH, Washington, DC USA; [Thior, Ibou] JSI Res & Training Inst Inc, Arlington, VA USA; [Kruse-Levy, Natalie] USAID, Harare, Zimbabwe; [Mugurungi, Owen; Ncube, Getrude] Minist Hlth & Child Care, AIDS & TB Unit, Harare, Zimbabwe; [Leclerc-Madlala, Suzanne] USAID, Arlington, VA USA	Liverpool School of Tropical Medicine; United States Agency for International Development (USAID); United States Agency for International Development (USAID)	Mavhu, W (corresponding author), Ctr Sexual Hlth & HIV AIDS Res CeSHHAR, Harare, Zimbabwe.; Mavhu, W (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England.	wmavhu@gmail.com		Mavhu, Webster/0000-0003-1881-4398	U.S. Agency for International Development [AID-OAA-A-14-00046]; President's Emergency Plan for AIDS Relief (PEPFAR)	U.S. Agency for International Development(United States Agency for International Development (USAID)); President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was conducted by the Strengthening High Impact Interventions for an AIDS-free generation (AIDSFree) project funded by the U.S. Agency for International Development under Cooperative Agreement AID-OAA-A-14-00046 with support from the Presidents Emergency Plan for AIDS Relief (PEPFAR). AIDSFree is implemented by JSI Research & Training Institute, Inc. with partners Abt Associates Inc., Elizabeth Glaser Pediatric AIDS Foundation, Encompass LLC, IMA World Health, the International HIV/AIDS Alliance, Jhpiego Corporation, and PATH (IT received the funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, GUID ANT THER PREV T; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bygrave H, 17 INT C AIDS STIS A, P2913; Calabrese SK, 2012, AIDS CARE, V24, P1092, DOI 10.1080/09540121.2012.699670; Dellar RC, 2015, J INT AIDS SOC, V18, P64, DOI 10.7448/IAS.18.2.19408; Evangeli M, 2017, AIDS BEHAV, V21, P1, DOI 10.1007/s10461-016-1453-3; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Grimm P, 2022, WILEY INT ENCY MARKE, DOI [10.1002/9781444316568.WIEM02057, DOI 10.1002/9781444316568.WIEM02057, 10.1002/9781444316568.wiem02057]; Harichund C, 2017, AIDS BEHAV; Harrison A, 2015, CURR HIV-AIDS REP, V12, P207, DOI 10.1007/s11904-015-0261-0; Hightow-Weidman LB, 2013, AIDS BEHAV, V17, P360, DOI 10.1007/s10461-012-0331-x; Idele P, 2014, JAIDS-J ACQ IMM DEF, V66, pS144, DOI 10.1097/QAI.0000000000000176; Indravudh PP, 2017, AIDS, V31, pS203, DOI 10.1097/QAD.0000000000001516; KARIM QA, 1992, AIDS, V6, P1535, DOI 10.1097/00002030-199212000-00018; Karim QA, 2017, JAIDS-J ACQ IMM DEF, V75, pS17, DOI [10.1097/QAI.0000000000001316, 10.1097/qai.0000000000001316]; Kelly RJ, 2003, JAIDS-J ACQ IMM DEF, V32, P446, DOI 10.1097/00126334-200304010-00016; King R, 2008, AIDS BEHAV, V12, P232, DOI 10.1007/s10461-007-9307-7; MacPhail C, 2002, INT J STD AIDS, V13, P331, DOI 10.1258/0956462021925162; Malcolm RK, 2012, INT J WOMENS HEALTH, V4, P595, DOI 10.2147/IJWH.S36282; Maughan-Brown B, 2014, AIDS BEHAV, V18, P2469, DOI 10.1007/s10461-014-0828-6; Mavhu W, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2198-7; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Mkandawire-Valhmu L, 2013, GLOB PUBLIC HEALTH, V8, P187, DOI 10.1080/17441692.2012.761261; Naicker N, 2015, AIDS BEHAV, V19, P1305, DOI 10.1007/s10461-015-1002-5; Pascoe SJS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115290; Pinkerton SD, 2007, AIDS BEHAV, V11, P698, DOI 10.1007/s10461-006-9187-2; Ramjee G, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-30; Schaefer R, 2017, AIDS, V31, P1461, DOI [10.1097/qad.0000000000001506, 10.1097/QAD.0000000000001506]; Sia D, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3783-5; Spangler SA, 2014, JAIDS-J ACQ IMM DEF, V67, pS235, DOI 10.1097/QAI.0000000000000376; UNAIDS, 2016, PREV GAP REP; UNAIDS, 2016, HIV PREV AD GIRLS YO; World Health Organization, 2007, NEW DAT MAL CIRC HIV	33	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194732	10.1371/journal.pone.0194732	http://dx.doi.org/10.1371/journal.pone.0194732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566062	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000428093900097
J	Wuerfel, E; Weddige, A; Hagmayer, Y; Jacob, R; Wedekind, L; Stark, W; Gartner, J				Wuerfel, Eva; Weddige, Almuth; Hagmayer, York; Jacob, Rebecca; Wedekind, Lisa; Stark, Wiebke; Gaertner, Jutta			Cognitive deficits including executive functioning in relation to clinical parameters in paediatric MS patients	PLOS ONE			English	Article							ONSET MULTIPLE-SCLEROSIS; PSYCHOSOCIAL FEATURES; CHILDHOOD; CHILDREN; ADOLESCENTS; IMPAIRMENT; PERFORMANCE; DYSFUNCTION	Background A number of studies have investigated cognitive impairment in paediatric patients with multiple sclerosis (MS) but deficits regarding executive functions have not been comprehensively assessed up to now. This study was meant to explore cognitive impairment in German paediatric MS patients with a focus on deficits in executive functions and relate these to clinical disease parameters. Methods and findings Forty paediatric MS patients, which presented at the German centre for MS in childhood and adolescence, were assessed for cognitive deficits applying a very comprehensive battery of cognitive tests including the Wechsler Intelligence scale and subtests of the D-KEFS for executive functions. The performance of MS patients was compared with a group of age and sex matched healthy controls using between-subjects ANOVAs. Paediatric MS patients performed worse in tests assessing verbal comprehension and fluency, processing speed, memory, calculation skills and other executive functions. Arranged by the cognitive domain, group differences were most pronounced regarding verbal comprehension and fluency for the WISC subtests Comprehension (p = 0.000), Vocabulary (p = 0.003) and Information (p = 0.005); regarding processing speed for the written SDMT (p = 0.001) and the WISC subtest Coding (p = 0.005); regarding memory for the VLMT training (p = 0.007) and the BASIC MLT pattern learning training (p = 0.009); regarding executive functions including working memory for the WISC subtest Arithmetics (p = 0.002), the D-KEFS Design Fluency (p = 0.003) and the Corsi block tapping backward task (p = 0.003). Fluid reasoning was largely intact. Relations of cognitive performance and clinical parameters were assessed in MS patients. Disease duration was associated with a reduced performance in tests belonging to the domains verbal comprehension and fluency (WISC Vocabulary: p = 0.034, WISC Information: p = 0.015) and fluid reasoning (WISC Picture Completion: p = 0.003) as well as the WISC Working Memory Index (p = 0.047). Patients with a disease onset between 11 and 14 years performed better in fluid reasoning (WISC matrix reasoning: p = 0.024) than patients with a disease onset at an age above 14. The number of relapses negatively influenced the visual spatial memory performance (BASIC MLT pattern learning training: p = 0.009). Conclusions The distribution of cognitive deficits in a representative group German of paediatric MS patients was similar to the pattern known from other European and North-American cohorts. Paediatric MS patients do have cognitive deficits in executive functions and key qualities necessary for successful school performance. Disease duration, age of onset and the number of relapses influence cognitive performance. Cognitive screenings should be implemented on a regular basis for paediatric MS patients, enabling early intervention.	[Wuerfel, Eva; Weddige, Almuth; Jacob, Rebecca; Wedekind, Lisa; Stark, Wiebke; Gaertner, Jutta] Georg August Univ Gottingen, Univ Med Ctr Gottingen, Div Paediat Neurol, Dept Paediat & Adolescent Med, Gottingen, Germany; [Wuerfel, Eva] Univ Hosp Basel, Inst Med Genet & Pathol, Basel, Switzerland; [Wuerfel, Eva] Univ Basel, Dept Biomed, Human Genom Res Grp, Basel, Switzerland; [Hagmayer, York] Univ Gottingen, Dept Psychol, Gottingen, Germany	University of Gottingen; University of Basel; University of Basel; University of Gottingen	Wuerfel, E (corresponding author), Georg August Univ Gottingen, Univ Med Ctr Gottingen, Div Paediat Neurol, Dept Paediat & Adolescent Med, Gottingen, Germany.; Wuerfel, E (corresponding author), Univ Hosp Basel, Inst Med Genet & Pathol, Basel, Switzerland.; Wuerfel, E (corresponding author), Univ Basel, Dept Biomed, Human Genom Res Grp, Basel, Switzerland.	eva-kristin.wuerfel@med.uni-goettingen.de			University Medical Center Gottingen	University Medical Center Gottingen	This work was funded by a personal grant for Eva Wurfel supplied by the University Medical Center Gottingen as part of a program to support young researcher. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato MP, 2008, NEUROLOGY, V70, P1891, DOI 10.1212/01.wnl.0000312276.23177.fa; Amato MP, 2010, NEUROLOGY, V75, P1134, DOI 10.1212/WNL.0b013e3181f4d821; Amato MP, 2014, NEUROLOGY, V83, P1432, DOI 10.1212/WNL.0000000000000885; Aschenbrenner S., 2000, REGENSBURGER WORTFLU; Aubert-Broche B, 2014, NEUROLOGY, V83, P2140, DOI 10.1212/WNL.0000000000001045; Blaschek A, 2012, NEUROPEDIATRICS, V43, P176, DOI 10.1055/s-0032-1315429; Boiko A, 2002, NEUROLOGY, V59, P1006, DOI 10.1212/WNL.59.7.1006; Brickenkamp R., 2002, D2 TEST D2 AUFMERKSA; Cardoso M, 2015, PEDIATR NEUROL, V53, P287, DOI 10.1016/j.pediatrneurol.2015.06.007; Charvet LE, 2014, MULT SCLER J, V20, P1502, DOI 10.1177/1352458514527862; Charvet LE, 2014, J NEUROL SCI, V341, P79, DOI 10.1016/j.jns.2014.04.006; Cohen J.E., 1988, STAT POWER ANAL BEHA; Delis DC, 2001, DELIS KAPLAN EXECUTI; Fay AJ, 2012, MULT SCLER J, V18, P1008, DOI 10.1177/1352458511431725; Ghezzi A, 1997, MULT SCLER, V3, P43, DOI 10.1177/135245859700300105; Helmstaedter C, 2001, VERBALER LEM MERKFAH; Johnston MV, 2009, DEV DISABIL RES REV, V15, P94, DOI 10.1002/ddrr.64; Julian L, 2013, J CHILD NEUROL, V28, P102, DOI 10.1177/0883073812464816; Kaufman A. S., 2004, K NEK KAUFMAN NEUROP; Krupp LB, 2013, MULT SCLER J, V19, P1261, DOI 10.1177/1352458513484547; Lepach A.C., 2008, BATTERY ASSESSMENT C; MacAllister WS, 2007, DEV NEUROPSYCHOL, V32, P625, DOI 10.1080/87565640701375872; MacAllister WS, 2005, NEUROLOGY, V64, P1422, DOI 10.1212/01.WNL.0000158474.24191.BC; Nunan-Saah J, 2015, MULT SCLER J, V21, P1355, DOI 10.1177/1352458515586088; Pagulayan KF, 2006, J CLIN EXP NEUROPSYC, V28, P1043, DOI 10.1080/13803390500350977; Petermann F., 2008, WAIS 4 WECHSLER ADUL; Petermann F., 2007, HAWIK 4 HAMBURG WECH; Portaccio E, 2009, MULT SCLER J, V15, P620, DOI 10.1177/1352458508101950; Smith A, 2007, SYMBOL DIGIT MODALIT; Stark W, 2008, J NEUROL, V255, P119, DOI 10.1007/s00415-008-6022-x; Suppiej A, 2014, NEUROPSYCH DIS TREAT, V10, P1385, DOI 10.2147/NDT.S48495; Till C, 2012, ARCH CLIN NEUROPSYCH, V27, P495, DOI 10.1093/arclin/acs058; Till C, 2011, NEUROPSYCHOLOGY, V25, P319, DOI 10.1037/a0022051; Till C, 2013, NEUROPSYCHOLOGY, V27, P210, DOI 10.1037/a0031665; Till C, 2011, NEUROREPORT, V22, P1005, DOI 10.1097/WNR.0b013e32834dc301	35	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							0194873	10.1371/journal.pone.0194873	http://dx.doi.org/10.1371/journal.pone.0194873			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA1RF	29566099	Green Published, gold			2022-12-26	WOS:000428093900115
J	Zaman, M; Hanif, M; Shaheryar, ZA				Zaman, Muhammad; Hanif, Muhammad; Shaheryar, Zaib Ali			Development of Tizanidine HCI-Meloxicam loaded mucoadhesive buccal films: In-vitro and in-vivo evaluation	PLOS ONE			English	Article							ARABINOXYLAN; FORMULATION; DELIVERY; PHARMACOKINETICS; RABBITS; SINGLE	The purpose of the study was to develop Tizanidine HCI (TZN) and Meloxicam (MLX) loaded bilayer mucoadhesive films intended for buccal administration, aiming to enhance the bioavailability. Bilayer films were prepared by solvent evaporation technique selecting arabinoxylan (ARX) as a sustained release (SR) layer forming polymer and hydroxypropyl methylcellulose (HPMC) E-15 as an immediate release (IR) layer-forming polymer. Prepared films were subjected to in-vitro drug release, surface morphology, mechanical strength, compatibility of the ingredients, drug contents, ex-vivo mucoadhesion strength and drug permeation. Crossover study design was applied to study the in-vivo pharmacokinetics by using albino rabbits. Various pharmacokinetic parameters including AUC, C-max, t(max) and t(1/2) of both drugs loaded in films were compared with standard solution/dispersion administered to the rabbits at the dose of 1 mg/kg. The results unveiled instant release and permeation of MLX from IR layer, while good controlled release and permeation characteristics of TZN from SR films over 8 h. films were of uniform thickness with smooth surface and satisfactory mechanical strength. Mucoadhesion strength was sufficient to provide suitable contact time with mucosal membrane. The pharmacokinetic study exhibited prompt absorption of MLX with better AUC (0-t) (6655.64 ng/ml*h vs 6538.99 ng/ml*h) and C-max (436.98 ng/ml vs 411.33 ng/ml) from oral dispersion. Similarly buccal films has shown enhanced half-life (9.91hr vs 2.51 hr), AUC (0-t) (1043.4 ng/ml*h vs 149.1 ng/ml*h) and C-max (91.92 ng/ml vs 42.29 ng/ml) from oral solution. A statistical investigation disclosed a significantly improved pharmacokinetics of TZN and MLX after their absorption across buccal route following administration of buccal film (p<0.05). ARX proved expedient and bilayer buccal films as a drug delivery system ascertained the dual effect of providing instant release of one active agent and persistent release of another one with improved pharmacokinetics.	[Zaman, Muhammad; Hanif, Muhammad] Bahauddin Zakariya Univ, Dept Pharm, Multan, Pakistan; [Zaman, Muhammad; Shaheryar, Zaib Ali] Univ Lahore, Fac Pharm, Lahore, Pakistan	Bahauddin Zakariya University; University of Lahore	Hanif, M (corresponding author), Bahauddin Zakariya Univ, Dept Pharm, Multan, Pakistan.	muhammadhanif14@yahoo.com						Abd Elbary A, 2012, B FACULTY PHARM, V50, P89; Aher ND, 2014, SCI WORLD J, DOI 10.1155/2014/297603; Akbar J, 2012, CARBOHYD POLYM, V88, P1348, DOI 10.1016/j.carbpol.2012.02.016; Bahri-Najafi GK, 2012, RES PHARM SCI, V7, pS343; Bashir S, 2014, PAK J PHARM SCI, V27, P1761; Dodla S, 2013, ASIAN J PHARM CLIN R, V6, P39; El-Mahrouk GM, 2014, INT J PHARMACEUT, V467, P100, DOI 10.1016/j.ijpharm.2014.03.049; Eroglu H., 2009, HACETTEPE U J FACULT, P115; Erum A, 2015, DRUG CHEM TOXICOL, V38, P300, DOI 10.3109/01480545.2014.956219; Hanif M, 2017, DARU, V25, DOI 10.1186/s40199-017-0172-2; Henney HR, 2008, CLIN THER, V30, P2263, DOI 10.1016/j.clinthera.2008.12.014; Iqbal MS, 2011, CARBOHYD POLYM, V83, P1218, DOI 10.1016/j.carbpol.2010.09.024; Jain NK, 2002, LIFE SCI, V70, P2857, DOI 10.1016/S0024-3205(02)01549-7; Jay S, 2002, J PHARM SCI, V91, P2016, DOI 10.1002/jps.10198; Ketul P., 2013, IJPTP, V4, P655; Kimble B, 2013, J VET PHARMACOL THER, V36, P486, DOI 10.1111/jvp.12038; Koland M, 2011, INT J PHARM INVESTIG, V1, P164, DOI 10.4103/2230-973X.85967; Kreuder AJ, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-85; Kumar R, 2014, ASIAN J PHARM RES, V4, P47; Moawad FA, 2017, DRUG DELIV, V24, P252, DOI 10.1080/10717544.2016.1245369; Montoya L, 2004, VET RES COMMUN, V28, P415, DOI 10.1023/B:VERC.0000034995.81994.49; Patel MM, 2011, DRUG DELIV, V18, P281, DOI 10.3109/10717544.2010.538447; Prabhu P, 2011, INT J PHARM INVESTIG, V1, P99, DOI 10.4103/2230-973X.82417; Rajesh K., 2012, INT J PHARM RES, V3, P212; Rana P, 2013, DRUG DELIV, V20, P224, DOI 10.3109/10717544.2013.779331; Saghir S, 2008, CARBOHYD POLYM, V74, P309, DOI 10.1016/j.carbpol.2008.02.019; Singh AV, 2011, J PHARM ANA, V1, P251, DOI 10.1016/j.jpha.2011.08.001; Singla R, 2003, PHARM DEV TECHNOL, V8, P229, DOI 10.1081/PDT-120022152; Thimmasetty J, 2008, PAK J PHARM SCI, V21, P241; Turner PV, 2006, COMPARATIVE MED, V56, P63; Zaman M, 2016, ACTA POL PHARM, V73, P1351; Zaman M, 2016, BRIT J PHARM RES, V11, DOI 10.9734/BJPR/2016/23976	32	19	20	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194410	10.1371/journal.pone.0194410	http://dx.doi.org/10.1371/journal.pone.0194410			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566073	Green Published, gold, Green Submitted			2022-12-26	WOS:000428093900062
J	Americo-Da-Silva, L; Diaz, J; Bustamante, M; Mancilla, G; Oyarzun, I; Verdejo, HE; Quiroga, C				Americo-Da-Silva, Luan; Diaz, Jheimmy; Bustamante, Mario; Mancilla, Georthan; Oyarzun, Ingrid; Verdejo, Hugo E.; Quiroga, Clara			A new role for HERPUD1 and ERAD activation in osteoblast differentiation and mineralization	FASEB JOURNAL			English	Article						osteoblastogenesis; bone; proteostasis; proteasome	ENDOPLASMIC-RETICULUM; ALKALINE-PHOSPHATASE; PROTEASOMAL DEGRADATION; STRESS; CELLS; HOMEOSTASIS; CULTURE	Bone integrity depends on a finely tuned balance between bone synthesis by osteoblasts and resorption by osteoclasts. The secretion capacity of mature osteoblasts requires strict control of proteostasis. Endoplasmic reticulum-associated degradation (ERAD) prevents the accumulation of unfolded ER proteins via dislocation to the cytosol and degradation by the proteasome. The ER membrane protein, homocysteine-inducible endoplasmic reticulum protein with ubiquitin-like domain 1 (HERPUD1), is a key component of the ERAD multiprotein complex which helps to stabilize the complex and facilitate the efficient degradation of unfolded proteins. HERPUD1 expression is strongly up-regulated by the unfolded protein response and cellular stress. The aim of the current study was to establish whether HERPUD1 and ERAD play roles in osteoblast differentiation and maturation. We evaluated preosteoblastic MC3T3-E1 cell and primary rat osteoblast differentiation by measuring calcium deposit levels, alkaline phosphatase activity, and runt-related transcription factor 2 and osterix expression. We found that ERAD and proteasomal degradation were activated and that HERPUD1 expression was increased as osteoblast differentiation progressed. The absence of HERPUD1 blocked osteoblast mineralization in vitro and significantly reduced alkaline phosphatase activity. In contrast, HERPUD1 overexpression activated the osteoblast differentiation program. Our results demonstrate that HERPUD1 and ERAD are important for the activation of the osteoblast maturation program and may be useful new targets for elucidating bone physiology.Americo-Da-Silva, L., Diaz, J., Bustamante, M., Mancilla, G., Oyarzun, I., Verdejo, H. E., Quiroga, C. A new role for HERPUD1 and ERAD activation in osteoblast differentiation and mineralization.	[Americo-Da-Silva, Luan; Diaz, Jheimmy; Bustamante, Mario; Mancilla, Georthan; Oyarzun, Ingrid; Verdejo, Hugo E.; Quiroga, Clara] Pontificia Univ Catolica Chile, Fac Med, Div Enfermedades Cardiovasc, Marcoleta 391,Diagonal Paraguay 362, Santiago 8330077, Chile; [Bustamante, Mario; Mancilla, Georthan; Oyarzun, Ingrid; Verdejo, Hugo E.; Quiroga, Clara] Univ Chile, Adv Ctr Chron Dis, Santiago, Chile; [Bustamante, Mario; Mancilla, Georthan; Oyarzun, Ingrid; Verdejo, Hugo E.; Quiroga, Clara] Pontificia Univ Catolica Chile, Santiago, Chile	Pontificia Universidad Catolica de Chile; Universidad de Chile; Pontificia Universidad Catolica de Chile	Quiroga, C (corresponding author), Pontificia Univ Catolica Chile, Fac Med, Div Enfermedades Cardiovasc, Marcoleta 391,Diagonal Paraguay 362, Santiago 8330077, Chile.	clquiroga@uc.cl	Diaz, Jheimmy/AAF-6886-2019; Quiroga, Clara/AAB-4180-2020	Verdejo, Hugo/0000-0003-0078-4792	Comision Nacional de Investigacion Cientifica y Tecnologica (Santiago, Chile) Grants from Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [11140470, 3160287, 1150359, 11171024]; Fondo de Financiamiento de Centros de Investigacion en areas Prioritarias (FONDAP) [15130011]	Comision Nacional de Investigacion Cientifica y Tecnologica (Santiago, Chile) Grants from Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT); Fondo de Financiamiento de Centros de Investigacion en areas Prioritarias (FONDAP)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP)	The authors acknowledge the Advanced Microscopy Facility, Unidad de Microscopia Avanzada-Facultad de Medicina (UMA-MED), Pontificia Universidad Catolica de Chile, and Confocal Microscopy Unit, Faculty of Chemical and Pharmaceutical Sciences, Universidad de Chile, for equipment and technical support, and Roberto Bravo-Sagua, Ph.D. [Instituto de Nutricion y Tecnologia de los Alimentos (INTA), Universidad de Chile, Santiago, Chile], for illustrations of our results. This work was supported by the Comision Nacional de Investigacion Cientifica y Tecnologica (Santiago, Chile) Grants from Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) 11140470 (to C.Q.), 3160287 (to M.B.), 1150359 (to H.V.), 11171024 (to J.D.), and Fondo de Financiamiento de Centros de Investigacion en areas Prioritarias (FONDAP) 15130011 (to H.V. and C.Q.). L.A.-D.-S. and J.D. are cofirst authors. The authors declare no conflicts of interest.	Beck GR, 1998, J CELL BIOCHEM, V68, P269, DOI 10.1002/(SICI)1097-4644(19980201)68:2<269::AID-JCB13>3.0.CO;2-A; Bergmann TJ, 2016, AIMS BIOPHYS, V3, P456, DOI 10.3934/biophy.2016.4.456; Bravo R, 2011, J CELL SCI, V124, P2143, DOI 10.1242/jcs.080762; Chan SL, 2004, J BIOL CHEM, V279, P28733, DOI 10.1074/jbc.M404272200; Edwards MH, 2015, BONE, V80, P126, DOI 10.1016/j.bone.2015.04.016; Eura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034298; Fakhry Maya, 2013, World J Stem Cells, V5, P136, DOI 10.4252/wjsc.v5.i4.136; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Fitzgerald J, 1999, J BIOL CHEM, V274, P27392, DOI 10.1074/jbc.274.39.27392; Florencio-Silva R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/421746; Forlino A, 2007, MATRIX BIOL, V26, P604, DOI 10.1016/j.matbio.2007.06.005; Fumagalli F, 2016, NAT CELL BIOL, V18, P1173, DOI 10.1038/ncb3423; Golub EE., 2007, CURR OPIN ORTHOP, V18, P444, DOI [10.1097/BCO.0b013e3282630851, 10.1084/jem.93.5.415, DOI 10.1084/JEM.93.5.415]; Guo R, 2008, J BIOL CHEM, V283, P23084, DOI 10.1074/jbc.M709848200; Haarhaus M, 2017, NAT REV NEPHROL, V13, P429, DOI 10.1038/nrneph.2017.60; Haarhaus M, 2013, J VASC RES, V50, P167, DOI 10.1159/000346161; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Han Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06304-x; Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079; Hori O, 2004, GENES CELLS, V9, P457, DOI 10.1111/j.1356-9597.2004.00735.x; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Jonason JH, 2014, METHODS MOL BIOL, V1130, P295, DOI 10.1007/978-1-62703-989-5_22; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Kim TY, 2008, BIOCHEM BIOPH RES CO, V369, P741, DOI 10.1016/j.bbrc.2008.02.086; Kny M, 2011, J BIOL CHEM, V286, P5151, DOI 10.1074/jbc.M110.134551; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Komori T, 2010, ADV EXP MED BIOL, V658, P43, DOI 10.1007/978-1-4419-1050-9_5; Leitman J, 2014, MOL BIOL CELL, V25, P1050, DOI 10.1091/mbc.E13-06-0350; Liu JH, 2017, 2017 13TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND SECURITY (CIS), P6, DOI 10.1109/CIS.2017.00010; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Ma YJ, 2004, J BIOL CHEM, V279, P13792, DOI 10.1074/jbc.M313724200; Mihci E, 2012, J CLIN RES PEDIATR E, V4, P101, DOI [10.4274/Jcrpe.619, 10.4274/jcrpe.619]; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Murray EJB, 1998, EXP CELL RES, V242, P460, DOI 10.1006/excr.1998.4090; Office of the Surgeon General (US), 2004, BON HLTH OST REP SUR; Quiroga C, 2013, BBA-MOL CELL RES, V1833, P3295, DOI 10.1016/j.bbamcr.2013.09.006; Reifenstein EC, 2011, CLIN ORTHOP RELAT R, V469, P2096, DOI 10.1007/s11999-011-1832-z; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Sun FR, 2018, ONCOL RES, V26, P655, DOI 10.3727/096504017X15119525209765; Tuvia S, 2007, J CELL BIOL, V177, P51, DOI 10.1083/jcb.200611036; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wei JW, 2008, J CELL PHYSIOL, V217, P693, DOI 10.1002/jcp.21543; Wong M. Y., 2017, CURR TOP MICROBIOL I; Wong N, 2013, DIABETOLOGIA, V56, P1569, DOI 10.1007/s00125-013-2908-y; Yan XZ, 2014, TISSUE ENG PART C-ME, V20, P198, DOI 10.1089/ten.tec.2012.0412; Zuo C, 2012, OSTEOPOROSIS INT, V23, P1653, DOI 10.1007/s00198-012-1909-x	49	9	10	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4681	4695		10.1096/fj.201701229RR	http://dx.doi.org/10.1096/fj.201701229RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29570393				2022-12-26	WOS:000443817700006
J	Lin, JS; Pissaridou, P; Wu, HH; Tsai, MD; Filloux, A; Lai, EM				Lin, Jer-Sheng; Pissaridou, Panayiota; Wu, Hsin-Hui; Tsai, Ming-Daw; Filloux, Alain; Lai, Erh-Min			TagF-mediated repression of bacterial type VI secretion systems involves a direct interaction with the cytoplasmic protein Fha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ICMF FAMILY PROTEIN; ACTIVATION; TRANSPORTER; LOCUS; GENE; TSSB	The bacterial type VI secretion system (T6SS) delivers effectors into eukaryotic host cells or toxins into bacterial competitor for survival and fitness. The T6SS is positively regulated by the threonine phosphorylation pathway (TPP) and negatively by the T6SS-accessory protein TagF. Here, we studied the mechanisms underlying TagF-mediated T6SS repression in two distinct bacterial pathogens, Agrobacterium tumefaciens and Pseudomonas aeruginosa. We found that in A. tumefaciens, T6SS toxin secretion and T6SS-dependent antibacterial activity are suppressed by a two-domain chimeric protein consisting of TagF and PppA, a putative phosphatase. Remarkably, this TagF domain is sufficient to post-translationally repress the T6SS, and this inhibition is independent of TPP. This repression requires interaction with a cytoplasmic protein, Fha, critical for activating T6SS assembly. In P. aeruginosa, PppA and TagF are two distinct proteins that repress T6SS in TPP-dependent and -independent pathways, respectively. P. aeruginosa TagF interacts with Fha1, suggesting that formation of this complex represents a conserved TagF-mediated regulatory mechanism. Using TagF variants with substitutions of conserved amino acid residues at predicted protein-protein interaction interfaces, we uncovered evidence that the TagF-Fha interaction is critical for TagF-mediated T6SS repression in both bacteria. TagF inhibits T6SS without affecting T6SS protein abundance in A. tumefaciens, but TagF overexpression reduces the protein levels of all analyzed T6SS components in P. aeruginosa. Our results indicate that TagF interacts with Fha, which in turn could impact different stages of T6SS assembly in different bacteria, possibly reflecting an evolutionary divergence in T6SS control.	[Lin, Jer-Sheng; Lai, Erh-Min] Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan; [Wu, Hsin-Hui; Tsai, Ming-Daw] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Pissaridou, Panayiota; Filloux, Alain] Imperial Coll London, Dept Life Sci, Med Res Council Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [Lin, Jer-Sheng] Max Planck Inst Terr Microbiol, Dept Organism Interact, Karl von Frisch Str 10, D-35043 Marburg, Germany; [Wu, Hsin-Hui] Rosalind Franklin Univ Med & Sci, Dept Biochem & Mol Biol, 3333 Green Bay Rd, Chicago, IL 60064 USA	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Imperial College London; Max Planck Society; Chicago Medical School; Rosalind Franklin University Medical & Science	Lai, EM (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan.	emlai@gate.sinica.edu.tw	Lai, Erh-Min/ABG-9558-2020; Tsai, Ming-Daw/G-4689-2019; Pissaridou, Panayiota/AAJ-4261-2021	Lai, Erh-Min/0000-0003-3630-8683; Tsai, Ming-Daw/0000-0003-1374-0414; Pissaridou, Panayiota/0000-0003-4841-7676; Filloux, Alain/0000-0003-1307-0289	Ministry of Science and Technology of Taiwan (MOST) [104-2311-B-001-025-MY3]; MOST [105-0210-01-12-01, 106-0210-01-15-04]; Taiwan Protein Project [107-0210-01-19-02]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/N002539/1]; Medical Research Council (MRC) [MR/N023250/1]; MOST-BBSRC International Partnering Award [105-2911-I-001-503, BB/M02735X/1]; BBSRC [BB/N002539/1, BB/M02735X/1] Funding Source: UKRI; MRC [MR/K001930/1, MR/N023250/1] Funding Source: UKRI	Ministry of Science and Technology of Taiwan (MOST); MOST; Taiwan Protein Project; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MOST-BBSRC International Partnering Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Ministry of Science and Technology of Taiwan (MOST) Grants 104-2311-B-001-025-MY3 (to E.-M. L.) and MOST Grants 105-0210-01-12-01 and 106-0210-01-15-04 and Taiwan Protein Project Grant 107-0210-01-19-02 (to M.-D.T.); Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/N002539/1 and Medical Research Council (MRC) Grant MR/N023250/1 (to A.F.); and MOST-BBSRC International Partnering Award (Grant 105-2911-I-001-503) (to E.-M. L.) and Grant BB/M02735X/1 (to A. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Allsopp LP, 2017, P NATL ACAD SCI USA, V114, P7707, DOI 10.1073/pnas.1700286114; Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Basler M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0021; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; Bernard CS, 2010, J BACTERIOL, V192, P3850, DOI 10.1128/JB.00370-10; Bondage DD, 2016, P NATL ACAD SCI USA, V113, pE3931, DOI 10.1073/pnas.1600428113; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Brackmann M, 2017, TRENDS CELL BIOL, V27, P623, DOI 10.1016/j.tcb.2017.05.003; Brunet YR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005545; Brunet YR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002205; Casabona MG, 2013, ENVIRON MICROBIOL, V15, P471, DOI 10.1111/j.1462-2920.2012.02816.x; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Cianfanelli FR, 2016, TRENDS MICROBIOL, V24, P51, DOI 10.1016/j.tim.2015.10.005; Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386; Forster A, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.600510; Fritsch MJ, 2013, MOL CELL PROTEOMICS, V12, P2735, DOI 10.1074/mcp.M113.030502; Hachani A, 2016, CURR OPIN MICROBIOL, V29, P81, DOI 10.1016/j.mib.2015.11.006; Hachani A, 2013, JOVE-J VIS EXP, DOI 10.3791/50103; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Hsu FS, 2009, MOL MICROBIOL, V72, P1111, DOI 10.1111/j.1365-2958.2009.06701.x; Lai EM, 1998, J BACTERIOL, V180, P2711, DOI 10.1128/JB.180.10.2711-2717.1998; LeRoux M, 2015, ELIFE, V4, DOI 10.7554/eLife.05701; Leung KY, 2011, CURR OPIN MICROBIOL, V14, P9, DOI 10.1016/j.mib.2010.09.017; Lin JS, 2017, METHODS MOL BIOL, V1615, P177, DOI 10.1007/978-1-4939-7033-9_14; Lin JS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003991; Lin JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067647; Liu AC, 2008, J APPL MICROBIOL, V105, P1372, DOI 10.1111/j.1365-2672.2008.03874.x; Lossi NS, 2012, MOL MICROBIOL, V86, P437, DOI 10.1111/j.1365-2958.2012.08204.x; Ma LS, 2014, CELL HOST MICROBE, V16, P94, DOI 10.1016/j.chom.2014.06.002; Ma LS, 2012, J BIOL CHEM, V287, P15610, DOI 10.1074/jbc.M111.301630; Ma LS, 2009, J BACTERIOL, V191, P4316, DOI 10.1128/JB.00029-09; Mahajan A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.151re12; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Planamente S, 2016, EMBO J, V35, P1613, DOI 10.15252/embj.201694024; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Silverman JM, 2011, MOL MICROBIOL, V82, P1277, DOI 10.1111/j.1365-2958.2011.07889.x; Wu CF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002938; Wu HY, 2008, J BACTERIOL, V190, P2841, DOI 10.1128/JB.01775-07; Yang Z, 2018, ENVIRON MICROBIOL, V20, P903, DOI 10.1111/1462-2920.14039; ZHANG XG, 1995, J BIOL CHEM, V270, P11181, DOI 10.1074/jbc.270.19.11181; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zheng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023876; Zoued A, 2016, NATURE, V531, P59, DOI 10.1038/nature17182; Zoued A, 2014, BBA-MOL CELL RES, V1843, P1664, DOI 10.1016/j.bbamcr.2014.03.018	47	18	20	3	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8829	8842		10.1074/jbc.RA117.001618	http://dx.doi.org/10.1074/jbc.RA117.001618			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29599293	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000434941900009
J	Cardillo, E; Acedo, A; Abad, E				Cardillo, Enrique; Acedo, Angel; Abad, Enrique			Topographic effects on dispersal patterns of Phytophthora cinnamomi at a stand scale in a Spanish heathland	PLOS ONE			English	Article							LANDSCAPE EPIDEMIOLOGY; SPATIAL-PATTERNS; OAK WOODLANDS; DISEASE; SOIL; PERSPECTIVES; INVOLVEMENT; VILLUERCAS; MORTALITY; PATHOGENS	Phytophthora cinnamomi is one of the most important plant pathogens in the world, causing root rot in more than a thousand plant species. This observational study was carried out on a P. cinnamomi infected heathland of Erica umbellata used as goat pasture. The patterns and shapes of disease foci and their distribution were described in a spatial and temporal context using an aerial photograph record. A set of topographic traits was selected on the basis of a disease dynamic hypothesis and their effects on observed spatial disease patterns were analyzed. Incipient infections situated in flat terrain expanded as compact circular front patterns with a low growth rate. On slopes, disease patches developed more rapidly down slope, forming parabolic shapes. The axis direction of the parabolas was highly correlated with terrain aspect, while the parabolic amplitude was associated with land curvature and slope. New secondary foci appeared over the years producing an accelerated increase of the affected surface. These new foci were observed in sites where disease density was higher or near sites more frequently visited by animals such as the stable or the forage crop. In contrast, a smaller number of disease foci occur in areas which animals are reluctant to visit, such as where they have a short range of vision. Our results suggest that 1) the growth of existing P. cinnamomi foci is controlled by a combination of root-to-root contact and water flows, 2) the increase in the diseased area arises mainly from the multiplication of patches, 3) the formation of new foci is mediated by long-distance transport due to the movement of animals and humans along certain preferential pathways, and 4) geomorphology and topography traits are associated with the epidemiology of this soil-borne pathogen.	[Cardillo, Enrique; Acedo, Angel] Ctr Invest Cient & Tecnol Extremadura CICYTEX, Inst Corcho Madera & Carbon Vegetal, Merida, Spain; [Abad, Enrique] Univ Extremadura, Dept Fis Aplicada, Merida, Spain; [Abad, Enrique] Univ Extremadura, Inst Computac Cient Avanzada ICCAEX, Merida, Spain	Universidad de Extremadura; Universidad de Extremadura	Cardillo, E (corresponding author), Ctr Invest Cient & Tecnol Extremadura CICYTEX, Inst Corcho Madera & Carbon Vegetal, Merida, Spain.	enrique.cardillo@juntaex.es	Abad, E/I-7242-2012	Abad, E/0000-0002-1765-409X; Cardillo, Enrique/0000-0002-9148-7090	local Goverment of Extremadura (Junta de Extremadura - Spain); MIMECO [FIS2016-76359-P]	local Goverment of Extremadura (Junta de Extremadura - Spain); MIMECO	This work was funding by the local Goverment of Extremadura (Junta de Extremadura - Spain) and by MIMECO Grant No FIS2016-76359-P to EA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acedo A., 2013, New Disease Reports, V28, P8, DOI 10.5197/j.2044-0588.2013.028.008; Baddeley A, 1997, ANN STAT, V25, P263; Bailey DW, 2008, RESOURCE ECOLOGY; Balci Y, 2003, FOREST PATHOL, V33, P157, DOI 10.1046/j.1439-0329.2003.00318.x; Balci Y, 2010, FOREST PATHOL, V40, P430, DOI 10.1111/j.1439-0329.2009.00617.x; Bates D., 1988, NONLINEAR REGRESSION; Bivand R, 2015, J STAT SOFTW, V63, P1; BRASIER CM, 1992, NATURE, V360, P539, DOI 10.1038/360539a0; Burgess TI, 2017, GLOBAL CHANGE BIOL, V23, P1661, DOI 10.1111/gcb.13492; Conrad O, 2015, GEOSCI MODEL DEV, V8, P1991, DOI 10.5194/gmd-8-1991-2015; Costa A, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009097; Dillon WW, 2014, EUR J PLANT PATHOL, V138, P449, DOI 10.1007/s10658-013-0376-3; Ebdon D., 1985, A PRACTICAL APPROACH, V2nd; ESPEJO R, 1987, CATENA, V14, P399, DOI 10.1016/0341-8162(87)90012-9; ESRI, 2011, ARCGIS DESKT REL 10; Fox J., 2019, R COMPANION APPL REG, V.; Garbelotto M, 2006, PLANT DIS, V90, P685, DOI 10.1094/PD-90-0685C; Gaspar P, 2011, SMALL RUMINANT RES, V97, P1, DOI 10.1016/j.smallrumres.2011.03.001; Gomez-Aparicio L, 2012, NEW PHYTOL, V194, P1014, DOI 10.1111/j.1469-8137.2012.04108.x; CRANDALL B. S., 1950, Plant Disease Reporter, V34, P194; Hansen E., 2003, SUDD OAK DEATH ONL S, V4; Hengeveld R., 1989, DYNAMICS BIOL INVASI; HILL TCJ, 1994, AUST J BOT, V42, P725, DOI 10.1071/BT9940725; Holdenrieder O, 2004, TRENDS ECOL EVOL, V19, P446, DOI 10.1016/j.tree.2004.06.003; Hopewell L, 2005, BEHAV PROCESS, V70, P186, DOI 10.1016/j.beproc.2005.04.009; Huberli D, 2000, AUSTRALAS PLANT PATH, V29, P164, DOI 10.1071/AP00029; Jung T, 1996, EUR J FOREST PATHOL, V26, P253; Keith DA, 2012, P LINN SOC N S W, V134, pB147; Kelly M, 2002, PHOTOGRAMM ENG REM S, V68, P1001; KINAL J, 1993, PLANT DIS, V77, P1085, DOI 10.1094/PD-77-1085; KLIEJUNAS JT, 1976, PHYTOPATHOLOGY, V66, P457, DOI 10.1094/Phyto-66-457; Krull CR, 2013, AUSTRAL ECOL, V38, P534, DOI 10.1111/j.1442-9993.2012.02444.x; Lachica M, 1997, BRIT J NUTR, V77, P73, DOI 10.1017/S0007114500002890; Li AY, 2014, BIOL INVASIONS, V16, P765, DOI 10.1007/s10530-013-0535-7; Lopez-Herrera C.J., 1991, P 2 WORLD AVOCADO C, V1, P119; Lowe S., 2000, ENCY BIOL INVASIONS; Madden LV, 2006, EUR J PLANT PATHOL, V115, P3, DOI 10.1007/s10658-005-1229-5; Mariscal-Sancho IL, 2008, THESIS; Meentemeyer RK, 2012, ANNU REV PHYTOPATHOL, V50, P379, DOI 10.1146/annurev-phyto-081211-172938; MOORE ID, 1991, HYDROL PROCESS, V5, P3, DOI 10.1002/hyp.3360050103; Moreira AC, 2005, FOREST PATHOL, V35, P145, DOI 10.1111/j.1439-0329.2005.00397.x; Muller MM, 2016, BIOL INVASIONS, V18, P2841, DOI 10.1007/s10530-016-1174-6; Nagel JH, PHYTOPHTHORA GLOBAL; Okubo  A., 2013, DIFFUSION ECOLOGICAL, V14; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Plantegenest M, 2007, J R SOC INTERFACE, V4, P963, DOI 10.1098/rsif.2007.1114; R Core Team, 2014, R LANG ENV STAT COMP; RISENHOOVER KL, 1985, J WILDLIFE MANAGE, V49, P797, DOI 10.2307/3801714; Ristaino JB, 2000, ANNU REV PHYTOPATHOL, V38, P541, DOI 10.1146/annurev.phyto.38.1.541; Robin C, 1998, ANN SCI FOREST, P55; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rodriguez-Molina MC, 2005, FOREST PATHOL, V35, P411, DOI 10.1111/j.1439-0329.2005.00423.x; SHEA SR, 1983, PLANT DIS, V67, P970, DOI 10.1094/PD-67-970; Shearer BL, 2014, AUSTRALAS PLANT PATH, V43, P327, DOI 10.1007/s13313-014-0274-y; SHIGESADA N, 1995, AM NAT, V146, P229, DOI 10.1086/285796; Silverman B.W., 1986, DENSITY ESTIMATION S; Stubben C, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i11; Swiecki TJ, 2002, P S CAL OAK WOODL 5, P789; Thompson S, 2013, AM NAT, V181, pE1, DOI 10.1086/668572; Thompson SE, 2014, GLOBAL CHANGE BIOL, V20, P1299, DOI 10.1111/gcb.12463; Vannini A, 2010, FOREST PATHOL, V40, P73, DOI 10.1111/j.1439-0329.2009.00609.x; Venables WN., 2002, MODERN APPL STAT S 4; Wilson BA, 2003, AUSTRAL ECOL, V28, P108, DOI 10.1046/j.1442-9993.2003.01253.x; Wilson BA, 2012, AUST J BOT, V60, P495, DOI 10.1071/BT11305; Yokoyama R, 2002, PHOTOGRAMM ENG REM S, V68, P257; ZEVENBERGEN LW, 1987, EARTH SURF PROCESSES, V12, P47, DOI 10.1002/esp.3290120107	66	15	15	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195060	10.1371/journal.pone.0195060	http://dx.doi.org/10.1371/journal.pone.0195060			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601576	Green Published, gold, Green Submitted			2022-12-26	WOS:000428845900016
J	Rand, D				Rand, Debbie			Proprioception deficits in chronic stroke-Upper extremity function and daily living	PLOS ONE			English	Article							FUGL-MEYER ASSESSMENT; SENSORIMOTOR SYSTEM; POSITION SENSE; BLOCK TEST; RELIABILITY; RECOVERY; VALIDITY; PERFORMANCE; IMPAIRMENT; ARM	Background Proprioception deficits are common post-stroke and predict poor functional outcome. It is unknown if the presence of proprioception deficits is negatively associated with the motor and functional ability of the affected upper extremity and daily living at the chronic stage post-stroke. Aims 1) To describe proprioception deficits of individuals with chronic stroke, 2) to correlate the severity of proprioception deficits with the motor and functional ability of the upper extremity, and 3) to compare independence in basic and instrumental activities in daily living (BADL, IADL), upper extremity motor and functional abilities between individuals with and without proprioception deficits. Methods 102 adults aged 29-85 years with chronic stroke participated in this cross sectional study. The upper extremity was assessed for proprioception (Thumb localization Test), motor [Fugl-Meyer Motor Assessment (FMA)] and functional ability [Action Research Arm Test (ARAT), Box and Block Test (BBT)], grip strength and daily use [Motor Activity Log (MAL)]. Independence in BADL and IADL was also assessed. Results 71 participants had intact proprioception, 31 participants had mild-moderate proprioception deficits. Negative significant (p<.001) correlations were found between the severity of proprioception deficits to the motor ability (FMA) (r = -.41), functional ability (ARAT) (r = -.48), dexterity (BBT) (r = -.43), grip strength (r = -.41) and daily-use (MAL amount and quality) (r = -.55 and r = -.54, respectively) of the affected upper extremity. Significant between-group differences were found for BADL, IADL and upper extremity measures. Conclusion Proprioception deficits of individuals with chronic stroke are negatively associated with upper extremity motor and functional abilities and independence in daily living. Therefore, proprioception should be assessed at the chronic stage post-stroke.	[Rand, Debbie] Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Dept Occupat Therapy, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Rand, D (corresponding author), Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Dept Occupat Therapy, Tel Aviv, Israel.	drand@post.tau.ac.il		Rand, Debbie/0000-0001-6410-2389				Berthoz A., 2000, BRAINS SENSE MOVEMEN; Bohannon Richard W, 2005, J Hand Ther, V18, P426, DOI 10.1197/j.jht.2005.07.003; Carey L.M., 1995, CRIT REV PHYS REHABI, V7, P51, DOI [10.1615/CritRevPhysRehabilMed.v7.i1.40, DOI 10.1615/CRITREVPHYSREHABILMED.V7.I1.40]; Chalsen GG, 1987, J NEUROL REHABIL, V1, P137; Cohen J.E., 1988, STAT POWER ANAL BEHA; Connell LA, 2008, CLIN REHABIL, V22, P758, DOI 10.1177/0269215508090674; Cromwell FS, 1965, OCCUPATIONAL THERAPI, P29; Desrosiers J, 1996, STROKE, V27, P1564, DOI 10.1161/01.STR.27.9.1564; Dukelow SP, 2010, NEUROREHAB NEURAL RE, V24, P178, DOI 10.1177/1545968309345267; DUNCAN PW, 1983, PHYS THER, V63, P1606, DOI 10.1093/ptj/63.10.1606; Fess EE., 1992, CLIN ASSESSMENT RECO, P41; Findlater SE, 2017, J MOTOR BEHAV, V49, P27, DOI 10.1080/00222895.2016.1219303; Findlater SE, 2016, CORTEX, V79, P42, DOI 10.1016/j.cortex.2016.03.008; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gottlieb D, 1997, J NEUROL REHABIL, V11, P239; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; Haerer AF, 1997, DEJONGS NEUROLOGIC E; Harris JE, 2006, NEUROREHAB NEURAL RE, V20, P380, DOI 10.1177/1545968305284528; Hillier S, 2015, NEUROREHAB NEURAL RE, V29, P933, DOI 10.1177/1545968315573055; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; Kenzie JM, 2014, J NEUROL SCI, V342, P52, DOI 10.1016/j.jns.2014.04.025; Kessner SS, 2016, TOP STROKE REHABIL, V23, P136, DOI 10.1080/10749357.2015.1116822; Kielhofner G., 2006, RES OCCUPATIONAL THE, P155, DOI DOI 10.1136/JNNP.73.2.188; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; LAWTON MP, 1982, J GERONTOL, V37, P91, DOI 10.1093/geronj/37.1.91; Lephart SM, 2000, PROPRIOCEPTION AND NEUROMUSCULAR CONTROL IN JOINT STABILITY, pXVII; Lin JH, 2004, CLIN REHABIL, V18, P391, DOI 10.1191/0269215504cr737oa; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; Masedo AI, 2005, AM J PHYS MED REHAB, V84, P167, DOI 10.1097/01.PHM.0000154898.25609.4A; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; MATHIOWETZ V, 1984, J HAND SURG-AM, V9A, P222, DOI 10.1016/S0363-5023(84)80146-X; Niessen MHM, 2009, AM J PHYS MED REHAB, V88, P979, DOI 10.1097/PHM.0b013e3181c1eac1; Ogard WK, 2011, STRENGTH COND J, V33, P111, DOI 10.1519/SSC.0b013e31821bf3ae; Platz T, 2005, CLIN REHABIL, V19, P404, DOI 10.1191/0269215505cr832oa; Portney L.G., 2000, FDN CLIN RES APPL PR, P560; PRESCOTT RJ, 1982, STROKE, V13, P641, DOI 10.1161/01.STR.13.5.641; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Rand D, 1999, NEUROREHAB NEURAL RE, V13, P15, DOI 10.1177/154596839901300104; Rand D., 2001, PHYS OCCUPATIONAL TH, V18, P69, DOI DOI 10.1080/J148v18n03_05; Rand D, 2015, J STROKE CEREBROVASC, V24, P274, DOI 10.1016/j.jstrokecerebrovasdis.2014.07.039; REDING MJ, 1988, STROKE, V19, P1354, DOI 10.1161/01.STR.19.11.1354; REDING MJ, 1990, STROKE, V21, P35; Riemann BL, 2002, J ATHL TRAINING, V37, P71; Riemann BL, 2002, J ATHL TRAINING, V37, P80; Semrau JA, 2013, STROKE, V44, P3414, DOI 10.1161/STROKEAHA.113.002058; SMITH DL, 1983, AGE AGEING, V12, P63, DOI 10.1093/ageing/12.1.63; Stern PH, 1971, STROKE, V2, P213, DOI 10.1161/01.STR.2.3.213; Sunderland A, 2000, STROKE, V31, P430, DOI 10.1161/01.STR.31.2.430; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Uswatte G, 2005, STROKE, V36, P2493, DOI 10.1161/01.STR.0000185928.90848.2e; WADE DT, 1983, J NEUROL NEUROSUR PS, V46, P521, DOI 10.1136/jnnp.46.6.521; WADE DT, 1985, J NEUROL NEUROSUR PS, V48, P7, DOI 10.1136/jnnp.48.1.7; Wetter S, 2005, ARCH PHYS MED REHAB, V86, P776, DOI 10.1016/j.apmr.2004.08.009; Winward CE, 2002, CLIN REHABIL, V16, P523, DOI 10.1191/0269215502cr522oa; Ziegler DK, 1975, MAJORS PHYS DIAGNOSI, P118	56	27	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195043	10.1371/journal.pone.0195043	http://dx.doi.org/10.1371/journal.pone.0195043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB1XW	29601594	gold, Green Published, Green Submitted			2022-12-26	WOS:000428845900015
J	Joenvaara, S; Saraswat, M; Kuusela, P; Saraswat, S; Agarwal, R; Kaartinen, J; Jarvinen, A; Renkonen, R				Joenvaara, Sakari; Saraswat, Mayank; Kuusela, Pentti; Saraswat, Shruti; Agarwal, Rahul; Kaartinen, Johanna; Jarvinen, Asko; Renkonen, Risto			Quantitative N-glycoproteomics reveals altered glycosylation levels of various plasma proteins in bloodstream infected patients	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CRITICALLY-ILL PATIENTS; ACUTE-PANCREATITIS; BACTEREMIA; SEPSIS; SERUM; PROCALCITONIN; MORTALITY; OUTCOMES; DISEASE	Bloodstream infections are associated with high morbidity and mortality with rates varying from 10-25% and higher. Appropriate and timely onset of antibiotic therapy influences the prognosis of these patients. It requires the diagnostic accuracy which is not afforded by current gold standards such as blood culture. Moreover, the time from blood sampling to blood culture results is a key determinant of reducing mortality. No established biomarkers exist which can differentiate bloodstream infections from other systemic inflammatory conditions. This calls for studies on biomarkers potential of molecular profiling of plasma as it is affected most by the molecular changes accompanying bloodstream infections. N-glycosylation is a post-translational modification which is very sensitive to changes in physiology. Here we have performed targeted quantitative N-glycoproteomics from plasma samples of patients with confirmed positive blood culture together with age and sex matched febrile controls with negative blood culture reports. Three hundred and sixty eight potential N-glycopeptides were quantified by mass spectrometry and 149 were further selected for identification. Twenty four N-glycopeptides were identified with high confidence together with elucidation of the peptide sequence, N-glycosylation site, glycan composition and proposed glycan structures. Principal component analysis, orthogonal projections to latent structures-discriminant analysis (S-Plot) and self-organizing maps clustering among other statistical methods were employed to analyze the data. These methods gave us clear separation of the two patient classes. We propose high-confidence N-glycopeptides which have the power to separate the bloodstream infections from blood culture negative febrile patients and shed light on host response during bacteremia. Data are available via ProteomeXchange with identifier PXD009048.	[Joenvaara, Sakari; Saraswat, Mayank; Saraswat, Shruti; Renkonen, Risto] Univ Helsinki, Transplantat Lab, Haartmaninkatu 3, Helsinki, Finland; [Joenvaara, Sakari; Saraswat, Mayank; Kuusela, Pentti; Jarvinen, Asko; Renkonen, Risto] Helsinki Univ Hosp, HUSLAB, Helsinki, Finland; [Kuusela, Pentti] HUSLAB, Div Clin Microbiol, Helsinki, Finland; [Kuusela, Pentti] Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland; [Agarwal, Rahul] All India Inst Med Sci, Dept Reprod Biol, New Delhi, India; [Kaartinen, Johanna] Helsinki Univ Hosp, Emergency Med & Serv, Helsinki, Finland; [Jarvinen, Asko] Univ Helsinki, HUH Inflammat Ctr, Div Infect Dis, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Saraswat, M (corresponding author), Univ Helsinki, Transplantat Lab, Haartmaninkatu 3, Helsinki, Finland.; Saraswat, M (corresponding author), Helsinki Univ Hosp, HUSLAB, Helsinki, Finland.	sarawat.mk@gmail.com	Saraswat, Mayank/F-2985-2015	Saraswat, Mayank/0000-0002-5021-8150				ASSICOT M, 1993, LANCET, V341, P515, DOI 10.1016/0140-6736(93)90277-N; Basset C, 2000, SCAND J IMMUNOL, V51, P300; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Brinkman-van der Linden ECM, 1998, GLYCOCONJUGATE J, V15, P177, DOI 10.1023/A:1006972307166; Chatterjee B. P., 2014, Proceedings of the Indian National Science Academy Part B Biological Sciences, V84, P865, DOI 10.1007/s40011-014-0331-x; DeCoux A, 2015, CRIT CARE MED, V43, P2049, DOI 10.1097/CCM.0000000000001134; Fumagalli O, 1997, INFECT IMMUN, V65, P4445, DOI 10.1128/IAI.65.11.4445-4451.1997; Geyer PE, 2016, CELL SYST, V2, P185, DOI 10.1016/j.cels.2016.02.015; Gornik O, 2007, GLYCOBIOLOGY, V17, P1321, DOI 10.1093/glycob/cwm106; HALL MM, 1976, J CLIN MICROBIOL, V3, P643; Jenkins TC, 2008, CLIN INFECT DIS, V46, P1000, DOI 10.1086/529190; Joenvaara S, 2008, GLYCOBIOLOGY, V18, P339, DOI 10.1093/glycob/cwn013; Knezevic A, 2009, J PROTEOME RES, V8, P694, DOI 10.1021/pr800737u; Kollef MH, 1999, CHEST, V115, P462, DOI 10.1378/chest.115.2.462; Kontro H, 2014, PROTEOMICS, V14, P1713, DOI 10.1002/pmic.201300270; Kreisman LSC, 2012, GLYCOBIOLOGY, V22, P1019, DOI 10.1093/glycob/cws070; Kuusela P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172987; Moran AP, 2011, GUT, V60, P1412, DOI 10.1136/gut.2010.212704; Nakamura A, 2009, SHOCK, V31, P586, DOI 10.1097/SHK.0b013e31819716fa; Nargis Waheeda, 2014, Int J Crit Illn Inj Sci, V4, P195, DOI 10.4103/2229-5151.141356; Nikfardjam M, 2000, J INTERN MED, V247, P341, DOI 10.1046/j.1365-2796.2000.00670.x; Povoa P, 2005, CLIN MICROBIOL INFEC, V11, P101, DOI 10.1111/j.1469-0691.2004.01044.x; Pritchett J W, 1996, Am J Orthop (Belle Mead NJ), V25, P759; Saraswat M, 2014, MOL CELLULAR PROTEOM; Saraswat M, 2016, J PROTEOME RES, V15, P991, DOI 10.1021/acs.jproteome.5b01069; Schwetz I, 2007, J CLIN MICROBIOL, V45, P2691, DOI 10.1128/JCM.00085-07; Shadick NA, 2006, ARCH INTERN MED, V166, P2490, DOI 10.1001/archinte.166.22.2490; Siegel SJ, 2014, CELL HOST MICROBE, V16, P55, DOI 10.1016/j.chom.2014.06.005; Skogberg K, 2012, CLIN MICROBIOL INFEC, V18, pE170, DOI 10.1111/j.1469-0691.2012.03845.x; TENNEY JH, 1982, J CLIN MICROBIOL, V15, P558, DOI 10.1128/JCM.15.4.558-561.1982; van Dijk W, 1994, GLYCOSYLATION DIS, V1, P5; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wines BD, 2011, J BIOL CHEM, V286, P33118, DOI 10.1074/jbc.M111.272252; Zarkesh Marjaneh, 2015, Acta Med Iran, V53, P408; Zhang Y, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-18	35	9	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195006	10.1371/journal.pone.0195006	http://dx.doi.org/10.1371/journal.pone.0195006			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596458	Green Published, Green Submitted, gold			2022-12-26	WOS:000428630000065
J	Wang, KY; Yamada, S; Izumi, H; Tsukamoto, M; Nakashima, T; Tasaki, T; Guo, X; Uramoto, H; Sasaguri, Y; Kohno, K				Wang, Ke-Yong; Yamada, Sohsuke; Izumi, Hiroto; Tsukamoto, Manabu; Nakashima, Tamiji; Tasaki, Takashi; Guo, Xin; Uramoto, Hidetaka; Sasaguri, Yasuyuki; Kohno, Kimitoshi			Critical in vivo roles of WNT10A in wound healing by regulating collagen expression/synthesis in WNT10A-deficient mice	PLOS ONE			English	Article							NONALCOHOLIC-STEATOHEPATITIS; CELLS; APOPTOSIS; RECEPTORS; CANCER; ACTIVATION; FIBROSIS; DISEASE; PLAQUES; MODEL	Background We have reported that WNT10A plays a critical role in the growth of fibroblasts/myofibroblasts and microvascular endothelial cells, i.e.; wound healing/scarring. To ascertain the in vivo regulatory, central functions of WNT10A, we examined the net effects of WNT10A depletion using WNT10A-deficient mice (WNT10A(-/-)). Methods and results We generated WNT10A(-/-) mice, displaying a range of unique phenotypes of morpho/organogenetic failure, such as growth retardation, alopecia, kyphosis and infertility, and then focused on the functions of WNT10A in wound healing. We subjected C57BL/6J wild-type (WT) or WNT10A(-/-) mice to skin ulcer formation. The WNT10A(-/-) mice had significantly larger injured areas and delayed wound healing, which were associated with (a) a smaller number of fibroblasts/myofibroblasts and microvessels; and (b) more reduced expression and synthesis of collagen, compared with WT mice with intact WNT10A expression, especially in those with activated myofibroblasts. Conclusions These observations indicate that WNT10A signaling can play a pivotal in vivo role in wound healing by regulating the expression and synthesis of collagen, as one of fibrogenic factors, at least in part, and critical in vivo roles of WNT10A-mediated effective wound healing are extremely closely associated with collagen expression.	[Wang, Ke-Yong] Univ Occupat & Environm Hlth, Sch Med, Shared Use Res Ctr, Kitakyushu, Fukuoka, Japan; [Yamada, Sohsuke; Guo, Xin] Kanazawa Med Univ, Dept Pathol & Lab Med, Uchinada, Ishikawa, Japan; [Izumi, Hiroto] Univ Occupat & Environm Hlth, Sch Med, Dept Occupat Pneumol, Kitakyushu, Fukuoka, Japan; [Tsukamoto, Manabu] Univ Occupat & Environm Hlth, Sch Med, Dept Orthopaed Surg, Kitakyushu, Fukuoka, Japan; [Nakashima, Tamiji] Univ Occupat & Environm Hlth, Dept Human Informat & Life Sci, Sch Med, Kitakyushu, Fukuoka, Japan; [Tasaki, Takashi; Sasaguri, Yasuyuki] Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Cell Biol, Kitakyushu, Fukuoka, Japan; [Uramoto, Hidetaka] Kanazawa Med Univ, Dept Thorac Surg, Uchinada, Ishikawa, Japan; [Sasaguri, Yasuyuki] Fukuoka Tokushukai Hosp, Lab Pathol, Fukuoka, Japan; [Kohno, Kimitoshi] Asahi Matsumoto Hosp, Kitakyushu, Fukuoka, Japan	University of Occupational & Environmental Health - Japan; Kanazawa Medical University; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; Kanazawa Medical University	Yamada, S (corresponding author), Kanazawa Med Univ, Dept Pathol & Lab Med, Uchinada, Ishikawa, Japan.; Kohno, K (corresponding author), Asahi Matsumoto Hosp, Kitakyushu, Fukuoka, Japan.	sohsuke@kanazawa-med.ac.jp; kimitt2411@yahoo.co.jp	Tsukamoto, Manabu/AAJ-2632-2021	Tsukamoto, Manabu/0000-0003-4577-5072; wang, ke-yong/0000-0001-8295-1229	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [UM1OD023221] Funding Source: NIH RePORTER; NIH HHS [UM1 OD023221] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adaimy L, 2007, AM J HUM GENET, V81, P821, DOI 10.1086/520064; Darby IA, 2014, CLIN COSMET INV DERM, V7, P301, DOI 10.2147/CCID.S50046; Dunn L, 2013, JOVE-J VIS EXP, DOI 10.3791/50265; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Gallagher KA, 2015, DIABETES, V64, P1420, DOI 10.2337/db14-0872; Haddow A, 1972, Adv Cancer Res, V16, P181; Heise RL, 2011, J BIOL CHEM, V286, P17435, DOI 10.1074/jbc.M110.137273; Ji WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103224; Khosravi-Maharlooei M, 2016, IMMUNOLOGY, V148, P22, DOI 10.1111/imm.12584; Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001; Kina-Tanada M, 2017, DIABETOLOGIA, V60, P1138, DOI 10.1007/s00125-017-4259-6; Kirikoshi H, 2001, INT J ONCOL, V19, P533; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Kuma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103240; Lan Y, 2014, SEMIN CELL DEV BIOL, V25, P61, DOI 10.1016/j.semcdb.2013.12.003; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Liu F, 2010, J DENT RES, V89, P318, DOI 10.1177/0022034510363373; Macheda ML, 2008, CURR CANCER DRUG TAR, V8, P454, DOI 10.2174/156800908785699324; Nabeshima A, 2013, ANTIOXID REDOX SIGN, V19, P1983, DOI 10.1089/ars.2012.4946; Nawata A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152549; Noguchi H, 2014, AM J PATHOL, V184, P644, DOI 10.1016/j.ajpath.2013.11.030; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Oda K, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0357-0; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Seong I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031477; Su JL, 2005, CARCINOGENESIS, V26, P1, DOI 10.1093/carcin/bgh220; Tasaki T, 2013, AM J PATHOL, V182, P597, DOI 10.1016/j.ajpath.2012.10.008; ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013; Tsukamoto M, 2016, BONE, V85, P70, DOI 10.1016/j.bone.2016.01.025; Wang KY, 2011, ARTERIOSCL THROM VAS, V31, P800, DOI 10.1161/ATVBAHA.110.215228; Wang KY, 2010, AM J PATHOL, V177, P713, DOI 10.2353/ajpath.2010.091198; Xu MG, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15397; Yamada S, 2008, AM J PATHOL, V172, P1419, DOI 10.2353/ajpath.2008.070604; Yamada S, 2011, ARTERIOSCL THROM VAS, V31, P1555, DOI 10.1161/ATVBAHA.111.227140; Yang J, 2015, MOL GENET GENOM MED, V3, P40, DOI 10.1002/mgg3.111; Yasuniwa Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015330; Zhang JY, 2016, J CLIN MED, V5, DOI 10.3390/jcm5040041	38	17	16	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195156	10.1371/journal.pone.0195156	http://dx.doi.org/10.1371/journal.pone.0195156			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596490	Green Published, gold, Green Submitted			2022-12-26	WOS:000428630000088
J	Hamlington, KL; Bates, JHT; Roy, GS; Julianelle, AJ; Charlebois, C; Suki, B; Smith, BJ				Hamlington, Katharine L.; Bates, Jason H. T.; Roy, Gregory S.; Julianelle, Adele J.; Charlebois, Chantel; Suki, Bela; Smith, Bradford J.			Alveolar leak develops by a rich-get-richer process in ventilator-induced lung injury	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; EPITHELIAL-CELL DAMAGE; MECHANICAL VENTILATION; DEEP INFLATION; MODEL; PROGRESSION; DISRUPTION; PRESSURE; MICE; TRANSMIGRATION	Acute respiratory distress syndrome (ARDS) is a life-threatening condition for which there are currently no medical therapies other than supportive care involving the application of mechanical ventilation. However, mechanical ventilation itself can worsen ARDS by damaging the alveolocapillary barrier in the lungs. This allows plasma-derived fluid and proteins to leak into the airspaces of the lung where they interfere with the functioning of pulmonary surfactant, which increases the stresses of mechanical ventilation and worsens lung injury. Once such ventilator-induced lung injury (VILI) is underway, managing ARDS and saving the patient becomes increasingly problematic. Maintaining an intact alveolar barrier thus represents a crucial management goal, but the biophysical processes that perforate this barrier remain incompletely understood. To study the dynamics of barrier perforation, we subjected initially normal mice to an injurious ventilation regimen that imposed both volutrauma (overdistension injury) and atelectrauma (injury from repetitive reopening of closed airspaces) on the lung, and observed the rate at which macromolecules of various sizes leaked into the airspaces as a function of the degree of overall injury. Computational modeling applied to our findings suggests that perforations in the alveolocapillary barrier appear and progress according to a rich-get-richer mechanism in which the likelihood of a perforation getting larger increases with the size of the perforation. We suggest that atelectrauma causes the perforations after which volutrauma expands them. This mechanism explains why atelectrauma appears to be essential to the initiation of VILI in a normal lung, and why atelectrauma and volutrauma then act synergistically once VILI is underway.	[Hamlington, Katharine L.; Bates, Jason H. T.; Roy, Gregory S.; Julianelle, Adele J.; Charlebois, Chantel] Univ Vermont, Coll Med, Dept Med, Vermont Lung Ctr, Burlington, VT 05405 USA; [Suki, Bela] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Smith, Bradford J.] Univ Colorado Denver, Dept Bioengn, Aurora, CO 80045 USA	University of Vermont; Boston University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Smith, BJ (corresponding author), Univ Colorado Denver, Dept Bioengn, Aurora, CO 80045 USA.	bradford.smith@ucdenver.edu		Charlebois, Chantel/0000-0002-4139-3539; Hamlington, Katharine/0000-0002-5221-2123; Smith, Bradford/0000-0002-1583-6762	National Heart, Lung, and Blood Institute [R01 HL-124052, T32 HL-076122, R01 HL-111745, K99 HL-128944, R00 HL128944]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124052, T32HL076122, K99HL128944, R00HL128944, R01HL142702, R01HL111745] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by The National Heart, Lung, and Blood Institute (https://www.nhlbi.nih.gov/) grants R01 HL-124052 (JB), T32 HL-076122 (JB), R01 HL-111745 (BS), K99 HL-128944 (BJS), and R00 HL128944 (BJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 2004, J APPL PHYSIOL, V96, P293, DOI 10.1152/japplphysiol.00270.2003; Allen G, 2002, J APPL PHYSIOL, V93, P1709, DOI 10.1152/japplphysiol.00473.2002; Allen GB, 2007, AM J PHYSIOL-LUNG C, V292, pL1580, DOI 10.1152/ajplung.00483.2006; Amato MBP, 2015, NEW ENGL J MED, V372, P747, DOI 10.1056/NEJMsa1410639; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Armstrong JK, 2004, BIOPHYS J, V87, P4259, DOI 10.1529/biophysj.104.047746; Bagrow JP, J PHYS A, V1008, P41; Bak P., 1996, NATURE WORKDS SCI SE; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bates JHT, 2007, ANN BIOMED ENG, V35, P1165, DOI 10.1007/s10439-007-9291-0; Bilek AM, 2003, J APPL PHYSIOL, V94, P770, DOI 10.1152/japplphysiol.00764.2002; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Cavalcanti AB, 2017, JAMA-J AM MED ASSOC, V318, P1335, DOI 10.1001/jama.2017.14171; DREYFUSS D, 1988, AM REV RESPIR DIS, V137, P1159, DOI 10.1164/ajrccm/137.5.1159; Edens HA, 2000, ADV DRUG DELIVER REV, V41, P315, DOI 10.1016/S0169-409X(00)00049-1; Gajic O, 2003, AM J RESP CRIT CARE, V167, P1057, DOI 10.1164/rccm.200208-889OC; Ginzberg HH, 2001, AM J PHYSIOL-GASTR L, V281, pG705, DOI 10.1152/ajpgi.2001.281.3.G705; Gunther A, 1996, AM J RESP CRIT CARE, V153, P176; Hamlington KL, 2016, AM J RESP CRIT CARE, V193; Hamlington KL, 2016, CELL MOL BIOENG, V9, P151, DOI 10.1007/s12195-015-0426-3; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; HOLM BA, 1988, CHEM PHYS LIPIDS, V49, P49, DOI 10.1016/0009-3084(88)90063-1; Jain Sumeet V, 2016, Intensive Care Med Exp, V4, P11, DOI 10.1186/s40635-016-0085-2; Janda A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.248001; Kay SS, 2004, J APPL PHYSIOL, V97, P269, DOI 10.1152/japplphysiol.01288.2003; Knust J, 2009, ANAT REC, V292, P113, DOI 10.1002/ar.20747; Kollisch-Singule M, 2017, J PEDIATR SURG, V52, P50, DOI 10.1016/j.jpedsurg.2016.10.020; NASH S, 1988, LAB INVEST, V59, P531; Nusrat A, 1997, GASTROENTEROLOGY, V113, P1489, DOI 10.1053/gast.1997.v113.pm9352851; Ochs M, 2013, AM J PHYSIOL-LUNG C, V305, pL15, DOI 10.1152/ajplung.00429.2012; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Schneider JP, 2012, METHOD CELL BIOL, V113, P257, DOI 10.1016/B978-0-12-407239-8.00012-4; Seah AS, 2011, ANN BIOMED ENG, V39, P1505, DOI 10.1007/s10439-010-0237-6; Slutsky AS, 1999, CHEST, V116, p9S, DOI 10.1378/chest.116.suppl_1.9S-a; Smith BJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00466; Smith BJ, 2015, J APPL PHYSIOL, V118, P932, DOI 10.1152/japplphysiol.00902.2014; Smith BJ, 2013, IEEE T BIO-MED ENG, V60, P3449, DOI 10.1109/TBME.2013.2267151; Smith BJ, 2013, ANN BIOMED ENG, V41, P527, DOI 10.1007/s10439-012-0693-2; Sutherasan Y, 2014, CRIT CARE, V18, DOI 10.1186/cc13778; Thammanomai A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053934; Thorne RG, 2006, P NATL ACAD SCI USA, V103, P5567, DOI 10.1073/pnas.0509425103; Tremblay LN, 2006, INTENS CARE MED, V32, P24, DOI 10.1007/s00134-005-2817-8; WORTHEN GS, 1987, AM REV RESPIR DIS, V136, P19, DOI 10.1164/ajrccm/136.1.19; Yildiz C, 2015, ANESTHESIOLOGY, V122, P864, DOI 10.1097/ALN.0000000000000605; Zemans RL, 2009, AM J RESP CELL MOL, V40, P519, DOI 10.1165/rcmb.2008-0348TR	45	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193934	10.1371/journal.pone.0193934	http://dx.doi.org/10.1371/journal.pone.0193934			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590136	Green Submitted, gold, Green Published			2022-12-26	WOS:000428603100039
J	Lavictoire, L; Ramsey, AD; Moorkens, EA; Souch, G; Barnhart, MC				Lavictoire, Louise; Ramsey, Andrew D.; Moorkens, Evelyn A.; Souch, Graham; Barnhart, M. Christopher			Ontogeny of juvenile freshwater pearl mussels, Margaritifera margaritifera (Bivalvia: Margaritiferidae)	PLOS ONE			English	Article							LATERO-FRONTAL CIRRI; HYRIOPSIS LIMNOSCAPHA MYERSIANA; LABORATORY-CULTURED BACTERIA; CILIARY MECHANISMS; PARTICLE CAPTURE; MYTILUS-EDULIS; EVOLUTIONARY IMPLICATIONS; FUNCTIONAL-MORPHOLOGY; DREISSENA-POLYMORPHA; GILL DEVELOPMENT	The gills of juvenile freshwater bivalves undergo a complex morphogenesis that may correlate with changes in feeding ecology, but ontogenic studies on juvenile mussels are rare. Scanning electron microscopy was used to examine the ultrastructure and ontogeny of 117 juvenile freshwater pearl mussels (Margaritifera margaritifera) ranging in age from 1-44 months and length from 0.49-8.90 mm. Three stages of gill development are described. In Stage 1 (5-9 inner demibranch filaments), only unreflected inner demibranch filaments were present. In Stage 2 (9-17 inner demibranch filaments), inner demibranch filaments began to reflect when shell length exceeded 1.13 mm, at 13-16 months old. Reflection began in medial filaments and then proceeded anterior and posterior. In Stage 3 (28-94 inner demibranch filaments), outer demibranch filaments began developing at shell length > 3.1 mm and about 34 months of age. The oral groove on the inner demibranch was first observed in 34 month old specimens > 2.66 mm but was never observed on the outer demibranch. Shell length (R-2 = 0.99) was a better predictor of developmental stage compared to age (R-2 = 0.84). The full suite of gill ciliation was present on filaments in all stages. Interfilamentary distance averaged 31.3 mu m and did not change with age (4-44 months) or with size (0.75-8.9 mm). Distance between laterofrontal cirri couplets averaged 1.54 pm and did not change significantly with size or age. Labial palp primordia were present in even the youngest individuals but ciliature became more diverse in more developed individuals. Information presented here is valuable to captive rearing programmes as it provides insight in to when juveniles may be particularly vulnerable to stressors due to specific ontogenic changes. The data are compared with two other recent studies of Margaritifera development.	[Lavictoire, Louise] Freshwater Biol Assoc, Ambleside, Cumbria, England; [Lavictoire, Louise] Univ Cumbria, Ctr Wildlife Conservat, Ambleside, Cumbria, England; [Ramsey, Andrew D.; Souch, Graham] Univ Derby, Coll Life & Nat Sci, Derby, England; [Moorkens, Evelyn A.] Univ Dublin, Trinity Coll, Dublin, Ireland; [Barnhart, M. Christopher] Missouri State Univ, Dept Biol, Springfield, MO USA	Freshwater Biological Association (FBA); University of Cumbria; University of Derby; Trinity College Dublin; Missouri State University	Lavictoire, L (corresponding author), Freshwater Biol Assoc, Ambleside, Cumbria, England.; Lavictoire, L (corresponding author), Univ Cumbria, Ctr Wildlife Conservat, Ambleside, Cumbria, England.	louiselavictoire3@gmail.com	Moorkens, Evelyn/AAE-4609-2020	Ramsey, Andrew/0000-0002-6232-5869				ALDRIDGE DW, 1987, ENVIRON POLLUT, V45, P17, DOI 10.1016/0269-7491(87)90013-3; ANSELL AD, 1962, J MAR BIOL ASSOC UK, V42, P419, DOI 10.1017/S0025315400001405; Araujo R, 2018, J MORPHOL, V279, P4, DOI 10.1002/jmor.20748; Atkins D, 1938, Q J MICROSC SCI, V80, P345; Atkins D, 1937, Q J MICROSC SCI, V79, P375; Atkins D, 1937, Q J MICROSC SCI, V79, P339; Baker SM, 2003, HYDROBIOLOGIA, V505, P97, DOI 10.1023/B:HYDR.0000007298.52250.99; Barnhart MC., 2015, 2 INT REARING UNIONO; BENINGER PG, 1994, MAR BIOL, V119, P405, DOI 10.1007/BF00347537; Beninger PG, 1999, MAR ECOL PROG SER, V178, P259, DOI 10.3354/meps178259; Bogan AE, 2008, J N AM BENTHOL SOC, V27, P349, DOI 10.1899/07-069.1; BUDDENSIEK V, 1993, ARCH HYDROBIOL, V127, P151; Cannuel R, 2009, BIOL BULL-US, V217, P173, DOI 10.1086/BBLv217n2p173; Cannuel R, 2006, MAR BIOL, V149, P547, DOI 10.1007/s00227-005-0228-6; CUNJAK RA, 1991, CAN J ZOOL, V69, P353, DOI 10.1139/z91-055; Ellis MM, 1936, ECOLOGY, V17, P29, DOI 10.2307/1932951; Eybe T, 2013, AQUAT CONSERV, V23, P964, DOI 10.1002/aqc.2384; FITT WK, 1984, AQUACULTURE, V39, P181, DOI 10.1016/0044-8486(84)90265-5; Galbraith HS, 2009, J MOLLUS STUD, V75, P103, DOI 10.1093/mollus/eyn045; Gatenby CM, 1996, J N AM BENTHOL SOC, V15, P597, DOI 10.2307/1467810; Gatenby CM, 1997, AM MALACOL BULL, V14, P57; Graf DL, 2006, ZOOL J LINN SOC-LOND, V148, P343, DOI 10.1111/j.1096-3642.2006.00259.x; Gui Y, 2016, AQUACULTURE, V452, P120, DOI 10.1016/j.aquaculture.2015.07.035; Gum B, 2011, AQUAT CONSERV, V21, P743, DOI 10.1002/aqc.1222; Hanlon S. D, 2000, THESIS; Hastie LC, 2001, HYDROBIOLOGIA, V445, P109, DOI 10.1023/A:1017588222480; Henley WF, 2001, N AM J AQUACULT, V63, P144, DOI 10.1577/1548-8454(2001)063<0144:DAEORW>2.0.CO;2; Hruska Jaroslav, 1999, Heldia, V4, P69; Jones JW, 2005, N AM J AQUACULT, V67, P210, DOI 10.1577/A04-055.1; Jorgensen C.B., 1990, BIVALVE FILTER FEEDI; Jorgensen CB, 1996, MAR ECOL PROG SER, V142, P287, DOI 10.3354/meps142287; Kovitvadhi S, 2007, INVERTEBR REPROD DEV, V50, P207, DOI 10.1080/07924259.2007.9652248; Kovitvadhi S, 2006, INVERTEBR REPROD DEV, V49, P61, DOI 10.1080/07924259.2006.9652194; Lange M., 2005, P WORKSH PEARL MUSS, P47; Lasee BA, 1991, THESIS; Lavictoire L, 2017, THESIS, P115; Lavictoire L, 2016, HYDROBIOLOGIA, V766, P89, DOI 10.1007/s10750-015-2445-4; Lefevre G, 1910, J EXP ZOOL, V9, P79, DOI 10.1002/jez.1400090105; Lopes-Lima M, 2014, HYDROBIOLOGIA, V735, P1, DOI 10.1007/s10750-014-1902-9; Moorkens EA, 2011, IUCN RED LIST THREAT; Moorkens EA, 2014, AQUAT CONSERV, V24, P853, DOI 10.1002/aqc.2530; Moorkens EA, 2010, J CONCHOL, V40, P339; Murzina SA, 2017, BIOL BULL+, V44, P6, DOI 10.1134/S106235901701006X; Neumann D, 2003, BIOL BULL-US, V205, P73, DOI 10.2307/1543447; Ortmann A. E., 1911, Nautilus Boston Mass, V24; Ortmann A.E., 1911, MEM CARNEGIE MUS, V4, P279; Osterling ME, 2010, J APPL ECOL, V47, P759, DOI 10.1111/j.1365-2664.2010.01827.x; OWEN G, 1976, PROC R SOC SER B-BIO, V194, P527, DOI 10.1098/rspb.1976.0092; OWEN G, 1974, PROC R SOC SER B-BIO, V187, P83, DOI 10.1098/rspb.1974.0062; Passos FD, 2005, POLAR BIOL, V28, P372, DOI 10.1007/s00300-004-0702-5; Preston SJ, 2007, AQUAT CONSERV, V17, P539, DOI 10.1002/aqc.799; REID RGB, 1992, VELIGER, V35, P93; Riisgard HU, 2015, ACTA ZOOL-STOCKHOLM, V96, P273, DOI 10.1111/azo.12110; RIISGARD HU, 1988, MAR ECOL PROG SER, V45, P217, DOI 10.3354/meps045217; Riisgard HU, 2001, MAR ECOL PROG SER, V211, P275, DOI 10.3354/meps211275; Riisgard HU, 1996, MAR BIOL, V127, P259, DOI 10.1007/BF00942111; Santos RMB, 2015, SCI TOTAL ENVIRON, V511, P477, DOI 10.1016/j.scitotenv.2014.12.090; Schartum E, 2017, J MOLLUS STUD, V83, P36, DOI 10.1093/mollus/eyw037; Silverman H, 1997, CAN J ZOOL, V75, P1857, DOI 10.1139/z97-815; Silverman H, 1995, BIOL BULL-US, V189, P308, DOI 10.2307/1542148; Silverman H, 1996, BIOL BULL, V191, P42, DOI 10.2307/1543060; Skinner A, CONSERVING NATURA 20, V2; Sweeting RA, 2008, FRESHWATER PEARL MUS; Sweeting RA, 2010, FRESHWATER PEARL MUS; Tankersley RA, 1996, INVERTEBR BIOL, V115, P243, DOI 10.2307/3226934; Trump MP, 2010, THESIS; Veniot A, 2003, MAR BIOL, V142, P123, DOI 10.1007/s00227-002-0922-6; Ward JE, 2000, LIMNOL OCEANOGR, V45, P1203; Ward JE, 2004, J EXP MAR BIOL ECOL, V300, P83, DOI 10.1016/j.jembe.2004.03.002; WARD JE, 1993, LIMNOL OCEANOGR, V38, P265, DOI 10.4319/lo.1993.38.2.0265; YEAGER MM, 1994, J N AM BENTHOL SOC, V13, P217, DOI 10.2307/1467240; Yonge C. M., 1947, Philosophical Transactions London, V232B, P443, DOI 10.1098/rstb.1947.0003	72	6	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193637	10.1371/journal.pone.0193637	http://dx.doi.org/10.1371/journal.pone.0193637			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590123	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000428603100026
J	Vagnoni, E; Lewis, J; Tajadura-Jimenez, A; Cardini, F				Vagnoni, Eleonora; Lewis, Jessica; Tajadura-Jimenez, Ana; Cardini, Flavia			Listening to a conversation with aggressive content expands the interpersonal space	PLOS ONE			English	Article							PERIPERSONAL SPACE; PERSONAL-SPACE; TOOL-USE; PERIARCUATE NEURONS; AFFERENT PROPERTIES; MACAQUE MONKEYS; BODY; PERCEPTION; HAND; SELF	The distance individuals maintain between themselves and others can be defined as 'interpersonal space'. This distance can be modulated both by situational factors and individual characteristics. Here we investigated the influence that the interpretation of other people interaction, in which one is not directly involved, may have on a person's interpersonal space. In the current study we measured, for the first time, whether the size of interpersonal space changes after listening to other people conversations with neutral or aggressive content. The results showed that the interpersonal space expands after listening to a conversation with aggressive content relative to a conversation with a neutral content. This finding suggests that participants tend to distance themselves from an aggressive confrontation even if they are not involved in it. These results are in line with the view of the interpersonal space as a safety zone surrounding one's body.	[Vagnoni, Eleonora] Ist Italiano Tecnol, Ctr Human Technol, Dept Robot Brain & Cognit Sci, Genoa, Italy; [Lewis, Jessica; Cardini, Flavia] Anglia Ruskin Univ, Dept Psychol, Cambridge, England; [Tajadura-Jimenez, Ana] Univ Carlos III Madrid, Interact Syst DEI Lab, Madrid, Spain; [Tajadura-Jimenez, Ana] UCL, UCLIC, London, England	Istituto Italiano di Tecnologia - IIT; University of Genoa; Anglia Ruskin University; Universidad Carlos III de Madrid; University of London; University College London	Cardini, F (corresponding author), Anglia Ruskin Univ, Dept Psychol, Cambridge, England.	flavia.cardini@anglia.ac.uk	Tajadura-Jimenez, Ana/O-2906-2019; Tajadura-Jimenez, Ana/B-2355-2015	Tajadura-Jimenez, Ana/0000-0003-3166-3512; Tajadura-Jimenez, Ana/0000-0003-3166-3512; Vagnoni, Eleonora/0000-0003-3773-4342; Cardini, Flavia/0000-0003-4301-611X	Ministerio de Economia, lndustria y Competitividad of Spain [RYC-2014-15421, PSI2016-79004-R]	Ministerio de Economia, lndustria y Competitividad of Spain	ATJ was supported by RYC-2014-15421 and PSI2016-79004-R ("MAGIC SHOES: Changing sedentary lifestyles by altering mental body representation using sensory feedback"; AEI/FEDER, UE), Ministerio de Economia, lndustria y Competitividad of Spain.	Aiello J. R., 1987, HDB ENV PSYCHOL, V1, P505; ARGYLE M, 1965, SOCIOMETRY, V28, P289, DOI 10.2307/2786027; Bailenson JN, 2003, PERS SOC PSYCHOL B, V29, P819, DOI 10.1177/0146167203029007002; Berti A, 2000, J COGNITIVE NEUROSCI, V12, P415, DOI 10.1162/089892900562237; BOWERS D, 1980, NEUROPSYCHOLOGIA, V18, P491, DOI 10.1016/0028-3932(80)90151-7; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Brozzoli C, 2013, CURR BIOL, V23, P1764, DOI 10.1016/j.cub.2013.07.004; Brozzoli C, 2011, J NEUROSCI, V31, P9023, DOI 10.1523/JNEUROSCI.1172-11.2011; Candini M, 2017, AUTISM RES, V10, P144, DOI 10.1002/aur.1637; Canzoneri E, 2013, SCI REP-UK, V3, DOI 10.1038/srep02844; Canzoneri E, 2013, EXP BRAIN RES, V228, P25, DOI 10.1007/s00221-013-3532-2; Canzoneri E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044306; Cardini F, 2013, J EXP PSYCHOL HUMAN, V39, P630, DOI 10.1037/a0031049; Cardini F, 2011, J COGNITIVE NEUROSCI, V23, P503, DOI 10.1162/jocn.2010.21484; Churchman A., 2002, HDB ENV PSYCHOL, P1; de Haan AM, 2016, EXP BRAIN RES, V234, P1875, DOI 10.1007/s00221-016-4571-2; de Vignemont F, 2015, NEUROPSYCHOLOGIA, V70, P327, DOI 10.1016/j.neuropsychologia.2014.11.018; Deus Valentina, 2006, Psychiatr Danub, V18, P150; DOSEY MA, 1969, J PERS SOC PSYCHOL, V11, P93, DOI 10.1037/h0027040; EVANS GW, 1973, PSYCHOL BULL, V80, P334, DOI 10.1037/h0034946; Ferri F, 2015, NEUROPSYCHOLOGIA, V70, P468, DOI 10.1016/j.neuropsychologia.2015.03.001; Galli G, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00639; Gentile G, 2011, J NEUROPHYSIOL, V105, P910, DOI 10.1152/jn.00840.2010; GENTILUCCI M, 1983, EXP BRAIN RES, V50, P464; Gessaroli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074959; GIFFORD R, 1993, CAN J BEHAV SCI, V25, P165, DOI 10.1037/h0078784; Graydon MM, 2012, COGNITION EMOTION, V26, P1301, DOI 10.1080/02699931.2012.667391; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P845, DOI 10.1016/j.neuropsychologia.2005.09.009; Hall E.T., 1966, HIDDEN DIMENSION, V609; HAYDUK LA, 1983, PSYCHOL BULL, V94, P293, DOI 10.1037/0033-2909.94.2.293; Holmes Nicholas P, 2004, Cogn Process, V5, P94, DOI 10.1007/s10339-004-0013-3; HOROWITZ MJ, 1964, ARCH GEN PSYCHIAT, V11, P651; Horstmann G, 2003, EMOTION, V3, P150, DOI 10.1037/1528-3542.3.2.150; Hunley SB, 2017, EXP PSYCHOL, V64, P49, DOI 10.1027/1618-3169/a000350; HYVARINEN J, 1974, BRAIN, V97, P673, DOI 10.1093/brain/97.1.673; Iachini T, 2015, ACTA PSYCHOL, V161, P131, DOI 10.1016/j.actpsy.2015.09.003; Iacoboni M, 2006, NEUROPSYCHOLOGIA, V44, P2691, DOI 10.1016/j.neuropsychologia.2006.04.029; Iriki A, 1996, NEUROREPORT, V7, P2325; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Kennedy DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103369; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; Larsson P., 2005, THESIS; Larsson P, 2010, HUM-COMPUT INT-SPRIN, P143, DOI 10.1007/978-1-84882-733-2_8; Lieberz KA, 2017, AGGRESSIVE BEHAV, V43, P460, DOI 10.1002/ab.21704; Lloyd DM, 2008, NEUROPSYCHOLOGIA, V46, P95, DOI 10.1016/j.neuropsychologia.2007.08.007; Lloyd DM, 2009, NEUROSCI BIOBEHAV R, V33, P297, DOI 10.1016/j.neubiorev.2008.09.007; Longo MR, 2006, NEUROPSYCHOLOGIA, V44, P977, DOI 10.1016/j.neuropsychologia.2005.09.003; Lourenco SF, 2011, COGNITION, V119, P448, DOI 10.1016/j.cognition.2011.02.009; Maister L, 2015, NEUROPSYCHOLOGIA, V70, P455, DOI 10.1016/j.neuropsychologia.2014.10.027; Makin TR, 2007, J NEUROSCI, V27, P731, DOI 10.1523/JNEUROSCI.3653-06.2007; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; MCGREGOR PK, 1993, PHILOS T ROY SOC B, V340, P237, DOI 10.1098/rstb.1993.0063; Noel JP, 2017, SCHIZOPHR RES, V179, P8, DOI 10.1016/j.schres.2016.09.021; Olsson A, 2007, NAT NEUROSCI, V10, P1095, DOI 10.1038/nn1968; Parsons S, 2004, J AUTISM DEV DISORD, V34, P449, DOI 10.1023/B:JADD.0000037421.98517.8d; Patane I, 2017, COGNITION, V166, P13, DOI 10.1016/j.cognition.2017.04.013; Patane I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154247; Previc FH, 1998, PSYCHOL BULL, V124, P123, DOI 10.1037/0033-2909.124.2.123; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P147, DOI 10.1016/0166-4328(81)90053-X; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P125, DOI 10.1016/0166-4328(81)90052-8; Ruggiero G., 2016, PSYCHOL RES-PSYCH FO, P1; Salomon R, 2017, COGNITION, V166, P174, DOI 10.1016/j.cognition.2017.05.028; Sambo CF, 2012, J NEUROSCI, V32, P12921, DOI 10.1523/JNEUROSCI.0607-12.2012; Sambo CF, 2012, J NEUROPHYSIOL, V107, P880, DOI 10.1152/jn.00731.2011; Sambo CF, 2013, J NEUROSCI, V33, P14225, DOI 10.1523/JNEUROSCI.0706-13.2013; Seidel EM, 2010, J EXP PSYCHOL HUMAN, V36, P500, DOI 10.1037/a0018169; Serino A, 2015, SCI REP-UK, V5, DOI 10.1038/srep18603; Serino A, 2011, J COGNITIVE NEUROSCI, V23, P2956, DOI 10.1162/jocn_a_00006; SOMMER R, 1959, SOCIOMETRY, V22, P247, DOI 10.2307/2785668; Taffou M, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00122; Tajadura-Jimenez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026083; Tajadura-Jimenez A, 2010, EMOTION, V10, P216, DOI 10.1037/a0018422; Teneggi C, 2013, CURR BIOL, V23, P406, DOI 10.1016/j.cub.2013.01.043; Uzzell D, 2006, BRIT J SOC PSYCHOL, V45, P579, DOI 10.1348/014466605X58384; Vagnoni E, 2012, CURR BIOL, V22, pR826, DOI 10.1016/j.cub.2012.07.053	78	17	17	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0192753	10.1371/journal.pone.0192753	http://dx.doi.org/10.1371/journal.pone.0192753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590110	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100010
J	Gonzales, PK; Roberts, CM; Fonte, V; Jacobsen, C; Stein, GH; Link, CD				Gonzales, Patrick K.; Roberts, Christine M.; Fonte, Virginia; Jacobsen, Connor; Stein, Gretchen H.; Link, Christopher D.			Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21	PLOS ONE			English	Article							DOWN-SYNDROME; BRAIN TRANSCRIPTOME; GENE-EXPRESSION; DOSAGE; CORTEX; MAPS; TAU	Trisomy of chromosome 21, the genetic cause of Down syndrome, has the potential to alter expression of genes on chromosome 21, as well as other locations throughout the genome. These transcriptome changes are likely to underlie the Down syndrome clinical phenotypes. We have employed RNA-seq to undertake an in-depth analysis of transcriptome changes resulting from trisomy of chromosome 21, using induced pluripotent stem cells (iPSCs) derived from a single individual with Down syndrome. These cells were originally derived by Li et al, who genetically targeted chromosome 21 in trisomic iPSCs, allowing selection of disomic sibling iPSC clones. Analyses were conducted on trisomic/disomic cell pairs maintained as iPSCs or differentiated into cortical neuronal cultures. In addition to characterization of gene expression levels, we have also investigated patterns of RNA adenosine-toinosine editing, alternative splicing, and repetitive element expression, aspects of the transcriptome that have not been significantly characterized in the context of Down syndrome. We identified significant changes in transcript accumulation associated with chromosome 21 trisomy, as well as changes in alternative splicing and repetitive element transcripts. Unexpectedly, the trisomic iPSCs we characterized expressed higher levels of neuronal transcripts than control disomic iPSCs, and readily differentiated into cortical neurons, in contrast to another reported study. Comparison of our transcriptome data with similar studies of trisomic iPSCs suggests that trisomy of chromosome 21 may not intrinsically limit neuronal differentiation, but instead may interfere with the maintenance of pluripotency.	[Gonzales, Patrick K.; Roberts, Christine M.; Fonte, Virginia; Stein, Gretchen H.; Link, Christopher D.] Univ Colorado, Linda Crnic Inst Syndrome, Aurora, CO 80045 USA; [Gonzales, Patrick K.; Roberts, Christine M.; Fonte, Virginia; Jacobsen, Connor; Link, Christopher D.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Stein, Gretchen H.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Link, CD (corresponding author), Univ Colorado, Linda Crnic Inst Syndrome, Aurora, CO 80045 USA.; Link, CD (corresponding author), Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA.	linkc@colorado.edu		Link, Christopher D./0000-0003-2271-7697	Linda Crnic Institute for Down Syndrome	Linda Crnic Institute for Down Syndrome	This studywas funded by the Linda Crnic Institute for Down Syndrome http://www.ucdenver.edu/academics/colleges/medicalschool/institutes/lindacmic/Pages/lindacrnic.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorno M, 2013, NATURE, V501, P380, DOI 10.1038/nature12530; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrews S., 2010, FASTQC QUALITY CONTR; Antonarakis SE, 2001, BRAIN RES REV, V36, P265, DOI 10.1016/S0165-0173(01)00103-5; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Costa V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018493; Criscione SW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-583; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Do Long H, 2015, F1000Res, V4, P269, DOI 10.12688/f1000research.6735.1; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Fort A, 2014, NAT GENET, V46, P558, DOI 10.1038/ng.2965; Gardiner K, 2010, J NEUROSCI, V30, P14943, DOI 10.1523/JNEUROSCI.3728-10.2010; Gaspard N, 2009, CELL CYCLE, V8, P2491, DOI 10.4161/cc.8.16.9276; Guedj F, 2015, AM J MED GENET A, V167, P1993, DOI 10.1002/ajmg.a.37156; Hartley SW, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw501; Jiang J, 2013, NATURE, V500, P296, DOI 10.1038/nature12394; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lalioti MD, 1996, GENOMICS, V33, P298, DOI 10.1006/geno.1996.0196; Letourneau A, 2014, NATURE, V508, P345, DOI 10.1038/nature13200; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li LB, 2012, CELL STEM CELL, V11, P615, DOI 10.1016/j.stem.2012.08.004; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Ling KH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-624; Liu CH, 2011, DEV NEUROSCI-BASEL, V33, P404, DOI 10.1159/000329422; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Mittaz L, 1997, GENOMICS, V41, P210, DOI 10.1006/geno.1997.4655; Olmos-Serrano JL, 2016, NEURON, V89, P1208, DOI 10.1016/j.neuron.2016.01.042; Potier MC, 2006, J NEUROCHEM, V97, P104, DOI 10.1111/j.1471-4159.2005.03624.x; Qian W, 2011, NUCLEIC ACIDS RES, V39, P6161, DOI 10.1093/nar/gkr195; Roberts I, 2014, BRIT J HAEMATOL, V167, P587, DOI 10.1111/bjh.13096; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Santoni FA, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-111; Saran NG, 2003, HUM MOL GENET, V12, P2013, DOI 10.1093/hmg/ddg217; Shi JH, 2008, J BIOL CHEM, V283, P28660, DOI 10.1074/jbc.M802645200; Shi Y, 2012, NAT NEUROSCI, V15, pS1, DOI DOI 10.1038/NN.3041.; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Sullivan KD, 2016, ELIFE, V5, DOI 10.7554/eLife.16220; Toiber D, 2010, NEUROBIOL DIS, V40, P348, DOI 10.1016/j.nbd.2010.06.011; Wang JC, 2014, NATURE, V516, P405, DOI 10.1038/nature13804; Weick JP, 2013, P NATL ACAD SCI USA, V110, P9962, DOI 10.1073/pnas.1216575110; Zhang F, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1451-5	41	22	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194581	10.1371/journal.pone.0194581	http://dx.doi.org/10.1371/journal.pone.0194581			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584757	Green Published, Green Submitted, gold			2022-12-26	WOS:000428373000027
J	Morita, Y; Ito, H; Torii, M; Hanai, A; Furu, M; Hashimoto, M; Tanaka, M; Azukizawa, M; Arai, H; Mimori, T; Matsuda, S				Morita, Yugo; Ito, Hiromu; Torii, Mie; Hanai, Akiko; Furu, Moritoshi; Hashimoto, Motomu; Tanaka, Masao; Azukizawa, Masayuki; Arai, Hidenori; Mimori, Tsuneyo; Matsuda, Shuichi			Factors affecting walking ability in female patients with rheumatoid arthritis	PLOS ONE			English	Article							MINIMAL DISEASE-ACTIVITY; KNEE OSTEOARTHRITIS; PARKINSONS-DISEASE; JOINT DESTRUCTION; ACTIVITY SCORE; GAIT ANALYSIS; HEALTH; EPIDEMIOLOGY; METHOTREXATE; SATISFACTION	Objective To determine the factors associated with gait parameters in female patients with rheumatoid arthritis (RA). Methods The gait analysis was performed in a large cohort of RA patients, and three basic gait parameters (step length, cadence and gait speed) were calculated. Clinical and laboratory data were also collected. Factors associated with gait parameters were analyzed using multivariable linear regression in the three models with forced entry. Then, we divided those patients with Health Assessment Questionnaire disability index (HAQ) scores <= 0.5 into two groups according to their gait speed that were compared to identify the characteristics of patients with a good HAQ score but poor walking ability. Results A total of 318 female patients were analyzed. Knee extension strength had the strongest positive association with all three gait parameters (P < 0.0001), while methotrexate use was also positively associated with all three gait parameters (step length: P < 0.05, cadence: P < 0.05 in model 1 and 2; P < 0.01 in model 3, gait speed: P < 0.01). The disease activity score was negatively associated with step length and gait speed (step length, gait speed: P < 0.01 in model 1 and 2; P < 0.05 in model 3). 26% of patients with good HAQ scores showed slow gait speed. Patients with good HAQ scores and slow gait speed had higher disease activity scores (P < 0.05) and lower knee extension strength (P < 0.0001) than those with good HAQ scores and normal gait speed. Conclusions High knee extension strength, low disease activity and administration of methotrexate were strongly associated with good walking ability in female patients with RA. And, even if patients showed good HAQ scores, about quarter of those patients had poor walking ability, and they showed higher disease activity, lower knee extension strength, compared to the patients with normal gait speed.	[Morita, Yugo; Ito, Hiromu; Furu, Moritoshi; Azukizawa, Masayuki; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto, Japan; [Torii, Mie; Hanai, Akiko] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan; [Furu, Moritoshi; Hashimoto, Motomu; Tanaka, Masao] Kyoto Univ, Grad Sch Med, Dept Adv Med Rheumat Dis, Kyoto, Japan; [Arai, Hidenori] Natl Ctr Geriatr & Gerontol, Obu, Japan; [Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; National Center for Geriatrics & Gerontology; Kyoto University	Ito, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto, Japan.	hiromu@kuhp.kyoto-u.ac.jp	Arai, Hidenori/P-9816-2017	Arai, Hidenori/0000-0002-9000-6849; , Hiroyuki/0000-0001-7339-9030; Ito, Hiromu/0000-0002-1827-382X	Mitsubishi-Tanabe; Chugai; UCB Japan; city government (Nagahama city); Bristol-Myers; Astellas; Eli Lily; Ayumi	Mitsubishi-Tanabe(Mitsubishi Tanabe Pharma Corporation); Chugai; UCB Japan; city government (Nagahama city); Bristol-Myers(Bristol-Myers Squibb); Astellas(Astellas Pharmaceuticals); Eli Lily; Ayumi	M.H. and M.T. belong to a department that is financially supported by 4 pharmaceutical companies (Mitsubishi-Tanabe, Chugai, Ayumi, and UCB Japan) and a city government (Nagahama city). H.I. has received a research grant and/or speaker fee from Bristol-Myers, Astellas, and Eli Lily. Y.M., M.T., A.H., M.F., M.A., H.A., T.M., and S.M. declared no conflicts of interest. The sponsors were not involved in the study design; in the collection, analysis, interpretation of data; in the writing of this manuscript; or in the decision to submit the article for publication, and this commercial affiliation does not alter our adherence to PLOS ONE policies on sharing data and materials. The authors, their immediate families, and any research foundations with which they are affiliated have not received any financial payments or other benefits from any commercial entity related to the subject of this article. The funder provided support in the form of salaries for authors (H.I., M.H. and M.T.), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aletaha D, 2005, ARTHRITIS RES THER, V7, pR796, DOI 10.1186/ar1740; Amano T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159172; Carmona L, 2002, RHEUMATOLOGY, V41, P88, DOI 10.1093/rheumatology/41.1.88; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Daniilidis K, 2017, ARCH ORTHOP TRAUM SU, V137, P499, DOI 10.1007/s00402-017-2652-8; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Furu M, 2016, J ORTHOP SCI, V21, P38, DOI 10.1016/j.jos.2015.10.002; Gabriel SE, 1999, ARTHRITIS RHEUM-US, V42, P415, DOI 10.1002/1529-0131(199904)42:3<415::AID-ANR4>3.0.CO;2-Z; Gaujoux-Viala C, 2012, JOINT BONE SPINE, V79, P149, DOI 10.1016/j.jbspin.2011.04.008; Ha Misook, 2017, J Phys Ther Sci, V29, P662, DOI 10.1589/jpts.29.662; Hamamoto Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136611; Hatanaka N, 2016, EUR NEUROL, V75, P282, DOI 10.1159/000445111; Inoue E, 2007, ANN RHEUM DIS, V66, P407, DOI 10.1136/ard.2006.054205; Ishikawa M, 2016, MOD RHEUMATOL, V26, P696, DOI 10.3109/14397595.2015.1128871; Iwata T, 2016, OSTEOPOROSIS INT, V27, P691, DOI 10.1007/s00198-015-3256-1; Juhl C, 2014, ARTHRITIS RHEUMATOL, V66, P622, DOI 10.1002/art.38290; Katoh M, 2009, J PHYS THER SCI, V21, P37, DOI 10.1589/jpts.21.37; KREMER JM, 1992, ARTHRITIS RHEUM, V35, P138, DOI 10.1002/art.1780350203; McMeeken J, 1999, Physiother Res Int, V4, P55; Miyata Ryuji, 2017, J Phys Ther Sci, V29, P874, DOI 10.1589/jpts.29.874; Ohira M, 2017, J DIABETES INVESTIG; Pietrapertosa D, 2009, RHEUMATOLOGY, V48, P1242, DOI 10.1093/rheumatology/kep217; PINCUS T, 1983, ARTHRITIS RHEUM-US, V26, P1346, DOI 10.1002/art.1780261107; Rosano C, 2008, J AM GERIATR SOC, V56, P1618, DOI 10.1111/j.1532-5415.2008.01856.x; Rubbert-Roth A, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2666; Samson MM, 2001, AGING CLIN EXP RES, V13, P16, DOI 10.1007/BF03351489; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; STEINBROCKER O, 1949, JAMA-J AM MED ASSOC, V140, P659, DOI 10.1001/jama.1949.02900430001001; Sugihara T, 2015, RHEUMATOLOGY, V54, P798, DOI 10.1093/rheumatology/keu395; Turner DE, 2008, CLIN BIOMECH, V23, P93, DOI 10.1016/j.clinbiomech.2007.08.009; Uhlig T, 2008, ANN RHEUM DIS, V67, P1710, DOI 10.1136/ard.2007.084673; Wallaert B, 2013, CHEST, V144, P1652, DOI 10.1378/chest.13-0806; Weiss RJ, 2008, GAIT POSTURE, V28, P229, DOI 10.1016/j.gaitpost.2007.12.001; Wells GA, 2005, J RHEUMATOL, V32, P2016; Welsing PMJ, 2001, ARTHRITIS RHEUM, V44, P2009, DOI 10.1002/1529-0131(200109)44:9<2009::AID-ART349>3.0.CO;2-L; Wenham CYJ, 2013, RHEUMATOLOGY, V52, P888, DOI 10.1093/rheumatology/kes386; Yamada M, 2012, RHEUMATOL INT, V32, P3869, DOI 10.1007/s00296-011-2283-2; Yoneyama M, 2016, J MECH MED BIOL, V16, DOI 10.1142/S0219519416500299; Yoneyama M, 2014, IEEE T NEUR SYS REH, V22, P613, DOI 10.1109/TNSRE.2013.2260561	39	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0195059	10.1371/journal.pone.0195059	http://dx.doi.org/10.1371/journal.pone.0195059			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584787	gold, Green Submitted, Green Published			2022-12-26	WOS:000428373000059
J	Lombardo, J; Sun, JL; Harrington, MA				Lombardo, Joseph; Sun, Jianli; Harrington, Melissa A.			Rapid activity-dependent modulation of the intrinsic excitability through up-regulation of KCNQ/Kv7 channel function in neonatal spinal motoneurons	PLOS ONE			English	Article							ACTION-POTENTIAL THRESHOLD; RAT HIPPOCAMPAL-NEURONS; PYRAMIDAL NEURONS; SYNAPTIC-TRANSMISSION; HINDLIMB MOTONEURONS; CORD PLASTICITY; DOWN-REGULATION; I-H; PATTERNS; AXON	Activity-dependent changes in the properties of the motor system underlie the necessary adjustments in its responsiveness on the basis of the environmental and developmental demands of the organism. Although plastic changes in the properties of the spinal cord have historically been neglected because of the archaic belief that the spinal cord is constituted by a hardwired network that simply relays information to muscles, plenty of evidence has been accumulated showing that synapses impinging on spinal motoneurons undergo short and long-term plasticity. In the brain, brief changes in the activity level of the network have been shown to be paralleled by changes in the intrinsic excitability of the neurons and are suggested to either reinforce or stabilize the changes at the synaptic level. However, rapid activity-dependent changes in the intrinsic properties of spinal motoneurons have never been reported. In this study, we show that in neonatal mice the intrinsic excitability of spinal motoneurons is depressed after relatively brief but sustained changes in the spinal cord network activity. Using electrophysiological techniques together with specific pharmacological blockers of KCNQ/Kv7 channels, we demonstrate their involvement in the reduction of the intrinsic excitability of spinal motoneurons. This action results from an increased M-current, the product of the activation of KCNQ/Kv7 channels, which leads to a hyperpolarization of the resting membrane potential and a decrease in the input resistance of spinal motoneurons. Computer simulations showed that specific up-regulations in KCNQ/Kv7 channels functions lead to a modulation of the intrinsic excitability of spinal motoneurons as observed experimentally. These results indicate that KCNQ/Kv7 channels play a fundamental role in the activity-dependent modulation of the excitability of spinal motoneurons.	[Lombardo, Joseph; Sun, Jianli; Harrington, Melissa A.] Delaware State Univ, Dept Biol, Dover, DE 19901 USA; [Lombardo, Joseph] Boston VA Hosp, Dept Neurol, Boston, MA USA; [Lombardo, Joseph] Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA; [Lombardo, Joseph] Harvard Med Sch, Boston, MA USA	Delaware State University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Harrington, MA (corresponding author), Delaware State Univ, Dept Biol, Dover, DE 19901 USA.	mharrington@desu.edu		Lombardo, Joseph/0000-0003-4806-0849; Harrington, Melissa/0000-0002-6159-4477	National Science Foundation (NSF), Integrative Organismal Systems (IOS) [1608147]; Department of Defense (DoD), Army Research Laboratory (ARL) [67444-LS-H]; National Institute of Child Health and Human Disease (NICHD) [R15HD075207]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R15HD075207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103653] Funding Source: NIH RePORTER	National Science Foundation (NSF), Integrative Organismal Systems (IOS)(National Science Foundation (NSF)); Department of Defense (DoD), Army Research Laboratory (ARL); National Institute of Child Health and Human Disease (NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation (NSF), Integrative Organismal Systems (IOS) 1608147; Department of Defense (DoD), Army Research Laboratory (ARL) 67444-LS-H; National Institute of Child Health and Human Disease (NICHD) R15HD075207. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballerini L, 1999, J PHYSIOL-LONDON, V517, P459, DOI 10.1111/j.1469-7793.1999.0459t.x; Battefeld A, 2014, J NEUROSCI, V34, P3719, DOI 10.1523/JNEUROSCI.4206-13.2014; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Beaumont E, 2003, MUSCLE NERVE, V27, P228, DOI 10.1002/mus.10308; Beaumont V, 2001, NEURON, V32, P489, DOI 10.1016/S0896-6273(01)00483-4; Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; Benned-Jensen T, 2016, J NEUROSCI, V36, P2261, DOI 10.1523/JNEUROSCI.2631-15.2016; Bertrand SS, 2013, CURR PHARM DESIGN, V19, P4498, DOI 10.2174/1381612811319240014; Bracci E, 1998, J NEUROPHYSIOL, V79, P2643, DOI 10.1152/jn.1998.79.5.2643; Brager DH, 2007, J NEUROSCI, V27, P13926, DOI 10.1523/JNEUROSCI.3520-07.2007; Brown JT, 2009, J PHYSIOL-LONDON, V587, P1265, DOI 10.1113/jphysiol.2008.167007; CARP JS, 1994, J NEUROPHYSIOL, V72, P431, DOI 10.1152/jn.1994.72.1.431; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Cooke RM, 2012, J COMP PHYSIOL A, V198, P25, DOI 10.1007/s00359-011-0683-0; Cormery B, 2005, J PHYSIOL-LONDON, V568, P841, DOI 10.1113/jphysiol.2005.091835; CURTIS DR, 1960, J PHYSIOL-LONDON, V150, P374, DOI 10.1113/jphysiol.1960.sp006393; Daoudal G, 2003, LEARN MEMORY, V10, P456, DOI 10.1101/lm.64103; Demir R, 2002, J NEUROPHYSIOL, V87, P1094, DOI 10.1152/jn.00276.2001; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Fink AJP, 2014, NATURE, V509, P43, DOI 10.1038/nature13276; Ghezzi F, 2016, NEUROSCIENCE; Gordon T, 1997, J NEUROPHYSIOL, V77, P2585, DOI 10.1152/jn.1997.77.5.2585; Grubb MS, 2010, NATURE, V465, P1070, DOI 10.1038/nature09160; Henze DA, 2001, NEUROSCIENCE, V105, P121, DOI 10.1016/S0306-4522(01)00167-1; HOCHMAN S, 1994, J NEUROPHYSIOL, V71, P1468, DOI 10.1152/jn.1994.71.4.1468; Hoffman N, 2010, NEUROSCIENCE, V168, P732, DOI 10.1016/j.neuroscience.2010.04.014; Jia Y, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00004; KALB RG, 1992, P NATL ACAD SCI USA, V89, P8502, DOI 10.1073/pnas.89.18.8502; KALB RG, 1994, DEVELOPMENT, V120, P3063; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; King AE, 2016, EXP NEUROL, V275, P162, DOI 10.1016/j.expneurol.2015.09.019; KIRKWOOD A, 1992, BRAIN RES, V580, P281, DOI 10.1016/0006-8993(92)90955-9; Kole MHP, 2008, NAT NEUROSCI, V11, P1253, DOI 10.1038/nn.2203; Kuba H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9815; Kullmann PHM, 2010, J PHYSIOL-LONDON, V588, P923, DOI 10.1113/jphysiol.2009.182873; Lawrence JJ, 2006, J NEUROSCI, V26, P12325, DOI 10.1523/JNEUROSCI.3521-06.2006; Levin BE, 2004, DIABETES, V53, P2521, DOI 10.2337/diabetes.53.10.2521; Li WC, 2007, J NEUROSCI, V27, P12267, DOI 10.1523/JNEUROSCI.3694-07.2007; Lombardo J, 2016, J NEUROPHYSIOL, V116, P2114, DOI 10.1152/jn.00446.2016; MacDonell CW, 2012, J NEUROPHYSIOL, V107, P265, DOI 10.1152/jn.00122.2011; Marinelli S, 2000, NEUROPHARMACOLOGY, V39, P1021, DOI 10.1016/S0028-3908(99)00186-0; Martinello K, 2015, NEURON, V85, P346, DOI 10.1016/j.neuron.2014.12.030; Mentis GZ, 2011, NEURON, V69, P453, DOI 10.1016/j.neuron.2010.12.032; Nick TA, 2000, NAT NEUROSCI, V3, P142, DOI 10.1038/72082; Parker D, 2003, J NEUROSCI, V23, P11085; Parker D, 2000, MOL NEUROBIOL, V22, P55, DOI 10.1385/MN:22:1-3:055; Ranieri F, 2012, NEUROMUSCULAR DISORD, V22, pS157, DOI 10.1016/j.nmd.2012.10.006; ROBBINS J, 1992, J PHYSIOL-LONDON, V451, P159, DOI 10.1113/jphysiol.1992.sp019159; Shah MM, 2008, P NATL ACAD SCI USA, V105, P7869, DOI 10.1073/pnas.0802805105; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Szucs P, 2003, EUR J NEUROSCI, V17, P537, DOI 10.1046/j.1460-9568.2003.02484.x; Tahayori B, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/964843; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Velasco M, 2006, CELL MOL NEUROBIOL, V26, P307, DOI 10.1007/s10571-006-9000-9; Wainger BJ, 2014, CELL REP, V7, P1, DOI 10.1016/j.celrep.2014.03.019; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wolpaw JR, 2010, NEUROSCIENTIST, V16, P532, DOI 10.1177/1073858410368314; Wolpaw JR, 2001, ANNU REV NEUROSCI, V24, P807, DOI 10.1146/annurev.neuro.24.1.807; Wu WW, 2008, J NEUROPHYSIOL, V100, P1897, DOI 10.1152/jn.90346.2008; XIE HW, 1995, J NEUROSCI, V15, P5900; Yin L, 2015, CEREB CORTEX, V27; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	64	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0193948	10.1371/journal.pone.0193948	http://dx.doi.org/10.1371/journal.pone.0193948			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579068	gold, Green Published, Green Submitted			2022-12-26	WOS:000428351800016
J	Sbisa, A; van den Buuse, M; Gogos, A				Sbisa, Alyssa; van den Buuse, Maarten; Gogos, Andrea			The effect of estrogenic compounds on psychosis-like behaviour in female rats	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; PREPULSE INHIBITION; POSTMENOPAUSAL WOMEN; RECEPTOR MODULATORS; GENE-EXPRESSION; DOUBLE-BLIND; DOPAMINE TRANSPORTER; REPLACEMENT THERAPY; NUCLEUS-ACCUMBENS; ESTROUS-CYCLE	17 beta-estradiol treatment has shown benefit against schizophrenia symptoms, however long-term use may be associated with negative side-effects. Selective estrogen receptor modulators, such as raloxifene and tamoxifen, have been proposed as suitable alternatives to 17 beta-estradiol. An isomer of 17 beta-estradiol, 17 alpha-estradiol, is considered less carcinogenic, and non-feminising in males, however little is known about its potential as a treatment for schizophrenia. Moreover, the mechanism underlying the therapeutic action of estrogens remains unclear. We aimed to investigate the ability of these estrogenic compounds to attenuate psychosis-like behaviour in rats. We used two acute pharmacologically-induced assays of psychosis-like behaviour: psychotomimetic drug-induced hyperlocomotion and disruption of prepulse inhibition (PPI). Female Long Evans rats were either intact, ovariectomised (OVX), or OVX and chronically treated with 17 beta-estradiol, 17 alpha-estradiol, raloxifene or tamoxifen. Only 17 beta-estradiol treatment attenuated locomotor hyperactivity induced by the indirect dopamine receptor agonist, methamphetamine. 17 beta-estradiol- and tamoxifen-treated rats showed attenuated methamphetamine- and apomorphine (dopamine D1/D2 receptor agonist)-induced disruption of PPI. Raloxifene-treated rats showed attenuated apomorphineinduced PPI disruption only. Baseline PPI was significantly reduced following OVX, and this deficit was reversed by all estrogenic compounds. Further, PPI in OVX rats was increased following administration of apomorphine. This study confirms a protective effect of 17 beta-estradiol in two established animal models of psychosis, while tamoxifen showed beneficial effects against PPI disruption. In contrast, 17 alpha-estradiol and raloxifene showed little effect on dopamine receptor-mediated psychosis-like behaviours. This study highlights the utility of some estrogenic compounds to attenuate psychosis-like behaviour in rats, supporting the notion that estrogens have therapeutic potential for psychotic disorders.	[Sbisa, Alyssa; Gogos, Andrea] Florey Inst Neurosci & Mental Hlth, Hormones Psychiat Lab, Parkville, Vic, Australia; [Sbisa, Alyssa; van den Buuse, Maarten] La Trobe Univ, Sch Psychol & Publ Hlth, Bundoora, Vic, Australia; [van den Buuse, Maarten] Univ Melbourne, Dept Pharmacol, Parkville, Vic, Australia; [van den Buuse, Maarten] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia	Florey Institute of Neuroscience & Mental Health; La Trobe University; University of Melbourne; James Cook University	Gogos, A (corresponding author), Florey Inst Neurosci & Mental Hlth, Hormones Psychiat Lab, Parkville, Vic, Australia.	andrea.gogos@florey.edu.au	Sbisa, Alyssa/AAE-2956-2020	Sbisa, Alyssa/0000-0002-5420-3319; Gogos, Andrea/0000-0003-2107-4669; van den Buuse, Maarten/0000-0002-7555-3799	Career Development Fellowship; Senior Research Fellowship from the National Health and Medical Research Council of Australia; Australian Research Council Discovery Early Career Researcher Award; Jared Purton Award; Victorian Government's Operational Infrastructure Support Grant	Career Development Fellowship; Senior Research Fellowship from the National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Discovery Early Career Researcher Award(Australian Research Council); Jared Purton Award; Victorian Government's Operational Infrastructure Support Grant	AG is supported by a Career Development Fellowship and MvdB was supported by a Senior Research Fellowship from the National Health and Medical Research Council of Australia. AG was supported by an Australian Research Council Discovery Early Career Researcher Award. The authors gratefully acknowledge the financial support of the Jared Purton Award. The Florey Institute of Neuroscience and Mental Health acknowledges the support from the Victorian Government's Operational Infrastructure Support Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AL, 2008, J NEUROSCI METH, V173, P295, DOI 10.1016/j.jneumeth.2008.06.014; Akhondzadeh S, 2003, PROG NEURO-PSYCHOPH, V27, P1007, DOI 10.1016/S0278-5846(03)00161-1; Arevalo MA, 2011, J MOL ENDOCRINOL, V46, pR1, DOI 10.1677/JME-10-0122; Barha CK, 2010, NEUROPSYCHOPHARMACOL, V35, P547, DOI 10.1038/npp.2009.161; Becker JB, 1999, PHARMACOL BIOCHEM BE, V64, P803, DOI 10.1016/S0091-3057(99)00168-9; Bosse R, 1997, MOL BRAIN RES, V46, P343, DOI 10.1016/S0169-328X(97)00082-X; Chavez C, 2010, BRAIN RES, V1321, P51, DOI 10.1016/j.brainres.2009.12.093; Daly E, 1996, LANCET, V348, P977, DOI 10.1016/S0140-6736(96)07113-9; Einat H, 2007, NEUROPSYCHOBIOLOGY, V55, P123, DOI 10.1159/000106054; Fleckenstein AE, 1997, J PHARMACOL EXP THER, V282, P834; Gallo D, 2008, J ENDOCRINOL INVEST, V31, P48, DOI 10.1007/BF03345566; Gardiner SA, 2004, AM J GERIAT PSYCHIAT, V12, P621, DOI 10.1176/appi.ajgp.12.6.621; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Gibbs RB, 2000, NEUROBIOL AGING, V21, P107, DOI 10.1016/S0197-4580(00)00103-2; Gibbs RB, 2008, ENDOCRINOLOGY, V149, P3176, DOI 10.1210/en.2007-1645; Gogos A, 2007, BRIT J PHARMACOL, V150, P750, DOI 10.1038/sj.bjp.0707148; Gogos A, 2004, J PHARMACOL EXP THER, V309, P267, DOI 10.1124/jpet.103.061432; Gogos A, 2017, BEHAV BRAIN RES, V322, P157, DOI 10.1016/j.bbr.2017.01.028; Gogos A, 2015, SCHIZOPHR RES, V168, P634, DOI 10.1016/j.schres.2015.04.029; Gogos A, 2012, PSYCHOPHARMACOLOGY, V219, P213, DOI 10.1007/s00213-011-2389-y; Gogos A, 2010, J PHARMACOL EXP THER, V333, P218, DOI 10.1124/jpet.109.162123; Green PS, 1997, J NEUROSCI, V17, P511; Grodstein F, 1996, LANCET, V348, P983, DOI 10.1016/S0140-6736(96)07308-4; Halpin LE, 2014, LIFE SCI, V97, P37, DOI 10.1016/j.lfs.2013.07.014; Huerta-Ramos E, 2014, EUR NEUROPSYCHOPHARM, V24, P223, DOI 10.1016/j.euroneuro.2013.11.012; Ikeda T, 2015, NEUROPHARMACOLOGY, V90, P9, DOI 10.1016/j.neuropharm.2014.10.019; Jauhar S, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.270; Kaur SP, 2015, STEROIDS, V96, P7, DOI 10.1016/j.steroids.2015.01.004; Kianimehr G, 2014, DARU, V22, DOI 10.1186/2008-2231-22-55; Kinkead B, 2008, PSYCHONEUROENDOCRINO, V33, P178, DOI 10.1016/j.psyneuen.2007.11.005; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Kulkarni J, 2006, PSYCHONEUROENDOCRINO, V31, P543, DOI 10.1016/j.psyneuen.2005.11.001; Kulkarni J, 2010, PSYCHONEUROENDOCRINO, V35, P1142, DOI 10.1016/j.psyneuen.2010.01.014; Kumari V, 2002, SCHIZOPHR RES, V55, P139, DOI 10.1016/S0920-9964(01)00276-6; Kusljic S, 2005, BRAIN RES, V1049, P217, DOI 10.1016/j.brainres.2005.05.017; Labouesse MA, 2015, PSYCHOPHARMACOLOGY, V232, P2981, DOI 10.1007/s00213-015-3935-9; Labrie F, 2001, ADV PROTEIN CHEM, V56, P293; Landry M, 2002, NEUROENDOCRINOLOGY, V76, P214, DOI 10.1159/000065951; Le Saux M, 2006, J NEUROENDOCRINOL, V18, P25, DOI 10.1111/j.1365-2826.2005.01380.x; Leranth C, 2000, J NEUROSCI, V20, P8604; Ludewig K, 2003, BIOL PSYCHIAT, V54, P121, DOI 10.1016/S0006-3223(02)01925-X; Moretti M, 2011, PHARMACOL BIOCHEM BE, V98, P304, DOI 10.1016/j.pbb.2011.01.017; Purves-Tyson TD, 2015, HORM BEHAV, V70, P73, DOI 10.1016/j.yhbeh.2015.02.005; Saint Marie RL, 2006, BRAIN RES, V1119, P203, DOI 10.1016/j.brainres.2006.08.045; Saravi SSS, 2016, PSYCHOPHARMACOLOGY, V233, P1467, DOI 10.1007/s00213-016-4242-9; Sbisa AM, 2017, PSYCHIAT NEUROSCIENC, VII, P355; Shilling PD, 2008, BIOL PSYCHIAT, V63, P748, DOI 10.1016/j.biopsych.2007.10.015; Stout MB, 2017, J GERONTOL A-BIOL, V72, P3, DOI 10.1093/gerona/glv309; Swerdlow NR, 2012, PSYCHOPHARMACOLOGY, V224, P349, DOI 10.1007/s00213-012-2758-1; Swerdlow NR, 2011, PSYCHOPHARMACOLOGY, V216, P401, DOI 10.1007/s00213-011-2228-1; Toran-Allerand CD, 2005, ENDOCRINOLOGY, V146, P3843, DOI 10.1210/en.2004-1616; Toran-Allerand CD, 2002, J NEUROSCI, V22, P8391; Usall J, 2011, J CLIN PSYCHIAT, V72, P1552, DOI 10.4088/JCP.10m06610; van den Buuse M, 2010, SCHIZOPHRENIA BULL, V36, P246, DOI 10.1093/schbul/sbp132; Volz TJ, 2007, ADDICTION, V102, P44, DOI 10.1111/j.1360-0443.2007.01771.x; Walf AA, 2010, BEHAV PHARMACOL, V21, P231, DOI 10.1097/FBP.0b013e32833a5cb0; Weickert TW, 2015, MOL PSYCHIATR, V20, P685, DOI 10.1038/mp.2015.11; XIAO L, 1994, NEUROSCI LETT, V180, P155, DOI 10.1016/0304-3940(94)90510-X; Zhang D, 2008, PSYCHOPHARMACOLOGY, V199, P625, DOI 10.1007/s00213-008-1188-6; Zou AH, 1999, MOL ENDOCRINOL, V13, P418, DOI 10.1210/me.13.3.418	60	12	12	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0193853	10.1371/journal.pone.0193853	http://dx.doi.org/10.1371/journal.pone.0193853			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579065	Green Published, gold, Green Accepted			2022-12-26	WOS:000428351800015
J	Zhang, SL; Han, Y				Zhang, Shuangling; Han, Yue			Preparation, characterisation and antioxidant activities of rutin-loaded zein-sodium caseinate nanoparticles	PLOS ONE			English	Article							COLLOIDAL PARTICLES; ENCAPSULATION; DELIVERY; ACID; DISPERSION; STABILITY; EMULSIONS; CURCUMIN; RELEASE; COMPLEX	Novel rutin-loaded zein-sodium caseinate nanoparticles (ZP) with antioxidant activity in aqueous medium were investigated. The results showed that the sodium caseinate concentrations, dosages of rutin and ethanol volume fractions significantly affected the zein nano particles' characteristics. Concerning the antioxidant properties, the highest values of rutin loaded ZP obtained using 2, 2-dipheny1-1-picrylhydrazyl scavenging and 2 and 2'-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) decolourisation assays were 52.7% and 71.2%, respectively, and the total antioxidant capacity was 0.40 nmol g(-1). The results suggest that zein-sodium caseinate nanoparticles can be used as a new nano carrier system for rutin or other water insoluble active ingredients.	[Zhang, Shuangling; Han, Yue] Qingdao Agr Univ, Coll Food Sci & Engn, Qingdao, Shandong, Peoples R China	Qingdao Agricultural University	Zhang, SL (corresponding author), Qingdao Agr Univ, Coll Food Sci & Engn, Qingdao, Shandong, Peoples R China.	zhshuanaalicia@hotmail.com		Zhang, Shuangling/0000-0001-5077-9532	Shandong Provincial Natural Science Foundation, China [ZR201709240233]	Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province)	Funded by Shandong Provincial Natural Science Foundation, China (ZR201709240233).	Chang C, 2017, INT J BIOL MACROMOL, V104, P117, DOI 10.1016/j.ijbiomac.2017.05.178; Chang C, 2017, FOOD HYDROCOLLOID, V70, P143, DOI 10.1016/j.foodhyd.2017.03.033; Chen FP, 2015, J AGR FOOD CHEM, V63, P3559, DOI 10.1021/acs.jafc.5b00448; Chen HQ, 2015, FOOD HYDROCOLLOID, V43, P593, DOI 10.1016/j.foodhyd.2014.07.018; Donsi F, 2017, FOOD HYDROCOLLOID, V63, P508, DOI 10.1016/j.foodhyd.2016.09.039; Elzoghby AO, 2012, J CONTROL RELEASE, V161, P38, DOI 10.1016/j.jconrel.2012.04.036; Garcia-Mateos R, 2013, NAT PROD RES, V27, P834, DOI 10.1080/14786419.2012.704370; Gorji Ghorbani, 2014, INT J BIOL MACROMOL, V151, P506; Guo M, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/24/245101; Hu DD, 2012, J FOOD ENG, V109, P545, DOI 10.1016/j.jfoodeng.2011.10.025; Kandula S, 2014, J AM OIL CHEM SOC, V91, P1967, DOI 10.1007/s11746-014-2529-8; Kumari VS, 2012, POLYM BULL, V68, P1387, DOI 10.1007/s00289-011-0645-2; Lai LF, 2011, INT J PHARMACEUT, V404, P317, DOI 10.1016/j.ijpharm.2010.11.025; Li KK, 2014, J FOOD ENG, V127, P103, DOI 10.1016/j.jfoodeng.2013.12.001; Li KK, 2013, J FOOD ENG, V119, P343, DOI 10.1016/j.jfoodeng.2013.05.038; Lin Y, 2016, LWT-FOOD SCI TECHNOL, V72, P510, DOI 10.1016/j.lwt.2016.05.020; Liu F, 2013, J AGR FOOD CHEM, V61, P8888, DOI 10.1021/jf401859y; Luo YC, 2012, J AGR FOOD CHEM, V60, P836, DOI 10.1021/jf204194z; Mendes A. C., 2016, FOOD HYDROCOLLOIDS, V44, P10; Muthuselvi L, 2006, COLLOID SURFACE B, V51, P39, DOI 10.1016/j.colsurfb.2006.05.012; Natarajan V, 2011, J PHARM SCI-US, V100, P195, DOI 10.1002/jps.22266; Patel AR, 2012, FOOD CHEM, V133, P423, DOI 10.1016/j.foodchem.2012.01.054; Prieto P, 1999, ANAL BIOCHEM, V269, P337, DOI 10.1006/abio.1999.4019; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; SHIMADA K, 1992, J AGR FOOD CHEM, V40, P945, DOI 10.1021/jf00018a005; Surh J, 2005, J AGR FOOD CHEM, V53, P4236, DOI 10.1021/jf047944i; Teng Z, 2012, J AGR FOOD CHEM, V60, P2712, DOI 10.1021/jf205238x; Valentao P, 2002, J AGR FOOD CHEM, V50, P4989, DOI 10.1021/jf020225o; Wang L, 2016, J MICROENCAPSUL, V33, P43, DOI 10.3109/02652048.2015.1114042; Wu YP, 2012, LWT-FOOD SCI TECHNOL, V48, P283, DOI 10.1016/j.lwt.2012.03.027; Xiao D, 2011, J AGR FOOD CHEM, V59, P7393, DOI 10.1021/jf200774v; Zhang BC, 2011, FOOD CHEM, V124, P210, DOI 10.1016/j.foodchem.2010.06.019; Zhang SL, 2017, CARBOHYD POLYM, V169, P385, DOI 10.1016/j.carbpol.2017.04.044; Zhang YD, 2013, TRIBOL INT, V58, P7, DOI 10.1016/j.triboint.2012.09.004; Zhong QX, 2009, FOOD HYDROCOLLOID, V23, P2380, DOI 10.1016/j.foodhyd.2009.06.015	35	38	40	8	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194951	10.1371/journal.pone.0194951	http://dx.doi.org/10.1371/journal.pone.0194951			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579133	Green Published, gold, Green Submitted			2022-12-26	WOS:000428351800069
J	Zhou, X; Wu, LF; Wang, WY; Lu, X; Jiang, ZH; Zhang, YH; Jiang, DH; Jiang, JN; Gao, HQ; Lei, SF; Deng, FY				Zhou, Xu; Wu, Long-Fei; Wang, Wen-Yu; Lu, Xin; Jiang, Zhen-Huan; Zhang, Yun-Hong; Jiang, Ding-Hua; Jiang, Jian-Nong; Gao, Hong-Qing; Lei, Shu-Feng; Deng, Fei-Yan			Anxa2 attenuates osteoblast growth and is associated with hip BMD and osteoporotic fracture in Chinese elderly	PLOS ONE			English	Article							INCREASES OSTEOCLAST FORMATION; BONE-FORMATION; CIRCULATING MONOCYTES; GENE-EXPRESSION; RISK-FACTORS; ANNEXIN-II; RESORPTION; MICROENVIRONMENT; IDENTIFICATION; PRECURSORS	Low bone mineral density (BMD) is a risk factor of osteoporotic fracture (OF). Peripheral blood monocytes (PBM) can differentiate into osteoclasts to resorb bone. It was known that PBM-expressed Anxa2 protein is associated with BMD, and extracellular Anxa2 protein promotes osteoclastogenesis. This study aimed to test 1) whether Anxa2 protein level in PBM differs significantly between subjects with OF and without fracture history (NF); 2) whether Anxa2 level in plasma is associated with BMD; 3) how Anxa2 protein at various concentrations would affect osteoblastic activity in vitro. All the study subjects were Chinese Han elderly. Firstly, Anxa2 protein in PBM was identified and quantitated by LC-MS/MS and compared between 45 OF cases and 42 healthy controls. Secondly, plasma Anxa2 protein level was quantitated by ELISA and compared between unrelated subjects with extremely low vs. high hip BMD (0.63-0.10 vs. 1.05-0.10 g/cm(2), n = 75). Furthermore, in vitro functional assay was utilized to test the effects of extracellular Anxa2 protein on osteoblastic growth. We found that Anxa2 protein expression in PBM was significantly up-regulated in OF vs. NF subjects (fold change [FC)] = 1.16, P<0.05). Plasma Anxa2 protein concentration (range: 31.69 - 227.35ng/ml) was significantly elevated in low vs. high BMD subjects (84.85 vs. 66.15ng/ml, FC = 1.28, P<0.05). Cellular dynamical monitoring demonstrated that the general shape of dose-response relationship is the inverse U-shaped curve. Specifically, lower dose of Anxa2 protein may promote osteoblast growth and the optimal concentration for osteoblastic growth was around 50ng/ml, but even higher concentration could attenuate hFOB1.19 osteoprogenitor cell growth. We concluded that Anxa2 protein could attenuate osteoblast growth and be associated with hip BMD and OF in Chinese elderly.	[Zhou, Xu; Wu, Long-Fei; Wang, Wen-Yu; Lu, Xin; Lei, Shu-Feng; Deng, Fei-Yan] Soochow Univ, Sch Publ Hlth, Ctr Genet Epidemiol & Genom, Suzhou, Jiangsu, Peoples R China; [Zhou, Xu; Wu, Long-Fei; Wang, Wen-Yu; Lu, Xin; Lei, Shu-Feng; Deng, Fei-Yan] Soochow Univ, Sch Publ Hlth, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou, Jiangsu, Peoples R China; [Jiang, Zhen-Huan; Jiang, Jian-Nong] Municiple Peoples Hosp Yixin, Yixin, Jiangsu, Peoples R China; [Zhang, Yun-Hong; Gao, Hong-Qing] Shishan St Community Hlth Serv Ctr High Tech Dist, Suzhou, Jiangsu, Peoples R China; [Jiang, Ding-Hua] Soochow Univ, Affiliated Hosp 1, Dept Orthopaed, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Deng, FY (corresponding author), Soochow Univ, Sch Publ Hlth, Ctr Genet Epidemiol & Genom, Suzhou, Jiangsu, Peoples R China.	fdeng@suda.edu.cn			Natural Science Foundation of China [81373010, 81541068, 81473046, 31271336, 81502868]; Natural Science Foundation of Jiangsu Province [BK20130300, BK20150346]; Natural Science Research Project of Jiangsu Provincial Higher Education [16KJA330001]; Soochow University [Q413900112, Q413900712]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Research Project of Jiangsu Provincial Higher Education; Soochow University; Priority Academic Program Development of Jiangsu Higher Education Institutions	The study was supported by Natural Science Foundation of China (81373010, 81541068, 81473046, 31271336, 81502868), the Natural Science Foundation of Jiangsu Province (BK20130300, BK20150346), the Natural Science Research Project of Jiangsu Provincial Higher Education (16KJA330001), the Startup Fund from Soochow University (Q413900112, Q413900712) and a Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Deng FY, 2008, PROTEOMICS, V8, P4259, DOI 10.1002/pmic.200700480; Deng FY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011700; Everts V, 2002, J BONE MINER RES, V17, P77, DOI 10.1359/jbmr.2002.17.1.77; Genetos DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107482; Hopwood B, 2009, BONE, V44, P87, DOI 10.1016/j.bone.2008.08.120; Jevon M, 2003, SCAND J RHEUMATOL, V32, P95, DOI 10.1080/03009740310000102; Jordan KM, 2002, BEST PRACT RES CL RH, V16, P795, DOI 10.1053/berh.2002.0264; Komano Y, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2046; Lauritzen JB, 1996, BONE, V18, pS65, DOI 10.1016/8756-3282(95)00382-7; Li DF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10872; Liu YZ, 2005, J BIOL CHEM, V280, P29011, DOI 10.1074/jbc.M501164200; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Menaa C, 1999, J CLIN INVEST, V103, P1605, DOI 10.1172/JCI6374; Nakamura M, 2003, ENDOCRINOLOGY, V144, P5441, DOI 10.1210/en.2003-0717; NESBITT SA, 1995, J BONE MINER RES, V10, pS221; Roodman GD, 2006, ANN NY ACAD SCI, V1068, P100, DOI 10.1196/annals.1346.013; TAKAHASHI S, 1994, J BIOL CHEM, V269, P28696; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; Zhou Y, 2015, OSTEOPOROSIS INT, V26, P2561, DOI 10.1007/s00198-015-3250-7	23	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2018	13	3							e0194781	10.1371/journal.pone.0194781	http://dx.doi.org/10.1371/journal.pone.0194781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA2QK	29570731	Green Published, Green Submitted, gold			2022-12-26	WOS:000428168400029
J	Alatraktchi, FA; Noori, JS; Tanev, GP; Mortensen, J; Dimaki, M; Johansen, HK; Madsen, J; Molin, S; Svendsen, WE				Alatraktchi, Fatima AlZahra'a; Noori, Jafar Safaa; Tanev, Georgi Plamenov; Mortensen, John; Dimaki, Maria; Johansen, Helle Krogh; Madsen, Jan; Molin, Soren; Svendsen, Winnie E.			Paper-based sensors for rapid detection of virulence factor produced by Pseudomonas aeruginosa	PLOS ONE			English	Article							PYOCYANIN; AIRWAY	Pyocyanin is a toxin produced by Pseudomonas aeruginosa. Here we describe a novel paper-based electrochemical sensor for pyocyanin detection, manufactured with a simple and inexpensive approach based on electrode printing on paper. The resulting sensors constitute an effective electrochemical method to quantify pyocyanin in bacterial cultures without the conventional time consuming pretreatment of the samples. The electrochemical properties of the paper-based sensors were evaluated by ferri/ferrocyanide as a redox mediator, and showed reliable sensing performance. The paper-based sensors readily allow for the determination of pyocyanin in bacterial cultures with high reproducibility, achieving a limit of detection of 95 nM and a sensitivity of 4.30 mu A/mu M in standard culture media. Compared to the similar commercial ceramic based sensors, it is a 2.3-fold enhanced performance. The simple in-house fabrication of sensors for pyocyanin quantification allows researchers to understand in vitro adaptation of P. aeruginosa infections via rapid screenings of bacterial cultures that otherwise are expensive and time-consuming.	[Alatraktchi, Fatima AlZahra'a; Noori, Jafar Safaa; Tanev, Georgi Plamenov; Dimaki, Maria; Svendsen, Winnie E.] Tech Univ Denmark, Dept Micro & Nanotechnol, Lyngby, Denmark; [Alatraktchi, Fatima AlZahra'a; Molin, Soren] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Lyngby, Denmark; [Alatraktchi, Fatima AlZahra'a] Tech Univ Denmark, Dept Bioengn & Biomed, Lyngby, Denmark; [Noori, Jafar Safaa] IPM Intelligent Pollutant Monitoring ApS, Lyngby, Denmark; [Tanev, Georgi Plamenov; Madsen, Jan] Tech Univ Denmark, Dept Appl Math & Comp Sci, Lyngby, Denmark; [Mortensen, John] Roskilde Univ, Dept Sci & Environm, Roskilde, Denmark; [Johansen, Helle Krogh] Univ Hosp, Rigshosp, Dept Clin Microbiol, Copenhagen, Denmark; [Johansen, Helle Krogh] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark	Technical University of Denmark; Technical University of Denmark; Technical University of Denmark; Technical University of Denmark; Roskilde University; Rigshospitalet; University of Copenhagen; University of Copenhagen	Alatraktchi, FA (corresponding author), Tech Univ Denmark, Dept Micro & Nanotechnol, Lyngby, Denmark.; Alatraktchi, FA (corresponding author), Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Lyngby, Denmark.; Alatraktchi, FA (corresponding author), Tech Univ Denmark, Dept Bioengn & Biomed, Lyngby, Denmark.	faaat@nanotech.dtu.dk	Noori, Jafar Safaa/AAC-5144-2019; Svendsen, Winnie/AAE-1674-2019; Dimaki, Maria/J-9985-2012	Noori, Jafar Safaa/0000-0001-8794-2049; Madsen, Jan/0000-0002-5098-8454; Molin, Soren/0000-0002-7973-2639; Dimaki, Maria/0000-0001-5037-2388; Alatraktchi, Fatima AlZahra'a/0000-0003-3297-2560	Novo Nordisk Foundation; Rigshospitalet [R88-A3537]; Novo Nordisk Foundation Center for Biosustainability; Department of Micro- and Nanotechnology; Department of Bioengineering and Biomedicine at DTU; CACHET; Department of Applied Mathematics and Computer Science; Eureka Eurostars through CoPS project [E10621]; IPM - Intelligent Pollutant Monitoring; Novo Nordisk Fonden [NNF10CC1016517, NNF12OC1015920] Funding Source: researchfish; NNF Center for Biosustainability [Infection Microbiology] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Rigshospitalet; Novo Nordisk Foundation Center for Biosustainability; Department of Micro- and Nanotechnology; Department of Bioengineering and Biomedicine at DTU; CACHET; Department of Applied Mathematics and Computer Science; Eureka Eurostars through CoPS project; IPM - Intelligent Pollutant Monitoring; Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability	HKJ was supported by The Novo Nordisk Foundation as a clinical research stipend and by a rammebevilling from Rigshospitalet R88-A3537. FZA was supported by the Novo Nordisk Foundation Center for Biosustainability, the Department of Micro- and Nanotechnology and the Department of Bioengineering and Biomedicine at DTU. GPT was supported by CACHET, the Department of Applied Mathematics and Computer Science and the Department of Micro- and Nanotechnology. MD and JSN were funded by Eureka Eurostars through the CoPS project E10621. IPM - Intelligent Pollutant Monitoring provided support in the form of salaries for JSN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agency for Toxic Substances and Disease Registry, 1997, CHLOR TOXFAQS; Alatraktchi FA, 2016, NANOMEDICINE-UK, V11, P2185, DOI 10.2217/nnm-2016-0155; Alatraktchi FA, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16030408; Buzid A, 2016, SCI REP-UK, V6, DOI 10.1038/srep30001; Cabeen MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088743; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Dropsens, 2017, SCREEN PRINT EL; El-Fouly MZ, 2015, J RADIAT RES APPL SC, V8, P36, DOI 10.1016/j.jrras.2014.10.007; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; GRIGIS A, 1993, EUR J EPIDEMIOL, V9, P390, DOI 10.1007/BF00157395; Hall S, 2016, TOXINS, V8, P1; Jayaseelan S, 2014, WORLD J MICROB BIOT, V30, P1159, DOI 10.1007/s11274-013-1552-5; Johansen HK, 2008, J CYST FIBROS, V7, P391, DOI 10.1016/j.jcf.2008.02.003; Liana DD, 2012, SENSORS-BASEL, V12, P11505, DOI 10.3390/s120911505; MENDELSON MH, 1994, CLIN INFECT DIS, V18, P886, DOI 10.1093/clinids/18.6.886; Micrux technologies, 2009, EL SENS; Oh JM, 2015, ANAL METHODS-UK, V7, P7951, DOI 10.1039/c5ay01724f; Rada B, 2013, TRENDS MICROBIOL, V21, P73, DOI 10.1016/j.tim.2012.10.004; Sharp D, 2010, BIOELECTROCHEMISTRY, V77, P114, DOI 10.1016/j.bioelechem.2009.07.008; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Stuart B, 2010, PAEDIATR RESPIR REV, V11, P177, DOI 10.1016/j.prrv.2010.05.003; Winstanley C, 2009, FEMS MICROBIOL LETT, V290, P1, DOI 10.1111/j.1574-6968.2008.01394.x	22	35	35	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194157	10.1371/journal.pone.0194157	http://dx.doi.org/10.1371/journal.pone.0194157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566025	Green Submitted, Green Published, gold			2022-12-26	WOS:000428093900037
J	Wangari, IM; Stone, L				Wangari, Isaac Mwangi; Stone, Lewi			Backward bifurcation and hysteresis in models of recurrent tuberculosis	PLOS ONE			English	Article							INTRINSIC TRANSMISSION DYNAMICS; EXOGENOUS REINFECTION; MULTIPLE EQUILIBRIA; EPIDEMIOLOGY; VACCINES; RELAPSE; HISTORY; DISEASE; IMPACT	An epidemiological model is presented that provides a comprehensive description of the transmission pathways involved for recurrent tuberculosis (TB), whereby cured individuals can become reinfected. Our main goal is to determine conditions that lead to the appearance of a backward bifurcation. This occurs when an asymptotically stable infection free equilibrium concurrently exists with a stable non-trivial equilibria even though the basic reproduction number R-0 is less than unity. Although, some 10-30% cases of TB are recurrent, the role of recurrent TB as far as the formation of backward bifurcation is concerned, is rarely if ever studied. The model used here incorporates progressive primary infection, exogenous reinfection, endogenous reactivation and recurrent TB as transmission mechanisms that contribute to TB progression. Unlike other studies of TB dynamics that make use of frequency dependent transmission rates, our analysis provides exact backward bifurcation threshold conditions without resorting to commonly applied approximations and simplifying assumptions. Exploration of the model through analytical and numerical analysis reveal that recurrent TB is sometimes capable of triggering hysteresis effects which allow TB to persist when R-0 < 1 even though there is no backward bifurcation. Furthermore, recurrent TB can independently induce backward bifurcation phenomena if it exceeds a certain threshold.	[Wangari, Isaac Mwangi; Stone, Lewi] RMIT Univ, Dept Math & Geospatial Sci, Sch Sci, Melbourne, Vic, Australia; [Stone, Lewi] Tel Aviv Univ, Fac Life Sci, Dept Zool, Biomath Unit, Tel Aviv, Israel	Royal Melbourne Institute of Technology (RMIT); Tel Aviv University	Wangari, IM (corresponding author), RMIT Univ, Dept Math & Geospatial Sci, Sch Sci, Melbourne, Vic, Australia.	mwangiisaac@aims.ac.za		Stone, Lewi/0000-0002-6465-579X; Wangari, Isaac Mwangi/0000-0002-8661-311X	Australia Research Council through ARC [DP170102303]	Australia Research Council through ARC(Australian Research Council)	Australia Research Council helped fund this project through ARC Discovery Project grant DP170102303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951; Beretta E, 2011, MATH BIOSCI ENG, V8, P931, DOI 10.3934/mbe.2011.8.931; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; Blower SM, 1996, SCIENCE, V273, P497, DOI 10.1126/science.273.5274.497; Caminero JA, 2001, AM J RESP CRIT CARE, V163, P717, DOI 10.1164/ajrccm.163.3.2003070; Castillo-Chavez C, 2004, MATH BIOSCI ENG, V1, P361, DOI 10.3934/mbe.2004.1.361; Chaisson RE, 2010, J INFECT DIS, V201, P653, DOI 10.1086/650531; Chiang CY, 2005, LANCET INFECT DIS, V5, P629, DOI 10.1016/S1473-3099(05)70240-1; Cohen T, 2005, EMERG INFECT DIS, V11, P725, DOI 10.3201/eid1105.041107; Daniel TM, 2006, RESP MED, V100, P1862, DOI 10.1016/j.rmed.2006.08.006; DHILLON J, 1994, TUBERCLE LUNG DIS, V75, P61, DOI 10.1016/0962-8479(94)90105-8; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Diekmann O., 2009, J R SOC INTERFACE; Dietz K., 1975, EPIDEMIOLOGY, P104; Elbasha EH, 2006, B MATH BIOL, V68, P577, DOI 10.1007/s11538-005-9057-5; Feng ZL, 2000, THEOR POPUL BIOL, V57, P235, DOI 10.1006/tpbi.2000.1451; Feng ZL., 2001, J DYN DIFFER EQU, V13, P425, DOI DOI 10.1023/A:1016688209771; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Garba SM, 2008, MATH BIOSCI, V215, P11, DOI 10.1016/j.mbs.2008.05.002; Gerberry DJ, 2016, J THEOR BIOL, V388, P15, DOI 10.1016/j.jtbi.2015.10.003; Gomes MGM, 2007, J THEOR BIOL, V248, P608, DOI 10.1016/j.jtbi.2007.06.005; Gomes MGM, 2004, P ROY SOC B-BIOL SCI, V271, P617, DOI 10.1098/rspb.2003.2606; Gomes MGM, 2012, P BIOL SCI; Greenhalgh D, 2009, J MATH BIOL, V59, P1, DOI 10.1007/s00285-008-0206-y; Gumel AB, 2012, J MATH ANAL APPL, V395, P355, DOI 10.1016/j.jmaa.2012.04.077; Hadeler KP, 1997, MATH BIOSCI, V146, P15, DOI 10.1016/S0025-5564(97)00027-8; Herrera M, 2013, COMP MATH MATH PHYS, V2013, P1; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Jia ZW, 2008, THEOR POPUL BIOL, V73, P437, DOI 10.1016/j.tpb.2007.12.007; Kar TK., 2012, J MATH MODEL ALGORIT, V11, P433, DOI [3004224, 10.1007/s10852-012-9210-8, DOI 10.1007/S10852-012-9210-8]; Karus C A, 1983, Nurse Pract, V8, P21; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Knipl DH, 2014, BIOMATH, V2, P1, DOI [10.11145/j.biomath.2013.12.051, DOI 10.11145/J.BIOMATH.2013.12.051]; Lambert ML, 2003, LANCET INFECT DIS, V3, P282, DOI 10.1016/S1473-3099(03)00607-8; Li MY., 2011, CANADIAN APPL MATH Q, V19; Lipsitch M, 2003, THEOR POPUL BIOL, V63, P169, DOI 10.1016/S0040-5809(02)00037-0; Murphy BM, 2003, J THEOR BIOL, V223, P391, DOI 10.1016/S0022-5193(03)00038-9; NARDELL E, 1986, NEW ENGL J MED, V315, P1570, DOI 10.1056/NEJM198612183152502; Porco TC, 1998, THEOR POPUL BIOL, V54, P117, DOI 10.1006/tpbi.1998.1366; Raimundo SM, 2006, MATH POPUL STUD, V13, P181, DOI 10.1080/08898480600950457; Reluga TC, 2008, J THEOR BIOL, V252, P155, DOI 10.1016/j.jtbi.2008.01.014; SLAVIN RE, 1980, MEDICINE, V59, P352, DOI 10.1097/00005792-198009000-00003; SMITH PG, 1994, TUBERCULOSIS PATHOGE; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; Verver S, 2005, AM J RESP CRIT CARE, V171, P1430, DOI 10.1164/rccm.200409-1200OC; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; Wang X, 2009, INT S MATH COMP BIOL, P304; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC; WHO, 2014, GLOB TUB REP 2014; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; Yang HM, 2010, THEOR BIOL MED MODEL, V7, P1; Zignol M, 2007, CLIN INFECT DIS, V44, P61, DOI 10.1086/509328	55	15	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194256	10.1371/journal.pone.0194256	http://dx.doi.org/10.1371/journal.pone.0194256			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566101	Green Published, gold, Green Submitted			2022-12-26	WOS:000428093900047
J	Mindus, S; Malinovschi, A; Ekerljung, L; Forsberg, B; Gislason, T; Jogi, R; Franklin, KA; Holm, M; Johannessen, A; Middelveld, R; Schlunssen, V; Svanes, C; Toren, K; Lindberg, E; Janson, C				Mindus, Stephanie; Malinovschi, Andrei; Ekerljung, Linda; Forsberg, Bertil; Gislason, Thorarinn; Jogi, Rain; Franklin, Karl A.; Holm, Mathias; Johannessen, Ane; Middelveld, Roelinde; Schlunssen, Vivi; Svanes, Cecilie; Toren, Kjell; Lindberg, Eva; Janson, Christer			Asthma and COPD overlap (ACO) is related to a high burden of sleep disturbance and respiratory symptoms: Results from the RHINE and Swedish GA(2)LEN surveys	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; HEALTH SURVEY; PREVALENCE; INSOMNIA; ADULTS	Background The term Asthma and COPD Overlap (ACO) describes a condition where asthma and COPD overlap. We aimed to investigate associations between ACO and insomnia and respiratory symptoms, and to investigate the prevalence of ACO and the characteristics of subjects with ACO in two Northern European population studies. Methods The study comprised 25 429 subjects aged >40 years who participated in one of two Northern European general population surveys. Both surveys included questions on asthma, COPD, respiratory and sleep-related symptoms, including difficulty initiating sleep, difficulty maintaining sleep, early-morning awakening, and excessive daytime sleepiness. ACO was defined as having both self-reported asthma and COPD. Results The prevalence of ACO was 1.0%. The group with ACO had a higher prevalence of both insomnia and respiratory symptoms than subjects with only asthma or COPD. Having ACO was independently associated with a 2-3 times higher probability of having sleep-related symptoms as compared with the group without asthma or COPD, after adjustment for age, sex, BMI, smoking history and educational level (adjusted odds ratio 2.14-3.36, 95% CI). Conclusion Subjects with ACO have a high prevalence of insomnia and respiratory symptoms. To our knowledge, this is the first study to assess the association between sleep-related symptoms and ACO.	[Mindus, Stephanie; Lindberg, Eva; Janson, Christer] Uppsala Univ, Dept Med Sci Resp Allergy & Sleep Res, Uppsala, Sweden; [Malinovschi, Andrei] Uppsala Univ, Dept Med Sci Clin Physiol, Uppsala, Sweden; [Ekerljung, Linda] Univ Gothenburg, Inst Med, Sahlgrenska Acad, Gothenburg, Sweden; [Forsberg, Bertil] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Gislason, Thorarinn] Univ Iceland, Fac Med, Reykjavik, Iceland; [Jogi, Rain] Tartu Univ Clin, Lung Clin, Tartu, Estonia; [Franklin, Karl A.] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden; [Holm, Mathias] Univ Gothenburg, Dept Occupat & Environm Med, Gothenburg, Sweden; [Johannessen, Ane] Haukeland Hosp, Clin Res Ctr, Bergen, Norway; [Middelveld, Roelinde] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Schlunssen, Vivi] Aarhus Univ, Dept Publ Hlth, Sect Environm Occupat & Hlth, Aarhus, Denmark; [Svanes, Cecilie] Haukeland Hosp, Dept Occupat Med, Bergen, Norway; [Svanes, Cecilie] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Toren, Kjell] Sahlgrens Univ Hosp, Dept Occupat & Environm Med, Gothenburg, Sweden	Uppsala University; University of Gothenburg; Umea University; University of Iceland; University of Tartu; Umea University; University of Gothenburg; University of Bergen; Haukeland University Hospital; Karolinska Institutet; Aarhus University; University of Bergen; Haukeland University Hospital; University of Bergen; Sahlgrenska University Hospital	Janson, C (corresponding author), Uppsala Univ, Dept Med Sci Resp Allergy & Sleep Res, Uppsala, Sweden.	christer.janson@medsci.uu.se	Svanes, Cecilie/N-7556-2017	Svanes, Cecilie/0000-0001-8512-5192; Franklin, Karl/0000-0002-5306-1697; Schlunssen, Vivi/0000-0003-4915-1734; Johannessen, Ane/0000-0003-3269-8354	EU Sixth Framework Programme for Research [FOOD-CT-2004-506378]; Swedish Heart and Lung Foundation; Swedish Asthma and Allergy Foundation; Swedish Association against Heart and Lung Diseases; VBG Group Centre for Asthma and Allergy Research; Swedish Association Against Asthma and Allergy; Swedish Association against Heart and Lung Disease; Swedish Council for Working Life and Social Research; Bror Hjerpstedt Foundation; Vardal Foundation for Health Care and Allergic Research; Faculty of. Health, Aarhus University, Denmark [240008]; Wood Dust Foundation [444508795]; Danish Lung Association; Norwegian Research Council [135773/330]; Norwegian Asthma and Allergy Association; Icelandic Research Council; Estonian Science Foundation [4350]	EU Sixth Framework Programme for Research(European Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Asthma and Allergy Foundation; Swedish Association against Heart and Lung Diseases; VBG Group Centre for Asthma and Allergy Research; Swedish Association Against Asthma and Allergy; Swedish Association against Heart and Lung Disease; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Bror Hjerpstedt Foundation; Vardal Foundation for Health Care and Allergic Research; Faculty of. Health, Aarhus University, Denmark; Wood Dust Foundation; Danish Lung Association; Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Asthma and Allergy Association; Icelandic Research Council; Estonian Science Foundation	The GA2LEN survey was financially supported by the EU Sixth Framework Programme for Research, contract no. FOOD-CT-2004-506378. The study was also financially supported by the Swedish Heart and Lung Foundation, the Swedish Asthma and Allergy Foundation and the Swedish Association against Heart and Lung Diseases. The Gothenburg part of the study was mainly funded by the VBG Group Centre for Asthma and Allergy Research. The RHINE study was funded by the Swedish Heart and Lung Foundation, the Swedish Association Against Asthma and Allergy, the Swedish Association against Heart and Lung Disease, the Swedish Council for Working Life and Social Research, the Bror Hjerpstedt Foundation, the Vardal Foundation for Health Care and Allergic Research, the Faculty of. Health, Aarhus University, Denmark (Project No. 240008), the Wood Dust Foundation (Project No 444508795), the Danish Lung Association, the Norwegian Research Council (project 135773/330), the Norwegian Asthma and Allergy Association, the Icelandic Research Council and the Estonian Science Foundation (Grant No. 4350); The GA<SUP>2</SUP>LEN survey was financially supported by the EU Sixth Framework Programme for Research, contract no. FOOD-CT-2004-506378. The study was also financially supported by the Swedish Heart and Lung Foundation, the Swedish Asthma and Allergy Foundation and the Swedish Association against Heart and Lung Diseases. The Gothenburg part of the study was mainly funded by the VBG Group Centre for Asthma and Allergy Research.; The RHINE study was funded by the Swedish Heart and Lung Foundation, the Swedish Association Against Asthma and Allergy, the Swedish Association against Heart and Lung Disease, the Swedish Council for Working Life and Social Research, the Bror Hjerpstedt Foundation, the Vardal Foundation for Health Care and Allergic Research, the Faculty of. Health, Aarhus University, Denmark (Project No. 240008), the Wood Dust Foundation (Project No 444508795), the Danish Lung Association, the Norwegian Research Council (project 135773/330), the Norwegian Asthma and Allergy Association, the Icelandic Research Council and the Estonian Science Foundation (Grant No. 4350).	[Anonymous], 2016, GLOBAL INITIATIVE AS; Bateman ED, 2015, LANCET RESP MED, V3, P719, DOI 10.1016/S2213-2600(15)00254-4; Burney P, 1996, EUR RESPIR J, V9, P687; Cosio BG, 2016, CHEST, V149, P45, DOI 10.1378/chest.15-1055; de Marco R, 2015, EUR RESPIR J, V46, P671, DOI 10.1183/09031936.00008615; Diaz-Guzman E, 2011, COPD, V8, P400, DOI 10.3109/15412555.2011.611200; Gibson PG, 2015, THORAX, V70, P683, DOI 10.1136/thoraxjnl-2014-206740; Hardin M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-127; Janson C, 1996, EUR RESPIR J, V9, P2132, DOI 10.1183/09031936.96.09102132; Janson C, 2001, EUR RESPIR J, V18, P598, DOI 10.1183/09031936.01.00205801; Jarvis D, 2012, ALLERGY, V67, P91, DOI 10.1111/j.1398-9995.2011.02709.x; Miravitlles M, 2013, RESP MED, V107, P1053, DOI 10.1016/j.rmed.2013.03.007; Rhee CK, 2014, COPD, V11, P163, DOI 10.3109/15412555.2013.831061; Stridsman C, 2013, COPD, V10, P125, DOI 10.3109/15412555.2012.728642; Sundbom F, 2013, ALLERGY, V68, P213, DOI 10.1111/all.12079; Sundbom F, 2016, J ASTHMA, V53, P398, DOI 10.3109/02770903.2015.1126846; Theorell-Haglow J, 2016, INT J CHRONIC OBSTR, V11, P151, DOI 10.2147/COPD.S94268	17	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195055	10.1371/journal.pone.0195055	http://dx.doi.org/10.1371/journal.pone.0195055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608582	Green Published, gold, Green Submitted			2022-12-26	WOS:000428988800023
J	Henneman, P; Bouman, A; Mul, A; Knegt, L; van der Kevie-Kersemaekers, AM; Zwaveling-Soonawala, N; Meijers-Heijboer, HEJ; van Trotsenburg, ASP; Mannens, MM				Henneman, Peter; Bouman, Arjan; Mul, Adri; Knegt, Lia; van der Kevie-Kersemaekers, Anne-Marie; Zwaveling-Soonawala, Nitash; Meijers-Heijboer, Hanne E. J.; van Trotsenburg, A. S. Paul; Mannens, Marcel M.			Widespread domain-like perturbations of DNA methylation in whole blood of Down syndrome neonates	PLOS ONE			English	Article							CHROMOSOME-21; PHENOTYPE; TRISOMY-21; IMBALANCE; PATTERNS; CHILDREN; GENOME; CELLS	Introduction Down syndrome (DS) is the most frequent genetic cause of intellectual disability. Despite the fact that more than 50 years have passed since the discovery of its genetic aberrations, the exact pathogenesis of the DS phenotype has remained largely unexplained. It was recently hypothesized that the DS pathogenesis involves complex (epi) genetic, molecular and cellular determinants. To date, many reports have addressed epigenetic aberrations associated with DS at different developmental stages/ages and tissue types, but to our best knowledge not in DS newborns. This study aimed to investigate genome-wide methylation patterns in DS newborns compared to non-trisomic newborns. Method We analyzed blood samples obtained from ten newborns with DS and five age-matched non-trisomic newborns. Epigenetic profiles were obtained from extracted DNA using the Illumina Infinium 450K array. Since aberrant blood cell distribution is known to be present in DS, we applied two distinct models: with and without correction for estimated blood cell distribution. Results Differentially methylated position (DMP) analysis of the uncorrected model detected 19525 significant hits (51,2% hypomethylated). In the corrected model, we found 121953 significant DMPs (49,8% hypomethylated). Independent of the used model we observed a chromosome 21 dosage effect. Moreover, we detected 46 and 145 differentially methylated regions in the uncorrected and corrected model respectively, both showing hypomethylation overrepresentation. Replication analyses of DMPs and DMRs found by Bacalini et al. (2015) showed a large overlap. Conclusion In this study, we found methylation profile differences between DS newborns and controls reflecting a systematically affected epigenetic profile. The observed chromosome 21 dosage effect suggests the involvement of affected essential regulatory factors/regions or altered expression of chromatin modeling enzymes located on chromosome 21. Additional research is necessary to substantiate these hypotheses.	[Henneman, Peter; Bouman, Arjan; Mul, Adri; Knegt, Lia; van der Kevie-Kersemaekers, Anne-Marie; Meijers-Heijboer, Hanne E. J.; Mannens, Marcel M.] Acad Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Zwaveling-Soonawala, Nitash] Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Endocrinol, Amsterdam, Netherlands; [van Trotsenburg, A. S. Paul] Emma Childrens Hosp, Acad Med Ctr, Dept Pediat & Translat Genet, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam	Henneman, P (corresponding author), Acad Med Ctr, Dept Clin Genet, Amsterdam, Netherlands.	p.henneman@amc.uva.nl	van Trotsenburg, Paul/ABC-2379-2020	van Trotsenburg, Paul/0000-0002-9677-7441; Zwaveling-Soonawala, Nitash/0000-0003-0318-5541				da Silva AFA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154108; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Bacalini MG, 2015, AGING-US, V7, P82; BURGIO GR, 1978, CLIN EXP IMMUNOL, V33, P298; Carsetti R, 2015, EUR J IMMUNOL, V45, P903, DOI 10.1002/eji.201445049; Chango A, 2006, BIOCHEM BIOPH RES CO, V349, P492, DOI 10.1016/j.bbrc.2006.08.038; De Hingh YCM, 2005, J PEDIATR-US, V147, P744, DOI 10.1016/j.jpeds.2005.07.022; Eckmann-Scholz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039014; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hatt L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160319; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Inoshita M, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0029-7; Jin SN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003515; Jones MJ, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-58; Kerkel K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001212; Korbel JO, 2007, P NATL ACAD SCI USA, V104, P10110, DOI 10.1073/pnas.0703834104; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; KORENBERG JR, 1990, AM J HUM GENET, V47, P236; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; Letourneau A, 2014, NATURE, V508, P345, DOI 10.1038/nature13200; Lu J, 2016, HUM MOL GENET, V25, P1714, DOI 10.1093/hmg/ddw043; Lyle R, 2009, EUR J HUM GENET, V17, P454, DOI 10.1038/ejhg.2008.214; Martin GM, 2005, P NATL ACAD SCI USA, V102, P10413, DOI 10.1073/pnas.0504743102; Mendioroz M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0827-6; Newton RW PSaML, 2015, ADV MOL GENETICS SYN, P3; Patterson D, 2007, MENT RETARD DEV D R, V13, P199, DOI 10.1002/mrdd.20162; Poulsen P, 2007, PEDIATR RES, V61, p38R, DOI 10.1203/pdr.0b013e31803c7b98; Sailani MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135555; van Iterson M, 2014, BIOINFORMATICS, V30, P3435, DOI 10.1093/bioinformatics/btu566; Xia YY, 2014, MOL MED REP, V9, P1681, DOI 10.3892/mmr.2014.1985; Yuen RKC, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-7	32	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0194938	10.1371/journal.pone.0194938	http://dx.doi.org/10.1371/journal.pone.0194938			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601581	Green Published, Green Submitted, gold			2022-12-26	WOS:000428845900013
J	Pimenta, NC; Antunes, AP; Barnett, AA; Macedo, VW; Shepard, GH				Pimenta, Natalia C.; Antunes, Andre P.; Barnett, Adrian A.; Macedo, Valencio W.; Shepard, Glenn H., Jr.			Differential resilience of Amazonian otters along the Rio Negro in the aftermath of the 20th century international fur trade	PLOS ONE			English	Article							MANU NATIONAL-PARK; PTERONURA-BRASILIENSIS; GIANT OTTERS; LONTRA-LONGICAUDIS; SUSTAINABILITY; CONSERVATION; MANAGEMENT; DISPERSAL; LANDSCAPE; COLLAPSE	Commercial hunting for the international trade in animal hides in the 20th century decimated many populations of aquatic wildlife in Amazonia. However, impacts varied significantly between different species and regions, depending upon hunting intensity, accessibility of habitat, and the inherent resilience of various species and their habitats. We investigated the differential responses of two Amazonian Mustelid species, the neotropical otter and giant otter, to commercial hunting pressure along the upper Rio Negro in Brazil, and examined historical factors that influenced spatial and temporal variation in commercial exploitation. We analyzed previously unanalyzed data from historical records of hide shipments to track changes in hide sales and prices for the two species in the late 20th century. We also gathered oral histories from older Baniwa people who had witnessed or participated in commercial otter hunting. These complimentary data sources reveal how intrinsic biological and social characteristics of the two otter species interacted with market forces and regional history. Whereas giant otter populations were driven to local or regional extinction during the late 20th century by commercial hunting, neotropical otters persisted. In recent decades, giant otter populations have returned to some parts of the upper Rio Negro, a development which local people welcome as part of a generalized recovery of the ecosystems in their territory as a result of the banning of animal pelt exports and indigenous land demarcation. This paper expands the scope of the field historical ecology and reflects on the role of local knowledge in biodiversity conservation.	[Pimenta, Natalia C.; Barnett, Adrian A.] Natl Inst Amazonian Res, Amazon Mammal Res Grp, Manaus, Amazonas, Brazil; [Pimenta, Natalia C.] Museu Paraense Emilio Goeldi, Inst Capac Bldg Program, Dept Anthropol, MCTIC, Belem, Para, Brazil; [Antunes, Andre P.] Natl Inst Amazonian Res, Dept Ecol, Manaus, Amazonas, Brazil; [Macedo, Valencio W.] Escola Indigena Baniwa & Coripaco Pamaali, Comunidade Urumutum Lago, Sao Gabriel Da Cachoeira, Amazonas, Brazil; [Shepard, Glenn H., Jr.] Museu Paraense Emilio Goeldi, Dept Anthropol, Belem, Para, Brazil	Institute Nacional de Pesquisas da Amazonia; Ministerio da Ciencia, Tecnologia, Inovacoes e Comunicacoes (MCTIC); Museu Paraense Emilio Goeldi; Institute Nacional de Pesquisas da Amazonia; Museu Paraense Emilio Goeldi	Pimenta, NC (corresponding author), Natl Inst Amazonian Res, Amazon Mammal Res Grp, Manaus, Amazonas, Brazil.; Pimenta, NC (corresponding author), Museu Paraense Emilio Goeldi, Inst Capac Bldg Program, Dept Anthropol, MCTIC, Belem, Para, Brazil.	natalia.camps@gmail.com	Shepard, Glenn H./C-3667-2014; Antunes, André P/Q-3236-2018	Shepard, Glenn H./0000-0003-3195-8230; Antunes, André P/0000-0003-4404-3486; Barnett, Adrian Ashton/0000-0002-8829-2719; Pimenta, Natalia/0000-0003-4312-126X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico through the Institutional Capacity Building Program of the Emilio Goeldi Museum [301089/2017-5]; Rufford Foundation [16845-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [140222/2011-1]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [14646/13-7]; Fundacao de Amparo a Pesquisa do Estado do Amazonas [062.00427/2013]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico through the Institutional Capacity Building Program of the Emilio Goeldi Museum; Rufford Foundation; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Amazonas	NCP received Master scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br); scholarship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico through the Institutional Capacity Building Program of the Emilio Goeldi Museum (http://www.museu-goeldibr/), grant number: 301089/2017-5; financial support to field logistics from The Rufford Foundation (http://www.rufford.org), grant number: 16845-1; and equipment donation for field activities from Idea Wild (http://www.ideawild.org). APA received Doctoral scholarship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://cnpq.br), grant number: 140222/2011-1, an exchange scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, grant number 14646/13-7 and financial support from Fundacao de Amparo a Pesquisa do Estado do Amazonas (http//www.fapeam.am.gov.br), grant number: 062.00427/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraao M. B., 2010, LANDSCAPE ETHNOECOLO, P83; Alexiades MN, 1986, SELECTED GUIDELINES, P53; Ames EP, 2004, FISHERIES, V29, P23; Antunes AP, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600936; Antunes André Pinassi, 2014, Bol. Mus. Para. Emílio Goeldi. Ciênc. hum., V9, P487, DOI 10.1590/1981-81222014000200013; Balee W, 2006, ANNU REV ANTHROPOL, V35, P75, DOI 10.1146/annurev.anthro.35.081705.123231; Bezerra BM, 2011, J ETHOL, V29, P169, DOI 10.1007/s10164-010-0218-0; Breheny P., 2017, PACKAGE VISREG VISUA; Cabalzar A., 2006, MAPA LIVRO POVOS IND; Carter SK, 1997, MAMMAL REV, V27, P1, DOI 10.1111/j.1365-2907.1997.tb00370.x; Conta M., 2016, BANDO PRESO COM SEIS, V1, P1; Damania R, 2005, P ROY SOC B-BIOL SCI, V272, P259, DOI 10.1098/rspb.2004.2945; de Oliveira GC, 2011, ANIM BIOL, V61, P175, DOI 10.1163/157075511X566506; Dean W., 1989, LUTA PELA BORRACHA B; deRodrigues L A, 2013, BIODIVERSIDADE BRAS, V3, P216; Diaz H. J., 2002, IUCN OTTER SPEC GROU, V19, P97; Duarte JCS, 1985, TRAFFIC B, V7, P1617; Duplaix N., 1980, REV ECOL, V34, P620; Duplaix Nicole, 2015, Latin American Journal of Aquatic Mammals, V10, P75; Eisenberg JF, 2000, MAMMALS NEOTROPICS, V3; Foster-Turley P, 1990, IUCN OTTER SPEC GR, V126; Groenendijk J, 2015, IUCN RED LIST THREAT, V8235; IBGE, 2015, SER HIST SEC 20; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JOSHI NV, 1991, THEOR POPUL BIOL, V40, P211, DOI 10.1016/0040-5809(91)90053-I; Kruuk H., 2006, BEHAV CONSERVATION; Lanman RB, 2012, CALIF FISH GAME, V98, P65; Lariviere Serge, 1999, Mammalian Species, V608, P1, DOI 10.2307/3504420; Levi T, 2011, ECOL APPL, V21, P1802, DOI 10.1890/10-0375.1; Levi T, 2009, J APPL ECOL, V46, P804, DOI 10.1111/j.1365-2664.2009.01661.x; Lima Danielle dos Santos, 2014, Ambient. soc., V17, P127, DOI 10.1590/S1414-753X2014000200009; MacCreagh G., 1985, WHITE WATERS BLACK; Michalski F, 2005, BIOL CONSERV, V124, P383, DOI 10.1016/j.biocon.2005.01.045; Navia R., 2018, FANG TRAFFICKING CHI; Novaro AJ, 2000, CONSERV BIOL, V14, P713, DOI 10.1046/j.1523-1739.2000.98452.x; Ohl-Schacherer J, 2007, CONSERV BIOL, V21, P1174, DOI 10.1111/j.1523-1739.2007.00759.x; Pamaali EIBC, KOPHENAI NAKO; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; Peres CA, 2003, CONSERV BIOL, V17, P521, DOI 10.1046/j.1523-1739.2003.01413.x; PERES CA, 1990, BIOL CONSERV, V54, P47, DOI 10.1016/0006-3207(90)90041-M; Peres CA, 2016, P NATL ACAD SCI USA, V113, P892, DOI 10.1073/pnas.1516525113; Pimenta N. C., 2016, THESIS; Read JM, 2010, J LAT AM GEOGR, V9, P213, DOI 10.1353/lag.2010.0030; Uscamaita MR, 2010, ORYX, V44, P83, DOI 10.1017/S0030605309990196; Reeves RR, 2004, MAR MAMMAL SCI, V20, P774, DOI 10.1111/j.1748-7692.2004.tb01192.x; Vieira MARD, 2015, CONSERV SOC, V13, P254, DOI 10.4103/0972-4923.170399; Rheingantz ML, 2015, IUCN RED LIST THREAT, V8235; Ribas C, 2012, STUD NEOTROP FAUNA E, V47, P19, DOI 10.1080/01650521.2012.662795; Ricardo CA, 2008, VISOES RIO NEGRO CON; Ripple WJ, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160498; Shepard GH, 2012, AM ANTHROPOL, V114, P652, DOI 10.1111/j.1548-1433.2012.01514.x; Shepard Glenn Harvey, 2004, TERRAS INDIGENAS UNI, P129; Silva RE, 2014, J NAT HIST, V48, P465, DOI 10.1080/00222933.2013.800607; Siren A, 2004, CONSERV BIOL, V18, P1315, DOI 10.1111/j.1523-1739.2004.00024.x; Smith N.J.H., 1976, Oryx, V13, P362; SMITH NJH, 1981, BIOL CONSERV, V19, P177, DOI 10.1016/0006-3207(81)90033-1; Szabo P, 2015, BIOL REV, V90, P997, DOI 10.1111/brv.12141; Szabo P, 2011, CONSERV BIOL, V25, P680, DOI 10.1111/j.1523-1739.2011.01710.x; Taylor MS, 2011, AM ECON REV, V101, P3162, DOI 10.1257/aer.101.7.3162; Tocantins L, 1983, LIVRARIA J OLYMPIO; Rosas FCW, 2009, BRAZ ARCH BIOL TECHN, V52, P587, DOI 10.1590/S1516-89132009000300010; Wood SN, 2006, GEN ADDITIVE MODELS; Wright Robin. M, 2005, HIST INDIGENA INDIGE	63	6	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0193984	10.1371/journal.pone.0193984	http://dx.doi.org/10.1371/journal.pone.0193984			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB1XW	29601590	Green Submitted, Green Published, gold			2022-12-26	WOS:000428845900003
J	Farrell, LE; Levy, DM; Donovan, T; Mickey, R; Howard, A; Vashon, J; Freeman, M; Royer, K; Kilpatrick, CW				Farrell, Laura E.; Levy, Daniel M.; Donovan, Therese; Mickey, Ruth; Howard, Alan; Vashon, Jennifer; Freeman, Mark; Royer, Kim; Kilpatrick, C. William			Landscape connectivity for bobcat (Lynx rufus) and lynx (Lynx canadensis) in the Northeastern United States	PLOS ONE			English	Article							SOUTHERN RANGE PERIPHERY; CANADA LYNX; HABITAT-SELECTION; MULTIPLE SCALES; CLIMATE-CHANGE; SPACE USE; MAMMALIAN CARNIVORES; BEHAVIORAL-RESPONSES; CENTRAL MISSISSIPPI; HUMAN FOOTPRINT	Landscape connectivity is integral to the persistence of metapopulations of wide ranging carnivores and other terrestrial species. The objectives of this research were to investigate the landscape characteristics essential to use of areas by lynx and bobcats in northern New England, map a habitat availability model for each species, and explore connectivity across areas of the region likely to experience future development pressure. A Mahalanobis distance analysis was conducted on location data collected between 2005 and 2010 from 16 bobcats in western Vermont and 31 lynx in northern Maine to determine which variables were most consistent across all locations for each species using three scales based on average 1) local (15 minute) movement, 2) linear distance between daily locations, and 3) female home range size. The bobcat model providing the widest separation between used locations and random study area locations suggests that they cue into landscape features such as edge, availability of cover, and development density at different scales. The lynx model with the widest separation between random and used locations contained five variables including natural habitat, cover, and elevation all at different scales. Shrub scrub habitat where lynx's preferred prey is most abundant was represented at the daily distance moved scale. Cross validation indicated that outliers had little effect on models for either species. A habitat suitability value was calculated for each 30 m(2) pixel across Vermont, New Hampshire, and Maine for each species and used to map connectivity between conserved lands within selected areas across the region. Projections of future landscape change illustrated potential impacts of anthropogenic development on areas lynx and bobcat may use, and indicated where connectivity for bobcats and lynx may be lost. These projections provided a guide for conservation of landscape permeability for lynx, bobcat, and species relying on similar habitats in the region.	[Farrell, Laura E.; Kilpatrick, C. William] Univ Vermont, Dept Biol, Burlington, VT 05405 USA; [Levy, Daniel M.] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Burlington, VT USA; [Donovan, Therese; Freeman, Mark] Univ Vermont, US Geol Survey, Vermont Cooperat Fish & Wildlife Res Unit, Rubenstein Sch Environm & Nat Resources, Burlington, VT USA; [Mickey, Ruth] Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA; [Howard, Alan] Univ Vermont, Stat Consulting Clin, Burlington, VT USA; [Vashon, Jennifer] Maine Dept Inland Fisheries & Wildlife, Bangor, ME USA; [Royer, Kim] Vermont Fish & Wildlife Dept Springfield, Springfield, VT USA; [Farrell, Laura E.] Otter Ridge Consulting LLC, Fukushima 96012, Japan; [Levy, Daniel M.] GIS Consultant, Waterbury, VT USA	University of Vermont; University of Vermont; United States Department of the Interior; United States Geological Survey; University of Vermont; University of Vermont; University of Vermont	Farrell, LE (corresponding author), Univ Vermont, Dept Biol, Burlington, VT 05405 USA.; Farrell, LE (corresponding author), Otter Ridge Consulting LLC, Fukushima 96012, Japan.	lfarrel@gmail.com			US EPA STAR Fellowship [F5F21809]; Lindbergh Foundation; U.S. Geological Survey; University of Vermont; Vermont Department of Fish and Wildlife; Wildlife Management Institute	US EPA STAR Fellowship(United States Environmental Protection Agency); Lindbergh Foundation; U.S. Geological Survey(United States Geological Survey); University of Vermont; Vermont Department of Fish and Wildlife; Wildlife Management Institute	This work was supported by the US EPA STAR Fellowship (https://cfpub.epa.gov/ncer_abstracts/index.cfm/fuseaction/display.abstractDetail/abstract/7582/report/0), F5F21809 to LF; and the Lindbergh Foundation (http://lindberghfoundation.org/) to LF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Walter Jakubas, of Maine Department of Inland Fisheries and Wildlife, for generously allowing the use of the lynx data in these analyses. The Vermont Advanced Computing Center and The Rubenstein School at University of Vermont provided computers. We thank Jennifer Morrow; Bob Devins; Christopher Hoving; Guoping Tang; T. Garin (Advanced Telemetry Systems); Tony Tur and Rachel Cliche of US Fish and Wildlife; Chris Bernier; wild-life agencies in Maine, New Hampshire and Vermont; and Joe Roman, for logistical support, assistance, and data sharing. Use of trade names or products does not constitute endorsement by the U.S. Government. The Vermont Cooperative Fish and Wildlife Research Unit is jointly supported by the U.S. Geological Survey, University of Vermont, Vermont Department of Fish and Wildlife, and Wildlife Management Institute.	Abouelezz HA, 2009, THESIS; Abrahms B, 2017, J APPL ECOL, V54, P412, DOI 10.1111/1365-2664.12714; Adams AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065763; Anderson EM, 2003, WILD MAMMALS N AM BI, P758; [Anonymous], 2007, DIFFERENCE CURRENT H; [Anonymous], 2013, FED REGISTER, V78, P187; BAILEY TN, 1974, J WILDLIFE MANAGE, V38, P435, DOI 10.2307/3800874; Ballinger N., 2004, PEOPLE AND EC; Bar Massada A, 2010, LANDSCAPE ECOL, V25, P711, DOI 10.1007/s10980-010-9452-7; Basille M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065493; Beier P, 2008, CONSERV BIOL, V22, P836, DOI 10.1111/j.1523-1739.2008.00942.x; Beier P, 2011, CONSERV BIOL, V25, P879, DOI 10.1111/j.1523-1739.2011.01716.x; Bernier CA, 2012, CANADA LYNX LYNX CAN; Burdett CL, 2007, J MAMMAL, V88, P457, DOI 10.1644/06-MAMM-A-181R.1; Buskirk Steven W., 2000, P83; Carroll C, 2007, CONSERV BIOL, V21, P1092, DOI 10.1111/j.1523-1739.2007.00719.x; Cejtin M., 2011, THESIS; Chamberlain M, 2003, AM MIDL NAT, V149, P395, DOI 10.1674/0003-0031(2003)149[0395:SUMAHS]2.0.CO;2; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; CLARK JD, 1993, J WILDLIFE MANAGE, V57, P519, DOI 10.2307/3809276; Collinge SK, 1996, LANDSCAPE URBAN PLAN, V36, P59, DOI 10.1016/S0169-2046(96)00341-6; Conservation Biology Institute, 2010, PADUS 1 1 NO REG PRO; Constible JM, 2006, AM MIDL NAT, V155, P352, DOI 10.1674/0003-0031(2006)155[352:RBLPAS]2.0.CO;2; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Cushman SA, 2008, FRONT ECOL ENVIRON, V6, P13, DOI 10.1890/070039; Cushman SA, 2010, LANDSCAPE ECOL, V25, P967, DOI 10.1007/s10980-010-9467-0; Cushman SA, 2009, CONSERV BIOL, V23, P368, DOI 10.1111/j.1523-1739.2008.01111.x; Donovan TM, 2011, BIOL CONSERV, V144, P2799, DOI 10.1016/j.biocon.2011.06.026; Duncan L, 2001, P SAS US GROUP INT 2; Eisenberg J.F., 1986, P293; Farber O, 2003, ECOL MODEL, V160, P115, DOI 10.1016/S0304-3800(02)00327-7; Farrell LE, 2012, THESIS; Foster D.R., 2010, WILDLANDS WOODLANDS; Frair JL, 2004, J APPL ECOL, V41, P201, DOI 10.1111/j.0021-8901.2004.00902.x; Fuller AK, 2010, J MAMMAL, V91, P1269, DOI 10.1644/10-MAMM-A-005.1; Hale ML, 2001, SCIENCE, V293, P2246, DOI 10.1126/science.1062574; HANSKI I, 1997, METAPOPULATION BIOL; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; HESS GR, 1994, CONSERV BIOL, V8, P256, DOI 10.1046/j.1523-1739.1994.08010256.x; Hilty JA, 2004, CONSERV BIOL, V18, P126, DOI 10.1111/j.1523-1739.2004.00225.x; Hoving CL, 2005, J WILDLIFE MANAGE, V69, P739, DOI 10.2193/0022-541X(2005)069[0739:BPOCLO]2.0.CO;2; Kesterson MD, 1988, THESIS; KNICK ST, 1986, AM MIDL NAT, V116, P222, DOI 10.2307/2425959; Kolowski JM, 2002, J WILDLIFE MANAGE, V66, P822, DOI 10.2307/3803146; Kuehl AK, 2002, J WILDLIFE MANAGE, V66, P1224, DOI 10.2307/3802955; Lariviere Serge, 1997, Mammalian Species, V563, P1, DOI 10.2307/3504533; Lindenmayer DB, 2000, BIODIVERS CONSERV, V9, P15, DOI 10.1023/A:1008943713765; Linforth J, 2013, CANADA LYNX COMING B; Linnell JDC, 2001, ANIM CONSERV, V4, P345, DOI 10.1017/S1367943001001408; LITVAITIS JA, 1986, J WILDLIFE MANAGE, V50, P110, DOI 10.2307/3801498; Litvaitis JA, 2006, BIOL CONSERV, V128, P517, DOI 10.1016/j.biocon.2005.10.019; Lovallo MJ, 1996, AM MIDL NAT, V135, P241, DOI 10.2307/2426706; Lyra-Jorge MC, 2010, EUR J WILDLIFE RES, V56, P359, DOI 10.1007/s10344-009-0324-x; MacFaden SW, 2002, FOREST SCI, V48, P243; Mayor SJ, 2009, ECOSCIENCE, V16, P238, DOI 10.2980/16-2-3238; McRae B.H., 2011, LINKAGE MAPPER CONNE; McRae BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052604; Millspaugh JJ, 2009, MODELS FOR PLANNING WILDLIFE CONSERVATION IN LARGE LANDSCAPES, P1; New Hampshire Fish and Game, 2011, CAN LYNX DOC NO NEW; Ng SJ, 2004, BIOL CONSERV, V115, P499, DOI 10.1016/S0006-3207(03)00166-6; O'Donoghue M, 1998, ECOLOGY, V79, P1193, DOI 10.1890/0012-9658(1998)079[1193:FROCAL]2.0.CO;2; Ohmark SM, 2015, CAN J ZOOL, V93, P391, DOI 10.1139/cjz-2014-0332; Parent J., 2009, LANDSCAPE FRAGMENTAT; Reed GC, 2017, ANIM CONSERV, V20, P308, DOI 10.1111/acv.12325; Rettie WJ, 1999, CAN J ZOOL, V77, P1175, DOI 10.1139/cjz-77-8-1175; Riley SPD, 2003, CONSERV BIOL, V17, P566, DOI 10.1046/j.1523-1739.2003.01458.x; Robillard CM, 2015, CONSERV BIOL, V29, P1586, DOI 10.1111/cobi.12556; Roland J, 1997, NATURE, V386, P710, DOI 10.1038/386710a0; Rotenberry JT, 2006, ECOLOGY, V87, P1458, DOI 10.1890/0012-9658(2006)87[1458:GNMFMS]2.0.CO;2; Rotenberry JT, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P281; Rudnick D.A., 2012, ISSUES ECOL, V16, P1; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Sanderson EW, 2002, LANDSCAPE URBAN PLAN, V58, P41, DOI 10.1016/S0169-2046(01)00231-6; Schwartz MW, 2012, BIOL CONSERV, V155, P149, DOI 10.1016/j.biocon.2012.06.011; Seton ET, 1925, LIVES GAME ANIMALS C, V1; SINGLETON PH, 2002, PNWRP549 USDA FOR SE; Slough BG, 1996, J WILDLIFE MANAGE, V60, P946, DOI 10.2307/3802397; Sorenson E., 2014, VERMONT HABITAT BLOC; Spring D, 2010, CONSERV BIOL, V24, P691, DOI 10.1111/j.1523-1739.2009.01419.x; Squires JR, 2013, BIOL CONSERV, V157, P187, DOI 10.1016/j.biocon.2012.07.018; Squires JR, ECOLOGY CONSERVATION; Sunquist M.E., 1989, P283; Sunquist ME, 2002, WILD CATS WORLD; Swingland I. R., 1984, ECOLOGY ANIMAL MOVEM; Thatcher CA, 2009, J MAMMAL, V90, P918, DOI 10.1644/08-MAMM-A-219.1; Thompson CM, 2002, LANDSCAPE ECOL, V17, P569, DOI 10.1023/A:1021501231182; Thompson EH, 2005, WETLAND WOODLAND WIL; Thornton DH, 2011, LANDSCAPE ECOL, V26, P7, DOI 10.1007/s10980-010-9549-z; Tigas LA, 2002, BIOL CONSERV, V108, P299, DOI 10.1016/S0006-3207(02)00120-9; Trombulak SC, 2008, NO APPALACHIAN ACAD; Van Rossum G, 2005, PYTHON 2 4 1; Vashon J.H., 2012, CANADA LYNX ASSESSME; Vashon JH, 2008, J WILDLIFE MANAGE, V72, P1479, DOI 10.2193/2007-462; Vashon JH, 2008, J WILDLIFE MANAGE, V72, P1488, DOI 10.2193/2007-475; VERBYLA DL, 1989, ENVIRON MANAGE, V13, P783, DOI 10.1007/BF01868317; Walpole AA, 2012, LANDSCAPE ECOL, V27, P761, DOI 10.1007/s10980-012-9728-1; WARD RMP, 1985, CAN J ZOOL, V63, P2817, DOI 10.1139/z85-421; WASSMER D A, 1988, Bulletin of the Florida State Museum Biological Sciences, V33, P159; Watrous KS, 2006, J WILDLIFE MANAGE, V70, P1228, DOI 10.2193/0022-541X(2006)70[1228:PMHCFT]2.0.CO;2; Weernetwerk, 2017, US CLIM DAT; Wiens JA, 1989, LANDSCAPE ECOL, V3, P87, DOI 10.1007/BF00131172; Wikramanayake ED, 1998, CONSERV BIOL, V12, P865, DOI 10.1046/j.1523-1739.1998.96428.x; Woolmer G, 2008, LANDSCAPE URBAN PLAN, V87, P42, DOI 10.1016/j.landurbplan.2008.04.005; Zeller KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179570	104	8	8	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194243	10.1371/journal.pone.0194243	http://dx.doi.org/10.1371/journal.pone.0194243			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590192	Green Published, gold, Green Submitted			2022-12-26	WOS:000428603100055
J	Nunez, FJ; Santalla, A; Carrasquila, I; Asian, JA; Reina, JI; Suarez-Arrones, LJ				Javier Nunez, Francisco; Santalla, Alfredo; Carrasquila, Irene; Antonio Asian, Jose; Ignacio Reina, Jose; Jesus Suarez-Arrones, Luis			The effects of unilateral and bilateral eccentric overload training on hypertrophy, muscle power and COD performance, and its determinants, in team sport players	PLOS ONE			English	Article							CROSS-SECTIONAL AREA; SKELETAL-MUSCLE; SOCCER PLAYERS; RESISTANCE EXERCISE; NEURAL ACTIVATION; VASTUS LATERALIS; DIRECTION SPEED; EARLY-PHASE; LEG POWER; BED REST	The study aimed to compare the chronic eccentric-overload training effects of unilateral (lateral lunge) vs bilateral (half-squat) using an inertial device, on hypertrophy and physical performance. Twenty-seven young team sports male players performed a 4 sets of 7 repetitions of inertial eccentric overload training, biweekly for 6 weeks, distributed in unilateral lunge group (UG: age: 22.8 +/- 2.9 years; body mass: 75.3 +/- 8.8 kg; height: 177.3 +/- 3.7 cm) and bilateral squat group (BG: age: 22.6 +/- 2.7 years; body mass: 79.5 +/- 12.8 kg; height: 164.2 +/- 7 cm). Lower limb muscle volume, counter movement jump (CMJ), power with both (POWER), dominant (POWERd) and no-dominant leg (POWERnd), change of direction turn of 90 with dominant (COD90d) and no-dominant leg (COD90nd) and 180 degrees (COD180d and COD180nd), and 10m sprint time (T-10m) were measured pre and post-intervention. The UG obtained an increase of adductor major (+11.1%) and vastus medialis (+12.6%) higher than BG. The BG obtained an increase of vastus lateralis (+9.9%) and lateral gastrocnemius (+9.1%) higher than UG. Both groups improved CMJ, POWER, POWERd, POWERnd, COD90 and DEC-COD90, without changes in T-10m. The UG decrease DEC-COD90nd (-21.1%) and BG increase POWER (+38.6%) substantially more than the other group. Six-weeks of unilateral / bilateral EO training induce substantial improvements in lower limbs muscle volume and functional performance, although unilateral training seems to be more effective in improving COD90 performance.	[Javier Nunez, Francisco; Santalla, Alfredo; Carrasquila, Irene; Antonio Asian, Jose; Jesus Suarez-Arrones, Luis] Pablo de Olavide Univ Sevilla, Sport Fac, Dept Sports & Comp, Seville, Spain; [Santalla, Alfredo; Antonio Asian, Jose; Jesus Suarez-Arrones, Luis] Pablo de Olavide Univ Sevilla, Futbol, Seville, Spain; [Santalla, Alfredo] Hospiltal 12 Octubre I 12, Res Inst, Madrid, Spain; [Ignacio Reina, Jose] Dos Hermanas Radiol Ctr, Seville, Spain	Universidad Pablo de Olavide; Universidad Pablo de Olavide	Nunez, FJ (corresponding author), Pablo de Olavide Univ Sevilla, Sport Fac, Dept Sports & Comp, Seville, Spain.	fjnunsan@upo.es	Sánchez, Francisco Javier Núñez/F-4501-2016	Sánchez, Francisco Javier Núñez/0000-0002-4166-3877; Suarez Moreno-Arrones, Luis Jesus/0000-0002-5432-4786; Santalla Hernandez, Alfredo/0000-0001-9418-0564				Aagaard P, 2001, J PHYSIOL-LONDON, V534, P613, DOI 10.1111/j.1469-7793.2001.t01-1-00613.x; Alkner BA, 2004, EUR J APPL PHYSIOL, V93, P294, DOI 10.1007/s00421-004-1172-8; Alkner BA, 2004, ACTA PHYSIOL SCAND, V181, P345, DOI 10.1111/j.1365-201X.2004.01293.x; Aughey RJ, 2011, INT J SPORT PHYSIOL, V6, P367, DOI 10.1123/ijspp.6.3.367; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Ben Abdelkrim N, 2010, J STRENGTH COND RES, V24, P1346, DOI 10.1519/JSC.0b013e3181cf7510; BERG HE, 1993, ACTA PHYSIOL SCAND, V148, P379, DOI 10.1111/j.1748-1716.1993.tb09573.x; BERG HE, 1994, AVIAT SPACE ENVIR MD, V65, P752; Berg HE, 1998, ACTA ASTRONAUT, V42, P219, DOI 10.1016/S0094-5765(98)00119-2; Brughelli M, 2008, SPORTS MED, V38, P1045, DOI 10.2165/00007256-200838120-00007; Castillo-Rodriguez A, 2012, J STRENGTH COND RES, V26, P725, DOI 10.1519/JSC.0b013e31822602db; Chelly MS, 2009, J STRENGTH COND RES, V23, P2241, DOI 10.1519/JSC.0b013e3181b86c40; COLLIANDER EB, 1990, ACTA PHYSIOL SCAND, V140, P31, DOI 10.1111/j.1748-1716.1990.tb08973.x; CRENSHAW AG, 1995, EUR J APPL PHYSIOL, V70, P13, DOI 10.1007/BF00601803; de Hoyo M, 2015, INT J SPORTS MED, V36, P308, DOI 10.1055/s-0034-1395521; de Hoyo M, 2015, J HUM KINET, V47, P155, DOI 10.1515/hukin-2015-0071; de Hoyo M, 2015, INT J SPORT PHYSIOL, V10, P46, DOI 10.1123/ijspp.2013-0547; Doan BK, 2002, J STRENGTH COND RES, V16, P9; Enoka RM, 1996, J APPL PHYSIOL, V81, P2339, DOI 10.1152/jappl.1996.81.6.2339; Fernandez-Gonzalo R, 2014, AVIAT SPACE ENVIR MD, V85, P694, DOI 10.3357/ASEM.3856.2014; Fernandez-Gonzalo R, 2014, EUR J APPL PHYSIOL, V114, P1075, DOI 10.1007/s00421-014-2836-7; Fisher J., 2014, J ATHL ENHANC, V3, DOI [10.4172/2324-9080.1000174, DOI 10.4172/2324-9080.1000174]; Gonzalo-Skok O, 2017, INT J SPORT PHYSIOL, V12, P951, DOI 10.1123/ijspp.2016-0251; Gonzalo-Skok O, 2017, INT J SPORT PHYSIOL, V12, P106, DOI 10.1123/ijspp.2015-0743; Gual G, 2016, J STRENGTH COND RES, V30, P1834, DOI 10.1519/JSC.0000000000001286; HATHER BM, 1991, ACTA PHYSIOL SCAND, V143, P177, DOI 10.1111/j.1748-1716.1991.tb09219.x; Higbie EJ, 1996, J APPL PHYSIOL, V81, P2173, DOI 10.1152/jappl.1996.81.5.2173; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hortobagyi T, 1996, J APPL PHYSIOL, V80, P765, DOI 10.1152/jappl.1996.80.3.765; Hortobagyi T, 2001, MED SCI SPORT EXER, V33, P1206; Irish SE, 2010, J STRENGTH COND RES, V24, P1256, DOI 10.1519/JSC.0b013e3181cf749f; JONES DA, 1987, J PHYSIOL-LONDON, V391, P1; Jones P, 2009, J SPORT MED PHYS FIT, V49, P97; Katz B, 1939, J PHYSIOL-LONDON, V96, P45, DOI 10.1113/jphysiol.1939.sp003756; KOMI PV, 1977, ACTA PHYSIOL SCAND, V100, P246, DOI 10.1111/j.1748-1716.1977.tb05943.x; Little T, 2005, J STRENGTH COND RES, V19, P76; MORITANI T, 1979, AM J PHYS MED REHAB, V58, P115; NARICI MV, 1989, EUR J APPL PHYSIOL O, V59, P310, DOI 10.1007/BF02388334; Norrbrand L, 2008, EUR J APPL PHYSIOL, V102, P271, DOI 10.1007/s00421-007-0583-8; Sanchez FJN, 2017, J STRENGTH COND RES, V31, P3177, DOI 10.1519/JSC.0000000000002095; Qian JG, 2014, J HUM KINET, V41, P59, DOI 10.2478/hukin-2014-0033; Schuenke MD, 2012, EUR J APPL PHYSIOL, V112, P3585, DOI 10.1007/s00421-012-2339-3; Seger JY, 1998, EUR J APPL PHYSIOL, V79, P49, DOI 10.1007/s004210050472; Seynnes OR, 2007, J APPL PHYSIOL, V102, P368, DOI 10.1152/japplphysiol.00789.2006; Sheppard JM, 2006, J SPORT SCI, V24, P919, DOI 10.1080/02640410500457109; Speirs DE, 2016, J STRENGTH COND RES, V30, P386, DOI 10.1519/JSC.0000000000001096; Spiteri T, 2014, J STRENGTH COND RES, V28, P2415, DOI 10.1519/JSC.0000000000000547; STARON RS, 1994, J APPL PHYSIOL, V76, P1247, DOI 10.1152/jappl.1994.76.3.1247; Tesch PA, 2004, ACTA PHYSIOL SCAND, V180, P89, DOI 10.1046/j.0001-6772.2003.01225.x; TESCH PA, 1990, ACTA PHYSIOL SCAND, V138, P263, DOI 10.1111/j.1748-1716.1990.tb08846.x; Tous-Fajardo J, 2016, INT J SPORT PHYSIOL, V11, P66, DOI 10.1123/ijspp.2015-0010; WESTING SH, 1989, INT J SPORTS MED, V10, P175, DOI 10.1055/s-2007-1024896; Young WB, 2002, J SPORT MED PHYS FIT, V42, P282	53	51	52	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193841	10.1371/journal.pone.0193841	http://dx.doi.org/10.1371/journal.pone.0193841			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590139	Green Submitted, Green Published, gold			2022-12-26	WOS:000428603100034
J	Reynolds, LM; Howard, TD; Ruczinski, I; Kanchan, K; Seeds, MC; Mathias, RA; Chilton, FH				Reynolds, Lindsay M.; Howard, Timothy D.; Ruczinski, Ingo; Kanchan, Kanika; Seeds, Michael C.; Mathias, Rasika A.; Chilton, Floyd H.			Tissue-specific impact of FADS cluster variants on FADS1 and FADS2 gene expression	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACID; CORONARY-ARTERY-DISEASE; METABOLISM; HEALTH; POLYMORPHISMS; GENOME; ASSOCIATION; BLOOD; LIVER; PHOSPHOLIPIDS	Omega-6 (n-6) and omega-3 (n-3) long (>= 20 carbon) chain polyunsaturated fatty acids (LC-PUFAs) play a critical role in human health and disease. Biosynthesis of LC-PUFAs from dietary 18 carbon PUFAs in tissues such as the liver is highly associated with genetic variation within the fatty acid desaturase (FADS) gene cluster, containing FADS1 and FADS2 that encode the rate-limiting desaturation enzymes in the LC-PUFA biosynthesis pathway. However, the molecular mechanisms by which FADS genetic variants affect LCPUFA biosynthesis, and in which tissues, are unclear. The current study examined associations between common single nucleotide polymorphisms (SNPs) within the FADS gene cluster and FADS1 and FADS2 gene expression in 44 different human tissues (sample sizes ranging 70-361) from the Genotype-Tissue Expression (GTEx) Project. FADS1 and FADS2 expression were detected in all 44 tissues. Significant cis-eQTLs (within 1 mega base of each gene, False Discovery Rate, FDR<0.05, as defined by GTEx) were identified in 12 tissues for FADS1 gene expression and 23 tissues for FADS2 gene expression. Six tissues had significant (FDR<0.05) eQTLs associated with both FADS1 and FADS2 (including artery, esophagus, heart, muscle, nerve, and thyroid). Interestingly, the identified eQTLs were consistently found to be associated in opposite directions for FADS1 and FADS2 expression. Taken together, findings from this study suggest common SNPs within the FADS gene cluster impact the transcription of FADS1 and FADS2 in numerous tissues and raise important questions about how the inverse expression of these two genes impact intermediate molecular (such a LC-PUFA and LC-PUFA-containing glycero-lipid levels) and ultimately clinical phenotypes associated with inflammatory diseases and brain health.	[Reynolds, Lindsay M.] Wake Forest Sch Med, Dept Epidemiol & Prevent, Winston Salem, NC USA; [Howard, Timothy D.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA; [Ruczinski, Ingo; Kanchan, Kanika; Mathias, Rasika A.] Johns Hopkins Univ, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD USA; [Seeds, Michael C.] Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC USA; [Chilton, Floyd H.] Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27101 USA	Wake Forest University; Wake Forest University; Johns Hopkins University; Wake Forest University; Wake Forest University	Chilton, FH (corresponding author), Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27101 USA.	schilton@wakehealth.edu		Reynolds, Lindsay/0000-0001-6157-0144	Common Fund of the Office of the Director of the National Institutes of Health; NCI; NHGRI; NHLBI; NIDA; NIMH; NINDS; National Institutes of Health [R01-AT008621]; National Institute on Aging of the National Institutes of Health [R03AG056959]; National Center for Complementary & Integrative Health [R01AT008621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG056959] Funding Source: NIH RePORTER	Common Fund of the Office of the Director of the National Institutes of Health; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The data used for the analyses described in this manuscript were obtained from the GTEx Portal on 12/02/16. The GTEx Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS. This work was supported by a grant (FHC) from the National Institutes of Health, R01-AT008621. Research reported in this publication was also supported by the National Institute on Aging of the National Institutes of Health under Award Number R03AG056959. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; The data used for the analyses described in this manuscript were obtained from the GTEx Portal on 12/02/16. The GTEx Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS.	BEZARD J, 1994, REPROD NUTR DEV, V34, P539, DOI 10.1051/rnd:19940603; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Buckley MT, 2017, MOL BIOL EVOL, V34, P1307, DOI 10.1093/molbev/msx103; Burr GO, 1930, J BIOL CHEM, V86, P0587; Burr GO, 1929, J BIOL CHEM, V82, P345; Chen YQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S16; Chen YQ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-519; Chilton FH, 2014, NUTRIENTS, V6, P1993, DOI 10.3390/nu6051993; Cui T, 2016, PROSTATE, V76, P1182, DOI 10.1002/pros.23205; Del Gobbo LC, 2016, JAMA INTERN MED, V176, P1155, DOI 10.1001/jamainternmed.2016.2925; Dorajoo R, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0502-2; Draisma HHM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8208; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; ELBOUSTANI S, 1989, METABOLISM, V38, P315, DOI 10.1016/0026-0495(89)90117-0; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Glaser C, 2011, MATERN CHILD NUTR, V7, P27, DOI 10.1111/j.1740-8709.2011.00319.x; Hoile SP, 2013, J NUTR BIOCHEM, V24, P1213, DOI 10.1016/j.jnutbio.2012.09.005; Hong SH, 2013, CLIN INTERV AGING, V8, P585, DOI 10.2147/CIA.S42096; HORROBIN DF, 1993, AM J CLIN NUTR, V57, P732; Howard TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097510; Hu Y, 2016, HUM MOL GENET, V25, P1215, DOI 10.1093/hmg/ddw002; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Koletzko B, 2011, AM J CLIN NUTR, V93, P211, DOI 10.3945/ajcn.110.006189; Kwak JH, 2011, ATHEROSCLEROSIS, V214, P94, DOI 10.1016/j.atherosclerosis.2010.10.004; Lattka E, 2013, BRIT J NUTR, V109, P1196, DOI 10.1017/S0007114512003108; Lattka E, 2012, ANN NUTR METAB, V60, P8, DOI 10.1159/000337308; Lattka E, 2010, CLIN NUTR, V29, P277, DOI 10.1016/j.clnu.2009.11.005; Lattka E, 2009, J NUTRIGENET NUTRIGE, V2, P119, DOI 10.1159/000235559; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Li S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073563, 10.1371/journal.pone.0053163, 10.1371/journal.pone.0081438]; Li YY, 2006, PLOS COMPUT BIOL, V2, P687, DOI 10.1371/journal.pcbi.0020074; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mathias Rasika A, 2014, Curr Nutr Rep, V3, P139; Mathias RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044926; Mathias RA, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-50; Morales E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017181; Mozaffarian D, 2015, AM J CLIN NUTR, V101, P398, DOI 10.3945/ajcn.114.094557; O'Neill CM, 2017, P NUTR SOC, V76, P64, DOI 10.1017/S0029665116000732; Pan G, 2017, NUCLEIC ACIDS RES, V45, P2408, DOI 10.1093/nar/gkw1186; Park HG, 2015, FASEB J, V29, P3911, DOI 10.1096/fj.15-271783; Pawlosky RJ, 2001, J LIPID RES, V42, P1257; POISSON JP, 1993, BIOCHIM BIOPHYS ACTA, V1167, P109, DOI 10.1016/0005-2760(93)90149-4; Rahbar E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180903; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Sergeant S, 2012, BRIT J NUTR, V107, P547, DOI 10.1017/S0007114511003230; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Spector AA, 2001, J MOL NEUROSCI, V16, P159, DOI 10.1385/JMN:16:2-3:159; SPRECHER H, 1981, Progress in Lipid Research, V20, P13, DOI 10.1016/0163-7827(81)90009-6; Standl M, 2012, ALLERGY, V67, P83, DOI 10.1111/j.1398-9995.2011.02708.x; Standl M, 2011, CLIN EXP ALLERGY, V41, P1757, DOI 10.1111/j.1365-2222.2011.03833.x; Standl M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037780; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Wang LB, 2015, HEPATOLOGY, V61, P119, DOI 10.1002/hep.27373; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Xie L, 2009, J NUTRIGENET NUTRIGE, V2, P243, DOI 10.1159/000255636; Youdim KA, 2000, INT J DEV NEUROSCI, V18, P383, DOI 10.1016/S0736-5748(00)00013-7; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	63	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194610	10.1371/journal.pone.0194610	http://dx.doi.org/10.1371/journal.pone.0194610			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590160	Green Published, gold, Green Submitted			2022-12-26	WOS:000428603100067
J	Wade, TJ; Augustine, SAJ; Griffin, SM; Sams, EA; Oshima, KH; Egorov, AI; Simmons, KJ; Eason, TN; Dufour, AP				Wade, Timothy J.; Augustine, Swinburne A. J.; Griffin, Shannon M.; Sams, Elizabeth A.; Oshima, Kevin H.; Egorov, Andrey I.; Simmons, Kaneatra J.; Eason, Tarsha N.; Dufour, Alfred P.			Asymptomatic norovirus infection associated with swimming at a tropical beach: A prospective cohort study	PLOS ONE			English	Article							WATER-QUALITY; NORWALK VIRUS; GASTROENTERITIS; IMMUNOASSAY; DISEASE; ILLNESS	Background Swimming in fecally-contaminated waterbodies can result in gastrointestinal infections. However, the pathogenic microorganisms responsible are not well understood because sporadic cases of illness are not reported completely, exposure information is often not collected, and epidemiology studies rely on self-reported symptoms. Noroviruses are considered a likely cause because they are found in high densities in sewage, resistant to wastewater treatment and survive in the environment. In this study, saliva samples were collected from subjects at a beach in Puerto Rico and tested for evidence of norovirus-specific IgG responses as an indicator of incident norovirus infection. Methods Saliva samples were collected from 1298 participants using an oral swab. Samples were collected on the day of the beach visit (51); after 10-12 days (S2); and after three weeks (S3). Saliva was tested for IgG responses to GI.1 and GII.4 noroviruses using a microsphere based multiplex salivary immunoassay. Immunoconversion was defined as a four-fold increase in median fluorescence intensity (MFI) from 51 to S2 with the S3 sample at least three times above the 51 MFI. Results Thirty-four subjects (2.6%) immunoconverted to GI.1 or GII.4 norovirus. Swimmers who immersed their head in water had a higher rate of immunoconversion (3.4%), compared to either non-swimmers (0.0%, p = 0.003) or waders and non-swimmers combined (0.4%, Odds Ratio: 5.07, 95% Confidence Interval:1.48-17.00). Immunoconversion was not associated with gastrointestinal symptoms. Conclusions This is the first study to demonstrate an association between swimming at a beach impacted by fecal contamination and asymptomatic norovirus infection. The findings implicate recreational water as potentially important transmission pathway for norovirus infection.	[Wade, Timothy J.; Sams, Elizabeth A.; Egorov, Andrey I.; Eason, Tarsha N.] US EPA, Off Res & Dev, Res Triangle Pk, NC 27711 USA; [Augustine, Swinburne A. J.; Griffin, Shannon M.; Oshima, Kevin H.; Dufour, Alfred P.] US EPA, Off Res & Dev, Cincinnati, OH 45268 USA; [Simmons, Kaneatra J.] Oconee Fall Line Tech Coll, Dublin, GA USA	United States Environmental Protection Agency; United States Environmental Protection Agency	Wade, TJ (corresponding author), US EPA, Off Res & Dev, Res Triangle Pk, NC 27711 USA.	wade.tim@epa.gov	Augustine, Swinburne A J/U-9787-2019	Augustine, Swinburne A J/0000-0002-4948-884X; Eason, Tarsha/0000-0001-9881-3293	U.S. Environmental Protection Agency	U.S. Environmental Protection Agency(United States Environmental Protection Agency)	This work was supported by the U.S. Environmental Protection Agency. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman Drew, 2003, Journal of Water and Health, V1, P85; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Augustine SAJ, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00084; Auld H, 2004, J TOXICOL ENV HEAL A, V67, P1879, DOI 10.1080/15287390490493475; Bartsch SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151219; Currier RL, 2015, CLIN INFECT DIS, V60, P1631, DOI 10.1093/cid/civ165; Flannery J, 2012, APPL ENVIRON MICROB, V78, P3400, DOI 10.1128/AEM.07569-11; Frank E., 2010, REGRESSION MODELING; Gerba C. P., 2000, Quantitative Microbiology, V2, P55, DOI 10.1023/A:1010000230103; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Griffin SM, 2015, J IMMUNOL METHODS, V424, P53, DOI 10.1016/j.jim.2015.05.001; Griffin SM, 2011, J IMMUNOL METHODS, V364, P83, DOI 10.1016/j.jim.2010.11.005; KAY D, 1994, LANCET, V344, P905, DOI 10.1016/S0140-6736(94)92267-5; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Leon JS, 2011, APPL ENVIRON MICROB, V77, P5476, DOI 10.1128/AEM.02801-10; Lopman B, 2014, AM J EPIDEMIOL, V179, P507, DOI 10.1093/aje/kwt287; Lopman BA, 2015, J INFECT DIS, V211, P1813, DOI 10.1093/infdis/jiu672; Moe CL, 2004, CLIN DIAGN LAB IMMUN, V11, P1028, DOI 10.1128/CDLI.11.6.1028-1034.2004; POND K, 2005, WATER RECREATION DIS; Pringle K, 2015, FUTURE MICROBIOL, V10, P53, DOI 10.2217/fmb.14.102; Seitz SR, 2011, APPL ENVIRON MICROB, V77, P6884, DOI 10.1128/AEM.05806-11; Soller JA, 2016, MICROB RISK ANAL, V1, P2, DOI 10.1016/j.mran.2015.04.001; Soller JA, 2010, WATER RES, V44, P4736, DOI 10.1016/j.watres.2010.07.064; Tan M, 2008, VIROLOGY, V382, P115, DOI 10.1016/j.virol.2008.08.047; Teunis PFM, 2015, EPIDEMIOL INFECT, V143, P1710, DOI 10.1017/S095026881400274X; USEPA, 1997, EPA821R97004; van Beek J, 2016, J GEN VIROL, V97, P2255, DOI 10.1099/jgv.0.000533; Wade TJ, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-67; Wade TJ, 2006, ENVIRON HEALTH PERSP, V114, P24, DOI 10.1289/ehp.8273; Wade TJ, 2003, ENVIRON HEALTH PERSP, V111, P1102, DOI 10.1289/ehp.6241; Wade TJ., 2010, REPORT 2009 NATL EPI; Zlot A, 2015, MMWR-MORBID MORTAL W, V64, P485	32	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0195056	10.1371/journal.pone.0195056	http://dx.doi.org/10.1371/journal.pone.0195056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590196	Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100100
J	Conde-Sieira, M; Gesto, M; Batista, S; Linares, F; Villanueva, JLR; Miguez, JM; Soengas, JL; Valente, LMP				Conde-Sieira, Marta; Gesto, Manuel; Batista, Sonia; Linares, Fatima; Villanueva, Jose L. R.; Miguez, Jesus M.; Soengas, Jose L.; Valente, Luisa M. P.			Influence of vegetable diets on physiological and immune responses to thermal stress in Senegalese sole (Solea senegalensis)	PLOS ONE			English	Article							BASS DICENTRARCHUS-LABRAX; FATTY-ACID COMPOSITIONS; SEABREAM SPARUS-AURATA; PLASMA-CORTISOL LEVELS; HIGH STOCKING DENSITY; SALMON SALMO-SALAR; ATLANTIC SALMON; FISH-OIL; ARACHIDONIC-ACID; RAINBOW-TROUT	The substitution of fish resources as ingredients for aquafeeds by those based on vegetable sources is needed to ensure aquaculture sustainability in the future. It is known that Senegalese sole (Solea senegalensis) accepts high dietary content of plant ingredients without altering growth or flesh quality parameters. However, scarce information is available regarding the long-term impact of vegetable diets (combining the inclusion of both vegetable protein and oils) on the stress response and immunity of this fish species. This study aims to evaluate the concomitant effect of the extended use of vegetable protein-based diets with fish oil (FO) replacement (0, 50 or 100%) by vegetable oils (VO), on the response to acute (10 min) or prolonged (4 days) stress, induced by thermal shock. Plasma levels of cortisol, glucose and lactate as well as hepatic levels of glucose, glycogen and lactate were evaluated as primary and secondary responses to stress, 6 and 18 months after feeding the experimental diets (6 and 18 MAF). The brain monoaminergic activity in telencephalon and hypothalamus, and non-specific immune parameters were also evaluated. As expected, thermal shock induced an increase in values of plasma parameters related to stress, which was more evident in acute than in prolonged stress. Stress also affected lactate levels in the liver and the values of the alternative complement pathway-ACH50 in the plasma. Dietary substitution of FO induced an effect per se on some parameters such as decreased hepatic glucose and glycogen levels and peroxidase activity in plasma as well enhanced serotonergic activity in brain of non-stressed fish. The results obtained in some parameters indicate that there is an interaction between the use of vegetable diets with the physiological response to thermal stress, as is the case of the hepatic lactate, serotonergic neurotransmission in brain, and the activity of ACH50 in plasma. These results suggest that the inclusion of VO in plant protein based diets point to a slightly inhibited stress response, more evident for an acute than a prolonged stress.	[Conde-Sieira, Marta; Batista, Sonia; Valente, Luisa M. P.] Univ Porto, Ctr Interdisciplinar Invest Marinha & Ambiental, CIMAR CIIMAR, Matosinhos, Portugal; [Conde-Sieira, Marta; Gesto, Manuel; Miguez, Jesus M.; Soengas, Jose L.] Univ Vigo, Fac Biol, Dept Biol Func & Ciencias Saude, Lab Fisiol Anim, Vigo, Spain; [Conde-Sieira, Marta; Gesto, Manuel; Miguez, Jesus M.; Soengas, Jose L.] Univ Vigo, Ctr Singular Invest Marina ECIMAT, Vigo, Spain; [Batista, Sonia; Valente, Luisa M. P.] Univ Porto, ICBAS, Porto, Portugal; [Linares, Fatima] Ctr Invest Marinas, CIMA, Vilanova De Arouse, Pontevedra, Spain; [Linares, Fatima] Inst Galego Formac Acuicultura, IGAFA, Illa De Arousa, Pontevedra, Spain; [Gesto, Manuel] Tech Univ Denmark, Sect Aquaculture, North Sea Res Ctr, DTU Aqua, Hirtshals, Denmark	Universidade do Porto; Universidade de Vigo; Universidade de Vigo; CIM UVIGO; Universidade do Porto; Technical University of Denmark	Conde-Sieira, M (corresponding author), Univ Porto, Ctr Interdisciplinar Invest Marinha & Ambiental, CIMAR CIIMAR, Matosinhos, Portugal.; Conde-Sieira, M (corresponding author), Univ Vigo, Fac Biol, Dept Biol Func & Ciencias Saude, Lab Fisiol Anim, Vigo, Spain.; Conde-Sieira, M (corresponding author), Univ Vigo, Ctr Singular Invest Marina ECIMAT, Vigo, Spain.	monde@uvigo.es	Quality, Aquaculture Seafood/AAD-7718-2019; Miguez, J.M./M-3705-2014; Soengas, José L/M-1898-2014; Gesto, Manuel/G-1032-2018; Batista, Sonia/B-9150-2017; Valente, Luisa/A-3769-2010	Miguez, J.M./0000-0002-3474-2139; Soengas, José L/0000-0002-6847-3993; Gesto, Manuel/0000-0002-9136-7857; Batista, Sonia/0000-0002-4591-8873; Conde-Sieira, Marta/0000-0002-9763-6202; Valente, Luisa/0000-0002-2496-4854	Strategic Funding through national funds by FCT - Foundation for Science and Technology [UID/Multi/04423/2013]; European Regional Development Fund (ERDF); Spanish Agencia Estatal de Investigacion; European Fund for Regional Development [AGL 2016-74857-C3-1-R]; European Fund for Regional Development (FEDER); Xunta de Galicia (Plan I2C)	Strategic Funding through national funds by FCT - Foundation for Science and Technology; European Regional Development Fund (ERDF)(European Commission); Spanish Agencia Estatal de Investigacion(Spanish Government); European Fund for Regional Development(European Commission); European Fund for Regional Development (FEDER)(European Commission); Xunta de Galicia (Plan I2C)(Xunta de Galicia)	This research was partially supported by the Strategic Funding UID/Multi/04423/2013 through national funds provided by FCT - Foundation for Science and Technology and European Regional Development Fund (ERDF), in the framework of the programme PT2020" to L.M. P.V, and by research a grant from Spanish Agencia Estatal de Investigacion and European Fund for Regional Development (AGL 2016-74857-C3-1-R and FEDER) to J.L.S. M.C-S. is supported by a postdoctoral grant from Xunta de Galicia (Plan I2C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso C, 2017, AQUACULTURE, V474, P66, DOI 10.1016/j.aquaculture.2017.03.040; Afonso LOB, 2008, J FISH BIOL, V72, P157, DOI 10.1111/j.1095-8649.2007.01697.x; Martins DA, 2013, FISH PHYSIOL BIOCHEM, V39, P1223, DOI 10.1007/s10695-013-9778-6; Martins DA, 2011, FISH PHYSIOL BIOCHEM, V37, P733, DOI 10.1007/s10695-011-9473-4; Arjona FJ, 2010, MAR BIOL, V157, P1325, DOI 10.1007/s00227-010-1412-x; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; Batista S, 2016, APPL MICROBIOL BIOT, V100, P7223, DOI 10.1007/s00253-016-7592-7; BELL JG, 1994, BBA-LIPID LIPID MET, V1211, P335, DOI 10.1016/0005-2760(94)90158-9; BELL JG, 1991, J NUTR, V121, P1163, DOI 10.1093/jn/121.8.1163; Bell JG, 2006, AQUAC RES, V37, P606, DOI 10.1111/j.1365-2109.2006.01470.x; BELL JG, 1993, PROSTAG LEUKOTR ESS, V49, P665, DOI 10.1016/0952-3278(93)90075-8; Benftez-Dorta V, 2017, GEN COMP ENDOCRINOL; Benitez-Dorta V, 2013, FISH PHYSIOL BIOCHEM, V39, P335, DOI 10.1007/s10695-012-9703-4; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Borges P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102196; Borges P, 2009, BRIT J NUTR, V102, P1007, DOI 10.1017/S0007114509345262; Cabral EM, 2013, AQUACULTURE, V380, P130, DOI 10.1016/j.aquaculture.2012.12.006; Cabral EM, 2011, AQUACULTURE, V322, P74, DOI 10.1016/j.aquaculture.2011.09.023; Canavate J. P., 2005, Boletin Instituto Espanol de Oceanografia, V21, P147; Carey JB, 1998, AQUACULTURE, V168, P237, DOI 10.1016/S0044-8486(98)00352-4; Castro C, 2016, BRIT J NUTR, V116, P19, DOI 10.1017/S000711451600163X; Chalon S, 2001, LIPIDS, V36, P937, DOI 10.1007/s11745-001-0804-7; Choi CY, 2007, GEN COMP ENDOCR, V152, P47, DOI 10.1016/j.ygcen.2007.02.019; Costas B, 2008, AQUAC RES, V39, P1, DOI 10.1111/j.1365-2109.2007.01845.x; Costas B, 2013, FISH PHYSIOL BIOCHEM, V39, P1141, DOI 10.1007/s10695-013-9770-1; Costas B, 2012, AMINO ACIDS, V43, P327, DOI 10.1007/s00726-011-1082-0; Costas B, 2012, COMP BIOCHEM PHYS A, V161, P18, DOI 10.1016/j.cbpa.2011.08.014; Costas B, 2011, FISH SHELLFISH IMMUN, V31, P838, DOI 10.1016/j.fsi.2011.07.024; Costas B, 2011, AQUACULTURE, V316, P68, DOI 10.1016/j.aquaculture.2011.03.011; DALLMAN MF, 1984, AM J PHYSIOL, V246, pR1, DOI 10.1152/ajpregu.1984.246.1.R1; Delion S, 1996, J NEUROCHEM, V66, P1582; DELION S, 1994, J NUTR, V124, P2466, DOI 10.1093/jn/124.12.2466; Diaz-Lopez M, 2009, AQUACULT NUTR, V15, P500, DOI 10.1111/j.1365-2095.2008.00616.x; EKSTROM P, 1994, CELL MOL NEUROBIOL, V14, P381, DOI 10.1007/BF02088718; FAO, 2016, CONTRIBUTING FOOD SE; Ferraz AC, 2011, BEHAV BRAIN RES, V219, P116, DOI 10.1016/j.bbr.2010.12.028; Fiess JC, 2007, COMP BIOCHEM PHYS A, V146, P252, DOI 10.1016/j.cbpa.2006.10.027; Figueiredo-Silva AC, 2012, J EXP BIOL, V215, P169, DOI 10.1242/jeb.063933; Ganga R, 2011, AQUACULTURE, V311, P215, DOI 10.1016/j.aquaculture.2010.11.050; Geay F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-522; Gesto M, 2015, J NEUROENDOCRINOL, V27, P131, DOI 10.1111/jne.12248; Gesto M, 2008, AQUAT TOXICOL, V86, P341, DOI 10.1016/j.aquatox.2007.11.014; Gesto M, 2016, AQUACULTURE, V452, P272, DOI 10.1016/j.aquaculture.2015.11.006; Hardy RW, 2010, AQUAC RES, V41, P770, DOI 10.1111/j.1365-2109.2009.02349.x; Hutchinson TH, 1996, FISH SHELLFISH IMMUN, V6, P473, DOI 10.1006/fsim.1996.0045; Johnston I.A., 1987, Symposia of the Society for Experimental Biology, P67; Jutfelt F, 2007, AQUACULTURE, V273, P298, DOI 10.1016/j.aquaculture.2007.10.012; Keppler D., 1974, METHOD ENZYMAT AN, V3, P1127, DOI DOI 10.1242/JEB.037275; Koven W, 2003, AQUACULTURE, V228, P307, DOI 10.1016/S0044-8486(03)00317-X; Koven W, 2001, AQUACULTURE, V193, P107, DOI 10.1016/S0044-8486(00)00479-8; Lin YH, 2007, AQUACULT NUTR, V13, P137, DOI 10.1111/j.1365-2095.2007.00458.x; Lopez-Patino MA, 2013, AQUACULTURE, V388, P165, DOI 10.1016/j.aquaculture.2013.01.023; Metz JR, 2003, J EXP BIOL, V206, P2273, DOI 10.1242/jeb.00421; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; Montero D, 2008, FISH SHELLFISH IMMUN, V24, P147, DOI 10.1016/j.fsi.2007.08.002; Montero D, 2003, AQUACULTURE, V225, P353, DOI 10.1016/S0044-8486(03)00301-6; Montero D, 2010, FISH SHELLFISH IMMUN, V29, P1073, DOI 10.1016/j.fsi.2010.08.024; Montero D., 2010, FISH OIL REPLACEMENT, DOI [10.1201/9781439808634-c14, DOI 10.1201/9781439808634-C14]; Montero D, 2015, LIPIDS, V50, P1029, DOI 10.1007/s11745-015-4057-1; Montero D, 2015, J NUTR SCI, V4, DOI 10.1017/jns.2015.6; Montero D, 2015, FISH SHELLFISH IMMUN, V44, P100, DOI 10.1016/j.fsi.2015.01.020; Morais S, 2016, REV AQUACULT, V8, P227, DOI 10.1111/raq.12091; Silva PIM, 2010, APPL ANIM BEHAV SCI, V124, P75, DOI 10.1016/j.applanim.2010.01.008; Mourente G, 2007, BRIT J NUTR, V98, P770, DOI 10.1017/S000711450773461X; National Research Council, 2011, NUTR REQ FISH SHRIMP; Oliva-Teles A, 2012, J FISH DIS, V35, P83, DOI 10.1111/j.1365-2761.2011.01333.x; Pankhurst NW, 2008, AQUACULTURE, V275, P311, DOI 10.1016/j.aquaculture.2008.01.001; Pankhurst NW, 2011, GEN COMP ENDOCR, V170, P265, DOI 10.1016/j.ygcen.2010.07.017; Perez-Casanova JC, 2012, ECOTOX ENVIRON SAFE, V86, P239, DOI 10.1016/j.ecoenv.2012.09.026; Perez-Sanchez J, 2013, COMP BIOCHEM PHYS D, V8, P123, DOI 10.1016/j.cbd.2013.02.001; Pottinger TG, 2008, STRESS RESPONSE FISH; Reis B, 2014, AQUACULTURE, V434, P425, DOI 10.1016/j.aquaculture.2014.09.002; Salas-Leiton E, 2010, FISH SHELLFISH IMMUN, V28, P296, DOI 10.1016/j.fsi.2009.11.006; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SUNYER JO, 1995, VET IMMUNOL IMMUNOP, V45, P333, DOI 10.1016/0165-2427(94)05430-Z; Takeuchi T, 2003, BRAIN RES, V964, P136, DOI 10.1016/S0006-8993(02)04113-6; Tocher DR, 2010, AQUAC RES, V41, P717, DOI 10.1111/j.1365-2109.2008.02150.x; Torrecillas D, 2017, AQUACULTURE, V468; Tort L, 2011, DEV COMP IMMUNOL, V35, P1366, DOI 10.1016/j.dci.2011.07.002; Turchini GM, 2009, REV AQUACULT, V1, P10, DOI 10.1111/j.1753-5131.2008.01001.x; Valente LMP, 2011, AQUACULTURE, V318, P128, DOI 10.1016/j.aquaculture.2011.05.026; Vancassel S, 2008, J LIPID RES, V49, P340, DOI 10.1194/jlr.M700328-JLR200; Veron V, 2016, FISH PHYSIOL BIOCHEM, V42, P771, DOI 10.1007/s10695-015-0174-2; Weber RA, 2012, ECOTOXICOLOGY, V21, P362, DOI 10.1007/s10646-011-0797-8; Youdim KA, 2000, INT J DEV NEUROSCI, V18, P383, DOI 10.1016/S0736-5748(00)00013-7	85	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194353	10.1371/journal.pone.0194353	http://dx.doi.org/10.1371/journal.pone.0194353			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566022	Green Published, Green Submitted, gold			2022-12-26	WOS:000428093900056
J	Dimala, CA; Ngu, RC; Kadia, BM; Tianyi, FL; Choukem, SP				Dimala, Christian Akem; Ngu, Roland Cheofor; Kadia, Benjamin Momo; Tianyi, Frank-Leonel; Choukem, Simeon Pierre			Markers of adiposity in HIV/AIDS patients: Agreement between waist circumference, waist-to-hip ratio, waist-to-height ratio and body mass index	PLOS ONE			English	Article							HIV-1-INFECTED PATIENTS; CARDIOVASCULAR-DISEASE; PROTEASE INHIBITORS; METABOLIC SYNDROME; OBESITY; RISK; LIPODYSTROPHY; PREDICTORS; COULD	Background Waist circumference (WC), waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR) are all independent predictors of cardio-metabolic risk and therefore important in HIV/AIDS patients on antiretroviral therapy at risk of increased visceral adiposity. This study aimed to assess the extent of agreement between these parameters and the body mass index (BMI), as anthropometric parameters and in classifying cardio-metabolic risk in HIV/AIDS patients. Methods A secondary analysis of data from a cross-sectional study involving 200 HIV/AIDS patients was done. Anthropometric parameters were measured from participants using standard guidelines and central obesity defined according to recommended criteria. Increased cardio-metabolic risk was defined according to the standard cut-off values for all four parameters. Data were analyzed using STATA version 14.1. Results The prevalence of WC-defined central obesity, WHR-defined central obesity and WHtR > 0.50 were 33.5%, 44.5% and 36.5%, respectively. The prevalence of BMI-defined overweight and obesity was 40.5%. After adjusting for gender and HAART status, there was a significant linear association and correlation between WC and BMI (regression equation: WC (cm) = 37.184 + 1.756 BMI (Kg/m(2)) + 0.825 Male + 1.002 HAART, (p < 0.001, r = 0.65)), and between WHtR and BMI (regression equation: WHtR = 0.223 + 0.011 BMI (Kg/m(2))-0.0153 Male + 0.003 HAART, (p < 0.001, r = 0.65)), but not between WHR and BMI (p = 0.097, r = 0.13). There was no agreement between the WC, WHtR and BMI, and minimal agreement between the WHR and BMI, in identifying patients with an increased cardio-metabolic risk. Conclusion Despite the observed linear association and correlation between these anthropometric parameters, the routine use of WC, WHR and WHtR as better predictors of cardio-metabolic risk should be encouraged in these patients, due to their minimal agreement with BMI in identifying HIV/AIDS patients with increased cardio-metabolic risk. HAART status does not appear to significantly affect the association between these anthropometric parameters.	[Dimala, Christian Akem] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Dimala, Christian Akem] Southend Univ Hosp, Orthopaed Dept, Southend On Sea, Essex, England; [Dimala, Christian Akem; Ngu, Roland Cheofor; Choukem, Simeon Pierre] Hlth & Human Dev 2HD Res Network, Douala, Cameroon; [Ngu, Roland Cheofor] Univ Oxford, Nuffield Dept Med, Oxford, England; [Ngu, Roland Cheofor] Med Doctors MD Res Grp, Douala, Cameroon; [Kadia, Benjamin Momo] Foumbot Dist Hosp, Foumbot, Cameroon; [Kadia, Benjamin Momo] Grace Community Hlth & Dev Assoc, Kumba, Cameroon; [Tianyi, Frank-Leonel] Mayo Darle Dist Hosp, Mayo Darle, Cameroon; [Choukem, Simeon Pierre] Douala Gen Hosp, Dept Internal Med, Diabet & Endocrinol Unit, Douala, Cameroon; [Choukem, Simeon Pierre] Univ Buea, Fac Hlth Sci, Dept Internal Med & Paediat, Buea, Cameroon	University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Dimala, CA (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.; Dimala, CA (corresponding author), Southend Univ Hosp, Orthopaed Dept, Southend On Sea, Essex, England.; Dimala, CA (corresponding author), Hlth & Human Dev 2HD Res Network, Douala, Cameroon.	Chnstiart.Akem.Dimala1@alumni.lshtm.ac.uk	Kadia, Benjamin Momo/J-2806-2019; Tianyi, Frank-Leonel/AAJ-1007-2020	Kadia, Benjamin Momo/0000-0002-8566-7132; Tianyi, Frank-Leonel/0000-0001-5687-5285; Ngu, Roland Cheofor/0000-0003-4417-0653; Akem Dimala, Christian/0000-0002-0064-0126				Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; [Anonymous], 1997, AIDS CLIN CARE; Ashwell M, 2005, INT J FOOD SCI NUTR, V56, P303, DOI 10.1080/09637480500195066; Brown I, 2007, J ADV NURS, V59, P329, DOI 10.1111/j.1365-2648.2007.04297.x; Brown T, JAIDS J ACQUIR IMMUN, V43, P356; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Czernichow S, 2011, EUR J CARDIOV PREV R, V18, P312, DOI 10.1097/HJR.0b013e32833c1aa3; de Koning L, 2007, EUR HEART J, V28, P850, DOI 10.1093/eurheartj/ehm026; De Socio GVL, 2011, HIV MED, V12, P124, DOI 10.1111/j.1468-1293.2010.00852.x; Dhaliwal SS, 2009, AM J CARDIOL, V103, P1403, DOI 10.1016/j.amjcard.2008.12.048; Dimala CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148100; Dunkley AJ, 2009, FAM PRACT, V26, P365, DOI 10.1093/fampra/cmp048; Flint AJ, 2010, OBES RES CLIN PRACT, V4, pE171, DOI 10.1016/j.orcp.2010.01.001; Gierach M, 2014, ISRN ENDOCRINOL, V2014, P1; Goh LGH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004138; Jaime PC, 2006, REV SAUDE PUBL, V40, P634, DOI 10.1590/S0034-89102006000500012; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Martinez E, 2001, LANCET, V357, P592, DOI 10.1016/S0140-6736(00)04056-3; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; National Institutes of Health, 2000, PRACT GUID ID EV TRE; National Obesity Observatory, 2009, BOD MASS IND MEAS OB; Nunes Filomena, 2005, Acta Med Port, V18, P177; Nuttall FQ, 2015, NUTR TODAY, V50, P117, DOI [10.1097/NT.0000000000000092, DOI 10.1097/NT.0000000000000092]; Pereira Patrícia Feliciano, 2015, Rev. paul. pediatr., V33, P63, DOI 10.1016/j.rpped.2014.11.011; Savva SC, 2013, DIABET METAB SYND OB, V6, P403, DOI 10.2147/DMSO.S34220; Soares LR, 2015, REV INST MED TROP SP, V57, P105, DOI 10.1590/S0036-46652015000200002; Surveillance WHOD of ND, 1999, DEF DIAGN CLASS DI 1; van der Valk M, 2001, AIDS, V15, P847, DOI 10.1097/00002030-200105040-00005; Viera AJ, 2005, FAM MED, V37, P360; World Health Organization (WHO), 2011, WAIST CIRCUMFERENCE; Worm SW, 2010, AIDS, V24, P427, DOI 10.1097/QAD.0b013e328334344e	31	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194653	10.1371/journal.pone.0194653	http://dx.doi.org/10.1371/journal.pone.0194653			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566089	Green Submitted, Green Published, gold			2022-12-26	WOS:000428093900091
J	Lou, LL; Li, XR; Chen, JX; Li, Y; Tang, Y; Lv, JY				Lou, Lili; Li, Xiaorui; Chen, Junxiu; Li, Yue; Tang, Yan; Lv, Jinyin			Photosynthetic and ascorbate-glutathione metabolism in the flag leaves as compared to spikes under drought stress of winter wheat (Triticum aestivum L.)	PLOS ONE			English	Article							EAR PHOTOSYNTHESIS; REDOX HOMEOSTASIS; GAS-EXCHANGE; DURUM-WHEAT; LEAF; MECHANISMS; TOLERANCE; CULTIVARS; YIELD; GENE	Ascorbate-glutathione (ASA-GSH) cycle is a major pathway of H2O2 scavenging and an effective mechanism of detoxification in plants. The differences in photosynthesis, chlorophyll content (Chl), relative water content (RWC), antioxidants and antioxidative enzyme activities involved in ASA-GSH metabolism were measured between the flag leaves and spike bracts (glumes and lemmas) during grain filling under drought stress. The expression of APX1, GRC1, DHAR, MDHAR, GPX1, and GS3 in ASA-GSH cycle was also measured. Compared with the flag leaves, the spike bracts exhibited stable net photosynthetic rate (P-N) and chlorophyll content (Chl), a lower accumulation of reactive oxygen species (ROS), and more enhanced percentages of antioxidant enzyme activities and key enzymes gene transcription levels involved in ASA-GSH metabolism during the grain-filling stage under drought conditions. This could be the reasonable explanation for the more stable photosynthetic capacity in spikes, and the glumes and lemmas senesced later than the flag leaves at the late grain-filling stage. Also, the function of ASA-GSH cycle could not be ignored in alleviating oxidative damage by scavenging more excess ROS in spikes under drought stress.	[Lou, Lili; Li, Xiaorui; Chen, Junxiu; Li, Yue; Tang, Yan; Lv, Jinyin] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Lv, JY (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	jinyinlv@nwsuaf.edu.cn			National Natural Science Foundation of China [31271624]; Agricultural Science & Technology Innovation of Shaanxi Province Key Project (China) [2016NY-135]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science & Technology Innovation of Shaanxi Province Key Project (China)	This paper was financially supported by the National Natural Science Foundation of China (No. 31271624) and Agricultural Science & Technology Innovation of Shaanxi Province Key Project (China, 2016NY-135) to JYL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe T, 2010, FUNCT INTEGR GENOMIC, V10, P191, DOI 10.1007/s10142-009-0149-4; Alexieva V, 2001, PLANT CELL ENVIRON, V24, P1337, DOI 10.1046/j.1365-3040.2001.00778.x; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; ARAUS JL, 1993, PLANT CELL ENVIRON, V16, P383, DOI 10.1111/j.1365-3040.1993.tb00884.x; Begara-Morales JC, 2015, J EXP BOT, V66, P5983, DOI 10.1093/jxb/erv306; Benabdellah K, 2009, FUNGAL GENET BIOL, V46, P94, DOI 10.1016/j.fgb.2008.09.013; Boyer JS, 2004, J EXP BOT, V55, P2385, DOI 10.1093/jxb/erh219; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Busch FA, 2016, PLANT PHYSIOL, V172, P1357, DOI 10.1104/pp.16.01475; Chaves MM, 2004, J EXP BOT, V55, P2365, DOI 10.1093/jxb/erh269; Dabrowski P, 2017, J LUMIN, V183, P322, DOI 10.1016/j.jlumin.2016.11.031; de Pinto MC, 2000, PLANT PHYSIOL BIOCH, V38, P541, DOI 10.1016/S0981-9428(00)00773-7; Dietz KJ, 2016, PLANT PHYSIOL, V171, P1535, DOI 10.1104/pp.16.00938; Ding H, 2017, PHOTOSYNTHETICA, V55, p1 ; EVANS JR, 1983, PLANT PHYSIOL, V72, P297, DOI 10.1104/pp.72.2.297; Farooq M, 2014, CRIT REV PLANT SCI, V33, P331, DOI 10.1080/07352689.2014.875291; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Foyer CH, 2016, PLANT CELL ENVIRON, V39, P951, DOI 10.1111/pce.12621; Foyer CH, 2013, ANTIOXID REDOX SIGN, V18, P2087, DOI 10.1089/ars.2013.5278; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Grace SC, 1996, PLANT PHYSIOL, V112, P1631, DOI 10.1104/pp.112.4.1631; Hein JA, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0922-1; Huseynova IM, 2012, BBA-BIOENERGETICS, V1817, P1516, DOI 10.1016/j.bbabio.2012.02.037; Inoue T, 2004, PHOTOSYNTHETICA, V42, P559, DOI 10.1007/S11099-005-0013-2; Inupakutika MA, 2016, J EXP BOT, V67, P5933, DOI 10.1093/jxb/erw382; Jia S, 2015, PHOTOSYNTHETICA, V53, P95, DOI 10.1007/s11099-015-0087-4; KALAJI H, 1991, PHOTOSYNTHETICA, V25, P197; Kang GZ, 2013, BIOL PLANTARUM, V57, P718, DOI 10.1007/s10535-013-0335-z; Kimura S, 2017, PLANT CELL, p1 ; Konig J, 2012, CURR OPIN PLANT BIOL, V15, P261, DOI 10.1016/j.pbi.2011.12.002; Kohl S, 2015, J EXP BOT, V66, P1397, DOI 10.1093/jxb/eru492; Kong LA, 2016, PHOTOSYNTHETICA, V54, P40, DOI 10.1007/s11099-015-0153-y; Kong LQ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00158; Kulkarni M, 2017, FRONT CHEM, V5, DOI 10.3389/fchem.2017.00106; Lesk C, 2016, NATURE, V529, P84, DOI 10.1038/nature16467; Li CL, 2010, PLANT PHYSIOL, V154, P211, DOI 10.1104/pp.110.161182; Li FR, 2000, AGR ECOSYST ENVIRON, V79, P129, DOI 10.1016/S0167-8809(99)00149-8; Li XW, 2010, J INTEGR PLANT BIOL, V52, P616, DOI 10.1111/j.1744-7909.2010.00958.x; Li XJ, 2006, PHYSIOL PLANTARUM, V127, P701, DOI 10.1111/j.1399-3054.2006.00679.x; Li XJ, 2004, PLANT SCI, V166, P627, DOI 10.1016/j.plantsci.2003.10.031; Liu CG, 2017, FUNCT PLANT BIOL, V44, P302, DOI [10.1071/fp16214, 10.1071/FP16214]; Liu ST, 2014, PLANT CELL, V26, P164, DOI 10.1105/tpc.113.118687; Liu Y, 2016, PLANT PHYSIOL BIOCH, V100, P113, DOI 10.1016/j.plaphy.2016.01.003; Liu YF, 2011, INT J BIOL SCI, V7, P1161, DOI 10.7150/ijbs.7.1161; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo RY, 2009, P NATL ACAD SCI USA, V106, P847, DOI 10.1073/pnas.0810731105; Cossani CM, 2012, PLANT PHYSIOL, V160, P1710, DOI 10.1104/pp.112.207753; Martinez DE, 2003, PHYSIOL PLANTARUM, V119, P519, DOI 10.1046/j.1399-3054.2003.00195.x; Mastalerczuk G, 2017, PHOTOSYNTHETICA, V55, P20, DOI 10.1007/s11099-016-0665-0; Maydup ML, 2012, FIELD CROP RES, V134, P208, DOI 10.1016/j.fcr.2012.06.008; Maydup ML, 2010, FIELD CROP RES, V119, P48, DOI 10.1016/j.fcr.2010.06.014; Merah O, 2015, J AGRON CROP SCI, V201, P344, DOI 10.1111/jac.12109; Mittler R, 2017, TRENDS PLANT SCI, V22, P11, DOI 10.1016/j.tplants.2016.08.002; Mittler R, 2015, PLANT CELL, V27, P64, DOI 10.1105/tpc.114.133090; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Noctor G, 2012, PLANT CELL ENVIRON, V35, P454, DOI 10.1111/j.1365-3040.2011.02400.x; OKAMURA M, 1980, CLIN CHIM ACTA, V103, P259; Parry MAJ, 2011, J EXP BOT, V62, P453, DOI 10.1093/jxb/erq304; Petrov P, 2018, J AGRON CROP SCI, V204, P219, DOI 10.1111/jac.12255; Qiu SF, 1985, ACTA AGRON SIN, V11, p138 ; Rangan P, 2016, SCI REP-UK, V6, DOI 10.1038/srep31721; Ren J, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9851095; Reynolds MP, 2005, ANN APPL BIOL, V146, P239, DOI 10.1111/j.1744-7348.2005.040058.x; Sanchez-Bragado R, 2016, J EXP BOT, V67, P2787, DOI 10.1093/jxb/erw116; Sanchez-Bragado R, 2014, J EXP BOT, V65, P5401, DOI 10.1093/jxb/eru298; Sanchez-Bragado R, 2014, J INTEGR PLANT BIOL, V56, P444, DOI 10.1111/jipb.12106; Secenji M, 2010, PLANT CELL REP, V29, P37, DOI 10.1007/s00299-009-0796-x; SMART RE, 1974, PLANT PHYSIOL, V53, P258, DOI 10.1104/pp.53.2.258; Tambussi EA, 2005, PLANTA, V221, P446, DOI 10.1007/s00425-004-1455-7; Tambussi EA, 2007, CRIT REV PLANT SCI, V26, P1, DOI 10.1080/07352680601147901; TEARE ID, 1971, CROP SCI, V11, P627, DOI 10.2135/cropsci1971.0011183X001100050006x; van Heerden PDR, 2008, PHYSIOL PLANTARUM, V134, P99, DOI 10.1111/j.1399-3054.2008.01111.x; Wang HS, 2016, AGR FOREST METEOROL, V228, P1, DOI 10.1016/j.agrformet.2016.06.004; Wang HH, 2016, PLANT PHYSIOL BIOCH, V107, P126, DOI 10.1016/j.plaphy.2016.05.040; Wang X, 2014, J EXP BOT, V65, P6441, DOI 10.1093/jxb/eru362; Wang Y, 2015, PLANT J, V81, P438, DOI 10.1111/tpj.12737; Wei L., 2015, FRONT PLANT SCI, V6, P1, DOI DOI 10.3389/fpls.2015.00458; Xiang Y, 2011, J EXP BOT, V62, P5471, DOI 10.1093/jxb/err226; Zhang YP, 2011, FIELD CROP RES, V123, P187, DOI 10.1016/j.fcr.2011.04.014	80	45	46	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194625	10.1371/journal.pone.0194625	http://dx.doi.org/10.1371/journal.pone.0194625			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566049	Green Published, Green Submitted, gold			2022-12-26	WOS:000428093900088
J	Schwenke, PL; Park, LK; Hauser, L				Schwenke, Piper L.; Park, Linda K.; Hauser, Lorenz			Introgression among three rockfish species (Sebastes spp.) in the Salish Sea, northeast Pacific Ocean	PLOS ONE			English	Article							POPULATION-STRUCTURE; MIGRATION RATES; GENUS SEBASTES; PUGET-SOUND; HYBRIDIZATION; HYBRID; TELEOSTEI; DIVERGENCE; DISPERSAL; INFERENCE	Interspecific hybridization is often seen as a major conservation issue, potentially threatening endangered species and decreasing biodiversity. In natural populations, the conservation implications of hybridization depends on both on anthropogenic factors and the evolutionary processes maintaining the hybrid zone. However, the timeline and patterns of hybridization in the hybrid zone are often not known. Therefore, species conservation becomes a concern when recent anthropogenic changes influence hybridization and not if hybridization is part of a long-term process. Here, we use sequence data from one mitochondrial gene, three nuclear introns and one nuclear exon to estimate the direction, geographic extent, frequency and possible timeline of hybridization between three rockfish species (Sebastes auriculatus, S. caurinus, S. maliger) in the Salish Sea, Washington, USA. We show that (i) introgression occurred much more frequently in the Salish Sea than on the outer coast, (ii) introgression was highly asymmetrical from S. maliger into the other two species, (iii) almost 40% of individuals in the Salish Sea were hybrids, with frequency of hybrids increasing with isolation from the coast, and (iv) all hybrids were later generation backcrosses rather than F1 hybrids. Our results suggest long-standing lowlevel hybridization rather than recent onset of interbreeding because of human induced environmental change, possibly facilitated by specific environmental conditions in the sub -basins of the Salish Sea, and by differences in population sizes during recolonization of the area after the last glaciation. This rockfish hybrid system, with asymmetrical introgression and the maintenance of parental species, may prove useful to study both mechanisms that maintain species boundaries and that facilitate speciation in the presence of rapid environmental change.	[Schwenke, Piper L.; Park, Linda K.] Natl Marine Fisheries Serv, Northwest Fisheries Sci Ctr, Conservat Biol Div, Seattle, WA 98115 USA; [Schwenke, Piper L.; Hauser, Lorenz] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle	Schwenke, PL (corresponding author), Natl Marine Fisheries Serv, Northwest Fisheries Sci Ctr, Conservat Biol Div, Seattle, WA 98115 USA.; Schwenke, PL (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	piper.schwenke@noaa.gov	Hauser, Lorenz/E-4365-2010					Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Albertson SL, 2002, S PUGET SOUND WATER, V1; Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Anderson EC, 2002, GENETICS, V160, P1217; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Arnold ML, 2010, TRENDS ECOL EVOL, V25, P530, DOI 10.1016/j.tree.2010.06.005; Artamonova VS, 2013, J NAT HIST, V47, P1791, DOI 10.1080/00222933.2012.752539; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Beerli P, 2004, MOL ECOL, V13, P827, DOI 10.1111/j.1365-294X.2004.02101.x; Boecklen WJ, 1997, ECOLOGY, V78, P2611, DOI 10.1890/0012-9658(1997)078[2611:GAOHZN]2.0.CO;2; Brandenberger JM, 2011, AQUAT GEOCHEM, V17, P645, DOI 10.1007/s10498-011-9129-0; Buonaccorsi VP, 2011, MOL ECOL, V20, P2603, DOI 10.1111/j.1365-294X.2011.05119.x; Buonaccorsi VP, 2005, CONSERV GENET, V6, P697, DOI 10.1007/s10592-005-9029-1; Buonaccorsi VP, 2002, CANADIAN J FISHERIES, V59, P1374; Burford MO, 2011, MAR BIOL, V158, P1815, DOI 10.1007/s00227-011-1694-7; Burke JM, 2001, ANNU REV GENET, V35, P31, DOI 10.1146/annurev.genet.35.102401.085719; Burns R., 1985, SHAPE FORM PUGET SOU; Coyne J.A., 2004, SPECIATION; Cunningham KM, 2009, CAN J FISH AQUAT SCI, V66, P153, DOI 10.1139/F08-199; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Dick S, 2014, MOL ECOL, V23, P575, DOI 10.1111/mec.12630; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Donnelly MJ, 2004, HEREDITY, V92, P61, DOI 10.1038/sj.hdy.6800377; Drake JS, 2010, STATUS REV 4 ROCKFIS, P234; Ebbert JC, 2000, CIRCULAR, P1996; Engie K, 2007, ESTUAR COAST, V30, P201, DOI 10.1007/BF02700164; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; EXCOFFIER L, 1992, GENETICS, V131, P479; Falush D, 2003, GENETICS, V164, P1567; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Garrett DL, 2007, T AM FISH SOC, V136, P460, DOI 10.1577/T06-092.1; GRANT PR, 1994, EVOLUTION, V48, P297, DOI 10.1111/j.1558-5646.1994.tb01313.x; Grant PR, 2004, EVOLUTION, V58, P1588; Hare MP, 1998, MOL BIOL EVOL, V15, P119; Harrison R.G., 1990, Oxford Surveys in Evolutionary Biology, V7, P69; Hasselman DJ, 2014, MOL ECOL, V23, P1137, DOI 10.1111/mec.12674; Henriques R, 2016, PEERJ, V4, DOI 10.7717/peerj.1827; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; HUBBS CL, 1955, SYST ZOOL, V4, P1, DOI 10.2307/2411933; HUDSON RR, 1985, GENETICS, V111, P147; Hyde JR, 2008, MOL ECOL, V17, P1122, DOI 10.1111/j.1365-294X.2007.03653.x; Hyde JR, 2007, MOL PHYLOGENET EVOL, V44, P790, DOI 10.1016/j.ympev.2006.12.026; Iwamoto EM, 2015, ICES J MAR SCI, V72, P2720, DOI 10.1093/icesjms/fsv146; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Love M. S., 2002, ROCKFISHES NE PACIFI; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mallet J, 2005, HYBRIDIZATION INVASI; Mckay BD, 2010, MOL PHYLOGENET EVOL, V54, P647, DOI 10.1016/j.ympev.2009.08.024; Montanari SR, 2012, ECOL EVOL, V2, P310, DOI 10.1002/ece3.83; Muto N, 2013, J EVOLUTION BIOL, V26, P1750, DOI 10.1111/jeb.12175; Nei M., 1987, MOL EVOLUTIONARY GEN; Newton J., 2007, P 2007 GEORG BAS PUG; Nielsen R, 2001, GENETICS, V158, P885; Nolte AW, 2005, P ROY SOC B-BIOL SCI, V272, P2379, DOI 10.1098/rspb.2005.3231; Pacunski RE, 1998, DISTRIBUTION ABUNDAN; Palsson W, 2009, 0904 FPT; Palsson WA., 2009, BIOL ASSESSMENT ROCK; Palsson WS, 2005, GASP RESPONSE MARINE; Parker MS, 2003, J SHELLFISH RES, V22, P681; Pinho C, 2010, ANNU REV ECOL EVOL S, V41, P215, DOI 10.1146/annurev-ecolsys-102209-144644; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Ray JM, 2008, J FISH BIOL, V72, P418, DOI 10.1111/j.1095-8649.2007.01732.x; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Roberts DG, 2011, MAR ECOL PROG SER, V421, P199, DOI 10.3354/meps08901; Roques S, 2001, MOL ECOL, V10, P149, DOI 10.1046/j.1365-294X.2001.01195.x; Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795; Saha A, EVOLUTIONAY IN PRESS; Seeb LW, 1998, J HERED, V89, P393, DOI 10.1093/jhered/89.5.393; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Small RL, 2004, AUST SYST BOT, V17, P145, DOI 10.1071/SB03015; Stout HA, 2001, STATUS REV COPPER RO; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; TAJIMA F, 1989, GENETICS, V123, P585; Tringali MD, 2011, J HERED, V102, P416, DOI 10.1093/jhered/esr044; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Valentin A, 2002, J FISH BIOL, V60, P857, DOI 10.1006/jfbi.2002.1889; Williams GD, 2010, MAR POLICY, V34, P1010, DOI 10.1016/j.marpol.2010.02.008; Yaakub SM, 2006, MOL PHYLOGENET EVOL, V40, P84, DOI 10.1016/j.ympev.2006.02.012; Yatabe Y, 2007, GENETICS, V175, P1883, DOI 10.1534/genetics.106.064469	84	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194068	10.1371/journal.pone.0194068	http://dx.doi.org/10.1371/journal.pone.0194068			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566070	Green Submitted, gold, Green Published			2022-12-26	WOS:000428093900032
J	Stah, K; Rahmani, S; Prydz, A; Skauli, N; MacAulay, N; Mylonakou, MN; Torp, R; Skare, O; Berg, T; Leergaard, TB; Paulsen, RE; Ottersen, OP; Amiry-Moghaddam, M				Stah, Katja; Rahmani, Soulmaz; Prydz, Agnete; Skauli, Nadia; MacAulay, Nanna; Mylonakou, Maria N.; Torp, Reidun; Skare, Oivind; Berg, Torill; Leergaard, Trygve B.; Paulsen, Ragnhild E.; Ottersen, Ole P.; Amiry-Moghaddam, Mahmood			Targeted deletion of the aquaglyceroporin AQP9 is protective in a mouse model of Parkinson's disease	PLOS ONE			English	Article							1-METHYL-4-PHENYLPYRIDINIUM ION; MOLECULAR CHARACTERIZATION; PESTICIDE EXPOSURE; SUBSTANTIA-NIGRA; AQUAPORIN 9; RAT-BRAIN; EXPRESSION; RISK; DOPAMINE; PREVALENCE	More than 90% of the cases of Parkinson's disease have unknown etiology. Gradual loss of dopaminergic neurons of substantia nigra is the main cause of morbidity in this disease. External factors such as environmental toxins are believed to play a role in the cell loss, although the cause of the selective vulnerability of dopaminergic neurons remains unknown. We have previously shown that aquaglyceroporin AQP9 is expressed in dopaminergic neurons and astrocytes of rodent brain. AQP9 is permeable to a broad spectrum of substrates including purines, pyrimidines, and lactate, in addition to water and glycerol. Here we test our hypothesis that AQP9 serves as an influx route for exogenous toxins and, hence, may contribute to the selective vulnerability of nigral dopaminergic (tyrosine hydroxylase-positive) neurons. Using Xenopus oocytes injected with Aqp9 cRNA, we show that AQP9 is permeable to the parkinsonogenic toxin 1-methyl-4-phenylpyridinium (MPP+). Stable expression of AQP9 in HEK cells increases their vulnerability to MPP+ and to arsenite-another parkinsonogenic toxin. Conversely, targeted deletion of Aqp9 in mice protects nigral dopaminergic neurons against MPP+ toxicity. A protective effect of Aqp9 deletion was demonstrated in organotypic slice cultures of mouse midbrain exposed to MPP+ in vitro and in mice subjected to intrastriatal injections of MPP+ in vivo. Seven days after intrastriatal MPP+ injections, the population of tyrosine hydroxylase-positive cells in substantia nigra is reduced by 48% in Aqp9 knockout mice compared with 67% in WT littermates. Our results show that AQP9-selectively expressed in catecholaminergic neurons-is permeable to MPP+ and suggest that this aquaglyceroporin contributes to the selective vulnerability of nigral dopaminergic neurons by providing an entry route for parkinsonogenic toxins. To our knowledge this is the first evidence implicating a toxin permeable membrane channel in the pathophysiology of Parkinson's disease.	[Stah, Katja; Rahmani, Soulmaz; Prydz, Agnete; Skauli, Nadia; Torp, Reidun; Leergaard, Trygve B.; Ottersen, Ole P.; Amiry-Moghaddam, Mahmood] Univ Oslo, Inst Basic Med Sci, Div Anat, Dept Mol Med, Oslo, Norway; [MacAulay, Nanna] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Mylonakou, Maria N.] Univ Oslo, Ctr Mol Med Norway, Norway Biotechnol Ctr, Nord EMBL Partnership, Oslo, Norway; [Skare, Oivind] Natl Inst Occupat Hlth, Dept Occupat Med & Epidemiol, Oslo, Norway; [Berg, Torill] Univ Oslo, Inst Basic Med Sci, Div Physiol, Dept Mol Med, Oslo, Norway; [Paulsen, Ragnhild E.] Univ Oslo, Sch Pharm, Dept Pharmaceut Sci, Oslo, Norway; [Ottersen, Ole P.] Karolinska Inst, Stockholm, Sweden	University of Oslo; University of Copenhagen; University of Oslo; University of Oslo; University of Oslo; Karolinska Institutet	Amiry-Moghaddam, M (corresponding author), Univ Oslo, Inst Basic Med Sci, Div Anat, Dept Mol Med, Oslo, Norway.	mahmo@medisin.uio.no	Center, Norwegian Transgenic/T-2512-2018; MacAulay, Nanna/AER-7709-2022; Skare, Øivind/C-6330-2016	MacAulay, Nanna/0000-0002-7800-6600; Skare, Øivind/0000-0001-8043-2820; Leergaard, Trygve B./0000-0001-5965-8470; Skauli, Nadia/0000-0003-2410-5555; Paulsen, Ragnhild Elisabeth/0000-0003-0154-8775	University of Oslo, Institute of Basic Medical Sciences	University of Oslo, Institute of Basic Medical Sciences	The present work is funded by University of Oslo, Institute of Basic Medical Sciences. The funder approved the initial project description but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiry-Moghaddam M, 2005, FASEB J, V19, P1459, DOI 10.1096/fj.04-3515com; Arcienega II, 2010, NEUROSCIENCE, V167, P1103, DOI 10.1016/j.neuroscience.2010.02.059; Ascherio A, 2006, ANN NEUROL, V60, P197, DOI 10.1002/ana.20904; Badaut J, 2004, NEUROSCIENCE, V129, P971, DOI 10.1016/j.neuroscience.2004.06.035; Badaut J, 2004, NEUROSCIENCE, V128, P27, DOI 10.1016/j.neuroscience.2004.05.042; Badaut J, 2001, J CEREBR BLOOD F MET, V21, P477, DOI 10.1097/00004647-200105000-00001; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Carbrey JM, 2003, P NATL ACAD SCI USA, V100, P2945, DOI 10.1073/pnas.0437994100; Parodi MC, 2011, PLACENTA, V32, P1050, DOI 10.1016/j.placenta.2011.09.022; DAVIS GC, 1979, PSYCHIAT RES, V1, P249, DOI 10.1016/0165-1781(79)90006-4; de Rijk MC, 2000, NEUROLOGY, V54, pS21; deRijk MC, 1995, NEUROLOGY, V45, P2143, DOI 10.1212/WNL.45.12.2143; Driver JA, 2008, DIABETES CARE, V31, P2003, DOI 10.2337/dc08-0688; DUNNETT SB, 1988, NEUROSCIENCE, V24, P813, DOI 10.1016/0306-4522(88)90069-3; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; Fan SF, 2010, ANN NY ACAD SCI, V1199, P27, DOI 10.1111/j.1749-6632.2009.05170.x; Fan ZZ, 2017, BEHAV BRAIN RES, V320, P412, DOI 10.1016/j.bbr.2016.10.047; Fenton RA, 2010, CELL MOL LIFE SCI, V67, P829, DOI 10.1007/s00018-009-0218-9; Forno Lysia S., 1993, V60, P600; Frigerio R, 2006, MOVEMENT DISORD, V21, P1688, DOI 10.1002/mds.21009; GERMAN DC, 1989, ANN NEUROL, V26, P507, DOI 10.1002/ana.410260403; Ghorayeb I, 2002, NEUROSCIENCE, V115, P533, DOI 10.1016/S0306-4522(02)00401-3; Ghorayeb I, 2001, EXP NEUROL, V167, P133, DOI 10.1006/exnr.2000.7535; GIBB WRG, 1991, J NEUROL NEUROSUR PS, V54, P388, DOI 10.1136/jnnp.54.5.388; Gorell JM, 1999, NEUROTOXICOLOGY, V20, P239; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; HEIKKILA RE, 1989, MOL CHEM NEUROPATHOL, V10, P171, DOI 10.1007/BF03159727; HEIKKILA RE, 1985, NEUROSCI LETT, V62, P389, DOI 10.1016/0304-3940(85)90580-4; Hirsch L, 2016, NEUROEPIDEMIOLOGY, V46, P292, DOI 10.1159/000445751; Hirt L, 2018, J NEUROSCI RES, V96, P194, DOI 10.1002/jnr.24061; Holm LM, 2005, PFLUG ARCH EUR J PHY, V450, P415, DOI 10.1007/s00424-005-1399-1; Ishibashi K, 1998, BIOCHEM BIOPH RES CO, V244, P268, DOI 10.1006/bbrc.1998.8252; JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; KAFETZOPOULOS E, 1988, PHARMACOL BIOCHEM BE, V29, P403, DOI 10.1016/0091-3057(88)90176-1; Karlsson T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059901; Katoozi S, 2017, BRAIN STRUCT FUNCT, V222, P3959, DOI 10.1007/s00429-017-1448-5; Kitayama S, 1998, BBA-MOL CELL RES, V1404, P305, DOI 10.1016/S0167-4889(98)00071-8; KOLLER W, 1990, NEUROLOGY, V40, P1218, DOI 10.1212/WNL.40.8.1218; Kuriyama H, 2002, DIABETES, V51, P2915, DOI 10.2337/diabetes.51.10.2915; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Liu ZJ, 2002, P NATL ACAD SCI USA, V99, P6053, DOI 10.1073/pnas.092131899; Loitto VM, 2007, EXP CELL RES, V313, P1295, DOI 10.1016/j.yexcr.2007.01.023; Moeller HB, 2009, NEUROSCIENCE, V164, P1674, DOI 10.1016/j.neuroscience.2009.09.072; Mylonakou MN, 2009, J NEUROSCI RES, V87, P1310, DOI 10.1002/jnr.21952; Nakao N, 1997, NEUROSCIENCE, V76, P749, DOI 10.1016/S0306-4522(96)00223-0; NICKLAS WJ, 1987, LIFE SCI, V40, P721, DOI 10.1016/0024-3205(87)90299-2; Paxinos G.A.F.K., 2007, MOUSE BRAIN STEROTAX; Payami H, 1998, J GERIATR PSYCH NEUR, V11, P98, DOI 10.1177/089198879801100207; Pezzoli G, 2013, NEUROLOGY, V80, P2035, DOI 10.1212/WNL.0b013e318294b3c8; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Priyadarshi A, 2000, NEUROTOXICOLOGY, V21, P435; Richardson BD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10423; Rojek AM, 2007, P NATL ACAD SCI USA, V104, P3609, DOI 10.1073/pnas.0610894104; Shavali S, 2008, TOXICOL SCI, V102, P254, DOI 10.1093/toxsci/kfm302; Smeyne RJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164094; Stahl K, 2011, BRAIN RES, V1378, P105, DOI 10.1016/j.brainres.2010.12.090; Stahl K, 2009, THESCIENTIFICWORLDJO, V9, P811, DOI 10.1100/tsw.2009.68; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Tsukaguchi H, 1999, AM J PHYSIOL-RENAL, V277, pF685, DOI 10.1152/ajprenal.1999.277.5.F685; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; van der Mark Marianne, 2012, Environ Health Perspect, V120, P340, DOI 10.1289/ehp.1103881; Vilarino-Garcia T, 2016, HORM METAB RES, V48, P535, DOI 10.1055/s-0042-105152; Vilarino-Garcia T, 2018, GYNECOL ENDOCRINOL, V34, P175, DOI 10.1080/09513590.2017.1380184; Winterbottom EF, 2017, ENVIRON HEALTH-GLOB, V16, DOI 10.1186/s12940-017-0267-8	67	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							0194896	10.1371/journal.pone.0194896	http://dx.doi.org/10.1371/journal.pone.0194896			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566083	Green Published, Green Submitted, gold			2022-12-26	WOS:000428093900118
J	Zhang, L; Zhang, GX; Liang, ZZ; Ozioko, EF				Zhang, Lei; Zhang, Guoxing; Liang, Zhizheng; Ozioko, Ekene Frank			Multi-features taxi destination prediction with frequency domain processing	PLOS ONE			English	Article							TRAFFIC SPEED PREDICTION; NEURAL-NETWORK	The traditional taxi prediction methods model the taxi trajectory as a sequence of spatial points. It cannot represent two-dimensional spatial relationships between trajectory points. Therefore, many methods transform the taxi GPS trajectory into a two-dimensional image, and express the spatial correlations by trajectory image. However, the trajectory image may have noise and sparsity according to trajectory data characteristics. So, we import image frequency domain processing to taxi destination prediction to reduce noise and sparsity, then propose multi-features taxi destination prediction with frequency domain processing (MTDP-FD) method. Firstly, we transform the spatial domain trajectory image into frequency-domain representation by fast Fourier transform and reduce the noise of the trajectory images. Convolutional Neural Network (CNN) is adapted to extract the deep features from the processed trajectory image as CNN has a significant learning ability to images. Recurrent Neural Network (RNN) is adapted to predict the taxi destination as multiple hidden layers of RNN can store dependencies between input data to achieve better prediction. The deep features of the trajectory images are combined with trajectory metadata, trajectory data to act as the input to RNN. The experiments based on the taxi trajectory dataset of Porto show that the average distance error of MTDP-FD is reduced by 0.14km compared with the existing methods, and the GTOHL is the best combination of data and features to improve the prediction accuracy.	[Zhang, Lei; Zhang, Guoxing; Liang, Zhizheng] China Univ Min & Technol, Sch Comp Sci & Technol, Xuzhou, Jiangsu, Peoples R China; [Ozioko, Ekene Frank] Univ Reading, Sch Math Phys & Computat Sci, Reading, Berks, England	China University of Mining & Technology; University of Reading	Zhang, L (corresponding author), China Univ Min & Technol, Sch Comp Sci & Technol, Xuzhou, Jiangsu, Peoples R China.	zhanglei@cumt.edu.cn			Fundamental Research Funds for the Central Universities [2017XKQY078]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Fundamental Research Funds for the Central Universities (2017XKQY078, www.cumt.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besse P. C., 2016, IEEE T INTELLIGENT T; De Brebisson A., 2015, COMPUTER SCI; Endo Y., 2016, DEEP FEATURE EXTRACT; Endo Y., 2016, INT J DATA SCI ANAL, V3, P107, DOI 10.1007/s41060-016-0014-1; Endo Y, 2017, LECT NOTES ARTIF INT, V10234, P160, DOI 10.1007/978-3-319-57454-7_13; He Z, 2016, EUR J OPER RES, V250, P65, DOI 10.1016/j.ejor.2015.09.006; Helmy AK, 2016, APPL SOFT COMPUT, V40, P405, DOI 10.1016/j.asoc.2015.11.042; Hung CC, 2015, VLDB J, V24, P169, DOI 10.1007/s00778-011-0262-6; Karlaftis MG, 2011, TRANSPORT RES C-EMER, V19, P387, DOI 10.1016/j.trc.2010.10.004; Liu YP, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040712; Lv J., 2016, T CONV CONVOLUTIONAL; Ma XL, 2015, TRANSPORT RES C-EMER, V54, P187, DOI 10.1016/j.trc.2015.03.014; Moore J., 2016, USING RECURRENT NEUR; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Sundararajan D., 2017, IMAGE ENHANCEMENT FR; Talathi SS, 2015, COMPUTER SCI; Tang JJ, 2017, IEEE T INTELL TRANSP, V18, P2340, DOI 10.1109/TITS.2016.2643005; Tang JJ, 2018, PHYSICA A, V493, P430, DOI 10.1016/j.physa.2017.11.114; Tang JJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188796; Tang JJ, 2016, IEEE T INTELL TRANSP, V17, P3318, DOI 10.1109/TITS.2016.2544140; Tang JJ, 2015, PHYSICA A, V438, P140, DOI 10.1016/j.physa.2015.06.032; Tuske Z, 2015, INT CONF ACOUST SPEE, P4285, DOI 10.1109/ICASSP.2015.7178779; Xue AY, 2015, VLDB J, V24, P219, DOI 10.1007/s00778-014-0369-7; Xue AY, 2013, PROC INT CONF DATA, P254, DOI 10.1109/ICDE.2013.6544830; Zhang JP, 2011, IEEE T INTELL TRANSP, V12, P1624, DOI 10.1109/TITS.2011.2158001; Zhang L, 2017, IEICE T INF SYST, VE100D, P2215, DOI 10.1587/transinf.2017EDL8066; Zhang L, 2016, IEICE T INF SYST, VE99D, P1474, DOI 10.1587/transinf.2015CBP0001; Zhang S, 2017, J TRANSP GEOGR, V61, P72, DOI 10.1016/j.jtrangeo.2017.04.009; zheng y., 2015, TRAJECTORY DATA MINI; Zou YJ, 2014, TRANSPORT RES C-EMER, V43, P33, DOI 10.1016/j.trc.2013.10.007	30	11	12	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194629	10.1371/journal.pone.0194629	http://dx.doi.org/10.1371/journal.pone.0194629			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566042	gold, Green Published, Green Submitted			2022-12-26	WOS:000428093900090
J	Fazakerley, DJ; Minard, AY; Krycer, JR; Thomas, KC; Stockli, J; Harney, DJ; Burchfield, JG; Maghzal, GJ; Caldwell, ST; Hartley, RC; Stocker, R; Murphy, MP; James, DE				Fazakerley, Daniel J.; Minard, Annabel Y.; Krycer, James R.; Thomas, Kristen C.; Stockli, Jacqueline; Harney, Dylan. J.; Burchfield, James G.; Maghzal, Ghassan J.; Caldwell, Stuart T.; Hartley, Richard C.; Stocker, Roland; Murphy, Michael P.; James, David E.			Mitochondrial oxidative stress causes insulin resistance without disrupting oxidative phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						superoxide ion; oxidative stress; hydrogen peroxide; mitochondria; insulin resistance; insulin; adipocyte; muscle; adipose tissue; Mitochondrial dysfunction	ACTIVATED PROTEIN-KINASE; MANGANESE SUPEROXIDE-DISMUTASE; SKELETAL-MUSCLE; IN-VIVO; GLUCOSE-UPTAKE; COMPLEX-III; MICE; FAT; OBESITY; GLUT4	Mitochondrial oxidative stress, mitochondrial dysfunction, or both have been implicated in insulin resistance. However, disentangling the individual roles of these processes in insulin resistance has been difficult because they often occur in tandem, and tools that selectively increase oxidant production without impairing mitochondrial respiration have been lacking. Using the dimer/monomer status of peroxiredoxin isoforms as an indicator of compartmental hydrogen peroxide burden, we provide evidence that oxidative stress is localized to mitochondria in insulin-resistant 3T3-L1 adipocytes and adipose tissue from mice. To dissociate oxidative stress from impaired oxidative phosphorylation and study whether mitochondrial oxidative stress per se can cause insulin resistance, we used mitochondria-targeted paraquat (MitoPQ) to generate superoxide within mitochondria without directly disrupting the respiratory chain. At 10 m, MitoPQ specifically increased mitochondrial superoxide and hydrogen peroxide without altering mitochondrial respiration in intact cells. Under these conditions, MitoPQ impaired insulin-stimulated glucose uptake and glucose transporter 4 (GLUT4) translocation to the plasma membrane in both adipocytes and myotubes. MitoPQ recapitulated many features of insulin resistance found in other experimental models, including increased oxidants in mitochondria but not cytosol; a more profound effect on glucose transport than on other insulin-regulated processes, such as protein synthesis and lipolysis; an absence of overt defects in insulin signaling; and defective insulin- but not AMP-activated protein kinase (AMPK)-regulated GLUT4 translocation. We conclude that elevated mitochondrial oxidants rapidly impair insulin-regulated GLUT4 translocation and significantly contribute to insulin resistance and that MitoPQ is an ideal tool for studying the link between mitochondrial oxidative stress and regulated GLUT4 trafficking.	[Fazakerley, Daniel J.; Minard, Annabel Y.; Krycer, James R.; Thomas, Kristen C.; Stockli, Jacqueline; Harney, Dylan. J.; Burchfield, James G.; James, David E.] Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Camperdown, NSW 2006, Australia; [James, David E.] Univ Sydney, Sydney Med Sch, Charles Perkins Ctr, Camperdown, NSW 2006, Australia; [Maghzal, Ghassan J.; Stocker, Roland] Victor Chang Cardiac Res Inst, Vasc Biol Div, Darlinghurst, NSW 2010, Australia; [Maghzal, Ghassan J.; Stocker, Roland] Univ New South Wales, St Vincents Clin Sch, Sydney, NSW 2052, Australia; [Caldwell, Stuart T.; Hartley, Richard C.] Univ Glasgow, Sch Chem, Glasgow G12 8QQ, Lanark, Scotland; [Murphy, Michael P.] Univ Cambridge, MRC Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England; [Minard, Annabel Y.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Sydney; University of Sydney; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of Glasgow; University of Cambridge; University of Iowa	James, DE (corresponding author), Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Camperdown, NSW 2006, Australia.; James, DE (corresponding author), Univ Sydney, Sydney Med Sch, Charles Perkins Ctr, Camperdown, NSW 2006, Australia.	david.james@sydney.edu.au	Hartley, Richard/AAT-7834-2020; Stocker, Roland/AAV-4489-2021; Stocker, Roland/L-9157-2019; Stoeckli, Jacqueline/Z-4443-2019; Burchfield, James/C-1779-2019; Fazakerley, Daniel/J-2652-2019; Stoeckli, Jacqueline/D-7053-2016; Caldwell, Stuart/J-8863-2014; Hartley, Richard/E-3489-2010; Murphy, Michael/C-2120-2009	Hartley, Richard/0000-0003-1033-5405; Stoeckli, Jacqueline/0000-0002-6446-7350; Burchfield, James/0000-0002-6609-6151; Fazakerley, Daniel/0000-0001-8241-2903; Stoeckli, Jacqueline/0000-0002-6446-7350; Caldwell, Stuart/0000-0003-1604-3462; Hartley, Richard/0000-0003-1033-5405; Murphy, Michael/0000-0003-1115-9618; Krycer, James/0000-0003-1536-7270; Minard, Annabel Yurie/0000-0003-0715-622X; Cooke, Kristen/0000-0002-3534-1660; James, David/0000-0001-5946-5257	National Health and Medical Research Council of Australia (NHMRC) [1061122, 1086850]; Diabetes Australia Research Program [Y17G-BURJ]; Medical Research Council UK Grant [MC_U105663142]; Wellcome Trust Investigator Award [110159/Z/15/Z, 110158/Z/15/Z]; NHMRC Early Career Fellowship; MRC [MC_U105663142, MC_UU_00015/3] Funding Source: UKRI	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Program; Medical Research Council UK Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Investigator Award(Wellcome Trust); NHMRC Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by National Health and Medical Research Council of Australia (NHMRC) Project Grants 1061122 and 1086850 (to D.E.J.) and Diabetes Australia Research Program Grant Y17G-BURJ (to J.G.B. and D.J.F.). This work was also supported by Medical Research Council UK Grant MC_U105663142, by Wellcome Trust Investigator Award 110159/Z/15/Z (to M.P.M.), and by Wellcome Trust Investigator Award 110158/Z/15/Z (to R.C.H.). The authors declare that they have no conflicts of interest with the contents of this article. The contents of the published material are solely the responsibility of the individual authors and do not reflect the views of NHMRC.; Supported by an NHMRC Early Career Fellowship.	Aguer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028536; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Andersson S, 2009, EUR J ORG CHEM, V2009, P1163, DOI 10.1002/ejoc.200801012; Bayer SB, 2013, FASEB J, V27, P4659, DOI 10.1096/fj.13-227298.ERR; Bergeron R, 2001, DIABETES, V50, P1076, DOI 10.2337/diabetes.50.5.1076; Bloch-Damti A, 2006, DIABETOLOGIA, V49, P2463, DOI 10.1007/s00125-006-0349-6; Boden G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4765; Burchfield JG, 2018, J BIOL CHEM, V293, P5731, DOI [10.1074/jbc.RA117.000808, 10.1074/jbc.ra117.000808]; Burchfield JG, 2013, TRAFFIC, V14, P259, DOI 10.1111/tra.12035; Chen LJ, 2008, AGING CELL, V7, P866, DOI 10.1111/j.1474-9726.2008.00432.x; Dube JJ, 2014, AM J PHYSIOL-ENDOC M, V307, pE1117, DOI 10.1152/ajpendo.00257.2014; Fazakerley DJ, 2018, ELIFE, V7, DOI 10.7554/eLife.32111; Fazakerley DJ, 2015, J BIOL CHEM, V290, P23528, DOI 10.1074/jbc.M115.657361; Fazakerley DJ, 2010, J BIOL CHEM, V285, P1653, DOI 10.1074/jbc.M109.051185; Fletcher R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095598; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Gonzalez E, 2011, P NATL ACAD SCI USA, V108, P10162, DOI 10.1073/pnas.1019268108; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Han YH, 2016, DIABETES, V65, P2639, DOI 10.2337/db16-0283; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hoy AJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE67, DOI 10.1152/ajpendo.90945.2008; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Kenwood BM, 2014, MOL METAB, V3, P114, DOI 10.1016/j.molmet.2013.11.005; Kleinridders A, 2013, J CLIN INVEST, V123, P4667, DOI 10.1172/JCI67615; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Krycer JR, 2017, BIOCHEM BIOPH RES CO, V489, P399, DOI 10.1016/j.bbrc.2017.05.151; KUSUNOKI M, 1993, AM J PHYSIOL, V264, pE167, DOI 10.1152/ajpendo.1993.264.2.E167; Lark DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126732; Lee HY, 2017, DIABETES, V66, P2072, DOI 10.2337/db16-1334; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Li J, 2014, DIABETOLOGIA, V57, P2173, DOI 10.1007/s00125-014-3312-y; Lo KA, 2013, CELL REP, V5, P259, DOI 10.1016/j.celrep.2013.08.039; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; MARTIN IK, 1995, AM J PHYSIOL-ENDOC M, V269, pE583, DOI 10.1152/ajpendo.1995.269.3.E583; Martin SD, 2014, MOL METAB, V3, P408, DOI 10.1016/j.molmet.2014.02.001; Mottis A, 2014, MAMM GENOME, V25, P424, DOI 10.1007/s00335-014-9525-z; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Nadler ST, 2001, AM J PHYSIOL-ENDOC M, V281, pE1249, DOI 10.1152/ajpendo.2001.281.6.E1249; Paglialunga S, 2015, DIABETOLOGIA, V58, P1071, DOI 10.1007/s00125-015-3531-x; Park SY, 2005, J BIOL CHEM, V280, P9855, DOI 10.1074/jbc.M409399200; Patterson HC, 2015, P NATL ACAD SCI USA, V112, pE5679, DOI 10.1073/pnas.1517932112; Petersen MC, 2016, J CLIN INVEST, V126, P4361, DOI 10.1172/JCI86013; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Quinlan CL, 2013, REDOX BIOL, V1, P304, DOI 10.1016/j.redox.2013.04.005; Raha S, 2000, FREE RADICAL BIO MED, V29, P170, DOI 10.1016/S0891-5849(00)00338-5; Robb EL, 2015, FREE RADICAL BIO MED, V89, P883, DOI 10.1016/j.freeradbiomed.2015.08.021; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Scialo F, 2016, CELL METAB, V23, P725, DOI 10.1016/j.cmet.2016.03.009; Shi XR, 2008, J BIOL CHEM, V283, P30658, DOI 10.1074/jbc.M800510200; Tan SX, 2015, J BIOL CHEM, V290, P11337, DOI 10.1074/jbc.M114.623686; Tonks KT, 2013, DIABETOLOGIA, V56, P875, DOI 10.1007/s00125-012-2811-y; Turner N, 2013, DIABETOLOGIA, V56, P1638, DOI 10.1007/s00125-013-2913-1; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; van de Weijer T, 2015, DIABETES, V64, P1193, DOI 10.2337/db14-0667; Vernochet C, 2012, CELL METAB, V16, P765, DOI 10.1016/j.cmet.2012.10.016; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	61	68	69	4	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7315	7328		10.1074/jbc.RA117.001254	http://dx.doi.org/10.1074/jbc.RA117.001254			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29599292	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000432174500025
J	Zhang, HJ; Coblentz, C; Watanabe-Smith, K; Means, S; Means, J; Maxson, JE; Tyner, JW				Zhang, Haijiao; Coblentz, Cody; Watanabe-Smith, Kevin; Means, Sophie; Means, Jasmine; Maxson, Julia E.; Tyner, Jeffrey W.			Gain-of-function mutations in granulocyte colony-stimulating factor receptor (CSF3R) reveal distinct mechanisms of CSF3R activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; cell signaling; cell surface receptor; signal transduction; endocytosis; CSF3R; endocytosis; mutagenesis; receptor expression; signaling transduction	SEVERE CONGENITAL NEUTROPENIA; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; LIGAND INDEPENDENCE; CYTOPLASMIC DOMAIN; DOWN-REGULATION; T618I MUTATION; BETA-SUBUNIT; GM-CSF; REGIONS	Granulocyte colony-stimulating factor (G-CSF or CSF3) and its receptor CSF3R regulate granulopoiesis, neutrophil function, and hematopoietic stem cell mobilization. Recent studies have uncovered an oncogenic role of mutations in the CSF3R gene in many hematologic malignancies. To find additional CSF3R mutations that give rise to cell transformation, we performed a cellular transformation assay in which murine interleukin 3 (IL-3)-dependent Ba/F3 cells were transduced with WT CSF3R plasmid and screened for spontaneous growth in the absence of IL-3. Any outgrowth clones were sequenced to identify CSF3R mutations with transformation capacity. We identified several novel mutations and determined that they transform cells via four distinct mechanisms: 1) cysteine- and disulfide bond-mediated dimerization (S581C); 2) polar, noncharged amino acid substitution at the transmembrane helix dimer interface at residue Thr-640; 3) increased internalization by a Glu-524 substitution that mimics a low G-CSF dose; and 4) hydrophobic amino acid substitutions in the membrane-proximal residues Thr-612, Thr-615, and Thr-618. Furthermore, the change in signaling activation was related to an altered CSF3R localization. We also found that CSF3R-induced STAT3 and ERK activations require CSF3R internalization, whereas STAT5 activation occurred at the cell surface. Cumulatively, we have expanded the regions of the CSF3R extracellular and transmembrane domains in which missense mutations exhibit leukemogenic capacity and have further elucidated the mechanistic underpinnings that underlie altered CSF3R expression, dimerization, and signaling activation.	[Zhang, Haijiao; Coblentz, Cody; Means, Sophie; Means, Jasmine; Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Knight Canc Inst, Dept Cell Dev & Canc Biol, Portland, OR 97239 USA; [Watanabe-Smith, Kevin; Maxson, Julia E.] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Knight Canc Inst, 3181 SW Sam Jackson Pk Rd,BRB 553,Mailcode L592, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Maxson, JE (corresponding author), Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Knight Canc Inst, 3181 SW Sam Jackson Pk Rd,BRB 553,Mailcode L592, Portland, OR 97239 USA.; Tyner, JW (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, 3181 SW Sam Jackson Pk Rd,BRB 553,Mailcode L592, Portland, OR 97239 USA.	maxsonj@ohsu.edu; tynerj@ohsu.edu		Watanabe-Smith, Kevin/0000-0003-4231-8562	Aptose; Array; AstraZeneca; Constellation; Genentech; Gilead; Incyte; Janssen; Seattle Genetics; Syros; Takeda; American Society of Hematology award; NCI, National Institutes of Health [R00CA190605-03, 5R00CA151457-04, 1R01CA183947-01]; Leukemia and Lymphoma Society; V Foundation for Cancer Research; Gabrielle's Angel Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [R00CA190605, U54CA224019, U01CA217862] Funding Source: NIH RePORTER	Aptose; Array; AstraZeneca(AstraZeneca); Constellation; Genentech(Roche HoldingGenentech); Gilead(Gilead Sciences); Incyte; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Seattle Genetics; Syros; Takeda(Takeda Pharmaceutical Company Ltd); American Society of Hematology award; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); V Foundation for Cancer Research; Gabrielle's Angel Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	J. W. T. receives research support from Aptose, Array, AstraZeneca, Constellation, Genentech, Gilead, Incyte, Janssen, Seattle Genetics, Syros, and Takeda and is a member of the scientific advisory board for Leap Oncology. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by an American Society of Hematology award and NCI, National Institutes of Health Grant R00CA190605-03.; Supported by the Leukemia and Lymphoma Society, the V Foundation for Cancer Research, Gabrielle's Angel Foundation for Cancer Research, and NCI, National Institutes of Health Grants 5R00CA151457-04 and 1R01CA183947-01.	Aarts LHJ, 2004, BLOOD, V103, P571, DOI 10.1182/blood-2003-07-2250; Chakraborty A, 1999, BLOOD, V93, P15, DOI 10.1182/blood.V93.1.15.401a46_15_24; Ding JM, 2009, BLOOD, V114, P3325, DOI 10.1182/blood-2008-04-149047; Dong F, 1998, J IMMUNOL, V161, P6503; Ehlers S, 2010, J CLIN ONCOL, V28, P2591, DOI 10.1200/JCO.2009.25.9010; Frohling S, 2007, CANCER CELL, V12, P501, DOI 10.1016/j.ccr.2007.11.005; FUKUNAGA R, 1993, CELL, V74, P1079, DOI 10.1016/0092-8674(93)90729-A; Grandal MV, 2007, CARCINOGENESIS, V28, P1408, DOI 10.1093/carcin/bgm058; Grimes ML, 1996, J NEUROSCI, V16, P7950; Hendriks BS, 2003, CANCER RES, V63, P1130; Hermans MHA, 2003, BLOOD, V101, P2584, DOI 10.1182/blood-2002-07-2062; Hunter MG, 1999, BLOOD, V93, P440, DOI 10.1182/blood.V93.2.440.402k23_440_446; Jenkins BJ, 1998, BLOOD, V92, P1989, DOI 10.1182/blood.V92.6.1989; Joffre C, 2011, NAT CELL BIOL, V13, P827, DOI 10.1038/ncb2257; Kamezaki K, 2005, STEM CELLS, V23, P252, DOI 10.1634/stemcells.2004-0173a; Liu FL, 2008, J CLIN INVEST, V118, P946, DOI 10.1172/JCI32704; Maxson JE, 2016, CLIN CANCER RES, V22, P757, DOI 10.1158/1078-0432.CCR-14-3100; Maxson JE, 2014, J BIOL CHEM, V289, P5820, DOI 10.1074/jbc.M113.508440; Maxson JE, 2013, NEW ENGL J MED, V368, P1781, DOI 10.1056/NEJMoa1214514; Mehta HM, 2013, LEUKEMIA, V27, P2407, DOI 10.1038/leu.2013.164; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Neumann T.A., 2012, MILESTONES DRUG THER, P395, DOI DOI 10.1007/978-3-0348-0218-5; NICHOLSON SE, 1995, BLOOD, V86, P3698, DOI 10.1182/blood.V86.10.3698.bloodjournal86103698; Ohki K., 2013, BLOOD, V122, P1352; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Perugini M, 2010, BLOOD, V115, P3346, DOI 10.1182/blood-2009-08-235846; Peschard P, 2003, CANCER CELL, V3, P519, DOI 10.1016/S1535-6108(03)00136-3; Plo I, 2009, J EXP MED, V206, P1701, DOI 10.1084/jem.20090693; RAPOPORT AP, 1992, BLOOD REV, V6, P43, DOI 10.1016/0268-960X(92)90007-D; Rohrabaugh S, 2017, LEUKEMIA, V31, P1770, DOI 10.1038/leu.2016.376; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Tamada T, 2006, P NATL ACAD SCI USA, V103, P3135, DOI 10.1073/pnas.0511264103; Touw IP, 2013, HEMATOL ONCOL CLIN N, V27, P61, DOI 10.1016/j.hoc.2012.10.002; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; Watanabe-Smith K, 2017, ONCOTARGET, V8, P12596, DOI 10.18632/oncotarget.15392; Zhang H, 2017, LEUKEMIA, V31, P2752, DOI 10.1038/leu.2017.126; Zhang HJ, 2017, CANCER RES, V77, P4258, DOI 10.1158/0008-5472.CAN-17-1052; Zhuang DZ, 2005, J LEUKOCYTE BIOL, V78, P1008, DOI 10.1189/jlb.0105032; ZIEGLER SF, 1993, MOL CELL BIOL, V13, P2384, DOI 10.1128/MCB.13.4.2384	39	11	11	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7387	7396		10.1074/jbc.RA118.002417	http://dx.doi.org/10.1074/jbc.RA118.002417			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29572350	Green Published, hybrid			2022-12-26	WOS:000432174500031
J	Belyaeva, OV; Wu, LZ; Shmarakov, I; Nelson, PS; Kedishvili, NY				Belyaeva, Olga V.; Wu, Lizhi; Shmarakov, Igor; Nelson, Peter S.; Kedishvili, Natalia Y.			Retinol dehydrogenase 11 is essential for the maintenance of retinol homeostasis in liver and testis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vitamin A; carotenoid; retinoic acid; retinol; dehydrogenase; reductase; retinaldehyde	SHORT-CHAIN DEHYDROGENASE/REDUCTASE; BETA-CAROTENE 15,15'-DIOXYGENASE; RETINALDEHYDE REDUCTASE-ACTIVITY; ACID RESPONSE ELEMENT; BINDING-PROTEIN; VITAMIN-A; HUMAN TISSUES; BIOCHEMICAL-PROPERTIES; INTESTINAL-ABSORPTION; SUBSTRATE-SPECIFICITY	Retinol dehydrogenase 11 (RDH11) is a microsomal short-chain dehydrogenase/reductase that recognizes all-trans- and cis-retinoids as substrates and prefers NADPH as a cofactor. Previous work has suggested that RDH11 contributes to the oxidation of 11-cis-retinol to 11-cis-retinaldehyde during the visual cycle in the eye's retinal pigment epithelium. However, the role of RDH11 in metabolism of all-trans-retinoids remains obscure. Here, we report that microsomes isolated from the testes and livers of Rdh11(-/-) mice fed a regular diet exhibited a 3- and 1.7-fold lower rate of all-trans-retinaldehyde conversion to all-trans-retinol, respectively, than the microsomes of WT littermates. Testes and livers of Rdh11(-/-) mice fed a vitamin A-deficient diet had approximate to 35% lower levels of all-trans-retinol than those of WT mice. Furthermore, the conversion of -carotene to retinol via retinaldehyde as an intermediate appeared to be impaired in the testes of Rdh11(-/-)/retinol-binding protein 4(-/-)(Rbp4(-/-)) mice, which lack circulating holo RBP4 and rely on dietary supplementation with -carotene for maintenance of their retinoid stores. Together, these results indicate that in mouse testis and liver, RDH11 functions as an all-trans-retinaldehyde reductase essential for the maintenance of physiological levels of all-trans-retinol under reduced vitamin A availability.	[Belyaeva, Olga V.; Wu, Lizhi; Kedishvili, Natalia Y.] Univ Alabama Birmingham, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Belyaeva, Olga V.; Wu, Lizhi; Kedishvili, Natalia Y.] Univ Alabama Birmingham, Sch Dent, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Shmarakov, Igor] Columbia Univ, Dept Med, New York, NY 21007 USA; [Nelson, Peter S.] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Nelson, Peter S.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Columbia University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Kedishvili, NY (corresponding author), 720 20th St South,Kaul 440B, Birmingham, AL 35294 USA.	nkedishvili@uab.edu		Beliaeva, Olga/0000-0003-2512-925X	United States Public Health Services, National Institutes of Health [R01AA012153, R01DK068437, R01DK101251]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101251, R01DK068437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012153] Funding Source: NIH RePORTER	United States Public Health Services, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by United States Public Health Services, National Institutes of Health Grants R01AA012153, R01DK068437, and R01DK101251. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams MK, 2014, J BIOL CHEM, V289, P14868, DOI 10.1074/jbc.M114.552257; Belyaeva OV, 2008, FEBS J, V275, P138, DOI 10.1111/j.1742-4658.2007.06184.x; Belyaeva OV, 2017, J BIOL CHEM, V292, P5884, DOI 10.1074/jbc.M117.776914; Belyaeva OV, 2005, BIOCHEMISTRY-US, V44, P7035, DOI 10.1021/bi050226k; Belyaeva OV, 2003, BIOCHEMISTRY-US, V42, P14838, DOI 10.1021/bi035288u; Belyaeva OV, 2002, FEBS LETT, V531, P489, DOI 10.1016/S0014-5793(02)03588-3; BLANER WS, 1986, J LIPID RES, V27, P1084; BLANER WS, 1985, J LIPID RES, V26, P1241; D'Ambrosio DN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024993; During A, 1996, ANAL BIOCHEM, V241, P199, DOI 10.1006/abio.1996.0400; During A, 1998, BIOCHEM BIOPH RES CO, V249, P467, DOI 10.1006/bbrc.1998.9160; During A, 2001, J NUTR BIOCHEM, V12, P640, DOI 10.1016/S0955-2863(01)00184-X; Endo T, 2017, P NATL ACAD SCI USA, V114, pE10132, DOI 10.1073/pnas.1710837114; Gallego O, 2006, BIOCHEM J, V399, P101, DOI 10.1042/BJ20051988; Ghyselinck NB, 2006, DEV DYNAM, V235, P1608, DOI 10.1002/dvdy.20795; Haeseleer F, 2002, J BIOL CHEM, V277, P45537, DOI 10.1074/jbc.M208882200; Harrison EH, 2012, BBA-MOL CELL BIOL L, V1821, P70, DOI 10.1016/j.bbalip.2011.06.002; Hogarth CA, 2010, J CLIN INVEST, V120, P956, DOI 10.1172/JCI41303; HUSMANN M, 1992, BIOCHEM BIOPH RES CO, V187, P1558, DOI 10.1016/0006-291X(92)90480-9; Kanan Y, 2008, INVEST OPHTH VIS SCI, V49, P1071, DOI 10.1167/iovs.07-1207; Kasus-Jacobi A, 2005, J BIOL CHEM, V280, P20413, DOI 10.1074/jbc.M413789200; Kasus-Jacobi A, 2003, J BIOL CHEM, V278, P32380, DOI 10.1074/jbc.M304969200; KATO M, 1985, J BIOL CHEM, V260, P4832; Kedishvili NY, 2002, J BIOL CHEM, V277, P28909, DOI 10.1074/jbc.M202588200; Kim TS, 2005, J BIOL CHEM, V280, P8694, DOI 10.1074/jbc.M413172200; Lee CM, 1999, J NUTR, V129, P2271, DOI 10.1093/jn/129.12.2271; Li Yang, 2014, Hepatobiliary Surg Nutr, V3, P126, DOI 10.3978/j.issn.2304-3881.2014.05.04; Lin BY, 2001, CANCER RES, V61, P1611; Lindqvist A, 2002, J BIOL CHEM, V277, P23942, DOI 10.1074/jbc.M202756200; Lobo GP, 2010, FASEB J, V24, P1656, DOI 10.1096/fj.09-150995; Marchette LD, 2010, FREE RADICAL BIO MED, V48, P16, DOI 10.1016/j.freeradbiomed.2009.08.005; Napoli JL, 1998, METH MOL B, V89, P29; OKUNO M, 1995, J LIPID RES, V36, P137; Paik J, 2001, J BIOL CHEM, V276, P32160, DOI 10.1074/jbc.M010086200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; RAJAN N, 1990, J LIPID RES, V31, P821; Raverdeau M, 2012, P NATL ACAD SCI USA, V109, P16582, DOI 10.1073/pnas.1214936109; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; SCITA G, 1993, METHOD ENZYMOL, V214, P21; Shmarakov I, 2010, ARCH BIOCHEM BIOPHYS, V504, P3, DOI 10.1016/j.abb.2010.05.010; SMITH WC, 1991, EMBO J, V10, P2223, DOI 10.1002/j.1460-2075.1991.tb07758.x; Tong MH, 2013, P NATL ACAD SCI USA, V110, P543, DOI 10.1073/pnas.1214883110; van Bennekum A, 2005, BIOCHEMISTRY-US, V44, P4517, DOI 10.1021/bi0484320; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; Wei RR, 1998, NUTR CANCER, V30, P53, DOI 10.1080/01635589809514640; Wyss A, 2001, BIOCHEM J, V354, P521, DOI 10.1042/0264-6021:3540521	47	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6996	7007		10.1074/jbc.RA117.001646	http://dx.doi.org/10.1074/jbc.RA117.001646			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29567832	Green Published, hybrid			2022-12-26	WOS:000431487300030
J	Noh, MY; Muthukrishnan, S; Kramer, KJ; Arakane, Y				Noh, Mi Young; Muthukrishnan, Subbaratnam; Kramer, Karl J.; Arakane, Yasuyuki			Group I chitin deacetylases are essential for higher order organization of chitin fibers in beetle cuticle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA interference (RNAi); extracellular matrix; double-stranded RNA (dsRNA); electron microscopy (EM); immunohistochemistry; chitin deacetylase (CDA); elytron; pore canal; Tribolium castaneum	TRIBOLIUM-CASTANEUM; COLLETOTRICHUM-LINDEMUTHIANUM; PHYLOGENETIC ANALYSIS; PERITROPHIC MEMBRANE; DOMAIN ORGANIZATION; INSECT; MATRIX; DROSOPHILA; PROTEINS; BINDING	Roles in the organization of the cuticle (exoskeleton) of two chitin deacetylases (CDAs) belonging to group I, TcCDA1 and TcCDA2, as well as two alternatively spliced forms of the latter, TcCDA2a and TcCDA2b, from the red flour beetle, Tribolium castaneum, were examined in different body parts using transmission EM and RNAi. Even though all TcCDAs are co-expressed in cuticle-forming cells from the hardened forewing (elytron) and ventral abdomen, as well as in the softer hindwing and dorsal abdomen, there are significant differences in the tissue specificity of expression of the alternatively spliced transcripts. Loss of either TcCDA1 or TcCDA2 protein by RNAi causes abnormalities in organization of chitinous horizontal laminae and vertical pore canals in all regions of the procuticle of both the hard and soft cuticles. Simultaneous RNAi for TcCDA1 and TcCDA2 produces the most serious abnormalities. RNAi of either TcCDA2a or TcCDA2b affects cuticle integrity to some extent. Following RNAi, there is accumulation of smaller disorganized fibers in both the horizontal laminae and pore canals, indicating that TcCDAs play a critical role in elongation/organization of smaller nanofibers into longer fibers, which is essential for structural integrity of both hard/thick and soft/thin cuticles. Immunolocalization of TcCDA1 and TcCDA2 proteins and effects of RNAi on their accumulation indicate that these two proteins function in concert exclusively in the assembly zone in a step involving the higher order organization of the procuticle.	[Noh, Mi Young; Arakane, Yasuyuki] Chonnam Natl Univ, Dept Appl Biol, Gwangju 500757, South Korea; [Muthukrishnan, Subbaratnam; Kramer, Karl J.] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Arakane, Yasuyuki] Chonnam Natl Univ, Dept Forestry, Gwangju 500757, South Korea	Chonnam National University; Kansas State University; Chonnam National University	Arakane, Y (corresponding author), Chonnam Natl Univ, Dept Appl Biol, Gwangju 500757, South Korea.	arakane@chonnam.ac.kr			Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning Grant [NRF-2015R1A2A2A01006614]; National Research Foundation - Korea government (MSIT) [2018R1A2B6005106]; Basic Science Research Program through the National Research Foundation - Ministry of Education [NRF-2015R1A6A3A04060323]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning Grant; National Research Foundation - Korea government (MSIT); Basic Science Research Program through the National Research Foundation - Ministry of Education	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Science, ICT, and Future Planning Grant NRF-2015R1A2A2A01006614; by the National Research Foundation funded by the Korea government (MSIT) Grant 2018R1A2B6005106; and by the Basic Science Research Program through the National Research Foundation funded by Ministry of Education Grant NRF-2015R1A6A3A04060323 (to M. Y. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Arakane Y, 2003, INSECT BIOCHEM MOLEC, V33, P631, DOI 10.1016/S0965-1748(03)00049-3; Arakane Y, 2009, J BIOL CHEM, V284, P16584, DOI 10.1074/jbc.M901629200; Arakane Y, 2009, INSECT BIOCHEM MOLEC, V39, P355, DOI 10.1016/j.ibmb.2009.02.002; Aruchami M., 1986, P263; BANERJEE S, 1988, INT J INSECT MORPHOL, V17, P313, DOI 10.1016/0020-7322(88)90012-8; Beckham GT, 2011, J PHYS CHEM B, V115, P4516, DOI 10.1021/jp200912q; Blair DE, 2004, FEBS LETT, V570, P13, DOI 10.1016/j.febslet.2004.06.013; Chandran R, 2016, MICRON, V82, P74, DOI 10.1016/j.micron.2015.12.010; Dixit R, 2008, INSECT BIOCHEM MOLEC, V38, P440, DOI 10.1016/j.ibmb.2007.12.002; Fabritius HO, 2009, ADV MATER, V21, P391, DOI 10.1002/adma.200801219; GARDINER BG, 1979, ZOOL J LINN SOC-LOND, V66, P91, DOI 10.1111/j.1096-3642.1979.tb01903.x; Guo W, 2005, INSECT BIOCHEM MOLEC, V35, P1224, DOI 10.1016/j.ibmb.2005.06.003; HALISCAK JP, 1983, J ECON ENTOMOL, V76, P717, DOI 10.1093/jee/76.4.717; Heustis RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040426; Jakubowska AK, 2010, J VIROL, V84, P2547, DOI 10.1128/JVI.01860-09; Kang LX, 2012, J MICROBIOL BIOTECHN, V22, P1202, DOI 10.4014/jmb.1112.12026; Kaya M, 2017, CARBOHYD POLYM, V176, P177, DOI 10.1016/j.carbpol.2017.08.076; LOCKE M, 1979, TISSUE CELL, V11, P277, DOI 10.1016/0040-8166(79)90042-9; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Muthukrishnan S., 2016, EXTRACELLULAR COMPOS, P31, DOI DOI 10.1007/978-3-319-40740-1; NEVILLE AC, 1976, J CELL SCI, V21, P73; Noh MY, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007307; Noh MY, 2017, INSECT BIOCHEM MOLEC, V91, P21, DOI 10.1016/j.ibmb.2017.11.003; Noh MY, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004963; Noh MY, 2014, INSECT BIOCHEM MOLEC, V53, P22, DOI 10.1016/j.ibmb.2014.07.005; Pesch YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18340; Pesch YY, 2015, J BIOL CHEM, V290, P10071, DOI 10.1074/jbc.M114.614933; Qu MB, 2014, J PROTEOME RES, V13, P2931, DOI 10.1021/pr5000957; Tetreau G, 2015, INSECT BIOCHEM MOLEC, V62, P114, DOI 10.1016/j.ibmb.2015.01.006; Tokuyasu K, 1997, CARBOHYD RES, V303, P353, DOI 10.1016/S0008-6215(97)00166-3; Tomoyasu Y, 2009, CURR BIOL, V19, P2057, DOI 10.1016/j.cub.2009.11.014; Toprak U, 2008, INSECT MOL BIOL, V17, P573, DOI 10.1111/j.1365-2583.2008.00829.x; Tsigos I, 2000, TRENDS BIOTECHNOL, V18, P305, DOI 10.1016/S0167-7799(00)01462-1; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Xi Y, 2014, INSECT MOL BIOL, V23, P695, DOI 10.1111/imb.12113; Yu RR, 2016, J BIOL CHEM, V291, P24352, DOI 10.1074/jbc.M116.720581; Zhao Y, 2011, BIOTECHNOLOGY OF BIOPOLYMERS, P131; Zhao Y, 2010, MAR DRUGS, V8, P24, DOI 10.3390/md8010024; Zhong XW, 2014, INT J MOL SCI, V15, P1946, DOI 10.3390/ijms15021946	40	22	24	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2018	293	18					6985	6995		10.1074/jbc.RA117.001454	http://dx.doi.org/10.1074/jbc.RA117.001454			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GE8NB	29567838	hybrid, Green Published			2022-12-26	WOS:000431487300029
J	Asaf, S; Khan, AL; Khan, MA; Shahzad, R; Lubna; Kang, SM; Al-Harrasi, A; Al-Rawahi, A; Lee, IJ				Asaf, Sajjad; Khan, Abdul Latif; Khan, Muhammad Aaqil; Shahzad, Raheem; Lubna; Kang, Sang Mo; Al-Harrasi, Ahmed; Al-Rawahi, Ahmed; Lee, In-Jung			Complete chloroplast genome sequence and comparative analysis of loblolly pine (Pinus taeda L.) with related species	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; INVERTED REPEAT COPIES; PATERNAL INHERITANCE; MITOCHONDRIAL-DNA; PHYLOGENETIC-RELATIONSHIPS; GENE ORGANIZATION; PHYSICAL MAP; SEED PLANTS; GLYCINE-MAX; RED PINE	Pinaceae, the largest family of conifers, has a diversified organization of chloroplast (cp) genomes with two typical highly reduced inverted repeats (IRs). In the current study, we determined the complete sequence of the cp genome of an economically and ecologically important conifer tree, the loblolly pine (Pinus taeda L.), using Illumina paired-end sequencing and compared the sequence with those of other pine species. The results revealed a genome size of 121,531 base pairs (bp) containing a pair of 830-bp IR regions, distinguished by a small single copy (42,258 bp) and large single copy (77,614 bp) region. The chloroplast genome of P. taeda encodes 120 genes, comprising 81 protein-coding genes, four ribosomal RNA genes, and 35 tRNA genes, with 151 randomly distributed microsatellites. Approximately 6 palindromic, 34 forward, and 22 tandem repeats were found in the P. taeda cp genome. Whole cp genome comparison with those of other Pinus species exhibited an overall high degree of sequence similarity, with some divergence in intergenic spacers. Higher and lower numbers of indels and single-nucleotide polymorphism substitutions were observed relative to P. contorta and P. monophylla, respectively. Phylogenomic analyses based on the complete genome sequence revealed that 60 shared genes generated trees with the same topologies, and P. taeda was closely related to P. contorta in the subgenus Pinus. Thus, the complete P. taeda genome provided valuable resources for population and evolutionary studies of gymnosperms and can be used to identify related species.	[Asaf, Sajjad; Khan, Abdul Latif; Al-Harrasi, Ahmed; Al-Rawahi, Ahmed] Univ Nizwa, Omans Med Plants & Marine Nat Prod, Nizwa, Oman; [Khan, Muhammad Aaqil; Shahzad, Raheem; Kang, Sang Mo; Lee, In-Jung] Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea; [Lubna] Abdul Wali Khan Univ Mardan, Dept Bot, Garden Campus, Mardan, Pakistan; [Lee, In-Jung] Kyungpook Natl Univ, Res Inst Dok Do & Ulleung Do Isl, Daegu, South Korea	University of Nizwa; Kyungpook National University; Kyungpook National University	Lee, IJ (corresponding author), Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea.; Lee, IJ (corresponding author), Kyungpook Natl Univ, Res Inst Dok Do & Ulleung Do Isl, Daegu, South Korea.	ijlee@knu.ac.kr	Khan, Muhammad Aqil/ABB-9797-2021; Shahzad, Raheem/AAG-8370-2019; Lee, In-Jung/GLS-0432-2022; Asaf, Sajjad/ABA-3647-2021	Shahzad, Raheem/0000-0002-6594-8287; Lee, In-Jung/0000-0001-7154-4820; , Lubna/0000-0001-7869-7467; asaf, sajjad/0000-0001-8216-7549; Khan, Abdul Latif/0000-0001-9700-8903				Abe J, 1999, ECON BOT, V53, P285, DOI 10.1007/BF02866640; Akpinar BA, 2015, PLANT BIOTECHNOL J, V13, P740, DOI 10.1111/pbi.12302; Akpinar BA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10763; Ann W, 2007, MOL BIOL EVOL, V24, P90, DOI 10.1093/molbev/msl131; Asaf S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00304; Asaf S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00843; Asano T, 2004, DNA RES, V11, P93, DOI 10.1093/dnares/11.2.93; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; BIRKY CW, 1978, ANNU REV GENET, V12, P471, DOI 10.1146/annurev.ge.12.120178.002351; Bowe LM, 2000, P NATL ACAD SCI USA, V97, P4092, DOI 10.1073/pnas.97.8.4092; Cavalier-Smith T, 2002, CURR BIOL, V12, pR62, DOI 10.1016/S0960-9822(01)00675-3; Celinski K., 2016, CONSERV GENET, V9, P1; CHASE MW, 1993, ANN MO BOT GARD, V80, P528, DOI 10.2307/2399846; Chen JH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00447; CLARKE AK, 1994, PLANT MOL BIOL, V26, P851, DOI 10.1007/BF00028853; CLOSE PS, 1989, THEOR APPL GENET, V77, P768, DOI 10.1007/BF00268325; Cosner ME, 1997, CURR GENET, V31, P419, DOI 10.1007/s002940050225; Dagan T, 2013, GENOME BIOL EVOL, V5, P31, DOI 10.1093/gbe/evs117; Daniell H, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1004-2; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; DONG JS, 1994, GENETICS, V136, P1187; Downie S, 1992, MOL SYSTEMATICS PLAN, P14, DOI DOI 10.1007/978-1-4615-3276-7_2; DOYLE JJ, 1995, SYST BOT, V20, P272, DOI 10.2307/2419496; Duan RY, 2016, CONSERV GENET RESOUR, V8, P395, DOI 10.1007/s12686-016-0567-2; Echt CS, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-17; Echt CS, 1998, MOL ECOL, V7, P307, DOI 10.1046/j.1365-294X.1998.00350.x; Eckert AJ, 2006, MOL PHYLOGENET EVOL, V40, P166, DOI 10.1016/j.ympev.2006.03.009; Eckert AJ, 2010, GENETICS, V185, P969, DOI 10.1534/genetics.110.115543; Eckert AJ, 2009, TREE GENET GENOMES, V5, P225, DOI 10.1007/s11295-008-0183-8; Elsik CG, 2001, THEOR APPL GENET, V103, P1189, DOI 10.1007/s001220100725; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; Fang MF, 2016, MITOCHONDRIAL DNA A, V27, P2732, DOI 10.3109/19401736.2015.1046169; Farjon A, 2001, WORLD CHECKLIST BIBL; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Frederick WJ, 2008, BIORESOURCE TECHNOL, V99, P5051, DOI 10.1016/j.biortech.2007.08.086; Gao C-W, 2016, CONSERV GENET, P1; Gao L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-130; Gernandt DS, 2005, TAXON, V54, P29, DOI 10.2307/25065300; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Goremykin VV, 2004, MOL BIOL EVOL, V21, P1445, DOI 10.1093/molbev/msh147; Hao ZD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161809; Heather JM, 2016, GENOMICS, V107, P1, DOI 10.1016/j.ygeno.2015.11.003; HILDEBRAND M, 1988, P NATL ACAD SCI USA, V85, P372, DOI 10.1073/pnas.85.2.372; Hirao T, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-70; Hirata T, 1996, SOYBEAN GENETICS NEW; Do HDK, 2014, GENOME BIOL EVOL, V6, P1699, DOI 10.1093/gbe/evu138; Hohmann N, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0224-x; HONG YP, 1993, GENETICS, V135, P1187; Hu XS, 1997, HEREDITY, V79, P541, DOI 10.1038/hdy.1997.194; Huotari T, 2012, GENE, V508, P96, DOI 10.1016/j.gene.2012.07.020; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Jiao Y., 2017, NATURE; Johansson JT, 1999, PLANT SYST EVOL, V218, P133, DOI 10.1007/BF01087041; KANNO A, 1993, CURR GENET, V23, P166, DOI 10.1007/BF00352017; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KLUGE AG, 1989, SYST ZOOL, V38, P7, DOI 10.2307/2992432; KOHCHI T, 1988, CURR GENET, V14, P147, DOI 10.1007/BF00569338; Kondo T, 1998, BREEDING SCI, V48, P177; Kovach A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-420; Kraemer L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-41; Kuang DY, 2011, GENOME, V54, P663, DOI [10.1139/G11-026, 10.1139/g11-026]; Kugita M, 2003, NUCLEIC ACIDS RES, V31, P716, DOI 10.1093/nar/gkg155; Kumar S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-131; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; LAVIN M, 1990, EVOLUTION, V44, P390, DOI 10.1111/j.1558-5646.1990.tb05207.x; Leclercq S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-125; LEE DJ, 1992, THEOR APPL GENET, V85, P261, DOI 10.1007/BF00222868; Li XW, 2013, SCI CHINA LIFE SCI, V56, P189, DOI 10.1007/s11427-012-4430-8; Li ZH, 2016, MITOCHONDRIAL DNA A, V27, P2635, DOI 10.3109/19401736.2015.1041130; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LIDHOLM J, 1991, CURR GENET, V20, P161, DOI 10.1007/BF00312780; LIDHOLM J, 1988, MOL GEN GENET, V212, P6, DOI 10.1007/BF00322438; Liston A., 1995, USE POLYMERASE CHAIN; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lopez GG, 2002, INT J PLANT SCI, V163, P737, DOI 10.1086/342213; Lucas SJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1080; Mackay J, 2012, PLANT MOL BIOL, V80, P555, DOI 10.1007/s11103-012-9961-7; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; MCCAULEY DE, 1995, TRENDS ECOL EVOL, V10, P198, DOI 10.1016/S0169-5347(00)89052-7; Millar Constance L., 1998, P69; Miller Jr CN, 1973, SILICIFIED CONES VEG; Mogensen HL, 1996, AM J BOT, V83, P383, DOI 10.2307/2446172; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Morse AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004332; Morton BR, 1998, J MOL EVOL, V46, P449, DOI 10.1007/PL00006325; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; NEALE DB, 1989, THEOR APPL GENET, V77, P212, DOI 10.1007/BF00266189; NEALE DB, 1989, P NATL ACAD SCI USA, V86, P9347, DOI 10.1073/pnas.86.23.9347; Newton AC, 1999, TRENDS ECOL EVOL, V14, P140, DOI 10.1016/S0169-5347(98)01555-9; Nie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036869; Niu SH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-263; PALMER JD, 1981, P NATL ACAD SCI-BIOL, V78, P5533, DOI 10.1073/pnas.78.9.5533; PALMER JD, 1986, CURR GENET, V10, P823, DOI 10.1007/BF00418529; PALMER JD, 1982, CELL, V29, P537, DOI 10.1016/0092-8674(82)90170-2; Parkinson CL, 1999, CURR BIOL, V9, P1485, DOI 10.1016/S0960-9822(00)80119-0; Pauwels M, 2012, NEW PHYTOL, V193, P916, DOI 10.1111/j.1469-8137.2011.04003.x; Peterson DG, 2002, GENOME RES, V12, P795, DOI 10.1101/gr.226102; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; POWELL W, 1995, CURR BIOL, V5, P1023, DOI 10.1016/S0960-9822(95)00206-5; POWELL W, 1995, P NATL ACAD SCI USA, V92, P7759, DOI 10.1073/pnas.92.17.7759; Provan J, 1997, GENOME, V40, P104, DOI 10.1139/g97-014; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Qian J, 2013, PLOS ONE, V8; Raj M, 2005, SILVAE GENET, V54, P126, DOI 10.1515/sg-2005-0020; Raubeson L, 2005, CHLOROPLAST GENOMES, P45; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Resende MFR, 2012, NEW PHYTOL, V193, P617, DOI 10.1111/j.1469-8137.2011.03895.x; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rose O, 1998, MOL BIOL EVOL, V15, P613, DOI 10.1093/oxfordjournals.molbev.a025964; Saski C, 2005, PLANT MOL BIOL, V59, P309, DOI 10.1007/s11103-005-8882-0; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; SHIMADA H, 1991, NUCLEIC ACIDS RES, V19, P983, DOI 10.1093/nar/19.5.983; Shimamoto Y, 1992, SOYBEAN GENETICS NEW; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; SHOEMAKER RC, 1986, J HERED, V77, P26, DOI 10.1093/oxfordjournals.jhered.a110161; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Steane DA, 2005, DNA RES, V12, P215, DOI 10.1093/dnares/dsi006; Stewart JF, 2012, TREE GENET GENOMES, V8, P725, DOI 10.1007/s11295-011-0459-2; STRAUSS SH, 1988, P NATL ACAD SCI USA, V85, P3898, DOI 10.1073/pnas.85.11.3898; Sugiura C, 2004, PLANT J, V40, P314, DOI 10.1111/j.1365-313X.2004.02202.x; SUGIURA M, 1992, PLANT MOL BIOL, V19, P149, DOI 10.1007/BF00015612; SWOFFORD DL, 1993, J GEN PHYSIOL, V102, pA9; Syring J, 2005, AM J BOT, V92, P2086, DOI 10.3732/ajb.92.12.2086; SZMIDT AE, 1987, PLANT MOL BIOL, V9, P59, DOI 10.1007/BF00017987; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; TSUDZUKI J, 1992, MOL GEN GENET, V232, P206, DOI 10.1007/BF00279998; Tsuji S, 2007, J PLANT RES, V120, P281, DOI 10.1007/s10265-006-0055-y; TSUMURA Y, 1994, THEOR APPL GENET, V89, P922, DOI 10.1007/BF00224518; TSUMURA Y, 1993, THEOR APPL GENET, V86, P166, DOI 10.1007/BF00222075; UMESONO K, 1988, J MOL BIOL, V203, P299, DOI 10.1016/0022-2836(88)90002-2; Vasil IK, 1991, CELL CULTURE SOMAT A, V7a, P5, DOI DOI 10.1016/B978-0-12-715007-9.50009-8; Vieira LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090618; WAGNER DB, 1987, P NATL ACAD SCI USA, V84, P2097, DOI 10.1073/pnas.84.7.2097; Wakasugi T, 1996, P NATL ACAD SCI USA, V93, P8766, DOI 10.1073/pnas.93.16.8766; Wakasugi T, 1994, P NATL ACAD SCI USA, P91; Wambugu PW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13957; Wang XR, 1999, AM J BOT, V86, P1742, DOI 10.2307/2656672; Wegrzyn JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072439; WHITE EE, 1990, THEOR APPL GENET, V79, P119, DOI 10.1007/BF00223797; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wu CS, 2007, MOL BIOL EVOL, V24, P1366, DOI 10.1093/molbev/msm059; Wu CS, 2014, PLANT BIOTECHNOL J, V12, P344, DOI 10.1111/pbi.12141; Wu CS, 2011, GENOME BIOL EVOL, V3, P1284, DOI 10.1093/gbe/evr095; Wu CS, 2011, GENOME BIOL EVOL, V3, P309, DOI 10.1093/gbe/evr026; Wu ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118019; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yap JYS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128126; Yi X, 2013, GENOME BIOL EVOL, V5, P688, DOI 10.1093/gbe/evt042; Zheng WW, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071084; Zonneveld BJM, 2012, NORD J BOT, V30, P490, DOI 10.1111/j.1756-1051.2012.01516.x	157	32	33	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0192966	10.1371/journal.pone.0192966	http://dx.doi.org/10.1371/journal.pone.0192966			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596414	Green Published, Green Submitted, gold			2022-12-26	WOS:000428630000004
J	Borgeat, K; Niessen, SJM; Wilkie, L; Harrington, N; Church, DB; Fuentes, VL; Connolly, DJ				Borgeat, Kieran; Niessen, Stijn J. M.; Wilkie, Lois; Harrington, Norelene; Church, David B.; Fuentes, Virginia Luis; Connolly, David J.			Time spent with cats is never wasted: Lessons learned from feline acromegalic cardiomyopathy, a naturally occurring animal model of the human disease	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; CARDIOVASCULAR RISK-FACTORS; GROWTH-HORMONE; DIABETIC CATS; ECHOCARDIOGRAPHIC FINDINGS; SYSTEMIC HYPERTENSION; DOMESTIC CATS; HEART-FAILURE; I LEVELS; HYPERTHYROIDISM	Background In humans, acromegaly due to a pituitary somatotrophic adenoma is a recognized cause of increased left ventricular (LV) mass. Acromegalic cardiomyopathy is incompletely understood, and represents a major cause of morbidity and mortality. We describe the clinical, echocardiographic and histopathologic features of naturally occurring feline acromegalic cardiomyopathy, an emerging disease among domestic cats. Methods Cats with confirmed hypersomatotropism (IGF-1>1000ng/ml and pituitary mass; n = 67) were prospectively recruited, as were two control groups: diabetics (IGF-1<800ng/ml; n = 24) and healthy cats without known endocrinopathy or cardiovascular disease (n = 16). Echocardiography was performed in all cases, including after hypersomatotropism treatment where applicable. Additionally, tissue samples from deceased cats with hypersomatotropism, hypertrophic cardiomyopathy and age-matched controls (n = 21 each) were collected and systematically histopathologically reviewed and compared. Results By echocardiography, cats with hypersomatotropism had a greater maximum LV wall thickness (6.5mm, 4.1-10.1mm) than diabetic (5.9mm, 4.2-9.1mm; Mann Whitney, p<0.001) or control cats (5.2mm, 4.1-6.5mm; Mann Whitney, p<0.001). Left atrial diameter was also greater in cats with hypersomatotropism (16.6mm, 13.0-29.5mm) than in diabetic (15.4mm, 11.2-20.3mm; Mann Whitney, p<0.001) and control cats (14.0mm, 12.6-17.4mm; Mann Whitney, p<0.001). After hypophysectomy and normalization of IGF-1 concentration (n = 20), echocardiographic changes proved mostly reversible. As in humans, histopathology of the feline acromegalic heart was dominated by myocyte hypertrophy with interstitial fibrosis and minimal myofiber disarray. Conclusions These results demonstrate cats could be considered a naturally occurring model of acromegalic cardiomyopathy, and as such help elucidate mechanisms driving cardiovascular remodeling in this disease.	[Borgeat, Kieran; Niessen, Stijn J. M.; Wilkie, Lois; Church, David B.; Fuentes, Virginia Luis; Connolly, David J.] Royal Vet Coll, Clin Sci & Serv, Hatfield, Herts, England; [Borgeat, Kieran] Univ Bristol, Langford Vet Serv, Bristol, Avon, England; [Harrington, Norelene] Royal Vet Coll, Pathol & Pathogen Biol, Hatfield, Herts, England	University of London; University of London Royal Veterinary College; University of Bristol; University of London; University of London Royal Veterinary College	Borgeat, K (corresponding author), Royal Vet Coll, Clin Sci & Serv, Hatfield, Herts, England.; Borgeat, K (corresponding author), Univ Bristol, Langford Vet Serv, Bristol, Avon, England.	k.borgeat@bristol.ac.uk	Harrington, Norelene/AAQ-4669-2020; Borgeat, Kieran/W-9342-2019	Borgeat, Kieran/0000-0001-9199-4941				Baldelli R, 2000, J CLIN ENDOCR METAB, V85, P4099, DOI 10.1210/jc.85.11.4099; BOND BR, 1988, J AM VET MED ASSOC, V192, P1546; Brown S, 2007, J VET INTERN MED, V21, P542, DOI 10.1892/0891-6640(2007)21[542:GFTIEA]2.0.CO;2; Colao A, 2000, J CLIN ENDOCR METAB, V85, P193, DOI 10.1210/jc.85.1.193; Colao A, 2000, J CLIN ENDOCR METAB, V85, P3132, DOI 10.1210/jc.85.9.3132; Colao A, 2004, ENDOCR REV, V25, P102, DOI 10.1210/er.2002-0022; Colao A, 2002, EUR J ENDOCRINOL, V146, P303, DOI 10.1530/eje.0.1460303; Colao A, 1999, J CLIN ENDOCR METAB, V84, P17, DOI 10.1210/jc.84.1.17; Colao A, 2001, J CLIN ENDOCR METAB, V86, P1551, DOI 10.1210/jc.86.4.1551; Colao A, 2011, EUR J ENDOCRINOL, V165, P713, DOI 10.1530/EJE-11-0408; Colao A, 2009, J CLIN ENDOCR METAB, V94, P3746, DOI 10.1210/jc.2009-0941; Connolly DJ, 2005, J FELINE MED SURG, V7, P289, DOI 10.1016/j.jfms.2005.01.002; Dal J, 2016, EUR J ENDOCRINOL, V175, P181, DOI 10.1530/EJE-16-0117; Dekkers OM, 2008, J CLIN ENDOCR METAB, V93, P61, DOI 10.1210/jc.2007-1191; Dirtu AC, 2013, ENVIRON INT, V57-58, P60, DOI 10.1016/j.envint.2013.04.004; FAZIO S, 1993, EUR HEART J, V14, P26, DOI 10.1093/eurheartj/14.1.26; Fazio S, 1996, INTERNAL J ANGINA, V5, P55; Fazio S, J CLIN ENDOCRINOLOGY, V79, P441; Fieffe S, 2011, EUR J ENDOCRINOL, V164, P877, DOI 10.1530/EJE-10-1050; Fletcher JM, 2016, J VET INTERN MED, V30, P1216, DOI 10.1111/jvim.14360; Fox Philip R, 2003, J Vet Cardiol, V5, P39, DOI 10.1016/S1760-2734(06)70051-0; Fox PR, 2014, CARDIOVASC PATHOL, V23, P28, DOI 10.1016/j.carpath.2013.08.001; Fox PR, 2000, CIRCULATION, V102, P1863; FOX PR, 1995, CIRCULATION, V92, P2645, DOI 10.1161/01.CIR.92.9.2645; Fox PR, 1999, J AM ANIM HOSP ASSOC, V35, P27, DOI 10.5326/15473317-35-1-27; Fracassi F, 2016, J FELINE MED SURG OP; GALDERISI M, 1991, AM J CARDIOL, V68, P85, DOI 10.1016/0002-9149(91)90716-X; Gilbert J, 2003, Pituitary, V6, P11, DOI 10.1023/A:1026273509058; Gostelow R, 2017, J VET INTERN MED, V31, P355, DOI 10.1111/jvim.14662; JACOBS G, 1986, J AM VET MED ASSOC, V188, P52; Jaffrain-Rea ML, 2003, EUR J ENDOCRINOL, V148, P193, DOI 10.1530/eje.0.1480193; Kershaw O, 2012, J COMP PATHOL, V147, P73, DOI 10.1016/j.jcpa.2011.11.196; Keyte SV, 2016, J VET INTERN MED, V30, P973, DOI 10.1111/jvim.14373; Kittleson MD, 1999, CIRCULATION, V99, P3172, DOI 10.1161/01.CIR.99.24.3172; Lamb CR, 2014, J FELINE MED SURG, V16, P99, DOI 10.1177/1098612X13497212; LESSER M, 1992, J SMALL ANIM PRACT, V33, P55, DOI 10.1111/j.1748-5827.1992.tb01072.x; LIE JT, 1980, AM HEART J, V100, P41, DOI 10.1016/0002-8703(80)90277-X; Little CJL, 2008, J SMALL ANIM PRACT, V49, P17, DOI 10.1111/j.1748-5827.2007.00466.x; Liu CY, 2013, J AM COLL CARDIOL, V62, P1280, DOI 10.1016/j.jacc.2013.05.078; Liu S K, 1975, Recent Adv Stud Cardiac Struct Metab, V10, P627; LIU SK, 1984, J AM VET MED ASSOC, V185, P52; Lombardi G, 1996, METABOLISM, V45, P57, DOI 10.1016/S0026-0495(96)90083-9; Lombardi G, 2002, J ENDOCRINOL INVEST, V25, P971, DOI 10.1007/BF03344070; Maron BJ, 2015, J VET CARDIOL, V17, pS6, DOI 10.1016/j.jvc.2015.03.007; Maxie Grant M, 2007, PATHOLOGY DOMESTIC A, V3, P737; MCGUFFIN WL, 1974, ANN INTERN MED, V81, P11, DOI 10.7326/0003-4819-81-1-11; Meij BP, 2010, J FELINE MED SURG, V12, P406, DOI 10.1016/j.jfms.2010.03.014; Menaut P, 2012, J SMALL ANIM PRACT, V53, P673, DOI 10.1111/j.1748-5827.2012.01301.x; Mestron A, 2004, EUR J ENDOCRINOL, V151, P439, DOI 10.1530/eje.0.1510439; MOISE NS, 1986, AM J VET RES, V47, P1476; MOISE NS, 1986, AM J VET RES, V47, P1487; Murarka S, 2010, J CARD FAIL, V16, P971, DOI 10.1016/j.cardfail.2010.07.249; Myers JA, 2014, J VET INTERN MED, V28, P1235, DOI 10.1111/jvim.12386; Niessen SJM, 2007, J VET INTERN MED, V21, P899, DOI 10.1892/0891-6640(2007)21[899:FAAUE]2.0.CO;2; Niessen S, 2010, J FELINE MED SURG, V12, P15, DOI 10.1016/j.jfms.2009.12.003; Niessen SJM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127794; Niessen SJM, 2013, VET CLIN N AM-SMALL, V43, P319, DOI 10.1016/j.cvsm.2012.12.004; Nishiki M, 1997, ENDOCR J, V44, P655, DOI 10.1507/endocrj.44.655; Paige CF, 2009, JAVMA-J AM VET MED A, V234, P1398, DOI 10.2460/javma.234.11.1398; Payne JR, 2015, J VET CARDIOL, V17, pS244, DOI 10.1016/j.jvc.2015.03.008; Pereira AM, 2004, J CLIN ENDOCR METAB, V89, P71, DOI 10.1210/jc.2003-030849; Pereira NJ, 2017, VET J, V225, P50, DOI 10.1016/j.tvjl.2017.04.017; PETERSON ME, 1990, J VET INTERN MED, V4, P192, DOI 10.1111/j.1939-1676.1990.tb00897.x; PETERSON ME, 1983, J AM VET MED ASSOC, V183, P103; PIOVESAN A, 1994, HORM METAB RES, V26, P234, DOI 10.1055/s-2007-1001672; Pivonello R, 2007, J CLIN ENDOCR METAB, V92, P476, DOI 10.1210/jc.2006-1587; Posch B, 2011, VET RADIOL ULTRASOUN, V52, P422, DOI 10.1111/j.1740-8261.2011.01821.x; Rosca M, 2014, J FELINE MED SURG, V16, P82, DOI 10.1177/1098612X13496246; Rosol T., 2016, PATHOLOGY DOMESTIC A, P271; Sangster JK, 2014, J VET INTERN MED, V28, P465, DOI 10.1111/jvim.12259; Wagner Tobias, 2010, J Vet Cardiol, V12, P171, DOI 10.1016/j.jvc.2010.05.003; Weichselbaum RC, 2005, VET RADIOL ULTRASOUN, V46, P506, DOI 10.1111/j.1740-8261.2005.00099.x; Wilkie LJ, 2015, J VET CARDIOL, V17, pS329, DOI 10.1016/j.jvc.2015.09.006	73	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194342	10.1371/journal.pone.0194342	http://dx.doi.org/10.1371/journal.pone.0194342			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596445	gold, Green Published, Green Submitted			2022-12-26	WOS:000428630000022
J	Sun, YJ; Rajput, IR; Ying, H; Fei, Y; Sanganyado, E; Ping, L; Wang, JZ; Liu, WH				Sun Yajing; Rajput, Imran Rashid; Ying, Huang; Fei, Yu; Sanganyado, Edmond; Ping, Li; Wang Jingzhen; Liu Wenhua			Establishment and characterization of pygmy killer whale (Feresa attenuata) dermal fibroblast cell line	PLOS ONE			English	Article							MOUSE FIBROBLASTS; TUMOR-ANTIGEN; TRANSFORMATION; SKIN; CONSERVATION; GENERATION; NEURONS	The pygmy killer whale (Feresa attenuata) (PKW) is a tropical and subtropical marine mammal commonly found in the Atlantic, Indian and Pacific oceans. Since the PKWs live in offshore protected territories, they are rarely seen onshore. Hence, PKW are one of the most poorly understood oceanic species of odontocetes. The dermal tissue comes primarily from stranding events that occur along the coast of the Shantou, Guangdong, China. The sampled tissues were immediately processed and attached on collagen-coated 6-well tissue culture plate. The complete medium (DMEM and Ham's F12, fetal bovine serum, antibiotic and essential amino acids) was added to the culture plates. The primary culture (PKW-LWH) cells were verified as fibroblast by vimentin and karyotype analyses, which revealed 42 autosomes and two sex chromosomes X and Y. Following transfection of PKW-LWH cells with a plasmid encoding, the SV40 large T-antigens and the transfected cells were isolated and expanded. Using RT-PCR, western blot, immunofluorescence analysis and SV40 large T-antigen stability was confirmed. The cell proliferation rate of the fibroblast cells, PKW-LWHT was faster than the primary cells PKW-LWH with the doubling time 68.9h and 14.4h, respectively. In this study, we established PKW dermal fibroblast cell line for the first time, providing a unique opportunity for in vitro studies on the effects of environmental pollutants and pathogens that could be determined in PKW and/or Cetaceans.	[Sun Yajing; Rajput, Imran Rashid; Ying, Huang; Fei, Yu; Sanganyado, Edmond; Ping, Li; Liu Wenhua] Shantou Univ, Marine Biol Inst, Coll Sci, Shantou, Guangdong, Peoples R China; [Rajput, Imran Rashid] Lasbela Univ Agr Water & Marine Sci, Fac Vet & Anim Sci, Uthal, Balochistan, Pakistan; [Wang Jingzhen] Qinzhou Univ, Ocean Coll, Qinzhou, Guangxi, Peoples R China	Shantou University; Lasbela University of Agricultural Water & Marine Science; Beibu Gulf University	Rajput, IR; Liu, WH (corresponding author), Shantou Univ, Marine Biol Inst, Coll Sci, Shantou, Guangdong, Peoples R China.; Rajput, IR (corresponding author), Lasbela Univ Agr Water & Marine Sci, Fac Vet & Anim Sci, Uthal, Balochistan, Pakistan.	drimranrajput@gmail.com; whliu@stu.edu.cn	Sanganyado, Edmond/B-8542-2013; Wang, Jingzhen/F-7816-2018	Sanganyado, Edmond/0000-0001-6244-3059; Wang, Jingzhen/0000-0002-1293-8368; RASHID, IMRAN/0000-0002-3172-4541; Sun, Yajing/0000-0002-7650-2205				Auburger G, 2012, MOL NEUROBIOL, V46, P20, DOI 10.1007/s12035-012-8245-1; Baird RW, 2011, MARINE MAMMAL SCI, V27; Burkard M, 2015, AQUAT TOXICOL, V167, P240, DOI 10.1016/j.aquatox.2015.08.005; Chen W, 2003, HISTOL HISTOPATHOL, V18, P541, DOI 10.14670/HH-18.541; Donahue MA, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P938; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Heinzelmann L, 2009, J HERED, V100, P119, DOI 10.1093/jhered/esn064; Holt WV, 1999, REV REPROD, V4, P143, DOI 10.1530/revreprod/4.3.143; Huang SL, 2012, BIOL CONSERV, V147, P234, DOI 10.1016/j.biocon.2012.01.004; IUCN-UNEP-WWF, 1980, WORLD CONS STRAT LIV; Jin W, 2013, IN VITRO CELL DEV-AN, V49, P449, DOI 10.1007/s11626-013-9611-7; Leon-Quinto T, 2009, ANIM REPROD SCI, V112, P347, DOI 10.1016/j.anireprosci.2008.05.070; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Li X, 2015, CELL STEM CELL, V17, P195, DOI 10.1016/j.stem.2015.06.003; McSweeney DJ, 2009, MAR MAMMAL SCI, V25, P557, DOI 10.1111/j.1748-7692.2008.00267.x; Pennarossa G, 2014, STEM CELL REV REP, V10, P31, DOI 10.1007/s12015-013-9477-9; Pine M, 2004, AQUAT TOXICOL, V67, P195, DOI 10.1016/j.aquatox.2004.01.003; RICHARDS RG, 1995, BIOL REPROD, V52, P609, DOI 10.1095/biolreprod52.3.609; Rundell K, 2001, SEMIN CANCER BIOL, V11, P5, DOI 10.1006/scbi.2000.0341; Sakai D, 2004, SPINE, V29, P1515, DOI 10.1097/01.BRS.0000131419.25265.23; Sontag JM, 2006, CELL MOL LIFE SCI, V63, P2979, DOI 10.1007/s00018-006-6300-7; Stacey GN, 2008, NAT PROTOC, V3, P1981, DOI 10.1038/nprot.2008.190; Sutherland WJ, 2009, CONSERV BIOL, V23, P557, DOI 10.1111/j.1523-1739.2009.01212.x; Wade P.R., 1993, REPORTS INT WHALING, V43, P477; Wang JZ, 2011, IN VITRO CELL DEV-AN, V47, P618, DOI 10.1007/s11626-011-9448-x; Wang YX, 2017, STEM CELL REP, V8, P1587, DOI 10.1016/j.stemcr.2017.04.018; Wang YH, 2016, EXP CELL RES, V347, P283, DOI 10.1016/j.yexcr.2016.07.026; Whitworth DJ, 2012, STEM CELLS DEV, V21, P2288, DOI 10.1089/scd.2011.0608; Yi MS, 2010, NAT PROTOC, V5, P1418, DOI 10.1038/nprot.2010.104; Yu J, 2005, ANAT REC PART A, V287A, P1246, DOI 10.1002/ar.a.20266	30	15	16	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195128	10.1371/journal.pone.0195128	http://dx.doi.org/10.1371/journal.pone.0195128			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596530	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000428630000081
J	Pasqualini, FS; Agarwal, A; O'Connor, BB; Liu, QH; Sheehy, SP; Parker, KK				Pasqualini, Francesco Silvio; Agarwal, Ashutosh; O'Connor, Blakely Bussie; Liu, Qihan; Sheehy, Sean P.; Parker, Kevin Kit			Traction force microscopy of engineered cardiac tissues	PLOS ONE			English	Article							ON-A-CHIP; STEM-CELL; EXTRACELLULAR-MATRIX; HEART; CARDIOMYOCYTES; ELASTICITY; HYDROGELS; STIFFNESS; FIBROSIS; DEVICES	Cardiac tissue development and pathology have been shown to depend sensitively on microenvironmental mechanical factors, such as extracellular matrix stiffness, in both in vivo and in vitro systems. We present a novel quantitative approach to assess cardiac structure and function by extending the classical traction force microscopy technique to tissue-level preparations. Using this system, we investigated the relationship between contractile proficiency and metabolism in neonate rat ventricular myocytes (NRVM) cultured on gels with stiffness mimicking soft immature (1 kPa), normal healthy (13 kPa), and stiff diseased (90 kPa) cardiac microenvironments. We found that tissues engineered on the softest gels generated the least amount of stress and had the smallest work output. Conversely, cardiomyocytes in tissues engineered on healthy- and disease-mimicking gels generated significantly higher stresses, with the maximal contractile work measured in NRVM engineered on gels of normal stiffness. Interestingly, although tissues on soft gels exhibited poor stress generation and work production, their basal metabolic respiration rate was significantly more elevated than in other groups, suggesting a highly ineffective coupling between energy production and contractile work output. Our novel platform can thus be utilized to quantitatively assess the mechanotransduction pathways that initiate tissue-level structural and functional remodeling in response to substrate stiffness.	[Pasqualini, Francesco Silvio; Agarwal, Ashutosh; O'Connor, Blakely Bussie; Liu, Qihan; Sheehy, Sean P.; Parker, Kevin Kit] Harvard Univ, Wyss Inst Biol Inspired Engn, Dis Biophys Grp, Cambridge, MA 02138 USA; [Pasqualini, Francesco Silvio; Agarwal, Ashutosh; O'Connor, Blakely Bussie; Liu, Qihan; Sheehy, Sean P.; Parker, Kevin Kit] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Agarwal, Ashutosh] Univ Miami, Dept Biomed Engn, Miami, FL USA; [Agarwal, Ashutosh] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Agarwal, Ashutosh] Dr John T Macdonald Fdn, Biomed Nanotechnol Inst, Miami, FL USA	Harvard University; Harvard University; University of Miami; University of Miami	Parker, KK (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Dis Biophys Grp, Cambridge, MA 02138 USA.; Parker, KK (corresponding author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	kkparker@seas.harvard.edu	Pasqualini, Francesco/AAQ-5928-2021; Liu, Qihan/F-9044-2010; Liu, Qihan/AAY-5040-2020	Pasqualini, Francesco/0000-0001-7038-3121; Liu, Qihan/0000-0002-0907-4773; Parker, Kevin Kit/0000-0002-5968-7535; O'Connor, Blakely/0000-0003-0636-9514	NIH NCATS UH2 award [TR000522]; NIH NCATS UH3 award [TR000522]; DARPA [BM-11-73]; NSF Materials Research Science and Engineering Center (MRSEC) [DMR-1420570]; NSF [ECS-0335765]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH3TR000522] Funding Source: NIH RePORTER	NIH NCATS UH2 award; NIH NCATS UH3 award; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF Materials Research Science and Engineering Center (MRSEC)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The authors also acknowledge support from NIH NCATS UH2 and UH3 awards TR000522 "Human Cardiopulmonary System On-a-Chip" to KKP, DARPA BM-11-73 "Human Microphysiological Systems Program" to KKP, and NSF Materials Research Science and Engineering Center (MRSEC) grant DMR-1420570. This work was partially performed at the Harvard University Center for Nanoscale Systems (CNS), a member of the National Nanotechnology Infrastructure Network (NNIN), which is supported by NSF award ECS-0335765. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Prof. Megan McCain for valuable discussions and would like to thank Michael Rosnach for the figure illustrations. The authors also acknowledge support from NIH NCATS UH2 and UH3 awards TR000522 "Human Cardiopulmonary System-On-a-Chip," DARPA BAA-11- 73 "Human Microphysiological Systems Program," and NSF Materials Research Science and Engineering Center (MRSEC) grant DMR-1420570. Parts of this work were performed at the Harvard University Center for Nanoscale Systems (CNS), a member of the National Nanotechnology Infrastructure Network (NNIN), which is supported by NSF award ECS-0335765. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Abaci HE, 2015, INTEGR BIOL-UK, V7, P383, DOI 10.1039/c4ib00292j; Agarwal A, 2013, LAB CHIP, V13, P3599, DOI 10.1039/c3lc50350j; Annoni G, 1998, MECH AGEING DEV, V101, P57, DOI 10.1016/S0047-6374(97)00165-6; Aratyn-Schaus Y, 2016, J CELL BIOL, V212, P389, DOI 10.1083/jcb.201508026; Ariyasinghe NR, 2017, INTEGR BIOL-UK, V9, P730, DOI 10.1039/c7ib00081b; Baillargeon B, 2014, EUR J MECH A-SOLID, V48, P38, DOI 10.1016/j.euromechsol.2014.04.001; Banerjee S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.108101; Broeckel U, 2016, CELL STEM CELL, V19, P282, DOI 10.1016/j.stem.2016.08.016; Chabiniok R, 2016, INTERFACE FOCUS, V6, DOI 10.1098/rsfs.2015.0083; Chaudhuri O, 2017, BIOMATER SCI-UK, V5, P1480, DOI 10.1039/c7bm00261k; Dabiri GA, 1997, P NATL ACAD SCI USA, V94, P9493, DOI 10.1073/pnas.94.17.9493; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Genet M, 2016, ANN BIOMED ENG, V44, P112, DOI 10.1007/s10439-015-1351-2; Grosberg A, 2011, LAB CHIP, V11, P4165, DOI 10.1039/c1lc20557a; Grosberg A, 2009, BIOINSPIR BIOMIM, V4, DOI 10.1088/1748-3182/4/2/026003; Grosberg A, 2009, J THEOR BIOL, V257, P359, DOI 10.1016/j.jtbi.2008.11.022; Grosberg A, 2009, MED BIOL ENG COMPUT, V47, P301, DOI 10.1007/s11517-008-0431-y; Han SJ, 2015, NAT METHODS, V12, P653, DOI [10.1038/NMETH.3430, 10.1038/nmeth.3430]; Hazeltine Laurie B, 2012, Int J Cell Biol, V2012, P508294, DOI 10.1155/2012/508294; Hinson JT, 2015, SCIENCE, V349, P982, DOI 10.1126/science.aaa5458; Jacot JG, 2010, ANN NY ACAD SCI, V1188, P121, DOI 10.1111/j.1749-6632.2009.05091.x; Lee LC, 2015, BIOMECH MODEL MECHAN, V14, P217, DOI 10.1007/s10237-014-0598-0; Lind JU, 2017, NAT MATER, V16, P303, DOI [10.1038/NMAT4782, 10.1038/nmat4782]; Lyra-Leite DM, 2017, AM J PHYSIOL-HEART C, V313, pH757, DOI 10.1152/ajpheart.00290.2017; Maass C, 2017, INTEGR BIOL-UK, V9, P290, DOI 10.1039/c6ib00243a; McCain ML, 2014, AM J PHYSIOL-HEART C, V306, pH1525, DOI 10.1152/ajpheart.00799.2013; McCain ML, 2014, BIOMATERIALS, V35, P5462, DOI 10.1016/j.biomaterials.2014.03.052; McCain ML, 2013, P NATL ACAD SCI USA, V110, P9770, DOI 10.1073/pnas.1304913110; McCain ML, 2012, P NATL ACAD SCI USA, V109, P9881, DOI 10.1073/pnas.1203007109; Merkel R, 2007, BIOPHYS J, V93, P3314, DOI 10.1529/biophysj.107.111328; Mertz AF, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.198101; Nam S, 2016, P NATL ACAD SCI USA, V113, P5492, DOI 10.1073/pnas.1523906113; Park SJ, 2016, SCIENCE, V353, P158, DOI 10.1126/science.aaf4292; Parker KK, 2007, PHILOS T R SOC B, V362, P1267, DOI 10.1098/rstb.2007.2114; Pasqualini FS, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4081638; Pasqualini FS, 2015, STEM CELL REP, V4, P340, DOI 10.1016/j.stemcr.2015.01.020; Ribeiro AJS, 2016, METHODS, V94, P51, DOI 10.1016/j.ymeth.2015.08.005; Ribeiro AJS, 2015, P NATL ACAD SCI USA, V112, P12705, DOI 10.1073/pnas.1508073112; Schoen I, 2010, NANO LETT, V10, P1823, DOI 10.1021/nl100533c; Shapira-Schweitzer K, 2007, ACTA BIOMATER, V3, P33, DOI 10.1016/j.actbio.2006.09.003; Sheehy SP, 2014, STEM CELL REP, V2, P282, DOI 10.1016/j.stemcr.2014.01.015; Sheehy SP, 2017, EXPT BIOL MED; Smith NP, 2005, PROG BIOPHYS MOL BIO, V88, P1, DOI 10.1016/j.pbiomolbio.2003.11.014; Stokes CL, 2015, CPT-PHARMACOMET SYST, V4, P559, DOI 10.1002/psp4.12042; Tang X, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003631; Tiburcy M, 2017, CIRCULATION; van Heerebeek L, 2008, CIRCULATION, V117, P43, DOI 10.1161/CIRCULATIONAHA.107.728550; VILLARI B, 1993, J AM COLL CARDIOL, V22, P1477, DOI 10.1016/0735-1097(93)90560-N; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Wikswo JP, 2013, LAB CHIP, V13, P3496, DOI 10.1039/c3lc50243k; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566	52	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194706	10.1371/journal.pone.0194706	http://dx.doi.org/10.1371/journal.pone.0194706			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590169	Green Published, gold, Green Submitted			2022-12-26	WOS:000428603100071
J	Peressotti, F; Scaltritti, M; Miozzo, M				Peressotti, Francesca; Scaltritti, Michele; Miozzo, Michele			Can sign language make you better at hand processing?	PLOS ONE			English	Article							SIMON; ATTENTION; GAZE; DEAF	The languages developed by deaf communities are unique for using visual signs produced by the hand. In the present study, we explored the cognitive effects of employing the hand as articulator. We focused on the arbitrariness of the form-meaning relationship a fundamental feature of natural languages and asked whether sign languages change the processing of arbitrary non-linguistic stimulus-response (S-R) associations involving the hand. This was tested using the Simon effect, which specifically requires such type of associations. Differences between signers and speakers (non-signers) only appeared in the Simon task when hand stimuli were shown. Response-time analyses revealed that the distinctiveness of signers' responses derived from an increased ability to process memory traces of arbitrary S-R pairs related to the hand. These results shed light on the interplay between language and cognition as well as on the effects of sign language acquisition.	[Peressotti, Francesca] Univ Padua, Dipartimento Psicol Sviluppo & Socializzaz, Padua, Italy; [Scaltritti, Michele] Univ Trento, Dipartimento Psicol & Sci Cognit, Rovereto, Italy; [Miozzo, Michele] New Sch Social Res, Dept Psychol, New York, NY 10011 USA	University of Padua; University of Trento; The New School	Peressotti, F (corresponding author), Univ Padua, Dipartimento Psicol Sviluppo & Socializzaz, Padua, Italy.	francesca.peressani@unipd.it	Peressotti, Francesca/AAB-7795-2022	Peressotti, Francesca/0000-0002-2425-9231	University of Padua [CPDA143734/14]	University of Padua	This research was supported by a grant from the University of Padua (CPDA143734/14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the personnel of the Istituto Magarotto, and particularly to Arianna Caccaro, for having facilitated the testing of the deaf participants. We also want to acknowledge the help of Anna Cacciavillani with data collection, and the comments received by Victoria Shuster and Carlo Umilta. This research was supported by a grant from the University of Padua (CPDA143734/14).	Ansorge U, 2003, VIS COGN, V10, P363, DOI 10.1080/13506280244000122; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bavelier D, 2001, J NEUROSCI, V21, P8931, DOI 10.1523/JNEUROSCI.21-22-08931.2001; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; Bettger J, 1997, J Deaf Stud Deaf Educ, V2, P223; Dalmaso M, 2013, NEUROPSYCHOLOGY, V27, P608, DOI 10.1037/a0033518; De Saussure F., 2011, COURSE GEN LINGUISTI; Dye MWG, 2016, EXP BRAIN RES, V234, P1067, DOI 10.1007/s00221-015-4530-3; EMMOREY K, 1993, COGNITION, V46, P139, DOI 10.1016/0010-0277(93)90017-P; Fox J., 2018, R COMPANION APPL REG, VThird; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; Hommel B, 2011, ACTA PSYCHOL, V136, P189, DOI 10.1016/j.actpsy.2010.04.011; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; LU CH, 1995, PSYCHON B REV, V2, P174, DOI 10.3758/BF03210959; MacSweeney M, 2004, NEUROIMAGE, V22, P1605, DOI 10.1016/j.neuroimage.2004.03.015; Masaki H, 2000, PSYCHOPHYSIOLOGY, V37, P464, DOI 10.1017/S0048577200981976; Masson MEJ, 2013, J EXP PSYCHOL LEARN, V39, P898, DOI 10.1037/a0029180; Miozzo M, 2016, COGNITION, V154, P69, DOI 10.1016/j.cognition.2016.05.008; Newman AJ, 2002, NAT NEUROSCI, V5, P76, DOI 10.1038/nn775; Nishimura A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00219; Praamstra P, 1999, NEUROREPORT, V10, P3671, DOI 10.1097/00001756-199911260-00038; R Core Team, 2021, R LANGUAGE ENV STAT; Sakai KL, 2005, BRAIN, V128, P1407, DOI 10.1093/brain/awh465; Sandler W, 2006, SIGN LANGUAGE AND LINGUISTIC UNIVERSALS, P1, DOI 10.2277/ 0521483956; Siple Patricia, 1990, THEORETICAL ISSUES S, V1, P191, DOI DOI 10.1007/978-94-011-3468-2; Stokoe WC, 2005, J DEAF STUD DEAF EDU, V10, P3, DOI 10.1093/deafed/eni001; Sturmer B, 2002, J EXP PSYCHOL HUMAN, V28, P1345, DOI 10.1037//0096-1523.28.6.1345; UMILTA C, 1990, ADV PSYCHOL, V65, P89, DOI DOI 10.1016/S0166-4115(08)61; Zorzi M, 2003, PSYCHON B REV, V10, P423, DOI 10.3758/BF03196501	29	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194771	10.1371/journal.pone.0194771	http://dx.doi.org/10.1371/journal.pone.0194771			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590204	gold, Green Submitted, Green Published			2022-12-26	WOS:000428603100073
J	Rahimi, F; Rasekh, HR; Abbasian, E; Peiravian, F; Etemadifar, M; Ashtari, F; Sabzghabaee, AM; Amirsadri, MR				Rahimi, Farimah; Rasekh, Hamid Reza; Abbasian, Ezatollah; Peiravian, Farzad; Etemadifar, Masoud; Ashtari, Fereshteh; Sabzghabaee, Ali Mohammad; Amirsadri, Mohammad Reza			Patient preferences for Interferon-beta in Iran: A discrete choice experiment	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; ECONOMIC-EVALUATION; CONJOINT-ANALYSIS; HEALTH; THERAPY	Multiple sclerosis is a chronic, progressive, and common disease affecting the central nervous system in young adults. Interferon-beta is one of the most widely used medicines to reduce the disease progression. Given the variety of drugs in this category, we aimed to identify the preferences of patients for IFN-beta that play an important role in policymaking in this area. Discrete choice experiment method was used in the present study to identify and prioritize those attributes that are of interest to MS patients and increases the utility of the use of IFN-beta in their treatment. Questionnaires were given to 358 patients in Isfahan-Iran, who were asked to choose between the two treatment choices in each scenario. The results of the logit model showed that the changes in the efficacy lead to the most changes in the patient utility. Changes in side effects and ease of injection have been placed in the next rankings. Considering the drug attributes considered more desirable by patients can lead to greater medication adherence and possibly better treatment outcomes. Also, pharmaceutical companies, the health ministry, the Food and Drug Administration, insurance organizations, and neurologists can benefit from this information in production and importation, policymaking, and prescription.	[Rahimi, Farimah] Isfahan Univ Med Sci, Hlth Management & Econ Res Ctr, Esfahan, Iran; [Rahimi, Farimah; Rasekh, Hamid Reza; Peiravian, Farzad] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Pharmacoecon & Pharmaceut Management, Tehran, Iran; [Abbasian, Ezatollah] Bu Ali Sina Univ, Dept Econ, Hamadan, Iran; [Etemadifar, Masoud; Ashtari, Fereshteh] Isfahan Univ Med Sci, Med Sch, Dept Neurol, Esfahan, Iran; [Sabzghabaee, Ali Mohammad] Isfahan Univ Med Sci, Isfahan Clin Toxicol Res Ctr, Esfahan, Iran; [Amirsadri, Mohammad Reza] Isfahan Univ Med Sci, Sch Pharm & Pharmaceut & Hlth Management & Econ S, Dept Clin Pharm & Pharm Practice, Esfahan, Iran	Isfahan University Medical Science; Shahid Beheshti University Medical Sciences; Bu Ali Sina University; Isfahan University Medical Science; Isfahan University Medical Science; Isfahan University Medical Science	Rahimi, F (corresponding author), Isfahan Univ Med Sci, Hlth Management & Econ Res Ctr, Esfahan, Iran.; Rahimi, F (corresponding author), Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Pharmacoecon & Pharmaceut Management, Tehran, Iran.	Farimah.Rahimi@gmail.com	Sabzghabaee, Alimohammad/AAE-7584-2020; abbasian, ezatollah/X-6077-2019; Rahimi, Farimeh/V-7494-2018	abbasian, ezatollah/0000-0001-8364-6461; Rahimi, Farimeh/0000-0001-5745-1839				Alpizar F., 2003, EC ISSUES, V8, P83; Asgari A, 2015, BIOMEDICAL PHARM J M, V8, P105; Bridges JFP, 2005, PHARMACOECONOMICS, V23, P317, DOI 10.2165/00019053-200523040-00002; Bridges JFP, 2011, VALUE HEALTH, V14, P403, DOI 10.1016/j.jval.2010.11.013; Cary N, 2012, DESIGN EXPT GUIDE; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; de Vries ST, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139755; Ebrahimi HA, 2013, NEUROL ASIA, V18, P385; Eskandarieh S, PREVALENCE INCIDENCE; Etemadifar M, 2013, EUR NEUROL, V70, P356, DOI 10.1159/000355140; Gerard K, 2005, FAM PRACT, V22, P28, DOI 10.1093/fampra/cmh623; Goverover Y, 2017, CHANGES IN THE BRAIN, P145, DOI [10.1007/978-0-387-98188-8_7, DOI 10.1007/978-0-387-98188-8_7]; Gries KS, 2016, APPL HEALTH ECON HEA, P1; Helter TM, 2016, J SUBST USE, V21, P662, DOI 10.3109/14659891.2015.1118563; Lloyd A, 2011, CLIN THER, V33, P1258, DOI 10.1016/j.clinthera.2011.07.017; Mansfield C, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.150433; Neumann PJ, 2000, ANNU REV PUBL HEALTH, V21, P587, DOI 10.1146/annurev.publhealth.21.1.587; Pinto SL, 2009, RES SOC ADMIN PHARM, V5, P253, DOI 10.1016/j.sapharm.2008.10.001; Poulos C, 2016, THERAPEUTIC ADV NEUR; Poulos C, 2016, PATIENT, V9, P171, DOI 10.1007/s40271-015-0136-x; Ryan M, 2000, BMJ-BRIT MED J, V320, P1530, DOI 10.1136/bmj.320.7248.1530; Ryan Mandy, 2003, Appl Health Econ Health Policy, V2, P55; Shah SA, 2016, J SOC OBSTET GYNAECO, V6, P106; Shingler S L, 2013, J Med Econ, V16, P1036, DOI 10.3111/13696998.2013.811079; Stewart KD, 2016, PATIENT PREFER ADHER, V10, P1385, DOI 10.2147/PPA.S101821; Utz KS, 2014, THER ADV NEUROL DISO, V7, P263, DOI 10.1177/1756285614555335; WHO. World Health Organization, 2013, MULT SCLER INT FED A; Wicks P, 2015, INTERACT J MED RES, V4, P3, DOI 10.2196/ijmr.3776; Wilson L, 2014, J NEUROL SCI, V344, P80, DOI 10.1016/j.jns.2014.06.030; Witney AG, 2006, RHEUMATOLOGY, V45, P975, DOI 10.1093/rheumatology/kel027; Zare N, 2013, J KOREAN MED SCI, V28, P1801, DOI 10.3346/jkms.2013.28.12.1801	31	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193090	10.1371/journal.pone.0193090	http://dx.doi.org/10.1371/journal.pone.0193090			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590134	Green Published, gold			2022-12-26	WOS:000428603100013
J	Ahmadizadeh, S; Karoly, PJ; Nesic, D; Grayden, DB; Cook, MJ; Soudry, D; Freestone, DR				Ahmadizadeh, Saeed; Karoly, Philippa J.; Nesic, Dragan; Grayden, David B.; Cook, Mark J.; Soudry, Daniel; Freestone, Dean R.			Bifurcation analysis of two coupled Jansen-Rit neural mass models	PLOS ONE			English	Article							SYNCHRONIZATION; WILSON; EEG; GENERATION; EPILEPSY; NETWORK	We investigate how changes in network structure can lead to pathological oscillations similar to those observed in epileptic brain. Specifically, we conduct a bifurcation analysis of a network of two Jansen-Rit neural mass models, representing two cortical regions, to investigate different aspects of its behavior with respect to changes in the input and interconnection gains. The bifurcation diagrams, along with simulated EEG time series, exhibit diverse behaviors when varying the input, coupling strength, and network structure. We show that this simple network of neural mass models can generate various oscillatory activities, including delta wave activity, which has not been previously reported through analysis of a single Jansen-Rit neural mass model. Our analysis shows that spike-wave discharges can occur in a cortical region as a result of input changes in the other region, which may have important implications for epilepsy treatment. The bifurcation analysis is related to clinical data in two case studies.	[Ahmadizadeh, Saeed; Nesic, Dragan] Univ Melbourne, Dept Elect & Elect Engn, Melbourne, Vic, Australia; [Karoly, Philippa J.; Grayden, David B.] Univ Melbourne, Dept Biomed Engn, Melbourne, Vic, Australia; [Grayden, David B.; Cook, Mark J.; Freestone, Dean R.] Univ Melbourne, St Vincents Hosp Melbourne, Dept Med, Melbourne, Vic, Australia; [Soudry, Daniel; Freestone, Dean R.] Columbia Univ, Dept Stat, New York, NY 10027 USA; [Grayden, David B.] Univ Melbourne, Ctr Neural Engn, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; Columbia University; University of Melbourne	Freestone, DR (corresponding author), Univ Melbourne, St Vincents Hosp Melbourne, Dept Med, Melbourne, Vic, Australia.; Freestone, DR (corresponding author), Columbia Univ, Dept Stat, New York, NY 10027 USA.	deanrf@unimelb.edu.au	Karoly, Philippa/ABC-9135-2021; Karoly, Philippa Jane/AAG-1544-2020; Grayden, David B/L-5782-2018; Cook, Mark/A-7096-2010	Karoly, Philippa/0000-0002-9879-5854; Karoly, Philippa Jane/0000-0002-9879-5854; Grayden, David B/0000-0002-5497-7234; Cook, Mark/0000-0002-8875-4135; Freestone, Dean/0000-0003-2411-5358				Ahmadizadeh S, 2017, LINEAR ALGEBRA APPL, V530, P541, DOI 10.1016/j.laa.2017.06.023; Ahmadizadeh S, 2017, LINEAR ALGEBRA APPL, V523, P281, DOI 10.1016/j.laa.2017.02.029; Ahmadizadeh S, 2016, AUTOMATICA, V71, P169, DOI 10.1016/j.automatica.2016.04.030; Ahmadizadeh S, 2015, IEEE DECIS CONTR P, P3104, DOI 10.1109/CDC.2015.7402686; Badawy RAB, 2012, NEUROSCIENCE, V222, P89, DOI 10.1016/j.neuroscience.2012.07.015; Bettus G, 2008, EPILEPSY RES, V81, P58, DOI 10.1016/j.eplepsyres.2008.04.020; BEURLE RL, 1956, PHILOS T ROY SOC B, V240, P55, DOI 10.1098/rstb.1956.0012; Breakspear M, 2006, CEREB CORTEX, V16, P1296, DOI 10.1093/cercor/bhj072; Campbell S, 1996, IEEE T NEURAL NETWOR, V7, P541, DOI 10.1109/72.501714; Cook MJ, 2013, LANCET NEUROL, V12, P563, DOI 10.1016/S1474-4422(13)70075-9; David O, 2003, NEUROIMAGE, V20, P1743, DOI 10.1016/j.neuroimage.2003.07.015; David O, 2006, NEUROIMAGE, V30, P1255, DOI 10.1016/j.neuroimage.2005.10.045; FitzHugh R., 1955, B MATH BIOPHYS, V17, P257, DOI [10.1007/BF02477753, DOI 10.1007/BF02477753, 10.1007/bf02477753]; Freestone DR, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00383; Freyer F, 2011, J NEUROSCI, V31, P6353, DOI 10.1523/JNEUROSCI.6693-10.2011; Geng S, 2014, BIOL CYBERN, P1; Genz A, 2004, STAT COMPUT, V14, P251, DOI 10.1023/B:STCO.0000035304.20635.31; Govaerts W, 2011, TECH REP; Grimbert F, 2006, NEURAL COMPUT, V18, P3052, DOI 10.1162/neco.2006.18.12.3052; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Holliday Stephen L, 2003, Neurology, V60, pE3; Huang G, 2011, NEUROCOMPUTING, V74, P1026, DOI 10.1016/j.neucom.2010.11.019; JANSEN BH, 1995, BIOL CYBERN, V73, P357, DOI 10.1007/BF00199471; Jedynak M., 2017, COUPLING STOCHASTICI; Jedynak M, 2017, ARXIV170703812; Jirsa VK, 2014, BRAIN, V137, P2210, DOI 10.1093/brain/awu133; Julier S.J., 1997, P AEROSENSE 11 INT S; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Kuznetsov Yu. A., 2004, ELEMENTS APPL BIFURC, Vthird; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lopes da Silva F H, 1976, Prog Brain Res, V45, P281; Merrison-Hort R, 2013, J MATH NEUROSCI, V3, DOI 10.1186/2190-8567-3-14; SHILNIKOV AL, 1993, PHYSICA D, V62, P338, DOI 10.1016/0167-2789(93)90292-9; Spiegler A, 2010, NEUROIMAGE, V52, P1041, DOI 10.1016/j.neuroimage.2009.12.081; Terry JR, 2012, EPILEPSIA, V53, pe166, DOI 10.1111/j.1528-1167.2012.03560.x; Touboul J, 2011, NEURAL COMPUT, V23, P3232, DOI 10.1162/NECO_a_00206; Wendling F, 2000, BIOL CYBERN, V83, P367, DOI 10.1007/s004220000160; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5	38	13	13	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0192842	10.1371/journal.pone.0192842	http://dx.doi.org/10.1371/journal.pone.0192842			51	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584728	Green Published, Green Submitted, gold			2022-12-26	WOS:000428373000003
J	Loas, G; Lefebvre, G; Rotsaert, M; Englert, Y				Loas, Gwenole; Lefebvre, Guillaume; Rotsaert, Marianne; Englert, Yvon			Relationships between anhedonia, suicidal ideation and suicide attempts in a large sample of physicians	PLOS ONE			English	Article							DEPRESSION; BEHAVIOR; SCHIZOPHRENIA; EXPERIENCES; VALIDATION; PSYCHOLOGY; PREDICTION; COMPONENTS; INPATIENTS; DISORDERS	Background The relationships between anhedonia and suicidal ideation or suicide attempts were explored in a large sample of physicians using the interpersonal psychological theory of suicide. We tested two hypotheses: firstly, that there is a significant relationship between anhedonia and suicidality and, secondly, that anhedonia could mediate the relationships between suicidal ideation or suicide attempts and thwarted belongingness or perceived burdensomeness. Methods In a cross-sectional study, 557 physicians filled out several questionnaires measuring suicide risk, depression, using the abridged version of the Beck Depression Inventory (BDI-13), and demographic and job-related information. Ratings of anhedonia, perceived burdensomeness and thwarted belongingness were then extracted from the BDI-13 and the other questionnaires. Results Significant relationships were found between anhedonia and suicidal ideation or suicide attempts, even when significant variables or covariates were taken into account and, in particular, depressive symptoms. Mediation analyses showed significant partial or complete mediations, where anhedonia mediated the relationships between suicidal ideation (lifetime or recent) and perceived burdensomeness or thwarted belongingness. For suicide attempts, complete mediation was found only between anhedonia and thwarted belongingness. When the different components of anhedonia were taken into account, dissatisfaction not the loss of interest or work inhibition had significant relationships with suicidal ideation, whereas work inhibition had significant relationships with suicide attempts. Conclusions Anhedonia and its component of dissatisfaction could be a risk factor for suicidal ideation and could mediate the relationship between suicidal ideation and perceived burdensomeness or thwarted belongingness in physicians. Dissatisfaction, in particular in the workplace, may be explored as a strong predictor of suicidal ideation in physicians.	[Loas, Gwenole] ULB, Dept Psychiat, Brussels, Belgium; ULB, Clin Univ Bruxelles, Lab Psychiat Res ULB 266, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles	Loas, G (corresponding author), ULB, Dept Psychiat, Brussels, Belgium.	Gwenole.Loas@erasme.ulb.ac.be		loas, gwenole/0000-0003-1719-916X				Auerbach RP, 2015, J AFFECT DISORDERS, V186, P127, DOI 10.1016/j.jad.2015.06.031; Ballard ED, 2016, BIPOLAR DISORD, V18, P363, DOI 10.1111/bdi.12397; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Carpenter LM, 1997, OCCUP ENVIRON MED, V54, P388, DOI 10.1136/oem.54.6.388; Chew-Graham CA, 2003, MED EDUC, V37, P873, DOI 10.1046/j.1365-2923.2003.01627.x; Cornette MM, 2009, ARCH SUICIDE RES, V13, P1, DOI 10.1080/13811110802571801; Ducasse D, 2017, DEPRESS ANXIETY, P1; EPSTEIN LC, 1973, J NERV MENT DIS, V156, P19, DOI 10.1097/00005053-197301000-00002; FAWCETT J, 1990, AM J PSYCHIAT, V147, P1189; Fenton WS, 1997, AM J PSYCHIAT, V154, P199; Fink-Miller EL, 2015, PSYCHIAT RES, V229, P143, DOI 10.1016/j.psychres.2015.07.055; Fink-Miller EL, 2015, SUICIDE LIFE-THREAT, V45, P488, DOI 10.1111/sltb.12147; Frank E, 1999, AM J PSYCHIAT, V156, P1887; Gard DE, 2006, J RES PERS, V40, P1086, DOI 10.1016/j.jrp.2005.11.001; Gold KJ, 2013, GEN HOSP PSYCHIAT, V35, P45, DOI 10.1016/j.genhosppsych.2012.08.005; Golding S, 2015, J CLIN SLEEP MED, V11, P1385, DOI 10.5664/jcsm.5270; Hikiji W, 2014, J FORENSIC LEG MED, V22, P37, DOI 10.1016/j.jflm.2013.12.022; Joiner TE, 2005, ANNU REV PSYCHOL, V56, P287, DOI 10.1146/annurev.psych.56.091103.070320; Joiner TE, 2003, PSYCHIAT RES, V119, P243, DOI 10.1016/S0165-1781(03)00131-8; Joormann J, 2010, COGNITION EMOTION, V24, P281, DOI 10.1080/02699930903407948; Kleiman EM, 2014, COMPR PSYCHIAT, V55, P431, DOI 10.1016/j.comppsych.2013.10.015; Lapyte A, 2015, ANN PSYCHIAT MENTAL, V3, P8; Leventhal AM, 2006, J CLIN PSYCHOL, V62, P1545, DOI 10.1002/jclp.20327; Lindeman S, 1996, BRIT J PSYCHIAT, V168, P274, DOI 10.1192/bjp.168.3.274; Loas G, 2000, COMPR PSYCHIAT, V41, P369, DOI 10.1053/comp.2000.9008; Loas G., 2014, ANHEDONIA SUICIDE BE, VVolume II; Loas G, 2007, PSYCHOL REP, V100, P183, DOI 10.2466/PR0.100.1.183-190; Loas G, 2016, PSYCHIAT RES, V246, P296, DOI 10.1016/j.psychres.2016.09.056; Lussier A, 2015, PSYCHOL REP, V116, P855, DOI 10.2466/09.02.PR0.116k27w2; Martin EA, 2016, J PERS DISORD, V30, P451, DOI 10.1521/pedi_2015_29_203; OLKINUORA M, 1990, SOC PSYCH PSYCH EPID, V25, P81; Pedrazza M, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01238; PETERSON CA, 1983, J PERS ASSESS, V47, P539, DOI 10.1207/s15327752jpa4705_16; Rout U, 1999, PSYCHOL REP, V85, P981, DOI 10.2466/PR0.85.7.981-986; Ruitenburg MM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-292; Schernhammer ES, 2004, AM J PSYCHIAT, V161, P2295, DOI 10.1176/appi.ajp.161.12.2295; Spijker J, 2010, SOC PSYCH PSYCH EPID, V45, P513, DOI 10.1007/s00127-009-0093-6; Treadway MT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006598; Van Orden KA, 2012, PSYCHOL ASSESSMENT, V24, P197, DOI 10.1037/a0025358; Winer ES, 2016, J CLIN PSYCHOL, V72, P947, DOI 10.1002/jclp.22298; Winer ES, 2016, ARCH SUICIDE RES, V20, P265, DOI 10.1080/13811118.2015.1025119; Winer ES, 2014, PSYCHIAT RES, V218, P124, DOI 10.1016/j.psychres.2014.04.016; Winer ES, 2014, J AFFECT DISORDERS, V152, P193, DOI 10.1016/j.jad.2013.09.010; Wurm W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149913; Yaseen ZS, 2016, J AFFECT DISORDERS, V203, P77, DOI 10.1016/j.jad.2016.05.066	45	37	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0193619	10.1371/journal.pone.0193619	http://dx.doi.org/10.1371/journal.pone.0193619			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5KQ	29584785	Green Published, Green Submitted, gold			2022-12-26	WOS:000428373000006
J	Wang, RR; Liu, JJ; Li, XY; Liang, AP; Bourgoin, T				Wang, Rong-Rong; Liu, Jia-Jia; Li, Xin-Yu; Liang, Ai-Ping; Bourgoin, Thierry			Relating antennal sensilla diversity and possible species behaviour in the planthopper pest Lycorma delicatula (Hemiptera: Fulgoromorpha: Fulgoridae)	PLOS ONE			English	Article							CLOTHING WAX CICADA; INSECTA HEMIPTERA; BROWN PLANTHOPPER; ORGANS; MORPHOLOGY; HOMOPTERA; RECORD; KOREA; OIL	Antennal sensory units in nymphs and adults of the spotted Lanternfly, Lycorma delicatula (White) (Hemiptera: Fulgoromorpha: Fulgoridae), an economically important plant pest, are studied with scanning electron microscopy. Sensilla trichodea / chaetica type recognition is based on their external morphology and ratio of their size to diameter. The flagellum Bourgoin's organ is a complex sensory unit with 2-3 internal sensilla coeloconica. During nymphal stages, the sensory surface available for a chemoreceptive function particularly increases with the number and size of sensilla placodea on the antennal pedicel. From first to fourth instar and to adult males and females, plate organ sensory surface is estimated to increase respectively by 33x, 68x and 125x (= 2.72 mm(2) and 5.02 mm(2) respectively for males and females). The most important increase (5x) occurs between second and third instar. In parallel, a distinctive pair of plate organs on the flagellum decreases in size from first to third instar, and disappears. Sexual dimorphism occurs in sensilla placodea in adults. Diversity, disparity and evolution of nymphal sensilla, and their sexual dimorphism in adults are discussed in the context of the species and planthopper behaviour.	[Wang, Rong-Rong; Liang, Ai-Ping] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; [Liu, Jia-Jia] Beihang Univ, Sch Biol Sci & Med Engn, Beijing, Peoples R China; [Li, Xin-Yu] Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China; [Bourgoin, Thierry] SorbonneUniversite, Inst Systemat Evolut Biodiversite ISYEB, UMR MNHN 7205, CNRS,EPHE,Museum Natl Hist Nat, CP50, Paris, France	Chinese Academy of Sciences; Institute of Zoology, CAS; Beihang University; Beijing Forestry University; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite	Liang, AP (corresponding author), Chinese Acad Sci, Inst Zool, Beijing, Peoples R China.; Bourgoin, T (corresponding author), SorbonneUniversite, Inst Systemat Evolut Biodiversite ISYEB, UMR MNHN 7205, CNRS,EPHE,Museum Natl Hist Nat, CP50, Paris, France.	liangap@ioz.ac.cn; thierry.bourgoin@mnhn.fr	Bourgoin, Thierry/L-5146-2019	Bourgoin, Thierry/0000-0001-9277-2478; LI, XINYU/0000-0001-5136-0303	National Natural Science Foundation of China [31270043, 30900145]; Fundamental Research Funds for the Central Universities [XS201405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Natural Science Foundation of China (Grant Nos. 31270043 and 30900145) awarded to RRW, and the Fundamental Research Funds for the Central Universities (No. XS201405) to JJL.; We are grateful to Ms. Jun-Na Shi (Beijing Forestry University), who gave us invaluable help with this study. This study was supported by the National Natural Science Foundation of China (Grant Nos. 31270043 and 30900145) awarded to RRW, and the Fundamental Research Funds for the Central Universities (No. XS201405) to JJL. Part of these results were also first lectured during the ICE Symposium 660: An invasive planthopper goes global: shedding light on the spotted lanternfly (Lycorma delicatula) [51].	ALJUNID SF, 1983, CELL TISSUE RES, V228, P313, DOI 10.1007/BF00204881; BACKUS EA, 1988, J INSECT PHYSIOL, V34, P151, DOI 10.1016/0022-1910(88)90045-5; BAKER GT, 1993, P ENTOMOL SOC WASH, V95, P245; Barringer LE, 2015, ENTOMOL NEWS, V125, P20, DOI 10.3157/021.125.0105; BOURGOIN T, 1985, Nouvelle Revue d'Entomologie, V2, P11; BOURGOIN T, 1994, INT J INSECT MORPHOL, V23, P159, DOI 10.1016/0020-7322(94)90008-6; Brozek J, 2013, ZOOMORPHOLOGY, V132, P33, DOI 10.1007/s00435-012-0174-z; Bugnion E, 1908, J PSYCHOL NEUROL, V13, P326; Chen XX, 2006, PARASITOIDS PREDATOR; Cheng Chiou-Ling, 1996, Chinese Journal of Entomology, V16, P187; Choi Man-Young, 2014, Korean Journal of Applied Entomology, V53, P135, DOI 10.5656/KSAE.2014.01.1.075; Cobben R.H., 1988, P81; Dara SK, 2015, J INTEGR PEST MANAG, V6, DOI 10.1093/jipm/pmv021; Denno RF, 1994, PLANTHOPPERS THEIR E, P599; Emelyanov A.F., 1987, Trudy Vsesoyuznogo Entomologicheskogo Obshchestva, V69, P19; Fennah RG, 1975, NZ J ZOOL, V2, P277; Fu BX, 2012, MICROSC RES TECHNIQ, V75, P1492, DOI 10.1002/jemt.22093; Hamilton K.G. Andrew, 2011, Cicadina, V12, P57; Han Jung Min, 2008, Entomological Research, V38, P281, DOI 10.1111/j.1748-5967.2008.00188.x; Jang Y, 2013, ENTOMOL RES, V43, P115, DOI 10.1111/1748-5967.12012; Jones McKee L., 2018, WINES VINES     1202; Jung M, 2016, FLA ENTOMOL, V99, P47, DOI 10.1653/024.099.0109; Kim JG, 2011, J INSECT BEHAV, V24, P423, DOI 10.1007/s10905-011-9266-8; Lee Jeong-Eun, 2009, Korean Journal of Applied Entomology, V48, P467; Lewis C. T, 1970, Tissue Cell, V2, P375, DOI 10.1016/S0040-8166(70)80038-6; Liang AP, 2001, RAFFLES B ZOOL, V49, P221; MARSHALL AT, 1973, TISSUE CELL, V5, P233, DOI 10.1016/S0040-8166(73)80019-9; MARSHALL AT, 1971, ZOOL J LINN SOC-LOND, V50, P181, DOI 10.1111/j.1096-3642.1971.tb00758.x; METCALF ZP, 1947, GEN CATALOGUE HOMOPT, P1; Moon SR, 2011, J KOREAN SOC APPL BI, V54, P558, DOI 10.3839/jksabc.2011.085; Nault LR, 1985, LEAFHOPPERS PLANTHOP, P1; Park Ji-Doo, 2009, Korean Journal of Applied Entomology, V48, P53; Park M, 2013, B ENTOMOL RES, V103, P414, DOI 10.1017/S0007485313000011; Pham H.T., 2011, P 3 NAT SCI C EC BIO, P317; Riolo P, 2012, J CHEM ECOL, V38, P1017, DOI 10.1007/s10886-012-0154-2; Romani R, 2009, ARTHROPOD STRUCT DEV, V38, P473, DOI 10.1016/j.asd.2009.08.002; SCHNEIDER D, 1964, ANNU REV ENTOMOL, V9, P103, DOI 10.1146/annurev.en.09.010164.000535; Sforza R, 1999, EUR J ENTOMOL, V96, P409; Shields V.D.C., 2010, MICROSCOPY SCI TECHN, P321; Shih Hsien-Tzung, 1996, Chinese Journal of Entomology, V16, P279; Shih Hsien-Tzung, 1997, Chinese Journal of Entomology, V17, P33; Soulier-Perkins A, 2007, AUST J ENTOMOL, V46, P129, DOI 10.1111/j.1440-6055.2007.00566.x; Spichiger SE., 2016, 25 INT C ENT ORL FLO; Stroinski A, 2011, ZOOTAXA, P1; Wang RR, 2016, 25 INT C ENT ORL FLO; Xue G, 1996, Zhongguo Zhong Yao Za Zhi, V21, P554; Yang Chung-Tu, 1994, Chinese Journal of Entomology, V14, P529; Yoon C, 2011, J ASIA-PAC ENTOMOL, V14, P411, DOI 10.1016/j.aspen.2011.06.003; Youn YN, 2002, J ECON ENTOMOL, V95, P269, DOI 10.1603/0022-0493-95.2.269; Zacharuk R.Y., 1985, COMPREHENSIVE INSECT, P1; ZACHARUK RY, 1991, ANNU REV ENTOMOL, V36, P331, DOI 10.1146/annurev.en.36.010191.001555	51	11	13	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194995	10.1371/journal.pone.0194995	http://dx.doi.org/10.1371/journal.pone.0194995			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584780	Green Submitted, gold, Green Published			2022-12-26	WOS:000428373000054
J	Phillips, EG; Beggs, LA; Ye, F; Conover, CF; Beck, DT; Otzel, DM; Ghosh, P; Bessit, ACF; Borst, SE; Yarrow, JF				Phillips, Ean G.; Beggs, Luke A.; Ye, Fan; Conover, Christine F.; Beck, Darren T.; Otzel, Dana M.; Ghosh, Payal; Bessit, Anna C. F.; Borst, Stephen E.; Yarrow, Joshua F.			Effects of pharmacologic sclerostin inhibition or testosterone administration on soleus muscle atrophy in rodents after spinal cord injury	PLOS ONE			English	Article							SKELETAL-MUSCLE; BONE LOSS; REPLACEMENT THERAPY; HYPOGONADAL MEN; CAST IMMOBILIZATION; HYBRID FIBERS; PREVENTS BONE; SHORT-TERM; RATS; MODEL	Sclerostin is a circulating osteocyte-derived glycoprotein that negatively regulates Wnt-signaling after binding the LRP5/LRP6 co-receptors. Pharmacologic sclerostin inhibition produces bone anabolic effects after spinal cord injury (SCI), however, the effects of sclerostin-antibody (Scl-Ab) on muscle morphology remain unknown. In comparison, androgen administration produces bone antiresorptive effects after SCI and some, but not all, studies have reported that testosterone treatment ameliorates skeletal muscle atrophy in this context. Our purposes were to determine whether Scl-Ab prevents hindlimb muscle loss after SCI and compare the effects of Scl-Ab to testosterone enanthate (TE), an agent with known myotrophic effects. Male Sprague-Dawley rats aged 5 months received: (A) SHAM surgery (T8 laminectomy), (B) moderate-severe contusion SCI, (C) SCI+TE (7.0 mg/wk, im), or (D) SCI+Scl-Ab (25 mg/kg, twice weekly, sc). Twenty-one days post-injury, SCI animals exhibited a 31% lower soleus mass in comparison to SHAM, accompanied by >50% lower soleus muscle fiber cross-sectional area (fCSA) (p<0.01 for all fiber types). Scl-Ab did not prevent soleus atrophy, consistent with the relatively low circulating sclerostin concentrations and with the 91-99% lower LRP5/LRP6 gene expressions in soleus versus tibia (p<0.001), a tissue with known anabolic responsiveness to Scl-Ab. In comparison, TE partially prevented soleus atrophy and increased levator ani/bulbocavernosus (LABC) mass by 30-40% (p<0.001 vs all groups). The differing myotrophic responsiveness coincided with a 3-fold higher androgen receptor gene expression in LABC versus soleus (p<0.01). This study provides the first direct evidence that Scl-Ab does not prevent soleus muscle atrophy in rodents after SCI and suggests that variable myotrophic responses in rodent muscles after androgen administration are influenced by androgen receptor expression.	[Phillips, Ean G.; Beggs, Luke A.; Ye, Fan; Conover, Christine F.; Yarrow, Joshua F.] North Florida South Georgia Vet Hlth Syst, Malcom Randall VA Med Ctr, Res Serv, Gainesville, FL 32608 USA; [Beck, Darren T.] Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA; [Beck, Darren T.] Edward Via Coll Osteopath Med, Dept Cell Biol & Physiol, Auburn Campus, Auburn, AL USA; [Otzel, Dana M.] North Florida South Georgia Vet Hlth Syst, Malcom Randall VA Med Ctr, Brain Rehabil Res Ctr, Gainesville, FL USA; [Ghosh, Payal] Florida State Univ, Dept Nutr Food & Exercise Sci, Tallahassee, FL 32306 USA; [Bessit, Anna C. F.] Shriners Hosp Children, Orthoped Dept, Montreal, PQ, Canada; [Borst, Stephen E.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL USA; [Yarrow, Joshua F.] Univ Florida, Coll Med, Div Endocrinol Diabet & Metab, Gainesville, FL 32611 USA	Auburn University System; Auburn University; State University System of Florida; Florida State University; McGill University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Yarrow, JF (corresponding author), North Florida South Georgia Vet Hlth Syst, Malcom Randall VA Med Ctr, Res Serv, Gainesville, FL 32608 USA.; Yarrow, JF (corresponding author), Univ Florida, Coll Med, Div Endocrinol Diabet & Metab, Gainesville, FL 32611 USA.	jfyarrow@ufl.edu			Office of Research and Development, Rehabilitation Research and Development, Department of Veterans Affairs SPiRE [I21RX001371-01]; Presidential Early Career Award for Scientist and Engineers (PECASE) [B9280-0]	Office of Research and Development, Rehabilitation Research and Development, Department of Veterans Affairs SPiRE; Presidential Early Career Award for Scientist and Engineers (PECASE)	This work was supported by the Office of Research and Development, Rehabilitation Research and Development, Department of Veterans Affairs SPiRE (#I21RX001371-01) and Presidential Early Career Award for Scientist and Engineers (PECASE #B9280-0) to JFY, and by resources provided by the North Florida/South Georgia Veterans Health System. The sclerostinneutralizing monoclonal antibody (Scl-AbIII) was generously provided by Amgen, Inc. and UCB through a Department of Veterans Affairs Cooperative Research and Development Agreement (CRADA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work reported herein does not represent the views of the US Department of Veterans Affairs of the US government.	Battaglino RA, 2012, BONE, V51, P600, DOI 10.1016/j.bone.2012.04.019; Bauman WA, 2011, HORM METAB RES, V43, P574, DOI 10.1055/s-0031-1280797; Bauman WA, 2015, J SPINAL CORD MED, V38, P38, DOI 10.1179/2045772314Y.0000000206; Bauman WA, 2014, J SPINAL CORD MED, V37, P32, DOI 10.1179/2045772313Y.0000000122; Beck DT, 2014, J BONE MINER RES, V29, P2405, DOI 10.1002/jbmr.2265; Beggs LA, 2015, J BONE MINER RES, V30, P681, DOI 10.1002/jbmr.2396; Borst SE, 2007, AM J PHYSIOL-ENDOC M, V293, pE507, DOI 10.1152/ajpendo.00130.2007; Borst SE, 2014, AM J PHYSIOL-ENDOC M, V306, pE433, DOI 10.1152/ajpendo.00592.2013; Brotto M, 2015, BONE, V80, P109, DOI 10.1016/j.bone.2015.02.010; Byers JS, 2012, J COMP NEUROL, V520, P2683, DOI 10.1002/cne.23066; Dalbo VJ, 2017, ANDROLOGIA, V49, DOI 10.1111/and.12622; Giangregorio L, 2006, J SPINAL CORD MED, V29, P489, DOI 10.1080/10790268.2006.11753898; Graham ZA, 2016, J NEUROTRAUM, V33, P1128, DOI 10.1089/neu.2015.4058; Gregory CM, 2003, CAN J APPL PHYSIOL, V28, P491, DOI 10.1139/h03-036; Gregory CM, 2003, SPINAL CORD, V41, P23, DOI 10.1038/sj.sc.3101370; Huang J, 2017, JBMR PLUS, V1, P86, DOI 10.1002/jbm4.10015; Hutchinson KJ, 2001, J NEUROTRAUM, V18, P1075, DOI 10.1089/08977150152693764; Karczewska-Kupczewska M, 2016, J CLIN ENDOCR METAB, V101, P3079, DOI 10.1210/jc.2016-1594; Khuyagbaatar B, 2015, J NEUROTRAUM, V32, P1987, DOI 10.1089/neu.2015.3875; Liu M, 2010, EUR J APPL PHYSIOL, V109, P709, DOI 10.1007/s00421-010-1392-z; Moore PD, 2016, WORLD J CLIN CASES, V4, P172, DOI 10.12998/wjcc.v4.i7.172; Park S, 2014, J APPL PHYSIOL, V116, P797, DOI 10.1152/japplphysiol.00955.2013; Qin W, 2016, OSTEOPOROSIS INT, V27, P3627, DOI 10.1007/s00198-016-3700-x; Qin WP, 2015, J BONE MINER RES, V30, P1994, DOI 10.1002/jbmr.2549; Qin WP, 2013, J BIOL CHEM, V288, P13511, DOI 10.1074/jbc.M113.454892; Rogerson S, 2007, J STRENGTH COND RES, V21, P354; Rudnicki MA, 2015, BONE, V80, P60, DOI 10.1016/j.bone.2015.02.009; Spatz JM, 2013, J BONE MINER RES, V28, P865, DOI 10.1002/jbmr.1807; Stevens JE, 2006, J NEUROTRAUM, V23, P1671, DOI 10.1089/neu.2006.23.1671; Sun L, 2013, J SPINAL CORD MED, V36, P616, DOI 10.1179/2045772312Y.0000000020; Tagliaferri C, 2015, AGEING RES REV, V21, P55, DOI 10.1016/j.arr.2015.03.002; Takeda I, 2014, PATHOBIOLOGY, V81, P94, DOI 10.1159/000357238; TALMADGE RJ, 1995, J APPL PHYSIOL, V78, P1256, DOI 10.1152/jappl.1995.78.4.1256; Talmadge RJ, 1999, ANAT RECORD, V255, P188, DOI 10.1002/(SICI)1097-0185(19990601)255:2<188::AID-AR9>3.0.CO;2-H; Tian XY, 2011, BONE, V48, P197, DOI 10.1016/j.bone.2010.09.009; Tran TH, 2012, J BIOL CHEM, V287, P32651, DOI 10.1074/jbc.M112.353243; Wu Y, 2012, SPINAL CORD, V50, P57, DOI 10.1038/sc.2011.91; Wu Y, 2012, J NEUROTRAUM, V29, P1663, DOI 10.1089/neu.2011.2203; Yarrow JF, 2014, J MUSCULOSKEL NEURON, V14, P255; Yarrow JF, 2017, J NEUROTRAUM, V34, P2972, DOI 10.1089/neu.2016.4814; Yarrow JF, 2014, J NEUROTRAUM, V31, P834, DOI 10.1089/neu.2013.3155; Yarrow JF, 2012, MED SCI SPORT EXER, V44, P818, DOI 10.1249/MSS.0b013e31823bfcbf; Ye F, 2013, EXP PHYSIOL, V98, P1038, DOI 10.1113/expphysiol.2012.070722; Ye F, 2013, J NEUROTRAUM, V30, P227, DOI 10.1089/neu.2012.2504; Zhang DY, 2016, BONE, V87, P161, DOI 10.1016/j.bone.2016.02.005	45	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194440	10.1371/journal.pone.0194440	http://dx.doi.org/10.1371/journal.pone.0194440			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579075	Green Published, Green Submitted, gold			2022-12-26	WOS:000428351800030
J	Thorpe, CJ; Lewis, TR; Kulkarni, S; Watve, A; Gaitonde, N; Pryce, D; Davies, L; Bilton, DT; Knight, ME				Thorpe, Christopher J.; Lewis, Todd R.; Kulkarni, Siddharth; Watve, Aparna; Gaitonde, Nikhil; Pryce, David; Davies, Lewis; Bilton, David T.; Knight, Mairi E.			Micro-habitat distribution drives patch quality for sub-tropical rocky plateau amphibians in the northern Western Ghats, India	PLOS ONE			English	Article							ANURA RHACOPHORIDAE; REPRODUCTIVE MODES; NATIONAL-PARK; HABITAT; FROG; CONSERVATION; ASSEMBLAGES; MAHARASHTRA; VEGETATION; DIVERSITY	The importance of patch quality for amphibians is frequently overlooked in distribution models. Here we demonstrate that it is highly important for the persistence of endemic and endangered amphibians found in the threatened and fragile ecosystems that are the rocky plateaus in Western Maharashtra, India. These plateaus are ferricretes of laterite and characterise the northern section of the Western Ghats/Sri Lanka Biodiversity Hotspot, the eighth most important global hotspot and one of the three most threatened by population growth. We present statistically supported habitat associations for endangered and data deficient Indian amphibians, demonstrating significant relationships between individual species and their microhabitats. Data were collected during early monsoon across two seasons. Twenty-one amphibian taxa were identified from 14 lateritic plateaus between 67 and 1179m above sea level. Twelve of the study taxa had significant associations with microhabitats using a stepwise analysis of the AICc subroutine (distLM, Primer-e, v7). Generalist taxa were associated with increased numbers of microhabitat types. Non-significant associations are reported for the remaining 9 taxa. Microhabitat distribution was spatially structured and driven by climate and human activity. Woody plants were associated with 44% of high-elevation taxa. Of the 8 low-elevation taxa 63% related to water bodies and 60% of those were associated with pools. Rock size and abundance were important for 33% of high elevation specialists. Three of the 4 caecilians were associated with rocks in addition to soil and stream presence. We conclude the plateaus are individualistic patches whose habitat quality is defined by their microhabitats within climatic zones.	[Thorpe, Christopher J.; Pryce, David; Davies, Lewis; Bilton, David T.; Knight, Mairi E.] Univ Plymouth, Sch Biol & Marine Sci, Ecol & Evolut Res Grp, Plymouth, Devon, England; [Lewis, Todd R.] Westfield, Wareham, Dorset, England; [Kulkarni, Siddharth] George Washington Univ, Washington, DC USA; [Watve, Aparna] Tata Inst Social Sci, Osmanabad, Maharashtra, India; [Gaitonde, Nikhil] Natl Ctr Biol Sci, Bengaluru, Karnataka, India	University of Plymouth; George Washington University; Tata Institute of Social Sciences; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Thorpe, CJ (corresponding author), Univ Plymouth, Sch Biol & Marine Sci, Ecol & Evolut Res Grp, Plymouth, Devon, England.; Lewis, TR (corresponding author), Westfield, Wareham, Dorset, England.	Christapher.tharpe@plymouth.ac.uk; ecolewis@gmail.com	Kulkarni, Siddharth/X-6449-2019; Lewis, Todd/E-2225-2019	Lewis, Todd/0000-0001-5433-8777	Royal Geographical Society; IBG; Monica Cole Award; Erasmus Darwin Barlow Expedition Fund; Zoological Society of London	Royal Geographical Society; IBG; Monica Cole Award; Erasmus Darwin Barlow Expedition Fund; Zoological Society of London	This work was supported by the following: CJT: The Royal Geographical Society with IBG (www.rgs.org) through Geographical Fieldwork Grants in 2013 and 2014 and the Monica Cole Award 2012. CJT: The Erasmus Darwin Barlow Expedition Fund, Zoological Society of London (https://www.zsl.org) grant in 2014. TRL: Percy Sladen Memorial Trust (https://www.linnean.org > The Society > Medals, Awards, Prizes and Grants) award in 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Amstrup S.C., 2010, HDB CAPTURE RECAPTUR; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], APPL HERPETOL, DOI DOI 10.1163/157075405774483094; Aravind N, 2011, THEME PAPER AM UNPUB, P20; Babbitt KJ, 2009, AMPHIBIAN ECOLOGY CO; Baillie J. E. M., 2004, 2004 IUCN RED LIST T; Balaji D, 2014, J NAT CONSERV, V22, P337, DOI 10.1016/j.jnc.2014.03.004; BELL EA, 1994, NEW ZEAL J ZOOL, V21, P437, DOI 10.1080/03014223.1994.9518014; Bharucha EK, 2010, CURRENT ECOLOGICAL S; Bhatta G, 1998, J BIOSCIENCE, V23, P73, DOI 10.1007/BF02728526; Biju SD, 2009, ZOOL J LINN SOC-LOND, V155, P374, DOI 10.1111/j.1096-3642.2008.00466.x; Biju S. D., 2001, OCCAS PUBL INDIAN SO, V1, P1; Biju Sd, 2009, BMC Res Notes, V2, P241, DOI 10.1186/1756-0500-2-241; Bossuyt F, 2002, J HERPETOL, V36, P656, DOI 10.2307/1565937; CEPF, 2016, AS PAC BIOD HOTSP CR; Chan LM, 2003, BIOL J LINN SOC, V78, P489, DOI 10.1046/j.0024-4066.2002.00157.x; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Clarke KR, 1994, CHANGE MARINE COMMUN; Clarke KR, 2015, PRIMER V7 USER MANUA; Cortes-Gomez AM, 2013, TROP CONSERV SCI, V6, P749, DOI 10.1177/194008291300600604; Crump M.L., 1994, MEASURING MONITORING, P84, DOI DOI 10.1007/S10682-018-9929-4; da Silva FR, 2012, J BIOGEOGR, V39, P1720, DOI 10.1111/j.1365-2699.2012.02726.x; Daniel, 2002, BOOK INDIAN REPTILES; DANIELS RJR, 1992, J BIOGEOGR, V19, P521, DOI 10.2307/2845771; Deans RA, 2016, OIKOS; Dinesh KP, 2017, CHECKLIST AMPHIBIANS; Dinesh KP., 2009, ANNOTATED CHECKLIST; Doan TM, 2003, J HERPETOL, V37, P72, DOI 10.1670/0022-1511(2003)037[0072:WMAMEF]2.0.CO;2; Dubois Alain, 2001, Alytes (Paris), V19, P53; DUELLMAN WE, 1988, ANN MO BOT GARD, V75, P79, DOI 10.2307/2399467; Ernst Raffael, 2006, Ecotropica-Bonn, V12, P113; FAUTH JE, 1989, BIOTROPICA, V21, P178, DOI 10.2307/2388708; Feeley KJ, 2016, DIVERS DISTRIB; Ficetola GF, 2004, BIOL CONSERV, V119, P219, DOI 10.1016/j.biocon.2003.11.004; FRIEND GR, 1990, J TROP ECOL, V6, P131, DOI 10.1017/S0266467400004235; Frishkoff LO, 2015, GLOBAL CHANGE BIOL, V21, P3901, DOI 10.1111/gcb.13016; Frost D. R., 2015, AMPHIBIAN SPECIES WO; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Gaitonde N, 2016, J NAT HIST, V50, P2557, DOI 10.1080/00222933.2016.1200686; Gaitonde N, 2014, CURR SCI INDIA, V107, P109; GASCON C, 2007, AMPHIBIAN CONSERVATI; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Giri V, 2016, THREATENED AMPHIBIAN, P80; Giri Varad, 2003, Zootaxa, V351, P1; Gower DJ, 2011, MOL PHYLOGENET EVOL, V59, P698, DOI 10.1016/j.ympev.2011.03.002; Gower DJ, 2005, CONSERV BIOL, V19, P45, DOI 10.1111/j.1523-1739.2005.00589.x; Gururaja K, 2013, RUSSIAN J HERPETOLOG, V10, P87; Haddad CFB, 2005, BIOSCIENCE, V55, P207, DOI 10.1641/0006-3568(2005)055[0207:RMIFAT]2.0.CO;2; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hartel T, 2007, HYDROBIOLOGIA, V583, P173, DOI 10.1007/s10750-006-0490-8; Heard GW, 2017, CONSERV LETT, V12375, P1; Hillis DM, 2007, MOL PHYLOGENET EVOL, V42, P331, DOI 10.1016/j.ympev.2006.08.001; Hiragond NC, 2001, J HERPETOL, V35, P166, DOI 10.2307/1566044; Holdridge L. R., 1967, Life zone ecology.; Hopper SD, 2015, PLANT SOIL, P1; Humraskar D, 2007, NEED STUDIES AMPHIBI, P1032; Hussain Q. A., 2012, International Journal of Biodiversity and Conservation, V4, P348; IMD India Meteorological Department, 2016, ONS WITHDR SW MONS 2; India Go. Indiastat, 2017, IND MET DAT RAINF; Iskandar DT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119988; IUCN, IUCN RED LIST THREAT; Jocque A M, 2010, FRESHWATER BIOL, V2010, P1; Jocque M, 2007, HYDROBIOLOGIA, V592, P271, DOI 10.1007/s10750-007-0766-7; Krishnamurthy SV, 2003, ENVIRON CONSERV, V30, P274, DOI 10.1017/S0376892903000274; Krishnamurthy SV, 2001, CURR SCI INDIA, V80, P887; Kumar A, 2001, CURR SCI INDIA, V80; Kupfer A, 2005, ACTA OECOL, V28, P95, DOI 10.1016/j.actao.2005.03.002; Kuramoto Mitsuru, 2007, Current Herpetology, V26, P81, DOI 10.3105/1881-1019(2007)26[81:TGFARI]2.0.CO;2; Kuramoto Mitsuru, 2003, Current Herpetology, V22, P51; Lad R. J., 2013, INT J RECENT SCI RES, V4, P1275; Laurance WF, 2011, BIOL CONSERV, V144, P548, DOI 10.1016/j.biocon.2010.10.010; Lee JC, 1993, GEOGRAPHIC VARIATION; Lekhak M. M., 2012, Rheedea, V22, P39; Lynch JDD, 1980, ELEUTHERODACTYLUS AM; Mahabal A, 2012, FAUNA OF MAHARASHTRA; Menin M, 2011, HERPETOL J, V21, P255; Molur S, 2015, DIS AQUAT ORGAN, V112, P251, DOI 10.3354/dao02804; Mortelliti A, 2010, OECOLOGIA, V163, P535, DOI 10.1007/s00442-010-1623-3; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naniwadekar R, 2007, J BIOGEOGR, V34, P842, DOI 10.1111/j.1365-2699.2006.01648.x; Oertli B, 2002, BIOL CONSERV, V104, P59, DOI 10.1016/S0006-3207(01)00154-9; Padhye A.D., 2002, Zoos' Print Journal, V17, P735; Padhye Anand D., 2013, Journal of Threatened Taxa, V5, P4913; Phillips J, 2012, ENVIRON EARTH SCI, V67, P1587, DOI 10.1007/s12665-012-1601-7; Pinder A. M., 2000, Journal of the Royal Society of Western Australia, V83, P149; Porembski S, 2005, PHYTOCOENOLOGIA, V35, P389, DOI 10.1127/0340-269X/2005/0035-0389; Porembski S, 2016, BIODIVERS CONSERV, V25, P2827, DOI 10.1007/s10531-016-1171-1; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Pyron RA, 2014, SYST BIOL, V63, P779, DOI 10.1093/sysbio/syu042; Raj Prudhvi, 2011, Herpetology Notes, V4, P11; Ram MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142597; Ramesh V, 2017, BIOL CONSERV, V210, P205, DOI 10.1016/j.biocon.2017.03.019; Rittenhouse TAG, 2007, WETLANDS, V27, P153, DOI 10.1672/0277-5212(2007)27[153:DOAITH]2.0.CO;2; Robin VV, 2012, CURR SCI INDIA, V103, P1427; Santos-Barrera G, 2011, REV MEX BIODIVERS, V82, P679; Scheffer M, 2006, OIKOS, V112, P227, DOI 10.1111/j.0030-1299.2006.14145.x; Scheffers BR, 2014, GLOBAL CHANGE BIOL, V20, P495, DOI 10.1111/gcb.12439; Schut AGT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082778; Seshadri KS, 2015, BIOL J LINN SOC, V114, P1, DOI 10.1111/bij.12388; Seshadri KS, 2012, ZOOTAXA, P19; Sloan S, 2014, BIOL CONSERV, V177, P12, DOI 10.1016/j.biocon.2014.05.027; Smith GR, 1999, FRESHWATER BIOL, V41, P829, DOI 10.1046/j.1365-2427.1999.00445.x; Smith HM, 2006, HERPETOL CONSERV BIO, V1, P6; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Thorpe C. J., 2016, J ECOL SOC, V29, P25; Van Bocxlaer I, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000074; Van Bocxlaer I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-131; Vidya TNC, 2005, HEREDITY, V94, P71, DOI 10.1038/sj.hdy.6800568; Vonesh J. R., 1998, THESIS; Vonesh JR, 2001, BIOTROPICA, V33, P502, DOI 10.1111/j.1744-7429.2001.tb00204.x; Vonesh JR, 2010, AMPHIBIAN ECOLOGY CO, P263, DOI 10.1007/BF02728526; Watve A., 2010, ROCKY PLATEAUS SPECI; Watve Aparna, 2013, Journal of Threatened Taxa, V5, P3935, DOI 10.11609/JoTT.o3372.3935-62; Wells KD, 2007, SPR HDB AUD, V28, P44; Widdowson M, 1996, EARTH PLANET SC LETT, V137, P57, DOI 10.1016/0012-821X(95)00211-T; Widdowson M., 2007, GEOCHEMICAL SEDIMENT, P46; Williams SE, 2001, BIOL CONSERV, V98, P1, DOI 10.1016/S0006-3207(99)00093-2	118	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194810	10.1371/journal.pone.0194810	http://dx.doi.org/10.1371/journal.pone.0194810			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579111	gold, Green Published			2022-12-26	WOS:000428351800057
J	Aho, I; Kaijomaa, M; Kivela, P; Surcel, HM; Sutinen, J; Heikinheimo, O				Aho, Inka; Kaijomaa, Marja; Kivela, Pia; Surcel, Helja-Marja; Sutinen, Jussi; Heikinheimo, Oskari		FINHIVPREG Study Team	Most women living with HIV can deliver vaginally-National data from Finland 1993-2013	PLOS ONE			English	Article							ELECTIVE CESAREAN-SECTION; HIV-1-INFECTED WOMEN; INFECTED WOMEN; TRANSMISSION; PREVENTION; COMPLICATIONS; POPULATION; GUIDELINES; PREDICTORS; MODE	Introduction Vaginal delivery has been recommended for more than ten years for women living with HIV (WLWH) with good virological control. However, in Europe most WLWH still deliver by cesarean section (CS). Our aim was to assess the rate of vaginal delivery and the indications for CS in WLWH over 20 years in a setting of low overall CS rate. Materials and methods This was a retrospective study of all WLWH delivering in Finland 1993-2013. We identified the women by combining national health registers and extracted data from patient files. Results The study comprised 212 women with 290 deliveries. Over 35% of the women delivered several children during the study years. During 2000-2013, with consistent viral load monitoring, 80.0% showed HIV viral loads <50 copies/mL in the last measurement preceding the delivery. Altogether 74.5% of all WLWH delivered vaginally and the rate of both elective CS and emergency CS was 12.8% each. For most CSs (63.5%) the indication was obstetrical, for 28.4% it was avoiding HIV transmission and for 0.7% it was mother's request. In hospitals with less than ten HIV-related deliveries during the study period, the rate of elective CS was higher than in more experienced hospitals (22.7% versus 10.6% [p = 0.024]). No perinatal HIV transmissions occurred. Conclusions Most WLWH can achieve good virological control and deliver vaginally. This will help them to maintain their future child bearing potential and reduce CS-related morbidity.	[Aho, Inka; Kivela, Pia; Sutinen, Jussi] Helsinki Univ Hosp, Dept Infect Dis, Helsinki, Finland; [Aho, Inka; Kaijomaa, Marja; Kivela, Pia; Sutinen, Jussi; Heikinheimo, Oskari] Univ Helsinki, Helsinki, Finland; [Kaijomaa, Marja; Heikinheimo, Oskari] Helsinki Univ Hosp, Dept Obstet & Gynecol, Helsinki, Finland; [Surcel, Helja-Marja] Natl Inst Hlth & Welf, Oulu, Finland; [Surcel, Helja-Marja] Univ Oulu, Fac Med, Oulu, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University of Oulu	Aho, I (corresponding author), Helsinki Univ Hosp, Dept Infect Dis, Helsinki, Finland.; Aho, I (corresponding author), Univ Helsinki, Helsinki, Finland.	inka.aho@hus.fi	Aho, Inka J/K-8567-2014; Heikinheimo, Oskari/ABC-7792-2020	Aho, Inka J/0000-0002-0281-8485; 	Finnish Medical Association; Infektiotautien tutkimusyhdistys	Finnish Medical Association; Infektiotautien tutkimusyhdistys	IA has received non-restricted grants from the Finnish Medical Association and Infektiotautien tutkimusyhdistys. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi-Popp K, 2013, EUR J PUBLIC HEALTH, V23, P1053, DOI 10.1093/eurpub/ckt028; Aebi-Popp K, 2013, JAIDS-J ACQ IMM DEF, V64, P58, DOI 10.1097/QAI.0b013e3182a334e3; Andiman W, 1999, NEW ENGL J MED, V340, P977, DOI 10.1056/NEJM199904013401301; [Anonymous], 2017, NATL INFECT DIS REGI; [Anonymous], 2016, DHHS GUIDELINES; [Anonymous], 2016, EUROPEAN AIDS CLIN S; [Anonymous], 2017, FINNISH MATERNITY CO; Boer K, 2010, HIV MED, V11, P368, DOI 10.1111/j.1468-1293.2009.00800.x; Briand N, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.06.021; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Cotter AM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.10.862; de Ruiter A, 2014, HIV MED, V15, P1, DOI 10.1111/hiv.12185; Floridia M, 2017, HIV MED, V18, P440, DOI 10.1111/hiv.12473; Forbes JC, 2012, AIDS, V26, P757, DOI 10.1097/QAD.0b013e328350995c; French CE, 2012, JAIDS-J ACQ IMM DEF, V59, P287, DOI 10.1097/QAI.0b013e31823dbeac; Kind C, 1998, AIDS, V12, P205, DOI 10.1097/00002030-199802000-00011; Kourtis AP, 2014, AIDS, V28, P2609, DOI 10.1097/QAD.0000000000000474; Livingston EG, 2016, JAIDS-J ACQ IMM DEF, V73, P74, DOI 10.1097/QAI.0000000000001021; Mark Siobhan, 2012, Infect Dis Obstet Gynecol, V2012, P267969, DOI 10.1155/2012/267969; Orbaek M, 2017, HIV MED, V18, P736, DOI 10.1111/hiv.12519; Parazzini F, 1999, LANCET, V353, P1035, DOI 10.1016/S0140-6736(98)08084-2; Peters H, 2016, BJOG-INT J OBSTET GY, V123, P975, DOI 10.1111/1471-0528.13442; Silver RM, 2012, SEMIN PERINATOL, V36, P315, DOI 10.1053/j.semperi.2012.04.013; Thompson DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144592; Townsend CL, 2014, AIDS, V28, P1049, DOI 10.1097/QAD.0000000000000212	25	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194370	10.1371/journl.pone.0194370	http://dx.doi.org/10.1371/journl.pone.0194370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566017				2022-12-26	WOS:000428093900058
J	Fujii, T; Hirota, K; Yasoda, A; Takizawa, A; Morozumi, N; Nakamura, R; Yotsumoto, T; Kondo, E; Yamashita, Y; Sakane, Y; Kanai, Y; Ueda, Y; Yamauchi, I; Yamanaka, S; Nakao, K; Kuwahara, K; Jindo, T; Furuya, M; Mashimo, T; Inagaki, N; Serikawa, T; Nakao, K				Fujii, Toshihito; Hirota, Keisho; Yasoda, Akihiro; Takizawa, Akiko; Morozumi, Naomi; Nakamura, Ryuichi; Yotsumoto, Takafumi; Kondo, Eri; Yamashita, Yui; Sakane, Yoriko; Kanai, Yugo; Ueda, Yohei; Yamauchi, Ichiro; Yamanaka, Shigeki; Nakao, Kazumasa; Kuwahara, Koichiro; Jindo, Toshimasa; Furuya, Mayumi; Mashimo, Tomoji; Inagaki, Nobuya; Serikawa, Tadao; Nakao, Kazuwa			Rats deficient C-type natriuretic peptide suffer from impaired skeletal growth without early death	PLOS ONE			English	Article							RECEPTOR-B NPR2; GUANYLYL CYCLASE-B; SHORT STATURE; HETEROZYGOUS MUTATIONS; ENDOCHONDRAL OSSIFICATION; MOLECULAR-BIOLOGY; KNOCKOUT RATS; BONE-GROWTH; GENE; OVERGROWTH	We have previously investigated the physiological role of C-type natriuretic peptide (CNP) on endochondral bone growth, mainly with mutant mouse models deficient in CNP, and reported that CNP is indispensable for physiological endochondral bone growth in mice. However, the survival rate of CNP knockout (KO) mice fell to as low as about 70% until 10 weeks after birth, and we could not sufficiently analyze the phenotype at the adult stage. Herein, we generated CNP KO rats by using zinc-finger nuclease-mediated genome editing technology. We established two lines of mutant rats completely deficient in CNP (CNP KO rats) that exhibited a phenotype identical to that observed in mice deficient in CNP, namely, a short stature with severely impaired endochondral bone growth. Histological analysis revealed that the width of the growth plate, especially that of the hypertrophic chondrocyte layer, was markedly lower and the proliferation of growth plate chondrocytes tended to be reduced in CNP KO rats. Notably, CNP KO rats did not have malocclusions and survived for over one year after birth. At 33 weeks of age, CNP KO rats persisted significantly shorter than wild-type rats, with closed growth plates of the femur in all samples, which were not observed in wild-type rats. Histologically, CNP deficiency affected only bones among all body tissues studied. Thus, CNP KO rats survive over one year, and exhibit a deficit in endochondral bone growth and growth retardation throughout life.	[Fujii, Toshihito; Hirota, Keisho; Yasoda, Akihiro; Kondo, Eri; Yamashita, Yui; Sakane, Yoriko; Kanai, Yugo; Ueda, Yohei; Yamauchi, Ichiro; Inagaki, Nobuya] Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto, Japan; [Takizawa, Akiko] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Morozumi, Naomi; Nakamura, Ryuichi; Yotsumoto, Takafumi; Jindo, Toshimasa; Furuya, Mayumi] Asubio Pharma Co Ltd, Kobe, Hyogo, Japan; [Yamanaka, Shigeki; Nakao, Kazumasa] Kyoto Univ, Grad Sch Med, Dept Maxillofacial Surg, Kyoto, Japan; [Kuwahara, Koichiro] Shinshu Univ, Grad Sch Med, Dept Cardiovasc Med, Matsumoto, Nagano, Japan; [Furuya, Mayumi; Nakao, Kazuwa] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Kyoto, Japan; [Mashimo, Tomoji] Osaka Univ, Grad Sch Med, Genome Editing Res & Dev R&D Ctr, Osaka, Japan; [Mashimo, Tomoji] Osaka Univ, Grad Sch Med, Inst Expt Anim Sci, Osaka, Japan; [Serikawa, Tadao] Osaka Univ Pharmaceut Sci, Pharmacol Lab, Takatsuki, Osaka, Japan	Kyoto University; Medical College of Wisconsin; Asubio Pharma Co., Ltd.; Kyoto University; Shinshu University; Kyoto University; Osaka University; Osaka University; Osaka University of Pharmaceutical Sciences	Yasoda, A (corresponding author), Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto, Japan.	ayasoda@kuhp.kyoto-u.ac.jp	Kuwahara, Koichiro/AFK-1723-2022	Kuwahara, Koichiro/0000-0003-2670-7170	Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Uehara Memorial Foundation [19591075, 21591176, 21229013]; Asubio Pharma Co., Ltd.; Grants-in-Aid for Scientific Research [26290033] Funding Source: KAKEN	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Asubio Pharma Co., Ltd.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Health, Labour and Welfare of Japan, the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Uehara Memorial Foundation (#19591075, 21591176, and 21229013). Asubio Pharma Co., Ltd. provided support in the form of salaries for authors [NM, RN, TY, TJ, and ME], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section	Abbott A, 2009, NATURE, V460, P788, DOI 10.1038/460788a; Amano N, 2014, J CLIN ENDOCR METAB, V99, pE713, DOI 10.1210/jc.2013-3525; Bartels CF, 2004, AM J HUM GENET, V75, P27, DOI 10.1086/422013; Bocciardi R, 2007, HUM MUTAT, V28, P724, DOI 10.1002/humu.20511; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Chusho H, 2001, P NATL ACAD SCI USA, V98, P4016, DOI 10.1073/pnas.071389098; Fujii T, 2010, ENDOCRINOLOGY, V151, P4381, DOI 10.1210/en.2010-0078; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Hachiya R, 2007, J CLIN ENDOCR METAB, V92, P4009, DOI 10.1210/jc.2007-1101; Hisado-Oliva A, 2017, GENET MED; Hisado-Oliva A, 2015, J CLIN ENDOCR METAB, V100, pE1133, DOI 10.1210/jc.2015-1612; JOHN SWM, 1995, SCIENCE, V267, P679, DOI 10.1126/science.7839143; Kake T, 2009, AM J PHYSIOL-ENDOC M, V297, pE1339, DOI 10.1152/ajpendo.00272.2009; Kitada K, 2007, NAT METHODS, V4, P131, DOI 10.1038/nmeth1002; Ko JM, 2015, AM J MED GENET A, V167, P1033, DOI 10.1002/ajmg.a.36884; Kondo E, 2012, CALCIFIED TISSUE INT, V90, P307, DOI 10.1007/s00223-011-9567-0; Langenickel TH, 2006, P NATL ACAD SCI USA, V103, P4735, DOI 10.1073/pnas.0510019103; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Mashimo T, 2012, CELL REP, V2, P685, DOI 10.1016/j.celrep.2012.08.009; Mashimo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008870; Miura K, 2014, AM J MED GENET A, V164, P156, DOI 10.1002/ajmg.a.36218; Miura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042180; Moncla A, 2007, HUM MUTAT, V28, P1183, DOI 10.1002/humu.20611; Nakao K, 2013, J DENT RES, V92, P58, DOI 10.1177/0022034512466413; NAKAO K, 1992, J HYPERTENS, V10, P907; NAKAO K, 1992, J HYPERTENS, V10, P1111, DOI 10.1097/00004872-199210000-00002; Nakao K, 2015, SCI REP-UK, V5, DOI 10.1038/srep10554; Olney RC, 2006, J CLIN ENDOCR METAB, V91, P1229, DOI 10.1210/jc.2005-1949; Richette P, 2008, JOINT BONE SPINE, V75, P125, DOI 10.1016/j.jbspin.2007.06.007; Robinson JW, 2013, BONE, V56, P375, DOI 10.1016/j.bone.2013.06.024; Shim Kye Shik, 2015, Ann Pediatr Endocrinol Metab, V20, P8, DOI 10.6065/apem.2015.20.1.8; Smits BMG, 2006, PHARMACOGENET GENOM, V16, P159; Tamura N, 2004, P NATL ACAD SCI USA, V101, P17300, DOI 10.1073/pnas.0407894101; Tsuji T, 2008, BIOCHEM BIOPH RES CO, V376, P186, DOI 10.1016/j.bbrc.2008.08.139; Vasques GA, 2013, J CLIN ENDOCR METAB, V98, pE1636, DOI 10.1210/jc.2013-2142; Wang SR, 2015, HUM MUTAT, V36, P474, DOI 10.1002/humu.22773; Yamanaka S, 2017, J DENT RES; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971; Yasoda A, 2009, ENDOCRINOLOGY, V150, P3138, DOI 10.1210/en.2008-1676; Zan YH, 2003, NAT BIOTECHNOL, V21, P645, DOI 10.1038/nbt830	40	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194812	10.1371/journal.pone.0194812	http://dx.doi.org/10.1371/journal.pone.0194812			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566041	gold, Green Submitted, Green Published			2022-12-26	WOS:000428093900107
J	Wang, T; Thien, C; Wang, C; Ni, M; Gao, JJ; Wang, A; Jiang, Q; Tuan, RS; Zheng, QJ; Zheng, MH				Wang, Tao; Thien, Christine; Wang, Carolyn; Ni, Ming; Gao, Junjie; Wang, Allan; Jiang, Qing; Tuan, Rocky S.; Zheng, Qiujian; Zheng, Ming H.			3D uniaxial mechanical stimulation induces tenogenic differentiation of tendon-derived stem cells through a PI3K/AKT signaling pathway	FASEB JOURNAL			English	Article						bioreactor; mechanical loading; tendon formation; mechanobiology	CYCLIC TENSILE STRAIN; ACHILLES-TENDON; GENE-EXPRESSION; BIOARTIFICIAL TENDONS; SCLERAXIS EXPRESSION; BIOREACTOR SYSTEM; KINASE; AKT; ACTIVATION; REPAIR	The tendon is a mechanosensitive tissue, but little is known about how mechanical stimulation selectively signals tenogenic differentiation and neo-tendon formation. In this study, we compared the impact of uniaxial and biaxial mechanical loading on tendon-derived stem cells (TDSCs). Our data show that there are variations in cell signaling and cell differentiation of mouse TDSCs in response to uniaxial and biaxial loading in monolayer culture. Whereas uniaxial loading induced TDSCs toward tenogenic and osteogenic differentiation, biaxial loading induced osteogenic, adipogenic, and chondrogenic differentiation of TDSCs. Furthermore, by applying uniaxial loading on 3-dimensional (3D) TDSC constructs, tenogenic-specific differentiation and neo-tendon formation were observed, results that were replicated in human TDSCs. We also showed that uniaxial loading induced PKB (AKT) phosphorylation (pAKT), whereas biaxial loading induced pERK. Most importantly, we found that inhibition of the PI3K/AKT signaling pathway could attenuate tenogenic differentiation and tendon formation in 3D TDSC constructs subjected to uniaxial loading. Taken together, our study highlights the importance of appropriate mechanobiological stimulation in 3D cell niches on tendon-like tissue formation and demonstrates that uniaxial mechanical loading plays an essential role in tenogenic differentiation and tendon formation by activating the PI3K/AKT signaling pathway.Wang, T., Thien, C., Wang, C., Ni, M., Gao, J., Wang, A., Jiang, Q., Tuan, R. S., Zheng, Q., Zheng, M. H. 3D uniaxial mechanical stimulation induces tenogenic differentiation of tendon-derived stem cells through a PI3K/AKT signaling pathway.	[Wang, Tao; Zheng, Qiujian; Zheng, Ming H.] Guangdong Acad Med Sci, Guangdong Gen Hosp, Div Orthopaed Surg, Dept Surg, Guangzhou, Guangdong, Peoples R China; [Wang, Tao; Thien, Christine; Wang, Carolyn; Gao, Junjie; Wang, Allan; Zheng, Ming H.] Univ Western Australia, Sch Biomed Sci, Ctr Orthopaed Translat Res, Nedlands, WA, Australia; [Ni, Ming] Chinese Peoples Liberat Army, Dept Orthopaed, Gen Hosp, Beijing, Peoples R China; [Wang, Allan] Sir Charles Gairdner Hosp, Perth, WA, Australia; [Jiang, Qing] Nanjing Univ, Drum Tower Hosp, Dept Sports Med & Adult Reconstruct, Sch Med, Nanjing, Jiangsu, Peoples R China; [Tuan, Rocky S.] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Ctr Cellular & Mol Engn, Pittsburgh, PA 15261 USA; [Tuan, Rocky S.] Chinese Univ Hong Kong, Inst Tissue Engn & Regenerat Med, Hong Kong, Hong Kong, Peoples R China; [Tuan, Rocky S.] Inst Tissue Engn & Regenerat Med, Hong Kong, Hong Kong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; University of Western Australia; Chinese People's Liberation Army General Hospital; University of Western Australia; Nanjing University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chinese University of Hong Kong	Zheng, QJ (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, 106 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.; Zheng, MH (corresponding author), Univ Western Australia, Fac Med Dent & Hlth Sci, 35 Stirling Hwy, Crawley, WA 6009, Australia.	zqj650@126.com; minghao.zheng@uwa.edu.au	Thien, Christine/GQP-0424-2022	Wang, Carolyn/0000-0002-4345-119X; Thien, Christine/0000-0003-3884-5546; Zheng, Minghao/0000-0003-1185-4768	Australia Research Council Linkage Grant [LP150100905]; National Natural Science Foundation of China [8180090299]; Guangdong Science and Technology Department [2015B020225007]	Australia Research Council Linkage Grant(Australian Research Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Department	This work is supported by the Australia Research Council Linkage Grant (LP150100905), National Natural Science Foundation of China (8180090299), and Guangdong Science and Technology Department (2015B020225007). The authors declare no conflicts of interest.	Ansorge HL, 2012, J ORTHOP RES, V30, P448, DOI 10.1002/jor.21542; Ansorge HL, 2011, ANN BIOMED ENG, V39, P1904, DOI 10.1007/s10439-011-0299-0; Azuma N, 2000, J VASC SURG, V32, P789, DOI 10.1067/mva.2000.107989; Bakker AD, 2016, J CELL PHYSIOL, V231, P1283, DOI 10.1002/jcp.25228; Briata P, 2012, CELL DEATH DIFFER, V19, P478, DOI 10.1038/cdd.2011.117; Charoenpanich A, 2014, TISSUE ENG PT A, V20, P67, DOI [10.1089/ten.tea.2013.0006, 10.1089/ten.TEA.2013.0006]; Chiu CZ, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-50; Cong X. X., 2018, STEM CELLS; Cosgrove BD, 2016, NAT MATER, V15, P1297, DOI [10.1038/NMAT4725, 10.1038/nmat4725]; Fitzgerald JB, 2004, J BIOL CHEM, V279, P19502, DOI 10.1074/jbc.M400437200; Gao JJ, 2016, ONCOTARGET, V7, P26966, DOI 10.18632/oncotarget.9034; Garvin J, 2003, TISSUE ENG, V9, P967, DOI 10.1089/107632703322495619; Govoni M, 2017, TISSUE ENG PT A, V23, P811, DOI [10.1089/ten.tea.2016.0407, 10.1089/ten.TEA.2016.0407]; Ishikawa S, 2012, AM J PHYSIOL-HEART C, V302, pH2536, DOI 10.1152/ajpheart.00940.2011; Jones ER, 2013, BBA-MOL CELL RES, V1833, P2596, DOI 10.1016/j.bbamcr.2013.06.019; Khan KM, 2009, BRIT J SPORT MED, V43, P247, DOI 10.1136/bjsm.2008.054239; Kuo CK, 2008, TISSUE ENG PT A, V14, P1615, DOI 10.1089/ten.tea.2006.0415; Li YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13149; Lin TW, 2004, J BIOMECH, V37, P865, DOI 10.1016/j.jbiomech.2003.11.005; Liu Y, 2017, FASEB J, V31, P3800, DOI 10.1096/fj.201601181R; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Ni M, 2013, BIOMATERIALS, V34, P2024, DOI 10.1016/j.biomaterials.2012.11.046; Niehoff A, 2008, J ORTHOP RES, V26, P616, DOI 10.1002/jor.20542; Paterno J, 2011, WOUND REPAIR REGEN, V19, P49, DOI 10.1111/j.1524-475X.2010.00643.x; Qi J, 2011, J APPL PHYSIOL, V110, P1425, DOI 10.1152/japplphysiol.00477.2010; Rice KM, 2007, EXP PHYSIOL, V92, P963, DOI 10.1113/expphysiol.2007.037275; Scott A, 2011, J MUSCULOSKEL NEURON, V11, P124; Simmons CA, 2003, J BIOMECH, V36, P1087, DOI 10.1016/S0021-9290(03)00110-6; Smith TG, 2005, DEVELOPMENT, V132, P1305, DOI 10.1242/dev.01699; Spangenburg EE, 2009, APPL PHYSIOL NUTR ME, V34, P328, DOI 10.1139/H09-010; Stanley RL, 2007, J ANAT, V211, P325, DOI 10.1111/j.1469-7580.2007.00781.x; Thompson WR, 2012, GENE, V503, P179, DOI 10.1016/j.gene.2012.04.076; Trumbull A, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0150-9; Wall ME, 2007, AM J PHYSIOL-CELL PH, V293, pC1532, DOI 10.1152/ajpcell.00065.2007; Wall ME, 2007, CELL MOTIL CYTOSKEL, V64, P121, DOI 10.1002/cm.20170; Wang T, 2018, J ORTHOP RES, V36, P566, DOI 10.1002/jor.23752; Wang T, 2015, J ORTHOP RES, V33, P1888, DOI 10.1002/jor.22960; Wang T, 2013, BIOTECHNOL BIOENG, V110, P1495, DOI 10.1002/bit.24809; Ward DF, 2007, STEM CELLS DEV, V16, P467, DOI 10.1089/scd.2007.0034; Yanagiya T, 2007, OBESITY, V15, P572, DOI 10.1038/oby.2007.547; Yang HS, 2016, CELL PHYSIOL BIOCHEM, V38, P237, DOI 10.1159/000438625; Yu HS, 2016, J TISSUE ENG, V7, DOI [10.1177/2041731415618342, 10.1177/2041731416676337]; Zhang ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep20300; Zhong XH, 2014, EXP THER MED, V7, P295, DOI 10.3892/etm.2013.1394	45	35	37	3	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4804	4814		10.1096/fj.201701384R	http://dx.doi.org/10.1096/fj.201701384R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29596022				2022-12-26	WOS:000443817700016
J	Jia, LY; Zhou, XY; Huang, XJ; Xu, XH; Jia, YH; Wu, YT; Yao, JL; Wu, YM; Wang, K				Jia, Linyan; Zhou, Xinyao; Huang, Xiaojie; Xu, Xianghong; Jia, Yuanhui; Wu, Yingting; Yao, Julei; Wu, Yanming; Wang, Kai			Maternal and umbilical cord serum-derived exosomes enhance endothelial cell proliferation and migration	FASEB JOURNAL			English	Article						microRNA; hepatocyte growth factor; angiogenesis; pregnancy	STEM-CELLS; ANGIOGENESIS; MICROPARTICLES; PREECLAMPSIA; MICRORNAS; GROWTH; CONTRIBUTES; REGULATORS; CANCER	We investigated the role of exosomes derived from maternal and umbilical cord blood in the regulation of angiogenesis. We report here that both maternal exosomes (MEs) and umbilical exosomes (UEs) significantly enhance HUVEC proliferation, migration, and tube formation. Importantly, ME-treated HUVECs (MEXs) displayed significantly increased migration, but not proliferation or tube formation, compared with UE-treated HUVECs (UEXs). We found that the expression of a subset of migration-related microRNAs (miRNAs), including miR-210-3p, miR-376c-3p, miR-151a-5p, miR-296-5p, miR-122-5p, and miR-550a-5p, among others, were significantly increased or decreased in UEs, and this altered expression was likely correlated with the differential regulation of HUVEC migration. We also found that the mRNA expression of hepatocyte growth factor (HGF) was up-regulated in MEXs and UEXs and, moreover, that inhibiting HGF partially abolished the enhanced cell migration induced by UEs. Our results suggest that both MEs and UEs greatly enhanced endothelial cell (EC) functions and differentially regulated EC migration, which was mostly attributed to the different expression profiles of exosomal miRNA. These findings highlight the importance of exosomes in the regulation of angiogenesis during pregnancy. Exosomal miRNAs, in particular, may be of great significance for the regulation of angiogenesis in maintaining normal pregnancy.Jia, L., Zhou, X., Huang, X., Xu, X., Jia, Y., Wu, Y., Yao, J., Wu, Y., Wang, K. Maternal and umbilical cord serum-derived exosomes enhance endothelial cell proliferation and migration.	[Jia, Linyan; Huang, Xiaojie; Xu, Xianghong; Jia, Yuanhui; Yao, Julei; Wang, Kai] Tongji Univ, Sch Med, Clin & Translat Res Ctr, Shanghai Matern & Infant Hosp 1, GaoKe West Rd 2699, Shanghai 201204, Peoples R China; [Zhou, Xinyao] Tongji Univ, Sch Med, Unit Fetal Med, Shanghai Matern & Infant Hosp 1, Shanghai, Peoples R China; [Wu, Yingting] Tongji Univ, Sch Med, Dept Lab Med, Shanghai Matern & Infant Hosp 1, Shanghai, Peoples R China; [Wu, Yanming] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA	Tongji University; Tongji University; Tongji University; University of Texas System; University of Texas Health San Antonio	Wang, K (corresponding author), Tongji Univ, Sch Med, Clin & Translat Res Ctr, Shanghai Matern & Infant Hosp 1, GaoKe West Rd 2699, Shanghai 201204, Peoples R China.	kaiwangcn@yahoo.com		Wu, Yanming/0000-0003-3357-3051	National Key Research and Development Program of China [2017YFA0104600]; National Natural Science Foundation of China [81601312, 81501270]; Shanghai Municipal Medical and Health Discipline Construction Project [2017ZZ02015]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Medical and Health Discipline Construction Project	This research was supported, in part, by National Key Research and Development Program of China (2017YFA0104600; to K. W.), National Natural Science Foundation of China (81601312; to X.Z.; 81501270; to X.X.), and Shanghai Municipal Medical and Health Discipline Construction Project (2017ZZ02015; to K.W.). The authors declare no conflicts of interest.	Alcayaga-Miranda F, 2016, ONCOTARGET, V7, P44462, DOI 10.18632/oncotarget.9852; Aliotta JM, 2016, CARDIOVASC RES, V110, P319, DOI 10.1093/cvr/cvw054; Baek R, 2016, J IMMUNOL METHODS, V438, P11, DOI 10.1016/j.jim.2016.08.007; Buendia P, 2015, FASEB J, V29, P173, DOI 10.1096/fj.14-249706; Burton GJ, 2009, REPRODUCTION, V138, P895, DOI 10.1530/REP-09-0092; Camus SM, 2015, BLOOD, V125, P3805, DOI 10.1182/blood-2014-07-589283; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110; Gong X, 2013, BIOCHEM BIOPH RES CO, V439, P493, DOI 10.1016/j.bbrc.2013.08.096; Gray WD, 2015, CIRC RES, V116, P255, DOI 10.1161/CIRCRESAHA.116.304360; Jonsson ME, 2015, DEVELOPMENT, V142, P3166, DOI 10.1242/dev.122747; Kambe S, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121616; Li N, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0551-0; Liang HW, 2016, J HEPATOL, V64, P278, DOI 10.1016/j.jhep.2015.09.013; Liang XL, 2016, J CELL SCI, V129, P2182, DOI 10.1242/jcs.170373; Liu C, 2016, ONCOTARGET, V7, P76250, DOI 10.18632/oncotarget.12841; Ma XJ, 2017, MOL MED REP, V16, P1565, DOI 10.3892/mmr.2017.6701; Mahmoud AM, 2017, FASEB J, V31, P4636, DOI 10.1096/fj.201601244RR; Maroun CR, 2014, PHARMACOL THERAPEUT, V142, P316, DOI 10.1016/j.pharmthera.2013.12.014; Mincheva-Nilsson L, 2014, AM J REPROD IMMUNOL, V72, P440, DOI 10.1111/aji.12311; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Salomon C, 2017, PROG MOL BIOL TRANSL, V145, P163, DOI 10.1016/bs.pmbts.2016.12.006; Salomon C, 2017, J CLIN ENDOCR METAB, V102, P3182, DOI 10.1210/jc.2017-00672; Scagliotti GV, 2013, CANCER TREAT REV, V39, P793, DOI 10.1016/j.ctrv.2013.02.001; Selmaj I, 2017, ANN NEUROL, V81, P703, DOI 10.1002/ana.24931; Skow RJ, 2017, CLIN SCI, V131, P2223, DOI 10.1042/CS20171036; Su MT, 2011, HUM REPROD UPDATE, V17, P803, DOI 10.1093/humupd/dmr027; Su R, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0737-1; Tang YT, 2017, INT J MOL MED, V40, P834, DOI 10.3892/ijmm.2017.3080; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Teng XM, 2015, CELL PHYSIOL BIOCHEM, V37, P2415, DOI 10.1159/000438594; Umezu T, 2014, BLOOD, V124, P3748, DOI 10.1182/blood-2014-05-576116; Wang K, 2017, BIOMED PHARMACOTHER, V91, P517, DOI 10.1016/j.biopha.2017.04.050; Wang P, 2016, ONCOL REP, V36, P247, DOI 10.3892/or.2016.4815; Xu JF, 2017, ONCOTARGET, V8, P75968, DOI 10.18632/oncotarget.18373; Yang XM, 2017, AM J CANCER RES, V7, P1738; Zhou XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep19910	37	40	41	1	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4534	4543		10.1096/fj.201701337RR	http://dx.doi.org/10.1096/fj.201701337RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29570394				2022-12-26	WOS:000439325400039
J	Jacques, B; Coincon, M; Sygusch, J				Jacques, Benoit; Coincon, Mathieu; Sygusch, Jurgen			Active site remodeling during the catalytic cycle in metal-dependent fructose-1,6-bisphosphate aldolases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme mechanism; crystal structure; Helicobacter pylori; metalloenzyme; zinc; conformational change; active site remodeling; fructose-1; 6-bisphosphate aldolase	CLASS-II ALDOLASES; PREVENT GASTRIC-CANCER; HELICOBACTER-PYLORI; ESCHERICHIA-COLI; CARBONIC-ANHYDRASE; MYCOBACTERIUM-TUBERCULOSIS; SUBSTRATE-BINDING; STRUCTURAL BASIS; ESSENTIAL GENES; FUNCTIONAL-ROLE	Crystal structures of two bacterial metal (Zn2+)-dependent d-fructose-1,6-bisphosphate (FBP) aldolases in complex with substrate, analogues, and triose-P reaction products were determined to 1.5-2.0 angstrom resolution. The ligand complexes cryotrapped in native or mutant Helicobacter pylori aldolase crystals enabled a novel mechanistic description of FBP C3-C4 bond cleavage. The reaction mechanism uses active site remodeling during the catalytic cycle, implicating relocation of the Zn2+ cofactor that is mediated by conformational changes of active site loops. Substrate binding initiates conformational changes triggered upon P1 phosphate binding, which liberates the Zn2+-chelating His-180, allowing it to act as a general base for the proton abstraction at the FBP C4 hydroxyl group. A second zinc-chelating His-83 hydrogen bonds the substrate C4 hydroxyl group and assists cleavage by stabilizing the developing negative charge during proton abstraction. Cleavage is concerted with relocation of the metal cofactor from an interior to a surface-exposed site, thereby stabilizing the nascent enediolate form. Conserved residue Glu-142 is essential for protonation of the enediolate form prior to product release. A d-tagatose 1,6-bisphosphate enzymatic complex reveals how His-180-mediated proton abstraction controls stereospecificity of the cleavage reaction. Recognition and discrimination of the reaction products, dihydroxyacetone-P and d-glyceraldehyde 3-P, occurs via charged hydrogen bonds between hydroxyl groups of the triose-Ps and conserved residues, Asp-82 and Asp-255, respectively, and are crucial aspects of the enzyme's role in gluconeogenesis. Conformational changes in mobile loops 5-7 and 6-8 (containing catalytic residues Glu-142 and His-180, respectively) drive active site remodeling, enabling the relocation of the metal cofactor.	[Jacques, Benoit; Coincon, Mathieu; Sygusch, Jurgen] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Sygusch, J (corresponding author), Univ Montreal, Biochim & Med Mol, CP 6128,Stn Ctr Ville, Montreal, PQ H3C 3J7, Canada.	Jurgen.Sygusch@umontreal.ca		Sygusch, Jurgen/0000-0002-6629-2128	Office of Biological and Environmental Research of the United States Department of Energy [DE-AC02-98CH10886]; Office of Basic Energy Sciences of the United States Department of Energy [DE-AC02-98CH10886]; National Center for Research Resources [P41RR012408]; National Institutes of Health [P41GM103473]; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103473] Funding Source: NIH RePORTER	Office of Biological and Environmental Research of the United States Department of Energy(United States Department of Energy (DOE)); Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Diffraction data for this study were collected in part on beamlines X12B, X25, and X29 of the National Synchrotron Light Source. Financial support comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy (Contract DE-AC02-98CH10886) and from the National Center for Research Resources (Grant P41RR012408) and the National Institutes of Health (Grant P41GM103473). Kind assistance by beamline personnel, Drs. L. Flaks, D. K. Schneider, A. Soares, A. Heroux, and H. Robinson, is gratefully acknowledged. Diffraction data were also collected using beamline 08ID-1 and 08B1-1 at the Canadian Light Source, which is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan. Data were collected with the assistance of Shaun Labiuk. We thank Dr. Alexandra Furtos of the Universite de Montreal Mass Spectrometry Facility for mass spectral analysis. We thank Oktavian Toka for assistance in the kinetic characterization of native and mutant H. pylori aldolases.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine P., 2005, LBNL60873, V42; BELASCO JG, 1983, BIOCHEMISTRY-US, V22, P122, DOI 10.1021/bi00270a018; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blom NS, 1996, NAT STRUCT BIOL, V3, P856, DOI 10.1038/nsb1096-856; BOCK CW, 1995, J AM CHEM SOC, V117, P3754, DOI 10.1021/ja00118a012; Capodagli GC, 2014, BIOCHEMISTRY-US, V53, P7604, DOI 10.1021/bi501141t; Capodagli GC, 2014, BIOCHEMISTRY-US, V53, P202, DOI 10.1021/bi401022b; CHALK PA, 1994, MICROBIOL-UK, V140, P2085, DOI 10.1099/13500872-140-8-2085; Chalker AF, 2001, J BACTERIOL, V183, P1259, DOI 10.1128/JB.183.4.1259-1268.2001; COLLINS KD, 1974, J BIOL CHEM, V249, P136; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI 10.1038/hr.2014.17; Doig P, 1999, MICROBIOL MOL BIOL R, V63, P675, DOI 10.1128/MMBR.63.3.675-707.1999; Dudev T, 2003, J AM CHEM SOC, V125, P3168, DOI 10.1021/ja0209722; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fonvielle M, 2008, CHEM-EUR J, V14, P8521, DOI 10.1002/chem.200800857; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Galkin A, 2007, J BIOL CHEM, V282, P4859, DOI 10.1074/jbc.M609534200; Galkin A, 2009, BIOCHEMISTRY-US, V48, P3186, DOI 10.1021/bi9001166; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; GINSBURG A, 1966, BIOCHEMISTRY-US, V5, P2623, DOI 10.1021/bi00872a021; Hall DR, 1999, J MOL BIOL, V287, P383, DOI 10.1006/jmbi.1999.2609; HEALY MJ, 1973, BIOCHEMISTRY-US, V12, P35, DOI 10.1021/bi00725a006; Hoffman PS, 1996, J BACTERIOL, V178, P4822, DOI 10.1128/jb.178.16.4822-4829.1996; Islam Z, 2015, J BIOL CHEM, V290, P11293, DOI 10.1074/jbc.M114.611830; Izard T, 2004, J BIOL CHEM, V279, P11825, DOI 10.1074/jbc.M311375200; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kimura E, 1999, J AM CHEM SOC, V121, P1267, DOI 10.1021/ja982904e; KOBES RD, 1969, BIOCHEMISTRY-US, V8, P585, DOI 10.1021/bi00830a018; Leatherbarrow R.J., 2001, GRAFIT VERSION 5; Lee SH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02211-3; Lee YC, 2008, J FORMOS MED ASSOC, V107, P591, DOI 10.1016/S0929-6646(08)60176-X; LEWIS DJ, 1973, J CHEM SOC CHEM COMM, P713, DOI 10.1039/c39730000713; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mabiala-Bassilou CG, 2008, BIOORG MED CHEM LETT, V18, P1735, DOI 10.1016/j.bmcl.2008.01.076; Marais A, 1999, MICROBIOL MOL BIOL R, V63, P642, DOI 10.1128/MMBR.63.3.642-674.1999; Marshall B.J., 2001, HELICOBACTER PYLORI; MARTIN RB, 1974, P NATL ACAD SCI USA, V71, P4346, DOI 10.1073/pnas.71.11.4346; MITCHELL HM, 2001, HELICOBACTER PYLORI, P7; Motta CRA, 2008, DIGESTION, V78, P3, DOI 10.1159/000151297; Mura C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000918; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pegan SD, 2013, BIOCHEMISTRY-US, V52, P912, DOI 10.1021/bi300928u; Pegan SD, 2009, J MOL BIOL, V386, P1038, DOI 10.1016/j.jmb.2009.01.003; Plater AR, 1999, J MOL BIOL, V285, P843, DOI 10.1006/jmbi.1998.2376; Plaumann M, 1997, CURR GENET, V31, P430, DOI 10.1007/s002940050226; Qamar S, 1996, PROTEIN SCI, V5, P154; RICHARDS OC, 1961, J BIOL CHEM, V236, P3177; ROSE IA, 1965, J BIOL CHEM, V240, P1758; RUTTER WJ, 1964, FED PROC, V23, P1248; Sharma A, 2011, J AM CHEM SOC, V133, P20194, DOI 10.1021/ja2030646; SINGER M, 1991, J BACTERIOL, V173, P6249, DOI 10.1128/jb.173.19.6249-6257.1991; SINGER M, 1991, J BACTERIOL, V173, P6242, DOI 10.1128/jb.173.19.6242-6248.1991; SMITH GM, 1980, BIOCHEMISTRY-US, V19, P1248, DOI 10.1021/bi00547a032; STEINER H, 1975, EUR J BIOCHEM, V59, P253, DOI 10.1111/j.1432-1033.1975.tb02449.x; Stingl K, 2001, INFECT IMMUN, V69, P1178, DOI 10.1128/IAI.69.2.1178-1181.2001; SZWERGOLD BS, 1995, ARCH BIOCHEM BIOPHYS, V317, P244, DOI 10.1006/abbi.1995.1159; Talley NJ, 2008, LANCET, V372, P350, DOI 10.1016/S0140-6736(08)61136-8; Terwilliger TC, 2007, ACTA CRYSTALLOGR D, V63, P101, DOI 10.1107/S0907444906046233; Terwilliger TC, 2006, ACTA CRYSTALLOGR D, V62, P915, DOI 10.1107/S0907444906017161; Touw WG, 2015, NUCLEIC ACIDS RES, V43, pD364, DOI 10.1093/nar/gku1028; TRENTHAM DR, 1969, BIOCHEM J, V114, P19, DOI 10.1042/bj1140019; TUNG TC, 1954, BIOCHIM BIOPHYS ACTA, V14, P488, DOI 10.1016/0006-3002(54)90228-0; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Warburg O, 1943, BIOCHEM Z, V314, P149; Wehmeier UF, 2001, FEMS MICROBIOL LETT, V197, P53, DOI 10.1111/j.1574-6968.2001.tb10582.x; Zgiby S, 2002, J MOL BIOL, V315, P131, DOI 10.1006/jmbi.2001.5237; Zgiby SM, 2000, EUR J BIOCHEM, V267, P1858, DOI 10.1046/j.1432-1327.2000.01191.x; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	70	10	10	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7737	7753		10.1074/jbc.RA117.001098	http://dx.doi.org/10.1074/jbc.RA117.001098			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29593097	hybrid, Green Published			2022-12-26	WOS:000437256500023
J	Liu, K; Xu, C; Lei, M; Yang, A; Loppnau, P; Hughes, TR; Min, JR				Liu, Ke; Xu, Chao; Lei, Ming; Yang, Ally; Loppnau, Peter; Hughes, Timothy R.; Min, Jinrong			Structural basis for the ability of MBD domains to bind methyl-CG and TG sites in DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						X-ray crystallography; epigenetics; DNA methylation; 5-methylcytosine; gene regulation; CAC motif; CpH methylation; methyl-CpG-binding domain (MBD); methyl-CpG-binding protein 2	NON-CPG METHYLATION; EMBRYONIC STEM-CELLS; RETT-SYNDROME; SEQUENCE SPECIFICITY; PROTEIN ARBP; MECP2; RECOGNITION; TRANSCRIPTION; COMPLEX; FAMILY	Cytosine methylation is a well-characterized epigenetic mark and occurs at both CG and non-CG sites in DNA. Both methylated CG (mCG)- and mCH (H = A, C, or T)-containing DNAs, especially mCAC-containing DNAs, are recognized by methyl-CpG-binding protein 2 (MeCP2) to regulate gene expression in neuron development. However, the molecular mechanism involved in the binding of methyl-CpG-binding domain (MBD) of MeCP2 to these different DNA motifs is unclear. Here, we systematically characterized the DNA-binding selectivities of the MBD domains in MeCP2 and MBD1-4 with isothermal titration calorimetry-based binding assays, mutagenesis studies, and X-ray crystallography. We found that the MBD domains of MeCP2 and MBD1-4 bind mCG-containing DNAs independently of the sequence identity outside the mCG dinucleotide. Moreover, some MBD domains bound to both methylated and unmethylated CA dinucleotide-containing DNAs, with a preference for the CAC sequence motif. We also found that the MBD domains bind to mCA or nonmethylated CA DNA by recognizing the complementary TG dinucleotide, which is consistent with an overlooked ligand of MeCP2, i.e. the matrix/scaffold attachment regions (MARs/SARs) with a consensus sequence of 5-GGTGT-3 that was identified in early 1990s. Our results also explain why MeCP2 exhibits similar binding affinity to both mCA- and hmCA-containing dsDNAs. In summary, our results suggest that in addition to mCG sites, unmethylated CA or TG sites also serve as DNA-binding sites for MeCP2 and other MBD-containing proteins. This discovery expands the genome-wide activity of MBD-containing proteins in gene regulation.	[Liu, Ke; Xu, Chao; Lei, Ming; Loppnau, Peter; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Yang, Ally; Hughes, Timothy R.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Liu, Ke; Xu, Chao; Lei, Ming; Min, Jinrong] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto; University of Toronto	Min, JR (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada.; Min, JR (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada.	jr.min@utoronto.ca	Min, Jinrong/G-3449-2011; Xu, Chao/G-3885-2010	Min, Jinrong/0000-0001-5210-3130; Xu, Chao/0000-0003-0444-7080; , KE/0000-0002-7082-262X	National Institutes of Health Grant from NCI [ACB-12002]; National Institutes of Health Grant from NIGMS [AGM-12006]; United States Department of Energy [DE-AC02-06CH11357]; AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada through Ontario Genomics Institute Grant [OGI-055]; Innovative Medicines Initiative (EU/EFPIA) ULTRA-DD Grant [115766]; Janssen (Darmstadt, Germany); Merck KGaA (Darmstadt, Germany); Merck Sharp and Dohme; Novartis Pharma AG; Ontario Ministry of Research, Innovation and Science (MRIS); Pfizer; SAo Paulo Research Foundation (FAPESP); Takeda; Wellcome	National Institutes of Health Grant from NCI; National Institutes of Health Grant from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy(United States Department of Energy (DOE)); AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada through Ontario Genomics Institute Grant(Genome Canada); Innovative Medicines Initiative (EU/EFPIA) ULTRA-DD Grant; Janssen (Darmstadt, Germany); Merck KGaA (Darmstadt, Germany); Merck Sharp and Dohme(Merck & Company); Novartis Pharma AG; Ontario Ministry of Research, Innovation and Science (MRIS); Pfizer(Pfizer); SAo Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome	We thank Wolfram Tempel for the structure determination. We thank Chuanbing Bian for the MBD2-mCG crystal structure, Aiping Dong for a coordinate averaging program, and Amy Wernimont for some diffraction data collection and crystal structure review. Some diffraction data were collected at the Structural Biology Center and the General Medical Sciences and Cancer Institutes Structural Biology Facility at the Advanced Photon Source (GM/CA at APS) is part of the X-ray Science Division at APS, Argonne National Laboratory. GM/CA received support from National Institutes of Health Grants ACB-12002 from NCI and AGM-12006 from NIGMS. Argonne is operated by the United States Department of Energy under Contract DE-AC02-06CH11357. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the following: AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada through Ontario Genomics Institute Grant OGI-055; Innovative Medicines Initiative (EU/EFPIA) ULTRA-DD Grant 115766; Janssen, Merck KGaA (Darmstadt, Germany); Merck Sharp and Dohme; Novartis Pharma AG; Ontario Ministry of Research, Innovation and Science (MRIS); Pfizer; SAo Paulo Research Foundation (FAPESP); Takeda; and Wellcome.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Baubec T, 2013, CELL, V153, P480, DOI 10.1016/j.cell.2013.03.011; Buck-Koehntop BA, 2012, P NATL ACAD SCI USA, V109, P15229, DOI 10.1073/pnas.1213726109; BUHRMESTER H, 1995, BIOCHEMISTRY-US, V34, P4108, DOI 10.1021/bi00012a029; Chen L, 2015, P NATL ACAD SCI USA, V112, P5509, DOI 10.1073/pnas.1505909112; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clouaire T, 2010, NUCLEIC ACIDS RES, V38, P4620, DOI 10.1093/nar/gkq228; Cramer JM, 2014, J BIOL CHEM, V289, P1294, DOI 10.1074/jbc.M113.512236; Daniel JM, 2002, NUCLEIC ACIDS RES, V30, P2911, DOI 10.1093/nar/gkf398; DEREWENDA ZS, 1995, J MOL BIOL, V252, P248, DOI 10.1006/jmbi.1995.0492; Du Q, 2015, EPIGENOMICS-UK, V7, P1051, DOI 10.2217/epi.15.39; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fraga MF, 2003, NUCLEIC ACIDS RES, V31, P1765, DOI 10.1093/nar/gkg249; Gabel HW, 2015, NATURE, V522, P89, DOI 10.1038/nature14319; Gildea RJ, 2011, J APPL CRYSTALLOGR, V44, P1259, DOI 10.1107/S0021889811041161; Guo JU, 2014, NAT NEUROSCI, V17, P215, DOI 10.1038/nn.3607; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Ichiyanagi T, 2013, NUCLEIC ACIDS RES, V41, P738, DOI 10.1093/nar/gks1117; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kinde B, 2015, P NATL ACAD SCI USA, V112, P6800, DOI 10.1073/pnas.1411269112; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Kozlenkov A, 2014, NUCLEIC ACIDS RES, V42, P109, DOI 10.1093/nar/gkt838; Kribelbauer JF, 2017, CELL REP, V19, P2383, DOI 10.1016/j.celrep.2017.05.069; Lagger S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006793; Lam KN, 2011, NUCLEIC ACIDS RES, V39, P4680, DOI 10.1093/nar/gkq1303; Lamoureux JS, 2006, STRUCTURE, V14, P555, DOI 10.1016/j.str.2005.11.017; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu YW, 2014, NUCLEIC ACIDS RES, V42, P4859, DOI 10.1093/nar/gku134; Liu YW, 2013, TRENDS BIOCHEM SCI, V38, P177, DOI 10.1016/j.tibs.2012.12.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; Otani J, 2013, J BIOL CHEM, V288, P6351, DOI 10.1074/jbc.M112.431098; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Rooman M, 2002, J MOL BIOL, V319, P67, DOI 10.1016/S0022-2836(02)00263-2; Saito M, 2002, J BIOL CHEM, V277, P35434, DOI 10.1074/jbc.M203455200; Scarsdale JN, 2011, NUCLEIC ACIDS RES, V39, P6741, DOI 10.1093/nar/gkr262; Schuetz A, 2011, CELL MOL LIFE SCI, V68, P3121, DOI 10.1007/s00018-010-0618-x; Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465; Shin J, 2013, CELL, V152, P940, DOI 10.1016/j.cell.2013.02.017; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; VONKRIES JP, 1991, CELL, V64, P123, DOI 10.1016/0092-8674(91)90214-J; Weirauch MT, 2013, NAT BIOTECHNOL, V31, P126, DOI 10.1038/nbt.2486; Weitzel JM, 1997, MOL CELL BIOL, V17, P5656, DOI 10.1128/MCB.17.9.5656; WOODCOCK DM, 1987, BIOCHEM BIOPH RES CO, V145, P888, DOI 10.1016/0006-291X(87)91048-5; Xu C, 2018, STRUCTURE, V26, P85, DOI 10.1016/j.str.2017.11.022; Xu YF, 2012, CELL, V151, P1200, DOI 10.1016/j.cell.2012.11.014; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389; Zou XQ, 2012, NUCLEIC ACIDS RES, V40, P2747, DOI 10.1093/nar/gkr1057; Zucker F, 2010, ACTA CRYSTALLOGR D, V66, P889, DOI 10.1107/S0907444910020421	60	38	40	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7344	7354		10.1074/jbc.RA118.001785	http://dx.doi.org/10.1074/jbc.RA118.001785			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29567833	hybrid, Green Published			2022-12-26	WOS:000432174500027
J	Ulfig, A; Freudl, R				Ulfig, Agnes; Freudl, Roland			The early mature part of bacterial twin-arginine translocation (Tat) precursor proteins contributes to TatBC receptor binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Escherichia coli (E; coli); membrane transport; protein targeting; protein translocation; protein export; early mature region; protein folding; secretion pathway; substrate receptor; twin arginine translocation	ESCHERICHIA-COLI; SIGNAL PEPTIDE; TRANSPORT-SYSTEM; FOLDED PROTEINS; EXPORT PATHWAY; COMPONENT; MEMBRANE; COMPLEX; MUTANT; SITE	The twin-arginine translocation (Tat) pathway transports folded proteins across bacterial membranes. Tat precursor proteins possess a conserved twin-arginine (RR) motif in their signal peptides that is involved in the binding of the proteins to the membrane-associated TatBC receptor complex. In addition, the hydrophobic region in the Tat signal peptides also contributes to TatBC binding, but whether regions beyond the signal-peptide cleavage site are involved in this process is unknown. Here, we analyzed the contribution of the early mature protein part of the Escherichia coli trimethylamine N-oxide reductase (TorA) to productive TatBC receptor binding. We identified substitutions in the 30 amino acids immediately following the TorA signal peptide (30aa-region) that restored export of a transport-defective TorA[KQ]-30aa-MalE precursor, in which the RR residues had been replaced by a lysine-glutamine pair. Some of these substitutions increased the hydrophobicity of the N-terminal part of the 30aa-region and thereby likely enhanced hydrophobic substrate-receptor interactions within the hydrophobic TatBC substrate-binding cavity. Another class of substitutions increased the positive net charge of the region's C-terminal part, presumably leading to strengthened electrostatic interactions between the mature substrate part and the cytoplasmic TatBC regions. Furthermore, we identified substitutions in the C-terminal domains of TatB following the transmembrane segment that restored transport of various transport-defective TorA-MalE derivatives. Some of these substitutions most likely affected the orientation or conformation of the flexible, carboxy-proximal helices of TatB. Therefore, we propose that a tight accommodation of the folded mature region by TatB contributes to productive binding of Tat substrates to TatBC.	[Ulfig, Agnes; Freudl, Roland] Forschungszentrum Julich, Inst Bio & Geosci, IBG Biotechnol 1, Wilhelm Johnen Str, D-52425 Julich, Germany; [Ulfig, Agnes] Ruhr Univ Bochum, Microbial Biochem, Inst Biochem & Pathobiochem, Univ Str 150, D-44780 Bochum, Germany	Helmholtz Association; Research Center Julich; Ruhr University Bochum	Freudl, R (corresponding author), Forschungszentrum Julich, Inst Bio & Geosci, IBG Biotechnol 1, Wilhelm Johnen Str, D-52425 Julich, Germany.	r.freudl@fz-juelich.de	Freudl, Roland/N-4179-2017	Freudl, Roland/0000-0003-0743-1279; Ulfig, Agnes/0000-0003-2689-6311				Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Alcock F, 2016, ELIFE, V5, DOI 10.7554/eLife.20718; Bageshwar UK, 2009, MOL MICROBIOL, V74, P209, DOI 10.1111/j.1365-2958.2009.06862.x; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Berks BC, 2015, ANNU REV BIOCHEM, V84, P843, DOI 10.1146/annurev-biochem-060614-034251; Blaudeck N, 2005, J BIOL CHEM, V280, P3426, DOI 10.1074/jbc.M411210200; Blaudeck N, 2003, J BACTERIOL, V185, P2811, DOI 10.1128/JB.185.9.2811-2819.2003; Blummel AS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8234; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; Buchanan G, 2001, ARCH MICROBIOL, V177, P107, DOI 10.1007/s00203-001-0366-2; Celedon JM, 2013, BBA-MOL CELL RES, V1833, P341, DOI 10.1016/j.bbamcr.2012.06.028; Chatzi KE, 2017, J CELL BIOL, V216, P1357, DOI 10.1083/jcb.201609022; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cline K, 2015, J BIOL CHEM, V290, P16530, DOI 10.1074/jbc.R114.626820; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Denks K, 2014, MOL MEMBR BIOL, V31, P58, DOI 10.3109/09687688.2014.907455; Eimer E, 2015, J BIOL CHEM, V290, P29281, DOI 10.1074/jbc.M115.696005; Fincher V, 1998, FEBS LETT, V423, P66, DOI 10.1016/S0014-5793(98)00066-0; Frobel J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2308; Frobel J, 2012, PHILOS T R SOC B, V367, P1029, DOI 10.1098/rstb.2011.0202; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Goosens VJ, 2014, BBA-MOL CELL RES, V1843, P1698, DOI 10.1016/j.bbamcr.2013.10.008; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HENGGE R, 1983, BIOCHIM BIOPHYS ACTA, V737, P443, DOI 10.1016/0304-4157(83)90009-6; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; Hou B, 2006, J MOL BIOL, V355, P957, DOI 10.1016/j.jmb.2005.11.029; Hou Bo, 2011, Biomol Concepts, V2, P507, DOI 10.1515/BMC.2011.040; Huang Q, 2017, MBIO, V8, DOI 10.1128/mBio.00909-17; Huang Q, 2017, P NATL ACAD SCI USA, V114, pE1958, DOI 10.1073/pnas.1615056114; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; Lausberg F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039867; Lee PA, 2002, J BACTERIOL, V184, P5871, DOI 10.1128/JB.184.21.5871-5879.2002; Lee PA, 2006, J BIOL CHEM, V281, P34072, DOI 10.1074/jbc.M607295200; Maurer C, 2010, MOL BIOL CELL, V21, P4151, DOI 10.1091/mbc.E10-07-0585; McDevitt CA, 2006, FEBS J, V273, P5656, DOI 10.1111/j.1742-4658.2006.05554.x; MILLER JG, 1972, SHORT COURSE BACTERI; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Robinson C, 2011, BBA-BIOMEMBRANES, V1808, P876, DOI 10.1016/j.bbamem.2010.11.023; Rodriguez F, 2013, P NATL ACAD SCI USA, V110, pE1092, DOI 10.1073/pnas.1219486110; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shanmugham A, 2006, BIOCHEMISTRY-US, V45, P2243, DOI 10.1021/bi052188a; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Strauch EM, 2007, J MOL BIOL, V374, P283, DOI 10.1016/j.jmb.2007.09.050; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; TANAKA S, 1967, J BACTERIOL, V93, P642, DOI 10.1128/JB.93.2.642-648.1967; Ulfig A, 2017, J BIOL CHEM, V292, P10865, DOI 10.1074/jbc.M117.788950; Zhang Y, 2014, BBA-BIOMEMBRANES, V1838, P1881, DOI 10.1016/j.bbamem.2014.03.015; Zoufaly S, 2012, J BIOL CHEM, V287, P13430, DOI 10.1074/jbc.M112.343798	52	4	4	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7281	7299		10.1074/jbc.RA118.002576	http://dx.doi.org/10.1074/jbc.RA118.002576			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29593092	Green Published, hybrid			2022-12-26	WOS:000432174500023
J	Clarke, BR; Ovchinnikova, OG; Kelly, SD; Williamson, ML; Butler, JE; Liu, B; Wang, L; Gou, X; Follador, R; Lowary, TL; Whitfield, C				Clarke, Bradley R.; Ovchinnikova, Olga G.; Kelly, Steven D.; Williamson, Monica L.; Butler, Jennifer E.; Liu, Bin; Wang, Lu; Gou, Xi; Follador, Rainer; Lowary, Todd L.; Whitfield, Chris			Molecular basis for the structural diversity in serogroup O2-antigen polysaccharides in Klebsiella pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPOLYSACCHARIDE O-ANTIGEN; D-GALACTAN-I; GENOMIC ANALYSIS; SEROTYPE O1-K20; IDENTIFICATION; BIOSYNTHESIS; GENE; RESISTANCE; VIRULENCE; MEMBRANE	Klebsiella pneumoniae is a major health threat. Vaccination and passive immunization are considered as alternative therapeutic strategies for managing Klebsiella infections. Lipopolysaccharide O antigens are attractive candidates because of the relatively small range of known O-antigen polysaccharide structures, but immunotherapeutic applications require a complete understanding of the structures found in clinical settings. Currently, the precise number of Klebsiella O antigens is unknown because available serological tests have limited resolution, and their association with defined chemical structures is sometimes uncertain. Molecular serotyping methods can evaluate clinical prevalence of Oserotypes but require a full understanding of the genetic determinants for each O-antigen structure. This is problematic with Klebsiella pneumoniae because genes outside the main rfb (O-antigen biosynthesis) locus can have profound effects on the final structure. Here, we report two new loci encoding enzymes that modify a conserved polysaccharide backbone comprising disaccharide repeat units [-> 3)-alpha-D-Galp-( 1 -> 3)-beta-D-Galf-(1 ->] (O2a antigen). We identified in serotype O2aeh a three-component system that modifies completed O2a glycan in the periplasm by adding 1,2-linked alpha-Galp side-group residues. In serotype O2ac, a polysaccharide comprising disaccharide repeat units [-> 5)-beta-D-Galf-(1 -> 3)-beta-D-GlcpNAc-(1 ->] (O2c antigen) is attached to the non-reducing termini of O2a-antigen chains. O2c-polysaccharide synthesis is dependent on a locus encoding three glycosyltransferase enzymes. The authentic O2aeh and O2c antigens were recapitulated in recombinant Escherichia coli hosts to establish the essential gene set for their synthesis. These findings now provide a complete understanding of the molecular genetic basis for the known variations in Klebsiella O-antigen carbohydrate structures based on the O2a backbone.	[Clarke, Bradley R.; Ovchinnikova, Olga G.; Kelly, Steven D.; Williamson, Monica L.; Butler, Jennifer E.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada; [Liu, Bin; Wang, Lu; Gou, Xi] Nankai Univ, TEDA Inst Biol Sci & Biotechnol, 23 Hongda St TEDA, Tianjin 300457, Peoples R China; [Follador, Rainer] LimmaTech Biol AG, CH-8952 Schlieren, Switzerland; [Lowary, Todd L.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Lowary, Todd L.] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada	University of Guelph; Nankai University; University of Alberta; University of Alberta	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca	Lowary, Todd L/F-9608-2019	Lowary, Todd L/0000-0002-8331-8211; Kelly, Steven/0000-0003-1250-7055	National Science and Engineering Research Council of Canada; Canadian Glycomics Network	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Glycomics Network	This work was supported by Discovery Grants from the National Science and Engineering Research Council of Canada (to T. L. L. and C. W.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Canada Research Chair, supported by the Canadian Glycomics Network.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ardiccioni C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10175; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bengoechea JA, 2002, MOL MICROBIOL, V44, P1045, DOI 10.1046/j.1365-2958.2002.02940.x; Bethesda Research Laboratories, 1986, BETHESDA RES LAB FOC, V8, P9; BOCK K, 1983, ADV CARBOHYD CHEM BI, V41, P27, DOI 10.1016/S0065-2318(08)60055-4; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; BRONNER D, 1994, MOL MICROBIOL, V14, P505, DOI 10.1111/j.1365-2958.1994.tb02185.x; CLARK CA, 1991, GENE, V107, P43, DOI 10.1016/0378-1119(91)90295-M; CLARKE BR, 1995, J BACTERIOL, V177, P5411, DOI 10.1128/jb.177.19.5411-5418.1995; CLARKE BR, 1992, J BACTERIOL, V174, P4614, DOI 10.1128/JB.174.14.4614-4621.1992; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Darwin AJ, 1999, MOL MICROBIOL, V32, P51, DOI 10.1046/j.1365-2958.1999.01324.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Davies MR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003568; Fang CT, 2016, J CLIN MICROBIOL, V54, P666, DOI 10.1128/JCM.02494-15; Follador R, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000073; Gorrie CL, 2017, CLIN INFECT DIS, V65, P208, DOI 10.1093/cid/cix270; Guan S, 2001, J BACTERIOL, V183, P3318, DOI 10.1128/JB.183.11.3318-3327.2001; Hansen DS, 1999, J CLIN MICROBIOL, V37, P56, DOI 10.1128/JCM.37.1.56-62.1999; The HC, 2015, EMBO MOL MED, V7, P227, DOI 10.15252/emmm.201404767; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Holt KE, 2015, P NATL ACAD SCI USA, V112, pE3574, DOI 10.1073/pnas.1501049112; Hsieh PF, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00608; KELLY RF, 1995, J ENDOTOXIN RES, V0002; KELLY RF, 1993, MOL MICROBIOL, V10, P615, DOI 10.1111/j.1365-2958.1993.tb00933.x; Kintz E, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.01021-16; KOL O, 1992, CARBOHYD RES, V236, P339, DOI 10.1016/0008-6215(92)85028-X; Koplin R, 1997, J BIOL CHEM, V272, P4121, DOI 10.1074/jbc.272.7.4121; Kos V, 2010, J BIOL CHEM, V285, P19668, DOI 10.1074/jbc.M110.122598; Kos V, 2009, J BIOL CHEM, V284, P2947, DOI 10.1074/jbc.M807213200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDBERG B, 1973, ACTA CHEM SCAND, V27, P3787, DOI 10.3891/acta.chem.scand.27-3787; LIPKIND GM, 1988, CARBOHYD RES, V175, P59, DOI 10.1016/0008-6215(88)80156-3; Loibl M, 2013, BBA-MOL CELL RES, V1833, P2438, DOI 10.1016/j.bbamcr.2013.02.008; MACLEAN LL, 1993, CARBOHYD RES, V239, P325, DOI 10.1016/0008-6215(93)84231-T; Mann E, 2016, CAN J CHEM, V94, P883, DOI 10.1139/cjc-2015-0594; Mann E, 2015, J BIOL CHEM, V290, P25561, DOI 10.1074/jbc.M115.660803; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; MCCALLUM KL, 1989, INFECT IMMUN, V57, P3816, DOI 10.1128/IAI.57.12.3816-3822.1989; Miller J. H., 1972, EXPT MOL GENETICS, P432; Nair A, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-67; ORSKOV I, 1954, ACTA PATHOL MIC SC, V34, P145; ORSKOV I, 1984, METHOD MICROBIOL, V14, P143, DOI 10.1016/S0580-9517(08)70449-5; Paczosa MK, 2016, MICROBIOL MOL BIOL R, V80, P629, DOI 10.1128/MMBR.00078-15; Pan YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15573; Pennini ME, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02223-7; Pitout JDD, 2015, ANTIMICROB AGENTS CH, V59, P5873, DOI 10.1128/AAC.01019-15; Rukavina T, 1997, INFECT IMMUN, V65, P1754, DOI 10.1128/IAI.65.5.1754-1760.1997; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Slauch JM, 1996, J BACTERIOL, V178, P5904, DOI 10.1128/jb.178.20.5904-5909.1996; Stojkovic K, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00684; STRALEY SC, 1995, TRENDS MICROBIOL, V3, P310, DOI 10.1016/S0966-842X(00)88960-X; Sun QZ, 2014, J BACTERIOL, V196, P3656, DOI 10.1128/JB.02009-14; Szijarto V, 2017, VIRULENCE, V8, P1203, DOI 10.1080/21505594.2017.1279778; Szijarto V, 2016, INT J MED MICROBIOL, V306, P89, DOI 10.1016/j.ijmm.2015.12.002; Trautmann M, 1997, CLIN DIAGN LAB IMMUN, V4, P550, DOI 10.1128/CDLI.4.5.550-555.1997; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; VERMA NK, 1991, MOL MICROBIOL, V5, P71, DOI 10.1111/j.1365-2958.1991.tb01827.x; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; Wand ME, 2015, ANTIMICROB AGENTS CH, V59, P3966, DOI 10.1128/AAC.05009-14; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; WHITFIELD C, 1991, J BACTERIOL, V173, P1420, DOI 10.1128/jb.173.4.1420-1431.1991; WHITFIELD C, 1992, J BACTERIOL, V174, P4913, DOI 10.1128/JB.174.15.4913-4919.1992; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Wyres KL, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000102; Yan AX, 2007, J BIOL CHEM, V282, P36077, DOI 10.1074/jbc.M706172200; Young GM, 1997, MOL MICROBIOL, V25, P319, DOI 10.1046/j.1365-2958.1997.4661829.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang LJ, 1997, MOL MICROBIOL, V23, P63, DOI 10.1046/j.1365-2958.1997.1871558.x	72	20	21	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4666	4679		10.1074/jbc.RA117.000646	http://dx.doi.org/10.1074/jbc.RA117.000646			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29602878	Green Published, hybrid			2022-12-26	WOS:000428848300010
J	Huvanandana, J; Carberry, AE; Turner, RM; Bek, EJ; Raynes-Greenow, CH; McEwan, AL; Jeffery, HE				Huvanandana, Jacqueline; Carberry, Angela E.; Turner, Robin M.; Bek, Emily J.; Raynes-Greenow, Camille H.; McEwan, Alistair L.; Jeffery, Heather E.			An anthropometric approach to characterising neonatal morbidity and body composition, using air displacement plethysmography as a criterion method	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; BIRTH-WEIGHT; DEVELOPING-COUNTRIES; HEAD CIRCUMFERENCE; FAT PERCENTAGE; INFANTS; VALIDATION; NEWBORNS; BRAIN; AGE	Background With the greatest burden of infant undernutrition and morbidity in low and middle income countries (LMICs), there is a need for suitable approaches to monitor infants in a simple, low-cost and effective manner. Anthropometry continues to play a major role in characterising growth and nutritional status. Methods We developed a range of models to aid in identifying neonates at risk of malnutrition. We first adopted a logistic regression approach to screen for a composite neonatal morbidity, low and high body fat (BF%) infants. We then developed linear regression models for the estimation of neonatal fat mass as an assessment of body composition and nutritional status. Results We fitted logistic regression models combining up to four anthropometric variables to predict composite morbidity and low and high BF% neonates. The greatest area under receiver-operator characteristic curves (AUC with 95% confidence intervals (CI)) for identifying composite morbidity was 0.740 (0.63, 0.85), resulting from the combination of birthweight, length, chest and mid-thigh circumferences. The AUCs (95% CI) for identifying low and high BF% were 0.827 (0.78, 0.88) and 0.834 (0.79, 0.88), respectively. For identifying composite morbidity, BF% as measured via air displacement plethysmography showed strong predictive ability (AUC 0.786 (0.70, 0.88)), while birthweight percentiles had a lower AUC (0.695 (0.57, 0.82)). Birthweight percentiles could also identify low and high BF% neonates with AUCs of 0.792 (0.74, 0.85) and 0.834 (0.79, 0.88). We applied a sex-specific approach to anthropometric estimation of neonatal fat mass, demonstrating the influence of the testing sample size on the final model performance. Conclusions These models display potential for further development and evaluation in LMICs to detect infants in need of further nutritional management, especially where traditional methods of risk management such as birthweight for gestational age percentiles may be variable or non-existent, or unable to detect appropriately grown, low fat newborns.	[Huvanandana, Jacqueline; Carberry, Angela E.; McEwan, Alistair L.; Jeffery, Heather E.] Univ Sydney, Sch Elect & Informat Engn, Sydney, NSW, Australia; [Turner, Robin M.] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Bek, Emily J.; Jeffery, Heather E.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Raynes-Greenow, Camille H.; Jeffery, Heather E.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia	University of Sydney; University of New South Wales Sydney; University of Sydney; University of Sydney	Huvanandana, J (corresponding author), Univ Sydney, Sch Elect & Informat Engn, Sydney, NSW, Australia.	j.huvanandana@gmail.com	McEwan, Alistair L/W-6552-2019	McEwan, Alistair L/0000-0001-7597-6372				[Anonymous], 2010, WORLD HLTH STAT 2010; Aris IM, 2013, EUR J CLIN NUTR, V67, P922, DOI 10.1038/ejcn.2013.69; Carberry AE, 2013, PEDIATR RES, V74, P730, DOI 10.1038/pr.2013.156; CATALANO PM, 1995, AM J OBSTET GYNECOL, V173, P1176, DOI 10.1016/0002-9378(95)91348-3; Cauble JS, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0844-6; COOKE RWI, 1977, EARLY HUM DEV, V1, P145, DOI 10.1016/0378-3782(77)90015-9; Deierlein AL, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-21; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Donnelly JM, 2015, PEDIATR OBES, V10, P52, DOI 10.1111/j.2047-6310.2013.00216.x; Ellis KJ, 2007, AM J CLIN NUTR, V85, P90, DOI 10.1093/ajcn/85.1.90; Ellis KJ, 2007, SEMINARS FETAL NEONA; Flynn M, 1999, REPORT BRIT NUTR FDN, P45; Fonseca MJ, 2015, ACTA PAEDIATR, V104, P1028, DOI 10.1111/apa.12894; Goto E, 2011, J EPIDEMIOL, V21, P354, DOI 10.2188/jea.JE20100182; Thi HN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142420; Hawkes CP, 2011, PEDIATRICS, V128, pE645, DOI 10.1542/peds.2010-3856; Jeffery HE, 1996, MED EDUC, V30, P440, DOI 10.1111/j.1365-2923.1996.tb00865.x; Koo WWK, 2004, PEDIATR RES, V56, P694, DOI 10.1203/01.PDR.0000142587.59238.BD; Lawoyin T., 1997, AFRICAN J MED MED SC, V27, P143; LEVITSKY DA, 1995, J NUTR, V125, pS2212, DOI 10.1093/jn/125.suppl_8.2212S; Lingwood BE, 2012, BRIT J NUTR, V107, P1545, DOI 10.1017/S0007114511004624; Ma GS, 2004, AM J CLIN NUTR, V79, P653; Mwangome MK, 2012, B WORLD HEALTH ORGAN, V90, P887, DOI 10.2471/BLT.12.109009; OCONNELL EJ, 1965, PEDIATRICS, V36, P62; Paley C, 2015, PEDIAT OBESITY; Pelletier DL, 2003, J NUTR, V133, P107, DOI 10.1093/jn/133.1.107; Prado EL, 2014, NUTR REV, V72, P267, DOI 10.1111/nure.12102; R Core Team, 2013, LANG ENV STAT COMP; Regnault N, 2011, ARCH DIS CHILD-FETAL, V96, pF217, DOI 10.1136/adc.2010.185546; Rodriguez G, 2004, EUR J PEDIATR, V163, P457, DOI 10.1007/s00431-004-1468-z; Roggero P, 2010, NEONATOLOGY, V97, P139, DOI 10.1159/000239767; Sauder KA, 2017, J PEDIATR-US, V183, P94, DOI 10.1016/j.jpeds.2017.01.014; Schmelzle HR, 2002, AM J CLIN NUTR, V76, P1096, DOI 10.1093/ajcn/76.5.1096; Singh KA, 2010, OBSTET GYNECOL, V115, P998, DOI 10.1097/AOG.0b013e3181da901a; United Nations Children's Fund (UNICEF), 2010, FACTS LIF, VFourth; West J, 2011, PAEDIATR PERINAT EP, V25, P164, DOI 10.1111/j.1365-3016.2010.01181.x; Wood AJ, 2013, J PAEDIATR CHILD H, V49, P199, DOI 10.1111/jpc.12119; Wrottesley SV, 2016, EUR J CLIN NUTR, V70, P1254, DOI 10.1038/ejcn.2016.91; Yajnik CS, 2003, INT J OBESITY, V27, P173, DOI 10.1038/sj.ijo.802219	40	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195193	10.1371/journal.pone.0195193	http://dx.doi.org/10.1371/journal.pone.0195193			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601596	Green Published, Green Submitted, gold			2022-12-26	WOS:000428845900022
J	Patry, C; Remme, C; Betzen, C; Tonshoff, B; Yard, BA; Beck, G; Rafat, N				Patry, Christian; Remme, Christoph; Betzen, Christian; Toenshoff, Burkhard; Yard, Benito A.; Beck, Grietje; Rafat, Neysan			VCAM-1 expression is upregulated by CD34(+)/CD133(+)-stem cells derived from septic patients	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; INTERCELLULAR-ADHESION MOLECULE-1; ACUTE LUNG INJURY; GROWTH-FACTOR; ORGAN FAILURE; SEVERE SEPSIS; MYOCARDIAL-INFARCTION; PERIPHERAL-BLOOD; STEM-CELLS; RECRUITMENT	CD34(+)/CD133(+)-cells are a bone marrow derived stem cell population, which presumably contain vascular progenitor cells and are associated with improved vascular repair. In this study, we investigated whether the adhesion molecules ICAM-1 (intercellular adhesion molecule-1), VCAM-1 (vascular adhesion molecule-1), E-selectin und L-selectin, which are involved in homing of vascular stem cells, are upregulated by CD34(+)/CD133(+)-stem cells from septic patients and would be associated with improved clinical outcome. Peripheral blood mononuclear cells from intensive care unit (ICU) patients with (n = 30) and without sepsis (n = 10), and healthy volunteers (n = 15) were isolated using Ficoll density gradient centrifugation. The expression of VCAM-1, ICAM-1, E-selectin and L-selectin was detected on CD34(+)/CD133(+)-stem cells by flow cytometry. The severity of disease was assessed by the Simplified Acute Physiology Score (SAPS) II. Serum concentrations of vascular endothelial growth factor (VEGF) and angiopoietin (Ang)-2 were determined by Enzyme-linked immunosorbent assay. The expression of VCAM-1, ICAM-1, E-selectin and L-selectin by CD34(+)/CD133(+)-stem cells was significantly upregulated in septic patients, and correlated with sepsis severity. Furthermore, high expression of VCAM-1 by CD34(+)/CD133(+)-stem cells revealed a positive association with mortalitiy (p<0.05). Furthermore, significantly higher serum concentrations of VEGF and Ang-2 were found in septic patients, however none showed a strong association with survival. Our data suggest, that VCAM-1 upregulation on CD34(+)/CD133(+)-stem cells could play a crucial role in their homing in the course of sepsis. An increase in sepsis severity resulted in both and increase in CD34(+)/CD133(+)-stem cells and VCAM-1-expression by those cells, which might reflect an increase in need for vascular repair.	[Patry, Christian; Betzen, Christian; Toenshoff, Burkhard; Rafat, Neysan] Univ Childrens Hosp Heidelberg, Dept Pediat 1, Heidelberg, Germany; [Patry, Christian] Heidelberg Univ, Div Cardiovasc Physiol, Inst Physiol & Pathophysiol, Heidelberg, Germany; [Remme, Christoph] Univ Med Ctr Mannheim, Dept Anaesthesiol & Crit Care Med, Mannheim, Germany; [Betzen, Christian] German Canc Res Ctr, Div Funct Genome Anal, Heidelberg, Germany; [Yard, Benito A.] Univ Med Ctr Mannheim, Dept Med 5, Mannheim, Germany; [Beck, Grietje] HELIOS Dr Horst Schmidt Kliniken, Dept Anaesthesiol & Crit Care Med, Wiesbaden, Germany; [Rafat, Neysan] Bahai Inst Higher Educ BIHE, Dept Pharmaceut Sci, Tehran, Iran	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Rafat, N (corresponding author), Univ Childrens Hosp Heidelberg, Dept Pediat 1, Heidelberg, Germany.; Rafat, N (corresponding author), Bahai Inst Higher Educ BIHE, Dept Pharmaceut Sci, Tehran, Iran.	Neysan.Rafat@med.uni-heidelberg.de		Patry, Christian/0000-0002-1270-6508	University of Heidelberg	University of Heidelberg	Christian Patry and Neysan Rafat have been granted a 2 year research scholarship by the University of Heidelberg (physician scientist program). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Becchi C, 2008, INT J IMMUNOPATH PH, V21, P697, DOI 10.1177/039463200802100324; Besnier E, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1734-x; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Burnham EL, 2010, AM J RESP CELL MOL, V43, P326, DOI 10.1165/rcmb.2009-0015OC; Caiado F, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-4; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Cribbs SK, 2012, INTENS CARE MED, V38, P429, DOI 10.1007/s00134-012-2480-9; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Foubert P, 2007, J CLIN INVEST, V117, P1527, DOI 10.1172/JCI28338; Gill KA, 2005, BIOCHEM BIOPH RES CO, V336, P392, DOI 10.1016/j.bbrc.2005.08.097; Hanjaya-Putra D, 2010, J CELL MOL MED, V14, P2436, DOI 10.1111/j.1582-4934.2009.00981.x; Hattori K, 2001, J EXP MED, V193, P1005, DOI 10.1084/jem.193.9.1005; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Herrmann M, 2014, STEM CELL RES, V13, P465, DOI 10.1016/j.scr.2014.10.005; Karlsson S, 2008, ANESTH ANALG, V106, P1820, DOI 10.1213/ane.0b013e31816a643f; Kung CT, 2016, CLIN CHIM ACTA, V455, P1, DOI 10.1016/j.cca.2016.01.015; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Liu ZJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34416; Luo TH, 2009, CRIT CARE, V13, DOI 10.1186/cc7968; Mackie AR, 2012, CIRC RES, V111, P312, DOI 10.1161/CIRCRESAHA.112.266015; Mackie AR, 2011, TEX HEART I J, V38, P474; Mutunga M, 2001, AM J RESP CRIT CARE, V163, P195, DOI 10.1164/ajrccm.163.1.9912036; Nolte D, 2004, EUR SURG RES, V36, P331, DOI 10.1159/000081641; Sosa-Bustamante GP, 2011, REV INVEST CLIN, V63, P601; Rafat N, 2014, J PULM RESP MED, V4; Rafat N, 2007, CRIT CARE MED, V35, P1677, DOI 10.1097/01.CCM.0000269034.86817.59; Rafat Neysan, 2014, BMC Res Notes, V7, P613, DOI 10.1186/1756-0500-7-613; Rafat N, 2013, AM J RESP CELL MOL, V48, P399, DOI 10.1165/rcmb.2011-0132TR; Sakr Y, 2004, CRIT CARE MED, V32, P1825, DOI 10.1097/01.CCM.0000138558.16257.3F; Silverman MD, 2007, ARTHRITIS RHEUM-US, V56, P1817, DOI 10.1002/art.22706; Siner JM, 2009, SHOCK, V31, P348, DOI 10.1097/SHK.0b013e318188bd06; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Thum T, 2005, J AM COLL CARDIOL, V46, P1693, DOI 10.1016/j.jacc.2005.04.066; Tilling L, 2009, BRIT J CLIN PHARMACO, V68, P484, DOI 10.1111/j.1365-2125.2009.03486.x; Vajkoczy P, 2003, J EXP MED, V197, P1755, DOI 10.1084/jem.20021659; van der Flier M, 2005, SHOCK, V23, P35, DOI 10.1097/01.shk.0000150728.91155.41; Verma I, 2017, INT J ANGIOL, V26, P36, DOI 10.1055/s-0036-1593445; Whalen MJ, 2000, CRIT CARE MED, V28, P2600, DOI 10.1097/00003246-200007000-00070; Yan R, 2017, J INNATE IMMUN, V9, P546, DOI 10.1159/000477211; Yano K, 2006, J EXP MED, V203, P1447, DOI 10.1084/jem.20060375; Yoon CH, 2006, ARTERIOSCL THROM VAS, V26, P1066, DOI 10.1161/01.ATV.0000215001.92941.6c; Zahran AM, 2016, PEDIATR EMERG CARE, V32, P163, DOI 10.1097/PEC.0000000000000727; Zhang YM, 2009, AM J PHYSIOL-HEART C, V296, pH1675, DOI 10.1152/ajpheart.00665.2008	45	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195064	10.1371/journal.pone.0195064	http://dx.doi.org/10.1371/journal.pone.0195064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601599	Green Published, gold, Green Submitted			2022-12-26	WOS:000428845900017
J	Burkholder, GA; Tamhane, AR; Safford, MM; Muntner, PM; Willig, AL; Willig, JH; Raper, JL; Saag, MS; Mugavero, MJ				Burkholder, Greer A.; Tamhane, Ashutosh R.; Safford, Monika M.; Muntner, Paul M.; Willig, Amanda L.; Willig, James H.; Raper, James L.; Saag, Michael S.; Mugavero, Michael J.			Racial disparities in the prevalence and control of hypertension among a cohort of HIV-infected patients in the southeastern United States	PLOS ONE			English	Article							BLOOD-PRESSURE CONTROL; ACUTE MYOCARDIAL-INFARCTION; AFRICAN-ORIGIN; RISK; HEALTH; CARE; ATHEROSCLEROSIS; RACE/ETHNICITY; METAANALYSIS; POPULATIONS	Background African Americans are disproportionately affected by both HIV and hypertension. Failure to modify risk factors for cardiovascular disease and chronic kidney disease such as hypertension among HIV-infected patients may attenuate the benefits conferred by combination anti-retroviral therapy. In the general population, African Americans with hypertension are less likely to have controlled blood pressure than whites. However, racial differences in blood pressure control among HIV-infected patients are not well studied. Methods We conducted a cross-sectional study evaluating racial differences in hypertension prevalence, treatment, and control among 1,664 patients attending the University of Alabama at Birmingham HIV Clinic in 2013. Multivariable analyses were performed to calculate prevalence ratios (PR) with 95% confidence intervals (CI) as the measure of association between race and hypertension prevalence and control while adjusting for other covariates. Results The mean age of patients was 47 years, 77% were male and 54% African-American. The prevalence of hypertension was higher among African Americans compared with whites (49% vs. 43%; p = 0.02). Among those with hypertension, 91% of African Americans and 93% of whites were treated (p = 0.43). Among those treated, 50% of African Americans versus 60% of whites had controlled blood pressure (systolic blood pressure < 140 mmHg and diastolic blood pressure < 90 mmHg) (p = 0.007). After multivariable adjustment for potential confounders, prevalence of hypertension was higher among African Americans compared to whites (PR 1.25; 95% CI 1.12-1.39) and prevalence of BP control was lower (PR 0.80; 95% CI 0.69-0.93). Conclusions Despite comparable levels of hypertension treatment, African Americans in our HIV cohort were less likely to achieve blood pressure control. This may place them at increased risk for adverse outcomes that disproportionately impact HIV-infected patients, such as cardiovascular disease and chronic kidney disease, and thus attenuate the benefits conferred by combination antiretroviral therapy.	[Burkholder, Greer A.; Tamhane, Ashutosh R.; Willig, Amanda L.; Willig, James H.; Raper, James L.; Saag, Michael S.; Mugavero, Michael J.] Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL 35294 USA; [Tamhane, Ashutosh R.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Safford, Monika M.] Weill Cornell Med Coll, Div Gen Internal Med, New York, NY USA; [Muntner, Paul M.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Cornell University; University of Alabama System; University of Alabama Birmingham	Burkholder, GA (corresponding author), Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL 35294 USA.	gburkholder@uabmc.edu		Burkholder, Greer/0000-0001-7185-3025; Willig, Amanda/0000-0001-8802-4311	NHLBI NIH HHS [K23 HL126570] Funding Source: Medline; NIAID NIH HHS [R24 AI067039, P30 AI027767] Funding Source: Medline; NIH HHS [P30-AI27767, 1R24 AI067039-1] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL126570] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akgun KM, 2013, JAIDS-J ACQ IMM DEF, V62, P52, DOI 10.1097/QAI.0b013e318278f3fa; Allison Paul D., 2003, LOGISTIC REGRESSION; Armah KA, 2014, CLIN INFECT DIS, V58, P121, DOI 10.1093/cid/cit652; Bartley K, 2014, ETHNIC DIS, V24, P175; Bosworth HB, 2008, J GEN INTERN MED, V23, P692, DOI 10.1007/s11606-008-0547-7; Buchacz K, 2013, ANTIVIR THER, V18, P65, DOI 10.3851/IMP2450; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Chow FC, 2012, JAIDS-J ACQ IMM DEF, V60, P351, DOI 10.1097/QAI.0b013e31825c7f24; Chu C, 2011, J URBAN HEALTH, V88, P507, DOI 10.1007/s11524-010-9540-7; Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160; Cooper RS, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-2; Cooper RS, 2015, J HYPERTENS, V33, P473, DOI 10.1097/HJH.0000000000000429; Crane HM, 2009, HIV MED, V10, P496, DOI 10.1111/j.1468-1293.2009.00720.x; D'Ascenzo F, 2014, J CARDIOVASC MED HAG; De Socio GV, 2014, AM J HYPERTENS, V27, P222, DOI 10.1093/ajh/hpt182; Farahani M, 2017, INT J STD AIDS, V28, P636, DOI 10.1177/0956462416632428; Florkowski Christopher M, 2011, Clin Biochem Rev, V32, P75; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Fuchs FD, 2011, HYPERTENSION, V57, P379, DOI 10.1161/HYPERTENSIONAHA.110.163196; Gazzaruso C, 2003, J HYPERTENS, V21, P1377, DOI 10.1097/00004872-200307000-00028; Howard G, 2006, STROKE, V37, P1171, DOI 10.1161/01.STR.0000217222.09978.ce; Islam FM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-234; Kozak MS, 2012, CLIN INFECT DIS, V54, P141, DOI 10.1093/cid/cir727; Kramer H, 2004, AM J HYPERTENS, V17, P963, DOI 10.1016/j.amjhyper.2004.06.001; Krauskopf Katherine, 2013, J Int Assoc Provid AIDS Care, V12, P325, DOI 10.1177/2325957413491432; Kressin NR, 2010, CIRC-CARDIOVASC QUAL, V3, P173, DOI 10.1161/CIRCOUTCOMES.109.860841; Lackland DT, 2014, AM J MED SCI, V348, P135, DOI 10.1097/MAJ.0000000000000308; Langness J, 2014, J MANAG CARE SPEC PH, V20, P809, DOI 10.18553/jmcp.2014.20.8.809; Lesko CR, 2015, CLIN INFECT DIS, V60, P1700, DOI 10.1093/cid/civ183; Logie C, 2009, AIDS CARE, V21, P742, DOI 10.1080/09540120802511877; McNaughton CD, 2014, MED CARE, V52, P346, DOI 10.1097/MLR.0000000000000101; Medina-Torne Sheila, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P20, DOI 10.1177/1545109711418361; Morlat P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066223; Mujahid MS, 2011, AM J HYPERTENS, V24, P187, DOI 10.1038/ajh.2010.200; Mujib M, 2011, AM J CARDIOL, V107, P935, DOI 10.1016/j.amjcard.2010.11.012; Myerson M, 2014, JAIDS-J ACQ IMM DEF, V66, P370, DOI 10.1097/QAI.0000000000000168; Nuesch R, 2013, JAIDS-J ACQ IMM DEF, V62, P396, DOI 10.1097/QAI.0b013e3182847cd0; Phillips AN, 2010, AIDS, V24, P1561, DOI 10.1097/QAD.0b013e32833a6056; Plantinga L, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-17; Prejean J, 2013, J COMMUN HEALTH, V38, P414, DOI 10.1007/s10900-012-9633-1; Richardson KK, 2016, J NATL MED ASSOC, V108, P201, DOI 10.1016/j.jnma.2016.08.001; Safford MM, 2007, ETHNIC DIS, V17, P421; Sampson UKA, 2014, CIRC-CARDIOVASC QUAL, V7, P33, DOI 10.1161/CIRCOUTCOMES.113.000155; Spruill TM, 2010, CURR HYPERTENS REP, V12, P10, DOI 10.1007/s11906-009-0084-8; Wiernik E, 2014, J HYPERTENS, V32, P1979, DOI 10.1097/HJH.0000000000000288; Williams SF, 2014, WORLD J CARDIOL, V6, P878, DOI 10.4330/wjc.v6.i9.878; Willig AL, 2015, AIDS RES HUM RETROV, V31, P898, DOI [10.1089/aid.2015.0062, 10.1089/AID.2015.0062]; Willig JH, 2008, CLIN INFECT DIS, V46, P1315, DOI 10.1086/533466; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	49	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194940	10.1371/journal.pone.0194940	http://dx.doi.org/10.1371/journal.pone.0194940			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596462	Green Published, Green Submitted, gold			2022-12-26	WOS:000428630000054
J	Duan, WX; Wang, QM; Zhang, HY; Xie, BT; Li, AX; Hou, FY; Dong, SX; Wang, BQ; Qin, Z; Zhang, LM				Duan, Wenxue; Wang, Qingmei; Zhang, Haiyan; Xie, Beitao; Li, Aixian; Hou, Fuyun; Dong, Shunxu; Wang, Baoqing; Qin, Zhen; Zhang, Liming			Differences between nitrogen-tolerant and nitrogen-susceptible sweetpotato cultivars in photosynthate distribution and transport under different nitrogen conditions	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; IPOMOEA-BATATAS; PHLOEM; YIELD; GROWTH; POTASSIUM; STORAGE; EXPORT; ROOT; ASSIMILATION	To characterize the differences in photosynthate distribution and transport between nitrogen (N)-tolerant and N-susceptible sweetpotato cultivars under different N conditions, three N levels, including 0 (N0), 120 (N120), and 240 kg ha(-1) (N240), were used in field experiments with the Jishu26 (J26) and Xushu32 (X32) cultivars in 2015 and 2016. The results from both years revealed that high N application reduced the tuberous root yield, the tuber/vine rate of carbon-13 (C-13), and top-to-base (three equal segments of stem divided from the fifth opened leaf of the shoot tip to the main stem, defined as the top, middle, and base parts, respectively) gradients such as sucrose, ammonia N and potassium along the stem. 'J26' showed a higher yield than 'X32' under N0 but lower yield than 'X32' under N120 and N240. It also exhibited a higher C-13 distribution to tuberous roots compared with that of (')X32' under N0, and the opposite trend was observed under N120 and N240. Under N0, 'J26' showed a steep top-to-base amino acid gradient and a significantly lower top-to-base sucrose increase along the stem in the late growth stage. Under N120 and N240, 'X32' exhibited a greater top-to-base decrease in the ammonia N along the stem during the main growth stages, a steep top-to-base sucrose gradient along the stem in the early growth stage, and a lower top-to-base sucrose increase along the stem in the middle and late growth stages. The formation of a reasonable photosynthate distribution structure attributed to high yield was related to a desirable sucrose, ammonia N or K+ gradient downward along the stem. These results might help provide farmers with sweetpotato cultivars using less or no N fertilizer in soils of different fertility and enhance the knowledge of yield-related physiology.	[Duan, Wenxue; Wang, Qingmei; Zhang, Haiyan; Xie, Beitao; Li, Aixian; Hou, Fuyun; Dong, Shunxu; Wang, Baoqing; Qin, Zhen] Shandong Acad Agr Sci, Crop Res Inst, Jinan, Shandong, Peoples R China; [Duan, Wenxue; Wang, Qingmei; Zhang, Haiyan; Xie, Beitao; Li, Aixian; Hou, Fuyun; Dong, Shunxu; Wang, Baoqing; Qin, Zhen; Zhang, Liming] Sci Observat & Expt Stn Tuber & Root Crops Huang, Jinan, Shandong, Peoples R China; [Zhang, Liming] Shandong Acad Agr Sci, Jinan, Shandong, Peoples R China	Shandong Academy of Agricultural Sciences; Shandong Academy of Agricultural Sciences	Zhang, LM (corresponding author), Sci Observat & Expt Stn Tuber & Root Crops Huang, Jinan, Shandong, Peoples R China.; Zhang, LM (corresponding author), Shandong Acad Agr Sci, Jinan, Shandong, Peoples R China.	zhanglm11@sina.com						Alvim PDT, 1977, ROOT CROPS, P187; Bel AJEV, 1992, CROP PHOTOSYNTHESIS, P177; BOURKE RM, 1985, FIELD CROP RES, V12, P363, DOI 10.1016/0378-4290(85)90081-4; CHEN XK, 1982, J SHANDONG AGR U, V13, P79; Chen YC, 1961, SCI AGR SIN, V2, P25; Chen ZH, 2007, FUNCT PLANT BIOL, V34, P150, DOI 10.1071/FP06237; Eckardt NA, 2001, PLANT CELL, V13, P989; Ehlers K, 2000, PROTOPLASMA, V214, P80, DOI 10.1007/BF02524265; FADER GM, 1983, PLANT PHYSIOL, V73, P297, DOI 10.1104/pp.73.2.297; Gould N, 2004, FUNCT PLANT BIOL, V31, P987, DOI 10.1071/FP04058; Grodzinski B, 1998, PLANT PHYSIOL, V117, P207, DOI 10.1104/pp.117.1.207; Hartemink AE, 2000, AGR ECOSYST ENVIRON, V79, P271, DOI 10.1016/S0167-8809(00)00138-9; HILL WA, 1990, AGRON J, V82, P1120, DOI 10.2134/agronj1990.00021962008200060019x; Jonik C, 2012, PLANT BIOTECHNOL J, V10, P1088, DOI 10.1111/j.1467-7652.2012.00736.x; Kaupa P, 2014, FIELD CROP RES, V168, P48, DOI 10.1016/j.fcr.2014.08.011; Kaur G, 2015, INT J AGRIC BIOL, V17, P531, DOI 10.17957/IJAB/17.3.14.539; Kelm M., 2000, PLANT PRODUCTIVITY W, P273; Kockenberger W, 1997, PLANTA, V201, P53, DOI 10.1007/BF01258680; Komor E, 1996, J EXP BOT, V47, P1155, DOI 10.1093/jxb/47.Special_Issue.1155; Komor E, 2000, AUST J PLANT PHYSIOL, V27, P497; Lemoine R, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00272; Li RongLin, 2013, Food and Nutrition Sciences, V4, P1102; Liu CW, 2014, INT J ENV RES PUB HE, V11, P4427, DOI 10.3390/ijerph110404427; Liu HJ, 2015, PHOTOSYNTHETICA, V53, P378, DOI 10.1007/s11099-015-0121-6; Loewe A, 2010, NEW PHYTOL, V145, P565; Luo XingLu, 2011, Journal of Agricultural Science (Toronto), V3, P64; Ma DaiFu, 2012, Jiangsu Journal of Agricultural Sciences, V28, P969; MINCHIN PEH, 1984, J EXP BOT, V35, P538, DOI 10.1093/jxb/35.4.538; Nedunchezhiyan M., 2012, ISRN AGRON, V2012, P1, DOI [10.5402/2012/291285, DOI 10.5402/2012/291285]; Ning YunWang, 2015, Acta Agronomica Sinica, V41, P432; Njiti VN, 2013, HORTSCIENCE, V48, P73, DOI 10.21273/HORTSCI.48.1.73; Onunka NA, 2011, AGRO SCI, V10, P22; Patrick JW, 2001, AUST J PLANT PHYSIOL, V28, P695, DOI 10.1071/PP01023; Phillips SB, 2005, HORTSCIENCE, V40, P214, DOI 10.21273/HORTSCI.40.1.214; Ravi V., 2009, J ROOT CROPS, V35, P1; Satapathy M. R., 2007, Indian Journal of Agricultural Research, V41, P195; Sebastiani SK, 2006, ACTA HORTIC, P219, DOI 10.17660/ActaHortic.2006.703.27; Shedge M, 2013, ROLE PREHARVEST SPRA; Tekalign T, 2005, SCI HORTIC-AMSTERDAM, V105, P29, DOI 10.1016/j.scienta.2005.01.021; Uwah D. F., 2013, Journal of Agricultural Science (Toronto), V5, P61; Villagarcia MR, 1998, J AM SOC HORTIC SCI, V123, P814, DOI 10.21273/JASHS.123.5.814; Villordon A, 2010, HORTSCIENCE, V45, P1167, DOI 10.21273/HORTSCI.45.8.1167; Villordon AQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107384; Viola R, 2001, PLANT CELL, V13, P385, DOI 10.1105/tpc.13.2.385; VREUGDENHIL D, 1989, PHYSIOL PLANTARUM, V77, P385, DOI 10.1111/j.1399-3054.1989.tb05657.x; WALKER DW, 1987, COMMUN SOIL SCI PLAN, V18, P529, DOI 10.1080/00103628709367839; Wu ChunHong, 2016, Acta Agronomica Sinica, V42, P113; [徐聪 Xu Cong], 2014, [水土保持学报, Journal of Soil and Water Conservation], V28, P149; Yang ChangQin, 2014, Acta Agronomica Sinica, V40, P908; Zhang L., 2009, P325, DOI 10.1007/978-1-4020-9475-0_15	50	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194570	10.1371/journal.pone.0194570	http://dx.doi.org/10.1371/journal.pone.0194570			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596436	Green Submitted, gold, Green Published			2022-12-26	WOS:000428630000031
J	Malagnino, V; Salpini, R; Maffongelli, G; Battisti, A; Fabeni, L; Piermatteo, L; Colagrossi, L; Fini, V; Ricciardi, A; Sarrecchia, C; Perno, CF; Andreoni, M; Svicher, V; Sarmati, L				Malagnino, Vincenzo; Salpini, Romina; Maffongelli, Gaetano; Battisti, Arianna; Fabeni, Lavinia; Piermatteo, Lorenzo; Colagrossi, Luna; Fini, Vanessa; Ricciardi, Alessandra; Sarrecchia, Cesare; Perno, Carlo Federico; Andreoni, Massimo; Svicher, Valentina; Sarmati, Loredana			High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; COST-EFFECTIVENESS; HEPATOCELLULAR-CARCINOMA; PHYLOGENETIC RELATEDNESS; GENETIC DIVERSITY; SURFACE-ANTIGEN; EPIDEMIOLOGY; STRAINS; HBSAG; DNA	Hepatitis B virus (HBV) genotype E almost exclusively occurs in African people, and its presence is more commonly associated with the development of chronic HBV (CHB) infection. Moreover, an epidemiological link has been found between the distribution of HBV genotype E infection and African countries with high incidences of hepatocellular carcinoma. As part of a programme for the health assessment of migrants, we evaluated 358 young African subjects for HBV infection; 58.1% (208/358) were positive for an HBV marker, and 54 (25.5%) had CHB. Eighty-one percent of the CHB subjects were infected with HBV genotype E, with a median serum HBV-DNA of 3.2 (IQR: 2.7-3.6) logIU/ml. All patients had high serum HBsAg titres (10,899 [range 5,359-20,272] IU/ml), and no correlation was found between HBsAg titres and HBV-DNA plasma levels. RT sequence analysis showed the presence of a number of immune escape mutations: strains from all of the patients had a serine at HBsAg position 140; 3 also had T116N, Y100C, and P142L + S143L substitutions; and 1 had a G112R substitution. Six (18%) patients had stop-codons at position 216. In 5 of the 9 (26.5%) CHB patients, ultrasound liver biopsy, quantification of total intrahepatic HBV-DNA and cccDNA, and RT/HBsAg sequencing were performed. The median (IQR) total intrahepatic HBV-DNA was 766 (753-1139) copies/1000 cells, and the median (IQR) cccDNA was 17 (10- 27) copies/1000 cells. Correlations were observed for both total intra-hepatic HBV-DNA and cccDNA with serum HBV-DNA, while no correlation was found for the HBsAg titres. A difference of 2.5/1,000 nucleotides was found in the HBsAg sequences obtained from plasma and from liver tissue, with 3 cases of possible viral anatomical compartmentalization. In conclusion, a high rate of CHB infection due to the E genotype was demonstrated in a group of immigrants from Western Africa. An analysis of the viral strains obtained showed the virological characteristics of immune escape, which may be the cause of viral replication persistence. Moreover, a fair percentage of stop codon mutations were found. The lack of correlation between HBsAg titres and plasma or intrahepatic HBV-DNA found in these subjects suggests a pathway of virus production that is not linked to HBsAg secretion. Studies with a larger number of patients with CHB due to the E genotype are advisable to corroborate these observations.	[Malagnino, Vincenzo; Maffongelli, Gaetano; Ricciardi, Alessandra; Sarrecchia, Cesare; Andreoni, Massimo; Sarmati, Loredana] Tor Vergata Univ, Dept Syst Med, Clin Infect Dis, Rome, Italy; [Salpini, Romina; Battisti, Arianna; Fabeni, Lavinia; Piermatteo, Lorenzo; Colagrossi, Luna; Fini, Vanessa; Perno, Carlo Federico; Svicher, Valentina] Tor Vergata Univ, Dept Expt Med & Surg, Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata	Sarmati, L (corresponding author), Tor Vergata Univ, Dept Syst Med, Clin Infect Dis, Rome, Italy.	sarmati@med.uniroma2.it	Piermatteo, Lorenzo/J-5796-2018; Maffongelli, Gaetano/AAB-8651-2022; FABENI, LAVINIA/J-6626-2016; Andreoni, Masimo/AAL-2214-2020; Salpini, Romina/ABE-4828-2021; Salpini, Romina/K-2170-2016; Fini, Vanessa/AAL-3672-2021	Piermatteo, Lorenzo/0000-0002-3500-0858; FABENI, LAVINIA/0000-0002-2975-8611; Salpini, Romina/0000-0002-2488-2082; Salpini, Romina/0000-0002-2488-2082; Malagnino, Vincenzo/0000-0002-6561-5298; Fini, Vanessa/0000-0002-4489-8137; MAFFONGELLI, GAETANO/0000-0001-7784-2511; PERNO, CARLO FEDERICO/0000-0002-0825-5388; Battisti, Arianna/0000-0001-6831-9227; SVICHER, VALENTINA/0000-0002-2377-504X; Colagrossi, Luna/0000-0001-5618-1523; sarmati, loredana/0000-0003-1452-0333				Andernach IE, 2009, REV MED VIROL, V19, P231, DOI 10.1002/rmv.618; Bjornsdottir TB, 2005, J MED VIROL, V77, P481, DOI 10.1002/jmv.20480; Boglione L, 2014, J INFECTION, V69, P81, DOI 10.1016/j.jinf.2014.02.018; Coppola N, 2015, EUROSURVEILLANCE, V20, P7, DOI 10.2807/1560-7917.ES.2015.20.35.30009; Echevarria JM, 2006, J MED VIROL, V78, pS36, DOI 10.1002/jmv.20605; Eckman MH, 2011, CLIN INFECT DIS, V52, P1294, DOI 10.1093/cid/cir199; Erhardt A, 2009, J MED VIROL, V81, P1716, DOI 10.1002/jmv.21588; European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021; Ganne-Carrie N, 2006, J MED VIROL, V78, P335, DOI 10.1002/jmv.20545; Hayashi PH, 2005, MED CLIN N AM, V89, P371, DOI 10.1016/j.mcna.2004.08.014; Hutton DW, 2007, ANN INTERN MED, V147, P460, DOI 10.7326/0003-4819-147-7-200710020-00004; Karra VK, 2016, J CLIN EXP HEPATOL, V6, P209, DOI 10.1016/j.jceh.2016.07.002; Kato H, 2004, J MED VIROL, V73, P516, DOI 10.1002/jmv.20120; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kirk GD, 2004, HEPATOLOGY, V39, P211, DOI 10.1002/hep.20027; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; Mendy M, 2008, J MED VIROL, V80, P1537, DOI 10.1002/jmv.21221; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; NORDER H, 1992, J GEN VIROL, V73, P1201, DOI 10.1099/0022-1317-73-5-1201; NORDER H, 1994, VIROLOGY, V198, P489, DOI 10.1006/viro.1994.1060; Palumbo Emilio, 2007, Arq. Gastroenterol., V44, P54, DOI 10.1590/S0004-28032007000100012; Pourkarim MR, 2014, WORLD J GASTROENTERO, V20, P7152, DOI 10.3748/wjg.v20.i23.7152; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salpini R, 2015, HEPATOLOGY, V61, P823, DOI 10.1002/hep.27604; Shimakawa Y, 2016, GUT, V65, P2007, DOI 10.1136/gutjnl-2015-309892; Suzuki S, 2003, J MED VIROL, V69, P459, DOI 10.1002/jmv.10331; Svicher V, 2009, J HEPATOL, V50, P461, DOI 10.1016/j.jhep.2008.07.038; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Veldhuijzen IK, 2010, GASTROENTEROLOGY, V138, P522, DOI 10.1053/j.gastro.2009.10.039; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; Wong WWL, 2011, LIVER INT, V31, P1179, DOI 10.1111/j.1478-3231.2011.02559.x; Wooddell CI, 2015, HEPATOLOGY, V62, p222A; World Health Organization, 2017, WHO GUID HEP B C TES	35	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195045	10.1371/journal.pone.0195045	http://dx.doi.org/10.1371/journal.pone.0195045			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596494	Green Submitted, gold, Green Published			2022-12-26	WOS:000428630000071
J	Archer, JA; Lee, A; Qiu, AQ; Chen, SHA				Archer, Jo A.; Lee, Annie; Qiu, Anqi; Chen, S-H Annabel			Working memory, age and education: A lifespan fMRI study	PLOS ONE			English	Article							COGNITIVE NEUROSCIENCE; ALZHEIMERS-DISEASE; MIDDLE-AGE; BRAIN; PERFORMANCE; ACTIVATION; METAANALYSIS; ASSOCIATION; CEREBELLUM; RESERVE	Ageing is associated with grey matter atrophy and changes in task-related neural activations. This study investigated the effects of age and education on neural activation during a spatial working memory task in 189 participants aged between 20-80 years old, whilst controlling for grey matter density. Age was related to linear decreases in neural activation in task activated areas, and this effect was no longer significant when adjusting for education or accuracy. Age was also related to cubic increases in neural activation in non-task related areas, such as the temporal gyrus, cuneus and cerebellum when adjusting for accuracy and education. These findings support previous lifespan datasets indicating linear age-related decreases in task activation, but non-linear increases in non-task related areas during episodic memory tasks. The findings also support past studies indicating education offers a form of cognitive reserve through providing a form of neural compensation and highlights the need to consider education in ageing studies.	[Archer, Jo A.; Chen, S-H Annabel] Nanyang Technol Univ, Psychol, Singapore, Singapore; [Lee, Annie; Qiu, Anqi] Natl Univ Singapore, Dept Biomed Engn, Singapore, Singapore; [Qiu, Anqi] Natl Univ Singapore, Clin Imaging Res Ctr, Singapore, Singapore; [Qiu, Anqi] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore; [Chen, S-H Annabel] Nanyang Technol Univ, Ctr Res & Dev Learning, Singapore, Singapore; [Chen, S-H Annabel] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Chen, SHA (corresponding author), Nanyang Technol Univ, Psychol, Singapore, Singapore.; Chen, SHA (corresponding author), Nanyang Technol Univ, Ctr Res & Dev Learning, Singapore, Singapore.; Chen, SHA (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.	annabelchen@ntu.edu.sg	Qiu, Anqi/H-2267-2011; Chen, SH Annabel/F-3742-2011	Qiu, Anqi/0000-0002-0215-6338; Chen, SH Annabel/0000-0002-1540-5516	Singapore Ministry of Education AcRF Tier 1 grant [RG41/08]; Singapore Ministry of Education Academic Research Fund Tier 2 [MOE2012-T2-2-130]; Young Investigator Award at the National University of Singapore [NUSYIA FY10 P07]; Singapore Ministry of Healths National Medical Research Council (NMRC) [NMRC/CBRG/0039/ 2013]; NTU Humanities and Social Sciences post-doctoral fellowship	Singapore Ministry of Education AcRF Tier 1 grant(Ministry of Education, Singapore); Singapore Ministry of Education Academic Research Fund Tier 2(Ministry of Education, Singapore); Young Investigator Award at the National University of Singapore(National University of Singapore); Singapore Ministry of Healths National Medical Research Council (NMRC)(Ministry of Health-SingaporeNational Medical Research Council, Singapore); NTU Humanities and Social Sciences post-doctoral fellowship	This work was supported by Singapore Ministry of Education AcRF Tier 1 grant (RG41/08), Singapore Ministry of Education Academic Research Fund Tier 2 (MOE2012-T2-2-130), the Young Investigator Award at the National University of Singapore (NUSYIA FY10 P07), and the Singapore Ministry of Healths National Medical Research Council (NMRC; NMRC/CBRG/0039/ 2013), all awarded to AQ. JA was funded by the NTU Humanities and Social Sciences post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip	[Anonymous], 2010, MATLAB VERS 7 9 0; Arenaza-Urquijo EM, 2013, NEUROIMAGE, V83, P450, DOI 10.1016/j.neuroimage.2013.06.053; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bernard JA, 2013, CEREBELLUM LONDON EN, V12; Cambridge Cognition, 2017, CANTAB COGN ASS SOFT; Crowe M, 2013, J GERONTOL A-BIOL, V68, P198, DOI 10.1093/gerona/gls122; Daselaar SM, 2006, HDB FUNCTIONAL NEURO; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; Duff K, 2005, J CLIN EXP NEUROPSYC, V27, P565, DOI 10.1080/13803390490918363; Duff K, 2008, ARCH CLIN NEUROPSYCH, V23, P603, DOI 10.1016/j.acn.2008.06.004; Fabiani M, 2014, NEUROIMAGE, V85, P592, DOI 10.1016/j.neuroimage.2013.04.113; Finch CE, 2009, NEUROBIOL AGING, V30, P515, DOI 10.1016/j.neurobiolaging.2008.11.011; Fjell AM, 2010, NEUROIMAGE, V50, P1376, DOI 10.1016/j.neuroimage.2010.01.061; Fjell AM, 2009, CEREB CORTEX, V19, P2001, DOI 10.1093/cercor/bhn232; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Grady C, 2012, NAT REV NEUROSCI, V13, P491, DOI 10.1038/nrn3256; Grady CL, 2006, J COGNITIVE NEUROSCI, V18, P227, DOI 10.1162/jocn.2006.18.2.227; Hale S, 2011, PSYCHOL AGING, V26, P92, DOI 10.1037/a0021483; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Huettel SA, 2001, NEUROIMAGE, V13, P161, DOI 10.1006/nimg.2000.0675; Iachini Ina, 2009, Curr Aging Sci, V2, P43; Jamadar S, 2013, NEUROBIOL AGING, V34, P110, DOI 10.1016/j.neurobiolaging.2012.07.013; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Lee A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080648; Luis EO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131536; Maillet D, 2013, AGEING RES REV, V12, P479, DOI 10.1016/j.arr.2012.11.001; Marien P, 2014, CEREBELLUM, V13, P386, DOI 10.1007/s12311-013-0540-5; Nagel IE, 2009, P NATL ACAD SCI USA, V106, P22552, DOI 10.1073/pnas.0908238106; Nee DE, 2013, CEREB CORTEX, V23, P264, DOI 10.1093/cercor/bhs007; Ng TP, 2007, AM J GERIAT PSYCHIAT, V15, P130, DOI 10.1097/01.JGP.0000235710.17450.9a; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park H, 2013, NEUROPSYCHOLOGIA, V51, P448, DOI 10.1016/j.neuropsychologia.2012.11.025; Psychology Software Tools Incorporated, 2012, E PRIME; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; ROBBINS TW, 1994, DEMENTIA, V5, P266, DOI 10.1159/000106735; Salthouse TA, 2011, PSYCHOL BULL, V137, P753, DOI 10.1037/a0023262; Salthouse TA, 2010, J INT NEUROPSYCH SOC, V16, P754, DOI 10.1017/S1355617710000706; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Schneider-Garces NJ, 2010, J COGNITIVE NEUROSCI, V22, P655, DOI 10.1162/jocn.2009.21230; Sobczak-Edmans M, 2016, NEUROIMAGE, V124, P1021, DOI 10.1016/j.neuroimage.2015.09.038; StataCorp, 2021, STATA STAT SOFTWARE; Steffener J, 2016, NEUROBIOL AGING, V40, P138, DOI 10.1016/j.neurobiolaging.2016.01.014; Steffener J, 2012, BBA-MOL BASIS DIS, V1822, P467, DOI 10.1016/j.bbadis.2011.09.012; Steffener J, 2011, BRAIN IMAGING BEHAV, V5, P212, DOI 10.1007/s11682-011-9125-4; Stern Y, 2012, BRAIN RES, V1435, P130, DOI 10.1016/j.brainres.2011.11.061; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, pS69, DOI 10.1097/00002093-200607001-00010; Takeuchi H, 2014, HUM BRAIN MAPP, V35, P185, DOI 10.1002/hbm.22167; Talairach J., 1988, COPLANAR STEREOTAXIC; Trivedi MA, 2008, NEUROPSYCHOLOGIA, V46, P1667, DOI 10.1016/j.neuropsychologia.2007.11.035; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Ward LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125012; Yang X, 2011, NEUROIMAGE, V57, P423, DOI 10.1016/j.neuroimage.2011.04.046	52	21	24	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194878	10.1371/journal.pone.0194878	http://dx.doi.org/10.1371/journal.pone.0194878			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584781	Green Published, gold			2022-12-26	WOS:000428373000046
J	Garber, DA; Mitchell, J; Adams, D; Guenthner, P; Deyounks, F; Ellis, S; Kelley, K; Johnson, R; Dobard, C; Heneine, W; McNicholl, J				Garber, David A.; Mitchell, James; Adams, Debra; Guenthner, Patricia; Deyounks, Frank; Ellis, Shanon; Kelley, Kristen; Johnson, Ryan; Dobard, Charles; Heneine, Walid; McNicholl, Janet			Development of a repeat-exposure penile SHIV infection model in macaques to evaluate biomedical preventions against HIV	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; RHESUS MACAQUES; CHLAMYDIA-TRACHOMATIS; MUCOSAL TRANSMISSION; NONHUMAN-PRIMATES; MALE CIRCUMCISION; ANIMAL-MODELS; VACCINE; TRIAL; SHIVSF162P3	Penile acquisition of HIV infection contributes substantially to the global epidemic. Our goal was to establish a preclinical macaque model of penile HIV infection for evaluating the efficacy of new HIV prevention modalities. Rhesus macaques were challenged once or twice weekly with consistent doses of SHIV(sf)162P3 (a chimeric simian-human immunodeficiency virus containing HIV env) ranging from 4-600 TCID50 (50% tissue culture infective dose), via two penile routes, until systemic SHIV infection was confirmed. One route exposed the inner foreskin, glans and urethral os to virus following deposition into the prepuce (foreskin) pouch. The second route introduced the virus non-traumatically into the distal urethra only. Single-route challenges resulted in dose-dependent rates of SHIV acquisition informing selection of optimal SHIV dosing. Concurrent SHIV challenges via the prepuce pouch (200 TCID50) and urethra (16 TCID50) resulted in infection of 100% (10/10) animals following a median of 2.5 virus exposures (range, 1-12). We describe the first rhesus macaque repeat-exposure SHIV challenge model of penile HIV acquisition. Utilization of the model should further our understanding of penile HIV infection and facilitate the development of new HIV prevention strategies for men.	[Garber, David A.; Mitchell, James; Adams, Debra; Guenthner, Patricia; Deyounks, Frank; Ellis, Shanon; Kelley, Kristen; Johnson, Ryan; Dobard, Charles; Heneine, Walid; McNicholl, Janet] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Lab Branch, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Garber, DA (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Lab Branch, Atlanta, GA 30333 USA.	david.garber@cdc.hhs.gov			Centers for Disease Control and Prevention (CDC)	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funded by Centers for Disease Control and Prevention (CDC), intramural funding (DAG, JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D, 2011, AM J REPROD IMMUNOL, V65, P220, DOI 10.1111/j.1600-0897.2010.00941.x; Anderson DJ, 2010, AIDS, V24, P163, DOI 10.1097/QAD.0b013e32833424c8; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Butler K, 2013, AIDS RES HUM RETROV, V29, P1091, DOI [10.1089/AID.2012.0383, 10.1089/aid.2012.0383]; Del Prete GQ, 2016, CURR OPIN HIV AIDS, V11, P546, DOI 10.1097/COH.0000000000000311; Dinh MH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004729; Fischetti L, 2009, AIDS, V23, P319, DOI 10.1097/QAD.0b013e328321b778; Ganor Y, 2013, MUCOSAL IMMUNOL, V6, P776, DOI 10.1038/mi.2012.116; Garcia-Lerma JG, 2012, CURR OPIN HIV AIDS, V7, P505, DOI 10.1097/COH.0b013e328358e484; Garcia-Lerma JG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000391; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Harouse JM, 2001, J VIROL, V75, P1990, DOI 10.1128/JVI.75.4.1990-1995.2001; Henning TR, 2017, J MED PRIMATOL, V46, P218, DOI 10.1111/jmp.12272; Kirmaier A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000462; Lim SY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000738; Ma ZM, 2016, J VIROL, V90, P4093, DOI 10.1128/JVI.02947-15; Makarova N, 2017, AIDS, V31, P745, DOI 10.1097/QAD.0000000000001389; McChesney MB, 2013, CURR OPIN HIV AIDS, V8, P376, DOI 10.1097/COH.0b013e328363d3a2; McCoombe SG, 2006, AIDS, V20, P1491, DOI 10.1097/01.aids.0000237364.11123.98; McDermott AB, 2004, J VIROL, V78, P3140, DOI 10.1128/JVI.78.6.3140-3144.2004; MILLER CJ, 1989, J VIROL, V63, P4277, DOI 10.1128/JVI.63.10.4277-4284.1989; Otten RA, 2005, J INFECT DIS, V191, P164, DOI 10.1086/426452; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; Qureshi H, 2012, J VIROL, V86, P2239, DOI 10.1128/JVI.06175-11; Radzio J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050632; Regoes RR, 2005, PLOS MED, V2, P798, DOI 10.1371/journal.pmed.0020249; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; UNAIDS, GLOB SUMM AIDS EP; Yeh WW, 2011, J VIROL, V85, P10389, DOI 10.1128/JVI.00854-11	30	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194837	10.1371/journal.pone.0194837	http://dx.doi.org/10.1371/journal.pone.0194837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584769	gold, Green Submitted, Green Published			2022-12-26	WOS:000428373000042
J	Dresselhaus, E; Duerr, JM; Vincent, F; Sylvain, EK; Beyna, M; Lanyon, LF; LaChapelle, E; Pettersson, M; Bales, KR; Ramaswamy, G				Dresselhaus, Erica; Duerr, James M.; Vincent, Fabien; Sylvain, Emily K.; Beyna, Mercedes; Lanyon, Lorraine F.; LaChapelle, Erik; Pettersson, Martin; Bales, Kelly R.; Ramaswamy, Gayathri			Class I HDAC inhibition is a novel pathway for regulating astrocytic apoE secretion	PLOS ONE			English	Article							HUMAN APOLIPOPROTEIN-E; LIVER-X-RECEPTOR; ISOFORM-SPECIFIC BINDING; PROSTATE-CANCER CELLS; LONG-TERM-MEMORY; ALZHEIMERS-DISEASE; HISTONE DEACETYLASE; E GENE; SYNAPTIC PLASTICITY; MOUSE MODEL	Despite the important role of apolipoprotein E (apoE) secretion from astrocytes in brain lipid metabolism and the strong association of apoE4, one of the human apoE isoforms, with sporadic and late onset forms of Alzheimer's disease (AD) little is known about the regulation of astrocytic apoE. Utilizing annotated chemical libraries and a phenotypic screening strategy that measured apoE secretion from a human astrocytoma cell line, inhibition of pan class I histone deacetylases (HDACs) was identified as a mechanism to increase apoE secretion. Knocking down select HDAC family members alone or in combination revealed that inhibition of the class I HDAC family was responsible for enhancing apoE secretion. Knocking down LXR alpha and LXR beta genes revealed that the increase in astrocytic apoE in response to HDAC inhibition occurred via an LXR-independent pathway. Collectively, these data suggest that pan class I HDAC inhibition is a novel pathway for regulating astrocytic apoE secretion.	[Dresselhaus, Erica; Duerr, James M.; Sylvain, Emily K.; Beyna, Mercedes; Bales, Kelly R.; Ramaswamy, Gayathri] Pfizer, Internal Med Res Unit, Cambridge, MA 02139 USA; [Vincent, Fabien; Lanyon, Lorraine F.] Pfizer, Hit Discovery & Lead Profiling, Groton, CT USA; [LaChapelle, Erik] Pfizer, Med Chem, Groton, CT USA; [Pettersson, Martin] Pfizer, Med Chem, Cambridge, MA USA	Pfizer; Pfizer; Pfizer; Pfizer	Bales, KR; Ramaswamy, G (corresponding author), Pfizer, Internal Med Res Unit, Cambridge, MA 02139 USA.	krbales01@gmail.com; drgayathric@outlook.com		Beyna, Mercedes/0000-0003-0603-3981	Pfizer Inc.	Pfizer Inc.(Pfizer)	The authors did not receive specific funding for this work and are employees of Pfizer Inc. The funder (Pfizer Inc.) provided support in the form of salaries for authors [E.D., J.M.D., F.V., M.B., L.F.L., E.K.S., E.L.C., M.P., K.R.B., G.R.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Akhtar MW, 2009, J NEUROSCI, V29, P8288, DOI 10.1523/JNEUROSCI.0097-09.2009; Baloglu E, 2013, Patent, Patent No. [WO/2011/088192, 2011088192]; Bardai FH, 2012, J BIOL CHEM, V287, P35444, DOI 10.1074/jbc.M112.394544; Boehm-Cagan A, 2014, J NEUROSCI, V34, P7293, DOI 10.1523/JNEUROSCI.5198-13.2014; Butler LM, 2000, CANCER RES, V60, P5165; Cantuti-Castelvetri L, 2018, SCIENCE; Chen Y, 2010, P NATL ACAD SCI USA, V107, P12011, DOI 10.1073/pnas.0914984107; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Chung WS, 2016, P NATL ACAD SCI USA, V113, P10186, DOI 10.1073/pnas.1609896113; CORDER EH, 1995, NEUROLOGY, V45, P1323, DOI 10.1212/WNL.45.7.1323; Costet P, 2000, J BIOL CHEM, V275, P28240; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; ELBELTAGI HM, 1993, CANCER RES, V53, P3008; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Ferrari A, 2012, MOL MEMBR BIOL, V29, P257, DOI 10.3109/09687688.2012.729094; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Grehan S, 2001, J NEUROSCI, V21, P812, DOI 10.1523/JNEUROSCI.21-03-00812.2001; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Hauser PS, 2013, CURR ALZHEIMER RES, V10, P809; Hauser PS, 2011, PROG LIPID RES, V50, P62, DOI 10.1016/j.plipres.2010.09.001; Hirsch-Reinshagen V, 2004, J BIOL CHEM, V279, P41197, DOI 10.1074/jbc.M407962200; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Huang YD, 2004, J MOL NEUROSCI, V23, P189, DOI 10.1385/JMN:23:3:189; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kozikowski AP, 2008, J MED CHEM, V51, P4370, DOI 10.1021/jm8002894; Kraker AJ, 2003, MOL CANCER THER, V2, P401; LADU MJ, 1994, J BIOL CHEM, V269, P23403; LADU MJ, 1995, J BIOL CHEM, V270, P9039, DOI 10.1074/jbc.270.16.9039; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Lefterov I, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-20; Li Y, 2002, MOL ENDOCRINOL, V16, P506, DOI 10.1210/me.16.3.506; Liang Y, 2004, J NEUROCHEM, V88, P623, DOI 10.1111/j.1471-4159.2004.02183.x; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Mandrekar-Colucci S, 2012, J NEUROSCI, V32, P10117, DOI 10.1523/JNEUROSCI.5268-11.2012; McQuown SC, 2011, NEUROBIOL LEARN MEM, V96, P27, DOI [10.1016/j.nlm.2011.04.005, 10.1016/j.nlm.2011.04.002]; McQuown SC, 2011, J NEUROSCI, V31, P764, DOI 10.1523/JNEUROSCI.5052-10.2011; Michaelson DM, 2014, ALZHEIMERS DEMENT, V10, P861, DOI 10.1016/j.jalz.2014.06.015; Mitro N, 2007, HEPATOLOGY, V46, P885, DOI 10.1002/hep.21819; MYKLEBOST O, 1988, HUM GENET, V78, P244, DOI 10.1007/BF00291670; Ramaswamy G, 2005, J NEUROSCI, V25, P10658, DOI 10.1523/JNEUROSCI.1922-05.2005; Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008; Riddell DR, 2007, MOL CELL NEUROSCI, V34, P621, DOI 10.1016/j.mcn.2007.01.011; Saito A, 1999, P NATL ACAD SCI USA, V96, P4592, DOI 10.1073/pnas.96.8.4592; Shi Y, 2017, NATURE, V549, P523, DOI 10.1038/nature24016; Shih SJ, 2000, J BIOL CHEM, V275, P31567, DOI 10.1074/jbc.M005468200; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Stowell John C., 1995, Journal of Medicinal Chemistry, V38, P1411; Sullivan PM, 2011, NEUROBIOL AGING, V32, P791, DOI 10.1016/j.neurobiolaging.2009.05.011; Suzuki T, 1999, J MED CHEM, V42, P3001, DOI 10.1021/jm980565u; Swank MW, 2001, J NEUROSCI, V21, P3383, DOI 10.1523/JNEUROSCI.21-10-03383.2001; Terwel D, 2011, J NEUROSCI, V31, P7049, DOI 10.1523/JNEUROSCI.6546-10.2011; Tokuda T, 2000, BIOCHEM J, V348, P359, DOI 10.1042/0264-6021:3480359; Volmar C.H., 2015, NEUROEPIGENETICS, V1, P20, DOI [10.1016/j.nepig.2014.10.002, DOI 10.1016/J.NEPIG.2014.10.002]; Wahrle SE, 2004, J BIOL CHEM, V279, P40987, DOI 10.1074/jbc.M407963200; Weisgraber KH, 1996, FASEB J, V10, P1485, DOI 10.1096/fasebj.10.13.8940294; Yang CP, 2011, DEVELOPMENT, V138, P4351, DOI 10.1242/dev.065540	58	15	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194661	10.1371/journal.pone.0194661	http://dx.doi.org/10.1371/journal.pone.0194661			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579087	Green Published, Green Submitted, gold			2022-12-26	WOS:000428351800044
J	Grobe, H; Wustenhagen, A; Baarlink, C; Grosse, R; Grikscheit, K				Grobe, Hanna; Wuestenhagen, Andrea; Baarlink, Christian; Grosse, Robert; Grikscheit, Katharina			A Rac1-FMNL2 signaling module affects cell-cell contact formation independent of Cdc42 and membrane protrusions	PLOS ONE			English	Article							ARP2/3 COMPLEX; ACTIN POLYMERIZATION; MOTILITY DOWNSTREAM; FILOPODIA FORMATION; ADHERENS JUNCTIONS; IMAGE-ANALYSIS; E-CADHERIN; FORMINS; DYNAMICS; ADHESION	De novo formation of epithelial cell-cell contacts relies on actin-based protrusions as well as tightly controlled turnover of junctional actin once cells encounter each other and adhesion complexes assemble. The specific contributions of individual actin regulators on either protrusion formation or junctional actin turnover remain largely unexplored. Based on our previous findings of Formin-like 2 (FMNL2)-mediated control of junctional actin dynamics, we investigated its potential role in membrane protrusions and impact on newly forming epithelial contacts. CRISPR/Cas9-mediated loss of FMNL2 in human MCF10A cells combined with optogenetic control of Rac1 activity confirmed its critical function in the establishment of intercellular contacts. While lamellipodial protrusion rates remained unaffected, FMNL2 knockout cells were characterized by impaired filopodia formation similar to depletion of the Rho GTPase Cdc42. Silencing of Cdc42, however, failed to affect FMNL2-mediated contact formation. Hence, we propose a cell-cell contact-specific and Rac1-mediated function of FMNL2 entirely independent of Cdc42. Consistent with this, direct visualizations of native epithelial junction formation revealed a striking and specifically Rac1- and not Cdc42-dependent recruitment of FMNL2 to newly forming junctions as well as established cell-cell contacts within epithelial sheets.	[Grobe, Hanna; Wuestenhagen, Andrea; Baarlink, Christian; Grosse, Robert; Grikscheit, Katharina] Philipps Univ Marburg, Inst Pharmacol, Biochem Pharmacol Ctr, Marburg, Germany; [Grikscheit, Katharina] Philipps Univ Marburg, Inst Virol, Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Grikscheit, K (corresponding author), Philipps Univ Marburg, Inst Pharmacol, Biochem Pharmacol Ctr, Marburg, Germany.; Grikscheit, K (corresponding author), Philipps Univ Marburg, Inst Virol, Marburg, Germany.	katharina.grikscheit@staff.uni-marburg.de			DFG [SPP-1782]	DFG(German Research Foundation (DFG))	This work was supported by DFG SPP-1782 (RG).	Baarlink C, 2013, SCIENCE, V340, P864, DOI 10.1126/science.1235038; Baarlink C, 2010, CELL, V142, DOI 10.1016/j.cell.2010.06.030; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Block J, 2012, CURR BIOL, V22, P1005, DOI 10.1016/j.cub.2012.03.064; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cavey M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002998; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Gardberg M, 2016, J PATHOL CLIN RES, V2, P41, DOI 10.1002/cjp2.34; Gauvin TJ, 2015, MOL BIOL CELL, V26, P467, DOI 10.1091/mbc.E14-07-1247; Grikscheit K, 2016, TRENDS BIOCHEM SCI, V41, P148, DOI 10.1016/j.tibs.2015.12.002; Grikscheit K, 2015, J CELL BIOL, V209, P367, DOI 10.1083/jcb.201412015; Grosse R, 2003, EMBO J, V22, P3050, DOI 10.1093/emboj/cdg287; Guo ZH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005473; Harris ES, 2010, CYTOSKELETON, V67, P755, DOI 10.1002/cm.20485; Henson JH, 2015, MOL BIOL CELL, V26, P887, DOI 10.1091/mbc.E14-07-1244; Isogai T, 2015, J CELL SCI, V128, P3796, DOI 10.1242/jcs.176768; Kage F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14832; Kitzing TM, 2010, ONCOGENE, V29, P2441, DOI 10.1038/onc.2009.515; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Kuhn S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8088; Kuhn Sonja, 2014, Small GTPases, V5, pe29513, DOI 10.4161/sgtp.29513; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Millard TH, 2008, DEVELOPMENT, V135, P621, DOI 10.1242/dev.014001; Moriya K, 2012, BIOSCI BIOTECH BIOCH, V76, P1201, DOI 10.1271/bbb.120069; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Nurnberg A, 2011, NAT REV CANCER, V11, P177, DOI 10.1038/nrc3003; Peladeau C, 2016, BMC CELL BIOL, V17, DOI 10.1186/s12860-016-0110-z; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rao MV, 2016, MOL BIOL CELL, V27, P2844, DOI 10.1091/mbc.E16-06-0429; Ratheesh A, 2012, NAT REV MOL CELL BIO, V13, P673, DOI 10.1038/nrm3431; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Rose R, 2005, ACTA CRYSTALLOGR F, V61, P225, DOI 10.1107/S1744309105001065; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spiering D, 2011, CELL ADHES MIGR, V5, P170, DOI 10.4161/cam.5.2.14403; Takeichi M, 2014, NAT REV MOL CELL BIO, V15, P397, DOI 10.1038/nrm3802; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Wang Y, 2015, DEV CELL, V34, P475, DOI 10.1016/j.devcel.2015.06.015; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Young LE, 2015, MOL BIOL CELL, V26, P4646, DOI 10.1091/mbc.E15-09-0626	47	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194716	10.1371/journal.pone.0194716	http://dx.doi.org/10.1371/journal.pone.0194716			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579104	Green Submitted, Green Published, gold			2022-12-26	WOS:000428351800048
J	Hortsch, SK; Kremling, A				Hortsch, Sayuri Katharina; Kremling, Andreas			Characterization of noise in multistable genetic circuits reveals ways to modulate heterogeneity	PLOS ONE			English	Article							POSITIVE FEEDBACK; EXPRESSION; STOCHASTICITY; TRANSCRIPTION; COMPETENCE; INITIATION; NETWORKS	Random fluctuations in the amount of cellular components like mRNA and protein molecules are inevitable due to the stochastic and discrete nature of biochemical reactions. If large enough, this so-called "cellular noise" can lead to random transitions between the expression states of a multistable genetic circuit. That way, heterogeneity within isogenic populations is created. Our aim is to understand which dynamical features of a simple auto regulatory system determine its intrinsic noise level, and how they can be modified in order to regulate state-transitions. To that end, novel mathematical methods for the state-dependent characterization and prediction of noise in multistable systems are developed. First, we introduce the hybrid LNA, a modified version of the Linear Noise Approximation. It yields good predictions on variances of mRNA and protein fluctuations, even for reaction systems comprising low-copy-number components (e.g. mRNA) and highly nonlinear reaction rates. Furthermore, the temporal structure of fluctuations and the skewness of the protein distribution are characterized via state-dependent protein burst sizes and burst frequencies. Based on this mathematical framework, we develop graphical methods which support the intuitive design of regulatory circuits with a desired noise pattern. The methods are then used to predict how overall noise in the system can be adapted, and how state-specific noise modifications are possible that allow, e.g., the generation of unidirectional transitions. Our considerations are validated by stochastic simulations. This way, a design of genetic circuits is possible that takes population heterogeneity into account and is valuable in applications of synthetic biology and biotechnology. Moreover, natural phenomena like the bimodal development of genetic competence can be studied.	[Hortsch, Sayuri Katharina; Kremling, Andreas] Tech Univ Munich, Fac Mech Engn, Syst Biotechnol, Garching, Germany	Technical University of Munich	Hortsch, SK (corresponding author), Tech Univ Munich, Fac Mech Engn, Syst Biotechnol, Garching, Germany.	sayuri.Hortsch@tum.de			German Ministry of Education and Research (BMBF) through the e:bio initiative [031A299C]	German Ministry of Education and Research (BMBF) through the e:bio initiative(Federal Ministry of Education & Research (BMBF))	SKH was funded by the German Ministry of Education and Research (BMBF) through the e:bio initiative (grant number: 031A299C).	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Chen M, 2013, ACS SYNTH BIOL, V2, P587, DOI 10.1021/sb400044g; Chong SS, 2014, CELL, V158, P314, DOI 10.1016/j.cell.2014.05.038; Dobrzynski M, 2009, P NATL ACAD SCI USA, V106, P2583, DOI 10.1073/pnas.0803507106; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Grima R, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3454685; Grossman AD, 1995, ANNU REV GENET, V29, P477, DOI 10.1146/annurev.ge.29.120195.002401; Guisoni N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151086; Gutierrez PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044812; Hahl SK, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00157; Hasenauer J, 2014, J MATH BIOL, V69, P687, DOI 10.1007/s00285-013-0711-5; Hornung G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040008; Jahnke T, 2011, MULTISCALE MODEL SIM, V9, P1646, DOI 10.1137/110821500; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Karmakar R, 2007, PHYS BIOL, V4, P29, DOI 10.1088/1478-3975/4/1/004; Kaufmann BB, 2007, CURR OPIN GENET DEV, V17, P107, DOI 10.1016/j.gde.2007.02.007; Kierzek AM, 2001, J BIOL CHEM, V276, P8165, DOI 10.1074/jbc.M006264200; Leisner M, 2008, CURR OPIN MICROBIOL, V11, P553, DOI 10.1016/j.mib.2008.09.020; Lin YK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/234245; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Mehta P, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026005; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Reck M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005353; Singh A, 2011, IEEE T NANOBIOSCI, V10, P194, DOI 10.1109/TNB.2011.2168826; Son MJ, 2012, MOL MICROBIOL, V86, P258, DOI 10.1111/j.1365-2958.2012.08187.x; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Thomas P, 2012, COMPUTATION BIOCH PA; Thomas P, 2014, P NATL ACAD SCI USA, V111, P6994, DOI 10.1073/pnas.1400049111; Tomioka R, 2004, J THEOR BIOL, V229, P501, DOI 10.1016/j.jtbi.2004.04.034; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Wang LM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000764	39	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194779	10.1371/journal.pone.0194779	http://dx.doi.org/10.1371/journal.pone.0194779			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579101	Green Published, gold, Green Submitted			2022-12-26	WOS:000428351800053
J	Shamimuzzaman, M; Vodkin, L				Shamimuzzaman, Md.; Vodkin, Lila			Ribosome profiling reveals changes in translational status of soybean transcripts during immature cotyledon development	PLOS ONE			English	Article							SEED STORAGE PROTEINS; GLYCINE-MAX; GENE-EXPRESSION; GENOME SEQUENCE; MESSENGER-RNAS; IN-VIVO; ARABIDOPSIS; LECTIN; CYSTEINE; BIOSYNTHESIS	To understand translational capacity on a genome-wide scale across three developmental stages of immature soybean seed cotyledons, ribosome profiling was performed in combination with RNA sequencing and cluster analysis. Transcripts representing 216 unique genes demonstrated a higher level of translational activity in at least one stage by exhibiting higher translational efficiencies (TEs) in which there were relatively more ribosome footprint sequence reads mapping to the transcript than were present in the control total RNA sample. The majority of these transcripts were more translationally active at the early stage of seed development and included 12 unique serine or cysteine proteases and 16 2S albumin and low molecular weight cysteine-rich proteins that may serve as substrates for turnover and mobilization early in seed development. It would appear that the serine proteases and 2S albumins play a vital role in the early stages. In contrast, our investigation of profiles of 19 genes encoding high abundance seed storage proteins, such as glycinins, beta-conglycinins, lectin, and Kunitz trypsin inhibitors, showed that they all had similar patterns in which the TE values started at low levels and increased approximately 2 to 6-fold during development. The highest levels of these seed protein transcripts were found at the mid-developmental stage, whereas the highest ribosome footprint levels of only up to 1.6 TE were found at the late developmental stage. These experimental findings suggest that the major seed storage protein coding genes are primarily regulated at the transcriptional level during normal soybean cotyledon development. Finally, our analyses also identified a total of 370 unique gene models that showed very low TE values including over 48 genes encoding ribosomal family proteins and 95 gene models that are related to energy and photosynthetic functions, many of which have homology to the chloroplast genome. Additionally, we showed that genes of the chloroplast were relatively translationally inactive during seed development.	[Shamimuzzaman, Md.; Vodkin, Lila] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Shamimuzzaman, Md.] USDA ARS, US Vegetable Lab, Charleston, SC USA	University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA)	Vodkin, L (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	l-vodkin@illinois.edu		SHAMIMUZZAMAN, MD/0000-0002-3477-6232	United Soybean Board; University of Illinois Foundation Adlai Ewing Fellowship	United Soybean Board; University of Illinois Foundation Adlai Ewing Fellowship	We are grateful to the United Soybean Board for grant support and the University of Illinois Foundation Adlai Ewing Fellowship for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrianopoulos A, 1998, J BACTERIOL, V180, P1973, DOI 10.1128/JB.180.7.1973-1977.1998; Asano K, 2014, TRANSLATION, V2, DOI 10.4161/trla.28387; Bai B, 2017, NEW PHYTOL, V214, P233, DOI 10.1111/nph.14355; Bazan J, 2017, P NATL ACAD SCI USA, V146; Beilinson V, 2002, PHYSIOL PLANTARUM, V115, P585, DOI 10.1034/j.1399-3054.2002.1150413.x; Chang SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056502; Chotewutmontri P, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006106; Coate JE, 2014, PLANT CELL, V26, P136, DOI 10.1105/tpc.113.119966; Fan CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062288; Gerashchenko MV, 2012, P NATL ACAD SCI USA, V109, P17394, DOI 10.1073/pnas.1120799109; GOLDBERG RB, 1981, DEV BIOL, V83, P218, DOI 10.1016/0012-1606(81)90468-1; GOLDBERG RB, 1989, CELL, V56, P149, DOI 10.1016/0092-8674(89)90888-X; GOLDBERG RB, 1983, CELL, V33, P465, DOI 10.1016/0092-8674(83)90428-2; Golombek S, 2001, J PLANT PHYSIOL, V158, P457, DOI 10.1078/0176-1617-00357; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Gutierrez L, 2007, TRENDS PLANT SCI, V12, P294, DOI 10.1016/j.tplants.2007.06.003; HARADA JJ, 1989, PLANT CELL, V1, P415, DOI 10.1105/tpc.1.4.415; Hinnebusch A.G., 2007, TRANSLATIONAL CONTRO, P225; Hinnebusch AG, 2016, SCIENCE, V352, P1413, DOI 10.1126/science.aad9868; Huang F, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-89; Ingolia NT, 2014, NAT REV GENET, V15, P205, DOI 10.1038/nrg3645; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2010, METHOD ENZYMOL, V470, P119, DOI 10.1016/S0076-6879(10)70006-9; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jiao YL, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.76; Jones SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059270; Jones SI, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-136; Juntawong P, 2014, P NATL ACAD SCI USA, V111, pE203, DOI 10.1073/pnas.1317811111; Kawaguchi R, 2004, PLANT J, V38, P823, DOI 10.1111/j.1365-313X.2004.02090.x; Kumar G, 2016, SCI REP-UK, V6, DOI 10.1038/srep20695; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le BH, 2007, PLANT PHYSIOL, V144, P562, DOI 10.1104/pp.107.100362; Lei L, 2015, PLANT J, V84, P1206, DOI 10.1111/tpj.13073; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu W, 2015, INT J MOL SCI, V16, P20657, DOI 10.3390/ijms160920657; Liu XW, 2001, SEED SCI RES, V11, P55, DOI 10.1079/SSR200060; Locascio A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00412; MEINKE DW, 1981, PLANTA, V153, P130, DOI 10.1007/BF00384094; Moreno F Javier, 2008, Open Biochem J, V2, P16, DOI 10.2174/1874091X00802010016; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mustroph A, 2010, PLANT SIGNAL BEHAV, V5, P320, DOI 10.4161/psb.5.3.11187; Mustroph A, 2009, P NATL ACAD SCI USA, V106, P18843, DOI 10.1073/pnas.0906131106; Mylne JS, 2014, FUNCT PLANT BIOL, V41, P671, DOI 10.1071/FP14035; NIELSEN NC, 1985, J AM OIL CHEM SOC, V62, P1680, DOI 10.1007/BF02541665; Otegui MS, 2006, PLANT CELL, V18, P2567, DOI 10.1105/tpc.106.040931; PAPASTOITSIS G, 1991, PLANT PHYSIOL, V96, P1086, DOI 10.1104/pp.96.4.1086; Philip R, 1998, PLANT SCI, V137, P191, DOI 10.1016/S0168-9452(98)00137-X; QI XQ, 1992, PLANT PHYSIOL, V99, P725, DOI 10.1104/pp.99.2.725; RAINBIRD RM, 1984, PLANT PHYSIOL, V74, P329, DOI 10.1104/pp.74.2.329; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SAITO GY, 1989, NEW PHYTOL, V113, P459, DOI 10.1111/j.1469-8137.1989.tb00357.x; Saski C, 2005, PLANT MOL BIOL, V59, P309, DOI 10.1007/s11103-005-8882-0; Schmidt MA, 2011, PLANT PHYSIOL, V156, P330, DOI 10.1104/pp.111.173807; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shamimuzzaman M, 2014, FUNCT INTEGR GENOMIC, V14, P683, DOI 10.1007/s10142-014-0388-x; Shamimuzzaman M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-310; SHEWRY PR, 1995, PLANT CELL, V7, P945, DOI 10.1105/tpc.7.7.945; Shi Z, 2017, MOL CELL, V67, P71, DOI 10.1016/j.molcel.2017.05.021; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Smaczniak C, 2012, DEVELOPMENT, V139, P3081, DOI 10.1242/dev.074674; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; VODKIN LO, 1983, CELL, V34, P1023, DOI 10.1016/0092-8674(83)90560-3; VODKIN LO, 1981, PLANT PHYSIOL, V68, P766, DOI 10.1104/pp.68.3.766; WALLING L, 1986, P NATL ACAD SCI USA, V83, P2123, DOI 10.1073/pnas.83.7.2123; Wei B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084781; YOULE RJ, 1981, AM J BOT, V68, P44, DOI 10.2307/2442990; Zabala G, 2005, PLANT CELL, V17, P2619, DOI 10.1105/tpc.105.033506; Zakharov A, 2004, J EXP BOT, V55, P2241, DOI 10.1093/jxb/erh247; Zanetti ME, 2005, PLANT PHYSIOL, V138, P624, DOI 10.1104/pp.105.059477	72	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2018	13	3							e0194596	10.1371/journal.pone.0194596	http://dx.doi.org/10.1371/journal.pone.0194596			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA2QK	29570733	Green Published, gold, Green Submitted			2022-12-26	WOS:000428168400024
J	Voloshin, S; Smoldovskaya, O; Feyzkhanova, G; Arefieva, A; Pavlushkina, L; Filatova, T; Butvilovskaya, V; Filippova, M; Lysov, Y; Shcherbo, S; Makarov, A; Rubina, A; Zasedatelev, A				Voloshin, Sergei; Smoldovskaya, Olga; Feyzkhanova, Guzel; Arefieva, Alla; Pavlushkina, Lyudmila; Filatova, Tatiana; Butvilovskaya, Veronika; Filippova, Marina; Lysov, Yuri; Shcherbo, Sergey; Makarov, Alexander; Rubina, Alla; Zasedatelev, Alexander			Patterns of sensitization to inhalant and food allergens among pediatric patients from the Moscow region (Russian Federation)	PLOS ONE			English	Article							MULTIPLEX ASSAY; PREVALENCE; IGE; IGG(4); DIAGNOSTICS; ANTIBODIES; CHILDHOOD; TOLERANCE; PROFILES; SYMPTOMS	The immunological profiles of human specific IgE (sIgE) and specific IgG4 (sIgG4) vary by genetic predisposition, living conditions in different geographical locations and patient's age. The aim of our study was to analyze sIgE and sIgG4 patterns and their age-dependent changes in patients from the Moscow region. For identifying sIgE and sIgG4 profiles the blood samples from 513 patients aged 6 months to 17 years who were showing symptoms of allergic diseases were analyzed using microarrays containing 31 allergens. The highest sIgE prevalence was observed for birch pollen (32%) among pollen allergens, cat dander (24%) among indoor allergens, and egg whites (21%) among food allergens. The most common sIgG4 response was developed toward egg whites (80% of patients). Age-related elevation was identified for patients with increased sIgE to pollen allergens and indoor allergens (cat or dog dander and house dust mites). For each allergen, the proportion of cases with significant levels of sIgG4 appeared to increase with patients' age. The data on allergen-specific sIgE and sIgG4 prevalence show both general trends and some local special aspects that are indicative for the Moscow region. This information should be useful in terms of epidemiology of allergic diseases.	[Voloshin, Sergei; Smoldovskaya, Olga; Feyzkhanova, Guzel; Arefieva, Alla; Butvilovskaya, Veronika; Filippova, Marina; Lysov, Yuri; Makarov, Alexander; Rubina, Alla; Zasedatelev, Alexander] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Pavlushkina, Lyudmila; Filatova, Tatiana; Shcherbo, Sergey] Filatov Moscow City Pediat Clin 13, Moscow, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS	Smoldovskaya, O (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia.	asmoldovskaya@gmail.com	Feyzkhanova, Guzel/L-9273-2017; Arefieva, Alla/G-9037-2017; butvilovskaya, veronika/GOK-2506-2022; Smoldovskaya, Olga/AAF-3505-2019; Filippova, Marina/G-9006-2017; Smoldovskaya, Olga/Q-8796-2017	Feyzkhanova, Guzel/0000-0001-6706-4488; Arefieva, Alla/0000-0001-9046-3196; Smoldovskaya, Olga/0000-0002-9947-4446; Smoldovskaya, Olga/0000-0002-9947-4446; Rubina, Alla/0000-0002-6120-7780; Filippova, Marina/0000-0002-9454-5938	Russian Science Foundation [14-50-00060]; Program of fundamental research for state academies [01201363819]	Russian Science Foundation(Russian Science Foundation (RSF)); Program of fundamental research for state academies	This work was supported by the Russian Science Foundation (http://rscf.ru/en), Grant No. 14-50-00060. Optimization of the software for analysis of IgG4 profiles was supported by the Program of fundamental research for state academies for the period 2013 2020 (http://fano.gov.ru/), subprogram No. 01201363819. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Аак Олег Владимирович Aak O.V.], 2013, [Российский аллергологический журнал, Rossiiskii allergologicheskii zhurnal], P74; Bartunkova J, 2009, AUTOIMMUN REV, V8, P302, DOI 10.1016/j.autrev.2008.09.004; Beitia JM, 2014, INT ARCH ALLERGY IMM, V165, P9, DOI 10.1159/000365866; BOUSQUET PJ, 2007, GEOGRAPHICAL VARIATI, V62, P301, DOI DOI 10.1111/J.1398-9995.2006.01293.X; Burks AW, 2012, J ALLERGY CLIN IMMUN, V129, P906, DOI 10.1016/j.jaci.2012.02.001; Burnett M, 2013, J ALLER CL IMM-PRACT, V1, P350, DOI 10.1016/j.jaip.2013.03.011; Burney PGJ, 2014, ALLERGY, V69, P365, DOI 10.1111/all.12341; Charpin D, 2017, INT ARCH ALLERGY IMM, V172, P236, DOI 10.1159/000471511; Chen Y, 2017, PEDIAT ALLERG IMM-UK, V28, P340, DOI 10.1111/pai.12709; Chiu CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102809; Dalal I, 2002, ALLERGY, V57, P362, DOI 10.1034/j.1398-9995.2002.1s3412.x; de Jong AB, 2011, PEDIAT ALLERG IMM-UK, V22, P166, DOI 10.1111/j.1399-3038.2010.00993.x; Farioli L, 2017, INT ARCH ALLERGY IMM, V24, P3; Feyzkhanova GU, 2014, J IMMUNOL METHODS, V406, P51, DOI 10.1016/j.jim.2014.03.003; Feyzkhanova G, 2017, CLIN PROTEOM, V14, DOI 10.1186/s12014-016-9136-7; Fleiss J.L., 2013, STAT METHODS RATES P; Gocki J, 2016, POSTEP DERM ALERGOL, V33, P253, DOI 10.5114/ada.2016.61600; Inam M, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2980-0; Ito Komei, 2012, Clin Mol Allergy, V10, P1, DOI 10.1186/1476-7961-10-1; Ivkovic-Jurekovic I, 2015, INT DENT J, V65, P164, DOI 10.1111/idj.12164; Lee Sooyoung, 2017, Korean J Pediatr, V60, P99, DOI 10.3345/kjp.2017.60.4.99; Lok SD, 2017, ALLERGY ASTHMA CL IM, V13, DOI 10.1186/s13223-017-0181-1; Lysov Y, 2017, BIOMED OPT EXPRESS, V8, P4798, DOI 10.1364/BOE.8.004798; Mallol J, 2013, ALLERGOL IMMUNOPATH, V41, P73, DOI 10.1016/j.aller.2012.03.001; Matsumoto N, 2009, PEPTIDES, V30, P1840, DOI 10.1016/j.peptides.2009.07.005; Matsuoka T, 2013, ALLERGOL INT, V62, P403, DOI 10.2332/allergolint.13-RAI-0650; Mazumder A, 2017, J EVOL MED DENT SCI-, V6, P1, DOI 10.14260/jemds/2017/1; McWilliam V, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0555-8; Mittermann I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156077; Ogorodova LM, 2007, PARASITOL RES, V101, P1165, DOI 10.1007/s00436-007-0588-6; Onell Annica, 2012, Clin Transl Allergy, V2, P24, DOI 10.1186/2045-7022-2-24; Rubina AY, 2012, DOKL BIOCHEM BIOPHYS, V447, P289, DOI 10.1134/S1607672912060063; Rubina AY, 2008, PROTEOMICS, V8, P817, DOI 10.1002/pmic.200700629; Scott-Taylor TH, 2017, IMMUN INFLAMM DIS; Smoldovskaya O, 2016, ALLERGY ASTHMA CL IM, V12, DOI 10.1186/s13223-016-0117-1; Steckelbroeck S, 2008, J ALLERGY CLIN IMMUN, V121, P1323, DOI 10.1016/j.jaci.2008.04.008; Tomicic S, 2009, PEDIAT ALLERG IMM-UK, V20, P35, DOI 10.1111/j.1399-3038.2008.00738.x; van de Veen W, 2016, J ALLERGY CLIN IMMUN, V138, P1434, DOI 10.1016/j.jaci.2016.07.022; Vazquez-Ortiz M, 2014, CLIN EXP ALLERGY, V44, P579, DOI 10.1111/cea.12273; Wong L, 2016, ALLERGY ASTHMA IMMUN, V8, P101, DOI 10.4168/aair.2016.8.2.101; Woo Chee K, 2011, Clin Transl Allergy, V1, P3, DOI 10.1186/2045-7022-1-3; Yeoh SM, 2003, INT ARCH ALLERGY IMM, V132, P215, DOI 10.1159/000074302; Yong SB, 2013, J MICROBIOL IMMUNOL, V46, P295, DOI 10.1016/j.jmii.2012.07.002; Zheng YW, 2015, BIOMED ENVIRON SCI, V28, P709, DOI 10.3967/bes2015.101	44	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194775	10.1371/Journal.pone.0194775	http://dx.doi.org/10.1371/Journal.pone.0194775			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566093	Green Submitted, Green Published, gold			2022-12-26	WOS:000428093900104
J	Picard-Jean, F; Brand, C; Tremblay-Letourneau, M; Allaire, A; Beaudoin, MC; Boudreault, S; Duval, C; Rainville-Sirois, J; Robert, F; Pelletier, J; Geiss, BJ; Bisaillon, M				Picard-Jean, Frederic; Brand, Carolin; Tremblay-Letourneau, Maude; Allaire, Andrea; Beaudoin, Maxime C.; Boudreault, Simon; Duval, Cyntia; Rainville-Sirois, Julien; Robert, Francis; Pelletier, Jerry; Geiss, Brian J.; Bisaillon, Martin			2 '-O-methylation of the mRNA cap protects RNAs from decapping and degradation by DXO	PLOS ONE			English	Article							LINKED MENTAL-RETARDATION; QUALITY-CONTROL MECHANISM; RIG-I; EXORIBONUCLEASE ACTIVITY; IDENTIFICATION; RECOGNITION; ENCODES; SELF	The 5' RNA cap structure ((m7)GpppRNA) is a key feature of eukaryotic mRNAs with important roles in stability, splicing, polyadenylation, mRNA export, and translation. Higher eukaryotes can further modify this minimal cap structure with the addition of a methyl group on the ribose 2'-O position of the first transcribed nucleotide ((m7)GpppN(m)pRNA) and sometimes on the adjoining nucleotide ((m7)GpppN(m)pN(m)pRNA). In higher eukaryotes, the DXO protein was previously shown to be responsible for both decapping and degradation of RNA transcripts harboring aberrant 5' ends such as pRNA, pppRNA, GpppRNA, and surprisingly, (m7)GpppRNA. It was proposed that the interaction of the cap binding complex with the methylated cap would prevent degradation of (m7)GpppRNAs by DXO. However, the critical role of the 2'-O-methylation found in higher eukaryotic cap structures was not previously addressed. In the present study, we demonstrate that DXO possesses both decapping and exoribonuclease activities toward incompletely capped RNAs, only sparing RNAs with a 2'O-methylated cap structure. Fluorescence spectroscopy assays also revealed that the presence of the 2'-O-methylation on the cap structure drastically reduces the affinity of DXO for RNA. Moreover, immunofluorescence and structure-function assays also revealed that a nuclear localisation signal is located in the amino-terminus region of DXO. Overall, these results are consistent with a quality control mechanism in which DXO degrades incompletely capped RNAs.	[Picard-Jean, Frederic; Brand, Carolin; Tremblay-Letourneau, Maude; Allaire, Andrea; Beaudoin, Maxime C.; Boudreault, Simon; Duval, Cyntia; Rainville-Sirois, Julien; Bisaillon, Martin] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ, Canada; [Robert, Francis; Pelletier, Jerry] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Geiss, Brian J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	University of Sherbrooke; McGill University; Colorado State University	Bisaillon, M (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ, Canada.	Martin.Bisaillon@USherbrooke.ca	Geiss, Brian/J-3021-2017; Duval, Cyntia/AAF-7468-2021	Geiss, Brian/0000-0001-8180-5772; 	Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); Faculte de medecine et des sciences de la sante de l'Universite de Sherbrooke; CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Faculte de medecine et des sciences de la sante de l'Universite de Sherbrooke; CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council of Canada (NSERC) (MB). M.B. is a Chercheur-boursier Senior from the Fonds de recherche du Quebec-Sante (FRQ-S). C.B. holds a graduate training award from the Faculte de medecine et des sciences de la sante de l'Universite de Sherbrooke. A.A. holds a graduate training award from the CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang JH, 2012, NAT STRUCT MOL BIOL, V19, P1011, DOI 10.1038/nsmb.2381; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Devarkar SC, 2016, P NATL ACAD SCI USA, V113, P596, DOI 10.1073/pnas.1515152113; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; FURUICHI Y, 1975, P NATL ACAD SCI USA, V72, P1904, DOI 10.1073/pnas.72.5.1904; Grudzien-Nogalska E., 2017, WILEY INTERDISCIP RE, V8; Jiao XF, 2013, MOL CELL, V50, P104, DOI 10.1016/j.molcel.2013.02.017; Jiao XF, 2010, NATURE, V467, P608, DOI 10.1038/nature09338; Jiao XF, 2009, J NEUROSCI, V29, P12419, DOI 10.1523/JNEUROSCI.5954-08.2009; Jiao XF, 2006, MOL CELL, V24, P713, DOI 10.1016/j.molcel.2006.10.013; KENNA M, 1993, MOL CELL BIOL, V13, P341, DOI 10.1128/MCB.13.1.341; Khanna R, 2004, EMBO J, V23, P1968, DOI 10.1038/sj.emboj.7600213; Nagarajan VK, 2013, BBA-GENE REGUL MECH, V1829, P590, DOI 10.1016/j.bbagrm.2013.03.005; Picard-Jean F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054621; Ramanathan A, 2016, NUCLEIC ACIDS RES, V44, P7511, DOI 10.1093/nar/gkw551; Schuberth-Wagner C, 2015, IMMUNITY, V43, P41, DOI 10.1016/j.immuni.2015.06.015; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Xiang S, 2009, NATURE, V458, P784, DOI 10.1038/nature07731; Xue Y, 2000, MOL CELL BIOL, V20, P4006, DOI 10.1128/MCB.20.11.4006-4015.2000; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zheng DH, 2011, RNA, V17, P1619, DOI 10.1261/rna.2789611; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	23	28	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0193804	10.1371/journal.pone.0193804	http://dx.doi.org/10.1371/journal.pone.0193804			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601584	Green Submitted, Green Published, gold			2022-12-26	WOS:000428845900002
J	Sanna, C; Scognamiglio, M; Fiorentino, A; Corona, A; Graziani, V; Caredda, A; Cortis, P; Montisci, M; Ceresola, ER; Canducci, F; Poli, F; Tramontano, E; Esposito, F				Sanna, Cinzia; Scognamiglio, Monica; Fiorentino, Antonio; Corona, Angela; Graziani, Vittoria; Caredda, Alessia; Cortis, Pierluigi; Montisci, Mariofilippo; Ceresola, Elisa Rita; Canducci, Filippo; Poli, Ferruccio; Tramontano, Enzo; Esposito, Francesca			Prenylated phloroglucinols from Hypericum scruglii, an endemic species of Sardinia (Italy), as new dual HIV-1 inhibitors effective on HIV-1 replication	PLOS ONE			English	Article							RIBONUCLEASE-H ACTIVITY; LA MADDALENA ARCHIPELAGO; DIKETO ACID-DERIVATIVES; REVERSE-TRANSCRIPTASE; RNASE-H; NATURAL-PRODUCTS; CHEMICAL-COMPOSITION; INTEGRASE INHIBITOR; BIOLOGICAL-ACTIVITY; ACTIVE-SITE	In a search for new potential multitarget anti-HIV compounds from natural products, we have identified in Hypericum scruglii, an endemic and exclusive species of Sardinia (Italy), a potent plant lead. The phytochemical study of the hydroalcoholic extract obtained from its leaves led to the isolation of its most abundant secondary metabolites, belonging to different chemical classes. In particular, three phloroglucinols derivatives were identified, confirming their significance as chemotaxonomic markers of the Hypericum genus. Among them, the 3-(13-hydroxygeranyl)-1-(2'-methylbutanoyl) phloroglucinol was reported here for the first time. All six isolated compounds have been evaluated firstly for the inhibition of both Human Immunodeficiency Virus type 1 (HIV-1) Reverse Transcriptase (RT)-associated DNA Polymerase (RDDP) and Ribonuclease H (RNase H) activities, for the inhibition of HIV-1 integrase (IN) in biochemical assays, and also for their effect on viral replication. Among the isolated metabolites, three phloroglucinol derivatives and quercitrin were effective on both RT-associated RDDP and RNase H activities in biochemical assays. The same active compounds affected also HIV-1 IN strand transfer function, suggesting the involvement of the RNase H active site. Furthermore, phloroglucinols compounds, included the newly identified compound, were able to inhibit the HIV-1 replication in cell based assays.	[Sanna, Cinzia; Corona, Angela; Caredda, Alessia; Cortis, Pierluigi; Montisci, Mariofilippo; Tramontano, Enzo; Esposito, Francesca] Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy; [Scognamiglio, Monica] Max Planck Inst Chem Ecol, Beutenberg Campus, Jena, Germany; [Fiorentino, Antonio; Graziani, Vittoria] Univ Campania, Dept Environm Biol & Pharmaceut Sci & Technol, Caserta, Italy; [Ceresola, Elisa Rita; Canducci, Filippo] Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy; [Canducci, Filippo] Osped San Raffaele, IRCCS, Microbiol Lab, Milan, Italy; [Poli, Ferruccio] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy	University of Cagliari; Max Planck Society; Universita della Campania Vanvitelli; University of Insubria; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Bologna	Sanna, C (corresponding author), Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy.	cinziasanna@unica.it	Corona, Angela/G-7327-2014; Scognamiglio, Monica/U-1116-2017; Graziani, Vittoria/AAO-2436-2020; Fiorentino, Antonio/W-3531-2018; Tramontano, Enzo/B-4919-2012	Corona, Angela/0000-0002-6630-8636; Graziani, Vittoria/0000-0002-8391-2763; Fiorentino, Antonio/0000-0002-9439-7074; SANNA, CINZIA/0000-0001-9797-2460; Scognamiglio, Monica/0000-0001-9614-0929; Tramontano, Enzo/0000-0002-4849-0980				Alcaro S, 2010, CURR MED CHEM, V17, P290, DOI 10.2174/092986710790192695; Appendino G, 2005, J NAT PROD, V68, P853, DOI 10.1021/np050120q; Artan M, 2008, BIOORGAN MED CHEM, V16, P7921, DOI 10.1016/j.bmc.2008.07.078; ARTS EJ, 2012, COLD SPRING HARB PER, V2, DOI DOI 10.1101/CSHPERSPECT.A007161; Bacchetta G, 2010, NORD J BOT, V28, P469, DOI 10.1111/j.1756-1051.2009.00736.x; Bicchi C, 2009, PLANTA MED, V75, P1331, DOI 10.1055/s-0029-1185546; Birt DF, 2009, PHARM BIOL, V47, P774, DOI 10.1080/13880200902988645; Brolis M, 1998, J CHROMATOGR A, V825, P9, DOI 10.1016/S0021-9673(98)00697-9; Cagno V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172322; Cakir A, 2005, BIOCHEM SYST ECOL, V33, P245, DOI 10.1016/j.bse.2004.08.006; Camas N, 2014, PLANT SYST EVOL, V300, P953, DOI 10.1007/s00606-013-0934-3; Canducci F, 2011, J INFECT DIS, V204, P1811, DOI 10.1093/infdis/jir636; Canducci F, 2010, J ANTIMICROB CHEMOTH, V65, P425, DOI 10.1093/jac/dkp477; Cangelosi B, 2015, PHYTOCHEMISTRY, V115, P216, DOI 10.1016/j.phytochem.2015.02.008; Carcelli M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00440; Chauthe SK, 2010, BIOORGAN MED CHEM, V18, P2029, DOI 10.1016/j.bmc.2010.01.023; Chimenti F, 2006, J NAT PROD, V69, P945, DOI 10.1021/np060015w; Cirak C, 2006, BIOCHEM SYST ECOL, V34, P1, DOI 10.1016/j.bse.2005.06.004; Cirak C, 2016, S AFR J BOT, V104, P82, DOI 10.1016/j.sajb.2015.09.022; Cirak C, 2010, NAT PROD COMMUN, V5, P897; Cirak C, 2006, BIOCHEM SYST ECOL, V34, P897, DOI 10.1016/j.bse.2006.08.002; Cirak C, 2013, PHARM BIOL, V51, P391, DOI 10.3109/13880209.2012.733012; Conforti F, 2007, NAT PROD RES, V21, P42, DOI 10.1080/14786410500356243; Corona A, 2016, PLOS ONE, P11; Corona A, 2017, PATHOG DIS, P75; Corona A, 2016, ANTIVIR RES, V134, P236, DOI 10.1016/j.antiviral.2016.09.008; Corona A, 2014, ANTIMICROB AGENTS CH, V58, P6101, DOI 10.1128/AAC.03605-14; Corona A, 2014, FUTURE VIROL, V9, P445, DOI 10.2217/fvl.14.24; Corona A, 2014, ANTIMICROB AGENTS CH, V58, P4086, DOI 10.1128/AAC.00056-14; Corona A, 2013, FUTURE MED CHEM, V5, P2127, DOI 10.4155/fmc.13.178; Cos P, 2008, PLANTA MED, V74, P1323, DOI 10.1055/s-2008-1081314; Costi R, 2013, J MED CHEM, V56, P8588, DOI 10.1021/jm401040b; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Craigie R, 2001, J BIOL CHEM, V276, P23213, DOI 10.1074/jbc.R100027200; Crockett SL, 2008, PHYTOCHEM LETT, V1, P37, DOI 10.1016/j.phytol.2007.12.003; Crucitti GC, 2015, J MED CHEM, V58, P1915, DOI 10.1021/jm501799k; Distinto S, 2013, CURR PHARM DESIGN, V19, P1850, DOI 10.2174/1381612811319100009; Esposito F, 2016, PHYTOMEDICINE, V23, P1383, DOI 10.1016/j.phymed.2016.08.001; Esposito F, 2015, CHEMBIOCHEM, V16, P2507, DOI 10.1002/cbic.201500385; Esposito Francesca, 2014, Antiviral Chemistry & Chemotherapy, V23, P129, DOI 10.3851/IMP2690; Esposito F, 2013, PATHOG DIS, V68, P116, DOI 10.1111/2049-632X.12051; FARNET CM, 1991, J VIROL, V65, P1910, DOI 10.1128/JVI.65.4.1910-1915.1991; FESEN MR, 1993, P NATL ACAD SCI USA, V90, P2399, DOI 10.1073/pnas.90.6.2399; Fiebich BL, 2011, FITOTERAPIA, V82, P474, DOI 10.1016/j.fitote.2010.12.006; Fobofou SAT, 2015, BIOORGAN MED CHEM, V23, P6327, DOI 10.1016/j.bmc.2015.08.028; Gambari R, 2006, ADV PHYTOMED, V2, P299; Gibbons S, 2005, PHYTOCHEMISTRY, V66, P1472, DOI 10.1016/j.phytochem.2005.04.024; Guo ZR, 2017, ACTA PHARM SIN B, V7, P119, DOI 10.1016/j.apsb.2016.06.003; Gupta P, 2010, BIOORG MED CHEM LETT, V20, P4427, DOI 10.1016/j.bmcl.2010.06.057; Hicks C, 2009, CLIN INFECT DIS, V48, P931, DOI 10.1086/597290; Hillwig ML, 2008, J AGR FOOD CHEM, V56, P4359, DOI 10.1021/jf800411v; Hosseinzadeh H, 2005, J ETHNOPHARMACOL, V98, P207, DOI 10.1016/j.jep.2004.12.007; Jurgenliemk G, 2002, PLANTA MED, V68, P88, DOI 10.1055/s-2002-20053; Kawasuji T, 2013, J MED CHEM, V56, P1124, DOI 10.1021/jm301550c; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; Kharlamova T, 2009, MED CHEM, V5, P398, DOI 10.2174/157340609789117840; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Mandrone M, 2017, FITOTERAPIA, V120, P184, DOI 10.1016/j.fitote.2017.06.020; Mandrone M, 2015, IND CROP PROD, V76, P402, DOI 10.1016/j.indcrop.2015.07.012; Martini R, 2017, CHEMBIOCHEM, V18, P374, DOI 10.1002/cbic.201600592; Maxia A, 2015, IND CROP PROD, V65, P472, DOI 10.1016/j.indcrop.2014.10.039; Meleddu R, 2017, J ENZYM INHIB MED CH, V32, P264, DOI 10.1080/14756366.2016.1247061; Meleddu R, 2014, CHEMMEDCHEM, V9, P1869, DOI 10.1002/cmdc.201402015; Menendez-Arias L, 2013, ANTIVIR RES, V98, P93, DOI 10.1016/j.antiviral.2013.01.007; Mishra BB, 2011, EUR J MED CHEM, V46, P4769, DOI 10.1016/j.ejmech.2011.07.057; NAKANE H, 1991, FEBS LETT, V286, P83, DOI 10.1016/0014-5793(91)80946-Z; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; ONO K, 1990, EUR J BIOCHEM, V190, P469, DOI 10.1111/j.1432-1033.1990.tb15597.x; Ornano L, 2016, NAT PROD RES, V30, P1802, DOI 10.1080/14786419.2015.1079190; Ornano L, 2016, NAT PROD RES, V30, P920, DOI 10.1080/14786419.2015.1079189; Ornano L, 2015, J OLEO SCI, V64, P19, DOI 10.5650/jos.ess14171; Ozkan EE, 2018, S AFR J BOT, V114, P104, DOI 10.1016/j.sajb.2017.10.022; Palaniappan C, 1997, J BIOL CHEM, V272, P11157, DOI 10.1074/jbc.272.17.11157; Patridge E, 2016, DRUG DISCOV TODAY, V21, P204, DOI 10.1016/j.drudis.2015.01.009; Peruzzi L, 2014, PHYTOTAXA, V168, P1; Porzel A, 2014, METABOLOMICS, V10, P574, DOI 10.1007/s11306-013-0609-7; Salim A. A., 2008, P1, DOI 10.1007/978-3-540-74603-4_1; Sanchez-Mateo CC, 2002, J ETHNOPHARMACOL, V79, P119, DOI 10.1016/S0378-8741(01)00393-2; Sato M, 2006, J MED CHEM, V49, P1506, DOI 10.1021/jm0600139; SCHATZ O, 1990, ADV AP BIOT, V7, P293; Schmidt B, 2008, METABOLISM, V57, pS3, DOI 10.1016/j.metabol.2008.03.001; Schneider A, 2016, NUCLEIC ACIDS RES, V44, P2310, DOI 10.1093/nar/gkw060; Shah S, 2013, NAT PROD RES, V27, P1502, DOI 10.1080/14786419.2012.724409; Shiu WKP, 2006, PHYTOCHEMISTRY, V67, P2568, DOI 10.1016/j.phytochem.2006.09.037; Smelcerovic A, 2008, BIOCHEM SYST ECOL, V36, P316, DOI 10.1016/j.bse.2007.09.002; sposito F, 2017, PATHOG DIS, P75; Stella-Ascariz N, 2017, J INFECT DIS, V216, pS847, DOI 10.1093/infdis/jix430; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; Tanaka T., 2011, Journal of Experimental and Clinical Medicine, V3, P27, DOI 10.1016/j.jecm.2010.12.005; Tiberi M, 2014, ANTIMICROB AGENTS CH, V58, P3043, DOI 10.1128/AAC.02739-13; Tintori C, 2015, BIOORG MED CHEM LETT, V25, P3013, DOI 10.1016/j.bmcl.2015.05.011; Tramontano E, 2005, ANTIVIR RES, V65, P117, DOI 10.1016/j.antiviral.2004.11.002; Tramontano E, 2006, MINI-REV MED CHEM, V6, P727, DOI 10.2174/138955706777435733; UNAIDS, 2017, GLOB HIV STAT JUL 20, P18; Vandegraaff N, 2001, ANTIMICROB AGENTS CH, V45, P2510, DOI 10.1128/AAC.45.9.2510-2516.2001; Vanegas M, 2005, J CELL SCI, V118, P1733, DOI 10.1242/jcs.02299; Venditti A, 2017, CHEM BIODIVERS, V14, DOI 10.1002/cbdv.201700072; Venditti A, 2016, NAT PROD RES, V30, P789, DOI 10.1080/14786419.2015.1067619; Vernekar SKV, 2017, J MED CHEM, V60, P5045, DOI 10.1021/acs.jmedchem.7b00440; Wang X, 2017, CURR MED CHEM, V24, P1; Xu LJ, 2015, J MICROBIOL, V53, P288, DOI 10.1007/s12275-015-4652-0; Yu DL, 2007, MED RES REV, V27, P108, DOI 10.1002/med.20075; Zhan P, 2016, J MED CHEM, V59, P2849, DOI 10.1021/acs.jmedchem.5b00497; Zorzetto C, 2015, FITOTERAPIA, V100, P95, DOI 10.1016/j.fitote.2014.11.013	104	27	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195168	10.1371/journal.pone.0195168	http://dx.doi.org/10.1371/journal.pone.0195168			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601601	Green Submitted, Green Published, gold			2022-12-26	WOS:000428845900021
J	He, P; Luo, YN; Hu, XY; Gong, R; Wen, X; Zheng, XY				He, Ping; Luo, Yanan; Hu, Xiangyang; Gong, Rui; Wen, Xu; Zheng, Xiaoying			Association of socioeconomic status with hearing loss in Chinese working-aged adults: A population-based study	PLOS ONE			English	Article							RISK-FACTORS; HEALTH RESEARCH; OLDER-ADULTS; IMPAIRMENT; PREVALENCE; EPIDEMIOLOGY; OCCUPATION; EDUCATION; POSITION; EXPOSURE	Hearing loss is the most common sensory impairment, but limited studies focused on the association of socioeconomic status (SES) with hearing loss among adults of working age. This paper aimed to fill this gap among Chinese adults. We obtained data from Ear and Hearing Disorder Survey conducted in four provinces of China in 2014-2015. The survey was based on WHO Ear and Hearing Disorders Survey Protocol and 25,860 adults aged 25 to 59 years were selected in this study. Trained local examiners performed pure tone audiometry to screen people with hearing loss, and those who were screened positively for hearing loss were referred to audiologists to make final diagnosis. SES was measured by occupation, education and income. Results show after adjusting for SES measures and covariates, in urban areas, compared with white-collar workers, blue-collar workers and the unemployed were more likely to have hearing loss, with an odds ratio of 1.2 (95% CI: 1.0, 1.3) and 1.2 (95% CI: 1.0, 1.4), respectively. Compared with people with education of senior high school or above, those with junior high school, primary school and illiteracy had 1.6 (95% CI: 1.4, 1.8), 2.1(95% CI: 1.7, 2.5) and 2.6 (95% CI: 1.9, 3.7) times as likely to have hearing loss, respectively. In rural areas, the unemployed had 1.5 (95% CI: 1.0, 2.3) times the risk of hearing loss compared with white-collar workers, and illiterates had 1.6 (95% CI: 1.6, 2.1) times the risk of hearing loss compared with people with education of senior high school or above, after SES variables and covariates were taken into considerations. Income was not significantly associated with hearing loss in urban and rural areas. In conclusion, SES, in the form of occupation and education, was associated with hearing loss among working-aged population, and further studies are needed to explore the mechanism of such association.	[He, Ping] Peking Univ, China Ctr Hlth Dev Studies, Beijing, Peoples R China; [He, Ping; Luo, Yanan; Wen, Xu; Zheng, Xiaoying] Peking Univ, Inst Populat Res, Beijing, Peoples R China; [He, Ping] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Hu, Xiangyang; Gong, Rui] China Rehabil Res Ctr Deaf Children, Beijing, Peoples R China; [Zheng, Xiaoying] Peking Univ, APEC Hlth Sci Acad HeSAY, Beijing, Peoples R China	Peking University; Peking University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Peking University	Zheng, XY (corresponding author), Peking Univ, Inst Populat Res, Beijing, Peoples R China.; Zheng, XY (corresponding author), Peking Univ, APEC Hlth Sci Acad HeSAY, Beijing, Peoples R China.	xzheng@pku.edu.cn	Hu, Xiangyang/AAQ-3313-2021					Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; Agrawal Y, 2009, OTOL NEUROTOL, V30, P139, DOI 10.1097/MAO.0b013e318192483c; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; [Anonymous], INFECT HEARING IMPAI; Bu X., 2011, AUDIOLOGICAL MED, V9, P141, DOI [10.3109/1651386X.2011.631285, DOI 10.3109/1651386X.2011.631285]; Bu X., 2003, INFORM CONSULTATION; Bu Xingkuan, 2005, J Am Acad Audiol, V16, P687, DOI 10.3766/jaaa.16.9.6; Chen ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132918; Cheng YJ, 2009, PREV MED, V49, P360, DOI 10.1016/j.ypmed.2009.07.021; Chou CF, 2015, AM J PUBLIC HEALTH, V105, P1262, DOI 10.2105/AJPH.2014.302475; Cruickshanks KJ, 2015, JAMA OTOLARYNGOL, V141, P641, DOI 10.1001/jamaoto.2015.0889; Cruickshanks KJ, 2010, HEARING RES, V264, P3, DOI 10.1016/j.heares.2009.10.008; Cubbin C, 2011, AM J PUBLIC HEALTH, V101, P939, DOI 10.2105/AJPH.2010.194175; Dalton DS, 2003, GERONTOLOGIST, V43, P661, DOI 10.1093/geront/43.5.661; Emmett SD, 2015, OTOL NEUROTOL, V36, P545, DOI 10.1097/MAO.0000000000000562; Engdahl B, 2010, SCAND J WORK ENV HEA, V36, P250, DOI 10.5271/sjweh.2887; Feder K, 2015, HEALTH REP, V26, P18; Galobardes B, 2007, BRIT MED BULL, V81-82, P21, DOI 10.1093/bmb/ldm001; Geyer S, 2006, J EPIDEMIOL COMMUN H, V60, P804, DOI 10.1136/jech.2005.041319; Guo H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117354; Hasson D, 2010, J EPIDEMIOL COMMUN H, V64, P453, DOI 10.1136/jech.2009.095430; Helvik AS, 2009, AM J PUBLIC HEALTH, V99, P1376, DOI 10.2105/AJPH.2007.133215; Hong JW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000611; Horner KC, 2003, NEUROSCI BIOBEHAV R, V27, P437, DOI 10.1016/S0149-7634(03)00071-X; Hu X Y, 2016, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V51, P819, DOI 10.3760/cma.j.issn.1673-0860.2016.11.004; Jarvelin MR, 1997, BRIT J AUDIOL, V31, P165, DOI 10.3109/03005364000000019; Lee JS, 2015, J KOREAN MED SCI, V30, P1175, DOI 10.3346/jkms.2015.30.8.1175; Looi LM, 2015, LANCET, V385, P943, DOI 10.1016/S0140-6736(15)60208-2; National Bureau of Statistics of China, 2010, 2010 POP CENS; Pollack CE, 2007, AM J PREV MED, V33, P250, DOI 10.1016/j.amepre.2007.04.033; Power C, 2008, J EPIDEMIOL COMMUN H, V62, P1030, DOI 10.1136/jech.2007.068817; Stam M, 2013, WORK, V46, P207, DOI 10.3233/WOR-131747; Tak S, 2009, AM J IND MED, V52, P358, DOI 10.1002/ajim.20690; Uehata Tetsunojo, 1991, Journal of Human Ergology, V20, P147; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Vyskocil A, 2012, TOXICOL IND HEALTH, V28, P796, DOI 10.1177/0748233711425067; Wang HX, 2014, ALCOHOL CLIN EXP RES, V38, P1035, DOI 10.1111/acer.12321; Wilson DH, 1999, INT J EPIDEMIOL, V28, P247, DOI 10.1093/ije/28.2.247; World Health Organization, 1999, WHO EAR HEAR DIS SUR; Zhan WH, 2011, PREV MED, V53, P338, DOI 10.1016/j.ypmed.2011.08.012	40	13	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195227	10.1371/journal.pone.0195227	http://dx.doi.org/10.1371/journal.pone.0195227			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596478	Green Submitted, Green Published, gold			2022-12-26	WOS:000428630000095
J	Syczylo, K; Platt-Samoraj, A; Bancerz-Kisiel, A; Szczerba-Turek, A; Pajdak-Czaus, J; Labuc, S; Procajlo, Z; Socha, P; Chuzhebayeva, G; Szweda, W				Syczylo, Kinga; Platt-Samoraj, Aleksandra; Bancerz-Kisiel, Agata; Szczerba-Turek, Anna; Pajdak-Czaus, Joanna; Labuc, Sebastian; Procajlo, Zbigniew; Socha, Piotr; Chuzhebayeva, Gulzhan; Szweda, Wojciech			The prevalence of Yersinia enterocolitica in game animals in Poland	PLOS ONE			English	Article							WILD BOARS; SUS-SCROFA; YSTB GENES; STRAINS; CARCASSES; AIL	Natural reservoirs of Yersinia (Y.) enterocolitica comprise different animal species, but little is known about the role of wild animals in the epidemiology of yersiniosis. The aim of the study was to evaluate the prevalence of Y. enterocolitica among game animals in Poland. The bio-serotypes and the pathogenicity markers of the analyzed isolates were determined. The experimental material comprised rectal swabs from 857 free-living animals hunter-harvested over a period of 2 years (2013-2014) in hunting districts across Poland. The isolates from bacteriological studies were confirmed by PCR and bio-serotyped based on the results of biochemical and agglutination tests. In the group of the 218 analyzed isolates of Y. enterocolitica, 133 were derived from wild boars, 70 from red deer, 11 from roe deer and 4 from fallow deer, and they accounted for 61.0%, 32.1%, 5.1% and 1.8% of all isolates, respectively. Bio-serotyping assays revealed that 91.7% of the examined isolates belonged to biotype 1A (200/218). The remaining 18 isolates belonged to bio-serotypes 1B/NI (3/218, 1.4%), 1B/O: 8 (1/218, 0.5%), 2/NI (6/218, 2.8%), 2/O: 27 (1/218, 0.5%), 2/O: 3 (1/218, 0.5%), 2/O: 9 (2/218, 0.9%), 3/NI (2/218, 0.9%), 4/O: 3 (1/218, 0.5%) and 4/O: 9 (1/218, 0.5%). The ail gene, a suggestive virulence gene for Y. enterocolitica, has been found in 30 isolates from 20 wild boars, in 6 isolates from red deer, and in 1 isolate from roe deer. Our study demonstrated that Y. enterocolitica is frequently isolated from game animals in Poland, which poses a risk of spreading these infectious agents to other animal species and humans.	[Syczylo, Kinga; Platt-Samoraj, Aleksandra; Bancerz-Kisiel, Agata; Szczerba-Turek, Anna; Pajdak-Czaus, Joanna; Labuc, Sebastian; Procajlo, Zbigniew; Szweda, Wojciech] Univ Warmia & Mazury, Dept Epizootiol, Fac Vet Med, Oczapowskiego 13, Olsztyn, Poland; [Socha, Piotr] Univ Warmia & Mazury, Dept Anim Reprod Clin, Fac Vet Med, Oczapowskiego 13, Olsztyn, Poland; [Chuzhebayeva, Gulzhan] Baitursynov Kostanay State Univ, Fac Vet & Livestock Technol, Dept Vet Publ Hlth, Baitursynov 47, Kostanay, Kazakhstan	University of Warmia & Mazury; University of Warmia & Mazury; Baitursynov Kostanay Regional University	Platt-Samoraj, A (corresponding author), Univ Warmia & Mazury, Dept Epizootiol, Fac Vet Med, Oczapowskiego 13, Olsztyn, Poland.	platt@uwm.edu.pl	Szczerba-Turek, Anna/F-8411-2011; Bancerz-Kisiel, Agata/AGN-6782-2022; Pajdak-Czaus, Joanna/R-6662-2018; Szczerba-Turek, Anna/AAY-6237-2020	Szczerba-Turek, Anna/0000-0002-7340-0991; Bancerz-Kisiel, Agata/0000-0003-0514-0363; Pajdak-Czaus, Joanna/0000-0003-2289-2241; Procajlo, Zbigniew/0000-0003-3377-6174; Labuc, Sebastian/0000-0001-9369-4395; Chuzhebayeva, Gulzhagan/0000-0002-0091-8888				Al Dahouk S, 2005, J VET MED B, V52, P444, DOI 10.1111/j.1439-0450.2005.00898.x; [Anonymous], 2005, 10273 PNEN ISO; Arrausi-Subiza M, 2016, ACTA VET SCAND, V58, DOI 10.1186/s13028-016-0184-9; Avagnina A, 2012, MEAT SCI, V91, P266, DOI 10.1016/j.meatsci.2012.01.025; Bancerz-Kisiel A, 2015, EPIDEMIOL INFECT, V143, P2758, DOI 10.1017/S0950268814003872; Bancerz-Kisiel A, 2014, POL J VET SCI, V17, P315, DOI 10.2478/pjvs-2014-0043; Bancerz-Kisiel A, 2012, POL J VET SCI, V15, P609, DOI 10.2478/v10181-012-0096-1; Bancerz-Kisiel A, 2016, VET J, V208, P102, DOI 10.1016/j.tvjl.2015.08.010; Bottone EJ, 1997, CLIN MICROBIOL REV, V10, P257, DOI 10.1128/CMR.10.2.257; Bucher M, 2008, FOODBORNE PATHOG DIS, V5, P273, DOI 10.1089/fpd.2007.0076; EFSA, 2016, EFSA J, V14, DOI [10.2903/j.efsa.2016.4375, 10.2903/j.efsa.2016.4584]; Fredriksson-Ahomaa M, 2003, CLIN MICROBIOL REV, V16, P220, DOI 10.1128/CMR.16.2.220-229.2003; Fredriksson-Ahomaa M, 2006, FEMS IMMUNOL MED MIC, V47, P315, DOI 10.1111/j.1574-695X.2006.00095.x; Fredriksson-Ahomaa M, 2011, FOODBORNE PATHOG DIS, V8, P733, DOI 10.1089/fpd.2010.0711; Gurtler M, 2005, J FOOD PROTECT, V68, P850; HACKING M A, 1974, Journal of Wildlife Diseases, V10, P452; Harnett N, 1996, EPIDEMIOL INFECT, V117, P59, DOI 10.1017/S0950268800001138; Huovinen E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-122; Jakubczak Antoni, 1993, Medycyna Weterynaryjna, V49, P301; Nikolova S, 2001, J VET MED B, V48, P203, DOI 10.1046/j.1439-0450.2001.00448.x; Platt-Samoraj A, 2006, J VET MED B, V53, P341, DOI 10.1111/j.1439-0450.2006.00969.x; Platt-Samoraj A, 2017, VET J, V221, P11, DOI 10.1016/j.tvjl.2017.01.013; Platt-Samoraj A, 2015, POL J VET SCI, V18, P449, DOI 10.1515/pjvs-2015-0058; Przybylak R., 2016, CLIMATES REGIONAL LO; Ramamurthy T, 1997, MICROB PATHOGENESIS, V23, P189, DOI 10.1006/mpat.1997.0146; Rastawicki W, 2013, EPIDEMIOL INFECT, V141, P2039, DOI 10.1017/S0950268812002786; Riksson-Ahomaa MF, 2009, INT J FOOD MICROBIOL, V135, P199, DOI 10.1016/j.ijfoodmicro.2009.08.019; Sihvonen LM, 2011, FOODBORNE PATHOG DIS, V8, P455, DOI 10.1089/fpd.2010.0747; Stanisz A., 2007, PRZYSTEPNY KURS STAT, V1; Syczylo K, 2016, POL J VET SCI, V19, P221, DOI 10.1515/pjvs-2016-0027; Tennant SM, 2003, FEMS IMMUNOL MED MIC, V38, P127, DOI 10.1016/S0928-8244(03)00180-9; Tirziu E., 2011, Lucrari Stiintifice - Zootehnie si Biotehnologii, Universitatea de Stiinte Agricole si Medicina Veterinara a Banatului Timisoara, V44, P144; von Altrock A, 2015, APPL ENVIRON MICROB, V81, P4835, DOI 10.1128/AEM.00550-15; Wauters G, 1987, Contrib Microbiol Immunol, V9, P14; Wauters G., 1987, YERSINIA ENTERCOLITI, P41; Wren BW, 2003, NAT REV MICROBIOL, V1, P55, DOI 10.1038/nrmicro730	36	25	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195136	10.1371/journal.pone.0195136	http://dx.doi.org/10.1371/journal.pone.0195136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596492	Green Submitted, Green Published, gold			2022-12-26	WOS:000428630000083
J	Hume, JP; Martill, D; Hing, R				Hume, Julian P.; Martill, David; Hing, Richard			A terrestrial vertebrate palaeontological review of Aldabra Atoll, Aldabra Group, Seychelles	PLOS ONE			English	Review							WESTERN INDIAN-OCEAN; HIPPOSIDERIDAE; PLEISTOCENE; CHIROPTERA; PETROLOGY; EVOLUTION; LIZARDS	The Pleistocene vertebrate assemblage of Aldabra Atoll has been comparatively well studied. Three Upper Pleistocene fossil localities have been described yielding birds, reptiles and terrestrial molluscs. Those of Bassin Cabri and Bassin Lebine on Ile Picard are undated but must be in excess of 136,000 YBP, whereas Point Hodoul on Malabar Island is circa 100,000 YBP. Aldabra was seemingly completely submerged between deposition of the Ile Picard and Point Hodoul deposits, resulting in local faunal extinctions. Here we present the results of an ongoing study of fossil material collected on Ile Picard in 1987, which reveals a more diverse assemblage than previously realised. Notable discoveries are an Ardeola heron, three Procellariformes, tropic-bird Phaethon, gull Larus, rail Dryolimnas, harrier Circus and owl Tyto, plus evidence of recolonisation of the atoll by some seabirds, rail, harrier, owl, giant tortoises and lizards after the Ile Picard/Point Hodoul submergence event.	[Hume, Julian P.] Nat Hist Museum, Dept Life Sci, Bird Grp, Akeman St, Tring, Herts, England; [Martill, David; Hing, Richard] Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth, Hants, England	Natural History Museum London; University of Portsmouth	Hume, JP (corresponding author), Nat Hist Museum, Dept Life Sci, Bird Grp, Akeman St, Tring, Herts, England.	j.hume@nhm.ac.uk		Martill, David/0000-0002-3208-5702	Percy Sladen Centenary Fund	Percy Sladen Centenary Fund	JPH received funding for fossil preparation from the Percy Sladen Centenary Fund. https://www.linnean.org/the.society/medals-awards-prizes-grants/percy-sladen memorial fund-grants. The other authors received no specific funding for this work.; We thank Robert Prys-Jones (NHMUK), Anthony Cheke, Steve Goodman and an anonymous reviewer for comments that helped improve this paper. We thank Storrs Olson, Helen James, Jennifer Strotman and Mark Florence (USNM) for the long term loan of the J. Becker Aldabra material. We thank Sandra Chapman and Lorna Steel (NHMUK) for access to material in their care; Harry Taylor (NHMUK) for photography, and Robert Loveridge for some fossil preparation. We especially thank the Percy Sladen Centenary Fund whose financial support made this research possible.	ARNOLD E.N., 1976, B BRIT MUSEUM NATURA, V29, P83; ARNOLD EN, 1979, PHILOS T ROY SOC B, V286, P127, DOI 10.1098/rstb.1979.0022; Batsch G.C., 1788, VERSUCH UNLEITUNG KE; Benda P, 2009, FOLIA ZOOL, V58, P1; BENSON CW, 1971, PHILOS T R SOC B, V260, P417, DOI 10.1098/rstb.1971.0021; BGde, 1799, TABL SOUS CLASS DIV; Billberg GJ, 1828, SYNOPSIS FAUNAE SCAN, V1; BLAISE B, 1990, QUATERNARY RES, V34, P282, DOI 10.1016/0033-5894(90)90041-I; Bloom AL, 1971, LATE CENOZOIC GLACIA, P355; Boddaert P., 1783, TABLE PLANCHEES ENLU; Boie F., 1822, UEBER CLASSICATION I; Bonaparte C. L, 1854, CONSPECTUS GENERUM A, V2; Bonaparte C. -L., 1856, CR HEBD ACAD SCI, V42, P764; Braithwaite C., 1984, BIOGEOGRAPHY ECOLOGY, P17; BRAITHWAITE CJ, 1973, PHILOS T R SOC B, V266, P307, DOI 10.1098/rstb.1973.0051; BRAITHWAITE CJR, 1975, PHILOS T ROY SOC B, V273, P1, DOI 10.1098/rstb.1975.0101; BRAITHWAITE CJR, 1980, PHILOS T ROY SOC B, V288, P511, DOI 10.1098/rstb.1980.0025; Brandt JF, 1840, MEM ACAD IMP SCI ST, V5, P239; Brisson MJ, 1760, ORNITHOLOGIA ORNITHO; Brochu CA, 2006, COPEIA, P149; Camoin GF, 2004, MAR GEOL, V206, P119, DOI 10.1016/j.margeo.2004.02.003; Camp CL, 1923, B AM MUS NAT HIST, V48, P289; Cheke A., 2008, LOST LAND DODO ECOLO; Cheke A.S., 1984, Monographiae Biologicae, V55, P331; Cheke Anthony, 2010, Phelsuma, V18, P38; Cheke Anthony S., 2014, P31; Cope ED., 1868, P ACAD NATURAL SCI, V1868, P242; FARROW GE, 1971, PHILOS T ROY SOC B, V260, P93, DOI 10.1098/rstb.1971.0008; Farrow GE., 1971, PHILOS T R SOC B, V260, P67; Fitzinger L., 1843, SYSTEMA REPTILIUM FA; Fitzinger L.J.F.J., 1826, NEUE CLASSIFICATION, DOI [10.5962/bhl.title.4683, DOI 10.5962/BHL.TITLE.4683]; Fosberg F.R, 1980, FLORA ALDABRA NEIGHB; FOSBERG FR, 1971, PHILOS T ROY SOC B, V260, P215, DOI 10.1098/rstb.1971.0011; Fuarbringer M., 1888, UNTERSUCHUNGEN MORPH, V15; Gerlach J., 2006, TERRESTRIAL FRESHWAT; Gerlach J, 2006, J NAT HIST, V40, P2403, DOI 10.1080/00222930601058290; Goodman SM, 2008, ZOOSYSTEMA, V30, P681; Gray J. E., 1831, ANIMAL KINGDOM ARRAN, P1, DOI [10.5962/bhl.title.45021, DOI 10.5962/BHL.TITLE.45021]; Gray J. E., 1825, ANN PHILOS, V10, P193; Gray JE., 1827, PHILOS MAG, V2, P54, DOI [10.1080/14786442708675620, DOI 10.1080/14786442708675620]; Gunther A., 1867, Annals & Magazine of Natural History, Vxx, P45; Gunther A.C.L.G, 1879, ANN MAG NAT HIST, V3, P164, DOI [10.1080/00222937908682495, DOI 10.1080/00222937908682495]; HARRISON CJO, 1978, J NAT HIST, V12, P7, DOI 10.1080/00222937800770021a; HNATIUK RJ, 1979, PHILOS T ROY SOC B, V286, P25, DOI 10.1098/rstb.1979.0013; Hume J.P., 2017, EXTINCT BIRDS; Hutson A.M., 2004, Phelsuma, V12, P126; Huxley Thomas H., 1867, Proceedings of the Zoological Society, P415; Leach W. E., 1820, SYNOPSIS CONTENTS BR, P65; Linnaeus C., 1758, SYSTEMA NATURAE REGN, DOI [10.5962/bhl.title.542, DOI 10.5962/BHL.TITLE.542]; Loveridge A., 1957, B MUS COMP ZOOL HARV, V115, P161; MACNAE W, 1971, PHILOS T ROY SOC B, V260, P237, DOI 10.1098/rstb.1971.0013; Mathews GM, 1912, BIRDS AUSTR 2, V2; Olson SL, 2006, J HERPETOL, V40, P394, DOI 10.1670/0022-1511(2006)40[394:GCOEAS]2.0.CO;2; Oppel M., 1811, ORDNUNGEN FAMILIEN U; Plummer P.S., 1995, ALDABRA WORLD HERITA, P49; Rafinesque C. S., 1815, ANAL NATURE TABLEAU, DOI 10.5962/bhl.title.106607; Ridgway R, 1914, B US NATL MUS, V50, P1; Rocha Sara, 2009, Herpetological Bulletin, P20; Safford R, 2013, BIRDS OF AFRICA, VVIII; Scheyer TM, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171800; Sharpe R. B, 1893, B BRIT ORNITHOLOGIST, V5, P26; Stoddart D.R., 1983, Nature and Resources, V19, P20; STODDART D. R., 1967, ATOLL RES BULL, V118/119, P11; STODDART DR, 1979, PHILOS T ROY SOC B, V286, P11, DOI 10.1098/rstb.1979.0012; STODDART DR, 1971, PHILOS T ROY SOC B, V260, P31, DOI 10.1098/rstb.1971.0006; Stoddart DR, 1984, BIOGEOGRAPHY ECOLOGY, P220; SUNDEVALL CJ, 1836, KUNGLIGA SVENSKA VET, V1836, P43; Swinhoe R., 1867, IBIS               2, V3, P226; Swinhoe R., 1867, IBIS, V385-413, P52; TAYLOR JD, 1979, PHILOS T ROY SOC B, V286, P47, DOI 10.1098/rstb.1979.0015; THOMSON J, 1972, NATURE, V240, P145, DOI 10.1038/240145a0; Titus TA, 1996, MOL PHYLOGENET EVOL, V6, P49, DOI 10.1006/mpev.1996.0057; Trudgill ST, 1981, ATOLL RES B, V255, P11; Vieillot LJP, 1816, NOUVEAU DICT HIST NA, V5; Wagler JG, 1830, BEITRAGE VERLEICHHEN; Walsh R.P.D., 1984, BIOGEOGRAPHY ECOLOGY, P39; [No title captured]	77	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0192675	10.1371/journal.pone.0192675	http://dx.doi.org/10.1371/journal.pone.0192675			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590117	Green Published, gold, Green Submitted			2022-12-26	WOS:000428603100007
J	Jaffey, JA; Backus, RC; McDaniel, KM; DeClue, AE				Jaffey, Jared A.; Backus, Robert C.; McDaniel, Kaylyn M.; DeClue, Amy E.			Serum vitamin D concentrations in hospitalized critically ill dogs	PLOS ONE			English	Article							D DEFICIENCY; PULMONARY TUBERCULOSIS; INCREASED MORTALITY; SURGICAL-PATIENTS; SEVERE SEPSIS; D LEVEL; MACROPHAGES; OUTCOMES; CARE; EXPRESSION	Hypovitaminosis D has been extensively documented in critically ill humans. However, whether or not critically ill dogs have alterations in vitamin D concentrations remains unconfirmed. The primary aims of our study were to compare serum 25-hydroxycholecalciferol [25 (OH)D] concentrations in critically ill dogs with healthy control dogs, determine the prognostic utility of serum 25(OH)D concentration as a biomarker in critically ill dogs, and to assess if serum 25(OH)D concentrations in critically ill dogs are associated with length of stay in the intensive care unit or illness severity. Serum concentrations of 25(OH)D together with a range of other clinical, biochemical, and hematological parameters, were measured in 99 dogs within 24 hours of admission to the Intensive Care Unit (ICU). Critically ill dogs (P = 0.001) and dogs with sepsis (P = 0.002) had significantly lower serum 25(OH)D concentrations compared to healthy control dogs. In addition, serum 25(OH)D concentration was an independent predictor of in-hospital and 30 day survival. Using a cut-off of 33 ng/mL, serum 25(OH)D concentrations had excellent sensitivity (0.94; 95% CI, 0.71-1.00), but poor specificity (0.41; 95% CI, 0.31-0.53) for detection of survival. Serum 25(OH)D concentrations were inversely associated with acute patient physiologic and laboratory evaluation (APPLE) fast score but were not associated with ICU length of stay. Hospitalized dogs with critical illness have decreased serum 25(OH)D concentrations compared to healthy dogs and can be used to predict survival in this cohort.	[Jaffey, Jared A.; Backus, Robert C.; McDaniel, Kaylyn M.; DeClue, Amy E.] Univ Missouri, Dept Vet Med & Surg, Vet Hlth Ctr, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Jaffey, JA (corresponding author), Univ Missouri, Dept Vet Med & Surg, Vet Hlth Ctr, Columbia, MO 65211 USA.	jaffeyj@missouri.edu		Jaffey, Jared/0000-0002-0270-4728				Alizadeh N, 2015, J RES PHARM PRACT, V4, P193, DOI 10.4103/2279-042X.167051; Altieri B, 2017, REV ENDOCR METAB DIS, V18, P335, DOI 10.1007/s11154-016-9405-9; Amrein K, 2014, CRIT CARE, V18, DOI 10.1186/cc13790; Anwar E, 2017, NUTR CLIN PRACT, V32, P378, DOI 10.1177/0884533616671741; Arnson Y, 2012, QJM-INT J MED, V105, P633, DOI 10.1093/qjmed/hcs014; Atalan HK, 2017, TURK J ANAESTHESIOL, V45, P193, DOI 10.5152/TJAR.2017.60234; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Baeke F, 2010, PEDIATR NEPHROL, V25, P1597, DOI 10.1007/s00467-010-1452-y; Barnett N, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/2110-5820-4-5; Braun A, 2011, CRIT CARE MED, V39, P671, DOI 10.1097/CCM.0b013e318206ccdf; Braun AB, 2012, CRIT CARE MED, V40, P63, DOI 10.1097/CCM.0b013e31822d74f3; Carnevale V, 2001, OSTEOPOROSIS INT, V12, P1026, DOI 10.1007/s001980170012; Chandra G, 2004, J CLIN IMMUNOL, V24, P249, DOI 10.1023/B:JOCI.0000025446.44146.52; Czarnik T, 2018, J CRIT CARE, V43, P294, DOI 10.1016/j.jcrc.2017.09.179; de Haan K, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0660-4; De Pascale G, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.12.015; DeClue AE, 2011, J VET INTERN MED, V25, P453, DOI 10.1111/j.1939-1676.2011.0713.x; Deitch EA, 2012, SURG-J R COLL SURG E, V10, P350, DOI 10.1016/j.surge.2012.03.003; Dickerson RN, 2016, BURNS TRAUMA, V4, DOI 10.1186/s41038-016-0054-8; Gordon CM, 2004, ARCH PEDIAT ADOL MED, V158, P531, DOI 10.1001/archpedi.158.6.531; Grubczak K, 2015, INT ARCH ALLERGY IMM, V166, P170, DOI 10.1159/000380882; Guan J, 2016, J NEUROSURG; Harishankar M, 2014, INT IMMUNOPHARMACOL, V23, P148, DOI 10.1016/j.intimp.2014.08.021; Hayes G, 2010, J VET INTERN MED, V24, P1034, DOI 10.1111/j.1939-1676.2010.0552.x; Higgins DM, 2012, JPEN-PARENTER ENTER, V36, P713, DOI 10.1177/0148607112444449; HOW KL, 1994, GEN COMP ENDOCR, V96, P12, DOI 10.1006/gcen.1994.1154; Jaffey J, 2017, J VET INTERN MED, V31, P775; Jeng L, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-28; Klenk J, 2013, AGE AGEING, V42, P404, DOI 10.1093/ageing/aft042; Krishnan A, 2010, CRIT CARE, V14, DOI 10.1186/cc9341; Leaf DE, 2014, AM J RESP CRIT CARE, V190, P533, DOI 10.1164/rccm.201405-0988OC; Leary PF, 2017, J AM OSTEOPATH ASSOC, V117, P433, DOI 10.7556/jaoa.2017.089; Lee P, 2009, INTENS CARE MED, V35, P2028, DOI 10.1007/s00134-009-1642-x; Lensmeyer GL, 2006, CLIN CHEM, V52, P1120, DOI 10.1373/clinchem.2005.064956; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Madden K, 2015, ANN AM THORAC SOC, V12, P1654, DOI 10.1513/AnnalsATS.201503-160OC; Matthews LR, 2012, AM J SURG, V204, P37, DOI 10.1016/j.amjsurg.2011.07.021; Moromizato T, 2014, CRIT CARE MED, V42, P97, DOI 10.1097/CCM.0b013e31829eb7af; Motlagh BM, 2015, IRAN J BASIC MED SCI, V18, P672; Neve A, 2014, CLIN EXP MED, V14, P275, DOI 10.1007/s10238-013-0249-2; Nye CJ, 2017, J VET EMERG CRIT CAR, V27, P66, DOI 10.1111/vec.12557; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Putzu A, 2017, J CRIT CARE, V38, P109, DOI 10.1016/j.jcrc.2016.10.029; Quraishi SA, 2014, CRIT CARE MED, V42, P1365, DOI 10.1097/CCM.0000000000000210; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Szymczak I, 2016, SCAND J IMMUNOL, V83, P83, DOI 10.1111/sji.12403; Tokuda N, 1996, P SOC EXP BIOL MED, V211, P244, DOI 10.3181/00379727-211-43967; Venkatram S, 2011, CRIT CARE, V15, DOI 10.1186/cc10585; Villaggio B, 2012, CLIN EXP RHEUMATOL, V30, P934; Vipul P, 2017, INDIAN J CRIT CARE M, V21, P199, DOI 10.4103/ijccm.IJCCM_192_16; Walsh JS, 2017, CURR OPIN ENDOCRINOL, V24, P389, DOI 10.1097/MED.0000000000000371; Young LR, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2016.23	53	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194062	10.1371/journal.pone.0194062	http://dx.doi.org/10.1371/journal.pone.0194062			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590167	Green Submitted, Green Published, gold			2022-12-26	WOS:000428603100047
J	Porter, CK; Lynen, A; Riddle, MS; Talaat, K; Sack, D; Gutierrez, RL; McKenzie, R; DeNearing, B; Feijoo, B; Kaminski, RW; Taylor, DN; Kirkpatrick, BD; Bourgeois, AL				Porter, Chad K.; Lynen, Amanda; Riddle, Mark S.; Talaat, Kawsar; Sack, David; Gutierrez, Ramiro L.; McKenzie, Robin; DeNearing, Barbara; Feijoo, Brittany; Kaminski, Robert W.; Taylor, David N.; Kirkpatrick, Beth D.; Bourgeois, A. Louis			Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score	PLOS ONE			English	Article							TRAVELERS DIARRHEA; DEVELOPING-COUNTRIES; SONNEI VACCINE; GLOBAL BURDEN; ETIOLOGY; CONSEQUENCES; POPULATIONS; VOLUNTEERS; EXPERIENCE; CANDIDATE	Background Since 1946 the controlled human infection model (CHIM) for Shigella has been used to improve understanding of disease pathogenesis, describe clinical and immunologic responses to infection and as a tool for vaccine development. As the frequency and intent for use in vaccine comparisons increases, standardization of the primary endpoint definition is necessary. Methods Subject-level data were obtained from previously conducted experimental Shigella CHIM studies. Signs and symptoms severity were categorized consistently across all studies. Sign and symptom correlations were estimated and univariate models were utilized to describe the association between stool output and other Shigella-attributable signs and symptoms. Multiple correspondence and hierarchical clustering analyses were performed to describe the co-occurrence of signs and symptoms. A disease score is proposed based on the co-occurrence of these events. Results Data were obtained on 54 subjects receiving 800 to 2000 colony forming units (cfu) of S. flexneri. The median maximum 24 hour stool output was 514 ml (IQR: 300, 998 ml) with a median frequency of 6 (IQR: 4, 9). Subjects reported abdominal pain or cramps (81.5%), headache (66.7%) and anorexia (64.8%), 50.0% had a fever and 27.8% had gross blood in multiple loose stools. Multiple correspondence analyses highlighted co-occurrence of symptoms based on severity. A 3-parameter disease severity score predicted shigellosis endpoints and better differentiated disease spectrum. Conclusion Dichotomous endpoints for Shigella CHIM fail to fully account for disease variability. An ordinal disease score characterizing the breadth of disease severity may enable a better characterization of shigellosis and can decrease sample size requirements. Furthermore, the disease severity score may be a useful tool for portfolio management by enabling prioritization across vaccine candidates with comparable efficacy estimates using dichotomous endpoints.	[Porter, Chad K.; Lynen, Amanda; Riddle, Mark S.; Gutierrez, Ramiro L.] Naval Med Res Ctr, Enter Dis Dept, Infect Dis Directorate, Silver Spring, MD 20910 USA; [Talaat, Kawsar; Sack, David; DeNearing, Barbara; Feijoo, Brittany; Bourgeois, A. Louis] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [McKenzie, Robin] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Kaminski, Robert W.] Walter Reed Army Inst Res, Dept Enter Infect, Silver Spring, MD USA; [Taylor, David N.] PATH, Drug Dev Global Program, Seattle, WA USA; [Kirkpatrick, Beth D.] Univ Vermont, Coll Med, Vaccine Testing Ctr, Dept Med, Burlington, VT USA; [Bourgeois, A. Louis] PATH, Enter Vaccine Initiat, Washington, DC USA	Naval Medical Research Center (NMRC); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University of Vermont	Porter, CK (corresponding author), Naval Med Res Ctr, Enter Dis Dept, Infect Dis Directorate, Silver Spring, MD 20910 USA.	chad.k.porter2.civ@mail.mil	Riddle, Mark/R-8788-2019	Riddle, Mark/0000-0002-0607-7880; Porter, Chad/0000-0001-7258-1690; Kaminski, Robert/0000-0002-4015-5694	Military Infectious Disease Research Program	Military Infectious Disease Research Program	The views expressed in this article are those of the author and do not necessarily reflect the official policy or position of the Department of the Navy, Department of the Army, Department of Defense, nor the U.S. Government. This is a US Government work. There are no restrictions on its use. There were no financial conflicts of interests among any of the authors. Funding for this study was provided by the Military Infectious Disease Research Program. Authors (CKP, MSR, RLG, RWK) are employees of the U.S. Government or military service members. This work was prepared as part of official duties. Title 17 U.S.C. 105 provides that 'Copyright protection under this title is not available for any work of the United States Government.' Title 17 U.S.C. 101 defines a U.S. Government work as a work prepared by a military service member or employee of the U.S. Government as part of that person's official duties.	Coster TS, 1999, INFECT IMMUN, V67, P3437, DOI 10.1128/IAI.67.7.3437-3443.1999; Das JK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S11; DUPONT HL, 1972, J INFECT DIS, V125, P12, DOI 10.1093/infdis/125.1.12; Durbin AP, 2001, INF DIS SOC AM 39 AN; Fedorov V, 2009, PHARM STAT, V8, P50, DOI 10.1002/pst.331; Feijoo B., 2017, VACCINES ENTERIC DIS; Frenck Jr RW, 2017, VACCINES ENTERIC DIS; Giersing BK, 2019, VACCINE, V37, P7315, DOI 10.1016/j.vaccine.2016.10.090; Greenacre Michael, 1984, THEORY APPL CORRES A; Harro C, 2009, 5 INT VACC ENT DIS C; HERRINGTON DA, 1990, VACCINE, V8, P353, DOI 10.1016/0264-410X(90)90094-3; Hosangadi D, 2019, VACCINE, V37, P7372, DOI 10.1016/j.vaccine.2017.09.083; Kahsay Atsebaha Gebrekidan, 2016, BMC Res Notes, V9, P422, DOI 10.1186/s13104-016-2236-7; KEAN BH, 1969, LANCET, V2, P583; Kotloff KL, 2017, VACCINE, V35, P6783, DOI 10.1016/j.vaccine.2017.07.036; KOTLOFF KL, 1995, VACCINE, V13, P495, DOI 10.1016/0264-410X(94)00011-B; KOTLOFF KL, 1995, VACCINE, V13, P1488, DOI 10.1016/0264-410X(95)00102-7; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Nataro JP, 2017, VACCINE, V35, P6807, DOI 10.1016/j.vaccine.2017.05.035; Pitisuttithum P, 2016, CLIN VACCINE IMMUNOL, V23, P564, DOI 10.1128/CVI.00665-15; Porter CK, 2013, EPIDEMIOL INFECT, V141, P223, DOI 10.1017/S0950268812001677; Porter CK, 2017, MIL MED, V182, P4, DOI 10.7205/MILMED-D-17-00064; Porter CK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149358; Riddle MS, 2006, AM J TROP MED HYG, V74, P891, DOI 10.4269/ajtmh.2006.74.891; Riddle MS, 2017, MIL MED, V182, P34, DOI 10.7205/MILMED-D-17-00077; Shah N, 2009, AM J TROP MED HYG, V80, P609, DOI 10.4269/ajtmh.2009.80.609; SHAUGHNESSY HJ, 1946, JAMA-J AM MED ASSOC, V132, P362, DOI 10.1001/jama.1946.02870420002002; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; TACKET CO, 1992, AM J TROP MED HYG, V47, P276, DOI 10.4269/ajtmh.1992.47.276; Taylor DN, 2008, ANTIMICROB AGENTS CH, V52, P1179, DOI 10.1128/AAC.01108-07; Taylor DN, 2006, CLIN INFECT DIS, V42, P1283, DOI 10.1086/503039; Troeger C, 2017, LANCET INFECT DIS, V17, P909, DOI 10.1016/S1473-3099(17)30276-1	32	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194325	10.1371/journal.pone.0194325	http://dx.doi.org/10.1371/journal.pone.0194325			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590182	Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100057
J	Tomaszewska, E; Dobrowolski, P; Klebaniuk, R; Kwiecien, M; Tomczyk-Warunek, A; Szymanczyk, S; Kowalik, S; Milczarek, A; Blicharski, T; Muszynski, S				Tomaszewska, Ewa; Dobrowolski, Piotr; Klebaniuk, Renata; Kwiecien, Malgorzata; Tomczyk-Warunek, Agnieszka; Szymanczyk, Sylwia; Kowalik, Sylwester; Milczarek, Anna; Blicharski, Tomasz; Muszynski, Siemowit			Gut-bone axis response to dietary replacement of soybean meal with raw low-tannin faba bean seeds in broiler chickens	PLOS ONE			English	Article							2-OXOGLUTARIC ACID IMPROVES; ALBUS VAR. MULTITALIA; SORGHUM GRAIN DIETS; PEA PISUM-SATIVUM; VICIA-FABA; ALPHA-KETOGLUTARATE; INTESTINAL-TRACT; METABOLIZABLE ENERGY; JEJUNAL EPITHELIUM; GROWTH-PERFORMANCE	It seems that faba bean (FB) seeds could be a good protein-energy component in animal feed, but the presence of anti-nutritional substances limits their use as a substitute of soybean meal. The aim of the study was to examine the influence of different concentrations of raw, low-tannin, FB seeds on the gut-bone axis in Ross 308 broilers. One-day old chickens were randomly subjected to one of the 3 dietary treatments: the control group was fed standard diet based on soybean meal and without FB seeds, and two groups were fed 8%/15% and 16%/22% of raw low-tannin FB seeds in the starter and grower, respectively. On the 35(th) day, hematological and serum biochemical analyses as well histomorphometry of the small intestine and liver tissue and bone mechanical tests were performed. The diet type had no effect on the body weight gain and feed conversion ratio. However, the basal intestinal structures were significantly reduced in birds fed the lower concentration of FB. The enlargement of nerve plexuses was dependent on the concentration used in the diet and, additionally, on the kind of plexus and location in the intestinal tract. The liver was characterized by an increase in non-hepatocytes. There was no influence of the low-tannin FB seeds on most of the analyzed serum parameters in the 35-day-old broiler chickens, except the decreased concentration of total cholesterol and Ca in both experimental groups, triglycerides in group I, and P and uric acid in group II. Furthermore, the increasing concentration of the dietary low-tannin FB did not influence the activities of AspAT (except the group fed the higher amount of FB), ALAT, and LDH. The broiler chickens had no visible leg lesions and no problem in the locomotor function, but the tibiae were lighter mainly in birds fed the higher concentration of FB seeds. Geometric analysis revealed reduction of the cross section area and wall thickness, indicating a decline in the bone midshaft, which influenced the densitometric parameters and the results of mechanical tests. In conclusion, the dietary inclusion of raw low-tannin FB seeds had no negative effects on broiler growth, but disturbed the intestine structure and tibia characteristics. Therefore, all these negative effects necessitate additional examinations before inclusion of raw low-tannin FB seed into poultry diet.	[Tomaszewska, Ewa; Tomczyk-Warunek, Agnieszka; Szymanczyk, Sylwia; Kowalik, Sylwester] Univ Life Sci Lublin, Dept Anim Physiol, Lublin, Poland; [Dobrowolski, Piotr] Marie Curie Sklodowska Univ, Dept Comparat Anat & Anthropol, Lublin, Poland; [Klebaniuk, Renata; Kwiecien, Malgorzata] Univ Life Sci Lublin, Dept Bromatol & Food Physiol, Lublin, Poland; [Milczarek, Anna] Siedlce Univ Nat Sci & Humanities, Dept Anim Nutr & Feed Management, Siedlce, Poland; [Blicharski, Tomasz] Med Univ Lublin, Chair & Dept Rehabil & Orthopaed, Lublin, Poland; [Muszynski, Siemowit] Univ Life Sci, Dept Phys, Lublin, Poland	University of Life Sciences in Lublin; Maria Curie-Sklodowska University; University of Life Sciences in Lublin; Medical University of Lublin	Tomaszewska, E (corresponding author), Univ Life Sci Lublin, Dept Anim Physiol, Lublin, Poland.; Muszynski, S (corresponding author), Univ Life Sci, Dept Phys, Lublin, Poland.	ewaRST@interia.pl; siemowit.muszynski@up.lublin.pl	Milczarek, Anna/AAB-9644-2020; Kowalik, Sylwester/AAD-2296-2021; Milczarek, Anna/R-1798-2017; Tomaszewska, Ewa/U-5490-2018; Dobrowolski, Piotr Jerzy/R-7917-2019; Muszyński, Siemowit/U-4945-2018; Klebaniuk, Renata/V-2664-2018	Milczarek, Anna/0000-0002-2714-3533; Kowalik, Sylwester/0000-0002-0498-2924; Milczarek, Anna/0000-0002-2714-3533; Tomaszewska, Ewa/0000-0002-7574-2653; Dobrowolski, Piotr Jerzy/0000-0001-5873-9666; Muszyński, Siemowit/0000-0002-4118-6302; Klebaniuk, Renata/0000-0003-1700-3390; Blicharski, Tomasz/0000-0001-9747-8817; Szymanczyk, Sylwia/0000-0003-2469-6113; Tomczyk-Warunek, Agnieszka/0000-0002-5007-7327; Kwiecien, Malgorzata/0000-0002-8047-8682				Abbel-Monein Mamdouh Abbas, 2013, Journal of Agrobiology, V30, P43, DOI 10.2478/agro-2013-0005; AHMED AE, 1991, BRIT J NUTR, V65, P189, DOI 10.1079/BJN19910080; [Anonymous], 1990, ANN ANIM SCI; ARMSTRON.WD, 1973, POULTRY SCI, V52, P1592, DOI 10.3382/ps.0521592; Bederska-Lojewska D, 2017, ANN ANIM SCI, V17, P351, DOI 10.1515/aoas-2016-0090; Blicharski T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179693; Brevault N, 2003, JOURN RECH AV TOURS; BURR ML, 1985, NUTR RES, V5, P465, DOI 10.1016/S0271-5317(85)80156-1; Carew LB, 2003, TROPICAL SUBTROPICAL, V1, P267; Crepon K, 2010, FIELD CROP RES, V115, P329, DOI 10.1016/j.fcr.2009.09.016; Diaz D, 2006, ITAL J ANIM SCI, V5, P43; Dobrowolski P, 2012, NUTRITION, V28, P428, DOI 10.1016/j.nut.2011.10.002; Eder K, 1996, ARCH ANIM NUTR, V49, P221, DOI 10.1080/17450399609381883; ELKIN RG, 1978, POULTRY SCI, V57, P757, DOI 10.3382/ps.0570757; Emiola I. A., 2013, INT J API AGR RES, V9, P140; GATEL F, 1994, ANIM FEED SCI TECH, V45, P317, DOI 10.1016/0377-8401(94)90036-1; Gdala J, 1998, J ANIM FEED SCI, V7, P131; Hanczakowska E, 2014, ANN ANIM SCI, V14, P921, DOI 10.2478/aoas-2014-0068; Harr KE, 2002, VET CLIN PATH, V31, P140, DOI 10.1111/j.1939-165X.2002.tb00295.x; Hassan IAG, 2003, TROP ANIM HEALTH PRO, V35, P189, DOI 10.1023/A:1022833820757; Helsper JPFG, 1996, J AGR FOOD CHEM, V44, P1070, DOI 10.1021/jf950484w; HEVIA P, 1977, J NUTR, V107, P959, DOI 10.1093/jn/107.6.959; Horwitz W, 2011, OFFICIAL METHODS ANA; Houshmand M, 2015, BRAZ J POULTRY SCI, V17, P17, DOI 10.1590/1516-635x170117-24; JANSMAN AJM, 1993, ARCH GEFLUGELKD, V57, P220; Jimenez-Moreno E, 2009, POULTRY SCI, V88, P2562, DOI 10.3382/ps.2009-00179; KAKADE ML, 1974, CEREAL CHEM, V51, P376; KING TP, 1983, J SCI FOOD AGR, V34, P1404, DOI 10.1002/jsfa.2740341214; Kowalik S, 2005, B VET I PULAWY, V49, P343; Kumar V, 2007, BRIT POULTRY SCI, V48, P198, DOI 10.1080/00071660701251089; Lacassagne L, 2000, SCI TECHNIQUES AVICO, V32, P17; Laudadio V, 2011, J APPL POULTRY RES, V20, P12, DOI 10.3382/japr.2010-00173; LONGSTAFF M, 1991, BRIT J NUTR, V65, P199, DOI 10.1079/BJN19910081; Metayer JP, 2003, JOURN RECH AV TOURS; Mikulski D, 2017, ANIMAL IN PRESS; Moschini M, 2005, ITAL J ANIM SCI, V4, P59; Moundras C, 1997, J NUTR, V127, P1068, DOI 10.1093/jn/127.6.1068; Muszynski S, 2017, POULTRY SCI, V96, P491, DOI 10.3382/ps/pew301; Nalle CL, 2010, ANIM FEED SCI TECH, V156, P104, DOI 10.1016/j.anifeedsci.2010.01.010; OKUMURA JI, 1969, J NUTR, V97, P316, DOI 10.1093/jn/97.3.316; OLABORO G, 1981, J SCI FOOD AGR, V32, P1163, DOI 10.1002/jsfa.2740321205; Oomah BD, 2011, J AGR FOOD CHEM, V59, P3763, DOI 10.1021/jf200338b; ORTIZ LT, 1994, BRIT POULTRY SCI, V35, P743, DOI 10.1080/00071669408417739; Palander S, 2006, ANIM FEED SCI TECH, V127, P89, DOI 10.1016/j.anifeedsci.2005.07.003; Perez-Maldonado RA, 1999, BRIT POULTRY SCI, V40, P667, DOI 10.1080/00071669987061; Potokar M, 2016, ARCH ANIM NUTR, V70, P378; Przywitowski M, 2016, ANIM FEED SCI TECH, V221, P124, DOI 10.1016/j.anifeedsci.2016.08.027; RUBIO LA, 1989, BRIT POULTRY SCI, V30, P101, DOI 10.1080/00071668908417129; SALIH ME, 1991, ANIM FEED SCI TECH, V33, P139, DOI 10.1016/0377-8401(91)90052-T; SELL DR, 1985, NUTR REP INT, V31, P1369; Shargh MS, 2010, INDIAN J ANIM SCI, V80, P940; Silva PRL, 2007, BRAZ J POULTRY SCI, V9, P229, DOI 10.1590/S1516-635X2007000400004; Sliwa E, 2006, J MATERN-FETAL NEO M, V19, P489, DOI 10.1080/14767050600850381; Sliwa E, 2005, B VET I PULAWY, V49, P117; Sliwa E, 2009, J ANIM PHYSIOL AN N, V93, P192, DOI 10.1111/j.1439-0396.2007.00805.x; Smulikowska S., 2018, NUTR RECOMMENDATIONS, Vfourth; Suvara SK., 2013, BANCROFTS THEORY PRA, V7th ed; Tatara MR, 2006, BONE, V39, P100, DOI 10.1016/j.bone.2005.12.016; Tatara MR, 2005, POULTRY SCI, V84, P1604, DOI 10.1093/ps/84.10.1604; Tomaszewska E, 2018, ANIM PROD SCI, V58, P507, DOI 10.1071/AN16289; Tomaszewska E, 2014, J PHYSIOL PHARMACOL, V65, P107; Tomaszewska E, 2012, J PHYSIOL PHARMACOL, V63, P547; Tomaszewska E, 2017, ANN ANIM SCI, V17, P477, DOI 10.1515/aoas-2016-0056; Tomaszewska E, 2016, ANN ANIM SCI, V16, P507, DOI 10.1515/aoas-2015-0087; Tomaszewska E, 2016, J VET MED SCI, V78, P563, DOI 10.1292/jvms.15-0385; Tomaszewska E, 2015, B VET I PULAWY, V59, P563, DOI 10.1515/bvip-2015-0084; Tomaszewska E, 2015, ENVIRON TOXICOL PHAR, V40, P708, DOI 10.1016/j.etap.2015.09.002; Tomaszewska E, 2015, CONNECT TISSUE RES, V56, P483, DOI 10.3109/03008207.2015.1069822; Tomaszewska E, 2015, EXP TOXICOL PATHOL, V67, P331, DOI 10.1016/j.etp.2015.02.005; Tomaszewska E, 2012, NUTRITION, V28, P190, DOI 10.1016/j.nut.2011.05.010; Vilarino M, 2009, ANIM FEED SCI TECH, V150, P114, DOI 10.1016/j.anifeedsci.2008.08.001; VOHRA P, 1966, POULTRY SCI, V45, P135, DOI 10.3382/ps.0450135; Wiryawan KG, 1990, ANIM FEED SCI TECHNO, V76, P185; Zantop D. W., 1997, AVIAN MED PRINCIPLES, P115	74	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194969	10.1371/journal.pone.0194969	http://dx.doi.org/10.1371/journal.pone.0194969			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590191	Green Published, gold, Green Submitted			2022-12-26	WOS:000428603100092
J	Wu, TH; Shi, LF; Adrian, J; Shi, MY; Nair, RV; Snyder, MP; Kao, PN				Wu, Ting-Hsuan; Shi, Lingfang; Adrian, Jessika; Shi, Minyi; Nair, Ramesh V.; Snyder, Michael P.; Kao, Peter N.			NF90/ILF3 is a transcription factor that promotes proliferation over differentiation by hierarchical regulation in K562 erythroleukemia cells	PLOS ONE			English	Article							IL-2 MESSENGER-RNA; GENE-EXPRESSION; NUCLEAR FACTOR; NEGATIVE REGULATOR; PROTEOMIC ANALYSIS; CHROMATIN STATE; BIND DNA; IN-VIVO; NF90; NF45	NF90 and splice variant NF110 are DNA- and RNA-binding proteins encoded by the Interleukin enhancer-binding factor 3 (ILF3) gene that have been established to regulate RNA splicing, stabilization and export. The roles of NF90 and NF110 in regulating transcription as chromatin-interacting proteins have not been comprehensively characterized. Here, chromatin immunoprecipitation followed by deep sequencing (ChIP-seq) identified 9,081 genomic sites specifically occupied by NF90/NF110 in K562 cells. One third of NF90/NF110 peaks occurred at promoters of annotated genes. NF90/NF110 occupancy colocalized with chromatin marks associated with active promoters and strong enhancers. Comparison with 150 ENCODE ChIP-seq experiments revealed that NF90/NF110 clustered with transcription factors exhibiting preference for promoters over enhancers (POLR2A, MYC, YY1). Differential gene expression analysis following shRNA knockdown of NF90/NF110 in K562 cells revealed that NF90/NF110 activates transcription factors that drive growth and proliferation (EGR1, MYC), while attenuating differentiation along the erythroid lineage (KLF1). NF90/NF110 associates with chromatin to hierarchically regulate transcription factors that promote proliferation and suppress differentiation.	[Wu, Ting-Hsuan; Shi, Lingfang; Kao, Peter N.] Stanford Univ, Sch Med, Pulm & Crit Care Med, Stanford, CA 94305 USA; [Wu, Ting-Hsuan] Stanford Univ, Sch Med, Biomed Informat, Stanford, CA 94305 USA; [Adrian, Jessika; Shi, Minyi; Snyder, Michael P.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA USA; [Nair, Ramesh V.] Stanford Univ, Sch Med, Stanford Ctr Genom & Personalized Med, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; Stanford University	Wu, TH; Kao, PN (corresponding author), Stanford Univ, Sch Med, Pulm & Crit Care Med, Stanford, CA 94305 USA.; Wu, TH (corresponding author), Stanford Univ, Sch Med, Biomed Informat, Stanford, CA 94305 USA.	thsuanwu@stanford.edu; peterkao@stanford.edu	Wu, Timothy Ting Hsuan/AAQ-8510-2020	Snyder, Michael/0000-0003-0784-7987; Wu, Timothy/0000-0002-6869-362X	National Institutes of Health [R01 AI39624, U54 HG006996]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039624] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health; R01 AI39624 provided support for PNK and LF; and U54 HG006996 provided support for JA, MS, RVN and MPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Benayoun BA, 2009, TRENDS CELL BIOL, V19, P189, DOI 10.1016/j.tcb.2009.02.003; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bregman A, 2011, CELL, V147, P1473, DOI 10.1016/j.cell.2011.12.005; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Cassiday LA, 2002, NUCLEIC ACIDS RES, V30, P4118, DOI 10.1093/nar/gkf512; Castella S, 2015, WIRES RNA, V6, P243, DOI 10.1002/wrna.1270; Cazanove O, 2008, BIOCHEMISTRY-US, V47, P8350, DOI 10.1021/bi7008486; Chaumet A, 2013, BIOCHIMIE, V95, P1146, DOI 10.1016/j.biochi.2013.01.004; Core LJ, 2014, NAT GENET, V46, P1311, DOI 10.1038/ng.3142; CORTHESY B, 1994, J BIOL CHEM, V269, P20682; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2013, GENOME RES, V23, P1142, DOI 10.1101/gr.144840.112; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fung LF, 2000, LIFE SCI, V67, P923, DOI 10.1016/S0024-3205(00)00684-6; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Gomila RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016687; Guan DY, 2008, MOL CELL BIOL, V28, P4629, DOI 10.1128/MCB.00120-08; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Higuchi T, 2016, J BIOL CHEM, V291, P21074, DOI 10.1074/jbc.M116.748210; Huang Q, 2014, TUMOUR BIOL J INT SO; Hudson WH, 2014, NAT REV MOL CELL BIO, V15, P749, DOI 10.1038/nrm3884; Isken O, 2007, RNA, V13, P1675, DOI 10.1261/rna.594207; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jiang W., 2015, CELL CYCLE HEPATOCEL, V34, P4460, DOI DOI 10.1038/onc.2014.373; Jiang ZY, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0853-2; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KAO PN, 1994, J BIOL CHEM, V269, P20691; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435; Kornberg RD, 1999, TRENDS BIOCHEM SCI, V24, pM46, DOI 10.1016/S0962-8924(99)01679-7; Kuwano Y, 2010, NUCLEIC ACIDS RES, V38, P225, DOI 10.1093/nar/gkp861; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li WB, 2016, NAT REV GENET, V17, P207, DOI 10.1038/nrg.2016.4; Li Y, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8020047; Li Y, 2014, J VIROL, V88, P7199, DOI 10.1128/JVI.00225-14; Masuda K, 2013, INT J MOL SCI, V14, P17111, DOI 10.3390/ijms140817111; Nadel J, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0040-6; Nakadai T, 2015, J BIOL CHEM, V290, P26832, DOI 10.1074/jbc.M115.688317; Ni TT, 2015, J MOL HISTOL, V46, P325, DOI 10.1007/s10735-015-9624-5; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Parrott AM, 2005, J MOL BIOL, V348, P281, DOI 10.1016/j.jmb.2005.02.047; Parrott AM, 2007, METHOD ENZYMOL, V429, P243, DOI 10.1016/S0076-6879(07)29012-3; Pei Y, 2008, J IMMUNOL, V180, P222, DOI 10.4049/jimmunol.180.1.222; Pfeifer I, 2008, P NATL ACAD SCI USA, V105, P4173, DOI 10.1073/pnas.0711222105; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Reichman TW, 2003, J MOL BIOL, V332, P85, DOI 10.1016/S0022-2836(03)00885-4; Reichman TW, 2003, RNA, V9, P543, DOI 10.1261/rna.2181103; Reichman TW, 2002, MOL CELL BIOL, V22, P343, DOI 10.1128/MCB.22.1.343-356.2002; Ren B, 2010, NATURE, V465, P173, DOI 10.1038/465173a; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Sakamoto S, 2009, MOL CELL BIOL, V29, P3754, DOI 10.1128/MCB.01836-08; Saunders LR, 2001, GENOMICS, V71, P256, DOI 10.1006/geno.2000.6423; Shabman RS, 2011, J INFECT DIS, V204, pS911, DOI 10.1093/infdis/jir343; Shamanna RA, 2011, MOL CELL BIOL, V31, P4832, DOI 10.1128/MCB.05849-11; Shi LF, 2005, J BIOL CHEM, V280, P18981, DOI 10.1074/jbc.M411034200; Shi LF, 2007, J EXP MED, V204, P971, DOI 10.1084/jem.20052078; Shi LF, 2007, NUCLEIC ACIDS RES, V35, P2302, DOI 10.1093/nar/gkm117; Shim J, 2002, MOL CELL, V10, P1331, DOI 10.1016/S1097-2765(02)00730-X; Sigova AA, 2015, SCIENCE, V350, P978, DOI 10.1126/science.aad3346; Stark R., 2012, DIFFBIND DIFFERENTIA; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; Vinjamur DS, 2014, HAEMATOLOGICA, V99, P1565, DOI 10.3324/haematol.2014.104943; Vumbaca F, 2008, MOL CELL BIOL, V28, P772, DOI 10.1128/MCB.02078-06; Wang P, 2009, J VIROL, V83, P7850, DOI 10.1128/JVI.00735-09; Wei W, 2011, TRENDS GENET, V27, P267, DOI 10.1016/j.tig.2011.04.002; Wolkowicz UM, 2012, NUCLEIC ACIDS RES, V40, P9356, DOI 10.1093/nar/gks696; Ye JL, 2017, RNA, V23, P1270, DOI 10.1261/rna.061499.117; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031; Zhu P, 2010, J IMMUNOL, V185, P5140, DOI 10.4049/jimmunol.1000849	78	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193126	10.1371/journal.pone.0193126	http://dx.doi.org/10.1371/journal.pone.0193126			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590119	Green Submitted, gold, Green Published			2022-12-26	WOS:000428603100014
J	Kelly, AC; Ward, TJ				Kelly, Amy C.; Ward, Todd J.			Population genomics of Fusarium graminearum reveals signatures of divergent evolution within a major cereal pathogen	PLOS ONE			English	Article							GENE-CLUSTER; FUNCTIONAL-ANALYSIS; POSITIVE SELECTION; GIBBERELLA-ZEAE; IN-VITRO; WHEAT; FUNGUS; DIVERSITY; PROTEINS; NUMBER	The cereal pathogen Fusarium graminearum is the primary cause of Fusarium head blight (FHB) and a significant threat to food safety and crop production. To elucidate population structure and identify genomic targets of selection within major FHB pathogen populations in North America we sequenced the genomes of 60 diverse F. graminearum isolates. We also assembled the first pan-genome for F. graminearum to clarify population-level differences in gene content potentially contributing to pathogen diversity. Bayesian and phylogenomic analyses revealed genetic structure associated with isolates that produce the novel NX-2 mycotoxin, suggesting a North American population that has remained genetically distinct from other endemic and introduced cereal-infecting populations. Genome scans uncovered distinct signatures of selection within populations, focused in high diversity, frequently recombining regions. These patterns suggested selection for genomic divergence at the trichothecene toxin gene cluster and thirteen additional regions containing genes potentially involved in pathogen specialization. Gene content differences further distinguished populations, in that 121 genes showed population-specific patterns of conservation. Genes that differentiated populations had predicted functions related to pathogenesis, secondary metabolism and antagonistic interactions, though a subset had unique roles in temperature and light sensitivity. Our results indicated that F. graminearum populations are distinguished by dozens of genes with signatures of selection and an array of dispensable accessory genes, suggesting that FHB pathogen populations may be equipped with different traits to exploit the agroecosystem. These findings provide insights into the evolutionary processes and genomic features contributing to population divergence in plant pathogens, and highlight candidate genes for future functional studies of pathogen specialization across evolutionarily and ecologically diverse fungi.	[Kelly, Amy C.; Ward, Todd J.] USDA ARS, Peoria, IL 61604 USA	United States Department of Agriculture (USDA)	Ward, TJ (corresponding author), USDA ARS, Peoria, IL 61604 USA.	todd.ward@ars.usda.gov			United States Department of Agriculture Agricultural Research Service National Program for Food Safety	United States Department of Agriculture Agricultural Research Service National Program for Food Safety	This study was supported by the United States Department of Agriculture Agricultural Research Service National Program for Food Safety. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanen DK, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P274; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Alexander NJ, 2009, TOXIN REV, V28, P198, DOI 10.1080/15569540903092142; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambrose KV, 2015, SCI REP-UK, V5, DOI 10.1038/srep10939; Arnold B, 2013, MOL ECOL, V22, P3179, DOI 10.1111/mec.12276; Backhouse D, 2014, EUR J PLANT PATHOL, V139, P161, DOI 10.1007/s10658-013-0374-5; Badouin H, 2017, MOL ECOL, V26, P2041, DOI 10.1111/mec.13976; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bidard F, 2013, G3-GENES GENOM GENET, V3, P1015, DOI 10.1534/g3.113.006262; Branco S, 2017, MOL ECOL, V26, P2063, DOI 10.1111/mec.13892; Branco S, 2015, MOL ECOL, V24, P2747, DOI 10.1111/mec.13132; Brown NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033731; Castrillo M, 2013, APPL ENVIRON MICROB, V79, P2777, DOI 10.1128/AEM.03110-12; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Cheng P, 2001, EMBO J, V20, P101, DOI 10.1093/emboj/20.1.101; Coleman ML, 2010, P NATL ACAD SCI USA, V107, P18634, DOI 10.1073/pnas.1009480107; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Connolly LR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003916; Cordero OX, 2014, NAT REV MICROBIOL, V12, P263, DOI 10.1038/nrmicro3218; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Debets AJM, 2012, P NATL ACAD SCI USA, V109, P10432, DOI 10.1073/pnas.1205333109; den Bakker HC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-425; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Desjardins AE, 2007, INT J FOOD MICROBIOL, V119, P47, DOI 10.1016/j.ijfoodmicro.2007.07.024; Diernfellner A, 2007, FEBS LETT, V581, P5759, DOI 10.1016/j.febslet.2007.11.043; Dubin H, 2002, BREAD WHEAT IMPROVEM; Duveiller E., 2012, WHEAT DIS PESTS GUID, Vsecond; Ellison CE, 2011, P NATL ACAD SCI USA, V108, P2831, DOI 10.1073/pnas.1014971108; Estrada AER, 2011, FUNGAL GENET BIOL, V48, P874, DOI 10.1016/j.fgb.2011.06.006; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Excoffier L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003905; Falush D, 2003, GENETICS, V164, P1567; Fang H, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0384-y; Fang WG, 2010, ENVIRON MICROBIOL, V12, P810, DOI 10.1111/j.1462-2920.2009.02127.x; Foroud NA, 2012, PLANT DIS, V96, P1271, DOI 10.1094/PDIS-10-11-0863-RE; Gaffoor I, 2005, EUKARYOT CELL, V4, P1926, DOI 10.1128/EC.4.11.1926-1933.2005; Gale LR, 2007, PHYTOPATHOLOGY, V97, P1434, DOI 10.1094/PHYTO-97-11-1434; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Harris LJ, 1999, PLANT DIS, V83, P954, DOI 10.1094/PDIS.1999.83.10.954; Henriksson G, 2000, J BIOTECHNOL, V78, P93, DOI 10.1016/S0168-1656(00)00206-6; Hoang DT, 2017, MOL BIOL EVOLUTION; Hohenlohe Paul A, 2012, Methods Mol Biol, V888, P235, DOI 10.1007/978-1-61779-870-2_14; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Hu G, 2014, MBIO, V5, DOI 10.1128/mBio.00941-14; HUDSON RR, 1992, GENETICS, V132, P583; HUDSON RR, 1985, GENETICS, V111, P147; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jansen C, 2005, P NATL ACAD SCI USA, V102, P16892, DOI 10.1073/pnas.0508467102; Jensen JD, 2007, GENETICS, V176, P2371, DOI 10.1534/genetics.106.069450; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Kelly A, 2016, FUNGAL GENET BIOL, V95, P39, DOI 10.1016/j.fgb.2016.08.003; Kelly AC, 2015, FUNGAL GENET BIOL, V82, P22, DOI 10.1016/j.fgb.2015.05.016; Kimura M, 2003, FEBS LETT, V539, P105, DOI 10.1016/S0014-5793(03)00208-4; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Laurent B, 2017, MOL PLANT PATHOLOGY; Laurent B, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3524-x; LESLIE JF, 1993, ANNU REV PHYTOPATHOL, V31, P127, DOI 10.1146/annurev.py.31.090193.001015; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Li PF, 2016, VIROLOGY, V489, P86, DOI 10.1016/j.virol.2015.12.004; Liang JM, 2014, FUNGAL GENET BIOL, V73, P83, DOI 10.1016/j.fgb.2014.10.002; Liang JM, 2015, PHYTOPATHOLOGY, V105, P1466, DOI 10.1094/PHYTO-01-15-0021-R; Lofgren L, 2017, EUROPEAN J PLANT PAT, P1; Lofgren LA, 2017, NEW PHYTOL, P1; Lu SW, 2016, PHYTOPATHOLOGY, V106, P166, DOI 10.1094/PHYTO-09-15-0215-R; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Matei E, 2011, PROTEINS, V79, P1538, DOI 10.1002/prot.22981; McDonald BA, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2016.0026; McMullen M, 1997, PLANT DIS, V81, P1340, DOI 10.1094/PDIS.1997.81.12.1340; McMullen M, 2012, PLANT DIS, V96, P1712, DOI 10.1094/PDIS-03-12-0291-FE; Muirhead CA, 2002, GENETICS, V161, P633; Nganje WE, 2004, 538 N DAK STAT U DEP; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; O'Donnell K, 2000, P NATL ACAD SCI USA, V97, P7905, DOI 10.1073/pnas.130193297; O'Donnell K, 1998, MYCOLOGIA, V90, P465, DOI 10.2307/3761407; O'Donnell K, 2013, FUNGAL GENET BIOL, V52, P20, DOI 10.1016/j.fgb.2012.12.004; Paper JM, 2007, PROTEOMICS, V7, P3171, DOI 10.1002/pmic.200700184; Pattengale ND, 2009, MANY BOOTSTRAP REPLI, P184, DOI [10.1007/978-3-642-02008-7_13, DOI 10.1007/978-3-642-02008-7_13]; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfeifer B, 2014, MOL BIOL EVOL, V31, P1929, DOI 10.1093/molbev/msu136; Pritchard JK, 2000, GENETICS, V155, P945; Proctor RH, 2013, MOL MICROBIOL, V90, P290, DOI 10.1111/mmi.12362; Puri KD, 2010, PHYTOPATHOLOGY, V100, P1007, DOI 10.1094/PHYTO-12-09-0332; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rutter WB, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3678-6; Salichos L, 2010, MYCOLOGIA, V102, P269, DOI 10.3852/09-073; SAS Institute Inc, 2012, JMP; Schmale DG, 2011, PLANT PATHOL, V60, P909, DOI 10.1111/j.1365-3059.2011.02443.x; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Sieber CMK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110311; Siewers V, 2005, MOL PLANT MICROBE IN, V18, P602, DOI 10.1094/MPMI-18-0602; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Snipen L, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0517-0; Son H, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006595; Son H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002310; Song XS, 2016, NEW PHYTOL, V210, P997, DOI 10.1111/nph.13806; Stajich JE, 2005, MOL BIOL EVOL, V22, P63, DOI 10.1093/molbev/msh252; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanke M, 2016, AUGUSTUS REFERENCES; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Stergiopoulos I, 2012, MOL BIOL EVOL, V29, P3371, DOI 10.1093/molbev/mss143; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Sweigard JA, 1998, MOL PLANT MICROBE IN, V11, P404, DOI 10.1094/MPMI.1998.11.5.404; TAJIMA F, 1989, GENETICS, V123, P585; TAKAHATA N, 1985, GENETICS, V110, P325; Talas F, 2016, MOL PLANT MICROBE IN, V29, P417, DOI 10.1094/MPMI-09-15-0218-R; Talas F, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2166-0; Thatcher LF, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3192-2; Urban M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1412-9; Varga E, 2015, ENVIRON MICROBIOL, V17, P2588, DOI 10.1111/1462-2920.12718; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wagacha JM, 2012, FUNGAL BIOL-UK, V116, P836, DOI 10.1016/j.funbio.2012.05.001; Wakeley J, 1996, THEOR POPUL BIOL, V49, P39, DOI 10.1006/tpbi.1996.0002; Walkowiak S, 2015, MOL PLANT MICROBE IN, V28, P1256, DOI 10.1094/MPMI-06-15-0120-R; Ward TJ, 2002, P NATL ACAD SCI USA, V99, P9278, DOI 10.1073/pnas.142307199; Ward TJ, 2008, FUNGAL GENET BIOL, V45, P473, DOI 10.1016/j.fgb.2007.10.003; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wight WD, 2009, MOL PLANT MICROBE IN, V22, P1258, DOI 10.1094/MPMI-22-10-1258; Wong P, 2011, NUCLEIC ACIDS RES, V39, pD637, DOI 10.1093/nar/gkq1016; Wu J, 1998, P NATL ACAD SCI USA, V95, P12398, DOI 10.1073/pnas.95.21.12398; Xu XM, 2005, EUR J PLANT PATHOL, V112, P143, DOI 10.1007/s10658-005-2446-7; Zeller KA, 2003, PHYTOPATHOLOGY, V93, P874, DOI 10.1094/PHYTO.2003.93.7.874; Zhao JH, 2015, MOL BIOL EVOL, V32, P2417, DOI 10.1093/molbev/msv125	135	51	52	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194616	10.1371/journal.pone.0194616	http://dx.doi.org/10.1371/journal.pone.0194616			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584736	Green Published, gold, Green Submitted			2022-12-26	WOS:000428373000029
J	Uwitonze, A; Huang, JQ; Ye, YQ; Cheng, WQ; Li, ZP				Uwitonze, Alfred; Huang, Jiaqing; Ye, Yuanqing; Cheng, Wenqing; Li, Zongpeng			Exact and heuristic algorithms for Space Information Flow	PLOS ONE			English	Article							STEINER MINIMAL-TREES; UNDIRECTED NETWORKS; MULTICAST	Space Information Flow (SIF) is a new promising research area that studies network coding in geometric space, such as Euclidean space. The design of algorithms that compute the optimal SIF solutions remains one of the key open problems in SIF. This work proposes the first exact SIF algorithm and a heuristic SIF algorithm that compute min-cost multicast network coding for N (N >= 3) given terminal nodes in 2-D Euclidean space. Furthermore, we find that the Butterfly network in Euclidean space is the second example besides the Pentagram network where SIF is strictly better than Euclidean Steiner minimal tree. The exact algorithm design is based on two key techniques: Delaunay triangulation and linear programming. Delaunay triangulation technique helps to find practically good candidate relay nodes, after which a min-cost multicast linear programming model is solved over the terminal nodes and the candidate relay nodes, to compute the optimal multicast network topology, including the optimal relay nodes selected by linear programming from all the candidate relay nodes and the flow rates on the connection links. The heuristic algorithm design is also based on Delaunay triangulation and linear programming techniques. The exact algorithm can achieve the optimal SIF solution with an exponential computational complexity, while the heuristic algorithm can achieve the sub-optimal SIF solution with a polynomial computational complexity. We prove the correctness of the exact SIF algorithm. The simulation results show the effectiveness of the heuristic SIF algorithm.	[Uwitonze, Alfred; Huang, Jiaqing; Cheng, Wenqing] Huazhong Univ Sci & Technol, Sch Elect Informat & Commun, Wuhan 430074, Hubei, Peoples R China; [Uwitonze, Alfred] Univ Rwanda, Coll Sci & Technol, POB 3900, Kigali, Rwanda; [Ye, Yuanqing] Carnegie Mellon Univ, Dept Elect & Comp Engn, Pittsburgh, PA 15213 USA; [Li, Zongpeng] Univ Calgary, Dept Comp Sci, Calgary, AB, Canada	Huazhong University of Science & Technology; University of Rwanda; Carnegie Mellon University; University of Calgary	Huang, JQ (corresponding author), Huazhong Univ Sci & Technol, Sch Elect Informat & Commun, Wuhan 430074, Hubei, Peoples R China.	jqhuang@mail.hust.edu.cn			National Natural Science Foundation of China [61271227]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by No.61271227, National Natural Science Foundation of China, JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2004, 2004 IEEE INFORMATION THEORY WORKSHOP, PROCEEDINGS, P247; Ahlswede R, 2000, IEEE T INFORM THEORY, V46, P1204, DOI 10.1109/18.850663; Arora S, 1998, J ACM, V45, P753, DOI 10.1145/290179.290180; Barekatain B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069844; Fragouli C, 2006, IEEE T INFORM THEORY, V52, P829, DOI 10.1109/TIT.2005.864435; GILBERT EN, 1968, SIAM J APPL MATH, V16, P1, DOI 10.1137/0116001; Huang J., 2013, ADV MECH ENG, V2013, P1, DOI DOI 10.1038/NSMB; Huang Jun Z., 2016, 2016 74th Annual Device Research Conference (DRC), P1, DOI 10.1109/DRC.2016.7548456; Huang JQ, 2014, IEEE GLOB COMM CONF, P1460, DOI 10.1109/GLOCOM.2014.7037014; Leach G, 1992, 4 CAN C COMP GEOM, P340; Li Z., 2011, SPACE INFORM FLOW; Li ZP, 2007, IEEE INFOCOM SER, P231, DOI 10.1109/INFCOM.2007.35; Li ZP, 2006, IEEE T INFORM THEORY, V52, P2467, DOI 10.1109/TIT.2006.874515; Maheshwar S, 2012, IEEE T INFORM THEORY, V58, P570, DOI 10.1109/TIT.2011.2173720; Muhammad RB, 2008, ICWN, P229; PRIM RC, 1957, AT&T TECH J, V36, P1389, DOI 10.1002/j.1538-7305.1957.tb01515.x; SMITH JM, 1981, NETWORKS, V11, P23, DOI 10.1002/net.3230110104; Uwitonze A, 2016, 4 INT C GEO INF RES, P254; Uwitonze A, 2016, 11 INT C COMM NETW C, P475; Uwitonze A, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040902; Van Laarhoven J. W., 2010, THESIS; WAXMAN BM, 1988, IEEE J SEL AREA COMM, V6, P1617, DOI 10.1109/49.12889; WENG JF, 1995, DISCRETE MATH, V141, P259, DOI 10.1016/0012-365X(93)E0183-5; Winter P, 1997, NETWORKS, V30, P149, DOI 10.1002/(SICI)1097-0037(199710)30:3<149::AID-NET1>3.0.CO;2-L; Xiahou T, 2014, IEEE T INFORM THEORY, V60, P2884, DOI 10.1109/TIT.2014.2308998; Xunrui Yin, 2012, Proceedings of the 2012 IEEE International Symposium on Information Theory - ISIT, P1316, DOI 10.1109/ISIT.2012.6283071; Yue M, 1990, MINIMUM NETWORK STEI, V41, P1069; Zhang GY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148725; Zongpeng Li, 2012, Proceedings of the 2012 IEEE International Symposium on Information Theory - ISIT, P1897, DOI 10.1109/ISIT.2012.6283627	30	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0193350	10.1371/journal.pone.0193350	http://dx.doi.org/10.1371/journal.pone.0193350			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584729	gold, Green Published, Green Submitted			2022-12-26	WOS:000428373000005
J	Anutrakunchai, C; Bolscher, JGM; Krom, BP; Kanthawong, S; Chareonsudjai, S; Taweechaisupapong, S				Anutrakunchai, Chitchanok; Bolscher, Jan G. M.; Krom, Bastiaan P.; Kanthawong, Sakawrat; Chareonsudjai, Sorujsiri; Taweechaisupapong, Suwimol			Impact of nutritional stress on drug susceptibility and biofilm structures of Burkholderia pseudomallei and Burkholderia thailandensis grown in static and microfluidic systems	PLOS ONE			English	Article							ACTIVE ATTACHMENT MODEL; LISTERIA-MONOCYTOGENES; STREPTOCOCCUS-MUTANS; SEVERE MELIOIDOSIS; IN-VITRO; IMIPENEM; ARCHITECTURE; ANTIBIOTICS; CEFTAZIDIME; DIVERSITY	Burkholderia pseudomallei is the causative agent of melioidosis and regarded as a bioterrorism threat. It can adapt to the nutrient-limited environment as the bacteria can survive in triple distilled water for 16 years. Moreover, B. pseudomallei exhibits intrinsic resistance to diverse groups of antibiotics in particular while growing in biofilms. Recently, nutrient-limited condition influenced both biofilm formation and ceftazidime (CAZ) tolerance of B. pseudomallei were found. However, there is no information about how nutrient-limitation together with antibiotics used in melioidosis treatment affects the structure of the biofilm produced by B. pseudomallei. Moreover, no comparative study to investigate the biofilm architectures of B. pseudomallei and the related B. thailandensis under different nutrient concentrations has been reported. Therefore, this study aims to provide new information on the effects of four antibiotics used in melioidosis treatment, viz. ceftazidime (CAZ), imipenem (IMI), meropenem (MEM) and doxycycline (DOX) on biofilm architecture of B. pseudomallei and B. thailandensis with different nutrient concentrations under static and flow conditions using confocal laser scanning microscopy. Impact of nutritional stress on drug susceptibility of B. pseudomallei and B. thailandensis grown planktonically or as biofilm was also evaluated. The findings of this study indicate that nutrient-limited environment enhanced survival of B. pseudomallei in biofilm after exposure to the tested antibiotics. The shedding planktonic B. pseudomallei and B. thailandensis were also found to have increased CAZ tolerance in nutrient-limited environment. However, killing activities of MEM and IMI were stronger than CAZ and DOX on B. pseudomallei and B. thailandensis both in planktonic cells and in 2-day old biofilm. In addition, MEM and IMI were able to inhibit B. pseudomallei and B. thailandensis biofilm formation to a larger extend compared to CAZ and DOX. Differences in biofilm architecture were observed for biofilms grown under static and flow conditions. Under static conditions, biofilms grown in full strength modified Vogel and Bonner's medium (MVBM) showed honeycomb-like architecture while a knitted-like structure was observed under limited nutrient condition (0.1xMVBM). Under flow conditions, biofilms grown in MVBM showed a multilayer structure while merely dispersed bacteria were found when grown in 0.1xMVBM. Altogether, this study provides more insight on the effect of four antibiotics against B. pseudomallei and B. thailandensis in biofilm under different nutrient and flow conditions. Since biofilm formation is believed to be involved in disease relapse, MEM and IMI may be better therapeutic options than CAZ for melioidosis treatment.	[Anutrakunchai, Chitchanok; Kanthawong, Sakawrat; Chareonsudjai, Sorujsiri; Taweechaisupapong, Suwimol] Khon Kaen Univ, Biofilm Res Grp, Fac Dent, Khon Kaen, Thailand; [Anutrakunchai, Chitchanok; Kanthawong, Sakawrat; Chareonsudjai, Sorujsiri; Taweechaisupapong, Suwimol] Khon Kaen Univ, Melioidosis Res Ctr, Khon Kaen, Thailand; [Bolscher, Jan G. M.] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Oral Biochem, Amsterdam, Netherlands; [Bolscher, Jan G. M.; Krom, Bastiaan P.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Krom, Bastiaan P.] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Prevent Dent, Amsterdam, Netherlands; [Kanthawong, Sakawrat; Chareonsudjai, Sorujsiri] Khon Kaen Univ, Dept Microbiol, Fac Med, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Khon Kaen University	Taweechaisupapong, S (corresponding author), Khon Kaen Univ, Biofilm Res Grp, Fac Dent, Khon Kaen, Thailand.; Taweechaisupapong, S (corresponding author), Khon Kaen Univ, Melioidosis Res Ctr, Khon Kaen, Thailand.	suvi_taw@kku.ac.th	Krom, Bastiaan/ABC-7026-2020; Bolscher, Jan/ABF-6102-2021; Taweechaisupapong, suwimol/F-6759-2010; Chareonsudjai, Sorujsiri/AFM-5607-2022	Krom, Bastiaan/0000-0002-1497-1161; Bolscher, Jan/0000-0001-5669-6164; Chareonsudjai, Sorujsiri/0000-0001-7176-2924	Biofilm Research Group; Research Affairs and Graduate School, Khon Kaen University [58437]; Division for Earth and Life Sciences; Netherlands Organization for Scientific Research (NWO); University of Amsterdam	Biofilm Research Group; Research Affairs and Graduate School, Khon Kaen University; Division for Earth and Life Sciences; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); University of Amsterdam	This work was supported by Biofilm Research Group and the Post-doctoral Program from Research Affairs and Graduate School, Khon Kaen University [grant number 58437 to Chitchanok Anutrakunchai]. Purchase of the Bioflux Z1000 system was made possible by a grant to BPK from the Division for Earth and Life Sciences to Bastiaan P. Krom (ALW; http://www.nwo.nl/en) with financial aid from the Netherlands Organization for Scientific Research (NWO). Bastiaan P. Krom is supported by a grant from the University of Amsterdam for research into the focal point "Oral Infections and Inflammation".	Allegrini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063914; Anutrakunchai C, 2016, TROP BIOMED, V33, P786; Anutrakunchai C, 2015, TROP BIOMED, V32, P300; Bachtiar EW, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00094; Bridier A, 2010, J MICROBIOL METH, V82, P64, DOI 10.1016/j.mimet.2010.04.006; Buijs J, 2008, CLIN MICROBIOL INFEC, V14, P344, DOI 10.1111/j.1469-0691.2007.01940.x; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; Chen K, 2005, ANTIMICROB AGENTS CH, V49, P1002, DOI 10.1128/AAC.49.3.1002-1009.2005; Chen P, 2014, ANTIMICROB AGENTS CH, V58, P1208, DOI 10.1128/AAC.01353-13; Cheng AC, 2010, CURR OPIN INFECT DIS, V23, P554, DOI 10.1097/QCO.0b013e32833fb88c; Cherifi T, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00864; Clinical and Laboratory Standards Institute (CLSI), 2015, M07A10 CLIN LAB STAN, V10th; Combrouse T, 2013, J APPL MICROBIOL, V114, P1120, DOI 10.1111/jam.12127; Currie BJ, 2015, SEMIN RESP CRIT CARE, V36, P111, DOI 10.1055/s-0034-1398389; Currie BJ, 2000, T ROY SOC TROP MED H, V94, P301, DOI 10.1016/S0035-9203(00)90333-X; Dance D, 2014, INT J ANTIMICROB AG, V43, P310, DOI 10.1016/j.ijantimicag.2014.01.005; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Exterkate RAM, 2010, CARIES RES, V44, P372, DOI 10.1159/000316541; Guilbaud M, 2015, APPL ENVIRON MICROB, V81, P1804, DOI 10.1128/AEM.03173-14; Hall BG, 2014, MOL BIOL EVOL, V31, P232, DOI 10.1093/molbev/mst187; Harvey J, 2007, FOOD MICROBIOL, V24, P380, DOI 10.1016/j.fm.2006.06.006; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Justice SS, 2008, NAT REV MICROBIOL, V6, P162, DOI 10.1038/nrmicro1820; Kadam SR, 2013, INT J FOOD MICROBIOL, V165, P259, DOI 10.1016/j.ijfoodmicro.2013.05.025; Kamjumphol W, 2013, SE ASIAN J TROP MED, V44, P72; Kanthawong S, 2012, INT J ANTIMICROB AG, V39, P39, DOI 10.1016/j.ijantimicag.2011.09.010; LAM J, 1980, INFECT IMMUN, V28, P546; Lee J, 2013, MACROMOL RAPID COMM, V34, P1351, DOI 10.1002/marc.201300444; Li XL, 2014, J BASIC MICROB, V54, P97, DOI 10.1002/jobm.201200457; Limmathurotsakul D, 2014, CLIN MICROBIOL INFEC, V20, pO854, DOI 10.1111/1469-0691.12614; Limmathurotsakul D, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.8, 10.1038/nmicrobiol.2015.8]; Majewski M., 2014, POL ANN MED, V21, P57, DOI [10.1016/j.poamed.2013.12.001, DOI 10.1016/J.POAMED.2013.12.001]; Pibalpakdee P, 2012, INT J ANTIMICROB AG, V39, P356, DOI 10.1016/j.ijantimicag.2011.12.010; Puknun A, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-015-1988-x; Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000; Sawasdidoln C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009196; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schweizer HP, 2008, EMERG INFECT DIS, V14, P1689, DOI [10.3201/eid1411.080431, 10.3201/eid1407.071501]; Schweizer HP, 2012, FUTURE MICROBIOL, V7, P1389, DOI [10.2217/fmb.12.116, 10.2217/FMB.12.116]; Silva TC, 2012, J DENT, V40, P41, DOI 10.1016/j.jdent.2011.09.009; Simpson AJH, 2000, J INFECT DIS, V181, P1014, DOI 10.1086/315306; Simpson AJH, 1999, CLIN INFECT DIS, V29, P381, DOI 10.1086/520219; Stepanovic S, 2004, LETT APPL MICROBIOL, V38, P428, DOI 10.1111/j.1472-765X.2004.01513.x; Taweechaisupapong S, 2005, MICROB PATHOGENESIS, V39, P77, DOI 10.1016/j.micpath.2005.06.001; Van Laar TA, 2015, ANTIMICROB AGENTS CH, V59, P1712, DOI 10.1128/AAC.04581-14; Vorachit M, 1995, J TROP MED HYG, V98, P379; Wang YC, 2016, ANTIMICROB AGENTS CH, V60, P4670, DOI 10.1128/AAC.00551-16; Wiersinga WJ, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2017.107; Wuthiekanun Vanaporn, 2006, Expert Rev Anti Infect Ther, V4, P445, DOI 10.1586/14787210.4.3.445	49	10	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194946	10.1371/journal.pone.0194946	http://dx.doi.org/10.1371/journal.pone.0194946			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579106	Green Published, gold, Green Submitted			2022-12-26	WOS:000428351800068
J	Dwyer, CP; MacNeela, P; Durand, H; Gibbons, A; Reynolds, B; Doherty, E; Conneely, S; Slattery, BW; Murphy, AW; McGuire, BE				Dwyer, Christopher P.; MacNeela, Padraig; Durand, Hannah; Gibbons, Andrea; Reynolds, Bronagh; Doherty, Edel; Conneely, Sinead; Slattery, Brian W.; Murphy, Andrew W.; McGuire, Brian E.			Judgement analysis of case severity and future risk of disability regarding chronic low back pain by general practitioners in Ireland	PLOS ONE			English	Article							INTERVENTION; WORK; GPS; MANAGEMENT; QUALITY; HELP	Chronic low back pain is a major healthcare burden that has wide ranging effects on the individual, their family, society and the workplace. However, appropriate management and treatment is often difficult, as a majority of cases are non-specific in terms of underlying pathology. As a result, there are extensive differences in both individual patient preferences for treatment and treatment decisions amongst general practitioners. The current study examined the clinical judgements of GPs in Ireland, regarding fictional patients' case severity and future risk of disability, through judgement analysis. Judgement analysis (JA) is an idiographic regression modelling technique that has been utilised in extant healthcare research for the purpose of allocating weighting to judgement criteria, or cues, observed by professionals in their clinical decision-making. The primary aim of the study was to model two critical information utilisation tasks performed by GPs with regard to CLBP-in combining information cues to form a judgement about current case severity and a judgement about the same patient's risk of future disability. It was hypothesised that the judgement weighting would differ across the two judgements and that judgements regarding future risk of disability would be less consistent among GPs than judgements about case severity. Results from the regression-based judgement analysis and subsequent follow-up statistical analysis provided support for both study hypotheses. Study findings are discussed in light of theory and research on judgement, clinical decision-making and chronic low back pain.	[Dwyer, Christopher P.; Durand, Hannah; Reynolds, Bronagh; Slattery, Brian W.; McGuire, Brian E.] Natl Univ Ireland, Ctr Pain Res, Galway, Ireland; [Dwyer, Christopher P.; MacNeela, Padraig; Durand, Hannah; Conneely, Sinead; Slattery, Brian W.; McGuire, Brian E.] Natl Univ Ireland, Sch Psychol, Galway, Ireland; [Gibbons, Andrea] Royal Holloway Univ London, Hlth Psychol Res Unit, London, England; [Doherty, Edel] Natl Univ Ireland, JE Cairnes Sch Business & Econ, Discipline Econ, Galway, Ireland; [Murphy, Andrew W.] Natl Univ Ireland, Sch Med, Discipline Gen Practice, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; University of London; Royal Holloway University London; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Dwyer, CP (corresponding author), Natl Univ Ireland, Ctr Pain Res, Galway, Ireland.; Dwyer, CP (corresponding author), Natl Univ Ireland, Sch Psychol, Galway, Ireland.	cdwyer@nuigalway.ie	Durand, Hannah/O-1732-2015	Durand, Hannah/0000-0002-8761-0519; Dwyer, Christopher/0000-0001-5935-4338; Murphy, Andrew/0000-0001-5549-8246; Gibbons, Andrea/0000-0002-7774-0563	Health Research Board (IE) [ICE/2011/19]	Health Research Board (IE)	This work was supported by the Health Research Board (IE). Reference number: ICE/2011/19 (BEM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adderley UJ, 2015, INT J NURS STUD, V52, P345, DOI 10.1016/j.ijnurstu.2014.09.004; Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Baumeister R., 2003, PSYCHOL EC DECISIONS, V1, P3; BRING J, 1994, AM STAT, V48, P209, DOI 10.2307/2684719; Brunswik Egon, 1952, CONCEPTUAL FRAMEWORK; Chibnall JT, 1997, J BEHAV MED, V20, P257, DOI 10.1023/A:1025504827787; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; COOK RL, 1975, ORGAN BEHAV HUM PERF, V13, P31, DOI 10.1016/0030-5073(75)90004-5; Cooksey R. W., 1996, JUDGMENT ANAL THEORY; Cooksey R.W., 1996, THINK REASONING, V2, P141, DOI DOI 10.1080/135467896394483; Coole C, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-190; Denig P, 2002, MED EDUC, V36, P770, DOI 10.1046/j.1365-2923.2002.01202.x; Deyo RA, 1996, SPINE, V21, P2840, DOI 10.1097/00007632-199612150-00007; Harries C, 1996, TRAV HUMAIN, V59, P87; Hayden JA, 2009, J CLIN EPIDEMIOL, V62, P781, DOI 10.1016/j.jclinepi.2008.09.004; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Hummers-Pradier E, 1999, FAM PRACT, V16, P605, DOI 10.1093/fampra/16.6.605; Janknegt R, 1997, DRUGS, V53, P550, DOI 10.2165/00003495-199753040-00002; Kendall NAS, 2009, TACKLING MUSCULOSKEL; Kent Peter M, 2005, Chiropr Osteopat, V13, P13, DOI 10.1186/1746-1340-13-13; Koes BW, 2006, BMJ-BRIT MED J, V332, P1430, DOI 10.1136/bmj.332.7555.1430; Kuijer W, 2006, DISABIL REHABIL, V28, P379, DOI 10.1080/09638280500287635; Linton SJ, 2001, J OCCUP REHABIL, V11, P53, DOI 10.1023/A:1016656225318; MacNeela P, 2010, QUAL HLTH RES; Menefee LA, 2000, CLIN J PAIN, V16, P290, DOI 10.1097/00002508-200012000-00003; Nicholas MK, 2011, PHYS THER; Parsons S, 2015, EUR J PAIN, V19, P167, DOI 10.1002/ejp.533; Pillastrini P, 2013, MED LAV, V104, P380; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Raftery MN, 2011, PAIN, V152, P1096, DOI 10.1016/j.pain.2011.01.019; Rasmussen-Barr E, 2012, DISABIL REHABIL, V34, P136, DOI 10.3109/09638288.2011.591886; Schultz IZ, 2008, J OCCUP REHABIL, V18, P140, DOI 10.1007/s10926-008-9130-7; Shaw WS, 2006, J OCCUP REHABIL, V16, P591, DOI 10.1007/s10926-006-9061-0; Skaner Y, 1998, SCAND J PRIM HEALTH, V16, P95; Skaner Y, 2003, BMC FAM PRACT, V4; Smith L, 2003, APPL COGNITIVE PSYCH, V17, P51, DOI 10.1002/acp.844; Sweller J., 2010, COGNITIVE LOAD THEOR, P29, DOI [10.1017/CBO9780511844744.004, DOI 10.1017/CBO9780511844744.004]; Tait RC, 1997, SOC SCI MED, V45, P1199, DOI 10.1016/S0277-9536(97)00033-6; Thompson C, 2009, J CLIN NURS, V18, P601, DOI 10.1111/j.1365-2702.2007.02191.x; TVERSKY A, 1988, PSYCHOL REV, V95, P371, DOI 10.1037/0033-295X.95.3.371; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; Wigton R. S., 1996, THINK REASONING, V2, P175, DOI DOI 10.1080/135467896394492	42	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194387	10.1371/journal.pone.0194387	http://dx.doi.org/10.1371/journal.pone.0194387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5DH	29579072	Green Published, Green Submitted, gold			2022-12-26	WOS:000428351800027
J	Hajdu-Szucs, K; Fenyvesi, N; Steger, J; Vattay, G				Hajdu-Szucs, Katalin; Fenyvesi, Nora; Steger, Jozsef; Vattay, Gabor			Audio-based performance evaluation of squash players	PLOS ONE			English	Article							SOURCE LOCALIZATION; SQUARES	In competitive sports it is often very hard to quantify the performance. A player to score or overtake may depend on only millesimal of seconds or millimeters. In racquet sports like tennis, table tennis and squash many events will occur in a short time duration, whose recording and analysis can help reveal the differences in performance. In this paper we show that it is possible to architect a framework that utilizes the characteristic sound patterns to precisely classify the types of and localize the positions of these events. From these basic information the shot types and the ball speed along the trajectories can be estimated. Comparing these estimates with the optimal speed and target the precision of the shot can be defined. The detailed shot statistics and precision information significantly enriches and improves data available today. Feeding them back to the players and the coaches facilitates to describe playing performance objectively and to improve strategy skills. The framework is implemented, its hardware and software components are installed and tested in a squash court.	[Hajdu-Szucs, Katalin] Eotvos Lorand Univ, Dept Informat Syst, Budapest, Hungary; [Fenyvesi, Nora; Steger, Jozsef; Vattay, Gabor] Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand University	Hajdu-Szucs, K (corresponding author), Eotvos Lorand Univ, Dept Informat Syst, Budapest, Hungary.	szucsk@caesar.elte.hu	Vattay, Gabor/Q-4266-2019; Stéger, József/ABC-5922-2021; Vattay, Gabor/G-9638-2017	Stéger, József/0000-0003-2836-1855; Vattay, Gabor/0000-0002-0919-9429	Hungarian National Research, Development and Innovation Office [125280]; Ericsson Ltd.	Hungarian National Research, Development and Innovation Office; Ericsson Ltd.	The authors thank the Hungarian National Research, Development and Innovation Office under Grant No. 125280 and the grant of Ericsson Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Barris S, 2008, SPORTS MED, V38, P1025, DOI 10.2165/00007256-200838120-00006; Boris S, 2013, 2013 IEEE INT C AC S; Broadbent DP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174311; Bugatti A, 2002, EURASIP J ADV SIG PR, V2002, P1; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chen JC, 2002, IEEE SIGNAL PROC MAG, V19, P30, DOI 10.1109/79.985676; Friedland G., 2009, P 17 ACM INT C MULT, P195; Gehrig T, 2005, IEEE WORK APPL SIG, P118, DOI 10.1109/ASPAA.2005.1540183; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; Huang YT, 2001, PROCEEDINGS OF THE 2001 IEEE WORKSHOP ON THE APPLICATIONS OF SIGNAL PROCESSING TO AUDIO AND ACOUSTICS, P67, DOI 10.1109/ASPAA.2001.969544; Huang YT, 2001, IEEE T SPEECH AUDI P, V9, P943, DOI 10.1109/89.966097; Huang YT, 2000, INT CONF ACOUST SPEE, P909; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; OBE NM, 2016, SCI SPORT SQUASH; Shao X, 2003, ICICS-PCM 2003, VOLS 1-3, PROCEEDINGS, P1821; Travassos B, 2013, INT J PERF ANAL SPOR, V13, P83, DOI 10.1080/24748668.2013.11868633; Wang YS, 2007, J SOUND VIB, V299, P933, DOI 10.1016/j.jsv.2006.07.034; WELFORD BP, 1962, TECHNOMETRICS, V4, P419, DOI 10.2307/1266577; Williams BK, 2014, ISBS C P ARCH	20	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194394	10.1371/journal.pone.0194394	http://dx.doi.org/10.1371/journal.pone.0194394			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579067	Green Submitted, Green Published, gold			2022-12-26	WOS:000428351800029
J	Jablonski, KE; Boone, RB; Meiman, PJ				Jablonski, Kevin E.; Boone, Randall B.; Meiman, Paul J.			An agent-based model of cattle grazing toxic Geyer's larkspur	PLOS ONE			English	Article							TALL LARKSPUR; DELPHINIUM-NUTTALLIANUM; FORAGE INTAKE; SMALL HERD; LIVESTOCK; SELECTION; TERMINOLOGY; CONSUMPTION; MANAGEMENT; SYSTEMS	By killing cattle and otherwise complicating management, the many species of larkspur (Delphinium spp.) present a serious, intractable, and complex challenge to livestock grazing management in the western United States. Among the many obstacles to improving our understanding of cattle-larkspur dynamics has been the difficulty of testing different grazing management strategies in the field, as the risk of dead animals is too great. Agent-based models (ABMs) provide an effective method of testing alternate management strategies without risk to livestock. ABMs are especially useful for modeling complex systems such as livestock grazing management, and allow for realistic bottom-up encoding of cattle behavior. Here, we introduce a spatially-explicit, behavior-based ABM of cattle grazing in a pasture with a dangerous amount of Geyer's larkspur (D. geyeri). This model tests the role of herd cohesion and stocking density in larkspur intake, finds that both are key drivers of larkspur induced toxicosis, and indicates that alteration of these factors within realistic bounds can mitigate risk. Crucially, the model points to herd cohesion, which has received little attention in the discipline, as playing an important role in lethal acute toxicosis. As the first ABM to model grazing behavior at realistic scales, this study also demonstrates the tremendous potential of ABMs to illuminate grazing management dynamics, including fundamental aspects of livestock behavior amidst ecological heterogeneity.	[Jablonski, Kevin E.; Meiman, Paul J.] Colorado State Univ, Dept Forest & Rangeland Stewardship, Ft Collins, CO 80523 USA; [Boone, Randall B.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Jablonski, KE (corresponding author), Colorado State Univ, Dept Forest & Rangeland Stewardship, Ft Collins, CO 80523 USA.	kevin.jablonski@colostate.edu	Boone, Randall B/N-6566-2013	Boone, Randall B/0000-0003-3362-2976; Jablonski, Kevin/0000-0002-2431-8043	Colorado State University Agricultural Experiment Station [AES-0650, C0L00770]	Colorado State University Agricultural Experiment Station	This work was funded by consecutive grants from the Colorado State University Agricultural Experiment Station, grant numbers AES-0650 and C0L00770. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CR., 2008, DISCONTINUITIES ECOS; Allen VG, 2011, GRASS FORAGE SCI, V66, P2, DOI 10.1111/j.1365-2494.2010.00780.x; Anderson D. R., 2008, MODEL BASED INFERENC; Anderson DM, 2014, RANGELAND J, V36, P205, DOI 10.1071/RJ13092; [Anonymous], 2012, FARMING SYSTEMS RES; [Anonymous], 2013, MEASUREMENTS TERREST; Augusiak J, 2014, ECOL MODEL, V280, P117, DOI 10.1016/j.ecolmodel.2013.11.009; Augustine DJ, 2014, J APPL ECOL, V51, P242, DOI 10.1111/1365-2664.12186; Bailey DW, 2017, J ANIM SCI, V95, P360, DOI 10.2527/asasann.2017.740; Bailey Derek W., 2008, V23, P7; BAILEY DW, 1995, APPL ANIM BEHAV SCI, V45, P183, DOI 10.1016/0168-1591(95)00586-H; Barnes M., 2015, LIVESTOCK MANAGEMENT; CORDOVA FJ, 1978, J RANGE MANAGE, V31, P430, DOI 10.2307/3897201; DISTEL RA, 1995, APPL ANIM BEHAV SCI, V45, P11, DOI 10.1016/0168-1591(95)00593-H; Dumont B, 2004, ANIM RES, V53, P419, DOI 10.1051/animres:2004028; ESRI, 2017, COLL ARCGIS 17 01; ESRI, 2015, ARCGIS DESKT 10 4; Faraway JJ, 2016, EXTENDING LINEAR MOD, DOI DOI 10.1201/B21296; FUNTOWICZ SO, 1993, FUTURES, V25, P739, DOI 10.1016/0016-3287(93)90022-L; Galyean ML, 2016, J ANIM SCI, V94, P26, DOI 10.2527/jas.2016-0523; Gardner DR, 2007, RANGELAND ECOL MANAG, V60, P441, DOI 10.2111/1551-5028(2007)60[441:TACIDN]2.0.CO;2; Green B. T., 2014, Rangelands, V36, P10, DOI 10.2111/RANGELANDS-D-13-00031.1; Green BT, 2009, AM J VET RES, V70, P926, DOI 10.2460/ajvr.70.7.926; GREEN BT, 2009, RANGELANDS, V31, P22, DOI DOI 10.2111/1551-501X-31.1.22; Grimm V, 1999, ECOL MODEL, V115, P129, DOI 10.1016/S0304-3800(98)00188-4; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 2013, INTEGR ENVIRON ASSES, V9, pE58, DOI 10.1002/ieam.1423; Grimm Volker, 2002, Natural Resource Modeling, V15, P23; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; GRINA JA, 1986, J ORG CHEM, V51, P390, DOI 10.1021/jo00353a023; Harris NR, 2007, RANGELAND ECOL MANAG, V60, P339, DOI 10.2111/1551-5028(2007)60[339:SAADOI]2.0.CO;2; HART RH, 1993, J RANGE MANAGE, V46, P81, DOI 10.2307/4002452; Hexagon Geospatial, 2016, ERDAS IMAGINE 2016; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Holechek J.L., 2011, RANGE MANAGEMENT PRI, V6th ed.; HUETE A R, 1988, Remote Sensing of Environment, V25, P295; Institute SAS, 2016, JMP; LACA EA, 1994, ECOLOGY, V75, P706, DOI 10.2307/1941728; LAZO A, 1994, ANIM BEHAV, V48, P1133, DOI 10.1006/anbe.1994.1346; McLane AJ, 2011, ECOL MODEL, V222, P1544, DOI 10.1016/j.ecolmodel.2011.01.020; National Research Council, 2000, NUTR REQ BEEF CATTL; NIELSEN DB, 1994, J RANGE MANAGE, V47, P369, DOI 10.2307/4002332; Northrop R.B., 2010, INTRO COMPLEXITY COM; Panter KE, 2002, BIOCHEM SYST ECOL, V30, P113, DOI 10.1016/S0305-1978(01)00123-5; Pfister JA, 2010, RANGELAND ECOL MANAG, V63, P263, DOI 10.2111/REM-D-09-00084.1; Pfister J. A., 1997, Rangelands, V19, P12; PFISTER JA, 1988, J RANGE MANAGE, V41, P509, DOI 10.2307/3899528; Pfister JA, 1997, J CHEM ECOL, V23, P759, DOI 10.1023/B:JOEC.0000006409.20279.59; Pfister JA, 2002, J RANGE MANAGE, V55, P291, DOI 10.2307/4003137; Pfister JA, 1999, J NAT TOXINS, V8, P81; Provenza F. D., 2003, Rangelands, V25, P4; Provenza FD, 2003, SMALL RUMINANT RES, V49, P257, DOI 10.1016/S0921-4488(03)00143-3; R Core Team, 2017, R LANG STAT COMP; RALPHS MH, 1994, J RANGE MANAGE, V47, P275, DOI 10.2307/4002547; RALPHS MH, 1988, J ANIM SCI, V66, P2334; SATO S, 1982, APPL ANIM ETHOL, V8, P53, DOI 10.1016/0304-3762(82)90132-8; SENFT RL, 1987, BIOSCIENCE, V37, P789, DOI 10.2307/1310545; Shiyomi M, 2004, APPL ENTOMOL ZOOL, V39, P575, DOI 10.1303/aez.2004.575; Shiyomi M, 1999, ECOL MODEL, V119, P231, DOI 10.1016/S0304-3800(99)00059-9; Smith MA, 2010, MP11113 U WYOM COOP; Teague W.R, 2013, RANGELANDS, V35, P6, DOI DOI 10.2111/RANGELANDS-D-13-00013.1; WALKER JW, 1985, J RANGE MANAGE, V38, P90, DOI 10.2307/3899343; WallisDeVries MF, 1998, APPL ANIM BEHAV SCI, V60, P301, DOI 10.1016/S0168-1591(98)00158-0; Welch KD, 2015, J ANIM SCI, V93, P4181, DOI 10.2527/jas.2015-9101; Welch KD, 2015, AGRICULTURE-BASEL, V5, P456, DOI 10.3390/agriculture5030456; Wilensky U., 1999, NETLOGO 6 01	66	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194450	10.1371/journal.pone.0194450	http://dx.doi.org/10.1371/journal.pone.0194450			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566054	Green Submitted, gold, Green Published			2022-12-26	WOS:000428093900066
J	Lee, YJ; Yu, JE; Kim, P; Lee, JY; Cheong, YC; Lee, YJ; Chang, J; Seong, BL				Lee, Young Jae; Yu, Ji Eun; Kim, Paul; Lee, Jeong-Yoon; Cheong, Yu Cheol; Lee, Yoon Jae; Chang, Jun; Seong, Baik Lin			Eliciting unnatural immune responses by activating cryptic epitopes in viral antigens	FASEB JOURNAL			English	Article						antigen processing; invariable site; hemagglutinin; influenza virus	INFLUENZA-A VIRUS; ANTIBODY-DEPENDENT ENHANCEMENT; VACCINE DONOR STRAIN; CATHEPSIN-S; HONG-KONG; HEMAGGLUTININ GENES; CYSTEINE PROTEASES; ESCHERICHIA-COLI; INNATE IMMUNITY; T-CELLS	Antigenic variation in viral surface antigens is a strategy for escaping the host's adaptive immunity, whereas regions with pivotal functions for infection are less subject to antigenic variability. We hypothesized that genetically invariable and immunologically dormant regions of a viral surface antigen could be exposed to the host immune system and activated by rendering them susceptible to antigen-processing machinery in professional antigen-presenting cells (APCs). Considering the frequent antigen drift and shift in influenza viruses, we identified and used structural modeling to evaluate the conserved regions on the influenza hemagglutinin (HA) surface as potential epitopes. Mutant viruses containing the cleavage motifs of cathepsin S within HA were generated. Immunization of mice showed that the mutant, but not the wild-type virus, elicited specific antibodies against the cryptic epitope. Those antibodies were purified, and specific binding to HA was confirmed. These results suggest that an unnatural immune response can be elicited through the processing of target antigens in APCs, followed by presentation via the major histocompatibility complex, if not subjected to regulatory pathways. By harnessing the antigen-processing machinery, our study shows a proof-of-principle for designer vaccines with increased efficacy and safety by either activating cryptic, or inactivating naturally occurring, epitopes of viral antigens.Lee, Y. J., Yu, J. E., Kim, P., Lee, J.-Y., Cheong, Y. C., Lee, Y. J., Chang, J., Seong, B. L. Eliciting unnatural immune responses by activating cryptic epitopes in viral antigens.	[Lee, Young Jae; Yu, Ji Eun; Kim, Paul; Cheong, Yu Cheol; Lee, Yoon Jae; Seong, Baik Lin] Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, 134 Shinchondong, Seoul 03722, South Korea; [Chang, Jun; Seong, Baik Lin] Yonsei Univ, VTRC, Seoul, South Korea; [Lee, Jeong-Yoon; Chang, Jun] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea	Yonsei University; Yonsei University; Ewha Womans University	Seong, BL (corresponding author), Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, 134 Shinchondong, Seoul 03722, South Korea.	blseong@yonsei.ac.kr		Lee, Young Jae/0000-0002-4902-2281; CHANG, JUN/0000-0002-8423-5987	Korean Health Technology Research and Development Project, Ministry of Health and Welfare [HI13C0826, HI15C2875, HI15C2934]; National Research Foundation of Korea - Ministry of Education [2014M3A9E4064743]	Korean Health Technology Research and Development Project, Ministry of Health and Welfare; National Research Foundation of Korea - Ministry of Education	This study was supported by the Korean Health Technology Research and Development Project, Ministry of Health and Welfare (Grants HI13C0826, HI15C2875, and HI15C2934) and the National Research Foundation of Korea funded by the Ministry of Education (Grant 2014M3A9E4064743). The authors declare no conflicts of interest.	Alcami A, 2000, IMMUNOL TODAY, V21, P447, DOI 10.1016/S0167-5699(00)01699-6; Ashkenazi A, 2013, BLOOD, V121, P2244, DOI 10.1182/blood-2012-11-468900; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Beck H, 2001, EUR J IMMUNOL, V31, P3726, DOI 10.1002/1521-4141(200112)31:12<3726::AID-IMMU3726>3.0.CO;2-O; Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Busch R, 1996, EMBO J, V15, P418, DOI 10.1002/j.1460-2075.1996.tb00372.x; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Cezari MHS, 2002, BIOCHEM J, V368, P365, DOI 10.1042/BJ20020840; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Choi SI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002677; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Dorner T, 2007, IMMUNITY, V27, P384, DOI 10.1016/j.immuni.2007.09.002; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Esposito S, 2011, J INFECTION, V63, P300, DOI 10.1016/j.jinf.2011.07.015; Francin M, 2002, J BIOL CHEM, V277, P1762, DOI 10.1074/jbc.M109759200; Gao P, 1999, J VIROL, V73, P3184, DOI 10.1128/JVI.73.4.3184-3189.1999; GETHING MJ, 1980, NATURE, V287, P301, DOI 10.1038/287301a0; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Giodini A, 2010, CURR OPIN IMMUNOL, V22, P94, DOI 10.1016/j.coi.2010.01.023; Gottlieb T, 2014, J AUTOIMMUN, V54, P15, DOI 10.1016/j.jaut.2014.07.005; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Hartman IZ, 2010, NAT MED, V16, P1333, DOI 10.1038/nm.2248; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Jang YH, 2016, VACCINE, V34, P1343, DOI 10.1016/j.vaccine.2016.01.053; Jang YH, 2014, VIRUSES-BASEL, V6, P3159, DOI 10.3390/v6083159; Jang YH, 2014, J VIROL METHODS, V196, P56, DOI 10.1016/j.jviromet.2013.10.035; Jang YH, 2013, VACCINE, V31, P3339, DOI 10.1016/j.vaccine.2013.05.080; Jang YH, 2013, YONSEI MED J, V54, P271, DOI 10.3349/ymj.2013.54.2.271; Jung EJ, 2010, EXP MOL MED, V42, P116, DOI 10.3858/emm.2010.42.2.013; Kiecker F, 2004, HUM IMMUNOL, V65, P523, DOI 10.1016/j.humimm.2004.02.017; Klenk HD, 2011, BIOESSAYS, V33, P180, DOI 10.1002/bies.201000118; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; KRYSTAL M, 1982, P NATL ACAD SCI-BIOL, V79, P4800, DOI 10.1073/pnas.79.15.4800; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee KH, 2006, VACCINE, V24, P1966, DOI 10.1016/j.vaccine.2005.10.051; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; Lutzner N, 2008, J BIOL CHEM, V283, P36185, DOI 10.1074/jbc.M806500200; Magadan JG, 2013, J VIROL, V87, P9742, DOI 10.1128/JVI.00471-13; Mason D, 2001, IMMUNOL REV, V182, P80, DOI 10.1034/j.1600-065X.2001.1820106.x; Mettu RR, 2016, J IMMUNOL METHODS, V432, P72, DOI 10.1016/j.jim.2016.02.013; MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500; Munz C, 2010, CURR OPIN IMMUNOL, V22, P89, DOI 10.1016/j.coi.2010.01.016; Nagler DK, 1999, BIOCHEMISTRY-US, V38, P4868, DOI 10.1021/bi982632s; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; NOVOTNY J, 1986, P NATL ACAD SCI USA, V83, P226, DOI 10.1073/pnas.83.2.226; Pluger EBE, 2002, EUR J IMMUNOL, V32, P467, DOI 10.1002/1521-4141(200202)32:2<467::AID-IMMU467>3.0.CO;2-Y; Reimann J, 1999, IMMUNOL REV, V172, P131, DOI 10.1111/j.1600-065X.1999.tb01362.x; Sahini L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009268; Segura E, 2011, TRAFFIC, V12, P1677, DOI 10.1111/j.1600-0854.2011.01254.x; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; SHRAKE A, 1973, J MOL BIOL, V79, P351, DOI 10.1016/0022-2836(73)90011-9; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Steers NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042579; Subbarao K, 2013, TRENDS MICROBIOL, V21, P350, DOI 10.1016/j.tim.2013.04.003; Sui J, 2011, CLIN INFECT DIS, V52, P1003, DOI 10.1093/cid/cir121; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; tenOever BR, 2016, CELL HOST MICROBE, V19, P142, DOI 10.1016/j.chom.2016.01.006; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Wang L, 1995, ARCH VIROL, V140, P2201, DOI 10.1007/BF01323240; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Zhu H, 2005, J IMMUNOL, V175, P2252, DOI 10.4049/jimmunol.175.4.2252	68	3	3	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4658	4669		10.1096/fj.201701024RRR	http://dx.doi.org/10.1096/fj.201701024RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29570395	Green Published, hybrid			2022-12-26	WOS:000443817700004
J	Chase, AJ; Wombacher, R; Fackler, OT				Chase, Amanda J.; Wombacher, Rebecka; Fackler, Oliver T.			Intrinsic properties and plasma membrane trafficking route of Src family kinase SH4 domains sensitive to retargeting by HIV-1 Nef	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-ACTIVATION; VIRUS TYPE-1 NEF; IMMUNOLOGICAL SYNAPSE; SUBCELLULAR-LOCALIZATION; DOWN-REGULATION; MAL PROTEIN; PDE-DELTA; C-SRC; INFECTION; SURFACE	The HIV type 1 pathogenicity factor Nef enhances viral replication by modulating multiple host cell pathways, including tuning the activation state of infected CD4 T lymphocytes to optimize virus spread. For this, Nef inhibits anterograde transport of the Src family kinase (SFK) Lck toward the plasma membrane (PM). This leads to retargeting of the kinase to the trans-Golgi network, whereas the intracellular transport of a related SFK, Fyn, is unaffected by Nef. The 18-amino acid Src homology 4 (SH4) domain membrane anchor of Lck is necessary and sufficient for Nef-mediated retargeting, but other details of this process are not known. The goal of this study was therefore to identify characteristics of SH4 domains responsive to Nef and the transport machinery used. Screening a panel of SFK SH4 domains revealed two groups that were sensitive or insensitive for trans-Golgi network retargeting by Nef as well as the importance of the amino acid at position 8 for determining Nef sensitivity. Anterograde transport of Nef-sensitive domains was characterized by slower delivery to the PM and initial targeting to Golgi membranes, where transport was arrested in the presence of Nef. For Nef-sensitive SH4 domains, ectopic expression of the lipoprotein binding chaperone Unc119a or the GTPase Arl3 or reduction of their endogenous expression phenocopied the effect of Nef. Together, these results suggest that, analogous to K-Ras, Nef-sensitive SH4 domains are transported to the PM by a cycle of solubilization and membrane insertion and that intrinsic properties define SH4 domains as cargo of this Nef-sensitive lipoprotein binding chaperone-GTPase transport cycle.	[Chase, Amanda J.; Wombacher, Rebecka; Fackler, Oliver T.] Univ Hosp Heidelberg, Ctr Integrat Infect Dis Res CIID, Dept Infect Dis, Integrat Virol, Neuenheimer Feld 344, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Fackler, OT (corresponding author), Univ Hosp Heidelberg, Ctr Integrat Infect Dis Res CIID, Dept Infect Dis, Integrat Virol, Neuenheimer Feld 344, D-69120 Heidelberg, Germany.	oliver.fackler@med.uni-heidelberg.de		Fackler, Oliver Till/0000-0003-2982-4209	Deutsche Forschungsgemeinschaft [TRR83, 15]; postdoctoral program of the medical faculty of the University Hospital Heidelberg; Alexander von Humboldt postdoctoral fellowship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); postdoctoral program of the medical faculty of the University Hospital Heidelberg; Alexander von Humboldt postdoctoral fellowship(Alexander von Humboldt Foundation)	This work was supported by Deutsche Forschungsgemeinschaft TRR83 Project 15. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the postdoctoral program of the medical faculty of the University Hospital Heidelberg and an Alexander von Humboldt postdoctoral fellowship.	Abraham L, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-39; Abraham L, 2012, J IMMUNOL, V189, P1898, DOI 10.4049/jimmunol.1200652; Agopian K, 2006, J VIROL, V80, P3050, DOI 10.1128/JVI.80.6.3050-3061.2006; ALLAND L, 1994, J BIOL CHEM, V269, P16701; Andres-Delgado L, 2010, BLOOD, V116, P5919, DOI 10.1182/blood-2010-08-300665; Anton O, 2008, J EXP MED, V205, P3201, DOI 10.1084/jem.20080552; Anton OM, 2011, J IMMUNOL, V186, P6345, DOI 10.4049/jimmunol.1003771; Arhel NJ, 2009, CURR TOP MICROBIOL, V339, P147, DOI 10.1007/978-3-642-02175-6_8; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Baur AS, 1997, IMMUNITY, V6, P283, DOI 10.1016/S1074-7613(00)80331-3; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; CAMP LA, 1993, J BIOL CHEM, V268, P22566; Cen O, 2003, J BIOL CHEM, V278, P8837, DOI 10.1074/jbc.M208261200; Cerboni C, 2007, J GEN VIROL, V88, P242, DOI 10.1099/vir.0.82125-0; Chandra A, 2012, NAT CELL BIOL, V14, P148, DOI 10.1038/ncb2394; Chaudhry A, 2008, TRAFFIC, V9, P1925, DOI 10.1111/j.1600-0854.2008.00802.x; Chu PH, 2014, P NATL ACAD SCI USA, V111, P12420, DOI 10.1073/pnas.1404487111; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; Galaski J, 2016, JAIDS-J ACQ IMM DEF, V72, P1, DOI 10.1097/QAI.0000000000000917; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Geist MM, 2014, J BIOL CHEM, V289, P14030, DOI 10.1074/jbc.M114.563528; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Giese SI, 2006, VIROLOGY, V355, P175, DOI 10.1016/j.virol.2006.07.003; Gorska MM, 2009, J IMMUNOL, V183, P1675, DOI 10.4049/jimmunol.0900792; Gorska MM, 2004, J EXP MED, V199, P369, DOI 10.1084/jem.20030589; Haller C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001212; Haller C, 2006, J BIOL CHEM, V281, P19618, DOI 10.1074/jbc.M513802200; Haller C, 2014, J VIROL, V88, P14241, DOI 10.1128/JVI.02333-14; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Hill BT, 2005, J VIROL, V79, P1133, DOI 10.1128/JVI.79.2.1133-1141.2005; Imle A, 2015, MBIO, V6, DOI 10.1128/mBio.01309-15; Ismail SA, 2012, EMBO J, V31, P4085, DOI 10.1038/emboj.2012.257; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Jaiswal M, 2016, J BIOL CHEM, V291, P20766, DOI 10.1074/jbc.M116.741827; Kasahara K, 2004, J CELL BIOL, V165, P641, DOI 10.1083/jcb.200403011; Kasahara K, 2007, EXP CELL RES, V313, P2651, DOI 10.1016/j.yexcr.2007.05.001; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kirchhoff F, 2008, CELL MOL LIFE SCI, V65, P2621, DOI 10.1007/s00018-008-8094-2; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Konitsiotis AD, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00116-3; Lee JH, 2013, MOL CELL, V49, P668, DOI 10.1016/j.molcel.2012.12.004; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Lu XB, 1998, IMMUNITY, V8, P647, DOI 10.1016/S1074-7613(00)80569-5; Madrid R, 2005, J BIOL CHEM, V280, P5032, DOI 10.1074/jbc.M401202200; Manninen A, 1998, VIROLOGY, V250, P273, DOI 10.1006/viro.1998.9381; Matheson NJ, 2015, CELL HOST MICROBE, V18, P409, DOI 10.1016/j.chom.2015.09.003; Matusali G, 2012, J VIROL, V86, P4496, DOI 10.1128/JVI.05788-11; Mazzolini J, 2010, BLOOD, V115, P4226, DOI 10.1182/blood-2009-12-259473; McCabe JB, 1999, MOL BIOL CELL, V10, P3771, DOI 10.1091/mbc.10.11.3771; Mejuch T, 2015, CHEMBIOCHEM, V16, P2460, DOI 10.1002/cbic.201500355; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Newman LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099270; Ostalecki C, 2016, EBIOMEDICINE, V13, P294, DOI 10.1016/j.ebiom.2016.10.027; Pan XY, 2013, CELL MICROBIOL, V15, P1605, DOI 10.1111/cmi.12148; Pan XY, 2012, BLOOD, V119, P786, DOI 10.1182/blood-2011-08-373209; Pujol FM, 2016, J VIROL, V90, P6709, DOI 10.1128/JVI.00504-16; Reinecke James, 2014, Biomol Concepts, V5, P143, DOI 10.1515/bmc-2014-0003; Rudolph JM, 2009, J VIROL, V83, P11528, DOI 10.1128/JVI.01423-09; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Schmick M, 2015, TRENDS CELL BIOL, V25, P190, DOI 10.1016/j.tcb.2015.02.004; Schmick M, 2014, CELL, V157, P459, DOI 10.1016/j.cell.2014.02.051; Schmidt S, 2015, J LEUKOCYTE BIOL, V98, P5, DOI 10.1189/jlb.4HI0714-338RR; Schmidt S, 2011, MBIO, V2, DOI 10.1128/mBio.00036-11; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; SIGAL CT, 1994, P NATL ACAD SCI USA, V91, P12253, DOI 10.1073/pnas.91.25.12253; Silva JG, 2016, J IMMUNOL, V197, P4042, DOI 10.4049/jimmunol.1601132; Simmons A, 2005, IMMUNITY, V23, P621, DOI 10.1016/j.immuni.2005.11.003; Simmons A, 2001, IMMUNITY, V14, P763, DOI 10.1016/S1074-7613(01)00158-3; Soares H, 2013, J EXP MED, V210, P2415, DOI 10.1084/jem.20130150; Stolp B, 2012, P NATL ACAD SCI USA, V109, P18541, DOI 10.1073/pnas.1204322109; Stolp B, 2009, CELL HOST MICROBE, V6, P174, DOI 10.1016/j.chom.2009.06.004; Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498; Thoulouze MI, 2006, IMMUNITY, V24, P547, DOI 10.1016/j.immuni.2006.02.016; Tournaviti S, 2007, J CELL SCI, V120, P3820, DOI 10.1242/jcs.011130; Trautz B, 2016, J VIROL, V90, P10915, DOI 10.1128/JVI.01246-16; Trotard M, 2016, J VIROL, V90, P2064, DOI 10.1128/JVI.02966-15; vantHof W, 1997, J CELL BIOL, V136, P1023, DOI 10.1083/jcb.136.5.1023; Wolf D, 2008, VIROLOGY, V370, P45, DOI 10.1016/j.virol.2007.08.015; Wolven A, 1997, MOL BIOL CELL, V8, P1159, DOI 10.1091/mbc.8.6.1159; Wright KJ, 2011, GENE DEV, V25, P2347, DOI 10.1101/gad.173443.111; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Xu XN, 1999, J EXP MED, V189, P1489, DOI 10.1084/jem.189.9.1489; Zhang HB, 2011, NAT NEUROSCI, V14, P874, DOI 10.1038/nn.2835; Zhu YP, 2017, CELL HOST MICROBE, V21, P220, DOI 10.1016/j.chom.2017.01.002	90	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7824	7840		10.1074/jbc.RA118.002794	http://dx.doi.org/10.1074/jbc.RA118.002794			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29588370	hybrid, Green Published			2022-12-26	WOS:000437256500030
J	Mariappa, D; Ferenbach, AT; van Aalten, DMF				Mariappa, Daniel; Ferenbach, Andrew T.; van Aalten, Daan M. F.			Effects of hypo-O-GlcNAcylation on Drosophila development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						O-linked N-acetylglucosamine (O-GlcNAc); O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT); Drosophila genetics; CRISPR; Cas; polycomb; post-translational modification (PTM); Drosophila development; Host cell factor; hypomorphic sxc mutant; Mediator complex	GLCNAC TRANSFERASE; GENE-EXPRESSION; GENOME MODIFICATION; ORGAN DEVELOPMENT; X-CHROMOSOME; CELL-GROWTH; PROTEIN; MELANOGASTER; RESISTANCE; MUTATIONS	Post-translational modification of serine/threonine residues in nucleocytoplasmic proteins with GlcNAc (O-GlcNAcylation) is an essential regulatory mechanism in many cellular processes. In Drosophila, null mutants of the Polycomb gene O-GlcNAc transferase (OGT; also known as super sex combs (sxc)) display homeotic phenotypes. To dissect the requirement for O-GlcNAc signaling in Drosophila development, we used CRISPR/Cas9 gene editing to generate rationally designed sxc catalytically hypomorphic or null point mutants. Of the fertile males derived from embryos injected with the CRISPR/Cas9 reagents, 25% produced progeny carrying precise point mutations with no detectable off-target effects. One of these mutants, the catalytically inactive sxc(K872M), was recessive lethal, whereas a second mutant, the hypomorphic sxc(H537A), was homozygous viable. We observed that reduced total protein O-GlcNAcylation in the sxc(H537A) mutant is associated with a wing vein phenotype and temperature-dependent lethality. Genetic interaction between sxc(H537A) and a null allele of Drosophila host cell factor (dHcf), encoding an extensively O-GlcNAcylated transcriptional coactivator, resulted in abnormal scutellar bristle numbers. A similar phenotype was also observed in sxc(H537A) flies lacking a copy of skuld (skd), a Mediator complex gene known to affect scutellar bristle formation. Interestingly, this phenotype was independent of OGT Polycomb function or dHcf downstream targets. In conclusion, the generation of the endogenous OGT hypomorphic mutant sxc(H537A) enabled us to identify pleiotropic effects of globally reduced protein O-GlcNAc during Drosophila development. The mutants generated and phenotypes observed in this study provide a platform for discovery of OGT substrates that are critical for Drosophila development.	[Mariappa, Daniel; Ferenbach, Andrew T.; van Aalten, Daan M. F.] Univ Dundee, Sch Life Sci, Div Gene Regulat & Express, Dundee DD1 5EH, Scotland	University of Dundee	Mariappa, D; van Aalten, DMF (corresponding author), Univ Dundee, Sch Life Sci, Div Gene Regulat & Express, Dundee DD1 5EH, Scotland.	d.mariyappa@dundee.ac.uk; d.m.f.vanaalten@dundee.ac.uk	Mariappa, Daniel/AAQ-7135-2020	Mariyappa, Daniel/0000-0003-4775-1656; Ferenbach, Andrew/0000-0002-1562-7987	Wellcome Trust [097945/B/11/Z]; MRC Next Generation Optical Microscopy Award [MR/K015869/1]; MRC [MR/K015869/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MRC Next Generation Optical Microscopy Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Fly stocks were obtained from the Drosophila Stock Center (Bloomington, IN). Microinjections were performed at the University of Cambridge Department of Genetics Fly Facility. We thank the University Imaging Facility, Dundee, which is supported by Wellcome Trust Technology Platform Award 097945/B/11/Z and MRC Next Generation Optical Microscopy Award MR/K015869/1.	Baena-Lopez LA, 2013, DEVELOPMENT, V140, P4818, DOI 10.1242/dev.100933; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bassett AR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5640; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Biryukova I, 2008, DEV BIOL, V323, P64, DOI 10.1016/j.ydbio.2008.08.014; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Bouazzi H, 2015, CLIN CASE REP, V3, P604, DOI 10.1002/ccr3.301; Brennan K, 1999, DEV BIOL, V216, P230, DOI 10.1006/dbio.1999.9501; Buse MG, 2002, AM J PHYSIOL-ENDOC M, V283, pE241, DOI 10.1152/ajpendo.00060.2002; Capotosti F, 2007, MOL CELL BIOL, V27, P7063, DOI 10.1128/MCB.00769-07; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Chou TB, 1996, GENETICS, V144, P1673; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Culi J, 1998, GENE DEV, V12, P2036, DOI 10.1101/gad.12.13.2036; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Douris V, 2017, INSECT BIOCHEM MOLEC, V87, P127, DOI 10.1016/j.ibmb.2017.06.013; DURA JM, 1988, DEVELOPMENT, V103, P733; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Furrer M, 2010, J BIOL CHEM, V285, P39623, DOI 10.1074/jbc.M110.140467; Gambetta MC, 2014, DEV CELL, V31, P629, DOI 10.1016/j.devcel.2014.10.020; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Garcia-Bellido A, 2009, GENETICS, V182, P631, DOI 10.1534/genetics.109.104083; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Guinez C, 2007, BIOCHEM BIOPH RES CO, V361, P414, DOI 10.1016/j.bbrc.2007.07.020; Hart GW, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00183; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; Hu YH, 2013, G3-GENES GENOM GENET, V3, P1607, DOI 10.1534/g3.113.007021; Huang LL, 2012, AM J HUM GENET, V91, P694, DOI 10.1016/j.ajhg.2012.08.011; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; INGHAM PW, 1984, CELL, V37, P815, DOI 10.1016/0092-8674(84)90416-1; Jang H, 2012, CELL STEM CELL, V11, P62, DOI 10.1016/j.stem.2012.03.001; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; Kazemi Z, 2010, J BIOL CHEM, V285, P39096, DOI 10.1074/jbc.M110.131102; Kenwrick S, 2004, DEV DYNAM, V229, P289, DOI 10.1002/dvdy.10440; Kristie TM, 2010, BBA-GENE REGUL MECH, V1799, P257, DOI 10.1016/j.bbagrm.2009.08.003; Lim KH, 2006, FEBS LETT, V580, P4645, DOI 10.1016/j.febslet.2006.07.040; Lin SL, 2015, GENETICS, V201, P433, DOI 10.1534/genetics.115.181065; Liu TW, 2017, NAT CHEM BIOL, V13, P161, DOI [10.1038/nchembio.2247, 10.1038/NCHEMBIO.2247]; Mao CX, 2017, DIS MODEL MECH, V10, P1245, DOI 10.1242/dmm.028316; Mariappa D, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150234; Mariappa D, 2015, BIOCHEM J, V470, P255, DOI 10.1042/BJ20150610; Mueller H. -Arno J., 2008, V420, P207, DOI 10.1007/978-1-59745-583-1_12; Niranjan TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116454; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Olivier-Van Stichelen S, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00256; Parker JB, 2014, CELL REP, V9, P967, DOI 10.1016/j.celrep.2014.09.051; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prescott TE, 2016, EUR J MED GENET, V59, P367, DOI 10.1016/j.ejmg.2016.06.001; Radermacher PT, 2014, P NATL ACAD SCI USA, V111, P5592, DOI 10.1073/pnas.1322396111; Rodriguez-Jato S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027479; ROMANI S, 1989, GENE DEV, V3, P997, DOI 10.1101/gad.3.7.997; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Selvan N, 2017, NAT CHEM BIOL, V13, P882, DOI 10.1038/nchembio.2404; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; SHELDON BL, 1972, GENETICS, V71, P567; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Sohn KC, 2004, BIOCHEM BIOPH RES CO, V322, P1045, DOI 10.1016/j.bbrc.2004.08.023; Swamy M, 2016, NAT IMMUNOL, V17, P712, DOI 10.1038/ni.3439; Treisman JE, 2001, DEVELOPMENT, V128, P603; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Vella P, 2013, MOL CELL, V49, P645, DOI 10.1016/j.molcel.2012.12.019; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Webster DM, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-28; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Yin JW, 2014, DEVELOPMENT, V141, P977, DOI 10.1242/dev.098392; Yu HC, 2013, AM J HUM GENET, V93, P506, DOI 10.1016/j.ajhg.2013.07.022; Zachara NE, 2011, AMINO ACIDS, V40, P793, DOI 10.1007/s00726-010-0695-z; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zhu YP, 2015, NAT CHEM BIOL, V11, P319, DOI [10.1038/NCHEMBIO.1774, 10.1038/nchembio.1774]; Zimmer CT, 2016, INSECT BIOCHEM MOLEC, V73, P62, DOI 10.1016/j.ibmb.2016.04.007	74	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7209	7221		10.1074/jbc.RA118.002580	http://dx.doi.org/10.1074/jbc.RA118.002580			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29588363	Green Published, hybrid			2022-12-26	WOS:000432174500013
J	Lin, J; Qin, Z; Qian, H; Li, YJ; Luo, NF; Du, L				Lin, Jing; Qin, Zhen; Qian, Hong; Li, Yajiao; Luo, Nanfu; Du, Lei			A novel catheter with retractable stent that can prevent aortic insufficiency during left ventricular assist	PLOS ONE			English	Article							EXTRACORPOREAL MEMBRANE-OXYGENATION; CARDIOGENIC-SHOCK; DEVICE IMPLANTATION; DECOMPRESSION; EXPERIENCE; SECONDARY; PIGTAIL	Left ventricle (LV) assist, which refers to the use of a mini-pump or catheter implanted across the aortic valve connected to the pump, can promote myocardial recovery after left ventricle failure. However, conventional LV assist catheters compress the aortic valve, which can induce aortic insufficiency. Here we describe a novel LV assist catheter containing a retractable stent at its distal end that may prevent such insufficiency. The device was tested in six goats in which the coronary artery was ligated to induce acute LV failure, and then an LV assist was installed with a novel catheter in the left ventricle via the left subclavian artery. Inserting the catheter into the left ventricle caused mild to moderate aortic insufficiency. Releasing the stent maintained the catheter in the center of the three valve leaflets, which resolved the aortic insufficiency and, within a few minutes, led to significantly lower left ventricle end diastolic pressure (9.0 +/- 3.0 mmHg) than without stent release (17.6 +/- 5.0 mmHg, p = 0.012) as well as significantly higher left ventricle dP/dt(max), (614 +/- 299 mmHg/s) than without stent release (343 +/- 245 mmHg/s, p = 0.03). Our results indicate that this novel drainage catheter with retractable stent can effectively prevent aortic insufficiency by maintaining the catheter in the center of the aortic valve leaflets, thereby lowering left ventricular end diastolic pressure and improving systolic function.	[Lin, Jing; Qin, Zhen; Luo, Nanfu; Du, Lei] Sichuan Univ, West China Hosp, Dept Anesthesiol, Chengdu, Sichuan, Peoples R China; [Lin, Jing; Qin, Zhen; Luo, Nanfu; Du, Lei] Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Chengdu, Sichuan, Peoples R China; [Qian, Hong] Sichuan Univ, West China Hosp, Dept Cardiovasc Surg, Chengdu, Sichuan, Peoples R China; [Li, Yajiao] Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University	Du, L (corresponding author), Sichuan Univ, West China Hosp, Dept Anesthesiol, Chengdu, Sichuan, Peoples R China.; Du, L (corresponding author), Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Chengdu, Sichuan, Peoples R China.	dulei@scu.edu.cn			National Natural Science Foundation of China [81600394, 81270324]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grants No. 81600394, 81270324).; This work was supported by the National Natural Science Foundation of China (Grant Nos.: 81600394 and 81270324), https://isisn.nsfc.gov.cn/egrantweb/.	Alkhouli M, 2016, J CARDIAC SURG, V31, P177, DOI 10.1111/jocs.12696; Barbone A, 2011, INTERACT CARDIOV TH, V13, P293, DOI 10.1510/icvts.2011.269795; Cattermole GN, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13195; Chandola R, 2012, J CARDIAC SURG, V27, P400, DOI 10.1111/j.1540-8191.2012.01454.x; Dixon SR, 2009, JACC-CARDIOVASC INTE, V2, P91, DOI 10.1016/j.jcin.2008.11.005; Hong TH, 2016, ASAIO J, V62, P117, DOI 10.1097/MAT.0000000000000327; Jiang CL, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0611-8; Kim WH, 2017, ASAIO J, V63, P346, DOI 10.1097/MAT.0000000000000472; Lima B, 2016, AM J CARDIOL, V117, P1622, DOI 10.1016/j.amjcard.2016.02.038; Maini B, 2012, CATHETER CARDIO INTE, V80, P717, DOI 10.1002/ccd.23403; Pappalardo F, 2017, EUR J HEART FAIL, V19, P404, DOI 10.1002/ejhf.668; Rajagopal K, 2013, J THORAC CARDIOV SUR, V145, P1373, DOI 10.1016/j.jtcvs.2012.11.066; Schiller P, 2016, ASAIO J, V62, P518, DOI 10.1097/MAT.0000000000000392; Sharma S, 2014, INT J CARDIOL, V176, pE9, DOI 10.1016/j.ijcard.2014.06.057; Siegenthaler MP, 2004, J THORAC CARDIOV SUR, V127, P812, DOI 10.1016/j.jtcvs.2003.09.055; Soleimani B, 2012, PERFUSION-UK, V27, P326, DOI 10.1177/0267659112443722; Swartz MF, 2012, PEDIATR CARDIOL, V33, P185, DOI 10.1007/s00246-011-0113-7; Weymann A, 2014, J CARDIOTHORAC SURG, V9, DOI 10.1186/1749-8090-9-60	18	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0194658	10.1371/journal.pone.0194658	http://dx.doi.org/10.1371/journal.pone.0194658			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608576	gold, Green Published, Green Submitted			2022-12-26	WOS:000428988800013
J	Krajacich, BJ; Huestis, DL; Dao, A; Yaro, AS; Diallo, M; Krishna, A; Xu, JN; Lehmann, T				Krajacich, Benjamin J.; Huestis, Diana L.; Dao, Adama; Yaro, Alpha S.; Diallo, Moussa; Krishna, Asha; Xu, Jiannong; Lehmann, Tovi			Investigation of the seasonal microbiome of Anopheles coluzzii mosquitoes in Mali	PLOS ONE			English	Article							MALARIA MOSQUITO; AEDES-AEGYPTI; GAMBIAE; IDENTIFICATION; ESTIVATION; BACTERIA; VILLAGE; GENE	The poorly understood mechanisms of dry season persistence of Anopheles spp. mosquitoes through the dry season in Africa remain a critical gap in our knowledge of Plasmodium disease transmission. While it is thought that adult mosquitoes remain in a dormant state throughout this seven-month dry season, the nature of this state remains unknown and has largely not been recapitulated in laboratory settings. To elucidate possible connections of this state with microbial composition, the whole body microbiomes of adult mosquitoes in the dry and wet seasons in two locations of Mali with varying water availability were compared by sequencing the 16S ribosomal RNA gene. These locations were a village near the Niger River with year-round water sources (N'Gabakoro, "riparian"), and a typical Sahelian area with highly seasonal breeding sites (Thierola Area, "Sahelian"). The 16S bacterial data consisted of 2057 sequence variants in 426 genera across 184 families. From these data, we found several compositional differences that were seasonally and spatially linked. Counter to our initial hypothesis, there were more pronounced seasonal differences in the bacterial microbiome of riparian, rather than Sahelian areas. These seasonal shifts were primarily in Ralstonia, Sphingorhabdus, and Duganella spp. bacteria that are usually soil and water-associated, indicating these changes may be from bacteria acquired in the larval environment, rather than adulthood. In Sahelian dry season mosquitoes, there was a unique intracellular bacteria, Anaplasma, which likely was acquired through non-human blood feeding. Cytochrome B analysis of blood meals showed greater heterogeneity in host choice of An. coluzzii independent of season in the Thierola area compared to N'Gabakoro (77.5% vs. 94.6% human-origin blood meal, respectively), indicating a relaxation of anthropophily. Overall, this exploratory study provides valuable indications of spatial and seasonal differences in bacterial composition which help refine this difficult to study state.	[Krajacich, Benjamin J.; Huestis, Diana L.; Krishna, Asha; Lehmann, Tovi] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Dao, Adama; Yaro, Alpha S.; Diallo, Moussa] Univ Sci Tech & Technol, Fac Med Pharm & Odontostomatol, MRTC, Bamako, Mali; [Xu, Jiannong] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Science & Technology of Bamako; New Mexico State University	Krajacich, BJ; Lehmann, T (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.	Benjamin.krajacich@nih.gov; tlehmann@niaid.nih.gov	Xu, Jiannong/N-1583-2019	Xu, Jiannong/0000-0001-7332-4370; Lehmann, Tovi/0000-0002-8142-3915	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM092789] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham NM, 2017, P NATL ACAD SCI USA; Akorli J, 2016, PLOS ONE, P11; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apte-Deshpande A, 2012, PLOS ONE, P7; Besansky NJ, 2004, TRENDS PARASITOL, V20, P249, DOI 10.1016/j.pt.2004.03.007; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bivand R.S., 2013, APPL SPATIAL DATA AN, DOI 10.1007/978-1-4614-7618-4; Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Buck M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22806; Callahan B., 2016, SILVA TAXONOMIC TRAI, DOI [10.5281/zenodo.158958, DOI 10.5281/ZENODO.158958]; Callahan Ben J, 2016, F1000Res, V5, P1492; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006; Clark RI, 2015, CELL REP, V12, P1656, DOI 10.1016/j.celrep.2015.08.004; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Coon KL, 2016, MOL ECOL, V25, P5806, DOI 10.1111/mec.13877; Coon KL, 2014, MOL ECOL, V23, P2727, DOI 10.1111/mec.12771; Coulibaly Mamadou B., 2007, PLoS ONE, V2, P1; Dao A, 2014, NATURE, V516, P387, DOI 10.1038/nature13987; David MR, 2016, MEM I OSWALDO CRUZ, V111, P577, DOI 10.1590/0074-02760160238; de la Fuente J, 2007, VET MICROBIOL, V119, P375, DOI 10.1016/j.vetmic.2006.09.011; Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326; Edillo FE, 2002, J MED ENTOMOL, V39, P70, DOI 10.1603/0022-2585-39.1.70; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Gillian P, 2003, MANUAL CLIN MICROBIO, P729; Hijmans R.J., 2016, RASTER GEOGRAPHIC DA; Holstein M., 1954, WORLD HEAL ORGAN, P274; Huestis DL, 2014, INFECT GENET EVOL, V28, P648, DOI 10.1016/j.meegid.2014.05.027; Huestis DL, 2012, J EXP BIOL, V215, P2013, DOI 10.1242/jeb.069468; Hughes GL, 2014, P NATL ACAD SCI USA, V111, P12498, DOI 10.1073/pnas.1408888111; Kent RJ, 2005, AM J TROP MED HYG, V73, P336, DOI 10.4269/ajtmh.2005.73.336; Kuhn M, 2021, CARET CLASSIFICATION, DOI DOI 10.1887/0750303123/B365C43; leBorgne P, 2007, P 2007 EUMETSAT C, P1; Lefevre T, 2009, AM J TROP MED HYG, V81, P1023, DOI 10.4269/ajtmh.2009.09-0124; Lehmann T, 2014, J MED ENTOMOL, V51, P27, DOI 10.1603/ME13094; Lehmann T, 2010, AM J TROP MED HYG, V83, P601, DOI 10.4269/ajtmh.2010.09-0779; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Minard G, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00059; OMER SM, 1968, NATURE, V217, P879, DOI 10.1038/217879b0; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pebesma E.J., 2005, R NEWS, V5; Price MN, 2010, PLOS ONE, P5; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2021, R LANGUAGE ENV STAT; Rstudio T, 2020, RSTUDIO INT DEV R; Ryan MP, 2006, J HOSP INFECT, V62, P278, DOI 10.1016/j.jhin.2005.08.015; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sankaran K, 2014, J STAT SOFTW, V59; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Sohn E., 2014, NATURE, V511, P145; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016383, 10.1371/journal.pone.0020422]; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wright ES, 2016, R J, V8, P352; Yaro AS, 2012, J INSECT PHYSIOL, V58, P1050, DOI 10.1016/j.jinsphys.2012.04.002; Yekutieli D, 2008, J AM STAT ASSOC, V103, P309, DOI 10.1198/016214507000001373; Zouache K, 2011, FEMS MICROBIOL ECOL, V75, P377, DOI 10.1111/j.1574-6941.2010.01012.x	60	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194899	10.1371/journal.pone.0194899	http://dx.doi.org/10.1371/journal.pone.0194899			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596468	Green Published, gold, Green Submitted			2022-12-26	WOS:000428630000048
J	Kim, CR; Kim, EY; Kim, YS; Ahn, HK; Kim, KW; Jeong, YM; Kim, JH				Kim, Chang Rae; Kim, Eun Young; Kim, Young Saing; Ahn, Hee Kyung; Kim, Kun Woo; Jeong, Yu Mi; Kim, Jeong Ho			Histologic subtypes are not associated with the presence of sarcopenia in lung cancer	PLOS ONE			English	Article							SOLID TUMORS; OBESITY; PREVALENCE; CACHEXIA; CLASSIFICATION; ADULTS; HEALTH	Background Sarcopenia is prevalent and a known adverse prognostic effector in lung cancer (LCA). However, the relationship between sarcopenia and histology remains uncertain in LCA. Methods Consecutive patients with newly diagnosed LCA (n = 778) between June 2012 and February 2015 were retrospectively reviewed to identify factors associated with sarcopenia. Sarcopenia was defined as CT-determined L3 muscle index (muscle area at L3/height(2)) of < 55 cm(2)/m(2) for men and < 39 cm(2)/m(2) for women. Results Mean patient age was 67.7 +/- 10.8 years, and most (73.1%) were male. The most prevalent histology was adenocarcinoma (44.0%) and 71.6% of patients had stage III or IV disease. The overall prevalence of sarcopenia was 48.2% (60.3% in men, and 15.3% in women). Univariable analysis showed sarcopenia was significantly associated with male gender, age (> 65 years), smoking status, lower BMI (< 23 kg/m(2)), advanced stage (III and IV), and high comorbidity score (Charlson index > 3). Furthermore, the prevalence of sarcopenia was higher in squamous cell carcinoma (54.9%) and small cell LCA (56.4%) than in adenocarcinoma (39.8%). Multivariable analyses showed sarcopenia was independently associated with a male gender (odds ratio [OR], 11.13), elderly (OR, 2.02) and low BMI (OR, 6.28), stage IV (OR, 1.98), and high comorbidity (OR, 1.93). However, no significant association was found between histologic subtypes and sarcopenia. Conclusions Sarcopenia was found to be significantly associated with old age, male gender, an advanced stage, comorbidities, and low BMI in LCA. However, histology subtype was not an independent factor for the presence of sarcopenia.	[Kim, Chang Rae; Kim, Eun Young; Jeong, Yu Mi; Kim, Jeong Ho] Gachon Univ, Gil Med Ctr, Dept Radiol, Incheon, South Korea; [Kim, Young Saing; Ahn, Hee Kyung] Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Hematol & Oncol, Incheon, South Korea; [Kim, Kun Woo] Gachon Univ, Gil Med Ctr, Dept Thorac & Cardiovasc Surg, Incheon, South Korea	Gachon University; Gachon University; Gachon University	Kim, EY (corresponding author), Gachon Univ, Gil Med Ctr, Dept Radiol, Incheon, South Korea.	oneshot0229@gmail.com	Kim, Jeong Ho/AAA-7538-2022	Kim, Eun Young/0000-0002-2101-7982	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [HA17C0045]; Gachon University Gil Medical Center Research fund	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Gachon University Gil Medical Center Research fund	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (grant no. HA17C0045) (YSK), and was partially supported by a grant from Gachon University Gil Medical Center Research fund (EYK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng HY, 2015, EXPERT OPIN EMERG DR, V20, P149, DOI 10.1517/14728214.2015.1001365; Collins J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003697; Edge SB, 2009, AJCC CANC STAGING MA, V7; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Kim TN, 2009, INT J OBESITY, V33, P885, DOI 10.1038/ijo.2009.130; Kim YS, 2012, J GERONTOL A-BIOL, V67, P1107, DOI 10.1093/gerona/gls071; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Morley JE, 2006, AM J CLIN NUTR, V83, P735, DOI 10.1093/ajcn/83.4.735; Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075; O'Callaghan DS, 2010, J THORAC ONCOL, V5, P2024, DOI 10.1097/JTO.0b013e3181f387e4; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Prado CM, 2013, AM J CLIN NUTR, V98, P1012, DOI 10.3945/ajcn.113.060228; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Ross PJ, 2004, BRIT J CANCER, V90, P1905, DOI 10.1038/sj.bjc.6601781; Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049; Sculier JP, 2008, J THORAC ONCOL, V3, P457, DOI 10.1097/JTO.0b013e31816de2b8; Shachar SS, 2016, EUR J CANCER, V57, P58, DOI 10.1016/j.ejca.2015.12.030; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Travis WD, 2015, J THORAC ONCOL, V10, P1240, DOI 10.1097/JTO.0000000000000663; Yang CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132908; Zhang GX, 2016, ONCOL LETT, V11, P1230, DOI 10.3892/ol.2015.4019	22	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194626	10.1371/journal.pone.0194626	http://dx.doi.org/10.1371/journal.pone.0194626			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590170	Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100070
J	Camelier, P; Menezes, NA; Costa-Silva, GJ; Oliveira, C				Camelier, Priscila; Menezes, Naercio Aquino; Costa-Silva, Guilherme Jose; Oliveira, Claudio			Molecular and morphological data of the freshwater fish Glandulocauda melanopleura (Characiformes: Characidae) provide evidences of river captures and local differentiation in the Brazilian Atlantic Forest	PLOS ONE			English	Article							SPECIES DELIMITATION; POPULATION-GENETICS; PHYLOGENETIC-RELATIONSHIPS; DNA TAXONOMY; EVOLUTIONARY; BIOGEOGRAPHY; TELEOSTEI; INSIGHTS; PHYLOGEOGRAPHY; OSTARIOPHYSI	The current distribution of freshwater fishes across multiple basins along Eastern Brazil can be associated to two main events: river captures or temporary paleoconnections. Apparently, river captures had a more significant role on distribution and structuring of species from upland areas, such as Glandulocauda melanopleura. Populations of this species are found in contiguous drainages in presently isolated upper parts of Rio Tiete and the coastal basins of Guaratuba, Itatinga, Itanhaem, and Ribeira de Iguape, in the Atlantic Forest domain. The allopatric and disjoint distribution of G. melanopleura associated with variation of morphological characters detected among geographically isolated populations stimulated this study. Thus, an integrative approach was undertaken, including morphological and molecular data, to better understand the evolutionary history of the species and the area where it occurs. Molecular analyses based on two mitochondrial markers revealed a strong genetic structure within G. melanopleura, that allowed recognition of two lineages, one distributed in both the upper Tiete and Itanhaem and the other in the Guaratuba. Overall, morphological data revealed some intraspecific overlapping variation, indicating that all samples are conspecific. Phylogenetic and phylogeographic analyses allied to divergence times and geomorphological information indicate that the current distribution of G. melanopleura is a result of relatively recent river captures involving the Tiete and some other coastal drainages. Although of recent origin, they occurred long enough to completely isolate these populations, since there are no haplotypes sharing between them. The conservation status of this species is also discussed, and our results corroborate the need to understand population structure for conservation planning.	[Camelier, Priscila; Menezes, Naercio Aquino] Univ Sao Paulo, Museu Zool, Sao Paulo, SP, Brazil; [Costa-Silva, Guilherme Jose] Univ Santo Amaro, Rua Prof Eneas de Siqueira Neto, Sao Paulo, SP, Brazil; [Oliveira, Claudio] Univ Estadual Paulista, Inst Biociencias, Dept Morfol, Lab Biol & Genet Peixes, Botucatu, SP, Brazil	Universidade de Sao Paulo; Universidade de Santo Amaro (UNISA); Universidade Estadual Paulista	Camelier, P (corresponding author), Univ Sao Paulo, Museu Zool, Sao Paulo, SP, Brazil.	pricamelier@gmail.com	Oliveira, Claudio/D-7713-2012; Menezes, Naercio A./K-8763-2013; de Assis Cardoso, Priscila Camelier/W-3740-2017	Oliveira, Claudio/0000-0002-7010-8880; Menezes, Naercio A./0000-0002-9634-6051; de Assis Cardoso, Priscila Camelier/0000-0002-1228-0076	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional Desenvovlvimento Cientifico Tecnologico (CNPq) [FAPESP 2012/00840-6, FAPESP 2016/03966-1, FAPESP 2011/50282-7, FAPESP 2014/26508-3, CNPq 306054/2006-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional Desenvovlvimento Cientifico Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This study was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, http://ww.fapesp.br/) and Conselho Nacional Desenvovlvimento Cientifico Tecnologico (CNPq, http://cnpq.br/) through of doctoral and postdoctoral fellowships (PC: FAPESP 2012/00840-6 and FAPESP 2016/03966-1, respectively) and support to projects (NAM: FAPESP 2011/50282-7 and CO: FAPESP 2014/26508-3 and CNPq 306054/2006-0).	Ab'saber AN, 2007, GEOMORFOLOGIA SITIO; AbSaber AN, 1975, B PAULISTA GEOGRAFIA, V26, P38; Aguirre WE, 2016, COPEIA, V104, P554, DOI 10.1643/CG-15-289; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrett CF, 2011, MOL ECOL, V20, P2771, DOI 10.1111/j.1365-294X.2011.05124.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bishop P, 1995, PROG PHYS GEOG, V19, P449, DOI 10.1177/030913339501900402; Buckup PA, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P203; Buhrnheim CM, 2008, NEOTROP ICHTHYOL, V6, P663; Camelier P, 2014, NEOTROP ICHTHYOL, V12, P683, DOI 10.1590/1982-0224-20130228; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Cohen KM, 2013, EPISODES, V36, P199, DOI 10.18814/epiiugs/2013/v36i3/002; Cook BD, 2017, BIOL J LINN SOC, P1; Cooke GM, 2012, MOL ECOL, V21, P2410, DOI 10.1111/j.1365-294X.2012.05540.x; Costa Wilson J.E.M., 2001, Ichthyological Exploration of Freshwaters, V12, P333; Costa-Silva GJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135075; Dagosta FCP, 2017, NEOTROP ICHTHYOL, V15, DOI 10.1590/1982-0224-20170034; Souza CRDG, 2015, WOR GEOMORPHOL LANDS, P115, DOI 10.1007/978-94-017-8023-0_11; de Lima RAF, 2015, BIODIVERS CONSERV, V24, P2135, DOI 10.1007/s10531-015-0953-1; de Queiroz K, 1998, ENDLESS FORMS, P57; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eigenmann C.H., 1911, ANN CARNEGIE MUS, V8, P164; Ellis M.D., 1911, ANN CARNEGIE MUS, V8, P148; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fink W.L., 1974, Smithsonian Contributions to Zoology, VNo. 172, P1; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Forest F, 2009, ANN BOT-LONDON, V104, P789, DOI 10.1093/aob/mcp192; Fricke R, 2017, GUIDE FISH COLLECTIO; Fu YX, 1997, GENETICS, V147, P915; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gery J., 1964, Opuscula Zoologica, VNo. 78, P1; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Henriques J.M., 2015, DNA BARCODES, V3, P118, DOI [10.1515/dna-2015-0015, DOI 10.1515/DNA-2015-0015]; Hirschmann A, 2015, ZOOL SCR, V44, P374, DOI 10.1111/zsc.12106; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; Jacintho LRC, 2003, THESIS; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kekkonen M, 2014, MOL ECOL RESOUR, V14, P706, DOI 10.1111/1755-0998.12233; Leliaert F, 2009, MOL PHYLOGENET EVOL, V53, P122, DOI 10.1016/j.ympev.2009.06.004; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lima FCT, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P145; Lohse K, 2009, SYST BIOL, V58, P439, DOI 10.1093/sysbio/syp039; Malabarba MC, 1998, PHYLOGENY CLASSIFICA, P69; Malachin G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179881; Mirande JM, 2013, NEOTROP ICHTHYOL, V11, P747, DOI 10.1590/S1679-62252013000400003; Marinho MMF, 2014, NEOTROP ICHTHYOL, V12, P257, DOI 10.1590/1982-0224-20130091; Martins FM, 2011, BIOGEOGRAFIA AM PADR, P137; Melo BF, 2016, ZOOL SCR, V45, P650, DOI 10.1111/zsc.12178; MENEZES NA, 1990, P BIOL SOC WASH, V103, P380; Menezes NA., 2007, CATALOGO ESPECIES PE, P38; Menezes NA, 2008, LIVRO VERMELHO FAUNA, P62; Menezes NA, 2007, PEIXES AGUA DOCE MAT; Menezes Naercio A., 2008, Zootaxa, V1726, P33; Menezes NA, 2009, NEOTROP ICHTHYOL, V7, P295, DOI 10.1590/S1679-62252009000300002; Miller M.A., 2010, P GAT COMP ENV WORKS; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Pena JM, 2016, PROCEEDINGS OF THE 2016 IEEE ANDESCON; Myers G. S., 1938, Smithsonian Report Washington, V1937, P339; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Neto J., 2007, GEOUSP ESPACO E TEMP, V22, P73, DOI [179-0892.geousp.2007.74067, DOI 10.11606/ISSN.2179-0892.GE0USP2007.74067]; Nylander JAA, 2014, MRMODELTEST V2 PROGR; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Oliveira D., 2010, REV DEP GEOGRAFIA, V20, P37, DOI DOI 10.7154/RDG.2010.0020.0003; Oliveira D, 2003, THESIS; Palumbi Stephen R., 1996, P205; Pereira LHG, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-20; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; R Core Team, 2021, R LANGUAGE ENV STAT; R Development Core Team, 2009, WRIT R EXT MAN INCL; Rambaut A., 2009, TRACER VERSION 1 5; Rambaut A., 2009, FIGTREE VERSION 1 3; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Razkin O, 2017, ZOOL SCR, V46, P55, DOI 10.1111/zsc.12192; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; Ribeiro AC, 2006, ICHTHYOL EXPLOR FRES, V17, P157; Ribeiro AC, 2006, NEOTROP ICHTHYOL, V4, P225, DOI 10.1590/S1679-62252006000200009; Riccomini C, 2004, GEOLOGIA CONTINENTE, P383; Roxo F.F., 2015, DNA BARCODES, V3, P110, DOI DOI 10.1515/dna-2015-0014; Roxo FF, 2012, ECOL EVOL, V2, P2438, DOI 10.1002/ece3.368; Saadi A., 1998, GEONOMOS, V3, P41; Seehausen O, 2014, ANNU REV ECOL EVOL S, V45, P621, DOI 10.1146/annurev-ecolsys-120213-091818; Serra Jane Piton, 2007, Biota Neotrop., V7, P0, DOI 10.1590/S1676-06032007000100011; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Small RJ, 1977, STUDY LANDFORMS TXB; Spellman GM, 2006, P ROY SOC B-BIOL SCI, V273, P3057, DOI 10.1098/rspb.2006.3682; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; TAJIMA F, 1983, GENETICS, V105, P437; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TAYLOR W R, 1985, Cybium, V9, P107; Thomaz AT, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0403-4; Thomaz AT, 2017, HEREDITY, P1, DOI DOI 10.1002/9781119000822.HFCM060; Thompson AS, 2016, J MULTILING MULTICUL, V37, P115, DOI 10.1080/01434632.2015.1031136; Vari RP, 1998, P WORKSH NEOTR DISTR, P343; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Weiss FE, 2012, J SYST PALAEONTOL, V10, P73, DOI 10.1080/14772019.2011.565082; WEITZMAN S H, 1985, Smithsonian Contributions to Zoology, P1; Weitzman SH., 2003, CHECK LIST FRESHWATE, P222; Weitzman Stanley H., 1999, Ichthyological Exploration of Freshwaters, V10, P1; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Zamudio KR, 2009, BIOL J LINN SOC, V97, P259, DOI 10.1111/j.1095-8312.2009.01209.x	113	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194247	10.1371/journal.pone.0194247	http://dx.doi.org/10.1371/journal.pone.0194247			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579069	gold, Green Published, Green Submitted			2022-12-26	WOS:000428351800024
J	Ghosh, SK; Banerjee, S; Pal, S; Chakraborty, N				Ghosh, Swapan Kumar; Banerjee, Subhankar; Pal, Sujoy; Chakraborty, Niloy			Encountering epidemic effects of leaf spot disease (Alternaria brassicae) on Aloe vera by fungal biocontrol agents in agrifields-An ecofriendly approach	PLOS ONE			English	Article							RHIZOCTONIA-SOLANI; ANTAGONISTIC PROPERTIES; TRICHODERMA-HARZIANUM; BIOLOGICAL-CONTROL; 1ST REPORT; ROOT-ROT; PHYLOGENY; SYNTHASE	Aloe vera (L.) Burm.f. is a highly important and extensively cultivated medicinal plant and that is also extensively used in the cosmetic industry. It has been frequently reported to suffer from Alternaria leaf spot disease in various parts of the world. Various fungicides used to combat this disease, have deleterious effects on the environment and on pharmacologically important constituents of Aloe vera. To avoid the harmful effects of fungicides an ecofriendly approach has been adopted here. A weekly survey was conducted during 2013-2015 in and around North 24 Parganas (West Bengal) to obtain the percentage of disease index (PDI). For biological control of the disease, screening of the antagonistic efficacy of biocontrol agents was carried out through the in vitro dual-culture-plate method and scanning electron microscopy (SEM) was used to study the mechanism. The in vitro effects of fungicides on the radial growth of the pathogen were evaluated through the poison food method and were compared with potent antagonistic fungi. Field application of potent antagonistic fungi was conducted through the dip-and-spray method. The results showed that, the PDI peaked during the hot and humid conditions of May to September (76.57%-98.57%) but decreased during the winter, December-January (35.71-46.66%). Trichoderma asperellum exerted the greatest inhibition of the radial growth of A. brassicae acting through non volatile (70.39%) and volatile metabolites (72.17%). A SEM study confirmed the hyperparasitic nature of T. asperellum through hyphal coiling- T. asperellum was similar to 2% blitox-50 (73.92%) and better than 2% bavistin (59.77%) (in vitro). In agricultural field trials (2013-15), Trichoderma application restricted the disease to the smallest area (PDI 24.00-29.33%) in comparison to untreated plots (73.33%). In conclusion, saplings treated with the dip method (10(8) spores / mL) and sprayed 4 times with a spore suspension of biocontrol agents such as T. asperellum, T. viride and T. harzianum, standardized at a rate of 2.5 L /plot (36 sq ft) (10(8) spores/mL) are suggested for the ecofriendly management of this epidemic leaf spot disease of Aloe vera in agricultural fields.	[Ghosh, Swapan Kumar; Banerjee, Subhankar; Pal, Sujoy; Chakraborty, Niloy] Ramakrishna Mission Vivekananda Centenary Coll, Postgrad Dept Bot, Kolkata, W Bengal, India		Ghosh, SK (corresponding author), Ramakrishna Mission Vivekananda Centenary Coll, Postgrad Dept Bot, Kolkata, W Bengal, India.	gswapan582@gmail.com		GHOSH, SWAPAN/0000-0001-9016-6271	AYUSH; National Medicinal Plant Board of India; Ministry of Health & Family Welfare, Government of India [Z.18017/187/CSS/R & D/WB-01/2012-13-NMPB]	AYUSH; National Medicinal Plant Board of India; Ministry of Health & Family Welfare, Government of India	This work was supported by AYUSH, National Medicinal Plant Board of India, Ministry of Health & Family Welfare, Government of India, Project Sanction No: Z.18017/187/CSS/R & D/WB-01/2012-13-NMPB, to GSKG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahman M, 2016, PLANT SCI, V246, P128, DOI 10.1016/j.plantsci.2016.02.008; Anderson TH., 1980, COMPENDIUM SOIL FUNG, V1; ANUPAMA N, 2014, ASIAN J SCI TECH, V5, P412; Anupama N.B., 2015, PLANT SCI, V231, P62, DOI DOI 10.1016/j.plantsci.2014.11.006; Bajwa R, 2010, CAN J PLANT PATHOL, V32, P490, DOI 10.1080/07060661.2010.510644; BAKER R, 1986, CAN J PLANT PATHOL, V8, P218, DOI 10.1080/07060668609501829; Benitez T, 2004, INT MICROBIOL, V7, P249; BLISS DE, 1951, PHYTOPATHOLOGY, V41, P665; Almeida FBDR, 2007, BIOTECHNOL LETT, V29, P1189, DOI 10.1007/s10529-007-9372-z; Chavan S. P., 2011, Recent Research in Science and Technology, V3, P15; CHET I, 1981, MICROBIAL ECOL, V7, P29, DOI 10.1007/BF02010476; Chet I., 1997, MYCOTA 4 ENV MICROBI, P165; Chet I, 2009, P 5 INT C BIOP STAK; Chutima R, 2011, MYCORRHIZA, V21, P221, DOI 10.1007/s00572-010-0327-1; da Silva WL, 2012, PLANT DIS, V96, P1379, DOI 10.1094/PDIS-04-12-0343-PDN; Daodu T., 2000, ALOE VERA MIRACLE HE; DAVIS RH, 1989, J AM PODIAT MED ASSN, V79, P24, DOI 10.7547/87507315-79-1-24; DENNIS C, 1971, T BRIT MYCOL SOC, V57, P41, DOI 10.1016/S0007-1536(71)80078-5; Djeraba A, 2000, INT J IMMUNOPHARMACO, V22, P365, DOI 10.1016/S0192-0561(99)00091-0; Domsch K. H., 1980, COMPENDIUM SOIL FUNG, V2; Durell L.W, 1986, MYCOPATHOLOGY MYCOLO, V35, P138; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Ghildiyal A., 2008, Research Journal of Microbiology, V3, P559; Ghosh S. K., 2012, Agriculture and Biology Journal of North America, V3, P306, DOI 10.5251/abjna.2012.3.8.306.310; Ghosh S. K., 2002, Journal of Mycopathological Research, V40, P117; Ghosh S. K., 2000, Journal of Mycopathological Research, V38, P113; Ghosh S.K, 2017, INT J CURRENT RES, V5, P14; Ghosh SK, 2014, EUROPEAN J BIOTECHNO, V2, P37; Gveroska B., 2012, APPL TECHNOL INNOV, V7, P67, DOI [10.15208/ati.2012.9, DOI 10.15208/ATI.2012.9]; Harman GE, 1996, C BIOL CONTR CORN CO; HOWELL CR, 1988, PHYTOPATHOLOGY, V78, P1075, DOI 10.1094/Phyto-78-1075; HUMPHERSONJONES FM, 1989, ANN APPL BIOL, V114, P449, DOI 10.1111/j.1744-7348.1989.tb03360.x; Hussaini S. H., 1989, Plant Disease Research, V4, P105; Jogaiah S, 2017, MOL PLANT PATH; Jogaiah S, 2013, J EXP BOT, V64, P3829, DOI 10.1093/jxb/ert212; Kamalakannan A, 2008, AUSTRALAS PLANT DIS, V3, P110, DOI 10.1071/DN08044; Kullnig-Gradinger CM, 2002, MYCOL RES, V106, P757, DOI 10.1017/S0953756202006172; Laville J, 1998, J BACTERIOL, V180, P3187, DOI 10.1128/JB.180.12.3187-3196.1998; Meena M, 2017, ARCH PHYTOPATHOLOGY; Nagamani A., 2006, HDB SOIL FUNGI; Nagaraju A, 2012, AUSTRALAS PLANT PATH, V41, P609, DOI 10.1007/s13313-012-0165-z; Nallathambi P, 2009, CROP PROT, V28, P525, DOI 10.1016/j.cropro.2009.02.002; Olusegun A., 2000, ONE HUNDRED MED US A; Pandian RTP, 2016, INDIAN PHYTOPATHOL, V69, P303; PAPAVIZAS GC, 1985, ANNU REV PHYTOPATHOL, V23, P23, DOI 10.1146/annurev.py.23.090185.000323; Parkinson D., 1971, METHODS STUDYING ECO; Prabhakaran N, 2015, J ENVIRON BIOL, V36, P191; Pratibha Sharma, 2014, Indian Phytopathology, V67, P1; Ramette A, 2003, MOL PLANT MICROBE IN, V16, P525, DOI 10.1094/MPMI.2003.16.6.525; SAHNI M. L., 1967, INDIAN PHYTOPATHOL, V20, P71; Sinha P. P., 1989, Indian Journal of Mycology and Plant Pathology, V19, P204; Sitansu Pan, 1997, Journal of Mycopathological Research, V35, P153; Sudisha J, 2006, BIOL CONTROL, V37, P196, DOI 10.1016/j.biocontrol.2005.11.018; Tagaram N., 2015, IOSR J PHARM BIOLOGI, V10, P145; Topps JH, 1957, ANN APPL BIOL, V45, P506, DOI 10.1111/j.1744-7348.1957.tb05888.x; Ubalua AO, 2007, AFR J BIOTECHNOL, V6, P2447; VOISARD C, 1989, EMBO J, V8, P351, DOI 10.1002/j.1460-2075.1989.tb03384.x; WEI G, 1991, Phytopathology, V81, P1508, DOI 10.1094/Phyto-81-1508; Weindling R, 1934, PHYTOPATHOLOGY, V24, P1153; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; WINDHAM MT, 1986, PHYTOPATHOLOGY, V76, P518, DOI 10.1094/Phyto-76-518; World Health Organization (WHO), 1979, MYCOT ENV HLTH CRIT; Zimand G, 1996, PHYTOPATHOLOGY, V86, P1255, DOI 10.1094/Phyto-86-1255	63	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0193720	10.1371/journal.pone.0193720	http://dx.doi.org/10.1371/journal.pone.0193720			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579070	Green Published, gold, Green Submitted			2022-12-26	WOS:000428351800012
J	Gotsman, I; Shauer, A; Elizur, Y; Zwas, DR; Lotan, C; Keren, A				Gotsman, Israel; Shauer, Ayelet; Elizur, Yair; Zwas, Donna R.; Lotan, Chaim; Keren, Andre			Temporal changes in electrocardiographic frontal QRS-T angle and survival in patients with heart failure	PLOS ONE			English	Article							GENERAL-POPULATION; CARDIAC DEATH; MORTALITY; ASSOCIATION; SOCIETY; DISEASE; HEALTH; RISK	Background Heart failure (HF) is associated with considerable mortality. The electrocardiographic frontal QRS-T angle is a simple parameter to measure, reflects changes in the direction of the repolarization sequence and predicts outcome in patients with HF. Data regarding temporal changes in the frontal QRS-T angle in patients with HF and its impact on outcome is limited. Aim To evaluate temporal changes in the frontal QRS-T angle and its effect on survival in patients with HF. Methods Baseline and follow-up QRS-T angle were calculated from the frontal QRS and T axis of the 12-lead surface electrocardiogram. Patients were followed for survival. Results 2,929 HF patients were evaluated. Median interval between baseline ECG and follow-up ECG was 895 days, median follow-up time was 1526 days. Overall, the QRS-T angle tended to be stable, with minor changes in the angle over time. The median QRS-T angle change was +3 degrees (IQR-19 degrees to +30 degrees). Overall survival during follow-up was 60%. Cox regression analysis after adjustment for significant predictors demonstrated that the QRS-T angle was an incremental predictor of increased mortality. A widening of the QRS-T angle during followup was independently associated with an increase in mortality, evident with an increase of the QRS-T angle difference above 0 degrees (P<0.0001 for the adjusted model). Conclusion QRS-T angle is relatively stable in patients with HF and is a powerful predictor of outcome. Widening of the QRS-T angle has predictive value and is an ominous sign.	[Gotsman, Israel; Shauer, Ayelet; Elizur, Yair; Zwas, Donna R.; Lotan, Chaim; Keren, Andre] Hadassah Univ Hosp, Heart Inst, Heart Failure Ctr, Jerusalem, Israel; [Gotsman, Israel; Zwas, Donna R.; Keren, Andre] Clalit Hlth Serv, Heart Failure Clin, Jerusalem, Israel	Hebrew University of Jerusalem; Clalit Health Services	Gotsman, I (corresponding author), Hadassah Univ Hosp, Heart Inst, Heart Failure Ctr, Jerusalem, Israel.; Gotsman, I (corresponding author), Clalit Hlth Serv, Heart Failure Clin, Jerusalem, Israel.	igotsman@bezeqint.net	Gotsman, Israel/AAH-8833-2021	Gotsman, Israel/0000-0001-9608-2298				Aro AL, 2012, EUROPACE, V14, P872, DOI 10.1093/europace/eur393; Borleffs CJW, 2009, CIRC-ARRHYTHMIA ELEC, V2, P548, DOI 10.1161/CIRCEP.109.859108; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Gotsman I, 2012, EUR J HEART FAIL; Gotsman I, 2013, AM J CARDIOL, V111, P1452, DOI 10.1016/j.amjcard.2013.01.294; Gotsman I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041022; Kardys I, 2003, EUR HEART J, V24, P1357, DOI 10.1016/S0195-668X(03)00203-3; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Pavri BB, 2008, CIRCULATION, V117, P3181, DOI 10.1161/CIRCULATIONAHA.107.733451; Rautaharju PM, 2006, CIRCULATION, V113, P473, DOI 10.1161/CIRCULATIONAHA.104.496091; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Selvaraj S, 2014, J AM SOC ECHOCARDIOG, V27, P74, DOI 10.1016/j.echo.2013.08.023; Whang W, 2012, AM J CARDIOL, V109, P981, DOI 10.1016/j.amjcard.2011.11.027; Zhang ZM, 2007, AM J CARDIOL, V100, P844, DOI 10.1016/j.amjcard.2007.03.104	14	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194520	10.1371/journal.pone.0194520	http://dx.doi.org/10.1371/journal.pone.0194520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579123	Green Submitted, gold, Green Published			2022-12-26	WOS:000428351800034
J	Kayadjanian, N; Schwartz, L; Farrar, E; Comtois, KA; Strong, TV				Kayadjanian, Nathalie; Schwartz, Lauren; Farrar, Evan; Comtois, Katherine Anne; Strong, Theresa V.			High levels of caregiver burden in Prader-Willi syndrome	PLOS ONE			English	Article							GROWTH-HORMONE THERAPY; QUALITY-OF-LIFE; MALADAPTIVE BEHAVIOR; FRAGILE-X; CHILDREN; PARENTS; DISABILITIES; INTERVIEW; METAANALYSIS; CHILDHOOD	Objectives Prader-Willi syndrome (PWS) is a rare genetic neurodevelopmental disorder that is characterized by hyperphagia, developmental delay, incomplete sexual development, mild-to moderate intellectual disability, and a variety of challenging behavioral and psychiatric symptoms. The characteristics of PWS can be difficult for caregivers to cope with and are likely to cause significant and long-term caregiver burden. The current study examined burden in 142 caregivers of children and adults with PWS living in the US using the Zarit Burden Interview (ZBI). The study aimed to measure the level of burden in caregivers of individuals with PWS, to explore the impact of PWS on caregiver quality of life, and to assess ZBI as an indicator of that impact. Results Caregivers participating in this study were predominantly mothers, 30-59 years old, non Hispanic Whites, married or in a relationship, with an annual household income slightly distributed towards higher income. Nearly 90% of the caregiver's children with PWS lived at home. Caregivers experienced high caregiver burden with an average ZBI score of 44.4 15.4. ZBI scores were highest for caregivers of teenage and young adult individuals with PWS (49.2 +/- 14.6 and 49.2 +/- 14.1, respectively), while those caring for older adults (>30) and the youngest age group had lower scores (38.6 +/- 10.5 and 34.8 +/- 12.5, respectively). Caregivers reported that caring for a person with PWS negatively impacted their romantic relationship, ability to work, sleep, and mood. Whereas we did not find strong correlations between family income or level of help the caregiver receives and ZBI scores, the results showed significant correlations and a linear relationship between ZBI scores and caregiver depressed mood, feelings of anxiety, negative romantic relationship impact, as well as sleep and work disruption. Conclusions Our study reveals that PWS incurs high caregiver burden and impacts many aspects of the lives of caregiver. We identified the ZBI as a good predictor of that impact. Our findings draw attention to the critical unmet need for support for caregivers of individuals with PWS.	[Kayadjanian, Nathalie; Schwartz, Lauren; Strong, Theresa V.] Fdn Prader Willi Res, Walnut, CA 91789 USA; [Kayadjanian, Nathalie; Schwartz, Lauren; Farrar, Evan; Strong, Theresa V.] PWS Clin Trial Consortium, Walnut, CA 91789 USA; [Schwartz, Lauren] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Farrar, Evan] Prader Willi Syndrome Assoc USA, Sarasota, FL USA; [Comtois, Katherine Anne] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Strong, Theresa V.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Alabama System; University of Alabama Birmingham	Kayadjanian, N (corresponding author), Fdn Prader Willi Res, Walnut, CA 91789 USA.; Kayadjanian, N (corresponding author), PWS Clin Trial Consortium, Walnut, CA 91789 USA.	nathalie.kayadjanian@fpwr.org	Strong, Theresa/GSM-6652-2022	Strong, Theresa/0000-0001-6783-8703	PWS-Clinical Trial Consortium	PWS-Clinical Trial Consortium	The study was funded by the PWS-Clinical Trial Consortium (www.pwsctc.org) who provided support in the form of publication costs, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Beach SR, 2005, J AM GERIATR SOC, V53, P255, DOI 10.1111/j.1532-5415.2005.53111.x; Bello-Mojeed M.A., 2013, OA AUTISM, V1, P4; Boer H, 2002, LANCET, V359, P135, DOI 10.1016/S0140-6736(02)07340-3; Butler JV, 2010, DEV MED CHILD NEUROL, V52, pE88, DOI 10.1111/j.1469-8749.2009.03530.x; Cadman T, J AM ACAD CHILD ADOL, V51, P879; Clarke DJ, 1996, J INTELL DISABIL RES, V40, P159, DOI 10.1046/j.1365-2788.1996.743743.x; Deal CL, 2013, J CLIN ENDOCR METAB, V98, pE1072, DOI 10.1210/jc.2012-3888; Driscoll DJ, 1993, GENEREVIEWS R; Ducharme F, 2014, BMC NURS, V13, DOI 10.1186/s12912-014-0049-3; Dykens EM, 2007, OBESITY, V15, P1816, DOI 10.1038/oby.2007.216; DYKENS EM, 1992, J AM ACAD CHILD PSY, V31, P1131, DOI 10.1097/00004583-199211000-00023; Dykens EM, 1995, AM J MED GENET, V60, P546, DOI 10.1002/ajmg.1320600612; Einfeld SL, 2006, AM J MENT RETARD, V111, P193, DOI 10.1352/0895-8017(2006)111[193:MIPS]2.0.CO;2; Etnfeld S, 1999, J INTELLECT DEV DIS, V24, P349; Eysenbach G, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.2.e13; Hebert R, 2000, CAN J AGING, V19, P494, DOI 10.1017/S0714980800012484; Hodapp RM, 1997, J AUTISM DEV DISORD, V27, P11, DOI 10.1023/A:1025865004299; King G, 1999, J PEDIATR PSYCHOL, V24, P41, DOI 10.1093/jpepsy/24.1.41; Lanfranchi S, 2012, AJIDD-AM J INTELLECT, V117, P207, DOI 10.1352/1944-7558-117.3.207; Lingler JH, 2005, J AM GERIATR SOC, V53, P983, DOI 10.1111/j.1532-5415.2005.53313.x; Lopez-Bastida B, 2016, EUR J HEALTH ECON, V17, P99, DOI 10.1007/s10198-016-0788-z; Lopez-Wagner MC, 2008, J GENET PSYCHOL, V169, P245, DOI 10.3200/GNTP.169.3.245-260; Mazaheri MM, 2013, J INTELL DISABIL RES, V57, P861, DOI 10.1111/j.1365-2788.2012.01634.x; Miller JL, 2011, AM J MED GENET A, V155A, P1040, DOI 10.1002/ajmg.a.33951; Mohamed S, 2010, AM J GERIAT PSYCHIAT, V18, P917, DOI 10.1097/JGP.0b013e3181d5745d; Parish SL, 2004, MENT RETARD, V42, P413, DOI 10.1352/0047-6765(2004)42<413:EIOCAM>2.0.CO;2; Rice LJ, 2015, AM J MED GENET C, V169, P182, DOI 10.1002/ajmg.c.31442; Richdale AL, 1999, J INTELL DISABIL RES, V43, P380, DOI 10.1046/j.1365-2788.1999.043005380.x; Sanchez-Ortiga R, 2012, CLIN ENDOCRINOL, V77, P86, DOI 10.1111/j.1365-2265.2011.04303.x; Schoenmakers B, 2009, FAM PRACT, V26, P279, DOI 10.1093/fampra/cmp024; Schreiner AS, 2006, AGING MENT HEALTH, V10, P107, DOI 10.1080/13607860500312142; Schwartz L, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0504-1; Shearn J, 2000, J APPL RES INTELLECT, V13, P109, DOI 10.1046/j.1468-3148.2000.00021.x; Siegert RJ, 2010, J REHABIL MED, V42, P302, DOI 10.2340/16501977-0511; Sinnema M, 2011, RES DEV DISABIL, V32, P604, DOI 10.1016/j.ridd.2010.12.014; Skokauskas N, 2012, J CAN ACAD CHILD ADO, V21, P194; Stabile M, 2012, FUTURE CHILD, V22, P65; van den Borne HW, 1999, PATIENT EDUC COUNS, V38, P205, DOI 10.1016/S0738-3991(99)00004-X; WHITMAN BY, 1987, AM J MED GENET, V28, P897, DOI 10.1002/ajmg.1320280415; Williams VSL, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-57; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072640; YOUNG RF, 1989, GERONTOLOGIST, V29, P660, DOI 10.1093/geront/29.5.660; Zammit GK, 1999, SLEEP, V22, pS379; Zarit S. H., 1990, MEMORY BEHAV PROBLEM; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	45	35	35	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194655	10.1371/journal.pone.0194655	http://dx.doi.org/10.1371/journal.pone.0194655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5DH	29579119	Green Submitted, gold, Green Published			2022-12-26	WOS:000428351800042
J	Medrano-Soto, A; Moreno-Hagelsieb, G; McLaughlin, D; Ye, ZS; Hendargo, KJ; Saier, MH				Medrano-Soto, Arturo; Moreno-Hagelsieb, Gabriel; McLaughlin, Daniel; Ye, Zachary S.; Hendargo, Kevin J.; Saier, Milton H., Jr.			Bioinformatic characterization of the Anoctamin Superfamily of Ca2+-activated ion channels and lipid scramblases	PLOS ONE			English	Article							TMEM16 PROTEIN FAMILY; CHLORIDE CHANNEL; CRYSTAL-STRUCTURE; PHYLOGENETIC CHARACTERIZATION; SECONDARY CARRIERS; CALCIUM; TRANSPORT; SEQUENCE; TOPOLOGY; ACTIVATION	Our laboratory has developed bioinformatic strategies for identifying distant phylogenetic relationships and characterizing families and superfamilies of transport proteins. Results using these tools suggest that the Anoctamin Superfamily of cation and anion channels, as well as lipid scramblases, includes three functionally characterized families: the Anoctamin (ANO), Transmembrane Channel (TMC) and Ca2+-permeable Stress-gated Cation Channel (CSC) families; as well as four families of functionally uncharacterized proteins, which we refer to as the Anoctamin-like (ANO-L), Transmembrane Channel-like (TMC-L), and CSC like (CSC-L1 and CSC-L2) families. We have constructed protein clusters and trees showing the relative relationships among the seven families. Topological analyses suggest that the members of these families have essentially the same topologies. Comparative examination of these homologous families provides insight into possible mechanisms of action, indicates the currently recognized organismal distributions of these proteins, and suggests drug design potential for the disease-related channel proteins.	[Medrano-Soto, Arturo; McLaughlin, Daniel; Ye, Zachary S.; Hendargo, Kevin J.; Saier, Milton H., Jr.] Univ Calif San Diego, Dept Mol Biol, La Jolla, CA 92093 USA; [Moreno-Hagelsieb, Gabriel] Wilfrid Laurier Univ, Dept Biol, Waterloo, ON, Canada	University of California System; University of California San Diego; Wilfrid Laurier University	Saier, MH (corresponding author), Univ Calif San Diego, Dept Mol Biol, La Jolla, CA 92093 USA.	msaier@ucsd.edu	Medrano-Soto, Arturo/ABC-1969-2020; Medrano-Soto, Arturo/AAU-7223-2020	Medrano-Soto, Arturo/0000-0002-6095-3829; Saier, Milton/0000-0001-5530-0017; Moreno-Hagelsieb, Gabriel/0000-0002-2457-4450	NIH [GM077402]; NSF [IOS-1444435]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077402] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM077402 and NSF grant IOS-1444435. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Askew C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1996; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Bethel NP, 2016, P NATL ACAD SCI USA, V113, P14049, DOI 10.1073/pnas.1607574113; Betto G, 2014, J GEN PHYSIOL, V143, P703, DOI 10.1085/jgp.201411182; Bevers EM, 2016, PHYSIOL REV, V96, P605, DOI 10.1152/physrev.00020.2015; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Brunner JD, 2016, CURR OPIN STRUC BIOL, V39, P61, DOI 10.1016/j.sbi.2016.05.020; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cha JY, 2015, P NATL ACAD SCI USA, V112, P9722, DOI 10.1073/pnas.1423827112; Chang AB, 2004, MOL MEMBR BIOL, V21, P171, DOI 10.1080/09687680410001720830; Chatzigeorgiou M, 2013, NATURE, V494, P95, DOI 10.1038/nature11845; Chen JS, 2011, J MOL MICROB BIOTECH, V21, P83, DOI 10.1159/000334611; Chun H, 2015, CELL CALCIUM, V58, P431, DOI 10.1016/j.ceca.2015.06.011; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Dobson L, 2015, NUCLEIC ACIDS RES, V43, pW408, DOI 10.1093/nar/gkv451; Duran C, 2011, ACTA PHARMACOL SIN, V32, P685, DOI 10.1038/aps.2011.48; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Feenstra B, 2014, NAT GENET, V46, P1274, DOI 10.1038/ng.3129; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Galietta LJV, 2009, BIOPHYS J, V97, P3047, DOI 10.1016/j.bpj.2009.09.024; Hahn Y, 2009, INT J MOL MED, V24, P51, DOI 10.3892/ijmm_00000205; Hammer C, 2015, MOL MED, V21, DOI 10.2119/molmed.2014.00219; Han JH, 2015, J PERIODONTAL IMPLAN, V45, P69, DOI 10.5051/jpis.2015.45.2.69; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Harvat EM, 2005, J BIOL CHEM, V280, P12028, DOI 10.1074/jbc.M414368200; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Holt JR, 2014, HEARING RES, V311, P17, DOI 10.1016/j.heares.2014.01.001; Horton JS, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28288; Hou CC, 2014, CELL RES, V24, P632, DOI 10.1038/cr.2014.14; Hvorup RN, 2002, MICROBIOL-SGM, V148, P3760, DOI 10.1099/00221287-148-12-3760; Jeng G, 2016, J GEN PHYSIOL, V148, P393, DOI 10.1085/jgp.201611651; Jiang T., 2017, ELIFE, V6; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keresztes G, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-24; Kim KX, 2013, J GEN PHYSIOL, V141, P141, DOI 10.1085/jgp.201210913; KIYOSUE T, 1994, PLANT PHYSIOL, V106, P1707, DOI 10.1104/pp.106.4.1707; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kunzelmann K, 2015, TRENDS BIOCHEM SCI, V40, P535, DOI 10.1016/j.tibs.2015.07.005; Kurima K, 2003, GENOMICS, V82, P300, DOI 10.1016/S0888-7543(03)00154-X; Labay V, 2010, BIOCHEMISTRY-US, V49, P8592, DOI 10.1021/bi1004377; Lam VH, 2011, BIOL CHEM, V392, P5, DOI 10.1515/BC.2011.018; Lee BC, 2016, BIOPHYS J, V111, P1919, DOI 10.1016/j.bpj.2016.09.032; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Lloyd D, 2014, MOL BIOCHEM PARASIT, V197, P43, DOI 10.1016/j.molbiopara.2014.10.002; Ma K, 2017, J CELL PHYSIOL, V232, P707, DOI 10.1002/jcp.25621; Maniero Carmela, 2015, Lancet, V385 Suppl 1, pS62, DOI 10.1016/S0140-6736(15)60377-4; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Nelson R D, 1999, J Mol Microbiol Biotechnol, V1, P281; O'Driscoll KE, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-35; Oh U, 2016, PFLUG ARCH EUR J PHY, V468, P443, DOI 10.1007/s00424-016-1790-0; Ousingsawat J, 2015, J BIOL CHEM, V290, P6270, DOI 10.1074/jbc.M114.602979; Ousingsawat J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7245; Pan BF, 2013, NEURON, V79, P504, DOI 10.1016/j.neuron.2013.06.019; Pang CL, 2014, PROTEIN PEPTIDE LETT, V21, P94; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Paulino C, 2017, NATURE, V552, P421, DOI 10.1038/nature24652; Paulino C, 2017, ELIFE, V6, DOI 10.7554/eLife.26232; PEARSON WR, 1991, GENOMICS, V11, P635, DOI 10.1016/0888-7543(91)90071-L; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Pedersen BP, 2013, NATURE, V496, P533, DOI 10.1038/nature12042; Picollo A, 2015, J MOL BIOL, V427, P94, DOI 10.1016/j.jmb.2014.09.028; Pifferi S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169572; Reddy VS, 2012, FEBS J, V279, P2036, DOI 10.1111/j.1742-4658.2012.08590.x; Reddy VS, 2012, FEBS J, V279, P2022, DOI 10.1111/j.1742-4658.2012.08588.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Saier MH, 2016, CURR OPIN STRUC BIOL, V38, P9, DOI 10.1016/j.sbi.2016.05.001; Sanders KM, 2012, EXP PHYSIOL, V97, P200, DOI 10.1113/expphysiol.2011.058248; Savarese M, 2015, NEUROMUSCULAR DISORD, V25, P533, DOI 10.1016/j.nmd.2015.03.011; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Segawa K, 2011, P NATL ACAD SCI USA, V108, P19246, DOI 10.1073/pnas.1114799108; Seo Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133656; Silveira JC, 2015, CURR OPIN ENDOCRINOL, V22, P374, DOI 10.1097/MED.0000000000000188; Sirianant L, 2014, CELL SIGNAL, V26, P2826, DOI 10.1016/j.cellsig.2014.09.001; Stehlikova K, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0154-7; Steuber J, 2014, NATURE, V516, P62, DOI 10.1038/nature14003; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; ten Dam L, 2014, NEUROMUSCULAR DISORD, V24, P1097, DOI 10.1016/j.nmd.2014.07.004; Terashima H, 2013, P NATL ACAD SCI USA, V110, P19354, DOI 10.1073/pnas.1312014110; Tian YM, 2011, FASEB J, V25, P1058, DOI 10.1096/fj.10-166884; Tien J, 2014, ELIFE, V3, DOI 10.7554/eLife.02772; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Twyffels L, 2014, AM J PHYSIOL-CELL PH, V307, pC1102, DOI 10.1152/ajpcell.00126.2014; Vastermark A, 2015, PROTEINS, V83, P735, DOI 10.1002/prot.24755; Vastermark A, 2014, J MOL MICROB BIOTECH, V24, P82, DOI 10.1159/000358429; Vastermark A, 2014, P NATL ACAD SCI USA, V111, pE1162, DOI 10.1073/pnas.1400016111; Vermeer S, 2010, AM J HUM GENET, V87, P813, DOI 10.1016/j.ajhg.2010.10.015; Wadskog I, 2006, MOL BIOL CELL, V17, P4988, DOI 10.1091/mbc.E05-08-0798; Wang B, 2009, J MEMBRANE BIOL, V231, P1, DOI 10.1007/s00232-009-9200-6; Wassner AJ, 2015, CURR OPIN ENDOCRINOL, V22, P407, DOI 10.1097/MED.0000000000000181; Whitlock JM, 2017, ANNU REV PHYSIOL, V79, P119, DOI 10.1146/annurev-physiol-022516-034031; Whitlock JM, 2016, PFLUG ARCH EUR J PHY, V468, P455, DOI 10.1007/s00424-015-1777-2; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Witting N, 2012, MUSCLE NERVE, V46, P829, DOI 10.1002/mus.23440; Wong WC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000867; Xiao QH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099376; Xu J, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0069-z; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yee DC, 2013, FEBS J, V280, P5780, DOI 10.1111/febs.12499; Yen MR, 2010, METHODS MOL BIOL, V637, P47, DOI 10.1007/978-1-60761-700-6_3; Yen MR, 2009, J MOL MICROB BIOTECH, V17, P163, DOI 10.1159/000239667; Yu K, 2014, J GEN PHYSIOL, V143, P253, DOI 10.1085/jgp.201311047; Yu K, 2012, CIRC RES, V110, P990, DOI 10.1161/CIRCRESAHA.112.264440; Yu YW, 2015, J GEN PHYSIOL, V145, P79, DOI 10.1085/jgp.201411294; Yu YW, 2014, J GEN PHYSIOL, V144, P113, DOI 10.1085/jgp.201411179; Zhai YF, 2001, J MOL MICROB BIOTECH, V3, P285; Zhang SH, 2014, J THEOR BIOL, V355, P229, DOI 10.1016/j.jtbi.2014.04.004; Zhao Y, 2014, STRUCTURE, V22, P1152, DOI 10.1016/j.str.2014.06.008; Zheng WH, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-98	120	33	33	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0192851	10.1371/journal.pone.0192851	http://dx.doi.org/10.1371/journal.pone.0192851			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579047	Green Published, Green Accepted, gold			2022-12-26	WOS:000428351800007
J	Vilson, A; Ramadan, Z; Li, QH; Hedhammar, A; Reynolds, A; Spears, J; Labuda, J; Pelker, R; Bjorksten, B; Dicksved, J; Hansson-Hamlin, H				Vilson, Asa; Ramadan, Ziad; Li, Qinghong; Hedhammar, Ake; Reynolds, Arleigh; Spears, Julie; Labuda, Jeff; Pelker, Robyn; Bjorksten, Bengt; Dicksved, Johan; Hansson-Hamlin, Helene			Disentangling factors that shape the gut microbiota in German Shepherd dogs	PLOS ONE			English	Article							FECAL MICROBIOTA; INTESTINAL MICROBIOTA; IMMUNE-SYSTEM; HEALTHY DOGS; CATS; BACTERIAL; LIFE; SUPPLEMENTATION; MICROFLORA; PREGNANCY	The aim of this study was to explore the development of the gut microbiota in 168 German Shepherd dogs (30 litters) from 7 weeks to 18 months of age and furthermore, to study the effect of relatedness, maternal microbiota composition and living environment in a large and well-defined population of dogs. Using 454 pyrosequencing, we assessed the effects of preand postnatal probiotic supplementation (Lactobacillus johnsonii NCC533 (La1)) and analysed whether administration of the probiotic strain influenced fecal microbiota composition in a placebo controlled double-blinded study. The bitches were treated with probiotics or placebo during last trimester of pregnancy and until their puppies were 8 weeks old, the puppies received the same treatment as their mothers between 3 +/- 12 weeks of age. Samples from bitches were collected at pregnancy day 42, partum, 4 weeks postpartum and 7 weeks postpartum and from puppies at the age 4 weeks, 7 weeks, 12 +/- 13 months and 15 +/- 18 months. Serum IgA, total serum IgE, fecal IgA and IgG antibody responses against canine distemper virus were analysed by ELISA in order to detect any immune stimulating effects of the probiotic strain. Analysis of the fecal microbiota composition showed that the predominant phyla were the same in 7 weeks old puppies as in pregnant and lactating bitches (Firmicutes, Fusobacteria, Bacteroidetes). Proportions among different bacteria as well as diversity varied from 7 weeks old puppies up to 15 +/- 18 months of age. Litter mates had a more similar fecal microbiota compared to unrelated dogs and 7 weeks old puppies were more similar to their mothers than to unrelated bitches at 7 weeks postpartum but not at partum. We observed a change in the relative abundance of different bacteria during lactation, and an increase in diversity from pregnancy to end of lactation. The microbial diversity was affected by living area where dogs living in big cities had higher diversity compared to dogs living at the countryside. However, we were not able to demonstrate an effect by pre and postnatal exposure to Lactobacillus johnsonii NCC533 (La1) upon the diversity or composition of the microbiota or the levels of serum IgA, total serum IgE, fecal IgA or vaccine response. Our findings provide a better understanding of the canine fecal microbiota in growing dogs as well as in pregnant and lactating bitches. This information forms a basis for further research on the connection between early gut colonization and immune function later in life.	[Vilson, Asa; Hedhammar, Ake; Hansson-Hamlin, Helene] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Ramadan, Ziad; Li, Qinghong; Reynolds, Arleigh; Spears, Julie; Labuda, Jeff; Pelker, Robyn] Nestle Purina Res, One Checkerboard Sq, St Louis, MO USA; [Bjorksten, Bengt] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Dicksved, Johan] Swedish Univ Agr Sci, Dept Anim Nutr & Management, Uppsala, Sweden	Swedish University of Agricultural Sciences; Nestle SA; Karolinska Institutet; Swedish University of Agricultural Sciences	Vilson, A (corresponding author), Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden.	asa.vilson@ostersundsdjursjukhus.se		Dicksved, Johan/0000-0002-7515-4480; Hamlin, Helene/0000-0002-8015-4688; Li, Qinghong/0000-0002-2584-6024; Hedhammar, Ake/0000-0001-7048-3851	Nestle Purina PetCare; Nestec S.A.	Nestle Purina PetCare(Nestle SA); Nestec S.A.	This work was supported by the Nestle Purina PetCare (https://www.purina.com/). The study was financed by Nestec S.A. and several authors were employees of Nestec S.A. when the study was conducted. The funder/employer had a role in study design, data analysis, decision to publish, and preparation of the manuscript.	Bates D., 2012, IME4 LINEAR MIXED EF; BENNO Y, 1992, J VET MED SCI, V54, P703, DOI 10.1292/jvms.54.703; Benyacoub J, 2003, J NUTR, V133, P1158, DOI 10.1093/jn/133.4.1158; Bjorksten B, 2001, J ALLERGY CLIN IMMUN, V108, P516, DOI 10.1067/mai.2001.118130; Bjorksten B, 2009, CURR OPIN ALLERGY CL, V9, P185, DOI 10.1097/ACI.0b013e32832abfc2; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carrothers JM, 2015, J NUTR, V145, P2379, DOI 10.3945/jn.115.211110; Dicksved J, 2007, APPL ENVIRON MICROB, V73, P2284, DOI 10.1128/AEM.02223-06; Donnet-Hughes A, 2010, P NUTR SOC, V69, P407, DOI 10.1017/S0029665110001898; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Fuller R., 1986, PROBIOTICS SOC APPL, V15, p1S; Garcia-Mazcorro JF, 2012, MICROBIOLOGYOPEN, V1, P340, DOI 10.1002/mbo3.36; Garcia-Mazcorro JF, 2011, FEMS MICROBIOL ECOL, V78, P542, DOI 10.1111/j.1574-6941.2011.01185.x; Hand D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053115; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; Hesla HM, 2014, FEMS MICROBIOL ECOL, V90, P791, DOI 10.1111/1574-6941.12434; Hooda Seema, 2012, Animal Health Research Reviews, V13, P78, DOI 10.1017/S1466252312000059; Inoue R, 2007, BRIT J DERMATOL, V156, P499, DOI 10.1111/j.1365-2133.2006.07695.x; Jost T, 2014, ENVIRON MICROBIOL, V16, P2891, DOI 10.1111/1462-2920.12238; Jost T, 2014, CURR MICROBIOL, V68, P419, DOI 10.1007/s00284-013-0491-6; Kaburagi T, 2007, NUTRITION, V23, P342, DOI 10.1016/j.nut.2007.02.001; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Martin R, 2010, VET J, V185, P193, DOI 10.1016/j.tvjl.2009.04.014; Martinez I, 2015, CELL REP, V11, P527, DOI 10.1016/j.celrep.2015.03.049; Middelbos IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009768; Perez PF, 2007, PEDIATRICS, V119, pE724, DOI 10.1542/peds.2006-1649; Prescott SL, 2007, J ALLERGY CLIN IMMUN, V120, P255, DOI 10.1016/j.jaci.2007.04.027; Ramadan Z, 2014, J VET INTERN MED, V28, P59, DOI 10.1111/jvim.12261; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Roos S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056710; Sanchez M, 2014, BRIT J NUTR, V111, P1507, DOI 10.1017/S0007114513003875; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Suchodolski JS, 2011, VET CLIN N AM-SMALL, V41, P261, DOI 10.1016/j.cvsm.2010.12.006; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Vilson A, 2013, VET REC, P173	37	21	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2018	13	3							e0193507	10.1371/journal.pone.0193507	http://dx.doi.org/10.1371/journal.pone.0193507			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA2QK	29570709	Green Published, gold, Green Submitted			2022-12-26	WOS:000428168400004
J	Chang, JS; Ha, K				Chang, Ji Suk; Ha, Kyoungsoo			A truncated PPAR gamma 2 localizes to mitochondria and regulates mitochondrial respiration in brown adipocytes	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; BINDING PROTEIN CREB; ADIPOSE-TISSUE; STRUCTURAL ORGANIZATION; GENE-EXPRESSION; COMPLEX-I; NT-PGC-1-ALPHA; TRANSCRIPTION; PPAR-GAMMA-2; GENOME	Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a key regulator of brown adipocyte differentiation and thermogenesis. The PPAR gamma gene produces two isoforms, PPAR gamma 1 and PPAR gamma 2. PPAR gamma 2 is identical to PPAR gamma 1 except for additional 30 amino acids present in the N-terminus of PPAR gamma 2. Here we report that the C-terminally truncated form of PPAR gamma 2 is predominantly present in the mitochondrial matrix of brown adipocytes and that it binds to the D-loop region of mitochondrial DNA (mtDNA), which contains the promoter for mitochondrial electron transport chain (ETC) genes. Expression of mitochondrially targeted MLS-PPAR gamma 2 in brown adipocytes increases mtDNA-encoded ETC gene expression concomitant with enhanced mitochondrial respiration. These results suggest that direct regulation of mitochondrially encoded ETC gene expression by mitochondrial PPAR gamma 2, in part, underlies the isoform-specific role for PPAR gamma 2 in brown adipocytes.	[Chang, Ji Suk; Ha, Kyoungsoo] Pennington Biomed Res Ctr, Lab Gene Regulat & Metab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Chang, JS (corresponding author), Pennington Biomed Res Ctr, Lab Gene Regulat & Metab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	jisuk.chang@pbrc.edu	Chang, Ji Suk/N-1957-2017		National Institute of Diabetes and Digestive and Kidney Diseases [R01DK104748]; NIH [P30-DK072476]; National Institutes of Health [NIH8 1P30GM118430-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104748, P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103528, P30GM118430] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by R01DK104748, National Institute of Diabetes and Digestive and Kidney Diseases https://www.niddk.nih.gov/; NIH P30-DK072476, Dr. Ji Suk Chang National Institute of Diabetes and Digestive and Kidney Diseases; NIH8 1P30GM118430-01, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200; BIGLER J, 1988, MOL CELL BIOL, V8, P4155, DOI 10.1128/MCB.8.10.4155; Bourges I, 2004, BIOCHEM J, V383, P491, DOI 10.1042/BJ20040256; Casas F, 1999, MOL CELL BIOL, V19, P7913; Casas F, 2000, FEBS LETT, V478, P4, DOI 10.1016/S0014-5793(00)01814-7; Casas F, 2003, FASEB J, V17, P426, DOI 10.1096/fj.02-0732com; Chang JS, 2017, J BIOL CHEM, V292, P9958, DOI 10.1074/jbc.M117.778373; Chang JS, 2010, J BIOL CHEM, V285, P18039, DOI 10.1074/jbc.M109.083121; Commins SP, 1999, ENDOCRINOLOGY, V140, P292, DOI 10.1210/en.140.1.292; Dai QS, 2013, MOL ENDOCRINOL, V27, P741, DOI 10.1210/me.2012-1292; De Rasmo D, 2009, FEBS J, V276, P4325, DOI 10.1111/j.1742-4658.2009.07133.x; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; Jun HJ, 2014, DIABETES, V63, P3615, DOI 10.2337/db13-1837; Kim J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159990; Lee J, 2005, J BIOL CHEM, V280, P40398, DOI 10.1074/jbc.C500140200; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Macias E, 2014, J INVEST DERMATOL; Nedergaard J, 2005, BBA-MOL BASIS DIS, V1740, P293, DOI 10.1016/j.bbadis.2005.02.003; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Psarra AMG, 2008, IUBMB LIFE, V60, P210, DOI 10.1002/iub.37; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Ryu H, 2005, P NATL ACAD SCI USA, V102, P13915, DOI 10.1073/pnas.0502878102; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; She H, 2011, J CLIN INVEST, V121, P930, DOI 10.1172/JCI43871; Siersbaek MS, 2012, MOL CELL BIOL, V32, P3452, DOI 10.1128/MCB.00526-12; Szczepanek K, 2011, J BIOL CHEM, V286, P29610, DOI 10.1074/jbc.M111.226209; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Thuillier P, 1998, J LIPID RES, V39, P2329; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Umemoto T, 2012, GENES CELLS, V17, P576, DOI 10.1111/j.1365-2443.2012.01607.x; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; von Knethen A, 2010, J CELL SCI, V123, P192, DOI 10.1242/jcs.055475; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101; Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556; Zhou ZQ, 2012, BIOCHEM BIOPH RES CO, V427, P305, DOI 10.1016/j.bbrc.2012.09.047; Zhou ZQ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011056; ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921	41	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0195007	10.1371/journal.pone.0195007	http://dx.doi.org/10.1371/journal.pone.0195007			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566074	Green Submitted, Green Published, gold			2022-12-26	WOS:000428093900124
J	Holmes, HL; Wilson, B; Goerger, JP; Silverberg, JL; Cohen, I; Zipfel, WR; Fortier, LA				Holmes, Hannah L.; Wilson, Brooke; Goerger, Julian P.; Silverberg, Jesse L.; Cohen, Itai; Zipfel, Warren R.; Fortier, Lisa A.			Facilitated recruitment of mesenchymal stromal cells by bone marrow concentrate and platelet rich plasma	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; DOUBLE-BLIND; GROWTH-FACTOR; STEM-CELLS; KNEE OSTEOARTHRITIS; CHEMOTAXIS; INJECTION; ASPIRATE; RESPONSES; TRACKING	Background Biologics containing growth factors are frequently used to enhance healing after musculoskeletal injuries. One mechanism of action is thought to be though the ability of biologics to induce homing and migration of endogenous mesenchymal stromal cells (MSCs) to a target tissue. However, the ability of biologics to stimulate chemotaxis (directed migration of cells) and chemokinesis (increase rate of cell migration) of MSCs is unknown. Hypothesis/Purpose The aim of this study was to directly compare the ability of biologics including platelet rich plasma (PRP) and bone marrow concentrate (BMC) to induce MSC migration. The hypothesis was that leukocyte-low platelet rich plasma (L-lo PRP) would induce migration to a greater extent than leukocyte-high platelet rich plasma (L-hi PRP) or BMC. Methods Bone marrow-derived MSCs were isolated from 8 horses. Migration of MSCs toward a biologic (BMC, L-lo PRP, and L-hi PRP) or the positive control platelet derived growth factor (PDGF) was continuously traced and measured for 24hrs using time-lapse microscopy and a microfluidics device. Cell migration, chemotaxis and chemokinesis were determined by measurements of displacement, number of cells migrated, and cell flux. Results All biologics resulted in a significantly greater percentage of MSCs migrated compared to the positive control (PDGF). MSCs migrated further toward BMC compared to L-lo PRP. Cell migration, measured as cell flux, was greater toward BMC and L-hi PRP than L-lo PRP. Conclusion The biologics BMC and L-hi PRP elicit greater chemotaxis and chemokinesis of MSCs than L-lo PRP. However, all biologics recruited the same number of MSCs suggesting that differences in other regenerative effects, such as growth factor concentration, between biologics should be strongly considered when choosing a biologic for treatment of musculoskeletal injuries. The results of this study have the potential to reduce the need, risks, and costs associated with MSC culture and delivery.	[Holmes, Hannah L.; Wilson, Brooke; Fortier, Lisa A.] Cornell Univ, Dept Clin Sci, Ithaca, NY 14850 USA; [Goerger, Julian P.; Zipfel, Warren R.] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA; [Silverberg, Jesse L.; Cohen, Itai] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Fortier, LA (corresponding author), Cornell Univ, Dept Clin Sci, Ithaca, NY 14850 USA.	laf4@cornell.edu		Cohen, Itai/0000-0001-9218-043X; Fortier, Lisa/0000-0003-1072-5059	Harry M. Zweig Fund for Equine Research (LAF); NIH grant [T32RR018269]; Empire State Stem Cell Fund through New York State Department of Health [C028097]	Harry M. Zweig Fund for Equine Research (LAF); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Empire State Stem Cell Fund through New York State Department of Health	The study was funded by the Harry M. Zweig Fund for Equine Research (LAF). Brooke Wilson was supported by NIH grant T32RR018269. Hannah Holmes was supported by the Empire State Stem Cell Fund through New York State Department of Health Contract # C028097. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Lisa Fortier is a consultant to Arthrex, Inc. who makes PRP. Arthrex, Inc. did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Barrick B, 1999, WOUND REPAIR REGEN, V7, P410, DOI 10.1046/j.1524-475X.1999.00410.x; Behar TN, 1996, J NEUROSCI, V16, P1808; Betsch M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071602; Cassano JM, 2018, KNEE SURG SPORT TR A, V26, P333, DOI 10.1007/s00167-016-3981-9; Centeno CJ, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0714-z; Cheng NC, 2012, BIOMATERIALS, V33, P1748, DOI 10.1016/j.biomaterials.2011.11.049; Choi D, 2017, CHEM MATER, V29, P2055, DOI 10.1021/acs.chemmater.6b04096; Cole BJ, 2017, AM J SPORT MED, V45, P339, DOI 10.1177/0363546516665809; de Witte SFH, 2018, STEM CELLS; Docheva D, 2015, ADV DRUG DELIVER REV, V84, P222, DOI 10.1016/j.addr.2014.11.015; Duygulu F, 2012, ACTA ORTHOP TRAUMATO, V46, P61, DOI 10.3944/AOTT.2012.2762; Gomes JLE, 2012, KNEE SURG SPORT TR A, V20, P373, DOI 10.1007/s00167-011-1607-9; Fong ELS, 2011, BIOMATERIALS, V32, P395, DOI 10.1016/j.biomaterials.2010.08.101; Fortier LA, 2011, CLIN ORTHOP RELAT R, V469, P2706, DOI 10.1007/s11999-011-1857-3; Fortier LA, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt50; Gobbi A, 2011, CARTILAGE, V2, P286, DOI 10.1177/1947603510392023; Goldberg A, 2017, J ORTHOP SURG RES, V12, DOI 10.1186/s13018-017-0534-y; Gosens T, 2011, AM J SPORT MED, V39, P1200, DOI 10.1177/0363546510397173; Isakova IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087238; Lee DH, 2014, CLIN ORTHOP RELAT R, V472, P3789, DOI 10.1007/s11999-014-3548-3; Liu Z, ANTICANCER RES, V24, P1625; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; MacAskill MG, 2017, SCI REP-UK, V7, DOI 10.1038/srep44233; Madry H, 2017, STEM CELLS INT, V2017, P1; Mendicino M, 2014, CELL STEM CELL, V14, P141, DOI 10.1016/j.stem.2014.01.013; Mishima Y, 2008, J ORTHOP RES, V26, P1407, DOI 10.1002/jor.20668; Moatshe G, 2017, ACTA ORTHOP, V88, P670, DOI 10.1080/17453674.2017.1368899; Murphy MB, 2012, BIOMATERIALS, V33, P5308, DOI 10.1016/j.biomaterials.2012.04.007; Nejadnik H, 2010, AM J SPORT MED, V38, P1110, DOI 10.1177/0363546509359067; Noth U, 2010, ADV DRUG DELIVER REV, V62, P765, DOI 10.1016/j.addr.2010.04.004; Patel S, 2013, AM J SPORT MED, V41, P356, DOI 10.1177/0363546512471299; Pepperell EE, 2013, STEM CELL RES, V11, P707, DOI 10.1016/j.scr.2013.04.006; Pezzanite LM, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0053-x; Riboh JC, 2016, AM J SPORT MED, V44, P792, DOI 10.1177/0363546515580787; RUBINI M, 1994, EXP CELL RES, V211, P374, DOI 10.1006/excr.1994.1101; Sampson S, 2016, REGEN MED, V11, P511, DOI 10.2217/rme-2016-0081; Schmidt MB, 2006, OSTEOARTHR CARTILAGE, V14, P403, DOI 10.1016/j.joca.2005.10.011; Schnabel LV, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt402; Schu S, 2012, J CELL MOL MED, V16, P2094, DOI 10.1111/j.1582-4934.2011.01509.x; Shapiro SA, 2017, AM J SPORT MED, V45, P82, DOI 10.1177/0363546516662455; Smith PA, 2016, AM J SPORT MED, V44, P884, DOI 10.1177/0363546515624678; Smyth NA, 2012, WORLD J ORTHOP, V3, P101, DOI 10.5312/wjo.v3.i7.101; Steadman J.R., 1997, OPER TECH ORTHOP, V7, P300, DOI [10.1016/S1048-6666(97)80033-X, DOI 10.1016/S1048-6666(97)80033-X]; TIDBALL JG, 1995, MED SCI SPORT EXER, V27, P1022, DOI 10.1249/00005768-199507000-00011; Vangsness CT, 2014, J BONE JOINT SURG AM, V96A, P90, DOI 10.2106/JBJS.M.00058; Xu ZL, 2017, SCI REP-UK, V7, DOI 10.1038/srep43301; Yi DK, 2017, J MATER CHEM B, V5, P9429, DOI 10.1039/c7tb02532g; Zheng YQ, 2017, MATH PROBL ENG, V2017, DOI 10.1155/2017/3412723	48	11	11	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194567	10.1371/journal.pone.0194567	http://dx.doi.org/10.1371/journal.pone.0194567			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566102	Green Published, gold			2022-12-26	WOS:000428093900079
J	Luciano, AK; Zhou, WP; Santana, JM; Kyriakides, C; Velazquez, H; Sessa, WC				Luciano, Amelia K.; Zhou, Wenping; Santana, Jeans M.; Kyriakides, Cleo; Velazquez, Heino; Sessa, William C.			CLOCK phosphorylation by AKT regulates its nuclear accumulation and circadian gene expression in peripheral tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURVIVAL; MOUSE CLOCK; PROTEIN; RHYTHMS; TRANSCRIPTION; RECEPTOR; DBP	Circadian locomotor output cycles kaput (CLOCK) is a transcription factor that activates transcription of clock-controlled genes by heterodimerizing with BMAL1 and binding to E-box elements on DNA. Although several phosphorylation sites on CLOCK have already been identified, this study characterizes a novel phosphorylation site at serine 845 (Ser-836 in humans). Here, we show that CLOCK is a novel AKT substrate in vitro and in cells, and this phosphorylation site is a negative regulator of CLOCK nuclear localization by acting as a binding site for 14-3-3 proteins. To examine the role of CLOCK phosphorylation in vivo, Clock(S845A) knockin mice were generated using CRISPR/Cas9 technology. Clock(S845A) mice are essentially normal with normal central circadian rhythms and hemodynamics. However, examination of core circadian gene expression from peripheral tissues demonstrated that Clock(S845A) mice have diminished expression of Per2, Reverba, Dbp, and Npas2 in skeletal muscle and Per2, Reverba, Dbp, Per1, Rora, and Npas2 in the liver during the circadian cycle. The reduction in Dbp levels is associated with reduced H3K9ac at E-boxes where CLOCK binds despite no change in total CLOCK levels. Thus, CLOCK phosphorylation by AKT on Ser-845 regulates its nuclear translocation and the expression levels of certain core circadian genes in insulin-sensitive tissues.	[Luciano, Amelia K.; Santana, Jeans M.; Kyriakides, Cleo; Sessa, William C.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Zhou, Wenping] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Luciano, Amelia K.; Zhou, Wenping; Santana, Jeans M.; Kyriakides, Cleo; Sessa, William C.] Yale Univ, Sch Med, Vasc Biol & Therapeut Program VBT, New Haven, CT 06520 USA; [Velazquez, Heino] Vet Affairs Connecticut Healthcare Syst, Dept Internal Med, West Haven, CT 06516 USA	Yale University; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Sessa, WC (corresponding author), Yale Univ, Dept Pharmacol, Sch Med, Vasc Biol & Therapeut Program, Amistad Res Bldg,10 Amistad St, New Haven, CT 06520 USA.	william.sessa@yale.edu	Sessa, William C/B-6844-2011	Sessa, William C/0000-0001-5759-1938; Santana, Jeans/0000-0001-9933-9255; Luciano, Amelia/0000-0002-4178-3422	National Institutes of Health [R01 HL64793, R01 HL61371, HL133018, R35 HL139945, T32 GM007324]; American Heart Association MERIT; Leducq Foundation; MIRVAD network; American Heart Association [15PRE21670000]; George M. O'Brien Kidney Center Grant from National Institutes of Health [P30 DK079310]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133018, R01HL064793, R01HL061371, R35HL139945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079310, P01DK057751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association MERIT; Leducq Foundation(Leducq Foundation); MIRVAD network; American Heart Association(American Heart Association); George M. O'Brien Kidney Center Grant from National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 HL64793, R01 HL61371, HL133018, and R35 HL139945, American Heart Association MERIT and the Leducq Foundation, MIRVAD network (to W. C. S.), American Heart Association Pre-doctoral Grant 15PRE21670000, National Institutes of Health T32 Training Grant T32 GM007324 (to A. K. L.), an American Heart Association Sarnoff fellowship (to J. M. S.), and George M. O'Brien Kidney Center Grant from National Institutes of Health P30 DK079310 (to H. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Dang FB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12696; DeBruyne JP, 2007, CURR BIOL, V17, pR538, DOI 10.1016/j.cub.2007.05.067; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Goedeke L, 2015, NAT MED, V21, P1280, DOI 10.1038/nm.3949; Huang NA, 2012, SCIENCE, V337, P189, DOI 10.1126/science.1222804; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Lee MY, 2014, P NATL ACAD SCI USA, V111, P12865, DOI 10.1073/pnas.1408472111; Marin EP, 2016, ARTERIOSCL THROM VAS, V36, P370, DOI 10.1161/ATVBAHA.115.306942; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Mertins P, 2014, MOL CELL PROTEOMICS, V13, P1690, DOI 10.1074/mcp.M113.036392; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Parker BL, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa3139; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rudic RD, 2005, CIRCULATION, V112, P2716, DOI 10.1161/CIRCULATIONAHA.105.568626; Spengler ML, 2009, CELL CYCLE, V8, P4138, DOI 10.4161/cc.8.24.10273; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Tahara Y, 2016, NAT REV GASTRO HEPAT, V13, P217, DOI 10.1038/nrgastro.2016.8; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Yagita K, 2000, FEBS LETT, V465, P79, DOI 10.1016/S0014-5793(99)01724-X; Yoshitane H, 2014, MOL CELL BIOL, V34, P1776, DOI 10.1128/MCB.01465-13; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	31	37	37	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					9126	9136		10.1074/jbc.RA117.000773	http://dx.doi.org/10.1074/jbc.RA117.000773			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29588368	hybrid, Green Published			2022-12-26	WOS:000434941900034
J	Lebeau, P; Platko, K; Al-Hashimi, AA; Byun, JH; Lhotak, S; Holzapfel, N; Gyulay, G; Igdoura, SA; Cool, DR; Trigatti, B; Seidah, NG; Austin, RC				Lebeau, Paul; Platko, Khrystyna; Al-Hashimi, Ali A.; Byun, Jae Hyun; Lhotak, Sarka; Holzapfel, Nicholas; Gyulay, Gabriel; Igdoura, Suleiman A.; Cool, David R.; Trigatti, Bernardo; Seidah, Nabil G.; Austin, Richard C.			Loss-of-function PCSK9 mutants evade the unfolded protein response sensor GRP78 and fail to induce endoplasmic reticulum stress when retained	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proprotein convertase subtilisin; kexin type 9 (PCSK9); endoplasmic reticulum stress (ER stress); cardiovascular disease; hepatocyte; GRP78	AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; INTRACELLULAR RETENTION; BINDING-SPECIFICITY; LIVER-REGENERATION; AFRICAN POPULATION; CELL-PROLIFERATION; STORAGE DISEASES; LIPID-METABOLISM; LDL CHOLESTEROL; MUTATIONS	The proprotein convertase subtilisin/kexin type-9 (PCSK9) plays a central role in cardiovascular disease (CVD) by degrading hepatic low-density lipoprotein receptor (LDLR). As such, loss-of-function (LOF) PCSK9 variants that fail to exit the endoplasmic reticulum (ER) increase hepatic LDLR levels and lower the risk of developing CVD. The retention of misfolded protein in the ER can cause ER stress and activate the unfolded protein response (UPR). In this study, we investigated whether a variety of LOF PCSK9 variants that are retained in the ER can cause ER stress and hepatic cytotoxicity. Although overexpression of these PCSK9 variants caused an accumulation in the ER of hepatocytes, UPR activation or apoptosis was not observed. Furthermore, ER retention of endogenous PCSK9 via splice switching also failed to induce the UPR. Consistent with these in vitro studies, overexpression of PCSK9 in the livers of mice had no impact on UPR activation. To elucidate the cellular mechanism to explain these surprising findings, we observed that the 94-kDa glucose-regulated protein (GRP94) sequesters PCSK9 away from the 78-kDa glucose-regulated protein (GRP78), the major activator of the UPR. As a result, GRP94 knockdown increased the stability of GRP78-PCSK9 complex and resulted in UPR activation following overexpression of ER-retained PCSK9 variants relative to WT secreted controls. Given that overexpression of these LOF PCSK9 variants does not cause UPR activation under normal homeostatic conditions, therapeutic strategies aimed at blocking the autocatalytic cleavage of PCSK9 in the ER represent a viable strategy for reducing circulating PCSK9.	[Lebeau, Paul; Platko, Khrystyna; Al-Hashimi, Ali A.; Byun, Jae Hyun; Lhotak, Sarka; Holzapfel, Nicholas; Gyulay, Gabriel; Austin, Richard C.] McMaster Univ, St Josephs Healthcare Hamilton, Div Nephrol, Dept Med, Hamilton, ON L8N 4A6, Canada; [Lebeau, Paul; Platko, Khrystyna; Al-Hashimi, Ali A.; Byun, Jae Hyun; Lhotak, Sarka; Holzapfel, Nicholas; Gyulay, Gabriel; Austin, Richard C.] Hamilton Ctr Kidney Res, 50 Charlton Ave East,Rm T-3313, Hamilton, ON L8N 4A6, Canada; [Trigatti, Bernardo; Austin, Richard C.] Hamilton Hlth Sci, Thrombosis & Atherosclerosis Res Inst TaARI, Hamilton, ON L8L 2X2, Canada; [Trigatti, Bernardo; Austin, Richard C.] McMaster Univ, Hamilton, ON L8L 2X2, Canada; [Igdoura, Suleiman A.] McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada; [Igdoura, Suleiman A.] McMaster Univ, Dept Pathol, Hamilton, ON L8S 4K1, Canada; [Trigatti, Bernardo] McMaster Univ, Dept Biochem, Hamilton, ON L8S 4L8, Canada; [Trigatti, Bernardo] McMaster Univ, Dept Biomed Sci, Hamilton, ON L8S 4L8, Canada; [Cool, David R.] Wright State Univ, Boonshoft Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA; [Seidah, Nabil G.] Univ Montreal, Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; University System of Ohio; Wright State University Dayton; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Austin, RC (corresponding author), Hamilton Ctr Kidney Res, 50 Charlton Ave East,Rm T-3313, Hamilton, ON L8N 4A6, Canada.; Austin, RC (corresponding author), St Josephs Healthcare Hamilton, 50 Charlton Ave East,Rm T-3313, Hamilton, ON L8N 4A6, Canada.	austinr@taari.ca	Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342; Byun, Jae Hyun/0000-0002-1231-511X; Trigatti, Bernardo (Dino) L./0000-0002-4556-119X	Heart and Stroke Foundation of Ontario Grant [T-6146]; Heart and Stroke Foundation of Canada Grant [G-13-0003064, G-15-0009389]; Canadian Institutes of Health Research (CIHR) Grant [74477]; Leducq Foundation [13 CVD 03]; CIHR Foundation [148363]; Canada Research Chair [216684]; National Institutes of Health [DK58111]; St. Joseph's Healthcare Hamilton; CIHR Team Grant in Thromboembolism [FRN-79846]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058111] Funding Source: NIH RePORTER	Heart and Stroke Foundation of Ontario Grant; Heart and Stroke Foundation of Canada Grant; Canadian Institutes of Health Research (CIHR) Grant(Canadian Institutes of Health Research (CIHR)); Leducq Foundation(Leducq Foundation); CIHR Foundation(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Joseph's Healthcare Hamilton; CIHR Team Grant in Thromboembolism; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Heart and Stroke Foundation of Ontario Grant T-6146, Heart and Stroke Foundation of Canada Grants G-13-0003064 and G-15-0009389, Canadian Institutes of Health Research (CIHR) Grant 74477 (to R.C.A.); Leducq Foundation Grant 13 CVD 03, CIHR Foundation Grant 148363, and Canada Research Chair 216684 (to N.G.S.); National Institutes of Health Grant DK58111 (to D.R.C.); and St. Joseph's Healthcare Hamilton and CIHR Team Grant in Thromboembolism FRN-79846. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abifadel M, 2012, ATHEROSCLEROSIS, V223, P394, DOI 10.1016/j.atherosclerosis.2012.04.006; Austin RC, 2009, ANTIOXID REDOX SIGN, V11, P2279, DOI [10.1089/ars.2009.2686, 10.1089/ARS.2009.2686]; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2012, J BIOL CHEM, V287, P33745, DOI 10.1074/jbc.M112.399725; Beuret N, 1999, J BIOL CHEM, V274, P18965, DOI 10.1074/jbc.274.27.18965; Birk J, 2009, J CELL SCI, V122, P3994, DOI 10.1242/jcs.051136; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; CALLEA F, 1992, LIVER, V12, P357; Cameron J, 2008, J INTERN MED, V263, P420, DOI 10.1111/j.1365-2796.2007.01915.x; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; CARLSON J, 1990, HISTOPATHOLOGY, V16, P309, DOI 10.1111/j.1365-2559.1990.tb01124.x; Chen WT, 2014, HEPATOLOGY, V59, P947, DOI 10.1002/hep.26711; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Daniels TF, 2009, INT J BIOL SCI, V5, P474; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Gidalevitz T, 2013, BBA-MOL CELL RES, V1833, P2410, DOI 10.1016/j.bbamcr.2013.03.007; Gilbert A, 1998, EXP CELL RES, V242, P144, DOI 10.1006/excr.1998.4101; Hooper AJ, 2007, ATHEROSCLEROSIS, V193, P445, DOI 10.1016/j.atherosclerosis.2006.08.039; Hooper AJ, 2013, EXPERT OPIN BIOL TH, V13, P429, DOI 10.1517/14712598.2012.748743; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kim PS, 2008, MOL ENDOCRINOL, V22, P477, DOI 10.1210/me.2007-0183; Lebeau P, 2017, J BIOL CHEM, V292, P1510, DOI 10.1074/jbc.M116.744235; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lhotak S, 2012, AM J PHYSIOL-RENAL, V303, pF266, DOI 10.1152/ajprenal.00482.2011; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Lin L, 2001, J BIOL CHEM, V276, P33893, DOI 10.1074/jbc.M105226200; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Madison BB, 2016, J LIPID RES, V57, P333, DOI 10.1194/jlr.C066712; Marzec M, 2012, BBA-MOL CELL RES, V1823, P774, DOI 10.1016/j.bbamcr.2011.10.013; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayne J, 2011, CLIN CHEM, V57, P1415, DOI 10.1373/clinchem.2011.165191; Nohturfft A, 2009, ANNU REV CELL DEV BI, V25, P539, DOI 10.1146/annurev.cellbio.24.110707.175344; Pagny S, 1999, J EXP BOT, V50, P157, DOI 10.1093/jexbot/50.331.157; Pai JT, 1996, P NATL ACAD SCI USA, V93, P5437, DOI 10.1073/pnas.93.11.5437; Poirier S, 2015, CELL REP, V13, P2064, DOI 10.1016/j.celrep.2015.11.006; Rocha CSJ, 2015, J MOL CELL CARDIOL, V82, P186, DOI 10.1016/j.yjmcc.2015.03.009; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Rutishauser J, 2002, SWISS MED WKLY, V132, P211; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Schwarz DS, 2016, CELL MOL LIFE SCI, V73, P79, DOI 10.1007/s00018-015-2052-6; Seidah NG, 2017, PHARMACOL REV, V69, P33, DOI 10.1124/pr.116.012989; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Sirois F, 2008, GENET TEST, V12, P377, DOI 10.1089/gte.2008.0013; Takahashi K, 2010, HUM MOL GENET, V19, P79, DOI 10.1093/hmg/ddp468; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V279, pG961, DOI 10.1152/ajpgi.2000.279.5.G961; Wu FL, 2016, EXPERT REV GASTROENT, V10, P1041, DOI 10.1080/17474124.2016.1179575; Wu NQ, 2014, CLIN CHIM ACTA, V431, P148, DOI 10.1016/j.cca.2014.01.043; Yan Zhongyu, 2011, Open Neuroendocrinol J, V4, P136; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354	55	20	23	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7329	7343		10.1074/jbc.RA117.001049	http://dx.doi.org/10.1074/jbc.RA117.001049			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29593095	Green Published, hybrid			2022-12-26	WOS:000432174500026
J	Makkar, P; Kang, HJ; Padalhin, AR; Park, I; Moon, BG; Lee, BT				Makkar, Preeti; Kang, Hoe Jin; Padalhin, Andrew R.; Park, Ihho; Moon, Byoung-Gi; Lee, Byong Taek			Development and properties of duplex MgF2/PCL coatings on biodegradable magnesium alloy for biomedical applications	PLOS ONE			English	Article							IN-VITRO DEGRADATION; POLYMER-COATED MAGNESIUM; CORROSION-RESISTANCE; CELL ATTACHMENT; MG; COMPOSITE; IMPLANTS; FILM; CYTOCOMPATIBILITY; PERFORMANCE	The present work addresses the performance of polycaprolactone (PCL) coating on fluoride treated (MgF2) biodegradable ZK60 magnesium alloy (Mg) for biomedical application. MgF2 conversion layer was first produced by immersing Mg alloy substrate in hydrofluoric acid solution. The outer PCL coating was then prepared using dip coating technique. Morphology, elements profile, phase structure, roughness, mechanical properties, invitro corrosion, and biocompatibility of duplex MgF2/PCL coating were then characterized and compared to those of fluoride coated and uncoated Mg samples. The invivo degradation behavior and biocompatibility of duplex MgF2/PCL coating with respect to ZK60 Mg alloy were also studied using rabbit model for 2 weeks. SEM and TEM analysis showed that the duplex coating was uniform and comprised of porous PCL film (similar to 3.3 mu m) as upper layer with compact MgF2 (similar to 2.2 mu m) as inner layer. No significant change in microhardness was found on duplex coating compared with uncoated ZK60 Mg alloy. The duplex coating showed improved invitro corrosion resistance than single layered MgF2 or uncoated alloy samples. The duplex coating also resulted in better cell viability, cell adhesion, and cell proliferation compared to fluoride coated or uncoated alloy. Preliminary invivo studies indicated that duplex MgF2/PCL coating reduced the degradation rate of ZK60 Mg alloy and exhibited good biocompatibility. These results suggested that duplex MgF2/PCL coating on magnesium alloy might have great potential for orthopedic applications.	[Makkar, Preeti; Padalhin, Andrew R.; Lee, Byong Taek] Soonchunhyang Univ, Coll Med, Inst Tissue Regenerat, Cheonan, South Korea; [Kang, Hoe Jin; Lee, Byong Taek] Soonchunhyang Univ, Coll Med, Dept Regenerat Med, Cheonan, South Korea; [Park, Ihho] Sk Innovat Global Technol, Daejeon, South Korea; [Moon, Byoung-Gi] Korea Inst Mat Sci, Adv Met Div, Chang Won, Gyeongnam, South Korea	Soonchunhyang University; Soonchunhyang University; SK Group; SK Innovation; Korea Institute of Materials Science (KIMS)	Lee, BT (corresponding author), Soonchunhyang Univ, Coll Med, Inst Tissue Regenerat, Cheonan, South Korea.; Lee, BT (corresponding author), Soonchunhyang Univ, Coll Med, Dept Regenerat Med, Cheonan, South Korea.	lbt@sch.ac.kr	Padalhin, Andrew/ABF-4523-2021	Padalhin, Andrew/0000-0002-3869-5720; Lee, Byong-Taek/0000-0001-9072-0033	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2015R1A6A1A03032522]; Soonchunhyang University, South Korea	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Soonchunhyang University, South Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. 2015R1A6A1A03032522) to Byong Taek Lee and partially supported by Soonchunhyang University, South Korea.; This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. 2015R1A6A1A03032522) and partially supported by Soonchunhyang University, South Korea. The authors extend their special thanks to Dr. Jhaleh Amirian for their support in conducting experiments.	Abdal-hay A, 2013, SOLID STATE SCI, V18, P131, DOI 10.1016/j.solidstatesciences.2012.11.017; Abdal-hay A, 2013, CERAM INT, V39, P183, DOI 10.1016/j.ceramint.2012.06.008; Abdal-Hay A, 2012, APPL SURF SCI, V261, P536, DOI 10.1016/j.apsusc.2012.08.051; Alvarez K, 2009, MATERIALS, V2, P790, DOI 10.3390/ma2030790; [Anonymous], 2009, PREPARATION VITRO EV; Arafat MT, 2011, SOFT MATTER, V7, P8013, DOI 10.1039/c1sm05793f; Bakhsheshi-Rad HR, 2016, J MATER ENG PERFORM, V25, P3948, DOI 10.1007/s11665-016-2247-5; Bakhsheshi-Rad HR, 2014, VACUUM, V110, P127, DOI 10.1016/j.vacuum.2014.08.013; Bakhsheshi-Rad HR, 2013, SURF COAT TECH, V222, P79, DOI 10.1016/j.surfcoat.2013.02.007; Bakhsheshi-Rad HR, 2013, T NONFERR METAL SOC, V23, P699, DOI 10.1016/S1003-6326(13)62519-4; Budke E, 1999, SURF COAT TECH, V112, P108, DOI 10.1016/S0257-8972(98)00791-9; Carboneras M, 2010, J ALLOY COMPD, V496, P442, DOI 10.1016/j.jallcom.2010.02.043; Catauro M, 2014, MAT SCI ENG C-MATER, V39, P344, DOI 10.1016/j.msec.2014.03.025; Chiu KY, 2007, SURF COAT TECH, V202, P590, DOI 10.1016/j.surfcoat.2007.06.035; Diba M, 2012, COMPOS SCI TECHNOL, V72, P716, DOI 10.1016/j.compscitech.2012.01.023; Gao JH, 2011, APPL SURF SCI, V257, P2231, DOI 10.1016/j.apsusc.2010.09.080; Herrasti P, 2011, ELECTROCHIM ACTA, V56, P1323, DOI 10.1016/j.electacta.2010.09.094; Hornberger H, 2012, ACTA BIOMATER, V8, P2442, DOI 10.1016/j.actbio.2012.04.012; Huang LL, 2014, SURF COAT TECH, V258, P664, DOI 10.1016/j.surfcoat.2014.08.020; Khan SP, 2005, NANOMED-NANOTECHNOL, V1, P125, DOI 10.1016/j.nano.2005.03.007; Kim BR, 2014, TISSUE ENG PT A, V20, P3279, DOI [10.1089/ten.TEA.2014.0081, 10.1089/ten.tea.2014.0081]; Li JN, 2010, J MATER SCI, V45, P6038, DOI 10.1007/s10853-010-4688-9; Li X, 2016, ACTA BIOMATER, V45, P2, DOI 10.1016/j.actbio.2016.09.005; Liu J, 2015, J MATER CHEM B, V3, P878, DOI 10.1039/c4tb01527d; Manivasagam Geetha, 2010, RECENT PATENTS CORRO; Meng EC, 2011, APPL SURF SCI, V257, P4811, DOI 10.1016/j.apsusc.2010.12.073; Neacsu P, 2017, MATERIALS, V10, DOI 10.3390/ma10070686; Ono S, 2001, MATER TRANS, V42, P1225, DOI 10.2320/matertrans.42.1225; Orchard A, 1977, HDB XRAY ULTRAVIOLET, P48; Ostrowski N, 2013, ACTA BIOMATER, V9, P8704, DOI 10.1016/j.actbio.2013.05.010; Pereda MD, 2010, ACTA BIOMATER, V6, P1772, DOI 10.1016/j.actbio.2009.11.004; Poinern G. Eddy Jai, 2013, AM J BIOMED ENG, V2, P218, DOI [10.5923/j.ajbe.20120206.02, DOI 10.5923/J.AJBE.20120206.02]; Seal C., 2009, IOP C SERIES MAT SCI; Shadanbaz S, 2012, ACTA BIOMATER, V8, P20, DOI 10.1016/j.actbio.2011.10.016; Supplit R, 2007, CORROS SCI, V49, P3015, DOI 10.1016/j.corsci.2007.02.006; Vandrovcova M, 2011, PHYSIOL RES, V60, P403, DOI 10.33549/physiolres.932045; Wang SR, 2010, T NONFERR METAL SOC, V20, P763, DOI [10.1016/S1003-6326(09)60211-9, 10.1016/S1003-6326(09)60211]; Wang YQ, 2005, MATER LETT, V59, P1727, DOI 10.1016/j.matlet.2005.01.050; Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049; Wong HM, 2010, BIOMATERIALS, V31, P2084, DOI 10.1016/j.biomaterials.2009.11.111; Xin Y, 2011, ACTA BIOMATER, V7, P1452, DOI 10.1016/j.actbio.2010.12.004; Xu LP, 2012, APPL SURF SCI, V258, P6353, DOI 10.1016/j.apsusc.2012.03.036; Xu LP, 2012, COLLOID SURFACE B, V93, P67, DOI 10.1016/j.colsurfb.2011.12.009	43	17	17	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0193927	10.1371/journal.pone.0193927	http://dx.doi.org/10.1371/journal.pone.0193927			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608572	Green Published, gold, Green Submitted			2022-12-26	WOS:000428988800006
J	Wharton, TH; Nomie, KJ; Wharton, RP				Wharton, Tammy H.; Nomie, Krystle J.; Wharton, Robin P.			No significant regulation of bicoid mRNA by Pumilio or Nanos in the early Drosophila embryo	PLOS ONE			English	Article							GERMLINE STEM-CELLS; POSTERIOR DETERMINANT; BRAIN-TUMOR; TRANSLATIONAL REGULATOR; BINDING PROTEIN; BODY PATTERN; CYCLIN-B; GENE; DOMAIN; LOCALIZATION	Drosophila Pumilio (Pum) is a founding member of the conserved Puf domain class of RNA-binding translational regulators. Pum binds with high specificity, contacting eight nucleotides, one with each of the repeats in its RNA-binding domain. In general, Pum is thought to block translation in collaboration with Nanos (Nos), which exhibits no binding specificity in isolation but is recruited jointly to regulatory sequences containing a Pum binding site in the 3'-UTRs of target mRNAs. Unlike Pum, which is ubiquitous in the early embryo, Nos is tightly restricted to the posterior, ensuring that repression of its best-characterized target, maternal hunchback (hb) mRNA, takes place exclusively in the posterior. An exceptional case of Nos-independent regulation by Pum has been described-repression of maternal bicoid (bcd) mRNA at the anterior pole of the early embryo, dependent on both Pum and conserved Pum binding sites in the 3'-UTR of the mRNA. We have re-investigated regulation of bcd in the early embryo; our experiments reveal no evidence of a role for Pum or its conserved binding sites in regulation of the perdurance of bcd mRNA or protein. Instead, we find that Pum and Nos control the accumulation of bcd mRNA in testes.	[Wharton, Tammy H.; Wharton, Robin P.] Ohio State Univ, Dept Mol Genet, Ctr RNA Biol, Columbus, OH 43210 USA; [Wharton, Tammy H.; Wharton, Robin P.] Ohio State Univ, Dept Canc Biol & Genet, Ctr RNA Biol, Columbus, OH 43210 USA; [Nomie, Krystle J.] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Holcombe Blvd, Houston, TX 77030 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Texas System; UTMD Anderson Cancer Center	Wharton, RP (corresponding author), Ohio State Univ, Dept Mol Genet, Ctr RNA Biol, Columbus, OH 43210 USA.; Wharton, RP (corresponding author), Ohio State Univ, Dept Canc Biol & Genet, Ctr RNA Biol, Columbus, OH 43210 USA.	wharton.88@osu.edu			NIGMS [GM084376]	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIGMS grant GM084376 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT MK, 1991, GENETICS, V129, P783; Arrizabalaga G, 1999, GENETICS, V153, P1825; Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; BARKER DD, 1992, GENE DEV, V6, P2312, DOI 10.1101/gad.6.12a.2312; Bergsten SE, 1999, DEVELOPMENT, V126, P659; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; Bhogal B, 2016, DEVELOPMENT, V143, P2147, DOI 10.1242/dev.132415; Blewett NH, 2012, MOL CELL BIOL, V32, P4181, DOI 10.1128/MCB.00483-12; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; Curtis D, 1997, EMBO J, V16, P834, DOI 10.1093/emboj/16.4.834; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Drocco JA, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/055004; EDGAR BA, 1994, GENE DEV, V8, P440, DOI 10.1101/gad.8.4.440; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; FINKELSTEIN R, 1990, NATURE, V346, P485, DOI 10.1038/346485a0; Foe Victoria E., 1993, P149; Forbes A, 1998, DEVELOPMENT, V125, P679; Gamberi C, 2002, DEVELOPMENT, V129, P2699; GAVIS ER, 1992, CELL, V71, P301, DOI 10.1016/0092-8674(92)90358-J; Gerber AP, 2006, P NATL ACAD SCI USA, V103, P4487, DOI 10.1073/pnas.0509260103; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; HULSKAMP M, 1989, NATURE, V338, P629, DOI 10.1038/338629a0; IRISH V, 1989, NATURE, V338, P646, DOI 10.1038/338646a0; Kadyrova LY, 2007, DEVELOPMENT, V134, P1519, DOI 10.1242/dev.002212; Kronja I, 2014, CELL REP, V7, P1495, DOI 10.1016/j.celrep.2014.05.002; Laver JD, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0659-4; Lin HF, 1997, DEVELOPMENT, V124, P2463; Little SC, 2015, NAT CELL BIOL, V17, P558, DOI 10.1038/ncb3143; Little SC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000596; Loedige I, 2015, CELL REP, V13, P1206, DOI 10.1016/j.celrep.2015.09.068; MACDONALD PM, 1992, DEVELOPMENT, V114, P221; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; Menon KP, 2009, J NEUROSCI, V29, P5558, DOI 10.1523/JNEUROSCI.0520-09.2009; Miles WO, 2014, EMBO J, V33, P2201, DOI 10.15252/embj.201488057; Muraro NI, 2008, J NEUROSCI, V28, P2099, DOI 10.1523/JNEUROSCI.5092-07.2008; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4; Olesnicky EC, 2012, DEV BIOL, V365, P208, DOI 10.1016/j.ydbio.2012.02.028; Raisch T, 2016, EMBO J, V35, P974, DOI 10.15252/embj.201593634; Reveal B, 2011, RNA BIOL, V8, P1047, DOI 10.4161/rna.8.6.17542; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Sato K, 2007, P NATL ACAD SCI USA, V104, P7455, DOI 10.1073/pnas.0610052104; Schroeder MD, 2011, DEVELOPMENT, V138, P3067, DOI 10.1242/dev.062141; Slaidina M, 2014, J CELL BIOL, V207, P13, DOI 10.1083/jcb.201407102; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; STRUHL G, 1989, NATURE, V338, P741, DOI 10.1038/338741a0; Tadros W, 2007, DEV CELL, V12, P143, DOI 10.1016/j.devcel.2006.10.005; TAUTZ D, 1988, NATURE, V332, P281, DOI 10.1038/332281a0; Thomsen S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r93; Vardy L, 2007, DEV CELL, V12, P157, DOI 10.1016/j.devcel.2006.10.017; Vardy L, 2009, P NATL ACAD SCI USA, V106, P1838, DOI 10.1073/pnas.0813237106; Verrotti AC, 2000, DEVELOPMENT, V127, P5225; Wallenfang MR, 2006, AGING CELL, V5, P297, DOI 10.1111/j.1474-9726.2006.00221.x; WANG C, 1991, CELL, V66, P637, DOI 10.1016/0092-8674(91)90110-K; WANG C, 1994, DEV DYNAM, V199, P103, DOI 10.1002/aja.1001990204; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Weidmann CA, 2016, ELIFE, V5, DOI 10.7554/eLife.17096; WHARTON RP, 1989, CELL, V59, P881, DOI 10.1016/0092-8674(89)90611-9; WHARTON RP, 1991, CELL, V67, P955, DOI 10.1016/0092-8674(91)90368-9; Wharton RP, 1998, MOL CELL, V1, P863, DOI 10.1016/S1097-2765(00)80085-4; Zamore PD, 1997, RNA, V3, P1421	63	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0194865	10.1371/journal.pone.0194865	http://dx.doi.org/10.1371/journal.pone.0194865			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601592	Green Published, Green Submitted, gold			2022-12-26	WOS:000428845900011
J	Cheong, SK; Strazzeri, JM; Williams, DR; Merigan, WH				Cheong, Soon Keen; Strazzeri, Jennifer M.; Williams, David R.; Merigan, William H.			All-optical recording and stimulation of retinal neurons in vivo in retinal degeneration mice	PLOS ONE			English	Article							IMAGING LIGHT RESPONSES; LIVING MOUSE EYE; GANGLION-CELLS; ADAPTIVE OPTICS; RETINITIS-PIGMENTOSA; VISUAL RESPONSES; NEURAL ACTIVITY; BIPOLAR CELLS; GENE-THERAPY; RD10 MICE	Here we demonstrate the application of a method that could accelerate the development of novel therapies by allowing direct and repeatable visualization of cellular function in the living eye, to study loss of vision in animal models of retinal disease, as well as evaluate the time course of retinal function following therapeutic intervention. We use high-resolution adaptive optics scanning light ophthalmoscopy to image fluorescence from the calcium sensor GCaMP6s. In mice with photoreceptor degeneration (rd10), we measured restored visual responses in ganglion cell layer neurons expressing the red-shifted channelrhodopsin ChrimsonR over a six-week period following significant loss of visual responses. Combining a fluorescent calcium sensor, a channelrhodopsin, and adaptive optics enables all-optical stimulation and recording of retinal neurons in the living eye. Because the retina is an accessible portal to the central nervous system, our method also provides a novel non-invasive method of dissecting neuronal processing in the brain.	[Cheong, Soon Keen; Strazzeri, Jennifer M.; Williams, David R.; Merigan, William H.] Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA; [Strazzeri, Jennifer M.; Merigan, William H.] Univ Rochester, Flaum Eye Inst, Rochester, NY USA; [Williams, David R.] Univ Rochester, Inst Opt, Rochester, NY 14627 USA; [Cheong, Soon Keen] Stanford Univ, Dept Ophthalmol, Palo Alto, CA 94304 USA	University of Rochester; University of Rochester; University of Rochester; Stanford University	Cheong, SK (corresponding author), Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA.; Cheong, SK (corresponding author), Stanford Univ, Dept Ophthalmol, Palo Alto, CA 94304 USA.	skcheong@stanford.edu		Williams, David R/0000-0003-3227-8333	NATIONAL EYE INSTITUTE [R01EY021166, P30EY001319] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY021166, EY021166, P30 EY001319] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Baden T, 2016, NATURE, V529, P345, DOI 10.1038/nature16468; Bar-Noam AS, 2016, LIGHT-SCI APPL, V5, DOI 10.1038/lsa.2016.7; Barhoum R, 2008, NEUROSCIENCE, V155, P698, DOI 10.1016/j.neuroscience.2008.06.042; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Borghuis BG, 2011, J NEUROSCI, V31, P2855, DOI 10.1523/JNEUROSCI.6064-10.2011; Bourne RRA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162229; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Chang B, 2007, VISION RES, V47, P624, DOI 10.1016/j.visres.2006.11.020; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chiu K, 2003, GLAUCOMA BASIC CLIN; Chiu K, 2012, AGE, V34, P633, DOI 10.1007/s11357-011-9260-2; Criscuolo C, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00053; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Dubra A, 2010, LECT NOTES COMPUT SC, V6204, P60, DOI 10.1007/978-3-642-14366-3_6; Fine I, 2015, VISION RES, V111, P115, DOI 10.1016/j.visres.2015.04.012; Fletcher EL, 2011, PROG MOL BIOL TRANSL, V100, P211, DOI 10.1016/B978-0-12-384878-9.00006-6; Garg SJ, 2013, CURR OPIN OPHTHALMOL, V24, P407, DOI 10.1097/ICU.0b013e328363829b; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Geng Y, 2012, BIOMED OPT EXPRESS, V3, P715, DOI 10.1364/BOE.3.000715; Goo YS, 2011, KOREAN J PHYSIOL PHA, V15, P415, DOI 10.4196/kjpp.2011.15.6.415; HAM WT, 1976, NATURE, V260, P153, DOI 10.1038/260153a0; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P237, DOI 10.1113/jphysiol.1976.sp011594; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Hunter JJ, 2012, PROG RETIN EYE RES, V31, P28, DOI 10.1016/j.preteyeres.2011.11.001; Jaissle GB, 2001, INVEST OPHTH VIS SCI, V42, P506; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Johnson TV, 2010, BRAIN RES BULL, V81, P349, DOI 10.1016/j.brainresbull.2009.04.004; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Kim IJ, 2010, J NEUROSCI, V30, P1452, DOI 10.1523/JNEUROSCI.4779-09.2010; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Krieger B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180091; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; LI ZY, 1995, J NEUROSCI, V15, P5429; Liang JZ, 1997, J OPT SOC AM A, V14, P2884, DOI 10.1364/JOSAA.14.002884; Lin B, 2009, EXP EYE RES, V88, P589, DOI 10.1016/j.exer.2008.11.022; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; Mace E, 2015, MOL THER, V23, P7, DOI 10.1038/mt.2014.154; Menzler J, 2011, J NEUROSCI, V31, P2280, DOI 10.1523/JNEUROSCI.4238-10.2011; Morgan JIW, 2008, INVEST OPHTH VIS SCI, V49, P3715, DOI 10.1167/iovs.07-1430; O'Brien EE, 2012, CLIN EXP OPTOM, V95, P473, DOI 10.1111/j.1444-0938.2012.00783.x; Prilloff S, 2007, EUR J NEUROSCI, V25, P3339, DOI 10.1111/j.1460-9568.2007.05550.x; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rickgauer JP, 2014, NAT NEUROSCI, V17, P1816, DOI 10.1038/nn.3866; Rosch S, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/874751; Roorda A, 2002, OPT EXPRESS, V10, P405, DOI 10.1364/OE.10.000405; Scholl HPN, 2014, LANCET, V383, P1105, DOI 10.1016/S0140-6736(14)60033-7; Sengupta A, 2016, EMBO MOL MED; Sharma R, 2013, BIOMED OPT EXPRESS, V4, P1285, DOI 10.1364/BOE.4.001285; Siegert S, 2009, NAT NEUROSCI, V12, P1197, DOI 10.1038/nn.2370; Stasheff SF, 2011, J NEUROPHYSIOL, V105, P3002, DOI 10.1152/jn.00704.2010; Theogarajan L, 2012, NEUROSCI LETT, V519, P129, DOI 10.1016/j.neulet.2012.02.001; Thyagarajan S, 2010, J NEUROSCI, V30, P8745, DOI 10.1523/JNEUROSCI.4417-09.2010; THYLEFORS B, 1994, B WORLD HEALTH ORGAN, V72, P323; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tomita H, 2010, EXP EYE RES, V90, P429, DOI 10.1016/j.exer.2009.12.006; Tsien RY, 2009, COLD SPRING HARB PRO, V2009; Walker MT, 2008, P NATL ACAD SCI USA, V105, P8861, DOI 10.1073/pnas.0711397105; Wang YV, 2011, J NEUROSCI, V31, P7670, DOI 10.1523/JNEUROSCI.0629-11.2011; Yin L, 2014, J NEUROSCI, V34, P6596, DOI 10.1523/JNEUROSCI.4438-13.2014; Yin L, 2013, J NEUROPHYSIOL, V109, P2415, DOI 10.1152/jn.01043.2012	63	11	12	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194947	10.1371/journal.pone.0194947	http://dx.doi.org/10.1371/journal.pone.0194947			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596518	Green Submitted, gold, Green Published			2022-12-26	WOS:000428630000055
J	Govani, SM; Higgins, PDR; Rubenstein, JH; Stidham, RW; Waljee, AK				Govani, Shail M.; Higgins, Peter D. R.; Rubenstein, Joel H.; Stidham, Ryan W.; Waljee, Akbar K.			CT utilization abruptly increases at age 18 among patients with inflammatory bowel diseases in the hospital	PLOS ONE			English	Article							RADIATION-DOSE AWARENESS; COMPUTED-TOMOGRAPHY; CROHNS-DISEASE; EMERGENCY-DEPARTMENT; IONIZING-RADIATION; ULCERATIVE-COLITIS; EXPOSURE; ENTEROGRAPHY; PREVALENCE; CANCER	Objectives Patients with inflammatory bowel disease(IBD) are frequently exposed to computed tomography (CT). Each CT exposes patients to radiation that cumulatively could increase the risk of malignancy, particularly in younger patients. We aim to study the effect of age on CT use in IBD patients seen in the Emergency Department (ED) or the hospital. Methods We conducted a retrospective cohort study of IBD patients identified in Truven Health Marketscan databases between 2009-2013. The main outcome was use of CT during an ED or inpatient visit. Effect of age on CT use was characterized using logistic regression accounting for important covariables. Results There were 66,731 patients with IBD with 144,147 ED or inpatient visits in this cohort with a diagnosis code of IBD. At first visit, 5.8% percent were below age 18. CT was utilized in 26.6% of visits. In multivariable analysis, adjusting for medications, recent surgery, and gender, patients 18-35 were more likely to undergo CT (OR 2.35, 95% CI: 2.20-2.52) compared to those <18. Examining patients only between 16 and 19, the odds of an 18 or 19-year-old undergoing CT is significantly higher than a 16 or 17-year-old (OR 1.96, 95% CI: 1.71-2.24). Conclusions Patients with IBD undergo CT more than a quarter of the time in the ED or inpatient setting. Pediatric providers limit radiation exposure among those <18 while adult providers are not as cautious with radiation exposure for the young adult population. Increased awareness of the risks of cumulative radiation exposure in the young adult population is needed.	[Govani, Shail M.; Higgins, Peter D. R.; Rubenstein, Joel H.; Stidham, Ryan W.; Waljee, Akbar K.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Govani, Shail M.; Rubenstein, Joel H.] South Texas Vet Healthcare Syst, San Antonio, TX 78228 USA; [Govani, Shail M.] UT Hlth San Antonio, San Antonio, TX 78229 USA; [Waljee, Akbar K.] VA Ann Arbor Hlth Care Syst, VA Ctr Clin Management Res, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Govani, SM (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.; Govani, SM (corresponding author), UT Hlth San Antonio, San Antonio, TX 78229 USA.	shailgovani@gmail.com	Waljee, Akbar K/G-2067-2010	Waljee, Akbar K/0000-0003-1964-8790; Govani, Shail/0000-0002-5360-8576	NIDDK NIH HHS [K23 DK101687] Funding Source: Medline; HSRD VA [IK2 HX000775] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); HSRD VA		[Anonymous], 2014, IM GENTL DEV PED CT; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Bruining DH, 2008, INFLAMM BOWEL DIS, V14, P1701, DOI 10.1002/ibd.20529; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chatu S, 2012, ALIMENT PHARM THER, V35, P529, DOI 10.1111/j.1365-2036.2011.04975.x; Desmond AN, 2008, GUT, V57, P1524, DOI 10.1136/gut.2008.151415; Dillman JR, 2015, RADIOGRAPHICS, V35, P835, DOI 10.1148/rg.2015140002; Gandhi NS, 2016, RADIOLOGY, V280, P436, DOI 10.1148/radiol.2016151281; Gashin L, 2015, INFLAMM BOWEL DIS, V21, P793, DOI 10.1097/MIB.0000000000000321; Goske MJ, 2008, PEDIATR RADIOL, V38, P265, DOI 10.1007/s00247-007-0743-3; Govani SM, 2014, CLIN GASTROENTEROL H, V12, P1702, DOI 10.1016/j.cgh.2014.02.036; Griffey RT, 2014, ACAD EMERG MED, V21, P768, DOI 10.1111/acem.12410; Guentner AS, GASTROENTEROLOGY, V144, pS403; Higgins PDR, 2007, INFLAMM BOWEL DIS, V13, P262, DOI 10.1002/ibd.20013; Kerner C, 2012, CLIN GASTROENTEROL H, V10, P52, DOI 10.1016/j.cgh.2011.09.005; Kroeker K, 2009, GASTROENTEROLOGY, V136, pA99; Lee CI, 2004, RADIOLOGY, V231, P393, DOI 10.1148/radiol.2312030767; Loftus CG, 2007, INFLAMM BOWEL DIS, V13, P254, DOI 10.1002/ibd.20029; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Nguyen GC, 2017, INFLAMM BOWEL DIS, V23, P858, DOI 10.1097/MIB.0000000000001152; Panes J, 2011, ALIMENT PHARM THER, V34, P125, DOI 10.1111/j.1365-2036.2011.04710.x; Peloquin JM, 2008, AM J GASTROENTEROL, V103, P2015, DOI 10.1111/j.1572-0241.2008.01920.x; Smith-Bindman R, 2015, RADIOLOGY, V277, P134, DOI 10.1148/radiol.2015142728; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Thomas KE, 2006, PEDIATR RADIOL, V36, P823, DOI 10.1007/s00247-006-0170-x; Waljee AK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158017; Yarur AJ, 2014, J CROHNS COLITIS, V8, P504, DOI 10.1016/j.crohns.2013.11.003	28	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195022	10.1371/journal.pone.0195022	http://dx.doi.org/10.1371/journal.pone.0195022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596461	Green Published, gold, Green Submitted			2022-12-26	WOS:000428630000068
J	Kamm, F; Strauch, U; Degenhardt, F; Lopez, R; Kunst, C; Rogler, G; Franke, A; Klebl, F; Rieders, F				Kamm, Florian; Strauch, Ulrike; Degenhardt, Frauke; Lopez, Rocio; Kunst, Claudia; Rogler, Gerhard; Franke, Andre; Klebl, Frank; Rieders, Florian			Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE ANTIBODIES; CROHNS-DISEASE; MANNAN ANTIBODIES; INTESTINAL PERMEABILITY; FAMILIAL EXPRESSION; SEROLOGICAL MARKERS; IBD; ASSOCIATION; DIAGNOSIS; FLAGELLIN	Background Serum anti-glycan antibodies are a promising tool for differential diagnosis, disease stratification and prediction of Crohn's disease (CD). To investigate possible heritability of the markers we assessed the presence of serum anti-glycan antibodies in affected and unaffected relatives of patients with CD. Methods Serum samples of 169 IBD patients of the German inflammatory bowel disease (IBD) network (140 CD & 29 Ulcerative colitis (UC)), 349 relatives of CD patients, 63 relatives of UC patients and 46 healthy controls were tested for the presence of anti-glycan antibodies by ELISA in a blinded fashion. Clinical data of the IBD patients and controls were available. Results A higher proportion of non-affected CD relatives was positive for anti-glycan antibodies compared to healthy subjects. No inheritance of a specific pattern of anti-glycan antibodies could be detected. No difference in marker expression depending on the degree of relationship in the non-affected relatives was noted and the presence of family history did not lead to a difference in marker levels in the affected CD subjects. Conclusions Non-affected CD relatives had a higher frequency of anti-glycan antibodies compared to healthy subjects. This difference was mild and was found to be true for the overall reactivity to glycan antigens, but not for specific patterns. This may indicate an inherited mechanism resulting in a non-specific increased reactivity to microbial antigens in IBD.	[Kamm, Florian; Strauch, Ulrike; Kunst, Claudia; Klebl, Frank; Rieders, Florian] Univ Regensburg, Dept Internal Med 1, Regensburg, Germany; [Degenhardt, Frauke; Franke, Andre] Christian Albrechts Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Lopez, Rocio] Cleveland Clin Fdn, Dept Quantitat Hlth Sci, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Rogler, Gerhard] Univ Hosp Zurich, Dept Gastroenterol & Hepatol, Zurich, Switzerland; [Rogler, Gerhard] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Rieders, Florian] Cleveland Clin Fdn, Dept Pathobiol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA	University of Regensburg; University of Kiel; Cleveland Clinic Foundation; University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Cleveland Clinic Foundation	Rieders, F (corresponding author), Univ Regensburg, Dept Internal Med 1, Regensburg, Germany.; Rieders, F (corresponding author), Cleveland Clin Fdn, Dept Pathobiol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	riederf@ccf.org	Franke, Andre/B-2151-2010	Franke, Andre/0000-0003-1530-5811; Degenhardt, Frauke/0000-0001-7516-3179; Lopez, Ana Rocio/0000-0002-4319-420X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK110415] Funding Source: NIH RePORTER; NIDDK NIH HHS [K08 DK110415] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Annese V, 2001, AM J GASTROENTEROL, V96, P2407, DOI 10.1111/j.1572-0241.2001.04043.x; Bonen DK, 2003, GASTROENTEROLOGY, V124, P521, DOI 10.1053/gast.2003.50045; Crawford DC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015088; D'Haens GR, 1998, GASTROENTEROLOGY, V114, P262, DOI 10.1016/S0016-5085(98)70476-7; de Souza HSP, 2016, NAT REV GASTRO HEPAT, V13, P13, DOI [10.1038/nrgastro.2016.186, 10.1038/nrgastro.2015.186]; Dotan I, 2006, GASTROENTEROLOGY, V131, P366, DOI 10.1053/j.gastro.2006.04.030; Ferrante M, 2007, GUT, V56, P1394, DOI 10.1136/gut.2006.108043; Ferrante M, 2007, INFLAMM BOWEL DIS, V13, P123, DOI 10.1002/ibd.20054; Folwaczny C, 1997, GASTROENTEROLOGY, V113, P101, DOI 10.1016/S0016-5085(97)70085-4; Glas J, 2002, DIGESTION, V66, P173, DOI 10.1159/000066760; Gomollon F, 2017, J CROHNS COLITIS, V11, P3, DOI 10.1093/ecco-jcc/jjw168; Hadrich I, 2007, SCAND J GASTROENTERO, V42, P717, DOI 10.1080/00365520601083625; Halme L, 2002, SCAND J GASTROENTERO, V37, P692, DOI 10.1080/00365520212511; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; Hugot JP, 2003, EUR J GASTROEN HEPAT, V15, P593, DOI 10.1097/00042737-200306000-00003; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Joossens M, 2010, INFLAMM BOWEL DIS, V16, P58, DOI 10.1002/ibd.20985; Landers CJ, 2002, GASTROENTEROLOGY, V123, P689, DOI 10.1053/gast.2002.35379; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Magro F, 2017, J CROHNS COLITIS; Mei L, 2006, GASTROENTEROLOGY, V130, P1078, DOI 10.1053/j.gastro.2006.02.013; Mow WS, 2004, DIGEST DIS SCI, V49, P1280, DOI 10.1023/B:DDAS.0000037824.66186.e2; Nores GA, 2008, BBA-GEN SUBJECTS, V1780, P538, DOI 10.1016/j.bbagen.2007.09.008; Papp M, 2008, AM J GASTROENTEROL, V103, P665, DOI 10.1111/j.1572-0241.2007.01652.x; Peeters M, 1997, GASTROENTEROLOGY, V113, P802, DOI 10.1016/S0016-5085(97)70174-4; Poulain D, 2000, GUT, V47, P870; Rieder F, 2010, INFLAMM BOWEL DIS, V16, P1367, DOI 10.1002/ibd.21179; Rieder F, 2010, INFLAMM BOWEL DIS, V16, P263, DOI 10.1002/ibd.21046; Russell RK, 2004, BEST PRACT RES CL GA, V18, P525, DOI 10.1016/j.bpg.2003.12.006; Seibold F, 2001, SCAND J GASTROENTERO, V36, P196, DOI 10.1080/003655201750065960; SEIBOLD F, 1991, GUT, V32, P1192, DOI 10.1136/gut.32.10.1192; Sendid B, 1998, AM J GASTROENTEROL, V93, P1306, DOI 10.1111/j.1572-0241.1998.00415.x; Seow CH, 2009, AM J GASTROENTEROL, V104, P1426, DOI 10.1038/ajg.2009.79; Sutton CL, 2000, GUT, V46, P58, DOI 10.1136/gut.46.1.58; Targan SR, 2005, GASTROENTEROLOGY, V128, P2020, DOI 10.1053/j.gastro.2005.03.046; Vermeire S, 2001, INFLAMM BOWEL DIS, V7, P8, DOI 10.1097/00054725-200102000-00002	36	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194222	10.1371/journal.pone.0194222	http://dx.doi.org/10.1371/journal.pone.0194222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596443	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000428630000020
J	Belluau, M; Shipley, B				Belluau, Michael; Shipley, Bill			Linking hard and soft traits: Physiology, morphology and anatomy interact to determine habitat affinities to soil water availability in herbaceous dicots	PLOS ONE			English	Article							PLANT FUNCTIONAL TRAITS; RELATIVE GROWTH-RATE; STOMATAL CONDUCTANCE; ASSIMILATION RATE; LEAF TRAITS; ECOLOGY; WORLDWIDE; STRESS; COMMUNITIES; RESPONSES	Background and aims Species' habitat affinities along environmental gradients should be determined by a combination of physiological (hard) and morpho-anatomical (soft) traits. Using a gradient of soil water availability, we address three questions: How well can we predict habitat affinities from hard traits, from soft traits, and from a combination of the two? How well can we predict species' physiological responses to drought (hard traits) from their soft traits? Can we model a causal sequence as soft traits -> hard traits -> species distributions? Methods We chose 25 species of herbaceous dicots whose affinities for soil moisture have already been linked to 5 physiological traits (stomatal conductance and net photosynthesis measured at soil field capacity, water use efficiency, stomatal conductance and soil water potential measured when leaves begin to wilt). Under controlled conditions in soils at field capacity, we measured five soft traits (leaf dry matter content, specific leaf area, leaf nitrogen content, stomatal area, specific root length). Key results Soft traits alone were poor predictors (R-2 = 0.129) while hard traits explained 48% of species habitat affinities. Moreover, hard traits were significantly related to combinations of soft traits. From a priori biological knowledge and hypothesized ecological links we built a path model showing a sequential pattern soft traits -> hard traits -> species distributions and accounting for 59.6% (p = 0.782) of habitat wetness. Conclusions Both direct and indirect causal relationships existed between soft traits, hard traits and species' habitat preferences. The poor predictive abilities of soft traits alone were due to the existence of antagonistic and synergistic direct and indirect effects of soft traits on habitat preferences mediated by the hard traits. To obtain a more realistic model applicable to a population level, it has to be tested in an experiment including species competition for water supply.	[Belluau, Michael; Shipley, Bill] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ, Canada	University of Sherbrooke	Belluau, M (corresponding author), Univ Sherbrooke, Dept Biol, Sherbrooke, PQ, Canada.	Michael.Belluau@USherbrooke.ca	Shipley, Bill/A-4578-2011	Shipley, Bill/0000-0002-7026-3880; Belluau, Michael/0000-0001-6707-546X	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (B. Shipley). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alameda D, 2012, ENVIRON EXP BOT, V79, P49, DOI 10.1016/j.envexpbot.2012.01.004; Araya YN, 2011, NEW PHYTOL, V189, P253, DOI 10.1111/j.1469-8137.2010.03475.x; Belluau M, 2017, ANN BOT-LONDON, V119, P1073, DOI 10.1093/aob/mcw267; CHAPIN FS, 1993, AM NAT, V142, pS78, DOI 10.1086/285524; Chaturvedi RK, 2014, J PLANT ECOL, V7, P544, DOI 10.1093/jpe/rtt053; Christensen RHB., 2015, ORDINAL REGRESSION M; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Galmes J, 2007, PLANT SOIL, V290, P139, DOI 10.1007/s11104-006-9148-6; Galmes J, 2013, PLANT CELL ENVIRON, V36, P920, DOI 10.1111/pce.12022; Garnier E., 2016, PLANT FUNCTIONAL DIV, V1st, DOI DOI 10.1093/ACPROF:OSO/9780198757368.001.0001; Hodgson JG, 1999, OIKOS, V85, P282, DOI 10.2307/3546494; Juhrbandt J, 2004, FOREST ECOL MANAG, V202, P245, DOI 10.1016/j.foreco.2004.07.021; Krober W, 2014, TREES-STRUCT FUNCT, V28, P901, DOI 10.1007/s00468-014-1004-3; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; McFadden D., 1973, FRONTIERS ECONOMETRI, P105, DOI DOI 10.1108/EB028592; Mitchell PJ, 2008, PLANT CELL ENVIRON, V31, P1791, DOI 10.1111/j.1365-3040.2008.01882.x; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Pugnaire F.I., 2007, FUNCTIONAL PLANT ECO; R Core Team, 2015, R LANG ENV STAT COMP, V55, P275; Reich PB, 1998, FUNCT ECOL, V12, P395, DOI 10.1046/j.1365-2435.1998.00209.x; Romermann C, 2016, FOLIA GEOBOT, V51, P143, DOI 10.1007/s12224-016-9250-3; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Sack L, 2010, FUNCT PLANT BIOL, V37, P687, DOI 10.1071/FP10097; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SCHULZE ED, 1994, ANNU REV ECOL SYST, V25, P629, DOI 10.1146/annurev.es.25.110194.003213; Shipley B, 2006, FUNCT ECOL, V20, P565, DOI 10.1111/j.1365-2435.2006.01135.x; Shipley B., 2015, CAUSE CORRELATION BI; Shipley B, 2017, J VEG SCI, V28, P1082, DOI 10.1111/jvs.12554; Shipley B, 2016, OECOLOGIA, V180, P923, DOI 10.1007/s00442-016-3549-x; Silvertown J, 2015, J ECOL, V103, P93, DOI 10.1111/1365-2745.12332; Tyree M. T., 2007, FUNCTIONAL PLANT ECO, P175; Venables WN., 2002, MODERN APPL STAT S 4; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Weiher E, 1999, J VEG SCI, V10, P609, DOI 10.2307/3237076; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; WRIGHT SJ, 1992, OECOLOGIA, V89, P457, DOI 10.1007/BF00317149	38	23	25	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193130	10.1371/journal.pone.0193130	http://dx.doi.org/10.1371/journal.pone.0193130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590137	Green Submitted, gold, Green Published			2022-12-26	WOS:000428603100015
J	Dehghanizadeh, S; Khoddami, V; Mosbruger, TL; Hammoud, SS; Edes, K; Berry, TS; Done, M; Samowitz, WS; DiSarici, JA; Luba, DG; Burt, RW; Jones, DA				Dehghanizadeh, Somaye; Khoddami, Vahid; Mosbruger, Timothy L.; Hammoud, Sue S.; Edes, Kornelia; Berry, Therese S.; Done, Michelle; Samowitz, Wade S.; DiSarici, James A.; Luba, Daniel G.; Burt, Randall W.; Jones, David A.			Active BRAF-V600E is the key player in generation of a sessile serrated polyp-specific DNA methylation profile	PLOS ONE			English	Article							COLORECTAL-CANCER; BRAF MUTATION; MICROSATELLITE INSTABILITY; TUMOR PROGRESSION; THYROID-CANCER; PHENOTYPE; TUMORIGENESIS; SURVEILLANCE; SENESCENCE; CARCINOMA	Background Sessile serrated polyps (SSPs) have emerged as important precursors for a large number of sporadic colorectal cancers. They are difficult to detect during colonoscopy due to their flat shape and the excessive amounts of secreted mucin that cover the polyps. The underlying genetic and epigenetic basis for the emergence of SSPs is largely unknown with existing genetic studies confined to a limited number of oncogenes and tumor suppressors. A full characterization of the genetic and epigenetic landscape of SSPs would provide insight into their origin and potentially offer new biomarkers useful for detection of SSPs in stool samples. Methods We used a combination of genome-wide mutation detection, exome sequencing and DNA methylation profiling (via methyl-array and whole-genome bisulfite sequencing) to analyze multiple samples of sessile serrated polyps and compared these to familial adenomatous polyps. Results Our analysis revealed BRAF-V600E as the sole recurring somatic mutation in SSPs with no additional major genetic mutations detected. The occurrence of BRAF-V600E was coincident with a unique DNA methylation pattern revealing a set of DNA methylation markers showing significant (similar to 3 to 30 fold) increase in their methylation levels, exclusively in SSP samples. These methylation patterns effectively distinguished sessile serrated polys from adenomatous polyps and did so more effectively than parallel gene expression profiles. Conclusions This study provides an important example of a single oncogenic mutation leading to reproducible global DNA methylation changes. These methylated markers are specific to SSPs and could be of important clinical relevance for the early diagnosis of SSPs using non-invasive approaches such as fecal DNA testing.	[Dehghanizadeh, Somaye] Univ Utah, Sch Med, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT USA; [Khoddami, Vahid] Harvard Med Sch, Dept Cell Biol, Boston, MA USA; [Khoddami, Vahid; Mosbruger, Timothy L.] ACECR, Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Stem Cells & Dev Biol, Tehran, Iran; [Hammoud, Sue S.; Edes, Kornelia; Berry, Therese S.; Done, Michelle; Burt, Randall W.] Univ Utah, Sch Med, Huntsman Canc Inst, Salt Lake City, UT USA; [Hammoud, Sue S.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI USA; [Samowitz, Wade S.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA; [DiSarici, James A.; Luba, Daniel G.] Monterey Bay Gastroenterol Res Inst, Monterey, CA USA; [Burt, Randall W.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA; [Jones, David A.] Oklahoma Med Res Fdn, Funct & Chem Genom, 825 NE 13th St, Oklahoma City, OK 73104 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Harvard University; Harvard Medical School; Academic Center for Education, Culture & Research (ACECR); Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Oklahoma Medical Research Foundation	Jones, DA (corresponding author), Oklahoma Med Res Fdn, Funct & Chem Genom, 825 NE 13th St, Oklahoma City, OK 73104 USA.	David-Jones@omrf.org			National Cancer Institute of the National Institutes of Health [R01CA11648, PO1CA073992]; HHMI Med2Grad program; NATIONAL CANCER INSTITUTE [R01CA116468] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); HHMI Med2Grad program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Numbers R01CA11648 and P01CA073992 and by HHMI Med2Grad program.; We are grateful to all the patients that donate their biopsies. We thank Drs. Alana Welm, Bryan Welm, Brad Cairns, Rodney Stewart, and Charles Murtaugh, for their helpful suggestions and comments. We thank Brian Dalley and Michael Klein at the sequencing core, and David Nix, Ying Sun, Brett Milash, Clint Mason, and Russell Bell for their help in data analysis. We also thank Ann Cline, and Paulette Bowman for their help in sample preparation and processing. Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Numbers R01CA11648 and PO1CA073992 and by HHMI Med2Grad program.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bennecke M, 2010, CANCER CELL, V18, P135, DOI 10.1016/j.ccr.2010.06.013; Bosch LJW, 2011, CLIN COLORECTAL CANC, V10, P8, DOI 10.3816/CCC.2011.n.002; Brait M, 2012, EPIGENETICS-US, V7, P710, DOI 10.4161/epi.20524; Carragher LAS, 2010, EMBO MOL MED, V2, P458, DOI 10.1002/emmm.201000099; Chang H, 2016, CYTOPATHOLOGY, V27, P122, DOI 10.1111/cyt.12248; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davila RE, 2006, GASTROINTEST ENDOSC, V63, P546, DOI 10.1016/j.gie.2006.02.002; Delker DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088367; Dhir M, 2011, INT J CANCER, V129, P1889, DOI 10.1002/ijc.25847; Ensari A, 2010, J CLIN PATHOL, V63, P665, DOI 10.1136/jcp.2010.077222; Ensari A, 2012, VIRCHOWS ARCH, V461, P495, DOI 10.1007/s00428-012-1319-7; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fernando WC, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/374926; Fu XS, 2014, INT J CLIN EXP PATHO, V7, P1275; Gaiser T, 2013, INT J CANCER, V132, P1800, DOI 10.1002/ijc.27869; Heigh RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085659; Hinoue T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008357; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Lange CPE, 2013, EPIGENOMICS-UK, V5, P105, DOI [10.2217/EPI.13.4, 10.2217/epi.13.4]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nix DA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-455; Noffsinger AE, 2009, ANNU REV PATHOL-MECH, V4, P343, DOI 10.1146/annurev.pathol.4.110807.092317; O'Brien MJ, 2006, AM J SURG PATHOL, V30, P1491, DOI 10.1097/01.pas.0000213313.36306.85; O'Brien MJ, 2007, GASTROENTEROL CLIN N, V36, P947, DOI 10.1016/j.gtc.2007.08.007; Rad R, 2013, CANCER CELL, V24, P15, DOI 10.1016/j.ccr.2013.05.014; Rex DK, 2012, AM J GASTROENTEROLOG; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Snover DC, 2011, HUM PATHOL, V42, P1, DOI 10.1016/j.humpath.2010.06.002; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Vedeld HM, 2017, INT J CANCER, V141, P967, DOI 10.1002/ijc.30796; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007	36	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0192499	10.1371/journal.pone.0192499	http://dx.doi.org/10.1371/journal.pone.0192499			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590112	Green Published, gold, Green Submitted			2022-12-26	WOS:000428603100005
J	Ghosh, R; Roy, S; Franco, S				Ghosh, Rajib; Roy, Sanchita; Franco, Sonia			PARP1 depletion induces RIG-I-dependent signaling in human cancer cells	PLOS ONE			English	Article							STRAND BREAK REPAIR; DNA-DAMAGE; POLY(ADP-RIBOSE) POLYMERASE-1; ENDOGENOUS RETROELEMENTS; RNA; INTERFERON; RESPONSES; IMMUNITY; SYSTEM; STRESS	DNA Damage Response (DDR) and DNA repair pathways are emerging as potent, ubiquitous suppressors of innate immune signaling in human cells. Here, we show that human cells surviving depletion of the Single Strand Break (SSB) repair protein PARP1 undergo p21-dependent senescence or cell cycle checkpoint activation in the context of activation of innate immune signaling, or viral mimicry. Specifically, we observe induction of a large number of interferon-stimulated genes (ISGs) and multiple pattern recognition receptors (PRRs; including RIG-I, MDA-5, MAVS, TLR3 and STING) and increased nuclear IRF3 staining. Mechanistically, depletion of the double-stranded RNA (dsRNA) helicase RIG-I or its downstream effector MAVS specifically rescues ISG induction in PARP1-depleted cells, suggesting that the RIG-I/MAVS pathway is required for sustained ISG expression in this context. Experiments with conditioned media or a neutralizing antibody to the alpha/beta-IFN receptor revealed that persistent ISG expression additionally requires an autocrine/paracrine loop. Finally, loss of PARP1 and radiation-induced DNA damage strongly synergize in the induction of p21 and ISGs. Overall, these findings increase our understanding of how PARP1 may suppress deleterious phenotypes associated to aging, inflammation and cancer in humans.	[Ghosh, Rajib; Roy, Sanchita; Franco, Sonia] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine	Franco, S (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21218 USA.	sfranco2@jhmi.edu			National Cancer Institute [R21 CA181417-01A1]; Basser Center for BRCA Research; Allegheny Health Network-Johns Hopkins Cancer Fund	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Basser Center for BRCA Research; Allegheny Health Network-Johns Hopkins Cancer Fund	This study was supported by the National Cancer Institute (www.cancer.gov; grant R21 CA181417-01A1 to SF); the Basser Center for BRCA Research (www.basser.org; unnumbered Basser Innovation Award to SF) and the Allegheny Health Network-Johns Hopkins Cancer Fund (www.hopkinsinedicine.org; unnumbered Pilot Grant to SF). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmeyer M, 2009, AGING-US, V1, P458, DOI 10.18632/aging.100052; Beck C, 2014, EXP CELL RES, V329, P18, DOI 10.1016/j.yexcr.2014.07.003; Benci JL, 2016, CELL, V167, P1540, DOI 10.1016/j.cell.2016.11.022; Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burnette BC, 2011, CANCER RES, V71, P2488, DOI 10.1158/0008-5472.CAN-10-2820; Chaudhuri AR, 2017, NAT REV MOL CELL BIO, V18, P610, DOI 10.1038/nrm.2017.53; Cheon H, 2013, EMBO J, V32, P2751, DOI 10.1038/emboj.2013.203; Chiang C, 2017, TRENDS IMMUNOL, V38, P39, DOI 10.1016/j.it.2016.10.008; Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; Dantzer F, 2000, BIOCHEMISTRY-US, V39, P7559, DOI 10.1021/bi0003442; Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Gluck S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Goubau D, 2014, NATURE, V514, P372, DOI 10.1038/nature13590; Ha HC, 2001, P NATL ACAD SCI USA, V98, P3364, DOI 10.1073/pnas.051633498; Hagan CR, 2003, NAT GENET, V35, P219, DOI 10.1038/ng1259; Hanzlikova H, 2016, NUCL ACIDS RES; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Hartlova A, 2015, IMMUNITY, V42, P332, DOI 10.1016/j.immuni.2015.01.012; Holm CK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10680; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; ISAACS A, 1963, LANCET, V2, P113; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Jazaeri AA, 2002, JNCI-J NATL CANCER I, V94, P990, DOI 10.1093/jnci/94.13.990; Kassiotis G, 2016, NAT REV IMMUNOL, V16, P207, DOI 10.1038/nri.2016.27; Langelier MF, 2012, SCIENCE, V336, P728, DOI 10.1126/science.1216338; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Mangerich A, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/321653; Minn AJ, 2015, TRENDS IMMUNOL, V36, P725, DOI 10.1016/j.it.2015.09.007; Mu X, 2016, ADV IMMUNOL, V132, P47, DOI 10.1016/bs.ai.2016.07.001; Nabet BY, 2017, CELL, V170, P352, DOI 10.1016/j.cell.2017.06.031; Orsburn B, 2010, MOL CELL BIOL, V30, P2341, DOI 10.1128/MCB.00091-10; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Pommier Y, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9246; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rank L, 2016, NUCLEIC ACIDS RES, V44, P10386, DOI 10.1093/nar/gkw859; Ranoa DRE, 2016, ONCOTARGET, V7, P26496, DOI 10.18632/oncotarget.8420; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Rudin CM, 2001, GENE CHROMOSOME CANC, V30, P64, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1066>3.0.CO;2-F; Sangfelt O, 2000, FRONT BIOSCI-LANDMRK, V5, pD479, DOI 10.2741/Sangfelt; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Suschak JJ, 2016, J IMMUNOL, V196, P310, DOI 10.4049/jimmunol.1501836; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Volkman HE, 2014, NAT IMMUNOL, V15, P415, DOI 10.1038/ni.2872; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; Widau RC, 2014, P NATL ACAD SCI USA, V111, pE484, DOI 10.1073/pnas.1323253111; Xia TL, 2016, CELL REP, V14, P282, DOI 10.1016/j.celrep.2015.12.029; Xu H, 2014, J PATHOL, V234, P386, DOI 10.1002/path.4404; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2015, CURR OPIN IMMUNOL, V32, P48, DOI 10.1016/j.coi.2014.12.012; Zeng M, 2014, SCIENCE, V346, P1486, DOI 10.1126/science.346.6216.1486; Zevini A, 2017, TRENDS IMMUNOL, V38, P194, DOI 10.1016/j.it.2016.12.004	63	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194611	10.1371/journal.pone.0194611	http://dx.doi.org/10.1371/journal.pone.0194611			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590171	gold, Green Published, Green Submitted			2022-12-26	WOS:000428603100068
J	Marra, F; Motta, L; Brock, AL; Macri, P; Florindo, F; Sadori, L; Terrenato, N				Marra, Fabrizio; Motta, Laura; Brock, Andrea L.; Macri, Patrizia; Florindo, Fabio; Sadori, Laura; Terrenato, Nicola			Rome in its setting. Post-glacial aggradation history of the Tiber River alluvial deposits and tectonic origin of the Tiber Island	PLOS ONE			English	Article							COASTAL-PLAIN TUSCANY; LATE-HOLOCENE; CLIMATE CHANGES; SEA-LEVEL; EVOLUTION; SUCCESSIONS; STRATIGRAPHY; SEDIMENTARY; RECORD; AGE	The Tiber valley is a prominent feature in the landscape of ancient Rome and an important element for understanding its urban development. However, little is known about the city's original setting. Our research provides new data on the Holocene sedimentary history and human-environment interactions in the Forum Boarium, the location of the earliest harbor of the city. Since the Last Glacial Maximum, when the fluvial valley was incised to a depth of tens of meters below the present sea level, C-14 and ceramic ages coupled with paleomagnetic analysis show the occurrence of three distinct aggradational phases until the establishment of a relatively stable alluvial plain at 6-8 m a.s.l. during the late 3rd century BCE. Moreover, we report evidence of a sudden and anomalous increase in sedimentation rate around 2600 yr BP, leading to the deposition of a 4-6m thick package of alluvial deposits in approximately one century. We discuss this datum in the light of possible tectonic activity along a morpho-structural lineament, revealed by the digital elevation model of this area, crossing the Forum Boarium and aligned with the Tiber Island. We formulate the hypothesis that fault displacement along this structural lineament may be responsible for the sudden collapse of the investigated area, which provided new space for the observed unusually large accumulation of sediments. We also posit that, as a consequence of the diversion of the Tiber course and the loss in capacity of transport by the river, this faulting activity triggered the origin of the Tiber Island.	[Marra, Fabrizio; Macri, Patrizia; Florindo, Fabio] Ist Nazl Geofis & Vulcanol, Rome, Italy; [Motta, Laura] Univ Michigan, Kelsey Museum Archaeol, Ann Arbor, MI 48109 USA; [Brock, Andrea L.; Terrenato, Nicola] Univ Michigan, Dept Class Studies, Ann Arbor, MI 48109 USA; [Sadori, Laura] Univ Roma La Sapienza, Dipartimento Biol Ambientale, Rome, Italy	Istituto Nazionale Geofisica e Vulcanologia (INGV); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Sapienza University Rome	Marra, F (corresponding author), Ist Nazl Geofis & Vulcanol, Rome, Italy.	fabrizio.marra@ingv.it	Florindo, Fabio/F-4119-2010; MARRA, Fabrizio/AAB-9514-2019; Sadori, Laura/E-4774-2015; Florindo, Fabio/AAU-2548-2021; Terrenato, Nicola/AAZ-2008-2020; Florindo, Fabio/M-1459-2019; Macrì, Patrizia/ABD-2144-2021	Florindo, Fabio/0000-0002-6058-9748; MARRA, Fabrizio/0000-0002-4881-9563; Sadori, Laura/0000-0002-2774-6705; Terrenato, Nicola/0000-0002-1053-0094; Florindo, Fabio/0000-0002-6058-9748; Macrì, Patrizia/0000-0003-2287-4019; Brock, Andrea L./0000-0001-5390-7499; Motta, Laura/0000-0003-4136-3142	DTS-MIUR NextData project; University of Michigan; Etruscan Foundation; Fondazione Lemmermann; National Science Foundation [1259122]	DTS-MIUR NextData project; University of Michigan(University of Michigan System); Etruscan Foundation; Fondazione Lemmermann(Fondazione CarifeFondazione Caritro); National Science Foundation(National Science Foundation (NSF))	The Sant'Omobono Project is promoted by the Sovrintendenza ai Beni Culturali di Roma Capitale in collaboration with the University of Michigan and the Universita della Calabria. M. Ceci and G. Caruso supervise the work for the Sovraintendenza. Work in the field is conducted by P. Brocato and N. Terrenato. The borehole campaign was facilitated by M. Ceci and contracted to CONGEO snc (now CNG) under the supervision of M. Martinelli. Support for this work was provided by the DTS-MIUR NextData project, the University of Michigan, the Etruscan Foundation, and the Fondazione Lemmermann. This work includes data collected with funding from the National Science Foundation under Grant No. 1259122. Any opinions, findings, and conclusions expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation.; Support for this work was provided by the DTS-MIUR NextData project, the University of Michigan, the Etruscan Foundation, and the Fondazione Lemmermann. This work includes data collected with funding from the National Science Foundation under Grant No. 1259122 (ALB). Any opinions, findings, and conclusions expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrete GS, 2007, FLOODS TIBER ANCIENT, Vxviii; AMMERMAN A. J., 1998, J ROMAN ARCHAEOL, V11, P213, DOI DOI 10.1017/S1047759400017268; Ammerman AJ, 2004, B COMUNALE, V99, P272; Ammerman Albert J., 2015, J ROMAN ARCHAEOL, V21, P7; Ammerman Albert J., 2000, SOC PREISTORIA PROTO, V8, P9; Amorosi A, 2013, QUATERN INT, V303, P93, DOI 10.1016/j.quaint.2013.03.030; Bellotti P, 2007, Z GEOMORPHOL, V51, P505, DOI 10.1127/0372-8854/2007/0051-0505; Belluomini G., 1986, GEOL ROMANA, V25, P213; Bencivenga M., 2001, PIENE TEVERE ROMA DA; Benito G, 2015, SCI REP-UK, V5, DOI 10.1038/srep16398; Benito G, 2015, CATENA, V130, P13, DOI 10.1016/j.catena.2014.11.014; Benvenuti M, 2006, HOLOCENE, V16, P863, DOI 10.1191/0959683606hl978rp; Bozzano F, 2008, J GEOPHYS RES SOLID, V113; Brocato P, 2016, RICERCHE NELL AREA T; Brocato P., 2017, AGE TARQUINIUS SUPER, P97; Brock AL, 2016, ANTIQUITY, V90, P654, DOI 10.15184/aqy.2016.65; Campo B, 2017, PALAEOGEOGR PALAEOCL, V466, P265, DOI 10.1016/j.palaeo.2016.11.016; Cinti FR, 2008, ANN GEOPHYS-ITALY, V51, P849; Ciotoli G, 2016, J GEOPHYS RES-SOL EA, V121, P48, DOI 10.1002/2015JB012557; Colini Antonio Maria, 1980, MAAR, V36, P43; Diffendale DP, 2016, J ROMAN ARCHAEOL, V29, P7, DOI 10.1017/S1047759400072032; Drescher-Schneider R, 2007, VEG HIST ARCHAEOBOT, V16, P279, DOI 10.1007/s00334-006-0089-z; Faccenna C, 1996, GEOPHYS J INT, V126, P781, DOI 10.1111/j.1365-246X.1996.tb04702.x; FOLLIERI M, 1988, Pollen et Spores, V30, P329; Frepoli A, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006322; Fulminante F, 2014, URBANISATION ROME LA, Vxx; Giraudi C, 2011, HOLOCENE, V21, P105, DOI 10.1177/0959683610377529; Giraudi C, 2014, HOLOCENE, V24, P932, DOI 10.1177/0959683614534738; Goudeau MLS, 2015, PALAEOGEOGR PALAEOCL, V418, P304, DOI 10.1016/j.palaeo.2014.11.004; Guilizzoni P, 2002, QUATERN INT, V88, P57, DOI 10.1016/S1040-6182(01)00073-8; Hopkins JN, 2016, GENESIS ROMAN ARCHIT, Vxiv; Horden P, 2000, CORRUPTING SEA STUDY, Vxiii; Karner DB, 2001, EARTH PLANET SC LETT, V188, P135, DOI 10.1016/S0012-821X(01)00325-9; KIRSCHVINK JL, 1980, GEOPHYS J ROY ASTR S, V62, P699, DOI 10.1111/j.1365-246X.1980.tb02601.x; Lambeck K, 2011, QUATERN INT, V232, P250, DOI 10.1016/j.quaint.2010.04.026; Luberti GM, 2017, QUATERN INT, V438, P40, DOI 10.1016/j.quaint.2017.01.044; Lurcock PC, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004098; Magny M, 2013, CLIM PAST, V9, P2043, DOI 10.5194/cp-9-2043-2013; Magny M, 2007, QUATERNARY SCI REV, V26, P1736, DOI 10.1016/j.quascirev.2007.04.014; Magri D, 1999, VEG HIST ARCHAEOBOT, V8, P247, DOI 10.1007/BF01291777; Marra F, 2016, EARTH PLANET SC LETT, V449, P105, DOI 10.1016/j.epsl.2016.05.037; Marra F, 2016, ARCHAEOMETRY, V58, P177, DOI 10.1111/arcm.12154; Marra F, 2004, J STRUCT GEOL, V26, P679, DOI 10.1016/j.jsg.2003.09.003; Marra F, 2013, GLOBAL PLANET CHANGE, V107, P157, DOI 10.1016/j.gloplacha.2013.05.002; Marra F, 2001, J STRUCT GEOL, V23, P127, DOI 10.1016/S0191-8141(00)00068-7; Marra F, 1999, GEOPHYS J INT, V138, P231, DOI 10.1046/j.1365-246x.1999.00866.x; Marra F, 2016, QUATERNARY SCI REV, V148, P85, DOI 10.1016/j.quascirev.2016.07.003; Marra F, 2015, QUATERNARY SCI REV, V129, P260, DOI 10.1016/j.quascirev.2015.10.027; Mensing SA, 2015, QUATERNARY SCI REV, V116, P72, DOI 10.1016/j.quascirev.2015.03.022; Mercuri AM, 2002, VEG HIST ARCHAEOBOT, V11, P263, DOI 10.1007/s003340200039; Mogetta M, 2015, J ROMAN STUD, V105, P1, DOI 10.1017/S007543581500043X; Molin D., 1989, TERREMOTI PRIMA MILL, P194; Peccerillo A., 2005, PLIO QUATERNARY VOLC, VXIV; Pepe C, 2016, J PALEOLIMNOL, V56, P173, DOI 10.1007/s10933-016-9903-5; Perkins P, 1999, ETRUSCAN SETTLEMENT; Peyron O, 2011, HOLOCENE, V21, P131, DOI 10.1177/0959683610384162; Ramrath A, 2000, HOLOCENE, V10, P87, DOI 10.1191/095968300669348734; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Roberts N, 2011, HOLOCENE, V21, P3, DOI 10.1177/0959683610388058; Rossi V, 2012, GEOMORPHOLOGIE, P201; Sadori L, 2013, CLIM PAST, V9, P1969, DOI 10.5194/cp-9-1969-2013; Sadori L, 2016, HOLOCENE, V26, P1502, DOI 10.1177/0959683616640054; Sadori L, 2011, HOLOCENE, V21, P117, DOI 10.1177/0959683610377530; Salomon F, 2017, GEOARCHAEOLOGY, V32, P215, DOI 10.1002/gea.21589; Sarti G, 2015, PALAEOGEOGR PALAEOCL, V424, P183, DOI 10.1016/j.palaeo.2015.02.020; Stanford JD, 2011, GLOBAL PLANET CHANGE, V79, P193, DOI 10.1016/j.gloplacha.2010.11.002; Terrenato Nicola, 2006, CELTES GAULOIS ARCHE, P225; ZANCHETTA G, 2016, ALP MEDITERR QUAT, V29, P5	68	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194838	10.1371/journal.pone.0194838	http://dx.doi.org/10.1371/journal.pone.0194838			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590208	Green Published, gold			2022-12-26	WOS:000428603100077
J	McLaren, D; Fedje, D; Dyck, A; Mackie, Q; Gauvreau, A; Cohen, J				McLaren, Duncan; Fedje, Daryl; Dyck, Angela; Mackie, Quentin; Gauvreau, Alisha; Cohen, Jenny			Terminal Pleistocene epoch human footprints from the Pacific coast of Canada	PLOS ONE			English	Article							SEA-LEVEL CHANGE; BUENOS-AIRES PROVINCE; BRITISH-COLUMBIA; CONTINENTAL-SHELF; DEPOSITS; LAETOLI; CLOVIS; AGE; ENVIRONMENTS; MIGRATION	Little is known about the ice age human occupation of the Pacific Coast of Canada. Here we present the results of a targeted investigation of a late Pleistocene shoreline on Calvert Island, British Columbia. Drawing upon existing geomorphic information that sea level in the area was 2-3 m lower than present between 14,000 and 11,000 years ago, we began a systematic search for archaeological remains dating to this time period beneath intertidal beach sediments. During subsurface testing, we uncovered human footprints impressed into a 13,000-year-old paleosol beneath beach sands at archaeological site EjTa-4. To date, our investigations at this site have revealed a total of 29 footprints of at least three different sizes. The results presented here add to the growing body of information pertaining to the early deglaciation and associated human presence on the west coast of Canada at the end of the Last Glacial Maximum.	[McLaren, Duncan; Fedje, Daryl; Dyck, Angela; Gauvreau, Alisha] Hakai Inst, Calvert Island, BC, Canada; [McLaren, Duncan; Fedje, Daryl; Dyck, Angela; Mackie, Quentin; Gauvreau, Alisha; Cohen, Jenny] Univ Victoria, Victoria, BC, Canada	Hakai Institute; University of Victoria	McLaren, D (corresponding author), Hakai Inst, Calvert Island, BC, Canada.; McLaren, D (corresponding author), Univ Victoria, Victoria, BC, Canada.	dsmclaren@gmail.com			Tula Foundation, HALAP; Tula Foundation; Hakai Institute	Tula Foundation, HALAP; Tula Foundation; Hakai Institute	Funded by Tula Foundation, HALAP 2012-2017. https://tula.org/ to DM. The Tula Foundation provided funding for research expenses. The funders participated in meetings concerning the overall scope of this project. 'In kind' support was provided for transportation and accommodations while in the field. The funders encouraged us to pursue this line of investigation but had no role in the preparation of this manuscript.; Funding and in-kind support was provided by the Tula Foundation and Hakai Institute. We thank Christina Munck and Eric Peterson for their involvement, guidance and assistance in all aspects of this project. We are grateful to the staff at the Hakai Institute for providing meals and accommodations. Many thanks to Harvey Humchitt, Kelly Brown of the Heiltsuk Integrated Resource Management Department for their guidance and to Jennifer Carpenter for providing comments on an earlier version of this manuscript. We acknowledge Peter Johnson of the Wuikinuxv First Nation for his input and support. Thanks to the researchers that helped in the field or lab including: Maxwell Johnson Jr., John Maxwell, Jennifer Walkus, Joanne McSporran, Farid Rahemtulla, Andrea Walkus, Jim Stafford, Aurora Skala, Joshua Vickers, Jess Barton, Cecilia Porter, Johnny Johnson, Seonaid Duffield, Callum Abbott, Brittany Witherspoon, Carling Reid, Alex Nichini, Alex Lausanne, Grant Callegari, Meigan Henry and Iain McKechnie. Thanks to John Southon and the W.M. Keck Carbon Cycle Accelerator Mass Spectrometry Laboratory at the University of California, Irvine, for running all radiocarbon date samples. All work was conducted under BC Archaeology Branch permit #2011-171 and BC Park Use Permits #105588 and #105935. We acknowledge Steve Acheson and Vashti Thiesson who were the BC Archaeology Branch project officers for this work. A preliminary version of this paper was presented at the Prehistoric Human Tracks conference (May 11-13, 2017) at the University of Cologne and Neanderthal Museum in Germany, and we are grateful for the insights and feedback given by trackers, archaeologists and ethnographers who attended. Many thanks to Neil Roach, Jon Erlandson and two anonymous scholars for their time and effort in conducting peer reviews for this paper.	Ackerman R, 1996, EARLY HUMAN OCCUPATI, P123; Al-Suwaidi M, 2006, GEOARCHAEOLOGY, V21, P307, DOI 10.1002/gea.20106; Allen J, 2004, ARCHAEOLOGY SEVERN E, V14, P55; Aramayo SA, 2009, ICHNOS, V16, P25, DOI 10.1080/10420940802470714; Aramayo SA, 2009, ICHNOS, V16, P49, DOI 10.1080/10420940802470748; Ashton N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088329; Barrie JV, 2002, SEDIMENT GEOL, V150, P171, DOI 10.1016/S0037-0738(01)00274-3; Bayon C, 2011, EVOLUTION ED OUTREAC, V4, P205, DOI DOI 10.1007/S12052-011-0335-4; BEHRENSMEYER AK, 1981, NATURE, V289, P167, DOI 10.1038/289167a0; Bennett MR, 2009, SCIENCE, V323, P1197, DOI 10.1126/science.1168132; Berge C, 2006, CR PALEVOL, V5, P561, DOI 10.1016/j.crpv.2005.09.001; BLAISE B, 1990, QUATERNARY RES, V34, P282, DOI 10.1016/0033-5894(90)90041-I; Bohannon RW, 2007, PHYS THER, V87, P1642, DOI 10.2522/ptj.20060037; Bourgeon L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169486; Braadbaart F, 2009, J ARCHAEOL SCI, V36, P1672, DOI 10.1016/j.jas.2009.03.006; Braje T. J., 2017, PALEOAMERICA, V3, P200, DOI DOI 10.1080/20555563.2017.1348091; Braje TJ, 2017, SCIENCE, V358, P592, DOI 10.1126/science.aao5473; Brannock C, 1928, US Patent, Patent No. 1682366; Burns A, 2014, PREHISTORIC FOOTPRIN; Carlson R, 2008, PROJECTILE POINT SEQ, P353; Carlson R.L., 1996, EARLY HUMAN OCCUPATI, P83; CLAGUE J, 1982, CAN J EARTH SCI, V19, P597, DOI 10.1139/e82-048; Clague J, 2002, QUATERN INT, V68-71, P29; Clague J.J., 2004, ENTERING AM NE ASIA, P63; Crompton RH, 2012, J R SOC INTERFACE, V9, P707, DOI 10.1098/rsif.2011.0258; Dillehay T., 2000, SETTLEMENT AM NEW PR; Dillehay TD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141923; Dixon J, 1999, BONES BOATS BISON AR; Eamer J, 2015, REPORT HAKAI ANCIENT; Eamer JBR, 2017, QUATERNARY RES, V87, P468, DOI 10.1017/qua.2017.16; Erlandson JM, 2015, J ISL COAST ARCHAEOL, V10, P392, DOI 10.1080/15564894.2014.1001923; Falkingham P, 2016, DINOSAUR TRACKS NEXT; Fedje D, 1996, EARLY HUMAN OCCUPATI, P35; Fedje D, 2011, QUATERN INT, V242, P452, DOI 10.1016/j.quaint.2011.03.042; Fedje DW, 2005, PACIF RIM ARCHAEOL, P21; Fedje DW, 1999, AM ANTIQUITY, V64, P635, DOI 10.2307/2694209; Fedje DW, 2000, GEOLOGY, V28, P99, DOI 10.1130/0091-7613(2000)28<99:DFAAOT>2.0.CO;2; Felstead NJ, 2014, J ARCHAEOL SCI, V42, P250, DOI 10.1016/j.jas.2013.11.010; Fladmark K, 1996, EARLY HUMAN OCCUPATI, P11; FLADMARK KR, 1979, AM ANTIQUITY, V44, P55, DOI 10.2307/279189; Friedman J, 1978, WOOD IDENTIFICATION; Gonzalez S, 2006, QUATERNARY SCI REV, V25, P201, DOI 10.1016/j.quascirev.2005.10.004; Halligan JJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600375; Harman J, 2017, DSTRETCH WEBSITE DST; Hatala KG, 2017, J HUM EVOL, V112, P93, DOI 10.1016/j.jhevol.2017.08.013; Heaton TH, 2004, ICE AGE CAVE FAUNAS OF NORTH AMERICA, P17; Hetherington R, 2004, QUATERNARY SCI REV, V23, P295, DOI 10.1016/j.quascirev.2003.04.001; Hoadley B. R., 1990, IDENTIFYING WOOD ACC; Holen SR, 2017, NATURE, V544, P479, DOI 10.1038/nature22065; James T, 2002, GEOLOGICAL SURVEY CA, V16, P1; Jenkins DL, 2012, SCIENCE, V337, P223, DOI 10.1126/science.1218443; LEAKEY MD, 1979, NATURE, V278, P317, DOI 10.1038/278317a0; Letham B, 2016, QUATERNARY SCI REV, V153, P156, DOI 10.1016/j.quascirev.2016.10.004; Liebenberg L., 1990, ART TRACKING ORIGIN; Lockley MG, 2009, ICHNOS, V16, P55, DOI 10.1080/10420940802470755; Lucas S, 2017, PALEOAMERICA, V3, P97; Luebbers R, STUDIES BELLA BELLA; LUTERNAUER JL, 1989, GEOLOGY, V17, P357, DOI 10.1130/0091-7613(1989)017<0357:LPTDOT>2.3.CO;2; Marty D, 2009, ICHNOS, V16, P127, DOI 10.1080/10420940802471027; Masao FT, 2016, ELIFE, V5, DOI 10.7554/eLife.19568; McLaren D, 2001, CANADIAN J ARCHAEOLO, V35, P86; McLaren D., 2015, BC STUDIES, V187, P155, DOI DOI 10.14288/BCS.V0I187.186161; McLaren D, ARCHAEOLOGY LOWER FR; McLaren D., 2005, CANADIAN ZOOARCHAEOL, V22, P3; McLaren D, 2014, QUATERNARY SCI REV, V97, P148, DOI 10.1016/j.quascirev.2014.05.023; Morse S.A., 2014, HUMAN FOOTPRINTS FOS; Morse SA, 2013, AM J PHYS ANTHROPOL, V151, P265, DOI 10.1002/ajpa.22276; Morse SA, 2010, QUATERNARY SCI REV, V29, P2571, DOI 10.1016/j.quascirev.2010.03.012; Panshin AJ, 1970, TXB WOOD TECHNOLOGY; Peltier WR, 2006, QUATERNARY SCI REV, V25, P3322, DOI 10.1016/j.quascirev.2006.04.010; Pruett C, 2017, CONDOR, V115, P725; Rahemtulla F, 2014, RES INVESTIGATIONS A; Rahemtulla F, 2006, THESIS; Rahemtulla F, 2014, ARCHAEOLOGICAL INVES; Raichlen DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009769; Ramsey CL, 2004, QUATERNARY RES, V62, P105, DOI 10.1016/j.yqres.2004.05.003; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Roach NT, 2016, SCI REP-UK, V6, DOI 10.1038/srep26374; Robbins L, 1985, FOOTPRINTS COLLECTIO; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Sheldon I, 1971, ANIMAL TRACKS BRIT C; Shugar DH, 2014, QUATERNARY SCI REV, V97, P170, DOI 10.1016/j.quascirev.2014.05.022; Waters MR, 2007, SCIENCE, V315, P1122, DOI 10.1126/science.1137166; Waters MR, 2011, SCIENCE, V334, P351, DOI 10.1126/science.1207663; Willey P, 2009, ICHNOS, V16, P70, DOI 10.1080/10420940802470839	85	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193522	10.1371/journal.pone.0193522	http://dx.doi.org/10.1371/journal.pone.0193522			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590165	Green Published, gold			2022-12-26	WOS:000428603100023
J	Kobayashi, Y; Inagawa, H; Kohchi, C; Kazumura, K; Tsuchiya, H; Miwa, T; Okazaki, K; Soma, GI				Kobayashi, Yutaro; Inagawa, Hiroyuki; Kohchi, Chie; Kazumura, Kimiko; Tsuchiya, Hiroshi; Miwa, Toshiyuki; Okazaki, Katsuichiro; Soma, Gen-Ichiro			Oral administration of Pantoea agglomerans-derived lipopolysaccharide prevents development of atherosclerosis in high-fat diet-fed apoE-deficient mice via ameliorating hyperlipidemia, pro-inflammatory mediators and oxidative responses	PLOS ONE			English	Article							ACTIVATED MACROPHAGE; WHEAT-FLOUR; BIOLOGICAL-ACTIVITIES; POLLEN ALLERGY; MURINE MODEL; HOMEOSTASIS; EXTRACT; LPS; CHOLESTEROL; DISEASES	Pantoea agglomerans (P. agglomerans) is a Gram-negative bacterium that grows symbiotically with various edible plants, and the oral or sublingual administration of lipopolysaccharide derived from P. agglomerans (LPSp) have been suggested to contribute to prevention of immune-related diseases. Our previous study indicated that orally administered LPSp was shown to exhibit an LDL-lowering effect in hyperlipidemic volunteers; however, a preventive effect of LPSp on atherosclerosis is unclear. The present study attempted to evaluate the anti-atherosclerotic effect by LPSp in a mouse model of high-fat diet (HFD)-induced atherosclerosis. For 16 weeks, apoE-deficient mice were fed an HFD and received drinking water containing LPSp (0.3 or 1 mg/kg body weight/day). The results showed that the orally administered LPSp decreased body weight. A significant reduction in atherosclerotic plaque deposition was observed even with the lower dose of LPSp. The biochemical analyses showed that LPSp markedly improved glucose tolerance and reduced plasma LDL and oxidized LDL levels. In addition, LPSp significantly reduced the production of pro-inflammatory mediators including MCP-1 (in the plasma), TNF-alpha and IL-6 (in the colon), and decreased the oxidative burst activities in the peripheral blood sample. Taken together, these results suggest the possibility that oral administration of LPSp can effectively ameliorate HFD-induced hyperlipidemia and inflammatory/oxidative responses to prevent atherosclerosis and related metabolic disorders.	[Kobayashi, Yutaro; Inagawa, Hiroyuki; Kohchi, Chie; Soma, Gen-Ichiro] Kagawa Univ, Fac Med, Dept Integrated Immunol, Takamatsu, Kagawa, Japan; [Kobayashi, Yutaro; Inagawa, Hiroyuki; Kohchi, Chie; Soma, Gen-Ichiro] Kagawa Univ, Fac Med, Dept Holist Immunol, Takamatsu, Kagawa, Japan; [Inagawa, Hiroyuki; Soma, Gen-Ichiro] Control Innate Immun Technol Res Assoc, Takamatsu, Kagawa, Japan; [Inagawa, Hiroyuki; Soma, Gen-Ichiro] Niigata Univ Pharm & Appl Life Sci, Res Inst Hlth Living, Niigata, Japan; [Kohchi, Chie] Macrophi Inc, Takamatsu, Kagawa, Japan; [Kazumura, Kimiko; Tsuchiya, Hiroshi; Miwa, Toshiyuki] Hamamatsu Photon KK, Cent Res Lab, Shizuoka, Japan; [Okazaki, Katsuichiro] Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Takamatsu, Kagawa, Japan	Kagawa University; Kagawa University; Niigata University; Hamamatsu Photonics; Kagawa University	Kobayashi, Y (corresponding author), Kagawa Univ, Fac Med, Dept Integrated Immunol, Takamatsu, Kagawa, Japan.; Kobayashi, Y (corresponding author), Kagawa Univ, Fac Med, Dept Holist Immunol, Takamatsu, Kagawa, Japan.	kobayashi@shizenmeneki.org		Kobayashi, Yutaro/0000-0003-0253-077X	Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP); Council for Science, Technology and Innovation (CSTI), 'Technologies for creating next generation agriculture, forestry and fisheries' (funding agency: Bio-oriented Technology Research Advancement Institution, NARO)	Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP); Council for Science, Technology and Innovation (CSTI), 'Technologies for creating next generation agriculture, forestry and fisheries' (funding agency: Bio-oriented Technology Research Advancement Institution, NARO)	This work was supported by the Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP) and 'Technologies for creating next generation agriculture, forestry and fisheries' (funding agency: Bio-oriented Technology Research Advancement Institution, NARO). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CK is employed by Macrophi Inc. The funder provided support in the form of salary for author CK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. KK, HT and TM are employed by Hamamatsu Photonics K.K. The funder provided support in the form of salaries for authors KK, HT and TM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aiello RJ, 1999, ARTERIOSCL THROM VAS, V19, P1518, DOI 10.1161/01.ATV.19.6.1518; Amano S, 2015, ANTICANCER RES, V35, P4509; Andoh Y, 2013, IMMUNOBIOLOGY, V218, P561, DOI 10.1016/j.imbio.2012.07.022; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chan YK, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0883-4; Cole JE, 2013, TRENDS PHARMACOL SCI, V34, P629, DOI 10.1016/j.tips.2013.09.008; Cui GM, 2013, ACTA PHARMACOL SIN, V34, P231, DOI 10.1038/aps.2012.155; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fukasaka M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126849; Grundtman C, 2015, ATHEROSCLEROSIS, V242, P303, DOI 10.1016/j.atherosclerosis.2015.06.044; Gustafson B, 2010, J ATHEROSCLER THROMB, V17, P332, DOI 10.5551/jat.3939; IGUCHI M, 1992, CHEM PHARM BULL, V40, P1004, DOI 10.1248/cpb.40.1004; INAGAWA H, 1992, CHEM PHARM BULL, V40, P998, DOI 10.1248/cpb.40.998; INAGAWA H, 1992, CHEM PHARM BULL, V40, P994, DOI 10.1248/cpb.40.994; Inagawa H, 2016, IN VIVO, V30, P205; Inagawa H, 2011, ANTICANCER RES, V31, P2431; Andres-Manzano MJ, 2015, METHODS MOL BIOL, V1339, P85, DOI 10.1007/978-1-4939-2929-0_5; Kazumura K, 2016, J CLIN BIOCHEM NUTR, V59, P1, DOI 10.3164/jcbn.16-4; Komori T, 2015, ANTICANCER RES, V35, P4461; Lewkowicz N, 2016, MUCOSAL IMMUNOL, V9, P364, DOI 10.1038/mi.2015.66; Lim MK, 2015, EXP THER MED, V9, P1369, DOI 10.3892/etm.2015.2238; LINDH E, 1991, APMIS, V99, P347, DOI 10.1111/j.1699-0463.1991.tb05160.x; Lofgren L, 2016, SCI REP-UK, V6, DOI 10.1038/srep27688; Matsushima Y, 1999, MAMM GENOME, V10, P352, DOI 10.1007/s003359901000; Matsuyama N, 2001, J MED MICROBIOL, V50, P865, DOI 10.1099/0022-1317-50-10-865; Miyake Y, 2016, FOOD SCI TECHNOL RES, V22, P713, DOI 10.3136/fstr.22.713; Montenegro D, 2015, BIOORG MED CHEM LETT, V25, P466, DOI 10.1016/j.bmcl.2014.12.036; Nakata K, 2011, NUTR RES PRACT, V5, P435, DOI 10.4162/nrp.2011.5.5.435; Ni JQ, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/476856; NISHIZAWA T, 1992, CHEM PHARM BULL, V40, P479, DOI 10.1248/cpb.40.479; Nunes C, 2001, INT J FOOD MICROBIOL, V70, P53, DOI 10.1016/S0168-1605(01)00523-2; OKUTOMI T, 1992, CHEM PHARM BULL, V40, P1268; Peluso Ilaria, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P351; Rabot S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32484; Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357; Rom O, 2017, ARCH TOXICOL, V91, P1709, DOI 10.1007/s00204-016-1859-8; Ryan PM, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0246-x; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SKARNES RC, 1966, ANN NY ACAD SCI, V133, P644, DOI 10.1111/j.1749-6632.1966.tb52395.x; Takahashi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087279; Takehara M, 2017, BIOCHEM BIOPH RES CO, V487, P419, DOI 10.1016/j.bbrc.2017.04.077; Tamura Y, 2015, ANTICANCER RES, V35, P4467; Taniguchi Y, 2009, ANTICANCER RES, V29, P859; van Puijvelde HM, 2007, ARTERIOSCL THROM VAS, V27, P2677, DOI 10.1161/ATVBAHA.107.151274; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; Vonghia L, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/239623; Wakame K, 2015, ANTICANCER RES, V35, P4501; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Wu HZ, 2009, CIRCULATION, V119, P2708, DOI 10.1161/CIRCULATIONAHA.108.823740; Xie JJ, 2010, CYTOKINE, V49, P185, DOI 10.1016/j.cyto.2009.09.007; Yamauchi T, 2008, INT J OBESITY, V32, pS13, DOI 10.1038/ijo.2008.233; Yokota T, 2016, J NUTR BIOCHEM, V32, P46, DOI 10.1016/j.jnutbio.2016.01.011; Yoshida K, 2015, NAT IMMUNOL, V16, P1034, DOI 10.1038/ni.3257; Zhao YT, 2015, J AGR FOOD CHEM, V63, P4843, DOI 10.1021/acs.jafc.5b01246	56	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0195008	10.1371/journal.pone.0195008	http://dx.doi.org/10.1371/journal.pone.0195008			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584779	Green Published, gold, Green Submitted			2022-12-26	WOS:000428373000055
J	Shin, H; Park, YH; Kim, YG; Lee, JY; Park, J				Shin, Hyunwoo; Park, Yong Hyun; Kim, Yong-Goo; Lee, Ji Youl; Park, Jaesung			Aqueous two-phase system to isolate extracellular vesicles from urine for prostate cancer diagnosis	PLOS ONE			English	Article							CELL-DERIVED EXOSOMES; BIOMARKERS; ANTIGEN; SEPARATION; PARTITION; LIQUID	Analyzing extracellular vesicles (EVs) is an attractive approach to diagnosis of prostate diagnosis. However, existing methods of EVs isolation have low efficiency, purity, and long process time, and therefore have low diagnostic ability. To solve these the problems, a two-phase system is adapted to isolate EVs from a patient's urine. Urine from 20 prostate cancer (PCA) patients and 10 benign prostate hyperplasia patients was used to quantify the EVs-isolation ability of an aqueous two-phase system (ATPS) and to compare the diagnostic ability of ATPS with that of the conventional diagnosis method. An optimized ATPS isolates EVs with similar to 100% efficiency within similar to 30 min, with 14 times as high as achieved by ultracentrifugation. Afterward, PCR and ELISA are used to detect EVs derived from PCA cells in urine. The results demonstrate that diagnostic ability based on ATPS is better than other conventional diagnostic methods. ATPS can obtain a high quality and quantity of EVs from patients' urine. EVs contain cancer-related protein and genes, so these abundant sources enable diagnosis with high specificity and sensitivity. Therefore, ATPS is a useful tool to increase the specificity and sensitivity of diagnosis.	[Shin, Hyunwoo; Park, Jaesung] POSTECH, Dept Mech Engn, Pohang, South Korea; [Park, Yong Hyun; Lee, Ji Youl] Catholic Univ Korea, Seoul St Marys Hosp, Dept Urol, Seoul, South Korea; [Kim, Yong-Goo] Catholic Univ Korea, Marys Hosp, Dept Lab Med, Seoul, South Korea	Pohang University of Science & Technology (POSTECH); Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Park, J (corresponding author), POSTECH, Dept Mech Engn, Pohang, South Korea.; Lee, JY (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Urol, Seoul, South Korea.	uroljy@catholic.ac.kr; jpark@postech.ac.kr			Korea Health Industry Development Institute grant (KHIDI) - Korea government [HI16C0665]	Korea Health Industry Development Institute grant (KHIDI) - Korea government	This work was supported by Korea Health Industry Development Institute grant (KHIDI) funded by the Korea government (No. HI16C0665). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTSSON PA, 1958, BIOCHIM BIOPHYS ACTA, V27, P378, DOI 10.1016/0006-3002(58)90345-7; Alix-Panabieres C, 2014, NAT REV CANCER, V14, P623, DOI 10.1038/nrc3820; Clayton A, 2001, J IMMUNOL METHODS, V247, P163, DOI 10.1016/S0022-1759(00)00321-5; Coren LV, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-64; D'Souza-Schorey C, 2012, GENE DEV, V26, P1287, DOI 10.1101/gad.192351.112; Davies RT, 2012, LAB CHIP, V12, P5202, DOI 10.1039/c2lc41006k; Coelho FF, 2015, GENET MOL RES, V14, P13519, DOI 10.4238/2015.October.28.13; Freedland SJ, 2005, J UROLOGY, V174, P1276, DOI 10.1097/01.ju.0000173907.84852.ec; Gyorgy B, 2011, BLOOD, V117, pE39, DOI 10.1182/blood-2010-09-307595; He CY, 2005, J CHROMATOGR A, V1082, P143, DOI [10.1016/j.chroma.2005.05.065, 10.1016/j.chroma.2005.04.054]; Hessels D, 2003, EUR UROL, V44, P8, DOI 10.1016/S0302-2838(03)00201-X; Hessels D, 2007, CLIN CANCER RES, V13, P5103, DOI 10.1158/1078-0432.CCR-07-0700; JOHANSSO.G, 1970, BIOCHIM BIOPHYS ACTA, V222, P381, DOI 10.1016/0304-4165(70)90127-3; Kim J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129760; Lamparski HG, 2002, J IMMUNOL METHODS, V270, P211, DOI 10.1016/S0022-1759(02)00330-7; LANTZ PG, 1994, APPL ENVIRON MICROB, V60, P3416, DOI 10.1128/AEM.60.9.3416-3418.1994; Laxman B, 2008, CANCER RES, V68, P645, DOI 10.1158/0008-5472.CAN-07-3224; Nawaz M, 2014, NAT REV UROL, V11, P688, DOI 10.1038/nrurol.2014.301; Nilsson J, 2009, BRIT J CANCER, V100, P1603, DOI 10.1038/sj.bjc.6605058; Park YH, 2016, SCI REPORTS, P6; Rabesandratana H, 1998, BLOOD, V91, P2573, DOI 10.1182/blood.V91.7.2573.2573_2573_2580; Raimondo F, 2011, PROTEOMICS, V11, P709, DOI 10.1002/pmic.201000422; Ralib AM, 2011, J AM SOC NEPHROLOGY; Rana S, 2012, INT J BIOCHEM CELL B, V44, P1574, DOI 10.1016/j.biocel.2012.06.018; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Shao HL, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150180; Shin H, 2015, SCI REPORTS, P5; Tauro BJ, 2012, METHODS, V56, P293, DOI 10.1016/j.ymeth.2012.01.002; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C., 2006, CURR PROTOC CELL BIO, V3, P1; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Viau C, 2004, INT ARCH OCC ENV HEA, V77, P177, DOI 10.1007/s00420-003-0495-9; WALTER H, 1976, BIOCHEMISTRY-US, V15, P2959, DOI 10.1021/bi00659a004; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200	35	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194818	10.1371/journal.pone.0194818	http://dx.doi.org/10.1371/journal.pone.0194818			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584777	Green Published, Green Submitted, gold			2022-12-26	WOS:000428373000039
J	Zhu, WB; Yan, J; Song, JR; You, P				Zhu, Wenbo; Yan, Jun; Song, Jingrui; You, Ping			The first mitochondrial genomes for Pyralinae (Pyralidae) and Glaphyriinae (Crambidae), with phylogenetic implications of Pyraloidea	PLOS ONE			English	Article							PRAYING-MANTISES DICTYOPTERA; LEPIDOPTERA; EVOLUTION	In the present study, we report five complete and one nearly complete mitochondrial genomes of the Pyraloidea including the first representatives from the Pyralinae (Pyralidae) and Glaphyriinae (Crambidae). We also conduct a comparative analysis of mitogenomic features of this group. Our results show that Pyraloidea mitogenomes evolved under a common trend found in lepidopteran mitogenomes and share several typical genomic characters. The extra conserved blocks are identified in the Pyraloidea control region, and diverse missing codons formed another unique trait within Pyraloidea mitogenome. Furthermore, we reconstruct the mitogenomic phylogeny of Pyraloidea and confirm the phylogenetic position of Pyralinae and Glaphyriinae within the Pyraloidea using BI and ML method based on multiple mitochondrial datasets.	[Zhu, Wenbo; Yan, Jun; Song, Jingrui; You, Ping] Shaanxi Normal Univ, Coll Life Sci, Xian, Shaanxi, Peoples R China; [Zhu, Wenbo] Northwestern Polytech Univ, Res Ctr Ecoenvironm Sci, Xian, Shaanxi, Peoples R China	Shaanxi Normal University; Northwestern Polytechnical University	You, P (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Xian, Shaanxi, Peoples R China.	youping@snnu.edu.cn		You, Ping/0000-0002-2913-1544	National Natural Science Foundation of China [31372158]; Natural Science Foundation of Shaanxi Province [2017JM3014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province)	This study was supported by grants from the National Natural Science Foundation of China (31372158) and the Natural Science Foundation of Shaanxi Province (2017JM3014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck J, 2011, BIOTROPICA, V43, P208, DOI 10.1111/j.1744-7429.2010.00689.x; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Gong YJ, 2012, MOL BIOL REP, V39, P2893, DOI 10.1007/s11033-011-1049-y; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Lavrov DV, 2000, P NATL ACAD SCI USA, V97, P13738, DOI 10.1073/pnas.250402997; Li H., 2012, MICROLEPIDOPTERA QIN; Li Q, 2016, GENOME BIOL EVOL, V8, P2651, DOI 10.1093/gbe/evw184; Li XK, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040773; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma HF, 2016, J ASIA-PAC ENTOMOL, V19, P697, DOI 10.1016/j.aspen.2016.05.011; Mitter C, 2017, ANNU REV ENTOMOL, V62, P265, DOI 10.1146/annurev-ento-031616-035125; MORITZ C, 1987, P NATL ACAD SCI USA, V84, P7183, DOI 10.1073/pnas.84.20.7183; Philippe H, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-50; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Regier JC, 2012, SYST ENTOMOL, V37, P635, DOI 10.1111/j.1365-3113.2012.00641.x; Shi Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep30660; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Solis M. Alma, 2002, Belgian Journal of Entomology, V4, P53; SOLIS MA, 1992, SYST ENTOMOL, V17, P79, DOI 10.1111/j.1365-3113.1992.tb00323.x; Staden R, 2000, Methods Mol Biol, V132, P115; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang M, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku917; Timmermans MJTN, 2014, MOL PHYLOGENET EVOL, V79, P169, DOI 10.1016/j.ympev.2014.05.031; Yang XS, 2015, MOL PHYLOGENET EVOL, V85, P230, DOI 10.1016/j.ympev.2015.02.005; Ye F, 2016, SCI REP-UK, V6, DOI 10.1038/srep25634; Ye F, 2013, AQUAT INSECT, V35, P71, DOI 10.1080/01650424.2014.948456; Yong HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15155; You P, 2003, AQUAT INSECT, V25, P211, DOI 10.1076/aqin.25.3.211.15264; ZHANG DX, 1995, J MOL EVOL, V40, P382, DOI 10.1007/BF00164024; Zhang HL, 2017, INT J BIOL SCI, V13, P367, DOI 10.7150/ijbs.17035; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zhu WB, 2016, MITOCHONDRIAL DNA A, V27, P4528, DOI 10.3109/19401736.2015.1101547	35	7	8	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194672	10.1371/journal.pone.0194672	http://dx.doi.org/10.1371/journal.pone.0194672			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584761	Green Published, Green Submitted, gold			2022-12-26	WOS:000428373000031
J	Curtis, JT; Assefa, S; Francis, A; Kohler, GA				Curtis, J. Thomas; Assefa, Senait; Francis, Arnie; Kohler, Gerwald A.			Fecal microbiota in the female prairie vole (Microtus ochrogaster)	PLOS ONE			English	Article							GUT-BRAIN AXIS; SOCIAL ATTACHMENT; BEHAVIOR; COMMUNITIES; DIVERSITY; MONOGAMY; MOUSE; MICE; RUMINOCOCCACEAE; MICROORGANISMS	We examined the fecal microbiota of female prairie voles. This species is socially and, likely, sexually monogamous, and thus serves as a valuable model in which to examine the interaction between the microbiota-gut-brain axis and social behavior. At present, little is known about the gastrointestinal microbiota of prairie voles; therefore, we performed a first characterization of the fecal microbiota using 16S rRNA gene amplicon sequencing. Semiconductor sequencing technology on an Ion Torrent PGM platform was used to assess the composition of fecal microbiotas from twelve female prairie voles. Following quality filtering, 1,017,756 sequencing reads were classified from phylum to genus level. At the phylum level, Firmicutes, Bacteroidetes, and Saccharibacteria were the predominant taxa, while the Bacteriodales, Erysipelotrichaceae, Ruminococcaceae, and Lachnospiraceae contributed the most dominant microbial groups and genera. Microbial community membership was most similar between vole sibling pairs, but consideration of taxon abundances weakened these associations. The interdependence of host factors such as genetics and behavior with the gastrointestinal microbiota is likely to be particularly pronounced in prairie voles. Our pilot characterization of the prairie vole intestinal microbiota revealed a microbial community composition remarkably consistent with the monogastric alimentary system of these rodents and their diet rich in complex plant carbohydrates. The highly social nature of these animals poses specific challenges to microbiome analyses that nonetheless are valuable for advancing research on the microbiota-gut-brain-behavior axis. Our study provides an important basis for future microbiome research in this emerging model organism for studying social behavior.	[Curtis, J. Thomas; Francis, Arnie] Oklahoma State Univ, Ctr Hlth Sci, Dept Pharmacol & Physiol, Tulsa, OK USA; [Assefa, Senait; Kohler, Gerwald A.] Oklahoma State Univ, Ctr Hlth Sci, Dept Biochem & Microbiol, Tulsa, OK 74106 USA	Oklahoma State University System; Oklahoma State University Center for Health Sciences; Oklahoma State University System; Oklahoma State University Center for Health Sciences	Kohler, GA (corresponding author), Oklahoma State Univ, Ctr Hlth Sci, Dept Biochem & Microbiol, Tulsa, OK 74106 USA.	gerwald.kohler@okstate.edu	Curtis, J. Thomas/J-4193-2019; Koehler, Gerwald/L-3624-2019	Koehler, Gerwald/0000-0002-0087-8206	National Institute Of General Medical Sciences of the National Institutes of Health [R15GM110593]; National Science Foundation [OCI-1126330]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM110593] Funding Source: NIH RePORTER	National Institute Of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute Of General Medical Sciences of the National Institutes of Health under award number R15GM110593 to JTC and GAK. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Some of the computing for this project was performed at the OSU High Performance Computing Center at Oklahoma State University supported in part through the National Science Foundation grant OCI-1126330. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, DIVERSITY-BASEL, DOI DOI 10.3390/d5030627; Asnicar F, 2015, PEERJ, V3, DOI 10.7717/peerj.1029; Assefa S, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0082-0; Barb JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148047; Batzli G.O., 1985, Special Publication American Society of Mammalogists, P779; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CARTER CS, 1987, HORM BEHAV, V21, P74, DOI 10.1016/0018-506X(87)90032-8; CARTER CS, 1988, PHYSIOL BEHAV, V44, P691, DOI 10.1016/0031-9384(88)90049-2; Carter CS, 1998, PSYCHONEUROENDOCRINO, V23, P779; CARTER CS, 1993, SCI AM, V268, P100, DOI 10.1038/scientificamerican0693-100; Collins SM, 2009, GASTROENTEROLOGY, V136, P2003, DOI 10.1053/j.gastro.2009.01.075; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Curtis JT, 2006, BRAIN RES, V1126, P76, DOI 10.1016/j.brainres.2006.07.126; Curtis JT, 2010, ANIM BEHAV, V80, P319, DOI 10.1016/j.anbehav.2010.05.014; Curtis JT, 2005, PHYSIOL BEHAV, V86, P338, DOI 10.1016/j.physbeh.2005.08.022; Davis DJ, 2017, BRAIN BEHAV IMMUN, V59, P38, DOI 10.1016/j.bbi.2016.09.003; Di Rienzi SC, 2013, ELIFE, V2, DOI 10.7554/eLife.01102; Dirksen P, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0258-1; DLUZEN DE, 1979, PHYSIOL BEHAV, V23, P597, DOI 10.1016/0031-9384(79)90063-5; DLUZEN DE, 1981, SCIENCE, V212, P573, DOI 10.1126/science.7010608; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Fetissov SO, 2017, NAT REV ENDOCRINOL, V13, P11, DOI 10.1038/nrendo.2016.150; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Flint HJ, 2004, ADV APPL MICROBIOL, V56, P89, DOI 10.1016/S0065-2164(04)56003-3; Forsythe P, 2013, CELL MOL LIFE SCI, V70, P55, DOI 10.1007/s00018-012-1028-z; Forsythe P, 2010, BRAIN BEHAV IMMUN, V24, P9, DOI 10.1016/j.bbi.2009.05.058; Frost G, 2014, NAT COMMUN, P5; Getz LL, 2001, J MAMMAL, V82, P22, DOI 10.1644/1545-1542(2001)082<0022:TFYOPF>2.0.CO;2; Gill N, 2010, NAT IMMUNOL, V11, P558, DOI 10.1038/ni0710-558; Godon JJ, 2016, BMC ECOL, V16, DOI 10.1186/s12898-016-0071-2; Greetham HL, 2004, ANAEROBE, V10, P301, DOI 10.1016/j.anaerobe.2004.06.004; Holzer P, 2014, ADV EXP MED BIOL, V817, P195, DOI 10.1007/978-1-4939-0897-4_9; Huson DH, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004957; Julliand V, 1999, APPL ENVIRON MICROB, V65, P3738; Kim JW, 1996, BIOL PSYCHIAT, V40, P918, DOI 10.1016/0006-3223(95)00546-3; Kohl KD, 2016, FRONT MICROBIOL, P7; Koskela KA, 2017, VECTOR-BORNE ZOONOT, V17, P123, DOI 10.1089/vbz.2016.1969; Krause DO, 1999, J APPL MICROBIOL, V86, P487, DOI 10.1046/j.1365-2672.1999.00688.x; Kreisinger J, 2014, MOL ECOL, V23, P5048, DOI 10.1111/mec.12909; KUDO H, 1984, VET RES COMMUN, V8, P77, DOI 10.1007/BF02214700; La Reau AJ, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000099; Leclercq S, 2016, CAN J PSYCHIAT, V61, P204, DOI 10.1177/0706743716635535; Lewis R, 2016, PHYSIOL BEHAV, V156, P106, DOI 10.1016/j.physbeh.2016.01.012; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li H, 2016, FRONT MICROBIOL, P7; Liu QS, 2007, J COMP PHYSIOL B, V177, P423, DOI 10.1007/s00360-006-0141-4; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lyte M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003726; Martin R, 2010, BENEF MICROBES, V1, P367, DOI 10.3920/BM2010.0027; McGraw LA, 2010, TRENDS NEUROSCI, V33, P103, DOI 10.1016/j.tins.2009.11.006; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Niu Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep09938; Ormerod KL, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0181-2; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ravussin Y, 2012, OBESITY, V20, P738, DOI 10.1038/oby.2011.111; Resendez SL, 2013, J NEUROSCI, V33, P9140, DOI 10.1523/JNEUROSCI.4123-12.2013; Rhee SH, 2009, NAT REV GASTRO HEPAT, V6, P306, DOI 10.1038/nrgastro.2009.35; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scott KA, 2017, BRAIN BEHAV IMMUN, V65, P20, DOI 10.1016/j.bbi.2017.02.004; Shang QS, 2016, FOOD FUNCT, V7, P3224, DOI [10.1039/c6fo00309e, 10.1039/C6FO00309E]; Soo RM, 2014, GENOME BIOL EVOL, V6, P1031, DOI 10.1093/gbe/evu073; Sperling JL, 2017, TICKS TICK-BORNE DIS, V8, P453, DOI 10.1016/j.ttbdis.2017.02.002; Stilling RM, 2014, GENES BRAIN BEHAV, V13, P69, DOI 10.1111/gbb.12109; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Vipperla K, 2012, NUTR CLIN PRACT, V27, P624, DOI 10.1177/0884533612452012; Wang H, 2013, NAT NEUROSCI, V16, P919, DOI 10.1038/nn.3420; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weldon L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134643; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Young KA, 2008, COMP BIOCHEM PHYS C, V148, P401, DOI 10.1016/j.cbpc.2008.02.004; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Young LJ, 1998, TRENDS NEUROSCI, V21, P71, DOI 10.1016/S0166-2236(97)01167-3; Zeber-Lubecka N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150306; Zeng B, 2015, SCI REP-UK, V5, DOI 10.1038/srep09342	79	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0190648	10.1371/journal.pone.0190648	http://dx.doi.org/10.1371/journal.pone.0190648			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579049	Green Submitted, Green Published, gold			2022-12-26	WOS:000428351800002
J	Jin, YX; Liu, Y; Li, ZP; Santostefano, K; Shi, J; Zhang, XW; Wu, DH; Cheng, ZH; Wu, WH; Terada, N; Jin, SG; Bai, F				Jin, Yongxin; Liu, Ying; Li, Zhenpeng; Santostefano, Katherine; Shi, Jing; Zhang, Xinwen; Wu, Donghai; Cheng, Zhihui; Wu, Weihui; Terada, Naohiro; Jin, Shouguang; Bai, Fang			Enhanced differentiation of human pluripotent stem cells into cardiomyocytes by bacteria-mediated transcription factors delivery	PLOS ONE			English	Article							III SECRETION SYSTEM; PSEUDOMONAS-AERUGINOSA; PROTEIN DELIVERY; HUMAN FIBROBLASTS; ARCHITECTURE; INDUCTION; INJECTION; INTERACT; SURVIVAL; DISEASE	Virus-mediated expression of defined transcription factor (TF) genes can effectively induce cellular reprogramming. However, sustained expression of the TFs often hinders pluripotent stem cell (PSC) differentiation into specific cell types, as each TF exerts its effect on PSCs for a defined period of time during differentiation. Here, we applied a bacterial type III secretion system (T3SS)-based protein delivery tool to directly translocate TFs in the form of protein into human PSCs. This transient protein delivery technique showed high delivery efficiency for hPSCs, and it avoids potential genetic alterations caused by the introduction of transgenes. In an established cardiomyocyte de novo differentiation procedure, five transcriptional factors, namely GATA4, MEF2C, TBX5, ESRRG and MESP1 (abbreviated as GMTEM), were translocated at various time points. By detecting the expression of cardiac marker genes (Nkx2.5 and cTnT), we found that GMTEM proteins delivered on mesoderm stage of the cardiomyocytes lineage differentiation significantly enhanced both the human ESC and iPSC differentiation into cardiomyocytes, while earlier or later delivery diminished the enhancing effect. Furthermore, all of the five factors were required to enhance the cardiac differentiation. This work provides a virus-free strategy of transient transcription factors delivery for directing human stem cell fate without jeopardizing genome integrity, thus safe for biomedical applications.	[Jin, Yongxin; Liu, Ying; Li, Zhenpeng; Shi, Jing; Zhang, Xinwen; Cheng, Zhihui; Wu, Weihui; Jin, Shouguang; Bai, Fang] Nankai Univ, Dept Microbiol, Coll Life Sci,State Key Lab Med Chem Biol, Key Lab Mol Microbiol & Technol,Minist Educ, Tianjin, Peoples R China; [Santostefano, Katherine; Terada, Naohiro] Univ Florida, Coll Med, Dept Pathol, Gainesville, FL USA; [Wu, Donghai] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China; [Jin, Shouguang] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA	Nankai University; State University System of Florida; University of Florida; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State University System of Florida; University of Florida	Jin, SG; Bai, F (corresponding author), Nankai Univ, Dept Microbiol, Coll Life Sci,State Key Lab Med Chem Biol, Key Lab Mol Microbiol & Technol,Minist Educ, Tianjin, Peoples R China.; Jin, SG (corresponding author), Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA.	sjin@ufl.edu; baifang1122@nankai.edu.cn	Jin, Shouguang/N-5548-2016		International Science & Technology Cooperation Program of China [2015DFG32500]; National Science Foundation of China [31670130, 31370168, 31370167, 31600110]; Tianjin Municipal Science and Technology Commission, China [15JCYBJC53900, 15JCZDJC33000]; State Key Laboratory of Medicinal Chemical Biology [2017005]	International Science & Technology Cooperation Program of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Commission, China; State Key Laboratory of Medicinal Chemical Biology	This work was supported by International Science & Technology Cooperation Program of China (2015DFG32500), National Science Foundation of China (31670130, 31370168, 31370167 and 31600110), Tianjin Municipal Science and Technology Commission, China (15JCYBJC53900 and 15JCZDJC33000) and the State Key Laboratory of Medicinal Chemical Biology (2017005).	Ameen C, 2008, CRIT REV ONCOL HEMAT, V65, P54, DOI 10.1016/j.critrevonc.2007.06.012; Bai F, 2015, SCI REP-UK, V5, DOI 10.1038/srep15014; Bichsel C, 2013, CELL REPROGRAM, V15, P117, DOI 10.1089/cell.2012.0058; Bichsel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016465; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Chauchet X, 2016, MOL THER-ONCOLYTICS, V3, DOI 10.1038/mto.2016.33; Debril MB, 2004, J BIOL CHEM, V279, P16677, DOI 10.1074/jbc.M312288200; Discola KF, 2014, J BIOL CHEM, V289, P3591, DOI 10.1074/jbc.M113.517920; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Fu JD, 2013, STEM CELL REP, V1, P235, DOI 10.1016/j.stemcr.2013.07.005; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Galan JE, 2014, ANNU REV MICROBIOL, V68, P415, DOI 10.1146/annurev-micro-092412-155725; Gauthier A, 2003, J BACTERIOL, V185, P6747, DOI 10.1128/JB.185.23.6747-6755.2003; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Guye P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10243; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Higuchi A, 2015, LAB INVEST, V95, P26, DOI 10.1038/labinvest.2014.132; Hu B, 2017, CELL, V168, P1065, DOI 10.1016/j.cell.2017.02.022; Ionta V, 2015, STEM CELL REP, V4, P129, DOI 10.1016/j.stemcr.2014.11.004; Jia J, 2015, STEM CELLS TRANSLATI, V4; Jia JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091547; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Li WD, 2014, NAT BIOTECHNOL, V32, P1223, DOI 10.1038/nbt.3082; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd-Jones DM, 2006, CIRCULATION, V113, P791, DOI 10.1161/CIRCULATIONAHA.105.548206; Neeld D, 2014, MICROBIOL-SGM, V160, P1417, DOI 10.1099/mic.0.078139-0; Nishimura K, 2011, J BIOL CHEM, V286, P4760, DOI 10.1074/jbc.M110.183780; Paige SL, 2012, CELL, V151, P221, DOI 10.1016/j.cell.2012.08.027; Puri PL, 2012, GENE DEV, V26, P2673, DOI 10.1101/gad.207415.112; Ray M, 2015, BIOCONJUGATE CHEM, V26, P1004, DOI 10.1021/acs.bioconjchem.5b00141; Santostefano KE, 2015, LAB INVEST, V95, P4, DOI 10.1038/labinvest.2014.104; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Wada R, 2013, P NATL ACAD SCI USA, V110, P12667, DOI 10.1073/pnas.1304053110; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wang Y, 2012, J IMMUNOTHER, V35, P223, DOI 10.1097/CJI.0b013e31824747e5; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	43	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194895	10.1371/journal.pone.0194895	http://dx.doi.org/10.1371/journal.pone.0194895			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579079	gold, Green Published, Green Submitted			2022-12-26	WOS:000428351800065
J	Miragall, M; Etchemendy, E; Cebolla, A; Rodriguez, V; Medrano, C; Banos, RM				Miragall, Marta; Etchemendy, Ernestina; Cebolla, Ausias; Rodriguez, Victor; Medrano, Carlos; Maria Banos, Rosa			Expand your body when you look at yourself: The role of the posture in a mirror exposure task	PLOS ONE			English	Article							ANOREXIA-NERVOSA; EATING-DISORDERS; IMAGE; POWER; RESPONSES; WOMEN; SHAPE; RISK; NEUROENDOCRINE; VALIDATION	Mirror exposure (ME) is one of the main components of the treatment of patients with eating disorders symptomatology and it has shown its effectiveness in improving several outcomes (e.g., body dissatisfaction). However, the study as to what body posture should be adopted to maximize its effectiveness has been neglected. From embodied cognition and emotion theories, the adoption of an expansive (vs. contractive) body posture has been associated with positive changes in cognitive and emotional responses. The objective of this study was to analyze the effect of adopting an expansive (vs. contractive) posture before an ME task on body-related emotions and cognitions, as well as to analyze the possible moderator and mediator variables of these relationships. The sample was composed of 68 women (age: M = 21.74, SD = 3.12) with high scores on body dissatisfaction. Participants were randomly assigned to the expansive or contractive condition, where the openness of the arms/legs and the back position were manipulated. Posture was monitored by an electronic device and participants filled out several self-reported measures. ANCOVAs, moderation, mediation, and moderated mediated analyses were performed. Results showed that women in the expansive condition showed higher positive emotions after the ME. Moreover, exploratory analyses showed that adopting an expansive posture improved positive emotions, leading to improvements in negative emotions, body image satisfaction, and appraisal of the person's own body. Psychological interventions should explore the value of holding an expansive posture before the ME in women with body dissatisfaction.	[Miragall, Marta; Cebolla, Ausias; Maria Banos, Rosa] Univ Valencia, Dept Personal Evaluat & Psychol Treatment, Valencia, Spain; [Etchemendy, Ernestina] Univ Zaragoza, Dept Personal & Sociol, Teruel, Spain; [Cebolla, Ausias; Maria Banos, Rosa] Inst Carlos III, CIBER Fisiopatol Obesidad Nutr CIBEROBN, Madrid, Spain; [Rodriguez, Victor; Medrano, Carlos] Univ Zaragoza, EduQTech, EUPT, Teruel, Spain; [Medrano, Carlos] Univ Zaragoza, Aragon Inst Hlth Res IIS Aragon, Zaragoza, Spain	University of Valencia; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Zaragoza; University of Zaragoza	Miragall, M (corresponding author), Univ Valencia, Dept Personal Evaluat & Psychol Treatment, Valencia, Spain.	marta.miragall@uv.es	Miragall, Marta/P-6942-2015; BAÑOS, ROSA MARIA/C-6077-2011; Marti, Ausias Cebolla/E-8410-2012	Miragall, Marta/0000-0002-0646-3597; BAÑOS, ROSA MARIA/0000-0003-0626-7665; Marti, Ausias Cebolla/0000-0002-3456-9743; Rodriguez Ontiveros, Victor Hugo/0000-0002-6963-0727; Medrano Sanchez, Carlos Tomas/0000-0001-7671-7540	Ministerio de Economia y Competitividad (Spain) under grant "BODYTA" [PSI2014-51928-R]	Ministerio de Economia y Competitividad (Spain) under grant "BODYTA"	This work was supported by the Ministerio de Economia y Competitividad (Spain) under grant "BODYTA" (Plan Nacional I+D+I 2013-2016 PSI2014-51928-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J, 2013, PSYCHOL WOMEN QUART, V37, P325, DOI 10.1177/0361684313476477; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Brinol P, 2009, EUR J SOC PSYCHOL, V39, P1053, DOI 10.1002/ejsp.607; Carney DR, 2015, PSYCHOL SCI, V26, P657, DOI 10.1177/0956797614566855; Carney DR, 2010, PSYCHOL SCI, V21, P1363, DOI 10.1177/0956797610383437; Cash Thomas F, 2002, Eat Disord, V10, P103, DOI 10.1080/10640260290081678; COOPER MJ, 1992, BEHAV RES THER, V30, P501, DOI 10.1016/0005-7967(92)90034-E; COOPER PJ, 1987, INT J EAT DISORDER, V6, P485, DOI 10.1002/1098-108X(198707)6:4<485::AID-EAT2260060405>3.0.CO;2-O; COOPER PJ, 1988, BRIT J PSYCHIAT, V153, P32, DOI 10.1192/S0007125000298966; Craske MG, 2008, BEHAV RES THER, V46, P5, DOI 10.1016/j.brat.2007.10.003; Craske MG, 2014, BEHAV RES THER, V58, P10, DOI 10.1016/j.brat.2014.04.006; Cuddy AJC, 2015, J APPL PSYCHOL, V100, P1286, DOI 10.1037/a0038543; de Zavala AG, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00752; Delinsky SS, 2006, INT J EAT DISORDER, V39, P108, DOI 10.1002/eat.20207; Diaz-Ferrer S, 2017, EUR EAT DISORD REV, V25, P562, DOI 10.1002/erv.2546; Diaz-Ferrer S, 2015, J BEHAV THER EXP PSY, V48, P1, DOI 10.1016/j.jbtep.2015.01.003; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Folk JB, 2016, J PSYCHOR INTEGR; Forghieri M, 2016, NEUROSCI LETT, V629, P155, DOI 10.1016/j.neulet.2016.07.002; Galeazzi GM, 2006, NEUROSCI LETT, V410, P71, DOI 10.1016/j.neulet.2006.09.077; Gandarillas A, 2003, DOC TECNICOS SALUD P, P38; GARNER DM, 1982, PSYCHOL MED, V12, P871, DOI 10.1017/S0033291700049163; Garrison KE, 2016, SOC PSYCHOL PERS SCI, V7, P623, DOI 10.1177/1948550616652209; Gronau QF., 2017, COMPREHENSIVE RESULT, V2, P123, DOI [10.1080/23743603.2017.1326760, DOI 10.1080/23743603.2017.1326760, DOI 10.1080/23743603.2017.1342447]; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hildebrandt T, 2012, BEHAV RES THER, V50, P797, DOI 10.1016/j.brat.2012.09.004; Jansen A, 2016, J BEHAV THER EXP PSY, V50, P90, DOI 10.1016/j.jbtep.2015.06.002; Jonas K., 2017, COMPR RESULTS SOC PS, V2, P139, DOI [10.1080/23743603.2017.1342447, DOI 10.1080/23743603.2017.1342447]; Key A, 2002, INT J EAT DISORDER, V31, P185, DOI 10.1002/eat.10027; Korner A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00940; Kolnes LJ, 2012, J BODYW MOV THER, V16, P281, DOI 10.1016/j.jbmt.2011.12.005; Koskina A, 2013, NEUROSCI BIOBEHAV R, V37, P193, DOI 10.1016/j.neubiorev.2012.11.010; Luethcke CA, 2011, BODY IMAGE, V8, P251, DOI 10.1016/j.bodyim.2011.03.006; Michalak J, 2014, CLIN PSYCHOL PSYCHOT, V21, P519, DOI 10.1002/cpp.1890; Nair S, 2015, HEALTH PSYCHOL, V34, P632, DOI 10.1037/hea0000146; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Ortega-Roldan B, 2014, EUR EAT DISORD REV, V22, P470, DOI 10.1002/erv.2323; Ortega-Roldan B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102595; Piedmont R.L., 2014, ENCY QUALITY LIFE WE, DOI DOI 10.1007/978-94-007-0753-5_1493; Raich R.M., 1996, CLIN SALUD, V7, P51; Ranehill E, 2015, PSYCHOL SCI, V26, P653, DOI 10.1177/0956797614553946; Saghaei Mahmood, 2004, BMC Med Res Methodol, V4, P26, DOI 10.1186/1471-2288-4-26; Servian-Franco F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122737; Simmons JP, 2017, PSYCHOL SCI, V28, P687, DOI 10.1177/0956797616658563; Stice E, 2002, PSYCHOL BULL, V128, P825, DOI 10.1037//0033-2909.128.5.825; Trentowska M, 2017, BEHAV RES THER, V90, P111, DOI 10.1016/j.brat.2016.12.006; Trentowska M, 2014, J BEHAV THER EXP PSY, V45, P178, DOI 10.1016/j.jbtep.2013.09.010; Trentowska M, 2013, BEHAV RES THER, V51, P1, DOI 10.1016/j.brat.2012.03.012; Tuschen-Caffier B, 2003, BEHAV RES THER, V41, P573, DOI 10.1016/S0005-7967(02)00030-X; Vocks S, 2007, J PSYCHOSOM RES, V62, P231, DOI 10.1016/j.jpsychores.2006.08.007; Walton GM, 2014, CURR DIR PSYCHOL SCI, V23, P73, DOI 10.1177/0963721413512856; Wilkes C, 2017, J BEHAV THER EXP PSY, V54, P143, DOI 10.1016/j.jbtep.2016.07.015; Winkielman P., 2015, APA HDB PERSONALITY, P151, DOI DOI 10.1037/14341-004	54	5	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2018	13	3							e0194686	10.1371/journal.pone.0194686	http://dx.doi.org/10.1371/journal.pone.0194686			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA2QK	29570729	gold, Green Published, Green Submitted			2022-12-26	WOS:000428168400027
J	Clifton, EH; Jaronski, ST; Coates, BS; Hodgson, EW; Gassmann, AJ				Clifton, Eric H.; Jaronski, Stefan T.; Coates, Brad S.; Hodgson, Erin W.; Gassmann, Aaron J.			Effects of endophytic entomopathogenic fungi on soybean aphid and identification of Metarhizium isolates from agricultural fields	PLOS ONE			English	Article							INSECT PATHOGENIC FUNGI; INDUCED SYSTEMIC RESISTANCE; BEAUVERIA-BASSIANA; GENETIC DIVERSITY; SEED TREATMENT; ANISOPLIAE; RESPONSES; SOILS; CORN; COLONIZATION	Terrestrial plants can harbor endophytic fungi that may induce changes in plant physiology that in turn affect interactions with herbivorous insects. We evaluated whether the application of entomopathogenic fungi Beauveria bassiana and Metarhizium brunneum to soybean seeds could become endophytic and affect interactions with soybean aphid (Aphis glycines Matsumura). It was found that A. glycines population sizes increased on plants with M. brunneum (strain F52) seed inoculum, but no significant effects were shown with analogous treatments with B. bassiana (strain GHA). Fungi recovered from soybean plant tissues indicate that endophytism was established, and that B. bassiana was more prevalent. Metarhizium brunneum was only recovered from stems, but B. bassiana was recovered from stems and leaves. This work confirms that some entomopathogenic fungi can be endophytic in soybean, however, some of these fungi may have a negative effect on the plants by increasing susceptibility of soybean to A. glycines. We also used DNA sequence data to identify species of Metarhizium obtained from agricultural fields in Iowa. Phylogenetic analyses, based on DNA sequence data, found that all isolates were Metarhizium robertsii, which is consistent with past studies indicating a cosmopolitan distribution and wide host range for this species. These results are important for understanding the dynamics of implementing environmentally sustainable measures for the control of pest insects.	[Clifton, Eric H.; Coates, Brad S.; Hodgson, Erin W.; Gassmann, Aaron J.] Iowa State Univ, Dept Entomol, Ames, IA 50011 USA; [Jaronski, Stefan T.] USDA, Northern Plains Agr Res Lab, Sidney, MT USA; [Coates, Brad S.] ARS, USDA, Corn Insects & Crop Genet Res Unit, Ames, IA USA; Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA	Iowa State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Cornell University	Clifton, EH (corresponding author), Iowa State Univ, Dept Entomol, Ames, IA 50011 USA.; Clifton, EH (corresponding author), Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA.	eclifton88@gmail.com	Jaronski, Stefan/AFU-7254-2022; Hodgson, Erin/M-9115-2019	Coates, Brad/0000-0001-8908-1529; Clifton, Eric/0000-0003-4978-2157; Hodgson, Erin/0000-0003-2492-3558	College of Agriculture and Life Sciences at Iowa State University	College of Agriculture and Life Sciences at Iowa State University	This work was supported by the College of Agriculture and Life Sciences at Iowa State University. There was no additional external funding received for this study.	Akello J, 2007, J INVERTEBR PATHOL, V96, P34, DOI 10.1016/j.jip.2007.02.004; Akello J, 2012, BIOL CONTROL, V61, P215, DOI 10.1016/j.biocontrol.2012.02.007; Aqueel MA, 2011, CROP PROT, V30, P216, DOI 10.1016/j.cropro.2010.09.013; Barelli L, 2016, PLANT MOL BIOL, V90, P657, DOI 10.1007/s11103-015-0413-z; Behie SW, 2012, SCIENCE, V336, P1576, DOI 10.1126/science.1222289; Behie SW, 2015, FUNGAL ECOL, V13, P112, DOI 10.1016/j.funeco.2014.08.001; Bidochka MJ, 1998, CAN J BOT, V76, P1198, DOI 10.1139/cjb-76-7-1198; Bischoff JF, 2009, MYCOLOGIA, V101, P512, DOI 10.3852/07-202; Bruck DJ, 2004, ENVIRON ENTOMOL, V33, P1335, DOI 10.1603/0046-225X-33.5.1335; Lopez DC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103891, 10.1371/journal.pone.0093811]; Chandler D, 2017, MICROBIAL CONTROL OF INSECT AND MITE PESTS: FROM THEORY TO PRACTICE, P69, DOI 10.1016/B978-0-12-803527-6.00005-6; CHASE AR, 1986, FLA ENTOMOL, V69, P285, DOI 10.2307/3494930; CHEEKE PR, 1995, J ANIM SCI, V73, P909; Clifton EH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133613; Conrath U, 2006, PLANT SIGNAL BEHAV, V1, P179, DOI 10.4161/psb.1.4.3221; De Bary A, 1866, HOLFMEISTERS HDB PHY, V2; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Elena G.J., 2011, ADV BIOL RES, V5, P22; Fargues J, 2002, MYCOL RES, V106, P1066, DOI 10.1017/S0953756202006408; Goettel Mark S., 1997, P213, DOI 10.1016/B978-012432555-5/50013-0; Gomez-Vidal S, 2009, ELECTROPHORESIS, V30, P2996, DOI 10.1002/elps.200900192; Gurulingappa P, 2010, BIOL CONTROL, V55, P34, DOI 10.1016/j.biocontrol.2010.06.011; Hernandez-Dominguez C, 2017, MICROB ECOL, V74, P194, DOI 10.1007/s00248-017-0942-x; Hodgson EW, 2012, J INTEGR PEST MANAG, V3, DOI 10.1603/IPM11019; Hu G, 2002, APPL ENVIRON MICROB, V68, P6383, DOI 10.1128/AEM.68.12.6383-6387.2002; Jaber LR, 2018, BIOL CONTROL, V116, P36, DOI 10.1016/j.biocontrol.2017.01.018; Jaronski ST, 2012, MANUAL TECHNIQUES IN, P257, DOI DOI 10.1016/B978-0-12-386899-2.00008-7; Kabaluk JT, 2007, AGRON J, V99, P1377, DOI 10.2134/agronj2007.0017N; Kepler RM, 2015, ENVIRON MICROBIOL, V17, P2791, DOI 10.1111/1462-2920.12778; Khan AL, 2012, WORLD J MICROB BIOT, V28, P1483, DOI 10.1007/s11274-011-0950-9; Klingen I, 2002, AGR ECOSYST ENVIRON, V91, P191, DOI 10.1016/S0167-8809(01)00227-4; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Lacey LA, 2016, MICROBIAL CONTROL IN, P69; Liao XG, 2014, APPL MICROBIOL BIOT, V98, P7089, DOI 10.1007/s00253-014-5788-2; Lopes RB, 2013, NEOTROP ENTOMOL, V42, P436, DOI 10.1007/s13744-013-0146-0; Maurer P, 1997, MYCOL RES, V101, P159, DOI 10.1017/S0953756296002213; McKinnon AC, 2017, BIOCONTROL, V62, P1, DOI 10.1007/s10526-016-9769-5; Meyling NV, 2007, BIOL CONTROL, V43, P145, DOI 10.1016/j.biocontrol.2007.07.007; Michel AP, 2011, SOYBEAN - MOLECULAR ASPECTS OF BREEDING, P355; Michel AP, 2010, J ECON ENTOMOL, V103, P949, DOI 10.1603/EC09337; Newman MA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00139; Parsa S, 2016, BIOL CONTROL; Pedigo LP, 2014, ENTOMOLOGY PEST MANA; Petrini O, 1991, MICROBIAL ECOLOGY LE, P179, DOI DOI 10.1007/978-1-4612-3168-4_9; Pieterse CMJ, 2014, ANNU REV PHYTOPATHOL, V52, P347, DOI 10.1146/annurev-phyto-082712-102340; Powell WA, 2009, J ENTOMOL SCI, V44, P391, DOI 10.18474/0749-8004-44.4.391; Quesada-Moraga E, 2006, MYCOPATHOLOGIA, V161, P323, DOI 10.1007/s11046-006-0014-0; Quesada-Moraga E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089278; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; Rehner SA, 2005, MYCOLOGIA, V97, P84, DOI 10.3852/mycologia.97.1.84; Rehner SA, 2017, J INVERTEBR PATHOL, V148, P60, DOI 10.1016/j.jip.2017.05.008; Resquin-Romero G, 2016, J INVERTEBR PATHOL, V136, P23, DOI 10.1016/j.jip.2016.03.003; Rezende JM, 2015, BIOCONTROL, V60, P495, DOI 10.1007/s10526-015-9656-5; Rudeen ML, 2013, J INVERTEBR PATHOL, V114, P329, DOI 10.1016/j.jip.2013.09.009; RUPPEL RF, 1983, J ECON ENTOMOL, V76, P375, DOI 10.1093/jee/76.2.375; Russo ML, 2015, BIOCONTROL SCI TECHN, V25, P475, DOI 10.1080/09583157.2014.982511; Saikkonen K, 2004, TRENDS PLANT SCI, V9, P275, DOI 10.1016/j.tplants.2004.04.005; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sasan RK, 2012, AM J BOT, V99, P101, DOI 10.3732/ajb.1100136; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Selig P, 2016, ARTHROPOD-PLANT INTE, V10, P273, DOI 10.1007/s11829-016-9437-9; Shoresh M, 2010, ANNU REV PHYTOPATHOL, V48, P21, DOI 10.1146/annurev-phyto-073009-114450; SIEGEL MR, 1990, J CHEM ECOL, V16, P3301, DOI 10.1007/BF00982100; Sokal R. H., 1995, BIOMETRY PRINCIPLES; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; Stucky Brian J, 2012, J Biomol Tech, V23, P90, DOI 10.7171/jbt.12-2303-004; Studham ME, 2013, MOL PLANT MICROBE IN, V26, P116, DOI 10.1094/MPMI-05-12-0124-FI; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tilmon KJ, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10016; van Esse HP, 2007, MOL PLANT MICROBE IN, V20, P1092, DOI 10.1094/MPMI-20-9-1092; Varenhorst AJ, 2015, ENVIRON ENTOMOL, V44, P658, DOI 10.1093/ee/nvv051; Vega FE, 2010, FUNGAL ECOL, V3, P122, DOI [10.1016/j.funeco.2009.05.001, 10.1016/j.funeco.2009.07.002]; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; Wilkinson HH, 2000, MOL PLANT MICROBE IN, V13, P1027, DOI 10.1094/MPMI.2000.13.10.1027; Wyrebek M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059357; Wyrebek M, 2011, MICROBIOL-SGM, V157, P2904, DOI 10.1099/mic.0.051102-0; Zhang YJ, 2010, LETT APPL MICROBIOL, V51, P114, DOI 10.1111/j.1472-765X.2010.02867.x; Zimmermann G, 2007, BIOCONTROL SCI TECHN, V17, P553, DOI 10.1080/09583150701309006; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	79	34	36	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194815	10.1371/journal.pone.0194815	http://dx.doi.org/10.1371/journal.pone.0194815			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566067	Green Published, Green Submitted, gold			2022-12-26	WOS:000428093900108
J	Peeters, F; Straile, D				Peeters, Frank; Straile, Dietmar			Trait selection and co-existence of phytoplankton in partially mixed systems: Trait based modelling and potential of an aggregated approach	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY; WATER COLUMN; COMMUNITY STRUCTURE; BLOOM DEVELOPMENT; BIOMASS MAXIMUM; COMPETITION; ECOSYSTEM; BIODIVERSITY; NUTRIENTS; LIGHT	Trait selection and co-existence in phytoplankton communities in partially mixed water columns is investigated using trait based modelling. In the models employed, trait selection results from phytoplankton competition for two limiting resources, light and nutrients. The study employs spatially resolved models, in which the phytoplankton community is represented as a large number of trait-groups characterized by fixed trait combinations (tradeoffs). Results from the trait-group resolving model (RM) are compared to results from an aggregated trait based model with adaptive traits (AM). Differences in specific production resulting from a trade-off between the half saturation constants of light and nutrients are sufficient to support evolutionary stable co-existence confirming that co-existence does not require differences in resource consumption. If abiotic conditions lead to the selection of a single trait group in RM, AM provides excellent approximations of the development of total biomass, average community trait and trait variance in the phytoplankton community. However, if selection leads to bimodal trait distributions, e.g. to co-existence of two trait groups (or species), functionally important properties of the phytoplankton community cannot be adequately represented by the aggregated information provided by AM. Because the increase in variance due to the development of bimodal trait distributions cannot be distinguished from an increase in variance due to an increase in trait diversity, the development of trait variance in AM models is not a reliable measure of trait diversity. Furthermore, AM may not provide reliable simulations of trophic interactions if the performance of the consumers depends on the traits of their resources. However, AM may support exploration of the consequences of environmental conditions and of the parameterization of species for co-existence within communities.	[Peeters, Frank; Straile, Dietmar] Univ Konstanz, Limnol Inst, Constance, Germany	University of Konstanz	Peeters, F (corresponding author), Univ Konstanz, Limnol Inst, Constance, Germany.	frank.peeters@uni-konstanz.de	Straile, Dietmar/A-4065-2008	Straile, Dietmar/0000-0002-7441-8552	German Research Foundation (DFG) [FP 590/14]	German Research Foundation (DFG)(German Research Foundation (DFG))	D. Straile was funded by the German Research Foundation (DFG grant FP 590/14 within the DFG priority program "Flexibility matters: DynaTrait").	Acevedo-Trejos E, 2016, GEOSCI MODEL DEV, V9, P4071, DOI 10.5194/gmd-9-4071-2016; Brauer VS, 2012, AM NAT, V179, P721, DOI 10.1086/665650; Bruggeman J, 2009, THESIS, P158; Bruggeman J, 2007, LIMNOL OCEANOGR, V52, P1533, DOI 10.4319/lo.2007.52.4.1533; Chen B, 2017, GEOSCI MODEL DEV DIS; Coutinho RM, 2016, THEOR ECOL-NETH, V9, P389, DOI 10.1007/s12080-016-0297-9; Edwards KF, 2013, ECOLOGY, V94, P1626, DOI 10.1890/12-1459.1; Edwards KF, 2013, ECOL LETT, V16, P56, DOI 10.1111/ele.12012; Edwards KF, 2012, LIMNOL OCEANOGR, V57, P554, DOI 10.4319/lo.2012.57.2.0554; Huisman J, 2006, NATURE, V439, P322, DOI 10.1038/nature04245; HUISMAN J, 1995, AM NAT, V146, P536, DOI 10.1086/285814; Huisman J, 2002, AM NAT, V159, P245, DOI 10.1086/338511; Jager CG, 2010, AM NAT, V175, pE91, DOI 10.1086/650728; Kenitz KM, 2017, LIMNOL OCEANOGR, V62, P1184, DOI 10.1002/lno.10494; Kerimoglu O, 2012, J THEOR BIOL, V300, P330, DOI 10.1016/j.jtbi.2012.01.044; LEVINS R, 1971, P NATL ACAD SCI USA, V68, P1246, DOI 10.1073/pnas.68.6.1246; Merico A, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00059; Merico A, 2009, ECOL MODEL, V220, P3001, DOI 10.1016/j.ecolmodel.2009.05.005; Mieleitner J, 2007, ECOL MODEL, V1, P279; Norberg J, 2004, LIMNOL OCEANOGR, V49, P1269, DOI 10.4319/lo.2004.49.4_part_2.1269; Norberg J, 2001, P NATL ACAD SCI USA, V98, P11376, DOI 10.1073/pnas.171315998; Peeters F, 2013, THEOR ECOL-NETH, V6, P115, DOI 10.1007/s12080-012-0164-2; Peeters F, 2007, LIMNOL OCEANOGR, V52, P286, DOI 10.4319/lo.2007.52.1.0286; Ryabov AB, 2014, AM NAT, V184, pE132, DOI 10.1086/677544; Ryabov AB, 2012, THEOR ECOL-NETH, V5, P373, DOI 10.1007/s12080-012-0158-0; Ryabov AB, 2010, J THEOR BIOL, V263, P120, DOI 10.1016/j.jtbi.2009.10.034; Savage VM, 2007, J THEOR BIOL, V247, P213, DOI 10.1016/j.jtbi.2007.03.007; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; Terseleer N, 2014, LIMNOL OCEANOGR, V59, P1958, DOI 10.4319/lo.2014.59.6.1958; Thingstad TF, 2010, PROG OCEANOGR, V84, P6, DOI 10.1016/j.pocean.2009.09.001; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; TILMAN D, 1980, AM NAT, V116, P362, DOI 10.1086/283633; Webb CT, 2010, ECOL LETT, V13, P267, DOI 10.1111/j.1461-0248.2010.01444.x; Wickman J, 2017, AM NAT, V189, P381, DOI 10.1086/690908; Wirtz KW, 1996, ECOL MODEL, V92, P33, DOI 10.1016/0304-3800(95)00196-4; Yoshiyama K, 2009, AM NAT, V174, P190, DOI 10.1086/600113	36	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194076	10.1371/journal.pone.0194076	http://dx.doi.org/10.1371/journal.pone.0194076			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566012	Green Published, gold, Green Submitted			2022-12-26	WOS:000428093900033
J	Chen, ZZ; Liu, YT; Yao, LT; Guo, SY; Gao, YF; Zhu, PP				Chen, Zhenzhen; Liu, Yating; Yao, Lintong; Guo, Shiying; Gao, Yanfeng; Zhu, Pingping			The long noncoding RNA lncZic2 drives the self-renewal of liver tumor-initiating cells via the protein kinase C substrates MARCKS and MARCKSL1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer stem cells; long noncoding RNA (long ncRNA; lncRNA); liver cancer; chromatin regulation; tumor promoter; tumor therapy; myristoylated alanine-rich protein kinase C substrate; protein kinase C signaling; self-renewal; tumor targeting; Zic family member 2	CANCER STEM-CELLS; IDENTIFICATION; ACTIVATION; HEDGEHOG; EXPRESSION; EVOLUTION; LNCRNAS; CD133	Liver tumor-initiating cells (TICs) form small subsets of cells in hepatocellular tumors and account for tumorigenesis, metastasis, recurrence, and drug resistance. Recently, we found that the transcription factor Zic family member 2 (ZIC2) is highly expressed in liver TICs and required for their self-renewal. However, the molecular mechanisms underlying self-renewal of liver TICs remain unclear. Here, using expression profiling and CRISPR-interference assays with clinical samples of human liver cancers, we identified a long noncoding RNA (lncRNA), lncZic2, that is located near the ZIC2 locus and was highly expressed in liver cancer and liver TICs. We found that lncZic2 is required for the self-renewal of liver TICs in a ZIC2-independent manner. lncZic2 drove the expression of myristoylated alanine-rich protein kinase C substrate (MARCKS) and MARCKS-like 1 (MARCKSL1), whose expression levels were increased during liver tumorigenesis and liver TIC self-renewal. Mechanistically, lncZic2 interacted with BRM/SWI2-related gene 1 (BRG1) and recruited this transcriptional regulator to the promoters of the MARCKS and MARCKSL1 gene, which activated expression of these genes. Moreover, we noted that depletion of lncZic2 and BRG1 decreases MARCKS and MARCKSL1 expression and diminishes liver TIC levels. In conclusion, lncZic2 is required for the self-renewal of liver TICs by up-regulating MARCKS and MARCKSL1 gene expression via the transcription factor BRG1. Our findings suggest that the lncZic2-BRG1-MARCKS/MARCKSL1 signaling cascade might be a potential target for eliminating liver TICs in the management of liver cancer.	[Chen, Zhenzhen; Liu, Yating; Yao, Lintong; Gao, Yanfeng; Zhu, Pingping] Zhengzhou Univ, Sch Life Sci, Zhengzhou 450001, Henan, Peoples R China; [Guo, Shiying] Wuhan Univ Technol, Sch Chem, Dept Pharmaceut Engn, Wuhan 430070, Hubei, Peoples R China	Zhengzhou University; Wuhan University of Technology	Gao, YF; Zhu, PP (corresponding author), Zhengzhou Univ, Sch Life Sci, Zhengzhou 450001, Henan, Peoples R China.	gaoyf@zzu.edu.cn; pingpingchustc@hotmail.com		, Chen/0000-0003-2093-4639	National Natural Science Foundation of China [U1604286, U1704174, 81601450, 81601448]; Development Fund for Outstanding Young Teachers of Zhengzhou University [1521311059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Development Fund for Outstanding Young Teachers of Zhengzhou University	This work was supported by the National Natural Science Foundation of China (U1604286, U1704174, 81601450, and 81601448) and the Development Fund for Outstanding Young Teachers of Zhengzhou University (1521311059). The authors declare that they have no conflicts of interest with the contents of this article.	ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; Anderson KM, 2016, NATURE, V539, P433, DOI 10.1038/nature20128; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Chen ZZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12598; Chen ZZ, 2018, ONCOGENE, V37, P3098, DOI 10.1038/s41388-018-0203-6; Chen ZZ, 2016, MOL PHARMACEUT, V13, P2749, DOI 10.1021/acs.molpharmaceut.6b00352; Chen ZZ, 2015, SMALL, V11, P952, DOI 10.1002/smll.201401397; Chen ZH, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-90; Feng DF, 2015, J BIOMATER TISS ENG, V5, P635, DOI 10.1166/jbt.2015.1363; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Justilien V, 2014, CANCER CELL, V25, P139, DOI 10.1016/j.ccr.2014.01.008; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Kurtova AV, 2015, NATURE, V517, P209, DOI 10.1038/nature14034; Liu BY, 2017, NAT IMMUNOL, V18, P499, DOI 10.1038/ni.3712; Liu BD, 2015, CANCER CELL, V27, P370, DOI 10.1016/j.ccell.2015.02.004; Luo S, 2016, CELL STEM CELL, V18, P637, DOI 10.1016/j.stem.2016.01.024; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Ramos AD, 2013, CELL STEM CELL, V12, P616, DOI 10.1016/j.stem.2013.03.003; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; Roessler S, 2012, GASTROENTEROLOGY, V142, P957, DOI 10.1053/j.gastro.2011.12.039; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Shimokawa M, 2017, NATURE, V545, P187, DOI 10.1038/nature22081; Takebe N, 2015, NAT REV CLIN ONCOL, V12, P445, DOI 10.1038/nrclinonc.2015.61; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Wang YY, 2015, CELL STEM CELL, V16, P413, DOI 10.1016/j.stem.2015.03.003; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; Zhu PP, 2017, PROG BIOCHEM BIOPHYS, V44, P697, DOI 10.16476/j.pibb.2017.0242; Zhu PP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13608; Zhu PP, 2016, NAT STRUCT MOL BIOL, V23, P631, DOI 10.1038/nsmb.3235; Zhu PP, 2015, J CLIN INVEST, V125, P3795, DOI 10.1172/JCI81979; Zhu PP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8122	41	25	26	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					7982	7992		10.1074/jbc.RA117.001321	http://dx.doi.org/10.1074/jbc.RA117.001321			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29588366	hybrid, Green Published			2022-12-26	WOS:000433224600006
J	Ferecatu, I; Canal, F; Fabbri, L; Mazure, NM; Bouton, C; Golinelli-Cohen, MP				Ferecatu, Ioana; Canal, Frederic; Fabbri, Lucilla; Mazure, Nathalie M.; Bouton, Cecile; Golinelli-Cohen, Marie-Pierre			Dysfunction in the mitochondrial Fe-S assembly machinery leads to formation of the chemoresistant truncated VDAC1 isoform without HIF-1 alpha activation	PLOS ONE			English	Article							IRON-SULFUR CLUSTER; NITRIC-OXIDE; ENDOPLASMIC-RETICULUM; REGULATORY PROTEIN-1; CYSTEINE RESIDUES; CA2+ HOMEOSTASIS; CANCER-CELLS; IN-VITRO; HYPOXIA; CHANNEL	Biogenesis of iron-sulfur clusters (ISC) is essential to almost all forms of life and involves complex protein machineries. This process is initiated within the mitochondrial matrix by the ISC assembly machinery. Cohort and case report studies have linked mutations in ISC assembly machinery to severe mitochondrial diseases. The voltage-dependent anion channel (VDAC) located within the mitochondrial outer membrane regulates both cell metabolism and apoptosis. Recently, the C-terminal truncation of the VDAC1 isoform, termed VDAC1-Delta C, has been observed in chemoresistant late-stage tumor cells grown under hypoxic conditions with activation of the hypoxia-response nuclear factor HIF-1 alpha. These cells harbored atypical enlarged mitochondria. Here, we show for the first time that depletion of several proteins of the mitochondrial ISC machinery in normoxia leads to a similar enlarged mitochondria phenotype associated with accumulation of VDAC1-Delta C. This truncated form of VDAC1 accumulates in the absence of HIF-1 alpha and HIF-2 alpha activations and confers cell resistance to drug-induced apoptosis. Furthermore, we show that when hypoxia and siRNA knock-down of the ISC machinery core components are coupled, the cell phenotype is further accentuated, with greater accumulation of VDAC1-Delta C. Interestingly, we show that hypoxia promotes the downregulation of several proteins (ISCU, NFS1, FXN) involved in the early steps of mitochondrial Fe-S cluster biogenesis. Finally, we have identified the mitochondria-associated membrane (MAM) localized Fe-S protein CISD2 as a link between ISC machinery downregulation and accumulation of anti-apoptotic VDAC1-Delta C. Our results are the first to associate dysfunction in Fe-S cluster biogenesis with cleavage of VDAC1, a form which has previously been shown to promote tumor resistance to chemotherapy, and raise new perspectives for targets in cancer therapy.	[Ferecatu, Ioana; Canal, Frederic; Bouton, Cecile; Golinelli-Cohen, Marie-Pierre] Univ Paris Saclay, Univ Paris Sud, CNRS, ICSN,UPR 2301, Gif Sur Yvette, France; [Fabbri, Lucilla; Mazure, Nathalie M.] Univ Nice Sophia Antipolis, CNRS, INSERM,U1081,UMR 7284, Inst Res Canc & Aging Nice,Ctr Antoine Lacassagne, Nice, France; [Ferecatu, Ioana] Univ Paris 05, Sorbonne Paris Cite, INSERM, Fac Sci Pharmaceut & Biol,UMR S1139, Paris, France; [Fabbri, Lucilla; Mazure, Nathalie M.] INSERM, U1065, C3M, Nice, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Bouton, C; Golinelli-Cohen, MP (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, ICSN,UPR 2301, Gif Sur Yvette, France.	cecile.bouton@cnrs.fr; marie-pierre.golinelli@cnrs.fr	Ferecatu, Ioana/AAW-5055-2021; Golinelli, Marie-Pierre/K-4287-2013	Ferecatu, Ioana/0000-0001-6842-9506; Golinelli, Marie-Pierre/0000-0002-6738-8631; Mazure, Nathalie/0000-0003-1350-7161				Abu-Hamad S, 2006, P NATL ACAD SCI USA, V103, P5787, DOI 10.1073/pnas.0600103103; Allouche M, 2012, BIOCHEM BIOPH RES CO, V429, P12, DOI 10.1016/j.bbrc.2012.10.108; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Andreini C, 2016, J PROTEOME RES, V15, P1308, DOI 10.1021/acs.jproteome.6b00045; Aram L, 2010, BIOCHEM J, V427, P445, DOI 10.1042/BJ20091690; Beilschmidt LK, 2014, BIOCHIMIE, V100, P48, DOI 10.1016/j.biochi.2014.01.009; Bogdan AR, 2016, TRENDS BIOCHEM SCI, V41, P274, DOI 10.1016/j.tibs.2015.11.012; Bouton Cecile, 2003, Sci STKE, V2003, ppe17, DOI 10.1126/stke.2003.182.pe17; Brahimi-Horn MC, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0133-5; Brahimi-Horn MC, 2015, MOL CELL BIOL, V35, P1491, DOI 10.1128/MCB.01402-14; Brahimi-Horn MC, 2012, CANCER RES, V72, P2140, DOI 10.1158/0008-5472.CAN-11-3940; Braymer JJ, 2017, J BIOL CHEM, V292, P12754, DOI 10.1074/jbc.R117.787101; Canal F, 2007, ARCH BIOCHEM BIOPHYS, V465, P282, DOI 10.1016/j.abb.2007.06.003; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chang NC, 2012, HUM MOL GENET, V21, P2277, DOI 10.1093/hmg/dds048; Chang NC, 2010, EMBO J, V29, P606, DOI 10.1038/emboj.2009.369; Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509; Chen Z, 2010, ONCOGENE, V29, P4362, DOI 10.1038/onc.2010.193; Chepelev NL, 2011, FREE RADICAL BIO MED, V50, P645, DOI 10.1016/j.freeradbiomed.2010.12.023; Chiche J, 2010, J CELL PHYSIOL, V222, P648, DOI 10.1002/jcp.21984; Ciesielski SJ, 2017, CURR GENET, V63, P51, DOI 10.1007/s00294-016-0618-y; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Corce V, 2016, BIOORG MED CHEM LETT, V26, P251, DOI 10.1016/j.bmcl.2015.11.094; Drapier JC, 1996, BIOESSAYS, V18, P549, DOI 10.1002/bies.950180706; Favaro E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010345; Ferecatu I, 2014, J BIOL CHEM, V289, P28070, DOI 10.1074/jbc.M114.548438; Golinelli-Cohen M.-P., 2017, CURR CHEM BIOL, V11, P70, DOI [10.2174/2212796811666170406163809, DOI 10.2174/2212796811666170406163809]; Guardiani C, 2016, BBA-BIOMEMBRANES, V1858, P813, DOI 10.1016/j.bbamem.2016.01.013; Guccini I, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.5; Habener A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156054; Hagen T, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/436981; Holt SH, 2016, J CELL SCI, V129, P155, DOI 10.1242/jcs.178293; Karmi O., 2017, PLOS ONE, V12; Lill R, 2015, EUR J CELL BIOL, V94, P280, DOI 10.1016/j.ejcb.2015.05.002; Maiuri MC, 2010, EMBO J, V29, P515, DOI 10.1038/emboj.2009.377; Maurya SR, 2015, J BIOL CHEM, V290, P30240, DOI 10.1074/jbc.M115.693978; Maurya SR, 2013, J BIOL CHEM, V288, P25584, DOI 10.1074/jbc.M113.493692; Mazure NM, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00193; McCormick RI, 2013, BRIT J CANCER, V108, P1133, DOI 10.1038/bjc.2013.56; Messina A, 2012, BBA-BIOMEMBRANES, V1818, P1466, DOI 10.1016/j.bbamem.2011.10.005; Meyer J, 2008, J BIOL INORG CHEM, V13, P157, DOI 10.1007/s00775-007-0318-7; Michieli P, 2009, CELL CYCLE, V8, P3291, DOI 10.4161/cc.8.20.9741; Mons C, 2017, METHOD ENZYMOL, V595, P83, DOI 10.1016/bs.mie.2017.07.010; Mylonis I, 2017, J CELL SCI, V130, P466, DOI 10.1242/jcs.195339; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Okazaki M, 2015, BBA-BIOMEMBRANES, V1848, P3188, DOI 10.1016/j.bbamem.2015.09.017; Reina S, 2016, ONCOTARGET, V7, P2249, DOI 10.18632/oncotarget.6850; Rostovtseva T, 1996, J BIOL CHEM, V271, P28006, DOI 10.1074/jbc.271.45.28006; Rouzier C, 2017, HUM MOL GENET, V26, P1599, DOI 10.1093/hmg/ddx060; Saletta F, 2010, MOL PHARMACOL, V77, P443, DOI 10.1124/mol.109.061028; Sampson MJ, 1997, J BIOL CHEM, V272, P18966, DOI 10.1074/jbc.272.30.18966; Sandau KB, 2001, BLOOD, V97, P1009, DOI 10.1182/blood.V97.4.1009; Shi Y, 2003, BIOCHEM BIOPH RES CO, V303, P475, DOI 10.1016/S0006-291X(03)00359-0; Shore GC, 2009, EMBO REP, V10, P1311, DOI 10.1038/embor.2009.249; Soum E, 2003, BIOCHEMISTRY-US, V42, P7648, DOI 10.1021/bi030041i; STEVENS RG, 1994, INT J CANCER, V56, P364, DOI 10.1002/ijc.2910560312; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Uhrigshardt H, 2010, HUM MOL GENET, V19, P3816, DOI 10.1093/hmg/ddq301; Ullmann P, 2016, ONCOTARGET, V7, P65454, DOI 10.18632/oncotarget.11772; Vickery LE, 2007, CRIT REV BIOCHEM MOL, V42, P95, DOI 10.1080/10409230701322298; Wachnowsky C, 2017, METHOD ENZYMOL, V595, P55, DOI 10.1016/bs.mie.2017.06.045; Wang CH, 2014, HUM MOL GENET, V23, P4770, DOI 10.1093/hmg/ddu193; White K, 2015, EMBO MOL MED, V7, P695, DOI 10.15252/emmm.201404511; Ye H, 2010, J CLIN INVEST, V120, P1749, DOI 10.1172/JCI40372; Yoshioka Y, 2012, J BIOL CHEM, V287, P34110, DOI 10.1074/jbc.M112.356717; Yu TY, 2012, BBA-BIOMEMBRANES, V1818, P1562, DOI 10.1016/j.bbamem.2011.11.012; ZHOU G, 1992, J BIOL CHEM, V267, P7936	69	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194782	10.1371/journal.pone.0194782	http://dx.doi.org/10.1371/journal.pone.0194782			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596470	Green Published, gold, Green Submitted			2022-12-26	WOS:000428630000042
J	Grzywocz, Z; Hoser, G; Sabalinska, S; Ladyzynski, P; Czubak, J; Dworczynska, M; Debski, R; Pius-Sadowska, E; Machalinski, B; Kawiak, J				Grzywocz, Zofia; Hoser, Grazyna; Sabalinska, Stanislawa; Ladyzynski, Piotr; Czubak, Jaroslaw; Dworczynska, Malgorzata; Debski, Romuald; Pius-Sadowska, Ewa; Machalinski, Boguslaw; Kawiak, Jerzy			Response of human normal and leukemia cells to factors released by amnion fragments in vitro	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; MEMBRANE TRANSPLANTATION; ENDOTHELIAL-CELLS; SCATTER FACTOR; PROLIFERATION; EXPRESSION; RECEPTORS; PECAM-1; AXIS; BETA	Amnion is a membrane surrounding the embryo/fetus which determine growth factors and interleukins with angiogenic, immunogenic, and anti-inflammatory properties. The aim of the present study was to investigate the effects of conditioned culture medium from 24-h cultures of human amnion (hAM CCM) on migration and proliferation of human umbilical vein endothelial primary cells (HUVECs), freshly isolated bone marrow mononuclear cells (BM MNCs), and Jurkat leukemia cell line. Amnion membrane was freshly isolated from healthy placenta and its fragments cultured in vitro to produce hAM CCM. Members of the IGFBP protein family made up one third of all assayed proteins present in the hAM medium. The hAM CCM did not affect the proliferation rate of HUVECs or MNCs, but we observed more intensive migration of those cells, and lower expression of CD31 surface antigen on HUVECs as compared to control cultures. In contrast, Jurkat cells did not respond to hAM CCM treatment by proliferation or mobility change. The conditioned medium from 24-h cultures of human amnion is easy to obtain and is a convenient source of various growth and other factors that may be useful in practical medicine.	[Grzywocz, Zofia] Med Ctr Postgrad Educ, Dept Clin Cytophysiol, Warsaw, Poland; [Hoser, Grazyna; Kawiak, Jerzy] Med Ctr Postgrad Educ, Lab Flow Cytometry, Warsaw, Poland; [Sabalinska, Stanislawa; Ladyzynski, Piotr; Kawiak, Jerzy] Nalecz Inst Biocybernet & Biomed Engn PAS, Warsaw, Poland; [Czubak, Jaroslaw] Med Ctr Postgrad Educ, Clin Pediat Orthopedy & Traumatol, Warsaw, Poland; [Dworczynska, Malgorzata; Debski, Romuald] Bielanski Hosp, Obstet & Gynecol Clin, Warsaw, Poland; [Pius-Sadowska, Ewa; Machalinski, Boguslaw] Pomeranian Med Univ, Dept Gen Pathol, Szczecin, Poland	Centre of Postgraduate Medical Education - Poland; Centre of Postgraduate Medical Education - Poland; Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences; Centre of Postgraduate Medical Education - Poland; Pomeranian Medical University	Kawiak, J (corresponding author), Med Ctr Postgrad Educ, Lab Flow Cytometry, Warsaw, Poland.; Kawiak, J (corresponding author), Nalecz Inst Biocybernet & Biomed Engn PAS, Warsaw, Poland.	jkawiak@ibib.waw.pl	Ladyzynski, Piotr/U-2741-2019; Pius-Sadowska, Ewa/O-8254-2014	Ladyzynski, Piotr/0000-0003-3268-9896; Pius-Sadowska, Ewa/0000-0003-3106-8705; Machalinski, Boguslaw/0000-0002-6013-0419; Czubak, Jaroslaw/0000-0003-2358-8735; Hoser, Grazyna/0000-0002-0917-5611; Kawiak, Jerzy/0000-0002-3048-0653; Sabalinska, Stanislawa/0000-0001-5870-3647				Alio JL, 2005, EXPERT REV MED DEVIC, V2, P153, DOI 10.1586/17434440.2.2.153; BUSSOLINO F, 1991, J CLIN INVEST, V87, P986, DOI 10.1172/JCI115107; COLOTTA F, 1993, EXP CELL RES, V206, P311, DOI 10.1006/excr.1993.1151; Duan-Arnold Y, 2015, ADV WOUND CARE, V4, P329, DOI 10.1089/wound.2015.0637; Duncan GS, 1999, J IMMUNOL, V162, P3022; GALIMI F, 1994, J CELL BIOL, V127, P1743, DOI 10.1083/jcb.127.6.1743; Gomes Jose A P, 2005, Curr Opin Ophthalmol, V16, P233, DOI 10.1097/01.icu.0000172827.31985.3a; Grzywocz Z, 2012, ADV CELL BIOL, V39, P637; Grzywocz Z, 2014, FOLIA HISTOCHEM CYTO, V52, P163, DOI 10.5603/FHC.2014.0019; Jung HJ, 2015, FRONT GENET, V5, DOI 10.3389/fgene.2014.00472; Kasprzak A, 2017, MUTAT RES-REV MUTAT, V772, P78, DOI 10.1016/j.mrrev.2016.08.007; KOJIMA S, 1989, J CELL PHYSIOL, V138, P192, DOI 10.1002/jcp.1041380125; Koob TJ, 2013, INT WOUND J, V10, P493, DOI 10.1111/iwj.12140; Lertkiatmongkol P, 2016, CURR OPIN HEMATOL, V23, P253, DOI 10.1097/MOH.0000000000000239; Lo V, 2009, INT J DERMATOL, V48, P935, DOI 10.1111/j.1365-4632.2009.04173.x; MAKELA TP, 1987, MOL CELL BIOL, V7, P3656; Mermet I, 2007, WOUND REPAIR REGEN, V15, P459, DOI 10.1111/j.1524-475X.2007.00252.x; NALDINI L, 1991, EMBO J, V10, P2867, DOI 10.1002/j.1460-2075.1991.tb07836.x; Park S, 2015, CLIN SCI, V129, P217, DOI 10.1042/CS20140714; SORSBY A, 1947, BRIT J OPHTHALMOL, V31, P409, DOI 10.1136/bjo.31.7.409; Steinritz D, 2015, JOVE-J VIS EXP, DOI 10.3791/52768; WEIDNER KM, 1991, P NATL ACAD SCI USA, V88, P7001, DOI 10.1073/pnas.88.16.7001; Wolbank S, 2009, J TISSUE ENG REGEN M, V3, P651, DOI 10.1002/term.207; Zhao B, 2016, CELL TISSUE RES, V365, P85, DOI 10.1007/s00441-016-2366-1; Zloza A, 2011, CANCER IMMUNOL IMMUN, V60, P291, DOI 10.1007/s00262-010-0962-6	25	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195035	10.1371/journal.pone.0195035	http://dx.doi.org/10.1371/journal.pone.0195035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596519	Green Published, gold, Green Submitted			2022-12-26	WOS:000428630000069
J	Heo, JY; Seo, YB; Choi, WS; Lee, J; Yoon, JG; Lee, SN; Choi, MJ; Noh, JY; Ahn, JY; Jeong, HW; Cheong, HJ; Kim, WJ; Lee, HY; Song, JY				Heo, Jung Yeon; Seo, Yu Bin; Choi, Won Suk; Lee, Jacob; Yoon, Jin Gu; Lee, Saem Na; Choi, Min Joo; Noh, Ji Yun; Ahn, Jin-Young; Jeong, Hye Won; Cheong, Hee Jin; Kim, Woo Joo; Lee, Hee Young; Song, Joon Young			Incidence and case fatality rates of community-acquired pneumonia and pneumococcal diseases among Korean adults: Catchment population-based analysis	PLOS ONE			English	Article							CONJUGATE VACCINE; REQUIRING HOSPITALIZATION; COST-EFFECTIVENESS; ECONOMIC BURDEN; EPIDEMIOLOGY	Background Pneumonia is a leading infectious cause of morbidity and mortality among adults. Pneumococcal pneumonia (PP) is the most common vaccine-preventable bacterial etiology of pneumonia. In this study, we estimated the incidence of community-acquired pneumonia (CAP) and pneumococcal diseases among Korean adults. Methods Clinical and microbiological databases from three hospitals were retrospectively reviewed to determine the incidence and case fatality rates of CAP and pneumococcal diseases in Korean adults aged >= 19 years from 2011 to 2014. Incidence and case fatality rates of CAP, PP and invasive pneumococcal diseases (IPD) were evaluated based on the catchment population. Catchment population was calculated using national health insurance data, estimating the proportion of patients with pneumonia that were medically attended at each hospital. Results Among 5,783 patients with medically attended CAP, 833 (14.4%) had PP. For IPD, a total of 91 culture-confirmed cases were identified. The overall incidence of CAP was 307.7 cases per 100,000 persons per year with an in-hospital mortality rate of 6.2%. The estimated annual incidence of pneumococcal pneumonia was 42.2-49.4 cases per 100,000 persons per year, increasing with age to 280 per 100,000 persons per year in older patients over 70 years. The annual incidence of IPD had a range of 4.1-6.5 cases per 100,000 persons per year. The overall case fatality rate for invasive pneumococcal diseases was 30.8% with the highest rate of 66.7% in patients over 80 years. Conclusion Over the study period, incidences of CAP, PP and IPD were consistently high, particularly in older people. These results provide baseline data to establish healthcare strategies and estimate their impact among Korean adults.	[Heo, Jung Yeon] Ajou Univ, Dept Infect Dis, Sch Med, Suwon, South Korea; [Seo, Yu Bin; Lee, Jacob] Hallym Univ, Coll Med, Dept Internal Med, Div Infect Dis, Chunchon, South Korea; [Choi, Won Suk; Yoon, Jin Gu; Lee, Saem Na; Choi, Min Joo; Noh, Ji Yun; Cheong, Hee Jin; Kim, Woo Joo; Song, Joon Young] Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea; [Noh, Ji Yun; Cheong, Hee Jin; Kim, Woo Joo; Song, Joon Young] Korea Univ, Guro Hosp, APII, Seoul, South Korea; [Ahn, Jin-Young; Jeong, Hye Won] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju, South Korea; [Ahn, Jin-Young] Chungbuk Natl Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Cheongju, South Korea; [Jeong, Hye Won] Chungbuk Natl Univ Hosp, Dept Internal Med, Div Infect Dis, Cheongju, South Korea; [Lee, Hee Young] Seoul Natl Univ, Bundang Hosp, Ctr Prevent Med & Publ Hlth, Seongnam, South Korea	Ajou University; Hallym University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Chungbuk National University; Chungbuk National University; Chungbuk National University Hospital; Chungbuk National University; Chungbuk National University Hospital; Seoul National University (SNU)	Song, JY (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea.; Song, JY (corresponding author), Korea Univ, Guro Hosp, APII, Seoul, South Korea.; Lee, HY (corresponding author), Seoul Natl Univ, Bundang Hosp, Ctr Prevent Med & Publ Hlth, Seongnam, South Korea.	wanderingstone@gmail.com; infection@korea.ac.kr	lee, hy/GRS-0797-2022; Choi, Won Suk/V-2730-2017	Heo, Jung Yeon/0000-0002-6548-1939; Cheong, Hee Jin/0000-0002-2532-1463; Choi, Won Suk/0000-0001-5874-4764; Song, Joon Young/0000-0002-0148-7194				Almirall J, 2000, EUR RESPIR J, V15, P757, DOI 10.1034/j.1399-3003.2000.15d21.x; BARTLETT JG, 1995, NEW ENGL J MED, V333, P1618, DOI 10.1056/NEJM199512143332408; Bodi M, 2005, CLIN INFECT DIS, V41, P1709, DOI 10.1086/498119; Bravo LC, 2009, VACCINE, V27, P7282, DOI 10.1016/j.vaccine.2009.04.046; CDC, 2016, ACT BACT COR SURV RE; Choi MJ, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008429; Choi MJ, 2015, J INFECT CHEMOTHER, V21, P672, DOI 10.1016/j.jiac.2015.06.003; Chowdhary S, 2008, B WHO, V86; Dirmesropian S, 2015, HUM VACC IMMUNOTHER, V11, P818, DOI 10.1080/21645515.2015.1011954; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; Heo JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177342; Hoshi SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139140; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Kim JA, 2017, J KOREAN MED SCI, V32, P718, DOI 10.3346/jkms.2017.32.5.718; Kyaw MH, 2003, CLIN INFECT DIS, V37, P1283, DOI 10.1086/379016; Lee HY, 2017, J MICROBIOL IMMUNOL; Lee SG., 2013, KOREAN NATL IMMUNIZA; Marrie Thomas J, 2005, Can Respir J, V12, P139; MARRIE TJ, 1994, CLIN INFECT DIS, V18, P501, DOI 10.1093/clinids/18.4.501; MARRIE TJ, 1989, REV INFECT DIS, V11, P586; Reinert RR, 2005, CLIN MICROBIOL INFEC, V11, P985, DOI 10.1111/j.1469-0691.2005.01282.x; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Schnoor M, 2007, J INFECTION, V55, P233, DOI 10.1016/j.jinf.2007.04.355; Smith KJ, 2012, JAMA-J AM MED ASSOC, V307, P804, DOI 10.1001/jama.2012.169; Sohn JW, 2006, J KOREAN MED SCI, V21, P602, DOI 10.3346/jkms.2006.21.4.602; Song JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093477; Song JY, 2013, INFECT CHEMOTHER, V45, P351, DOI 10.3947/ic.2013.45.4.351; Song JY, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-202; Song JY, 2013, J KOREAN MED SCI, V28, P4, DOI 10.3346/jkms.2013.28.1.4; Statistics Korea, 2017, KOR STAT INF SERV; Stoecker C, 2016, J GEN INTERN MED, V31, P901, DOI 10.1007/s11606-016-3651-0; Takaki M, 2014, JPN J INFECT DIS, V67, P269, DOI 10.7883/yoken.67.269; van Hoek AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149540; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yang TU, 2016, VACCINE, V34, P1623, DOI 10.1016/j.vaccine.2016.01.043; Yoo KH, 2013, J KOREAN MED SCI, V28, P888, DOI 10.3346/jkms.2013.28.6.888; Zar HJ, 2013, THORAX, V68, P1052, DOI 10.1136/thoraxjnl-2013-204247	38	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194598	10.1371/journal.pone.0194598	http://dx.doi.org/10.1371/journal.pone.0194598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596444	gold, Green Submitted, Green Published			2022-12-26	WOS:000428630000033
J	Jang, MH; Hwang, YS				Jang, Min-Hee; Hwang, Yu Sik			Effects of functionalized multi-walled carbon nanotubes on toxicity and bioaccumulation of lead in Daphnia magna	PLOS ONE			English	Article							HEAVY-METAL IONS; AQUEOUS-SOLUTION; ADSORPTION; CADMIUM; SURFACE; SINGLE; ACCUMULATION; EXPOSURE; SORPTION; REMOVAL	Increased production of carbon nanotubes (CNTs) and their widespread application in industrial and consumer products have led to a rise in the release of CNTs into the aquatic environment. CNTs have a very strong adsorption affinity for various environmental contaminants; therefore, they may also influence the toxic effects of other pollutants, such as toxic metals. In this study, the effect of two different functionalized carbon nanotubes, carboxylate and polyethyleneimine modified multi-walled carbon nanotubes (C-MWCNTs and N-MWCNT, respectively) on lead toxicity and bioaccumulation was investigated with a freshwater zooplankton Daphnia magna. The acute toxicity results indicate that the different surface properties of the two types of MWCNTs have different effects on lead toxicity to D. magna. The negatively charged C-MWCNT showed a notable decrease in lead toxicity (LC50 value increased from 0.15 mg L-1 to 1.08 mg L-1 in the presence of 10 mg L-1 C-MWCNT), whereas the positively charged N-MWCNT had only a slight effect on lead toxicity (LC50 value increased from 0.15 mg L-1 to 0.16 mg L-1 in the presence of 10 mg L-1 N-MWCNT). The decrease of lead toxicity was related with the reduced bioavailability of free metal form (Pb2+) caused by greater adsorption of lead onto the MWCNTs. The present study suggests that there is a need to consider carefully the complex interaction of CNTs with toxic metals in future ecotoxicological studies.	[Jang, Min-Hee; Hwang, Yu Sik] Korea Inst Toxicol, Future Environm Res Ctr, Jinju, Gyeongsangnam D, South Korea	Korea Institute of Toxicology	Hwang, YS (corresponding author), Korea Inst Toxicol, Future Environm Res Ctr, Jinju, Gyeongsangnam D, South Korea.	yshwang@kitox.re.kr						Altindag A, 2008, AFR J BIOTECHNOL, V7, P4298; [Anonymous], EURASIP J WIRELESS C, DOI DOI 10.11646/Z00TAXA.3989.1.1; Balasubramanian K, 2005, SMALL, V1, P180, DOI 10.1002/smll.200400118; Bianco A, 2005, CHEM COMMUN, P571, DOI 10.1039/b410943k; Dumortier H, 2006, NANO LETT, V6, P1522, DOI 10.1021/nl061160x; Frolov AI, 2010, CHEMPHYSCHEM, V11, P2612, DOI 10.1002/cphc.201000231; Gao HJ, 2016, WATER SCI TECHNOL, V73, P1269, DOI 10.2166/wst.2015.601; Ihsanullah, 2016, SEP PURIF TECHNOL, V157, P141, DOI 10.1016/j.seppur.2015.11.039; Kim KT, 2009, ENVIRON SCI TECHNOL, V43, P8979, DOI 10.1021/es900647f; Kumar R, 2015, J WATER HEALTH, V13, P18, DOI 10.2166/wh.2014.024; Lee J, 2007, MEAS SCI TECHNOL, V18, P3707, DOI 10.1088/0957-0233/18/12/005; Li YH, 2003, CARBON, V41, P1057, DOI 10.1016/S0008-6223(02)00440-2; Li YH, 2005, WATER RES, V39, P605, DOI 10.1016/j.watres.2004.11.004; Liu J, 2015, ENVIRON TOXICOL CHEM, V34, P2824, DOI 10.1002/etc.3122; Moradi O, 2011, INT J NANO DIMENS, V1, P203, DOI 10.7508/ijnd.2010.03.004; Mueller NC, 2008, ENVIRON SCI TECHNOL, V42, P4447, DOI 10.1021/es7029637; Murray AR, 2009, TOXICOLOGY, V257, P161, DOI 10.1016/j.tox.2008.12.023; Pacurari M, 2008, ENVIRON HEALTH PERSP, V116, P1211, DOI 10.1289/ehp.10924; Park M, 2011, CARBON, V49, P811, DOI 10.1016/j.carbon.2010.10.019; Qin L, 2014, ENVIRON TOXICOL PHAR, V38, P199, DOI 10.1016/j.etap.2014.05.016; Qu RJ, 2014, J HAZARD MATER, V275, P89, DOI 10.1016/j.jhazmat.2014.04.051; Rao CNR, 2001, CHEMPHYSCHEM, V2, P78, DOI 10.1002/1439-7641(20010216)2:2<78::AID-CPHC78>3.0.CO;2-7; Rao GP, 2007, SEP PURIF TECHNOL, V58, P224, DOI 10.1016/j.seppur.2006.12.006; Saleh NB, 2010, ENVIRON SCI TECHNOL, V44, P2412, DOI 10.1021/es903059t; Sayanty S., 2009, THESIS; Shooto N. D., 2015, CHEM SCI J, V6; Srivastava S., 2013, MATER LETT, V4, P2, DOI [DOI 10.5185/amlett.2013.icnano.110, 10.5185/amlett.2013.icnano.110, DOI 10.5185/AMLETT.2013.ICNANO.110]; Stafiej A, 2007, SEP PURIF TECHNOL, V58, P49, DOI 10.1016/j.seppur.2007.07.008; Tejral G, 2009, J APPL BIOMED, V7, P1; Tian XL, 2012, CHEMOSPHERE, V89, P1316, DOI 10.1016/j.chemosphere.2012.05.082; Tofighy MA, 2011, J HAZARD MATER, V185, P140, DOI 10.1016/j.jhazmat.2010.09.008; Uo M, 2011, DENT MATER J, V30, P245, DOI 10.4012/dmj.2010-039; Vukovic GD, 2011, CHEM ENG J, V173, P855, DOI 10.1016/j.cej.2011.08.036; Wang HJ, 2007, J COLLOID INTERF SCI, V316, P277, DOI 10.1016/j.jcis.2007.07.075; Wang XH, 2016, ENVIRON TOXICOL CHEM, V35, P1852, DOI 10.1002/etc.3340; Wang XH, 2016, ENVIRON POLLUT, V208, P732, DOI 10.1016/j.envpol.2015.10.053; World Health Organization, 2017, LEAD POIS HLTH; Xu D, 2008, J HAZARD MATER, V154, P407, DOI 10.1016/j.jhazmat.2007.10.059; Yu XL, 2013, J ENVIRON SCI, V25, P933, DOI 10.1016/S1001-0742(12)60145-4; Zhou Y, 2017, WATER SCI TECHNOL, V76, P302, DOI 10.2166/wst.2017.198	40	29	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194935	10.1371/journal.pone.0194935	http://dx.doi.org/10.1371/journal.pone.0194935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596457	Green Submitted, gold, Green Published			2022-12-26	WOS:000428630000053
J	Biscotti, MA; Barucca, M; Canapa, A				Biscotti, Maria Assunta; Barucca, Marco; Canapa, Adriana			New insights into the genome repetitive fraction of the Antarctic bivalve Adamussium colbecki	PLOS ONE			English	Article							MOLLUSK DONAX-TRUNCULUS; TRANSPOSABLE ELEMENTS MITES; SATELLITE DNA; PECTINIDAE MOLLUSCA; MOLECULAR PHYLOGENY; TANDEM REPEATS; TRNASCAN-SE; RNA GENES; EVOLUTION; FAMILY	Repetitive DNA represents the major component of the genome in both plant and animal species. It includes transposable elements (TEs), which are dispersed throughout the genome, and satellite DNAs (satDNAs), which are tandemly organized in long arrays. The study of the structure and organization of repetitive DNA contributes to our understanding of genome architecture and the mechanisms leading to its evolution. Molluscs represent one of the largest groups of invertebrates and include organisms with a wide variety of morphologies and lifestyles. To increase our knowledge of bivalves at the genome level, we analysed the Antarctic scallop Adamussium colbecki. The screening of the genomic library evidenced the presence of two novel satDNA elements and the CvA transposon. The interspecific investigation performed in this study demonstrated that one of the two satDNAs isolated in A. colbecki is widespread in polar molluscan species, indicating a possible link between repetitive DNA and abiotic factors. Moreover, the transcriptional activity of CvA and its presence in long-diverged bivalves suggests a possible role for this ancient element in shaping the genome architecture of this Glade.	[Biscotti, Maria Assunta; Barucca, Marco; Canapa, Adriana] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy	Marche Polytechnic University	Barucca, M (corresponding author), Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy.	m.barucca@univpm.it			"Programma Nazionale di Ricerche in Antartide" (PNRA) [PdR 2009/A1.10]	"Programma Nazionale di Ricerche in Antartide" (PNRA)	This work was supported by a grant (PdR 2009/A1.10) from "Programma Nazionale di Ricerche in Antartide" (PNRA).	Albertin CB, 2015, NATURE, V524, P220, DOI 10.1038/nature14668; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barucca M, 2004, MOL PHYLOGENET EVOL, V31, P89, DOI 10.1016/j.ympev.2003.07.003; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Biscotti MA, 2007, GENE, V406, P91, DOI 10.1016/j.gene.2007.06.027; Biscotti MA, 2014, CYTOGENET GENOME RES, V144, P212, DOI 10.1159/000370054; Biscotti MA, 2008, CHROMOSOME RES, V16, P907, DOI 10.1007/s10577-008-1248-0; Biscotti MA, 2015, CHROMOSOME RES, V23, P415, DOI 10.1007/s10577-015-9499-z; Biscotti MA, 2015, CHROMOSOME RES, V23, P463, DOI 10.1007/s10577-015-9494-4; Canapa A, 2000, J MOL EVOL, V50, P93, DOI 10.1007/s002399910010; Canapa A, 2015, CYTOGENET GENOME RES, V147, P217, DOI 10.1159/000444429; Cheng ZJ, 2003, GENETICS, V164, P665; Clabby C, 1996, GENE, V168, P205, DOI 10.1016/0378-1119(95)00749-0; Emadzade K, 2014, ANN BOT-LONDON, V114, P1597, DOI 10.1093/aob/mcu178; Feliciello I, 2013, EPIGENETICS-US, V8, P534, DOI 10.4161/epi.24507; Ferreira D, 2015, CHROMOSOME RES, V23, P479, DOI 10.1007/s10577-015-9482-8; Gaffney PM, 2003, J MOL EVOL, V56, P308, DOI 10.1007/s00239-002-2402-5; Garrido-Ramos MA, 1998, CYTOGENET CELL GENET, V83, P3, DOI 10.1159/000015151; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Hernandez-Ibarra NK, 2008, GENOME, V51, P570, DOI 10.1139/G08-041; Heslop-Harrison JS, 2011, PLANT J, V66, P18, DOI 10.1111/j.1365-313X.2011.04544.x; Junier T, 2000, BIOINFORMATICS, V16, P178, DOI 10.1093/bioinformatics/16.2.178; Kapitonov VV, 1998, MOL BIOL EVOL, V15, P611, DOI 10.1093/oxfordjournals.molbev.a025963; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; KNIGHT M, 1992, GENE, V118, P181, DOI 10.1016/0378-1119(92)90187-T; Koga A, 2014, DNA RES, V21, P407, DOI 10.1093/dnares/dsu005; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kourtidis A, 2006, GENOME, V49, P1451, DOI 10.1139/G06-111; Kuang HH, 2009, GENOME RES, V19, P42, DOI [10.1101/gr.07816.108, 10.1101/gr.078196.108]; Levitsky VG, 2014, J BIOMOL STRUCT DYN, V32, P115, DOI 10.1080/07391102.2012.755796; Lopez-Flores I, 2004, GENE, V339, P181, DOI 10.1016/j.gene.2004.06.049; Lopez-Flores I, 2012, GENOME DYNAM, V7, P1, DOI 10.1159/000337118; Lopez-Flores I, 2010, GENETICA, V138, P1211, DOI 10.1007/s10709-010-9517-1; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Macas J, 2009, GENE, V448, P198, DOI 10.1016/j.gene.2009.06.014; Martinez-Lage A, 2005, GENOME, V48, P247, DOI 10.1139/G04-115; Martinez-Lage A, 2002, GENOME, V45, P922, DOI [10.1139/g02-056, 10.1139/G02-056]; Matveev V, 2009, GENE, V434, P16, DOI 10.1016/j.gene.2008.04.022; Melters DP, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r10; Mestrovic N, 2015, CHROMOSOME RES, V23, P583, DOI 10.1007/s10577-015-9483-7; Miller WJ, 2000, MOL BIOL EVOL, V17, P1597, DOI 10.1093/oxfordjournals.molbev.a026259; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Mravinac B, 2005, J MOL EVOL, V61, P542, DOI 10.1007/s00239-004-0342-y; Mravinac B, 2010, MOL BIOL EVOL, V27, P1857, DOI 10.1093/molbev/msq068; Muchmore ME, 1998, MOL MAR BIOL BIOTECH, V7, P1; Nakanishi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043785; Nishihara H, 2016, GENOME BIOL EVOL, V8, P528, DOI 10.1093/gbe/evw029; Noma K, 2000, DNA RES, V7, P1, DOI 10.1093/dnares/7.1.1; Oki N, 2008, GENES GENET SYST, V83, P321, DOI 10.1266/ggs.83.321; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Panchin Y, 2008, BIOCHEM BIOPH RES CO, V369, P818, DOI 10.1016/j.bbrc.2008.02.097; Passamonti M, 1998, ZOOL SCI, V15, P599, DOI 10.2108/0289-0003(1998)15[599:COAHRD]2.0.CO;2; Pennisi E, 2010, SCIENCE, V330, P1614, DOI 10.1126/science.330.6011.1614; Petraccioli A, 2015, MOL GENET GENOMICS, V290, P1717, DOI 10.1007/s00438-015-1036-4; Petrovic V, 2005, GENE, V362, P37, DOI 10.1016/j.gene.2005.06.044; Petrovic V, 2009, CYTOGENET GENOME RES, V124, P63, DOI 10.1159/000200089; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Piacentini L, 2014, CHROMOSOMA, V123, P345, DOI 10.1007/s00412-014-0464-y; Plohl M, 1997, J MOL EVOL, V44, P189, DOI 10.1007/PL00006135; Plohl M, 2012, GENOME DYNAM, V7, P126, DOI 10.1159/000337122; Plohl M, 2010, HEREDITY, V104, P543, DOI 10.1038/hdy.2009.141; Plohl M, 1996, GENE, V169, P157, DOI 10.1016/0378-1119(95)00734-2; Plohl M, 2008, GENE, V409, P72, DOI 10.1016/j.gene.2007.11.013; Pontecorvo G, 2000, MOL BIOL REP, V27, P225, DOI 10.1023/A:1011003928698; RUIZLARA S, 1992, GENE, V117, P237; Satovic E, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3347-1; Satovic E, 2013, GENOME BIOL EVOL, V5, P2549, DOI 10.1093/gbe/evt202; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Serb JM, 2017, J EVOLUTION BIOL, V30, P1736, DOI 10.1111/jeb.13137; Sharma A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-142; Simakov O, 2013, NATURE, V493, P526, DOI 10.1038/nature11696; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Vera M, 2015, MAR GENOM, V24, P335, DOI 10.1016/j.margen.2015.08.006; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Vittorazzi SE, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0111-x; Wang S, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0120; Warren IA, 2015, CHROMOSOME RES, V23, P505, DOI 10.1007/s10577-015-9493-5; Willard HF, 1998, CURR OPIN GENET DEV, V8, P219, DOI 10.1016/S0959-437X(98)80144-5; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	79	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194502	10.1371/journal.pone.0194502	http://dx.doi.org/10.1371/journal.pone.0194502			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590185	Green Published, gold, Green Submitted			2022-12-26	WOS:000428603100063
J	Chen, T; Ren, CH; Jiang, X; Zhang, LP; Li, HM; Huang, W; Hu, CQ				Chen, Ting; Ren, Chunhua; Jiang, Xiao; Zhang, Lvping; Li, Hongmei; Huang, Wen; Hu, Chaoqun			Mechanisms for type-II vitellogenesis-inhibiting hormone suppression of vitellogenin transcription in shrimp hepatopancreas: Crosstalk of GC/cGMP pathway with different MAPK-dependent cascades	PLOS ONE			English	Article							PACIFIC WHITE SHRIMP; CRUSTACEAN HYPERGLYCEMIC HORMONE; PRAWN MARSUPENAEUS-JAPONICUS; LOBSTER HOMARUS-AMERICANUS; CDNA-ENCODING VITELLOGENIN; MESSENGER-RNA EXPRESSION; SYNDROME VIRUS-INFECTION; VTG GENE-EXPRESSION; GREEN SHORE CRAB; LITOPENAEUS-VANNAMEI	Vitellogenesis is the process of yolk formation via accumulating vitellin (Vn) with nutrients in the oocytes. Expression of vitellogenin (Vg), the precursor of Vn, is one of the indicators for the start of vitellogenesis. In Pacific white shrimp (Litopenaeus vannamel), the type-II vitellogenesis-inhibiting hormone (VIH-2) effectively suppresses hepatopancreatic Vg mRNA expression. In this study, we demonstrate the increasing transcript levels of hepatopancreatic Vg during L. vannamei ovarian development, suggesting that the hepatopancreas-derived Vg/Nn may also contribute to vitellogenesis in this species. Using a combination of in vivo injections and in vitro primary cell cultures, we provide evidences that the inhibition of VIH-2 on hepatopancreatic Vg gene expression is mediated through a functional coupling of the GC/cGMP pathway with different MAPK-dependent cascades in female shrimp. In VIH-2 signaling, the NO-independent GC/cGMP/PKG cascades were upstream of the MAPKs. Activations of the MAPK signal by VIH-2 include the phosphorylation of JNK and the mRNA/protein expression of P(38)MAPK. Additionally, the cAMP/PKA pathway is another positive intracellular signal for hepatopancreatic Vg mRNA expression but is independent of its VIH-2 regulation. Our findings establish a model for the signal transduction mechanism of Vg regulation by VIH and shed light on the biological functions and signaling of the CHH family in crustaceans.	[Chen, Ting; Ren, Chunhua; Jiang, Xiao; Zhang, Lvping; Li, Hongmei; Huang, Wen; Hu, Chaoqun] Chinese Acad Sci, South China Sea Inst Oceanol, CAS Key Lab Trop Marine Bioresources & Ecol LMB, Guangzhou, Guangdong, Peoples R China; [Chen, Ting; Ren, Chunhua; Jiang, Xiao; Zhang, Lvping; Li, Hongmei; Huang, Wen; Hu, Chaoqun] Chinese Acad Sci, South China Sea Inst Oceanol, Guangdong Prov Key Lab Appl Marine Biol LAMB, Guangzhou, Guangdong, Peoples R China; [Chen, Ting; Ren, Chunhua; Huang, Wen; Hu, Chaoqun] South China Sea Bioresource Exploitat & Utilizat, Guangzhou, Guangdong, Peoples R China; [Li, Hongmei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Huang, W; Hu, CQ (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, CAS Key Lab Trop Marine Bioresources & Ecol LMB, Guangzhou, Guangdong, Peoples R China.; Huang, W; Hu, CQ (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, Guangdong Prov Key Lab Appl Marine Biol LAMB, Guangzhou, Guangdong, Peoples R China.; Huang, W; Hu, CQ (corresponding author), South China Sea Bioresource Exploitat & Utilizat, Guangzhou, Guangdong, Peoples R China.	huangwen@scsio.ac.cn; hucq@scsio.ac.cn	huang, wen/GXW-0661-2022	Chen, Ting/0000-0002-5777-909X	National Natural Science Foundation of China [31402287, 31602135]; Guangdong Province Program [2016A020210062, 2017B030314052, 2017A030310429, 2013B091300020, 2014B030301064, 2015B020231007, 2016A030310112]; Science & Technology Promoting Projects for Oceanic & Fishery in Guangdong Province [A201601A03]; National High Technology Research & Development Program of China (863 Program) [2012AA10A404-4]; Science and Technology Service Network Initiative of the Chinese Academy of Sciences [KFJ-SW-STS-146]; National Share & Service Platform Construction Program for Aquaculture Germplasm and Resources [2017DKA30470]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Program; Science & Technology Promoting Projects for Oceanic & Fishery in Guangdong Province; National High Technology Research & Development Program of China (863 Program)(National High Technology Research and Development Program of China); Science and Technology Service Network Initiative of the Chinese Academy of Sciences; National Share & Service Platform Construction Program for Aquaculture Germplasm and Resources	This work was supported by grants from the National Natural Science Foundation of China (31402287 to Dr. Ting Chen and 31602135 to Dr. Wen Huang), the Guangdong Province Program (2016A020210062 to Dr. Ting Chen, 2017B030314052 to Dr. Wen Huang, 2017A030310429 to Dr. Xiao Jiang, 2013B091300020 to Prof. Chaoqun Hu, 2014B030301064 to Prof. Chaoqun Hu, 2015B020231007 to Prof. Chaoqun Hu and 2016A030310112 to Prof. Chaoqun Hu), the Science & Technology Promoting Projects for Oceanic & Fishery in Guangdong Province (A201601A03 to Prof. Chaoqun Hu), the National High Technology Research & Development Program of China (863 Program) (2012AA10A404-4 to Ms. Chunhua Ren), the Science and Technology Service Network Initiative of the Chinese Academy of Sciences (KFJ-SW-STS-146 to Prof. Chaoqun Hu) and the National Share & Service Platform Construction Program for Aquaculture Germplasm and Resources (2017DKA30470 to Dr. Lvping Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcos FG, 2011, AQUACULTURE, V316, P93, DOI 10.1016/j.aquaculture.2011.02.045; Avarre JC, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-3; Azzouna A, 2003, GEN COMP ENDOCR, V131, P134, DOI 10.1016/S0016-6480(02)00645-7; Bae SH, 2017, GEN COMP ENDOCR, V246, P301, DOI 10.1016/j.ygcen.2017.01.006; Bae SH, 2013, FISHERIES SCI, V79, P895, DOI 10.1007/s12562-013-0652-3; Chan SM, 2003, GEN COMP ENDOCR, V134, P214, DOI 10.1016/S0016-6480(03)00263-6; Chen T, 2016, AQUACULTURE, V451, P405, DOI 10.1016/j.aquaculture.2015.10.005; Chen T, 2015, FISH SHELLFISH IMMUN, V42, P114, DOI 10.1016/j.fsi.2014.10.042; Chen T, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115030; Chung JS, 2006, GEN COMP ENDOCR, V147, P206, DOI 10.1016/j.ygcen.2006.01.002; Covi JA, 2009, COMP BIOCHEM PHYS A, V152, P470, DOI 10.1016/j.cbpa.2008.12.005; DEKLEIJN DPV, 1994, FEBS LETT, V353, P255, DOI 10.1016/0014-5793(94)01055-2; Feijo RG, 2016, MAR BIOTECHNOL, V18, P117, DOI 10.1007/s10126-015-9676-2; Francis SH, 1999, CRIT REV CL LAB SCI, V36, P275, DOI 10.1080/10408369991239213; Hopkins PM, 2012, GEN COMP ENDOCR, V175, P357, DOI 10.1016/j.ygcen.2011.12.002; Huang W, 2017, PLOS ONE, V12; Huang XS, 2017, GEN COMP ENDOCR, V250, P175, DOI 10.1016/j.ygcen.2017.06.013; Jasmani S, 2000, FISHERIES SCI, V66, P535, DOI 10.1046/j.1444-2906.2000.00084.x; Kang BJ, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.112243; Kung SY, 2004, BIOL REPROD, V71, P863, DOI 10.1095/biolreprod.103.022905; Lee SG, 2007, J EXP BIOL, V210, P3245, DOI 10.1242/jeb.007740; Li FH, 2013, FISH SHELLFISH IMMUN, V34, P973, DOI 10.1016/j.fsi.2012.08.023; Li GL, 2015, GENET MOL RES, V14, P14056, DOI 10.4238/2015.October.29.25; Li GL, 2015, GENES GENOM, V37, P883, DOI 10.1007/s13258-015-0315-0; Li K, 2006, COMP BIOCHEM PHYS B, V143, P453, DOI 10.1016/j.cbpb.2005.12.019; Li R, 2016, J EXP BIOL, V219, P1259, DOI 10.1242/jeb.133181; Luo X, 2015, PEPTIDES, V68, P58, DOI 10.1016/j.peptides.2014.11.002; Mykles DL, 2010, PHYSIOL BIOCHEM ZOOL, V83, P836, DOI 10.1086/648470; Nagai C, 2014, J BIOL CHEM, V289, P32166, DOI 10.1074/jbc.M114.590646; Nagai C, 2009, ANN NY ACAD SCI, V1163, P478, DOI 10.1111/j.1749-6632.2009.04452.x; Ohira T, 2006, PEPTIDES, V27, P1251, DOI 10.1016/j.peptides.2005.10.019; Okumura T, 2007, COMP BIOCHEM PHYS A, V147, P1028, DOI 10.1016/j.cbpa.2007.03.011; Okumura T, 2007, ZOOL SCI, V24, P233, DOI 10.2108/zsj.24.233; Okumura T, 2006, GEN COMP ENDOCR, V148, P245, DOI 10.1016/j.ygcen.2006.03.005; Okuno A, 2002, J EXP ZOOL, V292, P417, DOI 10.1002/jez.10083; Pitts NL, 2017, COMP BIOCHEM PHYS A, V203, P328, DOI 10.1016/j.cbpa.2016.10.012; Qiao H, 2015, COMP BIOCHEM PHYS A, V185, P1, DOI [10.1016/j.cbpa.2015.03.005, 10.1016/j.hemonc.2014.09.004]; Quackenbush LS, 2001, AM ZOOL, V41, P458, DOI 10.1668/0003-1569(2001)041[0458:YSITMS]2.0.CO;2; Raviv S, 2006, GEN COMP ENDOCR, V145, P39, DOI 10.1016/j.ygcen.2005.06.009; Shi H, 2014, DEV COMP IMMUNOL, V44, P180, DOI 10.1016/j.dci.2013.12.005; Shi H, 2012, FISH SHELLFISH IMMUN, V33, P813, DOI 10.1016/j.fsi.2012.07.008; Shi H, 2012, DEV COMP IMMUNOL, V37, P421, DOI 10.1016/j.dci.2012.03.002; SOYEZ D, 1987, J EXP ZOOL, V244, P479, DOI 10.1002/jez.1402440314; Treerattrakool S, 2008, FEBS J, V275, P970, DOI 10.1111/j.1742-4658.2008.06266.x; Treerattrakool S, 2011, MAR BIOTECHNOL, V13, P163, DOI 10.1007/s10126-010-9276-0; Tsukimura B, 2001, AM ZOOL, V41, P465, DOI 10.1668/0003-1569(2001)041[0465:CVIRIO]2.0.CO;2; Tsutsui N, 2000, ZOOL SCI, V17, P651, DOI 10.2108/zsj.15.651; Tsutsui N, 2004, J EXP ZOOL PART A, V301A, P802, DOI 10.1002/jez.a.53; Tsutsui N, 2007, MAR BIOTECHNOL, V9, P360, DOI 10.1007/s10126-006-6151-0; Tsutsui N, 2013, FISHERIES SCI, V79, P357, DOI 10.1007/s12562-013-0603-z; Ventura-Lopez C, 2017, GEN COMP ENDOCR, V246, P164, DOI 10.1016/j.ygcen.2016.12.005; Vrinda S, 2017, COMP BIOCHEM PHYS A, V203, P167, DOI 10.1016/j.cbpa.2016.09.007; Wang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084921; Webster SG, 2012, GEN COMP ENDOCR, V175, P217, DOI 10.1016/j.ygcen.2011.11.035; Wongprasert K, 2006, AQUACULTURE, V261, P1447, DOI 10.1016/j.aquaculture.2006.08.044; Wu LT, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104752; Xu DD, 2014, DEV COMP IMMUNOL, V47, P287, DOI 10.1016/j.dci.2014.08.004; Yamano K, 2004, BIOL REPROD, V70, P1670, DOI 10.1095/biolreprod.103.025379; Yan AF, 2016, INT J BIOL SCI, V12, P1544, DOI 10.7150/ijbs.16612; Yao DF, 2015, DEV COMP IMMUNOL, V49, P282, DOI 10.1016/j.dci.2014.12.012; Zheng J, 2008, GEN COMP ENDOCR, V155, P780, DOI 10.1016/j.ygcen.2007.10.009; Zmora Nilli, 2009, Saline Syst, V5, P6, DOI 10.1186/1746-1448-5-6	62	20	20	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194459	10.1371/journal.pone.0194459	http://dx.doi.org/10.1371/journal.pone.0194459			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590153	Green Published, gold, Green Submitted			2022-12-26	WOS:000428603100060
J	Nguenha, N; Tivane, A; Pale, M; Machalele, L; Nacoto, A; Pires, G; Mationane, E; Salencia, J; Gundane, F; Muteto, D; Chilundo, J; Mavale, S; Adamo, N; Sema-Baltazar, C; Augusto, O; Gudo, E; Mussa, T				Nguenha, Neuza; Tivane, Almiro; Pale, Mirela; Machalele, Loira; Nacoto, Afonso; Pires, Germano; Mationane, Edirsse; Salencia, Judite; Gundane, Felix; Muteto, Delcio; Chilundo, Josina; Mavale, Sandra; Adamo, Noorbebi; Sema-Baltazar, Cynthia; Augusto, Orvalho; Gudo, Eduardo; Mussa, Tufaria			Clinical and epidemiological characterization of influenza virus infections in children with severe acute respiratory infection in Maputo, Mozambique: Results from the implementation of sentinel surveillance, 2014-2016	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HOSPITALIZED CHILDREN; GLOBAL BURDEN; SOUTH-AFRICA; SEASONAL INFLUENZA; HIGH-PREVALENCE; RISK-FACTORS; ILLNESS; COUNTRIES; ETIOLOGY	In Sub-Saharan Africa, where burden, impact, and incidence of acute respiratory infections (ARI) are the highest in the world, conversely, the epidemiology of influenza-associated severe acute respiratory infections (SARI) is incompletely known. The aim of this study was to describe the clinical and epidemiological features of influenza-associated SARI in hospitalized children in Maputo city, Mozambique. Nasopharyngeal and oropharyngeal swabs were collected from children aged 0-14 years old who met the case definition for SARI in two hospitals in Maputo city after their parents or legal representative consented to participate. A structured questionnaire was used to collect clinical and demographic data. Typing and subtyping of influenza were performed by real-time PCR. From January 2014 to December 2016, a total of 2,007 eligible children were recruited, of whom 1,997 (99.5%) were screened for influenza by real-time PCR. The median age of participants was 16.9 months (IQR: 7.0-38.9 months) and 53.9% (1076/1991) were male. A total of 77 were positive for influenza, yielding a frequency of 3.9% (77/1,991), with the highest frequency being reported in the age group 1-5 years old. Cases of influenza peaked twice each year, during which, its frequency reached up to 60%-80%. Among all influenza confirmed cases, 33.7% (26/77), 35.1% (27/77) and 28.6% (22/77) were typed as influenza A/H3N2, A/H1N1pdm09, and B, respectively. This represents the first report of influenza in urban/sub urban setting in Mozambique and the first evidence of distribution of strains of influenza in the country. Our data showed that frequency of influenza was lower than reported in a rural setting in Mozambique and the frequency of seasonal (A/H1N1pdm09) and (A/H3N2) subtypes were similar in children with SARI.	[Nguenha, Neuza; Tivane, Almiro; Pale, Mirela; Machalele, Loira; Nacoto, Afonso; Pires, Germano; Mationane, Edirsse; Salencia, Judite; Gundane, Felix; Adamo, Noorbebi; Sema-Baltazar, Cynthia; Gudo, Eduardo; Mussa, Tufaria] Minist Hlth, Natl Inst Hlth, Maputo, Mozambique; [Salencia, Judite; Gundane, Felix] Hosp Geral de Mavalane, Pediat Dept, Maputo, Mozambique; [Muteto, Delcio; Chilundo, Josina; Mavale, Sandra] Hosp Cent Maputo, Pediat Dept, Maputo, Mozambique; [Augusto, Orvalho; Mussa, Tufaria] Eduardo Mondlane Univ, Fac Med, Maputo, Mozambique	Eduardo Mondlane University	Nguenha, N (corresponding author), Minist Hlth, Natl Inst Hlth, Maputo, Mozambique.	neusaguenha@gmail.com	Augusto, Orvalho/J-8767-2019	Augusto, Orvalho/0000-0002-0005-3968; Mussa, Tufaria/0000-0002-9635-3585	Centers for Diseases Control and Prevention [1U51IP000825-01]; World Health Organization	Centers for Diseases Control and Prevention; World Health Organization(World Health Organization)	This work was supported by the Centers for Diseases Control and Prevention (Grant #1U51IP000825-01) http://www.cdc.gov and the World Health Organization, www.who.int The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso WJ, 2015, INFLUENZA OTHER RESP, V9, P101, DOI 10.1111/irv.12308; Cohen AL, 2014, EMERG INFECT DIS, V20, P1162, DOI 10.3201/eid2007.131869; Cohen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118884; Cohen C, 2013, EMERG INFECT DIS, V19, P1766, DOI 10.3201/eid1911.130546; Cummings MJ, 2016, ANN AM THORAC SOC, V13, P2159, DOI 10.1513/AnnalsATS.201607-561OC; Cunguara B FG, 2012, J AFRICAN DEV 2012 J, V14; El Kholy AA, 2014, J INFECT DEV COUNTR, V8, P1285, DOI 10.3855/jidc.4682; Emukule GO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138708; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Heraud JM, 2012, J INFECT DIS, V206, pS5, DOI 10.1093/infdis/jis541; Hirve S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153003; Ho A, 2017, CLIN INFECT DIS; Huai Y, 2017, INFLUENZA OTHER RESP, V11, P148, DOI 10.1111/irv.12419; INE, 2007, ANUARIO ESTATSTICO R; Iuliano A. D., 2017, LANCET; Katz MA, 2012, J INFECT DIS, V206, pS1, DOI 10.1093/infdis/jis548; Kyu HH, 2016, JAMA PEDIATR, V170, P267, DOI 10.1001/jamapediatrics.2015.4276; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Ma HY, 2016, J MICROBIOL IMMUNOL, V49, P387, DOI 10.1016/j.jmii.2015.05.015; Mainassara HB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133178; McMorrow ML, 2015, J INFECT DIS, V212, P853, DOI 10.1093/infdis/jiv100; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Mulholland K, 2003, PEDIATR PULM, V36, P469, DOI 10.1002/ppul.10344; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; O'Callaghan-Gordo C, 2011, TROP MED INT HEALTH, V16, P1054, DOI 10.1111/j.1365-3156.2011.02811.x; O'Callaghan-Gordo C, 2011, PEDIATR INFECT DIS J, V30, P39, DOI 10.1097/INF.0b013e3181f232fe; Peterson I, 2016, J INFECT DIS, V214, P1700, DOI 10.1093/infdis/jiw426; Pretorius MA, 2016, J CLIN VIROL, V75, P21, DOI 10.1016/j.jcv.2015.12.004; Radin JM, 2012, J INFECT DIS, V206, pS14, DOI 10.1093/infdis/jis606; Robertson SE, 2004, B WORLD HEALTH ORGAN, V82, P914; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; SaUde INd Estatistica INd Macro I., 2010, INQ NAC PREV RISC CO; Simusika P, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0779-1; Tamerius JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003194; Theo A, 2012, J INFECT DIS, V206, pS173, DOI 10.1093/infdis/jis599; UNAIDS, 2015, AIDSINFO 2015; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Vasileiou E, 2017, CLIN INFECT DIS, V65, P1388, DOI 10.1093/cid/cix524; Wabwire-Mangen F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164861; Walaza S, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx116; WHO, 2016, INFL SEAS 2016; WHO, 2017, WHO SURV CAS DEF ILI; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0	43	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194138	10.1371/journal.pone.0194138	http://dx.doi.org/10.1371/journal.pone.0194138			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590162	gold, Green Submitted, Green Published			2022-12-26	WOS:000428603100050
J	Pandey, PR; Sarwade, RD; Khalique, A; Seshadri, V				Pandey, Poonam R.; Sarwade, Rucha D.; Khalique, Abdul; Seshadri, Vasudevan			Interaction of HuDA and PABP at 5'UTR of mouse insulin2 regulates insulin biosynthesis	PLOS ONE			English	Article							BINDING PROTEIN HUD; PRE-MESSENGER-RNA; TRANSLATIONAL CONTROL; 5'-UNTRANSLATED REGION; GLUCOSE REGULATION; GENE-EXPRESSION; POLY(A); ELAV; TRANSCRIPTION; ELEMENTS	Understanding the regulation of insulin biosynthesis is important as it plays a central role in glucose metabolism. The mouse insulin gene2 (Ins2) has two splice variants; long (Ins2L) and short (Ins2S), that differ only in their 5'UTR sequence and Ins2S is the major transcript which translate more efficiently as compared to Ins2L. Here, we show that cellular factors bind preferentially to the Ins2L 5'UTR, and that PABP and HuD can bind to Ins2 splice variants and regulate its translation. In vitro binding assay with insulin 5'UTR and different HuD isoforms indicate that the 'N' terminal region of HuD is important for RNA binding and insulin translation repression. Using reporter assay we showed that specifically full-length HuD A isoform represses translation of reporter containing insulin 5'UTR. We further show that PABP and HuD interact with each other in RNA-dependent manner and this interaction is affected by glucose and PDI (5'UTR associated translation activator). These results suggest that PABP interacts with HuD in basal glucose conditions making translation inhibitory complex, however upon glucose stimulation this association is affected and PABP is acted upon by PDI resulting in stimulation of insulin translation. Together, our findings snapshot the mechanism of post-transcriptional regulation of insulin biosynthesis.	[Pandey, Poonam R.; Sarwade, Rucha D.; Khalique, Abdul; Seshadri, Vasudevan] Natl Ctr Cell Sci, Pune, Maharashtra, India; [Pandey, Poonam R.; Sarwade, Rucha D.; Khalique, Abdul] Savitribai Phule Pune Univ, Dept Biotechnol, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Savitribai Phule Pune University	Seshadri, V (corresponding author), Natl Ctr Cell Sci, Pune, Maharashtra, India.	seshadriv@nces.res.in	PANDEY, POONAM/AAV-5030-2020; Khalique, Abdul/AAJ-8079-2020	Khalique, Abdul/0000-0003-0499-1115; Seshadri, Vasudevan/0000-0002-1603-2969	Department of Biotechnology, Government of India [BT/PR14109/BRB/10/812/2010]; National Centre for Cell Science (NCCS), Pune, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); National Centre for Cell Science (NCCS), Pune, India	This work is supported by grant from Department of Biotechnology, Government of India (BT/PR14109/BRB/10/812/2010) and intramural funds from National Centre for Cell Science (NCCS), Pune, India. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2010, MOL CELL BIOL, V30, P4197, DOI 10.1128/MCB.00316-10; Bronicki LM, 2013, EMERGING COMPLEXITY, P1019; Bronicki LM, 2012, J NEUROSCI, V32, P11164, DOI 10.1523/JNEUROSCI.2247-12.2012; Evans-Molina C, 2007, DIABETES, V56, P827, DOI 10.2337/db06-1440; Fred RG, 2009, MOL CELL ENDOCRINOL, V297, P28, DOI 10.1016/j.mce.2008.06.007; Fukao A, 2009, MOL CELL, V36, P1007, DOI 10.1016/j.molcel.2009.11.013; Hayashi S, 2015, ALTERNATIVE ROLE HUD, V409, P399; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; ITOH N, 1980, NATURE, V283, P100, DOI 10.1038/283100a0; Kini HK, 2015, CYTOPLASMIC POLY A B, P1; Kulkarni SD, 2011, J BIOL CHEM, V286, P14146, DOI 10.1074/jbc.M110.190553; Lee EK, 2012, MOL CELL, V45, P826, DOI 10.1016/j.molcel.2012.01.016; Lisbin MJ, 2000, GENETICS, V155, P1789; LOMEDICO P, 1979, CELL, V18, P545, DOI 10.1016/0092-8674(79)90071-0; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Melo EO, 2003, FEBS LETT, V546, P329, DOI 10.1016/S0014-5793(03)00620-3; Minn AH, 2005, MOL ENDOCRINOL, V19, P794, DOI 10.1210/me.2004-0119; Muralidharan B, 2007, FEBS LETT, V581, P4103, DOI 10.1016/j.febslet.2007.07.050; Nayler O, 1998, NUCLEIC ACIDS RES, V26, P3542, DOI 10.1093/nar/26.15.3542; Panda AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101084; Panda AC, 2010, FEBS LETT, V584, P1169, DOI 10.1016/j.febslet.2010.02.020; Park-Lee S, 2003, J BIOL CHEM, V278, P39801, DOI 10.1074/jbc.M307105200; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Perrone-Bizzozero Nora, 2013, Front Biosci (Schol Ed), V5, P554; Safaee N, 2012, MOL CELL, V48, P375, DOI 10.1016/j.molcel.2012.09.001; SOARES MB, 1985, MOL CELL BIOL, V5, P2090, DOI 10.1128/MCB.5.8.2090; Steller U, 1996, MOL BRAIN RES, V35, P285, DOI 10.1016/0169-328X(95)00231-G; Svitkin YV, 2006, MOL BIOL+, V40, P684; Tabassum R, 2012, PLOS ONE, V7; Wang HW, 2010, NUCLEIC ACIDS RES, V38, P3760, DOI 10.1093/nar/gkq028; Wang ZH, 2011, NEUROCHEM RES, V36, P1027, DOI 10.1007/s11064-011-0443-0; Wicksteed B, 2003, J BIOL CHEM, V278, P42080, DOI 10.1074/jbc.M303509200; Wicksteed B, 2007, CELL METAB, V5, P221, DOI 10.1016/j.cmet.2007.02.007; Yannoni YM, 1999, J CELL SCI, V112, P4501; Yoo YM, 2013, J PINEAL RES, V55, P207, DOI 10.1111/jpi.12064; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	36	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194482	10.1371/journal.pone.0194482	http://dx.doi.org/10.1371/journal.pone.0194482			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590218	Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100061
J	Pittermann, J; Cowan, J; Kaufman, N; Baer, A; Zhang, E; Kuty, D				Pittermann, Jarmila; Cowan, Joshua; Kaufman, Nathan; Baer, Alex; Zhang, Elaine; Kuty, David			The water relations and xylem attributes of albino redwood shoots (Sequioa sempervirens (D. Don.) Endl.)	PLOS ONE			English	Article							HYDRAULIC EFFICIENCY; CAVITATION RESISTANCE; STOMATAL CONDUCTANCE; CLIMATE-CHANGE; CONIFER XYLEM; WOODY-PLANTS; CUPRESSACEAE; ANGIOSPERMS; PRESSURE; DROUGHT	Plants that lack chlorophyll are rare and typically restricted to holoparasites that obtain their carbon, water and mineral resources from a host plant. Although not parasites in the traditional sense, albino foliage, such as the sprouts that sometimes develop from redwood tree trunks, are comparable in function. They occur sporadically, and can reach the size of shrubs and in rare cases, trees. Albino redwoods are interesting because in addition to their reduced carbon resources, the absence of chloroplasts may impede proper stomatal function, and both aspects may have upstream consequences on water transport and xylem quality. We examined the water relations, water transport and xylem anatomical attributes of albino redwoods and show that similar to achlorophyllous and parasitic plants, albino redwoods have notably higher stomatal conductance than green sprouts. Given that stem xylem tracheid size as well as water transport efficiency are nearly equivalent in both albino and green individuals, we attribute the increased leaf water loss in albino sprouts to lower leaf to xylem area ratios, which favour improved hydration relative to green sprouts. The stems of albino redwoods were more vulnerable to drought-induced embolism than green stems, and this was consistent with the albino's weaker tracheids, as characterized by wall thickness to lumen diameter measures. Our results are both complementary and consistent with previous research on achlorophyllous plants, and suggest that the loss of stomatal control and photosynthetic capacity results in substantial vascular and anatomical adjustments.	[Pittermann, Jarmila; Cowan, Joshua] Univ Calif Berkeley, Dept Ecol & Evolutionary Biol, Berkeley, CA 94720 USA; [Kaufman, Nathan] Urban Adamah, Berkeley, CA USA; [Baer, Alex] Calif State Univ Fullerton, Dept Biol, Fullerton, CA 92634 USA; [Zhang, Elaine] Univ San Francisco, Coll Arts & Sci, San Francisco, CA 94117 USA; [Kuty, David] Henry Cowell Redwoods State Pk, Felton, CA USA	University of California System; University of California Berkeley; California State University System; California State University Fullerton; University of San Francisco	Pittermann, J (corresponding author), Univ Calif Berkeley, Dept Ecol & Evolutionary Biol, Berkeley, CA 94720 USA.	jpitterm@ucsc.edu			Faculty Research Grant from the University of California, Santa Cruz	Faculty Research Grant from the University of California, Santa Cruz	This work was supported by Faculty Research Grant, University of California, Santa Cruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Joshua Cowan, a former undergraduate at UC Santa Cruz, could not be reached regarding co-authorship on this paper, but his interest and contributions to data collection underpin the study. Christine Manuck, Lindsey Roark and Sherwin Bastami were helpful and fun assistants in the field and lab. We thank the staff at Henry Cowell State Park, the Santa Cruz District of California State Parks and the Fernwood Resort at Big Sur for allowing us to work on their redwood trees. This work was supported in part by a Faculty Research Grant from the University of California, Santa Cruz.	Alder NN, 1997, J EXP BOT, V48, P665, DOI 10.1093/jxb/48.3.665; Assmann SM, 2016, CURR OPIN PLANT BIOL, V33, P157, DOI 10.1016/j.pbi.2016.07.003; Baer A, 2016, NEW PHYTOL, V210, P122, DOI 10.1111/nph.13770; Beaulieu JM, 2008, NEW PHYTOL, V179, P975, DOI 10.1111/j.1469-8137.2008.02528.x; Dawson TE, 1998, OECOLOGIA, V117, P476, DOI 10.1007/s004420050683; Dawson TE, 2007, TREE PHYSIOL, V27, P561, DOI 10.1093/treephys/27.4.561; Delzon S, 2010, PLANT CELL ENVIRON, V33, P2101, DOI 10.1111/j.1365-3040.2010.02208.x; Drake PL, 2013, J EXP BOT, V64, P495, DOI 10.1093/jxb/ers347; Ehleringer J. R., 1995, P125; Feild TS, 2005, PLANT CELL ENVIRON, V28, P1316, DOI 10.1111/j.1365-3040.2005.01378.x; Gitelson AA, 1999, REMOTE SENS ENVIRON, V69, P296, DOI 10.1016/S0034-4257(99)00023-1; Gleason SM, 2016, NEW PHYTOL, V209, P123, DOI 10.1111/nph.13646; Hacke UG, 2001, OECOLOGIA, V126, P457, DOI 10.1007/s004420100628; Jacobsen AL, 2005, PLANT PHYSIOL, V139, P546, DOI 10.1104/pp.104.058404; Jansen S, 2012, PLANT CELL ENVIRON, V35, P1109, DOI 10.1111/j.1365-3040.2011.02476.x; Jaret P., 2014, NATL GEOGRAPHIC NEWS; Kolb KJ, 1999, ECOLOGY, V80, P2373, DOI 10.1890/0012-9658(1999)080[2373:DIDABS]2.0.CO;2; Lawson T, 2009, NEW PHYTOL, V181, P13, DOI 10.1111/j.1469-8137.2008.02685.x; Lo Gullo MA, 2012, ANN BOT-LONDON, V109, P1101, DOI 10.1093/aob/mcs033; Lo Gullo MA, 2007, TREE PHYSIOL, V27, P209, DOI 10.1093/treephys/27.2.209; Monteith J.L., 1990, PRINCIPLES ENV PHYS, V2nd; Murray F., 1967, J APPL METEOROL CLIM, V6, P203, DOI [10.1175/1520-0450(1967)0062.0.CO;2, DOI 10.1175/1520-0450(1967)0062.0.CO;2]; NEUFELD HS, 1992, PLANT PHYSIOL, V100, P1020, DOI 10.1104/pp.100.2.1020; Pittermann J, 2006, PLANT CELL ENVIRON, V29, P1618, DOI 10.1111/j.1365-3040.2006.01539.x; Pittermann J, 2012, P NATL ACAD SCI USA, V109, P9647, DOI 10.1073/pnas.1114378109; Pittermann J, 2010, PLANT PHYSIOL, V153, P1919, DOI 10.1104/pp.110.158824; POCKMAN WT, 1995, NATURE, V378, P715, DOI 10.1038/378715a0; PRESS MC, 1991, FUNCT ECOL, V5, P278, DOI 10.2307/2389265; R Core Team, 2013, R LANG ENV STAT COMP; Rasband W., 2006, IMAGEJ; Rico C, 2013, NEW PHYTOL, V199, P956, DOI 10.1111/nph.12339; Scott AD, 2016, NEW PHYTOL, V211, P186, DOI 10.1111/nph.13930; Shimazaki K, 2007, ANNU REV PLANT BIOL, V58, P219, DOI 10.1146/annurev.arplant.57.032905.105434; Sperry J., 1993, P86, DOI 10.1017/CBO9780511753305.009; STEWART GR, 1990, ANNU REV PLANT PHYS, V41, P127, DOI 10.1146/annurev.pp.41.060190.001015; Stockel M, 2011, NEW PHYTOL, V189, P790, DOI 10.1111/j.1469-8137.2010.03510.x; WONG SC, 1979, NATURE, V282, P424, DOI 10.1038/282424a0	37	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0191836	10.1371/journal.pone.0191836	http://dx.doi.org/10.1371/journal.pone.0191836			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590113	Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100001
J	Xu, XJ; Liu, XY; Zhang, Y				Xu, Xiaojun; Liu, Xiaoyuan; Zhang, Yan			Osthole inhibits gastric cancer cell proliferation through regulation of PI3K/AKT	PLOS ONE			English	Article							CYCLE ARREST; HEPATOCELLULAR-CARCINOMA; SIGNALING PATHWAY; A549 CELLS; APOPTOSIS; ACTIVATION	Osthole is an active compound isolated from Chinese herb Cnidium monnieri (L.) Cusson, and had been reported to possess antitumor effect. However, the effect of osthole on the gastric cancer cells has not been investigated. In this study, the effects of osthole on the proliferation of human gastric cancer cells were tested. The data showed that osthole treatment significantly inhibited the proliferation of gastric cancer cells and resulted in the cell cycle arrest at G2/M phase in a dose-dependent manner. Western-blot study showed that the expression of cyclin B1 and cdc2 was markedly reduced by osthole. Moreover, expression of P13K and pAKT was also significantly suppressed, and the results indicated that the inhibition of pAKT, cyclin B1, and cdc2 levels by osthole was notably enhanced by a P13K inhibitor. These results demonstrate that osthole could inhibit gastric cancer cells proliferation via induction of cell cycle arrest at G2/M phase by the reduction of PI3K/AKT.	[Xu, Xiaojun] Second Peoples Hosp Wuxi, Dept Pharm, Wuxi, Peoples R China; [Liu, Xiaoyuan] Forth Peoples Hosp Wuxi, Dept Pharm, Wuxi, Peoples R China; [Zhang, Yan] Wuxi M & Child Hlth Hosp, Dept Pharm, Wuxi, Peoples R China	Jiangnan University	Zhang, Y (corresponding author), Wuxi M & Child Hlth Hosp, Dept Pharm, Wuxi, Peoples R China.	2004zhangshanshi@163.com			National Natural Science Foundation of China [81401222, 81671489]; Youth project of Wuxi Health Bureau [2014Z02]; Youth Medicine project of Jiangsu province [QNRC2016166]; Doctor Fund of Wuxi Health Bureau [2014BS01]; Wuxi City Hospital Management Center Pharmacy Program [YGZXY1303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth project of Wuxi Health Bureau; Youth Medicine project of Jiangsu province; Doctor Fund of Wuxi Health Bureau; Wuxi City Hospital Management Center Pharmacy Program	This work was supported by grants from the National Natural Science Foundation of China under Grant #81401222 and #81671489, Youth project of Wuxi Health Bureau under Grant 2014Z02, Youth Medicine project of Jiangsu province under Grant QNRC2016166 and Doctor Fund of Wuxi Health Bureau under Grant 2014BS01 and Wuxi City Hospital Management Center Pharmacy Program (YGZXY1303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Natural Science Foundation of China under Grant #81401222 and #81671489, Youth project of Wuxi Health Bureau under Grant 2014Z02, Youth Medicine project of Jiangsu province under Grant QNRC2016166 and Doctor Fund of Wuxi Health Bureau under Grant 2014BS01.	Chen R, 2013, J PHARM PHARM SCI, V16, P732, DOI 10.18433/J3HK5C; Ding DF, 2013, CELL PHYSIOL BIOCHEM, V32, P1751, DOI 10.1159/000356609; Feng HT, 2017, CELL ADHES MIGR, V11, P464, DOI 10.1080/19336918.2016.1259058; Gao P, 2017, MINERVA MED, V108, P74, DOI 10.23736/S0026-4806.16.04628-0; Jiang GQ, 2016, J ETHNOPHARMACOL, V193, P368, DOI 10.1016/j.jep.2016.08.045; Kaya DM, 2017, EXPERT REV CLIN PHAR, V10, P263, DOI 10.1080/17512433.2017.1279969; Li K, 2016, BIOL PHARM BULL, V39, P336, DOI 10.1248/bpb.b15-00699; Li LW, 2011, EUR J PHARMACOL, V670, P13, DOI 10.1016/j.ejphar.2011.08.054; Morgensztern D, 2005, ANTI-CANCER DRUG, V16, P797, DOI 10.1097/01.cad.0000173476.67239.3b; Muller S, 2017, NAT REV GENET, V18, P192, DOI 10.1038/nrg.2016.157; Venerito M, 2016, HELICOBACTER, V21, P39, DOI 10.1111/hel.12339; Wang H, 2016, ONCOL REP, V35, P3659, DOI 10.3892/or.2016.4730; Wang LT, 2015, J BIOMED RES, V29, P132, DOI 10.7555/JBR.27.20120115; Wang L, 2016, CELL PHYSIOL BIOCHEM, V38, P2173, DOI 10.1159/000445573; Xu XM, 2016, ONCOL LETT, V12, P3779, DOI 10.3892/ol.2016.5170; Xu XM, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-33; Yan YH, 2017, NEUROCHEM RES, V42, P398, DOI 10.1007/s11064-016-2082-y; Yang SM, 2014, FREE RADICAL BIO MED, V73, P260, DOI 10.1016/j.freeradbiomed.2014.05.009; Yoon MK, 2012, BIOCHEM SOC T, V40, P981, DOI 10.1042/BST20120092; Yuan L, 2015, MOL MED REP, V11, P2459, DOI 10.3892/mmr.2014.3100; Zhai YK, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/921954; Zhang LR, 2015, IMMUNOPHARM IMMUNOT, V37, P301, DOI 10.3109/08923973.2015.1035391; Zhang ZR, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/919616; Zhao L, 2016, MOL CARCINOGEN, V55, P778, DOI 10.1002/mc.22321	24	29	31	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193449	10.1371/journal.pone.0193449	http://dx.doi.org/10.1371/journal.pone.0193449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590128	Green Published, gold, Green Submitted			2022-12-26	WOS:000428603100020
J	Zhong, L; Liu, EX; Yang, CZ; Diao, Y; Harijati, N; Liu, JD; Hu, ZL; Jin, SR				Zhong, Lin; Liu, Erxi; Yang, Chaozhu; Diao, Ying; Harijati, Nunung; Liu, Jiangdong; Hu, Zhongli; Jin, Surong			Gene cloning of a neutral ceramidase from the sphingolipid metabolic pathway based on transcriptome analysis of Amorphophallus muelleri	PLOS ONE			English	Article							MOLECULAR-CLONING; PURIFICATION; SPHINGOSINE	Amorphophallus is a perennial herbaceous plant species mainly distributed in the tropics or subtropics of Asia and Africa. It has been used as a traditional medicine for a long time and now is utilized for the pharmaceutical, chemical and agriculture industries as a valued economic crop. Recently, Amorphophallus has attracted tremendous interest because of its high ceramide content. However, the breeding and genome studies are severely limited by the arduous whole genome sequencing of Amorphophallus. In this study, the transcriptome data of A. muelleri was obtained by utilizing the high-throughput Illumina sequencing platform. Based on this information, the majority of the significant genes involved in the proposed sphingolipid metabolic pathway were identified. Then, the full-length neutral ceramidase cDNA was obtained with the help of its candidate transcripts, which were acquired from the transcriptome data. Furthermore, we demonstrated that this neutral ceramidase was a real ceramidase by eukaryotic expression in the yeast double knockout mutant Delta ypc1 Delta ydc1, which lacks the ceramidases-dihydroCDase (YDC1p), phytoCDase (YPC1p). In addition, the biochemical characterization of purified A. muelleri ceramidase (AmCDase) exhibited classical Michaelis-Menten kinetics with an optimal activity ranging from pH 6.5 to 8.0. Based on our knowledge, this study is the first to report the related information of the neutral ceramidase in Amorphophallus. All datasets can provide significant information for related studies, such as gene expression, genetic improvement and application on breeding in Amorphophallus.	[Zhong, Lin; Hu, Zhongli] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan, Hubei, Peoples R China; [Liu, Erxi; Yang, Chaozhu] Enshi Acad Agr Sci, Inst Konjac, Enshi, Hubei, Peoples R China; [Diao, Ying] Wuhan Univ, Coll Life Sci, Lotus Engn Res Ctr Hubei Prov, Wuhan, Hubei, Peoples R China; [Harijati, Nunung] Brawijaya Univ, Dept Biol, Fac Math & Nat Sci, Jl Vet, Malang, Indonesia; [Liu, Jiangdong] Wuhan Univ, Coll Life Sci, Dept Biol, Coll Life Sci, Wuhan, Hubei, Peoples R China; [Jin, Surong] Wuhan Univ Technol, Inst Chem & Life Sci, Wuhan, Hubei, Peoples R China	Wuhan University; Wuhan University; Brawijaya University; Wuhan University; Wuhan University of Technology	Hu, ZL (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan, Hubei, Peoples R China.; Jin, SR (corresponding author), Wuhan Univ Technol, Inst Chem & Life Sci, Wuhan, Hubei, Peoples R China.	huzhongli@whu.edu.cn; rsjin@whut.edu.cn			National Science and Technology Supporting Program [2011BAD33B03]; National Natural Science Foundation of China [30971829]; Philanthropic Project of Scientific Research of Hubei [2012DBA11001]	National Science and Technology Supporting Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Philanthropic Project of Scientific Research of Hubei	This study was supported by grants from the National Science and Technology Supporting Program (No. 2011BAD33B03), the National Natural Science Foundation of China (No. 30971829) and Philanthropic Project of Scientific Research of Hubei (No. 2012DBA11001). The funders had a role in study design, decision to publish of the manuscript.	Chen M, 2009, ADV PHOTOSYNTH RESP, V30, P77; [寸湘琴 CUN Xiang-qin], 2009, [云南农业大学学报, Journal of Yunnan Agricultural University], V24, P764; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Diao Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095428; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; Galadari S, 2006, BIOCHEM J, V393, P687, DOI 10.1042/BJ20050682; GATT S, 1963, J BIOL CHEM, V238, P3131; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hetterscheid W., 1996, AROIDEANA, V19, P7; Hua Zhang Dong, 2010, RESOURCE DEV MARKET; Liu H, 2015, S AFR J BOT, V97, P101, DOI 10.1016/j.sajb.2014.11.008; Liu Ren-ping, 2011, NATURAL PRODUCT RES, V23; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Monjusho H, 2003, BIOCHEM J, V376, P473, DOI 10.1042/BJ20030652; Okino N, 2010, BIOSCI BIOTECH BIOCH, V74, P316, DOI 10.1271/bbb.90645; Pata MO, 2008, PLANT J, V55, P1000, DOI 10.1111/j.1365-313X.2008.03569.x; Pata MO, 2010, NEW PHYTOL, V185, P611, DOI 10.1111/j.1469-8137.2009.03123.x; Santosa E, 2007, MOL ECOL NOTES, V7, P814, DOI 10.1111/j.1471-8286.2007.01713.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tani M, 2000, J BIOL CHEM, V275, P3462, DOI 10.1074/jbc.275.5.3462; Wu JX, 2015, PLANT J, V81, P767, DOI 10.1111/tpj.12769; Xu RJ, 2006, FASEB J, V20, P1813, DOI 10.1096/fj.05-5689com; Yoshimura Y, 2002, J BIOCHEM, V132, P229, DOI 10.1093/oxfordjournals.jbchem.a003215; Yu XM, 2011, MOL BIOL REP, V38, P3447, DOI 10.1007/s11033-010-0454-y; Zhong L, 2017, OPEN LIFE SCI, V12, P34, DOI 10.1515/biol-2017-0004; Zhou H., 2013, CHEM BIOENGINEERING, V4	29	1	3	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194863	10.1371/journal.pone.0194863	http://dx.doi.org/10.1371/journal.pone.0194863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590184	gold, Green Submitted, Green Published			2022-12-26	WOS:000428603100083
J	Peng, W; Berry, EM				Peng, Wen; Berry, Elliot M.			Global nutrition 1990-2015: A shrinking hungry, and expanding fat world	PLOS ONE			English	Article							STRATEGIES; POLICY; INDEX	Objectives Following its publication in 2008, the Global Nutritional Index (GNI) which captures the triple burden of malnutrition, has been updated to assess the overall nutritional status and nutritional trends of countries, regions and the world, including both under-nutrition and over-nutrition. Methods The GNI was modeled on the Human Development Index, using geometric means of three normalized indicators: protein-energy malnutrition (PEM, measured by Disability-Adjusted Life Years (DALYs) from PEM), micronutrient deficiency (MID, measured by DALYs from MID), and penalizing obesity (percent female obesity). GNI (range 0-1) was calculated from 1990-2015 for 186 countries, in seven World Bank income and WHO region groupings. Results World GNI increased from 0.433 to 0.473 as decreased deficits overcompensated for the rise in obesity. GNI for African low- and middle-income countries (LMIC) (median 0.301 to 0.392) and South-East Asian LMIC (0.456 to 0.564) improved significantly (P<0.001), while for high-income countries (0.657 to 0.611) worsened significantly (P<0.001). GNI for American LMIC (0.459 to 0.457), European LMIC (0.571 to 0.575), Eastern Mediterranean LMIC (0.484 to 0.483) and Western Pacific LMIC (0.433 to 0.494) were unchanged. The disaggregation of the GNI showed that in nearly all the seven country groups there was a significant decrease in both PEM and MID (all P<0.01) (except in HIC where only PEM dropped), and a significant increase in obesity (all P<0.001). Conclusion These trends are the result of the reciprocal changes between decreased under-nutrition and increased over-nutrition, which has become a major cause of malnutrition worldwide. We suggest, therefore, that future Sustainable Development Goals should include alongside "zero hunger"-"reduce obesity".	[Peng, Wen] Qinghai Univ, Sch Med, Dept Publ Hlth Nutr, Xining, Qinghai, Peoples R China; [Peng, Wen] Amity Fdn, Res Ctr, Nanjing, Jiangsu, Peoples R China; [Berry, Elliot M.] Hebrew Univ Jerusalem, Hadassah Med Sch, Braun Sch Publ Hlth, Dept Human Nutr & Metab, Jerusalem, Israel	Qinghai University; Hebrew University of Jerusalem	Berry, EM (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Braun Sch Publ Hlth, Dept Human Nutr & Metab, Jerusalem, Israel.	elliotb@ekmd.huji.ac.il						[Anonymous], 2016, LANCET, V388, P1447, DOI 10.1016/S0140-6736(16)31790-1; [Anonymous], 2015, AFSUN FOOD SECURITY; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Berrocal E, 2015, PUBLIC HEALTH NUTR, P1; Black R, 2003, B WORLD HEALTH ORGAN, V81, P79; Gould J, 2017, NATURE, V544, pS6, DOI 10.1038/544S6a; International Food Policy Research Institue (IFPRI), 2016, GLOB HUNG IND GETT Z; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Metrics IfH Evaluation. Global Burden of Disease Collaborative Network, 2017, GLOBAL BURDEN DIS ST; Miller DD, 2013, FOOD POLICY, V42, P115, DOI 10.1016/j.foodpol.2013.06.008; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Pinstrup-Andersen P, 2007, AGR ECON-BLACKWELL, V37, P187, DOI 10.1111/j.1574-0862.2007.00244.x; Rosenbloom JI, 2008, FOOD NUTR BULL, V29, P266, DOI 10.1177/156482650802900403; UNDP, 2016, HUM DEV IND HDI; WHO, 2017, ALPH LIST WHO MEMB S; World Bank, 2016, DAT WORLD BANK COUNT; World Health Organization, 2017, DEF REG GROUP; World Health Organization, 2017, OB BOD MASS IND 30 A; World Health Organization, 2018, OB OV FACT SHEET 311	19	19	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194821	10.1371/journal.pone.0194821	http://dx.doi.org/10.1371/journal.pone.0194821			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584768	Green Published, Green Submitted, gold			2022-12-26	WOS:000428373000041
J	Jan, M; Upadhyay, C; Pertejo, JA; Hioe, CE; Arora, SK				Jan, Muzafar; Upadhyay, Chitra; Alcami Pertejo, Jose; Hioe, Catarina E.; Arora, Sunil K.			Heterogeneity in glycan composition on the surface of HIV-1 envelope determines virus sensitivity to lectins	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NEUTRALIZING ANTIBODY-RESPONSE; N-LINKED GLYCANS; CYANOVIRIN-N; VIRAL ENTRY; INACTIVATING PROTEIN; ANTIVIRAL LECTINS; MASS-SPECTROMETRY; SITE OCCUPANCY; CELL LINE	Lectins that target N-glycans on the surface of HIV-1 envelope (Env) glycoprotein have the potential for use as antiviral agents. Although progress has been made in deciphering the molecular details of lectin and Env glycan interaction, further studies are needed to better understand Env glycan heterogeneity among HIV-1 isolates and its influence on virus-neutralization sensitivity to lectins. This study evaluated a panel of lectins with fine specificity for distinct oligosaccharides and assessed their ability to inhibit infection of HIV-1 viruses known to have differing sensitivity to anti-HIV Env antibodies. The results showed that HIV-1 isolates have different sensitivity to lectins specific for alpha 1-3Man, alpha 1-6Man, and alpha 1-2Man binding lectins. Considering that lectins exclusively recognize the oligosaccharide components of virus Env, these data suggest that glycan heterogeneity among HIV-1 isolates may explain this differential sensitivity. To evaluate this further, chronic and acute viruses were produced in the presence of different glycosidase inhibitors to express more homogenous glycans. Viruses enriched for alpha 1-2Man terminating Man(5-9)GlcNAc(2) glycans became similarly sensitive to alpha 1-2Man-binding lectins. The alpha 1-3Man- and alpha 1-6Man-binding lectins also were more potent against viruses expressing predominantly Man(5)GlcNAc(2) and hybrid type glycans with terminal alpha 1-3Man and alpha 1-6Man. Furthermore, lectin-mediated inhibition was competitively alleviated by mannan and this effect was augmented by enrichment of man nose -type glycans on the virus. In addition, while Env of viruses enriched with mannosetype glycans were sensitive to Endo-H deglycosylation, Env of untreated viruses were partially resistant, indicating that HIV-1 Env glycans are heterogeneously comprised of complex, hybrid, and mannose types. Overall, our data demonstrate that HIV-1 isolates display differential sensitivity to lectins, in part due to the microheterogeneity of N-linked glycans expressed on the surface of the virus Env glycoprotein.	[Jan, Muzafar; Arora, Sunil K.] Post Grad Inst Med Educ Res, Dept Immunopathol, Chandigarh, India; [Jan, Muzafar; Upadhyay, Chitra; Hioe, Catarina E.] Icahn Sch Med Mt Sinai, Div Infect Dis, Dept Med, New York, NY 10029 USA; [Jan, Muzafar; Hioe, Catarina E.] James J Peters VA Med Ctr, Bronx, NY USA; [Alcami Pertejo, Jose] Inst Salud Carlos III, Ctr Nacl Microbiol, Imunopatol SIDA, Madrid, Spain	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Arora, SK (corresponding author), Post Grad Inst Med Educ Res, Dept Immunopathol, Chandigarh, India.	arora.sunilkumar@pgimer.edu.in	Upadhyay, Chitra/K-8756-2019; Arora, Sunil K/V-9083-2019; Alcami, Jose/T-2242-2018	Arora, Sunil K/0000-0002-8294-5360; Alcami, Jose/0000-0003-0023-7377	Indian Council of Medical Research [59/58/2012/online/WS/MM]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work received support from the Indian Council of Medical Research, Grant Ref. No. 59/58/2012/online/WS/MM.	Alexandre KB, 2010, VIROLOGY, V402, P187, DOI 10.1016/j.virol.2010.03.021; Alexandre KB, 2011, J VIROL, V85, P9039, DOI 10.1128/JVI.02675-10; Balzarini J, 2006, ANTIVIR RES, V71, P237, DOI 10.1016/j.antiviral.2006.02.004; BALZARINI J, 1991, ANTIMICROB AGENTS CH, V35, P410, DOI 10.1128/AAC.35.3.410; Balzarini J, 2007, MOL PHARMACOL, V71, P3, DOI 10.1124/mol.106.030155; Balzarini J, 2006, J VIROL, V80, P8411, DOI 10.1128/JVI.00369-06; Behrens AJ, 2016, CELL REP, V14, P2695, DOI 10.1016/j.celrep.2016.02.058; Binley JM, 2010, J VIROL, V84, P5637, DOI 10.1128/JVI.00105-10; Bokesch HR, 2003, BIOCHEMISTRY-US, V42, P2578, DOI 10.1021/bi0205698; Bonomelli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023521; Botos I, 2005, PROG BIOPHYS MOL BIO, V88, P233, DOI 10.1016/j.pbiomolbio.2004.05.001; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Cao LW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14954; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Crooks ET, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004932; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; Francois KO, 2011, J BIOL CHEM, V286, P42900, DOI 10.1074/jbc.M111.274456; Go EP, 2013, J PROTEOME RES, V12, P1223, DOI 10.1021/pr300870t; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Hopper JTS, 2017, STRUCTURE, V25, P773, DOI 10.1016/j.str.2017.03.015; Hu QX, 2007, VIROLOGY, V368, P145, DOI 10.1016/j.virol.2007.06.029; Huang X, 2011, J GEN VIROL, V92, P2367, DOI 10.1099/vir.0.033092-0; Jan M, 2017, AIDS RES HUM RETROV, V33, P941, DOI [10.1089/aid.2016.0262, 10.1089/AID.2016.0262]; Jan M, 2017, AIDS RES HUM RETROV, V33, P765, DOI 10.1089/aid.2016.0290; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Koharudin LMI, 2014, CURR OPIN VIROL, V7, P95, DOI 10.1016/j.coviro.2014.05.006; Kong L, 2010, J MOL BIOL, V403, P131, DOI 10.1016/j.jmb.2010.08.033; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; LAURENCE J, 1993, ANN NY ACAD SCI, V693, P52, DOI 10.1111/j.1749-6632.1993.tb26256.x; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li Y, 2006, J VIROL, V80, P1414, DOI 10.1128/JVI.80.3.1414-1426.2006; Lusvarghi S, 2016, ACS INFECT DIS, V2, P882, DOI 10.1021/acsinfecdis.6b00139; Mitchell CA, 2017, ANTIVIR RES, V142, P37, DOI 10.1016/j.antiviral.2017.03.007; Montefiori D. C., 2005, CURR PROT IMMUNOL, V12, P1, DOI DOI 10.1002/; MONTEFIORI DC, 1988, P NATL ACAD SCI USA, V85, P9248, DOI 10.1073/pnas.85.23.9248; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Moulaei T, 2010, STRUCTURE, V18, P1104, DOI 10.1016/j.str.2010.05.016; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Pritchard LK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8479; Provine NM, 2009, J VIROL, V83, P9002, DOI 10.1128/JVI.00423-09; Quinones-Kochs MI, 2002, J VIROL, V76, P4199, DOI 10.1128/JVI.76.9.4199-4211.2002; Raska M, 2010, J BIOL CHEM, V285, P20860, DOI 10.1074/jbc.M109.085472; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Rudd PM, 1997, CRIT REV BIOCHEM MOL, V32, P1, DOI 10.3109/10409239709085144; Saidi H, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-28; Sanders RW, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-10; SHARON N, 1989, SCIENCE, V246, P227, DOI 10.1126/science.2552581; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Stamatatos L, 1998, AIDS RES HUM RETROV, V14, P1129, DOI 10.1089/aid.1998.14.1129; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; Struwe WB, 2017, ACS CHEM BIOL, V12, P357, DOI 10.1021/acschembio.6b00854; Townsley S, 2016, J VIROL, V90, P8644, DOI 10.1128/JVI.00853-16; van Montfort T, 2011, J IMMUNOL, V187, P4676, DOI 10.4049/jimmunol.1101876; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Woodrum BW, 2013, BIOCHEM SOC T, V41, P1170, DOI 10.1042/BST20130154; Zhu ZK, 2014, J AM SOC MASS SPECTR, V25, P1012, DOI 10.1007/s13361-014-0859-2	63	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194498	10.1371/journal.pone.0194498	http://dx.doi.org/10.1371/journal.pone.0194498			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579062	Green Published, gold, Green Submitted			2022-12-26	WOS:000428351800032
J	Ramirez-Olvera, SM; Trejo-Tellez, LI; Garcia-Morales, S; Perez-Sato, JA; Gomez-Merino, FC				Monzerrat Ramirez-Olvera, Sara; Iris Trejo-Tellez, Libia; Garcia-Morales, Soledad; Antonio Perez-Sato, Juan; Carlos Gomez-Merino, Fernando			Cerium enhances germination and shoot growth, and alters mineral nutrient concentration in rice	PLOS ONE			English	Article							RARE-EARTH-ELEMENTS; BIOCHEMICAL-CONSTITUENTS; OXIDE NANOPARTICLES; LANTHANUM; TOXICITY; SEEDLINGS; ARABIDOPSIS; NUTRITION; CADMIUM; NITRATE	Cerium (Ce) belongs to the rare earth elements (REEs), and although it is not essential for plants, it can stimulate growth and other physiological processes. The objective of this research was to evaluate the effect of Ce on seed germination, initial seedling growth, and vegetative growth in rice (Oryza sativa L.) cv. Morelos A-98. During the germination process, the seeds were treated with Ce concentrations of 0, 4, 8, and 12 mu M; after 5 d, germination percentage was recorded and after 10 d seedling growth was measured. For vegetative growth, a hydroponic system was established where 14-d-old plants without previous Ce treatment were transferred into nutrient solution. After two weeks of acclimatizing, 0, 25, 50, and 100 mu M Ce were added to the nutrient solution for 28 d. Ce significantly increased germination and the initial growth variables of the seedlings. During vegetative growth, Ce increased plant height, number of tillers, root volume, and shoot fresh and dry biomass, without affecting root biomass weight. With low Ce concentrations (25 and 50 mu M), the concentrations of chlorophylls and amino acids in the shoots were similar to those in the control, like amino acid concentration in the roots at a concentration of 25 mu M Ce. Conversely, the concentration of total sugars increased in the shoot with the application of 25, 50, and 100 mu M Ce, and in the roots with the application of 50 mu M Ce. Also, Ce did not affect the concentration of macro or micronutrients in the shoots. However, in the roots, the high Ce concentration decreased the concentrations of Ca, Fe, Mn, and Zn, while the Mg concentration increased. Our results indicate that Ce, at the right concentrations, can function as a biostimulant in rice germination and growth.	[Monzerrat Ramirez-Olvera, Sara; Antonio Perez-Sato, Juan; Carlos Gomez-Merino, Fernando] Colegio Postgrad, Dept Biotechnol, Campus Cordoba, Amatlan De Los Reyes, Veracruz, Mexico; [Iris Trejo-Tellez, Libia] Colegio Postgrad, Lab Plant Nutr, Dept Soil Sci, Campus Montecillo, Texcoco, State Of Mexico, Mexico; [Garcia-Morales, Soledad] Ctr Invest & Asistencia Tecnol & Diserio Estado J, CONACYT Ctr Res & Assistance Technol & Design Sta, Dept Plant Biotechnol, Zapopan, Jalisco, Mexico	Colegio de Postgraduados - Mexico; Colegio de Postgraduados - Mexico	Gomez-Merino, FC (corresponding author), Colegio Postgrad, Dept Biotechnol, Campus Cordoba, Amatlan De Los Reyes, Veracruz, Mexico.	fernandg@colpos.mx	LIBIA, TREJO-TÉLLEZ/AAV-8118-2021; Gómez-Merino, Fernando Carlos/D-2224-2014; Sato, Juan Antonio Perez/AAC-7562-2019; Gomez-Merino, Fernando Carlos/B-2423-2015	Sato, Juan Antonio Perez/0000-0002-8842-6262; RAMIREZ-OLVERA, SARA MONZERRAT/0000-0002-4652-8906; Gomez-Merino, Fernando Carlos/0000-0001-8496-2095; Garcia-Morales, Soledad/0000-0002-2551-2518	Mexico's National Science and Technology Council (CONACYT-Mexico); Colegio de Postgraduados Campus Cordoba and Campus Montecillo	Mexico's National Science and Technology Council (CONACYT-Mexico); Colegio de Postgraduados Campus Cordoba and Campus Montecillo	The authors are grateful to Mexico's National Science and Technology Council (CONACYT-Mexico) for the M. Sc. scholarship awarded to SMRO, and for the infrastructure and financial support provided by Colegio de Postgraduados Campus Cordoba and Campus Montecillo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aery NC, 1997, COMMUN SOIL SCI PLAN, V28, P949, DOI 10.1080/00103629709369845; Alcantar G.G., 1999, HDB CHEM ANAL PLANT, V1st; [Anonymous], 2011, STAT AN SYST VERS 9; Arsovski AA, 2015, PLANT PHYSIOL, V169, P2982, DOI 10.1104/pp.15.00717; BAILEY RW, 1958, BIOCHEM J, V68, P669, DOI 10.1042/bj0680669; Busoms S, 2015, PLANT PHYSIOL, V168, P915, DOI 10.1104/pp.15.00427; Calabrese EJ, 2014, MICROB CELL, V1, P145, DOI 10.15698/mic2014.05.145; Chen Y, 2015, PLANT CELL TISS ORG, V123, P283, DOI 10.1007/s11240-015-0831-2; d'Aquino L, 2009, CHEMOSPHERE, V75, P900, DOI 10.1016/j.chemosphere.2009.01.026; Diatloff E, 2008, ANN BOT-LONDON, V101, P971, DOI 10.1093/aob/mcn021; Famoso AN, 2010, PLANT PHYSIOL, V153, P1678, DOI 10.1104/pp.110.156794; FAO, FAO CER SUPPL DEM BR; Fashui H, 2002, BIOL TRACE ELEM RES, V87, P191, DOI 10.1385/BTER:87:1-3:191; GABBRIELLI R, 1990, PLANT SOIL, V122, P271, DOI 10.1007/BF02851985; Geiger M, 1998, PLANT CELL ENVIRON, V21, P253, DOI 10.1046/j.1365-3040.1998.00277.x; Gong XL, 2011, BIOL TRACE ELEM RES, V141, P305, DOI 10.1007/s12011-010-8716-z; Espindola MCG, 2013, BIOSCI J, V29, P1501; He YW, 2000, PLANT SCI, V159, P117, DOI 10.1016/S0168-9452(00)00338-1; Hong FS, 2017, J AGR FOOD CHEM, V65, P9022, DOI 10.1021/acs.jafc.7b03398; Hong FS, 2002, SCI CHINA SER C, V45, P166, DOI 10.1360/02yc9019; Hong FS, 2002, BIOL TRACE ELEM RES, V89, P263, DOI 10.1385/BTER:89:3:263; Hu X, 2002, CHEMOSPHERE, V48, P621, DOI 10.1016/S0045-6535(02)00109-1; Hu YF, 2015, FRESEN ENVIRON BULL, V24, P4173; Hu ZY, 2004, J PLANT NUTR, V27, P183, DOI 10.1081/PLN-120027555; Liu D, 2013, PLANT SOIL ENVIRON, V59, P196, DOI 10.17221/760/2012-PSE; Liu DW, 2012, ENVIRON SCI POLLUT R, V19, P3282, DOI 10.1007/s11356-012-0844-x; Liu DW, 2012, PROTEIN PEPTIDE LETT, V19, P198, DOI 10.2174/092986612799080121; Ma JJ, 2014, BIOL TRACE ELEM RES, V160, P427, DOI 10.1007/s12011-014-0062-0; Mali M, 2009, COMMUN SOIL SCI PLAN, V40, P1041, DOI 10.1080/00103620902753590; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; MOORE S, 1954, J BIOL CHEM, V211, P907; Moreno-Alvarado M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00073; Moyer M., 2010, SCI AM ENV, V2010, P74; PANDOLFINI T, 1992, PLANT CELL ENVIRON, V15, P719, DOI 10.1111/j.1365-3040.1992.tb01014.x; Paoli L, 2014, ECOTOX ENVIRON SAFE, V104, P379, DOI 10.1016/j.ecoenv.2014.02.028; Barbieri Ana Paula Piccinin, 2013, Pesqui. Agropecu. Trop., V43, P104, DOI 10.1590/S1983-40632013000100013; Poscic F, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060577; Ramos SJ, 2016, CURR POLLUT REP, V2, P28, DOI 10.1007/s40726-016-0026-4; Rico CM, 2014, J AGR FOOD CHEM, V62, P9669, DOI 10.1021/jf503526r; Rico CM, 2013, J AGR FOOD CHEM, V61, P11278, DOI 10.1021/jf404046v; Shan XQ, 2003, PLANT SCI, V165, P1343, DOI 10.1016/S0168-9452(03)00361-3; Shi XL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1954; Shtangeeva I, 2007, ENVIRON EXP BOT, V59, P49, DOI 10.1016/j.envexpbot.2005.10.011; Shtangeeva I, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-1964-3; Shyam R, 2012, J SOIL SCI PLANT NUT, V12, P1, DOI 10.4067/S0718-95162012000100001; SOMASHEKARAIAH BV, 1992, PHYSIOL PLANTARUM, V85, P85, DOI 10.1111/j.1399-3054.1992.tb05267.x; Suryawanshi V, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3319-5; Thomas PJ, 2014, CHEMOSPHERE, V96, P57, DOI 10.1016/j.chemosphere.2013.07.020; Velasco J. R., 1979, Philippine Journal of Coconut Studies, V4, P1; [王建安 Wang Jian'an], 2010, [南京师大学报. 自然科学版, Journal of Nanjing Normal University. Natural Science], V33, P94; Wang X, 2007, RUSS J PLANT PHYSL+, V54, P693, DOI 10.1134/S1021443707050184; Wang X, 2012, J RARE EARTH, V30, P579, DOI 10.1016/S1002-0721(12)60094-5; Wu M, 2014, PLANT GROWTH REGUL, V74, P251, DOI 10.1007/s10725-014-9916-x; Xie YF, 2015, J RARE EARTH, V33, P898, DOI 10.1016/S1002-0721(14)60502-0; Yin ST, 2009, BIOL TRACE ELEM RES, V132, P247, DOI 10.1007/s12011-009-8392-z; Zhang CH, 2013, ACTA PHARM SIN B, V3, P20, DOI 10.1016/j.apsb.2012.12.005; Zhao HQ, 2012, BIOL TRACE ELEM RES, V148, P102, DOI 10.1007/s12011-012-9340-x; Zhou M, 2011, BIOL TRACE ELEM RES, V142, P760, DOI 10.1007/s12011-010-8769-z	58	31	32	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194691	10.1371/journal.pone.0194691	http://dx.doi.org/10.1371/journal.pone.0194691			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579100	Green Published, Green Submitted, gold			2022-12-26	WOS:000428351800046
J	Gbogbo, F; Arthur-Yartel, A; Bondzie, JA; Dorleku, WP; Dadzie, S; Kwansa-Bentum, B; Ewool, J; Billah, MK; Lamptey, AM				Gbogbo, Francis; Arthur-Yartel, Anna; Bondzie, Josephine A.; Dorleku, Winfred-Peck; Dadzie, Stephen; Kwansa-Bentum, Bethel; Ewool, Julliet; Billah, Maxwell K.; Lamptey, Angela M.			Risk of heavy metal ingestion from the consumption of two commercially valuable species of fish from the fresh and coastal waters of Ghana	PLOS ONE			English	Article							HEALTH-RISK; MERCURY; RIVER; ASSESSMENTS; POLLUTION; SELENIUM; TISSUES; LAGOON; CHINA; LAKE	Background The need to evaluate the human health safety of fishery resources remain urgent in the mist of the ever-increasing fear of heavy metal toxicity from the consumption of Ghana's fisheries resource, as a consequence of pollution from several anthropogenic activities including artisanal gold mining. Nevertheless, the bigeye grunt (Brachydeuterus auritus) and Bagrid catfish (Chrysichthys nigrodigitatus) remain commercially valuable fish species in West Africa and continue to attract high patronage. Method Forty-five specimens each of C. nigrodigitatus and B. auritus collected from the Weija Dam and the Tema Fishing Habour in Ghana, between June and September 2016, were analysed for seven heavy metals using Atomic Absorption Spectrometry. Result Lead and Cadmium were below detection in all samples while Cu was not detected in B. auritus. Levels of the remaining metals (mg kg(-1)) were below FAO/WHO maximum permissible limits in fish and occurred in the rank order Se (3.5) > Zn (2.34) > Cu (0.59) > As (0.37) > Hg (0.19) in C. nigrodigitatus and Se (2.97) > Zn (2.28) > Hg (0.31) > As (0.21) in B. auritus. Only As in C. nigrodigitatus recorded Estimated Weekly Intake (EWI) greater than FAO/WHO Provisional Tolerable Weekly Intake (PTWI). Also, As in C. nigrodigitatus and Hg in B. auritus had Targeted Hazard Quotient (THQ) greater than 1 for individuals consuming the fishes on daily basis and therefore, raising concerns. However, for both species of fish, cancer risk of As was 1 in 10,000,000,000 and modified Health Benefits values of Se (HBVSe) were positive indicating the health risks that might accompany Hg exposure would be negated. Since toxicity depends on the concentration and quantity of a pollutant consumed, safe maximum consumption rate of C. nigrodigitatus based on As concentrations was 0.21 mg per day and that of B. auritus was 0.058 mg per day for Hg. With an average of 0.227 kg fish per meal of an adult human, these translated into not more than 24 C. nigrodigitatus and nine (9) B. auritus meals in a month but because fish is consumed at 0.0685 kg per person per day in Ghana, these values respectively translates to 93 and 30 safe days of consumption per month. Conclusion At the rate of 0.0685 kg fish per person per day that fish is consumed in Ghana, the consumption of the two species of fish in Ghana would essentially be of little or no consequence to consumers.	[Gbogbo, Francis; Arthur-Yartel, Anna; Bondzie, Josephine A.; Dadzie, Stephen; Kwansa-Bentum, Bethel; Ewool, Julliet; Billah, Maxwell K.] Univ Ghana, Dept Anim Biol & Conservat Sci, Legon, Accra, Ghana; [Dorleku, Winfred-Peck] Univ Ghana, Dept Biochem Cell & Mol Biol, Legon, Accra, Ghana; [Lamptey, Angela M.] Univ Ghana, Dept Marine & Fisheries Sci, Legon, Accra, Ghana	University of Ghana; University of Ghana; University of Ghana	Gbogbo, F (corresponding author), Univ Ghana, Dept Anim Biol & Conservat Sci, Legon, Accra, Ghana.	fgbogbo@ug.edu.gh	Kwansa-Bentum, Bethel/ABD-9984-2021	Gbogbo, Francis/0000-0003-0821-1120				Abadi DRV, 2015, ENVIRON SCI POLLUT R, V22, P6670, DOI 10.1007/s11356-014-3852-1; Akoto O, 2014, INT J ENVIRON RES, V8, P403; Akoto O, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3544-z; Henriquez-Hernandez LA, 2017, ENVIRON POLLUT, V230, P817, DOI 10.1016/j.envpol.2017.07.036; [Anonymous], 1982, WHO TECHN REP SER; [Anonymous], 2004, 2 M TECHN ADV COMM F; [Anonymous], 2003, ENV BURDEN DIS SERIE; [Anonymous], 2010, 72 M JECFA SUMM CONC, P16; [Anonymous], 1997, EPA452R97003, V1; Armah FA, 2010, J ENV STAT, V1, P1; Armah FA, 2013, ENVIRON JUSTICE, V6, P94, DOI 10.1089/env.2013.0006; Atiemo S.M., 2012, RES J ENVIRON EARTH, V4, P605; Bannerman PO, 2002, FISH RES, V59, P197, DOI 10.1016/S0165-7836(01)00404-0; Ben-Tuvia A., 1986, FISHES NE ATLANTIC M, P858; Blight GE, 2005, GEOTECH GEOL ENG, V23, P219, DOI 10.1007/s10706-004-7067-y; Borak J, 2007, REGUL TOXICOL PHARM, V47, P204, DOI 10.1016/j.yrtph.2006.09.005; Bosch AC, 2016, FOOD CHEM, V190, P871, DOI 10.1016/j.foodchem.2015.06.034; Caravanos J., 2011, J HEALTH POLLUT, V1, P16, DOI DOI 10.5696/jhp.v1i1.22; Cizdziel J, 2003, J ENVIRON MONITOR, V5, P802, DOI 10.1039/b307641p; Codex Alimentarius Commission (CAC), 1995, CXFAC9617 CAC; Copat C, 2013, FOOD CHEM TOXICOL, V53, P33, DOI 10.1016/j.fct.2012.11.038; Crawford C, 2017, COMMONW COMP POLIT; Darko F, 2011, THESIS; Donkor AK, 2005, SOIL SEDIMENT CONTAM, V14, P479, DOI 10.1080/15320380500263675; Dural M, 2007, FOOD CHEM, V102, P415, DOI 10.1016/j.foodchem.2006.03.001; FAO/WHO Expert Committee on Food Additives, 2011, WHO TECHN REP SER, V960, P228; Fianko JR, 2007, ENVIRON MONIT ASSESS, V131, P467, DOI 10.1007/s10661-006-9492-2; Food and Agriculture Organization/World Health Organization (FAO/WHO), 2011, JOINT FAO WHO FOOD S, P468; Garcia-Sevillano MA, 2015, CHEM-BIOL INTERACT, V229, P82, DOI 10.1016/j.cbi.2015.02.001; Gbogbo F, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-6118-9; Gbogbo F, 2017, ENVIRON SCI POLLUT R, V24, P5619, DOI [10.1007/s11356-016-8309-2, 10.1007/s11356-016-]; Gbogbo F, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4880-0; Global Fish Alliance, 2010, IMP CAPT FISH GHAN; Gu YG, 2017, MAR POLLUT BULL, V114, P1125, DOI 10.1016/j.marpolbul.2016.10.040; Gu YG, 2015, MAR POLLUT BULL, V96, P508, DOI 10.1016/j.marpolbul.2015.04.022; International Union for the Conservation of Nature (IUCN), 2017, RED LIST THREAT SPEC, P1; Kalantzi I, 2016, FOOD CHEM, V194, P659, DOI 10.1016/j.foodchem.2015.08.072; Kojadinovic J, 2006, SCI TOTAL ENVIRON, V366, P688, DOI 10.1016/j.scitotenv.2006.02.006; Koranteng K.A., 2004, INT S MAR FISH EC SO, P75; Li YH, 2015, MAR POLLUT BULL, V97, P528, DOI 10.1016/j.marpolbul.2015.05.017; National Residue Survey (NRS), 2012, NRS ANN REP 2010 11, P272; Offem BO, 2008, REV BIOL TROP, V56, P1785; Onsanit S, 2012, J HAZARD MATER, V203, P13, DOI 10.1016/j.jhazmat.2011.11.021; Parlemo EFA, BIOGEOCHEMISTRY, V2; Ralston NVC, 2016, BIOL TRACE ELEM RES, V171, P262, DOI 10.1007/s12011-015-0516-z; Ralston NVC, 2008, NEUROTOXICOL; Ralston NVC, 2013, EPA PROGR REPORT FIS; Risch L, 2007, COLLECTION FAUNE FLO, V42, P607; Schneider W., 1990, FAO SPECIES IDENTIFI; Svobodova A Z, 1993, 54 FAO EIFAC; Taweel A, 2013, ECOTOX ENVIRON SAFE, V93, P45, DOI 10.1016/j.ecoenv.2013.03.031; Tay C, 2008, WAJAE, V13, P27; Teugels, 2003, FAUNE FLORE TROPICAL, V40, P495; Tongesayi T, 2013, FOOD CHEM TOXICOL, V62, P142, DOI 10.1016/j.fct.2013.08.052; United States Environmental Protection Agency (USEPA), 2000, 823B00008 USEPA, VII; USEPA, 2016, INT RISK INF SYST; USEPA, 1989, RISK ASS GUID SUP A, P289; Vega FA, 2004, ANAL CHIM ACTA, V524, P141, DOI 10.1016/j.aca.2004.06.073; Wang XL, 2005, SCI TOTAL ENVIRON, V350, P28, DOI 10.1016/j.scitotenv.2004.09.044; *WHO, 2010, PREV DIS HLTH ENV AC	60	36	36	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2018	13	3							e0194682	10.1371/journal.pone.0194682	http://dx.doi.org/10.1371/journal.pone.0194682			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA2QK	29570730	Green Published, Green Submitted, gold			2022-12-26	WOS:000428168400026
J	Hirt, H; Hall, JW; Larson, E; Gorr, SU				Hirt, Helmut; Hall, Jeffrey W.; Larson, Elliot; Gorr, Sven-Ulrik			A D-enantiomer of the antimicrobial peptide GL1 3K evades antimicrobial resistance in the Gram positive bacteria Enterococcus faecalis and Streptococcus gordonii	PLOS ONE			English	Article							LIPOTEICHOIC ACID; BIOFILM FORMATION; SURFACE HYDROPHOBICITY; MAJOR AUTOLYSIN; TEICHOIC-ACIDS; D-ALANYLATION; SUSCEPTIBILITY; EVOLUTION; MAGAININS; SEQUENCE	Antimicrobial peptides represent an alternative to traditional antibiotics that may be less susceptible to bacterial resistance mechanisms by directly attacking the bacterial cell membrane. However, bacteria have a variety of defense mechanisms that can prevent cationic antimicrobial peptides from reaching the cell membrane. The L- and D-enantiomers of the antimicrobial peptide GL13K were tested against the Gram-positive bacteria Enterococcus faecalis and Streptococcus gordonii to understand the role of bacterial proteases and cell wall modifications in bacterial resistance. GL13K was derived from the human salivary protein BPIFA2. Minimal inhibitory concentrations were determined by broth dilution and a serial assay used to determine bacterial resistance. Peptide degradation was determined in a bioassay utilizing a luminescent strain of Pseudomonas aeruginosa to detect peptide activity. Autolysis and D-alanylation-deficient strains of E. faecalis and S. gordonii were tested in autolysis assays and peptide activity assays. E. faecalis protease inactivated L-GL13K but not D-GL13K, whereas autolysis did not affect peptide activity. Indeed, the D-enantiomer appeared to kill the bacteria prior to initiation of autolysis. D-alanylation mutants were killed by L-GL13K whereas this modification did not affect killing by D-GL13K. The mutants regained resistance to L-GL13K whereas bacteria did not gain resistance to DGL13K after repeated treatment with the peptides. D-alanylation affected the hydrophobicity of bacterial cells but hydrophobicity alone did not affect GL13K activity. D-GL13K evades two resistance mechanisms in Gram-positive bacteria without giving rise to substantial new resistance. D-GL13K exhibits attractive properties for further antibiotic development.	[Hirt, Helmut; Hall, Jeffrey W.; Larson, Elliot; Gorr, Sven-Ulrik] Univ Minnesota, Sch Dent, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA; [Hirt, Helmut] Univ Minnesota, Med Sch, Dept Microbiol & Immunol, Minneapolis, MN USA; [Hall, Jeffrey W.] Pharmgate Biol, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Gorr, SU (corresponding author), Univ Minnesota, Sch Dent, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA.	sugorr@umn.edu		Hall, Jeffrey/0000-0002-0214-4062	National Institute of Dental and Craniofacial Research at the National Institutes of Health [R01 DE017989]; University of Minnesota MinnCResT program - National Institute of Dental and Craniofacial Research [T90 DE0227232]; National Institute of Dental and Craniofacial Research [F32DE02578]; University of Minnesota School of Dentistry	National Institute of Dental and Craniofacial Research at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); University of Minnesota MinnCResT program - National Institute of Dental and Craniofacial Research; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); University of Minnesota School of Dentistry	This work was partially supported by the National Institute of Dental and Craniofacial Research at the National Institutes of Health (R01 DE017989 to S.-U.G); an institutional post-doctoral fellowship (to J.W.H.) from the University of Minnesota MinnCResT program funded by the National Institute of Dental and Craniofacial Research (T90 DE0227232); an individual post-doctoral fellowship funded by the National Institute of Dental and Craniofacial Research (F32DE02578 to J.W.H.) and the University of Minnesota School of Dentistry (to S.-U.G.). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Abdolhosseini M, 2012, PEPTIDES, V35, P231, DOI 10.1016/j.peptides.2012.03.017; Balhara V, 2013, BBA-BIOMEMBRANES, V1828, P2193, DOI 10.1016/j.bbamem.2013.05.027; Bauer ME, 2015, BBA-BIOMEMBRANES, V1848, P3101, DOI 10.1016/j.bbamem.2015.02.012; Bechinger B, 2017, J DENT RES, V96, P254, DOI 10.1177/0022034516679973; Bell G, 2003, MICROBIOL-SGM, V149, P1367, DOI 10.1099/mic.0.26265-0; Chan KG, 2007, INFECT IMMUN, V75, P3033, DOI 10.1128/IAI.01549-06; Chen XF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091830, 10.1371/journal.pone.0085716, 10.1371/journal.pone.0115462, 10.1371/journal.pone.0103330, 10.1371/journal.pone.0091809, 10.1371/journal.pone.0087752]; Chernysh S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130788; Coats SR, 2009, INT J ORAL SCI, V1, P126, DOI 10.4248/IJOS.09062; Cole Jason N, 2016, Microbiol Spectr, V4, DOI 10.1128/microbiolspec.VMBF-0006-2015; CORNETT JB, 1978, J BACTERIOL, V135, P153, DOI 10.1128/JB.135.1.153-160.1978; Curtis MA, 2011, INFECT IMMUN, V79, P1187, DOI 10.1128/IAI.00900-10; DUNNY GM, 1978, P NATL ACAD SCI USA, V75, P3479, DOI 10.1073/pnas.75.7.3479; Fabretti F, 2006, INFECT IMMUN, V74, P4164, DOI 10.1128/IAI.00111-06; Fan LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24482; Fox JL, 2013, NAT BIOTECHNOL, V31, P379, DOI 10.1038/nbt.2572; Giaouris E, 2008, APPL ENVIRON MICROB, V74, P4764, DOI 10.1128/AEM.00078-08; Gorr SU, 2011, BIOCHEM SOC T, V39, P1028, DOI 10.1042/BST0391028; Guilhelmelli F, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00353; Hancock R. E. W., 1999, MODIFIED MIC METHOD; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; Harmouche N, 2017, BIOCHEMISTRY-US, V56, P4269, DOI 10.1021/acs.biochem.7b00526; Hirt H, 2013, ANTIMICROB AGENTS CH, V57, P4903, DOI 10.1128/AAC.00311-13; JACOB L, 1994, CIBA F SYMP, V186, P197; Jacob L, 1994, CIBA F SYMP, V186, P223; Kaltinger M., 2007, THESIS; KOLENBRANDER PE, 1990, APPL ENVIRON MICROB, V56, P3890, DOI 10.1128/AEM.56.12.3890-3894.1990; Koprivnjak T, 2011, CELL MOL LIFE SCI, V68, P2243, DOI 10.1007/s00018-011-0716-4; Kovacs M, 2006, J BACTERIOL, V188, P5797, DOI 10.1128/JB.00336-06; Liu YL, 2011, J BACTERIOL, V193, P2826, DOI 10.1128/JB.00056-11; Malanovic N, 2016, BBA-BIOMEMBRANES, V1858, P936, DOI 10.1016/j.bbamem.2015.11.004; Mazda Y, 2012, MOL ORAL MICROBIOL, V27, P124, DOI 10.1111/j.2041-1014.2012.00637.x; MIORNER H, 1983, INFECT IMMUN, V39, P336; Mohamed JA, 2004, INFECT IMMUN, V72, P3658, DOI 10.1128/IAI.72.6.3658-3663.2004; Nesuta O, 2017, PATHOG DIS, V75, DOI 10.1093/femspd/ftx091; Ong ZY, 2014, BIOMATERIALS, V35, P1315, DOI 10.1016/j.biomaterials.2013.10.053; PERLMAN D, 1971, ANNU REV BIOCHEM, V40, P449, DOI 10.1146/annurev.bi.40.070171.002313; Perron GG, 2006, P ROY SOC B-BIOL SCI, V273, P251, DOI 10.1098/rspb.2005.3301; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Poyart C, 2003, MOL MICROBIOL, V49, P1615, DOI 10.1046/j.1365-2958.2003.03655.x; Qin X, 2000, INFECT IMMUN, V68, P2579, DOI 10.1128/IAI.68.5.2579-2586.2000; Ramesh S, 2016, J PEPT SCI, V22, P438, DOI 10.1002/psc.2894; Revilla-Guarinos A, 2013, APPL ENVIRON MICROB, V79, P3160, DOI 10.1128/AEM.00178-13; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Sani MA, 2016, ACCOUNTS CHEM RES, V49, P1130, DOI 10.1021/acs.accounts.6b00074; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; Singh KV, 1998, J INFECT DIS, V178, P1416, DOI 10.1086/314453; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; Wang GS, 2016, NUCLEIC ACIDS RES, V44, pD1087, DOI 10.1093/nar/gkv1278; Won A, 2011, BBA-BIOMEMBRANES, V1808, P1592, DOI 10.1016/j.bbamem.2010.11.010; Xie ZJ, 2011, APPL ENVIRON MICROB, V77, P8025, DOI 10.1128/AEM.06362-11; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zasloff M, 2002, NEW ENGL J MED, V347, P1199, DOI 10.1056/NEJMe020106; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	54	25	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194900	10.1371/journal.pone.0194900	http://dx.doi.org/10.1371/journal.pone.0194900			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566082	Green Published, gold, Green Submitted			2022-12-26	WOS:000428093900119
J	Lajko, A; Meggyes, M; Polgar, B; Szereday, L				Lajko, Adrienn; Meggyes, Matyas; Polgar, Beata; Szereday, Laszlo			The immunological effect of Galectin-9/TIM-3 pathway after low dose Mifepristone treatment in mice at 14.5 day of pregnancy	PLOS ONE			English	Article							INDUCED BLOCKING FACTOR; T-CELLS; MEDICAL ABORTION; IMMUNE CELLS; TIM-3; PROGESTERONE; TH17; MISOPROSTOL; EXPRESSION; RESPONSES	The abortifacient Mifepristone (RU486) has proven to be a safe, effective, acceptable option for millions of women seeking abortion during the first and second trimester of pregnancy although its precise mechanism of action is not well understood. The main objective of this study was to investigate the impact of low dose Mifepristone administration on placental Galectin-9 (Gal-9) expression, as well as its effect on the cell surface expression of Gal-9, TIM-3 and CD107a molecules by different T and NK cell subsets. A model of Mifepristone-induced immunological changes was established in syngeneic pregnant BALB/c mice. RU486-induced alteration in placental Gal-9 expression was determined by immunohistochemistry. For immunophenotypic analysis, mid-pregnancy decidual lymphocytes and peripheral mononuclear cells were obtained from Mifepristone treated and control mice at the 14.5 day of gestation. TIM-3 and Gal-9 expression by peripheral and decidual immune cells were examined by flow cytometry. Our results revealed a dramatically decreased intracellular Gal-9 expression in the spongiotrophoblast layer of the haemochorial placenta in Mifepristone treated pregnant mice. Although low dose RU486 treatment did not cause considerable change in the phenotypic distribution of decidual and peripheral immune cells, it altered the Gal-9 and TIM-3 expression by different NK and T cell subsets. In addition, the treatment significantly decreased the CD107a expression by decidual TIM-3+ NK cells, but increased its expression by decidual NKT cell compared to the peripheral counterparts. These findings suggest that low dose Mifepristone administration might induce immune alterations in both progesterone dependent and independent way.	[Lajko, Adrienn; Meggyes, Matyas; Polgar, Beata; Szereday, Laszlo] Univ Pecs, Med Sch, Dept Med Microbiol & Immunol, Pecs, Hungary; [Meggyes, Matyas; Polgar, Beata; Szereday, Laszlo] Janos Szentagothai Res Ctr, Pecs, Hungary	University of Pecs	Szereday, L (corresponding author), Univ Pecs, Med Sch, Dept Med Microbiol & Immunol, Pecs, Hungary.; Szereday, L (corresponding author), Janos Szentagothai Res Ctr, Pecs, Hungary.	szereday.laszlo@pte.hu	Szereday, Laszlo/AAR-5741-2021	Szereday, Laszlo/0000-0002-1208-2969	Hungarian National Research Fund [OTKA K104960, K119529]; TAMOP [4.2.4. A/2-11-1-2012-0001]; Hungarian Academy of Sciences	Hungarian National Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); TAMOP; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by grants from Hungarian National Research Fund (OTKA K104960 and K119529), TAMOP 4.2.4. A/2-11-1-2012-0001 and the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences to L. Szereday.; This work was supported by grants from Hungarian National Research Fund (OTKA K104960 and K119529), TAMOP 4.2.4. A/2-11-1-2012-0001 and the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences to L. Szereday. The present scientific contribution is dedicated to the 650th anniversary of the foundation of the University of Pecs, Hungary.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Atsukawa M, 2012, J GASTROEN HEPATOL, V27, P823, DOI 10.1111/j.1440-1746.2011.06882.x; Boenisch IG, 2013, J IMMUNOL MAT S, V190, P88; Bogdan A, 2017, J REPROD IMMUNOL, V119, P38, DOI 10.1016/j.jri.2016.12.001; Chen YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036413; Chien CH, 2009, HUM REPROD, V24, P1968, DOI 10.1093/humrep/dep099; de Weyer PSV, 2006, BIOCHEM BIOPH RES CO, V351, P571, DOI 10.1016/j.bbrc.2006.10.079; HANSEN KA, 1992, AM J OBSTET GYNECOL, V166, P87, DOI 10.1016/0002-9378(92)91835-X; Hastings WD, 2009, EUR J IMMUNOL, V39, P2492, DOI 10.1002/eji.200939274; Heusschen R, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105460; Hu XH, 2016, J REPROD IMMUNOL, V118, P92, DOI 10.1016/j.jri.2016.10.113; Kapp N, 2013, CONTRACEPTION, V88, P350, DOI 10.1016/j.contraception.2012.10.027; Lee JH, 2011, J IMMUNOL, V187, P1778, DOI 10.4049/jimmunol.1003919; Lee J, 2011, MOL CELL BIOL, V31, P3963, DOI 10.1128/MCB.05297-11; Li XS, 2012, ENERGY, V40, P59, DOI 10.1016/j.energy.2012.02.030; Liu YS, 2011, AM J REPROD IMMUNOL, V65, P503, DOI 10.1111/j.1600-0897.2010.00921.x; Louie KS, 2017, EUR J CONTRACEP REPR, V22, P76, DOI 10.1080/13625187.2016.1258461; Lu S, 2001, Zhonghua Fu Chan Ke Za Zhi, V36, P625; Lv F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048384; Mao GP, 2010, ENDOCRINOLOGY, V151, P5477, DOI 10.1210/en.2010-0426; Meggyes M, 2015, PLACENTA, V36, P1153, DOI 10.1016/j.placenta.2015.07.124; Meggyes M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092371; Milne SA, 2005, J CLIN ENDOCR METAB, V90, P4315, DOI 10.1210/jc.2004-2338; Miyaura H, 2002, J IMMUNOL, V168, P1087, DOI 10.4049/jimmunol.168.3.1087; Nissi R, 2016, ARCH GYNECOL OBSTET, V294, P1243, DOI 10.1007/s00404-016-4169-8; Oomizu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048574; Piccinni MP, 2010, J REPROD IMMUNOL, V85, P71, DOI 10.1016/j.jri.2010.01.006; Popovici RM, 2005, J CLIN ENDOCR METAB, V90, P6170, DOI 10.1210/jc.2004-2529; Raymond EG, 2013, CONTRACEPTION, V87, P26, DOI 10.1016/j.contraception.2012.06.011; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Sedgh G, 2016, LANCET, V388, P258, DOI 10.1016/S0140-6736(16)30380-4; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Shimizu Y, 2008, ENDOCR J, V55, P879, DOI 10.1507/endocrj.K08E-111; Sun JT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147186; Szekeres-Bartho J, 2005, CHEM IMMUNOL ALLERGY, V89, P118, DOI 10.1159/000087953; SzekeresBartho J, 1997, CELL IMMUNOL, V177, P194, DOI 10.1006/cimm.1997.1090; SZEKERESBARTHO J, 1990, AM J OBSTET GYNECOL, V163, P1320, DOI 10.1016/0002-9378(90)90713-H; Tao Y, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.26; Than NG, 2009, P NATL ACAD SCI USA, V106, P9731, DOI 10.1073/pnas.0903568106; Zhao J, 2009, J IMMUNOL, V182, P6618, DOI 10.4049/jimmunol.0803876; Zhong X, 2007, FRONT AGR CHINA, V1, P96; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	44	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194870	10.1371/journal.pone.0194870	http://dx.doi.org/10.1371/journal.pone.0194870			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566059	Green Published, gold, Green Submitted			2022-12-26	WOS:000428093900114
J	Rotstein, B; Post, Y; Reinhardt, M; Lammers, K; Buhr, A; Heinisch, JJ; Meyer, H; Paululat, A				Rotstein, Barbara; Post, Yanina; Reinhardt, Marcel; Lammers, Kay; Buhr, Annika; Heinisch, Juergen J.; Meyer, Heiko; Paululat, Achim			Distinct domains in the matricellular protein Lonely heart are crucial for cardiac extracellular matrix formation and heart function in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAMTS; cardiac development; Drosophila; Drosophila genetics; extracellular matrix; extracellular matrix protein; thrombospondin; cardiogenesis; ADAMTSL; cardiac matrix; TSR repeats; GAG; cardiogenesis; Drosophila melanogaster	PERICARDIAL CELLS; TYPE-1 REPEATS; THROMBOSPONDIN; INTEGRINS; PEPTIDES; BINDING	The biomechanical properties of extracellular matrices (ECMs) are critical to many biological processes, including cell-cell communication and cell migration and function. The correct balance between stiffness and elasticity is essential to the function of numerous tissues, including blood vessels and the lymphatic system, and depends on ECM constituents (the matrisome) and on their level of interconnection. However, despite its physiological relevance, the matrisome composition and organization remain poorly understood. Previously, we reported that the ADAMTS-like protein Lonely heart (Loh) is critical for recruiting the type IV collagen-like protein Pericardin to the cardiac ECM. Here, we utilized Drosophila as a simple and genetically amenable invertebrate model for studying Loh-mediated recruitment of tissue-specific ECM components such as Pericardin to the ECM. We focused on the functional relevance of distinct Loh domains to protein localization and Pericardin recruitment. Analysis of Loh deletion constructs revealed that one thrombospondin type 1 repeat (TSR1-1), which has an embedded WXXW motif, is critical for anchoring Loh to the ECM. Two other thrombospondin repeats, TSR1-2 and TSR1-4, the latter containing a CXXTCXXG motif, appeared to be dispensable for tethering Loh to the ECM but were crucial for proper interaction with and recruitment of Pericardin. Moreover, our results also suggested that Pericardin in the cardiac ECM primarily ensures the structural integrity of the heart, rather than increasing tissue flexibility. In conclusion, our work provides new insights into the roles of thrombospondin type 1 repeats and advances our understanding of cardiac ECM assembly and function.	[Rotstein, Barbara; Post, Yanina; Reinhardt, Marcel; Lammers, Kay; Buhr, Annika; Meyer, Heiko; Paululat, Achim] Univ Osnabruck, Fac Biol & Chem, Dept Zool & Dev Biol, Barbarastr 11, D-49076 Osnabruck, Germany; [Heinisch, Juergen J.] Univ Osnabruck, Fac Biol & Chem, Dept Genet, Barbarastr 11, D-49076 Osnabruck, Germany	University Osnabruck; University Osnabruck	Paululat, A (corresponding author), Univ Osnabruck, Fac Biol & Chem, Dept Zool & Dev Biol, Barbarastr 11, D-49076 Osnabruck, Germany.	paululat@biologie.uni-osnabrueck.de	Heinisch, Juergen J./G-3801-2017	Reinhardt, Marcel/0000-0001-5158-7890; Harten, Heiko/0000-0002-3304-4523; Paululat, Achim/0000-0002-8845-6859	German Research Foundation [SFB 944]; State of Lower-Saxony, Hannover, Germany [11-76251-99-15/12 (ZN2832)]	German Research Foundation(German Research Foundation (DFG)); State of Lower-Saxony, Hannover, Germany	This work was supported by funding from the German Research Foundation (SFB 944: Physiology and Dynamics of Cellular Microcompartments) (to A. P.) and by State of Lower-Saxony, Hannover, Germany, Grant 11-76251-99-15/12 (ZN2832). The authors declare that they have no conflicts of interest with the contents of this article.	Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]; Albrecht S, 2011, DEV BIOL, V350, P89, DOI 10.1016/j.ydbio.2010.11.016; Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Asha H, 2003, GENETICS, V163, P203; Bradshaw AD, 2010, AM J PHYSIOL-HEART C, V298, pH614, DOI 10.1152/ajpheart.00474.2009; Cammarato A, 2008, MOL BIOL CELL, V19, P553, DOI 10.1091/mbc.E07-09-0890; Das D, 2008, CELL TISSUE RES, V331, P565, DOI 10.1007/s00441-007-0518-z; Drechsler M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003616; Fink M, 2009, BIOTECHNIQUES, V46, P101, DOI 10.2144/000113078; GOTWALS PJ, 1994, CURR OPIN CELL BIOL, V6, P734, DOI 10.1016/0955-0674(94)90101-5; GUO NH, 1992, J BIOL CHEM, V267, P19349; Hallier B, 2016, ELIFE, V5, DOI 10.7554/eLife.19430; Hynes R.O., 2012, EXTRACELLULAR MATRIX; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ivy JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134620; Kaushik G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5843; Kohfeldt E, 1998, J MOL BIOL, V282, P99, DOI 10.1006/jmbi.1998.2004; Kolsch V, 2002, DEV GENES EVOL, V212, P473, DOI 10.1007/s00427-002-0268-6; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Kuno K, 1998, J BIOL CHEM, V273, P13912, DOI 10.1074/jbc.273.22.13912; Lammers K, 2017, J EXP BIOL, V220, P1852, DOI 10.1242/jeb.156265; Lehmacher C, 2012, ARTHROPOD STRUCT DEV, V41, P459, DOI 10.1016/j.asd.2012.02.002; Linford NJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50068; Meyer H, 2009, J EXP BIOL, V212, P3673, DOI 10.1242/jeb.034272; Nichols CD, 2012, JOVE-J VIS EXP, DOI 10.3791/3795; Nishimura M, 2014, AGING CELL, V13, P431, DOI 10.1111/acel.12193; Ocorr K, 2014, METHODS, V68, P265, DOI 10.1016/j.ymeth.2014.03.031; Pastor-Pareja JC, 2011, DEV CELL, V21, P245, DOI 10.1016/j.devcel.2011.06.026; Paululat A, 2012, GENE, V511, P300, DOI 10.1016/j.gene.2012.09.058; Rasband WS, 2012, ASCL; Rotstein B, 2016, J CARDIOVASC DEV DIS, V3, DOI 10.3390/jcdd3020015; Sarov M, 2016, ELIFE, V5, DOI 10.7554/eLife.12068; Schwede T, 2000, RES MICROBIOL, V151, P107, DOI 10.1016/S0923-2508(00)00121-2; Sessions AO, 2017, MATRIX BIOL, V62, P15, DOI 10.1016/j.matbio.2016.10.008; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; Togel M, 2008, DEV BIOL, V318, P29, DOI 10.1016/j.ydbio.2008.02.043; Togel M, 2013, INT J DEV BIOL, V57, P13, DOI 10.1387/ijdb.120111ap; Tortorella MD, 2009, CURR PHARM DESIGN, V15, P2359, DOI 10.2174/138161209788682433; TUSZYNSKI GP, 1992, J CELL BIOL, V116, P209, DOI 10.1083/jcb.116.1.209; Tutor AS, 2014, DEVELOPMENT, V141, P367, DOI 10.1242/dev.099408; Vogler Georg, 2009, J Vis Exp, DOI 10.3791/1425; Volk T, 2014, MATRIX BIOL, V37, P162, DOI 10.1016/j.matbio.2014.03.006; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; Wilmes AC, 2018, BIOL OPEN, V7, DOI 10.1242/bio.030361	45	8	8	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7864	7879		10.1074/jbc.M117.817940	http://dx.doi.org/10.1074/jbc.M117.817940			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29599288	Green Published, hybrid			2022-12-26	WOS:000437256500033
J	Li, LH; Yu, NH; Chan, CY; Lee, WB				Li, L. H.; Yu, N. H.; Chan, C. Y.; Lee, W. B.			Al6061 surface roughness and optical reflectance when machined by single point diamond turning at a low feed rate	PLOS ONE			English	Article								Ultra-precision face turning of Al6061 mirrors using single point diamond turning (SPDT) was undertaken to investigate the correlation between the surface roughness and reflectance. By reducing the feed rate, the optimal feed rate when the chip formation became unstable was studied. Most importantly, the impact on the roughness and reflectance was examined when the chip formation ceased to be continuous. It was determined that for a feed rate below 3 mm/min, the surface roughness always improved as the feed rate decreased, at the cost of a reduction of the normalized reflectance. The reduction of reflectance was determined to be the result of the lower material removal rates that led to a discontinuous chip formation.	[Li, L. H.; Yu, N. H.; Chan, C. Y.; Lee, W. B.] Hong Kong Polytech Univ, State Key Lab Ultraprecis Machining Technol, Dept Ind & Syst Engn, Hong Kong, Hong Kong, Peoples R China; [Li, L. H.; Yu, N. H.; Chan, C. Y.; Lee, W. B.] Hong Kong Polytech Univ, Shenzhen Res Inst, Shenzhen Branch, State Key Lab Ultra Precis Machining Technol, Shenzhen, Peoples R China	Hong Kong Polytechnic University; China Construction Bank; Hong Kong Polytechnic University	Yu, NH (corresponding author), Hong Kong Polytech Univ, State Key Lab Ultraprecis Machining Technol, Dept Ind & Syst Engn, Hong Kong, Hong Kong, Peoples R China.; Yu, NH (corresponding author), Hong Kong Polytech Univ, Shenzhen Res Inst, Shenzhen Branch, State Key Lab Ultra Precis Machining Technol, Shenzhen, Peoples R China.	yudadashi@gmail.com		ninghui, yu/0000-0002-0832-921X	RTRB from The Hong Kong Polytechnic University; Shenzhen Fundamental Research fund [JCYJ20160331185006518]	RTRB from The Hong Kong Polytechnic University; Shenzhen Fundamental Research fund	This study was supported by grant number RTRB from The Hong Kong Polytechnic University to N.H. Yu (https://www.polyu.edu.hk/web/en/home/index.html), and this work is partially supported by Shenzhen Fundamental Research fund (JCYJ20160331185006518). I accept to publish this information with my article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and analysis, decision to publish, or preparation of the manuscript.	Ahmed SA, 2017, PRECIS ENG, V47, P397, DOI 10.1016/j.precisioneng.2016.09.013; [Anonymous], 2010, ASIAN J SCI RES; BENNETT HE, 1961, J OPT SOC AM, V51, P123, DOI 10.1364/JOSA.51.000123; Childs THC, 2015, PROC CIRP, V31, P270, DOI 10.1016/j.procir.2015.03.077; GINDELE K, 1985, APPL OPTICS, V24, P1757, DOI 10.1364/AO.24.001757; Hashmi S, 2014, COMPREHENSIVE MATERIALS PROCESSING, VOL 1: ASSESSING PROPERTIES OF CONVENTIONAL AND SPECIALIZED MATERIALS, pXXVII; Huang B., 2016, INT S OPT TECHN APPL; Jeon MW, 2016, INT J PRECIS ENG MAN, V17, P685, DOI 10.1007/s12541-016-0084-y; Ji SJ, 2016, STROJ VESTN-J MECH E, V62, P213, DOI 10.5545/sv-jme.2015.2528; Li L, 2010, J MANUF SCI E-T ASME, V132, DOI 10.1115/1.4001037; Mandal S, 2013, INT J OPTOMECHATRONI, V7, P244, DOI 10.1080/15599612.2013.879499; PEIPONEN KE, 1990, OPT LASER TECHNOL, V22, P127, DOI 10.1016/0030-3992(90)90022-V; Rahman MA, 2017, PRECIS ENG, V50, P393, DOI 10.1016/j.precisioneng.2017.06.014; Whitehouse D.J., 1994, HDB SURFACE METROLOG; WHITLEY JQ, 1987, OPT LASER TECHNOL, V19, P189, DOI 10.1016/0030-3992(87)90065-X; Yen YC, 2004, THESIS; Yonehara M, 2004, MATER TRANS, V45, P1027, DOI 10.2320/matertrans.45.1027; Zhang JB, 2017, CURR OPT PHOTONICS, V1, P364, DOI 10.3807/COPP.2017.1.4.364	18	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195083	10.1371/journal.pone.0195083	http://dx.doi.org/10.1371/journal.pone.0195083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608580	Green Submitted, gold, Green Published			2022-12-26	WOS:000428988800025
J	Coleman, LG; Maile, R; Jones, SW; Cairns, BA; Crews, FT				Coleman, Leon G., Jr.; Maile, Robert; Jones, Samuel W.; Cairns, Bruce A.; Crews, Fulton T.			HMGB1/IL-1 beta complexes in plasma microvesicles modulate immune responses to burn injury	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; BRAIN REGIONAL VOLUMES; MOBILITY GROUP BOX-1; EXTRACELLULAR VESICLES; IL-1-BETA PRODUCTION; SECRETORY PATHWAY; FLOW-CYTOMETRY; THERMAL-INJURY; ALARMIN HMGB1; DOUBLE-BLIND	Modulating immune responses to sepsis and trauma remain one of the most difficult challenges in modern medicine. Large burn injuries (LBI) are a severe form of trauma associated with sepsis, immune impairment, and mortality. Immune dysfunction after LBI is complex, involving both enhanced and impaired immune activation. The release of Damage-Associated Molecular Patterns (DAMPs), such as HMGB1, and cytokines (e.g. IL-1 beta) creates an environment of immune dysfunction often leading to end organ failure and death. Both HMGB1 and IL-1 beta have been found to play critical roles in sepsis and post-burn immune dysfunction. HMGB1 and IL-1 beta have been shown previously to form potent complexes in vitro. We recently identified the presence of HMGB1/IL-1 beta heterocomplexes in human tissue. We now find HMGB1/IL-1 beta complexes in human and mouse plasma, and identify a synergistic role of HMGB1/IL-1 beta complexes in post-burn immune dysfunction. In both humans and mice, we found that HMGB1 was enriched in plasma microvesicles (MVs) after LBI. HMGB1 was found form complexes with IL-1 beta. Using flow cytometry of mouse plasma MVs, we identified an increase in an HMGB1+/IL-1 beta+ MVs. Using co-IP, HMGB1 was found to bind the pro-form of IL-1 beta in mouse and human plasma. Pro-IL-1 beta, which is traditionally considered inactive, became active when complexed with HMGB1. Human THP-1 monocytes treated with HMGB1-pro-IL-1 beta complexes showed increased transcription of LBI associated cytokines IL-6 and IFN beta along with suppression of iNOS, mimicking findings associated with LBI. These findings identify that HMGB1/IL-1 beta complexes released after burn injuries can modulate immune responses, and microvesicles are identified as a novel reservoir for these immune mediators. These complexes might serve as novel immune targets for the treatment of systemic immune responses due to LBI or other causes of sepsis.	[Coleman, Leon G., Jr.; Crews, Fulton T.] Univ North Carolina Chapel Hill, Dept Pharmacol, Sch Med, Chapel Hill, NC 27599 USA; [Coleman, Leon G., Jr.; Crews, Fulton T.] Univ North Carolina Chapel Hill, Sch Med, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA; [Maile, Robert; Jones, Samuel W.; Cairns, Bruce A.] Univ North Carolina Chapel Hill, Dept Surg, North Carolina Jaycee Burn Ctr, Chapel Hill, NC USA; [Maile, Robert; Cairns, Bruce A.] Univ North Carolina Chapel Hill, Dept Microbiol & Immunol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Coleman, LG (corresponding author), Univ North Carolina Chapel Hill, Dept Pharmacol, Sch Med, Chapel Hill, NC 27599 USA.; Coleman, LG (corresponding author), Univ North Carolina Chapel Hill, Sch Med, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA.	leon_coleman@med.unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022; Crews, Fulton/T-1181-2019	Crews, Fulton/0000-0003-2393-4976; Coleman, Leon/0000-0003-1693-3799; Maile, Robert/0000-0002-9126-4188	NIGMS [2T32GM008450, K08GM109106]; NIAAA [AA011605, AA020024]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM109106] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by NIGMS 2T32GM008450, K08GM109106 - https://www.nigms.nih.gov; NIAAA AA011605, AA020024-https://www.niaaa..nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Ardoin SP, 2008, MOD RHEUMATOL, V18, P319, DOI 10.1007/s10165-008-0054-z; Barnay-Verdier S, 2011, CYTOKINE, V55, P4, DOI 10.1016/j.cyto.2011.03.011; Barteneva NS, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-23; Berckmans RJ, 2002, ARTHRITIS RHEUM-US, V46, P2857, DOI 10.1002/art.10587; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Bruno S., 2012, PLOS ONE, V7, DOI DOI 10.1371/journal.pone.0033115; Burger D, 2013, CLIN SCI, V124, P423, DOI 10.1042/CS20120309; Bussolati B, 2017, NAT REV NEPHROL, V13, P523, DOI 10.1038/nrneph.2017.117; Buzas EI, 2014, NAT REV RHEUMATOL, V10, P356, DOI 10.1038/nrrheum.2014.19; Cairns BA, 2008, J TRAUMA, V64, P1069, DOI 10.1097/TA.0b013e318166b7d9; Chen Y, 2016, J CELL PHYSIOL, V231, P2319, DOI 10.1002/jcp.25352; Coleman Jr LG, 2017, BRAIN BEHAV IMMUNITY; Coleman LG, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0799-4; Coleman LG, 2011, ALCOHOL CLIN EXP RES, V35, P671, DOI 10.1111/j.1530-0277.2010.01385.x; Coleman LG, 2014, PHARMACOL BIOCHEM BE, V116, P142, DOI 10.1016/j.pbb.2013.11.021; Coleman LG, 2017, HMGB1 IL 1B IN PRESS; DeWalt RI, 2013, BIOCHEM BIOPH RES CO, V432, P695, DOI 10.1016/j.bbrc.2013.01.122; DIMAIO A, 1976, J SURG RES, V21, P437, DOI 10.1016/0022-4804(76)90169-4; Dunn JLM, 2016, BURNS, V42, P1522, DOI 10.1016/j.burns.2016.05.005; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Eriksson M, 1998, ACTA ANAESTH SCAND, V42, P551, DOI 10.1111/j.1399-6576.1998.tb05165.x; Finnerty CC, 2006, SHOCK, V26, P13, DOI 10.1097/01.shk.0000223120.26394.7d; FISHER CJ, 1994, JAMA-J AM MED ASSOC, V271, P1836, DOI 10.1001/jama.271.23.1836; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Gong J, 2015, SEMIN CELL DEV BIOL, V40, P35, DOI [10.1016/j.semdb.2015.03.009, 10.1016/j.semcdb.2015.03.009]; Hailey KL, 2009, J BIOL CHEM, V284, P26137, DOI 10.1074/jbc.M109.027375; Hreggvidsdottir HS, 2009, J LEUKOCYTE BIOL, V86, P655, DOI 10.1189/jlb.0908548; Huang LF, 2011, CYTOKINE, V53, P29, DOI 10.1016/j.cyto.2010.09.010; Huang LF, 2009, SHOCK, V31, P322, DOI 10.1097/SHK.0b013e3181834070; Hulsmans M, 2013, CARDIOVASC RES, V100, P7, DOI 10.1093/cvr/cvt161; Hur J, 2015, ANN LAB MED, V35, P105, DOI 10.3343/alm.2015.35.1.105; Jeschke MG, 2008, ANN SURG, V248, P387, DOI 10.1097/SLA.0b013e3181856241; Jeschke MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021245; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Larsson A, 1996, PLATELETS, V7, P153, DOI 10.3109/09537109609023574; Lehner GF, 2016, SHOCK, V46, P373, DOI 10.1097/SHK.0000000000000657; Lopatina T, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00125; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Mackman N, 2009, J THROMB HAEMOST, V7, P136, DOI 10.1111/j.1538-7836.2009.03368.x; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; Mobarrez F, 2016, SCI REP-UK, V6, DOI 10.1038/srep36025; Monteleone M, 2015, CYTOKINE; MOSLEY B, 1987, J BIOL CHEM, V262, P2941; Neely CJ, 2011, J TRAUMA, V70, P681, DOI 10.1097/TA.0b013e31820d18a6; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Norling LV, 2013, CURR OPIN PHARMACOL, V13, P570, DOI 10.1016/j.coph.2013.05.008; Novikov A, 2011, J IMMUNOL, V187, P2540, DOI 10.4049/jimmunol.1100926; O'Dea KP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167801; Opal SM, 1997, CRIT CARE MED, V25, P1115, DOI 10.1097/00003246-199707000-00010; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Pisetsky DS, 2014, MOL MED, V20, P158, DOI 10.2119/molmed.2014.00014; Pomatto MAC, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00037; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Saha B, 2016, J BIOL CHEM, V291, P149, DOI 10.1074/jbc.M115.694133; Schiraldi M, 2012, J EXP MED, V209, P551, DOI 10.1084/jem.20111739; Sha YG, 2008, J IMMUNOL, V180, P2531, DOI 10.4049/jimmunol.180.4.2531; Shelhamer MC, 2015, J TRAUMA ACUTE CARE, V79, P431, DOI [10.1097/TA.0000000000000786, 10.1097/TA.0000000000000754]; Shen LY, 2015, BURNS, V41, P372, DOI 10.1016/j.burns.2014.05.008; Spencer DM, 2014, SCAND J IMMUNOL, V80, P101, DOI 10.1111/sji.12191; Tetta C, 2013, ENDOCRINE, V44, P11, DOI 10.1007/s12020-012-9839-0; Tetta C, 2011, ORGANOGENESIS, V7, P105, DOI 10.4161/org.7.2.15782; Timar CI, 2013, BLOOD, V121, P510, DOI 10.1182/blood-2012-05-431114; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Walter TJ, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0856-z; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Xiu FM, 2013, SHOCK, V40, P81, DOI 10.1097/SHK.0b013e318299f774; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Zou JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087915	72	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195335	10.1371/journal.pone.0195335	http://dx.doi.org/10.1371/journal.pone.0195335			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601597	Green Published, gold, Green Submitted			2022-12-26	WOS:000428845900027
J	Amiri, E; Kryger, P; Meixner, MD; Strand, MK; Tarpy, DR; Rueppell, O				Amiri, Esmaeil; Kryger, Per; Meixner, Marina D.; Strand, Micheline K.; Tarpy, David R.; Rueppell, Olav			Quantitative patterns of vertical transmission of deformed wing virus in honey bees	PLOS ONE			English	Article							APIS-MELLIFERA; PARALYSIS VIRUS; SACBROOD VIRUS; VIRAL LOAD; ASSAY; INFECTION; IMMUNITY; ROUTES; HOST	Deformed wing virus (DWV) is an important pathogen in a broad range of insects, including honey bees. Concordant with the spread of Varroa, DWV is present in the majority of honey bee colonies and can result in either low-level infections with asymptomatic bees that nonetheless exhibit increased colony loss under stress, or high-level infections with acute effects on bee health and viability. DWV can be transmitted vertically or horizontally and evidence suggests that horizontal transmission via Varroa is associated with acute symptomatic infections. Vertical transmission also occurs and is presumably important for the maintenance of DWV in honey bee populations. To further our understanding the vertical transmission of DWV through queens, we performed three experiments: we studied the quantitative effectiveness of vertical transmission, surveyed the prevalence of successful egg infection under commercial conditions, and distinguished among three possible mechanisms of transmission. We find that queen-infection level predicts the DWV titers in their eggs, although the transmission is not very efficient. Our quantitative assessment of DWV demonstrates that eggs in 1/3 of the colonies are infected with DWV and highly infected eggs are rare in newly-installed spring colonies. Additionally, our results indicate that DWV transmission occurs predominantly by virus adhering to the surface of eggs (transovum) rather than intracellularly. Our combined results suggest that the queens' DWV vectoring capacity in practice is not as high as its theoretical potential. Thus, DWV transmission by honey bee queens is part of the DWV epidemic with relevant practical implications, which should be further studied.	[Amiri, Esmaeil; Rueppell, Olav] Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA; [Amiri, Esmaeil; Kryger, Per] Aarhus Univ, Dept Agroecol, Slagelse, Denmark; [Amiri, Esmaeil; Tarpy, David R.] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA; [Meixner, Marina D.] Landesbetrieb Landwirtschaft Hessen, Bieneninst Kirchhain, Kirchhain, Germany; [Strand, Micheline K.] US Army, Res Off, Life Sci Div, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Greensboro; Aarhus University; University of North Carolina; North Carolina State University; United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL)	Amiri, E (corresponding author), Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA.; Amiri, E (corresponding author), Aarhus Univ, Dept Agroecol, Slagelse, Denmark.; Amiri, E (corresponding author), North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA.	e.amiri79@gmail.com	Meixner, Marina/ABD-6400-2021; Kryger, Per/H-4600-2019; Rueppell, Olav/G-2679-2010	Meixner, Marina/0000-0002-7785-4894; Kryger, Per/0000-0001-5306-3230; Rueppell, Olav/0000-0001-5370-4229; Tarpy, David/0000-0001-8601-6094; Amiri, Esmaeil/0000-0001-8536-5815				Amiri E, 2016, SCI REP-UK, V6, DOI 10.1038/srep33065; Amiri E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140272; Benaets K, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2149; Blanchard P, 2007, J VIROL METHODS, V141, P7, DOI 10.1016/j.jviromet.2006.11.021; Blanchard P, 2014, J VIROL METHODS, V197, P7, DOI 10.1016/j.jviromet.2013.09.012; Boncristiani HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073429; Brosi BJ, 2017, NAT ECOL EVOL, V1, P1250, DOI 10.1038/s41559-017-0246-z; Buchler R, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.07; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen YP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004261; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Chen YP, 2006, J INVERTEBR PATHOL, V92, P152, DOI 10.1016/j.jip.2006.03.010; Chen YP, 2006, APPL ENVIRON MICROB, V72, P606, DOI 10.1128/AEM.72.1.606-611.2006; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Dainat B, 2013, J INVERTEBR PATHOL, V112, P278, DOI 10.1016/j.jip.2012.12.009; de Miranda JR, 2008, J INVERTEBR PATHOL, V98, P184, DOI 10.1016/j.jip.2008.02.004; de Miranda JR, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.22; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; Delaplane KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142985; Di Prisco G, 2016, P NATL ACAD SCI USA, V113, P3203, DOI 10.1073/pnas.1523515113; Di Prisco G, 2011, VIRUSES-BASEL, V3, P2425, DOI 10.3390/v3122425; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; Fievet J, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-16; Forsgren E, 2009, EXP APPL ACAROL, V47, P87, DOI 10.1007/s10493-008-9204-4; Forzan M, 2017, B INSECTOL, V70, P261; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; Francis RM, 2013, J GEN VIROL, V94, P668, DOI 10.1099/vir.0.047019-0; Francis RM, 2012, J APIC SCI, V56, P137, DOI 10.2478/v10289-012-0014-x; Fries I, 2001, APIDOLOGIE, V32, P199, DOI 10.1051/apido:2001122; Gauthier L, 2007, APIDOLOGIE, V38, P426, DOI 10.1051/apido:2007026; Gauthier L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016217; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Glenny William, 2017, PLoS One, V12, pe0182814, DOI 10.1371/journal.pone.0182814; Kevill JL, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110314; Maori E, 2007, VIROLOGY, V362, P342, DOI 10.1016/j.virol.2006.11.038; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Mazzei M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113448; McMahon DP, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0811; McMahon DP, 2015, J ANIM ECOL, V84, P615, DOI 10.1111/1365-2656.12345; McMenamin AJ, 2015, CURR OPIN INSECT SCI, V8, P121, DOI 10.1016/j.cois.2015.01.015; Mockel N, 2011, J GEN VIROL, V92, P370, DOI 10.1099/vir.0.025940-0; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Oldroyd BP, 2008, TRENDS ECOL EVOL, V23, P59, DOI 10.1016/j.tree.2007.10.012; Ravoet J, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0386-9; Ryabov EV, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004230; Sebastien A, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0610; Shen MQ, 2005, J GEN VIROL, V86, P2281, DOI 10.1099/vir.0.80824-0; Simone-Finstrom M, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.1007; Tarpy DR, 2013, NATURWISSENSCHAFTEN, V100, P723, DOI 10.1007/s00114-013-1065-y; Tentcheva D, 2006, APIDOLOGIE, V37, P41, DOI 10.1051/apido:2005057; Wilfert L, 2016, SCIENCE, V351, P594, DOI 10.1126/science.aac9976; Yanez O, 2012, APIDOLOGIE, V43, P17, DOI 10.1007/s13592-011-0088-7; Yue C, 2005, J GEN VIROL, V86, P3419, DOI 10.1099/vir.0.81401-0; Yue C, 2007, J GEN VIROL, V88, P2329, DOI 10.1099/vir.0.83101-0; Zhang X, 2012, J INVERTEBR PATHOL, V109, P156, DOI 10.1016/j.jip.2011.09.010	55	25	26	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195283	10.1371/journal.pone.0195283	http://dx.doi.org/10.1371/journal.pone.0195283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596509	gold, Green Submitted, Green Published			2022-12-26	WOS:000428630000103
J	Bastien, R; Guayasamin, O; Douady, S; Moulia, B				Bastien, Renaud; Guayasamin, Olivia; Douady, Stephane; Moulia, Bruno			Coupled ultradian growth and curvature oscillations during gravitropic movement in disturbed wheat coleoptiles	PLOS ONE			English	Article							STIMULATION ANGLE; INDOLEACETIC-ACID; CORN COLEOPTILES; POSTURE CONTROL; AUXIN; PLANTS; QUANTIFICATION; ARABIDOPSIS; HYPOCOTYLS; DEPENDENCE	To grow straight and upright, plants need to regulate actively their posture. Gravitropic movement, which occurs when plants modify their growth and curvature to orient their aerial organ against the force of gravity, is a major feature of this postural control. A recent model has shown that graviception and proprioception are sufficient to account for the gravitropic movement and subsequent organ posture demonstrated by a range of species. However, some plants, including wheat coleoptiles, exhibit a stronger regulation of posture than predicted by the model. Here, we performed an extensive kinematics study on wheat coleoptiles during a gravitropic perturbation (tilting) experiment in order to better understand this unexpectedly strong regulation. Close temporal observations of the data revealed that both perturbed and unperturbed coleoptiles showed oscillatory pulses of elongation and curvature variation that propagated from the apex to the base of their aerial organs. In perturbed coleoptiles, we discovered a non-trivial coupling between the oscillatory dynamics of curvature and elongation. The relationship between those oscillations and the postural control of the organ remains unclear, but indicates the presence of a mechanism that is capable of affecting the relationship between elongation rate, differential growth, and curvature.	[Bastien, Renaud; Guayasamin, Olivia] Max Planck Inst Ornithol, Dept Collect Behav, Constance, Germany; [Bastien, Renaud; Guayasamin, Olivia] Univ Konstanz, Dept Biol, Constance, Germany; [Guayasamin, Olivia] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Douady, Stephane] Univ Paris Diderot, Matiere & Syst Complexes, F-75205 Paris 13, France; [Moulia, Bruno] UCA, INRA, UMR PIAF, F-63000 Clermont Ferrand, France	Max Planck Society; University of Konstanz; Princeton University; UDICE-French Research Universities; Universite Paris Cite; INRAE	Bastien, R (corresponding author), Max Planck Inst Ornithol, Dept Collect Behav, Constance, Germany.; Bastien, R (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.	rbastien@orn.mpg.de	DOUADY, Stephane/C-4498-2018	DOUADY, Stephane/0000-0002-3416-886X				Band LR, 2012, P NATL ACAD SCI USA, V109, P4668, DOI 10.1073/pnas.1201498109; Baskin TI, 2006, RYTHMS IN PLANTS, P3; Bastien R, 2017, GROWTH WHEAT COLEOPT; Bastien R, 2017, GRAVITROPISM WHEAT C; Bastien R, 2017, OSCILLATORY MOVEMENT; Bastien R, 2016, PLOS COMPUTATIONAL B, V12, P1, DOI DOI 10.1371/J0URNAL.PCBI.1005238); Bastien R, 2016, PLANT J, V88, P468, DOI 10.1111/tpj.13255; Bastien R, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004037; Bastien R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00136; Bastien R, 2013, P NATL ACAD SCI USA, V110, P755, DOI 10.1073/pnas.1214301109; Basu P, 2007, PLANT PHYSIOL, V145, P305, DOI 10.1104/pp.107.103226; BERG AR, 1992, AM J BOT, V79, P77, DOI 10.2307/2445200; Chavarria-Krauser A, 2008, NEW PHYTOL, V177, P811, DOI 10.1111/j.1469-8137.2007.02299.x; COSGROVE DJ, 1990, PLANT CELL ENVIRON, V13, P227, DOI 10.1111/j.1365-3040.1990.tb01307.x; Galland P, 2002, PLANTA, V215, P779, DOI 10.1007/s00425-002-0813-6; GOLDSMITH MH, 1967, PLANT PHYSIOL, V42, P258, DOI 10.1104/pp.42.2.258; Hamant O, 2016, NEW PHYTOLOGIST; Iino M, 1996, PLANT CELL ENVIRON, V19, P1160, DOI 10.1111/j.1365-3040.1996.tb00431.x; Kramer EM, 2011, TRENDS PLANT SCI, V16, P461, DOI 10.1016/j.tplants.2011.05.003; Monshausen GB, 2007, P NATL ACAD SCI USA, V104, P20996, DOI 10.1073/pnas.0708586104; Monshausen GB, 2008, PLANT PHYSIOL, V147, P1690, DOI 10.1104/pp.108.123638; Morita MT, 2010, ANNU REV PLANT BIOL, V61, P705, DOI 10.1146/annurev.arplant.043008.092042; Moulia B, 2006, AM J BOT, V93, P1477, DOI 10.3732/ajb.93.10.1477; Moulia B, 2009, J EXP BOT, V60, P461, DOI 10.1093/jxb/ern341; Nick P, 2010, PLANT SIGNAL BEHAV, V5, P94, DOI 10.4161/psb.5.2.10337; Philippar K, 1999, P NATL ACAD SCI USA, V96, P12186, DOI 10.1073/pnas.96.21.12186; SHENMILLER J, 1973, PLANT PHYSIOL, V51, P615, DOI 10.1104/pp.51.4.615; SHENMILLER J, 1973, PLANT PHYSIOL, V52, P166, DOI 10.1104/pp.52.2.166; SILK WK, 1984, ANNU REV PLANT PHYS, V35, P479, DOI 10.1146/annurev.pp.35.060184.002403; Tarui Y, 1997, PLANT CELL PHYSIOL, V38, P1346, DOI 10.1093/oxfordjournals.pcp.a029128; Walter A, 2002, J EXP BOT, V53, P689, DOI 10.1093/jexbot/53.369.689	31	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194893	10.1371/journal.pone.0194893	http://dx.doi.org/10.1371/journal.pone.0194893			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596500	Green Submitted, Green Published, gold			2022-12-26	WOS:000428630000047
J	Ling, L; Jiang, Y; Meng, JJ; Cai, LM; Cao, GC				Ling, Lin; Jiang, Yang; Meng, Jiao Jing; Cai, Li Ming; Cao, Gui Cou			Phloem transport capacity of transgenic rice T1c-19 (Cry1C*) under several potassium fertilizer levels	PLOS ONE			English	Article							DIFFERENTIAL RESPONSES; VASCULAR BUNDLE; HIGHER-PLANTS; QTL ANALYSIS; YIELD; PANICLE; COTTON; LINES; CULTIVAR; GROWTH	Genetic modification of Cry-proteins from Bacillus thuringiensis (Bt) is a common practice in economically important crops to improve insecticide resistance and reduce the use of pesticides. However, introduction of these genes can have unintended side effects, which should be closely monitored for effective breeding and crop management. To determine the potential cause of these negative effects, we explored assimilate partitioning in the transgenic Bt rice line T1c-19 (Cry1C*), which was compared with that of its wild-type counterpart Minghui 63 (MH63) under different potassium fertilization application treatment conditions. In a pot experiment, 0, 0.4, and 0.6 g K2O was applied per kg of dry soil to determine the phloem transport characteristics of the two rice lines. We used a variety of assessment indicators ranging from morphological to physiological aspects, including the number of large and small vascular bundles in the neck internode at the heading stage, the diameter and bleeding intensity of the neck internode at the filling stage, and the content and apparent ratio of transferred non-structural carbohydrates (NSC) in the culm and sheath from the heading to maturing stages. The K utilization and grain yield at the maturing stage were also concerned. Results presented that the mean setting rate and grain yield of T1c-19 (Cry1C*) decreased by 22.3% and 26.2% compared to those in MH63, respectively. Compared to MH63, the K concentration and accumulation were significantly higher in the culms and leaves, but significantly lower in grain of T1c-19 (Cry1C*). T1c-19 (Cry1C*) had less apparent NSC efflux in the culm and sheath, fewer small vascular bundles, and a smaller diameter and bleeding intensity of the neck internode than MH63. In addition, linear correlation analysis indicated that there were positive correlations among grain yield, setting rate, the apparent NSC efflux in the culm and sheath, number of small vascular bundles, and the neck internode diameter and bleeding intensity. These unintended effects may directly or indirectly be caused by insertion of exogenous Bt (Cry1C*) gene, which should be further considered in the future breeding of transgenic crops.	[Ling, Lin; Jiang, Yang; Meng, Jiao Jing; Cai, Li Ming; Cao, Gui Cou] Huazhong Agr Univ, Minist Agr, Key Lab Crop Physiol Ecol & Cultivat Middle Reach, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Jiang, Y (corresponding author), Huazhong Agr Univ, Minist Agr, Key Lab Crop Physiol Ecol & Cultivat Middle Reach, Wuhan, Hubei, Peoples R China.	jiangyang@webmail.hzau.edu.cn						Ansari TH, 2004, SOIL SCI PLANT NUTR, V50, P57, DOI 10.1080/00380768.2004.10408452; Chen LY, 2006, AM J BOT, V93, P94, DOI 10.3732/ajb.93.1.94; CLARKSON DT, 1980, ANNU REV PLANT PHYS, V31, P239, DOI 10.1146/annurev.pp.31.060180.001323; Cowling WA, 2007, FIELD CROP RES, V104, P103, DOI 10.1016/j.fcr.2006.12.014; Coz I, 2008, J ENVIRON QUAL, V37, P647, DOI 10.2134/jeq2007.0352; Dingkuhn M, 2015, FIELD CROP RES, V182, P43, DOI 10.1016/j.fcr.2015.05.025; Guo RQ, 2011, PHOTOSYNTHETICA, V49, P507, DOI 10.1007/s11099-011-0060-9; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Jia Q, 2005, SCI AGR SINICA, V38, P73; Jia Q, 2004, ACTA AGR ZHEJIANGENS, V17, P39; Jiang Y, 2013, FIELD CROP RES, V151, P101, DOI 10.1016/j.fcr.2013.06.017; Kasturikasen Beura, 2013, Open Journal of Ecology, V3, P505, DOI 10.4236/oje.2013.38059; Kato T, 2004, J AGR SCI, V142, P177, DOI 10.1017/S0021859604004265; Kato T, 1996, CROP SCI, V36, P1135, DOI 10.2135/cropsci1996.0011183X003600050011x; LEIGH RA, 1984, NEW PHYTOL, V97, P1, DOI 10.1111/j.1469-8137.1984.tb04103.x; Liu GL, 2008, PLANT SCI, V174, P71, DOI 10.1016/j.plantsci.2007.09.011; Liu W, 2004, PESTICIDES; Lundegardh H., 1995, MECH ABSORPTION TRAN, V6, P1; LYNCH PT, 1995, EUPHYTICA, V85, P395, DOI 10.1007/BF00023972; Morita S, 2011, CROP SCI, V51, P818, DOI 10.2135/cropsci2010.06.0373; OPARKA KJ, 1981, PLANTA, V151, P561, DOI 10.1007/BF00387436; Pan JF, 2011, PHYSIOL PLANTARUM, V141, P321, DOI 10.1111/j.1399-3054.2010.01441.x; RAVEN JA, 1976, NEW PHYTOL, V76, P415, DOI 10.1111/j.1469-8137.1976.tb01477.x; Sanvido O, 2007, ADV BIOCHEM ENG BIOT, V107, P235, DOI 10.1007/10_2007_048; Shu QY, 2002, EUPHYTICA, V127, P345, DOI 10.1023/A:1020358617257; Takai T, 2006, FIELD CROP RES, V96, P328, DOI 10.1016/j.fcr.2005.08.001; Tang W, 2006, MOL BREEDING, V18, P1, DOI 10.1007/s11032-006-9002-9; Teng S, 2002, ACTA BOT SIN, V44, P301; Terai K., 2008, Japanese Journal of Crop Science, V77, P191, DOI 10.1626/jcs.77.191; Wang F, 2012, FIELD CROP RES, V126, P8, DOI 10.1016/j.fcr.2011.09.017; Wang M, 2013, INT J MOL SCI, V14, P7390; Wang Y., 2003, PRACTICAL HDB REFERE, P16; Wang Y, 2013, ANNU REV PLANT BIOL, V64, P451, DOI 10.1146/annurev-arplant-050312-120153; WARD G. M., 1960, Canadian Journal of Plant Science, V40, P729; Wu LL, 2011, AUST J CROP SCI, V5, P1356; Xia H, 2010, FIELD CROP RES, V118, P215, DOI 10.1016/j.fcr.2010.05.008; Xu Z, 1998, ACTA AGRONOMICA SINI, V1; Xu ZhengJin, 1996, Acta Agronomica Sinica, V22, P167; YOSHIDA S, 1972, ANN REV PLANT PHYSIO, V23, P437, DOI 10.1146/annurev.pp.23.060172.002253; YUKUI R, 2009, PLANT BIOSYST, V143, P137, DOI DOI 10.1080/11263500802709731; Zhang BL, 2010, PLANT PROD SCI, V13, P279, DOI 10.1626/pps.13.279; Zhang ZY, 2007, J PLANT NUTR, V30, P659, DOI 10.1080/01904160701289206; Zhao Q., 1999, SCI AGR SINICA; [左开井 Zuo Kaijing], 2003, [福建农林大学学报. 自然科学版, Journal of Fujian Agriculture and Forestry University], V32, P409	44	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195058	10.1371/journal.pone.0195058	http://dx.doi.org/10.1371/journal.pone.0195058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596474	gold, Green Published, Green Submitted			2022-12-26	WOS:000428630000073
J	Blanco-Gandia, MC; Minarro, J; Aguilar, MA; Rodriguez-Arias, M				Carmen Blanco-Gandia, M.; Minarro, Jose; Asuncion Aguilar, Maria; Rodriguez-Arias, Marta			Increased ethanol consumption after interruption of fat bingeing	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; EATING-DISORDERS; GENE-EXPRESSION; NEUROBIOLOGICAL MECHANISMS; NATIONAL COMORBIDITY; INTERMITTENT ACCESS; SEEKING BEHAVIOR; REWARD; DIET; RAT	There is a marked comorbidity between alcohol abuse and eating disorders, especially in the young population. We have previously reported that bingeing on fat during adolescence increases the rewarding effects of ethanol (EtOH). The aim of the present work was to study if vulnerability to EtOH persists after cessation of binge eating. OF1 mice binged on fat (HFB: high-fat binge) during adolescence (PND 25-43) and were tested for 15 days after the last access to HFB (on PND 59) using the self-administration paradigm, the conditioned place preference (CPP) and locomotor sensitization to ethanol. Our results showed that after 15 days of cessation of fat ingestion, mice increased their consumption of ethanol and showed greater motivation to obtain ethanol. On the other hand, no effects were observed in the CPP, while an increased locomotor response to ethanol was detected. The present results confirm and extend our previous study demonstrating that the compulsive intake of fat induces long-lasting effects on the reward system that lead to an increased consumption of EtOH.	[Carmen Blanco-Gandia, M.; Minarro, Jose; Asuncion Aguilar, Maria; Rodriguez-Arias, Marta] Univ Valencia, Fac Psicol, Dept Psicobiol, Unidad Invest Psicobiol Drogodependenc, Valencia, Spain	University of Valencia	Rodriguez-Arias, M (corresponding author), Univ Valencia, Fac Psicol, Dept Psicobiol, Unidad Invest Psicobiol Drogodependenc, Valencia, Spain.	marta.rodriguez@uv.es	Rodriguez-Arias, Marta/B-5163-2011; Minarro, Jose/B-4414-2011; Blanco-Gandia, M.Carmen/M-1538-2014	Minarro, Jose/0000-0002-5731-7821; Rodriguez-Arias, Marta/0000-0002-1121-8879; Blanco-Gandia, M.Carmen/0000-0001-5990-1266	Ministerio de Sanidad, Servicios Sociales e Igualdad; Delegacion del Gobierno para el Plan Nacional Sobre Drogas, Proyectos de Investigacion sobre Drogodependencias [2014I007]; Generalitat Valenciana [PROMETEOII/2014/063]; Ministerio de Economia y Competitividad (MINECO), Institute de Salud Carlos III, Red de Trastornos Adictivos (RTA) [RD12/0028/0005, RD16/0017/0007]; Union Europea; Fondos FEDER "una manera de hacer Europa";  [PSI2014-51847-R]	Ministerio de Sanidad, Servicios Sociales e Igualdad(Spanish Government); Delegacion del Gobierno para el Plan Nacional Sobre Drogas, Proyectos de Investigacion sobre Drogodependencias; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Ministerio de Economia y Competitividad (MINECO), Institute de Salud Carlos III, Red de Trastornos Adictivos (RTA); Union Europea; Fondos FEDER "una manera de hacer Europa"; 	This work was supported by the Ministerio de Sanidad, Servicios Sociales e Igualdad. Delegacion del Gobierno para el Plan Nacional Sobre Drogas, Proyectos de Investigacion sobre Drogodependencias, 2014I007; Generalitat Valenciana, PROMETEOII/2014/063; Ministerio de Economia y Competitividad (MINECO), Institute de Salud Carlos III, Red de Trastornos Adictivos (RTA) RD12/0028/0005 y RD16/0017/0007 and Union Europea, Fondos FEDER "una manera de hacer Europa", and PSI2014-51847-R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger H, 2013, PEDIATR REV, V34, P103, DOI 10.1542/pir.34-3-103; Aguilar MA, 2009, BRAIN RES REV, V59, P253, DOI 10.1016/j.brainresrev.2008.08.002; Avena NA, 2004, ALCOHOL, V34, P203, DOI 10.1016/j.alcohol.2004.09.006; Avena NM, 2008, NEUROSCI BIOBEHAV R, V32, P20, DOI 10.1016/j.neubiorev.2007.04.019; Avena NM, 2007, EXP CLIN PSYCHOPHARM, V15, P481, DOI 10.1037/1064-1297.15.5.481; Avena NM, 2003, NEUROSCIENCE, V122, P17, DOI 10.1016/S0306-4522(03)00502-5; Baladi MG, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv024; Baladi MG, 2012, NEUROPHARMACOLOGY, V63, P76, DOI 10.1016/j.neuropharm.2012.02.005; Bava S, 2010, NEUROPSYCHOL REV, V20, P398, DOI 10.1007/s11065-010-9146-6; Bekker L, 2014, BEHAV BRAIN RES, V270, P108, DOI 10.1016/j.bbr.2014.04.050; Bello NT, 2003, AM J PHYSIOL-REG I, V284, pR1260, DOI 10.1152/ajpregu.00716.2002; Brown SA, 2008, PEDIATRICS, V121, pS290, DOI 10.1542/peds.2007-2243D; Carlin JL, 2016, NEUROSCIENCE, V326, P170, DOI 10.1016/j.neuroscience.2016.04.002; Ledesma JC, 2013, PSYCHOPHARMACOLOGY, V226, P673, DOI 10.1007/s00213-012-2831-9; Blanco-Gandia MC, 2017, PSYCHOPHARMACOLOGY, V234, P2337, DOI 10.1007/s00213-017-4630-9; Blanco-Gandia MC, 2017, NEUROPHARMACOLOGY, V121, P219, DOI 10.1016/j.neuropharm.2017.04.040; Blanco-Gandia MC, 2017, NEUROPHARMACOLOGY, V113, P31, DOI 10.1016/j.neuropharm.2016.09.020; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Colantuoni C, 2001, NEUROREPORT, V12, P3549, DOI 10.1097/00001756-200111160-00035; Corwin R. L., 2006, CURRENT PROTOCOLS NE, V36, P1, DOI [10.1002/0471142301.ns0923bs36, DOI 10.1002/0471142301.NS0923BS36]; Corwin RL, 1998, PHYSIOL BEHAV, V65, P545, DOI 10.1016/S0031-9384(98)00201-7; Cota D, 2006, BRAIN RES REV, V51, P85, DOI 10.1016/j.brainresrev.2005.10.004; Cottone P, 2008, AM J PHYSIOL-REG I, V295, pR1066, DOI 10.1152/ajpregu.90309.2008; Cottone P, 2009, P NATL ACAD SCI USA, V106, P20016, DOI 10.1073/pnas.0908789106; Cruz JAA, 2000, EUR J CLIN NUTR, V54, pS29, DOI 10.1038/sj.ejcn.1600981; Davis C, 2009, APPETITE, V53, P1, DOI 10.1016/j.appet.2009.05.018; Daws LC, 2011, NEUROPHARMACOLOGY, V61, P1123, DOI 10.1016/j.neuropharm.2011.02.028; Degenhardt L, 2009, PSYCHOL MED, V39, P157, DOI 10.1017/S0033291708003425; Didone V, 2016, ADDICT BIOL, V21, P387, DOI 10.1111/adb.12216; Ganji V, 1995, EUR J CLIN NUTR, V49, P915; Gold MS, 2011, PHYSIOL BEHAV, V104, P157, DOI 10.1016/j.physbeh.2011.04.027; Gold MS, 2003, PSYCHIAT ANN, V33, P117, DOI 10.3928/0048-5713-20030201-08; Gosnell BA, 2005, BRAIN RES, V1031, P194, DOI 10.1016/j.brainres.2004.10.037; Groblewski PA, 2008, PSYCHOPHARMACOLOGY, V201, P97, DOI 10.1007/s00213-008-1251-3; Guerri C, 2002, NEUROTOX RES, V4, P327, DOI 10.1080/1029842021000010884; Harper C, 2005, CURR OPIN PHARMACOL, V5, P73, DOI 10.1016/j.coph.2004.06.011; Herpertz-Dahlmann B, 2015, CHILD ADOL PSYCH CL, V24, P177, DOI 10.1016/j.chc.2014.08.003; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Jonsson S, 2014, ALCOHOL CLIN EXP RES, V38, P722, DOI 10.1111/acer.12307; Klump KL, 2013, HORM BEHAV, V64, P399, DOI 10.1016/j.yhbeh.2013.02.019; Koob GF, 2010, CURR OPIN INVEST DR, V11, P63; Martire SI, 2014, BEHAV BRAIN RES, V265, P132, DOI 10.1016/j.bbr.2014.02.027; Matson LM, 2013, ADDICT BIOL, V18, P921, DOI 10.1111/j.1369-1600.2011.00412.x; Miquel M, 2003, EUR J NEUROSCI, V17, P2163, DOI 10.1046/j.1460-9568.2003.02646.x; Morales-Mulia M, 2012, BEHAV BRAIN RES, V235, P189, DOI 10.1016/j.bbr.2012.07.036; Murray S, 2014, NAT REV ENDOCRINOL, V10, P540, DOI 10.1038/nrendo.2014.91; NANCE DM, 1983, NEUROSCI BIOBEHAV R, V7, P189, DOI 10.1016/0149-7634(83)90015-5; Nasrallah NA, 2009, P NATL ACAD SCI USA, V106, P17600, DOI 10.1073/pnas.0906629106; Navarrete F, 2014, ADDICT BIOL, V19, P862, DOI 10.1111/adb.12058; Navarrete F, 2012, BRIT J PHARMACOL, V165, P260, DOI 10.1111/j.1476-5381.2011.01542.x; Oliva JM, 2008, EUR NEUROPSYCHOPHARM, V18, P373, DOI 10.1016/j.euroneuro.2007.09.001; Ortiz S, 2004, ALCOHOL ALCOHOLISM, V39, P88, DOI 10.1093/alcalc/agh036; Pascual M, 2007, EUR J NEUROSCI, V25, P541, DOI 10.1111/j.1460-9568.2006.05298.x; Pina MM, 2015, NEUROPHARMACOLOGY, V99, P627, DOI 10.1016/j.neuropharm.2015.08.033; Puhl MD, 2011, BEHAV NEUROSCI, V125, P930, DOI 10.1037/a0025759; Roberts AJ, 1998, ALCOHOL CLIN EXP RES, V22, P1564, DOI 10.1111/j.1530-0277.1998.tb03950.x; Roberts AJ, 2001, ALCOHOL CLIN EXP RES, V25, P1249, DOI 10.1111/j.1530-0277.2001.tb02344.x; SAMSON HH, 1986, ALCOHOL CLIN EXP RES, V10, P436, DOI 10.1111/j.1530-0277.1986.tb05120.x; Schneider M, 2008, ADDICT BIOL, V13, P253, DOI 10.1111/j.1369-1600.2008.00110.x; Sharma S, 2013, INT J OBESITY, V37, P1183, DOI 10.1038/ijo.2012.197; Sirohi S, 2017, PHARMACOL BIOCHEM BE, V153, P105, DOI 10.1016/j.pbb.2016.12.009; Spear LP, 2000, CURR DIR PSYCHOL SCI, V9, P111, DOI 10.1111/1467-8721.00072; Steinberg L, 2010, DEV PSYCHOBIOL, V52, P216, DOI 10.1002/dev.20445; Steinberg L, 2009, CHILD DEV, V80, P28, DOI 10.1111/j.1467-8624.2008.01244.x; Sturman DA, 2011, J NEUROSCI, V31, P1471, DOI 10.1523/JNEUROSCI.4210-10.2011; Teegarden SL, 2009, NEUROSCIENCE, V162, P924, DOI 10.1016/j.neuroscience.2009.05.029; Teegarden SL, 2007, BIOL PSYCHIAT, V61, P1021, DOI 10.1016/j.biopsych.2006.09.032; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Volkow ND, 2013, OBES REV, V14, P2, DOI 10.1111/j.1467-789X.2012.01031.x; Weiss F, 2005, CURR OPIN PHARMACOL, V5, P9, DOI 10.1016/j.coph.2004.11.001; Wojnicki FHE, 2007, PHYSIOL BEHAV, V92, P566, DOI 10.1016/j.physbeh.2007.05.002; Zghoul T, 2007, PSYCHOPHARMACOLOGY, V190, P13, DOI 10.1007/s00213-006-0592-z	72	4	4	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194431	10.1371/journal.pone.0194431	http://dx.doi.org/10.1371/journal.pone.0194431			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590149	Green Submitted, Green Published, gold			2022-12-26	WOS:000428603100058
J	Kinoshita, A; Nara, K; Sasaki, H; Feng, B; Obase, K; Yang, ZL; Yamanaka, T				Kinoshita, Akihiko; Nara, Kazuhide; Sasaki, Hiromi; Feng, Bang; Obase, Keisuke; Yang, Zhu L.; Yamanaka, Takashi			Using mating-type loci to improve taxonomy of the Tuber indicum complex, and discovery of a new species, T. longispinosum	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; DISTANCE ANALYSIS; CHINESE TRUFFLES; TAIWAN; GENES; SEQUENCES; PSEUDOEXCAVATUM; RECOGNITION; MYCORRHIZAE; PERFORMANCE	Black truffles that morphologically resemble Tuber indicum have been known to occur in Japan since 1979. Our previous studies showed that there are two phylotypes of these truffles, both of which fell into the T. indicum complex (hereinafter "Tubersp. 6" and "Tuber sp. 7"). However, their taxonomic treatment is still unclear. In this study, we conducted morphological and phylogenetic analyses for a total of 52 specimens from Japan (16 Tuber sp. 6 and 13 Tubersp. 7), China (10 T. himalayense and 8 T. indicum), and Taiwan (5 T. formosanum). We compared ascospore ornamentation, size, distribution of asci with average number of spores per ascus, spine size and shape of the Japanese specimens with their allied taxa. For phylogenetic analysis, we sequenced two mating loci (MAT1-1-1 and MAT-12-1) and three commonly used loci (ITS, beta-tubulin, and TEF1-alpha). Three distinct lineages were recognized by phylogenetic analyses based on the sequences of the two mating related loci and three independent loci. The Tubersp. 6 sequences clustered with those of T. himalayense and T. formosanum, and there was no clear difference in morphology among them. Tubersp. 7 formed a distinct lineage in each phylogram. The specimens tended to have five-spored asci more frequently than other allied species and could be characterized as having ascospore ornamentation with longer spines and narrower spine bases. We therefore described Tubersp. 7 as a new species (T. longispinosum), and treat Tuber sp. 6 and T. formosanum as synonyms of T. himalayense.	[Kinoshita, Akihiko] Forestry & Forest Prod Res Inst, Kyushu Res Ctr, Kumamoto, Kumamoto, Japan; [Nara, Kazuhide] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Sasaki, Hiromi] Mycologist Circle Japan, Fujisawa, Kanagawa, Japan; [Feng, Bang; Yang, Zhu L.] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Obase, Keisuke; Yamanaka, Takashi] Forestry & Forest Prod Res Inst, Dept Mushroom Sci & Forest Microbiol, Tsukuba, Ibaraki, Japan	Forestry & Forest Products Research Institute - Japan; University of Tokyo; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Forestry & Forest Products Research Institute - Japan	Kinoshita, A (corresponding author), Forestry & Forest Prod Res Inst, Kyushu Res Ctr, Kumamoto, Kumamoto, Japan.	akinoshita@affrc.go.jp		Obase, Keisuke/0000-0002-1893-1001	JSPS [24710271, 21658054, 22380083, 15H02449]; Ministry of Agriculture, Forestry and Fisheries of Japan	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported by JSPS KAKENHI Grants to AK (24710271) and KN (21658054, 22380083, 15H02449), and also by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan, entitled "Technology development for the optimal use of forest resources."	Aoki M, 2008, ILLUSTRATIONS JAPANE, VVI, P137; Belfiori B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082353; Bonito G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052765; Bonito GM, 2010, MOL ECOL, V19, P4994, DOI 10.1111/j.1365-294X.2010.04855.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen J, 2012, NAN FANG YI KE DA XU, V32, DOI DOI 10.7872/CRYM.V32.ISS1.2012.083; Chen J, 2016, SOIL BIOL, V47, P19, DOI 10.1007/978-3-319-31436-5_2; Chen JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014625; Du MZ, 2005, MYCOLOGIA, V97, P641, DOI 10.3852/mycologia.97.3.641; Feng B, 2017, MYCORRHIZA, V27, P261, DOI 10.1007/s00572-016-0751-y; Feng B, 2016, SCI REP-UK, V6, DOI 10.1038/srep21811; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Geng Y, 2014, MYCOLOGIA, V106, P649, DOI 10.3852/13-383; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gyganskyi AP, 2010, PLOS ONE, V5; Hall I. R., 2012, EDIBLE ECTOMYCORRHIZ, P191; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hu H, 1992, J EXP FOR NATL TAIWA, V6, P79; Huang JY, 2009, FEMS MICROBIOL LETT, V294, P157, DOI 10.1111/j.1574-6968.2009.01571.x; Huang SSF, 2002, MOL ECOL, V11, P2349, DOI 10.1046/j.1365-294X.2002.01624.x; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kinoshita A, 2016, MYCOSCIENCE, V57, P366, DOI 10.1016/j.myc.2016.06.006; Kinoshita A, 2011, MYCOLOGIA, V103, P779, DOI 10.3852/10-138; Kizaki K., 1977, MARINE SCI MONTHLY, V9, P542; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lee YJ, 2006, J HERED, V97, P261, DOI 10.1093/jhered/esj030; Lefevre C., 2012, EDIBLE ECTOMYCORRHIZ, P209, DOI [10.1007/978-3-642-33823-6_12, DOI 10.1007/978-3-642-33823-6_12]; Lin TP, 2003, MOL ECOL, V12, P2661, DOI 10.1046/j.1365-294X.2003.01912.x; Lopes A, 2017, FUNGAL BIOL-UK, V121, P394, DOI 10.1016/j.funbio.2016.08.011; Manjon JL, 2009, MYCOTAXON, V110, P399, DOI 10.5248/110.399; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; Martin SH, 2013, FUNGAL DIVERS, V58, P1, DOI 10.1007/s13225-012-0217-2; Merenyi Z, 2017, MYCOLOGICAL IN PRESS; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; O'Donnell K, 2004, FUNGAL GENET BIOL, V41, P600, DOI 10.1016/j.fgb.2004.03.003; Paolocci F, 1997, FEMS MICROBIOL LETT, V153, P255, DOI 10.1111/j.1574-6968.1997.tb12582.x; Qiao P, 2013, MYCOTAXON, V123, P293, DOI 10.5248/123.293; Rambaut A, 2014, FIGTREE; Rambaut A, 2014, TRACER VERSION 1 6 S; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roux C, 1999, FEMS MICROBIOL LETT, V180, P147, DOI 10.1111/j.1574-6968.1999.tb08789.x; Rubini A, 1998, FEMS MICROBIOL LETT, V164, P7, DOI 10.1016/S0378-1097(98)00183-9; Rubini A, 2011, NEW PHYTOL, V189, P710, DOI 10.1111/j.1469-8137.2010.03492.x; Sibuet JC, 2004, TECTONOPHYSICS, V379, P159, DOI 10.1016/j.tecto.2003.10.022; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Wang YJ, 2006, MYCOL RES, V110, P1034, DOI 10.1016/j.mycres.2006.06.013; Wang YJ, 2006, FEMS MICROBIOL LETT, V259, P269, DOI 10.1111/j.1574-6968.2006.00283.x; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wiens JJ, 1998, SYST BIOL, V47, P568, DOI 10.1080/106351598260581; Xu J, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0805-2; Zhang BC, 1988, T BRIT MYCOLOGICAL S, V91, P593; Zhang LF, 2005, FEMS MICROBIOL LETT, V245, P85, DOI 10.1016/j.femsle.2005.02.028; Zhang XW, 2015, BIOCHEM SYST ECOL, V63, P190, DOI 10.1016/j.bse.2015.10.010	54	12	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193745	10.1371/journal.pone.0193745	http://dx.doi.org/10.1371/journal.pone.0193745			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590201	Green Published, gold, Green Submitted			2022-12-26	WOS:000428603100029
J	Kondoh, Y; Taniguchi, H; Kataokal, K; Furukawa, T; Shintani, A; Fujisawa, T; Suda, T; Arita, M; Baba, T; Ichikado, K; Inoue, Y; Kishi, K; Kishaba, T; Nishiyama, O; Ogura, T; Tomii, K; Homma, S				Kondoh, Yasuhiro; Taniguchi, Hiroyuki; Kataokal, Kensuke; Furukawa, Taiki; Shintani, Ayumi; Fujisawa, Tomoyuki; Suda, Takafumi; Arita, Machiko; Baba, Tomohisa; Ichikado, Kazuya; Inoue, Yoshikazu; Kishi, Kazuma; Kishaba, Tomoo; Nishiyama, Osamu; Ogura, Takashi; Tomii, Keisuke; Homma, Sakae			Clinical spectrum and prognostic factors of possible UIP pattern on high-resolution CT in patients who underwent surgical lung biopsy	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; CONTROLLED-TRIAL; DIAGNOSIS; PIRFENIDONE; DISEASE; PREDICTORS; EFFICACY; UPDATE	Background Few studies have reported the diagnostic variability in patients with a possible usual interstitial pneumonia (UIP) pattern on high-resolution CT (HRCT) who underwent surgical lung biopsy (SLB), and the prognostic factors for these patients have not been fully evaluated. We retrospectively investigated the frequency of idiopathic pulmonary fibrosis (IPF) and prognostic factors in patients with possible UIP pattern on HRCT. Methods Consecutive patients who had a possible UIP pattern on HRCT, underwent SLB, and had a diagnosis of IIPs before SLB were retrospectively recruited from 10 hospitals. Diagnoses were made based on multidisciplinary discussion using the criteria for current IPF guidelines and multidisciplinary classification for IIPs in each hospital. Results 179 patients who underwent SLB were enrolled. The diagnoses were IPF in 91 patients (51%), unclassifiable IIPs in 47 (26%), idiopathic NSIP in 18 (10%), and chronic hypersensitivity pneumonia in 17 (9%). One-year FVC changes showed significant differences between IPF and non-IPF (-138.6 mL versus 18.2 mL, p = 0.014). Patients with IPF had a worse mortality than those with non-IPF (Logrank test, p = 0.025). Multivariable Cox regression analysis demonstrated that diagnoses of IPF (HR, 2.961; 95% CI, 1.183-7.410; p = 0.02), high modified MRC score (HR, 1.587; 95% CI, 1.003-2.510; p = 0.049), and low %FVC (HR, 0.972; 95% CI, 0.953-0.992; p = 0.005). Conclusions About a half of patients with a possible UIP pattern on HRCT had diagnoses other than IPF, and patients with IPF had a worse mortality than those with an alternative diagnosis. We reaffirmed that multidisciplinary discussion is crucial in patients with possible UIP pattern on HRCT.	[Kondoh, Yasuhiro; Taniguchi, Hiroyuki; Kataokal, Kensuke] Tosei Gen Hosp, Dept Resp Med & Allergy, Seto, Japan; [Furukawa, Taiki] Nagoya Univ, Dept Resp Med, Grad Sch Med, Showa Ku, Nagoya, Aichi, Japan; [Shintani, Ayumi] Osaka City Univ, Dept Med Stat, Grad Sch Med, Osaka, Japan; [Fujisawa, Tomoyuki; Suda, Takafumi] Hamamatsu Univ Sch Med, Div 2, Dept Internal Med, Hamamatsu, Shizuoka, Japan; [Arita, Machiko] Kurashiki Cent Hosp, Dept Resp Med, Okayama, Japan; [Baba, Tomohisa; Ogura, Takashi] Kanagawa Cardiovasc & Resp Ctr, Dept Resp Med, Yokohama, Kanagawa, Japan; [Ichikado, Kazuya] Saiseikai Kumamoto Hosp, Div Resp Med, Kumamoto, Japan; [Inoue, Yoshikazu] Natl Hosp Org Kinki Chuo Chest Med Ctr, Clin Res Ctr, Osaka, Japan; [Kishi, Kazuma] Toranomon Gen Hosp, Dept Resp Med, Resp Ctr, Tokyo, Japan; [Kishaba, Tomoo] Okinawa Chubu Hosp, Dept Resp Med, Okinawa, Japan; [Nishiyama, Osamu] Kindai Univ, Dept Resp Med & Allergol, Fac Med, Osaka, Japan; [Tomii, Keisuke] Kobe City Med Ctr Gen Hosp, Dept Resp Med, Kobe, Hyogo, Japan; [Homma, Sakae] Toho Univ, Dept Resp Med, Omori Med Ctr, Tokyo, Japan	Tosei General Hospital; Nagoya University; Osaka Metropolitan University; Hamamatsu University School of Medicine; Kurashiki Central Hospital; Kanagawa Cardiovascular & Respiratory Center; Saiseikai Kumamoto Hospital; Toranomon Hospital; Okinawa Chubu Central Hospital; Kindai University (Kinki University); Kobe City Medical Center General Hospital; Toho University	Kondoh, Y (corresponding author), Tosei Gen Hosp, Dept Resp Med & Allergy, Seto, Japan.	konyasu2003@yahoo.co.jp	Kondo, Yasuhiro/AAP-3658-2020; Inoue, Yoshikazu/ABE-9772-2020	Furukawa, Taiki/0000-0002-3522-1845; Nishiyama, Osamu/0000-0002-9163-9605				Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Azuma A, 2005, AM J RESP CRIT CARE, V171, P1040, DOI 10.1164/rccm.200404-571OC; Brownell R, 2017, THORAX, V72, P424, DOI 10.1136/thoraxjnl-2016-209671; du Bois RM, 2012, EUR RESPIR REV, V21, P141, DOI 10.1183/09059180.00000812; Fell CD, 2010, AM J RESP CRIT CARE, V181, P832, DOI 10.1164/rccm.200906-0959OC; Johannson KA, 2014, LANCET RESP MED, V2, pE5, DOI 10.1016/S2213-2600(14)70075-X; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Raghu G, 2015, AM J RESP CRIT CARE, V192, pE3, DOI 10.1164/rccm.201506-1063ST; Raghu G, 2014, LANCET RESP MED, V2, P277, DOI 10.1016/S2213-2600(14)70011-6; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Richeldi L, 2011, NEW ENGL J MED, V365, P1079, DOI 10.1056/NEJMoa1103690; Ryerson CJ, 2017, AM J RESP CRIT CARE, V196, P1249, DOI 10.1164/rccm.201702-0400PP; Ryerson CJ, 2013, EUR RESPIR J, V42, P750, DOI 10.1183/09031936.00131912; Salisbury ML, 2016, RESP MED, V118, P88, DOI 10.1016/j.rmed.2016.07.016; Skolnik K, 2016, RESPIROLOGY, V21, P51, DOI 10.1111/resp.12568; Taniguchi H, 2010, EUR RESPIR J, V35, P821, DOI 10.1183/09031936.00005209; Travis W.D., 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Walsh SLF, 2016, LANCET RESP MED, V4, P557, DOI 10.1016/S2213-2600(16)30033-9; Yagihashi K, 2016, EUR RESPIR J, V47, P1189, DOI 10.1183/13993003.01680-2015	22	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193608	10.1371/journal.pone.0193608	http://dx.doi.org/10.1371/journal.pone.0193608			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590152	Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100025
J	Malhi, SK; Buchanan, L				Malhi, Simritpal Kaur; Buchanan, Lori			A test of the symbol interdependency hypothesis with both concrete and abstract stimuli	PLOS ONE			English	Article							DUAL CODING THEORY; CONTEXT-AVAILABILITY; METAPHOR COMPREHENSION; IMAGEABILITY RATINGS; DEEP DYSPHASIA; MENTAL-IMAGERY; BRAIN SYSTEMS; MOTOR; WORDS; LANGUAGE	In Experiment 1, the symbol interdependency hypothesis was tested with both concrete and abstract stimuli. Symbolic (i.e., semantic neighbourhood distance) and embodied (i.e., iconicity) factors were manipulated in two tasks one that tapped symbolic relations (i.e., semantic relatedness judgment) and another that tapped embodied relations (i.e., iconicity judgment). Results supported the symbol interdependency hypothesis in that the symbolic factor was recruited for the semantic relatedness task and the embodied factor was recruited for the iconicity task. Across tasks, and especially in the iconicity task, abstract stimuli resulted in shorter RTs. This finding was in contrast to the concreteness effect where concrete words result in shorter RTs. Experiment 2 followed up on this finding by replicating the iconicity task from Experiment 1 in an ERP paradigm. Behavioural results continued to show a reverse concreteness effect with shorter RTs for abstract stimuli. However, ERP results paralleled the N400 and anterior N700 concreteness effects found in the literature, with more negative amplitudes for concrete stimuli.	[Malhi, Simritpal Kaur; Buchanan, Lori] Univ Windsor, Dept Psychol, Windsor, ON, Canada	University of Windsor	Buchanan, L (corresponding author), Univ Windsor, Dept Psychol, Windsor, ON, Canada.	buchanan@uwindsor.ca		Malhi, Simritpal/0000-0002-5257-8790	Social Sciences and Humanities Research Council scholarship [767-2016-1440]; Social Sciences and Humanities Research Council Partnership grant [895-2016-1008]	Social Sciences and Humanities Research Council scholarship(Social Sciences and Humanities Research Council of Canada (SSHRC)); Social Sciences and Humanities Research Council Partnership grant	This research was supported by a Social Sciences and Humanities Research Council scholarship (767-2016-1440) awarded to SKM and a Social Sciences and Humanities Research Council Partnership grant (Words in the World 895-2016-1008), http://www.sshrc-crsh.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altarriba J, 1999, BEHAV RES METH INS C, V31, P578, DOI 10.3758/BF03200738; Andrews M, 2014, TOP COGN SCI, V6, P359, DOI 10.1111/tops.12096; [Anonymous], 2021, LANG ENV STAT COMP; Aravena P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011751; Aziz-Zadeh L, 2006, CURR BIOL, V16, P1818, DOI 10.1016/j.cub.2006.07.060; Bak TH, 2001, BRAIN, V124, P103, DOI 10.1093/brain/124.1.103; Barber HA, 2013, BRAIN LANG, V125, P47, DOI 10.1016/j.bandl.2013.01.005; Barsalou L., 2008, SYMBOLS EMBODIMENT D, P245, DOI [DOI 10.1093/ACPROF:OSO/9780199217274.003.0013, 10.1093/acprof:oso/9780199217274.003.0013, DOI 10.1093/ACPROF:OSO/9780199217274.003]; Barsalou L., 1999, BRAIN BEHAV SCI, V22; Bennett SDR, 2011, BEHAV RES METHODS, V43, P1100, DOI 10.3758/s13428-011-0117-5; Binder JR, 2005, J COGNITIVE NEUROSCI, V17, P905, DOI 10.1162/0898929054021102; Binkofski F, 2000, HUM BRAIN MAPP, V11, P273, DOI 10.1002/1097-0193(200012)11:4<273::AID-HBM40>3.0.CO;2-0; Bird H, 2001, BEHAV RES METH INS C, V33, P73, DOI 10.3758/BF03195349; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Boulenger V, 2008, NEUROPSYCHOLOGIA, V46, P743, DOI 10.1016/j.neuropsychologia.2007.10.007; Boulenger V, 2009, CEREB CORTEX, V19, P1905, DOI 10.1093/cercor/bhn217; Buchanan L, 2001, PSYCHON B REV, V8, P531, DOI 10.3758/BF03196189; Burgess C, 1997, LANG COGNITIVE PROC, V12, P177, DOI 10.1080/016909697386844; Burgess C, 1998, BRAIN COGNITION, V40, P67; Chasteen AL, 2010, NEUROPSYCHOLOGIA, V48, P627, DOI 10.1016/j.neuropsychologia.2009.09.029; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; COLLINS AM, 1969, J VERB LEARN VERB BE, V8, P240, DOI 10.1016/S0022-5371(69)80069-1; Coltheart M, 1980, DEEP DYSLEXIA; Danguecan AN, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01034; Dhond RP, 2007, HUM BRAIN MAPP, V28, P355, DOI 10.1002/hbm.20282; Dove G, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00242; Dove G, 2009, COGNITION, V110, P412, DOI 10.1016/j.cognition.2008.11.016; Durda K., 2006, WORDMINE2; Durda K, 2008, BEHAV RES METHODS, V40, P705, DOI 10.3758/BRM.40.3.705; ERNEST CH, 1971, CAN J PSYCHOLOGY, V25, P83, DOI 10.1037/h0082371; Esopenko C, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00084; Estes Z, 2008, PSYCHOL SCI, V19, P93, DOI 10.1111/j.1467-9280.2008.02051.x; Foltz PW, 1998, DISCOURSE PROCESS, V25, P285, DOI 10.1080/01638539809545029; Fowler Harold N., 1921, PLATO 12 VOLUMES, V12; FRANKLIN S, 1995, COGNITIVE NEUROPSYCH, V12, P549, DOI 10.1080/02643299508252007; Gibbs Raymond W., 1994, POETICS MIND FIGURAT; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Glenberg AM, 1999, DISCOURSE PROCESS, V28, P1, DOI 10.1080/01638539909545067; Glenberg AM, 2008, Q J EXP PSYCHOL, V61, P905, DOI 10.1080/17470210701625550; Goodhew SC, 2014, PSYCHON B REV, V21, P1287, DOI 10.3758/s13423-014-0593-6; Griffiths TL, 2007, PSYCHOL REV, V114, P211, DOI 10.1037/0033-295X.114.2.211; Guan CQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075183; Gullick MM, 2013, PSYCHOPHYSIOLOGY, V50, P431, DOI 10.1111/psyp.12033; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hinton G., 1986, EXPLORATIONS MICROST, V1, P77, DOI [10.1146/ANNUREV-PSYCH-120710-100344., DOI 10.1146/ANNUREV-PSYCH-120710-100344]; Holcomb PJ, 1999, J EXP PSYCHOL LEARN, V25, P721, DOI 10.1037/0278-7393.25.3.721; Huang HW, 2015, LANG LINGUIST-TAIWAN, V16, P503, DOI 10.1177/1606822X15583233; Huang HW, 2010, NEUROIMAGE, V49, P1116, DOI 10.1016/j.neuroimage.2009.07.031; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Jarvis B. G., 2012, DIRECTRT COMPUTER SO; Jeannerod M, 1995, CURR OPIN NEUROBIOL, V5, P727, DOI 10.1016/0959-4388(95)80099-9; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Jirak D, 2010, CONSCIOUS COGN, V19, P711, DOI 10.1016/j.concog.2010.06.020; Jones MN, 2007, PSYCHOL REV, V114, P1, DOI 10.1037/0033-295X.114.1.1; KATZ RB, 1990, BRAIN LANG, V39, P153, DOI 10.1016/0093-934X(90)90009-6; Kintsch W, 2000, PSYCHON B REV, V7, P257, DOI 10.3758/BF03212981; KOUNIOS J, 1994, J EXP PSYCHOL LEARN, V20, P804, DOI 10.1037/0278-7393.20.4.804; Kousta ST, 2011, J EXP PSYCHOL GEN, V140, P14, DOI 10.1037/a0021446; KROLL JF, 1986, J EXP PSYCHOL LEARN, V12, P92, DOI 10.1037/0278-7393.12.1.92; Kuperman V, 2012, BEHAV RES METHODS, V44, P978, DOI 10.3758/s13428-012-0210-4; Kuznetsova A, 2013, IMERTEST TESTS RANDO, V2; Lakoff George, 2003, METAPHOR WE LIVE BY; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Laszlo S, 2011, PSYCHOPHYSIOLOGY, V48, P176, DOI 10.1111/j.1469-8986.2010.01058.x; Lee CL, 2008, BRAIN LANG, V104, P145, DOI 10.1016/j.bandl.2007.06.002; Lenth R., 2016, R PACKAGE VERSION, V2; LEVINE SC, 1982, BRAIN LANG, V17, P34, DOI 10.1016/0093-934X(82)90003-7; Louwerse M, 2010, COGNITIVE SCI, V35, P381; Louwerse M.M., 2007, HDB LATENT SEMANTIC, P107; Louwerse M, 2006, INT J ARTIF INTELL T, V15, P1021, DOI 10.1142/S0218213006003090; Louwerse M, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00385; Louwerse MM, 2011, TOP COGN SCI, V3, P273, DOI 10.1111/j.1756-8765.2010.01106.x; Louwerse MM, 2010, COGNITION, V114, P96, DOI 10.1016/j.cognition.2009.09.002; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Lugli L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064500; Lund K, 1996, BEHAV RES METH INSTR, V28, P203, DOI 10.3758/BF03204766; Markman AB, 2000, TRENDS COGN SCI, V4, P470, DOI 10.1016/S1364-6613(00)01559-X; MARTIN N, 1992, BRAIN LANG, V43, P240, DOI 10.1016/0093-934X(92)90130-7; McRae K, 2004, PSYCHOL LEARN MOTIV, V45, P41, DOI 10.1016/S0079-7421(03)45002-0; Meier BP, 2004, PSYCHOL SCI, V15, P243, DOI 10.1111/j.0956-7976.2004.00659.x; Meteyard L, 2012, CORTEX, V48, P788, DOI 10.1016/j.cortex.2010.11.002; Nittono H, 2002, INT J PSYCHOPHYSIOL, V44, P219, DOI 10.1016/S0167-8760(02)00002-8; PAIVIO A, 1991, CAN J PSYCHOL, V45, P255, DOI 10.1037/h0084295; Paivio A, 1971, IMAGERY VERBAL PROCE; Paivio A, 2013, J EXP PSYCHOL GEN, V142, P282, DOI 10.1037/a0027004; Pexman PM, 2007, J COGNITIVE NEUROSCI, V19, P1407, DOI 10.1162/jocn.2007.19.8.1407; Santana E, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00090; Schubert TW, 2005, J PERS SOC PSYCHOL, V89, P1, DOI 10.1037/0022-3514.89.1.1; SCHWANENFLUGEL PJ, 1989, READ RES QUART, V24, P114, DOI 10.2307/748013; SCHWANENFLUGEL PJ, 1983, J EXP PSYCHOL LEARN, V9, P82, DOI 10.1037/0278-7393.9.1.82; SCHWANENFLUGEL PJ, 1988, J MEM LANG, V27, P499, DOI 10.1016/0749-596X(88)90022-8; Segalowitz S.J., 1999, ERPSCORE PROGRAM PEA; Setic M, 2007, LANG COGNITIVE PROC, V22, P297, DOI 10.1080/01690960600732430; Shaoul C, 2010, BEHAV RES METHODS, V42, P393, DOI 10.3758/BRM.42.2.393; Shen ZY, 2015, LANG LINGUIST-TAIWAN, V16, P615, DOI 10.1177/1606822X15583241; Shibahara N, 2002, PERCEPT MOTOR SKILL, V94, P1292; Siakaluk PD, 2008, COGNITION, V106, P433, DOI 10.1016/j.cognition.2006.12.011; Siakaluk PD, 2003, MEM COGNITION, V31, P100, DOI 10.3758/BF03196086; Simmons WK, 2008, J PHYSIOL-PARIS, V102, P106, DOI 10.1016/j.jphysparis.2008.03.014; Stadthagen-Gonzalez H, 2006, BEHAV RES METHODS, V38, P598, DOI 10.3758/BF03193891; Sysoeva OV, 2007, INT J PSYCHOPHYSIOL, V65, P272, DOI 10.1016/j.ijpsycho.2007.05.003; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Tremblay A, 2015, LMERCONVENIENCEFUNCT, V2; van Schie HT, 2005, COGN NEUROPSYCHOL, V22, P364, DOI 10.1080/02643290442000338; Vigliocco G, 2009, LANG COGN, V1, P219, DOI 10.1515/LANGCOG.2009.011; Wang J, 2010, HUM BRAIN MAPP, V31, P1459, DOI 10.1002/hbm.20950; Warriner AB, 2013, BEHAV RES METHODS, V45, P1191, DOI 10.3758/s13428-012-0314-x; Weiskopf DA, 2010, STUD HIST PHILOS SCI, V41, P294, DOI 10.1016/j.shpsa.2010.07.005; Welcome SE, 2011, EXP BRAIN RES, V212, P347, DOI 10.1007/s00221-011-2734-8; West WC, 2000, J COGNITIVE NEUROSCI, V12, P1024, DOI 10.1162/08989290051137558; Wiemer-Hastings K, 2005, COGNITIVE SCI, V29, P719, DOI 10.1207/s15516709cog0000_33; Wilson NL, 2007, COGNITIVE SCI, V31, P721, DOI 10.1080/15326900701399962; Zhang Y, 2015, J COGN PSYCHOL, V27, P218, DOI 10.1080/20445911.2014.995667; Zwaan RA, 2006, J EXP PSYCHOL GEN, V135, P1, DOI 10.1037/0096-3445.135.1.1; Zwaan RA, 2003, PSYCHON B REV, V10, P954, DOI 10.3758/BF03196557	116	7	7	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0192719	10.1371/journal.pone.0192719	http://dx.doi.org/10.1371/journal.pone.0192719			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590121	Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100009
J	Sanchez-Montoya, MM; von Schiller, D; Barbera, GG; Diaz, AM; Arce, MI; del Campo, R; Tockner, K				Mar Sanchez-Montoya, Maria; von Schiller, Daniel; Barbera, Gonzalo G.; Diaz, Angela M.; Arce, Maria Isabel; del Campo, Ruben; Tockner, Klement			Understanding the effects of predictability, duration, and spatial pattern of drying on benthic invertebrate assemblages in two contrasting intermittent streams	PLOS ONE			English	Article							MACROINVERTEBRATE ASSEMBLAGES; COMMUNITY STRUCTURE; TEMPORARY STREAMS; BIOLOGICAL TRAITS; RIVER; DROUGHT; RESPONSES; HABITAT; RESILIENCE; RESISTANCE	In the present study, we examined the effects of different drying conditions on the composition, structure and function of benthic invertebrate assemblages. We approached this objective by comparing invertebrate assemblages in perennial and intermittent sites along two intermittent Mediterranean streams with contrasting predictability, duration, and spatial patterns of drying: Fuirosos (high predictability, short duration, downstream drying pattern) and Rogativa (low predictability, long duration, patchy drying pattern). Specifically, we quantified the contribution of individual taxa to those differences, the degree of nestedness, and shifts in the composition, structure and function of benthic invertebrate assemblages along flow intermittence gradients. We observed greater effects of drying on the benthic invertebrate composition in Fuirosos than in Rogativa, resulting in a higher dissimilarity of assemblages between perennial and intermittent sites, as well as a lower degree of nestedness. Furthermore, a higher number of biotic metrics related to richness, abundance and biological traits were significantly different between perennial and intermittent sites in Fuirosos, despite a shorter dry period compared to Rogativa. At the same time, slightly different responses were detected during post-drying (autumn) than pre-drying (spring) conditions in this stream. In Rogativa, shifts in benthic invertebrate assemblages along increasing gradients of flow intermittence were found for three metrics (Ephemeroptera, Plecoptera and Trichoptera (EPT) and Odonata, Coleoptera and Heteroptera (OCH) abundances and aerial active dispersal. Furthermore, we demonstrated that combined gradients of dry period duration and distance to nearest perennial reach can generate complex, and different, responses of benthic invertebrate assemblages, depending on the flow intermittence metric. Our study advances the notion that special attention should be paid to the predictability, duration and spatial patterns of drying in intermittent streams in order to disentangle the effects of drying on benthic invertebrate assemblages, in particular in areas subject to high spatial heterogeneity and temporal variability in drying conditions.	[Mar Sanchez-Montoya, Maria; Diaz, Angela M.; Arce, Maria Isabel; Tockner, Klement] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Berlin, Germany; [Mar Sanchez-Montoya, Maria; del Campo, Ruben] Univ Murcia, Dept Ecol & Hydrol, Reg Campus Int Excellence Campus Mare Nostrum, Campus Espinardo, Murcia, Spain; [von Schiller, Daniel] Univ Basque Country UPV EHU, Dept Plant Biol & Ecol, Fac Sci & Technol, Bilbao, Spain; [Barbera, Gonzalo G.] CEBAS, CSIC, Dept Soil & Water Conservat, Campus Univ Espinardo, Murcia, Spain; [Tockner, Klement] Free Univ Berlin, Inst Biol, Berlin, Germany; [Tockner, Klement] Austrian Sci Fund, Vienna, Austria	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Murcia; University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS); University of Murcia; Free University of Berlin	Sanchez-Montoya, MM (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries I, Berlin, Germany.; Sanchez-Montoya, MM (corresponding author), Univ Murcia, Dept Ecol & Hydrol, Reg Campus Int Excellence Campus Mare Nostrum, Campus Espinardo, Murcia, Spain.	marsanch@um.es	von Schiller, Daniel/C-1384-2009; del Campo, Rubén/Q-4365-2019; Sanchez-Montoya, Maria Mar/K-4387-2016; arce, maria isabel/L-2678-2014; Gonzalez Barbera, Gonzalo/D-8386-2011	von Schiller, Daniel/0000-0002-9493-3244; del Campo, Rubén/0000-0002-0560-831X; Sanchez-Montoya, Maria Mar/0000-0001-8179-7805; arce, maria isabel/0000-0001-7407-3884; Gonzalez Barbera, Gonzalo/0000-0003-2166-0633	CLITEMP Project [330466]; Marie-Curie postdoctoral fellowship; University of Murcia [FPU R-269/2014]; Alexander von Humboldt foundation [1162886]; Open Access Fund of the Leibniz Association	CLITEMP Project; Marie-Curie postdoctoral fellowship(European Commission); University of Murcia; Alexander von Humboldt foundation(Alexander von Humboldt Foundation); Open Access Fund of the Leibniz Association	This study was funded by the CLITEMP Project (330466 to M.M. Sanchez-Montoya; MC-IEF; FP7-people-2012-IEF). M. M. Sanchez-Montoya was financially supported by a Marie-Curie postdoctoral fellowship, R. del Campo by a PhD contract (FPU R-269/2014) from the University of Murcia, and M.I. Arce by a postdoc fellowship from the Alexander von Humboldt foundation (1162886). The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna V, 2005, J N AM BENTHOL SOC, V24, P919, DOI 10.1899/04-078.1; ADAMS A, 1983, ANTENNA, V8, P58; Amalfitano S, 2008, MICROB ECOL, V55, P270, DOI 10.1007/s00248-007-9274-6; Armitage P., 1995, THE CHIRONOMIDAE, VXII, P572, DOI 10.1007/978-94-011-0715-0; Arscott DB, 2010, J N AM BENTHOL SOC, V29, P530, DOI 10.1899/08-124.1; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Barthes A, 2015, RIVER RES APPL, V31, P993, DOI 10.1002/rra.2793; Bergaya F, 2017, DEV CLAY SCI, V8, P1, DOI 10.1016/B978-0-08-100355-8.00001-1; Bernal S, 2013, HYDROBIOLOGIA, V719, P31, DOI 10.1007/s10750-012-1246-2; Bilton DT, 2001, ANNU REV ECOL SYST, V32, P159, DOI 10.1146/annurev.ecolsys.32.081501.114016; Boersma KS, 2014, FRESHWATER BIOL, V59, P491, DOI 10.1111/fwb.12280; Bogan MT, 2015, FRESHWATER BIOL, V60, P2547, DOI 10.1111/fwb.12522; Bogan MT, 2013, FRESHWATER BIOL, V58, P1016, DOI 10.1111/fwb.12105; Bogan MT, 2001, FRESH WATER BIOL, V56, P2070; Boix-Fayos C, 2007, GEOMORPHOLOGY, V91, P103, DOI 10.1016/j.geomorph.2007.02.003; Bonada N, 2011, LIMNETICA, V30, P129; Bonada N, 2007, HYDROBIOLOGIA, V589, P91, DOI 10.1007/s10750-007-0723-5; Bonada N, 2007, GLOBAL CHANGE BIOL, V13, P1658, DOI 10.1111/j.1365-2486.2007.01375.x; Bonada N, 2013, HYDROBIOLOGIA, V719, P1, DOI 10.1007/s10750-013-1634-2; BOULTON AJ, 1992, FRESHWATER BIOL, V27, P123, DOI 10.1111/j.1365-2427.1992.tb00528.x; Bunn SE, 2006, RIVER RES APPL, V22, P179, DOI 10.1002/rra.904; Canedo-Arguelles M, 2015, J BIOGEOGR, V42, P778, DOI 10.1111/jbi.12457; Canedo-Arguelles M, 2016, ECOL INDIC, V71, P155, DOI 10.1016/j.ecolind.2016.07.002; Crosskey RW, 2004, REVISED TAXONOMIC GE, V8, P78; Datry T, 2014, ECOGRAPHY, V37, P94, DOI 10.1111/j.1600-0587.2013.00287.x; Datry T, 2016, OIKOS, V125, P149, DOI 10.1111/oik.02922; Datry T, 2014, BIOSCIENCE, V64, P229, DOI 10.1093/biosci/bit027; Datry T, 2012, FRESHWATER BIOL, V57, P563, DOI 10.1111/j.1365-2427.2011.02725.x; Datry T, 2011, AQUAT SCI, V73, P453, DOI 10.1007/s00027-011-0236-1; Davey AJH, 2007, FRESHWATER BIOL, V52, P1719, DOI 10.1111/j.1365-2427.2007.01800.x; Doll P, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014037; Finn MA, 2009, FUND APPL LIMNOL, V175, P231, DOI 10.1127/1863-9135/2009/0175-0231; Franklin P, 2008, SCI TOTAL ENVIRON, V400, P369, DOI 10.1016/j.scitotenv.2008.06.018; Fritz KM, 2005, MAR FRESHWATER RES, V56, P13, DOI 10.1071/MF04244; Gallart F, 2012, HYDROL EARTH SYST SC, V16, P3165, DOI 10.5194/hess-16-3165-2012; Garcia-Roger EM, 2011, AQUAT SCI, V73, P567, DOI 10.1007/s00027-011-0218-3; Gasith A, 1999, ANNU REV ECOL SYST, V30, P51, DOI 10.1146/annurev.ecolsys.30.1.51; Gleick PH, 2010, P NATL ACAD SCI USA, V107, P11155, DOI 10.1073/pnas.1004812107; Gorley C.K., 2006, GETTING STARTED PRIM; Gungle B, 2006, TIMING DURATION FLOW; Lake PS, 2003, FRESHWATER BIOL, V48, P1161, DOI 10.1046/j.1365-2427.2003.01086.x; Larned ST, 2010, FRESHWATER BIOL, V55, P717, DOI 10.1111/j.1365-2427.2009.02322.x; Leigh C, 2016, ECOGRAPHY, V39, P1; Leigh C, 2016, AQUAT SCI, V78, P291, DOI 10.1007/s00027-015-0427-2; Lopez-Rodriguez MJ, 2008, HYDROBIOLOGIA, V610, P277, DOI 10.1007/s10750-008-9444-7; Lytle DA, 2004, TRENDS ECOL EVOL, V19, P94, DOI 10.1016/j.tree.2003.10.002; Matthews WJ, 2003, FRESHWATER BIOL, V48, P1232, DOI 10.1046/j.1365-2427.2003.01087.x; Diaz AM, 2008, FRESHWATER BIOL, V53, P1, DOI 10.1111/j.1365-2427.2007.01854.x; Morais M, 2004, HYDROBIOLOGIA, V516, P229, DOI 10.1023/B:HYDR.0000025268.66163.32; Navarro-Martinez Daniel, 2007, Illiesia, V3, P65; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Picazo F, 2012, FRESHWATER BIOL, V57, P2192, DOI 10.1111/j.1365-2427.2012.02859.x; Raymond PA, 2013, NATURE, V503, P355, DOI 10.1038/nature12760; Rosset E, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1809; Sabater S, 2016, FRONT ENV SCI-SWITZ, V4, DOI 10.3389/fenvs.2016.00014; Sanchez-Montoya MM, 2010, ECOL INDIC, V10, P896, DOI 10.1016/j.ecolind.2010.01.008; Sanchez-Montoya MM, 2009, HYDROBIOLOGIA, V619, P39, DOI 10.1007/s10750-008-9580-0; Sanchez-Montoya MD, 2007, FRESHWATER BIOL, V52, P2240, DOI 10.1111/j.1365-2427.2007.01826.x; Sanchez-Montoya MM, 2016, ECOHYDROLOGY; SAS Institute, 2013, SAS STAT 13 1 US GUI; Stanley EH, 2004, AQUAT SCI, V66, P130, DOI 10.1007/s00027-003-0646-9; Steinman Alan D., 2007, P357, DOI 10.1016/B978-012332908-0.50024-3; Steward AL, 2011, AQUAT SCI, V73, P551, DOI 10.1007/s00027-011-0217-4; Strachan SR., 2015, SPRINGER SCI REV, V3, P57, DOI [10.1007/s40362-015-0031-9, DOI 10.1007/S40362-015-0031-9]; Stubbington R, 2017, INTERMITTENT RIVERS AND EPHEMERAL STREAMS: ECOLOGY AND MANAGEMENT, P217, DOI 10.1016/B978-0-12-803835-2.00007-3; Stubbington R, 2015, FRESHW SCI, V34, P344, DOI 10.1086/679467; Suarez ML, 2016, AQUAT SCI; Suemoto T, 2004, HYDROBIOLOGIA, V515, P107, DOI 10.1023/B:HYDR.0000027322.11005.20; Team Core Writing, 2014, CLIMATE CHANGE SYNTH; Timoner X, 2014, AQUAT SCI, V76, P565, DOI 10.1007/s00027-014-0355-6; Tockner K, 2009, RIVERS OF EUROPE, 1ST EDITION, P1, DOI 10.1016/B978-0-12-369449-2.00001-1; Tornes E, 2010, MAR FRESHWATER RES, V61, P441, DOI 10.1071/MF09095; Usseglio-Polatera, 2010, INVERTEBRES EAU DOUC, V15; Vardakas L, 2015, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2015026; Vazquez E., 2013, BODENKULTUR, V64, P13; Velasco J, 1998, SOUTHWEST NAT, V43, P80; Vorste RV, 2016, FRESHW SCI, V35, P164, DOI 10.1086/683274; Westwood CG, 2006, RIVER RES APPL, V22, P703, DOI 10.1002/rra.934	78	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193933	10.1371/journal.pone.0193933	http://dx.doi.org/10.1371/journal.pone.0193933			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590140	Green Published, gold			2022-12-26	WOS:000428603100038
J	Green, DB; Shackleton, TM; Grimsley, JMS; Zobay, O; Palmer, AR; Wallace, MN				Green, David B.; Shackleton, Trevor M.; Grimsley, Jasmine M. S.; Zobay, Oliver; Palmer, Alan R.; Wallace, Mark N.			Communication calls produced by electrical stimulation of four structures in the guinea pig brain	PLOS ONE			English	Article							PERIAQUEDUCTAL GRAY; ULTRASONIC VOCALIZATIONS; CHOLINERGIC STIMULATION; STRIA TERMINALIS; BED NUCLEUS; EXPRESSION; FOREBRAIN; INJECTION; RESPONSES; AMYGDALA	One of the main central processes affecting the cortical representation of conspecific vocalizations is the collateral output from the extended motor system for call generation. Before starting to study this interaction we sought to compare the characteristics of calls produced by stimulating four different parts of the brain in guinea pigs (Cavia porcellus). By using anaesthetised animals we were able to reposition electrodes without distressing the animals. Trains of 100 electrical pulses were used to stimulate the midbrain periaqueductal grey (PAG), hypothalamus, amygdala, and anterior cingulate cortex (ACC). Each structure produced a similar range of calls, but in significantly different proportions. Two of the spontaneous calls (chirrup and purr) were never produced by electrical stimulation and although we identified versions of chutter, durr and tooth chatter, they differed significantly from our natural call templates. However, we were routinely able to elicit seven other identifiable calls. All seven calls were produced both during the 1.6 s period of stimulation and subsequently in a period which could last for more than a minute. A single stimulation site could produce four or five different calls, but the amygdala was much less likely to produce a scream, whistle or rising whistle than any of the other structures. These three high-frequency calls were more likely to be produced by females than males. There were also differences in the timing of the call production with the amygdala primarily producing calls during the electrical stimulation and the hypothalamus mainly producing calls after the electrical stimulation. For all four structures a significantly higher stimulation current was required in males than females. We conclude that all four structures can be stimulated to produce fictive vocalizations that should be useful in studying the relationship between the vocal motor system and cortical sensory representation.	[Green, David B.; Shackleton, Trevor M.; Zobay, Oliver; Palmer, Alan R.; Wallace, Mark N.] Univ Nottingham, Sch Med, Med Res Council, Inst Hearing Res, Nottingham, England; [Grimsley, Jasmine M. S.] Northeast Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH USA	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Nottingham; Northeast Ohio Medical University (NEOMED)	Wallace, MN (corresponding author), Univ Nottingham, Sch Med, Med Res Council, Inst Hearing Res, Nottingham, England.	Mark.Wallace@nottingham.ac.uk	Wallace, Mark/ABC-1573-2020	Wallace, Mark/0000-0001-6894-4903; Grimsley, Jasmine/0000-0002-7993-9699; Zobay, Oliver/0000-0002-0229-0668	Medical Research Council [MC_U135097126]; MRC [MC_UU_00010/5, MC_U135097126] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was wholly funded by the Medical Research Council (GB) as part of a core intramural grant to ARP (MC_U135097126). The MRC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arch-Tirado E, 2000, J SPEECH LANG HEAR R, V43, P432, DOI 10.1044/jslhr.4302.432; ARVOLA A, 1974, Annales Zoologici Fennici, V11, P1; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BERRYMAN JC, 1976, Z TIERPSYCHOL, V41, P80; Borszcz GS, 2006, PAIN, V123, P155, DOI 10.1016/j.pain.2006.02.026; Boyce S, 2001, NEUROPHARMACOLOGY, V41, P130, DOI 10.1016/S0028-3908(01)00051-X; BRUDZYNSKI SM, 1990, NEUROSCI LETT, V109, P222, DOI 10.1016/0304-3940(90)90567-S; Burgdorf J, 2007, BEHAV BRAIN RES, V182, P274, DOI 10.1016/j.bbr.2007.03.010; Burnstein DD, 1967, PSYCHON SCI, V8, P39; Coulon J, 1973, REV COMPORT ANIM, V7, P123; Dujardin E, 2006, BEHAV BRAIN RES, V168, P23, DOI 10.1016/j.bbr.2005.10.006; Eisenberg J. F., 1974, Symposia of the Zoological Society of London, P211; Eliades SJ, 2008, NATURE, V453, P1102, DOI 10.1038/nature06910; EPPLE G, 1968, FOLIA PRIMATOL, V8, P1, DOI 10.1159/000155129; FEDIGAN L M, 1984, Primates, V25, P279, DOI 10.1007/BF02382267; Fischer J, 2016, NEUROSCI BIOBEHAV RE; Gibbs EL, 1936, J COMP NEUROL, V64, P209, DOI 10.1002/cne.900640203; Grimsley JMS, 2011, HEARING RES, V277, P134, DOI 10.1016/j.heares.2011.01.018; Grimsley JMS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051646; Grimsley JMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017460; Groenink L, 2015, EUR J PHARMACOL, V753, P191, DOI 10.1016/j.ejphar.2014.10.062; Hennessy MB, 2005, DEV PSYCHOBIOL, V46, P86, DOI 10.1002/dev.20045; HERMAN BH, 1981, SCIENCE, V211, P1060, DOI 10.1126/science.7466377; HINES M, 1985, J NEUROSCI, V5, P40; HINES M, 1992, BRAIN RES, V579, P321, DOI 10.1016/0006-8993(92)90068-K; Jurgens U, 2009, J VOICE, V23, P1, DOI 10.1016/j.jvoice.2007.07.005; Jurgens U, 1998, NATURWISSENSCHAFTEN, V85, P376, DOI 10.1007/s001140050519; JURGENS U, 1986, BRAIN RES, V373, P349, DOI 10.1016/0006-8993(86)90349-5; JURGENS U, 1994, BEHAV BRAIN RES, V62, P107, DOI 10.1016/0166-4328(94)90017-5; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; JURGENS U, 1967, EXP BRAIN RES, V4, P114; KIRZINGER A, 1991, EXP BRAIN RES, V84, P545; KUNKEL P., 1964, Zeitschrift fur Tierpsychologie, V21, P602; Kyuhou S, 1999, NEUROSCI LETT, V260, P113, DOI 10.1016/S0304-3940(98)00956-2; Kyuhou S, 1998, NEUROREPORT, V9, P1607, DOI 10.1097/00001756-199805110-00064; Leite-Panissi CRA, 2003, BRAIN RES BULL, V60, P167, DOI 10.1016/S0361-9230(03)00031-5; Lenell C, 2017, LARYNGOSCOPE, V127, pE270, DOI 10.1002/lary.26561; LU CL, 1993, BRAIN RES BULL, V32, P143, DOI 10.1016/0361-9230(93)90068-M; Ma J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00055; MAGGIO JC, 1985, J COMP PSYCHOL, V99, P420, DOI 10.1037/0735-7036.99.4.420; Manteuffel G, 2007, BEHAV BRAIN RES, V178, P177, DOI 10.1016/j.bbr.2006.12.007; MARTIN JR, 1976, J COMP PHYSIOL PSYCH, V90, P1011, DOI 10.1037/h0078658; Michelsson K, 2002, FOLIA PHONIATR LOGO, V54, P190, DOI 10.1159/000063190; Monticelli PE, 2004, AN ACAD BRAS CIENC, V76, P368, DOI 10.1590/S0001-37652004000200027; Panksepp J., 1988, PHYSL CONTROL MAMMAL, P263, DOI 10.1007/978-1-4613-1051-8_15; PHILLIPS RE, 1972, ANIM BEHAV, V20, P689, DOI 10.1016/S0003-3472(72)80141-6; Rapisarda C, 1977, Arch Sci Biol (Bologna), V61, P1; ROBINSON BW, 1967, PHYSIOL BEHAV, V2, P345, DOI 10.1016/0031-9384(67)90050-9; Rood J.P., 1972, Animal Behav Monogr, V5, P1; Scheiner E, 2004, FOLIA PHONIATR LOGO, V56, P27, DOI 10.1159/000075326; Scheiner E, 2002, J VOICE, V16, P509, DOI 10.1016/S0892-1997(02)00127-3; Scheiner E, 2006, J VOICE, V20, P585, DOI 10.1016/j.jvoice.2005.09.001; SMITH WK, 1945, J NEUROPHYSIOL, V8, P241, DOI 10.1152/jn.1945.8.4.241; Sugiyama Y, 2014, NEUROSCI RES, V80, P17, DOI 10.1016/j.neures.2013.12.004; Sugiyama Y, 2010, NEUROSCI RES, V66, P359, DOI 10.1016/j.neures.2009.12.006; Syka J, 2005, HEARING RES, V206, P177, DOI 10.1016/j.heares.2005.01.013; Tehovnik EJ, 1996, J NEUROSCI METH, V65, P1, DOI 10.1016/0165-0270(95)00131-X; Tomaszycki ML, 2001, HORM BEHAV, V39, P267, DOI 10.1006/hbeh.2001.1659; Van Daele DJ, 2009, NEUROSCIENCE, V162, P501, DOI 10.1016/j.neuroscience.2009.05.005; Varty GB, 2005, PSYCHOPHARMACOLOGY, V182, P132, DOI 10.1007/s00213-005-0041-4; Wang HR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001893; Zugaib J, 2017, BRAIN RES, V1671, P131, DOI 10.1016/j.brainres.2017.07.013; Zugaib J, 2014, PHYSIOL BEHAV, V126, P8, DOI 10.1016/j.physbeh.2013.12.004	63	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194091	10.1371/journal.pone.0194091	http://dx.doi.org/10.1371/journal.pone.0194091			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5KQ	29584746	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000428373000014
J	Hausmann, J; Deiner, C; Patra, AK; Immig, I; Starke, A; Aschenbach, JR				Hausmann, Janis; Deiner, Carolin; Patra, Amlan K.; Immig, Irmgard; Starke, Alexander; Aschenbach, Joerg R.			Effects of a combination of plant bioactive lipid compounds and biotin compared with monensin on body condition, energy metabolism and milk performance in transition dairy cows	PLOS ONE			English	Article							NONESTERIFIED FATTY-ACIDS; EARLY-LACTATION; ESSENTIAL OILS; RUMINAL FERMENTATION; SUBCLINICAL KETOSIS; DIETARY BIOTIN; HOLSTEIN COWS; REPRODUCTIVE-PERFORMANCE; BETA-HYDROXYBUTYRATE; PROPYLENE-GLYCOL	The aim of this study was to test whether a combination of plant bioactive lipid compounds (also termed 'essential oils') and biotin (PBLC+B) could decrease the mobilization of body reserves and ketosis incidence in postpartum dairy cows. We compared non-supplemented control (CON) cows with cows receiving monensin (MON) as a controlled-release capsule at d -21, and with cows receiving PBLC+B from day (d) -21 before calving until calving (Phase 1) and further until d 37 after calving (Phase 2), followed by PBLC+B discontinuation from d 38 to d 58 (Phase 3). The PBLC+B cows had higher body weight and higher back fat thickness than CON cows and lesser body weight change than MON and CON cows in Phase 3. Body condition score was not different among groups. Milk protein concentration tended to be higher on the first herd test day in PBLC+B vs. CON cows. Milk fat concentration tended to be highest in PBLC+B cows throughout Phases 2 and 3, with significantly higher values in PBLC+B vs. MON cows on the second herd test day. Yields of energy-corrected milk were higher in PBLC+B vs. CON and MON cows in Phase 2 and higher in PBLC+B and MON cows vs. CON cows in Phase 3. The incidence of subclinical ketosis was 83%, 61% and 50% in CON, PBLC+B and MON cows, respectively, with lower mean beta-hydroxybutyrate values in MON than in PBLC+B cows in Phase 1 prepartum. The serum triglyceride concentration was higher in PBLC+B vs. CON cows on d 37. No differences were observed in serum glucose, urea, non-esterified fatty acids, cholesterol and bilirubin concentrations. Aspartate transaminase and y-glutamyltranspeptidase but not glutamate dehydrogenase activities tended to be highest in MON and lowest in PBLC+B in Phase 2. We conclude that PBLC+B prevent body weight loss after parturition and are associated with similar ketosis incidence and partly higher yields of energy-corrected milk compared to MON supplementation of dairy cows.	[Hausmann, Janis; Deiner, Carolin; Patra, Amlan K.; Aschenbach, Joerg R.] Free Univ Berlin, Inst Vet Physiol, Berlin, Oertzenweg, Germany; [Patra, Amlan K.] West Bengal Univ Anim & Fishery Sci, Dept Anim Nutr, Kolkata, India; [Immig, Irmgard] DSM Nutr Prod Ltd, Kaiseraugst, Wurmisweg, Switzerland; [Starke, Alexander] Univ Leipzig, Clin Ruminants & Swine, Leipzig, Germany	Free University of Berlin; West Bengal University of Animal & Fishery Sciences; DSM NV; Leipzig University	Aschenbach, JR (corresponding author), Free Univ Berlin, Inst Vet Physiol, Berlin, Oertzenweg, Germany.	joerg.achenbach@fu-berin.de	Aschenbach, Joerg R/R-7572-2016; Patra, Amlan K./U-7781-2019	Aschenbach, Joerg R/0000-0001-5080-1007; Patra, Amlan/0000-0003-1410-0902	DSM Nutritional Products Ltd.	DSM Nutritional Products Ltd.	This study was supported by DSM Nutritional Products Ltd. Coauthor II is an employee of DSM Nutritional Products Ltd and contributed to the study design and preparation of the manuscript. Data collection, data analysis and the decision to publish were independent of the sponsor.	Aschenbach JR, 2010, IUBMB LIFE, V62, P869, DOI 10.1002/iub.400; Benchaar C, 2006, J DAIRY SCI, V89, P4352, DOI 10.3168/jds.S0022-0302(06)72482-1; Bradford BJ, 2005, J NUTR, V135, P2206, DOI 10.1093/jn/135.9.2206; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Chen B, 2011, J DAIRY SCI, V94, P3537, DOI 10.3168/jds.2010-3764; Chen B, 2012, LIVEST SCI, V148, P168, DOI 10.1016/j.livsci.2012.06.002; Chibisa GE, 2008, J DAIRY SCI, V91, P3512, DOI 10.3168/jds.2007-0920; Compton CWR, 2015, NEW ZEAL VET J, V63, P249, DOI 10.1080/00480169.2014.999842; DeFrain JM, 2004, J DAIRY SCI, V87, P4195, DOI 10.3168/jds.S0022-0302(04)73564-X; Drackley JK, 2014, ANIMAL, V8, P5, DOI 10.1017/S1751731114000731; Drackley JK, 2001, J DAIRY SCI, V84, P1231, DOI 10.3168/jds.S0022-0302(01)74584-5; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; Drong C, 2017, J ANIM PHYSIOL AN N, V101, P791, DOI 10.1111/jpn.12494; Drong C, 2016, J ANIM PHYSIOL AN N, V100, P537, DOI 10.1111/jpn.12401; Duffield T, 2002, J DAIRY SCI, V85, P397, DOI 10.3168/jds.S0022-0302(02)74087-3; Duffield TF, 2008, J DAIRY SCI, V91, P2328, DOI 10.3168/jds.2007-0801; Duffield TF, 2008, J DAIRY SCI, V91, P1347, DOI 10.3168/jds.2007-0608; Duffield TF, 2008, J DAIRY SCI, V91, P1334, DOI 10.3168/jds.2007-0607; Duffield TF, 2003, J DAIRY SCI, V86, P1171, DOI 10.3168/jds.S0022-0302(03)73700-X; Duffield TF, 1998, J DAIRY SCI, V81, P2866, DOI 10.3168/jds.S0022-0302(98)75846-1; EDMONSON AJ, 1989, J DAIRY SCI, V72, P68, DOI 10.3168/jds.S0022-0302(89)79081-0; Emmerich IU, 2013, TIERAERZTL PRAX G N, V41, P247; Ferreira G, 2015, J DAIRY SCI, V98, P6449, DOI 10.3168/jds.2015-9620; FOSTER LA, 1988, VET CLIN N AM-FOOD A, V4, P253, DOI 10.1016/S0749-0720(15)31047-1; FOX FH, 1971, J DAIRY SCI, V54, P974, DOI 10.3168/jds.S0022-0302(71)85953-2; GfE (Gesellschaft fur Ernahrungsphysiologie), 2001, EMPF EN NAHRST MILCH; Gohary K, 2016, CAN VET J, V57, P733; Grummer RR, 2007, THERIOGENOLOGY, V68, pS281, DOI 10.1016/j.theriogenology.2007.04.031; Grummer RR, 2008, VET J, V176, P10, DOI 10.1016/j.tvjl.2007.12.033; GRUMMER RR, 1993, J DAIRY SCI, V76, P3882, DOI 10.3168/jds.S0022-0302(93)77729-2; Guo J, 2008, J DAIRY SCI, V91, P4293, DOI 10.3168/jds.2007-0962; Hammer KA, 1999, J APPL MICROBIOL, V86, P985, DOI 10.1046/j.1365-2672.1999.00780.x; Hausmann J, 2017, ANIM FEED SCI TECH, V225, P27, DOI 10.1016/j.anifeedsci.2017.01.009; Hayirli A, 2002, J DAIRY SCI, V85, P3430, DOI 10.3168/jds.S0022-0302(02)74431-7; Herdt TH, 2000, VET CLIN N AM-FOOD A, V16, P215, DOI 10.1016/S0749-0720(15)30102-X; Hinde K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086169; Jain Sushil K, 2006, Pathophysiology, V13, P163, DOI 10.1016/j.pathophys.2006.05.005; Khiaosa-ard R, 2013, J ANIM SCI, V91, P1819, DOI 10.2527/jas.2012-5691; Kung L, 2008, J DAIRY SCI, V91, P4793, DOI 10.3168/jds.2008-1402; Larsen M, 2012, J DAIRY SCI, V95, P5946, DOI 10.3168/jds.2012-5458; Lean IJ, 2011, J DAIRY SCI, V94, P1465, DOI 10.3168/jds.2010-3682; Leroy JLMR, 2008, REPROD DOMEST ANIM, V43, P96, DOI 10.1111/j.1439-0531.2008.01148.x; Lischer CJ, 2002, VET J, V163, P51, DOI 10.1053/tvjl.2001.0627; McArt JAA, 2015, J DAIRY SCI, V98, P2043, DOI 10.3168/jds.2014-8740; McArt JAA, 2012, J DAIRY SCI, V95, P5056, DOI 10.3168/jds.2012-5443; McArt JAA, 2013, VET J, V198, P560, DOI 10.1016/j.tvjl.2013.08.011; McCarthy MM, 2015, J DAIRY SCI, V98, P3351, DOI 10.3168/jds.2014-8821; McIntosh FM, 2003, APPL ENVIRON MICROB, V69, P5011, DOI 10.1128/AEM.69.8.5011-5014.2003; Mirzaei-Alamouti H, 2016, ANIM FEED SCI TECH, V219, P132, DOI 10.1016/j.anifeedsci.2016.06.009; Naumann C, 2004, CHEM UNTERSUCHUNG FU, V3; Offer N. W., 2005, Proceedings of the British Society of Animal Science annual conference 2005, York, UK. 4th-6th April, 2005, P188; Ospina PA, 2010, J DAIRY SCI, V93, P1596, DOI 10.3168/jds.2009-2852; Rehage J., 2014, DTSCH TIERARZTEBL, V2014, P494; Rosendo O, 2004, J DAIRY SCI, V87, P2535, DOI 10.3168/jds.S0022-0302(04)73378-0; Ruoff J, 2017, J DAIRY SCI, V100, P5462, DOI 10.3168/jds.2016-12237; Shi XX, 2015, J STEROID BIOCHEM, V145, P103, DOI 10.1016/j.jsbmb.2014.10.014; Shingfield KJ, 2010, ANIMAL, V4, P1140, DOI 10.1017/S1751731110000510; Stangaferro ML, 2016, J DAIRY SCI, V99, P7395, DOI 10.3168/jds.2016-10907; Staufenbiel R, 1997, PRAKT TIERARZT, V78, P87; Waldrop GL, 2012, PROTEIN SCI, V21, P1597, DOI 10.1002/pro.2156; White HM, 2016, J DAIRY SCI, V99, P812, DOI 10.3168/jds.2015-9953; Wood KM, 2016, J ANIM SCI, V94, P2471, DOI 10.2527/jas.2016-0356; Wright TC, 2006, J DAIRY SCI, V89, P2552, DOI 10.3168/jds.S0022-0302(06)72331-1; Yousefi AR, 2016, THERIOGENOLOGY, V85, P1540, DOI 10.1016/j.theriogenology.2016.01.015; Zebeli Q, 2015, RES VET SCI, V103, P126, DOI 10.1016/j.rvsc.2015.09.020; Zimmerly CA, 2001, J DAIRY SCI, V84, P498, DOI 10.3168/jds.S0022-0302(01)74500-6	66	10	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0193685	10.1371/journal.pone.0193685	http://dx.doi.org/10.1371/journal.pone.0193685			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584764	Green Submitted, Green Published, gold			2022-12-26	WOS:000428373000007
J	Dennis, EM; Hao, Y; Tamambang, M; Roshan, TN; Gatlin, KJ; Bghigh, H; Ogunyemi, OT; Diallol, F; Spooner, KK; Salemi, JL; Olaleyel, OA; Khan, KZ; Aliyu, MH; Salihu, HM				Dennis, Erika M.; Hao, Yun; Tamambang, Mabella; Roshan, Tasha N.; Gatlin, Knubian J.; Bghigh, Hanane; Ogunyemi, Oladimeji T.; Diallol, Fatoumata; Spooner, Kiara K.; Salemi, Jason L.; Olaleyel, Omonike A.; Khan, Kashif Z.; Aliyu, Muktar H.; Salihu, Hamisu M.			Tuberculosis during pregnancy in the United States: Racial/ethnic disparities in pregnancy complications and in-hospital death	PLOS ONE			English	Article							RESILIENCE; TRENDS; TRANSMISSION; MORTALITY; VETERANS; BORN; RISK; USA	Background Despite decades of efforts to eliminate tuberculosis (TB) in the United States (US), TB still contributes to adverse ill health, especially among racial/ethnic minorities. According to the Centers for Disease Control and Prevention, in 2016, about 87% of the TB cases reported in the US were among racial and ethnic minorities. The objective of this study is to explore the risks for pregnancy complications and in-hospital death among mothers diagnosed with TB across racial/ethnic groups in the US. Methods This retrospective cohort study utilized National Inpatient Sample data for all inpatient hospital discharges in the US. We analyzed pregnancy-related hospitalizations and births in the US from January 1, 2002 through December 31, 2014 (n = 57,393,459). Multivariable logistic regression was applied to generate odds ratios for the association between TB status and the primary study outcomes (i.e., pregnancy complications and in-hospital death) across racial/ethnic categories. Results The prevalence of TB was 7.1 per 100,000 pregnancy-related hospitalizations. The overall prevalence of pregnancy complications was 80% greater among TB-infected mothers than their uninfected counterparts. Severe pre-eclampsia, eclampsia, placenta previa, postpartum hemorrhage, sepsis and anemia occurred with greater frequency among mothers with a TB diagnosis than those without TB, irrespective of race/ethnicity. The rate of in-hospital death among TB patients was 37 times greater among TB-infected than in non-TB infected mothers (468.8 per 100,000 versus 12.6 per 100,000). A 3-fold increased risk of in hospital death was observed among black TB-negative mothers compared to their white counterparts. No racial/ethnic disparities in maternal morbidity or in -hospital death were found among mothers with TB disease. Conclusion TB continues to be an important cause of morbidity and mortality among pregnant women in the US. Resources to address TB disease should also target pregnant women, especially racial/ethnic minorities who bear the greatest burden of the disease.	[Dennis, Erika M.; Hao, Yun; Tamambang, Mabella; Roshan, Tasha N.; Gatlin, Knubian J.; Bghigh, Hanane; Ogunyemi, Oladimeji T.; Diallol, Fatoumata; Olaleyel, Omonike A.] Texas Southern Univ, Houston, TX 77004 USA; [Spooner, Kiara K.; Salemi, Jason L.; Khan, Kashif Z.; Salihu, Hamisu M.] Baylor Coll Med, Dept Family & Community Med, Houston, TX 77030 USA; [Aliyu, Muktar H.] Vanderbilt Univ, Med Ctr, Dept Hlth Policy, Nashville, TN USA	Texas Southern University; Baylor College of Medicine; Vanderbilt University	Salihu, HM (corresponding author), Baylor Coll Med, Dept Family & Community Med, Houston, TX 77030 USA.	Hamisu.Salihu@bcm.edu	Salemi, Jason/N-9492-2013	Salemi, Jason/0000-0002-0077-6023; Aliyu, Muktar/0000-0001-9504-4679	U.S. Department of Health and Human Services; Health Resources and Services Administration for the Maternal and Child Health Pipeline Training Program: TSU-BCM Maternal and Child Health Student Training for Academic Readiness and Success (MCH STARS) Undergraduate Fellowship Program [T16MC29831]	U.S. Department of Health and Human Services; Health Resources and Services Administration for the Maternal and Child Health Pipeline Training Program: TSU-BCM Maternal and Child Health Student Training for Academic Readiness and Success (MCH STARS) Undergraduate Fellowship Program	Research funding support was provided by the U.S. Department of Health and Human Services, Health Resources and Services Administration for the Maternal and Child Health Pipeline Training Program: TSU-BCM Maternal and Child Health Student Training for Academic Readiness and Success (MCH STARS) Undergraduate Fellowship Program, Grant No: T16MC29831.	[Anonymous], 2011, GLOB TUB CONTR 2011; [Anonymous], JOINP REGR PROGR VER; Centers for Disease Control and Prevention (CDC), REP TUB US CDC SURV; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Creanga AA, 2017, OBSTET GYNECOL, V130, P366, DOI 10.1097/AOG.0000000000002114; DeLuca A, 2009, JAIDS-J ACQ IMM DEF, V50, P196, DOI 10.1097/QAI.0b013e3181900201; El-Messidi A, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.08.009; Figueroa-Damian R, 2001, ARCH MED RES, V32, P66, DOI 10.1016/S0188-4409(00)00266-6; GOOD JT, 1981, AM J OBSTET GYNECOL, V140, P492, DOI 10.1016/0002-9378(81)90222-2; Health Care Cost and Utilization Project, 2013, INTRODUCTION TO THE; Hill AN, 2012, EPIDEMIOL INFECT, V140, P1862, DOI 10.1017/S095026881100286X; Houchens R., 2014, NATIONWIDE INPATIENT, DOI DOI 10.1161/CIRCOUTCOMES.114.001144; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Nnadi CD, 2016, THORAX, V71, P356, DOI 10.1136/thoraxjnl-2015-207915; Pagaoa MA, 2015, INT J TUBERC LUNG D, V19, P1485, DOI 10.5588/ijtld.14.0965; Salemi JL, 2017, AM J OBSTET GYNECOL; Salinas JL, 2016, MMWR-MORBID MORTAL W, V65, P273, DOI 10.15585/mmwr.mm6511a2; Schilling E. A., 2007, BMC PUBLIC HLTH, V7; Schmit KM, 2017, MMWR-MORBID MORTAL W, V66, P289, DOI 10.15585/mmwr.mm6611a2; Scott C, 2015, MMWR-MORBID MORTAL W, V64, P265; Sobhy S, 2017, BJOG-INT J OBSTET GY, V124, P727, DOI 10.1111/1471-0528.14408; Turner RJ, 2004, ARCH GEN PSYCHIAT, V61, P481, DOI 10.1001/archpsyc.61.5.481; WHO, 2017, GLOB TUB REP; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; Youssef NA, 2013, ARCH SUICIDE RES, V17, P106, DOI 10.1080/13811118.2013.776445; Youssef NA, 2013, ANN CLIN PSYCHIATRY, V25, P59; Zelner JL, 2017, EPIDEMIOL INFECT, V145, P1797, DOI 10.1017/S0950268817000802	27	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194836	10.1371/journal.pone.0194836	http://dx.doi.org/10.1371/journal.pone.0194836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579086	Green Published, Green Submitted, gold			2022-12-26	WOS:000428351800061
J	Martin, M; Wrotniak, BH; Hicar, M				Martin, Meghan; Wrotniak, Brian H.; Hicar, Mark			Suppressed plasmablast responses in febrile infants, including children with Kawasaki disease	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; GENOME-WIDE ASSOCIATION; EARLY-LIFE; B-CELLS; VACCINE RESPONSES; VIRUS-INFECTION; ACUTE-PHASE; GENERATION; IL-21; IGA	Background Kawasaki disease (KD), the leading cause of acquired heart disease in children, primarily affects infants and toddlers. Investigations on immune responses during KD are hampered by a limited understanding of normal immune responses in these ages. It's well known that Infants have poorer vaccine responses and difficulty with maintaining prolonged serum immunity, but there are few studies on human infants detailing immune deficiencies. Limited studies propose an inability to maintain life-long bone marrow plasma cells. Plasmablasts are a transitional cell form of B cells that lead to long-term Plasma cells. Plasmablasts levels rise in the peripheral blood after exposure to a foreign antigen. In adult studies, these responses are both temporally and functionally well characterized. To date, there have been few studies on plasmablasts in the predominant age range of KD. Methods Children presenting to an urban pediatric emergency room undergoing laboratory evaluation, who had concern of KD or had fever and symptoms overlapping those of KD, were recruited. Peripheral blood mononuclear cells were isolated and evaluated utilizing flow cytometry with specific B cell markers from 18 KD subjects and 69 febrile controls. Results Plasmablast numbers and temporal formation are similar between infectious disease controls and KD subjects. In both groups, infants have diminished plasmablast responses compared to older children. Conclusion In this single-time point survey, infants have a blunted peripheral plasmablast response. Overall, similar plasmablast responses in KD and controls support an infectious disease relationship to KD. Future time-course studies of plasmablasts in infants are warranted as this phenomenon may contribute to observed immune responses in this age group.	[Martin, Meghan; Wrotniak, Brian H.; Hicar, Mark] SUNY Buffalo, Sch Med & Biomed Sci, Dept Pediat, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Hicar, M (corresponding author), SUNY Buffalo, Sch Med & Biomed Sci, Dept Pediat, Buffalo, NY 14260 USA.	mhicar@upa.chob.edu			Wildermuth Foundation via the Variety Club of Buffalo	Wildermuth Foundation via the Variety Club of Buffalo	This work was supported from the Wildermuth Foundation via the Variety Club of Buffalo to MH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae YJ, 2012, ALLERGY ASTHMA IMMUN, V4, P351, DOI 10.4168/aair.2012.4.6.351; Balakrishnan T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029430; Belnoue E, 2008, BLOOD, V111, P2755, DOI 10.1182/blood-2007-09-110858; Blanchard-Rohner G, 2009, BLOOD, V114, P4998, DOI 10.1182/blood-2009-03-211052; Burns JC, 2005, EPIDEMIOLOGY, V16, P220, DOI 10.1097/01.ede.0000152901.06689.d4; BUTMAN S, 1977, JAMA-J AM MED ASSOC, V238, P2394, DOI 10.1001/jama.238.22.2394; Chang CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072037; Daniels LB, 2012, CIRCULATION, V125, P2447, DOI 10.1161/CIRCULATIONAHA.111.082107; Di Niro R, 2015, IMMUNITY, V43, P120, DOI 10.1016/j.immuni.2015.06.013; Engelberg R, 2017, PEDIATR RHEUMATOL, V15, DOI 10.1186/s12969-017-0163-3; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Fink K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00078; Gans HA, 1998, JAMA-J AM MED ASSOC, V280, P527, DOI 10.1001/jama.280.6.527; Garcia M, 2017, IMMUNOLOGY, V151, P122, DOI 10.1111/imm.12713; Giordani L, 2011, CLIN EXP IMMUNOL, V163, P346, DOI 10.1111/j.1365-2249.2010.04297.x; Holman RC, 2010, PEDIATR INFECT DIS J, V29, P483, DOI 10.1097/INF.0b013e3181cf8705; Holve TJ, 2014, PEDIATRICS, V133, pE305, DOI 10.1542/peds.2013-1638; Hosomi S, 2011, CLIN EXP IMMUNOL, V163, P215, DOI 10.1111/j.1365-2249.2010.04290.x; Ikeda K, 2010, CLIN EXP IMMUNOL, V160, P246, DOI 10.1111/j.1365-2249.2009.04073.x; Jun Hyun Ok, 2015, Korean J Pediatr, V58, P369, DOI 10.3345/kjp.2015.58.10.369; Kauffman RC, 2016, MBIO, V7, DOI [10.1128/mbio.02021-16, 10.1128/mBio.02021-16]; Kelly DF, 2006, BLOOD, V108, P2642, DOI 10.1182/blood-2006-01-009282; Kelly DF, 2009, IMMUNOLOGY, V127, P134, DOI 10.1111/j.1365-2567.2008.02934.x; Krumbholz M, 2012, NAT REV NEUROL, V8, P613, DOI 10.1038/nrneurol.2012.203; Kuo HC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144603; Kuwabara M, 2015, J EPIDEMIOL, V25, P189, DOI 10.2188/jea.JE20140128; Lee FEH, 2010, J INFECT DIS, V202, P1659, DOI 10.1086/657158; Lee HH, 2009, YONSEI MED J, V50, P493, DOI 10.3349/ymj.2009.50.4.493; Lee YC, 2012, NAT GENET, V44, P522, DOI 10.1038/ng.2227; Liao HY, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01691; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Makino N, 2015, J EPIDEMIOL, V25, P239, DOI 10.2188/jea.JE20140089; Martinez-Hernandez E, 2011, NEUROLOGY, V77, P589, DOI 10.1212/WNL.0b013e318228c136; Mattoo H, 2014, J ALLERGY CLIN IMMUN, V134, P679, DOI 10.1016/j.jaci.2014.03.034; McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484; Mohr E, 2016, CURR OPIN IMMUNOL, V41, P1, DOI 10.1016/j.coi.2016.04.004; Newburger Jane W, 2003, Pediatr Res, V53, P153, DOI 10.1203/00006450-200301000-00026; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Odendahl M, 2005, BLOOD, V105, P1614, DOI 10.1182/blood-2004-07-2507; OHSHIO G, 1987, MICROBIOL IMMUNOL, V31, P891, DOI 10.1111/j.1348-0421.1987.tb03150.x; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Pinna GS, 2008, CURR OPIN INFECT DIS, V21, P263, DOI 10.1097/QCO.0b013e3282fbf9cd; Rivas JR, 2017, ACTA NEUROPATHOL, V133, P43, DOI 10.1007/s00401-016-1627-0; Rodo X, 2011, SCI REP-UK, V1, DOI 10.1038/srep00152; Rowley AH, 1997, J IMMUNOL, V159, P5946; Rowley AH, 2001, J IMMUNOL, V166, P1334, DOI 10.4049/jimmunol.166.2.1334; Saso A, 2017, SEMIN IMMUNOPATHOL, V39, P627, DOI 10.1007/s00281-017-0654-9; Shingadia D, 2001, PEDIATR RES, V50, P538, DOI 10.1203/00006450-200110000-00019; Siegrist CA, 2007, J COMP PATHOL, V137, pS4, DOI 10.1016/j.jcpa.2007.04.004; Siegrist CA, 2009, NAT REV IMMUNOL, V9, P185, DOI 10.1038/nri2508; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Suda K, 2011, CIRCULATION, V123, P1836, DOI 10.1161/CIRCULATIONAHA.110.978213; Takuma K, 2011, CURR OPIN RHEUMATOL, V23, P80, DOI 10.1097/BOR.0b013e3283412f60; Tarlton NJ, 2012, INFLAMM BOWEL DIS, V18, P2381, DOI 10.1002/ibd.22962; Terai M, 2003, CIRCULATION, V108, P325, DOI 10.1161/01.CIR.0000079166.93475.5F; Tremoulet AH, 2011, PEDIATR INFECT DIS J, V30, P1022, DOI 10.1097/INF.0b013e31822d4f56; Tsuda E, 2011, CARDIOL YOUNG, V21, P74, DOI 10.1017/S1047951110001502; van Zelm MC, 2007, CELL CYCLE, V6, P2890, DOI 10.4161/cc.6.23.4952; Wallace ZS, 2015, ANN RHEUM DIS, V74, P190, DOI 10.1136/annrheumdis-2014-205233; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11; Yellen ES, 2010, PEDIATRICS, V125, pE234, DOI 10.1542/peds.2009-0606; Yorifuji T, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3919	63	10	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0193539	10.1371/journal.pone.0193539	http://dx.doi.org/10.1371/journal.pone.0193539			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579044	Green Published, gold, Green Submitted			2022-12-26	WOS:000428351800009
J	Parrales, A; McDonald, P; Ottomeyer, M; Roy, A; Shoenen, FJ; Broward, M; Bruns, T; Themm, DH; Weir, SJ; Neville, KA; Iwakuma, T; Fulbright, JM				Parrales, Alejandro; McDonald, Peter; Ottomeyer, Megan; Roy, Anuradha; Shoenen, Frank J.; Broward, Melinda; Bruns, Tyce; Themm, Douglas H.; Weir, Scott J.; Neville, Kathleen A.; Iwakuma, Tomoo; Fulbright, Joy M.			Comparative oncology approach to drug repurposing in osteosarcoma	PLOS ONE			English	Article							GASTROINTESTINAL STROMAL TUMOR; HISTONE DEACETYLASE INHIBITORS; CANINE OSTEOSARCOMA; PRECLINICAL ACTIVITY; APPENDICULAR OSTEOSARCOMA; THIOREDOXIN REDUCTASE; COMBINATION THERAPY; MUTANT P53; IN-VITRO; CANCER	Background Osteosarcoma is an orphan disease for which little improvement in survival has been made since the late 1980s. New drug discovery for orphan diseases is limited by the cost and time it takes to develop new drugs. Repurposing already approved FDA-drugs can help overcome this limitation. Another limitation of cancer drug discovery is the lack of preclinical models that accurately recapitulate what occurs in humans. For OS using dogs as a model can minimize this limitation as OS in canines develops spontaneously, is locally invasive and metastasizes to the lungs as it does in humans. Methods In our present work we used high-throughput screens to identify drugs from a library of 2,286 FDA-approved drugs that demonstrated selective growth inhibition against both human and canine OS cell lines. The identified lead compound was then tested for synergy with 7 other drugs that have demonstrated activity against OS. These results were confirmed with in vitro assays and an in vivo murine model of OS. Results We identified 13 drugs that demonstrated selective growth inhibition against both human and canine OS cell lines. Auranofin was selected for further in vitro combination drug screens. Auranofin showed synergistic effects with vorinostat and rapamycin on OS viability and apoptosis induction. Auranofin demonstrated single-agent growth inhibition in both human and canine OS xenografts, and cooperative growth inhibition was observed in combination with rapamycin or vorinostat. There was a significant decrease in Ki67-positive cells and an increase in cleaved caspase-3 levels in tumor tissues treated with a combination of auranofin and vorinostat or rapamycin. Conclusions Auranofin, alone or in combination with rapamycin or vorinostat, may be useful new treatment strategies for OS. Future studies may evaluate the efficacy of auranofin in dogs with OS as a prelude to human clinical evaluation.	[Parrales, Alejandro; Ottomeyer, Megan; Iwakuma, Tomoo] Univ Kansas, Med Ctr, Dept Canc Biol, Kansas City, KS 66103 USA; [McDonald, Peter; Roy, Anuradha] Univ Kansas, Canc Ctr, High Throughput Screening Lab, Lawrence, KS 66045 USA; [Roy, Anuradha; Shoenen, Frank J.; Broward, Melinda; Weir, Scott J.; Iwakuma, Tomoo; Fulbright, Joy M.] Univ Kansas, Canc Ctr, Kansas City, KS 66160 USA; [Shoenen, Frank J.] Univ Kansas, Biotechnol Innovat & Optimizat Ctr, Lawrence, KS 66045 USA; [Broward, Melinda; Bruns, Tyce; Weir, Scott J.] Univ Kansas, Med Ctr, Inst Adv Med Innovat, Kansas City, KS 66103 USA; [Themm, Douglas H.] Colorado State Univ, Flint Anim Canc Ctr, Ft Collins, CO 80523 USA; [Themm, Douglas H.] Univ Colorado, Comprehens Canc Ctr, Aurora, CO USA; [Weir, Scott J.; Fulbright, Joy M.] Univ Missouri, Dept Pediat, Kansas City, MO 64110 USA; [Weir, Scott J.] Univ Kansas, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS USA; [Neville, Kathleen A.] Arkansas Childrens Hosp, 800 Marshall St, Little Rock, AR 72202 USA; [Iwakuma, Tomoo; Fulbright, Joy M.] Childrens Mercy Hosp & Clin, Div Hematol & Oncol, Kansas City, MO 64108 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas; University of Kansas; University of Kansas; University of Kansas Medical Center; Colorado State University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Missouri System; University of Missouri Kansas City; University of Kansas; Arkansas Children's Hospital; Children's Mercy Hospital	Iwakuma, T (corresponding author), Univ Kansas, Med Ctr, Dept Canc Biol, Kansas City, KS 66103 USA.; Iwakuma, T; Fulbright, JM (corresponding author), Univ Kansas, Canc Ctr, Kansas City, KS 66160 USA.; Fulbright, JM (corresponding author), Univ Missouri, Dept Pediat, Kansas City, MO 64110 USA.; Iwakuma, T; Fulbright, JM (corresponding author), Childrens Mercy Hosp & Clin, Div Hematol & Oncol, Kansas City, MO 64108 USA.	twakuma@kumc.edu; jmfulbright@cmh.edu	Broward, Melinda/AAB-3293-2020; Thamm, Douglas H/I-5976-2013	Thamm, Douglas H/0000-0002-8914-7767; McDonald, Peter/0000-0002-1880-7414; Schoenen, Frank/0000-0003-2711-1117; Weir, Scott/0000-0002-8020-434X; Roy, Anuradha/0000-0002-1057-1443	National Institute of Health [P30 CA168524, CA174735]; NATIONAL CANCER INSTITUTE [P30CA168524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113117] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Health P30 CA168524 (Roy A. Jenson grant for the University of Kansas Cancer Center), https://www.nih.gov/; National Institute of Health CA174735 (TI), https://www.nih.gov/; Midwest Cancer Alliance (JF), http://www.midwestcanceralliance.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari AS, 2010, CANCER RES, V70, P4602, DOI 10.1158/0008-5472.CAN-09-3463; Alvarez FJ, 2014, J AM ANIM HOSP ASSOC, V50, P12, DOI 10.5326/JAAHA-MS-5958; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Berg J, 1996, VET CLIN N AM-SMALL, V26, P111, DOI 10.1016/S0195-5616(96)50010-0; Celegato M, 2015, BLOOD, V126, P1394, DOI 10.1182/blood-2015-07-660365; Debnath A, 2012, NAT MED, V18, P956, DOI 10.1038/nm.2758; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Fiskus W, 2014, CANCER RES, V74, P2520, DOI 10.1158/0008-5472.CAN-13-2033; Gordon IK, 2008, AM J VET RES, V69, P1079, DOI 10.2460/ajvr.69.8.1079; Grignani G, 2015, LANCET ONCOL, V16, P98, DOI 10.1016/S1470-2045(14)71136-2; Hwang-Bo H, 2017, GEN PHYSIOL BIOPHYS, V36, P117, DOI 10.4149/gpb_2016043; Ibrahim N, 2012, ONCOL REP, V27, P1303, DOI 10.3892/or.2012.1675; Iyer SV, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13561; Iyer SV, 2016, ONCOTARGET, V7, P5401, DOI 10.18632/oncotarget.6634; Kiebala M, 2015, EXP HEMATOL, V43, P89, DOI 10.1016/j.exphem.2014.10.004; Legare ME, 2011, J CANCER, V2, P262, DOI 10.7150/jca.2.262; Liu CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053945; Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691; Maeda J, 2016, ONCOL LETT, V12, P1597, DOI 10.3892/ol.2016.4808; Marina NM, 2016, LANCET ONCOL, V17, P1396, DOI 10.1016/S1470-2045(16)30214-5; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Morello E, 2011, VET J, V189, P268, DOI 10.1016/j.tvjl.2010.08.014; Mottamal M, 2015, MOLECULES, V20, P3898, DOI 10.3390/molecules20033898; Mu XD, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/290368; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; Nardon C, 2016, CURR MED CHEM, V23, P3374, DOI 10.2174/0929867323666160504103843; O'Donoghue LE, 2011, J VET DIAGN INVEST, V23, P780, DOI 10.1177/1040638711408064; Panieri E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.105; Paoloni M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-625; Park SH, 2014, INT J ONCOL, V45, P1691, DOI 10.3892/ijo.2014.2579; Parrales A, 2016, NAT CELL BIOL, V18, P1233, DOI 10.1038/ncb3427; Penel-Page M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1894-5; Pessetto ZY, 2017, ONCOTARGET, V8, P4079, DOI 10.18632/oncotarget.13385; Pessetto ZY, 2014, MOL CANCER THER, V13, P2276, DOI 10.1158/1535-7163.MCT-14-0043; Pessetto ZY, 2013, MOL CANCER THER, V12, P1299, DOI 10.1158/1535-7163.MCT-12-0968; Morelli MP, 2012, CLIN CANCER RES, V18, P1051, DOI 10.1158/1078-0432.CCR-11-1507; Rebucci M, 2013, BIOCHEM PHARMACOL, V85, P1219, DOI 10.1016/j.bcp.2013.02.017; Selmic LE, 2014, J VET INTERN MED, V28, P554, DOI 10.1111/jvim.12313; Szewczyk M, 2015, VET RES COMMUN, V39, P61, DOI 10.1007/s11259-014-9623-0; Tong LY, 2015, CANCER LETT, V367, P18, DOI 10.1016/j.canlet.2015.07.008; Wan XL, 2005, CANCER RES, V65, P2406, DOI 10.1158/0008-5472.CAN-04-3135; Weir SJ, 2012, CANCER RES, V72, P1055, DOI 10.1158/0008-5472.CAN-11-3439; Whelan JS, 2015, ANN ONCOL, V26, P407, DOI 10.1093/annonc/mdu526; WITHROW SJ, 1991, CLIN ORTHOP RELAT R, P159; Withrow SJ, 2009, CANCER TREAT RES, V152, P439, DOI 10.1007/978-1-4419-0284-9_24; Wu ZK, 2013, J BUON, V18, P1032; Xie CH, 2016, ONCOTARGETS THER, V9, P4005, DOI 10.2147/OTT.S105418; York D, 2017, VET COMP ONCOL, V15, P1087, DOI 10.1111/vco.12250	48	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194224	10.1371/journal.pone.0194224	http://dx.doi.org/10.1371/journal.pone.0194224			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579058	Green Published, gold, Green Submitted			2022-12-26	WOS:000428351800022
J	Zheng, TC; Chen, ZL; Ju, YQ; Zhang, H; Cai, M; Pan, HT; Zhang, QX				Zheng, Tangchun; Chen, Zhilin; Ju, Yiqian; Zhang, Han; Cai, Ming; Pan, Huitang; Zhang, Qixiang			Reference gene selection for qRT-PCR analysis of flower development in Lagerstroemia indica and L. speciosa	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SUITABLE REFERENCE GENES; REAL-TIME PCR; NORMALIZATION; EXPRESSION; VALIDATION	Quantitative real-time polymerase chain reaction (qRT-PCR) is a prevalent method for gene expression analysis, depending on the stability of the reference genes for data normalization. Lagerstroemia indica and L. speciosa are popular ornamental plants which are famous for the long flowering period. However, no systematic studies on reference genes in Lagerstroemia have yet been conducted. In the present study, we selected nine candidate reference genes (GAPDH, TUA, TUB, 18S, RPII, EF-1 alpha, ATC, EIF5A and CYP) and evaluated their expression stability in different tissues during floral development of L. indica and L. speciosa using four algorithms (geNorm, NormFinder, BestKeeper and, RefFinder). Results showed that RPII and EF-1 alpha were the most stably expressed and suitable reference genes for both of Lagerstroemia species. Moreover, ACT exhibited high expression stability in L. indica and GAPDH was a suitable reference gene for L. speciosa in different flower development stages. TUB was an unsuitable reference gene for gene expression normalization due to significant variations in expression across all samples. Finally, we verified the reliability of the selected candidate reference genes by amplifying an AGAMOUS homolog (LsAG1) of Arabidopsis thaliana. This study provides a list of suitable reference genes, thereby broadening the genetic basis of the gene expression patterns in Lagerstroemia species.	[Zheng, Tangchun; Chen, Zhilin; Ju, Yiqian; Zhang, Han; Cai, Ming; Pan, Huitang; Zhang, Qixiang] Beijing Forestry Univ, Beijing Key Lab Ornamental Plants Germplasm Innov, Beijing, Peoples R China; [Zheng, Tangchun; Chen, Zhilin; Ju, Yiqian; Zhang, Han; Cai, Ming; Pan, Huitang; Zhang, Qixiang] Beijing Forestry Univ, Natl Engn Res Ctr Floriculture, Beijing, Peoples R China; [Zheng, Tangchun; Chen, Zhilin; Ju, Yiqian; Zhang, Han; Cai, Ming; Pan, Huitang; Zhang, Qixiang] Beijing Forestry Univ, Beijing Lab Urban & Rural Ecol Environm, Beijing, Peoples R China; [Zheng, Tangchun; Chen, Zhilin; Ju, Yiqian; Zhang, Han; Cai, Ming; Pan, Huitang; Zhang, Qixiang] Beijing Forestry Univ, Minist Educ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Beijing, Peoples R China; [Chen, Zhilin; Ju, Yiqian; Zhang, Han; Cai, Ming; Pan, Huitang; Zhang, Qixiang] Beijing Forestry Univ, Sch Landscape Architecture, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University; Beijing Forestry University; Beijing Forestry University; Beijing Forestry University	Zhang, QX (corresponding author), Beijing Forestry Univ, Beijing Key Lab Ornamental Plants Germplasm Innov, Beijing, Peoples R China.; Zhang, QX (corresponding author), Beijing Forestry Univ, Natl Engn Res Ctr Floriculture, Beijing, Peoples R China.; Zhang, QX (corresponding author), Beijing Forestry Univ, Beijing Lab Urban & Rural Ecol Environm, Beijing, Peoples R China.; Zhang, QX (corresponding author), Beijing Forestry Univ, Minist Educ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Beijing, Peoples R China.; Zhang, QX (corresponding author), Beijing Forestry Univ, Sch Landscape Architecture, Beijing, Peoples R China.	zqxbjfu@126.com			Fundamental Research Funds for the Central Universities [2016ZCQ02]; Special Fund for Beijing Common Construction Project	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Special Fund for Beijing Common Construction Project	The research was supported by the Fundamental Research Funds for the Central Universities (No. 2016ZCQ02) and Special Fund for Beijing Common Construction Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Bin WS, 2012, MOL BREEDING, V30, P1393, DOI 10.1007/s11032-012-9726-7; Cai M, 2011, SCI HORTIC-AMSTERDAM, V131, P88, DOI 10.1016/j.scienta.2011.09.031; Causier B, 2010, SEMIN CELL DEV BIOL, V21, P73, DOI 10.1016/j.semcdb.2009.10.005; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Fernandez P, 2011, PLANT CELL REP, V30, P63, DOI 10.1007/s00299-010-0944-3; Ferradas Y, 2016, PLANT PHYSIOL BIOCH, V102, P27, DOI 10.1016/j.plaphy.2016.02.011; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Han XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043084; Hong Y, 2015, J AM SOC HORTIC SCI, V140, P68, DOI 10.21273/JASHS.140.1.68; Hou JH, 2011, PLANT MOL BIOL REP, V29, P473, DOI 10.1007/s11105-010-0248-3; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jin XH, 2013, SCI HORTIC-AMSTERDAM, V153, P64, DOI 10.1016/j.scienta.2013.01.023; Kanakachari M, 2016, APPL BIOCHEM BIOTECH, V178, P433, DOI 10.1007/s12010-015-1884-8; Klie Maik, 2011, BMC Res Notes, V4, P518, DOI 10.1186/1756-0500-4-518; Li Y, 2015, GENES GENOM, V37, P851, DOI 10.1007/s13258-015-0317-y; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Moazzam J, 2016, PLOS ONE, V11; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pooler M, 2006, FLOWER BREEDING AND GENETICS: ISSUES, CHALLENGES AND OPPORTUNITIES FOR THE 21ST CENTURY, P439; Pounders C, 2007, HORTSCIENCE, V42, P1317, DOI 10.21273/HORTSCI.42.6.1317; Qi S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00287; Reddy DS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148451; Rivera-Vega L, 2012, PLANT MOL BIOL REP, V30, P242, DOI 10.1007/s11105-011-0340-3; Sun YK, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0288-1; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang T, 2014, J AM SOC HORTIC SCI, V139, P113, DOI 10.21273/JASHS.139.2.113; Wang X, 2015, INT J GENOMICS, V2015, P1, DOI DOI 10.1109/GL0C0M.2015.7417517; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Xiao D, 2012, FUNCT PLANT BIOL, V39, P342, DOI 10.1071/FP11246; Yan JW, 2012, MOL BIOL REP, V39, P1831, DOI 10.1007/s11033-011-0925-9; Ye YJ, 2015, GENET MOL RES, V14, P4369, DOI 10.4238/2015.April.30.10; Yi SJ, 2012, SCI HORTIC-AMSTERDAM, V138, P128, DOI 10.1016/j.scienta.2012.02.013; Zhang Q, 1991, J BEIJING FORESTRY U, V4, P57; Zhou L, 2016, J AM SOC HORTIC SCI, V141, P99, DOI 10.21273/JASHS.141.2.99	38	29	36	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0195004	10.1371/journal.pone.0195004	http://dx.doi.org/10.1371/journal.pone.0195004			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579116	Green Submitted, gold, Green Published			2022-12-26	WOS:000428351800078
J	Du, BG; Kreuzwieser, J; Dannenmann, M; Junker, LV; Kleiber, A; Hess, M; Jansen, K; Eiblmeier, M; Gessler, A; Kohnle, U; Ensminger, I; Rennenberg, H; Wildhagen, H				Du, Baoguo; Kreuzwieser, Juergen; Dannenmann, Michael; Junker, Laura Verena; Kleiber, Anita; Hess, Moritz; Jansen, Kirstin; Eiblmeier, Monika; Gessler, Arthur; Kohnle, Ulrich; Ensminger, Ingo; Rennenberg, Heinz; Wildhagen, Henning			Foliar nitrogen metabolism of adult Douglas-fir trees is affected by soil water availability and varies little among provenances	PLOS ONE			English	Article							SPRUCE PICEA-ABIES; ELEVATED CARBON-DIOXIDE; FREE AMINO-ACID; PSEUDOTSUGA-MENZIESII; SCOTS PINE; FOREST MANAGEMENT; ISOTOPIC COMPOSITION; ALLOCATION PATTERNS; NATURAL-ABUNDANCE; ORGANIC-MATTER	The coniferous forest tree Douglas-fir (Pseudotsuga menziesii) is native to the pacific North America, and is increasingly planted in temperate regions worldwide. Nitrogen (N) metabolism is of great importance for growth, resistance and resilience of trees. In the present study, foliar N metabolism of adult trees of three coastal and one interior provenance of Douglas-fir grown at two common gardens in southwestern Germany (Wiesloch, W; Schluchsee, S) were characterized in two subsequent years. Both the native North American habitats of the seed sources and the common garden sites in Germany differ in climate conditions. Total and mineral soil N as well as soil water content were higher in S compared to W. We hypothesized that i) provenances differ constitutively in N pool sizes and composition, ii) N pools are affected by environmental conditions, and iii) that effects of environmental factors on N pools differ among interior and coastal provenances. Soil water content strongly affected the concentrations of total N, soluble protein, total amino acids (TAA), arginine and glutamate. Foliar concentrations of total N, soluble protein, structural N and TAA of trees grown at W were much higher than in trees at S. Provenance effects were small but significant for total N and soluble protein content (interior provenance showed lowest concentrations), as well as arginine, asparagine and glutamate. Our data suggest that needle N status of adult Douglas-fir is independent from soil N availability and that low soil water availability induces a re-allocation of N from structural N to metabolic N pools. Small provenance effects on N pools suggest that local adaptation of Douglas-fir is not dominated by N conditions at the native habitats.	[Du, Baoguo] Mianyang Normal Univ, Coll Life Sci & Biotechnol, Mianyang, Peoples R China; [Du, Baoguo; Kreuzwieser, Juergen; Kleiber, Anita; Eiblmeier, Monika; Rennenberg, Heinz] Albert Ludwigs Univ Freiburg, Inst Forest Sci, Chair Tree Physiol, Freiburg, Germany; [Dannenmann, Michael] KIT, Inst Meteorol & Climate Res IMK, Atmospher Environm Res IMK IFU, Campus Alpin, Garmisch Partenkirchen, Germany; [Junker, Laura Verena; Hess, Moritz; Ensminger, Ingo] Univ Toronto, Grad Program Cell & Syst Biol, Dept Biol, Mississauga, ON, Canada; [Junker, Laura Verena; Hess, Moritz; Ensminger, Ingo] Univ Toronto, Grad Program Ecol & Evolutionary Biol, Dept Biol, Mississauga, ON, Canada; [Junker, Laura Verena; Hess, Moritz; Kohnle, Ulrich; Ensminger, Ingo; Wildhagen, Henning] Forest Res Inst Baden Wurttemberg FVA, Freiburg, Germany; [Hess, Moritz] Univ Med Ctr Mainz, IMBEI, Mainz, Germany; [Jansen, Kirstin; Gessler, Arthur] Leibniz Ctr Agr Landscape Res ZALF, Inst Landscape Biogeochem, Muncheberg, Germany; [Jansen, Kirstin] Leuphana Univ Luneburg, Inst Ecol, Luneburg, Germany; [Gessler, Arthur] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany; [Gessler, Arthur] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Rennenberg, Heinz] King Saud Univ, Riyadh, Saudi Arabia; [Junker, Laura Verena] Forschungszentrum Julich, IBG Plant Sci 2, Inst Bio & Geosci, Julich, Germany; [Wildhagen, Henning] HAWK Univ Appl Sci & Arts Hildesheim Holzminden G, Fac Resource Management, Gottingen, Germany	Mianyang Teachers' College; University of Freiburg; Helmholtz Association; Karlsruhe Institute of Technology; University of Toronto; University Toronto Mississauga; University of Toronto; University Toronto Mississauga; Johannes Gutenberg University of Mainz; Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF); Leuphana University Luneburg; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; King Saud University; Helmholtz Association; Research Center Julich; HAWK University of Applied Sciences & Arts Hildesheim Holzminden Gottingen	Wildhagen, H (corresponding author), Forest Res Inst Baden Wurttemberg FVA, Freiburg, Germany.; Wildhagen, H (corresponding author), HAWK Univ Appl Sci & Arts Hildesheim Holzminden G, Fac Resource Management, Gottingen, Germany.	henning.wildhagen@hawk.de	Dannenmann, Michael/A-7278-2013; Wildhagen, Henning/I-1276-2019; Gessler, Arthur/C-7121-2008; Ensminger, Ingo/D-8566-2012	Wildhagen, Henning/0000-0003-4970-8539; Gessler, Arthur/0000-0002-1910-9589; Dannenmann, Michael/0000-0001-5924-7612; Ensminger, Ingo/0000-0001-9014-2499	Deutsche Forschungsgemeinschaft [KR 2010/4-1, EN829/5-1, GE1090/7-1]; Forest Research Institute of the German Federal State Baden-Wurttemberg (FVA); Natural Sciences and Engineering Research Council of Canada (NSERC); Swiss National Science Foundation SNF [31003A_159866]; China Scholarship Council; Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg of Germany; University of Freiburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forest Research Institute of the German Federal State Baden-Wurttemberg (FVA); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Swiss National Science Foundation SNF(Swiss National Science Foundation (SNSF)); China Scholarship Council(China Scholarship Council); Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg of Germany; University of Freiburg	This work was financially supported by the Deutsche Forschungsgemeinschaft (www.dfg.de; grants KR 2010/4-1 to JK, EN829/5-1 to IE and GE1090/7-1 to AG), the Forest Research Institute of the German Federal State Baden-Wurttemberg (FVA, to IE, UK, HW), the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Swiss National Science Foundation SNF (31003A_159866 to AG). BD obtained funding from the China Scholarship Council, the Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg of Germany and the University of Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto FJ, 2013, GLOBAL CHANGE BIOL, V19, P1645, DOI 10.1111/gcb.12181; Anderson JT, 2011, TRENDS GENET, V27, P258, DOI 10.1016/j.tig.2011.04.001; [Anonymous], 2021, LANG ENV STAT COMP; BAETHGEN WE, 1989, COMMUN SOIL SCI PLAN, V20, P961, DOI 10.1080/00103628909368129; Bassirirad H, 2000, NEW PHYTOL, V147, P155, DOI 10.1046/j.1469-8137.2000.00682.x; Benomar L, 2016, FRONT PLANT SCI, V7, P48; Benomar L, 2015, TREE PHYSIOL, V35, P864, DOI 10.1093/treephys/tpv054; BRANDL H, 1989, ALLG FORST JAGDZTG, V160, P91; Dannenmann M, 2006, PLANT SOIL, V287, P279, DOI 10.1007/s11104-006-9077-4; Dannenmann M, 2009, SOIL BIOL BIOCHEM, V41, P1622, DOI 10.1016/j.soilbio.2009.04.024; De Diego N, 2015, J PLANT PHYSIOL, V188, P64, DOI 10.1016/j.jplph.2015.08.006; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Driessche R. van den, 1975, Canadian Journal of Forest Research, V5, P580, DOI 10.1139/x75-084; Du BG, 2016, TREE PHYSIOL, V36, P148, DOI 10.1093/treephys/tpv105; Du BG, 2014, TREE PHYSIOL, V34, P1090, DOI 10.1093/treephys/tpu074; Eckert AJ, 2009, GENETICS, V182, P1289, DOI 10.1534/genetics.109.102350; Eilmann B, 2013, FOREST ECOL MANAG, V302, P133, DOI 10.1016/j.foreco.2013.03.031; FEGER KH, 1992, WATER AIR SOIL POLL, V61, P295, DOI 10.1007/BF00482612; FIELD C, 1983, OECOLOGIA, V56, P341, DOI 10.1007/BF00379710; Field C. H., 1986, EC FORM FUNCTION, P25; Fotelli MN, 2002, NEW PHYTOL, V154, P85, DOI 10.1046/j.1469-8137.2002.00365.x; Gessler A, 2005, EUR J FOREST RES, V124, P95, DOI 10.1007/s10342-005-0055-9; Gessler A, 2004, PLANT BIOLOGY, V6, P289, DOI 10.1055/s-2004-820878; Gessler A, 2017, NEW PHYTOL, V214, P513, DOI 10.1111/nph.14340; GEZELIUS K, 1993, TREE PHYSIOL, V13, P71, DOI 10.1093/treephys/13.1.71; GOOD AG, 1994, PHYSIOL PLANTARUM, V90, P9, DOI 10.1111/j.1399-3054.1994.tb02185.x; Gould PJ, 2012, TREE PHYSIOL, V32, P1482, DOI 10.1093/treephys/tps106; Guo JY, 2010, PHYSIOL PLANTARUM, V139, P335, DOI 10.1111/j.1399-3054.2010.01370.x; Hamann A, 2013, B AM METEOROL SOC, V94, P1307, DOI 10.1175/BAMS-D-12-00145.1; Hao YB, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0150717, 10.1371/journal.pone.0163147]; Hermann RK, 1999, NEW FOREST, V17, P53, DOI 10.1023/A:1006581028080; Hess M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3022-6; Hobbie EA, 2001, TREE PHYSIOL, V21, P1113, DOI 10.1093/treephys/21.15.1113; Hogberg P, 1997, NEW PHYTOL, V137, P179, DOI 10.1046/j.1469-8137.1997.00808.x; Hu B, 2013, PLANT BIOLOGY, V15, P198, DOI 10.1111/j.1438-8677.2012.00658.x; Jansen K, 2013, TREES-STRUCT FUNCT, V27, P37, DOI 10.1007/s00468-012-0765-9; Junker LV, 2017, SCI REP-UK, V7, DOI 10.1038/srep40145; Keitel C, 2006, PLANT CELL ENVIRON, V29, P1492, DOI 10.1111/j.1365-3040.2006.01520.x; KENK G, 1984, ALLG FORST JAGDZTG, V155, P165; Kohnle U, 2012, CAN J FOREST RES, V42, P382, DOI [10.1139/X11-191, 10.1139/x11-191]; Kranabetter JM, 2014, BOTANY, V92, P417, DOI 10.1139/cjb-2013-0198; Krutovsky KV, 2009, TREE GENET GENOMES, V5, P641, DOI 10.1007/s11295-009-0216-y; Leites LP, 2012, ECOL APPL, V22, P154, DOI 10.1890/11-0150.1; Lewis JD, 2004, NEW PHYTOL, V162, P355, DOI 10.1111/j.1469-8137.2004.01036.x; Li H, 2012, J EXP BOT, V63, P6173, DOI 10.1093/jxb/ers271; Lin GH, 1999, GLOB CHANGE BIOL, V5, P157, DOI 10.1046/j.1365-2486.1999.00211.x; Lin GH, 2001, PLANT SOIL, V229, P259, DOI 10.1023/A:1004883221036; Liu M, 2015, BIOGEOSCIENCES, V12, P4831, DOI 10.5194/bg-12-4831-2015; Luo J, 2015, TREE PHYSIOL, V35, P1283, DOI 10.1093/treephys/tpv091; Luo J, 2013, J EXP BOT, V64, P4207, DOI 10.1093/jxb/ert234; Luo ZB, 2009, PLANT PHYSIOL, V151, P1902, DOI 10.1104/pp.109.143735; MARGOLIS HA, 1986, CAN J FOREST RES, V16, P897, DOI 10.1139/x86-160; Millard P, 2010, TREE PHYSIOL, V30, P1083, DOI 10.1093/treephys/tpq042; Muller T, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0816-z; Nakazawa, 2017, FMSB FUNCTIONS MED S; NASHOLM T, 1990, TREE PHYSIOL, V6, P267, DOI 10.1093/treephys/6.3.267; Neophytou C, 2016, EUR J FOREST RES, V135, P465, DOI 10.1007/s10342-016-0946-y; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Oleksyn J, 1998, FUNCT ECOL, V12, P573, DOI 10.1046/j.1365-2435.1998.00236.x; Oleksyn J, 2003, OECOLOGIA, V136, P220, DOI 10.1007/s00442-003-1265-9; PEREZSOBA M, 1994, TREES-STRUCT FUNCT, V9, P19, DOI 10.1007/BF00197865; Pinheiro J., 2021, CRAN, V3, P1; RABE E, 1986, PLANT PHYSIOL, V81, P774, DOI 10.1104/pp.81.3.774; Rai VK, 2002, BIOL PLANTARUM, V45, P481, DOI 10.1023/A:1022308229759; Raitio H, 2000, PLANT SOIL, V221, P231, DOI 10.1023/A:1004745122911; REICH PB, 1995, OECOLOGIA, V104, P24, DOI 10.1007/BF00365558; Rennenberg H, 1998, NEW PHYTOL, V139, P71, DOI 10.1046/j.1469-8137.1998.00181.x; Rennenberg H, 2006, PLANT BIOLOGY, V8, P556, DOI 10.1055/s-2006-924084; Rennenberg H, 2015, FORESTS, V6, P2820, DOI 10.3390/f6082820; Ripullone F, 2003, TREE PHYSIOL, V23, P137, DOI 10.1093/treephys/23.2.137; Russell DJ, 1998, APPL SOIL ECOL, V9, P483, DOI 10.1016/S0929-1393(98)00109-7; Savolainen O, 2013, NAT REV GENET, V14, P807, DOI 10.1038/nrg3522; Schlotter D, 2012, J PLANT NUTR SOIL SC, V175, P236, DOI 10.1002/jpln.201000399; Schneider S, 1996, NEW PHYTOL, V134, P103, DOI 10.1111/j.1469-8137.1996.tb01150.x; Sergent AS, 2014, ANN FOREST SCI, V71, P709, DOI 10.1007/s13595-014-0393-1; Shay PE, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01097; Smith WB., 2009, GEN TECHNICAL REPORT; St Clair JB, 2005, ANN BOT, V96, P1199, DOI [10.1093/aob/mci278, DOI 10.1093/AOB/MCI278, DOI 10.1093/A0B/MCI278]; Stewart G. R., 1980, The biochemistry of plants. A comprehensive treatise. Volume 5. Amino acids and derivatives., P609; Tingey DT, 2003, GLOBAL CHANGE BIOL, V9, P1038, DOI 10.1046/j.1365-2486.2003.00646.x; TURNER J, 1976, ANN BOT-LONDON, V40, P1185, DOI 10.1093/oxfordjournals.aob.a085239; van Breemen N, 1998, ECOSYSTEMS, V1, P345, DOI 10.1007/s100219900028; VANCLEVE K, 1990, CAN J FOREST RES, V20, P1530, DOI 10.1139/x90-203; VANDIJK HFG, 1988, PHYSIOL PLANTARUM, V73, P494, DOI 10.1111/j.1399-3054.1988.tb05431.x; Walters MB, 2013, TREE PHYSIOL, V33, P297, DOI 10.1093/treephys/tps134; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; Weber P, 1998, NEW PHYTOL, V140, P461, DOI 10.1111/j.1469-8137.1998.00285.x; Wellburn FAM, 1996, J EXP BOT, V47, P1361, DOI 10.1093/jxb/47.9.1361; Winter G, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00534; WINTER H, 1992, PLANT PHYSIOL, V99, P996, DOI 10.1104/pp.99.3.996; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; ZHANG JW, 1995, FUNCT ECOL, V9, P402, DOI 10.2307/2390003; Zuur Alain F., 2009, P1	93	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194684	10.1371/journal.pone.0194684	http://dx.doi.org/10.1371/journal.pone.0194684			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566035	Green Published, Green Submitted, gold			2022-12-26	WOS:000428093900093
J	Heinemeier, KM; Schjerling, P; Ohlenschlaeger, TF; Eismark, C; Olsen, J; Kjaer, M				Heinemeier, Katja Maria; Schjerling, Peter; Ohlenschlaeger, Tommy F.; Eismark, Christian; Olsen, Jesper; Kjaer, Michael			Carbon-14 bomb pulse dating shows that tendinopathy is preceded by years of abnormally high collagen turnover	FASEB JOURNAL			English	Article						tendon; tendon disease; metabolism; collagen synthesis	ROTATOR CUFF TENDONS; ASPARTIC-ACID; ACHILLES; RACEMIZATION; RADIOCARBON; AGE; MECHANISMS; EXPRESSION; TENDINITIS; TENDINOSIS	Tendons are essential weight-bearing structures that are often affected by tendinopathy, which leads to pain and impaired mobility. In healthy Achilles tendons, no significant renewal of the weight-bearing collagen matrix seems to occur during adult life, but tendinopathy may lead to increased turnover. The carbon-14 ([C-14]) bomb pulse method was used to measure lifelong replacement rates of collagen in tendinopathic and healthy Achilles tendons (tendinopathic: n = 25, born 1937-1972. Healthy: n = 10, born 1929-1966). As expected, the healthy tendon collagen had not been replaced during adulthood, but in tendinopathic tendon, a substantial renewal had occurred. Modeling of the [C-14] data suggested that one half of the collagen in tendinopathic matrix had undergone continuous slow turnover for years before the presentation of symptoms. This finding allows for a new concept in tendon pathogenesis because it suggests that either the symptoms of tendinopathy represent a late phase of a very prolonged disease process, or an abnormally high collagen exchange could be a risk factor for tendon disorders rather than being a result of disease.Heinemeier, K. M., Schjerling, P., Ohlenschlaeger, T. F., Eismark, C., Olsen, J., Kjaer, M. Carbon-14 bomb pulse dating shows that tendinopathy is preceded by years of abnormally high collagen turnover.	[Heinemeier, Katja Maria; Schjerling, Peter; Ohlenschlaeger, Tommy F.; Eismark, Christian; Kjaer, Michael] Univ Copenhagen, Inst Sports Med Copenhagen, Dept Orthoped Surg M, Bispebjerg Hosp, Copenhagen, Denmark; [Heinemeier, Katja Maria; Schjerling, Peter; Ohlenschlaeger, Tommy F.; Eismark, Christian; Kjaer, Michael] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Hlth Aging, Copenhagen, Denmark; [Olsen, Jesper] Aarhus Univ, Dept Phys & Astron, Aarhus Accelerator Mass Spectrometry AMS Ctr, Aarhus, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Aarhus University	Heinemeier, KM (corresponding author), Univ Copenhagen, Inst Sports Med, Bispebjerg Hosp, Dept Orthoped Surg M, Bldg 8,1 Floor,Bispebjerg Bakke 23, DK-2400 Copenhagen NV, Denmark.	kmh.ismc@gmail.com	Schjerling, Peter/F-6194-2011; Kjaer, Michael/W-6842-2019; Olsen, Jesper/F-1656-2013	Schjerling, Peter/0000-0001-7138-3211; Kjaer, Michael/0000-0002-4582-8755; Olsen, Jesper/0000-0002-4445-5520	Lundbeck Foundation; Novo Nordisk Foundation; Danish Council for Independent Research (Health and Disease); Nordea Foundation (Healthy Ageing Grant); Bispebjerg Hospital Research Grant	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Independent Research (Health and Disease); Nordea Foundation (Healthy Ageing Grant); Bispebjerg Hospital Research Grant	The authors thank Prof. JOrgen Tranum-Jensen (Faculty of Health and Medical Sciences, University of Copenhagen) for advice and help with tissue sampling, and to Ulla Ramer Mikkelsen (Institute of Sports Medicine, Bispebjerg Hospital) for help with tissue sampling. Financial support from the Lundbeck Foundation, Bispebjerg Hospital Research Grant, Novo Nordisk Foundation, Danish Council for Independent Research (Health and Disease), and the Nordea Foundation (Healthy Ageing Grant) is greatly appreciated. The authors declare no conflicts of interest.	Alkass K, 2010, MOL CELL PROTEOMICS, V9, P1022, DOI 10.1074/mcp.M900525-MCP200; Bailey AJ, 2001, MECH AGEING DEV, V122, P735, DOI 10.1016/S0047-6374(01)00225-1; Bank RA, 1999, ANN RHEUM DIS, V58, P35, DOI 10.1136/ard.58.1.35; Birch HL, 2007, INT J EXP PATHOL, V88, P241, DOI 10.1111/j.1365-2613.2007.00552.x; Canoira L, 2003, INT J CHEM KINET, V35, P576, DOI 10.1002/kin.10153; Corps AN, 2012, ANN RHEUM DIS, V71, P746, DOI 10.1136/annrheumdis-2011-200391; de Mos M, 2007, AM J SPORT MED, V35, P1549, DOI 10.1177/0363546507301885; DYER DG, 1993, J CLIN INVEST, V91, P2463, DOI 10.1172/JCI116481; FERRETTI A, 1986, SPORTS MED, V3, P289, DOI 10.2165/00007256-198603040-00005; Frost P, 2002, AM J IND MED, V41, P11, DOI 10.1002/ajim.10019; Heinemeier KM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8335; Heinemeier KM, 2017, J APPL PHYSIOL, V123, P1397, DOI 10.1152/japplphysiol.00281.2017; Heinemeier KM, 2013, FASEB J, V27, P2074, DOI 10.1096/fj.12-225599; Hoemann CD, 2004, METH MOLEC MED, V101, P127; Kueppers LM, 2004, OECOLOGIA, V141, P641, DOI 10.1007/s00442-004-1689-x; Levin I, 2013, TELLUS B, V65, DOI 10.3402/tellusb.v65i0.20092; Lynnerup N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001529; MAROUDAS A, 1992, CONNECT TISSUE RES, V28, P161, DOI 10.3109/03008209209015033; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; Nielsen RH, 2014, MATRIX BIOL, V34, P96, DOI 10.1016/j.matbio.2013.09.005; Ohberg L, 2001, KNEE SURG SPORT TR A, V9, P233, DOI 10.1007/s001670000189; Olsen J, 2017, RADIOCARBON, V59, P905, DOI 10.1017/RDC.2016.85; Pingel J, 2013, EUR J APPL PHYSIOL, V113, P2101, DOI 10.1007/s00421-013-2638-3; RILEY GP, 1994, ANN RHEUM DIS, V53, P367, DOI 10.1136/ard.53.6.367; Riley GP, 2002, MATRIX BIOL, V21, P185, DOI 10.1016/S0945-053X(01)00196-2; RILEY GP, 1994, ANN RHEUM DIS, V53, P359, DOI 10.1136/ard.53.6.359; Riley G, 2008, NAT CLIN PRACT RHEUM, V4, P82, DOI 10.1038/ncprheum0700; SCHMIDT MB, 1990, J ORTHOPAED RES, V8, P353, DOI 10.1002/jor.1100080307; Stabler TV, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2639; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Sunding K, 2016, KNEE SURG SPORT TR A, V24, P1988, DOI 10.1007/s00167-014-3270-4; Svensson RB, 2017, ACTA BIOMATER, V50, P293, DOI 10.1016/j.actbio.2017.01.006; Tanaka S, 2001, AM J IND MED, V39, P328, DOI 10.1002/1097-0274(200103)39:3<328::AID-AJIM1021>3.0.CO;2-I; Thomopoulos S, 2015, J ORTHOP RES, V33, P832, DOI 10.1002/jor.22806; Van Duin ACT, 1998, ORG GEOCHEM, V29, P1227, DOI 10.1016/S0146-6380(98)00098-9	35	26	26	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4763	4775		10.1096/fj.201701569R	http://dx.doi.org/10.1096/fj.201701569R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29570396				2022-12-26	WOS:000443817700012
J	Leiphrakpam, PD; Brattain, MG; Black, JD; Wang, J				Leiphrakpam, Premila D.; Brattain, Michael G.; Black, Jennifer D.; Wang, Jing			TGF and IGF1R signaling activates protein kinase A through differential regulation of ezrin phosphorylation in colon cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transforming growth factor beta (TGF-); ezrin; A-kinase anchoring protein (AKAP); X-linked inhibitor of apoptosis protein (XIAP); survivin; colon cancer; apoptosis; metastasis; IGF1R; Smad3	COLORECTAL-CANCER; CARCINOMA CELLS; ERM PROTEINS; PLASMA-MEMBRANE; MONOCLONAL-ANTIBODY; METASTASIS; EXPRESSION; RECEPTOR; BINDING; BETA	Aberrant cell survival plays a critical role in cancer progression and metastasis. We have previously shown that ezrin, a cAMP-dependent protein kinase A-anchoring protein (AKAP), is up-regulated in colorectal cancer (CRC) liver metastasis. Phosphorylation of ezrin at Thr-567 activates ezrin and plays an important role in CRC cell survival associated with XIAP and survivin up-regulation. In this study, we demonstrate that in FET and GEO colon cancer cells, knockdown of ezrin expression or inhibition of ezrin phosphorylation at Thr-567 increases apoptosis through protein kinase A (PKA) activation in a cAMP-independent manner. Transforming growth factor (TGF) signaling inhibits ezrin phosphorylation in a Smad3-dependent and Smad2-independent manner and regulates pro-apoptotic function through ezrin-mediated PKA activation. On the other hand, ezrin phosphorylation at Thr-567 by insulin-like growth factor 1 receptor (IGF1R) signaling leads to cAMP-dependent PKA activation and enhances cell survival. Further studies indicate that phosphorylated ezrin forms a complex with PKA RII, and dephosphorylated ezrin dissociates from the complex and facilitates the association of PKA RII with AKAP149, both of which activate PKA yet lead to either cell survival or apoptosis. Thus, our studies reveal a novel mechanism of differential PKA activation mediated by TGF and IGF1R signaling through regulation of ezrin phosphorylation in CRC, resulting in different cell fates. This is of significance because TGF and IGF1R signaling pathways are well-characterized tumor suppressor and oncogenic pathways, respectively, with important roles in CRC tumorigenesis and metastasis. Our studies indicate that they cross-talk and antagonize each other's function through regulation of ezrin activation. Therefore, ezrin may be a potential therapeutic target in CRC.	[Leiphrakpam, Premila D.; Brattain, Michael G.; Black, Jennifer D.; Wang, Jing] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Brattain, Michael G.; Wang, Jing] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Black, Jennifer D.; Wang, Jing] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Wang, J (corresponding author), Univ Nebraska Med Ctr, Omaha, NE 68198 USA.	jjwang@unmc.edu	Leiphrakpam, Premila/I-6685-2019	Leiphrakpam, Premila/0000-0002-2319-8844	National Institutes of Health [R01CA038173, R01CA054807, R01CA208063, R01CA212241, R01CA215389, R01CA191894]; Fred and Pamela Buffett Cancer Center [P30 CA036727]; NATIONAL CANCER INSTITUTE [R01CA038173, P30CA036727, R01CA215389, R01CA208063, R01CA054807, R01CA212241, R21CA191894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fred and Pamela Buffett Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01CA038173 and R01CA054807 (to M.G.B.), R01CA208063, R01CA212241, and R01CA215389 (to J.W.), and R01CA191894 (to J.D.B.) and by Fred and Pamela Buffett Cancer Center Grant P30 CA036727.	Agarwal E, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-145; ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Beck SE, 2007, CELL SIGNAL, V19, P1465, DOI 10.1016/j.cellsig.2007.01.017; BRATTAIN MG, 1984, CANCER METAST REV, V3, P177, DOI 10.1007/BF00048384; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bretscher A, 1997, J CELL SCI, V110, P3011; Bulut G, 2012, ONCOGENE, V31, P269, DOI 10.1038/onc.2011.245; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Chen Y, 2011, CANCER RES, V71, P1721, DOI 10.1158/0008-5472.CAN-09-4683; Chowdhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019335; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Elzagheid A, 2008, HUM PATHOL, V39, P1737, DOI 10.1016/j.humpath.2008.04.020; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; GOULD KL, 1989, EMBO J, V8, P4133, DOI 10.1002/j.1460-2075.1989.tb08598.x; Grau AM, 2006, CELL SIGNAL, V18, P1041, DOI 10.1016/j.cellsig.2005.08.021; Halder SK, 2008, BRIT J CANCER, V99, P957, DOI 10.1038/sj.bjc.6604562; Hedrick Erik D, 2013, J Mol Signal, V8, P10, DOI 10.1186/1750-2187-8-10; Hogan FS, 2007, J SURG RES, V143, P58, DOI 10.1016/j.jss.2007.03.080; Hu YP, 2008, CANCER RES, V68, P8004, DOI 10.1158/0008-5472.CAN-08-0280; Jiang YJ, 2011, CANCER RES, V71, P234, DOI 10.1158/0008-5472.CAN-10-1487; Leiphrakpam PD, 2014, CELL SIGNAL, V26, P868, DOI 10.1016/j.cellsig.2014.01.014; Leiphrakpam PD, 2014, ONCOL REP, V31, P87, DOI 10.3892/or.2013.2819; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Mariotti E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-120; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; Nakamura N, 2000, GENES CELLS, V5, P571, DOI 10.1046/j.1365-2443.2000.00348.x; Napolitano S, 2015, CLIN CANCER RES, V21, P2975, DOI 10.1158/1078-0432.CCR-15-0020; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Pysz MA, 2009, EXP CELL RES, V315, P1415, DOI 10.1016/j.yexcr.2009.02.002; Ren L, 2009, ONCOGENE, V28, P792, DOI 10.1038/onc.2008.437; SATO N, 1992, J CELL SCI, V103, P131; Shiue H, 2005, J BIOL CHEM, V280, P1688, DOI 10.1074/jbc.M409471200; Su B, 2010, J BIOL CHEM, V285, P4578, DOI 10.1074/jbc.M109.073494; Tabernero J, 2007, J CLIN ONCOL, V25, P5225, DOI 10.1200/JCO.2007.13.2183; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; Troger J, 2012, BRIT J PHARMACOL, V166, P420, DOI 10.1111/j.1476-5381.2011.01796.x; Tynninen O, 2004, NEUROPATH APPL NEURO, V30, P472, DOI 10.1111/j.1365-2990.2004.00562.x; Wang HJ, 2009, WORLD J GASTROENTERO, V15, P2016, DOI 10.3748/wjg.15.2016; Wang J, 1996, J BIOL CHEM, V271, P17366, DOI 10.1074/jbc.271.29.17366; Wang J, 2008, CANCER RES, V68, P3152, DOI 10.1158/0008-5472.CAN-07-5348; Wang J, 2007, MOL CANCER THER, V6, P1143, DOI 10.1158/1535-7163.MCT-06-0555; Wang XZ, 2010, INT J ONCOL, V36, P1573, DOI 10.3892/ijo_00000644; Weng WH, 2005, CLIN CANCER RES, V11, P6198, DOI 10.1158/1078-0432.CCR-05-0548; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Zh LX, 2007, AM J PHYSIOL-CELL PH, V293, pC874, DOI 10.1152/ajpcell.00111.2007; Zhang LZ, 2004, MOL CELL BIOL, V24, P2169, DOI 10.1128/MCB.24.5.2169-2180.2004	57	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8242	8254		10.1074/jbc.RA117.001299	http://dx.doi.org/10.1074/jbc.RA117.001299			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29599290	hybrid, Green Published			2022-12-26	WOS:000433224600028
J	Meyer, T; Vigouroux, A; Aumont-Nicaise, M; Comte, G; Vial, L; Lavire, C; Morera, S				Meyer, Thibault; Vigouroux, Armelle; Aumont-Nicaise, Magali; Comte, Gilles; Vial, Ludovic; Lavire, Celine; Morera, Solange			The plant defense signal galactinol is specifically used as a nutrient by the bacterial pathogen Agrobacterium fabrum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; sugar transport; bacteria; ABC transporter; microbiology; agrobacterium; galactinol; periplasmic binding protein; RFOs; plant defense; Agrobacterium fabrum	SUGAR-TRANSPORT; SYNTHASE GENE; GALACTOSIDES; RHIZOSPHERE; RESISTANCE; MELILOTI; MODEL	The bacterial plant pathogen Agrobacterium fabrum uses periplasmic-binding proteins (PBPs) along with ABC transporters to import a wide variety of plant molecules as nutrients. Nonetheless, how A. fabrum acquires plant metabolites is incompletely understood. Using genetic approaches and affinity measurements, we identified here the PBP MelB and its transporter as being responsible for the uptake of the raffinose family of oligosaccharides (RFO), which are the most widespread d-galactose-containing oligosaccharides in higher plants. We also found that the RFO precursor galactinol, recently described as a plant defense molecule, is imported into Agrobacterium via MelB with nanomolar range affinity. Structural analyses and binding mode comparisons of the X-ray structures of MelB in complex with raffinose, stachyose, galactinol, galactose, and melibiose (a raffinose degradation product) revealed how MelB recognizes the nonreducing end galactose common to all these ligands and that MelB has a strong preference for a two-unit sugar ligand. Of note, MelB conferred a competitive advantage to A. fabrum in colonizing the rhizosphere of tomato plants. Our integrative work highlights the structural and functional characteristics of melibiose and galactinol assimilation by A. fabrum, leading to a competitive advantage for these bacteria in the rhizosphere. We propose that the PBP MelB, which is highly conserved among both symbionts and pathogens from Rhizobiace family, is a major trait in these bacteria required for early steps of plant colonization.	[Meyer, Thibault; Comte, Gilles; Vial, Ludovic; Lavire, Celine] Univ Lyon, CNRS, UCBL, UMR Ecol Microbienne,INRA, F-69622 Villeurbanne, France; [Vigouroux, Armelle; Aumont-Nicaise, Magali; Morera, Solange] Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,Inst Integrat Biol Cell I2BC, Ave Terrasse, F-91198 Gif Sur Yvette, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Lavire, C (corresponding author), Univ Lyon, CNRS, UCBL, UMR Ecol Microbienne,INRA, F-69622 Villeurbanne, France.; Morera, S (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,Inst Integrat Biol Cell I2BC, Ave Terrasse, F-91198 Gif Sur Yvette, France.	celine.lavire@univ-lyon1.fr; solange.morera@i2bc.paris-saclay.fr	LAVIRE, Céline/D-3126-2019; COMTE, Gilles/P-5701-2016; LAVIRE, Céline/AAC-4222-2019	LAVIRE, Céline/0000-0002-0698-4683; COMTE, Gilles/0000-0003-1191-6455; LAVIRE, Céline/0000-0002-0698-4683; Vial, ludovic/0000-0001-6021-0251; MEYER, Thibault/0000-0002-8526-9804; morera, solange/0000-0001-7781-0448	FRISBI [ANR-10-INSB-05-01]	FRISBI	This work has benefited from the I2BC crystallization and microcalorimetry platforms supported by FRISBI ANR-10-INSB-05-01 as well as from the "Centre Technologique des Microstructures" and the "Serre et chambres climatiques" platforms, supported by the FR BioEnviS Research Federation. We acknowledge SOLEIL for provision of synchrotron radiation facilities (proposals ID 20130869, 20140774, and 20160782) in using Proxima beamlines. We thank Andrew Saurin for critical reading of the manuscript.	Abarca-Grau AM, 2011, PLANT PATHOL, V60, P416, DOI 10.1111/j.1365-3059.2010.02385.x; Andersen KE, 2005, J AGR FOOD CHEM, V53, P5809, DOI 10.1021/jf040471v; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Barret M, 2015, APPL ENVIRON MICROB, V81, P1257, DOI 10.1128/AEM.03722-14; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Bringhurst RM, 2001, P NATL ACAD SCI USA, V98, P4540, DOI 10.1073/pnas.071375898; Charaoui-Boukerzaza S, 2013, MICROBIOL-SGM, V159, P2395, DOI 10.1099/mic.0.071407-0; Cho SM, 2010, BOTANY, V88, P452, DOI 10.1139/B10-009; CORNISH A, 1989, J GEN MICROBIOL, V135, P3001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Gage DJ, 1998, J BACTERIOL, V180, P5739, DOI 10.1128/JB.180.21.5739-5748.1998; Hall BG, 2009, MOL BIOL EVOL, V26, P2487, DOI 10.1093/molbev/msp162; Ibanez C, 2013, TREES-STRUCT FUNCT, V27, P1309, DOI 10.1007/s00468-013-0879-8; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kemner JM, 1997, J BACTERIOL, V179, P2452, DOI 10.1128/jb.179.7.2452-2458.1997; Kim MS, 2008, MOL PLANT MICROBE IN, V21, P1643, DOI 10.1094/MPMI-21-12-1643; Kristin A, 2013, PLANT SOIL, V370, P671, DOI 10.1007/s11104-013-1647-7; Lang J, 2013, MOL MICROBIOL, V90, P1178, DOI 10.1111/mmi.12423; Lassalle F, 2011, GENOME BIOL EVOL, V3, P762, DOI 10.1093/gbe/evr070; LILJESTROM PL, 1987, NUCLEIC ACIDS RES, V15, P2213, DOI 10.1093/nar/15.5.2213; Liu YB, 2017, INT J CLIN EXP PATHO, V10, P1094; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer T, 2018, MOL PLANT MICROBE IN, V31, P814, DOI [10.1094/MPMI-10-17-0236-R, 10.1094/mpmi-10-17-0236-r]; Nelson EB, 2004, ANNU REV PHYTOPATHOL, V42, P271, DOI 10.1146/annurev.phyto.42.121603.131041; Nelson EB, 2018, PLANT SOIL, V422, P7, DOI 10.1007/s11104-017-3289-7; Nester EW, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00730; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sengupta S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00656; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Siddique S, 2014, NEW PHYTOL, V201, P476, DOI 10.1111/nph.12535; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Vacheron J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01212; Veena, 2003, PLANT J, V35, P219, DOI 10.1046/j.1365-313X.2003.01796.x; Westover BP, 2005, BIOINFORMATICS, V21, P880, DOI 10.1093/bioinformatics/bti123; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804	40	10	11	0	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					7930	7941		10.1074/jbc.RA118.001856	http://dx.doi.org/10.1074/jbc.RA118.001856			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29602905	Green Published, hybrid			2022-12-26	WOS:000433224600003
J	Lewien, MJ; Murray, TD; Jernigan, KL; Garland-Campbell, KA; Carter, AH				Lewien, Megan J.; Murray, Timothy D.; Jernigan, Kendra L.; Garland-Campbell, Kimberly A.; Carter, Arron H.			Genome-wide association mapping for eyespot disease in US Pacific Northwest winter wheat	PLOS ONE			English	Article							HERPOTRICHOIDES FRON DEIGHTON; PSEUDOCERCOSPORELLA-HERPOTRICHOIDES; OCULIMACULA-YALLUNDAE; TAPESIA-YALLUNDAE; CEREAL EYESPOT; RESISTANCE; REGISTRATION; GENE; IDENTIFICATION; POPULATIONS	Eyespot, caused by the soil-borne necrotrophic fungi Oculimacula yallundae and O. acuformis, is a disease of major economic significance for wheat, barley and rye. Pacific Northwest (PNW) winter wheat (Triticum aestivum L.) grown in areas of high rainfall and moderate winters is most vulnerable to infection. The objective of this research was to identify novel genomic regions associated with eyespot resistance in winter wheat adapted to the PNW. Two winter wheat panels of 469 and 399 lines were compiled for one of the first genome-wide association studies (GWAS) of eyespot resistance in US winter wheat germplasm. These panels were genotyped with the Infinium 9K and 90K iSelect SNP arrays. Both panels were phenotyped for disease resistance in a two-year field study and in replicated growth chamber trials. Growth chamber trials were used to evaluate the genetic resistance of O. acuformis and O. yallundae species separately. Best linear unbiased predictors (BLUPs) were calculated across all field and growth chamber environments. A total of 73 marker-trait associations (MTAs) were detected on nine different chromosomes (1A, 2A, 2B, 4A, 5A, 5B, 7A, 7B and 7D) that were significantly associated (p-value <0.001) with eyespot resistance in Panel A, and 19 MTAs on nine different chromosomes (1A, 1B, 2A, 2D, 3B, 5A, 5B, 7A, and 7B) in Panel B. The most significant SNPs were associated with Pch1 and Pch2 resistance genes on the long arms of chromosome 7D and 7A. Most of the novel MTAs appeared to have a minor effect on reducing eyespot disease. Nevertheless, eyespot disease scores decreased as the number of resistance alleles increased. Seven SNP markers, significantly associated with reducing eyespot disease across environments and in the absence and presence of Pch1 were identified. These markers were located on chromosomes 2A (IWB8331), 5A (IWB73709), 5B (IWB47298), 7AS (IWB47160), 7B (IWB45005) and two SNPs (Ex_c44379_2509 and IAAV4340) had unknown map positions. The additive effect of the MTAs explained most of the remaining phenotypic variation not accounted for by Pch1 or Pch2. This study provides breeders with adapted germplasm and novel sources of eyespot resistance to be used in the development of superior cultivars with increased eyespot resistance.	[Lewien, Megan J.; Jernigan, Kendra L.; Carter, Arron H.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Murray, Timothy D.] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Garland-Campbell, Kimberly A.] Washington State Univ, USDA ARS, Wheat Hlth Genet & Qual Unit, Pullman, WA 99164 USA; [Jernigan, Kendra L.] Univ Mt Olive, Sch Arts & Sci, Mt Olive, NC USA	Washington State University; Washington State University; United States Department of Agriculture (USDA); Washington State University	Carter, AH (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.	ahcarter@wsu.edu	Murray, Timothy D/A-9771-2016; Carter, Arron/E-9631-2019	Murray, Timothy D/0000-0002-6772-202X; Carter, Arron/0000-0002-8019-6554	National Institute of Food and Agriculture, U.S. Department of Agriculture [2016-68004-24770]; Washington State University [3019-0232]	National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Washington State University	We would like to thank the National Institute of Food and Agriculture, U.S. Department of Agriculture, under award number 2016-68004-24770 to Arron H Carter and Washington State University (3019-0232) to Arron H Carter, for providing funding to support this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN RE, 1989, CROP SCI, V29, P1575, DOI 10.2135/cropsci1989.0011183X002900060068x; Bajgain P, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0628-9; Bates D., 2011, WELCOME LME4 MIXED E; Borner A, 2006, GENET RESOUR CROP EV, V53, P453, DOI 10.1007/s10722-004-1158-8; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Burt C, 2011, THEOR APPL GENET, V122, P119, DOI 10.1007/s00122-010-1427-1; Burt C, 2010, PLANT PATHOL, V59, P819, DOI 10.1111/j.1365-3059.2010.02307.x; Cadle MM, 1997, PLANT DIS, V81, P1181, DOI 10.1094/PDIS.1997.81.10.1181; Carter AH, 2017, J PLANT REGIST, V11, P263, DOI 10.3198/jpr2016.09.0051crc; Carter AH, 2014, J PLANT REGIST, V8, P273, DOI 10.3198/jpr2013.12.0074crc; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; delaPena RC, 1997, GENOME, V40, P249, DOI 10.1139/g97-035; DOUSSINAULT G, 1983, NATURE, V303, P698, DOI 10.1038/303698a0; DOUSSINAULT G, 1977, Z PFLANZENZUCHT, V79, P122; Feuillet C, 2008, TRENDS GENET, V24, P24, DOI 10.1016/j.tig.2007.11.001; Garland-Campbell K, 2017, J PLANT REGIST, V11, P152, DOI 10.3198/jpr2016.04.0018crc; Garland-Campbell K, 2013, J PLANT REGIST, V7, P81, DOI 10.3198/jpr2012.01.0005crc; HOLLINS TW, 1988, PLANT PATHOL, V37, P251, DOI 10.1111/j.1365-3059.1988.tb02070.x; Leonard JM, 2008, THEOR APPL GENET, V116, P261, DOI 10.1007/s00122-007-0664-4; Li HJ, 2005, THEOR APPL GENET, V111, P932, DOI 10.1007/s00122-005-0025-0; Li HJ, 2004, PHYTOPATHOLOGY, V94, P932, DOI 10.1094/PHYTO.2004.94.9.932; Lind V, 1999, PLANT BREEDING, V118, P281, DOI 10.1046/j.1439-0523.1999.00388.x; LIND V, 1992, PLANT BREEDING, V108, P202, DOI 10.1111/j.1439-0523.1992.tb00121.x; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Liu W, 2017, PLANT GEN, V11; Morrill W., 2010, COMPENDIUM WHEAT DIS, P32; Murray TD, 1996, PLANT DIS, V80, P19, DOI 10.1094/PD-80-0019; MURRAY TD, 1994, PLANT BREEDING, V113, P281, DOI 10.1111/j.1439-0523.1994.tb00737.x; Naruoka Y, 2015, THEOR APPL GENET, V128, P1083, DOI 10.1007/s00122-015-2492-2; Parnell S, 2008, PLANT PATHOL, V57, P509, DOI 10.1111/j.1365-3059.2007.01786.x; PETERSON CJ, 1991, CROP SCI, V31, P1704; RCore Team, 2020, R LANG ENV STAT COMP; Sheng H, 2013, PLANT DIS, V97, P346, DOI 10.1094/PDIS-12-11-1048-RE; STRAUSBAUGH CA, 1989, PHYTOPATHOLOGY, V79, P1048, DOI 10.1094/Phyto-79-1048; Summers RW, 2013, PLANT PATHOL, V62, P115, DOI 10.1111/ppa.12165; van Berloo R, 2008, J HERED, V99, P232, DOI 10.1093/jhered/esm109; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wetzel HC, 2011, PLANT DIS MANAG REP, V5; Wetzel HC, 2010, PLANT DIS MANAGE REP, V4; Wilkinson PA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-219; WORLAND AJ, 1988, PLANT BREEDING, V101, P43, DOI 10.1111/j.1439-0523.1988.tb00265.x; Yildirim A, 2000, PLANT DIS, V84, P40, DOI 10.1094/PDIS.2000.84.1.40; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zanke CD, 2016, THEOR APPL GENET, V3, P505; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	46	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0194698	10.1371/journal.pone.0194698	http://dx.doi.org/10.1371/journal.pone.0194698			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608579	gold, Green Submitted, Green Published			2022-12-26	WOS:000428988800014
J	Oryan, A; Alidadi, S; Bigham-Sadegh, A; Moshiri, A				Oryan, Ahmad; Alidadi, Soodeh; Bigham-Sadegh, Amin; Moshiri, Ali			Healing potentials of polymethylmethacrylate bone cement combined with platelet gel in the critical-sized radial bone defect of rats	PLOS ONE			English	Article							RICH PLASMA; POLYMETHYL METHACRYLATE; COMPOSITE SCAFFOLD; CANCELLOUS BONE; IN-VIVO; REGENERATION; MODEL; AUGMENTATION; RABBIT; PHOSPHATE	Polymethylmethacrylate (PMMA) is the most commonly used filler material that lacks biological properties and osteoconductivity or osteoinductivity. Platelet gel (PG) is a typical source of growth factors, cytokines and molecules efficient for bone formation and remodeling. The aim of this study was to evaluate bone healing and regeneration of bone defect in rat model by combining PMMA with PG. A total of 50 defects were created in the diaphysis of the radii of 25 male Sprague-Dawley rats. These defects were randomly divided into five groups (n = 10 defects for each group) and treated by autograft, plain PMMA, PG and PMMA-PG or left untreated. The rats were examined clinically and radiologically during the experiment and also after euthanasia at the 8th post-operative week, the healed defects were evaluated by gross morphology, histopathology, histomorphometry, computed tomography, scanning electron microscopy and biomechanical testing. PG could function as efficiently as autograft in promoting bone healing of the radial bones. Additionally, bone formation, and densities of cartilaginous and osseous tissues in the defects treated with autograft, PG and PMMA-PG were more satisfactory than the untreated and PMMA treated defects. Compared with the PMMA-PG implant, more PMMA residuals remained in the defect area and induced more intense inflammatory reaction. In conclusion, addition of PG could improve the bone regenerative properties of PMMA bone cement compared with PMMA alone in vivo. Therefore, the PG-PMMA can be proposed as a promising option to increase regenerative potential of PMMA, particularly when it is used as fixator, filler or adhesive in the dentistry, neurosurgery and bone tissue engineering applications.	[Oryan, Ahmad; Alidadi, Soodeh] Shiraz Univ, Sch Vet Med, Dept Pathol, Shiraz, Iran; [Bigham-Sadegh, Amin] Shahrekord Univ, Sch Vet Med, Dept Clin Sci, Shahrekord, Iran; [Moshiri, Ali] AJA Univ Med Sci, Dept Orthoped Surg, Fac Med, Tehran, Iran	Shiraz University; Shahrekord University	Bigham-Sadegh, A (corresponding author), Shahrekord Univ, Sch Vet Med, Dept Clin Sci, Shahrekord, Iran.	dr.bigham@gmail.com	Alidadi, Soodeh/M-4690-2017; Moshiri, Ali/H-1851-2013; Oryan, Ahmad/J-6539-2014	Alidadi, Soodeh/0000-0003-2341-8533; Moshiri, Ali/0000-0003-3967-7468; Oryan, Ahmad/0000-0003-1697-2376				Aghyarian S, 2014, J BIOMATER APPL, V29, P688, DOI 10.1177/0885328214544770; Arabmotlagh M, 2014, J BIOMED MATER RES B, V102, P1613, DOI 10.1002/jbm.b.33140; Arora M, 2013, WORLD J ORTHOP, V4, P67, DOI 10.5312/wjo.v4.i2.67; Betoni W, 2013, J ORAL IMPLANTOL, V39, P14, DOI 10.1563/AAID-JOI-D-10-00043; Dalby MJ, 2002, BIOMATERIALS, V23, P569, DOI 10.1016/S0142-9612(01)00139-9; Fini M, 2002, BIOMATERIALS, V23, P4523, DOI 10.1016/S0142-9612(02)00196-5; Hatten HP, 2012, INTERV NEURORADIOL, V18, P105, DOI 10.1177/159101991201800114; Hautaamaki MP, 2008, ACTA ORTHOP, V79, P555, DOI 10.1080/17453670710015571; He FP, 2015, J BIOMED MATER RES A, V103, P1312, DOI 10.1002/jbm.a.35248; Jager M, 2003, J BIOMAT SCI-POLYM E, V14, P1283, DOI 10.1163/156856203322553491; Khairy NM, 2013, INT J ORAL MAX SURG, V42, P249, DOI 10.1016/j.ijom.2012.09.009; Kim SB, 2004, BIOMATERIALS, V25, P5715, DOI 10.1016/j.biomaterials.2004.01.022; LANE JM, 1987, ORTHOP CLIN N AM, V18, P213; Lv Q, 2006, J MATER SCI-MATER M, V17, P1349, DOI 10.1007/s10856-006-0610-z; Lye KW, 2013, CLIN ORAL IMPLAN RES, V24, P100, DOI 10.1111/j.1600-0501.2011.02388.x; Magnan B, 2013, Musculoskelet Surg, V97, P93, DOI 10.1007/s12306-013-0293-9; Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4; Mooren RECM, 2010, INT J ORAL MAX SURG, V39, P371, DOI 10.1016/j.ijom.2009.12.019; Moshiri A, 2015, J CELL MOL MED, V19, P1308, DOI 10.1111/jcmm.12511; Moshiri A, 2014, EXPERT OPIN BIOL TH, V14, P1065, DOI 10.1517/14712598.2014.915305; Mousa WF, 2000, BIOMATERIALS, V21, P2137, DOI 10.1016/S0142-9612(00)00097-1; Niemeyer P, 2010, BIOMATERIALS, V31, P3572, DOI 10.1016/j.biomaterials.2010.01.085; Ogundipe OK, 2011, J ORAL MAXIL SURG, V69, P2305, DOI 10.1016/j.joms.2011.02.014; Oryan A, 2012, CELL TISSUE BANK, V13, P639, DOI 10.1007/s10561-011-9285-x; Oryan A, 2017, CALCIFIED TISSUE INT; Oryan A, 2017, J CONTROL RELEASE, V254, P65, DOI 10.1016/j.jconrel.2017.03.040; Oryan A, 2016, EXPERT OPIN BIOL TH, V16, P213, DOI 10.1517/14712598.2016.1118458; Oryan A, 2015, EXP BIOL MED, V240, P194, DOI 10.1177/1535370214554532; Oryan A, 2014, BIODRUGS, V28, P537, DOI 10.1007/s40259-014-0107-0; Parizi AM, 2012, J MATER SCI-MATER M, V23, P473, DOI 10.1007/s10856-011-4478-1; Peng W, 2016, MAXILLOFAC PLAST REC, V38, P1; Plachokova AS, 2009, INT J ORAL MAX SURG, V38, P861, DOI 10.1016/j.ijom.2009.04.009; Rodriguez IA, 2014, BIOMED RES INT, V2014; Tajima S, 2015, TISSUE ENG PT A, V21, P895, DOI [10.1089/ten.tea.2014.0336, 10.1089/ten.TEA.2014.0336]; van Bergen CJA, 2013, OSTEOARTHR CARTILAGE, V21, P1746, DOI 10.1016/j.joca.2013.07.014; Weibrich G, 2004, BONE, V34, P665, DOI 10.1016/j.bone.2003.12.010; Wildemann B, 2005, BIOMATERIALS, V26, P4035, DOI 10.1016/j.biomaterials.2004.10.004; Wolf-Brandstetter C, 2013, J BIOMED MATER RES B, V101B, P599, DOI 10.1002/jbm.b.32862; Xing ZC, 2013, J BIOMAT SCI-POLYM E, V24, P61, DOI 10.1163/156856212X623526; Yang J, 2015, MED SCI MONITOR, V21, P1162, DOI 10.12659/MSM.893845; Zhang ZY, 2013, CELL TRANSPLANT, V22, P175, DOI 10.3727/096368912X653183; Zhu TJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03207-9	42	10	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0194751	10.1371/journal.pone.0194751	http://dx.doi.org/10.1371/journal.pone.0194751			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608574	Green Published, gold, Green Submitted			2022-12-26	WOS:000428988800017
J	Germino, EA; Miller, JP; Diehl, L; Swanson, CJ; Durinck, S; Modrusan, Z; Miner, JH; Shaw, AS				Germino, Elizabeth A.; Miller, Joseph P.; Diehl, Lauri; Swanson, Carter J.; Durinck, Steffen; Modrusan, Zora; Miner, Jeffrey H.; Shaw, Andrey S.			Homozygous KSR1 deletion attenuates morbidity but does not prevent tumor development in a mouse model of RAS-driven pancreatic cancer	PLOS ONE			English	Article							KINASE SUPPRESSOR; SIGNAL-TRANSDUCTION; DUCTAL ADENOCARCINOMA; GENE ENCODES; C-ELEGANS; PROTEIN; SCAFFOLD; MICE; MEK; IDENTIFICATION	Given the frequency with which MAP kinase signaling is dysregulated in cancer, much effort has been focused on inhibiting RAS signaling for therapeutic benefit. KSR1, a pseudokinase that interacts with RAF, is a potential target; it was originally cloned in screens for suppressors of constitutively active RAS, and its deletion prevents RAS-mediated transformation of mouse embryonic fibroblasts. In this work, we used a genetically engineered mouse model of pancreatic cancer to assess whether KSR1 deletion would influence tumor development in the setting of oncogenic RAS. We found that Ksr1(-/-) mice on this background had a modest but significant improvement in all-cause morbidity compared to Ksr1(+/+) and Ksr1(+/-) cohorts. Ksr1(-/-) mice, however, still developed tumors, and precursor pancreatic intraepithelial neoplastic (PanIN) lesions were detected within a similar timeframe compared to Ksr1(+/+) mice. No significant differences in pERK expression or in proliferation were noted. RNA sequencing also did not reveal any unique genetic signature in Ksr1(-/-) tumors. Further studies will be needed to determine whether and in what settings KSR inhibition may be clinically useful.	[Germino, Elizabeth A.; Shaw, Andrey S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Germino, Elizabeth A.; Swanson, Carter J.; Shaw, Andrey S.] Genentech Inc, Dept Biol Res, San Francisco, CA 94080 USA; [Miller, Joseph P.; Miner, Jeffrey H.] Washington Univ, Sch Med, Div Nephrol, St Louis, MO USA; [Diehl, Lauri] Genentech Inc, Dept Pathol, San Francisco, CA USA; [Durinck, Steffen] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA USA; [Durinck, Steffen; Modrusan, Zora] Genentech Inc, Dept Mol Biol, San Francisco, CA USA	Washington University (WUSTL); Roche Holding; Genentech; Washington University (WUSTL); Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Shaw, AS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.; Shaw, AS (corresponding author), Genentech Inc, Dept Biol Res, San Francisco, CA 94080 USA.	shaw.andrey@gene.com		Shaw, Andrey/0000-0001-5685-0272	NIDDK NIH HHS [R01 DK058366] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058366] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Cacace AM, 1999, MOL CELL BIOL, V19, P229; Denouel-Galy A, 1998, CURR BIOL, V8, P46, DOI 10.1016/S0960-9822(98)70019-3; Dhawan NS, 2016, NATURE, V537, P112, DOI 10.1038/nature19327; Evans RA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88328; Guerra C, 2013, MOL ONCOL, V7, P232, DOI 10.1016/j.molonc.2013.02.002; Herreros-Villanueva M, 2012, WORLD J GASTROENTERO, V18, P1286, DOI 10.3748/wjg.v18.i12.1286; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hu JC, 2011, P NATL ACAD SCI USA, V108, P6067, DOI 10.1073/pnas.1102554108; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jacobetz MA, 2013, GUT, V62, P112, DOI 10.1136/gutjnl-2012-302529; KORNFELD K, 1995, CELL, V83, P903, DOI 10.1016/0092-8674(95)90206-6; Kortum RL, 2006, MOL CELL BIOL, V26, P2202, DOI 10.1128/MCB.26.6.2202-2214.2006; Kortum RL, 2004, MOL CELL BIOL, V24, P4407, DOI 10.1128/MCB.24.10.4407-4416.2004; Lozano J, 2003, CANCER RES, V63, P4232; Marino S, 2000, GENE DEV, V14, P994; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Muller J, 2000, MOL CELL BIOL, V20, P5529, DOI 10.1128/MCB.20.15.5529-5539.2000; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Shalin SC, 2006, NEURON, V50, P765, DOI 10.1016/j.neuron.2006.04.029; Stebbing J, 2015, ONCOGENE, V34, P2103, DOI 10.1038/onc.2014.129; Stewart S, 1999, MOL CELL BIOL, V19, P5523; SUNDARAM M, 1995, CELL, V83, P889, DOI 10.1016/0092-8674(95)90205-8; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Xing HM, 1997, CURR BIOL, V7, P294, DOI 10.1016/S0960-9822(06)00152-7; Xing HR, 2003, NAT MED, V9, P1266, DOI 10.1038/nm927; Yu W, 1998, CURR BIOL, V8, P56, DOI 10.1016/S0960-9822(98)70020-X; Zhang JJ, 2008, CANCER BIOL THER, V7, P1492, DOI 10.4161/cbt.7.9.6472	35	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194998	10.1371/journal.pone.0194998	http://dx.doi.org/10.1371/journal.pone.0194998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596465	Green Published, gold, Green Submitted			2022-12-26	WOS:000428630000063
J	Konstantinou, D; Gerovasileiou, V; Voultsiadou, E; Gkelis, S				Konstantinou, Despoina; Gerovasileiou, Vasilis; Voultsiadou, Eleni; Gkelis, Spyros			Sponges-Cyanobacteria associations: Global diversity overview and new data from the Eastern Mediterranean	PLOS ONE			English	Article							BARRIER-REEF SPONGE; OSCILLATORIA-SPONGELIAE; BACTERIAL COMMUNITIES; MICROBIAL COMMUNITY; MARINE SPONGES; CHLOROPHYLL-A; AEGEAN SEA; SYMBIONTS; PHYLOGENY; AUSTRALIA	Sponge-cyanobacteria associations have attracted research interest from an ecological, evolutionary and biotechnological perspective. Current knowledge is, in its majority, "hidden" in metagenomics research studying the entire microbial communities of sponges, while knowledge on these associations is totally missing for certain geographic areas. In this study, we (a) investigated the occurrence of cyanobacteria in 18 sponge species, several of which are studied for the first time for their cyanobionts, from a previously unexplored eastern Mediterranean ecoregion, the Aegean Sea, (b) isolated sponge-associated cyanobacteria, and characterized them based on a polyphasic (morphological-morphometric and molecular phylogenetic analysis) approach, and (c) conducted a meta-analysis on the global diversity of sponge species hosting cyanobacteria, as well as the diversity of cyanobacterial symbionts. Our research provided new records for nine sponge species, previously unknown for this association, while the isolated cyanobacteria were found to form novel clades within Synechococcus, Leptolyngbyaceae, Pseudanabaenaceae, and Schizotrichaceae, whose taxonomic status requires further investigation; this is the first report of a Schizotrichaceae cyanobacterium associated with sponges. The extensive evaluation of the literature along with the new data from the Aegean Sea raised the number of sponge species known for hosting cyanobacteria to 320 and showed that the cyanobacterial diversity reported from sponges is yet underestimated.	[Konstantinou, Despoina; Gkelis, Spyros] Aristotle Univ Thessaloniki, Sch Biol, Dept Bot, Thessaloniki, Greece; [Konstantinou, Despoina; Voultsiadou, Eleni] Aristotle Univ Thessaloniki, Sch Biol, Dept Zool, Thessaloniki, Greece; [Gerovasileiou, Vasilis] Hellen Ctr Marine Res, Inst Marine Biol Biotechnol & Aquaculture, Iraklion, Crete, Greece	Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; Hellenic Centre for Marine Research	Gkelis, S (corresponding author), Aristotle Univ Thessaloniki, Sch Biol, Dept Bot, Thessaloniki, Greece.	sgkelis@bio.auth.gr	Gkelis, Spyros/N-3484-2015; Gerovasileiou, Vasilis/H-6376-2019	Gkelis, Spyros/0000-0002-7746-3199; Gerovasileiou, Vasilis/0000-0002-9143-7480; Voultsiadou, Eleni/0000-0003-3429-6754				Alex A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051834; Antoniadou C, 2006, BELG J ZOOL, V136, P69; ARILLO A, 1993, MAR BIOL, V117, P159, DOI 10.1007/BF00346438; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Atashpaz S, 2010, MICROBIOLOGY+, V79, P538, DOI 10.1134/S0026261710040168; Bayer K, 2014, FEMS MICROBIOL ECOL, V89, P679, DOI 10.1111/1574-6941.12369; BERGQUIST P R, 1978, P268; Bergquist PR, 1980, SYSTEMA PORIFERA GUI, P1094; Betti F, 2012, MAR ECOL-EVOL PERSP, V33, P49, DOI [10.1111/j.1439-0485.2012.00525.x, 10.1111/j.1439-0485.2011.00456.x]; Burgsdorf I, 2015, MBIO, V6, DOI 10.1128/mBio.00391-15; Burgsdorf I, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00529; Burja AM, 2001, HYDROBIOLOGIA, V461, P41, DOI 10.1023/A:1012713130404; Caroppo C, 2012, FOTTEA, V12, P315, DOI 10.5507/fot.2012.022; CHISHOLM SW, 1992, ARCH MICROBIOL, V157, P297, DOI 10.1007/BF00245165; COX GC, 1985, MAR BIOL, V89, P149, DOI 10.1007/BF00392886; Diaz Maria Cristina, 2007, V28, P31; Dittmann E, 2015, TRENDS MICROBIOL, V23, P642, DOI 10.1016/j.tim.2015.07.008; Erwin PM, 2008, MOL ECOL, V17, P2937, DOI 10.1111/j.1365-294X.2008.03808.x; Erwin PM, 2008, MAR ECOL PROG SER, V362, P139, DOI 10.3354/meps07464; Erwin PM, 2012, MICROB ECOL, V64, P771, DOI 10.1007/s00248-012-0047-5; Friedrich AB, 2001, FEMS MICROBIOL ECOL, V38, P105, DOI 10.1111/j.1574-6941.2001.tb00888.x; Fromont J, 2016, J MAR BIOL ASSOC UK, V96, P541, DOI 10.1017/S0025315415000491; Gao ZM, 2014, MBIO, V5, DOI 10.1128/mBio.00079-14; Gerovasileiou V, 2016, J MAR BIOL ASSOC UK, V96, P407, DOI 10.1017/S0025315415000697; Gerovasileiou V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039873; Gkelis S, 2016, BIODIVERS DATA J, V4, DOI 10.3897/BDJ.4.e7965; Guiry MD, 2017, ALGAEBASE; Hardoim CCP, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00611; Hentschel U, 2001, FEMS MICROBIOL ECOL, V35, P305, DOI 10.1111/j.1574-6941.2001.tb00816.x; HINDE R, 1994, MAR BIOL, V119, P99, DOI 10.1007/BF00350111; Hooper JN, 2002, GUIDE CLASSIFICATION; Isaacs LT, 2009, MAR BIOTECHNOL, V11, P758, DOI 10.1007/s10126-009-9192-3; Komarek J, 1999, SUSSWASSERFLORA MITT, V19; Komarek J., 2005, SUSSWASSERFLORA MITT, V19/2, P759; Luo CW, 2015, NAT BIOTECHNOL, V33, P1045, DOI 10.1038/nbt.3319; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morrow C, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-015-0099-8; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Olson JB, 2014, FEMS MICROBIOL ECOL, V87, P268, DOI 10.1111/1574-6941.12222; Pagliara P, 2011, TOXICON, V57, P889, DOI 10.1016/j.toxicon.2011.03.006; Pfannkuchen M, 2010, J EXP MAR BIOL ECOL, V390, P169, DOI 10.1016/j.jembe.2010.04.038; Pita L, 2013, FEMS MICROBIOL ECOL, V86, P268, DOI 10.1111/1574-6941.12159; Ramos V, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.54; Ribes M, 2012, ENVIRON MICROBIOL, V14, P1224, DOI 10.1111/j.1462-2920.2012.02701.x; Ridley CP, 2005, APPL ENVIRON MICROB, V71, P7366, DOI 10.1128/AEM.71.11.7366-7375.2005; RIPPKA R, 1988, METHOD ENZYMOL, V167, P3; Roling WF, MOL MICROBIAL ECOLOG, P177; SARA M, 1971, MAR BIOL, V11, P214, DOI 10.1007/BF00401270; SCHMIDT TM, 1991, J BACTERIOL, V173, P4371, DOI 10.1128/JB.173.14.4371-4378.1991; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Slaby BM, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.00268-17; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Steindler L, 2005, APPL ENVIRON MICROB, V71, P4127, DOI 10.1128/AEM.71.7.4127-4131.2005; Steinert G, 2016, PEERJ, V4, DOI 10.7717/peerj.1936; Stewart EJ, 2012, J BACTERIOL, V194, P4151, DOI 10.1128/JB.00345-12; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taton A, 2003, APPL ENVIRON MICROB, V69, P5157, DOI 10.1128/AEM.69.9.5157-5169.2003; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Thacker RW, 2012, ADV MAR BIOL, V62, P57, DOI 10.1016/B978-0-12-394283-8.00002-3; Thacker RW, 2003, MAR BIOL, V142, P643, DOI 10.1007/s00227-002-0971-x; Thomas T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11870; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; URIZ MJ, 1992, PSZNI MAR ECOL, V13, P101; Usher KM, 2008, MAR ECOL-EVOL PERSP, V29, P178, DOI 10.1111/j.1439-0485.2008.00245.x; Usher KM, 2004, MICROB ECOL, V48, P167, DOI 10.1007/s00248-003-1062-3; Usher KM, 2004, SYMBIOSIS, V36, P183; VACELET J, 1977, J EXP MAR BIOL ECOL, V30, P301, DOI 10.1016/0022-0981(77)90038-7; Van Soest R.W.M, 2017, WORLD PORIFERA DATAB; Van Soest RWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035105; VANSOEST RWM, 1994, SPONGES IN TIME AND SPACE, P213; Voigt O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033417; Voultsiadou E, 2005, ITAL J ZOOL, V72, P53, DOI 10.1080/11250000509356653; Voultsiadou E, 2016, BIODIVERS DATA J, V4, DOI 10.3897/BDJ.4.e7984; Voultsiadou E, 2009, HYDROBIOLOGIA, V628, P1, DOI 10.1007/s10750-009-9725-9; Wang GY, 2009, ISME J, V3, P374, DOI 10.1038/ismej.2008.107; WATERBURY JB, 1978, MICROBIOL REV, V42, P2, DOI 10.1128/MMBR.42.1.2-44.1978; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Webster NS, 2001, MAR BIOL, V138, P843, DOI 10.1007/s002270000503; Wilkinson C.R., 1979, Colloques Internationaux du Centre National de la Recherche Scientifique, P373; WILKINSON CR, 1983, SCIENCE, V219, P410, DOI 10.1126/science.219.4583.410; Worheide G, 2012, ADV MAR BIOL; WoRMS Editorial Board, 2017, WORLD REGISTER MARIN, DOI 10.14284/170; Zhang F, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00561	83	22	24	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195001	10.1371/journal.pone.0195001	http://dx.doi.org/10.1371/journal.pone.0195001			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596453	gold, Green Published, Green Submitted			2022-12-26	WOS:000428630000064
J	Hague, E; Banik, U; Monwar, T; Anthony, L; Adhikary, AK				Hague, Ezazul; Banik, Urmila; Monwar, Tahmina; Anthony, Leela; Adhikary, Arun Kumar			Worldwide increased prevalence of human adenovirus type 3 (HAdV-3) respiratory infections is well correlated with heterogeneous hypervariable regions (HVRs) of hexon	PLOS ONE			English	Article							CONSECUTIVE YEARS 1991-2007; KOREAN CHILDREN; MOLECULAR EPIDEMIOLOGY; TRACT INFECTIONS; YOUNG-ADULTS; SEROTYPES 4; OUTBREAK; IDENTIFICATION; PNEUMONIA; STRAINS	Human adenovirus type 3 (HAdV-3) respiratory infections occurs worldwide in both children and adults, leading to severe morbidity and mortality, particularly in the paediatric age group and especially in neonates. During HAdV infection, neutralizing antibodies are formed against the epitopes located in the hyper variable regions (HVRs) of the hexon protein. These neutralizing antibodies provide protection against reinfection by viruses of the same type. Therefore it is reasonable to speculate that variations of HAdV-3 in the HVRs could impair the immunity acquired by previous infection with a different strain with variation in its HVRs. HAdV-3 has recently become the major agent of acute respiratory infection worldwide, being responsible for 15% to 87% of all adenoviral respiratory infections. However, despite the increased prevalence of HAdV-3 as respiratory pathogen, the diversity of hexon proteins in circulating strains remains unexplored. This study was designed to explore the variation in HVRs of hexon among globally distributed strains of HAdV-3 as well as to discover possible relationship among them, thus possibly shedding light on the cause for the increased prevalence of HAdV-3. In this study, for the first time we analysed the hexon proteins of all 248 available strains of HAdV-3 from the NCBI database and compared them with those of the HAdV-3 prototype (GB stain). We found that the HVRs of HAdV-3 strains circulating worldwide were highly heterogeneous and have been mutating continuously since-their original isolation. Based on their immense heterogeneity, the strains can be categorized into 25 hexon variants (3Hv-1 to 3Hv-25), 4 of which (3Hv-1 to 3Hv-4) comprises 80% of the strains. This heterogeneity may explain why HAdV-3 has become the most prevalent HAdVs type worldwide. The heterogeneity of hexon proteins also shows that the development of a vaccine against HAdV-3 might be challenging. The data on hexon variants provided here may be useful for the future epidemiological study of HAdV-3 infection.	[Hague, Ezazul; Monwar, Tahmina; Adhikary, Arun Kumar] AIMST Univ, Unit Microbiol, Fac Med, Jalan Bedong Semeling, Bedong, Kedah, Malaysia; [Banik, Urmila] AIMST Univ, Unit Pathol, Fac Med, Jalan Bedong Semeling, Bedong, Kedah, Malaysia; [Anthony, Leela] AIMST Univ, Unit Community Med, Fac Med, Jalan Bedong Semeling, Bedong, Kedah, Malaysia	AIMST University; AIMST University; AIMST University	Adhikary, AK (corresponding author), AIMST Univ, Unit Microbiol, Fac Med, Jalan Bedong Semeling, Bedong, Kedah, Malaysia.	arun_adhikary@msn.com	Monowar, Tahmina/P-2915-2019	Monowar, Tahmina/0000-0002-6885-9562; Banik, Urmila/0000-0003-2578-0288; Adhikary, Arun Kumar/0000-0002-6009-1608				Adhikary AK, 2017, J MED MICROBIOL, V66, P1616, DOI 10.1099/jmm.0.000625; Adhikary AK, 2014, J CLIN VIROL, V61, P477, DOI 10.1016/j.jcv.2014.10.015; Banik U, 2005, J CLIN MICROBIOL, V43, P1064, DOI 10.1128/JCM.43.3.1064-1068.2005; Barker JH, 2003, CLIN INFECT DIS, V37, pE142, DOI 10.1086/379127; Blasiole DA, 2004, J CLIN MICROBIOL, V42, P1686, DOI 10.1128/JCM.42.4.1686-1693.2004; Chang SY, 2008, J MED VIROL, V80, P102, DOI 10.1002/jmv.21045; Chen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121375; Chen Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155412; Choi EH, 2006, J MED VIROL, V78, P379, DOI 10.1002/jmv.20550; Cooper RJ, 2000, EPIDEMIOL INFECT, V125, P333, DOI 10.1017/S0950268899004550; Crawford-Miksza LK, 1999, J CLIN MICROBIOL, V37, P1107, DOI 10.1128/JCM.37.4.1107-1112.1999; CrawfordMiksza L, 1996, J VIROL, V70, P1836, DOI 10.1128/JVI.70.3.1836-1844.1996; Demian PN, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-50; Fujimoto T, 2008, JPN J INFECT DIS, V61, P143; Girouard G, 2011, CAN J INFECT DIS MED, V22, pE4, DOI 10.1155/2011/575476; Gray GC, 2007, CLIN INFECT DIS, V45, P1120, DOI 10.1086/522188; Harley D, 2001, Commun Dis Intell, V25, P9; HERBERT FA, 1977, CAN MED ASSOC J, V116, P274; HILLEMAN MR, 1958, ARCH INTERN MED, V102, P428, DOI 10.1001/archinte.1958.00030010428013; HILLEMAN MR, 1958, J IMMUNOL, V80, P299; Hong JY, 2001, CLIN INFECT DIS, V32, P1423, DOI 10.1086/320146; HUEBNER RJ, 1954, NEW ENGL J MED, V251, P1077, DOI 10.1056/NEJM195412302512701; Hung K-H, 2015, MEDICINE, P94; James L, 2007, CLIN INFECT DIS, V45, P416, DOI 10.1086/519938; Jin Y, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-271; Kajon AE, 1996, J MED VIROL, V48, P151, DOI 10.1002/(SICI)1096-9071(199602)48:2&lt;151::AID-JMV6&gt;3.0.CO;2-8; Kim YJ, 2003, J CLIN MICROBIOL, V41, P4594, DOI 10.1128/JCM.41.10.4594-4599.2003; Lai CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053614; Landry ML, 2009, J MED VIROL, V81, P1380, DOI 10.1002/jmv.21539; Lebeck MG, 2009, J CLIN VIROL, V46, P331, DOI 10.1016/j.jcv.2009.09.023; Lee J, 2010, J CLIN VIROL, V49, P115, DOI 10.1016/j.jcv.2010.07.007; Lee J, 2010, J MED VIROL, V82, P624, DOI 10.1002/jmv.21701; LI QG, 1988, J CLIN MICROBIOL, V26, P1009, DOI 10.1128/JCM.26.5.1009-1015.1988; Lin YK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137890; Ludwig SL, 1998, J INFECT DIS, V178, P1776, DOI 10.1086/314498; Lynch JP, 2016, SEMIN RESP CRIT CARE, V37, P586, DOI 10.1055/s-0036-1584923; Mizuta K, 2009, VIRUS RES, V140, P32, DOI 10.1016/j.virusres.2008.10.014; Pichla-Gollon SL, 2007, J VIROL, V81, P1680, DOI 10.1128/JVI.02023-06; Rebelo-De-Andrade H, 2010, J CLIN MICROBIOL, V48, P1391, DOI 10.1128/JCM.02019-09; ROBERTS MM, 1986, SCIENCE, V232, P1148, DOI 10.1126/science.3704642; Rojas LJ, 2012, EPIDEMIOL INFECT, V140, P818, DOI 10.1017/S0950268811001269; Russell WC, 2009, J GEN VIROL, V90, P1, DOI 10.1099/vir.0.003087-0; Russell WC, 2000, J GEN VIROL, V81, P2573, DOI 10.1099/0022-1317-81-11-2573; Rux JJ, 2003, J VIROL, V77, P9553, DOI 10.1128/JVI.77.17.9553-9566.2003; Ryan MAK, 2002, CLIN INFECT DIS, V34, P577, DOI 10.1086/338471; SCHMITZ H, 1983, AM J EPIDEMIOL, V117, P455, DOI 10.1093/oxfordjournals.aje.a113563; Sriwanna P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-193; Takeuchi S, 1999, J CLIN MICROBIOL, V37, P1839, DOI 10.1128/JCM.37.6.1839-1845.1999; Wang YF, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003577; Yeung R, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-11; Zhang QW, 2006, J GEN VIROL, V87, P1531, DOI 10.1099/vir.0.81515-0; Zou LR, 2012, APMIS, V120, P683, DOI 10.1111/j.1600-0463.2012.02890.x	52	12	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194516	10.1371/journal.pone.0194516	http://dx.doi.org/10.1371/journal.pone.0194516			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590206	Green Published, gold, Green Submitted			2022-12-26	WOS:000428603100064
J	Nozaki, S; Katoh, Y; Kobayashi, T; Nakayama, K				Nozaki, Shohei; Katoh, Yohei; Kobayashi, Takuya; Nakayama, Kazuhisa			BBS1 is involved in retrograde trafficking of ciliary GPCRs in the context of the BBSome complex	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; INTRAFLAGELLAR TRANSPORT; B COMPLEX; IFT; CILIOGENESIS; RECOGNITION; BINDING; MOTIFS; ROLES; ENTRY	Protein trafficking within cilia is mediated by the intraflagellar transport (IFT) machinery composed of large protein complexes. The BBSome consists of eight BBS proteins encoded by causative genes of Bardet-Biedl syndrome (BBS), and has been implicated in the trafficking of ciliary membrane proteins, including G protein-coupled receptors (GPCRs), by connecting the IFT machinery to cargo GPCRs. Membrane recruitment of the BBSome to promote cargo trafficking has been proposed to be regulated by the Arf-like small GTPase ARL6/BBS3, through its interaction with the BBS1 subunit of the BBSome. We here investigated how the BBSome core subcomplex composed of BBS1, BBS2, BBS7, and BBS9 assembles and interacts with ARL6, and found that the ARL6 BBS1 interaction is reinforced by BBS9. BBS1-knockout (KO) cells showed defects in the ciliary entry of other BBSome subunits and ARL6, and in ciliary retrograde trafficking and the export of the GPCRs, Smoothened and GPR161. The trafficking defect of these GPCRs was rescued by the exogenous expression of wild-type BBS1, but not by its mutant lacking BBS9-binding ability. Our data thus indicate that the intact BBSome is required for retrograde trafficking of GPCRs out of cilia.	[Nozaki, Shohei; Katoh, Yohei; Kobayashi, Takuya; Nakayama, Kazuhisa] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto, Japan	Kyoto University	Nakayama, K (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto, Japan.	kazunaka@pharm.kyoto-u.ac.jp	Katoh, Yohei/AAA-3378-2020; Nakayama, Kazuhisa/ABF-2924-2020	Nakayama, Kazuhisa/0000-0001-7701-7183	Ministry of Education, Culture, Sports, Science and Technology, Japan [15H01211]; Japan Society for the Promotion of Science (JSPS) [15H04370, 15K07929, 16J03865]; Astellas Foundation for Research on Metabolic Disorders; Takeda Science Foundation; Uehara Memorial Foundation; JSPS Research Fellowship; Grants-in-Aid for Scientific Research [15H04370, 16J03865] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Astellas Foundation for Research on Metabolic Disorders; Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); JSPS Research Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas "Cilia and Centrosome" from the Ministry of Education, Culture, Sports, Science and Technology, Japan (grant number 15H01211 to K.N.); grants from the Japan Society for the Promotion of Science (JSPS) (grant numbers 15H04370 to K.N., 15K07929 to Y.K., and 16J03865 to S.N.); and grants from the Astellas Foundation for Research on Metabolic Disorders to K.N., and from the Takeda Science Foundation and the Uehara Memorial Foundation to Y.K. S.N. was supported by a JSPS Research Fellowship.	Boldt K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11491; Braun DA, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028191; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Eguether T, 2014, DEV CELL, V31, P279, DOI 10.1016/j.devcel.2014.09.011; Funabashi T, 2017, MOL BIOL CELL, V28, P624, DOI 10.1091/mbc.E16-09-0648; Hirano T, 2017, MOL BIOL CELL, V28, P429, DOI 10.1091/mbc.E16-11-0813; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Jackson LP, 2012, DEV CELL, V23, P1255, DOI 10.1016/j.devcel.2012.10.017; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Katoh Y, 2017, MOL BIOL CELL, V28, P898, DOI 10.1091/mbc.E17-01-0051; Katoh Y, 2016, J BIOL CHEM, V291, P10962, DOI 10.1074/jbc.M116.713883; Katoh Y, 2015, J CELL SCI, V128, P2351, DOI 10.1242/jcs.168740; Klink BU, 2017, ELIFE, V6, DOI 10.7554/eLife.27434; Knockenhauer KE, 2015, J BIOL CHEM, V290, P19569, DOI 10.1074/jbc.M115.649202; Liew GM, 2014, DEV CELL, V31, P265, DOI 10.1016/j.devcel.2014.09.004; Ma WF, 2013, EMBO J, V32, P926, DOI 10.1038/emboj.2013.41; Madhivanan K, 2014, TRAFFIC, V15, P1031, DOI 10.1111/tra.12195; Mourao A, 2014, NAT STRUCT MOL BIOL, V21, P1035, DOI 10.1038/nsmb.2920; Mukhopadhyay S, 2014, SEMIN CELL DEV BIOL, V33, P63, DOI 10.1016/j.semcdb.2014.05.002; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nakayama K, 2003, CELL STRUCT FUNCT, V28, P431, DOI 10.1247/csf.28.431; Nakayama K, 2018, J BIOCHEM, V163, P155, DOI 10.1093/jb/mvx087; Nishijima Y, 2017, MOL BIOL CELL, V28, P1652, DOI 10.1091/mbc.E17-01-0017; Nozaki S, 2017, J CELL SCI, V130, P563, DOI 10.1242/jcs.197004; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Seo S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002358; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Sung CH, 2013, NAT CELL BIOL, V15, P1387, DOI 10.1038/ncb2888; Takahashi S, 2012, J CELL SCI, V125, P4049, DOI 10.1242/jcs.102913; Taschner M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a028092; Taschner M, 2016, EMBO J, V35, P773, DOI 10.15252/embj.201593164; Thomas S, 2009, J BIOL CHEM, V284, P12410, DOI 10.1074/jbc.M809746200; Verhey KJ, 2016, CURR OPIN CELL BIOL, V41, P109, DOI 10.1016/j.ceb.2016.05.004; Wei Q, 2015, CURR OPIN CELL BIOL, V35, P98, DOI 10.1016/j.ceb.2015.04.015; Williams CL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6813; Woodsmith J, 2017, NAT METHODS, V14, P1213, DOI [10.1038/NMETH.4464, 10.1038/nmeth.4464]; Zhang QH, 2011, P NATL ACAD SCI USA, V108, P20678, DOI 10.1073/pnas.1113220108	38	31	32	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0195005	10.1371/journal.pone.0195005	http://dx.doi.org/10.1371/journal.pone.0195005			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590217	Green Published, gold, Green Submitted			2022-12-26	WOS:000428603100096
J	Rios-Garaizar, J; Lopez-Bulto, O; Iriarte, E; Perez-Garrido, C; Pique, R; Aranburu, A; Iriarte-Chiapusso, MJ; Ortega-Cordellat, I; Bourguignon, L; Garate, D; Libano, I				Rios-Garaizar, Joseba; Lopez-Bulto, Oriol; Iriarte, Eneko; Perez-Garrido, Carlos; Pique, Raquel; Aranburu, Arantza; Jose Iriarte-Chiapusso, Maria; Ortega-Cordellat, Illuminada; Bourguignon, Laurence; Garate, Diego; Libano, Inaki			A Middle Palaeolithic wooden digging stick from Aranbaltza III, Spain	PLOS ONE			English	Article							BONE TOOLS; ABRIC-ROMANI; ARTIFACTS; SITE; NEANDERTHALS; PLEISTOCENE; BARCELONA; INSIGHTS; CAVE	Aranbaltza is an archaeological complex formed by at least three open-air sites. Between 2014 and 2015 a test excavation carried out in Aranbaltza I I I revealed the presence of a sand and clay sedimentary sequence formed in floodplain environments, within which six sedimentary units have been identified. This sequence was formed between 137-50 ka, and includes several archaeological horizons, attesting to the long-term presence of Neanderthal communities in this area. One of these horizons, corresponding with Unit 4, yielded two wooden tools. One of these tools is a beveled pointed tool that was shaped through a complex operational sequence involving branch shaping, bark peeling, twig removal, shaping, polishing, thermal exposition and chopping. A use-wear analysis of the tool shows it to have traces related with digging soil so it has been interpreted as representing a digging stick. This is the first time such a tool has been identified in a European Late Middle Palaeolithic context; it also represents one of the first well-preserved Middle Palaeolithic wooden tool found in southern Europe. This artefact represents one of the few examples available of wooden tool preservation for the European Palaeolithic, allowing us to further explore the role wooden technologies played in Neanderthal communities.	[Rios-Garaizar, Joseba] Ctr Nacl Invest Evoluc Humana CENIEH, Burgos, Spain; [Lopez-Bulto, Oriol; Pique, Raquel] Univ Autonoma Barcelona, Dept Prehist, Barcelona, Spain; [Iriarte, Eneko] Univ Burgos, Lab Evoluc Humana, Burgos, Spain; [Perez-Garrido, Carlos] Univ Complutense Madrid, Dept Cristalog & Mineral, Madrid, Spain; [Aranburu, Arantza] Univ Pais Vasco EHU, Fac Ciencia & Tecnol, Dept Mineral & Petr, Leioa, Spain; [Jose Iriarte-Chiapusso, Maria] Euskal Herriko Unibertsitatea UPV EHU, Fac Letras, Dept Geog Prehist & Arqueol, Vitoria, Spain; [Jose Iriarte-Chiapusso, Maria] Basque Fdn Sci, Ikerbasque, Bilbao, Spain; [Ortega-Cordellat, Illuminada; Bourguignon, Laurence] INRAP, UMR Arscan AnTet 7041, Campagne, France; [Garate, Diego] Univ Cantabria, Inst Int Invest Prehist Cantabria, Gobiemo Cantabria, Santander, Spain; [Libano, Inaki] Edestiaurre Arkeol Elkartea, Barrika, Spain	Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); Autonomous University of Barcelona; Universidad de Burgos; Complutense University of Madrid; University of Basque Country; University of Basque Country; Basque Foundation for Science; Universidad de Cantabria; Instituto Internacional de Investigaciones Prehistoricas de Cantabria (IIIPC)	Rios-Garaizar, J (corresponding author), Ctr Nacl Invest Evoluc Humana CENIEH, Burgos, Spain.	joseba.rios@cenieh.es	Iriarte, Eneko/L-4707-2014; Rios-Garaizar, Joseba/M-5604-2018; López-Bultó, Oriol/AAH-8732-2019; Pérez-Garrido, Carlos/AHD-5209-2022; Iriarte-Chiapusso, Maria-Jose/B-5705-2011; Garate, Diego/M-7028-2017	Iriarte, Eneko/0000-0001-8365-5616; Rios-Garaizar, Joseba/0000-0001-8474-2156; López-Bultó, Oriol/0000-0001-5327-1881; Iriarte-Chiapusso, Maria-Jose/0000-0002-4409-2408; Garate, Diego/0000-0001-6685-9588; Pique Huerta, Raquel/0000-0002-8253-6874; Aranburu, Arantza/0000-0002-0493-085X	Diputacion Foral de Bizkaia [2147/2013, 1602/2014, 2396/2015, 1518/2016, 1797/2017]; Basque Government (Gobierno Vasco) [2015/04424, 2014/03867]; Basque Government	Diputacion Foral de Bizkaia; Basque Government (Gobierno Vasco)(Basque Government); Basque Government(Basque Government)	The archeological work at Aranbaltza site is financed by the Diputacion Foral de Bizkaia (2147/2013; 1602/2014; 2396/2015; 1518/2016; 1797/2017), the Basque Government (Gobierno Vasco: 2015/04424; 2014/03867). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The archeological work at Aranbaltza site is funded by the Diputacion Foral de Bizkaia (2013-2017) and the Basque Government (2014, 2015). The project was also helped by the Barrika Town Council and Harpea Kultur Elkartea. The site of Aranbaltza is located in the private property of the "Club Hipico Barrika" and during the fieldwork we always had the disinterested help of the owner, Damian Libano. The Microscopy Laboratory technicians Belen Notario Collado and Pablo Pardo (CENIEH) helped through the CT scan and the microscopic analysis of the piece. Asier Gomez-Olivencia (IKERBASQUE) helped with the CT scan image processing. Pablo Aparicio made the virtual restoration of the piece. The restoration technician, Pilar Fernandez (CENIEH) preserved the piece in its current condition. Patricia Bello (CENIEH) was helpful providing tuber processing references. We want to thank also Aranbaltza fieldwork volunteers, especially Daniel Ruiz and Fazia Bouchoud who found the point, and the Arkeologi Museoa of Bilbao.	Allue Ethel, 2012, P373; Altuna Etxabe J., 1972, FAUNA MAMIFEROS YACI; Altuna J., 1989, HOMME NEANDERTAL, V6, P41; Alvarez-Alonso D., 2012, ZEPHYRUS, VLXIX, P15; Anderson-Gerfaud P., 1990, EMERGENCE MODERN HUM, P389; [Anonymous], 2015, SETTLEMENT DYNAMICS; [Anonymous], 2002, THESIS; Aranguren B., 2018, P NATL ACAD SCI; Backwell LR, 2001, P NATL ACAD SCI USA, V98, P1358, DOI 10.1073/pnas.021551598; Badal E., 2011, SAGUNTUM PAPELES LAB, V11, P77; Barandiaran Ayerbe J. M., 1960, ESTACION KURTZIA BAR; Benvenuti M, 2017, QUATERNARY RES, V88, P327, DOI 10.1017/qua.2017.51; BEYRIES S., 1987, BRIT ARCHAEOLOGICAL, V328; Blasco R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076780; Bonet Avalos A., 1995, RECONSTRUCCION PALEO, P363; Bosch A., 2006, ELS OBJECTES FUSTA P, V6, P27; Bourguignon L., 2002, PALE, V14, P29; CARBONELL E, 1992, J ARCHAEOL SCI, V19, P707, DOI 10.1016/0305-4403(92)90040-A; Carciumaru M, 2012, J ARCHAEOL SCI, V39, P1942, DOI 10.1016/j.jas.2012.02.016; Carrion JS, 2007, J QUATERNARY SCI, V22, P191, DOI 10.1002/jqs.1024; Castanos P., 2005, NEANDERTALES CANTABR, V20, P201; CASTROCUREL Z, 1995, J FIELD ARCHAEOL, V22, P376, DOI 10.1179/009346995791974206; Claud E., 2013, REGARDS CROISES OUTI, P367; d'Errico F, 2012, P NATL ACAD SCI USA, V109, P13214, DOI 10.1073/pnas.1204213109; Ennos AR, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0174; Garofoli D., 2015, J MIND BEHAV, V36, P1; Gaudzinski S, 1999, J ARCHAEOL SCI, V26, P125, DOI 10.1006/jasc.1998.0311; Grunberg JM, 2002, ANTIQUITY, V76, P15, DOI 10.1017/S0003598X00089638; Gutierrez-Zugasti I., 2017, CHRONO CULTURAL REAS; Haidle M.N, 2009, COGNITIVE ARCHAEOLOG, P57; Hardy BL, 2010, QUATERNARY SCI REV, V29, P662, DOI 10.1016/j.quascirev.2009.11.016; Hardy K, 2012, NATURWISSENSCHAFTEN, V99, P617, DOI 10.1007/s00114-012-0942-0; Heider K. G., 1970, DUGUM DANI PAPUAN HI; Henry AG, 2011, P NATL ACAD SCI USA, V108, P486, DOI 10.1073/pnas.1016868108; Iovita R., MULTIDISCIPLINARY AP, P213; Jequier CA, 2012, CR PALEVOL, V11, P283, DOI 10.1016/j.crpv.2011.12.001; Lazuen T, 2015, QUATERN INT, V361, P229, DOI 10.1016/j.quaint.2014.04.008; Lopez O., 2015, PROCESSOS OBTENCIO T; Mallye J.-B., J ARCHAEOLOGICAL SCI, V39, P1131; Mazza PPA, 2006, J ARCHAEOL SCI, V33, P1310, DOI 10.1016/j.jas.2006.01.006; Mozota Holgueras M., 2007, CUADERNOS ARQUEOLOGI, V15, P31; Holgueras MM, 2014, COMPLUTUM, V25, P17, DOI 10.5209/rev_CMPL.2014.v25.n1.45353; Holgueras MM, 2009, TRABAJOS PREHIST, V66, P27, DOI 10.3989/tp.2009.09011; Nugent P., 2006, MEM QLD MUS CULT HER, V4, P89; Oakley K.P., 1977, P PREHIST SOC, V43, P13, DOI [10.1017/S0079497X00010343, DOI 10.1017/S0079497X00010343]; Oswalt W. H, 1976, ANTHR ANAL FOOD GETT; Pawlik AF, 2011, J ARCHAEOL SCI, V38, P1699, DOI 10.1016/j.jas.2011.03.001; Rendu W, 2014, P NATL ACAD SCI USA, V111, P81, DOI 10.1073/pnas.1316780110; Rios Garaizar J., 2003, B SEDECK, V5, P62; Rios-Garaizar J, 2012, IND LITICA SOC TRANS; Rios-Garaizar J., 2012, CUEVA ASKONDO BIZKAI, V2, P39; Rios-Garaizar J., 2012, MUNIBE ANTROPOLOGIA, V63, P81; Rios-Garaizar J., 2016, TESTING POTENTIAL US; Rios-Garaizar J, 2017, QUATERN INT, V433, P50, DOI 10.1016/j.quaint.2016.02.020; Rios-Garaizar J, 2015, CR PALEVOL, V14, P233, DOI 10.1016/j.crpv.2014.11.006; Rios-Garaizar J, 2015, QUATERN INT, V361, P188, DOI 10.1016/j.quaint.2014.07.025; Rots V., 2009, QUARTAR, V56, P37; Rots V, 2013, J ARCHAEOL SCI, V40, P497, DOI 10.1016/j.jas.2012.06.042; Schoch WH, 2015, J HUM EVOL, V89, P214, DOI 10.1016/j.jhevol.2015.08.004; Schweingruber F. H., 1978, MIKROSKOPISCHE HOLZA; Sistiaga A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101045; Soressi M, 2013, P NATL ACAD SCI USA, V110, P14186, DOI 10.1073/pnas.1302730110; Teit JA, 1909, MEMOIR AM MUSEUM NAT, V2; Thieme H, 1997, NATURE, V385, P807, DOI 10.1038/385807a0; Thieme H., 1985, LDKR VERDEN KUNDE, V36, P11; Tuner N. J., 2014, HIST PRACTICE INDIGE, V1; Uzquiano P, 2015, VEG HIST ARCHAEOBOT, V24, P229, DOI 10.1007/s00334-014-0475-x; Vinagre A., 2006, MONOGRAFIAS MUESO NA; Wagner E., 1995, CANNSTATT; Wood JG, 1870, NATURAL HIST MAN BEI; Wood JG, 1868, NATURAL HIST MAN BEI	71	34	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0195044	10.1371/Journal.pone.0195044	http://dx.doi.org/10.1371/Journal.pone.0195044			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590205	Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100098
J	Sember, A; Bohlen, J; Slechtova, V; Altmanova, M; Pelikanova, S; Rab, P				Sember, Alexandr; Bohlen, Jorg; Slechtova, Vendula; Altmanova, Marie; Pelikanova, Sarka; Rab, Petr			Dynamics of tandemly repeated DNA sequences during evolution of diploid and tetraploid botiid loaches (Teleostei: Cobitoidea: Botiidae)	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; 5S RDNA; CHROMOSOMAL CHARACTERISTICS; REPETITIVE DNAS; RIBOSOMAL DNA; COMPARATIVE CYTOGENETICS; EXTENSIVE POLYMORPHISM; PERICENTRIC INVERSIONS; TRANSPOSABLE ELEMENTS; TELOMERIC REPEATS	Polyploidization has played an important role in the evolution of vertebrates, particularly at the base of Teleostei an enormously successful ray-finned fish group with additional genome doublings on lower taxonomic levels. The investigation of post-polyploid genome dynamics might provide important clues about the evolution and ecology of respective species and can help to decipher the role of polyploidy per se on speciation. Few studies have attempted to investigate the dynamics of repetitive DNA sequences in the post-polyploid genome using molecular cytogenetic tools in fishes, though recent efforts demonstrated their usefulness. The demonstrably monophyletic freshwater loach family Botiidae, branching to evolutionary diploid and tetraploid lineages separated >25 Mya, offers a suited model group for comparing the long-term repetitive DNA evolution. For this, we integrated phylogenetic analyses with cytogenetical survey involving Giemsa-and Chromomycin A(3) (CMA(3))/DAPI stainings and fluorescence in situ hybridization with 5S/45S rDNA, U2 snDNA and telomeric probes in representative sample of 12 botiid species. The karyotypes of all diploids were composed of 2n = 50 chromosomes, while majority of tetraploids had 2n = 4x = 100, with only subtle interspecific karyotype differences. The exceptional karyotype of Botia dario (2n = 4x = 96) suggested centric fusions behind the 2n reduction. Variable patterns of FISH signals revealed cases of intraspecific polymorphisms, rDNA amplification, variable degree of correspondence with CMA(3)(+) sites and almost no phylogenetic signal. In tetraploids, either additivity or loci gain/loss was recorded. Despite absence of classical interstitial telomeric sites, large blocks of interspersed rDNA/telomeric regions were found in diploids only. We uncovered different molecular drives of studied repetitive DNA classes within botiid genomes as well as the advanced stage of the re-diploidization process in tetraploids. Our results may contribute to link genomic approach with molecular cytogenetic analyses in addressing the origin and mechanism of this polyploidization event.	[Sember, Alexandr; Bohlen, Jorg; Slechtova, Vendula; Altmanova, Marie; Pelikanova, Sarka; Rab, Petr] Czech Acad Sci, Inst Anim Physiol & Genet, Lab Fish Genet, Rumburska 89, Libechov, Czech Republic; [Altmanova, Marie] Charles Univ Prague, Dept Ecol, Fac Sci, Vinicna 7, Prague 2, Czech Republic	Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Charles University Prague	Sember, A (corresponding author), Czech Acad Sci, Inst Anim Physiol & Genet, Lab Fish Genet, Rumburska 89, Libechov, Czech Republic.	alexandr.sember@seznam.cz	Sember, Alexandr/W-4446-2017; Altmanova, Marie/C-9645-2015	Sember, Alexandr/0000-0003-4441-9615; Altmanova, Marie/0000-0001-7193-8918	Czech Science Foundation [13-37277S]; Ministry of Education, Youth and Sports [EXCELLENCE CZ.02.1.01/0.0/0.0/15_003/0000460 OP RDE]; Czech Academy of Sciences [RVO: 67985904]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Czech Academy of Sciences(Czech Academy of Sciences)	This study was supported by The Czech Science Foundation (https://gacr.cz/): grant no. 13-37277S (VS, JB, AS, PR) and further by the projects EXCELLENCE CZ.02.1.01/0.0/0.0/15_003/0000460 OP RDE (Ministry of Education, Youth and Sports; http://www.msmt.cz/) (PR) and RVO: 67985904 (Czech Academy of Sciences; http://www.avcr.cz/cs/) (AS, JB, VS, MA, SP, PR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JR, 2008, EARTH-SCI REV, V88, P145, DOI 10.1016/j.earscirev.2008.01.007; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andreyushkova DA, 2017, GENES-BASEL, V8, DOI 10.3390/genes8110318; Arai R., 2011, FISH KARYOTYPES CHEC; Araya-Jaime C, 2017, ZEBRAFISH, V14, P464, DOI 10.1089/zeb.2017.1422; Ayata MK, 2018, TURK J FISH AQUAT SC, V18, P991, DOI 10.4194/1303-2712-v18_8_07; Barbosa P, 2015, GENETICA, V143, P55, DOI 10.1007/s10709-014-9813-2; Barman AS, 2016, GENETICA, V144, P723, DOI 10.1007/s10709-016-9938-6; Betancur-R R, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0958-3; Biltueva LS, 2017, CYTOGENET GENOME RES, V152, P148, DOI 10.1159/000479472; Bohlen J, 2008, ICHTHYOL RES, V55, P82, DOI 10.1007/s10228-007-0007-0; Bohlen J, 2009, ICHTHYOL EXPLOR FRES, V20, P157; Bohlen J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159311; Boron A, 2006, GENETICA, V128, P71, DOI 10.1007/s10709-005-5536-8; Braasch I., 2012, POLYPLOIDY GENOME EV, P341, DOI DOI 10.1007/978-3-642-31442-1_17; Bueno D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066532; Cabral-de-Mello D, 2010, MICROSC SCI TECHNOL, V1, P658; Cazaux B, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-124; Chairi H, 2015, J MOL EVOL, V80, P209, DOI 10.1007/s00239-015-9674-z; Chen WJ, 2008, GENE, V423, P125, DOI 10.1016/j.gene.2008.07.016; Cioffi MB, 2012, GENOME DYNAM, V7, P197, DOI 10.1159/000337950; Clift PD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027772; Collares-Pereira MJ, 1999, GENETICA, V105, P301, DOI 10.1023/A:1003885922023; Coluccia E, 2010, J APPL ICHTHYOL, V26, P445, DOI 10.1111/j.1439-0426.2009.01384.x; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; da Silva M, 2016, CYTOGENET GENOME RES, V149, P297, DOI 10.1159/000449431; de Barros AV, 2011, AQUACULTURE, V322, P47, DOI 10.1016/j.aquaculture.2011.10.002; de Oliveira EA, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0161-4; Sousa JFDE, 2017, CYTOGENET GENOME RES, V152, P194, DOI 10.1159/000480141; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Eschmeyer WN, CATALOG FISHES GENER; Fernandes CA, 2017, ZEBRAFISH, V14, P471, DOI 10.1089/zeb.2017.1432; FERRIS SD, 1980, AM NAT, V115, P650, DOI 10.1086/283590; Feulner PGD, 2017, J EVOLUTION BIOL, V30, P1488, DOI 10.1111/jeb.13101; FLAJSHANS M, 1992, THEOR APPL GENET, V85, P68, DOI 10.1007/BF00223846; Fujiwara A, 2001, GENETICA, V111, P77, DOI 10.1023/A:1013788626712; Fukova I, 2005, GENOME, V48, P1083, DOI 10.1139/G05-063; Getlekha N, 2018, ZEBRAFISH, V15, P45, DOI 10.1089/zeb.2017.1484; Ghigliotti L, 2010, ANTARCT SCI, V22, P805, DOI 10.1017/S0954102010000660; Glasauer SMK, 2014, MOL GENET GENOMICS, V289, P1045, DOI 10.1007/s00438-014-0889-2; Gornung E, 2013, CYTOGENET GENOME RES, V141, P90, DOI 10.1159/000354832; GRAHAM DE, 1978, ANAL BIOCHEM, V85, P609, DOI 10.1016/0003-2697(78)90262-2; Gromicho M, 2006, CHROMOSOME RES, V14, P297, DOI 10.1007/s10577-006-1047-4; Guillen AKZ, 2004, CHROMOSOME RES, V12, P225, DOI 10.1023/B:CHRO.0000021911.43225.eb; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; He W, 2012, PLOS ONE, V7, P27; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Amorim KDJ, 2016, COMP CYTOGENET, V10, P555, DOI 10.3897/CompCytogen.v10i4.10227; Kaewmad P, 2014, CYTOLOGIA, V79, P299, DOI 10.1508/cytologia.79.299; Khuda-Bukhsh A.R., 1986, P886; Kirtiklis L, 2014, BIOLOGIA, V69, P536, DOI 10.2478/s11756-014-0339-y; Knytl M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190924; Kottelat M, 2012, RAFFLES B ZOOL, P1; Laurent S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176384; Leitch IJ, 2008, ANN BOT-LONDON, V101, P805, DOI 10.1093/aob/mcm326; Leitch IJ, 2004, BIOL J LINN SOC, V82, P651, DOI 10.1111/j.1095-8312.2004.00349.x; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Li J, 2012, PROTOPLASMA, V249, P207, DOI 10.1007/s00709-011-0279-0; Li YJ, 2010, ICHTHYOL RES, V57, P358, DOI 10.1007/s10228-010-0168-0; Lien S, 2016, NATURE, V533, P200, DOI 10.1038/nature17164; Luo J, 2014, HEREDITY, V112, P415, DOI 10.1038/hdy.2013.121; Ma XF, 2005, CYTOGENET GENOME RES, V109, P236, DOI 10.1159/000082406; Machado MD, 2017, ZEBRAFISH, V14, P459, DOI 10.1089/zeb.2017.1435; Macqueen DJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2881; Majtanova Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146872; Maneechot N, 2016, MOL CYTOGENET, V9, DOI 10.1186/s13039-016-0215-2; Marburger S, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2732; MAYR B, 1985, GENETICA, V67, P51, DOI 10.1007/BF02424460; Nakajima RT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-198; Nguyen P, 2010, GENETICA, V138, P343, DOI 10.1007/s10709-009-9424-5; Nieto Feliner G., 2012, PLANT GENOME DIVERSI, VVol. 1, P171, DOI [10.1007/978-3-7091-1130-7_12, DOI 10.1007/978-3-7091-1130-7_12]; Nirchio M, 2008, NEOTROP ICHTHYOL, V6, P101, DOI 10.1590/S1679-62252008000100012; Ocalewicz K, 2013, CYTOGENET GENOME RES, V141, P114, DOI 10.1159/000354278; Papasaikas P, 2016, TRENDS BIOCHEM SCI, V41, P33, DOI 10.1016/j.tibs.2015.11.003; Parisod C, 2010, NEW PHYTOL, V186, P5, DOI 10.1111/j.1469-8137.2009.03142.x; Parisod C, 2010, NEW PHYTOL, V186, P37, DOI 10.1111/j.1469-8137.2009.03096.x; Pereira CSA, 2013, CYTOGENET GENOME RES, V141, P143, DOI 10.1159/000354582; Piscor D, 2016, ZEBRAFISH, V13, P565, DOI 10.1089/zeb.2016.1292; Porto-Foresti F, 2004, GENET MOL BIOL, V27, P51, DOI 10.1590/S1415-47572004000100009; Pucci MB, 2014, BIOL J LINN SOC, V111, P541, DOI 10.1111/bij.12218; Rab P, 2002, CYTOGENET GENOME RES, V98, P194, DOI 10.1159/000069800; Rab P, 1999, CHROMOSOME RES, V7, P475, DOI 10.1023/A:1009202030456; Rab P, 2000, FOLIA ZOOL, V49, P55; Rab Petr, 1995, Acta Universitatis Carolinae-Biologica, V39, P201; Rab P, 2016, CYTOGENET GENOME RES, V149, P312, DOI 10.1159/000450534; Rabova M, 2004, CYTOGENET GENOME RES, V106, P16; Rabova M, 2001, GENETICA, V111, P413, DOI 10.1023/A:1013763903513; Rebordinos L, 2013, CYTOGENET GENOME RES, V141, P103, DOI 10.1159/000354871; Rishi K. K., 1984, INT J ACAD ICHTHYOL, V5, P139; Rocchi M, 2012, HEREDITY, V108, P59, DOI 10.1038/hdy.2011.101; Romanenko SA, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0194-8; de Moraes RLR, 2017, ZEBRAFISH, V14, P536, DOI 10.1089/zeb.2017.1465; Ruiz-Herrera A, 2008, CYTOGENET GENOME RES, V122, P219, DOI 10.1159/000167807; Saitoh K, 2010, MOL PHYLOGENET EVOL, V56, P1001, DOI 10.1016/j.ympev.2010.04.021; Sakofsky CJ, 2015, MOL CELL, V60, P860, DOI 10.1016/j.molcel.2015.10.041; Sallan LC, 2014, BIOL REV, V89, P950, DOI 10.1111/brv.12086; SAWADA Y, 1976, Japanese Journal of Ichthyology, V23, P175; Scacchetti PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137231; Scali V, 2016, ITAL J ZOOL, V83, P285, DOI 10.1080/11250003.2016.1219403; SCHMID M, 1988, CHROMOSOMA, V97, P101, DOI 10.1007/BF00327367; Schmidt RC, 2015, MOL PHYLOGENET EVOL, V90, P193, DOI 10.1016/j.ympev.2015.05.025; Sember A, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0532-9; Slechtova V, 2006, MOL PHYLOGENET EVOL, V39, P529, DOI 10.1016/j.ympev.2005.09.018; Slechtova V, 2007, MOL PHYLOGENET EVOL, V44, P1358, DOI 10.1016/j.ympev.2007.02.019; Sliwinska-Jewsiewicka A, 2015, GENETICA, V143, P425, DOI 10.1007/s10709-015-9841-6; Sochorova J, 2018, CHROMOSOMA, V127, P141, DOI 10.1007/s00412-017-0651-8; SOLA L, 1992, CYTOGENET CELL GENET, V60, P229, DOI 10.1159/000133346; Soltis DE, 2016, AM J BOT, V103, P1146, DOI 10.3732/ajb.1500501; Spoz A, 2017, FOLIA BIOL-KRAKOW, V65, P62, DOI 10.3409/fb65_1.63; Spoz A, 2014, COMP CYTOGENET, V8, P233, DOI 10.3897/CompCytogen.v8i3.7718; Stimpson KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092432; Suzuki A., 1996, Cytobios, V85, P229; Symonova R, 2013, CYTOGENET GENOME RES, V141, P153, DOI 10.1159/000354882; Symonova R, 2018, GENES-BASEL, V9, DOI 10.3390/genes9020096; Symonova R, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3774-7; Symonova R, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0484-8; Symonova R, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-42; Takagui FH, 2014, ZEBRAFISH, V11, P300, DOI 10.1089/zeb.2014.0985; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang QY, 2005, HYDROBIOLOGIA, V544, P249, DOI 10.1007/s10750-005-0863-4; Tayale A, 2013, CYTOGENET GENOME RES, V140, P79, DOI 10.1159/000351318; Traldi JB, 2016, ZEBRAFISH, V13, P19, DOI 10.1089/zeb.2015.1124; Tsekrekou M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071411; Tsigenopoulos CS, 2002, HEREDITY, V88, P466, DOI 10.1038/sj.hdy.6800080; UYENO T, 1972, SCIENCE, V175, P644, DOI 10.1126/science.175.4022.644; Vicari MR, 2008, CYTOGENET GENOME RES, V122, P67, DOI 10.1159/000151318; Volker M, 2015, FISH CYTOGENETIC TEC, P37, DOI [10.1201/b18534-4, DOI 10.1201/B18534-4]; Votkov RA, 2007, SYST BIODIVERS, V5, P261, DOI 10.1017/S1477200007002447; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang XY, 2011, GENES-BASEL, V2, P1, DOI 10.3390/genes2010001; Wang XZ, 2016, SCI CHINA LIFE SCI, V59, P1149, DOI 10.1007/s11427-016-0007-7; da Costa GWWF, 2016, J HERED, V107, P173, DOI 10.1093/jhered/esv136; Wertheim B, 2013, CYTOGENET GENOME RES, V140, P256, DOI 10.1159/000351998; Winterfeld G, 2009, SYST BIODIVERS, V7, P277, DOI 10.1017/S1477200009003041; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009; Yang L, 2015, MOL PHYLOGENET EVOL, V85, P97, DOI 10.1016/j.ympev.2015.01.014; Yano CF, 2017, ZEBRAFISH, V14, P146, DOI 10.1089/zeb.2016.1351; Ye LH, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0542-2; Yu X. Z., 1989, CHROMOSOMES CHINESE; Yue X, 2013, SICHUAN J ZOOLOGY, V3; Zhan SH, 2014, J EVOLUTION BIOL, V27, P391, DOI 10.1111/jeb.12308; Zhdanova NS, 2007, CHROMOSOME RES, V15, P881, DOI 10.1007/s10577-007-1170-x; Zhu HP, 2006, CHROMOSOME RES, V14, P767, DOI 10.1007/s10577-006-1083-0	146	10	10	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0195054	10.1371/Journal.pone.0195054	http://dx.doi.org/10.1371/Journal.pone.0195054			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590207	Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100099
J	Browne, S; Jha, AK; Ameri, K; Marcus, SG; Yeghiazarians, Y; Healy, KE				Browne, Shane; Jha, Amit K.; Ameri, Kurosh; Marcus, Sivan G.; Yeghiazarians, Yerem; Healy, Kevin E.			TGF-beta 1/CD105 signaling controls vascular network formation within growth factor sequestering hyaluronic acid hydrogels	PLOS ONE			English	Article							CARDIOSPHERE-DERIVED CELLS; MESENCHYMAL STEM-CELLS; TGF-BETA RECEPTOR; ENDOTHELIAL-CELL; MOLECULAR-WEIGHT; PROGENITOR CELLS; DELIVERY-SYSTEM; ANGIOGENESIS; ENDOGLIN; PROLIFERATION	Cell-based strategies for the treatment of ischemic diseases are at the forefront of tissue engineering and regenerative medicine. Cell therapies purportedly can play a key role in the neovascularization of ischemic tissue; however, low survival and poor cell engraftment with the host vasculature following implantation limits their potential to treat ischemic diseases. To overcome these limitations, we previously developed a growth factor sequestering hyaluronic acid (HyA)-based hydrogel that enhanced transplanted mouse cardiosphere-derived cell survival and formation of vasculature that anastomosed with host vessels. In this work, we examined the mechanism by which HyA hydrogels presenting transforming growth factor beta-1 (TGF-beta 1) promoted proliferation of more clinically relevant human cardiospherederived cells (hCDC), and their formation of vascular-like networks in vitro. We observed hCDC proliferation and enhanced formation of vascular-like networks occurred in the presence of TGF-beta 1. Furthermore, production of nitric oxide (NO), VEGF, and a host of angiogenic factors were increased in the presence of TGF-beta 1. This response was dependent on the co-activity of CD105 (Endoglin) with the TGF-beta R2 receptor, demonstrating its role in the process of angiogenic differentiation and vascular organization of hCDC. These results demonstrated that hCDC form vascular-like networks in vitro, and that the induction of vascular networks by hCDC within growth factor sequestering HyA hydrogels was mediated by TGF-beta 1/CD105 signaling.	[Browne, Shane; Jha, Amit K.; Marcus, Sivan G.; Healy, Kevin E.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Browne, Shane; Jha, Amit K.; Marcus, Sivan G.; Healy, Kevin E.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Browne, Shane] Natl Univ Ireland Galway, Ctr Res Med Devices CURAM, Galway, Ireland; [Ameri, Kurosh; Yeghiazarians, Yerem] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Yeghiazarians, Yerem] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Yeghiazarians, Yerem] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Ollscoil na Gaillimhe-University of Galway; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Healy, KE (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.; Healy, KE (corresponding author), Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.	kehealy@berkeley.edu		Browne, Shane/0000-0002-1005-1712	National Heart Lung and Blood Institute of the National Institutes of Health [R01HL096525]; Jan Fandrianto and Selfia Halim Chair; Irish Research Council ELEVATE fellowship [ELEVATEPD/2014/33]; UCSF Translational Cardiac Stem Cell Program; Leone-Perkins Foundation; Torian Foundation; Vadasz Foundation	National Heart Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Jan Fandrianto and Selfia Halim Chair; Irish Research Council ELEVATE fellowship(Irish Research Council for Science, Engineering and Technology); UCSF Translational Cardiac Stem Cell Program; Leone-Perkins Foundation; Torian Foundation; Vadasz Foundation	This work was supported in part by National Heart Lung and Blood Institute of the National Institutes of Health R01HL096525 (KEH), the Jan Fandrianto and Selfia Halim Chair (KEH), an Irish Research Council ELEVATE fellowship to SB (ELEVATEPD/2014/33), the UCSF Translational Cardiac Stem Cell Program (YY), the Leone-Perkins Foundation (YY), and by the Torian Foundation and the Vadasz Foundation (YY).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed TAE, 2011, TISSUE ENG PT A, V17, P323, DOI 10.1089/ten.TEA.2009.0773; Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Bartunek J, 2010, HEART, V96, P792, DOI 10.1136/hrt.2007.139394; Bir SC, 2012, CARDIOVASC RES, V95, P7, DOI 10.1093/cvr/cvs143; Briquez PS, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2015.6; Browne S, 2017, CURR OPIN PHARMACOL, V36, P34, DOI 10.1016/j.coph.2017.07.002; Browne S, 2015, BIOMATERIALS, V69, P133, DOI 10.1016/j.biomaterials.2015.08.012; Browne S, 2013, TISSUE ENG PT A, V19, P1491, DOI [10.1089/ten.tea.2012.0721, 10.1089/ten.TEA.2012.0721]; Chang CY, 2012, BIOMATERIALS, V33, P8026, DOI 10.1016/j.biomaterials.2012.07.058; Cheng K, 2014, JACC-HEART FAIL, V2, P49, DOI 10.1016/j.jchf.2013.08.008; Cheng K, 2012, BIOMATERIALS, V33, P5317, DOI 10.1016/j.biomaterials.2012.04.006; Cheng K, 2012, BIOMATERIALS, V33, P2872, DOI 10.1016/j.biomaterials.2011.12.040; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Duff SE, 2003, FASEB J, V17, P984, DOI 10.1096/fj.02-0634rev; Gaffey AC, 2015, J THORAC CARDIOV SUR, V150, P1268, DOI 10.1016/j.jtcvs.2015.07.035; Gao JS, 2012, BIOMATERIALS, V33, P3673, DOI 10.1016/j.biomaterials.2012.01.061; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Gurski LA, 2009, BIOMATERIALS, V30, P6076, DOI 10.1016/j.biomaterials.2009.07.054; Harbers GM, 2005, J BIOMED MATER RES A, V75A, P855, DOI 10.1002/jbm.a.30482; Highley CB, 2016, CURR OPIN BIOTECH, V40, P35, DOI 10.1016/j.copbio.2016.02.008; Hoban DB, 2013, BIOMATERIALS, V34, P9420, DOI 10.1016/j.biomaterials.2013.08.073; Holladay CA, 2012, BIOMATERIALS, V33, P1303, DOI 10.1016/j.biomaterials.2011.10.019; Huang NF, 2009, REGEN MED, V4, P527, DOI 10.2217/RME.09.32; Jha AK, 2016, BIOMATERIALS, V89, P136, DOI 10.1016/j.biomaterials.2016.02.023; Jha AK, 2015, J CONTROL RELEASE, V209, P308, DOI 10.1016/j.jconrel.2015.04.034; Jha AK, 2015, BIOMATERIALS, V47, P1, DOI 10.1016/j.biomaterials.2014.12.043; Khademhosseini A, 2006, J BIOMED MATER RES A, V79A, P522, DOI 10.1002/jbm.a.30821; Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]; Kim S, 2005, DEGRADATION CELL MIG, P13; Kogan G, 2007, BIOTECHNOL LETT, V29, P17, DOI 10.1007/s10529-006-9219-z; Kusuma S, 2013, SELF ORG VASCULAR NE, P110; Lam J, 2014, ADV FUNCT MATER, V24, P7053, DOI 10.1002/adfm.201401483; Lam J, 2013, BIOMATERIALS, V34, P3938, DOI 10.1016/j.biomaterials.2013.01.091; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lee ST, 2011, J AM COLL CARDIOL, V57, P455, DOI 10.1016/j.jacc.2010.07.049; Lei YG, 2011, BIOMATERIALS, V32, P39, DOI 10.1016/j.biomaterials.2010.08.103; Li RX, 2017, J CONTROL RELEASE, V261, P234, DOI 10.1016/j.jconrel.2017.07.008; Li TS, 2012, J AM COLL CARDIOL, V59, P942, DOI 10.1016/j.jacc.2011.11.029; Martino MM, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00045; Mayfield AE, 2014, BIOMATERIALS, V35, P133, DOI 10.1016/j.biomaterials.2013.09.085; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Namba T, 2003, CIRCULATION, V108, P2250, DOI 10.1161/01.CIR.0000093190.53478.78; Nelson TJ, 2010, STEM CELLS CLONING, V3, P29; Nikitovic D, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00169; Park HJ, 2016, BIOMACROMOLECULES, V17, P1939, DOI 10.1021/acs.biomac.5b01670; Popa ER, 2006, J MOL CELL CARDIOL, V41, P86, DOI 10.1016/j.yjmcc.2006.04.021; Poynter JA, 2011, J AM COLL SURGEONS, V213, P253, DOI 10.1016/j.jamcollsurg.2011.04.005; Prestwich GD, 2011, J CONTROL RELEASE, V155, P193, DOI 10.1016/j.jconrel.2011.04.007; Rayahin JE, 2015, ACS BIOMATER SCI ENG, V1, P481, DOI 10.1021/acsbiomaterials.5b00181; Redgrave RE, 2017, STEM CELL REP, V8, P1287, DOI 10.1016/j.stemcr.2017.04.015; Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b; Robinson ST, 2016, ACTA BIOMATER, V36, P86, DOI 10.1016/j.actbio.2016.03.002; Segers VFM, 2011, CIRC RES, V109, P910, DOI 10.1161/CIRCRESAHA.111.249052; She XW, 2004, INT J CANCER, V108, P251, DOI 10.1002/ijc.11551; Shen DL, 2012, J CELL MOL MED, V16, P2112, DOI 10.1111/j.1582-4934.2011.01512.x; Shen YI, 2016, BIOMATERIALS, V102, P107, DOI 10.1016/j.biomaterials.2016.06.009; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Song H, 2010, STEM CELLS, V28, P555, DOI 10.1002/stem.302; Tang JM, 2009, EXP CELL RES, V315, P3521, DOI 10.1016/j.yexcr.2009.09.026; Thibeault S, 2010, MOL CELL, V39, P468, DOI 10.1016/j.molcel.2010.07.013; Tian HY, 2012, EMBO J, V31, P3885, DOI 10.1038/emboj.2012.246; Valluru M, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00089; van Meeteren LA, 2012, CELL TISSUE RES, V347, P177, DOI 10.1007/s00441-011-1222-6; Wall ST, 2010, J BIOMED MATER RES A, V95A, P1055, DOI 10.1002/jbm.a.32904; Wang JL, 2012, J BIOMED MATER RES A, V100A, P1438, DOI 10.1002/jbm.a.34081; WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; Xu X, 2012, SOFT MATTER, V8, P3280, DOI 10.1039/c2sm06463d; Xu YY, 2016, ACTA BIOMATER, V31, P99, DOI 10.1016/j.actbio.2015.12.021; Yu JS, 2010, BIOMATERIALS, V31, P7012, DOI 10.1016/j.biomaterials.2010.05.078; Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044	74	22	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194679	10.1371/journal.pone.0194679	http://dx.doi.org/10.1371/journal.pone.0194679			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566045	Green Submitted, Green Published, gold			2022-12-26	WOS:000428093900092
J	Johnson, CD; Barlow-Anacker, AJ; Pierre, JF; Touw, K; Erickson, CS; Furness, JB; Epstein, ML; Gosain, A				Johnson, Carl D.; Barlow-Anacker, Amanda J.; Pierre, Joseph F.; Touw, Ketrija; Erickson, Christopher S.; Furness, John B.; Epstein, Miles L.; Gosain, Ankush			Deletion of choline acetyltransferase in enteric neurons results in postnatal intestinal dysmotility and dysbiosis	FASEB JOURNAL			English	Article						acetylcholine; enteric nervous system; development; microbiome	MYENTERIC AH NEURONS; GUINEA-PIG ILEUM; SYNAPTIC-TRANSMISSION; NERVOUS-SYSTEM; PERISTALTIC REFLEX; TACHYKININS; PLEXUS; ROLES; MOUSE; NEUROTRANSMITTER	Acetylcholine (ACh)-synthesizing neurons are major components of the enteric nervous system (ENS). They release ACh and peptidergic neurotransmitters onto enteric neurons and muscle. However, pharmacological interrogation has proven inadequate to demonstrate an essential role for ACh. Our objective was to determine whether elimination of ACh synthesis during embryogenesis alters prenatal viability, intestinal function, the neurotransmitter complement, and the microbiome. Conditional deletion of choline acetyltransferase (ChAT), the ACh synthetic enzyme, in neural crest-derived neurons (ChAT-Null) was performed. Survival, ChAT activity, gut motility, and the microbiome were studied. ChAT was conditionally deleted in ENS neural crest-derived cells. Despite ChAT absence, mice were born live and survived the first 2 wk. They failed to gain significant weight in the third postnatal week, dying between postnatal d 18 and 30. Small intestinal transit of carmine red was 50% slower in ChAT-Nullsvs. WT and ChAT-Het. The colons of many neonatal ChAT-Null mice contained compacted feces, suggesting dysmotility. Microbiome analysis revealed dysbiosis in ChAT-Null mice. Developmental deletion of ChAT activity in enteric neurons results in proximal gastrointestinal tract dysmotility, critically diminished colonic transit, failure to thrive, intestinal dysbiosis, and death. ACh is necessary for sustained gut motility and survival of neonatal mice after weaning.Johnson, C. D., Barlow-Anacker, A. J., Pierre, J. F., Touw, K., Erickson, C. S., Furness, J. B., Epstein, M. L., Gosain, A. Deletion of cholineacetyltransferase in enteric neurons results in postnatal intestinal dysmotility and dysbiosis.	[Johnson, Carl D.] Univ Wisconsin, Dept Integrat Biol, Madison, WI USA; [Barlow-Anacker, Amanda J.; Erickson, Christopher S.] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI USA; [Epstein, Miles L.] Univ Wisconsin, Dept Neurosci, Sch Med & Publ Hlth, Madison, WI USA; [Pierre, Joseph F.] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA; [Gosain, Ankush] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Div Pediat Surg, Memphis, TN 38163 USA; [Pierre, Joseph F.; Gosain, Ankush] Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, 50 N Dunlap St,Room 320, Memphis, TN 38105 USA; [Touw, Ketrija] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Furness, John B.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Chicago; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Gosain, A (corresponding author), Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, 50 N Dunlap St,Room 320, Memphis, TN 38105 USA.	agosain@uthsc.edu	Furness, John B/B-2763-2016; Pierre, Joseph F./AAA-2469-2020; Pierre, Joseph/HCH-3993-2022	Furness, John B/0000-0002-0219-3438; Gosain, Ankush/0000-0002-0428-1503	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [K08DK098271, R03DK114543, P30DK42086]; American Pediatric Surgical Association Foundation Scholars Award; American College of Surgeons George H.A. Clowes Career Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086, R03DK114543, K08DK098271] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Pediatric Surgical Association Foundation Scholars Award; American College of Surgeons George H.A. Clowes Career Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Brian Torres for assistance in performing assays, Dr. Timur Mavlyutov (University of Wisconsin-Madison) for assistance with confocal imaging, and Dr. June Dahl (University of Wisconsin-Madison) for suggestions on the manuscript. This work was supported by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grants K08DK098271, R03DK114543, and P30DK42086; by an American Pediatric Surgical Association Foundation Scholars Award (to A.G.); and by an American College of Surgeons George H.A. Clowes Career Development Award (to A.G.). The authors declare no conflicts of interest.	Alex G, 2001, NEUROSCIENCE, V104, P263, DOI 10.1016/S0306-4522(01)00064-1; Bornstein JC, 2004, NEUROGASTROENT MOTIL, V16, P34, DOI 10.1111/j.1743-3150.2004.00472.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Erickson CS, 2014, NEUROGASTROENT MOTIL, V26, P874, DOI 10.1111/nmo.12343; FINK S, 1959, GASTROENTEROLOGY, V36, P661; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Galligan JJ, 2000, J AUTONOM NERV SYST, V81, P97, DOI 10.1016/S0165-1838(00)00130-2; GIULIANI S, 1993, J PHARMACOL EXP THER, V265, P1224; GRIDER JR, 1989, AM J PHYSIOL, V257, pG709, DOI 10.1152/ajpgi.1989.257.5.G709; GRIDER JR, 1989, GASTROENTEROLOGY, V97, P1414, DOI 10.1016/0016-5085(89)90384-3; HOLZER P, 1989, AM J PHYSIOL, V256, pG540, DOI 10.1152/ajpgi.1989.256.3.G540; Holzer P, 1997, PHARMACOL THERAPEUT, V73, P219, DOI 10.1016/S0163-7258(96)00196-9; HOLZER P, 1993, J PHARMACOL EXP THER, V264, P391; Huttenhower C., GALAXY; JOHNSON SM, 1981, J PHYSIOL-LONDON, V320, P175, DOI 10.1113/jphysiol.1981.sp013942; Li ZS, 2011, J NEUROSCI, V31, P8998, DOI 10.1523/JNEUROSCI.6684-10.2011; MCCAMAN RE, 1971, ANAL BIOCHEM, V42, P171, DOI 10.1016/0003-2697(71)90023-6; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Monro RL, 2005, NEUROSCIENCE, V134, P975, DOI 10.1016/j.neuroscience.2005.05.006; MORITA K, 1980, NATURE, V287, P151, DOI 10.1038/287151a0; NORTH RA, 1982, J PHYSIOL-LONDON, V333, P151, DOI 10.1113/jphysiol.1982.sp014445; Nurgali K, 2003, NEUROSCIENCE, V116, P335, DOI 10.1016/S0306-4522(02)00749-2; Pierre JF, 2014, J PEDIATR SURG, V49, P1242, DOI 10.1016/j.jpedsurg.2014.01.060; Qu ZD, 2008, CELL TISSUE RES, V334, P147, DOI 10.1007/s00441-008-0684-7; RAFFA RB, 1987, LIFE SCI, V41, P2229, DOI 10.1016/0024-3205(87)90520-0; RAND JB, 1981, ANAL BIOCHEM, V116, P361, DOI 10.1016/0003-2697(81)90372-9; Rolig AS, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000689; Sang Q, 1996, CELL TISSUE RES, V284, P39, DOI 10.1007/s004410050565; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shimizu Y, 2008, CELL MOL LIFE SCI, V65, P295, DOI 10.1007/s00018-007-7148-1; Touw K, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13182; Ward NL, 2012, NEUROGASTROENT MOTIL, V24, P874, DOI 10.1111/j.1365-2982.2012.01937.x; Wiles TJ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002517	34	14	14	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4744	4752		10.1096/fj.201701474RR	http://dx.doi.org/10.1096/fj.201701474RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29570391	Green Published			2022-12-26	WOS:000443817700010
J	Laufer, JM; Lyck, R; Legler, DF				Laufer, Julia M.; Lyck, Ruth; Legler, Daniel F.			ZAP70 expression enhances chemokine-driven chronic lymphocytic leukemia cell migration and arrest by valency regulation of integrins	FASEB JOURNAL			English	Article						CLL; CCR7; CXCR4; cell adhesion	BLOOD-BRAIN-BARRIER; LYMPH-NODES; ZAP-70 EXPRESSION; PERIPHERAL-BLOOD; RECEPTOR CCR7; BONE-MARROW; ENDOTHELIAL ICAM-1; SIGNALING PATHWAYS; CLL CELLS; PROLIFERATION	The -associated protein of 70 kDa (ZAP70) is expressed in the aggressive form of B-cell chronic lymphocytic leukemia (CLL). Moreover, the integrin very late antigen (VLA)-1 is highly expressed on subtypes of CLL that are associated with high proliferation rates in the lymph node context. We herein identify a critical role for ZAP70 in chemokine-mediated, inside-out signaling to integrins in trisomy 12 carrying Ohio State University-CLL cell lines derived from a patient with previously treated CLL. We found that ZAP70-positive CLL cells migrated significantly better toward ligands of the lymph node homing chemokine receptors CCR7 and CXCR4 compared with ZAP70-negative cells. In addition, ZAP70-expressing CLL cells adhered more efficiently to integrin ligands under static conditions. We discovered that ZAP70 expression controls chemokine-driven clustering of the integrins VLA-4 and lymphocyte function-associated antigen-1. More precisely, chemokine stimulation resulted in a ZAP70-dependent integrin valency regulation on CLL cells, whereas high-affinity regulation of integrins was independent of ZAP70. Consequently, ZAP70-expressing CLL cells show increased chemokine-driven arrest on immobilized integrin ligands and on chemokine-presenting endothelial cells under physiologic flow conditions. Hence, we describe a novel mechanism showing how ZAP70 controls chemokine-driven valency regulation of integrins and arrest of CLL cells on endothelial cells, a process that might contribute to CLL disease progression.Laufer, J. M., Lyck, R., Legler, D. F. ZAP70 expression enhances chemokine-driven chronic lymphocytic leukemia cell migration and arrest by valency regulation of integrins.	[Laufer, Julia M.; Legler, Daniel F.] Univ Konstanz, Biotechnol Inst Thurgau BITg, Unterseestr 47, CH-8280 Kreuzlingen, Switzerland; [Laufer, Julia M.; Legler, Daniel F.] Univ Konstanz, Konstanz Res Sch Chem Biol KoRS CB, Constance, Germany; [Lyck, Ruth] Univ Bern, Theodor Kocher Inst, Bern, Switzerland	University of Konstanz; University of Bern	Legler, DF (corresponding author), Univ Konstanz, Biotechnol Inst Thurgau BITg, Unterseestr 47, CH-8280 Kreuzlingen, Switzerland.	daniel.legler@bitg.ch		Lyck, Ruth/0000-0002-6479-4837; Legler, Daniel F./0000-0001-8610-4764	Swiss National Science Foundation [31003A_169936, 31003A_143841]; Thurgauische Krebsliga; Thurgauische Stiftung fur Wissenschaft und Forschung; State Secretariat for Education, Research and Innovation (Bern, Switzerland); Konstanz Research School of Chemical Biology (KoRS-CB)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Thurgauische Krebsliga; Thurgauische Stiftung fur Wissenschaft und Forschung; State Secretariat for Education, Research and Innovation (Bern, Switzerland); Konstanz Research School of Chemical Biology (KoRS-CB)	The authors thank Tanja Hartmann (Salzburg Cancer Research Institute, Salzburg, Austria) for helpful discussions and advice. This work was supported by Swiss National Science Foundation Grants 31003A_169936 and 31003A_143841, the Thurgauische Krebsliga, the Thurgauische Stiftung fur Wissenschaft und Forschung, and the State Secretariat for Education, Research and Innovation (Bern, Switzerland). J.M.L. is recipient of a stipend from the Konstanz Research School of Chemical Biology (KoRS-CB). The authors declare no conflicts of interest.	Abadier M, 2015, EUR J IMMUNOL, V45, P1043, DOI 10.1002/eji.201445125; Alon R, 2012, CURR OPIN CELL BIOL, V24, P670, DOI 10.1016/j.ceb.2012.06.001; Bulian P, 2014, J CLIN ONCOL, V32, P897, DOI 10.1200/JCO.2013.50.8515; Calpe E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081221; Calpe E, 2011, BLOOD, V118, P4401, DOI 10.1182/blood-2011-01-333682; Chen LG, 2005, BLOOD, V105, P2036, DOI 10.1182/blood-2004-05-1715; Chen LG, 2002, BLOOD, V100, P4609, DOI 10.1182/blood-2002-06-1683; Ciccone M, 2012, LEUKEMIA, V26, P499, DOI 10.1038/leu.2011.247; Coisne C, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-7; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Deaglio S, 2007, BLOOD, V110, P4012, DOI 10.1182/blood-2007-06-094029; Dighiero G, 2008, LANCET, V371, P1017, DOI 10.1016/S0140-6736(08)60456-0; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; Fiorcari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083830; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Ganghammer S, 2015, ONCOTARGET, V6, P12048, DOI 10.18632/oncotarget.3660; Ghobrial IM, 2004, MAYO CLIN PROC, V79, P318, DOI 10.4065/79.3.318; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Hauser MA, 2016, J LEUKOCYTE BIOL, V99, P869, DOI 10.1189/jlb.2MR0815-380R; Hauser MA, 2016, IMMUNITY, V44, P59, DOI 10.1016/j.immuni.2015.12.010; Herishanu Y, 2011, BLOOD, V117, P563, DOI 10.1182/blood-2010-05-284984; Hertlein E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076607; Kipps TJ, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1038/nrdp.2016.96, 10.1038/nrdp.2017.8]; Lafarge ST, 2015, BRIT J HAEMATOL, V168, P139, DOI 10.1111/bjh.13063; Legler DF, 2014, INT J BIOCHEM CELL B, V54, P78, DOI 10.1016/j.biocel.2014.07.002; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liso V, 1999, HAEMATOLOGICA, V84, P212; Lopez-Giral S, 2004, J LEUKOCYTE BIOL, V76, P462, DOI 10.1189/jlb.1203652; Luo JX, 2014, MOL CELL BIOCHEM, V385, P287, DOI 10.1007/s11010-013-1837-x; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Montresor A, 2009, CANCER RES, V69, P9281, DOI 10.1158/0008-5472.CAN-09-2009; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Otero C, 2008, J CELL SCI, V121, P2759, DOI 10.1242/jcs.029074; Packham G, 2014, HAEMATOLOGICA, V99, P1138, DOI 10.3324/haematol.2013.098384; Pasikowska M, 2016, BLOOD, V128, P563, DOI 10.1182/blood-2016-01-683128; Rai KR, 2016, AM J HEMATOL, V91, P330, DOI 10.1002/ajh.24282; Richardson SJ, 2006, BLOOD, V107, P3584, DOI 10.1182/blood-2005-04-1718; Riches JC, 2014, BLOOD, V123, P4101, DOI 10.1182/blood-2014-01-552307; Rossi D, 2013, BLOOD, V121, P4902, DOI 10.1182/blood-2013-02-486209; Schaeuble K, 2011, J IMMUNOL, V187, P5645, DOI 10.4049/jimmunol.1101850; Soma LA, 2006, HUM PATHOL, V37, P152, DOI 10.1016/j.humpath.2005.09.029; Steiner O, 2010, J IMMUNOL, V185, P4846, DOI 10.4049/jimmunol.0903732; Su'ut L, 1998, BRIT J HAEMATOL, V101, P165; Till KJ, 2002, BLOOD, V99, P2977, DOI 10.1182/blood.V99.8.2977; Tsimberidou AM, 2005, CANCER-AM CANCER SOC, V103, P216, DOI 10.1002/cncr.20773; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wiestner A, 2003, BLOOD, V101, P4944, DOI 10.1182/blood-2002-10-3306; Winderlich M, 2009, J CELL BIOL, V185, P657, DOI 10.1083/jcb.200811159; Zucchetto A, 2013, BLOOD, V122, P3317, DOI 10.1182/blood-2013-06-507335; Zwick C, 2013, BLOOD, V121, P4708, DOI 10.1182/blood-2012-08-447904	53	13	14	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4824	4835		10.1096/fj.201701452RR	http://dx.doi.org/10.1096/fj.201701452RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29589978				2022-12-26	WOS:000443817700018
J	King, SL; Goth, CK; Eckhard, U; Joshi, HJ; Haue, AD; Vakhrushev, SY; Schjoldager, KT; Overall, CM; Wandall, HH				King, Sarah L.; Goth, Christoffer K.; Eckhard, Ulrich; Joshi, Hiren J.; Haue, Amalie D.; Vakhrushev, Sergey Y.; Schjoldager, Katrine T.; Overall, Christopher M.; Wandall, Hans H.			TAILS N-terminomics and proteomics reveal complex regulation of proteolytic cleavage by O-glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFERASE GENE FAMILY; C-TERMINAL REGION; ACETYLGALACTOSAMINYLTRANSFERASE FAMILY; SUBSTRATE SPECIFICITIES; CASPASE CLEAVAGE; PROTEIN TERMINI; CEREBRAL-CORTEX; GLYCOPROTEOME; GENERATION; DISCOVERY	Proteolytic processing is an irreversible post-translational modification functioning as a ubiquitous regulator of cellular activity. Protease activity is tightly regulated via control of gene expression, enzyme and substrate compartmentalization, zymogen activation, enzyme inactivation, and substrate availability. Emerging evidence suggests that proteolysis can also be regulated by substrate glycosylation and that glycosylation of individual sites on a substrate can decrease or, in rare cases, increase its sensitivity to proteolysis. Here, we investigated the relationship between site-specific, mucin-type (or GalNAc-type) O-glycosylation and proteolytic cleavage of extracellular proteins. Using in silico analysis, we found that O-glycosylation and cleavage sites are significantly associated with each other. We then used a positional proteomic strategy, terminal amine isotopic labeling of substrates (TAILS), to map the in vivo cleavage sites in HepG2 SimpleCells with and without one of the key initiating GalNAc transferases, GalNAc-T2, and after treatment with exogenous matrix metalloproteinase 9 (MMP9) or neutrophil elastase. Surprisingly, we found that loss of GalNAc-T2 not only increased cleavage, but also decreased cleavage across a broad range of other substrates, including key regulators of the protease network. We also found altered processing of several central regulators of lipid homeostasis, including apolipoprotein B and the phospholipid transfer protein, providing new clues to the previously reported link between GALNT2 and lipid homeostasis. In summary, we show that loss of GalNAc-T2 O-glycosylation leads to a general decrease in cleavage and that GalNAc-T2 O-glycosylation affects key regulators of the cellular proteolytic network, including multiple members of the serpin family.	[King, Sarah L.; Goth, Christoffer K.; Joshi, Hiren J.; Haue, Amalie D.; Vakhrushev, Sergey Y.; Schjoldager, Katrine T.; Wandall, Hans H.] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Glyc, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark; [Eckhard, Ulrich; Overall, Christopher M.] Univ British Columbia, Dept Oral Biol & Med Sci, Fac Dent, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Eckhard, Ulrich; Overall, Christopher M.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of Copenhagen; University of British Columbia; University of British Columbia	Overall, CM (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.; Overall, CM (corresponding author), Univ British Columbia, Ctr Blood Res, Fac Dent, Vancouver, BC V6T 1Z3, Canada.; Wandall, HH (corresponding author), Univ Copenhagen, Ctr Glyc, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark.	chris.overall@ubc.ca; hhw@sund.ku.dk	Eckhard, Ulrich/L-3733-2016; Vakhrushev, Sergey Y/A-7638-2014; Joshi, Hiren/B-5739-2016	Eckhard, Ulrich/0000-0001-5863-4514; Vakhrushev, Sergey Y/0000-0002-0418-5765; Wandall, Hans H./0000-0003-0240-9232; Haue, Amalie Dahl/0000-0001-7656-7976; Goth, Christoffer/0000-0002-5766-1411; Joshi, Hiren/0000-0002-8192-2829	CIHR [MOP-37937] Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR))		Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Bagdonaite I, 2016, J BIOL CHEM, V291, P12014, DOI 10.1074/jbc.M116.721746; Bagdonaite I, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004784; Bellac CL, 2014, CELL REP, V9, P618, DOI 10.1016/j.celrep.2014.09.006; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; BIRCH NP, 1991, FEBS LETT, V290, P191, DOI 10.1016/0014-5793(91)81257-9; Boskovski MT, 2013, NATURE, V504, P456, DOI 10.1038/nature12723; DAVIE EW, 1964, SCIENCE, V145, P1310, DOI 10.1126/science.145.3638.1310; Deu E, 2012, NAT STRUCT MOL BIOL, V19, P9, DOI 10.1038/nsmb.2203; Ding YY, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad5578; Dix MM, 2012, CELL, V150, P426, DOI 10.1016/j.cell.2012.05.040; Dufour A, 2013, TRENDS PHARMACOL SCI, V34, P233, DOI 10.1016/j.tips.2013.02.004; Duguay SJ, 1998, J BIOL CHEM, V273, P18443, DOI 10.1074/jbc.273.29.18443; Eckhard U, 2016, BIOCHIMIE, V122, P110, DOI 10.1016/j.biochi.2015.10.018; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Fortelny N, 2015, NUCLEIC ACIDS RES, V43, pD290, DOI 10.1093/nar/gku1012; Fortelny N, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001869; Goth CK, 2017, J BIOL CHEM, V292, P4714, DOI 10.1074/jbc.M116.730614; Goth CK, 2015, P NATL ACAD SCI USA, V112, P14623, DOI 10.1073/pnas.1511175112; Gould WR, 2004, J BIOL CHEM, V279, P2383, DOI 10.1074/jbc.M308600200; Ha S, 2017, J NEUROSCI, V37, P960, DOI 10.1523/JNEUROSCI.1826-16.2016; Herbert E, 1980, Ann N Y Acad Sci, V343, P79, DOI 10.1111/j.1749-6632.1980.tb47244.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ihara S, 2004, GLYCOBIOLOGY, V14, P139, DOI 10.1093/glycob/cwh013; Joshi HJ, 2018, GLYCOBIOLOGY, V28, P131, DOI 10.1093/glycob/cwx104; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Keller UAD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003512; Khetarpal SA, 2016, CELL METAB, V24, P234, DOI 10.1016/j.cmet.2016.07.012; King SL, 2017, BLOOD ADV, V1, P429, DOI 10.1182/bloodadvances.2016002121; KINGSLEY DM, 1986, J CELL BIOL, V102, P1576, DOI 10.1083/jcb.102.5.1576; Kleifeld O, 2011, NAT PROTOC, V6, P1578, DOI 10.1038/nprot.2011.382; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; Klein T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9777; Kohno T, 2015, J NEUROSCI, V35, P4776, DOI 10.1523/JNEUROSCI.4119-14.2015; Kong Y, 2015, GLYCOBIOLOGY, V25, P55, DOI 10.1093/glycob/cwu089; KOZARSKY K, 1988, P NATL ACAD SCI USA, V85, P4335, DOI 10.1073/pnas.85.12.4335; Lange PF, 2014, J PROTEOME RES, V13, P2028, DOI 10.1021/pr401191w; Lange PF, 2012, NUCLEIC ACIDS RES, V40, pD351, DOI 10.1093/nar/gkr1025; Lau HT, 2014, J PROTEOME RES, V13, P4164, DOI 10.1021/pr500630a; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Luo SZ, 2007, BLOOD, V109, P603, DOI 10.1182/blood-2006-05-024091; Maddelein D, 2015, NUCLEIC ACIDS RES, V43, pW543, DOI 10.1093/nar/gkv385; MAINS RE, 1981, J BIOL CHEM, V256, P5683; Martinez-Olivan J, 2014, FEBS J, V281, P1534, DOI 10.1111/febs.12721; MELDAL M, 1994, GLYCOCONJUGATE J, V11, P59, DOI 10.1007/BF00731144; Minond D, 2012, J BIOL CHEM, V287, P36473, DOI 10.1074/jbc.M112.389114; NESHEIM ME, 1988, J BIOL CHEM, V263, P1037; O'Donoghue AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075141; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Overall CM, 2002, BIOL CHEM, V383, P1059, DOI 10.1515/BC.2002.114; Petrovan RJ, 1998, BIOCHEMISTRY-US, V37, P1185, DOI 10.1021/bi971948h; Prudova A, 2010, MOL CELL PROTEOMICS, V9, P894, DOI 10.1074/mcp.M000050-MCP201; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Russell D, 2009, CARBOHYD RES, V344, P1508, DOI 10.1016/j.carres.2009.06.033; Schjoldager KT, 2015, EMBO REP, V16, P1713, DOI 10.15252/embr.201540796; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Schjoldager KTBG, 2012, P NATL ACAD SCI USA, V109, P9893, DOI 10.1073/pnas.1203563109; Schjoldager KTBG, 2011, J BIOL CHEM, V286, P40122, DOI 10.1074/jbc.M111.287912; Shirakabe K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46174; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Stavenhagen K, 2013, J MASS SPECTROM, V48, P627, DOI [10.1002/jms.3189, 10.1002/jms.3210]; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tabak LA, 2010, SEMIN CELL DEV BIOL, V21, P616, DOI 10.1016/j.semcdb.2010.02.001; Ten Hagen KG, 2003, J BIOL CHEM, V278, P35039, DOI 10.1074/jbc.M303836200; Tian E, 2007, GLYCOBIOLOGY, V17, P820, DOI 10.1093/glycob/cwm056; Tseng WL, 2014, J THROMB HAEMOST, V12, P2054, DOI 10.1111/jth.12736; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Turowec JP, 2014, MOL CELL PROTEOMICS, V13, P1184, DOI 10.1074/mcp.M113.037374; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; Wang L, 2015, HEPATOB PANCREAT DIS, V14, P361, DOI 10.1016/S1499-3872(15)60396-4; Wasser CR, 2017, J BIOL CHEM, V292, P1330, DOI 10.1074/jbc.R116.766782; Weber S, 2012, DEVELOPMENT, V139, P3693, DOI 10.1242/dev.076398; Wen W, 1999, CANCER RES, V59, P6052; Wigle TJ, 2010, CHEM BIOL, V17, P695, DOI 10.1016/j.chembiol.2010.04.014	81	19	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7629	7644		10.1074/jbc.RA118.001978	http://dx.doi.org/10.1074/jbc.RA118.001978			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29593093	Green Published, hybrid			2022-12-26	WOS:000437256500015
J	Charlton, B; Adeboyeje, G; Barron, JJ; Grady, D; Shin, J; Redberg, RF				Charlton, Blake; Adeboyeje, Gboyega; Barron, John J.; Grady, Deborah; Shin, Jaekyu; Redberg, Rita F.			Length of hospitalization and mortality for bleeding during treatment with warfarin, dabigatran, or rivaroxaban	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; ORAL ANTICOAGULANTS; PROPENSITY SCORE; MANAGEMENT; HEMORRHAGE; APIXABAN; OUTCOMES; THERAPY; EVENTS; DEATH	Background Different outcomes among patients hospitalized for bleeding after starting anticoagulation could influence choice of anticoagulant. We compared length of hospitalization, proportion of Intensive Care Unit (ICU) admissions, ICU length of stay, and 30- and 90-day mortality for adults with atrial fibrillation hospitalized for bleeding after starting warfarin, dabigatran, or rivaroxaban. Methods An US commercial database of 38 million members from 1 November 2010 to 31 March 2014 was used to examine adults with atrial fibrillation hospitalized for bleeding after starting warfarin (2,446), dabigatran (442), or rivaroxaban (256). Outcomes included difference in mean total length of hospitalization, proportion of ICU admissions, mean length of ICU stay, and all-cause 30- and 90-day mortality. Results Warfarin users were older and had more comorbidities. Multivariable regression modeling with propensity score weighting showed warfarin users were hospitalized 2.0 days longer (95% CI 1.8-2.3; p < 0.001) than dabigatran users and 2.6 days longer (95% CI 2.4-2.9; p < 0.001) than rivaroxaban users. Dabigatran users were hospitalized 0.6 days longer (95% CI 0.2-1.0; p = 0.001) than rivaroxaban users. There were no differences in the proportion of ICU admissions. Among ICU admissions, warfarin users stayed 3.0 days (95% CI 1.9-3.9; p < 0.001) longer than dabigatran users and 2.4 days longer (95% CI 0.9-3.7; p = 0.003) than rivaroxaban users. There was no difference in ICU stay between dabigatran and rivaroxaban users. There were no differences in 30- and 90-day all-cause mortality. Conclusions Rivaroxaban and dabigatran were associated with shorter hospitalizations; however, there were no differences in 30- and 90-day mortality. These findings suggest bleeding associated with the newer agents is not more dangerous than bleeding associated with warfarin.	[Charlton, Blake; Grady, Deborah; Redberg, Rita F.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Adeboyeje, Gboyega; Barron, John J.] HealthCore Inc, Wilmington, DE USA; [Shin, Jaekyu] Univ Calif San Francisco, Sch Pharm, Dept Clin Pharm, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; HealthCore, Inc; University of California System; University of California San Francisco	Charlton, B (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	blake.charlton@ucsf.edu		Adeboyeje, Gboyega/0000-0002-1088-751X	Clinical & Translational Science Institute, University of California San Francisco; HealthCore	Clinical & Translational Science Institute, University of California San Francisco; HealthCore	Blake Charlton was supported by the Outstanding Resident Research Award, Resident ResearchFunding Grant, and Resident Research Travel Grant all from the Clinical & Translational Science Institute, University of California San Francisco. These awards and grants provided funding for statistical consultation and travel to the American Heart Association's 2015 conference, where this project was presented as a scientific poster. Gboyega Adeboyeje and John J Barron were employed by HealthCore, a wholly-owned and independently operated subsidiary of Anthem, Inc. HealthCore provided support in the form of salaries for the Gboyega Adeboyeje and John J Barron but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Anthem has no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Adam SS, 2012, ANN INTERN MED, V157, P796, DOI 10.7326/0003-4819-157-10-201211200-00532; Ashburner JM, 2015, AM J CARDIOL, V115, P40, DOI 10.1016/j.amjcard.2014.10.006; Beyer-Westendorf J, 2014, BLOOD, V124, P955, DOI 10.1182/blood-2014-03-563577; Cadarette SM, 2008, ANN INTERN MED, V148, P637, DOI 10.7326/0003-4819-148-9-200805060-00003; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cunningham A, 2011, PHARMACOEPIDEM DR S, V20, P560, DOI 10.1002/pds.2109; da Graca B, 2013, CIRC-CARDIOVASC QUAL, V6, P124, DOI 10.1161/CIRCOUTCOMES.112.968826; Dahl OE, 2012, INT ORTHOP, V36, P741, DOI 10.1007/s00264-011-1393-5; Fang MC, 2007, AM J MED, V120, P700, DOI 10.1016/j.amjmed.2006.07.034; Gheorghiade M, 2013, J AM COLL CARDIOL, V61, P391, DOI 10.1016/j.jacc.2012.09.038; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Go AS, 2003, JAMA-J AM MED ASSOC, V290, P2685, DOI 10.1001/jama.290.20.2685; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hagii J, 2014, STROKE, V45, P2805, DOI 10.1161/STROKEAHA.114.006661; Halbritter K, 2013, J THROMB HAEMOST, V11, P651, DOI 10.1111/jth.12148; Held C, 2015, EUR HEART J, V36, P1264, DOI 10.1093/eurheartj/ehu463; Imbens GW, 2000, BIOMETRIKA, V87, P706, DOI 10.1093/biomet/87.3.706; Majeed A, 2013, CIRCULATION, V128, P2325, DOI 10.1161/CIRCULATIONAHA.113.002332; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Piccini JP, 2014, EUR HEART J, V35, P1873, DOI 10.1093/eurheartj/ehu083; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Saji N, 2015, CIRC J, V79, P1018, DOI 10.1253/circj.CJ-14-1209; Sherwood MW, 2015, J AM COLL CARDIOL, V66, P2271, DOI 10.1016/j.jacc.2015.09.024; Siegal DM, 2015, N ENGL J MED; Singer DE, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000250; Skaistis J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137444; Spreeuwenberg MD, 2010, MED CARE, V48, P166, DOI 10.1097/MLR.0b013e3181c1328f; Sturmer T, 2006, J CLIN EPIDEMIOL, V59, P437, DOI 10.1016/j.jclinepi.2005.07.004; Wahl PM, 2010, PHARMACOEPIDEM DR S, V19, P596, DOI 10.1002/pds.1924	31	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193912	10.1371/journal.pone.0193912	http://dx.doi.org/10.1371/journal.pone.0193912			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590141	gold, Green Submitted, Green Published			2022-12-26	WOS:000428603100036
J	Hagenaars, TJ; Melchior, MB; Windig, JJ; Bossers, A; Davidse, A; van Zijderveld, FG				Hagenaars, Thomas J.; Melchior, Marielle B.; Windig, Jack J.; Bossers, Alex; Davidse, Aart; van Zijderveld, Fred G.			Modelling of strategies for genetic control of scrapie in sheep: The importance of population structure	PLOS ONE			English	Article							PROGRAM	Scrapie is a transmissible spongiform encephalopathy in sheep and an example of a disease that may be controlled through breeding for disease resistance. Member states of the European Union have introduced strategies for breeding against scrapie based on the selection of genetically resistant breeding rams. An ambitious strategy adopted in The Netherlands consisted of selecting resistant rams for breeding throughout both breeding and production sectors. Mathematical modelling of the effect of a breeding program on the spreading capacity of scrapie in a national flock is needed for making assessments on how long a breeding strategy needs to be maintained to achieve disease control. Here we describe such a model applied to the Dutch situation, with the use of data on the genetic content of the Dutch sheep population as well as on scrapie occurrence in this population. We show that the time needed for obtaining scrapie control depends crucially on two parameters measuring sheep population structure: the between-flock heterogeneity in genotype frequencies, and the heterogeneity of mixing (contact rates) between sheep flocks. Estimating the first parameter from Dutch genetic survey data and assuming scenario values for the second one, enables model prediction of the time needed to achieve scrapie control in The Netherlands.	[Hagenaars, Thomas J.; Melchior, Marielle B.; Bossers, Alex; Davidse, Aart; van Zijderveld, Fred G.] Wageningen Biovet Res, Lelystad, Netherlands; [Windig, Jack J.] Wageningen Livestock Res, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Hagenaars, TJ (corresponding author), Wageningen Biovet Res, Lelystad, Netherlands.	thomas.hagenaars@wur.nl	Bossers, Alex/AAA-6025-2021; Bossers, Alex/F-7757-2019	Bossers, Alex/0000-0002-6586-717X; Bossers, Alex/0000-0002-6586-717X	Dutch Ministry of Agriculture, Nature and Food Quality [WOT-01-002-01.06, WOT-01-002-001.01]	Dutch Ministry of Agriculture, Nature and Food Quality	This work was supported by the Dutch Ministry of Agriculture, Nature and Food Quality, research project codes WOT-01-002-01.06 and WOT-01-002-001.01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Arnold M, 2002, PREV VET MED, V56, P227, DOI 10.1016/S0167-5877(02)00159-9; Bozzetta E, 2011, J VIROL METHODS, V173, P161, DOI 10.1016/j.jviromet.2011.01.008; Diekmann O., 2012, MATH TOOLS UNDERSTAN; Goldmann W, 2008, VET RES, V39, DOI 10.1051/vetres:2008010; Gubbins S, 2005, PREV VET MED, V69, P175, DOI 10.1016/j.prevetmed.2004.12.009; Gubbins S, 2010, VET RES, V41, DOI 10.1051/vetres/2010014; Hagenaars TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139436; Hagenaars TJ, 2006, EPIDEMIOL INFECT, V134, P359, DOI 10.1017/S0950268805004966; Hagenaars TJ, 2001, EPIDEMIOL INFECT, V127, P157, DOI 10.1017/S0950268801005738; Hagenaars TJ, 2010, BMC VET RES, V6; Kao RR, 2001, MATH BIOSCI, V174, P61, DOI 10.1016/S0025-5564(01)00082-7; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Lokhorst C, 2007, REPORTS ASG LIVESTOC, V50; Melchior MB, 2011, TIJDSCHR DIERGENEESK, V136, P84; Melchior MB, 2010, BMC VET RES, V6; Moreno CR, 2008, GENETICS, V179, P723, DOI 10.1534/genetics.108.088146; Nodelijk G, 2011, VET RES, V42; Ortiz-Pelaez A, 2014, VET REC, V174, P530, DOI 10.1136/vr.102255; Ortiz-Pelaez A, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-31; Vaccari G, 2009, VET RES, V40; van Keulen LJM, 2008, VET RES, V39, DOI 10.1051/vetres:2007061	22	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0195009	10.1371/journal.pone.0195009	http://dx.doi.org/10.1371/journal.pone.0195009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584772	Green Published, Green Submitted, gold			2022-12-26	WOS:000428373000056
J	Pagnuco, IA; Revuelta, MV; Bondino, HG; Brun, M; ten Have, A				Anabela Pagnuco, Inti; Victoria Revuelta, Maria; Gabriel Bondino, Hernan; Brun, Marcel; ten Have, Arjen			HMMER Cut-off Threshold Tool (HMMERCTTER): Supervised classification of superfamily protein sequences with a reliable cut-off threshold	PLOS ONE			English	Article							FUNCTIONAL CLASSIFICATION; PHOSPHOLIPASE-C; GENE; IDENTIFICATION; ANNOTATION; EVOLUTION; HOMOLOGY	Background Protein superfamilies can be divided into subfamilies of proteins with different functional characteristics. Their sequences can be classified hierarchically, which is part of sequence function assignation. Typically, there are no clear subfamily hallmarks that would allow pattern-based function assignation by which this task is mostly achieved based on the similarity principle. This is hampered by the lack of a score cut-off that is both sensitive and specific. Results HMMER Cut-off Threshold Tool (HMMERCTTER) adds a reliable cut-off threshold to the popular HMMER. Using a high quality superfamily phylogeny, it clusters a set of training sequences such that the cluster-specific HMMER profiles show cluster or subfamily member detection with 100% precision and recall (P&R), thereby generating a specific threshold as inclusion cut-off. Profiles and thresholds are then used as classifiers to screen a target dataset. Iterative inclusion of novel sequences to groups and the corresponding HMMER profiles results in high sensitivity while specificity is maintained by imposing 100% P&R self detection. In three presented case studies of protein superfamilies, classification of large datasets with 100% precision was achieved with over 95% recall. Limits and caveats are presented and explained. Conclusions HMMERCTTER is a promising protein superfamily sequence classifier provided high quality training datasets are used. It provides a decision support system that aids in the difficult task of sequence function assignation in the twilight zone of sequence similarity. All relevant data and source codes are available from the Github repository at the following URL: https://github.com/BBCMdP/HMMERCTTER.	[Anabela Pagnuco, Inti; Brun, Marcel] Univ Nacl Mar del Plata, Inst Invest Cient & Tecnol Elect ICyTE, Fac Ingn, Lab Procesamiento Digital Imagenes, Mar Del Plata, Buenos Aires, Argentina; [Victoria Revuelta, Maria; Gabriel Bondino, Hernan; ten Have, Arjen] Univ Nacl Mar del Plata, Fac Ciencias Exactas & Nat, IIB, CONICET, Mar Del Plata, Buenos Aires, Argentina; [Victoria Revuelta, Maria] Weill Cornell Med, Hematol & Oncol Div, Dept Med, New York, NY USA	National University of Mar del Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Mar del Plata; Cornell University	ten Have, A (corresponding author), Univ Nacl Mar del Plata, Fac Ciencias Exactas & Nat, IIB, CONICET, Mar Del Plata, Buenos Aires, Argentina.	atenhave@mdp.edu.ar	Have, Arjen ten/N-3934-2019; Have, Arjen ten/J-2524-2014	Have, Arjen ten/0000-0001-6210-5017; Have, Arjen ten/0000-0001-6210-5017; Revuelta, Maria/0000-0002-7922-0713; Brun, Marcel/0000-0002-6452-5856	Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP11420100100286]; Fondo para la Investigacion Cientifica y Tecnologica [PICT2013-2296]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fondo para la Investigacion Cientifica y Tecnologica	IAP was a Consejo Nacional de Investigaciones Cientificas y Tecnicas doctoral fellow. MVR was a Consejo Nacional de Investigaciones Cientificas y Tecnicas doctoral fellow. HB was a Consejo Nacional de Investigaciones Cientificas y Tecnicas postdoctoral fellow. AtH is a Consejo Nacional de Investigaciones Cientificas y Tecnicas career researcher. The project was funded by PIP11420100100286 from the Consejo Nacional de Investigaciones Cientificas y Tecnicas (AtH) and PICT2013-2296 from the Fondo para la Investigacion Cientifica y Tecnologica (AtH and MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhiman S, 2005, NUCLEIC ACIDS RES, V33, pD197, DOI 10.1093/nar/gki067; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDOH T, 1995, YEAST, V11, P179, DOI 10.1002/yea.320110209; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Brown DP, 2007, PLOS COMPUT BIOL, V3, P1526, DOI 10.1371/journal.pcbi.0030160; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Das S, 2015, BIOINFORMATICS, V31, P3460, DOI 10.1093/bioinformatics/btv398; Eddy Sean R, 2009, Genome Inform, V23, P205; Eirin-Lopez JM, 2012, GENOME DYNAM, V7, P170, DOI 10.1159/000337119; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; Engelhardt BE, 2011, GENOME RES, V21, P1969, DOI 10.1101/gr.104687.109; Engelhardt BE, 2005, PLOS COMPUT BIOL, V1, P432, DOI 10.1371/journal.pcbi.0010045; Bondino HG, 2012, PLANTA, V235, P1299, DOI 10.1007/s00425-011-1575-9; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Lee DA, 2010, NUCLEIC ACIDS RES, V38, P720, DOI 10.1093/nar/gkp1049; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Neuwald AF, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-144; OHTA S, 1988, FEBS LETT, V242, P31, DOI 10.1016/0014-5793(88)80979-7; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Ten Have A, 2002, MYCOTA, V11, P341; ten Have A, 1998, MOL PLANT MICROBE IN, V11, P1009, DOI 10.1094/MPMI.1998.11.10.1009; Thompson JD, 2003, BIOINFORMATICS, V19, P1155, DOI 10.1093/bioinformatics/btg133; Vossen JH, 2010, PLANT J, V62, P224, DOI 10.1111/j.1365-313X.2010.04136.x; Willats WGT, 2001, PLANT MOL BIOL, V47, P9, DOI 10.1023/A:1010662911148; Zhang Z, 1998, NUCLEIC ACIDS RES, V26, P3986, DOI 10.1093/nar/26.17.3986; Zmasek CM, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-14	38	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0193757	10.1371/journal.pone.0193757	http://dx.doi.org/10.1371/journal.pone.0193757			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579071	Green Published, gold, Green Submitted			2022-12-26	WOS:000428351800013
J	Bebber, MR; Spurlock, LB; Fisch, M				Bebber, Michelle Rae; Spurlock, Linda B.; Fisch, Michael			A performance-based evaluation of chemically similar (carbonate) tempers from Late Prehistoric (AD 1200-1700) Ohio: Implications for human selection and production of ceramic technology	PLOS ONE			English	Article							POTTERY; ARCHAEOLOGY; STRENGTH	Purpose This study was designed to assess the mechanical properties of two calcium carbonate tempers, limestone and burnt shell. These tempers have been previously compared, in separate studies, to silicate-based grit or sand temper and, relative to the latter, are assumed to possess similar mechanical properties. However, their simultaneous use at the Morrison Village site begs the question: do these two calcium carbonate tempers indeed possess similar mechanical properties? In order to assess their performance characteristics, a side-by-side controlled experimental test was conducted to determine the degree of similarity in providing increased vessel strength and toughness. Methods Standardized ceramic test samples were systematically prepared via a set, explicit protocol. An Instron Series IX universal testing machine configured with a four-point flexural test jig was used to perform a flexural strength test of the test samples. The Instron load and deflection data were used to calculate three values related to mechanical performance: peak load, modulus of rupture, and modulus of elasticity. Results All four comparative tests clearly show substantial differences in peak load, modulus of rupture, and modulus of elasticity. These differences are statistically significant for each performance attribute in every iteration of the experiment and as indicated by Mann-Whitney U Tests. Conclusions These results do not support the hypothesis that limestone and burnt shell offer the same performance characteristics. These results have implications for our understanding of prehistoric human selection of temper and the evolution of ceramic technology. Although both carbonate-based tempers are currently thought to offer the same benefits during the initial phase of pottery production, their contrasting post firing properties would have provided distinct benefits in different contexts. Future assessments of the Morrison Village ceramic assemblage should focus on residue analysis, or other functional indicators, to support or falsify this hypothesis.	[Bebber, Michelle Rae; Spurlock, Linda B.] Kent State Univ, Dept Anthropol, Kent, OH 44242 USA; [Fisch, Michael] Kent State Univ, Coll Aeronaut & Engn, Kent, OH 44242 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Bebber, MR (corresponding author), Kent State Univ, Dept Anthropol, Kent, OH 44242 USA.	mbebber@ken.edu		Bebber, Michelle/0000-0002-6084-8420	Kent State University Biomedical Sciences (Biological Anthropology) Program; Kent State University's College of Arts and Sciences Eren Lab for Prehistoric and Experimental Archaeology	Kent State University Biomedical Sciences (Biological Anthropology) Program; Kent State University's College of Arts and Sciences Eren Lab for Prehistoric and Experimental Archaeology	M.R.B. is financially supported by the Kent State University Biomedical Sciences (Biological Anthropology) Program and gratefully acknowledges support from Kent State University's College of Arts and Sciences Eren Lab for Prehistoric and Experimental Archaeology.	Aronson Meredith, 1994, KALINGA ETHNOARCHAEO, P83; Bebber MR, 2017, J ARCHAEOL SCI, V86, P1, DOI 10.1016/j.jas.2017.08.002; Braun D. P., 1983, ARCHAEOLOGICAL HAMME; BRONITSKY G, 1986, AM ANTIQUITY, V51, P89, DOI 10.2307/280396; Bronitsky G., 1989, POTTERY TECHNOLOGY I; Callister WD, 2018, MAT SCI ENG INTRO, V9; Cochrane E.E., 2002, ARCHAEOL OCEAN, V37, P37, DOI [10.1002/j.1834-4453.2002.tb00499.x, DOI 10.1002/J.1834-4453.2002.TB00499.X]; Dytham C., 2011, CHOOSING USING STAT; Eren MI, 2016, ETHNOARCHAEOLOGY, V8, P103, DOI 10.1080/19442890.2016.1213972; Feathers JK, 2006, J ARCHAEOL METHOD TH, V13, P89, DOI 10.1007/s10816-006-9003-3; FEATHERS JK, 1989, AM CERAM SOC BULL, V68, P554; FEATHERS JK, 1989, AM ANTIQUITY, V54, P579, DOI 10.2307/280784; Ferguson Jr, 2010, DESIGNING EXPERIMENTAL RESEARCH IN ARCHAEOLOGY: EXAMINING TECHNOLOGY THROUGH PRODUCTION AND USE, P1; Field A., 2013, DISCOVERING STAT USI; GOSSELAIN OP, 1992, J ARCHAEOL SCI, V19, P243, DOI 10.1016/0305-4403(92)90014-T; Griffin James B., 1943, FORT ANCIENT ASPECT; Grim R.E., 1962, APPL CLAY MINERALOGY, DOI 10.1080/11035896209447314; HOARD RJ, 1995, J ARCHAEOL SCI, V22, P823, DOI 10.1016/0305-4403(95)90011-X; Hodges H., 1989, ARTIFACTS INTRO EARL; KILIKOGLOU V, 1995, ACTA METALL MATER, V43, P2959, DOI 10.1016/0956-7151(95)00006-H; Kilikoglou V, 1998, ARCHAEOMETRY, V40, P261, DOI 10.1111/j.1475-4754.1998.tb00837.x; Lycett SJ, 2013, WORLD ARCHAEOL, V45, P519, DOI 10.1080/00438243.2013.821670; Mesoudi A., 2011, CULTURAL EVOLUTION D; Moore D. M., 1997, XRAY DIFFRACTION IDE, pxviii; Muller NS, 2010, J EUR CERAM SOC, V30, P2457, DOI 10.1016/j.jeurceramsoc.2010.04.039; Orton C, 2013, CAMB MAN ARCHAEOL, P1; Outram AK, 2008, WORLD ARCHAEOL, V40, P1, DOI 10.1080/00438240801889456; Prufer O., 1967, STUDIES OHIO ARCHAEO, P187; Prufer O. H., 1970, BLAIN VILLAGE AND TH; Reedy Chandra L., 2008, THIN SECTION PETROGR; Rice P.M., 2015, POTTERY ANAL SOURCEB, V2nd ed., DOI DOI 10.7208/CHICAGO/9780226923222.001.0001; Rye O. S, 1976, ARCHAEOL PHYS ANTHRO, V11, P106, DOI 10.1002/j.1834-4453.1976.tb00245.x; Skibo J. M., 2013, UNDERSTANDING POTTER, P1, DOI [10.1007/978-1-4614-4199-1_1, DOI 10.1007/978-1-4614-4199-1_1, http%3A//doi.org/10.1007/978-1-4614-4199-1, DOI 10.1007/978-1-4614-4199-1]; SKIBO JM, 1989, AM ANTIQUITY, V54, P122, DOI 10.2307/281335; Smith AL, 2001, J ARCHAEOL SCI, V28, P991; Steponaitis V.P., 1984, MANY DIMENSIONS POTT, P79; Zhu J, 2014, ARCHAEOMETRY, V56, P562, DOI 10.1111/arcm.12033	37	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194992	10.1371/journal.pone.0194992	http://dx.doi.org/10.1371/journal.pone.0194992			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5DH	29579085	gold, Green Published, Green Submitted			2022-12-26	WOS:000428351800073
J	Lee, SY; Lee, SC; Shin, SD; Song, KJ; Ro, YS; Park, JH; Kong, SY				Lee, Sun Young; Lee, Seung Chul; Shin, Sang Do; Song, Kyoung Jun; Ro, Young Sun; Park, Jeong Ho; Kong, So Yeon			Epidemiology and outcomes of anaphylaxis-associated out-of-hospital cardiac arrest	PLOS ONE			English	Article							BYSTANDER CARDIOPULMONARY-RESUSCITATION; UNITED-STATES; EUROPEAN RESUSCITATION; IMMUNOLOGY; GUIDELINES; FATALITIES; COUNCIL; ALLERGY; UPDATE; ASTHMA	Background Understanding the epidemiological characteristics of anaphylaxis-associated out-of-hospital cardiac arrest (OHCA) is the first step toward developing preventative strategies and optimizing care systems. We aimed to describe and compare epidemiological features and clinical outcomes among patients with anaphylaxis-associated OHCAs according to causative agent groups. Methods We identified emergency medical service (EMS)-treated anaphylaxis-associated OHCA patients from a nationwide OHCA registry between 2008 and 2015. We compared epidemiological characteristics and outcomes according to causal agents (a natural agents group and an iatrogenic agents group) and evaluated temporal variability in incidence. Multivariate logistic regression analysis was performed to compare survival to discharge between causative agent groups. Results During the study period (8 years), the total number of anaphylaxis-associated OHCAs was 233. A total of 224 eligible cases were included in the analysis. There were 192 patients (85.6%) in the natural agents group and 32 patients (14.3%) in the iatrogenic agents group. There was significant diurnal and seasonal variability in the frequency of anaphylaxis-associated OHCAs (p values<0.01 for both), with the highest incidences occurring during the day (7:01 am to 3 pm; 64.6%) and in summer (June to August, 48.7%). Compared with the natural agents group, the adjusted odds ratio (AOR) for survival to discharge in the iatrogenic agents group was statistically insignificant (AOR 3.61, 95% CI 0.86 to 15.06). Conclusion The incidence of anaphylaxis-associated OHCA is considerably low, and significant temporal variability, with a peak during the day and in summer, is evident. Anaphylaxis-associated OHCA is more common by natural agents than by iatrogenic agents, but no difference in the survival-to-discharge rate is evident.	[Lee, Sun Young; Shin, Sang Do; Song, Kyoung Jun; Ro, Young Sun; Park, Jeong Ho; Kong, So Yeon] Seoul Natl Univ, Dept Emergency Med, Coll Med, Seoul, South Korea; [Lee, Sun Young; Lee, Seung Chul; Shin, Sang Do; Song, Kyoung Jun; Ro, Young Sun; Park, Jeong Ho; Kong, So Yeon] Seoul Natl Univ Hosp, Lab Emergency Med Serv, Biomed Res Inst, Seoul, South Korea; [Lee, Seung Chul] Dongguk Univ, Dept Emergency Med, Ilsan Hosp, Goyang Si, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Dongguk University; NHIS Ilsan Hospital	Lee, SC (corresponding author), Seoul Natl Univ Hosp, Lab Emergency Med Serv, Biomed Res Inst, Seoul, South Korea.; Lee, SC (corresponding author), Dongguk Univ, Dept Emergency Med, Ilsan Hosp, Goyang Si, South Korea.	edlee@dumc.or.kr	Lee, Jae Hyuk/W-5616-2018	Lee, Jae Hyuk/0000-0003-2429-4085; Lee, Sun Young/0000-0002-1626-2721	Research Program - Korea Centers for Disease Control and Prevention [2009-E00543-00, 2010-E33022-00, 2011-E33004-00, 2012-E33010-00, 2013-E33015-00, 2014-E33011-00]; Dongguk University	Research Program - Korea Centers for Disease Control and Prevention; Dongguk University	This study was financially supported by the Research Program funded by the Korea Centers for Disease Control and Prevention (Grant No.:2009-E00543-00, 2010-E33022-00, 2011-E33004-00, 2012-E33010-00, 2013-E33015-00, 2014-E33011-00)(Sang Do Shin). This work was supported by the Dongguk University Research Fund of 2017(Seung Chul Lee). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KO, 2011, RESUSCITATION, V82, P270, DOI 10.1016/j.resuscitation.2010.10.023; Bagai A, 2013, CIRCULATION, V128, P2595, DOI 10.1161/CIRCULATIONAHA.113.004164; Ben-Shoshan M, 2011, ALLERGY, V66, P1, DOI 10.1111/j.1398-9995.2010.02422.x; Bock SA, 2001, J ALLERGY CLIN IMMUN, V107, P191, DOI 10.1067/mai.2001.112031; Herlitz J, 2002, RESUSCITATION, V54, P133, DOI 10.1016/S0300-9572(02)00097-7; Jacobsen RC, 2011, PREHOSP EMERG CARE, V15, P570, DOI 10.3109/10903127.2011.598619; Jerschow E, 2014, J ALLERGY CLIN IMMUN, V134, P1318, DOI 10.1016/j.jaci.2014.08.018; Kounis NG, 2013, CLIN THER, V35, P563, DOI 10.1016/j.clinthera.2013.02.022; Lee SY, 2016, RESUSCITATION, V99, P84, DOI 10.1016/j.resuscitation.2015.11.027; Lieberman P, 2006, ANN ALLERG ASTHMA IM, V97, P596, DOI 10.1016/S1081-1206(10)61086-1; Lieberman P, 2015, ANN ALLERG ASTHMA IM, V115, P341, DOI 10.1016/j.anai.2015.07.019; Ma L, 2014, J ALLERGY CLIN IMMUN, V133, P1075, DOI 10.1016/j.jaci.2013.10.029; Moneret-Vautrin DA, 2005, ALLERGY, V60, P443, DOI 10.1111/j.1398-9995.2005.00785.x; Muraro A, 2014, ALLERGY, V69, P1026, DOI 10.1111/all.12437; Neugut AI, 2001, ARCH INTERN MED, V161, P15, DOI 10.1001/archinte.161.1.15; Nieto-Nieto A, 2017, J INVEST ALLERG CLIN, V27, P111, DOI 10.18176/jiaci.0146; Park HK, 2017, ALLERGOL INT, V66, P557, DOI 10.1016/j.alit.2017.02.008; Perkins GD, 2015, CIRCULATION, V132, P1286, DOI 10.1161/CIR.0000000000000144; Pumphrey Richard S H, 2004, Novartis Found Symp, V257, P116; Sampson HA, 2003, PEDIATRICS, V111, P1601; Simons FER, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0080-1; Smit DV, 2005, J EMERG MED, V28, P381, DOI 10.1016/j.jemermed.2004.11.028; Soar J, 2010, RESUSCITATION, V81, P1400, DOI 10.1016/j.resuscitation.2010.08.015; Song KJ, 2014, RESUSCITATION, V85, P34, DOI 10.1016/j.resuscitation.2013.06.004; Turner PJ, 2015, J ALLERGY CLIN IMMUN, V135, P956, DOI 10.1016/j.jaci.2014.10.021; Yang MS, 2008, ANN ALLERG ASTHMA IM, V100, P31, DOI 10.1016/S1081-1206(10)60401-2; Yang MS, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005750	27	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194921	10.1371/journal.pone.0194921	http://dx.doi.org/10.1371/journal.pone.0194921			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579130	Green Published, gold, Green Submitted			2022-12-26	WOS:000428351800066
J	Chang, HJ; Gao, QY; Ding, W; Qing, XQ				Chang, Huijuan; Gao, Qiuying; Ding, Wei; Qing, Xueqin			Identification of a robust subpathway-based signature for acute myeloid leukemia prognosis using an miRNA integrated strategy	PLOS ONE			English	Article							BIOMARKERS; METABOLISM; MICRORNAS; SURVIVAL; NETWORK; TARGET; AML	Acute myeloid leukemia (AML) is a heterogeneous disease, and survival signatures are urgently needed to better monitor treatment. MiRNAs displayed vital regulatory roles on target genes, which was necessary involved in the complex disease. We therefore examined the expression levels of miRNAs and genes to identify robust signatures for survival benefit analyses. First, we reconstructed subpathway graphs by embedding miRNA components that were derived from low-throughput miRNA-gene interactions. Then, we randomly divided the data sets from The Cancer Genome Atlas (TCGA) into training and testing sets, and further formed 100 subsets based on the training set. Using each subset, we identified survival-related miRNAs and genes, and identified survival subpathways based on the reconstructed subpathway graphs. After statistical analyses of these survival subpathways, the most robust subpathways with the top three ranks were identified, and risk scores were calculated based on these robust subpathways for AML patient prognoses. Among these robust subpathways, three representative subpathways, path: 05200_10 from Pathways in cancer, path: 04110_20 from Cell cycle, and path: 04510_8 from Focal adhesion, were significantly associated with patient survival in the TCGA training and testing sets based on subpathway risk scores. In conclusion, we performed integrated analyses of miRNAs and genes to identify robust prognostic subpathways, and calculated subpathway risk scores to characterize AML patient survival.	[Chang, Huijuan] Zhengzhou Univ, Henan Childrens Hosp, Zhengzhou Childrens Hosp, Dept Pneumol,Childrens Hosp, Zhengzhou, Henan, Peoples R China; [Gao, Qiuying] Shaanxi Prov Peoples Hosp, Deparment Haematol, Xian, Shanxi, Peoples R China; [Ding, Wei] Gaobeidian Hosp, Bur 18, Dept Gastroenterol, Gaobeidian, Hebei, Peoples R China; [Qing, Xueqin] Shanghai Gen Hosp, Dept Pediat, Shanghai, Peoples R China	Zhengzhou University; Xi'an Medical University	Qing, XQ (corresponding author), Shanghai Gen Hosp, Dept Pediat, Shanghai, Peoples R China.	qingdoctor99@163.com						Behbehani GK, 2015, CANCER DISCOV, V5, P988, DOI 10.1158/2159-8290.CD-15-0298; Carter BZ, 2017, MOL CANCER THER, V16, P1133, DOI 10.1158/1535-7163.MCT-16-0719; Chen HY, 2012, RESPIROLOGY, V17, P620, DOI 10.1111/j.1440-1843.2012.02154.x; Costa AFO, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00816-2; de Lima M, 2004, BLOOD, V104, P865, DOI 10.1182/blood-2003-11-3750; Feng L, 2015, ONCOTARGET, V6, P39151, DOI 10.18632/oncotarget.5341; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang R, 2017, ONCOTARGETS THER, V10, P5243, DOI 10.2147/OTT.S147717; Huang SJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003851; Hung Jui-Hung, 2013, Methods Mol Biol, V939, P201, DOI 10.1007/978-1-62703-107-3_13; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Li CQ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt161; Li CQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047326; Li CQ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp667; Li P, 2018, MED CHEM, V14, P60, DOI 10.2174/1573406413666170620091543; Li X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021131; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Lu TP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-371; Ooi CH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000676; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Shah NM, 2015, CELL DEATH DIFFER, V22, P654, DOI 10.1038/cdd.2014.152; Srinivasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017438; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tomasetti M, 2014, MITOCHONDRION, V19, P29, DOI 10.1016/j.mito.2014.06.004; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Wan YW, 2012, LUNG CANCER, V76, P98, DOI 10.1016/j.lungcan.2011.09.016; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yang XA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002350; Zhang CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096908; Zhang CM, 2017, MED SCI MONITOR, V23, P4705, DOI 10.12659/MSM.903989	31	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2018	13	3							e0194245	10.1371/journal.pone.0194245	http://dx.doi.org/10.1371/journal.pone.0194245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA2QK	29570744	Green Published, gold, Green Submitted			2022-12-26	WOS:000428168400015
J	Gilis-Januszewska, A; Barengo, NC; Lindstrom, J; Ewa, W; Acosta, T; Tuomilehto, J; Schwarz, PEH; Piwonska-Solska, B; Szybinski, Z; Windak, A; Hubalewska-Dydejczyk, A				Gilis-Januszewska, Aleksandra; Barengo, Noel C.; Lindstrom, Jaana; Wojtowicz, Ewa; Acosta, Tania; Tuomilehto, Jaakko; Schwarz, Peter E. H.; Piwonska-Solska, Beata; Szybinski, Zbigniew; Windak, Adam; Hubalewska-Dydejczyk, Alicja			Predictors of long term weight loss maintenance in patients at high risk of type 2 diabetes participating in a lifestyle intervention program in primary health care: The DE-PLAN study	PLOS ONE			English	Article							FOLLOW-UP; PREVENTION PROGRAMS; PHYSICAL-ACTIVITY; GLUCOSE; OBESITY	Lifestyle interventions in type 2 diabetes (DM2) prevention implementation studies can be effective and lasting. Long-term weight loss maintenance enhances the intervention effect through a significant decrease in diabetes incidence over time. Our objective was to identify factors predicting long-term successful weight reduction maintenance achieved during a DM2 prevention program in patients with high DM2 risk in primary health care. Study participants (n = 263), middle-aged, slightly obese with baseline increased DM2 risk (Finnish Diabetes Risk Score (FINDRISC)>14), but no diabetes were invited to receive 11 lifestyle counselling sessions, guided physical activity sessions and motivational support during 10-months. The study participants had three clinical examinations during the study (baseline, one and three years). Stepwise regression analysis was used to determine demographic, clinical, and lifestyle predictors of weight reduction maintenance two years after the discontinuation of the intervention. Out of 105 patients who completed all three examinations (baseline age 56.6 (standard deviation (SD) = 10.7), body mass index 31.1 kg/m(2) (SD = 4.9), FINDRISC 18.6 (SD = 3.1)), 73 patients (70%) showed weight loss during the intervention (mean weight loss 4.2 kg, SD = 5.1). The total weight loss achieved in the maintainers (27 of 73 study participants) two years after the intervention had finished was 6.54 kg (4.47 kg+2.0 kg). The non-maintainers, on the other hand, returned to their initial weight at the start of the intervention (+0.21 kg). In multivariable analysis baseline history of increased glucose (odds ratio (OR) = 3.7; 95% confidence interval (CI) 1.0-13.6) and reduction of total fat in diet during follow-up (OR = 4.3; 95% CI 1.5-12.2) were independent predictors of successful weight loss. Further studies exploring predictors of weight loss maintenance in diabetes prevention are needed to help health care providers to redesign interventions and improve long-term outcomes of real life interventions.	[Gilis-Januszewska, Aleksandra; Wojtowicz, Ewa; Piwonska-Solska, Beata; Szybinski, Zbigniew; Hubalewska-Dydejczyk, Alicja] Jagiellonian Univ, Chair & Dept Endocrinol, Coll Med, Krakow, Poland; [Barengo, Noel C.] Florida Int Univ, Herbert Wertheim Coll Med, Dept Med & Populat Hlth Sci Res, Miami, FL 33199 USA; [Lindstrom, Jaana] Natl Inst Hlth & Welf THL, Chron Dis Prevent Unit, Helsinki, Finland; [Acosta, Tania] Univ Norte, Dept Publ Hlth, Barranquilla, Colombia; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Tuomilehto, Jaakko] King Abdulaziz Univ, Diabet Res Grp, Jeddah, Saudi Arabia; [Tuomilehto, Jaakko] Dasman Diabet Inst, Dasman, Kuwait; [Schwarz, Peter E. H.] Tech Univ Dresden, Univ Clin Carl Gustav Carus, Med Clin Unit 3, Dept Prevent & Care Diabet, Dresden, Germany; [Schwarz, Peter E. H.] Tech Univ Dresden, Univ Hosp, Helmholtz Ctr Munich, Paul Langerhans Inst Dresden, Dresden, Germany; [Schwarz, Peter E. H.] Tech Univ Dresden, Fac Med, Dresden, Germany; [Schwarz, Peter E. H.] German Ctr Diabet Res, Neuherberg, Germany; [Windak, Adam] Jagiellonian Univ, Med Coll, Dept Family Med, Chair Med & Gerontol, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; State University System of Florida; Florida International University; Finland National Institute for Health & Welfare; Universidad del Norte; Danube University Krems; Finland National Institute for Health & Welfare; King Abdulaziz University; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Jagiellonian University; Collegium Medicum Jagiellonian University	Gilis-Januszewska, A (corresponding author), Jagiellonian Univ, Chair & Dept Endocrinol, Coll Med, Krakow, Poland.	myjanusz@cyfronet.pl	Acosta, tania/J-2488-2018	Acosta, tania/0000-0002-9112-8290; Windak, Adam/0000-0001-9844-8935; Lindstrom, Jaana/0000-0001-9255-020X	Commission of the European Communities, Directorate C-Public Health [2004310]; Ministry of Science and Higher Education in Poland [40/PUBLIC HEALTH 2004/2006/7]	Commission of the European Communities, Directorate C-Public Health; Ministry of Science and Higher Education in Poland(Ministry of Science and Higher Education, Poland)	The study was funded by The Commission of the European Communities, Directorate C-Public Health, grant agreement no. 2004310 to Jaakko Tuomilehto, supported by The Ministry of Science and Higher Education in Poland, grant agreement no. 40/PUBLIC HEALTH 2004/2006/7 to Zbigniew Szybinski.	Absetz P, 2009, DIABETES CARE, V32, P1418, DOI 10.2337/dc09-0039; Aziz Z, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0354-6; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Dunkley AJ, 2014, DIABETES CARE, V37, P922, DOI 10.2337/dc13-2195; Gilis-Januszewska A, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009790; Gilis-Januszewska A, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4977-1; Gilis-Januszewska A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4104-3; Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560; Hjorth MF, 2017, AM J CLIN NUTR, V106, P499, DOI 10.3945/ajcn.117.155200; Jensen, 2014, CIRCULATION, V129, pS139, DOI 10.1161/CIR.0000000000000070; Johnson M, 2013, DIABETIC MED, V30, P3, DOI 10.1111/dme.12018; Lahti-Koski M, 2001, INT J OBESITY, V25, P727, DOI 10.1038/sj.ijo.0801588; Lindstrom J, 2013, DIABETOLOGIA, V56, P284, DOI 10.1007/s00125-012-2752-5; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Montesi L, 2016, DIABET METAB SYND OB, V9, P37, DOI 10.2147/DMSO.S89836; Penn L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057143; Santos I, 2015, OBESITY, V23, P957, DOI 10.1002/oby.21082; Schwarz PEH, 2008, EXP CLIN ENDOCR DIAB, V116, P167, DOI 10.1055/s-2007-992115; Schwarz PE, 2014, REAL LIFE DIABETES P, P233; Teixeira PJ, 2005, OBES REV, V6, P43, DOI 10.1111/j.1467-789X.2005.00166.x; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wadden TA, 2012, CIRCULATION, V125, P1157, DOI 10.1161/CIRCULATIONAHA.111.039453; Wadden TA, 2011, OBESITY, V19, P1987, DOI 10.1038/oby.2011.230; Wing RR, 2006, NEW ENGL J MED, V355, P1563, DOI 10.1056/NEJMoa061883; Wing RR, 2005, AM J CLIN NUTR, V82, p222S, DOI 10.1093/ajcn/82.1.222S	25	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2018	13	3							e0194589	10.1371/journal.pone.0194589	http://dx.doi.org/10.1371/journal.pone.0194589			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA2QK	29570724	Green Published, gold, Green Submitted			2022-12-26	WOS:000428168400023
J	Burri, A; Ogata, S; Rice, D; Williams, F				Burri, Andrea; Ogata, Soshiro; Rice, David; Williams, Frances			Pain catastrophizing, neuroticism, fear of pain, and anxiety: Defining the genetic and environmental factors in a sample of female twins	PLOS ONE			English	Article							SEX-DIFFERENCES; CURRENT STATE; BACK-PAIN; SCALE; VALIDATION; DISABILITY; ARTHRITIS; SYMPTOMS; VALIDITY; BELIEFS	The objective of the present study was to establish the heritability of pain catastrophizing and its subdomains of helplessness, magnification, and rumination and to further explore the genetic and environmental sources that may contribute to pain catastrophizing as well as to its commonly reported psycho-affective correlates, including neuroticism, anxiety sensitivity, and fear of pain. N = 2,401 female twin individuals from the TwinsUK registry were subject to univariate and multivariate twin analyses. Well validated questionnaires including the Pain Catastrophizing Scale, the Pain Anxiety Symptom Scale, the Ten Item Personality Index, and the Anxiety Sensitivity Index were used to assess the study variables. Moderate estimates of heritability for pain catastrophizing (36%) and the three subdomains of helplessness (35%), rumination (27%), and magnification (36%) were detected. The high correlations observed between the three subdomains were explained mainly by overlapping genetic factors, with a single factor loading on all three phenotypes. High genetic correlations between pain catastrophizing and its psycho-affective correlates of fear of pain and anxiety sensitivity were found, while the genetic overlap between neuroticism and pain catastrophizing was low. Each measure of negative affect demonstrated relatively distinct environmental contributing factors, with very little overlap. This is the first study to show shared genetic factors in the observed association between pain catastrophizing and other measures of negative affect. Our findings provide deeper insight into the aetiology of pain catastrophizing and confirm that it is at least partially distinct from other measures of negative affect and personality that may influence the development and treatment of chronic pain conditions. Further research in males is warranted to check the comparability of the findings.	[Burri, Andrea; Rice, David] Auckland Univ Technol, Hlth & Rehabil Res Inst, Auckland, New Zealand; [Burri, Andrea; Rice, David] European Inst Sexual Hlth, Hamburg, Germany; [Ogata, Soshiro] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Ogata, Soshiro] Harvard Med Sch, Boston, MA USA; [Ogata, Soshiro] Osaka Univ, Grad Sch Med, Dept Hlth Promot Sci, 1-7 Yamadaoka, Suita, Osaka, Japan; [Ogata, Soshiro] Japan Soc Promot Sci, Tokyo, Japan; [Williams, Frances] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England	Auckland University of Technology; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Osaka University; Japan Society for the Promotion of Science; University of London; King's College London	Burri, A (corresponding author), Auckland Univ Technol, Hlth & Rehabil Res Inst, Auckland, New Zealand.; Burri, A (corresponding author), European Inst Sexual Hlth, Hamburg, Germany.	andrea.burri@aut.ac.nz		Burri, Andrea/0000-0002-4705-3551; Rice, David/0000-0002-3327-8776; Williams, Frances/0000-0002-2998-2744	EU FP7 project Pain_OMICS; Arthritis Research UK [20682]; Chronic Disease Research Foundation; JSPS KAKENHI Grant [15J03698]; Wellcome Trust; European Community's Seventh Framework Programme (FP7); National Institute for Health Research (NIHR)	EU FP7 project Pain_OMICS; Arthritis Research UK(Versus Arthritis); Chronic Disease Research Foundation; JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Wellcome Trust(Wellcome TrustEuropean Commission); European Community's Seventh Framework Programme (FP7)(European Commission); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	FW is supported by the EU FP7 project Pain_OMICS and has grant support from Arthritis Research UK (grant number 20682) and the Chronic Disease Research Foundation. SO is supported by JSPS KAKENHI Grant No. 15J03698. TwinsUK is supported by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013). The study also receives support from the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Buer N, 2002, PAIN, V99, P485, DOI 10.1016/S0304-3959(02)00265-8; Craner JR, 2016, CLIN J PAIN, V32, P1028, DOI 10.1097/AJP.0000000000000355; D'Eon JL, 2004, J BEHAV MED, V27, P361, DOI 10.1023/B:JOBM.0000042410.34535.64; Dong YR, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-222; Edwards RR, 2006, ARTHRIT RHEUM-ARTHR, V55, P325, DOI 10.1002/art.21865; Edwards RR, 2004, J PAIN, V5, P164, DOI 10.1016/j.jpain.2004.02.226; Fisher RA, 1919, GENETICS, V4, P489; George SZ, 2006, EUR J PAIN, V10, P457, DOI 10.1016/j.ejpain.2005.06.007; Gilliam W., 2016, CLIN J PAIN; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Goubert L, 2004, PAIN, V107, P234, DOI 10.1016/j.pain.2003.11.005; Hirsh A. T., 2005, J PAIN, V6, pS60; Horjales-Araujo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078889; KEEFE FJ, 1989, PAIN, V37, P51, DOI 10.1016/0304-3959(89)90152-8; Keefe FJ, 2004, J PAIN, V5, P195, DOI 10.1016/j.jpain.2004.02.576; Keogh E., 2004, UNDERSTANDING TREATI, P91; Kraljevic S, 2012, INT J BEHAV MED, V19, P115, DOI 10.1007/s12529-011-9151-z; Kyvic K., 2000, ADV TWIN SIB PAIR AN, P67; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Lewis GN, 2015, BRIT J ANAESTH, V114, P551, DOI 10.1093/bja/aeu441; McCracken Lance M, 2002, Pain Res Manag, V7, P45; MCCRACKEN LM, 1992, PAIN, V50, P67, DOI 10.1016/0304-3959(92)90113-P; Meints SM, 2016, J PAIN; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; Mogil JS, 2012, NAT REV NEUROSCI, V13, P859, DOI 10.1038/nrn3360; Osman A, 1997, J BEHAV MED, V20, P589, DOI 10.1023/A:1025570508954; Peterson RA, 1999, LEA SER PER CLIN PSY, P61; Plomin R., 2013, BEHAV GENET; Posthuma D, 2010, HANDBOOK OF BEHAVIOR GENETICS, P47, DOI 10.1007/978-0-387-76727-7_4; REISS S, 1986, BEHAV RES THER, V24, P1, DOI 10.1016/0005-7967(86)90143-9; Rijsdijk Fruhling V, 2002, Brief Bioinform, V3, P119, DOI 10.1093/bib/3.2.119; Sloan TJ, 2008, SPINE, V33, P966, DOI 10.1097/BRS.0b013e31816c8ab4; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; Sullivan MJL, 2008, CLIN J PAIN, V24, P281, DOI 10.1097/AJP.0b013e318164bb15; Sullivan MJL, 1998, PAIN, V77, P253, DOI 10.1016/S0304-3959(98)00097-9; Sullivan MJL, 2001, CLIN J PAIN, V17, P52, DOI 10.1097/00002508-200103000-00008; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Thorn BE, 2004, CLIN J PAIN, V20, P275, DOI 10.1097/00002508-200409000-00001; Thorn BE, 2003, PAIN, V106, P1, DOI 10.1016/S0304-3959(03)00228-8; Tremblay I, 2008, PAIN RES MANAG, V13, P19, DOI 10.1155/2008/845674; Trost Z, 2015, PAIN, V156, P514, DOI 10.1097/01.j.pain.0000460326.02891.fc; Turk D, 1983, PAIN BEHAV MED COGNI; Turk DC, 2002, J CONSULT CLIN PSYCH, V70, P678, DOI 10.1037//0022-006X.70.3.678; Van Damme S, 2002, PAIN, V96, P319, DOI 10.1016/S0304-3959(01)00463-8; Vervoort T, 2013, PAIN, V154, P1979, DOI 10.1016/j.pain.2013.05.052; WHITEHEAD WE, 1994, PSYCHOSOM MED, V56, P541, DOI 10.1097/00006842-199411000-00010; Wilson AC, 2014, J PEDIATR PSYCHOL, V39, P418, DOI 10.1093/jpepsy/jst094; Woods SA, 2005, EUR J PERSONALITY, V19, P373, DOI 10.1002/per.542; Yap JC, 2008, PAIN MED, V9, P186, DOI 10.1111/j.1526-4637.2007.00307.x	50	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194562	10.1371/journal.pone.0194562	http://dx.doi.org/10.1371/journal.pone.0194562			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA1RF	29566063	Green Published, gold, Green Submitted			2022-12-26	WOS:000428093900078
J	Gu, H; You, H; Yana, ZW; Yang, NC; Kou, Y; Sun, J; Yu, T; Zhang, N				Gu, Hai; You, Hua; Yana, Zhiwen; Yang, Nichao; Kou, Yun; Sun, Jun; Yu, Ting; Zhang, Ning			Determinants of the utilization of postpartum family visits: Evidence from rural areas of Eastern China	PLOS ONE			English	Article							MEDICAL-CARE; POSTNATAL CARE; PREDICTORS; WOMEN	Background Postpartum Family Visits (PFVs) have been advocated as a way to improve health outcomes for puerperal women and their newborns. This study aimed to identify individual factors associated with the utilization of PFVs in rural Jiangsu Province, China. Methods We employed responses of the household survey in Jiangsu province, part of the National Health Service Survey (NHSS), a nationally representative survey in China. The data analysis framework was designed based on Andersen's behavioral model. The outcome variables included nonuse and deficient use of PFVs, and the explanatory variables were organized into three hierarchical levels: predisposing, enabling and need factors. Univariate analysis and multivariate logistic regression analysis were conducted to examine the impact of the three hierarchical levels on PFVs utilization. Results A total of 884 rural women who had a childbearing history in the prior five years answered PFVs questions. About 23.4% of them had never received any PFVs, and 40.4% received <3 visits. In the results of multivariate logistic regression, educational level (OR = 0.43, 95% CI: 0.24-0.77), income (OR = 0.62, 95% CI: 0.43-0.88), the distance from the nearest hospital (OR = 1.49, 95% CI: 1.07-2.07) and parity (OR = 2.17, 95% CI: 1.54-3.05) had significant relationship with nonuse. Factors significantly associated with deficient use of PFVs included employment (OR = 0.62, 95% CI: 0.39-0.98), the distance from the nearest hospital (OR = 1.73, 95% CI: 1.26-2.36), level of delivery institution (OR = 1.57, 95% CI: 1.14-2.17), and parity (OR = 1.45, 95% CI: 1.03-2.05). Conclusion The study found lower Social Economic Status (SES), long distance with primary health institutions, and the increased need for services stemming from multi-parity reduced the likelihood of nonuse or deficient use of PFVs in rural areas. Multiparous, low SES women and those living far away from primary health institutions should be paid more attention to assure the coverage of postpartum care.	[Gu, Hai; Yang, Nichao; Kou, Yun; Sun, Jun; Yu, Ting] Nanjing Univ, Ctr Hlth Policy & Management Studies, Nanjing, Jiangsu, Peoples R China; [You, Hua] Nanjing Med Univ, Sch Publ Hlth, Dept Social Med & Hlth Educ, Nanjing, Jiangsu, Peoples R China; [Yana, Zhiwen] Nanjing Med Univ, Clin Med Sch 1, Nanjing, Jiangsu, Peoples R China; [Yu, Ting] Yangzhou City Peoples Govt, Mayors Off, Yangzhou, Jiangsu, Peoples R China; [Zhang, Ning] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Hlth Policy & Promot, Amherst, MA 01003 USA	Nanjing University; Nanjing Medical University; Nanjing Medical University; University of Massachusetts System; University of Massachusetts Amherst	You, H (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Social Med & Hlth Educ, Nanjing, Jiangsu, Peoples R China.; Zhang, N (corresponding author), Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Hlth Policy & Promot, Amherst, MA 01003 USA.	youhua98@163.com; ningzhang@schoolph.umass.edu	Dangal, Ganesh/O-1989-2017	Dangal, Ganesh/0000-0002-5834-5525; you, hua/0000-0002-0004-0470	National Natural Science Foundation of China [71603131]; Jiangsu Provincial Natural Science Foundation of China [BK20161030]; Top-notch Academic Programs Project of Jiangsu Higher Education Institutions, TAPP [PPZY2015A067]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Natural Science Foundation of China(Natural Science Foundation of Jiangsu Province); Top-notch Academic Programs Project of Jiangsu Higher Education Institutions, TAPP	This study was supported by National Natural Science Foundation of China (71603131), https://isisn.nsfc.gov.cn/egrantweb/; Jiangsu Provincial Natural Science Foundation of China (BK20161030), http://210.73.128.81/13kjskj2/; Top-notch Academic Programs Project of Jiangsu Higher Education Institutions, TAPP (PPZY2015A067), http://180.209.64.40/.	Aday L A, 1974, Health Serv Res, V9, P208; Albers LL, 2000, J MIDWIFERY WOM HEAL, V45, P55, DOI 10.1016/S1526-9523(99)00003-3; American College of Obstetricians and Gynecologists, 2002, GUID PER CAR; ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; Andersen R, 1968, BEHAV MODEL FAMILIES BEHAV MODEL FAMILIES; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Bryant AS, 2006, MATERN CHILD HLTH J, V10, P511, DOI 10.1007/s10995-006-0128-5; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Chakraborty N, 2002, HEALTH SOC CARE COMM, V10, P492, DOI 10.1046/j.1365-2524.2002.00389.x; Dhakal Sulochana, 2007, BMC Pregnancy Childbirth, V7, P19, DOI 10.1186/1471-2393-7-19; Dijkstra-Kersten SMA, 2015, J EPIDEMIOL COMMUN H, V69, P660, DOI 10.1136/jech-2014-205088; Fahey JO, 2013, J MIDWIFERY WOM HEAL, V58, P613, DOI 10.1111/jmwh.12139; GARFIELD SR, 1976, NEW ENGL J MED, V294, P426, DOI 10.1056/NEJM197602192940806; Henderson V, 2016, MATERN CHILD HLTH J, V20, pS132, DOI 10.1007/s10995-016-2044-7; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jean Yeung WJ, 2013, CHINESE SOCIOLOGICAL, V45, P54; Jiang L, 2005, MATERN CHILD HLTH J, V20, P2626; Kim Yangho, 2013, J Prev Med Public Health, V46, P96, DOI 10.3961/jpmph.2013.46.2.96; LEVKOFF SE, 1987, MED CARE, V25, P1148, DOI 10.1097/00005650-198712000-00004; Li XM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-319; Lu MC, 2002, AM J OBSTET GYNECOL, V187, P1329, DOI 10.1067/mob.2002.126848; Midhet F, 1998, SOC SCI MED, V46, P1587, DOI 10.1016/S0277-9536(97)10137-X; Mirkovic KR, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-016-1202-7; Moran AC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001415; National Health and Family Planning Commission of People's Republic of China, MAN MEAS SYST MAT HE; National Health and Family Planning Commission of People's Republic of China, 2009, NOT MIN HLTH ISS NAT; National Health and Family Planning Commission of People's Republic of China, REP 3 NAT HLTH SERV; National Health and Family Planning Commission of People's Republic of China, 2013, 5 NAT HLTH SERV SURV; Pan Y, 2001, MATERN CHILD HLTH J, V16, P89; Sword WA, 2006, CAN J PUBLIC HEALTH, V97, P191, DOI 10.1007/BF03405582; Tao FB, 2011, MIDWIFERY, V27, P707, DOI 10.1016/j.midw.2009.10.001; Wang XL, 2000, CHINESE J BEHAV MED, V9, P175; WHO Department of Reproductive Health and Research, 1998, POSTP CAR MOTH NEWB; WHO Technical working group, 1996, POSTP CAR MOTH NEWB, V26, P255; WOLINSKY FD, 1978, J HEALTH SOC BEHAV, V19, P384, DOI 10.2307/2136586; Wu J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161683; Xu D, 2016, CHINESE PRIMARY HLTH, V30, P35; You H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055955; [于贞杰 Yu Zhenjie], 2013, [中国全科医学, Chinese General Practice], V16, P4037; Zhang T, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0543-9; Zhang Wei, 2016, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V41, P1220; [赵光斌 Zhao Guangbin], 2013, [中国全科医学, Chinese General Practice], V16, P2930; Zou M, 2015, SOCIOLOGY, V49, P1133, DOI 10.1177/0038038514562853	43	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194061	10.1371/journal.pone.0194061	http://dx.doi.org/10.1371/journal.pone.0194061			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA1RF	29566028	Green Submitted, Green Published, gold			2022-12-26	WOS:000428093900031
J	Javaid, MM; Florentine, S; Ali, HH; Weller, S				Javaid, Muhammad Mansoor; Florentine, Singarayer; Ali, Hafiz Haider; Weller, Sandra			Effect of environmental factors on the germination and emergence of Salvia verbenaca L. cultivars (verbenaca and vernalis): An invasive species in semi-arid and arid rangeland regions	PLOS ONE			English	Article							SEED-GERMINATION; ECOLOGY; WEEDS; SALINITY	Salvia verbenaca (wild sage) is a commonly cultivated herbal medicine plant, which is native to the Mediterranean climate regions of Europe, Africa, Asia and the Middle East. However, it has become an invasive species in semi-arid and arid regions of southern Australia. Two varieties are present in this region, var. verbenaca and var. vernalis, each of which can be distinguished by differences in morphology and flowering period. Following trials to determine the optimum temperate regime for germination and response to light and dark, seeds of both varieties were tested for their response to variations in pH, moisture stress, salinity, and burial depth. The temperature and light trial was carried out using three different temperature regimes; 30/20 degrees C, 25/15 degrees C and 20/12 degrees C, and two light regimes; 12 hours light/12 hours dark and 24 hours dark, with var. vernalis responding to relatively higher temperatures than var. verbenaca. The germination rate of neither species was significantly inhibited by complete darkness when compared to rates under periodic light exposure. Both varieties germinated at near optimum rates strongly to very strongly in all pH buffer solutions, from pH 5 to pH 10, but they responded most strongly at neutral pH. Var. vernalis showed slightly more tolerance to reduced moisture availability, moderate to strong salinity, and burial depth, compared to var. verbenaca. However, even a fairly shallow burial depth of 2 cm completely inhibited germination of both varieties. Thus, in circumstances where both varieties are present in a soil seedbank, var. vernalis could be expected to establish in more challenging conditions, where moisture is limited and salinity is 'moderate to high', implying that it is a more serious threat for invasive weed in conditions where crop plants are already challenged.	[Javaid, Muhammad Mansoor; Ali, Hafiz Haider] Univ Sargodha, Univ Coll Agr, Dept Agron, Sargodha, Pakistan; [Javaid, Muhammad Mansoor; Florentine, Singarayer; Weller, Sandra] Federat Univ Australia, Fac Sci & Technol, Ctr Environm Management, Ballarat, Vic, Australia	Bahauddin Zakariya University; University of Sargodha; Federation University Australia	Florentine, S (corresponding author), Federat Univ Australia, Fac Sci & Technol, Ctr Environm Management, Ballarat, Vic, Australia.	s.florentine@federation.edu.au	Florentine, Singarayer/Q-7198-2019; Florentine, Singarayer/ABA-7740-2020; Ali, Hafiz Haider/ABE-6457-2021	Florentine, Singarayer/0000-0002-5734-3421; Ali, Hafiz Haider/0000-0002-8262-6327; Javaid, Muhammad/0000-0003-3918-1729; Weller, Sandra/0000-0003-4204-8582	Australian Endeavour Fellowship; University of Sargodha; Federation University Australia	Australian Endeavour Fellowship(Australian GovernmentDepartment of Industry, Innovation and Science); University of Sargodha; Federation University Australia	This work was supported by the Australian Endeavour Fellowship in the form of salaries to MMJ, by University of Sargodha in the form of salary to HHA and by Federation University Australia in the form of salaries to SW and SF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABCB, 2015, CLIM ZON MAP VICT; Agropolis Fondation, 2017, PL NTNET RIC SPEC IN; [Anonymous], 2000, SAGE GENUS SALVIA; [Anonymous], 2017, ATLAS LIVING AUSTR D; Armengot L, 2016, AGR ECOSYST ENVIRON, V222, P276, DOI 10.1016/j.agee.2016.02.021; ARNOLD RLB, 1991, NEW PHYTOL, V118, P339, DOI 10.1111/j.1469-8137.1991.tb00986.x; Australian Bureau of Meteorology, 2017, CLIM DAT ONL; BABADOOST M, 1993, SEED SCI TECHNOL, V21, P1; Batlla D, 2014, WEED BIOL MANAG, V14, P77, DOI 10.1111/wbm.12039; Biosecurity Queensland, 2016, FACT SHEET SALV VERB; Capon B., 1970, ALISO, V7, P207, DOI [10.5642/aliso.19700702.09, DOI 10.5642/ALISO.19700702.09]; Chachalis D, 2000, WEED SCI, V48, P212, DOI 10.1614/0043-1745(2000)048[0212:FACRSG]2.0.CO;2; Chauhan BS, 2009, WEED SCI, V57, P379, DOI 10.1614/WS-08-179.1; COOLBEAR P, 1984, J EXP BOT, V35, P1609, DOI 10.1093/jxb/35.11.1609; Dekker J, 2014, ARXIV14086187; ELLIS RH, 1981, SEED SCI TECHNOL, V9, P373; Eslami SV, 2011, WEED SCI, V59, P90, DOI 10.1614/WS-D-10-00059.1; Fisher R. L., 2016, 20th Australasian Weeds Conference, Perth, Western Australia, 11-15 September 2016, P329; Florentine SK, 2016, RANGELAND J, V38, P417, DOI 10.1071/RJ16022; Gorai M, 2011, SAUDI J BIOL SCI, V18, P255, DOI 10.1016/j.sjbs.2011.01.004; Guan B, 2009, J ARID ENVIRON, V73, P135, DOI 10.1016/j.jaridenv.2008.08.009; Guillemin JP, 2013, WEED RES, V53, P76, DOI 10.1111/wre.12000; Hanif Z, 2017, RANGELAND ECOL MANAG, V70, P638, DOI 10.1016/j.rama.2017.02.003; Javaid MM, 2014, WEED RES, V54, P565, DOI 10.1111/wre.12111; Kader M. A., 2005, Journal and Proceedings of the Royal Society of New South Wales, V138, P65; Larson JE, 2015, J APPL ECOL, V52, P199, DOI 10.1111/1365-2664.12350; Mahmood AH, 2016, WEED SCI, V64, P486, DOI 10.1614/WS-D-15-00184.1; MICHEL BE, 1983, PLANT PHYSIOL, V72, P66, DOI 10.1104/pp.72.1.66; Mijani S., 2013, Notulae Scientia Biologicae, V5, P462; Steel R., 1997, PRINCIPLES PROCEDURE; Tanveer A, 2014, PLANTA DANINHA, V32, P69, DOI 10.1590/S0100-83582014000100008; Tanveer A, 2013, PLANTA DANINHA, V31, P587, DOI 10.1590/S0100-83582013000300011; USDA, 2017, FACT SHEET ASPH FIST; USDA, 2017, EM SPIN L CAMPD; USDA, 2017, EM AUSTR STEINH; Walsh NG, 1999, FLORA VICTORIA, V4, P428; YEO AR, 1990, THEOR APPL GENET, V79, P377, DOI 10.1007/BF01186082	37	13	15	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194319	10.1371/journal.pone.0194319	http://dx.doi.org/10.1371/journal.pone.0194319			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566039	Green Published, gold, Green Submitted			2022-12-26	WOS:000428093900054
J	Wattanavanitchakorn, S; Rojvirat, P; Chavalit, T; MacDonald, MJ; Jitrapakdee, S				Wattanavanitchakorn, Siriluck; Rojvirat, Pinnara; Chavalit, Tanit; MacDonald, Michael J.; Jitrapakdee, Sarwut			CCAAT-enhancer binding protein-alpha (C/EBP alpha) and hepatocyte nuclear factor 4 alpha (HNF4 alpha) regulate expression of the human fructose-1,6-bisphosphatase 1 (FBP1) gene in human hepatocellular carcinoma HepG2 cells	PLOS ONE			English	Article							PYRUVATE-CARBOXYLASE GENE; ZEALAND OBESE MOUSE; FRUCTOSE 1,6-BISPHOSPHATASE; HEPATIC FRUCTOSE-1,6-BISPHOSPHATASE; IMPAIRED REGULATION; GLUCOSE-METABOLISM; P300; MICE; GLUCONEOGENESIS; FACTOR-4-ALPHA	Fructose-1,6-bisphosphatase (FBP1) plays an essential role in gluconeogenesis. Here we report that the human FBP1 gene is regulated by two liver-enriched transcription factors, CCAAT-enhancer binding protein-alpha (C/EBP alpha) and hepatocyte nuclear factor 4 alpha (HNF4 alpha) in human hepatoma HepG2 cells. C/EBP alpha regulates transcription of FBP1 gene via binding to the two overlapping C/EBP alpha sites located at nucleotide-228/-208 while HNF4 alpha regulates FBP1 gene through binding to the classical H4-SBM site and direct repeat 3 (DR3) located at nucleotides-566/-554 and-212/-198, respectively. Mutations of these transcription factor binding sites result in marked decrease of C/EBP alpha- or HNF4 alpha-mediated transcription activation of FBP1 promoter-luciferase reporter expression. Electrophoretic mobility shift assays of -228/-208 C/EBP alpha or -566/-554 and -212/-198 HNF4 alpha sites with nuclear extract of HepG2 cells overexpressing C/EBP alpha or HNF4 alpha confirms binding of these two transcription factors to these sites. Finally, we showed that siRNA-mediated suppression of C/EBP alpha or HNF4 alpha expression in HepG2 cells lowers expression of FBP1 in parallel with down-regulation of expression of other gluconeogenic enzymes. Our results suggest that an overall gluconeogenic program is regulated by these two transcription factors, enabling transcription to occur in a liver-specific manner.	[Wattanavanitchakorn, Siriluck; Chavalit, Tanit; Jitrapakdee, Sarwut] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok, Thailand; [Rojvirat, Pinnara] Mahidol Univ, Div Interdisciplinary, Kanjanaburi, Thailand; [MacDonald, Michael J.] Univ Wisconsin, Sch Med & Publ Hlth, Childrens Diabet Ctr, Madison, WI USA	Mahidol University; Mahidol University; University of Wisconsin System; University of Wisconsin Madison	Jitrapakdee, S (corresponding author), Mahidol Univ, Fac Sci, Dept Biochem, Bangkok, Thailand.	sarawut.jit@mahidol.ac.th		MacDonald, Michael/0000-0002-0201-9245	international research network grant [IRN 59W0003]; Thailand Research Fund; RGJ-PHD scholarship [4CMU56010]	international research network grant; Thailand Research Fund(Thailand Research Fund (TRF)); RGJ-PHD scholarship	This work was supported by an international research network (grant IRN 59W0003), the Thailand Research Fund. S.W. was supported by an RGJ-PHD scholarship (4CMU56010), the Thailand Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRIKOPOULOS S, 1993, DIABETES, V42, P1731, DOI 10.2337/diabetes.42.12.1731; Andrikopoulos S, 1996, METABOLISM, V45, P622, DOI 10.1016/S0026-0495(96)90034-7; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Bertinat R, 2012, J CELL BIOCHEM, V113, P848, DOI 10.1002/jcb.23413; Bie JB, 2015, EUR J MED CHEM, V90, P394, DOI 10.1016/j.ejmech.2014.11.049; Chavalit T, 2013, BBA-GENE REGUL MECH, V1829, P987, DOI 10.1016/j.bbagrm.2013.05.001; Chen MQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025564; Croniger CM, 2001, J BIOL CHEM, V276, P629, DOI 10.1074/jbc.M007576200; Crosson SM, 1997, DIABETOLOGIA, V40, P1117, DOI 10.1007/s001250050796; Crosson SM, 2000, J BIOL CHEM, V275, P5804, DOI 10.1074/jbc.275.8.5804; Dang Q, 2007, J AM CHEM SOC, V129, P15491, DOI 10.1021/ja074871l; Dang Q, 2011, J MED CHEM, V54, P153, DOI 10.1021/jm101035x; Dong CF, 2013, CANCER CELL, V23, P316, DOI 10.1016/j.ccr.2013.01.022; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; ELMAGHRABI MR, 1984, J CELL BIOCHEM, V26, P1, DOI 10.1002/jcb.240260102; ELMAGHRABI MR, 1995, GENOMICS, V27, P520, DOI 10.1006/geno.1995.1085; Erion MD, 2005, P NATL ACAD SCI USA, V102, P7970, DOI 10.1073/pnas.0502983102; Fang B, 2012, NUCLEIC ACIDS RES, V40, P5343, DOI 10.1093/nar/gks190; Fang YP, 2013, BIOINFORMATICS, V29, P295, DOI 10.1093/bioinformatics/bts693; Fujisawa K, 2000, J BIOCHEM-TOKYO, V127, P373, DOI 10.1093/oxfordjournals.jbchem.a022618; Gautier-Stein A, 2005, MOL ENDOCRINOL, V19, P163, DOI 10.1210/me.2004-0105; Gupta RK, 2004, TRENDS MOL MED, V10, P521, DOI 10.1016/j.molmed.2004.09.004; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; He L, 2013, MOL ENDOCRINOL, V27, P1322, DOI 10.1210/me.2012-1413; He L, 2012, J BIOL CHEM, V287, P32069, DOI 10.1074/jbc.M112.385864; Herzog B, 2000, BIOCHEM J, V351, P385, DOI 10.1042/0264-6021:3510385; Hirata H, 2016, CANCER RES, V76, P3265, DOI 10.1158/0008-5472.CAN-15-2601; Holloway MG, 2008, MOL ENDOCRINOL, V22, P1274, DOI 10.1210/me.2007-0564; Jitrapakdee S, 2005, J BIOL CHEM, V280, P27466, DOI 10.1074/jbc.M503836200; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Klover PJ, 2004, INT J BIOCHEM CELL B, V36, P753; Kovacs KA, 2003, J BIOL CHEM, V278, P36959, DOI 10.1074/jbc.M303147200; Kubota K, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.138; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; Li B, 2014, NATURE, V513, P251, DOI 10.1038/nature13557; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MCKNIGHT SL, 1989, GENE DEV, V3, P2021, DOI 10.1101/gad.3.12b.2021; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; Osada S, 1996, J BIOL CHEM, V271, P3891; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80; Rakus D, 2004, BIOCHEMISTRY-US, V43, P14948, DOI 10.1021/bi048886x; Rakus D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076669; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Samuel VT, 2009, P NATL ACAD SCI USA, V106, P12121, DOI 10.1073/pnas.0812547106; Schwartz C, 2003, EMBO J, V22, P882, DOI 10.1093/emboj/cdg076; Sever R, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016709; Sharabi K, 2015, MOL ASPECTS MED, V46, P21, DOI 10.1016/j.mam.2015.09.003; SOLOMON DH, 1988, P NATL ACAD SCI USA, V85, P6904, DOI 10.1073/pnas.85.18.6904; TEJWANI GA, 1983, ADV ENZYMOL RAMB, V54, P121; Tillmann H, 1998, GENE, V212, P295, DOI 10.1016/S0378-1119(98)00181-4; Tillmann H, 2000, GENE, V247, P241, DOI 10.1016/S0378-1119(00)00079-2; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P2861; Visinoni S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1132, DOI 10.1152/ajpendo.90552.2008; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Wu CD, 2001, J CLIN INVEST, V107, P91, DOI 10.1172/JCI11103; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yang JQ, 2005, J BIOL CHEM, V280, P38689, DOI 10.1074/jbc.M503486200; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yoshida T, 2011, J PHARMACOL SCI, V115, P329, DOI 10.1254/jphs.10262FP	64	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194252	10.1371/journal.pone.0194252	http://dx.doi.org/10.1371/journal.pone.0194252			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566023	gold, Green Submitted, Green Published			2022-12-26	WOS:000428093900046
J	Akberdin, IR; Omelyanchuk, NA; Fadeev, SI; Leskova, NE; Oschepkova, EA; Kazantsev, FV; Matushkin, YG; Afonnikov, DA; Kolchanov, NA				Akberdin, Ilya R.; Omelyanchuk, Nadezda A.; Fadeev, Stanislav I.; Leskova, Natalya E.; Oschepkova, Evgeniya A.; Kazantsev, Fedor V.; Matushkin, Yury G.; Afonnikov, Dmitry A.; Kolchanov, Nikolay A.			Pluripotency gene network dynamics: System views from parametric analysis	PLOS ONE			English	Article							EMBRYONIC STEM-CELL; SELF-RENEWAL; TRANSCRIPTIONAL REGULATION; NANOG AUTOREPRESSION; EXPRESSION; DIFFERENTIATION; HETEROGENEITY; STATE; FEEDBACK; OCT4	Multiple experimental data demonstrated that the core gene network orchestrating self-renewal and differentiation of mouse embryonic stem cells involves activity of Oct4, Sox2 and Nanog genes by means of a number of positive feedback loops among them. However, recent studies indicated that the architecture of the core gene network should also incorporate negative Nanog autoregulation and might not include positive feedbacks from Nanog to Oct4 and Sox2. Thorough parametric analysis of the mathematical model based on this revisited core regulatory circuit identified that there are substantial changes in model dynamics occurred depending on the strength of Oct4 and Sox2 activation and molecular complexity of Nanog autorepression. The analysis showed the existence of four dynamical domains with different numbers of stable and unstable steady states. We hypothesize that these domains can constitute the checkpoints in a developmental progression from naive to primed pluripotency and vice versa. During this transition, parametric conditions exist, which generate an oscillatory behavior of the system explaining heterogeneity in expression of pluripotent and differentiation factors in serum ESC cultures. Eventually, simulations showed that addition of positive feedbacks from Nanog to Oct4 and Sox2 leads mainly to increase of the parametric space for the naive ESC state, in which pluripotency factors are strongly expressed while differentiation ones are repressed.	[Akberdin, Ilya R.; Omelyanchuk, Nadezda A.; Leskova, Natalya E.; Oschepkova, Evgeniya A.; Kazantsev, Fedor V.; Matushkin, Yury G.; Afonnikov, Dmitry A.; Kolchanov, Nikolay A.] Fed Res Ctr Inst Cytol & Genet SB RAS, Novosibirsk, Russia; [Akberdin, Ilya R.; Omelyanchuk, Nadezda A.; Fadeev, Stanislav I.; Leskova, Natalya E.; Oschepkova, Evgeniya A.; Kazantsev, Fedor V.; Matushkin, Yury G.; Afonnikov, Dmitry A.; Kolchanov, Nikolay A.] Novosibirsk State Univ, Novosibirsk, Russia; [Akberdin, Ilya R.] San Diego State Univ, San Diego, CA 92182 USA; [Fadeev, Stanislav I.] Sobolev Inst Math SB RAS, Novosibirsk, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Novosibirsk State University; California State University System; San Diego State University; Russian Academy of Sciences; Sobolev Institute of Mathematics	Akberdin, IR (corresponding author), Fed Res Ctr Inst Cytol & Genet SB RAS, Novosibirsk, Russia.; Akberdin, IR (corresponding author), Novosibirsk State Univ, Novosibirsk, Russia.; Akberdin, IR (corresponding author), San Diego State Univ, San Diego, CA 92182 USA.	akberdin@bionet.nsc.ru	Oshchepkova, Evgeniya/AAT-3362-2021; Afonnikov, Dmitry/J-7806-2018; Akberdin, Ilya R/J-3172-2018; Kazantsev, Fedor V./AAC-8773-2020	Afonnikov, Dmitry/0000-0001-9738-1409; Akberdin, Ilya R/0000-0003-0010-8620; 				Abranches E, 2014, DEVELOPMENT, V141, P2770, DOI 10.1242/dev.108910; Abranches E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059928; Angarica VE, 2016, BIOESSAYS, V38, P758, DOI 10.1002/bies.201600103; Betschinger J., 2016, J MOL BIOL; Bilic J, 2012, STEM CELLS, V30, P33, DOI 10.1002/stem.700; Boroviak T, 2015, DEV CELL, V35, P366, DOI 10.1016/j.devcel.2015.10.011; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen CJ, 2017, SHOCK VIB, V2017, DOI 10.1155/2017/1427270; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Chickarmane V, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-98; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; D'Aniello C, 2017, STEM CELL REP, V8, P1, DOI 10.1016/j.stemcr.2016.11.011; Fadeev S. I., 2004, INT J PURE APPL MATH, V14, P467; Fadeev S. I., 2006, P 6 INT C BIOINF GEN, V118, P120; Fernandes MG, 2016, STEM CELL REP, V6, P85, DOI 10.1016/j.stemcr.2015.11.012; Fidalgo M, 2012, P NATL ACAD SCI USA, V109, P16202, DOI 10.1073/pnas.1208533109; Filipczyk A, 2015, NAT CELL BIOL, V17, P1235, DOI 10.1038/ncb3237; Furusawa C, 2012, SCIENCE, V338, P215, DOI 10.1126/science.1224311; Furusawa T, 2006, BIOL REPROD, V75, P555, DOI 10.1095/biolreprod.105.049502; Galvin-Burgess KE, 2013, STEM CELLS, V31, P48, DOI 10.1002/stem.1252; Gingold JA, 2014, MOL CELL, V56, P140, DOI 10.1016/j.molcel.2014.08.014; Glauche I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011238; Hahn S, 2014, J MOL MED, V92, P571, DOI 10.1007/s00109-014-1160-3; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Herberg M, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0167; Herberg M, 2015, DEVELOPMENT, V142, P2250, DOI 10.1242/dev.116343; Herberg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092496; Imayoshi I, 2013, SCIENCE, V342, P1203, DOI 10.1126/science.1242366; Ji PF, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/8415010; Kalkan T., 2017, DEVELOPMENT; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Karwacki-Neisius V, 2013, CELL STEM CELL, V12, P531, DOI 10.1016/j.stem.2013.04.023; Kholodniok M, 1991, METHODS ANAL NONLINE; Komatsu K, 2015, DEV GROWTH DIFFER, V57, P648, DOI 10.1111/dgd.12244; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Lakatos D, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0112-4; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Li M., 2017, NATURE REV GENETICS; Likhoshvai V, 2007, J BIOINF COMPUT BIOL, V5, P521, DOI 10.1142/S0219720007002837; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MacArthur BD, 2012, NAT CELL BIOL, V14, P1139, DOI 10.1038/ncb2603; MacArthur BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003086; Makarev E, 2015, ONCOTARGET, V6, P23204, DOI 10.18632/oncotarget.4673; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Martello G., 2014, ANNU REV CELL DEV BI, P30; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyamoto T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004476; Montserrat N, 2013, CELL STEM CELL, V13, P341, DOI 10.1016/j.stem.2013.06.019; Mullin NP, 2008, BIOCHEM J, V411, P227, DOI 10.1042/BJ20080134; Navarro P, 2012, EMBO J, V31, P4547, DOI 10.1038/emboj.2012.321; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Osorno R, 2011, PHILOS T R SOC B, V366, P2230, DOI 10.1098/rstb.2011.0043; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Pigolotti S, 2007, P NATL ACAD SCI USA, V104, P6533, DOI 10.1073/pnas.0610759104; Radzisheuskaya A, 2013, NAT CELL BIOL, V15, P579, DOI 10.1038/ncb2742; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Saxe JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004467; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Shimozaki K, 2003, DEVELOPMENT, V130, P2505, DOI 10.1242/dev.00476; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Singer ZS, 2014, MOL CELL, V55, P319, DOI 10.1016/j.molcel.2014.06.029; Smith A, 2017, DEVELOPMENT, V144, P365, DOI 10.1242/dev.142679; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Theunissen T. W., 2012, STEM CELLS CANC STEM, V6, P377; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; van den Hurk M, 2016, EPIGENOMICS-UK, V8, P1131, DOI 10.2217/epi-2016-0032; Wang J, 2016, CELL DEATH DIFFER, V23, P393, DOI 10.1038/cdd.2015.106; Wang J, 2008, P NATL ACAD SCI USA, V105, P6326, DOI 10.1073/pnas.0802288105; Wray J., 2010, GROUND STATE PLURIPO; Wu QQ, 2015, INT J BIFURCAT CHAOS, V25, DOI 10.1142/S021812741540009X	89	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194464	10.1371/journal.pone.0194464	http://dx.doi.org/10.1371/journal.pone.0194464			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596533	Green Published, Green Submitted, gold			2022-12-26	WOS:000428630000026
J	Leung, LY; Han, PKJ; Lundquist, C; Weinstein, G; Thaler, DE; Kent, D				Leung, Lester Y.; Han, Paul K. J.; Lundquist, Christine; Weinstein, Gene; Thaler, David E.; Kent, David			Clinicians' perspectives on incidentally discovered silent brain infarcts - A qualitative study	PLOS ONE			English	Article							HEALTH-CARE PROFESSIONALS; STROKE; STATEMENT; PREVENTION; SATURATION; INTERVIEWS; DISEASE	Background While silent brain infarcts (SBIs) in screened cohorts are associated with risk of symptomatic stroke and dementia, the clinical significance of incidentally discovered SBIs (id-SBIs) is unknown. Detection may offer an opportunity to initiate prevention measures, but uncertainties about id-SBIs may impede clinicians from addressing them and complicate further study of this condition. Methods and results This study used semi-structured interviews of practicing clinicians. Interviews were audio recorded, transcribed, and analyzed using a grounded theory approach. A constant comparative method was used to organize emergent themes and examine new themes. Purposeful sampling was employed to achieve participant diversity. Fifteen clinicians were interviewed. Emergent themes centered on uncertainty about id-SBIs, clinical decision making in response to uncertainty, and evidence needed to resolve uncertainty. All clinicians reported uncertainty about id-SBIs: diagnostic, prognostic, or therapeutic. Differential responses to uncertainties resulted in practice variation within and between specialties. Diagnostic and prognostic uncertainty discouraged disclosure of imaging findings to patients. Vascular neurologists viewed the prognostic significance of id-SBIs as similar to symptomatic stroke. Therapeutic uncertainty was common, but most participants endorsed using stroke secondary prevention strategies. Regarding future research, all internists indicated they would consider changing practices in response to observational studies, whereas half of the neurologists expressed reluctance to modify practices based on non-randomized data. Several expressed concerns about clinical trial feasibility and lack of equipoise. Conclusions id-SBIs are a focus of uncertainty for clinicians, leading to practice variation. Future studies must address diagnostic and prognostic uncertainty to facilitate implementation of prevention strategies.	[Leung, Lester Y.; Thaler, David E.] Tufts Med Ctr, Dept Neurol, Div Stroke & Cerebrovasc Dis, Boston, MA 02111 USA; [Han, Paul K. J.] Maine Med Ctr, Res Inst, Ctr Outcomes Res & Evaluat, Portland, ME 04102 USA; [Lundquist, Christine; Kent, David] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Predict Analyt & Comparat Effectiveness Ctr, Boston, MA USA; [Weinstein, Gene] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA	Tufts Medical Center; Maine Medical Center; Tufts Medical Center; Harvard University; Massachusetts General Hospital	Leung, LY (corresponding author), Tufts Med Ctr, Dept Neurol, Div Stroke & Cerebrovasc Dis, Boston, MA 02111 USA.	lester.y.leung.md@gmail.com			NINDS NIH HHS [R01 NS102233] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS102233] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Fanning JP, 2014, STROKE, V45, P3461, DOI 10.1161/STROKEAHA.114.005919; Fanning JP, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0119-0; GLASER BG, 1965, SOC PROBL, V12, P436, DOI 10.1525/sp.1965.12.4.03a00070; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Gupta A, 2016, STROKE, V47, P719, DOI 10.1161/STROKEAHA.115.011889; Hennink MM, 2017, QUAL HEALTH RES, V27, P591, DOI 10.1177/1049732316665344; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Leary MC, 2003, CEREBROVASC DIS, V16, P280, DOI 10.1159/000071128; Meschia JF, 2014, STROKE, V45, P3754, DOI 10.1161/STR.0000000000000046; Ryan GW, 2003, COLLECTING INTERPRET, P259; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Smith EE, 2017, STROKE, V48, pE44, DOI 10.1161/STR.0000000000000116; Strauss A., 1998, BASICS QUALITATIVE R; Vermeer SE, 2007, LANCET NEUROL, V6, P611, DOI 10.1016/S1474-4422(07)70170-9; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8	15	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194971	10.1371/journal.pone.0194971	http://dx.doi.org/10.1371/journal.pone.0194971			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596459	Green Published, gold, Green Submitted			2022-12-26	WOS:000428630000060
J	Siegle, L; Schwab, JD; Kuhlwein, SD; Lausser, L; Tumpel, S; Pfister, AS; Kuhl, M; Kestler, HA				Siegle, Lea; Schwab, Julian D.; Kuehlwein, Silke D.; Lausser, Ludwig; Tuempel, Stefan; Pfister, Astrid S.; Kuehl, Michael; Kestler, Hans A.			A Boolean network of the crosstalk between IGF and Wnt signaling in aging satellite cells	PLOS ONE			English	Article							GENE REGULATORY NETWORK; INTESTINAL STEM-CELLS; RAPAMYCIN COMPLEX 2; FORKHEAD-BOX-O; BETA-CATENIN; OXIDATIVE STRESS; MAMMALIAN TARGET; PHOSPHOINOSITIDE 3-KINASE; INSULIN-RESISTANCE; KINASE KINASE	Aging is a complex biological process, which determines the life span of an organism. Insulin-like growth factor (IGF) and Wnt signaling pathways govern the process of aging. Both pathways share common downstream targets that allow competitive crosstalk between these branches. Of note, a shift from IGF to Wnt signaling has been observed during aging of satellite cells. Biological regulatory networks necessary to recreate aging have not yet been discovered. Here, we established a mathematical in silico model that robustly recapitulates the crosstalk between IGF and Wnt signaling. Strikingly, it predicts critical nodes following a shift from IGF to Wnt signaling. These findings indicate that this shift might cause age-related diseases.	[Siegle, Lea; Schwab, Julian D.; Kuehlwein, Silke D.; Lausser, Ludwig; Kestler, Hans A.] Ulm Univ, Inst Med Syst Biol, Ulm, Germany; [Siegle, Lea; Schwab, Julian D.; Kuehlwein, Silke D.] Ulm Univ, Int Grad Sch Mol Med, Ulm, Germany; [Tuempel, Stefan] Fritz Lipmann Inst, Leibniz Inst Aging, Jena, Germany; [Pfister, Astrid S.; Kuehl, Michael] Ulm Univ, Inst Biochem & Mol Biol, Ulm, Germany	Ulm University; Ulm University; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Ulm University	Kestler, HA (corresponding author), Ulm Univ, Inst Med Syst Biol, Ulm, Germany.; Kuhl, M (corresponding author), Ulm Univ, Inst Biochem & Mol Biol, Ulm, Germany.	michael.kuehl@uni-ulm.de; hans.kestler@uni-ulm.de	Kestler, Hans A./D-5799-2012	Kestler, Hans A./0000-0002-4759-5254; Werle, Silke D./0000-0002-5153-0269				Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Avin KG, 2014, FRONT PHYSIOL, P5; Avruch J, 2001, RECENT PROG HORM RES, V56, P127, DOI 10.1210/rp.56.1.127; Boulter E, 2012, FASEB J, V26, P469, DOI 10.1096/fj.11-192252; Bracho-Valdes I, 2011, IUBMB LIFE, V63, P896, DOI 10.1002/iub.558; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brandt D, 2002, J BIOL CHEM, V277, P20903, DOI 10.1074/jbc.M200946200; Britten CD, 2013, CANCER CHEMOTH PHARM, V71, P1395, DOI 10.1007/s00280-013-2121-1; Cappola AR, 2001, J CLIN ENDOCR METAB, V86, P4139, DOI 10.1210/jc.86.9.4139; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Chiu TT, 2013, J BIOL CHEM, V288, P17520, DOI 10.1074/jbc.M113.467647; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Dahlhaus M, 2016, CANCER LETT, V371, P79, DOI 10.1016/j.canlet.2015.11.025; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Famili F, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.326; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Florian MC, 2013, NATURE, V503, P392, DOI 10.1038/nature12631; Florian MC, 2010, STEM CELLS, V28, P1623, DOI 10.1002/stem.481; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; FRIEDMAN DB, 1988, GENETICS, V118, P75; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Ganguly G, 2017, DRUG DES DEVELOOPMEN, P11; Graudenzi A, 2011, J COMPUT BIOL, V18, P559, DOI 10.1089/cmb.2010.0224; Grieb M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131832; Gruber J, 2016, CANCERS, V8, DOI 10.3390/cancers8080073; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; Hernandez-Negrete I, 2007, J BIOL CHEM, V282, P23708, DOI 10.1074/jbc.M703771200; Herrmann F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046798; Hitomi H, 2011, AM J PHYSIOL-CELL PH, V301, pC1415, DOI 10.1152/ajpcell.00017.2011; Holmes WR, 2016, PHYS BIOL, V13, DOI 10.1088/1478-3975/13/4/046001; Hoogeboom D, 2009, BBA-REV CANCER, V1796, P63, DOI 10.1016/j.bbcan.2009.02.002; Hu ZY, 2014, AGING-US, V6, P160, DOI 10.18632/aging.100643; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang JX, 2009, CANCER RES, V69, P6107, DOI 10.1158/0008-5472.CAN-09-0975; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Kauffman S.A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kenyon C, 2011, PHILOS T R SOC B, V366, P9, DOI 10.1098/rstb.2010.0276; Kervizic G, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-99; Kestler HA, 2008, PHILOS T R SOC B, V363, P1333, DOI 10.1098/rstb.2007.2251; Kikuchi A, 2011, INT REV CEL MOL BIO, V291, P21, DOI 10.1016/B978-0-12-386035-4.00002-1; Kim D, 2007, ONCOGENE, V26, P4571, DOI 10.1038/sj.onc.1210230; Kim EK, 2011, ONCOGENE, V30, P2954, DOI 10.1038/onc.2011.22; Kim JW, 2003, J BIOL CHEM, V278, P13995, DOI 10.1074/jbc.M300253200; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Klipp Edda, 2009, SYSTEMS BIOL TXB; Lan T, 2012, ONCOL REP, V27, P2039, DOI 10.3892/or.2012.1726; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Lee K, 2002, FREE RADICAL BIO MED, V33, P1121, DOI 10.1016/S0891-5849(02)01000-6; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Li G, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.519; Li H, 2009, BIOINFORMATICS, V25, P358, DOI 10.1093/bioinformatics/btn635; Lin AF, 2014, CANCER RES, V74, P1682, DOI 10.1158/0008-5472.CAN-13-1729; Lin GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086520; Liu AY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0083736, 10.1371/journal.pone.0095291]; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131; Liu LY, 2014, INT J MOL MED, V33, P1089, DOI 10.3892/ijmm.2014.1701; Manolagas SC, 2007, MOL ENDOCRINOL, V21, P2605, DOI 10.1210/me.2007-0259; Marchand A, 2011, AGING CELL, V10, P220, DOI 10.1111/j.1474-9726.2010.00661.x; McCubrey JA, 2012, ONCOTARGET, V3, P1068, DOI 10.18632/oncotarget.659; McCubrey JA, 2012, ONCOTARGET, V3, P954, DOI 10.18632/oncotarget.652; Miranti CK, 1999, J BIOL CHEM, V274, P10571, DOI 10.1074/jbc.274.15.10571; Mitchell L, 2013, ANTIOXID REDOX SIGN, V18, P250, DOI 10.1089/ars.2012.4687; Mussel C, 2010, BIOINFORMATICS, V26, P1378, DOI 10.1093/bioinformatics/btq124; Munshi Anupama, 2013, Genes Cancer, V4, P401, DOI 10.1177/1947601913485414; Naito AT, 2010, CIRC RES, V107, P1295, DOI 10.1161/CIRCRESAHA.110.223776; Nalapareddy K, 2017, CELL REP, V18, P2608, DOI 10.1016/j.celrep.2017.02.056; Naldi A, 2015, BIOINFORMATICS, V31, P1154, DOI 10.1093/bioinformatics/btv013; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Paul Indranil, 2013, Genes Cancer, V4, P427, DOI 10.1177/1947601913503341; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Richardson A, 2004, BEST PRACT RES CL EN, V18, P393, DOI 10.1016/j.beem.2004.02.002; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005; Saxena M, 2015, ONCOGENE, V34, P188, DOI 10.1038/onc.2013.549; Schlupf J, 2014, DIFFERENTIATION, V87, P209, DOI 10.1016/j.diff.2014.07.003; Schulte G, 2010, BRIT J PHARMACOL, V159, P1051, DOI 10.1111/j.1476-5381.2009.00466.x; Schwab J, 2017, BIOINFORMATICS, V33, P601, DOI 10.1093/bioinformatics/btw661; Selvaraj N, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-61; Shah AV, 2017, EUR J PHARMACOL, V816, P82; Shimizu T, 2008, MOL CELL BIOL, V28, P7427, DOI 10.1128/MCB.01962-07; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Shin S, 2011, P NATL ACAD SCI USA, V108, pE1204, DOI 10.1073/pnas.1110195108; Smith GR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011092; Steed E, 2014, J CELL BIOL, V204, P821, DOI 10.1083/jcb.201304115; Strle K, 2006, ENDOCRINOLOGY, V147, P4363, DOI 10.1210/en.2005-1541; Tao S, 2015, EMBO J, V34, P624, DOI 10.15252/embj.201490700; Terai K, 2005, EMBO REP, V6, P251, DOI 10.1038/sj.embor.7400349; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tian H, 2015, CELL REP, V11, P33, DOI 10.1016/j.celrep.2015.03.007; van Amerongen R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007914; von Maltzahn J, 2012, NAT CELL BIOL, V14, P186, DOI 10.1038/ncb2404; Watanabe S, 2015, FASEB J, V29, P1003, DOI 10.1096/fj.14-262154; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200; Wullschleger S, 2006, CELL, V127, P5, DOI 10.1016/j.cell.2006.01.016; Xiao YF, 2009, CURR GENOMICS, V10, P511, DOI 10.2174/138920209789208237; Xie XD, 2011, CELL, V144, P640, DOI 10.1016/j.cell.2011.02.029; Yang HW, 2012, MOL CELL, V47, P281, DOI 10.1016/j.molcel.2012.05.007; Yin F, 2013, BIOCHEM SOC T, V41, P101, DOI 10.1042/BST20120260; Yokoyama N, 2009, J CELL SCI, V122, P4439, DOI 10.1242/jcs.051847; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601; Zhai GG, 2006, J NEURO-ONCOL, V76, P227, DOI 10.1007/s11060-005-6499-4; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010; Zhou D, 2011, REPOS U ULM, V25, P16; Zhou HY, 2011, CURR PROTEIN PEPT SC, V12, P30; Zhu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037823; Zielinski R, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-88; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; ZSNAGY I, 1988, ANN NY ACAD SCI, V521, P215, DOI 10.1111/j.1749-6632.1988.tb35280.x	128	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195126	10.1371/journal.pone.0195126	http://dx.doi.org/10.1371/journal.pone.0195126			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596489	gold, Green Submitted, Green Published			2022-12-26	WOS:000428630000080
J	Tamez-Pena, JG; Rodriguez-Rojas, JA; Gomez-Rueda, H; Celaya-Padilla, JM; Rivera-Prieto, RA; Palacios-Corona, R; Garza-Montemayor, M; Cardona-Huerta, S; Trevino, V				Tamez-Pena, Jose-Gerardo; Rodriguez-Rojas, Juan-Andres; Gomez-Rueda, Hugo; Celaya-Padilla, Jose-Maria; Rivera-Prieto, Roxana-Alicia; Palacios-Corona, Rebeca; Garza-Montemayor, Margarita; Cardona-Huerta, Servando; Trevino, Victor			Radiogenomics analysis identifies correlations of digital mammography with clinical molecular signatures in breast cancer	PLOS ONE			English	Article							RECURRENCE SCORE; IMAGING FEATURES; RISK PREDICTION; IN-SITU; RADIOMICS; CLASSIFICATION; MICROCALCIFICATIONS; HETEROGENEITY; SEGMENTATION; ASSOCIATIONS	In breast cancer, well-known gene expression subtypes have been related to a specific clinical outcome. However, their impact on the breast tissue phenotype has been poorly studied. Here, we investigate the association of imaging data of tumors to gene expression signatures from 71 patients with breast cancer that underwent pre-treatment digital mammograms and tumor biopsies. From digital mammograms, a semi-automated radiogenomics analysis generated 1,078 features describing the shape, signal distribution, and texture of tumors along their contralateral image used as control. From tumor biopsy, we estimated the OncotypeDX and PAM50 recurrence scores using gene expression microarrays. Then, we used multivariate analysis under stringent cross-validation to train models predicting recurrence scores. Few univariate features reached Spearman correlation coefficients above 0.4. Nevertheless, multivariate analysis yielded significantly correlated models for both signatures (correlation of OncotypeDX = 0.49 +/- 0.07 and PAM50 = 0.32 +/- 0.10 in stringent cross-validation and OncotypeDX = 0.83 and PAM50 = 0.78 for a unique model). Equivalent models trained from the unaffected contralateral breast were not correlated suggesting that the image signatures were tumor-specific and that overfitting was not a considerable issue. We also noted that models were improved by combining clinical information (triple negative status and progesterone receptor). The models used mostly wavelets and fractal features suggesting their importance to capture tumor information. Our results suggest that molecular-based recurrence risk and breast cancer subtypes have observable radiographic phenotypes. To our knowledge, this is the first study associating mammographic information to gene expression recurrence signatures.	[Tamez-Pena, Jose-Gerardo; Rodriguez-Rojas, Juan-Andres; Gomez-Rueda, Hugo; Celaya-Padilla, Jose-Maria; Rivera-Prieto, Roxana-Alicia; Trevino, Victor] Tecnol Monterrey, Escuela Med, Catedra Bioinformat, Ave Morones Prieto Pte 3000, Monterrey, NL, Mexico; [Celaya-Padilla, Jose-Maria] Univ Autonoma Zacatecas, Zacatecas, Zacatecas, Mexico; [Palacios-Corona, Rebeca] Inst Mexicano Seguro Social, Ctr Invest Biomed Noreste, Ave 2 Abril & San Luis Potosi S-N, Monterrey, NL, Mexico; [Garza-Montemayor, Margarita; Cardona-Huerta, Servando] Hosp Zambrano Hell, Ctr Canc Mama, Ave Col Real San Agustin, San Pedro Garza Garcia, Nuevo Leon, Mexico	Tecnologico de Monterrey; Universidad Autonoma de Zacatecas; Instituto Mexicano del Seguro Social	Trevino, V (corresponding author), Tecnol Monterrey, Escuela Med, Catedra Bioinformat, Ave Morones Prieto Pte 3000, Monterrey, NL, Mexico.	vtrevino@itesm.mx	Tamez-Pena, Jose/B-1845-2009; Trevino, Victor/C-9219-2009	Tamez-Pena, Jose/0000-0003-1361-5162; Trevino, Victor/0000-0002-7472-9844				Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Antonini M, 1992, IEEE T IMAGE PROCESS, V1, P205, DOI 10.1109/83.136597; Ashraf AB, 2013, IEEE T MED IMAGING, V32, P637, DOI 10.1109/TMI.2012.2219589; Ashraf AB, 2014, RADIOLOGY, V272, P374, DOI 10.1148/radiol.14131375; Axelrod DE, 2008, CANCER INFORM, V6, P99; Baish JW, 2000, CANCER RES, V60, P3683; Boisserie-Lacroix M, 2013, Diagn Interv Imaging, V94, P1069, DOI 10.1016/j.diii.2013.04.010; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Celaya-Padilla JM, 2015, BIOMED RES INT, V2015, P12; Celaya-Padilla JM, 2013, P SPIE INT SOC OPT E; Celaya-Padilla J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/231656; Cheng HD, 2006, PATTERN RECOGN, V39, P646, DOI 10.1016/j.patcog.2005.07.006; D'Orsi CJ., 2013, ACR BI RADS ATLAS BR; Dhahbi S, 2015, COMPUT BIOL MED, V64, P79, DOI 10.1016/j.compbiomed.2015.06.012; Drukker K, 2015, MED PHYS, V42, P3602, DOI 10.1118/1.4925588; Ergin S, 2014, COMPUT BIOL MED, V51, P171, DOI 10.1016/j.compbiomed.2014.05.008; Evans KK, 2016, P NATL ACAD SCI USA, V113, P10292, DOI 10.1073/pnas.1606187113; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gendoo DMA, 2016, BIOINFORMATICS, V32, P1097, DOI 10.1093/bioinformatics/btv693; Gevaert O, 2012, RADIOLOGY, V264, P387, DOI 10.1148/radiol.12111607; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Guo WT, 2015, J MED IMAGING, V2, DOI 10.1117/1.JMI.2.4.041007; Haibe-Kains B, 2012, JNCI-J NATL CANCER I, V104, P311, DOI 10.1093/jnci/djr545; Haspinger ER, 2015, EUR J CANCER, V51, pS101, DOI 10.1016/S0959-8049(16)30301-X; Jain S, 2014, CURR ONCOL REP, V16, DOI 10.1007/s11912-013-0360-2; Karlo CA, 2014, RADIOLOGY, V270, P464, DOI 10.1148/radiol.13130663; Keller BM, 2015, J MED IMAGING, V2, DOI 10.1117/1.JMI.2.2.024501; Kelly CM, 2012, ONCOLOGIST, V17, P492, DOI 10.1634/theoncologist.2012-0007; Kendall EJ, 2013, BMC MED IMAGING, V13, DOI 10.1186/1471-2342-13-43; Khatcheressian JL, 2006, J CLIN ONCOL, V24, P5091, DOI 10.1200/JCO.2006.08.8575; Kooi T, 2017, MED IMAGE ANAL, V35, P303, DOI 10.1016/j.media.2016.07.007; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1771; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Kuo MD, 2014, RADIOLOGY, V270, P320, DOI 10.1148/radiol.13132195; LAINE AF, 1994, IEEE T MED IMAGING, V13, P725, DOI 10.1109/42.363095; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Li H, 1997, IEEE T MED IMAGING, V16, P785, DOI 10.1109/42.650875; Li H, 2016, RADIOLOGY, V281, P382, DOI 10.1148/radiol.2016152110; Liu ZQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04002; Malkov S, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0778-1; Napel S, 2015, J MED IMAGING, V2, DOI 10.1117/1.JMI.2.4.041001; Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282; Oh J, 2015, MED PHYS, V42, P3588, DOI 10.1118/1.4925514; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Parkin DM, 1999, CA-CANCER J CLIN, V49, P33, DOI 10.3322/canjclin.49.1.33; Petushi Sokol, 2006, BMC Med Imaging, V6, P14, DOI 10.1186/1471-2342-6-14; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Rahbar H, 2016, ACAD RADIOL, V23, P768, DOI 10.1016/j.acra.2016.02.008; Rakha EA, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1827; Rockhill B, 2001, J NATL CANCER I, V93, P358, DOI 10.1093/jnci/93.5.358; Rodriguez-Rojas J, 2013, SPIE MED IMAGING; Rutman AM, 2009, EUR J RADIOL, V70, P232, DOI 10.1016/j.ejrad.2009.01.050; Trop I, 2014, RADIOGRAPHICS, V34, P1178, DOI 10.1148/rg.345130049; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Wang TC, 1998, IEEE T MED IMAGING, V17, P498, DOI 10.1109/42.730395; Yamamoto S, 2012, AM J ROENTGENOL, V199, P654, DOI 10.2214/AJR.11.7824; Yepes MM, 2014, BREAST CANCER RES TR, V148, P117, DOI 10.1007/s10549-014-3143-z; Zheng YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063332; Zinn PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025451	62	11	11	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0193871	10.1371/journal.pone.0193871	http://dx.doi.org/10.1371/journal.pone.0193871			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596496	Green Published, Green Submitted, gold			2022-12-26	WOS:000428630000014
J	Wedell-Neergaard, AS; Krogh-Madsen, R; Petersen, GL; Hansen, AM; Pedersen, BK; Lund, R; Bruunsgaard, H				Wedell-Neergaard, Anne-Sophie; Krogh-Madsen, Rikke; Petersen, Gitte Lindved; Hansen, Ase Marie; Pedersen, Bente Klarlund; Lund, Rikke; Bruunsgaard, Helle			Cardiorespiratory fitness and the metabolic syndrome: Roles of inflammation and abdominal obesity	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BODY-MASS INDEX; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; ADIPOSE-TISSUE; RISK-FACTORS; EXERCISE; MARKERS; FAT; ATHEROSCLEROSIS	Objective Individuals with metabolic syndrome have increased risk of type 2 diabetes and cardiovascular disease. We aimed to test the hypothesis that a high level of cardiorespiratory fitness (CR-fitness), counteracts accumulation of visceral fat, decreases inflammation and lowers risk factors of the metabolic syndrome. Method The study sample included 1,293 Danes (age 49-52 years) who from 2009 to 2011 participated in the Copenhagen Aging and Midlife Biobank, including a questionnaire, physical tests, and blood samples. Multiple linear regression models were performed with CR-fitness as exposure and plasma levels of cytokines and high sensitive C-reactive protein as outcomes and measures of abdominal obesity were added to test if they explained the potential association. Similarly, multiple linear regression models were performed with CR-fitness as exposure and factors of the metabolic syndrome as outcomes and the potential explanation by inflammatory biomarkers were tested. All models were adjusted for the effect of age, sex, smoking, alcohol consumption, socio-economic status, and acute inflammatory events within the preceding two weeks. Results CR-fitness was inversely associated with high sensitive C-reactive protein, Interleukin (IL) 6, and IL-18, and directly associated with the anti-inflammatory cytokine IL-10, but not associated with tumor necrosis factor alpha, interferon gamma or IL-113. Abdominal obesity could partly explain the significant associations. Moreover, CR-fitness was inversely associated with an overall metabolic syndrome score, as well as triglycerides, glycated haemoglobin Alc, systolic blood pressure, diastolic blood pressure and directly associated with high-density lipoprotein. Single inflammatory biomarkers and a combined inflammatory score partly explained these associations. Conclusion Data suggest that CR-fitness has anti-inflammatory effects that are partly explained by a reduction in abdominal obesity and a decrease in the metabolic syndrome risk profile. The overall inflammatory load was mainly driven by high sensitive C-reactive protein and IL-6.	[Wedell-Neergaard, Anne-Sophie; Krogh-Madsen, Rikke; Pedersen, Bente Klarlund; Bruunsgaard, Helle] Univ Copenhagen, Rigshosp, Ctr Inflammat & Metab, Ctr Phys Act Res, Copenhagen, Denmark; [Petersen, Gitte Lindved; Hansen, Ase Marie; Lund, Rikke] Univ Copenhagen, Dept Publ Hlth, Sect Social Med, Copenhagen, Denmark; [Petersen, Gitte Lindved; Lund, Rikke] Univ Copenhagen, Ctr Hlth Ageing, Copenhagen, Denmark; [Hansen, Ase Marie] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Bruunsgaard, Helle] Univ Copenhagen Hosp, Rigshosp, Dept Clin Immunol, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; National Research Centre for the Working Environment; Rigshospitalet; University of Copenhagen	Bruunsgaard, H (corresponding author), Univ Copenhagen, Rigshosp, Ctr Inflammat & Metab, Ctr Phys Act Res, Copenhagen, Denmark.; Bruunsgaard, H (corresponding author), Univ Copenhagen Hosp, Rigshosp, Dept Clin Immunol, Copenhagen, Denmark.	helle.bruunsgaard@regionh.dk	Petersen, Gitte Lindved/AAQ-1190-2020; Pedersen, Bente Klarlund/AGR-3217-2022; Hansen, Åse/AAJ-1043-2020; Bruunsgaard, Helle/AAY-3293-2020	Petersen, Gitte Lindved/0000-0001-8920-4015; Pedersen, Bente Klarlund/0000-0001-6508-6288; Hansen, Åse/0000-0002-4075-3918; Bruunsgaard, Helle/0000-0003-2330-0834; Krogh-Madsen, Rikke/0000-0003-4914-2715; Lund, Rikke/0000-0002-0381-4291	VELUX FOUNDATION [VELUX 26145, 31539]; TrygFonden; Danish Council for Strategic Research [09067009, 09-075724]	VELUX FOUNDATION(Velux Fonden); TrygFonden; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	The Copenhagen Aging and Midlife Biobank has been supported by a generous grant from the VELUX FOUNDATION (VELUX 26145 and 31539). The Centre for Physical Activity Research (CFAS) is supported by a grant from TrygFonden. CFAS is a member of DD2 - the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research, grant no. 09067009 and 09-075724). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson JL, 2002, ARCH INTERN MED, V162, P1286, DOI 10.1001/archinte.162.11.1286; Albert MA, 2004, AM J CARDIOL, V93, P221, DOI 10.1016/j.amjcard.2003.09.046; Aronson D, 2004, ATHEROSCLEROSIS, V176, P173, DOI 10.1016/j.atherosclerosis.2004.04.025; Asghar A, 2017, CELL IMMUNOL, V315, P18, DOI 10.1016/j.cellimm.2017.03.001; ASHWELL M, 1985, BRIT MED J, V290, P1692, DOI 10.1136/bmj.290.6483.1692; ASTRAND PO, 1954, J APPL PHYSIOL, V7, P218, DOI 10.1152/jappl.1954.7.2.218; Avlund K, 2014, J AGING HEALTH, V26, P5, DOI 10.1177/0898264313509277; Benatti FB, 2015, NAT REV RHEUMATOL, V11, P86, DOI 10.1038/nrrheum.2014.193; Blake GJ, 2001, CIRC RES, V89, P763, DOI 10.1161/hh2101.099270; Booth F, 2014, COMPR PHYSL, V2, P1143; Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001; C Reactive Protein Coronary Heart Disease Genetics Collaboration, 2011, BMJ-BRIT MED J, V342, P1; Carnethon MR, 2009, AM J LIFESTYLE MED, V3, p44S, DOI 10.1177/1559827609332737; Chan CS, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.348599; Christensen U, 2014, J AGING HEALTH, V26, P106, DOI 10.1177/0898264314522894; Church TS, 2002, ARTERIOSCL THROM VAS, V22, P1869, DOI 10.1161/01.ATV.0000036611.77940.F8; Cottam DR, 2004, OBES SURG, V14, P589, DOI 10.1381/096089204323093345; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; El Said HW, 2017, INT UROL NEPHROL, V49, P1251, DOI 10.1007/s11255-017-1568-0; Eng JJ, 2004, ARCH PHYS MED REHAB, V85, P113, DOI 10.1016/S0003-9993(03)00436-2; Garnett SP, 2008, INT J OBESITY, V32, P1028, DOI 10.1038/ijo.2008.51; Goh LGH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004138; Hansen AM, 2014, J AGING HEALTH, V26, P72, DOI 10.1177/0898264313508187; Hayashino Y, 2014, METABOLISM, V63, P431, DOI 10.1016/j.metabol.2013.08.018; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Ilhan F, 2015, WORLD J CLIN CASES, V3, P345, DOI 10.12998/wjcc.v3.i4.345; Janssen I, 2002, AM J CLIN NUTR, V75, P683, DOI 10.1093/ajcn/75.4.683; Karstoft K, 2016, IMMUNOL CELL BIOL, V94, P146, DOI 10.1038/icb.2015.101; Kim HY, 2013, CLIN CHEM LAB MED, V51, P2195, DOI 10.1515/cclm-2013-0045; Knudsen SH, 2012, J APPL PHYSIOL, V113, P7, DOI 10.1152/japplphysiol.00189.2011; Koene RJ, 2016, CIRCULATION, V133, P1104, DOI 10.1161/CIRCULATIONAHA.115.020406; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Krogh-Madsen R, 2014, J APPL PHYSIOL, V116, P231, DOI 10.1152/japplphysiol.00155.2013; Landi F, 1999, J AM GERIATR SOC, V47, P1072, DOI 10.1111/j.1532-5415.1999.tb05229.x; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Lee WY, 2004, INT J CARDIOL, V97, P101, DOI 10.1016/j.ijcard.2003.08.016; Leon MLA, 2005, INFLAMM RES, V54, P395, DOI 10.1007/s00011-005-1377-2; Mally K, 2011, EUR J APPL PHYSIOL, V111, P1879, DOI 10.1007/s00421-010-1795-x; Mathers C, 2009, GLOB HLTH RISKS MORT; McKellar GE, 2009, NAT REV CARDIOL, V6, P410, DOI 10.1038/nrcardio.2009.57; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Nakanishi K, 2001, CYTOKINE GROWTH F R, V12, P53, DOI 10.1016/S1359-6101(00)00015-0; Oliveros E, 2014, PROG CARDIOVASC DIS, V56, P426, DOI 10.1016/j.pcad.2013.10.003; Olsen RH, 2008, JAMA-J AM MED ASSOC, V299, P1261, DOI 10.1001/jama.299.11.1259; Onat A, 2004, INT J OBESITY, V28, P1018, DOI 10.1038/sj.ijo.0802695; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pedersen BK, 2015, SCAND J MED SCI SPOR, V25, P1, DOI 10.1111/sms.12581; Pedersen BK, 2017, EUR J CLIN INVEST, V47, P600, DOI 10.1111/eci.12781; Peter I, 2014, MED SCI SPORT EXER, V46, P302, DOI 10.1249/MSS.0b013e3182a66155; Rana JS, 2006, INT J CARDIOL, V110, P224, DOI 10.1016/j.ijcard.2005.08.040; Reuben DB, 2003, J AM GERIATR SOC, V51, P1125, DOI 10.1046/j.1532-5415.2003.51380.x; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Ridker PM, 2017, LANCET, V6736, P1; Shoji K, 2008, OBES RES CLIN PRACT, V2, P269, DOI 10.1016/j.orcp.2008.09.001; Sigal RJ, 2010, DIABETES CARE, V33, P147, DOI DOI 10.2337/DC10-9990; Slaats J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005973; Starkie R, 2003, FASEB J, V17, P884, DOI 10.1096/fj.02-0670fje; Steensberg A, 2003, AM J PHYSIOL-ENDOC M, V285, pE433, DOI 10.1152/ajpendo.00074.2003; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wensveen FM, 2015, EUR J IMMUNOL, V45, P2446, DOI 10.1002/eji.201545502; Williams MJA, 2005, EUR J CARDIOV PREV R, V12, P216, DOI 10.1097/00149831-200506000-00005; Wu ZJ, 2017, CLIN CHEM, V63, P663, DOI 10.1373/clinchem.2016.260828; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402	69	54	56	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194991	10.1371/journal.pone.0194991	http://dx.doi.org/10.1371/journal.pone.0194991			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590212	Green Submitted, Green Published, gold			2022-12-26	WOS:000428603100095
J	Garcia-Amado, MA; Shin, H; Sanz, V; Lentino, M; Martinez, LM; Contreras, M; Michelangeli, F; Dominguez-Bello, MG				Alexandra Garcia-Amado, M.; Shin, Hakdong; Sanz, Virginia; Lentino, Miguel; Margarita Martinez, L.; Contreras, Monica; Michelangeli, Fabian; Dominguez-Bello, Maria Gloria			Comparison of gizzard and intestinal microbiota of wild neotropical birds	PLOS ONE			English	Article							GUT MICROBIOTA; GASTROINTESTINAL-TRACT; BACTERIAL COMMUNITY; MOLECULAR CHARACTERIZATION; DIVERSITY; PHYLOGENY; HOATZINS; ECOLOGY; MAMMALS	Gut bacterial communities have been shown to be influenced by diet, host phylogeny and anatomy, but most of these studies have been done in captive animals. Here we compare the bacterial communities in the digestive tract of wild birds. We characterized the gizzard and intestinal microbiota among 8 wild Neotropical bird species, granivorous or frugivorous species of the orders Columbiformes and Passeriformes. We sequenced the V4 region of the 16S rRNA gene in 94 collected samples from 32 wild birds from 5 localities, and compared bacterial communities by foraging guild, organ, locality and bird taxonomy. 16S rRNA gene-based sequencing data were examined using QIIME with linear discriminant analysis effect size (LEfSe) and metabolic pathways were predicted using PICRUSt algorism. We identified 8 bacterial phyla, dominated by Firmicutes, Actinobacteria and Proteobacteria. Beta diversity analyses indicated significant separation of gut communities by bird orders (Columbiformes vs. Passerifomes) and between bird species (p<0.01). In lower intestine, PICRUSt shows a predominance of carbohydrate metabolism in granivorous birds and xenobiotics biodegradation pathways in frugivorous birds. Gizzard microbiota was significantly richer in granivorous, in relation to frugivorous birds (Chao 1; non-parametric t-test, p<0.05), suggesting a microbial gizzard function, beyond grinding food. The results suggest that the most important factor separating the bacterial community structure was bird taxonomy, followed by foraging guild. However, variation between localities is also likely to be important, but this could not been assessed with our study design.	[Alexandra Garcia-Amado, M.; Contreras, Monica; Michelangeli, Fabian] Inst Invest Cient IVIC, Ctr Biofis & Bioquirn, Lab Fisiol Gastrointestinal, Caracas, Venezuela; [Shin, Hakdong] Sejong Univ, Dept Food Sci & Biotechnol, Coll Life Sci, Seoul, South Korea; [Sanz, Virginia] Inst Invest Cient IVIC, Ctr Ecol, Lab Biol Organismos, Caracas, Venezuela; [Lentino, Miguel; Margarita Martinez, L.] Colecc Ornitol Phelps, Caracas, Venezuela; [Dominguez-Bello, Maria Gloria] NYU, Sch Med, New York, NY USA; [Dominguez-Bello, Maria Gloria] Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ 08901 USA	Sejong University; New York University; Rutgers State University New Brunswick	Garcia-Amado, MA (corresponding author), Inst Invest Cient IVIC, Ctr Biofis & Bioquirn, Lab Fisiol Gastrointestinal, Caracas, Venezuela.; Dominguez-Bello, MG (corresponding author), NYU, Sch Med, New York, NY USA.; Dominguez-Bello, MG (corresponding author), Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ 08901 USA.	magarciamado@gmail.com; mg.dominguezbello@rutgers.edu	Garcia-Amado, Maria Alexandra/B-5297-2015	Garcia-Amado, Maria Alexandra/0000-0001-6396-4681; Contreras Valero, Monica/0000-0003-4729-9559				BUCKLEY P. A., 1985, ORNITHOL MONOGR, V36, P865, DOI [10.2307/40168322, DOI 10.2307/40168322]; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carrillo-Araujo M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00447; Cheng YY, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0143-0; Clarke K., 2001, PRIMER V5 USER MANUA; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Daniel DS, 2013, MICROBIOL RES, V168, P485, DOI 10.1016/j.micres.2013.04.001; Dearing MD, 2005, ANNU REV ECOL EVOL S, V36, P169, DOI 10.1146/annurev.ecolsys.36.102003.152617; DELRIO CM, 1993, VEGETATIO, V108, P205; Deusch S, 2015, COMPUT STRUCT BIOTEC, V13, P55, DOI 10.1016/j.csbj.2014.12.005; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Garcia-Mazcorro JF, 2017, MICROB ECOL, V73, P224, DOI 10.1007/s00248-016-0840-7; Godoy-Vitorino F, 2012, RES MICROBIOL, V163, P211, DOI 10.1016/j.resmic.2012.01.001; Godoy-Vitorino F, 2012, ISME J, V6, P531, DOI 10.1038/ismej.2011.131; Gong JH, 2007, FEMS MICROBIOL ECOL, V59, P147, DOI 10.1111/j.1574-6941.2006.00193.x; Hale VL, 2018, MICROB ECOL, V75, P515, DOI 10.1007/s00248-017-1041-8; Hanning I, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0113-6; Hilty SL, 2003, BIRDS VENEZUELA, V2nd; Hird SM, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2075.01403, 10.3389/fmicb.2015.01403]; Hird SM, 2014, PEERJ, V2, DOI 10.7717/peerj.321; Karasov WH, 2013, COMPR PHYSIOL, V3, P741, DOI 10.1002/cphy.c110054; Kohl KD, 2012, J COMP PHYSIOL B, V182, P591, DOI 10.1007/s00360-012-0645-z; Kropackova L, 2017, MOL ECOL, V26, P5292, DOI 10.1111/mec.14144; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McDonald R, 2015, ISME J, V9, P2712, DOI 10.1038/ismej.2015.65; Mirn L., 2014, METAGENOMICS, V3, P1, DOI [10.4303/mg/235853, DOI 10.4303/MG/235853]; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Oakley BB, 2014, FEMS MICROBIOL LETT, V360, P100, DOI 10.1111/1574-6968.12608; Ohkuma M, 1996, APPL ENVIRON MICROB, V62, P461, DOI 10.1128/AEM.62.2.461-468.1996; Preest MR, 2003, AUK, V120, P1091, DOI 10.1642/0004-8038(2003)120[1091:DONCBI]2.0.CO;2; Roggenbuck M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6498; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sekelja M, 2012, APPL ENVIRON MICROB, V78, P2941, DOI 10.1128/AEM.05391-11; Singer MA, 2003, COMP BIOCHEM PHYS B, V134, P543, DOI 10.1016/S1096-4959(03)00027-7; Stanley D, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0388-6; Su HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099826; Vecherskii MV, 2014, BIOL BULL+, V41, P251, DOI 10.1134/S1062359014030108; Waite DW, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00223; Waite DW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00673; Wang W, 2016, MICROBIOL RES, V182, P59, DOI 10.1016/j.micres.2015.10.003; Wilkinson TJ, 2017, FRONT MICROBIOL, V8, P1, DOI 10.3389/fmicb.2017.01089; Xenoulis PG, 2010, VET MICROBIOL, V146, P320, DOI 10.1016/j.vetmic.2010.05.024; Yang YZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32655; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x	48	25	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194857	10.1371/journal.pone.0194857	http://dx.doi.org/10.1371/journal.pone.0194857			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579092	Green Submitted, Green Published, gold			2022-12-26	WOS:000428351800062
J	Buchanan, B; Meng, Q; Poulin, MM; Zuccolo, J; Azike, CG; Gabriele, J; Baranowski, DC				Buchanan, Beth; Meng, Qingfang; Poulin, Mathieu-Marc; Zuccolo, Jonathan; Azike, Chike Godwin; Gabriele, Joseph; Baranowski, David Charles			Comparative pharmacokinetics and safety assessment of transdermal berberine and dihydroberberine	PLOS ONE			English	Article							RAT PLASMA APPLICATION; UPLC-MS/MS METHOD; MASS-SPECTROMETRY; ACID; SIMVASTATIN; JATRORRHIZINE; COMBINATION; VALIDATION; HYDRASTINE; PALMATINE	The natural alkaloid berberine has been ascribed numerous health benefits including lipid and cholesterol reduction and improved insulin sensitivity in diabetics. However, oral (PO) administration of berberine is hindered by poor bioavailability and increasing dose often elicits gastro-intestinal side effects. To overcome the caveats associated with oral berberine, we developed transdermal (TD) formulations of berberine (BBR) and the berberine precursor dihydroberberine (DHB). These formulations were compared to oral BBR using pharmacokinetics, metabolism, and general safety studies in vivo. To complete this work, a sensitive quantitative LC-MS/MS method was developed and validated according the FDA guidelines for bioanalytical methods to simultaneously measure berberine, simvastatin, and simvastatin hydroxy acid with relative quantification used for the berberine metabolite demethylene berberine glucuronide (DBG). Acute pharmacokinetics in Sprague-Dawley rats demonstrated a statistically relevant ranking for berberine bioavailability based upon AUC(0-8) as DHB TD > BBR TD >> BBR PO with similar ranking for the metabolite DBG, indicating that transdermal administration achieves BBR levels well above oral administration. Similarly, chronic administration (14 days) resulted in significantly higher levels of circulating BBR and DBG in DHB TD treated animals. Chronically treated rats were given a single dose of simvastatin with no observed change in the drugs bioavailability compared with control, suggesting the increased presence of BBR had no effect on simvastatin metabolism. This observation was further supported by consistent CYP3A4 expression across all treatment groups. Moreover, no changes in kidney and liver biomarkers, including alanine aminotransferase and alkaline phosphatase, were observed between treatment formats, and confirming previous reports that BBR has no effect on HMG-CoA expression. This study supports the safe use of transdermal compositions that improve on the poor bioavailability of oral berberine and have the potential to be more efficacious in the treatment of dyslipidemia or hypercholesterolemia.	[Buchanan, Beth; Meng, Qingfang; Poulin, Mathieu-Marc; Zuccolo, Jonathan; Azike, Chike Godwin; Gabriele, Joseph; Baranowski, David Charles] Delivra Corp, Res & Dev, Charlottetown, PE, Canada		Baranowski, DC (corresponding author), Delivra Corp, Res & Dev, Charlottetown, PE, Canada.	dbaranowski@delivrainc.com		Baranowski, David/0000-0002-5372-7727	Innovation PEI [201606-33]; Atlantic Canada Opportunities Agency; National Research Council of Canada Industrial Research Assistance Program; Delivra Corp.	Innovation PEI; Atlantic Canada Opportunities Agency; National Research Council of Canada Industrial Research Assistance Program; Delivra Corp.	This work was partially supported by Innovation PEI through a post-doctoral award (201606-33 to BB), by the Atlantic Canada Opportunities Agency through equipment funding, and by the National Research Council of Canada Industrial Research Assistance Program through salary and consumables support. Delivra Corp., provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIN AH, 1969, CAN J MICROBIOL, V15, P1067, DOI 10.1139/m69-190; BAHADUR S, 1983, J NAT PROD, V46, P454, DOI 10.1021/np50028a002; Car BD, 2006, AM COLL LAB, P127, DOI 10.1016/B978-012074903-4/50008-X; Chen W, 2011, AAPS PHARMSCITECH, V12, P705, DOI 10.1208/s12249-011-9632-z; Cicero AFG, 2017, ARCH MED SCI, V13, P965, DOI [10.1093/nutrit/nux047, 10.5114/aoms.2017.69326]; Cui HM, 2016, MOLECULES, V21, DOI 10.3390/molecules21040464; Deng YT, 2008, J CHROMATOGR B, V863, P195, DOI 10.1016/j.jchromb.2007.12.028; Di Pierro F, 2013, CLIN PHARMACOL-ADV A, V5, P167, DOI 10.2147/CPAA.S54308; Dong H, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/591654; Feng RJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10131; Gentry EJ, 1998, J NAT PROD, V61, P1187, DOI 10.1021/np9701889; Germoush MO, 2014, J CANCER RES CLIN, V140, P1103, DOI 10.1007/s00432-014-1665-8; Godugu Chandraiah, 2014, PLoS One, V9, pe89919, DOI 10.1371/journal.pone.0089919; Guo Y, 2012, EUR J CLIN PHARMACOL, V68, P213, DOI 10.1007/s00228-011-1108-2; Gupta PK, 2009, J PHARMACEUT BIOMED, V49, P1021, DOI 10.1016/j.jpba.2009.01.036; Han Zhong-Ze, 2010, Laboratory Animal Research, V26, P153; Kong W-J, 2017, METAB D CLIN EXP, V57, P1029; Kong WJ, 2008, METABOLISM, V57, P1029, DOI 10.1016/j.metabol.2008.01.037; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Kurz A, 2009, INT J CLIN PRACT, V63, P799, DOI 10.1111/j.1742-1241.2009.02052.x; Li GF, 2016, BIOMED CHROMATOGR, V30, P1075, DOI 10.1002/bmc.3652; Li H, 2016, PHARM BIOL, V54, P2886, DOI 10.1080/13880209.2016.1190762; Li J, 2014, LIFE SCI, V98, P24, DOI 10.1016/j.lfs.2013.12.211; Liu M, 2015, J CHROMATOGR B, V1006, P8, DOI 10.1016/j.jchromb.2015.09.033; Liu YT, 2010, DRUG METAB DISPOS, V38, P1779, DOI 10.1124/dmd.110.033936; Lv Z, 2015, ANTIMICROB AGENTS CH, V59, P3726, DOI 10.1128/AAC.04794-14; Markgraf CG, 2010, J PHARMACOL TOX MET, V62, P89, DOI 10.1016/j.vascn.2010.06.001; Mehrzadi S, 2018, BIOMED PHARMACOTHER, V97, P233, DOI 10.1016/j.biopha.2017.10.113; Moricz AM, 2015, CHROMATOGRAPHIA, V78, P707, DOI 10.1007/s10337-015-2870-6; Munaga SB, 2016, J CHROMATOGR SCI, V54, P985, DOI 10.1093/chromsci/bmw043; Pingali S, 2014, ACTA CRYSTALLOGR C, V70, P388, DOI 10.1107/S2053229614003751; Schulz E.R., 1926, J AM PHARM ASSOC, V15, P33, DOI [10.1002/jps.3080150109, DOI 10.1002/JPS.3080150109]; Tan Wen, 2011, Int J Nanomedicine, V6, P1773, DOI 10.2147/IJN.S22683; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; US Department of Health and Human Services FDA, 2013, GUID IND BIOAN METH; Wu N, 2011, AM J PHYSIOL-REG I, V300, pR635, DOI 10.1152/ajpregu.00441.2010; Xia XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016556; Xin HW, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2013-z; Yin J, 2008, METABOLISM, V57, P712, DOI 10.1016/j.metabol.2008.01.013; Yu F, 2017, DRUG DELIV, V24, P825, DOI 10.1080/10717544.2017.1321062; Yu S, 2007, INT J MASS SPECTROM, V268, P30, DOI 10.1016/j.ijms.2007.08.003; ZHANG MF, 1989, ACTA PHARM SINIC, V10, P174; Zhao JJ, 2002, J MASS SPECTROM, V37, P421, DOI 10.1002/jms.299; Zhou Y, 2017, DRUG DEV IND PHARM, V43, P1703, DOI 10.1080/03639045.2017.1339076; Zuo F, 2006, DRUG METAB DISPOS, V34, P2064, DOI 10.1124/dmd.106.011361	45	18	18	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194979	10.1371/journal.pone.0194979	http://dx.doi.org/10.1371/journal.pone.0194979			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579096	Green Submitted, Green Published, gold			2022-12-26	WOS:000428351800070
J	Deziel, NC; Humeau, Z; Elliott, EG; Warren, JL; Niccolai, LM				Deziel, Nicole C.; Humeau, Zoe; Elliott, Elise G.; Warren, Joshua L.; Niccolai, Linda M.			Shale gas activity and increased rates of sexually transmitted infections in Ohio, 2000-2016	PLOS ONE			English	Article							UNITED-STATES; NATURAL-GAS; DETERMINANTS; MIGRANT; RISK; HIV; MEN; PREVENTION; DISEASES; HEALTH	Background The growing shale gas ("fracking") industry depends on a mobile workforce, whose influx could have social impacts on host communities. Sexually transmitted infections (STIs) can increase through sexual mixing patterns associated with labor migration. No prior studies have quantified the relationship between shale gas activity and rates of three reportable STIs: chlamydia, gonorrhea, and syphilis. Methods We conducted a longitudinal, ecologic study from 2000-2016 in Ohio, situated in a prolific shale gas region in the United States (US). Data on reported cases of chlamydia, gonorrhea, and syphilis by county and year were obtained from the Ohio Department of Health. All 88 counties were classified as none, low, and high shale gas activity in each year, using data from the Ohio Department of Natural Resources. Annual rate ratios (RR) and 95% confidence intervals (95% CIs) were calculated from mixed-effects Poisson regression models evaluating the relationship between shale gas activity and reported annual STI rates while adjusting for secular trends and potential confounders obtained from the US Census. Results Compared to counties with no shale gas activity, counties with high activity had 21% (RR = 1.21; 95% CI = 1.08-1.36) increased rates of chlamydia and 19% (RR = 1.27; 95% CI 0.98-1.44) increased rates of gonorrhea, respectively. No association was observed for syphilis. Conclusion This first report of a link between shale gas activity and increased rates of both chlamydia and gonorrhea may inform local policies and community health efforts.	[Deziel, Nicole C.; Humeau, Zoe; Elliott, Elise G.] Yale Sch Publ Hlth, Dept Environm Hlth Sci, New Haven, CT USA; [Humeau, Zoe] McGill Univ, Montreal, PQ, Canada; [Warren, Joshua L.] Yale Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [Niccolai, Linda M.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA	Yale University; McGill University; Yale University; Yale University	Deziel, NC (corresponding author), Yale Sch Publ Hlth, Dept Environm Hlth Sci, New Haven, CT USA.	nicole.deziel@yale.edu		Warren, Joshua/0000-0002-6274-6970; Elliott, Elise/0000-0002-0038-2294; Deziel, Nicole/0000-0002-5751-9191	CTSA from the National Center for Advancing Translational Science (NCATS) [UL1 TR001863, KL2 TR001862]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863, KL2TR001862] Funding Source: NIH RePORTER	CTSA from the National Center for Advancing Translational Science (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Joshua Warren was supported by CTSA Grant Number UL1 TR001863 and KL2 TR001862 from the National Center for Advancing Translational Science (NCATS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramzon S, 2014, J INFRASTRUCT SYST, V20, DOI 10.1061/(ASCE)IS.1943-555X.0000203; Aggleton P, 2014, GLOB PUBLIC HEALTH, V9, P257, DOI 10.1080/17441692.2014.889736; Aral SO, 2002, SEX TRANSM INFECT, V78, pI3, DOI 10.1136/sti.78.suppl_1.i3; Baltazar CS, 2015, AIDS BEHAV, V19, pS59, DOI 10.1007/s10461-014-0941-6; Carpenter DO, 2016, REV ENVIRON HEALTH, V31, P47, DOI 10.1515/reveh-2015-0055; Centers for Disease Control and Prevention, INC PREV COST SEX TR; Centers for Disease Control and Prevention, 2016, SEX TRANSM DIS SURV; Doyle TJ, 2002, AM J EPIDEMIOL, V155, P866, DOI 10.1093/aje/155.9.866; Goldenberg S, 2008, SEX TRANSM INFECT, V84, P220, DOI 10.1136/sti.2007.027219; Graham J, 2015, ACCIDENT ANAL PREV, V74, P203, DOI 10.1016/j.aap.2014.11.003; Hirsch JS, 2014, SOC SCI MED, V100, P38, DOI 10.1016/j.socscimed.2013.10.021; Hogben M, 2008, SEX TRANSM DIS, V35, pS13, DOI 10.1097/OLQ.0b013e31818d3cad; Howarth RW, 2011, CLIMATIC CHANGE, V106, P679, DOI 10.1007/s10584-011-0061-5; James A, 2017, J ENVIRON ECON MANAG, V84, P125, DOI 10.1016/j.jeem.2016.12.004; Johnston JE, 2016, AM J PUBLIC HEALTH, V106, P550, DOI 10.2105/AJPH.2015.303000; Kearney Melissa, 2017, 23408 NBER; Kissinger P, 2008, SEX TRANSM DIS, V35, P924, DOI 10.1097/OLQ.0b013e31817fa2cc; Komarek T, 2017, J PUBLIC HLTH POLICY; Lin JS, 2008, ANN INTERN MED, V149, P497, DOI 10.7326/0003-4819-149-7-200810070-00011; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Mabey D, 1997, GENITOURIN MED, V73, P18; Manhart LE, 2005, J INFECT DIS, V191, pS7, DOI 10.1086/425275; Morrone M., 2015, J APPALACHIAN STUD, V21, P207, DOI [10.5406/jappastud.21.2.0207, DOI 10.5406/jappastud.21.2.0207]; Ohio Department of Natural Resources, SHAL DEV ACT 2017; Owusu-Edusei K, 2013, SEX TRANSM DIS, V40, P197, DOI 10.1097/OLQ.0b013e318285c6d2; Purcell David W, 2012, Open AIDS J, V6, P98, DOI 10.2174/1874613601206010098; Rhodes SD, 2010, AM J IND MED, V53, P976, DOI 10.1002/ajim.20807; Satterwhite CL, 2013, SEX TRANSM DIS, V40, P187, DOI 10.1097/OLQ.0b013e318286bb53; Saunders PJ, 2016, ENV GEOCHEM HLTH; Shonkoff SBC, 2014, ENVIRON HEALTH PERSP, V122, P787, DOI 10.1289/ehp.1307866; Sovacool BK, 2014, RENEW SUST ENERG REV, V37, P249, DOI 10.1016/j.rser.2014.04.068; Tsevat DG, 2017, AM J OBSTET GYNECOL, V216, P1, DOI 10.1016/j.ajog.2016.08.008; Udoh IA, 2008, HEALTH EDUC RES, V23, P670, DOI 10.1093/her/cym042; United States Census Bureau, 2010, INT EST RES POP COUN; US Energy Information Administration, MARC REG DRILL PROD; Weber BA, 2014, SOC WORK, V59, P62, DOI 10.1093/sw/swt068; Westwood E, 2016, EXTRACT IND SOC, V3, P240, DOI 10.1016/j.exis.2015.10.008; Winett L, 2011, CULT HEALTH SEX, V13, P643, DOI 10.1080/13691058.2011.565369; Zuma K, 2005, EPIDEMIOL INFECT, V133, P421, DOI 10.1017/S0950268804003607	39	12	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2018	13	3							e0194203	10.1371/journal.pone.0194203	http://dx.doi.org/10.1371/journal.pone.0194203			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA2QK	29570712	gold, Green Published, Green Submitted			2022-12-26	WOS:000428168400013
J	Wiberg, N; Klausen, TW; Tyrberg, T; Nordstrom, L; Wiberg-Itzel, E				Wiberg, Nana; Klausen, Tobias Wirenfeldt; Tyrberg, Tobias; Nordstrom, Lennart; Wiberg-Itzel, Eva			Infant outcome at four years of age after intrapartum sampling of scalp blood lactate for fetal assessment. A cohort study	PLOS ONE			English	Article							CEREBRAL-PALSY; PRESCHOOL-CHILDREN; METABOLIC-ACIDOSIS; LABOR; PH; COMPLICATIONS; ACIDEMIA; NEWBORN; TRIAL; LONG	Objective To correlate the value of lactate in fetal scalp blood at delivery and the outcomes of the offspring at four years of age. Methods Cases where scalp blood lactate was taken within sixty minutes before delivery were identified from the randomized trial "Determination of pH or lactate in fetal scalp blood in management of intrapartum fetal distress". Data were grouped according to the generally accepted cutoffs for normality, pre-acidemia, acidemia and concentrations above mean +2 SD during the second stage. The outcome measures included gross-/fine motor function, vision, hearing, speaking and cognitive disorders, signs of central motor damage and referral to specialized pediatric services. Results 307 cases were available for final analyse. With normal scalp lactate concentration, the number of children with a diagnosed disorder was lower compared to the pre-acidemic/acidemic groups, although the findings were only significant for fine motor dysfunction (p = 0.036). Elevated lactate values were significantly associated with increased risk for a poorer capacity of attention and understanding of instructions (OR 1.37, 95% CI 1.07 +/- 1.74), and for fine motor dysfunction (OR 1.22, 95% CI 1.00 +/- 1.49) at the age of four. Conclusion Higher levels of lactate in fetal scalp blood seems to be associated with increased risk of an aberrant developmental outcome at four years of age in some areas.	[Wiberg, Nana] Skane Univ Hosp, Dept Obstet & Gynecol, Lund, Sweden; [Wiberg, Nana] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Klausen, Tobias Wirenfeldt] Herlev Univ Hosp, Dept Hematol, Herlev, Denmark; [Tyrberg, Tobias] Sahlgrens Univ Hosp, Dept Infect Dis, Gothenburg, Sweden; [Nordstrom, Lennart] Karolinska Univ Hosp, Dept Obstet & Gynecol, Stockholm, Sweden; [Nordstrom, Lennart] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Wiberg-Itzel, Eva] Karolinska Inst, Sodersjukhuset, Sect Obstet & Gynecol, Dept Clin Sci & Educ, Stockholm, Sweden	Lund University; Skane University Hospital; Lund University; University of Copenhagen; Herlev & Gentofte Hospital; Sahlgrenska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Sodersjukhuset Hospital	Wiberg, N (corresponding author), Skane Univ Hosp, Dept Obstet & Gynecol, Lund, Sweden.; Wiberg, N (corresponding author), Lund Univ, Dept Clin Sci, Malmo, Sweden.	nana.wiberg@med.lu.se		Nordstrom, Lennart/0000-0002-7547-2569; wiberg, nana/0000-0002-9032-5428				Alfirevic Z, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006066.pub2; [Anonymous], 2009, VAGL ATG; [Anonymous], VAGL BARNH, P35; Ciner EB, 1998, OPTOMETRY VISION SCI, V75, P571, DOI 10.1097/00006324-199808000-00022; East CE, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0709-7; Ellenberg JH, 2013, DEV MED CHILD NEUROL, V55, P210, DOI 10.1111/dmcn.12016; GOODWIN TM, 1992, AM J OBSTET GYNECOL, V167, P1506, DOI 10.1016/0002-9378(92)91728-S; Grether JK, 1997, JAMA-J AM MED ASSOC, V278, P207, DOI 10.1001/jama.278.3.207; HAVERKAMP AD, 1979, AM J OBSTET GYNECOL, V134, P399, DOI 10.1016/S0002-9378(16)33082-4; Heinis AMF, 2012, CLIN CHEM LAB MED, V50, P89, DOI 10.1515/CCLM.2011.734; Heinis AMF, 2011, ACTA OBSTET GYN SCAN, V90, P1107, DOI 10.1111/j.1600-0412.2011.01237.x; Himmelmann K, 2005, ACTA PAEDIATR, V94, P287, DOI 10.1111/j.1651-2227.2005.tb03071.x; Holzmann M, 2011, J PERINAT MED, V39, P545, DOI [10.1515/JPM.2011.062, 10.1515/jpm.2011.062]; Ingemarsson I, 1993, FETAL HEART MONITORI; Jorgensen JS, 2014, ACTA OBSTET GYN SCAN, V93, P548, DOI 10.1111/aogs.12421; Kruger K, 1999, AM J OBSTET GYNECOL, V181, P1072, DOI 10.1016/S0002-9378(99)70083-9; Low JA, 1997, AM J OBSTET GYNECOL, V177, P1391, DOI 10.1016/S0002-9378(97)70080-2; Malin GL, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1471; Nelson HD, 2006, PEDIATRICS, V117, pE298, DOI 10.1542/peds.2005-1467; Nelson S., DEV COORDINATION DIS; NICE, INTR CAR CAR HLTH WO; NORDSTROM L, 1995, BRIT J OBSTET GYNAEC, V102, P894, DOI 10.1111/j.1471-0528.1995.tb10878.x; Nordstrom L, 2001, BRIT J OBSTET GYNAEC, V108, P263; Nordstrom L, 2011, CLIN BIOCHEM, V44, P456, DOI 10.1016/j.clinbiochem.2011.03.007; Ramanah R, 2010, FETAL DIAGN THER, V27, P14, DOI 10.1159/000262281; Rydz D, 2005, J CHILD NEUROL, V20, P4, DOI 10.1177/08830738050200010201; Steer PJ, 2014, BJOG-INT J OBSTET GY, V121, P1749, DOI 10.1111/1471-0528.13120; Teune MJ, 2013, BJOG-INT J OBSTET GY, V120, P15, DOI 10.1111/j.1471-0528.2012.03465.x; Tuffnell D, 2006, BJOG-INT J OBSTET GY, V113, P332, DOI 10.1111/j.1471-0528.2006.00859.x; Westgren M, 1998, BRIT J OBSTET GYNAEC, V105, P29, DOI 10.1111/j.1471-0528.1998.tb09346.x; Wiberg N, 2016, J MATERN-FETAL NEO M, P1; Wiberg N, 2010, ACTA OBSTET GYNECOL, V89; Wiberg-Itzel E, 2008, BRIT MED J, V336, P1284, DOI 10.1136/bmj.39553.406991.25	33	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2018	13	3							e0193887	10.1371/journal.pone.0193887	http://dx.doi.org/10.1371/journal.pone.0193887			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA2QK	29570701	Green Submitted, gold, Green Published			2022-12-26	WOS:000428168400009
J	Yi, L; Kaler, SG				Yi, Ling; Kaler, Stephen G.			Interaction between the AAA ATPase p97/VCP and a concealed UBX domain in the copper transporter ATP7A is associated with motor neuron degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VALOSIN-CONTAINING PROTEIN; TOUCH-TURN MOTIF; CRYSTAL-STRUCTURE; ENDOPLASMIC-RETICULUM; MEMBRANE-FUSION; VCP MUTATIONS; P97 ATPASE; DISEASE; DEGRADATION; COFACTOR	The copper-transporting ATPase ATP7A contains eight transmembrane domains and is required for normal human copper homeostasis. Mutations in the ATP7A gene may lead to infantile-onset cerebral degeneration (Menkes disease); occipital horn syndrome (OHS), a related but much milder illness; or an adult-onset isolated distal motor neuropathy. The ATP7A missense mutation T994I is located in the sixth transmembrane domain of ATP7A, represents one of the variants associated with the latter phenotype, and is associated with an abnormal interaction with p97/valosin-containing protein (VCP), a hexameric AAA ATPase (ATPase associated with diverse cellular activities) with multiple biological functions. In this study, we further characterized this interaction and discovered a concealed UBX domain in the third lumenal loop of ATP7A, between its fifth and sixth transmembrane domains. We show that the T994I substitution results in conformational exposure of the UBX domain, which then binds the N-terminal domain of p97/VCP. We also show that this abnormal interaction occurs at or near the cell plasma membrane. The UBX domain has a conserved hydrophobic FP (Phe-Pro) motif, and substitution with di-alanine abrogated the interaction and restored the proper intracellular localization of ATP7A in the trans-Golgi network. Using protein MS, we identified potential coordinating components of the ATP7A(T994I)-p97 complex, including NSFL1 cofactor (NSF1C or p47) that may be relevant to the pathophysiology and clinical effects associated with ATP7A(T994I). Our study represents the first report of p97/VCP binding to a UBX domain that is not normally exposed, resulting in an aberrant protein-protein interaction leading to motor neuron degeneration.	[Yi, Ling; Kaler, Stephen G.] Eunice Kennedy Shriver NICHD, Sect Translat Neurosci, Mol Med Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Kaler, SG (corresponding author), Eunice Kennedy Shriver NICHD, Sect Translat Neurosci, Mol Med Branch, NIH,Porter Neurosci Res Ctr, Bldg 35,Rm 2D-971,35A Convent Dr,MSC 3754, Bethesda, MD 20892 USA.	kalers@mail.nih.gov	Kaler, Stephen/GPT-3845-2022		Eunice Kennedy Shriver NICHD, National Institutes of Health [1ZIA HD008892]; National Institutes of Health Office of Dietary Supplements; National Institutes of Health Clinical Center Bench-to-Bedside Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008892] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Clinical Center Bench-to-Bedside Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the intramural research program of the Eunice Kennedy Shriver NICHD, National Institutes of Health (Project 1ZIA HD008892) and a National Institutes of Health Clinical Center Bench-to-Bedside Award supported by the National Institutes of Health Office of Dietary Supplements. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Allen MD, 2006, J BIOL CHEM, V281, P25502, DOI 10.1074/jbc.M601173200; Bodnar Nicholas, 2017, F1000Res, V6, P1318, DOI 10.12688/f1000research.11683.1; Boeddrich A, 2006, EMBO J, V25, P1547, DOI 10.1038/sj.emboj.7601043; Chen XQ, 2010, J BIOL CHEM, V285, P7197, DOI 10.1074/jbc.M109.047084; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Gonzalez MA, 2014, BRAIN, V137, P2897, DOI 10.1093/brain/awu224; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Hitt R, 2004, FEMS YEAST RES, V4, P721, DOI 10.1016/j.femsyr.2004.02.003; Jerath N. U., 2015, CASE REP GENET, V2015, DOI [10.1155/2015/239167, DOI 10.1155/2015/239167]; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Ju JS, 2010, AUTOPHAGY, V6, P283, DOI 10.4161/auto.6.2.11063; KALER SG, 1994, NAT GENET, V8, P195, DOI 10.1038/ng1094-195; Kaler SG, 2011, NAT REV NEUROL, V7, P15, DOI 10.1038/nrneurol.2010.180; Kang W, 2011, BIOCHEM BIOPH RES CO, V407, P531, DOI 10.1016/j.bbrc.2011.03.052; Kano F, 2005, GENES CELLS, V10, P989, DOI 10.1111/j.1365-2443.2005.00894.x; Kennerson ML, 2010, AM J HUM GENET, V86, P343, DOI 10.1016/j.ajhg.2010.01.027; Kim KH, 2011, PROTEINS, V79, P2583, DOI 10.1002/prot.23073; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Madsen L, 2008, INT J BIOCHEM CELL B, V40, P2927, DOI 10.1016/j.biocel.2008.06.008; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; PLEASURE IT, 1993, NATURE, V365, P459, DOI 10.1038/365459a0; Qiu LY, 2010, J BIOL CHEM, V285, P365, DOI 10.1074/jbc.M109.044685; Ramanathan HN, 2012, CELL RES, V22, P346, DOI 10.1038/cr.2011.80; Ritz D, 2011, NAT CELL BIOL, V13, P1116, DOI 10.1038/ncb2301; Song EJ, 2005, MOL CELL BIOL, V25, P2511, DOI 10.1128/MCB.25.6.2511-2524.2005; Stapf C, 2011, J BIOL CHEM, V286, P38670, DOI 10.1074/jbc.M111.274472; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Watts GDJ, 2007, CLIN GENET, V72, P420, DOI 10.1111/j.1399-0004.2007.00887.x; Woodman PG, 2003, J CELL SCI, V116, P4283, DOI 10.1242/jcs.00817; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yi L, 2015, HUM MOL GENET, V24, P2411, DOI 10.1093/hmg/ddv002; Yi L, 2012, HUM MOL GENET, V21, P1794, DOI 10.1093/hmg/ddr612; Zhang XY, 2015, P NATL ACAD SCI USA, V112, pE1705, DOI 10.1073/pnas.1418820112; Zhao G, 2007, P NATL ACAD SCI USA, V104, P8785, DOI 10.1073/pnas.0702966104	36	7	7	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7606	7617		10.1074/jbc.RA117.000686	http://dx.doi.org/10.1074/jbc.RA117.000686			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29599289	Green Published, hybrid			2022-12-26	WOS:000437256500013
J	Briot, J; Mailhot, O; Bourdin, B; Tetreault, MP; Najmanovich, R; Parent, L				Briot, Julie; Mailhot, Olivier; Bourdin, Benoite; Tetreault, Marie-Philippe; Najmanovich, Rafael; Parent, Lucie			A three-way inter-molecular network accounts for the Ca(V)21-induced functional modulation of the pore-forming Ca(V)1.2 subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						homology modeling; molecular dynamics; patch clamp; protein-protein interaction; calcium channel; channel activation; Western blot; protein structure; structure-function; coimmunoprecipitation; MIDAS; von Willebrand factor type A domain	VON-WILLEBRAND-FACTOR; DEPENDENT ADHESION SITE; MOLECULAR-DYNAMICS SIMULATIONS; GATED CALCIUM-CHANNELS; FACTOR-A DOMAIN; INTEGRIN REGULATION; I-DOMAIN; CA-V-ALPHA-2-DELTA-1 SUBUNIT; ALPHA(2)DELTA SUBUNITS; CA2+ CHANNELS	L-type Ca(V)1.2 channels are essential for the excitation-contraction coupling in cardiomyocytes and are hetero-oligomers of a pore-forming Ca(V)1C assembled with Ca-V and Ca(V)21 subunits. A direct interaction between Ca(V)21 and Asp-181 in the first extracellular loop of Ca(V)1 reproduces the native properties of the channel. A 3D model of the von Willebrand factor type A (VWA) domain of Ca(V)21 complexed with the voltage sensor domain of Ca(V)1C suggests that Ser-261 and Ser-263 residues in the metal ion-dependent adhesion site (MIDAS) motif are determinant in this interaction, but this hypothesis is untested. Here, coimmunoprecipitation assays and patch-clamp experiments of single-substitution variants revealed that Ca(V)21 Asp-259 and Ser-261 are the two most important residues in regard to protein interactions and modulation of Ca(V)1.2 currents. In contrast, mutating the side chains of Ca(V)21 Ser-263, Thr-331, and Asp-363 with alanine did not completely prevent channel function. Molecular dynamics simulations indicated that the carboxylate side chain of Ca(V)21 Asp-259 coordinates the divalent cation that is further stabilized by the oxygen atoms from the hydroxyl side chain of Ca(V)21 Ser-261 and the carboxylate group of Ca(V)1C Asp-181. In return, the hydrogen atoms contributed by the side chain of Ser-261 and the main chain of Ser-263 bonded the oxygen atoms of Ca(V)1.2 Asp-181. We propose that Ca(V)21 Asp-259 promotes Ca2+ binding necessary to produce the conformation of the VWA domain that locks Ca(V)21 Ser-261 and Ser-263 within atomic distance of Ca(V)1C Asp-181. This three-way network appears to account for the Ca(V)21-induced modulation of Ca(V)1.2 currents.	[Briot, Julie; Mailhot, Olivier; Najmanovich, Rafael; Parent, Lucie] Univ Montreal, Fac Med, Dept Pharmacol & Physiol, Montreal, PQ H1T 1C8, Canada; [Mailhot, Olivier] Univ Montreal, Fac Med, Dept Biochim & Med Mol, Montreal, PQ H1T 1C8, Canada; [Briot, Julie; Bourdin, Benoite; Tetreault, Marie-Philippe; Parent, Lucie] Univ Montreal, Ctr Rech, Inst Cardiol Montreal, Montreal, PQ H1T 1C8, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Institut de Cardiologie de Montreal	Parent, L (corresponding author), Univ Montreal, Ctr Rech, Inst Cardiol Montreal, Dept Pharmacol & Physiol, 5000 Belanger, Montreal, PQ H1T 1C8, Canada.	lucie.parent@umontreal.ca	Mailhot, Olivier/AAQ-5942-2021	Briot, Julie/0000-0003-4154-6766	Canadian Institutes of Health Research [130256]; Canadian Heart and Stroke Foundation [G-15-0009329]; Fonds de la Recherche du Quebec en Nature et Technologie	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Fonds de la Recherche du Quebec en Nature et Technologie	This work was supported in part by Operating Grant 130256 from the Canadian Institutes of Health Research and Grant G-15-0009329 from the Canadian Heart and Stroke Foundation (to L.P.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Ph.D. award from "Fonds de la Recherche du Quebec en Nature et Technologie."	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Becker AKA, 2015, PROTEIN EXPRES PURIF, V107, P20, DOI 10.1016/j.pep.2014.11.005; BERGELSON JM, 1995, CURR BIOL, V5, P615, DOI 10.1016/S0960-9822(95)00124-2; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Bourdin B, 2017, J BIOL CHEM, V292, P17236, DOI 10.1074/jbc.M117.806893; Bourdin B, 2016, JOVE-J VIS EXP, DOI 10.3791/54732; Bourdin B, 2015, J BIOL CHEM, V290, P2854, DOI 10.1074/jbc.M114.597930; Briot J., 2016, BIOCH MOL BIOL J, V2, P3, DOI [10.21767/2471-8084.100025, DOI 10.21767/2471-8084.100025]; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; COLOMBATTI A, 1991, BLOOD, V77, P2305; Craig D, 2004, STRUCTURE, V12, P2049, DOI 10.1016/j.str.2004.09.009; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; Dolphin AC, 2013, BBA-BIOMEMBRANES, V1828, P1541, DOI 10.1016/j.bbamem.2012.11.019; EDWARDS YJK, 1995, FEBS LETT, V358, P283, DOI 10.1016/0014-5793(94)01447-9; Kamata T, 1999, J BIOL CHEM, V274, P32108, DOI 10.1074/jbc.274.45.32108; Kwasigroch JM, 1996, J MOL BIOL, V259, P855, DOI 10.1006/jmbi.1996.0363; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P6367, DOI 10.1073/pnas.0401506101; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mahalingam B, 2011, J IMMUNOL, V187, P6393, DOI 10.4049/jimmunol.1102394; NAGLE JF, 1993, BIOPHYS J, V64, P1476, DOI 10.1016/S0006-3495(93)81514-5; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Patel AC, 2009, ANNU REV PHYSIOL, V71, P425, DOI 10.1146/annurev.physiol.010908.163253; Pereverzev A, 2002, MOL CELL NEUROSCI, V21, P352, DOI 10.1006/mcne.2002.1179; Pihlajamaa T, 2013, BIOCHEM J, V450, P469, DOI 10.1042/BJ20121058; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Sala-Rabanal M, 2017, J BIOL CHEM, V292, P9164, DOI 10.1074/jbc.M117.788232; Sala-Rabanal M, 2015, ELIFE, V4, DOI 10.7554/eLife.05875; San Sebastian E, 2006, J AM CHEM SOC, V128, P3554, DOI 10.1021/ja054142a; Schmidt TH, 2012, J CHEM INF MODEL, V52, P2657, DOI [10.1021/ci3000453, 10.1021/ci30006531]; Segura E, 2017, J BIOL CHEM, V292, P11109, DOI 10.1074/jbc.M117.784355; Shakeri B, 2012, J BIOL CHEM, V287, P32835, DOI 10.1074/jbc.M112.387233; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Springer TA, 2006, STRUCTURE, V14, P1611, DOI 10.1016/j.str.2006.10.001; Tetreault MP, 2016, J BIOL CHEM, V291, P4826, DOI 10.1074/jbc.M115.692178; Tuckwell D, 1999, BIOCHEM SOC T, V27, P835, DOI 10.1042/bst0270835; Valdramidou D, 2008, J BIOL CHEM, V283, P32704, DOI 10.1074/jbc.M802066200; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Webb B, 2017, METHODS MOL BIOL, V1654, P39, DOI 10.1007/978-1-4939-7231-9_4; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Wu JP, 2016, NATURE, V537, P191, DOI 10.1038/nature19321; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395; Yan BX, 1997, J BIOL CHEM, V272, P3190, DOI 10.1074/jbc.272.6.3190; Zhang K, 2012, CELL ADHES MIGR, V6, P20, DOI 10.4161/cam.18702	48	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7176	7188		10.1074/jbc.RA118.001902	http://dx.doi.org/10.1074/jbc.RA118.001902			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29588365	Green Published, hybrid			2022-12-26	WOS:000432174500010
J	Caselle, JE; Hamilton, SL; Davis, K; Thompson, CDH; Turchik, A; Jenkinson, R; Simpson, D; Sala, E				Caselle, Jennifer E.; Hamilton, Scott L.; Davis, Kathryn; Thompson, Christopher D. H.; Turchik, Alan; Jenkinson, Ryan; Simpson, Doug; Sala, Enric			First quantification of subtidal community structure at Tristan da Cunha Islands in the remote South Atlantic: From kelp forests to the deep sea	PLOS ONE			English	Article							GIANT-KELP; MACROCYSTIS-PYRIFERA; GLOBAL PATTERNS; BASE-LINES; PREDATOR DIVERSITY; MARINE RESERVES; FRONTAL ZONES; TOP-DOWN; BIOMASS; TRAJECTORIES	Tristan da Cunha Islands, an archipelago of four rocky volcanic islands situated in the South Atlantic Ocean and part of the United Kingdom Overseas Territories (UKOTs), present a rare example of a relatively unimpacted temperate marine ecosystem. We conducted the first quantitative surveys of nearshore kelp forests, offshore pelagic waters and deep sea habitats. Kelp forests had very low biodiversity and species richness, but high biomass and abundance of those species present. Spatial variation in assemblage structure for both nearshore fish and invertebrates/algae was greatest between the three northern islands and the southern island of Gough, where sea temperatures were on average 3-4 degrees colder. Despite a lobster fishery that provides the bulk of the income to the Tristan islands, lobster abundance and biomass are comparable to or greater than many Marine Protected Areas in other parts of the world. Pelagic camera surveys documented a rich biodiversity offshore, including large numbers of juvenile blue sharks, Prionace glauca. Species richness and abundance in the deep sea is positively related to hard rocky substrate and biogenic habitats such as sea pens, crinoids, whip corals, and gorgonians were present at 40% of the deep camera deployments. We observed distinct differences in the deep fish community above and below similar to 750 m depth. Concurrent oceanographic sampling showed a discontinuity in temperature and salinity at this depth. While currently healthy, Tristan's marine ecosystem is not without potential threats: shipping traffic leading to wrecks and species introductions, pressure to increase fishing effort beyond sustainable levels and the impacts of climate change all could potentially increase in the coming years. The United Kingdom has committed to protection of marine environments across the UKOTs, including Tristan da Cunha and these results can be used to inform future management decisions as well as provide a baseline against which future monitoring can be based.	[Caselle, Jennifer E.; Davis, Kathryn; Jenkinson, Ryan] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Hamilton, Scott L.] Moss Landing Marine Labs, Pob 450, Moss Landing, CA 95039 USA; [Thompson, Christopher D. H.] Univ Western Australia, Ctr Marine Futures, M092, Crawley, WA USA; [Turchik, Alan; Sala, Enric] Natl Geog Soc, Pristine Seas, Washington, DC USA; [Simpson, Doug] Univ Montana, Sch Journalism, Missoula, MT 59812 USA	University of California System; University of California Santa Barbara; Moss Landing Marine Laboratories; University of Western Australia; National Geographic Society; University of Montana System; University of Montana	Caselle, JE (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA.	Caselle@ucsb.edu		Thompson, Christopher/0000-0001-8202-0221				Aburto-Oropeza O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023601; Anderson Orea R. J., 2011, Endangered Species Research, V14, P91, DOI 10.3354/esr00347; Andrew T.G., 1995, Ichthyological Bulletin of the J. L. B. Smith Institute of Ichthyology, V63, P1; Andrew T. G., 1992, South African Journal of Antarctic Research, V22, P41; Babcock RC, 2007, MAR FRESHWATER RES, V58, P286, DOI 10.1071/MF06204; Bakun A, 2006, SCI MAR, V70, P105, DOI 10.3989/scimar.2006.70s2105; Barrientos CA, 2006, FISH B-NOAA, V104, P489; Bax N, 2003, MAR POLICY, V27, P313, DOI 10.1016/S0308-597X(03)00041-1; Baxter J. L., 1960, Fishery Bulletin Sacramento, VNo. 110, P1; Bell TW, 2015, J BIOGEOGR, V42, P2010, DOI 10.1111/jbi.12550; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Borrvall C, 2000, ECOL LETT, V3, P131, DOI 10.1046/j.1461-0248.2000.00130.x; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Bradshaw CJA, 2004, ANIM BEHAV, V68, P1349, DOI 10.1016/j.anbehav.2003.12.013; BREEN PA, 1976, MAR BIOL, V34, P137, DOI 10.1007/BF00390755; Brown KM, 2004, OECOLOGIA, V141, P121, DOI 10.1007/s00442-004-1648-6; Caselle JE, 2015, SCI REP-UK, V5, DOI 10.1038/srep14102; Chernova NV, 2014, PEERJ, V2, DOI 10.7717/peerj.692; Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.1890/1051-0761(1998)008[0309:SBGARE]2.0.CO;2; DAYTON PK, 1994, AM ZOOL, V34, P90; DAYTON PK, 1984, SCIENCE, V224, P283, DOI 10.1126/science.224.4646.283; Deacon G., 1933, DISCOVERY REP, V7; DEACON GER, 1982, DEEP-SEA RES, V29, P1, DOI 10.1016/0198-0149(82)90058-9; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Doolittle DF, 2008, NOVA HEDWIGIA, P147; Dubiaski-Silva J, 2006, J COASTAL RES, P1190; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; EBERT DA, 1991, S AFR J MARINE SCI, V11, P565, DOI 10.2989/025776191784287547; Eklof A, 2006, J ANIM ECOL, V75, P239, DOI 10.1111/j.1365-2656.2006.01041.x; Etnoyer Peter, 2004, Oceanography, V17, P90; Freeman DT, 2012, ENVIRON CONSERV, V39, P295, DOI 10.1017/S037689291200015X; Friedlander AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145059; Friedlander AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100142; Friedlander AM, 2013, AQUAT CONSERV, V23, P515, DOI 10.1002/aqc.2333; Friedlander AM, 2010, MAR ECOL PROG SER, V410, P219, DOI 10.3354/meps08634; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Froese R., 2011, WORLD WIDE WEB ELECT; Glass JP, 2014, THESIS; Guggenheim DE, 2014, INT OIL SPILL C P; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hamilton SL, 2010, P NATL ACAD SCI USA, V107, P18272, DOI 10.1073/pnas.0908091107; Heydorn AEF, 1969, S ATLANTIC ROCK LOBS; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; JACKSON GA, 1987, MAR BIOL, V95, P611, DOI 10.1007/BF00393105; Jackson GA, 1977, OCEANOGRAPHY, V22; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Jordan F, 2002, J THEOR BIOL, V215, P441, DOI 10.1006/jtbi.2001.2523; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Krumhansl KA, 2016, P NATL ACAD SCI USA, V113, P13785, DOI 10.1073/pnas.1606102113; Lafferty KD, 2004, ECOL APPL, V14, P1566, DOI 10.1890/03-5088; LAUBSCHER RK, 1993, POLAR BIOL, V13, P471; Letessier T.B., 2013, METHODS OCEANOGR, V8, P41, DOI [10.1016/j.mio.2013.11.003, DOI 10.1016/J.MIO.2013.11.003]; Lewison RL, 2014, P NATL ACAD SCI USA, V111, P5271, DOI 10.1073/pnas.1318960111; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lutjeharms J. R. E., 1985, ANTARCTIC NUTR CYCLE, P11; McCauley DJ, 2015, SCIENCE, V347, DOI 10.1126/science.1255641; Nonato EF, 2000, POLAR BIOL, V23, P580, DOI 10.1007/s003000000129; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; POLLOCK DE, 1991, S AFR J MARINE SCI, V10, P1; Polovina JJ, 2001, PROG OCEANOGR, V49, P469, DOI 10.1016/S0079-6611(01)00036-2; Queiroz N, 2016, P NATL ACAD SCI USA, V113, P1582, DOI 10.1073/pnas.1510090113; Raymond B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010960; Reed D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13757; Reed D, 2009, MAR BIOL, V156, P2077, DOI 10.1007/s00227-009-1238-6; Reed DC, 2008, ECOLOGY, V89, P2493, DOI 10.1890/07-1106.1; Reed DC, 2011, ECOLOGY, V92, P2108, DOI 10.1890/11-0377.1; Robinson PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036728; Rodriguez GE, 2013, ECOLOGY, V94, P1848, DOI 10.1890/12-1340.1; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Scales KL, 2014, J APPL ECOL, V51, P1575, DOI 10.1111/1365-2664.12330; Scott S., 2016, BIOPHYSICAL PROFILE; SEYMOUR RJ, 1989, ESTUAR COAST SHELF S, V28, P277, DOI 10.1016/0272-7714(89)90018-8; Shears NT, 2002, OECOLOGIA, V132, P131, DOI 10.1007/s00442-002-0920-x; Smith CD, 2003, MAR BIOL, V143, P1127, DOI 10.1007/s00227-003-1144-2; Tegner MJ, 1997, MAR ECOL PROG SER, V146, P117, DOI 10.3354/meps146117; Utter BD, 1996, J EXP BIOL, V199, P2645; VANTUSSENBROEK BI, 1993, EUR J PHYCOL, V28, P161, DOI 10.1080/09670269300650251; Vroom PS, 2010, BIODIVERS CONSERV, V19, P797, DOI 10.1007/s10531-009-9735-y; Wanless RM, 2010, BIOL INVASIONS, V12, P2573, DOI 10.1007/s10530-009-9666-2; Weng KC, 2008, MAR ECOL PROG SER, V372, P253, DOI 10.3354/meps07706; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P7, DOI 10.1016/j.jembe.2011.02.021; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399; Worm B, 2003, P NATL ACAD SCI USA, V100, P9884, DOI 10.1073/pnas.1333941100; Zainuddin M, 2006, DEEP-SEA RES PT II, V53, P419, DOI 10.1016/j.dsr2.2006.01.007	88	11	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195167	10.1371/journal.pone.0195167	http://dx.doi.org/10.1371/journal.pone.0195167			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596484	Green Published, Green Submitted, gold			2022-12-26	WOS:000428630000089
J	Coughlan, MR; Nelson, DR				Coughlan, Michael R.; Nelson, Donald R.			Influences of Native American land use on the Colonial Euro-American settlement of the South Carolina Piedmont	PLOS ONE			English	Article							EASTERN NORTH-AMERICA; SOUTHEASTERN UNITED-STATES; HUMAN NICHE CONSTRUCTION; HISTORICAL ECOLOGY; USE LEGACIES; APPALACHIAN LANDSCAPES; CULTURAL LANDSCAPES; FRENCH PYRENEES; RIVER VALLEY; LONG-TERM	We test the hypothesis that prehistoric Native American land use influenced the Euro-American settlement process in a South Carolina Piedmont landscape. Long term ecological studies demonstrate that land use legacies influence processes and trajectories in complex, coupled social and ecological systems. Native American land use likely altered the ecological and evolutionary feedback and trajectories of many North American landscapes. Yet, considerable debate revolves around the scale and extent of land use legacies of prehistoric Native Americans. At the core of this debate is the question of whether or not European colonists settled a mostly "wild" landscape or an already "humanized" landscape. We use statistical event analysis to model the effects of prehistoric Native American settlement on the rate of Colonial land grants (1749-1775). Our results reveal how abandoned Native American settlements were among the first areas claimed and homesteaded by Euro-Americans. We suggest that prehistoric land use legacies served as key focal nodes in the Colonial era settlement process. As a consequence, localized prehistoric land use legacies likely helped structure the long term, landscape-to regional-level ecological inheritances that resulted from Euro-American settlement.	[Coughlan, Michael R.; Nelson, Donald R.] Univ Georgia, Dept Anthropol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Coughlan, MR (corresponding author), Univ Georgia, Dept Anthropol, Athens, GA 30602 USA.	coughlan@uga.edu	coughlan, michael/X-7634-2019; Nelson, Donald R/C-3225-2014	coughlan, michael/0000-0001-6071-1873; Nelson, Donald R/0000-0002-7878-2853				Abrams MD, 2008, HOLOCENE, V18, P1123, DOI 10.1177/0959683608095581; Allison P.D., 1984, EVENT HIST ANAL REGR; Bain DJ, 2012, BIOSCIENCE, V62, P575, DOI 10.1525/bio.2012.62.6.8; Bain DJ, 2004, LANDSCAPE ECOL, V19, P843, DOI 10.1007/s10980-004-0167-5; Bass RD, 1989, 96 STRUGGLE S CAROLI; Bennett J. W., 1969, NO PLAINSMEN ADAPTIV; Benson R. W, 2006, CULTURAL RESOURCES O; Bird RB, 2013, P R SOC B; Black BA, 2006, CAN J FOREST RES, V36, P1266, DOI 10.1139/X06-027; Blossfeld H-P., 2012, EVENT HIST ANAL STAT; Bolstad PV, 2007, J ARCHAEOLOGICAL SCI, V10; Brantley CG, 2001, WILDLIFE SOC B, V29, P1175; Brook BW, 2004, J BIOGEOGR, V31, P517, DOI 10.1046/j.1365-2699.2003.01028.x; Charles Allen D., 1987, NARRATIVE HIST UNION; Chisholm M., 2017, RURAL SETTLEMENT LAN; Christensen N. L., 1989, Journal of Forest History, V33, P116, DOI 10.2307/4005121; CLARK JS, 1995, HOLOCENE, V5, P1, DOI 10.1177/095968369500500101; CORE EARL L., 1949, JOUR ELISHA MITCHELL SCI SOC, V65, P306; Coughlan MR, 2017, LAND-BASEL, V6, DOI 10.3390/land6020032; Coughlan MR, 2016, HUM ECOL, V44, P65, DOI 10.1007/s10745-016-9808-y; Coughlan MR, 2014, FOREST ECOL MANAG, V312, P55, DOI 10.1016/j.foreco.2013.10.021; Cousins SAO, 2001, LANDSCAPE ECOL, V16, P41, DOI 10.1023/A:1008108704358; COX DR, 1972, J R STAT SOC B, V34, P187; Cronon William, 1983, CHANGES LAND INDIANS; Delcourt HR, 1997, CONSERV BIOL, V11, P1010, DOI 10.1046/j.1523-1739.1997.96338.x; Delcourt PA, 1998, AM ANTIQUITY, V63, P263, DOI 10.2307/2694697; DELCOURT PA, 1986, QUATERNARY RES, V25, P330, DOI 10.1016/0033-5894(86)90005-0; Delcourt Paul A., 1998, Castanea, V63, P337; DENEVAN WM, 1992, ANN ASSOC AM GEOGR, V82, P369, DOI 10.1111/j.1467-8306.1992.tb01965.x; Donahue Brian., 2004, GREAT MEADOW FARMERS; Dotterweich M, 2014, ANTHROPOCENE, V8, P6, DOI 10.1016/j.ancene.2015.05.003; Duilts TE, 2015, TOPOGRAPHY TOOLS ARC; Dyer JM, 2010, APPL VEG SCI, V13, P195, DOI 10.1111/j.1654-109X.2009.01061.x; Erickson CL, 2006, HIST ECOL SER, P187; Ethridge R, 2004, CREEK COUNTRY CREEK; Foster D, 2003, BIOSCIENCE, V53, P77, DOI 10.1641/0006-3568(2003)053[0077:TIOLUL]2.0.CO;2; FOSTER DR, 1992, J ECOL, V80, P753, DOI 10.2307/2260864; Foster HT, 2007, AM ANTIQUITY, V72, P35, DOI 10.2307/40035297; Foster HT, 2004, HUM ECOL, V32, P27, DOI 10.1023/B:HUEC.0000015211.98991.9c; Foundation UCH, 1995, LAND GRANT MAPS; Fowler C, 2007, HUM ECOL REV, V14, P165; Gagnon PR, 2009, WETLANDS, V29, P520, DOI 10.1672/08-50.1; Garnett A, 1935, GEOGR REV, V25, P601, DOI 10.2307/209399; Gragson T. L, 2008, AGRARIAN LANDSCAPES, P89; Gragson TL, 2015, CAPITAL CULT, P565; Gragson TL, 2006, SOC NATUR RESOUR, V19, P175, DOI 10.1080/08941920500394857; Green W, 2003, SE ARCH C CHARL N CA; Heckenberger MJ, 2007, PHILOS T R SOC B, V362, P197, DOI 10.1098/rstb.2006.1979; HILLIARD SB, 1982, GEOGR REV, V72, P416, DOI 10.2307/214594; HUDSON C, 1976, SE INDIANS; Hudson Charles, 1984, SE ARCHAEOLOGY, V3, P65; Ivers LE, 1970, COLONIAL FORTS S CAR; Jogiste K, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1706; Jones EE, 2017, J ARCHAEOL SCI, V84, P54, DOI 10.1016/j.jas.2017.05.009; Jones EE, 2012, J ARCHAEOL SCI, V39, P2593, DOI 10.1016/j.jas.2012.04.019; Jones Eric E., 2016, SE ARCHAEOLOGY, V35, P85; Kendal J, 2011, PHILOS T R SOC B, V366, P785, DOI 10.1098/rstb.2010.0306; Klein Rachel N., 2012, UNIFICATION SLAVE ST; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Lehmann J, 2007, AMAZONIAN DARK EARTH; Leigh D, 2015, QUATERNARY INT; Leigh DS, 2013, J ARCHAEOL SCI, V40, P4107, DOI 10.1016/j.jas.2013.05.009; LEWIS HT, 1988, HUM ECOL, V16, P57, DOI 10.1007/BF01262026; Logan J.H., 1859, HIST UPPER COUNTRY S; Lunt ID, 2005, J BIOGEOGR, V32, P1859, DOI 10.1111/j.1365-2699.2005.01296.x; Martin P.S., 1984, P354; Mensing SA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20286-4; Meriwether Robert L., 1940, EXPANSION S CAROLINA; Minnis P, 2001, BIODIVERSITY NATIVE; Morgan C, 2008, J ARCHAEOL SCI, V35, P247, DOI 10.1016/j.jas.2007.02.025; Munoz SE, 2014, J BIOGEOGR, V41, P2195, DOI 10.1111/jbi.12386; Munoz SE, 2010, HOLOCENE, V20, P967, DOI 10.1177/0959683610362815; Nigh R, 2013, FRONT ECOL ENVIRON, V11, pE45, DOI 10.1890/120344; Odling-Smee John, 2011, Biological Theory, V6, P220, DOI 10.1007/s13752-012-0030-x; Pettus L., 1995, BACKSIGHTS MAGAZINE; Platt Steven G., 1997, Castanea, V62, P8; Plieninger T, 2011, REG ENVIRON CHANGE, V11, P603, DOI 10.1007/s10113-010-0192-7; Pope TH, 1973, HIST NEWBERRY COUNTY; Prunty MC, 1965, P 4 ANN TALL TIMB FI; Richter D. D., 2001, UNDERSTANDING SOIL C, P272; RUSSELL EWB, 1983, ECOLOGY, V64, P78, DOI 10.2307/1937331; Silver T., 1990, NEW FACE COUNTRYSIDE, Vxii; Smith BD, 2015, J ARCHAEOL RES, V23, P215, DOI 10.1007/s10814-015-9081-4; Smith Bruce D., 2011, Biology Theory, V6, P260, DOI 10.1007/s13752-012-0028-4; Smith BD, 2011, CURR ANTHROPOL, V52, pS471, DOI 10.1086/659645; Smith BD, 2011, PHILOS T R SOC B, V366, P836, DOI 10.1098/rstb.2010.0253; Smith BD, 2009, J ETHNOBIOL, V29, P167, DOI 10.2993/0278-0771-29.2.167; Smith BD, 2009, P NATL ACAD SCI USA, V106, P6561, DOI 10.1073/pnas.0901846106; STEPONAITIS VP, 1986, ANNU REV ANTHROPOL, V15, P363, DOI 10.1146/annurev.an.15.100186.002051; Stewart Omer C., 2002, FORGOTTEN FIRES NATI; Stone G.D., 1996, SETTLEMENT ECOLOGY S; Sylvester K.M., 2008, AGRARIAN LANDSCAPES, P16; Turner F.J, 2010, FRONTIER AM HIST; Vale T.R., 2002, FIRE NATIVE PEOPLES; Vale TR, 1998, NAT AREA J, V18, P231; Warren RJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150707; Waselkov Gregory A., 1997, STUDIES PALEOETHNOBO, P179; Wear DN, 1998, ECOSYSTEMS, V1, P575, DOI 10.1007/s100219900052; Whitlock C, 2017, CONSERVATION BIOL; WILHELM G, 1978, APPALACHIAN J, V5, P204; Williams G. W., 2005, REFERENCES AM INDIAN; Wood PH, 1989, CHANGING POPULATION; Zeder MA, 2012, J ANTHROPOL ARCHAEOL, V31, P241, DOI 10.1016/j.jaa.2012.03.003	103	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195036	10.1371/journal.pone.0195036	http://dx.doi.org/10.1371/journal.pone.0195036			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596504	Green Published, Green Submitted, gold			2022-12-26	WOS:000428630000070
J	Yu, M; Wei, CH; Niu, LL; Li, SH; Yu, YJ				Yu, Miao; Wei, Chenhui; Niu, Leilei; Li, Shaohua; Yu, Yongjun			Calculation for tensile strength and fracture toughness of granite with three kinds of grain sizes using three-point-bending test	PLOS ONE			English	Article							MODE-I FRACTURE; PROCESS ZONE; ACOUSTIC-EMISSION; CONCRETE; ROCKS; SPECIMENS; ENERGY	Tensile strength and fracture toughness, important parameters of the rock for engineering applications are difficult to measure. Thus this paper selected three kinds of granite samples (grain sizes = 1.01mm, 2.12mm and 3mm), used the combined experiments of physical and numerical simulation (RFPA-DIP version) to conduct three-point-bending (3-p-b) tests with different notches and introduced the acoustic emission monitor system to analyze the fracture mechanism around the notch tips. To study the effects of grain size on the tensile strength and toughness of rock samples, a modified fracture model was established linking fictitious crack to the grain size so that the microstructure of the specimens and fictitious crack growth can be considered together. The fractal method was introduced to represent microstructure of three kinds of granites and used to determine the length of fictitious crack. It is a simple and novel method to calculate the tensile strength and fracture toughness directly. Finally, the theoretical model was verified by the comparison to the numerical experiments by calculating the nominal strength sigma(n) and maximum loads P-max.	[Yu, Miao; Wei, Chenhui; Niu, Leilei; Li, Shaohua; Yu, Yongjun] Northeastern Univ, Sch Resources & Civil Engn, Shenyang, Liaoning, Peoples R China	Northeastern University - China	Yu, M (corresponding author), Northeastern Univ, Sch Resources & Civil Engn, Shenyang, Liaoning, Peoples R China.	741975392@qq.com						Aliha MRM, 2012, INT J ROCK MECH MIN, V51, P128, DOI 10.1016/j.ijrmms.2012.01.017; [Anonymous], 1988, INT J ROCK MECH MIN, V25, P71; Astm, 1996, E39990 ASTM; Bazant ZP, 1983, MATERIALS STRUCTURES, V16, P155, DOI DOI 10.1007/BF02486267; Bearman RA, 1999, INT J ROCK MECH MIN, V36, P257, DOI 10.1016/S0148-9062(99)00015-7; CEDOLIN L, 1983, CEMENT CONCRETE RES, V13, P557, DOI 10.1016/0008-8846(83)90015-7; Chalivendra VB, 2009, INT J IMPACT ENG, V36, P888, DOI 10.1016/j.ijimpeng.2008.11.009; CHONG KP, 1988, ENG FRACT MECH, V30, P701, DOI 10.1016/0013-7944(88)90160-9; Dai F, 2015, COMPUT GEOTECH, V69, P424, DOI 10.1016/j.compgeo.2015.06.011; FOWELL RJ, 1995, INT J ROCK MECH MIN, V32, P57, DOI 10.1016/0148-9062(94)00015-U; Guinea GV, 2000, ENG FRACT MECH, V65, P189, DOI 10.1016/S0013-7944(99)00115-0; HASHIDA T, 1993, INT J ROCK MECH MIN, V30, P47, DOI 10.1016/0148-9062(93)90175-D; HILLERBORG A, 1991, INT J FRACTURE, V51, P95; Hillerborg A., 1976, CEMENT CONCRETE RES, V6, P773, DOI [10.1016/0008-8846(76)90007-7, DOI 10.1016/0008-8846(76)90007-7]; Hoover CG, 2013, ENG FRACT MECH, V110, P281, DOI 10.1016/j.engfracmech.2013.08.008; Hu XZ, 2007, ENG FRACT MECH, V74, P1093, DOI 10.1016/j.engfracmech.2006.12.009; Hu XZ, 2008, INT J FRACTURE, V154, P3, DOI 10.1007/s10704-008-9290-7; Hu XZ, 2004, CEMENT CONCRETE RES, V34, P1321, DOI 10.1016/j.cemconres.2003.12.027; Iqbal MJ, 2007, ROCK MECH ROCK ENG, V40, P453, DOI 10.1007/s00603-006-0107-6; JANACH W, 1977, INT J ROCK MECH MIN, V14, P209, DOI 10.1016/0148-9062(77)90950-0; KRANZ RL, 1979, INT J ROCK MECH MIN, V16, P23, DOI 10.1016/0148-9062(79)90772-1; Mavko G., 1998, ROCK PHYS HDB TOOLS; Muralidhara S, 2010, CONSTR BUILD MATER, V24, P479, DOI 10.1016/j.conbuildmat.2009.10.014; Nasseri MHB, 2008, INT J ROCK MECH MIN, V45, P167, DOI 10.1016/j.ijrmms.2007.04.005; Nasseri MHB, 2005, INT J ROCK MECH MIN, V42, P450, DOI 10.1016/j.ijrmms.2004.11.007; Ohno K, 2014, CONSTR BUILD MATER, V67, P139, DOI 10.1016/j.conbuildmat.2014.05.012; Ouchterlony F, 1981, FRACTURE MECH METHOD, P237, DOI DOI 10.1520/STP28309S; ROSSMANITH HP, 1983, ENG FRACT MECH, V17, P509, DOI 10.1016/0013-7944(83)90112-1; Tang TX, 1996, ENG FRACT MECH, V55, P383, DOI 10.1016/0013-7944(96)00030-6; TAPPONNIER P, 1976, INT J ROCK MECH MIN, V13, P103, DOI 10.1016/0148-9062(76)91937-9; Tutluoglu L, 2011, INT J ROCK MECH MIN, V48, P1248, DOI 10.1016/j.ijrmms.2011.09.019; Wang YS, 2016, ROCK MECH ROCK ENG, V10, P48; Wei MD, 2016, ENG FRACT MECH, V154, P43, DOI 10.1016/j.engfracmech.2016.01.002; Yao SF, 2016, ROCK SOIL MECH, V37, P2341, DOI 10.16285/j.rsm.2016.08.028; Yin TB, 2015, ROCK MECH ROCK ENG, V48, P2213, DOI 10.1007/s00603-015-0712-3; Zhang ZX, 2002, INT J ROCK MECH MIN, V39, P401, DOI 10.1016/S1365-1609(02)00032-1	36	13	13	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0180880	10.1371/journal.pone.0180880	http://dx.doi.org/10.1371/journal.pone.0180880			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596422	Green Submitted, Green Published, gold			2022-12-26	WOS:000428630000001
J	Atinga, RA; Yarney, L; Gavu, NM				Atinga, Roger A.; Yarney, Lily; Gavu, Narissa Minta			Factors influencing long-term medication non-adherence among diabetes and hypertensive patients in Ghana: A qualitative investigation	PLOS ONE			English	Article							HEALTH-CARE; ADHERENCE; PREVALENCE; MEDICINES; AWARENESS; THERAPY; HEALERS; ADULTS	Background Evidence remains limited on why diabetes and hypertensive patients admitted to long-term drug therapy miss doses or discontinue medication taking. We examined this phenomenon from the perspective of diabetes and hypertension patients at a Ghanaian teaching hospital. Methods Between July and December 2015, we conducted a qualitative study targeting caregivers and their patients with chronic diabetes and hypertensive on re-admission at the Korle Bu Teaching Hospital due to non-adherence to prescribed medication. Participants were sampled purposefully and taking through in-depth interviews using an interview guide. Notes and audio recordings of interviews were transcribed, managed and coded for themes guided by the thematic network analysis recommended by Attride-Stirling. Results Non-adherence was the result of perceptions that the medications are not effective for managing the conditions. Patients with these perceptions rejected the medications and turned to herbal medicines and spiritual healing as therapeutic alternatives, because of their easy accessibility, perceived efficacy and affordability. Other factors identified to influence non-adherence included polypharmacy practice; tight work schedules; social norms; poor prescription instruction by health providers; and knowledge and experience of medication. Conclusion Findings suggests the need for health providers to adopt therapeutic approaches that take into account patients' beliefs, values and norms in administering medications. Sensitisation of patients and caregivers during admission on the implication of non-adherence, as well as interventions that monitor and provide feedback mechanisms on patients' medication taking behaviour holds promise for maximising diabetes and hypertensive medication adherence.	[Atinga, Roger A.; Yarney, Lily] Univ Ghana, Business Sch, Dept Publ Adm & Hlth Serv Management, Legon, Accra, Ghana; [Gavu, Narissa Minta] Korle Bu Teaching Hosp, Med Dept, Accra, Ghana	University of Ghana	Atinga, RA (corresponding author), Univ Ghana, Business Sch, Dept Publ Adm & Hlth Serv Management, Legon, Accra, Ghana.	ayimbillah@yahoo.com		Yarney, Lily/0000-0003-3423-326X	University of Ghana Business School Faculty support	University of Ghana Business School Faculty support	This research received support from the University of Ghana Business School Faculty support.	Ae-Ngibise K, 2010, INT REV PSYCHIATR, V22, P558, DOI 10.3109/09540261.2010.536149; Aikins Ad-G, 2005, BMJ, V33; Akter S, 2014, B WORLD HEALTH ORGAN, V92, P204, DOI 10.2471/BLT.13.128371; [Anonymous], 2013, ANN REP KORL BU TEAC; Attride-Stirling J, 2001, QUAL RES, V1, P385, DOI DOI 10.1177/146879410100100307; Atun R, 2013, LANCET, V381, P690, DOI 10.1016/S0140-6736(13)60063-X; Berkowitz AD, 2002, SOCIAL NORMS APPROAC; Beune EJAJ, 2008, J HYPERTENS, V26, P648, DOI 10.1097/HJH.0b013e3282f4d20b; Brown MT, 2011, MAYO CLIN PROC, V86, P304, DOI 10.4065/mcp.2010.0575; Bruce Suliasnaia P, 2015, Pharm Pract (Granada), V13, P533; Calys-Tagoe Benedict N L, 2014, BMC Res Notes, V7, P577, DOI 10.1186/1756-0500-7-577; Chatio S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116856; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; Dako-Gyeke P, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-211; Dakubo J, 2014, POSTGRADUATE MED J G, V3, P15; Dodor EA, 2005, T ROY SOC TROP MED H, V99, P827, DOI 10.1016/j.trstmh.2005.06.011; Farnes C, 2011, INT NURS REV, V58, P491, DOI 10.1111/j.1466-7657.2011.00917.x; Ghana Health Service, 2015, ANN REP GHAN HLTH SE; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Ho SC, 2016, J AFFECT DISORDERS, V193, P1, DOI 10.1016/j.jad.2015.12.029; Hogerzeil HV, 2013, LANCET, V381, P680, DOI 10.1016/S0140-6736(12)62128-X; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Laryeh JG, 2013, FACTORS INFLUENCING; Lehane E, 2007, INT J NURS STUD, V44, P1468, DOI 10.1016/j.ijnurstu.2006.07.010; Lloyd-Sherlock P, 2014, INT J EPIDEMIOL, V43, P116, DOI 10.1093/ije/dyt215; Luppa M, 2007, J AFFECT DISORDERS, V98, P29, DOI 10.1016/j.jad.2006.07.017; Mattke S., 2011, IMPROVING ACCESS MED; McMullen CK, 2015, PATIENT EDUC COUNS, V98, P102, DOI 10.1016/j.pec.2014.09.015; Mills E, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-19; Mohan V, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/409083; Munro S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-104; Ofosu-Amaah S., 1996, HOSP AUTONOMY GHANA; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pereira M, 2009, J HYPERTENS, V27, P963, DOI 10.1097/HJH.0b013e3283282f65; Read UM, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-13; Sabate AL, 2003, ADHERENCE LONG TERM; Sackey MB., 2002, I AFRICAN STUDIES RE, V18, P5; Saha S, 2008, J NATL MED ASSOC, V100, P1275, DOI 10.1016/S0027-9684(15)31505-4; Sarki AM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001959; Sato A, 2012, HLTH POLICY PLANNING, V2013, P1; Schiffrin EL, 2012, LANCET, V380, P539, DOI 10.1016/S0140-6736(12)61219-7; Skinner M, 2015, GERIATR NURS, V36, P367, DOI 10.1016/j.gerinurse.2015.05.003; Tabi MM, 2006, INT NURS REV, V53, P52, DOI 10.1111/j.1466-7657.2006.00444.x; Ventana Systems Inc., 2014, VENS PLE SOFTW; Vervoort SCJM, 2007, AIDS, V21, P271, DOI 10.1097/QAD.0b013e328011cb20; Vlasnik Jon J, 2005, Case Manager, V16, P47; Voorham J, 2011, CLIN THER, V33, P121, DOI 10.1016/j.clinthera.2011.01.024; Wolf MS, 2011, MED CARE, V49, P96, DOI 10.1097/MLR.0b013e3181f38174; World Health Organization, 2014, FACT SHEET; Zarowitz BJ, 2005, PHARMACOTHERAPY, V25, P1636, DOI 10.1592/phco.2005.25.11.1636	51	26	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193995	10.1371/journal.pone.0193995	http://dx.doi.org/10.1371/journal.pone.0193995			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590156	Green Published, gold, Green Submitted			2022-12-26	WOS:000428603100044
J	Khajah, MA; Mathew, PM; Luqmani, YA				Khajah, Maitham A.; Mathew, Princy M.; Luqmani, Yunus A.			Na+/K+ ATPase activity promotes invasion of endocrine resistant breast cancer cells	PLOS ONE			English	Article							BETA-SUBUNIT; ESTROGEN-RECEPTOR; ALPHA-SUBUNIT; OUABAIN; NA,K-ATPASE; EXPRESSION; NA+,K+-ATPASE; SRC; PROLIFERATION; INHIBITION	Background The Na+/K+-ATPase (NKP) is an important ion transporter also involved in signal transduction. Its expression profile is altered in various tumours including that of the breast. We studied the effect of inhibiting NKP activity in non-tumorigenic breast cell line and in estrogen receptor positive and negative breast cancer cells. Methods Expression and localization of NKP and downstream signaling molecules were determined by RT-PCR, western blotting and immunofluorescence. Cell proliferation, apoptosis and cell cycle stage were determined using MTT, annexin V and flow cytometry. Cell motility and invasion were determined using wound healing and matrigel assays. Total matrix metalloproteinase (MMP) was determined by a fluorescence-based assay. Results NKP was mainly localized on the cell membrane. Its baseline expression and activity were enhanced in breast cancer compared to the non-tumorigenic breast cell line. Ouabain and 3,4,5,6-tetrahydroxyxanthone (TTX) treatment significantly inhibited NKP activity, which significantly reduced cell proliferation, motility, invasion and pH-induced membrane blebbing. EGF stimulation induced internalization of NKP from the cell membrane to the cytoplasm. Ouabain inhibited EGF-induced phosphorylation of Rac/cdc42, profillin, ERK1/2 and P70S6K. Conclusions The NKP may offer a novel therapeutic target in breast cancer patients who have developed metastasis, aiming to improve therapeutic outcomes and enhance survival rate.	[Khajah, Maitham A.; Mathew, Princy M.; Luqmani, Yunus A.] Kuwait Univ, Fac Pharm, Safat, Kuwait	Kuwait University	Khajah, MA (corresponding author), Kuwait Univ, Fac Pharm, Safat, Kuwait.	maitham@hsc.edu.kw	Khajah, Maitham/AAZ-8841-2020		Kuwait University [PT01/14];  [SRUL02/13]	Kuwait University; 	This work was supported by Kuwait University Research Sector grant PT01/14 (MAK). Parts of this work were supported by grant SRUL02/13 to the Research Unit for Genomics, Proteomics and Cellomics Studies (OMICS), Kuwait University.	Abramowitz J, 2003, CIRCULATION, V108, P3048, DOI 10.1161/01.CIR.0000101919.00548.86; ACKERMANN U, 1990, FEBS LETT, V269, P105, DOI 10.1016/0014-5793(90)81130-G; Aizman O, 2003, ANN NY ACAD SCI, V986, P489, DOI 10.1111/j.1749-6632.2003.tb07233.x; Aizman O, 2001, P NATL ACAD SCI USA, V98, P13420, DOI 10.1073/pnas.221315298; Al Saleh S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020610; Al Saleh S, 2011, INT J ONCOL, V38, P1197, DOI 10.3892/ijo.2011.942; Alevizopoulos K, 2014, CURR DRUG TARGETS, V15, P988, DOI 10.2174/1389450115666140908125025; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Blok LJ, 1999, BRIT J CANCER, V81, P28, DOI 10.1038/sj.bjc.6690647; Bogdanov A, 2017, F1000RES, V6; Chauhan NB, 1997, J MOL NEUROSCI, V9, P151, DOI 10.1007/BF02800498; Contreras RG, 1999, J CELL SCI, V112, P4223; Espineda C, 2003, CANCER-AM CANCER SOC, V97, P1859, DOI 10.1002/cncr.11267; Ferrandi M, 2014, J PHARMACOL EXP THER, V351, P278, DOI 10.1124/jpet.114.217133; Fu Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/628064; Goncalves-de-Albuquerque CF, 2017, MOLECULES, V22, DOI 10.3390/molecules22040578; Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200; Ho HT, 2011, J PHYSIOL-LONDON, V589, P4697, DOI 10.1113/jphysiol.2011.210005; Huang YT, 2004, BIOCHEM PHARMACOL, V67, P727, DOI 10.1016/j.bcp.2003.10.013; Khajah MA, 2015, INT J ONCOL, V46, P1685, DOI 10.3892/ijo.2015.2884; Khajah MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076327; Khajah MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041847; Khundmiri SJ, 2006, AM J PHYSIOL-CELL PH, V291, P28; Kometiani P, 2005, MOL PHARMACOL, V67, P929, DOI 10.1124/mol.104.007302; Li ZC, 2009, PFLUG ARCH EUR J PHY, V457, P635, DOI 10.1007/s00424-008-0470-0; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; Liu N, 2013, ONCOL LETT, V6, P475, DOI 10.3892/ol.2013.1406; Liu X, 1997, EUR J PHARMACOL, V327, P151, DOI 10.1016/S0014-2999(97)89654-9; Luqmani YA, 2009, INT J ONCOL, V34, P231, DOI 10.3892/ijo_00000145; Miyakawa-Naito A, 2003, J BIOL CHEM, V278, P50355, DOI 10.1074/jbc.M305378200; Mohammadi K, 2003, J CARDIOVASC PHARM, V41, P609, DOI 10.1097/00005344-200304000-00014; Ozdemir A, 2015, ARCH PHARM RES, V38, P1897, DOI 10.1007/s12272-015-0597-4; Pongrakhananon V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068623; Rajasekaran AK, 2003, ANN NY ACAD SCI, V986, P649, DOI 10.1111/j.1749-6632.2003.tb07276.x; Rajasekaran SA, 2003, ANN NY ACAD SCI, V986, P652, DOI 10.1111/j.1749-6632.2003.tb07277.x; Rajasekaran SA, 1999, J UROLOGY, V162, P574, DOI 10.1016/S0022-5347(05)68629-6; Rajasekaran SA, 2003, AM J PHYSIOL-CELL PH, V284, P5; Saunders R, 2004, EUR J BIOCHEM, V271, P1054, DOI 10.1111/j.1432-1033.2004.04012.x; Simpson CD, 2009, CANCER RES, V69, P2739, DOI 10.1158/0008-5472.CAN-08-2530; Sorsa T, 2004, MOL CELL BIOCHEM, V266, P87, DOI 10.1023/B:MCBI.0000049141.37823.19; Strasser-Weippl K, 2005, J CLIN ONCOL, V23, P1751, DOI 10.1200/JCO.2005.11.038; Sweadner KJ, 2000, BIOCHEM BIOPH RES CO, V279, P196, DOI 10.1006/bbrc.2000.3907; THOMAS GP, 1986, BRIT J PHARMACOL, V89, P385, DOI 10.1111/j.1476-5381.1986.tb10271.x; THOMAS GP, 1991, BRIT J PHARMACOL, V104, P995, DOI 10.1111/j.1476-5381.1991.tb12539.x; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Tian J, 2009, J BIOL CHEM, V284, P14921, DOI 10.1074/jbc.M808355200; Tsimaratos M, 2001, CELL MOL BIOL, V47, P239; Winnicka K, 2008, BIOL PHARM BULL, V31, P1131, DOI 10.1248/bpb.31.1131; Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x; Yeh JY, 2001, J UROLOGY, V166, P1937, DOI 10.1016/S0022-5347(05)65724-2; Yuan YS, 2014, JARO-J ASSOC RES OTO, V15, P31, DOI 10.1007/s10162-013-0419-7; Schneider NFZ, 2017, MOLECULES, V22, DOI 10.3390/molecules22111932	54	24	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193779	10.1371/journal.pone.0193779	http://dx.doi.org/10.1371/journal.pone.0193779			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590154	gold, Green Published, Green Submitted			2022-12-26	WOS:000428603100031
J	Zhen, XM; Li, YY; Chen, YX; Dong, P; Liu, S; Dong, HJ				Zhen, Xuemei; Li, Yuanyuan; Chen, Yixi; Dong, Peng; Liu, Stephanie; Dong, Hengjin			Effect of multiple drug resistance on total medical costs among patients with intra-abdominal infections in China	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; CLINICAL CHARACTERISTICS; KLEBSIELLA-PNEUMONIAE; RISK-FACTORS; IMPACT; MANAGEMENT; ORGANISMS; BACTERIA; OUTCOMES	Background Multiple drug resistant (MDR) intra-abdominal infections (IAls) are associated with notable direct and societal costs. As previous studies have not considered the impact of MDR on the total medical costs (TMCs) of lAls, the present one examines this, as well as further estimates the additional costs at a national level. Methods This is a retrospective study. Firstly, we randomly selected a sample of 40% of all inpatients discharged between 2014 and 2015 from a teaching hospital, due to limits in budget and the large number of patients. Then, we manually selected 254 patients with lAls according to the International Classification of Disease, 10th revision, using electronic medical records. Eventually, 101 patients with lAls (64 MDR patients and 37 non-MDR patients) were included after excluding cases without laboratory test results, any pathogens detected, or antimicrobial resistant pathogens. Univariate analysis and a generalized linear model were applied to assess the parameters associated with TMCs. Results Compared to non-MDR patients, those with MDR pathogens were significantly associated with higher TMCs, higher antimicrobial costs, higher antimicrobial usage, larger number of pathogens, and longer length of stay and were more likely to have insurance and combination antimicrobial therapy. In addition, the average TMC among patients with MDR pathogens was 131801, which is 90201 higher than those without MDR pathogens. If our results are applied to the whole country, the sum of all attributable TMCs was 37 billion. The societal costs, furthermore, were Y111 billion in 2015. Conclusion Our results provide information that should lead to increased efforts to reduce inappropriate antimicrobial therapy, in order to decrease the emergence of MDR pathogens and to reduce their economic burden.	[Zhen, Xuemei; Li, Yuanyuan; Liu, Stephanie; Dong, Hengjin] Zhejiang Univ, Sch Med, Sch Publ Hlth, Ctr Hlth Policy Studies, Hangzhou, Zhejiang, Peoples R China; [Chen, Yixi; Dong, Peng] Pfizer Investment Co Ltd, Beijing, Peoples R China	Zhejiang University; Pfizer	Dong, HJ (corresponding author), Zhejiang Univ, Sch Med, Sch Publ Hlth, Ctr Hlth Policy Studies, Hangzhou, Zhejiang, Peoples R China.	donghj@zju.edu.cn		Dong, Hengjin/0000-0002-5064-7297	Pfizer Investment Co. Ltd.; Pfizer Investment Co. Ltd., Beijing China	Pfizer Investment Co. Ltd.; Pfizer Investment Co. Ltd., Beijing China	This study was supported by Pfizer Investment Co. Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; It is acknowledged that in the data collection we obtained valuable help from the Center for Health Policy Studies, Zhejiang University School of Medicine. This study was funded by Pfizer Investment Co. Ltd., Beijing China. The views expressed in this paper are those of the authors and not the Pfizer Investment Co. Ltd. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Blot S, 2002, CLIN INFECT DIS, V34, P1600, DOI 10.1086/340616; Burns A. S., 2017, J NEUROTRAUMA; Carson JG, 2008, SURG INFECT, V9, P15, DOI 10.1089/sur.2006.081; Chong YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119956; Chusri S, 2015, J INFECT CHEMOTHER, V21, P90, DOI 10.1016/j.jiac.2014.10.002; Geue C, 2016, AGE AGEING, V45, P376, DOI 10.1093/ageing/afw040; Grau S, 2015, APPL HEALTH ECON HEA, V13, P369, DOI 10.1007/s40258-015-0162-9; Hsueh PR, 2010, INT J ANTIMICROB AG, V35, P94, DOI 10.1016/j.ijantimicag.2009.09.004; Hu BJ, 2010, CURR MED RES OPIN, V26, P1443, DOI 10.1185/03007991003769068; Hu FP, 2016, CLIN MICROBIOL INFEC, V22, pS9, DOI 10.1016/j.cmi.2016.01.001; Jean SS, 2014, INT J ANTIMICROB AG, V44, P222, DOI 10.1016/j.ijantimicag.2014.05.018; Jiao Y, 2015, PATHOG GLOB HEALTH, V109, P68, DOI 10.1179/2047773215Y.0000000004; Judd WR, 2016, AM J INFECT CONTROL, V44, P1275, DOI 10.1016/j.ajic.2016.04.218; Lee YR, 2015, DRUGS, V75, P2097, DOI 10.1007/s40265-015-0506-7; MAULDIN PD, 1994, AM J CARDIOL, V74, P772, DOI 10.1016/0002-9149(94)90432-4; Menichetti F, 2013, J CHEMOTHERAPY, V21, P3; Mutters NT, 2016, J HOSP INFECT, V93, P191, DOI 10.1016/j.jhin.2016.02.013; National Health and Family Planning Commission of the People's Republic of China, 2016, STAT B DEV HLTH FAM; ONeill Jim, 2015, INT EC J ONEILL VISI; Ouyang WW, 2016, INT J ANTIMICROB AG, V47, P210, DOI 10.1016/j.ijantimicag.2015.12.019; Paterson DL, 2001, J CLIN MICROBIOL, V39, P2206, DOI 10.1128/JCM.39.6.2206-2212.2001; Pogue JM, 2015, CLIN MICROBIOL INFEC, V21, P302, DOI 10.1016/j.cmi.2014.12.025; Sartelli M, 2015, SURG INFECT, V16, P213, DOI 10.1089/sur.2013.262; Sartelli M, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-37; Sartelli M, 2012, WORLD J GASTROENTERO, V18, P865, DOI 10.3748/wjg.v18.i9.865; Stone PW, 2005, AM J INFECT CONTROL, V33, P501, DOI 10.1016/j.ajic.2005.04.246; Syue LS, 2016, INT J ANTIMICROB AG, V47, P250, DOI 10.1016/j.ijantimicag.2015.12.021; Tan X, 2016, J CLIN PHARM THER, V41, P524, DOI 10.1111/jcpt.12430; Tansarli GS, 2013, EXPERT REV ANTI-INFE, V11, P321, DOI [10.1586/eri.13.4, 10.1586/ERI.13.4]; World Health Organisation, 2009, MED US PRIM HLTH CAR; World Health Organization, 2014, WHAT IS ANT RES; World Health Organization, 2014, ANT RES; World Health Organization (WHO), 2014, WHOS 1 GLOB REP ANT; Wu DD, 2011, SOUTH MED J, V104, P106, DOI 10.1097/SMJ.0b013e318206063d; Zhang H, 2016, ANTIMICROB AGENTS CH, V60, P245, DOI 10.1128/AAC.00956-15	36	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193977	10.1371/journal.pone.0193977	http://dx.doi.org/10.1371/journal.pone.0193977			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590138	Green Published, gold, Green Submitted			2022-12-26	WOS:000428603100042
J	Masumoto, H; Matsuyama, S				Masumoto, Hiroshi; Matsuyama, Shigeru			The combination of NAD(+)-dependent deacetylase gene deletion and the interruption of gluconeogenesis causes increased glucose metabolism in budding yeast	PLOS ONE			English	Article							IONIZATION MASS-SPECTROMETRY; SACCHAROMYCES-CEREVISIAE; FLUX ANALYSIS; TCA CYCLE; ACETYLATION; GENOME; FAMILY	Metabolic engineering focuses on rewriting the metabolism of cells to enhance native products or endow cells with the ability to produce new products. This engineering has the potential for wide-range application, including the production of fuels, chemicals, foods and pharmaceuticals. Glycolysis manages the levels of various secondary metabolites by controlling the supply of glycolytic metabolites. Metabolic reprogramming of glycolysis is expected to cause an increase in the secondary metabolites of interest. In this study, we constructed a budding yeast strain harboring the combination of triple sirtuin gene deletion (hst3 Delta, hst4 Delta sir2 Delta) and interruption of gluconeogenesis by the deletion of the FBP1 gene encoding fructose-1,6-bisphosphatase (fbp1 Delta). hst3 Delta hst4 Delta sir2 Delta fbp1 Delta cells harbored active glycolysis with high glucose consumption and active ethanol productivity. Using capillary electrophoresis time-of-flight mass spectrometry (CE TOF/MS) analysis, hst3 Delta hst4 Delta sir2 Delta fbp1 Delta cells accumulated not only glycolytic metabolites but also secondary metabolites, including nucleotides that were synthesized throughout the pentose phosphate (PP) pathway, although various amino acids remained at low levels. Using the stable isotope labeling assay for metabolites, we confirmed that hst3 Delta hst4 Delta sir2 Delta fbp1 Delta cells directed the metabolic fluxes of glycolytic metabolites into the PP pathway. Thus, the deletion of three sirtuin genes (HST3, HST4 and SIR2) and the FBP1 gene can allow metabolic reprogramming to increase glycolytic metabolites and several secondary metabolites except for several amino acids.	[Masumoto, Hiroshi] Natl Inst Genet, Transdisciplinary Res Integrat Ctr, 1111 Yata, Mishima, Shizuoka, Japan; [Matsuyama, Shigeru] Univ Tsukuba, Fac Life & Environm Sci, 1-1-1 Tennoudai, Tsukuba, Ibaraki, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Tsukuba	Masumoto, H (corresponding author), Natl Inst Genet, Transdisciplinary Res Integrat Ctr, 1111 Yata, Mishima, Shizuoka, Japan.	himasumo@nagasaki-u.ac.jp	Matsuyama, Shigeru/AAC-1955-2020	Matsuyama, Shigeru/0000-0003-2673-5673	NIG Collaborative Research Program [2016-A1-2]; Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government	NIG Collaborative Research Program; Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government	This work was supported by NIG Collaborative Research Program (2016-A1-2) and Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government.	Anderson KA, 2017, CELL METAB, V25, P838, DOI 10.1016/j.cmet.2017.03.003; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Blank LM, 2004, MICROBIOL-SGM, V150, P1085, DOI 10.1099/mic.0.26845-0; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Brown G.W., 2015, METHODS YEAST GENETI; Buijs NA, 2013, CURR OPIN CHEM BIOL, V17, P480, DOI 10.1016/j.cbpa.2013.03.036; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Chen SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aal3655; Coyle WT., 2010, NEXT GENERATION BIOF; Devantier R, 2005, BIOTECHNOL BIOENG, V90, P703, DOI 10.1002/bit.20457; Devic S, 2016, J CANCER, V7, P817, DOI 10.7150/jca.14274; Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x; Fraenkel D. G., 2011, YEAST INTERMEDIARY M; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hachinohe M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054011; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Lee CS, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0013-2014; Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Nielsen J, 2016, CELL, V164, P1185, DOI 10.1016/j.cell.2016.02.004; Noronha SB, 2000, BIOTECHNOL BIOENG, V68, P316, DOI 10.1002/(SICI)1097-0290(20000505)68:3<316::AID-BIT10>3.0.CO;2-2; Potter M, 2016, BIOCHEM SOC T, V44, P1499, DOI 10.1042/BST20160094; Salway J.G., 2017, METABOLISM GLANCE; Sauer U, 2004, CURR OPIN BIOTECH, V15, P58, DOI 10.1016/j.copbio.2003.11.001; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Steen EJ, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-36; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Wiechert W, 2001, METAB ENG, V3, P195, DOI 10.1006/mben.2001.0187; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang C, 2002, METAB ENG, V4, P202, DOI 10.1006/mben.2002.0226; Zamboni N, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-209; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58	36	7	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194942	10.1371/journal.pone.0194942	http://dx.doi.org/10.1371/journal.pone.0194942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579121	gold, Green Published, Green Submitted			2022-12-26	WOS:000428351800067
J	Matsuzaki, R; Nozaki, H; Kawachi, M				Matsuzaki, Ryo; Nozaki, Hisayoshi; Kawachi, Masanobu			Taxonomic revision of Chloromonas nivalis (Volvocales, Chlorophyceae) strains, with the new description of two snow-inhabiting Chloromonas species	PLOS ONE			English	Article							COMB-NOV CHLOROPHYTA; UPSTATE NEW-YORK; MOLECULAR PHYLOGENY; LIFE-HISTORY; GEN. NOV; ELECTRON-MICROSCOPY; WINDMILL ISLANDS; ALGA; ITS2; MOUNTAINS	Chloromonas nivalis (Volvocales, Chlorophyceae) is considered a cosmopolitan species of a snow-inhabiting microalga because cysts morphologically identifiable as zygotes of the species are distributed worldwide. However, recent molecular data demonstrated that field-collected cysts identified as the zygotes consist of multiple species. Recently, we demonstrated that species identification of snow-inhabiting Chloromonas species is possible based on light and electron microscopy of asexual life cycles in strains and molecular phylogenetic analyses. Vegetative cells without eyespots and of inverted-teardrop shape have been reported once in North American material of C. nivalis; however, strains with such vegetative cells in snow-inhabiting species of Chloromonas have not been examined taxonomically in detail. Here, we used light and transmission electron microscopy together with molecular analyses of multiple DNA sequences to examine several C. nivalis strains. The morphological data demonstrated that one North American strain could be identified as C. nivalis, whereas three other strains should be re-classified as C. hoshawii sp. nov. and C. remiasii sp. nov. based on vegetative cell morphology, the number of zoospores within the parental cell wall during asexual reproduction, and whether cell aggregates (resulting from repeated divisions of daughter cells retained within a parental cell wall) were observed in the culture. This taxonomic treatment was supported by multigene phylogeny and comparative molecular analyses that included a rapidly evolving DNA region. Our molecular phylogenetic analyses also demonstrated that the North American strain of C. nivalis was phylogenetically separated from the Austrian and Japanese specimens previously identified as C. nivalis based on zygote morphology.	[Matsuzaki, Ryo; Kawachi, Masanobu] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan; [Nozaki, Hisayoshi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan	National Institute for Environmental Studies - Japan; University of Tokyo	Matsuzaki, R (corresponding author), Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan.	matsuzaki.ryo@nies.go.jp		Matsuzaki, Ryo/0000-0002-8989-5933	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI [15H06148, 16J09828]; Grants-in-Aid for Scientific Research [25304012] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	RM was supported by Grants-in-Aid for Research Activity Start-up (No. 15H06148) and JSPS Research Fellow (No. 16J09828) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI (https://www.jsps.go.jp/english/e-grants/). The funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	[Anonymous], 2017, UTEX CULT COLL ALG; [Anonymous], 2016, CULT COLL CRYOPH ALG; Brabez R, 1941, ZUM BOT CENTRALB A S, V61, P13; Chodat R., 1902, BEITR KRYPTOGAMENFL, VI, P1; Coleman AW, 2007, NUCLEIC ACIDS RES, V35, P3322, DOI 10.1093/nar/gkm233; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Coleman AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5; Ettl H, 1983, SUSSWASSERFLORA MITT, V9; Ettl H., 1970, NOVA HEDWIGIA S, V34, P1; HOHAM R W, 1975, Phycologia, V14, P213, DOI 10.2216/i0031-8884-14-4-213.1; Hoham R.W., 1980, Developments in Marine Biology, V2, P61; HOHAM R W, 1977, Phycologia, V16, P53, DOI 10.2216/i0031-8884-16-1-53.1; Hoham RW, 2008, ARCT ANTARCT ALP RES, V40, P355, DOI 10.1657/1523-0430(07-038)[HOHAM]2.0.CO;2; Hoham Ronald W., 2001, P168; HOHAM RW, 1983, CAN J BOT, V61, P2416, DOI 10.1139/b83-266; HOHAM RW, 1978, PHYCOLOGIA, V17, P106, DOI 10.2216/i0031-8884-17-1-106.1; Hoham RW, 2006, PHYCOLOGIA, V45, P319, DOI 10.2216/04-103.1; Hoham RW, 2002, J PHYCOL, V38, P1051, DOI 10.1046/j.1529-8817.2002.t01-1-01227.x; HOHAM RW, 1979, PHYCOLOGIA, V18, P55, DOI 10.2216/i0031-8884-18-1-55.1; HOSHAW RW, 1966, J PHYCOL, V2, P93, DOI 10.1111/j.1529-8817.1966.tb04600.x; HOSHAW RW, 1988, PHYCOLOGIA, V27, P511, DOI 10.2216/i0031-8884-27-4-511.1; Kawachi M., 2013, MCC NIES LIST STRAIN; Kirjakov IK, 2016, INT J FISHERIES AQUA, V4, P94; Kol E, 1968, BINNENGEWASSER, P1; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Leya T, 2004, THESIS; Ling HU, 1998, POLAR BIOL, V20, P320, DOI 10.1007/s003000050309; Ling HU, 1996, HYDROBIOLOGIA, V336, P99, DOI 10.1007/BF00010823; Lukavsky J, 2010, ACTA BOT CROAT, V69, P163; MARCHANT HJ, 1982, PHYCOLOGIA, V21, P178, DOI 10.2216/i0031-8884-21-2-178.1; Matsuzaki R, 2015, PHYCOLOGIA, V54, P491, DOI 10.2216/15-33.1; Matsuzaki R, 2014, PHYCOLOGIA, V53, P293, DOI 10.2216/14-3.1; Matsuzaki R, 2013, PHYCOLOGIA, V52, P239, DOI 10.2216/12-083.1; Matsuzaki R, 2012, PHYCOLOGIA, V51, P74, DOI 10.2216/11-18.1; Muller T, 1998, POLAR BIOL, V20, P14, DOI 10.1007/s003000050272; Muramoto K, 2008, CYTOLOGIA, V73, P91, DOI 10.1508/cytologia.73.91; Muramoto K, 2010, EUR J PHYCOL, V45, P27, DOI 10.1080/09670260903272607; Nakada T, 2008, J PHYCOL, V44, P751, DOI 10.1111/j.1529-8817.2008.00525.x; Nakada T, 2008, MOL PHYLOGENET EVOL, V48, P281, DOI 10.1016/j.ympev.2008.03.016; Nakada T, 2016, J PHYCOL, V52, P283, DOI 10.1111/jpy.12397; Nakada T, 2009, J PHYCOL, V45, P482, DOI 10.1111/j.1529-8817.2009.00652.x; Nozaki H, 2003, MOL PHYLOGENET EVOL, V29, P58, DOI 10.1016/S1055-7903(03)00089-7; Nozaki H, 2002, J MOL EVOL, V55, P414, DOI 10.1007/s00239-002-2338-9; Nozaki H, 2010, J PHYCOL, V46, P195, DOI 10.1111/j.1529-8817.2009.00773.x; Peterfi S, 1939, B JARDIN MUSEE BOT U, V19, P87; Playfair G. I., 1918, Proceedings of the Linnean Society of New South Wales, V43; Prochazkova L, 2018, FOTTEA, V18, P1, DOI 10.5507/fot.2017.010; Proschold T, 2001, PROTIST, V152, P265, DOI 10.1078/1434-4610-00068; Remias D, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw030; Remias D, 2013, ANTARCT SCI, V25, P648, DOI 10.1017/S0954102013000060; Remias D, 2010, PROTOPLASMA, V243, P73, DOI 10.1007/s00709-010-0123-y; Schultz J, 2005, RNA, V11, P361, DOI 10.1261/rna.7204505; Schultz J, 2009, MOL PHYLOGENET EVOL, V52, P520, DOI 10.1016/j.ympev.2009.01.008; Seibel PN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-490; Seibel Philipp N, 2008, BMC Res Notes, V1, P91, DOI 10.1186/1756-0500-1-91; STARR RC, 1993, J PHYCOL, V29, P1, DOI 10.1111/j.0022-3646.1993.00001.x; Sugasawa M, 2015, PHYCOLOGIA, V54, P342, DOI 10.2216/15-27.1; Wawrik F., 1974, Nova Hedwigia, V25, P665; Wille N., 1903, Nyt Magazin for Naturvidenskaberne, Vxli, P89	59	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2018	13	3							e0193603	10.1371/journal.pone.0193603	http://dx.doi.org/10.1371/journal.pone.0193603			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA2QK	29570718	Green Published, gold, Green Submitted			2022-12-26	WOS:000428168400005
J	Ghilamicael, AM; Boga, HI; Anami, SE; Mehari, T; Budambula, NLM				Ghilamicael, Amanuel Menghs; Boga, Hamadi Iddi; Anami, Sylvester Elikana; Mehari, Tadesse; Budambula, Nancy L. M.			Potential human pathogenic bacteria in five hot springs in Eritrea revealed by next generation sequencing	PLOS ONE			English	Article							LEGIONELLA-PNEUMOPHILA; SOFT-TISSUE; INFECTIONS; DIVERSITY; EPIDEMIOLOGY; PREVALENCE; OUTBREAK; BRUCELLA; CULTURE; AREAS	Human pathogens can survive and grow in hot springs. For water quality assessment, Escherichia coli or Enterococci are the main thermotolerant enteric bacteria commonly used to estimate the load of pathogenic bacteria in water. However, most of the environmental bacteria are unculturable thus culture methods may cause bias in detection of most pathogens. Illumina sequencing can provide a more comprehensive and accurate insight into environmental bacterial pathogens, which can be used to develop better risk assessment methods and promote public health awareness. In this study, high-throughput Illumina sequencing was used to identify bacterial pathogens from five hot springs; Maiwooi, Akwar, Garbanabra, Elegedi and Gelti, in Eritrea. Water samples were collected from the five hot springs. Total community DNA was extracted from samples using the phenol-chloroform method. The 16S rRNA gene variable region (V4-V7) of the extracted DNA was amplified and library construction done according to Illumina sequencing protocol. The sequence reads (length >200 bp) from Illumina sequencing libraries ranged from 22,091 sequences in the wet sediment sample from Garbanabra to 155,789 sequences in the mat sample from Elegedi. Taxonomy was assigned to each OTU using BLASTn against a curated database derived from GreenGenes, RDPII, SILVA SSU Reference 119 and NCBI. The proportion of potential pathogens from the water samples was highest in Maiwooi (17.8%), followed by Gelti (16.7%), Akwar (13.6%) and Garbanabra (10.9%). Although the numbers of DNA sequence reads from Illumina sequencing were very high for the Elegedi (104,328), corresponding proportion of potential pathogens very low (3.6%). Most of the potential pathogenic bacterial sequences identified were from Proteobacteria and Firmicutes. Legionella and Clostridium were the most common detected genera with different species. Most of the potential pathogens were detected from the water samples. However, sequences belonging to Clostridium were observed more abundantly from the mat samples. This study employed high-throughput sequencing technologies to determine the presence of pathogenic bacteria in the five hot springs in Eritrea.	[Ghilamicael, Amanuel Menghs; Anami, Sylvester Elikana] Jomo Kenyatta Univ Agr & Technol, Inst Biotechnol Res, Nairobi, Kenya; [Boga, Hamadi Iddi] Taita Taveta Univ, Taita, Kenya; [Mehari, Tadesse] Natl Commiss Higher Educ Eritrea, Asmera, Eritrea; [Budambula, Nancy L. M.] Univ Embu, Embu, Kenya	Jomo Kenyatta University of Agriculture & Technology	Ghilamicael, AM (corresponding author), Jomo Kenyatta Univ Agr & Technol, Inst Biotechnol Res, Nairobi, Kenya.	amenghs@gmail.com	Anami, Sylvester/P-2740-2019; Budambula, Nancy/W-2391-2019	Budambula, Nancy/0000-0001-8093-2702	Japan International Cooperation Agency	Japan International Cooperation Agency	This work was supported by Japan International Cooperation Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldape MJ, 2006, CLIN INFECT DIS, V43, P1436, DOI 10.1086/508866; Amala S. E., 2016, Natural Science, V8, P79, DOI 10.4236/ns.2016.83010; Ayandele AA., 2015, IOSR J ENV SCI TOXIC, V9, P2319, DOI [10.9790/2402-09812530, DOI 10.9790/2402-09812530]; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chan CS, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00177; Collado L, 2011, CLIN MICROBIOL REV, V24, P174, DOI 10.1128/CMR.00034-10; Dallal M M Soltan, 2014, J Prev Med Hyg, V55, P27; Danaher PJ, 2011, MIL MED, V176, P1444, DOI 10.7205/MILMED-D-11-00211; de Figueiredo P, 2015, AM J PATHOL, V185, P1505, DOI 10.1016/j.ajpath.2015.03.003; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Diaz JH, 2014, J TRAVEL MED, V21, P207, DOI 10.1111/jtm.12115; Dizbay M, 2009, J INFECT DEV COUNTR, V3, P273; GOLD WL, 1993, CLIN INFECT DIS, V16, P69, DOI 10.1093/clinids/16.1.69; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P8, DOI 10.2174/1874285801004010008; Harb M, 2017, ENVIRON SCI POLLUT R, V24, P5370, DOI 10.1007/s11356-016-8211-y; Hsu BM, 2006, WATER RES, V40, P3267, DOI 10.1016/j.watres.2006.07.007; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Ibekwe AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079490; Kambura AK, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0748-x; Khajanchi BK, 2010, APPL ENVIRON MICROB, V76, P2313, DOI 10.1128/AEM.02535-09; Kostic T., 2012, MICROARRAYS, V1, P3; Kumaraswamy R, 2014, ENVIRON SCI TECHNOL; Kuroki T, 2017, EMERG INFECT DIS, V23, P349, DOI 10.3201/eid2302.161012; Kuroki T, 2009, JPN J INFECT DIS, V62, P201; Leoni E, 2001, WATER RES, V35, P3749, DOI 10.1016/S0043-1354(01)00075-6; Martson BJ, 1999, ARH INT MED J, V157, P1709; Masoud G, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5427-8; Oksanen A. J, 2016, PACKAGE VEGAN VERSIO; Osei-Adjei G., 2014, Journal of Natural Sciences Research, V4, P126; Pappas G, 2006, CELL MOL LIFE SCI, V63, P2229, DOI 10.1007/s00018-006-6311-4; R Core Team, 2018, R LANG ENV STAT COMP; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Sambrok J.A. D.W.R., 2001, MOL CLONING LAB MANU, V3rd; Savichtcheva O, 2006, WATER RES, V40, P2463, DOI 10.1016/j.watres.2006.04.040; Shen SM, 2015, PATHOG GLOB HEALTH, V109, P236, DOI 10.1179/2047773215Y.0000000023; Spring S, 2003, INT J SYST EVOL MICR, V53, P1019, DOI 10.1099/ijs.0.02554-0; Straub TM, 2003, J MICROBIOL METH, V53, P185, DOI 10.1016/S0167-7012(03)00023-X; Thorolfsdottir BOT, 2013, INT J ENV RES PUB HE, V10, P1085, DOI 10.3390/ijerph10031085; Vally H, 2004, CLIN INFECT DIS, V38, P1084, DOI 10.1086/382876; Vartoukian SR, 2010, FEMS MICROBIOL LETT, V309, P1, DOI 10.1111/j.1574-6968.2010.02000.x; VERISSIMO A, 1991, APPL ENVIRON MICROB, V57, P2921; Weingart OG, 2010, APPL ENVIRON MICROB, V76, P3293, DOI 10.1128/AEM.02937-09; Whiley H., 2017, INT J ENV RES PUBLIC, V14; Ramirez-Castillo FY, 2015, PATHOGENS, V4, P307, DOI 10.3390/pathogens4020307; Yohannes E, 2010, GEOTHERMAL EXPLORATI; Yu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038183; Zhang L, 2017, INT J ENV RES PUBLIC, V14; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188	48	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194554	10.1371/journal.pone.0194554	http://dx.doi.org/10.1371/journal.pone.0194554			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566040	Green Published, Green Submitted, gold			2022-12-26	WOS:000428093900076
J	Santos, EB; Shemilt, S; de Carvalho, CAL; Martin, SJ				Santos, Eliaber B.; Shemilt, Sue; de Carvalho, Carlos A. L.; Martin, Stephen J.			Life history and chemical ecology of the Warrior wasp Synoeca septentrionalis (Hymenoptera: Vespidae, Epiponini)	PLOS ONE			English	Article							CUTICULAR HYDROCARBONS; APIS-MELLIFERA; EUSOCIAL WASP; RECOGNITION; NESTMATE; ALKENES; PROFILES	Swarm-founding 'Warrior wasps' (Synoeca spp.) are found throughout the tropical regions of South America, are much feared due to their aggressive nest defence and painful sting. There are only five species of Synoeca, all construct distinctive nests that consist of a single sessile comb built onto the surface of a tree or rock face, which is covered by a ribbed envelope. Although locally common, research into this group is just starting. We studied eight colonies of Synoeca septentrionalis, a species recently been described from Brazil. A new colony is established by a swarm of 52 to 140 adults that constructs a colony containing around 200 brood cells. The largest colony collected containing 865 adults and over 1400 cells. The number of queen's present among the eight colonies varied between 3 and 58 and no clear association between colony development and queen number was detected. Workers and queens were morphologically indistinguishably, but differences in their cuticular hydrocarbons were detected, particularly in their (Z)-9-alkenes. The simple cuticular profile, multiple queens, large size and small number of species makes the 'Warrior wasps' an excellent model group for further chemical ecology studies of swarm-founding wasps.	[Santos, Eliaber B.; de Carvalho, Carlos A. L.] Univ Fed Reconcavo Bahia, Rua Rui Barbosa 710, Cruz Das Almas, BA, Brazil; [Shemilt, Sue] Keele Univ, Lennard Jones Lab, Sch Phys & Geog Sci, Chem Ecol Grp, Keele, Staffs, England; [Martin, Stephen J.] Univ Salford, Sch Environm & Life Sci, Manchester, Lancs, England	Universidade Federal do Reconcavo da Bahia; Keele University; University of Manchester; University of Salford	Martin, SJ (corresponding author), Univ Salford, Sch Environm & Life Sci, Manchester, Lancs, England.	s.j.martin@salford.ac.uk	Santos, Eliaber/N-6559-2017; Carvalho, Carlos A L/N-3321-2016	Santos, Eliaber/0000-0001-6929-0972; Carvalho, Carlos A L/0000-0002-3306-3003; Martin, Stephen/0000-0001-9418-053X	CNPq (Brazilian government) via Special Visiting Researcher-PVE [400425/2014-9]	CNPq (Brazilian government) via Special Visiting Researcher-PVE	This work was supported by CNPq (Brazilian government) via Special Visiting Researcher-PVE (400425/2014-9) to C.A.L. de Carvalho & S.J. Martin.	Andena SR, 2009, ENTOMOL AM-NY, V115, P81, DOI 10.1664/07-RA-002R.1; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; CARLSON DA, 1989, ANAL CHEM, V61, P1564, DOI 10.1021/ac00189a019; CASTELLON E G, 1980, Acta Amazonica, V10, P883; CASTELLON E G, 1980, Acta Amazonica, V10, P679; Chaline N, 2005, CHEM SENSES, V30, P327, DOI 10.1093/chemse/bji027; Dani FR, 2005, CHEM SENSES, V30, P477, DOI 10.1093/chemse/bji040; Kather R, 2015, J CHEM ECOL, V41, P871, DOI 10.1007/s10886-015-0631-5; Kelstrup HC, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0078-5; Kelstrup HC, 2014, J EXP BIOL, V217, P2399, DOI 10.1242/jeb.096750; Lorenzi MC, 2004, J INSECT PHYSIOL, V50, P935, DOI 10.1016/j.jinsphys.2004.07.005; Martin SJ, 2008, P ROYAL SOC B, V275, P1271; Martin SJ, 2018, J CHEM ECOLOGY; Martin SJ, 2017, J CHEM ECOL, V43, P1066, DOI 10.1007/s10886-017-0901-5; Martin SJ, 2010, J CHEM ECOL, V36, P855, DOI 10.1007/s10886-010-9805-3; Menezes RST, 2011, ZOOKEYS, P75, DOI 10.3897/zookeys.151.1882; Murakami ASN, 2015, SOCIOBIOLOGY, V62, P109; Nascimento FS, 2004, INSECT SOC, V51, P17, DOI 10.1007/s00040-003-0696-y; Noda SCM, 2003, SOCIOBIOLOGY, V41, P547; Noll F. B., 2004, AM MUSEUM NOVITATES, P1; OVERAL WL, 1982, J GEORGIA ENTOMOL SO, V17, P1; Oxley PR, 2014, CURR BIOL, V24, P451, DOI 10.1016/j.cub.2014.01.018; Panek LM, 2001, ETHOLOGY, V107, P55, DOI 10.1046/j.1439-0310.2001.00633.x; Poiani SB, 2017, CAN J ZOOL, V95, P453, DOI 10.1139/cjz-2016-0102; Richards O. W., 1978, SOCIAL WASPAM EXCL; Ross K, 1991, NATURE; SANTOS Cristiano Sousa dos, 2009, THESIS, P99; STARR CK, 1985, J ENTOMOL SCI, V20, P225, DOI 10.18474/0749-8004-20.2.225; Menezes RST, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119151; WESTEBERHARD MJ, 1978, SCIENCE, V200, P441, DOI 10.1126/science.200.4340.441	30	5	5	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194689	10.1371/journal.pone.0194689	http://dx.doi.org/10.1371/journal.pone.0194689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566087	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000428093900094
J	Kim, HY; Kim, YH; Yun, G; Chang, W; Lee, YJ; Kim, B				Kim, Hae Young; Kim, Young Hoon; Yun, Gabin; Chang, Won; Lee, Yoon Jin; Kim, Bohyoung			Could texture features from preoperative CT image be used for predicting occult peritoneal carcinomatosis in patients with advanced gastric cancer?	PLOS ONE			English	Article							INTRAPERITONEAL CHEMOTHERAPY; TUMOR HETEROGENEITY; METASTASES; SURVIVAL; METAANALYSIS; PARAMETERS; BIOMARKER; THERAPY; LIVER	Purpose To retrospectively investigate whether texture features obtained from preoperative CT images of advanced gastric cancer (AGC) patients could be used for the prediction of occult peritoneal carcinomatosis (PC) detected during operation. Materials and methods 51 AGC patients with occult PC detected during operation from January 2009 to December 2012 were included as occult PC group. For the control group, other 51 AGC patients without evidence of distant metastasis including PC, and whose clinical T and N stage could be matched to those of the patients of the occult PC group, were selected from the period of January 2011 to July 2012. Each group was divided into test (n = 41) and validation cohort (n = 10). Demographic and clinical data of these patients were acquired from the hospital database. Texture features including average, standard deviation, kurtosis, skewness, entropy, correlation, and contrast were obtained from manually drawn region of interest (ROI) over the omentum on the axial CT image showing the omentum at its largest cross sectional area. After using Fisher's exact and Wilcoxon signed-rank test for comparison of the clinical and texture features between the two groups of the test cohort, conditional logistic regression analysis was performed to determine significant independent predictor for occult PC. Using the optimal cut-off value from receiver operating characteristic (ROC) analysis for the significant variables, diagnostic sensitivity and specificity were determined in the test cohort. The cut-off value of the significant variables obtained from the test cohort was then applied to the validation cohort. Bonferroni correction was used to adjust P value for multiple comparisons. Results Between the two groups, there was no significant difference in the clinical features. Regarding the texture features, the occult PC group showed significantly higher average, entropy, standard deviation, and significantly lower correlation (P value < 0.004 for all). Conditional logistic regression analysis demonstrated that entropy was significant independent predictor for occult PC. When the cut-off value of entropy (> 7.141) was applied to the validation cohort, sensitivity and specificity for the prediction of occult PC were 80% and 90%, respectively. Conclusion For AGC patients whose PC cannot be detected with routine imaging such as CT, texture analysis may be a useful adjunct for the prediction of occult PC.	[Kim, Hae Young; Kim, Young Hoon; Yun, Gabin; Chang, Won; Lee, Yoon Jin] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Dept Radiol,Bundang Hosp,Coll Med, Seoul, South Korea; [Kim, Bohyoung] Hankuk Univ Foreign Studies, Div Biomed Engn, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Hankuk University Foreign Studies	Kim, YH (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Dept Radiol,Bundang Hosp,Coll Med, Seoul, South Korea.	yhkrad@gmail.com		Kim, Hae Young/0000-0002-9508-4280				Bang YJ, 2010, LANCET, V376, P1302; Bashir U, 2016, AM J ROENTGENOL, V207, P534, DOI 10.2214/AJR.15.15864; Bilici A, 2014, WORLD J GASTROENTERO, V20, P3905, DOI 10.3748/wjg.v20.i14.3905; Coakley FV, 2002, RADIOLOGY, V223, P495, DOI 10.1148/radiol.2232011081; Coccolini F, 2014, EJSO-EUR J SURG ONC, V40, P12, DOI 10.1016/j.ejso.2013.10.019; Davnall F, 2012, INSIGHTS IMAGING, V3, P573, DOI 10.1007/s13244-012-0196-6; De Bree E, 2004, J SURG ONCOL, V86, P64, DOI 10.1002/jso.20049; FUKUYA T, 1995, RADIOLOGY, V197, P705, DOI 10.1148/radiology.197.3.7480743; Ganeshan B, 2007, CLIN RADIOL, V62, P761, DOI 10.1016/j.crad.2007.03.004; Ganeshan B, 2012, CLIN RADIOL, V67, P157, DOI 10.1016/j.crad.2011.08.012; Ganeshan B, 2013, RADIOLOGY, V266, P326, DOI 10.1148/radiol.12112428; Ganeshan B, 2011, INVEST RADIOL, V46, P160, DOI 10.1097/RLI.0b013e3181f8e8a2; Ganeshan B, 2009, EUR J RADIOL, V70, P101, DOI 10.1016/j.ejrad.2007.12.005; Giganti F, 2017, EUR J RADIOL, V90, P129, DOI 10.1016/j.ejrad.2017.02.043; Giganti F, 2017, EUR RADIOL, V27, P1831, DOI 10.1007/s00330-016-4540-y; Ji ZH, 2016, TRANSL GASTROENT HEP, V1, DOI 10.21037/tgh.2016.08.03; Kim SJ, 2009, RADIOLOGY, V253, P407, DOI 10.1148/radiol.2532082272; La Yun B, 2014, KOREAN J RADIOL, V15, P591, DOI 10.3348/kjr.2014.15.5.591; Liu SL, 2017, EUR RADIOL, V27, P4951, DOI 10.1007/s00330-017-4881-1; Lordick F, 2013, LANCET ONCOL, V14, P490, DOI 10.1016/S1470-2045(13)70102-5; Miles KA, 2013, CANCER IMAGING, V13, P400, DOI 10.1102/1470-7330.2013.9045; Nelson DA, 2004, GENE DEV, V18, P2095, DOI 10.1101/gad.1204904; Ng F, 2013, RADIOLOGY, V266, P177, DOI 10.1148/radiol.12120254; Niekel MC, 2010, RADIOLOGY, V257, P674, DOI 10.1148/radiol.10100729; Ryu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108335; Sadeghi B, 2000, CANCER-AM CANCER SOC, V88, P358, DOI 10.1002/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O; Thomassen I, 2014, INT J CANCER, V134, P622, DOI 10.1002/ijc.28373; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Yang DY, 2011, J GASTROINTEST ONCOL, V2, P77, DOI 10.3978/j.issn.2078-6891.2010.025; Yip C, 2014, RADIOLOGY, V270, P141, DOI 10.1148/radiol.13122869; Yoon SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152690	31	15	17	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194755	10.1371/journal.pone.0194755	http://dx.doi.org/10.1371/journal.pone.0194755			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596522	gold, Green Published, Green Submitted			2022-12-26	WOS:000428630000040
J	Thwala, SBP; Blaauw, D; Ssengooba, F				Thwala, Siphiwe Bridget Pearl; Blaauw, Duane; Ssengooba, Freddie			Measuring the preparedness of health facilities to deliver emergency obstetric care in a South African district	PLOS ONE			English	Article							MATERNAL MORTALITY; AVAILABILITY; INDICATORS; SERVICES; QUALITY; BARRIERS; ZAMBIA; GHANA	Background Improving the delivery of emergency obstetric care (EmNOC) remains critical in addressing direct causes of maternal mortality. United Nations (UN) agencies have promoted standard methods for evaluating the availability of EmNOC facilities although modifications have been proposed by others. This study presents an assessment of the preparedness of public health facilities to provide EmNOC using these methods in one South African district with a persistently high maternal mortality ratio. Methods Data collection took place in the final quarter of 2014. Cross-sectional surveys were conducted to classify the 7 hospitals and 8 community health centres (CHCs) in the district as either basic EmNOC (BEmNOC) or comprehensive EmNOC (CEmNOC) facilities using UN EmNOC signal functions. The required density of EmNOC facilities was calculated using UN norms. We also assessed the availability of EmNOC personnel, resuscitation equipment, drugs, fluids, and protocols at each facility. The workload of skilled EmNOC providers at hospitals and CHCs was compared. Results All 7 hospitals in the district were classified as CEmNOC facilities, but none of the 8 CHCs performed all required signal functions to be classified as BEmNOC facilities. UN norms indicated that 25 EmNOC facilities were required for the district population, 5 of which should be CEmNOCs. None of the facilities had 100% of items on the EmNOC checklists. Hospital midwives delivered an average of 36.4 +/- 14.3 deliveries each per month compared to only 7.9 +/- 3.2 for CHC midwives (p<0.001). Conclusions The analysis indicated a shortfall of EmNOC facilities in the district. Full EmNOC services were centralised to hospitals to assure patient safety even though national policy guidelines sanction more decentralisation to CHCs. Studies measuring EmNOC availability need to consider facility opening hours, capacity and staffing in addition to the demonstrated performance of signal functions.	[Thwala, Siphiwe Bridget Pearl; Blaauw, Duane] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Ctr Hlth Policy, Johannesburg, South Africa; [Thwala, Siphiwe Bridget Pearl] Univ Swaziland, Fac Hlth Sci, Mbabane, Swaziland; [Ssengooba, Freddie] Makerere Univ, Sch Publ Hlth, Kampala, Uganda	University of Witwatersrand; Makerere University	Thwala, SBP (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Ctr Hlth Policy, Johannesburg, South Africa.; Thwala, SBP (corresponding author), Univ Swaziland, Fac Hlth Sci, Mbabane, Swaziland.	siphiwe.thwala2@wits.ac.za		Thwala, Siphiwe Bridget Pearl/0000-0002-6528-584X				Admasu K, 2011, INT J GYNECOL OBSTET, V115, P101, DOI 10.1016/j.ijgo.2011.07.010; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; AMDD, MOD 5 EMOC SIGN FUNC; Banke-Thomas A, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.31880; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Blaauw D, 2010, MATERNAL HLTH; Bosomprah S, 2016, INT J GYNECOL OBSTET, V132, P130, DOI 10.1016/j.ijgo.2015.11.004; Campbell OMR, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0872-5; Chiang CF, 2013, NAGOYA J MED SCI, V75, P225; Collender G, 2012, TROP MED INT HEALTH, V17, P694, DOI 10.1111/j.1365-3156.2012.02983.x; Dickson KE, 2014, LANCET, V384, P438, DOI 10.1016/S0140-6736(14)60582-1; Dippenaar J, 2015, HUMAN RESOURCES; DoH, 2015, MAT CAR GUID S AFR M; [DoH Health NDo], 2015, MAT CAR GUID S AFR; Douangphachanh X, 2010, BIOSCI TRENDS, V4, P318; Duysburgh E, 2013, TROP MED INT HEALTH, V18, P534, DOI 10.1111/tmi.12076; Echoka E, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-113; EPMM Working Group, 2015, STRAT END PREV MAT M; Gabrysch S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001340; Gabrysch S, 2011, INT J GYNECOL OBSTET, V114, P174, DOI 10.1016/j.ijgo.2011.05.007; Gabrysch S, 2011, TROP MED INT HEALTH, V16, P627, DOI 10.1111/j.1365-3156.2011.02741.x; Gilbert J., 2002, EXPLANATION OPF CURR; Greenfield D., 2006, 25 C PRIOR PER NAT C; Greenfield DH, 2006, 25 C PRIOR PER CAR 7; Kalaba FK, 2016, FOREST POLICY ECON, V69, P40, DOI 10.1016/j.forpol.2016.04.004; Kruk ME, 2016, LANCET GLOB HEALTH, V4, pE845, DOI [10.1016/s2214-109x(16)30180-2, 10.1016/S2214-109X(16)30180-2]; Larson E, 2017, INT J QUAL HEALTH C, V29, P104, DOI 10.1093/intqhc/mzw141; Liyew EF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179013; Lohela TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052110; Makhudu M, 2014, STATUS PRIMARY HLTH; Massyn N, 2016, TUBERCULOSIS; Massyn N, DISTRICT HLTH BAROME; Massyn N, 2015, DISTRICT HLTH BAROME; Mbonye AK, 2007, INT J GYNECOL OBSTET, V96, P220, DOI 10.1016/j.ijgo.2006.12.017; Mercer S, 2006, BIOMED CENTRAL, V3; Mezie-Okoye M. M., 2012, African Journal of Reproductive Health, V16, P170; Mezie-Okoye Margaret M, 2012, Afr J Reprod Health, V16, P171; Munoz C, 2016, INT J PUBLIC HEALTH; NCCEMD, 2012, SAV MOTH 2008 2010 5; NCCEMD, 2014, SAV MOTH 2011 2013 6; Pattinson RC, 2015, SAMJ S AFR MED J, V105, P261, DOI [10.7196/SAMJ.9182, 10.7196/samj.9182]; Pattinson RC, 2015, SAMJ S AFR MED J, V105, P256, DOI [10.7196/SAMJ.9181, 10.7196/samj.9181]; Pattinson RC, 2014, SAVING BABIES 2012 2; Paxton A, 2006, INT J GYNECOL OBSTET, V93, P300, DOI 10.1016/j.ijgo.2006.01.030; Paxton A, 2005, INT J GYNECOL OBSTET, V88, P181, DOI 10.1016/j.ijgo.2004.11.026; Roozbeh N, 2016, SAUDI MED J, V37, P1319, DOI 10.15537/smj.2016.12.15505; Roy R, 2017, PLOS ONE, V12; STATSSA, 2015, MILL DEV GOALS 5 IMP; STATSSA, 2015, CENS 2011 FERT S AFR; UNFPA/UNICEF, 2020, TECHN NOT GEND TRANS; United Nations, 2015, DEP EC SOC AFF POP D; van Schaik N., 2015, DISTRICT HLTH BAROME; Wichaidit W, 2016, AM J TROP MED HYG, V95, P298, DOI 10.4269/ajtmh.15-0350; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization (WHO); UNFPA; UNICEF; Columbia University. Mailman School of Public Health, 2009, MON EM OBST CAR HDB; Zariba A, 2009, BMC HEALTH SERV RES, V46, DOI [10.1186/472-6963-9-46, DOI 10.1186/472-6963-9-46]	57	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194576	10.1371/journal.pone.0194576	http://dx.doi.org/10.1371/journal.pone.0194576			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596431	Green Published, Green Submitted, gold			2022-12-26	WOS:000428630000032
J	Eichinger, S; Eischer, L; Sinkovec, H; Wittgruber, G; Traby, L; Kammer, M; Kyrie, PA; Steinbrecher, O; Kaloud, H; Kyrie, V; Moser, H; Wildburger, R				Eichinger, Sabine; Eischer, Lisbeth; Sinkovec, Hana; Wittgruber, Gabriela; Traby, Ludwig; Kammer, Michael; Kyrie, Paul A.; Steinbrecher, Oskar; Kaloud, Herbert; Kyrie, Victoria; Moser, Hartwig; Wildburger, Renate			Risk of venous thromboembolism during rehabilitation of patients with spinal cord injury	PLOS ONE			English	Article							ORAL ANTICOAGULANTS; TRAUMA; THROMBOPROPHYLAXIS; PROPHYLAXIS; THROMBOSIS; ENOXAPARIN; COHORT; SURGERY; PHASE	Background Patients with spinal cord injury (SCI) are at risk of thrombosis and bleeding. Data on the risks during rehabilitation are inconsistent, and thromboprophylactic strategies are heterogeneous. We aimed to evaluate the thrombotic risk and bleeding events of SCI patients during rehabilitation. Methods We retrospectively collected hospital record data of 263 consecutive SCI patients admitted at a rehabilitation clinic. 78 patients with acute venous thromboembolism (VTE) at the primary center, without acute trauma or lower extremity paresis, less than one month rehabilitation, or reasons for long-term therapeutic anticoagulation, were excluded. All patients received pharmacologic thromboprophylaxis throughout rehabilitation. Primary endpoint was objectively diagnosed VTE; secondary endpoint was bleeding. Results Of 185 patients, 162 (88%) were men; mean age was 47.8 years. 94 patients were tetraplegic, 91 paraplegic. During a mean (SD) time of 5.1 2.1 months, VTE was diagnosed in 8 patients. After excluding five patients with VTE detected within 2 days after admission, the probability of developing VTE after 6 months of rehabilitation was 2% (95% CI 0-4.4%). Only high D-Dimer upon admission was associated with risk of VTE (adjusted HR 2.3, 95% CI 1.4-4.1). Of 24 bleedings, 14 (64%) occurred at the heparin injection site. Two patients had major bleeding and five had clinically relevant non major bleeding. Conclusion SCI patients are at risk of VTE and bleeding during rehabilitation. Strategies need to be developed to identify these patients in order to initiate adequate anticoagulation. Direct oral anticoagulants, which have a favourable risk-benefit profile and are convenient, should be explored.	[Eichinger, Sabine; Eischer, Lisbeth; Traby, Ludwig; Kyrie, Paul A.; Steinbrecher, Oskar; Kyrie, Victoria] Med Univ Vienna, Dept Med 1, Vienna, Austria; [Eichinger, Sabine; Kyrie, Paul A.] Karl Landsteiner Inst Clin Thrombosis Res, Vienna, Austria; [Sinkovec, Hana; Kammer, Michael] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria; [Wittgruber, Gabriela; Kaloud, Herbert; Moser, Hartwig; Wildburger, Renate] Allgemeine Unfallversicherungsanstalt Rehabil Cli, Tobelbad, Austria	Medical University of Vienna; Medical University of Vienna	Eichinger, S (corresponding author), Med Univ Vienna, Dept Med 1, Vienna, Austria.; Eichinger, S (corresponding author), Karl Landsteiner Inst Clin Thrombosis Res, Vienna, Austria.	sabine.eichinger@meduniwien.ac.at	Traby, Ludwig/ABC-2338-2020	Traby, Ludwig/0000-0003-2861-5771; , Sabine/0000-0003-1135-4878; Kammer, Michael/0000-0003-4821-9928	Allgemeine Unfallversicherungsanstalt [FK 16/14]	Allgemeine Unfallversicherungsanstalt	Funded by Allgemeine Unfallversicherungsanstalt FK 16/14 (RW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabed S, 2016, ASIAN SPINE J, V10, P972, DOI 10.4184/asj.2016.10.5.972; [Anonymous], 2016, TOP SPINAL CORD INJ, V22, P209, DOI [10.1310/sci2203-209, DOI 10.1310/SCI2203-209]; Chiou-Tan FY, 2003, AM J PHYS MED REHAB, V82, P678, DOI 10.1097/01.PHM.0000083671.27501.47; Chung WS, 2014, THROMB RES, V133, P579, DOI 10.1016/j.thromres.2014.01.008; DeVivo MJ, 1999, ARCH PHYS MED REHAB, V80, P1411, DOI 10.1016/S0003-9993(99)90252-6; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Godat LN, 2015, J TRAUMA ACUTE CARE, V78, P475, DOI 10.1097/TA.0000000000000556; Green D, 2003, AM J PHYS MED REHAB, V82, P950, DOI 10.1097/01.PHM.0000098043.88979.BA; Heinze G, 2001, BIOMETRICS, V57, P114, DOI 10.1111/j.0006-341X.2001.00114.x; Hoffmeyer P, 2017, ORTHOPEDICS, V40, P109, DOI 10.3928/01477447-20161116-05; Jones T, 2005, ARCH PHYS MED REHAB, V86, P2240, DOI 10.1016/j.apmr.2005.07.286; Kadyan V, 2003, J SPINAL CORD MED, V26, P231, DOI 10.1080/10790268.2003.11753689; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Mackiewicz-Milewska M, 2016, J SPINAL CORD MED, V39, P400, DOI 10.1179/2045772315Y.0000000032; Marciniak CM, 2012, PM&R, V4, P11, DOI 10.1016/j.pmrj.2011.10.007; Merli G, 2003, J TRAUMA, V54, P1111, DOI 10.1097/01.TA.0000042159.90102.C2; Monzon DG, 2012, J EMERG MED, V43, P612, DOI 10.1016/j.jemermed.2011.09.006; National Spinal Cord Injury Statistical Center, COMPL PUBL VERS 2016; Pierfranceschi MG, 2013, THROMB HAEMOSTASIS, V109, P34, DOI 10.1160/TH12-06-0390; Piran S, 2016, THROMB RES, V147, P97, DOI 10.1016/j.thromres.2016.09.030; Ploumis A, 2009, J BONE JOINT SURG AM, V91A, P2568, DOI 10.2106/JBJS.H.01411; Ploumis A, 2009, SPINE J, V9, P530, DOI 10.1016/j.spinee.2009.01.008; Quinlan DJ, 2013, BEST PRACT RES CL HA, V26, P171, DOI 10.1016/j.beha.2013.07.003; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; van Es N, 2014, BLOOD, V124, P1968, DOI [10.1182/blood-2014-04571232, 10.1182/blood-2014-04-571232]	27	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193735	10.1371/journal.pone.0193735	http://dx.doi.org/10.1371/journal.pone.0193735			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590126	gold, Green Submitted, Green Published			2022-12-26	WOS:000428603100027
J	Woldesemayat, AA; Modise, DM; Gemeildien, J; Ndimba, BK; Christoffels, A				Woldesemayat, Adugna Abdi; Modise, David M.; Gemeildien, Junaid; Ndimba, Bongani K.; Christoffels, Alan			Cross-species multiple environmental stress responses: An integrated approach to identify candidate genes for multiple stress tolerance in sorghum (Sorghum bicolor (L.) Moench) and related model species	PLOS ONE			English	Article							DROUGHT TOLERANCE; PLANT; EXPRESSION; ONTOLOGY; TOOL; QTL; IDENTIFICATION; DUPLICATION; ASSOCIATION; ANNOTATION	Background Crop response to the changing climate and unpredictable effects of global warming with adverse conditions such as drought stress has brought concerns about food security to the fore; crop yield loss is a major cause of concern in this regard. Identification of genes with multiple responses across environmental stresses is the genetic foundation that leads to crop adaptation to environmental perturbations. Methods In this paper, we introduce an integrated approach to assess candidate genes for multiple stress responses across-species. The approach combines ontology based semantic data integration with expression profiling, comparative genomics, phylogenomics, functional gene enrichment and gene enrichment network analysis to identify genes associated with plant stress phenotypes. Five different ontologies, viz., Gene Ontology (GO), Trait Ontology (TO), Plant Ontology (PO), Growth Ontology (GRO) and Environment Ontology (EO) were used to semantically integrate drought related information. Results Target genes linked to Quantitative Trait Loci (QTLs) controlling yield and stress tolerance in sorghum (Sorghum bicolor (L.) Moench) and closely related species were identified. Based on the enriched GO terms of the biological processes, 1116 sorghum genes with potentialheat (8%) and oxidative stress (25%) were identified to be over-expressed. Out of 169 sorghum drought responsive QTLs associated genes that were identified based on expression datasets, 56% were shown to have multiple stress responses. On the other hand, out of 168 additional genes that have been evaluated for orthologous pairs, 90% were conserved across species for drought tolerance. Over 50% of identified maize and rice genes were responsive to drought and salt stresses and were co-located within multifunctional QTLs. Among the total identified multi-stress responsive genes, 272 targets were shown to be co localized within QTLs associated with different traits that are responsive to multiple stresses. Ontology mapping was used to validate the identified genes, while reconstruction of the phylogenetic tree was instrumental to infer the evolutionary relationship of the sorghum orthologs. The results also show specific genes responsible for various interrelated components of drought response mechanism such as drought tolerance, drought avoidance and drought escape. Conclusions We submit that this approach is novel and to our knowledge, has not been used previously in any other research; it enables us to perform cross-species queries for genes that are likely to be associated with multiple stress tolerance, as a means to identify novel targets for engineering stress resistance in sorghum and possibly, in other crop species.	[Woldesemayat, Adugna Abdi; Gemeildien, Junaid; Christoffels, Alan] Univ Western Cape, South African Natl Bioinformat Inst, South African Med Res Council, Bioinformat Unit, Bellville, South Africa; [Woldesemayat, Adugna Abdi] Univ South Africa, Coll Agr & Environm Sci, Dept Life & Consumer Sci, Sci Campus, Johannesburg, South Africa; [Modise, David M.] Univ South Africa, Coll Agr & Environm Sci, Dept Agr & Anim Hlth, Sci Campus, Johannesburg, South Africa; [Ndimba, Bongani K.] Univ Western Cape, Dept Biotechnol, Cape Town, Western Cape, South Africa; [Ndimba, Bongani K.] Infruitech Nietvoorbij, Agr Res Council, Stellenbosch, South Africa	South African Medical Research Council; University of the Western Cape; University of South Africa; University of South Africa; University of the Western Cape; Agricultural Research Council of South Africa	Woldesemayat, AA (corresponding author), Univ Western Cape, South African Natl Bioinformat Inst, South African Med Res Council, Bioinformat Unit, Bellville, South Africa.; Woldesemayat, AA (corresponding author), Univ South Africa, Coll Agr & Environm Sci, Dept Life & Consumer Sci, Sci Campus, Johannesburg, South Africa.	woldeaa@unisa.ac.za		Woldesemayat, Adugna Abdi/0000-0002-0704-1636	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation of South Africa; University of the Western Cape; University of South Africa	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation of South Africa(National Research Foundation - South Africa); University of the Western Cape; University of South Africa	This work is based on the research supported by the South African Research Chairs Initiative of the Department of Science and Technology (www.dst.gov.za) and National Research Foundation of South Africa (http:/www..nrf.ac.za/). AC received funding. The University of the Western Cape and the University of South Africa also provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work is based on the research supported by the South African Research Chairs Initiative of the Department of Science and Technology (www.dst.gov.za) and National Research Foundation of South Africa (http://www.nrf.ac.za/). The University of the Western Cape and the University of South Africa also provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anjum SA, 2011, AFR J AGR RES, V6, P2026; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Blake JA, 2012, NUCLEIC ACIDS RES, V40, pD559, DOI 10.1093/nar/gkr1028; Bolser D, 2016, METHODS MOL BIOL, V1374, P115, DOI 10.1007/978-1-4939-3167-5_6; Breitling R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-181; Brown GR, 2015, NUCLEIC ACIDS RES, V43, pD36, DOI 10.1093/nar/gku1055; Cantoro R, 2016, EUPHYTICA, V211, P41, DOI 10.1007/s10681-016-1717-z; Cattivelli L, 2008, FIELD CROP RES, V105, P1, DOI 10.1016/j.fcr.2007.07.004; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cooper L, 2013, PLANT CELL PHYSIOL, V54, pE1, DOI 10.1093/pcp/pcs163; Cooper M, 2016, CROP SCI, V56, P2141, DOI 10.2135/cropsci2015.08.0512; Daraselia N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-243; Das M, 2016, PLANT PHYSIOL, V171, P2343, DOI 10.1104/pp.15.01207; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dugas DV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-514; Farber CR, 2009, J BONE MINER RES, V24, P105, DOI 10.1359/JBMR.080908; Fracasso A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0800-x; Gabaldon T, 2013, NAT REV GENET, V14, P360, DOI 10.1038/nrg3456; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hernandez KM, 2015, NEW PHYTOL, V208, P1, DOI 10.1111/nph.13607; Hivrale V, 2016, PLANT SCI, V242, P214, DOI 10.1016/j.plantsci.2015.07.018; Huang LY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1026; Ilic K, 2007, PLANT PHYSIOL, V143, P587, DOI 10.1104/pp.106.092825; Joung JG, 2009, PLANT PHYSIOL, V151, P1758, DOI 10.1104/pp.109.145169; Kakumanu A, 2012, PLANT PHYSIOL, V160, P846, DOI 10.1104/pp.112.200444; Kattge J, 2011, METHODS ECOL EVOL, V2, P202, DOI 10.1111/j.2041-210X.2010.00067.x; Kebede H, 2001, THEOR APPL GENET, V103, P266, DOI 10.1007/s001220100541; Krannich CT, 2015, INT J MOL SCI, V16, P16378, DOI 10.3390/ijms160716378; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Gall Hyacinthe, 2015, Plants-Basel, V4, P112, DOI 10.3390/plants4010112; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Lynch M, 2004, TRENDS GENET, V20, P544, DOI 10.1016/j.tig.2004.09.001; Mace ES, 2012, THEOR APPL GENET, V124, P97, DOI 10.1007/s00122-011-1690-9; Makarova KS, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-33; Makita Y, 2015, PLANT CELL PHYSIOL, V56, DOI 10.1093/pcp/pcu187; Monaco MK, 2014, NUCLEIC ACIDS RES, V42, pD1193, DOI 10.1093/nar/gkt1110; Narain P, 2010, MOL BREEDING, V26, P135, DOI 10.1007/s11032-010-9406-4; Ni JJ, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap005; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Oliveros JC, 2014, VENNY INTERACTIVE TO; Ongom PO, 2016, FIELD CROP RES, V198, P312, DOI 10.1016/j.fcr.2016.03.015; Pandey P, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00537; Pandey P, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00723; Proost S, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1861-z; Pujar A, 2006, PLANT PHYSIOL, V142, P414, DOI 10.1104/pp.106.085720; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Ramegowda V, 2015, J PLANT PHYSIOL, V176, P47, DOI 10.1016/j.jplph.2014.11.008; Rensing SA, 2014, CURR OPIN PLANT BIOL, V17, P43, DOI 10.1016/j.pbi.2013.11.002; Ruprecht C, 2017, PLANT J, V90, P447, DOI 10.1111/tpj.13502; Sabadin PK, 2012, THEOR APPL GENET, V124, P1389, DOI 10.1007/s00122-012-1795-9; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shaar-Moshe L, 2017, PLANT PHYSIOL, V174, P421, DOI 10.1104/pp.17.00030; Shaik R, 2014, PLANT PHYSIOL, V164, P481, DOI 10.1104/pp.113.225862; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shirdelmoghanloo H, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0784-6; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Snel B, 2002, P NATL ACAD SCI USA, V99, P5890, DOI 10.1073/pnas.092632599; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sukumaran S, 2016, CROP SCI, V56, P1429, DOI 10.2135/cropsci2015.02.0097; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tian T, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw099; Tiffin N, 2011, METHODS MOL BIOL, V760, P175, DOI 10.1007/978-1-61779-176-5_11; Varshney RK, 2014, THEOR APPL GENET, V127, P445, DOI 10.1007/s00122-013-2230-6; Woldesemayat AA, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0584-5; Youens-Clark K, 2011, NUCLEIC ACIDS RES, V39, pD1085, DOI 10.1093/nar/gkq1148; Yue B, 2006, GENETICS, V172, P1213, DOI 10.1534/genetics.105.045062; ZHANG LF, 2017, PLANT SYST EVOL, V110, P1; Zhou Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146242; Zyla J, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1674-0	75	5	5	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0192678	10.1371/journal.pone.0192678	http://dx.doi.org/10.1371/journal.pone.0192678			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590108	Green Published, gold, Green Submitted			2022-12-26	WOS:000428603100008
J	Harikrishnan, S; Sarma, S; Sanjay, G; Jeemon, P; Krishnan, MN; Venugopal, K; Mohanan, PP; Jeyaseelan, L; Thankappanl, KR; Zachariah, G				Harikrishnan, S.; Sarma, Smitha; Sanjay, G.; Jeemon, P.; Krishnan, M. N.; Venugopal, K.; Mohanan, P. P.; Jeyaseelan, L.; Thankappanl, K. R.; Zachariah, G.			Prevalence of metabolic syndrome and its risk factors in Kerala, South India: Analysis of a community based cross-sectional study	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; TYPE-2 DIABETES-MELLITUS; CARDIOVASCULAR-DISEASE; DEFINITION; STATEMENT; DIAGNOSIS	Background Coronary Artery Disease (CAD) is a leading cause of death and disability in Kerala, India. Metabolic syndrome (MS) is a constellation of established risk factors for CAD. We aimed to estimate the prevalence of MS and evaluate the association between MS and CAD using a community-based sample population. Methods A cross-sectional community based survey was conducted in urban and rural areas of Kerala in 2011. We included 5063 individuals for analysis. Age standardized prevalence of MS, associated diagnoses (hypertension, diabetes and hypercholesterolemia) and other potential risk factors were assessed for men and women in both urban and rural locations. Univariate and multivariate logistic regression models were developed to identify participant characteristics that are associated with MS. Results After standardization for age and adjustment for sex and urban-rural distribution, the prevalence of metabolic syndrome in Kerala was 24%, 29% and 33% for the NCEP ATP III, IDF and AHA/NHLBI Harmonization definitions, respectively. The mean (SD) age of the participants was 51 (14) years, and 60% were women. Women had a higher prevalence of MS than men (28% versus 20% for ATP III, p<0.001). Similarly, participants living in urban areas had higher prevalence of MS than their rural counterparts (26% versus 22%, p<0.001). Elevated body mass index, older age, and female sex were associated with MS in an adjusted multivariate model. The propensity for definite CAD was 1.7 times higher in individuals with MS defined based on ATP III criteria compared to those without MS (Adjusted OR = 1.69; 95% CI: 1.3-2.2, p<0.001). Conclusions One of four to one of three adult individuals in Kerala have MS based on different criteria. Higher propensity for CAD in individuals with MS in Kerala calls for urgent steps to prevent and control the burden of metabolic conditions.	[Harikrishnan, S.; Sanjay, G.; Thankappanl, K. R.] Sree Chitra Tirunal Inst Med Sci & Technol, Dept Cardiol, Thiruvananthapuram, Kerala, India; [Sarma, Smitha] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Jeemon, P.] Sree Chitra Tirunal Inst Med Sci & Technol, Achutha Menon Ctr Hlth Sci Studies, Thiruvananthapuram, Kerala, India; [Krishnan, M. N.] Govt Med Coll, Dept Cardiol, Kozhikode, Kerala, India; [Venugopal, K.] Pushpagiri Hosp, Dept Cardiol, Kottayam, Kerala, India; [Mohanan, P. P.] Wesffort High Tech Hosp, Dept Cardiol, Trichur, Kerala, India; [Jeyaseelan, L.] Christian Med Coll & Hosp, Dept Biostat, Vellore, Tamil Nadu, India; [Zachariah, G.] Mother Hosp, Dept Cardiol, Trichur, Kerala, India	Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); Northwestern University; Feinberg School of Medicine; Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); Christian Medical College & Hospital (CMCH) Vellore	Harikrishnan, S (corresponding author), Sree Chitra Tirunal Inst Med Sci & Technol, Dept Cardiol, Thiruvananthapuram, Kerala, India.	drharikrishnan@outlook.com	S, Harikrishnan/AAT-8083-2021; SOUNDRARAJAN, JOYSON/I-1779-2019	Bhaumik, Smitha/0000-0002-2981-9293; , KR/0000-0002-4536-2684; Jeemon, Panniyammakal/0000-0003-4172-4307; Harikrishnan, Sivadasanpillai/0000-0001-8754-4243	Cardiological Society of India, Kerala Chapter	Cardiological Society of India, Kerala Chapter	The study was funded exclusively by the Cardiological Society of India, Kerala Chapter; this is the professional organization of cardiologists in this region. The funders had no role in the design, data collection, analysis or interpretation or writing up of the article.	Ahmad OB, 2001, PAPER SERIES GENEVA, V31, P1; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Althoff T, 2017, NATURE, V547, P336, DOI 10.1038/nature23018; [Anonymous], 2005, OBESITY METABOLISM, DOI [10.14341/2071-8713-4854, DOI 10.14341/2071-8713-4854]; [Anonymous], 2000, WHO TECHN REP SER; Eckel RH, 2014, CIRCULATION, V129, pS76, DOI 10.1161/01.cir.0000437740.48606.d1; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Government of Kerala, 2015, ANN VIT STAT REP; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180; Krauss RM, 2001, J NUTR, V131, P132, DOI 10.1093/jn/131.1.132; Krishnan MN, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0189-3; Menon VU, 2006, DIABETES RES CLIN PR, V74, P289, DOI 10.1016/j.diabres.2006.03.025; Prabhakaran D, 2007, CHRONIC ILLN, V3, P8, DOI 10.1177/1742395307079197; Prineas RJ., 2009, MINNESOTA CODE MANUA; Raman Kutty V, 1999, Ethn Health, V4, P231; Ranasinghe P, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4041-1; Rose G, 1982, CARDIOVASCULAR SURVE; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Sathish T, 2012, PUBLIC HEALTH, V126, P25, DOI 10.1016/j.puhe.2011.11.002; Sebastian N. M., 2016, International Journal of Medical Science and Public Health, V5, P2041; Soman CR, 2011, ASIA-PAC J PUBLIC HE, V23, P896, DOI 10.1177/1010539510365100; Thankappan KR, 2015, J HYPERTENS, V33, pE9, DOI 10.1097/01.hjh.0000469749.88501.33; Thankappan KR, 2010, INDIAN J MED RES, V131, P53; Vijayakumar G, 2009, J Assoc Physicians India, V57, P563; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; World Health Organization, 2008, WHO STEPS MAN WHO ST; Zachariah Geevar, 2013, Indian Heart J, V65, P243, DOI 10.1016/j.ihj.2013.04.008; Zachariah Manu G, 2003, Indian Heart J, V55, P245	30	37	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0192372	10.1371/journal.pone.0192372	http://dx.doi.org/10.1371/journal.pone.0192372			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584725	Green Submitted, Green Published, gold			2022-12-26	WOS:000428373000002
J	Tributino, A; Montgomery, MC; Bertrand, T; Marak, T; Almonte, A; van den Berg, J; St John, K; Browning, C; Medina, MM; Morsel, A; Chan, PA				Tributino, Alec; Montgomery, Madeline C.; Bertrand, Thomas; Marak, Theodore; Almonte, Alexi; van den Berg, Jacob; St John, Kristen; Browning, Carol; Medina, Martha M.; Morsel, Ashley; Chan, Philip A.			Partner notification outcomes after integration of an on-site disease intervention specialist at a sexually transmitted disease clinic	PLOS ONE			English	Article							HIV INCIDENCE; MEN; SEX; CARE; STD; INFECTIONS; PREVENTION; DIAGNOSIS; RISK	Background Partner notification services (PNS) are highly effective in reducing transmission of sexually transmitted diseases (STDs). We assessed outcomes of PNS before and after integration of an on-site disease intervention specialist (DIS) at a publicly-funded STD clinic. Methods From August 2014 to December 2015, patients testing positive for infectious syphilis or gonorrhea at the Rhode Island STD Clinic were referred to on-site DIS for partner notification. Data on PNS outcomes were reviewed for eight months before integration of DIS at the clinic and compared to eight months after. Results Of the 145 index patients referred for PNS during the study period (n = 58 before DIS integration, n = 87 after), 86% were interviewed. DIS integration resulted in a significantly greater proportion of index patients interviewed overall (92% versus 76%, p<0.01), on the day of diagnosis (85% versus 61%; p<0.01), and in person at the STD clinic (64% versus 11%; p<0.01). However, there was no significant difference in number of sexual partners named or treated. Conclusions Integrating DIS at a publicly-funded STD clinic resulted in a greater number of index cases interviewed, a greater number interviewed in person, and a greater number interviewed on the day of diagnosis. Challenges remain in identifying and engaging partners for treatment.	[Tributino, Alec; Montgomery, Madeline C.; Almonte, Alexi; Medina, Martha M.; Morsel, Ashley; Chan, Philip A.] Brown Univ, Dept Med, Providence, RI 02912 USA; [Bertrand, Thomas; Marak, Theodore; St John, Kristen; Browning, Carol; Chan, Philip A.] Rhode Isl Dept Hlth, Ctr HIV Hepatitis Sexually Transmitted Dis & TB E, Providence, RI 02908 USA; [van den Berg, Jacob; Chan, Philip A.] Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI 02912 USA	Brown University; Brown University	Chan, PA (corresponding author), Brown Univ, Dept Med, Providence, RI 02912 USA.; Chan, PA (corresponding author), Rhode Isl Dept Hlth, Ctr HIV Hepatitis Sexually Transmitted Dis & TB E, Providence, RI 02908 USA.; Chan, PA (corresponding author), Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI 02912 USA.	Philip_Chan@brown.edu		Montgomery, Madeline/0000-0002-4528-1964				Althaus CL, 2014, HEALTH TECHNOL ASSES, V18, pXIX, DOI 10.3310/hta18020; Bernstein KT, 1999, J ACQ IMMUN DEF SYND, V53, P537; Bernstein KT, 2008, ARCH INTERN MED, V168, P1458, DOI 10.1001/archinte.168.13.1458; Beymer MR, 2014, SEX TRANSM INFECT, V90, P567, DOI 10.1136/sextrans-2013-051494; Centers for Disease Control and Prevention, 2014, PARTN SERV QUICKGUID; Centers for Disease Control and Prevention, 2017, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention National Network of STD/ HIV Prevention Training Centers, 2013, PASSP PARTN SERV; Chan PA, 2016, PUBLIC HEALTH REP, V131, P264, DOI 10.1177/003335491613100210; Cramer R, 2014, SEX TRANSM DIS, V41, P628, DOI 10.1097/OLQ.0000000000000187; Farley TA, 2003, PREV MED, V36, P502, DOI 10.1016/S0091-7435(02)00058-0; Ferreira A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002843.pub2; Girometti N, 2017, SEX TRANSM INFECT, V93, P320, DOI 10.1136/sextrans-2016-052865; Gorbach PM, 2000, SEX TRANSM DIS, V27, P193, DOI 10.1097/00007435-200004000-00003; Herek GM, 2009, J COUNS PSYCHOL, V56, P32, DOI 10.1037/a0014672; John SA, 2017, ARCH SEX BEHAV; Katz DA, 2016, SEX TRANSM DIS, V43, P249, DOI 10.1097/OLQ.0000000000000423; Manning Susan E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Mimiaga MJ, 2007, SEX TRANSM DIS, V34, P113, DOI 10.1097/01.olq.0000225327.13214.bf; Mimiaga MJ, 2009, PUBLIC HEALTH REP, V124, P111, DOI 10.1177/003335490912400114; Pathela P, 2015, SEX TRANSM DIS, V42, P286, DOI 10.1097/OLQ.0000000000000255; Rudy ET, 2012, SEX TRANSM DIS, V39, P701, DOI 10.1097/OLQ.0b013e3182593b51; St Lawrence JS, 2002, AM J PUBLIC HEALTH, V92, P1784, DOI 10.2105/AJPH.92.11.1784; Stephens SC, 2014, SEX TRANSM DIS, V41, P227, DOI 10.1097/OLQ.0000000000000109; Taylor MM, 2010, SEX TRANSM DIS, V37, P767, DOI 10.1097/OLQ.0b013e3181e65e8b	24	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194041	10.1371/journal.pone.0194041	http://dx.doi.org/10.1371/journal.pone.0194041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5KQ	29584743	Green Submitted, gold, Green Published			2022-12-26	WOS:000428373000011
J	Eskildsen, GA; Rovira, JR; Smith, O; Miller, MJ; Bennett, KL; McMillan, WO; Loaiza, J				Eskildsen, Gilberto A.; Rovira, Jose R.; Smith, Octavio; Miller, Matthew J.; Bennett, Kelly L.; McMillan, W. Owen; Loaiza, Jose			Maternal invasion history of Aedes aegypti and Aedes albopictus into the Isthmus of Panama: Implications for the control of emergent viral disease agents	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; POPULATION-GENETICS; VECTOR; DIPTERA; PHYLOGEOGRAPHY; SOFTWARE; SPREAD; TIGER	Despite an increase in dengue outbreaks and the arrival of chikungunya and Zika disease in Panama, studies on the demographic history of the invasive Aedes mosquitoes that are the principle vectors of these diseases are still lacking in this region. Here, we assess the genetic diversity of these mosquitoes in order to decipher their invasion histories into the Isthmus of Panama. DNA sequences from the mitochondrial cytochrome C oxidase I gene obtained from 30 localities in 10 provinces confirmed the presence of more than one mitochondrial haplogroup (i.e., maternal lineage) in each species. The invasion of Aedes albopictus was likely from temperate European countries, as the most frequent and widespread haplogroup in Panama harbored variants that are uncommon elsewhere in the Americas. Two infrequent and geographically restricted Ae. albopictus haplotypes appear to have subsequently invaded Panama from neighboring Costa Rica and the USA, respectively. In addition, we recovered two deeply divergent mitochondrial clades in Panamanian Aedes aegypti. The geographic origins of these clades is unknown, given that divergence in the mitochondrial genome is probably due to ancient population processes within the native range of Ae. aegypti, rather than due to its global expansion out of Africa. However, Panamanian Ae. aegypti mitochondrial sequences within the first Glade were closely related to others from Colombia, Bolivia, Brazil, Mexico and the USA, suggesting two separate invasions from Western Hemisphere source populations. The pattern of increased genetic diversity in Aedes mosquitoes in Panama is likely facilitated by the numerous land and water inter-connections across the country, which allows them to enter via sea- and land-transportation from Europe, North, Central and South America. Our results here should be considered in disease mitigation programs if emergent arboviruses are to be effectively diminished in Panama through vector suppression.	[Eskildsen, Gilberto A.; Rovira, Jose R.; Miller, Matthew J.; Loaiza, Jose] Inst Invest Cient & Serv Alta Tecnol, Panama City, Panama; [Eskildsen, Gilberto A.] Acharya Nagarjuna Univ, Dept Biotechnol, Guntur, India; [Rovira, Jose R.; Bennett, Kelly L.; McMillan, W. Owen; Loaiza, Jose] Smithsonian Trop Res Inst, Unit 0948, Panama City, Panama; [Smith, Octavio] Ctr Agua Trop Humedo Amer Latina & El Caribe, Panama City, Panama; [Miller, Matthew J.] Univ Oklahoma, Sam Noble Oklahoma Museum Nat Hist, Norman, OK 73019 USA; [Miller, Matthew J.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA; [Loaiza, Jose] Univ Panama, Programa Ctr Amer Maestria Entomol, Panama City, Panama	Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP); Acharya Nagarjuna University; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; Universidad de Panama	Loaiza, J (corresponding author), Inst Invest Cient & Serv Alta Tecnol, Panama City, Panama.; Loaiza, J (corresponding author), Smithsonian Trop Res Inst, Unit 0948, Panama City, Panama.; Loaiza, J (corresponding author), Univ Panama, Programa Ctr Amer Maestria Entomol, Panama City, Panama.	jloaiza@indicasat.org.pa	; Miller, Matthew/B-4560-2008	Bennett, Kelly/0000-0003-0330-5275; Miller, Matthew/0000-0002-2939-0239; Eskildsen, Gilberto A./0000-0001-8868-423X	Secretaria Nacional de Ciencia, Tecnologia e Innovacion de Panama [SENACYT- IDDS15_047]	Secretaria Nacional de Ciencia, Tecnologia e Innovacion de Panama	This work was supported by Secretaria Nacional de Ciencia, Tecnologia e Innovacion de Panama (SENACYT- IDDS15_047). http:/www.senacyt.gob.pa/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battaglia V, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00208; Bell Jonathan, 2008, Biotechniques, V44, P834, DOI 10.2144/000112890; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bennett KL, 2016, MOL ECOL, V25, P4337, DOI 10.1111/mec.13762; Birungi J, 2002, ANN ENTOMOL SOC AM, V95, P125, DOI 10.1603/0013-8746(2002)095[0125:GSOAAD]2.0.CO;2; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Bracco JE, 2007, MEM I OSWALDO CRUZ, V102, P573, DOI 10.1590/S0074-02762007005000062; Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469; Brown L, 2014, PUBLIC HEALTH, V128, P29, DOI 10.1016/j.puhe.2013.09.006; Cafferata Maria Luisa, 2013, Value Health Reg Issues, V2, P347, DOI 10.1016/j.vhri.2013.10.002; CORNEL AJ, 1991, J AM MOSQUITO CONTR, V7, P107; da Silva AG, 2012, EVOL APPL, V5, P664, DOI 10.1111/j.1752-4571.2012.00244.x; FORATTINI OP, 1986, REV SAUDE PUBL, V20, P244, DOI 10.1590/S0034-89101986000300009; Futami K, 2015, J ECON ENTOMOL, V108, P761, DOI 10.1093/jee/tou028; Gorman K, 2016, PEST MANAG SCI, V72, P618, DOI 10.1002/ps.4151; Goubert C, 2016, HEREDITY, V117, P125, DOI 10.1038/hdy.2016.35; Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Herrera F, 2006, MEM I OSWALDO CRUZ, V101, P625, DOI 10.1590/S0074-02762006000600008; Jaimes-Duenez J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003553; KAMBHAMPATI S, 1991, HEREDITY, V67, P85, DOI 10.1038/hdy.1991.67; Kamgang B, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002590; Kamgang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020257; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maynard AJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005546; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; Miller MJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003383; Moore M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002175; Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627; Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Paupy C, 2012, INFECT GENET EVOL, V12, P1260, DOI 10.1016/j.meegid.2012.04.012; Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rueda LM, 2004, ZOOTAXA, P1, DOI 10.11646/zootaxa.589.1.1; Scarpassa VM, 2008, AM J TROP MED HYG, V78, P895, DOI 10.4269/ajtmh.2008.78.895; Shaikevich E., 2013, ISRN Entomology, V2013, P157426; Shi QM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2213-6; TABACHNICK WJ, 1979, GENET RES, V34, P215, DOI 10.1017/S0016672300019467; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; Usmani- Brown S, 2009, BIOMED CENTRAL, V102, P144, DOI [https:// doi. org/ 10. 1603/ 008. 102. 0116, 10. 1603/ 008. 102. 0116, DOI 10.1186/313071016-1505-6]; Usmani-Brown S, 2009, ANN ENTOMOL SOC AM, V102, P144, DOI 10.1603/008.102.0116; Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780; Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716; Zhang RL, 2018, MITOCHONDRIAL DNA A, V29, P594, DOI 10.1080/24701394.2017.1325481	50	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194874	10.1371/journal.pone.0194874	http://dx.doi.org/10.1371/journal.pone.0194874			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579112	gold, Green Published, Green Submitted			2022-12-26	WOS:000428351800063
J	Pardikes, NA; Lumpkin, W; Hurtado, PJ; Dyer, LA				Pardikes, Nicholas A.; Lumpkin, Will; Hurtado, Paul J.; Dyer, Lee A.			Simulated tri-trophic networks reveal complex relationships between species diversity and interaction diversity	PLOS ONE			English	Article							HERBIVOROUS INSECTS; POLLINATION NETWORK; HOST-SPECIFICITY; SPECIALIZATION; ECOLOGY; BIODIVERSITY; LEPIDOPTERA; CONNECTANCE; NESTEDNESS; STABILITY	Most of earth's biodiversity is comprised of interactions among species, yet it is unclear what causes variation in interaction diversity across space and time. We define interaction diversity as the richness and relative abundance of interactions linking species together at scales from localized, measurable webs to entire ecosystems. Large-scale patterns suggest that two basic components of interaction diversity differ substantially and predictably between different ecosystems: overall taxonomic diversity and host specificity of consumers. Understanding how these factors influence interaction diversity, and quantifying the causes and effects of variation in interaction diversity are important goals for community ecology. While previous studies have examined the effects of sampling bias and consumer specialization on determining patterns of ecological networks, these studies were restricted to two trophic levels and did not incorporate realistic variation in species diversity and consumer diet breadth. Here, we developed a food web model to generate tri-trophic ecological networks, and evaluated specific hypotheses about how the diversity of trophic interactions and species diversity are related under different scenarios of species richness, taxonomic abundance, and consumer diet breadth. We investigated the accumulation of species and interactions and found that interactions accumulate more quickly; thus, the accumulation of novel interactions may require less sampling effort than sampling species in order to get reliable estimates of either type of diversity. Mean consumer diet breadth influenced the correlation between species and interaction diversity significantly more than variation in both species richness and taxonomic abundance. However, this effect of diet breadth on interaction diversity is conditional on the number of observed interactions included in the models. The results presented here will help develop realistic predictions of the relationships between consumer diet breadth, interaction diversity, and species diversity within multi-trophic communities, which is critical for the conservation of biodiversity in this period of accelerated global change.	[Pardikes, Nicholas A.; Lumpkin, Will; Hurtado, Paul J.; Dyer, Lee A.] Univ Nevada, Dept Biol, Program Ecol Evolut & Conservat Biol, Reno, NV 89557 USA; [Pardikes, Nicholas A.] Czech Acad Sci, Inst Entomol, Ceske Budejovice, Czech Republic; [Hurtado, Paul J.] Univ Nevada, Dept Math & Stat, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Nevada System of Higher Education (NSHE); University of Nevada Reno	Pardikes, NA (corresponding author), Univ Nevada, Dept Biol, Program Ecol Evolut & Conservat Biol, Reno, NV 89557 USA.; Pardikes, NA (corresponding author), Czech Acad Sci, Inst Entomol, Ceske Budejovice, Czech Republic.	n.a.pardikes@entu.cas.cz	Pardikes, Nick/O-5272-2017; Hurtado, Paul/AAE-8657-2019	Pardikes, Nick/0000-0002-9175-4494; Hurtado, Paul/0000-0002-8499-5986	Department of Defense Strategic Environmental Research and Development Program grant [RC-2243]; National Science Foundation [DEB 1344250, DEB 1442103]; Earthwatch Institute	Department of Defense Strategic Environmental Research and Development Program grant; National Science Foundation(National Science Foundation (NSF)); Earthwatch Institute	This work was made possible through funding by the Department of Defense Strategic Environmental Research and Development Program grant [RC-2243], the National Science Foundation (DEB 1344250 and DEB 1442103), and the Earthwatch Institute (http://eu.earthwatch.org/) (LAD).	[Anonymous], 1878, TROPICAL NATURE OTHE; Ballantyne G, 2015, P ROY SOC B-BIOL SCI, V282, P14, DOI 10.1098/rspb.2015.1130; BEAVER RA, 1985, ECOL ENTOMOL, V10, P241, DOI 10.1111/j.1365-2311.1985.tb00720.x; Beckerman AP, 2006, P NATL ACAD SCI USA, V103, P13745, DOI 10.1073/pnas.0603039103; Bluthgen N, 2010, BASIC APPL ECOL, V11, P185, DOI 10.1016/j.baae.2010.01.001; Burkle LA, 2012, ECOLOGY, V93, P2329, DOI 10.1890/12-0367.1; Chacoff NP, 2012, J ANIM ECOL, V81, P190, DOI 10.1111/j.1365-2656.2011.01883.x; CHAO A, 1984, SCAND J STAT, V11, P265; CORNELL HV, 1992, J ANIM ECOL, V61, P1, DOI 10.2307/5503; Darwin C., 1859, ORIGINS SPECIES MEAN; Dattilo W, 2014, BIOTROPICA, V46, P712, DOI 10.1111/btp.12157; Dormann C.F., 2008, R NEWS, V8, P8; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; Dyer Lee A., 2012, American Entomologist, V58, P15; Dyer LA, 2010, BIOTROPICA, V42, P281, DOI 10.1111/j.1744-7429.2009.00624.x; Fang Q, 2016, INTEGR ZOOL, V11, P199, DOI 10.1111/1749-4877.12190; Forister ML, 2015, P NATL ACAD SCI USA, V112, P442, DOI 10.1073/pnas.1423042112; Frund J, 2016, OIKOS, V125, P502, DOI 10.1111/oik.02256; Gibson RH, 2011, OIKOS, V120, P822, DOI 10.1111/j.1600-0706.2010.18927.x; Gonzalez-Varo JP, 2016, TRENDS ECOL EVOL, V31, P700, DOI 10.1016/j.tree.2016.06.009; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gross T, 2009, SCIENCE, V325, P747, DOI 10.1126/science.1173536; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Janzen DH., 1974, NAT HIST, V83; Jiang L, 2009, AM NAT, V173, P389, DOI 10.1086/596540; Jimenez-Alfaro B, 2016, ECOLOGY EVOLUTION; Jordan F, 2009, ECOL MODEL, V220, P3141, DOI 10.1016/j.ecolmodel.2009.05.002; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; King C, 2013, METHODS ECOL EVOL, V4, P811, DOI 10.1111/2041-210X.12074; Kruschke J. K., 2015, BEST BAYESIAN ESTIMA; Kruschke JK, 2013, J EXP PSYCHOL GEN, V142, P573, DOI 10.1037/a0029146; Lopez-Carretero A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110430; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Mougi A, 2012, SCIENCE, V337, P349, DOI 10.1126/science.1220529; Nielsen A, 2007, J ECOL, V95, P1134, DOI 10.1111/j.1365-2745.2007.01271.x; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; Novotny V, 2007, NATURE, V448, P692, DOI 10.1038/nature06021; Novotny V, 2006, SCIENCE, V313, P1115, DOI 10.1126/science.1129237; Novotny V, 2010, J ANIM ECOL, V79, P1193, DOI 10.1111/j.1365-2656.2010.01728.x; Ohgushi T, 2007, ECOLOGICAL COMMUNITI; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Peralta G, 2014, ECOLOGY, V95, P1888, DOI 10.1890/13-1569.1; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Poisot T, 2012, ECOL LETT, V15, P1353, DOI 10.1111/ele.12002; R Core Team, 2014, R A LANG ENV STAT CO; Ricklefs Robert E., 1993, P215; SAS Institute Inc, 2011, BAS SAS 9 3 PROC GUI; Schleuning M, 2012, CURR BIOL, V22, P1925, DOI 10.1016/j.cub.2012.08.015; Staniczenko PPA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00913-w; Staniczenko PPA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2422; Tewksbury JJ, 2014, BIOSCIENCE, V64, P300, DOI 10.1093/biosci/biu032; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thompson JN, 1996, TRENDS ECOL EVOL, V11, P300, DOI 10.1016/0169-5347(96)20048-5; Thompson John N., 1997, P285; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; Valdovinos FS, 2016, ECOL LETT, V19, P1277, DOI 10.1111/ele.12664; Vazquez DP, 2009, ECOLOGY, V90, P2039, DOI 10.1890/08-1837.1; Vazquez DP, 2004, ECOLOGY, V85, P1251, DOI 10.1890/03-3112; Weiher E, 2001, ECOLOGICAL ASSEMBLY; WINEMILLER KO, 1989, AM NAT, V134, P960, DOI 10.1086/285024	61	6	6	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0193822	10.1371/journal.pone.0193822	http://dx.doi.org/10.1371/journal.pone.0193822			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579077	Green Published, gold, Green Submitted			2022-12-26	WOS:000428351800014
J	Smykal, P; Trneny, O; Brus, J; Hanacek, P; Rathore, A; Das Roma, R; Pechanec, V; Duchoslav, M; Bhattacharyya, D; Bariotakis, M; Pirintsos, S; Berger, J; Toker, C				Smykal, Petr; Trneny, Oldrich; Brus, Jan; Hanacek, Pavel; Rathore, Abhishek; Das Roma, Rani; Pechanec, Vilem; Duchoslav, Martin; Bhattacharyya, Debjyoti; Bariotakis, Michalis; Pirintsos, Stergios; Berger, Jens; Toker, Cengiz			Genetic structure of wild pea (Pisum sativum subsp elatius) populations in the northern part of the Fertile Crescent reflects moderate cross-pollination and strong effect of geographic but not environmental distance	PLOS ONE			English	Article							CLIMATE-CHANGE; NICHE SHIFTS; R PACKAGE; DIVERSITY; LEGUME; EVOLUTIONARY; RELATIVES; L.; TEMPERATURE; STATISTICS	Knowledge of current genetic diversity and mating systems of crop wild relatives (CWR) in the Fertile Crescent is important in crop genetic improvement, because western agriculture began in the area after the cold-dry period known as Younger Dryas about 12,000 years ago and these species are also wild genepools of the world's most important food crops. Wild pea (Pisum sativum subsp. elatius) is an important source of genetic diversity for further pea crop improvement harbouring traits useful in climate change context. The genetic structure was assessed on 187 individuals of Pisum sativum subsp. elatius from fourteen populations collected in the northern part of the Fertile Crescent using 18,397 genome wide single nucleotide polymorphism DARTseq markers. AMOVA showed that 63% of the allelic variation was distributed between populations and 19% between individuals within populations. Four populations were found to contain admixed individuals. The observed heterozygosity ranged between 0.99 to 6.26% with estimated self-pollination rate between 47 to 90%. Genetic distances of wild pea populations were correlated with geographic but not environmental (climatic) distances and support a mixed mating system with predominant self-pollination. Niche modelling with future climatic projections showed a local decline in habitats suitable for wild pea, making a strong case for further collection and ex situ conservation.	[Smykal, Petr; Duchoslav, Martin] Palacky Univ, Dept Bot, Olomouc, Czech Republic; [Trneny, Oldrich] Agr Res Ltd, Troubsko, Czech Republic; [Brus, Jan; Pechanec, Vilem] Palacky Univ, Dept Geoinformat, Olomouc, Czech Republic; [Hanacek, Pavel] Mendel Univ Brno, Dept Plant Biol, Brno, Czech Republic; [Rathore, Abhishek; Das Roma, Rani] Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India; [Bhattacharyya, Debjyoti] Assam Univ, Dept Life Sci & Bioinformat, Silchar, India; [Bariotakis, Michalis; Pirintsos, Stergios] Univ Crete, Dept Biol & Bot Garden, Iraklion, Greece; [Berger, Jens] CSIRO Agr & Food, Wembley, WA, Australia; [Toker, Cengiz] Akdeniz Univ, Dept Field Crops, Antalya, Turkey	Palacky University Olomouc; Research Institute for Fodder Crops, Ltd. Troubsko; Palacky University Olomouc; Mendel University in Brno; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Assam University; University of Crete; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Akdeniz University	Smykal, P (corresponding author), Palacky Univ, Dept Bot, Olomouc, Czech Republic.	petr.smykal@upol.cz	Brus, Jan/D-8406-2013; SMÝKAL, Petr/I-3569-2019; Hanacek, Pavel/E-6683-2012; Pechanec, Vilem/J-1877-2014; Trněný, Oldřich/ABE-1572-2020	Brus, Jan/0000-0001-5613-9798; SMÝKAL, Petr/0000-0002-6117-8510; Hanacek, Pavel/0000-0002-9807-1370; Pechanec, Vilem/0000-0001-6728-6646; Trněný, Oldřich/0000-0003-0935-2806; Bariotakis, Michael/0000-0002-7624-5675; Duchoslav, Martin/0000-0002-8553-8226; Toker, Cengiz/0000-0001-7042-1132; Bhattacharyya, Debjyoti/0000-0001-9999-6765	Grant Agency of the Czech Republic [16-21053S]; Palacky University grant Agency [IGA 2015_001, 2016_001, 2017_01]; partial institutional funding on long-term conceptual development of Agricultural Research, Ltd. organisation	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Palacky University grant Agency; partial institutional funding on long-term conceptual development of Agricultural Research, Ltd. organisation	P.S. research is funded by the Grant Agency of the Czech Republic, 16-21053S and Palacky University grant Agency IGA 2015_001, 2016_001, 2017_01 projects. O.T. is supported by partial institutional funding on long-term conceptual development of Agricultural Research, Ltd. organisation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Gharaibeh MM, 2017, PLANT BIOLOGY, V19, P227, DOI 10.1111/plb.12512; [Anonymous], 2017, INT J CLIMATOL; Balice RG, 1998, LA13714MS US LOS AL; Berger JD, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00548; Bishop J, 2017, J EXP BOT, V68, P2055, DOI 10.1093/jxb/erw430; Blondel J, 2006, HUM ECOL, V34, P713, DOI 10.1007/s10745-006-9030-4; Bogdanova V. S., 2000, Pisum Genetics, V32, P16; Bonnin I, 2001, MOL ECOL, V10, P1371, DOI 10.1046/j.1365-294X.2001.01278.x; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; BRADSHAW AD, 1991, PHILOS T R SOC B, V333, P289, DOI 10.1098/rstb.1991.0079; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Cronk QCB, 2006, P NATL ACAD SCI USA, V103, P4801, DOI 10.1073/pnas.0601298103; D'hondt B, 2012, PLANT ECOL, V213, P1241, DOI 10.1007/s11258-012-0082-9; David P, 2007, MOL ECOL, V16, P2474, DOI 10.1111/j.1365-294X.2007.03330.x; Dempewolf H, 2017, CROP SCI, V57, P1070, DOI 10.2135/cropsci2016.10.0885; Dempewolf H, 2014, AGROECOL SUST FOOD, V38, P369, DOI 10.1080/21683565.2013.870629; Dempewolf H, 2012, PLANT CELL, V24, P2710, DOI 10.1105/tpc.112.100115; Dostalova R., 2005, Czech Journal of Genetics and Plant Breeding, V41, P51; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Franks SJ, 2009, EVOL APPL, V2, P481, DOI 10.1111/j.1752-4571.2009.00073.x; Fuchs EJ, 2016, PEERJ, V4, DOI 10.7717/peerj.1875; GESSLER PE, 1995, INT J GEOGR INF SYST, V9, P421, DOI 10.1080/02693799508902047; Hamasha HR, 2013, PLANT BIOLOGY, V15, P882, DOI 10.1111/j.1438-8677.2012.00689.x; Hijmans RJ., 2015, PACKAGE RASTER R PAC; Hoban S, 2015, BIOL CONSERV, V187, P182, DOI 10.1016/j.biocon.2015.04.023; Hoffman JI, 2014, P NATL ACAD SCI USA, V111, P3775, DOI 10.1073/pnas.1318945111; Holdsworth WL, 2017, HORTIC RES-ENGLAND, V4, DOI 10.1038/hortres.2017.17; Huber S, 2009, MOL ECOL, V18, P1523, DOI 10.1111/j.1365-294X.2009.04106.x; HUSBAND BC, 1992, OECOLOGIA, V89, P365, DOI 10.1007/BF00317414; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Iverson LR, 1997, LANDSCAPE ECOL, V12, P331, DOI 10.1023/A:1007989813501; Jakob SS, 2014, GENOME BIOL EVOL, V6, P685, DOI 10.1093/gbe/evu047; Jing RC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-44; Johnston MO, 2008, AM NAT, V173, P1; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jump AS, 2009, TRENDS PLANT SCI, V14, P51, DOI 10.1016/j.tplants.2008.10.002; Kaljund K, 2010, BIOCHEM SYST ECOL, V38, P510, DOI 10.1016/j.bse.2010.05.007; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Karron JD, 2011, ANN BOT, V109, P493; Kilian Andrzej, 2012, Methods Mol Biol, V888, P67, DOI 10.1007/978-1-61779-870-2_5; Kosterin OE, 2014, INDIAN J GENET PL BR, V74, P50, DOI 10.5958/j.0975-6906.74.1.007; Kouam EB, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-113; Ladizinski G, 2015, THE PISUM GENUS, P55; Leimu R, 2006, J ECOL, V94, P942, DOI 10.1111/j.1365-2745.2006.01150.x; Levin DA, 2010, J ECOL, V98, P1276, DOI 10.1111/j.1365-2745.2010.01715.x; Loenning W.-E., 1984, PISUM NEWSLETTER, V16, P38; Maxted N, 2001, CURR PLANT SCI BIOT, V39, P181; McCue KA, 1998, AM J BOT, V85, P30, DOI 10.2307/2446551; McCune B, 2002, J VEG SCI, V13, P603, DOI 10.1111/j.1654-1103.2002.tb02087.x; Moore I. D., 1993, Modelling change in environmental systems., P189; Naeem Saboor, 2016, Journal of Entomology and Zoology Studies, V4, P112; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Norman HC, 2005, AUST J AGR RES, V56, P33, DOI 10.1071/AR03236; Norman HC, 2002, AUST J AGR RES, V53, P821, DOI 10.1071/AR01115; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pebesma E.J., 2005, R NEWS, V5; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Polowick PL, 2002, TRANSGENIC RES, V11, P515, DOI 10.1023/A:1020368322335; Pritchard JK, 2000, GENETICS, V155, P945; Redden R, 2015, CROP WILD RELATIVES AND CLIMATE CHANGE, P61; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; SAFRIEL UN, 1994, ISR J PLANT SCI, V42, P331, DOI 10.1080/07929978.1994.10676584; Smykal P, 2017, PLANT SYST EVOL, V303, P267, DOI 10.1007/s00606-016-1368-5; Smykal P, 2015, CRIT REV PLANT SCI, V34, P43, DOI 10.1080/07352689.2014.897904; Smykal P, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00351; Smykal P, 2011, PLANT GENET RESOUR-C, V9, P4, DOI 10.1017/S147926211000033X; Stoffel MA, 2016, METHODS ECOL EVOL, V7, P1331, DOI 10.1111/2041-210X.12588; Suso MJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00333; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Thompson JD., 2005, PLANT EVOLUTION MEDI, DOI DOI 10.1093/ACPROF:OSO/9780198515340.001.0001; Thormann I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160745; Ugurlu E, 2012, APPL VEG SCI, V15, P590, DOI 10.1111/j.1654-109X.2012.01192.x; VanDerWal, 2014, SPECIES DISTRIBUTION; Warschefsky E, 2014, AM J BOT, V101, P1791, DOI 10.3732/ajb.1400116; WEIR BS, 1973, GENET RES, V21, P247, DOI 10.1017/S0016672300013446; Zaytseva O, 2015, GENE, V556, P235, DOI 10.1016/j.gene.2014.11.062	80	26	27	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194056	10.1371/journal.pone.0194056	http://dx.doi.org/10.1371/journal.pone.0194056			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579076	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000428351800018
J	Michalik, M; Samet, A; Marszalek, A; Krawczyk, B; Kotlowski, R; Nowicki, A; Anyszek, T; Nowicki, S; Kur, J; Nowicki, B				Michalik, Michal; Samet, Alfred; Marszalek, Andrzej; Krawczyk, Beata; Kotlowski, Roman; Nowicki, Alex; Anyszek, Tomasz; Nowicki, Stella; Kur, Jozef; Nowicki, Bogdan			Intra-operative biopsy in chronic sinusitis detects pathogenic Escherichia coli that carry fimG/H, fyuA and agn43 genes coding biofilm formation	PLOS ONE			English	Article							CHRONIC RHINOSINUSITIS; BACTERIAL; STRAINS; NASAL; BLOOD; RISK; TRANSLOCATION; EPIDEMIOLOGY; ADHERENCE; ETIOLOGY	The aim of this study was to investigate whether or not surgical biopsy of sinus tissue in chronic sinusitis, not responsive to treatment, would detect E. coli. We intended to evaluate E. coli virulence genes, therefore dispute the causal role of such an unusual microorganism in chronic sinusitis, as well as consider effective pathogen-targeted therapy. Patients with E. coli isolated by intra-operative puncture biopsy were included in the study. Genetic analysis of E. coli isolates, including phylogenetic grouping and virulence factor characteristics, were done by multiplex PCR. We identified 26 patients with chronic sinusitis, in which 26 E. coli isolates were cultured. The E. coli isolates belonged mainly to pathogenic phylogenetic group B2, and carried multiple virulence genes. Three genes in particular were present in all (100%) of examined isolates, they were (1) marker agn43 gene for forming biofilm, (2) type 1 fimbriae (fimG/H gene) and (3) yersiniabactin receptor (fyuA). Furthermore, a pseudo-phylogenetic tree of virulence genes distribution revealed possible cooperation between agn43, fimG/H, and fyuA in the coding of biofilm formation. Intra-operative-biopsy and culture-based therapy, targeting the isolated E. coli, coincided with long-term resolution of symptoms. This is the first report demonstrating an association between a highly pathogenic E. coli, chronic sinus infection, and resolution of symptoms upon E. coli targeted therapy, a significant finding due to the fact that E. coli has not been considered to be a commensal organism of the oropharynx or sinuses. We postulate that the simultaneous presence of three genes, each coding biofilm formation, may in part account for the chronicity of E. coli sinusitis.	[Michalik, Michal; Samet, Alfred] Med Ctr MML, Warsaw, Poland; [Marszalek, Andrzej; Anyszek, Tomasz] SYNEVO, Med Labs, Warsaw, Poland; [Krawczyk, Beata; Kotlowski, Roman; Kur, Jozef] Gdansk Univ Technol, Fac Chem, Dept Mol Biotechnol & Microbiol, Gdansk, Poland; [Nowicki, Alex; Nowicki, Stella; Nowicki, Bogdan] Nowicki Inst Womens Hlth Res, 114 Governors Way, Brentwood, TN 37037 USA	Fahrenheit Universities; Gdansk University of Technology	Nowicki, B (corresponding author), Nowicki Inst Womens Hlth Res, 114 Governors Way, Brentwood, TN 37037 USA.	bnowicki1949@gmail.com	Kotlowski, Roman/K-7709-2019; Krawczyk, Beata/ABG-4358-2020	Kotlowski, Roman/0000-0001-7793-9786; Krawczyk, Beata/0000-0001-5528-8898	Medical Center MML [2015-01]; SYNEVO Medical Laboratories	Medical Center MML; SYNEVO Medical Laboratories	This study was supported by research grant from Medical Center MML, Award Number 2015-01 to J. Kur. SYNEVO Medical Laboratories provided support in the form of salaries for authors AM and TA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Hamad W, 2009, AM J RHINOL ALLERGY, V23, P261, DOI 10.2500/ajra.2009.23.3317; Adamus-Bialek W, 2009, J CLIN MICROBIOL, V47, P3937, DOI 10.1128/JCM.01036-09; Al-Mutairi D, 2011, CURR OPIN ALLERGY CL, V11, P18, DOI 10.1097/ACI.0b013e3283423376; Beule AG, 2015, LARYNGO RHINO OTOL, V94, pS1, DOI 10.1055/s-0034-1396869; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Dlugaszewska J, 2016, EUR ARCH OTO-RHINO-L, V273, P1989, DOI 10.1007/s00405-015-3650-5; Ferguson BJ, 2005, AM J RHINOL, V19, P452, DOI 10.1177/194589240501900506; Foreman A, 2009, AM J RHINOL ALLERGY, V23, P556, DOI 10.2500/ajra.2009.23.3413; Goluszko P, 1997, J CLIN INVEST, V99, P1662, DOI 10.1172/JCI119329; Halawi AM, 2013, ALLERGY ASTHMA PROC, V34, P328, DOI 10.2500/aap.2013.34.3675; Hancock V, 2008, MICROBIOL-SGM, V154, P167, DOI 10.1099/mic.0.2007/011981-0; Heras B, 2014, P NATL ACAD SCI USA, V111, P457, DOI 10.1073/pnas.1311592111; Ivanchenko OA, 2016, RHINOLOGY, V54, P68, DOI [10.4193/Rhin15.018, 10.4193/Rhino15.018]; Jain R, 2016, INT FORUM ALLERGY RH, V6, P631, DOI 10.1002/alr.21712; Johnson JR, 1998, J INFECT DIS, V177, P1120, DOI 10.1086/517409; Johnson JR, 2001, J INFECT DIS, V183, P897, DOI 10.1086/319263; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Kostakioti M., 2013, COLD SPRING HARB PER, V3; Kotlowski R, 2007, GUT, V56, P669, DOI 10.1136/gut.2006.099796; Krawczyk B, 2015, EUR J CLIN MICROBIOL, V34, P1135, DOI 10.1007/s10096-015-2331-z; Krawczyk B, 2006, J CLIN MICROBIOL, V44, P2327, DOI 10.1128/JCM.00052-06; Krawczyk B, 2017, J APPL GENET, V58, P415, DOI 10.1007/s13353-017-0393-6; Kremer B, 2001, EUR ARCH OTO-RHINO-L, V258, P220, DOI 10.1007/s004050100342; Lam K, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0540-2; Larson DA, 2011, CURR OPIN OTOLARYNGO, V19, P199, DOI 10.1097/MOO.0b013e328344f67a; LEBOUGUENEC C, 1992, J CLIN MICROBIOL, V30, P1189, DOI 10.1128/JCM.30.5.1189-1193.1992; Manes RP, 2013, EXPERT REV ANTI-INFE, V11, P25, DOI [10.1586/ERI.12.151, 10.1586/eri.12.151]; Mobley HLT, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5010001; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Nowak-Zaleska A, 2016, J GLOB ANTIMICROB RE, V7, P145, DOI 10.1016/j.jgar.2016.09.004; Nowicki B, 2011, BJOG-INT J OBSTET GY, V118, P109, DOI 10.1111/j.1471-0528.2010.02706.x; Oakley GM, 2015, INT FORUM ALLERGY RH, V5, P276, DOI 10.1002/alr.21469; Puttamreddy S, 2011, FEMS MICROBIOL LETT, V315, P46, DOI 10.1111/j.1574-6968.2010.02173.x; Radtsig E. Yu., 2014, Vestnik Otorinolaringologii, P39, DOI 10.17116/otorino2014639-40; Ramadan HH, 2005, OTOLARYNG HEAD NECK, V132, P414, DOI 10.1016/j.otohns.2004.11.011; Schubert S, 1998, INFECT IMMUN, V66, P480, DOI 10.1128/IAI.66.2.480-485.1998; Soler ZM, 2012, AM J RHINOL ALLERGY, V26, P110, DOI 10.2500/ajra.2012.26.3741; Spaulding CN, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5010030; Stephenson MF, 2010, J OTOLARYNGOL-HEAD N, V39, P182, DOI 10.2310/7070.2009.090060; Stevens WW, 2015, J ALLERGY CLIN IMMUN, V136, P1442, DOI 10.1016/j.jaci.2015.10.009; Stressmann FA, 2011, AM J RHINOL ALLERGY, V25, pE133, DOI 10.2500/ajra.2011.25.3628; Szemiako K, 2013, EUR J CLIN MICROBIOL, V32, P1579, DOI 10.1007/s10096-013-1913-x; Udayasri B, 2016, JDENT MED SCI, V15, P118; Zhao LX, 2009, MICROBIOL-SGM, V155, P1634, DOI 10.1099/mic.0.024869-0	44	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2018	13	3							e0192899	10.1371/journal.pone.0192899	http://dx.doi.org/10.1371/journal.pone.0192899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA2QK	29570706	Green Published, gold, Green Submitted			2022-12-26	WOS:000428168400002
J	Pannuti, A; Filipovic, A; Hicks, C; Lefkowitz, E; Ptacek, T; Stebbing, J; Miele, L				Pannuti, Antonio; Filipovic, Aleksandra; Hicks, Chindo; Lefkowitz, Elliot; Ptacek, Travis; Stebbing, Justin; Miele, Lucio			Novel putative drivers revealed by targeted exome sequencing of advanced solid tumors	PLOS ONE			English	Article							CELL LUNG-CANCER; METASTATIC COLORECTAL-CANCER; RANDOMIZED PHASE-II; INTRATUMOR HETEROGENEITY; CLINICAL-APPLICATIONS; ACQUIRED-RESISTANCE; SOMATIC MUTATIONS; EGFR MUTATIONS; PD-1 BLOCKADE; PATCHED GENE	Next generation sequencing (NGS) is becoming increasingly integrated into oncological practice and clinical research. NGS methods have also provided evidence for clonal evolution of cancers during disease progression and treatment. The number of variants associated with response to specific therapeutic agents keeps increasing. However, the identification of novel driver mutations as opposed to passenger (phenotypically silent or clinically irrelevant) mutations remains a major challenge. We conducted targeted exome sequencing of advanced solid tumors from 44 pre-treated patients with solid tumors including breast, colorectal and lung carcinomas, neuroendocrine tumors, sarcomas and others. We catalogued established driver mutations and putative new drivers as predicted by two distinct algorithms. The established drivers we detected were consistent with published observations. However, we also detected a significant number of mutations with driver potential never described before in each tumor type we studied. These putative drivers belong to key cell fate regulatory networks, including potentially druggable pathways. Should our observations be confirmed, they would support the hypothesis that new driver mutations are selected by treatment in clinically aggressive tumors, and indicate a need for longitudinal genomic testing of solid tumors to inform second line cancer treatment.	[Pannuti, Antonio; Miele, Lucio] Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA; [Filipovic, Aleksandra; Stebbing, Justin] Imperial Coll Med, Dept Oncol, London, England; [Hicks, Chindo; Miele, Lucio] Louisiana State Univ, Sch Med, Dept Genet, New Orleans, LA 70112 USA; [Hicks, Chindo] Louisiana Clin & Translat Sci Ctr, Biomed Informat Key Component, Baton Rouge, LA USA; [Lefkowitz, Elliot; Ptacek, Travis] Univ Alabama Birmingham, Sch Med, Dept Microbiol, Birmingham, AL 35294 USA; [Lefkowitz, Elliot; Ptacek, Travis] Univ Alabama Birmingham, Sch Med, Ctr Clin & Translat Sci, Informat Inst, Birmingham, AL USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Imperial College London; Louisiana State University System; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Miele, L (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA.; Stebbing, J (corresponding author), Imperial Coll Med, Dept Oncol, London, England.; Miele, L (corresponding author), Louisiana State Univ, Sch Med, Dept Genet, New Orleans, LA 70112 USA.	j.stebbing@imperial.ac.uk; lmiele@lsuhsc.edu		Miele, Lucio/0000-0002-5853-7287; Lefkowitz, Elliot/0000-0002-4748-4925; Stebbing, Justin/0000-0002-1117-6947	National Institute of General Medical Sciences [1 U54 GM104940]; National Center for Advancing Translational Sciences [ULTR001417]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences (https://www.nigms.nih.gov/Pages/default.aspx) Grant #1 U54 GM104940; National Center for Advancing Translational Sciences (https://ncats.nih.gov/) Grant#ULTR001417. Dr. Justin Stebbing acknowledges support from the following institutions: Imperial BRC, AAC and NIHR for infrastructure support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix-Panabieres C, 2016, CANCER DISCOV, V6, P479, DOI 10.1158/2159-8290.CD-15-1483; Bang YJ, 2010, LANCET, V376, P1302; Basset-Seguin N, 2004, M S-MED SCI, V20, P899, DOI 10.1051/medsci/20042010899; Beau-Faller M, 2014, ANN ONCOL, V25, P126, DOI 10.1093/annonc/mdt418; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Bhang HEC, 2015, NAT MED, V21, P440, DOI 10.1038/nm.3841; Blumenschein GR, 2015, ANN ONCOL, V26, P894, DOI 10.1093/annonc/mdv072; Bronte G, 2015, ONCOTARGET, V6, P24780, DOI 10.18632/oncotarget.4959; Bubici C, 2014, BRIT J PHARMACOL, V171, P24, DOI 10.1111/bph.12432; Cao J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002496; Carneiro BA, 2016, ONCOLOGY-NY, V30, P293; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Carter Philip, 2018, Oncotarget, V9, P9456, DOI 10.18632/oncotarget.24258; Cheng F, 2016, ONCOTARGET; Choi M, 2016, MOL CANCER THER, V15, P1781, DOI 10.1158/1535-7163.MCT-15-0945; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Corcoran RB, 2015, J GASTROINTEST ONCOL, V6, P650, DOI 10.3978/j.issn.2078-6891.2015.076; Danaee H, 2006, J INVEST DERMATOL, V126, P1152, DOI 10.1038/sj.jid.5700209; Daya-Grosjean L, 2000, MUTAT RES-FUND MOL M, V450, P193, DOI 10.1016/S0027-5107(00)00025-7; de Souza N, 2012, NAT METHODS, V9, P1046, DOI 10.1038/nmeth.2238; Di Liso E, 2015, CANCER BIOL THER, V16, P1128, DOI 10.1080/15384047.2015.1057359; Ding L, 2014, NAT REV GENET, V15, P556, DOI 10.1038/nrg3767; Douville C, 2013, BIOINFORMATICS, V29, P647, DOI 10.1093/bioinformatics/btt017; Eifert C, 2017, PERS MED, V14, P309, DOI 10.2217/pme-2017-0011; Elez E, 2016, BRIT J CANCER, V114, P372, DOI 10.1038/bjc.2015.480; Fanotto V, 2016, ONCOTARGET; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fecteau RE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087966; Forde PM, 2015, CLIN ADV HEMATOL ONC, V13, P528; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Go H, 2014, HISTOPATHOLOGY, V65, P261, DOI 10.1111/his.12416; Hahn H, 1999, J MOL MED-JMM, V77, P459, DOI 10.1007/s001099900018; Hainsworth JD, 2014, VIRCHOWS ARCH, V464, P393, DOI 10.1007/s00428-014-1545-2; Heitzer E, 2016, MOL ONCOL, V10, P494, DOI 10.1016/j.molonc.2015.12.004; Hodges C., 2016, COLD SPRING HARB PER, V6; Hohmann AF, 2014, TRENDS GENET, V30, P356, DOI 10.1016/j.tig.2014.05.001; Ignatiadis M, 2015, CLIN CANCER RES, V21, P4786, DOI 10.1158/1078-0432.CCR-14-1190; Janku F, 2014, CELL REP, V6, P377, DOI 10.1016/j.celrep.2013.12.035; Kempf E, 2016, EUR RESPIR REV, V25, DOI 10.1183/16000617.0071-2015; Kourtis N, 2015, CURR OPIN CELL BIOL, V37, P28, DOI 10.1016/j.ceb.2015.09.003; Krishnaswamy S, 2009, CLIN CANCER RES, V15, P5714, DOI 10.1158/1078-0432.CCR-09-0070; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lee JJX, 2015, CANCER BIOL MED, V12, P342, DOI 10.7497/j.issn.2095-3941.2015.0089; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Ma MW, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.09.29; Manchado E, 2016, NATURE, V534, P647, DOI 10.1038/nature18600; Martelotto LG, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0484-1; Marusiak AA, 2016, CANCER RES, V76, P724, DOI 10.1158/0008-5472.CAN-15-0701-T; Massacesi C, 2016, ONCOTARGETS THER, V9, P203, DOI 10.2147/OTT.S89967; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; McGranahan N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1408; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Melton C, 2015, NAT GENET, V47, P710, DOI 10.1038/ng.3332; Momcilovic M, 2015, CANCER RES, V75, P4910, DOI 10.1158/0008-5472.CAN-15-0797; Moorcraft SY, 2015, CRIT REV ONCOL HEMAT, V96, P463, DOI 10.1016/j.critrevonc.2015.06.007; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakagawa H, 2015, ONCOGENE, V34, P5943, DOI 10.1038/onc.2015.90; Nemecek R, 2016, ONCOTARGETS THER, V9, P4695, DOI 10.2147/OTT.S102891; Pakneshan S, 2013, PATHOLOGY, V45, P346, DOI 10.1097/PAT.0b013e328360b61d; Perera D, 2016, NATURE, V532, P259, DOI 10.1038/nature17437; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rodriguez J, 2010, CRIT REV ONCOL HEMAT, V74, P193, DOI 10.1016/j.critrevonc.2009.07.005; Rogers MF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11746-4; Ryu D, 2016, HUM GENET, V135, P635, DOI 10.1007/s00439-016-1670-x; Sakai E, 2016, INT J CANCER, V138, P1634, DOI 10.1002/ijc.29903; Sakai E, 2014, INT J CANCER, V135, P1586, DOI 10.1002/ijc.28814; Schmitt MW, 2016, NAT REV CLIN ONCOL, V13, P335, DOI 10.1038/nrclinonc.2015.175; Segelov E, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2389-8; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shen T, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00215; Shihab HA, 2015, BIOINFORMATICS, V31, P1536, DOI 10.1093/bioinformatics/btv009; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stewart EL, 2015, TRANSL LUNG CANCER R, V4, P67, DOI 10.3978/j.issn.2218-6751.2014.11.06; Sundar R, 2017, CANCER DISCOV, V7, P558, DOI 10.1158/2159-8290.CD-17-0087; Tan DSW, 2016, J THORAC ONCOL, V11, P946, DOI 10.1016/j.jtho.2016.05.008; Tetreault M, 2015, EXPERT REV MOL DIAGN, V15, P749, DOI 10.1586/14737159.2015.1039516; Therkildsen C, 2014, ACTA ONCOL, V53, P852, DOI 10.3109/0284186X.2014.895036; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Tian R, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S8-S7; Tomasetti C, 2015, P NATL ACAD SCI USA, V112, P118, DOI 10.1073/pnas.1421839112; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Weber AM, 2015, PHARMACOL THERAPEUT, V149, P124, DOI 10.1016/j.pharmthera.2014.12.001; Whittaker SR, 2017, PHARMACOL THERAPEUT, V173, P83, DOI 10.1016/j.pharmthera.2017.02.008; Yamada M, 2012, J PATHOL, V228, P113, DOI 10.1002/path.4012; Yang JCH, 2015, LANCET ONCOL, V16, P830, DOI 10.1016/S1470-2045(15)00026-1; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304	89	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2018	13	3							e0194790	10.1371/journal.pone.0194790	http://dx.doi.org/10.1371/journal.pone.0194790			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA2QK	29570743	Green Submitted, Green Published, gold			2022-12-26	WOS:000428168400031
J	Kashiri, M; Marin, C; Garzon, R; Rosell, CM; Rodrigo, D; Martinez, A				Kashiri, Mahboobeh; Marin, Cuauhtemoc; Garzon, Raquel; Rosell, Cristina M.; Rodrigo, Dolores; Martinez, Antonio			Use of high hydrostatic pressure to inactivate natural contaminating microorganisms and inoculated E-coli O157:H7 on Hermetia illucens larvae	PLOS ONE			English	Article							RAINBOW-TROUT; SURVIVAL; STRAINS	A chemical and microbiological characterization on Hermetia illucens larvae was carried out as well as an inactivation study of natural contaminating microorganisms and inoculated E. coli O157:H7 in black soldier larvae by using High Hydrostatic Pressure (250 to 400 MPa, for 1.5 to 15 min). Hermetia illucens was mainly composed of proteins (46.49%, d.m.) followed by fat (37.88%, d.m.). Larvae had a high contamination load of Total Aerobic Mesophilic bacteria (AMB) (1.58x10(7) cfu/g) and Enterobacteriaceae (1.15x10(6) cfu/g). The presence of pathogenic microorganism varied: no Listeria spp. were found, but Salmonella (1.15x10(6) cfu/g) and E. coli (7.08x10(5) cfu/g) were detected in the larvae extract. High Hydrostatic Pressure (HHP) was effective against natural contaminating yeasts and molds producing more than 5 log cycle reductions at 400 MPa for any of the times considered (2.5 to 7 min), but a low reduction of total microbial load was achieved. The inactivation level of larvae inoculated with E. coli O157:H7 varied. At 400 MPa for 7 min more than 5 log cycle reductions were achieved. Among the three inactivation models studied, the one that best described the inactivation pattern of the cells, according to the Akaike index, was the Biphasic model.	[Kashiri, Mahboobeh] Univ Agr Sci & Nat Resources, Dept Food Sci & Technol, Gorgan, Iran; [Marin, Cuauhtemoc; Garzon, Raquel; Rosell, Cristina M.; Rodrigo, Dolores; Martinez, Antonio] CSIC, IATA, Catedrat Agustin Escardino 7, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Martinez, A (corresponding author), CSIC, IATA, Catedrat Agustin Escardino 7, Valencia, Spain.	conami@iata.csic.es	Kashiri, Mahboobeh/ABA-8340-2022; Rosell, Cristina M/F-4888-2010; Garzón, Raquel/V-2271-2018; Rodrigo, Dolores/H-6083-2012; Martinez, Antonio/H-4094-2012; Garzon, Raquel/T-9167-2018	Rosell, Cristina M/0000-0001-7197-5874; Garzón, Raquel/0000-0002-5326-6510; Rodrigo, Dolores/0000-0001-9854-111X; Martinez, Antonio/0000-0002-2323-8463; Garzon, Raquel/0000-0002-5326-6510	Spanish Ministry of Economy and Competiveness [AGL2013-48993-C2-2-R, AGL2017-86840-C2-2-R]; FEDER funds	Spanish Ministry of Economy and Competiveness(Spanish Government); FEDER funds(European Commission)	The authors acknowledge the financial support of the project AGL2013-48993-C2-2-R and AGL2017-86840-C2-2-R from the Spanish Ministry of Economy and Competiveness and FEDER funds and acknowledge BioFlyTech, S.L. (Alicante, Spain) for rearing insects and supplying the samples. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpas H, 2000, INT J FOOD MICROBIOL, V60, P33, DOI 10.1016/S0168-1605(00)00324-X; AOAC, 1990, OFFICIAL METHODS ANA; Arango Gutierrez G. P., 2004, REV FACULT AGRON MED, V5, P2491; Bayindirli A, 2006, FOOD CONTROL, V17, P52, DOI 10.1016/j.foodcont.2004.09.002; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; CERF O, 1977, J APPL BACTERIOL, V42, P1, DOI 10.1111/j.1365-2672.1977.tb00665.x; Daryaei H, 2008, INNOV FOOD SCI EMERG, V9, P201, DOI 10.1016/j.ifset.2007.06.011; Ekpo KE, 2009, AFR J PHARM PHARMACO, V3, P51; Geeraerd AH, 2000, INT J FOOD MICROBIOL, V59, P185, DOI 10.1016/S0168-1605(00)00362-7; Geeraerd AH, 2005, INT J FOOD MICROBIOL, V102, P95, DOI 10.1016/j.ijfoodmicro.2004.11.038; Gervilla R, 1997, J DAIRY SCI, V80, P2297, DOI 10.3168/jds.S0022-0302(97)76179-4; Grabowski N., 2016, FOOD SCI TECHNOLOGY; Grabowski N. T., 2014, INSECTS FEED WORLD; Halloran A, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0392-8; Huis A., 2013, EDIBLE INSECTS FUTUR; Janssen RH, 2017, J AGR FOOD CHEM, V65, P2275, DOI 10.1021/acs.jafc.7b00471; Jeon H, 2011, CURR MICROBIOL, V62, P1390, DOI 10.1007/s00284-011-9874-8; Klunder HC, 2012, FOOD CONTROL, V26, P628, DOI 10.1016/j.foodcont.2012.02.013; Lalander C. H., 2014, INSECTS FEED WORLD; Li H, 2016, INNOV FOOD SCI EMERG, V38, P321, DOI 10.1016/j.ifset.2016.05.003; Mafart P, 2002, INT J FOOD MICROBIOL, V72, P107, DOI 10.1016/S0168-1605(01)00624-9; Makkar HPS, 2014, ANIM FEED SCI TECH, V197, P1, DOI 10.1016/j.anifeedsci.2014.07.008; Melo V., 2011, Emirates Journal of Food and Agriculture, V23, P283; Mengden R, 2015, INNOV FOOD SCI EMERG, V32, P9, DOI 10.1016/j.ifset.2015.10.002; Menzel Peter, 1998, MAN EATING BUGS ART; Neacsu M, 2017, SUSTAINABLE PROTEIN SOURCES, P359, DOI 10.1016/B978-0-12-802778-3.00022-6; Phillips J., 1995, FOOD INSECTS NEWSLET, V8, P1; Rendueles E, 2011, LWT-FOOD SCI TECHNOL, V44, P1251, DOI 10.1016/j.lwt.2010.11.001; Rumpold BA, 2014, INNOV FOOD SCI EMERG, V26, P232, DOI 10.1016/j.ifset.2014.09.002; Rumpold BA, 2013, MOL NUTR FOOD RES, V57, P802, DOI 10.1002/mnfr.201200735; Salomone R, 2017, J CLEAN PROD, V140, P890, DOI 10.1016/j.jclepro.2016.06.154; SHEPPARD DC, 1994, BIORESOURCE TECHNOL, V50, P275, DOI 10.1016/0960-8524(94)90102-3; St-Hilaire S, 2007, J WORLD AQUACULT SOC, V38, P59, DOI 10.1111/j.1749-7345.2006.00073.x; Van Opstal I, 2005, INT J FOOD MICROBIOL, V98, P179, DOI 10.1016/j.ijfoodmicro.2004.05.022; Vega S., 2016, FOOD SCI TECHNOLOGY; VIESCA GFC, 2009, PERIPLO SUSTENTABLE, V16, P57, DOI DOI 10.21854/eps.v0i16.922	36	14	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194477	10.1371/journal.pone.0194477	http://dx.doi.org/10.1371/journal.pone.0194477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566029	Green Published, Green Submitted, gold			2022-12-26	WOS:000428093900067
J	Melis, M; Mastinu, M; Arca, M; Crnjar, R; Barbarossa, LT				Melis, Melanie; Mastinu, Mariano; Arca, Massimiliano; Crnjar, Roberto; Barbarossa, Lole Tomassini			Effect of chemical interaction between oleic acid and L-Arginine on oral perception, as a function of polymorphisms of CD36 and OBPII alpha and genetic ability to taste 6-n-propylthiouracil	PLOS ONE			English	Article							LONG-CHAIN FATTY; BODY-MASS INDEX; BITTER TASTE; PROP BITTERNESS; BASIS-SETS; OROSENSORY DETECTION; SENSITIVITY; RESPONSES; WEIGHT; PREFERENCE	Oral sensitivity to fats varies in individuals influencing nutritional status and health. Variations in oleic acid perception are associated with CD36 and odorant binding protein (OBPIIa) polymorphisms, and 6-n-propylthiouracil (PROP) sensitivity, which is mediated by TAS2R38 receptor. L-Arginine (L-Arg) supplementation was shown to modify the perception of the five taste qualities. Here we analyzed the effect of three concentrations (5, 10, 15 mmol/L) of L-Arg on oral perception of oleic acid in forty-six subjects classified for PROP taster status and genotyped for TAS2R38, CD36 and OBPIIa polymorphisms. L-Arg supplementation was effective in increasing the perceived intensity of oleic acid in most subjects. The lowest concentration was the most effective, especially in PROP non-tasters or medium tasters, and in subjects with at least an allele A in CD36 and OBPIIa loci. Density Functional Theory (DFT) calculations were exploited to characterize the chemical interaction between L-Arg and oleic acid, showing that a stable 1:1 oleate-ArgH(+) adduct can be formed, stabilized by a pair of hydrogen bonds. Results indicate that L-Arg, acting as a 'carrier' of fatty acids in saliva, can selectively modify taste response, and suggest that it may to be used in personalized dietetic strategies to optimize eating behaviors and health.	[Melis, Melanie; Mastinu, Mariano; Crnjar, Roberto; Barbarossa, Lole Tomassini] Univ Cagliari, Sect Physiol, Dept Biomed Sci, Monserrato, CA, Italy; [Arca, Massimiliano] Univ Cagliari, Dept Chem & Geol Sci, Monserrato, CA, Italy	University of Cagliari; University of Cagliari	Barbarossa, LT (corresponding author), Univ Cagliari, Sect Physiol, Dept Biomed Sci, Monserrato, CA, Italy.	tomassin@unica.it	Arca, Massimiliano/L-6902-2017; Mastinu, Mariano/AAV-3508-2021	Arca, Massimiliano/0000-0002-0058-6406; TOMASSINI BARBAROSSA, IOLE/0000-0002-2849-4052; MASTINU, MARIANO/0000-0003-3833-9707; MELIS, MELANIA/0000-0003-3410-3158	University of Cagliari (Progetti di Ricerca di Interesse Dipartimentale, PRID)	University of Cagliari (Progetti di Ricerca di Interesse Dipartimentale, PRID)	This work was supported by a grant from the University of Cagliari (Progetti di Ricerca di Interesse Dipartimentale, PRID 2015).	Adamo C, 1998, J CHEM PHYS, V108, P664, DOI 10.1063/1.475428; Ahijevych K, 2015, NICOTINE TOB RES, V17, P1149, DOI 10.1093/ntr/ntu281; Alberti-Fidanza A, 1998, INT J VITAM NUTR RES, V68, P149; Andre I, 2007, J AM CHEM SOC, V129, P15805, DOI 10.1021/ja0721824; Bajec MR, 2008, PHYSIOL BEHAV, V95, P581, DOI 10.1016/j.physbeh.2008.08.009; Banerjee M, 2010, INT J DIABETES MELLI, V2, P179, DOI [10.1016/j.ijdm.2010.08.002, DOI 10.1016/J.IJDM.2010.08.002]; Barbarossa IT, 2017, BEHAV BRAIN RES, V329, P200, DOI 10.1016/j.bbr.2017.05.015; Barbarossa IT, 2015, PHYSIOL BEHAV, V138, P6, DOI 10.1016/j.physbeh.2014.09.011; Barbarossa IT, 2013, NUTRITION, V29, P531, DOI 10.1016/j.nut.2012.09.018; Bartoshuk L. M., 1993, Food Quality and Preference, V4, P21, DOI 10.1016/0950-3293(93)90310-3; Bartoshuk L. M., 1992, Chemical Senses, V17, P594; BARTOSHUK LM, 1988, CHEM SENSES, V13, P517, DOI 10.1093/chemse/13.4.517; Bartoshuk LM, 1998, ANN NY ACAD SCI, V855, P793, DOI 10.1111/j.1749-6632.1998.tb10660.x; BARTOSHUK LM, 1994, PHYSIOL BEHAV, V56, P1165, DOI 10.1016/0031-9384(94)90361-1; BARTOSHUK LM, 1979, SCIENCE, V205, P934, DOI 10.1126/science.472717; BARTOSHUK LM, 1986, J GERONTOL, V41, P51, DOI 10.1093/geronj/41.1.51; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Cabras T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030962; Calo C, 2011, PHYSIOL BEHAV, V104, P1065, DOI 10.1016/j.physbeh.2011.06.013; Fernandez-Garcia JC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171204; Carta G., 2017, SCI REP, V7; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; Chale-Rush A, 2007, AM J PHYSIOL-GASTR L, V292, pG1206, DOI 10.1152/ajpgi.00471.2006; Chevrot M, 2014, AM J CLIN NUTR, V99, P975, DOI 10.3945/ajcn.113.077198; CISTOLA DP, 1988, BIOCHEMISTRY-US, V27, P1881, DOI 10.1021/bi00406a013; CISTOLA DP, 1987, J BIOL CHEM, V262, P10971; de Sousa F.F., 2010, J BIONANOSCI, V3, P1; Dennington R., 2016, GAUSSVIEW VERSION 6; Donaldson LF, 2009, AM J CLIN NUTR, V90, p800S, DOI 10.3945/ajcn.2009.27462Q; Drewnowski A, 1998, PHYSIOL BEHAV, V63, P771, DOI 10.1016/S0031-9384(97)00540-4; Drewnowski A, 1997, ANNU REV NUTR, V17, P237, DOI 10.1146/annurev.nutr.17.1.237; Drewnowski A, 2007, J AM DIET ASSOC, V107, P1340, DOI 10.1016/j.jada.2007.05.013; Duffy V., 2004, GENETIC VARIATION TA, P195; Duffy VB, 2000, J AM DIET ASSOC, V100, P647, DOI 10.1016/S0002-8223(00)00191-7; Duffy VB, 2004, ALCOHOL CLIN EXP RES, V28, P1629, DOI 10.1097/01.ALC.0000145789.55183.D4; Ebba S, 2012, PHYSIOL BEHAV, V106, P579, DOI 10.1016/j.physbeh.2012.04.006; Essick GK, 2003, PHYSIOL BEHAV, V80, P289, DOI 10.1016/j.physbeh.2003.08.007; Feeney EL, 2017, APPETITE, V113, P116, DOI 10.1016/j.appet.2017.02.026; FORRAI G, 1984, ACTA PHYSIOL HUNG, V64, P33; Fox AL, 1932, P NATL ACAD SCI USA, V18, P115, DOI 10.1073/pnas.18.1.115; Galindo MM, 2012, CHEM SENSES, V37, P123, DOI 10.1093/chemse/bjr069; GENT JF, 1983, CHEM SENSES, V7, P265, DOI 10.1093/chemse/7.3-4.265; Ghosh A, 2011, BLOOD, V117, P6355, DOI 10.1182/blood-2011-02-338582; Gilbertson TA, 1997, AM J PHYSIOL-CELL PH, V272, pC1203, DOI 10.1152/ajpcell.1997.272.4.C1203; GLANVILL.EV, 1965, NATURE, V205, P930, DOI 10.1038/205930a0; GREEN BG, 1993, CHEM SENSES, V18, P683, DOI 10.1093/chemse/18.6.683; Hayes JE, 2008, PHYSIOL BEHAV, V95, P77, DOI 10.1016/j.physbeh.2008.04.023; Hayes JE, 2008, CHEM SENSES, V33, P255, DOI 10.1093/chemse/bjm084; Hayes JE, 2007, CHEM SENSES, V32, P225, DOI 10.1093/chemse/bjl050; Kanicky JR, 2002, J COLLOID INTERF SCI, V256, P201, DOI 10.1006/jcis.2001.8009; Keller KL, 2014, APPETITE, V77, P113, DOI 10.1016/j.appet.2014.02.019; Keller KL, 2012, OBESITY, V20, P1066, DOI 10.1038/oby.2011.374; Keller KL, 2002, APPETITE, V38, P3, DOI 10.1006/appe.2001.0441; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Kirkmeyer SV, 2003, CHEM SENSES, V28, P527, DOI 10.1093/chemse/28.6.527; Koch W., 2002, CHEM GUIDE DENSITY F; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Leksrisompong P, 2012, J FOOD SCI, V77, pS282, DOI 10.1111/j.1750-3841.2012.02800.x; Love-Gregory L, 2011, HUM MOL GENET, V20, P193, DOI 10.1093/hmg/ddq449; Ma XW, 2004, HUM MOL GENET, V13, P2197, DOI 10.1093/hmg/ddh233; Madden J, 2008, PROSTAG LEUKOTR ESS, V78, P327, DOI 10.1016/j.plefa.2008.04.003; Martin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024014; Martin C, 2011, PHYSIOL BEHAV, V105, P36, DOI 10.1016/j.physbeh.2011.02.029; Matsumura S, 2009, NEUROSCI LETT, V450, P186, DOI 10.1016/j.neulet.2008.11.056; Matsuo R, 2000, CRIT REV ORAL BIOL M, V11, P216, DOI 10.1177/10454411000110020501; Mattes R. D., 2010, FAT DETECTION TASTE; Mattes RD, 2011, PHYSIOL BEHAV, V105, P27, DOI 10.1016/j.physbeh.2011.02.016; Mattes RD, 2009, CHEM SENSES, V34, P145, DOI 10.1093/chemse/bjn072; MELIS M, 2017, NUTRIENTS, V9; Melis M, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01006; Melis M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131104; Melis M, 2015, NUTRIENTS, V7, P2068, DOI 10.3390/nu7032068; Melis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074151; Melis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059810; Mounayar R, 2014, METABOLOMICS, V10, P688, DOI 10.1007/s11306-013-0602-1; Ogawa T, 2005, J PHARM SCI-US, V94, P353, DOI 10.1002/jps.20248; Padiglia A, 2010, AM J CLIN NUTR, V92, P539, DOI 10.3945/ajcn.2010.29418; PAL T, 1989, INDIAN J EXP BIOL, V27, P695; Pani D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177246; Pepino MY, 2010, OBESITY, V18, P959, DOI 10.1038/oby.2009.493; Pepino MY, 2012, J LIPID RES, V53, P561, DOI 10.1194/jlr.M021873; Prescott J, 2000, CHEM SENSES, V25, P239, DOI 10.1093/chemse/25.3.239; Prescott J, 2004, PHYSIOL BEHAV, V82, P459, DOI 10.1016/j.physbeh.2004.04.009; Prescott J., 2004, GENETIC VARIATION TA, P89; Rawal S, 2017, OBESITY, V25, P781, DOI 10.1002/oby.21785; REED AE, 1985, J CHEM PHYS, V83, P735, DOI 10.1063/1.449486; Salentinig S, 2010, LANGMUIR, V26, P11670, DOI 10.1021/la101012a; Sandell M, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0433-3; Saraswathi NT, 2003, ACTA CRYSTALLOGR B, V59, P641, DOI 10.1107/S0108768103013685; Sartor F, 2011, APPETITE, V57, P237, DOI 10.1016/j.appet.2011.05.107; Sayed A, 2015, INT J OBESITY, V39, P920, DOI 10.1038/ijo.2015.20; SCHAFER A, 1992, J CHEM PHYS, V97, P2571, DOI 10.1063/1.463096; Sclafani A, 2007, AM J PHYSIOL-REG I, V293, pR1823, DOI 10.1152/ajpregu.00211.2007; Sette S, 2011, NUTR METAB CARDIOVAS, V21, P922, DOI 10.1016/j.numecd.2010.03.001; Shahbake M, 2005, BRAIN RES, V1052, P196, DOI 10.1016/j.brainres.2005.06.031; Simchen U, 2006, EUR J CLIN NUTR, V60, P698, DOI 10.1038/sj.ejcn.1602371; Smit LA, 2009, ANN NUTR METAB, V55, P44, DOI 10.1159/000228995; Smutzer G, 2013, CHEM SENSES, V38, P529, DOI 10.1093/chemse/bjt023; Sollai G, 2017, SCI REP-UK, V7, DOI 10.1038/srep40353; SPIELMAN AI, 1990, J DENT RES, V69, P838, DOI 10.1177/00220345900690030101; Stewart JE, 2011, CLIN NUTR, V30, P838, DOI 10.1016/j.clnu.2011.06.007; Stewart JE, 2010, BRIT J NUTR, V104, P145, DOI 10.1017/S0007114510000267; Strittmatter EF, 2000, J PHYS CHEM A, V104, P6069, DOI 10.1021/jp000038y; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Tepper BJ, 2008, ANNU REV NUTR, V28, P367, DOI 10.1146/annurev.nutr.28.061807.155458; Tepper BJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121275; Tepper BJ, 2014, NUTRIENTS, V6, P3363, DOI 10.3390/nu6093363; Tepper BJ, 2011, APPETITE, V56, P104, DOI 10.1016/j.appet.2010.11.144; Tepper BJ, 2009, ANN NY ACAD SCI, V1170, P126, DOI 10.1111/j.1749-6632.2009.03916.x; Tepper BJ, 1998, ANN NY ACAD SCI, V855, P802, DOI 10.1111/j.1749-6632.1998.tb10662.x; Tepper BJ, 1997, PHYSIOL BEHAV, V61, P949, DOI 10.1016/S0031-9384(96)00608-7; Tepper BJ, 2001, PHYSIOL BEHAV, V73, P571, DOI 10.1016/S0031-9384(01)00500-5; THAN TT, 1994, PHYSIOL BEHAV, V56, P237, DOI 10.1016/0031-9384(94)90189-9; Tsuruta M, 1999, PHYSIOL BEHAV, V66, P285, DOI 10.1016/S0031-9384(98)00299-6; Tucker RM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169583; Tucker RM, 2015, CHEM SENSES, V40, P557, DOI 10.1093/chemse/bjv040; Weigend F, 2006, PHYS CHEM CHEM PHYS, V8, P1057, DOI 10.1039/b515623h; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; Yeomans MR, 2007, PHYSIOL BEHAV, V91, P264, DOI 10.1016/j.physbeh.2007.03.011; Yoo J, 2008, BIOPHYS J, V94, pL61, DOI 10.1529/biophysj.107.122945; Zhang X, 2010, J NANOMATER, V2010, P7, DOI DOI 10.1016/J.SCIT0TENV.2010.07.022; Zhao LQ, 2003, PHYSIOL BEHAV, V78, P625, DOI 10.1016/S0031-9384(03)00057-X	122	13	13	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194953	10.1371/journal.pone.0194953	http://dx.doi.org/10.1371/journal.pone.0194953			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566052	Green Submitted, gold, Green Published			2022-12-26	WOS:000428093900121
J	Padalino, B; Raidal, SL; Knight, P; Celi, P; Jeffcott, L; Muscatello, G				Padalino, Barbara; Raidal, Sharanne L.; Knight, Peter; Celi, Pietro; Jeffcott, Leo; Muscatello, Gary			Behaviour during transportation predicts stress response and lower airway contamination in horses	PLOS ONE			English	Article							LOWER RESPIRATORY-TRACT; RISK-FACTORS; PLEUROPNEUMONIA; INFLAMMATION; CONFINEMENT; DATABASE; POSTURE; REST	This study aimed to document the effects of an eight hour journey on behavioural, clinical, haematological, environmental and respiratory parameters, and to identify possible associations between factors. Twelve horses underwent clinical examination, respiratory endoscopy with tracheal wash (TW) aspiration, and collection of venous and arterial blood before (BJ) and after the journey (AJ). TW were submitted for conventional quantitative bacteriological evaluation and genetic microbiome analyses. Behaviour was assessed in stables prior to transportation and throughout the journey. Transportation caused mild, but significant, effects on fluid and electrolyte balance and an acute phase response, characterized by neutrophilia, hyperfibrinogenaemia and hyperglobulinaemia. The proportion of neutrophils in TW, tracheal mucus and TW bacterial concentration was increased AJ, with preferential replication of Pasteurellaceae. Horse behaviour en route predicted clinical and respiratory outcomes. The frequency of stress related behaviours was greatest in the first hour of the journey, and balance-related behaviours were most common in the final hour of the journey. Horses which lowered their heads less frequently en route and showed more stress-related behaviours had higher physiological stress (serum cortisol and heart rate on arrival), increased tracheal mucus and inflammation scores, and higher TW bacterial concentration AJ (P<0.05). Six horses with abnormal lung auscultation AJ proved to have had higher tracheal inflammation scores at preloading (P = 0.017), an overall higher concentration of bacteria in their TW (P = 0.013), and an increased percentage of neutrophils in TW at five days AJ (P = 0.003) in comparison to the other horses. While transport-related health problems are multifactorial, clinical examination, including auscultation and endoscopic inspection of the lower respiratory tract before and after journey, and behavioural observation en route may identify animals at increased risk of transport associated respiratory disease.	[Padalino, Barbara; Celi, Pietro; Jeffcott, Leo; Muscatello, Gary] Univ Sydney, Sch Life & Environm Sci, Fac Vet Sci, Sydney, NSW, Australia; [Padalino, Barbara] Univ Bari, Dept Vet Med, Bari, Italy; [Padalino, Barbara] City Univ Hong Kong, Coll Vet Med, Kowloon, Hong Kong, Peoples R China; [Raidal, Sharanne L.] Charles Stuart Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW, Australia; [Knight, Peter] Univ Sydney, Sydney Med Sch, Sch Med Sci, Discipline Biomed Sci, Lidcombe, NSW, Australia; [Celi, Pietro] DSM Nutr Prod Anim Nutr & Hlth, Columbia, MD USA; [Celi, Pietro] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic, Australia	University of Sydney; Universita degli Studi di Bari Aldo Moro; City University of Hong Kong; Charles Sturt University; University of Sydney; DSM NV; University of Melbourne	Padalino, B (corresponding author), Univ Sydney, Sch Life & Environm Sci, Fac Vet Sci, Sydney, NSW, Australia.; Padalino, B (corresponding author), Univ Bari, Dept Vet Med, Bari, Italy.; Padalino, B (corresponding author), City Univ Hong Kong, Coll Vet Med, Kowloon, Hong Kong, Peoples R China.	barbara.padalino@sydney.edu.au	Muscatello, Gary/AAG-1047-2021; Knight, Peter/A-9555-2011; Padalino, Barbara/AAJ-7498-2020; Celi, Pietro/D-6567-2014	Knight, Peter/0000-0002-1076-5379; Celi, Pietro/0000-0002-7933-3160; PADALINO, BARBARA/0000-0002-7630-8285; Raidal, Sharanne/0000-0001-5558-3133	University of Sydney International Postgraduate Research Scholarship (IPRS); Faculty of Health Science, University of Sydney	University of Sydney International Postgraduate Research Scholarship (IPRS); Faculty of Health Science, University of Sydney	This study was funded by the University of Sydney International Postgraduate Research Scholarship (IPRS) to BP and Faculty of Health Science, Internal grant scheme, University of Sydney to PK.	[Anonymous], 2016, PRACTICAL GUIDELINES; AUSTIN SM, 1995, J AM VET MED ASSOC, V207, P325; Bohak Z, 2013, DOMEST ANIM ENDOCRIN, V45, P38, DOI 10.1016/j.domaniend.2013.04.001; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CARROLL CL, 1988, EQUINE VET J, V20, P41, DOI 10.1111/j.2042-3306.1988.tb01451.x; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fazio E, 2016, VET WORLD, V9, P856, DOI 10.14202/vetworld.2016.856-861; Fazio E, 2013, ANIM SCI J, V84, P258, DOI 10.1111/j.1740-0929.2012.01065.x; Fazio E, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-6; Gerber V, 2004, EQUINE VET J, V36, P576, DOI 10.2746/0425164044864525; GREEN H. H., 1935, JOUR COMP PATH AND THERAP, V48, P74, DOI 10.1016/S0368-1742(35)80009-X; Hillstrom A, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-8; Hines T., 2000, GUIDELINES HORSE TRA, P93; Hobo S, 1997, AM J VET RES, V58, P531; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Katayama Yoshinari, 1995, Journal of Equine Science, V6, P99, DOI 10.1294/jes.6.99; Kiley-Worthington M, 1997, BEHAV HORSES RELATIO; LEADON D, 1989, J EQUINE VET SCI, V9, P200, DOI 10.1016/S0737-0806(89)80051-6; Leadon D.P., 2014, ATHLETIC HORSE PRINC, V2nd ed., P155, DOI DOI 10.1016/B978-0-7216-0075-8.00019-8; LEADON DP, 1994, EQUINE VET J, V26, P346, DOI 10.1111/j.2042-3306.1994.tb04400.x; Marlin D. J., 2004, Equine sports medicine and surgery: basic and clinical sciences of the equine athlete, P1239, DOI 10.1016/B978-0-7020-2671-3.50067-2; MCDONNELL SM, 1995, APPL ANIM BEHAV SCI, V43, P147, DOI 10.1016/0168-1591(94)00550-X; McGorum BC., 2007, EQUINE RESP MED SURG; McGreevy P., 2012, EQUINE BEHAV GUIDE V; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; MILLAR HR, 1971, J CLIN PATHOL, V24, P827, DOI 10.1136/jcp.24.9.827; Morgan K, 1998, J THERM BIOL, V23, P59, DOI 10.1016/S0306-4565(97)00047-8; Oikawa M, 2005, J COMP PATHOL, V132, P153, DOI 10.1016/j.jcpa.2004.09.006; Oikawa M, 2000, GUIDELINES HORSE TRA, p[35, 117]; Padalino B, 2017, EQUINE VET J, V49, P507, DOI 10.1111/evj.12631; Padalino B, 2017, RES VET SCI, V115, P78, DOI 10.1016/j.rvsc.2017.01.024; Padalino B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162371; Padalino B, 2015, ANIMALS, V5, P1296, DOI 10.3390/ani5040412; Padalino B, 2012, J VET BEHAV, V7, P135, DOI 10.1016/j.jveb.2011.09.003; PICKRELL J, 1991, VET HUM TOXICOL, V33, P32; Purswell JL, 2010, T ASABE, V53, P1885; R Core Team, R LANG ENV STAT COMP; RACKLYEFT DJ, 1990, AUST VET J, V67, P402, DOI 10.1111/j.1751-0813.1990.tb03028.x; Racklyeft DJ, 2000, AUST VET J, V78, P334, DOI 10.1111/j.1751-0813.2000.tb11788.x; RAIDAL SL, 1995, AUST VET J, V72, P45, DOI 10.1111/j.1751-0813.1995.tb15328.x; Raidal SL, 1996, AUST VET J, V73, P45, DOI 10.1111/j.1751-0813.1996.tb09963.x; Raidal SL, 1997, AUST VET J, V75, P433, DOI 10.1111/j.1751-0813.1997.tb14349.x; Reed S.M., 2003, EQUINE INTERNAL MED, V4th; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saslow CA, 2002, APPL ANIM BEHAV SCI, V78, P209, DOI 10.1016/S0168-1591(02)00092-8; Schmidt A, 2010, DOMEST ANIM ENDOCRIN, V38, P179, DOI 10.1016/j.domaniend.2009.10.002; Schmidt A, 2010, HORM BEHAV, V57, P209, DOI 10.1016/j.yhbeh.2009.11.003; Siniscalchi M, 2014, BEHAV PROCESS, V107, P61, DOI 10.1016/j.beproc.2014.07.018; Smith BL, 1996, EQUINE VET J, V28, P446, DOI 10.1111/j.2042-3306.1996.tb01616.x; Stull CL, 2008, VET REC, V162, P609, DOI 10.1136/vr.162.19.609; Stull CL, 2004, EQUINE VET J, V36, P583, DOI 10.2746/0425164044864589; Stull CL, 1999, J ANIM SCI, V77, P2925; Stull CL, 2002, EQUINE VET J, V34, P550, DOI 10.2746/042516402776180214; Tateo A, 2012, J VET BEHAV, V7, P33, DOI 10.1016/j.jveb.2011.04.007; van den Berg JS, 1998, EQUINE VET J, V30, P316, DOI 10.1111/j.2042-3306.1998.tb04104.x; Waring G.H., 2003, HORSE BEHAV, V2; Young T, 2012, APPL ANIM BEHAV SCI, V140, P33, DOI 10.1016/j.applanim.2012.05.008; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	61	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194272	10.1371/journal.pone.0194272	http://dx.doi.org/10.1371/journal.pone.0194272			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566072	Green Published, gold			2022-12-26	WOS:000428093900048
J	Zettermark, S; Vicente, RP; Merlo, J				Zettermark, Sofia; Vicente, Raquel Perez; Merlo, Juan			Hormonal contraception increases the risk of psychotropic drug use in adolescent girls but not in adults: A pharmacoepidemiological study on 800 000 Swedish women	PLOS ONE			English	Article							COMBINED ORAL-CONTRACEPTIVES; NATIONAL COMORBIDITY SURVEY; DEPRESSIVE SYMPTOMS; ADVERSE MOOD; DOUBLE-BLIND; POPULATION; DISCONTINUATION; ASSOCIATION; EXPERIENCE; DISORDERS	The burden of depression and anxiety disorders is greater in women, and female sex hormones have been shown to affect mood. Psychological side effects of hormonal contraception (HC) are also a common complaint in the clinic, but few previous studies have investigated this subject. We therefore wanted to investigate whether use of HC was associated with adverse psychological health outcomes, and whether this association was modified by age. All women aged 12-30 years on 31 December 2010, residing in Sweden for at least four years and with no previous psychiatric morbidity (n = 815 662), were included. We followed the women from their first HC use (or 31 December 2010, if they were non-users) at baseline, until a prescription fill of psychotropic drugs or the end of the one-year follow-up. We performed age -stratified logistic regression models and estimated odds ratios (OR) to measure the association between different HC methods and psychotropic drug use, as well as the area under the receiver operating curve to estimate discriminatory accuracy of HC in relation to psychotropic drugs. Overall, we found an association between HC and psychotropic drugs (adjusted OR 1.34, 95% confidence interval [CI] 1.30-1.37). In the age -stratified analysis, the strongest association was found in adolescent girls (adjusted OR 3.46, 95% CI 3.04-4.94 for age 12 to 14 years), while it was non-existent for adult women. We conclude that hormonal contraception is associated with psychotropic drug use among adolescent girls, suggesting an adverse effect of HC on psychological health in this population.	[Zettermark, Sofia; Vicente, Raquel Perez; Merlo, Juan] Lund Univ, Clin Res Ctr, Dept Clin Sci, Unit Social Epidemiol, Malmo, Sweden	Lund University	Zettermark, S (corresponding author), Lund Univ, Clin Res Ctr, Dept Clin Sci, Unit Social Epidemiol, Malmo, Sweden.	sofia.zettermark@med.lu.se	Merlo, Juan/E-2136-2011; Zettermark, Sofia/AAD-1920-2021	Merlo, Juan/0000-0001-8379-9708; Zettermark, Sofia/0000-0003-3181-8609	Swedish Scientific Council [2013-2484]; Faculty of Medicine, Lund University; Region Skane County Council	Swedish Scientific Council; Faculty of Medicine, Lund University; Region Skane County Council	This work was supported by the Swedish Scientific Council (# 2013-2484, PI: Juan Merlo) and research funds from the Faculty of Medicine, Lund University, and Region Skane County Council.	Andreen L, 2009, PSYCHONEUROENDOCRINO, V34, P1121, DOI 10.1016/j.psyneuen.2009.02.003; Berenson AB, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.048; Berlin M, 2017, DEV MENTAL HLTH ISSU; Bottcher B, 2012, ARCH GYNECOL OBSTET, V286, P231, DOI 10.1007/s00404-012-2298-2; Borgstom A, 2008, EUR J OBSTET GYN R B, V141, P127, DOI 10.1016/j.ejogrb.2008.07.018; Duke JM, 2007, CONTRACEPTION, V75, P27, DOI 10.1016/j.contraception.2006.08.002; Francis J, 2015, CONTRACEPTION, V91, P336, DOI 10.1016/j.contraception.2014.12.010; Gardarsdottir H, 2007, J AFFECT DISORDERS, V98, P109, DOI 10.1016/j.jad.2006.07.003; Graham CA, 1995, CONTRACEPTION, V52, P363, DOI 10.1016/0010-7824(95)00226-X; Joffe H, 1998, BIOL PSYCHIAT, V44, P798, DOI 10.1016/S0006-3223(98)00169-3; KESSLER RC, 1994, J AFFECT DISORDERS, V30, P15, DOI 10.1016/0165-0327(94)90147-3; Kessler RC, 2006, ARCH GEN PSYCHIAT, V63, P415, DOI 10.1001/archpsyc.63.4.415; Keyes KM, 2013, AM J EPIDEMIOL, V178, P1378, DOI 10.1093/aje/kwt188; Kulkarni J, 2007, EXPERT OPIN DRUG SAF, V6, P371, DOI 10.1517/14740338.6.4.371; Kurshan N, 2005, ARCH WOMEN MENT HLTH, V9, P1, DOI 10.1007/s00737-005-0102-z; Lara LAS, 2016, J PEDIATR ADOL GYNEC, V29, P417, DOI 10.1016/j.jpag.2015.11.012; Lindberg M, 2012, EUR J CONTRACEP REPR, V17, P106, DOI 10.3109/13625187.2012.658925; Longitudinal integration database for health insurance and labour market studies (LISA), 2016, STAT SWED GUID RES U; Lopez Laureen M, 2013, COCHRANE DB SYST REV, V30; Ludvigsson JF, 2016, EUR J EPIDEMIOL, V31, P125, DOI 10.1007/s10654-016-0117-y; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Merlo J, 2017, SSM-POPUL HLTH, V3, P684, DOI 10.1016/j.ssmph.2017.08.005; O'Connell K, 2007, CONTRACEPTION, V75, P299, DOI 10.1016/j.contraception.2006.09.008; Oinonen KA, 2002, J AFFECT DISORDERS, V70, P229, DOI 10.1016/S0165-0327(01)00356-1; Ott MA, 2008, ARCH SEX BEHAV, V37, P605, DOI 10.1007/s10508-007-9302-0; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; Rogines-Velo MP, 2012, MENOPAUSE, V19, P471, DOI 10.1097/gme.0b013e3182333847; Rosenberg MJ, 1998, AM J OBSTET GYNECOL, V179, P577, DOI 10.1016/S0002-9378(98)70047-X; Sanders SA, 2001, CONTRACEPTION, V64, P51, DOI 10.1016/S0010-7824(01)00218-9; Segebladh B, 2009, CONTRACEPTION, V79, P50, DOI 10.1016/j.contraception.2008.08.001; Shen H, 2007, NAT NEUROSCI, V10, P469, DOI 10.1038/nn1868; Sivin I, 2003, DRUG SAFETY, V26, P303, DOI 10.2165/00002018-200326050-00002; Skovlund C, 2016, JAMA PSYCHIAT, V73, P1154, DOI 10.1001/jamapsychiatry.2016.2387; Sundstrom I, 1998, NEUROENDOCRINOLOGY, V67, P126, DOI 10.1159/000054307; Svendal G, 2012, J AFFECT DISORDERS, V140, P92, DOI 10.1016/j.jad.2012.03.030; Toffol E, 2011, HUM REPROD, V26, P3085, DOI 10.1093/humrep/der269; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Wiebe ER, 2013, AM J EPIDEMIOL, V178, P1389, DOI 10.1093/aje/kwt186; Wirehn AB, 2010, EUR J CONTRACEP REPR, V15, P41, DOI 10.3109/13625181003587004; Yonkers KA, 2003, J CLIN PSYCHIAT, V64, P8; Zethraeus N, 2016, J CLIN ENDOCR METAB, V101, P4046, DOI 10.1210/jc.2016-2032	42	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194773	10.1371/journal.pone.0194773	http://dx.doi.org/10.1371/journal.pone.0194773			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA1RF	29566064	Green Published, Green Submitted, gold			2022-12-26	WOS:000428093900103
J	Bageghni, SA; Hemmings, KE; Zava, N; Denton, CP; Porter, KE; Ainscough, JFX; Drinkhill, MJ; Turner, NA				Bageghni, Sumia A.; Hemmings, Karen E.; Zava, Ngonidzashe; Denton, Christopher P.; Porter, Karen E.; Ainscough, Justin F. X.; Drinkhill, Mark J.; Turner, Neil A.			Cardiac fibroblast-specific p38 alpha MAP kinase promotes cardiac hypertrophy via a putative paracrine interleukin-6 signaling mechanism	FASEB JOURNAL			English	Article						heart; cardiomyocyte; microRNA; isoproterenol; mouse	ACTIVATED PROTEIN-KINASE; II TYPE-1 RECEPTOR; PRESSURE-OVERLOAD; HEART-FAILURE; P38 MAPK; MYOCARDIAL-INFARCTION; CYTOKINE EXPRESSION; GENE-EXPRESSION; REGULATORY ROLE; UP-REGULATION	Recent studies suggest that cardiac fibroblast-specific p38 MAPK contributes to the development of cardiac hypertrophy, but the underlying mechanism is unknown. Our study used a novel fibroblast-specific, tamoxifen-inducible p38 knockout (KO) mouse line to characterize the role of fibroblast p38 in modulating cardiac hypertrophy, and we elucidated the mechanism. Myocardial injury was induced in tamoxifen-treated Cre-positive p38 KO mice or control littermates via chronic infusion of the -adrenergic receptor agonist isoproterenol. Cardiac function was assessed by pressure-volume conductance catheter analysis and was evaluated for cardiac hypertrophy at tissue, cellular, and molecular levels. Isoproterenol infusion in control mice promoted overt cardiac hypertrophy and dysfunction (reduced ejection fraction, increased end systolic volume, increased cardiac weight index, increased cardiomyocyte area, increased fibrosis, and up-regulation of myocyte fetal genes and hypertrophy-associated microRNAs). Fibroblast-specific p38 KO mice exhibited marked protection against myocardial injury, with isoproterenol-induced alterations in cardiac function, histology, and molecular markers all being attenuated. In vitro mechanistic studies determined that cardiac fibroblasts responded to damaged myocardium by secreting several paracrine factors known to induce cardiomyocyte hypertrophy, including IL-6, whose secretion was dependent upon p38 activity. In conclusion, cardiac fibroblast p38 contributes to cardiomyocyte hypertrophy and cardiac dysfunction, potentially via a mechanism involving paracrine fibroblast-to-myocyte IL-6 signaling.Bageghni, S. A., Hemmings, K. E., Zava, N., Denton, C. P., Porter, K. E., Ainscough, J. F. X., Drinkhill, M. J., Turner, N. A. Cardiac fibroblast-specific p38 MAP kinase promotes cardiac hypertrophy via a putative paracrine interleukin-6 signaling mechanism.	[Bageghni, Sumia A.; Hemmings, Karen E.; Zava, Ngonidzashe; Porter, Karen E.; Ainscough, Justin F. X.; Drinkhill, Mark J.; Turner, Neil A.] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Sch Med, Leeds, W Yorkshire, England; [Denton, Christopher P.] UCL, Div Med, Ctr Rheumatol, London, England	University of Leeds; University of London; University College London	Turner, NA (corresponding author), Univ Leeds, Leeds Inst Cardiovasc & Metab Med, LIGHT Labs, Discovery & Translat Sci Dept, Clarendon Way, Leeds LS2 9JT, W Yorkshire, England.	n.a.turner@leeds.ac.uk		Hemmings, Karen/0000-0002-4967-6314; Turner, Neil/0000-0002-4957-5433; Bageghni, Sumia Abdulaziz/0000-0001-9640-3717; Ainscough, Justin/0000-0003-0231-433X	British Heart Foundation [PG/11/110/29248, PG/11/80/29135]	British Heart Foundation(British Heart Foundation)	The authors thank Drs. Juan-Jose Ventura [Katholieke Universiteit (KU) Leuven, Leuven, Belgium] and Manolis Pasparakis (University of Cologne, Cologne, Germany), for the provision of floxed Mapk14 mice, and Emmanuel Pinteaux (University of Manchester, Manchester, United Kingdom) for the provision of floxed Il1r1 mice. This work was supported by funding from the British Heart Foundation (Grants PG/11/110/29248 and PG/11/80/29135) awarded to N.A.T. (principal investigator), J.F.X.A., M.J.D., and K.E.P. The authors declare no conflicts of interest.	Abdulaal WH, 2016, EUR J IMMUNOL, V46, P912, DOI 10.1002/eji.201546075; Abonnenc M, 2013, CIRC RES, V113, P1138, DOI 10.1161/CIRCRESAHA.113.302400; Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Ainscough JFX, 2009, CARDIOVASC RES, V81, P592, DOI 10.1093/cvr/cvn230; Ancey C, 2003, CARDIOVASC RES, V59, P78, DOI 10.1016/S0008-6363(03)00346-8; Arabacilar P, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00102; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Braz JC, 2003, J CLIN INVEST, V111, P1475, DOI 10.1172/JCI200317295; Cha HN, 2010, KOREAN J PHYSIOL PHA, V14, P377, DOI 10.4196/kjpp.2010.14.6.377; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Coles B, 2007, AM J PATHOL, V171, P315, DOI 10.2353/ajpath.2007.061078; Denton CP, 2009, J INVEST DERMATOL, V129, P194, DOI 10.1038/jid.2008.171; Diao XH, 2011, MOL MED REP, V4, P633, DOI 10.3892/mmr.2011.489; Dingar D, 2010, CELL SIGNAL, V22, P1634, DOI 10.1016/j.cellsig.2010.06.002; Dostal D, 2015, COMPR PHYSIOL, V5, P887, DOI 10.1002/cphy.c140053; Du WJ, 2016, CELL PHYSIOL BIOCHEM, V39, P827, DOI 10.1159/000447793; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Emde B, 2014, EUR J HISTOCHEM, V58, P315, DOI 10.4081/ejh.2014.2448; Frentzou GA, 2015, DIS MODEL MECH, V8, P783, DOI 10.1242/dmm.019174; Fujiu K, 2014, J MOL CELL CARDIOL, V70, P64, DOI 10.1016/j.yjmcc.2014.01.013; Goldsmith Steven R, 2004, Curr Heart Fail Rep, V1, P45, DOI 10.1007/s11897-004-0024-5; Grisanti LA, 2015, AM J PHYSIOL-HEART C, V308, pH316, DOI 10.1152/ajpheart.00635.2014; Heinrichsdorff J, 2008, EMBO REP, V9, P1048, DOI 10.1038/embor.2008.149; Hou YL, 2012, MED SCI MONITOR, V18, pBR309, DOI 10.12659/MSM.883263; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Kamo T, 2015, CIRC RES, V117, P89, DOI 10.1161/CIRCRESAHA.117.305349; Koivisto E, 2011, MOL CELL ENDOCRINOL, V338, P18, DOI 10.1016/j.mce.2011.02.015; Lal H, 2014, CIRCULATION, V130, P419, DOI 10.1161/CIRCULATIONAHA.113.008364; Lal H, 2008, J MOL CELL CARDIOL, V45, P770, DOI 10.1016/j.yjmcc.2008.09.121; Lemke LE, 2001, J MOL CELL CARDIOL, V33, P1527, DOI 10.1006/jmcc.2001.1415; Li YL, 2017, CIRCULATION, V135, P2041, DOI 10.1161/CIRCULATIONAHA.116.024599; Li ZH, 2004, J CARDIOVASC PHARM, V44, P486, DOI 10.1097/01.fjc.0000141474.06383.6f; Lugrin J, 2015, J IMMUNOL, V194, P499, DOI 10.4049/jimmunol.1401948; Mann DL, 2015, CIRC RES, V116, P1254, DOI 10.1161/CIRCRESAHA.116.302317; Marber MS, 2011, J MOL CELL CARDIOL, V51, P485, DOI 10.1016/j.yjmcc.2010.10.021; Martin ED, 2015, BRIT J PHARMACOL, V172, P2101, DOI 10.1111/bph.12901; Meier H, 2009, CELL PHYSIOL BIOCHEM, V23, P327, DOI 10.1159/000218180; Molkentin JD, 2017, CIRCULATION, V136, P549, DOI 10.1161/CIRCULATIONAHA.116.026238; Mylonas KJ, 2017, J ENDOCRINOL, V233, P315, DOI 10.1530/JOE-16-0501; Nawaito SA, 2017, AM J PHYSIOL-HEART C, V313, pH46, DOI 10.1152/ajpheart.00597.2016; Ning QL, 2013, BIOMED REP, V1, P776, DOI 10.3892/br.2013.144; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Ohkura S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182329; Perez DM, 2009, MOL PHARMACOL, V76, P144, DOI 10.1124/mol.108.054320; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Ramanujam D, 2016, MOL THER, V24, P1939, DOI 10.1038/mt.2016.166; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Sari FR, 2011, CELL PHYSIOL BIOCHEM, V27, P487, DOI 10.1159/000329970; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Sinfield JK, 2013, BIOCHEM BIOPH RES CO, V430, P419, DOI 10.1016/j.bbrc.2012.11.071; Singh VP, 2008, AM J PHYSIOL-HEART C, V294, pH1675, DOI 10.1152/ajpheart.91493.2007; Stratton MS, 2017, CIRCULATION, V136, P562, DOI 10.1161/CIRCULATIONAHA.117.028957; Sun C, 2017, BIOCHEM BIOPH RES CO, V490, P1106, DOI 10.1016/j.bbrc.2017.06.182; Sun M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18351; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Turner NA, 2001, CELL SIGNAL, V13, P269, DOI 10.1016/S0898-6568(01)00135-8; Turner NA, 2016, J MOL CELL CARDIOL, V94, P189, DOI 10.1016/j.yjmcc.2015.11.002; Turner NA, 2011, FUTUR CARDIOL, V7, P673, DOI [10.2217/fca.11.41, 10.2217/FCA.11.41]; Turner NA, 2010, MATRIX BIOL, V29, P613, DOI 10.1016/j.matbio.2010.06.007; Turner NA, 2009, AM J PHYSIOL-HEART C, V297, pH1117, DOI 10.1152/ajpheart.00372.2009; Ubil E, 2014, NATURE, V514, P585, DOI 10.1038/nature13839; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Xiao H, 2018, EUR HEART J, V39, P60, DOI 10.1093/eurheartj/ehx261; Yang SF, 2015, ONCOTARGET, V6, P2736, DOI 10.18632/oncotarget.3088; Yokota T, 2016, GENE, V575, P369, DOI 10.1016/j.gene.2015.09.030; Zhang SS, 2003, J CLIN INVEST, V111, P833, DOI 10.1172/JCI200316290; Zhao L, 2015, CELL SIGNAL, V27, P2026, DOI 10.1016/j.cellsig.2015.07.007; Zhao L, 2016, CIRC RES, V118, P1918, DOI 10.1161/CIRCRESAHA.116.308688; Zheng B, 2002, AM J PATHOL, V160, P1609, DOI 10.1016/S0002-9440(10)61108-X; Zhu JY, 2012, CYTOKINE, V58, P368, DOI 10.1016/j.cyto.2012.02.008	73	42	45	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4941	4954		10.1096/fj.201701455RR	http://dx.doi.org/10.1096/fj.201701455RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29601781	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000443817700027
J	Gutierrez, BA; Chavez, MA; Rodarte, AI; Ramos, MA; Dominguez, A; Petrova, Y; Davalos, AJ; Costa, RM; Elizondo, R; Tuvim, MJ; Dickey, BF; Burns, AR; Heidelberger, R; Adachi, R				Gutierrez, Berenice A.; Chavez, Miguel A.; Rodarte, Alejandro I.; Ramos, Marco A.; Dominguez, Andrea; Petrova, Youlia; Davalos, Alfredo J.; Costa, Renan M.; Elizondo, Ramon; Tuvim, Michael J.; Dickey, Burton F.; Burns, Alan R.; Heidelberger, Ruth; Adachi, Roberto			Munc18-2, but not Munc18-1 or Munc18-3, controls compound and single-vesicle-regulated exocytosis in mast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mast cell; exocytosis; SNARE proteins; patch clamp; allergy; secretion; electrophysiology; anaphylaxis; Munc18; syntaxin-binding protein	SYNTAXIN 4; CAPACITANCE MEASUREMENTS; GLUT4 TRANSLOCATION; SECRETORY RESPONSES; SNARE; FUSION; MICE; PROTEIN; DEGRANULATION; ACTIVATION	Mast cells (MCs) play pivotal roles in many inflammatory conditions including infections, anaphylaxis, and asthma. MCs store immunoregulatory compounds in their large cytoplasmic granules and, upon stimulation, secrete them via regulated exocytosis. Exocytosis in many cells requires the participation of Munc18 proteins (also known as syntaxin-binding proteins), and we found that mature MCs express all three mammalian isoforms: Munc18-1, -2, and -3. To study their functions in MC effector responses and test the role of MC degranulation in anaphylaxis, we used conditional knockout (cKO) mice in which each Munc18 protein was deleted exclusively in MCs. Using recordings of plasma membrane capacitance for high-resolution analysis of exocytosis in individual MCs, we observed an almost complete absence of exocytosis in Munc18-2-deficient MCs but intact exocytosis in MCs lacking Munc18-1 or Munc18-3. Stereological analysis of EM images of stimulated MCs revealed that the deletion of Munc18-2 also abolishes the homotypic membrane fusion required for compound exocytosis. We confirmed the severe defect in regulated exocytosis in the absence of Munc18-2 by measuring the secretion of mediators stored in MC granules. Munc18-2 cKO mice had normal morphology, development, and distribution of their MCs, indicating that Munc18-2 is not essential for the migration, retention, and maturation of MC-committed progenitors. Despite that, we found that Munc18-2 cKO mice were significantly protected from anaphylaxis. In conclusion, MC-regulated exocytosis is required for the anaphylactic response, and Munc18-2 is the sole Munc18 isoform that mediates membrane fusion during MC degranulation.	[Gutierrez, Berenice A.; Chavez, Miguel A.; Rodarte, Alejandro I.; Ramos, Marco A.; Petrova, Youlia; Davalos, Alfredo J.; Tuvim, Michael J.; Dickey, Burton F.; Adachi, Roberto] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, 2121 W Holcombe Blvd, Houston, TX 77030 USA; [Gutierrez, Berenice A.] Tecnol Monterrey, Escuela Ingn & Ciencias, Monterrey 64849, NL, Mexico; [Chavez, Miguel A.; Rodarte, Alejandro I.; Dominguez, Andrea; Elizondo, Ramon] Tecnol Monterrey, Escuela Med & Ciencias Salud, Monterrey 64710, NL, Mexico; [Costa, Renan M.] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, McGovern Med Sch, Houston, TX 77030 USA; [Heidelberger, Ruth] Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, McGovern Med Sch, Houston, TX 77030 USA; [Burns, Alan R.] Univ Houston, Coll Optometry, Houston, TX 77204 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; UTMD Anderson Cancer Center; Tecnologico de Monterrey; Tecnologico de Monterrey; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Houston System; University of Houston	Adachi, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	radachi@mdanderson.org		Heidelberger, Ruth/0000-0002-8033-2050; Adachi, Roberto/0000-0002-0146-0768; Tuvim, Michael/0000-0001-8126-7716; Costa, Renan/0000-0001-7195-5259	National Institutes of Health [AI093533, HL129795, CA016672, EY012128, EY007551]; Cancer Prevention Research Institute of Texas Grant [RP110166]; Mexican National Council for Science and Technology Ph.D. Grant Scholarship [448085]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R29EY012128, P30EY007551, R01EY012128] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL129795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas Grant; Mexican National Council for Science and Technology Ph.D. Grant Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI093533, HL129795, CA016672, EY012128, and EY007551; Cancer Prevention Research Institute of Texas Grant RP110166; and Mexican National Council for Science and Technology Ph.D. Grant Scholarship 448085. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi R, 2012, J BIOL CHEM, V287, P20047, DOI 10.1074/jbc.M112.360388; Adhikari P, 2018, INFLAMM RES, V67, P1, DOI 10.1007/s00011-017-1097-4; Araki S, 1997, BIOCHEM BIOPH RES CO, V234, P257, DOI 10.1006/bbrc.1997.6560; Baram D, 1999, J EXP MED, V189, P1649, DOI 10.1084/jem.189.10.1649; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; Bin NR, 2013, P NATL ACAD SCI USA, V110, P4610, DOI 10.1073/pnas.1214887110; Blank U, 2002, MOL IMMUNOL, V38, P1341, DOI 10.1016/S0161-5890(02)00085-8; Brochetta C, 2008, BBA-MOL CELL RES, V1783, P1781, DOI 10.1016/j.bbamcr.2008.05.023; Brochetta C, 2014, J IMMUNOL, V192, P41, DOI 10.4049/jimmunol.1301277; BROCK TA, 1988, AM J PHYSIOL, V255, pC667, DOI 10.1152/ajpcell.1988.255.5.C667; BUGAJSKI J, 1981, AGENTS ACTIONS, V11, P443, DOI 10.1007/BF02004704; Christie MP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187302; Dernick G, 2007, FRONT NEUROENG, V1, P315; DETOLEDO GA, 1990, J CELL BIOL, V110, P1033, DOI 10.1083/jcb.110.4.1033; DETOLEDO GA, 1990, J GEN PHYSIOL, V95, P397, DOI 10.1085/jgp.95.3.397; Dulubova I, 2003, P NATL ACAD SCI USA, V100, P32, DOI 10.1073/pnas.232701299; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; FINKELSTEIN A, 1986, ANNU REV PHYSIOL, V48, P163, DOI 10.1146/annurev.ph.48.030186.001115; Friend DS, 1996, J CELL BIOL, V135, P279, DOI 10.1083/jcb.135.1.279; Fu J, 2005, J BIOL CHEM, V280, P3178, DOI 10.1074/jbc.M410044200; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gillis Kevin D., 1995, P155; GINSBURG H, 1982, IMMUNOLOGY, V45, P371; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gurish MF, 2012, IMMUNITY, V37, P25, DOI 10.1016/j.immuni.2012.07.003; HATA Y, 1995, J BIOL CHEM, V270, P13022, DOI 10.1074/jbc.270.22.13022; Heeroma JH, 2004, EUR J NEUROSCI, V20, P623, DOI 10.1111/j.1460-9568.2004.03503.x; Houng A, 2003, J BIOL CHEM, V278, P19627, DOI 10.1074/jbc.M212465200; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Imai A, 2004, ARCH BIOCHEM BIOPHYS, V422, P175, DOI 10.1016/j.abb.2003.12.021; Innocenti B, 2008, J NEUROPHYSIOL, V99, P25, DOI 10.1152/jn.00737.2007; IRANI AMA, 1987, J IMMUNOL, V138, P4381; Jewell JL, 2010, AM J PHYSIOL-REG I, V298, pR517, DOI 10.1152/ajpregu.00597.2009; Kanda H, 2005, J CLIN INVEST, V115, P291, DOI 10.1172/JCI200522681; Kim K, 2012, BIOCHEM J, V446, P383, DOI 10.1042/BJ20120057; Lai Y, 2017, NEURON, V95, P591, DOI 10.1016/j.neuron.2017.07.004; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; Li Y, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00256; Lieberman P, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0598-5; Lin RC, 1997, NEURON, V19, P1087, DOI 10.1016/S0896-6273(00)80399-2; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Ma C, 2011, NAT STRUCT MOL BIOL, V18, P542, DOI 10.1038/nsmb.2047; Makabe-Kobayashi Y, 2002, J ALLERGY CLIN IMMUN, V110, P298, DOI 10.1067/mai.2002.125977; Marti-Verdeaux S, 2003, J CELL SCI, V116, P325, DOI 10.1242/jcs.00216; MCNEIL HP, 1992, J IMMUNOL, V149, P2466; Melicoff E, 2009, J BIOL CHEM, V284, P19445, DOI 10.1074/jbc.M109.002550; Messler P, 1996, J NEUROSCI METH, V69, P137, DOI 10.1016/S0165-0270(96)00032-5; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Moon TC, 2010, MUCOSAL IMMUNOL, V3, P111, DOI 10.1038/mi.2009.136; NEHER E, 1988, J PHYSIOL-LONDON, V395, P193, DOI 10.1113/jphysiol.1988.sp016914; Nigam R, 2005, BBA-GENE STRUCT EXPR, V1728, P77, DOI 10.1016/j.bbaexp.2005.01.018; Oberhauser AF, 1996, P NATL ACAD SCI USA, V93, P14349, DOI 10.1073/pnas.93.25.14349; Oh E, 2005, DIABETES, V54, P638, DOI 10.2337/diabetes.54.3.638; OZAWA K, 1993, J BIOL CHEM, V268, P1749; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Paumet F, 2000, J IMMUNOL, V164, P5850, DOI 10.4049/jimmunol.164.11.5850; Pickett JA, 2006, TRAFFIC, V7, P109, DOI 10.1111/j.1600-0854.2005.00372.x; Puri N, 2006, TRAFFIC, V7, P1482, DOI 10.1111/j.1600-0854.2006.00490.x; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Rodarte EM, 2018, J BIOL CHEM, V293, P345, DOI 10.1074/jbc.M117.816884; ROHLICH P, 1971, J CELL BIOL, V51, P465, DOI 10.1083/jcb.51.2.465; RUITENBER EJ, 1976, NATURE, V264, P258, DOI 10.1038/264258a0; Salinas E, 2008, J INVEST ALLERG CLIN, V18, P366; Sander LE, 2008, EUR J IMMUNOL, V38, P855, DOI 10.1002/eji.200737634; Scholten J, 2008, TRANSGENIC RES, V17, P307, DOI 10.1007/s11248-007-9153-4; Schraw TD, 2003, BIOCHEM J, V374, P207, DOI 10.1042/BJ20030610; SCHWARTZ LB, 1981, J IMMUNOL, V126, P1290; Shen C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9852; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shen JS, 2010, J CELL BIOL, V190, P55, DOI 10.1083/jcb.201003148; STEVENS RL, 1994, P NATL ACAD SCI USA, V91, P128, DOI 10.1073/pnas.91.1.128; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tadokoro S, 2007, MOL IMMUNOL, V44, P3427, DOI 10.1016/j.molimm.2007.02.013; Tamori Y, 1998, J BIOL CHEM, V273, P19740, DOI 10.1074/jbc.273.31.19740; TATHAM PER, 1991, J CELL SCI, V98, P217; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; ter Beest MBA, 2005, MOL BIOL CELL, V16, P5784, DOI 10.1091/mbc.E05-070-0661; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Woska JR, 2011, SCAND J IMMUNOL, V73, P8, DOI 10.1111/j.1365-3083.2010.02471.x; Woska JR, 2012, J CELL MOL MED, V16, P649, DOI 10.1111/j.1582-4934.2011.01443.x; Wu ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058560; Yang XY, 2015, NAT STRUCT MOL BIOL, V22, P547, DOI 10.1038/nsmb.3038	86	14	14	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7148	7159		10.1074/jbc.RA118.002455	http://dx.doi.org/10.1074/jbc.RA118.002455			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29599294	Green Published, hybrid			2022-12-26	WOS:000432174500008
J	Santos, ARS; Gerhardt, ECM; Moure, VR; Pedrosa, FO; Souza, EM; Diamanti, R; Hogbom, M; Huergo, LF				Schenberger Santos, Adrian Richard; Marques Gerhardt, Edileusa Cristina; Moure, Vivian Rotuno; Pedrosa, Fabio Oliveira; Souza, Emanuel Maltempi; Diamanti, Riccardo; Hogbom, Martin; Huergo, Luciano Fernandes			Kinetics and structural features of dimeric glutamine-dependent bacterial NAD(+) synthetases suggest evolutionary adaptation to available metabolites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NAD biosynthesis; nitrogen metabolism; glutamine; glutamine synthase; ammonia; ammonia assimilation; NadE; nitrogenase	ESCHERICHIA-COLI; ADP-RIBOSYLATION; NITROGEN ASSIMILATION; BACILLUS-SUBTILIS; BINDING; PROTEIN; AMTB	NADH (NAD(+)) and its reduced form NADH serve as cofactors for a variety of oxidoreductases that participate in many metabolic pathways. NAD(+) also is used as substrate by ADP-ribosyl transferases and by sirtuins. NAD(+) biosynthesis is one of the most fundamental biochemical pathways in nature, and the ubiquitous NAD(+) synthetase (NadE) catalyzes the final step in this biosynthetic route. Two different classes of NadE have been described to date: dimeric single-domain ammonium-dependent NadE(NH3) and octameric glutamine-dependent NadE(Gln), and the presence of multiple NadE isoforms is relatively common in prokaryotes. Here, we identified a novel dimeric group of NadE(Gln) in bacteria. Substrate preferences and structural analyses suggested that dimeric NadE(Gln) enzymes may constitute evolutionary intermediates between dimeric NadE(NH3) and octameric NadE(Gln). The characterization of additional NadE isoforms in the diazotrophic bacterium Azospirillum brasilense along with the determination of intracellular glutamine levels in response to an ammonium shock led us to propose a model in which these different NadE isoforms became active accordingly to the availability of nitrogen. These data may explain the selective pressures that support the coexistence of multiple isoforms of NadE in some prokaryotes.	[Schenberger Santos, Adrian Richard; Marques Gerhardt, Edileusa Cristina; Moure, Vivian Rotuno; Pedrosa, Fabio Oliveira; Souza, Emanuel Maltempi; Huergo, Luciano Fernandes] Univ Fed Parana UFPR, Dept Biochem & Mol Biol, BR-512 Curitiba, Parana, Brazil; [Huergo, Luciano Fernandes] Univ Fed Parana UFPR, Setor Litoral, BR-512 Curitiba, PR, Brazil; [Diamanti, Riccardo; Hogbom, Martin] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden	Universidade Federal do Parana; Universidade Federal do Parana; Stockholm University	Huergo, LF (corresponding author), UFPR, Setor Litoral, Rua Jaguariaiva 512, Matinhos, PR, Brazil.	luciano.huergo@gmail.com		Rotuno Moure, Vivian/0000-0003-0968-8190; Hogbom, Martin/0000-0001-5574-9383; Schenberger Santos, Adrian Richard/0000-0002-5788-2193	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Araucaria; Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES); CNPq-Instituto Nacional de Ciencia e Tecnologia (INCT)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq-Instituto Nacional de Ciencia e Tecnologia (INCT)	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Araucaria, Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES), and CNPq-Instituto Nacional de Ciencia e Tecnologia (INCT). The authors declare that they have no conflicts of interest with the contents of this article.	Aravind L, 2015, CURR TOP MICROBIOL, V384, P3, DOI 10.1007/82_2014_414; Baugh L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053851; Bellinzoni M, 2002, PROTEIN EXPRES PURIF, V25, P547, DOI 10.1016/S1046-5928(02)00041-4; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bheda P, 2016, ANNU REV BIOCHEM, V85, P405, DOI 10.1146/annurev-biochem-060815-014537; Brenner C, 2002, CURR OPIN STRUC BIOL, V12, P775, DOI 10.1016/S0959-440X(02)00387-1; Chuenchor W, 2012, BIOCHEM J, V443, P417, DOI 10.1042/BJ20112210; De Ingeniis J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039115; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; Floquet N, 2007, FEBS LETT, V581, P2981, DOI 10.1016/j.febslet.2007.05.068; Gazzaniga F, 2009, MICROBIOL MOL BIOL R, V73, P529, DOI 10.1128/MMBR.00042-08; Huergo LF, 2006, MOL MICROBIOL, V59, P326, DOI 10.1111/j.1365-2958.2005.04944.x; Huergo LF, 2015, MICROBIOL MOL BIOL R, V79, P419, DOI 10.1128/MMBR.00038-15; Huergo LF, 2013, FEMS MICROBIOL REV, V37, P251, DOI 10.1111/j.1574-6976.2012.00351.x; Huergo LF, 2012, MICROBIOL-SGM, V158, P176, DOI 10.1099/mic.0.049783-0; Jauch R, 2005, J BIOL CHEM, V280, P15131, DOI 10.1074/jbc.M413195200; Javelle A, 2008, P NATL ACAD SCI USA, V105, P5040, DOI 10.1073/pnas.0711742105; KLEINER D, 1985, FEMS MICROBIOL LETT, V32, P87, DOI 10.1016/0378-1097(85)90059-X; LaRonde-LeBlanc N, 2009, NAT STRUCT MOL BIOL, V16, P421, DOI 10.1038/nsmb.1567; Laskoski K, 2016, ARCH MICROBIOL, V198, P307, DOI 10.1007/s00203-016-1190-z; Li J, 2017, SCIENCE, V355, P1312, DOI 10.1126/science.aad8242; Moure VR, 2015, CURR TOP MICROBIOL, V384, P89, DOI 10.1007/82_2014_380; Okano H, 2010, J MOL BIOL, V404, P522, DOI 10.1016/j.jmb.2010.09.046; Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820; Resto M, 2009, BBA-PROTEINS PROTEOM, V1794, P1648, DOI 10.1016/j.bbapap.2009.07.014; Rizzi M, 1996, EMBO J, V15, P5125, DOI 10.1002/j.1460-2075.1996.tb00896.x; Rodrigues TE, 2014, MOL MICROBIOL, V91, P751, DOI 10.1111/mmi.12493; Symersky J, 2002, ACTA CRYSTALLOGR D, V58, P1138, DOI 10.1107/S0907444902006698; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; van Heeswijk WC, 2013, MICROBIOL MOL BIOL R, V77, P628, DOI 10.1128/MMBR.00025-13; Yuan J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.60	31	5	5	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7397	7407		10.1074/jbc.RA118.002241	http://dx.doi.org/10.1074/jbc.RA118.002241			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29581233	Green Published, hybrid			2022-12-26	WOS:000432174500032
J	Kang, J; Lee, SH; Son, JH; Lee, JW; Choi, YH; Choi, JH; Paik, WH; Ryu, JK; Kim, YT				Kang, Jinwoo; Lee, Sang Hyub; Son, Jun Hyuk; Lee, Jae Woo; Choi, Young Hoon; Choi, Jin Ho; Paik, Woo Hyun; Ryu, Ji Kon; Kim, Yong-Tae			Body mass index and weight change during initial period of chemotherapy affect survival outcome in advanced biliary tract cancer patients	PLOS ONE			English	Article							ADVANCED PANCREATIC-CANCER; PROGNOSTIC-FACTOR; OBESITY PARADOX; OVERWEIGHT; SARCOPENIA; CHOLANGIOCARCINOMA; IMPACT; METAANALYSIS; MANAGEMENT; MORTALITY	Background The impact of obesity on survival is known to vary in different cancers. Advanced biliary tract cancer was rarely analyzed about the relationship between obesity and prognosis. We performed this study to evaluate the BMI and body weight change as prognostic factors for advanced biliary tract cancer patients with palliative chemotherapy. Methods Between January 2005 and December 2016, two hundred and seventy-six patients who underwent chemotherapy for biliary tract cancer were retrospectively analyzed. The relationship between BMI (kg/m(2)) and clinical outcomes including overall and progression-free survival was assessed. Additionally the relationship between change in body composition and overall survival was evaluated. Results Median overall survival was 9.7 months for underweight patients, 10.1 months for normal patients, 15.8 months for overweight group, 13.1 months for obese patients, respectively. (p = 0.047) Univariate analysis showed that BMI, stage III, age less than 64 year-old, gallbladder cancer, operation, radiotherapy and ECOG performance were significantly associated with better survival. Compared with normal patients, overweight patients (BMI 23-24.9kg/m(2)) had a reduced risk of mortality in multivariate analysis (HR 0.632; 95% CI 0.436-0.918, p = 0.016). In the additional analysis for the effect of changes in body weight and BMI to the overall survival, decrease in body weight and BMI (HR 1.410, 95% CI 1.168-1.986, p = 0.046) was associated with a shorter in overall survival. Conclusion Overweight status and the maintenance of body weight during the initial period of chemotherapy are important and independent predictors of better overall survival in advanced biliary tract cancer patients.	[Kang, Jinwoo; Lee, Sang Hyub; Son, Jun Hyuk; Lee, Jae Woo; Choi, Young Hoon; Choi, Jin Ho; Paik, Woo Hyun; Ryu, Ji Kon; Kim, Yong-Tae] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kang, Jinwoo; Lee, Sang Hyub; Son, Jun Hyuk; Lee, Jae Woo; Choi, Young Hoon; Choi, Jin Ho; Paik, Woo Hyun; Ryu, Ji Kon; Kim, Yong-Tae] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Kang, Jinwoo; Lee, Sang Hyub; Son, Jun Hyuk; Lee, Jae Woo; Choi, Young Hoon; Choi, Jin Ho; Paik, Woo Hyun; Ryu, Ji Kon; Kim, Yong-Tae] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Kang, Jinwoo] SMG SNU Boramae Med Ctr, Dept Gastroenterolgy & Hepatol, Seoul, South Korea; [Son, Jun Hyuk] Inje Univ, Ilsan Paik Hosp, Dept Internal Med, Goyang, South Korea; [Lee, Jae Woo] Mediplex Sejong Hosp, Incheon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Inje University	Lee, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Lee, SH (corresponding author), Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea.; Lee, SH (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.	gidoctor@snuh.org		Choi, Jin Ho/0000-0003-2758-1370; Lee, Sang Hyub/0000-0003-2174-9726				Arnold M, 2016, CANCER EPIDEMIOL, V41, P8, DOI 10.1016/j.canep.2016.01.003; Banack HR, 2015, EUR J EPIDEMIOL, V30, P1111, DOI 10.1007/s10654-015-0069-7; Barber MD, 1999, NUTR CANCER, V35, P106, DOI 10.1207/S15327914NC352_2; Bouillanne O, 2009, AM J CLIN NUTR, V90, P505, DOI 10.3945/ajcn.2009.27819; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Choi YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135083; Esnaola NF, 2016, CANCER-AM CANCER SOC, V122, P1349, DOI 10.1002/cncr.29692; Farhat MH, 2008, WORLD J GASTROENTERO, V14, P3224, DOI 10.3748/wjg.14.3224; Fouladiun M, 2005, CANCER-AM CANCER SOC, V103, P2189, DOI 10.1002/cncr.21013; Gonzalez MC, 2014, AM J CLIN NUTR, V99, P999, DOI 10.3945/ajcn.113.071399; Hines RB, 2009, CANCER-AM CANCER SOC, V115, P5798, DOI 10.1002/cncr.24598; Horowitz NS, 2015, GYNECOL ONCOL, V138, P201, DOI 10.1016/j.ygyno.2015.04.002; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Kaneko M, 2016, MOL CLIN ONCOL, V5, P289, DOI 10.3892/mco.2016.964; Kasenda B, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-728; Kim MK, 2014, ENDOCRINOL METAB, V29, P405, DOI 10.3803/EnM.2014.29.4.405; Lanic H, 2014, LEUKEMIA LYMPHOMA, V55, P817, DOI 10.3109/10428194.2013.816421; Lennon H, 2016, CURR ONCOL REP, V18, DOI 10.1007/s11912-016-0539-4; Li JS, 2014, TUMOR BIOL, V35, P6831, DOI 10.1007/s13277-014-1939-4; Li Z, 2016, ONCOTARGET; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Meza-Junco J, 2013, J CLIN GASTROENTEROL, V47, P861, DOI 10.1097/MCG.0b013e318293a825; Mitsiopoulos N, 1998, J APPL PHYSIOL, V85, P115, DOI 10.1152/jappl.1998.85.1.115; Murphy RA, 2010, CLIN NUTR, V29, P482, DOI 10.1016/j.clnu.2009.11.006; Myers J, 2011, AM J MED, V124, P924, DOI 10.1016/j.amjmed.2011.04.018; Rutten IJG, 2017, J CACHEXIA SARCOPENI, V8, P630, DOI 10.1002/jcsm.12180; Sabel MS, 2011, ANN SURG ONCOL, V18, P3579, DOI 10.1245/s10434-011-1976-9; Shachar SS, 2017, CLIN CANCER RES, V23, P658, DOI 10.1158/1078-0432.CCR-16-0940; Tan WB, 2015, NUTRIENTS, V7, P8321, DOI 10.3390/nu7105387; Tsang NM, 2016, CANCER MED-US, V5, P665, DOI 10.1002/cam4.634; Wigmore SJ, 2000, BRIT J SURG, V87, P53, DOI 10.1046/j.1365-2168.2000.01317.x; Yildirim BA, 2016, PANCREATOLOGY, V16, P599, DOI 10.1016/j.pan.2016.03.006	32	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195118	10.1371/journal.pone.0195118	http://dx.doi.org/10.1371/journal.pone.0195118			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608578	gold, Green Published, Green Submitted			2022-12-26	WOS:000428988800026
J	Chang, CH; Sakaguchi, M; Weil, J; Verstraeten, T				Chang, Chia-Hsien; Sakaguchi, Motonobu; Weil, John; Verstraeten, Thomas			The incidence of medically-attended norovirus gastro-enteritis in Japan: Modelling using a medical care insurance claims database	PLOS ONE			English	Article							GENETIC-CHARACTERIZATION; ENTERIC VIRUSES; MOLECULAR EPIDEMIOLOGY; GENOTYPE DISTRIBUTION; SPORADIC NOROVIRUSES; NARA PREFECTURE; OSAKA CITY; CHILDREN; INFANTS; INFECTION	Background The burden of medically-attended acute gastro-enteritis (MA-AGE) that can be attributed to norovirus is not well established in Japan. Using a nationwide database of medical care insurance claims, we estimated the incidence of medically-attended norovirus-attributable gastroenteritis (MA-NGE) in Japan. Methods The incidences of MA-NGE outpatient consultations or hospitalization in Japan were modelled on seasonal patterns of MA-AGE for unspecified causes derived from the Japan Medical Data Center (JMDC) database for the period July 2007 to June 2015. Results Mean age-adjusted annual incidence rates (per 10,000 person-years) of MA-NGE associated with outpatient care or hospitalization were 389 (95% CI 269-558) and 13 (95% CI 9-20), respectively. Highest rates were in children under 5 years of age: 1,569 (95% CI 1,325-1,792) for outpatient consultations and 48 (95% CI 39-56) for hospitalizations. Of all gastroenteritis episodes associated with outpatient care or hospitalization, 29% and 31% were attributed to norovirus, respectively. Norovirus was estimated to be responsible for 4,964,000 outpatient visits (95% CI 3,435,000-7,123,000) and 171,000 hospitalizations (95% CI 110,000-251,000) per year across Japan. Conclusions Incidence rates of MA-AGE are high in Japan, and norovirus-attributable disease is at least as high as in some other developed countries.	[Chang, Chia-Hsien; Sakaguchi, Motonobu] Takeda Pharmaceut Co Ltd, Global Patient Safety Evaluat Japan, Takeda Dev Ctr Japan, Osaka, Japan; [Weil, John] Takeda Pharmaceut Int AG, Zurich, Switzerland; [Verstraeten, Thomas] P95 Pharmacovigilance & Epidemiol, Heverlee, Belgium	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.	Chang, CH (corresponding author), Takeda Pharmaceut Co Ltd, Global Patient Safety Evaluat Japan, Takeda Dev Ctr Japan, Osaka, Japan.	chia-hsien.chang@takeda.com		Chang, Chia-Hsien/0000-0002-6988-7944	Takeda, Japan	Takeda, Japan	The funder (Takeda, Japan) provided support in the form of salaries for authors (CHC, MS) and research materials only, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; [Anonymous], 2011, NOR FOOD POIS JAP 20; [Anonymous], 2013, DET GASTR VIR JAP 20; Chan-It W, 2011, CLIN LAB, V57, P213; Dey SK, 2011, CLIN LAB, V57, P193; Dey SK, 2010, PEDIATR INFECT DIS J, V29, pE32, DOI 10.1097/INF.0b013e3181d742bf; Fujita M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151690; Gastanaduy PA, 2013, J INFECT DIS, V207, P1058, DOI 10.1093/infdis/jis942; Grytdal SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148395; Harada S, 2009, J MED VIROL, V81, P1117, DOI 10.1002/jmv.21454; Iritani N, 2014, J MED VIROL, V86, P2019, DOI 10.1002/jmv.23883; Ishida Y, 2012, PEDIATRICS, V129, pE113, DOI 10.1542/peds.2011-1321; Kawada JI, 2012, MICROBIOL IMMUNOL, V56, P756, DOI 10.1111/j.1348-0421.2012.00498.x; Kimura S, 2010, J EPIDEMIOL, V20, P413, DOI 10.2188/jea.JE20090066; Kitahori Y, 2008, JPN J INFECT DIS, V61, P89; Kitahori Y, 2009, JPN J INFECT DIS, V62, P82; Kumazaki M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1999-8; Lopman BA, 2004, CLIN INFECT DIS, V39, P318, DOI 10.1086/421948; Lopman BA, 2011, CLIN INFECT DIS, V52, P466, DOI 10.1093/cid/ciq163; Lopman BA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001999; Minister for the Environment, 2016, NOR Q A MAN CAS NOR, P5; Mori K, 2017, JPN J INFECT DIS, V70, P143, DOI 10.7883/yoken.JJID.2015.456; Morton VK, 2015, EPIDEMIOL INFECT, V143, P3528, DOI 10.1017/S0950268815000734; Motomura K, 2008, J VIROL, V82, P11247, DOI 10.1128/JVI.00897-08; Nakamura N, 2016, J MED VIROL, V88, P1180, DOI 10.1002/jmv.24445; Nakanishi K, 2009, J CLIN VIROL, V46, P94, DOI 10.1016/j.jcv.2009.06.014; National Institute of Infectious Diseases N, 2017, DET GASTR VIR JAP; Okame M, 2006, J MED VIROL, V78, P1318, DOI 10.1002/jmv.20696; Onishi N, 2008, PEDIATR INT, V50, P65, DOI 10.1111/j.1442-200X.2007.02529.x; Phan TG, 2006, J MED VIROL, V78, P839, DOI 10.1002/jmv.20632; Phan TG, 2005, ARCH VIROL, V150, P1415, DOI 10.1007/s00705-005-0514-0; Phan TG, 2004, J MED VIROL, V74, P173, DOI 10.1002/jmv.20162; Phan TG, 2007, CLIN LAB, V53, P567; Phan TG, 2007, J MED VIROL, V79, P1388, DOI 10.1002/jmv.20924; Phan TG, 2006, CLIN LAB, V52, P519; Phan TG, 2006, J MED VIROL, V78, P971, DOI 10.1002/jmv.20649; Rha B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148505; Sakon N, 2015, J INFECT DIS, V211, P879, DOI 10.1093/infdis/jiu496; Taniguchi K, 2007, J EPIDEMIOL, V17, pS3, DOI 10.2188/jea.17.S3; Thongprachum A, 2016, J MED VIROL, V88, P551, DOI 10.1002/jmv.24387; Thongprachum A, 2015, J MED VIROL, V87, P1141, DOI 10.1002/jmv.24155; Trivedi TK, 2012, JAMA-J AM MED ASSOC, V308, P1668, DOI 10.1001/jama.2012.14023; Ushijima H, 2014, JPN J INFECT DIS, V67, P374, DOI 10.7883/yoken.67.374; Van Cauteren D, 2017, EMERG INFECT DIS, V23, P1486, DOI 10.3201/eid2309.170081; Verstraeten T, 2017, J INFECT DIS, V216, P957, DOI 10.1093/infdis/jix410; Yoneda M, 2014, INTERVIROLOGY, V57, P31, DOI 10.1159/000353852	46	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195164	10.1371/journal.pone.0195164	http://dx.doi.org/10.1371/journal.pone.0195164			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601600	Green Submitted, gold, Green Published			2022-12-26	WOS:000428845900020
J	Adams, GG; Meal, A; Morgan, PS; Alzahrani, QE; Zobel, H; Lithgo, R; Kok, MS; Besong, DTM; Jiwani, SI; Ballance, S; Harding, SE; Chayen, N; Gillis, RB				Adams, Gary G.; Meal, Andrew; Morgan, Paul S.; Alzahrani, Qushmua E.; Zobel, Hanne; Lithgo, Ryan; Kok, M. Samil; Besong, David T. M.; Jiwani, Shahwar I.; Ballance, Simon; Harding, Stephen E.; Chayen, Naomi; Gillis, Richard B.			Characterisation of insulin analogues therapeutically available to patients	PLOS ONE			English	Article							CHEMICAL-STABILITY; MOLECULAR-WEIGHT; SELF-ASSOCIATION; BOVINE INSULIN; EQUILIBRIUM ULTRACENTRIFUGE; PHARMACEUTICAL-PREPARATIONS; SEDIMENTATION EQUILIBRIUM; NEUTRAL PH; FORMULATION; ZINC	The structure and function of clinical dosage insulin and its analogues were assessed. This included 'native insulins' (human recombinant, bovine, porcine), 'fast-acting analogues' (aspart, glulisine, lispro) and 'slow-acting analogues' (glargine, detemir, degludec). Analytical ultracentrifugation, both sedimentation velocity and equilibrium experiments, were employed to yield distributions of both molar mass and sedimentation coefficient of all nine insulins. Size exclusion chromatography, coupled to multi-angle light scattering, was also used to explore the function of these analogues. On ultracentrifugation analysis, the insulins under investigation were found to be in numerous conformational states, however the majority of insulins were present in a primarily hexameric conformation. This was true for all native insulins and two fast-acting analogues. However, glargine was present as a dimer, detemir was a multi-hexameric system, degludec was a dodecamer (di-hexamer) and glulisine was present as a dimer-hexamer-dihexamer system. However, size-exclusion chromatography showed that the two hexameric fast-acting analogues (aspart and lispro) dissociated into monomers and dimers due to the lack of zinc in the mobile phase. This comprehensive study is the first time all nine insulins have been characterised in this way, the first time that insulin detemir have been studied using analytical ultracentrifugation and the first time that insulins aspart and glulisine have been studied using sedimentation equilibrium. The structure and function of these clinically administered insulins is of critical importance and this research adds novel data to an otherwise complex functional physiological protein.	[Adams, Gary G.; Meal, Andrew; Morgan, Paul S.; Alzahrani, Qushmua E.; Kok, M. Samil; Jiwani, Shahwar I.; Gillis, Richard B.] Univ Nottingham, Queens Med Ctr, Fac Med & Hlth Sci, Nottingham NG7 2UH, England; [Adams, Gary G.; Alzahrani, Qushmua E.; Lithgo, Ryan; Jiwani, Shahwar I.; Harding, Stephen E.; Gillis, Richard B.] Univ Nottingham, Sch Biosci, Natl Ctr Macromol Hydrodynam, Loughborough LE12 5RD, England; [Alzahrani, Qushmua E.] Taif Univ, Fac Sci, At Taif, Saudi Arabia; [Zobel, Hanne; Ballance, Simon] Nofima AS, Osloveien 1, As, Norway; [Kok, M. Samil] Abant Izzet Baysal Univ, Dept Food Engn, Bolu, Turkey; [Besong, David T. M.] KAUST, Funct Nanomat Lab, Thuwal, Saudi Arabia; [Chayen, Naomi] Imperial Coll London, Fac Med, Dept Surg & Canc, Computat & Syst Med, London SW7 2AZ, England	University of Nottingham; University of Nottingham; Taif University; Nofima; Abant Izzet Baysal University; King Abdullah University of Science & Technology; Imperial College London	Adams, GG; Gillis, RB (corresponding author), Univ Nottingham, Queens Med Ctr, Fac Med & Hlth Sci, Nottingham NG7 2UH, England.; Adams, GG; Gillis, RB (corresponding author), Univ Nottingham, Sch Biosci, Natl Ctr Macromol Hydrodynam, Loughborough LE12 5RD, England.	gary.adams@nottingham.ac.uk; richard.gillis@nottingham.ac.uk	Adams, Gary/ABG-2959-2020	Adams, Gary/0000-0002-0335-2162; Alzahrani, Qushmua/0000-0001-5305-799X; Morgan, Paul/0000-0002-5870-1446; Harding, Stephen E./0000-0002-7798-9692; Lithgo, Ryan/0000-0002-4706-9916; Chayen, Naomi/0000-0003-2861-2458				Adams GG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06642-w; Aizen D, 2015, MOL CELL ENDOCRINOL, V406, P27, DOI 10.1016/j.mce.2015.02.011; Ang S, 2010, MACROMOL BIOSCI, V10, P798, DOI 10.1002/mabi.201000065; Bakaysa DL, 1996, PROTEIN SCI, V5, P2521, DOI 10.1002/pro.5560051215; Birkeland KI, 2011, DIABETES CARE, V34, P661, DOI 10.2337/dc10-1925; BRANGE J, 1992, PHARMACEUT RES, V9, P727, DOI 10.1023/A:1015887001987; BRANGE J, 1992, ACTA PHARM NORDICA, V4, P149; BRANGE J, 1992, PHARMACEUT RES, V9, P715, DOI 10.1023/A:1015835017916; BRANGE J, 1992, ACTA PHARM NORDICA, V4, P223; BRANGE J, 1992, ACTA PHARM NORDICA, V4, P209; BREMS DN, 1992, PROTEIN ENG, V5, P527, DOI 10.1093/protein/5.6.527; Coppolino R, 2006, J PHARM SCI-US, V95, P1029, DOI 10.1002/jps.20609; FREDERICQ E, 1956, ARCH BIOCHEM BIOPHYS, V65, P218, DOI 10.1016/0003-9861(56)90189-8; Gast K, 2017, PHARM RES-DORDR, V34, P2270, DOI 10.1007/s11095-017-2233-0; Gillis RB, 2013, EUR BIOPHYS J BIOPHY, V42, P777, DOI 10.1007/s00249-013-0924-y; GOLDMAN J, 1974, BIOCHEMISTRY-US, V13, P4566, DOI 10.1021/bi00719a015; GRANT PT, 1972, BIOCHEM J, V126, P433, DOI 10.1042/bj1260433; GUTFREUND H, 1948, BIOCHEM J, V42, P544, DOI 10.1042/bj0420544; Havelund S, 2004, PHARM RES-DORDR, V21, P1498, DOI 10.1023/B:PHAM.0000036926.54824.37; Hayes D. B., 1995, SEDNTERP; Hinds K, 2000, BIOCONJUGATE CHEM, V11, P195, DOI 10.1021/bc9901189; Hinoi E, 2008, J CELL BIOL, V183, P1235, DOI 10.1083/jcb.200809113; HOLLADAY LA, 1977, BIOCHIM BIOPHYS ACTA, V494, P245, DOI 10.1016/0005-2795(77)90152-0; Home PD, 2015, DIABETES OBES METAB, V17, P1011, DOI 10.1111/dom.12501; Jacober SJ, 2014, DIABETES OBES METAB, V16, P351, DOI 10.1111/dom.12223; JEFFREY PD, 1966, BIOCHEMISTRY-US, V5, P489, DOI 10.1021/bi00866a014; JEFFREY PD, 1965, BIOCHIM BIOPHYS ACTA, V109, P551, DOI 10.1016/0926-6585(65)90181-0; JEFFREY PD, 1966, BIOCHEMISTRY-US, V5, P3820, DOI 10.1021/bi00876a012; JEFFREY PD, 1976, BIOCHEMISTRY-US, V15, P4660, DOI 10.1021/bi00666a018; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Miller GL, 1942, J BIOL CHEM, V144, P459; Nakazawa S, 2012, ANAL BIOCHEM, V420, P61, DOI 10.1016/j.ab.2011.09.002; PEKAR AH, 1972, BIOCHEMISTRY-US, V11, P4013, DOI 10.1021/bi00772a001; Provencher SW, 1992, LASER LIGHT SCATTERI; Richards JP, 1998, PHARMACEUT RES, V15, P1434, DOI 10.1023/A:1011961923870; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P, 2014, ANALYST, V139, P79, DOI 10.1039/c3an01507f; Sjogren B, 1931, J AM CHEM SOC, V53, P2657, DOI 10.1021/ja01358a029; Steensgaard DB, 2013, BIOCHEMISTRY-US, V52, P295, DOI 10.1021/bi3008609; Teska BM, 2014, J PHARM SCI-US, V103, P2255, DOI 10.1002/jps.24039; Whittingham JL, 2002, J MOL BIOL, V318, P479, DOI 10.1016/S0022-2836(02)00021-9; Wyatt P. J., 1992, LASER LIGHT SCATTERI; Zemler RS, 2015, ARCH PHYSIOL BIOCHEM, V121, P32, DOI 10.3109/13813455.2014.1001856	43	12	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195010	10.1371/journal.pone.0195010	http://dx.doi.org/10.1371/journal.pone.0195010			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596514	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000428630000066
J	Hachiya, M; Miyano, S; Mori, Y; Vynnycky, E; Keungsaneth, P; Vongphrachanh, P; Xeuatvongsa, A; Sisouk, T; Som-Oulay, V; Khamphaphongphane, B; Sengkeopaseuth, B; Pathammavong, C; Phounphenghak, K; Kitamura, T; Takeda, M; Komase, K				Hachiya, Masahiko; Miyano, Shinsuke; Mori, Yoshio; Vynnycky, Emilia; Keungsaneth, Phath; Vongphrachanh, Phengta; Xeuatvongsa, Anonh; Sisouk, Thongchanh; Som-Oulay, Vilasak; Khamphaphongphane, Bouaphan; Sengkeopaseuth, Bounthanom; Pathammavong, Chansay; Phounphenghak, Kongxay; Kitamura, Tomomi; Takeda, Makoto; Komase, Katsuhiro			Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine	PLOS ONE			English	Article							DRIED BLOOD SPOTS; PREGNANT-WOMEN; SYNDROME CRS; ELIMINATION; INFECTION; IMMUNITY; PROGRESS; IMPACT; AGE	Background Measles outbreaks have occurred in some countries despite supplementary immunization activities (SIA) using measles-containing vaccine with high vaccination coverage. We conducted a cross-sectional seroprevalence survey to estimate population immunity in Lao People's Democratic Republic where repeated mass immunization has failed to eliminate measles. Methods and findings In this nationwide multistage cluster sampling survey conducted in 2014 based on probability proportionate to size sampling, blood samples were collected from 2,135 children and adults living in 52 randomly selected villages. Anti-measles and anti-rubella IgG were measured, and IgG prevalence was calculated. We applied mathematical modelling to estimate the number of cases of congenital rubella syndrome (CRS) in 2013 that were averted by the 2011 SIA. A stability testing was applied to the MR vaccine at 4 degrees C, 25 degrees C, and 35 degrees C to examine stability differences between measles and rubella vaccine components. Measles IgG prevalence was significantly lower in the target age groups (5-21 years) of the 2011 SIA using a combination vaccine for measles and rubella vaccine (MR vaccine) than in young adults (22-39 years) (86.8% [95% CI: 83.0-90.6] vs. 99.0% [98.3-99.8]; p<0.001), whereas rubella IgG prevalence was significantly higher (88.2% [84.5-91.8] vs. 74.6% [70.7-78.5]; p<0.001). In the SIA target age groups, prevalence of measles IgG, but not rubella IgG, increased with age. CRS cases prevented in 2013 ranged from 16 [0-50] to 92 [32-180] if the force of infection had remained unchanged or had been reduced by 75%, respectively. In freeze-dried conditions, the measles vaccine component was more heat sensitive than the rubella component. Conclusions Inconsistent IgG prevalence between measles and rubella in Lao PDR can be partly explained by different stability of the measles and rubella vaccine components under heat exposure. Suboptimal vaccine handling may cause insufficient immunogenicity for measles, which subsequently leads to an outbreak despite high SIA coverage, while direct evidence is lacking. Temperature monitoring of the vaccine should be conducted.	[Hachiya, Masahiko; Miyano, Shinsuke; Kitamura, Tomomi] Natl Ctr Global Hlth & Med, Bur Int Hlth Cooperat, Shinjuku Ku, Tokyo, Japan; [Mori, Yoshio; Takeda, Makoto; Komase, Katsuhiro] Natl Inst Infect Dis, Dept Virol 3, Tokyo, Japan; [Vynnycky, Emilia] Publ Hlth England, Modelling & Econ Unit, London, England; [Vynnycky, Emilia] London Sch Hyg & Trop Med, TB Modelling Grp, London, England; [Vynnycky, Emilia] London Sch Hyg & Trop Med, TB Ctr, London, England; [Vynnycky, Emilia] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England; [Keungsaneth, Phath] Minist Hlth, Dept Hyg & Hlth Promot, Vientiane Capital, Laos; [Vongphrachanh, Phengta; Sisouk, Thongchanh; Som-Oulay, Vilasak; Khamphaphongphane, Bouaphan; Sengkeopaseuth, Bounthanom] Minist Hlth, Natl Ctr Lab & Epidemiol, Vientiane Capital, Laos; [Xeuatvongsa, Anonh; Pathammavong, Chansay; Phounphenghak, Kongxay] Minist Hlth, Natl Immunizat Program, Vientiane Capital, Laos	National Center for Global Health & Medicine - Japan; National Institute of Infectious Diseases (NIID); Public Health England; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Hachiya, M (corresponding author), Natl Ctr Global Hlth & Med, Bur Int Hlth Cooperat, Shinjuku Ku, Tokyo, Japan.	m-hachiya@it.ncgm.go.jp	Hachiya, Masahiko/ABF-8472-2021	Hachiya, Masahiko/0000-0002-8720-5097; Kitamura, Tomomi/0000-0002-7956-4751				Alleman MM, 2016, VACCINE, V34, P6502, DOI 10.1016/j.vaccine.2016.10.059; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P301; Anonymous, 2011, Morbidity and Mortality Weekly Report, V60, P374; Cutts FT, 2016, TROP MED INT HEALTH, V21, P1086, DOI 10.1111/tmi.12737; Cutts FT, 2013, EXPERT REV VACCINES, V12, P917, DOI 10.1586/14760584.2013.814847; Cutts FT, 1999, INT J EPIDEMIOL, V28, P1176, DOI 10.1093/ije/28.6.1176; Fitter DL, 2013, VACCINE, V32, P69, DOI 10.1016/j.vaccine.2013.10.071; Goodson JL, 2012, VACCINE, V30, P4709, DOI 10.1016/j.vaccine.2012.04.058; Komada K, 2015, INT J INFECT DIS, V36, P21, DOI 10.1016/j.ijid.2015.04.020; Mao B, 2015, EPIDEMIOL INFECT, V143, P1858, DOI 10.1017/S0950268814002817; Ministry of Health and Lao Statistics Bureau, 2012, LAO SOC IND SURV 201; Miyakawa M, 2014, VACCINE, V32, P1192, DOI 10.1016/j.vaccine.2013.08.076; Perry RT, 2014, MMWR-MORBID MORTAL W, V63, P1034; Plans-Rubio P, 2014, EXPERT REV ANTI-INFE, V12, P723, DOI 10.1586/14787210.2014.917047; Plotkin S.A., 2013, VACCINES-BASEL, P688; Rentsen T, 2007, JPN J INFECT DIS, V60, P198; Riddell MA, 2003, B WORLD HEALTH ORGAN, V81, P701; Robertson SE, 1997, B WORLD HEALTH ORGAN, V75, P69; Sakata M, 2009, VACCINE, V27, P234, DOI 10.1016/j.vaccine.2008.10.049; Shkedy Z, 2006, STAT MED, V25, P1577, DOI 10.1002/sim.2291; Strebel P, 2013, VACCINES, P352; Toda K, 2015, VACCINE, V33, P3673, DOI 10.1016/j.vaccine.2015.06.035; Uzicanin A, 2011, J INFECT DIS, V204, pS564, DOI 10.1093/infdis/jir088; Vynnycky E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149160; Vynnycky E, 2016, HUM VACC IMMUNOTHER, V12, P150, DOI 10.1080/21645515.2015.1060380; *WHO, 2009, IMM BAS IMM SER; WHO, 2013, GUID COND SER SUPP M; World Health Organization, 2008, WKLY EPIDEMIOL REC, V83, P393; World Health Organization, 2008, IMM BAS IMM MOD 11 R; World Health Organization, 2009, MEAS VACC WHO POS PA, V84, P349; Xeuatvongsa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088829	31	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194931	10.1371/journal.pone.0194931	http://dx.doi.org/10.1371/journal.pone.0194931			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596472	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000428630000051
J	Nilsen, EB; Strand, O				Nilsen, Erlend B.; Strand, Olav			Integrating data from multiple sources for insights into demographic processes: Simulation studies and proof of concept for hierarchical change-in-ratio models	PLOS ONE			English	Article							AGE-SPECIFIC SURVIVAL; POPULATION-DYNAMICS; TEMPORAL VARIATION; LARGE HERBIVORES; RED DEER; ROE DEER; LIFE; MANAGEMENT; DENSITY; CONSEQUENCES	We developed a model for estimating demographic rates and population abundance based on multiple data sets revealing information about population age- and sex structure. Such models have previously been described in the literature as change-in-ratio models, but we extend the applicability of the models by i) using time series data allowing the full temporal dynamics to be modelled, by ii) casting the model in an explicit hierarchical modelling framework, and by iii) estimating parameters based on Bayesian inference. Based on sensitivity analyses we conclude that the approach developed here is able to obtain estimates of demographic rate with high precision whenever unbiased data of population structure are available. Our simulations revealed that this was true also when data on population abundance are not available or not included in the modelling framework. Nevertheless, when data on population structure are biased due to different observability of different age-and sex categories this will affect estimates of all demographic rates. Estimates of population size is particularly sensitive to such biases, whereas demographic rates can be relatively precisely estimated even with biased observation data as long as the bias is not severe. We then use the models to estimate demographic rates and population abundance for two Norwegian reindeer (Rangifer tarandus) populations where age-sex data were available for all harvested animals, and where population structure surveys were carried out in early summer (after calving) and late fall (after hunting season), and population size is counted in winter. We found that demographic rates were similar regardless whether we include population count data in the modelling, but that the estimated population size is affected by this decision. This suggest that monitoring programs that focus on population age- and sex structure will benefit from collecting additional data that allow estimation of observability for different age- and sex classes. In addition, our sensitivity analysis suggests that focusing monitoring towards changes in demographic rates might be more feasible than monitoring abundance in many situations where data on population age-and sex structure can be collected.	[Nilsen, Erlend B.; Strand, Olav] Norwegian Inst Nat Res, Trondheim, Norway	Norwegian Institute Nature Research	Nilsen, EB (corresponding author), Norwegian Inst Nat Res, Trondheim, Norway.	erlend.nilsen@nina.no	Nilsen, Erlend B./G-3134-2017	Nilsen, Erlend B./0000-0002-5119-8331				Andersen R, 2000, J WILDLIFE MANAGE, V64, P698, DOI 10.2307/3802739; Arnold TW, 2018, J WILDLIFE MANAGE, V82, P266, DOI 10.1002/jwmg.21404; Bled F, 2017, ECOL EVOL, V7, P9531, DOI 10.1002/ece3.3469; Bonenfant C, 2004, P ROY SOC B-BIOL SCI, V271, P883, DOI 10.1098/rspb.2003.2661; Broms K, 2010, J WILDLIFE MANAGE, V74, P310, DOI 10.2193/2008-469; Caswell, 2000, MATRIX POPULATION MO; Chandler RB, 2014, METHODS ECOL EVOL, V5, P1351, DOI 10.1111/2041-210X.12153; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Coulson T, 2005, J ANIM ECOL, V74, P789, DOI 10.1111/j.1365-2656.2005.00975.x; Coulson T, 2004, ECOLOGY, V85, P411, DOI 10.1890/03-0009; De Barba M, 2010, J APPL ECOL, V47, P172, DOI 10.1111/j.1365-2664.2009.01752.x; Delgiudice GD, 2006, J WILDLIFE MANAGE, V70, P1556, DOI 10.2193/0022-541X(2006)70[1556:ALASAO]2.0.CO;2; Engen S, 2007, J THEOR BIOL, V244, P308, DOI 10.1016/j.jtbi.2006.08.009; Fieberg JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012114; Gaillard JM, 2003, POPUL DEV REV, V29, P39; Gaillard JM, 2003, ECOLOGY, V84, P3294, DOI 10.1890/02-0409; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Gaillard JM, 2005, AM NAT, V166, P119, DOI 10.1086/430330; Gaillard JM, 2003, J WILDLIFE MANAGE, V67, P767, DOI 10.2307/3802684; Gervasi V, 2016, WILDLIFE BIOL, V22, P95, DOI 10.2981/wlb.00142; Gervasi V, 2014, ECOL EVOL, V4, P4637, DOI 10.1002/ece3.1258; Gervasi V, 2012, J ANIM ECOL, V81, P443, DOI 10.1111/j.1365-2656.2011.01928.x; Gordon IJ, 2004, J APPL ECOL, V41, P1021, DOI 10.1111/j.0021-8901.2004.00985.x; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; Loison A, 1999, ECOLOGY, V80, P2539, DOI 10.1890/0012-9658(1999)080[2539:ASSIFP]2.0.CO;2; Melis C, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00099.1; Nilsen EB, 2017, POPULASJONSDYNAMISKE; Nilsen EB, 2009, J ANIM ECOL, V78, P585, DOI 10.1111/j.1365-2656.2009.01523.x; O'Brien S, 2005, J APPL ECOL, V42, P1096, DOI 10.1111/j.1365-2664.2005.01084.x; Panzacchi M, 2015, ECOGRAPHY, V38, P659, DOI 10.1111/ecog.01075; Panzacchi M, 2013, LANDSCAPE ECOL, V28, P847, DOI 10.1007/s10980-012-9793-5; Popescu VD, 2016, J APPL ECOL, V53, P1248, DOI 10.1111/1365-2664.12660; Robinson RA, 2014, METHODS ECOL EVOL, V5, P1361, DOI 10.1111/2041-210X.12204; Saether BE, 1998, OIKOS, V83, P344; Schaub M, 2007, CONSERV BIOL, V21, P945, DOI 10.1111/j.1523-1739.2007.00743.x; Schaub M, 2011, J ORNITHOL, V152, P227, DOI 10.1007/s10336-010-0632-7; Skalski J.R., 2005, WILDLIFE DEMOGRAPHY; Solberg EJ, 2017, OPPSUMMERINGSRAPPORT; Strand O, 2012, CAN J ZOOL, V90, P163, DOI 10.1139/Z11-123; Su Y-S, R PACKAGE VERSION 0; Testa JW, 2004, ECOLOGY, V85, P1439, DOI 10.1890/02-0671; Thomas L, 2005, AUST NZ J STAT, V47, P19, DOI 10.1111/j.1467-842X.2005.00369.x; UDEVITZ MS, 1992, WILDLIFE 2001 : POPULATIONS, P90; White GC, 1996, J WILDLIFE MANAGE, V60, P37, DOI 10.2307/3802037; Yamamura K, 2008, POPUL ECOL, V50, P131, DOI 10.1007/s10144-007-0069-x; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	49	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194566	10.1371/journal.pone.0194566	http://dx.doi.org/10.1371/journal.pone.0194566			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596430	Green Submitted, Green Published, gold			2022-12-26	WOS:000428630000030
J	Walker, M; Schonborn, S; Greifeneder, R; Vetter, T				Walker, Mirella; Schonborn, Sandro; Greifeneder, Rainer; Vetter, Thomas			The Basel Face Database: A validated set of photographs reflecting systematic differences in Big Two and Big Five personality dimensions	PLOS ONE			English	Article							SOCIAL-PERCEPTION; 1ST IMPRESSIONS; JUDGMENTS; DECISIONS; TRUSTWORTHINESS; STEREOTYPES; COMPETENCE; WARMTH; IMAGES	Upon a first encounter, individuals spontaneously associate faces with certain personality dimensions. Such first impressions can strongly impact judgments and decisions and may prove highly consequential. Researchers investigating the impact of facial information often rely on (a) real photographs that have been selected to vary on the dimension of interest, (b) morphed photographs, or (c) computer-generated faces (avatars). All three approaches have distinct advantages. Here we present the Basel Face Database, which combines these advantages. In particular, the Basel Face Database consists of real photographs that are subtly, but systematically manipulated to show variations in the perception of the Big Two and the Big Five personality dimensions. To this end, the information specific to each psychological dimension is isolated and modeled in new photographs. Two studies serve as systematic validation of the Basel Face Database. The Basel Face Database opens a new pathway for researchers across psychological disciplines to investigate effects of perceived personality.	[Walker, Mirella; Greifeneder, Rainer] Univ Basel, Dept Psychol, Basel, Switzerland; [Schonborn, Sandro; Vetter, Thomas] Univ Basel, Dept Math & Comp Sci, Basel, Switzerland	University of Basel; University of Basel	Walker, M (corresponding author), Univ Basel, Dept Psychol, Basel, Switzerland.	mirella.walker@unibas.ch	Walker, Mirella/Q-4374-2019	Walker, Mirella/0000-0002-1827-0733; Greifeneder, Rainer/0000-0002-0725-5626; Schonborn, Sandro/0000-0003-4316-8519	Swiss National Science Foundation [100014_135213, PZ00P1_168070]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by the Swiss National Science Foundation (http://www.snf.ch) under grant no. 100014_135213 (Recipients: MW, RG, TV) and grand no. PZ00P1_168070 (Recipient: MW).; We would like to thank Konstantin Escher and Anja Schenk for their help developing the database, Matthias Keller, Michael Lambertus, and Fatima Pigat for their assistance running and analyzing the validation studies, and to Leonie Reutner for discussing the project. This research was supported by the Swiss National Science Foundation under grant no. 100014_135213 and grant no. PZ00P1_168070.	Abele AE, 2008, EUR J SOC PSYCHOL, V38, P1202, DOI 10.1002/ejsp.575; [Anonymous], 2014, R LANG ENV STAT COMP; Ballew CC, 2007, P NATL ACAD SCI USA, V104, P17948, DOI 10.1073/pnas.0705435104; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Blanz V, 1999, COMP GRAPH, P187, DOI 10.1145/311535.311556; Crookes K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141353; Engell AD, 2007, J COGNITIVE NEUROSCI, V19, P1508, DOI 10.1162/jocn.2007.19.9.1508; Fincher KM, 2016, J EXP PSYCHOL GEN, V145, P131, DOI 10.1037/xge0000132; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; Gebauer JE, 2012, PERS SOC PSYCHOL B, V38, P1579, DOI 10.1177/0146167212456300; Hassin R, 2000, J PERS SOC PSYCHOL, V78, P837, DOI 10.1037/0022-3514.78.5.837; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Judd CM, 2012, J PERS SOC PSYCHOL, V103, P54, DOI 10.1037/a0028347; Kramer RSS, 2010, Q J EXP PSYCHOL, V63, P2273, DOI 10.1080/17470211003770912; Little AC, 2007, EVOL HUM BEHAV, V28, P18, DOI 10.1016/j.evolhumbehav.2006.09.002; McCrae R. R., 1999, HDB PERSONALITY THEO, V2, P139; Miller SL, 2012, PERS SOC PSYCHOL B, V38, P1358, DOI 10.1177/0146167212450516; Moore D, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-182; Mulyanegara R.C., 2007, J BRAND MANAG, V16, P234; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Paysan P, 2009, AVSS: 2009 6TH IEEE INTERNATIONAL CONFERENCE ON ADVANCED VIDEO AND SIGNAL BASED SURVEILLANCE, P296, DOI 10.1109/AVSS.2009.58; Penton-Voak IS, 2006, SOC COGNITION, V24, P607, DOI 10.1521/soco.2006.24.5.607; Porter S, 2010, PSYCHOL CRIME LAW, V16, P477, DOI 10.1080/10683160902926141; Prinzie P, 2009, J PERS SOC PSYCHOL, V97, P351, DOI 10.1037/a0015823; Rammstedt B, 2005, DIAGNOSTICA, V51, P195, DOI 10.1026/0012-1924.51.4.195; Rauschenbach C, 2012, EDUC GERONTOL, V38, P511, DOI 10.1080/03601277.2011.567187; Re D. E., 2013, EVOL PSYCHIATR, V11, p147470491301100109; Rudert SC, J EXP SOC PSYCHOL; RUNGE TE, 1981, J CROSS CULT PSYCHOL, V12, P142, DOI 10.1177/0022022181122002; Sutherland CAM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01616; Todorov A, 2016, 25 MAXIMALLY DISTINC; Todorov A, 2013, EMOTION, V13, P724, DOI 10.1037/a0032335; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Vetter T, 2016, MORPHFACE; Walker M, 2016, J PERS SOC PSYCHOL, V110, P609, DOI 10.1037/pspp0000064; Walker M, 2011, SOC PSYCHOL PERS SCI, V2, P609, DOI 10.1177/1948550611402519; Walker M, 2009, J VISION, V9, DOI 10.1167/9.11.12; Watkins CD, 2010, PERS INDIV DIFFER, V49, P967, DOI 10.1016/j.paid.2010.08.006; Westfall J., 2015, PANGEA POWER ANAL GE, DOI [DOI 10.1002/CNM, 10.1002/cnm]; Wiggins J.S., 1991, THINKING CLEARLY PSY, P89; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Zebrowitz L.A., 2011, OXFORD HDB FACE PERC, P31, DOI DOI 10.1093/OXFORDHB/9780199559053.013.0003; Zebrowitz LA, 2008, SOC PERSONAL PSYCHOL, V2, P1497, DOI 10.1111/j.1751-9004.2008.00109.x	45	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193190	10.1371/journal.pone.0193190	http://dx.doi.org/10.1371/journal.pone.0193190			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590124	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100016
J	Chae, JJ; Shin, YJ; Lee, JD; Seo, K; Elisseeff, JH				Chae, J. Jeremy; Shin, Yu Jung; Lee, Justin D.; Seo, Kangmoon; Elisseeff, Jennifer H.			Nictitating membrane fixation improves stability of the contact lens on the animal corneal surface	PLOS ONE			English	Article							EYELID CLOSURE; DOGS; PLACEMENT; REMOVAL; HYPOXIA; GLAND; CELLS; WEAR	We evaluated the feasibility and safety of nictitating membrane fixation to address reduced contact lens stability by the nictitating membrane in a rabbit model. Under general anesthesia, twelve animals received a horizontal mattress suture between the nictitating membrane and the upper eyelid of one eye. To assess the effects of this technique and secondary side effects, contact lens stability test, Schirmer tear test, tear break-up time measurement, eye tissue pathology and morphology were evaluated. Contact lens stability was increased after nictitating membrane fixation. The percentage of contact lens retention in the nictitating membrane fixed rabbit after 4 hours was 90% whereas that in the untreated rabbit was 42.5%. In addition, there were no significant differences in tear quantity and quality between the fixed and untreated eyes. Furthermore, no remarkable pathological lesions were found in gross observation during the 1-month time period or the following pathological examination. In this study, we demonstrated that nictitating membrane fixation increases contact lens stability without specific side effects using a rabbit model. This minimally invasive procedure could be useful when designing animal models for testing new contact lenses and has potential to apply to other biomaterial research on the ocular surface.	[Chae, J. Jeremy; Shin, Yu Jung; Lee, Justin D.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Wilmer Eye Inst, Translat Tissue Engn Ctr, Baltimore, MD 21218 USA; [Chae, J. Jeremy; Shin, Yu Jung; Lee, Justin D.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Chae, J. Jeremy; Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Ophthalmol, Baltimore, MD 21218 USA; [Seo, Kangmoon] Seoul Natl Univ, Coll Vet Med, Dept Vet Clin, Seoul, South Korea; [Chae, J. Jeremy] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Lee, Justin D.] Univ Calif Los Angeles, David Geffen Sch Med, Med Scientist Training Program, Los Angeles, CA 90095 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Seoul National University (SNU); University System of Georgia; Georgia Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Elisseeff, JH (corresponding author), Johns Hopkins Univ, Wilmer Eye Inst, Translat Tissue Engn Ctr, Baltimore, MD 21218 USA.; Elisseeff, JH (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.; Elisseeff, JH (corresponding author), Johns Hopkins Univ, Dept Ophthalmol, Baltimore, MD 21218 USA.	jhe@jhu.edu	Elisseeff, Jennifer/A-3324-2010	Elisseeff, Jennifer/0000-0002-5066-1996	Congressionally Directed Medical Research Program under the U.S. Army Medical Research and Materiel Command at Ft. Detrick, MD [W81XWH-09-2-0173]; Jules Stein Professorship from Research to Prevent Blindness; Morton Goldberg Chair; National Eye Institute - the Animal Module of the Wilmer Core Grant [EY001765]	Congressionally Directed Medical Research Program under the U.S. Army Medical Research and Materiel Command at Ft. Detrick, MD; Jules Stein Professorship from Research to Prevent Blindness; Morton Goldberg Chair; National Eye Institute - the Animal Module of the Wilmer Core Grant	This study was funded by the Congressionally Directed Medical Research Program under the U.S. Army Medical Research and Materiel Command at Ft. Detrick, MD (Contract No W81XWH-09-2-0173, Program Manager Dr. Dwayne Taliaferro) (http://cdmrp.army.mil/) to JHE, the Jules Stein Professorship from Research to Prevent Blindness (https://www.rpbusa.org/) to JHE, the Morton Goldberg Chair to JHE, and the National Eye Institute - the Animal Module of the Wilmer Core Grant, EY001765 (https://nei.nih.gov/ ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabino S, 2012, PROG RETIN EYE RES, V31, P271, DOI 10.1016/j.preteyeres.2012.02.003; Carvalho IM, 2015, J CONTROL RELEASE, V202, P76, DOI 10.1016/j.jconrel.2015.01.023; Chang JH, 2001, CURR OPIN OPHTHALMOL, V12, P242, DOI 10.1097/00055735-200108000-00002; EFRON N, 1979, INVEST OPHTH VIS SCI, V18, P93; Grinninger P, 2015, J SMALL ANIM PRACT, V56, P446, DOI 10.1111/jsap.12360; HELPER LC, 1974, J AM VET MED ASSOC, V165, P172; Hendrix DVH, 2007, VET OPHTHALMOL CANIN, P675; Ioannidis JPA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004631; Ladage PM, 2003, INVEST OPHTH VIS SCI, V44, P1843, DOI 10.1167/iovs.02-0897; Li Ling, 2002, CLAO Journal, V28, P48; Maitchouk DY, 2000, ARCH OPHTHALMOL-CHIC, V118, P246; McCanna DJ, 2008, EYE CONTACT LENS, V34, P160, DOI 10.1097/ICL.0b013e31815788d7; MCLAUGHLIN SA, 1988, J AM VET MED ASSOC, V193, P820; Park SA, 2009, J AM ANIM HOSP ASSOC, V45, P164, DOI 10.5326/0450164; Robertson DM, 2012, EYE CONTACT LENS, V38, P214, DOI 10.1097/ICL.0b013e3182482948; Sapienza JS, 2014, VET OPHTHALMOL, V17, P81, DOI 10.1111/vop.12073; Umeda Y, 2010, EXP EYE RES, V91, P721, DOI 10.1016/j.exer.2010.08.020; Yamamoto K, 2002, CORNEA, V21, P85, DOI 10.1097/00003226-200201000-00018	18	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194795	10.1371/journal.pone.0194795	http://dx.doi.org/10.1371/journal.pone.0194795			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584737	gold, Green Published, Green Submitted			2022-12-26	WOS:000428373000036
J	Schay, G; Kaposi, AD; Smeller, L; Szigeti, K; Fidy, J; Herenyi, L				Schay, Gusztav; Kaposi, Andras D.; Smeller, Laszlo; Szigeti, Krisztian; Fidy, Judit; Herenyi, Levente			Dissimilar flexibility of alpha and beta subunits of human adult hemoglobin influences the protein dynamics and its alteration induced by allosteric effectors	PLOS ONE			English	Article							CYTOCHROME-C; R-STATE; HETEROTROPIC EFFECTORS; ANGSTROM RESOLUTION; T-STATE; PRESSURE; SIMULATIONS; SPECTRA; MODEL; COMPRESSIBILITY	The general question by what mechanism an "effector" molecule and the hemes of hemoglobin interact over widely separated intramolecular distances to change the oxygen affinity has been extensively investigated, and still has remained of central interest. In the present work we were interested in clarifying the general role of the protein matrix and its dynamics in the regulation of human adult hemoglobin (HbA). We used a spectroscopy approach that yields the compressibility (K) of the protein matrix around the hemes of the subunits in HbA and studied how the binding of heterotropic allosteric effectors modify this parameter. K is directly related to the variance of volume fluctuation, therefore it characterizes the molecular dynamics of the protein structure. For the experiments the heme groups either in the alpha or in the beta subunits of HbA were replaced by fluorescent Zn-protoporphyrinlX, and series of fluorescence line narrowed spectra were measured at varied pressures. The evaluation of the spectra yielded the compressibility that showed significant dynamic asymmetry between the subunits: K of the alpha subunit was 0.17 +/- 0.05/GPa, while for the beta subunit it was much higher, 0.36 +/- 0.07/GPa. The heterotropic effectors, chloride ions, inositol hexaphosphate and bezafibrate did not cause significant changes in roof the a subunits, while in the beta subunits the effectors lead to a significant reduction down to 0.15 +/- 0.04/GPa. We relate our results to structural data, to results of recent functional studies and to those of molecular dynamics simulations, and find good agreements. The observed asymmetry in the flexibility suggests a distinct role of the subunits in the regulation of Hb that results in the observed changes of the oxygen binding capability.	[Schay, Gusztav; Kaposi, Andras D.; Smeller, Laszlo; Szigeti, Krisztian; Fidy, Judit; Herenyi, Levente] Semmelweis Univ, Dept Biophys & Radiat Biol, Budapest, Hungary	Semmelweis University	Herenyi, L (corresponding author), Semmelweis Univ, Dept Biophys & Radiat Biol, Budapest, Hungary.	herenyi.levente@med.semmelweis-univ.hu	Kaposi, Andras/P-8355-2019	Kaposi, Andras/0000-0002-0913-3622	Semmelweis Egyetem [VKSZ_14-1-2015-0052]	Semmelweis Egyetem	This work was supported by VKSZ_14-1-2015-0052, Semmelweis Egyetem, http://nkfih.gov.hu/palyazatok/ktia/tamogatott-projektek/2015/vksz-14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackers GK, 2006, J BIOL CHEM, V281, P11441, DOI 10.1074/jbc.R500019200; ANGIOLILLO PJ, 1982, PHOTOCHEM PHOTOBIOL, V36, P133, DOI 10.1111/j.1751-1097.1982.tb04354.x; AVARMAA RA, 1985, SPECTROCHIM ACTA A, V41, P1365, DOI 10.1016/0584-8539(85)80189-6; Changeux JP, 2011, PROTEIN SCI, V20, P1119, DOI 10.1002/pro.658; Chao HL, 2014, SCI WORLD J, DOI 10.1155/2014/535308; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; FIDY J, 1992, BIOPHYS J, V63, P1605, DOI 10.1016/S0006-3495(92)81749-6; FORMAN RA, 1972, SCIENCE, V176, P284, DOI 10.1126/science.176.4032.284; FRIEDRICH J, 1994, P NATL ACAD SCI USA, V91, P1029, DOI 10.1073/pnas.91.3.1029; GEKKO K, 1986, BIOCHEMISTRY-US, V25, P6563, DOI 10.1021/bi00369a034; Henry ER, 2002, BIOPHYS CHEM, V98, P149, DOI 10.1016/S0301-4622(02)00091-1; Herenyi L, 1998, J PHYS CHEM B, V102, P5932, DOI 10.1021/jp981176e; Hub JS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000774; Imai K., 1982, ALLOSTERIC EFFECTS H; Jones EM, 2014, J AM CHEM SOC, V136, P10325, DOI 10.1021/ja503328a; Kharakoz DP, 2000, BIOPHYS J, V79, P511, DOI 10.1016/S0006-3495(00)76313-2; KOLOCZEK H, 1987, J CHEM PHYS, V87, P4388, DOI 10.1063/1.452899; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kovesi I, 2006, BBA-PROTEINS PROTEOM, V1764, P516, DOI 10.1016/j.bbapap.2005.12.002; Laberge M, 2005, FEBS LETT, V579, P627, DOI 10.1016/j.febslet.2004.12.033; LAIRD BB, 1989, J CHEM PHYS, V90, P3274, DOI 10.1063/1.455881; Landau L.D., 1980, COURSE THEORETICAL P, V5; Lesch H, 2004, BIOPHYS J, V86, P467, DOI 10.1016/S0006-3495(04)74124-7; Lukin JA, 2003, P NATL ACAD SCI USA, V100, P517, DOI 10.1073/pnas.232715799; Marechal JD, 2006, J COMPUT CHEM, V27, P1446, DOI 10.1002/jcc.20427; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Mouawad L, 2005, BBA-GEN SUBJECTS, V1724, P385, DOI 10.1016/j.bbagen.2005.05.014; Mouawad L, 2002, BIOPHYS J, V82, P3224, DOI 10.1016/S0006-3495(02)75665-8; Nagatomo S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135080; Nussinov R, 2015, CURR OPIN STRUC BIOL, V30, P17, DOI 10.1016/j.sbi.2014.11.005; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; Personov R. I., 1983, SPECTROSCOPY EXCITAT; PERSONOV RI, 1992, J PHOTOCH PHOTOBIO A, V62, P321, DOI 10.1016/1010-6030(92)85062-Y; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; PERUTZ MF, 1994, J MOL BIOL, V239, P555, DOI 10.1006/jmbi.1994.1394; POYART C, 1994, METHOD ENZYMOL, V232, P496; Ribeiro AAST, 2016, CHEM REV, V116, P6488, DOI 10.1021/acs.chemrev.5b00543; RICHARD V, 1993, J MOL BIOL, V233, P270, DOI 10.1006/jmbi.1993.1505; Ronda L, 2013, BBA-PROTEINS PROTEOM, V1834, P1860, DOI 10.1016/j.bbapap.2013.03.013; Safo MK, 2011, BBA-PROTEINS PROTEOM, V1814, P797, DOI 10.1016/j.bbapap.2011.02.013; Scharnagl C, 2005, BIOPHYS J, V89, P64, DOI 10.1529/biophysj.104.057265; Schay G, 2006, J BIOL CHEM, V281, P25972, DOI 10.1074/jbc.M604216200; Shibayama N, 2014, J AM CHEM SOC, V136, P5097, DOI 10.1021/ja500380e; Smeller L, 2002, BIOPHYS J, V82, P426, DOI 10.1016/S0006-3495(02)75407-6; Sun DZP, 1997, BIOCHEMISTRY-US, V36, P6663, DOI 10.1021/bi963121d; Takayanagi M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04601; Tsuneshige A, 2002, BIOPHYS CHEM, V98, P49, DOI 10.1016/S0301-4622(02)00084-4; Vesper MD, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003232; Viappiani C, 2014, P NATL ACAD SCI USA, V111, P12758, DOI 10.1073/pnas.1413566111; Yonetani T, 2002, J BIOL CHEM, V277, P34508, DOI 10.1074/jbc.M203135200; Yonetani T, 2013, BBA-PROTEINS PROTEOM, V1834, P1873, DOI 10.1016/j.bbapap.2013.04.026; ZOLLFRANK J, 1991, J CHEM PHYS, V94, P8600, DOI 10.1063/1.460042; ZOLLFRANK J, 1992, BIOPHYS J, V61, P716, DOI 10.1016/S0006-3495(92)81876-3	54	2	2	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194994	10.1371/journal.pone.0194994	http://dx.doi.org/10.1371/journal.pone.0194994			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584765	Green Submitted, Green Published, gold			2022-12-26	WOS:000428373000053
J	Shellnutt, JG				Shellnutt, J. Gregory			Derivation of intermediate to silicic magma from the basalt analyzed at the Vega 2 landing site, Venus	PLOS ONE			English	Article							EASTERN APHRODITE TERRA; LARGE IGNEOUS PROVINCE; THERMAL EVOLUTION; CONTINENTAL-CRUST; VOLCANIC-ROCKS; MELT GENERATION; ALPHA REGIO; SW CHINA; PERALKALINE; ERUPTION	Geochemical modeling using the basalt composition analyzed at the Vega 2 landing site indicates that intermediate to silicic liquids can be generated by fractional crystallization and equilibrium partial melting. Fractional crystallization modeling using variable pressures (0.01 GPa to 0.5 GPa) and relative oxidation states (FMQ 0 and FMQ-1) of either a wet (H2O = 0.5 wt%) or dry (H2O = 0 wt%) parental magma can yield silicic (SiO2 > 60 wt%) compositions that are similar to terrestrial ferroan rhyolite. Hydrous (H2O = 0.5 wt%) partial melting can yield intermediate (trachyandesite to andesite) to silicic (trachydacite) compositions at all pressures but requires relatively high temperatures (>= 950 degrees C) to generate the initial melt at intermediate to low pressure whereas at high pressure (0.5 GPa) the first melts will be generated at much lower temperatures (< 800 degrees C). Anhydrous partial melt modeling yielded mafic (basaltic andesite) and alkaline compositions (trachybasalt) but the temperature required to produce the first liquid is very high (>= 1130 degrees C). Consequently, anhydrous partial melting is an unlikely process to generate derivative liquids. The modeling results indicate that, under certain conditions, the Vega 2 composition can generate silicic liquids that produce granitic and rhyolitic rocks. The implication is that silicic igneous rocks may form a small but important component of the northeast Aphrodite Terra.	[Shellnutt, J. Gregory] Natl Taiwan Normal Univ, Dept Earth Sci, Taipei, Taiwan	National Taiwan Normal University	Shellnutt, JG (corresponding author), Natl Taiwan Normal Univ, Dept Earth Sci, Taipei, Taiwan.	jgshelln@ntnu.edu.tw	Shellnutt, Greg/H-7554-2019	Shellnutt, Greg/0000-0003-2289-2903	Ministry of Science and Technology of Taiwan [106-2116-M-003-007]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology of Taiwan (Grant No. 106-2116-M-003-007).	Abdrakhimov AM, 2002, SOLAR SYST RES+, V36, P136, DOI 10.1023/A:1015222316518; Airey MW, 2015, PLANET SPACE SCI, V113, P33, DOI 10.1016/j.pss.2015.01.009; Annen C, 2002, EARTH PLANET SC LETT, V203, P937, DOI 10.1016/S0012-821X(02)00929-9; Annen C, 2006, J PETROL, V47, P505, DOI 10.1093/petrology/egi084; Annen C, 2015, LITHOS, V230, P206, DOI 10.1016/j.lithos.2015.05.008; [Anonymous], 1977, P 8 LUN SCI C HOUS T; Ansan V, 1996, PLANET SPACE SCI, V44, P833, DOI 10.1016/0032-0633(96)00011-6; Armann M, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004231; ATHERTON MP, 1993, J GEOL SOC LONDON, V150, P1009, DOI 10.1144/gsjgs.150.6.1009; Bachmann O, 2008, ELEMENTS, V4, P17, DOI 10.2113/GSELEMENTS.4.1.17; Bachmann O, 2016, AM MINERAL, V101, P2377, DOI 10.2138/am-2016-5675; Bachmann O, 2008, J PETROL, V49, P2277, DOI 10.1093/petrology/egn068; BAKER VR, 1992, J GEOPHYS RES-PLANET, V97, P13421, DOI 10.1029/92JE00927; BALLHAUS C, 1993, CONTRIB MINERAL PETR, V114, P331, DOI 10.1007/BF01046536; Basaltic Volcanism Study Project, 1981, BASALTIC VOLCANISM T; Basilevsky AT, 2012, ICARUS, V217, P434, DOI 10.1016/j.icarus.2011.11.003; BASILEVSKY AT, 1988, ANNU REV EARTH PL SC, V16, P295; Befus KS, 2014, B VOLCANOL, V76, DOI 10.1007/s00445-014-0808-8; BERGANTZ GW, 1989, SCIENCE, V245, P1093, DOI 10.1126/science.245.4922.1093; BINDSCHADLER DL, 1992, J GEOPHYS RES-PLANET, V97, P13563, DOI 10.1029/92JE01332; BINDSCHADLER DL, 1991, J GEOPHYS RES-SOLID, V96, P5889, DOI 10.1029/90JB02742; Bohrson WA, 1997, J PETROL, V38, P1137, DOI 10.1093/petrology/38.9.1137; Bonin B, 2004, LITHOS, V78, P1, DOI 10.1016/j.lithos.2004.04.042; Bonin B, 2012, LITHOS, V153, P3, DOI 10.1016/j.lithos.2012.04.007; Brooks CK., 1976, B GEOL SOC DENMARK, V25, P117; Brown CD, 1999, ICARUS, V139, P40, DOI 10.1006/icar.1999.6083; Budd DA, 2017, SCI REP-UK, V7, DOI 10.1038/srep40624; BUDDINGTON AF, 1964, J PETROL, V5, P310, DOI 10.1093/petrology/5.2.310; CAMPBELL BA, 1992, J GEOPHYS RES-PLANET, V97, P16293, DOI 10.1029/92JE01558; CAMPBELL IH, 1983, GEOPHYS RES LETT, V10, P1061, DOI 10.1029/GL010i011p01061; Cashman KV, 2014, J VOLCANOL GEOTH RES, V288, P28, DOI 10.1016/j.jvolgeores.2014.09.007; Cawood PA, 2013, GEOL SOC AM BULL, V125, P14, DOI 10.1130/B30722.1; Charreteur G, 2013, CONTRIB MINERAL PETR, V166, P471, DOI 10.1007/s00410-013-0886-1; Chassefiere E, 2012, PLANET SPACE SCI, V63-64, P15, DOI 10.1016/j.pss.2011.04.007; Christiansen EH, 2008, B VOLCANOL, V70, P251, DOI 10.1007/s00445-007-0138-1; CRUMPLER LS, 1990, EARTH MOON PLANETS, V50-1, P343, DOI 10.1007/BF00142399; DONAHUE TM, 1982, SCIENCE, V216, P630, DOI 10.1126/science.216.4546.630; Dostal J, 2017, LITHOS, V292, P146, DOI 10.1016/j.lithos.2017.09.005; Ducea MN, 2017, GEOLOGY, V45, P235, DOI 10.1130/G38726.1; Ducea MN, 2010, TECTONICS, V29, DOI 10.1029/2009TC002615; EICHELBERGER JC, 1986, NATURE, V323, P598, DOI 10.1038/323598a0; Ernst RE., 2014, LARGE IGNEOUS PROVIN; Fegley Jr B, 2014, TREATISE GEOCHEMISTR, V2, P127, DOI DOI 10.1016/13978-0-08-095975-7.00122-4; Filiberto J, 2014, ICARUS, V231, P131, DOI 10.1016/j.icarus.2013.12.003; FINK JH, 1993, GEOPHYS RES LETT, V20, P261, DOI 10.1029/92GL03010; Frost CD, 2011, J PETROL, V52, P39, DOI 10.1093/petrology/egq070; Gale A, 2013, GEOCHEM GEOPHY GEOSY, P14; Gerya TV, 2007, PHYS EARTH PLANET IN, V160, P124, DOI 10.1016/j.pepi.2006.10.004; Ghail RC, 2015, GEOL SOC SPEC PUBL, V401, P97, DOI 10.1144/SP401.1; Gillmann C, 2014, J GEOPHYS RES-PLANET, V119, P1189, DOI 10.1002/2013JE004505; Gilmore MS, 2015, ICARUS, V254, P350, DOI 10.1016/j.icarus.2015.04.008; Gilmore MS, 2000, METEORIT PLANET SCI, V35, P667, DOI 10.1111/j.1945-5100.2000.tb01451.x; GRINSPOON DH, 1993, NATURE, V363, P428, DOI 10.1038/363428a0; Gualda GAR, 2012, J PETROL, V53, P875, DOI 10.1093/petrology/egr080; Hansen VL, 2010, GEOLOGY, V38, P311, DOI 10.1130/G30587.1; Hansen VL, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002714; Hansen VL, 2007, DEV PREC G, V15, P987, DOI 10.1016/S0166-2635(07)15081-7; HANSEN VL, 1993, SCIENCE, V260, P526, DOI 10.1126/science.260.5107.526; Hansen VL, 1999, GEOLOGY, V27, P1071, DOI 10.1130/0091-7613(1999)027<1071:TTACPV>2.3.CO;2; Harris LB, 2014, MOD APPR SOL EARTH S, V7, P215, DOI 10.1007/978-94-007-7615-9_9; Hashimoto GL, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003134; Hauri E, 2002, CHEM GEOL, V183, P115, DOI 10.1016/S0009-2541(01)00374-6; Hawkesworth CJ, 2010, J GEOL SOC LONDON, V167, P229, DOI 10.1144/0016-76492009-072; HEAD JW, 1992, J GEOPHYS RES-PLANET, V97, P13153, DOI 10.1029/92JE01273; Herzberg C, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002057; Herzberg C, 2015, GEOCHEM GEOPHY GEOSY, V16, P536; HESS PC, 1990, EARTH MOON PLANETS, V50-1, P57, DOI 10.1007/BF00142389; Houghton BF, 2010, J VOLCANOL GEOTH RES, V195, P31, DOI 10.1016/j.jvolgeores.2010.06.002; Huang HH, 2015, SCIENCE, V348, P773, DOI 10.1126/science.aaa5648; HUPPERT HE, 1988, J PETROL, V29, P599, DOI 10.1093/petrology/29.3.599; Jaxybulatov K, 2014, SCIENCE, V346, P617, DOI 10.1126/science.1258582; KARGEL JS, 1993, ICARUS, V103, P253, DOI 10.1006/icar.1993.1069; LEBAS MJ, 1986, J PETROL, V27, P745, DOI 10.1093/petrology/27.3.745; Lee CTA, 2010, NATURE, V463, P930, DOI 10.1038/nature08824; Lee CTA, 2009, EARTH PLANET SC LETT, V279, P20, DOI 10.1016/j.epsl.2008.12.020; Marshall AS, 1998, MINERAL MAG, V62, P477, DOI 10.1180/002646198547855; MCKENZIE D, 1992, J GEOPHYS RES-PLANET, V97, P13533, DOI 10.1029/92JE01350; Nathues A, 2015, NATURE, V528, P237, DOI 10.1038/nature15754; NIKOLAYEVA OV, 1990, EARTH MOON PLANETS, V50-1, P329, DOI 10.1007/BF00142398; Nimmo F, 1998, ANNU REV EARTH PL SC, V26, P23, DOI 10.1146/annurev.earth.26.1.23; O'Rourke JG, 2015, ICARUS, V260, P128, DOI 10.1016/j.icarus.2015.07.009; Owen-Smith TM, 2013, LITHOS, V182, P33, DOI 10.1016/j.lithos2013.09.011; PAVRI B, 1992, J GEOPHYS RES-PLANET, V97, P13445, DOI 10.1029/92JE01162; Petford N, 2000, T ROY SOC EDIN-EARTH, V91, P87, DOI 10.1017/S0263593300007318; RUDNICK RL, 1995, NATURE, V378, P571, DOI 10.1038/378571a0; Sandor BJ, 2005, ICARUS, V177, P129, DOI 10.1016/j.icarus.2005.03.020; SAUNDERS RS, 1991, SCIENCE, V252, P249, DOI 10.1126/science.252.5003.249; Scaillet B, 1998, J GEOPHYS RES-SOL EA, V103, P27257, DOI 10.1029/98JB02469; Shellnutt JG, 2010, EARTH PLANET SC LETT, V289, P509, DOI 10.1016/j.epsl.2009.11.044; Shellnutt JG, 2007, CHEM GEOL, V243, P286, DOI 10.1016/j.chemgeo.2007.05.022; Shellnutt JG, 2016, ICARUS, V277, P98, DOI 10.1016/j.icarus.2016.05.014; Shellnutt JG, 2013, J GEOPHYS RES-PLANET, V118, P1350, DOI 10.1002/jgre.20094; Shellnutt JG, 2011, AM J SCI, V311, P773, DOI 10.2475/09.2011.02; Shellnutt JG, 2011, EUR J MINERAL, V23, P45, DOI 10.1127/0935-1221/2010/0022-2073; Sliwinski JT, 2015, J PETROL, V56, P2173, DOI 10.1093/petrology/egv068; Smrekar SE, 2007, GEOPHYS MONOGR SER, V176, P45, DOI 10.1029/176GM05; SPULBER SD, 1983, J PETROL, V24, P1; Stofan ER, 2016, ICARUS, V271, P375, DOI 10.1016/j.icarus.2016.01.034; SURKOV YA, 1986, J GEOPHYS RES-SOLID, V91, pE215, DOI 10.1029/JB091iB13p0E215; Surkov Yu. A., 1984, Journal of Geophysical Research, V89, P393, DOI 10.1029/JB089iS02p0B393; Takeuchi S, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008243; Treiman AH, 2007, GEOPHYS MONOGR SER, V176, P7, DOI 10.1029/176GM03; Van der Pluijm B.A., 2004, EARTH STRUCTURE; Vaniman DT, 2004, NATURE, V431, P663, DOI 10.1038/nature02973; Walker G.P.L, 1965, B VOLCANOL, V29, P375, DOI DOI 10.1007/BF02597164; Wanless VD, 2010, J PETROL, V51, P2377, DOI 10.1093/petrology/egq056; Way MJ, 2016, GEOPHYS RES LETT, V43, P8376, DOI 10.1002/2016GL069790; Weller M., 2015, LUNAR PLANET SCI C A, V46, P2749; Wiebe RA, 1996, T ROY SOC EDIN-EARTH, V87, P233, DOI 10.1017/S0263593300006647; Williams-Jones G, 1998, J GEOPHYS RES-PLANET, V103, P8545, DOI 10.1029/98JE00243; WILSON M, 1993, J GEOL SOC LONDON, V150, P611, DOI 10.1144/gsjgs.150.4.0611	112	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194155	10.1371/journal.pone.0194155	http://dx.doi.org/10.1371/journal.pone.0194155			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584745	gold, Green Published, Green Submitted			2022-12-26	WOS:000428373000017
J	Gillio-Tos, A; Fiano, V; Grasso, C; Trevisan, M; Gori, S; Mongia, A; De Marco, L; Ronco, G				Gillio-Tos, Anna; Fiano, Valentina; Grasso, Chiara; Trevisan, Morena; Gori, Silvia; Mongia, Alessandra; De Marco, Laura; Ronco, Guglielmo		New Technologies Cervical Canc Scr	Assessment of viral methylation levels for high risk HPV types by newly designed consensus primers PCR and pyrosequencing	PLOS ONE			English	Article							CERVICAL INTRAEPITHELIAL NEOPLASIA; HUMAN-PAPILLOMAVIRUS; DNA METHYLATION; GENES; WOMEN; TECHNOLOGIES; RECRUITMENT; PROGRESSION; BIOMARKERS; SEVERITY	Background Measuring viral DNA methylation in human papillomavirus (HPV) infected women showed promise for accurate detection of high-grade cervical lesions and cancer. Methylation status has been widely investigated for HPV16, sporadically for other HPV types. Methods Objective of this methodological study was to set up molecular methods to test the methylation levels in the twelve oncogenic HPV types by pyrosequencing, minimizing the number of HPV type-specific PCR protocols. Target CpGs were selected on the HPV L1 (two regions, L1 I and L1 II) and L2 genes. Study samples included DNA stored at Turin, Italy, purified by cervical cells collected in Standard Transport Medium or PreservCyt from women who participated in two studies (N = 126 and 140) nested within the regional organized screening programme. PCR consensus primers were designed by PyroMark Assay Design software to be suitable for amplification of many different oncogenic HPV types. Results Generation of consensus primers was successful for L1 I and II regions, unsuccessful for L2 region, for which HPV type-specific primers remained necessary. The difference between replicated tests on the same sample was <= 4% in 88%, 77% and 91% of cases when targeting the L1 I, L1 II and L2 regions, respectively. The corresponding intra-class correlation coefficients (ICC) were 0.94, 0.87 and 0.97 respectively. When comparing methylation measures based on consensus and type-specific primers, ICC was 0.97 for the L1 I region and 0.99 the for L1 II region. Conclusions The proposed protocols, applying consensus primers suitable to amplify the oncogenic HPV types and minimize the number of PCR reactions, represent a promising tool to quantify viral methylation in women positive for any high risk HPV type. Impact Potential application of these methylation protocols in screening settings can be explored to identify women with high probability of progression to high grade lesions.	[Gillio-Tos, Anna; Fiano, Valentina; Grasso, Chiara; Trevisan, Morena] Univ Turin, Dept Med Sci, Canc Epidemiol Unit CERMS, Turin, Italy; [Gori, Silvia] Veneto Inst Oncol IOV IRCCS, Immunol & Diagnost Mol Oncol Unit, Padua, Italy; [Mongia, Alessandra] Prevent & Res Inst ISPRO, Reg Canc Prevent Lab Oncol Network, Florence, Italy; [De Marco, Laura] City Hlth & Sci Hosp & CPO, Canc Epidemiol CERMS, Turin, Italy; [Ronco, Guglielmo] Ctr Oncol Prevent, Turin, Italy	University of Turin; IRCCS Istituto Oncologico Veneto (IOV); A.O.U. Citta della Salute e della Scienza di Torino	Gillio-Tos, A (corresponding author), Univ Turin, Dept Med Sci, Canc Epidemiol Unit CERMS, Turin, Italy.	gilliotos.demarco@cpo.it	zappa, marco/AAB-3294-2019; Sapino, Anna/AGY-9901-2022; Gori, Silvia/R-4088-2018; Baboci, Lorena/K-4790-2014; Rossi, Paolo Giorgi/K-6367-2016; VITALI, BENEDETTA/AAA-9660-2021; Carozzi, Francesca/AAB-4985-2019; Frayle, Helena/S-7496-2018; SANI, CRISTINA/J-8722-2016	zappa, marco/0000-0002-6606-9786; Sapino, Anna/0000-0003-3542-9571; Gori, Silvia/0000-0002-8528-0608; Baboci, Lorena/0000-0002-7380-2106; Rossi, Paolo Giorgi/0000-0001-9703-2460; VITALI, BENEDETTA/0000-0001-8387-0623; Carozzi, Francesca/0000-0002-6980-8011; Confortini, Massimo/0000-0002-9978-8592; Frayle, Helena/0000-0002-4906-3075; Gillio-Tos, Anna/0000-0001-6553-5362; SANI, CRISTINA/0000-0001-8955-8913	Italian Association for Cancer Research (AIRC) [IG 14119]; European Union (Europe against cancer) [S1.2.327046, SPC2002473]; Italian Ministry of Health; Regional Health Administration of Piemonte; Regional Health Administration of Tuscany; Regional Health Administration of Veneto; Regional Health Administration of Emilia Romagna; Public Health Agency of Lazio Region [ISRCTN81678807]	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); European Union (Europe against cancer); Italian Ministry of Health(Ministry of Health, Italy); Regional Health Administration of Piemonte; Regional Health Administration of Tuscany; Regional Health Administration of Veneto; Regional Health Administration of Emilia Romagna; Public Health Agency of Lazio Region	This study was supported by the Italian Association for Cancer Research (AIRC) IG 14119. The NTCC main trial was financially supported by the European Union (Europe against cancer contracts S1.2.327046 and SPC2002473), by the Italian Ministry of Health, by the Regional Health Administrations of Piemonte, Tuscany, Veneto, and Emilia Romagna, and by the Public Health Agency of Lazio Region, ISRCTN81678807.	Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Brandsma JL, 2009, VIROLOGY, V389, P100, DOI 10.1016/j.virol.2009.03.029; Brentnall AR, 2014, INT J CANCER, V135, P1425, DOI 10.1002/ijc.28790; Bryant D, 2014, J CLIN VIROL, V59, P24, DOI 10.1016/j.jcv.2013.10.029; Clarke MA, 2018, CLIN CANCER RES, V24, P2194, DOI 10.1158/1078-0432.CCR-17-3251; Clarke MA, 2017, INT J CANCER, V141, P701, DOI 10.1002/ijc.30781; Clarke MA, 2012, CANCER EPIDEM BIOMAR, V21, P2125, DOI 10.1158/1055-9965.EPI-12-0905; Depuydt CE, 2016, INT J CANCER, V139, P2021, DOI 10.1002/ijc.30238; Doeberitz MV, 2009, ARCH MED RES, V40, P435, DOI 10.1016/j.arcmed.2009.06.002; Galvan SC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-580; Gillio-Tos A, 2013, J CLIN MICROBIOL, V51, P2901, DOI 10.1128/JCM.01047-13; Grasso C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150483; Hoelzer K, 2008, NUCLEIC ACIDS RES, V36, P2825, DOI 10.1093/nar/gkn121; Izzi Benedetta, 2014, Med Epigenet, V2, P28; Jimenez-Wences H, 2014, ONCOL REP, V31, P2467, DOI 10.3892/or.2014.3142; Joura EA, 2014, CANCER EPIDEM BIOMAR, V23, P1997, DOI 10.1158/1055-9965.EPI-14-0410; Kalantari M, 2014, VIROLOGY, V448, P314, DOI 10.1016/j.virol.2013.10.032; Liu PY, 2017, CANCER EPIDEM BIOMAR, V26, P642, DOI [10.1158/1055-9965.EPI-16-0368, 10.1158/1055-9965.epi-16-0368]; Lorincz AT, 2013, INT J CANCER, V133, P637, DOI 10.1002/ijc.28050; Louvanto K, 2015, INT J CANCER, V136, pE638, DOI 10.1002/ijc.29196; Marongiu L, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-384; Marsh Sharon, 2007, V373, P15; Mirabello L, 2012, JNCI-J NATL CANCER I, V104, P1; Mirabello L, 2015, INT J CANCER, V136, pE146, DOI 10.1002/ijc.29119; Mirabello L, 2013, INT J CANCER, V132, P1412, DOI 10.1002/ijc.27750; Murakami I, 2013, J CLIN VIROL, V58, P149, DOI 10.1016/j.jcv.2013.06.026; Ronco G, 2008, J NATL CANCER I, V100, P492, DOI 10.1093/jnci/djn065; Ronco G, 2006, JNCI-J NATL CANCER I, V98, P765, DOI 10.1093/jnci/djj209; Ronco Guglielmo, 2012, Epidemiol Prev, V36, pe1; Smelov V, 2015, INT J CANCER, V136, P1171, DOI 10.1002/ijc.29085; Sun C, 2011, GYNECOL ONCOL, V121, P59, DOI 10.1016/j.ygyno.2011.01.013; Tost J, 2003, BIOTECHNIQUES, V35, P152, DOI 10.2144/03351md02; Turan T, 2006, VIROLOGY, V349, P175, DOI 10.1016/j.virol.2005.12.033; van der Marel J, 2015, AM J SURG PATHOL, V39, P496, DOI 10.1097/PAS.0000000000000342; Vasiljevic N, 2014, J CLIN VIROL, V59, P161, DOI 10.1016/j.jcv.2013.12.014; Vasiljevic N, 2011, DIS MARKERS, V30, P151, DOI 10.3233/DMA-2011-0790; Wentzensen N, 2009, INT J CANCER, V124, P964, DOI 10.1002/ijc.23969; Wentzensen N, 2016, J CLIN VIROL, V76, pS49, DOI 10.1016/j.jcv.2015.11.015; Wentzensen N, 2012, JNCI-J NATL CANCER I, V104, P1738, DOI 10.1093/jnci/djs425; Wentzensen N, 2009, INT J CANCER, V125, P2151, DOI 10.1002/ijc.24528	40	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194619	10.1371/journal.pone.0194619	http://dx.doi.org/10.1371/journal.pone.0194619			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579066	Green Submitted, Green Published, gold			2022-12-26	WOS:000428351800039
J	Abeyratne, SAE; Amarasekera, SSC; Ranaweera, LT; Salpadoru, TB; Thilakarathne, SMNK; Knowles, NJ; Wadsworth, J; Puvanendiran, S; Kothalawala, H; Jayathilake, BK; Wijithasiri, HA; Chandrasena, MMPSK; Sooriyapathirana, SDSS				Abeyratne, S. A. E.; Amarasekera, S. S. C.; Ranaweera, L. T.; Salpadoru, T. B.; Thilakarathne, S. M. N. K.; Knowles, N. J.; Wadsworth, J.; Puvanendiran, S.; Kothalawala, H.; Jayathilake, B. K.; Wijithasiri, H. A.; Chandrasena, M. M. P. S. K.; Sooriyapathirana, S. D. S. S.			The phylogenetic analysis of VP1 genomic region in foot-and-mouth disease virus serotype O isolates in Sri Lanka reveals the existence of 'Srl-97', a newly named endemic lineage	PLOS ONE			English	Article							INDIA; EVOLUTION; AFRICA	Foot and mouth disease (FMD) has devastated the cattle industry in Sri Lanka many times in the past. Despite its seriousness, limited attempts have been made to understand the disease to ameliorate its effects +/- current recommendation for vaccines being based solely on immunological assessments rather than on molecular identification. The general belief is that the cattle population in Sri Lanka acquired the FMD virus (FMDV) strains via introductions from India. However, there could be endemic FMDV lineages circulating in Sri Lanka. To infer the phylogenetic relationships of the FMDV strains in the island, we sequenced the VP1 genomic region of the virus isolates collected during the 2014 outbreak together with a few reported cases in 2012 and 1997 and compared them to VP1 sequences from South Asia. The FMDV strains collected in the 2014 outbreak belonged to the lineage, Ind-2001d, of the topotype, ME-SA. The strains collected in 2012 and 1997 belonged to another lineage called 'unnamed' by the World Reference Laboratory for Foot and Mouth Disease (WRLFMD). Based on the present analysis, we designate the lineage 'unnamed' as Srl-97 which we found endemic to Sri Lanka. The evolutionary rates of Srl-97 and Ind-2001d in Sri Lanka were estimated to be 0.0004 and 0.0046 substitutions/site/year, respectively, suggesting that Srl-97 evolves slowly.	[Abeyratne, S. A. E.; Puvanendiran, S.; Kothalawala, H.; Jayathilake, B. K.; Wijithasiri, H. A.; Chandrasena, M. M. P. S. K.] Vet Res Inst, Anim Virus Lab, Kandy, Sri Lanka; [Abeyratne, S. A. E.; Sooriyapathirana, S. D. S. S.] Univ Peradeniya, Postgrad Inst Sci, Peradeniya, Sri Lanka; [Amarasekera, S. S. C.; Ranaweera, L. T.; Salpadoru, T. B.; Thilakarathne, S. M. N. K.; Sooriyapathirana, S. D. S. S.] Univ Peradeniya, Fac Sci, Dept Mol Biol & Biotechnol, Peradeniya, Sri Lanka; [Knowles, N. J.; Wadsworth, J.] Pirbright Inst, Woking, Surrey, England	University of Peradeniya; University of Peradeniya; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Sooriyapathirana, SDSS (corresponding author), Univ Peradeniya, Postgrad Inst Sci, Peradeniya, Sri Lanka.; Sooriyapathirana, SDSS (corresponding author), Univ Peradeniya, Fac Sci, Dept Mol Biol & Biotechnol, Peradeniya, Sri Lanka.	sunethuop@gmail.com	Amarasekera, Sumudu/GRF-2131-2022	Thilakarathne, Nirmani/0000-0001-9561-5283	National Research Council of Sri Lanka [NRC/TO/11-14]; Department for Environment, Food and Rural Affairs of UK [SE2943]	National Research Council of Sri Lanka; Department for Environment, Food and Rural Affairs of UK	This work was funded by the National Research Council of Sri Lanka (http://www.nrc.gov.lk); Research Grant Scheme: Target Oriented; Grant No. NRC/TO/11-14. SDSSS received the funding grant. The work of the WRLFMD was supported by Department for Environment, Food and Rural Affairs of UK (https://www.gov.uk/government/organisations/department-for-environment-food-rural-affairs) (Grant No. SE2943). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P667, DOI 10.1109/TAC.1974.1100707; [Anonymous], 2014, TRACER V1 6; BECK E, 1987, J VIROL, V61, P1621, DOI 10.1128/JVI.61.5.1621-1629.1987; Biswal JK, 2012, INDIAN J ANIM SCI, V82, P109; Brito BP, 2017, TRANSBOUND EMERG DIS, V64, P316, DOI 10.1111/tbed.12373; Bruckner GK, 2002, REV SCI TECH OIE, V21, P751, DOI 10.20506/rst.21.3.1368; Cottam EM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000050; DEP'T INS. FIN. INST. & PROF'L REGISTRATION, 2014, AUD REP, P4; Di Nardo A, 2011, REV SCI TECH OIE, V30, P63; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fernando WW, 1969, CEYLON VET J; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Gunarathne A, 2016, ASIAN AUSTRAL J ANIM, V29, P280, DOI 10.5713/ajas.15.0241; Hettiarachchi R, 2009, SRI LANKA VET J OFFI, V56, P21; JAMAL SM, 2013, BMC VET RES, V44, DOI DOI 10.1186/1297-9716-44-116; Knowles NJ, 2016, REV SCI TECH OIE, V35, P741, DOI 10.20506/rst.35.3.2565; Knowles NJ, 2005, EMERG INFECT DIS, V11, P1887; Knowles NJ, 2003, VIRUS RES, V91, P65, DOI 10.1016/S0168-1702(02)00260-5; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; MARTINEZ MA, 1992, J VIROL, V66, P3557; Miller M.A., 2010, P GAT COMP ENV WORKS; Park JH, 2013, CLIN EXP VACCINE RES, V2, P8, DOI 10.7774/cevr.2013.2.1.8; Paton DJ, 2009, PHILOS T R SOC B, V364, P2657, DOI 10.1098/rstb.2009.0100; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Samuel AR, 2001, J GEN VIROL, V82, P609, DOI 10.1099/0022-1317-82-3-609; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Subramaniam S, 2013, TRANSBOUND EMERG DIS, V60, P197, DOI 10.1111/j.1865-1682.2012.01332.x; Subramaniam S, 2015, VET MICROBIOL, V178, P181, DOI 10.1016/j.vetmic.2015.05.015; Subramaniam S, 2013, INFECT GENET EVOL, V18, P1, DOI 10.1016/j.meegid.2013.04.027; Tosh C, 2002, ARCH VIROL, V147, P493, DOI 10.1007/s007050200002; Valdazo-Gonzalez B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049650; Le VP, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0896-0; Vu LT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177361; Wijewardana B D R, 1983, Rev Sci Tech, V2, P171, DOI 10.20506/rst.2.1.107; WRLFMD, 2014, REP FMDV O SRI LANKA; WRLFMD, 2012, REP FMDV O SRI LANKA; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; ZHARKIKH A, 1994, J MOL EVOL, V39, P315, DOI 10.1007/BF00160155	39	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2018	13	3							e0194077	10.1371/journal.pone.0194077	http://dx.doi.org/10.1371/journal.pone.0194077			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA2QK	29570746	Green Published, Green Submitted, gold			2022-12-26	WOS:000428168400012
J	Ahle, M; Drott, P; Elfvin, A; Andersson, RE				Ahle, Margareta; Drott, Peder; Elfvin, Anders; Andersson, Roland E.			Maternal, fetal and perinatal factors associated with necrotizing enterocolitis in Sweden. A national case-control study	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; INTRAUTERINE GROWTH RESTRICTION; RISK-FACTORS; INTRAVENTRICULAR HEMORRHAGE; INTRAVENOUS IMMUNOGLOBULIN; HEMOLYTIC-DISEASE; GESTATIONAL-AGE; PRETERM INFANTS; GUT MICROBIOTA; BREAST-MILK	Objective To analyze associations of maternal, fetal, gestational, and perinatal factors with necrotizing enterocolitis in a matched case-control study based on routinely collected, nationwide register data. Study design All infants born in 1987 through 2009 with a diagnosis of necrotizing enterocolitis in any of the Swedish national health care registers were identified. For each case up to 6 controls, matched for birth year and gestational age, were selected. The resulting study population consisted of 720 cases and 3,567 controls. Information on socioeconomic data about the mother, maternal morbidity, pregnancy related diagnoses, perinatal diagnoses of the infant, and procedures in the perinatal period, was obtained for all cases and controls and analyzed with univariable and multivariable logistic regressions for the whole study population as well as for subgroups according to gestational age. Results In the study population as a whole, we found independent positive associations with necrotizing enterocolitis for isoimmunization, fetal distress, cesarean section, neonatal bacterial infection including sepsis, erythrocyte transfusion, persistent ductus arteriosus, cardiac malformation, gastrointestinal malformation, and chromosomal abnormality. Negative associations were found for maternal weight, preeclampsia, maternal urinary infection, premature rupture of the membranes, and birthweight. Different patterns of associations were seen in the subgroups of different gestational age. Conclusion With some interesting exceptions, especially in negative associations, the results of this large, population based study, are in keeping with earlier studies. Although restrained by the limitations of register data, the findings mirror conceivable pathophysiological processes and underline that NEC is a multifactorial disease.	[Ahle, Margareta] Linkoping Univ, Dept Radiol, Linkoping, Sweden; [Ahle, Margareta] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Drott, Peder; Andersson, Roland E.] Linkoping Univ, Dept Clin & Expt Med, Div Surg, Linkoping, Sweden; [Elfvin, Anders] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Pediat, Gothenburg, Sweden; [Andersson, Roland E.] Ryhov Cty Hosp, Dept Surg, Jonkoping, Sweden	Linkoping University; Linkoping University; Linkoping University; University of Gothenburg	Ahle, M (corresponding author), Linkoping Univ, Dept Radiol, Linkoping, Sweden.; Ahle, M (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden.	Margareta.Ahle@regionostergotland.se	Ahle, Margareta/AAF-2120-2019	Ahle, Margareta/0000-0001-5176-4949	Region Ostergotland, Sweden [LiO-107641]; Medical Research Council of Southeast Sweden [FORSS-77481]; Futurum - the Academy of Health Care, Jonkoping County Council, Jonkoping, Sweden; Region Ostergotland [LIO-130291, LIO-204581, LIO-280451, LIO-361481, LIO-449011, LIO-538881]	Region Ostergotland, Sweden; Medical Research Council of Southeast Sweden(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Futurum - the Academy of Health Care, Jonkoping County Council, Jonkoping, Sweden; Region Ostergotland	This study was supported by Region Ostergotland, Sweden, https://www.fou.nu/is/lio LiO-107641 (MA); and the Medical Research Council of Southeast Sweden, https://www.fou.nu/is/forss/FORSS-77481 (MA). Further support was received through non-specific research funding by Futurum - the Academy of Health Care, Jonkoping County Council, Jonkoping, Sweden http://plus.rjl.se/futurum (RA) and participation in the following grants from Region Ostergotland https://www.fou.nu/is/lio: LIO-130291, LIO-204581, LIO-280451, LIO-361481, LIO-449011, and LIO-538881 (MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahle M, 2013, PEDIATRICS, V132, pE443, DOI 10.1542/peds.2012-3847; Ali MA, 2013, J HUM NUTR DIET, V26, P164, DOI 10.1111/jhn.12097; Avci ME, 2015, J MATERN-FETAL NEO M, V28, P2080, DOI 10.3109/14767058.2014.978279; BEEBY PJ, 1992, ARCH DIS CHILD-FETAL, V67, P432, DOI 10.1136/adc.67.4_Spec_No.432; Been JV, 2013, J PEDIATR-US, V162, P236, DOI 10.1016/j.jpeds.2012.07.012; Bernstein IM, 2000, AM J OBSTET GYNECOL, V182, P198, DOI 10.1016/S0002-9378(00)70513-8; Bertino E, 2009, J PEDIATR GASTR NUTR, V48, P437, DOI 10.1097/MPG.0b013e31817b6dbe; Bocca-Tjeertes I, 2014, PEDIATRICS, V133, pE650, DOI 10.1542/peds.2013-1739; Bouhlila DS, 2013, LARGE-SCALE ASSESS E, V1, DOI 10.1186/2196-0739-1-4; Breij LM, 2015, HORM RES PAEDIAT, V84, P388, DOI 10.1159/000441298; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Cetinkaya M, 2012, EARLY HUM DEV, V88, P893, DOI 10.1016/j.earlhumdev.2012.07.004; Cooley SM, 2012, J OBSTET GYNAECOL, V32, P439, DOI 10.3109/01443615.2012.667172; Denning TW, 2017, SEMIN PERINATOL, V41, P15, DOI 10.1053/j.semperi.2016.09.014; Figueras-Aloy J, 2010, PEDIATRICS, V125, P139, DOI 10.1542/peds.2009-0676; Rodrigo FGM, 2014, NEONATOLOGY, V106, P229, DOI 10.1159/000363127; Garite TJ, 2004, AM J OBSTET GYNECOL, V191, P481, DOI 10.1016/j.ajog.2004.01.036; Gordon PV, 2016, SEMIN PERINATOL; Guthrie Scott O, 2003, J Perinatol, V23, P278, DOI 10.1038/sj.jp.7210892; Hallstrom M, 2003, ACTA PAEDIATR, V92, P111, DOI 10.1111/j.1651-2227.2003.tb00479.x; Hay S, 2016, SEMIN PERINATOL; Heida FH, 2015, J PEDIATR SURG, V50, P1837, DOI 10.1016/j.jpedsurg.2015.07.009; Heida FH, 2016, CLIN INFECT DIS, V62, P863, DOI 10.1093/cid/ciw016; Kenyon S, 2013, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001058; Kicinski Przemyslaw, 2017, Pol Merkur Lekarski, V42, P71; Krishnan L, 2011, INDIAN J PEDIATR, V78, P743, DOI 10.1007/s12098-010-0334-4; Lambert DK, 2007, J PERINATOL, V27, P437, DOI 10.1038/sj.jp.7211738; Lee Lleona C L, 2006, BMC Pediatr, V6, P15, DOI 10.1186/1471-2431-6-15; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Luig M, 2005, J PAEDIATR CHILD H, V41, P174, DOI 10.1111/j.1440-1754.2005.00583.x; Maayan-Metzger Ayala, 2004, J Perinatol, V24, P494, DOI 10.1038/sj.jp.7211135; Magnusson A, 2017, ACTA PAEDIATR, V106, P1097, DOI 10.1111/apa.13851; Makela J, 2013, EUR J NUTR, V52, P727, DOI 10.1007/s00394-012-0378-5; McElhinney DB, 2000, PEDIATRICS, V106, P1080, DOI 10.1542/peds.106.5.1080; Ment LR, 2015, SEMIN PERINATOL, V39, P592, DOI 10.1053/j.semperi.2015.09.006; Mitsiakos G, 2016, HIPPOKRATIA, V20, P121; Navarro M, 2009, ACTA PAEDIATR, V98, P1214, DOI 10.1111/j.1651-2227.2009.01279.x; Neu J, 2017, SEMIN PERINATOL, V41, P29, DOI 10.1053/j.semperi.2016.09.015; Oh W, 2005, J PEDIATR-US, V147, P786, DOI 10.1016/j.jpeds.2005.06.039; Ostlie DJ, 2003, J PEDIATR SURG, V38, P1039, DOI 10.1016/S0022-3468(03)00187-8; Palleri E., 2017, J PEDIAT SURG; Perger L, 2016, J MATERN-FETAL NEO M, V29, P2098, DOI 10.3109/14767058.2015.1076386; Quinn EA, 2015, J HUM LACT, V31, P273, DOI 10.1177/0890334414553247; Rutayisire E, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0498-0; Sankaran K, 2004, J PEDIATR GASTR NUTR, V39, P366, DOI 10.1097/00005176-200410000-00012; Seiberth V, 2000, OPHTHALMOLOGICA, V214, P131, DOI 10.1159/000027482; Sharma R, 2013, CLIN PERINATOL, V40, P27, DOI 10.1016/j.clp.2012.12.012; Szpecht D, 2016, CHILD NERV SYST, V32, P2097, DOI 10.1007/s00381-016-3217-9; Triunfo S, 2015, J ENDOCRINOL INVEST, V38, P31, DOI 10.1007/s40618-014-0168-4; Tsai LY, 2015, PEDIATR NEONATOL, V56, P101, DOI 10.1016/j.pedneo.2014.07.007; Warner BB, 2016, LANCET, V387, P1928, DOI 10.1016/S0140-6736(16)00081-7; Yee WH, 2012, PEDIATRICS, V129, pE298, DOI 10.1542/peds.2011-2022	53	18	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2018	13	3							e0194352	10.1371/journal.pone.0194352	http://dx.doi.org/10.1371/journal.pone.0194352			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA2QK	29570713	Green Published, gold, Green Submitted			2022-12-26	WOS:000428168400016
J	Enoki, S; Hamaguchi, Y; Suzuki, S; Fujisawa, H; Hattori, T; Arita, K; Yamaguchi, C; Mikami, M; Nagasaka, S; Tanaka, K				Enoki, Shinichi; Hamaguchi, Yu; Suzuki, Shunji; Fujisawa, Hiroyuki; Hattori, Tomoki; Arita, Kayo; Yamaguchi, Chiho; Mikami, Masachika; Nagasaka, Shu; Tanaka, Keisuke			Physiological characterization of leaf and internode after bud break in Japanese indigenous Koshu grape by comparative RNA sequencing analysis	PLOS ONE			English	Article							VITIS-VINIFERA L.; CV PINOT-NOIR; GENE-EXPRESSION; HIGHER-PLANTS; VINE VIGOR; ANTHOCYANINS; WINE; TRANSCRIPTOME; STRESS; LIGHT	Koshu is indigenous to Japan and considered the most important wine grape in Japan. Koshu grape berry possesses characteristics that make it unique from European V. vinifera as wine grape. However, the physiological characteristics of Koshu leaf and internode remain unknown. An understanding of those characteristics would contribute to improvements in Koshu cultivation, thereby enhancing grape berry and wine quality. To identify the genes responsible for the physiological characteristics of Koshu, we comprehensively analyzed leaf and internode differences at the transcriptome level between Koshu and Pinot Noir by RNA sequencing. A total of 248 and 131 differentially expressed genes (DEGs) were detected in leaves and internodes, respectively. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses of these DEGs revealed that "flavonoid biosynthesis" and "glutathione metabolism" pathways were significantly enriched in Koshu leaves. On the other hand, when internodes were compared, "flavonoid"-related GO terms were specifically detected in Koshu. KEGG pathway enrichment analysis suggested that the expression of such genes as leucoanthocyanidin reductase and flavonol synthase in the flavonoid biosynthesis pathway was higher in Koshu than Pinot Noir. Measurement of the relative expression levels of these genes by RT-qPCR validated the results obtained by RNA sequencing. The characteristics of Koshu leaf and internode, which are expected to produce flavonoids with antibacterial activity and UV protection function, would suit Japanese climate as a survival strategy.	[Enoki, Shinichi; Suzuki, Shunji; Hattori, Tomoki; Arita, Kayo; Yamaguchi, Chiho; Mikami, Masachika; Nagasaka, Shu] Univ Yamanashi, Inst Enol & Viticulture, Lab Fruit Genet Engn, Yamanashi, Japan; [Hamaguchi, Yu; Tanaka, Keisuke] Tokyo Univ Agr, NODAI Genome Res Ctr, Tokyo, Japan; [Fujisawa, Hiroyuki] Tokyo Univ Agr, Dept Agr, Tokyo, Kanagawa, Japan	University of Yamanashi; Tokyo University of Agriculture; Tokyo University of Agriculture	Tanaka, K (corresponding author), Tokyo Univ Agr, NODAI Genome Res Ctr, Tokyo, Japan.	kt205453@nodai.ac.jp			Cooperative Research Program of the Genome Research for BioResource, NODAI Genome Research Center, Tokyo University of Agriculture	Cooperative Research Program of the Genome Research for BioResource, NODAI Genome Research Center, Tokyo University of Agriculture	This study was supported by the Cooperative Research Program of the Genome Research for BioResource, NODAI Genome Research Center, Tokyo University of Agriculture.; This study was supported by the Cooperative Research Program of the Genome Research for BioResource, NODAI Genome Research Center, Tokyo University of Agriculture.	Cortell JM, 2007, J AGR FOOD CHEM, V55, P6575, DOI 10.1021/jf070195v; Cortell JM, 2005, J AGR FOOD CHEM, V53, P5798, DOI 10.1021/jf0504770; Cramer GR, 2007, FUNCT INTEGR GENOMIC, V7, P111, DOI 10.1007/s10142-006-0039-y; Deluc LG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-429; Fernandez L, 2007, PLANT MOL BIOL, V63, P307, DOI 10.1007/s11103-006-9090-2; Feucht W, 1999, PRINCIPLES AND PRACTICES IN PLANT ECOLOGY, P307; Fung RWM, 2007, GENET RESOUR CROP EV, V54, P1541, DOI 10.1007/s10722-006-9146-9; Goto-Yamamoto N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140841; GRAYER RJ, 1994, PHYTOCHEMISTRY, V37, P19, DOI 10.1016/0031-9422(94)85005-4; Grimplet J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-187; HASAN MRM, 2017, PHYSIOL MOL BIOL PLA, V1892, DOI DOI 10.1063/1.5005731; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jansen MAK, 1998, TRENDS PLANT SCI, V3, P131, DOI 10.1016/S1360-1385(98)01215-1; JAPAN WINERIES ASSOCIATION, 2017, WHAT IS JAP WIN, V12, P25; Julius Ku E hn- Institut D Bundesforschungsinstitut fu E r Kulturpflanzen (JKI), 2018, VIT INT VAR CAT VIVC, V02, P15; Kobayashi H, 2007, J ASEV JPN, V18, P22; Kobayashi H, 2011, J JPN SOC HORTIC SCI, V80, P255, DOI 10.2503/jjshs1.80.255; Kobayashi H, 2011, PLANT BIOTECHNOL REP, V5, P79, DOI 10.1007/s11816-010-0162-z; Kobayashi H, 2010, AM J ENOL VITICULT, V61, P176; Kobayashi H, 2009, AM J ENOL VITICULT, V60, P362; Kobayashi H, 2009, PLANT BIOTECHNOL REP, V3, P225, DOI 10.1007/s11816-009-0095-6; KOSHU OF JAPAN D KOJ, 2017, KOSH HAS CREAT NICH, V12, P25; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Nakagawa S, 1966, J JAPAN SOC HORTIC S, V35, P117; Nunez-Olivera E, 2006, AM J ENOL VITICULT, V57, P441; Ogawa K, 2017, Patent No, Patent No. [9,532,519, 9532519]; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Reuber S, 1996, PHYSIOL PLANTARUM, V97, P160, DOI 10.1111/j.1399-3054.1996.tb00492.x; Shangguan LF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170571; Shimazaki M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021308; Simsek O., 2017, AM J PLANT BIOL, V2, P1, DOI DOI 10.11648/j.ajpb.s.2017020501.11; Sun L, 2016, HEREDITAS, V153, DOI 10.1186/s41065-016-0021-1; Tattini M, 2004, NEW PHYTOL, V163, P547, DOI 10.1111/j.1469-8137.2004.01126.x; Terrier N, 2005, PLANTA, V222, P832, DOI 10.1007/s00425-005-0017-y; Van Leeuwen Cornelis, 2006, Journal of Wine Research, V17, P1, DOI 10.1080/09571260600633135; Waters DLE, 2006, PLANT SCI, V171, P132, DOI 10.1016/j.plantsci.2006.03.002; Yokotsuka Koki, 2005, Journal of Wine Research, V16, P233, DOI 10.1080/09571260500327697	37	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194807	10.1371/jourrial.pone.0194807	http://dx.doi.org/10.1371/jourrial.pone.0194807			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566077				2022-12-26	WOS:000428093900106
J	Izrailtyan, I; Qiu, JJ; Overdyk, FJ; Erslon, M; Gan, TJ				Izrailtyan, Igor; Qiu, Jiejing; Overdyk, Frank J.; Erslon, Mary; Gan, Tong J.			Risk factors for cardiopulmonary and respiratory arrest in medical and surgical hospital patients on opioid analgesics and sedatives	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; CARDIAC-ARREST; AMERICAN-SOCIETY; PAIN MANAGEMENT; UNITED-STATES; ASSOCIATION; GUIDELINES; OUTCOMES; OBESITY; CARE	Background Opioid induced respiratory depression is a known cause of preventable death in hospitals. Medications with sedative properties additionally potentiate opioid-induced respiratory and sedative effects, thereby elevating the risk for adverse events. The goal of this study was to determine what specific factors increase the risk of in-hospital cardiopulmonary and respiratory arrest (CPRA) in medical and surgical patients on opioid and sedative therapy. Methods The present study analyzed 14,504,809 medical inpatient and 6,771,882 surgical inpatient discharges reported into the Premier database from 2008 to 2012. Patients were divided in four categories: on opioids; on sedatives; on both opioids and sedatives; and on neither opioids nor sedatives. Results During hospital admission, 57% of all medical patients and 90% of all surgical patients were prescribed opioids, sedatives, or both. Surgical patients had a higher incidence of CPRA than medical patients (6.17 vs. 3.77 events per 1000 admissions; Relative Risk: 1.64 [95% CI: 1.62-1.66; p<0.0001). Opioids and sedatives were found to be independent predictors of CPRA (adjusted OR of 2.24 [95% CI: 2.18-2.29] for opioids and adjusted OR 1.80 [95% CI: 1.75-1.85] for sedatives in medical patients, and adjusted OR of 1.12 [95% CI: 1.07-1.16] for opioids and adjusted OR of 1.58 [95% CI: 1.51-1.66] for sedatives in surgical patients), with the highest risk in groups who received both types of medications (adjusted OR of 3.83 [95% CI: 3.74-3.92] in medical patients, and adjusted OR of 2.34 [95% CI: 2.25-2.42] in surgical patients) compared with groups that received neither type of medication. The common risk factors of CPRA in medical and surgical patients receiving both opioids and sedatives were Hispanic origin, mild liver disease, obesity, and COPD. Additionally, medical and surgical groups had their own unique risk factors for CPRA when placed on opioid and sedative therapy. Conclusions Opioids and sedatives are independent and additive predictors of CPRA in both medical and surgical patients. Receiving both classes of medications further exacerbates the risk of CPRA for these patients. By identifying groups at risk among medical and surgical in-hospital patients, this study provides a step towards improving our understanding of how to use opioid and sedative medications safely, which may influence our treatment strategies and outcomes. More precise monitoring of selected high-risk patients may help prevent catastrophic cardiorespiratory complications from these medications. As a retrospective administrative database analysis, this study does not establish the causality or the temporality of the events but rather draws statistically significant associations between the clinical factors and outcomes.	[Izrailtyan, Igor; Gan, Tong J.] SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA; [Qiu, Jiejing] Medtronic, Hlth Econ & Outcomes Res, Mansfield, MA USA; [Overdyk, Frank J.] Roper St Francis Hlth Syst, Dept Anesthesiol, Charleston, SC USA; [Erslon, Mary] Medtronic, Resp Gastrointestinal & Informat, Boulder, CO USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Medtronic; Medtronic	Gan, TJ (corresponding author), SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA.	tong.gan@stonybrookmedicine.edu			Medtronic Healthcare Economics and Outcome Research; Medtronic	Medtronic Healthcare Economics and Outcome Research; Medtronic(Medtronic)	This analysis was supported by Medtronic Healthcare Economics and Outcome Research. JQ and ME are Medtronic employees. The funder, Medtronic, provided support in the form of salaries for authors JQ and ME, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Anderson ML, 2016, JAMA CARDIOL, V1, P37, DOI 10.1001/jamacardio.2015.0275; [Anonymous], 2004, CONTIN ED ANAESTH CR, DOI DOI 10.1093/BJACEACCP/MKH042; [Anonymous], 2007, CLIN DIABETES, DOI [DOI 10.2337/DIACLIN.25.1.6], DOI 10.2337/DIACLIN.25.1.6]; Atwood C, 2005, RESUSCITATION, V67, P75, DOI 10.1016/j.resuscitation.2005.03.021; Brack A, 2011, J NEUROIMMUNE PHARM, V6, P490, DOI 10.1007/s11481-011-9290-7; Carlisle H, 2014, AM NURSE TODAY, V9, P22; Chen L., 2011, P 54 ANN IEEE GLOB T, V2011, P1, DOI DOI 10.1109/PADS.2011.5936752; Chung SA, 2008, ANESTH ANALG, V107, P1543, DOI 10.1213/ane.0b013e318187c83a; Churpek MM, 2015, CRIT CARE MED, V43, P816, DOI 10.1097/CCM.0000000000000818; COOK DJ, 1994, NEW ENGL J MED, V330, P377, DOI 10.1056/NEJM199402103300601; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr6501e1, 10.1001/jama.2016.1464, 10.15585/mmwr.rr7103a1]; Ekstrom MP, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g445; Fala Loretta, 2015, Am Health Drug Benefits, V8, pS51; Fecho Karamarie, 2009, Ther Clin Risk Manag, V5, P961; Frenk Steven M, 2015, NCHS Data Brief, P1; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1016/S0928-8244(99)00142-X; Gross JB, 2014, ANESTHESIOLOGY, V120, P268, DOI 10.1097/ALN.0000000000000053; Hogan H, 2012, BMJ QUAL SAF, V21, P737, DOI 10.1136/bmjqs-2011-001159; Huxtable CA, 2011, ANAESTH INTENS CARE, V39, P804, DOI 10.1177/0310057X1103900505; Ibrahim AM, 2016, JAMA-J AM MED ASSOC, V315, P2095, DOI 10.1001/jama.2016.5618; Jarzyna D, 2011, PAIN MANAG NURS, V12, P118, DOI 10.1016/j.pmn.2011.06.008; Jensen, 2014, CIRCULATION, V129, pS139, DOI 10.1161/CIR.0000000000000070; Karlsson HK, 2015, J NEUROSCI, V35, P3959, DOI 10.1523/JNEUROSCI.4744-14.2015; Kessler ER, 2013, PHARMACOTHERAPY, V33, P383, DOI 10.1002/phar.1223; Kolte D, 2015, CIRCULATION, V131, P1415, DOI 10.1161/CIRCULATIONAHA.114.014542; Korc-Grodzicki B, 2014, J CLIN ONCOL, V32, P2647, DOI 10.1200/JCO.2014.55.0962; Kronick SL, 2015, CIRCULATION, V132, pS397, DOI 10.1161/CIR.0000000000000258; Lee LA, 2015, ANESTHESIOLOGY, V122, P659, DOI 10.1097/ALN.0000000000000564; Lee SS, 2007, GUT, V56, P746, DOI 10.1136/gut.2006.112169; Makadia Rupa, 2014, EGEMS (Wash DC), V2, P1110, DOI 10.13063/2327-9214.1110; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Merchant RM, 2011, CRIT CARE MED, V39, P2401, DOI 10.1097/CCM.0b013e3182257459; Mokhlesi Babak, 2008, Proc Am Thorac Soc, V5, P218, DOI 10.1513/pats.200708-122MG; Morrison LJ, 2013, CIRCULATION, V127, P1538, DOI 10.1161/CIR.0b013e31828b2770; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; National Center for Health Statistics: Health United States, 2014, HLTH US 2014 SPEC FE; Nolan J, 2013, COMMENTARY IHCA CATC; Overdyk F, 2011, AM NURSE TODAY, V6, P26; Overdyk FJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150214; Overdyk FJ, 2010, ANESTHESIOLOGY, V113, P259, DOI 10.1097/ALN.0b013e3181e2c1d9; Practice Guidelines for the Prevention Detection and Management of Respiratory Depression Associated with Neuraxial Opioid Administration, 2016, ANESTHESIOLOGY, V124, P535; Punjabi NM, 2009, DRUGS, V69, P13, DOI 10.2165/11531150-000000000-00000; Robert Graham MAM, 2015, STRATEGIES IMPROVE C; ROSE DK, 1994, ANESTHESIOLOGY, V81, P410, DOI 10.1097/00000542-199408000-00020; Sessler DI, 2015, ANESTHESIOLOGY, V122, P484, DOI 10.1097/ALN.0000000000000565; SOBOTKA PA, 1986, J CLIN ENDOCR METAB, V62, P658, DOI 10.1210/jcem-62-4-658; Stokes ME, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-135; Stone AA, 2012, OBESITY, V20, P1491, DOI 10.1038/oby.2011.397; Substance Abuse and Mental Health Services Administration, NSDUH SER, VSMA, P13; The Joint Commission, 2012, SAF US OP HOSP; Verbeeck RK, 2008, EUR J CLIN PHARMACOL, V64, P1147, DOI 10.1007/s00228-008-0553-z; Vinik AI, 2013, J DIABETES INVEST, V4, P4, DOI 10.1111/jdi.12042; WHO, 2014, COMM MAN OP OV; Zedler B, 2015, PAIN MED, V16, P1566, DOI 10.1111/pme.12777	54	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194553	10.1371/journal.pone.0194553	http://dx.doi.org/10.1371/journal.pone.0194553			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566020	gold, Green Submitted, Green Published			2022-12-26	WOS:000428093900075
J	Lawrence, JP; Noonan, BP				Lawrence, J. P.; Noonan, Brice P.			Avian learning favors colorful, not bright, signals	PLOS ONE			English	Article							POISON FROG; CONVERGENT EVOLUTION; WARNING SIGNALS; PREDATORS; PATTERN; COLORATION; SELECTION; MIMICRY; DIVERSITY	A few colors, such as red and yellow, are commonly found in aposematic (warning) signaling across taxa, independent of evolutionary relationships. These colors have unique traits (i.e., hue, brightness) that aid in their differentiation, and perhaps, their effectiveness in promoting avoidance learning. This repeated use calls into question the influence of selection on specific warning colors adopted by aposematic prey-predator systems. To disentangle the influence of color characteristics on this process, we trained week-old chickens (Gallus gallus domesticus) to learn to avoid distasteful food that was associated with one of three color signals (yellow, white, red) that varied in both hue and in brightness in order to assess which of these traits most influenced their ability to learn avoidance. Our results show that while chicks learned to avoid all three colors, avoidance was based on the hue, not brightness of the different signals. We found that yellow was the most effective for avoidance learning, followed by red, and finally white. Our results suggest that while these three colors are commonly used in aposematic signaling, predators' ability to learn avoidance differs among them. These results may explain why yellow is among the most common signals across aposematic taxa.	[Lawrence, J. P.; Noonan, Brice P.] Univ Mississippi, Dept Biol, University, MS 38677 USA	University of Mississippi	Lawrence, JP (corresponding author), Univ Mississippi, Dept Biol, University, MS 38677 USA.	JPLarry@gmail.corn		Lawrence, Justin/0000-0001-8577-4870				Allen WL, 2013, BEHAV ECOL, V24, P1237, DOI 10.1093/beheco/art058; Aronsson M, 2008, ANIM BEHAV, V75, P417, DOI 10.1016/j.anbehav.2007.05.006; Ashfield T, 2004, PLANT CELL, V16, P309, DOI 10.1105/tpc.016725; Chouteau M, 2011, AM NAT, V178, P810, DOI 10.1086/662667; Comeault AA, 2011, J EVOLUTION BIOL, V24, P1374, DOI 10.1111/j.1420-9101.2011.02258.x; Dreher CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130571; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; ENDLER JA, 1988, PHILOS T R SOC B, V319, P505, DOI 10.1098/rstb.1988.0062; Endler JA, 2009, AM NAT, V173, pE62, DOI 10.1086/596528; Finkbeiner SD, 2017, ULTRAVIOLET YELLOW R, P1267; Finkbeiner SD, 2014, EVOLUTION; GOLDSMITH TH, 1990, Q REV BIOL, V65, P281, DOI 10.1086/416840; Ham AD, 2006, BEHAV ECOL SOCIOBIOL, V60, P482, DOI 10.1007/s00265-006-0190-4; Kazemi B, 2014, CURR BIOL, V24, P965, DOI 10.1016/j.cub.2014.02.061; Kikuchi DW, 2010, AM NAT, V176, P830, DOI 10.1086/657041; Kraemer AC, 2013, EVOLUTION, P1197; Lindstrom L, 1999, BEHAV ECOL, V10, P317, DOI 10.1093/beheco/10.3.317; Maan ME, 2008, EVOLUTION, V62, P2334, DOI 10.1111/j.1558-5646.2008.00454.x; Maan ME, 2012, AM NAT, V179, pE1, DOI 10.1086/663197; Maan ME, 2009, P NATL ACAD SCI USA, V106, P19072, DOI 10.1073/pnas.0903327106; Maia R, 2013, METHODS ECOL EVOL, V4, P906, DOI 10.1111/2041-210X.12069; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; Mappes J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6016; Noonan BP, 2009, BIOL LETTERS, V5, P51, DOI 10.1098/rsbl.2008.0586; OKANO T, 1992, P NATL ACAD SCI USA, V89, P5932, DOI 10.1073/pnas.89.13.5932; OSTROM JH, 1974, Q REV BIOL, V49, P27, DOI 10.1086/407902; Paluh DJ, 2015, COPEIA, V103, P58, DOI 10.1643/CE-13-126; Pfennig DW, 2001, NATURE, V410, P323, DOI 10.1038/35066628; Preissler K, 2017, EVOL ECOL, V31, P683, DOI 10.1007/s10682-017-9903-6; Prescott NB, 1999, BRIT POULTRY SCI, V40, P332, DOI 10.1080/00071669987412; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Ratcliffe JM, 2008, NATURE, V455, P96, DOI 10.1038/nature07087; RCT, 2014, R LANG ENV STAT COMP; Rojas B, 2014, BEHAV PROCESS, V109, P164, DOI 10.1016/j.beproc.2014.08.014; Rojas B, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0193; Roper TJ, 1997, ODOUR COLOUR CUES TA, P1241; Rowe C, 1999, EVOL ECOL, V13, P655, DOI 10.1023/A:1011021630244; Ruxton G. D., 2004, AVOIDING ATTACK; Saporito RA, 2007, COPEIA, P1006, DOI 10.1643/0045-8511(2007)7[1006:EEFAIT]2.0.CO;2; SCHULER W, 1985, BEHAV ECOL SOCIOBIOL, V16, P249, DOI 10.1007/BF00310988; Siddiqi A, 2004, J EXP BIOL, V207, P2471, DOI 10.1242/jeb.01047; Skelhorn J, 2010, P ROY SOC B-BIOL SCI, V277, P1729, DOI 10.1098/rspb.2009.2092; Thurman TJ, 2016, J ZOOL, V298, P159, DOI 10.1111/jzo.12305; Valkonen JK, 2014, CONSERV BIOL, V28, P1568, DOI 10.1111/cobi.12368; Weldon PJ, 2013, NATURWISSENSCHAFTEN, V100, P185, DOI 10.1007/s00114-013-1010-0	45	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194279	10.1371/journal.pone.0194279	http://dx.doi.org/10.1371/journal.pone.0194279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566013	Green Published, Green Submitted, gold			2022-12-26	WOS:000428093900050
J	Ondruschka, B; Rosinsky, F; Trauer, H; Schneider, E; Dressler, J; Franke, H				Ondruschka, Benjamin; Rosinsky, Franziska; Trauer, Heiner; Schneider, Eckhardt; Dressler, Jan; Franke, Heike			Drug- and/or trauma-induced hyperthermia? Characterization of HSP70 and myoglobin expression	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; METHAMPHETAMINE-INDUCED HYPERTHERMIA; BRAIN-INJURY; MYOCARDIAL-INFARCTION; DEATH; HEAT-SHOCK-PROTEIN-70; INDUCTION; HSP27; RHABDOMYOLYSIS; NEUROTOXICITY	Introduction Heat shock protein 70 (HSP70) expression could be discussed as an adaption that promotes repair and counteracts cell damage. Myoglobin is released upon muscle damage of several pathways. The purpose of the present study was to determine whether the expression of HSP70 in kidney, heart and brain and of myoglobin in the kidney were associated with the cause of death and the survival times after lethal intoxications with three of the drugs most widely used in our local area (Saxony, Germany) as well as after fatal traumatic brain injury (TBI). Methods We retrospectively collected kidney, heart and brain samples of 50 autopsy cases with toxicological proved lethal intoxication (main drugs methamphetamine, morphine, alcohol), 14 TBI cases and 15 fatalities with acute myocardial injury in age- and gender-matched compilations. Results Our main findings suggest that HSP70 is associated with hyperthermal and other stress factors of most cell populations. HSP70 expressions in kidney and heart muscle are useful for a differentiation between fatal intoxications and cases without toxicological influence (p < 0.05). There were significant differences in the cerebral expression patterns between meth-amphetamine-and morphine-associated deaths compared to alcohol fatalities (p < 0.05). An intensive staining of HSP70 in the pericontusional zone and the hippocampus after TBI (especially neuronal and vascular) was shown even after short survival times and may be useful as an additional marker in questions of vitality or wound age. A relevant myoglobin decoration of renal tubules was only shown for methamphetamine abuse in the study presented. Conclusion In sum, the immunohistochemical characteristics presented can be supportive for determining final death circumstances and minimal trauma survival times but are not isolated usefully for the detection of drug-or trauma-induced hyperthermia.	[Ondruschka, Benjamin; Rosinsky, Franziska; Trauer, Heiner; Dressler, Jan] Univ Leipzig, Inst Legal Med, Med Fac, Leipzig, Germany; [Schneider, Eckhardt] Grp Practice Leipzig, Dept Pathol, Leipzig, Germany; [Franke, Heike] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, Med Fac, Leipzig, Germany	Leipzig University; Leipzig University	Ondruschka, B (corresponding author), Univ Leipzig, Inst Legal Med, Med Fac, Leipzig, Germany.	benjamin.ondruschka@medizin.uni-leipzig.de			German Research Foundation (DFG); University of Leipzig within the program of Open Access Publishing	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Leipzig within the program of Open Access Publishing	We acknowledge support from the German Research Foundation (DFG) and the University of Leipzig within the program of Open Access Publishing.	Ammon-Treiber S, 2004, CELL STRESS CHAPERON, V9, P182, DOI 10.1379/CSC-42.1; BLAKE MJ, 1990, J BIOL CHEM, V265, P15275; Bonds BW, 2015, BRAIN INJURY, V29, P1642, DOI 10.3109/02699052.2015.1075157; Bratzke H, 2011, RECHTSMEDIZIN, V21, P258, DOI 10.1007/s00194-011-0760-2; Brown IR, 2007, ANN NY ACAD SCI, V1113, P147, DOI 10.1196/annals.1391.032; CHAVERON M, 1995, CELL BIOL TOXICOL, V11, P161, DOI 10.1007/BF00756518; CIOCCA DR, 1993, JNCI-J NATL CANCER I, V85, P1558, DOI 10.1093/jnci/85.19.1558; Guisasola MC, 2016, MED CLIN-BARCELONA, V146, P292, DOI 10.1016/j.medcli.2015.12.011; Currie RW, 2000, BRAIN RES, V863, P169, DOI 10.1016/S0006-8993(00)02133-8; Da Rocha AB, 2005, J NEUROTRAUM, V22, P966, DOI 10.1089/neu.2005.22.966; Darke S, 2016, ADDICTION, V111, P1607, DOI 10.1111/add.13429; Dettmeyer R, 2016, RECHTSMEDIZIN, V26, P444, DOI 10.1007/s00194-016-0100-7; Dettmeyer R, 2013, RECHTSMEDIZIN, V23, P333; Doberentz E, 2014, INT J LEGAL MED, V128, P967, DOI 10.1007/s00414-014-0994-0; Doberentz E, 2017, FORENSIC SCI MED PAT; Doberentz E, 2017, INT J LEGAL MED; Doberentz E, 2016, FORENSIC SCI MED PAT, V12, P33, DOI 10.1007/s12024-015-9730-4; Dybdahl B, 2005, HEART, V91, P299, DOI 10.1136/hrt.2003.028092; Fracasso T, 2011, INT J LEGAL MED, V125, P537, DOI 10.1007/s00414-011-0547-8; Franke H, 2013, PURINERG SIGNAL, V9, P451, DOI 10.1007/s11302-013-9366-3; Freyaldenhoven TE, 1997, ANN NY ACAD SCI, V825, P167, DOI 10.1111/j.1749-6632.1997.tb48427.x; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; GOTO S, 1993, BRAIN RES, V626, P351, DOI 10.1016/0006-8993(93)90602-J; Hecker JG, 2011, CELL STRESS CHAPERON, V16, P119, DOI 10.1007/s12192-010-0224-8; Ishigami Akiko, 2003, Journal of Medical Investigation, V50, P112; Ishigami Akiko, 2003, Leg Med (Tokyo), V5, P42, DOI 10.1016/S1344-6223(03)00005-1; Jeng Wilson, 2015, F1000Res, V4, DOI 10.12688/f1000research.7214.1; Kacimi R, 2015, GLIA, V63, P1200, DOI 10.1002/glia.22811; Kacprzak M, 2012, CARDIOL J, V19, P369, DOI 10.5603/CJ.2012.0067; Kennedy D, 2014, IUBMB LIFE, V66, P327, DOI 10.1002/iub.1274; Kita T, 2000, Nihon Hoigaku Zasshi, V54, P367; Kitamura O., 2009, LEGAL MED, V11, p63 ; Kiyatkin EA, 2011, J NEURAL TRANSM, V118, P47, DOI 10.1007/s00702-010-0477-5; Kostenko S, 2009, CELL MOL LIFE SCI, V66, P3289, DOI 10.1007/s00018-009-0086-3; Krohn M, 2015, J NEUROTRAUM, V32, P430, DOI 10.1089/neu.2014.3524; Kunitz O, 2003, ANAESTHESIST, V52, P511, DOI 10.1007/s00101-003-0474-2; Kuperman DI, 1997, BRAIN RES, V771, P221, DOI 10.1016/S0006-8993(97)00710-5; Mash DC, 2009, FORENSIC SCI INT, V190, pE13, DOI 10.1016/j.forsciint.2009.05.012; Matsumoto RR, 2014, PHARMACOL THERAPEUT, V144, P28, DOI 10.1016/j.pharmthera.2014.05.001; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Milroy CM, 2011, HISTOPATHOLOGY, V59, P579, DOI 10.1111/j.1365-2559.2010.03728.x; Muralidharan S, 2014, J IMMUNOL, V193, P1975, DOI 10.4049/jimmunol.1303468; Nikolov R, 2010, METHOD FIND EXP CLIN, V32, P401, DOI 10.1358/mf.2010.32.6.1514688; Ondruschka B, 2013, J NEUROTRAUM, V30, P1862, DOI 10.1089/neu.2013.2895; Park Y, 2015, J NEUROTRAUM, V32, P1449, DOI 10.1089/neu.2014.3694; Plotnikov EY, 2009, BBA-MOL BASIS DIS, V1792, P796, DOI 10.1016/j.bbadis.2009.06.005; Preuss J, 2008, FORENSIC SCI INT, V176, P248, DOI 10.1016/j.forsciint.2007.09.017; Richards JR, 1999, AM J EMERG MED, V17, P681, DOI 10.1016/S0735-6757(99)90159-6; Schober K, 2015, INT J LEGAL MED, V129, P701, DOI 10.1007/s00414-014-1129-3; Sharma HS, 2011, CURR NEUROPHARMACOL, V9, P223, DOI 10.2174/157015911795017100; Tomita M, 2011, CHEM-BIOL INTERACT, V190, P54, DOI 10.1016/j.cbi.2011.01.025; Wagner R, 2016, RECHTSMEDIZIN, V26, P363; Wang SH, 2003, J BIOMECH ENG-T ASME, V125, P794, DOI 10.1115/1.1632522; Weber M., 2017, INT J LEGAL MED; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zhang J, 2012, CHIN J TRAUMATOL, V15, P338, DOI 10.3760/cma.j.issn.1008-1275.2012.06.004	56	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194442	10.1371/journal.pone.0194442	http://dx.doi.org/10.1371/journal.pone.0194442			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566034	Green Published, gold, Green Submitted			2022-12-26	WOS:000428093900065
J	Zeng, LX; Mathew, AV; Byun, J; Atkins, KB; Brosius, FC; Pennathur, S				Zeng, Lixia; Mathew, Anna V.; Byun, Jaeman; Atkins, Kevin B.; Brosius, Frank C., III; Pennathur, Subramaniam			Myeloperoxidase-derived oxidants damage artery wall proteins in an animal model of chronic kidney disease-accelerated atherosclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myeloperoxidase; 3-chlorotyrosine; atherosclerosis; mass spectrometry (MS); macrophage; oxidative stress; 3-nitrotyrosine; Chronic Kidney Disease; oxidized amino acids	LOW-DENSITY-LIPOPROTEIN; MASS-SPECTROMETRIC QUANTIFICATION; RENIN-ANGIOTENSIN SYSTEM; CHRONIC-RENAL-FAILURE; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; VASCULAR CALCIFICATION; PROGNOSTIC VALUE; NITRIC-OXIDE; ENDOTHELIAL DYSFUNCTION	Increased myeloperoxidase (MPO) levels and activity are associated with increased cardiovascular risk among individuals with chronic kidney disease (CKD). However, a lack of good animal models for examining the presence and catalytic activity of MPO in vascular lesions has impeded mechanistic studies into CKD-associated cardiovascular diseases. Here, we show for the first time that exaggerated atherosclerosis in a pathophysiologically relevant CKD mouse model is associated with increased macrophage-derived MPO activity. Male 7-week-old LDL receptor-deficient mice underwent sham (control mice) or 5/6 nephrectomy and were fed either a low-fat or high-fat, high-cholesterol diet for 24 weeks, and the extents of atherosclerosis and vascular reactivity were assessed. MPO expression and oxidation productsprotein-bound oxidized tyrosine moieties 3-chlorotyrosine, 3-nitrotyrosine, and o,o-dityrosinewere examined with immunoassays and confirmed with mass spectrometry (MS). As anticipated, the CKD mice had significantly higher plasma creatinine, urea nitrogen, and intact parathyroid hormone along with lower hematocrit and body weight. On both the diet regimens, CKD mice did not have hypertension but had lower cholesterol and triglyceride levels than the control mice. Despite the lower cholesterol levels, CKD mice had increased aortic plaque areas, fibrosis, and luminal narrowing. They also exhibited increased MPO expression and activity (i.e. increased oxidized tyrosines) that co-localized with infiltrating lesional macrophages and diminished vascular reactivity. In summary, unlike non-CKD mouse models of atherosclerosis, CKD mice exhibit increased MPO expression and catalytic activity in atherosclerotic lesions, which co-localize with lesional macrophages. These results implicate macrophage-derived MPO in CKD-accelerated atherosclerosis.	[Zeng, Lixia; Mathew, Anna V.; Byun, Jaeman; Atkins, Kevin B.; Brosius, Frank C., III; Pennathur, Subramaniam] Univ Michigan, Dept Med, Div Nephrol, Ann Arbor, MI 48105 USA; [Brosius, Frank C., III; Pennathur, Subramaniam] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Pennathur, S (corresponding author), Univ Michigan, Div Nephrol, Brehm Ctr 5309, 1000 Wall St, Ann Arbor, MI 48105 USA.	spennath@umich.edu	Mathew, Anna V/V-2511-2018	Mathew, Anna/0000-0002-7043-4221	National Institutes of Health Grants from NIDDK [P30DK081943, P30DK089503]; NHLBI [K08HL130944]; Renal Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL130944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503, P30DK081943, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health Grants from NIDDK; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Renal Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported National Institutes of Health Grants P30DK081943 and P30DK089503 from NIDDK (to S.P.) and Grant K08HL130944 from NHLBI (to A.V.M.), and a grant from the Renal Research Institute (to K.A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; Afshinnia F, 2017, AM J NEPHROL, V46, P73, DOI 10.1159/000477766; Asselbergs FW, 2004, AM J MED, V116, P429, DOI 10.1016/j.amjmed.2003.10.025; Atkins KB, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12299; Baldus S, 2002, FREE RADICAL BIO MED, V33, P1010, DOI 10.1016/S0891-5849(02)00993-0; Bansal V, 2007, FASEB J, V21, pA438; Bisgaard LS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168396; Bouali H, 2007, J RHEUMATOL, V34, P2028; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Brennan ML, 2001, J CLIN INVEST, V107, P419, DOI 10.1172/JCI8797; Bro S, 2006, ARTERIOSCL THROM VAS, V26, P570, DOI 10.1161/01.ATV.0000201060.47945.cb; Bro S, 2003, J AM SOC NEPHROL, V14, P2466, DOI 10.1097/01.ASN.0000088024.72216.2E; Bro S, 2008, SCAND J CLIN LAB INV, V68, P660, DOI 10.1080/00365510802037272; Bro S, 2007, ARTERIOSCL THROM VAS, V27, P1080, DOI 10.1161/ATVBAHA.107.139634; Bro S, 2009, DAN MED BULL, V56, P177; Bro S, 2008, ATHEROSCLEROSIS, V201, P274, DOI 10.1016/j.atherosclerosis.2008.01.015; BROWN MS, 1992, CELL, V71, P187, DOI 10.1016/0092-8674(92)90346-E; Castellani LW, 2006, J LIPID RES, V47, P1366, DOI 10.1194/jlr.M600005-JLR200; Cayley WE, 2004, NEW ENGL J MED, V350, P516; Cheung AK, 2000, KIDNEY INT, V58, P353, DOI 10.1046/j.1523-1755.2000.00173.x; Chumakov AM, 2000, INT J ONCOL, V16, P401; Csanyi G, 2012, PROSTAG OTH LIPID M, V98, P107, DOI 10.1016/j.prostaglandins.2012.02.002; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; Davies MR, 2003, J AM SOC NEPHROL, V14, P1559, DOI 10.1097/01.ASN.0000068404.57780.DD; Davies MR, 2001, KIDNEY INT, V60, P472, DOI 10.1046/j.1523-1755.2001.060002472.x; Doi K, 2007, HYPERTENS RES, V30, P1193, DOI 10.1291/hypres.30.1193; Drueke TB, 2010, NAT REV NEPHROL, V6, P723, DOI 10.1038/nrneph.2010.143; Duzguncinar O, 2008, ACTA CARDIOL, V63, P147, DOI 10.2143/AC.63.2.2029520; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Eraranta A, 2014, AM J NEPHROL, V39, P400, DOI 10.1159/000362507; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; GERDES LU, 1992, CLIN CHIM ACTA, V205, P1, DOI 10.1016/0009-8981(92)90348-T; Gluba-Brzozka A, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0191-x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Grahl DA, 2007, BLOOD PURIFICAT, V25, P210, DOI 10.1159/000100419; Guilgen G, 2011, BLOOD PURIFICAT, V32, P296, DOI 10.1159/000330327; HABERLAND ME, 1988, SCIENCE, V241, P215, DOI 10.1126/science.2455346; Hazell LJ, 1996, J CLIN INVEST, V97, P1535, DOI 10.1172/JCI118576; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Heller JI, 2000, J BIOL CHEM, V275, P9957, DOI 10.1074/jbc.275.14.9957; Hostetter TH, 2004, NEW ENGL J MED, V351, P1344, DOI 10.1056/NEJMe048211; Jaisson S, 2011, CLIN CHEM, V57, P1499, DOI 10.1373/clinchem.2011.163188; Ketonen J, 2008, HEART VESSELS, V23, P420, DOI 10.1007/s00380-008-1066-5; Kisic Bojana, 2016, Oxid Med Cell Longev, V2016, P1069743, DOI 10.1155/2016/1069743; Klebanoff S J, 1978, Ciba Found Symp, P263; KLEBANOFF SJ, 1980, ANN INTERN MED, V93, P480, DOI 10.7326/0003-4819-93-3-480; Koeth RA, 2013, J AM SOC NEPHROL, V24, P853, DOI 10.1681/ASN.2012030254; Kon V, 2015, ARCH MED RES, V46, P379, DOI 10.1016/j.arcmed.2015.05.009; Kon V, 2011, NAT REV NEPHROL, V7, P45, DOI 10.1038/nrneph.2010.157; Kumar AP, 2005, BIOCHEM BIOPH RES CO, V331, P442, DOI 10.1016/j.bbrc.2005.03.204; Kumar AP, 2004, J BIOL CHEM, V279, P8300, DOI 10.1074/jbc.M311625200; Landmesser U, 2003, EUR HEART J SUPPL, V5, pA3, DOI 10.1016/S1520-765X(03)90057-5; Leeuwenburgh C, 1997, J BIOL CHEM, V272, P1433, DOI 10.1074/jbc.272.3.1433; Leeuwenburgh C, 1997, J BIOL CHEM, V272, P3520, DOI 10.1074/jbc.272.6.3520; Locatelli F, 2003, NEPHROL DIAL TRANSPL, V18, P1272, DOI 10.1093/ndt/gfg074; Malyszko J, 2010, CLIN CHIM ACTA, V411, P1412, DOI 10.1016/j.cca.2010.06.019; Massy ZA, 2005, J AM SOC NEPHROL, V16, P109, DOI 10.1681/ASN.2004060495; Mathew AV, 2015, J PROTEOMICS BIO S14; McCormick ML, 1998, J BIOL CHEM, V273, P32030, DOI 10.1074/jbc.273.48.32030; McMillen TS, 2005, CIRCULATION, V111, P2798, DOI 10.1161/CIRCULATIONAHA.104.516278; Meyrelles SS, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-211; Nikpoor B, 2001, AM HEART J, V142, P336, DOI 10.1067/mhj.2001.116769; Pecoits R, 2003, KIDNEY INT, V63, pS172, DOI 10.1046/j.1523-1755.63.s84.32.x; Pennathur S, 1999, J BIOL CHEM, V274, P34621, DOI 10.1074/jbc.274.49.34621; Pennathur S, 2001, J CLIN INVEST, V107, P853, DOI 10.1172/JCI11194; Pennathur S, 2016, AM J RESP CRIT CARE, V193, P861, DOI 10.1164/rccm.201505-0992OC; Penno G, 2011, J HYPERTENS, V29, P1802, DOI 10.1097/HJH.0b013e3283495cd6; Phan O, 2005, CIRCULATION, V112, P2875, DOI 10.1161/CIRCULATIONAHA105.541854; Phan O, 2008, NEPHROL DIAL TRANSPL, V23, P82, DOI 10.1093/ndt/gfm699; Piedrafita FJ, 1996, J BIOL CHEM, V271, P14412, DOI 10.1074/jbc.271.24.14412; Rao AM, 2011, INDIAN J CLIN BIOCHE, V26, P28, DOI 10.1007/s12291-010-0075-1; Reynolds WF, 2006, BIOCHEM BIOPH RES CO, V349, P846, DOI 10.1016/j.bbrc.2006.08.119; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Samak MJ, 2002, CLIN NEPHROL, V57, P327; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Shishehbor Mehdi H, 2004, Curr Atheroscler Rep, V6, P243, DOI 10.1007/s11883-004-0038-1; Shishehbor MH, 2003, CIRCULATION, V108, P426, DOI 10.1161/01.CIR.0000080895.05158.8B; Shishehbor MH, 2003, JAMA-J AM MED ASSOC, V289, P1675, DOI 10.1001/jama.289.13.1675; Shobeiri N, 2010, AM J NEPHROL, V31, P471, DOI 10.1159/000299794; Smith CK, 2014, ARTHRITIS RHEUMATOL, V66, P2532, DOI 10.1002/art.38703; Steinberg D, 2002, NAT MED, V8, P1211, DOI 10.1038/nm1102-1211; Tang WHW, 2013, J CARD FAIL, V19, P219, DOI 10.1016/j.cardfail.2013.02.001; USRDS, 2017, ANN DAT REP ATL CHRO; Vaziri ND, 2004, CURR OPIN NEPHROL HY, V13, P93, DOI 10.1097/00041552-200401000-00013; Vaziri ND, 2004, SEMIN NEPHROL, V24, P469, DOI 10.1016/j.semnephrol.2004.06.026; Vivekanandan-Giri A, 2013, ANN RHEUM DIS, V72, P1725, DOI 10.1136/annrheumdis-2012-202033; Vivekanandan-Giri A, 2011, METHOD ENZYMOL, V491, P73, DOI 10.1016/B978-0-12-385928-0.00005-5; Wang AYM, 2010, AM J KIDNEY DIS, V56, P937, DOI 10.1053/j.ajkd.2010.05.008; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Wattanakit K, 2007, J AM SOC NEPHROL, V18, P629, DOI 10.1681/ASN.2005111204; WITZTUM JL, 1991, J CLIN INVEST, V88, P1785, DOI 10.1172/JCI115499; Wolfle SE, 2005, J VASC RES, V42, P475, DOI 10.1159/000088101; Wu-Wong JR, 2015, J STEROID BIOCHEM, V148, P202, DOI 10.1016/j.jsbmb.2014.12.002; Yamamoto Y, 2010, THROMB RES, V125, P246, DOI 10.1016/j.thromres.2009.11.008; YLAHERTTUALA S, 1994, ARTERIOSCLER THROMB, V14, P32, DOI 10.1161/01.ATV.14.1.32; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271; Zalba G, 2006, NEPHROL DIAL TRANSPL, V21, P2686, DOI 10.1093/ndt/gfl398; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	100	17	17	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7238	7249		10.1074/jbc.RA117.000559	http://dx.doi.org/10.1074/jbc.RA117.000559			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29581235	Green Published, hybrid			2022-12-26	WOS:000432174500015
J	Buy, S; Le Floch, S; Tang, N; Sidiboulenouar, R; Zanca, M; Canadas, P; Nativel, E; Cardoso, M; Alibert, E; Dupont, G; Ambard, D; Maurel, C; Verdeil, JL; Bertin, N; Goze-Bac, C; Coillot, C				Buy, Simon; Le Floch, Simon; Tang, Ning; Sidiboulenouar, Rahima; Zanca, Michel; Canadas, Patrick; Nativel, Eric; Cardoso, Maida; Alibert, Eric; Dupont, Guillaume; Ambard, Dominique; Maurel, Christophe; Verdeil, Jean-Luc; Bertin, Nadia; Goze-Bac, Christophe; Coillot, Christophe			Flip-flop method: A new T1-weighted flow-MRI for plants studies	PLOS ONE			English	Article							NUCLEAR MAGNETIC-RESONANCE; TRANSPORT; PHLOEM	The climate warming implies an increase of stress of plants (drought and torrential rainfall). The understanding of plant behavior, in this context, takes a major importance and sap flow measurement in plants remains a key issue for plant understanding. Magnetic Resonance Imaging (MRI) which is well known to be a powerful tool to access water quantity can be used to measure moving water. We describe a novel flow-MRI method which takes advantage of inflow slice sensitivity. The method involves the slice selectivity in the context of multi slice spin echo sequence. Two sequences such as a given slice is consecutively inflow and outflow sensitive are performed, offering the possiblility to perform slow flow sensitive imaging in a quite straigthforward way. The method potential is demonstrated by imaging both a slow flow measurement on a test bench (as low as 10 mu m.s(-1)) and the Poiseuille's profile of xylemian sap flow velocity in the xylematic tissues of a tomato plant stem.	[Buy, Simon; Sidiboulenouar, Rahima; Zanca, Michel; Cardoso, Maida; Alibert, Eric; Dupont, Guillaume; Goze-Bac, Christophe; Coillot, Christophe] Univ Montpellier, CNRS, L2C, Montpellier, France; [Le Floch, Simon; Canadas, Patrick; Ambard, Dominique] Univ Montpellier, CNRS, LMGC, Montpellier, France; [Zanca, Michel] Univ Montpellier, CHU Gui Chauliac, Montpellier, France; [Tang, Ning; Maurel, Christophe] Univ Montpellier, CNRS, INRA, BPMP,Montpellier SupAgro, Montpellier, France; [Nativel, Eric] Univ Montpellier, CNRS, IES, Montpellier, France; [Sidiboulenouar, Rahima; Verdeil, Jean-Luc] Univ Montpellier, INRA, Montpellier SupAgro, AGAP,CIRAD, Montpellier, France; [Buy, Simon; Bertin, Nadia] INRA, PSH, Avignon, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; INRAE	Coillot, C (corresponding author), Univ Montpellier, CNRS, L2C, Montpellier, France.	christophe.coillot@umontpellier.fr		TANG, Ning/0000-0003-2185-4737; Canadas, Patrick/0000-0002-8943-8943				Coillot C, 2016, J SENS SENS SYST, V5, P137, DOI 10.5194/jsss-5-137-2016; HEMMINGA MA, 1977, J MAGN RESON, V27, P359, DOI 10.1016/0022-2364(77)90001-4; HEMMINGA MA, 1980, J MAGN RESON, V37, P1, DOI 10.1016/0022-2364(80)90088-8; HOULT DI, 1976, J MAGN RESON, V24, P71, DOI 10.1016/0022-2364(76)90233-X; KOSE K, 1985, J PHYS SOC JPN, V54, P81, DOI 10.1143/JPSJ.54.81; Markl M., VELOCITY ENCODING FL; Meme S, 2013, MAGN RESON IMAGING, V31, P109, DOI 10.1016/j.mri.2012.06.019; Mispelter J, 2006, NMR PROBEHADS BIOPHY; Nagata A, 2016, J MAGN RESON, V265, P129, DOI 10.1016/j.jmr.2016.02.004; Peuke AD, 2015, PLANT CELL ENVIRON, V38, P433, DOI 10.1111/pce.12399; POPE JM, 1993, CONCEPT MAGNETIC RES, V5, P281; Scheenen TWJ, 2001, J MAGN RESON, V151, P94, DOI 10.1006/jmre.2001.2362; Steppe K, 2015, TREE PHYSIOL, V35, P341, DOI 10.1093/treephys/tpv033; VANAS H, 1984, BIOPHYS J, V45, P469, DOI 10.1016/S0006-3495(84)84170-3; Windt CW, 2006, PLANT CELL ENVIRON, V29, P1715, DOI 10.1111/j.1365-3040.2006.01544.x	15	5	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194845	10.1371/journal.pone.0194845	http://dx.doi.org/10.1371/journal.pone.0194845			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596455	Green Published, gold, Green Submitted			2022-12-26	WOS:000428630000045
J	Corsetti, S; Borruso, S; Di Traglia, M; Lai, O; Alfieri, L; Villavecchia, A; Cariola, G; Spaziani, A; Natoli, E				Corsetti, Sara; Borruso, Simona; Di Traglia, Mario; Lai, Olga; Alfieri, Lavinia; Villavecchia, Agnese; Cariola, Giuseppe; Spaziani, Alessandra; Natoli, Eugenia			Bold personality makes domestic dogs entering a shelter less vulnerable to diseases	PLOS ONE			English	Article							PUBLIC ANIMAL SHELTER; MALE RHESUS MACAQUES; WILD-TYPE RATS; SOCIAL STRESS; PLASMA-CORTISOL; IMMUNE FUNCTION; IMMUNODEFICIENCY-VIRUS; INDIVIDUAL-DIFFERENCES; LEUKOCYTE TRAFFICKING; SPATIAL RESTRICTION	It is widely recognised that for vertebrate species, personalities vary along an axis with extremes represented by 'proactive' and 'reactive' individuals. The aim of this study was to verify whether there is a relationship between personality and disease vulnerability in domestic dogs (Canis familiaris) exposed to an intensely stressful situation such as entering a shelter. Twenty-eight shelter dogs participated in the study. The ethogram consisted of approximately 100 behavioural patterns. Behavioural observations of dogs in their new environment, a Novel Object and a T-maze test were used to evaluate the personality of the dogs captured as strays and entering the shelter. A blood sample from each dog was obtained at admission into the shelter and after a month to evaluate their immunological state. Based on PCA analyses of observational combined with experimental data, the dogs were ordered along the boldness-shyness axis, with the first being the boldest. Excluding one (the 6th), the first 10 dogs showed an improved health status: absence of disease symptoms during the 30 days of monitoring and improved immunological parameters; the opposite was found for shy dogs. The results of this research seem to confirm findings in other vertebrate species, i.e., bold and shy dog vulnerability to diseases might be different, especially when they must cope with a stressful and highly infectious environment such as a dog shelter.	[Corsetti, Sara; Borruso, Simona] Univ Rome Sapienza, Biol & Biotechnol Dept, Rome, Italy; [Di Traglia, Mario] Univ Rome Sapienza, Publ Hlth & Infect Dis, Rome, Italy; [Lai, Olga; Alfieri, Lavinia] Expt Zoo Prophylact Inst Latium & Tuscany, Rome, Italy; [Cariola, Giuseppe; Spaziani, Alessandra; Natoli, Eugenia] Local Hlth Unit Rome 3, Interzonal Dog Shelter, Rome, Italy	Sapienza University Rome; Sapienza University Rome	Natoli, E (corresponding author), Local Hlth Unit Rome 3, Interzonal Dog Shelter, Rome, Italy.	enatoli@tiscali.it	Natoli, Eugenia/AAE-2156-2020	, Eugenia/0000-0002-9232-7048; Corsetti, Sara/0000-0001-9183-9749				ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Beerda B, 1999, PHYSIOL BEHAV, V66, P243, DOI 10.1016/S0031-9384(98)00290-X; Beerda B, 1999, PHYSIOL BEHAV, V66, P233, DOI 10.1016/S0031-9384(98)00289-3; BENUS RF, 1990, BEHAVIOUR, V112, P176, DOI 10.1163/156853990X00185; BLANCHARD RJ, 1985, BEHAV PROCESS, V11, P209, DOI 10.1016/0376-6357(85)90062-2; BONIZZI L, 1989, J VET MED B, V36, P365, DOI 10.1111/j.1439-0450.1989.tb00615.x; Bourne Godfrey R., 2008, AACL Bioflux, V1, P39; Bray E. E., 2017, ANIM COGN; Cafazzo S, 2014, PHYSIOL BEHAV, V133, P223, DOI 10.1016/j.physbeh.2014.05.046; Capitanio JP, 1998, AM J PRIMATOL, V44, P29, DOI 10.1002/(SICI)1098-2345(1998)44:1<29::AID-AJP3>3.0.CO;2-Z; Capitanio JP, 1999, BRAIN BEHAV IMMUN, V13, P138, DOI 10.1006/brbi.1998.0540; Caramaschi D., 2013, ANIMAL PERSONALITIES; Careau V, 2010, AM NAT, V175, P753, DOI 10.1086/652435; Carere C, 2003, HORM BEHAV, V43, P540, DOI 10.1016/S0018-506X(03)00065-5; Carnevali L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068316; Cavigelli SA, 2003, P NATL ACAD SCI USA, V100, P16131, DOI 10.1073/pnas.2535721100; Coppens CM, 2014, AGGRESSIVE BEHAV, V40, P300, DOI 10.1002/ab.21527; Costantini D, 2008, BIOL LETTERS, V4, P119, DOI 10.1098/rsbl.2007.0513; Costantini D, 2012, J EXP BIOL, V215, P374, DOI 10.1242/jeb.062034; Cray C, 2009, COMPARATIVE MED, V59, P517; De Palma C, 2005, BEHAVIOUR, V142, P1307, DOI 10.1163/156853905774539337; Dhabhar FS, 2002, BRAIN BEHAV IMMUN, V16, P785, DOI 10.1016/S0889-1591(02)00036-3; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; Dudley ES, 2015, JAVMA-J AM VET MED A, V247, P1289, DOI 10.2460/javma.247.11.1289; FLESHNER M, 1989, PHYSIOL BEHAV, V45, P1183, DOI 10.1016/0031-9384(89)90107-8; Gazzano A., 2004, Annali della Facolta di Medicina Veterinaria di Pisa, V57, P189; GODDARD ME, 1986, APPL ANIM BEHAV SCI, V15, P247, DOI 10.1016/0168-1591(86)90095-X; Gosling SD, 2003, J PERS SOC PSYCHOL, V85, P1161, DOI 10.1037/0022-3514.85.6.1161; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; Hennessy MB, 1997, PHYSIOL BEHAV, V62, P485, DOI 10.1016/S0031-9384(97)80328-9; Hennessy MB, 2002, J AM VET MED ASSOC, V221, P65, DOI 10.2460/javma.2002.221.65; Hennessy MB, 2001, APPL ANIM BEHAV SCI, V73, P217, DOI 10.1016/S0168-1591(01)00139-3; Hennessy MB, 1998, APPL ANIM BEHAV SCI, V61, P63, DOI 10.1016/S0168-1591(98)00179-8; Hennessy Michael B., 2002, Journal of Applied Animal Welfare Science, V5, P253, DOI 10.1207/S15327604JAWS0504_01; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Kavelaars A, 1999, BRAIN BEHAV IMMUN, V13, P279, DOI 10.1006/brbi.1998.0534; King T, 2003, APPL ANIM BEHAV SCI, V82, P45, DOI 10.1016/S0168-1591(03)00040-6; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; KOOLHAAS JM, 1988, NETH J ZOOL, V38, P111; Kurvers R. H. J. M., 2009, ANIM BEHAV, V9, P1; Lendvai AZ, 2011, J EXP BIOL, V214, P821, DOI 10.1242/jeb.047712; Ley J, 2007, APPL ANIM BEHAV SCI, V104, P71, DOI 10.1016/j.applanim.2006.03.021; Santillan-Doherty AM, 2010, J COMP PSYCHOL, V124, P211, DOI 10.1037/a0018267; Marketon JIW, 2008, CELL IMMUNOL, V252, P16, DOI 10.1016/j.cellimm.2007.09.006; Mettke-Hofmann C, 2005, BEHAVIOUR, V142, P1357, DOI 10.1163/156853905774539427; Natoli E, 2005, NEUROSCI BIOBEHAV R, V29, P151, DOI 10.1016/j.neubiorev.2004.06.011; OSSERMAN EF, 1966, J EXP MED, V124, P921, DOI 10.1084/jem.124.5.921; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Protopopova A, 2016, PHYSIOL BEHAV, V159, P95, DOI 10.1016/j.physbeh.2016.03.020; Rooney NJ, 2007, PHYSIOL BEHAV, V92, P847, DOI 10.1016/j.physbeh.2007.06.011; Ruis MAW, 2000, APPL ANIM BEHAV SCI, V66, P31, DOI 10.1016/S0168-1591(99)00070-2; Sgoifo A, 2001, PHYSIOL BEHAV, V73, P253, DOI 10.1016/S0031-9384(01)00544-3; Sgoifo A, 2014, NEUROSCI BIOBEHAV R, V39, P51, DOI 10.1016/j.neubiorev.2013.12.005; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Stefanski V, 2001, PHYSIOL BEHAV, V73, P385, DOI 10.1016/S0031-9384(01)00495-4; Svartberg K, 2005, APPL ANIM BEHAV SCI, V91, P103, DOI 10.1016/j.applanim.2004.08.030; Svartberg K, 2005, ANIM BEHAV, V69, P283, DOI 10.1016/j.anbehav.2004.04.011; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P133, DOI 10.1016/S0168-1591(02)00121-1; Tasca S, 2010, J VET DIAGN INVEST, V22, P111, DOI 10.1177/104063871002200123; Taylor KD, 2006, J VET BEHAV, V1, P94, DOI 10.1016/j.jveb.2006.09.002; Thomson JS, 2011, HORM BEHAV, V59, P67, DOI 10.1016/j.yhbeh.2010.10.010; Veenema AH, 2003, J NEUROENDOCRINOL, V15, P256, DOI 10.1046/j.1365-2826.2003.00986.x; Wilson ADM, 2005, ETHOLOGY, V111, P849, DOI 10.1111/j.1439-0310.2005.01110.x; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; WOODGUSH DGM, 1991, ANIM BEHAV, V42, P599, DOI 10.1016/S0003-3472(05)80243-X	66	10	10	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0193794	10.1371/journal.pone.0193794	http://dx.doi.org/10.1371/journal.pone.0193794			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596432	Green Submitted, Green Published, gold			2022-12-26	WOS:000428630000013
J	Jarlais, DCD; Cooper, HLF; Arasteh, K; Feelemyer, J; McKnight, C; Ross, Z				Des Jarlais, D. C.; Cooper, H. L. F.; Arasteh, K.; Feelemyer, J.; McKnight, C.; Ross, Z.			Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US	PLOS ONE			English	Article							C VIRUS-INFECTION; HEPATITIS-C; UNITED-STATES; PREVENTION; PEOPLE; INTERVENTIONS; BEHAVIORS; MANHATTAN; PROGRAMS; DEATHS	Objective We identified potential geographic "hotspots" for drug-injecting transmission of HIV and hepatitis C virus (HCV) among persons who inject drugs (PWID) in New York City. The HIV epidemic among PWID is currently in an "end of the epidemic" stage, while HCV is in a continuing, high prevalence (> 50%) stage. Methods We recruited 910 PWID entering Mount Sinai Beth Israel substance use treatment programs from 2011-2015. Structured interviews and HIV/HCV testing were conducted. Residential ZIP codes were used as geographic units of analysis. Potential "hotspots" for HIV and HCV transmission were defined as 1) having relatively large numbers of PWID 2) having 2 or more HIV (or HCV) seropositive PWID reporting transmission risk-passing on used syringes to others, and 3) having 2 or more HIV (or HCV) seronegative PWID reporting acquisition risk-injecting with previously used needles/syringes. Hotspots for injecting drug use initiation were defined as ZIP codes with 5 or more persons who began injecting within the previous 6 years. Results Among PWID, 96% injected heroin, 81% male, 34% White, 15% African-American, 47% Latinx, mean age 40 (SD = 10), 7% HIV seropositive, 62% HCV seropositive. Participants resided in 234 ZIP codes. No ZIP codes were identified as potential hotspots due to small numbers of HIV seropositive PWID reporting transmission risk. Four ZIP codes were identified as potential hotspots for HCV transmission. 12 ZIP codes identified as hotspots for injecting drug use initiation. Discussion For HIV, the lack of potential hotspots is further validation of widespread effectiveness of efforts to reduce injecting-related HIV transmission. Injecting-related HIV transmission is likely to be a rare, random event. HCV prevention efforts should include focus on potential hotspots for transmission and on hotspots for initiation into injecting drug use. We consider application of methods for the current opioid epidemic in the US.	[Des Jarlais, D. C.; Arasteh, K.; Feelemyer, J.; McKnight, C.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Cooper, H. L. F.] Emory Univ, Rollins Sch Publ Hlth, Dept Behav Sci & Hlth Educ, Atlanta, GA 30322 USA; [Ross, Z.] ZevRoss Spatial Anal, Ithaca, NY USA	Icahn School of Medicine at Mount Sinai; Emory University; Rollins School Public Health	Jarlais, DCD (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	don.desjarlais@mountsinai.org		Des Jarlais, Don/0000-0002-0157-8168; Feelemyer, Jonathan/0000-0001-6617-4992	NIDA NIH HHS [R01 DA003574, P30 DA011041] Funding Source: Medline; NIH HHS [R01DA003574] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA003574, P30DA011041] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Appalachian Regional Commission, 2018, COMM OP APP CHALL OP; Bluthenthal RN, 2000, AIDS, V14, P605, DOI 10.1097/00002030-200003310-00015; Boodram B, 2010, DRUG ALCOHOL DEPEN, V111, P136, DOI 10.1016/j.drugalcdep.2010.04.003; Courtwright D, 1989, ADDICTS WHO SURVIVED; Davis CS, 2005, AM J PUBLIC HEALTH, V95, P233, DOI 10.2105/AJPH.2003.031310; De P, 2007, ADDICTION, V102, P1730, DOI 10.1111/j.1360-0443.2007.01936.x; Des Jarlais DC, 2014, AIDS BEHAV, V18, P443, DOI 10.1007/s10461-013-0664-0; Des Jarlais DC, 2000, AM J PUBLIC HEALTH, V90, P1112; Des Jarlais DC, 1998, AM J PUBLIC HEALTH, V88, P1801, DOI 10.2105/AJPH.88.12.1801; Des Jarlais DC, 2005, DRUG ALCOHOL DEPEN, V77, P1, DOI 10.1016/j.drugalcdep.2004.06.010; Des Jarlais DC, 2003, AM J EPIDEMIOL, V157, P467, DOI 10.1093/aje/kwf222; Des Jarlais DC, 2017, AM J PUBLIC HEALTH, V107, P1157, DOI 10.2105/AJPH.2017.303787; Des Jarlais DC, 2016, AM J PUBLIC HEALTH, V106, P503, DOI 10.2105/AJPH.2015.303019; Des Jarlais DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087993; DESJARLAIS DC, 1989, JAMA-J AM MED ASSOC, V261, P1008, DOI 10.1001/jama.261.7.1008; Diaz T, 2001, AM J PUBLIC HEALTH, V91, P23, DOI 10.2105/AJPH.91.1.23; Dowdy DW, 2012, P NATL ACAD SCI USA, V109, P9557, DOI 10.1073/pnas.1203517109; Eckhardt B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177341; Fordyce J, 2001, J URBAN HEALTH, V78, P669, DOI 10.1093/jurban/78.4.669; Fraser H, 2018, ADDICTION, V113, P173, DOI 10.1111/add.13948; Galea S, 2002, PUBLIC HEALTH REP, V117, pS135; Hagan H, 2011, J INFECT DIS, V204, P74, DOI 10.1093/infdis/jir196; Harocopos A, 2009, INT J DRUG POLICY, V20, P317, DOI 10.1016/j.drugpo.2008.06.003; Jarlais DCD, 2009, AM J PUBLIC HEALTH, V99, pS445, DOI 10.2105/AJPH.2008.159327; Jordan AE, 2015, DRUG ALCOHOL DEPEN, V152, P194, DOI 10.1016/j.drugalcdep.2015.03.039; Kauhl B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135656; Kuo M, 2015, AM J PUBLIC HEALTH, V105, P1604, DOI 10.2105/AJPH.2015.302591; Levy MZ, 2009, CLIN INFECT DIS, V48, P1104, DOI 10.1086/597464; Meyers DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114822; Morris MD, 2017, CLIN INFECT DIS, V64, P860, DOI 10.1093/cid/ciw869; Murrill CS, 2001, J URBAN HEALTH, V78, P152, DOI 10.1093/jurban/78.1.152; Neaigus A, 2017, JAIDS-J ACQ IMM DEF, V75, pS325, DOI 10.1097/qai.0000000000001407; New York State Department of Health, 2015, ACH GOAL SET FORTH G; O'Donnell JK, 2017, MMWR-MORBID MORTAL W, V66, P897, DOI 10.15585/mmwr.mm6634a2; Paull SH, 2012, FRONT ECOL ENVIRON, V10, P75, DOI 10.1890/110111; Peters PJ, 2016, NEW ENGL J MED, V375, P229, DOI 10.1056/NEJMoa1515195; Ramjee G, 2014, AIDS BEHAV, V18, P317, DOI 10.1007/s10461-013-0578-x; Rockwell R, 1999, AIDS CARE, V11, P437, DOI 10.1080/09540129947811; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Sorensen JL, 2000, DRUG ALCOHOL DEPEN, V59, P17, DOI 10.1016/S0376-8716(99)00104-0; STATA Corp, 2012, STAT 12; Tempalski B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064789; Van Handel MM, 2016, JAIDS-J ACQ IMM DEF, V73, P323, DOI 10.1097/QAI.0000000000001098; Wand H, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-41; Wilkerson Richard Gentry, 2016, Emerg Med Clin North Am, V34, pe1, DOI 10.1016/j.emc.2015.11.002	45	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194799	10.1371/journal.pone.0194799	http://dx.doi.org/10.1371/journal.pone.0194799			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8ZI	29596464	Green Published, Green Submitted, gold			2022-12-26	WOS:000428630000044
J	Matsumura, T; Terada, J; Kinoshita, T; Sakurai, Y; Yahaba, M; Tsushima, K; Sakao, S; Nagashima, K; Ozaki, T; Kobayashi, Y; Hiwasa, T; Tatsumi, K				Matsumura, Takuma; Terada, Jiro; Kinoshita, Taku; Sakurai, Yoriko; Yahaba, Misuzu; Tsushima, Kenji; Sakao, Seiichiro; Nagashima, Kengo; Ozaki, Toshinori; Kobayashi, Yoshio; Hiwasa, Takaki; Tatsumi, Koichiro			Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; CARDIOVASCULAR-DISEASE; ENDOTHELIAL-CELLS; EXPRESSION; PROTEIN-4; ATHEROSCLEROSIS; METAANALYSIS; ACTIVATION; MEDIATORS; MORTALITY	Objective Although severe obstructive sleep apnea (OSA) is an important risk factor for atherosclerosis-related diseases including coronary artery disease (CAD), there is no reliable biomarker of CAD risks in patients with OSA. This study aimed to test our hypothesis that circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1-Abs) are associated with the prevalence of CAD in patients with OSA. Methods Eighty-two adults diagnosed with OSA by polysomnography, 96 patients with a diagnosis of acute coronary syndrome (ACS) and 64 healthy volunteers (HVs) were consecutively enrolled. Serum samples were collected from patients with OSA at diagnostic polysomnography and from patients with ACS at disease onset. Serum NBL1-Ab level was measured by amplified luminescence proximity homogeneous assay and its association with clinical variables related to atherosclerosis was evaluated. Results NBL1-Ab level was significantly elevated in patients with both OSA and ACS compared with HVs. Subgroup analyses showed that NBL1-Ab level was markedly higher in patients with severe OSA and OSA patients with a history of CAD. Weak associations were observed between NBL1-Ab level and apnea-hypopnea index, age, mean SpO2 and arousal index, whereas significantly higher NBL1-Ab levels were observed in OSA patients with a history of CAD than in those without a history of CAD. Sensitivity analysis using a logistic regression model also demonstrated that increased NBL1-Ab levels were associated with the previous history of CAD in patients with OSA. Conclusions Elevated NBL1-Ab levels may be associated with the prevalence of CAD in patients with OSA, which needs to be confirmed further.	[Matsumura, Takuma; Terada, Jiro; Kinoshita, Taku; Sakurai, Yoriko; Yahaba, Misuzu; Tsushima, Kenji; Sakao, Seiichiro; Tatsumi, Koichiro] Chiba Univ, Grad Sch Med, Dept Respirol, Chiba, Chiba, Japan; [Nagashima, Kengo] Chiba Univ, Grad Sch Med, Dept Global Clin Res, Chiba, Chiba, Japan; [Ozaki, Toshinori] Chiba Canc Ctr, Res Inst, Lab DNA Damage Signaling, Chiba, Chiba, Japan; [Kobayashi, Yoshio] Chiba Univ, Grad Sch Med, Dept Cardiovasc Med, Chiba, Chiba, Japan; [Hiwasa, Takaki] Chiba Univ, Grad Sch Med, Dept Biochem & Genet, Chiba, Chiba, Japan	Chiba University; Chiba University; Chiba Cancer Center; Chiba University; Chiba University	Terada, J (corresponding author), Chiba Univ, Grad Sch Med, Dept Respirol, Chiba, Chiba, Japan.	jirotera@chiba-u.jp	Nagashima, Kengo/I-4258-2019	Nagashima, Kengo/0000-0003-4529-9045; Terada, Jiro/0000-0001-9019-4053	Grants-in-Aid for Scientific Research [15K08412] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Ali SS, 2014, SLEEP MED REV, V18, P379, DOI 10.1016/j.smrv.2014.01.004; Csiszar A, 2005, CIRCULATION, V111, P2364, DOI 10.1161/01.CIR.0000164201.40634.1D; Cui CJ, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160199; Dewan NA, 2015, CHEST, V147, P266, DOI 10.1378/chest.14-0500; Dionne MS, 2001, MOL CELL BIOL, V21, P636, DOI 10.1128/MCB.21.2.636-643.2001; Drager LF, 2005, AM J RESP CRIT CARE, V172, P613, DOI 10.1164/rccm.200503-340OC; Fesmire J, 2010, REV BRAS REUMATOL, V50, P545, DOI 10.1590/S0482-50042010000500007; Garrigue-Antar L, 2004, J BIOL CHEM, V279, P49835, DOI 10.1074/jbc.M408134200; Goto K, 2015, J MOL BIOMARK DIAGN, V6, P2; Guo J, 2016, SLEEP BREATH, V20, P965, DOI 10.1007/s11325-016-1319-y; Hiwasa T., 2015, IMMUNOME RES, V11; Hopkins CR, 2016, EXPERT OPIN THER PAT, V26, P1115, DOI 10.1080/13543776.2016.1217330; Hung WT, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096172; Jullian-Desayes I, 2015, SLEEP MED REV, V21, P23, DOI 10.1016/j.smrv.2014.07.004; Kozawa O, 2001, J CELL BIOCHEM, V81, P430, DOI 10.1002/1097-4644(20010601)81:3<430::AID-JCB1056>3.0.CO;2-G; Lee MYK, 2016, AM J PHYSIOL-CELL PH, V310, pC446, DOI 10.1152/ajpcell.00240.2015; Machida T, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0393-4; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Matsumura T, 2017, J CLIN SLEEP MED, V13, P393, DOI 10.5664/jcsm.6488; Miriyala S, 2006, CIRCULATION, V113, P2818, DOI 10.1161/CIRCULATIONAHA.106.611822; Montecucco F, 2011, EUR HEART J, V32, P412, DOI 10.1093/eurheartj/ehq521; Morrell NW, 2016, NAT REV CARDIOL, V13, P106, DOI 10.1038/nrcardio.2015.156; Nadlonek NA, 2013, J SURG RES, V184, P6, DOI 10.1016/j.jss.2013.05.001; OZAKI T, 1994, CANCER RES, V54, P646; Sorescu GP, 2004, CIRC RES, V95, P773, DOI 10.1161/01.RES.0000145728.22878.45; Veres K, 2004, LUPUS, V13, P423, DOI 10.1191/0961203304lu1011oa; Wozniak DR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007736.pub2; Xie XM, 2013, SLEEP MED, V14, P1139, DOI 10.1016/j.sleep.2013.07.006; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Young T, 2008, SLEEP, V31, P1071; Zhang M, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0214-3	31	7	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195015	10.1371/journal.pone.0195015	http://dx.doi.org/10.1371/journal.pone.0195015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596467	gold, Green Submitted, Green Published			2022-12-26	WOS:000428630000067
J	Sartorius, CM; Schoetzau, A; Kettelhack, H; Fink, D; Hacker, NF; Fedier, A; Jacob, F; Heinzelmann-Schwarz, V				Sartorius, Celine Montavon; Schoetzau, Andreas; Kettelhack, Henriette; Fink, Daniel; Hacker, Neville F.; Fedier, Andre; Jacob, Francis; Heinzelmann-Schwarz, Viola			ABO blood groups as a prognostic factor for recurrence in ovarian and vulvar cancer	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; SQUAMOUS-CELL CARCINOMA; GROUP ANTIGENS; GENETIC-BASIS; LUNG-CANCER; RISK; ASSOCIATION; METAANALYSIS; POPULATION; MORTALITY	The relationship between ABO blood groups (BG) and risk of incidence in cancers including gynecological cancers has been widely studied, showing increased incidence risk for BG A patients. As available data are inconsistent we investigated whether BG and their anti-glycan antibodies (anti-A and anti-B) have prognostic values in gynecological cancers. We retrospectively evaluated 974 patients with gynecological cancers in three cancer centers (Switzerland and Australia) between 1974 and 2014 regarding the relationships between clinico-pathological findings and the BG. Time to disease recurrence was significantly influenced by BG in patients with ovarian (n = 282) and vulvar (n = 67) cancer. BG O or B patients showed a significantly increased risk for ovarian cancer relapse compared to A, 59% and 82%, respectively (p = 0.045; HR O vs A = 1.59 (CI 1.01-2.51) and (p = 0.036; HR A vs B = 0.55 (CI 0.32-0.96). Median time to relapse for advanced stage (n = 126) ovarian cancer patients was 18.2 months for BG O and 32.2 for A (p = 0.031; HR O vs A = 2.07 (CI 1.07-4.02)). BG also significantly influenced relapse-free survival in patients with vulvar cancer (p = 0.002), with BG O tending to have increased relapse risk compared to A (p = 0.089). Blood groups hence associate with recurrence in ovarian and vulvar cancer: women with BG O seem to have a lower ovarian cancer incidence, however are more likely to relapse earlier. The significance of the BG status as a prognostic value is evident and may be helpful to oncologists in prognosticating disease outcome and selecting the appropriate therapy.	[Sartorius, Celine Montavon; Heinzelmann-Schwarz, Viola] Univ Hosp Basel, Hosp Women, Dept Gynecol & Gynecol Oncol, Basel, Switzerland; [Sartorius, Celine Montavon; Schoetzau, Andreas; Kettelhack, Henriette; Fedier, Andre; Jacob, Francis; Heinzelmann-Schwarz, Viola] Univ Basel, Basel, Switzerland; [Schoetzau, Andreas; Kettelhack, Henriette; Fedier, Andre; Jacob, Francis; Heinzelmann-Schwarz, Viola] Univ Hosp Basel, Ovarian Canc Res, Dept Biomed, Basel, Switzerland; [Fink, Daniel] Univ Hosp Zurich, Dept Gynecol, Zurich, Switzerland; [Fink, Daniel] Univ Zurich, Zurich, Switzerland; [Hacker, Neville F.] UNSW, Sch Womens & Childrens Hlth, Royal Hosp Women, Gynaecol Canc Ctr, Sydney, NSW, Australia; [Jacob, Francis] Univ Hosp Basel, Dept Biomed, Glycooncol Res, Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Zurich; University Zurich Hospital; University of Zurich; University of New South Wales Sydney; University of Basel	Heinzelmann-Schwarz, V (corresponding author), Univ Hosp Basel, Hosp Women, Dept Gynecol & Gynecol Oncol, Basel, Switzerland.; Heinzelmann-Schwarz, V (corresponding author), Univ Basel, Basel, Switzerland.; Heinzelmann-Schwarz, V (corresponding author), Univ Hosp Basel, Ovarian Canc Res, Dept Biomed, Basel, Switzerland.	viola.heinzelmann@usb.ch	Jacob, Francis/C-7910-2009	Jacob, Francis/0000-0002-0446-1942; Hacker, Neville/0000-0002-1445-2302; Heinzelmann-Schwarz, Viola/0000-0002-4056-3225				AIRD I, 1953, BRIT MED J, V1, P799, DOI 10.1136/bmj.1.4814.799; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Barbalic M, 2010, HUM MOL GENET, V19, P1863, DOI 10.1093/hmg/ddq061; Bowtell DD, 2015, NAT REV CANCER, V15, P668, DOI 10.1038/nrc4019; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Cao X, 2014, BRIT J CANCER, V111, P174, DOI 10.1038/bjc.2014.302; Cihan YB, 2014, ASIAN PAC J CANCER P, V15, P4055, DOI 10.7314/APJCP.2014.15.9.4055; Cozzi GD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175119; Gao S, 2004, INT J CANCER, V109, P230, DOI 10.1002/ijc.11592; Gates MA, 2012, INT J CANCER, V130, P2129, DOI 10.1002/ijc.26220; Hakomori S, 1999, BBA-GEN SUBJECTS, V1473, P247, DOI 10.1016/S0304-4165(99)00183-X; Jacob F, 2014, BRIT J CANCER, V111, P1634, DOI 10.1038/bjc.2014.455; Jacobs IJ, 2016, LANCET, V387, P945, DOI 10.1016/S0140-6736(15)01224-6; Joh HK, 2012, CANCER EPIDEMIOL, V36, P528, DOI 10.1016/j.canep.2012.07.001; Kaczmarek R, 2014, TRANSFUS MED REV, V28, P126, DOI 10.1016/j.tmrv.2014.04.007; Khalili H, 2011, CANCER EPIDEM BIOMAR, V20, P1017, DOI 10.1158/1055-9965.EPI-10-1250; Le Pendu J, 2001, APMIS, V109, P9; Liumbruno GM, 2013, BLOOD TRANSFUS-ITALY, V11, P491, DOI 10.2450/2013.0152-13; Manegold-Brauer G, 2016, INT J GYNECOL CANCER, V26, P1062, DOI 10.1097/IGC.0000000000000718; Marinaccio M, 1995, Minerva Ginecol, V47, P69; MATSUMOTO H, 1993, CANCER-AM CANCER SOC, V72, P75, DOI 10.1002/1097-0142(19930701)72:1<75::AID-CNCR2820720116>3.0.CO;2-Z; Miao SY, 2014, ASIA-PAC J CLIN ONCO, V10, P101, DOI 10.1111/ajco.12083; Oguz A, 2013, ASIAN PAC J CANCER P, V14, P453, DOI 10.7314/APJCP.2013.14.1.453; PANDEY M, 1995, BRIT MED J, V310, P1639, DOI 10.1136/bmj.310.6995.1639; Paterson AD, 2009, ARTERIOSCL THROM VAS, V29, P1958, DOI 10.1161/ATVBAHA.109.192971; Poole EM, 2012, CANCER CAUSE CONTROL, V23, P1805, DOI 10.1007/s10552-012-0059-y; Redman Rachel, 2005, J Low Genit Tract Dis, V9, P89, DOI 10.1097/00128360-200504000-00004; Rolfe KJ, 2002, EUR J GYNAECOL ONCOL, V23, P111; Seltsam A, 2003, BLOOD, V102, P3035, DOI 10.1182/blood-2003-03-0955; Sheng LM, 2013, INT J CANCER, V133, P893, DOI 10.1002/ijc.28087; Su M, 2001, WORLD J GASTROENTERO, V7, P657; Urun Y, 2013, ASIAN PAC J CANCER P, V14, P2801, DOI 10.7314/APJCP.2013.14.5.2801; Urun Y, 2012, ASIAN PAC J CANCER P, V13, P6097, DOI 10.7314/APJCP.2012.13.12.6097; Wang W, 2014, CANCER CAUSE CONTROL, V25, P1369, DOI 10.1007/s10552-014-0442-y; Welshinger M, 1996, GYNECOL ONCOL, V62, P106, DOI 10.1006/gyno.1996.0198; Xie J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011972; Xu YQ, 2016, J SURG RES, V201, P188, DOI 10.1016/j.jss.2015.10.039; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; Yang X, 2014, INT J CLIN EXP MED, V7, P2214; Yuzhalin AE, 2012, ASIAN PAC J CANCER P, V13, P5091, DOI 10.7314/APJCP.2012.13.10.5091; Zhang BL, 2014, ASIAN PAC J CANCER P, V15, P4643, DOI 10.7314/APJCP.2014.15.11.4643	41	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195213	10.1371/journal.pone.0195213	http://dx.doi.org/10.1371/journal.pone.0195213			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596526	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000428630000091
J	Bocage-Barthelemy, Y; Chatard, A; Jaafari, N; Tello, N; Billieux, J; Daveau, E; Selimbegovic, L				Bocage-Barthelemy, Yvana; Chatard, Armand; Jaafari, Nematollah; Tello, Nina; Billieux, Joel; Daveau, Emmanuel; Selimbegovic, Leila			Automatic social comparison: Cognitive load facilitates an increase in negative thought accessibility after thin ideal exposure among women	PLOS ONE			English	Article							BODY-IMAGE; MEDIA IMAGES; DISCLAIMER LABELS; SELF-ESTEEM; APPEARANCE; DISSATISFACTION; INTERNALIZATION; MOOD	Women are routinely exposed to images of extremely slim female bodies (the thin ideal) in advertisements, even if they do not necessarily pay much attention to these images. We hypothesized that paradoxically, it is precisely in such conditions of low attention that the impact of the social comparison with the thin ideal might be the most pronounced. To test this prediction, one hundred and seventy-three young female participants were exposed to images of the thin ideal or of women's fashion accessories. They were allocated to either a condition of high (memorizing 10 digits) or low cognitive load (memorizing 4 digits). The main dependent measure was implicit: mean recognition latency of negative words, relative to neutral words, as assessed by a lexical decision task. The results showed that thin-ideal exposure did not affect negative word accessibility under low cognitive load but that it increased it under high cognitive load. These findings are consistent with the hypothesis that social comparison with the thin ideal is an automatic process, and contribute to explain why some strategies to prevent negative effects of thin-ideal exposure are inefficient.	[Bocage-Barthelemy, Yvana; Chatard, Armand; Tello, Nina; Selimbegovic, Leila] Univ Poitiers, Univ Tours, Poitiers, France; [Bocage-Barthelemy, Yvana; Chatard, Armand; Tello, Nina; Selimbegovic, Leila] CNRS, Poitiers, France; [Chatard, Armand; Jaafari, Nematollah; Tello, Nina] Serv Hosp Univ Psychiat & Psychol Med, Ctr Hosp Henri Laborit, Poitiers, France; [Billieux, Joel] Univ Luxembourg, Esch Sur Alzette, Luxembourg; [Billieux, Joel] Univ Catholic Louvain, Louvain La Neuve, Belgium; [Daveau, Emmanuel] Univ Reading, Reading, Berks, England	Universite de Poitiers; Universite de Tours; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; CHU de Toulouse; University of Luxembourg; University of Reading	Selimbegovic, L (corresponding author), Univ Poitiers, Univ Tours, Poitiers, France.; Selimbegovic, L (corresponding author), CNRS, Poitiers, France.	leila.selimbegovic@univ-poitiers.fr	Chatard, Armand/N-9213-2017; Billieux, Joel/HCH-3334-2022	Chatard, Armand/0000-0003-4823-2903; Billieux, Joel/0000-0002-7388-6194	National Agency for Research (ANR), Paris, France [ANR-13-BSH2-0008-01, ANR-13-BSH2-0008]	National Agency for Research (ANR), Paris, France(French National Research Agency (ANR))	This work was supported by the National Agency for Research (ANR), Paris, France [grant number ANR-13-BSH2-0008-01] (http://www.agence-nationale-recherche.fr/?Projet=ANR-13-BSH2-0008) to LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ata RN, 2013, BODY IMAGE, V10, P472, DOI 10.1016/j.bodyim.2013.04.004; Bargh J. A., 2000, HDB RES METHODS SOCI, P253; Bargh J. A., HDB SOCIAL COGNITION, P1; Bessenoff GR, 2006, PSYCHOL WOMEN QUART, V30, P239, DOI 10.1111/j.1471-6402.2006.00292.x; Borau S, 2016, J BUS ETHICS, P21; Brown A, 2005, J SOC CLIN PSYCHOL, V24, P1088, DOI 10.1521/jscp.2005.24.8.1088; Buote VM, 2011, BODY IMAGE, V8, P322, DOI 10.1016/j.bodyim.2011.06.002; Bury B, 2016, BODY IMAGE, V17, P136, DOI 10.1016/j.bodyim.2016.03.005; Cattarin JA, 2000, J SOC CLIN PSYCHOL, V19, P220, DOI 10.1521/jscp.2000.19.2.220; Chatard A, 2017, J EXP SOC PSYCHOL, V73, P1, DOI 10.1016/j.jesp.2017.05.005; Chatard A, 2011, J PERS SOC PSYCHOL, V100, P587, DOI 10.1037/a0022461; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cragg DN, 2017, J HEALTH PSYCHOL; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Frederick DA, 2016, BODY IMAGE, V17, P171, DOI 10.1016/j.bodyim.2016.03.009; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; GILBERT DT, 1995, J PERS SOC PSYCHOL, V69, P227, DOI 10.1037/0022-3514.69.2.227; Grabe S, 2008, PSYCHOL BULL, V134, P460, DOI 10.1037/0033-2909.134.3.460; Groesz LM, 2002, INT J EAT DISORDER, V31, P1, DOI 10.1002/eat.10005; Grogan S, 2006, J HEALTH PSYCHOL, V11, P523, DOI 10.1177/1359105306065013; Hackman R., GUARDIAN; Halliwell Emma, 2005, Body Image, V2, P249, DOI 10.1016/j.bodyim.2005.05.001; Jansen A, 2002, EUR EAT DISORD REV, V10, P208, DOI 10.1002/erv.430; Mills JS, 2002, PERS SOC PSYCHOL B, V28, P1687, DOI 10.1177/014616702237650; Moors A, 2006, PSYCHOL BULL, V132, P297, DOI 10.1037/0033-2909.132.2.297; Mussweiler T, 2004, J EXP SOC PSYCHOL, V40, P689, DOI 10.1016/j.jesp.2004.01.004; Myers TA, 2009, J ABNORM PSYCHOL, V118, P683, DOI 10.1037/a0016763; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Patrick H, 2004, PERS SOC PSYCHOL B, V30, P501, DOI 10.1177/0146167203261891; Payne B.K., 2012, SAGE HDB SOCIAL COGN, P12, DOI [10.4135/9781446247631, DOI 10.4135/9781446247631.N2, 10.4135/9781446247631.n2]; Peirce JW, 2009, FRONT NEUROINFORM, V2, DOI 10.3389/neuro.11.010.2008; Rice K, 2016, BODY IMAGE, V19, P142, DOI 10.1016/j.bodyim.2016.09.005; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Selimbegovic L, 2015, BODY IMAGE, V12, P1, DOI 10.1016/j.bodyim.2014.08.012; Thompson JK, 2004, INT J EAT DISORDER, V35, P293, DOI 10.1002/eat.10257; Thompson JK, 2001, CURR DIR PSYCHOL SCI, V10, P181, DOI 10.1111/1467-8721.00144; Tiggemann M, 2017, BODY IMAGE, V21, P107, DOI 10.1016/j.bodyim.2017.04.001; Tiggemann M, 2010, PSYCHOL WOMEN QUART, V34, P356, DOI 10.1111/j.1471-6402.2010.01581.x; Tiggemann M, 2009, J SOC CLIN PSYCHOL, V28, P73, DOI 10.1521/jscp.2009.28.1.73; Want SC, 2017, BODY IMAGE, V20, P1, DOI 10.1016/j.bodyim.2016.10.009; Want SC, 2015, SEX ROLES, V73, P519, DOI 10.1007/s11199-015-0538-1; Want SC, 2009, BODY IMAGE, V6, P257, DOI 10.1016/j.bodyim.2009.07.008	43	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193200	10.1371/journal.pone.0193200	http://dx.doi.org/10.1371/journal.pone.0193200			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590125	Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100017
J	Janzen, C; Lei, MYY; Jeong, SD; Ganguly, A; Sullivan, P; Paharkova, V; Capodanno, G; Nakamura, H; Perry, A; Shin, BC; Lee, KW; Devaskar, SU				Janzen, Carla; Lei, Margarida Y. Y.; Jeong, Seok D.; Ganguly, Amit; Sullivan, Peggy; Paharkova, Vladislava; Capodanno, Gina; Nakamura, Hiromi; Perry, Alix; Shin, Bo-Chul; Lee, Kuk-Wha; Devaskar, Sherin U.			Humanin (HN) and glucose transporter 8 (GLUT8) in pregnancies complicated by intrauterine growth restriction	PLOS ONE			English	Article							OXIDATIVE STRESS; 1ST TRIMESTER; PLACENTAL DEVELOPMENT; SKELETAL-MUSCLES; PEPTIDE HUMANIN; CELL-DEATH; EXPRESSION; APOPTOSIS; ONSET; LOCALIZATION	Background Intrauterine growth restriction (IUGR) results from a lack of nutrients transferred to the developing fetus, particularly oxygen and glucose. Increased expression of the cytoprotective mitochondrial peptide, humanin (HN), and the glucose transporter 8, GLUT8, has been reported under conditions of hypoxic stress. However, the presence and cellular localization of HN and GLUT8 in IUGR-related placental pathology remain unexplored. Thus, we undertook this study to investigate placental expression of HN and GLUT8 in IUGR-affected versus normal pregnancies. Results We found 1) increased HN expression in human IUGR-affected pregnancies on the maternal aspect of the placenta (extravillous trophoblastic (EVT) cytoplasm) compared to control (i.e. appropriate for gestational age) pregnancies, and a concomitant increase in GLUT8 expression in the same compartment, 2) HN and GLUT8 showed a protein-protein interaction by co-immunoprecipitation, 3) elevated HN and GLUT8 levels in vitro under simulated hypoxia in human EVT cells, HTR8/SVneo, and 4) increased HN expression but attenuated GLUT8 expression in vitro under serum deprivation in HTR8/SVneo cells. Conclusions There was elevated HN expression with cytoplasmic localization to EVTs on the maternal aspect of the human placenta affected by IUGR, also associated with increased GLUT8 expression. We found that while hypoxia increased both HN and GLUT8, serum deprivation increased HN expression alone. Also, a protein -protein interaction between HN and GLUT8 suggests that their interaction may fulfill a biologic role that requires interdependency. Future investigations delineating molecular interactions between these proteins are required to fully uncover their role in IUGR-affected pregnancies.	[Janzen, Carla; Lei, Margarida Y. Y.; Perry, Alix] UCLA, David Geffen Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Los Angeles, CA 90095 USA; [Jeong, Seok D.; Paharkova, Vladislava; Capodanno, Gina; Nakamura, Hiromi; Lee, Kuk-Wha] UCLA, David Geffen Sch Med, Dept Pediat, Div Endocrinol, Los Angeles, CA 90095 USA; [Jeong, Seok D.; Ganguly, Amit; Paharkova, Vladislava; Capodanno, Gina; Nakamura, Hiromi; Shin, Bo-Chul; Lee, Kuk-Wha; Devaskar, Sherin U.] UCLA, David Geffen Sch Med, Neonatal Res Ctr, UCLA Childrens Discovery & Innovat Inst, Los Angeles, CA 90095 USA; [Ganguly, Amit; Shin, Bo-Chul; Devaskar, Sherin U.] UCLA, David Geffen Sch Med, Dept Pediat, Div Neonatol, Los Angeles, CA 90095 USA; [Sullivan, Peggy] UCLA, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Janzen, C (corresponding author), UCLA, David Geffen Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Los Angeles, CA 90095 USA.	CJanzen@mednet.ucla.edu	Jeong, Il Seok/AAN-5361-2020	Jeong, Il Seok/0000-0001-5465-6185; Shin, Bo-Chul/0000-0002-7569-5121	National Institutes of Health (NIH) [HD-041230, HD-081206, HD-089714, U01-HD-08722]; UCLA Undergraduate Research Center: URFP; URSP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD089714] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Undergraduate Research Center: URFP; URSP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institutes of Health (NIH): HD-041230 (SD), HD-081206 (SD), HD-089714 (SD), U01-HD-08722 (SD, CJ), https://www.nih.gov/; and UCLA Undergraduate Research Center: URFP (IJ) and URSP (IJ), http://www.ugresearchsci.ucla.edu/default.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adastra KL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.097675; Bachar AR, 2010, CARDIOVASC RES, V88, P360, DOI 10.1093/cvr/cvq191; Biri A, 2007, GYNECOL OBSTET INVES, V64, P187, DOI 10.1159/000106488; Bodzioch M, 2009, GENOMICS, V94, P247, DOI 10.1016/j.ygeno.2009.05.006; Boulet SL, 2006, AM J OBSTET GYNECOL, V195, P1571, DOI 10.1016/j.ajog.2006.03.069; Brown K, 2011, PLACENTA, V32, P1041, DOI 10.1016/j.placenta.2011.09.014; Burton GJ, 2011, BEST PRACT RES CL OB, V25, P287, DOI 10.1016/j.bpobgyn.2010.10.016; Caniggia I, 2000, PLACENTA, V21, pS25, DOI 10.1053/plac.1999.0522; Carayannopoulos MO, 2000, P NATL ACAD SCI USA, V97, P7313, DOI 10.1073/pnas.97.13.7313; Chen PY, 2013, PHYSIOL GENOMICS, V45, P565, DOI 10.1152/physiolgenomics.00034.2013; Chen XP, 2012, NEURAL REGEN RES, V7, P376, DOI 10.3969/j.issn.1673-5374.2012.05.009; Colon E, 2006, J CELL PHYSIOL, V208, P373, DOI 10.1002/jcp.20672; Dennery PA, 2010, FREE RADICAL BIO MED, V49, P1147, DOI 10.1016/j.freeradbiomed.2010.07.011; DEVASKAR SU, 1992, PEDIATR RES, V31, P1, DOI 10.1203/00006450-199201000-00001; Diril MK, 2009, FEBS J, V276, P4153, DOI 10.1111/j.1742-4658.2009.07089.x; Doege H, 2000, J BIOL CHEM, V275, P16275, DOI 10.1074/jbc.275.21.16275; Ericsson A, 2005, HUM REPROD, V20, P521, DOI 10.1093/humrep/deh596; Gawlik V, 2008, MOL MEMBR BIOL, V25, P224, DOI 10.1080/09687680701855405; Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669; Gidlund EK, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.13063; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Griendling KK, 2003, CIRCULATION, V108, P1912, DOI 10.1161/01.CIR.0000093660.86242.BB; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Hashimoto Y, 2001, J NEUROSCI, V21, P9235, DOI 10.1523/JNEUROSCI.21-23-09235.2001; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; HaugueldeMouzon S, 1997, J CLIN ENDOCR METAB, V82, P2689, DOI 10.1210/jc.82.8.2689; Herrera EA, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00149; Hoang PT, 2010, METABOLISM, V59, P343, DOI 10.1016/j.metabol.2009.08.001; Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100; Janzen C, 2013, PLACENTA, V34, P1072, DOI 10.1016/j.placenta.2013.08.010; Kariya S, 2005, ACTA NEUROPATHOL, V109, P367, DOI 10.1007/s00401-004-0965-5; KAYANO T, 1988, J BIOL CHEM, V263, P15245; Kin T, 2006, J HUM GENET, V51, P555, DOI 10.1007/s10038-006-0397-2; Klein LE, 2013, BIOCHEM BIOPH RES CO, V440, P197, DOI 10.1016/j.bbrc.2013.08.055; Limesand SW, 2004, PLACENTA, V25, P70, DOI 10.1016/j.placenta.2003.08.012; Muzumdar RH, 2010, ARTERIOSCL THROM VAS, V30, P1940, DOI 10.1161/ATVBAHA.110.205997; Niikura T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016259; Nikolakopoulos P, 2017, J MATERN-FETAL NEO M, V9, P1; Paharkova V, 2015, MOL CELL ENDOCRINOL, V413, P96, DOI 10.1016/j.mce.2015.06.015; Rajakumar A, 2007, AM J PHYSIOL-REG I, V293, pR766, DOI 10.1152/ajpregu.00097.2007; Rosen P, 2001, DIABETES-METAB RES, V17, P189, DOI 10.1002/dmrr.196; Saleem T, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-41; Sankar R, 2002, MOL BRAIN RES, V107, P157, DOI 10.1016/S0169-328X(02)00487-4; Schmidt S, 2009, AM J PHYSIOL-ENDOC M, V296, pE614, DOI 10.1152/ajpendo.91019.2008; Shao Y, 2014, AM J PHYSIOL-REG I, V307, pR237, DOI 10.1152/ajpregu.00093.2014; Shin BC, 2004, J NEUROSCI RES, V75, P835, DOI 10.1002/jnr.20054; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Tajima H, 2002, NEUROSCI LETT, V324, P227, DOI 10.1016/S0304-3940(02)00199-4; TAKATA K, 1990, BIOCHEM BIOPH RES CO, V173, P67, DOI 10.1016/S0006-291X(05)81022-8; Tarry-Adkins JL, 2010, FASEB J, V24, P2762, DOI 10.1096/fj.10-156075; Thamotharan M, 2005, AM J PHYSIOL-ENDOC M, V288, pE935, DOI 10.1152/ajpendo.00342.2004; Voigt A, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12796; Wright JD, 2013, OBSTET GYNECOL, V121, P1217, DOI [10.1097/AOG.0b013e31828ec686, 10.1097/01.AOG.0000429658.85846.f9]; Xie Y, 2014, DIABETES RES CLIN PR, V106, P560, DOI 10.1016/j.diabres.2014.09.020; Xu XS, 2006, STROKE, V37, P2613, DOI 10.1161/01.STR.0000242772.94277.1f; Yamanaka-Tatematsu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076605; Yen K, 2013, J MOL ENDOCRINOL, V50, pR11, DOI 10.1530/JME-12-0203; Zhang X, 2012, LIFE SCI, V91, P199, DOI 10.1016/j.lfs.2012.07.010	58	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193583	10.1371/journal.pone.0193583	http://dx.doi.org/10.1371/journal.pone.0193583			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590129	Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100024
J	Liang, HB; Yang, RH; Liu, Z; Li, M; Liu, HT; Jin, X				Liang, Huabin; Yang, Ruoheng; Liu, Zhihua; Li, Min; Liu, Haitao; Jin, Xia			Recombinant Zika virus envelope protein elicited protective immunity against Zika virus in immunocompetent mice	PLOS ONE			English	Article							WEST-NILE-VIRUS; DENGUE VIRUS; MOUSE MODEL; SEXUAL TRANSMISSION; DOMAIN-III; VACCINE; EFFICACY; IMMUNOGENICITY; ANTIBODIES; INFECTION	Zika virus (ZIKV) has caused great public concerns due to its recent large outbreaks and a close association with microcephaly in fetus and Guillain-Barre syndrome in adults. Rapid development of vaccines against ZIKV is a public health priority. To this end, we have constructed and purified recombinant ZIKV envelope protein using both prokaryotic and eukaryotic expression systems, and then tested their immunogenicity and protective efficacy in immune competent mice. Both protein immunogens elicited humoral and cellular immune responses, and protected immune competent mice from ZIKV challenge in vivo. These products could be further evaluated either as stand-alone vaccine candidate, or used in a prime-and-boost regimen with other forms of ZIKV vaccine.	[Liang, Huabin; Yang, Ruoheng; Liu, Zhihua; Li, Min; Liu, Haitao; Jin, Xia] Chinese Acad Sci, Inst Pasteur Shanghai, Viral Dis & Vaccine Translat Res Unit, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Liang, Huabin; Yang, Ruoheng; Liu, Zhihua; Li, Min; Jin, Xia] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Jin, X (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Viral Dis & Vaccine Translat Res Unit, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.; Jin, X (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	xjin@ips.a.c.cn		liu, zhihua/0000-0002-8959-2350	National Key Program Project Grant from the Ministry of Science and Technology China [2016YFC1201000]; National Science Foundation of China [31670941]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDPB030405]	National Key Program Project Grant from the Ministry of Science and Technology China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported in part by a National Key Program Project Grant from the Ministry of Science and Technology China (2016YFC1201000)(http://www.most.gov.cn/), a National Science Foundation of China grant (31670941)(http://www.nsfc.gov.cn/), and The Strategic Priority Research Program of the Chinese Academy of Sciences (XDPB030405)(http://www.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157; Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Caufour PS, 2001, VIRUS RES, V79, P1, DOI 10.1016/S0168-1702(01)00273-8; Chambers TJ, 2003, J VIROL, V77, P3655, DOI 10.1128/JVI.77.6.3655-3668.2003; D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449; Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300; Goo L, 2018, VIROLOGY, V515, P191, DOI 10.1016/j.virol.2017.12.032; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004; Han JF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10595-5; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028; Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Li DP, 2016, J VIROL, V90, P10486, DOI 10.1128/JVI.01462-16; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21; Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206; Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428; Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184; Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042; Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040; Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017; Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564; Shan C., 2017, NAT MED; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296; SRIVASTAVA AK, 1995, VACCINE, V13, P1251, DOI 10.1016/0264-410X(94)00059-V; Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375; Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002; Tebas P, 2017, N ENGL J MED; Vogel G, 2016, SCIENCE, V354, P1088, DOI 10.1126/science.354.6316.1088; Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336; Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36; Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X; Yang M, 2017, VACCINE; Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052; Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020; Zhao H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086573; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6	62	27	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194860	10.1371/journal.pone.0194860	http://dx.doi.org/10.1371/journal.pone.0194860			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590178	Green Submitted, Green Published, gold			2022-12-26	WOS:000428603100081
J	Lichtenstein, G; Perlman, A; Shpitzen, S; Durst, R; Shaham, D; Leitersdorf, E; Szalat, A				Lichtenstein, Gabriel; Perlman, Amichai; Shpitzen, Shoshana; Durst, Ronen; Shaham, Dorit; Leitersdorf, Eran; Szalat, Auryan			Correlation between coronary artery calcification by non-cardiac CT and Framingham score in young patients	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; ALL-CAUSE MORTALITY; HEART-DISEASE; RISK-FACTORS; CARDIOVASCULAR-DISEASE; PROGNOSTIC VALUE; LUNG-CANCER; FOLLOW-UP; CALCIUM; PREDICTION	Background Previous studies have established a correlation between coronary artery calcification (CAC) measured by ECG-gated chest computed tomography (CT) and cardiovascular disease. Recent reports which included asymptomatic patients suggest that CAC measured on non ECG gated CT is similarly associated with cardiovascular risk. This study investigates the correlation between the Framingham Risk Score (FRS) and an incidental finding of CAC on a non-gated chest CT performed for non-cardiac indications in young and seemingly healthy adults. Methods A cross-sectional study that included 162 CT scans performed in young patients aged 1850 years old for non-cardiac indications in our institution was conducted. CAC score (CACS) was calculated using the Agatston method. FRS was calculated and compared to the CACS using three different approaches. The correlations between the CACS and several specific factors (i.e. age, body mass index, smoking, statins, etc.), were also evaluated. Results Mean age of patients was 36.43 year old and 105 (64.8%) were male. We found a significant positive correlation between the CACS and the FRS in all three approaches (p<0.05). Increased age, smoking and statin use were the only individual factors clearly associated with an increase in CACS (p = 0.002, p = 0.045 and p = 0.009, respectively). Conclusion This is the first report indicating that incidental CACS identified in non-gated MDCT is also associated with cardiovascular risk evaluated by FRS in a young population. Our findings suggest that young asymptomatic individuals with incidental CAC should be seriously evaluated for cardiovascular risk factors despite presumption of belonging to a low cardiovascular risk category.	[Lichtenstein, Gabriel; Shpitzen, Shoshana; Durst, Ronen; Leitersdorf, Eran; Szalat, Auryan] Hadassah Hebrew Univ, Med Ctr, Ctr Res Prevent & Treatment Atherosclerosis, Jerusalem, Israel; [Perlman, Amichai; Leitersdorf, Eran; Szalat, Auryan] Hadassah Hebrew Univ, Med Ctr, Internal Med Ward, Jerusalem, Israel; [Durst, Ronen] Hadassah Hebrew Univ, Med Ctr, Heart Inst, Jerusalem, Israel; [Shaham, Dorit] Hadassah Hebrew Univ, Med Ctr, Med Imaging Dept, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Szalat, A (corresponding author), Hadassah Hebrew Univ, Med Ctr, Ctr Res Prevent & Treatment Atherosclerosis, Jerusalem, Israel.; Szalat, A (corresponding author), Hadassah Hebrew Univ, Med Ctr, Internal Med Ward, Jerusalem, Israel.	auryans@hadassah.org.il	Perlman, Amichai/I-9496-2018; Perlman, Amichai/AFV-3884-2022	Perlman, Amichai/0000-0001-6034-7995; Perlman, Amichai/0000-0001-6034-7995; Durst, Ronen/0000-0003-3559-1050	Israel Atherosclerosis Association	Israel Atherosclerosis Association	This study was supported by a grant given by the Israel Atherosclerosis Association and attributed to AS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Allan GM, 2014, CURR OPIN LIPIDOL, V25, P254, DOI 10.1097/MOL.0000000000000095; Arad Y, 2005, J AM COLL CARDIOL, V46, P158, DOI 10.1016/j.jacc.2005.02.088; Arad Y, 2000, J AM COLL CARDIOL, V36, P1253, DOI 10.1016/S0735-1097(00)00872-X; Arad Y, 1996, CIRCULATION, V93, P1951, DOI 10.1161/01.CIR.93.11.1951; Azour L, 2017, J CARDIOVASC COMPUT, V11, P8, DOI 10.1016/j.jcct.2016.10.001; Bielak LF, 2000, CIRCULATION, V102, P380; Bielak LF, 2004, J HYPERTENS, V22, P719, DOI 10.1097/00004872-200404000-00014; Budoff MJ, 2007, J AM COLL CARDIOL, V49, P1860, DOI 10.1016/j.jacc.2006.10.079; Budoff MJ, 2013, J AM COLL CARDIOL, V61, P1231, DOI 10.1016/j.jacc.2012.12.035; Cassidy AE, 2005, CIRCULATION, V111, P1877, DOI 10.1161/01.CIR.0000161820.40494.5D; Detrano RC, 2005, RADIOLOGY, V236, P477, DOI 10.1148/radiol.2362040513; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Jacobs PC, 2012, AM J ROENTGENOL, V198, P505, DOI 10.2214/AJR.10.5577; Joergensen C, 2012, DIABETES CARE, V35, P168, DOI 10.2337/dc11-1372; Kirsch J, 2016, INT J CARDIOVASC IMA; Kirsch J, 2012, INT J CARDIOVAS IMAG, V28, P1249, DOI 10.1007/s10554-011-9928-9; Kondos GT, 2003, CIRCULATION, V107, P2571, DOI 10.1161/01.CIR.0000068341.61180.55; Lim S, 2012, J CLIN ENDOCR METAB, V97, P169, DOI 10.1210/jc.2011-1580; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Loria CM, 2007, J AM COLL CARDIOL, V49, P2013, DOI 10.1016/j.jacc.2007.03.009; Mahoney LT, 1996, J AM COLL CARDIOL, V27, P277, DOI 10.1016/0735-1097(95)00461-0; Mayer B, 2007, J HYPERTENS, V25, P1731, DOI 10.1097/HJH.0b013e328165cbb6; Nasir K, 2005, J AM COLL CARDIOL, V46, P1931, DOI 10.1016/j.jacc.2005.07.052; Paixao ARM, 2015, JACC-CARDIOVASC IMAG, V8, P1285, DOI 10.1016/j.jcmg.2015.06.015; Puri R, 2015, J AM COLL CARDIOL, V65, P1273, DOI 10.1016/j.jacc.2015.01.036; Shao L, 2017, J CARDIOVASC COMPUT, V11, P196, DOI 10.1016/j.jcct.2017.03.004; Shaw LJ, 2003, RADIOLOGY, V228, P826, DOI 10.1148/radiol.2283021006; Shemesh J, 2010, RADIOLOGY, V257, P541, DOI 10.1148/radiol.10100383; Taylor AJ, 2005, J AM COLL CARDIOL, V46, P807, DOI 10.1016/j.jacc.2005.05.049; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wu MT, 2008, AM J ROENTGENOL, V190, P923, DOI 10.2214/AJR.07.2974; Young KA, 2011, DIABETES CARE, V34, P454, DOI 10.2337/dc10-0757; Zondervan RL, 2013, RADIOLOGY, V267, P460, DOI 10.1148/radiol.12121324	34	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0195061	10.1371/journal.pone.0195061	http://dx.doi.org/10.1371/journal.pone.0195061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590197	Green Published, gold, Green Submitted			2022-12-26	WOS:000428603100101
J	Sallard, E; Mouthon, M; De Pretto, M; Spierer, L				Sallard, Etienne; Mouthon, Michael; De Pretto, Michael; Spierer, Lucas			Modulation of inhibitory control by prefrontal anodal tDCS: A crossover double-blind sham-controlled fMRI study	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; STOP-SIGNAL TASK; RESPONSE-INHIBITION; PARIETAL CORTEX; FRONTAL-CORTEX; MOTOR CORTEX; PERFORMANCE; CONFLICT; CONNECTIVITY; SERIES	Prefrontal anodal transcranial direct current stimulation (tDCS) has been proposed as a potential approach to improve inhibitory control performance. The functional consequences of tDCS during inhibition tasks remain, however, largely unresolved. We addressed this question by analyzing functional magnetic resonance imaging (fMRI) recorded while participants completed a Go/NoGo task after right-lateralized prefrontal anodal tDCS with a crossover, sham-controlled, double-blind experimental design. We replicated previous evidence for an absence of offline effect of anodal stimulation on Go/NoGo performance. The fMRI results revealed a larger increase in right ventrolateral prefrontal activity for Go than NoGo trials in the anodal than sham condition. This pattern suggests that tDCS-induced increases in cortical excitability have larger effects on fMRI activity in regions with a lower task-related engagement. This was the case for the right prefrontal cortex in the Go condition in our task because while reactive inhibition was not engaged during execution trials, the unpredictability of the demand for inhibitory control still incited an engagement of proactive inhibition. Exploratory analyses further revealed that right prefrontal stimulation interacted with task related functional demands in the supplementary motor area and the thalamus. Our collective results emphasize the dependency of offline tDCS functional effects on the task-related engagement of the stimulated areas and suggest that this factor might partly account for the discrepancies in the functional effects of tDCS observed in previous studies.	[Sallard, Etienne; Mouthon, Michael; De Pretto, Michael; Spierer, Lucas] Univ Fribourg, Neurol Unit, Dept Med, Fac Sci, Fribourg, Switzerland	University of Fribourg	Sallard, E; Spierer, L (corresponding author), Univ Fribourg, Neurol Unit, Dept Med, Fac Sci, Fribourg, Switzerland.	etienne.sallard@gmail.com; lucas.spierer@unifr.ch	De Pretto, Michael/ABO-0995-2022; Spierer, Lucas/E-1771-2011	De Pretto, Michael/0000-0003-4176-4798; Spierer, Lucas/0000-0003-3558-4408; Mouthon, Michael/0000-0002-2557-4102	Swiss National Science Foundation [32003B_156854, 316030_144998, 320030_175469, P2LAP3-158917]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grants from the Swiss National Science Foundation www.snf.ch/ [Grants #32003B_156854, #316030_144998 and #320030_175469 to LS and #P2LAP3-158917 to ES]. We thank Dr Camille Chavan, Julia Pichard and Fabio Roveri for their help with data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal A, 2011, NEUROIMAGE, V55, P590, DOI 10.1016/j.neuroimage.2010.11.085; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Aron AR, 2003, BRAIN, V126, P713, DOI 10.1093/brain/awg067; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Beeli G, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-33; Cai Y, 2016, J COGNITIVE NEUROSCI, V28, P177, DOI 10.1162/jocn_a_00888; Campanella S, 2016, CLIN EEG NEUROSCI; Campanella S, 2017, CLIN EEG NEUROSCI, V48, P176, DOI 10.1177/1550059416645977; Castro-Meneses LJ, 2016, EXP BRAIN RES, V234, P185, DOI 10.1007/s00221-015-4452-0; Chavan CF, 2015, HUM BRAIN MAPP, V36, P2527, DOI 10.1002/hbm.22789; Chevrier AD, 2007, HUM BRAIN MAPP, V28, P1347, DOI 10.1002/hbm.20355; Conley AC, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00384; Conley AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124509; Cunillera T, 2016, NEUROIMAGE, V140, P66, DOI 10.1016/j.neuroimage.2015.11.044; Cunillera T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113537; Cunnington R, 2002, NEUROIMAGE, V15, P373, DOI 10.1006/nimg.2001.0976; de Lara Gabriel A, 2017, Front Neurosci, V11, P452, DOI 10.3389/fnins.2017.00452; De Pretto M, 2016, EUR J NEUROSCI, V44, P1826, DOI 10.1111/ejn.13265; Deiber MP, 1996, J NEUROPHYSIOL, V75, P233, DOI 10.1152/jn.1996.75.1.233; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Ditye T, 2012, EXP BRAIN RES, V219, P363, DOI 10.1007/s00221-012-3098-4; Enriquez-Geppert S, 2010, NEUROIMAGE, V51, P877, DOI 10.1016/j.neuroimage.2010.02.043; Friston KJ, 2007, NEUROIMAGE, V34, P220, DOI 10.1016/j.neuroimage.2006.08.035; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Geuzaine C, 2009, INT J NUMER METH ENG, V79, P1309, DOI 10.1002/nme.2579; Grezes J, 2002, NEUROPSYCHOLOGIA, V40, P212, DOI 10.1016/S0028-3932(01)00089-6; Hogeveen J, 2016, BRAIN STIMUL, V9, P720, DOI 10.1016/j.brs.2016.04.015; Holland R, 2011, CURR BIOL, V21, P1403, DOI 10.1016/j.cub.2011.07.021; Horvath JC, 2015, NEUROPSYCHOLOGIA, V66, P213, DOI 10.1016/j.neuropsychologia.2014.11.021; Hsu TY, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00643; Hsu TY, 2014, NEUROIMAGE, V98, P306, DOI 10.1016/j.neuroimage.2014.04.069; Hsu TY, 2011, NEUROIMAGE, V56, P2249, DOI 10.1016/j.neuroimage.2011.03.059; Jacobson L, 2011, J COGNITIVE NEUROSCI, V23, P3380, DOI 10.1162/jocn_a_00020; Jahfari S, 2010, J COGNITIVE NEUROSCI, V22, P1479, DOI 10.1162/jocn.2009.21307; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Kwon YH, 2013, J PHYS THER SCI, V25, P1083, DOI 10.1589/jpts.25.1083; Kwon YH, 2013, NEURAL REGEN RES, V8, P1048, DOI 10.3969/j.issn.1673-5374.2013.11.011; Kwon YH, 2011, NEUROSCI LETT, V492, P105, DOI 10.1016/j.neulet.2011.01.066; Learmonth G, 2015, NEUROPSYCHOLOGIA, V74, P108, DOI 10.1016/j.neuropsychologia.2015.01.037; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Meinzer M, 2013, J NEUROSCI, V33, P12470, DOI 10.1523/JNEUROSCI.5743-12.2013; Meinzer M, 2012, J NEUROSCI, V32, P1859, DOI 10.1523/JNEUROSCI.4812-11.2012; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Oldenburg IA, 2015, NEURON, V86, P1174, DOI 10.1016/j.neuron.2015.05.008; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Rae CL, 2014, NEUROIMAGE, V86, P381, DOI 10.1016/j.neuroimage.2013.10.012; Roelofs A, 2012, Q J EXP PSYCHOL, V65, P135, DOI 10.1080/17470218.2011.605152; Spieler DH, 1996, J EXP PSYCHOL HUMAN, V22, P461, DOI 10.1037/0096-1523.22.2.461; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; Steinhauser M, 2009, J EXP PSYCHOL HUMAN, V35, P1398, DOI 10.1037/a0016467; Streitburger DP, 2014, NEUROIMAGE, V87, P170, DOI 10.1016/j.neuroimage.2013.10.051; Swick D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-102; Thielscher A, 2015, IEEE ENG MED BIO, P222, DOI 10.1109/EMBC.2015.7318340; Townsend JT, 1975, PHILOS ASPECTS MIND, P200; Townsend JT, 1979, COGNITIVE THEORY, V3, P200; Tseng P, 2012, J NEUROSCI, V32, P10554, DOI 10.1523/JNEUROSCI.0362-12.2012; Wiecki TV, 2013, PSYCHOL REV, V120, P329, DOI 10.1037/a0031542; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Worth A, 2014, EXPLORING NEUROANATO; Yu JX, 2015, HUM BRAIN MAPP, V36, P4004, DOI 10.1002/hbm.22893	65	13	13	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194936	10.1371/journal.pone.0194936	http://dx.doi.org/10.1371/journal.pone.0194936			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590181	Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100090
J	Yravedra, J; Aramendi, J; Mate-Gonzalez, MA; Courtenay, LA; Gonzalez-Aguilera, D				Yravedra, Jose; Aramendi, Julia; Angel Mate-Gonzalez, Miguel; Austin Courtenay, Lloyd; Gonzalez-Aguilera, Diego			Differentiating percussion pits and carnivore tooth pits using 3D reconstructions and geometric morphometrics	PLOS ONE			English	Article							3.3-MILLION-YEAR-OLD STONE TOOLS; FLK 22 ZINJANTHROPUS; OLDUVAI GORGE; HAMMERSTONE PERCUSSION; LONG BONES; CUT MARKS; HOMINID; SITE; PATTERNS; SURFACES	During the end of the 20th century and the beginning of the 21st century the discussion on early human behavioral patterns revolved around the hunting versus scavenging debate. The correct identification of bone modifications, including percussion, cut and tooth marks, is a key issue within this debate. While many authors have shown that carnivore and human modifications can be easily distinguished, it is true that sometimes percussion marks without associated microstriations and tooth pits overlap morphologically, causing confusion, especially when unmodified hammerstones are used. In order to solve this equifinality problem, many investigations have focused their efforts on other pieces of evidence such as the identification of notches, fragmentation patterns and frequencies, among others. These studies, however, cannot be considered as fully conclusive. Within this paper we address the problem of equifinality when identifying percussion marks produced with unmodified hammer stones and tooth pits created by carnivores using new methodologies based on the 3D reconstruction of marks and their statistical multivariate analysis. For the purpose of this study a total of 128 marks 39 percussion marks produced with an unmodified quartzite hammerstone, and 89 pits generated by different carnivores were virtually modelled with the aid of a DAVID structured-light scanner SLS-2 and later analyzed by means of geometric morphometrics. Our results show that percussion marks not associated with striae fields and the pits generated by the carnivores studied here can be successfully distinguished.	[Yravedra, Jose; Aramendi, Julia; Austin Courtenay, Lloyd] Univ Complutense Madrid, Dept Prehist, Prof Aranguren S-N, Madrid, Spain; [Yravedra, Jose; Aramendi, Julia] Origins Museum, IDEA Inst Evolut Africa, Plaza San Andres 2, Madrid, Spain; [Angel Mate-Gonzalez, Miguel; Gonzalez-Aguilera, Diego] Univ Salamanca, Higher Polytech Sch Avila, Dept Cartog & Land Engn, Hornos Caleros 50, Avila, Spain; [Angel Mate-Gonzalez, Miguel] Univ Complutense Madrid, CAI Arqueometry & Archaeol Anal, Prof Aranguren S-N, Madrid, Spain	Complutense University of Madrid; University of Salamanca; Complutense University of Madrid	Gonzalez-Aguilera, D (corresponding author), Univ Salamanca, Higher Polytech Sch Avila, Dept Cartog & Land Engn, Hornos Caleros 50, Avila, Spain.	daguilera@usal.es	Maté-González, Miguel Ángel/I-4466-2017; Aramendi, Julia/ABC-2702-2021; Yravedra, Jose/E-9815-2016; Yravedra, Jose/AAC-2073-2019	Maté-González, Miguel Ángel/0000-0001-5721-346X; Yravedra, Jose/0000-0002-4323-3379; Aramendi, Julia/0000-0003-3725-3776; Courtenay, Lloyd/0000-0002-4810-2001; Gonzalez-Aguilera, Diego/0000-0002-8949-4216				Alcantara-Garcia V, 2006, TRABAJOS PREHISTORIA; Andres M, 2012, ARCHAEOL ANTHROP SCI, V4, P209, DOI 10.1007/s12520-012-0093-4; Mate-Gonzalez MA, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9090873; Aramendi J, 2017, DISCERNING CARNIVORE; Arriaza MC, 2017, APPL MICROPHOTOGRAMM, V3; BEHRENSMEYER AK, 1986, NATURE, V319, P768, DOI 10.1038/319768a0; Bello SM, 2008, J ARCHAEOL SCI, V35, P1542, DOI 10.1016/j.jas.2007.10.018; Bello SM, 2011, DEV QUATER SCI, V14, P249; Bello SM, 2009, J ARCHAEOL SCI, V36, P1869, DOI 10.1016/j.jas.2009.04.014; Binford L.R., 1981, BONES ANCIENT MEN MO; Blumenschine R, 1986, BAR INT SERIES, V283; Blumenschine R.j., 1991, CULTURAL BEGINNINGS, P17; Blumenschine R. J., 1994, J HUM EVOL, V27, P94; BLUMENSCHINE RJ, 1988, NATURE, V333, P763, DOI 10.1038/333763a0; BLUMENSCHINE RJ, 1995, J HUM EVOL, V29, P21, DOI 10.1006/jhev.1995.1046; Blumenschine RJ, 1996, J ARCHAEOL SCI, V23, P493, DOI 10.1006/jasc.1996.0047; Bookstein F., 1991, TYPES LANDMARKS MORP, P63; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; BRAIN C. K, 1981, HUNTERS HUNTED INTRO; Bunn H, 1982, MEAT EATING HUMAN EV; Cadee GC, 1990, PROCESSES FOSSILIZAT, P3; Capaldo SD, 1997, J HUM EVOL, V33, P555, DOI 10.1006/jhev.1997.0150; CAPALDO SD, 1994, AM ANTIQUITY, V59, P724, DOI 10.2307/282345; CAVALLO JA, 1989, J HUM EVOL, V18, P393, DOI 10.1016/0047-2484(89)90038-9; Coilm R, 2017, ARCHEOMETRY; Core Team R, 2015, LANG ENV STAT COMP; De Juana S, 2011, ARCHAEOMETRY, V53, P996, DOI 10.1111/j.1475-4754.2010.00576.x; Dominguez-Rodrigo M, 1997, J HUM EVOL, V33, P669, DOI 10.1006/jhev.1997.0161; Dominguez-Rodrigo M, 2006, J HUM EVOL, V50, P170, DOI 10.1016/j.jhevol.2005.09.005; Dominguez-Rodrigo M, 2007, VERTEBR PALEOBIOL PA, P1; Dominguez-Rodrigo M, 2003, J ARCHAEOL SCI, V30, P1385, DOI 10.1016/S0305-4403(03)00027-X; Dominguez-Rodrigo M, 2010, QUATERNARY RES, V74, P363, DOI 10.1016/j.yqres.2010.07.004; Dominguez-Rodrigo M, 2009, J ARCHAEOL SCI, V36, P2643, DOI 10.1016/j.jas.2009.07.017; Dominguez-Rodrigo M, 2016, PALEOANTHROPOLOGY, V2016, P46, DOI DOI 10.4207/PA.2016.ART99; Dominguez-Rodrigo M, 2015, J ARCHAEOL SCI, V59, P35, DOI 10.1016/j.jas.2015.04.007; Dominguez-Rodrigo Manuel, 2012, Journal of Taphonomy, V10, P147; Dominguez-Rodrigo M, 2011, P NATL ACAD SCI USA, V108, pE117, DOI 10.1073/pnas.1104647108; Efremov LA, 1940, AM GEOL, V74, P81; Palomeque-Gonzalez JF, 2017, J ARCHAEOL SCI-REP, V13, P60, DOI 10.1016/j.jasrep.2017.03.033; Galan AB, 2009, J ARCHAEOL SCI, V36, P776, DOI 10.1016/j.jas.2008.11.003; Gidna A, 2013, J ARCHAEOL SCI, V40, P1903, DOI 10.1016/j.jas.2012.11.023; Hall BK, 2003, BIOL REV, V78, P409, DOI 10.1017/S1464793102006097; Harmand S, 2015, NATURE, V521, P310, DOI 10.1038/nature14464; Klingenberg CP, 2008, EVOL BIOL, V35, P186, DOI 10.1007/s11692-008-9029-4; Klingenberg CP, 2005, SYST BIOL, V54, P678, DOI 10.1080/10635150590947258; Lupo KD, 2002, J ARCHAEOL SCI, V29, P85, DOI 10.1006/jasc.2001.0690; MAREAN CW, 1992, J ARCHAEOL SCI, V19, P101, DOI 10.1016/0305-4403(92)90009-R; Mate-Gonzalez MA, 2016, ARCHAEOL ANTHR SCIM; McPherron SP, 2011, P NATL ACAD SCI USA, V108, pE116, DOI 10.1073/pnas.1101298108; McPherron SP, 2010, NATURE, V466, P857, DOI 10.1038/nature09248; Mitteroecker P, 2013, HYSTRIX, V24, P59, DOI 10.4404/hystrix-24.1-6369; O'Higgins P, 1998, J ANAT, V193, P251, DOI 10.1046/j.1469-7580.1998.19320251.x; O'Higgins P., 1988, CRITIC REV ANATOM SC, V1, P149; OLSEN SL, 1988, J ARCHAEOL SCI, V15, P535, DOI 10.1016/0305-4403(88)90081-7; Pickering TR, 2006, J ARCHAEOL SCI, V33, P459, DOI 10.1016/j.jas.2005.09.001; Pineda A, 2014, J ARCHAEOL SCI, V50, P84, DOI 10.1016/j.jas.2014.06.018; Richtsmeier JT, 2002, YEARB PHYS ANTHROPOL, V45, P63, DOI 10.1002/ajpa.10174; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; SELVAGGIO MM, 1994, J HUM EVOL, V27, P215, DOI 10.1006/jhev.1994.1043; Selvaggio MM, 2001, J ARCHAEOL SCI, V28, P465, DOI 10.1006/jasc.2000.0557; Semaw S, 2003, J HUM EVOL, V45, P169, DOI 10.1016/S0047-2484(03)00093-9; Shipman P., 1981, LIFE HIST FOSSIL INT; Slice DE, 2001, SYST BIOL, V50, P141, DOI 10.1080/10635150119110; Thompson JC, 2015, J HUM EVOL, V86, P112, DOI 10.1016/j.jhevol.2015.06.013; Timm NH, 2002, APPL MULTIVARIATE AN, DOI 10.1007/b98963; Yravedra J, 2014, ARCHAEOL ANTHROP SCI, V6, P113, DOI 10.1007/s12520-013-0164-1; Yravedra J, 2017, J ARCHAEOL SCI-REP, V14, P106, DOI 10.1016/j.jasrep.2017.05.043	68	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194324	10.1371/journal.pone.0194324	http://dx.doi.org/10.1371/journal.pone.0194324			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590164	gold, Green Published, Green Submitted			2022-12-26	WOS:000428603100056
J	Bivia-Roig, G; Lison, JF; Sanchez-Zuriaga, D				Bivia-Roig, Gemma; Francisco Lison, Juan; Sanchez-Zuriaga, Daniel			Changes in trunk posture and muscle responses in standing during pregnancy and postpartum	PLOS ONE			English	Article							LOW-BACK-PAIN; PELVIC GIRDLE PAIN; LOCATION; GRAVITY; MOTION; RELIABILITY; PREVALENCE; POSITION; SYSTEM; RANGE	The aim of this study was to analyze the position of the lumbopelvic region and the muscle activation of erector spinae and biceps femoris muscles in a group of pregnant women in the third trimester. The hypothesis was that pregnancy-related biomechanical and morphological changes modify the position of the lumbopelvic region and the activation of extensor muscles. The position of the lumbar spine and pelvis in the sagittal plane, and the EMG activity of the erector spinae and biceps femoris muscles, were recorded during standing in 34 nulliparous and 34 pregnant women in the third trimester, and also two months after birth in the group of pregnant women. No significant differences in the position of the lumbar spine or pelvis between the group of pregnant women and nulliparous or postpartum were observed. A significant increase was observed in the EMG activity of the erector spinae (4.6% vs 2.4% and 2.1% in the nulliparous group and postpartum respectively) and the biceps femoris (3.4% vs 1.2% and 1.4%) in pregnant women compared to the other two groups (p<0.01). We conclude that pregnant women in the third trimester show no alterations in lumbopelvic position compared to nulliparous and postpartum women. However, there is an increase of the EMG activity of the trunk extensors. These results indicate that the extensor muscles of the trunk show, in static positions, adaptive responses to the increase of anterior loads during pregnancy.	[Bivia-Roig, Gemma] Univ CEU Cardenal Herrera, Fac Hlth Sci, Dept Physiotherapy, Valencia, Spain; [Francisco Lison, Juan] Univ CEU Cardenal Herrera, Fac Hlth Sci, Dept Med, Valencia, Spain; [Sanchez-Zuriaga, Daniel] Univ Valencia, Fac Med, Dept Anat & Human Embryol, Valencia, Spain	Universidad CEU Cardenal Herrera; Universidad CEU Cardenal Herrera; University of Valencia	Sanchez-Zuriaga, D (corresponding author), Univ Valencia, Fac Med, Dept Anat & Human Embryol, Valencia, Spain.	daniel.sanchez@uv.es	Lisón, Juan Francisco/E-8387-2016; Biviá-roig, Gemma/AAA-4945-2020	Lisón, Juan Francisco/0000-0002-4983-4052; Biviá-roig, Gemma/0000-0001-7611-5347; Sanchez-Zuriaga, Daniel/0000-0001-7105-5744	Universitat de Valencia [UV-INV AE16-495476]; University CEU Gardenal Herrera	Universitat de Valencia; University CEU Gardenal Herrera	This work was supported by grants from the Universitat de Valencia (UV-INV AE16-495476; "Estudio de la funcion lumbopelvica para el tratamiento del dolor lumbar en el embarazo y la lactancia") and the University CEU Gardenal Herrera (convocatoria de Proyectos en Consolidacion CEU-Banco Santander 2017-2018). The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	ADAMS MA, 1990, J BONE JOINT SURG BR, V72, P266, DOI 10.1302/0301-620X.72B2.2138156; Bastiaanssen JM, 2005, EUR J OBSTET GYN R B, V120, P3, DOI 10.1016/j.ejogrb.2004.11.021; Betsch M, 2015, EUR SPINE J, V24, P1282, DOI 10.1007/s00586-014-3521-6; BIERINGSORENSEN F, 1984, SPINE, V9, P106, DOI 10.1097/00007632-198403000-00002; Bullock J E, 1987, Aust J Physiother, V33, P10, DOI 10.1016/S0004-9514(14)60580-8; Carlsoo S., 1961, STATIC MUSCLE LOAD D, V4, P193; Dankaerts W, 2004, J ELECTROMYOGR KINES, V14, P333, DOI 10.1016/j.jelekin.2003.07.001; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FLOYD WF, 1951, LANCET, V260, P133, DOI 10.1016/S0140-6736(51)91212-3; Franklin ME, 1998, J ORTHOP SPORT PHYS, V28, P133, DOI 10.2519/jospt.1998.28.3.133; Fries EC, 1943, AM J OBSTET GYNECOL, V46, P374, DOI 10.1016/S0002-9378(43)90431-4; Gilleard WL, 2002, ARCH PHYS MED REHAB, V83, P1739, DOI 10.1053/apmr.2002.36069; GLEESON PB, 1988, PHYS THER, V68, P1699, DOI 10.1093/ptj/68.11.1699; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Jensen RK, 1996, J BIOMECH, V29, P251, DOI 10.1016/0021-9290(95)00042-9; Jordan K, 2004, J RHEUMATOL, V31, P2207; Kim MH, 2013, J PHYS THER SCI, V25, P535, DOI 10.1589/jpts.25.535; Kippers V, 1985, Aust J Physiother, V31, P95, DOI 10.1016/S0004-9514(14)60627-9; KLAUSEN K, 1968, ACTA PHYSIOL SCAND, V72, P45, DOI 10.1111/j.1748-1716.1968.tb03824.x; Kovacs FM, 2012, SPINE, V37, P1516, DOI 10.1097/BRS.0b013e31824dcb74; MAYER TG, 1984, SPINE, V9, P588, DOI 10.1097/00007632-198409000-00009; MOORE K, 1990, CLIN BIOMECH, V5, P169, DOI 10.1016/0268-0033(90)90020-7; Neblett R, 2003, SPINE, V28, P1435, DOI 10.1097/00007632-200307010-00015; Okanishi N, 2012, ACTA OBSTET GYN SCAN, V91, P856, DOI 10.1111/j.1600-0412.2012.01400.x; Opala-Berdzik A, 2015, PLOS ONE, V8, P10; Opala-Berdzik A, 2010, J HUM KINET, V26, P5, DOI 10.2478/v10078-010-0042-1; OSTGAARD HC, 1993, SPINE, V18, P61; OTMAN AS, 1989, EUR J OBSTET GYN R B, V31, P155, DOI 10.1016/0028-2243(89)90176-7; PEARCY MJ, 1989, CLIN BIOMECH, V4, P73, DOI 10.1016/0268-0033(89)90042-9; Sanchez-Zuriaga D, 2016, J ELECTROMYOGR KINES, V28, P152, DOI 10.1016/j.jelekin.2016.04.007; Sanchez-Zuriaga D, 2015, J MANIP PHYSIOL THER, V38, P130, DOI 10.1016/j.jmpt.2014.11.002; Sihvonen T, 1998, ARCH PHYS MED REHAB, V79, P1210, DOI 10.1016/S0003-9993(98)90264-7; To WWK, 2003, ACTA OBSTET GYN SCAN, V82, P1086, DOI 10.1046/j.1600-0412.2003.00235.x; WALSH M, 1995, CLIN BIOMECH, V10, P222, DOI 10.1016/0268-0033(95)91402-Z; Wu WH, 2004, EUR SPINE J, V13, P575, DOI 10.1007/s00586-003-0615-y	35	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194853	10.1371/journal.pone.0194853	http://dx.doi.org/10.1371/journal.pone.0194853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584774	Green Published, Green Submitted, gold			2022-12-26	WOS:000428373000044
J	Cartmell, KB; Sterba, KR; Pickett, K; Zapka, J; Alberg, AJ; Sood, AJ; Esnaola, NF				Cartmell, Kathleen B.; Sterba, Katherine R.; Pickett, Kim; Zapka, Jane; Alberg, Anthony J.; Sood, Amit J.; Esnaola, Nestor F.			Availability of patient-centered cancer support services: A statewide survey of cancer centers	PLOS ONE			English	Article							PALLIATIVE CARE; UNITED-STATES; NAVIGATION; DISPARITIES; COMMISSION; PROGRAMS; SCIENCE; IMPACT	The Institute of Medicine recommended in their landmark report "From Cancer Patient to Cancer Survivor: Lost in Transition" that services to meet the needs of cancer patients should extend beyond physical health issues to include functional and psychosocial consequences of cancer. However, no systems exist in the US to support state-level data collection on availability of support services for cancer patients. Developing a mechanism to systematically collect these data and document service availability is essential for guiding comprehensive cancer control planning efforts. This study was carried out to develop a protocol for implementing a statewide survey of all Commission on Cancer (CoC) accredited cancer centers in South Carolina and to implement the survey to examine availability of patient support services within the state. We conducted a cross-sectional survey of CoC-certified cancer centers in South Carolina. An administrator at each center completed a survey on availability of five services: 1) patient navigation; 2) distress screening; 3) genetic risk assessment and counseling, 4) survivorship care planning; and 5) palliative care. Completed surveys were received from 16 of 17 eligible centers (94%). Of the 16 centers, 44% reported providing patient navigation; 31% reported conducting distress screening; and 44% reported providing genetic risk assessment and counseling. Over 85% of centers reported having an active palliative care program, palliative care providers and a hospice program, but fewer had palliative outpatient services (27%), palliative inpatient beds (50%) or inpatient consultation teams (31%). This was a small, yet systematic survey in one state. This study demonstrated a practical method for successfully monitoring statewide availability of cancer patient support services, including identifying service gaps.	[Cartmell, Kathleen B.; Pickett, Kim; Zapka, Jane] Med Univ South Carolina, Coll Nursing, Charleston, SC 29425 USA; [Cartmell, Kathleen B.; Sterba, Katherine R.; Zapka, Jane; Sood, Amit J.] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Sterba, Katherine R.; Zapka, Jane] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Alberg, Anthony J.] Univ South Carolina, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Esnaola, Nestor F.] Fox Chase Canc Ctr, Dept Surg, Philadelphia, PA 19111 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Fox Chase Cancer Center	Cartmell, KB (corresponding author), Med Univ South Carolina, Coll Nursing, Charleston, SC 29425 USA.; Cartmell, KB (corresponding author), Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA.	cartmelk@musc.edu		Sterba, Katherine/0000-0001-9780-8695; Cartmell, Kathleen/0000-0001-9324-1636	South Carolina Cancer Alliance	South Carolina Cancer Alliance	The project was funded by a grant from the South Carolina Cancer Alliance. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2014, CANC TREATM SURV FAC; American College of Surgeons, 2015, CANC PROGR STAND 201; American College of Surgeons Commission on Cancer, 2012, CANC PROGR STAND 201; [Anonymous], HLTH INF NAT TRENDS; Birken SA, 2014, J CANCER EDUC, V29, P689, DOI 10.1007/s13187-014-0628-8; Bruera E, 2010, J CLIN ONCOL, V28, P4013, DOI 10.1200/JCO.2010.29.5618; Davis MP, 2015, SUPPORT CARE CANCER, V23, P2677, DOI 10.1007/s00520-015-2630-z; Freeman H P, 1995, Cancer Pract, V3, P19; Freeman HP, 2006, J CANCER EDUC, V21, pS11, DOI 10.1207/s15430154jce2101s_4; Hedlund N, 2014, J PUBLIC HEALTH MAN, V20, pE15, DOI 10.1097/PHH.0b013e3182a505ec; Institute of Medicine (US) Committee on Psychosocial Services to Cancer Patients/Families in a Community Setting, 2008, CANC CARE WHOLE PATI; Kerr CW, 2014, J PAIN SYMPTOM MANAG, V48, P883, DOI 10.1016/j.jpainsymman.2014.02.003; Kirsch LJ, 2015, J CANCER SURVIV, V9, P80, DOI 10.1007/s11764-014-0391-1; Lazenby M, 2015, J ONCOL PRACT, V11, pE413, DOI 10.1200/JOP.2014.002816; Meade CD, 2014, J CANCER EDUC, V29, P449, DOI 10.1007/s13187-014-0640-z; Merport A, 2012, SUPPORT CARE CANCER, V20, P1579, DOI 10.1007/s00520-012-1458-z; Moser RP, 2013, INTEGRATIVE ANAL MET; Paskett ED, 2011, CA-CANCER J CLIN, V61, P237, DOI 10.3322/caac.20111; Rodday AM, 2015, CANCER-AM CANCER SOC, V121, P4025, DOI 10.1002/cncr.29612; South Carolina Cancer Alliance, S CAR CANC CONTR PLA; Stovall E., 2006, I MED IOM CANC PATIE; Wells KJ, 2008, CANCER-AM CANCER SOC, V113, P1999, DOI 10.1002/cncr.23815	22	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194649	10.1371/journal.pone.0194649	http://dx.doi.org/10.1371/journal.pone.0194649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584744	Green Published, gold, Green Submitted			2022-12-26	WOS:000428373000030
J	Fuji, Y; Uchida, A; Fukahori, K; Chino, M; Ohtsuki, T; Matsufuji, H				Fuji, Yushiro; Uchida, Ayumi; Fukahori, Katsunori; Chino, Makoto; Ohtsuki, Takashi; Matsufuji, Hiroshi			Chemical characterization and biological activity in young sesame leaves (Sesamum indicum L.) and changes in iridoid and polyphenol content at different growth stages	PLOS ONE			English	Article							PHENYLPROPANOID GLYCOSIDE; PHENYLETHANOID GLYCOSIDES; CISTANCHE-DESERTICOLA; PTEROGYNE-NITENS; IN-VITRO; ACTEOSIDE; GLUCOSIDES; CONSTITUENTS; EXTRACTS; RATS	Three iridoids (lamalbid (I1), sesamoside (I2) and shanzhiside methyl ester (I3)) and seven polyphenols (cistanoside F (P1), chlorogenic acid (P2), pedalitin-6-O-laminaribioside (P3), pedaliin (P4), isoacteoside (P6), pedalitin (P7) and martynoside (P8)) were identified in young sesame leaves (Sesamum indicum L.) other than the acteoside (P5) reported previously. P3 was a new compound, and I1, I3, P2 and P8 were found in a species of Sesamum for the first time. HPLC analyses revealed that the compounds I1 (0.29-1.75% of dry leaves), I2 (0.38-0.87%), I3 (0.04-1.07%), P4 (0.01-2.05%) and P5 (0.13-4.86%) were present primarily in young sesame leaves and were found in plants cultivated on different farms (plant height, 30-70 cm). Of the identified compounds, P5 and P6 showed high 1,1-dipheny1-2-picrylhydrazyl (DPPH) radical scavenging, oxygen radical absorbance capacity (ORAC), and in vitro antiglycation activities. Given its content, P5 makes a major contribution to the biological activities of young sesame leaves. The compounds were examined at six different growth stages of plants cultured in a greenhouse to determine the optimum harvest stage and for end-use assessment. P5 accumulated in the leaves during growth, and the content reached a maximum of 12.9% of dry leaves in the 4th stage (plant height, 74.5 +/- 9.7 cm), which is one of the highest percentages reported in plants from nature.	[Fuji, Yushiro; Chino, Makoto; Ohtsuki, Takashi; Matsufuji, Hiroshi] Nihon Univ, Coll Bioresource Sci, Dept Food Biosci & Biotechnol, Fujisawa, Kanagawa, Japan; [Uchida, Ayumi; Fukahori, Katsunori] Wadaman Sci Co Ltd, Nakagyo Ku, Nijoden Cho, Kyoto, Japan	Nihon University	Matsufuji, H (corresponding author), Nihon Univ, Coll Bioresource Sci, Dept Food Biosci & Biotechnol, Fujisawa, Kanagawa, Japan.	hmatsufu@brs.nihon-u.ac.jp			Wadaman Science Co., Ltd.; Nihon University President Grant Initiative; Grants-in-Aid for Scientific Research [15K12247] Funding Source: KAKEN	Wadaman Science Co., Ltd.; Nihon University President Grant Initiative; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study received financial support from Wadaman Science Co., Ltd. The funder provided support in the form of salaries for authors AU and KF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Also, a part of this study was financially supported by the Nihon University President Grant Initiative. The funder provided support in the form of salaries for authors MC, TO and HM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AgMRC, 2011, SES PROF; Alagna F, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-162; Alipieva K, 2007, BIOCHEM SYST ECOL, V35, P17, DOI 10.1016/j.bse.2006.07.004; Alipieva K, 2014, BIOTECHNOL ADV, V32, P1065, DOI 10.1016/j.biotechadv.2014.07.001; Bolzani VDS, 1995, J NAT PROD, V58, P1683, DOI 10.1021/np50125a006; CALIS I, 1984, PHYTOCHEMISTRY, V23, P2313, DOI 10.1016/S0031-9422(00)80542-7; FAOSTAT, 2014, PROD YIELD QUANT SES; Fernandes DC, 2008, CHEM PHARM BULL, V56, P723, DOI 10.1248/cpb.56.723; Georgiev M, 2010, FOOD CHEM, V121, P967, DOI 10.1016/j.foodchem.2010.01.028; Georgiev MI, 2011, PHYTOCHEMISTRY, V72, P2045, DOI 10.1016/j.phytochem.2011.07.005; Hata N, 2010, PLANT SCI, V178, P510, DOI 10.1016/j.plantsci.2010.02.020; He J, 2011, J ASIAN NAT PROD RES, V13, P449, DOI 10.1080/10286020.2011.568940; Imperato F, 1997, PHYTOCHEMISTRY, V45, P1729, DOI 10.1016/S0031-9422(96)00801-1; JAIN SC, 1981, AGR BIOL CHEM TOKYO, V45, P2127, DOI 10.1080/00021369.1981.10864843; Jankovic T, 2012, BIOCHEM SYST ECOL, V42, P69, DOI 10.1016/j.bse.2012.02.013; KOBAYASHI H, 1985, CHEM PHARM BULL, V33, P1452; KOBAYASHI S, 1986, CHEM PHARM BULL, V34, P876; Konan AB, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-23; Koo KA, 2005, PLANTA MED, V71, P778, DOI 10.1055/s-2005-871213; Korshavn KJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17842; Kubmarawa D, 2008, AFR J BIOTECHNOL, V7, P3502; Kwak Y, 2013, KOREAN J FOOD COOKER, V29, P241; Liu LE, 2012, BIORESOURCES, V7, P3555; Liu YH, 2013, BOT STUD, V54, DOI 10.1186/1999-3110-54-6; Lukeman AJS, 2009, AFR J BIOTECHNOL, V8, P2878; Matsufuji H, 2011, J JPN SOC FOOD SCI, V58, P88, DOI 10.3136/nskkk.58.88; Morikawa T, 2014, J NAT MED-TOKYO, V68, P561, DOI 10.1007/s11418-014-0837-9; Morita N., 1960, NII ELECT LIBR SERV, V8, P59, DOI 10.1248/cpb.8.59; Olivier DK, 2010, S AFR J BOT, V76, P58, DOI 10.1016/j.sajb.2009.07.002; Phakeovilay C, 2013, J NAT MED-TOKYO, V67, P228, DOI 10.1007/s11418-012-0658-7; POTTERAT O, 1988, PHYTOCHEMISTRY, V27, P2677, DOI 10.1016/0031-9422(88)87042-0; Saimaru H, 2010, J NAT MED-TOKYO, V64, P139, DOI 10.1007/s11418-009-0383-z; SASAKI H, 1978, CHEM PHARM BULL, V26, P2111; Seo ES, 2013, MOL CELLS, V35, P348, DOI 10.1007/s10059-013-0021-1; Shanghai Scientific & Technical Publishers, 1998, DICT CHIN MAT MED JA, p[800, 867]; Shi HM, 2009, BIOL PHARM BULL, V32, P142, DOI 10.1248/bpb.32.142; Shiao YJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040895; SUZUKI N, 1993, PHYTOCHEMISTRY, V34, P729, DOI 10.1016/0031-9422(93)85348-U; Takase R, 2014, NAT PROD COMMUN, V9, P1539; TERAHARA N, 1994, BIOSCI BIOTECH BIOCH, V58, P1324, DOI 10.1271/bbb.58.1324; Tsuji-Naito K, 2009, FOOD CHEM, V116, P854, DOI 10.1016/j.foodchem.2009.03.042; Wang J, 2015, TOXICOL APPL PHARM, V285, P128, DOI 10.1016/j.taap.2015.04.004; Watanabe J, 2012, ANAL SCI, V28, P159, DOI 10.2116/analsci.28.159; Wu YT, 2006, J CHROMATOGR B, V844, P89, DOI 10.1016/j.jchromb.2006.07.011; Xiong QB, 1996, BIOL PHARM BULL, V19, P1580, DOI 10.1248/bpb.19.1580; Yu SY, 2013, PLANTA MED, V79, P1705, DOI 10.1055/s-0033-1351101; Yuan JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162696	47	21	23	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194449	10.1371/journal.pone.0194449	http://dx.doi.org/10.1371/journal.pone.0194449			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584748	Green Published, Green Submitted, gold			2022-12-26	WOS:000428373000024
J	Tsai, T; Kuehn, S; Tsiampalis, N; Vu, MK; Kakkassery, V; Stute, G; Dick, HB; Joachim, SC				Tsai, Teresa; Kuehn, Sandra; Tsiampalis, Nikolaos; Minh-Khoa Vu; Kakkassery, Vinodh; Stute, Gesa; Dick, H. Burkhard; Joachim, Stephanie C.			Anti-inflammatory cytokine and angiogenic factors levels in vitreous samples of diabetic retinopathy patients	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; AQUEOUS-HUMOR; IFN-GAMMA; INTERLEUKIN-1-BETA; DEGENERATION; INHIBITION; IL-1	Evaluation of cytokines in patients with diabetic retinopathy (DR) is important for the identification of future additive or alternative treatment options. Therefore, vitreous samples were obtained from patients with DR and patients with macular hole or macular pucker (control group) during 23-gauge-vitrectomy (n = 17/group). The levels of three pro-inflammatory (IL-1 beta, IL-6, IFN-gamma) and pleiotropic cytokines (IL-2, IL-4, IL-13) as well as VEGF, VEGF-A, and PGF were measured using an enzyme linked immunosorbent assay (ELISA). IL-1 beta (p = 0.02) and IFN-gamma (p = 0.04), two of the three tested pro-inflammatory cytokines, were elevated in the DR patients, while IL-6 (p = 0.51) level was comparable in both groups. Moreover, in DR samples, a trend towards an IL-13 down-regulation (p = 0.36) was observable. The IL-2 (p = 0.62) and IL-4 (p = 0.78) levels were comparable in both groups. All analyzed angiogenetic factors were up-regulated in DR patients (VEGF: p<0.001; VEGF-A: p = 0.002; PGF: p<0.001). The up-regulation of angiogenetic factors underline their importance in DR development. However, the interaction of the other cytokines showed an interesting pattern. Pro-inflammatory cytokines were also up-regulated, which could be evidence for inflammation processes in the diabetic retina. Furthermore, it seems that a counter response of immunomodulatory cytokines is in an initial process, but not strong enough to regulate the processes. Therefore, to support these anti-inflammatory mechanisms might be additive treatment option in the future.	[Tsai, Teresa; Kuehn, Sandra; Tsiampalis, Nikolaos; Minh-Khoa Vu; Kakkassery, Vinodh; Stute, Gesa; Dick, H. Burkhard; Joachim, Stephanie C.] Ruhr Univ Bochum, Eye Hosp, Expt Eye Res Inst, Bochum, Germany	Ruhr University Bochum	Joachim, SC (corresponding author), Ruhr Univ Bochum, Eye Hosp, Expt Eye Res Inst, Bochum, Germany.	stephanie.joachim@rub.cie	Dick, Burkhard/AAI-7504-2020; Kakkassery, Vinodh/AAJ-9544-2020; Joachim, Stephanie/AAV-5980-2021	Kakkassery, Vinodh/0000-0001-6212-8964; 	Bayer Vital GmbH.	Bayer Vital GmbH.(Bayer AG)	The study was in part supported by Bayer Vital GmbH. No additional external funding was received for this study. The funders had no role in the study design; collection, analysis, and interpretation of data; writing of the paper; and/or decision to submit for publication.	Abu El-Asrar AM, 2012, MIDDLE EAST AFR J OP, V19, P70, DOI 10.4103/0974-9233.92118; Adamiec-Mroczek J, 2010, CYTOKINE, V49, P269, DOI 10.1016/j.cyto.2009.11.004; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Arellano G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00492; Balasubramanian SA, 2013, CLIN EXP OPTOM, V96, P214, DOI 10.1111/cxo.12038; Berger S, 2008, INVEST OPHTH VIS SCI, V49, P3605, DOI 10.1167/iovs.07-0817; Bolinger MT, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091498; Bringmann A, 2012, OPHTHALMOLOGICA, V227, P1, DOI 10.1159/000328979; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Brooks HL, 2004, ARCH OPHTHALMOL-CHIC, V122, P1801, DOI 10.1001/archopht.122.12.1801; Chernykh VV, 2015, INDIAN J OPHTHALMOL, V63, P33, DOI 10.4103/0301-4738.151464; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Citirik M, 2012, OPHTHALMIC RES, V47, P7, DOI 10.1159/000324200; Cunha-Vaz J, 2014, PROG RETIN EYE RES, V41, P90, DOI 10.1016/j.preteyeres.2014.03.003; De Falco S, 2012, EXP MOL MED, V44, P1, DOI 10.3858/emm.2012.44.1.025; de Vries JE, 1998, J ALLERGY CLIN IMMUN, V102, P165, DOI 10.1016/S0091-6749(98)70080-6; Demircan N, 2006, EYE, V20, P1366, DOI 10.1038/sj.eye.6702138; Domingueti CP, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2315260; Dong N, 2013, MOL VIS, V19, P1734; Duh EJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93751; Grigsby JG, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/705783; Hagan S, 2016, EPMA J, V7, DOI 10.1186/s13167-016-0065-3; Hillier RJ, 2017, RETINA-J RET VIT DIS, V37, P761, DOI 10.1097/IAE.0000000000001210; Jenkins Alicia J, 2015, Rev Diabet Stud, V12, P159, DOI 10.1900/RDS.2015.12.159; Jesus AA, 2014, ANNU REV MED, V65, P223, DOI 10.1146/annurev-med-061512-150641; Johnsen-Soriano S, 2010, GRAEF ARCH CLIN EXP, V248, P985, DOI 10.1007/s00417-009-1289-x; Khaliq A, 1998, LAB INVEST, V78, P109; Kortus-Gotze B, 2011, CLIN KIDNEY J, V4, P404, DOI 10.1093/ndtplus/sfr118; Kowluru RA, 2004, INVEST OPHTH VIS SCI, V45, P4161, DOI 10.1167/iovs.04-0633; Lachmann HJ, 2009, NEW ENGL J MED, V360, P2416, DOI 10.1056/NEJMoa0810787; MACHOLD KP, 1992, ANN RHEUM DIS, V51, P1039, DOI 10.1136/ard.51.9.1039; Magrinelli F, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/547834; Manni G, 2005, AM J OPHTHALMOL, V139, P72, DOI 10.1016/j.ajo.2004.08.028; Meng ZJ, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-016-0558-5; Minhas G, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00444; Miyamoto K, 2000, AM J PATHOL, V156, P1733, DOI 10.1016/S0002-9440(10)65044-4; Mocan MC, 2006, CAN J OPHTHALMOL, V41, P747, DOI 10.1139/I06-070; Pelikan Z, 2013, MOL VIS, V19, P1453; Reverter JL, 2009, INVEST OPHTH VIS SCI, V50, P1378, DOI 10.1167/iovs.08-2736; Rivera JC, 2013, ARTERIOSCL THROM VAS, V33, P1881, DOI 10.1161/ATVBAHA.113.301331; Roy S, 2016, AM J PATHOLOGY; Shen XI, 2000, BIOCHEM J, V352, P913, DOI 10.1042/0264-6021:3520913; Skurkovich B, 2006, E SCHERING RES FDN W, V56, P1; Statistics CoDCaPND, 2014, REP EST DIAB ITS BUR; Stefansson E, 2000, ACTA OPHTHALMOL SCAN, V78, P374, DOI 10.1034/j.1600-0420.2000.078004374.x; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Tjwa M, 2003, CELL TISSUE RES, V314, P5, DOI 10.1007/s00441-003-0776-3; Tosi GM, 2017, INVEST OPHTH VIS SCI, V58, P162, DOI 10.1167/iovs.16-20922; Vincent JA, 2007, DIABETES, V56, P224, DOI 10.2337/db06-0427; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wu D, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43017; Wu L, 2013, WORLD J DIABETES, V4, P290, DOI 10.4239/wjd.v4.i6.290; Yoneda S, 2001, EXP EYE RES, V73, P661, DOI 10.1006/exer.2001.1072; Zhang WB, 2011, IMMUNOTHERAPY-UK, V3, P609, DOI [10.2217/imt.11.24, 10.2217/IMT.11.24]; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	55	53	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194603	10.1371/journal.pone.0194603	http://dx.doi.org/10.1371/journal.pone.0194603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584759	Green Published, Green Submitted, gold			2022-12-26	WOS:000428373000028
J	Weintrob, N; Eyal, O; Slakman, M; Becker, AS; Israeli, G; Kalter-Leibovici, O; Ben-Shachar, S				Weintrob, Naomi; Eyal, Ori; Slakman, Meital; Becker, Anat Segev; Israeli, Galit; Kalter-Leibovici, Ofra; Ben-Shachar, Shay			The effect of CAG repeats length on differences in hirsutism among healthy Israeli women of different ethnicities	PLOS ONE			English	Article							ANDROGEN-RECEPTOR GENE; POLYCYSTIC-OVARY-SYNDROME; TRINUCLEOTIDE REPEATS; POLYMORPHIC CAG; HAIR-GROWTH; PREGNANCY; TRANSACTIVATION; ASSOCIATION; INFERTILITY; PREVALENCE	Purpose Variations in the degree of hirsutism among women of different ethnic backgrounds may stem from multiple etiologies. Shorter length of the polymorphic CAG repeats of the androgen receptor (AR) gene may be associated with increased activity of the receptor leading to hirsutism. We hypothesized that there are ethnic differences in the degree of hirsutism that is unrelated to androgen levels among Israeli women, and that the CAG repeats length may contribute to these differences. Anti-androgenic therapies, such as spironolactone, could be suggested if a shorter CAG repeats length is found to affect the difference in the degree of hirsutism between the ethnic groups. Methods Healthy Israeli Jewish women aged 18-45 years of Ashkenazi and non-Ashkenazi origin were invited to participate. Hirsutism was assessed using the simplified Ferriman Gallwey (sFG) score, and serum total testosterone levels were measured as well. The CAG repeats length was determined by PCR. Methylation-sensitive methods were used to detect the fractional activity of each allele, and the weighted mean was calculated for the CAG repeats length. Results One-hundred and eight women were recruited (49 Ashkenazi and 59 non-Ashkenazi). The Ashkenazi women had a significantly lower degree of hirsutism (P<0.01), lower mean BMI (P = 0.003), total testosterone levels (P = 0.017), and longer weighted bi-allelic CAG repeats mean (P = 0.015) compared to non-Ashkenazi women. For the group as a whole, there was a significant negative correlation between the number of CAG repeats in the AR gene and the sFG score, while the number of repeats was not related to testosterone levels. Stepwise logistic regression revealed that ethnic origin and the CAG repeats length were the strongest factors affecting hirsutism (P<0.001, P = 0.03, respectively). Conclusions There is a significant difference in the degree of hirsutism between Ashkenazi and non-Ashkenazi women in Israel that is partially explained by CAG repeats length.	[Weintrob, Naomi; Eyal, Ori; Becker, Anat Segev; Israeli, Galit] Dana Dwek Childrens Hosp, Pediat Endocrinol & Diabet Unit, Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel; [Weintrob, Naomi; Eyal, Ori; Slakman, Meital; Kalter-Leibovici, Ofra; Ben-Shachar, Shay] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Kalter-Leibovici, Ofra] Gertner Inst Epidemiol & Hlth Policy Res, Tel Hashomer, Israel; [Ben-Shachar, Shay] Tel Aviv Sourasky Med Ctr, Genet Inst, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Eyal, O (corresponding author), Dana Dwek Childrens Hosp, Pediat Endocrinol & Diabet Unit, Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel.; Eyal, O (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.	oriey@tlvmc.gov.il			Hamer Israel for Medicine Fund, Sackler Faculty of Medicine, Tel Aviv University	Hamer Israel for Medicine Fund, Sackler Faculty of Medicine, Tel Aviv University	This study was supported by the Hamer Israel for Medicine Fund, Sackler Faculty of Medicine, Tel Aviv University.	ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P453, DOI 10.1210/jc.2003-031122; Ben-Shachar S, 2015, HORM METAB RES, V47, P491, DOI 10.1055/s-0034-1389901; Buchanan G, 2004, HUM MOL GENET, V13, P1677, DOI 10.1093/hmg/ddh181; CARMINA E, 1992, AM J OBSTET GYNECOL, V167, P1807, DOI 10.1016/0002-9378(92)91779-A; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Cook H, 2011, FERTIL STERIL, V96, P1266, DOI 10.1016/j.fertnstert.2011.08.022; DeUgarte CM, 2006, J CLIN ENDOCR METAB, V91, P1345, DOI 10.1210/jc.2004-2301; Dixon WJ., 1993, BMDP STAT SOFTWARE; Escobar-Morreale HF, 2017, HUM REPROD UPDATE, V23, P390, DOI 10.1093/humupd/dmx012; Eyal O, 2017, CLIN ENDOCRINOL, V87, P552, DOI 10.1111/cen.13429; FERRIMAN D, 1961, J CLIN ENDOCR METAB, V21, P1440, DOI 10.1210/jcem-21-11-1440; HAMILTON JB, 1964, CLIN OBSTET GYNECOL, V7, P1075, DOI 10.1097/00003081-196412000-00015; Hickey T, 2002, J CLIN ENDOCR METAB, V87, P161, DOI 10.1210/jc.87.1.161; Hsing AW, 2000, CANCER RES, V60, P5111; Ibanez L, 2003, J CLIN ENDOCR METAB, V88, P3333, DOI 10.1210/jc.2002-021791; Joham AE, 2014, HUM REPROD, V29, P802, DOI 10.1093/humrep/deu020; Karrer-Voegeli S, 2009, MEDICINE, V88, P32, DOI 10.1097/md.0b013e3181946a2c; Lashen H, 2004, HUM REPROD, V19, P1644, DOI 10.1093/humrep/deh277; LOOKINGBILL DP, 1991, J CLIN ENDOCR METAB, V72, P1242, DOI 10.1210/jcem-72-6-1242; LUBAHN DB, 1988, SCIENCE, V240, P327, DOI 10.1126/science.3353727; Mifsud A, 2000, J CLIN ENDOCR METAB, V85, P3484, DOI 10.1210/jc.85.9.3484; Palomba S, 2015, HUM REPROD UPDATE, V21, P575, DOI 10.1093/humupd/dmv029; Pasquali R, 2011, EUR J ENDOCRINOL, V164, P53, DOI 10.1530/EJE-10-0692; Shah NA, 2008, J CLIN ENDOCR METAB, V93, P1939, DOI 10.1210/jc.2008-0038; Souter I, 2004, AM J OBSTET GYNECOL, V191, P1914, DOI 10.1016/j.ajog.2004.06.064; Tut TG, 1997, J CLIN ENDOCR METAB, V82, P3777, DOI 10.1210/jc.82.11.3777; Van Nieuwerburgh F, 2008, GYNECOL ENDOCRINOL, V24, P669, DOI 10.1080/09513590802342841; Vottero A, 1999, J CLIN ENDOCR METAB, V84, P1091, DOI 10.1210/jc.84.3.1091; Wang R, 2012, MOL HUM REPROD, V18, P498, DOI 10.1093/molehr/gas024; Yildiz BO, 2010, HUM REPROD UPDATE, V16, P51, DOI 10.1093/humupd/dmp024	31	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0195046	10.1371/journal.pone.0195046	http://dx.doi.org/10.1371/journal.pone.0195046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584789	Green Submitted, gold, Green Published			2022-12-26	WOS:000428373000058
J	Sardone, V; Ellis, M; Torelli, S; Feng, L; Chambers, D; Eastwood, D; Sewry, C; Phadke, R; Morgan, JE; Muntonl, F				Sardone, Valentina; Ellis, Matthew; Torelli, Silvia; Feng, Lucy; Chambers, Darren; Eastwood, Deborah; Sewry, Caroline; Phadke, Rahul; Morgan, Jennifer E.; Muntonl, Francesco			A novel high-throughput immunofluorescence analysis method for quantifying dystrophin intensity in entire transverse sections of Duchenne muscular dystrophy muscle biopsy samples	PLOS ONE			English	Article							EXPRESSION; MOUSE; SARCOLEMMA; THERAPY; DMD	Clinical trials using strategies aimed at inducing dystrophin expression in Duchenne muscular dystrophy (DMD) are underway or at advanced planning stage, including splice switching antisense oligonucleotides (AON), drugs to induce read-through of nonsense mutations and viral mediated gene therapy. In all these strategies, different dystrophin proteins, often internally deleted, are produced, similar to those found in patients with the milder DMD allelic variant, Becker muscular dystrophy (BMD). The primary biological endpoint of these trials is to induce functional dystrophin expression. A reliable and reproducible method for quantification of dystrophin protein expression at the sarcolemma is crucial to monitor the biochemical outcome of such treatments. We developed a new high throughput semi quantitative fluorescent immunofluorescence method for quantifying dystrophin expression in transverse sections of skeletal muscle. This technique is completely operator independent as it based on an automated scanning system and an image processing script developed with Definiens software. We applied this new acquisition-analysis method to quantify dystrophin and sarcolemma-related proteins using paediatric control muscles from cases without a neuromuscular disorder as well as DMD and BMD samples. The image analysis script was instructed to recognize myofibres immunostained for spectrin or laminin while dystrophin was quantified in each identified myofibre (from 2,000 to over 20,000 fibres, depending on the size of the biopsy). We were able to simultaneously extrapolate relevant parameters such as mean sarcolemmal dystrophin, mean spectrin and laminin intensity, fibre area and diameter. In this way we assessed dystrophin production in each muscle fibre in samples of DMD, BMD and controls. This new method allows the unbiased quantification of dystrophin in every myofibre within a transverse muscle section and will be of help for translational research projects as a biological outcome in clinical trials in DMD and BMD.	[Sardone, Valentina; Torelli, Silvia; Feng, Lucy; Chambers, Darren; Sewry, Caroline; Phadke, Rahul; Morgan, Jennifer E.; Muntonl, Francesco] UCL Great Ormond St Inst Child Hlth, Dubowitz Neuromuscular Ctr, Mol Neurosci Sect, Dev Neurosci Programme, London, England; [Ellis, Matthew] UCL, Dept Neurodegenerat Dis, Inst Neurol, London, England; [Feng, Lucy; Chambers, Darren; Phadke, Rahul] UCLH NHS Fdn Trust, Natl Hosp Neurol & Neurosurg, UCL Inst Neurol, Div Neuropathol, London, England; [Eastwood, Deborah] Great Ormond St Hosp Sick Children, Dept Orthopaed, London, England; [Eastwood, Deborah] Royal Natl Orthopaed Hosp, Stanmore, Middx, England; [Sewry, Caroline] RJAH Orthopaed Hosp, Wolfson Ctr Inherited Neuromuscular Dis, Oswestry, Shrops, England; [Muntonl, Francesco] NIHR Great Ormond St Hosp, Biomed Res Ctr, London, England	University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; Keele University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Muntonl, F (corresponding author), UCL Great Ormond St Inst Child Hlth, Dubowitz Neuromuscular Ctr, Mol Neurosci Sect, Dev Neurosci Programme, London, England.; Muntonl, F (corresponding author), NIHR Great Ormond St Hosp, Biomed Res Ctr, London, England.	f.muntoni@ucl.ac.uk	Chambers, Darren/AAZ-6637-2021; Phadke, Rahul/U-6960-2019	Chambers, Darren/0000-0002-0200-9274; Ellis, Matthew/0000-0002-5264-0531; Sardone, Valentina/0000-0003-2499-9560	European Union Framework Project 7 grant SKIP-NMD [HEALTH-F4-2012-30537]; Sarepta Therapeutics; EU grant SKIP-NMD [HEALTH-F4-2012-30537]; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London; Great Ormond Street Hospital Children's Charity; Centre for Neuromuscular Disease Bank; NIHR Great Ormond Street Hospital Biomedical Research Centre; MRC [G0900872] Funding Source: UKRI	European Union Framework Project 7 grant SKIP-NMD; Sarepta Therapeutics; EU grant SKIP-NMD; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London; Great Ormond Street Hospital Children's Charity; Centre for Neuromuscular Disease Bank; NIHR Great Ormond Street Hospital Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a European Union Framework Project 7 grant SKIP-NMD (No. HEALTH-F4-2012-30537) and by Sarepta Therapeutics (both awarded to FM). VS was supported by the EU grant SKIP-NMD (No. HEALTH-F4-2012-30537) and by Sarepta Therapeutics. FM is supported by the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London. JEM is supported by Great Ormond Street Hospital Children's Charity. We gratefully acknowledge the support of the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London and for their support of the Centre for Neuromuscular Disease Bank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was supported by the NIHR Great Ormond Street Hospital Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Anthony K, 2014, NEUROLOGY; Anthony K, 2014, JAMA NEUROL, V71, P32, DOI 10.1001/jamaneurol.2013.4908; Arechavala-Gomeza V, 2010, NEUROPATH APPL NEURO, V36, P265, DOI 10.1111/j.1365-2990.2009.01056.x; Arechavala-Gomeza V, 2010, NEUROMUSCULAR DISORD, V20, P295, DOI 10.1016/j.nmd.2010.03.007; Athanasopoulos T, 2004, GENE THER, V11, pS109, DOI 10.1038/sj.gt.3302379; Bajek A, 2015, CRIT REV EUKAR GENE, V25, P1, DOI 10.1615/CritRevEukaryotGeneExpr.2015011074; Beekman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107494; Brown K.J., 2012, J BIOANAL BIOMED S7; Cirak S, 2011, LANCET; Fairclough RJ, 2013, NAT REV GENET, V14, P373, DOI 10.1038/nrg3460; Finkel RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081302; Fiorillo AA, 2015, CELL REP, V12, P1678, DOI 10.1016/j.celrep.2015.07.066; Godfrey C, 2015, HUM MOL GENET, V24, P4225, DOI 10.1093/hmg/ddv155; Janghra N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150818; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Lu QL, 2000, J CELL BIOL, V148, P985, DOI 10.1083/jcb.148.5.985; Malandrini A, 1997, ACTA NEUROPATHOL, V93, P166, DOI 10.1007/s004010050598; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Sardone V, 2017, MOLECULES, V22, DOI 10.3390/molecules22040563; Sharp PS, 2011, MOL THER, V19, P165, DOI 10.1038/mt.2010.213; Straub V, 2016, LANCET NEUROL, V15, P882, DOI 10.1016/S1474-4422(16)30035-7; Taylor LE, 2012, NEUROPATH APPL NEURO, V38, P591, DOI 10.1111/j.1365-2990.2012.01250.x	24	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194540	10.1371/journal.pone.0194540	http://dx.doi.org/10.1371/journal.pone.0194540			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579078	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000428351800036
J	Kohler, P; Eshaghi, A; Kim, HC; Plevneshi, A; Green, K; Willey, BM; McGeer, A; Patel, SN				Kohler, Philipp; Eshaghi, Alireza; Kim, Hyunjin C.; Plevneshi, Agron; Green, Karen; Willey, Barbara M.; McGeer, Allison; Patel, Samir N.		Toronto Invasive Bacterial Dis Net	Prevalence of vancomycin-variable Enterococcus faecium (VVE) among vanA-positive sterile site isolates and patient factors associated with VVE bacteremia	PLOS ONE			English	Article							RESISTANT ENTEROCOCCI; BREAKTHROUGH BACTEREMIA; RISK-FACTORS; THERAPY; METAANALYSIS; INFECTIONS; COMMUNITY; OUTBREAK; FUNGEMIA; OUTCOMES	Vancomycin-variable enterococci (VVE) are vanA-positive, vancomycin-susceptible enterococci with the ability to revert to a vancomycin-resistant phenotype on exposure to vancomycin. We sought to assess the prevalence of VVE and to determine clinical characteristics of patients infected with VVE. We prospectively collected Enterococcus faecium sterile site isolates from Toronto Invasive Bacterial Diseases Network hospitals from January 2015 to June 2016 and calculated VVE (defined as vanA-positive, vancomycin-susceptible isolates) prevalence among vanA-containing isolates. We performed chart reviews of VVE and vancomycin-resistant E. faecium (VRE) bacteremias identified from January 2012 to June 2016, and on a random sample of patients with bacteremia due to vanA/vanB-negative, vancomycinsusceptible enterococci (VSE) from January 2015 to June 2016. Clinical characteristics were compared and factors associated with mortality assessed. Because of the potential reversion from VVE to VRE, pulsed-field gel electrophoresis (PFGE) was performed for strains causing breakthrough bacteremia in order to identify relatedness among strains with different phenotypic resistance within the same patient. VVE comprised 47% (18/38) of vanA-positive isolates. The charts of 36 VRE, 25 VVE, and 79 VSE patients were reviewed. Central venous catheter associated bacteremia was more common in VVE (44%) and VRE patients (57%) than in VSE patients (28%) (P = 0.01). The Pitt bacteremia (OR 1.3, P = 0.002) and the Charlson score (OR 1.2, P = 0.008) were the only independent mortality predictors. PFGE of strains causing breakthrough bacteremia showed high within-patient clonality, irrespective of vanA-positivity or vancomycin-susceptibility. A substantial proportion of vanA-positive isolates are VVE and are therefore not detected with conventional selective culture methods. Bacteremia sources of patients with VVE are similar to those infected with VRE. We detected no association between VVE and 30-day mortality or breakthrough bacteremia.	[Kohler, Philipp; Kim, Hyunjin C.; Plevneshi, Agron; Green, Karen; Willey, Barbara M.; McGeer, Allison] Mt Sinai Hosp, Microbiol Dept, Toronto, ON, Canada; [Kohler, Philipp] Cantonal Hosp St Gallen, Clin Infect Dis & Hosp Epidemiol, St Gallen, Switzerland; [Eshaghi, Alireza; Patel, Samir N.] Publ Hlth Ontario, Publ Hlth Ontario Lab, Toronto, ON, Canada; [Kim, Hyunjin C.; McGeer, Allison; Patel, Samir N.] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Kantonsspital St. Gallen; University of Toronto	Kohler, P (corresponding author), Mt Sinai Hosp, Microbiol Dept, Toronto, ON, Canada.; Kohler, P (corresponding author), Cantonal Hosp St Gallen, Clin Infect Dis & Hosp Epidemiol, St Gallen, Switzerland.	philipp.kohler@kssg.ch	McGeer, Allison/AAB-6885-2020	McGeer, Allison/0000-0001-5647-6137; Kohler, Philipp/0000-0003-0427-8934; Eshaghi, Alireza/0000-0001-5150-483X	Swiss National Science Foundation Fellowship [158728]; Public Health Ontario Laboratories; Toronto Invasive Bacterial Diseases Network	Swiss National Science Foundation Fellowship(Swiss National Science Foundation (SNSF)); Public Health Ontario Laboratories; Toronto Invasive Bacterial Diseases Network	This work was supported by the Swiss National Science Foundation Fellowship (158728 to P.K.), and internal funding from Public Health Ontario Laboratories and the Toronto Invasive Bacterial Diseases Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, CANADIAN NOSOCOMIAL; Arena F, 2013, ANTIMICROB AGENTS CH, V57, P6411, DOI 10.1128/AAC.01112-13; Baran J, 2001, CLIN INFECT DIS, V32, P1381, DOI 10.1086/319996; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Choi HJ, 2011, DIAGN MICR INFEC DIS, V69, P105, DOI 10.1016/j.diagmicrobio.2010.08.030; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; Coburn B, 2014, J CLIN MICROBIOL, V52, P1766, DOI 10.1128/JCM.03579-13; Coque TM, 1996, ANTIMICROB AGENTS CH, V40, P2605, DOI 10.1128/AAC.40.11.2605; DiazGranados CA, 2005, CLIN INFECT DIS, V41, P327, DOI 10.1086/430909; Downing MA, 2015, J CLIN MICROBIOL, V53, P3951, DOI 10.1128/JCM.02046-15; Gagnon S, 2011, J ANTIMICROB CHEMOTH, V66, P2758, DOI 10.1093/jac/dkr379; Holzknecht B. J., 2017, New Microbes and New Infections, V16, P54, DOI 10.1016/j.nmni.2016.12.020; Jung Y., 2014, WATER, V6, P2014, DOI DOI 10.1016/J.DIAGMICR0BI0.2014.06.012; Lucas GM, 1998, CLIN INFECT DIS, V26, P1127, DOI 10.1086/520311; MURRAY BE, 1990, J CLIN MICROBIOL, V28, P2059, DOI 10.1128/JCM.28.9.2059-2063.1990; Paterson DL, 2004, ANN INTERN MED, V140, P26, DOI 10.7326/0003-4819-140-1-200401060-00008; Peel T, 2012, CLIN MICROBIOL INFEC, V18, P388, DOI 10.1111/j.1469-0691.2011.03591.x; Prematunge C, 2016, INFECT CONT HOSP EP, V37, P26, DOI 10.1017/ice.2015.228; Roghmann MC, 1997, CLIN INFECT DIS, V24, P514, DOI 10.1093/clinids/24.3.514; Sivertsen A, 2016, ANTIMICROB AGENTS CH, V60, P4119, DOI 10.1128/AAC.00286-16; Spanik S, 1997, J MED MICROBIOL, V46, P517, DOI 10.1099/00222615-46-6-517; Szakacs TA, 2014, J CLIN MICROBIOL, V52, P1682, DOI 10.1128/JCM.03563-13; Thaker MN, 2015, ANTIMICROB AGENTS CH, V59, P1405, DOI 10.1128/AAC.04490-14; van Duin D, 2016, INFECT DIS CLIN N AM, V30, P377, DOI 10.1016/j.idc.2016.02.004; Weinstein MP, 1997, CLIN INFECT DIS, V24, P584, DOI 10.1093/clind/24.4.584	25	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0193926	10.1371/journal.pone.0193926	http://dx.doi.org/10.1371/journal.pone.0193926			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566004	Green Submitted, Green Published, gold			2022-12-26	WOS:000428093900022
J	Torres, M; Zuniga, R; Gutierrez, M; Vergara, M; Collazo, N; Reyes, J; Berrios, J; Aguillon, JC; Molina, MC; Altamirano, C				Torres, Mauro; Zuniga, Roberto; Gutierrez, Matias; Vergara, Mauricio; Collazo, Norberto; Reyes, Juan; Berrios, Julio; Carlos Aguillon, Juan; Carmen Molina, Maria; Altamirano, Claudia			Mild hypothermia upregulates myc and xbp1s expression and improves anti-TNF alpha production in CHO cells	PLOS ONE			English	Article							CHINESE-HAMSTER OVARY; LOW CULTURE TEMPERATURE; RECOMBINANT PROTEIN-PRODUCTION; FED-BATCH PROCESSES; RHEUMATOID-ARTHRITIS; LACTATE METABOLISM; MAMMALIAN-CELLS; TRANSCRIPTION LEVEL; SODIUM-BUTYRATE; GENE-EXPRESSION	Chinese hamster ovary (CHO) cells are the most frequently used host for commercial production of therapeutic proteins. However, their low protein productivity in culture is the main hurdle to overcome. Mild hypothermia has been established as an effective strategy to enhance protein specific productivity, although the causes of such improvement still remain unclear. The self-regulation of global transcriptional regulatory factors, such as Myc and XBP1s, seems to be involved in increased the recombinant protein production at low temperature. This study evaluated the impact of low temperature in CHO cell cultures on myc and xbp1s expression and their effects on culture performance and cell metabolism. Two anti-TNF alpha producing CHO cell lines were selected considering two distinct phenotypes: i.e. maximum cell growth, (CN1) and maximum specific anti-TNF alpha production (CN2), and cultured at 37, 33 and 31 degrees C in a batch system. Low temperature led to an increase in the cell viability, the expression of the recombinant anti-TNF alpha and the production of anti-TNF alpha both in CN1 and CN2. The higher production of anti-TNF alpha in CN2 was mainly associated with the large expression of anti-TNF alpha. Under mild hypothermia myc and xbp1s expression levels were directly correlated to the maximal viable cell density and the specific anti-TNF alpha productivity, respectively. Moreover, cells showed a simultaneous metabolic shift from production to consumption of lactate and from consumption to production of glutamine, which were exacerbated by reducing culture temperature and coincided with the increased anti-TNF alpha production. Our current results provide new insights of the regulation of myc and xbp1s in CHO cells at low temperature, and suggest that the presence and magnitude of the metabolic shift might be a relevant metabolic marker of productive cell line.	[Torres, Mauro; Vergara, Mauricio; Berrios, Julio; Altamirano, Claudia] Pontificia Univ Catolica Valparaiso, Escuela Ingn Bioquim, Valparaiso, Chile; [Zuniga, Roberto; Gutierrez, Matias; Collazo, Norberto; Carlos Aguillon, Juan; Carmen Molina, Maria] Univ Chile, Fac Med, Inst Ciencias Biomed ICBM, Ctr InmunoBiotecnol,Programa Inmunol D, Santiago, Chile; [Zuniga, Roberto; Vergara, Mauricio] Univ Republ Oriental Uruguay, Doctorado Quim, Montevideo, Uruguay; [Reyes, Juan] Pontificia Univ Catolica Valparaiso, Inst Quim, Valparaiso, Chile; [Altamirano, Claudia] CREAS CONICYT Reg GORE, Valparaiso, Chile	Pontificia Universidad Catolica de Valparaiso; Universidad de Chile; Universidad de la Republica, Uruguay; Pontificia Universidad Catolica de Valparaiso	Altamirano, C (corresponding author), Pontificia Univ Catolica Valparaiso, Escuela Ingn Bioquim, Valparaiso, Chile.; Altamirano, C (corresponding author), CREAS CONICYT Reg GORE, Valparaiso, Chile.	claudia.altamirano@pucv.cl	Aguillon, Juan C/H-9234-2013	Aguillon, Juan C/0000-0003-3148-6843; Altamirano, Claudia/0000-0002-6389-086X; Berrios, Julio/0000-0002-6180-0023; Gutierrez-Gonzalez, Matias/0000-0002-9729-6850; Torres, Mauro/0000-0002-4054-4323	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) through Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1161452]; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1130330]; Fondo de Fomento al Desarrollo Cientifico y Tecnologico (FONDEF) [D09I1190]; Proyecto Asociativo I+D PUCV [039.324]	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) through Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo de Fomento al Desarrollo Cientifico y Tecnologico (FONDEF)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDEF); Proyecto Asociativo I+D PUCV	This work was supported by the Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) through the 1161452 Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT; http://www.conicyt.cl/fondecyt/) to CA, 1130330 Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT; http://www.conicyt.cl/fondecyt/ to MCM, D09I1190 Fondo de Fomento al Desarrollo Cientifico y Tecnologico (FONDEF; http://www.conicyt.cl/fondef/) to MCM, and the 039.324 Proyecto Asociativo I+D PUCV to CA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamirano C, 2006, J BIOTECHNOL, V125, P547, DOI 10.1016/j.jbiotec.2006.03.023; Aravena O, 2011, IMMUNOBIOLOGY, V216, P1256, DOI 10.1016/j.imbio.2011.07.006; Avello V, 2017, ELECTRON J BIOTECHN, V27, P55, DOI 10.1016/j.ejbt.2017.03.008; Baik JY, 2006, BIOTECHNOL BIOENG, V93, P361, DOI 10.1002/bit.20717; Becerra S, 2012, BIOCHEM ENG J, V60, P1, DOI 10.1016/j.bej.2011.10.003; Becker E, 2008, J BIOTECHNOL, V135, P217, DOI 10.1016/j.jbiotec.2008.03.008; Bedoya-Lopez A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151529; Berrios J, 2009, BIOTECHNOL LETT, V31, P1493, DOI 10.1007/s10529-009-0050-1; Bollati-Fogolin M, 2005, BIOTECHNOL PROGR, V21, P17, DOI 10.1021/bp049825t; BRENNAN FM, 1989, LANCET, V2, P244; Cain K, 2013, BIOTECHNOL PROGR, V29, P697, DOI 10.1002/btpr.1693; Campos-Da-Paz M, 2008, MOL BIOTECHNOL, V39, P155, DOI 10.1007/s12033-008-9055-6; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Carvalhal AV, 2003, CELL, P1000; Chuppa S, 1997, BIOTECHNOL BIOENG, V55, P328, DOI 10.1002/(SICI)1097-0290(19970720)55:2<328::AID-BIT10>3.0.CO;2-D; Coronel J, 2016, BIOCHEM ENG J, V114, P104, DOI 10.1016/j.bej.2016.06.031; Curtis J, 2013, CLIN THER, V33, P679, DOI DOI 10.1016/J.CLINTHERA.2011.05.044.THE; Dickson AJ, 2014, CURR OPIN BIOTECH, V30, P73, DOI 10.1016/j.copbio.2014.06.004; Dorai H, 2013, J PROTEOM BIOINFORM, V6, P99, DOI DOI 10.4172/JPB.1000268; Dorai H, 2009, BIOTECHNOL BIOENG, V103, P592, DOI 10.1002/bit.22269; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Fogolin MB, 2004, J BIOTECHNOL, V109, P179, DOI 10.1016/j.jbiotec.2003.10.035; Fox SR, 2004, BIOTECHNOL BIOENG, V85, P177, DOI 10.1002/bit.10861; Furukawa K, 1998, CYTOTECHNOLOGY, V26, P153, DOI 10.1023/A:1007934216507; Gulis G, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-26; Hong JK, 2011, J BIOTECHNOL, V155, P225, DOI 10.1016/j.jbiotec.2011.06.020; Ifandi V, 2005, BIOTECHNOL PROGR, V21, P671, DOI 10.1021/bp049594q; Ifandi V, 2003, CYTOTECHNOLOGY, V41, P1, DOI 10.1023/A:1024203518501; Kaufmann H, 1999, BIOTECHNOL BIOENG, V63, P573, DOI 10.1002/(SICI)1097-0290(19990605)63:5<573::AID-BIT7>3.0.CO;2-Y; Kochanowski Nadine, 2011, BMC Proc, V5 Suppl 8, pP75, DOI 10.1186/1753-6561-5-S8-P75; Kou TC, 2011, J BIOSCI BIOENG, V111, P365, DOI 10.1016/j.jbiosc.2010.11.016; Ku SCY, 2008, BIOTECHNOL BIOENG, V99, P155, DOI 10.1002/bit.21562; Ku SCY, 2010, BIOTECHNOL PROGR, V26, P517, DOI 10.1002/btpr.322; Kuystermans D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-76; Lattenmayer C, 2006, CYTOTECHNOLOGY, V51, P171, DOI 10.1007/s10616-006-9029-0; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Li JC, 2012, BIOTECHNOL BIOENG, V109, P1173, DOI 10.1002/bit.24389; Locasale JW, 2011, CELL METAB, V14, P443, DOI 10.1016/j.cmet.2011.07.014; Ma NN, 2009, BIOTECHNOL PROGR, V25, P1353, DOI 10.1002/btpr.238; Marchant RJ, 2008, MOL BIOTECHNOL, V39, P69, DOI 10.1007/s12033-008-9032-0; Martinez VS, 2013, BIOTECHNOL BIOENG, V110, P660, DOI 10.1002/bit.24728; Mead EJ, 2009, BIOTECHNOL BIOENG, V102, P1593, DOI 10.1002/bit.22201; Moore A, 1997, CYTOTECHNOLOGY, V23, P47, DOI 10.1023/A:1007919921991; Mulukutla BC, 2012, METAB ENG, V14, P138, DOI 10.1016/j.ymben.2011.12.006; Nolan RP, 2011, METAB ENG, V13, P108, DOI 10.1016/j.ymben.2010.09.003; Oguchi S, 2006, CYTOTECHNOLOGY, V52, P199, DOI 10.1007/s10616-007-9059-2; Pybus LP, 2014, BIOTECHNOL BIOENG, V111, P372, DOI 10.1002/bit.25116; R Core Team, 2015, R LANG ENV STAT COMP, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Rahimpour A, 2013, J MICROBIOL BIOTECHN, V23, P1116, DOI 10.4014/jmb.1302.02035; Rodriguez J, 2005, BIOTECHNOL PROGR, V21, P22, DOI 10.1021/bp049807b; Sellick CA, 2015, BIOTECHNOL J, V10, P1434, DOI 10.1002/biot.201400664; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Sinclair AM, 2005, J PHARM SCI-US, V94, P1626, DOI 10.1002/jps.20319; Smales CM, 2004, BIOTECHNOL BIOENG, V88, P474, DOI 10.1002/bit.20272; Sonna L, 2002, J APPL PHYSIOL, V89, P1253, DOI DOI 10.1152/JAPPLPHYSIOL.00017.2004; Sou SN, 2015, BIOTECHNOL BIOENG, V112, P1165, DOI 10.1002/bit.25524; Sou SN, 2017, BIOTECHNOL BIOENG, P1, DOI [10.1002/bit.26101, DOI 10.1002/BIT.26101, 10.1002/bit.26456]; Sunley K, 2008, BIOTECHNOL PROGR, V24, P898, DOI 10.1021/bp.9; Sunley K, 2010, BIOTECHNOL ADV, V28, P385, DOI 10.1016/j.biotechadv.2010.02.003; Tigges M, 2006, METAB ENG, V8, P264, DOI 10.1016/j.ymben.2006.01.006; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Vergara M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144224; Walsh G, 2014, NAT BIOTECHNOL, V32, P992, DOI 10.1038/nbt.3040; WILLIAMS RO, 1992, P NATL ACAD SCI USA, V89, P9784, DOI 10.1073/pnas.89.20.9784; Wulhfard S, 2008, BIOTECHNOL PROGR, V24, P458, DOI 10.1021/bp070286c; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Yoon SK, 2006, J BIOTECHNOL, V122, P463, DOI 10.1016/j.jbiotec.2005.09.010; Yoon SK, 2005, BIOTECHNOL BIOENG, V89, P345, DOI 10.1002/bit.20353; Yoon SK, 2004, BIOTECHNOL PROGR, V20, P1683, DOI 10.1021/bp049847f; Yoon SK, 2003, BIOTECHNOL BIOENG, V82, P289, DOI 10.1002/bit.10566; Yoon SK, 2003, BIOTECHNOL PROGR, V19, P1383, DOI 10.1021/bp034051m; Zagari F, 2013, NEW BIOTECHNOL, V30, P238, DOI 10.1016/j.nbt.2012.05.021	73	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194510	10.1371/journal.pone.0194510	http://dx.doi.org/10.1371/journal.pone.0194510			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566086	Green Submitted, Green Published, gold			2022-12-26	WOS:000428093900072
J	Yang, WT; Baek, D; Yun, DJ; Lee, KS; Hong, SY; Bae, KD; Chung, YS; Kwon, YS; Kim, DH; Jung, KH; Kim, DH				Yang, Won Tae; Baek, Dongwon; Yun, Dae-Jin; Lee, Kwang Sik; Hong, So Yeon; Bae, Ki Deuk; Chung, Young Soo; Kwon, Yong Sham; Kim, Du Hyun; Jung, Ki Hong; Kim, Doh Hoon			Rice OsMYB5P improves plant phosphate acquisition by regulation of phosphate transporter	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; TRANSCRIPTION FACTOR; MOLECULAR-MECHANISMS; ARABIDOPSIS; HOMEOSTASIS; PHOSPHORUS; EXPRESSION; RESPONSES; PHR1; TRANSLOCATION	Myeloblastosis (MYB) transcription factors play central roles in plant developmental processes and in responses to nutrient deficiency. In this study, OsMYB5P, an R2R3-MYB transcription factor, was isolated and identified from rice (Oryza sativa L. 'Dongjin') under inorganic phosphate (Pi)-deficient conditions. OsMYB5P protein is localized to the nucleus and functions as a transcription activator in plant development. Overexpression of OsMYB5P in rice and Arabidopsis (Arabidopsis thaliana Col-0) increases tolerance to phosphate starvation, whereas OsMYB5P knock-out through RNA interference increases sensitivity to Pi depletion in rice. Furthermore, shoots and roots of transgenic rice plants overexpressing OsMYB5P were longer than those of wild plants under both normal and Pi-deficient conditions. These results indicate that OsMYB5P is associated with the regulation of shoot development and root- system architecture. Overexpression of OsMYB5P led to increased Pi accumulation in shoots and roots. Interestingly, OsMYB5P directly bound to MBS (MYB binding site) motifs on the OsPT5 promoter and induced transcription of OsPT5 in rice. In addition, overexpression of OsMYB5P in Arabidopsis triggered increased expression of AtPht1;3, an Arabidopsis Pi transporter, in shoots and roots under normal and Pi-deficient conditions. Together, these results demonstrate that overexpression of OsMYB5P increases tolerance to Pi deficiency in plants by modulating Pi transporters at the transcriptional level in monocots and dicots.	[Yang, Won Tae; Lee, Kwang Sik; Hong, So Yeon; Bae, Ki Deuk; Chung, Young Soo; Kwon, Yong Sham; Kim, Du Hyun; Kim, Doh Hoon] Dong A Univ, Coll Life Sci & Nat Resources, Busan, South Korea; [Baek, Dongwon] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Div Appl Life Sci PLUS BK21, Jinju, South Korea; [Yun, Dae-Jin] Konkuk Univ, Dept Biomed Sci & Engn, Seoul, South Korea; [Jung, Ki Hong] Kyung Hee Univ, Grad Sch Biotechnol, Yongin, South Korea; [Jung, Ki Hong] Kyung Hee Univ, Crop Biotech Inst, Yongin, South Korea	Dong A University; Gyeongsang National University; Konkuk University; Kyung Hee University; Kyung Hee University	Kim, DH (corresponding author), Dong A Univ, Coll Life Sci & Nat Resources, Busan, South Korea.	dhkim@dau.ac.kr	Jung, Ki Hong/L-5570-2019	Jung, Ki Hong/0000-0003-0427-5901; Yun, Dae-Jin/0000-0002-3638-6043	Dong-A University; URLs	Dong-A University; URLs	This study was supported by the Dong-A University research fund(no grant numbers) and the URLs http://www.donga.ac.kr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2002, PHYSIOL PLANTARUM, V115, P1, DOI 10.1034/j.1399-3054.2002.1150101.x; Ai PH, 2009, PLANT J, V57, P798, DOI 10.1111/j.1365-313X.2008.03726.x; Allan AC, 2008, TRENDS PLANT SCI, V13, P99, DOI 10.1016/j.tplants.2007.11.012; Baek D, 2013, PLANT PHYSIOL, V161, P362, DOI 10.1104/pp.112.205922; Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; Bechtold N, 1998, METH MOL B, V82, P259; Bustos R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001102; Chen JY, 2011, PLANT PHYSIOL, V157, P269, DOI 10.1104/pp.111.181669; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; Chiou TJ, 2011, ANNU REV PLANT BIOL, V62, P185, DOI 10.1146/annurev-arplant-042110-103849; Cominelli E, 2009, CELL RES, V19, P1231, DOI 10.1038/cr.2009.123; Dai XW, 2012, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2012-232; Devaiah BN, 2007, PLANT PHYSIOL, V143, P1789, DOI 10.1104/pp.106.093971; Franco-Zorrilla JM, 2004, J EXP BOT, V55, P285, DOI 10.1093/jxb/erh009; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; Glassop D, 2005, PLANTA, V222, P688, DOI 10.1007/s00425-005-0015-0; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Gu MA, 2016, MOL PLANT, V9, P396, DOI 10.1016/j.molp.2015.12.012; Guimil S, 2005, P NATL ACAD SCI USA, V102, P8066, DOI 10.1073/pnas.0502999102; Guo MN, 2015, PLANT PHYSIOL, V168, P1762, DOI 10.1104/pp.15.00736; Harrison MJ, 2002, PLANT CELL, V14, P2413, DOI 10.1105/tpc.004861; Holford ICR, 1997, AUST J SOIL RES, V35, P227, DOI 10.1071/S96047; Jain A, 2012, CELL MOL LIFE SCI, V69, P3207, DOI 10.1007/s00018-012-1090-6; Jia HF, 2011, PLANT PHYSIOL, V156, P1164, DOI 10.1104/pp.111.175240; Karthikeyan AS, 2002, PLANT PHYSIOL, V130, P221, DOI 10.1104/pp.020007; Katiyar A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-544; Lin WY, 2009, J EXP BOT, V60, P1427, DOI 10.1093/jxb/ern303; Liu F, 2010, PLANT J, V62, P508, DOI 10.1111/j.1365-313X.2010.04170.x; Lopez-Arredondo DL, 2014, ANNU REV PLANT BIOL, V65, P95, DOI 10.1146/annurev-arplant-050213-035949; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Mohanty A, 1999, PLANT SCI, V147, P127, DOI 10.1016/S0168-9452(99)00103-X; Mudge SR, 2002, PLANT J, V31, P341, DOI 10.1046/j.1365-313X.2002.01356.x; Nilsson L, 2007, PLANT CELL ENVIRON, V30, P1499, DOI 10.1111/j.1365-3040.2007.01734.x; Nussaume L, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00083; Paszkowski U, 2002, P NATL ACAD SCI USA, V99, P13324, DOI 10.1073/pnas.202474599; Poirier Yves, 2002, Arabidopsis Book, V1, pe0024, DOI 10.1199/tab.0024; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; Ren F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044005; Ruan WY, 2015, PLANT MOL BIOL, V87, P429, DOI 10.1007/s11103-015-0289-y; Rubio V, 2001, GENE DEV, V15, P2122, DOI 10.1101/gad.204401; Saleh A, 2008, NAT PROTOC, V3, P1018, DOI 10.1038/nprot.2008.66; Shen JB, 2011, PLANT PHYSIOL, V156, P997, DOI 10.1104/pp.111.175232; Shin H, 2004, PLANT J, V39, P629, DOI 10.1111/j.1365-313X.2004.02161.x; Su T, 2015, PLANT PHYSIOL, V167, P1579, DOI 10.1104/pp.114.253799; Sun LC, 2016, PLANT PHYSIOL, V170, P499, DOI 10.1104/pp.15.01336; Sun SB, 2012, PLANT PHYSIOL, V159, P1571, DOI 10.1104/pp.112.196345; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Toki S, 1997, PLANT MOL BIOL REP, V15, P16, DOI 10.1007/BF02772109; Valdes-Lopez O, 2008, PLANT CELL ENVIRON, V31, P1834, DOI 10.1111/j.1365-3040.2008.01883.x; Veneklaas EJ, 2012, NEW PHYTOL, V195, P306, DOI 10.1111/j.1469-8137.2012.04190.x; Versaw WK, 2002, PLANT CELL, V14, P1751, DOI 10.1105/tpc.002220; Wang H, 2014, PLANT PHYSIOL, V164, P2020, DOI 10.1104/pp.113.235077; Wang J, 2013, ANN BOT-LONDON, V111, P1139, DOI 10.1093/aob/mct080; Wang XF, 2014, PLANT CELL ENVIRON, V37, P1159, DOI 10.1111/pce.12224; Yang SY, 2012, PLANT CELL, V24, P4236, DOI 10.1105/tpc.112.104901; Yang WT, 2014, PLANT PHYSIOL BIOCH, V80, P259, DOI 10.1016/j.plaphy.2014.02.024; Ye Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126186; Yu B, 2002, P NATL ACAD SCI USA, V99, P5732, DOI 10.1073/pnas.082696499; Yuan H, 2008, J INTEGR PLANT BIOL, V50, P849, DOI 10.1111/j.1744-7909.2008.00709.x; Zhang ZL, 2014, J INTEGR PLANT BIOL, V56, P192, DOI 10.1111/jipb.12163; Zhou J, 2008, PLANT PHYSIOL, V146, P1673, DOI 10.1104/pp.107.111443; Zhu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043530	63	20	22	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194628	10.1371/journal.pone.0194628	http://dx.doi.org/10.1371/journal.pone.0194628			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566032	Green Published, Green Submitted, gold			2022-12-26	WOS:000428093900089
J	Wang, L; Wang, Y; Meng, Y; Zhang, C; Di, LJ				Wang, Li; Wang, Yuan; Meng, Yuan; Zhang, Chao; Di, Lijun			GSK3-activated STAT5 regulates expression of SFRPs to modulate adipogenesis	FASEB JOURNAL			English	Article						adipocyte differentiation; GSK3; Wnt pathway	GLYCOGEN-SYNTHASE KINASE-3; FRIZZLED-RELATED PROTEIN-1; ACTIVATED-RECEPTOR-GAMMA; SIGNALING PATHWAY; ADIPOCYTE DIFFERENTIATION; SKELETAL-MUSCLE; INSULIN ACTION; INHIBIT ADIPOGENESIS; GLUCOSE-TRANSPORT; METABOLISM	Adipogenesis is a tightly regulated cellular process and is closely associated with obesity and its associated metabolic disorders, such as diabetes. Multiple transcription factors and signaling pathways are involved in the regulation of adipogenesis. Here, we report that glycogen synthase kinase (GSK3), which was reported to play an important role in many cellular processes, is essential to adipocyte differentiation at early and terminal differentiation phases. Mechanistically, GSK3 modulates adipogenesis through regulation of both canonical Wnt pathways, which involve Wnt/-catenin signaling, and noncanonical Wnt pathways, which include JNK and Ras-related C3 botulinum toxin substrate signaling. GSK3-regulated adipogenesis is also mediated by secreted frizzled-related proteins (SFRPs), especially SFRP1, the canonical Wnt antagonist. The obesity-induced increase of Sfrp1 expression can be reversed by the GSK3 inhibitor. GSK3-regulated expression of Sfrp is mediated by signal transducer and activator of transcription 5 (STAT5). We demonstrated that GSK3 activates STAT5 through regulation of its phosphorylation to bind to the promoter of Sfrp genes and the peroxisome proliferator-activated receptor gene to stimulate their expression, which could ultimately lead to a modulated adipogenic process. Our findings identify a GSK3/STAT5/SFRP/Wnt regulatory axis of adipogenesis and shed light on the molecular mechanism of adipogenesis by suggesting that different pathways and adipogenic regulators coordinately modulate adipocyte differentiation.Wang L., Wang, Y., Meng, Y., Zhang, C., Di, L. GSK3-activated STAT5 regulates expression of SFRPs to modulate adipogenesis.	[Wang, Li; Wang, Yuan; Meng, Yuan; Zhang, Chao; Di, Lijun] Univ Macau, Fac Hlth Sci, Taipa, Macau, Peoples R China	University of Macau	Wang, L; Di, LJ (corresponding author), Univ Macau, Fac Hlth Sci, Taipa, Macau, Peoples R China.	liwang@umac.mo; lijundi@umac.mo			Science and Technology Development Fund (FDCT) of Macao [025/2014/A1, 088/2014/A2]; Multi-Year Research Grants from the University of Macau [MYRG2015-00037-FHS, MYRG2015-00167-FHS, MYRG2016-00251-FHS]	Science and Technology Development Fund (FDCT) of Macao; Multi-Year Research Grants from the University of Macau	This work was supported by the Science and Technology Development Fund (FDCT) of Macao (Grants 025/2014/A1 and 088/2014/A2; to L.D.), and by Multi-Year Research Grants MYRG2015-00037-FHS and MYRG2015-00167-FHS (to L.D.) and MYRG2016-00251-FHS (to L.W.) from the University of Macau. The authors declare no conflicts of interest.	Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Camp HS, 1999, ENDOCRINOLOGY, V140, P392, DOI 10.1210/en.140.1.392; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; EldarFinkelman H, 1997, P NATL ACAD SCI USA, V94, P9660, DOI 10.1073/pnas.94.18.9660; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Gustafson B, 2015, TRENDS ENDOCRIN MET, V26, P193, DOI 10.1016/j.tem.2015.01.006; Hong KM, 2007, J BIOL CHEM, V282, P22910, DOI 10.1074/jbc.M703597200; Kanazawa A, 2005, BIOCHEM BIOPH RES CO, V330, P505, DOI 10.1016/j.bbrc.2005.03.007; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Keats EC, 2014, STEM CELLS, V32, P1649, DOI 10.1002/stem.1659; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Lagathu C, 2010, INT J OBESITY, V34, P1695, DOI 10.1038/ijo.2010.107; Lagathu C, 2009, DIABETES, V58, P609, DOI 10.2337/db08-1180; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Moreno-Navarrete J.M., 2017, ADIPOSE TISSUE BIOL, P69, DOI DOI 10.1007/978-3-319-52031-5_3; Mori H, 2012, J CLIN INVEST, V122, P2405, DOI 10.1172/JCI63604; Nanbu-Wakao R, 2002, MOL ENDOCRINOL, V16, P1565, DOI 10.1210/me.16.7.1565; Nikoulina SE, 2000, DIABETES, V49, P263, DOI 10.2337/diabetes.49.2.263; Nikoulina SE, 2002, DIABETES, V51, P2190, DOI 10.2337/diabetes.51.7.2190; Nishizuka M, 2008, FEBS LETT, V582, P3201, DOI 10.1016/j.febslet.2008.08.011; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Okada Y., 2009, J MED SCI, V54, pE241; Okamoto M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04493; Orena SJ, 2000, J BIOL CHEM, V275, P15765, DOI 10.1074/jbc.M910002199; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Park BH, 2004, MOL CELL BIOL, V24, P8671, DOI 10.1128/MCB.24.19.8671-8680.2004; Patel S, 2008, MOL CELL BIOL, V28, P6314, DOI 10.1128/MCB.00763-08; Plotkin B, 2003, J PHARMACOL EXP THER, V305, P974, DOI 10.1124/jpet.102.047381; Prestwich TC, 2007, CURR OPIN CELL BIOL, V19, P612, DOI 10.1016/j.ceb.2007.09.014; Rascle A, 2003, NUCLEIC ACIDS RES, V31, P6882, DOI 10.1093/nar/gkg907; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Schmidt C, 2007, DEV DYNAM, V236, P2502, DOI 10.1002/dvdy.21260; Stephens JM, 1996, J BIOL CHEM, V271, P10441, DOI 10.1074/jbc.271.18.10441; TABATA I, 1994, DIABETES, V43, P903, DOI 10.2337/diabetes.43.7.903; van Amerongen R, 2012, DEV BIOL, V369, P101, DOI 10.1016/j.ydbio.2012.06.020; Wakao Hiroshi, 2011, Environmental Health and Preventive Medicine, V16, P247, DOI 10.1007/s12199-010-0193-7; Wang L, 2015, J BIOL CHEM, V290, P19458, DOI 10.1074/jbc.M115.641332; Wang YH, 2010, MOL CELL BIOL, V30, P3480, DOI 10.1128/MCB.00057-10; Woodgett J. R., 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P281, DOI 10.2174/1568008033340153; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; WOODGETT JR, 1984, BIOCHIM BIOPHYS ACTA, V788, P339, DOI 10.1016/0167-4838(84)90047-5; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Zaragosi LE, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-11	53	18	19	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4714	4726		10.1096/fj.201701314R	http://dx.doi.org/10.1096/fj.201701314R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29579399				2022-12-26	WOS:000443817700008
J	Mondal, N; Dykstra, B; Lee, J; Ashline, DJ; Reinhold, VN; Rossi, DJ; Sackstein, R				Mondal, Nandini; Dykstra, Brad; Lee, Jungmin; Ashline, David J.; Reinhold, Vernon N.; Rossi, Derrick J.; Sackstein, Robert			Distinct human (1,3)-fucosyltransferases drive Lewis-X/sialyl Lewis-X assembly in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; fucosyltransferase; mesenchymal stem cells (MSCs); mRNA; mass spectrometry (MS); glycoengineering; Lewis-X; modified mRNA; sialyl Lewis-X; E-selectin ligand	HUMAN ALPHA(1,3)FUCOSYLTRANSFERASE GENE; SELECTIN LIGAND EXPRESSION; MOLECULAR-CLONING; STEM-CELLS; FUC-TVII; FUCOSYL-TRANSFERASE; EMBRYONIC ANTIGEN; SUBSTRATE SPECIFICITIES; DETERMINES EXPRESSION; MASS-SPECTROMETRY	In humans, six (1,3)-fucosyltransferases ((1,3)-FTs: FT3/FT4/FT5/FT6/FT7/FT9) reportedly fucosylate terminal lactosaminyl glycans yielding Lewis-X (Le(X); CD15) and/or sialyl Lewis-X (sLe(X); CD15s), structures that play key functions in cell migration, development, and immunity. Prior studies analyzing (1,3)-FT specificities utilized either purified and/or recombinant enzymes to modify synthetic substrates under nonphysiological reaction conditions or molecular biology approaches wherein (1,3)-FTs were expressed in mammalian cell lines, notably excluding investigations using primary human cells. Accordingly, although significant insights into (1,3)-FT catalytic properties have been obtained, uncertainty persists regarding their human Le(X)/sLe(X) biosynthetic range across various glycoconjugates. Here, we undertook a comprehensive evaluation of the lactosaminyl product specificities of intracellularly expressed (1,3)-FTs using a clinically relevant primary human cell type, mesenchymal stem cells. Cells were transfected with modified mRNA encoding each human (1,3)-FT, and the resultant (1,3)-fucosylated lactosaminyl glycoconjugates were analyzed using a combination of flow cytometry and MS. The data show that biosynthesis of sLe(X) is driven by FTs-3, -5, -6, and -7, with FT6 and FT7 having highest potency. FT4 and FT9 dominantly biosynthesize Le(X), and, among all FTs, FT6 holds a unique capacity in creating sLe(X) and Le(X) determinants across protein and lipid glycoconjugates. Surprisingly, FT4 does not generate sLe(X) on glycolipids, and neither FT4, FT6, nor FT9 synthesizes the internally fucosylated sialyllactosamine VIM-2 (CD65s). These results unveil the relevant human lactosaminyl glycans created by human (1,3)-FTs, providing novel insights on how these isoenzymes stereoselectively shape biosynthesis of vital glycoconjugates, thereby biochemically programming human cell migration and tuning human immunologic and developmental processes.	[Mondal, Nandini; Dykstra, Brad; Sackstein, Robert] Harvard Med Sch, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Mondal, Nandini; Dykstra, Brad; Sackstein, Robert] Harvard Med Sch, Brigham & Womens Hosp, Harvard Skin Dis Res Ctr, Boston, MA 02115 USA; [Mondal, Nandini; Dykstra, Brad; Ashline, David J.; Reinhold, Vernon N.; Sackstein, Robert] Harvard Med Sch, Brigham & Womens Hosp, Program Excellence Glycosci, Boston, MA 02115 USA; [Lee, Jungmin; Rossi, Derrick J.] Harvard Med Sch, Boston Childrens Hosp, Div Hematol Oncol, Program Cellular & Mol Med, Boston, MA 02115 USA; [Lee, Jungmin; Rossi, Derrick J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Ashline, David J.; Reinhold, Vernon N.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Glyc Ctr, Durham, NH 03828 USA; [Sackstein, Robert] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Dykstra, Brad] Platelet Biogenesis, Boston, MA 02125 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; University System Of New Hampshire; University of New Hampshire; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Sackstein, R (corresponding author), Harvard Inst Med, 77 Ave Louis Pasteur,Rm 671, Boston, MA 02115 USA.	rsackstein@partners.org			National Institutes of Health [RO1HL107630, UO1HL107440, UC4DK104218, U19HL129903]; Program of Excellence in Glycosciences; National Institutes of Health NHLBI [PO1 HL107146]; Team Jobie Fund; Leona M. and Harry B. Helmsley Charitable Trust; New York Stem Cell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107146, U01HL107440, U19HL129903, R01HL107630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UC4DK104218] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Program of Excellence in Glycosciences; National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Team Jobie Fund; Leona M. and Harry B. Helmsley Charitable Trust; New York Stem Cell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by National Institutes of Health Grants RO1HL107630, UO1HL107440, UC4DK104218, and U19HL129903, The Leona M. and Harry B. Helmsley Charitable Trust, and the New York Stem Cell Foundation.; Supported by the National Institutes of Health NHLBI Grant PO1 HL107146, the Program of Excellence in Glycosciences, and the Team Jobie Fund.	Alley WR, 2010, ANAL CHEM, V82, P5095, DOI 10.1021/ac100131e; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Ashline DJ, 2017, ANAL BIOANAL CHEM, V409, P439, DOI 10.1007/s00216-016-0018-7; Ashline DJ, 2014, J AM SOC MASS SPECTR, V25, P444, DOI 10.1007/s13361-013-0776-9; Bai XM, 2001, GLYCOBIOLOGY, V11, P621, DOI 10.1093/glycob/11.8.621; Barthel SR, 2009, P NATL ACAD SCI USA, V106, P19491, DOI 10.1073/pnas.0906074106; BASU M, 1991, Glycobiology, V1, P527, DOI 10.1093/glycob/1.5.527; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Buffone A, 2013, J BIOL CHEM, V288, P1620, DOI 10.1074/jbc.M112.400929; Cailleau-Thomas A, 2000, GLYCOBIOLOGY, V10, P789, DOI 10.1093/glycob/10.8.789; Canis K, 2010, J THROMB HAEMOST, V8, P137, DOI 10.1111/j.1538-7836.2009.03665.x; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; CARLSON DM, 1966, J BIOL CHEM, V241, P2984; Chou MY, 1996, J BIOL CHEM, V271, P19219, DOI 10.1074/jbc.271.32.19219; Dykstra B, 2016, STEM CELLS, V34, P2501, DOI 10.1002/stem.2435; FENDERSON BA, 1984, J EXP MED, V160, P1591, DOI 10.1084/jem.160.5.1591; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; FUKUSHI Y, 1984, J BIOL CHEM, V259, P511; Garner B, 2002, J LIPID RES, V43, P205; Geisler C, 2011, GLYCOBIOLOGY, V21, P988, DOI 10.1093/glycob/cwr080; GERSTEN KM, 1995, J BIOL CHEM, V270, P25047, DOI 10.1074/jbc.270.42.25047; GOELZ SE, 1990, CELL, V63, P1349, DOI 10.1016/0092-8674(90)90430-M; GOOI HC, 1981, NATURE, V292, P156, DOI 10.1038/292156a0; Gruss HJ, 1996, BAILLIERE CLIN HAEM, V9, P417, DOI 10.1016/S0950-3536(96)80019-9; Handa K, 1997, BIOCHEMISTRY-US, V36, P12412, DOI 10.1021/bi971181t; Homeister JW, 2004, ARTERIOSCL THROM VAS, V24, P1897, DOI 10.1161/01.ATV.0000141844.28073.df; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; Huang MC, 2002, J BIOL CHEM, V277, P47786, DOI 10.1074/jbc.M208283200; Julien S, 2011, CANCER RES, V71, P7683, DOI 10.1158/0008-5472.CAN-11-1139; Kaneko M, 1999, FEBS LETT, V452, P237, DOI 10.1016/S0014-5793(99)00640-7; Kang P, 2005, RAPID COMMUN MASS SP, V19, P3421, DOI 10.1002/rcm.2210; Kimura H, 1997, BIOCHEM BIOPH RES CO, V237, P131, DOI 10.1006/bbrc.1997.7100; Klassen H, 2001, NEUROSCI LETT, V312, P180, DOI 10.1016/S0304-3940(01)02215-7; Knibbs RN, 1996, J CELL BIOL, V133, P911, DOI 10.1083/jcb.133.4.911; KUKOWSKALATALLO JF, 1990, GENE DEV, V4, P1288, DOI 10.1101/gad.4.8.1288; Kumar A, 2013, J BIOL CHEM, V288, P28859, DOI 10.1074/jbc.M113.469403; KUMAR R, 1991, J BIOL CHEM, V266, P21777; Liang JX, 2016, ONCOTARGETS THER, V9, P3113, DOI 10.2147/OTT.S102389; LOWE JB, 1991, J BIOL CHEM, V266, P17467; Madeira C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/735349; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Mandal PK, 2013, NAT PROTOC, V8, P568, DOI 10.1038/nprot.2013.019; Merzaban JS, 2011, BLOOD, V118, P1774, DOI 10.1182/blood-2010-11-320705; Mollicone R, 2009, J BIOL CHEM, V284, P4723, DOI 10.1074/jbc.M809312200; Mondal N, 2016, ARTERIOSCL THROM VAS, V36, P718, DOI 10.1161/ATVBAHA.115.306748; Nakayama F, 2001, J BIOL CHEM, V276, P16100, DOI 10.1074/jbc.M007272200; NATSUKA S, 1994, J BIOL CHEM, V269, P16789; Niemela R, 1998, J BIOL CHEM, V273, P4021, DOI 10.1074/jbc.273.7.4021; Nishihara S, 1999, FEBS LETT, V462, P289, DOI 10.1016/S0014-5793(99)01549-5; Patnaik SK, 2004, J BIOL CHEM, V279, P49716, DOI 10.1074/jbc.M408755200; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Sackstein R, 2004, J INVEST DERMATOL, V122, P1061, DOI 10.1111/j.0022-202X.2004.09301.x; Sackstein R, 2008, NAT MED, V14, P181, DOI 10.1038/nm1703; Sackstein R, 2012, EXP HEMATOL, V40, P518, DOI 10.1016/j.exphem.2012.03.004; Sackstein R, 2009, IMMUNOL REV, V230, P51, DOI 10.1111/j.1600-065X.2009.00792.x; SASAKI K, 1994, J BIOL CHEM, V269, P14730; Seidmann L, 2016, PLACENTA, V38, P93, DOI 10.1016/j.placenta.2015.12.013; Shetterly S, 2007, J BIOL CHEM, V282, P24882, DOI 10.1074/jbc.M702395200; Silva M, 2017, J IMMUNOL, V198, P3576, DOI 10.4049/jimmunol.1601636; Smithson G, 2001, J EXP MED, V194, P601, DOI 10.1084/jem.194.5.601; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; St Hill CA, 2011, FRONT BIOSCI-LANDMRK, V16, P3233, DOI 10.2741/3909; Stolfa G, 2016, SCI REP-UK, V6, DOI 10.1038/srep30392; TIEMEYER M, 1991, P NATL ACAD SCI USA, V88, P1138, DOI 10.1073/pnas.88.4.1138; Tu LN, 2010, CELL MOL LIFE SCI, V67, P29, DOI 10.1007/s00018-009-0126-z; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; WESTON BW, 1992, J BIOL CHEM, V267, P4152; WESTON BW, 1992, J BIOL CHEM, V267, P24575; Yagi H, 2012, J BIOL CHEM, V287, P24356, DOI 10.1074/jbc.M112.365643; Yanagisawa M, 2005, J NEUROCHEM, V95, P1311, DOI 10.1111/j.1471-4159.2005.03452.x; Zollner O, 1996, J BIOL CHEM, V271, P33002, DOI 10.1074/jbc.271.51.33002	72	39	40	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7300	7314		10.1074/jbc.RA117.000775	http://dx.doi.org/10.1074/jbc.RA117.000775			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29593094	hybrid, Green Published			2022-12-26	WOS:000432174500024
J	Albuquerque, PL; Campelo, M; Mendonca, T; Augusto, L; Fontes, M; Brito, RD; Monte-Silva, K				Albuquerque, Plinio Luna; Campelo, Mayara; Mendonca, Thyciane; Augusto, Luis; Fontes, Mendes; Brito, Rodrigo de Mattos; Monte-Silva, Katia			Effects of repetitive transcranial magnetic stimulation and trans-spinal direct current stimulation associated with treadmill exercise in spinal cord and cortical excitability of healthy subjects: A triple-blind, randomized and sham-controlled study	PLOS ONE			English	Article							HUMAN MOTOR CORTEX; TRAINING-INDUCED PLASTICITY; NOCICEPTIVE FLEXION REFLEX; HIGH-FREQUENCY RTMS; SOLEUS H-REFLEX; OF-THE-ART; RECIPROCAL INHIBITION; CONTROLLED-TRIAL; RECOVERY CURVE; HUMANS	Repetitive transcranial magnetic stimulation (rTMS) over motor cortex and trans-spinal direct current stimulation (tsDCS) modulate corticospinal circuits in healthy and injured subjects. However, their associated effects with physical exercise is still not defined. This study aimed to investigate the effect of three different settings of rTMS and tsDCS combined with treadmill exercise on spinal cord and cortical excitability of healthy subjects. We performed a triple blind, randomized, sham-controlled crossover study with 12 healthy volunteers who underwent single sessions of rTMS (1Hz, 20Hz and Sham) and tsDCS (anodal, cathodal and Sham) associated with 20 minutes of treadmill walking. Cortical excitability was assessed by motor evoked potential (MEP) and spinal cord excitability by the Hoffmann reflex (Hr), nociceptive flexion reflex (NFR) and homosynaptic depression (HD). All measures were assessed before, immediately, 30 and 60 minutes after the experimental procedures. Our results demonstrated that anodal tsDCS/treadmill exercise reduced MEP's amplitude and NFR's area compared to sham condition, conversely, cathodal tsDCS/treadmill exercise increased NFR's area. High-frequency rTMS increased MEP's amplitude and NFR's area compared to sham condition. Anodal tsDCS/treadmill exercise and 20Hz rTMS/treadmill exercise reduced Hr amplitude up to 30 minutes after stimulation offset and no changes were observed in HD measures. We demonstrated that tsDCS and rTMS combined with treadmill exercise modulated cortical and spinal cord excitability through different mechanisms. tsDCS modulated spinal reflexes in a polarity-dependent way acting at local spinal circuits while rTMS probably promoted changes in the presynaptic inhibition of spinal motoneurons. In addition, the association of two neuromodulatory techniques induced long-lasting changes.	[Albuquerque, Plinio Luna; Campelo, Mayara; Mendonca, Thyciane; Augusto, Luis; Fontes, Mendes; Brito, Rodrigo de Mattos; Monte-Silva, Katia] Univ Fed Pernambuco, Dept Phys Therapy, Appl Neurosci Lab, Recife, PE, Brazil; [Albuquerque, Plinio Luna] Ctr Univ Tabosa Almeida, Dept Phys Therapy, Caruaru, PE, Brazil; [Albuquerque, Plinio Luna; Campelo, Mayara; Monte-Silva, Katia] Univ Fed Pernambuco, Postgrad Program Neuropsychiat & Behav Sci, Recife, PE, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco	Monte-Silva, K (corresponding author), Univ Fed Pernambuco, Dept Phys Therapy, Appl Neurosci Lab, Recife, PE, Brazil.; Monte-Silva, K (corresponding author), Univ Fed Pernambuco, Postgrad Program Neuropsychiat & Behav Sci, Recife, PE, Brazil.	monte.silvakk@gmail.com	Silva, Katia Monte/V-4004-2019; Monte-Silva, Katia KMS/A-2444-2014	Silva, Katia Monte/0000-0001-7301-2553; Monte-Silva, Katia KMS/0000-0001-7301-2553				Aguilar J, 2011, J PHYSIOL-LONDON, V589, P4981, DOI 10.1113/jphysiol.2011.214189; Ahmed Z, 2013, J NEUROSCI, V33, P14949, DOI 10.1523/JNEUROSCI.2793-13.2013; Ahmed Z, 2012, J APPL PHYSIOL, V112, P1576, DOI 10.1152/japplphysiol.00967.2011; Arai N, 2007, CLIN NEUROPHYSIOL, V118, P2227, DOI 10.1016/j.clinph.2007.07.006; Galvao SCB, 2014, ARCH PHYS MED REHAB, V95, P222, DOI 10.1016/j.apmr.2013.10.023; Berardelli A, 1998, EXP BRAIN RES, V122, P79, DOI 10.1007/s002210050493; Bhatia BD, 2011, NEUROSCI LETT, V488, P107, DOI 10.1016/j.neulet.2010.08.087; Bocci T, 2014, NEUROSCI LETT, V578, P75, DOI 10.1016/j.neulet.2014.06.037; Bolognini N, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-8; Brunoni AR, 2011, INT J NEUROPSYCHOPH, V14, P1133, DOI 10.1017/S1461145710001690; Cogiamanian F, PAIN; Cogiamanian F, 2008, CLIN NEUROPHYSIOL, V119, P2636, DOI 10.1016/j.clinph.2008.07.249; Cosentino G, 2012, EUR J NEUROSCI, V35, P119, DOI 10.1111/j.1460-9568.2011.07939.x; CRONE C, 1994, ACTA PHYSIOL SCAND, V152, P351, DOI 10.1111/j.1748-1716.1994.tb09817.x; Donges SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172333; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Grecco LH, 2015, J NEURORESTORATOLOGY, V3, P73, DOI 10.2147/JN.S77813; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Harel NY, 2015, J ELECTROMYOGR KINES, V25, P438, DOI 10.1016/j.jelekin.2015.02.009; Heide AC, 2014, BRAIN STIMUL, V7, P636, DOI 10.1016/j.brs.2014.06.008; Hosseinzadeh M, 2013, EUR J APPL PHYSIOL, V113, P2595, DOI 10.1007/s00421-013-2701-0; Hubli M, 2013, CLIN NEUROPHYSIOL, V124, P1187, DOI 10.1016/j.clinph.2012.11.021; Inghilleri M, 2004, CLIN NEUROPHYSIOL, V115, P1063, DOI 10.1016/j.clinph.2003.12.003; Johnson S, 2006, PAIN, V123, P187, DOI 10.1016/j.pain.2006.02.030; Jubeau M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089157; Knikou M, 2010, CLIN NEUROPHYSIOL, V121, P1655, DOI 10.1016/j.clinph.2010.01.039; Kumru H, 2015, MUSCLE NERVE, V52, P616, DOI 10.1002/mus.24579; Kumru H, 2010, NEUROREHAB NEURAL RE, V24, P435, DOI 10.1177/1545968309356095; Lamy JC, 2012, J NEUROPHYSIOL, V108, P906, DOI 10.1152/jn.10898.2011; Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021; Matsudo S, 2001, REV BRAS ATIV SAUDE, V6, P5, DOI DOI 10.12820/RBAFS.V.6N2P5-18; Mazzocchio R, 2006, CLIN NEUROPHYSIOL, V117, P1682, DOI 10.1016/j.clinph.2006.04.019; McDonnell MN, 2013, J APPL PHYSIOL, V114, P1174, DOI 10.1152/japplphysiol.01378.2012; Meunier S, 2007, J PHYSIOL-LONDON, V579, P375, DOI 10.1113/jphysiol.2006.122911; Motl RW, 2003, NEUROSCI LETT, V347, P69, DOI 10.1016/S0304-3940(03)00652-9; Muller-Dahlhaus F, 2015, NEUROSCIENTIST, V21, P185, DOI 10.1177/1073858414526645; Mylius V, 2007, NEUROSCI LETT, V415, P49, DOI 10.1016/j.neulet.2006.12.042; Nahmias F, 2009, PAIN, V147, P224, DOI 10.1016/j.pain.2009.09.016; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PANIZZA M, 1995, AM J PHYS MED REHAB, V74, P357; Peinemann A, 2004, CLIN NEUROPHYSIOL, V115, P1519, DOI 10.1016/j.clinph.2004.02.005; Perez MA, 2005, J PHYSIOL-LONDON, V568, P343, DOI 10.1113/jphysiol.2005.089904; Perez MA, 2005, EXP BRAIN RES, V162, P202, DOI 10.1007/s00221-004-2144-2; Perrotta A, 2016, CLIN NEUROPHYSIOL, V127, P755, DOI 10.1016/j.clinph.2015.01.031; Price DD, 2003, PAIN, V106, P215, DOI 10.1016/j.pain.2003.10.016; Priori A, 2014, J PHYSIOL-LONDON, V592, P3345, DOI 10.1113/jphysiol.2013.270280; Quartarone A, 2005, EXP BRAIN RES, V161, P114, DOI 10.1007/s00221-004-2052-5; Rastgoo M, 2016, DISABIL REHABIL, V38, P1918, DOI 10.3109/09638288.2015.1107780; Rhudy JL, 2007, PAIN, V128, P244, DOI 10.1016/j.pain.2006.09.024; Rocha S, 2016, DISABIL REHABIL, V38, P653, DOI 10.3109/09638288.2015.1055382; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Sadowski B, 2008, J HUM KINET, V20, P5, DOI 10.2478/v10078-008-0014-x; SCHOMBURG ED, 1990, NEUROSURG REV, V13, P179, DOI 10.1007/BF00313016; Shen Y, 2016, BIOL PSYCHIAT, V80, pE13, DOI 10.1016/j.biopsych.2016.02.006; Singh AM, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-23; Summers J, 2004, NEUROSCI LETT, V368, P197, DOI 10.1016/j.neulet.2004.07.008; Terao Y, 2002, J CLIN NEUROPHYSIOL, V19, P322, DOI 10.1097/00004691-200208000-00006; Terraneo A, 2016, EUR NEUROPSYCHOPHARM, V26, P37, DOI 10.1016/j.euroneuro.2015.11.011; Truini A, 2011, EUR J PAIN, V15, P1023, DOI 10.1016/j.ejpain.2011.04.009; Valero-Cabre A, 2001, NEUROREPORT, V12, P3845, DOI 10.1097/00001756-200112040-00048; Winkler T, 2010, CLIN NEUROPHYSIOL, V121, P957, DOI 10.1016/j.clinph.2010.01.014; [No title captured], DOI DOI 10.1016/J.EJPAIN.2009.04.010	64	14	16	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195276	10.1371/journal.pone.0195276	http://dx.doi.org/10.1371/journal.pone.0195276			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596524	Green Published, gold			2022-12-26	WOS:000428630000101
J	Conceicao, MS; Gaspari, AF; Ramkrapes, APB; Junior, EMM; Bertuzzi, R; Cavaglieri, CR; Chacon-Mikahil, MPT				Conceicao, Miguel S.; Gaspari, Arthur F.; Ramkrapes, Ana P. B.; Junior, Edson M. M.; Bertuzzi, Romulo; Cavaglieri, Claudia R.; Chacon-Mikahil, Mara Patricia T.			Anaerobic metabolism induces greater total energy expenditure during exercise with blood flow restriction	PLOS ONE			English	Article							MUSCLE METABOREFLEX CONTROL; CARDIOVASCULAR-RESPONSES; HEART-RATE; INTENSITY; STRENGTH; ACTIVATION; WALKING; KINETICS; INCREASE; LACTATE	Purpose We investigated the energy system contributions and total energy expenditure during low intensity endurance exercise associated with blood flow restriction (LIE-BFR) and without blood flow restriction (LIE). Methods Twelve males participated in a contra-balanced, cross-over design in which subjects completed a bout of low-intensity endurance exercise (30min cycling at 40% of <(V)over dot>O-2max) with or without BFR, separated by at least 72 hours of recovery. Blood lactate accumulation and oxygen uptake during and after exercise were used to estimate the anaerobic lactic metabolism, aerobic metabolism, and anaerobic alactic metabolism contributions, respectively. Results There were significant increases in the anaerobic lactic metabolism (P = 0.008), aerobic metabolism (P = 0.020), and total energy expenditure (P = 0.008) in the LIE-BFR. No significant differences between conditions for the anaerobic alactic metabolism were found (P = 0.582). Plasma lactate concentration was significantly higher in the LIE-BFR at 15min and peak post-exercise (all P <= 0.008). Heart rate was significantly higher in the LIE-BFR at 10, 15, 20, 25, and 30min during exercise, and 5, 10, and 15min after exercise (all P <= 0.03). Ventilation was significantly higher in the LIE-BFR at 10, 15, and 20min during exercise (all P <= 0.003). Conclusion Low-intensity endurance exercise performed with blood flow restriction increases the anaerobic lactic and aerobic metabolisms, total energy expenditure, and cardiorespiratory responses.	[Conceicao, Miguel S.; Gaspari, Arthur F.; Ramkrapes, Ana P. B.; Junior, Edson M. M.; Cavaglieri, Claudia R.; Chacon-Mikahil, Mara Patricia T.] Univ Estadual Campinas, Sch Phys Educ, Exercise Physiol Lab, Campinas, SP, Brazil; [Conceicao, Miguel S.; Bertuzzi, Romulo] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Gaspari, Arthur F.; Bertuzzi, Romulo] Univ Sao Paulo, Sch Phys Educ & Sport, Endurance Sports Res Grp GEDAE, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade de Sao Paulo	Conceicao, MS (corresponding author), Univ Estadual Campinas, Sch Phys Educ, Exercise Physiol Lab, Campinas, SP, Brazil.; Conceicao, MS (corresponding author), Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil.	conceicao.miguel0106@gmail.com	Bertuzzi, Romulo/E-7048-2012; Roschel, Hamilton/D-4353-2012; CONCEIÇÃO, MIGUEL SOARES/P-3451-2019; Cavaglieri, Cláudia Regina/C-4291-2012; Conceição, Miguel S/G-9437-2012	Roschel, Hamilton/0000-0002-9513-6132; CONCEIÇÃO, MIGUEL SOARES/0000-0002-9170-7890; Cavaglieri, Cláudia Regina/0000-0002-7795-6575; Conceição, Miguel S/0000-0002-9170-7890; Chacon-Mikahil, Mara Patricia Traina/0000-0002-6109-5141				Abe T, 2006, J APPL PHYSIOL, V100, P1460, DOI 10.1152/japplphysiol.01267.2005; Abe T, 2010, J SPORT SCI MED, V9, P452; Augustyniak RA, 2000, AM J PHYSIOL-HEART C, V278, pH530, DOI 10.1152/ajpheart.2000.278.2.H530; Augustyniak RA, 2001, AM J PHYSIOL-HEART C, V280, pH1645, DOI 10.1152/ajpheart.2001.280.4.H1645; Bertuzzi R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145733; Bertuzzi R, 2013, J SPORT SCI MED, V12, P454; BORG G, 1985, EUR J APPL PHYSIOL O, V54, P343, DOI 10.1007/BF02337176; Boushel R, 2010, ACTA PHYSIOL, V199, P367, DOI 10.1111/j.1748-1716.2010.02133.x; Conceicao MS, 2016, MED SCI SPORT EXER, V48, P1699, DOI 10.1249/MSS.0000000000000970; di Prampero PE, 1999, RESP PHYSIOL, V118, P103, DOI 10.1016/S0034-5687(99)00083-3; Egan B, 2010, J PHYSIOL-LONDON, V588, P1779, DOI 10.1113/jphysiol.2010.188011; Engelen M, 1996, J APPL PHYSIOL, V81, P2500, DOI 10.1152/jappl.1996.81.6.2500; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fisher JP, 2015, COMPR PHYSIOL, V5, P475, DOI 10.1002/cphy.c140022; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; HANSEN J, 1994, AM J PHYSIOL, V266, pH2508, DOI 10.1152/ajpheart.1994.266.6.H2508; Hartwich D, 2011, J PHYSIOL-LONDON, V589, P6157, DOI 10.1113/jphysiol.2011.219964; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; Hughson RL, 1996, J APPL PHYSIOL, V81, P1619, DOI 10.1152/jappl.1996.81.4.1619; Ichinose M, 2015, AM J PHYSIOL-REG I, V309, pR1234, DOI 10.1152/ajpregu.00063.2015; Iida H, 2007, EUR J APPL PHYSIOL, V100, P275, DOI 10.1007/s00421-007-0430-y; Karabulut M, 2017, CLIN PHYSIOL FUNCT I, V37, P1, DOI 10.1111/cpf.12258; Karabulut M, 2011, J SPORT SCI, V29, P951, DOI 10.1080/02640414.2011.572992; Laurentino GC, 2012, MED SCI SPORT EXER, V44, P406, DOI 10.1249/MSS.0b013e318233b4bc; Melzer K, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2015.36; Mendonca GV, 2014, CLIN PHYSIOL FUNCT I, V34, P308, DOI 10.1111/cpf.12098; Mendonca GV, 2015, INT J SPORTS MED; Meyer T, 2005, INT J SPORTS MED, V26, pS38, DOI 10.1055/s-2004-830514; Michael S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00301; Mouser JG, 2017, APPL PHYSIOL NUTR ME, V42, P1165, DOI 10.1139/apnm-2017-0102; Nakajima T, 2008, EUR J APPL PHYSIOL, V104, P727, DOI 10.1007/s00421-008-0834-3; O'Leary DS, 1999, AM J PHYSIOL-HEART C, V276, pH1399, DOI 10.1152/ajpheart.1999.276.4.H1399; Ozaki H, 2014, ACTA PHYSIOL, V211, P97, DOI 10.1111/apha.12243; Ozaki H, 2010, J SPORT SCI MED, V9, P224; Park S, 2010, EUR J APPL PHYSIOL, V109, P591, DOI 10.1007/s00421-010-1377-y; Prodel E, 2016, AM J PHYSIOL-HEART C, V310, pH1201, DOI 10.1152/ajpheart.00894.2015; Renzi CP, 2010, MED SCI SPORT EXER, V42, P726, DOI 10.1249/MSS.0b013e3181bdb454; Sakamaki-Sunaga M, 2012, COMP EXERC PHYSIOL, V8, P117, DOI 10.3920/CEP12007; Seals D R, 1991, Exerc Sport Sci Rev, V19, P313; Spranger MD, 2015, AM J PHYSIOL-HEART C, V309, pH1440, DOI 10.1152/ajpheart.00208.2015; Swain DP, 2002, MED SCI SPORT EXER, V34, P152, DOI 10.1097/00005768-200201000-00023; Takada S, 2012, J APPL PHYSIOL, V113, P199, DOI 10.1152/japplphysiol.00149.2012; Tanimoto M, 2005, INT J KAATSU TRAININ, V1, P51, DOI DOI 10.3806/IJKTR.1.51; van Hall G, 2010, ACTA PHYSIOL, V199, P499, DOI 10.1111/j.1748-1716.2010.02122.x; Ferreira MLV, 2017, J SPORT SCI, V35, P2412, DOI 10.1080/02640414.2016.1271139; Yasuda T, 2010, METABOLISM, V59, P1510, DOI 10.1016/j.metabol.2010.01.016; Zinner C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140616	47	14	14	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194776	10.1371/journal.pone.0194776	http://dx.doi.org/10.1371/journal.pone.0194776			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596452	Green Published, Green Submitted, gold			2022-12-26	WOS:000428630000041
J	Deike-Hofmann, K; Thunemann, D; Breckwoldt, MO; Schwarz, D; Radbruch, A; Enk, A; Bendszus, M; Hassel, J; Schlemmer, HP; Baumer, P				Deike-Hofmann, Katerina; Thuenemann, Daniel; Breckwoldt, Michael O.; Schwarz, Daniel; Radbruch, Alexander; Enk, Alexander; Bendszus, Martin; Hassel, Jessica; Schlemmer, Heinz-Peter; Baeumer, Philipp			Sensitivity of different MRI sequences in the early detection of melanoma brain metastases	PLOS ONE			English	Article							SPIN-ECHO; CONTRAST ENHANCEMENT; MALIGNANT-MELANOMA; IMPROVES DETECTION; GLOBUS-PALLIDUS; BONE METASTASES; DENTATE NUCLEUS; MP-RAGE; TIME; ACQUISITION	Background After the emergence of new MRI techniques such as susceptibility-and diffusion-weighted imaging (SWI and DWI) and because of specific imaging characteristics of melanoma brain metastases (MBM), it is unclear which MRI sequences are most beneficial for detection of MBM. This study was performed to investigate the sensitivity of six clinical MRI sequences in the early detection of MBM. Methods Medical records of all melanoma patients referred to our center between November 2005 and December 2016 were reviewed for presence of MBM. Analysis encompassed six MRI sequences at the time of initial diagnosis of first or new MBM, including non-enhanced T1-weighted (T1w), contrast-enhanced T1w (ceT1w), T2-weighted (T2w), T2w-FLAIR, susceptibility-weighted (SWI) and diffusion-weighted (DWI) MRI. Each lesion was rated with respect to its conspicuity (score from 0-not detectable to 3-clearly visible). Results Of 1210 patients, 217 with MBM were included in the analysis and up to 5 lesions per patient were evaluated. A total of 720 metastases were assessed and all six sequences were available for 425 MBM. Sensitivity (conspicuity >= 2) was 99.7% for ceT1w, 77.0% for FLAIR, 64.7% for SWI, 61.0% for T2w, 56.7% for T1w, and 48.4% for DWI. Thirty-one (7.3%) of 425 lesions were only detectable by ceT1w but no other sequence. Conclusions Contrast-enhanced T1-weighting is more sensitive than all other sequences for detection of MBM. Disruption of the blood-brain-barrier is consistently an earlier sign in MBM than perifocal edema, signal loss on SWI or diffusion restriction.	[Deike-Hofmann, Katerina; Thuenemann, Daniel; Breckwoldt, Michael O.; Schwarz, Daniel; Radbruch, Alexander; Schlemmer, Heinz-Peter; Baeumer, Philipp] DKFZ, Dept Radiol, German Canc Res Ctr, Heidelberg, Germany; [Breckwoldt, Michael O.; Schwarz, Daniel; Bendszus, Martin] Heidelberg Univ, Med Ctr, Dept Neuroradiol, Heidelberg, Germany; [Enk, Alexander; Hassel, Jessica] Heidelberg Univ, Med Ctr, Dept Dermatol, Natl Ctr Tumor Dis,NCT, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Baumer, P (corresponding author), DKFZ, Dept Radiol, German Canc Res Ctr, Heidelberg, Germany.	p.baeumer@dkfz.de	Radbruch, Alexander/ABA-6277-2021	Baumer, Philipp/0000-0003-2896-543X; Schwarz, Daniel/0000-0002-9017-8245; Radbruch, Alexander/0000-0001-6238-6525; Deike, Katerina/0000-0002-4319-0428				Ali S, 2015, AJNR Am J Neuroradiol, V36, pE69, DOI 10.3174/ajnr.A4581; Amer M, 1976, CANCER, V42, P660; Anzalone N, 2009, ACTA RADIOL, V50, P933, DOI 10.1080/02841850903095385; Ba-Ssalamah A, 2003, INVEST RADIOL, V38, P415, DOI 10.1097/00004424-200307000-00006; Barnholtz-Sloan JS, 2004, J CLIN ONCOL, V22, P2865, DOI 10.1200/JCO.2004.12.149; Beiderwellen K, 2013, EUR J RADIOL, V82, pE669, DOI 10.1016/j.ejrad.2013.07.027; Bluml S, 1996, MAGN RESON IMAGING, V14, P329, DOI 10.1016/0730-725X(95)02095-B; BUDMAN DR, 1978, EUR J CANCER, V14, P327, DOI 10.1016/0014-2964(78)90201-3; Chapman PB, 2012, J CLIN ONCOL, V30; CHAPPELL PM, 1994, AM J NEURORADIOL, V15, P37; Chen WW, 2012, AM J ROENTGENOL, V198, P27, DOI 10.2214/AJR.11.7030; Cohen-Inbar O, 2016, J NEURO-ONCOL, V130, P485, DOI 10.1007/s11060-016-2242-6; Costelloe CM, 2013, MAGN RESON IMAGING, V31, P669, DOI 10.1016/j.mri.2012.10.017; Davies MA, 2011, CANCER-AM CANCER SOC, V117, P1687, DOI 10.1002/cncr.25634; Eichler AF, 2011, NAT REV CLIN ONCOL, V8, P344, DOI 10.1038/nrclinonc.2011.58; Eon JY, 2014, KOREAN J RADIOL, V15, P145, DOI 10.3348/kjr.2014.15.1.145; Escott EJ, 2001, RADIOGRAPHICS, V21, P625, DOI 10.1148/radiographics.21.3.g01ma19625; Fan B, 2016, J MAGN RESON IMAGING; Flechsig P, 2015, EUR J RADIOL, V84, P1593, DOI 10.1016/j.ejrad.2015.04.009; Force J, 2017, IMMUNOTARGETS THER, V6, P1, DOI 10.2147/ITT.S110479; Franceschi AM, 2016, J COMPUT ASSIST TOMO, V40, P803, DOI 10.1097/RCT.0000000000000420; Furutani K, 2008, J COMPUT ASSIST TOMO, V32, P313, DOI 10.1097/RCT.0b013e318074fd9d; Gaviani P, 2006, AM J NEURORADIOL, V27, P605; Gramsch C, 2013, EUR RADIOL, V23, P2622, DOI 10.1007/s00330-013-2857-3; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; ISIKLAR I, 1995, AM J ROENTGENOL, V165, P1503, DOI 10.2214/ajr.165.6.7484597; Kato Y, 2009, AM J NEURORADIOL, V30, P923, DOI 10.3174/ajnr.A1506; Kim ES, 2010, AM J NEURORADIOL, V31, P1055, DOI 10.3174/ajnr.A2010; Komada Tomohiro, 2008, Magn Reson Med Sci, V7, P13, DOI 10.2463/mrms.7.13; Kushnirsky M, 2016, J NEUROSURG, V124, P489, DOI 10.3171/2015.2.JNS141993; Kwak HS, 2015, CLIN IMAG, V39, P571, DOI 10.1016/j.clinimag.2015.02.010; Long GV, 2015, LANCET, V386, P444, DOI 10.1016/S0140-6736(15)60898-4; McArthur GA, 2014, LANCET ONCOL, V15, P323, DOI 10.1016/S1470-2045(14)70012-9; MUGLER JP, 1993, JMRI-J MAGN RESON IM, V3, P761, DOI 10.1002/jmri.1880030512; Nobauer-Huhmann IM, 2002, INVEST RADIOL, V37, P114, DOI 10.1097/00004424-200203000-00003; Ohlmann-Knafo S, 2015, ROFO-FORTSCHR RONTG, V187, P924, DOI 10.1055/s-0035-1553207; Owonikoko TK, 2014, NAT REV CLIN ONCOL, V11, P203, DOI 10.1038/nrclinonc.2014.25; Platta CS, 2010, AM J CLIN ONCOL-CANC, V33, P398, DOI 10.1097/COC.0b013e318194f744; Radbruch A, 2015, INVEST RADIOL, V50, P805, DOI 10.1097/RLI.0000000000000227; Radbruch A, 2015, RADIOLOGY, V275, P783, DOI 10.1148/radiol.2015150337; Radbruch A, 2012, NEURO-ONCOLOGY, V14, P222, DOI 10.1093/neuonc/nor200; Reichert M, 2013, INVEST RADIOL, V48, P55, DOI 10.1097/RLI.0b013e318277b1aa; Smirniotopoulos JG, 2007, RADIOGRAPHICS, V27, P525, DOI 10.1148/rg.272065155; Spagnolo F, 2016, CANCER TREAT REV, V45, P38, DOI 10.1016/j.ctrv.2016.03.003; Suh CH, 2016, J NEURO-ONCOL, V129, P363, DOI 10.1007/s11060-016-2185-y; YUH WTC, 1992, AM J NEURORADIOL, V13, P335; YUH WTC, 1995, AM J NEURORADIOL, V16, P373; ZHANG RD, 1992, AM J PATHOL, V141, P1115	48	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0193946	10.1371/journal.pone.0193946	http://dx.doi.org/10.1371/journal.pone.0193946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596475	Green Submitted, Green Published, gold			2022-12-26	WOS:000428630000015
J	Goedegebuure, M; Melbourne-Thomas, J; Corney, SP; McMahon, CR; Hindell, MA				Goedegebuure, Merel; Melbourne-Thomas, Jessica; Corney, Stuart P.; McMahon, Clive R.; Hindell, Mark A.			Modelling southern elephant seals Mirounga leonina using an individual-based model coupled with a dynamic energy budget	PLOS ONE			English	Article							POPULATION-GROWTH; HOT-IRON; BEHAVIOR; SURVIVAL; RESTRICTION; COMPLEXITY; PARAMETERS; PROTOCOL; MASS	Higher trophic-level species are an integral component of any marine ecosystem. Despite their importance, methods for representing these species in end-to-end ecosystem models often have limited representation of life histories, energetics and behaviour. We built an individual-based model coupled with a dynamic energy budget for female southern elephant seals Mirounga leonina to demonstrate a method for detailed representation of marine mammals. We aimed to develop a model which could i) simulate energy use and life histories, as well as breeding traits of southern elephant seals in an emergent manner, ii) project a stable population over time, and iii) have realistic population dynamics and structure based on emergent life history features (such as age at first breeding, lifespan, fecundity and (yearling) survival). We evaluated the model's ability to represent a stable population over long time periods (> 10 generations), including the sensitivity of the emergent properties to variations in key parameters. Analyses indicated that the model is sensitive to changes in resource availability and energy requirements for the transition from pup to juvenile, and juvenile to adult stage. This was particularly the case for breeding success and yearling survival. This model is suitable for use as a standalone tool for investigating the impacts of changes to behaviour and population responses of southern elephant seals.	[Goedegebuure, Merel; McMahon, Clive R.; Hindell, Mark A.] Univ Tasmania, Inst Marine & Antarctic Studies, Private Bag 129, Hobart, Tas 7000, Australia; [Goedegebuure, Merel; Melbourne-Thomas, Jessica; Corney, Stuart P.; Hindell, Mark A.] Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Private Bag 80, Hobart, Tas 7000, Australia; [Melbourne-Thomas, Jessica] Australian Antarctic Div, Channel Highway, Kingston, Tas 7050, Australia; [McMahon, Clive R.] Sydney Inst Marine Sci, 19 Chowder Bay Rd, Mosman, NSW 2088, Australia	University of Tasmania; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania; Australian Antarctic Division; Sydney Institute of Marine Science	Goedegebuure, M (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Private Bag 129, Hobart, Tas 7000, Australia.; Goedegebuure, M (corresponding author), Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Private Bag 80, Hobart, Tas 7000, Australia.	merel.goedegebuure@utas.edu.au	Melbourne-Thomas, Jess/N-2437-2019; McMahon, Clive R/D-5713-2013	Melbourne-Thomas, Jess/0000-0001-6585-876X; McMahon, Clive R/0000-0001-5241-8917; Hindell, Mark/0000-0002-7823-7185; Goedegebuure, Merel/0000-0002-9129-888X				Arnbom T, 1997, ECOLOGY, V78, P471, DOI 10.1890/0012-9658(1997)078[0471:FAMEIS]2.0.CO;2; Bacher C, 2006, J SEA RES, V56, P140, DOI 10.1016/j.seares.2006.03.004; Beaudouin R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125841; Bedford M, 2015, MAR ECOL PROG SER, V526, P169, DOI 10.3354/meps11203; Bejarano AC, 2017, ECOL MODEL, V356, P162, DOI 10.1016/j.ecolmodel.2017.05.001; Bell CM, 2005, POLAR BIOL, V28, P395, DOI 10.1007/s00300-004-0694-1; Boyd IL, 1994, BIOMASS ENERGY CONSU, P98; Campagna C, 1999, J MAMMAL, V80, P1341, DOI 10.2307/1383185; CARRICK R., 1962, C S I R O WILDLIFE RES, V7, P119; Caswell, 2000, MATRIX POPULATION MO; Chittleborough RG, 1949, 1 ANARE, P1; Clausius E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173427; Costa Daniel P., 2012, P225; de Little C Siobhan, 2007, BMC BIOL, V7; DeAngelis Donald L, 2014, F1000Prime Rep, V6, P39, DOI 10.12703/P6-39; Desprez M., 2015, SO OCEAN SENTINELS D; Desprez M, 2018, J ANIM ECOL, V87, P199, DOI 10.1111/1365-2656.12775; Desprez M, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0264; DRENT RH, 1980, ARDEA, V68, P225; Eberhardt LL, 2002, ECOLOGY, V83, P2841, DOI 10.2307/3072020; Fedak MA, 1996, J VISUAL COMP ANIMAT, V7, P141, DOI 10.1002/(SICI)1099-1778(199607)7:3<141::AID-VIS147>3.0.CO;2-N; Fulton EA, 2003, MAR ECOL PROG SER, V253, P1, DOI 10.3354/meps253001; Gardmark A, 2013, ECOL APPL, V23, P742, DOI 10.1890/12-0267.1; Gerber LR, 2014, J APPL ECOL, V51, P270, DOI 10.1111/1365-2664.12177; Goedegebuure M, 2017, ECOL MODEL, V359, P182, DOI 10.1016/j.ecolmodel.2017.04.004; Goussen B, 2016, SCI REP-UK, V6, DOI 10.1038/srep36004; Grimm V, 1999, ECOL MODEL, V115, P129, DOI 10.1016/S0304-3800(98)00188-4; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2017, ECOSYSTEMS, V20, P229, DOI 10.1007/s10021-016-0071-2; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Groeneveld J, 2015, ECOL MODEL, V303, P78, DOI 10.1016/j.ecolmodel.2015.02.009; Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361; HINDELL MA, 1994, AUST J ZOOL, V42, P723, DOI 10.1071/ZO9940723; HINDELL MA, 1988, J MAMMAL, V69, P81, DOI 10.2307/1381750; HINDELL MA, 1988, MAR MAMMAL SCI, V4, P168, DOI 10.1111/j.1748-7692.1988.tb00197.x; Hindell MA, 1997, MARINE MAMMAL RESEARCH IN THE SOUTHERN HEMISPHERE, VOL 1, P72; HINDELL MA, 1987, J ZOOL, V213, P365, DOI 10.1111/j.1469-7998.1987.tb03712.x; HINDELL MA, 1991, J ANIM ECOL, V60, P119, DOI 10.2307/5449; HINDELL MA, 1994, POLAR BIOL, V14, P275; Hindell MA, 2017, GLOBAL CHANGE BIOL, V23, P5136, DOI 10.1111/gcb.13776; Hindell MA, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1213; Jusup M, 2017, PHYS LIFE REV, V20, P1, DOI 10.1016/j.plrev.2016.09.001; Kooijman SALM, 2008, BIOL REV, V83, P533, DOI 10.1111/j.1469-185X.2008.00053.x; Kooijman S. A. L. M., 2010, DYNAMIC ENERGY BUDGE; Kooijman S. A. L. M, 2010, NOTATION DYNAMIC ENE; Kooijman S. A. L. M., 2010, COMMENTS DYNAMIC ENE; Langton R, 2014, ECOL MODEL, V273, P31, DOI 10.1016/j.ecolmodel.2013.10.030; Laws R. M., 1953, Scientific Reports Falkland Islands Dependencies Survey, P1; Laws R. M., 1984, ANTARCTIC ECOLOGY; Laws R. M., 1956, FALKLAND ISLANDS DEP, V13; Lebreton JD, 2005, ECOL MODEL, V188, P22, DOI 10.1016/j.ecolmodel.2005.05.003; Martin BT, 2013, AM NAT, V181, P506, DOI 10.1086/669904; Martin BT, 2012, METHODS ECOL EVOL, V3, P445, DOI 10.1111/j.2041-210X.2011.00168.x; McConnell B, 2002, J ANIM ECOL, V71, P65, DOI 10.1046/j.0021-8790.2001.00576.x; MCLAREN IA, 1993, BIOL REV, V68, P1, DOI 10.1111/j.1469-185X.1993.tb00731.x; McMahon CR, 2006, J WILDLIFE MANAGE, V70, P1484, DOI 10.2193/0022-541X(2006)70[1484:AHACFP]2.0.CO;2; McMahon CR, 2007, CONSERV BIOL, V21, P271, DOI 10.1111/j.1523-1739.2006.00566.x; McMahon CR, 2017, J ANIM ECOL, V86, P359, DOI 10.1111/1365-2656.12611; McMahon CR, 2006, NATURE, V439, P392, DOI 10.1038/439392c; McMahon CR, 2005, P ROY SOC B-BIOL SCI, V272, P923, DOI 10.1098/rspb.2004.3038; McMahon CR, 2005, MAR ECOL PROG SER, V288, P273, DOI 10.3354/meps288273; McMahon CR, 2005, MAMMAL REV, V35, P82, DOI 10.1111/j.1365-2907.2005.00055.x; McMahon CR, 1999, POLAR BIOL, V21, P279, DOI 10.1007/s003000050363; McMahon CR, 2003, J ANIM ECOL, V72, P61, DOI 10.1046/j.1365-2656.2003.00685.x; McMahon CR, 2000, ANTARCT SCI, V12, P149, DOI 10.1017/S0954102000000195; Meurant G., 1995, HDB MILK COMPOSITION; Murphy EJ, 2012, PROG OCEANOGR, V102, P74, DOI 10.1016/j.pocean.2012.03.006; Murphy EJ, 2012, CURR OPIN ENV SUST, V4, P264, DOI 10.1016/j.cosust.2012.05.005; New LF, 2014, MAR ECOL PROG SER, V496, P99, DOI 10.3354/meps10547; Nisbet RM, 2012, J EXP BIOL, V215, P892, DOI 10.1242/jeb.059675; O'Toole MD, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00021; Pavlova V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104037; Pethybridge H, 2013, ECOL MODEL, V250, P370, DOI 10.1016/j.ecolmodel.2012.11.017; Punt AE, 2011, FISH RES, V109, P201, DOI 10.1016/j.fishres.2011.02.006; Railsback S.F., 2011, AGENT BASED INDIVIDU; Rankin DJ, 2007, OIKOS, V116, P335, DOI [10.1111/j.2006.0030-1299.15451.x, 10.1111/j.0030-1299.2007.15451.x]; RCore Team, 2020, R LANG ENV STAT COMP; Roberts J. A., 2014, THESIS; SCHEFFER M, 1995, ECOL MODEL, V80, P161, DOI 10.1016/0304-3800(94)00055-M; Sohal RS, 2014, FREE RADICAL BIO MED, V73, P366, DOI 10.1016/j.freeradbiomed.2014.05.015; Sousa T, 2010, PHILOS T R SOC B, V365, P3413, DOI 10.1098/rstb.2010.0166; Southwell D, 2015, MAR ECOL PROG SER, V526, P183, DOI 10.3354/meps11182; van den Hoff J, 2004, WILDLIFE RES, V31, P619, DOI 10.1071/WR03101; van den Hoff J, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2842; van der Meer J, 2006, J SEA RES, V56, P85, DOI 10.1016/j.seares.2006.03.001; Wilensky U., 1999, NETLOGO NETLOGO US M; Xavier JC, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00094	88	14	14	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194950	10.1371/journal.pone.0194950	http://dx.doi.org/10.1371/journal.pone.0194950			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596456	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000428630000057
J	Napolitano, F; Navaro, M; Vezzosi, L; Santagati, G; Angelillo, IF				Napolitano, Francesco; Navaro, Monica; Vezzosi, Luigi; Santagati, Gabriella; Angelillo, Italo Francesco			Primary care pediatricians' attitudes and practice towards HPV vaccination: A nationwide survey in Italy	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; GENERAL-PRACTITIONERS; KNOWLEDGE; PHYSICIANS; TRANSMISSION; INFLUENZA; VACCINES; IMMUNIZATION; ADOLESCENTS; PREVALENCE	This national online cross-sectional survey in Italy assessed primary care pediatricians' (PCPs) attitudes and practices regarding Human papillomavirus (HPV) vaccination and the contribution of several characteristics. The questionnaire was distributed from September 2016 to June 2017 to a random sample of 640 PCPs by email via an internet-link leading to a web-based survey platform (Lime Survey). Only 18.4% of PCPs always recommend the HPV vaccine to 11-12 year old boys. PCPs with longer practice activity, working in solo practice, always recommended the HPV vaccine to 11-12 year old girls, and believed that the vaccine was effective for boys were more likely to always recommend the HPV vaccine. PCPs working in a Region where the vaccination was actively recommended and provided free of charge to 11-12 year old boys had higher odds of recommending vaccination. More than two thirds of PCPs (77.4%) always recommend the HPV vaccine to 11-12 year old girls. PCPs who believed that the vaccine was effective for girls and safe in both boys and girls, who always talk with patients of 11-18 years or their parents about HPV infection and vaccination, and who obtain vaccine information from scientific journals were more likely to always recommend the vaccine. PCPs should employ evidence-based educational strategies in order to achieve a better coverage and to reduce the morbidities and mortality of diseases associated with HPV.	[Napolitano, Francesco; Navaro, Monica; Vezzosi, Luigi; Santagati, Gabriella; Angelillo, Italo Francesco] Univ Campania Luigi Vanvitelli, Dept Expt Med, Naples, Italy	Universita della Campania Vanvitelli	Angelillo, IF (corresponding author), Univ Campania Luigi Vanvitelli, Dept Expt Med, Naples, Italy.	italof.angelillo@unicampania.it	Vezzosi, Luigi/HHZ-4047-2022; Angelillo, Italo Francesco/AAK-1301-2021	Angelillo, Italo Francesco/0000-0003-1213-6602; Napolitano, Francesco/0000-0003-4694-2418; Vezzosi, Luigi/0000-0001-6461-2231				Adey LA, 2006, DESIGNING CONDUCTING; Allison MA, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2488; Anastasi D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-463; Anton-Ladislao A, 2015, VACCINE, V33, P885, DOI 10.1016/j.vaccine.2014.12.012; Awali RA, 2014, AM J INFECT CONTROL, V42, P649, DOI 10.1016/j.ajic.2014.02.025; Bahmanyar ER, 2012, GYNECOL ONCOL, V127, P440, DOI 10.1016/j.ygyno.2012.08.033; Bianco A, 2014, HUM VACC IMMUNOTHER, V10, P2536, DOI 10.4161/21645515.2014.969614; Breitkopf CR, 2016, CANCER MED-US, V5, P3346, DOI 10.1002/cam4.933; Brisson M, 2016, LANCET PUBLIC HEALTH, V1, pE8, DOI 10.1016/S2468-2667(16)30001-9; Canon C, 2017, J CANCER EDUC, V32, P382, DOI 10.1007/s13187-016-0999-0; Chadenier GMC, 2011, VACCINE, V29, P4405, DOI 10.1016/j.vaccine.2011.04.007; Collange F, 2016, VACCINE, V34, P762, DOI 10.1016/j.vaccine.2015.12.054; Daley MF, 2010, PEDIATRICS, V126, P425, DOI 10.1542/peds.2009-3500; Di Giuseppe G, 2008, BRIT J CANCER, V99, P225, DOI 10.1038/sj.bjc.6604454; Di Giuseppe G, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-176; Dillner J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3493; Federazione Nazionale degli Ordini dei Medici Chirurghi e degli Odontoiatri. CED, SIT NAZ SPEC SUDD SE; Ferris D, 2014, PEDIATRICS, V134, pE657, DOI 10.1542/peds.2013-4144; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Giuliano AR, 2015, INT J CANCER, V136, P2752, DOI 10.1002/ijc.29082; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Jackowska J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141003; Jing LP, 2014, SEX TRANSM DIS, V41, P725, DOI 10.1097/OLQ.0000000000000201; Killian M, 2016, EUR J CLIN MICROBIOL, V35, P1837, DOI 10.1007/s10096-016-2735-4; Kulczycki A, 2016, MATERN CHILD HLTH J, V20, P2539, DOI 10.1007/s10995-016-2079-9; Leval A, 2013, JNCI-J NATL CANCER I, V105, P469, DOI 10.1093/jnci/djt032; McBride KR, 2017, HLTH ED BEHAV; McRee AL, 2014, J PEDIATR HEALTH CAR, V28, P541, DOI 10.1016/j.pedhc.2014.05.003; Ministero della Salute, VACC CONTR PAP VIR H; Ministero Della Salute, PIAN NAZ PREV VACC P; Mortensen GL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1863-6; Napolitano F, 2016, HUM VACC IMMUNOTHER, V12, P1504, DOI 10.1080/21645515.2016.1156271; Nicol AF, 2015, ANN DIAGN PATHOL, V19, P418, DOI 10.1016/j.anndiagpath.2015.07.008; Nicotera G, 2004, ORAL ONCOL, V40, P490, DOI 10.1016/j.oraloncology.2003.10.001; Nikolic Z, 2015, J PEDIATR ADOL GYNEC, V28, P12, DOI 10.1016/j.jpag.2014.01.107; Oakeshott P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4168; Perez MRO, 2015, INFECT AGENTS CANCER, V10, DOI 10.1186/s13027-015-0034-9; Parmeggiani C, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-35; Pavia M, 2003, PUBLIC HEALTH, V117, P202, DOI 10.1016/S0033-3506(03)00066-0; Pelullo CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042856; Shih TH, 2008, FIELD METHOD, V20, P249, DOI 10.1177/1525822X08317085; Stata Corporation, 2007, STAT REF MAN REL 10; Vadaparampil ST, 2011, VACCINE, V29, P8634, DOI 10.1016/j.vaccine.2011.09.006; Veldhuijzen NJ, 2010, LANCET INFECT DIS, V10, P862, DOI 10.1016/S1473-3099(10)70190-0; Vichnin M, 2015, PEDIATR INFECT DIS J, V34, P983, DOI 10.1097/INF.0000000000000793; Weltermann BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105119; Wong LP, 2017, J OBSTET GYNAECOL, V37, P937, DOI 10.1080/01443615.2017.1317239; Wong TY, 2017, CURR PROBL DIAGN RAD, V46, P263, DOI 10.1067/j.cpradiol.2016.11.003; World Health Organization, 2014, HUM PAP VACC WHO POS	49	44	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194920	10.1371/journal.pone.0194920	http://dx.doi.org/10.1371/journal.pone.0194920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596515	Green Published, Green Submitted, gold			2022-12-26	WOS:000428630000050
J	Takahashi, S; Tanaka, F; Yonekura, Y; Tanno, K; Ohsawa, M; Sakata, K; Koshiyama, M; Okayama, A; Nakamura, M				Takahashi, Shuko; Tanaka, Fumitaka; Yonekura, Yuki; Tanno, Kozo; Ohsawa, Masaki; Sakata, Kiyomi; Koshiyama, Makoto; Okayama, Akira; Nakamura, Motoyuki			The urine albumin-creatinine ratio is a predictor for incident long-term care in a general population	PLOS ONE			English	Article							C-REACTIVE PROTEIN; TYPE-2 DIABETES-MELLITUS; LOW-GRADE ALBUMINURIA; SMALL VESSEL DISEASE; COGNITIVE IMPAIRMENT; CARDIOVASCULAR-DISEASE; OLDER-ADULTS; RISK; INDIVIDUALS; MICROALBUMINURIA	Background Several types of cardiovascular diseases (CVDs) impair the physical and mental status. The purpose of this study was to assess the predictive ability of several cardiovascular biomarkers for identifying the incidence of disability as future recipients of public long-term care (LTC) service. Methods The subjects of this study were community-dwelling elderly individuals >= 65 years of age without a history of CVD (n = 5,755; mean age, 71 years). The endpoint of this study was official certification as a recipient of LTC. The cohort was divided into quartiles (Qs) based on the levels of three CVD biomarkers: the urinary albumin-creatinine ratio (UACR), plasma B-type natriuretic peptide concentration (BNP), and serum high-sensitivity C-reactive protein concentration (hsCRP). A time-dependent Cox proportional hazard model was used to determine the multi-adjusted relative hazard ratios (HRs) for incident LTC among the quartiles of each biomarker. Results During the follow-up (mean 5.6 years), 710 subjects were authorized as recipients of LTC. The HR was only significantly increased in the higher Qs of UACR (03, p < 0.01; 04, p < 0.001). However, other biomarkers were not significantly associated with the endpoint. The risk predictive performance for the incidence of LTC as evaluated by an essential model (i.e. age-and sex-adjusted) was significantly improved by incorporating the UACR (net reclassification improvement = 0.084, p < 0.01; integrated discrimination improvement = 0.0018, p < 0.01). Conclusions These results suggest that an increased UACR is useful for predicting physical and cognitive dysfunction in an elderly general population.	[Takahashi, Shuko; Tanaka, Fumitaka; Nakamura, Motoyuki] Iwate Med Univ, Div Cardioangiol, Dept Internal Med, Morioka, Iwate, Japan; [Yonekura, Yuki] St Lukes Int Univ, Chuo Ku, Akashi Cho, Tokyo, Japan; [Tanno, Kozo; Sakata, Kiyomi] Iwate Med Univ, Sch Med, Dept Hyg & Prevent Med, Yahaba, Iwate, Japan; [Ohsawa, Masaki] Morioka Tsunagi Onsen Hosp, Morioka, Iwate, Japan; [Koshiyama, Makoto] Iwate Hlth Serv Assoc, Morioka, Iwate, Japan; [Okayama, Akira] Res Inst Strategy Prevent, Chuo Ku, Tokyo, Japan	Iwate Medical University; St. Luke's International Hospital; Iwate Medical University	Takahashi, S (corresponding author), Iwate Med Univ, Div Cardioangiol, Dept Internal Med, Morioka, Iwate, Japan.	shutakahashi-iwt@umin.ac.jp	Ohsawa, Masaki/AAJ-5030-2020; Tanno, Kozo/HDM-5952-2022; Tanno, Kozo/ABE-5165-2020; Yonekura, Yuki/C-5973-2013	Ohsawa, Masaki/0000-0002-1152-1958; Tanno, Kozo/0000-0002-1264-0684; Tanno, Kozo/0000-0002-1264-0684; Yonekura, Yuki/0000-0002-2590-2022	Ministry of Education, Science, and Culture of Japan, Tokyo, Japan [26461082, 17K09520]; Japan Arteriosclerosis Prevention Fund (JAPF), Tokyo, Japan; Grants-in-Aid for Scientific Research [15K08745] Funding Source: KAKEN	Ministry of Education, Science, and Culture of Japan, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Arteriosclerosis Prevention Fund (JAPF), Tokyo, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by grants-in-aid from the scientific research funds of the Ministry of Education, Science, and Culture of Japan (Nos. 26461082 and 17K09520), Tokyo, Japan and the Japan Arteriosclerosis Prevention Fund (JAPF), Tokyo, Japan to MN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoudad S, 2015, INT J STROKE, V10, P603, DOI 10.1111/ijs.12465; Anan F, 2011, METABOLISM, V60, P460, DOI 10.1016/j.metabol.2010.04.002; [Anonymous], 2013, ELD PERS AG 65 YEARS; [Anonymous], 2016, CURR STAT TRENDS ELD; [Anonymous], 2013, STAT REP LONG TERM C; [Anonymous], 2010, SUMM REP COMPR SURV; [Anonymous], 2002, LONG TERM CAR INS SY; [Anonymous], 2013, OUTL RES NAT LVEL SU; BRANCH LG, 1982, AM J PUBLIC HEALTH, V72, P1373, DOI 10.2105/AJPH.72.12.1373; Chang CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep39434; Cho EB, 2016, SCI REP-UK, V6, DOI 10.1038/srep20692; Dhamoon MS, 2015, NEUROLOGY, V84, P1002, DOI 10.1212/WNL.0000000000001331; Douiri A, 2013, STROKE, V44, P138, DOI 10.1161/STROKEAHA.112.670844; Fried L, 2012, CLIN J AM SOC NEPHRO, V7, P376, DOI 10.2215/CJN.00210112; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; IOM (Institute of Medicine), 2010, CARD DIS UPD SOC SEC; Jassal SK, 2010, AM J EPIDEMIOL, V171, P277, DOI 10.1093/aje/kwp426; Johnson RW, 2007, M FUTURE LONG TERM C; Kalaria RN, 2016, BBA-MOL BASIS DIS, V1862, P915, DOI 10.1016/j.bbadis.2016.01.015; Knopman DS, 2010, AM J EPIDEMIOL, V171, P287, DOI 10.1093/aje/kwp429; Mehta D, 2014, METABOLISM, V63, P1390, DOI 10.1016/j.metabol.2014.07.008; Nakamura M, 2004, INTERNAL MED, V43, P919, DOI 10.2169/internalmedicine.43.919; Ohsawa M, 2009, INT J CARDIOL, V137, P226, DOI 10.1016/j.ijcard.2008.06.052; Olsen MH, 2010, CURR VASC PHARMACOL, V8, P134, DOI 10.2174/157016110790226633; Sajjad I, 2012, CLIN J AM SOC NEPHRO, V7, P437, DOI 10.2215/CJN.05330611; Singh M, 2014, EUR HEART J, V35, P1726, DOI 10.1093/eurheartj/ehu197; Tanaka F, 2016, J HYPERTENS, V34, P506, DOI 10.1097/HJH.0000000000000809; Teunissen CE, 2003, J NEUROIMMUNOL, V134, P142, DOI 10.1016/S0165-5728(02)00398-3; Tsutsui T, 2005, J AM GERIATR SOC, V53, P522, DOI 10.1111/j.1532-5415.2005.53175.x; Verghese J, 2012, AGE AGEING, V41, P541, DOI 10.1093/ageing/afs038; Wada M, 2007, J NEUROL SCI, V255, P27, DOI 10.1016/j.jns.2007.01.066	31	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0195013	10.1371/journal.pone.0195013	http://dx.doi.org/10.1371/journal.pone.0195013			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590199	gold, Green Published, Green Submitted			2022-12-26	WOS:000428603100097
J	Wu, MR; Hsiao, CY; Cheng, CH; Liao, FC; Chao, CL; Chen, CY; Yeh, HI; Su, MI				Wu, Meng-Ruey; Hsiao, Chia-Ying; Cheng, Chun-Han; Liao, Feng-Ching; Chao, Chuan-Lei; Chen, Chun-Yen; Yeh, Hung-I; Su, Min-I			Is endotracheal intubation a non-beneficial treatment in patients with respiratory failure due to paraquat poisoning?	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; CLINICAL-FEATURES; PALLIATIVE CARE; PULSE THERAPY; CYCLOPHOSPHAMIDE; PLASMA; METHYLPREDNISOLONE; TOXICITY; MODERATE; SUICIDE	Introduction Paraquat poisoning can result in dysfunction of multiple organs, and pulmonary fibrosis with respiratory failure is the major cause of mortality. For terminally ill patients, some life-prolonging treatments can be non-beneficial treatments (NBT). The objective of this study was to determine if intubation is a NBT for patients with respiratory failure due to paraquat poisoning. Methods The study included 68 patients with respiratory failure due to paraquat poisoning. Patients were hospitalized at MacKay Memorial Hospital, Taitung Branch, Taiwan, between 2005 to April 2016. Composite outcomes of intra-hospital mortality, the rate of do-not-resuscitate (DNR) orders, prescribed medications, length of stay, and medical costs were recorded and compared between the do-not-intubate (DNI) group and endotracheal intubation (EI) group. Results Intra-hospital mortality rate for the entire population was 100%. There were significantly more patients with DNR orders in the DNI group (P = 0.007). There were no differences in the length of hospital stay. However, patients in DNI group had significantly less vasopressor use and more morphine use, shorter time in the intensive care unit, and fewer medical costs. Conclusion The procedure of intubation in patients with respiratory failure due to paraquat poisoning can be considered inappropriate life-prolonging treatment.	[Wu, Meng-Ruey; Hsiao, Chia-Ying] MacKay Mem Hosp, Dept Internal Med, Div Nephrol, Taitung Branch, Taipei, Taiwan; [Cheng, Chun-Han] MacKay Mem Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Taipei, Taiwan; [Liao, Feng-Ching; Chao, Chuan-Lei; Su, Min-I] MacKay Mem Hosp, Dept Internal Med, Div Cardiol, Taitung Branch, Taipei, Taiwan; [Chen, Chun-Yen; Yeh, Hung-I] MacKay Mem Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Chen, Chun-Yen; Yeh, Hung-I; Su, Min-I] MacKay Med Coll, New Taipei, Taiwan	Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Medical College	Su, MI (corresponding author), MacKay Mem Hosp, Dept Internal Med, Div Cardiol, Taitung Branch, Taipei, Taiwan.; Su, MI (corresponding author), MacKay Med Coll, New Taipei, Taiwan.	wwfsone@gmail.com		Su, Min-I/0000-0002-9523-9676; Cheng, Chun-han/0000-0002-7262-861X				BATEMAN DN, 1987, HUM TOXICOL, V6, P57, DOI 10.1177/096032718700600109; BOUMPAS DT, 1992, LANCET, V340, P741, DOI 10.1016/0140-6736(92)92292-N; Campbell ML, 2004, CRIT CARE MED, V32, P1839, DOI 10.1097/01.CCM.0000138560.56577.88; Cha ES, 2016, INT J EPIDEMIOL, V45, P470, DOI 10.1093/ije/dyv304; Cheung W, 2010, CRIT CARE RESUSC, V12, P28; Dinis-Oliveira RJ, 2008, CRIT REV TOXICOL, V38, P13, DOI 10.1080/10408440701669959; Downar J, 2015, CRIT CARE MED, V43, P270, DOI 10.1097/CCM.0000000000000704; Greisinger AJ, 1997, CANCER PRACT, V5, P147; Kim SJ, 2009, NEPHROL DIAL TRANSPL, V24, P1226, DOI 10.1093/ndt/gfn615; Kyeremanteng K, 2016, J INTENSIVE CARE MED; Lee HL, 2008, HUM EXP TOXICOL, V27, P373, DOI 10.1177/0960327108094609; Lin JL, 1999, AM J RESP CRIT CARE, V159, P357, DOI 10.1164/ajrccm.159.2.9803089; Lin JL, 1996, THORAX, V51, P661, DOI 10.1136/thx.51.7.661; Lorenz K, 2004, END LIFE CARE OUTCOM; MCCUNE WJ, 1988, NEW ENGL J MED, V318, P1423, DOI 10.1056/NEJM198806023182203; Norton SA, 2007, CRIT CARE MED, V35, P1530, DOI 10.1097/01.CCM.0000266533.06543.0C; PROUDFOOT AT, 1979, LANCET, V2, P330; SCHERRMANN JM, 1987, HUM TOXICOL, V6, P91, DOI 10.1177/096032718700600116; Senarathna L, 2009, QJM-INT J MED, V102, P251, DOI 10.1093/qjmed/hcp006; Singal RK, 2014, CAN RESPIR J, V21, P165, DOI 10.1155/2014/429789; Suntres ZE, 2002, TOXICOLOGY, V180, P65, DOI 10.1016/S0300-483X(02)00382-7; SUZUKI K, 1993, HUM EXP TOXICOL, V12, P323, DOI 10.1177/096032719301200411; Tsai TY, 2011, HUM EXP TOXICOL, V30, P71, DOI 10.1177/0960327110368419; Walker KA, 2013, J PALLIAT MED, V16, P1237, DOI 10.1089/jpm.2013.0052; Wu WF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094697; Yang CJ, 2012, LIVER INT, V32, P1400, DOI 10.1111/j.1478-3231.2012.02829.x	26	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0195071	10.1371/journal.pone.0195071	http://dx.doi.org/10.1371/journal.pone.0195071			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590187	gold, Green Published			2022-12-26	WOS:000428603100102
J	Blaser, SRGA; Schluter, S; Vetterlein, D				Blaser, Sebastian R. G. A.; Schlueter, Steffen; Vetterlein, Doris			How much is too much?-Influence of X-ray dose on root growth of faba bean (Vicia faba) and barley (Hordeum vulgare)	PLOS ONE			English	Article							QUANTIFICATION; VISUALIZATION; IRRADIATION	X-ray CT is a powerful technology to study root growth in soil in-situ. Root systems can be studied in its true 3D geometry over time. Hence, the same plant can be scanned multiple times during development. A downside is the potential of X-rays to interfere with biological processes and therefore plant growth. The aim of this study is to evaluate the influence of cumulative X-ray dose on Vicia faba and Hordeum vulgare during a growth period of 17 days. One control treatment without X-ray scanning was compared to two treatments being scanned every two and four days, respectively. Scanned treatments received a maximum cumulative dose of less than 8 Gy. Plant species differed in their susceptibility to X-ray dose. For Vicia faba, mean total root length was reduced significantly. Leave growth was reduced as well. Number and length of second order laterals was reduced significantly, as well as length of first order laterals. Hordeum vulgare showed no negative impact of X-ray dose on any of the root parameters. Large differences between the two species investigated were detected in respect to susceptibility to X-ray dose. Results indicate that for X-ray CT studies involving temporal resolution a control treatment without scanning is required.	[Blaser, Sebastian R. G. A.; Schlueter, Steffen; Vetterlein, Doris] Helmholtz Ctr Environm Res GmbH UFZ, Dept Soil Syst Sci, Halle, Saale, Germany; [Vetterlein, Doris] Martin Luther Univ Halle Wittenberg, Inst Agr & Nutr Sci, Halle, Saale, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Martin Luther University Halle Wittenberg	Blaser, SRGA (corresponding author), Helmholtz Ctr Environm Res GmbH UFZ, Dept Soil Syst Sci, Halle, Saale, Germany.	sebastian.blaser@ufz.de						Bentzen S.M., 2009, BASIC CLIN RADIOBIOL, Vfourth, P102; Carminati A, 2013, PLANT SOIL, V367, P651, DOI 10.1007/s11104-012-1496-9; Cember H, 2009, INTRO HLTH PHYS, P888; CLOWES F. A. L., 1963, RADIATION BOT, V3, P45, DOI 10.1016/0033-7560(63)90007-3; CLOWES FAL, 1963, ANN BOT-LONDON, V27, P343; DAVIDSON D., 1960, ANN BOT, V24, P287; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; EVANS H. J., 1965, RADIAT BOT, V5, P171, DOI 10.1016/S0033-7560(65)80036-9; Flavel RJ, 2012, J EXP BOT, V63, P2503, DOI 10.1093/jxb/err421; Flavel RJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176433; GRAY LH, 1951, BRIT J RADIOL, V24, P82, DOI 10.1259/0007-1285-24-278-82; Gregory PJ, 2003, NONINVASIVE IMAGING, P351; Hargreaves CE, 2009, PLANT SOIL, V316, P285, DOI 10.1007/s11104-008-9780-4; HORNSEY S, 1956, EXP CELL RES, V11, P340, DOI 10.1016/0014-4827(56)90110-0; Johnson EL, 1936, PLANT PHYSIOL, V11, P319, DOI 10.1104/pp.11.2.319; Kaestner A, 2006, GEODERMA, V136, P459, DOI 10.1016/j.geoderma.2006.04.009; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Koebernick N, 2014, VADOSE ZONE J, V13, DOI 10.2136/vzj2014.03.0024; Mooney SJ, 2006, SOIL SCI, V171, P706, DOI 10.1097/01.ss.0000228041.03142.d3; Perret JS, 2007, SOIL BIOL BIOCHEM, V39, P391, DOI 10.1016/j.soilbio.2006.07.018; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schluter S, 2016, SOLID EARTH, V7, P129, DOI 10.5194/se-7-129-2016; Schmidt S, 2012, EUR J SOIL SCI, V63, P776, DOI 10.1111/j.1365-2389.2012.01487.x; Skoog F, 1935, J CELL COMPAR PHYSL, V7, P227, DOI 10.1002/jcp.1030070206; Tracy SR, 2010, J EXP BOT, V61, P311, DOI 10.1093/jxb/erp386; Vetterlein D, 2013, PLANT SOIL, V371, P267, DOI 10.1007/s11104-013-1680-6; Zappala S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067250	27	27	27	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0193669	10.1371/journal.pone.0193669	http://dx.doi.org/10.1371/journal.pone.0193669			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579093	Green Published, gold, Green Submitted			2022-12-26	WOS:000428351800011
J	Deressa, T; Birhan, W; Enawgaw, B; Abebe, M; Baynes, HW; Desta, M; Terefe, B; Melku, M				Deressa, Tekalign; Birhan, Wubet; Enawgaw, Bamlaku; Abebe, Molla; Baynes, Habtamu Wondiferaw; Desta, Mekuria; Terefe, Betelihem; Melku, Mulugeta			Proportion and predictors of transfusion-transmissible infections among blood donors in North Shewa Zone, Central North Ethiopia	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DAR-ES-SALAAM; HEPATITIS-B; TRANSMITTED INFECTIONS; C VIRUSES; SYPHILIS; PREVALENCE; SEROPREVALENCE	Background Transfusion-transmissible infections (TTIs) pose a significant challenge for the availability and safety of blood transfusion. The aim of this study was to investigate the prevalence and risk factors for TTIs among blood donors in North Shewa zone, central North Ethiopia. Methods A retrospective survey of blood donors' medical records was conducted from April 2014 to June 2017 to assess the presence of hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and syphilis infections. Descriptive statistics such as percentage, median and interquartile range were used to summarize the data. Results Out of 8460 donations, 207 (2.4%, 95% CI 2.06-2.71%) had serological evidence of infection with at least one pathogen. Four of the blood donors (0.047%) had co-infection with more than one pathogen; 2HIV/HBV and 2HIV/syphilis. The overall prevalence of HBV, HCV, HIV, and syphilis among the donors were 1.2% (95% CI 0.98-1.45%), 0.32% (95% CI 0.2-0.44%), 0.25% (95% CI 0.14-0.35%), and 0.71% (95% CI 0.53-0.89%) respectively. Male sex was significantly associated with higher risk of HBV (OR 1.75, 95% CI 1.1-2.8) and syphilis sero-reactivity (OR 4.5, 95% C11.9-10.5). Farmers and older donors were found to be at a higher risk for syphilis seropositivity. Conclusion The prevalence of TTIs among blood donors in North Shewa zone was relatively low compared to those of other geographic places in Ethiopia. However, TTIs remain a concern for the availability and safety of blood transfusion as they are still prevalent in the study area. Therefore, more efforts are required to ensure the safety of blood supply and transfusions.	[Deressa, Tekalign; Birhan, Wubet; Enawgaw, Bamlaku; Abebe, Molla; Baynes, Habtamu Wondiferaw; Terefe, Betelihem; Melku, Mulugeta] Univ Gondar, Sch Biomed & Lab Sci, Coll Med & Hlth Sci, Gondar, Ethiopia; [Deressa, Tekalign] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia; [Desta, Mekuria] Debre Berhan Blood Bank, North Shoa Zone, Debre Berhan, Ethiopia	University of Gondar	Deressa, T (corresponding author), Univ Gondar, Sch Biomed & Lab Sci, Coll Med & Hlth Sci, Gondar, Ethiopia.; Deressa, T (corresponding author), Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia.	tekalign09@gmail.com	Enawgaw, Bamlaku/AAZ-5489-2020	Enawgaw, Bamlaku/0000-0002-3828-5318; Gashaw, Betelihem Terefe/0000-0002-9451-1797				Abate M, 2016, ETHIOP J HLTH SCI, V26, P2; Adjei AA, 2003, JPN J INFECT DIS, V56, P165; Belyhun Y, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2090-1; Biadgo B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180416; Bisetegn FS, 2016, CANADIAN J INFECT DI, V2016; Bloch EM, 2012, TRANSFUS MED REV, V26, P164, DOI 10.1016/j.tmrv.2011.07.006; Bonja F, 2017, INT J BLOOD TRANSFUS, V7, P7, DOI DOI 10.5348/IJBTI-2017-29-OA-2; Buseri FI, 2009, BLOOD TRANSFUS-ITALY, V7, P293, DOI 10.2450/2009.0071-08; CSA ICF, 2012, ETH DEM HLTH SURV 20; Diro Ermias, 2008, Ethiop Med J, V46, P7; Farshadpour F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157615; Federal Democratic Republic of Ethiopia, NAT EXP PROGR IMM CO; Fessehaye N, 2011, PAN AFR MED J, V9; Gelaw B., 2007, ETHIOP J HEALTH DEV, V22, P3; Jayaraman S, 2010, TRANSFUSION, V50, P433, DOI 10.1111/j.1537-2995.2009.002402.x; Matee MIN, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-21; Matee MIN, 1999, E AFR MED J, V76, P167; Mavenyengwa RT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-424; Mohammed Yusuf, 2016, BMC Res Notes, V9, P129, DOI 10.1186/s13104-016-1925-6; Nagalo MB, 2011, BLOOD TRANSFUS-ITALY, V9, P419, DOI 10.2450/2011.0112-10; Stokx J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-141; Tagny CT, 2010, TRANSFUSION MED, V20, P1, DOI 10.1111/j.1365-3148.2009.00958.x; Tarekegne Daniel, 2016, BMC Res Notes, V9, P192, DOI 10.1186/s13104-016-2004-8; Tessema B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-111; WHO, BLOOD SAF ETH; World Health Organization, BLOOD DON SEL GUID A; World Health Organization, BLOOD SAF AV; Xie DD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139947; Yami A, 2011, ETHIOP J HLTH SCI, V21, P1; Zohreh A, 2005, TEHRAN IRAN TRANSF T, V64, P24	30	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194083	10.1371/journal.pone.0194083	http://dx.doi.org/10.1371/journal.pone.0194083			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579055	Green Published, Green Submitted, gold			2022-12-26	WOS:000428351800019
J	Gharbi, S; Khateri, S; Soroush, MR; Shamsara, M; Naeli, P; Najafi, A; Korsching, E; Mowla, SJ				Gharbi, Sedigheh; Khateri, Shahriar; Soroush, Mohammad Reza; Shamsara, Mehdi; Naeli, Parisa; Najafi, Ali; Korsching, Eberhard; Mowla, Seyed Javad			MicroRNA expression in serum samples of sulfur mustard veterans as a diagnostic gateway to improve care	PLOS ONE			English	Article							TIME PCR DATA; GENE-EXPRESSION; SKIN-LESIONS; MESENCHYMAL TRANSITION; WARTIME EXPOSURE; CANCER; LUNG; QUANTIFICATION; IDENTIFICATION; COMPLICATIONS	Sulfur mustard is a vesicant chemical warfare agent, which has been used during Iraq-Iran war. Many veterans and civilians still suffer from long-term complications of sulfur mustard exposure, especially in their lung. Although the lung lesions of these patients are similar to Chronic Obstructive Pulmonary Disease (COPD), there are some differences due to different etiology and clinical care. Less is known on the molecular mechanism of sulfur mustard patients and specific treatment options. microRNAs are master regulators of many biological pathways and proofed to be stable surrogate markers in body fluids. Based on that micro RNA expression for serum samples of sulfur mustard patients were examined, to establish specific microRNA patterns as a basis for diagnostic use and insight into affected molecular pathways. Patients were categorized based on their long-term complications into three groups and microRNA serum levels were measured. The differentially regulated microRNAs and their corresponding gene targets were identified. Cell cycle arrest, ageing and TGFbeta signaling pathways showed up to be the most deregulated pathways. The candidate microRNA miR-143-3p could be validated on all individual patients. In a ROC analysis miR-143-3p turned out to be a suitable diagnostic biomarker in the mild and severe categories of patients. Further microRNAs which might own a link to the biology of the sulfur mustard patients are miR-365a-3p, miR-200a-3p, miR-663a. miR-148a-3p, which showed up only in a validation study, might be linked to the airway complications of the sulfur mustard patients. All the other candidate microRNAs do not directly link to COPD phenotype or lung complications. In summary the microRNA screening study characterizes several molecular differences in-between the clinical categories of the sulfur mustard exposure groups and established some useful microRNA biomarkers. qPCR raw data is available via the Gene Expression Omnibus https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE110797.	[Gharbi, Sedigheh] Shahid Bahonar Univ Kerman, Fac Sci, Dept Biol, Kerman, Iran; [Khateri, Shahriar; Soroush, Mohammad Reza] JMERC, Tehran, Iran; [Shamsara, Mehdi] Natl Inst Genet Engn & Biotechnol, Tehran, Iran; [Naeli, Parisa; Mowla, Seyed Javad] Tarbiat Modares Univ, Fac Biol Sci, Dept Mol Genet, Tehran, Iran; [Najafi, Ali] Baqiyatallah Univ Med Sci, Mol Biol Res Ctr, Tehran, Iran; [Korsching, Eberhard] Univ Munster, Univ Hosp Munster, Inst Bioinformat, Munster, Germany	Shahid Bahonar University of Kerman (SBUK); Tarbiat Modares University; Baqiyatallah University of Medical Sciences (BMSU); University of Munster	Mowla, SJ (corresponding author), Tarbiat Modares Univ, Fac Biol Sci, Dept Mol Genet, Tehran, Iran.; Korsching, E (corresponding author), Univ Munster, Univ Hosp Munster, Inst Bioinformat, Munster, Germany.	korschi@uni-muenster.de; sjmowla@modares.ac.ir	gharbi, sedigheh/AAC-1914-2022; Najafi, Ali/K-1113-2015	gharbi, sedigheh/0000-0002-9032-3908; Najafi, Ali/0000-0001-7700-2053; Mowla, Seyed Javad/0000-0002-3300-6332	Janbazan Medical and Engineering Research Center, Iran (JMERC) [b101-89]; European TRANSCAN I consortium - prospective validation of biomarkers - BMBF [FZK 01KT1310]; Open Access Publication Fund of the University of Munster, Germany	Janbazan Medical and Engineering Research Center, Iran (JMERC); European TRANSCAN I consortium - prospective validation of biomarkers - BMBF; Open Access Publication Fund of the University of Munster, Germany	This study was financially supported by a research grant from Janbazan Medical and Engineering Research Center, Iran (JMERC, Grant # b101-89 to SG). Additionally, this work was supported partly by the European TRANSCAN I consortium - prospective validation of biomarkers supported by the BMBF (FZK 01KT1310 to EK). The authors acknowledge support by the Open Access Publication Fund of the University of Munster, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar L, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl034; Balali-Mood M, 2006, BASIC CLIN PHARMACOL, V99, P273, DOI 10.1111/j.1742-7843.2006.pto_429.x; Behravan E, 2013, J RES MED SCI, V18, P239; Blakesley RE, 2009, NEUROPSYCHOLOGY, V23, P255, DOI 10.1037/a0012850; Bonifacio LN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012519; Camargo A, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-15; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Ezzie ME, 2012, THORAX, V67, P122, DOI 10.1136/thoraxjnl-2011-200089; Francis SMS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-88; Geyer C. J., 1992, STAT SCI, V7, P473, DOI [10.1214/ss/1177011137, DOI 10.1214/SS/1177011137]; Ghanei M, 2011, INHAL TOXICOL, V23, P363, DOI 10.3109/08958378.2011.576278; Gharbi S, 2014, J CELL MOL RES, V6, P52; Gharbi S, 2015, CELL J, V17, P494; Ghasemi H, 2013, CUTAN OCUL TOXICOL, V32, P304, DOI 10.3109/15569527.2013.781615; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; He BF, 2016, ONCOL LETT, V12, P5023, DOI 10.3892/ol.2016.5363; Howe EN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2867; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Imani S, 2015, IRAN J BASIC MED SCI, V18, P723; Jiang XY, 2011, MOL CELL BIOCHEM, V353, P35, DOI 10.1007/s11010-011-0771-z; Joshi P, 2015, P NATL ACAD SCI USA, V112, P8650, DOI 10.1073/pnas.1500886112; Kehe K, 2009, TOXICOLOGY, V263, P12, DOI 10.1016/j.tox.2009.01.019; Kehe K, 2009, TOXICOLOGY, V263, P3, DOI 10.1016/j.tox.2009.04.060; Kehe K, 2000, J APPL TOXICOL, V21, pS81; Khaheshi I, 2011, BMC DERMATOL, V11, DOI 10.1186/1471-5945-11-2; Khateri S, 2003, J OCCUP ENVIRON MED, V45, P1136, DOI 10.1097/01.jom.0000094993.20914.d1; Kim HC, 2010, TUBERC RESPIR DIS, V68, P125, DOI 10.4046/trd.2010.68.3.125; Kim JY, 2014, AGING-US, V6, P524, DOI 10.18632/aging.100677; Klainer AS, 2003, PHYS GUIDE TERRORIST; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu W, 2015, NAT IMMUNOL, V16, P1185, DOI 10.1038/ni.3292; Marasa BS, 2010, AGING-US, V2, P333, DOI 10.18632/aging.100159; Panganiban RP, 2016, J ALLERGY CLIN IMMUN, V137, P1423, DOI 10.1016/j.jaci.2016.01.029; Park YH, 2014, BIOCHEM BIOPH RES CO, V443, P1155, DOI 10.1016/j.bbrc.2013.12.068; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pichler M, 2014, BRIT J CANCER, V110, P1614, DOI 10.1038/bjc.2014.51; Pirzad G, 2010, J TOXICOL-US, V2010, DOI 10.1155/2010/373612; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Romano JR, 2005, J AM STAT ASSOC, V100, P94, DOI 10.1198/016214504000000539; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shohrati M, 2008, RESP MED, V102, P443, DOI 10.1016/j.rmed.2007.10.004; Soriano-Arroquia A, 2016, AGING CELL, V15, P361, DOI 10.1111/acel.12442; Sugimoto M, 2003, MOL CELL, V11, P415, DOI 10.1016/S1097-2765(03)00057-1; Torres A, 2013, GYNECOL ONCOL, V130, P588, DOI 10.1016/j.ygyno.2013.06.026; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Valizadeh M, 2015, J RECEPT SIG TRANSD, V35, P634, DOI 10.3109/10799893.2015.1041646; Waaijer MEC, 2014, BIOGERONTOLOGY, V15, P269, DOI 10.1007/s10522-014-9496-1; Wu C, 2011, MOL CELL BIOL, V31, P4760, DOI 10.1128/MCB.05776-11; Xu Z, 2011, J BIOL CHEM, V286, P21401, DOI 10.1074/jbc.M110.198630; Zang WQ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0315-3	57	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194530	10.1371/journal.pone.0194530	http://dx.doi.org/10.1371/journal.pone.0194530			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566027	gold, Green Published, Green Submitted			2022-12-26	WOS:000428093900073
J	Lhermie, G; Tauer, LW; Grohn, YT				Lhermie, Guillaume; Tauer, Loren William; Grohn, Yrjo Tapio			The farm cost of decreasing antimicrobial use in dairy production	PLOS ONE			English	Article							DRY COW MANAGEMENT; CLINICAL MASTITIS; MILK-PRODUCTION; REPRODUCTIVE-PERFORMANCE; UDDER HEALTH; LAMENESS; DISEASE; ASSOCIATIONS; METAANALYSIS; REPLACEMENT	Antimicrobials are used in animal agriculture to cure bacterial infectious diseases. However, antimicrobial use (AMU) inevitably leads to the selection of resistant bacteria, potentially infecting humans. As a global public threat, antimicrobial resistance has led policy makers to implement regulations supervising AMU. The objective of our research was to investigate the farm impact of several potential policies aimed at decreasing AMU. We modeled a dairy herd of 1000 cows with an average level of disease prevalence for the nine most frequent bacterial dairy diseases found in western countries. We calculated the farm net costs of AMU prohibition, as well as cost increases in antimicrobial treatments prices, and an increase in the milk withdrawal period after AMU. Sensitivity analyses were conducted to assess the impact of output and input prices, and disease prevalence. At a mean disease prevalence, the average net costs of not using antimicrobials were $61 per cow per year greater compared to a scenario modeling current farm AMU. The model predicted that the minimum and maximum increased costs associated with AMU prohibition were $46 and $73 per cow per year compared to current AMU. In each scenario, the cost difference increased with disease prevalence. Sensitivity analysis showed that the three stochastic variables which most significantly influenced the cost difference were respectively, cow replacement prices, cow slaughter price, and the milk price. Antimicrobial price increases of a factor of five, or extending the milk withdrawal period by 15 days, resulted in increasing the costs of diseases to a level where the farmer was better off not using antimicrobials. Our results suggest that the farm level costs of AMU prohibition in many cases might be minor, although the consequences of any policy instrument should be carefully evaluated to reach the ultimate goal of decreasing AMU without threatening the sustainability of milk production.	[Lhermie, Guillaume; Grohn, Yrjo Tapio] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Tauer, Loren William] Cornell Univ, Dyson Sch Appl Econ & Management, Cornell SC Johnson Coll Business, Ithaca, NY USA	Cornell University; Cornell University	Lhermie, G (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	gl467@cornell.edu	Tauer, Loren/AAD-6301-2020; Lhermie, Guillaume/F-6396-2019	Lhermie, Guillaume/0000-0003-2538-1586	Cornell University, Academic Venture fund, Atkinson Center [555]	Cornell University, Academic Venture fund, Atkinson Center	This work was supported by Cornell University Grant number 555, Academic Venture fund 2017, Atkinson Center (http://www.atkinson.cornell.edu/grants/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AE, 2017, J DAIRY SCI, V100, P2119, DOI 10.3168/jds.2016-11517; Almasian M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14115-3; Bar D, 2008, J DAIRY SCI, V91, P2205, DOI 10.3168/jds.2007-0573; Bar D, 2008, J DAIRY SCI, V91, P2196, DOI 10.3168/jds.2007-0460; Bar D, 2007, J DAIRY SCI, V90, P4643, DOI 10.3168/jds.2007-0145; BARKEMA HW, 1994, PREV VET MED, V20, P249, DOI 10.1016/0167-5877(94)90058-2; Bewley JM, 2010, AGRIC FINANCE REV, V70, P97, DOI 10.1108/00021461011042666; Booth CJ, 2004, J DAIRY SCI, V87, P4115, DOI 10.3168/jds.S0022-0302(04)73554-7; Cazer CL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01753; CDC, 2013, ANTIBIOTIC RESISTANC; Cha E, 2011, J DAIRY SCI, V94, P4476, DOI 10.3168/jds.2010-4123; Cha E, 2010, PREV VET MED, V97, P1, DOI 10.1016/j.prevetmed.2010.07.011; De Vliegher S, 2012, J DAIRY SCI, V95, P1025, DOI 10.3168/jds.2010-4074; De Vries A, 2006, P 11 INT S VET EP EC, P19; Dohoo I., 2009, VET EPIDEMIOLOGIC RE; Dubuc J, 2011, J DAIRY SCI, V94, P1339, DOI 10.3168/jds.2010-3758; ECDC, 2017, PROP EU GUID PRUD US; Evans NJ, 2016, VET J, V211, P3, DOI 10.1016/j.tvjl.2015.10.028; Fourichon C, 2000, THERIOGENOLOGY, V53, P1729, DOI 10.1016/S0093-691X(00)00311-3; Fourichon C, 1999, PREV VET MED, V41, P1, DOI 10.1016/S0167-5877(99)00035-5; Francoz D, 2017, J DAIRY SCI, P1; Francoz D, 2016, ANIM HEALTH RES REV, V17, P169, DOI 10.1017/S1466252316000177; Gaddis KLP, 2012, J DAIRY SCI, V95, P5422, DOI 10.3168/jds.2012-5572; Gorden PJ, 2010, VET CLIN N AM-FOOD A, V26, P243, DOI 10.1016/j.cvfa.2010.03.004; Groenendaal H, 2004, J DAIRY SCI, V87, P2146, DOI 10.3168/jds.S0022-0302(04)70034-X; Grohn YT, 2003, PREV VET MED, V61, P27, DOI 10.1016/S0167-5877(03)00158-2; Grohn YT, 1998, J DAIRY SCI, V81, P966, DOI 10.3168/jds.S0022-0302(98)75657-7; Haimerl P, 2017, J DAIRY SCI, V100, P3783, DOI 10.3168/jds.2016-11834; Halasa T, 2007, VET QUART, V29, P18, DOI 10.1080/01652176.2007.9695224; Halasa T, 2009, J DAIRY SCI, V92, P3150, DOI 10.3168/jds.2008-1741; Halasa T, 2009, J DAIRY SCI, V92, P3134, DOI 10.3168/jds.2008-1740; Heikkila AM, 2012, J DAIRY SCI, V95, P139, DOI 10.3168/jds.2011-4321; Hill AE, 2009, PREV VET MED, V88, P264, DOI 10.1016/j.prevetmed.2008.12.001; Huxley JN, 2013, LIVEST SCI, V156, P64, DOI 10.1016/j.livsci.2013.06.012; Kausche FM, 2003, VET THER, V4, P83; LeBlanc SJ, 2008, VET J, V176, P102, DOI 10.1016/j.tvjl.2007.12.019; Lhermie G, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02114; Liang D, 2017, J DAIRY SCI, V100, P1472, DOI 10.3168/jds.2016-11565; Liang D, 2013, ESTIMATING EC LOSSES; McDougall S, 2007, ANIM REPROD SCI, V99, P9, DOI 10.1016/j.anireprosci.2006.03.017; National Research Council, 2001, NUTR REQ DAIR CATTL, V7th; Oliveira L, 2013, J DAIRY SCI, V96, P7538, DOI 10.3168/jds.2012-6078; Pinedo PJ, 2010, J DAIRY SCI, V93, P2250, DOI 10.3168/jds.2009-2572; Rabiee AR, 2013, J DAIRY SCI, V96, P6915, DOI 10.3168/jds.2013-6544; Raboisson D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164200; Rajala-Schultz PJ, 1999, J DAIRY SCI, V82, P1213, DOI 10.3168/jds.S0022-0302(99)75344-0; Richert RM, 2013, J DAIRY SCI, V96, P5018, DOI 10.3168/jds.2012-6257; Rollin E, 2015, PREV VET MED, V122, P257, DOI 10.1016/j.prevetmed.2015.11.006; Rowbotham RF, 2016, J DAIRY SCI, V99, P4707, DOI 10.3168/jds.2015-10675; Scherpenzeel CGM, 2016, J DAIRY SCI, V99, P3753, DOI 10.3168/jds.2015-9963; Schukken YH, 2009, J DAIRY SCI, V92, P3091, DOI 10.3168/jds.2008-1557; Seegers H, 2003, VET RES, V34, P475, DOI 10.1051/vetres:2003027; Stevens M, 2016, J DAIRY SCI, V99, P2118, DOI 10.3168/jds.2015-10199; Swinkels JM, 2005, J DAIRY SCI, V88, P4273, DOI 10.3168/jds.S0022-0302(05)73113-1; Tang KL, 2017, LANCET PLANET HEALTH, V1, pE316, DOI 10.1016/S2542-5196(17)30141-9; US Department of Agriculture, 2012, 2012 CENS AGR; USDA, 2017, EC RES SERV DAT PROD; USDA, MILK PROD PER COW US; USDA, 2015, USDA AGR PROJ 2025; USDA NAHMS, 2008, ANT US US DAIR OP 20; Van Boeckel TP, 2017, SCIENCE, V357, P1350, DOI 10.1126/science.aao1495; WHO/ FAO/ OIE, 2016, ANT RES MAN DEV NAT; Wisconsin University, UND DAIR MARK	63	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194832	10.1371/journal.pone.0194832	http://dx.doi.org/10.1371/journal.pone.0194832			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566103	Green Published, gold, Green Submitted			2022-12-26	WOS:000428093900111
J	Zhu, DD; Lyu, L; Shen, P; Wang, JX; Chen, JL; Sun, XL; Chen, LT; Zhang, L; Zhou, Q; Duan, YN				Zhu, Dandan; Lyu, Lei; Shen, Pei; Wang, Jianxin; Chen, Jinling; Sun, Xiaolei; Chen, Liuting; Zhang, Li; Zhou, Qi; Duan, Yinong			rSjP40 protein promotes PPAR gamma expression in LX-2 cells through microRNA-27b	FASEB JOURNAL			English	Article						Schistosoma japonicum; miR-27b; hepatic stellate cell; methylation	HEPATIC STELLATE CELLS; LIVER FIBROSIS; ACTIVATION; MIR-27B; METHYLATION; GROWTH	miR-27b is reported to participate in the proliferation and differentiation of hepatic stellate cells (HSCs) and to regulate fat metabolism of rat HSCs by targeting retinoid X receptor . Our previous study also indicated that the recombinant P40 protein from Schistosoma japonicum (rSjP40) inhibited the activation of HSCs. In this study, we observed the expression of miR-27b in rSjP40-treated LX-2 cells and explored its potential mechanisms. Quantitative real-time PCR showed that rSjP40 inhibits the expression of miR-27b in LX-2 cells. Further results obtained by Western blot and dual-luciferase reporter assay confirmed that miR-27b regulates peroxisome proliferator-activated receptor (PPAR) expression in rSjP40-treated LX-2 cells by targeting the 3-UTR of PPAR. 5-AZA-2-deoxycytidine (5-AZA-dC), which inhibits methylation of HSCs, partially reversed rSjP40-induced down-regulation expression of miR-27b in LX-2 cells. 5-AZA-dC also partially reversed rSjP40-induced up-regulation expression of PPAR in LX-2 cells. The increased expression of PPAR in rSjP40-treated LX-2 cells may be partially due to miR-27b methylation. Therefore, our study provides further insight into the mechanism by which rSjP40 inhibits HSC activation and provides a basis for future study of the blocking effect of rSjP40 in liver fibrosis.Zhu, D., Lyu, L., Shen, P., Wang, J., Chen, J., Sun, X., Chen, L., Zhang, L., Zhou, Q., Duan, Y. rSjP40 protein promotes PPAR expression in LX-2 cells through microRNA-27b.	[Zhu, Dandan; Lyu, Lei; Chen, Jinling; Sun, Xiaolei; Chen, Liuting; Zhang, Li; Zhou, Qi; Duan, Yinong] Nantong Univ, Sch Med, Dept Pathogen Biol, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China; [Lyu, Lei] Nanjing Red Cross Blood Ctr, Nanjing, Jiangsu, Peoples R China; [Shen, Pei; Wang, Jianxin] Nantong Univ, Lab Med Ctr, Affiliated Hosp, Nantong, Peoples R China	Nantong University; Nantong University	Duan, YN (corresponding author), Nantong Univ, Sch Med, Dept Pathogen Biol, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.	yinongduan@aliyun.com	Duan, yinong/GSD-9438-2022	Chen, Jinling/0000-0003-2992-6571	National Natural Science Foundation of China [81501763, 81471975, 81171589]; Jiangsu Provincial Natural Science Foundation [BK20140435]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	The authors thank Dr. Zhaolian Bian (Nantong Institute of Liver Disease, Nantong Third People's Hospital, Nantong, China) for providing the LX-2 cells. This work was supported by National Natural Science Foundation of China Grants 81501763, 81471975, and 81171589; by Jiangsu Provincial Natural Science Foundation Grant BK20140435; and by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The authors declare no conflicts of interest.	Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Cao Q, 2014, ENDOCRINOLOGY, V155, P4925, DOI 10.1210/en.2014-1595; Chan LS, 2012, HORM METAB RES, V44, P819, DOI 10.1055/s-0032-1321909; Dharap A, 2015, J NEUROCHEM, V135, P139, DOI 10.1111/jnc.13220; Du JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16163; Duan YN, 2014, INT J PARASITOL, V44, P217, DOI 10.1016/j.ijpara.2013.11.003; Ge JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22141; Halasz T, 2015, WORLD J GASTROENTERO, V21, P7814, DOI 10.3748/wjg.v21.i25.7814; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Kwiecinski M, 2012, LAB INVEST, V92, P978, DOI 10.1038/labinvest.2012.70; Lakner AM, 2012, HEPATOLOGY, V56, P300, DOI 10.1002/hep.25613; Lee JJ, 2012, ONCOGENE, V31, P3818, DOI 10.1038/onc.2011.543; Li XN, 2016, BIOCHEM BIOPH RES CO, V477, P768, DOI 10.1016/j.bbrc.2016.06.133; Lu L, 2015, BIOCHEM BIOPH RES CO, V465, P387, DOI 10.1016/j.bbrc.2015.08.012; Mann J, 2009, ADV DRUG DELIVER REV, V61, P497, DOI 10.1016/j.addr.2009.03.011; Murakami Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016081; Pan SF, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0193-4; Rapp J, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2943-4; Sun XL, 2015, PARASITOL RES, V114, P4251, DOI 10.1007/s00436-015-4663-0; Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87; Tsukamoto H, 2006, J GASTROEN HEPATOL, V21, pS102, DOI 10.1111/j.1440-1746.2006.04573.x; Tu KS, 2014, INT J MOL SCI, V15, P20486, DOI 10.3390/ijms151120486; Venugopal SK, 2010, AM J PHYSIOL-GASTR L, V298, pG101, DOI 10.1152/ajpgi.00220.2009; Zeng XM, 2017, BMC CELL BIOL, V18, DOI 10.1186/s12860-016-0123-7; Zhang Z, 2013, ONKOLOGIE, V36, P598, DOI 10.1159/000355328; Zhu DD, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-148	28	12	12	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4798	4803		10.1096/fj.201700520RR	http://dx.doi.org/10.1096/fj.201700520RR			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29608331				2022-12-26	WOS:000443817700015
J	Pentimalli, F; Forte, IM; Esposito, L; Indovina, P; Iannuzzi, CA; Alfano, L; Costa, C; Barone, D; Rocco, G; Giordano, A				Pentimalli, Francesca; Forte, Iris M.; Esposito, Luca; Indovina, Paola; Iannuzzi, Carmelina A.; Alfano, Luigi; Costa, Caterina; Barone, Daniela; Rocco, Gaetano; Giordano, Antonio			RBL2/p130 is a direct AKT target and is required to induce apoptosis upon AKT inhibition in lung cancer and mesothelioma cell lines	ONCOGENE			English	Article							TUMOR-SUPPRESSOR PROTEIN; RETINOBLASTOMA FAMILY; PRB2/P130 EXPRESSION; GENE-EXPRESSION; CDK INHIBITORS; CYCLE; PHOSPHORYLATION; KINASE; RB; ACTIVATION	The retinoblastoma (RB) protein family includes RB1/p105, RBL1/p107, and RBL2/p130, which are key factors in cell-cycle regulation and stand at the crossroads of multiple pathways dictating cell fate decisions. The role of RB proteins in apoptosis is controversial because they can inhibit or promote apoptosis depending on the context, on the apoptotic stimuli and on their intrinsic status, impacting on the response to antitumoral treatments. Here we identified RBL2/p130 as a direct substrate of the AKT kinase, a key antiapoptotic factor hyperactive in multiple cancer types. We showed that RBL2/p130 and AKT1 physically interact and AKT phosphorylates RBL2/p130 Ser941, located in the pocket domain, but not when this residue is mutated into Ala. We found that pharmacological inhibition of AKT, through the highly selective AKT inhibitor VIII (AKTiVIII), impairs RBL2/p130 Ser941 phosphorylation and increases RBL2/p130 stability, mRNA expression and nuclear levels in both lung cancer and mesothelioma cell lines, mirroring the more extensively studied effects on the p27 cell-cycle inhibitor. Consistently, AKT inhibition reduced cell viability, induced cell accumulation in G0/G1, and triggered apoptosis, which proved to be largely dependent on RBL2/p130 itself, as shown upon RBL2/p130 silencing. AKT inhibition induced RBL2/p130-dependent apoptosis also in HEK-293 cells, in which re-expression of a short hairpin-resistant RBL2/p130 was able to rescue AKTiVIII-induced apoptosis upon RBL2/p130 silencing. Our data also showed that the combination of AKT and cyclin-dependent kinases (CDK) inhibitors, which converge on the re-activation of RBL2/p130 antitumoral potential, could be a promising anticancer strategy.	[Pentimalli, Francesca; Forte, Iris M.; Esposito, Luca; Iannuzzi, Carmelina A.; Alfano, Luigi; Costa, Caterina; Barone, Daniela] Fdn G Pascale, Ist Nazl Tumori IRCCS, Oncol Res Ctr Mercogliano CROM, I-80131 Naples, Italy; [Indovina, Paola; Giordano, Antonio] Temple Univ, Ctr Biotechnol, Sbarro Inst Canc Res & Mol Med, Coll Sci & Technol, Philadelphia, PA 19122 USA; [Iannuzzi, Carmelina A.; Barone, Daniela; Giordano, Antonio] Univ Siena, Dept Med Surg & Neurosci, I-53100 Siena, Italy; [Rocco, Gaetano] Fdn G Pascale, Div Thorac Surg, Dept Thorac Surg & Oncol, Ist Nazl Tumori, I-80131 Naples, Italy; [Rocco, Gaetano] IRCCS, I-80131 Naples, Italy	IRCCS Fondazione Pascale; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Siena; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale	Pentimalli, F (corresponding author), Fdn G Pascale, Ist Nazl Tumori IRCCS, Oncol Res Ctr Mercogliano CROM, I-80131 Naples, Italy.; Giordano, A (corresponding author), Temple Univ, Ctr Biotechnol, Sbarro Inst Canc Res & Mol Med, Coll Sci & Technol, Philadelphia, PA 19122 USA.; Giordano, A (corresponding author), Univ Siena, Dept Med Surg & Neurosci, I-53100 Siena, Italy.	f.pentimalli@istitutotumori.na.it; president@shro.org	Alfano, Luigi/B-8330-2015; Forte, Iris Maria/K-7588-2016; Costa, Caterina/N-1742-2019; Barone, Daniela/N-1024-2015; Pentimalli, Francesca/K-4936-2014; Iannuzzi, CarmelinaAntonella/K-3131-2018; Giordano, Antonio/AAU-1201-2020; Costa, Caterina/ABE-2452-2020; Rocco, Gaetano/K-4801-2016	Alfano, Luigi/0000-0002-4516-9956; Forte, Iris Maria/0000-0001-9490-5844; Costa, Caterina/0000-0003-0909-7366; Barone, Daniela/0000-0002-5543-7686; Pentimalli, Francesca/0000-0003-4740-6801; Iannuzzi, CarmelinaAntonella/0000-0002-4445-9687; Giordano, Antonio/0000-0002-5959-016X; Indovina, Paola/0000-0001-8416-435X; Rocco, Gaetano/0000-0003-4150-8604	AIRC-Associazione Italiana per la Ricerca sul Cancro [IG 2014-15690]; Italian Ministry of Health; Sbarro Health Research Organization [phosphoRBL2/p130S941]	AIRC-Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); Sbarro Health Research Organization	This work was supported by the AIRC-Associazione Italiana per la Ricerca sul Cancro, IG 2014-15690 to AG and by the Italian Ministry of Health. We are grateful to the Sbarro Health Research Organization (www.shro.org) for its support and for providing the custom phosphoRBL2/p130S941 antibody, and to the Commonwealth of Pennsylvania. We are grateful to our intern students Flora Magnotti, Michela Napolitano, Caterina Miro and Sonia Sodano for technical help. We are grateful to Flavio Rizzolio for sharing RBL2/p130 silencing vectors and to Enrico Bucci for helpful discussion. AG is also Director of the Cell Cycle and Cancer Research Line at CROM, Istituto Nazionale Tumori; Naples. FP is also Adjunct Associate professor at Temple University, Department of Biology, Philadelphia, PA, USA.	Abate AA, 2013, EXPERT OPIN INV DRUG, V22, P895, DOI 10.1517/13543784.2013.798641; Alessio N, 2013, CELL MOL LIFE SCI, V70, P1637, DOI 10.1007/s00018-012-1224-x; Altomare DA, 2005, ONCOGENE, V24, P6080, DOI 10.1038/sj.onc.1208744; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Bellan C, 2002, INVEST OPHTH VIS SCI, V43, P3602; Bhattacharya S, 2003, ONCOGENE, V22, P2443, DOI 10.1038/sj.onc.1206339; Busacca S, 2010, AM J RESP CELL MOL, V42, P312, DOI 10.1165/rcmb.2009-0060OC; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Caputi M, 2002, CLIN CANCER RES, V8, P3850; Chestukhin A, 2002, MOL CELL BIOL, V22, P453, DOI 10.1128/MCB.22.2.453-468.2002; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Cirillo D, 2011, CURR MED CHEM, V18, P2854, DOI 10.2174/092986711796150496; D'Andrilli G, 2004, CLIN CANCER RES, V10, P3098, DOI 10.1158/1078-0432.CCR-03-0524; David O, 2004, CLIN CANCER RES, V10, P6865, DOI 10.1158/1078-0432.CCR-04-0174; De Falco G, 2006, ONCOGENE, V25, P5333, DOI 10.1038/sj.onc.1209614; DeLuca A, 1997, J BIOL CHEM, V272, P20971, DOI 10.1074/jbc.272.34.20971; Di Marzo D, 2014, CELL CYCLE, V13, P652, DOI 10.4161/cc.27546; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Ecker K, 2009, NAT CELL BIOL, V11, P377, DOI [10.1038/ncb1859, 10.1038/ncb0409-377]; Engeland K, 2018, CELL DEATH DIFFER, V25, P114, DOI 10.1038/cdd.2017.172; Helmbold H, 2012, J CELL PHYSIOL, V227, P508, DOI 10.1002/jcp.22786; Henley SA, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-10; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Ho VM, 2009, ONCOGENE, V28, P1393, DOI 10.1038/onc.2008.491; Howard CM, 2000, CANCER RES, V60, P2737; Indovina P, 2012, ONCOGENE, V31, P929, DOI 10.1038/onc.2011.286; Indovina P, 2015, ONCOTARGET, V6, P17873, DOI 10.18632/oncotarget.4286; Indovina P, 2013, J CELL PHYSIOL, V228, P525, DOI 10.1002/jcp.24170; Jorl FP, 2005, CELL DEATH DIFFER, V12, P65, DOI 10.1038/sj.cdd.4401499; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Knudsen ES, 2010, CLIN CANCER RES, V16, P1094, DOI 10.1158/1078-0432.CCR-09-0787; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; La Sala D, 2003, ONCOGENE, V22, P3518, DOI 10.1038/sj.onc.1206487; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011; Litovchick L, 2004, MOL CELL BIOL, V24, P8970, DOI 10.1128/MCB.24.20.8970-8980.2004; Liu DX, 2005, GENE DEV, V19, P719, DOI 10.1101/gad.1296405; Liu PD, 2014, CELL CYCLE, V13, P2162, DOI 10.4161/cc.29584; Liu PD, 2014, NATURE, V508, P541, DOI 10.1038/nature13079; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logie L, 2007, DIABETES, V56, P2218, DOI 10.2337/db07-0343; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Masciullo V, 2008, CLIN CANCER RES, V14, P4775, DOI 10.1158/1078-0432.CCR-07-4055; MAYOL X, 1993, ONCOGENE, V8, P2561; Meuillet EJ, 2011, CURR MED CHEM, V18, P2727; Ming LH, 2008, CARCINOGENESIS, V29, P1878, DOI 10.1093/carcin/bgn150; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pentimalli F, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-LB-080; Pentimalli F, 2010, CANCER DRUG DISCOV D, P109, DOI 10.1007/978-1-60761-178-3_8; Pucci B, 2002, ONCOGENE, V21, P5897, DOI 10.1038/sj.onc.1205750; Qiu ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081451; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Rizzolio F, 2012, CELL DEATH DIFFER, V19, P1152, DOI 10.1038/cdd.2011.202; Sadasivam S, 2013, NAT REV CANCER, V13, P585, DOI 10.1038/nrc3556; Saharia A, 2008, CURR BIOL, V18, P496, DOI 10.1016/j.cub.2008.02.071; Simpson DS, 2009, CANCER RES, V69, P8733, DOI 10.1158/0008-5472.CAN-09-1359; Tedesco D, 2002, GENE DEV, V16, P2946, DOI 10.1101/gad.1011202; Tsurutani J, 2006, J CLIN ONCOL, V24, P306, DOI 10.1200/JCO.2005.02.4133; Yang H, 2006, ONCOGENE, V25, P4585, DOI 10.1038/sj.onc.1209481; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010; Zhou S, 2014, BRIT J CANCER, V110, P2479, DOI 10.1038/bjc.2014.220	61	20	20	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 5	2018	37	27					3657	3671		10.1038/s41388-018-0214-3	http://dx.doi.org/10.1038/s41388-018-0214-3			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GM3CM	29606701				2022-12-26	WOS:000437975200004
J	Narayanan, A; Vago, FS; Li, KP; Qayyum, MZ; Yernool, D; Jiang, W; Murakami, KS				Narayanan, Anoop; Vago, Frank S.; Li, Kunpeng; Qayyum, M. Zuhaib; Yernool, Dinesh; Jiang, Wen; Murakami, Katsuhiko S.			Cryo-EM structure of Escherichia coli sigma(70) RNA polymerase and promoter DNA complex revealed a role of sigma non-conserved region during the open complex formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cryo-electron microscopy; RNA polymerase; structural biology; promoter; transcription; cryo-EM; sigma non-conserved region; promoter DNA; open complex	TRANSCRIPTION INITIATION; X-RAY; MYCOBACTERIUM-TUBERCULOSIS; CRYSTAL-STRUCTURES; MICROSCOPY	First step of gene expression is transcribing the genetic information stored in DNA to RNA by the transcription machinery including RNA polymerase (RNAP). In Escherichia coli, a primary sigma(70) factor forms the RNAP holoenzyme to express housekeeping genes. The sigma(70) contains a large insertion between the conserved regions 1.2 and 2.1, the sigma non-conserved region (sigma(NCR)), but its function remains to be elucidated. In this study, we determined the cryo-EM structures of the E. coli RNAP sigma(70) holoenzyme and its complex with promoter DNA (open complex, RPo) at 4.2 and 5.75 angstrom resolutions, respectively, to reveal native conformations of RNAP and DNA. The RPo structure presented here found an interaction between the sigma(NCR) and promoter DNA just upstream of the -10 element, which was not observed in a previously determined E. coli RNAP transcription initiation complex (RPo plus short RNA) structure by X-ray crystallography because of restraint of crystal packing effects. Disruption of the sigma(NCR) and DNA interaction by the amino acid substitutions (R157A/R157E) influences the DNA opening around the transcription start site and therefore decreases the transcription activity of RNAP. We propose that the sigma(NCR) and DNA interaction is conserved in proteobacteria, and RNAP in other bacteria replaces its role with a transcription factor.	[Narayanan, Anoop; Qayyum, M. Zuhaib; Murakami, Katsuhiko S.] Penn State Univ, Dept Biochem & Mol Biol, Ctr RNA Mol Biol, University Pk, PA 16802 USA; [Narayanan, Anoop; Vago, Frank S.; Li, Kunpeng; Yernool, Dinesh; Jiang, Wen] Purdue Univ, Dept Biol Sci, Markey Ctr Struct Biol, W Lafayette, IN 47906 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Murakami, KS (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr RNA Mol Biol, University Pk, PA 16802 USA.; Jiang, W (corresponding author), Purdue Univ, Dept Biol Sci, Markey Ctr Struct Biol, W Lafayette, IN 47906 USA.	jiang12@purdue.edu; kum14@psu.edu	jiang, wen/GYI-9662-2022; Qayyum, Mohammad Zuhaib/AAD-8672-2022	Qayyum, Mohammad Zuhaib/0000-0003-2442-4812; Jiang, Wen/0000-0002-1292-2411	National Institutes of Health [GM087350, GM093142]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087350, R01GM093142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM087350 (to K. S. M.) and GM093142 (to D. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonine PV, 2010, ACTA CRYSTALLOGR D, V66, P1153, DOI 10.1107/S0907444910026582; Artsimovitch I, 2003, J BIOL CHEM, V278, P12344, DOI 10.1074/jbc.M211214200; Bae B, 2015, ELIFE, V4, DOI 10.7554/eLife.08504; Bandwar RP, 2001, J BIOL CHEM, V276, P14075, DOI 10.1074/jbc.M011289200; Chen J, 2017, MOL CELL, V68, P388, DOI 10.1016/j.molcel.2017.09.006; Davis E, 2015, NUCLEIC ACIDS RES, V43, P433, DOI 10.1093/nar/gku1231; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Glyde R, 2017, MOL CELL, V67, P106, DOI 10.1016/j.molcel.2017.05.010; Hubin EA, 2017, ELIFE, V6, DOI 10.7554/eLife.22520; Kang JY, 2017, ELIFE, V6, DOI 10.7554/eLife.25478; Kuhlbrandt W, 2014, SCIENCE, V343, P1443, DOI 10.1126/science.1251652; Lin W, 2017, MOL CELL, V66, P169, DOI 10.1016/j.molcel.2017.03.001; Liu B, 2017, SCIENCE, V358, P947, DOI 10.1126/science.aao1923; Malhotra A, 1996, CELL, V87, P127, DOI 10.1016/S0092-8674(00)81329-X; Molodtsov V, 2017, MOL MICROBIOL, V103, P1034, DOI 10.1111/mmi.13606; Molodtsov V, 2015, J MED CHEM, V58, P3156, DOI 10.1021/acs.jmedchem.5b00050; Murakami KS, 2013, J BIOL CHEM, V288, P9126, DOI 10.1074/jbc.M112.430900; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Narayanan A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4282; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ruff EF, 2015, J MOL BIOL, V427, P2435, DOI 10.1016/j.jmb.2015.05.024; Ruff EF, 2015, BIOMOLECULES, V5, P1035, DOI 10.3390/biom5021035; Scheres SHW, 2016, METHOD ENZYMOL, V579, P125, DOI 10.1016/bs.mie.2016.04.012; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zuo YH, 2015, MOL CELL, V58, P534, DOI 10.1016/j.molcel.2015.03.010	27	39	39	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7367	7375		10.1074/jbc.RA118.002161	http://dx.doi.org/10.1074/jbc.RA118.002161			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29581236	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000432174500029
J	Rodriguez, Y; Duan, MR; Wyrick, JJ; Smerdon, MJ				Rodriguez, Yesenia; Duan, Mingrui; Wyrick, John J.; Smerdon, Michael J.			A cassette of basic amino acids in histone H2B regulates nucleosome dynamics and access to DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nucleosome; base excision repair (BER); DNA repair; chromatin; histone modification; glycosylase; HBR domain; histone H2B repression; polymerase beta	SITE-SPECIFIC ACETYLATION; EXCISION-REPAIR ENZYMES; CORE PARTICLES; POSTTRANSLATIONAL MODIFICATIONS; SACCHAROMYCES-CEREVISIAE; SEQUENCE; DOMAIN; STABILITY; BINDING; TAIL	Nucleosome dynamics, such as spontaneous DNA unwrapping, are postulated to have a critical role in regulating the access of DNA repair machinery to DNA lesions within nucleosomes. However, the specific histone domains that regulate nucleosome dynamics and the impact of such changes in intrinsic nucleosome dynamics on DNA repair are not well understood. Previous studies identified a highly conserved region in the N-terminal tail of histone H2B known as the histone H2B repression (or HBR) domain, which has a significant influence on gene expression, chromatin assembly, and DNA damage formation and repair. However, the molecular mechanism(s) that may account for these observations are limited. In this study, we characterized the stability and dynamics of HBR mutant nucleosome core particles (NCPs) in vitro by restriction enzyme accessibility (REA), FRET, and temperature-induced sliding of histone octamers. Our results indicate that HBR-NCPs are more dynamic, with a larger steady-state fraction of the NCP population occupying the unwrapped state than for WT-NCPs. Additionally, HBR-histone octamers are more susceptible to temperature-induced sliding on DNA than WT histone octamers. Furthermore, we show that the activity of base excision repair enzymes at uracil lesions and single nucleotide gaps is enhanced in a site-specific manner in HBR-NCPs. This enhanced activity correlates well with regions exhibiting increased DNA unwrapping. Finally, removal of the HBR domain is not sufficient to completely alleviate the structural constraints imposed by histone octamers on the activity of base excision repair enzymes.	[Rodriguez, Yesenia; Duan, Mingrui; Wyrick, John J.; Smerdon, Michael J.] Washington State Univ, Sch Mol Biosci, Biochem & Biophys, Pullman, WA 99164 USA; [Wyrick, John J.] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; [Rodriguez, Yesenia] NIEHS, NIH, Genome Integr & Struct Biol Lab, POB 12233,Mail Drop F3-01, Res Triangle Pk, NC 27709 USA	Washington State University; Washington State University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Smerdon, MJ (corresponding author), Washington State Univ, Sch Mol Biosci, Biotechnol Life Sci Bldg, Pullman, WA 99164 USA.	smerdon@wsu.edu			National Institutes of Health from the NIEHS, National Institutes of Health [ES002614, R21ES027937, ES004106]; National Institute of General Medical Sciences Training Grant [T32GM008336]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004106, R21ES027937, R01ES002614, R37ES002614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336] Funding Source: NIH RePORTER	National Institutes of Health from the NIEHS, National Institutes of Health; National Institute of General Medical Sciences Training Grant; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants ES002614 (to M. J. S. and J. J. W.), R21ES027937 (to J. J. W.), and ES004106 (to M. J. S.) from the NIEHS, National Institutes of Health, and by National Institute of General Medical Sciences Training Grant T32GM008336 (to Y. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bao YH, 2004, EMBO J, V23, P3314, DOI 10.1038/sj.emboj.7600316; Bauer NC, 2015, NUCLEIC ACIDS RES, V43, P10083, DOI 10.1093/nar/gkv1136; Beard BC, 2003, P NATL ACAD SCI USA, V100, P7465, DOI 10.1073/pnas.1330328100; Bowman GD, 2015, CHEM REV, V115, P2274, DOI 10.1021/cr500350x; Chafin DR, 2000, EMBO J, V19, P5492, DOI 10.1093/emboj/19.20.5492; Chua EYD, 2012, NUCLEIC ACIDS RES, V40, P6338, DOI 10.1093/nar/gks261; Cole HA, 2010, J BIOL CHEM, V285, P2876, DOI 10.1074/jbc.M109.073544; Donigan KA, 2012, J BIOL CHEM, V287, P23830, DOI 10.1074/jbc.M111.324947; Duan MR, 2010, J BIOL CHEM, V285, P26295, DOI 10.1074/jbc.M110.140087; Fernandez AG, 2007, J MOL BIOL, V371, P649, DOI 10.1016/j.jmb.2007.05.090; Gansen A, 2009, P NATL ACAD SCI USA, V106, P15308, DOI 10.1073/pnas.0903005106; Guintini L, 2015, DNA REPAIR, V36, P98, DOI 10.1016/j.dnarep.2015.09.012; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Hinz JM, 2014, MUTAT RES-FUND MOL M, V766, P19, DOI 10.1016/j.mrfmmm.2014.05.008; Hinz JM, 2010, P NATL ACAD SCI USA, V107, P4646, DOI 10.1073/pnas.0914443107; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Hodges AJ, 2015, GENETICS, V200, P795, DOI 10.1534/genetics.115.175885; Iwasaki W, 2013, FEBS OPEN BIO, V3, P363, DOI 10.1016/j.fob.2013.08.007; Kan PY, 2009, MOL CELL BIOL, V29, P538, DOI 10.1128/MCB.01343-08; Kelbauskas L, 2009, BIOCHEM CELL BIOL, V87, P323, DOI 10.1139/O08-126; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; Mao P, 2017, GENOME RES, V27, P1674, DOI 10.1101/gr.225771.117; Mao P, 2017, PHOTOCHEM PHOTOBIOL, V93, P216, DOI 10.1111/php.12646; Mao P, 2016, NUCLEIC ACIDS RES, V44, P9142, DOI 10.1093/nar/gkw588; McGinty RK, 2015, CHEM REV, V115, P2255, DOI 10.1021/cr500373h; Nag R, 2010, NUCLEIC ACIDS RES, V38, P1450, DOI 10.1093/nar/gkp1074; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Odell ID, 2011, MOL CELL BIOL, V31, P4623, DOI 10.1128/MCB.05715-11; Olmon ED, 2017, ACS CHEM BIOL, V12, P692, DOI 10.1021/acschembio.6b00921; Parra MA, 2006, MOL CELL BIOL, V26, P3842, DOI 10.1128/MCB.26.10.3842-3852.2006; PENNINGS S, 1991, J MOL BIOL, V220, P101, DOI 10.1016/0022-2836(91)90384-I; Rodriguez Y, 2016, J BIOL CHEM, V291, P11434, DOI 10.1074/jbc.M116.725788; Rodriguez Y, 2015, DNA REPAIR, V32, P113, DOI 10.1016/j.dnarep.2015.04.021; Rodriguez Y, 2013, J BIOL CHEM, V288, P13863, DOI 10.1074/jbc.M112.441444; Schermerhorn KM, 2014, ACCOUNTS CHEM RES, V47, P1238, DOI 10.1021/ar400275a; Shim Y, 2012, ANAL BIOCHEM, V427, P190, DOI 10.1016/j.ab.2012.05.006; Sivolob A, 2003, J MOL BIOL, V326, P49, DOI 10.1016/S0022-2836(02)01372-4; Sugiyama M, 2014, BIOPHYS J, V106, P2206, DOI 10.1016/j.bpj.2014.04.007; Tims HS, 2011, J MOL BIOL, V411, P430, DOI 10.1016/j.jmb.2011.05.044; TULLIUS TD, 1991, FREE RADICAL RES COM, V12-3, P521; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; Wyrick JJ, 2012, BBA-GENE REGUL MECH, V1819, P892, DOI 10.1016/j.bbagrm.2012.04.001; Wyrick JJ, 2009, BBA-GENE REGUL MECH, V1789, P37, DOI 10.1016/j.bbagrm.2008.07.001; YAGER TD, 1989, BIOCHEMISTRY-US, V28, P2271, DOI 10.1021/bi00431a045; Yang ZY, 2007, J BIOL CHEM, V282, P7930, DOI 10.1074/jbc.M610584200; Zheng S, 2014, MOL CELL BIOL, V34, P303, DOI 10.1128/MCB.00478-13	51	7	7	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7376	7386		10.1074/jbc.RA117.000358	http://dx.doi.org/10.1074/jbc.RA117.000358			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29588367	Green Published, hybrid			2022-12-26	WOS:000432174500030
J	Das, P; Ji, BY; Kovatcheva-Datchary, P; Backhed, F; Nielsen, J				Das, Promi; Ji, Boyang; Kovatcheva-Datchary, Petia; Backhed, Fredrik; Nielsen, Jens			In vitro co-cultures of human gut bacterial species as predicted from co-occurrence network analysis	PLOS ONE			English	Article							MICROBIOTA; PH; BIFIDOBACTERIUM; POLYSACCHARIDES; ASSOCIATION; METAGENOME; DIGESTION; ACIDS; DIET	Network analysis of large metagenomic datasets generated by current sequencing technologies can reveal significant co-occurrence patterns between microbial species of a biological community. These patterns can be analyzed in terms of pairwise combinations between all species comprising a community. Here, we construct a co-occurrence network for abundant microbial species encompassing the three dominant phyla found in human gut. This was followed by an in vitro evaluation of the predicted microbe-microbe co-occurrences, where we chose species pairs Bifidobacterium adolescentis and Bacteroides thetaiotaomicron, as well as Faecalibacterium prausnitzii and Roseburia inulinivorans as model organisms for our study. We then delineate the outcome of the co-cultures when equal distributions of resources were provided. The growth behavior of the co-culture was found to be dependent on the types of microbial species present, their specific metabolic activities, and resulting changes in the culture environment. Through this reductionist approach and using novel in vitro combinations of microbial species under anaerobic conditions, the results of this work will aid in the understanding and design of synthetic community formulations.	[Das, Promi; Ji, Boyang; Nielsen, Jens] Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden; [Kovatcheva-Datchary, Petia; Backhed, Fredrik] Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden; [Backhed, Fredrik] Univ Copenhagen, Fac Hlth Sci, Sect Metab Receptol & Enteroendocrinol, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Nielsen, Jens] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Lyngby, Denmark	Chalmers University of Technology; University of Gothenburg; Novo Nordisk Foundation; University of Copenhagen; Technical University of Denmark	Nielsen, J (corresponding author), Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden.; Nielsen, J (corresponding author), Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Lyngby, Denmark.	nielsenj@chalmers.se	Backhed, Fredrik/ABE-6613-2020; Nielsen, Jens/Q-1347-2017	Backhed, Fredrik/0000-0002-4871-8818; Ji, Boyang/0000-0002-7269-4342; Das, Promi/0000-0002-9843-1524; Das, Promi/0000-0001-6733-2059; Nielsen, Jens/0000-0002-9955-6003	Knut and Alice Wallenberg Foundation; Torsten Soderbergs Stiftelse; European Commission Framework Programme 7 project METACARDIS [HEALTH-F4-2012-305312]; NNF Center for Basic Metabolic Research [B�ckhed Group] Funding Source: researchfish; Novo Nordisk Fonden [NNF15OC0016798, NNF10CC1016517] Funding Source: researchfish; NNF Center for Biosustainability [Yeast Cell Factories] Funding Source: researchfish	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Torsten Soderbergs Stiftelse; European Commission Framework Programme 7 project METACARDIS; NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability	We acknowledge funding by the Knut and Alice Wallenberg Foundation, Torsten Soderbergs Stiftelse and European Commission Framework Programme 7 project METACARDIS with the grant agreement HEALTH-F4-2012-305312 (http://www.metacardis.net/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adai AT, 2004, J MOL BIOL, V340, P179, DOI 10.1016/j.jmb.2004.04.047; Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109; DEGNAN BA, 1995, ANAEROBE, V1, P25, DOI 10.1016/S1075-9964(95)80392-0; Duncan SH, 2009, ENVIRON MICROBIOL, V11, P2112, DOI 10.1111/j.1462-2920.2009.01931.x; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Duranti S, 2016, NAT PUBL GR; ENGLYST HN, 1985, AM J CLIN NUTR, V42, P778, DOI 10.1093/ajcn/42.5.778; ENGLYST HN, 1987, AM J CLIN NUTR, V45, P423, DOI 10.1093/ajcn/45.2.423; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Flint HJ, 2015, P NUTR SOC, V74, P13, DOI 10.1017/S0029665114001463; Freilich S, 2010, NUCLEIC ACIDS RES, V38, P3857, DOI 10.1093/nar/gkq118; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; HAMILTON IR, 1989, ORAL MICROBIOL IMMUN, V4, P89, DOI 10.1111/j.1399-302X.1989.tb00105.x; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Karlsson FH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003706; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Knights D, 2014, CELL HOST MICROBE, V16, P433, DOI 10.1016/j.chom.2014.09.013; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Li X, 2003, CANCER GENE THER, V10, P105, DOI 10.1038/sj.cgt.7700530; Lopez-Siles M, 2012, APPL ENVIRON MICROB, V78, P420, DOI 10.1128/AEM.06858-11; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Louis P, 2004, J BACTERIOL, V186, P2099, DOI 10.1128/JB.186.7.2099-2106.2004; Mitri S, 2013, ANNU REV GENET, V47, P247, DOI 10.1146/annurev-genet-111212-133307; Munoz-Tamayo R, 2011, FEMS MICROBIOL ECOL, V76, P615, DOI 10.1111/j.1574-6941.2011.01085.x; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Rios-Covian D, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv176; Rios-Covian D, 2013, APPL ENVIRON MICROB, V79, P7518, DOI 10.1128/AEM.02545-13; Riviere A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00979; Ruan QS, 2006, BIOINFORMATICS, V22, P2532, DOI 10.1093/bioinformatics/btl417; Ruiz L, 2009, INT J FOOD MICROBIOL; RUSSELL JB, 1991, APPL ENVIRON MICROB, V57, P3383, DOI 10.1128/AEM.57.11.3383-3384.1991; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Tomas-Pejo E, 2008, BIOTECHNOL BIOENG, V100, P1122, DOI 10.1002/bit.21849; Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005; Weiss S, 2016, ISME J, V10, P1669, DOI 10.1038/ismej.2015.235; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Xu J, 2003, SCIENCE, P299	42	29	29	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195161	10.1371/journal.pone.0195161	http://dx.doi.org/10.1371/journal.pone.0195161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601608	Green Published, Green Submitted, gold			2022-12-26	WOS:000428845900019
J	Vissers, M; Wijmenga-Monsuur, AJ; Knol, MJ; Badoux, P; van Houten, MA; van der Ende, A; Sanders, EAM; Rots, NY				Vissers, Marloes; Wijmenga-Monsuur, Alienke J.; Knol, Mirjam J.; Badoux, Paul; van Houten, Marlies A.; van der Ende, Arie; Sanders, Elisabeth A. M.; Rots, Nynke Y.			Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in The Netherlands	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; HAEMOPHILUS-INFLUENZAE; CHILDREN; ADULTS; REPLACEMENT; POPULATION; 13-VALENT; IMPLEMENTATION; COLONIZATION	The 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in The Netherlands in 2006 and was replaced by PHiD-CV10 in 2011. Data on carriage prevalence of S. pneumoniae serotypes in children and invasive pneumococcal disease (IPD) in children and older adults were collected to examine the impact of PCVs on carriage and IPD in The Netherlands. Pneumococcal carriage prevalence was determined by conventional culture of nasopharyngeal swabs in 24-month-old children in 2015/2016. Data were compared to similar carriage studies in 2005 (pre-PCV7 introduction), 2009, 2010/2011 and 2012/2013. Invasive pneumococcal disease isolates from hospitalized children < 5 years and adults > 65 years (2004-2016) were obtained by sentinel surveillance. All isolates were serotyped by Quellung. Serotype invasive disease potential was calculated using carriage and nationwide IPD data in children. The overall pneumococcal carriage rate was 48% in 2015/2016, lower than in 2010/2011 (64%) and pre-vaccination in 2005 (66%). Carriage of the previously dominant non-vaccine serotypes 19A and 11A has declined since 2010/2011, from 14.2% to 4.6% and 4.2% to 2.7%, respectively, whereas carriage of serotypes 6C and 23B has increased (4.2% to 6.7% and 3.9% to 7.3%), making serotypes 6C and 23B the most prevalent carriage serotypes. IPD incidence declined in children (20/100,000 cases in 2004/2006 to 6/100,000 cases in 2015/2016) as well as in older adults (63/100,000 cases to 51/100,000 cases). Serotypes 6C, 23B and 11A have high carriage prevalence in children, but show low invasive disease potential. Serotype 8 is the main causative agent for IPD in older adults (11.3%). In conclusion, 10 years after the introduction of pneumococcal vaccination in children in The Netherlands shifts in carriage and disease serotypes are still ongoing. Surveillance of both carriage and IPD is important to assess PCV impact and to predict necessary future vaccination strategies in both children and older adults.	[Vissers, Marloes; Wijmenga-Monsuur, Alienke J.; Knol, Mirjam J.; Sanders, Elisabeth A. M.; Rots, Nynke Y.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands; [Badoux, Paul] Reg Lab Publ Hlth, Haarlem, Netherlands; [van Houten, Marlies A.] Spaarne Gasthuis Acad, Hoofddorp, Netherlands; [van der Ende, Arie] Acad Med Ctr, Med Microbiol, Amsterdam, Netherlands; [van der Ende, Arie] Acad Med Ctr, Netherlands Reference Lab Bacterial Meningitis, Amsterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; Spaarne Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Vissers, M (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands.	Nynke.Rots@rivm.nl		van der Ende, Arie/0000-0003-1298-3086	Dutch Ministry of Health, the Netherlands	Dutch Ministry of Health, the Netherlands	This work was supported by the Dutch Ministry of Health, the Netherlands. Funders did not have any role in study design, collection of materials, analysis and interpretation of data, writing of the report and the decision to submit the article for publication.	Black SB, 2001, PEDIATR INFECT DIS J, V20, P1105, DOI 10.1097/00006454-200112000-00002; Bosch AATM, 2016, VACCINE, V34, P531, DOI 10.1016/j.vaccine.2015.11.060; Brandileone MCD, 2016, VACCINE, V34, P5604, DOI 10.1016/j.vaccine.2016.09.027; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; Dagan R, 2013, CLIN INFECT DIS, V57, P952, DOI 10.1093/cid/cit428; Elberse KEM, 2012, VACCINE, V30, P7644, DOI 10.1016/j.vaccine.2012.04.021; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Galanis I, 2016, EUR RESPIR J, V47, P1208, DOI 10.1183/13993003.01451-2015; Hanage WP, 2011, VACCINE, V29, P8877, DOI 10.1016/j.vaccine.2011.09.075; Harboe ZB, 2010, CLIN INFECT DIS, V50, P329, DOI 10.1086/649872; Isturiz R, 2017, EXPERT REV VACCINES, V16, P1007, DOI 10.1080/14760584.2017.1362339; Jansen AGSC, 2009, CLIN INFECT DIS, V49, pE23, DOI 10.1086/600045; Knol MJ, 2015, EMERG INFECT DIS, V21, P2040, DOI 10.3201/eid2111.140780; Kronenberg A, 2006, J CLIN MICROBIOL, V44, P2032, DOI 10.1128/JCM.00275-06; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Lindstrand A, 2016, VACCINE, V34, P4565, DOI 10.1016/j.vaccine.2016.07.031; Miller E, 2011, VACCINE, V29, P9127, DOI 10.1016/j.vaccine.2011.09.112; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Naucler P, 2017, CLIN INFECT DIS, V65, P1780, DOI 10.1093/cid/cix685; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Rivera-Olivero IA, 2011, EUR J CLIN MICROBIOL, V30, P1489, DOI 10.1007/s10096-011-1247-5; Shiri T, 2017, LANCET GLOB HEALTH, V5, pE51, DOI 10.1016/S2214-109X(16)30306-0; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Spijkerman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039730; Spijkerman J, 2011, EMERG INFECT DIS, V17, P584, DOI 10.3201/eid1704.101115; Stockmann C, 2016, CLIN INFECT DIS, V63, P619, DOI 10.1093/cid/ciw357; van den Bergh MR, 2013, CLIN INFECT DIS, V56, pE30, DOI 10.1093/cid/cis922; van der Linden M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161257; van Deursen AMM, 2012, EMERG INFECT DIS, V18, P1729, DOI 10.3201/eid1811.120329; van Gils EJM, 2009, JAMA-J AM MED ASSOC, V302, P159, DOI 10.1001/jama.2009.975; van Hoek AJ, 2014, VACCINE, V32, P4349, DOI 10.1016/j.vaccine.2014.03.017; van Lier E Alies, 2009, Ned Tijdschr Geneeskd, V153, P950; Wagenvoort GHJ, 2016, VACCINE, V34, P1077, DOI 10.1016/j.vaccine.2015.12.066; Wardlaw TM, 2006, PNEUMONIA FORGOTTEN; Weinberger DM, 2013, AM J EPIDEMIOL, V178, P1488, DOI 10.1093/aje/kwt156; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Wijmenga-Monsuur AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144739; Wyllie AL, 2016, SCI REP-UK, V6, DOI 10.1038/srep34888; Yildirim I, 2010, VACCINE, V29, P283, DOI 10.1016/j.vaccine.2010.10.032	40	33	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0194823	10.1371/journal.pone.0194823	http://dx.doi.org/10.1371/journal.pone.0194823			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601605	Green Published, Green Submitted, gold			2022-12-26	WOS:000428845900010
J	Turkia, T; Korpimaki, E; Villers, A; Selonen, V				Turkia, Tytti; Korpimaki, Erkki; Villers, Alexandre; Selonen, Vesa			Predation risk landscape modifies flying and red squirrel nest site occupancy independently of habitat amount	PLOS ONE			English	Article							PTEROMYS-VOLANS; REPRODUCTIVE SUCCESS; SCIURUS-VULGARIS; PREY HABITAT; HOME-RANGE; FOREST; POPULATION; SELECTION; FOOD; ABUNDANCE	Habitat choice often entails trade-offs between food availability and predation risk. Understanding the distribution of individuals in space thus requires that both habitat characteristics and predation risk are considered simultaneously. Here, we studied the nest box use of two arboreal squirrels who share preferred habitat with their main predators. Nocturnal Ural owls (Strix uralensis) decreased occurrence of night-active flying squirrels (Pteromys volans) and diurnal goshawks (Accipiter gentilis) that of day-active red squirrels (Sciurus vulgaris). Unexpectedly, the amount of preferred habitat had no effect on nest box use, but, surprisingly, both squirrel species seemed to benefit from close proximity to agricultural fields and red squirrels to urban areas. We found no evidence of trade-off between settling in a high-quality habitat and avoiding predators. However, the amount of poor-quality young pine forests was lower in occupied sites where goshawks were present, possibly indicating habitat specific predation on red squirrels. The results suggest that erecting nest boxes for Ural owls should be avoided in the vicinity of flying squirrel territories in order to conserve the near threatened flying squirrels. Our results also suggest that flying squirrels do not always need continuous old forests, and hence the currently insufficient conservation practices could be improved with reasonable increases in the areas left untouched around their nests. The results of this study demonstrate the importance of taking into account both habitat requirements and predation risk as well as their interactive effects when modeling the occupancy of threatened animal species and planning their conservation.	[Turkia, Tytti; Korpimaki, Erkki; Selonen, Vesa] Univ Turku, Dept Biol, Sect Ecol, Turku, Finland; [Villers, Alexandre] French Natl Ctr Agr Res, Chize, France	University of Turku; INRAE	Turkia, T (corresponding author), Univ Turku, Dept Biol, Sect Ecol, Turku, Finland.	tysisit@utu.fi	Villers, Alexandre/W-8184-2019; VILLERS, Arnauld/K-6629-2016	VILLERS, Arnauld/0000-0002-6298-7758; Villers, Alexandre/0000-0003-3050-4106				ANDREN H, 1992, ECOGRAPHY, V15, P303, DOI 10.1111/j.1600-0587.1992.tb00039.x; ANDREN H, 1994, OIKOS, V70, P43, DOI 10.2307/3545697; Barreto GR, 1998, ANIM CONSERV, V1, P129, DOI 10.1111/j.1469-1795.1998.tb00020.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bjorklund H, 2016, OECOLOGIA, V181, P257, DOI 10.1007/s00442-015-3523-z; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; Byholm P, 2012, ECOLOGY, V93, P1802, DOI 10.1890/12-0285.1; Calcagno V, 2013, R PACKAGE VERSION, V1, P7; CAREY AB, 1992, ECOL MONOGR, V62, P223, DOI 10.2307/2937094; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Delin AE, 1999, LANDSCAPE ECOL, V14, P67, DOI 10.1023/A:1008040001801; Di Pierro E, 2011, EUR J WILDLIFE RES, V57, P585, DOI 10.1007/s10344-010-0469-7; DICKMAN CR, 1992, ECOLOGY, V73, P313, DOI 10.2307/1938742; DONCASTER CP, 1994, OIKOS, V69, P182, DOI 10.2307/3546136; Doran PJ, 2005, CAN J ZOOL, V83, P1297, DOI 10.1139/Z05-127; Dupke C, 2016, ECOGRAPHY; Dussault C, 2005, ECOGRAPHY, V28, P619, DOI 10.1111/j.2005.0906-7590.04263.x; Evans KL, 2004, IBIS, V146, P1, DOI 10.1111/j.1474-919X.2004.00231.x; FORSMAN E D, 1984, Wildlife Monographs, P1; Fox J., 2018, R COMPANION APPL REG, VThird; Gorini L, 2012, MAMMAL REV, V42, P55, DOI 10.1111/j.1365-2907.2011.00189.x; GURNELL J, 1983, MAMMAL REV, V13, P133, DOI 10.1111/j.1365-2907.1983.tb00274.x; Hakkarainen H, 2003, OIKOS, V100, P162, DOI 10.1034/j.1600-0706.2003.11906.x; Hakkarainen H, 1996, ECOLOGY, V77, P1134, DOI 10.2307/2265582; Hanski IK, 2000, J MAMMAL, V81, P798, DOI 10.1644/1545-1542(2000)081<0798:HRSMAN>2.3.CO;2; Hanski IK, 2001, SUOMEN YMPARISTO, V459; Hanski IK, 1998, WILDLIFE BIOL, V4, P33, DOI 10.2981/wlb.1998.013; HOKKANEN H, 1982, BIOL CONSERV, V23, P273, DOI 10.1016/0006-3207(82)90083-0; Hokkanen T, 2000, FINNISH FOREST RES I, V790, P87; Hoset KS, 2017, J ANIM ECOL, V86, P1235, DOI 10.1111/1365-2656.12715; Hoset KS, 2009, OIKOS, V118, P1421, DOI 10.1111/j.1600-0706.2009.17263.x; Hurme E, 2008, ECOGRAPHY, V31, P469, DOI 10.1111/j.0906-7590.2008.05373.x; Jokimaki J, 2017, URBAN FOR URBAN GREE, V27, P100, DOI 10.1016/j.ufug.2017.06.021; Jokinen M, 2015, ANIM CONSERV, V18, P167, DOI 10.1111/acv.12157; Jordan F, 1997, J EXP MAR BIOL ECOL, V208, P45, DOI 10.1016/S0022-0981(96)02656-1; KLENNER W, 1991, J ANIM ECOL, V60, P961, DOI 10.2307/5425; Korpimaki E, 2012, BOREAL OWL: ECOLOGY, BEHAVIOUR AND CONSERVATION OF A FOREST-DWELLING PREDATOR, P1, DOI 10.1017/CBO9780511844164; KORPIMAKI E, 1986, ORNIS SCAND, V17, P126, DOI 10.2307/3676861; KORPIMAKI E, 1990, OIKOS, V58, P47, DOI 10.2307/3565359; Koskimaki J, 2014, POPUL ECOL, V56, P341, DOI 10.1007/s10144-013-0411-4; Lampila S, 2009, ECOSCIENCE, V16, P66, DOI 10.2980/16-1-3184; Laundre JW, 2014, ECOLOGY, V95, P1141, DOI 10.1890/13-1083.1; Laundre John W., 2010, OPEN ECOL J, V3, P1, DOI [10.2174/1874213001003030001, DOI 10.2174/1874213001003030001]; Lima SL, 2002, TRENDS ECOL EVOL, V17, P70, DOI 10.1016/S0169-5347(01)02393-X; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Liukko U-M., 2016, SUOMEN NISAKKAIDEN U; Lurz PWW, 2000, J ZOOL, V251, P167, DOI 10.1111/j.1469-7998.2000.tb00601.x; Magris L, 2002, J ZOOL, V256, P99, DOI 10.1017/S0952836902000134; Melin M, 2016, FOREST ECOL MANAG, V380, P202, DOI 10.1016/j.foreco.2016.09.007; METLA, 2012, FOR CLASS OP DAT; Mikkola H., 1983, P1; MOLLER H, 1983, MAMMAL REV, V13, P81, DOI 10.1111/j.1365-2907.1983.tb00270.x; Morosinotto C, 2017, ECOL MONOGR, V87, P4, DOI 10.1002/ecm.1238; Neter J, 1985, APPL LINEAR REGRESSI; NORRDAHL K, 1995, P ROY SOC B-BIOL SCI, V261, P49, DOI 10.1098/rspb.1995.0116; Nupp TE, 2000, J MAMMAL, V81, P512, DOI 10.1644/1545-1542(2000)081&lt;0512:LLCOSM&gt;2.0.CO;2; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Petty SJ, 2003, BIOL CONSERV, V111, P105, DOI 10.1016/S0006-3207(02)00254-9; PIETIAINEN H, 1989, J ANIM ECOL, V58, P905, DOI 10.2307/5132; R Core Team, 2021, R LANGUAGE ENV STAT; Rajala P., 1963, Suomen Riista Helsinki, V16, P155; Rassi P., 2010, 2010 RED LIST FINNIS; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; Ritchie LE, 2009, FOREST ECOL MANAG, V257, P1920, DOI 10.1016/j.foreco.2009.01.028; Roth TC, 2008, CONDOR, V110, P260, DOI 10.1525/cond.2008.8489; Roth TC, 2007, AM NAT, V169, P264, DOI 10.1086/510605; Ryall KL, 2006, ECOLOGY, V87, P1086, DOI 10.1890/0012-9658(2006)87[1086:ROPTLA]2.0.CO;2; Santangeli A, 2013, BIOL CONSERV, V157, P237, DOI 10.1016/j.biocon.2012.09.012; Santangeli A, 2013, BIOL CONSERV, V157, P31, DOI 10.1016/j.biocon.2012.06.027; Saurola P., 1987, U S Forest Service General Technical Report RM, P81; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Schneider MF, 2001, J APPL ECOL, V38, P720, DOI 10.1046/j.1365-2664.2001.00642.x; Selonen V, 2012, CAN J ZOOL, V90, P885, DOI [10.1139/Z2012-058, 10.1139/z2012-058]; Selonen V, 2010, ANIM CONSERV, V13, P579, DOI 10.1111/j.1469-1795.2010.00379.x; Selonen V, 2001, ECOGRAPHY, V24, P588, DOI 10.1034/j.1600-0587.2001.d01-214.x; Selonen V, 2015, RED SQUIRRELS ECOLOG, P67; Selonen V, 2017, HYSTRIX, V28, P134, DOI 10.4404/hystrix-28.2-12328; Selonen V, 2016, BMC ECOL, V16, DOI 10.1186/s12898-016-0107-7; Selonen V, 2016, ANN ZOOL FENN, V53, P183, DOI 10.5735/086.053.0407; Selonen V, 2015, OECOLOGIA, V177, P401, DOI 10.1007/s00442-014-3148-7; Selonen V, 2013, J MAMMAL, V94, P1266, DOI 10.1644/13-MAMM-A-129; Steele MA, 2008, CURR SCI INDIA, V95, P871; Sucksdorff Y, 1999, FINNISH ENV, V342, P1; SULLIVAN TP, 1990, J MAMMAL, V71, P579, DOI 10.2307/1381797; Thomson RL, 2006, ECOGRAPHY, V29, P507; Tornberg Risto, 2006, Studies in Avian Biology, P141; Trudeau C, 2011, J WILDLIFE MANAGE, V75, P1646, DOI 10.1002/jwmg.224; Turkia T, 2018, ECOGRAPHY, V40; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; Vuerola I., P FINN RUSS SEM REM; Wauters LA, 2001, ECOGRAPHY, V24, P525, DOI 10.1034/j.1600-0587.2001.d01-208.x; WERNER EE, 1983, ECOLOGY, V64, P1540, DOI 10.2307/1937508; Wheatley M, 2005, J APPL ECOL, V42, P577, DOI 10.1111/j.1365-2664.2005.01034.x; WIDEN P, 1987, HOLARCTIC ECOL, V10, P104; Zamorano JG, 2016, J PLANT ECOL; Zanette LY, 2011, SCIENCE, V334, P1398, DOI 10.1126/science.1210908	97	11	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0194624	10.1371/journal.pone.0194624	http://dx.doi.org/10.1371/journal.pone.0194624			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596438	gold, Green Published, Green Submitted			2022-12-26	WOS:000428630000035
J	Chiang, E; Schmidt, ML; Berry, MA; Biddanda, BA; Burtner, A; Johengen, TH; Palladino, D; Denef, VJ				Chiang, Edna; Schmidt, Marian L.; Berry, Michelle A.; Biddanda, Bopaiah A.; Burtner, Ashley; Johengen, Thomas H.; Palladino, Danna; Denef, Vincent J.			Verrucomicrobia are prevalent in north-temperate freshwater lakes and display class-level preferences between lake habitats	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; NITROGEN-FIXATION; BACTERIOPLANKTON; DIVERSITY; REVEALS; NOV.	The bacterial phylum Verrucomicrobia was formally described two decades ago and originally believed to be a minor member of many ecosystems; however, it is now recognized as ubiquitous and abundant in both soil and aquatic systems. Nevertheless, knowledge of the drivers of its relative abundance and within-phylum habitat preferences remains sparse, especially in lake systems. Here, we documented the distribution of Verrucomicrobia in 12 inland lakes in Southeastern Michigan, a Laurentian Great Lake (Lake Michigan), and a freshwater estuary, which span a gradient in lake sizes, depths, residence times, and trophic states. A wide range of physical and geochemical parameters was covered by sampling seasonally from the surface and bottom of each lake, and by separating samples into particle-associated and free-living fractions. On average, Verrucomicrobia was the 4th most abundant phylum (range 1.7-41.7%). Fraction, season, station, and depth explained up to 70% of the variance in Verrucomicrobia community composition and preference for these habitats was phylogenetically conserved at the class-level. When relative abundance was linearly modeled against environmental data, Verrucomicrobia and non-Verrucomicrobia bacterial community composition correlated to similar quantitative environmental parameters, although there were lake system-dependent differences and > 55% of the variance remained unexplained. A majority of the phylum exhibited preference for the particle-associated fraction and two classes (Opitutae and Verrucomicrobiae) were identified to be more abundant during the spring season. This study highlights the high relative abundance of Verrucomicrobia in north temperate lake systems and expands insights into drivers of within-phylum habitat preferences of the Verrucomicrobia.	[Chiang, Edna; Schmidt, Marian L.; Berry, Michelle A.; Denef, Vincent J.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Biddanda, Bopaiah A.] Grand Valley State Univ, Annis Water Resources Inst, Muskegon, MI USA; [Burtner, Ashley; Johengen, Thomas H.; Palladino, Danna] Univ Michigan, Cooperat Inst Great Lakes Res, Ann Arbor, MI 48109 USA; [Chiang, Edna] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Michigan System; University of Michigan; Grand Valley State University; University of Michigan System; University of Michigan; University of Wisconsin System; University of Wisconsin Madison	Denef, VJ (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	vdenef@umich.edu	Biddanda, Bopaiah/AAB-1705-2019	Biddanda, Bopaiah/0000-0002-9642-3379	Fred A. and Barbara M. Erb Family Foundation through the University of Michigan Water Center; Community Sequencing Program (U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility) [DE-AC02-05CH11231]; NOAA Michigan Sea Grant; National Science Foundation Graduate Research Fellowship Program; American Society of Microbiology-Undergraduate Research Fellowship; UM Honors Summer Fellowship; Beckman Scholars Program	Fred A. and Barbara M. Erb Family Foundation through the University of Michigan Water Center; Community Sequencing Program (U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility)(United States Department of Energy (DOE)); NOAA Michigan Sea Grant; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); American Society of Microbiology-Undergraduate Research Fellowship; UM Honors Summer Fellowship; Beckman Scholars Program	This work was supported by the Fred A. and Barbara M. Erb Family Foundation through the University of Michigan Water Center (VJD, THJ); the Community Sequencing Program (U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility, supported under Contract No. DE-AC02-05CH11231)(VJD); The NOAA Michigan Sea Grant (VJD); the National Science Foundation Graduate Research Fellowship Program (MLS); and scholarships from the American Society of Microbiology-Undergraduate Research Fellowship, the UM Honors Summer Fellowship, and the Beckman Scholars Program (EC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnds J, 2010, SYST APPL MICROBIOL, V33, P139, DOI 10.1016/j.syapm.2009.12.005; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Biddanda B., 2017, ENVIRONSCI, V98, P1, DOI [10.1029/2017EO069751, DOI 10.1029/2017EO069751]; Brewer TE, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.198; Briee C, 2007, RES MICROBIOL, V158, P213, DOI 10.1016/j.resmic.2006.12.012; Cardman Z, 2014, APPL ENVIRON MICROB, V80, P3749, DOI 10.1128/AEM.00899-14; Cole J.J, 2013, FRESHWATER ECOLOGY C, V18; De Wever A, 2008, AQUAT MICROB ECOL, V50, P113, DOI 10.3354/ame01157; DEBONT JAM, 1970, ANTON VAN LEE J M S, V36, P397, DOI 10.1007/BF02069040; Denef VJ, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2076.00606, 10.3389/fmicb.2016.00606]; Deng Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0094807, 10.1371/journal.pone.0103115]; Dunfield PF, 2007, NATURE, V450, P879, DOI 10.1038/nature06411; Eiler A, 2004, ENVIRON MICROBIOL, V6, P1228, DOI 10.1111/j.1462-2920.2004.00657.x; Freitas S, 2012, ISME J, V6, P1499, DOI 10.1038/ismej.2012.3; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Fujimoto M, 2016, J GREAT LAKES RES, V42, P1036, DOI 10.1016/j.jglr.2016.07.029; Gibbons SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097435; Giraudoux P., 2012, R PACKAGE VERSION, V1, P617; Gomez-Gallego C, 2016, BENEF MICROBES, V7, P571, DOI 10.3920/BM2016.0009; Guo JR, 2016, APPL ENVIRON MICROB, V82, P157, DOI 10.1128/AEM.02772-15; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Haukka K, 2006, MICROB ECOL, V51, P137, DOI 10.1007/s00248-005-0049-7; He SM, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00277-17; Hedlund BP, 1997, ANTON LEEUW INT J G, V72, P29, DOI 10.1023/A:1000348616863; Hedlund BP, 2010, BERGEYS MANUAL SYSTE, P795, DOI [10.1007/978-0-387-68572-4_12, DOI 10.1007/978-0-387-68572-4_12]; Henrici AT, 1935, J BACTERIOL, V30, P61, DOI 10.1128/JB.30.1.61-93.1935; Henrici AT, 1933, J BACTERIOL, V25, P277, DOI 10.1128/JB.25.3.277-287.1933; Herlemann DPR, 2013, MBIO, V4, DOI 10.1128/mBio.00569-12; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Johengen TH, 2013, QUAGGA ZEBRA MUSSELS, P445; Kamke J, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0201-2; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Khadem AF, 2010, MICROBIOL-SGM, V156, P1052, DOI 10.1099/mic.0.036061-0; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li M, 2016, FRONTIERS MICROBIOL, V7; Lindh MV, 2015, ENVIRON MICROBIOL, V17, P2459, DOI 10.1111/1462-2920.12720; Lindstrom ES, 2005, AQUAT SCI, V67, P210, DOI 10.1007/s00027-005-0769-2; Lindstrom ES, 2004, J PLANKTON RES, V26, P241, DOI 10.1093/plankt/fbh010; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Lumley T., LEAPS REGRESSION SUB; Mamaeva EV, 2016, MICROBIOLOGY+, V85, P220, DOI 10.1134/S0026261716020132; Martinez-Garcia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035314; McCarthy A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121659; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Oksanen J., 2007, COMMUNITY ECOLOGY PA, V10, P719; Salazar G, 2015, MOL ECOL, V24, P5692, DOI 10.1111/mec.13419; Sangwan P, 2005, APPL ENVIRON MICROB, V71, P8402, DOI 10.1128/AEM.71.12.8402-8410.2005; Sarkar D, 2008, USE R, P1; SCHLESNER H, 1987, SYST APPL MICROBIOL, V10, P54, DOI 10.1016/S0723-2020(87)80010-3; Schlesner H., 2006, PROKARYOTES, V7, P881, DOI [10.1007/0-387-30747-8_37, DOI 10.1007/0-387-30747-8_37, DOI 10.1007/0-387-30747-8]; Schliep KP, 2010, BIOINFORMATICS, pbtq706; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt ML, 2016, ENVIRON MICROBIOL, V18, P1212, DOI 10.1111/1462-2920.13143; Schneider JW, 2007, J AM SOC INF SCI TEC, V58, P1596, DOI 10.1002/asi.20642; Shen C, 2017, J DRUG TARGET, P1; Spring S, 2016, ISME J, V10, P2801, DOI 10.1038/ismej.2016.84; Steinman AD, 2008, J GREAT LAKES RES, V34, P169, DOI 10.3394/0380-1330(2008)34[169:CSATIM]2.0.CO;2; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Tremblay J, 2015, FRONT MICROBIOL, P6; Tucker CM, 2017, BIOL REV, V92, P698, DOI 10.1111/brv.12252; Wertz JT, 2012, APPL ENVIRON MICROB, V78, P1544, DOI 10.1128/AEM.06466-11; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Yang SJ, 2016, MICROB ECOL, V71, P29, DOI 10.1007/s00248-015-0695-3; Yung CM, 2015, ENVIRON MICROBIOL, V17, P2421, DOI 10.1111/1462-2920.12714; Zhang JX, 2014, ANN MICROBIOL, V64, P1405, DOI 10.1007/s13213-013-0785-8	69	34	35	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0195112	10.1371/journal.pone.0195112	http://dx.doi.org/10.1371/journal.pone.0195112			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590198	gold, Green Published, Green Submitted			2022-12-26	WOS:000428603100104
J	Terloyeva, D; Nugmanova, Z; Akhmetova, G; Akanov, A; Patel, N; Lazariu, V; Norelli, L; McNutt, LA				Terloyeva, Dina; Nugmanova, Zhamilya; Akhmetova, Gulzhakhan; Akanov, Aikan; Patel, Nimish; Lazariu, Victoria; Norelli, Lisa; McNutt, Louise-Anne			Untreated depression among persons living with human immunodeficiency virus in Kazakhstan: A cross-sectional study	PLOS ONE			English	Article							NATIONAL COMORBIDITY SURVEY; POSTTRAUMATIC-STRESS-DISORDER; ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED PATIENTS; DSM-IV DISORDERS; CD4 CELL COUNT; PSYCHIATRIC-DISORDERS; LONGITUDINAL ANALYSIS; MEDICATION ADHERENCE; LIFETIME PREVALENCE	Background In Kazakhstan, scarce official prevalence data exists for mood disorders. This study investigates the occurrence of depressive symptoms among people living with HIV/AIDS (PLWHA), and the relationship between depressive symptoms, HIV treatment initiation and antiretroviral treatment (ART) adherence. Methods A cross-sectional study was conducted among patients seen at the Almaty AIDS Center between April and December 2013. Two data sources were used: 1) self-administered survey that included the Patient Health Questionnaire (PHQ-9) to capture depression symptoms and 2) medical record review. Two primary outcomes were evaluated with log binomial models and Fisher's exact test: the relationship between depression symptoms and 1) HIV treatment group, and 2) HIV adherence. Results Of the 564 participants, 9.9% reported symptoms consistent with a depressive disorder. None had received treatment for depression. Among those not on ART, a relationship between depressive symptoms and low CD4 counts (<= 350 cells/mm(3)) was evident (7.1% for CD4 <= 350 cells/mm(3) vs. 0.9% for CD4 > 350 cells/mm(3), p = 0.029). In multivariable analysis, a higher prevalence of depressive symptoms was statistically associated with ART treatment, positive hepatitis C virus (HCV) status, and being unmarried. For those taking ART, treatment adherence was not statistically associated with a lower prevalence of depressive symptoms (12.5% vs 20.0%, p = 0.176); limited power may have impacted statistical significance. Conclusions Untreated depression was found among PLWHA suggesting the need to evaluate access to psychiatric treatment. A collaborative strategy may be helpful to optimize HIV treatment outcomes.	[Terloyeva, Dina; Nugmanova, Zhamilya] Asfendiyarov Kazakh Natl Med Univ KNMU, Dept HIV Infect & Infect Control, Alma Ata, Kazakhstan; [Terloyeva, Dina] Drexel Univ, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Akhmetova, Gulzhakhan] Almaty City AIDS Ctr, Alma Ata, Kazakhstan; [Akanov, Aikan] Asfendiyarov Kazakh Natl Med Univ KNMU, Dept Publ Hlth, Alma Ata, Kazakhstan; [Patel, Nimish] Albany Coll Pharm & Hlth Sci, Albany, NY USA; [Lazariu, Victoria] SUNY Albany, Dept Epidemiol & Biostat, Rensselaer, NY USA; [Norelli, Lisa] Albany Med Coll, Dept Psychiat, Albany, NY 12208 USA; [McNutt, Louise-Anne] SUNY Albany, Inst Hlth & Environm, Rensselaer, NY USA	Drexel University; Albany College of Pharmacy & Health Sciences; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Albany Medical College; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Terloyeva, D (corresponding author), Asfendiyarov Kazakh Natl Med Univ KNMU, Dept HIV Infect & Infect Control, Alma Ata, Kazakhstan.; Terloyeva, D (corresponding author), Drexel Univ, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA.	dt528@drexel.edu			Kazakh National Medical University Research Grant; New York State International Training and Research Program (NYS-ITRP) - Fogarty International Centre; National Institute of Drug Abuse, National Institutes of Health, USA (NIH) [D43 TW000233]	Kazakh National Medical University Research Grant; New York State International Training and Research Program (NYS-ITRP) - Fogarty International Centre; National Institute of Drug Abuse, National Institutes of Health, USA (NIH)	This study was supported by a Kazakh National Medical University Research Grant and New York State International Training and Research Program (NYS-ITRP) sponsored by the Fogarty International Centre and National Institute of Drug Abuse, National Institutes of Health, USA (NIH Grant D43 TW000233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewuya AO, 2007, J PSYCHOSOM RES, V63, P203, DOI 10.1016/j.jpsychores.2007.03.006; Adinolfi LE, 2017, CLIN LIVER DIS, V21, P517, DOI 10.1016/j.cld.2017.03.007; Ahuja A S, 1998, J Assoc Physicians India, V46, P277; AlHadi AN, 2017, ANN GEN PSYCHIATR, V16, DOI 10.1186/s12991-017-0155-1; Alpizar D, 2017, PSYCHOL ASSESSMENT; Amirkhanian YA, 2003, AIDS, V17, P2367, DOI 10.1097/00002030-200311070-00012; Ammassari A, 2004, PSYCHOSOMATICS, V45, P394, DOI 10.1176/appi.psy.45.5.394; Angst J, 2002, EUR ARCH PSY CLIN N, V252, P201, DOI 10.1007/s00406-002-0381-6; [Anonymous], 2013, KAL FULL PRESCR INF; Arrieta J, 2017, J CLIN PSYCHOL, V73, P1076, DOI 10.1002/jclp.22390; Atlani L, 2000, SOC SCI MED, V50, P1547, DOI 10.1016/S0277-9536(99)00464-5; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Bernard C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181960; Beyrer C, 2010, LANCET, V376, P208, DOI 10.1016/S0140-6736(10)61005-7; Bing EG, 2001, ARCH GEN PSYCHIAT, V58, P721, DOI 10.1001/archpsyc.58.8.721; Boarts JM, 2006, AIDS BEHAV, V10, P253, DOI 10.1007/s10461-006-9069-7; Byakika-Tusiime J, 2009, AIDS BEHAV, V13, pS82, DOI 10.1007/s10461-009-9546-x; Catz SL, 2000, HEALTH PSYCHOL, V19, P124, DOI 10.1037/0278-6133.19.2.124; Chandra PS, 1998, J PSYCHOSOM RES, V45, P401, DOI 10.1016/S0022-3999(98)00028-2; Ciesla JA, 2014, AM J PSYCHIAT; Costa JD, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25066; Crane PK, 2010, AIDS CARE, V22, P874, DOI 10.1080/09540120903483034; Deshmukh Namita Navanit, 2017, J Family Med Prim Care, V6, P549, DOI 10.4103/2249-4863.222016; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Du N, 2017, ASIA-PAC PSYCHIAT, V9, DOI 10.1111/appy.12266; Eshun-Wilson I, 2014, ANTIDEPRESSANTS DEPR; Field MG, 2004, NEW ENGL J MED, V351, P117, DOI 10.1056/NEJMp048066; Golub ET, 2004, J URBAN HEALTH, V81, P278, DOI 10.1093/jurban/jth114; Gonzalez JS, 2011, J ACQUIR IMMUNE DEFI, V1999, P58; Goodness TM, 2014, AIDS BEHAV, V18, P1085, DOI 10.1007/s10461-013-0674-y; HIV/AIDS JUNPo, 2016, GLOB AIDS UPD 2016; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466; Ironson G, 2005, PSYCHOSOM MED, V67, P1013, DOI 10.1097/01.psy.0000188569.58998.c8; JACOB KS, 1991, INDIAN J MED RES-A, V93, P62; Kacanek D, 2010, JAIDS-J ACQ IMM DEF, V53, P266, DOI 10.1097/QAI.0b013e3181b720e7; Kagee A, 2010, AIDS CARE, V22, P159, DOI 10.1080/09540120903111445; Kaharuza FM, 2006, AIDS BEHAV, V10, pS105, DOI 10.1007/s10461-006-9142-2; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim TW, 2007, AIDS CARE, V19, P1039, DOI 10.1080/09540120701294245; Kleinbaum D.G., 2008, APPL REGRESSION ANAL; Kornstein SG, 2000, AM J PSYCHIAT, V157, P1445, DOI 10.1176/appi.ajp.157.9.1445; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2001, PHQ 9 VALIDITY BRIEF; Leserman J, 2008, PSYCHOSOM MED, V70, P539, DOI 10.1097/PSY.0b013e3181777a5f; Lofgren SM, 2018, AIDS BEHAV, V22, P1, DOI 10.1007/s10461-017-1906-3; Lotrakul M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-46; MAJ M, 1994, ARCH GEN PSYCHIAT, V51, P39; Malta M, 2010, AIDS BEHAV, V14, P731, DOI 10.1007/s10461-008-9489-7; Marasheva A., 2007, MENTAL HLTH PROBLEMS; Marc LG, 2014, J GEN INTERN MED, V29, P1679, DOI 10.1007/s11606-014-2951-5; Martin A, 2006, GEN HOSP PSYCHIAT, V28, P71, DOI 10.1016/j.genhosppsych.2005.07.003; Martin LA, 2013, JAMA PSYCHIAT, V70, P1100, DOI 10.1001/jamapsychiatry.2013.1985; Marwick KFM, 2010, AIDS CARE, V22, P415, DOI 10.1080/09540120903253981; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Nallusamy V, 2016, INT J PSYCHIAT MED, V51, P508, DOI 10.1177/0091217417696732; Petrea I, 2012, PUBLIC HEALTH REV, V34, DOI 10.1007/BF03391673; Poli-Neto OB, 2016, REV BRAS GINECOL OBS, V38, P443, DOI 10.1055/s-0036-1592344; Raghunathan T. E., 2002, IVEWARE IMPUTATION V; Raghunathan TE, 2001, SURV METHODOL, V27, P85; Republican Research and Treatment Center for Psychiatry PaSA, 2011, PSYCH SERV REP KAZ 2; Roberts B, 2010, J PUBLIC MENT HEALTH, V9, P17, DOI 10.5042/jpmh.2010.0459; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Schantz K, 2017, INT J PSYCHIAT MED, V52, P315, DOI 10.1177/0091217417738934; Sebit M, 2004, E AFR MED J, V80, P503; Shaw SA, 2016, COMMUNITY MENT HLT J, V52, P1047, DOI 10.1007/s10597-015-9883-3; Sledjeski EM, 2005, AIDS PATIENT CARE ST, V19, P728, DOI 10.1089/apc.2005.19.728; Starace F, 2002, JAIDS, V31, pS136, DOI 10.1097/00126334-200212153-00010; Stein MD, 2003, AM J PSYCHIAT, V160, P1659, DOI 10.1176/appi.ajp.160.9.1659; Tegger MK, 2008, AIDS PATIENT CARE ST, V22, P233, DOI 10.1089/apc.2007.0092; Van Voren R., 2013, PSYCHIAT TOOL COERCI; Vranceanu AM, 2008, AIDS PATIENT CARE ST, V22, P313, DOI 10.1089/apc.2007.0069; Vrublevska J, 2018, NORD J PSYCHIAT, V72, P112, DOI 10.1080/08039488.2017.1397191; WHO, 2010, ANT THER HIV INF AD; WHO, 2013, HIV AIDS SUMM NEW RE; Woldetensay YK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191782; World Health Organization, 2012, 369 WHO; Xiong NN, 2015, J AFFECT DISORDERS, V174, P636, DOI 10.1016/j.jad.2014.12.042; Yun LWH, 2005, JAIDS-J ACQ IMM DEF, V38, P432, DOI 10.1097/01.qai.0000147524.19122.fd	80	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193976	10.1371/journal.pone.0193976	http://dx.doi.org/10.1371/journal.pone.0193976			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590151	Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100041
J	Hicks, J; Stuber, T; Lantz, K; Erdman, M; Robbe-Austerman, S; Huang, XQ				Hicks, Jessica; Stuber, Tod; Lantz, Kristina; Erdman, Matthew; Robbe-Austerman, Suelee; Huang, Xiaoqiu			Genomic diversity of Taylorella equigenitalis introduced into the United States from 1978 to 2012	PLOS ONE			English	Article							CONTAGIOUS EQUINE METRITIS; MYCOBACTERIUM-TUBERCULOSIS; STREPTOMYCIN RESISTANCE; SEQUENCING DATA; DNA; STRAINS; ALIGNMENT; SINGLE; GENE	Contagious equine metritis is a disease of worldwide concern in equids. The United States is considered to be free of the disease although sporadic outbreaks have occurred over the last few decades that were thought to be associated with the importation of horses. The objective of this study was to create finished, reference quality genomes that characterize the diversity of Taylorella equigenitalis isolates introduced into the USA, and identify their differences. Five isolates of T. equigenitalis associated with introductions into the USA from unique sources were sequenced using both short and long read chemistries allowing for complete assembly and annotation. These sequences were compared to previously published genomes as well as the short read sequences of the 200 isolates in the National Veterinary Services Laboratories' diagnostic repository to identify unique regions and genes, potential virulence factors, and characterize diversity. The 5 genomes varied in size by up to 100,000 base pairs, but averaged 1.68 megabases. The majority of that diversity in size can be explained by repeat regions and 4 main regions of difference, which ranged in size from 15,000 to 45,000 base pairs. The first region of difference contained mostly hypothetical proteins, the second contained the CRISPR, the third contained primarily hemagglutinin proteins, and the fourth contained primarily segments of a type IV secretion system. As expected and previously reported, little evidence of recombination was found within these genomes. Several additional areas of interest were also observed including a mechanism for streptomycin resistance and other virulence factors. A SNP distance comparison of the T. equigenitalis isolates and Mycobacterium tuberculosis complex (MTBC) showed that relatively, T. equigenitalis was a more diverse species than the entirety of MTBC.	[Hicks, Jessica; Stuber, Tod; Lantz, Kristina; Robbe-Austerman, Suelee] USDA, Diagnost Bacteriol & Pathol Lab, NVSL, Ames, IA 50010 USA; [Erdman, Matthew] USDA, Policy Evaluat & Licensing Sect, Ctr Vet Biol, Ames, IA USA; [Huang, Xiaoqiu] Iowa State Univ, Dept Comp Sci, Ames, IA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Iowa State University	Hicks, J (corresponding author), USDA, Diagnost Bacteriol & Pathol Lab, NVSL, Ames, IA 50010 USA.	jessica.a.hicks@aphis.usda.gov		Hicks, Jessica/0000-0003-1306-6917				Aalsburg AM, 2011, J CLIN MICROBIOL, V49, P829, DOI 10.1128/JCM.00956-10; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Bleumink-Pluym NMC, 1996, CLIN DIAGNOSTIC LAB; BLEUMINKPLUYM NMC, 1994, J CLIN MICROBIOL, V32, P893, DOI 10.1128/JCM.32.4.893-896.1994; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Duquesne F, 2013, VET MICROBIOL, V167, P609, DOI 10.1016/j.vetmic.2013.09.016; Erdman MM, 2011, PREV VET MED, V101, P219, DOI 10.1016/j.prevetmed.2011.05.015; Gardner SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081760; Gardner SN, 2010, J FORENSIC RES, V01, P1; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Harris RS, 2007, THESIS, DOI [10.5555/1414852, DOI 10.5555/1414852]; Hauser H, 2012, VET MICROBIOL, V159, P195, DOI 10.1016/j.vetmic.2012.03.041; Hebert L, 2011, J BACTERIOL, V193, P1785, DOI 10.1128/JB.01547-10; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kagawa S, 2001, VET RES COMMUN, V25, P261, DOI 10.1023/A:1010674524428; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Lee PA, 2006, ANNU REV MICROBIOL, V60, P373, DOI 10.1146/annurev.micro.60.080805.142212; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; MATSUDA M, 1994, VET RES COMMUN, V18, P93, DOI 10.1007/BF01839225; MIYAZAWA T, 1995, VET RES COMMUN, V19, P265, DOI 10.1007/BF01839309; NAIR J, 1993, MOL MICROBIOL, V10, P521, DOI 10.1111/j.1365-2958.1993.tb00924.x; Platt H, 1978, EQUINE VET J; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roy CR, 2015, NAT REV MICROBIOL, V13, P631, DOI 10.1038/nrmicro3520; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Springer B, 2001, ANTIMICROB AGENTS CH, V45, P2877, DOI 10.1128/AAC.45.10.2877-2884.2001; SWERCZEK TW, 1978, J AM VET MED ASSOC, V173, P405; Taylor CED, 1978, EQUINE VET J; Thoresen SI, 1995, J CLIN MICROBIOL; Timoney PJ, 1978, SURVIVAL PROPERTIES	39	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194253	10.1371/journal.pone.0194253	http://dx.doi.org/10.1371/journal.pone.0194253			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584782	Green Submitted, Green Published, gold			2022-12-26	WOS:000428373000019
J	Takaki, K; Ramakrishnan, L; Basu, S				Takaki, Kevin; Ramakrishnan, Lalita; Basu, Soumyava			A zebrafish model for ocular tuberculosis	PLOS ONE			English	Article							DISSEMINATION; MACROPHAGES; INFECTION; GRANULOMA	Ocular tuberculosis (TB) commonly causes severe inflammation and vision loss in TB endemic countries. The mechanism by which tuberculous infection becomes established in the eye is poorly understood. We have developed the zebrafish larva infected with Mycobacterium marinum as a model to study the early pathogenesis of ocular TB. We find that hematogenous bacterial seeding of the eye occurs despite a functional blood retinal barrier. Prototypical early granulomas form in response to bacteria in the eye. These granulomas involve the retinal vasculature and retinal pigment epithelium-choroid complex which are characteristic locations for human ocular TB. We find that peripheral blood monocytes are recruited to the nascent ocular granuloma further suggesting that the immune privileged nature of the eye is breached by this inflammatory focus.	[Takaki, Kevin; Ramakrishnan, Lalita] Univ Cambridge, Mol Immun Unit, Dept Med, MRC Lab Mol Biol, Cambridge, England; [Basu, Soumyava] LV Prasad Eye Inst, Brien Holden Eye Res Ctr, MTC Campus, Bhubaneswar, India	MRC Laboratory Molecular Biology; University of Cambridge; L. V. Prasad Eye Institute	Basu, S (corresponding author), LV Prasad Eye Inst, Brien Holden Eye Res Ctr, MTC Campus, Bhubaneswar, India.	eyetalk@gmail.com		Takaki, Kevin/0000-0002-4790-4598; Ramakrishnan, Lalita/0000-0003-0692-5533; Basu, Soumyava/0000-0002-6513-8786	Department of Health Research, Indian Council of Medical Research [DHR/HRD/Short Term Foreign/Type-11/1/2015]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI054503] Funding Source: NIH RePORTER	Department of Health Research, Indian Council of Medical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was partially funded by Shortterm fellowship to Soumyava Basu by Department of Health Research, Indian Council of Medical Research (Reference number: DHR/HRD/Short Term Foreign/Type-11/1/2015).	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Basu S, 2014, J OPHTHALMIC INFLAMM, V4, DOI 10.1186/1869-5760-4-3; Cambier CJ, 2017, IMMUNITY, V47, P552, DOI 10.1016/j.immuni.2017.08.003; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; DONAHUE HC, 1967, AM J OPHTHALMOL, V64, P742, DOI 10.1016/0002-9394(67)92860-7; Finoff WC., 1924, AM J OPHTHALMOL, V7, P81; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Krishnan N, 2010, TUBERCULOSIS, V90, P361, DOI 10.1016/j.tube.2010.08.005; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Rao NA, 2009, ARCH OPHTHALMOL-CHIC, V127, P1162, DOI 10.1001/archophthalmol.2009.220; SCHMITT EA, 1994, J COMP NEUROL, V344, P532, DOI 10.1002/cne.903440404; Takaki K, 2013, NAT PROTOC, V8, P1114, DOI 10.1038/nprot.2013.068; Wroblewski KJ, 2011, OPHTHALMOLOGY, V118, P772, DOI 10.1016/j.ophtha.2010.08.011; Xie J, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-76	15	15	15	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194982	10.1371/journal.pone.0194982	http://dx.doi.org/10.1371/journal.pone.0194982			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584775	Green Submitted, Green Published, gold			2022-12-26	WOS:000428373000052
J	Horndasch, S; Roesch, J; Forster, C; Dorfler, A; Lindsiepe, S; Heinrich, H; Graap, H; Moll, GH; Kratz, O				Horndasch, Stefanie; Roesch, Julie; Forster, Clemens; Doerfler, Arnd; Lindsiepe, Silja; Heinrich, Hartmut; Graap, Holmer; Moll, Gunther H.; Kratz, Oliver			Neural processing of food and emotional stimuli in adolescent and adult anorexia nervosa patients	PLOS ONE			English	Article							LOW-CALORIE FOODS; ALTERED INSULA RESPONSE; EATING-DISORDERS; BULIMIA-NERVOSA; ORBITOFRONTAL CORTEX; WORD STIMULI; FMRI; ACTIVATION; PICTURES; HUNGER	Background A constant preoccupation with food and restrictive eating are main symptoms of anorexia nervosa (AN). Imaging studies revealed aberrant neural activation patterns in brain regions processing hedonic and reward reactions as well as potentially aversive emotions. An imbalance between so called "bottom-up" and "top-down" control areas is discussed. The present study is focusing on neural processing of disease-specific food stimuli and emotional stimuli and its developmental course in adolescent and adult AN patients and could offer new insight into differential mechanisms underlying shorter or more chronic disease. Methods 33 adolescents aged 12-18 years (15 AN patients, 18 control participants) and 32 adult women (16 AN patients, 16 control participants) underwent functional magnetic resonance imaging (fMRI, 3T high-field scanner) while watching pictures of high and low-calorie food and affective stimuli. Afterwards, they rated subjective valence of each picture. FMRI data analysis was performed using a region of interest based approach. Results Pictures of high-calorie food items were rated more negatively by AN patients. Differences in activation between patients and controls were found in "bottom-up" and "top-down" control areas for food stimuli and in several emotion processing regions for affective stimuli which were more pronounced in adolescents than in adults. Conclusion A differential pattern was seen for food stimuli compared to generally emotion eliciting stimuli. Adolescents with AN show reduced processing of affective stimuli. Adolescents with AN show reduced processing of affective stimuli and enhanced activation of regions involved in "bottom up" reward processing and "top down" control as well as the insula with regard to food stimuli with a focus on brain regions which underlie changes during adolescent development. In adults less clear and less specific activation differences were present, pointing towards a high impact that regions undergoing maturation might have on AN symptoms.	[Horndasch, Stefanie; Lindsiepe, Silja; Heinrich, Hartmut; Moll, Gunther H.; Kratz, Oliver] Univ Erlangen Nurnberg, Dept Child & Adolescent Mental Hlth, Erlangen, Germany; [Roesch, Julie; Doerfler, Arnd] Univ Erlangen Nurnberg, Dept Neuroradiol, Erlangen, Germany; [Forster, Clemens] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, Erlangen, Germany; [Heinrich, Hartmut] Heckscher Klinikum, Munich, Germany; [Graap, Holmer] Univ Erlangen Nurnberg, Dept Psychosomat Med & Psychotherapy, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Horndasch, S (corresponding author), Univ Erlangen Nurnberg, Dept Child & Adolescent Mental Hlth, Erlangen, Germany.	stefanie.horndasch@uk-erlangen.de			Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing	We acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing.	Amianto F, 2013, PSYCHIAT RES-NEUROIM, V213, P210, DOI 10.1016/j.pscychresns.2013.03.010; Beck AT, 1996, PSYCHOL ASSESS; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brooks SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034000; Brooks SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022259; Cooke LJ, 2005, BRIT J NUTR, V93, P741, DOI 10.1079/BJN20051389; Costafreda SG, 2008, BRAIN RES REV, V58, P57, DOI 10.1016/j.brainresrev.2007.10.012; Cowdrey FA, 2011, BIOL PSYCHIAT, V70, P736, DOI 10.1016/j.biopsych.2011.05.028; Ellinson Z, 1998, LANCET, V352, P1192, DOI 10.1016/S0140-6736(05)60529-6; Fairburn CG, 2003, LANCET, V361, P407, DOI 10.1016/S0140-6736(03)12378-1; Frank GKW, 2015, CNS SPECTRUMS, V20, P391, DOI 10.1017/S1092852915000012; Frank GKW, 2012, NEUROPSYCHOPHARMACOL, V37, P2031, DOI 10.1038/npp.2012.51; Frank S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00499; Friederich HC, 2010, NEUROPSYCHOLOGIA, V48, P2878, DOI 10.1016/j.neuropsychologia.2010.04.036; Garcia-Garcia I, 2013, EUR EAT DISORDERS RE; Garner DM, 1991, EATING DISORDER INVE; Hagele C, 2016, NEUROSCI LETT, V623, P71, DOI 10.1016/j.neulet.2016.04.037; Hautzinger M., 2006, BECK DEPRESSIONS INV; Holsen LM, 2014, PSYCHIAT RES-NEUROIM, V223, P94, DOI 10.1016/j.pscychresns.2014.04.015; Holsen LM, 2012, J PSYCHIATR NEUROSCI, V37, P322, DOI 10.1503/jpn.110156; Holsen LM, 2005, NEUROIMAGE, V27, P669, DOI 10.1016/j.neuroimage.2005.04.043; Joos AAB, 2011, PSYCHIAT RES-NEUROIM, V191, P189, DOI 10.1016/j.pscychresns.2010.11.008; Killgore WDS, 2005, DEV PSYCHOBIOL, V47, P377, DOI 10.1002/dev.20099; Killgore WDS, 2003, NEUROIMAGE, V19, P1381, DOI 10.1016/S1053-8119(03)00191-5; Kim KR, 2012, NEUROSCI LETT, V521, P152, DOI 10.1016/j.neulet.2012.05.075; Konrad K, 2013, DTSCH ARZTEBL INT, V110, P425, DOI 10.3238/arztebl.2013.0425; Lee BT, 2008, PROG NEURO-PSYCHOPH, V32, P778, DOI 10.1016/j.pnpbp.2007.12.009; McCabe C, 2016, J PSYCHOPHARMACOL, V30, P1020, DOI 10.1177/0269881116653079; Meseguer V, 2007, PSICOTHEMA, V19, P483; Miyake Y, 2012, PSYCHIAT RES-NEUROIM, V201, P113, DOI 10.1016/j.pscychresns.2011.07.014; Miyake Y, 2010, NEUROIMAGE, V50, P1333, DOI 10.1016/j.neuroimage.2009.12.095; Muller B, 2004, Z KINDER JUG-PSYCH, V32, P235, DOI 10.1024/1422-4917.32.4.235; Oberndorfer TA, 2013, AM J PSYCHIAT, V170, P1143, DOI 10.1176/appi.ajp.2013.11111745; Paul T., 2004, EATING DISORDER INVE; Ringler R, 2003, PAIN, V105, P445, DOI 10.1016/S0304-3959(03)00258-6; Rolls ET, 2015, NEUROIMAGE, V113, P298, DOI 10.1016/j.neuroimage.2015.03.065; Sanders N, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00046; Santel S, 2006, BRAIN RES, V1114, P138, DOI 10.1016/j.brainres.2006.07.045; Schoenbaum G, 2011, ANN NY ACAD SCI, V1239, P87, DOI 10.1111/j.1749-6632.2011.06210.x; Seitz J, 2016, J NEURAL TRANSM VIEN; Siep N, 2009, BEHAV BRAIN RES, V198, P149, DOI 10.1016/j.bbr.2008.10.035; Uher R, 2004, AM J PSYCHIAT, V161, P1238, DOI 10.1176/appi.ajp.161.7.1238; Uher R, 2003, BIOL PSYCHIAT, V54, P934, DOI 10.1016/S0006-3223(03)00172-0; van Kuyck K, 2009, J PSYCHIATR RES, V43, P1133, DOI 10.1016/j.jpsychires.2009.04.005; Vink M, 2014, NEUROIMAGE, V91, P70, DOI 10.1016/j.neuroimage.2014.01.035; Wagner A, 2008, NEUROPSYCHOPHARMACOL, V33, P513, DOI 10.1038/sj.npp.1301443; Wang Y, 2016, NEUROSCI LETT, V631, P56, DOI 10.1016/j.neulet.2016.08.017; Zhu JN, 2008, CELL MOL NEUROBIOL, V28, P469, DOI 10.1007/s10571-007-9236-z; Zhu YK, 2012, EUR EAT DISORD REV, V20, P439, DOI 10.1002/erv.2197	49	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0191059	10.1371/journal.pone.0191059	http://dx.doi.org/10.1371/journal.pone.0191059			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5DH	29579064	Green Published, gold, Green Submitted			2022-12-26	WOS:000428351800003
J	Jung, S; Sielker, S; Hanisch, MR; Libricht, V; Schafer, E; Dammaschke, T				Jung, Susanne; Sielker, Sonja; Hanisch, Marcel R.; Libricht, Viktor; Schaefer, Edgar; Dammaschke, Till			Cytotoxic effects of four different root canal sealers on human osteoblasts	PLOS ONE			English	Article							MINERAL TRIOXIDE AGGREGATE; IN-VITRO; PHYSICOCHEMICAL PROPERTIES; RESTORATIVE MATERIALS; ENDODONTIC SEALERS; CELLS; BIOACTIVITY; TISSUE; RCS	The aim of this study was to evaluate the effect of an epoxy resin-based (AH-Plus), a zinc oxide eugenol containing (Pulp-Canal-Sealer) and two calcium silicate containing (MTA-Fillapex and BioRoot-RCS) sealers on primary human osteoblasts (hOB) in freshly mixed and set state. All sealers were mixed strictly according to the manufacturers' instructions and identically samples were produced. In a pretest cytotoxic sealer concentrations were determined. Thus, for the main cell culture study, dilutions of sealer extract 1:1, 1:2, and 1:10 were used. To simulate a clinical scenario, extracts from freshly mixed sealer were added to the cells on day one. Extracts form set sealers were used for subsequent culturing for 24h, 7d, 14d, and 21d. Cell viability was analyzed by living-cell-count, MTT-assay, and living/dead-staining, cytotoxicity by LDH-assay, and changes by Richardson-staining. All data were statistically evaluated by one way ANOVA and a posthoc analysis with Bonferroni-Holm testing (p<0.05). AH-Plus was cytotoxic in a freshly mixed state, but not when the sealer was set. MTA-Fillapex and Pulp-Canal-Sealer were cytotoxic in a fresh as well as in a set state. BioRoot-RCS showed the lowest toxicity in both states; where as a regeneration of the cells could be observed over time (p<0.05). Contact of freshly mixed AH-Plus to osteoblasts should be avoided. Pulp Canal Sealer and MTA-Fillapex showed no biocompatibility in contact with osteoblasts at all. BioRoot-RCS had a positive influence on the cell metabolism (bioactivity) and is biocompatible.	[Jung, Susanne; Sielker, Sonja; Hanisch, Marcel R.; Libricht, Viktor] Univ Hosp Munster, Res Unit Vasc Biol Oral Struct VABOS, Dept Craniomaxillofacial Surg, Munster, Germany; [Libricht, Viktor; Dammaschke, Till] Westphalian Wilhelms Univ, Dept Periodontol & Operat Dent, Munster, Germany; [Schaefer, Edgar] Cent Interdisciplinary Ambulance Sch Dent, Munster, Germany	University of Munster; University of Munster	Dammaschke, T (corresponding author), Westphalian Wilhelms Univ, Dept Periodontol & Operat Dent, Munster, Germany.	tilida@uni-muenster.de			Open Access Publication Fund of University of Munster	Open Access Publication Fund of University of Munster	We acknowledge support by Open Access Publication Fund of University of Munster for taking over the publication costs. No additional external funding was received for this study.	Al-Hiyasat AS, 2010, INT ENDOD J, V43, P148, DOI 10.1111/j.1365-2591.2009.01669.x; Assmann E, 2015, J ENDODONT, V41, P62, DOI 10.1016/j.joen.2014.09.019; Bernath M, 2003, INT ENDOD J, V36, P256, DOI 10.1046/j.1365-2591.2003.00662.x; Braga JM, 2015, DENT TRAUMATOL, V31, P390, DOI 10.1111/edt.12190; Camps J, 2015, J ENDODONT, V41, P1469, DOI 10.1016/j.joen.2015.04.011; Chandra S, 2014, GROSSMANS ENDODONTIC, V13th, P343; Cohen B I, 1998, Oral Health, V88, P37; Collado-Gonzalez M, 2017, INT ENDOD J, V50, P875, DOI 10.1111/iej.12703; Costa F, 2016, J ENDODONT, V42, P113, DOI 10.1016/j.joen.2015.09.020; Dammaschke T, 2004, QUINTESSENCE INT, V35, P699; Dammaschke T, 2006, DTSCH ZAHNARZTL Z, P15; Dimitrova-Nakov S, 2015, DENT MATER, V31, P1290, DOI 10.1016/j.dental.2015.08.163; Donnermeyer D, 2018, CLIN ORAL INVEST, V22, P811, DOI 10.1007/s00784-017-2156-5; Eldeniz AU, 2007, INT ENDOD J, V40, P329, DOI 10.1111/j.1365-2591.2007.01211.x; Eldeniz AU, 2016, INT ENDOD J, V49, P1141, DOI 10.1111/iej.12577; Geurtsen W, 2001, Aust Endod J, V27, P12; GRANCHI D, 1995, ORAL SURG ORAL MED O, V79, P359, DOI 10.1016/S1079-2104(05)80230-6; Huang FM, 2002, ORAL SURG ORAL MED O, V94, P361, DOI 10.1067/moe.2002.126341; Johnson W., 2016, COHENS PATHWAYS PULP, P280; Jung S, 2014, HEAD FACE MED, V10, DOI 10.1186/s13005-014-0055-4; Mahdi JG, 2006, CELL PROLIFERAT, V39, P249, DOI 10.1111/j.1365-2184.2006.00390.x; Mestieri LB, 2015, J APPL ORAL SCI, V23, P467, DOI 10.1590/1678-775720150170; Parirokh M, 2014, MINERAL TRIOXIDE AGGREGATE: PROPERTIES AND CLINICAL APPLICATIONS, P281; Prullage RK, 2016, J ENDODONT, V42, P1784, DOI 10.1016/j.joen.2016.09.018; Scelza MZ, 2012, INT ENDOD J, V45, P12, DOI 10.1111/j.1365-2591.2011.01941.x; Schafer E, 2015, ODONTOLOGY, V103, P61, DOI 10.1007/s10266-013-0137-y; Schafer E, 2003, INT ENDOD J, V36, P660, DOI 10.1046/j.1365-2591.2003.00705.x; Schafer E, 2002, J ENDODONT, V28, P638, DOI 10.1097/00004770-200209000-00003; Schweikl H, 1998, Clin Oral Investig, V2, P125, DOI 10.1007/s007840050057; Schweikl H, 2001, J DENT RES, V80, P1615, DOI 10.1177/00220345010800070401; Silva EJNL, 2013, J ENDODONT, V39, P274, DOI 10.1016/j.joen.2012.06.030; Silva Emmanuel João Nogueira Leal da, 2016, Braz. Dent. J., V27, P419, DOI 10.1590/0103-6440201600735; Spangberg L, 1969, Odontol Tidskr, V77, P133; TEPEL J, 1994, ENDOD DENT TRAUMATOL, V10, P233; Xuereb M, 2015, J ENDODONT, V41, P111, DOI 10.1016/j.joen.2014.09.015; Zatloukal K, 2004, PATHOLOGIE, P39; Zhou HM, 2014, CLIN HEMORHEOL MICRO, V12, P9, DOI DOI 10.1016/J.J0EN.2014.09.012	37	42	42	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194467	10.1371/journal.pone.0194467	http://dx.doi.org/10.1371/journal.pone.0194467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579090	Green Published, gold, Green Submitted			2022-12-26	WOS:000428351800031
J	Herrera-Perez, RM; Voytik-Harbinm, SL; Sarkaria, JN; Pollok, KE; Fishel, ML; Rickus, JL				Herrera-Perez, R. Marisol; Voytik-Harbinm, Sherry L.; Sarkaria, Jann N.; Pollok, Karen E.; Fishel, Melissa L.; Rickus, Jenna L.			Presence of stromal cells in a bioengineered tumor microenvironment alters glioblastoma migration and response to STAT3 inhibition	PLOS ONE			English	Article							STEM-LIKE CELLS; IN-VITRO; EXTRACELLULAR-MATRIX; HYALURONIC-ACID; CANCER CELLS; XENOGRAFT MODEL; COLLAGEN GELS; BREAST-CANCER; 3D MATRICES; GLIOMA	Despite the increasingly recognized importance of the tumor microenvironment (TME) as a regulator of tumor progression, only few in vitro models have been developed to systematically study the effects of TME on tumor behavior in a controlled manner. Here we developed a three-dimensional (3D) in vitro model that recapitulates the physical and compositional characteristics of Glioblastoma (GBM) extracellular matrix (ECM) and incorporates brain stromal cells such as astrocytes and endothelial cell precursors. The model was used to evaluate the effect of TME components on migration and survival of various patient-derived GBM cell lines (GBM10, GBM43 and GBAM1) in the context of STAT3 inhibition. Migration analysis of GBM within the 3D in vitro model demonstrated that the presence of astrocytes significantly increases the migration of GBM, while presence of endothelial precursors has varied effects on the migration of different GBM cell lines. Given the role of the tumor micro environment as a regulator of STAT3 activity, we tested the effect of the STAT3 inhibitor SH-4-54 on GBM migration and survival. SH-4-54 inhibited STAT3 activity and reduced 3D migration and survival of GBM43 but had no effect on GBM10. SH-4-54 treatment drastically reduced the viability of the stem-like line GBAM1 in liquid culture, but its effect lessened in presence of a 3D ECM and stromal cells. Our results highlight the interplay between the ECM and stromal cells in the microenvironment with the cancer cells and indicate that the impact of these relationships may differ for GBM cells of varying genetic and clinical histories.	[Herrera-Perez, R. Marisol; Rickus, Jenna L.] Purdue Univ, Coll Engn, Dept Agr & Biol Engn, W Lafayette, IN 47907 USA; [Herrera-Perez, R. Marisol; Rickus, Jenna L.] Purdue Univ, Physiol Sensing Facil, Bindley Biosci Ctr, W Lafayette, IN 47907 USA; [Herrera-Perez, R. Marisol; Rickus, Jenna L.] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA; [Voytik-Harbinm, Sherry L.; Rickus, Jenna L.] Purdue Univ, Coll Engn, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Voytik-Harbinm, Sherry L.] Purdue Univ, Coll Vet Med, Dept Basic Med Sci, W Lafayette, IN 47907 USA; [Sarkaria, Jann N.] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA; [Pollok, Karen E.; Fishel, Melissa L.] Indiana Univ Sch Med, Dept Pediat, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Pollok, Karen E.; Fishel, Melissa L.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Pollok, Karen E.; Fishel, Melissa L.] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Mayo Clinic; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Rickus, JL (corresponding author), Purdue Univ, Coll Engn, Dept Agr & Biol Engn, W Lafayette, IN 47907 USA.; Rickus, JL (corresponding author), Purdue Univ, Physiol Sensing Facil, Bindley Biosci Ctr, W Lafayette, IN 47907 USA.; Rickus, JL (corresponding author), Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA.; Rickus, JL (corresponding author), Purdue Univ, Coll Engn, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.	rickus@purdue.edu	Fishel, Melissa L./AAH-6608-2020; , Jenna/ABI-4302-2020	Fishel, Melissa L./0000-0002-9436-6382; Rickus, Jenna/0000-0002-6325-330X	Purdue University Center for Cancer Research Small Grants Program; National Cancer Institute of the National Institutes of Health [R01CA138798, CA167291]; IUSCC ITRAC program; Indiana Clinical and Translational Sciences Institute CTSR; IUPUI Signature Center Initiative for the Cure of Glioblastoma SCI; Team JOEY, a Heroes Foundation Program; Curing Kid's Cancer; Riley Children's Foundation; Jeff Gordon Foundation	Purdue University Center for Cancer Research Small Grants Program; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); IUSCC ITRAC program; Indiana Clinical and Translational Sciences Institute CTSR; IUPUI Signature Center Initiative for the Cure of Glioblastoma SCI; Team JOEY, a Heroes Foundation Program; Curing Kid's Cancer; Riley Children's Foundation; Jeff Gordon Foundation	Research in this publication was supported by the Purdue University Center for Cancer Research Small Grants Program (RMHP, JLR), the National Cancer Institute of the National Institutes of Health [under award number R01CA138798 (KEP) and CA167291 (MLF)], the IUSCC ITRAC program (KEP), the Indiana Clinical and Translational Sciences Institute CTSR (RMHP, JLR and KEP) and pilot funding provided by the IUPUI Signature Center Initiative for the Cure of Glioblastoma SCI (RMHP, MLF, and JLR). We greatly appreciate the generous support of the Team JOEY, a Heroes Foundation Program (KEP), Curing Kid's Cancer (KEP), the Riley Children's Foundation (MLF and KEP), and the Jeff Gordon Foundation (MLF and KEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftab Q, 2015, ONCOTARGET, V6, P11447, DOI 10.18632/oncotarget.3407; Agudelo-Garcia PA, 2011, NEOPLASIA, V13, P831, DOI 10.1593/neo.11612; Ananthanarayanan B, 2011, BIOMATERIALS, V32, P7913, DOI 10.1016/j.biomaterials.2011.07.005; Arpin CC, 2016, MOL CANCER THER, V15, P794, DOI 10.1158/1535-7163.MCT-15-0003; Aubert M, 2008, J R SOC INTERFACE, V5, P75, DOI 10.1098/rsif.2007.1070; Avci NG, 2015, IEEE T NANOBIOSCI, V14, P790, DOI 10.1109/TNB.2015.2477818; Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013; Bohrer LR, 2014, CANCER RES, V74, P374, DOI 10.1158/0008-5472.CAN-13-2469; Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Buno KP, 2016, ACS APPL MATER INTER, V8, P21848, DOI 10.1021/acsami.6b01194; Carlson BL, 2011, CURR PROTOC PHARM, V52, P1; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; Chen WL, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0487-0; Cheng L, 2011, BIOCHEM BIOPH RES CO, V406, P643, DOI 10.1016/j.bbrc.2011.02.123; Clarke A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002714; Cooper LAD, 2012, AM J PATHOL, V180, P2108, DOI 10.1016/j.ajpath.2012.01.040; Critser PJ, 2011, CELL PROLIFERAT, V44, P15, DOI 10.1111/j.1365-2184.2010.00719.x; Dhiman HK, 2005, BIOMATERIALS, V26, P979, DOI 10.1016/j.biomaterials.2004.04.012; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Fernandez-Fuente G, 2014, MOL CANCER THER, V13, P1664, DOI 10.1158/1535-7163.MCT-13-0854; Filatova A, 2013, BBA-GEN SUBJECTS, V1830, P2496, DOI 10.1016/j.bbagen.2012.10.008; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Gritsenko PG, 2012, J PATHOL, V226, P185, DOI 10.1002/path.3031; Grodecki J, 2015, BIOTECHNOL PROGR, V31, P1406, DOI 10.1002/btpr.2123; Gurski LA, 2009, BIOMATERIALS, V30, P6076, DOI 10.1016/j.biomaterials.2009.07.054; Haftchenary S, 2013, ACS MED CHEM LETT, V4, P1102, DOI 10.1021/ml4003138; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Herrera-Perez M, 2015, TISSUE ENG PT A, V21, P2572, DOI [10.1089/ten.tea.2014.0504, 10.1089/ten.TEA.2014.0504]; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Kesanakurti D, 2013, ONCOGENE, V32, P5144, DOI 10.1038/onc.2012.546; Kim JE, 2014, CANCERS, V6, P376, DOI 10.3390/cancers6010376; King A, 2013, J SURG RES, V184, P671, DOI 10.1016/j.jss.2013.04.009; Krausz E, 2013, J BIOMOL SCREEN, V18, P54, DOI 10.1177/1087057112456874; Kreger ST, 2010, BIOPOLYMERS, V93, P690, DOI 10.1002/bip.21431; Le DM, 2003, J NEUROSCI, V23, P4034, DOI [DOI 10.1523/JNEUROSCI.23-10-04034.2003, DOI 10.1523/JNEUR0SCI.23-10-04034.2003]; Lee YJ, 1999, J BIOL CHEM, V274, P22401, DOI 10.1074/jbc.274.32.22401; Li LY, 2011, J CANCER, V2, P458, DOI 10.7150/jca.2.458; Lima FRS, 2012, BBA-REV CANCER, V1826, P338, DOI 10.1016/j.bbcan.2012.05.004; Liu LP, 2010, CANCER RES, V70, P3750, DOI 10.1158/0008-5472.CAN-09-3838; Luwor RB, 2013, J CLIN NEUROSCI, V20, P907, DOI 10.1016/j.jocn.2013.03.006; Maritano D, 2004, NAT IMMUNOL, V5, P401, DOI 10.1038/ni1052; McCord AM, 2009, CLIN CANCER RES, V15, P5145, DOI 10.1158/1078-0432.CCR-09-0263; Motegi H, 2014, NEUROPATHOLOGY, V34, P378, DOI 10.1111/neup.12117; Oliveira R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-7; Onishi M, 2011, BRAIN TUMOR PATHOL, V28, P13, DOI 10.1007/s10014-010-0007-z; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Payne LS, 2013, MOL CANCER RES, V11, P1129, DOI 10.1158/1541-7786.MCR-13-0236; Pedron S, 2013, BIOMATERIALS, V34, P7408, DOI 10.1016/j.biomaterials.2013.06.024; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Placone AL, 2016, TUMOR BIOL, V37, P61, DOI 10.1007/s13277-015-4242-0; Ramanujan S, 2002, BIOPHYS J, V83, P1650, DOI 10.1016/S0006-3495(02)73933-7; Rao SS, 2013, ACS APPL MATER INTER, V5, P9276, DOI 10.1021/am402097j; Rath BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054752; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Sarkaria JN, 2006, CLIN CANCER RES, V12, P2264, DOI 10.1158/1078-0432.CCR-05-2510; Schneider SW, 2004, ACTA NEUROPATHOL, V107, P272, DOI 10.1007/s00401-003-0810-2; Schonberg DL, 2014, MOL ASPECTS MED, V39, P82, DOI 10.1016/j.mam.2013.06.004; Senft C, 2011, J NEURO-ONCOL, V101, P393, DOI 10.1007/s11060-010-0273-y; Serres E, 2014, ONCOGENE, V33, P3451, DOI 10.1038/onc.2013.305; Shain KH, 2009, CANCER RES, V69, P1009, DOI 10.1158/0008-5472.CAN-08-2419; Siveen KS, 2014, BBA-REV CANCER, V1845, P136, DOI 10.1016/j.bbcan.2013.12.005; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Wang HY, 2017, J NEUROSURG, V126, P446, DOI 10.3171/2016.1.JNS152513; Wang H, 2009, STEM CELLS, V27, P2393, DOI 10.1002/stem.188; Wang L, 2013, PLOS ONE, V8; Weber CE, 2012, SURG ONCOL, V21, P172, DOI 10.1016/j.suronc.2011.09.001; Wei Z, 2013, CELL SIGNAL, V25, P931, DOI 10.1016/j.cellsig.2013.01.011; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Whittington CF, 2013, MACROMOL BIOSCI, V13, P1135, DOI 10.1002/mabi.201300128; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Yang YL, 2010, BIOMATERIALS, V31, P5678, DOI 10.1016/j.biomaterials.2010.03.039; Yoder MC, 2007, ANALYSIS, V109, P1; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818	74	26	26	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194183	10.1371/journal.pone.0194183	http://dx.doi.org/10.1371/journal.pone.0194183			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566069	Green Submitted, Green Published, gold			2022-12-26	WOS:000428093900040
J	Metrustry, SJ; Karhunen, V; Edwards, MH; Menni, C; Geisendorfer, T; Huber, A; Reichel, C; Dennison, EM; Cooper, C; Spector, T; Jarvelin, MR; Valdes, AM				Metrustry, Sarah Jane; Karhunen, Ville; Edwards, Mark H.; Menni, Cristina; Geisendorfer, Thomas; Huber, Anja; Reichel, Christian; Dennison, Elaine M.; Cooper, Cyrus; Spector, Tim; Jarvelin, Marjo-Riitta; Valdes, Ana M.			Metabolomic signatures of low birthweight: Pathways to insulin resistance and oxidative stress	PLOS ONE			English	Article							FETAL-GROWTH; HERTFORDSHIRE COHORT; LIFE; AGE; ACYLCARNITINES; PATTERNS; DISEASE; MARKERS; HEALTH; IMPACT	Several studies suggest that low birthweight resulting from restricted intrauterine growth can leave a metabolic footprint which may persist into adulthood. To investigate this, we performed metabolomic profiling on 5036 female twins, aged 18-80, with weight at birth information available from the TwinsUK cohort and performed independent replication in two additional cohorts. Out of 422 compounds tested, 25 metabolites associated with birthweight in these twins, replicated in 1951 men and women from the Hertfordshire Cohort Study (HCS, aged 66) and in 2391 men and women from the North Finland Birth 1986 cohort (NFBC, aged 16). We found distinct heterogeneity between sexes and, after adjusting for multiple tests and heterogeneity, two metabolites were reproducible overall (propionylcarnitine and 3-4-hydroxyphenyllactate). Testing women only, we found other metabolites associated with lower birthweight from the meta-analysis of the three cohorts (2-hydroxy-butyric acid and y-glutamylleucine). Higher levels of all these metabolites can be linked to insulin resistance, oxidative stress or a dysfunction of energy metabolism, suggesting that low birth weight in both twins and singletons are having an impact on these pathways in adulthood.	[Metrustry, Sarah Jane; Spector, Tim; Valdes, Ana M.] Kings Coll London, St Thomas Hosp, Dept Twin Res & Genet Epidemiol, London, England; [Karhunen, Ville; Jarvelin, Marjo-Riitta] Univ Oulu, Ctr Life Course Hlth Res, Fac Med, Oulu, Finland; [Karhunen, Ville; Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland; [Edwards, Mark H.; Cooper, Cyrus] Univ Southampton, Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Geisendorfer, Thomas; Huber, Anja; Reichel, Christian] Seibersdorf Labor GmbH, Vienna, Austria; [Dennison, Elaine M.] Victoria Univ, Wellington, New Zealand; [Cooper, Cyrus] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, NIHR Musculoskeletal Biomed Res Unit, Oxford, England; [Cooper, Cyrus] Univ Southampton, NIHR Nutr Biomed Res Ctr, Southampton, Hants, England; [Cooper, Cyrus] Univ Hosp Southampton NHS Fdn Trust, Southampton Gen Hosp, Southampton, Hants, England; [Jarvelin, Marjo-Riitta] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC PHE Ctr Environm Hlth, London, England; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Valdes, Ana M.] Univ Nottingham, Nottingham, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Oulu; University of Oulu; University of Southampton; Seibersdorf Labor GmbH; Victoria University Wellington; University of Oxford; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; Imperial College London; University of Oulu; University of Nottingham	Valdes, AM (corresponding author), Kings Coll London, St Thomas Hosp, Dept Twin Res & Genet Epidemiol, London, England.; Valdes, AM (corresponding author), Univ Nottingham, Nottingham, England.	ana.valdes@kcl.ac.uk		Valdes, Ana M./0000-0003-1141-4471; Metrustry, Sarah/0000-0003-2028-7486; Karhunen, Ville/0000-0001-6064-1588	Wellcome Trust; European Community's Seventh Framework Programme (FP7); National Institute for Health Research (NIHR); King's College London; Medical Research Council (MRC) of Great Britain; Arthritis Research UK; International Osteoporosis Foundation; NIHR Nutrition BRC, University of Southampton; Oxford NIHR Musculoskeletal BRU, University of Oxford; Academy of Finland, University Hospital Oulu, Biocenter, University of Oulu, Finland; European Commission [QLG1-CT-2000-01643, 277849]; Medical Research Council, UK; MRC [G0400491, MC_UU_12011/2, MC_U147585827, MC_UP_A620_1015, MC_U147585819] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); European Community's Seventh Framework Programme (FP7)(European Commission); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); King's College London; Medical Research Council (MRC) of Great Britain(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); International Osteoporosis Foundation; NIHR Nutrition BRC, University of Southampton; Oxford NIHR Musculoskeletal BRU, University of Oxford; Academy of Finland, University Hospital Oulu, Biocenter, University of Oulu, Finland; European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	TwinsUK: The study was supported by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013). The study also receives support from the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. The Hertfordshire Cohort Study was supported by the Medical Research Council (MRC) of Great Britain; Arthritis Research UK; and the International Osteoporosis Foundation. The work herein was also supported by the NIHR Nutrition BRC, University of Southampton and the Oxford NIHR Musculoskeletal BRU, University of Oxford. NFBC1986 was supported by the Academy of Finland, University Hospital Oulu, Biocenter, University of Oulu, Finland, the European Commission (Framework 5 award, EURO-BLCS, QLG1-CT-2000-01643, Framework 7 EurHEALTHAgeing 277849), and the Medical Research Council, UK. Professor Cyrus Cooper has received consultancy and honoraria from commercial companies: Alliance for Better Bone Health, Amgen, Eli Lilly, GSK, Medtronic, Merck, Novartis, Pfizer, Roche, Servier, Takeda and UCB. The funder provided support in the form of salary for author [CC] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barberini L, 2014, J MATERN-FETAL NEO M, V27, P20, DOI 10.3109/14767058.2014.954786; BECK JR, 1986, ARCH PATHOL LAB MED, V110, P13; Brooks AM, 2001, ARCH PEDIAT ADOL MED, V155, P401, DOI 10.1001/archpedi.155.3.401; Cheng JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044106; Cleary-Goldman J, 2008, SEMIN PERINATOL, V32, P206, DOI 10.1053/j.semperi.2008.02.009; CRAWFORD MA, 1987, HUM REPROD, V2, P517, DOI 10.1093/oxfordjournals.humrep.a136581; de Zegher F, 1999, HORM RES, V51, P258, DOI 10.1159/000023382; Fagerberg B, 2004, J INTERN MED, V256, P254, DOI 10.1111/j.1365-2796.2004.01361.x; Freathy RM, 2010, NAT GENET, V42, P430, DOI 10.1038/ng.567; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Harvey N, 2014, J BONE MINER RES, V29, P1917, DOI 10.1002/jbmr.2286; Horikoshi M, 2013, NAT GENET, V45, P76, DOI 10.1038/ng.2477; Illig KA, 2010, J VASC SURG, V52, P248, DOI 10.1016/j.jvs.2010.03.022; Jarvelin MR, 2004, HYPERTENSION, V44, P838, DOI 10.1161/01.HYP.0000148304.33869.ee; Johansson S, 2008, EPIDEMIOLOGY, V19, P659, DOI 10.1097/EDE.0b013e31818131b9; Ke CF, 2015, INT J CANCER, V136, P516, DOI 10.1002/ijc.29010; Kuhara T, 2011, ANAL BIOANAL CHEM, V400, P1881, DOI 10.1007/s00216-011-4766-0; Leeson CPM, 2001, CIRCULATION, V103, P1264; Lehre AC, 2013, STAT MED, V32, P2962, DOI 10.1002/sim.5744; Li L, 2016, FREE RADIC BIOL MED; Maitre L, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-110; Mardones F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/472017; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; Menni C, 2013, INT J EPIDEMIOL, V42, P1111, DOI 10.1093/ije/dyt094; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Moayyeri A, 2013, INT J EPIDEMIOL, V42, P76, DOI 10.1093/ije/dyr207; OUNSTED C, 1970, LANCET, V2, P857; Phillips DIW, 2005, DIABETES, V54, pS145, DOI 10.2337/diabetes.54.suppl_2.S145; Robinson SM, 2006, AM J CLIN NUTR, V84, P237; Ruoppolo M, 2015, MOL BIOSYST, V11, P2483, DOI 10.1039/c5mb00297d; Schooneman MG, 2013, DIABETES, V62, P1, DOI 10.2337/db12-0466; Strohmaier J, 2015, TWIN RES HUM GENET, V18, P198, DOI 10.1017/thg.2015.3; Syddall HE, 2016, J EPIDEMIOL COMMUN H, V70, P292, DOI 10.1136/jech-2015-206425; Torche F, 2011, INT J EPIDEMIOL, V40, P1008, DOI 10.1093/ije/dyr030; Tsai PC, 2015, TWIN RES HUM GENET, V18, P635, DOI 10.1017/thg.2015.76; Walter EC, 2009, AM J RESP CRIT CARE, V180, P176, DOI 10.1164/rccm.200901-0046OC; Wilson K, 2014, PEDIATR RES, V75, P367, DOI 10.1038/pr.2013.212; Wu YW, 2011, PEDIATRICS, V127, pE674, DOI 10.1542/peds.2010-1656; Wurtz P, 2016, INT J EPIDEMIOL, V45, P1539, DOI 10.1093/ije/dyw255	41	17	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194316	10.1371/journal.pone.0194316	http://dx.doi.org/10.1371/journal.pone.0194316			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566009	gold, Green Published, Green Accepted			2022-12-26	WOS:000428093900053
J	Postnikova, E; Cong, Y; DeWald, LE; Dyall, J; Yu, SQ; Hart, BJ; Zhou, HY; Gross, R; Logue, J; Cai, YY; Deiuliis, N; Michelotti, J; Honko, AN; Bennett, RS; Holbrook, MR; Olinger, GG; Hensley, LE; Jahrling, PB				Postnikova, Elena; Cong, Yu; DeWald, Lisa Evans; Dyall, Julie; Yu, Shuiqing; Hart, Brit J.; Zhou, Huanying; Gross, Robin; Logue, James; Cai, Yingyun; Deiuliis, Nicole; Michelotti, Julia; Honko, Anna N.; Bennett, Richard S.; Holbrook, Michael R.; Olinger, Gene G.; Hensley, Lisa E.; Jahrling, Peter B.			Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs	PLOS ONE			English	Article							HEMORRHAGIC-FEVER VIRUS; EBOLA-VIRUS; SMALL-MOLECULE; IDENTIFICATION; TRANSMISSION; INHIBITORS; MONKEYS; EVENTS; TIME	Identifying effective antivirals for treating Ebola virus disease (EVD) and minimizing transmission of such disease is critical. A variety of cell-based assays have been developed for evaluating compounds for activity against Ebola virus. However, very few reports discuss the variable assay conditions that can affect the results obtained from these drug screens. Here, we describe variable conditions tested during the development of our cell-based drug screen assays designed to identify compounds with anti-Ebola virus activity using established cell lines and human primary cells. The effect of multiple assay readouts and variable assay conditions, including virus input, time of infection, and the cell passage number, were compared, and the impact on the effective concentration for 50% and/or 90% inhibition (EC50, EC90) was evaluated using the FDA-approved compound, toremifene citrate. In these studies, we show that altering cell-based assay conditions can have an impact on apparent drug potency as measured by the EC50. These results further support the importance of developing standard operating procedures for generating reliable and reproducible in vitro data sets for potential antivirals.	[Postnikova, Elena; Cong, Yu; DeWald, Lisa Evans; Dyall, Julie; Yu, Shuiqing; Hart, Brit J.; Zhou, Huanying; Gross, Robin; Logue, James; Cai, Yingyun; Deiuliis, Nicole; Michelotti, Julia; Honko, Anna N.; Bennett, Richard S.; Holbrook, Michael R.; Olinger, Gene G.; Hensley, Lisa E.; Jahrling, Peter B.] NIAID, Integrated Res Facil, Div Clin Res, NIH, Frederick, MD 21702 USA; [Jahrling, Peter B.] NIAID, Emerging Viral Pathogens Sect, NIH, Frederick, MD USA; [Hart, Brit J.] NMRC, Frederick, MD USA; [Michelotti, Julia; Olinger, Gene G.] MRIGlobal Global Hlth Surveillance & Diagnost, Gaithersburg, MD USA; [Honko, Anna N.] DSI, St Paul, MN USA; [Olinger, Gene G.] Boston Univ, Sch Med, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Naval Medical Research Center (NMRC); Boston University	Cong, Y (corresponding author), NIAID, Integrated Res Facil, Div Clin Res, NIH, Frederick, MD 21702 USA.	yu.cong@nih.gov	Holbrook, Michael/AAT-6865-2020; Logue, James/AAD-1040-2021	Holbrook, Michael/0000-0002-0824-2667; Logue, James/0000-0002-7410-9741; Olinger, Gene/0000-0001-7338-0292; Cai, Yingyun/0000-0002-1101-0920; Honko, Anna/0000-0001-9165-148X; Hensley, Lisa/0000-0003-1188-4342; Bennett, Richard/0000-0002-7227-4831	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Integrated Research Facility; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Integrated Research Facility; Battelle Memorial Institute's (BMI); NIAID [HHSN2722007000161]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIDAI009006, ZICAI009006] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Integrated Research Facility; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Integrated Research Facility; Battelle Memorial Institute's (BMI); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research and Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Integrated Research Facility; and Battelle Memorial Institute's (BMI) prime contract with NIAID (Contract # HHSN2722007000161). Y.C. (Yu Cong), L.E.D., S. Y., R.G., J.L., R.S.B. and M.R.H. performed this work as employees of BMI. E.P., B.J.H., J.D., and Y.C. (Yingyun Cai) performed this work as employees of Tunnell Consulting, Inc., a subcontractor to BMI. H.Z. performed this work as an employee of Lovelace Biomedical and Environmental Research Institute, a subcontractor to BMI. N.D., J.M. and G.G.O. Jr performed this work as employees of MRIGlobal, a subcontractor to BMI. The findings and conclusions in this report are those of the authors and do not necessarily reflect the views or policies of the US Department of Health and Human Services or of the institutions and companies affiliated with the authors.	Alibek K, 1999, ANN NY ACAD SCI, V894, P18, DOI 10.1111/j.1749-6632.1999.tb08038.x; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Basu A, 2015, J INFECT DIS, V212, pS425, DOI 10.1093/infdis/jiv223; Basu A, 2011, J VIROL, V85, P3106, DOI 10.1128/JVI.01456-10; Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; Cong Y, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004709; Cong Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166318; Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002; Elshabrawy HA, 2014, J VIROL, V88, P4353, DOI 10.1128/JVI.03050-13; Feldmann H, 2003, NAT REV IMMUNOL, V3, P677, DOI 10.1038/nri1154; Garcia M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003500; Geisbert TW, 2004, NAT MED, V10, pS110, DOI 10.1038/nm1142; Gene Olinger G., 2009, Infectious Disorders - Drug Targets, V9, P191; Gerken Patty, 2004, Clin J Oncol Nurs, V8, P529, DOI 10.1188/04.CJON.529-530; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; Jaax N, 1995, LANCET, V346, P1669, DOI 10.1016/S0140-6736(95)92841-3; Johansen LM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5597; Johansen LM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005471; JOHNSON E, 1995, INT J EXP PATHOL, V76, P227; Kilgore PE, 2015, PHARMACOTHERAPY, V35, P43, DOI 10.1002/phar.1545; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Madrid PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060579; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; McMullan LK, 2016, ANTIVIR RES, V125, P71, DOI 10.1016/j.antiviral.2015.10.010; Miller EH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207084; MOE JB, 1981, J CLIN MICROBIOL, V13, P791, DOI 10.1128/JCM.13.4.791-793.1981; Murakami Y, 2009, ANTIVIR RES, V83, P112, DOI 10.1016/j.antiviral.2009.03.008; Ogata Hideaki, 2013, Gan To Kagaku Ryoho, V40, P749; Panchal RG, 2012, ANTIVIR RES, V93, P23, DOI 10.1016/j.antiviral.2011.10.011; Panchal RG, 2010, J BIOMOL SCREEN, V15, P755, DOI 10.1177/1087057110374357; Riss TL, 2011, METHODS MOL BIOL, V740, P103, DOI 10.1007/978-1-61779-108-6_12; Riss TL, 2004, ASSAY DRUG DEV TECHN, V2, P51, DOI 10.1089/154065804322966315; Sisk JM, 2015, ACS INFECT DIS, V1, P401, DOI 10.1021/acsinfecdis.5b00089; Tominaga T, 1992, Gan To Kagaku Ryoho, V19, P2363; Towner JS, 2007, J INFECT DIS, V196, pS205, DOI 10.1086/520601; Towner JS, 2005, VIROLOGY, V332, P20, DOI 10.1016/j.virol.2004.10.048; Vogel CL, 2014, CLIN BREAST CANCER, V14, P1, DOI 10.1016/j.clbc.2013.10.014; Vogel P., 1997, CELL VISION, V4, P298; Wu YJ, 2011, SPECTROCHIM ACTA A, V81, P544, DOI 10.1016/j.saa.2011.06.047; Yu F, 2014, FOOD CHEM, V149, P71, DOI 10.1016/j.foodchem.2013.10.024; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	41	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194880	10.1371/journal.pone.0194880	http://dx.doi.org/10.1371/journal.pone.0194880			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566079	Green Published, gold, Green Submitted			2022-12-26	WOS:000428093900116
J	Torre, OM; Das, R; Berenblum, RE; Huang, AH; Iatridis, JC				Torre, Olivia M.; Das, Rohit; Berenblum, Ramy E.; Huang, Alice H.; Iatridis, James C.			Neonatal mouse intervertebral discs heal with restored function following herniation injury	FASEB JOURNAL			English	Article						annulus fibrosus; puncture model; healing	NEEDLE PUNCTURE INJURY; HUMAN LUMBAR DISC; DIGIT TIP REGENERATION; ANNULUS FIBROSUS; ANULUS FIBROSUS; IN-VIVO; PROGENITOR CELLS; GENE-EXPRESSION; ANIMAL-MODEL; RAT DISC	Adult intervertebral discs (IVDs) have poor endogenous healing capacity, because of their challenging microenvironment and complex mechanical demands, which can result in painful IVD herniation. There are no regenerative strategies available to improve IVD healing and restore its function. Neonatal mice are excellent models of mammalian regeneration, but there are no studies of the regenerative capacity of neonatal IVDs. In this study, we developed a neonatal model of improved IVD healing to inform repair strategies after herniation. In vivo puncture injuries were performed to simulate herniation with complete annulus fibrosus (AF) tears in caudal IVDs of neonatal (postnatal d 5) and adult (4-6 mo) Scleraxis green fluorescent protein (ScxGFP) mice. Acute and long-term healing responses were assessed with histologic, radiologic, and biomechanical measurements. Neonates underwent accelerated IVD healing compared to adults with functional restoration and enhanced structural repair after herniation. A population of ScxGFP(-) cells identified in the neonatal repair site may be associated with this improved healing and warrants future investigation. In summary, function of neonatal IVDs was restored after herniation injury, whereas that of adult discs was not. This improved healing response is likely driven by multiple mechanisms that may include differences in mechanical loading and available repair cells during growth.Torre, O. M., Das, R., Berenblum, R. E., Huang, A. H., Iatridis, J. C. Neonatal mouse intervertebral discs heal with restored function following herniation injury.	[Torre, Olivia M.; Das, Rohit; Berenblum, Ramy E.; Huang, Alice H.; Iatridis, James C.] Icahn Sch Med Mt Sinai, Leni & Peter W May Dept Orthopaed, 1 Gustave Levy Pl,Box 1188, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Huang, AH; Iatridis, JC (corresponding author), Icahn Sch Med Mt Sinai, Leni & Peter W May Dept Orthopaed, 1 Gustave Levy Pl,Box 1188, New York, NY 10029 USA.	alice.huang@mssm.edu; james.iatridis@mssm.edu	Huang, Alice H/L-2256-2015	Huang, Alice H/0000-0002-5037-6829; Iatridis, James/0000-0002-2186-0590; Torre, Olivia M/0000-0003-3405-6259	U. S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR064157, R01 AR064157-04S1, R01 AR069537]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR069537, R01AR064157, R01AR057397] Funding Source: NIH RePORTER	U. S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Dr. Ronen Schweitzer (Shriners Children Hospital, Portland, OR, USA) for the ScxGFP mice, Dr. Meredith Bartelstein (Icahn School of Medicine at Mount Sinai) for biomechanical testing assistance, and Dr. Peter J. Taub (Icahn School of Medicine at Mount Sinai) for animal surgery training. This work was supported by U. S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grants R01 AR064157 and R01 AR064157-04S1 (to J.C.I.), and R01 AR069537 (to A.H.H.). The authors declare no conflicts of interest.	Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181; Bassat E, 2017, NATURE, V547, P179, DOI 10.1038/nature22978; Beckstein JC, 2008, SPINE, V33, pE166, DOI 10.1097/BRS.0b013e318166e001; Brisby H, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0179; Bron JL, 2010, EUR SPINE J, V19, P1347, DOI 10.1007/s00586-010-1384-z; Bron J, 2009, EUR SPINE J, V18, P301, DOI 10.1007/s00586-008-0856-x; Carragee EJ, 2006, SPINE, V31, P653, DOI 10.1097/01.brs.0000203714.76250.68; Carragee EJ, 2009, SPINE, V34, P2338, DOI 10.1097/BRS.0b013e3181ab5432; CASSIDY JJ, 1989, CONNECT TISSUE RES, V23, P75, DOI 10.3109/03008208909103905; CHELBERG MK, 1995, J ANAT, V186, P43; Cortes D.H., 2014, INTERVERTEBRAL DISC, P17; Cox BC, 2014, DEVELOPMENT, V141, P816, DOI 10.1242/dev.103036; Dahia CL, 2009, SPINE, V34, P447, DOI 10.1097/BRS.0b013e3181990c64; Daneyemez M, 1999, MINIM INVAS NEUROSUR, V42, P63, DOI 10.1055/s-2008-1053372; Elliott DM, 2004, SPINE, V29, P713, DOI 10.1097/01.BRS.0000116982.19331.EA; Fan Y, 2017, J CELL BIOCHEM, V118, P2828, DOI 10.1002/jcb.25933; Fazzalari NL, 2001, SPINE, V26, P2575, DOI 10.1097/00007632-200112010-00010; Fujita Y, 2000, MED ENG PHYS, V22, P349, DOI 10.1016/S1350-4533(00)00053-9; Guerin HAL, 2006, J BIOMECH, V39, P1410, DOI 10.1016/j.jbiomech.2005.04.007; Guterl CC, 2013, EUR CELLS MATER, V25, P1; HAMPTON D, 1989, SPINE, V14, P398, DOI 10.1097/00007632-198904000-00009; Henriksen L, 1996, BRIT J NEUROSURG, V10, P289, DOI 10.1080/02688699650040160; Henriksson HB, 2012, SPINE, V37, P722, DOI 10.1097/BRS.0b013e318231c2f7; Howell K, 2017, SCI REP-UK, V7, DOI 10.1038/srep45238; Hsieh AH, 2009, SPINE, V34, P998, DOI 10.1097/BRS.0b013e31819c09c4; Iatridis JC, 2013, SPINE J, V13, P243, DOI 10.1016/j.spinee.2012.12.002; Iatridis JC, 1999, SPINE, V24, P996, DOI 10.1097/00007632-199905150-00013; Iatridis JC, 2006, J BONE JOINT SURG AM, V88A, P41, DOI 10.2106/JBJS.E.01407; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; KEY JA, 1948, J BONE JOINT SURG AM, V30-A, P621, DOI 10.2106/00004623-194830030-00009; Korecki CL, 2008, SPINE, V33, P235, DOI 10.1097/BRS.0b013e3181624504; Lai A, 2013, J ORTHOP RES, V31, P621, DOI 10.1002/jor.22281; Lebow RL, 2011, SPINE, V36, P2147, DOI 10.1097/BRS.0b013e3182054595; Lee JW, 2013, DEV BIOL, V382, P98, DOI 10.1016/j.ydbio.2013.07.020; Lehoczky JA, 2011, P NATL ACAD SCI USA, V108, P20609, DOI 10.1073/pnas.1118017108; Lequin Michiel B, 2012, Korean J Spine, V9, P340, DOI 10.14245/kjs.2012.9.4.340; Leung VYL, 2009, J HISTOCHEM CYTOCHEM, V57, P249, DOI 10.1369/jhc.2008.952184; MacLean JJ, 2005, J ORTHOP RES, V23, P1120, DOI 10.1016/j.orthres.2005.01.020; MacLean JJ, 2003, SPINE, V28, P973, DOI 10.1097/00007632-200305150-00004; MARCHAND F, 1990, SPINE, V15, P402, DOI 10.1097/00007632-199005000-00011; Martin JT, 2013, J ORTHOP RES, V31, P1276, DOI 10.1002/jor.22355; Masuda K, 2005, SPINE, V30, P5, DOI 10.1097/01.brs.0000148152.04401.20; Meakin JR, 2000, J BIOMECH, V33, P575, DOI 10.1016/S0021-9290(99)00215-8; Melrose J, 2008, EUR SPINE J, V17, P1131, DOI 10.1007/s00586-008-0712-z; Melrose J, 2007, EUR SPINE J, V16, P2193, DOI 10.1007/s00586-007-0497-5; Michalek AJ, 2012, SPINE J, V12, P425, DOI 10.1016/j.spinee.2012.04.001; Michalek AJ, 2010, EUR SPINE J, V19, P2110, DOI 10.1007/s00586-010-1473-z; Nakazawa KR, 2018, SPINE J, V18, P343, DOI 10.1016/j.spinee.2017.09.018; Nerlich AG, 2007, EUR SPINE J, V16, P547, DOI 10.1007/s00586-006-0213-x; Orias AAE, 2009, SPINE J, V9, P204, DOI 10.1016/j.spinee.2008.01.014; OSTI OL, 1990, SPINE, V15, P762, DOI 10.1097/00007632-199008010-00005; PANJABI MM, 1992, J SPINAL DISORD, V5, P390, DOI 10.1097/00002517-199212000-00002; Parker SL, 2016, CLIN SPINE SURG, V29, P454, DOI 10.1097/BSD.0b013e3182956ec5; Porrello ER, 2013, P NATL ACAD SCI USA, V110, P187, DOI 10.1073/pnas.1208863110; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Roberts S, 2006, J BONE JOINT SURG AM, V88A, P10, DOI 10.2106/JBJS.F.00019; Rousseau MAA, 2007, SPINE, V32, P17, DOI 10.1097/01.brs.0000251013.07656.45; Sarver JJ, 2005, J ORTHOP RES, V23, P150, DOI 10.1016/j.orthres.2004.04.010; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Shinohara Harumichi, 1999, Okajimas Folia Anatomica Japonica, V76, P17; Showalter BL, 2012, SPINE, V37, pE900, DOI 10.1097/BRS.0b013e31824d911c; SKAGGS DL, 1994, SPINE, V19, P1310, DOI 10.1097/00007632-199406000-00002; SMITH JW, 1951, J BONE JOINT SURG BR, V33, P612, DOI 10.1302/0301-620X.33B4.612; Sobajima S, 2005, SPINE, V30, P15, DOI 10.1097/01.brs.0000148048.15348.9b; Somerville JN, 2004, CALCIFIED TISSUE INT, V74, P469, DOI 10.1007/s00223-003-0101-x; Sugimoto Y, 2013, DEVELOPMENT, V140, P2280, DOI 10.1242/dev.096354; Taghiyar L, 2018, CELL J, V19, P585, DOI 10.22074/cellj.2018.4710; Torre OM, 2017, BIOL APPROACHES SPIN; URBAN JPG, 1995, MOL MED TODAY, V1, P329, DOI 10.1016/S1357-4310(95)80032-8; van den Akker GGH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144497; Walter BA, 2015, J ANAT, V227, P707, DOI 10.1111/joa.12258; Walters BJ, 2014, J NEUROSCI, V34, P15751, DOI 10.1523/JNEUROSCI.3200-14.2014; Wilke H.-J., 2011, SPINE J, V11, pS148, DOI DOI 10.1016/J.SPINEE.2011.08.358; Yasen M, 2013, ACTA BIOCH BIOPH SIN, V45, P368, DOI 10.1093/abbs/gmt019; Yu L, 2010, DEVELOPMENT, V137, P551, DOI 10.1242/dev.042424; Zhang HN, 2009, J NEUROSURG-SPINE, V10, P522, DOI 10.3171/2009.2.SPINE08925	78	23	23	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4753	4762		10.1096/fj.201701492R	http://dx.doi.org/10.1096/fj.201701492R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29570392	Green Published			2022-12-26	WOS:000443817700011
J	Liu, LJ; Huang, Y; Fang, C; Zhang, HY; Yang, J; Xuan, CY; Wang, FF; Lu, HY; Cao, SF; Wang, YF; Li, SW; Sha, J; Zha, MM; Guo, M; Wang, J				Liu, Lijie; Huang, Yi; Fang, Cong; Zhang, Hongyu; Yang, Jing; Xuan, Chuanying; Wang, Fanfan; Lu, Haiying; Cao, Shuangfeng; Wang, Yongfang; Li, Shengwei; Sha, Jun; Zha, Mingming; Guo, Min; Wang, Jian			Chronic noise-exposure exacerbates insulin resistance and promotes the manifestations of the type 2 diabetes in a high-fat diet mouse model	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; GLUCOSE-TOLERANCE; STRESS; ACIDS; METABOLISM; MECHANISMS; DEPRESSION; SECRETION; RISK	Epidemiological studies have revealed that noise exposure was associated with an increased risk of type 2 diabetes mellitus (T2DM). However, the exact nature of that association remains to be elucidated. The present study is designed to examine the effects of chronic noise exposure on the development of T2DM in combination with a high-fat-diet (HFD) in mice. Here we show that chronic noise exposure at 85 dB SPL (4 h / day, below the safety limit for occupational noise exposure) exaggerated multiple metabolic abnormalities induced by HFD in C57BL/6J male mice, including worsened glucose intolerance, insulin resistance, fasting hyperglycemia and dyslipidemia. Furthermore, noise exposure exhibited a paradoxical impact on fat accumulation and circulating levels of free fatty acid, indicating a potential stimulating effect of noise on lipolysis. These results provide first in vivo supporting evidence for the causative role of noise exposure in diabetogenesis and pinpoint a noise-associated increase in blood free fatty acid levels as a possible mediator accelerating the effect of noise on the development of insulin resistance and T2DM.	[Liu, Lijie; Wang, Yongfang; Li, Shengwei; Sha, Jun; Zha, Mingming; Guo, Min] Southeast Univ, Coll Med, Nanjing, Jiangsu, Peoples R China; [Huang, Yi; Fang, Cong; Zhang, Hongyu; Yang, Jing; Xuan, Chuanying; Wang, Fanfan; Lu, Haiying; Cao, Shuangfeng] Southeast Univ, Inst Life Sci, Nanjing, Jiangsu, Peoples R China; [Wang, Jian] Dalhousie Univ, Sch Human Commun Disorder, Halifax, NS, Canada	Southeast University - China; Southeast University - China; Dalhousie University	Liu, LJ (corresponding author), Southeast Univ, Coll Med, Nanjing, Jiangsu, Peoples R China.	liulijie1973@163.com	Zha, Mingming/AAI-6297-2021; liu, lijie/AAG-9041-2021	liu, lijie/0000-0002-8309-609X; Wang, Jian/0000-0003-3633-6799	National Natural Science Foundation of China [81670935, 81520108015, 81100548, 81271086]; Fundamental research Fund from Southeast University [2242016K40073]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental research Fund from Southeast University	This work was supported by the National Natural Science Foundation of China (81670935, LJL, http://www.nsfc.gov.cn) for data collection, analysis and preparation of the manuscript. This work was supported by the National Natural Science Foundation of China (81520108015, GJ T, http://www.nsfc.gov.cn) for data analysis and preparation of the manuscript. This work was supported by the National Natural Science Foundation of China (81100548, LJ L, http://www.nsfc.gov.cn) for data collection and preparation of the manuscript. This work was supported by the National Natural Science Foundation of China (81271086, J W, http://www.nsfc.gov.cn) for data collection. This work was supported by the Fundamental research Fund from Southeast University (2242016K40073, LJ L) for data collection.	Ahlkvist L, 2013, ENDOCR CONNECT, V2, P69, DOI 10.1530/EC-12-0079; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; ARMARIO A, 1983, REV ESP FISIOL, V39, P267; Basner M, 2014, LANCET, V383, P1325, DOI 10.1016/S0140-6736(13)61613-X; Bays H, 2004, J CLIN ENDOCR METAB, V89, P463, DOI 10.1210/jc.2003-030723; Brewer PD, 2014, J BIOL CHEM; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cui B, 2016, SCI REP-UK, V6, DOI 10.1038/srep36693; Dzhambov AM, 2015, NOISE HEALTH, V17, P23, DOI 10.4103/1463-1741.149571; Ebbert JO, 2013, NUTRIENTS, V5, P498, DOI 10.3390/nu5020498; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Gannouni N, 2013, NOISE HEALTH, V15, P406, DOI 10.4103/1463-1741.121236; Garza JC, 2012, MOL PSYCHIATR, V17, P790, DOI 10.1038/mp.2011.161; Gonzalez-Perez O, 2011, NEUROSCI RES, V70, P243, DOI 10.1016/j.neures.2011.03.013; Herzberg-Schafer SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014194; Jaworski K, 2007, AM J PHYSIOL-GASTR L, V293, pG1, DOI 10.1152/ajpgi.00554.2006; Khuwaja AK, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-72; Kiechl S, 2013, NAT MED, V19, P358, DOI 10.1038/nm.3084; Konkle ATM, 2017, NOISE HEALTH, V19, P213, DOI 10.4103/nah.NAH_15_17; Liu L, 2016, ENV HLTH PERSPECTIVE; Manikandan S, 2006, NEUROSCI LETT, V399, P17, DOI 10.1016/j.neulet.2006.01.037; Mensink Marco, 2005, Metabolic Syndrome and Related Disorders, V3, P26, DOI 10.1089/met.2005.3.26; Morral N, 2007, J LIPID RES, V48, P1499, DOI 10.1194/jlr.M700090-JLR200; Pacini G, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/986906; Pankow JS, 2004, DIABETES CARE, V27, P77, DOI 10.2337/diacare.27.1.77; Paul DS, 2007, TOXICOL APPL PHARM, V222, P305, DOI 10.1016/j.taap.2007.01.010; Samson J, 2007, NEUROSCI RES, V57, P143, DOI 10.1016/j.neures.2006.09.019; Sjostrand M, 2009, MOL CELL ENDOCRINOL, V297, P104, DOI 10.1016/j.mce.2008.05.010; Sorensen M, 2013, ENVIRON HEALTH PERSP, V121, P217, DOI 10.1289/ehp.1205503; Taban E, 2017, HEALTH SCOPE, V6, DOI 10.5812/jhealthscope.36108; Tiganis T, 2011, TRENDS PHARMACOL SCI, V32, P82, DOI 10.1016/j.tips.2010.11.006; Uchida Y, 2012, DIABETES, V61, P1552, DOI 10.2337/db11-0828; Valente MM, 2012, MOL PHARMACOL, V82, P271, DOI 10.1124/mol.112.077636; Wilcox Gisela, 2005, Clin Biochem Rev, V26, P19; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Wu Y, 2015, NAT MED, V21, P373, DOI 10.1038/nm.3826; Yagi S, 2016, HIPPOCAMPUS, V26, P87, DOI 10.1002/hipo.22493; Zimmet PZ, 2014, LANCET DIABETES ENDO, V2, P56, DOI 10.1016/S2213-8587(13)70112-8	38	10	10	7	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195411	10.1371/journal.pone.0195411	http://dx.doi.org/10.1371/journal.pone.0195411			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601606	gold, Green Published, Green Submitted			2022-12-26	WOS:000428845900028
J	Alamri, AS; Wood, RJ; Ivanusic, JJ; Brock, JA				Alamri, Abdulhakeem S.; Wood, Rhiannon J.; Ivanusic, Jason J.; Brock, James A.			The neurochemistry and morphology of functionally identified corneal polymodal nociceptors and cold thermoreceptors	PLOS ONE			English	Article							NERVE-TERMINAL IMPULSES; TRANSDUCTION SITES; A-DELTA; EXPRESSION; RECEPTORS; MOUSE; MECHANORECEPTORS; INNERVATION; ENDINGS; NEURONS	It is generally believed that the unencapsulated sensory nerve terminals of modality specific C-and A delta-neurons lack structural specialization. Here we determined the morphology of functionally defined polymodal receptors and cold thermoreceptors in the guinea pig corneal epithelium. Polymodal receptors and cold thermoreceptors were identified by extracellular recording at the surface of the corneal epithelium. After marking the recording sites, corneas were processed to reveal immunoreactivity for the transient receptor potential channels TRPV1 (transient receptor potential cation channel, subfamily V, member 1) or TPRM8 (transient receptor potential cation channel subfamily M member 8). Polymodal receptor nerve terminals (n = 6) were TRPV1-immunoreactive and derived from an axon that ascended from the sub-basal plexus to the squamous cell layer where it branched into fibers that ran parallel to the corneal surface and terminated with small bulbar endings (ramifying endings). Cold thermoreceptor nerve terminals were TRPM8-immunoreactive (n = 6) and originated from an axon that branched as it ascended through the wing cell and squamous cell layers and terminated with large bulbar endings (complex endings). These findings indicate that modality specific corneal sensory neurons with unencapsulated nerve endings have distinct nerve terminal morphologies that are likely to relate to their function.	[Alamri, Abdulhakeem S.; Wood, Rhiannon J.; Ivanusic, Jason J.; Brock, James A.] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia; [Alamri, Abdulhakeem S.] Taif Univ, Coll Appl Sci, Dept Clin Lab, At Taif, Saudi Arabia	University of Melbourne; Taif University	Brock, JA (corresponding author), Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia.	j.brock@unimelb.edu.au	Ivanusic, Jason John/AAN-9056-2021; Brock, James A/A-2929-2012	Ivanusic, Jason John/0000-0002-7413-5704; Brock, James/0000-0002-1381-1983; Alamri, Abdulhakeem/0000-0003-3174-0434	Taif University/Ministry of Education, Saudi Arabia	Taif University/Ministry of Education, Saudi Arabia	Abdulhakeem Alamri was supported by a scholarship provided by Taif University/Ministry of Education, Saudi Arabia. Otherwise the authors received no specific funding for this work.	Abe J, 2005, MOL BRAIN RES, V136, P91, DOI 10.1016/j.molbrainres.2005.01.013; Alamri A, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00071; Almaraz L, 2014, HANDB EXP PHARMACOL, V222, P547, DOI 10.1007/978-3-642-54215-2_22; Belmonte Carlos, 2004, Ocul Surf, V2, P248; Belmonte C, 2017, OCUL SURF, V15, P404, DOI 10.1016/j.jtos.2017.05.002; Brock JA, 2001, J PHYSIOL-LONDON, V533, P493, DOI 10.1111/j.1469-7793.2001.0493a.x; Brock JA, 1998, J PHYSIOL-LONDON, V512, P211, DOI 10.1111/j.1469-7793.1998.211bf.x; Bron R, 2014, J COMP NEUROL, V522, P2967, DOI 10.1002/cne.23560; Carr RW, 2009, J PHYSIOL-LONDON, V587, P1249, DOI 10.1113/jphysiol.2008.167023; Carr RW, 2003, J GEN PHYSIOL, V121, P427, DOI 10.1085/jgp.200308814; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Everaerts W, 2009, N-S ARCH PHARMACOL, V379, P421, DOI 10.1007/s00210-008-0391-7; Gonzalez-Gonzalez O, 2017, INVEST OPHTH VIS SCI, V58, P404, DOI 10.1167/iovs.16-20033; Heinricher MM, 2004, MICROELECTRODE RECORDING IN MOVEMENT DISORDER SURGERY, P8; HENSEL H, 1974, PFLUG ARCH EUR J PHY, V352, P1, DOI 10.1007/BF01061945; HEPPELMANN B, 1994, CELL TISSUE RES, V275, P493, DOI 10.1007/BF00318818; Heppelmann B, 2001, J COMP NEUROL, V441, P148, DOI 10.1002/cne.1403; HOLZER P, 1991, PHARMACOL REV, V43, P143; Ivanusic JJ, 2013, J COMP NEUROL, V521, P877, DOI 10.1002/cne.23207; Kandel E. R., 2013, PRINCIPLES NEURAL SC; Lawoko-Kerali G, 2004, MECH DEVELOP, V121, P287, DOI 10.1016/j.mod.2003.12.006; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Li LS, 2014, ELIFE, V3, DOI 10.7554/eLife.01901; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Lynn PA, 2003, GASTROENTEROLOGY, V125, P786, DOI 10.1016/S0016-5085(03)01050-3; MACIVER MB, 1993, J NEUROSCI, V13, P4511; MACIVER MB, 1993, J NEUROPHYSIOL, V69, P1779, DOI 10.1152/jn.1993.69.5.1779; Owens DM, 2014, COLD SPRING HARB PER, V4; Parra A, 2010, NAT MED, V16, P1396, DOI 10.1038/nm.2264; Wang TW, 2006, J COMP NEUROL, V497, P88, DOI 10.1002/cne.20984; Zagorodnyuk VP, 2000, J NEUROSCI, V20, P6249, DOI 10.1523/JNEUROSCI.20-16-06249.2000; ZANDER E, 1951, J ANAT, V85, P68; Zimmerman A, 2014, SCIENCE, V346, P950, DOI 10.1126/science.1254229	33	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0195108	10.1371/journal.pone.0195108	http://dx.doi.org/10.1371/journal.pone.0195108			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590195	Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100103
J	Eckstein, T; Vidal-Henriquez, E; Bae, A; Zykov, V; Bodenschatz, E; Gholami, A				Eckstein, Torsten; Vidal-Henriquez, Estefania; Bae, Albert; Zykov, Vladimir; Bodenschatz, Eberhard; Gholami, Azam			Influence of fast advective flows on pattern formation of Dictyostelium discoideum	PLOS ONE			English	Article							CYCLIC-AMP; DIFFERENTIAL FLOW; SIGNAL PROPAGATION; PLANKTON DYNAMICS; SPIRAL WAVES; AGGREGATION; CELLS; MODEL; INSTABILITIES; TRANSDUCTION	We report experimental and numerical results on pattern formation of self-organizing Dictyostelium discoideum cells in a microfluidic setup under a constant buffer flow. The external flow advects the signaling molecule cyclic adenosine monophosphate (cAMP) downstream, while the chemotactic cells attached to the solid substrate are not transported with the flow. At high flow velocities, elongated cAMP waves are formed that cover the whole length of the channel and propagate both parallel and perpendicular to the flow direction. While the wave period and transverse propagation velocity are constant, parallel wave velocity and the wave width increase linearly with the imposed flow. We also observe that the acquired wave shape is highly dependent on the wave generation site and the strength of the imposed flow. We compared the wave shape and velocity with numerical simulations performed using a reaction-diffusion model and found excellent agreement. These results are expected to play an important role in understanding the process of pattern formation and aggregation of D. discoideum that may experience fluid flows in its natural habitat.	[Eckstein, Torsten; Vidal-Henriquez, Estefania; Bae, Albert; Zykov, Vladimir; Bodenschatz, Eberhard; Gholami, Azam] Max Planck Inst Dynam & Selforg, D-37077 Gottingen, Germany; [Bodenschatz, Eberhard] Univ Gottingen, Inst Nonlinear Dynam, D-37073 Gottingen, Germany; [Bodenschatz, Eberhard] Cornell Univ, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA; [Bodenschatz, Eberhard] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA	Max Planck Society; University of Gottingen; Cornell University; Cornell University	Gholami, A (corresponding author), Max Planck Inst Dynam & Selforg, D-37077 Gottingen, Germany.	azam.gholami@ds.mpg.de		Vidal-Henriquez, Estefania/0000-0003-1244-5376; Eckstein, Torsten/0000-0001-9692-183X; Gholami, Azam/0000-0002-9332-4551	Deutsche Forschungsgemeinschaft (DFG) [GH 184/1-1]; Deutsche Akademische Austauschdienst (DAAD), Research Grants-Doctoral Programs in Germany; Federal Ministry of Education and Research of Germany; Max Planck Society	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Akademische Austauschdienst (DAAD), Research Grants-Doctoral Programs in Germany; Federal Ministry of Education and Research of Germany(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck Society)	The authors thank M. S. Muller and K. Gunkel for their cheerful help with the preparation of the cells. T. E. acknowledges Deutsche Forschungsgemeinschaft (DFG), project number GH 184/1-1. E.V.H. thanks the Deutsche Akademische Austauschdienst (DAAD), Research Grants-Doctoral Programs in Germany. A.G. acknowledges MaxSynBio Consortium, which is jointly funded by the Federal Ministry of Education and Research of Germany and the Max Planck Society.; T. E. acknowledges Deutsche Forschungsgemeinschaft (DFG), project number GH 184/1-1. E.V.H. thanks the Deutsche Akademische Austauschdienst (DAAD), Research GrantsDoctoral Programs in Germany. A.G. acknowledges MaxSynBio Consortium, which is jointly funded by the Federal Ministry of Education and Research of Germany and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCANTARA F, 1974, J GEN MICROBIOL, V85, P321, DOI 10.1099/00221287-85-2-321; BONNER JT, 1947, J EXP ZOOL, V106, P1, DOI 10.1002/jez.1401060102; Decave E, 2003, J CELL SCI, V116, P4331, DOI 10.1242/jcs.00726; DEVREOTES PN, 1983, DEV BIOL, V96, P405, DOI 10.1016/0012-1606(83)90178-1; Edelstein A. D., 2014, J BIOL METHODS, V1; Egolf DA, 1998, PHYS REV LETT, V80, P3228, DOI 10.1103/PhysRevLett.80.3228; Ermakova EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004454; Geberth D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000422; Gholami A, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/9/093040; Gholami A, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/6/063007; Gholami A, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.018103; GROSS JD, 1976, J CELL SCI, V22, P645; Hundsdorfer W., 2013, SPRINGER SER COMPUT, V33; Kaern M, 2002, J PHYS CHEM B, V106, P3751, DOI 10.1021/jp013541z; Kaern M, 2001, FARADAY DISCUSS, V120, P295, DOI 10.1039/b103244p; KESSLER DA, 1993, PHYS REV E, V48, P4801, DOI 10.1103/PhysRevE.48.4801; Lauzeral J, 1997, P NATL ACAD SCI USA, V94, P9153, DOI 10.1073/pnas.94.17.9153; Leconte M, 2004, J CHEM PHYS, V120, P7314, DOI 10.1063/1.1665555; Lee KJ, 1996, PHYS REV LETT, V76, P1174, DOI 10.1103/PhysRevLett.76.1174; MALCHOW H, 1995, ECOL MODEL, V82, P257, DOI 10.1016/0304-3800(94)00095-Y; Malchow H, 2000, J THEOR BIOL, V204, P639, DOI 10.1006/jtbi.2000.2074; Malchow H, 2000, FRESHWATER BIOL, V45, P239, DOI 10.1046/j.1365-2427.2000.00550.x; MARTIEL JL, 1987, BIOPHYS J, V52, P807, DOI 10.1016/S0006-3495(87)83275-7; Merson R., 1957, P S DAT PROC, P1; MOSLEY MP, 1982, J HYDROL, V55, P65, DOI 10.1016/0022-1694(82)90121-4; Palsson E, 1996, P NATL ACAD SCI USA, V93, P1151, DOI 10.1073/pnas.93.3.1151; Parent CA, 1996, ANNU REV BIOCHEM, V65, P411; ROVINSKY AB, 1993, PHYS REV LETT, V70, P778, DOI 10.1103/PhysRevLett.70.778; ROVINSKY AB, 1992, PHYS REV LETT, V69, P1193, DOI 10.1103/PhysRevLett.69.1193; SCHEFFER M, 1991, J PLANKTON RES, V13, P1291, DOI 10.1093/plankt/13.6.1291; SIEGERT F, 1989, J CELL SCI, V93, P325; SIEGERT F, 1995, CURR BIOL, V5, P937, DOI 10.1016/S0960-9822(95)00184-9; TOMCHIK KJ, 1981, SCIENCE, V212, P443, DOI 10.1126/science.6259734; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; TYSON JJ, 1989, PHYSICA D, V34, P193, DOI 10.1016/0167-2789(89)90234-0; VANHAASTERT PJM, 1984, J GEN MICROBIOL, V130, P2559; Vidal-Henriquez E, 2017, CHAOS, V27, DOI 10.1063/1.4986153; Wessels D, 2004, EUKARYOT CELL, V3, P646, DOI 10.1128/EC.3.3.646-662.2004; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; Wu XG, 1996, J PHYS CHEM-US, V100, P15810, DOI 10.1021/jp9603546	40	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194859	10.1371/journal.pone.0194859	http://dx.doi.org/10.1371/journal.pone.0194859			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590179	Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100080
J	Nguyen, VT; Dawson, P; Zhang, QH; Harris, Z; Limesand, KH				Nguyen, Vicky T.; Dawson, Peter; Zhang, Qionghui; Harris, Zoey; Limesand, Kirsten H.			Administration of growth factors promotes salisphere formation from irradiated parotid salivary glands	PLOS ONE			English	Article							STEM-CELLS; PROGENITOR CELLS; HAIR FOLLICLE; NECK-CANCER; RADIATION; HOMEOSTASIS; EXPANSION; ORGANOGENESIS; REGENERATION; XEROSTOMIA	Worldwide, 500,000 cases of head and neck cancer (HNC) are reported each year and the primary treatment for HNC is radiotherapy. Although the goal of radiotherapy is to target the tumor, secondary exposure occurs in surrounding normal tissues, such as the salivary glands. As a result, despite successful treatment of the cancer, patients are left with long-term side effects due to direct damage to the salivary glands. The effect is chronic and currently there is no treatment. Stem cells are an attractive therapeutic option for treatment of radiation-induced glandular dysfunction because of the potential to regenerate damaged cell populations and restore salivary gland function. However, limited knowledge about the endogenous stem cell population post irradiation hinders the development for stem cell based therapies. In this study, an ex vivo sphere formation cell culture system was utilized to assess the self-renewal capacity of cells derived from parotid salivary glands at a chronic time point following radiation. Salivary glands from irradiated mice generate significantly fewer salispheres, but can be stimulated with fetal bovine serum (FBS) to generate an equivalent number of salispheres as unirradiated salivary glands. Interestingly, the number and size of salispheres formed is dependent on the concentration of FBS supplemented into the media. Salispheres derived from irradiated glands and cultured in FBS media were found to contain cells that proliferate and express progenitor and acinar cell markers such as Keratin 5, Keratin 14, Aquaporin 5, and NKCC1. Utilization of insulin-like growth factor (IGF1) injections following radiation treatment restores salivary gland function and improves salisphere generation. These findings indicate that stimulation of these cellular populations may provide a promising avenue for the development of cell-based therapies for radiation induced salivary gland damage.	[Nguyen, Vicky T.; Zhang, Qionghui; Harris, Zoey; Limesand, Kirsten H.] Univ Arizona, Dept Nutr Sci, Tucson, AZ 85721 USA; [Dawson, Peter] Univ Arizona, Dept Biomed Engn, Tucson, AZ USA	University of Arizona; University of Arizona	Limesand, KH (corresponding author), Univ Arizona, Dept Nutr Sci, Tucson, AZ 85721 USA.	limesank@u.arizona.edu		Dawson, Peter/0000-0002-9950-7439	 [R01 DE023534]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023534] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by R01 DE023534 to KHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biteau B, 2011, CELL STEM CELL, V9, P402, DOI 10.1016/j.stem.2011.10.004; Chibly AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107893; Chibly AM, 2014, J PALLIAT CARE MED, V4; Chong LM, 2003, IMRT HEAD NECK CANC, P191; Cmelak AJ, 2012, CRIT REV ONCOL HEMAT, V84, P261, DOI 10.1016/j.critrevonc.2012.04.004; Coppes RP, 2011, ORAL DIS, V17, P143, DOI 10.1111/j.1601-0825.2010.01723.x; Devi Seema, 2014, Natl J Maxillofac Surg, V5, P117, DOI 10.4103/0975-5950.154812; Fox NF, 2015, OR SURG OR MED OR PA, V120, P22, DOI 10.1016/j.oooo.2015.03.007; Furness S, 2013, COCHRANE DB SYST REV, V30; Grundmann O, 2009, J DENT RES, V88, P894, DOI 10.1177/0022034509343143; Grundmann O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-417; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Knox SM, 2010, SCIENCE, V329, P1645, DOI 10.1126/science.1192046; Kwak M, 2015, STEM CELLS DEV, V24, P565, DOI 10.1089/scd.2014.0355; Limesand KH, 2006, MOL CELL BIOL, V26, P8840, DOI 10.1128/MCB.01846-05; Lin AL, 2001, ARCH ORAL BIOL, V46, P1085, DOI 10.1016/S0003-9969(01)00063-2; Lombaert IMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002063; Lombaert IMA, 2008, STEM CELLS, V26, P2595, DOI 10.1634/stemcells.2007-1034; Lombaert IMA, 2013, STEM CELL REP, V1, P604, DOI 10.1016/j.stemcr.2013.10.013; Lopez-Jornet P, 2012, J ORAL PATHOL MED, V41, P201, DOI 10.1111/j.1600-0714.2011.01088.x; Maimets M, 2015, RADIOTHER ONCOL, V116, P443, DOI 10.1016/j.radonc.2015.06.022; Manuel Iglesias J, 2013, PLOS ONE, V8, DOI DOI 10.1371/J0URNAL.P0NE.0077281; Marmary Y, 2016, CANCER RES, V76, P1170, DOI 10.1158/0008-5472.CAN-15-1671; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; Nagle PW, 2016, INT J RADIAT ONCOL, V95, P103, DOI 10.1016/j.ijrobp.2016.02.020; Nanduri LSY, 2011, RADIOTHER ONCOL, V99, P367, DOI 10.1016/j.radonc.2011.05.085; Okumura K, 2003, HEPATOLOGY, V38, P104, DOI 10.1053/jhep.2003.50259; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Pedersen AM, 2002, ORAL DIS, V8, P117, DOI 10.1034/j.1601-0825.2002.02851.x; Pringle S, 2016, STEM CELLS, V34, P640, DOI 10.1002/stem.2278; Schmitt CA, 2011, NAT REV CLIN ONCOL, V8, P19; Shubin AD, 2017, ACTA BIOMATER, V50, P437, DOI 10.1016/j.actbio.2016.12.049; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Spielman A, 1981, ORAL SURG ORAL MED O, V4, P283; Tatsuishi Y, 2009, INT J MOL MED, V24, P361, DOI 10.3892/ijmm_00000240; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van Rij CM, 2008, RADIAT ONCOL, V3, DOI 10.1186/1748-717X-3-41; Vissink A, 2010, INT J RADIAT ONCOL, V78, P983, DOI 10.1016/j.ijrobp.2010.06.052; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Xiao N, 2014, J CLIN INVEST, V124, P3364, DOI 10.1172/JCI74096; Xiong FL, 2011, CYTOTECHNOLOGY, V63, P621, DOI 10.1007/s10616-011-9379-0	43	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193942	10.1371/journal.pone.0193942	http://dx.doi.org/10.1371/journal.pone.0193942			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590144	gold, Green Published, Green Submitted			2022-12-26	WOS:000428603100040
J	Nowacka, A; Smuczynski, W; Rosc, D; Dabrowska, KW; Sniegocki, M				Nowacka, Agnieszka; Smuczynski, Wojciech; Rosc, Danuta; Dabrowska, Kamila Wozniak; Sniegocki, Maciej			Serum VEGF-A concentrations in patients with central nervous system (CNS) tumors	PLOS ONE			English	Article							BRAIN-TUMORS; ANGIOGENESIS; EXPRESSION	Angiogenesis plays an essential role in tumors development. In case of central nervous system tumors, the most important role in this process plays VEGF-A. The purpose of this study was to determine the plasma concentration of this agent in patients treated surgically because of intracranial tumors. The study involved 48 adult patients, both sexes, treated surgically because of a brain tumor. The control group consisted of 50 adult volunteers of both sexes, without cancer diagnosis. Based on the studies, it was found that serum VEGFA levels before surgery are higher in patients with central nervous system tumors (10.39-150.57 pg/ml, median 41.70 pg/ml) than in non -cancer patients (0.00-130.77 pg/ml, median 22.56 pg/ml). The association between serum VEGF-A level and malignancy and histological type of intracranial tumor has not beed confirmed. The highest average preoperative serum VEGF-A level was found in patients with low grade gliomas, slightly lower (close to each other) in those with high grade gliomas and meningiomas, while the lowest level was characteristic for metastatic tumors. High variation in results was observed in patients with low grade gliomas (52.56 pg/ml)-higher than those reported in patients with high grade gliomas (32.38 pg/ml). In the rest types of tumors the differentiation was similar and oscillated within 23.08-27.50 pg/ml.	[Nowacka, Agnieszka; Dabrowska, Kamila Wozniak; Sniegocki, Maciej] Nicolaus Copernicus Univ, Coll Med Bydgoszcz, Dept Neurosurg Neurotraumatol & Paediat Neurosurg, Bydgoszcz, Poland; [Smuczynski, Wojciech] Nicolaus Copernicus Univ, Coll Med Bydgoszcz, Dept Neurotraumatol, Bydgoszcz, Poland; [Rosc, Danuta] Nicolaus Copernicus Univ, Coll Med Bydgoszcz, Dept Pathophysiol, Bydgoszcz, Poland	Nicolaus Copernicus University; Nicolaus Copernicus University; Nicolaus Copernicus University	Nowacka, A (corresponding author), Nicolaus Copernicus Univ, Coll Med Bydgoszcz, Dept Neurosurg Neurotraumatol & Paediat Neurosurg, Bydgoszcz, Poland.	dr.agnieszka.nowacka@gmail.com		Rosc, Danuta/0000-0002-2971-9882; Sniegocki, Maciej/0000-0003-3152-3755				Chiorean R, 2014, CANCER BIOMARK, V14, P185, DOI 10.3233/CBM-130310; Crocker M, 2011, NEURO-ONCOLOGY, V13, P99, DOI 10.1093/neuonc/noq170; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Kajdaniuk D, 2011, ENDOKRYNOL POL, V62, P456; Kim WY, 2009, FEBS J, V276, P4653, DOI 10.1111/j.1742-4658.2009.07177.x; Peles E, 2004, NEUROSURGERY, V55, P562, DOI 10.1227/01.NEU.0000134383.27713.9A; Rafat N, 2010, J NEUROSURG, V112, P43, DOI 10.3171/2009.5.JNS081074; Veikkola T, 2000, CANCER RES, V60, P203; Yang JG, 2017, INT J CLIN EXP MED, V10, P3606	9	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0192395	10.1371/journal.pone.0192395	http://dx.doi.org/10.1371/journal.pone.0192395			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590109	Green Published, Green Submitted, gold			2022-12-26	WOS:000428603100003
J	Fernandez-Villar, A; Represas-Represas, C; Mouronte-Roibas, C; Ramos-Hernandez, C; Priegue-Carrera, A; Fernandez-Garcia, S; Lopez-Campos, JL				Fernandez-Villar, Alberto; Represas-Represas, Cristina; Mouronte-Roibas, Cecilia; Ramos-Hernandez, Cristina; Priegue-Carrera, Ana; Fernandez-Garcia, Sara; Luis Lopez-Campos, Jose			Reliability and usefulness of spirometry performed during admission for COPD exacerbation	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; OVERDIAGNOSIS; MANAGEMENT; DIAGNOSIS	Objectives Although not currently recommended, spirometry during hospitalization due to exacerbation of chronic obstructive pulmonary disease (COPD) is an opportunity to enhance the diagnosis of this disease. The aim of the present study was to assess the usefulness and reliability of spirometry before hospital discharge, comparing it to measurements obtained during clinical stability. Methods This prospective longitudinal observational study compares spirometry results before and 8 weeks after discharge in consecutive patients admitted for COPD exacerbation. Concordance between results was assessed by the Kappa index, intraclass correlation coefficient, and Bland-Altman graphs. Results From an initial population of 179 COPD patients, 100 completed the study (mean age 67.8 years, 83% men, 35% active smokers, FEVi at clinical stability 40.3%). Forty-nine patients could not complete the study because they did not reach clinical stability. In three patients with obstructive spirometry during admission, the results were normal at follow-up. In the remaining patients, the COPD diagnosis was confirmed at stability with acceptable concordance. In 27 cases, spirometry improved more than 200 mL.No variables were found to be associated with this improvement or to explain it. Conclusions This study provides information on the role of spirometry prior to hospital discharge in patients admitted for COPD exacerbation, demonstrating that it is a valid and reproducible method, representing an opportunity toimprove COPD diagnosis.	[Fernandez-Villar, Alberto; Represas-Represas, Cristina; Mouronte-Roibas, Cecilia; Ramos-Hernandez, Cristina; Priegue-Carrera, Ana; Fernandez-Garcia, Sara] Alvaro Cunqueiro Hosp, EOXI, Pulm Dept, Vigo, Spain; [Fernandez-Villar, Alberto; Represas-Represas, Cristina; Mouronte-Roibas, Cecilia; Ramos-Hernandez, Cristina; Priegue-Carrera, Ana; Fernandez-Garcia, Sara] IISGS, NeumoVigol I Res Grp, Vigo, Spain; [Luis Lopez-Campos, Jose] Sevilla Univ, Virgen del Rocio Univ Hosp, Sevilla Biomed Res Inst IBiS, Med Surg Unit Resp Dis, Seville, Spain; [Luis Lopez-Campos, Jose] Hlth Inst Carlos III, CIBER Resp Dis CIBERES, Madrid, Spain	University of Sevilla; Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Fernandez-Villar, A (corresponding author), Alvaro Cunqueiro Hosp, EOXI, Pulm Dept, Vigo, Spain.; Fernandez-Villar, A (corresponding author), IISGS, NeumoVigol I Res Grp, Vigo, Spain.	alberto.fernandez.villar@sergas.es	Bodineau, José Luis López-Campos/AAG-5203-2019; Represas-Represas, Cristina/AAA-7143-2019	Bodineau, José Luis López-Campos/0000-0003-1703-1367; Represas-Represas, Cristina/0000-0002-5908-6684; , IIS Galicia Sur/0000-0003-3812-7413; RAMOS HERNANDEZ, CRISTINA/0000-0001-5626-7810; FERNANDEZ-VILLAR, ALBERTO/0000-0001-7407-5249	Ferrer laboratories	Ferrer laboratories	The study was financed with funding of our investigation institution and unconditional aid from Ferrer laboratories. Ferrer laboratories had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Centurion VP, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-73; Cushen B, 2016, RESP MED, V119, P55, DOI 10.1016/j.rmed.2016.08.019; Fernandez-Villar A, 2017, BRIT J GEN PRACT, V67, P183, DOI 10.3399/bjgp17X690389; Fernandez-Villar A, 2015, INT J CHRONIC OBSTR, V10, P961, DOI 10.2147/COPD.S79547; Garcia-Rio F, 2004, EUR RESPIR J, V24, P397, DOI 10.1183/09031936.04.00088403; Garcia-Rio F, 2013, ARCH BRONCONEUMOL, V49, P388, DOI 10.1016/j.arbres.2013.04.001; Guerra B, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0061-2016; Gupta N, 2014, EUR RESPIR J, V44, P873, DOI 10.1183/09031936.00025214; Hartl S, 2016, EUR RESPIR J, V47, P113, DOI 10.1183/13993003.01391-2014; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; Kon SSC, 2014, LANCET RESP MED, V2, P195, DOI 10.1016/S2213-2600(14)70001-3; Lamprecht B, 2015, CHEST, V148, P971, DOI 10.1378/chest.14-2535; Lopez-Campos JL, 2014, LANCET RESP MED, V2, P54, DOI 10.1016/S2213-2600(13)70232-7; Lopez-Campos JL, 2013, CHEST, V144, P601, DOI 10.1378/chest.12-2690; Miravitlles M, 2017, ARCH BRONCONEUMOL, V53, P324, DOI 10.1016/j.arbres.2017.03.018; Miravitlles M, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-147; Parker CM, 2005, EUR RESPIR J, V26, P420, DOI 10.1183/09031936.05.00136304; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Perez-Padilla R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121832; Rea H, 2011, INT J CHRONIC OBSTR, V6, P527, DOI 10.2147/COPD.S24133; Rinne ST, 2017, AM J RESP CRIT CARE, V195, P1269, DOI 10.1164/rccm.201609-1783LE; Roberts CM, 2013, THORAX, V68, P1169, DOI 10.1136/thoraxjnl-2013-203465; Shah T, 2016, CHEST, V150, P916, DOI 10.1016/j.chest.2016.05.002; Spero K, 2017, INT J CHRONIC OBSTR, V12, P2417, DOI 10.2147/COPD.S139919; Vogelmeier CF, 2017, ARCH BRONCONEUMOL, V53, P128, DOI 10.1016/j.arbres.2017.02.001; Wu HM, 2017, CHEST, V151, P1263, DOI 10.1016/j.chest.2017.01.003; Yu WC, 2013, INT J CHRONIC OBSTR, V8, P389, DOI 10.2147/COPD.S48659	28	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194983	10.1371/journal.pone.0194983	http://dx.doi.org/10.1371/journal.pone.0194983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579084	Green Published, gold, Green Submitted			2022-12-26	WOS:000428351800071
J	Jedrzejewski, W; Robinson, HS; Abarca, M; Zeller, KA; Velasquez, G; Paemelaere, EAD; Goldberg, JF; Payan, E; Hoogesteijn, R; Boede, EO; Schmidt, K; Lampo, M; Viloria, AL; Carreno, R; Robinson, N; Lukacs, PM; Nowak, JJ; Salom-Perez, R; Castaneda, F; Boron, V; Quigley, H				Jedrzejewski, Wlodzimierz; Robinson, Hugh S.; Abarca, Maria; Zeller, Katherine A.; Velasquez, Grisel; Paemelaere, Evi A. D.; Goldberg, Joshua F.; Payan, Esteban; Hoogesteijn, Rafael; Boede, Ernesto O.; Schmidt, Krzysztof; Lampo, Margarita; Viloria, Angel L.; Carreno, Rafael; Robinson, Nathaniel; Lukacs, Paul M.; Nowak, J. Joshua; Salom-Perez, Roberto; Castaneda, Franklin; Boron, Valeria; Quigley, Howard			Estimating large carnivore populations at global scale based on spatial predictions of density and distribution - Application to the jaguar (Panthera onca)	PLOS ONE			English	Article							HOME-RANGE SIZE; SPECIES DISTRIBUTION; CONSERVATION PLAN; TIGER DENSITIES; PROTECTED AREA; CAMERA TRAPS; FOREST; PRODUCTIVITY; SELECTION; ECOLOGY	Broad scale population estimates of declining species are desired for conservation efforts. However, for many secretive species including large carnivores, such estimates are often difficult. Based on published density estimates obtained through camera trapping, presence/absence data, and globally available predictive variables derived from satellite imagery, we modelled density and occurrence of a large carnivore, the jaguar, across the species' entire range. We then combined these models in a hierarchical framework to estimate the total population. Our models indicate that potential jaguar density is best predicted by measures of primary productivity, with the highest densities in the most productive tropical habitats and a clear declining gradient with distance from the equator. Jaguar distribution, in contrast, is determined by the combined effects of human impacts and environmental factors: probability of jaguar occurrence increased with forest cover, mean temperature, and annual precipitation and declined with increases in human foot print index and human density. Probability of occurrence was also significantly higher for protected areas than outside of them. We estimated the world's jaguar population at 173,000 (95% CI: 138,000-208,000) individuals, mostly concentrated in the Amazon Basin; elsewhere, populations tend to be small and fragmented. The high number of jaguars results from the large total area still occupied (almost 9 million km(2)) and low human densities (< 1 person/km(2)) coinciding with high primary productivity in the core area of jaguar range. Our results show the importance of protected areas for jaguar persistence. We conclude that combining modelling of density and distribution can reveal ecological patterns and processes at global scales, can provide robust estimates for use in species assessments, and can guide broad-scale conservation actions.	[Jedrzejewski, Wlodzimierz; Abarca, Maria; Velasquez, Grisel; Lampo, Margarita; Viloria, Angel L.; Carreno, Rafael] IVIC, Ctr Ecol, Caracas, Venezuela; [Robinson, Hugh S.; Paemelaere, Evi A. D.; Payan, Esteban; Hoogesteijn, Rafael; Salom-Perez, Roberto; Castaneda, Franklin; Quigley, Howard] Panthera, New York, NY USA; [Robinson, Hugh S.; Lukacs, Paul M.; Nowak, J. Joshua] Univ Montana, Wildlife Biol Program, Dept Ecosyst & Conservat Sci, WA Franke Coll Forestry & Conservat, Missoula, MT 59812 USA; [Zeller, Katherine A.] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Goldberg, Joshua F.] Univ Calif Riverside, Evolut Ecol & Organismal Biol Program, Riverside, CA 92521 USA; [Boede, Ernesto O.] Fdn Desarrollo Ciencias Fis Matemat & Nat FUDECI, Caracas, Venezuela; [Schmidt, Krzysztof] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Robinson, Nathaniel] Univ Montana, WA Franke Coll Forestry & Conservat, Dept Forest Management, Missoula, MT 59812 USA; [Boron, Valeria] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England	Venezuelan Institute Science Research; University of Montana System; University of Montana; University of Massachusetts System; University of Massachusetts Amherst; University of California System; University of California Riverside; Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; University of Montana System; University of Montana; University of Kent	Jedrzejewski, W (corresponding author), IVIC, Ctr Ecol, Caracas, Venezuela.	wjedrzej1@gmail.com	Schmidt, Krzysztof/L-6437-2013	Lampo, Margarita/0000-0002-3669-701X; Schmidt, Krzysztof/0000-0002-9043-291X; Lukacs, Paul/0000-0002-3584-8314	Panthera (the Liz Claiborne Art Ortenberg Jaguar Research Grants); Institute Venezolano de Investigaciones Cientificas, IVIC; Polish Ministry of Science and Higher Education [NN304336339]	Panthera (the Liz Claiborne Art Ortenberg Jaguar Research Grants); Institute Venezolano de Investigaciones Cientificas, IVIC; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This study was funded by: (1) Panthera (the Liz Claiborne Art Ortenberg Jaguar Research Grants 2014, 2016) - WJ; (2) Institute Venezolano de Investigaciones Cientificas, IVIC (annual budgets) - WJ; (3) a grant from the Polish Ministry of Science and Higher Education (NN304336339) - KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya HR, 2000, CONSERV BIOL, V14, P1001, DOI 10.1046/j.1523-1739.2000.99125.x; Astete S, 2017, J MAMMAL, V98, P464, DOI 10.1093/jmammal/gyw184; Baillie J. E. M., 2004, 2004 IUCN RED LIST T; Bauer H, 2015, P NATL ACAD SCI USA, V112, P14894, DOI 10.1073/pnas.1500664112; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Boron V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153973; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Brodie J, 2013, J APPL ECOL, V50, P295, DOI 10.1111/1365-2664.12044; Burnham K P, 2003, MODEL SELECT MULTIMO; Carroll C, 2006, J APPL ECOL, V43, P1056, DOI 10.1111/j.1365-2664.2006.01237.x; Carvalho E.A.R., 2013, LAT AM J CONSERV, V3, P8; Cavalcanti SMC, 2009, J MAMMAL, V90, P935, DOI 10.1644/08-MAMM-A-188.1; Chavez C., 2016, JAGUAR SIGLO 21 PERS, P47; Cullen L, 2013, ZOOLOGIA-CURITIBA, V30, P379, DOI 10.1590/S1984-46702013000400003; De Angelo C, 2013, BIOL CONSERV, V159, P422, DOI 10.1016/j.biocon.2012.12.021; Durant SM, 2017, P NATL ACAD SCI USA, V114, P528, DOI 10.1073/pnas.1611122114; Efford M. G., 2004, Animal Biodiversity and Conservation, V27, P217; Efford M. G., 2012, DENSITY 5 0 SOFTWARE; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Ferraz KMPMB, 2012, CAT NEWS, V7, P38; FIELD CB, 1995, REMOTE SENS ENVIRON, V51, P74, DOI 10.1016/0034-4257(94)00066-V; Foster RJ, 2012, J WILDLIFE MANAGE, V76, P224, DOI 10.1002/jwmg.275; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gopalaswamy AM, 2012, METHODS ECOL EVOL, V3, P1067, DOI 10.1111/j.2041-210X.2012.00241.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Gutierrez-Gonzalez CE, 2012, ORYX, V46, P431, DOI 10.1017/S003060531100041X; Herfindal I, 2005, J ZOOL, V265, P63, DOI 10.1017/S0952836904006053; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hoogesteijn Rafael, 1996, Bulletin of the Florida Museum of Natural History, V39, P195; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Ibisch PL, 2016, SCIENCE, V354, P1423, DOI 10.1126/science.aaf7166; IUCN, 1994, INT UN CONS NAT RED; IUCN, 2021, WIKIPEDIA; Jedrzejewska Bogumila, 2005, P230; Jedrzejewski W, 1996, ACTA THERIOL, V41, P1; Jedrzejewski W, 2007, ECOGRAPHY, V30, P66, DOI 10.1111/j.2006.0906-7590.04826.x; Jedrzejewski W, 2017, BIOL CONSERV, V209, P524, DOI 10.1016/j.biocon.2017.03.025; Jedrzejewski W, 2017, BIOL CONSERV, V206, P132, DOI 10.1016/j.biocon.2016.09.027; Jedrzejewski W, 2017, MAMMAL RES, V62, P9, DOI 10.1007/s13364-016-0300-2; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Karanth KU, 2004, ANIM CONSERV, V7, P285, DOI 10.1017/S1367943004001477; Karanth KU, 1998, ECOLOGY, V79, P2852; Kery M, 2015, APPL HIERARCHICAL MO, V1; Legagneux P, 2012, ECOLOGY, V93, P1707, DOI 10.1890/11-1973.1; Leith H., 1975, PRIMARY PRODUCTIVITY, DOI [10.1007/978-3-642-80913-2_12, DOI 10.1007/978-3-642-80913-2_12]; Letnic M, 2017, GLOBAL ECOL BIOGEOGR, V26, P860, DOI 10.1111/geb.12593; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Maffei L, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P119, DOI 10.1007/978-4-431-99495-4_8; Mateos Del Vas J, 2017, ANALISIS COMP PRODUC, P1, DOI [10.1017/S0030605316001046, DOI 10.1017/S0030605316001046]; McCain EB, 2008, J MAMMAL, V89, P1, DOI 10.1644/07-MAMM-F-268.1; McFeeters SK, 1996, INT J REMOTE SENS, V17, P1425, DOI 10.1080/01431169608948714; Melis C, 2009, GLOBAL ECOL BIOGEOGR, V18, P724, DOI 10.1111/j.1466-8238.2009.00480.x; Miquelle Dale G., 2010, P325; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nilsen EB, 2005, ECOSCIENCE, V12, P68, DOI 10.2980/i1195-6860-12-1-68.1; Olsoy PJ, 2016, BIOL CONSERV, V203, P8, DOI 10.1016/j.biocon.2016.08.037; OTIS DL, 1978, WILDLIFE MONOGR, P1; Paviolo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep37147; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Pettorelli N, 2009, AM NAT, V173, P698, DOI 10.1086/597379; POWER ME, 1992, ECOLOGY, V73, P733, DOI 10.2307/1940153; Quigley H, IUCN RED LIST THREAT; QUIGLEY HB, 1992, BIOL CONSERV, V61, P149, DOI 10.1016/0006-3207(92)91111-5; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rabinowitz A, 2010, BIOL CONSERV, V143, P939, DOI 10.1016/j.biocon.2010.01.002; RABINOWITZ AR, 1986, J ZOOL, V210, P149, DOI 10.1111/j.1469-7998.1986.tb03627.x; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Robinson JG, 2004, ANIM CONSERV, V7, P397, DOI 10.1017/S1367943004001532; Robinson JG, 2000, BIOL RESOURCE MANAGE, P13; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rodriguez-Soto C, 2011, DIVERS DISTRIB, V17, P350, DOI 10.1111/j.1472-4642.2010.00740.x; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Sanderson EW, 2002, CONSERV BIOL, V16, P58, DOI 10.1046/j.1523-1739.2002.00352.x; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Segurado P, 2006, J APPL ECOL, V43, P433, DOI 10.1111/j.1365-2664.2006.01162.x; SEYMOUR K L, 1989, Mammalian Species, P1, DOI 10.2307/3504096; Sharma RK, 2010, ANIM CONSERV, V13, P94, DOI 10.1111/j.1469-1795.2009.00305.x; Silver SC, 2004, ORYX, V38, P148, DOI 10.1017/S0030605304000286; Sims DA, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2006JG000162; Sollmann Rahel, 2008, Cat News, P15; Stein A, 2016, PANTHERA PARDUS; Tabachnick B.G., 1983, USING MULTIVARIATE S; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Tobler MW, 2013, BIOL CONSERV, V159, P109, DOI 10.1016/j.biocon.2012.12.009; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x; Wang SW, 2009, BIOL CONSERV, V142, P606, DOI 10.1016/j.biocon.2008.11.023; Weber W, 1996, CONSERV BIOL, V10, P1046, DOI 10.1046/j.1523-1739.1996.10041046.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilkie DS, 2011, ANN NY ACAD SCI, V1223, P120, DOI 10.1111/j.1749-6632.2010.05908.x; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Yu-Sung S, 2012, R2JAGS PACKAGE RUNNI; ZELLER K., 2007, JAGUARS NEW MILLENNI; Zeller KA, 2011, BIOL CONSERV, V144, P892, DOI 10.1016/j.biocon.2010.12.003; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	99	52	56	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194719	10.1371/journal.pone.0194719	http://dx.doi.org/10.1371/journal.pone.0194719			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579129	Green Published, gold, Green Submitted			2022-12-26	WOS:000428351800049
J	Bernard, V; Lamothe, S; Beau, I; Guillou, A; Martin, A; Le Tissier, P; Grattan, D; Young, J; Binart, N				Bernard, Valerie; Lamothe, Sophie; Beau, Isabelle; Guillou, Anne; Martin, Agnes; Le Tissier, Paul; Grattan, David; Young, Jacques; Binart, Nadine			Autocrine actions of prolactin contribute to the regulation of lactotroph function in vivo	FASEB JOURNAL			English	Article						pituitary; autocrine effect; mouse model	RECEPTOR-DEFICIENT MICE; TRANSCRIPTION FACTOR; ANTERIOR-PITUITARY; SIGNAL TRANSDUCER; PRL SECRETION; DOPAMINE; HYPERPROLACTINEMIA; HYPOTHALAMUS; HYPERPLASIA; EXPRESSION	Prolactin (PRL), whose principal role is regulation of lactation, is mainly synthesized and secreted by lactotroph anterior pituitary cells. Its signaling is exerted via a transmembrane PRL receptor (PRLR) expressed in a wide variety of tissues, including the anterior pituitary. Dopamine, which is secreted by tuberoinfundibular hypothalamic neurons, is the major inhibitory regulator of prolactin secretion. Although PRL is well established to stimulate hypothalamic dopamine secretion, thereby exerting a negative feedback regulation on its own release, autocrine or paracrine actions of PRL on lactotroph cells have also been suggested. Within the pituitary, PRL may inhibit both lactotroph proliferation and secretion, but in vivo evaluation of these putative functions is limited. To determine whether the autocrine actions of prolactin have a significant role in the physiologic function of lactotrophs in vivo, we examined the consequences of conditional deletion of Prlr in lactotroph cells using a novel mouse line with loxP sites flanking the Prlr gene (Prlr(lox/lox)) and Cre-recombinase (Cre) expressed under the control of the pituitary-specific Prl promoter. Prlr(lox/lox)/Prl-Cre mice have normal PRL levels and did not develop any pituitary lactotroph adenoma, even at 20 mo of age. Nevertheless, Prlr(lox/lox)/Prl-Cre mice displayed an increased dopaminergic inhibitory tone compared with control Prlr(lox/lox) mice. These results elegantly confirm an autocrine/paracrine feedback of PRL on lactotroph cells in vivo, which can be fully compensated by an intact hypothalamic feedback system.Bernard, V., Lamothe, S., Beau, I., Guillou, A., Martin, A., Le Tissier, P., Grattan, D., Young, J., Binart, N. Autocrine actions of prolactin contribute to the regulation of lactotroph function in vivo.	[Bernard, Valerie; Lamothe, Sophie; Beau, Isabelle; Young, Jacques; Binart, Nadine] Univ Paris Saclay, Fac Med Paris Sud, U1185, INSERM, Le Kremlin Bicetre, France; [Guillou, Anne; Martin, Agnes] Inst Genom Fonct, CNRS, U1191, INSERM, Montpellier, France; [Le Tissier, Paul] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Grattan, David] Univ Otago, Dept Anat, Ctr Neuroendocrinol, Dunedin, New Zealand; [Young, Jacques] Hop Bicetre, AP HP, Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Edinburgh; University of Otago; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Binart, N (corresponding author), Univ Paris Sud, U1185, INSERM, 63 Rue Gabriel Peri, F-94276 Le Kremlin Bicetre, France.	nadine.binart@inserm.fr	Binart, Nadine/F-2949-2013; Beau, Isabelle/M-4423-2017; Young, Jacques/N-5251-2019; Grattan, David/M-4307-2019; Young, Jacques/T-2976-2018	Binart, Nadine/0000-0002-5606-3866; Beau, Isabelle/0000-0002-3352-6813; Young, Jacques/0000-0001-9286-5631; Grattan, David/0000-0001-5606-2559; Young, Jacques/0000-0001-9286-5631; Martin, Agnes/0000-0001-6680-7139	Agence Nationale de la Recherche [12 BSV1 0032-01]; Health Research Council of New Zealand	Agence Nationale de la Recherche(French National Research Agency (ANR)); Health Research Council of New Zealand(Health Research Council of New Zealand)	The authors thank Dr. Gwennhael Autret [INSERM Unite Mixte de Recherche (UMR) 970, Paris-Centre de Recherche Cardiovasculaire-Hopital Europeen Georges-Pompidou (PARCC-HEGP), Paris, France, and Plateforme Imageries du Vivant, Universite Paris Descartes, Sorbonne Paris Cite, Paris, France] for MRI performance, Virginie Tolle and Axelle Simon (INSERM UMR 894, Paris, France) for help in immunofluorescence experiments, Valerie Nicolas [Institut Paris Saclay d'Innovation Therapeutique (IPSIT), Chatenay-Malabry, France] for assistance in confocal microscopic analysis, Francoise Magnin (Unite INSERM 1185, Le Kremlin-Bicetre, France) for help in genotyping, Nathalie Ba (Institut Biomedical de Recherche Unite Mixte de Service (UMS) 32, Le Kremlin-Bicetre, France) for assistance in pathologic proceedings and Chiara Villa (Service d'Anatomie et Cytologie Pathologiques, Hopital Foch, Suresnes France) for help in pathologic analysis. Funding was from Poste d'Accueil Inserm/Plan Cancer 2014-2019, and la Societe Francaise d'Endocrinologie et Diabetologie Pediatrique. This research was supported by grants from Agence Nationale de la Recherche (12 BSV1 0032-01) and a grant from the Health Research Council of New Zealand (D.G.). V.B. and S.L. are cofirst authors. The authors declare no conflicts of interest.	Asa SL, 1999, ENDOCRINOLOGY, V140, P5348, DOI 10.1210/en.140.11.5348; Asa SL, 2009, ANNU REV PATHOL-MECH, V4, P97, DOI 10.1146/annurev.pathol.4.110807.092259; Bang Soyoung, 2016, Clin Exp Reprod Med, V43, P9, DOI 10.5653/cerm.2016.43.1.9; Ben-Jonathan N, 2001, ENDOCR REV, V22, P724, DOI 10.1210/er.22.6.724; Bernard V, 2016, NEUROENDOCRINOLOGY, V103, P738, DOI 10.1159/000442981; Bernard V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152872; Bernard V, 2015, NAT REV ENDOCRINOL, V11, P265, DOI 10.1038/nrendo.2015.36; Brown RSE, 2016, J NEUROSCI, V36, P9173, DOI 10.1523/JNEUROSCI.1471-16.2016; Brown RSE, 2010, J COMP NEUROL, V518, P92, DOI 10.1002/cne.22208; Buckley AR, 2001, LUPUS, V10, P684, DOI 10.1191/096120301717164912; Castrique E, 2010, J ENDOCRINOL, V205, P49, DOI 10.1677/JOE-09-0414; Chanson P, 2017, PITUITARY, 4TH EDITION, P467, DOI 10.1016/B978-0-12-804169-7.00016-7; Clevenger CV, 2003, ENDOCR REV, V24, P1, DOI 10.1210/er.2001-0036; Ding KS, 2017, ENDOCRINOLOGY, V158, P1595, DOI 10.1210/en.2016-1903; Ferraris J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097383; Ferraris J, 2012, AM J PHYSIOL-ENDOC M, V302, pE356, DOI 10.1152/ajpendo.00333.2011; Grattan DR, 2008, J NEUROENDOCRINOL, V20, P752, DOI 10.1111/j.1365-2826.2008.01736.x; Grattan DR, 2015, J ENDOCRINOL, V226, pT101, DOI 10.1530/JOE-15-0213; Grattan DR, 2001, ENDOCRINOLOGY, V142, P3935, DOI 10.1210/en.142.9.3935; Guillou A, 2015, ENDOCRINOLOGY, V156, P1924, DOI 10.1210/en.2014-1571; Hodson DJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1612; Huang C, 2009, ENDOCRINOLOGY, V150, P1618, DOI 10.1210/en.2008-1003; Jin L, 1997, J CLIN ENDOCR METAB, V82, P963, DOI 10.1210/jc.82.3.963; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; Le Tissier P, 2017, NAT REV ENDOCRINOL, V13, P257, DOI 10.1038/nrendo.2016.193; MohanKumar PS, 2001, J NEUROENDOCRINOL, V13, P261, DOI 10.1046/j.1365-2826.2001.00621.x; Molitch ME, 2017, JAMA-J AM MED ASSOC, V317, P516, DOI 10.1001/jama.2016.19699; MOREL G, 1994, NEUROENDOCRINOLOGY, V59, P78, DOI 10.1159/000126641; Nevalainen MT, 1997, J CLIN INVEST, V99, P618, DOI 10.1172/JCI119204; Schuff KG, 2002, J CLIN INVEST, V110, P973, DOI 10.1172/JCI200215912; Sonigo C, 2012, J CLIN INVEST, V122, P3791, DOI 10.1172/JCI63937; Yip SH, 2012, J NEUROENDOCRINOL, V24, P1484, DOI 10.1111/j.1365-2826.2012.02357.x	32	10	10	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4791	4797		10.1096/fj.201701111RR	http://dx.doi.org/10.1096/fj.201701111RR			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29596024				2022-12-26	WOS:000443817700014
J	Lim, JM; Lim, JC; Kim, G; Levine, RL				Lim, Jung Mi; Lim, Jung Chae; Kim, Geumsoo; Levine, Rodney L.			Myristoylated methionine sulfoxide reductase A is a late endosomal protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endosome; methionine; oxidation-reduction (redox); oxidative stress; protein myristoylation; methionine sulfoxide reductase A; STARD3	HIGH-DENSITY-LIPOPROTEINS; OXIDATIVE STRESS; APOLIPOPROTEINS AI; ESCHERICHIA-COLI; DAMAGE; CELLS; RESIDUES; COMPLEX; DOMAIN; ACTIN	Methionine residues in proteins provide antioxidant defense by reacting with oxidizing species, which oxidize methionine to methionine sulfoxide. Reduction of the sulfoxide back to methionine is catalyzed by methionine sulfoxide reductases, essential for protection against oxidative stress. The nonmyristoylated form of methionine sulfoxide reductase A (MSRA) is present in mitochondria, whereas the myristoylated form has been previously reported to be cytosolic. Despite the importance of MSRA in antioxidant defense, its in vivo binding partners and substrates have not been identified. Starting with a protein array, and followed by immunoprecipitation experiments, colocalization studies, and subcellular fractionation, we identified the late endosomal protein, StAR-related lipid transfer domain-containing 3 (STARD3), as a binding partner of myristoylated MSRA, but not of nonmyristoylated MSRA. STARD3 is known to have both membrane-binding and cytosolic domains that are important in STARD3-mediated transport of cholesterol from the endoplasmic reticulum to the endosome. We found that the STARD3 cytosolic domain localizes MSRA to the late endosome. We propose that the previous conclusion that myristoylated MSRA is strictly a cytosolic protein is artifactual and likely due to vigorous overexpression of MSRA. We conclude that myristoylated MSRA is a late endosomal protein that may play a role in lipid metabolism or may protect endosomal proteins from oxidative damage.	[Lim, Jung Mi; Lim, Jung Chae; Kim, Geumsoo; Levine, Rodney L.] NHLBI, Biochem Lab, NIH, Bldg 3, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Levine, RL (corresponding author), NHLBI, NIH, Bldg 50 Rm 2351, Bethesda, MD 20892 USA.	rlevine@nih.gov			National Institutes of Health NHLBI intramural research program [ZIA HL000225]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000225] Funding Source: NIH RePORTER	National Institutes of Health NHLBI intramural research program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health NHLBI intramural research program (Grant ZIA HL000225). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alpy F, 2005, J BIOL CHEM, V280, P17945, DOI 10.1074/jbc.M500723200; Alpy F, 2001, J BIOL CHEM, V276, P4261, DOI 10.1074/jbc.M006279200; Alpy F, 2014, BIOCHIMIE, V96, P85, DOI 10.1016/j.biochi.2013.09.015; APFFEL A, 1995, J CHROMATOGR A, V712, P177, DOI 10.1016/0021-9673(95)00175-M; Bender A, 2008, P NATL ACAD SCI USA, V105, P16496, DOI 10.1073/pnas.0802779105; Benoit SL, 2016, J BIOL CHEM, V291, P23366, DOI 10.1074/jbc.M116.747881; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; Chen J, 2014, FREE RADICAL BIO MED, V77, P57, DOI 10.1016/j.freeradbiomed.2014.08.016; Cole NB, 2010, EXP GERONTOL, V45, P596, DOI 10.1016/j.exger.2010.01.016; Donaldson JG, 2005, BBA-MOL CELL RES, V1744, P364, DOI 10.1016/j.bbamcr.2005.03.001; Douglas T, 2004, J BACTERIOL, V186, P3590, DOI 10.1128/JB.186.11.3590-3598.2004; Garcia-Bermudez M, 2012, SCAND J RHEUMATOL, V41, P350, DOI 10.3109/03009742.2012.677063; Garner B, 1998, J BIOL CHEM, V273, P6080, DOI 10.1074/jbc.273.11.6080; Garner B, 1998, J BIOL CHEM, V273, P6088, DOI 10.1074/jbc.273.11.6088; Ghesquiere B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006866; Gu HY, 2013, CLIN BIOCHEM, V46, P1668, DOI 10.1016/j.clinbiochem.2013.07.011; Horvath MP, 2016, ACTA CRYSTALLOGR F, V72, P609, DOI 10.1107/S2053230X16010694; Hung RJ, 2013, NAT CELL BIOL, V15, P1445, DOI 10.1038/ncb2871; Hung RJ, 2011, SCIENCE, V334, P1710, DOI 10.1126/science.1211956; Kim G, 2010, J BIOL CHEM, V285, P18085, DOI 10.1074/jbc.M110.119701; Kim HY, 2005, BIOCHEMISTRY-US, V44, P8059, DOI 10.1021/bi0501131; LAVINE TF, 1947, J BIOL CHEM, V169, P477; Lee BC, 2013, MOL CELL, V51, P397, DOI 10.1016/j.molcel.2013.06.019; Lee BC, 2009, BBA-GEN SUBJECTS, V1790, P1471, DOI 10.1016/j.bbagen.2009.04.014; Lee JY, 2014, J CELL SCI, V127, P4234, DOI 10.1242/jcs.152470; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Levine RL, 2006, RAPID COMMUN MASS SP, V20, P1828, DOI 10.1002/rcm.2519; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lim JC, 2013, FREE RADICAL BIO MED, V61, P257, DOI 10.1016/j.freeradbiomed.2013.04.004; Lim JC, 2012, J BIOL CHEM, V287, P25589, DOI 10.1074/jbc.M112.368936; Lim JC, 2011, P NATL ACAD SCI USA, V108, P10472, DOI 10.1073/pnas.1101275108; Mahawar M, 2011, J BIOL CHEM, V286, P19159, DOI 10.1074/jbc.M111.223677; Moskovitz J, 1997, P NATL ACAD SCI USA, V94, P9585, DOI 10.1073/pnas.94.18.9585; Moskovitz J, 1998, P NATL ACAD SCI USA, V95, P14071, DOI 10.1073/pnas.95.24.14071; MOSKOVITZ J, 1995, J BACTERIOL, V177, P502, DOI 10.1128/jb.177.3.502-507.1995; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Perricone N, 1999, ARCH GERONTOL GERIAT, V29, P45, DOI 10.1016/S0167-4943(99)00022-9; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Romero HM, 2004, PLANT PHYSIOL, V136, P3784, DOI 10.1104/pp.104.046656; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Salmon AB, 2009, FASEB J, V23, P3601, DOI 10.1096/fj.08-127415; Sigalov AB, 1998, FEBS LETT, V433, P196, DOI 10.1016/S0014-5793(98)00908-9; St John G, 2001, P NATL ACAD SCI USA, V98, P9901; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Thermo Fisher Scientific, 2015, PROTOARRAY APPL GUID; Toennies G, 1939, J BIOL CHEM, V128, P399; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Ubbink M, 2009, FEBS LETT, V583, P1060, DOI 10.1016/j.febslet.2009.02.046; Valley CC, 2012, J BIOL CHEM, V287, P34979, DOI 10.1074/jbc.M112.374504; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; Walker LR, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-015-0066-2; Wang XY, 2016, ADV NUTR, V7, p773S, DOI 10.3945/an.115.010991; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; Wilhelm LP, 2017, EMBO J, V36, P1412, DOI 10.15252/embj.201695917; Xu YY, 2015, J LIPID RES, V56, P1891, DOI 10.1194/jlr.M058776; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P1159, DOI 10.1073/pnas.0308215100; Zhao H, 2011, AM J PHYSIOL-HEART C, V301, pH1513, DOI 10.1152/ajpheart.00441.2011	58	9	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7355	7366		10.1074/jbc.RA117.000473	http://dx.doi.org/10.1074/jbc.RA117.000473			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29593096	Green Published, hybrid			2022-12-26	WOS:000432174500028
J	Mathew, MP; Donaldson, JG				Mathew, Mohit P.; Donaldson, Julie G.			Distinct cargo-specific response landscapes underpin the complex and nuanced role of galectin-glycan interactions in clathrin-independent endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosylation; endocytosis; membrane trafficking; major histocompatibility complex (MHC); galectin; CD59; clathrin-independent endocytosis (CIE); galectin 3; galectin lattice; macropinocytosis	PLASMA-MEMBRANE; CANCER BIOMARKERS; UNIQUE PLATFORM; GLYCOSYLATION; METASTASIS; EXPRESSION; CELLS; SECRETION; BETA-1-INTEGRINS; MACROPHAGES	Clathrin-independent endocytosis (CIE) is a form of endocytosis that lacks a defined cytoplasmic machinery. Here, we asked whether glycan interactions, acting from the outside, could be a part of that endocytic machinery. We show that the perturbation of global cellular patterns of protein glycosylation by modulation of metabolic flux affects CIE. Interestingly, these changes in glycosylation had cargo-specific effects. For example, in HeLa cells, GlcNAc treatment, which increases glycan branching, increased major histocompatibility complex class I (MHCI) internalization but inhibited CIE of the glycoprotein CD59 molecule (CD59). The effects of knocking down the expression of galectin 3, a carbohydrate-binding protein and an important player in galectin-glycan interactions, were also cargo-specific and stimulated CD59 uptake. By contrast, inhibition of all galectin-glycan interactions by lactose inhibited CIE of both MHCI and CD59. None of these treatments affected clathrin-mediated endocytosis, implying that glycosylation changes specifically affect CIE. We also found that the galectin lattice tailors membrane fluidity and cell spreading. Furthermore, changes in membrane dynamics mediated by the galectin lattice affected macropinocytosis, an altered form of CIE, in HT1080 cells. Our results suggest that glycans play an important and nuanced role in CIE, with each cargo being affected uniquely by alterations in galectin and glycan profiles and their interactions. We conclude that galectin-driven effects exist on a continuum from stimulatory to inhibitory, with distinct CIE cargo proteins having unique response landscapes and with different cell types starting at different positions on these conceptual landscapes.	[Mathew, Mohit P.; Donaldson, Julie G.] NHLBI, Cell Biol & Physiol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Mathew, MP (corresponding author), NHLBI, Cell Biol & Physiol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	mohit.mathew@nih.gov		Mathew, Mohit/0000-0001-7049-6660	NHLBI, National Institutes of Health, Intramural Research Program Grant [HL006130]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006130] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health, Intramural Research Program Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI, National Institutes of Health, Intramural Research Program Grant HL006130. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamczyk B, 2012, BBA-GEN SUBJECTS, V1820, P1347, DOI 10.1016/j.bbagen.2011.12.001; Almaraz RT, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M112.017558; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; Bresalier RS, 1998, GASTROENTEROLOGY, V115, P287, DOI 10.1016/S0016-5085(98)70195-7; Day CA, 2012, CURR PROTOC CYTOM, V2, DOI DOI 10.1002/0471142956.CY0219S62; Dennis JW, 2009, TRAFFIC, V10, P1569, DOI 10.1111/j.1600-0854.2009.00981.x; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; Donaldson JG, 2009, CELL SIGNAL, V21, P1, DOI 10.1016/j.cellsig.2008.06.020; Fritsch K, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2546-0; Furtak V, 2001, BIOCHEM BIOPH RES CO, V289, P845, DOI 10.1006/bbrc.2001.6064; Hakomori S, 1996, CANCER RES, V56, P5309; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Henderson NC, 2008, AM J PATHOL, V172, P288, DOI 10.2353/ajpath.2008.070726; Howes MT, 2010, CURR OPIN CELL BIOL, V22, P519, DOI 10.1016/j.ceb.2010.04.001; Huang EY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.120; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Johannes L, 2016, J MOL BIOL, V428, P4792, DOI 10.1016/j.jmb.2016.10.027; Johannes L, 2015, NAT REV MOL CELL BIO, V16, P311, DOI 10.1038/nrm3968; Kannagi R, 2004, CANCER SCI, V95, P377, DOI 10.1111/j.1349-7006.2004.tb03219.x; Kim HJ, 2013, HUM PATHOL, V44, P62, DOI 10.1016/j.humpath.2012.04.010; Kim YJ, 1997, GLYCOCONJUGATE J, V14, P569, DOI 10.1023/A:1018580324971; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Lakshminarayan R, 2014, NAT CELL BIOL, V16, P592, DOI 10.1038/ncb2970; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Mathew MP, 2016, ONCOTARGET, V7, P66491, DOI 10.18632/oncotarget.11582; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mechref Y, 2012, BIOANALYSIS, V4, P2457, DOI 10.4155/bio.12.246; Nabi IR, 2015, J CELL SCI, V128, P2213, DOI 10.1242/jcs.151159; Ochieng J, 2002, GLYCOCONJUGATE J, V19, P527, DOI 10.1023/B:GLYC.0000014082.99675.2f; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Patterson RJ, 2002, GLYCOCONJUGATE J, V19, P499, DOI 10.1023/B:GLYC.0000014079.87862.c7; Porat-Shliom N, 2008, MOL BIOL CELL, V19, P765, DOI 10.1091/mbc.E07-08-0841; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Reis CA, 2010, J CLIN PATHOL, V63, P322, DOI 10.1136/jcp.2009.071035; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; Santiago-Gomez A, 2013, BBA-MOL CELL RES, V1833, P2045, DOI 10.1016/j.bbamcr.2013.04.017; Takenaka Y, 2002, GLYCOCONJUGATE J, V19, P543, DOI 10.1023/B:GLYC.0000014084.01324.15; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; van Stijn CMW, 2009, MOL IMMUNOL, V46, P3292, DOI 10.1016/j.molimm.2009.07.026	48	14	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7222	7237		10.1074/jbc.RA118.001802	http://dx.doi.org/10.1074/jbc.RA118.001802			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29581232	Green Published, hybrid			2022-12-26	WOS:000432174500014
J	Huang, Y; Wang, DF; Zhang, JY; Guo, F				Huang, Yu; Wang, Dongfeng; Zhang, Jinying; Guo, Feng			Controlling and synchronizing a fractional-order chaotic system using stability theory of a time-varying fractional-order system	PLOS ONE			English	Article							PROJECTIVE SYNCHRONIZATION; ADAPTIVE SYNCHRONIZATION	Control and synchronization of fractional-order chaotic systems have attracted wide attention due to their numerous potential applications. To get suitable control method and parameters for fractional-order chaotic systems, the stability analysis of time-varying fractional-order systems should be discussed in the first place. Therefore, this paper analyzes the stability of the time-varying fractional-order systems and presents a stability theorem for the system with the order 0 <alpha < 1. This theorem is a sufficient condition which can discriminate the stability of time-varying systems conveniently. Feedback controllers are designed for control and synchronization of the fractional-order Lu chaotic system. The simulation results demonstrate the effectiveness of the proposed theorem.	[Huang, Yu; Wang, Dongfeng] North China Elect Power Univ, Dept Automat, Baoding, Peoples R China; [Zhang, Jinying] Shenhua Guohua Elect Power Res Inst Corp, Beijing, Peoples R China; [Guo, Feng] Xiamen Univ, Sch Informat Sci & Engn, Dept Cognit Sci, Xiamen, Peoples R China	North China Electric Power University; Xiamen University	Guo, F (corresponding author), Xiamen Univ, Sch Informat Sci & Engn, Dept Cognit Sci, Xiamen, Peoples R China.	betop@xmu.edu.cn			National Key R&D Program of China [2016YFB0600701]; Fundamental Fund for the Central Universities of China [2015MS66]	National Key R&D Program of China; Fundamental Fund for the Central Universities of China	This work was supported by the National Key R&D Program of China (2016YFB0600701) and the Fundamental Fund for the Central Universities of China under Grant 2015MS66. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguila-Camacho N, 2014, COMMUN NONLINEAR SCI, V19, P2951, DOI 10.1016/j.cnsns.2014.01.022; Bao HB, 2015, NONLINEAR DYNAM, V82, P1343, DOI 10.1007/s11071-015-2242-7; Boulkroune A, 2016, NEUROCOMPUTING, V173, P606, DOI 10.1016/j.neucom.2015.08.003; Global S., 2014, NONLINEAR DYNAM, V77, P1251; Golmankhaneh AK, 2015, J VIB CONTROL, V21, P1154, DOI 10.1177/1077546313494953; Jajarmi A, 2017, CHAOS SOLITON FRACT, V99, P285, DOI 10.1016/j.chaos.2017.04.025; Li CL, 2016, INT J SYST SCI, V47, P2440, DOI 10.1080/00207721.2014.998741; Li LX, 2013, PROBLEM ANAL STABILI; Li RH, 2014, NONLINEAR DYNAM, V76, P785, DOI 10.1007/s11071-013-1169-0; Li Y, 2010, COMPUT MATH APPL, V59, P1810, DOI 10.1016/j.camwa.2009.08.019; Lu JH, 2005, IEEE T AUTOMAT CONTR, V50, P841, DOI 10.1109/TAC.2005.849233; Maheri M, 2016, NONLINEAR DYNAM, V85, P825, DOI 10.1007/s11071-016-2726-0; Nourian A, 2016, PRAMANA-J PHYS, V86, P1401, DOI 10.1007/s12043-015-1178-2; Oustaloup A, 1993, SYST ENG SERV HUM C, P136; Pakzad MA, 2015, IET CONTROL THEORY A, V9, P2357, DOI 10.1049/iet-cta.2014.1188; Razminia A, 2013, MECHATRONICS, V23, P873, DOI 10.1016/j.mechatronics.2013.02.004; Semary MS, 2016, INT J CIRC THEOR APP, V44, P2114, DOI 10.1002/cta.2215; Shao SY, 2016, NONLINEAR DYNAM, V83, P1855, DOI 10.1007/s11071-015-2450-1; Soukkou A, 2016, NONLINEAR DYNAM, V85, P2183, DOI 10.1007/s11071-016-2823-0; TORVIK PJ, 1984, J APPL MECH-T ASME, V51, P294, DOI 10.1115/1.3167615; Wang Z, 2004, J DONGHUA U, V21, P6; Wang Zhen-Bin, 2004, Control and Decision, V19, P1171; Wu GC, 2014, SIGNAL PROCESS, V102, P96, DOI 10.1016/j.sigpro.2014.02.022; Xiang W, 2011, COMMUN NONLINEAR SCI, V16, P2970, DOI 10.1016/j.cnsns.2010.11.022; Yang CC, 2012, J FRANKLIN I, V349, P349, DOI 10.1016/j.jfranklin.2011.11.013; Zhang RX, 2012, NONLINEAR DYNAM, V69, P983, DOI 10.1007/s11071-011-0320-z; Zhou P, 2012, INDIAN J PHYS, V86, P497, DOI 10.1007/s12648-012-0073-7; Zhu ZW, 2000, IEEE T CIRCUITS-I, V47, P1072, DOI 10.1109/81.855462	28	7	8	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0194112	10.1371/journal.pone.0194112	http://dx.doi.org/10.1371/journal.pone.0194112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601587	gold, Green Published, Green Submitted			2022-12-26	WOS:000428845900004
J	Kogelman, B; Khmelinskii, A; Verhaart, I; van Vliet, L; Bink, DI; Aartsma-Rus, A; van Putten, M; van der Weerd, L				Kogelman, Bauke; Khmelinskii, Artem; Verhaart, Ingrid; van Vliet, Laura; Bink, Diewertje I.; Aartsma-Rus, Annemieke; van Putten, Maaike; van der Weerd, Louise			Influence of full-length dystrophin on brain volumes in mouse models of Duchenne muscular dystrophy	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; CENTRAL-NERVOUS-SYSTEM; INTELLECTUAL IMPAIRMENT; MDX; GENE; DIFFUSION; BEHAVIOR; MALES; CA1; DYSFUNCTION	Duchenne muscular dystrophy (DMD) affects besides muscle also the brain, resulting in memory and behavioral problems. The consequences of dystrophinopathy on gross macroscopic alterations are unclear. To elucidate the effect of full-length dystrophin expression on brain morphology, we used high-resolution post-mortem MRI in mouse models that either express 0% (mdx), 100% (BL10) or a low amount of full-length dystrophin (mdx-Xist(Delta hs)). While absence or low amounts of full-length dystrophin did not significantly affect whole brain volume and skull morphology, we found differences in volume of individual brain structures. The results are in line with observations in humans, where whole brain volume was found to be reduced only in patients lacking both full-length dystrophin and the shorter isoform Dp140.	[Kogelman, Bauke; Bink, Diewertje I.; van der Weerd, Louise] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Khmelinskii, Artem] Leiden Univ, Med Ctr, Dept Radiol, Div Image Proc, Leiden, Netherlands; [Khmelinskii, Artem] Percuros BV, Enschede, Netherlands; [Verhaart, Ingrid; van Vliet, Laura; Aartsma-Rus, Annemieke; van Putten, Maaike; van der Weerd, Louise] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Bink, Diewertje I.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	van der Weerd, L (corresponding author), Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands.; van der Weerd, L (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands.	l.van_der_weerd@lumc.nl	Verhaart, Ingrid/Y-2588-2018; Bink, D/AAW-8005-2020; van der Weerd, Louise/B-5421-2014; Khmelinskii, Artem/L-3714-2013	Verhaart, Ingrid/0000-0001-7348-7989; Kogelman, Bauke/0000-0001-8868-5515; Aartsma-Rus, Annemieke/0000-0003-1565-654X; Khmelinskii, Artem/0000-0002-2665-7380; van der Weerd, Louise/0000-0002-5997-2125; van Putten, Maaike/0000-0002-0683-8897; Bink, Diewertje/0000-0003-1389-1677	European Union Bioimage-NMD project; Seventh Framework Programme (FP7) [602485]; Percuros B.V. by the FP7 European Union Marie Curie IAPP Program; BRAINPATH [612360]; Percuros B.V.	European Union Bioimage-NMD project; Seventh Framework Programme (FP7)(European Commission); Percuros B.V. by the FP7 European Union Marie Curie IAPP Program; BRAINPATH; Percuros B.V.	BK was supported European Union Bioimage-NMD project (http://www.bioimage-nmd.eu), Seventh Framework Programme (FP7/2007-2013) under grant 602485. AK was supported by Percuros B.V. by the FP7 European Union Marie Curie IAPP Program, BRAINPATH (http://www.brainpath.eu), under grant 612360. The funder Percuros B.V. provided support in the form of salaries for author AK, but did not, as all other funders, have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AHN AH, 1993, NAT GENET, V3, P283, DOI 10.1038/ng0493-283; ALQUDAH AA, 1990, PEDIATR NEUROL, V6, P57, DOI 10.1016/0887-8994(90)90081-B; Austin RC, 2000, NEUROMUSCULAR DISORD, V10, P187, DOI 10.1016/S0960-8966(99)00105-4; BAR S, 1990, BIOCHEM J, V272, P557, DOI 10.1042/bj2720557; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENTSON J, 1978, J COMPUT ASSIST TOMO, V2, P16, DOI 10.1097/00004728-197801000-00003; Botteron S, 2009, ARCH ORAL BIOL, V54, P26, DOI 10.1016/j.archoralbio.2008.07.012; Brown ES, 2008, BIOL PSYCHIAT, V63, P705, DOI 10.1016/j.biopsych.2007.09.014; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Byron CD, 2006, ARCH ORAL BIOL, V51, P396, DOI 10.1016/j.archoralbio.2005.09.006; Chapman C, 2006, J CLIN NEUROSCI, V13, P636, DOI 10.1016/j.jocn.2005.08.012; Chaussenot R, 2015, NEUROBIOL LEARN MEM, V124, P111, DOI 10.1016/j.nlm.2015.07.006; Cotton S, 2001, DEV MED CHILD NEUROL, V43, P497, DOI 10.1017/S0012162201000913; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; Doorenweerd N, 2017, SCI REPORTS, V7, P1; Doorenweerd N, 2014, ANN NEUROL, V76, P403, DOI 10.1002/ana.24222; DSOUZA VN, 1995, HUM MOL GENET, V4, P837, DOI 10.1093/hmg/4.5.837; Eckardt L, 1996, AM J ORTHOD DENTOFAC, V110, P185, DOI 10.1016/S0889-5406(96)70107-5; Felisari G, 2000, NEUROLOGY, V55, P559, DOI 10.1212/WNL.55.4.559; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Goodnough CL, 2014, NEUROIMAGE, V102, P809, DOI 10.1016/j.neuroimage.2014.08.053; Goodwin F, 1997, Eur J Paediatr Neurol, V1, P115, DOI 10.1016/S1090-3798(97)80042-6; Hendriksen JGM, 2006, PEDIATR NEUROL, V34, P296, DOI 10.1016/j.pediatrneurol.2005.08.029; Hendriksen JGM, 2008, J CHILD NEUROL, V23, P477, DOI 10.1177/0883073807309775; Hendriksen RGF, 2015, NEUROSCI BIOBEHAV R, V51, P255, DOI 10.1016/j.neubiorev.2015.01.023; Johnson GA, 2010, NEUROIMAGE, V53, P365, DOI 10.1016/j.neuroimage.2010.06.067; Khmelinskii a, 2013, VISUALIZATION PLATFO, V8672; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kohler M, 2005, AM J RESP CRIT CARE, V172, P1032, DOI 10.1164/rccm.200503-322OC; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LIDOV HGW, 1995, HUM MOL GENET, V4, P329, DOI 10.1093/hmg/4.3.329; LIDOV HGW, 1993, NEUROSCIENCE, V54, P167, DOI 10.1016/0306-4522(93)90392-S; Lidov HGW, 1996, BRAIN PATHOL, V6, P63, DOI 10.1111/j.1750-3639.1996.tb00783.x; Miranda R, 2009, CEREB CORTEX, V19, P876, DOI 10.1093/cercor/bhn135; Miranda R, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0053-9; MOMOSE KJ, 1971, RADIOLOGY, V99, P341, DOI 10.1148/99.2.341; MOSER H, 1984, HUM GENET, V66, P17, DOI 10.1007/BF00275183; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Muntoni F, 1991, Neuromuscul Disord, V1, P121, DOI 10.1016/0960-8966(91)90059-2; Newall AET, 2001, HUM MOL GENET, V10, P581, DOI 10.1093/hmg/10.6.581; Pane M, 2013, NEUROMUSCULAR DISORD, V23, P313, DOI 10.1016/j.nmd.2013.01.011; Pane M, 2012, J PEDIATR-US, V161, P705, DOI 10.1016/j.jpeds.2012.03.020; Passamano Luigia, 2012, Acta Myol, V31, P121; PAXINOS G, 1985, J NEUROSCI METH, V13, P139, DOI 10.1016/0165-0270(85)90026-3; Perronnet C, 2010, J BIOMED BIOTECHNOL, V2010, P1, DOI DOI 10.1155/2010/849426; Perronnet C, 2012, HUM MOL GENET, V21, P2263, DOI 10.1093/hmg/dds047; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Remmelink E, 2016, GENES BRAIN BEHAV, V15, P558, DOI 10.1111/gbb.12301; Renaud S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-28; Sekiguchi M, 2009, BRAIN, V132, P124, DOI 10.1093/brain/awn253; Sesay AK, 1996, NEUROSCI LETT, V211, P207, DOI 10.1016/0304-3940(96)12747-6; Snow WM, 2013, NEUROSCI BIOBEHAV R, V37, P743, DOI 10.1016/j.neubiorev.2013.03.016; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; Straathof CSM, 2014, J CHILD NEUROL, V29, P1344, DOI 10.1177/0883073813518106; Sunkin SM, 2013, NUCL ACIDS RES, V41; Team RC, 2016, R LANG ENV STAT COMP; Team Rs, 2016, RSTUDIO INT DEV ENV; Tozawa T, 2012, MOL NEUROBIOL, V45, P287, DOI 10.1007/s12035-012-8233-5; Ueda H, 2000, HISTOL HISTOPATHOL, V15, P753, DOI 10.14670/HH-15.753; Ueki K, 2007, J ORAL MAXIL SURG, V65, P34, DOI 10.1016/j.joms.2005.11.108; Vaillend C, 1998, NEUROSCIENCE, V86, P53, DOI 10.1016/S0306-4522(98)00023-2; Vaillend C, 2004, NEUROBIOL DIS, V17, P10, DOI 10.1016/j.nbd.2004.05.004; VAILLEND C, 1995, BEHAV GENET, V25, P569, DOI 10.1007/BF02327580; van Putten M, 2014, J MOL CELL CARDIOL, V69, P17, DOI 10.1016/j.yjmcc.2014.01.009; van Putten M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031937; Veeravagu A, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/2/E16; Xu S, 2015, MATH PROBL ENG, V2015, P1, DOI DOI 10.1186/1758-2946-7-S1-S11; YOSHIOKA M, 1980, ARCH DIS CHILD, V55, P589, DOI 10.1136/adc.55.8.589; Young HK, 2008, J CHILD NEUROL, V23, P155, DOI 10.1177/0883073807307975; Zanardi VA, 2001, CLIN RHEUMATOL, V20, P245, DOI 10.1007/s100670170037	73	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0194636	10.1371/journal.pone.0194636	http://dx.doi.org/10.1371/journal.pone.0194636			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601589	Green Submitted, Green Published, gold			2022-12-26	WOS:000428845900008
J	Lee, HJ; Choi, EK; Lee, SH; Kim, YJ; Han, KD; Oh, S				Lee, Hyun-Jung; Choi, Eue-Keun; Lee, Seung-Hwan; Kim, Yong-Jin; Han, Kyung-Do; Oh, Seil			Risk of ischemic stroke in metabolically healthy obesity: A nationwide population-based study	PLOS ONE			English	Article							BODY-MASS INDEX; INCIDENT CARDIOVASCULAR-DISEASE; ATRIAL-FIBRILLATION; ORAL ANTICOAGULANTS; HEMORRHAGIC STROKE; PROSPECTIVE COHORT; NORMAL-WEIGHT; MORTALITY; OVERWEIGHT; ADIPOSITY	Background Whether metabolically healthy obese (MHO) individuals are at increased risk of ischemic stroke is not well known. We investigated the association of the MHO phenotype with ischemic stroke. Methods A total of 354,083 adults (age 45.8 +/- 14.2 years) from the Korean National Health Insurance Service +/- National Sample Cohort enrolled in 2004 +/- 2008 were followed-up for incident ischemic stroke until 2013. Subjects meeting none of the metabolic syndrome criteria were classified as 'metabolically healthy'. The cohort was categorized into four groups according to obesity and metabolic status: metabolically healthy normal weight (MHNW), metabolically unhealthy normal weight (MUNW), MHO, and metabolically unhealthy obese (MUO). Results Ischemic stroke was newly diagnosed in 4,884 (1.4%) individuals during a mean follow-up of 7.4 +/- 1.5 years. Stroke incidence rates for the MHNW, MUNW, MHO, and MUO groups were 0.56, 2.61, 0.61, and 2.76 per 1,000 person-years, respectively. While risk for stroke increased significantly in metabolically unhealthy groups, it was not increased in MHO compared to the MHNW group on multivariate analysis. In metabolically healthy individuals, obesity did not increase the risk for ischemic stroke, regardless of the severity of obesity. Meanwhile, in metabolically unhealthy individuals, being obese was significantly associated with increased risk of stroke. Conclusions MHO individuals were not at increased risk for ischemic stroke. However, obesity increased risk for ischemic stroke in persons with metabolic risk factors; therefore, maintaining normal weight may be more important for this population. Also, metabolic unhealthiness showed greater association than obesity with stroke.	[Lee, Hyun-Jung; Choi, Eue-Keun; Kim, Yong-Jin; Oh, Seil] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Lee, Seung-Hwan] Catholic Univ Korea, Div Endocrinol & Metab, Dept Internal Med, Seoul St Marys Hosp,Coll Med, Seoul, South Korea; [Han, Kyung-Do] Catholic Univ Korea, Dept Biostat, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Choi, EK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.	choiek17@snu.ac.kr	Oh, Seil/J-5539-2012; Choi, Eue-Keun/J-5968-2014; Choi, Eue-Keun/K-3752-2019	Oh, Seil/0000-0002-2504-9615; Choi, Eue-Keun/0000-0002-0411-6372; Lee, Hyun-Jung/0000-0002-7498-0705	Seoul National University Hospital Research Fund [0620160680]; National Research Foundation of Korea at Ministry of Education, Science and Technology [2014R1A1A2A16055218]; Korean Healthcare Technology R&D project at the Ministry of Health Welfare [HI15C1200]	Seoul National University Hospital Research Fund; National Research Foundation of Korea at Ministry of Education, Science and Technology; Korean Healthcare Technology R&D project at the Ministry of Health Welfare	This work was supported by the Seoul National University Hospital Research Fund [grant 0620160680]; the National Research Foundation of Korea at Ministry of Education, Science and Technology [grant 2014R1A1A2A16055218]; and the Korean Healthcare Technology R&D project at the Ministry of Health & Welfare [grant HI15C1200], received by EK Choi.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Appleton SL, 2013, DIABETES CARE, V36, P2388, DOI 10.2337/dc12-1971; Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Aung K, 2014, J CLIN ENDOCR METAB, V99, P462, DOI 10.1210/jc.2013-2832; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Cha MJ, 2017, STROKE, V48, P3040, DOI 10.1161/STROKEAHA.117.018773; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guo FJ, 2016, OBESITY, V24, P516, DOI 10.1002/oby.21344; Hinnouho GM, 2015, EUR HEART J, V36, P551, DOI 10.1093/eurheartj/ehu123; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Kang SH, 2017, CIRC J, V81, P1158, DOI 10.1253/circj.CJ-16-1267; Kang SH, 2016, INT J CARDIOL, V215, P449, DOI 10.1016/j.ijcard.2016.04.036; Kim KI, 2016, KOREAN CIRC J, V46, P275, DOI 10.4070/kcj.2016.46.3.275; Kroll ME, 2016, NEUROLOGY, V87, P1473; Lee H, 2017, INT J CARDIOL, V240, P221, DOI 10.1016/j.ijcard.2017.03.103; Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319; Lee SW, 2016, KOREAN CIRC J, V46, P507, DOI 10.4070/kcj.2016.46.4.507; Lee SR, 2016, INT J CARDIOL, V223, P953, DOI 10.1016/j.ijcard.2016.08.296; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; McNeill AM, 2005, DIABETES CARE, V28, P385, DOI 10.2337/diacare.28.2.385; Ogorodnikova AD, 2012, OBESITY, V20, P651, DOI 10.1038/oby.2011.243; Ortega FB, 2016, CIRC RES, V118, P1752, DOI 10.1161/CIRCRESAHA.115.306883; Ortega FB, 2016, MAYO CLIN PROC, V91, P443, DOI 10.1016/j.mayocp.2016.01.008; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Sanchez-Inigo L, 2017, INT J STROKE, V12, P187, DOI 10.1177/1747493016672083; Song SO, 2014, DIABETES METAB J, V38, P395, DOI 10.4093/dmj.2014.38.5.395; Song YM, 2004, STROKE, V35, P831, DOI 10.1161/01.STR.0000119386.22691.1C; Strazzullo P, 2010, STROKE, V41, pE418, DOI 10.1161/STROKEAHA.109.576967; van Vliet-Ostaptchouk JV, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-9; Wang CX, 2013, INT J STROKE, V8, P245, DOI 10.1111/j.1747-4949.2012.00830.x; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617	35	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195210	10.1371/journal.pone.0195210	http://dx.doi.org/10.1371/journal.pone.0195210			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601602	Green Published, gold, Green Submitted			2022-12-26	WOS:000428845900024
J	Tong, HL; Miyake, Y; Mi-ichi, F; Iwakura, Y; Hara, H; Yoshida, H				Tong, Honglian; Miyake, Yasunobu; Mi-ichi, Fumika; Iwakura, Yoichiro; Hara, Hiromitsu; Yoshida, Hiroki			Apaf1 plays a negative regulatory role in T cell responses by suppressing activation of antigen-stimulated T cells	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; CYTOCHROME-C; DIFFERENTIAL REQUIREMENT; CASPASE ACTIVATION; APOPTOSIS; PROTEIN; DEATH; PROCASPASE-9; INHIBITION; PATHWAYS	Apaf1 is a critical component of the apoptosome and initiates apoptosis downstream mitochondrial damages. Although the importance of Apaf1 in embryonic development was shown, the role of Apaf1 in immune responses, especially T cell responses, has yet to be elucidated. We generated T cell-specific Apaf1-deficient mice (Lck-Cre-Apaf1(f/f) mice) and examined the antigen-specific delayed-type hypersensitivity (DTH). Lck-Cre-Apaf1(f/f) mice exhibited exacerbation of DTH responses as compared with Apaf1-sufficient control mice. In Lck-Cre-Apaf1(f/f) mice, antigen-specific T cells proliferated more, and produced more inflammatory cytokines than control T cells. Apaf1-deficient T cells from antigen-immunized mice showed higher percentages of activation phenotypes upon restimulation in vitro. Apaf1-deficient T cells from naive (non-immunized) mice also showed higher proliferation activity and cytokine production over control cells. The impact of Apaf1-deficiency in T cells, however, was not restored by a pan-caspase inhibitor, suggesting that the role of Apaf1 in T cell responses was caspase-independent/non-apoptotic. These data collectively demonstrated that Apaf1 is a negative regulator of T cell responses and implicated Apaf1 as a potential target for immunosuppressive drug discovery.	[Tong, Honglian; Miyake, Yasunobu; Mi-ichi, Fumika; Hara, Hiromitsu; Yoshida, Hiroki] Saga Univ, Fac Med, Dept Biomol Sci, Div Mol & Cellular Immunosci, Saga, Japan; [Iwakura, Yoichiro] Tokyo Univ Sci, Ctr Expt Anim Models, Inst Biomed Sci, Chiba, Japan; [Hara, Hiromitsu] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Immunol, Kagoshima, Japan	Saga University; Tokyo University of Science; Kagoshima University	Yoshida, H (corresponding author), Saga Univ, Fac Med, Dept Biomol Sci, Div Mol & Cellular Immunosci, Saga, Japan.	yoshidah@cc.saga-u.ac.jp	Mi-ichi, Fumika/O-9668-2015	Hiroki, Yoshida/0000-0003-3447-117X; Mi-ichi, Fumika/0000-0001-7042-2266				Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Bouillet P, 2009, NAT REV IMMUNOL, V9, P514, DOI 10.1038/nri2570; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chau BN, 2000, MOL CELL, V6, P31, DOI 10.1016/S1097-2765(00)00005-8; Cho DH, 2004, J BIOL CHEM, V279, P39942, DOI 10.1074/jbc.M405747200; Chu ZL, 2001, J BIOL CHEM, V276, P9239, DOI 10.1074/jbc.M006309200; De Zio D, 2015, INT J DEV BIOL, V59, P33, DOI 10.1387/ijdb.150047dd; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; Doerfler P, 2000, J IMMUNOL, V164, P4071, DOI 10.4049/jimmunol.164.8.4071; Ferraro E, 2011, J CELL SCI, V124, P3450, DOI 10.1242/jcs.086298; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; Hara H, 2002, J IMMUNOL, V168, P2288, DOI 10.4049/jimmunol.168.5.2288; Jagot-Lacoussiere L, 2015, CELL CYCLE, V14, P1242, DOI 10.1080/15384101.2015.1014148; Jia L, 2001, BLOOD, V98, P414, DOI 10.1182/blood.V98.2.414; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Lawrence CP, 2012, TOXICOL APPL PHARM, V265, P103, DOI 10.1016/j.taap.2012.09.002; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Mondragon L, 2009, APOPTOSIS, V14, P182, DOI 10.1007/s10495-008-0310-x; Pandey P, 2000, EMBO J, V19, P4310, DOI 10.1093/emboj/19.16.4310; Reiner SL, 2009, NAT REV IMMUNOL, V9, P81, DOI 10.1038/nri2490; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Shakeri R, 2017, BIOCHIMIE, V135, P111, DOI 10.1016/j.biochi.2017.02.001; Tong H, 2010, IMMUNOL LETT, V128, P108, DOI 10.1016/j.imlet.2010.01.001; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Yoshida H, 2002, CELL DEATH DIFFER, V9, P1273, DOI 10.1038/sj.cdd.4401128; Zermati Y, 2007, MOL CELL, V28, P624, DOI 10.1016/j.molcel.2007.09.030; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	30	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195119	10.1371/journal.pone.0195119	http://dx.doi.org/10.1371/journal.pone.0195119			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596528	Green Published, Green Submitted, gold			2022-12-26	WOS:000428630000078
J	Xi, T; Zhang, GZ				Xi, Ting; Zhang, Guizhi			Integrated analysis of tumor differentiation genes in pancreatic adenocarcinoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CANCER STEM-CELLS; EXPRESSION; SOMATOSTATIN; REPLICATION; PROGRESSION; CARCINOMA; BREAST; OVEREXPRESSION; PROLIFERATION	Background Tumor differentiation is an important process in the development of cancer. It is valuable to identify key differentiation related genes in the prognosis and therapy of pancreatic adenocarcinoma. Methods The mRNA expression data were downloaded from the Cancer Genome Atlas database. Then, differentially expressed tumor differentiation related genes were identified. Additionally, Gene Ontology functional categories and Kyoto Encyclopedia of Genes and Genomes biochemical pathway was used to explore the function. In addition, receiver operating characteristic and survival analysis were carried out to assess the diagnosis and prognosis value. Finally, the electronic validation of selected tumor differentiation related genes was performed. Results A total of 932 genes were identified. Among which, 8 genes including JUB, ERLIN1, HMGA2, FAM110B, EGFR, MCM2, TCTA and SSTR1 were differentially expressed in all different tumor differentiation grades. Functional analysis revealed those genes between highly differentiated and other differentiation were remarkably enriched in pancreatic adenocarcinoma and cell cycle pathway. Finally, ERLIN1, HMGA2, FAM110B, EGFR, MCM2, BCL2L1, E2F1 and RAC1 were associated with the survival time of pancreatic adenocarcinoma patient. Among these genes, JUB, ERLIN1, FAM110B, MCM2 and BCL2L1 also had a diagnosis value for pancreatic adenocarcinoma. Additionally, the expression trend of JUB, HMGA2 and MCM2 was increased along with the tumor differentiation grades. And the expression trend of FAM110B was decreased along with the tumor differentiation grades. The electronic validation result was consistent with the bioinformatics analysis. Conclusions 12 tumor differentiation related genes including JUB, ERLIN1, HMGA2, FAM110B, EGFR, MCM2, TCTA, SSTR1, BCL2L1, E2F1, RAC1 and STAT1 played crucial roles in the differentiation of pancreatic adenocarcinoma.	[Xi, Ting] First Peoples Hosp Liaocheng, Dept Gastroenterol, Liaocheng, Shandong, Peoples R China; [Zhang, Guizhi] Second Peoples Hosp Liaocheng, Dept Gastroenterol, Liaocheng, Shandong, Peoples R China		Xi, T (corresponding author), First Peoples Hosp Liaocheng, Dept Gastroenterol, Liaocheng, Shandong, Peoples R China.	xitinglc@163.com						Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Anand A, 2000, NAT GENET, V24, P377, DOI 10.1038/74207; APLAN PD, 1995, CANCER RES, V55, P1917; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; ASHAR HR, 1995, CELL, V82, P57; Bousquet C, 2001, CHEMOTHERAPY, V47, P30, DOI 10.1159/000049159; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Bruns CJ, 2000, CLIN CANCER RES, V6, P1936; Chiariello M, 2001, NAT CELL BIOL, V3, P580, DOI 10.1038/35078555; Crnogorac-Jurcevic T, 2001, ONCOGENE, V20, P7437, DOI 10.1038/sj.onc.1204935; DeVita Prasad S., 2015, DEVITA HELLMAN ROSEN; Ebert MPA, 2001, J CANCER RES CLIN, V127, P449, DOI 10.1007/s004320100235; FRIESS H, 1993, GASTROENTEROLOGY, V105, P1846, DOI 10.1016/0016-5085(93)91084-U; Garcea G, 2008, J PANCREAS, V9, P99; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Gray PJ, 2004, MOL CANCER THER, V3, P641; Hauge H, 2007, GENOMICS, V90, P14, DOI 10.1016/j.ygeno.2007.03.002; Hejna M, 2002, ANN ONCOL, V13, P653, DOI 10.1093/annonc/mdf142; Hinz S, 2000, ONCOGENE, V19, P5477, DOI 10.1038/sj.onc.1203936; Hristov AC, 2009, MODERN PATHOL, V22, P43, DOI 10.1038/modpathol.2008.140; Johnson DG, 2000, MOL CARCINOGEN, V27, P151, DOI 10.1002/(SICI)1098-2744(200003)27:3<151::AID-MC1>3.0.CO;2-C; Kaistha BP, 2014, BRIT J CANCER, V111, P1780, DOI 10.1038/bjc.2014.460; Kim HK, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-48; Komura T, 2015, CANCER SCI, V106, P672, DOI 10.1111/cas.12663; La Thangue NB, 2003, NAT CELL BIOL, V5, P587, DOI 10.1038/ncb0703-587; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lei M, 2001, J CELL SCI, V114, P1447; Li M, 2008, CANCER SCI, V99, P2218, DOI 10.1111/j.1349-7006.2008.00940.x; Liu R, 1999, AM J PATHOL, V155, P1861, DOI 10.1016/S0002-9440(10)65505-8; Long J, 2016, MOL MED REP, V13, P3779, DOI 10.3892/mmr.2016.5007; Matsubayashi H, 2003, CLIN CANCER RES, V9, P1446; Nakamura T, 2007, CANCER RES, V67, P139, DOI 10.1158/0008-5472.CAN-06-2563; Nanke Y, 2014, CENT EUR J IMMUNOL, V39, P468, DOI 10.5114/ceji.2014.47730; Nola S, 2011, J CELL BIOL, V195, P855, DOI 10.1083/jcb.201107162; Ochs C, 2016, J BIOINF COMPUT BIOL, V14, DOI 10.1142/S0219720016420014; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Oncology TL, 2014, LANCET ONCOLOGY, V15, P586; Ouellet V, 2006, INT J CANCER, V119, P599, DOI 10.1002/ijc.21902; Pan JJ, 2011, J GASTROINTEST ONCOL, V2, P151, DOI 10.3978/j.issn.2078-6891.2011.022; Park SJ, 2015, INT J CLIN EXP PATHO, V8, P8298; Roberts NJ, 2016, CANCER DISCOV, V6, P166, DOI 10.1158/2159-8290.CD-15-0402; Ruark E, 2013, NATURE, V493, P406, DOI 10.1038/nature11725; Sarkar FH, 2009, MINERVA CHIR, V64, P489; Sato N, 2004, AM J PATHOL, V164, P903, DOI 10.1016/S0002-9440(10)63178-1; Satoh K, 1998, PANCREAS, V16, P468, DOI 10.1097/00006676-199805000-00002; Shetty A, 2005, BRIT J CANCER, V93, P1295, DOI 10.1038/sj.bjc.6602829; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Stoeber K, 2001, J CELL SCI, V114, P2027; Sun Y, 2014, PANCREAS, V43, P619, DOI 10.1097/MPA.0000000000000074; Thakur A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-11; Trauzold A, 2005, FASEB J, V19, P620, DOI 10.1096/fj.04-2984fje; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Walczak H, 2000, CANCER RES, V60, P3051; Wang P, 2014, ONCOGENE, V33, P514, DOI 10.1038/onc.2012.598; Weichert W, 2005, PANCREATOLOGY, V5, P259, DOI 10.1159/000085280; Widschwendter A, 2002, CLIN CANCER RES, V8, P3065; YAMANAKA Y, 1993, ANTICANCER RES, V13, P565; Yamazaki K, 2003, PATHOL RES PRACT, V199, P23, DOI 10.1078/0344-0338-00348; Yin ZQ, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-49	60	8	8	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0193427	10.1371/journal.pone.0193427	http://dx.doi.org/10.1371/journal.pone.0193427			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596435	Green Published, gold, Green Submitted			2022-12-26	WOS:000428630000009
J	Kfir, S; Basavaraja, R; Wigoda, N; Ben-Dor, S; Orr, I; Meidan, R				Kfir, Sigal; Basavaraja, Raghavendra; Wigoda, Noa; Ben-Dor, Shifra; Orr, Irit; Meidan, Rina			Genomic profiling of bovine corpus luteum maturation	PLOS ONE			English	Article							SIMULATED EARLY-PREGNANCY; ACUTE REGULATORY PROTEIN; ENDOTHELIAL-CELLS; ESTROUS-CYCLE; MENSTRUAL-CYCLE; CORPORA-LUTEA; PRIMATE OVARY; IMMUNE CELLS; ANGIOGENESIS; EXPRESSION	To unveil novel global changes associated with corpus luteum (CL) maturation, we analyzed transcriptome data for the bovine CL on days 4 and 11, representing the developing vs. mature gland. Our analyses revealed 681 differentially expressed genes (363 and 318 on day 4 and 11, respectively), with >= 2 fold change and FDR of <5%. Different gene ontology (GO) categories were represented prominently in transcriptome data at these stages (e.g. days 4: cell cycle, chromosome, DNA metabolic process and replication and on day 11: immune response; lipid metabolic process and complement activation). Based on bioinformatic analyses, select genes expression in day 4 and 11 CL was validated with quantitative real-time PCR. Cell specific expression was also determined in enriched luteal endothelial and steroidogenic cells. Genes related to the angiogenic process such as NOS3, which maintains dilated vessels and MMP9, matrix degrading enzyme, were higher on day 4. Importantly, our data suggests day 11 CL acquire mechanisms to prevent blood vessel sprouting and promote their maturation by expressing NOTCH4 and JAG1, greatly enriched in luteal endothelial cells. Another endothelial specific gene, CD300LG, was identified here in the CL for the first time. CD300LG is an adhesion molecule enabling lymphocyte migration, its higher levels at mid cycle are expected to support the transmigration of immune cells into the CL at this stage. Together with steroidogenic genes, most of the genes regulating de-novo cholesterol biosynthetic pathway (e.g HMGCS, HMGCR) and cholesterol uptake from plasma (LDLR, APOD and APOE) were upregulated in the mature CL. These findings provide new insight of the processes involved in CL maturation including blood vessel growth and stabilization, leucocyte transmigration as well as progesterone synthesis as the CL matures.	[Kfir, Sigal; Basavaraja, Raghavendra; Wigoda, Noa; Meidan, Rina] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Anim Sci, Rehovot, Israel; [Ben-Dor, Shifra; Orr, Irit] Weizmann Inst Sci, Dept Life Sci Core Facil, Bioinformat Unit, Rehovot, Israel	Hebrew University of Jerusalem; Weizmann Institute of Science	Meidan, R (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Anim Sci, Rehovot, Israel.	rina.meidan@mail.huji.ac.il	Basavaraja, Raghavendra/M-3000-2019; BEN-DOR, SHIFRA/M-6718-2019	Basavaraja, Raghavendra/0000-0002-8656-2615; BEN-DOR, SHIFRA/0000-0001-9604-1939; Wigoda, Noa/0000-0002-4496-881X	BARD (Binational Agricultural Research & Development Fund) [IS-3987-07]	BARD (Binational Agricultural Research & Development Fund)	This research was supported by grant No. IS-3987-07 from the BARD (Binational Agricultural Research & Development Fund). The grant was awarded to RM and funding played no role in the planning, writing, and decision to submit this manuscript.	Accialini P, 2015, REPRODUCTION, V149, P1, DOI 10.1530/REP-14-0449; Bauer M, 2001, REPRODUCTION, V121, P297, DOI 10.1530/rep.0.1210297; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bridges E, 2011, FUTURE ONCOL, V7, P569, DOI [10.2217/FON.11.20, 10.2217/fon.11.20]; Byrnes RW, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-99; CHEN HW, 1984, FED PROC, V43, P126; Christenson LK, 1996, ENDOCRINOLOGY, V137, P367, DOI 10.1210/en.137.1.367; CLARK BJ, 1995, MOL ENDOCRINOL, V9, P1346, DOI 10.1210/me.9.10.1346; COLLINS T, 1991, J BIOL CHEM, V266, P2466; DRISCOLL DM, 1984, J LIPID RES, V25, P1368; Fraser HM, 2012, ENDOCRINOLOGY, V153, P1972, DOI 10.1210/en.2011-1688; Fraser HM, 2001, REPROD FERT DEVELOP, V13, P557, DOI 10.1071/RD01055; Garcia-Pascual CM, 2013, FERTIL STERIL, V100, P1768, DOI 10.1016/j.fertnstert.2013.08.034; HANSEL W, 1991, J REPROD FERTIL, P77; HAUGER RL, 1977, ENDOCRINOLOGY, V101, P807, DOI 10.1210/endo-101-3-807; Hernandez F, 2011, BIOL REPROD, V84, P859, DOI 10.1095/biolreprod.110.088708; JABLONKASHARIFF A, 1993, ENDOCRINOLOGY, V133, P1871, DOI 10.1210/en.133.4.1871; James AC, 2014, BBA-MOL CELL RES, V1843, P1272, DOI 10.1016/j.bbamcr.2014.03.015; Jiang YF, 2011, ANIM REPROD SCI, V129, P152, DOI 10.1016/j.anireprosci.2011.12.004; JOHANSSON ED, 1969, ACTA ENDOCRINOL-COP, V61, P592, DOI 10.1530/acta.0.0610592; Kapourchali FR, 2015, CRITICAL REV FOOD SC; Kearney JB, 2004, BLOOD, V103, P4527, DOI 10.1182/blood-2003-07-2315; Klipper E, 2004, REPRODUCTION, V128, P463, DOI 10.1530/rep.1.00271; Klipper E, 2009, ENDOCRINOLOGY, V150, P413, DOI 10.1210/en.2008-0697; Krakowiak PA, 2003, HUM MOL GENET, V12, P1631, DOI 10.1093/hmg/ddg172; Kume T, 2012, ADV EXP MED BIOL, V727, P210, DOI 10.1007/978-1-4614-0899-4_16; Leong KG, 2002, MOL CELL BIOL, V22, P2830, DOI 10.1128/MCB.22.8.2830-2841.2002; Levy N, 2003, BIOL REPROD, V68, P1361, DOI 10.1095/biolreprod.102.009134; Levy N, 2001, ENDOCRINOLOGY, V142, P5254, DOI 10.1210/en.142.12.5254; MARES SE, 1962, J ANIM SCI, V21, P266, DOI 10.2527/jas1962.212266x; MARSDEN PA, 1992, FEBS LETT, V307, P287, DOI 10.1016/0014-5793(92)80697-F; MEIDAN R, 1990, BIOL REPROD, V43, P913, DOI 10.1095/biolreprod43.6.913; Meidan R, 2005, DOMEST ANIM ENDOCRIN, V29, P318, DOI 10.1016/j.domaniend.2005.04.003; Meidan R, 1997, SEMIN REPROD ENDOCR, V15, P371, DOI 10.1055/s-2008-1068375; MILLER WL, 1988, ENDOCR REV, V9, P295, DOI 10.1210/edrv-9-3-295; Mondal M, 2011, PHYSIOL GENOMICS, V43, P447, DOI 10.1152/physiolgenomics.00155.2010; Nio-Kobayashi J, 2015, MOL HUMAN REPROD; Niswender GD, 2000, PHYSIOL REV, V80, P1, DOI 10.1152/physrev.2000.80.1.1; OSHEA JD, 1989, J REPROD FERTIL, V85, P483, DOI 10.1530/jrf.0.0850483; Penny LA, 1999, J REPROD FERTIL, V115, P87, DOI 10.1530/jrf.0.1150087; Pescador N, 1996, BIOL REPROD, V55, P485, DOI 10.1095/biolreprod55.2.485; Rahimi N, 2006, FRONT BIOSCI-LANDMRK, V11, P818; RAINEY WE, 1992, STEROIDS, V57, P167, DOI 10.1016/0039-128X(92)90003-R; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Rizzo A, 2016, RES VET SCI, V109, P56, DOI 10.1016/j.rvsc.2016.08.006; Robinson RS, 2007, BIOL REPROD, V77, P28, DOI 10.1095/biolreprod.106.055434; Robker RL, 2000, STEROIDS, V65, P559, DOI 10.1016/S0039-128X(00)00114-8; RODGERS RJ, 1987, MOL ENDOCRINOL, V1, P172, DOI 10.1210/mend-1-2-172; RODGERS RJ, 1987, MOL ENDOCRINOL, V1, P274, DOI 10.1210/mend-1-3-274; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shirasuna K, 2013, REPROD FERT DEVELOP, V25, P351, DOI 10.1071/RD12096; Singh J, 1997, J REPROD FERTIL, V109, P35, DOI 10.1530/jrf.0.1090035; Sugino N, 2005, J CLIN ENDOCR METAB, V90, P6141, DOI 10.1210/jc.2005-0643; Takatsu H, 2006, BIOCHEM BIOPH RES CO, V348, P183, DOI 10.1016/j.bbrc.2006.07.047; Townson DH, 2002, BIOL REPROD, V66, P361, DOI 10.1095/biolreprod66.2.361; Umemoto E, 2006, J EXP MED, V203, P1603, DOI 10.1084/jem.20052543; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; Vorontchikhina MA, 2005, GENE EXPR PATTERNS, V5, P701, DOI 10.1016/j.modgep.2005.02.001; Walusimbi SS, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.114.117564; Wilcox CB, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-223; WILTBANK MC, 1988, J REPROD FERTIL, V84, P513, DOI 10.1530/jrf.0.0840513; WILTBANK MC, 1994, J ANIM SCI, V72, P1873, DOI 10.2527/1994.7271873x; Woad KJ, 2016, THERIOGENOLOGY, V86, P221, DOI 10.1016/j.theriogenology.2016.04.035; Wulff C, 2001, HUM REPROD, V16, P2515, DOI 10.1093/humrep/16.12.2515; Zalman Y, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095067	66	23	23	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194456	10.1371/journal.pone.0194456	http://dx.doi.org/10.1371/journal.pone.0194456			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590145	Green Submitted, Green Published, gold			2022-12-26	WOS:000428603100059
J	Buimer, HP; Bittner, M; Kostelijk, T; van der Geest, TM; Nemri, A; van Wezel, RJA; Zhao, Y				Buimer, Hendrik P.; Bittner, Marian; Kostelijk, Tjerk; van der Geest, Thea M.; Nemri, Abdellatif; van Wezel, Richard J. A.; Zhao, Yan			Conveying facial expressions to blind and visually impaired persons through a wearable vibrotactile device	PLOS ONE			English	Article							SUBSTITUTION; VALIDATION	In face-to-face social interactions, blind and visually impaired persons (VIPs) lack access to nonverbal cues like facial expressions, body posture, and gestures, which may lead to impaired interpersonal communication. In this study, a wearable sensory substitution device (SSD) consisting of a head mounted camera and a haptic belt was evaluated to determine whether vibrotactile cues around the waist could be used to convey facial expressions to users and whether such a device is desired by VIPs for use in daily living situations. Ten VIPs (mean age: 38.8, SD: 14.4) and 10 sighted persons (SPs) (mean age: 44.5, SD: 19.6) participated in the study, in which validated sets of pictures, silent videos, and videos with audio of facial expressions were presented to the participant. A control measurement was first performed to determine how accurately participants could identify facial expressions while relying on their functional senses. After a short training, participants were asked to determine facial expressions while wearing the emotion feedback system. VIPs using the device showed significant improvements in their ability to determine which facial expressions were shown. A significant increase in accuracy of 44.4% was found across all types of stimuli when comparing the scores of the control (mean SEM: 35.0 +/- 2.5%) and supported (mean SEM: 79.4 +/- 2.1%) phases. The greatest improvements achieved with the support of the SSD were found for silent stimuli (68.3% for pictures and 50.8% for silent videos). SPs also showed consistent, though not statistically significant, improvements while supported. Overall, our study shows that vibrotactile cues are well suited to convey facial expressions to VIPs in real-time. Participants became skilled with the device after a short training session. Further testing and development of the SSD is required to improve its accuracy and aesthetics for potential daily use.	[Buimer, Hendrik P.; Bittner, Marian; Nemri, Abdellatif; van Wezel, Richard J. A.; Zhao, Yan] Univ Twente, MIRA Inst, Dept Biomed Signals & Syst, Enschede, Netherlands; [Buimer, Hendrik P.; van Wezel, Richard J. A.] Radboud Univ Nijmegen, Dept Biophys, Donders Inst, Nijmegen, Netherlands; [Kostelijk, Tjerk] VicarVision, Amsterdam, Netherlands; [van der Geest, Thea M.] Univ Twente, Dept Media Commun & Org, Enschede, Netherlands; [van der Geest, Thea M.] HAN Univ Appl Sci, Dept Media & Design, Arnhem, Netherlands	University of Twente; Radboud University Nijmegen; University of Twente	Buimer, HP (corresponding author), Univ Twente, MIRA Inst, Dept Biomed Signals & Syst, Enschede, Netherlands.; Buimer, HP (corresponding author), Radboud Univ Nijmegen, Dept Biophys, Donders Inst, Nijmegen, Netherlands.	h.buimer@donders.ru.nl	van Wezel, Richard R J/G-4455-2011	van Wezel, Richard R J/0000-0001-5753-7069; Nemri, Abdellatif/0000-0003-1459-5634; Buimer, Hendrik/0000-0002-2798-8595	Stichting voor de Technische Wetenschappen (STW): Take Off [15666]; Oost NV: INTERREG-project MIND (Medische Innovaties Nederland Duitsland) [122035]; Netherlands Organisation for Health Research and Development (ZonMW): Inzicht [94211004]; VicarVision	Stichting voor de Technische Wetenschappen (STW): Take Off; Oost NV: INTERREG-project MIND (Medische Innovaties Nederland Duitsland); Netherlands Organisation for Health Research and Development (ZonMW): Inzicht; VicarVision	The research was funded by: Stichting voor de Technische Wetenschappen (STW): Take Off - Grant number: 15666, http://www.stw.nl/takeoff; Oost NV: INTERREG-project MIND (Medische Innovaties Nederland Duitsland) - Grant number: 122035, http://www.oostnv.nl/page/ grensoverschrijdende-medische-innovaties-mind; and The Netherlands Organisation for Health Research and Development (ZonMW): Inzicht - Grant number - 94211004, https://www.zonmw.nl/ en/research-and-results/handicap-andchronicdisease/programmas/programme-detail/insight/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Tjerk Kostelijk is employed by VicarVision, which developed the FaceReader software used in this study. VicarVision provided support in the form of salary for author TK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section	Abboud S, 2014, RESTOR NEUROL NEUROS, V32, P247, DOI 10.3233/RNN-130338; [Anonymous], 2013, FRONT HUM NEUROSCI; BACHYRITA P, 1967, ACTA NEUROL SCAND, V43, P417, DOI 10.1111/j.1600-0404.1967.tb05747.x; BachyRita P, 2003, TRENDS COGNITIVE SCI; Broerse J, 2015, BRAIN SCI; Danilov Yuri, 2005, Journal of Integrative Neuroscience, V4, P537, DOI 10.1142/S0219635205000914; DenUyl MJ, 2005, P NATL ACAD SCI US; Ekman P., 1970, CALIFORNIA MENTAL HL, V8, P151, DOI DOI 10.1016/J.SOC.2010.04.003; Elli GV, 2014, MULTISENS RES, V27, P271, DOI 10.1163/22134808-00002460; Ernst M. O., 2006, HUMAN BODY PERCEPTIO, P105; Fischer ME, 2009, OPHTHAL EPIDEMIOL, V16, P346, DOI 10.3109/09286580903312236; Hakobyan L, 2013, SURV OPHTHALMOL, V58, P513, DOI 10.1016/j.survophthal.2012.10.004; Hanassy S, 2013, MULTISENS RES, V26, P116; Hawk ST, 2009, EMOTION, V9, P293, DOI 10.1037/a0015178; Johannesson OI, 2017, EXP BRAIN RES, V235, P3505, DOI 10.1007/s00221-017-5073-6; Johannesson OI, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6030020; Jones LA, 2008, HUM FACTORS, V50, P90, DOI 10.1518/001872008X250638; Kaczmarek KA, 2011, SCI IRAN, V18, P1476, DOI 10.1016/j.scient.2011.08.020; Karcher SM, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00037; Krishna S, 2008, OPHTHALMIC EPIDEMIOL; Krishna S, 2005, ACM SIGACCESS C COMP, P106; Krishna S., 2010, CHI 10 EXTENDED ABST, P3637; Lewinski P, 2014, J NEUROSCI PSYCHOL E, V7, P227, DOI 10.1037/npe0000028; Lima CF, 2013, BEHAV RES METHODS, V45, P1234, DOI 10.3758/s13428-013-0324-3; McDaniel Troy, 2014, Universal Access in Human-Computer Interaction. Design and Development Methods for Universal Access. 8th International Conference, UAHCI 2014, Held as Part of HCI International 2014. Proceedings: LNCS 8513, P419, DOI 10.1007/978-3-319-07437-5_40; McDaniel T.L., 2009, CHI 09 HUM FACT COMP, P4669, DOI DOI 10.1145/1520340.1520718; McDaniel T, 2008, 2008 IEEE INTERNATIONAL WORKSHOP ON HAPTIC AUDIO VISUAL ENVIRONMENTS AND THEIR APPLICATIONS, P13, DOI 10.1109/HAVE.2008.4685291; Meijer PBL, 1992, IEEE T BIOMEDICAL EN, P112; Naraine MD, 2011, DISABIL SOC, V26, P389, DOI 10.1080/09687599.2011.567790; Nummenmaa L, 2014, P NATL ACAD SCI USA, V111, P646, DOI 10.1073/pnas.1321664111; Olszanowski M, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01516; Panchanathan S, 2016, IEEE J-STSP, V10, P942, DOI 10.1109/JSTSP.2016.2543681; Papadopoulos K, 2011, RES DEV DISABIL, V32, P1086, DOI 10.1016/j.ridd.2011.01.021; Spence C, 2014, MULTISENS RES, V27, P293, DOI 10.1163/22134808-00002452; ur Rehman Shafiq, 2008, Journal of Multimedia, V3, P18, DOI 10.4304/jmm.3.3.18-25; Van der Geest T. M., 2015, MENSCH COMPUTER 2015, P383; van der Schalk J, 2011, EMOTION, V11, P907, DOI 10.1037/a0023853; Van Erp J.B., 2002, PROC EUROHAPTICS, V2002, P18; vanErp JBF, EMOTION, P80; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb; Wang YL, 2016, INT J HUM-COMPUT ST, V89, P24, DOI 10.1016/j.ijhcs.2016.01.004	41	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194737	10.1371/journal.pone.0194737	http://dx.doi.org/10.1371/journal.pone.0194737			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA5KQ	29584738	Green Published, Green Submitted, gold			2022-12-26	WOS:000428373000033
J	Dhaouadi, T; Chahbi, M; Haouami, Y; Sfar, M; Abdelmoula, L; Ben Abdallah, T; Gorgi, Y				Dhaouadi, Tarak; Chahbi, Mayssa; Haouami, Youssra; Sfar, Men; Abdelmoula, Leila; Ben Abdallah, Taieb; Gorgi, Yousr			IL-17A, IL-17RC polymorphisms and IL17 plasma levels in Tunisian patients with rheumatoid arthritis	PLOS ONE			English	Article							GENE POLYMORPHISMS; HOST-DEFENSE; T-CELLS; ASSOCIATION; PATHOGENESIS; CYTOKINES; JOINT; MICE	Background Interleukin-17 (IL-17), a cytokine mainly secreted by Th17 cells, seems to play a significant role in the pathogenesis of rheumatoid arthritis (RA). Functional genetic polymorphisms in IL-17 and its receptor genes can influence either qualitatively or quantitatively their functions. Therefore, we aimed to study the impact of IL17-A and IL17RC polymorphisms on plasma level of IL-17 and RA susceptibility and severity. Methods In this context, IL-17A*rs2275913 and IL-17RC*rs708567 polymorphisms were investigated together with the quantification of IL17 plasma level in 115 RA patients and 91 healthy control subjects matched in age, sex and ethnic origin. Results There were no statistically significant associations between IL-17A and IL-17RC studied polymorphisms and RA susceptibility. In contrast, IL-17A plasma levels were significantly higher in patients (55.07 pg/ml) comparatively to controls (4.75 pg/ml), p<10E-12. A ROC curve was used to evaluate the performance of plasma IL-17 in detecting RA. Given 100% specificity, the highest sensitivity of plasma IL-17A was 61.7% at a cut-off value of 18.25 pg/ml; p < 10E-21, CI = [0.849-0.939]. Analytic results showed that the IgM-rheumatoid factor and anti-CCP antibodies were significantly less frequent in patients with the IL-17RC*A/A genotype than those carrying *G/G and *G/A genotypes; p = 0.013 and p = 0.015, respectively. Otherwise, IL-17 plasma levels analysis showed a significant association with the activity of RA (DAS28 >= 5.1 = 74.71 pg/ml vs. DAS28<5.1 = 11.96 pg/ml), p<10E-6. Conclusion IL-17A*rs2275913 (G/A) and IL-17RC*rs708567 (G/A) polymorphisms did not seem to influence RA susceptibility in Tunisian population. This result agrees with those reported previously. Plasma IL-17A level seems to be predictive of severe RA occurrence.	[Dhaouadi, Tarak; Chahbi, Mayssa; Haouami, Youssra; Sfar, Men; Ben Abdallah, Taieb; Gorgi, Yousr] Charles Nicolle Hosp, Res Lab Immunol Renal Transplantat & Immunopathol, Tunis, Tunisia; [Abdelmoula, Leila] Charles Nicolle Hosp, Dept Rheumatol, Tunis, Tunisia	Universite de Tunis-El-Manar; Hopital Charles Nicolle; Universite de Tunis-El-Manar; Hopital Charles Nicolle	Dhaouadi, T (corresponding author), Charles Nicolle Hosp, Res Lab Immunol Renal Transplantat & Immunopathol, Tunis, Tunisia.	dhaouaditarak@yahoo.fr	Dhaouadi, Tarak/O-2170-2019; Dhaouadi, Tarak/W-7013-2018	Dhaouadi, Tarak/0000-0002-6376-0950; Dhaouadi, Tarak/0000-0002-6376-0950; CHEIKHROUHOU ABDELMOULA, Leila/0000-0003-2000-4415; dhaouadi, tarak/0000-0003-1698-6938	Research Laboratory in Immunology of Renal Transplantation and Immunopathology, Charles Nicolle Hospital, Tunis El Manar University, Tunisia [LR03SP01]	Research Laboratory in Immunology of Renal Transplantation and Immunopathology, Charles Nicolle Hospital, Tunis El Manar University, Tunisia	This study was granted and supported by the Research Laboratory in Immunology of Renal Transplantation and Immunopathology (LR03SP01), Charles Nicolle Hospital, Tunis El Manar University, Tunisia.	Aletaha D, 2010, ARTHRITIS RHEUM, V62; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Azizi G, 2013, INT J RHEUM DIS, V16, P243, DOI 10.1111/1756-185X.12132; Bogunia-Kubik K, 2015, ARCH IMMUNOL THER EX, V63, P215, DOI 10.1007/s00005-014-0319-5; Carvalho CN, 2016, CLIN ORAL INVEST, V20, P495, DOI 10.1007/s00784-015-1540-2; Chen DY, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3431; Cope AP, 2007, CLIN EXP RHEUMATOL, V25, pS4; Dong WJ, 2012, AUTOIMMUN REV, V11, P844, DOI 10.1016/j.autrev.2012.02.019; Dunstan SJ, 2012, GENES IMMUN, V13, P503, DOI 10.1038/gene.2012.25; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Geremia A, 2012, EXPERT REV GASTROENT, V6, P223, DOI [10.1586/EGH.11.107, 10.1586/egh.11.107]; Gullick NJ, 2013, CLIN EXP IMMUNOL, V174, P292, DOI 10.1111/cei.12167; Hu Y, 2010, J IMMUNOL, V184, P4307, DOI 10.4049/jimmunol.0903614; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Kunwar S, 2016, RHEUMATOL INT, V36, P1065, DOI 10.1007/s00296-016-3480-9; Lee Y., 2017, P IEEE ICTON 2017, P1; Lewis BJ, 2013, CLIN EXP IMMUNOL, V173, P38, DOI 10.1111/cei.12086; Louahchi S, 2016, ACTA REUMATOL PORT, V41, P151; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Lubberts E, 2002, INFLAMM RES, V51, P102, DOI 10.1007/BF02684010; Marwa OS, 2017, IMMUNOL LETT, V183, P24, DOI 10.1016/j.imlet.2017.01.013; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Niu Q, 2012, RHEUMATOL INT, V32, P2731, DOI 10.1007/s00296-011-1984-x; Nordang GBN, 2009, RHEUMATOLOGY, V48, P367, DOI 10.1093/rheumatology/ken512; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pavlovic V, 2014, J RES MED SCI, V19, P18; Pawlik A, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1064-1; Rushansky E, 2017, ARCH IMMUNOL THER EX, P25; Shah K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2964; Shen L, 2015, GENE, V566, P18, DOI 10.1016/j.gene.2015.04.028; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Wang WH, 2012, RHEUMATOL INT, V32, P887, DOI 10.1007/s00296-010-1710-0; Zhou S, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-181	35	29	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194883	10.1371/journal.pone.0194883	http://dx.doi.org/10.1371/journal.pone.0194883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584788	Green Published, Green Submitted, gold			2022-12-26	WOS:000428373000047
J	Schmidt, N; Schulze, J; Warwas, DP; Ehlert, N; Lenarz, T; Warnecke, A; Behrens, P				Schmidt, Nadeschda; Schulze, Jennifer; Warwas, Dawid P.; Ehlert, Nina; Lenarz, Thomas; Warnecke, Athanasia; Behrens, Peter			Long-term delivery of brain-derived neurotrophic factor (BDNF) from nanoporous silica nanoparticles improves the survival of spiral ganglion neurons in vitro	PLOS ONE			English	Article							MESOPOROUS SILICA; AUDITORY NEURONS; DRUG-DELIVERY; ELECTRICAL-STIMULATION; INNER-EAR; CELL SURVIVAL; NEURITE OUTGROWTH; COCHLEAR IMPLANTS; DELAYED TREATMENT; DEGENERATION	Sensorineural hearing loss (SNHL) can be overcome by electrical stimulation of spiral ganglion neurons (SGNs) via a cochlear implant (CI). Restricted CI performance results from the spatial gap between the SGNs and the electrode, but the efficacy of CI is also limited by the degeneration of SGNs as one consequence of SHNL. In the healthy cochlea, the survival of SGNs is assured by endogenous neurotrophic support. Several applications of exogenous neurotrophic supply have been shown to reduce SGN degeneration in vitro and in vivo. In the present study, nanoporous silica nanoparticles (NPSNPs), with an approximate diameter of <100 nm, were loaded with the brain-derived neurotrophic factor (BDNF) to test their efficacy as long-term delivery system for neurotrophins. The neurotrophic factor was released constantly from the NPSNPs over a release period of 80 days when the surface of the nanoparticles had been modified with amino groups. Cell culture investigations with NIH3T3 fibroblasts attest a good general cytocompatibility of the NPSNPs. In vitro experiments with SGNs indicate a significantly higher survival rate of SGNs in cell cultures that contained BDNF-loaded nanoparticles compared to the control culture with unloaded NPSNPs (p<0.001). Importantly, also the amounts of BDNF released up to a time period of 39 days increased the survival rate of SGNs. Thus, NPSNPs carrying BDNF are suitable for the treatment of inner ear disease and for the protection and the support of SGNs. Their nanoscale nature and the fact that a direct contact of the nanoparticles and the SGNs is not necessary for neuroprotective effects, should allow for the facile preparation of nanocomposites, e.g., with biocompatible polymers, to install coatings on implants for the realization of implant-based growth factor delivery systems.	[Schmidt, Nadeschda; Warwas, Dawid P.; Ehlert, Nina; Behrens, Peter] Leibniz Univ Hannover, Inst Anorgan Chem, Hannover, Germany; [Schmidt, Nadeschda; Schulze, Jennifer; Ehlert, Nina; Lenarz, Thomas; Warnecke, Athanasia; Behrens, Peter] Cluster Excellence Hearing4all, Hannover, Germany; [Schulze, Jennifer; Lenarz, Thomas; Warnecke, Athanasia] Hannover Med Sch, Dept Otorhinolaryngol Head & Neck Surg, Hannover, Germany	Leibniz University Hannover; Hannover Medical School	Behrens, P (corresponding author), Leibniz Univ Hannover, Inst Anorgan Chem, Hannover, Germany.; Behrens, P (corresponding author), Cluster Excellence Hearing4all, Hannover, Germany.	Peter.Behrens@acb.uni-hannover.de	Warnecke, Athanasia/HHC-6174-2022		DFG Cluster of Excellence [EXC 1077/1]	DFG Cluster of Excellence(German Research Foundation (DFG))	This work was supported by DFG Cluster of Excellence EXC 1077/1 "Hearing4all', http://hearing4all.eu, NS JS NE.	Agterberg MJH, 2008, HEARING RES, V244, P25, DOI 10.1016/j.heares.2008.07.004; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; Bass JD, 2007, CHEM MATER, V19, P4349, DOI 10.1021/cm071305g; Block F, 1997, NEUROREPORT, V8, P3829, DOI 10.1097/00001756-199712010-00033; Bohne BA, 2000, AM J OTOL, V21, P505; BROWN JN, 1993, HEARING RES, V70, P167, DOI 10.1016/0378-5955(93)90155-T; Bukara K, 2016, EUR J PHARM BIOPHARM, V108, P220, DOI 10.1016/j.ejpb.2016.08.020; Cauda V, 2010, MICROPOR MESOPOR MAT, V132, P60, DOI 10.1016/j.micromeso.2009.11.015; Chikar JA, 2012, BIOMATERIALS, V33, P1982, DOI 10.1016/j.biomaterials.2011.11.052; Dee K. C., 2002, INTRO TISSUE BIOMATE; Di Santo S, 2014, NEUROREPORT, V25, P446, DOI 10.1097/WNR.0000000000000112; DUPONT J, 1993, HEARING RES, V68, P217, DOI 10.1016/0378-5955(93)90125-K; El Kechai N, 2015, INT J PHARMACEUT, V494, P83, DOI 10.1016/j.ijpharm.2015.08.015; Endo T, 2005, LARYNGOSCOPE, V115, P2016, DOI 10.1097/01.mlg.0000183020.32435.59; Frick C, 2017, COLLOID SURFACE B, V149, P105, DOI 10.1016/j.colsurfb.2016.10.003; Geral Claire, 2013, Pharmaceutics, V5, P127, DOI 10.3390/pharmaceutics5010127; Gillespie LN, 2001, NEUROREPORT, V12, P275, DOI 10.1097/00001756-200102120-00019; Gillespie LN, 2003, J NEUROSCI RES, V71, P785, DOI 10.1002/jnr.10542; Gillespie LN, 2005, EUR J NEUROSCI, V22, P2123, DOI 10.1111/j.1460-9568.2005.04430.x; Hardie NA, 1999, HEARING RES, V128, P147, DOI 10.1016/S0378-5955(98)00209-3; Hartley PG, 1997, LANGMUIR, V13, P2207, DOI 10.1021/la960997c; Havenith S, 2011, HEARING RES, V272, P168, DOI 10.1016/j.heares.2010.10.003; He QJ, 2011, SMALL, V7, P271, DOI 10.1002/smll.201001459; Hudson SP, 2008, BIOMATERIALS, V29, P4045, DOI 10.1016/j.biomaterials.2008.07.007; Kandalam S, 2017, ACTA BIOMATER, V49, P167, DOI 10.1016/j.actbio.2016.11.030; Kikkawa YS, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0280-4; Kim DH, 2006, BIOMATERIALS, V27, P3031, DOI 10.1016/j.biomaterials.2005.12.021; Konerding WS, 2017, HEARING RES, V350, P110, DOI 10.1016/j.heares.2017.04.013; Kranz K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092157; Kurakhmaeva KB, 2009, J DRUG TARGET, V17, P564, DOI 10.1080/10611860903112842; Leake PA, 1999, J COMP NEUROL, V412, P543, DOI 10.1002/(SICI)1096-9861(19991004)412:4<543::AID-CNE1>3.0.CO;2-3; Leake PA, 2013, JARO-J ASSOC RES OTO, V14, P187, DOI 10.1007/s10162-013-0372-5; Leake PA, 2011, J COMP NEUROL, V519, P1526, DOI 10.1002/cne.22582; Li H, 2017, BIOMATERIALS, V122, P1, DOI 10.1016/j.biomaterials.2016.12.020; Li LL, 2017, ADV DRUG DELIVER REV, V108, P2, DOI 10.1016/j.addr.2016.01.004; Li XQ, 2010, COLLOID SURFACE B, V75, P418, DOI 10.1016/j.colsurfb.2009.09.014; Li ZX, 2012, CHEM SOC REV, V41, P2590, DOI 10.1039/c1cs15246g; LOUSTEAU RJ, 1987, LARYNGOSCOPE, V97, P836; MCDONALD NQ, 1995, J BIOL CHEM, V270, P19669, DOI 10.1074/jbc.270.34.19669; Miller JM, 1997, INT J DEV NEUROSCI, V15, P631, DOI 10.1016/S0736-5748(96)00117-7; Mohtaram NK, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/022001; Neumann A, 2013, RSC ADV, V3, P24222, DOI 10.1039/c3ra44734k; Pakulska MM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600519; Praetorius M, 2007, ACTA OTO-LARYNGOL, V127, P486, DOI 10.1080/00016480600895102; Qiao ZA, 2009, CHEM MATER, V21, P3823, DOI 10.1021/cm901335k; Ramekers D, 2015, J NEUROSCI, V35, P12331, DOI 10.1523/JNEUROSCI.0096-15.2015; Rejali D, 2007, HEARING RES, V228, P180, DOI 10.1016/j.heares.2007.02.010; Richardson RT, 2009, BIOMATERIALS, V30, P2614, DOI 10.1016/j.biomaterials.2009.01.015; Roy S, 2012, NANOMEDICINE-UK, V7, P55, DOI [10.2217/NNM.11.84, 10.2217/nnm.11.84]; Schaal SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043634; Schendzielorz P, 2018, J BIOMED MATER RES B, V106, P1431, DOI 10.1002/jbm.b.33947; Scheper V, 2009, J NEUROSCI RES, V87, P1389, DOI 10.1002/jnr.21964; Schmidt DR, 2009, BIOLOGICAL INTERACTIONS ON MATERIALS SURFACES: UNDERSTANDING AND CONTROLLING PROTEIN, CELL, AND TISSUE RESPONSES, P1, DOI 10.1007/978-0-387-98161-1_1; Senn P, 2017, OTOL NEUROTOL, V38, pE224, DOI 10.1097/MAO.0000000000001439; Shepherd RK, 2005, J COMP NEUROL, V486, P145, DOI 10.1002/cne.20564; Shibata SB, 2011, HEARING RES, V281, P56, DOI 10.1016/j.heares.2011.04.019; Slowing II, 2007, J AM CHEM SOC, V129, P8845, DOI 10.1021/ja0719780; Staecker H, 1998, OTOLARYNG HEAD NECK, V119, P7, DOI 10.1016/S0194-5998(98)70194-9; Stankovic K, 2004, J NEUROSCI, V24, P8651, DOI 10.1523/JNEUROSCI.0733-04.2004; Stover Timo, 2009, GMS Curr Top Otorhinolaryngol Head Neck Surg, V8, pDoc10, DOI 10.3205/cto000062; Tamura T, 2005, LARYNGOSCOPE, V115, P2000, DOI 10.1097/01.mlg.0000180174.81036.5a; Tan J, 2012, ADV MATER, V24, P3362, DOI 10.1002/adma.201200634; Tang FQ, 2012, ADV MATER, V24, P1504, DOI 10.1002/adma.201104763; Timpe N., 2014, BIONANOMATERIALS, V15, P89, DOI [10.1515/bnm-2014-0010, DOI 10.1515/BNM-2014-0010]; Wang JG, 2010, CHEM MATER, V22, P3829, DOI 10.1021/cm101217k; Wang YJ, 2014, SMALL, V10, P4244, DOI 10.1002/smll.201401767; Wang Y, 2015, NANOMED-NANOTECHNOL, V11, P313, DOI 10.1016/j.nano.2014.09.014; Warnecke A, 2012, HEARING RES, V289, P86, DOI 10.1016/j.heares.2012.04.007; Wefstaedt P, 2005, NEUROREPORT, V16, P2011, DOI 10.1097/00001756-200512190-00008; Wenz A., 2016, BIONANOMATERIALS, V17, P179, DOI [10.1515/bnm-2015-0018, DOI 10.1515/BNM-2015-0018, 10.1515/BNM-2015-0018]; Williams S, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5409-3; Wilson BS, 2008, J REHABIL RES DEV, V45, P695, DOI 10.1682/JRRD.2007.10.0173; Wilson BS, 2017, LANCET, V390, P2503, DOI 10.1016/S0140-6736(17)31073-5; Wise AK, 2005, J COMP NEUROL, V487, P147, DOI 10.1002/cne.20563; Wise AK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164867; Xie Y, 2005, J CONTROL RELEASE, V105, P106, DOI 10.1016/j.jconrel.2005.03.005; Zilberstein Y, 2012, J NEUROSCI, V32, P405, DOI 10.1523/JNEUROSCI.4678-11.2012; ZIMMERMANN CE, 1995, HEARING RES, V90, P192, DOI 10.1016/0378-5955(95)00165-1; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	79	44	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2018	13	3							e0194778	10.1371/journal.pone.0194778	http://dx.doi.org/10.1371/journal.pone.0194778			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5KQ	29584754	Green Published, Green Submitted, gold			2022-12-26	WOS:000428373000034
J	Aita, A; Basso, D; Ramonda, R; Moz, S; Lorenzin, M; Navaglia, F; Zambon, CF; Padoan, A; Plebani, M; Punzi, L				Aita, Ada; Basso, Daniela; Ramonda, Roberta; Moz, Stefania; Lorenzin, Mariagrazia; Navaglia, Filippo; Zambon, Carlo-Federico; Padoan, Andrea; Plebani, Mario; Punzi, Leonardo			Genetics in TNF-TNFR pathway: A complex network causing spondyloarthritis and conditioning response to anti-TNF alpha therapy	PLOS ONE			English	Article							ANKYLOSING-SPONDYLITIS; PROMOTER POLYMORPHISMS; PSORIATIC-ARTHRITIS; 1ST UPDATE; ASSOCIATION; HLA-B27; MUTATIONS; DISEASE; RECOMMENDATIONS; MANAGEMENT	Objectives We investigated whether polymorphisms (SNPs) in the promoter region of TNFA, or in the autoinflammatory TNFRSF1A and MEFV genes, concur with HLA-B27 in enhancing the risk of Spondyloarthritis (SpA) and/or in predicting the response to anti-TNF alpha treatment. Methods 373 controls and 137 SpA (82 with Psoriatic Arthritis-PsA and 55 with Ankylosing Spondylitis-AS; 98/137 under TNF alpha inhibitor therapy) from the Veneto Region (Italy) were studied. TNFA polymorphisms (-1031T>C;-857C>T;-376G>A;-308G>A;-238G>A) and HLA-B27 were assayed by RT-PCR. Direct sequencing of MEFV (exons 2,3,5 and 10) and TNFRSF1A (exons 2,3,4 and 6) genes were performed. Results HLA-B27 was associated with AS (chi(2) = 120.1; p = 0.000). Only the TNFA-1031T>C was singly associated with SpA, and the haplotype C/G, resulting from -1031T>C/-308G>A combination, was significantly associated with a reduced risk of SpA (OR: 0.67, CI: 0.46-0.97; p = 0.035). Two SNPs were identified in TNFRSF1A, the R92Q (Minor allele frequency-MAF = 0.034) and c.625+10A>G (MAF = 0.479). None of them was associated with SpA (p>0.05). The TNFRSF1A c.625+10 G allele was associated with late response to anti-TNF alpha therapy (p = 0.031). Twenty-one SNPs were identified in MEFV gene, 10 with a known potential functional significance. Variant alleles were extremely rare in our population (MAF<0.025) except for R202Q (MAF = 0.27). None was associated with SpA diagnosis (p>0.05). Conclusion TNFRSF1A and MEFVgene SNPs are not associated with SpA in the North-East of Italy. AS risk appears to depend not only on HLA-B27, but also on the protective TNFA haplotype -1031C/-308G. The TNFRSF1A c.625+10A>G impacts on the response to anti-TNF alpha therapy.	[Aita, Ada; Basso, Daniela; Moz, Stefania; Navaglia, Filippo; Padoan, Andrea; Plebani, Mario] Univ Hosp Padua, Dept Med DIMED, Lab Med, Padua, Italy; [Ramonda, Roberta; Lorenzin, Mariagrazia; Punzi, Leonardo] Univ Hosp Padua, Dept Med DIMED, Rheumatol Unit, Padua, Italy; [Zambon, Carlo-Federico] Univ Padua, Dept Biomed Sci BIOMED, Padua, Italy	University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua	Basso, D (corresponding author), Univ Hosp Padua, Dept Med DIMED, Lab Med, Padua, Italy.	daniela.basso@unipd.it	Basso, Daniela/J-7855-2016; Padoan, Andrea/J-7869-2016; Plebani, Mario/AAF-4953-2020; ZAMBON, CARLO-FEDERICO/J-8187-2016	Basso, Daniela/0000-0001-8745-6171; Padoan, Andrea/0000-0003-1284-7885; Aita, Ada/0000-0001-5497-7544; ZAMBON, CARLO-FEDERICO/0000-0002-4244-879X; moz, stefania/0000-0002-7485-520X	University of Padova [60A07-4857/15]	University of Padova	This study was supported by University of Padova (Contract number:60A07-4857/15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar S, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4154; Akkoc N, 2011, CURR RHEUMATOL REP, V13, P388, DOI 10.1007/s11926-011-0191-9; Baraliakos X, 2012, RHEUMATOLOGY, V51, P1378, DOI 10.1093/rheumatology/kes026; Bernot A, 1997, NAT GENET, V17, P25; Braun J, 2006, ANN RHEUM DIS, V65, P316, DOI 10.1136/ard.2005.040758; Braun J, 2011, ANN RHEUM DIS, V70, P896, DOI 10.1136/ard.2011.151027; Braun J, 2003, CURR OPIN RHEUMATOL, V15, P394, DOI 10.1097/00002281-200307000-00005; Brown MA, 2010, CURR OPIN RHEUMATOL, V22, P126, DOI 10.1097/BOR.0b013e3283364483; Chatzikyriakidou A, 2011, AUTOIMMUN REV, V10, P464, DOI 10.1016/j.autrev.2011.01.011; Chung WT, 2011, RHEUMATOL INT, V31, P1167, DOI 10.1007/s00296-010-1434-1; Cinar M, 2008, RHEUMATOL INT, V29, P37, DOI 10.1007/s00296-008-0637-1; Coates LC, 2016, SEMIN ARTHRITIS RHEU; Cosan F, 2010, ARTHRITIS RHEUM-US, V62, P3232, DOI 10.1002/art.27683; Durmus D, 2009, JOINT BONE SPINE, V76, P260, DOI 10.1016/j.jbspin.2008.09.011; El-Tahan RR, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3197-y; Elahi MM, 2009, BBA-MOL BASIS DIS, V1792, P163, DOI 10.1016/j.bbadis.2009.01.007; Feldtkeller E, 2003, RHEUMATOL INT, V23, P61, DOI 10.1007/s00296-002-0237-4; Garg N, 2014, BEST PRACT RES CL RH, V28, P663, DOI 10.1016/j.berh.2014.10.007; Lee YH, 2009, RHEUMATOLOGY, V48, P1359, DOI 10.1093/rheumatology/kep260; Li B, 2010, CLIN RHEUMATOL, V29, P983, DOI 10.1007/s10067-010-1499-y; Liu J, 2016, SCI REP-UK, V6, DOI 10.1038/srep32202; de Castro JAL, 2007, IMMUNOL LETT, V108, P27, DOI 10.1016/j.imlet.2006.10.004; Maneiro JR, 2015, RMD OPEN, V1, DOI 10.1136/rmdopen-2014-000017; Maras Y, 2014, TURK J MED SCI, V44, P203, DOI 10.3906/sag-1304-140; Marchenko YV, 2008, STATA J, V8, P305, DOI 10.1177/1536867X0800800301; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; McLeod C, 2007, Health Technol Assess, V11, P1; Moz S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040830; O'Rielly DD, 2014, BEST PRACT RES CL RH, V28, P673, DOI 10.1016/j.berh.2014.10.010; Ottoboni L, 2013, NEUROLOGY, V81, P1891, DOI 10.1212/01.wnl.0000436612.66328.8a; Pointon JJ, 2010, ANN RHEUM DIS, V69, P1243, DOI 10.1136/ard.2009.115147; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Robinson PC, 2014, MOL IMMUNOL, V57, P2, DOI 10.1016/j.molimm.2013.06.013; Rossi E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123244; Rudwaleit M, 2004, ANN RHEUM DIS, V63, P665, DOI 10.1136/ard.2003.016386; Rudwaleit M, 2001, ANN RHEUM DIS, V60, P36, DOI 10.1136/ard.60.1.36; Schiotis R, 2014, RHEUMATOL INT, V34, P793, DOI 10.1007/s00296-013-2913-y; Skoog T, 1999, HUM MOL GENET, V8, P1443, DOI 10.1093/hmg/8.8.1443; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Song GG, 2015, PHARMACOGENOMICS, V16, P1427, DOI [10.2217/PGS.15.90, 10.2217/pgs.15.90]; Stolwijk C, 2016, ARTHRIT CARE RES, V68, P1320, DOI 10.1002/acr.22831; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Turina MC, 2017, EXPERT REV CLIN IMMU, V13, P333, DOI 10.1080/1744666X.2017.1244004; van der Heijde D, 2008, ARTHRITIS RHEUM-US, V58, P1324, DOI 10.1002/art.23471; van Kuijk AWR, 2006, ANN RHEUM DIS, V65, P1551, DOI 10.1136/ard.2005.050963; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Vastesaeger N, 2011, ANN RHEUM DIS, V70, P973, DOI 10.1136/ard.2010.147744; Yigit S, 2012, DIS MARKERS, V33, P113, DOI 10.1155/2012/890214; Zambon CF, 2005, CYTOKINE, V29, P141, DOI 10.1016/j.cyto.2004.10.013	49	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194693	10.1371/journal.pone.0194693	http://dx.doi.org/10.1371/journal.pone.0194693			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579081	Green Published, Green Submitted, gold			2022-12-26	WOS:000428351800047
J	Rombouts, J; Vandervelde, A; Gelens, L				Rombouts, Jan; Vandervelde, Alexandra; Gelens, Lendert			Delay models for the early embryonic cell cycle oscillator	PLOS ONE			English	Article							MULTISITE PROTEIN-PHOSPHORYLATION; XENOPUS-OOCYTE EXTRACTS; STATE-DEPENDENT DELAYS; M-PHASE CONTROL; DIFFERENTIAL EQUATIONS; HOPF-BIFURCATION; TRIGGER WAVES; MECHANISM; DIVISION; ULTRASENSITIVITY	Time delays are known to play a crucial role in generating biological oscillations. The early embryonic cell cycle in the frog Xenopus laevis is one such example. Although various mathematical models of this oscillating system exist, it is not clear how to best model the required time delay. Here, we study a simple cell cycle model that produces oscillations due to the presence of an ultrasensitive, time-delayed negative feedback loop. We implement the time delay in three qualitatively different ways, using a fixed time delay, a distribution of time delays, and a delay that is state-dependent. We analyze the dynamics in all cases, and we use experimental observations to interpret our results and put constraints on unknown parameters. In doing so, we find that different implementations of the time delay can have a large impact on the resulting oscillations.	[Rombouts, Jan; Vandervelde, Alexandra; Gelens, Lendert] Univ Leuven, Dept Cellular & Mol Med, Lab Dynam Biol Syst, B-3000 Leuven, Belgium	KU Leuven	Gelens, L (corresponding author), Univ Leuven, Dept Cellular & Mol Med, Lab Dynam Biol Syst, B-3000 Leuven, Belgium.	lendert.gelens@kuleuven.be	Gelens, Lendert/E-6348-2010	Gelens, Lendert/0000-0001-7290-9561; Rombouts, Jan/0000-0003-4135-0771	Research-Foundation Flanders (FWO-Vlaanderen) [G0A5217N]	Research-Foundation Flanders (FWO-Vlaanderen)(FWO)	The authors acknowledge support by the Research-Foundation Flanders (FWO-Vlaanderen) for individual support (J.R.) and project support (L.G. - grant G0A5217N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimy M, 2010, SIAM J APPL MATH, V70, P1611, DOI 10.1137/080742713; Anderson GA, 2017, CELL REP, V21, P37, DOI 10.1016/j.celrep.2017.09.017; Ashyraliyev M, 2009, FEBS J, V276, P886, DOI 10.1111/j.1742-4658.2008.06844.x; Babtie AC, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0237; Barrio M, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4793982; Bollen M, 2009, TRENDS CELL BIOL, V19, P531, DOI 10.1016/j.tcb.2009.06.005; Chang JB, 2013, NATURE, V500, P603, DOI 10.1038/nature12321; COOKE KL, 1982, J MATH ANAL APPL, V86, P592, DOI 10.1016/0022-247X(82)90243-8; Engelborghs K, 2002, ACM T MATH SOFTWARE, V28, P1, DOI 10.1145/513001.513002; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Erneux T., 2009, APPL DELAY DIFFERENT; Eurich CW, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.158104; FELIX MA, 1990, NATURE, V346, P379, DOI 10.1038/346379a0; Feng JC, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.032408; Ferrell JE, 2011, CELL, V144, P874, DOI 10.1016/j.cell.2011.03.006; Flunkert V, 2009, ARXIV09111633NLIN; Francois P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002585; Gelens L, 2015, CELL REP, V12, P892, DOI 10.1016/j.celrep.2015.06.070; Gelens L, 2014, MOL BIOL CELL, V25, P3486, DOI 10.1091/mbc.E14-08-1306; GOLDBETER A, 1991, P NATL ACAD SCI USA, V88, P9107, DOI 10.1073/pnas.88.20.9107; Gonze D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069573; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; HARA K, 1980, P NATL ACAD SCI-BIOL, V77, P462, DOI 10.1073/pnas.77.1.462; Hartung F, 2006, HBK DIFF EQUAT ORDIN, V3, P435, DOI 10.1016/S1874-5725(06)80009-X; Hegger R, 1998, PHYS REV LETT, V81, P558, DOI 10.1103/PhysRevLett.81.558; Heim A, 2015, EMBO REP, V16, P1501, DOI 10.15252/embr.201540876; Hinch R, 2004, J MATH CHEM, V35, P253, DOI 10.1023/B:JOMC.0000033258.42803.60; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; Insperger T, 2008, INT J NONLIN MECH, V43, P140, DOI 10.1016/j.ijnonlinmec.2007.11.002; Jungling T, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.062908; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; Leier A, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0108; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Lillacci G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000696; Ma HF, 2017, PHYS REV E, V96, DOI 10.1103/PhysRevE.96.012221; MacDonald N., 1989, BIOL DELAY SYSTEMS L; MACKEY MC, 1989, J ECON THEORY, V48, P497, DOI 10.1016/0022-0531(89)90039-2; Mahaffy JM, 1998, J THEOR BIOL, V190, P135, DOI 10.1006/jtbi.1997.0537; Marlovits G, 1998, BIOPHYS CHEM, V72, P169, DOI 10.1016/S0301-4622(98)00132-X; Martinez-Llinas J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8425; Mattingly HH, 2017, BIOPHYS J, V113, P743, DOI 10.1016/j.bpj.2017.06.045; MCGOWAN CH, 1993, EMBO J, V12, P75, DOI 10.1002/j.1460-2075.1993.tb05633.x; Meyer U, 2008, BIOL CYBERN, V99, P79, DOI 10.1007/s00422-008-0239-8; Mitchell JL, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046110; Mochida S, 2016, CURR BIOL, V26, P3361, DOI 10.1016/j.cub.2016.10.022; Mochida S, 2012, EMBO REP, V13, P197, DOI 10.1038/embor.2011.263; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Monk NAM, 2003, CURR BIOL, V13, P1409, DOI 10.1016/S0960-9822(03)00494-9; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; NOVAK B, 1993, J CELL SCI, V106, P1153; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Rateitschak K, 2007, MATH BIOSCI, V205, P163, DOI 10.1016/j.mbs.2006.08.010; Ruoff P, 1999, J BIOL RHYTHM, V14, P469, DOI 10.1177/074873099129001037; Salazar C, 2007, FEBS J, V274, P1046, DOI 10.1111/j.1742-4658.2007.05653.x; Salazar C, 2009, FEBS J, V276, P3177, DOI 10.1111/j.1742-4658.2009.07027.x; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Smith H, 2010, INTRO DELAY DIFFEREN; Srividhya J, 2007, BIOPHYS CHEM, V125, P286, DOI 10.1016/j.bpc.2006.09.001; Srividhya J, 2006, J THEOR BIOL, V241, P617, DOI 10.1016/j.jtbi.2005.12.020; TANG ZH, 1993, EMBO J, V12, P3427, DOI 10.1002/j.1460-2075.1993.tb06017.x; Trunnell NB, 2011, MOL CELL, V41, P263, DOI 10.1016/j.molcel.2011.01.012; Tsai TYC, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001788; Tyson J., 1978, PROG THEOR BIOL, V5, P1; Yang Q, 2013, NAT CELL BIOL, V15, P519, DOI 10.1038/ncb2737; Zhu SL, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.052210	68	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194769	10.1371/journal.pone.0194769	http://dx.doi.org/10.1371/journal.pone.0194769			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579091	Green Published, gold, Green Submitted			2022-12-26	WOS:000428351800052
J	Savion, N; Levine, A; Kotev-Emeth, S; Abu-Shach, UB; Broday, L				Savion, Naphtali; Levine, Amir; Kotev-Emeth, Shlomo; Abu-Shach, Ulrike Bening; Broday, Limor			S-allylmercapto-N-acetylcysteine protects against oxidative stress and extends lifespan in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; REACTIVE OXYGEN; GLUTATHIONE; RESISTANCE; LONGEVITY; DAMAGE; SKN-1; INVOLVEMENT; INHIBITION; EXTENSION	S-allylmercapto-N-acetylcysteine (ASSNAC) was shown in our previous study to activate Nrf2-mediated processes and increase glutathione level and resistance to oxidative stress in cultured endothelial cells. In this study, we explored the antioxidant protective effect of ASSNAC in Caenorhabditis elegans (C. elegans). Treatment of gst-4 reporter strain (CL2166) with increasing concentrations of ASSNAC (0.2 to 20 mM) for 24 hours and with ASSNAC (10 mM) for various time periods demonstrated a significant concentration- and time-dependent increase in Glutathione S-transferase (GST) gene expression (up to 60-fold at 20 mM after 24 hours). In addition, ASSNAC (2 mM; 24 hours) treatment of C. elegans strains N2 (wild type strain), gst-4 reporter (CL2166) and temperature sensitive sterile strain (CF512) significantly increased GST enzyme activity by 1.9-, 1.5- and 1.8-fold, respectively. ASSNAC (2.0 mM; 24 hours) increased the reduced glutathione content in N2 and CF512 strains by 5.9- and 4.9-fold, respectively. Exposure of C. elegans (N2 strain) to a lethal concentration of H2O2 (3.5 mM; 120 min) resulted in death of 88% of the nematodes while pretreatment with ASSNAC (24 hours) reduced nematodes death in a concentration-dependent manner down to 8% at 2.0 mM. C. elegans nematodes (strain CF512) cultured on agar plates containing ASSNAC (0.5 to 5.0 mM) demonstrated a significant increase in lifespan compared to control (mean lifespan 26.45 +/- 0.64 versus 22.90 +/- 0.59 days; log-rank p <= 0.001 at 2.0 mM) with a maximal lifespan of 40 versus 36 days. In conclusion, ASSNAC up regulates the GST gene expression and enzyme activity as well as the glutathione content in C. elegans nematodes and thereby increases their resistance to oxidative stress and extends their lifespan.	[Savion, Naphtali; Levine, Amir; Kotev-Emeth, Shlomo] Tel Aviv Univ, Dept Human Mol Genet & Biochem, Tel Aviv, Israel; [Savion, Naphtali; Levine, Amir; Kotev-Emeth, Shlomo] Tel Aviv Univ, Goldschleger Eye Res Inst, Tel Aviv, Israel; [Levine, Amir; Abu-Shach, Ulrike Bening; Broday, Limor] Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Savion, N (corresponding author), Tel Aviv Univ, Dept Human Mol Genet & Biochem, Tel Aviv, Israel.; Savion, N (corresponding author), Tel Aviv Univ, Goldschleger Eye Res Inst, Tel Aviv, Israel.	eyeres@post.tau.ac.il	Savion, Naphtali/K-1013-2019	Levine, Amir/0000-0002-0062-1523	Israel Science Foundation [1878/15]; Israel Cancer Research Fund [PG-14-101]	Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund	This work was supported by the Israel Science Foundation-grant number 1878/15 (https://www.isf.org.il/#/) to LB and the Israel Cancer Research Fund-grant number PG-14-101 (https://www.icrfonline.org/) to LB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Bergamini CM, 2004, CURR PHARM DESIGN, V10, P1611, DOI 10.2174/1381612043384664; Blagosklonny MV, 2009, AGING-US, V1, P1; BRENNER S, 1974, GENETICS, V77, P71; Cascella R, 2014, FREE RADICAL BIO MED, V73, P127, DOI 10.1016/j.freeradbiomed.2014.05.004; Choe KP, 2009, MOL CELL BIOL, V29, P2704, DOI 10.1128/MCB.01811-08; Dickinson DA, 2002, ANN NY ACAD SCI, V973, P488, DOI 10.1111/j.1749-6632.2002.tb04690.x; Guerrero-Beltran CE, 2012, EXP TOXICOL PATHOL, V64, P503, DOI 10.1016/j.etp.2010.11.005; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Fridovich I, 1999, ANN NY ACAD SCI, V893, P13, DOI 10.1111/j.1749-6632.1999.tb07814.x; Garigan D, 2002, GENETICS, V161, P1101; Ishii T, 2002, METHOD ENZYMOL, V348, P182, DOI 10.1016/S0076-6879(02)48637-5; Izigov N, 2011, FREE RADICAL BIO MED, V50, P1131, DOI 10.1016/j.freeradbiomed.2011.01.028; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kim JS, 2017, BIOSCI J, V33, P411; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Liao VHC, 2011, MECH AGEING DEV, V132, P480, DOI 10.1016/j.mad.2011.07.008; Link CD, 2002, METHOD ENZYMOL, V353, P497; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maman M, 2013, J NEUROSCI, V33, P6102, DOI 10.1523/JNEUROSCI.4023-12.2013; Masella R, 2005, J NUTR BIOCHEM, V16, P577, DOI 10.1016/j.jnutbio.2005.05.013; MEISTER A, 1995, METHOD ENZYMOL, V252, P26; Moriwaki T, 2013, J CLIN BIOCHEM NUTR, V53, P81, DOI 10.3164/jcbn.13-11; Munoz MJ, 2003, GENETICS, V163, P171; Ogawa T, 2016, SCI REP-UK, V6, DOI 10.1038/srep21611; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Pallauf K, 2017, P NUTR SOC, V76, P145, DOI 10.1017/S0029665116000720; Powolny AA, 2011, EXP GERONTOL, V46, P441, DOI 10.1016/j.exger.2011.01.005; Rodriguez M, 2013, TRENDS GENET, V29, P367, DOI 10.1016/j.tig.2013.01.010; Rosenblat M, 2002, ATHEROSCLEROSIS, V163, P17, DOI 10.1016/S0021-9150(01)00744-4; Salgueiro WG, 2017, FREE RADICAL BIO MED, V110, P133, DOI 10.1016/j.freeradbiomed.2017.05.020; Salvioli S, 2007, EVID-BASED COMPL ALT, V4, P181, DOI 10.1093/ecam/nem043; Savion N, 2014, NEUROSCI LETT, V583, P108, DOI 10.1016/j.neulet.2014.09.034; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Shurtz-Swirski R, 2001, DIABETES CARE, V24, P104, DOI 10.2337/diacare.24.1.104; Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Urban N, 2017, REDOX BIOL, V11, P502, DOI 10.1016/j.redox.2016.12.003; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wang Q, 2015, INT J MOL SCI, V16, P13885, DOI 10.3390/ijms160613885; Yang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023525	44	6	6	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2018	13	3							e0194780	10.1371/journal.pone.0194780	http://dx.doi.org/10.1371/journal.pone.0194780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA5DH	29579097	Green Published, gold, Green Submitted			2022-12-26	WOS:000428351800054
J	Furlanetto, RL; Teixeira, SH; Gracitelli, CPB; Lottenberg, CL; Emori, F; Michelan, M; Amaro, E; Paranhos, A				Furlanetto, Rafael Lacerda; Teixeira, Sergio Henrique; Barbosa Gracitelli, Carolina Pelegrini; Lottenberg, Claudio Luiz; Emori, Fabiano; Michelan, Michel; Amaro, Edson, Jr.; Paranhos, Augusto, Jr.			Structural and functional analyses of the optic nerve and lateral geniculate nucleus in glaucoma	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; RETINOGENICULATE PROJECTION FIBERS; GENERALIZED ESTIMATING EQUATIONS; NEURORETINAL RIM AREA; GANGLION-CELL LOSS; VISUAL-FIELD; PARVOCELLULAR LAYERS; SIZE; MONKEY; ATROPHY	Purpose To analyze the correlation between structural characteristics of intraorbital optic nerve (ION) and lateral geniculate nucleus (LGN) measured by 3-Tesla magnetic resonance imaging (3T MRI), and the severity of glaucomatous damage. Methods In this cross-sectional study, 41 glaucoma patients and 12 age-and sex-matched controls underwent standard automated perimetry (SAP) and frequency doubling technology (FDT) as functional evaluation; optic disc stereophotograph, spectral-domain optical coherence tomography (OCT) and confocal scanning laser tomography as ocular structural evaluation; and 3T MRI. Structure-structure and structure-function correlation were performed using bootstrap resampling method for clustered data. Results The ION mean diameter and cross-sectional area were different between glaucoma and control groups at 5mm and 10mm (all, p <= 0.011) from the globe, but not at 15mm (both, p >= 0.067). LGN height was significantly lower in glaucoma group (p = 0.005). OCT rim area and functional parameters (SAP and FDT) correlated significantly with all ION segments, showing stronger correlations at 10 and 15 mm. ION parameters at 10 and 15 mm presented mild-to-moderate correlation with OCT peripapillary nerve fiber layer thickness, and ION at 15mm had mild association with the neuroretinal rim area on stereophotographs. Although LGN height was significantly smaller in glaucoma group (p = 0.005), LGN parameters were not associated with any ocular structural or functional parameter. Conclusion Assessment of central and peripheral nervous systems using 3T MRI confirmed that glaucoma patients had smaller ION dimensions and LGN height compared to the control group. In general, ION dimensions presented mild to moderate correlations with functional and ocular structural parameters. Although ION had significant correlations at any distance from the eye, the ION distal locations correlated better with OCT results and functional parameters. However, LGN parameters were not associated with functional or ocular structural parameters.	[Furlanetto, Rafael Lacerda; Teixeira, Sergio Henrique; Barbosa Gracitelli, Carolina Pelegrini; Lottenberg, Claudio Luiz; Paranhos, Augusto, Jr.] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, SP, Brazil; [Teixeira, Sergio Henrique; Lottenberg, Claudio Luiz; Emori, Fabiano; Michelan, Michel; Amaro, Edson, Jr.; Paranhos, Augusto, Jr.] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Hospital Israelita Albert Einstein	Furlanetto, RL (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, SP, Brazil.	oftalmo.rafael@gmail.com	Gracitelli, Carolina/ABI-5387-2020; amaro, edson/GLR-7735-2022; Paranhos Jr, Augusto/E-6297-2012	Gracitelli, Carolina/0000-0001-5086-9060; amaro, edson/0000-0002-5889-1382; Paranhos Jr, Augusto/0000-0001-6266-6922; FURLANETTO, RAFAEL/0000-0002-0729-6460	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Foundation, Ministry of Education of Brazil [9033/11-4]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Foundation, Ministry of Education of Brazil	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Foundation, Ministry of Education of Brazil; http//www.capes.gov.br/; Grant: BEX number 9033/11-4 (RLF).	Anderson AJ, 2005, INVEST OPHTH VIS SCI, V46, P1540, DOI 10.1167/iovs.04-0968; BALAZSI AG, 1984, ARCH OPHTHALMOL-CHIC, V102, P1011, DOI 10.1001/archopht.1984.01040030813022; Beatty S, 1998, EYE, V12, P707, DOI 10.1038/eye.1998.173; Beatty S, 1998, BRIT J OPHTHALMOL, V82, P43, DOI 10.1136/bjo.82.1.43; BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; Brusini P, 2007, SURV OPHTHALMOL, V52, P156, DOI 10.1016/j.survophthal.2006.12.008; Burton P, 1998, STAT MED, V17, P1261, DOI 10.1002/(SICI)1097-0258(19980615)17:11<1261::AID-SIM846>3.0.CO;2-Z; Carenini BB, 2002, ACTA OPHTHALMOL SCAN, V80, P40; Chang ST, 2014, J GLAUCOMA, V23, P513, DOI 10.1097/IJG.0b013e318294861d; CHATURVEDI N, 1993, AM J OPHTHALMOL, V116, P182, DOI 10.1016/S0002-9394(14)71283-8; Chen WW, 2013, INVEST OPHTH VIS SCI, V54, P545, DOI 10.1167/iovs.12-9893; Chen ZQ, 2013, J NEURORADIOLOGY, V40, P281, DOI 10.1016/j.neurad.2012.10.004; Dai H, 2011, AM J NEURORADIOL, V32, P1347, DOI 10.3174/ajnr.A2486; De Moraes Carlos Gustavo, 2013, J Glaucoma, V22 Suppl 5, pS2, DOI 10.1097/IJG.0b013e3182934978; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dichtl A, 1996, AM J OPHTHALMOL, V122, P514, DOI 10.1016/S0002-9394(14)72111-7; Fan XA, 2010, OPHTHALMOLOGY, V117, P1530, DOI 10.1016/j.ophtha.2009.12.034; Field CA, 2007, J R STAT SOC B, V69, P369, DOI 10.1111/j.1467-9868.2007.00593.x; Garway-Heath DF, 2000, INVEST OPHTH VIS SCI, V41, P1774; Garway-Heath DF, 1998, BRIT J OPHTHALMOL, V82, P643, DOI 10.1136/bjo.82.6.643; GLOVINSKY Y, 1991, INVEST OPHTH VIS SCI, V32, P484; Gupta N, 2006, BRIT J OPHTHALMOL, V90, P674, DOI 10.1136/bjo.2005.086769; Gupta N, 2009, BRIT J OPHTHALMOL, V93, P56, DOI 10.1136/bjo.2008.138172; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hood DC, 2007, INVEST OPHTH VIS SCI, V48, P3662, DOI 10.1167/iovs.06-1401; Hu RR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178079; Ito Y, 2009, EXP EYE RES, V89, P246, DOI 10.1016/j.exer.2009.03.013; Johnson C A, 2000, Semin Ophthalmol, V15, P221, DOI 10.3109/08820530009037873; JONAS JB, 1993, OPHTHALMOLOGY, V100, P63; JONAS JB, 1988, INVEST OPHTH VIS SCI, V29, P1151; JONAS JB, 1995, GRAEF ARCH CLIN EXP, V233, P421, DOI 10.1007/BF00180945; JONAS JB, 1992, INVEST OPHTH VIS SCI, V33, P2012; Karim S, 2004, INVEST OPHTH VIS SCI, V45, P1047, DOI 10.1167/iovs.03-1246; Kashiwagi K, 2004, J GLAUCOMA, V13, P189, DOI 10.1097/00061198-200406000-00003; KUPFER C, 1962, AM J OPHTHALMOL, V54, P597, DOI 10.1016/0002-9394(62)92190-6; Lagreze WA, 2007, INVEST OPHTH VIS SCI, V48, P1913, DOI 10.1167/iovs.06-1075; Lagreze WA, 2009, INVEST OPHTH VIS SCI, V50, P4223, DOI 10.1167/iovs.08-2683; Lamparter J, 2012, INVEST OPHTH VIS SCI, V53, P7553, DOI 10.1167/iovs.12-10892; Lee JY, 2014, INVEST OPHTH VIS SCI, V55, P3468, DOI 10.1167/iovs.14-13902; LITTMANN H, 1982, KLIN MONATSBL AUGENH, V180, P286, DOI 10.1055/s-2008-1055068; Ly T, 2011, VISION RES, V51, P243, DOI 10.1016/j.visres.2010.08.003; McKetton L, 2015, JOVE-J VIS EXP, DOI 10.3791/53309; McManus JR, 2013, CURR OPIN OPHTHALMOL, V24, P144, DOI 10.1097/ICU.0b013e32835cf078; MONTERO VM, 1986, EXP BRAIN RES, V64, P615, DOI 10.1007/BF00340502; NAITO J, 1994, J COMP NEUROL, V346, P559, DOI 10.1002/cne.903460408; NAITO J, 1989, J COMP NEUROL, V284, P174, DOI 10.1002/cne.902840203; Omodaka K, 2014, CLIN EXP OPHTHALMOL, V42, P360, DOI 10.1111/ceo.12237; Pinto LM, 2014, INVEST OPHTH VIS SCI, V55, P3074, DOI 10.1167/iovs.13-13664; Prasad Sashank, 2011, Handb Clin Neurol, V102, P3, DOI 10.1016/B978-0-444-52903-9.00007-8; QUIGLEY HA, 1987, INVEST OPHTH VIS SCI, V28, P913; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Ramli NM, 2014, GRAEF ARCH CLIN EXP, V252, P995, DOI 10.1007/s00417-014-2622-6; Sasaoka M, 2008, EXP EYE RES, V86, P770, DOI 10.1016/j.exer.2008.02.004; Savini G, 2012, BRIT J OPHTHALMOL, V96, P57, DOI 10.1136/bjo.2010.196782; Sharma P, 2008, SURV OPHTHALMOL, V53, pS17, DOI 10.1016/j.survophthal.2008.08.003; SOMOGYI J, 1987, J COMP NEUROL, V255, P341, DOI 10.1002/cne.902550303; STROMAN GA, 1995, ARCH OPHTHALMOL-CHIC, V113, P168, DOI 10.1001/archopht.1995.01100020050027; Valeri G, 2015, RADIOL MED, V120, P309, DOI 10.1007/s11547-014-0437-5; Vickers JC, 1997, AUST NZ J OPHTHALMOL, V25, P239, DOI 10.1111/j.1442-9071.1997.tb01400.x; Weber AJ, 2000, INVEST OPHTH VIS SCI, V41, P1370; Weigel M, 2006, INVEST RADIOL, V41, P83, DOI 10.1097/01.rli.0000195820.98062.c5; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Willinek WA, 2008, EUR J RADIOL, V65, P2, DOI 10.1016/j.ejrad.2007.11.006; Yucel YH, 2003, PROG RETIN EYE RES, V22, P465, DOI 10.1016/S1350-9462(03)00026-0; Yucel YH, 2001, INVEST OPHTH VIS SCI, V42, P3216; Yucel YH, 2000, ARCH OPHTHALMOL-CHIC, V118, P378; Zhang YQ, 2012, ACTA OPHTHALMOL, V90, pE295, DOI 10.1111/j.1755-3768.2011.02346.x	68	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2018	13	3							e0194038	10.1371/journal.pone.0194038	http://dx.doi.org/10.1371/journal.pone.0194038			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA2QK	29570721	gold, Green Published, Green Submitted			2022-12-26	WOS:000428168400010
J	Zhang, WB; Luo, QQ; Zhu, Y; Ma, J; Cao, L; Yang, M; Wen, PC; Zhang, ZM; He, XL				Zhang, Weibing; Luo, Qiaoqiao; Zhu, Yan; Ma, Jiang; Cao, Lei; Yang, Min; Wen, Pencheng; Zhang, Zhongmin; He, Xiaoling			Microbial diversity in two traditional bacterial douchi from Gansu province in northwest China using Illumina sequencing	PLOS ONE			English	Article							MOLECULAR-IDENTIFICATION; IN-VITRO; COMMUNITY; FERMENTATION; NETWORK; MILK; VIVO	Douchi has been consumed as a flavoring ingredient for centuries. During production of douchi, numerous microorganisms play important roles in the hydrolysis and conversion of proteins and starch, which are related to the quality and flavor of the end product. Therefore, in the present study, the microbial diversity in two types of home-made traditional bacterial douchi from Gansu province in northwest China was studied by high-throughput sequencing, and a corresponding analysis of the bacterial and fungal communities were conducted. The results showed that geography may have impacted the fungal diversity and the bacterial and fungal species richness in the samples. The results also showed that the microbial community was significantly different in samples of different origin and the difference in the microbial community at the genus level was greater than at phylum level. Two dominant bacterial genera (Bacillus and Ignatzschineria) were common to the two samples, both of which had a relative abundance of more than 1%. Four bacterial genera (Staphylococcus, Aerococcus, Geobacillus, and Jeotgalicoccus) were dominant only in the sample from Qingyang, while another four (Carnobacterium, Proteus, Aneurinibacillus, and Enterococcus) were dominant only in the sample from Longnan. Two dominant fungal genera (Pichia and Candida) were shared by the two samples. Additionally, two genera (Rhodosporidium and Yarrowia) were dominant only in samples from Longnan. The functional genes of the bacteria present in samples indicated that a significant difference was observed in the bacterial community between samples of different origin. We also found that microbial interactions between bacterial and fungal communities in the samples were very complex. This study provides previously unknown information regarding the impact of the environment on microbial communities in douchi and lays a foundation for further investigations into food ecology in bacterial douchi.	[Zhang, Weibing; Luo, Qiaoqiao; Zhu, Yan; Ma, Jiang; Cao, Lei; Wen, Pencheng; Zhang, Zhongmin; He, Xiaoling] Gansu Agr Univ, Coll Food Sci & Engn, Lanzhou, Gansu, Peoples R China; [Yang, Min] Gansu Agr Univ, Coll Sci, Lanzhou, Gansu, Peoples R China	Gansu Agricultural University; Gansu Agricultural University	Zhang, WB (corresponding author), Gansu Agr Univ, Coll Food Sci & Engn, Lanzhou, Gansu, Peoples R China.	45330301@qq.com	Zhang, Weibing/ABF-4896-2021	zhang, weibing/0000-0003-1812-1372	Youth Mentor Support Fund of GAU [GAU-QNDS-201502]; National Natural Science Fund of China [31560442, 31760466]; Natural Science Fund of Gansu Province [1606RJZA079]	Youth Mentor Support Fund of GAU; National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Gansu Province	The authors are grateful to the Youth Mentor Support Fund of GAU (GAU-QNDS-201502), the National Natural Science Fund of China (31560442, 31760466), and the Natural Science Fund of Gansu Province (1606RJZA079) for financial support of this work.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; Bokulich NA, 2015, FOOD MICROBIOL, V50, P12, DOI 10.1016/j.fm.2015.01.018; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen C, 2015, J APPL MICROBIOL, V119, P1324, DOI 10.1111/jam.12917; Chen J, 2007, FOOD CHEM, V103, P1091, DOI 10.1016/j.foodchem.2006.10.003; Chen TT, 2012, J SCI FOOD AGR, V92, P2171, DOI 10.1002/jsfa.5604; Chen TT, 2011, FOOD SCI BIOTECHNOL, V20, P1633, DOI 10.1007/s10068-011-0225-0; Chen TT, 2011, INT J FOOD SCI TECH, V46, P1878, DOI 10.1111/j.1365-2621.2011.02696.x; Dalmasso A, 2016, LWT-FOOD SCI TECHNOL, V69, P490, DOI 10.1016/j.lwt.2016.02.004; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Feng LJ, 2017, BIORESOURCE TECHNOL, V224, P236, DOI 10.1016/j.biortech.2016.11.002; Freilich S, 2010, NUCLEIC ACIDS RES, V38, P3857, DOI 10.1093/nar/gkq118; Fu YJ, 2015, BIOTECHNOL BIOPROC E, V20, P931, DOI 10.1007/s12257-015-0228-4; Fusco V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00155; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Ishida H, 1998, BIOL PHARM BULL, V21, P62, DOI 10.1248/bpb.21.62; Konopka A, 2009, ISME J, V3, P1223, DOI 10.1038/ismej.2009.88; Kryachko Y, 2012, ANTON LEEUW INT J G, V101, P493, DOI 10.1007/s10482-011-9658-y; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lenchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066588; LIDICKER WZ, 1979, BIOSCIENCE, V29, P475, DOI 10.2307/1307540; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Manolakaki D, 2010, VIRULENCE, V1, P367, DOI 10.4161/viru.1.5.12796; MESSINA MJ, 1994, NUTR CANCER, V21, P113, DOI 10.1080/01635589409514310; Nai YS, 2017, SCI REP-UK, V7, DOI 10.1038/srep40767; Pfaller MA, 2006, J CLIN MICROBIOL, V44, P3578, DOI 10.1128/JCM.00863-06; Polka J, 2015, FOOD MICROBIOL, V46, P342, DOI 10.1016/j.fm.2014.08.023; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Solieri L, 2013, ANN MICROBIOL, V63, P21, DOI 10.1007/s13213-012-0478-8; Sun ZH, 2014, J DAIRY SCI, V97, P6085, DOI 10.3168/jds.2014-8360; Tago K, 2014, MICROBES ENVIRON, V29, P434, DOI 10.1264/jsme2.ME14122; Wang D, 2008, FOOD CHEM, V107, P1421, DOI 10.1016/j.foodchem.2007.09.072; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang YJ, 2012, SPRINGERPLUS, V1, DOI 10.1186/2193-1801-1-82; Wu J, 2016, ISME J, V10, P2435, DOI 10.1038/ismej.2016.37; Xu D, 2017, AMB EXPRESS, V7, DOI 10.1186/s13568-017-0336-y; Yang L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147833; Zhang FX, 2017, J DAIRY SCI, V100, P7812, DOI 10.3168/jds.2017-13244; Zhang JH, 2007, INT J FOOD SCI TECH, V42, P263, DOI 10.1111/j.1365-2621.2005.01150.x; Zhang YR, 2016, J STAT MECH-THEORY E, P1, DOI 10.1088/1742-5468/2016/11/113207; Zhou JZ, 2010, MBIO, V1, DOI 10.1128/mBio.00169-10	47	19	25	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2018	13	3							e0194876	10.1371/journal.pone.0194876	http://dx.doi.org/10.1371/journal.pone.0194876			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA2QK	29570735	Green Submitted, gold, Green Published			2022-12-26	WOS:000428168400035
J	Chavarie, L; Howland, KL; Harris, LN; Hansen, MJ; Harford, WJ; Gallagher, CP; Baillie, SM; Malley, B; Tonn, WM; Muir, AM; Krueger, CC				Chavarie, Louise; Howland, Kimberly L.; Harris, Les N.; Hansen, Michael J.; Harford, William J.; Gallagher, Colin P.; Baillie, Shauna M.; Malley, Brendan; Tonn, William M.; Muir, Andrew M.; Krueger, Charles C.			From top to bottom: Do Lake Trout diversify along a depth gradient in Great Bear Lake, NT, Canada?	PLOS ONE			English	Article							SHALLOW-WATER MORPHOTYPES; LAVARETUS L. FORMS; GENE FLOW; SALVELINUS-NAMAYCUSH; ARCTIC CHARR; ECOLOGICAL OPPORTUNITY; PHENOTYPIC PLASTICITY; MORPHOLOGICAL DIVERGENCE; RESOURCE POLYMORPHISMS; POPULATION-STRUCTURE	Depth is usually considered the main driver of Lake Trout intraspecific diversity across lakes in North America. Given that Great Bear Lake is one of the largest and deepest freshwater systems in North America, we predicted that Lake Trout intraspecific diversity to be organized along a depth axis within this system. Thus, we investigated whether a deep-water morph of Lake Trout co-existed with four shallow-water morphs previously described in Great Bear Lake. Morphology, neutral genetic variation, isotopic niches, and life-history traits of Lake Trout across depths (0-150 m) were compared among morphs. Due to the propensity of Lake Trout with high levels of morphological diversity to occupy multiple habitat niches, a novel multivariate grouping method using a suite of composite variables was applied in addition to two other commonly used grouping methods to classify individuals. Depth alone did not explain Lake Trout diversity in Great Bear Lake; a distinct fifth deep water morph was not found. Rather, Lake Trout diversity followed an ecological continuum, with some evidence for adaptation to local conditions in deep-water habitat. Overall, trout caught from deep-water showed low levels of genetic and phenotypic differentiation from shallow-water trout, and displayed higher lipid content (C:N ratio) and occupied a higher trophic level that suggested an potential increase of piscivory (including cannibalism) than the previously described four morphs. Why phenotypic divergence between shallow- and deep water Lake Trout was low is unknown, especially when the potential for phenotypic variation should be high in deep and large Great Bear Lake. Given that variation in complexity of freshwater environments has dramatic consequences for divergence, variation in the complexity in Great Bear Lake (i.e., shallow being more complex than deep), may explain the observed dichotomy in the expression of intraspecific phenotypic diversity between shallow vs. deep-water habitats. The ambiguity surrounding mechanisms driving divergence of Lake Trout in Great Bear Lake should be seen as reflective of the highly variable nature of ecological opportunity and divergent natural selection itself.	[Chavarie, Louise; Krueger, Charles C.] Michigan State Univ, Dept Fisheries & Wildlife, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA; [Howland, Kimberly L.; Harris, Les N.; Gallagher, Colin P.; Malley, Brendan] Fisheries & Oceans Canada, Winnipeg, MB, Canada; [Howland, Kimberly L.; Tonn, William M.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Hansen, Michael J.] US Geol Survey, Hammond Bay Biol Stn, Millersburg, MI USA; [Harford, William J.] Univ Miami, Cooperat Inst Marine & Atmospher Studies, Miami, FL USA; [Baillie, Shauna M.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Muir, Andrew M.] Great Lakes Fishery Commiss, Ann Arbor, MI USA	Michigan State University; Fisheries & Oceans Canada; University of Alberta; United States Department of the Interior; United States Geological Survey; University of Miami; Dalhousie University	Chavarie, L (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA.	chavarie@msu.edu		Hansen, Michael/0000-0001-8522-3876; Chavarie, Louise/0000-0002-1327-7872	NWT Cumulative Impact Monitoring Impact grant [18436643]; Department of Fisheries and Oceans; Great Lake Fishery Commission; Sahtu Renewable Resource Board; DFO; Aboriginal Affairs; Northern Development Canada North-west Territories Cumulative Impacts Monitoring Program; Great Lakes Fishery Commission	NWT Cumulative Impact Monitoring Impact grant; Department of Fisheries and Oceans; Great Lake Fishery Commission; Sahtu Renewable Resource Board; DFO; Aboriginal Affairs; Northern Development Canada North-west Territories Cumulative Impacts Monitoring Program; Great Lakes Fishery Commission	This study was supported by NWT Cumulative Impact Monitoring Impact (grant number: 18436643 to LC), http://www.enr.gov.nt.ca/en/services/cumulative-impact-monrtoring-program-nwt-cimp; Department of Fisheries and Oceans; Great Lake Fishery Commission; Sahtu Renewable Resource Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Deline Renewable Resources Council, Deline Lands and Finance Corporation, the community of Deline, Department of Fisheries and Oceans Canada (DFO) in Hay River, and the Department of Environment and Natural Resources in Deline provided valuable help with field planning and logistics. We especially thank J. Chavarie, S. Buckley, G. Lafferty, M. Lindsey, M. Low, Z. Martin, S. Wiley, and C. Yukon, who helped lead sampling teams and coordinate logistics. The following individuals who helped conduct field sampling in various years are gratefully acknowledeged: J. Baptiste, D. Betsidea, D. Baton, L. Dueck, R. Eshenroder, G. Menacho, N. Modeste, I. Neyelle, L. Neyelle, M. Smirle, A. Swietzer, C. Takazo, A. Vital, F. Vital, B. Yukon, M. Yukon, T. Yukon and C. Yukon. D. Phillibert, K. Laubriat, S. Thacker, and K. Theoret conducted isotopic lab work. Financial support was provided by DFO, Sahtu Renewable Resource Board, Aboriginal Affairs, and Northern Development Canada North-west Territories Cumulative Impacts Monitoring Program grants, and the Great Lakes Fishery Commission. Logistical support was provided by the Polar Continental Shelf Program. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government.	Andersson A, 2016, ECOL FRESHW FISH, P643; Andersson A, 2017, CONSERV GENET, P1; Baillie SM, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0788-8; Benjamini Y, 2001, ANN STAT, V29, P1165; Bernatchez L, 2003, EVOLUTION ILLUMINATED: SALMON AND THEIR RELATIVES, P175; Bernatchez S, 2016, MOL ECOL, V25, P4773, DOI 10.1111/mec.13795; Blake RW, 2004, J FISH BIOL, V65, P1193, DOI 10.1111/j.0022-1112.2004.00568.x; BONE Q, 1972, COPEIA, P78; Bookstein FL, 1997, COMPUT VIS IMAGE UND, V66, P97, DOI 10.1006/cviu.1997.0607; Bronte CR, 1995, J GREAT LAKES RES, V21, P233, DOI 10.1016/S0380-1330(95)71096-6; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Campana SE, 1990, CAN J FISH AQUAT SCI, V117, P59; CASSELMAN JM, 1992, CAN J FISH AQUAT SCI, V49, P102, DOI 10.1139/f92-305; Chavarie L, 2016, BIOL J LINN SOC; Chavarie L, 2016, J GREAT LAKES RES; Chavarie L, 2015, J GREAT LAKES RES, V10, P1016; Chavarie L, 2016, ECOL EVOL, V6, P7727, DOI 10.1002/ece3.2506; Chavarie L, 2016, ECOL FRESHW FISH, V25, P109, DOI 10.1111/eff.12195; Chavarie L, 2015, BIOL J LINN SOC, V114, P109, DOI 10.1111/bij.12398; Chavarie L, 2013, T AM FISH SOC, V142, P814, DOI 10.1080/00028487.2013.763855; Collar DC, 2005, EVOLUTION, V59, P1783, DOI 10.1111/j.0014-3820.2005.tb01826.x; Coplen TB, GUIDE LAB INFORM MAN, P2000; CORNER EDS, 1969, PROC R SOC SER B-BIO, V171, P415, DOI 10.1098/rspb.1969.0003; deVries MS, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2017.0055; DeWitt TJ, 1998, J EVOLUTION BIOL, V11, P465, DOI 10.1007/s000360050100; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; EASTMAN JT, 1988, COMP BIOCHEM PHYS B, V90, P529, DOI 10.1016/0305-0491(88)90292-1; Eklov P, 2006, AM NAT, V167, P440, DOI 10.1086/499544; Elmer KR, 2016, HYDROBIOLOGIA; Eloranta AP, 2015, ECOL EVOL, V5, P1664, DOI 10.1002/ece3.1464; Eshenroder RL, 2008, ENVIRON BIOL FISH, V83, P77, DOI 10.1007/s10641-007-9265-y; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faulks L, 2015, BIOL J LINN SOC, V114, P929, DOI 10.1111/bij.12452; GALLUCCI VF, 1979, T AM FISH SOC, V108, P14, DOI 10.1577/1548-8659(1979)108<14:RFATAS>2.0.CO;2; Garduno-Paz MV, 2012, BIOL J LINN SOC, V106, P794, DOI 10.1111/j.1095-8312.2012.01906.x; Gislason D, 1999, CAN J FISH AQUAT SCI, V56, P2229, DOI 10.1139/cjfas-56-12-2229; Goetz F, 2010, MOL ECOL, V19, P176, DOI 10.1111/j.1365-294X.2009.04481.x; GOODIER JL, 1981, CAN J FISH AQUAT SCI, V38, P1724, DOI 10.1139/f81-221; Hansen MJ, 2012, T AM FISH SOC, V141, P1492, DOI 10.1080/00028487.2012.711263; Harris LN, 2015, HEREDITY, V114, P94, DOI 10.1038/hdy.2014.74; Hart MW, 2010, INTEGR COMP BIOL, V50, P643, DOI 10.1093/icb/icq068; Henderson BA, 2002, ENVIRON BIOL FISH, V64, P203, DOI 10.1023/A:1016023027437; Hendry AP, 2009, J FISH BIOL, V75, P2000, DOI 10.1111/j.1095-8649.2009.02419.x; Hendry AP, 2016, J HERED, V107, P25, DOI 10.1093/jhered/esv060; Hendry AP, 2013, EVOL ECOL RES, V15, P343; Hendry AP, 2009, CAN J FISH AQUAT SCI, V66, P1383, DOI 10.1139/F09-074; Hooker OE, 2016, HYDROBIOLOGIA; Howland KL, 2013, VARIATION MORPHOLOGY, P40; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hudson AG, 2017, EVOL APPL, V10, P251, DOI 10.1111/eva.12446; Hudson AG, 2011, P ROY SOC B-BIOL SCI, V278, P58, DOI 10.1098/rspb.2010.0925; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; JOHNSON L, 1975, J FISH RES BOARD CAN, V32, P1989, DOI 10.1139/f75-235; Kahilainen K, 2006, J FISH BIOL, V68, P63, DOI 10.1111/j.0022-1112.2006.00876.x; Kahilainen K, 2003, ECOL FRESHW FISH, V12, P275, DOI 10.1046/j.1600-0633.2003.00029.x; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Klemetsen A., 2013, J ICHTHYOL, V53, P781, DOI [10.1134/S0032945213100044, DOI 10.1134/S0032945213100044]; Klemetsen Anders, 2010, Freshwater Reviews, V3, P49, DOI 10.1608/FRJ-3.1.3; Knudsen R, 2010, J ANIM ECOL, V79, P161, DOI 10.1111/j.1365-2656.2009.01625.x; Kokko H, 2007, ECOL LETT, V10, P773, DOI 10.1111/j.1461-0248.2007.01086.x; Kristjansson BK, 2012, ECOL EVOL, V2, P1099, DOI 10.1002/ece3.235; Kristjansson BK, 2011, BIOL J LINN SOC, V103, P761, DOI 10.1111/j.1095-8312.2011.01670.x; Kristjansson BK, 2002, BIOL J LINN SOC, V76, P247, DOI 10.1046/j.1095-8312.2002.00063.x; Krueger CC, 1995, J GREAT LAKES RES, V21, P348, DOI 10.1016/S0380-1330(95)71109-1; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Leinonen T, 2006, J EVOL BIOL, V19; Leinonen T, 2013, NAT REV GENET, V14, P179, DOI 10.1038/nrg3395; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Lohman BK, 2017, AM NAT, V189, P354, DOI 10.1086/690808; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; MacDonald D., 2004, STATE AQUATIC KNOWLE; Marin K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162325; Martin RA, 2015, BIOL J LINN SOC, V114, P588, DOI 10.1111/bij.12449; McCune Amy R., 1997, P585; Miller R. B., 1947, B FISH RES BOARD CAN, V72, P31; Mooij WM, 1999, T AM FISH SOC, V128, P483, DOI 10.1577/1548-8659(1999)128<0483:AACOFG>2.0.CO;2; Muir AM, 2014, T AM FISH SOC, V143, P972, DOI 10.1080/00028487.2014.900823; Muir A. M., 2012, Transactions of the American Fisheries Society, V141, P1161, DOI 10.1080/00028487.2012.685823; Muir AM, 2015, FISH FISHERIES; Murren CJ, 2014, AM NAT, V183, P453, DOI 10.1086/675302; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Niemiller ML, 2008, MOL ECOL, V17, P2258, DOI 10.1111/j.1365-294X.2008.03750.x; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Nosil P, 2008, MOL ECOL, V17, P2103, DOI 10.1111/j.1365-294X.2008.03715.x; Nosil P, 2009, TRENDS ECOL EVOL, V24, P145, DOI 10.1016/j.tree.2008.10.011; Oke KB, 2016, J EVOLUTION BIOL, V29, P126, DOI 10.1111/jeb.12767; Ostbye K, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0676-2; Page KS, 2004, T AM FISH SOC, V133, P674, DOI 10.1577/T03-007.1; Parker AD, 2009, T AM FISH SOC, V138, P899, DOI 10.1577/T08-093.1; Pfennig DW, 2010, TRENDS ECOL EVOL, V25, P459, DOI 10.1016/j.tree.2010.05.006; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P3, DOI DOI 10.1007/0-387-22747-4_1; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Pritchard JK, 2000, GENETICS, V155, P945; Quinn T.J., 1999, BIOL RES MANAG SER; R Core Team, 2012, R LANG ENV STAT COMP; Relethford JH, 1997, HUM BIOL, V69, P443; RELETHFORD JH, 1990, HUM BIOL, V62, P5; Richardson JL, 2014, TRENDS ECOL EVOL, V29, P165, DOI 10.1016/j.tree.2014.01.002; Robinson BW, 2002, CAN J FISH AQUAT SCI, V59, P1819, DOI 10.1139/F02-144; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Samways KM, 2015, CAN J FISH AQUAT SCI, V72, P1406, DOI 10.1139/cjfas-2015-0116; Scheiner SM, 1998, EVOLUTION, V52, P368, DOI 10.1111/j.1558-5646.1998.tb01638.x; Schluter D, 2004, AM NAT, V163, P809, DOI 10.1086/383621; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; Seehausen O, 2014, ANNU REV ECOL EVOL S, V45, P621, DOI 10.1146/annurev-ecolsys-120213-091818; Sharpe DMT, 2008, EVOL ECOL RES, V10, P849; Siepielski AM, 2009, ECOL LETT, V12, P1261, DOI 10.1111/j.1461-0248.2009.01381.x; Siwertsson A, 2013, ECOL EVOL, V3, P1590, DOI 10.1002/ece3.562; Siwertsson A, 2013, EVOL ECOL, V27, P547, DOI 10.1007/s10682-012-9607-x; Siwertsson A, 2010, EVOL ECOL RES, V12, P929; Skoglund S, 2015, ECOL EVOL, V5, P3114, DOI 10.1002/ece3.1573; SKULASON S, 1995, TRENDS ECOL EVOL, V10, P366, DOI 10.1016/S0169-5347(00)89135-1; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; Snorrason Signour S., 2004, P210; Stafford C. P., 2013, CANADIAN J FISHERIES, V71, P10; Svanback R, 2009, AM NAT, V174, P176, DOI 10.1086/600112; Swanson HK, 2015, ECOLOGY, V96, P318, DOI 10.1890/14-0235.1; Torres-Dowdall J, 2012, FUNCT ECOL, V26, P616, DOI 10.1111/j.1365-2435.2012.01980.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Videler JJ, 1993, FISH SWIMMING, P1, DOI [10.1007/978-94-011-1580-3, DOI 10.1007/978-94-011-1580-3]; Vigliola L, 2009, REV-METHODS TECHNOL, V11, P174, DOI 10.1007/978-1-4020-5775-5_6; Vonlanthen P, 2009, J EVOLUTION BIOL, V22, P498, DOI 10.1111/j.1420-9101.2008.01670.x; Wainwright PC, 2016, INTEGR COMP BIOL, V56, P479, DOI 10.1093/icb/icw081; WEBB PW, 1984, AM ZOOL, V24, P107; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wellborn GA, 2015, ECOL EVOL, V5, P176, DOI 10.1002/ece3.1347; Westley PAH, 2013, P ROYAL SOC B, V280; Wright S, 1943, GENETICS, V28, P114; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR; Zimmerman MS, 2007, J GREAT LAKES RES, V33, P156, DOI 10.3394/0380-1330(2007)33[156:MAEDBS]2.0.CO;2; Zimmerman MS, 2006, T AM FISH SOC, V135, P1056, DOI 10.1577/T05-237.1; Zimmerman MS, 2009, CAN J FISH AQUAT SCI, V66, P1007, DOI 10.1139/F09-060	138	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0193925	10.10371/journal.pone.0193925	http://dx.doi.org/10.10371/journal.pone.0193925			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566015				2022-12-26	WOS:000428093900021
J	Ebrahimi-Nik, H; Bassami, MR; Mohri, M; Rad, M; Khan, MI				Ebrahimi-Nik, Hakimeh; Bassami, Mohammad Reza; Mohri, Mehrdad; Rad, Mehrnaz; Khan, Mazhar I.			Bacterial ghost of avian pathogenic E. coli (APEC) serotype O78:K80 as a homologous vaccine against avian colibacillosis	PLOS ONE			English	Article							E-MEDIATED LYSIS; ESCHERICHIA-COLI; PROTEIN-E; CHICKENS; POULTRY; INFECTION; RESISTANCE; VIRULENCE; MOROCCO; TURKEYS	Avian Colibacillosis is among the major causes of economic loss in the poultry industry worldwide, with a more vivid impact on developing countries. The involvement of several bacteria has made it challenging to develop effective vaccines for this disease, particularly because it is notoriously difficult to make a vaccine that contains all the contributing pathogenic bacteria. Here, we report the design and fabrication of a bacterial ghost (BG) of E. coli O78:K80, which is among the major bacterial serotypes responsible for this disease. The generated ghost is then exploited as a homologous vaccine against Avian Colibacillosis. We demonstrate that hole formation in the cell wall of E. coli O78:K80 can happen properly in optical densities as high as 0.8 compared to the 0.3-0.4 standard for bacteria like E. coli TOP10. This is especially advantageous for mass production of this ghost which is a vital factor in development of any BG-based vaccine. Compared to E. coliTOP10, we faced a great challenge in transforming the wild type bacteria with the E-lysis plasmid which was probably due to higher thickness of the cell wall in O78:K80. This, however, was addressed by treating the cell wall with a different combination of ions. The vaccine was administered to Ross 308 broiler chickens via injection as well as through their respiratory system at a dose of 1010 BGs, repeated 3 times at weekly intervals. Chickens were then challenged with the wild type O78:K80 at a dose of 1011 bacteria together with Infectious Bronchitis H120 vaccine (as immunosuppressant) one week after the last immunization. Air sac lesions were significantly reduced in BG vaccinated groups in comparison with the control group. The levels of IFN gamma, IgA and IgY were measured in the serum of immunized chickens as an indication of immune response and were compared with those of the chickens vaccinated with killed bacteria. The results show that O78:K80 BG can be used as an efficient homologous vaccine against Colibacillosis disease in poultry. We expect our findings can serve as the starting point for designing more sophisticated vaccines that contain all three major pathogenic bacteria involved in avian Colibacillosis.	[Ebrahimi-Nik, Hakimeh; Rad, Mehrnaz] Ferdowsi Univ Mashhad, Dept Pathobiol, Fac Vet Med, Mashhad, Iran; [Bassami, Mohammad Reza; Mohri, Mehrdad] Ferdowsi Univ Mashhad, Dept Clin Sci, Fac Vet Med, Mashhad, Iran; [Khan, Mazhar I.] Univ Connecticut, Dept Pathobiol & Vet Sci, Storrs, CT USA	Ferdowsi University Mashhad; Ferdowsi University Mashhad; University of Connecticut	Mohri, M (corresponding author), Ferdowsi Univ Mashhad, Dept Clin Sci, Fac Vet Med, Mashhad, Iran.	mohri@ferdowsi.um.ac.ir	Mohri, Mehrdad/B-2355-2009		Ferdowsi University of Mashhad	Ferdowsi University of Mashhad	This work was supported by Ferdowsi University of Mashhad. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency EM, CVMP ASSESSMENT REPO; AMARA A, 1995, VET MICROBIOL, V43, P325, DOI 10.1016/0378-1135(94)00101-2; [Anonymous], 1997, DIS POULTRY; BLASI U, 1989, J BIOL CHEM, V264, P4552; Brussow H, 2005, MICROBIOL-SGM, V151, P2133, DOI 10.1099/mic.0.27849-0; Charleston B, 1998, ANTIMICROB AGENTS CH, V42, P83, DOI 10.1128/AAC.42.1.83; Derakhshandeh A, 2009, LETT APPL MICROBIOL, V49, P403, DOI 10.1111/j.1472-765X.2009.02681.x; Dziva F, 2008, AVIAN PATHOL, V37, P355, DOI 10.1080/03079450802216652; Ebrahimi Nik H, 2014, IN VITRO STUDIES DEV; Ebrahimi Nik HBMRRMMM, 2013, EXPRESSION VECTOR PM; Haidinger W, 2003, APPL ENVIRON MICROB, V69, P6106, DOI 10.1128/AEM.69.10.6106-6113.2003; Harry E. G., 1964, Veterinary Record, V76, P443; Haslberger AG, 2000, J BIOTECHNOL, V83, P57, DOI 10.1016/S0168-1656(00)00298-4; Kabir SML, 2017, EGG INNOVATIONS AND STRATEGIES FOR IMPROVEMENTS, P523, DOI 10.1016/B978-0-12-800879-9.00049-4; Kabir SML, 2010, INT J ENV RES PUB HE, V7, P89, DOI 10.3390/ijerph7010089; Kawano M, 2006, MICROBIOL IMMUNOL, V50, P961, DOI 10.1111/j.1348-0421.2006.tb03872.x; Kazemnia Ali, 2014, Iranian Biomedical Journal, V18, P219, DOI 10.6091/ibj.1394.2014; Kenneth EA, HUMANE FARM ANIMAL C; KLEVEN SH, 1972, AVIAN DIS, V16, P915, DOI 10.2307/1588772; KWAGA JKP, 1994, INFECT IMMUN, V62, P3766, DOI 10.1128/IAI.62.9.3766-3772.1994; La Ragione RM, 2001, VET MICROBIOL, V79, P133, DOI 10.1016/S0378-1135(00)00350-3; Lynne AM, 2012, AVIAN DIS, V56, P192, DOI 10.1637/9861-072111-Reg.1; Mayr UB, 2005, ADV DRUG DELIVER REV, V57, P1381, DOI 10.1016/j.addr.2005.01.027; MELAMED D, 1991, AVIAN DIS, V35, P17, DOI 10.2307/1591289; Mombarg M, 2014, AVIAN PATHOL, V43, P276, DOI 10.1080/03079457.2014.917760; Sadeyen JR, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-19; Singer RS, 2006, AVIAN DIS, V50, P161, DOI 10.1637/7569-033106R.1; SOERIPTO, 1989, AUST VET J, V66, P65, DOI 10.1111/j.1751-0813.1989.tb09746.x; STEVEN L, 2013, AVMA GUIDELINES EUTH; WITTE A, 1992, ARCH MICROBIOL, V157, P381, DOI 10.1007/BF00248685; WITTE A, 1990, BIOCHIMIE, V72, P191, DOI 10.1016/0300-9084(90)90145-7; Wu XY, 2007, APPL ENVIRON MICROB, V73, P83, DOI 10.1128/AEM.00990-06; Yang HC, 2004, J CLIN MICROBIOL, V42, P3483, DOI 10.1128/JCM.42.8.3483-3489.2004; Zahraei ST, 2002, J VET RES, V56	34	20	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194888	10.1371/journal.pone.0194888	http://dx.doi.org/10.1371/journal.pone.0194888			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566080	Green Published, gold			2022-12-26	WOS:000428093900117
J	Krishnamurthi, N; Francis, J; Fihn, SD; Meyer, CS; Whooley, MA				Krishnamurthi, Nirupama; Francis, Joseph; Fihn, Stephan D.; Meyer, Craig S.; Whooley, Mary A.			Leading causes of cardiovascular hospitalization in 8.45 million US veterans	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ELECTRONIC HEALTH RECORDS; ADMINISTRATIVE DATA; RACIAL-DIFFERENCES; VALIDATED METHODS; CLINICAL-TRIALS; UNITED-STATES; BIG DATA; HEART; AFFAIRS	Background We sought to determine the leading causes of cardiovascular (CV) hospitalization, and to describe and compare national rates of CV hospitalization by age, gender, race, ethnicity, region, and year, among U.S. veterans. Methods We evaluated the electronic health records of all veterans aged >18 years who had accessed any healthcare services at either a VA healthcare facility or a non-VA healthcare facility that was reimbursed by the VA, between January 1 2010 and December 31 2014. Among these 8,452,912 patients, we identified the 5 leading causes of CV hospitalization and compared rates of hospitalization by age, gender, race, ethnicity, region, year and type of VA healthcare user. Results The top 5 causes of CV hospitalization were: coronary atherosclerosis, heart failure, acute myocardial infarction, stroke and atrial fibrillation. Overall, 297,373 (3.5%) veterans were hospitalized for one or more of these cardiovascular conditions. The percentage of veterans hospitalized for one or more of these CV conditions decreased over time, from 1.23% in 2010 to 1.18% in 2013, followed by a slight increase to 1.20% in 2014. There was significant variation in rates of CV hospitalization by gender, race, ethnicity, geographic region, and urban vs. rural zip code. In particular, older, male, Black, non-Hispanic, urban and Continental region veterans experienced the highest rates of CV hospitalizations. Conclusions Among 8.5 million patients enrolled in the VA healthcare system from 2010 to 2014, there was substantial variation in rates of CV hospitalization by age, gender, race, geographical distribution, year, and use of non-VA (vs. VA only) healthcare care facilities.	[Krishnamurthi, Nirupama; Meyer, Craig S.; Whooley, Mary A.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Krishnamurthi, Nirupama; Meyer, Craig S.; Whooley, Mary A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Francis, Joseph] Vet Hlth Adm, Off Reporting Analyt Performance Improvement & De, Washington, DC USA; [Fihn, Stephan D.] Univ Washington, Dept Med, Seattle, WA USA; [Fihn, Stephan D.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Whooley, Mary A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco	Whooley, MA (corresponding author), Vet Affairs Med Ctr, San Francisco, CA 94121 USA.; Whooley, MA (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	mary.whooley@ucsf.edu	PAN, ZEQIANG/X-6341-2018; Fihn, Stephan/ABA-1040-2020; Krishnamurthi, Nirupama/Q-2925-2019	Krishnamurthi, Nirupama/0000-0001-5096-5888; Whooley, Mary/0000-0002-5943-0078	Veterans Affairs Health Services Research & Development Service Quality Enhancement Research Initiative (QUERI)	Veterans Affairs Health Services Research & Development Service Quality Enhancement Research Initiative (QUERI)	This study was funded by the Veterans Affairs Health Services Research & Development Service Quality Enhancement Research Initiative (QUERI). https://www.queri.research.va.gov/.	[Anonymous], RUR VET OUTR TOOLK; [Anonymous], LOC MAP; [Anonymous], CHRON COND DAT WAR; Antman EM, 2016, CIRCULATION, V133, P823, DOI 10.1161/CIRCULATIONAHA.116.020976; Ashton CM, 1999, NEW ENGL J MED, V340, P32, DOI 10.1056/NEJM199901073400106; Benjamin E.J., 2017, CIRCULATION, V135, P146; Bufalino V, 2014, CIRC-CARDIOVASC QUAL, V7, P493, DOI 10.1161/HCQ.0000000000000003; Casper M, 2003, ATLAS STROKE MORTALI; Casper M, 2010, J AM COLL CARDIOL, V55, P294, DOI 10.1016/j.jacc.2009.10.021; Centers for Disease Control and Prevention National Center for Health Statistics, 2017, UND CAUS DEATH 1999; Corley DA, 2015, J ONCOL PRACT, V11, P204, DOI 10.1200/JOP.2014.003194; Fihn SD, 2014, HEALTH AFFAIR, V33, P1203, DOI 10.1377/hlthaff.2014.0054; Fleurence RL, 2014, J AM MED INFORM ASSN, V21, P578, DOI 10.1136/amiajnl-2014-002747; Goldstein KM, 2014, WOMEN HEALTH ISS, V24, P477, DOI 10.1016/j.whi.2014.05.005; Hripcsak G, 2015, STUD HEALTH TECHNOL, V216, P574, DOI 10.3233/978-1-61499-564-7-574; Jensen PN, 2012, PHARMACOEPIDEM DR S, V21, P141, DOI 10.1002/pds.2317; Kim J, 2017, J AM COLL CARDIOL, V69, P899, DOI 10.1016/j.jacc.2017.01.006; Lau E, 2016, CIRCULATION, V134, P362, DOI 10.1161/CIRCULATIONAHA.116.021892; Li B, 2011, AM J EPIDEMIOL, V174, P761, DOI 10.1093/aje/kwr154; Liu LJ, 2011, INT J CARDIOL, V149, P39, DOI 10.1016/j.ijcard.2009.11.037; Maynard C, 2004, DIABETES CARE, V27, pB22, DOI 10.2337/diacare.27.suppl_2.B22; McCormick N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135834; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Mentz RJ, 2016, CIRCULATION, V133, P872, DOI 10.1161/CIRCULATIONAHA.115.019902; Newby LK, 2015, CIRCULATION, V132, P1303, DOI 10.1161/CIRCULATIONAHA.115.018750; Niesner K, 2013, EPIDEMIOLOGY, V24, P334, DOI 10.1097/EDE.0b013e3182821e75; Noel PH, 2010, J REHABIL RES DEV, V47, P739, DOI 10.1682/JRRD.2009.08.0110; Office of Research and Development, VA RES CARD DIS; PETERSON ED, 1994, JAMA-J AM MED ASSOC, V271, P1175, DOI 10.1001/jama.271.15.1175; Price Lauren E, 2015, Nurs Adm Q, V39, P311, DOI 10.1097/NAQ.0000000000000118; ROGOT E, 1989, J CLIN EPIDEMIOL, V42, P245, DOI 10.1016/0895-4356(89)90060-7; Saczynski JS, 2012, PHARMACOEPIDEM DR S, V21, P129, DOI 10.1002/pds.2313; Solomon SD, 2016, CIRCULATION, V133, P2662, DOI 10.1161/CIRCULATIONAHA.115.020723; Subramanian U, 2002, J GEN INTERN MED, V17, P604, DOI 10.1046/j.1525-1497.2002.11048.x; Vasan RS, 2016, CIRCULATION, V133, P2626, DOI 10.1161/CIRCULATIONAHA.116.023528; Weintraub WS, 2011, CIRCULATION, V124, P103, DOI 10.1161/CIR.0b013e31821ccf71; WHITTLE J, 1993, NEW ENGL J MED, V329, P621, DOI 10.1056/NEJM199308263290907; Wright SM, 1997, HEALTH SERV RES, V31, P739; Young BA, 2003, DIABETES CARE, V26, P2392, DOI 10.2337/diacare.26.8.2392	39	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0193996	10.1371/journal.pone.0193996	http://dx.doi.org/10.1371/journal.pone.0193996			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA1RF	29566396	Green Submitted, Green Published, gold			2022-12-26	WOS:000428093900026
J	Neumann, PA; Twardy, V; Becker, F; Geyer, C; Schwegmann, K; Mohr, A; Faust, A; Lenz, P; Rijcken, E				Neumann, Philipp-Alexander; Twardy, Vanessa; Becker, Felix; Geyer, Christiane; Schwegmann, Katrin; Mohr, Annika; Faust, Andreas; Lenz, Philipp; Rijcken, Emile			Assessment of MMP-2/-9 expression by fluorescence endoscopy for evaluation of anastomotic healing in a murine model of anastomotic leakage	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; COLORECTAL SURGERY; INTESTINAL ANASTOMOSES; COLON-CANCER; REPAIR; INHIBITION; COLITIS; MICE; RESECTION	Background Disturbance of intestinal wound closure leads to insufficient anastomotic healing and is associated with considerable morbidity following colorectal resections. Matrix metalloproteinases (MMPs) play a crucial role in regulation of wound closure. Here fluorescence endoscopy was evaluated for assessment of MMP-2/-9 expression during failed intestinal anastomotic healing. Methods Distal colonic anastomoses were performed as a model for disturbed healing in 36 Balb/c mice. Healing was evaluated endoscopically, macroscopically, and histologically after 1, 3 and 5 days. For detection of MMP-2/-9 expression fluorescence endoscopy (FE) was used following i.v.-administration of a Cy5.5-labeled MMP-2/-9 specific tracer. FE was complemented by quantification of the fluorescence signal using the MS-FX PRO Optical Imaging System. An overall leakage score was calculated and correlated with the results of FE. Results With increasing incidence of anastomotic leakage from POD1 (17%) to POD5 (83%) the uptake of the MMP tracer gradually increased (signal-to-noise ratio (SNR), POD1: 17.91 +/- 1.251 vs. POD3: 30.56 +/- 3.03 vs. PODS: 44.8 +/- 4.473, P<0.0001). Mice with defective anastomotic healing showed significantly higher uptake compared to non-defective (SNR: 37.37 +/- 3.63 vs. 26.16 +/- 3.635, P = 0.0369). White light endoscopy and FE allowed evaluation of anastomotic healing and visualization of mucosal MMPs in vivo. Using FE based detection of MMPs in the anastomosis, an overall positive predictive value of 71.4% and negative pre dictive value of 66.6% was calculated for detection of anastomotic leakage. Conclusion During disturbed anastomotic healing increased expression of MMP-2/-9 was observed in the anastomotic tissue. Fluorescence endoscopy for detection of MMP-2/-9 during the healing process might be a promising tool for early identification of anastomotic leakage.	[Neumann, Philipp-Alexander; Twardy, Vanessa; Becker, Felix; Mohr, Annika; Rijcken, Emile] Muenster Univ Hosp, Dept Gen & Visceral Surg, Munster, Germany; [Geyer, Christiane] Muenster Univ Hosp, Dept Radiol, Munster, Germany; [Schwegmann, Katrin; Faust, Andreas] Univ Munster, European Inst Mol Imaging, Munster, Germany; [Lenz, Philipp] Muenster Univ Hosp, Dept Palliat Med, Munster, Germany; [Neumann, Philipp-Alexander] Tech Univ Munich, Sch Med, Klinikum Rechts Isar, Dept Surg, Munich, Germany	University of Munster; University of Munster; University of Munster; University of Munster; Technical University of Munich	Neumann, PA (corresponding author), Muenster Univ Hosp, Dept Gen & Visceral Surg, Munster, Germany.; Neumann, PA (corresponding author), Tech Univ Munich, Sch Med, Klinikum Rechts Isar, Dept Surg, Munich, Germany.	Philipp-Alexander.Neumann@tum.de	Becker, Felix/AFJ-0777-2022; Becker, Felix/AAF-4456-2022; Neumann, Philipp-Alexander/AAE-2940-2019	Neumann, Philipp-Alexander/0000-0001-8361-3934	innovative medical research grant (IMF, Innovative Medizinische Forschung), University of Muenster, Germany [NE-211417]	innovative medical research grant (IMF, Innovative Medizinische Forschung), University of Muenster, Germany	This work has been funded by the innovative medical research grant (IMF, Innovative Medizinische Forschung, NE-211417), University of Muenster, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren MS, 2006, SURGERY, V140, P72, DOI 10.1016/j.surg.2005.12.013; Agren MS, 2011, INT J COLORECTAL DIS, V26, P329, DOI 10.1007/s00384-010-1106-3; Agren MS, 2004, MINI-REV MED CHEM, V4, P769; Attard JAP, 2005, DIS COLON RECTUM, V48, P1460, DOI 10.1007/s10350-005-0047-3; Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; Bettenworth D, 2016, CLIN EXP METASTAS, V33, P551, DOI 10.1007/s10585-016-9797-7; Bremer C, 2001, NAT MED, V7, P743, DOI 10.1038/89126; Bremer C, 2003, EUR RADIOL, V13, P231, DOI 10.1007/s00330-002-1610-0; Bremer C, 2001, RADIOLOGY, V221, P523, DOI 10.1148/radiol.2212010368; Deitmar S, 2009, ZBL CHIR, V134, P83, DOI 10.1055/s-0028-1098768; Faust A, 2008, BIOCONJUGATE CHEM, V19, P1001, DOI 10.1021/bc700409j; Garcia-Granero A, 2013, DIS COLON RECTUM, V56, P475, DOI 10.1097/DCR.0b013e31826ce825; Girard E, 2014, J VISC SURG, V151, P441, DOI 10.1016/j.jviscsurg.2014.10.004; HENDRIKS T, 1990, DIS COLON RECTUM, V33, P891, DOI 10.1007/BF02051930; Kim SH, 2015, J GASTRIC CANCER, V15, P167, DOI 10.5230/jgc.2015.15.3.167; Kingham TP, 2009, J AM COLL SURGEONS, V208, P269, DOI 10.1016/j.jamcollsurg.2008.10.015; Kornmann V, 2016, INT J COLORECTAL DIS, V31, P459, DOI 10.1007/s00384-015-2468-3; Krarup PM, 2013, INT J COLORECTAL DIS, V28, P1151, DOI 10.1007/s00384-013-1697-6; Kuehn F, 2016, J GASTROINTEST SURG, V20, P328, DOI 10.1007/s11605-015-3017-7; Mahmood U, 1999, RADIOLOGY, V213, P866, DOI 10.1148/radiology.213.3.r99dc14866; Paulasir S, 2015, DIS COLON RECTUM, V58, P870, DOI 10.1097/DCR.0000000000000430; PHILLIPS JD, 1992, AM J SURG, V163, P71, DOI 10.1016/0002-9610(92)90255-P; Power N, 2007, CLIN RADIOL, V62, P37, DOI 10.1016/j.crad.2006.08.004; Rijcken E, 2010, BRIT J SURG, V97, P258, DOI 10.1002/bjs.6781; Rijcken E, 2014, J SURG RES, V187, P202, DOI 10.1016/j.jss.2013.10.013; Savage FJ, 1997, DIS COLON RECTUM, V40, P962, DOI 10.1007/BF02051206; Schwegmann K, 2016, INFLAMM BOWEL DIS, V22, P82, DOI 10.1097/MIB.0000000000000605; Steingraber AK, 2013, EXP DERMATOL, V22, P730, DOI 10.1111/exd.12253; van't Sant HP, 2011, AM J SURG, V202, P321, DOI 10.1016/j.amjsurg.2010.10.018; Waldner MJ, 2011, NAT PROTOC, V6, P1471, DOI 10.1038/nprot.2011.377; Walker KG, 2004, ANN SURG, V240, P255, DOI 10.1097/01.sla.0000133186.81222.08; ZUHLKE HV, 1990, LANGENBECK ARCH CHIR, P1009	32	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194249	10.1371/journal.pone.0194249	http://dx.doi.org/10.1371/journal.pone.0194249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566031	gold, Green Published, Green Submitted			2022-12-26	WOS:000428093900045
J	Luo, BB; Xiang, D; Wu, D; Liu, CC; Fang, YQ; Chen, PJ; Hu, YP				Luo, Beibei; Xiang, Dao; Wu, Die; Liu, Changcheng; Fang, Yiqun; Chen, Peijie; Hu, Yi-Ping			Hepatic PHD2/HIF-1 axis is involved in postexercise systemic energy homeostasis	FASEB JOURNAL			English	Article						liver; swimming; metabolic chamber; hypoxia; energy metabolism	FATTY LIVER-DISEASE; PHYSICAL-ACTIVITY; ACID HOMEOSTASIS; SHORT-TERM; EXERCISE; HYPOXIA; MICE; HIF-1-ALPHA; GLUCOSE; BINDING	Exercise plays an important role in the prevention and treatment of chronic liver disease and associated metabolic disorders. A single bout of exercise induces tissue blood flow redistribution, which decreases splanchnic circulation and leads to physiologic hypoxia in the gastrointestinal system and liver. The transcription factor, hypoxia inducible factor-1 (HIF-1), and its regulator, prolylhydroxylase 2 (PHD2), play pivotal roles in the response to oxygen flux by regulating downstream gene expression levels in the liver. We hypothesized that exercise increases the HIF-1 levels in the liver, and that the hepatic PHD2/HIF-1 axis is involved in postexercise restoration of systemic energy homeostasis. Through constant O-2 consumption, CO2 production, food and water intake, and physical activity detection with metabolic chambers, we observed that one 30-min session of swimming exercise enhances systemic energy metabolism in mice. By using the noninvasive bioluminescence imaging ROSA26 oxygen-dependent domain Luc mouse model, we reveal that exercise increases in vivo HIF levels in the liver. Intraperitoneal injections of the PHD inhibitor, dimethyloxalylglycine, mimicked exercise-induced HIF increase, whereas the HIF-1 inhibitor, PX-478, blocked this effect. We next constructed liver-specific knockout (LKO) mouse models with albumin-Cre-mediated, hepatocyte-specific Hif1a and Phd2 deletion. Compared with their controls, Hif1a-LKO and Phd2-LKO mice exhibited distinct patterns of hepatic metabolism-related gene expression profiles. Moreover, Hif1a-LKO mice failed to restore systemic energy homeostasis after exercise. In conclusion, the current study demonstrates that a single bout of exercise disrupts systemic energy homeostasis, increasing the HIF-1 levels in the liver. These findings also provide evidence that the hepatic PHD2/HIF-1 axis is involved in postexercise systemic metabolic homeostasis.Luo, B., Xiang, D., Wu, D., Liu, C., Fang, Y., Chen, P., Hu, Y.-P. Hepatic PHD2/HIF-1 axis is involved in postexercise systemic energy homeostasis.	[Luo, Beibei; Wu, Die; Chen, Peijie; Hu, Yi-Ping] Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China; [Luo, Beibei; Liu, Changcheng; Hu, Yi-Ping] Second Mil Med Univ, Dept Cell Biol, 800 Xiangyin Rd, Shanghai 200433, Peoples R China; [Xiang, Dao; Fang, Yiqun] Second Mil Med Univ, Naval Med Res Inst, Dept Div Med, Shanghai, Peoples R China	Shanghai University of Sport; Naval Medical University; Naval Medical University	Hu, YP (corresponding author), Second Mil Med Univ, Dept Cell Biol, 800 Xiangyin Rd, Shanghai 200433, Peoples R China.	yphu@smmu.edu.cn			National Natural Science Foundation of China [31471135, 31701040]; China Postdoctoral Science Foundation [2015M572679]; Shanghai Sailing Program [17YF1418000]; Chenguang Program [16CG57]; Major Logistics Projects of the People's Liberation Army (PLA) [AWS16J033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Sailing Program; Chenguang Program; Major Logistics Projects of the People's Liberation Army (PLA)	The authors thank Shennian Ge and Prof. Yexiong Tan [Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (SMMU)] for bioluminescent imaging; Prof. Haiying Zhu, Prof. Wenlin Li, and Prof. Xiaoyuan Zi (Department of Cell Biology, SMMU) for useful discussions; Qin Yang and Prof. Xin Xu (School of Kinesiology, Shanghai University of Sport) for animal studies and proofreading; Yongchao Cai and Prof. Zhiying He (Shanghai East Hospital, Tongji University, Shanghai, China) for technical help and animal studies. P.C. was supported by the National Natural Science Foundation of China (31471135). B.L. was supported by the National Natural Science Foundation of China (31701040), China Postdoctoral Science Foundation (2015M572679), Shanghai Sailing Program (17YF1418000), and Chenguang Program (16CG57). Y.F. was supported by Major Logistics Projects of the People's Liberation Army (PLA) (AWS16J033). The authors declare no conflicts of interest.	Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; BISHOP JM, 1957, J PHYSIOL-LONDON, V137, P309, DOI 10.1113/jphysiol.1957.sp005814; Camacho RC, 2006, AM J PHYSIOL-ENDOC M, V290, pE405, DOI 10.1152/ajpendo.00385.2005; Campbell EL, 2014, IMMUNITY, V40, P66, DOI 10.1016/j.immuni.2013.11.020; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Emhoff CAW, 2013, J APPL PHYSIOL, V114, P297, DOI 10.1152/japplphysiol.01202.2012; Flannigan KL, 2015, FASEB J, V29, P1591, DOI 10.1096/fj.14-266015; George AS, 2009, HEPATOLOGY, V50, P68, DOI 10.1002/hep.22940; Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065; Haus JM, 2013, J CLIN ENDOCR METAB, V98, pE1181, DOI 10.1210/jc.2013-1229; Hawley JA, 2014, CELL, V159, P738, DOI 10.1016/j.cell.2014.10.029; Herbst EAF, 2014, AM J PHYSIOL-REG I, V306, pR102, DOI 10.1152/ajpregu.00150.2013; Hodson EJ, 2016, J PHYSIOL-LONDON, V594, P1179, DOI 10.1113/JP271050; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; Kim KH, 2017, HEPATOLOGY, V66, P498, DOI 10.1002/hep.29199; Knab AM, 2011, MED SCI SPORT EXER, V43, P1643, DOI 10.1249/MSS.0b013e3182118891; Kregel K. C., 2006, RESOURCE BOOK DESIGN, P53; Lee YS, 2014, CELL, V157, P1339, DOI 10.1016/j.cell.2014.05.012; Li TG, 2013, HEPATOLOGY, V58, P1111, DOI 10.1002/hep.26427; Liu Y, 2013, AM J PHYSIOL-GASTR L, V304, pG449, DOI 10.1152/ajpgi.00199.2012; Luo BB, 2014, BRAIN BEHAV IMMUN, V39, P99, DOI 10.1016/j.bbi.2013.11.013; Melanson EL, 2007, J APPL PHYSIOL, V103, P1576, DOI 10.1152/japplphysiol.01455.2006; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Nath B, 2011, HEPATOLOGY, V53, P1526, DOI 10.1002/hep.24256; Nishiyama Y, 2012, J HEPATOL, V56, P441, DOI 10.1016/j.jhep.2011.07.024; Olenchock BA, 2016, CELL, V164, P884, DOI 10.1016/j.cell.2016.02.006; Otte JA, 2001, J APPL PHYSIOL, V91, P866, DOI 10.1152/jappl.2001.91.2.866; Perko MJ, 1998, J PHYSIOL-LONDON, V513, P907, DOI 10.1111/j.1469-7793.1998.907ba.x; Powers SK, 2016, J PHYSIOL-LONDON, V594, P5081, DOI 10.1113/JP270646; RAVUSSIN E, 1986, J CLIN INVEST, V78, P1568, DOI 10.1172/JCI112749; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shibue K, 2015, AM J PHYSIOL-ENDOC M, V308, pE583, DOI 10.1152/ajpendo.00543.2014; Suhara T, 2015, P NATL ACAD SCI USA, V112, P11642, DOI 10.1073/pnas.1515872112; Sullivan S, 2012, HEPATOLOGY, V55, P1738, DOI 10.1002/hep.25548; Taniguchi CM, 2013, NAT MED, V19, P1325, DOI 10.1038/nm.3294; van Wijck K, 2012, AM J PHYSIOL-GASTR L, V303, pG155, DOI 10.1152/ajpgi.00066.2012; Wang F, 2012, P NATL ACAD SCI USA, V109, P9641, DOI 10.1073/pnas.1201433109; Wang QO, 2010, J LIPID RES, V51, P2516, DOI 10.1194/jlr.M003335; Wu D, 2017, ELIFE, V6, DOI 10.7554/eLife.25217; Yang YF, 2005, J APPL PHYSIOL, V98, P1745, DOI 10.1152/japplphysiol.01185.2004; Zelber-Sagi S, 2008, HEPATOLOGY, V48, P1791, DOI 10.1002/hep.22525; Zhang N, 2010, CELL METAB, V11, P364, DOI 10.1016/j.cmet.2010.03.001	45	8	9	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4670	4680		10.1096/fj.201701139R	http://dx.doi.org/10.1096/fj.201701139R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29601782				2022-12-26	WOS:000443817700005
J	Cheng, QW; Danao, J; Talreja, S; Wen, P; Yin, J; Sun, N; Li, CM; Chui, D; Tran, D; Koirala, S; Chen, H; Foltz, IN; Wang, SL; Sambashivan, S				Cheng, Qingwen; Danao, Jean; Talreja, Santosh; Wen, Paul; Yin, Jun; Sun, Ning; Li, Chi-Ming; Chui, Danny; Tran, David; Koirala, Samir; Chen, Hang; Foltz, Ian N.; Wang, Songli; Sambashivan, Shilpa			TREM2-activating antibodies abrogate the negative pleiotropic effects of the Alzheimer's disease variant Trem2(R47H) on murine myeloid cell function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neuroinflammation; neurodegeneration; Alzheimer's disease; microglia; antibody; myeloid cell; genetics; gene knockout; R47H TREM2	TREM2 DEFICIENCY; MOUSE MODEL; MICROGLIA; NEURODEGENERATION; MACROPHAGES; PROGRESSION; EXPRESSION; LIGAND; BINDS; DAP12	Triggering receptor expressed on myeloid cells 2 (TREM2) is an orphan immune receptor expressed on cells of myeloid lineage such as macrophages and microglia. The rare variant R47H TREM2 is associated with an increased risk for Alzheimer's disease, supporting the hypothesis that TREM2 loss of function may exacerbate disease progression. However, a complete knockout of the TREM2 gene in different genetic models of neurodegenerative diseases has been reported to result in both protective and deleterious effects on disease-related end points and myeloid cell function. Here, we describe a Trem2(R47H) transgenic mouse model and report that even in the absence of additional genetic perturbations, this variant clearly confers a loss of function on myeloid cells. The Trem2(R47H) variant-containing myeloid cells exhibited subtle defects in survival and migration and displayed an unexpected dysregulation of cytokine responses in a lipopolysaccharide challenge environment. These subtle phenotypic defects with a gradation in severity across genotypes were confirmed in whole-genome RNA-Seq analyses of WT, Trem2(-/-), and Trem2(R47H) myeloid cells under challenge conditions. Of note, TREM2-activating antibodies that boost proximal signaling abrogated survival defects conferred by the variant and also modulated migration and cytokine responses in an antibody-, ligand-, and challenge-dependent manner. In some instances, these antibodies also boosted WT myeloid cell function. Our studies provide a first glimpse into the boost in myeloid cell function that can be achieved by pharmacological modulation of TREM2 activity that can potentially be ameliorative in neurodegenerative diseases such as Alzheimer's disease.	[Cheng, Qingwen; Danao, Jean; Talreja, Santosh; Yin, Jun; Li, Chi-Ming; Chen, Hang; Wang, Songli; Sambashivan, Shilpa] Amgen Inc, Dept Discovery Res, San Francisco, CA 94080 USA; [Wen, Paul; Sun, Ning; Tran, David; Koirala, Samir] Amgen Inc, Dept Discovery Res, Thousand Oaks, CA 91320 USA; [Chui, Danny; Foltz, Ian N.] Amgen Inc, Dept Discovery Res, Burnaby, BC V5A 1V7, Canada; [Chui, Danny] Zymeworks, 540-1385 W 8th Ave, Vancouver, BC V6H 3V9, Canada; [Koirala, Samir] Biogen Inc, 225 Binney St, Cambridge, MA 02142 USA; [Chen, Hang] Denali Therapeut Inc, 151 Oyster Point Blvd, San Francisco, CA 94080 USA	Amgen; Amgen; Biogen	Sambashivan, S (corresponding author), Proneurotech Inc, 171 Oyester Point Blvd,Ste 400, San Francisco, CA 94080 USA.	shilpashivan@gmail.com	Li, Chi-Ming/ABA-6457-2020		Amgen Inc.	Amgen Inc.(Amgen)	This work was supported by Amgen Inc., and all authors were employees of Amgen at the time the research was conducted.	Allcock RJN, 2003, EUR J IMMUNOL, V33, P567, DOI 10.1002/immu.200310033; Atagi Y, 2015, J BIOL CHEM, V290, P26043, DOI 10.1074/jbc.M115.679043; Bailey CC, 2015, J BIOL CHEM, V290, P26033, DOI 10.1074/jbc.M115.677286; Bemiller SM, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0216-6; Benitez BA, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.12.010; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Guedes Joana R, 2016, Alzheimers Dement (Amst), V3, P7, DOI 10.1016/j.dadm.2015.11.004; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guerreiro RJ, 2013, JAMA NEUROL, V70, P78, DOI 10.1001/jamaneurol.2013.579; Hu J, 2012, BIOINFORMATICS, V28, P1933, DOI 10.1093/bioinformatics/bts294; Ishizuka K, 1997, PSYCHIAT CLIN NEUROS, V51, P135, DOI 10.1111/j.1440-1819.1997.tb02375.x; Jay TR, 2017, J NEUROSCI, V37, P637, DOI [10.1523/JNEUROSCI.2110-16.2017, 10.1523/JNEUROSCI.2110-16.2016]; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kang SS, 2018, HUM MOL GENET, V27, P211, DOI 10.1093/hmg/ddx366; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kiialainen A, 2005, NEUROBIOL DIS, V18, P314, DOI 10.1016/j.nbd.2004.09.007; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Leyns CEG, 2017, P NATL ACAD SCI USA, V114, P11524, DOI 10.1073/pnas.1710311114; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Otero K, 2009, NAT IMMUNOL, V10, P734, DOI 10.1038/ni.1744; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Schmid CD, 2002, J NEUROCHEM, V83, P1309, DOI 10.1046/j.1471-4159.2002.01243.x; Song W, 2017, ALZHEIMERS DEMENT, V13, P381, DOI 10.1016/j.jalz.2016.07.004; Song WM, 2018, J EXP MED, V215, P745, DOI 10.1084/jem.20171529; Ulland TK, 2017, CELL, V170, P649, DOI 10.1016/j.cell.2017.07.023; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Westin K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030525; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Yuan P, 2016, NEURON, V92, P252, DOI 10.1016/j.neuron.2016.09.016; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Zheng HH, 2016, NEUROBIOL AGING, V42, P132, DOI 10.1016/j.neurobiolaging.2016.03.004	37	39	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12620	12633		10.1074/jbc.RA118.001848	http://dx.doi.org/10.1074/jbc.RA118.001848			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29599291	hybrid, Green Published			2022-12-26	WOS:000441408500026
J	Ozes, AR; Pulliam, N; Ertosun, MG; Yilmaz, O; Tang, J; Copuroglu, E; Matei, D; Ozes, ON; Nephew, KP				Ozes, Ali R.; Pulliam, Nick; Ertosun, Mustafa G.; Yilmaz, Ozlem; Tang, Jessica; Copuroglu, Ece; Matei, Daniela; Ozes, Osman N.; Nephew, Kenneth P.			Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity	ONCOGENE			English	Article							OVARIAN-CANCER CELLS; ZESTE HOMOLOG 2; PKA PHOSPHORYLATES; PROSTATE-CANCER; TARGETING EZH2; STEM-CELLS; IN-VITRO; PROLIFERATION; COMPLEX; GENE	Polycomb repressive complex 2 (PRC2) member enhancer of zeste homolog 2 (EZH2) trimethylates histone H3 lysine 27 (H3K27me3), alters chromatin structure and contributes to epigenetic regulation of gene expression in normal and disease processes. Phosphorylation of EZH2 augmented EZH2 oncogenic activity in cancer but observations have been limited to threonine 350 (T350) and serine 21 (S21) residues by cyclin-dependent kinase 1 and protein kinase B, respectively. In addition, phosphorylation of the evolutionarily conserved T372 motif of EZH2 by p38 resulted in EZH2 interaction with Ying Yang 1 and promoted muscle stem cell differentiation. In the present study, we used epithelial ovarian cancer (OC) cells as a model to demonstrate that phosphorylation of EZH2 at T372 by protein kinase A (PKA) induced a dominant-negative EZH2 phenotype, inhibited OC cell proliferation and migration in vitro and decreased ovarian xenograft tumor growth in vivo. Phosphorylation of T372 by PKA enhanced the interaction between EZH2 and signal transducer and activator of transcription 3 (STAT3), and STAT3 binding to pT372-EZH2 reduced cellular levels of pSTAT3 and downregulated interleukin 6 receptor expression in OC. Furthermore, PKA-mediated pT372-EZH2 decreased ATP levels and altered mitochondrial gene expression, resulting in mitochondrial dysfunction and reduced OC cell growth. These findings demonstrate that PKA-mediated T372 phosphorylation reduces oncogenic EZH2 activity and reveal a novel role for pT372 in regulating EZH2 in OC and possibly other cancers.	[Ozes, Ali R.; Pulliam, Nick; Nephew, Kenneth P.] Indiana Univ, Mol & Cellular Biochem Dept, Bloomington, IN 47405 USA; [Ozes, Ali R.; Pulliam, Nick; Tang, Jessica; Nephew, Kenneth P.] Indiana Univ, Sch Med Med Sci, Bloomington, IN 47405 USA; [Ertosun, Mustafa G.; Yilmaz, Ozlem; Copuroglu, Ece; Ozes, Osman N.] Akdeniz Univ, Dept Med Biol & Genet, Antalya, Turkey; [Matei, Daniela] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Nephew, Kenneth P.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Nephew, Kenneth P.] Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Akdeniz University; Northwestern University; Feinberg School of Medicine; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Nephew, KP (corresponding author), Indiana Univ, Mol & Cellular Biochem Dept, Bloomington, IN 47405 USA.; Nephew, KP (corresponding author), Indiana Univ, Sch Med Med Sci, Bloomington, IN 47405 USA.; Ozes, ON (corresponding author), Akdeniz Univ, Dept Med Biol & Genet, Antalya, Turkey.; Nephew, KP (corresponding author), Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA.; Nephew, KP (corresponding author), Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA.	oozes@akdeniz.edu.tr; knephew@indiana.edu	Copuroglu, F.Ece/AAG-1925-2020	Matei, Daniela/0000-0003-2169-5035	National Cancer Institute [CA13001, CA182832]; V Foundation for Cancer Research Translational Grant; Walther Cancer Foundation (Indianapolis, IN); Doane and Eunice Dahl Wright Fellowship (Medical Sciences Program, Indiana University); NATIONAL CANCER INSTITUTE [R01CA182832] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); V Foundation for Cancer Research Translational Grant; Walther Cancer Foundation (Indianapolis, IN); Doane and Eunice Dahl Wright Fellowship (Medical Sciences Program, Indiana University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Fang Fang and Jay Pilrose for assistance with animal studies, Dr. Scott Michaels, Dr. Doug Rusch and Aaron Buechlein (Center for Genomics and Bioinformatics, Indiana University) for RNA-seq data analysis, Dr. Haojie Huang for EZH2-pGEX-4T-1 vectors (University of Minnesota) and Dr. Jian Jian (UC Davis) for PGL2-3 x -SIEGAS STAT3 reporter plasmid. We thank Dr. Heather O'Hagan and Dr. Peter Hollenorst (Medical Sciences, Indiana University School of Medicine) for critically reading the manuscript and offering valuable suggestions. This work was made possible by funding from the National Cancer Institute (Awards CA13001 and CA182832), The V Foundation for Cancer Research Translational Grant, Walther Cancer Foundation (Indianapolis, IN) and the Doane and Eunice Dahl Wright Fellowship (Medical Sciences Program, Indiana University).	Abbosh PH, 2006, CANCER RES, V66, P5582, DOI 10.1158/0008-5472.CAN-05-3575; Baba A, 2011, NAT CELL BIOL, V13, P668, DOI 10.1038/ncb2228; Bitler BG, 2015, NAT MED, V21, P231, DOI 10.1038/nm.3799; Cardenas H, 2016, ONCOTARGET, V7, P84453, DOI 10.18632/oncotarget.11497; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chen S, 2013, J IMMUNOL, V191, P2614, DOI 10.4049/jimmunol.1203143; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; Comet I, 2016, NAT REV CANCER, V16, P803, DOI 10.1038/nrc.2016.83; Copeland RA, 2013, ONCOGENE, V32, P939, DOI 10.1038/onc.2012.552; de Vries NA, 2015, CELL REP, V10, P383, DOI 10.1016/j.celrep.2014.12.028; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; Feliciello A, 2005, CELL SIGNAL, V17, P279, DOI 10.1016/j.cellsig.2004.09.009; Garcia-Bermudez J, 2015, CELL REP, V12, P2143, DOI 10.1016/j.celrep.2015.08.052; Garipov A, 2013, MOL CANCER RES, V11, P360, DOI 10.1158/1541-7786.MCR-12-0661; Gibaja V, 2016, ONCOGENE, V35, P558, DOI 10.1038/onc.2015.114; He AB, 2012, GENE DEV, V26, P37, DOI 10.1101/gad.173930.111; Hu S, 2010, CANCER BIOL THER, V10, P788, DOI 10.4161/cbt.10.8.12913; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Koppens M, 2016, ONCOGENE, V35, P1341, DOI 10.1038/onc.2015.195; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Li H, 2010, MOL CANCER RES, V8, P1610, DOI 10.1158/1541-7786.MCR-10-0398; Liu T, 2014, TUMOR BIOL, V35, P7239, DOI 10.1007/s13277-014-1950-9; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Matei D, 2012, CANCER RES, V72, P2197, DOI 10.1158/0008-5472.CAN-11-3909; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Ozes AR, 2016, ONCOGENE, V35, P5350, DOI 10.1038/onc.2016.75; Ozes AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00966-3; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Papa S, 2012, FEBS LETT, V586, P568, DOI 10.1016/j.febslet.2011.09.019; Rao X, 2011, ONCOGENE, V30, P1082, DOI 10.1038/onc.2010.487; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Villa R, 2007, CANCER CELL, V11, P513, DOI 10.1016/j.ccr.2007.04.009; Wang L, 2013, EMBO J, V32, P1584, DOI 10.1038/emboj.2013.95; Wang YN, 2014, CANCER RES, V74, P4922, DOI 10.1158/0008-5472.CAN-14-1022; Wee ZN, 2014, CELL REP, V8, P204, DOI 10.1016/j.celrep.2014.05.045; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Yamamoto Y, 2016, J PATHOL, V238, P519, DOI 10.1002/path.4649	42	13	14	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2018	37	26					3589	3600		10.1038/s41388-018-0218-z	http://dx.doi.org/10.1038/s41388-018-0218-z			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GK7TM	29576612	Green Accepted, Green Submitted			2022-12-26	WOS:000436412500009
J	Galera-Prat, A; Morais, S; Vazana, Y; Bayer, EA; Carrion-Vazquez, M				Galera-Prat, Albert; Morais, Sarah; Vazana, Yael; Bayer, Edward A.; Carrion-Vazquez, Mariano			The cohesin module is a major determinant of cellulosome mechanical stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atomic force microscopy (AFM); cellulosome; scaffold protein; single-molecule biophysics; protein stability; dockerin; linkers; nanomechanics; scaffoldin; single-molecule force spectroscopy	CLOSTRIDIUM-THERMOCELLUM; CRYSTAL-STRUCTURE; PROTEIN; DOMAIN; DEGRADATION; CELLULASE; CHIMERAS	Cellulosomes are bacterial protein complexes that bind and efficiently degrade lignocellulosic substrates. These are formed by multimodular scaffolding proteins known as scaffoldins, which comprise cohesin modules capable of binding dockerin-bearing enzymes and usually a carbohydrate-binding module that anchors the system to a substrate. It has been suggested that cellulosomes bound to the bacterial cell surface might be exposed to significant mechanical forces. Accordingly, the mechanical properties of these anchored cellulosomes may be important to understand and improve cellulosome function. Here we used single-molecule force spectroscopy to study the mechanical properties of selected cohesin modules from scaffoldins of different cellulosomes. We found that cohesins located in the region connecting the cell and the substrate are more robust than those located outside these two anchoring points. This observation applies to cohesins from primary scaffoldins (i.e. those that directly bind dockerin-bearing enzymes) from different cellulosomes despite their sequence differences. Furthermore, we also found that cohesin nanomechanics (specifically, mechanostability and the position of the mechanical clamp of cohesin) are not significantly affected by other cellulosomal components, including linkers between cohesins, multiple cohesin repeats, and dockerin binding. Finally, we also found that cohesins (from both the connecting and external regions) have poor refolding efficiency but similar refolding rates, suggesting that the high mechanostability of connecting cohesins may be an evolutionarily conserved trait selected to minimize the occurrence of cohesin unfolding, which could irreversibly damage the cellulosome. We conclude that cohesin mechanostability is a major determinant of the overall mechanical stability of the cellulosome.	[Galera-Prat, Albert; Carrion-Vazquez, Mariano] CSIC, Inst Cajal, Ave Doctor Arce 37, E-28002 Madrid, Spain; [Galera-Prat, Albert; Carrion-Vazquez, Mariano] Inst Madrileno Estudios Avanzados Nanociencia, Madrid 28049, Spain; [Morais, Sarah; Vazana, Yael; Bayer, Edward A.] Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Weizmann Institute of Science	Carrion-Vazquez, M (corresponding author), CSIC, Inst Cajal, Ave Doctor Arce 37, E-28002 Madrid, Spain.; Carrion-Vazquez, M (corresponding author), Inst Madrileno Estudios Avanzados Nanociencia, Madrid 28049, Spain.	mcarrion@cajal.csic.es	Carrion-Vazquez, Mariano/Y-3741-2018	Carrion-Vazquez, Mariano/0000-0001-7319-406X; Morais, Sarah/0000-0001-9026-2386	Seventh Framework Programme in Nanosciences, Nanotechnologies, Materials, and New Production Technologies [7PM-NMP 2013-17, 604530-2]; ERA-IB-ERANET through the Spanish MINECO [EIB.12.022, PCIN-2013-011-C02-01]; FPU fellowship from the Spanish MECD	Seventh Framework Programme in Nanosciences, Nanotechnologies, Materials, and New Production Technologies; ERA-IB-ERANET through the Spanish MINECO; FPU fellowship from the Spanish MECD(German Research Foundation (DFG))	This work was supported by a Seventh Framework Programme in Nanosciences, Nanotechnologies, Materials, and New Production Technologies (7PM-NMP 2013-17 and 604530-2) and ERA-IB-ERANET-2013-16 (EIB.12.022) through the Spanish MINECO (PCIN-2013-011-C02-01). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an FPU fellowship from the Spanish MECD.	Artzi L, 2017, NAT REV MICROBIOL, V15, P83, DOI 10.1038/nrmicro.2016.164; Artzi L, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-100; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Bayer EA., 2009, BIOTECHNOLOGY LIGNOC, P183; Bayer EA, 2007, CURR OPIN BIOTECH, V18, P237, DOI 10.1016/j.copbio.2007.04.004; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Cao Y, 2008, J MOL BIOL, V378, P1132, DOI 10.1016/j.jmb.2008.03.046; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Carvalho AL, 2003, P NATL ACAD SCI USA, V100, P13809, DOI 10.1073/pnas.1936124100; Carvalho AL, 2007, P NATL ACAD SCI USA, V104, P3089, DOI 10.1073/pnas.0611173104; Chwastyk M, 2014, PROTEINS, V82, P717, DOI 10.1002/prot.24436; Demain AL, 2005, MICROBIOL MOL BIOL R, V69, P124, DOI 10.1128/MMBR.69.1.124-154.2005; Fierobe HP, 2002, J BIOL CHEM, V277, P49621, DOI 10.1074/jbc.M207672200; Fierobe HP, 2001, J BIOL CHEM, V276, P21257, DOI 10.1074/jbc.M102082200; Garcia-Manyes S, 2009, P NATL ACAD SCI USA, V106, P10534, DOI 10.1073/pnas.0901213106; GERWIG GJ, 1989, J BIOL CHEM, V264, P1027; GERWIG GJ, 1993, J BIOL CHEM, V268, P26956; Hamberg Y, 2014, PEERJ, V2, DOI 10.7717/peerj.636; Hervas R, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001335; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Junker JP, 2009, SCIENCE, V323, P633, DOI 10.1126/science.1166191; Leibovitz E, 1996, J BACTERIOL, V178, P3077, DOI 10.1128/jb.178.11.3077-3084.1996; Li HB, 2008, J MOL BIOL, V379, P871, DOI 10.1016/j.jmb.2008.04.018; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Noach I, 2010, J MOL BIOL, V399, P294, DOI 10.1016/j.jmb.2010.04.013; Oroz J, 2011, J BIOL CHEM, V286, P9405, DOI 10.1074/jbc.M110.170399; Raman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005271; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1998, PHYS REV LETT, V81, P4764, DOI 10.1103/PhysRevLett.81.4764; Salama-Alber O, 2013, J BIOL CHEM, V288, P16827, DOI 10.1074/jbc.M113.466672; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schoeler C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6635; Shimon LJW, 1997, STRUCTURE, V5, P381, DOI 10.1016/S0969-2126(97)00195-0; Sievers Fabian, 2014, Curr Protoc Bioinformatics, V48, DOI 10.1002/0471250953.bi0313s48; Steward A, 2002, PROTEIN SCI, V11, P2179, DOI 10.1110/ps.0212702; Tavares GA, 1997, J MOL BIOL, V273, P701, DOI 10.1006/jmbi.1997.1326; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Valbuena A, 2009, P NATL ACAD SCI USA, V106, P13791, DOI 10.1073/pnas.0813093106; Valbuena A, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2794732; Vera AM, 2016, ANGEW CHEM INT EDIT, V55, P13970, DOI 10.1002/anie.201605284; White BA, 2014, ANNU REV MICROBIOL, V68, P279, DOI 10.1146/annurev-micro-092412-155618; Wojciechowski M, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4904726; Xu Q, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501254; Zhang MM, 2013, PHYS CHEM CHEM PHYS, V15, P6508, DOI 10.1039/c3cp51072g	46	10	10	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7139	7147		10.1074/jbc.RA117.000644	http://dx.doi.org/10.1074/jbc.RA117.000644			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29567834	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000432174500007
J	Wai, DCC; Szyszka, TN; Campbell, AE; Kwong, C; Wilkinson-White, LE; Silva, APG; Low, JKK; Kwan, AH; Gamsjaeger, R; Chalmers, JD; Patrick, WM; Lu, B; Vakoc, CR; Blobel, GA; Mackay, JP				Wai, Dorothy C. C.; Szyszka, Taylor N.; Campbell, Amy E.; Kwong, Cherry; Wilkinson-White, Lorna E.; Silva, Ana P. G.; Low, Jason K. K.; Kwan, Ann H.; Gamsjaeger, Roland; Chalmers, James D.; Patrick, Wayne M.; Lu, Bin; Vakoc, Christopher R.; Blobel, Gerd A.; Mackay, Joel P.			The BRD3 ET domain recognizes a short peptide motif through a mechanism that is conserved across chromatin remodelers and transcriptional regulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcriptional coactivator; acetylation; nuclear magnetic resonance (NMR); protein structure; protein; protein interaction; AF9; BET family proteins; bromodomain; extraterminal domain	BROMODOMAIN PROTEIN BRD3; AF9 YEATS DOMAIN; SELECTIVE-INHIBITION; EXTRATERMINAL DOMAIN; HISTONE ACETYLATION; MITOTIC CHROMOSOMES; BET BROMODOMAINS; TARGET GENES; COMPLEX; NURD	Members of the bromodomain and extra-terminal domain (BET) family of proteins (bromodomain-containing (BRD) 2, 3, 4, and T) are widely expressed and highly conserved regulators of gene expression in eukaryotes. These proteins have been intimately linked to human disease, and more than a dozen clinical trials are currently underway to test BET-protein inhibitors as modulators of cancer. However, although it is clear that these proteins use their bromodomains to bind both histones and transcription factors bearing acetylated lysine residues, the molecular mechanisms by which BET family proteins regulate gene expression are not well defined. In particular, the functions of the other domains such as the ET domain have been less extensively studied. Here, we examine the properties of the ET domain of BRD3 as a protein/protein interaction module. Using a combination of pulldown and biophysical assays, we demonstrate that BRD3 binds to a range of chromatin-remodeling complexes, including the NuRD, BAF, and INO80 complexes, via a short linear KIKL motif in one of the complex subunits. NMR-based structural analysis revealed that, surprisingly, this mode of interaction is shared by the AF9 and ENL transcriptional coregulators that contain an acetyl-lysine-binding YEATS domain and regulate transcriptional elongation. This observation establishes a functional commonality between these two families of cancer-related transcriptional regulators. In summary, our data provide insight into the mechanisms by which BET family proteins might link chromatin acetylation to transcriptional outcomes and uncover an unexpected functional similarity between BET and YEATS family proteins.	[Wai, Dorothy C. C.; Szyszka, Taylor N.; Kwong, Cherry; Wilkinson-White, Lorna E.; Silva, Ana P. G.; Low, Jason K. K.; Kwan, Ann H.; Gamsjaeger, Roland; Mackay, Joel P.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia; [Campbell, Amy E.; Blobel, Gerd A.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Campbell, Amy E.; Blobel, Gerd A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Chalmers, James D.; Patrick, Wayne M.] Univ Otago, Dept Biochem, Dunedin 9016, New Zealand; [Lu, Bin; Vakoc, Christopher R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	University of Sydney; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Otago; Cold Spring Harbor Laboratory	Mackay, JP (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia.	joel.mackay@sydney.edu.au	Mackay, Joel P/D-6834-2011	Mackay, Joel P/0000-0001-7508-8033; Szyszka, Taylor/0000-0002-9921-3086; Wai, Dorothy Che Ching/0000-0002-3871-9980; Kwan, Ann/0000-0002-1506-2226; Gamsjaeger, Roland/0000-0003-1095-2569; Patrick, Wayne/0000-0002-2718-8053; Campbell, Amy E./0000-0001-6513-5836; Low, Jason/0000-0003-0862-0012	Australian National Health and Medical Research Council [APP1063301, APP1058916]; National Institutes of Health Grant [R01DK054937]; National Institutes of Health Training Grant [T32 DK07780]; Australian National Health and Medical Research Council; NATIONAL CANCER INSTITUTE [R01CA174793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054937] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Australian National Health and Medical Research Council Grants APP1063301 and APP1058916 (to J.P.M.) and National Institutes of Health Grant R01DK054937 (to G.A.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Training Grant T32 DK07780.; Supported by a Senior Research Fellowship from the Australian National Health and Medical Research Council.	Aiyer S, 2014, NUCLEIC ACIDS RES, V42, P5917, DOI 10.1093/nar/gku175; Anthis NJ, 2013, PROTEIN SCI, V22, P851, DOI 10.1002/pro.2253; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Brand M, 2015, ACS CHEM BIOL, V10, P22, DOI 10.1021/cb500996u; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cheung KL, 2017, MOL CELL, V65, P1068, DOI 10.1016/j.molcel.2016.12.022; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Crowe BL, 2016, P NATL ACAD SCI USA, V113, P2086, DOI 10.1073/pnas.1516813113; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Denis GV, 2006, J PROTEOME RES, V5, P502, DOI 10.1021/pr050430u; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Erb MA, 2017, NATURE, V543, P270, DOI 10.1038/nature21688; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fox AH, 1999, EMBO J, V18, P2812, DOI 10.1093/emboj/18.10.2812; French CA, 2012, ANNU REV PATHOL-MECH, V7, P247, DOI 10.1146/annurev-pathol-011811-132438; French CA, 2010, J CLIN PATHOL, V63, P492, DOI 10.1136/jcp.2007.052902; Gamsjaeger R, 2011, MOL CELL BIOL, V31, P2632, DOI 10.1128/MCB.05413-11; Gerhold CB, 2014, TRENDS CELL BIOL, V24, P619, DOI 10.1016/j.tcb.2014.06.004; Goddard T. D., 2006, SPARKY 3; Gregory GD, 2010, BLOOD, V115, P2156, DOI 10.1182/blood-2009-10-251280; Guntert P, 2015, J BIOMOL NMR, V62, P453, DOI 10.1007/s10858-015-9924-9; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Gyuris A, 2009, BBA-GENE REGUL MECH, V1789, P413, DOI 10.1016/j.bbagrm.2009.03.005; Hellert J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003640; Hodges C, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026930; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Houzelstein D, 2002, MOL CELL BIOL, V22, P3794, DOI 10.1128/MCB.22.11.3794-3802.2002; Hsu SC, 2017, MOL CELL, V66, P102, DOI 10.1016/j.molcel.2017.02.027; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Kowalski K, 2002, J BIOL CHEM, V277, P35720, DOI 10.1074/jbc.M204663200; Kuntimaddi A, 2015, CELL REP, V11, P808, DOI 10.1016/j.celrep.2015.04.004; Lamonica JM, 2011, P NATL ACAD SCI USA, V108, pE159, DOI 10.1073/pnas.1102140108; Leach BI, 2013, STRUCTURE, V21, P176, DOI 10.1016/j.str.2012.11.011; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lejon S, 2011, J BIOL CHEM, V286, P1196, DOI 10.1074/jbc.M110.195842; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Li YY, 2016, MOL CELL, V62, P181, DOI 10.1016/j.molcel.2016.03.028; Li YY, 2014, CELL, V159, P558, DOI 10.1016/j.cell.2014.09.049; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Lin YJ, 2008, PROTEIN SCI, V17, P2174, DOI 10.1110/ps.037580.108; Liu ZQ, 2017, J MED CHEM, V60, P4533, DOI 10.1021/acs.jmedchem.6b01761; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Matangkasombut O, 2000, GENE DEV, V14, P951; McBride AA, 2013, VIRUSES-BASEL, V5, P1374, DOI 10.3390/v5061374; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Meyer C, 2013, LEUKEMIA, V27, P2165, DOI 10.1038/leu.2013.135; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Narlikar GJ, 2013, CELL, V154, P490, DOI 10.1016/j.cell.2013.07.011; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Nitarska J, 2016, CELL REP, V17, P1683, DOI 10.1016/j.celrep.2016.10.022; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ottinger M, 2006, J VIROL, V80, P10772, DOI 10.1128/JVI.00804-06; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Roberts TC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06483-7; Shang EY, 2009, DEV DYNAM, V238, P908, DOI 10.1002/dvdy.21911; Shen C, 2015, MOL CELL, V60, P847, DOI 10.1016/j.molcel.2015.10.033; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028; Silva APG, 2016, J BIOL CHEM, V291, P924, DOI 10.1074/jbc.M115.683227; Stonestrom AJ, 2015, BLOOD, V125, P2825, DOI 10.1182/blood-2014-10-607309; Tang LL, 2010, PROG BIOPHYS MOL BIO, V102, P122, DOI 10.1016/j.pbiomolbio.2010.05.001; Torchy MP, 2015, CELL MOL LIFE SCI, V72, P2491, DOI 10.1007/s00018-015-1880-8; Tsume M, 2012, BIOCHEM BIOPH RES CO, V425, P762, DOI 10.1016/j.bbrc.2012.07.149; Viejo-Borbolla A, 2005, J VIROL, V79, P13618, DOI 10.1128/JVI.79.21.13618-13629.2005; Wang FN, 2010, BIOCHEM J, V425, P71, DOI 10.1042/BJ20090928; Wu SY, 2006, GENE DEV, V20, P2383, DOI 10.1101/gad.1448206; Wu SY, 2013, MOL CELL, V49, P843, DOI 10.1016/j.molcel.2012.12.006; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7; Zhang Q, 2016, STRUCTURE, V24, P1201, DOI 10.1016/j.str.2016.04.019; Zhang W, 2016, J MOL BIOL, V428, P2931, DOI 10.1016/j.jmb.2016.04.025; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	82	22	22	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7160	7175		10.1074/jbc.RA117.000678	http://dx.doi.org/10.1074/jbc.RA117.000678			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29567837	Green Published, hybrid			2022-12-26	WOS:000432174500009
J	Srivastav, A; Santibanez, TA; Lu, PJ; Stringer, MC; Dever, JA; Bostwick, M; Kurtz, MS; Qualls, NL; Williams, WW				Srivastav, Anup; Santibanez, Tammy A.; Lu, Peng-Jun; Stringer, M. Christopher; Dever, Jill A.; Bostwick, Michael; Kurtz, Marshica Stanley; Qualls, Noreen L.; Williams, Walter W.			Preventive behaviors adults report using to avoid catching or spreading influenza, United States, 2015-16 influenza season	PLOS ONE			English	Article							SELF-REPORT; VACCINATION COVERAGE; ELDERLY OUTPATIENTS; PUBLIC-HEALTH; HAND HYGIENE; INTERVENTIONS; TRANSMISSION; POPULATIONS; VALIDATION; INFECTION	Introduction Influenza vaccination can prevent influenza and potentially serious influenza-related complications. Although the single best way to prevent influenza is annual vaccination, everyday preventive actions, including good hygiene, health, dietary, and social habits, might help, too. Several preventive measures are recommended, including: avoiding close contact with people who are sick; staying home when sick; covering your mouth and nose when coughing or sneezing; washing your hands often; avoiding touching your eyes, nose, and mouth; and practicing other good health habits like cleaning and disinfecting frequently touched surfaces, getting plenty of sleep, and drinking plenty of fluids. Understanding public acceptance and current usage of these preventive behaviors can be useful for planning both seasonal and pandemic influenza prevention campaigns. This study estimated the percentage of adults in the United States who reported practicing preventive behaviors to avoid catching or spreading influenza, and explored associations of reported behaviors with sociodemo-graphic factors. Methods We analyzed data from 2015 National Internet Flu Survey, a nationally representative probability-based Internet panel survey of the non-institutionalized U.S. population >= 18 years. The self-reported behaviors used to avoid catching or spreading influenza were grouped into four and three non-mutually exclusive subgroups, respectively. Weighted proportions were calculated. Multivariable logistic regression models were used to calculate adjusted prevalence differences and to determine independent associations between sociodemo-graphic characteristics and preventive behavior subgroups. Results Common preventive behaviors reported were: 83.2% wash hands often, 80.0% cover coughs and sneezes, 78.2% stay home if sick with a respiratory illness, 64.4% avoid people sick with a respiratory illness, 51.7% use hand sanitizers, 50.2% get treatment as soon as possible, and 49.8% report getting the influenza vaccination. Race/ethnicity, gender, age, education, income, region, receipt of influenza vaccination, and household size were associated with use of preventive behaviors after controlling for other factors. Conclusion Many adults in the United States reported using preventive behaviors to avoid catching or spreading influenza. Though vaccination is the most important tool available to prevent influenza, the addition of preventive behaviors might play an effective role in reducing or slowing transmission of influenza and complement prevention efforts.	[Srivastav, Anup] Leidos Inc, Atlanta, GA 30345 USA; [Srivastav, Anup; Santibanez, Tammy A.; Lu, Peng-Jun; Williams, Walter W.] Ctr Dis Control & Prevent, Immunizat Serv Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Stringer, M. Christopher] US Census Bur, Demog Stat Methods Div, Durham, NC USA; [Dever, Jill A.] RTI Int, Div Stat & Data Sci, Washington, DC USA; [Bostwick, Michael; Kurtz, Marshica Stanley] RTI Int, Stat & Operat Res, Res Triangle Pk, NC USA; [Qualls, Noreen L.] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Research Triangle Institute; Research Triangle Institute; Centers for Disease Control & Prevention - USA	Srivastav, A (corresponding author), Leidos Inc, Atlanta, GA 30345 USA.; Srivastav, A (corresponding author), Ctr Dis Control & Prevent, Immunizat Serv Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	xbs2@cdc.gov		Stanley, Marshica/0000-0002-3228-6440; Srivastav, Anup/0000-0001-9970-0872; Santibanez, Tammy A./0000-0002-5784-7427	Leidos Inc.	Leidos Inc.	Leidos Inc. is a U.S. government contractor agency, not a funder of the project. Leidos Inc. contributed no funds to the product only providing support in the form of salary for the lead author [AS]. Leidos Inc. did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	[Anonymous], 2016, ESTIMATED INFLUENZA; [Anonymous], 2015, NAT EARL SEAS FLU VA; Centers for Disease Control and Prevention, 2017, FLU VACC COV US 2016; Centers for Disease Control and Prevention, 2014, HLTH PEOPL 2020 TOP; Centers for Disease Control and Prevention (CDC), CDC NAT INFL VACC AW; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Di Giuseppe G, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-36; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Foppa IM, 2015, VACCINE, V33, P3003, DOI 10.1016/j.vaccine.2015.02.042; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Grayson ML, 2009, CLIN INFECT DIS, V48, P285, DOI 10.1086/595845; Grohskopf LA, 2017, MMWR RECOMM REP, V66, P3, DOI 10.15585/mmwr.rr6602a1; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; Jefferson T, 2008, BMJ-BRIT MED J, V336, P77, DOI 10.1136/bmj.b3675; Larson EL, 2012, AM J INFECT CONTROL, V40, P806, DOI 10.1016/j.ajic.2011.10.016; Lu PJ, 2013, AM J EPIDEMIOL, V178, P1478, DOI 10.1093/aje/kwt158; Mac Donald R, 1999, AM J PREV MED, V16, P173, DOI 10.1016/S0749-3797(98)00159-7; Mangtani P, 2007, EPIDEMIOL INFECT, V135, P139, DOI 10.1017/S0950268806006479; Phillipson L, 2013, CASES PUBLIC HLTH CO, V7, P99; Rolnick SJ, 2013, VACCINE, V31, P3928, DOI 10.1016/j.vaccine.2013.06.041; Stebbins S, 2009, J PUBLIC HEALTH MAN, V15, P112, DOI 10.1097/01.PHH.0000346007.66898.67; SteelFisher GK, 2015, INFLUENZA OTHER RESP, V9, P131, DOI 10.1111/irv.12306; Talaat M, 2011, EMERG INFECT DIS, V17, P619, DOI 10.3201/eid1704.101353; The American Association for Public Opinion Research, 2016, STAND DEF FIN DISP C; Toner E, 2006, BIOSECUR BIOTERROR, V4, P84, DOI 10.1089/bsp.2006.4.84; Warren-Gash C, 2013, INFLUENZA OTHER RESP, V7, P738, DOI 10.1111/irv.12015; Williams WW, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6501a1; Wu SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148448; Zimmerman RK, 2003, VACCINE, V21, P1486, DOI 10.1016/S0264-410X(02)00700-4	29	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2018	13	3							e0195085	10.1371/journal.pone.0195085	http://dx.doi.org/10.1371/journal.pone.0195085			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB1XW	29601610	gold, Green Published, Green Submitted			2022-12-26	WOS:000428845900018
J	Gentile, A; Lucion, MF; Juarez, MD; Martinez, AC; Romanin, V; Bakir, J; Viegas, M; Mistchenko, A				Gentile, Angela; Florencia Lucion, Maria; del Valle Juarez, Maria; Clara Martinez, Ana; Romanin, Viviana; Bakir, Julia; Viegas, Mariana; Mistchenko, Alicia			Influenza virus: 16 years' experience of clinical epidemiologic patterns and associated infection factors in hospitalized children in Argentina	PLOS ONE			English	Article							SEASONALITY; OUTPATIENT; BRAZIL	Background Influenza is an important cause of acute lower respiratory tract infection (aLRTI), hospitalization, and mortality in children. This study aimed to describe the clinical and epidemiologic patterns and infection factors associated with influenza, and compare case features of influenza A and B. Methods In a prospective, cross-sectional study, patients admitted for aLRTI, between 2000 and 2015, were tested for respiratory syncytial virus, adenovirus, influenza, or parainfluenza, and confirmed by fluorescent antibody (FA) or real-time polymerase chain reaction (RT-PCR) assay of nasopharyngeal aspirates. Results Of 14,044 patients, 37.7% (5290) had FA-or RT-PCR-confirmed samples that identified influenza in 2.8% (394/14,044; 91.4% [360] influenza A, 8.6% [34] influenza B) of cases. Influenza frequency followed a seasonal epidemic pattern (May-July, the lowest average temperature months). The median age of cases was 12 months (interquartile range: 6-21 months); 56.1% (221/394) of cases were male. Consolidated pneumonia was the most frequent clinical presentation (56.9%; 224/394). Roughly half (49.7%; 196/394) of all cases had previous respiratory admissions; 9.4% (37/394) were re-admissions; 61.5% (241/392) had comorbidities; 26.2% (102/389) had complications; 7.8% (30/384) had nosocomial infections. The average case fatality rate was 2.1% (8/389). Chronic neurologic disease was significantly higher in influenza B cases compared to influenza A cases (p = 0.030). The independent predictors for influenza were: age >= 6 months, odds ratio (OR): 1.88 (95% confidence interval [CI]: 1.44-2.45); p< 0.001; presence of chronic neurologic disease, OR: 1.48 (95% CI: 1.01-2.17); p = 0.041; previous respiratory admissions, OR: 1.71 (95% CI: 1.36-2.14); p<0.001; re-admissions, OR: 1.71 (95% CI: 1.17-2.51); p = 0.006; clinical pneumonia, OR: 1.50 (95% CI: 1.21-1.87); p<0.001; immunodeficiency, OR: 1.87 (95% CI: 1.15-3.05); p = 0.011; cystic fibrosis, OR: 4.42 (95% CI: 1.29-15.14); p = 0.018. Conclusion Influenza showed an epidemic seasonal pattern (May-July), with higher risk in children >= 6 months, or with pneumonia, previous respiratory admissions, or certain comorbidities.	[Gentile, Angela; Florencia Lucion, Maria; del Valle Juarez, Maria; Clara Martinez, Ana; Romanin, Viviana; Bakir, Julia] Ricardo Gutierrez Childrens Hosp, Dept Epidemiol, Buenos Aires, DF, Argentina; [Viegas, Mariana; Mistchenko, Alicia] Ricardo Gutierrez Childrens Hosp, Dept Virol, Buenos Aires, DF, Argentina	Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires	Gentile, A (corresponding author), Ricardo Gutierrez Childrens Hosp, Dept Epidemiol, Buenos Aires, DF, Argentina.	angelagentile21@gmail.com		Gentile, Angela/0000-0002-1072-7700				Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Comite Nacional de Neumonologoia Comite Nacional de Infectologoia Comite de Medicina Interna, REC MAN INF RESP AG; Daley AJ, 2000, J PAEDIATR CHILD H, V36, P332, DOI 10.1046/j.1440-1754.2000.00533.x; Dapat C, 2009, INTERVIROLOGY, V52, P310, DOI 10.1159/000237738; De Kirchner CEF, ABORDAJE INTERGAL IN; Arango AE, 2015, INFLUENZA OTHER RESP, V9, P1, DOI 10.1111/irv.12271; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137; Huai Y, 2017, INFLUENZA OTHER RESP, V11, P148, DOI 10.1111/irv.12419; Lucion MF, 2014, ARCH ARGENT PEDIATR, V112, P397, DOI [10.5546/aap.2014.397, 10.5546/aap.2014.eng.397]; Marcone DN, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1213-4; McMorrow ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138272; Mosnier A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136186; Moura FEA, 2009, AM J TROP MED HYG, V81, P180, DOI 10.4269/ajtmh.2009.81.180; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Reed C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118369; Savy V, 2013, INFLUENZA OTHER RESP, V7, P1017, DOI 10.1111/irv.12036; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383	18	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195135	10.1371/journal.pone.0195135	http://dx.doi.org/10.1371/journal.pone.0195135			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596527	Green Published, gold, Green Submitted			2022-12-26	WOS:000428630000082
J	Merlet, AN; Cattagni, T; Cornu, C; Jubeau, M				Merlet, Angele N.; Cattagni, Thomas; Cornu, Christophe; Jubeau, Marc			Effect of knee angle on neuromuscular assessment of plantar flexor muscles: A reliability study	PLOS ONE			English	Article							H-REFLEX; TRICEPS SURAE; HOFFMANN REFLEX; JOINT ANGLE; ELECTRICAL-STIMULATION; SPINAL EXCITABILITY; SUPRASPINAL FACTORS; SPORTS-MEDICINE; M-MAX; SOLEUS	Introduction This study aimed to determine the intra- and inter-session reliability of neuromuscular assessment of plantar flexor (PF) muscles at three knee angles. Methods Twelve young adults were tested for three knee angles (90 degrees, 30 degrees and 0 degrees) and at three time points separated by 1 hour (intra-session) and 7 days (inter-session). Electrical (H reflex, M wave) and mechanical (evoked and maximal voluntary torque, activation level) parameters were measured on the PF muscles. Intraclass correlation coefficients (ICC) and coefficients of variation were calculated to determine intra- and inter-session reliability. Results The mechanical measurements presented excellent (ICC> 0.75) intra-and inter-session reliabilities regardless of the knee angle considered. The reliability of electrical measurements was better for the 90 degrees knee angle compared to the 0 degrees and 30 degrees angles. Conclusions Changes in the knee angle may influence the reliability of neuromuscular assessments, which indicates the importance of considering the knee angle to collect consistent outcomes on the PF muscles.	[Merlet, Angele N.; Cattagni, Thomas; Cornu, Christophe; Jubeau, Marc] Univ Nantes, Fac Sport Sci, Lab Movement Interact Performance, Nantes, France; [Cattagni, Thomas] Raymond Poincare Teaching Hosp, AP HP, Team Technol & Innovat Therapies Appl Neuromuscul, UVSQ,CIC 805,Physiol Funct Testing Ward,Inserm Un, Garches, France	Nantes Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Cattagni, T (corresponding author), Univ Nantes, Fac Sport Sci, Lab Movement Interact Performance, Nantes, France.; Cattagni, T (corresponding author), Raymond Poincare Teaching Hosp, AP HP, Team Technol & Innovat Therapies Appl Neuromuscul, UVSQ,CIC 805,Physiol Funct Testing Ward,Inserm Un, Garches, France.	thomas.cattagni@uvsq.fr		Merlet, Angele/0000-0002-7597-119X				Ali A, 2001, Electromyogr Clin Neurophysiol, V41, P209; ALLEN GM, 1995, MUSCLE NERVE, V18, P593, DOI 10.1002/mus.880180605; Alrowayeh Hesham N, 2011, BMC Res Notes, V4, P102, DOI 10.1186/1756-0500-4-102; Alrowayeh HN, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-65; Arampatzis A, 2006, J BIOMECH, V39, P1891, DOI 10.1016/j.jbiomech.2005.05.010; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Baudry S, 2014, ACTA PHYSIOL, V210, P667, DOI 10.1111/apha.12233; Baudry S, 2015, EXP GERONTOL, V69, P62, DOI 10.1016/j.exger.2015.06.006; Baudry S, 2012, J PHYSIOL-LONDON, V590, P5541, DOI 10.1113/jphysiol.2012.228932; Bernecke V, 2015, J STRENGTH COND RES, V29, P1972, DOI 10.1519/JSC.0000000000000841; Billot M, 2011, SCAND J MED SCI SPOR, V21, pE273, DOI 10.1111/j.1600-0838.2010.01278.x; Cattagni T, 2014, J NEUROPHYSIOL, V111, P2525, DOI 10.1152/jn.00455.2013; Cattagni T, 2017, CLIN PHYSIOL FUNCT I, V15, P2256; Chen YS, 2010, J ELECTROMYOGR KINES, V20, P980, DOI 10.1016/j.jelekin.2009.11.003; Christie A, 2004, CLIN NEUROPHYSIOL, V115, P116, DOI 10.1016/S1388-2457(03)00306-7; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Clark BC, 2007, J ELECTROMYOGR KINES, V17, P90, DOI 10.1016/j.jelekin.2005.11.008; CRESSWELL AG, 1995, EXP BRAIN RES, V105, P283; Crone C, 1999, EXP BRAIN RES, V124, P265, DOI 10.1007/s002210050621; Dalton BH, 2014, EXP GERONTOL, V52, P70, DOI 10.1016/j.exger.2014.01.011; Fleiss J. L., 2003, WILEY STAT METHODS R, V3rd; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gandevia SC, 1996, J PHYSIOL-LONDON, V490, P529, DOI 10.1113/jphysiol.1996.sp021164; Gondin J, 2006, J NEUROPHYSIOL, V95, P3328, DOI 10.1152/jn.01002.2005; Grospretre S, 2012, J NEUROPHYSIOL, V107, P1649, DOI 10.1152/jn.00611.2011; Guissard N, 2006, EXERC SPORT SCI REV, V34, P154, DOI 10.1249/01.jes.0000240023.30373.eb; Halaki M., 2012, INTECH; Herbert RD, 2002, J PHYSIOL-LONDON, V539, P637, DOI 10.1113/jphysiol.2001.012756; Hopkins J T, 2000, Electromyogr Clin Neurophysiol, V40, P89; Hopkins J Ty, 2003, Electromyogr Clin Neurophysiol, V43, P85; Hultborn H, 1996, EXP BRAIN RES, V108, P450; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; Hwang IS, 2002, J ELECTROMYOGR KINES, V12, P361, DOI 10.1016/S1050-6411(02)00034-2; Kennedy PM, 2001, EXP BRAIN RES, V137, P58, DOI 10.1007/s002210000623; KentBraun JA, 1996, MUSCLE NERVE, V19, P861, DOI 10.1002/(SICI)1097-4598(199607)19:7<861::AID-MUS8>3.0.CO;2-7; Maffiuletti NA, 2000, NEUROSCI LETT, V288, P127, DOI 10.1016/S0304-3940(00)01212-X; Maganaris CN, 1998, EXP PHYSIOL, V83, P843, DOI 10.1113/expphysiol.1998.sp004164; McNulty PA, 2012, EXP BRAIN RES, V218, P601, DOI 10.1007/s00221-012-3053-4; MERTON PA, 1954, J PHYSIOL-LONDON, V123, P553, DOI 10.1113/jphysiol.1954.sp005070; Millet GY, 2011, EUR J APPL PHYSIOL, V111, P2489, DOI 10.1007/s00421-011-1996-y; Mynark RG, 2005, CLIN NEUROPHYSIOL, V116, P1400, DOI 10.1016/j.clinph.2005.02.001; NOZAKI D, 1995, EXP BRAIN RES, V105, P402; Palmieri RM, 2004, J ATHL TRAINING, V39, P268; Palmieri TM, 2002, INT J NEUROSCI, V112, P841, DOI 10.1080/00207450290025851; Patikas D A, 2004, Electromyogr Clin Neurophysiol, V44, P503; Place N, 2009, J ELECTROMYOGR KINES, V19, pE395, DOI 10.1016/j.jelekin.2009.01.001; ROBINSON KL, 1982, J NEUROL NEUROSUR PS, V45, P699, DOI 10.1136/jnnp.45.8.699; Rozand V, 2015, INT J SPORTS MED, V36, P35, DOI 10.1055/s-0034-1375614; SCHIEPPATI M, 1987, PROG NEUROBIOL, V28, P345, DOI 10.1016/0301-0082(87)90007-4; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Simoneau E, 2007, J ELECTROMYOGR KINES, V17, P307, DOI 10.1016/j.jelekin.2006.04.005; Stapley PJ, 2015, J VIS EXP MYJOVE COR, P9; Strojnik V, 1998, J APPL PHYSIOL, V84, P344, DOI 10.1152/jappl.1998.84.1.344; Stutzig N, 2016, MUSCLE NERVE, V53, P464, DOI 10.1002/mus.24767; Temesi J, 2017, J NEUROL SCI, V375, P442, DOI 10.1016/j.jns.2017.02.037; Todd G, 2004, J APPL PHYSIOL, P97; Tucker KJ, 2005, HUM MOVEMENT SCI, V24, P667, DOI 10.1016/j.humov.2005.09.010; Tucker KJ, 2004, SOMATOSENS MOT RES, V21, P189, DOI 10.1080/08990220400012489; Ushiyama J, 2010, J ELECTROMYOGR KINES, V20, P513, DOI 10.1016/j.jelekin.2009.09.004; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; WILLIAMS L R T, 1992, Electromyography and Clinical Neurophysiology, V32, P43; Zehr EP, 2002, EUR J APPL PHYSIOL, V86, P455, DOI 10.1007/s00421-002-0577-5	62	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195220	10.1371/journal.pone.0195220	http://dx.doi.org/10.1371/journal.pone.0195220			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596480	Green Published, Green Submitted, gold			2022-12-26	WOS:000428630000093
J	Reljin, N; Zimmer, G; Malyuta, Y; Shelley, K; Mendelson, Y; Blehar, DJ; Darling, CE; Chon, KH				Reljin, Natasa; Zimmer, Gary; Malyuta, Yelena; Shelley, Kirk; Mendelson, Yitzhak; Blehar, David J.; Darling, Chad E.; Chon, Ki H.			Using support vector machines on photoplethysmographic signals to discriminate between hypovolemia and euvolemia	PLOS ONE			English	Article							TIME-FREQUENCY ANALYSIS; HEMORRHAGIC-SHOCK; TRAUMA PATIENTS; BLOOD-LOSS; WAVE-FORM; MOTION; PROGRESSION; MORTALITY; RESPONSES; DETECT	Identifying trauma patients at risk of imminent hemorrhagic shock is a challenging task in intraoperative and battlefield settings given the variability of traditional vital signs, such as heart rate and blood pressure, and their inability to detect blood loss at an early stage. To this end, we acquired N = 58 photoplethysmographic (PPG) recordings from both trauma patients with suspected hemorrhage admitted to the hospital, and healthy volunteers subjected to blood withdrawal of 0.9 L. We propose four features to characterize each recording: goodness of fit (r(2)), the slope of the trend line, percentage change, and the absolute change between amplitude estimates in the heart rate frequency range at the first and last time points. Also, we propose a machine learning algorithm to distinguish between blood loss and no blood loss. The optimal overall accuracy of discriminating between hypovolemia and euvolemia was 88.38%, while sensitivity and specificity were 88.86% and 87.90%, respectively. In addition, the proposed features and algorithm performed well even when moderate blood volume was withdrawn. The results suggest that the proposed features and algorithm are suitable for the automatic discrimination between hypovolemia and euvolemia, and can be beneficial and applicable in both intraoperative/emergency and combat casualty care.	[Reljin, Natasa; Chon, Ki H.] Univ Connecticut, Dept Biomed Engn, Storrs, CT 06269 USA; [Zimmer, Gary] Campbell Univ, Sch Med, Buies Creek, NC 27506 USA; [Malyuta, Yelena; Blehar, David J.; Darling, Chad E.] Univ Massachusetts, Med Sch, Dept Emergency Med, Worcester, MA USA; [Shelley, Kirk] Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA; [Mendelson, Yitzhak] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA	University of Connecticut; Campbell University; University of Massachusetts System; University of Massachusetts Worcester; Yale University; Worcester Polytechnic Institute	Reljin, N (corresponding author), Univ Connecticut, Dept Biomed Engn, Storrs, CT 06269 USA.	natasa.reljin@gmail.com	Chon, Ki/W-5498-2019	Reljin, Natasa/0000-0001-8799-9379				Bishop Christopher M., 2006, PATTERN RECOGNITION; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chon KH, 2009, IEEE T BIO-MED ENG, V56, P2054, DOI 10.1109/TBME.2009.2019766; Chong JW, 2014, ANN BIOMED ENG, V42, P2238, DOI 10.1007/s10439-014-1080-y; Convertino VA, 2015, SHOCK, V44, P27, DOI 10.1097/SHK.0000000000000323; Convertino VA, 2013, J APPL PHYSIOL, V115, P1196, DOI 10.1152/japplphysiol.00668.2013; Cooke WH, 2004, J APPL PHYSIOL, V96, P1249, DOI 10.1152/japplphysiol.01155.2003; Cooke WH, 2006, AVIAT SPACE ENVIR MD, V77, P1107; Dao D, 2017, IEEE J BIOMED HEALTH, V21, P1242, DOI 10.1109/JBHI.2016.2612059; Evans RG, 2001, CLIN EXP PHARMACOL P, V28, P479, DOI 10.1046/j.1440-1681.2001.03473.x; Gesquiere Michael J, 2007, J Clin Monit Comput, V21, P277, DOI 10.1007/s10877-007-9085-9; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kecman V., 2001, LEARNING SOFT COMPUT; Kneale J., 2003, J ORTH NUR, V7, P207; Liu JB, 2015, SHOCK, V43, P429, DOI 10.1097/SHK.0000000000000328; Mackenzie CF, 2014, J TRAUMA ACUTE CARE, V76, P1379, DOI 10.1097/TA.0000000000000235; McGrath SP, 2011, ANESTH ANALG, V112, P368, DOI 10.1213/ANE.0b013e3181cb3f4a; Mendelson Y, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON BODY SENSOR NETWORKS (BSN); Nicia SB, 2016, ANAESTHESIA, V71, P163, DOI 10.1111/anae.13283; Reljin N, 2016, 2016 3RD IEEE EMBS INTERNATIONAL CONFERENCE ON BIOMEDICAL AND HEALTH INFORMATICS, P118, DOI 10.1109/BHI.2016.7455849; Salehizadeh SMA, 2014, ANN BIOMED ENG, V42, P2251, DOI 10.1007/s10439-014-1030-8; Salehizadeh SMA, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16010010; SCHADT JC, 1991, AM J PHYSIOL, V260, pH305; Scully CG, 2012, ANESTH ANALG, V115, P74, DOI 10.1213/ANE.0b013e318256486c; Selvaraj N, 2011, IEEE T BIO-MED ENG, V58, DOI 10.1109/TBME.2011.2144981; Stewart CL, 2014, J TRAUMA ACUTE CARE, V77, P892, DOI 10.1097/TA.0000000000000423; Wang HL, 2006, ANN BIOMED ENG, V34, P326, DOI 10.1007/s10439-005-9035-y; Warren KM, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16030342; Wilson M, 2003, J EMERG MED, V24, P413, DOI 10.1016/S0736-4679(03)00042-8	30	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195087	10.1371/journal.pone.0195087	http://dx.doi.org/10.1371/journal.pone.0195087			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596477	Green Published, gold, Green Submitted			2022-12-26	WOS:000428630000077
J	Toda, M; Nakatani, E; Omae, K; Fukushima, M; Chin, T				Toda, Mitsunori; Nakatani, Eiji; Omae, Kaoru; Fukushima, Masanori; Chin, Takaaki			Age-specific characterization of spinal cord injuries over a 19-year period at a Japanese rehabilitation center	PLOS ONE			English	Article							EPIDEMIOLOGY; AUSTRALIA	Regional demographics of spinal cord injuries (SCIs) are fundamental to identifying and implementing appropriate preventive measures. The current study was conducted as a longitudinal analysis of all patients with SCIs admitted to the Hyogo Rehabilitation Center over a 19-year period. The sex and age of the patient, time and nature of injury (i.e., cause, level, and extent), and period from injury to admission were evaluated retrospectively. Pertinent tests, including Poisson regression analysis, and the Cochran-Armitage, Kruskal-Wallis, and chi-square tests, were applied to assess demographic variables, with statistical significance set at p < 0.05. Between 1995 and 2013, a total of 632 patients with SCIs (predominantly male and largely < 60 years old) were admitted to our center for rehabilitation. Although the male: female ratio remained unchanged throughout the study period, the ratio of older adults increased over time. In assessing the cause of injury, the majority of the patients involved in road traffic accidents were aged <= 44 years, whereas patients aged >= 45 years accounted for the majority of low-distance falls and disease-related SCIs, the proportions of which gradually increased. Complete paralysis and paraplegia primarily occurred in patients aged <= 44 years, whereas the majority of incomplete injuries and tetraplegia were limited to those aged >= 45 years. The patient age at the time of SCI and the nature of the injury sustained were interrelated. Age-specific strategies thus offered the best means of preventing/reducing the incidence of SCIs in Hyogo prefecture.	[Toda, Mitsunori; Chin, Takaaki] Hyogo Rehabil Ctr, Dept Phys Med & Rehabil, Nishi Ku, Akebono Cho, Kobe, Hyogo, Japan; [Nakatani, Eiji; Omae, Kaoru; Fukushima, Masanori] Fdn Biomed Res & Innovat, Translat Res Informat Ctr, Chou Ku, Kobe, Hyogo, Japan; [Nakatani, Eiji] Osaka Univ, Grad Sch Med, Dept Biostat & Data Sci, Suita, Osaka, Japan; [Chin, Takaaki] Kobe Univ, Hyogo Rehabil Ctr, Grad Sch Med, Dept Rehabil Sci, Kobe, Hyogo, Japan	Institute for Biomedical Research & Innovation (IBRI); Osaka University; Kobe University	Chin, T (corresponding author), Hyogo Rehabil Ctr, Dept Phys Med & Rehabil, Nishi Ku, Akebono Cho, Kobe, Hyogo, Japan.; Chin, T (corresponding author), Kobe Univ, Hyogo Rehabil Ctr, Grad Sch Med, Dept Rehabil Sci, Kobe, Hyogo, Japan.	t-chin@pure.ne.jp	Nakatani, Eiji/O-2782-2013	Nakatani, Eiji/0000-0002-4876-446X				Ackery A, 2004, J NEUROTRAUM, V21, P1355, DOI 10.1089/neu.2004.21.1355; Ahoniemi E, 2008, SPINAL CORD, V46, P781, DOI 10.1038/sc.2008.53; BIERINGSORENSEN F, 1990, PARAPLEGIA, V28, P105, DOI 10.1038/sc.1990.13; DeVivo MJ, 2011, SPINAL CORD, V49, P596, DOI 10.1038/sc.2010.172; Hyogo Prefectural Government, STAT HYOG PREF; Ishii Noboru, 1996, Kobe Journal of Medical Sciences, V42, P173; Jabbour Pascal, 2008, Neurosurg Focus, V25, pE16, DOI 10.3171/FOC.2008.25.11.E16; Jackson AB, 2004, ARCH PHYS MED REHAB, V85, P1740, DOI 10.1016/j.apmr.2004.04.035; Jain NB, 2015, JAMA-J AM MED ASSOC, V314, P1643, DOI 10.1001/jama.2015.11200; Katoh S, 1996, SPINAL CORD, V34, P416, DOI 10.1038/sc.1996.74; KATOH S, 1995, PARAPLEGIA, V33, P330, DOI 10.1038/sc.1995.74; Katoh S, 2014, SPINAL CORD, P52; Krassioukov AV, 2003, J NEUROTRAUM, V20, P391, DOI 10.1089/089771503765172345; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; McKinley WO, 1999, ARCH PHYS MED REHAB, V80, P619, DOI 10.1016/S0003-9993(99)90162-4; Ministry of Internal Affairs and Communications, JAP STAT YB; Miyai I, 2011, NEUROREHAB NEURAL RE, V25, P540, DOI 10.1177/1545968311402696; New PW, 2008, SPINAL CORD, V46, P406, DOI 10.1038/sj.sc.3102152; New PW, 2014, SPINAL CORD, V52, P97, DOI 10.1038/sc.2012.165; New PW, 2014, SPINAL CORD, V52, P123, DOI 10.1038/sc.2012.160; New PW, 2011, SPINAL CORD, V49, P397, DOI 10.1038/sc.2010.77; O'Connor PJ, 2005, ARCH PHYS MED REHAB, V86, P48, DOI 10.1016/j.apmr.2004.07.346; Pickett GE, 2006, SPINE, V31, P799, DOI 10.1097/01.brs.0000207258.80129.03; SHINGU H, 1995, PARAPLEGIA, V33, P183, DOI 10.1038/sc.1995.42; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893	25	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2018	13	3							e0195120	10.1371/journal.pone.0195120	http://dx.doi.org/10.1371/journal.pone.0195120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8ZI	29596516	gold, Green Published, Green Submitted			2022-12-26	WOS:000428630000079
J	Chen, YL; Shu, JH; Hsu, HC; Liang, Y; Chou, RH; Hsu, PF; Wang, YJ; Ding, YZ; Liou, TL; Wang, YW; Huang, SS; Lin, CC; Lu, TM; Leu, HB; Lin, SJ; Chan, WL				Chen, Yuan-Lung; Shu, Jiah-Hwang; Hsu, Hsiu-Chuan; Liang, Ying; Chou, Ruey-Hsing; Hsu, Pai-Feng; Wang, Yuan-Jen; Ding, Yaw-Zon; Liou, Teh-Ling; Wang, Ying-Wen; Huang, Shao-Sung; Lin, Chung-Chi; Lu, Tse-Min; Leu, Hsin-Bang; Lin, Shing-Jong; Chan, Wan-Leong			High health literacy is associated with less obesity and lower Framingham risk score: Sub-study of the VGH-HEALTHCARE trial	PLOS ONE			English	Article							BLOOD-PRESSURE; METABOLIC SYNDROME; GLYCEMIC CONTROL; HEART-DISEASE; UNITED-STATES; OLDER-ADULTS; WEIGHT-LOSS; COMMUNITY; HYPERTENSION; POPULATION	Backgrounds Lower health literacy (HL) is associated with several cardiovascular disease (CVD) risk factors such as diabetes, hypertension, and metabolic syndrome (MS). The aim of our study was to investigate the association between HL and the Framingham 10-year risk score of CVD. Methods From 2015-2016, 1010 subjects aged 23 to 88 years receiving health check-up in Taipei Veterans General Hospital had complete clinical evaluations and laboratory examinations. Fatty liver was diagnosed by ultrasonography. The short form questionnaire adapted from the Mandarin Health Literacy Scale was used to assess HL. The Framingham risk score was calculated by patient characteristics. Results Subjects with higher BMIs were associated with lower HL scores. The proportion of subjects with MS was higher in the lower health literacy score group (<= 9) at 28.8%; further analysis found that lower HL was significantly associated with MS in women but not in men. The Spearman's rho demonstrated that the HL score was significantly associated with the BMI-based (rho=-0.11; P < 0.001) or lipid-based (rho =-0.09; P < 0.004) Framingham risk score. Conclusions Higher HL scores were associated with less CVD risk such as lower BMIs, less MS in women, and less fatty liver disease. Furthermore, HL had an inverse association with the Framingham risk score as expected. Therefore, HL in patients with CVD risk should be improved and considered as an important issue in terms of CVD reduction.	[Chen, Yuan-Lung; Chou, Ruey-Hsing; Hsu, Pai-Feng; Wang, Yuan-Jen; Ding, Yaw-Zon; Liou, Teh-Ling; Wang, Ying-Wen; Huang, Shao-Sung; Lin, Chung-Chi; Lu, Tse-Min; Leu, Hsin-Bang; Lin, Shing-Jong; Chan, Wan-Leong] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Yuan-Lung] Taipei Municipal Gan Dau Hosp, Taipei, Taiwan; [Shu, Jiah-Hwang; Hsu, Hsiu-Chuan; Liang, Ying] Taipei Vet Gen Hosp, Dept Nursing, Taipei, Taiwan; [Shu, Jiah-Hwang; Hsu, Hsiu-Chuan; Liang, Ying; Hsu, Pai-Feng; Wang, Yuan-Jen; Ding, Yaw-Zon; Liou, Teh-Ling; Wang, Ying-Wen; Huang, Shao-Sung; Lin, Chung-Chi; Lu, Tse-Min; Leu, Hsin-Bang; Lin, Shing-Jong; Chan, Wan-Leong] Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan; [Chou, Ruey-Hsing; Hsu, Pai-Feng; Huang, Shao-Sung; Lu, Tse-Min; Leu, Hsin-Bang; Lin, Shing-Jong; Chan, Wan-Leong] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei, Taiwan; [Lin, Chung-Chi] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Wang, YJ (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Liang, Y (corresponding author), Taipei Vet Gen Hosp, Dept Nursing, Taipei, Taiwan.; Liang, Y; Wang, YJ (corresponding author), Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan.	yliang@vghtpe.gov.tw; yjwang@vghtpe.gov.tw	Hsu, PF/AAH-1181-2020	Cheng, Yuan-Lung/0000-0002-8384-3315	Taipei Veterans General Hospital [V107-C-158]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	We received funding from Taipei Veterans General Hospital grant V107-C-158 to Hsin-Bang Leu. The funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar M, 2015, JAMA-J AM MED ASSOC, V313, P1973, DOI 10.1001/jama.2015.4260; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Brega AG, 2012, PATIENT EDUC COUNS, V88, P61, DOI 10.1016/j.pec.2012.03.008; Carels RA, 2017, EAT BEHAV, V26, P76, DOI 10.1016/j.eatbeh.2017.01.009; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Cheng YL, 2015, ANN HEPATOL, V14, P181, DOI 10.1016/S1665-2681(19)30780-X; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; DeWalt DA, 2007, AM J HEALTH BEHAV, V31, pS27; Geboers B, 2016, J HEALTH COMMUN, V21, P45, DOI 10.1080/10810730.2016.1201174; Gerber Ben S, 2006, J Appl Meas, V7, P55; Haun JN, 2014, J HEALTH COMMUN, V19, P302, DOI 10.1080/10810730.2014.936571; Huang MingChyi, 2012, Journal of Experimental and Clinical Medicine, V4, P108, DOI 10.1016/j.jecm.2012.01.004; Jan CF, 2006, INT J OBESITY, V30, P794, DOI 10.1038/sj.ijo.0803204; Kim KB, 2014, AM J HYPERTENS, V27, P1199, DOI 10.1093/ajh/hpu041; Kim SH, 2009, J CLIN NURS, V18, P2337, DOI 10.1111/j.1365-2702.2008.02739.x; Kuo KN, 2012, TAIWAN J PUB HLTH, V31, P184, DOI DOI 10.6288/TJPH2012-31-02-10; Lam LT, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-11; Lassetter JH, 2015, PUBLIC HEALTH NURS, V32, P15, DOI 10.1111/phn.12155; Lee SYD, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-614; Liang Lan, 2017, Health Lit Res Pract, V1, pe216, DOI 10.3928/24748307-20170929-01; Mancuso JM, 2010, NURS HEALTH SCI, V12, P94, DOI 10.1111/j.1442-2018.2009.00506.x; Marden S, 2012, DIABETIC MED, V29, P662, DOI 10.1111/j.1464-5491.2011.03466.x; Martin LT, 2011, J GEN INTERN MED, V26, P45, DOI 10.1007/s11606-010-1488-5; McCray AT, 2005, J AM MED INFORM ASSN, V12, P152, DOI 10.1197/jamia.M1687; McNaughton CD, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0028-1; McNaughton CD, 2014, PATIENT EDUC COUNS, V96, P165, DOI 10.1016/j.pec.2014.05.007; McNaughton CD, 2014, MED CARE, V52, P346, DOI 10.1097/MLR.0000000000000101; Mensah GA, 2017, CIRC RES, V120, P366, DOI 10.1161/CIRCRESAHA.116.309115; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Olesen K, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2017-000437; Osborn CY, 2009, DIABETES CARE, V32, P1614, DOI 10.2337/dc09-0425; Owen-Smith A. A., 2016, PERMANENTE J, V20, P15; Pandit AU, 2009, PATIENT EDUC COUNS, V75, P381, DOI 10.1016/j.pec.2009.04.006; Powell CK, 2007, DIABETES EDUCATOR, V33, P144, DOI 10.1177/0145721706297452; Powers BJ, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-219; Schillinger D, 2002, JAMA-J AM MED ASSOC, V288, P475, DOI 10.1001/jama.288.4.475; Shi D, 2017, INTERN EMERG MED; Shi D, 2017, INTERN EMERG MED, V12, P765, DOI 10.1007/s11739-017-1651-7; Shibuya A, 2011, BLOOD PRESS MONIT, V16, P224, DOI 10.1097/MBP.0b013e32834af7ba; Sookoian Silvia, 2008, Diabetes Care, V31, pe43, DOI 10.2337/dc08-0027; Sudore RL, 2006, J AM GERIATR SOC, V54, P770, DOI 10.1111/j.1532-5415.2006.00691.x; Tang YH, 2008, J ADV NURS, V62, P74, DOI 10.1111/j.1365-2648.2007.04526.x; Tiller D, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2210-7; Tsai TI, 2011, J HEALTH COMMUN, V16, P50, DOI 10.1080/10810730.2010.529488; Tsouros AD, 2013, SOLID FACTS HLTH LIT; Willens DE, 2013, J HEALTH COMMUN, V18, P129, DOI 10.1080/10810730.2013.825663; Yki-Jarvinen H, 2014, LANCET DIABETES ENDO, V2, P901, DOI 10.1016/S2213-8587(14)70032-4; Yokokawa H, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0142-8; Zoellner J, 2016, AM J HEALTH PROMOT, V30, P279, DOI 10.1177/0890117116639558	49	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0194813	10.1371/journal.pone.0194813	http://dx.doi.org/10.1371/journal.pone.0194813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GA8PV	29590183	gold, Green Published, Green Submitted			2022-12-26	WOS:000428603100075
J	Rahimi, N; Abdolghaffari, AH; Partoazar, A; Javadian, N; Dehpour, T; Mani, AR; Dehpour, AR				Rahimi, Nastaran; Abdolghaffari, Amir Hossein; Partoazar, Alireza; Javadian, Nina; Dehpour, Tara; Mani, Ali R.; Dehpour, Ahmad R.			Fresh red blood cells transfusion protects against aluminum phosphide-induced metabolic acidosis and mortality in rats	PLOS ONE			English	Article							SODIUM-BICARBONATE; INFARCT SIZE; ANEMIC RATS; ERYTHROCYTES; HEMOGLOBIN; VOLUME	Background Aluminum phosphide (AIP) is used as pesticide in some countries for protection of stored grains. Human poisoning with AIP due to suicide attempt or accidental environmental exposure is associated with very high mortality partially due to development of severe metabolic acidosis. Previous studies have shown that hemoglobin has high buffering capacity and erythrocytes can potentially be used for management of metabolic acidosis. The aim of this study was to evaluate the effect of fresh packed red blood cells (RBC) transfusion on survival and cardiovascular function in AIP-poisoned rats. Methodology/Principal findings Rats were poisoned with AIP by gavage. Fresh packed RBC was transfused via tail vein after AIP administration. Acid -base balance, vital signs and mortality was assessed and compared in experimental groups. Infusion of fresh packed RBC (1.5 ml) one hour after AIP (4-15 mg/kg) intoxication was associated with a significant decrease in mortality rate. Packed RBC infusion improved blood pH, HCO3-, Na+ and Ca2+ levels. Plasma troponin level was also reduced and ECG changes were reversed following packed RBC infusion in AIP intoxicated rats. Conclusions Our results showed that fresh RBC transfusion could ameliorate metabolic acidosis and enhance survival in AIP-poisoned rat. We assume that an increase in pool of RBCs may modulate acid -base balance or potentially chelate AIP-related toxic intermediates via phosphine-hemoglobin interaction.	[Rahimi, Nastaran; Abdolghaffari, Amir Hossein; Partoazar, Alireza; Javadian, Nina; Dehpour, Ahmad R.] Univ Tehran Med Sci, Expt Med Res Ctr, Tehran, Iran; [Rahimi, Nastaran; Javadian, Nina; Dehpour, Ahmad R.] Univ Tehran Med Sci, Sch Med, Dept Pharmacol, Tehran, Iran; [Abdolghaffari, Amir Hossein] ACECR, Inst Med Plants, Med Plants Res Ctr, Tehran, Iran; [Dehpour, Tara] Whittington Hosp NHS Trust, London, England; [Mani, Ali R.] UCL, UCL Div Med, London, England	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Academic Center for Education, Culture & Research (ACECR); University of London; University College London	Dehpour, AR (corresponding author), Univ Tehran Med Sci, Expt Med Res Ctr, Tehran, Iran.; Dehpour, AR (corresponding author), Univ Tehran Med Sci, Sch Med, Dept Pharmacol, Tehran, Iran.	dehpoura@sina.tums.ac.ir	Dehpour, Ahmad Reza/I-6422-2019; Abdolghaffari, Amir Hossein/AAQ-1161-2021; Mani, Alireza/H-3236-2015	Dehpour, Ahmad Reza/0000-0002-8001-5565; Mani, Alireza/0000-0003-0830-2022; Rahimi, Nastaran/0000-0002-4872-9082; Abdolghaffari, Amir Hossein/0000-0001-9961-9097; Dehpour, Tara/0000-0003-4797-3662	Experimental Medicine Research Center, Tehran University of Medical Sciences [94-04-158-30897]	Experimental Medicine Research Center, Tehran University of Medical Sciences	This study was funded and supported by Experimental Medicine Research Center, Tehran University of Medical Sciences (http://tums.ac.ir/?lang=en); grant no. 94-04-158-30897 to AD. "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Agrawal A, 2010, J CLIN DIAGN RES, V4, P2316; Agrawal VK, 2015, INDIAN J CRIT CARE M, V19, P109, DOI 10.4103/0972-5229.151019; Alter P, 2001, INTENS CARE MED, V27, P327, DOI 10.1007/s001340000744; Anand R, 2011, J APPL TOXICOL, V31, P499, DOI 10.1002/jat.1692; Baruah U, 2015, INDIAN J CRIT CARE M, V19, P735, DOI 10.4103/0972-5229.171412; BEECH JS, 1994, METABOLISM, V43, P518, DOI 10.1016/0026-0495(94)90087-6; Bumbrah GS, 2012, FORENSIC SCI INT, V214, P1, DOI 10.1016/j.forsciint.2011.06.018; Changal KH, 2017, BMJ CASE REP; CHIN KL, 1992, XENOBIOTICA, V22, P599, DOI 10.3109/00498259209053123; DITZEL J, 1975, DIABETOLOGIA, V11, P255, DOI 10.1007/BF00422388; Elzik ME, 2006, AM J HEMATOL, V81, P145, DOI 10.1002/ajh.20517; Gheshlaghi Farzad, 2015, Toxicol Int, V22, P40, DOI 10.4103/0971-6580.172255; Goodnough LT, 1999, NEW ENGL J MED, V340, P438, DOI 10.1056/NEJM199902113400606; Gurjar Mohan, 2011, J Emerg Trauma Shock, V4, P378, DOI 10.4103/0974-2700.83868; Hassanian-Moghaddam H, 2016, BASIC CLIN PHARMACOL, V118, P243, DOI 10.1111/bcpt.12481; Holcomb JB, 2015, PREHOSP EMERG CARE, V19, P1, DOI 10.3109/10903127.2014.923077; Hu HX, 2012, CRIT CARE MED, V40, P740, DOI 10.1097/CCM.0b013e3182376e84; Jaiswal S, 2009, INDIAN J CRIT CARE M, V13, P21, DOI 10.4103/0972-5229.53111; LaGamma EF, 1996, ARCH DIS CHILD-FETAL, V75, pF87, DOI 10.1136/fn.75.2.F87; Lasheen NN, 2016, PHYSIOL RES, V65, P927, DOI 10.33549/physiolres.933171; Lauterbach M, 2005, CLIN TOXICOL, V43, P575, DOI 10.1081/CLT-200068847; LEE HB, 1985, J NUCL MED, V26, P72; Louriz M, 2009, Indian J Med Sci, V63, P227, DOI 10.4103/0019-5359.53386; Marashi Sayed Mahdi, 2016, Acta Med Iran, V54, P475; Marashi SM, 2015, ARH HIG RADA TOKSIKO, V66, P83, DOI 10.1515/aiht-2015-66-2637; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; Mashayekhian M, 2016, BASIC CLIN PHARMACOL, V119, P322, DOI 10.1111/bcpt.12571; Mathai A, 2010, INDIAN J ANAESTH, V54, P302, DOI 10.4103/0019-5049.68372; Mohan B, 2016, J ASSOC PHYSICIAN I, V64, P66; Mostafalou S, 2013, IRAN RED CRESCENT ME, P15; Mostafazadeh B, 2012, TOXICITY AND DRUG TESTING, P345; Mostafazadeh B, 2011, J MED TOXICOL, V7, P40, DOI 10.1007/s13181-010-0121-7; ONeil MJ, 2001, MERCK INDEX ENCY CHE, P1317; Popp W, 2002, LANCET, V359, P1574, DOI 10.1016/S0140-6736(02)08518-5; POTTER WT, 1991, TOXICOL LETT, V57, P37, DOI 10.1016/0378-4274(91)90117-O; Singh S, 2006, CLIN TOXICOL, V44, P155, DOI 10.1080/15563650500514467; Swietach P, 2010, J PHYSIOL-LONDON, V588, P4995, DOI 10.1113/jphysiol.2010.197392; Van Slyke DD, 1923, J BIOL CHEM, V56, P765; Xenocostas A, 2010, CRIT CARE MED, V38, P2215, DOI 10.1097/CCM.0b013e3181f17d6e; Zamani N, 2013, EUR REV MED PHARMACO, V17, P994; Zambelli AB, 2009, J VET EMERG CRIT CAR, V19, P102, DOI 10.1111/j.1476-4431.2009.00386.x	41	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2018	13	3							e0193991	10.1371/journal.pone.0193991	http://dx.doi.org/10.1371/journal.pone.0193991			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA8PV	29590163	gold, Green Submitted, Green Published			2022-12-26	WOS:000428603100043
J	Lee, SE; Han, K; Kang, YM; Kim, SO; Cho, YK; Ko, KS; Park, JY; Lee, KU; Koh, EH				Lee, Seung Eun; Han, Kyungdo; Kang, Yu Mi; Kim, Seon-Ok; Cho, Yun Kyung; Ko, Kyung Soo; Park, Joong-Yeol; Lee, Ki-Up; Koh, Eun Hee		Taskforce Team Diabet Fact Sheet K	Trends in the prevalence of metabolic syndrome and its components in South Korea: Findings from the Korean National Health Insurance Service Database (2009-2013)	PLOS ONE			English	Article							INSULIN-RESISTANCE SYNDROME; CARDIOVASCULAR MORTALITY; OBESITY; NUTRITION; RISK; ASSOCIATION; ADULTS; HYPERINSULINEMIA; HYPERTENSION; INDEXES	Background The prevalence of metabolic syndrome has markedly increased worldwide. However, studies in the United States show that it has remained stable or slightly declined in recent years. Whether this applies to other countries is presently unclear. Objectives We examined the trends in the prevalence of metabolic syndrome and its components in Korea. Methods The prevalence of metabolic syndrome and its components was estimated in adults aged >30 years from the Korean National Health Insurance Service data from 2009 to 2013. The revised National Cholesterol Education Program criteria were used to define metabolic syndrome. Results Approximately 10 million individuals were analyzed annually. The age-adjusted prevalence of metabolic syndrome increased from 28.84% to 30.52%, and the increasing trend was more prominent in men. Prevalence of hypertriglyceridemia, low HDL-cholesterol, and impaired fasting plasma glucose significantly increased. However, the prevalence of hypertension decreased in both genders. The prevalence of abdominal obesity decreased in women over 50 years-of-age but significantly increased in young women and men (<50 years). Conclusions The prevalence of metabolic syndrome is still increasing in Korea. Trends in each component of metabolic syndrome are disparate according to the gender, or age groups. Notably, abdominal obesity among young adults increased significantly; thus, interventional strategies should be implemented particularly for this age group.	[Lee, Seung Eun; Kang, Yu Mi; Cho, Yun Kyung; Park, Joong-Yeol; Lee, Ki-Up; Koh, Eun Hee] Univ Ulsan, Dept Internal Med, Asan Med Ctr, Coll Med, Seoul, South Korea; [Han, Kyungdo] Catholic Univ Korea, Dept Biostat, Seoul, South Korea; [Kim, Seon-Ok] Univ Ulsan, Dept Clin Epidemiol & Biostat, Asan Med Ctr, Coll Med, Seoul, South Korea; [Ko, Kyung Soo] Inje Univ, Coll Med, Sanggye Paik Hosp, Dept Internal Med,Cardiovasc & Metab Dis Ctr, Seoul, South Korea; [Lee, Seung Eun] Dongguk Univ, Ilsan Hosp, Dept Internal Med, Coll Med, Goyang, South Korea	University of Ulsan; Asan Medical Center; Catholic University of Korea; University of Ulsan; Asan Medical Center; Inje University; Dongguk University; NHIS Ilsan Hospital	Koh, EH (corresponding author), Univ Ulsan, Dept Internal Med, Asan Med Ctr, Coll Med, Seoul, South Korea.	ehk@amc.seoul.kr	Kang, Yu Mi/AAW-2935-2020; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Kim, Seonok/0000-0001-9010-5460				Aguilar M, 2015, JAMA-J AM MED ASSOC, V313, P1973, DOI 10.1001/jama.2015.4260; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Beltran-Sanchez H, 2013, J AM COLL CARDIOL, V62, P697, DOI 10.1016/j.jacc.2013.05.064; Borch-Johnsen K, 2007, DAN MED BULL, V54, P157; Chen CH, 2000, AM J HYPERTENS, V13, P846, DOI 10.1016/S0895-7061(00)00255-7; Chen KH, 2011, AM J MED SCI, V341, P312, DOI 10.1097/MAJ.0b013e318203745b; Chien LY, 2004, INT J OBESITY, V28, P690, DOI 10.1038/sj.ijo.0802619; DeFronzo RA, 2011, AM J CARDIOL, V108, p3B, DOI 10.1016/j.amjcard.2011.03.013; FERRANNINI E, 1991, DIABETOLOGIA, V34, P416, DOI 10.1007/BF00403180; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; HAFFNER SM, 1992, DIABETES, V41, P715, DOI 10.2337/diabetes.41.6.715; Han TS, 2002, OBES RES, V10, P923, DOI 10.1038/oby.2002.126; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Kang YJ, 1997, KOREAN J NUTR, V30, P832; Khang YH, 2011, INT J PEDIATR OBES, V6, P206, DOI 10.3109/17477166.2010.490270; Khang YH, 2010, J KOREAN MED SCI, V25, P1582, DOI 10.3346/jkms.2010.25.11.1582; Ko KP, 2012, J EPIDEMIOL, V22, P433, DOI 10.2188/jea.JE20110164; Korean Ministry of Health and Welfare, 2014, NAT HLTH NUTR EX SUR; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lee SK, 2003, PUBLIC HEALTH NUTR, V6, P665, DOI 10.1079/PHN2003485; Lee YH, 2013, DIABETES RES CLIN PR, V101, P293, DOI 10.1016/j.diabres.2013.06.006; Lee YH, 2016, DIABETES METAB J, V40, P79, DOI 10.4093/dmj.2016.40.1.79; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Malhotra R, 2013, OBESITY, V21, P1923, DOI 10.1002/oby.20318; Manjunath C N, 2013, Indian J Endocrinol Metab, V17, P969, DOI 10.4103/2230-8210.122600; Meigs JB, 1997, DIABETES, V46, P1594, DOI 10.2337/diabetes.46.10.1594; Noh J, 2016, ENDOCRINOL METAB, V31, P349, DOI 10.3803/EnM.2016.31.3.349; Oh JY, 2017, J HYPERTENS, V35, P55, DOI [10.1097/HJH.0000000000001145, 10.1097/hjh.0000000000001145]; On JY, 2004, DIABETES CARE, V27, P2027, DOI 10.2337/diacare.27.8.2027; Pitsavos Christos, 2006, Review of Diabetic Studies, V3, P118, DOI 10.1900/RDS.2006.3.118; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Reaven GM, 2011, MED CLIN N AM, V95, P875, DOI 10.1016/j.mcna.2011.06.002; Rhee SY, 2013, KOREAN J INTERN MED, V28, P29, DOI 10.3904/kjim.2013.28.1.29; Shi ZM, 2016, ACTA DIABETOL, V53, P799, DOI 10.1007/s00592-016-0875-8; Statistics Korea, 2015, CONT STAT NAT NUTR; Suh I, 2001, ACTA CARDIOL, V56, P75, DOI 10.2143/AC.56.2.2005621; The world bank, 2015, GROSS NAT INC; Verhagen Arianne P, 2014, J Physiother, V60, P170, DOI 10.1016/j.jphys.2014.06.021; Yun S, 2017, NUTR RES PRACT, V11, P147, DOI 10.4162/nrp.2017.11.2.147	40	61	63	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194490	10.1371/journal.pone.0194490	http://dx.doi.org/10.1371/journal.pone.0194490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	29566051	gold, Green Published, Green Submitted			2022-12-26	WOS:000428093900069
